<SEC-DOCUMENT>0000950170-25-046035.txt : 20250327
<SEC-HEADER>0000950170-25-046035.hdr.sgml : 20250327
<ACCEPTANCE-DATETIME>20250327160028
ACCESSION NUMBER:		0000950170-25-046035
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250327
DATE AS OF CHANGE:		20250327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CalciMedica, Inc.
		CENTRAL INDEX KEY:			0001534133
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452120079
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39538
		FILM NUMBER:		25779161

	BUSINESS ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-952-5500

	MAIL ADDRESS:	
		STREET 1:		505 COAST BOULEVARD SOUTH
		STREET 2:		SUITE 307
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CalciMedica, Inc. /DE/
		DATE OF NAME CHANGE:	20230322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG VISION, INC.
		DATE OF NAME CHANGE:	20170717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAYBUG, Inc.
		DATE OF NAME CHANGE:	20150303
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ck0001534133-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-26T21:27:52.8263+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ck0001534133="http://www.calcimedica.com/20241231">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_1c6b85ab-c4c4-4749-bbe0-2ba05a3f1fc3" name="dei:DocumentFiscalPeriodFocus" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a">FY</ix:nonNumeric><ix:nonNumeric id="F_156bf09a-46d5-4825-b957-c2f209d2bcb6" name="ecd:NonRule10b51ArrAdoptedFlag" contextRef="C_5466f951-37bb-4006-839b-3b789d141025" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_260b0144-ace8-4327-8dac-1b2f723b18e9" name="dei:EntityCentralIndexKey" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a">0001534133</ix:nonNumeric><ix:nonNumeric id="F_68f77b38-c52f-4acc-9e97-294a6d3a4829" name="ecd:NonRule10b51ArrTrmntdFlag" contextRef="C_5466f951-37bb-4006-839b-3b789d141025" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_29c2de4d-da4f-4659-ad57-31f6ba55417f" name="ecd:Rule10b51ArrTrmntdFlag" contextRef="C_5466f951-37bb-4006-839b-3b789d141025" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_cc7c5a6c-91be-4683-8b65-3d5c37cdc94b" name="dei:AmendmentFlag" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a">false</ix:nonNumeric><ix:nonNumeric id="F_3ee68c06-cd9c-46c2-a659-db48d0d52a40" name="ecd:Rule10b51ArrAdoptedFlag" contextRef="C_5466f951-37bb-4006-839b-3b789d141025" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_02879790-34df-4b21-9555-1c6f87e49426" name="dei:SecurityExchangeName" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric><ix:nonFraction id="F_16371737-8ec4-45fa-a0b0-e6e4270790f5" name="us-gaap:CommitmentsAndContingencies" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_2307ffdb-2705-4620-ac9a-fe22cc657fdc" name="us-gaap:CommitmentsAndContingencies" contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_7d54053a-642e-4e39-bfc6-b012d14346a8" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ck0001534133-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8369d456-272d-4458-8976-3a21b4c87005"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_83845047-b7fc-4928-ac21-ffa4a320df4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_845be1e9-b257-47a6-89d4-733d8a31d6b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8830f19b-6e6b-4da2-87ee-d99253ee1c18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b167b7a-8a24-4ea0-afb0-63b670541fba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c641589-eb1e-4352-b3c3-0711c499ace9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f498825-0f78-45b4-812c-02787d22cde8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f77e296-92c8-4ecd-b45a-a2ad8b02e258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-28</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9114dadf-db78-4d1a-9686-04c4b1e69723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ck0001534133:CalcimedicaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9148156f-8f5b-4f26-a742-6ef0c92f952d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9170e96f-73fb-4585-913b-5bcc555319ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_941b1d38-af1f-420f-8b15-8eeae975a34e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94f7d9a0-cccf-4f75-aaa7-442f61778e94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95022a81-928c-45a6-b8a7-62e7dea3a945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_95e6491a-8251-490e-bafc-9db3d1602a4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_980a3e42-f670-42e5-8f84-d7c4be19f842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_987f342a-1b48-420e-b0a0-87f4ebbe2eda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-20</xbrli:startDate><xbrli:endDate>2023-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9aebc674-6f2c-4fb4-9168-add0619306fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9cbbe523-fc5d-4e57-a1bb-191ddd2df6a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0f4c105-a524-4767-9181-31be89a91199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a121b500-f9d5-4d26-a4b4-8bb964013862"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a170fca3-5c49-41df-8bf6-368143137572"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3c816ce-23b8-4647-a3b2-a0060ab3f6a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a67be958-f1a5-440f-a088-2296882808da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a707849b-9622-4270-8a14-4ccfb2234b96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a737ee8b-67fc-459e-b42a-32cd72a6e241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a9629230-9e39-4a56-a202-86fdb80c3901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aad10afc-0c1f-499f-9814-0ecba7487b5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ad05ad10-c218-4a2f-a090-5ef614c472a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PreMergerCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-20</xbrli:startDate><xbrli:endDate>2023-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_adccbd9d-5ceb-49f3-a3cc-4d2f76546d2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aea932f0-6864-4a4a-9a5a-1599150cb972"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b01b6d69-47c9-4adc-964a-cc6cc14542a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1ab3b90-45a9-4502-8252-c2e3034f292f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b204b444-02a9-4a57-97f1-861675088d01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2211e17-6778-4571-a5e3-51c977da82ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b73cefba-244b-4823-bb60-351dd5a123bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b775c5ab-ecf3-4dc4-bd12-7d3ef78e0d1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b8300b81-b096-4f13-9331-757ab5e2f317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b8a91730-f365-453b-88eb-5b8de08b2053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bb626b12-389d-4561-abdc-fe33a5ce2554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd15498b-f283-433b-97df-4b894a6ee8ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd4f7398-6d5e-489b-97c8-45a8789eb5d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdbc227c-2a4a-4d04-b7f6-a194d9ac93f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be96bce5-b6c0-422a-8b27-379ef3caef19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bef37a75-2e84-42ae-986f-82da4e7d2f72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c0b760ce-71ec-459a-969d-1893bdf340e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c45d60ac-8593-48c7-9b05-a42201654937"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ConfidentiallyMarketedPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4c9215d-494d-4c49-9611-ee223ffc9c1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c873a01a-651f-4a0f-bd98-70853e6ca684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb68adaa-9134-4f3e-97c2-816971662c99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cde8f9cc-6117-4cfa-a5bd-4b469cb961fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce86957a-ac6f-4086-9a65-13bded447356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d409c238-cc99-40c2-b647-976b6c07fe00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d641d938-a033-4dcf-9434-c6445ce1a637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d64e8688-0946-4276-a0e6-cc735d684d5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-19</xbrli:startDate><xbrli:endDate>2024-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d7c558d7-f9b7-46bd-a5cd-d32a30cceb1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7d378ac-3c97-4599-8815-59e8ff3b8864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-05</xbrli:startDate><xbrli:endDate>2024-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d8023328-2b80-4187-9be9-a472d3a65beb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d86661b2-0167-43cd-a6cc-c51935f0976c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_db94281f-2ca5-41c5-a7e1-183957513bcf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dcc03654-bedf-421b-b7f5-47598128324e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">ck0001534133:FederalResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd320420-0211-43de-95df-09b44d9868c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ddbe6d36-a378-4c84-83c6-f0933ab42deb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-20</xbrli:startDate><xbrli:endDate>2023-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de62953f-9a13-4e2a-a3fc-a8e40d129029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ck0001534133:AvenueVentureOpportunitiesFundIILPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de781a1c-b261-4323-9d34-9ecb0869f1f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e084ac77-ce86-42c4-b795-1e5530dcff59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e44a92b5-7664-4c8b-9ed0-b69338c26422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e4bb7cdd-0b6c-4d2b-8e43-6a6963cfc0c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e68758c4-3c29-4782-a87c-bcd7ee800eef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e6df5d02-68f7-49d4-ba51-986d32e23a91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7f86347-68d3-405b-8913-ba0bee5ee23b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:DirectorsEmployeesOrConsultantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb167185-a0eb-45f5-beb2-ad40dbc114b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ebe2620f-35df-4233-a846-f1495ccf0b18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed61293c-a493-4af6-9c31-23d8600a5a0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-17</xbrli:startDate><xbrli:endDate>2023-03-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eec723ad-c5c5-4de8-86cf-24ffe53a2b58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-20</xbrli:startDate><xbrli:endDate>2024-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eee5683f-33b3-4fbc-8cb5-42b8e91c1adb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0009405-42d5-4625-a5e9-57af57ac1cfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreferredStockWarrantsAndCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f113b0a6-620c-4aff-a136-ac77a52a078b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f20344e5-6e5f-49aa-9b9f-b8ff66728e89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f3e6c3db-a6a2-4f7d-99b3-1a4978c878f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f49ac070-365e-4892-838a-facd93bf557c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-20</xbrli:startDate><xbrli:endDate>2023-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6e2608c-dccd-43a5-9232-ce7da8fd0bfa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6e6eee2-3a7f-426a-995a-4c63812334ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-28</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8437473-43cf-4eea-9960-4a41c9ab6907"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f9e065dc-a9c1-4a5e-8636-0c7b7506b76b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ShelfRegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_01046067-75e4-47eb-859f-fdf6441b00c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_020d633a-de37-4a19-a0ef-493644e25660"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_03f70fa6-7284-496f-8c00-e58bf2ff1f48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_045dcafc-a4b7-4b72-a786-a17062bc9899"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_050c9307-b322-43a4-84b0-69234ed20231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09ae4982-7ccd-472c-a057-58036e311ec9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a03a7ba-0a9b-4bcb-b58e-debbbef7f6e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0ad991e6-bbac-44ce-ac44-e428594773e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0c6e1adc-65fd-4bc0-9b3f-a6a4ebc29353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d5c75d7-eaac-4f4b-9ade-6f0a083bd65e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1001d2cb-3125-43a0-ab65-f1fef2c3edd3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13118ae0-e9f5-4a7c-aa30-bab5991ca143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14ff6f4d-845b-4bfc-a43d-d0314b89a420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15e96634-9a83-4453-90fd-00b4f16e88b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1da4e079-61e5-45cc-a979-3a9615ff0665"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f43280b-4e22-429e-aa7d-ecce70368956"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_207c4b97-0faa-4d0f-809e-69e530a8d044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21b81df1-47cd-44ce-92dc-0822f330b821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_223da16c-eed7-4903-afb0-2d505376e14c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23e9b7c7-df34-4cf7-85aa-9468c513006d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_26ea50cb-0ee9-4b54-a249-f320c2ea018f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PreMergerCalcimedicaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-20</xbrli:startDate><xbrli:endDate>2023-03-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27307737-cae3-4ea7-a928-4b907971a80f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_288a2c47-1d31-472c-b116-f7fc50bd5783"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_29a301bb-4522-43d7-947b-4686e790d21a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ck0001534133:GraybugVisionIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_29cd52ec-1662-4876-b968-95dcdb404231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ac23ecf-2158-4a2f-ade7-ea9d3539490e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ca88b50-4b1e-42cb-b72d-edd91da9a612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f7897d6-1a4a-489c-9fd4-bf5c88b81551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ck0001534133:AuxoraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_30130670-4924-4031-bbd1-78ccb2dff022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_306bebf7-53a9-4887-b0b4-ecae6be09590"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_373a9e72-7343-4090-b130-badbbfa67767"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_376beb3d-3fc1-445d-b41b-a5cae382b0e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3a88b2b4-b053-4f3c-a6d0-2084b134a77e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b524ec9-8b7f-49d0-b33b-310d8a3db4b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c08a61f-703c-4719-8fb8-4579c9288562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3cab47fb-e5c1-4496-85a3-0d4ea86c41fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e3444e7-6081-449c-be1a-618a48f9ddb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f53ad55-92a4-4198-b148-88d91cc0fe54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-19</xbrli:startDate><xbrli:endDate>2024-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_42f60701-1d3e-46b2-9f02-e6238294dfdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46095950-bb43-4840-adef-994b8db12bbd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d206da2-83dd-40ec-8dd2-a7ed991121fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5157ff3b-9b07-4690-aab3-d94da0ef7278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">ck0001534133:AmendedAndRestatedCertificateOfIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53c253cb-c903-45b5-b952-e3bd63a5ace1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5466f951-37bb-4006-839b-3b789d141025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_559c60a1-fc91-4c05-9f90-246f875e3dbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5628ed6b-5082-4559-afdb-16e2688469bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-01</xbrli:startDate><xbrli:endDate>2024-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_56e4115b-d428-4783-a18e-66c26fd1da5d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56f08610-d053-44c8-b481-e6a9fd87daf4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_58198596-8919-43f6-85a6-830ab130f2c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ConfidentiallyMarketedPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d75438a-331f-4b70-b3ef-65f18fddf6b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5dde241e-162e-4824-aff5-4a7186f81373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60695399-bb34-4681-86ba-e8a3bfb9d100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_640fa722-803d-451f-878d-cea21bde32c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68dde00d-5365-4647-8868-3a6b2d18e226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheAAndTrancheBCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-19</xbrli:startDate><xbrli:endDate>2024-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6989cb5e-e674-4c1b-a3f4-8bde59a0e20c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6ae5bd8b-50f0-4642-b868-3aa969e2fa5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f09c985-ab40-4e3f-a4e4-e71945759749"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7161dd77-2036-4b7b-a3c9-8408ec371ec2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_75c3f7c7-0b54-4282-baac-1431db556fd7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_78496b12-3f28-430e-9d56-1d9d320d8e3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7a9252ad-93b8-4655-9d47-d20409702eab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b2ce76f-1ac6-463d-9417-582f1d672621"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7bf4d914-a107-476f-b07c-94d28143819c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c3efb00-1230-4736-ad23-faf73bdf57a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c5c9cab-f1bd-4526-94d8-3164adc3b2f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ee9e19d-1d4a-450f-9f03-e831fc128d22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534133</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>ck0001534133:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Contract"><xbrli:measure>ck0001534133:Contract</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d" fromRefs="F_12d5696b-58c6-49ec-90f5-83f181092884 F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08" fromRefs="F_1b6e4946-31e1-4a92-b886-3a04ed5d247c F_12d5696b-58c6-49ec-90f5-83f181092884 F_f4539e24-1082-434c-9e72-eaee54ca8723 F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"/></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7c9b82fe-ccb4-45ed-b85b-b58b819a6f00" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_da14a549-f480-4bc3-a9dd-cf5e62e39194" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentAnnualReport" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9ba52346-919f-4de7-a4cd-845dbead23fc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67f7ecfd-fb68-4d17-bf4b-224cab788d66" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2dc81d1-a5ed-4b8b-887e-1297ceed0975" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_17e72bc2-4059-4001-be2d-203e70f754c1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentTransitionReport" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">            </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">         </span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c8f2c3bd-c4e2-424d-8c37-2cd4fbd759be" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-39538</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:14.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36d30c49-6235-43c5-aa02-e7c0a4b8d532" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;box-sizing:content-box;"/>
    <td style="width:2%;box-sizing:content-box;"/>
    <td style="width:49%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c96ffed5-fbe1-458f-853b-e73c30f6b0f1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c6a89b1c-4678-4de9-963c-ed5e2863693e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">45-2120079</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4df7de9-2ede-495c-9088-b22bdc74f067" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">505 Coast Boulevard South</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56b5740f-301f-47ce-a713-24a1018631fc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 307</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bac6d7a9-cee3-4c40-aaf8-25485b7343ce" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">La Jolla</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_432b7bb3-8f1b-4d1e-9ac4-ffe9eee3119c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48ac4cef-e7b8-4cea-a050-583098e30b0e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92037</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices including zip code)</span></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b80390b-1621-409f-a51e-dacbb5288318" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">858</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b517db88-5afb-4a81-a30f-6c84c5b1e248" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">952-5500</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:39%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:39%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_b1025cb5-36da-4b26-9cf1-529ef382004d" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><ix:nonNumeric id="F_24a4698c-240d-4e85-bda6-7d76d6b5b944" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CALC</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9.5pt;"><span style="-sec-ix-hidden:F_02879790-34df-4b21-9555-1c6f87e49426;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Capital Market</span></span></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c733c0e-ffaa-415b-9082-d9b416eb2fcc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityWellKnownSeasonedIssuer"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9744;    </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56602347-a689-444b-b72c-a9ea3e9e09ce" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityVoluntaryFilers"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98846907-925f-4d3d-8437-db78a980159f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityCurrentReportingStatus"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e579a3f5-4049-4880-a76e-755e547695da" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.999%;box-sizing:content-box;"/>
    <td style="width:49.51%;box-sizing:content-box;"/>
    <td style="width:1.06%;box-sizing:content-box;"/>
    <td style="width:22.416%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.24%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:11.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_41fd1107-712a-4044-833f-5ef20ee61fed" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_9183b504-7978-4163-983e-2cf1a7b97910" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_3ef75084-f542-48e3-b458-b7b8482f7ce8" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:7pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_520d5948-0764-4dae-9988-a606c469a308" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_50bbfb29-8321-400b-9ce3-1ec3229a249e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_0ae45297-9cc0-4696-8b22-d5947f6c6ad9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  </span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:6.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f91cb1cb-ee7b-46ad-8c39-ca87c694117b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of June 30, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of common stock held by non-affiliates of the registrant computed by the closing price of the registrant&#8217;s common stock on June 30, 2024 on the Nasdaq Capital Market was approximately $</span><span style="font-size:6.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_821753a1-1941-480f-ba51-8c066fb1c1b7" contextRef="C_3b524ec9-8b7f-49d0-b33b-310d8a3db4b4" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">27.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Shares of common stock held by each executive officer, director and their affiliated holders have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of Registrant&#8217;s Common Stock outstanding as of March 21, 2025 was </span><span style="font-size:6.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f309146-945f-437c-8cf4-f4f251e533ed" contextRef="C_56e4115b-d428-4783-a18e-66c26fd1da5d" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">13,481,917</ix:nonFraction></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32d3180a-9a94-4365-b4c4-dc679c3c049a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true" continuedAt="F_32d3180a-9a94-4365-b4c4-dc679c3c049a_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                              </span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_32d3180a-9a94-4365-b4c4-dc679c3c049a_1"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive Proxy Statement (the &#8220;Proxy Statement&#8221;) for the 2025 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission not later than April 30, 2025 are incorporated by reference into Part III of this Annual Report on Form 10-K</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:4.533%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements, other than statements of historical facts contained in this Annual Report on Form 10-K, including statements regarding our future financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases you can identify these statements by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;expect&#8221; or the negative or plural of these words or similar expressions. These forward-looking statements include, but are not limited to, statements concerning the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the success, cost and timing of our development activities, non-clinical studies and clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the timing and outcome of our current and future clinical trials, and the reporting of data from those trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our research and development plans;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the potential of our technologies and our ability to execute on our corporate strategy;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract and retain key scientific, medical, commercial and management personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to fund our working capital needs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength and breadth of our patent portfolio;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the therapeutic potential of Auxora and our other product candidates and the expected patient populations, market opportunities, commercial potential and commercialization strategy thereof;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding our cash runway and expected use of cash, cash equivalents and short-term investments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our need to obtain additional funding and the ability to obtain such funding for our operations, including funding necessary to develop and commercialize our product candidates, subject to regulatory approvals:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability and plans to contract with third-party suppliers and manufacturers and their ability to perform adequately;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expected competitive position;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop and maintain our corporate infrastructure, including our ability to design and maintain an effective system of internal controls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">legislative and regulatory developments in the United States and other foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential claims relating to our intellectual property or other legal proceedings;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding future economic conditions or our financial performance;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and adequately protect intellectual property rights for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain regulatory approval for our product candidates and any related restrictions, limitations and/or warnings in the label of any approved product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to extend our operating capital;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of the market size of our product candidates, addressable patient populations, and future revenue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to continue to satisfy the Nasdaq listing requirements and have our stock continue to trade on Nasdaq; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">statements of belief and any statement of assumptions underlying any of the foregoing.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These statements are only current predictions and are subject to known and unknown risks, uncertainties and other factors that may cause our or our industry&#8217;s actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements. We discuss many of these risks in greater detail under the heading &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K. You should not rely upon forward-looking statements as predictions of future events. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risks and uncertainties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, after the date of this report, we are under no duty to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We obtained industry, market and competitive position data in this report from our own internal estimates and research as well as from industry and general publications and research surveys and studies conducted by third parties. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such information or estimates.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary of risks associated with our business</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An investment in our common stock involves a high degree of risk. Below is a list of the more significant risks associated with our business. This summary does not address all of the risks that we face. Additional discussion of the risks listed in this summary, as well as other risks that we face, are set forth under Part I, Item 1A, &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K. These risks include, but are not limited to, the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history. We have a history of net losses and anticipate that we will incur significant losses in the future. We have never generated any revenue from product sales and may never be profitable.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will need to obtain substantial additional funding to complete the development and any commercialization of our product candidates. If we are unable to raise this capital when needed, on acceptable terms, or at all, we may be forced to delay, reduce or eliminate the development of our product candidates or other operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our proprietary platform or product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any acquisitions or strategic collaborations may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities or subject us to other risks.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary CRAC channel inhibition science is based on novel technologies that are unproven and may not result in approvable or marketable products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval and we may not be successful in our efforts to use and expand our science to build a pipeline of product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is highly dependent on the success of our product candidates, in particular Auxora, and we may fail to develop Auxora successfully or be unable to obtain regulatory approval.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical development is a lengthy, expensive and uncertain process. The results of preclinical studies and early clinical trials are not always predictive of future results. Any product candidate that we advance into clinical trials may not achieve favorable results in later clinical trials, if any, or receive marketing approval.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted a significant portion of our CARPO trial in India, and regulatory authorities may not accept data from such trial or any future clinical trials we conduct outside the United States or the applicable foreign jurisdiction.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We depend on enrollment of patients in our clinical trials for our product candidates. If we experience delays or difficulties enrolling patients in our clinical trials, our research and development efforts and business, financial condition, results of operations and prospects could be adversely affected.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third parties to conduct and perform most of our research, preclinical studies and clinical trials. If these third parties do not satisfactorily carry out their contractual duties, fail to comply with applicable regulatory requirements, fail to meet projected clinical trial enrollment schedules or fail to meet expected deadlines, our development programs may be delayed or subject to increased costs, each of which may have an adverse effect on our business and prospects.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We contract with third parties for the manufacturing and supply of certain goods and services for our product candidates for use in preclinical studies and clinical trials, which supply may become limited or interrupted or may not be of satisfactory quality and quantity.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any approved product candidates may fail to achieve the degree of market acceptance by physicians, patients, hospitals, healthcare payors and others in the medical community necessary for commercial success.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The addressable market of our product candidates have not been established with precision and may be smaller than we estimate.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to successfully commercialize our product candidates due to unfavorable pricing regulations or third-party coverage and reimbursement policies, which could make it difficult for us to sell our product candidates profitably.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are highly dependent on our key personnel, and if we are not successful in attracting and retaining highly qualified personnel, we may not be able to continue to successfully develop or commercialize our product candidates or otherwise implement our business plan.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for Auxora, any future product candidates, and other proprietary technologies we develop, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize Auxora, any future product candidates, and other proprietary technologies if approved, may be adversely affected.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business operations may subject us to disputes, claims and lawsuits, which may be costly and time-consuming and could materially and adversely impact our financial position and results of operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2025 Loan and Security Agreement with Avenue Venture Opportunities Fund includes customary affirmative and negative covenants, as well as standard events of default, that could restrict our operating and financial flexibility.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXPLANATORY NOTE</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 20, 2023, the Delaware corporation formerly known as &#8220;Graybug Vision, Inc.&#8221; completed its merger transaction in accordance with the terms and conditions of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended on February 10, 2023 (the &#8220;Merger Agreement&#8221;), by and among Graybug Vision, Inc. (&#8220;Graybug&#8221;), Camaro Merger Sub, Inc., a wholly owned subsidiary of Graybug (&#8220;Merger Sub&#8221;), and CalciMedica, Inc. (&#8220;Private CalciMedica&#8221;), pursuant to which Merger Sub merged with and into Private CalciMedica, with Private CalciMedica surviving the merger as a wholly owned subsidiary of Graybug (the &#8220;Merger&#8221;). Additionally, on March 20, 2023, the Company changed its name from &#8220;Graybug Vision, Inc.&#8221; to &#8220;CalciMedica, Inc.&#8221; (the &#8220;Company&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 17, 2023, in connection with the transactions contemplated by the Merger Agreement, Graybug filed an Amended and Restated Certificate of Incorporation effecting a reverse stock split of Graybug&#8217;s common stock at a ratio of 14:1 (the &#8220;Reverse Stock Split&#8221;). As a result of the Reverse Stock Split, the number of issued and outstanding shares of Graybug&#8217;s common stock immediately prior to the Reverse Stock Split was reduced into a smaller number of shares, such that every 14 shares of Graybug&#8217;s common stock held by a stockholder immediately prior to the Reverse Stock Split were combined and reclassified into one share of common stock after the Reverse Stock Split. The information in this Annual Report on Form 10-K as of and for the periods prior to the effective date of the Merger gives effect to the Reverse Stock Split.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities&#8217; activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#8217;s assets and liabilities at their acquisition date fair value and the Company&#8217;s and Private CalciMedica&#8217;s activity from and after the Merger. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the exchange ratio of 0.0288.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In this Annual Report on Form 10-K, unless the context indicates otherwise, the terms &#8220;Company,&#8221; &#8220;CalciMedica,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to (i) Private CalciMedica, for periods prior to the effectiveness of the Merger and (ii) CalciMedica, Inc. (as a combined company) for periods following the effectiveness of the Merger.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K contains references to trademarks belonging to other entities, which are the property of their respective holders. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iv</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.998%;box-sizing:content-box;"/>
    <td style="width:81.924%;box-sizing:content-box;"/>
    <td style="width:7.079%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures_1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrants_common"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_selected_financial_data"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved</span></a><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">]</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_management_discussion"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">115</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_statement"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. Bu</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">siness.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Our product candidates act upon calcium release-activated calcium (&#8220;CRAC&#8221;) channels and would constitute a new class of drugs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical and preclinical data have demonstrated that the inhibition of CRAC channels may have a therapeutic effect based on a dual mechanism involving both anti-inflammatory and tissue cell protective activities. Our work has shown compelling evidence of the involvement of CRAC channels in a broad spectrum of both acute critical illnesses and chronic diseases that have the common thread of inflammation or immunologic activity in their pathogenesis. We intend to leverage our CRAC channel inhibitor platform to develop therapeutics for indications where this dual mechanism of action has the potential for clinical benefit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our lead product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. Multiple Phase 2 clinical trials with Auxora have been conducted: an open-label Phase 2a trial in acute pancreatitis (&#8220;AP&#8221;) with accompanying systematic inflammatory response syndrome (&#8220;SIRS&#8221;), an international, randomized, double-blind placebo-controlled Phase 2b trial in AP with SIRS (which we refer to as &#8220;CARPO&#8221;), an investigator led open-label Phase 1/2 trial in asparaginase-induced pancreatic toxicity (&#8220;AIPT&#8221;) (which we also refer to as &#8220;CRSPA&#8221;) in which the first cohort of patients has been completed, a placebo-controlled double-blind Phase 2 trial in severe COVID-19 pneumonia (which we also refer to as &#8220;CARDEA&#8221;) and an investigator led open-label Phase 2a trial in COVID-19 pneumonia patients with acute respiratory distress syndrome (&#8220;ARDS&#8221;). We observed in all of these trials that patients treated with Auxora experienced a reduction of organ damage and reduced time to recovery. We believe the consistency of the results we observed from these trials in two different acute critical care conditions are mutually supportive and reinforce our plans to further pursue the use of Auxora in several additional acute critical illnesses, including acute kidney injury (&#8220;AKI&#8221;) with associated acute hypoxemic respiratory failure (&#8220;AHRF&#8221;) in which we are currently conducting a Phase 2 trial (which we also refer to as &#8220;KOURAGE&#8221;) with data expected around the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we have compiled additional preclinical data supporting the potential to use CRAC channel inhibition for both chronic and acute inflammatory and immunologic diseases. We have animal model data suggesting CRAC channel inhibition may be useful in treating chronic pancreatitis, rheumatoid arthritis, ulcerative colitis, allergic asthma, and traumatic brain injury. We have several available product candidates that may be suitable for potential oral dosing. Pending additional funding, we have paused Investigational New Drug Application (&#8220;IND&#8221;) enabling preclinical work on these compounds to focus resources on our clinical programs. We expect to continue certain research activities to validate CRAC channel inhibition as a potential mechanism in other promising inflammatory and immunologic diseases.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Pipeline</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates are summarized in the table below:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_0.jpg" alt="img247211528_0.jpg" style="width:720px;height:289px;"/></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Experience with Auxora</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our clinical experience with Auxora is summarized in the table below:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_1.jpg" alt="img247211528_1.jpg" style="width:720px;height:322px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Table Notes: For illustrative purposes only. Not a head-to-head comparison. Differences exist between clinical trial design and patient populations, and caution should be exercised when comparing data across trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">38 patients who enrolled with AKI, defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&#178;.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The high and medium dose patients showed a reduction in respiratory failure and severe organ failure compared to both the placebo and low dose patients.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have studied Auxora in a number of clinical trials including multiple Phase 2 clinical trials conducted in the United States and internationally. Across these studies, we observed that patients treated with Auxora experienced a reduction of organ damage and a reduced time to recovery. In CARDEA, we observed a statistically significant 56% (p=0.016) relative reduction versus placebo in mortality at 30 days. Further, in a post-hoc analysis analyzing 38 patients who enrolled in CARDEA with AKI, defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&#178;, in addition to moderate or severe respiratory failure, which was an inclusion criterion, we observed a 62.7% relative reduction versus placebo in mortality at day 30 which persisted through day 60. In CARPO, the medium and high doses of Auxora both showed a 100% relative risk reduction compared to placebo in new-onset severe respiratory failure. This effect was statistically significant for the high and medium dose arms individually (p&lt;0.05) and for the combined high and medium doses of Auxora patients compared with the combined placebo and low dose of Auxora patients (p=0.0027). We believe the consistency of the results we observed from these trials in multiple acute critical care conditions affecting different primary organs are mutually supportive and reinforce our plans to further pursue the use of Auxora in several additional acute critical illnesses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results from several of our trials have been published or presented at medical meetings, including results from an open-label SOC controlled Phase 2a trial in AP, results from treating the first cohort of patients in the open-label, investigator-initiated Phase 1/2 CRSPA trial, and results from the 30-patient open-label part one portion of the Phase 2 CARDEA trial in severe and critical COVID-19 pneumonia patients, and the 284-patient blinded, randomized, controlled Part 2 component of this same trial.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Kidney Injury</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Ongoing Phase 2 clinical trial. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, we announced the first patient enrolled in KOURAGE, a Phase 2 clinical trial of Auxora for the treatment of AKI patients with AHRF. KOURAGE is a randomized, double-blind, placebo-controlled study that will evaluate 150 patients with Stage 2 and 3 AKI who have AHRF and are receiving oxygen by non-invasive mechanical ventilation, high flow nasal cannula or IMV. We expect to report data from this trial around the end of 2025.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical observations of Auxora for AKI.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We have both clinical observations and pre-clinical data that support the development of Auxora in AKI.  In our CARDEA trial, which studied Auxora in patients with severe and critical COVID-19 pneumonia, results showed a 40% reduction in newly reported AKI (a common consequence of COVID-19 pneumonia) </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in Auxora-treated patients as compared to placebo-treated patients. In a post-hoc analysis analyzing 38 patients who enrolled in CARDEA with AKI, defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&#178;, in addition to moderate or severe respiratory failure, which was an inclusion criterion, we observed a 62.7% relative reduction versus placebo in mortality at day 30 which persisted through day 60. Biomarker analysis from blood samples taken from over 190 CARDEA patients further showed that, when compared to placebo, Auxora had positive effects on cardiorenal biomarkers&#8212;increases in angiopoietin-1 and decreases in angiopoietin-2 and D-dimers&#8212;which have been linked to the prevention of endothelial damage in prior studies and were correlated with improved outcomes in CARDEA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical studies for Auxora in AKI.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> pre-clinical studies in an ischemia/reperfusion injury model of AKI in rats showed promising results, whereby animals receiving three daily doses of Auxora after injury had improvements in their GFR values while rats receiving placebo had little improvement. Further, in the setting of severe kidney injury, rats receiving Auxora survived whereas those receiving placebo died.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Pancreatitis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AP with SIRS</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed Phase 2b clinical trial</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We completed CARPO, an international, randomized, double-blind placebo-controlled Phase 2b trial in 216 patients with AP and accompanying SIRS. In October 2024, in a plenary session at the American College of Gastroenterology annual meeting, we presented late-breaking data and previously announced data from CARPO. The trial met its primary objective with a statistically significant dose response in median time to solid food tolerance in a prespecified subgroup of patients with hyper-inflamed AP. Additionally, the medium and high doses of Auxora both showed a reduction in severe organ failure and, specifically, a 100% relative risk reduction compared to placebo in new-onset severe respiratory failure. This effect was statistically significant for the high and medium dose arms individually (p&lt;0.05) and for the combined high and medium doses of Auxora patients compared with the combined placebo and low dose of Auxora patients (p=0.0027). There was an approximately 20% relative risk reduction for new onset necrotizing pancreatitis for patients in the high dose group compared to placebo patients and these high dose patients also had median time to medically indicated discharge of 15 hours less than placebo patients. Finally, a stratified win-ratio analysis of certain key endpoints gave a stratified 1.640 win-ratio benefit (p=0.0372) for the high dose patients compared to placebo patients.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed open-label Phase 2a clinical trial: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed a randomized, open-label Phase 2a clinical trial of Auxora in 21 patients with AP and accompanying SIRS who also had hypoxemia at presentation. Patients in this trial treated with Auxora in addition to SOC had multiple improved outcomes compared to patients treated with standard of care alone. In addition, there were several patients with severe respiratory failure at enrollment and the majority of those treated with Auxora did not require mechanical ventilation. Results from this randomized, open-label Phase 2a clinical trial conducted in the United States were published in March 2021 in the peer- reviewed journal Pancreas. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Ongoing planning for a potential Phase 3 clinical trial:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We plan to hold an End-of-Phase 2 meeting with the FDA around the middle of 2025 and expect to be in a position to initiate a Phase 3 program in AP and accompanying SIRS around the end of 2025 pending additional funding. We have received Fast Track designation from the FDA and orphan drug designation in the European Union (&#8220;EU&#8221;) from the European Medicines Agency (&#8220;EMA&#8221;) for Auxora for the treatment of AP. However, there is no guarantee that Fast Track designation will result in a faster regulatory review or regulatory approval, if at all.</span></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of AIPT: Pancreatitis as a Side Effect of Treatment for Pediatric ALL</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Ongoing Phase 1/2 clinical trial</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. CRSPA, an investigator led 24-patient Phase 1/2 trial, is being conducted in the United States in children who develop AIPT related to the use of the chemotherapeutic asparaginase in the course of their treatment for ALL. We believe this work is providing valuable information on the use of Auxora in critically ill pediatric patients. The first cohort of nine patients in this trial has been completed and the data presented at ASH in December 2023 showed that all patients who received a full course of Auxora treatment had a more rapid resolution of their symptoms as compared to historical controls. These patients spent less time in the hospital or intensive care unit and blinded central reading of pancreatic imaging showed reduction in the development of significant pancreatic necrosis and the severity of acute pancreatitis as compared to the historical control group, 27% of whom had greater than 30% necrosis of their pancreas at 30 days as compared to none of the Auxora treated patients. Over 50% of patients in the control group required total parenteral nutrition (&#8220;TPN&#8221;) for several weeks on average and none required TPN in the treatment group. This trial has expanded to additional sites and is over 50% enrolled, and we expect to provide an update in the second half of 2025.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Respiratory Failure</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Completed double-blind Phase 2 clinical trial in hospitalized COVID-19 pneumonia patients on oxygen. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In our CARDEA trial, a Phase 2 randomized double-blind placebo-controlled trial conducted in the United States in 284 patients with severe COVID-19 pneumonia (261 having moderate and severe respiratory failure&#8212;our efficacy set) and receiving supplemental oxygen but not on mechanical ventilation, treatment with Auxora resulted in a reduced time to recovery and a 56% relative reduction in mortality at 30 days (p=0.0165) and a 33% relative reduction in mortality at 60 days (p=0.1449) compared to placebo. Both of these findings are clinically relevant particularly in light of patients needing additional therapies on top of the current standard of care. Time to recovery was seven days for Auxora-treated patients compared to ten days for patients receiving placebo (p=0.098). Data from this study was published in April 2022 in the peer-reviewed journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Critical Care</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Potential Additional Indications</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Oral candidate for the treatment of chronic inflammatory and immunological diseases. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also developing oral CRAC channel inhibitors for use in chronic inflammatory indications. We have animal model data with several compounds suggesting CRAC channel inhibition may be useful in treating chronic pancreatitis, rheumatoid arthritis, ulcerative colitis and allergic asthma. Pending additional funding, we have paused IND enabling preclinical work on these compounds to focus resources on our clinical programs. We expect to continue certain research activities to validate CRAC channel inhibition as a potential mechanism in other promising inflammatory and immunologic diseases.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the treatment of acute ulcerative colitis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Recent animal data indicates that CRAC channel inhibition by zegocractin or CM4620 (active ingredient in Auxora) may be useful in the treatment of inflammatory bowel disease, such as ulcerative colitis. In a preclinical study performed with scientists from Charite &#8211; University Medicine, Berlin and New York University Grossman School of Medicine, it was shown that zegocractin, administered orally to mice every other day for a period of 30 days produced a significant reduction in intestinal inflammation in a model of ulcerative colitis. This work was published in EMBO Molecular Medicine in August 2022.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the treatment of allergic asthma</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Zegocractin was studied in mouse models of asthmatic airway inflammation and influenza A virus infection to determine if inhibition of CRAC channels reduces asthmatic inflammation without interfering with the antiviral response. Researchers from New York University Grossman School of Medicine showed that oral administration of zegocractin significantly lowered both peribronchiolar inflammation and lung mucus production in the asthma model and did not impact viral response in the influenza A model. This work was published in Science Advances in October 2022.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Auxora for the treatment of traumatic brain injury.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> CM5480 is a proprietary tool compound that is an Orai1-selective inhibitor like zegocractin, and using this compound it was shown that blocking Orai1 CRAC channels protected mice from brain damage following controlled cortical impact, a model of traumatic brain injury. The results supported the interpretation that CM5480 worked by suppressing the activation of brain microglia, which are immune cells residing in the central nervous system. This work was published in the Journal of Neurotrauma in 2019. Since zegocractin (the active ingredient in Auxora)and CM5480 are both brain penetrant, it is possible that patients with traumatic brain injury could be effectively treated with Auxora.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a company focused on the discovery and development of CRAC channel inhibitors. We intend to develop therapeutics to treat acute critical illnesses including AKI, AP, ARDS or ARHF, and chronic inflammatory and immunologic diseases potentially including chronic pancreatitis and rheumatoid arthritis. Our strategy to achieve this is as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leverage our proprietary CRAC channel inhibition science to develop drugs to treat acute critical illness and chronic inflammatory diseases where there are no effective therapies. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given that CRAC channels are found on many cell types in addition to immune cells, we believe that there will be a number of inflammatory and immunologic indications that can be targeted with the novel mechanism of action afforded by CRAC channel inhibitors. These indications can range from acute critical illnesses, the focus of our current efforts to date, to chronic inflammatory and immunologic conditions. Our portfolio of proprietary compounds with different pharmaceutical properties enables us to explore these indications with agents selected and formulated specifically for each unique clinical setting.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Develop Auxora for the treatment of AKI. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AKI represents a significant unmet medical need as there are no disease- modifying therapies to either prevent or treat AKI. We have a body of clinical observations and pre-clinical data that support the development of Auxora in this acute critical disease. In July 2024, we announced the first patient enrolled in KOURAGE, a Phase 2 clinical trial of Auxora for the treatment of AKI patients with AHRF. KOURAGE is a randomized, double-blind, placebo-controlled study that will evaluate 150 patients with Stage 2 and 3 AKI who have AHRF and are </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receiving oxygen by non-invasive mechanical ventilation, high flow nasal cannula or IMV. We expect to report data from this trial around the end of 2025.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Develop Auxora for the treatment of patients with AP and accompanying SIRS. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AP represents an unmet need in critical care medicine as there are no disease-modifying therapies. We believe we have shown that Auxora-treated AP patients with SIRS have better outcomes than SOC-treated control patients in both a Phase 2a and a Phase 2b clinical trial. We plan to hold an End-of-Phase 2 meeting with the FDA around the middle of 2025 and expect to be in a position to initiate a Phase 3 program in AP and accompanying SIRS around the end of 2025 pending additional funding.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Develop Auxora for the treatment AIPT. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRSPA, an open-label 24-patient Phase 1/2 clinical trial, is currently being conducted in pediatric patients with AIPT. The first cohort of nine patients in this trial has been completed and the results from this cohort as well as results from a blinded matched historical control group were presented at ASH 2023. While initially a single-center trial, CRSPA has been expanded to additional sites and is over 50% enrolled. We expect to provide an update in the second half of 2025.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Demonstrate the efficacy of Auxora for the treatment of patients with AHRF and ARDS caused by multiple etiologies. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have completed CARDEA, a Phase 2 randomized double-blind, placebo-controlled trial in patients with severe COVID-19 pneumonia and receiving supplemental oxygen, but not on mechanical ventilation, and with our collaborator we have completed the enrollment and treatment of patients of a Phase 2 clinical trial in mechanically ventilated COVID-19 pneumonia ARDS patients. Results from this trial may inform the design of a Phase 2 clinical trial for the treatment of AHRF and/or ARDS and we are evaluating next steps for potential clinical development of Auxora in patients with AHRF and ARDS.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Advance a second CRAC channel inhibitor into clinical development for the treatment of an additional inflammatory indication. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that there are multiple indications, including some chronic inflammatory and immunologic indications, that could potentially be treated with CRAC channel inhibitors from our portfolio of compounds, including orally available compounds. At present time, we have paused IND enabling preclinical work on these compounds to focus resources on our clinical programs; however, we expect to continue certain research activities to validate CRAC channel inhibition as a potential mechanism in other promising inflammatory and immunologic diseases and could restart IND enabling work in the future should we receive additional funding.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Explore additional indications for Auxora. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-clinical work in both acute ulcerative colitis, allergic asthma, pulmonary arterial hypertension, and traumatic brain injury have shown that zegocractin, the active molecule in Auxora, reduces inflammation and symptoms of these diseases in animal models.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursue licensing and partnership opportunities for Auxora and other compounds in our portfolio. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Development of Auxora in different geographies, and commercialization of Auxora in acute critical care indications that will require access to hospital emergency rooms, may benefit from partners with existing development capability and/or commercial channels and sales forces. We are exploring these types of relationships. In addition, we may elect to partner other of our compounds for specific indications.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Team</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive team is led by A. Rachel Leheny, Ph.D., our chief executive officer, who has more than 30 years of experience in the life sciences industry as a scientist, venture capital investor and investment banking research analyst. Kenneth Stauderman, Ph.D., a co-founder and our chief scientific officer with more than 30 years of experience in drug discovery and development, is a leading expert in CRAC channels and led the discovery of some of the foundational work in this field. Sudarshan Hebbar, M.D., our chief medical officer, has more than 15 years of clinical development and product development experience and was previously a practicing nephrologist and critical care physician. Raven Jaeger, MS, our chief regulatory officer, has over 20 years of regulatory affairs experience with several marketing approvals in serious diseases with high-unmet medical need.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Science</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Essential Roles of Calcium Signaling</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Calcium serves as an essential messenger for intracellular signals and plays diverse and important roles in biological systems. The major storehouse for calcium in a cell is a compartment called the endoplasmic reticulum (&#8220;ER&#8221;). Calcium is found there at average concentrations that are 1,000 to 5,000-fold higher than in a cell&#8217;s interior or cytoplasm. When an outside signal stimulates a cell in a particular way, the stored calcium is rapidly and periodically released from the ER into the cell interior, resulting in activation of a number of key cellular processes affecting synthesis and release of other signaling molecules, cell growth, differentiation and division. These processes include, for example, gene transcription and protein kinase signaling. In response to sufficient external stress on the cell, release of calcium from these intracellular stores can trigger cell death.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CRAC Channels</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A specific set of calcium-transporting ion channels known as CRAC channels are responsible, among other things, for replenishing the calcium stores in the ER. The two principal proteins that comprise CRAC channels are the ER calcium-sensing protein Stomal Interaction Molecule 1 (&#8220;STIM1&#8221;) and the cellular membrane calcium channel protein Orai1. When cells are stimulated in particular physiological ways, intracellular messengers are generated that cause the periodic release of calcium from the ER. The release of calcium from the ER is then sensed by STIM1, which unfolds and activates, or opens, the Orai1 calcium channel triggering an influx of calcium into the cell. In certain pathological conditions, however, CRAC channels can be activated in non-physiological ways, such as by a toxin that can cause excessive release of calcium from the ER, leading to overactivation of CRAC channels.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the extent of activation and the cell or tissue involved, calcium influx through CRAC channels can regulate calcium-dependent inflammatory pathways or can activate cell injury pathways. For example, in immune cells like T lymphocytes, activation of CRAC channels plays a key role in initiating the adaptive immune response and the generation of inflammatory cytokines. In certain acute critical illnesses such as AP, CRAC channels on affected organ tissue cells can become overactivated, resulting in excess calcium entry that is toxic to cells, causing cellular injury or death that can exacerbate an accompanying inflammatory response.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_2.jpg" alt="img247211528_2.jpg" style="width:540px;height:251px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CRAC channels serve to replenish calcium levels in the ER and to provide calcium for cellular signaling events.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is strong evidence linking STIM1 and Orai1 to the way the cell replenishes its calcium stores and to the physiological consequences of disrupting these proteins from both </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">models, including animal gene knock-out or knock-in models, and human genetics. This linkage is true at both the cellular and phenotypic levels. At the cellular level, manipulating STIM1 or Orai1 activity by genetic inactivation or enhancement has been shown to impact calcium transport. Inactivating STIM1 or Orai1 was shown to decrease calcium entry into cells, whereas creating mutations in STIM1 or Orai1 that enhance their activity was shown to increase calcium influx. At the phenotypic level, people with homozygous genetic deficiencies in the genes encoding Orai1 or STIM1 develop the life-threatening condition of severe combined immunodeficiency. Because these individuals lack the ability to mount an effective immune response, they suffer from an extreme risk of contracting life-threatening infections. People with a heterozygous genotype for the mutated genes encoding Orai1 or STIM1 do not have any notable conditions resulting from or associated with these genetic deficiencies despite a partial reduction in the functional activity of the Orai1 or STIM1 proteins.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In lymphocytes, CRAC channels are critically responsible for controlling the entry of calcium that subsequently initiates calcium-dependent events. Within minutes of activating CRAC channels, alterations in intracellular calcium levels result in both (a) the inhibition of lymphocyte migration and (b) the activation of immune cell activity. Both of these elements of CRAC channel biology are central to identifying potential therapies. Effects of prolonged calcium signaling supported by both calcium release from the ER and CRAC channel-mediated calcium entry include stimulation of cell proliferation; expression of immune-activated genes; production of cytokines and chemokines; and lymphocyte differentiation. These longer-duration effects, too, are central to the backdrop for therapeutic intervention. For example, genes triggered by calcium release and subsequent calcium entry through CRAC channels include many activators of inflammation. This mechanism involves various signaling proteins, including two in particular, calcineurin and a transcription factor called nuclear factor of activated T cells (&#8220;NFAT&#8221;), which form a critical link between calcium elevations and transcriptional activation. Calcineurin is a calcium- activated enzyme that removes inhibitory components from NFAT, triggering it to enter the nucleus and function as a transcription factor. Calcineurin has a well-validated immunoregulatory role; it is the target of two broadly prescribed immunosuppressive molecules, cyclosporine and tacrolimus. NFAT is expressed in a wide spectrum of immune cells and its activity drives inflammation via the production of many pro-inflammatory cytokines such as interleukin-6 (&#8220;IL-6&#8221;); tumor necrosis factor alpha (&#8220;TNF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#181;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;); and interleukin-2 (&#8220;IL-2&#8221;).</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_3.jpg" alt="img247211528_3.jpg" style="width:540px;height:362px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Increased levels of intracellular calcium mediated by CRAC channels activate a number of inflammatory pathways.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inflammatory diseases including AP, respiratory failure, kidney injury or traumatic brain injury are associated with activation or overactivation of CRAC channels. Preclinical experiments have shown that the inhibition of CRAC channels has the potential to provide therapeutic benefit in these and other diseases. Multiple compounds have been identified in the scientific literature that inhibit CRAC channels, but few of these have advanced to clinical trials as a result of unsuitable pharmaceutical properties required for potential therapeutic use.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Advantages to Our Approach</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe CRAC channels are promising drug targets as they are present on critical organ tissues (such as endothelium cells) and on immune system cells (such as T cells). Overactivation of these channels can lead to organ damage and cytokine-mediated pro-inflammatory processes. CRAC channel activation plays a critical role in endothelial damage and serves as the proximal step in T cell production of pro-inflammatory cytokines. We believe the key advantages of CRAC channel inhibition science are:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our CRAC channel inhibitors provide a dual mechanism to reduce cellular damage by both blocking direct tissue damage and down-regulating inflammation.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our CRAC channel inhibitors act upstream of several approved drugs (such as cyclosporin) affecting multiple pro-inflammatory pathways. This translates into down-regulation of multiple cytokines produced by the immune system in a disease state and may provide broader acting anti-inflammatory action compared to drugs that target a single cytokine.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our CRAC channel inhibitors are small molecule drugs that provide rapid onset of immunomodulatory action as well as rapid offset which can provide rapid recovery of immunocompetence.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that there may be underlying biological pathways common to a number of acute critical illnesses, including those indications we are pursuing, so that there could be the potential for a single agent to treat patients sharing this underlying biology regardless of disease.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our proprietary IV lipid nanoemulsion used in Auxora enhances the delivery of our drug to lipophilic organ tissues such as the pancreas, lung and kidney.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our proprietary CRAC channel inhibitors are orally bioavailable and can potentially be used to treat chronic inflammatory and immunologic conditions.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach is applicable to both acute and chronic inflammatory and immunologic diseases.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora, a Selective CRAC Channel Inhibitor</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing Auxora, a proprietary IV-formulated CRAC channel inhibitor, for several indications, including the treatment of severe AP, AIPT, AKI, severe acute respiratory diseases including AHRF, and ARDS, and other acute inflammatory diseases associated with dysregulation of intracellular calcium in organ tissues. We hold worldwide rights to the active ingredient in Auxora, zegocractin, which was previously referred to as CM4620. Auxora inhibits the transport of calcium into cells by inhibiting the Orai1 CRAC channel. Testing of Auxora in an </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">selectivity panel screen showed that the compound was highly selective over many other ion channels, receptors or transporters, which is consistent with the lack of sequence or structural similarity of CRAC channels with other channels.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora is specifically formulated as an IV lipid nanoemulsion that is designed to facilitate the rapid delivery to lipophilic organ tissues such as the pancreas, lung and kidney, which we believe makes it a promising product candidate for the treatment of acute critical illnesses. The nanoemulsion is composed of nanometer-sized lipid droplets suspended in water. Auxora dissolves into the lipid particles that, once infused, move quickly through the body and are attracted to lipophilic tissues that are hard-to-reach for aqueous solutions and hydrophilic drugs. We believe it is critically important to block CRAC channel activity as soon as possible in these acute indications to prevent further tissue damage and decrease morbidity or mortality. Auxora was well-tolerated in single dose and multiple dose Phase 1 clinical trials in healthy adults, and in both the Phase 2 COVID-19 clinical trials and the Phase 2a and 2b AP clinical trials.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Evidence for Anti-Inflammatory Activity of Zegocractin, the Active Ingredient in Auxora</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> treatment of activated human peripheral blood mononuclear cells (&#8220;PBMCs&#8221;), which are predominantly lymphocytes, with zegocractin (the active compound in Auxora) resulted in a concentration-dependent inhibition of the release of a number of pro-inflammatory cytokines including IL-2 and interleukin-17 (&#8220;IL-17&#8221;) when measured at 48 hours. The breadth of the spectrum of cytokines inhibited by zegocractin is consistent with the central role of calcium signaling in the inflammatory response.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_4.jpg" alt="img247211528_4.jpg" style="width:405px;height:219px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zegocractin inhibited the release of a number of cytokines from activated human PBMCs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The role of calcium and CRAC channels in inflammation extends beyond lymphocytes and other immune cells. Excess calcium in cells in tissues such as kidney, pancreas, lung and the nervous system leads to cell damage or activation of cell death pathways causing tissue damage and organ failure. These processes, in turn, trigger inflammatory immune responses that further exacerbate cell damage and cell death and can accelerate tissue damage and organ failure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_5.jpg" alt="img247211528_5.jpg" style="width:673px;height:462px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CRAC channel overactivation causes cell damage, leading to cell death and triggering an inflammatory immune response.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmacodynamic Profile of Auxora</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora is a proprietary lipid nanoemulsion IV formulation of the small molecule zegocractin that is administered by IV infusion. To test the activity of Auxora, we have developed an assay using ex vivo blood samples in which we stimulate IL-2 release as a surrogate pharmacodynamic (&#8220;PD&#8221;) marker for immune system activity. After administration, Auxora rapidly redistributes from the blood into lipophilic tissues and is predominantly cleared through the biliary system. Thereafter, the remaining drug is gradually cleared from lipophilic tissues over the course of a few months resulting in trace plasma levels without biological or clinical activity reported to date. Additional toxicity studies will be performed during Phase 3 development and may further address the safety of Auxora as it is cleared from the body. Auxora has demonstrated a rapid onset of immunomodulatory action within 30 minutes post-dosing in this assay performed on blood samples from patients with AP and treated with Auxora. Recovery of IL-2 release was observed within 24-48 hours following dosing completion, indicating offset of immunomodulation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_6.jpg" alt="img247211528_6.jpg" style="width:492px;height:371px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora has a rapid on-off effect as demonstrated by the onset of immunomodulation after dosing and the recovery of the immune system after the drug infusion is stopped.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that the timely termination of drug action is an important feature of Auxora as it may limit the potential for long-term immunosuppressive effects of prolonged CRAC channel inhibition, which have not been seen in clinical trials to date. In a rat model, administration of Auxora led to high levels of drug exposure in kidneys, pancreas, lung and plasma at two hours and four hours after the start of a four-hour infusion. By eight hours, drug levels dropped, consistent with rapid drug redistribution and/or clearance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_7.jpg" alt="img247211528_7.jpg" style="width:364px;height:319px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora led to rapid increase in drug levels in the pancreas, lung, kidney and plasma after administration to rats.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Potency and Selectivity of Auxora</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Zegocractin (the active molecule in Auxora) is among the most potent CRAC channel inhibitors reported in the scientific literature, as observed in published experiments performed in our labs, including experiments published in the journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cell Calcium</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The data in the figure below illustrate that Auxora potently inhibits Orai1-containing CRAC channels, as 50% of the activity of the channel can be inhibited with nanomolar (&#8220;nM&#8221;) concentrations of compound. Further, the compound is selective compared to other channels. For example, on two channels important in cardiac (heart) function, even micromolar (&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#181;M</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) quantities of zegocractin do not achieve measurable inhibition of the activity of those channels. All compounds in our portfolio of potential drug candidates have properties similar to those indicated in the table below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:41.392%;box-sizing:content-box;"/>
    <td style="width:1.18%;box-sizing:content-box;"/>
    <td style="width:24.695%;box-sizing:content-box;"/>
    <td style="width:1.18%;box-sizing:content-box;"/>
    <td style="width:31.554%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Channel</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Effect of Zegocractin</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Orai1 CRAC Channel Selectivity Ratio</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Human Orai1-containing CRAC channels</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">IC</span><span style="color:#000000;top:1pt;white-space:pre-wrap;font-size:5.025pt;position:relative;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;= 119 nM</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8211;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Human voltage-gated Ca channels (cardiac)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&lt;10% inhibition at 10 &#181;M</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&gt;100-fold</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Human hERG K channels (cardiac)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&lt;10% inhibition at 10 &#181;M</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&gt;100-fold</span></p></td>
   </tr>
  </table>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IC50 = concentration producing 50% inhibition of channel activity. Activity of each channel was assessed by electrophysiological (electrical) measurements of either calcium ion (Ca2+) or potassium ion (K+) flow through the indicated channel. The maximum soluble concentration of compound (10 &#181;M) was tested on the cardiac channels.</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assay performed by us in 2011-2012.</span></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assay performed by a contracted vendor in 2012.</span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Kidney Injury</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are recent examples in the scientific literature where CRAC channel inhibition was shown to reduce damage in animal models of AKI. We have conducted preclinical studies of Auxora in a rat model of AKI. Additionally, we have observed in our clinical trials that Auxora-treated patients appear to have less complications of kidney injury or failure in the setting of acute critical illness. In July 2024, we announced the first patient enrolled in KOURAGE, a Phase 2 clinical trial of Auxora for the treatment of AKI patients with AHRF. We expect to report data from this trial around the end of 2025.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acute Kidney Injury Background</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AKI is marked by three distinct phases, the initial injury, the recovery from that injury and then the long-term damage resulting from the initial injury. Patients who do not recover completely from the initial injury are at risk for long-term damage. We believe the administration of Auxora to patients with more severe AKI will result in a greater proportion of patients recovering completely from the initial injury, and in so doing, will lessen the long term complications of the initial injury. This is illustrated in the figure below. AKI is classified as Stage 1, Stage 2 and Stage 3 depending on the seriousness of the disease as measured by serum creatinine and urine output and may progress from one stage to the next as a patient&#8217;s condition worsens. Stage 1 patients have an increase in serum creatinine of &#8805; 0.3 mg/dL or 1.5 to 1.9 times baseline or urine output of &lt;0.5 mL/kg/hour for six to 12 hours. Stage 2 patients have an increase in serum creatinine to 2.0 to 2.9 times baseline or urine output of &lt;0.5 mL/kg/hour for 12 to 24 hours. Stage 3 patients have an increase in serum creatinine to &#8805; 3.0 times baseline, an increase in serum creatinine of &#8805; 0.3 mg/dL to &#8805; 4.0 mg/dL, urine output of &lt;0.3 mL/kg/ hour for &#8805; 24 hours, anuria for &#8805; 12 hours or initiation of kidney replacement therapy.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_8.jpg" alt="img247211528_8.jpg" style="width:475px;height:249px;"/></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Time course of acute kidney injury and progression to chronic kidney disease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AKI is caused by several factors including infection, trauma and myocardial infarction. According to the Healthcare Cost and Utilization project, there are more than 3.7 million patients hospitalized each year who have AKI in the US. Of these, 71% have Stage 1, 17% have Stage 2 and 12% have Stage 3 so that Stage 2 and Stage 3</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patients represent an incidence of over 1 million per year in the US alone. Additionally, over half of the Stage 2 and Stage 3 patients will have some form of respiratory failure and in these patients the expected mortality while hospitalized and up to 90 days post discharge is 50% or more. Currently there are no drugs that directly treat AKI and standard of care includes fluids, diuretics, nutritional support, and correction of the underlying cause of the AKI. Patients who suffer AKI may over the course of months develop chronic kidney disease and may go into end-stage renal failure. The goal of treatment would include reducing the need for dialysis, kidney transplantation, long-term illness and death.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_9.jpg" alt="img247211528_9.jpg" style="width:643px;height:216px;"/></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Early treatment with Auxora could offer significant benefits to AKI patients and prevent disease progression.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KOURAGE: Ongoing Phase 2 Clinical Trial in Severe Acute Kidney Injury</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KOURAGE is a randomized, double-blind, placebo-controlled study that will evaluate 150 patients with Stage 2 and 3 AKI who have AHRF and are receiving oxygen by non-invasive mechanical ventilation, high flow nasal cannula or IMV. Patients will be stratified by classification of stage of AKI as well as the use of IMV. Patients will receive either a four-hour infusion of Auxora or placebo at 1.25 mL/kg as a first dose, after which they will receive Auxora or placebo at 1.0 mL/kg at hours 24, 48, 72 and 96. The primary endpoint of the trial will be evaluation of patients through day 30 to determine days alive, ventilator-free and dialysis-free.  Secondary endpoints will include a composite of all-cause mortality, decrease in eGFR, and the incidence of dialysis over a period of 90 days, also known as MAKE-90. The first patient was enrolled in KOURAGE in July 2024, and we anticipate data to be available around the end of 2025.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_10.jpg" alt="img247211528_10.jpg" style="width:670px;height:214px;"/></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical Observations Supporting the Potential Use of Auxora in Acute Kidney Injury</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While the purpose of CARDEA was to test Auxora in severe COVID-19 pneumonia patients, AKI was reported in a number of patients as it is a common sequalae of this disease. We observed ~40% reduction in the frequency of newly reported AKI in patients treated with Auxora compared with placebo patients. In addition, in a post-hoc analysis analyzing 38 patients who enrolled in CARDEA with AKI, defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&#178;, in addition to moderate or severe respiratory failure, which was an inclusion criterion, we observed a 62.7% relative reduction versus placebo in mortality at day 30 which persisted through day 60.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><img src="img247211528_11.jpg" alt="img247211528_11.jpg" style="width:720px;height:266px;"/></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reduction in Mortality and Newly Reported AKI in CARDEA.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:11.194%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:5.108889039028894%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">N = 261 in efficacy data set, 281 in safety outcome data set</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:11.194%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:5.108889039028894%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">38 patients who enrolled with AKI, defined as an estimated glomerular filtration rate (eGFR) &#8804; 60 ml/min/1.73 m&#178;</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Biomarker analysis from blood samples taken from over 190 CARDEA patients further showed that Auxora had a positive impact on biomarkers in these patients. For example, Angiopoietin-1, Angiopoietin-2, and D-dimer levels are biomarkers for vascular endothelial cells. Angiopoietin-1 levels correlate with the maintenance of vascular integrity while Angiopoietin-2 and D-dimer levels correlate with endothelial inflammation and malfunction. We observed that Angiopoietin-1 levels increased more in patients treated with Auxora compared to placebo while Angiopoietin-2 and D-dimer levels decreased more. These changes were statistically significant and suggest a potential application for Auxora in AKI where endothelial cell function is compromised. Finally, work by others demonstrated that elevated serum IL&#8208;17 levels, a CRAC channel mediated cytokine, were differentially elevated in critically ill patients with Stage 2 and 3 AKI when compared to those without AKI and the extent of elevation was independently associated with both hospital mortality and long-term adverse outcomes.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_12.jpg" alt="img247211528_12.jpg" style="width:656px;height:235px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Angiopoietin-1 levels show a statistically significant greater increase in Auxora-treated patients compared to placebo patients while Angiopoietin-2 and D-dimer levels show a statistically greater decrease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical Studies with Auxora in Acute Kidney Injury</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In collaboration with researchers at Indiana University, we have conducted a series of studies referred to as Study 1 and Study 2 comparing Auxora with placebo in a rat model of AKI. In Study 1, AKI was induced in a rat model through ischemia reperfusion injury (&#8220;I/R&#8221;), a transient ligation of the renal artery, while control animals underwent sham-surgery. Within 30 minutes of injury, the animals were treated with a single intravenous infusion of either 16 mg/kg of Auxora or placebo over a period of four hours. GFR, an important indicator of kidney function, was evaluated at 24 hours post-injury. Study 2 evaluated recovery of kidney function following I/R similar to Study 1 but varying in intensity to mimic different severity of disease. In Study 2, GFR was measured two to four hours after injury but before treatment, and treatment with 16 mg/kg of Auxora or placebo was administered at six, 24 and 48 hours post-injury, with GFR again evaluated at 72 hours.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results from Study 1 showed that at 24 hours post-injury, GFR was significantly higher in rats treated with Auxora 30 minutes after injury versus placebo (61%, p&lt;0.05). Additionally, animals treated with Auxora showed a reduction in mononuclear (Th17 producing) cells in the kidney of approximately 50% as compared to those treated with placebo. In Study 2, in a group of animals with initial GFR reductions of approximately 50%, similar to Stage 2 AKI, GFR at 72 hours was significantly greater in Auxora-treated animals as compared to placebo-treated animals (0.81</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#177;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">0.03 vs. 0.47</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#177;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">0.04 ml/min/100g respectively; p&lt;0.001). In a group of animals with GFR reductions &#8805;66%, similar to Stage 3 AKI, placebo-treated rats experienced 100% mortality by 72 hours while Auxora-treated rats had no mortality at 72 hours and were stable, showing modest recovery of kidney function. These results indicate that Auxora has the ability to hasten the recovery of kidney function and improve survival in rat models of AKI.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_13.jpg" alt="img247211528_13.jpg" style="width:532px;height:254px;"/></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Study 1 results showing greater recovery of GFR in Auxora treated rats versus placebo as well as a reduction on mononuclear (Th17 producing cells.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_14.jpg" alt="img247211528_14.jpg" style="width:506px;height:269px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Study 2 results show the effects of Auxora on recovery of renal function after establishment of renal functional impairment. GFR is shown at two hours and 72 hours post I/R. Panel A: results from rats with initial loss of GFR of approximately 50% between two to four hours post I/R show that the recovery of GFR is greater in Auxora treated animals (n=5) compared to placebo (n=4). Panel B: results from rats with an initial loss of GFR &#8805; 66% show that placebo-treated rats (n=3) did not survive while Auxora-treated rats (n=2) survived.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Pancreatitis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted two Phase 2 clinical trials of Auxora in AP. In a Phase 2a clinical trial of Auxora in AP patients with SIRS along with hypoxemia predicted to have moderate or severe AP, Auxora treatment was associated with reduced local and systemic inflammation, improved ability to tolerate solid food, and shorter hospital stays. In CARPO, the medium and high doses of Auxora both showed a 100% relative risk reduction compared to placebo in new-onset severe respiratory failure. This effect was statistically significant for the high and medium dose arms individually (p&lt;0.05) and for the combined high and medium doses of Auxora patients compared with the combined placebo and low dose of Auxora patients (p=0.0027). We have received Fast Track designation from the FDA and orphan drug designation in the EU from the EMA for Auxora for the treatment of AP. However, there is no guarantee that Fast Track designation will result in a faster regulatory review or regulatory approval. We plan to hold an End-of-Phase 2 meeting with the FDA around the middle of 2025 and expect to be in a position to initiate a Phase 3 program in AP and accompanying SIRS around the end of 2025 pending additional funding.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_15.jpg" alt="img247211528_15.jpg" style="width:556px;height:192px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Treatment with Auxora could offer significant benefits to AP patients and prevent disease progression.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acute Pancreatitis Background</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acute pancreatitis is an acute inflammatory process of the pancreas that presents as severe upper abdominal pain, often accompanied by nausea and vomiting. During episodes of the disease, inflammation of the pancreas occurs, which can lead to pancreatic cell death or necrosis and systemic inflammation. Normal pancreatic functions, such as the secretion of digestive enzymes required to break down carbohydrates and fats, are disabled. There are no approved therapies for AP but most cases are mild and resolved after several days of supportive care, including avoiding oral feeding in the short term to not further aggravate the pancreas. Most patients are hospitalized and require IV fluids and monitoring for development of more severe symptoms.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severe complications arise because of the acute inflammatory response that takes place in the pancreas. These complications can lead to SIRS, in which the function of other tissues or organs, including the lung, may be compromised. Approximately one third of patients with severe AP develop acute lung injury or ARDS. Lung failure accounts for approximately 60% of deaths associated with AP in developed countries.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_16.jpg" alt="img247211528_16.jpg" style="width:520px;height:251px;"/></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are an estimated 300,000 hospitalizations for AP annually in the United States. Mortality in mild AP is less than 1% but climbs to 20-30% in patients with persistent, severe disease. Approximately 40% of hospitalized AP patients present with SIRS and are predicted to have moderate or severe disease, with 15% actually developing severe AP. The target population for Auxora in our ongoing Phase 2b clinical trial is AP patients with accompanying SIRS, which we estimate to be approximately 100,000 patients per year in the United States alone.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leading causes of AP are gallstones and resulting elevated levels of bile salts, and alcohol metabolites, together accounting for 60-80% of all cases depending on the specific population examined. Other causes include: hypertriglyceridemia, familial (genetic) types, hypercalcemia, abdominal injury or trauma (including endoscopic retrograde cholangiopancreatography), cancer, drug-induced, or autoimmune, each making up smaller slices of the total AP population. These different causes all appear to lead to a common mechanism in which calcium within pancreatic cells drives pathology.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_17.jpg" alt="img247211528_17.jpg" style="width:540px;height:261px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inhibition of CRAC channels has the potential to impact multiple pathologies associated with AP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excessive signaling through calcium-dependent pathways has been linked to multiple pathologies associated with AP. A primary function of the pancreas is to produce enzymes that are required to digest food. The secretion of these enzymes from the pancreas is dependent on the periodic release of calcium from internal stores in cells called the pancreatic acinar cells. In AP, aberrant activation of these cells results in elevated, toxic levels of intracellular calcium and, as a consequence, the inappropriate activation of digestive enzymes inside the cells causes the acinar cells to self-digest.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acute pancreatitis is also associated with a high level of inflammation. In some patients, the release of inflammatory cytokines and the triggering of SIRS can lead to life-threatening distal organ failure. Previous studies have established a strong link between calcium signaling and the release of inflammatory cytokines. The most frequent systemic complications in severe cases of AP are respiratory dysfunctions ranging from hypoxemia to ARDS. As in the case with ARDS from other underlying causes, AP-associated ARDS is the result of both increased vascular permeability and an increase in inflammation, which we believe are CRAC channel-dependent processes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Complete Phase 2a Clinical Trial in Acute Pancreatitis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed a Phase 2a clinical trial of Auxora in 21 patients with AP with predicted severe or moderately severe disease as determined by the presence of SIRS and hypoxemia. Patients were enrolled in two cohorts. Fourteen patients received Auxora plus SOC and seven received SOC only. The Auxora- treated patients received a daily IV dose of Auxora for up to four days. As an early-stage proof of concept trial, this trial was not powered for statistical significance for any of the endpoints.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_18.jpg" alt="img247211528_18.jpg" style="width:614px;height:259px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trial design for Auxora AP Phase 2a clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The primary symptom associated with AP is severe upper abdominal pain. Patients with AP are unable to tolerate any solid food without an increase in pain or the occurrence of nausea or vomiting until the pancreatitis resolves. In this clinical trial, only one patient in the Auxora-treated group and one patient in the SOC group were tolerating solid food at study entry. After 72 hours, seven of 14 Auxora patients were tolerating solid food while only one of seven SOC patients was tolerating solid food. At the time of hospital discharge, 13 of 14 Auxora patients could tolerate solid food compared to three of seven SOC patients.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_19.jpg" alt="img247211528_19.jpg" style="width:285px;height:245px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acute pancreatitis patients treated with Auxora were able to tolerate food sooner than matched controls.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora was generally well-tolerated in the trial. Treatment-emergent adverse events (&#8220;TEAEs&#8221;) were reported in 12 (86%) patients receiving Auxora and four (43%) patients receiving SOC alone. The majority of adverse events (&#8220;AEs&#8221;) in patients treated with Auxora were mild and considered resolved or resolving at the end of the trial. Severe TEAEs occurred in two patients (14%) receiving Auxora and two patients (29%) receiving SOC alone. Three patients (21%) treated with Auxora and two patients (29%) treated with SOC alone developed serious adverse events (&#8220;SAEs&#8221;). One death occurred in the Auxora treatment arm which was attributed to abdominal compartment syndrome and multi-organ failure. None of the AEs were deemed to be Auxora-related by the principal investigators. A summary of AEs reported in two or more patients receiving Auxora is listed below.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_20.jpg" alt="img247211528_20.jpg" style="width:527px;height:160px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Adverse Events Reported by Two or More Patients Receiving Auxora.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following SAEs occurred in patients treated with Auxora: death, non-infective cystitis, acute pancreatitis, sepsis, ARDS, hypoxic-ischemic encephalopathy (a type of brain dysfunction), pneumonia, respiratory failure and pulseless electrical activity. None of the SAEs were deemed to be Auxora-related by the principal investigators.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CARPO: Completed Phase 2b Clinical Trial in Acute Pancreatitis</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed CARPO, a randomized, double-blind placebo-controlled Phase 2b clinical trial in patients with AP and accompanying SIRS. This was a randomized, double-blind, placebo-controlled trial examining three dose levels of Auxora versus placebo. The clinical trial randomized patients 1:1:1:1 into one of four cohorts: high dose (2.0 mg/kg), medium dose (1.0 mg/kg), low dose (0.5 mg/kg), and matching placebo. Study drug was given intravenously over four hours once daily for three consecutive days. The primary objective of CARPO was to determine the optimal dosing regimen of Auxora that would effectively reduce the severity of AP and improve clinical outcomes. Secondary objectives included assessing the safety and tolerability of the varying doses of Auxora. The primary endpoint for determination of a dose response was time to solid food tolerance. The secondary endpoint for the determination</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of a dose response was the development of severe respiratory failure. Additional endpoints that were evaluated with the purpose of constructing a composite endpoint for a future Phase 3 trial included time to severe organ failure, medically indicated discharge, length of hospital stay, and the development of necrotizing pancreatitis, defined as pancreatic or extra-pancreatic necrosis. Time to solid food tolerance was defined as the time from the start of the first infusion of study drug to the time when the patient was able to eat &#8805; 50% of a low fat, &#8805; 500-calorie solid meal without an increase in abdominal pain or vomiting in the two hours after that meal and all subsequent meals while hospitalized. Severe respiratory failure was defined as respiratory failure that required the use of  IMV or the use for &#8805; 48 hours use of either high flow nasal cannula (HFNC) or non-invasive mechanical ventilation (&#8220;NIMV&#8221;). Time to medically indicated discharge was defined as the time from the start of the first infusion of study drug to the time where all three of the following criteria were met: the patient tolerated solid food; abdominal pain was controlled or resolved, which was defined by a reduction in pain, as assessed by the PNRS scale, of &#8805;50% from the peak level in the first 24 hours and no use of opioids; there was no clinical evidence of an infection that required continued hospitalization. A win ratio was calculated for each Auxora dose group compared to placebo using a hierarchical composite of mortality, new onset severe respiratory failure, necrotizing pancreatitis, and time to medically indicated discharge.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">216 patients were enrolled into the study in 37 centers. The median (25th %, 75th %) patient age was 43 (34, 57) years and the study groups were balanced with respect to sex, race, ethnicity, median BMI and alcohol consumption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_21.jpg" alt="img247211528_21.jpg" style="width:720px;height:285px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trial design for CARPO, Phase 2b clinical trial in AP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CARPO met its study objective by showing a dose response for time to solid food tolerance as well as other clinical endpoints. The primary endpoint of median time to solid food tolerance in the pre-specified subgroup of patients with hyper-inflammatory acute pancreatitis showed a statistically significant dose response with placebo patients requiring 4.7 days to tolerate solid food and patients in the high dose group showing a 1.9 day improvement (41.0% relative risk reduction) when compared to placebo, the medium dose group a 2.1 day improvement (43.6% relative risk reduction) and the low dose group a 1.5 day improvement (31.0% relative risk reduction). In patients without hyper-inflammatory AP, Auxora did not show a measurable benefit due to the patients tolerating solid food relatively quickly in all treatment groups.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora additionally showed a reduction in severe organ failure. Specifically, new onset severe respiratory failure was reduced by 100% (p=0.0027) in the combined medium and high dose patient population when compared to the combined placebo and low dose patient population. Additionally, this effect was statistically significant for the high and medium dose arms individually compared to the placebo arm(p&lt;0.05). Further, Auxora reduced new onset persistent respiratory failure by 64.2% (p=0.0476) when comparing these same patient groups.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><img src="img247211528_22.jpg" alt="img247211528_22.jpg" style="width:714px;height:270px;"/></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reduction in Severe Organ Failure and New Onset Severe Respiratory Failure in CARPO.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There was an approximately 20% relative risk reduction for new onset necrotizing pancreatitis for patients in the high dose group compared to placebo patients and these high dose patients also had median time to medically indicated discharge of 15 hours less than placebo patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_23.jpg" alt="img247211528_23.jpg" style="width:697px;height:262px;"/></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reduction in Severe Organ Failure and New Onset Severe Respiratory Failure in CARPO.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, a stratified win-ratio analysis of certain key endpoints gave a stratified 1.640 win-ratio benefit (p=0.0372) for the high dose patients compared to placebo patients.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.15pt;text-align:center;"><img src="img247211528_24.jpg" alt="img247211528_24.jpg" style="width:696px;height:178px;"/></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Win-Ratio analysis of key endpoints in CARPO.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As in prior Phase 2 trials, Auxora was well-tolerated. There was a trend of decreasing treatment emergent serious adverse event (TESAE) rates with increasing doses of drug. Additionally, there were no drug-related TESAEs or deaths in patients receiving the high dose of Auxora.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRSPA: Ongoing Open-Label Phase 1/2 Clinical Trial in AIPT (Pancreatitis as a Side Effect of Pediatric ALL Treatment)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRSPA is a 24-patient open-label Phase 1/2 investigator-sponsored clinical trial being conducted by St. Jude Children&#8217;s Research Hospital (&#8220;JCRH&#8221;) and exploring Auxora as a potential therapy in pediatric patients that develop AIPT as a result of treatment for their underlying acute lymphoblastic leukemia (&#8220;ALL&#8221;). Current therapies for ALL result in long term survival for over 90% of pediatric ALL patients. One of the mainstays of therapy in these patients is asparaginase (e.g., ONCASPAR&#153; and RYLAYZE&#153;), an enzyme that degrades the amino acid asparagine, which is essential for the leukemic cells to survive. However, the administration of asparaginase triggers the development of pancreatitis or AIPT in 7-10% of patients of the over 3,000 pediatric ALL patients treated per year in the US, with similar numbers in Europe. AIPT is a severe complication characterized by intense abdominal pain, nausea, vomiting and SIRS. AIPT can lead to further chronic problems such as insulin dependence, exocrine pancreatic insufficiency and chronic pain. Many of these children can no longer be treated with asparaginase which can have a negative impact on their recovery from ALL. It has been shown that over 50% of patients with AIPT develop pseudocysts or pancreatic necrosis. There is currently no disease modifying treatment for AIPT and standard of care only addresses the symptoms of the disease.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In CRSPA, pediatric patients suffering from AIPT are enrolled and treated with four daily doses of Auxora with the primary endpoints of safety, tolerability and the reduction in development of complications of AIPT, including necrotizing pancreatitis and SIRS.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investigators at SJCRH presented results from the first cohort of the CRSPA study at the ASH meeting in December 2023. This cohort of patients consists of nine children (average age 8.2 years) with ALL</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">who have developed AIPT (referred to as AAP in the abstract). Eight of nine patients in the CRSPA study received a full regimen of four daily doses of Auxora at dose level 1 (30mg/m</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on day one and 42mg/m</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on days two through four) administered as a four-hour infusion. Results from these patients were compared to a matched historical control group of 16 patients out of a total of 51 patients who developed AIPT within 30 days of receiving asparaginase in the Total Therapy XVI study (&#8220;T16&#8221;) being conducted at SJCRH.</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The comparison showed that Auxora reduced the average number of days patients spent in the hospital from 13.4 to 6.3 days. The need for ICU care was also reduced, with three control patients (18.8%) requiring ICU care compared to one treated patient (12.5%), and the average number of days in the ICU was reduced from five to three days. Additionally, no patients in the CRSPA study required TPN, compared to 68.8% in the historical matched control group, who required 27 days of nutritional support on average. Finally, blinded central reading of pancreatic imaging showed a reduction in the development of significant pancreatic necrosis (&#8805;30%) and the severity of acute pancreatitis by computed tomography severity index (&#8220;CTSI&#8221;) scoring in patients treated with Auxora</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compared to the matched historical cohort. Based on these results, investigators have established the dose level used in this cohort as the recommended Phase 2 dose (&#8220;RP2D&#8221;) of Auxora for children with ALL experiencing AIPT and will continue to enroll an additional 15 patients at this dose level to reach full enrollment at 24 patients.  CRSPA has expanded to additional sites and is over 50% enrolled, and we expect to provide an update in the second half of 2025.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total 16 (T16): All AIPT</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Matched T16 AIPT cohort</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CRSPA evaluable for efficacy</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patients with AIPT</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Age: mean (range)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3 (2.2-19.4)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9 (2.2-18.4)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.2 (3.1-17.6)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Female (%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17 (33.3%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 (31.3%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 (37.5%)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Low-risk therapy (%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9 (17.6%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 (6.3%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2 (25%)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Hospital days (range)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.1 (2-70)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.4 (2-27)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3 (5-8)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ICU needed (%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11 (21.6%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3 (18.8%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1 (12.5%)</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
    <td style="width:25%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ICU days mean (range)</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.1 (1-9)</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5 (3-7)</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TPN needed (%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27 (52.9%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11 (68.8%)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">TPN days mean (range)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.7 (3-153)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.2 (4-63)</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NA</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8805;30% pancreatic necrosis (%)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NA</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4 (26.7%) *</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CTSI mean (range)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NA</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4 (0-10) *</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4 (0-4)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CTSI &#8805; 7 (%)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NA</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4 (26.7%) *</span></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid #000000;padding-left:0.08in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One patient in matched T16 cohort was unable to be evaluated for pancreatic necrosis or a CTSI score.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CTSI score definitions:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">0-3 mild acute pancreatitis</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4-6 moderately severe acute pancreatitis</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8805;7 severe acute pancreatitis</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">According to clinical data published by Mauney, et. al., in the Journal of Pediatric Gastroenterology and Nutrition in March 2022, patients who developed AIPT had a median length of stay in the hospital of ten days consistent with that seen in the T16 database which is greater than the six day median length of stay for patients treated with Auxora, reflecting a faster resolution of symptoms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reclinical Studies with Auxora in AP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Treatment with Auxora led to a decrease in inflammatory markers in both the pancreas and the lung in a cerulein-induced rat model of AP. In this AP model, rats were given four hourly intraperitoneal injections of cerulein to induce pancreatitis and Auxora was given in a therapeutic mode by a four-hour intravenous infusion, starting 30 minutes after the first cerulein injection. Animals were examined 30 minutes after the end of infusion. Cerulein overstimulates pancreatic acinar cells, causing overactivation of CRAC channels, premature activation of digestive enzymes, mitochondrial dysfunction and death of the acinar cells, as well as enhanced accumulation of cytokines. Auxora administered post-insult decreased the acinar cell damage (50% as measured by histopathology) and decreased mRNA transcript levels (measured by quantitative real-time polymerase chain reaction) of myeloperoxidase (&#8220;MPO&#8221;) (80-90%) a biomarker of neutrophil activation, and the inflammatory cytokines TNF&#945; (80-90%), and IL-6 (80-90%) in the pancreas. Similar to AP in patients, inflammatory signals in the cerulein model are also observed in the lungs. The anti-inflammatory effects of Auxora in the pancreas were mirrored in lung tissue.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_25.jpg" alt="img247211528_25.jpg" style="width:462px;height:275px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora inhibited the expression of MPO, TNF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#945;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and IL-6 in the cerulein-induced acute pancreatitis model in both the pancreas and lung. These results have been published in The Journal of Physiology.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with the data described above, treatment with the active ingredient in Auxora, zegocractin, decreased pancreatic damage in two other models of AP in mice, gallstone and alcohol models. AP in a gallstone model was elicited by retrograde pancreatic ductal injection of a bile acid and in the alcohol model by intraperitoneal injections of a fatty acid and ethanol. Both bile acids and fatty acids + ethanol induce AP by overactivation of CRAC channels. Zegocractin was given by intraperitoneal injection in a therapeutic mode at one and 13 hours after disease induction and animals were examined 24 hours after disease induction. Under these conditions,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">zegocractin decreased the amount of inflammation, edema and acinar cell damage (each close to 50% as measured by histopathology; see the figure below).</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_26.jpg" alt="img247211528_26.jpg" style="width:378px;height:309px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Zegocractin decreases pancreatic damage in two models of AP in mice. Shown are histology photomicrographs of the pancreas. The top panels are examples from control animals in both the gallstone (left) and alcohol (right) models showing the presence of inflammatory cells (small dark dots), edema (white areas) and acinar cell necrosis (light red). Bottom panels are from animals treated with Zegocractin, showing reduced inflammation, edema and necrosis. White bars = 50 m.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ability of the pancreas to secrete digestive enzymes, fluid and bicarbonate is critical for the ability to digest food. Various toxins, including an alcohol metabolite, fatty acid ethyl ester, or bile acids can cause the premature activation of these digestive enzymes within the pancreas, leading to self-digestion and pancreatic cell death. One of the primary treatments for AP has been to completely stop all orally administered food for several days. A sign of the resolution of a case of AP is the ability to tolerate food, requiring functioning pancreatic ductal cells and appropriate secretion of digestive enzymes, fluid and bicarbonate. Thus, restoration of pancreatic ductal cell secretion is thought to be a critical element in the treatment of AP.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CRAC channel inhibition preserved pancreatic ductal fluid secretion in the cerulein-induced AP model in mice as well as in gallstone and alcohol models of AP. The mouse cerulein-induced AP model was performed like the rat model described above, except that seven hourly injections of cerulein were used and animals were examined 12 hours after the first cerulein injection. AP in the gallstone model was elicited by retrograde pancreatic ductal injection of a bile acid and in the alcohol model by intraperitoneal injections of a fatty acid and ethanol. Pancreatic fluid secretion was measured by collection of pancreatic juice from the pancreatic duct over a 30 minute period. In all three models, CM5480, a preclinical CRAC channel inhibitor model compound, given by intraperitoneal injection after disease onset was able to preserve pancreatic ductal fluid flow, suggesting that CRAC channel inhibition may have a direct protective effect on ductal cells that could help resolve AP.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_27.jpg" alt="img247211528_27.jpg" style="width:371px;height:230px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CM5480 (CM-C) treatment led to the preservation of pancreatic ductal secretion in a cerulein-induced acute pancreatitis model.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora for the Treatment of Acute Respiratory Failure</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The pathology of COVID-19 is consistent with both a significant increase in the levels of inflammatory cytokines and with the associated deterioration of lung barrier function that can culminate in ARDS. In the first quarter of 2020, we recognized that observations from our clinical trial of Auxora in patients with AP provided support for conducting a clinical trial to assess the potential of Auxora in severe COVID-19 pneumonia patients. In AP patients presenting with markedly elevated levels of IL-6, there was a significant reduction in IL-6 levels over the course of therapy in patients who were treated with Auxora versus SOC alone. Of the four AP patients enrolled in our Phase 2a clinical trial who presented with respiratory failure and were treated with Auxora, only one required intubation and mechanical ventilation. There was only one patient in the SOC control group with respiratory failure and this patient required intubation and mechanical ventilation. This preliminary data and the strong preclinical rationale both led us to propose that Auxora may have therapeutic benefit in the treatment of other diseases with respiratory failure, including severe COVID-19 pneumonia.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2020, we initiated a clinical trial to test Auxora in COVID-19 patients hospitalized and requiring oxygen therapy but not on ventilators. This trial was initially conducted as a Phase 2 randomized, open-label clinical trial in severe COVID-19 pneumonia patients with varying degrees of respiratory failure where time to survival, blood oxygen levels, ventilator use and mortality were evaluated. At our first safety analysis of the data we observed that patients receiving Auxora with SOC were less likely to be placed on mechanical ventilation or to die, and they experienced a reduced time to recovery than those treated with SOC alone. After 30 patients were enrolled in this first part of the trial (Part 1), the FDA recommended that we move to Part 2 of the trial and study Auxora in a randomized, double-blind, placebo-controlled clinical trial. Part 2 was initiated in September 2020, completed in the third quarter of 2021, and enrolled 284 severe COVID-19 pneumonia patients. We observed that patients treated with Auxora experienced a reduced time to recovery, higher rate of recovery and reduced mortality.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVID-19 and Acute Respiratory Failure Background</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVID-19 is a disease caused by the SARS-CoV-2 virus, a pandemic strain of coronavirus. Respiratory illness is the most common symptom associated with COVID-19; severity ranges from mild disease to life-threatening ARDS.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Most cases of COVID-19 occur approximately four to five days after exposure to the virus. Patients present with symptoms that include fever, dry cough, body ache, sore throat and diarrhea. As the disease progresses, some patients develop shortness of breath resulting from lung injury and are hospitalized. In the majority of these patients, this condition resolves over time, but in up to 20% of patients, it progresses to moderate to severe ARDS requiring mechanical ventilation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disease progression in severe COVID-19 has similarities to that of severe community-acquired pneumonia caused by other viruses besides SARS-CoV-2 or by bacteria. The immune response to severe COVID-19 infection may result in overproduction of early response proinflammatory cytokines and may also result in complement and coagulation dysfunction, leading to an increased risk of vascular hyperpermeability, respiratory failure, multi-organ failure, and sometimes death.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Completed Phase 2 Clinical Trial in Hospitalized COVID-19 Severe Pneumonia Patients on Oxygen (CARDEA)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2020, we began enrollment of our CARDEA trial, a Phase 2, randomized, double-blind, placebo- controlled trial evaluating the addition of Auxora to corticosteroids and standard of care in adults with severe COVID-19 pneumonia. Eligible patients were adults with more than one symptom consistent with COVID-19 infection, a diagnosis of COVID-19 confirmed by laboratory testing using polymerase chain reaction or other assay, and pneumonia documented by chest imaging. Patients were also required to be receiving oxygen therapy using either a high flow or low flow nasal cannula at the time of enrollment and, for the 261 patients in the efficacy analysis set, to have at the time of enrollment, a baseline imputed PaO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/FiO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ratio &gt; 75 and &#8804; 200.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were an additional 23 patients in the trial with 200&lt;PaO2/FiO2&lt;300 who were enrolled prior to the first independent data monitoring committee meeting, where it was determined those less hypoxemic patients all recovered and were less likely to need therapy beyond current standard of care so going forward, mild ARDS patients, e.g., patients with PaO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/FiO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&gt;200, were then excluded from enrollment. The PaO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/FiO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was imputed from a SpO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/FiO</span><span style="color:#000000;white-space:pre-wrap;vertical-align:sub;font-size:5.025pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> determined by pulse oximetry using a non-linear equation. Patients could not be receiving either non-invasive or invasive mechanical ventilation at the time of enrolment. The primary endpoint was time to recovery through Day 60, with secondary endpoints of all-cause mortality at Day 30 and Day 60. All patients received corticosteroids and 99% of patients received anticoagulation treatment as part of their standard of care.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The major findings of the CARDEA Phase 2 trial as reported in April 2022 in the peer-reviewed journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Critical Care </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are as follows:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Time to recovery was seven vs. ten days (P = 0.0979) for patients who received Auxora vs. placebo, respectively.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Day 30 all-cause mortality was 7.7% with Auxora vs. 17.6%, with placebo (P = 0.0165).</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Day 60 all-cause mortality was 13.8% with Auxora vs. 20.6% with placebo (P = 0.1449).</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Serious adverse events occurred in 24.1% of patients treated with Auxora vs. 35% of patients receiving Placebo (P = 0.0616).</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_28.jpg" alt="img247211528_28.jpg" style="width:720px;height:208px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOC included 100% corticosteroid use and 99% anticoagulation use</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trial design for double-blind Phase 2 clinical trial in hospitalized COVID-19 pneumonia patients on oxygen (Part 2).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_29.jpg" alt="img247211528_29.jpg" style="width:466px;height:215px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Baseline demographics were balanced across the treatment groups in the blinded Phase 2 trial of Auxora in severe COVID-19 pneumonia.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overall mortality was significantly reduced with Auxora treatment in the 261-patient efficacy dataset. At 30 days, the mortality rate for Auxora-treated patients with 7.7% compared to 17.6% for placebo (HR 0.42 and p=0.023) &#8211; a relative decrease of 56%. At 60 days, Auxora treatment was associated with a 13.8% mortality rate compared to 20.6% for placebo (HR 0.63 and p=0.130) &#8211; a relative decrease of 33%. Both of these findings are clinically relevant particularly in light of patients needing additional therapies on top of current standard of care. Patients treated with Auxora plus SOC demonstrated a trend toward a faster median time to recovery than those treated with SOC plus placebo. Our primary recovery endpoint was determined in the 261-patient efficacy analysis set where Auxora treatment demonstrated a trend toward a reduced time to recovery with a median of seven days compared to ten days with placebo (p=0.098). In an FDA-required supplementary analysis of our primary endpoint in the 284 patient safety analysis set (which included 23 patients with mild COVID-19 pneumonia (P/F 201 to 300)), the median recovery time for Auxora treated patients was maintained at seven days, while the median recovery time for placebo treated patients decreased to eight days (p=0.042). In both analysis sets, the percent of patients that recovered in the trial was higher when Auxora was added to SOC therapy. The recovery rate ratio, defined as the percent of patients who did not recover on placebo compared to the percent that did not recover with Auxora, was 1.25 for the efficacy analysis set and 1.30 for the safety analysis set. This means that not only did patients treated with Auxora plus SOC demonstrate a trend toward a reduced time to recovery, but that they were more likely to recover than patients treated with placebo plus SOC.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other key findings in the study were that patients receiving Auxora saw their PaO2/FiO2 ratios recover more quickly than patients receiving placebo and proportionally fewer patients receiving Auxora required ventilation over their course of treatment than patients receiving placebo. There were also fewer patients with reported serious adverse events in the Auxora treated group than in those receiving placebo. These findings are all clinically relevant, particularly given the relative risk reduction in mortality for patients</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receiving Auxora in addition to standard of care. Finally, there were improvements in a number of inflammatory biomarkers in Auxora treated patients versus those receiving placebo. Specifically, C-reactive protein, ferritin and d-dimer levels dropped over the course of six days and were lower than placebo over that time. CD-25 levels, which are a surrogate for the expansion of pro-inflammatory CD25+CD8 T cells that have been associated with mortality, were statistically significantly lower in Auxora patients compared to placebo.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_30.jpg" alt="img247211528_30.jpg" style="width:521px;height:213px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora positive effects compared to placebo on multiple clinical endpoints in CARDEA (N=261)</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_31.jpg" alt="img247211528_31.jpg" style="width:540px;height:278px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora positive effects compared to placebo on multiple biomarkers of respiratory inflammation in CARDEA (N=261)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_32.jpg" alt="img247211528_32.jpg" style="width:392px;height:203px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Auxora plus SOC demonstrated a significant decrease in mortality compared to placebo plus SOC. (N=261)</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_33.jpg" alt="img247211528_33.jpg" style="width:414px;height:248px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Kaplan Meier curve of mortality. Auxora plus SOC (blue), placebo plus SOC (red). (N=261)</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auxora was generally well-tolerated in our CARDEA trial. The number of adverse events in the blinded part of the study was similar between the two treatment groups (patients randomized to Auxora (331); patients randomized to placebo (342)). Fewer patients randomized to Auxora (34, 24.1%) had SAEs compared to patients randomized to Placebo (49, 35.0%). There were five SAEs that the investigators reported as possibly related to Auxora: increase in alanine aminotransferase (an indicator of liver dysfunction), increase in aspartate aminotransferase (an indicator of liver dysfunction), cardiac arrest, respiratory failure and shock. Two of these (increase in alanine aminotransferase and increase in aspartate aminotransferase) occurred in only two patients. There were no SAEs that required expedited safety reporting to institutional review boards or to the FDA. Three patients randomized to Auxora and five patients randomized to placebo discontinued study drug.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Planning for Additional Clinical Trials in AHRF and ARDS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the mechanism of action of Auxora and the reduction in ventilator use that was observed in our COVID-19 pneumonia and AP clinical trials, we believe that Auxora has the potential to bring therapeutic benefit to a broader population of patients suffering from AHRF and ARDS. Our recent work elucidating the activity of Auxora in an LPS-induced mouse model of respiratory failure confirmed that the drug down-regulates inflammatory cytokines in the lungs and likely protects the lung endothelium from damage.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The broader ARDS patient populations include many etiologies including sepsis, viral pneumonia, bacterial pneumonia and trauma. The incidence of ARDS is estimated to be approximately 190,000 cases per year in the United States alone, with sepsis being the most common cause. We believe that the Auxora clinical data in COVID-19 pneumonia suggests that Auxora can potentially be used in most ARDS settings. We are currently evaluating opportunities to continue clinical development of Auxora in the setting of acute respiratory failure particularly in partnership with sponsors such as government agencies both in the US and outside of the US.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical studies for Chronic Inflammatory and Immunological Diseases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing oral CRAC channel inhibitors that we intend to take into indications which are not treated in a critical care setting such as chronic inflammatory and immunological diseases. We have obtained or generated preclinical data that support the use of CRAC channel inhibitors in indications such as chronic pancreatitis, rheumatoid arthritis, asthma and psoriasis where an IV formulation would not represent a viable therapeutic approach. Repeated attacks of AP, as well as heavy alcohol use and genetic anomalies, can lead to the development of chronic pancreatitis, a debilitating disease characterized by pain, fibrosis and declining pancreatic function that increases the risk of developing pancreatic cancer by a factor of ten to 100. According to the Pancreatitis Foundation, approximately 140,000 people suffer from chronic pancreatitis in the United States alone. We believe this will be considered an orphan indication and intend to apply for orphan designation with the FDA. While there are numerous treatments for rheumatoid arthritis, most patients require injectable immunomodulatory drugs as the disease progresses. The need for safe oral therapies for more advanced patients persists. We are evaluating chronic pancreatitis and rheumatoid arthritis as potential first indications for our potential oral drug candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical Study with a CRAC Channel Inhibitor in Chronic Pancreatitis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our preclinical studies of CM5480, a proprietary compound, in chronic pancreatitis suggest that CRAC channel inhibition may decrease fibrosis and organ dysfunction in this setting. We have performed certain  IND-enabling preclinical studies with multiple</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">proprietary compounds in order to identify one or more candidates with good pharmaceutical properties. CM6336, one such oral CRAC channel inhibitor in our pipeline, is structurally distinct from CM5480 but with potentially improved pharmacokinetic properties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We tested CM5480 in a mouse model of chronic pancreatitis, in which animals are given eight hourly injections of cerulein per day on five occasions, each separated by two intervening cerulein-free days. CM5480, a model compound, was given by once-daily intraperitoneal injections for nine days starting after the third round of cerulein injections. The cerulein injections produced pancreatic fibrosis and reductions in pancreatic epithelial (mostly acinar) cells and ductal cell secretion. We found that CM5480 reduced pancreatic fibrosis by 50%, modestly increased epithelial cells, and restored pancreatic ductal cell secretion. These results suggest that there is the potential to treat chronic pancreatitis with a CRAC channel inhibitor, especially one that can be readily administered to patients, such as with an oral formulation.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_34.jpg" alt="img247211528_34.jpg" style="width:501px;height:198px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_35.jpg" alt="img247211528_35.jpg" style="width:515px;height:209px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CM5480 (CM-C) reduced acinar cell necrosis (top panels), prevented the formation of fibrosis (bottom left) and restored pancreatic ductal secretion (bottom right) in a mouse model of chronic pancreatitis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical Studies with CRAC Channel Inhibitors in Models of Rheumatoid Arthritis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Previous work by us and others has indicated that inhibition of Orai1 CRAC channels may be an effective treatment for rheumatoid arthritis. A 2015 study</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">published in the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">British Journal of Pharmacology </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">examined the effects of YM-58483 (aka BTP-2), a model CRAC channel blocker, and showed that the compound produced significant improvements in arthritis severity scores in a mouse model of collagen-induced arthritis (&#8220;CIA&#8221;). Likewise, a 2017 published study</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Journal of Pharmacological Sciences</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> showed that localized reduction of Orai1 mRNA in the joints and lymph nodes reduced the severity of arthritis in a mouse CIA model.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consistent with the findings above, in our preclinical studies we have demonstrated that several of our Orai1-selective CRAC channel blockers are efficacious at reducing histopathology in a rat model of CIA. Thus, zegocractin (CM4620) and model compounds CM5480 and CM6325 when dosed orally once-daily at 25 mg/kg produced significant reductions in knee histopathology that averaged 61%, 76% and 71%, respectively.  Data from a representative study with CM6325 is shown below.  In this study, the reductions in knee histopathology scores corresponded with reductions in a pharmacodynamic measure of stimulated IL-2 release in an ex vivo blood assay.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_36.jpg" alt="img247211528_36.jpg" style="width:510px;height:298px;"/></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CM6325 produced significant and dose-related reductions in summed knee histopathology scores (composed of measures of inflammation, pannus formation, cartilage damage and bone resorption) in rat model of collagen-induced arthritis. Blood samples taken at the end of the study showed that a pharmacodynamic (PD) readout, stimulated IL-2 release, was also decreased by CM6325 in a significant and dose-related manner. *p &lt; 0.05</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Study in Inflammatory Bowel Disease</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent animal data indicates that CRAC channel inhibition by zegocractin (CM4620) may be effective in the treatment of inflammatory bowel disease, such as ulcerative colitis. In a preclinical study performed with scientists from Charite &#8211; University Medicine, Berlin and New York University Grossman School of Medicine, it was shown that zegocractin administered orally to mice every other day for a period of 30 days produced a significant reduction in intestinal inflammation in a model of ulcerative colitis. Consistent with the anti-inflammatory action of zegocractin, reductions in the frequencies of IFN-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">g</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, TNF&#945; and IL-2 producing CD4 T cells were also observed in T cells isolated and stimulated </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex vivo </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at the end of the study. These data, published in 2022 in the journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EMBO Molecular Medicine, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suggest that zegocractin could be effective in treating patients with acute flares of inflammatory bowel disease.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_37.jpg" alt="img247211528_37.jpg" style="width:380px;height:140px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Systemic administration of CM4620 (zegocractin) alleviates colon inflammation in mice. Histological sections of distal and proximal colon were scored for the presence of inflammatory cells (Colitis Score). CD4+ T cells were isolated from animals after treatment with vehicle or CM4620 and stimulated ex vivo with a phorbol ester (PMA) + ionomycin for 4 hours. Frequencies (%) of IFN-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">g</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, TNF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#945;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and IL-2 T cells were then determined.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Study in Allergic Asthma</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The effectiveness of zegocractin (CM4620) was compared in mouse models of asthmatic airway inflammation and influenza A virus infection to determine if inhibition of CRAC channels reduces asthmatic inflammation without interfering with the antiviral response. Researchers from New York University Grossman School of Medicine showed that in a model of allergic airway inflammation oral administration of zegocractin significantly lowered both peribronchiolar inflammation and lung mucus production. Conversely, there was no effect of zegocractin on lung viral load in a model of influenza A virus infection. These results indicate zegocractin may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be an effective treatment for allergic asthma but will not decrease the anti-viral response to a viral infection. These data were published in the journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Science Advances in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2022.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_38.jpg" alt="img247211528_38.jpg" style="width:415px;height:176px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CM4620 (zegocractin) reduces lung inflammation in a mouse model of allergic asthma but does not compromise adaptive immunity to influenza A virus infection. Lung sections from control and CM4620 treated asthmatic mice were stained with hematoxylin and eosin (H&amp;E) or periodic acid- Schiff (PAS) to detect inflammation and mucus production, respectively. Influenza A virus (IAV) expression was quantified in lung by quantitative RT-PCR of RNA for nuclear segment 5 of IAV (a specific probe for IAV), and is presented as expression relative to the housekeeping gene Rpl32.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical Study in Traumatic Brain Injury</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In a preclinical study performed with investigators at the San Francisco Veterans Affairs Hospital and UCSF, CM5480, a proprietary tool compound, was tested in a mouse model of traumatic brain injury in which animals were subjected to a controlled cortical impact with an automated impactor to induce brain injury. It was observed that treatment with CM5480 led to significant protection of mice from traumatic brain injury as determined by decreased lesion size, brain hemorrhage and improved neurological deficits with decreased microglial activation. This study was published in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Journal of Neurotrauma </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in 2019.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img247211528_39.jpg" alt="img247211528_39.jpg" style="width:477px;height:174px;"/><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CM5480 (CM-EX-137) reduced injury in a traumatic brain injury model in mice.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">P-Values and Confidence Intervals</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The conventional method for measuring the statistical significance of a result is known as the &#8220;p-value,&#8221; which represents the probability of obtaining results at least as extreme as those that were observed in the study presuming that the null hypothesis of no effect is true. Generally, a p-value less than 0.05 is considered statistically significant and may be supportive of a finding of efficacy by regulatory authorities. However, regulatory authorities, including the FDA, do not rely on strict statistical significance thresholds as criteria for marketing approval and maintain the flexibility to evaluate the overall risks and benefits of a treatment. A confidence interval (&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CI</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) is a range of values within which the true value has a specified probability to exist. It is conventional to set the confidence interval at 95%, which means 95 of 100 times, the confidence interval will contain the true value. If the confidence interval does not contain the value of zero (the null value), it can be assumed that there is a statistically significant effect.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales and Marketing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given our stage of development, we have not yet established a commercial organization or distribution capabilities. We intend to build a commercial infrastructure to support sales of our product candidates. We expect to manage sales, marketing and distribution</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">through internal resources and third-party relationships. While we may commit significant financial and management resources to commercial activities, we will also consider collaborating with one or more pharmaceutical companies to enhance our commercial capabilities. As our future product candidates progress through our pipeline, our commercial plans may change. Clinical data, the size of the development programs, the size of our target markets, the size of a commercial infrastructure and manufacturing needs may all influence our commercialization strategies.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of any of our product candidates and potential future products, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely, and expect to continue to rely for the foreseeable future, on contract manufacturing organizations (&#8220;CMOs&#8221;) for all our required raw materials, drug substance and drug product needs for preclinical research, clinical trials and initial commercialization. We do not have long-term agreements with any of these third parties. We also do not have any current contractual relationships for the manufacture of commercial supplies of any of our product candidates and potential future products and do not plan to enter into any until we are further into clinical development. If any of our products are approved by any regulatory agency, we intend to enter into agreements with a CMO and one or more back-up manufacturers for the commercial production of those products. Development and commercial quantities of any products that we develop will need to be manufactured in facilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are conducting clinical research or seeking marketing approval.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The pharmaceutical and biotechnology industries are characterized by intense competition and rapid innovation. While we believe that our product candidates, as well as our development experience and scientific knowledge may provide significant advantages relative to current approaches and therapies in the treatment of acute critical illnesses and chronic inflammatory and immunologic diseases, our competitors may be able to develop other compounds or drugs that are able to achieve similar or better results. We face potential competition from many different sources, including large multinational pharmaceutical companies, established biotechnology companies and specialty pharmaceutical companies, and universities and other research institutions. Many of these groups have materially greater financial, manufacturing, marketing, research and drug development resources than we do. Large pharmaceutical companies in particular have extensive expertise in preclinical and clinical testing and in obtaining regulatory approvals for drugs. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious acute inflammatory illnesses driven by hyperinflammation processes and direct cellular damage. The molecular targets we are addressing are CRAC channels, and our most advanced clinical candidate, Auxora, is in clinical trials for AP with accompanying SIRS, AIPT, and AKI with AHRF. Other companies, including Daiichi-Sankyo Company, Limited, Rhizen Pharmaceuticals AG, PRCL Research, Inc., Vivreon Biosciences, LLC, Medshine Discovery, Inc., Eldec Pharmaceuticals, and ChemiCare srl, have CRAC channel inhibitors (including both small molecules, peptides, and monoclonal antibodies) in clinical or preclinical development for various indications. Several of these have reached Phase 1 or Phase 2 clinical trials in indications we are not currently pursuing. Any of these companies could elect to re-direct their efforts and compounds to indications we are pursuing.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to our lead indication, AP with accompanying SIRS, we are developing Auxora as a disease-modifying product candidate, whereas most other drug treatments and approaches in clinical development focus on addressing symptoms or sequelae. These include various types of pain medications, anti-inflammatories, anti-coagulants, antibiotics, fluids and feeding regimens. Ionis Pharmaceuticals has an approved drug and Amryt Pharma Plc and Regeneron Pharmaceuticals, Inc. also have agents in development that seek to reduce the risk of subsequent attacks of AP after a sentinel attack (known as recurrent AP) due to a particular etiology (familial chylomicronemia syndrome (&#8220;FCS&#8221;). FCS patients represent less than 2% of the AP population.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to AIPT, there is currently no disease modifying treatment for patients who develop pancreatic toxicity as a result of asparaginase treatment for ALL. The current SOC addresses symptoms like pain, the inability to eat, and infection, and withdraws asparaginase, a key component of the ALL treatment regimen.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to our efforts in other acute critical illnesses with Auxora, there are a number of companies that are potential competitors, particularly those with anti-inflammatory technologies. In the area of AKI, most companies in the space are pursuing strategies to prevent AKI in high risk populations. There is one ongoing clinical trial to treat AKI in the setting of sepsis, i.e., sepsis-associated AKI or SA-AKI. Other than this drug candidate, to our knowledge, there are no other novel compounds currently in clinical development in the US that are intended to treat rather than prevent AKI. If, however, a strategy to prevent AKI were to be effective, the number of patients we are targeting for Auxora could decrease. In the area of respiratory failure, acute lung injury and, specifically, COVID-19 pneumonia, there are a number of companies pursuing anti-inflammatory approaches to treating these diseases. Currently, Roche&#8217;s tocilizumab, Lilly&#8217;s baricitinib, SOBI&#8217;s anakinra and dexamethasone are all approved under EUAs to treat severe COVID-19 pneumonia patients on oxygen. Sanofi&#8217;s sarilumab which has the same mechanism of action as tocilizumab has also been recommended</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for use in severe COVID-19 pneumonia by WHO. Some of these drugs as well as others currently in development for COVID-19 pneumonia may prove efficacious in broader respiratory failure, particularly respiratory failure caused by viral pneumonias, and in other acute critical illnesses as well.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be substantially limited in the event that our competitors develop and commercialize products that are more effective, safer, more convenient or cheaper than our product candidates. In geographies that are critical to our commercial success, competitors may also obtain regulatory approvals before us, resulting in our competitors building a strong market position in advance of our product&#8217;s entry. We believe the competitive factors that will determine the success of our programs will be the efficacy, safety, pricing and reimbursement, and convenience of our future product candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have developed and continue to expand our patent portfolio for Auxora. As of December 31, 2024, we have issued patents and pending patent applications in the United States and other countries throughout the world directed to compositions of matter, various methods of use, formulations, and synthetic processes. For patents directed to compositions covering Auxora, we own four issued U.S. patents and over 60 issued patents world-wide. We also have one pending U.S. patent application and seven pending patent applications in Argentina, Japan, Canada, China and India directed to compositions covering Auxora. Composition of matter patents for Auxora have expirations ranging from 2031 and 2036 with Auxora and other pre-clinical drugs having world-wide composition of matter patents to 2036, not including any patent term adjustment or any patent term extension.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For patents and patent applications directed to methods of using Auxora for the treatment of AP, as of December 31, 2024, we own two issued U.S. patents and over 30 issued patents world-wide. We also own four U.S. patent applications, and 21 pending patent applications in the following jurisdictions:  Argentina, Australia, Canada, China, Europe, Hong Kong, India and Japan for AP and other indications. These issued patents and any patents issuing from pending U.S. and ex-U.S. applications are expected to expire between 2031-2046, not including any patent term adjustment or any patent term extension. We have also filed one U.S. patent application, and applications in Australia, Canada, China, Europe and Japan directed to using a subject&#8217;s P/F ratio (the ratio of arterial oxygen pressure to fractional inspired oxygen) as a biomarker when treating acute lung injury and acute respiratory distress syndrome with Auxora. Any patents ultimately issuing from these applications are expected to expire around 2043, not including any patent term adjustment or patent term extension. We jointly own U.S. patent application direct to treatment of pediatric pancreatitis. Any patents ultimately issuing from this application are expected to expire around 2046.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we jointly own one issued U.S. patent and, 13 issued patents world-wide directed to treatment for stroke and traumatic brain injury. These patents are expected to expire around 2036, not including any patent term adjustment or patent term extension. Also, we have filed one U.S patent application directed to treatment of non-alcoholic fatty liver disease using Auxora. Any patents ultimately issuing from this application are expected to expire around 2044, not including any patent term adjustment or patent term extension.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, for patent protection directed to formulations and crystalline forms of Auxora, we have filed one U.S. patent application, one granted in each Australia, China, and Mexico, and seven pending applications in the following jurisdictions: Australia, Brazil, Canada, Europe, Japan, and South Korea. Any patents that ultimately issue from these patent applications are expected to expire around 2038, not including any patent term adjustment or patent term extension.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to the synthetic of Auxora, we have filed two U.S. patent applications, and pending applications in Canada, China, Europe, India, Japan, and South Korea. Any patents ultimately issuing from these applications are expected to expire around 2040, not including any patent term adjustment or any patent term extension.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond patent coverage for Auxora, we have 18 issued U.S. patents, six issued patents world-wide, and a pending PCT application directed to CRAC channel inhibitors and their uses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to patent protection, we rely on trade secret protection and know-how to expand our proprietary position around our chemistry, technology, and other discoveries and inventions that we consider important to our business.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation and Product Approval</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a pharmaceutical company that operates in the United States, we are subject to extensive regulation. Government authorities in the United States (at the federal, state and local level) and in other countries extensively regulate, among other things, the research, development, testing, manufacturing, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of drug products such as those we are developing. Product candidates that we develop must be approved by the FDA, before they may be legally marketed in the United States and by the appropriate foreign regulatory agency before they may be legally marketed in a foreign country. Generally, our activities in other countries will be subject to regulation that is similar in nature and scope as that imposed in the United States, although there can be</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">important differences. Additionally, some significant aspects of regulation in Europe are addressed in a centralized way, but country-specific regulation remains essential in many respects.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. Drug Development Process</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the FDA regulates drugs under the Federal Food, Drug and Cosmetic Act (&#8220;FDCA&#8221;), and its implementing regulations. A new drug must be approved by the FDA pursuant to a new drug application (&#8220;NDA&#8221;) before it may be legally marketed in the United States. Drugs are also subject to other federal, state and local statutes and regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, and local statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to administrative or judicial sanctions. Sanctions brought by the FDA and the Department of Justice (&#8220;DOJ&#8221;), or other governmental entities, could include, among other actions, refusal to approve pending applications, withdrawal of an approval, a clinical hold, warning letters, product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process required by the FDA before a drug may be marketed in the United States generally involves the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of extensive preclinical laboratory tests, preclinical animal studies and formulation studies in accordance with applicable regulations, including the FDA&#8217;s Good Laboratory Practice (&#8220;GLP&#8221;) regulations and other applicable regulations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an IND, which must become effective before human clinical trials may begin;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an independent institutional review board (&#8220;IRB&#8221;) at each clinical site before each trial may be initiated;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation of clinical trial material in accordance with current Good Manufacturing Practices (&#8220;cGMPs&#8221;);</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials in accordance with applicable regulations, including the FDA&#8217;s good clinical practice (&#8220;GCP&#8221;) regulations to establish the safety and efficacy of the proposed drug for its proposed indication;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an NDA, including payment of application user fees, after completion of all pivotal trials, and which provides substantive evidence of the products&#8217; candidates safety and efficacy from results of nonclinical testing and clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of an NDA that the application is sufficiently complete to permit a substantive review, in which case the NDA is filed for review;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities where the drug is produced to assess compliance with the FDA&#8217;s cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential FDA audit of the preclinical and/or clinical trial sites that generated the data in support of the NDA to assess compliance with GCP regulations and data integrity, among other things;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA advisory committee review, if applicable; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of the NDA, including consideration of the views on the FDA advisory committee, if one was involved, prior to any commercial marketing or sale of the drug in the United States.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before testing any compound with potential therapeutic value in humans, the drug candidate enters the preclinical testing stage. Preclinical tests include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies, to assess the potential safety and activity of the drug candidate. The conduct of the preclinical tests must comply with federal regulations and requirements including GLPs. The sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol, to the FDA as part of the IND. An IND is an exemption from the FDCA that allows an unapproved product to be shipped in interstate commerce for use in an investigational clinical trial and a request for authorization from the FDA to administer an investigational drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for human trials. Some preclinical testing may continue even after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions regarding the proposed clinical trials and places the IND on clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA may also impose complete or partial clinical holds on an IND for a drug candidate at any time before or during clinical trials due to safety concerns or non-compliance. If the FDA imposes a clinical hold, trials may not recommence without FDA authorization and then only under terms authorized by the FDA. Submission of a study protocol, therefore, may or may not result in FDA authorization to begin a clinical trial.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the drug candidate to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#8217;s control, in accordance with GCPs, which include the requirement that all research participants provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the parameters to be used to monitor subject safety and assess efficacy. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Further, each clinical trial must be reviewed and approved by an independent IRB at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of trial participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the form and content of the informed consent that must be signed by each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information related to the investigational product, patient population, phase of investigation, study sites and investigators and other aspects of the clinical trial is made public as part of the U.S. registration of the clinical trial. Sponsors are also obligated to disclose the results of their clinical trials after completion. Disclosure of the results of these trials can be delayed in some cases for up to two years after the date of completion of the trial. Competitors may use this publicly available information to gain knowledge regarding the progress of development programs. Failure to timely register a covered clinical study or to submit study results as provided for in the law can give rise to civil monetary penalties and also prevent the non-compliant party from receiving future grant funds from the federal government.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human clinical trials are typically conducted in three sequential phases that may overlap or be combined:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The drug candidate is initially introduced into healthy human participants and tested for safety, dosage tolerance, absorption, metabolism, distribution and excretion, and the side effects associated with increasing doses and if possible, to gain early evidence of effectiveness. In the case of some products for severe or life-threatening diseases, especially when the product may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The drug candidate is evaluated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases or conditions and to determine dosage tolerance, optimal dosage and dosing schedule. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical trials.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The drug candidate is administered to an expanded patient population to further evaluate dosage and clinical efficacy at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall benefit/risk ratio of the product and provide an adequate basis for product approval. Generally, two adequate and well-controlled Phase 3 clinical trials are required by the FDA for approval of an NDA.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Post-approval studies, or Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of approval of an NDA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the development of a new drug, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to submission of an IND, at the end of Phase 2, and before an NDA is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date, for the FDA to provide advice, and for the sponsor and the FDA to reach agreement on the next phase of development. Sponsors typically use the meetings at the end of the Phase 2 trial to discuss Phase 2 clinical results and present plans for the pivotal Phase 3 clinical trials that they believe will support approval of the new drug.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA and written IND safety reports must be submitted to the FDA and the investigators for serious and unexpected AEs or any finding from tests in laboratory animals that suggests a significant risk for human participants. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, if at all. The FDA, the IRB, or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research participants or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the drug has been associated with unexpected serious harm to patients. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides authorization for whether or not a trial may move forward at designated check points based on access to certain data from the trial.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concurrent with clinical trials, companies usually complete additional animal studies and must also develop additional information about the chemistry and physical characteristics of the drug as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">drug. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are also various laws and regulations regarding laboratory practices, the experimental use of animals, and the use and disposal of hazardous or potentially hazardous substances in connection with the research. In each of these areas, the FDA and other regulatory authorities have broad regulatory and enforcement powers, including the ability to levy fines and civil penalties.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Review and Approval Processes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, preclinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests conducted on the chemistry of the drug candidate, proposed labeling and other relevant information are submitted to the FDA as part of an NDA requesting approval to market the product. Data may come from company-sponsored clinical trials intended to test the safety and effectiveness of a use of a product, or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and effectiveness of the investigational drug product to the satisfaction of the FDA. The submission of an NDA is subject to the payment of substantial user fees; a waiver of such fees may be obtained under certain limited circumstances.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the PREA requires a sponsor to conduct pediatric clinical trials for most drugs, for a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration. Under PREA, original NDAs and supplements must contain a pediatric assessment unless the sponsor has received a deferral or waiver. The required assessment must evaluate the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and support dosing and administration for each pediatric subpopulation for which the product is safe and effective. Sponsors are required to submit PSPs to the agency for review within sixty days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 clinical trial. The FDA and the sponsor must reach an agreement on the PSP although a sponsor can submit amendments to an agreed upon PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials or other clinical development programs. The sponsor or FDA may request a deferral of pediatric clinical trials for some or all of the pediatric subpopulations. A deferral may be granted for several reasons, including a finding that the drug is ready for approval for use in adults before pediatric clinical trials are complete or that additional safety or effectiveness data need to be collected before the pediatric clinical trials begin. Unless otherwise required by regulation, the Pediatric Research Equity Act does not apply to any drug for an indication for which orphan designation has been granted. However, if only one indication for a product has orphan designation, a pediatric assessment may still be required for any applications to market that same product for the non-orphan indication(s).</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA reviews all NDAs submitted to determine if they are substantially complete before it accepts them for filing and may request additional information rather than accepting an NDA for filing. The FDA must make a decision on accepting an NDA for filing within 60 days of receipt. The FDA may refuse to file any NDA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the NDA must be resubmitted with the additional information. Once the submission is accepted for filing, the FDA begins an in-depth review of the NDA. Under the PDUFA guidelines that are currently in effect, the FDA has a goal of ten months from the date of &#8220;filing&#8221; of a standard NDA for a new molecular entity to review and act on the submission. This review typically takes twelve months from the date the NDA is submitted to FDA because the FDA has approximately two months to make a &#8220;filing&#8221; decision after the application is submitted. The current review goal for priority NDAs for new-molecular entities is six months from the filing date, or eight months from the date of receipt in light of the 60-day filing period. The FDA does not always meet its PDUFA goal dates for standard and priority NDAs, and the review process is often significantly extended by FDA requests for additional information or clarification.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After the NDA submission is accepted for filing, the FDA reviews the NDA to determine, among other things, whether the proposed product is safe and effective for its intended use and whether the product is being manufactured in accordance with cGMP to assure and preserve the product&#8217;s identity, strength, quality and purity. The FDA may refer applications for novel drug products or drug products which present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes independent clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions and typically follows the advisory committee&#8217;s recommendations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving an NDA, the FDA will inspect the facilities at which the product is manufactured. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical sites to assure that the clinical trial was conducted in compliance with IND study requirements and GCP requirements by each of the entities involved in the clinical trials, including clinical investigators and any third- party CROs. After the FDA evaluates the application, manufacturing process and manufacturing facilities, it may issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">indications. A Complete Response Letter indicates that the review cycle of the application is complete and the application will not be approved in its present form. A Complete Response Letter usually describes all of the specific deficiencies in the NDA identified by the FDA. The Complete Response Letter may require additional clinical data and/or (an) additional pivotal Phase 3 clinical trial(s), and/or other significant and time-consuming requirements related to clinical trials, preclinical studies or manufacturing. If a Complete Response Letter is issued, the applicant may either resubmit the NDA, addressing all of the deficiencies identified in the letter, or withdraw the application. Even if such data and information are submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a product receives regulatory approval, the approval may be significantly limited to specific diseases and dosages or the indications for use may otherwise be limited, which could restrict the commercial value of the product. Further, the FDA may require that certain contraindications, warnings or precautions be included in the product labeling or may condition the approval of the NDA on other changes to the proposed labeling, development of adequate controls and specifications, or a commitment to conduct one or more post-market studies or clinical trials. For example, the FDA may require Phase 4 testing, which involves clinical trials designed to further assess a drug safety and effectiveness, and may require testing and surveillance programs to monitor the safety of approved products that have been commercialized; the FDA may prevent or limit further marketing of a product based on the results of post-marketing trials or surveillance programs. The FDA may also determine that a REMS is necessary to ensure that the benefits of the drug outweigh its risks and to ensure the safe use of the drug. If the FDA concludes a REMS is needed, the sponsor of the NDA must submit a proposed REMS during the application review process; the FDA will not approve the NDA without an approved REMS, if required. A REMS could include medication guides, physician communication plans, and/or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA determines the requirement for a REMS, as well as the specific REMS provisions, on a case-by-case basis.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan Drug Designation and Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Orphan Drug Act the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States or, if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making a drug product available in the United States for this type of disease or condition will be recovered from sales of the product. Orphan designation must be requested before submitting an NDA. After the FDA grants orphan designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity or inability to manufacture the product in sufficient quantities. The designation of such drug also entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers. Competitors, however, may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which the orphan product has exclusivity. If an orphan designated product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expedited Development and Review Programs and Accelerated Approval</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA has a fast track designation program that is intended to expedite or facilitate the process for reviewing new drug products that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a fast track product has opportunities for more frequent interactions with the applicable FDA review team during product development and, once an NDA is submitted, the product candidate may be eligible for priority review. With regard to a fast track product, the FDA may consider for review sections of the NDA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any product submitted to the FDA for approval, including a product with a fast track designation, may also be eligible for other types of FDA programs intended to expedite development and review, such as priority review. A product is eligible for priority review if it is designed to treat a serious condition, and if approved, would provide a significant improvement in the treatment, diagnosis or prevention of a serious condition compared to marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug designated for priority review in an effort to facilitate the review. The FDA endeavors to review</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">applications with priority review designations within six months of the filing date as compared to ten months of the filing date for review of new molecular entity NDAs under its current PDUFA review goals.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, a product may be eligible for accelerated approval. Drug products intended to treat serious or life- threatening diseases or conditions may be eligible for accelerated approval upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials to verify the predicted clinical benefit. Products receiving accelerated approval may be subject to expedited withdrawal procedures if the sponsor fails to conduct the required clinical trials, or if such trials fail to verify the predicted clinical benefit. In addition, the FDA requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A sponsor may seek FDA designation of a drug candidate as a &#8220;breakthrough therapy&#8221; if the drug is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough therapy designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance. The breakthrough therapy designation is a distinct status from both accelerated approval and priority review, which can also be granted to the same drug if relevant criteria are met. The FDA must take certain actions with respect to breakthrough therapies, such as holding timely meetings and providing advice to the product sponsor, intended to expedite the development and review of an application for approval of a breakthrough therapy.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fast track designation, priority review, accelerated approval, and breakthrough therapy designation do not change the standards for approval but may expedite the development, review, or approval process. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. In addition, such designations or shortened review periods may not provide a material commercial advantage.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Approval Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any drug products manufactured or distributed pursuant to FDA approvals are subject to continuing regulation by the FDA, including, among other things, record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, and complying with FDA promotion and advertising requirements. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual program fees for any marketed products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, quality control and manufacturing procedures must continue to conform to applicable manufacturing requirements after approval to ensure the long term stability of the drug product. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. In addition, changes to the manufacturing process are strictly regulated, and depending on the significance of the change, may require prior FDA approval before being implemented.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-market studies or clinical studies to assess new safety risks, or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, warning letters, or untitled letters;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical holds on clinical studies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of product approvals;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal to permit the import or export of products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mandated modification of promotional materials and labeling and the issuance of corrective information;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA closely regulates the marketing, labeling, advertising and promotion of drug products, including promotional activities involving the internet and industry-sponsored educational activities. A company can make only those claims relating to safety and efficacy that are approved by the FDA and in accordance with the approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion by manufacturers of uses or patient populations that are not described in the product&#8217;s approved labeling (known as &#8220;off label uses&#8221;). Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe, in their independent professional medical judgment, legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested and approved by the FDA. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products. The federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined companies from engaging in off-label promotion. The FDA and other regulatory agencies have also required that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#8217;s FDA-approved labeling.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug Marketing Act (&#8220;PDMA&#8221;) which regulates the distribution of drugs and drug samples at the federal level, and sets minimum standards for the registration and regulation of wholesale drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. Most recently, the Drug Supply Chain Security Act (&#8220;DSCSA&#8221;) was enacted with the aim of building an electronic system to identify and trace certain prescription drugs distributed in the United States. The DSCSA mandates phased-in and resource-intensive obligations for pharmaceutical manufacturers, wholesale distributors, and dispensers over a 10 year period that is expected to culminate in November 2023.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Patent Term Restoration and Marketing Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration and specifics of the FDA approval of the use of our product candidates, some of our U.S. patents, if granted, may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five years, as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one-half the time between the effective date of an IND and the submission date of an NDA plus the time between the submission date of an NDA and the approval of that application. Only one patent applicable to an approved drug is eligible for the extension and the application for the extension must be submitted prior to the expiration of the patent.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Patent and Trademark Office, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may intend to apply for restoration of patent term for one of our currently owned or licensed patents to add patent life beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Hatch-Waxman Amendments to the FDCA authorized the FDA to approve generic drugs that are the same as drugs previously approved by the FDA under the NDA provisions of the statute and also enacted Section 505(b)(2) of the FDCA. To obtain approval of a generic drug, an applicant must submit an abbreviated new drug application (&#8220;ANDA&#8221;), to the agency. In support of such applications, a generic manufacturer may rely on the preclinical and clinical testing conducted for a drug product previously approved under an NDA, known as the reference listed drug (&#8220;RLD&#8221;). Specifically, in order for an ANDA to be approved, the FDA must find that the generic version is identical to the RLD with respect to the active ingredients, the route of administration, the dosage form, and the strength of the drug. In contrast, Section 505(b)(2) permits the filing of an NDA where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. A Section 505(b)(2) applicant may eliminate the need to conduct certain preclinical or clinical studies, if it can establish that reliance on studies conducted for a previously-approved product is scientifically appropriate. Unlike the ANDA pathway used by developers of bioequivalent versions of innovator drugs, which does not allow applicants to submit new clinical data other than bioavailability or bioequivalence data, the 505(b)(2) regulatory pathway does not preclude the possibility that a follow-on applicant</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">would need to conduct additional clinical trials or nonclinical studies; for example, they may be seeking approval to market a previously approved drug for new indications or for a new patient population that would require new clinical data to demonstrate safety or effectiveness. The FDA may then approve the new product for all or some of the label indications for which the RLD has been approved, or for any new indication sought by the Section 505(b)(2) applicant, as applicable Market exclusivity provisions under the FDCA can also delay the submission or the approval of certain marketing applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve an ANDA or a 505(b)(2) NDA submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the RLD or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the RLD holder. The FDCA also provides three years of marketing exclusivity for an NDA, or a supplement to an existing NDA, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the original active agent. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA filed under section 505(b)(1) of the FDCA. However, an applicant submitting a full NDA would be required to either conduct or obtain a right of reference to all of the preclinical studies and adequate and well- controlled clinical trials necessary to demonstrate safety and effectiveness.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drug exclusivity, as described above, may offer a seven-year period of marketing exclusivity, except in certain circumstances. Pediatric exclusivity is another type of non-patent market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric trial in accordance with an FDA-issued &#8220;Written Request&#8221; for such a trial.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Federal and State Fraud and Abuse, Data Privacy and Security of Health Information, and Transparency Laws and Regulations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to FDA restrictions on marketing of pharmaceutical products, federal and state healthcare laws and regulations restrict business practices in the biopharmaceutical industry. These laws may impact, among other things, our current and future business operations, including our clinical research activities, and proposed sales, marketing and education programs and may constrain the business or financial arrangements and relationships with healthcare providers and other parties through which we market, sell and distribute our products for which we obtain marketing approval. These laws include anti-kickback and false claims laws and regulations, data privacy and security of health information, and transparency laws and regulations, including, without limitation, those laws described below.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. federal Anti-Kickback Statute prohibits any person or entity from, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or in return for purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order of any item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. The U.S. federal Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases or recommendations may be subject to scrutiny if they do not qualify for an exception or safe harbor. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the statute has been violated. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A person or entity does not need to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil FCA or the civil monetary penalties laws.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal civil and criminal false claims laws and civil monetary penalties laws, including the federal civil FCA, prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false claim for payment to the federal government or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. Actions under these laws may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. A claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceutical and other healthcare companies have been prosecuted under these laws for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product and for causing false claims to be submitted because of the companies&#8217; marketing of products for unapproved, and thus non-reimbursable, uses.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) also created new federal criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Also, many states have similar fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), and their respective implementing regulations, impose specified requirements on certain types of individuals and entities, including covered entities, business associates and their covered subcontractors, relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities, which include certain healthcare providers, healthcare clearinghouses and health plans, that create, receive, maintain or transmit individually identifiable health information in connection with providing a service for or on behalf of a covered entity as well as their covered subcontractors. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, many of which are not pre-empted by HIPAA, differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, the federal Physician Payments Sunshine Act, and its implementing regulations, require that certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) annually report information related to certain payments or other transfers of value made or distributed to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other healthcare professionals (such as physician assistants and nurse practitioners) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also be subject to state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures or drug pricing, and state and local laws</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">that require the registration of pharmaceutical sales representatives.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, certain states require, the registration of manufacturers and wholesale distributors of pharmaceutical products. All of our activities are also potentially subject to federal and state consumer protection and unfair competition laws.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the breadth of these laws and the narrowness of available statutory exceptions and regulatory safe harbors, it is possible that some of our business activities could be subject to challenge under one or more of such laws. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#8220;qui tam&#8221; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. To the extent that any of our products are sold in a foreign country, we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including safety surveillance, anti- fraud and abuse laws, implementation of corporate compliance programs, reporting of payments or transfers of value to healthcare professionals, and additional data privacy and security requirements.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pharmaceutical Coverage, Pricing and Reimbursement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we or our collaborators obtain regulatory approval. In the United States and markets in other countries, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage, and establish adequate reimbursement levels for such drug products.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, third-party payors include federal and state healthcare programs, government authorities, private managed care providers, private health insurers and other organizations. Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical drug products and medical services, in addition to questioning their safety and efficacy. Such payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the FDA-approved drugs for a particular indication. We or our collaborators may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain the FDA approvals. Nonetheless, our product candidates may not be considered medically necessary or cost-effective. Moreover, the process for determining whether a third-party payor will provide coverage for a drug product may be separate from the process for setting the price of a drug product or for establishing the reimbursement rate that such a payor will pay for the drug product. A payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. As a result, one payor&#8217;s determination to provide coverage for a drug product does not ensure that other payors will also provide coverage for the drug product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we elect to participate in certain governmental programs, we may be required to participate in discount and rebate programs, which may result in prices for our future products that will likely be lower than the prices we might otherwise obtain. For example, drug manufacturers participating under the Medicaid Drug Rebate Program must pay rebates on prescription drugs to state Medicaid programs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Different pricing and reimbursement schemes exist in other countries. In the EU, governments influence the price of pharmaceutical products through their pricing and reimbursement rules and control of national health care systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a particular drug candidate to currently available therapies. Other member states allow companies to fix their own prices for medicines, but monitor and control company profits. The downward pressure on health care costs in general, particularly prescription drugs, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert a commercial pressure on pricing within a country.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketability of any product candidates for which we or our collaborators receive regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide adequate coverage and reimbursement. In addition, emphasis on managed care in the United States has increased and we expect will continue to increase the pressure on pharmaceutical pricing. Coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we or our collaborators receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare Reform</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. For example, in December 2016, the 21st Century Cures Act (&#8220;Cures Act&#8221;) was signed into law. The Cures Act, among other things, was intended to modernize the regulation of drugs and devices and to spur innovation. Legislative proposals continue to be discussed in the U.S. Congress as potentially leading to a future &#8220;Cures 2.0&#8221; bill that is expected to have bipartisan support. In addition, in August 2017, the FDA Reauthorization Act was signed into law, which reauthorized the FDA&#8217;s user fee programs and included additional drug product provisions. The legislative reauthorization was completed in 2022, which reauthorized four of the largest FDA user fee programs for the next five-year cycle. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we otherwise may have obtained and we may not achieve or sustain profitability, which would adversely affect our business, prospects, financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, a primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and other third-party payors in the United States have attempted to control costs by limiting coverage and the amount of reimbursement for particular medical products and services, implementing reductions in Medicare and other healthcare funding and applying new payment methodologies. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively &#8220;Affordable Care Act&#8221;), was enacted, which substantially changed the way healthcare is financed by both the government and private insurers, and continues to significantly impact the U.S. pharmaceutical industry.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As another example, the 2021 Consolidated Appropriations Act signed into law on December 27, 2020 incorporated extensive healthcare provisions and amendments to existing laws, including a requirement that all manufacturers of drugs and biological products covered under Medicare Part B report the product&#8217;s average sales price to the Department of Health and Human Services (&#8220;HHS&#8221;) beginning on January 1, 2022, subject to enforcement via civil money penalties.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been amendments to and executive, judicial and Congressional challenges to certain aspects of the Affordable Care Act since its enactment, and it is possible that there will be additional challenges and amendments to the Affordable Care Act in the future. For example, on August 16, 2022, the Inflation Reduction Act of 2022 (&#8220;IRA&#8221;) was signed into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost through a newly established manufacturer discount program. It is possible that the Affordable Care Act will be subject to additional challenges in the future. It is unclear how any such challenges and the healthcare reform measures of the second Trump administration will impact the Affordable Care Act, our business, or financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have also been proposed and adopted in the United States since the Affordable Care Act was enacted that affect health care expenditures. These changes include aggregate reductions to Medicare payments to providers of up to 2% per fiscal year pursuant to the Budget Control Act of 2011, which began in 2013 and will remain in effect until 2032, unless additional Congressional action is taken.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There has been heightened governmental scrutiny recently over the manner in which pharmaceutical companies set prices for their marketed products, which has resulted in several Congressional inquiries, presidential executive orders and proposed federal legislation, as well as state efforts, designed to, among other things, bring more transparency to product pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 5, 2024, the FDA approved Florida&#8217;s Section 804 Importation Program (&#8220;SIP&#8221;) proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear how this program will be implemented, including which drugs will be chosen, and whether it will be subject to legal challenges in the United States or Canada. Other states have also submitted SIP proposals that are pending review by the FDA. Any such approved importation plans, when implemented, may result in lower drug prices for products covered by those programs. In addition, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs that have been on the market for at least 7 years covered under Medicare (the &#8220;Medicare Drug Price Negotiation Program&#8221;) and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions began to take effect progressively starting in fiscal year 2023. On August 15, 2024 HHS announced the agreed-upon prices for the first 10 drugs that were subject to price negotiations, although the Medicare Drug Price Negotiation Program is currently subject to legal challenges. On January 17, 2025, HHS selected 15 additional products covered under Part D for price negotiation in 2025. Each year thereafter more Part B and Part D products will become subject to the Medicare Drug Price Negotiation Program. Further, on December 7, 2023, an initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act was announced. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, particularly given recent U.S. Presidential and Congressional elections. We anticipate that such new laws will result in additional downward pressure on coverage and the price that we receive for any approved product, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. In addition, it is possible that there will be further legislation or regulation that could harm our business, financial condition, and results of operations. Additionally, health reform initiatives may arise in the future.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Privacy and Security Laws</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and in addition to federal laws described above, state laws govern the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. For instance, the California Consumer Privacy Act (&#8220;CCPA&#8221;),  created individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling certain personal data of consumers or households. The CCPA, among other things, imposes data privacy obligations on covered companies and provides privacy rights to California residents, including the right to access and delete their personal data, opt out of certain personal data sharing, and receive detailed information about how their personal data is used. The CCPA also includes a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. Further, the California Privacy Rights Act (&#8220;CPRA&#8221;) includes provisions  that  require us to incur additional costs and expenses in an effort to comply. Both the CCPA and CPRA have in the past and continue to impact our business activities depending on how they are interpreted and exemplifies the vulnerability of our business to not only cyber threats but also the evolving regulatory environment related to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personal data and protected health information. Other U.S. states have begun enacting their own laws similar to the CCPA, and we expect more states to pass similar laws in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also are subject to applicable data protection laws in the jurisdictions in which we are established or in which we sell or market our products or run clinical trials. For example, if we conduct EU-based clinical trials, we will be subject to the EU General Data Protection Regulation (&#8220;EU GDPR&#8221;) in relation to our collection, control, processing and other use of personal data of data participants within the European Economic Area (&#8220;EEA&#8221;) (i.e., data relating to an identifiable living individual). The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing activities and implement policies as part of its mandated privacy governance framework. It also requires data controllers to be transparent and disclose to data participants (in a concise, intelligible and easily accessible form) how their personal data is to be used, imposes limitations on retention of personal data; defines for the first time pseudonymized (i.e., key-coded) data; introduces mandatory data breach notification requirements; and sets higher standards for data controllers to demonstrate that they have obtained valid consent for certain data processing activities. If in the future we conducted clinical trials in the EU we would be subject to EU rules with respect to cross-border transfers of personal data out of the EU and EEA. We would be subject to the supervision of local data protection authorities in those EU jurisdictions where we conduct our trials or are otherwise subject to the GDPR. Fines for certain breaches of the GDPR are significant: up to the greater of &#8364;20 million or 4% of total global annual turnover. In addition to the foregoing, a breach of the GDPR or other applicable privacy and data protection laws and regulations could result in regulatory investigations, reputational damage, orders to cease/change our use of data, enforcement notices, or potential civil claims including class action type litigation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the GDPR includes restrictions on cross-border data transfers. Certain aspects of cross-border data transfers under the GDPR are uncertain as the result of legal proceedings in the EU. This may increase the complexity of transferring personal data across borders. The GDPR will increase our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Although there are legal mechanisms to allow for the transfer of personal data from the EEA to the United States, they are subject to legal challenges and uncertainty about compliance with EU data protection laws remains and there are similar uncertainties around data transfers to and from the United Kingdom.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The U.S. Foreign Corrupt Practices Act</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Foreign Corrupt Practices Act of 1977 (&#8220;FCPA&#8221;) prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. Importantly, United States authorities that enforce the FCPA, including the Department of Justice, deem most healthcare professionals and other employees of foreign hospitals, clinics, research facilities and medical schools in countries with public health care or public education systems to be &#8220;foreign officials&#8221; under the FCPA. We also may be implicated under the FCPA for activities by our partners, collaborators, contract research organizations, vendors or other agents. If and when we interact with foreign healthcare professionals and researchers in testing and marketing our products abroad, we must have policies and procedures in place sufficient to prevent us and agents acting on our behalf from providing any bribe, gift or gratuity, including excessive or lavish meals, travel or entertainment in connection with marketing our products and services or securing required permits and approvals such as those needed to initiate clinical trials in foreign jurisdictions.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Europe/Rest of World Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to regulations in the United States, we will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of our products. Whether or not we or our potential collaborators obtain FDA approval for a product, we must obtain the requisite approvals from regulatory authorities in foreign countries prior to the commencement of clinical trials or marketing of the product in those countries. Certain countries outside of the United States have a similar process that requires the submission of an application for a clinical trial authorization (&#8220;CTA&#8221;) much like the IND prior to the commencement of human clinical trials. In the EU, for example, a CTA must be submitted to each country&#8217;s national health authority and an application made to an independent ethics committee, much like the FDA and IRB, respectively. Once the CTA is approved in accordance with a country&#8217;s requirements and a favorable ethics committee opinion has been issued, clinical trial development may proceed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the United Kingdom&#8217;s departure from the EU on January 31, 2020, the United Kingdom followed the same regulations as the EU until the end of 2020, during the so-called Transition Period. As of January 1, 2021, the Medicines and Healthcare products Regulatory Agency (&#8220;MHRA&#8221;) is the United Kingdom&#8217;s standalone medicines and medical devices regulator. As a result of the Northern Ireland protocol, different rules will apply in Northern Ireland than in England, Wales, and Scotland, together, Great Britain (&#8220;GB&#8221;);</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">broadly, Northern Ireland will continue to follow the EU regulatory regime, but its national competent authority will remain the MHRA. The MHRA has recently published detailed guidance for industry and organizations to follow from January 1, 2021 now that the Transition Period is over, which will be updated as the United Kingdom&#8217;s regulatory position on medicinal products evolves over time. The guidance includes clinical trials, marketing authorizations, importing, exporting, and pharmacovigilance and is relevant to any business involved in the research, development, or commercialization of medicines in the United Kingdom.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The requirements and process governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. In all cases, the clinical trials are conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To obtain regulatory approval of an investigational drug under EU regulatory systems, we must submit a marketing authorization application either under the so-called centralized or national authorization procedures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Centralized procedure</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The centralized procedure provides for the grant of a single marketing authorization by the European Commission following a favorable opinion by the EMA that is valid in all EU member states, as well as Iceland, Liechtenstein and Norway. The centralized procedure is compulsory for medicines produced by specified biotechnological processes, products designated as orphan medicinal products, and products with a new active substance indicated for the treatment of specified diseases, such as HIV/AIDS, cancer, diabetes, neurodegenerative disorders or autoimmune diseases, other immune dysfunctions and viral diseases. The centralized procedure is optional for other products that represent a significant therapeutic, scientific or technical innovation, or whose authorization would be in the interest of public health or which contain a new active substance for indications other than those specified to be compulsory.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">National authorization procedures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. There are also two other possible routes to authorize medicinal products in several EU countries, which are available for investigational medicinal products that fall outside the scope of the centralized procedure:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Decentralized procedure. Using the decentralized procedure, an applicant may apply for simultaneous authorizations in more than one EU Member State of medicinal products that have not yet been authorized in any EU Member State and that do not fall within the mandatory scope of the centralized procedure.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mutual recognition procedure. In the mutual recognition procedure, a medicine is first authorized in one EU Member State, in accordance with the national procedures of that country. Following this, further marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned agree to recognize the validity of the original, national marketing authorization.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The EMA grants orphan drug designation to promote the development of products for the treatment, prevention or diagnosis of life-threatening or chronically debilitating conditions affecting not more than five in 10,000 people in the EU. In addition, orphan drug designation can be granted if the drug is intended for a life threatening or chronically debilitating condition in the EU and without incentives it is unlikely that sales of the drug in the EU would be sufficient to justify the investment required to develop the drug. Orphan drug designation is only available if there is no other satisfactory method approved in the EU of diagnosing, preventing or treating the condition, or if such a method exists, the proposed orphan drug will be of significant benefit to patients. Orphan drug designation provides opportunities for free or reduced-fee protocol assistance, fee reductions for marketing authorization applications and other post-authorization activities and ten years of market exclusivity following drug approval, which can be extended to 12 years if trials are conducted in accordance with an agreed-upon pediatric investigational plan. The exclusivity period may be reduced to six years if the designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For other countries outside of the EU, such as countries in Eastern Europe, Latin America or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. In all cases, again, the clinical trials are conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we or our potential collaborators fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Facilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters are located in La Jolla, California, where we lease approximately 2,850 square feet of office and laboratory space pursuant to a lease agreement. We believe that our existing facilities are adequate for the foreseeable future. As we expand, we believe that suitable additional and/or alternative spaces will be available in the future on commercially reasonable terms, if required.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees and Human Capital Resources</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 14 full-time employees, seven of whom were primarily engaged in research and development activities. A total of four employees have an M.D., Ph.D. or Pharm.D. degree. Most of our employees are located in La Jolla, California. None of our employees are represented by a labor union, and we consider our employee relations to be good. We also engage various consultants that are primarily engaged in research and development activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards and cash-based performance bonus awards.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We originally formed in May 2011 as Graybug, LLC, which was converted into a corporation in February 2015. Our corporate headquarters are located at 505 Coast Boulevard South, Suite 307, La Jolla, CA 92037, and our telephone number is (858) 952-5500. Our corporate website address is https://calcimedica.com/. Information contained on, or accessible through, our website shall not be deemed incorporated into and is not a part of this Annual Report on Form 10-K. Our periodic and current reports are available on our website, free of charge, as soon as reasonably practicable after filing. We may use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation Fair Disclosure promulgated by the SEC. These disclosures will be included under the Investor Relations section of our website at ir.calcimedica.com. We have included our website in this Annual Report on Form 10-K solely as an inactive textual reference.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 20, 2023, Graybug, now known as CalciMedica, Inc., completed the Merger with Private CalciMedica, in accordance with the terms of the Merger Agreement, whereby Merger Sub merged into Private CalciMedica, with Private CalciMedica surviving as Graybug&#8217;s wholly owned subsidiary. Pursuant to the Merger Agreement, Graybug changed its name to CalciMedica, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 31, 2024, Private CalciMedica was dissolved and combined into CalciMedica, Inc.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Item 1A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Risk Factors.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTORS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information contained in this Annual Report on Form 10-K, including our financial statements and the related notes and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding to invest in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. We cannot assure you that any of the events discussed below will not occur. If any of the following risks actually occur, our business, prospects, operating results and financial condition could suffer materially. In such event, the trading price of our common stock could decline and you might lose all or part of your investment.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Limited Operating History, Financial Position and Capital Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history. We have a history of net losses and anticipate that we will incur significant losses in the future. We have never generated any revenue from product sales and may never be profitable.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history that may make it difficult to evaluate the success of our business to date and assess our future viability. We commenced operations in October 2006, have no products approved for commercial sale and have never generated any revenue. We have devoted substantially all of our resources to organizing and staffing our company, business planning, establishing and maintaining our intellectual property portfolio, raising capital, developing our product candidates, undertaking research and development activities, and providing general and administrative support for these operations. We are conducting several clinical trials and preclinical studies for our lead product candidate, Auxora, which is currently in an ongoing Phase 2 trial in AKI with AHRF and a Phase 1/2 clinical trial in pediatric patients with AIPT as a side effect of pediatric acute lymphoblastic leukemia treatment with asparaginase. We recently completed a Phase 2b trial for Auxora in AP and accompanying SIRS and are planning a Phase 3 trial in this indication, and we previously completed a Phase 2 trial in COVID-19 pneumonia patients with ARDS.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our other pipeline programs, which include new product candidates, are in preclinical development. As of December 31, 2024, we had an accumulated deficit of $159.8 million and a net loss of $13.7 million for the year ended December 31, 2024. Other than the three months ended March 31, 2024, we have incurred net losses since our inception. We have never generated revenue from product sales and we expect that it will be several years, if ever, before we have a product candidate ready for commercialization. We expect to incur increasing levels of operating losses over the next several years and for the foreseeable future as we advance our product candidates through clinical development. Our prior losses, combined with expected future losses, have had and will continue to have an adverse effect on our stockholders&#8217; equity and working capital.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To become and remain profitable, we must develop and eventually commercialize product candidates with significant market potential. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials of our product candidates, obtaining marketing approval for these product candidates, finding external manufacturing capacity sufficient to meet commercial demand, marketing and selling those product candidates for which we may obtain marketing approval and satisfying any post-marketing requirements. We may never succeed in these activities and, even if we succeed in commercializing one or more of our product candidates, we may never generate revenue that is significant or large enough to achieve profitability. In addition, as a young business, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown challenges. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis and we will continue to incur substantial research and development and other expenditures to develop and market additional product candidates. Our failure to become and remain profitable would decrease the value of the company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company could also cause you to lose all or part of your investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will need to obtain substantial additional funding to complete the development and any commercialization of our product candidates. If we are unable to raise this capital when needed, on acceptable terms, or at all, we may be forced to delay, reduce or eliminate the development of our product candidates or other operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since we commenced operations in October 2006, we have primarily financed our operations through private placements of our preferred stock, convertible promissory notes, warrants and common stock, through the Merger with Graybug and through an underwritten public offering. We have used substantial amounts of cash to fund our operations and expect our expenses to increase substantially for the foreseeable future. The development of drug product candidates is highly capital intensive. As our product candidates enter and advance through preclinical studies and clinical trials, we will need substantial additional funds to expand our clinical, regulatory and quality capabilities. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to marketing, sales, manufacturing and distribution. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or eliminate our research and development programs or any future commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had $18.7 million in cash, cash equivalents and short-term investments. Based on our current operating plans, we believe our existing resources, including the net proceeds of $9.7 million from the Loan and Security Agreement with Avenue Venture Opportunities Fund entered into on February 28, 2025, will be sufficient to fund our current operations through certain clinical milestones into the middle of 2026. However, our current cash, cash equivalents and short-term investments will not be sufficient to fund any of our product candidates through regulatory approval, nor will it be sufficient to pursue additional indications for Auxora like AHRF, nor will it be sufficient to fund clinical trials on other product candidates in our portfolio aside from the ongoing KOURAGE trial of Auxora, and we will need to raise substantial additional capital to complete the development and any commercialization of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have based these estimates on assumptions that may prove to be incorrect or require adjustment as a result of business decisions, and we could utilize our available capital resources sooner than we currently expect. Our future funding requirements will depend on many factors, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the progress, costs and results of our ongoing clinical trials of Auxora and our planned trials for our other product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of discovery research, preclinical development, laboratory testing and clinical trials for our product candidates, including our ongoing clinical trials of Auxora;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing and outcome of regulatory review of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to enter into contract manufacturing arrangements for supply of active pharmaceutical ingredient (&#8220;API&#8221;) and manufacture of drug product for our product candidates and the terms of such arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of any future commercialization activities, including product manufacturing, sales, marketing and distribution, for any of our product candidates for which we may receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the amount and timing of revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property and proprietary rights and defending any intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other products, product candidates, technologies or data referencing rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the payment or receipt of milestones and receipt of other collaboration-based revenues, if any;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of, and development requirements for, other product candidates that we pursue;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impacts of the ongoing or future international conflicts and potential future bank failures; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of operating as a public company.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because we do not expect to generate revenue from product candidate sales for many years, if at all, we will need to obtain substantial additional funding in connection with our continuing operations and expected increases in expenses. Until such time as we can generate significant revenue from sales of our product candidates, if ever, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including potentially grants, collaborations, licenses or other similar arrangements. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating plans. The impacts of the ongoing or future international conflicts and potential future bank failures on capital markets may affect the availability, amount and type of financing available to us in the future. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs or future commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could adversely affect our growth strategy, financial performance and stock price and could require us to delay or abandon clinical development plans. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive an economic downturn, which could directly affect our ability to attain our operating goals on schedule and on budget.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our proprietary platform or product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through equity offerings, debt financings or other capital sources, including potentially grants, collaborations, licenses or other similar arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing, if available, may involve agreements that include covenants further limiting or restricting our ability to take specific actions, such as limitations on our ability to incur debt, make capital expenditures or declare dividends.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we raise funds through collaborations or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce or terminate our proprietary product candidate development process or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attempting to secure additional financing may also divert our management from our day-to-day activities, which may impair or delay our ability to develop our proprietary platform. In addition, demands on our cash resources may change as a result of many factors currently unknown to us including, but not limited to, any unforeseen costs we may incur as a result of preclinical study or clinical trial delays, or disruptions in the manufacturing of our product candidates, due to the ongoing or future international conflicts, potential future bank failures or other causes, and we may need to seek additional funds sooner than planned. If we are unable to obtain funding on a timely basis or at all, we may be required to significantly curtail or stop one or more of our research or development programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any acquisitions or strategic collaborations may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities or subject us to other risks.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may evaluate various acquisitions and strategic collaborations, including licensing or acquiring complementary products and technologies, intellectual property rights, technologies or businesses. Any acquisition or strategic partnership may entail numerous risks, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased operating expenses and cash requirements; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the assumption of indebtedness or contingent or unknown liabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assimilation of operations, intellectual property and products or product candidates of an acquired company, including difficulties associated with integrating new personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the diversion of our management&#8217;s attention from our existing product candidates and initiatives in pursuing such an acquisition or a strategic partnership;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">retention of key employees, the loss of key personnel and uncertainties about our ability to maintain key business relationships;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or product candidates and regulatory approvals, and the possibility of disagreements or disputes with such other party; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to generate revenue from acquired products, product candidates, intellectual property rights, technologies, and/or businesses sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 (the &#8220;Closing Date&#8221;), we entered into a Loan and Security Agreement (&#8220;2025 LSA&#8221;) with Avenue Venture Opportunities Fund (the &#8220;Lender&#8221;), for (i) an initial growth capital loan in the principal amount of $10,000,000 funded on March 3, 2025 (ii) up to $7,500,000 to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials and (iii) up to $15,000,000 to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#8217;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, if we engage in acquisitions or strategic partnerships, we may issue dilutive securities, assume or incur debt obligations, incur large one-time expenses or acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable acquisition opportunities, and this inability could impair our growth or limit access to technology or drugs that may be important to the development of our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The terms of the 2025 LSA place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our operating and financial flexibility.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2025 LSA includes customary affirmative and negative covenants, as well as standard events of default, including an event of default based on the occurrence of a material adverse event. The negative covenants include, among others, restrictions on us transferring collateral, incurring additional indebtedness, paying cash dividends or making other distributions, making investments, creating liens, and selling assets, in each case subject to certain exceptions. These restrictive covenants could limit our flexibility in operating our business and our ability to pursue business opportunities that we or our stockholders may consider beneficial. In addition, the Lender could declare a default upon the occurrence of an event that it interprets could have a material adverse effect, as defined in the 2025 LSA. Upon the occurrence and continuance of an event of default, the Lender may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the 2025 LSA. Any declaration by the Lender of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline. We may not have enough available cash or be able to raise additional funds through equity or debt financing to repay these outstanding obligations at the time any event of default occurs. Further, if we raise any additional capital through debt financing, the terms of such additional debt could further restrict our operating and financial flexibility.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to maintain our listing on Nasdaq, it could become more difficult to sell our common stock in the public market.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock was previously delisted from the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) and on June 12, 2023, Nasdaq approved our application to relist our common stock and we began trading on June 14, 2023 on the Nasdaq Capital Market. If we are unable to continue to meet Nasdaq&#8217;s listing standards for any reason, our common stock could be delisted from Nasdaq. If delisted, we may seek to list our securities on a different stock exchange or, if one or more broker-dealer market makers comply with applicable requirements, the OTC. Listing on such other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">market or exchange could reduce the liquidity of our common stock. If our common stock were to trade in the OTC market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A delisting from Nasdaq and failure to obtain listing on another market or exchange would subject our common stock to so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a market in such securities. Consequently, removal from Nasdaq and failure to obtain listing on another market or exchange could affect the ability or willingness of broker-dealers to sell or make a market in our common stock and the ability of purchasers of our common stock to sell their securities in the secondary market.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Discovery, Development and Regulatory Approval of Our Product Candidates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our proprietary CRAC channel inhibition science is based on novel technologies that are unproven and may not result in approvable or marketable products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval and we may not be successful in our efforts to use and expand our science to build a pipeline of product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are seeking to identify and develop a broad pipeline of product candidates using our proprietary CRAC channel inhibitor science to address acute critical illness and chronic inflammatory and immunologic diseases where there are no effective therapies. Our lead product candidate, Auxora, recently completed a Phase 2b clinical trial and we have only completed two randomized, blinded placebo-controlled trials with Auxora to date. We are not aware of any FDA approved therapeutics utilizing similar technology. Further, the scientific evidence to support the feasibility of developing therapeutic treatments based on our proprietary CRAC channel inhibition science is both preliminary and limited. Additionally, there are no drugs currently approved for the treatment of AP and as a result the FDA has not established the endpoints that will be required for approval in this indication. As a result, we are exposed to a number of unforeseen risks and it is difficult to predict the types of challenges and risks that we may encounter during development of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the novelty of our CRAC channel inhibition science, we intend to work closely with the FDA and comparable foreign regulatory authorities to perform the requisite scientific analyses and evaluation of our methods to obtain regulatory approval for our product candidates; however, due to a lack of relevant experience with the indications that we are pursuing, the regulatory pathway with the FDA and comparable regulatory authorities may be more complex and time-consuming. There can be no assurance as to the length of clinical development, the number of patients that the FDA may require to be enrolled in clinical trials to establish the safety and efficacy of our product candidates, or that the data generated in these clinical trials will be acceptable to the FDA to support marketing approvals. We cannot be certain that our approach will lead to the development of approvable or marketable products, alone or in combination with other therapies. If we are unable to develop, or obtain regulatory approval for, or, if approved, successfully commercialize our product candidates, we may not be able to generate sufficient revenue to continue our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business is highly dependent on the success of our product candidates, in particular Auxora, and we may fail to develop Auxora successfully or be unable to obtain regulatory approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success is dependent on our ability to complete clinical trials in a timely and successful manner and obtain marketing approval for and successfully commercialize Auxora, our lead product candidate. We are investing the majority of our efforts and financial resources in the research and development of Auxora for multiple indications. Auxora is currently in several studies: an ongoing Phase 1/2 clinical trial, for which the first cohort was completed, in pediatric patients with AIPT as a side effect of pediatric acute lymphoblastic leukemia treatment with asparaginase; and a Phase 2 trial in AKI that we initiated in July 2024. Auxora was also studied in a completed Phase 2b clinical trial in AP and accompanying SIRS and a completed Phase 2 trial in COVID-19 pneumonia patients with ARDS which may inform the design of clinical development in AHRS and/or ARDS due to a broad range of etiologies. We also have additional preclinical product candidates that will need to progress through IND application enabling studies prior to clinical development. None of our product candidates have advanced into a late-stage or pivotal trials for the indications for which we are pursuing development. Our ability to generate product revenues, which we do not expect will occur for many years, if ever, will depend heavily on the successful development and eventual commercialization of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although certain of our employees have prior experience with clinical trials, regulatory approvals and manufacturing of pharmaceutical products, we have not previously completed any late-stage or pivotal clinical trials or submitted an new drug application (&#8220;NDA&#8221;) to the FDA or regulatory approval filings to comparable foreign</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorities for any product candidate, and Auxora may not be successful in clinical trials and may not receive any regulatory approval. The FDA and other comparable global regulatory authorities can delay, limit or deny approval of a product candidate for many reasons. Any delay in obtaining, or inability to obtain, applicable regulatory approval will delay or harm our ability to successfully commercialize Auxora and harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, because Auxora is our most advanced product candidate, if our clinical trials of Auxora encounter safety, efficacy or manufacturing problems, development delays, regulatory issues or other problems, our development plans for Auxora and our other product candidates in our pipeline could be significantly impaired, which could harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The success of our business, including our ability to finance our company and generate any revenue in the future, will primarily depend on the successful development, regulatory approval and commercialization of our product candidates, which may never occur. We have not yet succeeded and may not succeed in demonstrating efficacy and safety for any product candidate in late-stage clinical trials for regulatory approval or in obtaining marketing approval thereafter. Given our early stage of development, it may be several years, if at all, before we have demonstrated the safety and efficacy of a treatment sufficient to warrant approval for commercialization. If we are unable to develop, or obtain regulatory approval for, or, if approved, successfully commercialize our product candidates, we may not be able to generate sufficient revenue to continue our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical development is a lengthy, expensive and uncertain process. The results of preclinical studies and early clinical trials are not always predictive of future results. Any product candidate that we advance into clinical trials may not achieve favorable results in later clinical trials, if any, or receive marketing approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The research and development of drugs is extremely risky. Only a small percentage of programs that enter the clinical development process ever receive marketing approval. Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidate in humans. Clinical testing is expensive, can take many years to complete and its outcome is uncertain. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of preclinical studies and early clinical trials of product candidates, even those with the same or similar mechanisms of action, may not be predictive of the results of later-stage clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy characteristics despite having progressed through preclinical studies and initial clinical trials. While we have previously received results, some preliminary, from two randomized, blinded placebo-controlled trials, one small blinded randomized SOC controlled trial, one small randomized open-label placebo-controlled trial, one small open-label single site trial, and one small open label investigator sponsored clinical trial, we do not know how Auxora will perform in the ongoing Phase 2 clinical trials or in future clinical trials with larger sample sizes. Results of clinical trials with smaller sample sizes, such as our completed SOC-controlled Phase 2a clinical trial of Auxora in 21 patients with AP and accompanying SIRS plus hypoxemia, can be disproportionately influenced by various biases associated with the conduct of small clinical trials, such as the potential failure of the smaller sample size to accurately depict the features of the broader patient population, which limits the ability to generalize the results across a broader community, thus making the clinical trial results less reliable than clinical trials with a larger number of patients. In general, clinical trial failure may result from a multitude of factors including flaws in trial design, dose selection, patient enrollment criteria and failure to demonstrate favorable safety or efficacy traits. As such, failure in clinical trials can occur at any stage of testing. A number of companies in the biopharmaceutical industry have suffered setbacks in the advancement of clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have not completed any clinical trials that the FDA has confirmed or accepted as late-stage or pivotal clinical trials for any of our product candidates. We cannot guarantee that any clinical trials will be initiated or conducted as planned or completed on schedule, if at all. We also cannot be sure that submission of an IND or similar application will result in the FDA or other regulatory authority, as applicable, allowing clinical trials to begin in a timely manner, if at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, even if these trials begin, issues may arise that could cause regulatory authorities to suspend or terminate such clinical trials. A failure of one or more clinical trials can occur at any stage of testing, and our future</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials may not be successful. Any of these events could cause delays and interruptions in our clinical trials, which could adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience delays in site initiation and patient enrollment, failures to comply with study protocols, delays in the manufacture of our product candidates for clinical testing and other difficulties in starting or completing our clinical trials. Other events that may prevent successful or timely completion of clinical development include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability to generate sufficient preclinical, toxicology, or other in vivo or in vitro data to support the initiation or continuation of clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching a consensus with regulatory agencies, the FDA or foreign regulatory authorities, on trial design or implementation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching agreement on acceptable terms with prospective clinical research organizations (&#8220;CROs&#8221;), and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in identifying, recruiting and training suitable clinical investigators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in obtaining required institutional review board (&#8220;IRB&#8221;) or independent ethics committee (&#8220;IEC&#8221;) approval at each clinical trial site;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in recruiting suitable patients to participate in our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imposition of a clinical hold by regulatory agencies for a number of reasons, including after review of an IND or amendment or equivalent foreign application or amendment, as a result of a new safety finding that presents unreasonable risk to clinical trial participants, or after a negative finding from an inspection of our clinical trial operations or study sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure by our CROs, other third parties or us to adhere to the trial protocol or good clinical practice (&#8220;GCP&#8221;);</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party contractors or clinical investigators becoming debarred or suspended or otherwise penalized by the FDA or other comparable foreign regulatory authorities for violations of applicable regulatory requirements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in the testing, validation, manufacturing and delivery of our product candidates to the treatment sites, including due to supply or manufacturing related delays, being ordered by the FDA or comparable foreign regulatory authorities to temporarily or permanently shut down due to violations of current good manufacturing practices (&#8220;cGMP&#8221;), regulations or other applicable requirements, or infections or cross-contaminations of our product candidates in the manufacturing process;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in having subjects&#8217; complete participation in a study or return for post-treatment follow-up;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes to the clinical trial protocols;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trial sites or subjects deviating from the trial protocol or dropping out of a study;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the SOC on which a clinical development plan was based, which may require new or additional trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">selection of clinical endpoints that require prolonged periods of observation or analyses of resulting data;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of our product candidates being greater than we anticipate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of our product candidates producing negative or inconclusive results, which may result in our deciding, or regulators requiring us, to conduct additional clinical trials or abandon development of such product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transfer of manufacturing processes to larger-scale facilities operated by a contract manufacturing organization, and delays or failure by our such manufacturers or us to make any necessary changes to such manufacturing process;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">occurrence of adverse events (&#8220;AEs&#8221;) associated with the product candidate that are viewed to outweigh its potential benefits, or occurrence of an AE in a trial of the same class of agents as our product candidate conducted by other companies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we conducted a significant portion of our CARPO trial in India and, to the extent that we conduct clinical trials in foreign countries, the failure of enrolled subjects in foreign countries to adhere to clinical protocols as a result of differences in SOC, provision of healthcare services or cultural customs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patients in different geographies, including foreign countries, may show differences in clinical outcomes than expected due to differences in underlying disease etiologies or genetic factors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conducting clinical trials in a foreign country may also present additional administrative burdens or delays associated with foreign regulatory schemes including different requirements for clinical trial protocols;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conducting clinical trials in a foreign country may introduce political and economic risks relevant to such foreign countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">receiving untimely or unfavorable feedback from applicable regulatory authorities regarding the trial or requests from regulatory authorities to modify the design of a trial;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">suspensions or terminations by us, the IRBs (or the IECs) of the institutions at which such trials are being conducted, by the data safety monitoring board (&#8220;DSMB&#8221;), for such trial or by regulatory authorities due to a number of factors, including those described above;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lack of adequate funding;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disruptions at the FDA and other governmental agencies caused by funding or staffing shortages.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, disruptions caused by international conflicts may increase the likelihood that we encounter such difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing clinical trials. Any inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability to raise capital, generate revenues from product candidate sales and enter into or maintain collaboration arrangements. For example, if enrollment in a clinical trial is slowed, certain of our expenses related to the trial would not decrease and therefore the overall costs to complete the trial would increase. In addition, if we make manufacturing changes to our product candidates, we may need to conduct additional studies to bridge our modified product candidates to earlier versions. Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring product candidates to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One of our product candidates is, and potential future product candidates may be, developed for the treatment of a pediatric population, for which safety concerns may be particularly scrutinized by regulatory agencies. Trials involving pediatric populations can be difficult to conduct, can be quite costly and, like other clinical trials, may not yield the anticipated results. In addition, pediatric trials are more dependent on a smaller number of specialized clinical trial sites, which in turn can limit site availability and make the trials more expensive to conduct. In addition, as interest in pediatric indications grows as a result of the Research to Accelerate Cures and Equity Act and other market forces, trial recruitment may become even more difficult due to competition for eligible patients. Moreover, it may be challenging to ensure that pediatric or adolescent patients adhere to clinical trial protocols.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and an investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We conducted a significant portion of our CARPO trial in India, and regulatory authorities may not accept data from such trial or any future clinical trials we conduct outside the United States or the applicable foreign jurisdiction.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted a significant portion of our CARPO trial in India. The acceptance of trial data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable non-U.S. regulatory authorities may be subject to certain conditions or may not be accepted at all. In cases where data from non-U.S. clinical trials are intended to serve as the basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of non-U.S. data alone unless (i) the data are applicable to the U.S. population and U.S. medical practice; and (ii) the trials were performed by clinical investigators of recognized competence and pursuant to GCP regulations. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many non-U.S. regulatory authorities have similar approval requirements. In addition, such non-U.S. trials would be subject to the applicable local laws of the non-U.S. jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable non-U.S. regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable non-U.S. regulatory authority does not accept such data or believes that additional data is necessary to supplement such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in product candidates that we may develop not receiving approval for commercialization in the applicable jurisdiction.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conducting clinical trials outside the United States also exposes us to additional risks, including risks associated with:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional foreign regulatory requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign exchange fluctuations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">compliance with foreign manufacturing, customs, shipment and storage requirements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the failure of enrolled subjects in foreign countries to adhere to clinical protocol as a result of differences in SOC;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cultural differences in medical practice and clinical research; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diminished protection of intellectual property in some countries.</span></div></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We depend on enrollment of patients in our clinical trials for our product candidates. If we experience delays or difficulties enrolling patients in our clinical trials, our research and development efforts and business, financial condition, results of operations and prospects could be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successful and timely completion of clinical trials will require that we enroll a sufficient number of patients to participate in each study. These trials may be subject to delays for a variety of reasons, including as a result of patient enrollment taking longer than anticipated, subject withdrawal from the trial or AEs. These types of developments could cause us to delay the trial or halt further development. Our clinical trials will compete with other clinical trials that are in the same therapeutic areas as our product candidates, and this competition reduces the number and types of patients available to us, as some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Because the number of qualified clinical investigators and clinical trial sites is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical trial sites. In addition, there may be limited patient pools from which to draw for clinical studies. In addition to the rarity of some diseases, the eligibility criteria of our clinical studies will further limit the pool of available study participants as we will require that patients have specific characteristics that we can measure or to assure their disease is either severe enough or not too advanced to include them in a clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Participant enrollment in clinical trials depends on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the size and nature of the patient population; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the severity of the disease under investigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eligibility criteria for the trial;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the proximity of patients to clinical sites;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the design of the clinical protocol;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to obtain and maintain research subject consents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to recruit clinical trial investigators with the appropriate competencies and experience;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of competing clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patients&#8217; perceptions of risk in traveling to clinical sites (for patients in non-hospitalized clinical trial settings); </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of new drugs approved for the indication the clinical trial is investigating; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These factors may make it difficult for us to enroll enough patients to complete our clinical trials in a timely and cost-effective manner. Delays in the completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process and delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, some of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preliminary, interim and topline data from our clinical trials may change as more participant data becomes available, and are subject to audit and verification procedures that could result in material changes in the final data.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may publicly disclose preliminary, interim or topline data from our preclinical studies and clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change as participant enrollment and treatment continues and more data become available. Our data to date is based on a small number of subjects, and as a result, data from additional subjects can have a significant impact on the overall data viewed as a whole. Adverse differences between previous preliminary or interim data and future interim or final data could significantly harm our business prospects. We may also announce topline data following the completion of a preclinical study or clinical trial, which may be subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the interim, topline or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim, topline and preliminary data should be viewed with caution until the final data are available.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine to be material or otherwise appropriate information to include in our disclosure. If the interim, top-line, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">SAEs, undesirable side effects or other unexpected properties of our product candidates could lead to the discontinuation of our clinical development programs, refusal by regulatory authorities to approve our product candidates or, if discovered following marketing approval, revocation of marketing authorizations or limitations on the use of our product candidates thereby limiting the commercial potential of such product candidate.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we continue developing Auxora and initiate clinical trials of our additional product candidates, Serious Adverse Events (&#8220;SAEs&#8221;), undesirable side effects, relapse of disease or unexpected characteristics may emerge</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">causing us to abandon these product candidates or limit their development to more narrow uses or subpopulations in which the SAEs or undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk- benefit perspective or in which efficacy is more pronounced or durable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, clinical trials by their nature utilize a sample of the potential patient population. With a limited number of subjects and limited duration of exposure, rare and severe side effects of our product candidates may only be uncovered with a significantly larger number of patients exposed to our therapies. Because of our planned dose escalation design for our clinical trials, undesirable side effects could also result in an expansion in the size of our clinical trials, increasing the expected costs and timeline of our clinical trials. Additionally, results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics, which may stem from our product candidates specifically or may be due to an illness from which the clinical trial subject is suffering.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If unacceptable side effects arise in the development of our product candidates such that there is no longer a positive benefit risk, we, the FDA, the IRBs at the institutions in which our trials are conducted or the DSMB could suspend or terminate our clinical trials or the FDA or comparable foreign regulatory authorities could order us to cease clinical trials or deny approval of our product candidates for any or all targeted indications. Treatment-related side effects could also affect patient recruitment or the ability of enrolled subjects to complete the trial or result in potential product liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff, and inadequate training in recognizing or managing the potential side effects of our product candidates could result in patient injury or death.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we believe our product candidates initially show promise in early clinical trials, side effects of product candidates may only be detectable after they are tested in larger, longer and more extensive clinical trials or, in some cases, after they are made available to patients on a commercial scale after approval. Sometimes, it can be difficult to determine if the serious adverse or unexpected side effects were caused by the product candidate or another factor. If serious adverse or unexpected side effects are identified during development or after approval (including pursuant to any toxicity studies, including reproductive toxicity studies) and are determined to be attributed to our product candidates, we may be required to develop a Risk Evaluation and Mitigation Strategy (&#8220;REMS&#8221;) to ensure that the benefits of treatment with such product candidate outweigh the risks for each potential patient, which may include, among other things, a communication plan to health care practitioners, patient education, extensive patient monitoring or distribution systems and processes that are highly controlled, restrictive and more costly than what is typical for the industry. Product-related side effects could also result in potential product liability claims. Any of these occurrences may harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, if one or more of our product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such product candidates, a number of potentially significant negative consequences could result, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may suspend, withdraw or limit approvals of such product candidate, or seek an injunction against its manufacture or distribution;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory authorities may require additional warnings on the label, including &#8220;boxed&#8221; warnings, or issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings or other safety information about the product candidate;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to create a medication guide outlining the risks of such side effects for distribution to patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to change the way a product candidate is administered or conduct additional clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the product candidate may become less competitive;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may decide to remove the product candidate from the marketplace; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be subject to fines, injunctions or the imposition of civil or criminal penalties.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance of the particular product candidate, if approved, and could seriously harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek special designations by the regulatory authorities to expedite regulatory approvals, but may not be successful in receiving such designations, and even if received, they may not benefit the development and regulatory approval process.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek various designations by the regulatory authorities for any product candidates that we develop, such as Fast Track designation or Breakthrough Therapy designation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a product candidate is intended for the treatment of a serious condition and nonclinical or clinical data demonstrate the potential to address unmet medical need for this condition, a product sponsor may apply for Fast Track designation from the FDA. The sponsor of a product candidate with Fast Track designation has opportunities for more frequent interactions with the applicable FDA review team during product development and, once an NDA is submitted, the candidate may be eligible for priority review if the relevant criteria are met. A product candidate with Fast Track designation may also be eligible for rolling review, where the FDA may consider for review sections of the NDA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA. We have received Fast Track designation for Auxora for the treatment of AP, and we may receive Fast Track designation for other product candidates in the future; however, we may not experience a faster development process, review or approval compared to conventional FDA approval timelines, and the FDA may still decline to approve Auxora or our other designated product candidates. The FDA may rescind the Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program or for any other reason.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Breakthrough Therapy is defined by the FDA as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug, may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For product candidates that have been designated as Breakthrough Therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. The designation also includes all of the Fast Track designation benefits, including eligibility for rolling review of an NDA submission.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Seeking and obtaining these designations is dependent upon results of our clinical program, and whether and when we may have the data from our clinical programs to support an application to obtain any such designation is uncertain. Even if we do receive the designations we may apply for, we may not experience a faster development process, review or approval compared to conventional FDA or similar foreign regulatory authorities&#8217; procedures, as applicable. The FDA or similar foreign regulatory authorities, as applicable, may rescind any granted designations if it believes that the designation is no longer supported by data from our clinical development program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek orphan drug designation for our product candidates, and we may be unsuccessful or may be unable to maintain the benefits associated with orphan drug designation, including the potential for market exclusivity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Similarly, in the European Union, the European Commission grants orphan drug designation after receiving the opinion of the European Medicines Agency (&#8220;EMA&#8221;) Committee for Orphan Medicinal Products on an orphan drug designation application. Orphan drug designation is intended to promote the development of drugs that are (1) intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions; (2) either (a) affecting not more than five in 10,000 persons in Europe, or (b) when, without incentives, it is unlikely that sales of the drug in Europe would be sufficient to justify the necessary investment in developing the drug; and (3) for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or if such a method exists, the product will be of significant benefit to those affected by the condition). In Europe, orphan drug designation entitles a party to a number of incentives, such as protocol assistance and scientific advice specifically for designated orphan medicines, and potential fee reductions depending on the status of the sponsor. We have received orphan drug designation for Auxora for the treatment of AP in the European Union, and we may receive orphan drug designation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for other product candidates in the future; however, we may not experience a faster development process, review or approval compared to conventional approval timelines, and the European Commission and EMA may still decline to approve Auxora or our other designated product candidates. The European Commission and EMA may rescind the orphan drug designation if it believes that the designation is no longer supported by data from our clinical development program or for any other reason.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, if a drug with an orphan drug designation subsequently receives the first marketing approval for the indication for which it has such designation, the drug is entitled to a period of marketing exclusivity, which precludes the EMA or the FDA from approving another marketing application for the same or similar drug and indication for that time period, except in limited circumstances. The applicable period is seven years in the United States and ten years in Europe. The European exclusivity period can be reduced to six years if, at the end of the fifth year, it is established that the drug no longer meets the criteria for orphan drug designation or if the drug is sufficiently profitable such that market exclusivity is no longer justified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we obtain orphan drug exclusivity for any of our product candidates that obtain approval, that exclusivity may not effectively protect those product candidates from competition because different therapies can be approved for the same condition. Even after an orphan drug is approved, the FDA or comparable foreign authorities can subsequently approve another drug for the same condition if the relevant authority concludes that the later drug is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. In addition, a designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. Moreover, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to meet the needs of patients with the rare disease or condition. Orphan drug designation neither shortens the development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process. While we may seek orphan drug designation for applicable indications for our product candidates, we may never receive such designations. Even if we do receive such designations, we may not enjoy the benefits of those designations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may attempt to secure approval from the FDA or comparable foreign regulatory authorities through the use of accelerated approval pathways. If we are unable to obtain such approval, we may be required to conduct additional clinical trials beyond those that we contemplate, which could increase the expense of obtaining, and delay the receipt of, necessary marketing approvals. Even if we receive accelerated approval from the FDA or other regulatory authorities, if our confirmatory trials do not verify clinical benefit, or if we do not comply with rigorous post-marketing requirements, the FDA or foreign regulatory authorities may seek to withdraw accelerated approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may in the future seek an accelerated approval for our one or more of our product candidates. Under the accelerated approval program, the FDA may grant accelerated approval to a product candidate designed to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies upon a determination that such product candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the drug&#8217;s clinical benefit. If such post-approval studies fail to confirm the drug&#8217;s clinical benefit, the FDA may withdraw its approval of the drug.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to seeking accelerated approval for any of our product candidates, we intend to seek feedback from the FDA and will otherwise evaluate our ability to seek and receive accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue or submit an NDA for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that after subsequent FDA feedback we will continue to pursue or apply for accelerated approval or any other form of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expedited development, review or approval, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated approval or receive an expedited regulatory designation (e.g., breakthrough therapy designation) for our product candidates, there can be no assurance that such submission or application will be accepted or that any expedited development, review or approval will be granted on a timely basis, or at all. The FDA or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering our application or granting approval of any type. A failure to obtain accelerated approval or any other form of expedited development, review or approval for our product candidates would result in a longer time period to commercialization of such product candidates, if any, could increase the cost of development of such candidates and could harm our competitive position in the marketplace.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates must meet extensive regulatory requirements before they can be commercialized and any regulatory approval may contain limitations or conditions that require substantial additional development expenses or limit our ability to successfully commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clinical development, manufacturing, labeling, storage, record-keeping, advertising, promotion, import, export, marketing and distribution of our product candidates are subject to extensive regulation by the FDA in the United States and by comparable foreign regulatory authorities in foreign markets. In the United States, we are not permitted to market our product candidates until we receive regulatory approval from the FDA. The process of obtaining regulatory approval is expensive, often takes many years following the commencement of clinical trials and can vary substantially based upon the type, complexity and novelty of the product candidates involved, as well as the target indications and patient population. Despite the time and expense invested in clinical development of product candidates, regulatory approval is never guaranteed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have not submitted an NDA or other marketing authorization application to the FDA or similar drug approval submissions to comparable foreign regulatory authorities for any product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we or our potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction of the FDA or comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. Even if we believe the preclinical or clinical data for our product candidates are promising, such data may not be sufficient to support approval by the FDA and comparable foreign regulatory authorities. In particular, because we are seeking to identify and develop product candidates using new technologies, there is heightened risk that the FDA or other regulatory authorities may impose additional requirements prior to granting marketing approval, including enhanced safety studies or monitoring. Furthermore, as more product candidates within a particular class of products proceed through clinical development to regulatory review and approval, the amount and type of clinical data that may be required by regulatory authorities may increase or change.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA or comparable foreign regulatory authorities can delay, limit or deny approval of a product candidate for many reasons, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree with the design or implementation of our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">negative or ambiguous results from our clinical trials or results may not meet the level of statistical significance required by the FDA or comparable foreign regulatory agencies for approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serious and unexpected product candidate-related side effects may be experienced by participants in our clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serious and unexpected results from preclinical toxicity studies that will be completed in conjunction with late stage clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the population studied in the clinical trial may not be sufficiently broad or representative to assure safety in the full population for which we seek approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may not accept clinical data from trials which are conducted at clinical facilities or in countries where the SOC is potentially different from that of the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to demonstrate that a product candidate&#8217;s clinical and other benefits outweigh its safety risks;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree with our interpretation of data from preclinical studies or clinical trials;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may not agree that the data collected from clinical trials of our product candidates are acceptable or sufficient to support the submission of an application for regulatory approval or other submissions or to obtain regulatory approval in the United States or elsewhere and such authorities may impose requirements for additional preclinical studies or clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may disagree regarding the formulation, labeling and/or the specifications of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval may be granted only for indications that are significantly more limited than what we apply for and/or with other significant restrictions on distribution and use;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such authorities may find deficiencies in the manufacturing processes or facilities of our or our third-party suppliers or manufacturers with which we or any of our potential future collaborators contract for clinical and commercial supplies; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval policies or regulations of such authorities may significantly change in a manner rendering our or any of our potential future collaborators&#8217; clinical data insufficient for approval.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to foreign markets, approval procedures vary among countries and, in addition to the foregoing risks, may involve additional product candidate testing, administrative review periods and agreements with pricing authorities. In addition, events raising questions about the safety of certain marketed pharmaceuticals may result in increased cautiousness by the FDA and comparable foreign regulatory authorities in reviewing new products based on safety, efficacy or other regulatory considerations and may result in significant delays in obtaining regulatory approvals.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we eventually complete clinical trials and receive approval to commercialize our product candidates, the FDA or comparable foreign regulatory authority may grant approval contingent on the performance of costly additional clinical trials, including Phase 4 clinical trials, and/or the implementation of a REMS. The FDA or the comparable foreign regulatory authority also may approve a product candidate for a more limited indication or patient population than we originally requested or may not approve the labeling that we believe is necessary or desirable for the successful commercialization of a product candidate. Manufacturers of our product candidates and manufacturers&#8217; facilities are also required to comply with cGMP regulations and other similar regulatory requirements, which include requirements related to quality control and quality assurance, as well as the corresponding maintenance of records and documentation. Further, regulatory authorities must approve these manufacturing facilities before they can be used to manufacture our product candidates, if approved, and these facilities are subject to continual review and periodic inspections by the FDA and other comparable foreign regulatory authorities for compliance with cGMP regulations and other similar regulatory requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any delay in obtaining, or inability to obtain, applicable regulatory approval would delay or prevent commercialization of that product candidate and could adversely impact our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will need to obtain FDA approval of any proposed product names, including Auxora, and any failure or delay associated with such approval may adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any name we intend to use for our current or future product candidates will require approval from the FDA regardless of whether we have secured a formal trademark registration from the United States Patent and Trademark Office (&#8220;USPTO&#8221;). The FDA typically conducts a review of proposed product names, including an evaluation of the potential for confusion with other product names. The FDA may also object to a product name if it believes the name inappropriately implies medical claims or contributes to an overstatement of efficacy. If the FDA objects to any of our proposed product names, we may be required to adopt alternative names for our product candidates. If we adopt alternative names, we would lose any goodwill or brand recognition developed for previously used names and marks as well as the benefit of our existing trademark applications for such product candidate and may be required to expend significant additional resources in an effort to identify a suitable product name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. We may be unable to build a successful brand identity for a new trademark in a timely manner or at all, which would limit our ability to commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we receive regulatory approval for any of our product candidates, we will be subject to ongoing obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the FDA, EMA or any other comparable foreign regulatory authority approves any of our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion and recordkeeping for the drug product will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration requirements and continued compliance with cGMPs and GCP requirements, for any clinical trials that we conduct post-approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, any regulatory approvals that we receive for our present or future product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the product candidate. The FDA may also require REMS as a condition of approval of our product candidates, which could entail requirements for long- term patient follow-up, a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Later discovery of previously unknown problems with a product candidate, including AEs of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on our ability to conduct clinical trials, including full or partial clinical holds on ongoing or planned trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of the product candidate, withdrawal of the product candidate from the market, or voluntary or mandatory product candidate recalls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, untitled or warning letters or holds on clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal by the FDA, the EMA or any other comparable foreign regulatory authority to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of product candidate approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product candidate seizure or detention, or refusal to permit the import or export of product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our or our collaborators&#8217; ability to commercialize our product candidates, and harm our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturers and manufacturers&#8217; facilities are required to comply with extensive FDA and other regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any NDA, other marketing application and previous responses to inspectional observations made by regulatory authorities. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production and quality control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be subject to enforcement action and we may not achieve or sustain profitability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates are approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, such as our product candidates, if approved. In particular, a product may not be promoted for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product&#8217;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. The U.S. federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The government has also required that companies enter into consent decrees or imposed permanent injunctions under which specified promotional conduct is changed or curtailed. If we cannot successfully manage the promotion of our product candidates, if approved, we could become subject to significant liability, which could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disruptions at the FDA and other government agencies caused by funding shortages, statutory, regulatory and policy changes, or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, or approved or commercialized in a timely manner or at all, which could negatively impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, including executive orders, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies such as the EMA, following its relocation to Amsterdam and corresponding staff changes, that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a prolonged government shutdown or slowdown occurs, or if global health concerns prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not identify or discover other product candidates and may fail to capitalize on our proprietary platform or product candidates that may present a greater commercial opportunity or for which there is a greater likelihood of success.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business depends upon our ability to identify, develop and commercialize product candidates. A key element of our strategy is to discover and develop additional product candidates based upon our CRAC channel inhibitor science. We are seeking to do so through our internal research programs, and may also explore strategic collaborations for the discovery of new product candidates. Research programs to identify product candidates require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. In addition, targets for different indications may require changes to our manufacturing processes, which may slow down development or make it impossible to manufacture our product candidates. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for many reasons, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the research methodology or technology platform used may not be successful in identifying potential product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">competitors may develop alternatives that render our product candidates obsolete or less attractive;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may choose to cease development if we determine that clinical results do not show promise;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other exclusive rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a product candidate may be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a product candidate may not be accepted as safe and effective by patients, the medical community or third- party payors.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because we have limited resources, we must choose to pursue and fund the development of specific types of treatment, or treatment for a specific indication, and we may forego or delay pursuit of opportunities with certain programs or product candidates or for indications that later prove to have greater commercial potential. Our estimates regarding the potential market for our product candidates could be inaccurate, and if we do not accurately evaluate the commercial potential for a particular product candidate, we may relinquish valuable rights to that product candidate through strategic collaboration, licensing or other arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. Alternatively, we may allocate internal resources to a product candidate in a therapeutic area in which it would have been more advantageous to enter into a partnering arrangement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of these events occur, we may be forced to abandon or delay our development efforts with respect to a particular product candidate or fail to develop a potentially successful product candidate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product candidate that we may develop.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of our product candidate programs in clinical trials and may face an even greater risk if we commercialize any product candidate that we may develop. If we cannot successfully defend ourselves against claims that any such product candidate programs caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decreased demand for any product candidate that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of revenue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial monetary awards to trial participants or patients;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant time and costs to defend the related litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">withdrawal of clinical trial participants;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased insurance costs;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to commercialize any product candidate that we may develop; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injury to our reputation and significant negative media attention.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any such outcomes could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Manufacturing, Commercialization and Reliance on Third Parties</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third parties to conduct and perform most of our research, preclinical studies and clinical trials. If these third parties do not satisfactorily carry out their contractual duties, fail to comply with applicable regulatory requirements, fail to meet projected clinical trial enrollment schedules or fail to meet expected deadlines, our development programs may be delayed or subject to increased costs, each of which may have an adverse effect on our business and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have the ability to conduct most aspects of our preclinical studies or clinical trials in-house. As a result, we are and expect to remain dependent on third parties to conduct or otherwise support our ongoing clinical trials and any future clinical trials of our product candidates. Specifically, CROs, clinical investigators, and consultants play a significant role in the conduct of these trials and the subsequent collection and analysis of data. However, we will not be able to control all aspects of their activities. Nevertheless, we are responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and our reliance on the CROs and other third parties does not relieve us of our regulatory responsibilities. We and our CROs are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA, the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competent Authorities of the member states of the EEA, and comparable foreign regulatory authorities for all of our product candidates in clinical development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, clinical trial investigators and clinical trial sites. If we or any of our CROs or clinical trial sites fail to comply with applicable GCP requirements, the data generated in our clinical trials may be deemed unreliable, and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. In addition, our clinical trials must be conducted with investigational product produced under cGMP regulations (and similar foreign requirements). Our failure to comply with these regulations may require us to stop and/or repeat clinical trials, which would delay the marketing approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CROs, clinical trial investigators or other third parties on which we rely may not devote adequate time and resources to our development activities or perform as contractually required. If any of these third parties fail to meet expected deadlines, adhere to our clinical protocols or meet regulatory requirements, otherwise performs in a substandard manner, or terminates its engagement with us, the timelines for our development programs may be extended or delayed or our development activities may be suspended or terminated. If any of our clinical trial sites terminates for any reason, we may experience the loss of follow-up information on subjects enrolled in such clinical trials unless we are able to transfer those subjects to another qualified clinical trial site, which may be difficult or impossible. In addition, clinical trial investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and may receive cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA or any comparable foreign regulatory authority concludes that the financial relationship may have affected the interpretation of the trial, the integrity of the data generated at the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection of any marketing application we submit by the FDA or any comparable foreign regulatory authority. Any such delay or rejection could prevent us from commercializing our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with alternative third parties on commercially reasonable terms, or at all. Further, under certain circumstances, these third parties may terminate their agreements with us upon as little as 30 days prior written notice. Entering into arrangements with alternative CROs, clinical trial investigators or other third parties involves additional cost and requires management focus and time, in addition to requiring a transition period when a new CRO, clinical trial investigator or other third party begins work. If third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain are compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, any clinical trials such third parties are associated with may be extended, delayed or terminated, and we may not be able to obtain marketing approval for or successfully commercialize our product candidates. As a result, we believe that our financial results and the commercial prospects for our product candidates in the subject indication would be harmed, our costs could increase and our ability to generate revenue could be delayed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, with respect to investigator-sponsored trials that are being conducted with Auxora (the CRSPA trial with SJCRH) and may be conducted in the future, we do not and would not control the design or conduct of these trials, and it is possible that the FDA will not view these investigator-sponsored trials as providing adequate support for future clinical trials or market approval, whether controlled by us or third parties, for any one or more reasons, including elements of the design or execution of the trials or safety concerns or other trial results. We expect that such arrangements will provide us certain information rights with respect to the investigator-sponsored trials, including access to and the ability to use and reference the data, including for our own regulatory submissions, resulting from the investigator-sponsored trials. However, we would not have control over the timing and reporting of the data from investigator-sponsored trials, nor would we own the data from the investigator-sponsored trials. If we are unable to confirm or replicate the results from the investigator-sponsored trials or if negative results are obtained, we would likely be further delayed or prevented from advancing further clinical development. Further, if investigators or institutions breach their obligations with respect to the clinical development of our product candidates, or if the data proves to be inadequate compared to the firsthand knowledge we might have gained had the investigator-sponsored trials been sponsored and conducted by us, then our ability to design and conduct any future clinical trials ourselves may be adversely affected. The investigators may design clinical trials with clinical endpoints that are more difficult to achieve, or in other ways that increase the risk of negative clinical trial results compared to clinical trials that we may design on our own. Negative results in investigator- sponsored clinical trials could have a material adverse effect on our efforts to obtain regulatory approval for our product candidates and the public perception of our product</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">candidates. Additionally, the FDA may disagree with the sufficiency of our right of reference to the preclinical or clinical data generated by these investigator-sponsored trials, or our interpretation of preclinical, manufacturing or clinical data from these investigator-sponsored trials. If so, the FDA may require us to obtain and submit additional preclinical or clinical data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, these third parties may also have relationships with other entities, some of which may be our competitors. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, marketing approvals for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We contract with third parties for the manufacturing and supply of certain goods and services for our product candidates for use in preclinical studies and clinical trials, which supply may become limited or interrupted or may not be of satisfactory quality and quantity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not have any manufacturing facilities. We produce in our laboratory relatively small quantities of product for evaluation in our research programs. We rely on third parties for the manufacture of most of our product candidates for preclinical testing and all of our product candidates for clinical testing and we will continue to rely on such third parties for commercial manufacture if any of our product candidates are approved. We currently have limited manufacturing arrangements for preclinical and clinical trial materials for each of our product candidates, including Auxora, and one component of the latter is provided by a single source supplier in China, and will continue to be for the intermediate future. In addition, our single source supplier in China and any other foreign suppliers we may utilize in the future may be subject to U.S. legislation, similar to what is proposed in the BIOSECURE Act considered by Congress in 2024, sanctions, trade restrictions and other foreign regulatory requirements, which may limit, delay, prevent or impair our ability to obtain preclinical and clinical trial materials for our product candidates. This reliance increases the risk that we will not have sufficient quantities of our product candidates or products, if approved, or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, all entities involved in the preparation of product candidates for clinical trials or commercial sale, including our existing contract manufacturers for our product candidates, are subject to extensive regulation. Components of a finished therapeutic product approved for commercial sale or used in clinical trials must be manufactured in accordance with cGMP requirements. These regulations govern manufacturing processes and procedures, including record keeping, and the implementation and operation of quality systems to control and assure the quality of investigational products and products approved for sale. Poor control of production processes can lead to the introduction of contaminants, or to inadvertent changes in the properties or stability of our product candidates that may not be detectable in final product testing. We or our contract manufacturers must supply all necessary documentation in support of an NDA on a timely basis and must adhere to the FDA&#8217;s GLP regulations and cGMP regulations enforced by the FDA through its facilities inspection program. Comparable foreign regulatory authorities may require compliance with similar requirements. Our facilities and quality systems, and those of our third-party contract manufacturers, must pass a pre-approval inspection for compliance with the applicable regulations as a condition of marketing approval of our product candidates. We do not control the manufacturing activities of, and are completely dependent on, our contract manufacturers for compliance with cGMP regulations, although the FDA will hold us responsible for any such non-compliance with respect to our product candidates and any future approved products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that any of our contracted third parties fails to comply with such requirements or to perform their obligations to us in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, including due to the ongoing or future international conflicts or other geopolitical or macroeconomic conditions, we may be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another third-party, which we may not be able to do on commercially reasonable terms, if at all. In particular, any replacement of a third-party contractor could require significant effort and expertise because there may be a limited number of qualified replacements. In some cases, the technical skills or technology required to manufacture a certain aspect of our product candidates may be unique or proprietary to the third-party performing such process and we may have difficulty transferring such skills or technology to another third-party and a feasible alternative may not exist. In addition, certain of our product candidates and our own proprietary methods have never been produced or implemented outside of our company, and we may therefore experience delays to our development programs if we attempt to establish new third-party</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arrangements for these product candidates or methods. If we are required to or voluntarily change a third-party contractor for any reason, we will be required to verify that the new third party maintains facilities, processes and procedures that comply with quality standards and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our or a third-party&#8217;s failure to execute on our manufacturing and supply requirements, do so on commercially reasonable terms and comply with cGMP could adversely affect our business in a number of ways, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the event of approval, to initiate or continue clinical trials of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in submitting regulatory applications, or receiving marketing approvals, for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loss of the cooperation of future collaborators;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">subjecting our or any third-party manufacturing facilities to additional inspections by regulatory authorities; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">requirements to cease development to market and commercialize our product candidates, an inability to meet commercial demands for our current or any other future product candidates, if approved. </span></div></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any approved product candidates may fail to achieve the degree of market acceptance by physicians, patients, hospitals, healthcare payors and others in the medical community necessary for commercial success.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates receives marketing approval, they may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors and others in the medical community. Our CRAC channel inhibitors are a relatively novel technology, and no CRAC channel inhibitor-based therapy has been approved to date. Public perception may be influenced by third-party claims, such as claims that CRAC channel inhibitors are unsafe, ineffective and, consequently, our approach may not gain the acceptance of the public or the medical community. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">efficacy and potential advantages compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to offer our product candidates for sale at competitive prices;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">convenience and ease of administration compared to alternative treatments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of coverage and adequate reimbursement by third-party payors, including government payors, for our products, if approved by applicable regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the strength of marketing and distribution support; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prevalence and severity of any side effects.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, Auxora is an injectable emulsion drug product that must be administered intravenously over four hours, and this dosing regimen may be inconvenient for some physicians or patients.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our product candidates do not achieve an adequate level of acceptance, we may not generate significant product revenue and we may not become profitable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to successfully commercialize our product candidates due to unfavorable pricing regulations or third-party coverage and reimbursement policies, which could make it difficult for us to sell our product candidates profitably.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to reimburse all or part of the costs associated with those medications. Patients are unlikely to use our product candidates unless coverage is provided and reimbursement is adequate to cover all or a significant portion of the cost of our product candidates. Therefore, coverage and adequate reimbursement are critical to a new product&#8217;s acceptance. Coverage decisions may depend upon clinical and economic standards that disfavor</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">new products when more established or lower cost therapeutic alternatives are already available or subsequently become available.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, there is no uniform policy among third-party payors for coverage and reimbursement. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting reimbursement policies, but also have their own methods and approval process apart from Medicare coverage and reimbursement determinations. Therefore, one third-party payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third- party payor&#8217;s determination that use of a product is:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit under its health plan;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective and medically necessary;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appropriate for the specific patient;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cost-effective; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">neither experimental nor investigational.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining coverage and reimbursement approval for a product from a government or other third-party payor is a time-consuming and costly process, with uncertain results, that could require us to provide supporting scientific, clinical and cost effectiveness data for the use of our product candidates to the payor. There may be significant delays in obtaining such coverage and reimbursement for newly approved product candidates, and coverage may not be available, or may be more limited than the purposes for which the product is approved by the FDA or comparable foreign regulatory authorities. Moreover, eligibility for coverage and reimbursement does not imply that a product will be paid for in all cases or at a rate that covers our costs, including research, development, intellectual property, manufacture, sale and distribution expenses. Interim reimbursement levels for new products, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the product and the clinical setting in which it is used, may be based on reimbursement levels already set for lower cost products and may be incorporated into existing payments for other services. Net prices for products may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors, by any future laws limiting drug prices and by any future relaxation of laws that presently restrict imports of product from countries where they may be sold at lower prices than in the United States.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reimbursement may not be available for any product that we commercialize and, if coverage and reimbursement are available, the level of reimbursement may not be adequate. Obtaining reimbursement for our product candidates may be particularly difficult because of the higher prices often associated with branded therapeutics and therapeutics administered under the supervision of a physician. Additionally, we expect our future products to potentially be more expensive than other therapeutics due to the personalized and proprietary product selection process of our product candidates, as well as our individualized approach to patient treatment, which requires patient hospitalization, in some cases intensive care unit admission and the potential administration of combination therapies, all of which increases costs and may result in reimbursement payment rates which may not be adequate or may require co-payments that patients find unacceptably high. Our inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for any approved product candidates that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize product candidates and our overall financial condition. Further, coverage policies and third-party reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained, less favorable coverage policies and reimbursement rates may be implemented in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, separate reimbursement for the product itself may or may not be available. Instead, the hospital or administering physician may be reimbursed only for providing the treatment or procedure in which our product is used. Further, from time to time, the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) revises the reimbursement systems used to reimburse health care providers, including the Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System, which may result in reduced Medicare payments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to experience pricing pressures in connection with the sale of any of our product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, and additional</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">legislative changes. The downward pressure on healthcare costs in general, particularly prescription medicines, medical devices and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the successful commercialization of new products. Further, the adoption and implementation of any future governmental cost containment or other health reform initiative may result in additional downward pressure on the price that we may receive for any approved product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outside of the United States, many countries require approval of the sale price of a product before it can be marketed, and the pricing review period only begins after marketing or product licensing approval is granted. In the European Union, governments influence the price of pharmaceutical products through their pricing and reimbursement rules and control of national health care systems that fund a large part of the cost of those products to consumers. Member states are free to restrict the range of pharmaceutical products for which their national health insurance systems provide reimbursement, and to control the prices and reimbursement levels of pharmaceutical products for human use. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost- effectiveness of a particular product candidate to currently available therapies. To obtain reimbursement or pricing approval in some of these countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our product candidate to other available therapies. Other member states allow companies to fix their own prices for medicines but monitor and control company profits. The downward pressure on health care costs in general, particularly prescription drugs, has become very intense. As a result, new products are facing increasingly high barriers to entry. In addition, in some countries, cross-border imports from low-priced markets exert a commercial pressure on pricing within a country. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain marketing approval for a product candidate in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue, if any, we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if such product candidates obtain marketing approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If any of our product candidates are approved for marketing and commercialization and we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market our product candidates, we will be unable to successfully commercialize our product candidates if and when they are approved.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have no sales, marketing or distribution capabilities or experience. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either develop a sales and marketing organization, which would be expensive and time consuming, or outsource these functions to other third parties. In the future, we may choose to build a focused sales and marketing infrastructure to sell, or participate in sales activities with our collaborators for, some of our product candidates if and when they are approved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are risks involved with both establishing our own sales and marketing capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our sales and marketing personnel.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we enter into arrangements with third parties to perform sales, marketing and distribution services, our product revenue or the profitability of such product revenue to us are likely to be lower than if we were to market and sell any products that we develop ourselves. In addition, we may not be successful in entering into arrangements with third parties to sell and market our product candidates or may be unable to do so on terms that are favorable to us. If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we obtain FDA approval of any of our product candidates, we may never obtain approval or commercialize such product candidates outside of the United States, which would limit our ability to realize their full market potential.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to market any product candidates outside of the United States, we must establish and comply with numerous and varying regulatory requirements of other countries regarding safety and efficacy. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one country does not mean that regulatory approval will be obtained in any other country. Approval procedures vary among countries and can involve additional product testing and validation and additional administrative review periods. Seeking foreign regulatory approvals could result in significant delays, difficulties and costs for us and may require additional preclinical studies or clinical trials which would be costly and time consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our product candidates in those countries. Satisfying these and other regulatory requirements is costly, time consuming, uncertain and subject to unanticipated delays. In addition, our failure to obtain regulatory approval in any country may delay or have negative effects on the process for regulatory approval in other countries. We do not have any product candidates approved for sale in any jurisdiction, including international markets, and we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, our ability to realize the full market potential of our product candidates will be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Industry and Business Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are highly dependent on our key personnel, and if we are not successful in attracting and retaining highly qualified personnel, we may not be able to continue to successfully develop or commercialize our product candidates or otherwise implement our business plan.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific, medical, legal, sales and marketing and other personnel. We are highly dependent on our management and scientific personnel. The loss of the services of any of these individuals could impede, delay or prevent the successful development of our product pipeline, completion of our planned clinical trials, commercialization of our product candidates or in-licensing or acquisition of new assets and could negatively impact our ability to successfully implement our business plan. If we lose the services of any of these individuals, we might not be able to find suitable replacements on a timely basis or at all, and our business could be harmed as a result.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conduct substantially all of our operations at our facility in La Jolla, California. This region is headquarters to many other biopharmaceutical companies and many academic and research institutions. Competition for skilled personnel in our market is intense and may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by movements in our stock price that are beyond our control and may at any time be insufficient to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. Although we have employment agreements with certain of our key employees, these employment agreements provide for at-will employment, which means that any of our employees could leave our employment at any time, with or without notice. We do not maintain &#8220;key person&#8221; insurance policies on the lives of these individuals or the lives of any of our other employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, mid-level and senior managers as well as junior, mid-level and senior scientific and medical personnel.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dr. Rachel Leheny, our Chief Executive Officer and a member of our Board of Directors, and Eric W. Roberts, our Chief Business Officer and a member of our Board of Directors, also provide services for Valence, an investment fund that is one of our significant stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Executive Officer and member of our Board of Directors, Dr. Leheny, and our Chief Business Officer and member of our Board of Directors, Mr. Roberts, are the co-founders of Valence Life Sciences (&#8220;Valence&#8221;), are employed as managing directors of Valence and beneficially own the shares of the company held by Valence. Entities affiliated with Valence together with Dr. Leheny and Mr. Roberts beneficially own a significant portion of our common stock. Although we expect that each of Dr. Leheny and Mr. Roberts will devote on average at least 40 hours per week to our company and remain highly active in our management, they will also continue to devote time to Valence. Because Dr. Leheny and Mr. Roberts are not required to work exclusively for us, their attention to other activities could slow our operations, which could adversely affect our business. In addition, although we do not believe Valence currently has any investments that conflict with our interests, in the future Valence may invest in companies that may compete with us for business opportunities or develop products that are competitive with ours. As a result, Dr. Leheny&#8217;s and Mr. Roberts&#8217; interests may not be aligned with the interests of our other stockholders, and they may</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from time to time be incentivized to take certain actions that benefit their other interests and that our other stockholders do not view as being in their interest as investors in our company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect to expand our development, regulatory and operational capabilities and, as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we employed 14 full-time employees, seven of whom were primarily engaged in research and development activities. We also engage various consultants that are primarily engaged in research and development activities. As we advance our research and development programs, we may be required to further increase the number of our employees, particularly in the areas of clinical development, quality, regulatory affairs and, if any of our product candidates receives marketing approval, sales, marketing and distribution. To manage any future growth, we must:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify, recruit integrate, maintain and motivate additional qualified personnel; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manage our development efforts effectively, including the initiation and conduct of clinical trials for our product candidates, both as a monotherapy and combination therapy; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">improve our operational, financial and management controls, reporting systems and procedures.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our need to effectively execute our growth strategy requires that we:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">discover new product candidates, develop the process and analytical methods for IND-enabling studies and regulatory submissions, complete the required IND-enabling studies for each, and receive approval from the FDA and other regulatory authorities to initiate clinical trials for such product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manage our clinical trials effectively;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identify, recruit, retain, incentivize and integrate additional employees; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain sufficient quantities of drug product for clinical supply and establish manufacturing capabilities or arrangements with third-party manufacturers for commercial supply, if and when approved; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">continue to improve our operational, financial and management controls, reports systems and procedures.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future financial performance and our ability to develop, manufacture and commercialize our product candidates will depend, in part, on our ability to effectively manage any future growth, and our management may also have to divert financial and other resources, and a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial amount of time, to managing these growth activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we may not be able to successfully implement the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our research, development and commercialization goals. Furthermore, the United States is currently experiencing an increasingly competitive labor market and we are uncertain as to the employment environment in the future, or how that environment will impact our workforce, including our ability to hire or retain qualified employees, consultants, contractors or other key personnel to facilitate our growth.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing product candidates more quickly or marketing them more successfully than us.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and commercialization of new product candidates is highly competitive. We compete in the segments of the pharmaceutical, biotechnology and other related markets that develop therapies for the treatment of acute critical illnesses. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize product candidates that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any product candidates that we may develop or that would render any product candidates that we may develop obsolete or non-competitive. Our competitors also may obtain marketing approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Moreover, with the proliferation of new drugs and therapies into critical illnesses, we expect to face increasingly intense competition as new technologies become available. If we fail to stay at the forefront of technological change, we may be unable to compete effectively. Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future. The highly competitive nature of and rapid technological changes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the biotechnology and pharmaceutical industries could render our product candidates or our technology obsolete, less competitive or uneconomical.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The amount and type of clinical data that may be required by regulatory authorities may increase or change. Consequently, the results of our clinical trials for product candidates will likely need to show a risk benefit profile that is competitive with or more favorable than products approved prior to ours in order to obtain marketing approval or, if approved, a product label that is favorable for commercialization. If the risk benefit profile is not competitive with those product candidates or product candidate candidates, we may have developed a product that is not commercially viable, that we are not able to sell profitably or that is unable to achieve favorable pricing or reimbursement. In such circumstances, our future product business, financial condition, results of operations and prospects could be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is significant investment across the biotechnology and pharmaceutical industries in developing novel and proprietary therapies for acute critical illnesses. We face substantial and increasing competition on multiple fronts, including from larger companies with access to more resources and capital, as well as more experience in research and development, clinical trials and commercialization. Smaller or earlier-stage companies as well as academic institutions, government agencies and public and private research institutions may also prove to be significant competitors. Additionally, we may face competition in hiring scientific and management personnel, establishing clinical trial sites, recruiting patients to participate in clinical trials and acquiring technologies complementary to, or necessary for our programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize product candidates that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any product candidates that we may develop. Our competitors also may obtain FDA or other regulatory approval for their product candidates more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. The key competitive factors affecting the success of all of our programs are likely to be their efficacy, safety, convenience, price and degree of reimbursement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and subject enrollment for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The key competitive factors affecting the success of all of our programs are likely to be the possibility of other companies developing drugs that address the same disease indications that we are aiming to address. Some of these markets are limited and significant competition could reduce the number of patients we are able to reach. If we are not successful in developing, commercializing and achieving higher levels of reimbursement than our competitors, we will not be able to compete against them and our business would be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may wish to form collaborations in the future with respect to our product candidates, but may not be able to do so or realize the potential benefits of such transactions, which may cause us to alter or delay our development and commercialization plans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and potential commercialization of our product candidates will require substantial additional capital to fund expenses. We may, in the future, decide to collaborate with other biopharmaceutical companies for the development and potential commercialization of those product candidates, including in territories outside the United States or for certain indications. We will face significant competition in seeking appropriate collaborators. We may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because they may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. If and when we collaborate with a third-party for development and commercialization of a product candidate, we can expect to relinquish some or all of the control over the future success of that product candidate to the third-party. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of our technologies, product candidates and market opportunities. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and whether such a collaboration could be more attractive than the one with us for our product candidates. We may also be restricted under any license agreements from entering into agreements on certain terms or at all with potential collaborators.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators and changes to our strategies. As a result, we may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of such product candidate, reduce or delay one or more of our other development programs, delay the potential commercialization or reduce the scope of any planned sales or marketing activities for such product candidate, or increase our expenditures and undertake development, manufacturing or commercialization activities at our own expense. If we elect to increase our expenditures to fund development, manufacturing or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product candidates may also require specific components to work effectively and efficiently, and rights to those components may be held by others. We may be unable to in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that we identify. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, which would harm our business. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any collaboration arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our products.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may include that:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of our products or may elect not to continue or renew development or commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding, or other external factors, such as a business combination that diverts resources or creates competing priorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with Auxora and any future product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator with marketing, manufacturing, and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes may arise between us and a collaborator that causes the delay or termination of the research, development, or commercialization of our current or future products or that results in costly litigation or arbitration that diverts management attention and resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated, and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable current or future products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator&#8217;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our (or the third parties with whom we work) actual or perceived failure to comply with applicable data protection laws, regulations, and other obligations could lead to government enforcement actions (which could include civil or criminal penalties), private litigation and mass arbitration demands, and/or adverse publicity and could negatively affect our operating results and business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We and the third parties with whom we work may be subject to federal, state, and foreign data protection laws, regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations that address privacy and data security. In the United States, numerous federal, state, and local laws and regulations, including federal and state health information privacy laws, state data breach notification laws, personal data protection laws, federal, state, and local consumer protection laws (e.g., Section 5 of the Federal Trade Commission Act), and other similar laws govern the collection, use, disclosure, and protection of health-related and other personal data. In addition, we obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under federal HIPAA, as amended by the HITECH. Depending on the facts and circumstances, we could be subject to significant penalties if we obtain, use, or disclose individually identifiable protected information provided by a HIPAA-covered entity or business associate in a manner that is not authorized or permitted by HIPAA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, new privacy rules are being enacted in the United States and globally, and existing ones are being updated and strengthened. For example, the CCPA requires covered companies to provide certain disclosures to California consumers (including business representatives and employees who are California residents) and provide such consumers data protection and privacy rights, including the ability to opt-out of certain sales or sharing of personal data. The CCPA provides for administrative penalties for violations, as well as a private right of action for certain data breaches that result in the loss of personal data. This private right of action may increase the likelihood of, and risks associated with, data breach litigation. The CPRA expanded the CCPA&#8217;s requirements, including by adding a right for consumers to correct their personal data and establishing a regulatory agency to implement and enforce the law. Moreover, a number of other states have enacted data protection laws, and similar laws are being considered in several other states, as well as at the federal and local levels. Although these laws exempt some data processed in the context of clinical trials, these evolving compliance and operational requirements impose significant costs that are likely to increase over time, may require us to modify our data processing practices and policies, divert resources from other initiatives and projects, and could restrict the way products and services involving data are offered, all of which may harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internationally, virtually every jurisdiction in which we operate has established its own data security and privacy legal framework that may also apply to health-related and other personal data obtained outside of the United States. For example, the EU has adopted the EU GDPR and the United Kingdom has adopted the UK General Data Protection Regulation (collectively, &#8220;GDPR&#8221;), which imposes strict requirements for processing the personal data of individuals within the EEA and the United Kingdom. Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and potential fines for noncompliance of up to 20 million euros, 17.5 million pounds sterling under the UK GDPR, or in each case, up to 4% of the annual global revenue of the noncompliant company, whichever is greater, as well as private litigation related to the processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law to represent their interests. Among other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the United States in compliance with law, such as the EEA standard contractual clauses, the United Kingdom&#8217;s International Data Transfer Agreement / Addendum, and the EU-U.S. Data Privacy Framework and the UK extension thereto (which allows for transfers for relevant U.S.-based organizations who self-certify compliance and participate in the Framework), these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the United States. If there is no lawful manner for us to transfer personal data from the EEA, the United Kingdom, or other jurisdictions to the United States, or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions (such as Europe) at significant expense, increased exposure to regulatory</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies that transfer personal data out of the EEA and United Kingdom to other jurisdictions, particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist groups. Some European regulators have ordered certain companies to suspend or permanently cease certain transfers out of Europe for allegedly violating the GDPR&#8217;s cross-border data transfer limitations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the new India Digital Personal Data Protection Act 2023 (&#8220;DPDP&#8221;) came into force in 2024. Like the GDPR, the DPDP has extra-territorial reach and failure to comply with the DPDP may lead to substantial fines. A significant portion of our CARPO trial was conducted in India and we and certain third parties with whom we work may be subject to the DPDP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also bound by contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. For example, clinical trial subjects about whom we or the third parties with whom we work obtain information, as well as the providers who share this information with us, contractually limit our ability to use and disclose the information. We publish privacy policies, marketing materials, whitepapers, and other statements such as statements related to compliance with certain certifications or self-regulatory principles, concerning data privacy and security. Regulators in the United States are increasingly scrutinizing these statements, and if these policies, materials or statements are found to be deficient, lacking in transparency, deceptive, unfair, misleading, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators or other adverse consequences.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obligations related to data privacy and security (and consumers&#8217; data privacy expectations) are quickly changing, becoming increasingly stringent, and creating uncertainty.  Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions.  Preparing for and complying with these obligations requires us to devote significant resources, which may necessitate changes to our services, information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. Failure by us or third parties with whom we work to comply with U.S. and international data protection laws, regulations, and other obligations could result in significant consequences, including without limitation government enforcement actions (which could include investigations, civil or criminal penalties, audits inspections), private litigation or mass arbitration demands, additional reporting requirements or oversight, bans on processing personal data, data breach reporting requirements and/or adverse publicity and could negatively affect our operating results and business. Claims that we have violated individuals&#8217; privacy rights, failed to comply with data protection or privacy obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our information technology systems, or those of our CROs, contractors, consultants, or other third parties with whom we work, may fail or suffer security breaches, loss or leakage of data, and other disruptions, which could result in a material disruption of our product candidates&#8217; development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are increasingly dependent upon information technology systems, infrastructure and data to operate our business. In the ordinary course of business, we collect, store and transmit confidential information (including but not limited to intellectual property, proprietary business information and personal data, including health-related information) (collectively, &#8220;sensitive information&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As use of digital technologies has increased, cyber incidents, including deliberate attacks and attempts to gain unauthorized access to computer systems and networks, which could result in material adverse impacts to our business, including the theft of our sensitive information, have increased in frequency and sophistication. Despite our implementation of security measures, given their size and complexity and the increasing amounts of confidential information that they maintain, our information technology systems and those of our third-party CROs, contractors, consultants, and other third parties with whom we work are potentially vulnerable to breakdown or other damage or interruption from service interruptions, system malfunction, natural disasters, terrorism, war and telecommunication and electrical failures, as well as security breaches from inadvertent or intentional actions by our employees, contractors, consultants, business partners, sophisticated nation-state and nation-state supported actors, and/or other third parties, or from cyber-attacks by malicious third parties (including the deployment of harmful malware, ransomware, denial-of-service attacks, social engineering attacks, malicious code, credential stuffing attacks, credential harvesting, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">data or other information technology assets, attacks enhanced or facilitated by AI, and other means to affect service reliability and threaten the confidentiality, integrity and availability of our sensitive information), which may compromise our or the third parties with whom we work systems infrastructure or lead to data leakage. For example, we have experienced phishing attacks in the past and we may be a target of phishing attacks or other cyber-attacks in the future. In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, ability to provide our products or services, loss of sensitive information and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. To the extent that any disruption or security breach were to result in a loss of, or damage to, our sensitive information or applications (or those of the third parties with whom we work), or inappropriate disclosure of sensitive information, we could incur liability and reputational damage, and the further development and commercialization of our product candidates could be delayed. It may be difficult or costly to detect, investigate, mitigate, contain, and remediate a security incident. Our efforts to do so may not be successful. Actions taken by us or the third parties with whom we work to detect, investigate, mitigate, contain, and remediate a security incident could result in outages, data losses, and disruptions of our business. Threat actors may also gain access to other networks and systems after a compromise of our networks and systems.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also have outsourced elements of our operations to third parties, and as a result we manage a number of third parties who have access to our sensitive information. We rely on these third parties and technologies to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, cloud-based infrastructure, data center facilities, encryption and authentication technology, employee email, content delivery to customers, and other functions. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> If the third parties with whom we work experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if the third parties with whom we work fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or the third parties with whom we work supply chains have not been compromised.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we invest in our information security systems, we cannot assure you that our data protection efforts and our investment in information technology will prevent breakdowns, data leakages, breaches in our systems or other cyber incidents that could have an adverse effect upon our reputation, business, financial condition, results or operations and prospects. We may not be successful in preventing or detecting cyber-attacks or mitigating their effects, or we may be perceived as having failed to do so. We take steps designed to detect, mitigate and remediate vulnerabilities in our information systems (such as hardware and/or software, including that of the third parties with whom we work), but we have not, and in the future may not, however, be able to detect and remediate all such vulnerabilities, including on a timely basis. Further, we have (and may in the future) experienced delays in developing and deploying remedial measures and patches designed to address any such identified vulnerabilities. Vulnerabilities [could] be exploited and result in a security incident.  For example, if a cyber-attack were to occur and cause interruptions in our operations, it could result in a material disruption of our programs and the development of our product candidates could be delayed. In addition, the loss of clinical trial data for our product candidates could result in delays in our marketing approval efforts and significantly increase our costs to recover or reproduce the data. Additionally, theft of our intellectual property or proprietary business information could require substantial expenditures to remedy. Furthermore, significant disruptions of our internal information technology systems or security breaches could result in the loss, misappropriation, and/or unauthorized access, use, or disclosure of, or the prevention of access to, sensitive information (including trade secrets or other intellectual property, proprietary business information, and personal data), which could result in financial, legal, business, and reputational harm to us. For example, any such event that leads to unauthorized access, use, or disclosure of personal data, including personal data regarding our clinical trial subjects or employees, could harm our reputation directly, compel us to comply with federal and/or state breach notification laws and foreign law equivalents, subject us to mandatory corrective action, and otherwise subject us to liability under laws and regulations that protect the privacy and security of personal data, which could result in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on our business (and that of the third parties with whom we work).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We or the third parties upon whom we depend may be adversely affected by earthquakes, fires or other natural disasters, terrorism or similar unforeseen events and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our headquarters and main research facility are located in California near major earthquake faults and fire zones. If earthquakes, fires, other natural disasters, terrorism or similar unforeseen events beyond our control prevent us from using all or a significant portion of our headquarters or research facility, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. We do not have a disaster recovery or business continuity plan in place and may incur substantial expenses as a result of the absence or limited nature of our internal or third-party service provider disaster recovery and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse effect on our business. Furthermore, integral parties in our supply chain are operating from single sites, increasing their vulnerability to natural disasters or other sudden, unforeseen and severe AEs. If such an event were to affect our supply chain, it could have a material adverse effect on our ability to conduct our clinical trials, our development plans and business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had federal and state net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $296.8 million and nil, respectively. $102.2 million of our federal NOLs were generated prior to 2018 and will begin to expire in 2026, unless previously utilized, but may be used to offset up to 100% of future taxable income before expiration. Under current law, our federal NOLs generated in tax years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such federal NOLs is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to federal tax law. We also have federal and state research and development credit carryforwards totaling $13.3 million and $3.1 million, respectively. The federal research and development credit carryforwards will begin to expire in 2027, unless previously utilized. The state research and development credits do not expire.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change,&#8221; which is generally defined as a greater than 50 percentage point change (by value) in its equity ownership over a rolling three-year period, the corporation&#8217;s ability to use its pre-change NOL carryforwards and certain other tax attributes to offset its post-change income or taxes may be limited. This could limit the amount of NOLs or other applicable tax attributes that we can utilize annually to offset future taxable income or tax liabilities. We have not undertaken a Section 382 study, and it is possible that we have previously undergone one or more ownership changes so that our use of net operating losses is subject to limitation. We may experience ownership changes in the future as a result of subsequent shifts in our stock ownership. As a result, if we earn net taxable income, our ability to use our pre-change NOLs to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to us. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. As a result, we may be unable to use all or a material portion of our NOL carryforwards and other tax attributes, which could adversely affect our future cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New income, sales, use, or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws, statutes, rules, regulations, or ordinances could be interpreted, changed, modified, or applied adversely to us. For example, legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;), the Coronavirus Aid, Relief, and Economic Security Act and the Inflation Reduction Act (&#8220;IRA&#8221;) enacted many significant changes to the U.S. tax laws. Future guidance from the Internal Revenue Service and other tax authorities with respect to such legislation may affect us, and certain aspects of such legislation could be repealed or modified in future legislation. In addition, it is uncertain if and to what extent various states will conform to federal tax laws. Future tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant one-time charges, and could increase our future U.S. tax expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in healthcare law and implementing regulations, as well as changes in healthcare policy, may impact our business in ways that we cannot currently predict, and may have a significant adverse effect on our business and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect our ability to profitably sell any product candidates for which we obtain marketing approval. Among policy makers and payors in the United States and elsewhere, including in the EU, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the &#8220;Affordable Care Act&#8221;), substantially changed the way healthcare is financed by both the government and private insurers, and continues to significantly impact the U.S. pharmaceutical industry. As another example, the 2021 Consolidated Appropriations Act signed into law on December 27, 2020 incorporated extensive healthcare provisions and amendments to existing laws, including a requirement that all manufacturers of drugs and biological products covered under Medicare Part B report the product&#8217;s average sales price, or ASP, to Department of Health and Human Services (&#8220;HHS&#8221;) beginning on January 1, 2022, subject to enforcement via civil money penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since its enactment, there have been amendments to and judicial, executive and Congressional challenges to certain aspects of the Affordable Care Act. For example, on August 16, 2022, the IRA was signed into law, which among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in Affordable Care Act marketplaces through plan year 2025. The IRA also eliminates the &#8220;donut hole&#8221; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost through a newly established manufacturer discount program. It is unclear how any such challenges and the healthcare reform measures of the second Trump administration will impact the Affordable Care Act, our business, or financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted that affect healthcare expenditures. These changes include aggregate reductions to Medicare payments to providers of 2% per fiscal year pursuant to the Budget Control Act of 2011, which began in 2013 and, due to legislative amendments to the statute, will remain in effect until 2032, unless additional Congressional action is taken. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. In addition, new laws may result in additional reductions in Medicare and other healthcare funding, which may adversely affect customer demand and affordability for our product candidates and, accordingly, the results of our financial operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, there has been heightened governmental scrutiny recently over the manner in which drug manufacturers set prices for their marketed products, which have resulted in several Congressional inquiries, presidential executive orders, and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. On January 5, 2024, the FDA approved Florida&#8217;s Section 804 Importation Program (&#8220;SIP&#8221;) proposal to import certain drugs from Canada for specific state healthcare programs. It is unclear how this program will be implemented, including which drugs will be chosen, and whether it will be subject to legal challenges in the United States or Canada. Other states have also submitted SIP proposals that are pending review by the FDA. Any such approved importation plans, when implemented, may result in lower drug prices for products covered by those programs. At the federal level, the IRA, among other things, (1) directs HHS to negotiate the price of certain single-source drugs that have been on the market for at least 7 years  covered under Medicare (the &#8220;Medicare Drug Price Negotiation Program&#8221;) and (2) imposes rebates under Medicare Part B and Medicare Part D to penalize price increases that outpace inflation. These provisions began to take effect progressively starting in fiscal year 2023. On August 15, 2024, HHS announced the agreed-upon prices of the first ten drugs that were subject to price negotiations, although the Medicare Drug Price Negotiation Program is currently subject to legal challenges. On January 17, 2025, HHS selected fifteen additional products covered under Part D for price negotiation in 2025. Each year thereafter more Part B and Part D products will become subject to the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare Drug Price Negotiation Program. Further, on December 7, 2023, initiative to control the price of prescription drugs through the use of march-in rights under the Bayh-Dole Act was announced. On December 8, 2023, the National Institute of Standards and Technology published for comment a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights which for the first time includes the price of a product as one factor an agency can use when deciding to exercise march-in rights. While march-in rights have not previously been exercised, it is uncertain if that will continue under the new framework.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that these and other healthcare reform measures that may be adopted in the future, particularly in light of the recent U.S. Presidential and Congressional elections, may result in more rigorous coverage criteria and lower reimbursement and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost-containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drugs, once marketing approval is obtained.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the European Union, coverage and reimbursement status of any product candidates for which we obtain regulatory approval are provided for by the national laws of member states. The requirements may differ across the EU member states. Also, at national level, actions have been taken to enact transparency and anti-gift laws (similar to the US Physician Payments Sunshine Act) regarding payments between pharmaceutical companies and health care professionals.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to applicable fraud and abuse, transparency, government price reporting, and other healthcare laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare providers and third-party payors will play a primary role in the recommendation and prescription of any future product candidates we may develop and any product candidates for which we obtain marketing approval. Our current and future arrangements with clinical investigators, third-party payors, healthcare provider and customers expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may affect the business or financial arrangements and relationships through which we research, market, sell and distribute our product candidates. The laws that may affect our ability to operate include, but are not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal Anti-Kickback Statute, which prohibits any person or entity from, among other things, knowingly and willfully soliciting, receiving, offering or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of an item or service reimbursable, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. The federal Anti-Kickback Statute has also been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, and purchasers, on the other the other hand. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, but these exceptions and safe harbors are narrowly drawn. Practices that are alleged to be intended to induce prescribing, purchases or recommendations, or include any payments of more than fair market value, may be subject to scrutiny if they do not qualify for an exception or safe harbor. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal civil and criminal false claims laws, such as the civil False Claims Act (&#8220;FCA&#8221;), which can be enforced by private citizens through civil qui tam actions, and civil monetary penalty laws prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment of federal funds, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. For example, pharmaceutical companies have been prosecuted under the FCA in connection with, among other things their alleged off-label promotion of drugs, engaging in improper consulting arrangements with physicians, concealing price concessions in the pricing information submitted to the government for government price reporting purposes, and providing free product to customers with the expectation that the customers would bill federal health care programs for the product. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. In addition, manufacturers can be held liable under the FCA even when they do not </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. Moreover, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA which, among other things, imposes criminal liability for executing or attempting to execute a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and creates federal criminal laws that prohibit knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation, or making or using any false writing or document knowing the same to contain any materially false, fictitious or fraudulent statement or entry in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by HITECH and their implementing regulations, which imposes privacy, security and breach reporting obligations with respect to individually identifiable health information upon covered entities, including certain healthcare providers, health plans, and healthcare clearinghouses, and their respective business associates and covered subcontractors. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in U.S. federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the federal transparency requirements under the Physician Payments Sunshine Act, created under the Affordable Care Act, which requires, among other things, certain manufacturers of drugs, devices, biologics and medical supplies reimbursed under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to report to CMS information related to payments and other transfers of value provided to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physician assistants and nurse practitioners) and teaching hospitals and physician ownership and investment interests, including such ownership and investment interests held by a physician&#8217;s immediate family members;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">federal and state consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, that may impose similar or more prohibitive restrictions, and may apply to items or services reimbursed by any non-governmental third-party payors, including private insurers; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">state and foreign laws that require pharmaceutical companies to implement compliance programs, comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or to track and report gifts, compensation and other remuneration provided to physicians and other health care providers; state and local laws that require the registration of pharmaceutical sales representatives; and state health information privacy laws, many of which differ from each other in significant ways and often are not pre-empted by HIPAA, thus requiring additional compliance efforts.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into consulting and scientific advisory board arrangements with physicians and other healthcare providers, including some who could influence the use of our product candidates, if approved, and have received equity awards as compensation for services provided to us. Because of the complex and far-reaching nature of these laws, regulatory agencies may view these transactions as prohibited arrangements that must be restructured, or discontinued, or for which we could be subject to other significant penalties. We could be adversely affected if regulatory agencies interpret our financial relationships with providers who may influence the ordering of and use our product candidates, if approved, to be in violation of applicable laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal and state enforcement bodies have continued their scrutiny of interactions between healthcare companies and healthcare providers, which has led to significant investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to investigations can be time-and resource-consuming and can</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">divert management&#8217;s attention from the business. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ensuring that our business arrangements with third parties comply with applicable healthcare laws and regulations will likely be costly. If our operations are found to be in violation of any of these laws or any other current or future governmental laws and regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could substantially disrupt our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our current or future employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk of fraud or other misconduct by our employees, principal investigators, consultants and commercial partners. Misconduct by these parties could include intentional failures to comply with the regulations of the FDA and applicable non-U.S. regulators, provide accurate information to the FDA and applicable non-U.S. regulators, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, diminished profits and future earnings, additional reporting obligations and oversight if subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for Auxora, any future product candidates, and other proprietary technologies we develop, or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize Auxora, any future product candidates, and other proprietary technologies if approved, may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success will depend in part on our ability to obtain and maintain a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related to Auxora, any future product candidates, and other proprietary technologies we develop. If we are unable to obtain or maintain patent protection with respect to Auxora, any future product candidates, and other proprietary technologies we may develop, our business, financial condition, results of operations, and prospects could be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies is highly uncertain and involves complex legal, scientific, and factual questions and has been the subject of frequent litigation in recent years. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. Our patent applications may not result in patents being issued which protect Auxora, any future product candidates, and other proprietary technologies we may develop or which effectively prevent others from commercializing competitive technologies and products. Further, no consistent policy regarding the breadth of claims allowed in pharmaceutical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patents has emerged to date in the United States or in many jurisdictions outside of the United States. Changes in either the patent laws or interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property. Accordingly, we cannot predict the breadth of claims that may be enforced in the patents that may be issued from the applications we currently or may in the future own or license from third parties. Further, if any patents we obtain or license are deemed invalid and unenforceable, our ability to commercialize or license our technology could be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or any of our actual or potential future collaborators will be successful in protecting Auxora, any future product candidates, and other proprietary technologies and their uses by obtaining, defending and enforcing patents. These risks and uncertainties include the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process, the noncompliance with which can result in abandonment or lapse of a patent or patent application, and partial or complete loss of patent rights in the relevant jurisdiction;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patent applications may not result in any patents being issued;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patents that may be issued may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable, or may otherwise not provide any competitive advantage;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our competitors, many of whom have substantially greater resources than we do and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with, or eliminate our ability to make, use and sell our potential product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other parties may have designed around our claims or developed technologies that may be related or competitive to our platform, may have filed or may file patent applications and may have received or may receive patents that overlap or conflict with our patent applications, either by claiming the same composition of matter, methods or formulations or by claiming subject matter that could dominate our patent position;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any successful opposition to any patents owned by or licensed to us could deprive us of rights necessary for the practice of our technologies or the successful commercialization of any products or product candidates that we may develop;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">because patent applications in the United States and most other countries are confidential for a period of time after filing, we cannot be certain that we were the first to file any patent application related to Auxora, any future product candidates, and other proprietary technologies and their uses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an interference proceeding can be provoked by a third party or instituted by the USPTO to determine who was the first to invent any of the subject matter covered by the patent claims of our applications for any application with an effective filing date before March 16, 2013;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the United States for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">countries other than the United States may have patent laws less favorable to patentees than those upheld by U.S. courts, allowing foreign competitors a better opportunity to create, develop, and market competing product candidates in those countries.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, or maintain all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach such agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection for such output. In addition, our ability to obtain and maintain</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">valid and enforceable patents depends on whether the differences between our inventions and the prior art allow our inventions to be patentable over the prior art. Furthermore, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in any of our owned patents or pending patent applications, or that we were the first to file for patent protection of such inventions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. If we do not adequately protect our intellectual property and proprietary technology, competitors may be able to use Auxora, any future product candidates, and other proprietary technologies and erode or negate any competitive advantage we may have, which could have a material adverse effect on our financial condition and results of operations. For example:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may be able to make compounds that are similar to Auxora and any future product candidates but that are not covered by the claims of our patents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we might not have been the first to make the inventions covered by our pending patent applications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we might not have been the first to file patent applications for these inventions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may independently develop similar or alternative technologies or duplicate any of our technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any patents that we obtain may not provide us with any competitive advantages;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not develop additional proprietary technologies that are patentable;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our competitors might conduct research and development activities in countries where we do not have patent rights or where patent protection is weak and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we cannot ensure that any of our patents, or any of our pending patent applications, if issued, will include claims having a scope sufficient to protect our products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we cannot ensure that we will be able to successfully commercialize our products on a substantial scale, if approved, before the relevant patents that we own expire; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patents of others may have an adverse effect on our business.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Others have filed, and in the future are likely to file, patent applications covering products and technologies that are similar, identical or competitive to ours or important to our business. We cannot be certain that any patent application owned by a third party will not have priority over patent applications filed by us, or that we will not be involved in interference, opposition or invalidity proceedings before U.S. or non-U.S. patent offices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be certain that the claims in our issued patents and pending patent applications covering Auxora or any future product candidates will be considered patentable by the USPTO, courts in the United States, or by patent offices and courts in foreign countries. Furthermore, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant problems in protecting and defending our intellectual property internationally.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The strength of patents in the biotechnology and pharmaceutical fields involves complex legal and scientific questions and can be uncertain. The patent applications that we own may fail to result in issued patents with claims that cover Auxora and any future product candidates in the United States or in foreign countries. Even if such patents do successfully issue, third parties may challenge the ownership, validity, enforceability, or scope thereof, which may result in such patents being narrowed, invalidated, or held unenforceable. Any successful opposition to our patents could deprive us of exclusive rights necessary for the successful commercialization of Auxora and any future product candidates. Furthermore, even if they are unchallenged, our patents may not adequately protect our intellectual property, provide exclusivity for Auxora or any future product candidates or prevent others from designing around our claims. If the breadth or strength of protection provided by the patents we hold with respect to Auxora or any future product candidates is threatened, it could dissuade companies from collaborating with us to develop, or threaten our ability to commercialize, Auxora or any future product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For U.S. patent applications in which claims are entitled to a priority date before March 16, 2013, an interference proceeding can be provoked by a third party or instituted by the USPTO to determine who was the first to invent any</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the subject matter covered by the patent claims of our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms. Our participation in an interference proceeding may fail and, even if successful, may result in substantial costs and distract our management and other employees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For U.S. patent applications containing a claim not entitled to priority before March 16, 2013, there is greater level of uncertainty in the patent law. In September 2011, the Leahy-Smith America Invents Act, or America Invents Act, was signed into law. The America Invents Act includes a number of significant changes to U.S. patent law, including provisions that affect the way patent applications will be prosecuted and may also affect patent litigation. The USPTO is developing regulations and procedures to govern the administration of the America Invents Act, and many of the substantive changes to patent law associated with the America Invents Act, and in particular, the &#8220;first to file&#8221; provisions, were enacted on March 16, 2013. This will require us to be cognizant going forward of the time from invention to filing of a patent application and be diligent in filing patent applications, but circumstances could prevent us from promptly filing patent applications on our inventions. It remains unclear what impact the America Invents Act will have on the operation of our business. As such, the America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term of any individual patent depends on applicable law in the country where the patent is granted. In the United States, provided all maintenance fees are timely paid, a patent generally has a term of 20 years from its application filing date or earliest claimed non-provisional filing date. Extensions may be available under certain circumstances, but the life of a patent and, correspondingly, the protection it affords is limited. Even if we obtain patents covering our product candidates, when the terms of all patents covering a product expire, our business may become subject to competition from competitive products, including generic products. Given the amount of time required for the development, testing, and regulatory review and approval of new product candidates, patents protecting such candidates may expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we do not obtain patent term extension for Auxora, our business may be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon the timing, duration, and specifics of any FDA marketing approval of Auxora, or any future product candidate we may develop, one or more of patents issuing from our U.S. patent applications may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984, (the &#8220;Hatch-Waxman Amendments&#8221;). The Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. Similar patent term restoration provisions to compensate for commercialization delay caused by regulatory review are also available in certain foreign jurisdictions, such as in Europe under Supplemental Protection Certificate, or (&#8220;SPC&#8221;). If we encounter delays in our development efforts, including our clinical trials, the period of time during which we could market Auxora and any future product candidates under patent protection would be reduced. Additionally, we may not receive an extension if we fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents, or otherwise fail to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or restoration, or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our product will be shortened and our competitors may obtain approval of competing products following our patent expiration, and our revenue could be reduced.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent process. Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on any issued patents and/or applications are due to be paid to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the USPTO and foreign patent agencies in several stages over the lifetime of the patents and/or applications. We have systems in place to remind us to pay these fees, and we employ an outside firm and rely on our outside counsel to pay these fees due to foreign patent agencies. While an inadvertent lapse may sometimes be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market with similar or identical products or technology earlier than should otherwise have been the case, which would have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect Auxora.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As is the case with other biotechnology and pharmaceutical companies, our success is heavily dependent on intellectual property, particularly on obtaining and enforcing patents. Our patent rights may be affected by developments or uncertainty in U.S. or foreign patent statutes, patent case law, USPTO rules and regulations or the rules and regulations of foreign patent offices. Obtaining and enforcing patents in the biotechnology and pharmaceutical industry involve both technological and legal complexity, and is therefore costly, time- consuming and inherently uncertain. In addition, the United States may, at any time, enact changes to U.S. patent law and regulations, including by legislation, by regulatory rule-making, or by judicial precedent, that adversely affect the scope of patent protection available and weaken the rights of patent owners to obtain patents, enforce patent infringement and obtain injunctions and/or damages. For example, the scope of patentable subject matter under 35 U.S.C. 101 has evolved significantly over the past several years as the Court of Appeals for the Federal Circuit and the Supreme Court issued various opinions, and the USPTO modified its guidance for practitioners on multiple occasions. The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. We cannot predict how decisions by the federal courts, the U.S. Congress or the USPTO may impact the value of our patent rights. For example, the Supreme Court of the United States held in Amgen v. Sanofi (2023) that a functionally claimed genus was invalid for failing to comply with the enablement requirement of the Patent Act. In addition, the Federal circuit recently issued a decision, In re Cellect, LLC (2023) involving the interaction of patent term adjustment (&#8220;PTA&#8221;), terminal disclaimers, and obvious-type double patenting which may affect the patent term of any issued patents that rely on any PTA. Other countries may likewise enact changes to their patent laws in ways that adversely diminish the scope of patent protection and weaken the rights of patent owners to obtain patents, enforce patent infringement, and obtain injunctions and/or damages.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, the United States and other governments may, at any time, enact changes to law and regulation that create new avenues for challenging the validity of issued patents. For example, the America Invents Act created new administrative post-grant proceedings, including post-grant review, inter partes review, and derivation proceedings that allow third parties to challenge the validity of issued patents. This applies to all of our U.S. patents, even those issued before March 16, 2013. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in U.S. federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. In the 2013 case Assoc. for Molecular Pathology v. Myriad Genetics, Inc., for instance, the U.S. Supreme Court held that certain claims to DNA molecules are not patentable. While we do not believe that any of the patents owned or licensed by us will be found invalid based on this decision, we cannot predict how future decisions by the courts, the U.S. Congress or the USPTO may impact the value of our patents. For example, the Inflation Reduction Act (IRA) passed by Congress authorizes the Secretary of the Department of HHS to negotiate prices directly with participating manufacturers for selected medicines covered by Medicare even if these medicines are protected by an existing patent. For small molecule medicines, the process begins seven years after initial approval by the FDA. While we do not believe that the IRA or its effects will impact our ability to obtain patents in the near future, we cannot be certain whether it will affect our patent strategy in the long run.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patents are of national or regional effect. Filing, prosecuting, and defending patents on Auxora, any future product candidates, and other proprietary technologies we develop in all countries throughout the world would be prohibitively expensive. In addition, the laws of some foreign countries do not protect intellectual property rights in the same manner and to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but enforcement of such patent protection is not as strong as that in the United States. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The requirements for patentability may differ in certain countries. For example, unlike other countries, China has a heightened requirement for patentability, and specifically requires a detailed description of medical uses of a claimed drug. In India, unlike the United States, there is no link between regulatory approval for a drug and its patent status. In addition to India, certain countries in Europe and developing countries, including China, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, some countries limit the enforceability of patents against government agencies or government contractors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In those countries, we may have limited remedies if patents are infringed or if we are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology or pharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. In Europe, beginning June 1, 2023, European applications and patent may be subjected to the jurisdiction of the Unified Patent Court (&#8220;UPC&#8221;). Also, European applications will have the option, upon grant of a patent, of becoming a Unitary Patent which will be subject to the jurisdiction of the UPC. This will be a significant change in European patent practice. As the UPC is a new court system, there is no precedent for the court, increasing the uncertainty. As a single court system can invalidate a European patent, we, where applicable may opt out of the UPC and as such, each European patent would need to be challenged in each individual country. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patent rights, trade secrets, or other intellectual property as an inventor or co-inventor. The failure to name the proper inventors on a patent application can result in the patents issuing thereon being unenforceable. For example, we may have inventorship disputes arise from conflicting views regarding the contributions of different individuals named as inventors, conflicting obligations of third parties involved in developing Auxora or as a result of questions regarding co-ownership of potential joint inventions. Litigation may be necessary to resolve these and other claims challenging inventorship and/or ownership. Alternatively, or additionally, we may enter into agreements to clarify the scope of our rights in such intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business, financial condition, results of operations and prospects. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be successful in obtaining or maintaining necessary rights to product components and processes for our development pipeline through acquisitions and in-licenses.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our program may require the use of intellectual property rights held by third parties. The growth of our business may depend in part on our ability to acquire, in-license or use these proprietary rights. In addition, Auxora may require specific formulations to work effectively and efficiently and these rights may be held by others. We may be unable to acquire or in-license, on reasonable terms, proprietary rights related to any compositions, formulations, methods of use, processes or other intellectual property rights from third parties that we identify as being necessary for Auxora. Even if we are able to obtain a license to such proprietary rights, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement technology.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Where we obtain licenses from or collaborate with third parties, we may not have the right to control the preparation, filing, and prosecution of patent applications, or to maintain the patents, covering technology that we license from third parties, or such activities, if controlled by us, may require the input of such third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business, or in compliance with applicable laws and regulations, which may affect the validity and enforceability of such patents or any patents that may issue from such application. Moreover, if we do obtain necessary licenses, we will likely have obligations under those licenses, including making royalty and milestone payments, and any failure to satisfy those obligations could give our licensor the right to terminate the license. Termination of a necessary license, or expiration of licensed patents or patent applications, could have a material adverse impact on our business. Our business would suffer if any such licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing third parties, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. Furthermore, if any licenses terminate, or if the underlying patents fail to provide the intended exclusivity, competitors or other third parties may gain the freedom to seek regulatory approval of, and to market, products identical or similar to ours. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#8217;s rights. In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of future products, if any, the amounts may be significant. The amount of our future royalty obligations will depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and commercialize products, we may be unable to achieve or maintain profitability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The licensing and acquisition of third-party proprietary rights is a competitive area, and companies, which may be more established, or have greater resources than we do, may also be pursuing strategies to license or acquire third-party proprietary rights that we may consider necessary or attractive in order to commercialize Auxora. More established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, we may collaborate with U.S. and foreign academic institutions to accelerate our research development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate an exclusive license to any of the institution&#8217;s proprietary rights in technology resulting from the collaboration. Regardless of such option to negotiate a license, we may be unable to negotiate a license within the specified time frame or under terms that are acceptable to us. If we are unable to do so, the institution may offer, on an exclusive basis, their proprietary rights to other parties, potentially blocking our ability to pursue our program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us, either on reasonable terms, or at all. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment, or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights on commercially reasonable terms, our ability to commercialize our products, and our business, financial condition, and prospects for growth, could suffer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Third-party claims alleging intellectual property infringement may prevent or delay our drug discovery and development efforts.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends in part on our avoiding infringement of the patents and proprietary rights of third parties. There is a substantial amount of litigation, both within and outside the United States, involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for challenging patents, including inter partes review, interference and reexamination proceedings before the USPTO, or oppositions and other comparable proceedings in foreign jurisdictions. The America Invents Act introduced new procedures including inter partes review and post grant review. The implementation of these procedures brings uncertainty to the possibility of challenges to our patents in the future and the outcome of such challenges. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing Auxora. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our activities related to Auxora may give rise to claims of infringement of the patent rights of others.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The pharmaceutical and biotechnology industries have produced a proliferation of patents, and it is not always clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the interpretation is not always uniform. We cannot assure you that any of our current or future product candidates will not infringe existing or future patents. We may not be aware of patents that have already issued that a third party might assert are infringed by one of our current or future product candidates. Nevertheless, we are not aware of any issued patents that will prevent us from marketing Auxora.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents of which we are currently unaware with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of Auxora. Because patent applications can take many years to issue and may be confidential for 18 months or more after filing, there may be currently pending third-party patent applications which may later result in issued patents that Auxora, any future product candidates, and other proprietary technologies may infringe, or which such third parties claim are infringed by the use of our technologies. Parties making claims against us for infringement or misappropriation of their intellectual property rights may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize Auxora or future product candidates. Defense of these claims, regardless of their merit, could involve substantial expenses and could be a substantial diversion of management and other employee resources from our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we collaborate with third parties in the development of technology in the future, our collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to litigation or potential liability. Further, collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability. In the future, we may agree to indemnify our commercial collaborators against certain intellectual property infringement claims brought by third parties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any claims of patent infringement asserted by third parties would be time-consuming and could:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">result in costly litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">divert the time and attention of our technical personnel and management;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cause development delays;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prevent us from commercializing Auxora or any future product candidates until the asserted patent expires or is finally held invalid, unenforceable, or not infringed in a court of law;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require us to develop non-infringing technology, which may not be possible on a cost-effective basis;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require us to pay damages to the party whose intellectual property rights we may be found to be infringing, which may include treble damages if we are found to have been willfully infringing such intellectual property;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require us to pay the attorney&#8217;s fees and costs of litigation to the party whose intellectual property rights we may be found to be willfully infringing; and/or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require us to enter into royalty or license agreements, which may not be available on commercially reasonable terms, or at all.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are sued for patent infringement, we would need to demonstrate that our products or methods either do not infringe the patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be able to do either. Proving invalidity or unenforceability is difficult. For example, in the United States, proving invalidity before federal courts requires a showing of clear and convincing evidence to overcome the presumption of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">validity enjoyed by issued patents. Even if we are successful in these proceedings, we may incur substantial costs and divert management&#8217;s time and attention in pursuing these proceedings, which could have a material adverse effect on us. If we are unable to avoid infringing the patent rights of others, we may be required to seek a license, which may not be available, defend an infringement action or challenge the validity or enforceability of the patents in court. Patent litigation is costly and time-consuming. We may not have sufficient resources to bring these actions to a successful conclusion. In addition, if we do not obtain a license, develop or obtain non-infringing technology, fail to defend an infringement action successfully or have infringed patents declared invalid or unenforceable, we may incur substantial monetary damages, encounter significant delays in bringing Auxora or any future product candidates to market and be precluded from developing, manufacturing or selling Auxora or any future product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not always conduct independent reviews of pending patent applications of and patents issued to third parties. We cannot be certain that any of our patent searches or analyses, including but not limited to the identification of relevant patents, analysis of the scope of relevant patent claims or determination of the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States, Europe and elsewhere that is relevant to or necessary for the commercialization of our product candidates in any jurisdiction, because:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">some patent applications in the United States may be maintained in secrecy until the patents are issued;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patent applications in the United States and elsewhere can be pending for many years before issuance, or unintentionally abandoned patents or applications can be revived;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our technologies, Auxora, and any future product candidates or the use of Auxora and any future product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identification of third-party patent rights that may be relevant to our technology is difficult because patent searching is imperfect due to differences in terminology among patents, incomplete databases, and the difficulty in assessing the meaning of patent claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patent applications in the United States are typically not published until 18 months after the priority date;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">publications in the scientific literature often lag behind actual discoveries; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additionally, generative artificial intelligence (AI) resources that are publicly available also present a risk that a company may inadvertently obtain, incorporate or use a third party's intellectual property.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history and can involve other factors such as expert opinion. Our interpretation of the relevance or the scope of claims in a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. Further, we may incorrectly determine that our technologies, products, or product candidates are not covered by a third-party patent or may incorrectly predict whether a third party&#8217;s pending patent application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or internationally that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our products or product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our competitors may have filed, and may in the future file, patent applications covering technology similar to ours, and others may have or obtain patents or proprietary rights that could limit our ability to make, use, sell, offer for sale or import Auxora and future approved products or impair our competitive position. Numerous third-party U.S. and foreign issued patents and pending patent applications exist in the fields in which we are developing product candidates. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of Auxora. Any such patent application may have priority over our patent applications, which could further require us to obtain rights to issued patents covering such technologies. If another party has filed a U.S. patent application on inventions similar to ours, we may have to participate in an interference proceeding declared by the USPTO to determine priority of invention in the United States. The costs of these proceedings could be substantial, and it is possible that such efforts would be unsuccessful if, unbeknownst to us, the other party had independently arrived at the same or similar invention prior to our own invention, resulting in a loss of our U.S. patent position with respect to such inventions. Other countries have similar laws that permit secrecy of patent applications and may be entitled to priority over our applications in such jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a third party prevails in a patent infringement lawsuit against us, we may have to stop making and selling the infringing product, pay substantial damages, including treble damages and attorneys&#8217; fees if we are found to be willfully infringing a third party&#8217;s patents, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict whether any such license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, we may need to obtain licenses from third parties to advance our research or allow commercialization of Auxora. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize Auxora, which could harm our business significantly. Even if we were able to obtain a license, the rights may be nonexclusive, which may give our competitors access to the same intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims that we have wrongfully hired an employee from a competitor or that we or our employees have wrongfully used or disclosed alleged confidential information or trade secrets of their former employers.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As is common in the biotechnology and pharmaceutical industries, in addition to our employees, we engage the services of consultants to assist us in the development of Auxora, any future product candidates, and other proprietary technologies. Many of these consultants, and many of our employees, were previously employed at, or may have previously provided or may be currently providing consulting services to, other pharmaceutical companies including our competitors or potential competitors. We may become subject to claims that we, our employees or a consultant inadvertently or otherwise used or disclosed trade secrets or other information proprietary to their former employers or their former or current clients. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely affect our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to our management team and other employees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be involved in lawsuits to protect or enforce our patents which could be expensive, time-consuming, and unsuccessful. Further, our issued patents could be found invalid or unenforceable if challenged in court, and we may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties including competitors may infringe, misappropriate or otherwise violate our patents or patents that may issue to us in the future. To counter infringement or unauthorized use, we may need to or choose to file infringement claims, which can be expensive and time-consuming. We may not be able to prevent, infringement, misappropriation, or other violation of our intellectual property, particularly in countries where the laws may not protect those rights as fully as in the United States.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we choose to go to court to stop another party from using the inventions claimed in our patents, that individual or company has the right to ask the court to rule that such patents are invalid, unenforceable, or should not be enforced against that third party for any number of reasons. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge include an alleged failure to meet any of several statutory requirements for patentability, including lack of novelty, obviousness, lack of written description, indefiniteness, or non-enablement. Grounds for an unenforceability assertion could include an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution, i.e., committed inequitable conduct. Third parties may also raise similar claims before the USPTO, even outside the context of litigation. Similar mechanisms for challenging the validity and enforceability of a patent exist in foreign patent offices and courts and may result in the revocation, cancellation, or amendment of any foreign patents we hold now or in the future. The outcome following legal assertions of invalidity and unenforceability is unpredictable, and prior art could render our patents invalid. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all, of the patent protection on such product candidate. Such a loss of patent protection would have a material adverse impact on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all if a non-exclusive license is offered and our competitors gain access to the same technology. Our defense of litigation or interference proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our research programs, license necessary technology from third parties, or enter into development or manufacturing partnerships that would help us bring Auxora and any future product candidates to market.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if resolved in our favor, litigation or other legal proceedings relating to our intellectual property rights may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could compromise our ability to compete in the marketplace. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to enforce our patent rights depends on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the components or methods that are used in connection with their products and services. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#8217;s or potential competitor&#8217;s product or service. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded if we were to prevail may not be commercially meaningful.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may not be in a position to enforce our intellectual property rights against third parties.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the expense and uncertainty of litigation, we may conclude that even if a third party is infringing our issued patent, any patents that may be issued as a result of our pending or future patent applications or other intellectual property rights, the risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the best interest of our company or our stockholders. In such cases, we may decide that the more prudent course of action is to simply monitor the situation or initiate or seek some other non-litigious action or solution.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may rely on trade secrets to protect our proprietary technologies, especially where we do not believe patent protection is appropriate or obtainable. However, trade secrets are difficult to protect. We rely in part on confidentiality agreements with our employees, consultants, outside scientific collaborators, sponsored researchers, and other advisors, and inventions agreements with employees, consultants, and advisors, to protect our trade secrets and other proprietary information. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using commonly accepted physical and technological security measures. Despite these efforts, we cannot provide any assurances that all such agreements have been duly executed, and these agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. In addition, others may independently discover our trade secrets and proprietary information. For example, the FDA, as part of its Transparency Initiative, is currently considering whether to make additional information publicly available on a routine basis, including information that we may consider to be trade secrets or other proprietary information, and it is not clear at the present time how the FDA&#8217;s disclosure policies may change in the future, if at all. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, such security measures may not provide adequate protection for our proprietary information, for example, in the case of misappropriation of a trade secret by an employee, consultant, customer, or third party with authorized access. Our security measures may not prevent an employee, consultant or customer from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. Even though we use commonly accepted security measures, the criteria for protection of trade secrets can vary among different jurisdictions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. Moreover, third parties may still obtain this information or may come upon this or similar information independently, and we would have no right to prevent them from using that technology or information to compete with us. Trade secrets will over time be disseminated within the industry through independent development, the publication of journal articles, and the movement of personnel skilled in the art from company to company or academic to industry scientific positions. Though our agreements with third parties typically restrict the ability of our advisors, employees, collaborators, licensors, suppliers, third-party contractors, and consultants to publish data potentially relating to our trade secrets, our agreements may contain certain limited publication rights. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Because from time to time we expect to rely on third parties in the development, manufacture, and distribution of our products and provision of our services, we must, at times, share trade secrets with them. Despite employing the contractual and other security precautions described above, the need to share trade secrets increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. If any of these events occurs or if we otherwise lose protection for our trade secrets, the value of this information may be greatly reduced and our competitive position would be harmed. If we do not apply for patent protection prior to such publication or if we cannot otherwise maintain the confidentiality of our proprietary technology and other confidential information, then our ability to obtain patent protection or to protect our trade secret information may be jeopardized.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future trademarks or trade names may be unable to be obtained, challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. We may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, domain names, copyrights, or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our financial condition or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, any trade name we have proposed to use for products in the United States, such as Auxora must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA (or an equivalent administrative body in a foreign jurisdiction) objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify a suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties, and be acceptable to the FDA. Similar requirements exist in Europe. Furthermore, in many countries,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">owning and maintaining a trademark registration may not provide an adequate defense against a subsequent infringement claim asserted by the owner of a senior trademark. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. If we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any collaboration arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our products.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may include that:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to collaborations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not pursue development and commercialization of our products or may elect not to continue or renew development or commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding, or other external factors, such as a business combination that diverts resources or creates competing priorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with Auxora and any future product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator with marketing, manufacturing, and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes may arise between us and a collaborator that causes the delay or termination of the research, development, or commercialization of our current or future products or that results in costly litigation or arbitration that diverts management attention and resources;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborations may be terminated, and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable current or future products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collaborators may own or co-own intellectual property covering our products that results from our collaborating with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a collaborator&#8217;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business operations may subject us to disputes, claims and lawsuits, which may be costly and time-consuming and could materially and adversely impact our financial position and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may become involved in disputes, claims and lawsuits relating to our business operations. In particular, we may face claims related to the safety of our products, intellectual property matters, employment matters, tax matters, commercial disputes, competition, sales and marketing practices, environmental matters, personal injury, insurance coverage and acquisition or divestiture-related matters. Any dispute, claim or lawsuit may divert management&#8217;s attention away from our business, we may incur significant expenses in addressing or defending any</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">dispute, claim or lawsuit, and we may be required to pay damage awards or settlements or become subject to equitable remedies that could adversely affect our operations and financial results.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Litigation related to these disputes may be costly and time-consuming and could materially and adversely impact our financial position and results of operations if resolved against us. In addition, the uncertainty associated with litigation could lead to increased volatility in our stock price.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, and the third parties with whom we share our facilities, are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials and produce hazardous waste products. We generally contract with third parties for the disposal of these materials and waste. We cannot eliminate the risk of contamination or injury from these materials. We could be held liable for any resulting damages in the event of contamination or injury resulting from the use of hazardous materials by us or the third parties with whom we share our facilities, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research and development. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business involves the use of hazardous materials and we and our third-party manufacturers and suppliers must comply with environmental laws and regulations, which can be expensive and restrict how we do business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our research and development activities and our or any third-party manufacturers&#8217; and suppliers&#8217; activities involve the controlled storage, use and disposal of hazardous materials owned by us. We and our manufacturers and suppliers are subject to laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials. In some cases, these hazardous materials and various wastes resulting from their use are stored at our manufacturers&#8217; facilities pending their use and disposal.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot eliminate the risk of contamination, which could cause an interruption of our research and development efforts and business operations, environmental damage resulting in costly clean-up and liabilities under applicable laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. Although we believe that the safety procedures utilized by our third-party manufacturers and suppliers for handling and disposing of these materials generally comply with the standards prescribed by these laws and regulations, this may not be the case or and we may not eliminate the risk of accidental contamination or injury from these materials. In such an event, we may be held liable for any resulting damages and such liability could exceed our resources and state or federal or other applicable authorities may curtail our use of certain materials and/or interrupt our business operations. Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent over time. We cannot predict the impact of such changes and cannot be certain of our future compliance. We do not currently carry biological or hazardous waste insurance coverage. Any contamination by such hazardous materials could therefore adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future changes in financial accounting standards or practices may cause adverse and unexpected revenue fluctuations and adversely affect our reported results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future changes in financial accounting standards may cause adverse, unexpected revenue fluctuations and affect our reported financial position or results of operations. Financial accounting standards in the United States are constantly under review and new pronouncements and varying interpretations of pronouncements have occurred with frequency in the past and are expected to occur again in the future. As a result, we may be required to make changes in our accounting policies. Those changes could affect our financial condition and results of operations or the way in which such financial condition and results of operations are reported. We intend to invest resources to comply with</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">evolving standards, and this investment may result in increased general and administrative expenses and a diversion of management time and attention from business activities to compliance activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations. We can face serious consequences for violations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations, including the U.S. Foreign Corrupt Practices Act (collectively, &#8220;Trade Laws&#8221;), prohibit, among other things, companies and their employees, agents, CROs, legal counsel, accountants, consultants, contractors, and other partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our non-U.S. activities to increase over time. We expect to rely on third parties for research, preclinical studies, and clinical trials and/or to obtain necessary permits, licenses, patent registrations, and other marketing approvals. We can be held liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The market price of our stock has been and may continue to be volatile, and you could lose all or part of your investment.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading price of our common stock has been in the past, and may continue to be, highly volatile and subject to wide fluctuations in response to various factors, many of which we cannot control. Market prices for securities of early-stage pharmaceutical, biotechnology, and other life sciences companies have historically been particularly volatile. Some of the factors that may cause the market price of our common stock to fluctuate include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain regulatory approvals for product candidates, and delays or failures to obtain such approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the failure of any of our product candidates, if approved for marketing and commercialization, to achieve commercial success;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any inability to obtain adequate supply of our product candidates or the inability to do so at acceptable prices;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the entry into, or termination of, key agreements, including key licensing, supply or collaboration agreements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the initiation of material developments in, or conclusion of, disputes or litigation to enforce or defend any of our intellectual property rights or defend against the intellectual property rights of others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in laws or regulations applicable to our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the results of current, and any future, nonclinical or clinical trials of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements by commercial partners or competitors of new commercial products, clinical progress (or the lack thereof), significant contracts, commercial relationships, or capital commitments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to meet or exceed financial and development projections we may provide to the public;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to meet or exceed the financial and development projections of the investment community;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the perception of the pharmaceutical industry by the public, legislatures, regulators and the investment community;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adverse publicity relating to our markets, including with respect to other products and potential products in such markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the introduction of technological innovations or new therapies competing with our potential products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by us or our competitors;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disputes or other developments relating to proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the loss of key employees;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant lawsuits, including patent or stockholder litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our business and stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the market valuations of similar companies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general and industry-specific economic conditions potentially affecting our research and development expenditures;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sales of our common stock by us or our stockholders in the future;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading volume of our common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the structure of health care payment systems;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adverse regulatory decisions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading volume of our common stock; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">period-to-period fluctuations in our financial results.</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, the stock markets in general have experienced substantial volatility that has often been unrelated to the operating performance of individual companies or the biotechnology and pharmaceutical sectors, including as a result of disruptions to and volatility in the credit and financial markets in the United States and worldwide from geopolitical and macroeconomic events, including the ongoing Russia-Ukraine and Middle East conflicts and related sanctions, and bank failures. These broad market fluctuations may also adversely affect the trading price of our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Regardless of the merits or the ultimate results of such litigation, if instituted, such litigation could result in substantial costs and diversion of management&#8217;s attention and resources, which could significantly harm our profitability and reputation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial reporting obligations of being a public company in the United States are expensive and time-consuming, and our management needs to devote substantial time to compliance matters.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a publicly traded company, we incur significant additional legal, accounting and other expenses that the Company did not incur as a privately held company, including costs associated with public company reporting requirements. The obligations of being a public company in the United States require significant expenditures and will place significant demands on our management and other personnel, including costs resulting from public company reporting obligations under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the rules and regulations regarding corporate governance practices, including those under the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) and the listing requirements of the stock exchange on which our securities are listed. These rules require the establishment and maintenance of effective disclosure and financial controls and procedures, internal control over financial reporting and changes in corporate governance practices, among many other complex rules that are often difficult to implement, monitor and maintain compliance with. In addition, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain such insurance. Moreover, despite recent reforms made possible by the JOBS Act, the reporting requirements, rules and regulations will make some activities more time-consuming and costly, particularly after we are no longer an &#8220;emerging growth company&#8221; or a &#8220;small reporting company&#8221;. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of our initial public offering (i.e. December 31, 2025), (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $750 million as of the prior June 30</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. Our management and other personnel will need to devote a substantial amount of time to ensure that we comply with all of these requirements and to keep pace with new regulations, otherwise we may fall out of compliance and risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">becoming subject to litigation, among other potential problems. Our management and other personnel will need to devote a substantial amount of time to ensure that we comply with all of these requirements and to keep pace with new regulations, otherwise we may fall out of compliance and risk becoming subject to litigation, among other potential problems.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The relative lack of public company experience of our management team may put us at a competitive disadvantage.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team lacks significant public company experience, which could impair our ability to comply with legal and regulatory requirements such as, but not limited to, those imposed by the Sarbanes-Oxley Act. Our senior management does not have significant experience managing a publicly traded company. Such responsibilities include complying with federal securities laws and making required disclosures on a timely basis. Our senior management may be unable to implement programs and policies in an effective and timely manner or that adequately respond to the increased legal, regulatory and reporting requirements associated with being a publicly traded company. Our failure to comply with all applicable requirements could lead to the imposition of fines and penalties, distract our management from attending to the management and growth of our business, result in a loss of investor confidence in our financial reports and have an adverse effect on our business and stock price.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Substantial future sales of shares of our common stock could adversely affect the market price of such shares.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, or there is the perception that these sales could occur, this could adversely affect the market price of such shares and could materially impair our ability to raise capital through equity offerings in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict what effect, if any, sales of our shares in the public market or the availability of shares for sale would have on the market price of our common stock. However, future sales of substantial amounts of our common stock in the public market, including shares issued upon exercise of outstanding options or warrants, or the perception that such sales may occur, could adversely affect the market price of our common stock.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the beneficial ownership of our common stock as of March 21, 2025, our executive officers, directors and holders of 5% or more of our capital stock and their respective affiliates beneficially owned a significant percentage of our voting stock. As a result, these stockholders, if continuing to act together, will continue to have significant influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, amendment of our organizational documents, any merger, consolidation or sale of all or substantially all of our assets and any other significant corporate transaction. The interests of these stockholders may not be the same as or may even conflict with your interests. For example, these stockholders could delay or prevent a change of control of our company, even if such a change of control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company or our assets and might affect the prevailing market price of our common stock. The significant concentration of stock ownership may adversely affect the trading price of our common stock due to investors&#8217; perception that conflicts of interest may exist or arise.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are a smaller reporting company. We cannot be certain whether the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investors or otherwise limit our ability to raise additional funds.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a &#8220;smaller reporting company&#8221; under applicable securities regulations. A smaller reporting company is a company that, as of the last business day of its most recently completed fiscal quarter, has an aggregate market value of the company&#8217;s voting stock held by non-affiliates, or public float, of less than $250 million, or has annual revenues less than $100 million and either no public float or public float less than $750 million. SEC rules provide that companies with a non-affiliate public float of less than $75 million may only sell shares under a Form S-3 shelf registration statement, during any 12-month period, in an amount less than or equal to one-third of the public float. If we do not meet this public float requirement, any offering by us under a Form S-3 will be limited to raising an aggregate of one-third of our public float in any 12-month period. In addition, a smaller reporting company is able to provide simplified executive compensation disclosures in its filings, is exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that an independent registered public accounting firm provide an attestation report on the effectiveness of internal control over financial reporting if its public float is less than $70 million, and has certain other reduced disclosure obligations in their SEC filings, including, among other things, only being required</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to provide two years of audited financial statements in annual reports. Reduced disclosure in our SEC filings due to our status as a smaller reporting company may make it harder for investors to analyze its results of operations and financial prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our common stock will be influenced by the research and reports that industry or equity research analysts publish about us and our business. Equity research analysts may elect not to provide research coverage of our common stock after the completion of the merger, and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts, or the content and opinions included in their reports. The price of our common stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for our common stock could decrease, which in turn could cause its stock price or trading volume to decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our management.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our amended and restated certificate of incorporation and bylaws may delay or prevent an acquisition or a change in management. These provisions include a classified board of directors, a prohibition on actions by written consent of our stockholders, and the ability of the board of directors to issue preferred stock without stockholder approval. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), which prohibits stockholders owning in excess of 15% of our voting stock from merging or combining with us in certain circumstances. Although we believe these provisions collectively will provide for an opportunity to receive higher bids by requiring potential acquirers to negotiate with our Board of Directors, they would apply even if the offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove then current management by making it more difficult for stockholders to replace members of our Board of Directors, which is responsible for appointing the members of management.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the federal district court for the District of Delaware) is the sole and exclusive forum for any state law claims for (a) any derivative action or proceeding brought on behalf of us; (b) any action asserting a claim of breach of a fiduciary duty owed by, or other wrongdoing by, any of our directors, officers, stockholders, employees or agents to us or our stockholders; (c) any action asserting a claim against us or any of our directors, officers, stockholders, employees or agents arising pursuant to any provision of the DGCL, the certificate of incorporation or the bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; (d) any action to interpret, apply, enforce or determine the validity of the certificate of incorporation or the bylaws; or (e) any action asserting a claim against us or any of our directors, officers, stockholders, employees or agents governed by the internal affairs doctrine; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that these choice of forum provisions do not apply to suits brought to enforce a duty or liability created by the Securities Act, the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. The amended and restated bylaws will provide that the federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. The choice of forum provision may make it more expensive for stockholders to bring a claim than if the stockholders were permitted to select another jurisdiction and limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. If a court were to find the choice of forum provision contained in the bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and to have consented to the provisions of our bylaws described above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including, weakened demand for our product candidates and our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption, or cause our customers to delay making payments for our products or services. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 1B. Unresolved Staff Comments.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <div><ix:nonNumeric id="F_1810a607-3443-4023-b8d4-a1724431bd0f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_1810a607-3443-4023-b8d4-a1724431bd0f_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk management and strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and our clinical trial data (&#8220;Information Systems and Data&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment and system, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: an incident response and disaster recovery plan, disaster recovery testing, data encryption for certain data, asset management, system monitoring and multi-factor authentication for certain systems, employee training and cybersecurity insurance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use a third-party information technology consultant to help identify, assess and manage the Company&#8217;s cybersecurity threats and risks. This consultant reports to and works with our management team, including our Chief Scientific Officer and President and Chief Operating Officer to identify and assess risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods and tools including for example by subscribing to reports and services that identify cybersecurity threats, leveraging certain system monitoring tools, and leveraging tools provided through Microsoft Office 365.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are taken into account as part of the Company&#8217;s risk management processes.  For example, our senior management works with our information technology consultant to evaluate material risks from cybersecurity threats against our overall business objectives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f2f20ad2-7498-4f33-9be4-70af46cd3696" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use third-party service providers, including cybersecurity consultants, to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use third-party service providers to perform a variety of critical functions throughout our business, such as hosting providers, application providers, contract research organizations, contract manufacturing organizations, and other third-party service providers. We review the cybersecurity risks associated with the use of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of assessment and due diligence designed to help identify cybersecurity risks associated with a vendor, as well as the imposition of security related contractual obligations on the vendor.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_1810a607-3443-4023-b8d4-a1724431bd0f_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e898a58b-1ed1-4161-a341-40c39b9105df" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our information technology systems, or those of our CROs, contractors, consultants, or other third parties with whom we work, may fail or suffer security breaches, loss or leakage of data, and other disruptions, which could result in a material disruption of our product candidates&#8217; development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governance</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </span></p><div><ix:nonNumeric id="F_2939e5c7-750a-44ae-8396-0baac5757125" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true" continuedAt="F_2939e5c7-750a-44ae-8396-0baac5757125_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7011ad2f-e113-4463-b71a-7cf4db6cf5ae" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd4ea0d0-14b8-4a5e-b380-66ee74485d71" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69b375e7-f53b-4c22-88bc-41f1823c216d" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true" continuedAt="F_69b375e7-f53b-4c22-88bc-41f1823c216d_1"><div><ix:nonNumeric id="F_ef6c1e23-369f-4620-bf41-834c5adb9ea5" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_76ede3b5-83db-4206-8c73-0f2db7a8ddb0" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_014c1e9e-a94d-439b-b222-f6a93cd4ba44" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_69b375e7-f53b-4c22-88bc-41f1823c216d_1" continuedAt="F_69b375e7-f53b-4c22-88bc-41f1823c216d_2"><span><ix:continuation id="F_2939e5c7-750a-44ae-8396-0baac5757125_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68cfad4b-f38e-488d-8358-491a915d9e9a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></ix:continuation></span><span style=""></span></p><div><ix:continuation id="F_69b375e7-f53b-4c22-88bc-41f1823c216d_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0daf7908-34fe-400b-815e-2b7b023cff69" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors receives periodic reports as needed from management </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.</span></p></ix:nonNumeric></div></ix:continuation></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 2. Properties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters are located in La Jolla, California, where we lease approximately 2,850 square feet of office space. The existing lease will expire on December 31, 2025. We believe that our existing facilities are adequate for our current needs.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii_or_information">&#160;</p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Leg</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">al Proceedings.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may be involved in legal proceedings arising in the ordinary course of our business.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity and reputational harm, and other factors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently believe there is no litigation pending that could, individually or in the aggregate, have a material adverse effect on our results of operations or financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 4. Mine Safety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrants_common"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock trades on The Nasdaq Capital Market under the symbol &#8220;CALC.&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Holders of Record</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 21, 2025, there were approximately 70 holders of record of our common stock. Certain shares of our common stock are held in &#8220;street&#8221; name and thus the actual number of beneficial owners of such shares is not known or included in the foregoing number.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings for use in the operation of our business and do not intend to declare or pay any cash dividends in the foreseeable future. Any future determination to pay dividends on our capital stock would be at the discretion of our board of directors, subject to applicable laws, and would depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors considers relevant.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 17, 2024, in connection with services provided under a consulting agreement (the &#8220;Danforth Consulting Agreement&#8221;) with Danforth Advisors, LLC (&#8220;Danforth&#8221;), a company affiliated with Dan Geffken, our former Interim Chief Financial Officer, we granted to SG Dan Equity Holdings, LLC, a company affiliated with Mr. Geffken (&#8220;SG Dan Equity&#8221;), a warrant (&#8220;SG 2024 Warrant&#8221;) to purchase 10,000 shares of our common stock at an exercise price of $5.45 per share (subject to adjustment as provided therein), which vest in equal monthly installments over a period of one year from the grant date and which are subject to accelerated vesting if the Danforth Consulting Agreement is terminated prior to May 17, 2025 . The SG 2024 Warrant is exercisable until May 24, 2034, unless earlier terminated. The SG 2024 Warrant shall terminate in the event of certain change of control transactions or asset transfers (as provided therein) unless exercised immediately prior to any such transaction.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance of securities described above was deemed to be exempt from registration under the Securities Act in reliance on Section 4(2) of the Securities Act as a transaction by an issuer not involving a public offering. The recipient of the securities in such transaction represented that it was an accredited investor as defined in Regulation D promulgated under the Securities Act and of its intention to acquire the securities for its own account for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the electronic records representing such securities in such transaction. The recipient received adequate information about us.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Proceeds</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_selected_financial_data"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 6. [Reserved]</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item_7_management_discussion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s D</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iscussion and Analysis of Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our audited consolidated financial statements and the related notes and other financial information included elsewhere in this Annual Report on Form 10-K. In addition to historical financial information, this discussion and other parts of this report contain forward-looking statements that involve risks and uncertainties. You should carefully read the sections entitled &#8220;Special Note Regarding Forward-Looking Statements&#8221; and &#8220;Risk Factors&#8221; to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Our product candidates act upon calcium release-activated calcium (&#8220;CRAC&#8221;) channels and would constitute a new class of drugs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical and preclinical data have demonstrated that the inhibition of CRAC channels may have a therapeutic effect based on a dual mechanism involving both anti-inflammatory and tissue cell protective activities. Our work has shown compelling evidence of the involvement of CRAC channels in a broad spectrum of both acute critical illnesses and chronic diseases that have the common thread of inflammation or immunologic activity in their pathogenesis. We intend to leverage our CRAC channel inhibitor platform to develop therapeutics for indications where this dual mechanism of action has the potential for clinical benefit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our lead product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. Multiple Phase 2 clinical trials with Auxora have been conducted: an open-label Phase 2a trial in acute pancreatitis (&#8220;AP&#8221;) with accompanying systematic inflammatory response syndrome (&#8220;SIRS&#8221;), an international, randomized, double-blind placebo-controlled Phase 2b trial in AP with SIRS (which we refer to as &#8220;CARPO&#8221;), an investigator led open-label Phase 1/2 trial in asparaginase-induced pancreatic toxicity (&#8220;AIPT&#8221;) (which we also refer to as &#8220;CRSPA&#8221;) in which the first cohort of patients has been completed, a placebo-controlled double-blind Phase 2 trial in severe COVID-19 pneumonia (which we also refer to as &#8220;CARDEA&#8221;) and an investigator led open-label Phase 2a trial in COVID-19 pneumonia patients with acute respiratory distress syndrome (&#8220;ARDS&#8221;). We observed in all of these trials that patients treated with Auxora experienced a reduction of organ damage and reduced time to recovery. We believe the consistency of the results we observed from these trials in two different acute critical care conditions are mutually supportive and reinforce our plans to further pursue the use of Auxora in several additional acute critical illnesses, including acute kidney injury (&#8220;AKI&#8221;) with associated acute hypoxemic respiratory failure (&#8220;AHRF&#8221;), in which we are currently conducting a Phase 2 trial (which we also refer to as &#8220;KOURAGE&#8221;) with data expected around the end of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we have compiled additional preclinical data supporting the potential to use CRAC channel inhibition for both chronic and acute inflammatory and immunologic diseases. We have animal model data suggesting CRAC channel inhibition may be useful in treating chronic pancreatitis, rheumatoid arthritis, ulcerative colitis, allergic asthma, and traumatic brain injury. We have several available product candidates that may be suitable for potential oral dosing. Pending additional funding, we have paused IND enabling preclinical work on these compounds to focus resources on our clinical programs. We expect to continue certain research activities to validate CRAC channel inhibition as a potential mechanism in other promising inflammatory and immunologic diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2023,</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we filed a shelf registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which contains two prospectuses, a base prospectus and an at the market offering prospectus, as supplemented on March 29, 2024 (as supplemented, the &#8220;Original Prospectus Supplement&#8221;) that covered the offering, issuance and sale of up to $17.3 million of common stock pursuant to an at the market offering agreement (the &#8220;ATM Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) acting as sales agent (the &#8220;ATM Facility&#8221;). The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities and warrants having an aggregate offering price of up to $100.0 million in one or more offerings and in any combination of the foregoing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2024, we entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited investors, in which we sold the following securities to the accredited investors in a private placement transaction (the &#8220;2024 Private Placement&#8221;): (i) an aggregate of 4,985,610 shares of our common stock; (ii) to certain investors, in lieu of shares, pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of 306,506</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shares of our common stock; (iii) Tranche A Common Warrants (the &#8220;Tranche A Common Warrants&#8221;) to purchase an aggregate of up to 2,646,058 shares of our common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of our common stock issuable upon exercise of such Pre-Funded Warrants); and (iv) Tranche B Common Warrants (the &#8220;Tranche B Common Warrants&#8221; and together with the Tranche A Common Warrants, the &#8220;Common Warrants&#8221;) to purchase an aggregate of up to 2,646,058 shares of our common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of our common stock issuable upon exercise of such Pre-Funded Warrants). The purchase price per share and accompanying Common Warrants was $3.827 (or $4.3915 for directors, employees or consultants participating in the 2024 Private Placement) (or $3.8269 per Pre-Funded Warrant and accompanying Common Warrants, which represented the price of $3.827 per share and accompanying Common Warrants minus the $0.0001 per share exercise price of each such Pre-Funded Warrant).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The initial closing of the 2024 Private Placement occurred on January 23, 2024 and the second closing occurred on February 5, 2024. Gross proceeds from the transaction were $20.4 million with net proceeds of approximately $19.0 million after deducting $1.4 million in commissions and other transaction costs. The Tranche A Common Warrants expired unexercised on July 27, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, we closed an underwritten public offering of 2,720,000 shares of our common stock at a price to the public of $3.75 per share pursuant to the Shelf Registration Statement (the &#8220;2024 Follow-On&#8221;). The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $10.2 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In connection with the 2024 Follow-On, on October 30, 2024, we suspended sales of common stock under the ATM Facility pursuant to the Original Prospectus Supplement, and until December 20, 2024, did not offer for sale any shares of common stock pursuant to the ATM Agreement. We filed a prospectus supplement (the &#8220;Current Prospectus Supplement&#8221;) with the SEC on December 20, 2024 for an aggregate gross sales price of up to $4,450,000 of shares of common stock to be sold pursuant to the ATM Facility. As of December 31, 2024, we sold an aggregate of 101,522 shares of common stock for net proceeds of $319,000 after deducting $13,000 of commissions paid under the ATM Facility and approximately $4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available for sale under the ATM Facility. As of December 31, 2024, $89.5</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remained available for sale under the Shelf Registration Statement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 (the &#8220;Closing Date&#8221;), the Company entered into a Loan and Security Agreement and the Supplement to the Loan and Security Agreement (together, the &#8220;Loan Agreement&#8221;) with Avenue Venture Opportunities Fund II, L.P. (&#8220;Lender&#8221;) and Avenue Capital Management II, L.P., as administrative agent and collateral agent, for growth capital loans in an aggregate principal amount of up to $32,500,000 (the &#8220;Loan&#8221;), with (i) $10,000,000 funded on the Closing Date (&#8220;Tranche 1&#8221;), (ii) up to $7,500,000 to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials (&#8220;Tranche 2&#8221;) and (iii) up to $15,000,000 to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#8217;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval). The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2. The Loan bears interest at an annual rate equal to the greater of (a) the sum of 5.00% plus the prime rate as reported in The Wall Street Journal and (b) 12.75%. The Loan is secured by a lien upon and security interest in all of the Company&#8217;s assets, including intellectual property, subject to agreed exceptions. The maturity date of the Loan is September 1, 2028 (the &#8220;Maturity Date&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to generate revenue from product sales sufficient to achieve profitability will depend heavily on the successful development and eventual commercialization of one or more of our product candidates. Through December 31, 2024, our operations have been funded primarily by aggregate net proceeds of $178.7 million from the issuance of convertible preferred stock, convertible notes, warrants, common stock and the Merger. Since inception we have had significant operating losses, except for the three month period ending March 31, 2024. Our net loss was $13.7 million for the year ended December 31, 2024. Included in the net loss for the year ended December 31, 2024 were total operating expenses of $24.2 million, offset by a gain from the fair value adjustment to our warrant liability of $9.5 million and interest income of $1.0 million. As of December 31, 2024, we had an accumulated deficit of $159.8 million and $18.7 million in cash, cash equivalents and short-term investments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses. We expect to continue to incur net losses for the foreseeable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future, and we expect our research and development expenses, general and administrative expenses, and capital expenditures will continue to increase. In particular, we expect our expenses to increase as we continue our development of, and seek regulatory approvals for, our product candidates, as well as hire additional personnel, pay fees to outside consultants, lawyers and accountants, and incur other increased costs associated with being a public company. In addition, if and when we seek and obtain regulatory approval to commercialize any product candidate, we will also incur increased expenses in connection with commercialization and marketing of any such product. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not had any products approved for sale and, therefore, have not generated any product revenue. We do not expect to generate any revenues from product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. As a result, until such time, if ever, that we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed or on favorable terms, if at all. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Components of Operating Results</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our research and development expenses have included:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personnel costs, which include salaries, benefits and stock-based compensation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred under agreements with consultants, third-party contract organizations that conduct research and development activities on our behalf;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs related to production of preclinical and clinical materials, including fees paid to contract manufacturers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratory and vendor expenses related to the execution of preclinical studies and previously planned and ongoing clinical trials;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratory supplies and materials used for internal research and development activities;</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Most of our historical research and development expenses have been related to the preclinical and clinical development of Auxora. We have not reported program costs since inception because we have not tracked or recorded our research and development expenses on a program-by-program basis historically due to the fact that these costs do not necessarily correlate to the overall research and development efforts attributable to such programs and these costs can vary significantly from period to period. We have historically used our personnel and infrastructure resources across the breadth of our research and development activities, which are directed toward identifying and developing product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expense all research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and third-party service providers.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, including investments in conducting clinical trials, manufacturing and otherwise advancing our programs. The process of conducting the necessary clinical research to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with product development, we cannot determine with certainty the duration and completion costs of the current or future preclinical studies and clinical trials or if, when, or to what extent we will generate revenues from the commercialization and sale of our product candidates or if we even continue to pursue such product development, commercialization or sales. We may never succeed in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">achieving regulatory approval for our product candidates. The duration, costs and timing of preclinical studies and clinical trials and development of our remaining product candidates, to the extent we continue to pursue such activities, will depend on a variety of factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful completion of preclinical studies and initiation of clinical trials for Auxora, our other current product candidates and any future product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful enrollment and completion of our clinical trials for Auxora and any clinical trials for future product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">data from our clinical programs that support an acceptable risk-benefit profile of our product candidates in the intended patient populations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acceptance by the FDA, regulatory authorities in Europe, Canada or other regulatory agencies of the IND applications, clinical trial applications and/or other regulatory filings for Auxora, our other current product candidates and any future product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expansion and maintenance of a workforce of experienced scientists and others to continue to develop our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful application for and receipt of marketing approvals from applicable regulatory authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtainment and maintenance of intellectual property protection and regulatory exclusivity for our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arrangements with third-party manufacturers for, or establishment of, clinical and commercial active pharmaceutical ingredient (&#8220;API&#8221;) and drug product manufacturing capabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishment of sales, marketing and distribution capabilities and successful launch of commercial sales of our products, if and when approved, whether alone or in collaboration with others;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acceptance of our products, if and when approved, by patients, the medical community and third-party payors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effective competition with other therapies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtainment and maintenance of coverage, adequate pricing and adequate reimbursement from third-party payors, including government payors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintenance, enforcement, defense and protection of our rights in our intellectual property portfolio;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">avoidance of infringement, misappropriation or other violations with respect to others&#8217; intellectual property or proprietary rights; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintenance of a continued acceptable safety profile of our products following receipt of any marketing approvals.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may never succeed in achieving regulatory approval for any of our remaining product candidates. We may obtain unexpected results from our preclinical studies and subsequent clinical trials, if any. We may elect to discontinue, delay or modify future clinical trials of some product candidates or focus on others. A change in the outcome of any of these factors could mean a significant change in the costs and timing associated with the development of our current preclinical product candidates. For example, if the FDA, or another regulatory authority, were to require us to conduct clinical trials beyond those that we currently anticipate will be required for the completion of clinical development, or if we experience significant delays in execution of or enrollment in any of our preclinical studies or future clinical trials, if any, we could be required to expend significant additional financial resources and time on the completion of preclinical and clinical development.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development activities account for a significant portion of our operating expenses. We expect our research and development expenses to increase for the foreseeable future as we continue to implement our business strategy, which includes advancing Auxora through clinical development and other product candidates further into clinical development, expanding our research and development efforts, including hiring additional personnel to support our research and development efforts, and seeking regulatory approvals for our product candidates that successfully complete clinical trials. In addition, product candidates in later stages of clinical development generally</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incur higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. As a result, we expect our research and development expenses to increase as our product candidates advance into later stages of clinical development. However, we do not believe that it is possible at this time to accurately project total program-specific expenses through commercialization. There are numerous factors associated with the successful commercialization of any of our product candidates, including future trial design and various regulatory requirements, many of which cannot be determined with accuracy at this time based on our stage of development.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our general and administrative expenses consist primarily of personnel costs, depreciation expense and other expenses for outside professional services, including legal related to intellectual property and corporate matters, human resources, audit and accounting services and facility-related fees not otherwise included in research and development expenses. Personnel costs consist of salaries, benefits and equity-based compensation expense for our personnel in executive, finance and accounting, business operations and other administrative functions. We expect our general and administrative expenses to increase over the next several years to support our continued research and development activities, manufacturing activities, increased costs of expanding our operations and operating as a public company. These increases will likely include increases related to the hiring of additional personnel and legal, regulatory and other fees and services associated with maintaining compliance with stock exchange listing rules and SEC requirements, director and officer insurance premiums and investor relations costs associated with being a public company.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our other income includes (i) interest and change in fair value of our convertible promissory notes; (ii) changes in the fair value of our warrant liabilities; and (iii) other non-operating income.</span><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of the Years Ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following sets forth our results of operations (in thousands):</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.37%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:11.202%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,478</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,859</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,381</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,726</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,216</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(12,490</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(56%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,871</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(24,204</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(38,075</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,871</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,504</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,718</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,786</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">183%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,700</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(34,357</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,657</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60%)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses comprised (in thousands):</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.37%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:11.202%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preclinical studies and clinical trial-related activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,294</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,939</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">355</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chemistry, manufacturing and controls</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,314</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,006</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,308</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,722</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,071</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,349</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(47%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consultants and other costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,148</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,843</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">305</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,478</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,859</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,381</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9%)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses were $14.5 million for the year ended December 31, 2024, compared to $15.9 million for the year ended December 31, 2023.  The decrease of $1.4 million was due primarily to a decrease in personnel expense of $3.3 million driven by a one-time charge for the acceleration of vesting of stock options of $1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million and a one-time severance charge of $1.6 million as a result of the Merger for the year ended December 31, 2023. This was partially offset by an increase of $1.3 million in chemistry, manufacturing and control activities in regard to our Phase 2 clinical trials of Auxora, costs related to our preclinical studies of $0.3 million and consultants and other costs of $0.3 million.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses to support our business activities comprised (in thousands):</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.37%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.182%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:11.202%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="5" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,864</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,872</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,008</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(77%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Facility costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">549</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">595</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(46</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(8%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional services</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,130</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,316</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(186</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6%)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consultants and other costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,183</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">750</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52%</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total general and administrative expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,726</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,216</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(12,490</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(56%)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses were $9.7 million for the year ended December 31, 2024, compared to $22.2 million for the year ended December 31, 2023.  The decrease of $12.5 million was primarily related to a decrease in personnel costs of $13.0 million driven by a one-time charge for acceleration of vesting of stock options of $8.6 million and a one-time severance charge of $4.1 million as a result of the Merger for the year ended December 31, 2023. Additionally, professional services decreased $0.2 million due to increased costs as a result of the Merger for the year ended December 31, 2023. These costs were partially offset by an increase of $0.7 million in consultants and other costs.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income for the year ended December 31, 2024 was $10.5 million, compared to $3.7 million for the year ended December 31, 2023. The increase of $6.8 million was due to the fair value adjustments to our warrant liability as a result of the 2024 Private Placement which resulted in a change in fair value adjustments for our warrants liability of $9.5 million compared to fair value adjustments to our warrant liability and convertible promissory notes for the year ended December 31, 2023, and due to an increase of $0.4 million of interest income on our cash equivalents and short-term investments due to additional funds to invest, for the year ended December 31, 2024, as compared to the year ended December 31, 2023.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 we had cash, cash equivalents and short-term investments of $18.7 million.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on our current operating plans, we believe our cash, cash equivalents and short-term investments along with the Loan Agreement entered into on February 28, 2025, will be sufficient to fund our current operations for the next twelve months from the date of this report. We expect that our cash, cash equivalents and short-term investments, will allow us to fund our operations through certain clinical milestones, into the middle of 2026. However, our current cash, cash equivalents and short-term investments will not be sufficient to fund any of our product candidates through regulatory approval, nor will it be sufficient to pursue additional indications for Auxora such as AHRF, nor will it be sufficient to fund clinical work on other product candidates in our portfolio aside from Auxora, and we will need to raise substantial additional capital to complete the development and commercialization of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to maintain sufficient financial resources, our business, financial condition and results of operations will be materially and adversely affected. To fund our operations in both the near term and long term (beyond 18 months), we will need to raise additional capital to develop our product candidates and implement our operating plans. There can be no assurance that we will be able to obtain the needed financing on acceptable terms or at all. Additionally, equity or debt financings may have a dilutive effect on the holdings of our existing stockholders.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the progress, costs and results of our ongoing clinical trials of Auxora and our planned trials for our other product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, progress, results and costs of discovery research, preclinical development, laboratory testing and clinical trials for our product candidates, including our ongoing clinical trials of Auxora;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of, and development requirements for, other product candidates that we pursue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing and outcome of regulatory review of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to enter into contract manufacturing arrangements for supply of API and manufacture of drug product for our product candidates and the terms of such arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such arrangements;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the payment or receipt of milestones and receipt of other collaboration-based revenues, if any;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of any future commercialization activities, including product manufacturing, sales, marketing and distribution, for any of our product candidates for which we may receive marketing approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the amount and timing of revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property and proprietary rights and defending any intellectual property-related claims;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other products, product candidates, technologies or data referencing rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to receive additional non-dilutive funding, including grants from organizations and foundations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impacts of the ongoing or future international conflicts; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of operating as a public company.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since we commenced operations in October 2006, we have primarily financed our operations through private placements of our preferred stock, convertible promissory notes, warrants and common stock, through the Merger with Graybug and through an underwritten public offering. We have used substantial amounts of cash to fund our operations and expect our expenses to increase substantially for the foreseeable future. The development of drug product candidates is highly capital intensive. As our product candidates enter and advance through preclinical studies and clinical trials, we will need substantial additional funds to expand our clinical, regulatory and quality capabilities. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to marketing, sales, manufacturing and distribution. Furthermore, we have incurred and expect to continue to incur additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or eliminate our research and development programs or any future commercialization efforts. The global credit and financial markets have experienced extreme volatility, including in liquidity and credit availability, declines in consumer confidence, declines in economic growth, and uncertainty about economic stability. There can be no assurance that deterioration in credit and financial markets and confidence in economic conditions will not occur. If equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult to obtain, more costly and/or more dilutive.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to finance our longer-term expected future cash requirements and obligations through a combination of existing cash, cash equivalents and short-term investments and equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. To continue to finance our operations, we will need to raise additional capital, which cannot be assured. We have based this estimate on assumptions that may prove</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to be wrong, and we could exhaust our available capital resources sooner than we expect. We will continue to require additional financing to advance our current product candidates through clinical development, to develop, acquire or in-license other potential product candidates and to fund operations for the foreseeable future. However, we may be unable to raise additional funds or enter into such other arrangement when needed or on favorable terms, if at all. If we do raise additional capital through public or private equity offerings, the ownership interest of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders&#8217; rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2023, we filed the Shelf Registration Statement, which contains two prospectuses, a base prospectus and the Original Prospectus Supplement that covered the offering, issuance and sale of up to $17.3 million of common stock pursuant to the ATM Agreement with Wainwright, acting as sales agent. The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities and warrants having an aggregate offering price of up to $100.0 million in one or more offerings and in any combination of the foregoing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2024, the Company entered into the Purchase Agreement with certain accredited investors, in which the Company sold the following securities to the accredited investors the 2024 Private Placement: (i) an aggregate of 4,985,610 shares of our common stock; (ii) to certain investors, in lieu of shares, Pre-Funded Warrants to purchase an aggregate of 306,506 shares of our common stock; (iii) Tranche A Common Warrants to purchase an aggregate of up to 2,646,058 shares of our common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of our common stock issuable upon exercise of such Pre-Funded Warrants); and (iv) Tranche B Common Warrants to purchase an aggregate of up to 2,646,058 shares of our common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of our common stock issuable upon exercise of such Pre-Funded Warrants). The purchase price per share and accompanying Common Warrants was $3.827 (or $4.3915 for directors, employees or consultants participating in the 2024 Private Placement) (or $3.8269 per Pre-Funded Warrant and accompanying Common Warrants, which represented the price of $3.827 per share and accompanying Common Warrants minus the $0.0001 per share exercise price of each such Pre-Funded Warrant).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The initial closing of the 2024 Private Placement occurred on January 23, 2024 and the second closing occurred on February 5, 2024. Gross proceeds from the transaction were $20.4 million with net proceeds of approximately $19.0 million after deducting $1.4 million in commissions and other transaction costs. The Tranche A Common Warrants expired unexercised on July 27, 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, the Company closed the 2024 Follow-On. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $10.2 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Follow-On, on October 30, 2024, we suspended sales of common stock under the ATM Facility pursuant to the Original Prospectus Supplement, and until December 20, 2024, did not offer for sale any shares of common stock. We filed the Current Prospectus Supplement with the SEC on December 20, 2024 for an aggregate gross sales price of up to $4,450,000 of shares of common stock to be sold pursuant to the ATM Facility. As of December 31, 2024, we sold an aggregate of 101,522 shares of common stock for net proceeds of $319,000 after deducting $13,000 of commissions paid under the ATM Facility and approximately $4.5 million remains available for sale under the ATM Facility. As of December 31, 2024, $89.5 million remained available for sale under the Shelf Registration Statement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025, the Company entered into the &#8220;Loan Agreement&#8221;) with Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P., as administrative agent and collateral agent, for growth capital loans in an aggregate principal amount of up to $32,500,000, with (i) $10,000,000 funded on the Closing Date (&#8220;Tranche 1&#8221;), (ii) up to $7,500,000 to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials (&#8220;Tranche 2&#8221;) and (iii) up to $15,000,000 to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#8217;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval). The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#8217;s achievement of certain</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2. The Loan bears interest at an annual rate equal to the greater of (a) the sum of 5.00% plus the prime rate as reported in The Wall Street Journal and (b) 12.75%. The Loan is secured by a lien upon and security interest in all of the Company&#8217;s assets, including intellectual property, subject to agreed exceptions. The maturity date of the Loan is September 1, 2028 (the &#8220;Maturity Date&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations through December 31, 2024, have been funded primarily by aggregate net proceeds of $178.7 million from the issuance of convertible preferred stock, convertible notes, common stock and the Merger. Since inception, we have had significant operating losses, except for the three month period ending March 31, 2024. Our net loss for the year ended December 31, 2024 was $13.7 million and consisted of total operating expenses of $24.2 million offset by a gain from the fair value adjustment to our warrant liability of $9.5 million and interest income of $1.0 million. For the year ended December 31, 2023, our net loss was $34.4 million consisting of $38.1 million of operating expenses (including $10.5 million in one-time charges related to the acceleration of vesting of the Graybug stock awards at the date of the Merger and $5.7 million of one-time severance charges as a result of the Merger). As of December 31, 2024, we had an accumulated deficit of $159.8 million and $18.7 million in cash, cash equivalents and short-term investments. During the year ended December 31, 2024, cash used in operations was $21.1 million, primarily due to cash outlays for operations. Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our cash flows for the periods indicated (in thousands):</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by (used in):</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(21,146</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(25,730</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,423</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,884</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing activities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,974</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,900</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in cash and cash equivalents</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,405</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,054</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash Used in Operating Activities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash used in operating activities of $21.1 million during the year ended December 31, 2024 was attributable to our net loss of $13.7 million, non-cash items of $7.0 million and a net change in our operating assets and liabilities of $0.5 million. Non-cash items consisted primarily of $9.5 million due to a change in our warrant liability as a result of the 2024 Private Placement and accretion on our short-term investments of $0.6 million offset by $2.3 million of stock based compensation and $0.8 million of transaction costs allocated to warrants as a result of the 2024 Private Placement.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash used in operating activities of $25.7 million during the year ended December 31, 2023 was attributable to our net loss of $34.4 million and a net change in our operating assets and liabilities of $0.3 million offset by non-cash items of $8.9 million. Non-cash items consisted primarily of $12.0 million of stock-based compensation, which includes $10.5 million in one-time charges related to the acceleration of vesting of the Graybug stock awards at the date of the Merger and $0.1 million in accrued interest on our convertible promissory notes offset by $1.1 million and $2.0 million change in the fair value of our warrant liability and convertible promissory notes, respectively based on the value the warrant holder and promissory note holder received in common stock and $0.1 million of accretion on the discounts associated with our short-term investments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash Provided by (Used in) Investing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investing activities of $4.4 million for the year ended December 31, 2024 consisted of the purchase of short-term investments of $29.0 million offset by the maturing of short-term investments of $24.6 million.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investing activities of $8.9 million for the year ended December 31, 2023 consisted of the maturing of short-term investments of $15.1 million, offset by the purchase of short-term investments of $6.1 million and purchases of property and equipment of $0.1 million.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Cash Provided by Financing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by financing activities for the year ended December 31, 2024 was $28.0 million comprised of the sale and issuance of common stock of $27.9 million in the 2024 Private Placement and 2024 Follow-On offerings and $0.1 million in the ATM Facility and exercise of stock options.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by financing activities for the year ended December 31, 2023 was $20.9 million comprised of net cash acquired as a result of the Merger of $14.9 million, the sale and issuance of common stock of $10.3 million in a private placement immediately prior to the Merger and $0.2 million in the ATM Facility, offset by transaction costs of $4.5 million.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Cash Requirements</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our material cash requirements from known contractual obligations consisted primarily of our lease obligation. We lease office and laboratory space in La Jolla, California with monthly rent expense of approximately $10,000 pursuant to a 12 month lease agreement that commenced in January 2024 and was amended and renewed in December 2024 for an additional 12 month term with monthly rent expense of approximately $10,500. Over the next 12 months, the Company expects cash requirements for our lease obligation to be approximately $126,000.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into contracts in the normal course of business with third-party service providers for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. These contracts generally provide for termination upon notice, and therefore, we believe that our non-cancelable obligations under these agreements are not material and we cannot reasonably estimate the timing of if and when they will occur. We could also enter into additional research, manufacturing, supplier and other agreements in the future, which may require up-front payments and even long-term commitments of cash.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also, from time to time, become party or subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. Some of these proceedings have involved, and may involve in the future, claims that are subject to substantial uncertainties and unascertainable damages.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Estimates</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We incur substantial expenses associated with clinical trials. Accounting for clinical trials relating to activities performed by CROs and other external vendors requires management to make estimates in regard to the timing and accounting for these expenses. We estimate costs of research and development activities conducted by service providers, which include, the conduct of sponsored research, preclinical studies and contract manufacturing activities. The diverse nature of services being provided under CRO and other arrangements, the different compensation arrangements that exist for each type of service and the lack of timely information related to certain clinical activities complicates the estimation of accruals for services rendered by CROs and other vendors in connection with clinical trials. We record the estimated costs of research and development activities based upon the number of services provided but not yet invoiced and include these costs in the accrued and other current liabilities on the balance sheets and within research and development expense on the statements of operations, and payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received. In estimating the duration of a clinical trial, we evaluate the start-up, treatment and wrap-up periods, compensation arrangements and services rendered attributable to each clinical trial and fluctuations are regularly tested against payment plans and trial completion assumptions.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We estimate these costs based on factors such as estimates of the work completed and budget provided and in accordance with agreements established with our collaboration partners and third-party service providers. We make estimates in determining the accrued liabilities and prepaid expense balances in each reporting period. As actual costs become known, we adjust our accrued liabilities or prepaid expenses. We have not experienced any material differences between accrued costs and actual costs incurred since our inception.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our expenses related to clinical trials are based on patient enrollment and related expenses at clinical investigator sites as well as estimates for the services received and efforts expended pursuant to contracts with multiple research institutions and CROs that may be used to conduct and manage clinical trials on our behalf. We generally accrue expenses related to clinical trials based on contracted amounts applied to the level of patient enrollment and activity. If timelines or contracts are modified based upon changes in the clinical trial protocol or scope of work to be performed, we modify our estimates of accrued expenses accordingly on a prospective basis.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Valuation of Warrants</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Warrants were valued using Black-Scholes utilizing the following inputs; (i) a risk-free interest rate (ii) volatility based on the expected term of the Common Warrant (iii) and an exercise price and stock price on the date of the transaction. Several different scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the Common Warrants can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of our initial public offering (i.e. December 31, 2025), (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#8220;smaller reporting company,&#8221; as defined by Rule 12b-2 of the Securities Exchange Act of 1934, because both the market value of our stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250.0 million or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700.0 million as of June 30th. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See Note 2 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information about recent accounting pronouncements, the timing of adoption, and our assessment, if any, of their potential impact on our financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_and_qualitative"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ite</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">m 7A. Quantitative and Qualitative Disclosures About Market Risk.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Rate Risk</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable to a &#8220;smaller reporting company&#8221; as defined under Item 10(f)(1) of Regulation S-K of the Securities Act.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ite</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">m 8. Financial Statements and Supplementary Data.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 8 is included as exhibits at the end of this Annual Report on Form 10-K beginning on page F-1and listed under Item 15(a)(1) and (2), and is incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_and_disagreements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tem 9A. Controls and Procedures.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Annual Report on Form 10-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures were effective at a reasonable assurance level.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Exchange Act Rule 13a-15(f) and 15d-15(f). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer, principal financial officer and principal accounting officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.</span></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal Control-Integrated Framework (2013 Framework). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on this assessment, our management concluded that, as of December 31, 2024, our internal control over financial reporting was effective based on those criteria.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were no changes in our internal control over financial reporting during the year ended December 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II &#8211; OTHER INFORMATION</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 9B. Other Information.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Notice of 2025 Annual Meeting Date and Related Deadlines</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the date of this Annual Report, we intend to hold our 2025 annual meeting of stockholders (the &#8220;2025 Annual Meeting&#8221;) on or about June 24, 2025. This date is more than 30 days before the one-year anniversary of our 2024 annual meeting of stockholders (the &#8220;2024 Annual Meeting&#8221;), which was held on August 27, 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our bylaws provide that for stockholder nominations to our board of directors or other proposals to be considered at an annual meeting of stockholders, the stockholder must give timely notice thereof in writing to the Corporate Secretary at CalciMedica, Inc., 505 Coast Boulevard South, Suite 307, La Jolla, CA 92037.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because the date of the 2025 Annual Meeting is more than 30 days before the one-year anniversary of the date of our 2024 Annual Meeting, for the stockholder notice to be timely, it must be delivered to the Corporate Secretary at our principal executive offices not earlier than 5:00 p.m. Eastern Time on the 105th day prior to the date of the 2025 Annual Meeting, March 11, 2025, and not later than 5:00 p.m. Eastern Time on the later of (1) the 90th day prior to the 2025 Annual Meeting or (2) the close of business on the tenth day following the day on which public announcement of the date of such meeting is first made by us, April 7, 2025. A stockholder&#8217;s notice to the Corporate Secretary must set forth as to each matter the stockholder proposes to bring before the 2025 Annual Meeting the information required by applicable law and our bylaws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, stockholder proposals submitted pursuant to Rule 14a-8 under the Exchange Act and intended to be presented at our 2025 Annual Meeting must be received by us a reasonable time before we mail our proxy materials for the 2025 Annual Meeting. We have determined that March 18, 2025, which is the date disclosed our definitive proxy statement on Schedule 14A for our 2024 Annual Meeting, remains a reasonable time before we expect to mail our proxy materials for the 2025 Annual Meeting, and that any stockholder proposals must be received on or before the close of business on that date in order to be considered for inclusion in our proxy materials for the 2025 Annual Meeting. A stockholder&#8217;s notice to the Corporate Secretary must set forth as to each matter the stockholder proposes to bring before the 2025 Annual Meeting, the information required by applicable law and our bylaws.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, stockholders who intend to solicit proxies in support of director nominees other than our nominees must provide in their notice any additional information required by Rule 14a-19(b) under the Exchange Act.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding_foreign"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_officers"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 10. Directors, Executive Officers and Corporate Governance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information required by Item 10 and not set forth below will be set forth in the sections</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or subsections titled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Proposal No. 1 Election of Class I Directors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Delinquent Section 16(A) Reports</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Board of Directors and Committees of the Board of Directors </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Executive Officers </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contained in our definitive proxy statement for our 2025 annual meeting of stockholders to be filed with the SEC not later than April 30, 2025 (the &#8220;Proxy Statement&#8221;) pursuant to General Instructions G(3) of Form 10-K and is incorporated herein by reference.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Code of Conduct and Ethics that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or vice president of finance, or person performing similar functions. A current copy of the Code of Conduct and Ethics is available on the Corporate Governance section of our website at https://ir.calcimedica.com. If we make any substantive amendments to the Code of Conduct and Ethics or grants any waiver from a provision of the Code of Conduct and Ethics to any executive officer or director that are required to be disclosed pursuant to SEC rules, we will promptly disclose the nature of the amendment or waiver on our website or in a current report on Form 8-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 11. Executive Compensation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 11 will be set forth in the sections or subsections titled  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation Committee Interlocks and Insider Participation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contained in the Proxy Statement and is incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security_ownership"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 12 will be set forth in the sections or subsections titled</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Security Ownership of Certain Beneficial Owners and Management</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Incentive Plan Compensation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contained in the Proxy Statement and is incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 13. Certain Relationships and Related Transactions, and Director Independence.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 13 will be set forth in the sections or subsections titled</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Certain Relationships and Related-Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Director Independence</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contained in the Proxy Statement and is incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ite</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">m 14. Principal Accounting Fees and Services.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required by this Item 14 will be set forth in the section titled</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Proposal No. 2 Ratification of Independent Registered Public Accounting Firm</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contained in the Proxy Statement and is incorporated herein by reference.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibits_financial_statement"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">em 15. Exhibits, Financial Statement Schedules.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Documents filed as a part of the report:</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:9.065%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.989278055754109%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Statements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The following financial statements of CalciMedica, Inc., together with the report of Moss Adams LLP and Ernst &amp; Young LLP, independent registered public accounting firms, required to be filed pursuant to Part II, Item 8 of this Annual Report are included on the following pages:</span></div></div>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:92.92%;box-sizing:content-box;"/>
    <td style="width:7.08%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_public_acct_moss"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm PCAOB ID: 659</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#report_of_independent_public_acct_moss"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-2</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_public_acct"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm PCAOB ID: 42</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_operations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_stockh"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Years ended December 31, 2024 and 202</span></a><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:24.5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:24.5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
   </tr>
  </table>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2)     </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Statement Schedules. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(3)   </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">  List of exhibits required by Item 601 of Regulation S-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See part (b) below.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)    </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">  Exhibits</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit Index</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.32%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed/Furnished</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1&#135;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex21.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, by and among Graybug Vision, Inc., Camaro Merger Sub, Inc. and CalciMedica, Inc., as amended by the First Amendment, dated February 10, 2023</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex31.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of the registrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex32.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment, dated March 20, 2023 to Amended and Restated Certificate of Incorporation of the registrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000156459020053539/gray-ex32_105.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Restated Bylaws of the registrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 12, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reference is made to Exhibits</span><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex31.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;"> 3.1</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">, </span><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex32.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">3.2</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><a href="https://www.sec.gov/Archives/edgar/data/1534133/000156459020053539/gray-ex32_105.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">3.3</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000095017024038064/calc-ex4_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Registrant&#8217;s Common Stock</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.32%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed/Furnished</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520249556/d796801dex41.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Common Stock Certificate</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 21, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex41.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Registration Rights Agreement, dated November 21, 2022, by and among CalciMedica, Inc. and the several purchasers signatory thereto.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337dex102.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 24, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520240042/d796801dex43.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Common Stock, dated December 11, 2019, by and between the Registrant and SG DAN Equity Holdings, LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 4, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex42.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Warrant to Purchase Shares of Series D Convertible Preferred Stock of CalciMedica, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex43.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Common Stock dated as of November 9, 2020, issued by CalciMedica, Inc. to SG Dan Equity Holdings, LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex44.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Common Stock, dated as of October 18, 2022, issued by CalciMedica, Inc. to SG Dan Equity Holdings, LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex45.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Common Stock, dated as of October 18, 2022, issued by CalciMedica, Inc. to Eric Roberts.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex46.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Common Stock, dated as of October 25,2022, issued by CalciMedica, Inc. to Fred Middleton.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523090982/d482049dex49.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Warrant to Purchase Shares of Series B Convertible Preferred Stock of CalciMedica, Inc.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-271115</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 4, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337dex42.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Tranche B Common Warrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 24, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337dex43.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 24, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.15</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337dex44.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Placement Agent Warrant.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 24, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex101.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and A. Rachel Leheny, Ph.D., dated May 20, 2020.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.32%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed/Furnished</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex102.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and Eric Roberts, dated May 20, 2020.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex10_3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and Sudarshan Hebbar, M.D., dated August 24, 2015, as amended.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex10_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and Michael Dunn, dated August 29, 2014, as amended.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex10_5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and Kenneth A. Stauderman, Ph.D., dated August 29, 2014, as amended.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex10_6.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Offer Letter between CalciMedica, Inc. and Stephen Bardin, MBA, dated November 7, 2024.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex1011.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consulting Agreement, dated as of October 26, 2020, by and between the CalciMedica, Inc. and Danforth Advisors, LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524207754/d884220dex101.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. 2023 Equity Incentive Plan.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 27, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex107.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Forms of Option Grant Notice and Option Agreement under CalciMedica, Inc. 2023 Equity Incentive Plan.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex108.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Forms of Restricted Stock Unit Grant Notice and Unit Award Agreement under CalciMedica, Inc. 2023 Equity Incentive Plan.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex109.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. 2023 Employee Stock Purchase Plan.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex1010.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. 2006 Stock Plan and Form of Stock Option Agreement thereunder.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520249556/d796801dex103.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2020 Equity Incentive Plan and forms of award agreements.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 21, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520249556/d796801dex104.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2020 Employee Stock Purchase Plan and forms of award agreements.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 21, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex1012.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Amendment to Stock Option Award Agreement, dated March 20, 2023, by and between Graybug Vision, Inc. and the Holder party thereto</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex1013.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Amendment to Restricted Stock Unit Award Agreement, dated March 20, 2023, by</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 22, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.32%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed/Furnished</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425dex1013.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">and between Graybug Vision, Inc. and the Holder party thereto</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520240042/d796801dex102.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2015 Stock Incentive Plan, as amended, and forms of award agreements thereunder.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 4, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520240042/d796801dex101.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 4, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex10_20.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation Policy.</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21+</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312520240042/d796801dex1011.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Change in Control and Severance Policy.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-248611</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 4, 2020</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312523210902/d516230dex12.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">At the Market Offering Agreement, dated as of August 11, 2023, by and between CalciMedica, Inc. and H.C. Wainwright &amp; Co., LLC</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-3</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-273949</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 11, 2023</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524013513/d738337dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated January 19, 2024, by and among CalciMedica, Inc. and the persons party thereto (Corrected)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K/A</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 24, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524248761/d904376dex11.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Underwriting Agreement, dated October 30, 2024, by and between CalciMedica, Inc. and JonesTrading Institutional Services LLC.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 31, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312525046225/d940326dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant to Purchase Shares of Stock of CalciMedica, Inc. dated February 28, 2025, by and between CalciMedica, Inc. and Avenue Venture Opportunities Fund II, LP.</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312525046225/d940326dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Loan and Security Agreement dated February 28, 2025, by and among CalciMedica, Inc., Avenue Capital Management II, L.P., and Avenue Venture Opportunities Fund II, L.P.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312525046225/d940326dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Supplement to the Loan and Security Agreement dated February 28, 2025, by and among CalciMedica, Inc., Avenue Capital Management II, L.P., and Avenue Venture Opportunities Fund II, L.P.</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 5, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000119312524092036/d690122dex161.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Letter from Ernst &amp; Young LLP to the SEC dated April 10, 2024.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 10, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex19_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. Insider Trading Policy, amended April 2023.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm - Moss Adams LLP.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:7%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.4%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.32%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.28%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing Date</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filed/Furnished</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Herewith</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex23_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm - Ernst &amp; Young LLP.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2*</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ck0001534133-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534133/000095017024038064/calc-ex97_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. Incentive Compensation Recoupment Policy</span></a></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39538</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">X</span></p></td>
   </tr>
  </table>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.</span></p>
  <p style="margin-left:4.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+ Indicates management contract or compensatory plan.</span><span style="color:#0000ff;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#135; Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="text-indent:4.133%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.96%;box-sizing:content-box;"/>
    <td style="width:1.1%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:43.94%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ A. Rachel Leheny</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">A. Rachel Leheny, Ph.D.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Stephen Bardin</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stephen Bardin, MBA</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Accounting and Financial Officer)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">POWER OF ATTORNEY</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints A. Rachel Leheny, Ph.D. and Stephen Bardin, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:32.98%;box-sizing:content-box;"/>
    <td style="width:1.04%;box-sizing:content-box;"/>
    <td style="width:43.3%;box-sizing:content-box;"/>
    <td style="width:1.04%;box-sizing:content-box;"/>
    <td style="width:21.64%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ A. Rachel Leheny</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">A. Rachel Leheny, Ph.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principle Executive Officer)</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Stephen Bardin</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Chief Financial Officer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stephen Bardin, MBA</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(Principal Accounting and Financial Officer)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Robert N. Wilson</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Chairman</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Robert N. Wilson</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Alan Glicklich</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Alan Glicklich, M.D., MBA</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Frederic Guerard</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Frederic Guerard, Pharm.D.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Fred Middleton</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fred Middleton, MBA</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Eric W. Roberts</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Eric W. Roberts</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:4pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Allan Shaw</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;March 27, 2025</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allan Shaw</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:92.92%;box-sizing:content-box;"/>
    <td style="width:7.08%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_public_acct_moss"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm PCAOB ID:</span><span><ix:nonNumeric id="F_ae982109-d058-4c18-ac37-b4d90dfc9eac" contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba" name="dei:AuditorFirmId" continuedAt="F_ae982109-d058-4c18-ac37-b4d90dfc9eac_1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">659</span></ix:nonNumeric></span></a><span style=""><ix:continuation id="F_ae982109-d058-4c18-ac37-b4d90dfc9eac_1"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></ix:continuation></span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_public_acct"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm PCAOB ID:</span><span><ix:nonNumeric id="F_245b2c13-7878-4a99-a36a-a659aff49660" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_operations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#consolidated_statement_of_comprehensive"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Comprehensive Loss for Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_stockh"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_statements_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_of_independent_public_acct_moss">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Shareholders and the Board of Directors of</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_53f1fd28-297f-41c0-8102-1599fa38c4f8" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:AuditorOpinionTextBlock" escape="true" continuedAt="F_53f1fd28-297f-41c0-8102-1599fa38c4f8_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (and subsidiaries)(the Company) as of December 31, 2024, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#8217; equity and cash flows for the year then ended, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2024, and the consolidated results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">consolidated</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> financial statements. We believe that our audit provide</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">s </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32b220a0-af7d-4311-a684-93e5c652d2b1" contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moss Adams LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_692fde7d-9272-47a2-aaf9-58a9f7abf59e" contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_of_independent_public_acct"><span style="color:#333333;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report of Independent </span><span style="color:#333333;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registered Public Accounting Firm</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of CalciMedica, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_53f1fd28-297f-41c0-8102-1599fa38c4f8_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (the Company) as of December 31, 2023, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ffdc59d4-2f7c-4c59-96b4-6fa6038d3499" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We served as the Company's auditor from 2008 to 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1bf875d8-37ab-48ab-8cc4-c81d76ce1244" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 28, 2024</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">except for the Segment Information section of Note 2, as to which the date is</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I&#8212;FINANCIAL </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INFORMATION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. Financial Statements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Balance Sheets</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except par value and share amounts)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.967%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:13.037%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.48%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:13.037%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2780b112-c1d6-4925-9dc6-a9e4fcadd97d" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,935</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebacc942-8c13-4d71-81fe-49539c43c07f" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,530</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd4cd37a-bf15-43ca-afec-f346f458421b" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,734</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_02329e11-db08-4435-ba98-5ba216fcc1b5" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,708</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid clinical trial expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e90d565c-c1a6-4cf8-a6a0-73c5c8f9fe2b" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:PrepaidClinicalTrialExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">748</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4b46e1a-afd4-4896-93ea-239b47385b43" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:PrepaidClinicalTrialExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other prepaid expenses and current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d5de457-7f2a-4374-a96a-0fbaf3247d9d" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">248</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5b5d823-9bc2-4dd7-a12f-1bf743f2a076" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c09fc0a-257f-4ac5-9e19-a2657727c276" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,665</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a910a36c-54f6-4ea7-a42a-efe39388328a" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,605</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33a1617e-c71c-4b9f-ab88-b143c0b652c2" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af6f1cd3-3614-485b-b879-3e01d72724ac" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">167</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_922805ad-1a69-496f-9ebe-d5095f8c410e" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:OtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3b5e200-775e-4d4d-8821-b4b5e658fabd" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:OtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">413</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c54ae0a-d7b9-4f42-9e5e-0e5ff65c859b" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,794</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97b41a6a-9bc7-48c7-886d-16c37b2b6e92" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,185</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders&#8217; Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00e06b31-8163-4a56-84b9-07cc7c06f730" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,998</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7145d4d-525b-4214-973d-ffc447d7511b" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,419</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued clinical trial costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f25c5fea-b439-4304-a13d-199f515b6fbe" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:AccruedClinicalTrialCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">820</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce38fb8b-0715-4c70-8a31-0dbc273d9a0b" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:AccruedClinicalTrialCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,141</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c42e759-4345-4546-80b0-be10bcbb29d5" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">866</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_baf02023-ca54-49af-96fa-d96d5875a7cf" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,468</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f13db4a-e110-4868-82ef-c9ff901a24c8" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,684</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_787aa739-fa3a-4ad5-985e-e8a51301bc63" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,028</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term liabilities</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b001c859-08b4-47cd-88fc-471061ff0ad3" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:WarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f58ac53-5cc1-4c03-8efe-2f71253b2930" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:WarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afe145af-de2b-4666-98cb-2c99a4baee51" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,384</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdadd2f8-3329-430a-889d-c85a41166aa9" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,028</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><span style="-sec-ix-hidden:F_16371737-8ec4-45fa-a0b0-e6e4270790f5;"><span style="-sec-ix-hidden:F_2307ffdb-2705-4620-ac9a-fe22cc657fdc;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 9)</span></span></span></span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">Preferred stock, $</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cd59486-b41b-4ad0-86fd-97bfbb274e3d" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fdccb848-cf5e-430a-a1c5-2777490d86d2" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9ae101b-e1cb-406b-bad5-c5392c346856" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e6fd2ce1-45be-40db-9b5c-b2b26b7e35c2" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and December 31, 2023, respectively; </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4da38cb-27cc-4025-83df-ad6a30dd0ce5" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d02a974c-6a37-458d-8c18-7f98918c8b51" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_16a62d31-fb1b-46c4-8f13-c18a4a4ea417" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b4e1c57a-5758-4143-b6fb-3d2decdedbce" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ecf9690-b957-44fe-956e-4721161086b2" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c971065d-d5d3-4b06-8bed-73ca409e8f32" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b81d5030-3418-40a9-bcb4-4473e61c6637" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_09d2cde0-c9ae-4f9b-a314-7a50dac0cf9c" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9155d60e-1834-4ab7-9787-b3f57dc2c715" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_48e6fb55-8f38-4c70-81a0-07002ee3a3ac" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">500,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;shares authorized at December 31, 2024 and December 31, 2023; </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ced8084-bbda-4a4d-9098-82cd71709f7f" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d0d6bd94-eb73-4dfd-9f2d-d55f907e63c6" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,481,917</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c0eca0b-0860-4a5a-a2fa-33c4f68dad0d" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3b61fd19-a573-4637-89fe-e71f583f1316" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,754,505</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">&#160;issued and outstanding at December 31, 2024 and December 31, 2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b56bce3-5723-468d-b7c6-745b0459c5e7" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b600b49a-435a-4b90-bfab-c7203e640ea5" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dda9faa0-f7e8-41b9-bfb0-7fc76c3baeea" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">174,166</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85de7a60-9c61-431e-b286-56c793bb044a" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af0a3c1f-376e-4998-ae73-862b13c42c9e" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,764</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cea6db69-6e2d-4f1c-8fa4-a3c8cd33fc82" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">146,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e0b1a59-7e52-467e-9f80-b1c3bee23ccf" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c736c4b-42ca-44d0-8462-9e5b6b8a5984" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ed8c4cb-bc8d-4e80-9843-1f2898c36a6b" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,410</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48c41702-8508-485f-a5c2-5c97ac648f27" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders&#8217; equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4645d67b-ff5d-407f-a2b2-c4b5e034e752" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,794</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f1d2b3c-0e91-4e63-9cbe-8c977349bace" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,185</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_statements_operations"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statemen</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ts of Operations</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share amounts)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.58%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.923%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.58%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.923%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_157094b2-ca93-4ac7-a9f3-385ca7b5325a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,478</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_043584c6-de24-4660-8a08-fa4b2c957988" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,859</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6db79b7-a66c-40ca-83e1-dcf922f261c3" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,726</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c0ca840-776a-4b3a-82d1-c3777b496e2f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,216</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1be9412-0add-4dea-96b5-cc2b9f2b1d32" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,204</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9693a49b-fef8-43e0-8bdd-a8bdf34dfe06" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,075</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff6d5db0-d1d9-45d7-9397-fa0447930ef4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,204</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c7195b0-e1e2-4c23-beac-bdd316cce3e7" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,075</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of financial instruments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27f22baf-fd6c-4bbb-aaf7-a3fd31f7bace" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ChangesInFairValueOfFinancialInstruments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,490</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b7f4549-6eee-47dc-8467-9e4e81f1fc59" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ChangesInFairValueOfFinancialInstruments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,168</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af632f21-6d1b-4a7b-9a54-5862cb28fe43" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,014</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7030efd-d361-46ce-b9d6-024939f5f20b" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">550</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11f138ed-2587-416b-a4b9-f55eaae9d13b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,504</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a32c9729-9b99-4afd-8feb-4a0a454cb573" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,718</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42a83ae5-0b53-40c4-adfb-53cb2ed1c45e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2a2bc26-31a3-4bdf-9653-6ff580b20a9e" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share - basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8345247b-dfd1-4cae-a649-68bd4423cfb9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7eaa5e52-a93e-422a-841e-31d0c0455e2b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.22</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b1b23c9-3f25-42f3-81ad-9f2b03a8153d" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f8e375cf-d4d3-44b3-864a-3eba7b78b3cd" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.66</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of shares outstanding used in<br/>&#160;&#160;&#160;computing net loss per share&#8212;basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_016ec5d3-8cdc-4acb-abfc-691a703cf21a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_556d09da-09c8-4787-bb7a-5e910844873f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">11,245,915</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcfda22f-a662-4af5-acd8-c02adf89760b" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e35261cd-5652-485a-9730-0beac4258671" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,486,258</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="consolidated_statement_of_comprehensive"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIM</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Comprehensive Loss</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.013%;box-sizing:content-box;"/>
    <td style="width:3.061%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.663%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.6%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.663%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0242d8a-2ac0-45a1-b295-d0f9894e0091" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29b4d6cf-da97-4ed1-a8de-dfad803cf19d" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale securities, <br/>&#160;&#160;&#160;net of tax</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dd26545-4424-4207-ba61-b62d66b6117b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8109612-d8dd-49df-a3d4-a3625443da7e" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3aaaeb0c-3be3-4564-97f2-fd0ef0863d4c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,698</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d06e6c9d-cdce-436e-921f-767ebb3d4a70" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,355</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_stockh"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Stateme</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nts of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share amounts)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:91.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36.84%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.04%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.5600000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.5600000000000005%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.24%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.34%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.96%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.16%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:7.82%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Other<br/>Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Stockholders&#8217;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gain</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance&#8212;December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab24e10f-14e8-4037-ba21-105f4312a6c4" contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,754,505</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8557881-e164-4ced-91f9-c2bb3f52e517" contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b9fcb3e-6800-4e2f-9f11-b6070dd3f17f" contextRef="C_a707849b-9622-4270-8a14-4ccfb2234b96" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13de27f5-cd24-4bb4-888f-85b701109d0d" contextRef="C_30130670-4924-4031-bbd1-78ccb2dff022" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">146,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6c347d9-4de6-4e6f-a3e4-51e4c41a631c" contextRef="C_d409c238-cc99-40c2-b647-976b6c07fe00" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ad33535-a27c-4849-81a0-b500464f60ff" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b376b56f-0cf5-494e-a49a-fc86d5255af2" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ed4b9b0-f88c-4a44-b6d9-2b455fc5bde6" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common shares from private placement (net of issuance costs)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_018b4df0-e2a0-4503-ac7f-6e9b1739eba0" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,985,610</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0382624-fb8d-4aa2-a9ae-b65a1356cbd7" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5158385a-fd3e-4386-8a38-c07b0aff5f14" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,903</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1977f94e-ae79-4534-a3cd-2a17bd2200ca" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of warrants in connection with the private placement</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c3e5c4d-77e4-47ad-ba04-b81f5692aee5" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">660</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df3d9040-1d57-4b09-aa8f-1b7a624ddfa8" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">660</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common shares from underwritten public offering (net of issuance costs)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a270c6c1-b3ff-4f25-8994-8c1086e599bb" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,720,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa672d82-fbc9-4d37-a8e5-9ae49f9e9fd4" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffe5b8a6-fcd0-4a63-b231-e459135b2871" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,003</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea450620-9838-4936-b798-197d87048b89" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,004</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from at-the-market offering (net of issuance costs)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_610c29e8-1562-436c-96df-c4349901b0bd" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,950</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ee1fc07-de33-45cc-b02a-123ef4aea4e0" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2035499a-e8af-48aa-940b-5e6ba5e2928b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39003da1-c23c-4ad1-b941-00ccf5f5aea8" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,852</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1db75f3-b0f6-4c5a-864a-4277cafa27a8" contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a35ba1d-6506-4b34-a20c-af3c82ecb11c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c5d4c1b-fe02-47ce-98c2-25a7577dfb23" contextRef="C_bb626b12-389d-4561-abdc-fe33a5ce2554" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13937b26-5dd6-4876-a178-ecc52f6246cb" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6c0c22b-d600-45b0-b3a7-31df46d17a47" contextRef="C_1da4e079-61e5-45cc-a979-3a9615ff0665" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cd8b801-1180-4fb9-8a82-d319016e115e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance&#8212;December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea17a1e9-9697-4f49-ab18-b2741a5fea1d" contextRef="C_8f498825-0f78-45b4-812c-02787d22cde8" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,481,917</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e63e0d3-4b3b-4e6f-86b9-64d50e8c5adb" contextRef="C_8f498825-0f78-45b4-812c-02787d22cde8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2f189c5-b288-452b-99a0-7dbf2ce1d0cd" contextRef="C_53c253cb-c903-45b5-b952-e3bd63a5ace1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">174,166</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf408b53-0117-4df2-a574-3e062beb0480" contextRef="C_845be1e9-b257-47a6-89d4-733d8a31d6b2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,764</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_549b93a0-f9fa-4db1-bec1-118a28013a49" contextRef="C_d7c558d7-f9b7-46bd-a5cd-d32a30cceb1d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc2e8dee-46f6-457a-b90e-9f5c3030d0e6" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,410</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share amounts)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:29.912%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.082%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.162000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.082%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.662000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.602%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.981999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.202%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.02%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:6.202%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Other<br/>Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Stockholders&#8217;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gain</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity/(Deficit)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance&#8212;December 31, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fda962c-e4d1-4959-a932-52c6e6287685" contextRef="C_640fa722-803d-451f-878d-cea21bde32c6" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">84,820,880</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10e8c446-2eec-4799-8d5c-df1576e67b56" contextRef="C_640fa722-803d-451f-878d-cea21bde32c6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15e90213-9164-4bc9-be1d-3bbcdb407103" contextRef="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">84,165</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f7ba5d0-f7a2-4d29-a564-f91fcf3fdbe3" contextRef="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8646c88-f9ac-4c81-9030-3411b1c28d95" contextRef="C_f3e6c3db-a6a2-4f7d-99b3-1a4978c878f9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,402</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c58ebdc-a22c-43c7-acbc-3e0366ddffa4" contextRef="C_2ca88b50-4b1e-42cb-b72d-edd91da9a612" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">111,707</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4848422c-a885-466f-ab68-86f45f222856" contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,304</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0b7e994-726d-4fe8-90a2-97bd36f1a959" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,039</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec86efd9-1844-4dfe-ba6b-5b237f62f969" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,039</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of preferred stock to common stock as a result of Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36c6d0cd-4234-447e-b0e4-588c01226979" contextRef="C_bd15498b-f283-433b-97df-4b894a6ee8ad" name="ck0001534133:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">84,820,880</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_279d3628-d754-48ed-87f9-4e89e9e39711" contextRef="C_bd15498b-f283-433b-97df-4b894a6ee8ad" name="ck0001534133:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">62,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7db3b8df-059e-48e3-b0b5-10cff97ab399" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,442,852</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55c3016e-4240-451e-958e-f582de4df7f3" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9f85f64-f030-4412-898e-5a238eff08ba" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cca9bead-660b-430b-80ea-278ac91a9753" contextRef="C_3cab47fb-e5c1-4496-85a3-0d4ea86c41fe" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55f6bac9-de10-4fe3-9272-c0ffc0005686" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,571,433</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_715eaa04-9020-48b1-85f5-d249a947efd5" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7748ddfa-771a-43ed-a4a9-25c2b91fbe17" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common shares from private placement (net of issuance costs)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bec77713-9c38-4b15-9de0-f70df18923b6" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">596,363</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b8b0172-c26f-4195-862c-008dee7ea308" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,340</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfa775e8-1a49-41b4-a231-4dc66d37e2d9" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,340</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of promissory notes into common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7110590-c237-41a5-9cbd-a70fb86036e8" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">590,031</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6af08284-56f5-468d-a166-b3ceb63b287e" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,245</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_276c84f6-97f0-4faf-9603-3b776e98ce12" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,245</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of Series C-2 warrants into common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51ad86dd-546e-44fb-86ee-6236c6838566" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:ExerciseAndConversionOfC2WarrantsShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">80,254</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a11153c-1601-43b8-bf59-943876853b70" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">442</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f262d43e-cee0-43d0-b379-98013c627223" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">442</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of promissory note warrants into common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ce23b87-d05e-49aa-aafc-2388b403fe72" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">152,875</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_898e162c-e2e0-42fb-822f-6fa74c43cc6d" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">841</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c87b7db-3566-451f-953a-efb2694b7daf" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">841</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Merger transaction costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fcd4c060-13a6-4f2e-b95b-d0ad5c31cc79" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:MergerTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e799fce-6a51-4077-8840-631ef0c42d51" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:MergerTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units net settlement</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75cdd762-b0e6-41ac-85d0-08cf7bf2e920" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="ck0001534133:RestrictedStockUnitsNetSettlementShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">143,960</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5f763f1-0d81-4be8-b0b7-c10e0b354308" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="ck0001534133:RestrictedStockUnitsNetSettlement" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">297</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dafd2d2c-df18-4db0-8e86-85e61d546aac" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:RestrictedStockUnitsNetSettlement" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">297</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reclassification of warrant liability to equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_094e0b49-ba43-4932-87a6-8f7a901e4977" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfb5d8bf-677a-472a-84c7-69a52cf94ca6" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from at-the-market offering (net of issuance costs)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b458385e-c511-44f5-82b8-1c94ebd5e63e" contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">92,572</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8cdb640-5851-4ec7-bd57-1664e711e6d9" contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6d51a7c-583c-417e-89bc-d603efd815c7" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c3b5779-e3fe-4da9-b59c-0c364dca5ea9" contextRef="C_a3c816ce-23b8-4647-a3b2-a0060ab3f6a7" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d5409af-6aee-4e4a-a1c2-6d4a205877c5" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_903d6bbc-5d26-4dda-a0e4-b1ff81a3f305" contextRef="C_b1ab3b90-45a9-4502-8252-c2e3034f292f" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fee33b8-7c43-4c11-ba03-1147a16d6d0b" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance&#8212;December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4831b49-d4f0-4661-91b5-b9e56e274739" contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,754,505</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_092d76c3-7def-413e-9caa-ee27b2c8761c" contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50ee0259-0a70-41c4-958a-b9168c836673" contextRef="C_a707849b-9622-4270-8a14-4ccfb2234b96" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f59b6af7-6883-4187-babf-b9afc76edde3" contextRef="C_30130670-4924-4031-bbd1-78ccb2dff022" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">146,064</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11c1fca3-d104-47b8-b2bd-2290bb9f979d" contextRef="C_d409c238-cc99-40c2-b647-976b6c07fe00" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b592c9c8-397d-4694-a42c-f6cc4a64fc80" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,157</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_statements_cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statemen</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ts of Cash Flows</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.16%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.8%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00108339-4338-4cf7-98ea-20258321ceb3" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8c3c2ad-8c04-445a-a431-d8ffecd712ee" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_748ba0a8-17fd-45f0-8558-147e6ed97102" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc0b53a7-1659-4c83-9e5d-74a315a91c6b" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,039</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d4b0f2f-f698-4467-b723-5c60e15d9bef" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f06bbcc6-4801-4720-9eda-6dc1aa17eaf4" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in the fair value of warrant liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b56c7214-4a13-482a-95a2-4383fddf1467" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9,490</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_907cc9a2-19b3-4b65-aaf7-6ec1ca0be488" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,146</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in the fair value of convertible promissory notes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a99a80d9-7788-43a3-b522-6fb5f7c05c26" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cbfcfbf-546a-4776-b0b0-c560ddb7f6d3" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,022</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transaction costs associated with warrants</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b55fc1a4-e083-49f3-b7c9-df3cbf671f3f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:TransactionCostsAssoicatedWithWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">776</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39c29ea3-8e04-4d09-b8f7-4fdb026f84dd" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:TransactionCostsAssoicatedWithWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a7f42d0-f209-482a-af8d-619da94d5196" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:NonCashInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0c9bc9b-42c9-4878-b5ac-fe367e4a2181" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:NonCashInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accretion of discount on short-term investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52f4e1e9-d853-471b-86cd-deca4011c29e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">608</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e5bae6f-1e20-4823-a5d5-af8fd82106a9" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">145</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current and non-current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5593b68-559e-4a17-8ffb-53fb57f6e902" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">228</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_150d19bd-189b-4a5a-96ca-519f4d9cf7e1" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,997</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a4f7540-4875-4f3e-a829-2df028a5e5f1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">601</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_316d7808-8abd-4a42-bfbe-bbcfbc8ef7ec" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,427</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b714f58a-a95b-4c5b-b01b-059b73d08d7c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">868</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6c410f1-c363-4061-b887-6597ace3a066" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,837</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e22a6d8a-d0cd-4875-aef8-d7ddf099f131" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">21,146</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4841b6cf-705b-481b-9ae6-e2947aece9c5" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,730</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Investing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75aa1d78-c2ed-440e-82b6-943116291fe7" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:PaymentsToAcquireInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,002</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74bc7550-1038-43e3-9e0b-e1fa5aee57fc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:PaymentsToAcquireInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,118</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Maturity of investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62af5fdd-11a7-4271-aad3-3cd1a9987ecf" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,587</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60be3133-7efa-4c7a-86e2-345fc039d777" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,080</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9aa8a004-142e-447b-a3ba-d1d7a08fd343" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5224ca0-375b-429c-8375-26660cb9994f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95432b67-b7fb-454f-8813-1e492cce0fdc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,423</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0d313be-d723-4ae1-a342-34514a6308dc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,884</ix:nonFraction></span></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of common stock, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bb01a6e-03b6-4492-8c78-027ab2bf2ef7" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbb35a38-4bd5-4b3d-a69e-421667fc149f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,340</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisition of stock of Graybug, net of cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c3465f5-c9cd-4631-9c13-0820dc26a0b6" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5f3e909-e6d5-4582-b542-a8ef49a67afc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,859</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81e17678-9547-4368-aaa0-ea6589451fda" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9f671d7-c2f4-4a7b-9ea7-83d6274a668f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Merger transaction costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5f0f226-e522-4cc9-a2d4-31fcf243ab67" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21c19457-f010-441e-a632-4fbafa7cf829" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,545</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of common stock from ATM Facility, net of issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9238f38e-7246-4027-93f5-dfb0beb425ef" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ProceedsFromOtherEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a375f209-0e9b-4d71-a405-df51657a8c71" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ProceedsFromOtherEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f6e665a-3356-4083-955d-6c11f22f84c7" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,974</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5800aea3-4ff3-46ad-b9d5-bc0d45d00458" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,900</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase in cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8adb3ae-72e7-42ea-8a94-67d3a8ab0be4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,405</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ce1ce69-d2f0-46a5-84fd-5f25e987de01" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,054</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0b20d47-744e-4619-9bcc-9d5884c18e07" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,530</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ee5a153-23ff-4fa0-9630-5c8e2be0d158" contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,476</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25e34185-6a2a-4484-8456-869abd333290" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,935</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f1779ed-ad0f-4ba2-8d66-372d61187a7d" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,530</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental cash flow information:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of Series A, B, C-1, C-2 and D convertible preferred stock to common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4905f382-11d1-41a3-a2d7-00ed6501dd9c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ae0799-438e-451e-b094-b55a20637ccc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,071</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock to Graybug stockholders as a result of the Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e4ea80-cacf-4561-9190-3433fa2c5165" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_997f8464-730b-44dd-bf87-56d4d376d118" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,218</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments assumed in the Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f311f8d-5dbc-4d2a-9d23-c36bf9ce5255" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ShortTermInvestmentsAssumedInTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_643e815d-1b5f-40b1-9a88-98f96430884c" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ShortTermInvestmentsAssumedInTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,776</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets assumed in the Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_294f4d1b-0242-408f-aebc-8a1ec8b80579" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:PrepaidExpensesAndOtherCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee95afed-54d7-46de-a58d-c681ae72adcc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:PrepaidExpensesAndOtherCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,096</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued liabilities assumed in the Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0db26eac-5223-4101-8cd2-469782d744a5" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8165f10-38b8-4119-bc7f-f728250c1f6a" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,258</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of C-2 warrants to common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6884d4f-3b98-4445-a921-b0cbf14771ee" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ConversionOfC2WarrantsToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa8c5615-4d93-440b-b774-d75f04b0e66d" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ConversionOfC2WarrantsToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">442</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible promissory notes to common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af3cc21c-7774-49e4-9799-bb2b893a4d57" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7ad9be8-2dc1-4bb4-be66-671027b4f09a" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,245</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible promissory note warrants to common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f5ade1a-645e-460f-9e8f-e3860767e920" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8df60294-0f94-42ce-a050-0be557c5df3a" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">841</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing costs included in accounts payable and accrued expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f4d3ede-0ce0-4b57-ba0f-9a0633604f47" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50961ca4-6e30-472d-a24d-6621b78c9690" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units net settlement</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d3aad87-391e-4a88-b4e9-efdb9a9ef843" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:RestrictedStockUnitsNetSettlement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9490791f-3950-42cf-b271-90b2d2e9d027" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:RestrictedStockUnitsNetSettlement" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">297</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reclassification of warrant liability to equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a18a5ed6-6c6f-4a54-bc44-d7e16356f2f4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5995a3e6-1632-4b2e-b713-6ef98246234c" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_condensed_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notes to Consolidated F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inancial Statements</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7acc863-3e39-4dac-b241-003cb6f16326" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NatureOfOperations" escape="true" continuedAt="F_f7acc863-3e39-4dac-b241-003cb6f16326_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of Business</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. (&#8220;CalciMedica&#8221; or the &#8220;Company&#8221;) (f/k/a Graybug Vision, Inc.) was incorporated in the state of Delaware in February 2015, following the conversion of Graybug, LLC, which was organized in May 2011, and has its principal operations in La Jolla, California. The Company is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory processes and direct cellular damage.&#8203; The Company had a wholly owned subsidiary, CalciMedica Subsidiary, Inc., incorporated in Delaware in October 2006, which survived the Merger as more fully described below. The CalciMedica Subsidiary entity was dissolved and combined with the Company as of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Merger Transaction</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 20, 2023, Graybug Vision, Inc. (&#8220;Graybug&#8221;) completed a reverse merger transaction in accordance with the terms and conditions of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended on February 10, 2023 (the &#8220;Merger Agreement&#8221;), by and among Graybug, Camaro Merger Sub, Inc., a wholly owned subsidiary of Graybug (&#8220;Merger Sub&#8221;), and CalciMedica, Inc. (&#8220;Private CalciMedica&#8221;), pursuant to which Merger Sub merged with and into Private CalciMedica, with Private CalciMedica surviving as a wholly owned subsidiary of Graybug (the &#8220;Merger&#8221;). Additionally, on March 20, 2023, Graybug changed its name from &#8220;Graybug Vision, Inc.&#8221; to &#8220;CalciMedica, Inc.&#8221; and Private CalciMedica changed its name from &#8220;CalciMedica, Inc.&#8221; to &#8220;CalciMedica Subsidiary, Inc.&#8221; At the completion of the Merger, the prior Private CalciMedica equity holders and the prior Graybug equity holders owned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c64dbe80-d1cc-41d3-9523-55a6a4d29d72" contextRef="C_9114dadf-db78-4d1a-9686-04c4b1e69723" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">72</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_069e1257-c2e3-40cc-b3e9-c3b53ee53864" contextRef="C_29a301bb-4522-43d7-947b-4686e790d21a" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively of the combined company, in each case, on a fully diluted basis using the treasury stock method and excluding out-of-the-money options and warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger was accounted for as a reverse recapitalization, with Private CalciMedica being treated as the acquirer for accounting purposes. See discussions of the transactions in connection with the Merger in Note 3 - Merger and Related Transactions.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has experienced net losses and negative cash flows from operating activities since its inception. The Company has an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59eafbf0-1736-4dd2-b536-3c179f3be9d1" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">159.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2024, and a net loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99b47221-b0ad-4780-b765-d413f816e99c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">13.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year ended December 31, 2024. Total operating expenses for the year ended December 31, 2024 were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a180fc0-4e8b-4509-9ad0-3e5bc9521cb1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">24.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Substantially all of the Company&#8217;s operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects to incur significant expenses and increasing operating losses for the foreseeable future as the Company initiates and continues the preclinical and clinical development of its product candidates and adds personnel necessary to operate as a company with an advanced clinical pipeline of product candidates. The Company expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of clinical development programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From inception to December 31, 2024, the Company has completed financings from the sale of preferred stock, warrants and common stock for total net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ce540e8-5c72-4ee2-99a4-744c1fb3b68d" contextRef="C_f0009405-42d5-4625-a5e9-57af57ac1cfe" name="ck0001534133:TotalNetProceeds" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">140.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, including the 204 Private Placement and 2024 Follow-On described below, and has issued convertible debt for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd4a6dfa-c867-4e02-955e-33d70bb99a29" contextRef="C_c45d60ac-8593-48c7-9b05-a42201654937" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In connection with the Merger, the Company received approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2285f3db-8e79-4c3f-9414-8ddcbe31513f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">29.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of cash, cash equivalents and short-term investments. As of December 31, 2024, the Company had cash, cash equivalents and short-term investments of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfaf50a1-8eeb-47dd-9f30-e4c69d897439" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">18.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">closed the 2024 Private Placement (as defined in Note 7 below) on January 23, 2024 and the second closing of this private placement occurred on February 5, 2024. Gross proceeds from the transaction were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13453952-23e0-48fc-8d31-1fc4dec91fb4" contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b" name="ck0001534133:GrossProceedsFromThePrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24db6107-3713-4d20-8d2e-47fa067902e9" contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b" name="ck0001534133:NetProceedsFromPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6fca0a7-488c-4ee5-8ead-2f3be7afc5ed" contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b" name="ck0001534133:CommissionsAndOtherTransactionExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in commissions and other transaction expenses. The Company closed a confidentially marketed public offering (the &#8220;2024 Follow On&#8221;) in October 2024 of the Company&#8217;s common stock for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79d9af6a-7626-44eb-b4b0-6e07276cf55d" contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and transaction costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71bc4c4d-db43-4804-a52b-1031ad28c28b" contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e16072a-14c4-4855-9b41-b5554a0f4ce4" contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On February 28, 2025, the Company entered into the (&#8220;Loan Agreement&#8221;) with Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P. for an initial $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f74eb1db-f439-4208-bab4-819bb22e53ad" contextRef="C_f6e6eee2-3a7f-426a-995a-4c63812334ed" name="us-gaap:ProceedsFromRepaymentsOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of gross proceeds (see Note 13).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to seek additional funding through public and private financings, debt financings, collaboration agreements, strategic alliances and licensing agreements. Although the Company has been successful in raising capital in the past, there is no assurance of success in obtaining such additional financing on terms acceptable to us, it at all, and there is no assurance that the Company will be able to enter into collaborations or other arrangements. If the Company is unable to obtain funding when required or on acceptable terms, the Company may be required to scale back or discontinue the advancement of the product candidates, reduce headcount, file for bankruptcy, reorganize, merge with another entity or cease operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_f7acc863-3e39-4dac-b241-003cb6f16326_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the Company&#8217;s current operating plans, management believes its cash, cash equivalents, short-term investments and additional financing in February 2025, will be sufficient to fund its operations for the period of at least one year following the issuance of these financial statements.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f4ba1e7-f48c-466e-90c4-15a1f8b98a44" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Update (&#8220;ASU&#8221;), of the Financial Accounting Standards Board (&#8220;FASB&#8221;). The consolidated financial statements include the accounts of the Company for the year ended December 31, 2024 and the Company and CalciMedica Subsidiary, Inc. for the year ended December 31, 2023. All intercompany accounts and transactions have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#8217;s activity from March 21, 2023 through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and assets and liabilities at their acquisition date fair value. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the merger exchange ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfec8440-d48e-460c-8eee-3cc88eda589a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:StockholdersEquityNoteStockSplitExchangeRatio" unitRef="U_pure" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0288</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c056a2b4-66df-48cd-aecf-9dc8328d6631" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">   </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accruals for research and development expenses, valuation of warrants and valuation of equity awards. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1db503be-6514-4ec0-a1df-025f97e449f4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk and other Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to concentration of risk, consist principally of cash and cash equivalents. The Company&#8217;s cash is deposited with major federally insured U.S. financial institutions. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract manufacturing organizations (&#8220;CMO&#8221;) to supply products for research and development of its product candidates, including preclinical and clinical studies, and for commercialization of its product candidates, if approved. The Company&#8217;s development programs could be adversely affected by any significant interruption in CMO&#8217;s operations or by a significant interruption in the supply of active pharmaceutical ingredients and other components.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Products developed by the Company require approval from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance the Company&#8217;s product candidates will receive the necessary approvals. If the Company is denied approvals, approvals are delayed, or the Company is unable to maintain approvals received, such events could have a materially adverse impact on the Company.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1fcb84ce-ea73-4862-a773-8e0bfe4f4604" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of readily available cash in checking accounts, money market funds and commercial paper. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29bc78c1-3c6c-4e13-a4dc-4c99c498190b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company invests excess cash in commercial paper, U.S. treasury bills and U.S. government sponsored entities, such as mortgage-backed securities. These investments are included in short-term investments on the balance sheet, classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Realized gains and losses on the sale of these securities are recognized in net loss.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_c1186ffc-edc8-44ed-8a68-8af10ab27a0e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true" continuedAt="F_c1186ffc-edc8-44ed-8a68-8af10ab27a0e_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The financial information is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7d54053a-642e-4e39-bfc6-b012d14346a8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s singular focus is on developing highly selective calcium release-activated calcium channel inhibitors to improve outcomes for patients with acute inflammatory indications. No significant revenue has been generated since inception, and all tangible assets are held in the United States.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc69329c-8094-48df-b8e2-07e413828634" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment focused on developing and commercializing innovative therapeutics primarily in the U.S. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_1" continuedAt="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c1186ffc-edc8-44ed-8a68-8af10ab27a0e_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the chief executive officer, who is the Company's CODM, in assessing segment performance and deciding how to allocate resources on a consolidated basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d6ef33bb-2d17-4ffe-8971-47a9ca2a60fd" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about reported segment loss and significant segment expenses for the years ended December 31, 2024 and 2023:</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e53f569e-caff-4b4c-90ff-bc9ac756d331" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.08%;box-sizing:content-box;"/>
          <td style="width:1.9%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:15.84%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1.9%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:12.28%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment research and development </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(a) (b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1" contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,607</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12d5696b-58c6-49ec-90f5-83f181092884" contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,380</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment general and administrative </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b6e4946-31e1-4a92-b886-3a04ed5d247c" contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,226</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4539e24-1082-434c-9e72-eaee54ca8723" contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,598</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation (see Note 8)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_900a088c-90d0-4fa7-9946-33f2f64eb734" contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2b68cdb-9968-4cc9-81c7-094e460c0288" contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12,039</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense (see Note 2)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a898c4b-f83f-41aa-a3d3-e95de775339c" contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84c7e58a-3b31-4127-895b-9107a92725c6" contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0399a133-4504-4e88-9092-c3f9948181d8" contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,204</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edfa38ff-03d2-4eb5-b5b0-037244bd661a" contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,075</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of profit or loss</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments and reconciling items</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7ccc669-f654-458d-a0f2-289a41002e40" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb3d3464-8fb5-4292-8d52-98b52114b851" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_923d0e8a-4536-48e3-ad8f-8f14b82a1e59" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,204</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0bfd697-a23f-4f40-a755-01a356d4479f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">38,075</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
        </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22f46de0-f902-47fc-a7d4-88e4ede9d65c" contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">840,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6216c01a-e8a1-4e68-9003-d0114c262167" contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">2,449,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06c4905f-6ecf-4015-a44b-cc521fa0b8f2" contextRef="C_050c9307-b322-43a4-84b0-69234ed20231" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">1,473,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d70ca794-eb9b-4647-8264-b81f2c1ab8c2" contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">9,590,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></ix:footnote></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fd6a4a4-a295-4880-a150-6dfbf8079180" contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">31,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f993458c-05fe-4e7b-9c0d-a5061c51285c" contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">29,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83626ab2-01f4-4cf4-8b62-894e02c69bf2" contextRef="C_050c9307-b322-43a4-84b0-69234ed20231" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">28,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3253d41d-5d1a-4511-9df1-97ea76caf24c" contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317" name="us-gaap:Depreciation" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">28,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></ix:footnote></div></div></ix:nonNumeric></div></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ec16e52-ea49-4ddc-bbb5-c98d0188e7be" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Option</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As permitted under ASC 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has elected the fair value option to account for its convertible promissory notes due to certain embedded features within the notes. The Company recognizes the convertible promissory notes at fair value with changes in fair value recognized in the consolidated statements of operations located on the change in fair value of financial instruments line item. Changes in fair value as a result of the Company&#8217;s own credit risk is reflected in other income in the consolidated statements of operations. As a result of applying the fair value option, direct costs and fees related to the convertible promissory notes were expensed as incurred and not deferred.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_014b0caf-8f27-41e5-b14a-573030524f8b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space with an original lease term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_752675e8-6438-4930-b549-fad199a5f1b4" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">twelve months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and does </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a743cec-b32d-4ae0-9791-a0938653f9a1" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:RightOfUseAssetOrLeaseLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have a right-of-use asset or lease liability recorded. The Company's policy is not to record leases with an original term of twelve months or less on the consolidated balance sheets. The Company recognizes lease expense for this short-term lease on a straight-line basis over the term of the lease. The lease is accounted for under ASC 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has been classified as an operating lease. Rent expense recognized for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13e0604b-af60-4f2e-a083-f21cb33caa75" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:RentExpenses" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">121,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23167040-4ff6-48ea-9555-1ca557f8b1bf" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:RentExpenses" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">274,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f9ad4022-2a33-4c59-a4d1-0ada427b60a9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:AccruedResearchAndDevelopmentCostsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs consist primarily of salaries, payroll taxes, employee benefits and stock-based compensation for those individuals involved in ongoing research and development efforts, as well as fees paid to consultants, external research fees, license fees paid to third parties for use of their intellectual property, laboratory supplies and development of compound materials, associated overhead expenses and facilities and depreciation costs. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. All research and development costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates preclinical studies and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers,  and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. The estimates are trued up to reflect the best information available at the time of the financial statement issuance. Although the Company does not expect its estimates to be materially different from amounts actually incurred, the Company&#8217;s estimate of the status and timing of services performed relative to the actual status and timing of services performed may vary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_2" continuedAt="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d449fdf7-9f1f-4d87-b0f9-dea642dac8f4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to executive, finance, business development, legal, human resources and support functions, including professional fees for auditing, tax, consulting and patent-related services, rent and utilities and insurance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fc37adaa-3123-4a79-8951-13fb3cf6f60b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:PatentsCostsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs related to filing and pursuing patent applications are expensed as incurred since recoverability of such expenditures is uncertain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_788661e8-d344-4ff1-aaf3-f2f5f2d53fdb" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:DeferredPolicyAcquisitionCostsTextBlock1" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Offering Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes costs that are directly associated with equity financings until such financings are consummated, at which time such costs are recorded against the gross proceeds of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations and comprehensive loss. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had deferred costs associated with its ATM Facility (as defined in Note 7)  and expensed these costs in the Company&#8217;s consolidated statement of operations.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_78e4c56c-02d0-4e1c-8a0f-a46e831090d4" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WarrantLiabilityPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Private CalciMedica has issued various freestanding warrants to purchase shares of its convertible preferred stock. Prior to the Merger, Private CalciMedica adjusted the carrying value of such convertible preferred stock warrants to the estimated fair value at each reporting date, with any related increases or decreases in the fair value being recorded within other income (expense) in the consolidated statements of operations and comprehensive loss. Pursuant to the Merger Agreement, the Series C convertible preferred stock warrants became warrants to purchase shares of the combined company's common stock. As a result of the Merger, the warrants no longer meet the requirements for liability accounting and, as such, Private CalciMedica adjusted the value of the warrants to the estimated fair value as of the Merger date and reclassified them to stockholders' equity (deficit).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the 2024 Private Placement, certain warrants to purchase common stock were deemed freestanding warrants and are reflected in the Company&#8217;s balance sheet as a liability as of and for the period ending December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cf67fea0-c92a-47f1-b8a8-bddf44f5f0ea" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense represents the cost of the grant date fair value of employee stock options recognized over the requisite service period of the awards (usually the vesting period) on a straight-line basis. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model (&#8220;Black-Scholes&#8221;). Forfeitures are recognized as a reduction of stock-based compensation expense as they occur. Equity-based compensation expense is classified in the statements of operations in the same manner in which the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified. The fair value of each stock option grant is estimated on the date of grant using Black Scholes. The following summarizes the inputs used:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the closing stock price the day prior to the grant date for the fair value.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Free Interest Rate</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free interest ra</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">te is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities similar to the expected term of the awards.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses an average volatility for comparable publicly-traded biopharmaceutical companies over a period equal to the expected term of the stock award grant as CalciMedica does not yet have sufficient historical trading history for its own stock. CalciMedica will continue to apply this method until a sufficient amount of historical information over a period equal to the expected term of the stock-based awards becomes available.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company used the simplified method to calc</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ulate the expected term for all grants during all periods, which is based on the midpoint between the vesting date and the end of the contractual term.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend Yield</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has never paid and has no present intention to pay cash dividends.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_6e50f19c-535d-460e-88ce-bdb05449d34e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_6e50f19c-535d-460e-88ce-bdb05449d34e_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_3" continuedAt="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6e50f19c-535d-460e-88ce-bdb05449d34e_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c35665eb-09e0-4f2f-933b-781503b1c420" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:TaxPostionMinimumPercentageOfTaxBenefit" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ba31fcd2-4ddc-41ed-b7d5-e4e741b43ce7" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources which are excluded from net loss. The Company&#8217;s only element of other comprehensive loss is unrealized gains and losses on marketable securities and short-term investments.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f6ec1ffc-8af8-471c-83f2-fd745f8e0e58" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:RelatedPartyTransactionsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s board of directors reviews and approves transactions with directors, officers and holders of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36ba18a4-78f3-485b-8253-a12f296d6103" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:VariableInterestEntityOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of its voting securities and their affiliates, each a related party. The material facts as to the related party&#8217;s relationship or interest in the transaction are disclosed to its board of directors prior to their consideration of such transaction, and the transaction is not considered approved by its board of directors unless a majority of the directors who are not interested in the transaction approve the transaction.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beginning in November 2020, Private CalciMedica has paid consulting fees monthly to a consulting firm affiliated with the Company&#8217;s interim chief financial officer in connection with its consulting agreement. CalciMedica recorded expense </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fbea5b7-a156-4353-a927-94ecf611cb6c" contextRef="C_f20344e5-6e5f-49aa-9b9f-b8ff66728e89" name="us-gaap:CostsAndExpensesRelatedParty" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">289,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_739a3934-1696-41c2-81eb-c4ea559d3192" contextRef="C_9148156f-8f5b-4f26-a742-6ef0c92f952d" name="us-gaap:CostsAndExpensesRelatedParty" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">521,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during years ended December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company granted a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37c9ca0b-fbed-47af-8ab3-fe0ec759fa60" contextRef="C_5628ed6b-5082-4559-afdb-16e2688469bc" name="ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to a consulting firm affiliated with the Company&#8217;s interim chief financial officer. The Company recorded expense of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1521e2cb-319d-441d-a42f-b7dbd3335a34" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:CompanyRecordedExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">13,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> general and administrative expense for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d3819c96-66ff-466c-afd4-b99169955dcc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net loss is equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. The Company calculates diluted net loss per share using the more dilutive of the (1) treasury stock method, if-converted method, or contingently issuable share method, as applicable, or (2) the two-class method. For warrants, the calculation of diluted net loss per share requires that, to the extent the average fair value of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to net loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the warrants for the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In all periods presented, the Company&#8217;s outstanding preferred stock, stock options, preferred, common and convertible promissory note warrants, and outstanding convertible promissory notes were excluded from the calculation of loss per share because the effect would be antidilutive. Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per share.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_96f818c8-df31-4cde-bd0d-c2d5b5730ec2" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_96f818c8-df31-4cde-bd0d-c2d5b5730ec2_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU provides guidance that simplified the accounting for certain financial instruments with characteristics of liabilities and equity. The new guidance reduced the number of accounting models for convertible debt and convertible preferred stock instruments and made certain disclosure amendments intended to improve the information provided to users. The guidance also amended the derivative guidance for the &#8220;own stock&#8221; scope exception, which exempts qualifying instruments from being accounted for as derivatives if certain criteria are met. Finally, the standard changed the way certain convertible instruments are treated when calculating earnings per share. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this ASU as of January 1, 2024, which did not have a material impact on its consolidated financial statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_96f818c8-df31-4cde-bd0d-c2d5b5730ec2_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">entity&#8217;s financial statements. The Company adopted the new accounting standard retrospectively for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements related disclosures, however, we have added additional footnote disclosure as part of the adoption.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued final guidance in ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (ASC 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> requiring entities to provide additional information in the rate reconciliation and disclosures about income taxes paid. For public business entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company has adopted this ASU No. 2023-09 effective December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which requires public entities to disclose in the notes to financial statements, of additional specified information about certain costs and expenses. For public business entities, the guidance is effective for annual periods beginning after December 15, 2026 and interim periods after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact that this guidance will have on the consolidated financial statements.</span></p></ix:continuation></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d1ce435-6f45-42ae-a645-ed9b8ef639ef" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:BusinessCombinationDisclosureTextBlock" escape="true" continuedAt="F_7d1ce435-6f45-42ae-a645-ed9b8ef639ef_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Merger and Related Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 1 - Nature of Business, Private CalciMedica merged with a wholly-owned subsidiary of Graybug on March 20, 2023. The Merger was accounted for as a reverse recapitalization under U.S. GAAP. Private CalciMedica was considered the accounting acquirer for financial reporting purposes. This determination is based on the facts that, immediately following the Merger: (i) former Private CalciMedica stockholders owned a substantial majority of the voting rights of the combined company; Private CalciMedica designated a majority (five of seven) of the initial members of the board of directors of the combined company; and former Private CalciMedica's senior management held all key positions in senior management of the combined company. The transaction is accounted for as a reverse recapitalization of Graybug by Private CalciMedica similar to the issuance of equity for the net assets of Graybug, which are primarily cash and cash equivalents, short-term investments and other non-operating assets. It was concluded that any in-process research and development assets that remained as of the Merger would be de minimis when compared to the cash, cash equivalents and short-term investments obtained through the Merger.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under reverse recapitalization accounting, the assets and liabilities of Graybug were recorded at their fair value, which approximated book value due to the short-term nature of the instruments. The Company's consolidated financial statements reflect the issuance of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6bbcb61-f58d-4d07-8ba3-138f8db295d4" contextRef="C_23e9b7c7-df34-4cf7-85aa-9468c513006d" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,571,433</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares to the former stockholders of Graybug.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding share of Private CalciMedica capital stock (after giving effect to the automatic conversion of all shares of Private CalciMedica preferred stock into shares of Private CalciMedica common stock, the automatic exercise of certain Private CalciMedica warrants to purchase shares of Private CalciMedica common stock in accordance with their terms (the &#8220;Private CalciMedica warrant exercises&#8221;), the conversion of Private CalciMedica convertible promissory notes into Private CalciMedica common stock and the closing of the 2023 Private Placement (as defined and discussed in Note 7 - Convertible Preferred Stock, Common Stock, and Stockholders' Equity (Deficit)), was converted into the right to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bb32946-9a59-4f61-918e-5bdc3d187f76" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:StockIssuedDuringPeriodPrivatePlacement" unitRef="U_shares" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0288</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock, which resulted in the issuance by Graybug of an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd000c85-d6a4-4a1c-85ac-20835be69799" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,946,540</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock to the stockholders of Private CalciMedica in a transaction exempt from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on Section 4(a)(2) of the Securities Act and the rules promulgated thereunder. In addition, Graybug assumed the Private CalciMedica 2006 Stock Plan (See Note 8 - Stock-Based Compensation), and each outstanding and unexercised option to purchase Private CalciMedica common stock and each outstanding and unexercised warrant to purchase Private CalciMedica common stock (excluding the warrants which were automatically exercised pursuant to the Private CalciMedica warrant exercises) became options and warrants, respectively, to purchase shares of Graybug common stock. Immediately following the consummation of the Merger prior Private CalciMedica and Graybug stockholders collectively own approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7c94cfc-b1e1-4738-aeb8-30a79311908b" contextRef="C_9114dadf-db78-4d1a-9686-04c4b1e69723" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">72</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f236f96-2d39-4a3e-92a9-fbc4b688bff2" contextRef="C_29a301bb-4522-43d7-947b-4686e790d21a" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company, respectively, on a fully diluted basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the reverse recapitalization, Private CalciMedica received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da498a4e-d2d5-42c0-8591-35c817ca561b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">29.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of cash, cash equivalents and short-term investments, net of transaction costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Private CalciMedica also obtained prepaid and other current assets of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c13d0b7d-584d-4506-a54e-ad5d7daf2b35" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and assumed payables and accrued expenses of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e52c6a1-723d-4381-9475-4402be59a606" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Private CalciMedica also incurred transaction costs of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eeec1eff-3a64-41b2-a3b7-2ce72391857a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:BusinessCombinationConsiderationTransferedCostIncurred" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is recorded as a reduction to additional paid-in capital in the accompanying consolidated statement of convertible preferred stock and stockholders' equity (deficit). The Company also recorded one-time charges of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5227faf-c4ef-4cc6-8803-f2653a417248" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the acceleration of the Graybug stock awards and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7738726a-bacf-45a5-93e6-a93ff29e97c1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in severance charges that are recorded in the consolidated statements of operations and comprehensive loss for the for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_7d1ce435-6f45-42ae-a645-ed9b8ef639ef_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 17, 2023, in connection with the transactions contemplated by the Merger Agreement and following a special meeting of Graybug&#8217;s stockholders, Graybug filed an Amended and Restated Certificate of Incorporation effecting a reverse stock split of Graybug&#8217;s common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f7aa96e-665c-462b-a5ec-bf41115e2c9e" contextRef="C_db94281f-2ca5-41c5-a7e1-183957513bcf" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, at a ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fb3e159-3cb1-4d2f-8ea7-11f3a50acc33" contextRef="C_ed61293c-a493-4af6-9c31-23d8600a5a0a" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:1.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div><ix:nonNumeric id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:DerivativesAndFairValueTextBlock" escape="true" continuedAt="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's assets and liabilities which are measured at fair value include short-term investments and warrants for common stock. The Warrants for preferred stock (&#8220;Preferred Warrants&#8221;) and warrants for common stock related to the convertible promissory notes (&#8220;Convertible Promissory Note Warrants&#8221;) were all accounted for at fair value prior to the Merger (see Note 7 -</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_1" continuedAt="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock, Common Stock and Stockholders&#8217; Equity). All assets and liabilities recorded at fair value are revalued at each measurement period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Common Warrants (as defined in Note 7 below) were valued using Black-Scholes utilizing the following inputs; (i) a risk-free interest rate; (ii) volatility based on the expected term of the Common Warrant; (iii) and an exercise price and stock price on the date of the transaction. Several different scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the Common Warrants can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following three levels:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4e55e61d-ef2c-406c-8dc4-0bedc5f4991b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true" continuedAt="F_4e55e61d-ef2c-406c-8dc4-0bedc5f4991b_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.333%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.333%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.333%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.333%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.222%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eabe1860-9603-4c96-a5f1-fcaef3a5d06c" contextRef="C_95022a81-928c-45a6-b8a7-62e7dea3a945" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a34f50b8-a931-48b4-91f6-bfb3ae8a57d3" contextRef="C_5dde241e-162e-4824-aff5-4a7186f81373" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a03a5a31-90d7-40ae-80fa-9fbedc95b9fb" contextRef="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">746</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad239a8b-18a8-4c7d-aa2c-9e2732dfacd9" contextRef="C_b204b444-02a9-4a57-97f1-861675088d01" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">746</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed6a502e-57ab-4062-b097-9ea69fabf489" contextRef="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">749</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6274af48-cc90-4410-a232-9a1db3667a75" contextRef="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">749</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c87b141e-0c79-4070-ac30-28d8aae17ba2" contextRef="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f002ef05-3f2b-496d-9188-678d943cb263" contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,495</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88765192-4128-4cf7-8b90-47ad987844f4" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6723b0c9-e014-4446-8429-bc4cdd41eddc" contextRef="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,573</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f06f063-99d0-42a1-a49e-779db3d36657" contextRef="C_b204b444-02a9-4a57-97f1-861675088d01" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,573</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d606eb88-1aa2-4a01-bde4-2c78d3ee4ec7" contextRef="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,227</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2a3a92f-5ce6-4949-87b0-a7a1bf4ae397" contextRef="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,227</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a5e922f-f949-4a1e-b448-3feacf621ac1" contextRef="C_045dcafc-a4b7-4b72-a786-a17062bc9899" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">934</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19c610b8-6530-4748-adcb-581c9300edc8" contextRef="C_e44a92b5-7664-4c8b-9ed0-b69338c26422" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">934</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f490a684-0437-4be3-a2b1-e60b572fe807" contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,734</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3f73468-cf4e-4346-8b94-21eacbb6941b" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,734</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd626d1e-a1d3-4790-9e77-0b83d57d95cf" contextRef="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54259a47-24c9-4e90-9c74-4d2d33984b8b" contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,229</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aab7862a-505f-4e2b-a1f4-79cb07e2bd01" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,346</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.353%;box-sizing:content-box;"/>
        <td style="width:1.112%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.362000000000002%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.334%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.918000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.334%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.918000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.334%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.34%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1364a00c-b1aa-46d6-a772-9536db16d6c3" contextRef="C_bdbc227c-2a4a-4d04-b7f6-a194d9ac93f1" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36f83854-bc1c-4eb0-b619-c3281d2ab4dd" contextRef="C_f113b0a6-620c-4aff-a136-ac77a52a078b" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1ad1548-675a-457a-8021-0b57df331bf4" contextRef="C_09ae4982-7ccd-472c-a057-58036e311ec9" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,738</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3884f7a-85d8-4e4b-9b5c-b97901417095" contextRef="C_8b167b7a-8a24-4ea0-afb0-63b670541fba" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,738</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2070b4f6-3a0b-4261-9fa7-82dec76aac86" contextRef="C_bef37a75-2e84-42ae-986f-82da4e7d2f72" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0da2e116-05db-4b8d-a45d-d187e53b642c" contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,738</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62887960-7f79-4fc2-b366-38dcdf18a259" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,372</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92f35f79-386a-48ac-9dde-d9666fd87c13" contextRef="C_09ae4982-7ccd-472c-a057-58036e311ec9" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9452b77b-055d-45a8-b5a9-adb1e08b97f9" contextRef="C_8b167b7a-8a24-4ea0-afb0-63b670541fba" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad79f8be-1709-496d-9474-efa806983597" contextRef="C_a170fca3-5c49-41df-8bf6-368143137572" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f7e1250-a936-4815-9b30-7829d20b460d" contextRef="C_eee5683f-33b3-4fbc-8cb5-42b8e91c1adb" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7315b82b-c678-4224-bbe6-4ac81967a90f" contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,708</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee6fc64d-dbd8-47c9-a51a-f206e1d4935b" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,708</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c62347e-fe7a-4100-a29b-7097dc5a07e9" contextRef="C_bef37a75-2e84-42ae-986f-82da4e7d2f72" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4b87217-3326-4670-a57c-bb9b7f197042" contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7c05211-2f0a-45cb-a376-4ac04555ea86" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,080</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are highly liquid investments which are actively traded. The pricing information on the Company&#8217;s money market funds is based on quoted prices in active markets for identical securities. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial paper and U.S. Government sponsored entities - mortgage-backed are classified as Level 2 with in the hierarchy and are carried at fair value with unrealized gains and losses included in other comprehensive income (loss) as a component of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_2" continuedAt="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_3"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stockholders&#8217; equity until realized. The Company estimates the fair values of these securities by taking into consideration valuations obtained from third-party pricing sources.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, there were no transfers between Level 1, Level 2 and Level 3.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4e55e61d-ef2c-406c-8dc4-0bedc5f4991b_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.24%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.24%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47fdd395-c613-4578-8043-d8d5fa5a815a" contextRef="C_c4c9215d-494d-4c49-9611-ee223ffc9c1e" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09b0e14d-9124-435d-b072-0e57ba57175c" contextRef="C_a67be958-f1a5-440f-a088-2296882808da" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49564718-4baf-4fb0-bc6d-c73d7048598c" contextRef="C_373a9e72-7343-4090-b130-badbbfa67767" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_525fa771-249a-48de-ade1-dbd441ab95d9" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be150b6d-dcc6-49cc-b714-e2db9ca64299" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> fair value liabilities existed as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c2962d35-1cc6-4942-8080-aa599dfee8da" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"/>
        <td style="width:1.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.88%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Warrant liability</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecb61a1f-4088-4ac8-a56d-c141bd912522" contextRef="C_eb167185-a0eb-45f5-beb2-ad40dbc114b5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Initial Fair Value of Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0cdd5dd-6d4c-4cb7-9547-df6e7853a304" contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,190</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeiture of warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d263b10-3137-4e1b-bf8f-92044f00b0bf" contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc" name="ck0001534133:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in Fair Value of Preferred Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_809e2714-5f6f-4dcb-a46b-473f330f061f" contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9,290</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_658c3308-b49c-49b2-b182-60284155a91d" contextRef="C_b775c5ab-ecf3-4dc4-bd12-7d3ef78e0d1d" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b85e83c-fbaa-4811-a5e3-6850a4aff5d9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" escape="true" continuedAt="F_1b85e83c-fbaa-4811-a5e3-6850a4aff5d9_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company&#8217;s financial assets measured at fair value on a recurring basis (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d93ab6f8-7996-4dd9-88b8-e310059a742d" contextRef="C_83845047-b7fc-4928-ac21-ffa4a320df4c" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25503905-f5ba-4d56-b372-342831979e95" contextRef="C_83845047-b7fc-4928-ac21-ffa4a320df4c" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56b64c22-3f83-4bba-a48c-8f2436ebf60f" contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">746</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_664aa5a7-01f9-4baf-a864-bf00e53d6ede" contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">746</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a46fca70-6529-468d-8f72-d26ef6ca9772" contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">749</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f61bab1c-99f2-43fd-8247-faa138e64646" contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">749</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a886c813-1810-4171-9b00-6b062be2eb33" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7c503bd-065a-4b89-a7fe-ed8c96efd34b" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12d0dd18-015e-44f9-acfb-f773ab1e02ae" contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,571</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91c25b84-e086-4eb5-b5d3-624436782021" contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7fb2b07-2582-4bcb-abb9-1a582f770404" contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,573</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_757226db-4675-4e72-9299-0da9fe1d15c1" contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,225</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff18c037-0980-46b1-a705-b158e8be2481" contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_651c73ba-d186-4d7c-8060-e6230e789019" contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,227</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8bcefa3-a183-445f-874a-35c33c2fdb2d" contextRef="C_95e6491a-8251-490e-bafc-9db3d1602a4a" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">934</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81201ad3-6f70-41d1-bd9d-0f0cee3023c8" contextRef="C_95e6491a-8251-490e-bafc-9db3d1602a4a" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">934</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eac12908-317f-46f6-84e8-9d04d7ee5be7" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,730</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05d990a-557f-4ad4-a7ba-535569798ca8" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47848bc5-e238-43d2-81f5-05012cd3da33" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,734</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_017f856d-7912-4630-adb9-61d3d5bc33d9" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,342</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_314a446d-861d-4b80-959b-3fdb56539dca" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17b59a26-1a1d-4ac6-8a17-f3f02d624c66" contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,346</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_1b85e83c-fbaa-4811-a5e3-6850a4aff5d9_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_3" continuedAt="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_4">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.18%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.236%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_882fe99a-1235-4bf4-bd78-227020f404e5" contextRef="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_111fba95-839e-47bf-b7dc-91e6b1b07615" contextRef="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8823006e-3e52-4af5-8636-6c2699a37ce7" contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,738</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f535a734-5d03-41f1-ac15-e77dd0c370eb" contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,738</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a3eadb5-35b3-47e0-92b1-70a5514165d1" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,372</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7628beab-9965-438e-84c6-d704bcf0449c" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,372</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb34a8ce-56fd-4a30-bc6b-28f0d959ebe4" contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,211</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba26be3e-8921-48bc-b2af-e787ba0156b5" contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41d6940d-ed76-4d93-91c6-675d62be5e6e" contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,213</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64b1faf4-91c7-40e3-a58d-a75c19fcf8c4" contextRef="C_46095950-bb43-4840-adef-994b8db12bbd" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d5dc049-12c6-4b97-b0b6-53c14b86ef10" contextRef="C_46095950-bb43-4840-adef-994b8db12bbd" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">495</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d875628-3c0c-46de-8a6e-6335c973b512" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,706</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c28bac7-fde0-4752-afd8-f5b659d6c544" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2674389a-ad81-4b28-a70a-7f77d37e46f1" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:ShortTermInvestmentFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,708</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75f63048-1a11-4886-a257-df2d7a72b193" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,078</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c664052-9022-4a71-be7b-63b4993c5ec7" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d66a1f2a-eeac-442a-bf61-87430af3bc15" contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,080</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:continuation></div>
  <div><ix:continuation id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7_4"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2023.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_0abdee0c-b9d1-4078-b4c7-a7b88e27c3ee" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_0abdee0c-b9d1-4078-b4c7-a7b88e27c3ee_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Convertible Promissory Notes and Convertible Promissory Note Warrants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2022, the Private CalciMedica board of directors approved a convertible promissory note financing pursuant to which it could issue and sell up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c59b9da-8cb0-4944-985e-0867b5af57f1" contextRef="C_d641d938-a033-4dcf-9434-c6445ce1a637" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of notes convertible into shares of common stock (the &#8220;convertible promissory notes&#8221;) and Convertible Promissory Note Warrants. The funding and issuance of the convertible promissory notes for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa3476eb-b0a5-4092-9293-146e422914bf" contextRef="C_d641d938-a033-4dcf-9434-c6445ce1a637" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and Convertible Promissory Note Warrants to purchase shares of the Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d9943e2-ac1a-45e9-8d73-887f9926060e" contextRef="C_2ac23ecf-2158-4a2f-ade7-ea9d3539490e" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share took place in multiple closings through October 2022.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2022, the Private CalciMedica board of directors amended the convertible promissory notes and Convertible Promissory Note Warrants to issue up to an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b12ccf9-b1b4-4cd1-82b9-f02b80cf67ac" contextRef="C_56f08610-d053-44c8-b481-e6a9fd87daf4" name="ck0001534133:DebtInstrumentPeriodicPaymentPrincipalAdditional" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (for a total of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a98195aa-00bd-4dcc-ab33-6cf20a2bae16" contextRef="C_56f08610-d053-44c8-b481-e6a9fd87daf4" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) and added the automatic conversion for a &#8220;de-SPAC&#8221; business combination or reverse merger transaction. In November 2022, Private CalciMedica issued additional convertible promissory notes for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6705025b-3c10-4108-92c2-5c5598302d30" contextRef="C_f8437473-43cf-4eea-9960-4a41c9ab6907" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and Convertible Promissory Note Warrants to purchase shares of Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da6b2b3c-4bdf-445b-aec8-99f84288c8a1" contextRef="C_7a9252ad-93b8-4655-9d47-d20409702eab" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The convertible promissory notes accrued interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62c14d32-0ca8-4529-ac2b-0c3a517d73ea" contextRef="C_f8437473-43cf-4eea-9960-4a41c9ab6907" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and had a maturity date of December 31, 2023. Immediately prior to the effective time of the Merger, all outstanding convertible promissory notes and unpaid and accrued interest automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1956a015-4775-423c-bfea-7a3c4fee90ee" contextRef="C_94f7d9a0-cccf-4f75-aaa7-442f61778e94" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">20,487,104</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica&#8217;s common stock at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a conversion price based on the equivalent valuation of the cash price paid per share by the private placement investors purchasing shares of common stock in the private placement multiplied by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73dc71cf-2b74-4a2b-afd6-a1aba5ee1a7f" contextRef="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719" name="ck0001534133:PublicCombinationMultipliedCashPricePaidPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Such shares of common stock were then converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c55b23ae-a1c6-4607-82a4-c5737c2ae0e6" contextRef="C_6f09c985-ab40-4e3f-a4e4-e71945759749" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">590,031</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock at the effective time of the Merger in accordance with the Merger Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with each purchase of a convertible promissory note, Private CalciMedica issued to each holder of such convertible promissory note Convertible Promissory Note Warrant to purchase shares of the Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30f4289f-206f-4d91-86e9-339e051ddcf2" contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Each holder of the Convertible Promissory Note Warrants had the right to purchase up to a number of shares of Private CalciMedica&#8217;s common stock equal to (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e81832eb-8c67-4abf-9b24-fc595247b5d8" contextRef="C_e4bb7cdd-0b6c-4d2b-8e43-6a6963cfc0c5" name="ck0001534133:PercentageOfWarrantCoverage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (&#8220;Warrant Coverage&#8221;) of the principal amount of the convertible promissory note purchased by such holder concurrently therewith, divided by (ii) the cash price paid per share by the investors in the qualified financing or an initial public offering, as applicable, or in the case of a &#8220;de-SPAC&#8221; business combination or a reverse merger transaction between Private CalciMedica and a publicly traded company (a &#8220;Public Combination&#8221;), the equivalent valuation of the lower of the cash price per share by the investors purchasing shares in the publicly traded company in connection with such Public Combination or the cash price per shares by the investors purchasing shares of Private CalciMedica&#8217;s common stock in connection with such Public Combination, in each case, rounding down to the nearest whole share and subject to the terms of the convertible promissory notes; provided, however, that any holder that purchased convertible promissory notes in excess of the holder&#8217;s pro rata commitment (as defined in the convertible promissory notes) received a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d66bff6-f940-4807-80a6-5d08650e7b39" contextRef="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719" name="ck0001534133:PercentageOfWarrantCoverage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% Warrant Coverage on the principal amount of the convertible promissory notes that is in excess of its pro rata commitment. The Convertible Promissory Note Warrants had a five-year term. In connection with the Merger, the Convertible Promissory Note Warrants were automatically net exercised in accordance with the terms of the Convertible Promissory Note Warrants. Immediately prior to the effective time of the Merger, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_933f8e00-d450-4a90-9596-6d6fe6dd8c81" contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1" name="ck0001534133:ConvertiblePromissoryNoteWarrantsConvertible" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,308,047</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Convertible Promissory Note Warrants were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daa04998-93cc-45c7-b1bd-f7ce16292144" contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1" name="ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,308,047</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica's common stock, which were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_582f5249-bf37-4e95-893f-629c1a3dfc79" contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1" name="ck0001534133:ExchangeOfStockForStock" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">152,875</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug's common stock, based on the principal amount of the convertible promissory note.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, the Convertible Promissory Note Warrants were not deemed equity and were classified as a liability on the balance sheets. The Convertible Promissory Note Warrants were valued using a series of Monte Carlo simulations and Black-Scholes to determine the fair value, probability weighted for difference scenarios. The Monte Carlo simulations determined the liquidity event price. The Black-Scholes warrant value is discounted from the respective event date using the risk-free rate. The Black-Scholes valuation included standard assumptions such as exercise price, expected term, risk-free rate, volatility, and a dividend yield of zero. The Company estimated initial fair value of the Convertible Promissory Note Warrants utilizing the following range of assumptions for the difference scenarios: exercise price ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee2d5052-f1f3-4c5b-93b5-ac8c4b34f247" contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), risk-free rate (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_291a769a-d2ed-48ff-abda-ef226ad1d5b1" contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.02</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89219e8d-dd3d-43e3-b64b-ddc48777bd11" contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%), volatility (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aff5da8d-9551-48ff-b464-915bb99de271" contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">63</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_603beb6c-5288-442c-a4d5-fd385165e648" contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">67</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%),</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_0abdee0c-b9d1-4078-b4c7-a7b88e27c3ee_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expected term (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ec6dc37-fda2-4176-ba37-db7f389b3c78" contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> - </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd6a379f-32ae-476f-9a2e-2be505dba468" contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.6</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years). As of the date of the Merger, the Convertible Promissory Note Warrants which were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdbb5b02-8a1a-4ad6-9526-75b986c4e0c8" contextRef="C_78496b12-3f28-430e-9d56-1d9d320d8e3f" name="ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">152,871</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock were revalued, using the price of the common stock of Graybug of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6a03029-e574-4b9f-87ae-3583c50f8c42" contextRef="C_78496b12-3f28-430e-9d56-1d9d320d8e3f" name="ck0001534133:ExpectedPerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_de667007-db1d-4cbe-94f8-897a956cfb49" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Accrued Expenses</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_30c92a75-07bf-491d-bdf2-262eb3c077e1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6f77d1d-e123-460f-af0e-725de5993dae" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:AccruedPayrollAndOtherEmployeeBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">531</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b73bd0c3-2b22-4017-a71c-e4a440e20bbc" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:AccruedPayrollAndOtherEmployeeBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">935</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90d6c2a9-9aec-4be3-8ca8-63bb8eff2c7d" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:AccruedSeveranceExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e8a75ad-895e-4448-ba15-7c840f043019" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:AccruedSeveranceExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64a5808f-dbd0-4817-ae53-25a30d2d40c4" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78e942dc-ed76-404b-8b0a-ed2003a792d8" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d27e1e0-283a-4edb-84e4-346f3bd31a5e" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:AccruedOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00a57576-506b-465d-98f8-b511b5855965" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:AccruedOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">99</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fef60471-4b21-4570-a096-9a181be4bace" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">866</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8c04a80-d792-4c89-9c74-f2d3de0d7401" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:TemporaryEquityDisclosureTextblock" escape="true" continuedAt="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Convertible Preferred Stock, Common Stock and Stockholders' Deficit</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Authorized Shares</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's current Amended and Restated Certificate of Incorporation authorizes </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e11e398-3c7a-48e5-bc78-7dc4f3c22570" contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">500,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c469fa18-3c37-4e29-8cb1-d92e287c294b" contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6ec8001-e40e-4598-9a26-823b71cfe62a" contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecef860b-e344-4003-a415-2eb65417b9b0" contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the effective time of the Merger, the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7743bd1d-125f-488a-8125-99cd002aed29" contextRef="C_26ea50cb-0ee9-4b54-a249-f320c2ea018f" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">84,820,880</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica preferred stock were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3055e21a-1515-4417-9c72-bbf73f9617fb" contextRef="C_f49ac070-365e-4892-838a-facd93bf557c" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">84,820,880</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding shares of Private CalciMedica's common stock to be exchanged for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b4e75f5-7d6d-49da-9467-c3223dbb54e0" contextRef="C_ddbe6d36-a378-4c84-83c6-f0933ab42deb" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,442,852</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug's common stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon completion of the Merger on March 20, 2023, as the accounting acquirer, Private CalciMedica is deemed to have issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4320de13-ad84-49e9-a29c-2b0c61be6916" contextRef="C_559c60a1-fc91-4c05-9f90-246f875e3dbf" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,571,433</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock to Graybug shareholders.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Placement of Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the consummation of the Merger, Private CalciMedica completed a private placement financing pursuant to which certain investors purchased approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c1104df-9eaf-4512-9516-34cdff140468" contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Private CalciMedica&#8217;s common stock (the &#8220;2023 Private Placement&#8221;) for gross proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5344b915-0c22-475e-8c8f-afabe2ac90c7" contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In conjunction with the Merger, immediately prior to the effective time of the Merger, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_152b47aa-50b8-46de-ad47-8bfa43e59e22" contextRef="C_ad05ad10-c218-4a2f-a090-5ef614c472a0" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">20,706,997</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica common stock were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_648874b8-3ebf-4372-bcbf-e4e31d3b3259" contextRef="C_987f342a-1b48-420e-b0a0-87f4ebbe2eda" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">596,363</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug&#8217;s common stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 19, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited investors, in which the Company sold the following securities to the accredited investors in a private placement transaction (the &#8220;2024 Private Placement&#8221;): (i) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_849222d5-e13e-421e-adc9-f16d244509da" contextRef="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,985,610</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock; (ii) to certain investors, in lieu of shares of common stock, pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad151e54-656a-4bb0-9fa5-ee2814d00821" contextRef="C_a737ee8b-67fc-459e-b42a-32cd72a6e241" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">306,506</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and exercisable at any time; (iii) Tranche A Common Warrants (the &#8220;Tranche A Common Warrants&#8221;) to purchase an aggregate of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3013994a-f0d3-432c-92c3-ce3d23fa123b" contextRef="C_bd4f7398-6d5e-489b-97c8-45a8789eb5d7" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,646,058</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants); and (iv) Tranche B Common Warrants (the &#8220;Tranche B Common Warrants&#8221; and together with the Tranche A Common Warrants, the &#8220;Common Warrants&#8221;) to purchase an aggregate of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75cb8692-f821-4f66-a7aa-db4d9b426198" contextRef="C_68dde00d-5365-4647-8868-3a6b2d18e226" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,646,058</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants). At date of issuance, the fair value of the common stock was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95892c2a-3894-4b74-af7e-f1be50cc8dd5" contextRef="C_be96bce5-b6c0-422a-8b27-379ef3caef19" name="us-gaap:EquityFairValueDisclosure" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in equity at December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company issued placement agent warrants (&#8220;Placement Agent Warrants&#8221;) to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e61a7d63-9958-446f-ae96-fe95e3c34743" contextRef="C_ce86957a-ac6f-4086-9a65-13bded447356" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">67,908</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the initial closing of the 2024 Private Placement and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6bcce9d-cea4-4783-86f6-1a9fd525aa50" contextRef="C_7bf4d914-a107-476f-b07c-94d28143819c" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,839</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the second closing of the 2024 Private Placement, at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b749bde1-bdb2-454a-841f-45e44dd0a212" contextRef="C_ce86957a-ac6f-4086-9a65-13bded447356" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42be6590-f7b6-4116-846a-13857315e5c2" contextRef="C_3f53ad55-92a4-4198-b148-88d91cc0fe54" name="us-gaap:ConversionOfStockDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e7631d0-ce13-4617-a5c3-0f0c5edacf50" contextRef="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">75,746</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Common Warrants.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The initial closing of the 2024 Private Placement occurred on January 23, 2024 and the second closing occurred on February 5, 2024. Gross proceeds from the transaction were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d369c00d-0924-4fca-acf8-43292839f996" contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864" name="ck0001534133:GrossProceedsFromThePrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52c58e37-f14e-405b-b0b6-ff45353baec9" contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864" name="ck0001534133:NetProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58de3e38-4b24-4217-a1c5-dadd1b040322" contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in commissions and other transaction costs. The Tranche A Common Warrants expired unexercised on July 29, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Underwritten Public Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, the Company closed an underwritten public offering of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9b03cf0-798f-4efd-b859-13b830fc5efa" contextRef="C_aad10afc-0c1f-499f-9814-0ecba7487b5e" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,720,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bf73894-fb87-4986-a151-250072b5743e" contextRef="C_ebe2620f-35df-4233-a846-f1495ccf0b18" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;2024 Follow-On&#8221;). The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd9d7610-8625-437e-98fb-51c5c6b77e2b" contextRef="C_adccbd9d-5ceb-49f3-a3cc-4d2f76546d2e" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In addition, the Company granted the underwriters a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cadc5c2c-bc05-4d7d-8e00-b5e9c5d7841a" contextRef="C_7c5c9cab-f1bd-4526-94d8-3164adc3b2f5" name="ck0001534133:UnderwritersOptionPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30-day</span></ix:nonNumeric></span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342_1" continuedAt="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> option </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to purchase up to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5767bc9b-4ed5-489f-bda0-7c8374ddd08a" contextRef="C_aad10afc-0c1f-499f-9814-0ecba7487b5e" name="ck0001534133:MaximumNumberOfAdditionalSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">408,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at the public offering price, less underwriting discounts and commissions, which option expired unexercised.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Shelf Registration Statement and At the Market Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2023, the Company filed a shelf registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;). The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities and warrants having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43e0bc73-5b51-4ba1-a39c-767c36f8a95a" contextRef="C_f9e065dc-a9c1-4a5e-8636-0c7b7506b76b" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in one or more offerings and in any combination of the foregoing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Shelf Registration Statement contains two prospectuses, a base prospectus and an at-the-market offering prospectus, as supplemented on March 29, 2024  (as supplemented, the &#8220;Original Prospectus Supplement&#8221;), that covered the offering, issuance and sale of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_010344b9-3483-45fa-a272-8d14b2780a4d" contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of common stock pursuant to an at-the-market offering agreement (&#8220;ATM Agreement&#8221;) with H.C Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;), acting as sales agent (&#8220;ATM Facility&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, the Company closed the 2024 Follow-On and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8a24042-9f5e-488b-94b1-a4690645c6d0" contextRef="C_1001d2cb-3125-43a0-ab65-f1fef2c3edd3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,720,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ef81f16-3c3b-4c61-9506-6ec2513e90db" contextRef="C_3a88b2b4-b053-4f3c-a6d0-2084b134a77e" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share pursuant to the Shelf Registration Statement. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c21b58c-2882-4dd2-aec6-f77cd5a2b4e4" contextRef="C_0d5c75d7-eaac-4f4b-9ade-6f0a083bd65e" name="ck0001534133:ProceedsFromFollowOnOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Follow-on, on October 30, 2024, the Company suspended sales of common stock under the ATM Facility pursuant to the Original Prospectus Supplement, and until December 20, 2024, did not offer for sale any shares of common stock. The Company filed a prospectus supplement (the &#8220;Current Prospectus Supplement&#8221;) with the SEC on December 20, 2024 for an aggregate gross sales price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f34e3982-ffeb-4b5d-ae4d-0e63ac815817" contextRef="C_eec723ad-c5c5-4de8-86cf-24ffe53a2b58" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,450,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of shares of common stock to be sold pursuant to the ATM Facility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to use the net proceeds from the ATM Facility for general corporate purposes, which may include research and development expenses, clinical trial expenses, capital expenditures and working capital. The ATM Facility will terminate upon the earlier of (i) the sale of all of the shares of our common stock provided for in the at the market offering prospectus or (ii) termination of the ATM Agreement as permitted therein. The ATM Agreement may be terminated at any time by either party upon written notice. During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6ecf3e8-e32f-4866-ab2b-7613f19703b6" contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">8,950</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares sold under the ATM Facility. As of December 31, 2024, the Company has sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cba1aff-8105-4f7f-9b54-639e5f8e4211" contextRef="C_8369d456-272d-4458-8976-3a21b4c87005" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">101,522</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e27e5303-65fe-4c69-a03b-b9279fafa245" contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">319,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_627a021b-663e-4cd8-8538-e44fc22ff2c4" contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">13,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of commissions and settlement expenses paid under the ATM Facility and approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e044be8a-fec2-4346-9f16-529f59dc186e" contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9" name="ck0001534133:SaleOfStockRemainingSalesAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available for sale under the ATM Facility. As of December 31, 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5a65259-135d-414e-a754-9d3afaeb1203" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:ShelfRegistrationStatementAvaliableForSale" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">89.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million remains available for sale under the Shelf Registration Statement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred and Common Stock Warrants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognized a change in fair value of the Preferred Stock Warrants for each of the years ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41f785c8-ea40-4ad5-bac9-c7ef332ee507" contextRef="C_b01b6d69-47c9-4adc-964a-cc6cc14542a7" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f12b6dc-9514-4a4e-be1f-a8d5e3efcd6a" contextRef="C_0ad991e6-bbac-44ce-ac44-e428594773e9" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">795,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The change in fair value for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 was due to the conversion of Preferred Warrants to common stock warrants as part of the Merger.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In November 2020, Private CalciMedica granted a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22b9d821-82b8-4433-b9b1-dff15c625258" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">400,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to a consulting firm affiliated with its former interim chief financial officer in connection with its consulting agreement. The warrant has a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_46cd6e72-f3de-4e0d-88a8-91efdd0d9bff" contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-year term, an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0f3fd2a-20d6-48e7-99b8-33cfd64291b3" contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.19</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and vests ratably over </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_debc6564-1a1b-4d92-90c0-5bd3c8169d09" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months commencing on the effective date. At the date of issuance, the fair value of the warrant was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d9a79ca-a5e8-4c9e-a7a8-a39c9e56e44a" contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">120,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c20ffe98-51cb-4621-912c-a3c15ddade63" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk-free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42f03ea1-24a1-4a0c-b97c-546335126684" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_725b87ea-6ef0-480d-9ece-51c15be5156b" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">80.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ade3dc-da39-482a-97b7-43c2e3f326c3" contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which has been recognized as general and administrative expense over the vesting period. In conjunction with the Merger, the warrant converted to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8984707-9e51-4c32-af3a-5dc922c9a9df" contextRef="C_14ff6f4d-845b-4bfc-a43d-d0314b89a420" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">11,520</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants of CalciMedica at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e875bb85-bf44-4f02-8c20-2ee4fc16aa61" contextRef="C_207c4b97-0faa-4d0f-809e-69e530a8d044" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In October 2022, Private CalciMedica granted warrants to certain officers and directors to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_927fb763-6a55-423c-bede-819dceff79d3" contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231" name="ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">496,970</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. In conjunction with the Merger, the warrants converted to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6014a76f-99d5-4189-b584-15c54bb2c901" contextRef="C_c0b760ce-71ec-459a-969d-1893bdf340e8" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,313</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants of CalciMedica at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b1b7e41-8c72-470a-aac1-b0db98b5909a" contextRef="C_c0b760ce-71ec-459a-969d-1893bdf340e8" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">10.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants have a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a47c45d-78fd-4cb7-83e4-fd7f2cc56a0d" contextRef="C_b2211e17-6778-4571-a5e3-51c977da82ba" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-year term and vest ratably over </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_924f7d26-b15a-43b3-a0ca-cda4472051ce" contextRef="C_1f43280b-4e22-429e-aa7d-ecce70368956" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cc6b49b4-695c-4060-8f51-3164d28174e8" contextRef="C_4d206da2-83dd-40ec-8dd2-a7ed991121fe" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months. At the date of issuance, the fair value of the warrants collectively was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_518bd398-66da-4ba9-90e9-d89702c295d6" contextRef="C_b2211e17-6778-4571-a5e3-51c977da82ba" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">125,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85ec6fb8-273a-487c-893c-a84966fa8ea0" contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17aca340-fbfa-49ca-a4a1-de4e577c2460" contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6345b16c-bfd0-4799-b5a2-2a107d6d7cc0" contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">82</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfd09a7e-3120-45ae-9a21-a2169975c557" contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants are classified as equity, and the Company expensed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c819d915-4c2d-48d1-a0d6-92fb41758adb" contextRef="C_376beb3d-3fc1-445d-b41b-a5cae382b0e7" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">6,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb3965ef-c5ff-46cb-9abe-f96933eb15c1" contextRef="C_7161dd77-2036-4b7b-a3c9-8408ec371ec2" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">90,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to general and administrative expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company issued Tranche A Common Warrants, Tranche B Common Warrants and Pre-Funded Warrants. Tranche A Common Warrants were exercisable until July 29, 2024. The Tranche B Common Warrants are exercisable upon the earlier of December 31, 2026 or 30 days following the Company&#8217;s public disclosure of topline results from the Company&#8217;s planned Phase 2 clinical trial in patients with acute kidney injury. The purchase price per share and accompanying Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ab56bdf-8407-4337-b9de-cd8219470923" contextRef="C_42f60701-1d3e-46b2-9f02-e6238294dfdc" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">3.827</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d86de1e-1a5b-4eb3-8794-e9677a3cd182" contextRef="C_e7f86347-68d3-405b-8913-ba0bee5ee23b" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">4.3915</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for directors, employees or consultants of the Company participating in the 2024 Private Placement) (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6520b75-31f2-4aa4-bf16-d49e2d09efc2" contextRef="C_223da16c-eed7-4903-afb0-2d505376e14c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">3.8269</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant and accompanying Common Warrants, which represented the price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ea67b52-769d-49f6-8b1c-7b08947cd1ba" contextRef="C_60695399-bb34-4681-86ba-e8a3bfb9d100" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">3.827</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and accompanying Common Warrants minus the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f640422-b6a2-4015-aa7b-4875a77f8cb6" contextRef="C_0c6e1adc-65fd-4bc0-9b3f-a6a4ebc29353" name="us-gaap:WarrantExercisePriceDecrease" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share exercise price of each such Pre-Funded Warrant).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Tranche A Common Warrants had a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08e90628-032b-4517-ab44-1878d4e56875" contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.36</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, were not deemed equity and were classified as a liability in the Company&#8217;s condensed consolidated balance sheets. At the date of issuance, the fair value of the Tranche A Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73c42f0d-2c8e-42b0-a210-b5baed527727" contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fdde7a50-65ea-4c58-ae34-1305c44073df" contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">0.94</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6e4e0de-7747-4cdd-8b1b-01c39b2d928f" contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf539352-93b4-4c29-af4a-074b398b3ff2" contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_364aafd4-a576-4017-81d3-3d793567e98b" contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of the balance sheet date of December 31, 2024, the value of the Tranche A Common Warrants was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b78ddb1c-2bdc-4206-bc33-d630e58053a9" contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">nil</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with the change in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_866a342d-c278-4508-8fb6-609884585e7a" contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">being recorded in consolidated statements of operations in other income as the Tranche A Common Warrants expired unexercised on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd607b49-932f-4a59-99ae-d18206a80582" contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 27, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Tranche B Common Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07667ef6-b167-44a2-8331-1268f7466342" contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are not deemed equity and are classified as a liability in the Company&#8217;s consolidated balance sheets. At the date of issuance, the fair value of the Tranche B Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_592b5fb2-ad0d-4e3a-b719-0e9315d6666e" contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6b907705-99ba-42ad-99e9-9c6f242c0951" contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.69</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1e8e636-a3d5-4c32-a55d-f6867546a08c" contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa42956a-a5bc-4daa-a8c9-1cfe0966d46e" contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_740b6007-8b01-4269-8655-2a5e17195b64" contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of the balance sheet date of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the value of the Tranche B Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20cc6637-0213-4cc3-8c1e-80e8ba24085a" contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, with the change in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4517fba-10a5-4772-9243-3542128318ce" contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cc8d2c0-90ff-4439-88a9-3e8a65cc1320" contextRef="C_0a03a7ba-0a9b-4bcb-b58e-debbbef7f6e6" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively, being recorded in the condensed consolidated statements of operations in other income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_538e0090-b6f5-4354-a93b-e4b99d7a538a" contextRef="C_9aebc674-6f2c-4fb4-9168-add0619306fd" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are deemed equity and included in the equity section of the Company&#8217;s consolidated balance sheets. At date of issuance, the fair value of the Pre-Funded Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f232c6b-16ff-4e08-a1b7-6cc4903b8bfc" contextRef="C_9aebc674-6f2c-4fb4-9168-add0619306fd" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in stockholders&#8217; equity at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Placement Agent Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d5186ad-c07b-4aa8-bc80-7258220b0886" contextRef="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are deemed equity and included in the equity section of the Company&#8217;s consolidated balance sheets. At date of issuance, the fair value of the Placement Agent Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d85f11e5-c928-4170-a256-94a6b351e8b1" contextRef="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in equity at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company granted a warrant to a consulting firm affiliated with its chief financial officer to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ca67bcc-ab6a-4a3f-8ee6-6ceeb1d9704f" contextRef="C_5628ed6b-5082-4559-afdb-16e2688469bc" name="ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. At the date of issuance, the fair value of the warrant was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd5bd88e-fb36-4acd-9e0d-04e7ae3f1ff9" contextRef="C_a9629230-9e39-4a56-a202-86fdb80c3901" name="us-gaap:FairValueNetAssetLiability" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ab35490-1f5a-418f-b9fc-af459cb6a1e0" contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">twelve months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e29d987-8dd9-45a1-9f7e-9e57ccdec203" contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_309492d5-256b-4947-b507-717627c8f856" contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">89</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_924e9f0b-00ec-40af-997f-14a70488eb94" contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrant is classified as equity, and the Company expensed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1bc8b3b-9b0f-4cdd-a68b-9f108e816c4d" contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">13,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> general and administrative expense for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_e11eaa09-8bde-4255-8fc0-26e80283f45a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_e11eaa09-8bde-4255-8fc0-26e80283f45a_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Stock-based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Equity Incentive Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company adopted 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;), which became effective at the closing of the Merger and replaced our 2020 Equity Incentive Plan (&#8220;2020 Plan&#8221;) on the effective date of the Merger. As of the effective date of the Merger, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4e16f12-21d1-4eaf-95b3-8650fcfd8e5c" contextRef="C_6ae5bd8b-50f0-4642-b868-3aa969e2fa5c" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock available for grant under the 2023 Plan. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 Plan of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8e6aa48-04f2-4617-84d2-ddbcd2653f53" contextRef="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2" name="ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of shares of the Company&#8217;s common stock outstanding (or a lesser number determined by the Company&#8217;s board of directors). As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_464882a7-0e38-446b-a4e0-89c55d607643" contextRef="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">228,475</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">options have been returned of whic</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b5173ab-1466-41cd-b74d-4f6c20049599" contextRef="C_f6e2608c-dccd-43a5-9232-ce7da8fd0bfa" name="ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">223,743</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(granted under the 2020 Plan) are unavailable for future grant. Effective January 1, 2024, the shares reserved for issuance under the 2023 Plan was increased by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f5d1c9e-916a-4f38-b1cd-044214a0063b" contextRef="C_8830f19b-6e6b-4da2-87ee-d99253ee1c18" name="ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">287,725</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. Effective March 28, 2024, the Board approved an increase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9562330a-fe60-4cfd-b851-d8488c7cc357" contextRef="C_e68758c4-3c29-4782-a87c-bcd7ee800eef" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved under the 2023 Plan. This increase was subsequently approved by the stockholders of the Company on August 27, 2024. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a1ae17c-a0b6-43c8-b384-d767c2908ccd" contextRef="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">820,266</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hares were available for grant under the 2023 Plan.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Employee Stock Purchase Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company adopted the 2023 Employee Stock Purchase Plan (the &#8220;2023 ESPP&#8221;) which became effective at the closing of the Merger. As of the effective time of the Merger, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6ff8e20-6457-4aa8-a058-3ccaee329718" contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b" name="ck0001534133:CommonStockCapitalSharesReservedForFutureIssuanceInitial" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">65,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock reserved for issuance under the 2023 ESPP. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 ESPP of the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5edd4158-8a03-409c-81f7-e73bbf6c89bf" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of the Company&#8217;s common stock outstanding on December 31 of the preceding calendar year, (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adcd0dec-7de4-4001-aaa1-e2f78c71b82a" contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">195,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, or (iii) such lesser number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s board of directors. An annual increase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23d0257a-0c3b-43f8-a365-ff2dbca5055e" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">57,545</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock was automatically added to the share reserve under the 2023 ESPP on January 1, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d5e25aa-c6d3-4aaf-a8c5-0b1c70dd9b30" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares have been issued under the 2023 ESPP.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b3dfc004-6af7-4659-89c2-40cfd7bb2ba9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option transactions for the 2023 Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.435%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.152%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1.111%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.353%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.178%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.466%;box-sizing:content-box;"/>
        <td style="width:1.178%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.687%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Contractual Term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate Intrinsic Value (in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3225068-517e-45df-aead-538077f3a061" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,739,270</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0cd0dfb-9f57-4046-9472-e0bb31857fee" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">15.71</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0ae6d96d-afbd-4c89-aa49-60bd26b39a17" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.99</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2e64915-4b6d-4fac-a812-87e51f2d5687" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fcf89db-7443-411a-9eda-bd82762c9c00" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,326,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae3b7943-8fb2-4ebf-9d2b-ef4ee826144c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.12</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f80ea95-94b9-488b-bfc6-ee3249988c46" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">9.47</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd545079-e4b3-4742-9377-560f5a0a51aa" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b61abd8-c60b-4b6d-a57d-47251012fa57" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,852</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b805f643-8475-4a40-ad63-78307c663ee9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f7f338d-8f12-49e7-8a4e-8a78f72f6834" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">228,475</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06d2a23b-e3af-4436-833c-4fa0974b20a6" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">75.27</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bd2319d-2e75-4f6d-832f-331e706e6cac" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,824,443</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3760b3c-353d-470d-aba3-348aeed701b2" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.51</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8e21eadd-5504-445e-9e5d-2514af94d8a9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.15</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f4a0a9d-6634-4104-b324-4bb1a157c916" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">316</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb46f7f3-653e-444a-9881-c5052055d694" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,350,852</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0b548f3-f584-425c-bdae-b70df0cf4c85" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.46</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_beb72d85-d220-4e46-8896-2ca5b4341cea" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.09</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e2418b5-6ed6-4fd3-b18a-afdd02fd00ff" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_e11eaa09-8bde-4255-8fc0-26e80283f45a_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf7827bc-a8dd-4d1f-8cb9-f69baf4eaaa6" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,852</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options exercised and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2c30811-69b7-414c-bad0-743b85e12420" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,326,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options granted during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024. The weighted-average fair value of options granted during the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13cbe293-194d-4bba-be6a-a4566a609030" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d62d711f-a7c8-4f02-bbd9-71145ac7b868" contextRef="C_aea932f0-6864-4a4a-9a5a-1599150cb972" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.34</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. The total fair value of shares vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38122036-8df8-4a56-a965-e2fd9275db54" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1371519-990d-4dad-9100-8b7e5bbaebe3" contextRef="C_aea932f0-6864-4a4a-9a5a-1599150cb972" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (which includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cfbd71f-4321-4b40-bd34-8a53f4a9f769" contextRef="C_23e9b7c7-df34-4cf7-85aa-9468c513006d" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f0e81b5d-d170-41c4-91f6-42c8b4c7dea1" contextRef="C_6989cb5e-e674-4c1b-a3f4-8bde59a0e20c" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the acceleration of vesting of the Graybug stock awards at the date of the Merger) for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, stock-based compensation not yet recognized is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0579a69-590e-4bd9-a595-fc32694b82ae" contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which the Company expects to recognize over an estimated weighted-average term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bae75c90-e4cd-407d-8402-47d9a8a8fc6e" contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.8</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0e5abc60-4735-47f5-bb3d-673bd5c45884" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.46%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:12.6%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:14.06%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_752879c0-a8d6-496c-abf1-d995d7b32682" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b23934dd-34cb-48d9-89b4-c238fb3feb32" contextRef="C_7b2ce76f-1ac6-463d-9417-582f1d672621" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_995ae2dc-38bf-4cca-aa2f-47ea7f36b778" contextRef="C_e6df5d02-68f7-49d4-ba51-986d32e23a91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.56</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54818ba8-80c5-4ab4-ae75-88647ddcce5f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">97</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca484aa9-332a-44ee-81df-18a441c58d26" contextRef="C_7b2ce76f-1ac6-463d-9417-582f1d672621" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f882906-e093-4cdf-84d2-06cf8e07d1b9" contextRef="C_e6df5d02-68f7-49d4-ba51-986d32e23a91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">76</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4b48ccb6-207c-4457-b2fc-810b2666a5ec" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.01</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5f66810d-3464-4ec1-b3e8-979111d3212c" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.25</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7059cf66-b517-4eff-bf4d-ab1a20603967" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83c2165b-7dab-4880-bc8e-f595b9456107" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSU&#8221;)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of RSUs is determined on the date of grant based on the market price of the Company&#8217;s common stock on that date. The aggregate grant date fair value of RSUs vested during the year ended December 31, 2024 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9caf1434-f0a7-481f-aaf2-45a2543ba879" contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">nil</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_270f01ee-49d4-4dc4-bbe7-6a414037c913" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes restricted stock unit activity for the CalciMedica Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.183%;box-sizing:content-box;"/>
        <td style="width:2.158%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.61%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:3.799%;box-sizing:content-box;"/>
        <td style="width:2.158%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.093%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Restricted Stock Units</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38234ca5-87bd-42f5-a9ac-5a4a369633f6" contextRef="C_3c08a61f-703c-4719-8fb8-4579c9288562" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84b5e87c-05bf-42c3-9916-bbcc277859f3" contextRef="C_3c08a61f-703c-4719-8fb8-4579c9288562" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1738e391-fcd2-4313-85cc-6084ad8c8e7d" contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5530a4e6-b3f4-40ab-b168-9d01c319e206" contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.50</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited/Cancelled (expired)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dce38992-9d31-4c0a-b038-ad43ce80e9ff" contextRef="C_a0f4c105-a524-4767-9181-31be89a91199" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79e71abe-ab60-4f73-91d8-e234933894bf" contextRef="C_a0f4c105-a524-4767-9181-31be89a91199" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.50</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a985303f-f798-4ef0-9878-be7445857f0d" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfb229d6-a454-410d-9dc2-64b10fb96424" contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">840</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_341ecdfd-77a0-43e3-853d-86e699dfdbfd" contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,449</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3807b1e-50e7-4920-92cc-a07299b7dbd5" contextRef="C_050c9307-b322-43a4-84b0-69234ed20231" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,473</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b5f0a7e-b28b-4602-9e8c-cacd9741744a" contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,590</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19ae7772-32d6-4b4d-afc2-a02db0875fba" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdd32925-791c-4718-9355-2d51a2830a71" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,039</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The stock-based compensation expense for the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, includes one-time charges for the acceleration of vesting of the Graybug stock options at the date of the Merger of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d61ec3be-31eb-45ef-abc9-17b73184711b" contextRef="C_020d633a-de37-4a19-a0ef-493644e25660" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5fe53de-ca74-4087-94cb-9afa579d7e7b" contextRef="C_cb68adaa-9134-4f3e-97c2-816971662c99" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in research and development and general and administrative expenses, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Reserved for Future Issuance</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7bae8f69-0d97-48e4-9582-d99208a4b075" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" escape="true" continuedAt="F_7bae8f69-0d97-48e4-9582-d99208a4b075_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common stock reserved for future issuance consists of the following at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"/>
        <td style="width:1.48%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1e3ccd8-c52f-4829-96df-2c0910119fad" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">3,352,621</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3bee4597-3cb3-4a88-a7e2-c3174a69274c" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,824,443</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available for issuance under the 2023 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51fb175a-0535-4f16-818c-e2a675cc89ef" contextRef="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">807,414</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available under the 2023 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e8ee07d-c850-46c3-a480-e5775d397435" contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">122,545</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f06d27c4-764a-43f9-8ae3-2989a0c72ff4" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,107,023</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_7bae8f69-0d97-48e4-9582-d99208a4b075_1"></ix:continuation></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5929931d-960a-4e2e-8634-8d29dc96c34a" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_5929931d-960a-4e2e-8634-8d29dc96c34a_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues liabilities for such matters when future expenditures are probable and such expenditures can be reasonably estimated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has historically entered into contracts in the normal course of business with contract development and manufacturing organizations, for the manufacturing process development and the preclinical/clinical supply manufacturing, and its vendors for preclinical research studies and other services or products for operating purposes. These contracts generally provide for termination on notice of 60 to 90 days. As of December 31, 2024, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cf706ba-bed7-4b57-8546-2b77b120323f" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:NumberOfContractCurrentlyInEffect" unitRef="U_Contract" decimals="0" format="ixt-sec:numwordsen">seven</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> such contracts, with one CMO related to its development of Auxora and one acquired as a result of the Merger with approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6192b6ac-d706-48bb-8771-a75ef94849ad" contextRef="C_2f7897d6-1a4a-489c-9fd4-bf5c88b81551" name="ck0001534133:ContractualObligationOfContractInEffect" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_224299a9-7618-4b06-920c-3e9af7e6565d" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:ContractualObligationOfContractInEffect" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of associated costs, respectively, still in effect for future services, and there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff21963b-4303-4289-a57c-1f0f47822600" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:UnpaidCancellationAndOtherRelatedCosts" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unpaid cancellation or other related costs.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may also, from time to time, become party or subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. Some of these proceedings have involved, and may involve in the future, claims that are subject to substantial uncertainties and unascertainable damages.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Lease Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has an operating lease for office space in La Jolla, California. In </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_61abf9e2-f08b-4b52-890e-4220ea035350" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:LeaseAmendmentDate" format="ixt:date-monthname-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an amendment was </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b336449-7a1b-4520-bd1a-eaca16594a75" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:LeaseExecutedTermPeriod"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">executed for a twelve month term as of January 1, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and therefore qualifies for the short-term lease exception. Since the lease was amended and renewed in December 2024 for an additional twelve month term it therefore qualifies for the short-term lease exception. Base rent for this lease is approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_742a8135-f837-4350-9632-549f1dbcac03" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:BaseRent" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">10,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> monthly.</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5929931d-960a-4e2e-8634-8d29dc96c34a_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rent expense for the years ended December 31, 2024 and 2023 wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da220dea-d7f6-40c9-b80a-56b9e06a0f3e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:RentExpenses" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">121,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d1487b9-3954-4d42-b1b9-3887788742f4" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:RentExpenses" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">274,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively, which is included in operating expenses.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e940ec2-c62a-4cf9-bff6-a379a7efe198" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Employee Benefits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2007, Private CalciMedica adopted a defined contribution 401(k) plan for substantially all employees. Contributions made by CalciMedica to the 401(k) plan were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5c00c54-f731-4885-a5ea-f8c26ef050f9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9f4afc9-e940-428b-a701-41ea3f3ae4e7" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_b40f5005-5d57-41b2-905a-1f2a42371c5e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_b40f5005-5d57-41b2-905a-1f2a42371c5e_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b6e10054-5e07-4f49-8540-7adca63aa9fe" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The effective tax rate if the Company&#8217;s provision (benefit) for income taxes differs from the federal statutory rate as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax computed at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_037cac5d-a39d-496c-9e02-4e7ba73727a9" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,877</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b8e71b2-9fd2-46c8-9192-2be28c633f4f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,214</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal tax benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c9b2e77-1441-495b-8948-875ff5e2a38f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">611</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7fca187-fef9-4d4e-bf6c-71ffdfc161f1" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fefe0ad0-3817-4b0b-be4d-e607b5a9a3eb" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IncomeTaxReconciliationPermanentDifferences" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99707584-8501-44a4-a83d-68da601adc6a" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IncomeTaxReconciliationPermanentDifferences" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">50</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8704949-3082-4dd6-8d00-447dbb563074" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IncomeTaxRateReconciliationWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,993</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11bd2db6-c2c0-4625-9faf-150fc3df7516" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IncomeTaxRateReconciliationWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">665</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits, net of uncertain positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea450571-2320-49ef-8185-24ac83390a2f" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,050</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60acc350-f4f1-41fc-933a-eca79d653c8b" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">705</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f549281e-df6c-48ed-bdd1-1b55b1e8a2fb" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,475</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f0fad20-ff05-41df-8c56-0f0139312dc1" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,534</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30051c41-7ec9-4742-81c2-69d76c65de88" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_681ce29e-b880-4c02-ae20-c9ff8d8f9691" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating losses and tax credit carryforwards. </span><span><ix:nonNumeric id="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of deferred tax assets (liabilities) are as follows (in thousands):</span></ix:nonNumeric></span></p><div><ix:continuation id="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8_1" continuedAt="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_b40f5005-5d57-41b2-905a-1f2a42371c5e_1" continuedAt="F_b40f5005-5d57-41b2-905a-1f2a42371c5e_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8_2">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d49f58f-093d-4964-a104-2c903cb02f38" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,407</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_562a0e36-8899-4fac-a75f-80cb64255ba3" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,535</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61b47429-f045-4ba6-8d42-24702d1d4371" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,356</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dae4ac9-dccb-4942-b062-0302c67ea107" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,865</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carry forwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56952a19-acfc-46ee-a227-6eab488c4dc6" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,506</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13430b36-2f36-418e-8cdf-145f967b57e0" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,403</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a53a67f2-558d-4e6a-934d-ce302ebc1d0c" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,026</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_500088b4-6c02-46a8-9022-9b41b4bf993b" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_956d8f2f-24e4-4b61-a054-9b46ba52a610" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:DeferredTaxAssetsAccruedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16bd89cc-be39-4c5a-8e06-3eee07de0b87" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:DeferredTaxAssetsAccruedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11540615-9e1c-4e94-a57e-2a81441a39a8" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,475</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f90fa8fe-ef7c-4880-8f59-b79e2d95a795" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,596</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9d21930-bc67-4b9e-8ed4-9dba616abc39" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d2c855f-57f1-49de-bc20-0a05400c0a26" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0874ffdf-36d9-41b9-952c-149f3e847e36" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd9fb78e-8d77-4413-9ff0-8f085556e20b" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f02d6fe-a558-4ca2-a16c-1addf6f8cfc2" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:NetDeferredTaxAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,460</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b523af58-6b5a-48d5-b66b-4343cc314371" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:NetDeferredTaxAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,575</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac20074-e1ac-43ca-b38a-6cf14f8701b5" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,460</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be210f22-4df5-4797-aecb-94a035264a71" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82,575</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34b5f081-fc84-4ca4-b581-da377c13b613" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d7aadcf-a1d1-438e-b100-325ad701d141" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provided a full valuation allowance on the net deferred tax asset because management has determined that it is more-likely-than-not that the Company will not earn income sufficient to realize the deferred tax assets during the carryforward period. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has federal and state NOLs available of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea1e7f13-9f56-457e-9b7e-0b36d52d8e3b" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">296.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a4e6671-478d-4d83-a388-fafa4f5e05aa" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">nil</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to offset future taxable income, if any, for federal and state income tax purposes. The federal and state NOLs expire beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3e663186-c0ea-470b-bbb1-e9d075001af9" contextRef="C_dd320420-0211-43de-95df-09b44d9868c0" name="ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear"><ix:nonNumeric id="F_93b12aee-9437-4cc7-ac62-8ee4ef409d88" contextRef="C_3e3444e7-6081-449c-be1a-618a48f9ddb6" name="ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2026</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b580f12-8c47-43d8-a40f-960b0f63cc84" contextRef="C_5d75438a-331f-4b70-b3ef-65f18fddf6b9" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">194.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of post-2017 federal NOL carryforwards that carry forward indefinitely. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_809539c1-d539-4a25-abf4-a68a7f76676b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Tax Act the amount of net operating losses generated in taxable periods beginning after December 31, 2017, that the Company is permitted to deduct in any taxable year is limited to 80% of taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Tax Act generally eliminates the ability to carry back any net operating loss to prior taxable years, while allowing post-2017 unused net operating losses to be carried forward indefinitely.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has federal and state research and development credit carryforwards available of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0f6406e-69a8-4e87-94be-10dd1c8f4174" contextRef="C_13118ae0-e9f5-4a7c-aa30-bab5991ca143" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a4acff0-319e-48e9-ab3b-0551c22d0a9d" contextRef="C_b8a91730-f365-453b-88eb-5b8de08b2053" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Federal research and development carryforwards expire beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_afc74938-dfdf-42bb-8748-4c9dac32fe80" contextRef="C_dcc03654-bedf-421b-b7f5-47598128324e" name="ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. State research and development carryforwards do not expire.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) specifically by IRC &#167;382, the Company&#8217;s ability to use net operating loss carryforwards to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab048d31-c61e-447b-a3fa-536c0ae55f6c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:PercentageOfChangeInOwnership" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% within a three-year testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly reduced. Any limitation may result in the expiration of a portion of the NOL carryforwards before utilization.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ea910230-0e41-4471-8464-60b650e48324" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the Company&#8217;s unrecognized tax benefits is summarized as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.823%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca162ebe-56ef-47b6-8f69-1daad5892922" contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,506</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f50a30d-0770-4b87-bc47-fe715fd0f9d8" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,846</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f3c81a4-38a8-42e0-9805-2fd1a09fadc4" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions in connection with the reverse merger</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f4bf2f8-750b-4fb2-87fc-69df0a7abc61" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">847</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reduction for tax positions of prior years</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bedbd649-84d6-457d-8203-53534003b4d9" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_285b1574-86b2-4207-9c77-b338f963a623" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,080</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5131a8a2-afea-4f9b-892f-6fc7231efb50" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f51bfd2-9880-48c6-9109-d25d51e70074" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0b71001-71d8-4473-b36a-7d295ece9c16" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,482</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertainty in income taxes in accordance with ASC 740 Income Taxes. Tax positions are evaluated in a two-step process, whereby the Company first determines whether it is more likely than not that a tax position will be sustained upon examination by the tax authority, including resolutions of any related appeals or litigation processes, based on technical merit. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more likely than not recognition threshold to be recognized. The Company&#8217;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7263e44b-bcf4-4cff-8f02-5dd6d4f11bb3" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2555fa51-3a4d-405b-8cea-a9abf828519f" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrual for interest and penalties and has not recognized interest and/ or penalties in the statements of operations and comprehensive loss for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. Uncertain tax positions are evaluated based upon the facts and circumstances that exist at each reporting period. Subsequent changes in judgment based upon new information may lead to changes in recognition, derecognition,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b40f5005-5d57-41b2-905a-1f2a42371c5e_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and measurement. Adjustments may result, for example, upon resolution of an issue with the taxing authorities or expiration of a statute of limitations barring an assessment for an issue.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, unrecognized tax benefits associated with uncertain tax positions was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96413c37-a408-4d7a-bea0-6cd7ce250c54" contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e" name="ck0001534133:UnrecognizedTaxBenefitsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd307b1e-2783-4d88-a435-86b560888fae" contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be" name="ck0001534133:UnrecognizedTaxBenefitsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million respectively. If recognized, this would affect the effective tax rate, subject to valuation allowance. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not recognize any interest and penalties associated with unrecognized tax benefits. Due to net operating losses incurred, tax years from inception remain open to examination by the Federal and State taxing jurisdictions to which we are subject. The Company is not currently under Internal Revenue Services (IRS), state or local tax examination.</span></p></ix:continuation></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_2cede081-9fdb-4de4-8631-27753e8a7b15" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c54410c-66fd-4d04-9c03-743e5ebd57dc" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.94%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.3%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.98%;box-sizing:content-box;"/>
        <td style="width:1.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.78%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73ee8a4e-4f56-4fa2-91bb-7a317c0a125b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,700</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91bda301-0fee-4d82-a65d-3fa3c10e76f0" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">34,357</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51bd7957-72ae-435c-b23d-b34119470e0e" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAverageCommonSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c3c6860c-b0ce-4497-990d-adcf72111a69" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAverageCommonSharesOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,886,920</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95f1aac2-c3d1-4913-aeee-5429c7a555b5" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAverageCommonSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_340ba866-e870-45cb-a9fa-eaf4afdfe16f" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAverageCommonSharesOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,486,258</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average pre-funded warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71a54436-f8f9-4f0e-9edb-84bfe26b7915" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2e039b8e-645c-4bb9-9723-9807e765a2f1" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">288,082</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36f82238-1a56-49e5-b903-00199a4d7461" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:fixed-zero"><ix:nonFraction id="F_3c862d9d-3c65-4807-bc63-494da8ed5a1d" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average placement agent warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9c7c9e6-7a67-4b52-a0ec-9cebc1377185" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b36844bf-41a5-4d75-9e00-11469f29389b" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">70,913</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2b4fc39-7b87-4e03-9c87-9ca4e5868608" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:fixed-zero"><ix:nonFraction id="F_a86c2ade-147c-4be8-a4e6-19ab94ec14b0" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of shares used to calculate basic and diluted net loss per share</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7299348f-a2d5-41d8-bca7-b39dbdb88159" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2f774ea6-6a37-476f-b7ca-4d506b652db6" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">11,245,915</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a4d49b9-523b-451e-88ec-f32ba2aa2792" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_20a8cd05-083c-4b09-b240-3fb3a8700ecc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,486,258</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share - basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee6bf770-a5b0-437c-99c6-4405da3606f8" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a8815ee2-d474-4245-aa82-e6414be716fb" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.22</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e87e340-b60a-4884-9398-2248dee55754" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cf337349-e50c-49ae-84b2-6d25265ffabc" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">7.66</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ef5f96f7-c252-440e-9919-509ffd102f4c" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_ef5f96f7-c252-440e-9919-509ffd102f4c_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.729%;box-sizing:content-box;"/>
        <td style="width:1.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:17.976%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:17.976%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea4d54e7-7f89-463d-9c37-cf22234f7ff7" contextRef="C_de781a1c-b261-4323-9d34-9ecb0869f1f7" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,824,443</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87e4ce6f-6293-4b38-8ac7-149970772ef3" contextRef="C_8c641589-eb1e-4352-b3c3-0711c499ace9" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,739,747</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94699f11-e731-44f7-86ce-a0d7d1b71454" contextRef="C_03f70fa6-7284-496f-8c00-e58bf2ff1f48" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,970,368</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4547a91-c5c6-40b8-9f9b-5babfe9d9a2a" contextRef="C_27307737-cae3-4ea7-a928-4b907971a80f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">276,437</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_074e1830-907e-4a1c-9489-68a3f12066d3" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,794,811</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23b5de85-f701-46d5-9ec4-12fa99e9bbeb" contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,016,184</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_ef5f96f7-c252-440e-9919-509ffd102f4c_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_07838bea-0052-4f5a-a65f-254d87476e72" contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a" name="us-gaap:SubsequentEventsTextBlock" escape="true" continuedAt="F_07838bea-0052-4f5a-a65f-254d87476e72_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Subsequent Events</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 (the &#8220;Closing Date&#8221;), the Company the Loan Agreement with Avenue Venture Opportunities Fund II, L.P. (&#8220;Lender&#8221;) and Avenue Capital Management II, L.P., as administrative agent and collateral agent, for growth capital loans in an aggregate principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffe447da-5f28-46e4-82d6-9897db244a14" contextRef="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">32,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Loan&#8221;), with (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6332ab84-ecf8-49e9-870f-f9025414e6a7" contextRef="C_9cbbe523-fc5d-4e57-a1bb-191ddd2df6a0" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> funded on the Closing Date (&#8220;Tranche 1&#8221;), (ii) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ec4bbe3-bf80-407e-8bef-0f26bb3aca7e" contextRef="C_cde8f9cc-6117-4cfa-a5bd-4b469cb961fe" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">7,500,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials (&#8220;Tranche 2&#8221;) and (iii) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9be8e7a7-e76e-4279-b91c-25d97da7e21d" contextRef="C_de62953f-9a13-4e2a-a3fc-a8e40d129029" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">15,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#8217;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval). </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e1bc201-437a-489d-b2d1-75508525b307" contextRef="C_8f77e296-92c8-4ecd-b45a-a2ad8b02e258" name="us-gaap:LongTermDebtMaturitiesRepaymentTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Loan bears interest at an annual rate equal to the greater of (a) the sum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe1e5548-e25e-4611-8a7b-1498b7d25556" contextRef="C_7ee9e19d-1d4a-450f-9f03-e831fc128d22" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% plus the prime rate as reported in The Wall Street Journal and (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2335e7a-2963-4e8d-af76-6db07802b166" contextRef="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">12.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The Loan is secured by a lien upon and security interest in all of the Company&#8217;s assets, including intellectual property, subject to agreed exceptions. The maturity date of the Loan is </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d8a5285c-3b93-458c-a4c6-9720da412eda" contextRef="C_f6e6eee2-3a7f-426a-995a-4c63812334ed" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2028</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Maturity Date&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Loan, pursuant to the funding of Tranche 1 on the Closing Date, the Company issued to the Lender a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12cde7c7-5baa-4aef-99ac-871e7f8c279e" contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">641,163</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock of the Company (the &#8220;Warrant&#8221;) at an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9f8266f-ce80-465c-a50f-3e7952adea00" contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.32</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Stock Purchase Price&#8221;). The Warrant is exercisable until </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b003cecf-86dc-4f3a-aa32-9c5b53b68037" contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 28, 2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Expiration Date&#8221;) and upon a change of control, the Lender would be entitled to receive the shares of common stock underlying the Warrant without payment of the exercise price.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_07838bea-0052-4f5a-a65f-254d87476e72_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>ck0001534133-ex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html>
 <head>
  <title>EX-10.3</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                      Exhibit 10.3</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">SUDARSHAN HEBBAR - AMENDMENT TO EMPLOYMENT OFFER LETTER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment is entered into as of March 20, 2025 by CalciMedica, Inc. (the &#x201c;Company&#x201d;) and Sudarshan Hebbar, M.D. (&#x201c;Employee&#x201d;) and amends that certain employment Offer Letter from the Company to Employee dated August 24, 2015 (&#x201c;Offer Letter&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, Employee is currently an executive officer of the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, the Board of Directors of the Company has approved an amendment to the employment offer letters of certain executives of the Company to adjust their severance benefits payable in the event employment is terminated by the Company prior to a Change in Control for reasons other than Cause or Good Reason( as such terms are defined in Appendix A attached hereto), death or disability; and</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, it is the intent of the parties that this Amendment replace the provisions regarding severance benefits set forth in Employee&#x2019;s Offer Letter.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NOW THEREFORE, the parties agree as follows:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In the event (i) Employee&#x2019;s employment is terminated without Cause or for Good Reason (each as defined in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Appendix A attached hereto</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) and provided that Employee (ii) remains in compliance with his continuing obligations to the Company, (iii) Employee resigns from any other positions or roles held with or on behalf of the Company, and (iv) Employee provides the Company with an executed release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) within sixty (60) days after such termination and allow the Release to become fully effective by its terms (clauses (i) through (iv) collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Conditions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee shall be entitled to receive the following severance benefits: </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Nine (9) months of salary continuation payments, paid subject to required withholdings and deductions, paid on the Company&#x2019;s customary payroll schedule, commencing on the first payroll date that is at least three (3) business days after the Severance Conditions have been satisfied and continuing over the nine (9) month period thereafter; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">If Employee timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 or applicable state insurance laws (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall reimburse Employee for the monthly COBRA premium paid by Employee for Employee and his dependents for COBRA continuation coverage. Such reimbursement shall be paid to Employee in accordance with the Company&#x2019;s customary reimbursement procedures following the date that Employee timely remits to the Company documentation of the fact and amount of such premium payment (which documentation must be submitted to the Company within sixty (60) days after the date the payment was made). Employee shall be eligible to receive the foregoing reimbursement during the period from the termination date until the earliest of: (i) the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img20776642_0.jpg" alt="img20776642_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">nine (9)-month anniversary of Employee&#x2019;s termination date; (ii) the date Employee is no longer eligible for COBRA continuation coverage; and (iii) the date on which Employee becomes eligible to receive substantially similar coverage from another employer or other source (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA Premium Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). Employee will be responsible for timely payment of all COBRA premiums (including, without limitation, all administrative expenses), and agrees to timely notify the Company if Employee becomes eligible for health insurance through another employer or other source before the nine-month anniversary of Employee&#x2019;s termination date. Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of the foregoing COBRA reimbursements would result in a violation of applicable law (including, but not limited to, Section 105(h) of the Internal Revenue Code of 1986, as amended, Section 2716 of the Public Health Service Act, or any statute or regulation of similar effect) or is otherwise impracticable, then, in lieu of providing the COBRA reimbursement benefit, the Company will instead pay Employee on the last day of each remaining month of the COBRA Premium Period, a fully taxable cash payment equal to the COBRA reimbursement amount for that month, subject to applicable tax withholdings. Employee may, but is not obligated to, use this taxable payment to pay for medical expenses, including COBRA premiums.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, if Employee&#x2019;s termination occurs in connection with a Change of Control and Employee is eligible for severance under the Company&#x2019;s Change in Control Severance Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee&#x2019;s severance rights shall be governed exclusively by the Severance Policy, and not this Amendment.  Employee may not cumulate any severance benefit under this Amendment with any other severance benefits made available by the Company pursuant to any written agreement, plan or policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, Employee will not be eligible for severance benefits pursuant to this Amendment if Employee&#x2019;s employment terminates due to Employee&#x2019;s death, Disability or voluntary resignation of employment (without Good Reason).  (For purposes of the foregoing, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall exist if Employee is unable to perform the essential functions of Employee&#x2019;s position (with or without accommodation) for more than six (6) months in any twelve (12) month period, or for more than four (4) consecutive months.  This provision shall be interpreted and construed in accordance with the federal Americans with Disabilities Act of 1990 and all other applicable laws.)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Code Section 409A Compliance</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding anything set forth in this Amendment to the contrary, any severance payments and benefits provided pursuant to this Amendment which constitute &#x201c;deferred compensation&#x201d; within the meaning of the Treasury Regulations issued pursuant to Section 409A shall not commence until Employee have incurred a &#x201c;separation from service&#x201d; (as such term is defined in the Treasury Regulation Section 1.409A-1(h) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Separation From Service</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;),</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img20776642_0.jpg" alt="img20776642_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">unless the Company reasonably determines that such amounts may be provided to Employee without causing Employee to incur the additional 20% tax under Section 409A.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, it is intended that the payments and benefits set forth in this Amendment satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9) and this Amendment will be construed to the greatest extent possible as consistent with those provisions.  To the extent not so exempt, this Amendment (and any definitions hereunder) will be construed in a manner that complies with Section 409A and incorporates by reference all required definitions and payment terms.  For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A 2(b)(2)(iii)), Employee&#x2019;s right to receive any installment payments under this Amendment (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Amendment, if the Company (or, if applicable, the successor entity thereto) determines that any payments upon Employee&#x2019;s Separation From Service set forth herein and/or under any other agreement with the Company constitute &#x201c;deferred compensation&#x201d; under Section 409A and Employee is, on Employee&#x2019;s Separation From Service, a &#x201c;specified employee&#x201d; of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely, to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the payments upon Employee&#x2019;s Separation From Service shall be delayed until the earlier to occur of: (a) the date that is six months and one day after Employee&#x2019;s Separation From Service or (b) the date of Employee&#x2019;s death (such applicable date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Specified Employee Initial Payment Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).  On the Specified Employee Initial Payment Date, the Company (or the successor entity thereto, as applicable) shall (A) pay Employee a lump sum amount equal to the sum of the payments that Employee would have otherwise received through the Specified Employee Initial Payment Date if the commencement of the payment of the severance benefits had not been so delayed pursuant to this section and (B) commence paying the balance of the severance benefits in accordance with the applicable payment schedules set forth in this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">None of the severance benefits under this Amendment will commence or otherwise be delivered prior to the effective date of the Release.  If the period of time Employee has to execute the Release &#x201c;crosses over&#x201d; two (2) calendar years, the Release will be deemed to have been executed on the 60th day after the date of termination. Except to the minimum extent that payments must be delayed because Employee is a &#x201c;specified employee&#x201d; (as described above) or until the effectiveness of the Release, all amounts will be paid as soon as practicable in accordance with the Company&#x2019;s normal payroll practices and no interest will be due on any amounts so deferred.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-2.557%;padding-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3. The Offer Letter shall be and continues to remain in full force and effect, except as modified by this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img20776642_0.jpg" alt="img20776642_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:0.139%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.398%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.4013378596248787%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The parties hereto agree that the laws of California govern this Amendment and that any questions arising under this Amendment shall be construed according to the laws of California.</font></div></div>
  <p style="margin-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment and the Company&#x2019;s Change in Control Severance Policy constitute the entire agreement between the parties hereto with respect to the Employee&#x2019;s severance benefits. Any changes, amendments, or supplements hereto must be made in writing and signed by both parties.</font></div></div>
  <p style="margin-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  IN WITNESS WHEREOF, the parties have caused this Amendment to be executed and delivered on the date written above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">__________________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">    			____________</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">/S/</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">___________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                        </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> By: Sudarshan Hebbar, M.D.                                           By:         Rachel Leheny, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                              Title:       Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img20776642_0.jpg" alt="img20776642_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">APPENDIX A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">      </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean (i) Employee&#x2019;s willful and material failure to perform his material duties and obligations (other than any such failure resulting from incapacity due to physical or mental illness), and, if the failure is one that can be corrected, Employee has been given notice specifying the failure and the actions reasonably required to correct the failure and ten (10) business days to correct it; (ii) Employee&#x2019;s willful failure to comply with one or more valid and legal directives of the Board, which failure is not corrected within ten (10) business days after the Company has given Employee written notice specifying the failure in reasonable detail, and Employee has had an opportunity to address the Company with counsel present; (iii) any act of personal dishonesty, fraud, embezzlement, or misrepresentation, committed by Employee which is injurious to the  Company; (iv) Employee&#x2019;s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (v) Employee&#x2019;s material violation of a material written policy of the Company or the rules of any governmental or regulatory body applicable to the Company and, if the breach is one that can be corrected, Employee has been given notice specifying the breach and ten (10) business days to correct it; or (vi) Employee&#x2019;s material breach of any material obligation under Employee&#x2019;s Offer Letter or any other written agreement between Employee and the Company, and, if the breach is one that can be corrected, Employee has been given written notice specifying the breach and the actions reasonably required to correct the breach and ten (10) business days to correct it. For purposes of this provision, no act or failure to act on Employee&#x2019;s part shall be considered &#x201c;willful&#x201d; unless it is done, or omitted to be done, by Employee in bad faith or without reasonable belief that Employee&#x2019;s action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Employee in good faith and in the best interests of the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the occurrence of any of the following, in each case during Employee&#x2019;s employment without Employee&#x2019;s written consent: (i) a material reduction in Employee&#x2019;s base salary (unless pursuant to a salary reduction program applicable generally to the Company&#x2019;s executives); (ii) a relocation of Employee&#x2019;s principal place of employment (at the request of the Company) by more than thirty (30) miles from Employee&#x2019;s then-current principal place of employment immediately prior to such relocation (and provided that Employee is not otherwise authorized to work remotely); (iii) any material breach by the Company of any material provision of the Offer Letter or any material provision of any other agreement between Employee and the Company; (iv) prior to a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or reporting structure (other than temporarily while Employee is physically or mentally</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img20776642_0.jpg" alt="img20776642_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">incapacitated or as required by applicable law); or (v) following a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or reporting structure (other than temporarily while Employee is physically or mentally incapacitated or as required by applicable law), provided, however, that such changes solely resulting from the Company becoming a subsidiary, division or line of business of an acquiror that succeeds to the Company&#x2019;s business will not by itself give rise to Good Reason. Employee cannot terminate Employee&#x2019;s employment for Good Reason unless Employee have provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within thirty (30) days of the initial existence of such grounds and the Company has had at least thirty (30) days from the date on which such notice is provided to cure such circumstances (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cure Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). If Employee does not terminate employment for Good Reason within thirty (30) days after the end of the Cure Period, then Employee will be deemed to have waived Employee&#x2019;s right to terminate for Good Reason with respect to such grounds. If the Company cures the Good Reason condition during the Cure Period, Good Reason is deemed not to have occurred.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>ck0001534133-ex10_4.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html>
 <head>
  <title>EX-10.4</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                         Exhibit 10.4</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">MICHAEL DUNN - AMENDMENT TO OFFER LETTER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment is entered into as of March 20, 2025 by CalciMedica, Inc. (the &#x201c;Company&#x201d;) and Michael J. Dunn (&#x201c;Employee&#x201d;) and amends that certain employment Offer Letter from the Company to Employee dated August 29, 2014 (&#x201c;Offer Letter&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, Employee is currently an executive officer of the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, the Board of Directors of the Company has approved an amendment to the employment offer letters of certain executives of the Company to adjust their severance benefits payable in the event employment is terminated by the Company prior to a Change in Control for reasons other than Cause or Good Reason (as such terms are defined in Appendix A attached hereto), death or disability; and</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, it is the intent of the parties that this Amendment replace the provisions regarding severance benefits set forth in Employee&#x2019;s Offer Letter.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NOW THEREFORE, the parties agree as follows:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:0.398%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:4.950703801128491%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In the event (i) Employee&#x2019;s employment is terminated without Cause or for Good Reason (each as defined in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Appendix A attached hereto</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) and provided that Employee (ii) remains in compliance with his continuing obligations to the Company, (iii) Employee resigns from any other positions or roles held with or on behalf of the Company, and (iv) Employee provides the Company with an executed release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) within sixty (60) days after such termination and allow the Release to become fully effective by its terms (clauses (i) through (iv) collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Conditions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee shall be entitled to receive the following severance benefits: </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Nine (9) months of salary continuation payments, paid subject to required withholdings and deductions, paid on the Company&#x2019;s customary payroll schedule, commencing on the first payroll date that is at least three (3) business days after the Severance Conditions have been satisfied and continuing over the nine (9) month period thereafter; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">If Employee timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 or applicable state insurance laws (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall reimburse Employee for the monthly COBRA premium paid by Employee for Employee and his dependents for COBRA continuation coverage. Such reimbursement shall be paid to Employee in accordance with the Company&#x2019;s customary reimbursement procedures following the date that Employee timely remits to the Company documentation of the fact and amount of such premium payment (which documentation must be submitted to the Company within sixty (60) days after the date the payment was made). Employee shall be eligible to receive the foregoing reimbursement during the period from the termination date until the earliest of: (i) the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img21700163_0.jpg" alt="img21700163_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">nine (9)-month anniversary of Employee&#x2019;s termination date; (ii) the date Employee is no longer eligible for COBRA continuation coverage; and (iii) the date on which Employee becomes eligible to receive substantially similar coverage from another employer or other source (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA Premium Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). Employee will be responsible for timely payment of all COBRA premiums (including, without limitation, all administrative expenses), and agrees to timely notify the Company if Employee becomes eligible for health insurance through another employer or other source before the nine-month anniversary of Employee&#x2019;s termination date. Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of the foregoing COBRA reimbursements would result in a violation of applicable law (including, but not limited to, Section 105(h) of the Internal Revenue Code of 1986, as amended, Section 2716 of the Public Health Service Act, or any statute or regulation of similar effect) or is otherwise impracticable, then, in lieu of providing the COBRA reimbursement benefit, the Company will instead pay Employee on the last day of each remaining month of the COBRA Premium Period, a fully taxable cash payment equal to the COBRA reimbursement amount for that month, subject to applicable tax withholdings. Employee may, but is not obligated to, use this taxable payment to pay for medical expenses, including COBRA premiums.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, if Employee&#x2019;s termination occurs in connection with a Change of Control and Employee is eligible for severance under the Company&#x2019;s Change in Control Severance Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee&#x2019;s severance rights shall be governed exclusively by the Severance Policy, and not this Amendment.  Employee may not cumulate any severance benefit under this Amendment with any other severance benefits made available by the Company pursuant to any written agreement, plan or policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, Employee will not be eligible for severance benefits pursuant to this Amendment if Employee&#x2019;s employment terminates due to Employee&#x2019;s death, Disability or voluntary resignation of employment (without Good Reason).  (For purposes of the foregoing, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall exist if Employee is unable to perform the essential functions of Employee&#x2019;s position (with or without accommodation) for more than six (6) months in any twelve (12) month period, or for more than four (4) consecutive months.  This provision shall be interpreted and construed in accordance with the federal Americans with Disabilities Act of 1990 and all other applicable laws.)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.3463183470211444%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Code Section 409A Compliance</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding anything set forth in this Amendment to the contrary, any severance payments and benefits provided pursuant to this Amendment which constitute &#x201c;deferred compensation&#x201d; within the meaning of the Treasury Regulations issued pursuant to Section 409A shall not commence until Employee have incurred a &#x201c;separation from service&#x201d; (as such term is defined in the Treasury Regulation Section 1.409A-1(h) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Separation From Service</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;),</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img21700163_0.jpg" alt="img21700163_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">unless the Company reasonably determines that such amounts may be provided to Employee without causing Employee to incur the additional 20% tax under Section 409A.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, it is intended that the payments and benefits set forth in this Amendment satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9) and this Amendment will be construed to the greatest extent possible as consistent with those provisions.  To the extent not so exempt, this Amendment (and any definitions hereunder) will be construed in a manner that complies with Section 409A and incorporates by reference all required definitions and payment terms.  For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A 2(b)(2)(iii)), Employee&#x2019;s right to receive any installment payments under this Amendment (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Amendment, if the Company (or, if applicable, the successor entity thereto) determines that any payments upon Employee&#x2019;s Separation From Service set forth herein and/or under any other agreement with the Company constitute &#x201c;deferred compensation&#x201d; under Section 409A and Employee is, on Employee&#x2019;s Separation From Service, a &#x201c;specified employee&#x201d; of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely, to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the payments upon Employee&#x2019;s Separation From Service shall be delayed until the earlier to occur of: (a) the date that is six months and one day after Employee&#x2019;s Separation From Service or (b) the date of Employee&#x2019;s death (such applicable date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Specified Employee Initial Payment Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).  On the Specified Employee Initial Payment Date, the Company (or the successor entity thereto, as applicable) shall (A) pay Employee a lump sum amount equal to the sum of the payments that Employee would have otherwise received through the Specified Employee Initial Payment Date if the commencement of the payment of the severance benefits had not been so delayed pursuant to this section and (B) commence paying the balance of the severance benefits in accordance with the applicable payment schedules set forth in this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">None of the severance benefits under this Amendment will commence or otherwise be delivered prior to the effective date of the Release.  If the period of time Employee has to execute the Release &#x201c;crosses over&#x201d; two (2) calendar years, the Release will be deemed to have been executed on the 60th day after the date of termination. Except to the minimum extent that payments must be delayed because Employee is a &#x201c;specified employee&#x201d; (as described above) or until the effectiveness of the Release, all amounts will be paid as soon as practicable in accordance with the Company&#x2019;s normal payroll practices and no interest will be due on any amounts so deferred.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-2.557%;padding-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3. The Offer Letter shall be and continues to remain in full force and effect, except as modified by this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img21700163_0.jpg" alt="img21700163_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:0.139%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.398%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.4013378596248787%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The parties hereto agree that the laws of California govern this Amendment and that any questions arising under this Amendment shall be construed according to the laws of California.</font></div></div>
  <p style="margin-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. </font></div></div>
  <p style="margin-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment and the Company&#x2019;s Change in Control Severance Policy constitute the entire agreement between the parties hereto with respect to the Employee&#x2019;s severance benefits. Any changes, amendments, or supplements hereto must be made in writing and signed by both parties.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  IN WITNESS WHEREOF, the parties have caused this Amendment to be executed and delivered on the date written above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">__________________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">    			</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">__________/S/</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">_____________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                        </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> By: Michael J. Dunn                                                            By:         Rachel Leheny, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                                Title:     Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img21700163_0.jpg" alt="img21700163_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">APPENDIX A</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">      (a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean (i) Employee&#x2019;s willful and material failure to perform his material duties and obligations (other than any such failure resulting from incapacity due to physical or mental illness), and, if the failure is one that can be corrected, Employee has been given notice specifying the failure and the actions reasonably required to correct the failure and ten (10) business days to correct it; (ii) Employee&#x2019;s willful failure to comply with one or more valid and legal directives of the Board, which failure is not corrected within ten (10) business days after the Company has given Employee written notice specifying the failure in reasonable detail, and Employee has had an opportunity to address the Company with counsel present; (iii) any act of personal dishonesty, fraud, embezzlement, or misrepresentation, committed by Employee which is injurious to the  Company; (iv) Employee&#x2019;s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (v) Employee&#x2019;s material violation of a material written policy of the Company or the rules of any governmental or regulatory body applicable to the Company and, if the breach is one that can be corrected, Employee has been given notice specifying the breach and ten (10) business days to correct it; or (vi) Employee&#x2019;s material breach of any material obligation under Employee&#x2019;s Offer Letter, as amended or any other written agreement between Employee and the Company, and, if the breach is one that can be corrected, Employee has been given written notice specifying the breach and the actions reasonably required to correct the breach and ten (10) business days to correct it. For purposes of this provision, no act or failure to act on Employee&#x2019;s part shall be considered &#x201c;willful&#x201d; unless it is done, or omitted to be done, by Employee in bad faith or without reasonable belief that Employee&#x2019;s action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Employee in good faith and in the best interests of the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the occurrence of any of the following, in each case during Employee&#x2019;s employment without Employee&#x2019;s written consent: (i) a material reduction in Employee&#x2019;s base salary (unless pursuant to a salary reduction program applicable generally to the Company&#x2019;s executives); (ii) a relocation of Employee&#x2019;s principal place of employment (at the request of the Company) by more than thirty (30) miles from Employee&#x2019;s then-current principal place of employment immediately prior to such relocation (and provided that Employee is not otherwise authorized to work remotely); (iii) any material breach by the Company of any material provision of the Offer Letter or any material provision of any other agreement between Employee and the Company; (iv) prior to a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or reporting structure (other than temporarily while Employee is physically or mentally</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img21700163_0.jpg" alt="img21700163_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">incapacitated or as required by applicable law); or (v) following a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or reporting structure (other than temporarily while Employee is physically or mentally incapacitated or as required by applicable law), provided, however, that such changes solely resulting from the Company becoming a subsidiary, division or line of business of an acquiror that succeeds to the Company&#x2019;s business will not by itself give rise to Good Reason. Employee cannot terminate Employee&#x2019;s employment for Good Reason unless Employee have provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within thirty (30) days of the initial existence of such grounds and the Company has had at least thirty (30) days from the date on which such notice is provided to cure such circumstances (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cure Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). If Employee does not terminate employment for Good Reason within thirty (30) days after the end of the Cure Period, then Employee will be deemed to have waived Employee&#x2019;s right to terminate for Good Reason with respect to such grounds. If the Company cures the Good Reason condition during the Cure Period, Good Reason is deemed not to have occurred.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>4
<FILENAME>ck0001534133-ex10_5.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html>
 <head>
  <title>EX-10.5</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                      </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">KENNETH STAUDERMAN - AMENDMENT TO EMPLOYMENT OFFER LETTER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment is entered into as of March 20, 2025 by CalciMedica, Inc. (the &#x201c;Company&#x201d;) and Kenneth Stauderman (&#x201c;Employee&#x201d;) and amends that certain employment Offer Letter from the Company to Employee dated August 29, 2014 (&#x201c;Offer Letter&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, Employee is currently an executive officer of the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, the Board of Directors of the Company has approved an amendment to the employment offer letters of certain executives of the Company to adjust their severance benefits payable in the event employment is terminated by the Company prior to a Change in Control for reasons other than Cause or Good Reason (as such terms are defined in Appendix A attached hereto), death or disability; and</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">WHEREAS, it is the intent of the parties that this Amendment replace the provisions regarding severance benefits set forth in Employee&#x2019;s Offer Letter.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">NOW THEREFORE, the parties agree as follows:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.3463183470211444%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In the event (i) Employee&#x2019;s employment is terminated without Cause or for Good Reason (each as defined in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Appendix A attached hereto</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) and provided that Employee (ii) remains in compliance with his continuing obligations to the Company, (iii) Employee resigns from any other positions or roles held with or on behalf of the Company, and (iv) Employee provides the Company with an executed release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) within sixty (60) days after such termination and allow the Release to become fully effective by its terms (clauses (i) through (iv) collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Conditions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee shall be entitled to receive the following severance benefits: </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Nine (9) months of salary continuation payments, paid subject to required withholdings and deductions, paid on the Company&#x2019;s customary payroll schedule, commencing on the first payroll date that is at least three (3) business days after the Severance Conditions have been satisfied and continuing over the nine (9) month period thereafter; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">If Employee timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 or applicable state insurance laws (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall reimburse Employee for the monthly COBRA premium paid by Employee for Employee and his dependents for COBRA continuation coverage. Such reimbursement shall be paid to Employee in accordance with the Company&#x2019;s customary reimbursement procedures following the date that Employee timely remits to the Company documentation of the fact and amount of such premium payment (which documentation must be submitted to the Company within sixty (60) days after the date the payment was made). Employee shall be eligible to receive the foregoing reimbursement during the period from the termination date until the earliest of: (i) the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img22623684_0.jpg" alt="img22623684_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3917105089092185%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">nine (9)-month anniversary of Employee&#x2019;s termination date; (ii) the date Employee is no longer eligible for COBRA continuation coverage; and (iii) the date on which Employee becomes eligible to receive substantially similar coverage from another employer or other source (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA Premium Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). Employee will be responsible for timely payment of all COBRA premiums (including, without limitation, all administrative expenses), and agrees to timely notify the Company if Employee becomes eligible for health insurance through another employer or other source before the nine-month anniversary of Employee&#x2019;s termination date. Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of the foregoing COBRA reimbursements would result in a violation of applicable law (including, but not limited to, Section 105(h) of the Internal Revenue Code of 1986, as amended, Section 2716 of the Public Health Service Act, or any statute or regulation of similar effect) or is otherwise impracticable, then, in lieu of providing the COBRA reimbursement benefit, the Company will instead pay Employee on the last day of each remaining month of the COBRA Premium Period, a fully taxable cash payment equal to the COBRA reimbursement amount for that month, subject to applicable tax withholdings. Employee may, but is not obligated to, use this taxable payment to pay for medical expenses, including COBRA premiums.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, if Employee&#x2019;s termination occurs in connection with a Change of Control and Employee is eligible for severance under the Company&#x2019;s Change in Control Severance Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Severance Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), Employee&#x2019;s severance rights shall be governed exclusively by the Severance Policy, and not this Amendment.  Employee may not cumulate any severance benefit under this Amendment with any other severance benefits made available by the Company pursuant to any written agreement, plan or policy.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, Employee will not be eligible for severance benefits pursuant to this Amendment if Employee&#x2019;s employment terminates due to Employee&#x2019;s death, Disability or voluntary resignation of employment (without Good Reason).  (For purposes of the foregoing, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Disability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall exist if Employee is unable to perform the essential functions of Employee&#x2019;s position (with or without accommodation) for more than six (6) months in any twelve (12) month period, or for more than four (4) consecutive months.  This provision shall be interpreted and construed in accordance with the federal Americans with Disabilities Act of 1990 and all other applicable laws.)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.398%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Calibri;font-kerning:none;min-width:3.3463183470211444%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Code Section 409A Compliance</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notwithstanding anything set forth in this Amendment to the contrary, any severance payments and benefits provided pursuant to this Amendment which constitute &#x201c;deferred compensation&#x201d; within the meaning of the Treasury Regulations issued pursuant to Section 409A shall not commence until Employee have incurred a &#x201c;separation from service&#x201d; (as such term is defined in the Treasury Regulation Section 1.409A-1(h) (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Separation From Service</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;),</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img22623684_0.jpg" alt="img22623684_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">unless the Company reasonably determines that such amounts may be provided to Employee without causing Employee to incur the additional 20% tax under Section 409A.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the avoidance of doubt, it is intended that the payments and benefits set forth in this Amendment satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9) and this Amendment will be construed to the greatest extent possible as consistent with those provisions.  To the extent not so exempt, this Amendment (and any definitions hereunder) will be construed in a manner that complies with Section 409A and incorporates by reference all required definitions and payment terms.  For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A 2(b)(2)(iii)), Employee&#x2019;s right to receive any installment payments under this Amendment (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Amendment, if the Company (or, if applicable, the successor entity thereto) determines that any payments upon Employee&#x2019;s Separation From Service set forth herein and/or under any other agreement with the Company constitute &#x201c;deferred compensation&#x201d; under Section 409A and Employee is, on Employee&#x2019;s Separation From Service, a &#x201c;specified employee&#x201d; of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i) of the Code, then, solely, to the extent necessary to avoid the incurrence of the adverse personal tax consequences under Section 409A, the timing of the payments upon Employee&#x2019;s Separation From Service shall be delayed until the earlier to occur of: (a) the date that is six months and one day after Employee&#x2019;s Separation From Service or (b) the date of Employee&#x2019;s death (such applicable date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Specified Employee Initial Payment Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).  On the Specified Employee Initial Payment Date, the Company (or the successor entity thereto, as applicable) shall (A) pay Employee a lump sum amount equal to the sum of the payments that Employee would have otherwise received through the Specified Employee Initial Payment Date if the commencement of the payment of the severance benefits had not been so delayed pursuant to this section and (B) commence paying the balance of the severance benefits in accordance with the applicable payment schedules set forth in this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">None of the severance benefits under this Amendment will commence or otherwise be delivered prior to the effective date of the Release.  If the period of time Employee has to execute the Release &#x201c;crosses over&#x201d; two (2) calendar years, the Release will be deemed to have been executed on the 60th day after the date of termination. Except to the minimum extent that payments must be delayed because Employee is a &#x201c;specified employee&#x201d; (as described above) or until the effectiveness of the Release, all amounts will be paid as soon as practicable in accordance with the Company&#x2019;s normal payroll practices and no interest will be due on any amounts so deferred.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:2.507%;text-indent:-2.557%;padding-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3. The Offer Letter shall be and continues to remain in full force and effect, except as    modified  by this Amendment.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img22623684_0.jpg" alt="img22623684_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:0.139%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.398%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.4013378596248787%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The parties hereto agree that the laws of California govern this Amendment and that any questions arising under this Amendment shall be construed according to the laws of California.</font></div></div>
  <p style="margin-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:2.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:2.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Amendment and the Company&#x2019;s Change in Control Severance Policy constitute the entire agreement between the parties hereto with respect to the Employee&#x2019;s severance benefits. Any changes, amendments, or supplements hereto must be made in writing and signed by both parties.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  IN WITNESS WHEREOF, the parties have caused this Amendment to be executed and delivered on the date written above.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">__________________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">    			_________</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">/S/</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">______________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                        </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> By: Kenneth Stauderman, Ph.D.                                    By:         Rachel Leheny, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                                                                                              Title:       Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img22623684_0.jpg" alt="img22623684_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:35.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">APPENDIX A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">      </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean (i) Employee&#x2019;s willful and material failure to perform his material duties and obligations (other than any such failure resulting from incapacity due to physical or mental illness), and, if the failure is one that can be corrected, Employee has been given notice specifying the failure and the actions reasonably required to correct the failure and ten (10) business days to correct it; (ii) Employee&#x2019;s willful failure to comply with one or more valid and legal directives of the Board, which failure is not corrected within ten (10) business days after the Company has given Employee written notice specifying the failure in reasonable detail, and Employee has had an opportunity to address the Company with counsel present; (iii) any act of personal dishonesty, fraud, embezzlement, or misrepresentation, committed by Employee which is injurious to the  Company; (iv) Employee&#x2019;s conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (v) Employee&#x2019;s material violation of a material written policy of the Company or the rules of any governmental or regulatory body applicable to the Company and, if the breach is one that can be corrected, Employee has been given notice specifying the breach and ten (10) business days to correct it; or (vi) Employee&#x2019;s material breach of any material obligation under Employee&#x2019;s Offer Letter, as amended, or any other written agreement between Employee and the Company, and, if the breach is one that can be corrected, Employee has been given written notice specifying the breach and the actions reasonably required to correct the breach and ten (10) business days to correct it. For purposes of this provision, no act or failure to act on Employee&#x2019;s part shall be considered &#x201c;willful&#x201d; unless it is done, or omitted to be done, by Employee in bad faith or without reasonable belief that Employee&#x2019;s action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Employee in good faith and in the best interests of the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the occurrence of any of the following, in each case during Employee&#x2019;s employment without Employee&#x2019;s written consent: (i) a material reduction in Employee&#x2019;s base salary (unless pursuant to a salary reduction program applicable generally to the Company&#x2019;s executives); (ii) a relocation of Employee&#x2019;s principal place of employment (at the request of the Company) by more than thirty (30) miles from Employee&#x2019;s then-current principal place of employment immediately prior to such relocation (and provided that Employee is not otherwise authorized to work remotely); (iii) any material breach by the Company of any material provision of the Offer Letter or any material provision of any other agreement between Employee and the Company; (iv) prior to a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img22623684_0.jpg" alt="img22623684_0.jpg" style="width:227px;height:44px;"></p><p style="text-indent:-10.085%;padding-left:9.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">reporting structure (other than temporarily while Employee is physically or mentally incapacitated or as required by applicable law); or (v) following a Change in Control (as defined in the Severance Policy), a material adverse change in Employee&#x2019;s authority, duties, responsibilities, or reporting structure (other than temporarily while Employee is physically or mentally incapacitated or as required by applicable law), provided, however, that such changes solely resulting from the Company becoming a subsidiary, division or line of business of an acquiror that succeeds to the Company&#x2019;s business will not by itself give rise to Good Reason. Employee cannot terminate Employee&#x2019;s employment for Good Reason unless Employee have provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within thirty (30) days of the initial existence of such grounds and the Company has had at least thirty (30) days from the date on which such notice is provided to cure such circumstances (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cure Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). If Employee does not terminate employment for Good Reason within thirty (30) days after the end of the Cure Period, then Employee will be deemed to have waived Employee&#x2019;s right to terminate for Good Reason with respect to such grounds. If the Company cures the Good Reason condition during the Cure Period, Good Reason is deemed not to have occurred.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>5
<FILENAME>ck0001534133-ex10_6.htm
<DESCRIPTION>EX-10.6
<TEXT>
<html>
 <head>
  <title>EX-10.6</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="margin-left:66.667%;text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 10.6</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">November 6, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stephen Bardin</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">[***]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VIA ELECTRONIC DELIVERY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Dear Stephen:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Position</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) is pleased to offer you employment with the Company on the terms described below. Your employment with the Company will commence on November 7, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Start Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) and you will be formally appointed to the role of Chief Financial Officer effective one day following the filing with the Securities and Exchange Commission by the Company of its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024. You will report to Dr. Rachel Leheny, the Company&#x2019;s Chief Executive Officer and will have such duties and responsibilities customarily associated with a principal financial and accounting officer and reasonably assigned to you by the Company from time to time.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">   </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Compensation and Benefits</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Your annual base salary will be $380,000, less applicable withholdings, which will be paid in accordance with the Company&#x2019;s normal payroll procedures. You will be eligible to earn an annual performance bonus for each fiscal year of the Company, less applicable withholdings (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Annual Bonus</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), based on achievement of individual and Company performance objectives to be established by the Company&#x2019;s Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), subject to your continuous employment with the Company through the date any Annual Bonus is paid. At target levels of performance, your Annual Bonus would equal 40% of your base salary for the prior fiscal year. The actual amount of any Annual Bonus payment will depend on actual performance as determined by the Board in its sole and absolute discretion. The Annual Bonus will be pro-rated for any partial year of eligibility.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Bonuses are not earned until paid, and you must be continuously employed through the date of payment to be eligible to earn the bonus. All bonuses, less applicable withholdings, will be paid as soon as practicable after the Company determines that any such bonus should be paid which is expected before March 15 following the calendar year in which such bonus is earned. The specific terms and conditions of the foregoing bonus program, including establishment of target performance objectives, are subject to determination by the Board in its discretion.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">You will also be entitled to a sign-on bonus of $20,000, less applicable withholdings, earned on commencement of employment and payable by January 15, 2025.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">During your employment, you will be eligible to participate in the benefits plans offered to similarly situated employees by the Company from time to time, subject to plan terms and generally applicable Company policies.  Currently, exempt employees do not accrue vacation and are not subject to any limits in how much vacation they take per year.  Supervisors will approve paid vacation requests based on the employee&#x2019;s progress on work goals or milestones, status of projects, fairness to the working team, and productivity and efficiency of the employee.  An employee&#x2019;s ability to take vacation is not a form of additional wages for services performed, but rather evidences the Company&#x2019;s commitment to provide exempt employees with a flexible work schedule.  Since vacation is not allotted or accrued, there is no &#x201c;unused&#x201d; vacation time to be carried over from one year to the next nor paid out upon termination.  A full description of current benefits is available for your review.  The Company may change compensation and benefits from time to time in its discretion.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> In the event your employment is terminated without Cause or for Good Reason (each as defined in Appendix A) and subject to your execution of a release of claims in favor of the Company, its affiliates and their respective officers and directors in a form provided by the Company (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Release</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), you shall be entitled to receive the following:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:4.215515879285826%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">payments aggregating to nine months of your base salary for the year in which the termination occurs, which shall be paid ratably in accordance with the Company&#x2019;s customary payroll procedures over nine months following the execution of a Release; <br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:4.215515879285826%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a payment equal to the Annual Bonus earned for the year preceding the year in which termination occurs, if not yet paid, payable within sixty (60) days following the date of termination; <br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:0.843%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:0.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3770474535208295%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">If you timely and properly elect health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">COBRA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall reimburse you for the monthly COBRA premium paid by you for you and your dependents. Such reimbursement shall be paid to you in accordance with the Company&#x2019;s customary reimbursement procedures following the date that you timely remit the premium payment. You shall be eligible to receive such reimbursement until the earliest of: (i) the nine-month anniversary of your termination; (ii) the date you are no longer eligible to receive COBRA continuation coverage; and (iii) the date on which you become eligible to receive substantially similar coverage from another employer or other source. You will thereafter be responsible for the payment of COBRA premiums (including, without limitation, all administrative expenses) for the remaining COBRA period.<br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <div class="item-list-element-wrapper" style="margin-left:5.065%;text-indent:0.843%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:0.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Calibri;font-kerning:none;min-width:3.3770474535208295%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the time period that you may have to exercise any vested stock options shall be extended for a period equal to the shorter of (x) 12 months from the date of termination or (y) the remaining term of the applicable stock option.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">You may not cumulate any severance benefit under this Agreement with any other severance benefits made available by the Company pursuant to any written agreement, plan or policy.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Equity</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Subject to Board approval, the Company will grant you within two weeks of your Start Date:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Calibri;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">an option to purchase 100,000 shares of the Company&#x2019;s Common Stock pursuant to the Company&#x2019;s 2023 Equity Incentive Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), at an exercise price equal to the fair market value of the Company&#x2019;s Common Stock on the date of grant (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).  The Option will be subject to the following vesting schedule: twenty-five percent (25%) of the shares subject to the Option shall vest on the one-year anniversary of October 1, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Vesting Commencement Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) and 1/48</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to your continuing to provide services to the Company through each such date. Notwithstanding anything herein to the contrary, the Options will be governed by the terms and conditions of the Plan and the applicable grant agreement thereunder.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-2.587%;padding-left:2.507%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.111%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2) An award of restricted stock units (&#x201c;RSUs&#x201d;) pursuant to the Plan covering 40,000 shares of the Company&#x2019;s common stock. The RSUs will be subject to the following vesting schedule: twenty-five percent (25%) of the RSUs shall vest on the one-year anniversary of the Vesting Commencement Date and 1/16</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> of the RSUs shall vest each three months thereafter on the same day of the month as the Vesting Commencement Date, subject to your continuing to provide services to the Company through each such date.  Notwithstanding anything herein to the contrary, the RSUs will be governed by the terms and conditions of the Plan and the applicable grant agreement thereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Confidential Information and Company Policies</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As a condition of employment, you must sign and comply with the attached Employee Confidential Information and Inventions Assignment Agreement which prohibits unauthorized use or disclosure of the Company&#x2019;s proprietary information, among other obligations.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">We also ask that, if you have not already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company&#x2019;s understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. Moreover, you agree that, during the term of your employment with the Company, you will not engage in any other employment,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company. Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company, you will not in any way utilize any such information.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As a Company employee, you will be expected to abide by the Company&#x2019;s rules and policies.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Your employment is expressly conditioned upon receipt of a satisfactory background check that does not reveal any incidences or matters that would impair or affect your ability to perform the duties of a chief financial officer or principal financial or accounting officer. If the Company terminates your employment as a result of unsatisfactory background check you will not be entitled to receive the severance and benefits payments described above for a termination without Cause or for Good Reason.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">At-Will Employment and Exempt Status</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Your employment with the Company will be &#x201c;at-will.&#x201d;  You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company. Likewise, the Company may terminate your employment at any time, with or without cause or advance notice.  Your employment at-will status can only be modified in a written agreement signed by you and by an officer of the Company. We request that, in the event of resignation, you give the Company at least two weeks&#x2019; notice.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As a full-time exempt salaried employee, you will be expected to work the Company&#x2019;s normal business hours as well as additional hours as required by the nature of your work assignments, and you will not be eligible for overtime compensation.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Conditions, Dispute Resolution, and Complete Agreement</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment relationship with you may be terminated.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">To ensure the rapid and economical resolution of disputes that may arise in connection with your employment with the Company, and in exchange for the mutual promises contained in this offer letter, you and the Company agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this letter agreement, your employment with the Company, or the termination of your employment, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. &#167; 1-16 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">FAA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS or its successor, under JAMS&#x2019; then applicable rules and procedures appropriate to the relief being sought (available upon request and also currently available at the following web addresses: (i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">https://www.jamsadr.com/rules-employment-arbitration/ and (ii) https://www.jamsadr.com/rules-comprehensive-arbitration/). </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">You acknowledge that by agreeing to this arbitration procedure, both you and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  In addition, all claims, disputes, or causes of action under this section, whether by you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity.  The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding.  To the extent that the preceding sentences regarding class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration.  This paragraph shall not apply to any action or claim that cannot be subject to mandatory arbitration as a matter of law, including, without limitation, sexual assault disputes and sexual harassment disputes as defined in the FAA including, without limitation, discrimination, retaliation, or</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">harassment claims, to the extent such claims are not permitted by applicable law(s) to be submitted to mandatory arbitration and the applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Excluded Claims</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).  In the event you intend to bring multiple claims, including one of the Excluded Claims listed above, the Excluded Claims may be filed with a court, while any other claims will remain subject to mandatory arbitration.  You will have the right to be represented, at your own expense, by legal counsel at any arbitration proceeding. Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator.  Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator.  The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator&#x2019;s essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all relief that you or the Company would be entitled to seek in a court of law. The Company shall pay all JAMS&#x2019; arbitration fees, or such fees shall be paid in such other manner to the extent required by, and in accordance with, applicable law to effectuate your and the Company&#x2019;s agreement to arbitrate.  Each party is responsible for its own attorneys&#x2019; fees, except as expressly set forth in your Employee Confidential Information and Inventions Assignment Agreement. Nothing in this letter agreement is intended to prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This letter, together with your Employee Confidential Information and Inventions Assignment Agreement, forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone, whether oral or written. You acknowledge and agree that you are not relying on any representations other than the terms set forth in this letter. Changes in your employment terms, other than those changes expressly reserved to the Company&#x2019;s discretion in this letter, require a written modification signed by an officer of the Company.  If any provision of this offer letter agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this offer letter agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.  This letter may be delivered and executed via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and shall be deemed to have been duly and validly delivered and executed and be valid and effective for all purposes.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">*	*	*</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This offer of employment will terminate if it is not accepted, signed and returned by November 6, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Best personal regards,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">						</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">/s/ Rachel Leheny					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Rachel Leheny</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ACCEPTED AND AGREED TO this</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6th day of November, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">/s/ Stephen Bardin					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stephen Bardin</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Enclosure:		Duplicate Original Offer Letter</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">                           Employee Confidential Information and Inventions Assignment Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="text-indent:35%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">APPENDIX  A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">      </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cause</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean (i) your willful and material failure to perform your material duties and obligations (other than any such failure resulting from incapacity due to physical or mental illness), and, if the failure is one that can be corrected, you have been given notice specifying the failure and the actions reasonably required to correct the failure and ten (10) business days to correct it; (ii) your willful failure to comply with one or more valid and legal directives of the Board, which failure is not corrected within ten (10) business days after the Company has given you written notice specifying the failure in reasonable detail, and you have had an opportunity to address the Company with counsel present; (iii) any act of personal dishonesty, fraud, embezzlement, or misrepresentation, committed by you which is injurious to the  Company; (iv) your conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony (or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (v) your material violation of a material written policy of the Company or the rules of any governmental or regulatory body applicable to the Company and, if the breach is one that can be corrected, you have been given notice specifying the breach and ten (10) business days to correct it; or (vi) your material breach of any material obligation under this offer letter or any other written agreement between you and the Company, and, if the breach is one that can be corrected, you have been given notice specifying the breach and the actions reasonably required to correct the breach and ten (10) business days to correct it. For purposes of this provision, no act or failure to act on your part shall be considered &#x201c;willful&#x201d; unless it is done, or omitted to be done, by you in bad faith or without reasonable belief that your action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by you in good faith and in the best interests of the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Good Reason</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; shall mean the occurrence of any of the following, in each case during your employment without your written consent: (i) a material reduction in your base salary or . benefits (unless pursuant to a salary or employee benefit reduction program applicable generally to the Company&#x2019;s executives); (ii) a relocation of your principal place of employment (at the request of the Company) by more than thirty (30) miles from your then-current principal place of employment immediately prior to such relocation; (iii) any material breach by the Company of any material provision of this offer letter or any material provision of any other agreement between you and the Company; (iv) prior to a Change in Control (as defined in the Plan), a material, adverse change in your position, authority, duties, responsibilities, or reporting structure (other than temporarily while you are physically or mentally incapacitated or as required by applicable law); or (v) following a Change in Control (as defined in the Plan), a material, adverse change in your duties or responsibilities, provided that changes solely resulting in your position, authority or reporting structure after a Change in Control (as defined in the Plan) being in a division or line of business of an acquiror that succeeds to the Company&#x2019;s</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img23547205_0.jpg" alt="img23547205_0.jpg" style="width:223px;height:46px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">business will not by itself give rise to Good Reason. You cannot terminate your employment for Good Reason unless you have provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within thirty (30) days of the initial existence of such grounds and the Company has had at least thirty (30) days from the date on which such notice is provided to cure such circumstances (the &#x201c;Cure Period&#x201d;). If you do not terminate employment for Good Reason within thirty (30) days after the end of the Cure Period, then you will be deemed to have waived your right to terminate for Good Reason with respect to such grounds. If the Company cures the Good Reason condition during the Cure Period, Good Reason is deemed not to have occurred.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.34in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">CalciMedica, Inc., 505 Coast Blvd. South, Suite 307, La Jolla, CA 92037</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">Tel: (858) 952-5500 </font><font style="color:#23408d;white-space:pre-wrap;font-weight:bold;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">I</font><font style="color:#23408d;white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font><font style="white-space:pre-wrap;font-size:10.5pt;font-family:'Trebuchet MS',sans-serif;font-kerning:none;min-width:fit-content;">www.calcimedica.com</font></font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>6
<FILENAME>ck0001534133-ex10_20.htm
<DESCRIPTION>EX-10.20
<TEXT>
<html>
 <head>
  <title>EX-10.20</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="margin-left:60%;text-indent:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.20</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation Policy</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each member of the Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) who is not also serving as an employee of or consultant to CalciMedica, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) or any of its subsidiaries (each such member, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Eligible Director</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) will receive the compensation described in this Non-Employee Director Compensation Policy for his or her Board service. The policy is effective as of May 8, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). An Eligible Director may decline all or any portion of his or her compensation by giving notice to the Company prior to the date cash may be paid or equity awards are to be granted, as the case may be. This policy is effective as of the Effective Date and may be amended at any time in the sole discretion of the Board or the Compensation Committee of the Board.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Cash Compensation</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The annual cash compensation amount set forth below is payable to Eligible Directors in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal quarter, with the pro-rated amount paid on the last day of the first fiscal quarter in which the Eligible Director provides the service and regular full quarterly payments thereafter. All annual cash fees are vested upon payment.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Board Service Retainer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a.	All Eligible Directors: $40,000</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b.	Chair of the Board Service Retainer (in addition to Eligible Director Service Retainer): $35,000</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Committee Chair Service Retainer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a.	Chair of the Audit Committee: $15,000</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b.	Chair of the Compensation Committee: $10,000</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c.	Chair of the Nominating and Corporate Governance Committee: $10,000</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Committee Member Service Retainer (not applicable to Committee Chairs)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a.	Member of the Audit Committee: $7,500</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b.	Member of the Compensation Committee: $5,000</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c.	Member of the Nominating and Corporate Governance Committee: $5,000  	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Compensation</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The equity compensation set forth below will be granted under the Company&#x2019;s 2023 Equity Incentive Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). All stock options granted under this policy will be nonstatutory stock options, with an exercise price per share equal to 100% of the Fair Market Value (as defined in the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Plan) of the underlying shares of the Company&#x2019;s common stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on the date of grant, and a term of ten years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Plan).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial Grant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: For each Eligible Director who is first elected or appointed to the Board following the Effective Date, on the date of such Eligible Director&#x2019;s initial election or appointment to the Board (or, if such date is not a market trading day, the first market trading day thereafter), the Eligible Director will automatically, and without further action by the Board or the Compensation Committee of the Board, be granted a stock option to purchase 20,000 shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Initial Grant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The shares subject to each Initial Grant will vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Eligible Director&#x2019;s Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annual Grant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: On the date of each annual stockholder meeting of the Company held after the Effective Date (an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Meeting</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), each Eligible Director who continues to serve as a non-employee member of the Board following such Annual Meeting will automatically, and without further action by the Board or the Compensation Committee of the Board, be granted a stock option to purchase 10,000 shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Grant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The shares subject to the Annual Grant will vest in equal monthly installments over the 12 months following the date of grant, provided that the Annual Grant will in any case be fully vested on the date of Company&#x2019;s next Annual Meeting, subject to the Eligible Director&#x2019;s Continuous Service through such vesting date; provided, further, that the shares subject to the Annual Grant will vest in full upon a Change in Control.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation Limit</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, the aggregate value of all compensation granted or paid, as applicable, to any individual for service as a Non-Employee Director (as defined in the Plan) shall in no event exceed the limits set forth in the Plan.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>7
<FILENAME>ck0001534133-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:66.667%;text-indent:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CALCIMEDICA, INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">INSIDER TRADING POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Amended April 2023</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I.	PURPOSE</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">It is illegal for any employee, officer or director of CalciMedica, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">to trade in the securities of the Company while in the possession of material nonpublic information about the Company.  It is also illegal for any employee, officer or director of the Company to give material nonpublic information to others who may trade on the basis of that information.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In order to comply with federal and state securities laws governing (i) trading in Company securities while in the possession of material nonpublic information concerning the Company and (ii) tipping or disclosing material nonpublic information to any outside person, and in order to prevent the appearance of improper trading or tipping, the Company has adopted this Inside Trading Policy (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) for all of its employees, officers and directors, members of their immediate families and others living in their households.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">II.	SCOPE</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A.	This Policy covers all employees, officers and directors of the Company, members of their immediate families and others living in their households (collectively referred to herein as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">employees, officers or directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) and other entities (such as partnerships, trusts and corporations) that are affiliated or associated with such persons.  An affiliate is someone who directly or indirectly controls, or is controlled by or is under common control with such person.  An associate is (x) a corporation or organization (other than the Company or a majority owned subsidiary of the Company) of which such person is an officer or partner or is directly or indirectly the beneficial owner of 10% or more of any class of equity securities or (y) any trust in which such person has a substantial beneficial interest or as to which such person serves as trustee or in a similar capacity.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Employees, officers and directors are responsible for ensuring compliance by their immediate families and other members of their households.  Notwithstanding the foregoing, this Policy shall not apply to any venture capital fund or other entity that engages in the investment of securities in the ordinary course of its business (e.g., an investment fund or partnership) other than for an employee, officer or director&#x2019;s own account if such entity has established its own insider trading controls and procedures in compliance with applicable securities laws.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">B.	This Policy applies to any and all transactions in the Company&#x2019;s securities, including shares of its Common Stock and options to purchase Common Stock (as</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">described in more detail in Section VI.E below), however acquired, and any other type of securities that the Company may issue, such as shares of preferred stock, convertible debentures, warrants and exchange-traded options or other derivative securities.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">C.	This Policy will be delivered to all employees, officers and directors upon its adoption by the Company, and to all new employees, officers and directors at the start of their employment or relationship with the Company.  Upon first receiving a copy of this Policy or any revised versions, each employee, officer or director must sign a certification that</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">he or she has received a copy and agrees to comply with the terms of this Policy.  This certification and agreement will constitute consent for the Company to impose sanctions for violation of this Policy and to issue any necessary stop-transfer orders to the Company&#x2019;s transfer agent to enforce compliance with this Policy.  As discussed in Section VII.B, sanctions for individuals may include demotion or other disciplinary actions, up to and including termination of employment, if the Company has a reasonable basis to conclude that this Policy has been violated.  Section 16 Parties, as defined below, may be required to certify compliance with this Policy on an annual basis.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">D.	This Policy allows for trades by employees, officers and directors made in compliance with Rule 10b5-1 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) promulgated by the Securities and Exchange Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) under the Securities Exchange Act of 1934, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), subject to the approval of the Compliance Officer (as defined in Section IV below).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">E.	The Company may change</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">these procedures or adopt such other procedures in the future as the Company considers appropriate in order to carry out the purposes of this Policy.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">III.	SECTION 16 PARTIES; ACCESS PERSONS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Section 16 Parties.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company has designated those persons listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> attached hereto as the officers and directors who are subject to the reporting provisions and trading restrictions of Section 16 of the Exchange Act,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and the underlying rules and regulations promulgated by the SEC.  Each such person is referred to herein as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Section 16 Party</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Section 16 Parties must obtain prior approval of all trades in Company securities from the Compliance Officer in accordance with the procedures set forth in Section VI.D below.  The Company will amend </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> from time to time as necessary to reflect the addition and the resignation or departure of Section 16 Parties.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">B.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Access Persons.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company has designated those persons listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> attached hereto as the persons who have regular access to material nonpublic information in the normal course of their duties for the Company (other than Section 16 Parties); each person listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> is referred to herein as an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Access Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;  Access Persons must obtain prior approval of all trades in Company securities from the Compliance Officer in accordance with the procedures set forth in Section VI.D below.  The Company will amend </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> from time to time as necessary to reflect the addition and the resignation, departure or change of status of Access Persons.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">IV.	INSIDER TRADING COMPLIANCE OFFICER</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Company has designated the Company&#x2019;s General Counsel as its</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Insider Trading Compliance Officer (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Compliance Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;) and in the event of the General Counsel&#x2019;s unavailability, the Company&#x2019;s Chief Executive Officer shall be authorized to serve as Compliance Officer in the interim.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Compliance Officer will review and either approve or prohibit all proposed trades by Section 16 Parties or Access Persons in accordance with the procedures set forth in Section VI.D below, except that with respect to proposed trades by the General Counsel when also serving as the Compliance Officer, any such proposed trades must be approved by the Company&#x2019;s Chief Executive Officer.  The Compliance Officer may consult with the Company&#x2019;s outside legal counsel.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In addition to the trading approval duties described in Section VI.D below, the duties of the Compliance Officer will include the following:</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A. 	Administering and interpreting this Policy and monitoring and enforcing compliance with all the provisions and procedures set forth in this Policy.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">B.	Responding to all inquiries relating to this Policy and its procedures.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">C.	Designating and announcing special trading blackout periods during which no designated employees, officers or directors may trade in Company securities.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">D.	Providing copies of this Policy and other appropriate materials to all current and new employees, officers and directors, and such other persons who the Compliance Officer determines may have access to material nonpublic information concerning the Company.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">E.	Administering, monitoring and enforcing compliance with all federal and state insider trading laws and regulations, including without limitation Sections 10(b), 16, 20A and 21A of the Exchange Act and the rules and regulations promulgated thereunder, and Rule 144 under the Securities Act of 1933, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;);</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and assisting in the preparation and filing of all required SEC reports relating to insider trading in Company securities, including without limitation Forms 3, 4, 5 and 144 and Schedules 13D and 13G.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">F.	Revising this Policy as necessary to reflect changes in federal or state insider trading laws and regulations, subject to approval by the Company&#x2019;s Board of Directors or a duly authorized committee thereof.</font></p>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">G.	Maintaining as Company records originals or copies of all documents required by the provisions of this Policy or the procedures set forth herein, and copies of all required SEC reports relating to insider trading, including without limitation Forms 3, 4, 5 and 144 and Schedules 13D and 13G.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:10%;text-indent:-4.847%;padding-left:4.173%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">H.	Maintaining the accuracy of the list of Section 16 Parties as attached on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> and the list of Access Persons as attached on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, and updating such lists periodically as necessary to reflect additions or deletions.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The Compliance Officer may designate one or more individuals who may perform the Compliance Officer&#x2019;s duties in the event that the Compliance Officer is unable or unavailable to perform such duties.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">V.	DEFINITION OF &#x201c;MATERIAL NONPUBLIC INFORMATION&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A.	&#x201c;Material&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Information about the Company is &#x201c;material&#x201d; if it would be expected to affect the investment or voting decisions of a reasonable stockholder or investor, or if the disclosure of the information would be expected to alter significantly the total mix of the information in the marketplace about the Company.  In simple terms, material information is any type of information that could reasonably be expected to affect the market price of the Company&#x2019;s securities.  Both positive and negative information may be material.  While it is not possible to identify all information that would be deemed &#x201c;material,&#x201d; the following types of information would ordinarily be considered material:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	financial performance, such as quarterly and year-end operating results, and changes in financial performance or liquidity;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	operational metrics, such as employee counts and distribution by geography or function;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	results or material data from clinical or pre-clinical testing or trials, or other significant development milestones;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	significant communications to or from regulatory agencies, or other significant regulatory developments;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	initiation of a new clinical trial for a product candidate;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	significant cybersecurity incidents or data breaches;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	potential mergers, acquisitions or material sales of Company assets or subsidiaries;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	developments regarding suppliers or partners, such as the acquisition or loss of a significant contract or a development agreement;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	stock splits, public or private securities and/or debt offerings or issuances of dividends;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	entry into a new, or cancellation of a, major strategic relationship;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	introduction of new product candidates;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	initiation of a significant lawsuit; and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#149;	significant changes in senior management.</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	B.	&#x201c;Nonpublic&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Material information is &#x201c;nonpublic&#x201d; if it has not been widely disseminated to the public, for example, through major newswire services, national news services, Web casts or financial news services.  For the purposes of this Policy, information will be considered public, i.e., no longer &#x201c;nonpublic,&#x201d; after two full trading days following the Company&#x2019;s widespread public release of the information.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">C.	Consult the Compliance Officer for Guidance</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Employees, officers or directors who are unsure whether the information that they possess is material or nonpublic must consult the Compliance Officer for guidance before trading in any Company securities.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">VI.	STATEMENT OF COMPANY POLICY AND PROCEDURES</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	A.	Prohibited Activities</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1.	No employee, officer or director may trade in Company securities while possessing material nonpublic information concerning the Company (except as permitted by Section VI.C).  It does not matter that there may exist a justifiable reason for a purchase or sale apart from the nonpublic information; if the employee, officer or director has material nonpublic information, the prohibition still applies.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2.	No employee, officer or director</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">may trade in Company securities during any trading blackout periods (described below) designated by the Compliance Officer that are applicable to such employee, officer or director (except as permitted by Section VI.C).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3.	No Section 16 Party or Access Person may trade in Company securities unless the trade has been approved by the Compliance Officer in accordance with the procedures set forth in Section VI.D below (except as permitted by Section VI.C). Employees who are not Section 16 Parties or Access Persons need not obtain approval from the Compliance Officer prior to trading.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4.	The Compliance Officer may not trade in Company securities unless the trade has been approved by the Company&#x2019;s Chief Executive</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:20%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Officer in accordance with the procedures set forth in Section VI.D below (except as permitted by Section VI.C).</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">5.	No employee, officer or director may disclose material nonpublic information concerning the Company to any outside person (including family members, analysts, individual investors and members of the investment community and news media), unless required as part of the regular duties of such employee, director or officer for the Company or authorized by the Compliance Officer; provided that a director may disclose such information to his or her affiliates so long as such affiliates have established their own insider trading controls and procedures in compliance with applicable securities laws.  In any instance in which such information is disclosed to outsiders, the Company will take such steps as are necessary to preserve the confidentiality of the information.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6.	No employee, officer or director may give trading advice of any kind about the Company to anyone while possessing material nonpublic information about the Company, except that employees, officers or directors should advise others not to trade if doing so might violate the law or this Policy; provided that a director may provide such advice to his or her affiliates so long as such affiliates have established their own insider trading controls and procedures in compliance with applicable securities laws.  The Company strongly discourages all employees, officers and directors from giving trading advice concerning the Company to third parties even when the employees, officers and directors do not possess material nonpublic information about the Company.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">7.	No employee, officer or director may engage in hedging or monetization transactions (i) involving the Company&#x2019;s stock, such as zero cost collars and forward sale contracts, or contribute the Company&#x2019;s stock to exchange funds in a manner that could be interpreted as hedging in the Company&#x2019;s stock or (ii) involving options or other derivative securities on the Company&#x2019;s stock, such as puts and calls, whether on an exchange or in any other market, unless such individual limits the transaction solely to exercising a compensatory equity grant issued by the Company.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">8.	No employee, officer or director may (a) trade in the securities of any other public company while possessing material nonpublic information concerning that company obtained in the course of service as an employee, officer or director, (b) &#x201c;tip&#x201d; or disclose such material nonpublic information concerning any other public company to anyone or (c) give trading advice of any kind to anyone concerning any other public company while possessing such material nonpublic</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:20%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">information about that company; provided that a director may provide such advice to his or her affiliates so long as such affiliates have established their own insider trading controls and procedures in compliance with applicable securities laws.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">9.	Except as permitted by Section VI.C, no employee, officer or director may make a gift or other transfer without consideration of Company securities during a period when that employee, officer or director is not permitted to trade.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">10.	No employee, officer or director may participate, in any manner other than passive observation, in any of the investment or stock-related Internet &#x201c;chat&#x201d; rooms, blogs, social media sites or message boards relating to the Company.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">11.	No employee, officer or director may use or pledge Company securities as collateral in a margin account or as collateral for a loan unless the pledge has been approved by the Compliance Officer.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">12.	No entity over which an employee, officer or director has or shares voting or investment control may distribute securities of the Company to its limited partners, general partners or stockholders during a period when the employee, officer or director is not permitted to trade,  unless the Company has established a trading window described in VI.B and the limited partners, general partners or stockholders of that entity have agreed in writing to hold the securities until such trading window is open.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">13.	It is the Company&#x2019;s policy to disclose material information concerning the Company to the public only in accordance with its Corporate Communications Policy in order to avoid inappropriate publicity and to ensure that all such information is communicated in a way that is reasonably designed to provide broad, non-exclusionary distribution of information to the public.  All inquiries or calls from the press, investors and financial analysts should be referred to a designated Company spokesperson.  Please see the Company&#x2019;s Corporate Communications Policy for details.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	B.	Trading Windows and Blackout Periods</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.87%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:6.835914754862%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">From time to time, the Company may require that certain persons limit their transactions in the Company&#x2019;s securities to certain trading window periods as described below. </font></div></div>
  <p style="margin-left:20.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:14.173%;text-indent:-8.422%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.13%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:5.87%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:6.835914754862%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">From time to time, the Company may generally prohibit Section 16 Parties and Access Persons from trading securities outside of a time period the Company designates as an open trading window (such period when trading is allowed is referred to as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">trading</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">window period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d; and such period when trading is not allowed is referred to as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">trading</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">blackout period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;).  As of the effective date of this amended policy, the Company has not instituted a trading window period. </font></div></div>
  <p style="margin-left:20.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:14.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:7.764061954116687%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In the event the Company institutes a trading window period, except as permitted by Section VI.C or described in this policy, Section 16 Parties and Access Persons</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">will be able to trade in Company securities </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">only</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> during limited open trading window periods that generally will begin after two full trading days have elapsed since the public dissemination of material information (such as the Company&#x2019;s annual or quarterly financial results) and end at the beginning of the next trading blackout period</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:7.692662720527998%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Any trading window period may be closed early or may not open if, in the judgment of the Compliance Officer, there exists undisclosed information that would make trades inappropriate. In addition the Compliance Officer may designate special trading blackouts that apply to particular individuals or groups of persons for such time as is determined by the Compliance Officer. It is important to note that the fact that the trading window is closed should itself be considered inside information and not shared outside of the Company.    </font></div></div>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">6.    A Section 16 Party or Access Person</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">who believes that special circumstances require him or her to trade during a trading blackout period should consult the Compliance Officer. Permission to trade during a trading blackout period will be granted only where the circumstances are extenuating, the Compliance Officer concludes that the person is not in fact aware of any material nonpublic information relating to the Company or its securities, and there appears to be no significant risk that the trade may subsequently be questioned.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	C.	Exception for Transfers Pursuant to Rule 10b5-1</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The restrictions outlined in Sections VI.A.1, 2, 3, 4 and 9 and VI.B shall not prohibit transfers of Company securities made pursuant to a written contract, letter of instruction or plan that is established by a Section 16 Party, or by an Access Person: (a) that</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">complies with the requirements of Rule 10b5-1 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201d;), (b) that has been approved by the Compliance Officer at least 60 days in advance of the first trade thereunder and (c) with respect to which the Compliance Officer has received the certification referred to in Section VI.D.2.c.  No such approval by the Compliance Officer shall be considered the Compliance Officer&#x2019;s or the Company&#x2019;s approval that the Rule 10b5-1 Plan satisfies the requirements of Rule 10b5-1.  It shall be the sole responsibility of the person establishing the Rule 10b5-1 Plan to ensure that such plan complies with the requirements of Rule 10b5-1.  The Company reserves the right to prevent any transactions in Company securities, even those pursuant to a Rule 10b5-1 Plan, if the Compliance Officer determines that prevention of such transaction is necessary to comply with securities law or contractual obligations.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">D.	Procedures for Approving Trades</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Section 16 Parties and Access Persons.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Except as provided in paragraph 2 of this subsection, no Section 16 Party or Access Person may trade in Company securities, until:</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">a.	The person proposing to trade has printed, completed and emailed to the Compliance Officer a signed PDF copy of the form attached as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> hereto, which form must be received by the Compliance Officer during a reasonable period prior to the proposed trade(s)and</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">b.	The Compliance Officer has approved the trade(s) via email.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Plans.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  No trades shall be treated as having been made pursuant to a Rule 10b5-1 Plan under this Policy unless:</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">a.	The Rule 10b5-1 Plan complies with the requirements of Rule 10b5-1;</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">b.	The Compliance Officer has approved the Rule 10b5-1 Plan, and has certified such approval in writing at least 60 days in advance of the first trade thereunder; and</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">c.	The person establishing the Rule 10b5-1 Plan has certified to the Compliance Officer in writing no earlier than two business days prior to the date that the Rule 10b5-1 Plan is formally established, that:</font></p>
  <p style="margin-left:26.667%;text-indent:-10%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(i)	Such person is not in possession of material nonpublic information concerning the Company and all such trades to be made pursuant to the Rule 10b5-1 Plan will be made in accordance with Section 16 of the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exchange Act and Rule 144 of the Securities Act to the extent such Sections are applicable; and</font></p>
  <p style="margin-left:26.667%;text-indent:-10%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(ii)	The Rule 10b5-1 Plan complies with the requirements of Rule 10b5-1.</font></p>
  <p style="margin-left:20%;text-indent:-9.091%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">d.	In order to effect an amendment to an existing Rule 10b5-1 Plan, the person amending such plan must satisfy all of the conditions set forth in Section VI.D.2.a-c with respect to such amendment.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">No Obligation to Approve Trades.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The existence of the foregoing approval procedures does not in any way obligate the Compliance Officer to approve any trades requested by Section 16 Parties or Access Persons or to approve any Rule 10b5-1 Plan.  The Compliance Officer may reject any trading requests or Rule 10b5-1 Plans at his or her sole reasonable discretion.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">4.        Pre-cleared transactions not completed within five business days will require new pre-clearance. The Company may choose to shorten this period.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	E.	Employee Stock Purchase and Equity Incentive Plans</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The trading prohibitions and restrictions set forth in this Policy do not apply to periodic wage withholding contributions by the Company or employees to the Company&#x2019;s Employee Stock Purchase Plan that is used to purchase Company securities pursuant to the employees&#x2019; advance instructions.  However, no officers or employees may alter their instructions regarding the level of withholding or purchase by the officer or employee of Company securities under such plan while in the possession of material nonpublic information.  Any sale of securities acquired under such plan is subject to the prohibitions and restrictions of this Policy.</font></p>
  <p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">  The trading prohibitions and restrictions of this Policy apply to all sales of securities acquired upon the exercise of options to purchase Company stock, but not to the acquisition of Company stock by such exercise.</font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">F.	Priority of Statutory or Regulatory Trading Restrictions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The trading prohibitions and restrictions set forth in this Policy will be superseded by any greater prohibitions or restrictions prescribed by federal or state securities laws</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">and regulations, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">e.g.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">, contractual restrictions on the sale of securities, short-swing trading by Section 16 Parties or restrictions on the sale of securities subject to Rule 144 under the Securities Act.  Any employee, officer or director who is uncertain whether other prohibitions or restrictions apply should ask the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">VII.	POTENTIAL CIVIL, CRIMINAL AND DISCIPLINARY SANCTIONS</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	A.	Civil and Criminal Penalties</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The consequences of prohibited insider trading or tipping can be severe.  Persons violating insider trading or tipping rules may be required to disgorge the profit made or the loss avoided by trading, pay the loss suffered by the persons who purchased securities from or sold securities to the insider tippee, pay civil penalties up to three times the profit made or loss avoided, pay a criminal penalty of up to $5 million and serve a jail term of up to 20 years.  The Company and/or the supervisors of the person violating the rules may also be required to pay major civil or criminal penalties and could under certain circumstances be subject to private lawsuits by contemporaneous traders for damages suffered as a result of illegal insider trading or tipping by persons under the Company&#x2019;s control.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	B.	Company Discipline</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Violation of this Policy or federal or state insider trading or tipping laws by any (i) employee or officer may subject such employee or officer to disciplinary action by the Company up to and including termination for cause and (ii) director may subject such director to dismissal proceedings.  A violation of this Policy is not necessarily the same as a violation of law.  In fact, for the reasons indicated above, this Policy is intended to be broader than the law.  The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Policy has been violated.  The Company may determine that specific conduct violates this Policy, whether or not the conduct also violates the law.  It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">C.	Reporting of Violations</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Any employee, officer or director who violates this Policy or any federal or state laws governing insider trading or tipping, or knows of any such violation by any other employee, officer or director, must report the violation immediately to the Compliance Officer or the Chief Executive Officer.  Upon learning of any such violation, the Compliance Officer or the Chief Executive Officer, in consultation with the Company&#x2019;s legal counsel, will determine whether the Company should release any material nonpublic information, or whether the Company should report the violation to the SEC or other appropriate governmental authority.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">VIII.	INQUIRIES</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Please direct all inquiries regarding any of the provisions or procedures of this Policy to the Compliance Officer.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.6in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.9in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><img src="img221834505_0.jpg" alt="img221834505_0.jpg" style="width:134px;height:31px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Section 16 Parties</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">As of January,, 2025</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">)</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">DIRECTORS:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Robert Wilson</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Eric Roberts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A Rachel Leheny</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Fred Guerard Fred Middleton Allan Shaw</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Alan Glicklich</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXECUTIVE OFFICERS:</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Name</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">						</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Title</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">A. Rachel Leheny                              Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Eric Roberts                                       Chief Business Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Michael Dunn                                     President and Chief Operating Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Kenneth Stauderman                         Chief Scientific Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Sudarshan Hebbar                             Chief Medical Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Raven Jaeger                                     Chief Regulatory Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Stephen Bardin                                    Chief Financial Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.9in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Access Persons</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-style:italic;font-kerning:none;min-width:fit-content;">As of January, 2025</font></p>
  <p style="margin-left:0.84%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Name</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">					</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Title</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">All Employees</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.9in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">EXHIBIT C</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CalciMedica, Inc.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">APPLICATION FOR TRADING<br>BY SECTION 16 PARTIES AND ACCESS PERSONS</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">												</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">												</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Proposed Trade Date:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">									</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Type of Security to be Traded:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">								</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Type of Trade (Purchase/Sale):</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">								</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Number of Shares or Other Securities to be Traded:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">					</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">CERTIFICATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I hereby certify that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I have read and understood the CalciMedica Trading Policy, </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I am not aware of any &#x201c;material nonpublic information&#x201d; concerning CalciMedica as defined in the Company&#x2019;s Insider Trading Policy, </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I understand that it is my responsibility to ensure that I do not transact in CalciMedica securities while I am aware of material non-public information about CalciMedica, and that clearance from CalciMedica to transact in CalciMedica securities is not a representation or certification that CalciMedica or any of its officers, employees or representatives is in agreement that I am not in possession of material non-public information,</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">to the best of my knowledge, the proposed trade(s) listed above do not violate the trading restrictions of Section 16 of the Securities Exchange Act of 1934, as amended, or Rule 144 under the Securities Act of 1933, as amended, and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I understand that if I trade while possessing material non-public information or if my trades violate Section 16 or Rule 144, I may be subject to severe civil and/or criminal penalties, and may be subject to discipline by the Company up to and including termination for cause.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">I understand that clearance to transact in CalciMedica securities, if received, will be immediately rescinded and no longer be in effect in the event of any of the below</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If I become aware of material non-public information affecting CalciMedica;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If a normal or special Blackout Window is or becomes effective under the Insider Trading Policy during the period that I plan to transact in CalciMedica securities; or</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:0.796%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:2.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.557356558203298%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">If this clearance is rescinded by the CalciMedica Compliance Officer.</font></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">					 		</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">				<br></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">(Signature)							(Date)</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:0.8in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:6pt;font-family:'Wingdings',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ck0001534133-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:60%;text-indent:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Georgia',serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-276793, No. 333-273949 and No. 333-271115) and Form S-8 (No. 333-281800, No. 333-278336, No. 333-271898, No. 333-266980, No. 333-263464, No. 333-263464, No. 333-254522 and No. 333-249033) of CalciMedica, Inc. (the &#x201c;Company&#x201d;), of our report dated March 27, 2025, relating to the consolidated financial statements as of and for the year ended December 31, 2024 of the Company (which report expresses an unqualified opinion), appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Moss Adams LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>9
<FILENAME>ck0001534133-ex23_2.htm
<DESCRIPTION>EX-23.2
<TEXT>
<html>
 <head>
  <title>EX-23.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:73.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.2</font></p>
  <p style="margin-left:73.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:73.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in the following Registration Statements:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-3 Nos. 333-276793, 333-273949 and 333-271115) of CalciMedica, Inc. (formerly Graybug Vision, Inc.), </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-271898) pertaining to the Amended and Restated 2006 Stock Plan, 2023 Equity Incentive Plan, and 2023 Employee Stock Purchase Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.),</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-249033) pertaining to the 2020 Equity Incentive Plan, 2020 Employee Stock Purchase Plan and 2015 Stock Incentive Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.),</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statements (Forms S-8 Nos. 333-254522 and 333-263464) pertaining to the 2020 Equity Incentive Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.),  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-266980) pertaining to the Amended and Restated 2020 Equity Incentive Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.),</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-278336) pertaining to the 2023 Equity Incentive Plan and 2023 Employee Stock Purchase Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.), and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-281800) pertaining to the 2023 Equity Incentive Plan of CalciMedica, Inc. (formerly Graybug Vision, Inc.);</font></div></div>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our report dated March 28, 2024 (except for the Segment Information section of Note 2, as to which the date is March 27, 2025) with respect to the consolidated financial statements of CalciMedica, Inc. included in this Annual Report (Form 10-K) of CalciMedica, Inc. for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">San Diego, California</font></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 27, 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>ck0001534133-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, A. Rachel Leheny, certify that:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of CalciMedica, Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:47%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ A. Rachel Leheny</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">A. Rachel Leheny, Ph.D.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>ck0001534133-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) OR 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Stephen Bardin, certify that:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of CalciMedica, Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.796%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.806%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.796%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.038132655419459%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:47%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 27, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Stephen Bardin</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stephen Bardin, MBA</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>ck0001534133-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#34;Exchange Act&#34;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167; 1350), A. Rachel Leheny, Chief Executive Officer of CalciMedica, Inc. (the &#34;Company&#34;), certifies that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, to which this Certification is attached as Exhibit 32.1 (the &#x201c;Annual Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the undersigned has set her hands hereto as of the 27</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day of March, 2025.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ A. Rachel Leheny		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A. Rachel Leheny, Ph.D.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#34;This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of CalciMedica, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.&#34;</font></p>
  <table style="margin-left:0.046%;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:15.582%;box-sizing:content-box;"></td>
    <td style="width:7.141%;box-sizing:content-box;"></td>
    <td style="width:77.277%;box-sizing:content-box;"></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.014in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.014in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.014in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.014in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.014in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.014in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>ck0001534133-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#34;Exchange Act&#34;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167; 1350), Stephen Bardin, Chief Financial Officer of CalciMedica, Inc. (the &#34;Company&#34;), certifies that:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Annual Report on Form 10-K for the fiscal ended December 31, 2024, to which this Certification is attached as Exhibit 32.2 (the &#x201c;Annual Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the undersigned has set his hands hereto as of the 27</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day of March, 2025.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Stephen Bardin	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stephen Bardin, MBA</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#34;This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of CalciMedica, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.&#34;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img20776642_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img20776642_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N .P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BOXY_\
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MH*^)X?%WAS]Y?^"J/P[_ ."?*_"+PK_P3;CUCQW^SW_87Q(\#?'VU^('PO\
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M<9%X \%8_+*G#N%P$L+1XVK^)+\27Q74Q%;'X;!\78'Q$QF$PV+56%%SPM'
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M[V;5SYO^&/[(/[-'P9^+/CGXY?"WX-^#_!/Q2^(G@_P'\//$?BC1+:[A^S^
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DQ!FV=RC4HTZE*C.+S/%XIJ=*E6JTZ<E[T*=6I"+49R3_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img21700163_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img21700163_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N .P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BOXY_\
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MH*^)X?%WAS]Y?^"J/P[_ ."?*_"+PK_P3;CUCQW^SW_87Q(\#?'VU^('PO\
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M<9%X \%8_+*G#N%P$L+1XVK^)+\27Q74Q%;'X;!\78'Q$QF$PV+56%%SPM'
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M[V;5SYO^&/[(/[-'P9^+/CGXY?"WX-^#_!/Q2^(G@_P'\//$?BC1+:[A^S^
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DQ!FV=RC4HTZE*C.+S/%XIJ=*E6JTZ<E[T*=6I"+49R3_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img22623684_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img22623684_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N .P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BOXY_\
M@Y;_ &T?VBO ?Q>^&_[(WP^^(6L?#[X.>*?@/;_$OQ]9>"=0U7PYK_Q)O?'?
MB?XJ_#+5/"'CO7=.U&*?6OAO;^%O#$T2^ TBM- UV]\1ZQ>>,[7Q2^G>#E\*
M_P!C%?GO^W+_ ,$POV2/^"@UEI5S\=_!^L6'Q!\.:.OA[PG\8OAWK2^%OB9X
M<T!M?L?$-SH:7EU8ZUX6\3Z/+/;ZE:V.F>/O"?BZR\,Q>*?%U_X-@\.:_P"(
M;_69/O\ PQXAR#A?C#+LYXDP,\=EN'AB(<M/#4<7/#8FK3<,/C5AZ\X0G]6F
M^=N+=:DKU:$*E:G3A*Z<E&2<E=>E[/H_D?SW_P#!M)^VC^T5X\^+WQ)_9&^(
M/Q"UCX@_!SPM\![CXE^ ;+QMJ&J^(]?^&U[X$\3_  J^&6E^$/ FNZCJ,L^B
M_#>X\+>)X8F\!O%=Z!H5[X<T>\\&6OA9]1\8KXJ_K0^,GC;7_AI\(?BK\1O"
M?@36/BEXI\ ?#?QSXV\-?#+P\UZNO_$77_"OAC5-=T;P)H;:;H_B'45UCQ=J
M-A;>'],:PT#7+T7NH0&UT?4Y_+LI_P .=.\8?LC_ /!"N_\ "'[,WP<^"7CO
MX@3_ !/M+'XH_&;XQ^)/%GA@?$S6?#]WXKU_PYX86>\L_"VFZ=XQN_!^G:9X
MMM?#?@2VM/AAX-T6+[/?PZC=^*?'_C[Q/7ZH?MM?M;Z1^QC\&[7XJ:EX+U'Q
M_>:QXTT3P+H'ANQUBV\/6UQJ^K6&M:Y-<:QKT]EJ\NE:=::#X;UN:*:RT+6[
MFZU<:7ICV=I9WUWK.E_+>)/BWX<9_P :\:9YE#HX3*.$IY>^),-/"8O"M/V#
MG+$UJ6$PZ;GF4:%5<N73Q6)<X-U7#'3J48?J%+P9\2\9/PX>'X4Q$UXN3Q</
M#R^/RBFN(WE^(H83&.+GF$5E<*%7$X>4ZF<O+H?5JU/&J3PDE7/\TWQI^V'^
MU5\0?C7%^T=XK_:'^,%[\=++^VHM#^*%CX]\1:!XL\(:;K]QXCN-3\.> =0\
M/7VE?\*^\'O_ ,)?XIM;/P7X(CT#PGI6FZ_JVDZ5HMEI=[/9O_I,?\$X_CG\
M3/VE?V'/V:OC;\8O#6L>&/B7XZ^&]E<>+(]<LHM-O?%5[HNH:CX:MOBA!IMK
MX;\):=IVC_&/3M&L_BSX>T_1M"M] L= \::9:^'[S6-$BL-9U#\KO@M_P1O_
M ."77[:-I\-_VT=,^"/Q!^&?AOX@Z=XKOO%'[-GA_P"(]YHGP=O_ !C'XF\<
MZ!XFO?(T&"W\:Z#IVE^)VF?P=I?PQ\;?##P5%H/A?P?&GPX\/6<_B3PSJ']"
M/A[P]H'A'0-#\)^$]#T?PQX6\,:/IGA[PUX:\/:99:+H'A[0-%LH--T;0]#T
M;38+;3M)T?2=.MK:PTS3+"VM[*PLK>"UM8(H(HXU_6_%#Q4X"\2.&N$9\'93
M4I1CA\/F6'S"K@:&!CALIQ>$E/#Y7A(4:C<\/7=:EC)Q=&E2HJEA_9?O*N)I
MTOA<_P IS'A_.,UX>SG!SP&<Y#F>/R;-\#4E2G4P6997BJN!Q^#G4H5*M&I+
M#8JA5HRG1J5*4I0YJ=2<&I/8HHHK\./&"BOB?]N7_@H!^SK_ ,$]_AGI7Q(^
M/FMZQ+/XGUA=#\"_#GP1::5K7Q,\?WMO+8G7I_"^@:MK7A[3FT?PCIU_!JWB
MOQ#K>N:+H&D17&E:0VIR^*?$_A'P_P"(/SW^%'[2/_!=']I[^W_B!\//V1_V
M/_V1?A;/_9?_  @_A#]M+4/CO=_%G4_*_M'1/$WVVV^'ESH'B*R^Q>(M O=4
MMO\ A./@_P#"S[3X:\2^%9/#/_";V*WOBB;ZO+.#LXS'+'G=2>7Y3DTJLL/A
M\SSO,,/EF'QV)A4A3J8?+85I?6LQJ4G*4J\L%AZ]'#1I5?K%6E*/*Z46U?1+
MNW:[\N_R/W@HK\9_V#OVT_\ @I%\1_CQXC_9R_;I_P""?VL?"34=)T?6/%0_
M:$^%\=U;? ?2K*/1_!]]X?\ "=YJ>O\ B[QUX6\::QJ4^L:I!<:O\*_B]XTU
M^RUBYT_P]J?PJTG3O"GQ&\;>&OV8KS<]R+&</8Y8#&U<OQ$YX>CBJ.(RO,L%
MFF#KX;$)RHUJ6*P-:O2Y:D4Y1A-PJ\CC-TU"I3E)-6=G9^CNM?-!117X_P#_
M  4?_:J_:7^"_P"U5_P2X^ G[/3^3H_[3G[2%_;?&O\ LGP/:>-?%FI_";X;
M^(OA)_PG&B6?]HV&MVOASP>/ OCWQGXK\?>*-.T:U\2^'M-\(6.NZ;XO\*Z/
MI?B/^UED628OB',Z>5X*IAJ5>IALQQ?M<75E1P].AEF78O-,5.I4A3JRCRX7
M!UG"T'S3Y8MQ3<D).3LM]?P5_P!#]@****\<045\3_MX^.?VX_ 'PA\.:S^P
M#\&_AO\ '#XQW/Q(TC3/$OA/XH:II^DZ!I_PSF\,>,+K6?$-G<ZE\5?A! ^L
M6GBFR\&:;;P)XEOI6LM6U"1=#N4CDO\ 3/#/B1^WAXU_9]\2_L!>#/VA=-^&
M?@WQ;\=?!%K<_M8>'M/U&PGNO@WXUU3PUX-TJRU#1-0D^)%QH7A[X9Z;\6-7
M\6V.K^)]>U;QI87?@[P9X@G\.ZUJ^H:+<W-WEG^)P'#/#F&XGS;,\LHY?B<S
MPV5.A#'8>IF6&K8O&X; T<1C,N4UB<-@I5L5"?UJI%4_8PK55=4I'U7!O!?$
M/'N=QX=X7P,LRS>>69[FM+!TV_:5<-P]DF/S[&PIVC*^(JX3+JU'!4FD\5CJ
MF&PD)*I7@?J7117P=\?_ -M[P_\ #7X]?!?]EWX;:1_PLKXV?$KXB^ M-\9Z
M/IL%[JEE\*OAEJFL:=?>+?$WB:+2&^U?\)'_ ,()_:WB#1M&\R&'P]X?AD^(
M_C*2U\,6NAZ7XV\_.,ZRS(<)'&YIBH8:C4Q.'P6'3O*KBL;C*JHX7!X6C!.I
M7Q->I*T*=.+:BIU9N%&E5J0CA/@[B/CC-*F3\,Y;6S'%X?+LPSC'2BX4L+EF
M393AY8O,\WS/%U90P^!R[ X>#E6Q%>I",JDZ.%HJKB\3AJ%7[QHHHKU3Y@**
M** "BORW_9X_:(_:C^+7C;_@I0MMI.G>(HO@EXTU[X=_LQ>&;CPY9Z'X)O?&
MW@B/XH:4/#=YXHEN=&O-=U'7;S1OAQJOCI-7\;QQZ))XFAN=-D\&Z#K&GV\/
MU;^REXI_:C\6_#O6=2_:V^&_@OX7_$>#QIJ-CHF@>!;ZSU#2+SP3'H?AR?3=
M8N)K+Q[\1(EU&XUZY\264T3:W:R+;:?9N=+@5TN[[Y;)N+<#GCP+P67YW&CF
M']KNCBZV658X&FLGS/%9756)QM.57#8:>+JX6=?+Z-6K&OB<+.G5=.G-SIP_
M3>+O"O.>"X9TLWSW@V>+R+_518O*L)Q)A)YUB'Q=PYEO$N%>79/B(87,LPHY
M5A<THX'/<7A<-4P>7YG1Q&'CB*]*-+$5?INBBBOJ3\R"BBB@#^%?]OC_ (.#
M_P!M&[_:*^)G@7]E3Q[\-_A/\'/A=\2/'_@GP=XJ\">'? 7Q>O?B_H&@ZK:^
M'=.\=ZQXR\?:'XR\+7^CZ[/X?U'Q=X)7X>:#X9LK+0/&2Z1K&L>/WTO2_$[_
M -!_[)G_  5PTCX]?\$W_&G[;WBWX5ZCI7B[X.:^WPM^)7@3PY?6T'ASQ%\5
M8T^'\%AJ/@;5=3OM2U/2/A]XDF^)OA'4;S^WX-3\1^!XY_$>BPP?$-O#>F:]
MXQ_.#]M'_@VRU_XY_M%?$+XZ_!W]IW1]#T[XX?'C4/B'X]\&_$OP+>S7O@'0
M/B'JNH^)_B=K7A#Q5X6U5H/'^L:9XIU"\N/ ?P_UGPM\/+*XT"^M=%\0?%./
M4=#E\1>(OVL_9$_X)K?L^_LH_L?7/['@L)_BKX0\9SWWB/XRZWXQ%S#)\2_B
M%KFG:#8:SXMM-'M]2N(O ,%C%X7\-VW@;3/"^H1ZCX-MO#/A_5?^$CUKQY;Z
MKXYUK]Q\5\?X8X_POP. \.Z>7X'CF."]GE^+CEN)IU<#C9X"I&M5XAQ.(PM/
M^U*=+'.BTZBQTYRA)X.*PLZKE]#PWB.'<+Q#P[B>)\#B\SX:PV=Y37XCRW+Z
MKP^/S#(:./P]3.,#@\1[;#^QQ>+R^.(P^&K?6*/LZU2$U6I<O/'\C_\ @I%_
MP4+^$GC#_@GYH_[9/@/]F/P)K/QMN/C7H_[+F@^(OC5X5\'^,?\ A5/BW5O@
M]XS\?:[XBTNUFLM6T[XP>$O"VG:QKUOX \,?$2PTCPDWC_4]*^)GB+X?7-QX
M4MO#6L_AK\-O^"W?[0_CWQKH'A;_ (*%OIW[7O[+FI:C9+XX^' \!_#3X<>-
MO#<D5Y;R6GQ(^%7C/X7^'?AKKVG?$'PM$MY;V^E:CXFM?#GC/PMJ_BKP)J]U
MH*^)X?%WAS]Y?^"J/P[_ ."?*_"+PK_P3;CUCQW^SW_87Q(\#?'VU^('PO\
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M<9%X \%8_+*G#N%P$L+1XVK^)+\27Q74Q%;'X;!\78'Q$QF$PV+56%%SPM'
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M[V;5SYO^&/[(/[-'P9^+/CGXY?"WX-^#_!/Q2^(G@_P'\//$?BC1+:[A^S^
M/AGX:T'PAX+\#>$-$ENYO#OP[\'Z7X=\*^%-.N?#/P^TCPOHNN?\(KX7N_$%
MEJE]X=T6YL?E?XO_ /!&W_@FM\=_B9XR^,'Q-_9AT?5OB#\0=8D\0^,=9T/X
MB?&'P)9:WK]S%#'J.N3^&O /Q#\,>%K?6-:GB;5/$.IV6BVU[XCU^[U/Q)KL
M^HZ_JVJ:E=_IQ15X7B?B7 XJ6.P7$.>8/&SPM' SQF%S;'X?%3P6&A3IX?!R
MQ%+$0JRPN'A1HPHX=S=&E"E3C3A%0BD)M.Z;3M:Z;O;MZ:+[CY7_ &I_V)?V
M6_VU] \*^&OVG?A%H_Q0T[P/K%[KGA&YGUCQ5X4U_P /7NIV0L-6@TSQ9X%U
M[PQXIM]'UJ"*QDUSP\-9.@:W>Z-X>U+5=,O-1\-Z#=:=X_\ LX_\$JOV OV2
M_B9:_&+X!_L[Z/X-^)>GZ/JVAZ3XLU/QK\3_ !_>Z%9:[%':ZO/X>MOB1XW\
M7:=X>UB_TY9]&G\0Z)9V&OG0-3USP\NIKHGB#7+#4/T(HJ:/$O$>&RR>2X?/
M\ZH9/5A6IU,IHYKCJ665*>(<I5X3P$*\<+.%>4I2K1E2<:KE)S4FW<N[6N[=
MKNWW'@_PP_9H^#/P<^)GQO\ C%X!\-:Q8?$O]HW6/#>N?&3Q9KGC[XB>-[WQ
M;>^#8M=M?",$%MXX\5^(].\+:/X6T[Q'JFC>'O#W@ZS\/Z!HV@#3/#VG:9;Z
M)H6A6&G:/P+_ &>O@_\ LU^$M1\"_!3PA_PA?A75O$=WXLU#2_[?\4>(_M'B
M"^TS2-'NM0^W>+-:U[48O-T[0=*M_LL-Y'9)]E\Z.V2>>YEF]GHKQ,;&.98[
M#9IF,5C\SP=!X7"9CC4L5CL+A70PV%>&PV+K^TQ%"@\+@L'AG1I5(TW0PF&H
M\OLZ%*,/0H9OFV%R[,,GPV:9CA\HS>K@*^:Y70QN)HY=F=?*GB7EE;,,#3JQ
MPV-JY<\9BW@*F)I59X-XK$O#RINO5YBO&/@7^SU\'_V:_"6H^!?@IX0_X0OP
MKJWB.[\6:AI?]O\ BCQ']H\07VF:1H]UJ'V[Q9K6O:C%YNG:#I5O]EAO([)/
MLOG1VR3SW,LWL]%<]3!X2KB<-C:N%PU7&8.&(IX3%U*%*>)PM/%JDL53PU>4
M75H0Q*H45B(TIQC65&DJBE[.%BAF^;87+LPR?"YGF.&RC-ZV!Q&:Y70QN)HY
M=F=?*WB9997S# TZL<-C:V72QF,>!J8FE5GA'BL2\/*FZ]7F^0?C-^P5^R3^
MT#XVG^(_Q9^#NG>)/&UYIVGZ7J&OV/B;QSX2N=5MM*C>#3I=8A\%^)_#UGK&
MHVEF8M-BUC4[:[U?^R+'2](:^;3-(TNTL^T^!?[)7[.7[-?]HR_!3X4>'/!>
MHZM]KCU#Q#YFJ^(_%MQ97W]D-=:-_P )CXLU'7O%47AR6?0=*OO^$9AUB/P^
MFIVO]J1Z:FHSW-U-]%45YE+ACANCF4\YH\/9'2S>I4J5JF:TLIP%/,IUJK;J
MU9XZ&'6*E4J-MU*DJKE-MN39]'B?$GQ$QG#U+A'%\?<:8KA2AAZ&#H<,8GBG
M/*_#U'"85*.&PM+):N.EEM/#X>,4J%"&&C2I))4XQ21\Z_'3]DK]G+]I3^SI
M?C7\*/#GC34=)^R1Z?XA\S5?#GBVWLK'^UVM=&_X3'PGJ.@^*I?#D4^O:K??
M\(S-K$GA]]3NO[4DTU]1@MKJ'QC_ (=C?L)_\(E_PA7_  SSX<_L?_A(_P#A
M*?MG_"1^/?\ A+?[3_LS^R?LO_"?_P#"5_\ "=_\(Y]E_>_\(?\ \)'_ ,(E
M_:?_ !.O[$_MC_3Z^\:*SQG"7"N88FMC<?PSP_CL9B8.GB,7C,FRW$XFO3:2
M=.M7K8:=6K!I).,YRBTDK:'3E/BIXGY#EV$R?(_$?CW)<HR^LL1@,KRGC#B'
M+LNP5=-R5?"8'!YC1PV&K*4I-5*-*$TY-J5VSQC6_P!GKX/^(_C;X/\ VC-9
M\(?;/C+X"\.77A/PGXQ_M_Q1;_V3X?O+?Q3:W.G_ /"/6NM0>%;[S(/&GB:/
M[5J6AWEZG]I;H[E7L]/:UT?C-\#_ (4_M">"9_AU\8_!FG>./"$^HZ?K":;?
M3ZCI]S8ZOI<CO9:IH^MZ)>Z9KVAZC'%-=6$M]HVIV%S=:1J&J:+=RSZ3JNI6
M5UZM17H2RG*IT,PPL\LR^6&S6I5K9IAY8+#2H9E6KTJ="M5S"DZ3IXRI6H4:
M-&K4Q$:DJE*E3IS;A"*7@0XJXHI8W(LRI\29]3S'A?#X;!\,X^&<9A#&\.X3
M!8K$8W!X7(L5'$*OE&'PF-Q>*Q>&H9?4P]*ABL3B,12C"K6J3E\/_#O_ ()O
M?L4_"KQMX;^(O@CX&Z=I_B_PCJ*:QX<U+5/&/Q&\5VVEZO!'(EGJD6B>+?&&
MN:#-J.F2R+?Z/?7.F3W.C:O;V.M:5+9ZMI]C>V_T5\9O@?\ "G]H3P3/\.OC
M'X,T[QQX0GU'3]833;Z?4=/N;'5]+D=[+5-'UO1+W3->T/48XIKJPEOM&U.P
MN;K2-0U31;N6?2=5U*RNO5J*Y,+PUPY@<#B\KP609)@\LQ_/]>R["Y5@</@<
M9[2FJ53ZWA*-"&'Q'/2C&G/VU.?-3BH2O%)'J9GXB^(.=YWE?$N<\=<99OQ'
MDGLO[%S_ #/B?.\?G>4>PKSQ5#^R\UQ6.JX[+_8XFI/$4OJE>E[.O.=6%JDG
M)_#_ ()_X)O?L4_#NY\17OA+X&Z=87GBCP7XK^'VK7=]XQ^(VOW*^%O'&D3Z
M!XJM-'G\0^,-5E\-ZCJ^A7=]HDOB+PX^E>)+?2-2U33;/5K:SU34(;GZ^\'^
M$_#_ ("\)>%O OA/3_[)\*^"_#FB>$_#.E_:KV^_LWP_X<TRUT?1M/\ MVI7
M-YJ-Y]CTZSMK?[5J%Y=7MQY?G75S/.\DK=%16N69!D62IK)\ERG*4XSBUEF7
M8/ )QG*,YQ:PM&DG&<X0E-;2E",G=Q37-Q'QSQMQA*,N+>,>*>*91G3J1EQ'
DQ!FV=RC4HTZE*C.+S/%XIJ=*E6JTZ<E[T*=6I"+49R3_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img23547205_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img23547205_0.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "/ K@# 2(  A$! Q$!_\0
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M^K_RI.W_  '_ -GI3U/U?^5  .H^J?RI.W_ ?_9Z4=1]4_E2=O\ @/\ [/0
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M *>I^K_RH'4?5/Y4'J?J_P#*@=1]4_E0 G;_ (#_ .STIZGZO_*D[?\  ?\
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MU3^5)V_X#_[/2CJ/JG\J3M_P'_V>@!3U/U?^5 ZCZI_*@]3]7_E0.H^J?RH
M3M_P'_V>E/4_5_Y4G;_@/_L]*>I^K_RH !U'U3^5)V_X#_[/2CJ/JG\J3M_P
M'_V>@!3U/U?^5 ZCZI_*@]3]7_E0.H^J?RH 3M_P'_V>E/4_5_Y4G;_@/_L]
M*>I^K_RH !U'U3^5)V_X#_[/2CJ/JG\J3M_P'_V>@!3U/U?^5 ZCZI_*@]3]
M7_E0.H^J?RH 3M_P'_V>E/4_5_Y4G;_@/_L]*>I^K_RH !U'U3^5)V_X#_[/
M2CJ/JG\J3M_P'_V>@!3U/U?^5 ZCZI_*@]3]7_E0.H^J?RH 3M_P'_V>E/4_
M5_Y4G;_@/_L]*>I^K_RH !U'U3^5)V_X#_[/2CJ/JG\J3M_P'_V>@!3U/U?^
M5 ZCZI_*@]3]7_E0.H^J?RH 3M_P'_V>E/4_5_Y4G;_@/_L]*>I^K_RH !U'
MU3^5)V_X#_[/2CJ/JG\J3M_P'_V>@!3U/U?^5 ZCZI_*@]3]7_E0.H^J?RH
M3M_P'_V>E/4_5_Y4G;_@/_L]*>I^K_RH !U'U3^5)V_X#_[/2CJ/JG\J3M_P
M'_V>@!3U/U?^52+T'T'\JC/4_5_Y5(O0?0?RH 6BBB@ HHHH **** "BBB@
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M4:F65H-5(RHU)?6HZCZI_*D[?\!_]GI1U'U3^5)V_P" _P#L]=!Y0IZGZO\
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M*D[?\!_]GI1U'U3^5138\IMP)&%P0N\JWFC:^,'_ %;8?<1A-N\\*:/ZZO\
M*[^Y-AZ$IZGZO_*@=1]4_E7S-\4OCY/\+=>31(?"D?B&.6+X<%+F3Q!)H^V7
MXB>.M0\$6X$:^'=15XK"6R;4KB3Y'G1Q"A)=9(M'X#?&^/XXZ=\1-6_X1O\
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M@YXU-5:5*.#J5848UJE>-/&XS%8*')2A2DZM6%;#>TG2IMWH5%*$IUXO#O\
M5@=1]4_E2=O^ _\ L]5[,8MX\$D%L@D1@X+N1_J@(R " #'E" "K,"&-CM_P
M'_V>G_77]4G]Z3\C);?U_DOR7H*>I^K_ ,J!U'U3^5!ZGZO_ "H'4?5/Y4 )
MV_X#_P"STIZGZO\ RI.W_ ?_ &>E/4_5_P"5  .H^J?RI.W_  '_ -GI1U'U
M3^5)V_X#_P"ST *>I^K_ ,JD7H/H/Y5&>I^K_P JD7H/H/Y4 +1110 4444
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M3;/C=_V3[7?_ $CBKY+_ &=O^3P/%/\ V*'QD_\ 37^Q-7UI^UI_R;9\;O\
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M\:U.,H.G:B\&TYN2J4ZE2C.FN;WH>K_";_DX72/^SAO$'_K(EQ7ZFGJ?J_\
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M/A+Q5XOO(3=67A;PSK'B&\MHI!!<30:)I5SJ30)-AF7S_LXM8F5&V371?HA
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M6CD]1UUAY5HQG]>G@9-0<HJ4,J_M-S3YDVK-4%&RUO4O9*$OTH_:E^[\&/\
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M_P DAG?_ &5.2?\ J'Q:<V8_\CK)_P#L79Y_Z@^'IC?M)?\ ('^'G_90Y?\
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M_7C-_P#UF<S//J_\B;$?]@N1_P#K19N?I-^U'.;7]G?XU7"#,G_"L/%UL.F
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M)_R1[2O^QQ^+?_JW?'5?E+X=_P"0!X6;JTO@S]B*YE<CYIKBY^*.LSW-Q(Q
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M97_Y-C_9S_[(7\(?_4 T"OA_]H'_ )+3\0O^PE^R;_ZN;7Z^X/V5_P#DV/\
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MBE]$'J?J_P#*@=1]4_E6=J4@BC\PLJ+&)Y&=I/)"JBIDM.)%\E,E2\KI) F
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MH **** "BBB@ HHHH **** (>W_ ?_9Z4]3]7_E2=O\ @/\ [/2GJ?J_\J
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MJVIRV5Q!!=:;X?DM$U*6RM[^VNM7B7[-I#M>2O,OMXJ$)8_*(T8U/K;PU/\
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MW4T\]WJ&JZE]EAMK>35=6OY[K4M5FAMK:.XU&ZNIUMX!)Y2<+\3_  !;^/\
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MN[B,ZCIMS<V&O00-XATZ[O-(FL;RYM+^/3K2:[BDG>.26RM'@9);>%DR=.^
M7PEL-1O=1/@?2=4FFU.TUB4^)+C5/%ELNLV-E'I5OK-K9>)KW5;>SUV#3+6R
MLWUFWA%\;:"*WAG"*2N5+#WA2I5ZG[NG3P,.:,?:<LJ&+=:=6%.I.$5>+BX>
M_>53W7)*/.^ROCJ?L:JIT9QJU<%GF%<JG+#EGFF/AB:2E.*E*2HT)UH5/=3<
MI\D8J%6<E^4'A6+4)/"7A&_O-"UW0H)/#W[&^E6*>(-+O-&NM4CT/XIZE:7>
MKV-EJ"QWS:+<:A)=6VDZA<06\.KVMFNKZ2MWH-]I.JZC]H_L!?\ (L_M'?\
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MW%:M1EB,%6JP3E)QIU:<7*4E)FK1116YPA1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img221834505_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img221834505_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" % !8 # 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4=.M%?-'Q^^)CZ'9?\(9H=P8]6U. /K%U"Y$FGZ9
M*/EM$9#F.ZU%<ER2&AL<D(3>0RQ?G'BQXG\.>#_ N=<=\35&\'E=)4\'@:4X
MQQ><YMB.:&791@5)-/$XVLK2J<LH87#0Q&.KI8;"UIQ[LNR^OF>,I8/#KWZC
MO*;7NTJ<?CJS_NP73>4G&$?>DD<1\9_C1-J4MWX1\(W9CTN,R6VL:Q;2*6U1
ML%)K*QF0G;IRY9+BXC8-?-NCC(L@QO/EVBBO^>'Q8\6.,/&3B_'<8<88^>(Q
M->4Z66Y;2G-99D.6*<I8?*LJP\FXT,-0BTZE2SKXRNZF,QE2MBJU6I+]KR[+
ML-E>&AA<-!1BK.I-I>TK5+)2J5)=9.VBVC&T8I1204445^:'>%%%% !1110
M4444 %;_ (:\3ZUX1U:WUK0KQK2]@RC<!X+F!R#+:W<#?)/;2[1O1L,K*DL3
MQSQQ2I@45W99FF99)F."S?)\?B\KS3+<31QN7YC@,15PN-P6+P\U4H8G"XFC
M*%6C6I5(J<*E.491:NF14IPJPG3JPC4ISBXSA.*E"<6K.,HM---:--6/TO\
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MW"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# \4^(;3PKX>U;
MQ#>_-!I=G)<",':UQ.2(K6U5NBO=74D-NC'A6D#-A037Y@ZSJU[KVJZAK.I2
MF:^U*[FN[F0DX\R9RVR,$G9#$NV*&,';%"B1H J@#ZN_:<\3-%;:#X2@DP;I
MI-<U% 0&,$#/:::A R3'+/\ ;I&!POF6L1&XK\GQ]7^)W[03Q6Q'%7BAAO#?
M XF7]@>'F%HO&482_=8KBK-\+2QF,Q$W%\M7^SLMK8'+J*DG+"XEYK",E[>I
M%?JW!>71P^7RQTXKVV-D^1M:QP]*3A&*ZKGJ*<W;24?9NWNIA1117\ 'V044
M44 %%%% !1110 4444 %%%% !7U#^S?XW>RU2Z\$WTI-IJOFW^D%VX@U*"+?
M=6RY/"7MI$9@ <+/:812]RYKY>K0TG4[K1=4T_5[&0Q7FFWEO>V[@D8EMI5E
M0-ZHQ7;(I!5T9D8%20?U+P6\2\Q\(O$OA7CO 3K>QRG,:4,YPM)_\C+A_%R6
M'SK+Y1;Y)RQ& G5>&=12C0QM/"XJ,?:4(->?FN AF6 Q&#FE>I!NE)_\NZT?
M>I3[KEFES6W@Y1>DF?K!16;H^IV^MZ3IFL6AS;:I86FH0<@E8KN!)U1B /G0
M/L<$ AU8$ @@:5?]*V#Q>&Q^$PN/P5:&)P>-P]#%X3$4GS4Z^&Q-*-:A6IRT
MO"K2G"<';6,DS\)E&4)2A).,H2<91>ZE%M-/S333"BBBN@D**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'Q7_ ,%!/^37O&?_ &&/!O\ ZE.EU_/'7]#G_!03_DU[
MQG_V&/!O_J4Z77\\=?291_NLO^OT_P#TBF?+9U_O</\ KQ#_ -+J!1117J'D
M!1110!^I'_!+?_D?_BE_V)^C_P#IZ-?M17XK_P#!+?\ Y'_XI?\ 8GZ/_P"G
MHU^U%?+YI_OE3_#3_P#2$?793_N-+_%4_P#3D@HHHKSST@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/\ ,(I[NCFW%W$&:X:6RTEA\;2E'R:U>[_%N*)JIGV826RG1A\Z>&HTY?\
MDT6%%%%?TZ> %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M $A'UV4_[C2_Q5/_ $Y(****\\](**** "BBB@ HHHH **** "BBB@ HHHH
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M_P O:S;ZJG%*W_;TKW_\!1YM3/'JJ5!+M*I-N_K&*5O_  -G]!NM_P#!0_\
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M5SN3EI*2ORJS6T6F_-VZ']/7_#3_ .SO_P!%H^'/_A4Z7_\ 'Z/^&G_V=_\
MHM'PY_\ "ITO_P"/U_,+177_ &/1_P"?M7[H_P"7K_2UX_[<K_\ /FE]\_\
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M.SLY/[HK1=6RBBBNTX HHHH ]>_9\_Y+W\$/^RO?#7_U,]%K^I*OY;?V?/\
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MW\85ABO]VQ'_ %XK?^FY'1A/][PO_811_P#3D3^C2BBBOCC[@**** "BBB@
MHHHH _$'_@J%_P E<^'W_9.5_P#4FUVOS-K],O\ @J%_R5SX??\ 9.5_]2;7
M:_,VOK<!_NE#_!_[<SXS,?\ ?<1_C7_I,0HHHKK.(**** /Z-/V#O^34?A5_
MW//_ *LCQA7UY7R'^P=_R:C\*O\ N>?_ %9'C"OKROCL5_O.(_Z_UO\ TY(^
MXPG^Z87_ +!Z/_IN(4445@= 444A( ))  !)).  .223P !R2>E  2 "20
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M81PQ(D42)&BH,6BBO<2222222LDM$DMDET2/GVVVVVVV[MO5MO=M]6PHHHH
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M^4"D^0GAN\NU(?+IMU# &U'$@#%MBY_X)H_L]SQ&.+5_B=9N6!\^V\1Z$\H
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MV/C;7M3]/:*_Y6_$_"2BOUE\:?\ !+C6(8I;CX>_%/3]1E^8Q:5XPT.XTH
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M/^R?%/A;XRZ7:E;/Q5!'X4\42QJ B^(-(M6DT.[G8+DSZGH4$]DN7(6'P[&
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M]K\</AY<:]H-@&^)?@>RN;_PY-;QK]JU[38@]SJ'A.=AAIUNU\VZT57)-MK
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M@M+2UBC@MK6VBC@M[>")0D4,$$2I%%%&BA(XXU5$4!54  5/117AGT 4444
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MAC3/_2V"L>MCP]_R']#_ .PQIG_I;!2EL_1_D..Z]5^9_6Q1117Q!]^%%%%
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MI3HU:SM2ISF^O+%M+U>R7FVD95:U*BKU:D*:W]Z23?HMWZ)-GVM17XO>,/\
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M7YE.IAP1L++_ $P          8  X  '  '  Z5XF;U]*>'B]_WD[>5U!/\
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M'_DD?Q2_[)SXW_\ 49U.O1J\Y^,/_)(_BE_V3GQO_P"HSJ=<U/\ B4_\<?\
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MMW;;;;W;>K;]3[M)))))))));)+1)>204444AA1110 4444 %>=?%OX?:?\
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M** "BBB@ HHHH **** /Y)_$/_(?US_L,:G_ .EL]8]>D?&/2'T#XN?%'1)
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M "BBB@ HHHH **** "BBB@#]D/\ @EC_ ,@#XR_]ACP7_P"D7B.OU@K\G_\
M@EC_ ,@#XR_]ACP7_P"D7B.OU@KY3,?]]K^L/_3<#['+/]QP_I4_].S"BBBN
M([PKXW_;G^$G_"TO@1KMWI]KY_B7X?,_C;1?+CWW$]KIUO*OB+3HRI$C"ZT1
MKFZCMXUD>ZO].T^)(VDV%?LBFNB2(\<B+)'(K))&ZAT='!5D=6!5E920RD$$
M$@@@UI2J2I5(5([PDI>MGJO1JZ?DS.M2C6I5*4_AJ1<7Y7V:\XNS7FD?R(T5
M[]^TY\)9?@O\:?&/@V*WDAT-[W^W?"<C#Y)_"^M-)=::L3[4\T::_P!IT2XE
M"(K7NE76P; I/@-?90G&I",XN\9Q4EZ-77_!/AJD)4YSIS5I0DXR7FG9^J[/
MJM0HHHJB K](?^";7Q8'A7XI:Q\,M2N?+TGXD:?YVEB1U6*'Q7X=@N;RV12^
M%B_M/1VU2W<JP>YO+72[8)([1A?S>K=\,>(M4\(>)- \5Z).;;6/#>L:;KFF
M3C)$=]I=W#>VS, 1OC\V%1)&?EDC+(P*L0<<125>C4I/[<6D^TEK%_*23-\-
M6>'KTJR^Q)-KO%Z37SBVO4_K3HKC/AWXVTKXD>!?"?CO16']F^*M"T_68(MZ
MR/:27<"M=:?.R_*;G3;L3V%T!PMS;2KVKLZ^.:<6XM6:;33W33LT_1GW$9*4
M5*+O&24DULTU=/YH\+_:3^*J?!KX,>-O'$4JQZQ;Z:=*\,*0CM)XFUEO[/T=
MUBD^29+">8ZK=1-]ZRL+K 8@*?YAI)))I))99'EEE=I)99&9Y))'8L\DCL2S
MN[$LS,2S,222237ZA?\ !3+XLC6O&?A?X0:9<J]CX.M%\2^(XXRV#XDUNW*:
M7:S@G:9=,T!Q=Q,B_<\12(SLR%(_RZKZ7*Z'LL.JC7OUGS[:J"T@O3>2_P 1
M\IF^(]MB733]R@G!?XW9U'\FE%^<0HHHKTCRPHHKN/AKX%U7XF^/O"7@'15)
MU#Q5KEEI*2A2ZV=M-('U#4IE'S&VTO3X[K4;K:&86UK*55F 4IM13DW9)-MO
M9)*[;]$.,7*2C%7E)J*2W;;LE\V?LK_P3;^$?_"*?#'5_BAJ=L$UCXCWOV?2
M6DC'FV_A/0)Y[:!D9@)(?[6UDZA<3(,1W-K8Z1<9<"/;^D=8OAOP_I?A/P[H
M7A;1(/LVC^'-'TW0]+M\J3#I^E6<-C:(S*J*SK! @=PJ[WW.0":VJ^.Q%5UZ
MU2J_MR;2[16D5\HI(^XPU%8>A3HJWN12DUUF]9R^<FWZ:!1116)N%%%% 'Q7
M_P %!/\ DU[QG_V&/!O_ *E.EU_/'7]#G_!03_DU[QG_ -ACP;_ZE.EU_/'7
MTF4?[K+_ *_3_P#2*9\MG7^]P_Z\0_\ 2Z@4445ZAY 4444 ?KS_ ,$K;3CX
MXWS1+R?AS:03G:7&/^$XFNHEYWJK9LW?("N53!8QL%_7>OQZ_P""5U]!'J/Q
MNTQF'VF[LOA]?1+N0$P:=/XRM[A@A82,%DU2U!95*)N =E9XP_["U\KF5_KM
M:_\ T[MZ>R@?895;ZC0MT]K?U]K/]+?(****X3T HHHH **** "BBB@#\\/^
M"F-DES^S_H5R6"OI_P 4/#]RAV!F<2^'O%UD\6XD%%/VI96(SN:%%*]&7\'J
M_=3_ (*<:FMK\#/">F+(%FU3XG:2[1E5)DL[#PUXJEF()Y4I=36!RHR02I(5
MB&_"NOILJO\ 5%?9U)V]-%^:9\GG%OKCM_S[IW];/]+!1117I'EA1110!^IO
M_!+:>5?''Q6M@Y$$OA309Y(\##2V^KW,<+DXW HEU.H (!\P[@2%(_:.OQB_
MX):6A?QA\6[[> +?PUX:M#'MR7-[JFHS!PV< 1BP*E=IW>:""-I#?L[7R^9_
M[Y4_PT[_ /@$?TL?793_ +C2_P 52W_@R7ZW"O.?C#_R2/XI?]DY\;_^HSJ=
M>C5YS\8?^21_%+_LG/C?_P!1G4ZXJ?\ $I_XX_\ I2.^I_#J?X)?^DL_E5HH
MHK[4^""BBB@ KZ\_8._Y.N^%7_<\_P#JM_&%?(=?6O["]S%:?M5?"B68L$>X
M\76PVC<?-O/ /BJS@!']TS3QAC_"I+'@5ABO]VQ'_7BK_P"FY'1A/]ZPW_81
M1_\ 3D3^CNBBBOCC[@**** "BBB@ HHHH _$'_@J%_R5SX??]DY7_P!2;7:_
M,VOT5_X*::DMW\>O#=C'*S)I7POT.&6([=L=W=>)/%MY(RX).9+26QW;MI^0
M87;AF_.JOKL"K82A_P!>T_O;:_!GQ>8.^-Q'_7RWW12?XH****ZCC"BBB@#^
MC3]@[_DU'X5?]SS_ .K(\85]>5\A_L'?\FH_"K_N>?\ U9'C"OKROCL5_O.(
M_P"O];_TY(^XPG^Z87_L'H_^FXA7S9^V#%YW[,_Q@3S9HMOA;S=\#^6Y^SZG
MI\_E,V#F&;R_)N$Q^\@DDCRN[(^DZ\;_ &B-&;Q!\!_C#I,<:RSW'PW\82VL
M31I)YEY9:'>WUFBJY"J[75M"L<N=T+E9E^9%J:#4:U&3VC5IM^BFFRZZO0K)
M;NE42^<)(_ESHHHK[,^$"BBB@ K[0_X)_P T47[4?@5)'57N-+\9PP*>LDJ^
M$=9N"B_[0A@FDYQ\L;=^*^+Z]J_9R\9Q?#_XZ_"SQ9<S+;V6G>,-+MM3N'94
M2WTC69&T/6)W9_E"PZ7J5W*V2H*J1O3.]<<1%SH5H+>5*I%>KBTOQ-\-)0Q-
M";VC6I2?HIQ;_ _J&HHHKXT^Y"BBB@ HHHH **** "BBH+FYM[.VN+RZFCM[
M6U@EN;F>5@D4%O!&TLTTCGA8XXU9W8\*JDG@4 ?S6_MBWL>H?M-?%^>, +'X
MEBLCAUD'F:9I&F:;*=RX )EM'+)]Z-B8VRRDU\T5VGQ(\4MXY^(7CGQFQDQX
MK\7>(_$,:R%BT<.KZO=W\$.&Y58(9XX8X^!''&L:A54 <77VE*+A2IP>\:<(
MOUC%)_D?!UIJ=:K-;3J3FO24FU^84445H9A6QX>_Y#^A_P#88TS_ -+8*QZV
M/#W_ "']#_[#&F?^EL%*6S]'^0X[KU7YG];%%%%?$'WX4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '\YW[=GA)O"?[3'CQEB\JS\4)HWBVQ^4J)
M5U;2[>/491DG=OUVSU8%A@%E(P,8'R!7[&_\%0/AP]UI/P\^*]E S'2KF[\$
M:_(J;R+34/-UCP[*Y!#106UW!KL$DCAHWGU.TC#1.RK/^.5?6X&JJN%HRO=Q
MBJ<NZE#W=?5)/T:/C,PI.CC*\>DINI'LU4]_3T;<?5,****ZSB"BBB@#]F_^
M":OQMM=0\.ZQ\#M;O FJZ%/>>)/!BS.!]LT.^E$VN:5;;B 9M+U.2355B&Z6
M:WU:[D1?)T^5E_56OY,O"/BSQ!X%\3:)XP\*ZE/I'B'P]J$&I:7J$&"T-Q"3
ME9(W#17%K<1-);7EI.DEM>6DT]I<Q2V\TD;?T8?LS_M.>$/VA_"T<MO+:Z-X
M]TFUC_X2KP?)<*;F!T\N)]9T=9")K_P_=3.FRX56DTZ>5+"_VRM;3WGSV9X2
M4*DL1!7IU'>=OL3V;?\ =F];_P S:=KQO]-E.-C4IQPU2252FK4[Z<\%LE_>
MCM;K%)K9V^G:***\@]H**** "BBB@ KS'XQ_%#1/@Y\-_%'Q"UV2(PZ'I\C:
M?8O)LDUC6[@>1HVCVX'[QI=0OWABD:-6^S6OVB]E"V]K-(G9^)/$F@^$-#U/
MQ+XGU6RT30=&M);[4]4OYA#;6MM"I9F9CEGD8XCA@B62XN)FC@MXI9I(XV_G
MM_:\_:BU#]H3Q;'I^BFYT_X9>%KJ<>&=,E#0S:O>%7@F\4ZO 3Q>74+/#IMK
M("=*TZ1X0J7=YJ3S]F"PDL356C]E!IU)=++7D3_FEMY+7IKPX_&1PE)M-.M-
M-4H[Z[<\E_+'?S=H]6U\I:]KFI^)M<UGQ'K5T][K&OZKJ&M:K>2??NM1U2[E
MO;VX?K\TUS/)(1T&[ X%9-%%?6)))):)*R79(^-;;;;=V]6WNWW84444 %%%
M% '],7[(G_)M7P>_[%&#_P!++ROHZOG']D3_ )-J^#W_ &*,'_I9>5]'5\97
M_CUO^OM3_P!+D?=8?_=Z'_7FE_Z1$****R-C\0?^"H7_ "5SX??]DY7_ -2;
M7:_,VOTR_P""H7_)7/A]_P!DY7_U)M=K\S:^MP'^Z4/\'_MS/C,Q_P!]Q'^-
M?^DQ"BBBNLX@HHHH _HT_8._Y-1^%7_<\_\ JR/&%?7E?(?[!W_)J/PJ_P"Y
MY_\ 5D>,*^O*^.Q7^\XC_K_6_P#3DC[C"?[IA?\ L'H_^FXA1116!T!1110
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M/C)\7=DO@'P#K>LZ>TGEMKDT<.D^'D8,RRC^W=7EL=+EDAVL9;>WNIKI<!1
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M4 33M:E#'S'C\0:='%>O<A1"^IKJMK"2;*0+]5U_,#^S[\=O%'[/WC^T\8Z
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MKXRO_'K?]?:G_I<C[K#_ .[T/^O-+_TB(4445D;'X@_\%0O^2N?#[_LG*_\
MJ3:[7YFU^F7_  5"_P"2N?#[_LG*_P#J3:[7YFU];@/]TH?X/_;F?&9C_ON(
M_P :_P#28A11176<04444 ?T:?L'?\FH_"K_ +GG_P!61XPKZ\KY#_8._P"3
M4?A5_P!SS_ZLCQA7UY7QV*_WG$?]?ZW_ *<D?<83_=,+_P!@]'_TW$****P.
M@**** "BBB@ K\:/^"IFI2R^*/@_I# ^18Z!XLU*,[@09=5U'1K68!=@8$)H
MT!+&1PV0%2,HS2?LO7XO?\%2;>5?&WPHNRH\B?PMX@MXVW#)EM=6M)9E*YW
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MKIHY31@U*K.55K7EMR0?JDY2?_@23ZKH<E?.J\TXT:<:*>G,W[2:]&U&*_\
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M?F;7Z9?\%0O^2N?#[_LG*_\ J3:[7YFU];@/]TH?X/\ VYGQF8_[[B/\:_\
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M\5S1P[1&NNR6'BH@("%4OXHL=8=D .-CLR$  @[1CQ:N3RNW1JJW2-5--?\
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M/QD598BK;^]+F_&5V?>?B+_@HY^T?K<+Q:=/X(\(LRE?/\.^%VN)E)&-Z_\
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MHHH **** "BBB@#^C3]@[_DU'X5?]SS_ .K(\85]>5\A_L'?\FH_"K_N>?\
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M  3,^$?]K>*?%/QEU2U+6?A6"3PIX7ED4%&\0:O:K)KEW Q7(GTS0IX+)L.
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M*KW754_R<GY\JVD?08#*FG&MBEJK.%%V?FG4W7_;G_@76(BJJ*J(JHBJ%55
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MSQZ5KL2[)-6T-I69TMWE2YTZ:26YTZ>'SKVWO?P,^+WP/^)'P/\ $$F@>/M
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MG\6=/&F_$/P9HGB>*.)X;:ZO;<Q:M8(^[<--UNS>VU?3=Q=F;[#?6^YSN;)
M->MA\VJ02C7C[6*TYXV53Y_9EI_A;>[9XV)R:E4;EAY>RD_L2O*F_1KWH?\
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MN+:YMYD$D4]O/"SQ30RHRO'+&[(Z,&5B"#4]9F@4444 %%%% !1110 4444
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M?]$M^(W_ (1'B;_Y64?\*>^+G_1+?B-_X1'B;_Y65_5516O]LS_Y\0_\#?\
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M_!-#QYKLEMJ/Q=\1V7@G2SY<DN@:!+;:]XHE4[&DMYKY/,\/:6^UG5;J"?Q
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ME3ONCS\RQ$L/A9N"ES3_ ':DD[04MY-I63MI&[7O--7L?$U%%%?5'QX4444
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M1;C3;0VMT+F^AO7M8#;3B65/)DV_E3\5?V5/^".7[3_Q>M?BGXUU?]G7Q?\
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M)B<%4J1C4<^:G*7-=4W3YX-Z<T*D9I<LKM-74KVY?]3RO\Y__@JQ\3Q\6_\
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M:M+#'&+[7M?U!KG6-<U*53-J&J7EU=2DO*<='\2_&EK\-_AQ\0/B)?1>?9>
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M[HW6D_#N/P=\,-))=F%N?"WA72Y?$5JJMQ&(/&NI^*%V)A2Q,A^>1R?ZA/\
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MCBA^&?PO\!^ E6)@ZL_A/POI>A2RF4%O/DGFL7GFN&9WN)9'GD=WD9V_ O\
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M$/#7A[PEH<)M]%\+Z'I/AW2+=BK-!I>B6%OIFGPL42-"8K2VA0E4125RJ*,
M?Q:_\'%_Q1_X2S]LSP-\-K2Z\W3_ (3?!C0HKVUSG[)XI\<:WK7B34FZ#'VC
MPRO@I\<GY,YP0!_;-7\-7_!1/]A/]OK]H7]MS]I/XM>'?V8/BEKWACQ#\2=1
MTOPIKMM8Z;)::WX2\%6=CX$\*ZQ8N=4#-I^J>'O#6FWVGEUCD^Q3P>9%%)NC
M3Q\C=-8V56M4A!0I3<95)QC><Y1CO)J[<7.^M]NY[?$2JO 0H4*52HZE:"E&
MG"4[4Z<92U44[+G4+7T^9^Y?_!OE\+%\"_L#P^-YHB+WXT?%CQYXTCN)$"R'
M1_#LMA\-;"S0@ O;0:CX*UN]A+@OYVIW)#&(Q!?W*KY:_8B^$%Y\!/V0_P!G
M+X1:KIW]D:_X+^$?@VS\6:8?*S9>-+_28-9\:V[- SQ2.GBS4M9#RH[B9LR[
MV+EC]2UYV,J^WQ6(JWNIUIN+_N*34/7W%%7ZGJX&C[#!86BU9TZ%)27]_D3G
M]\W)VZ'\)G_!?[XGCQ[_ ,%!M=\*0W1GM/@Y\+_AW\/Q$CL;:*_U.QO/B7?L
M@'[E[D_\)_;6EY,FZ0-91V4[[[$10_T9?\$+/A@/AQ_P3G^%NIS6K6>I?%7Q
M/\0/B?J<3HR22&_\1W'A+1+IMWWEO?"?@[P]=PNORM;30XR<D_S9_MF?L"?\
M%"?CM^UA^T3\7+#]ECXJ:AHWCGXO^.=6\,WD>GZ>4F\()KUY8^#B&DU0,VSP
MM::1&7*QARA98H5(B3^V']FOX8CX*_L\_ WX1&-(Y_AK\)OA]X)OM@0";5/#
MGA;2],U:Z<HS(TM[J5O=W<[HS*\T\CJ2&!KVLSJTX99@<+3J4YR2INHH3C*S
MITO>4E%NUYSOKU7J>!E%&M4S;,,96I5(1?M(TW4IR@FJE5<CCS)7Y:=.SM?2
M6MKH^%/^"V'C'4O!O_!-C]H6;2AMNO$:?#_P=+/YA3[/IOB3XD^$[+63L529
MOM>C_;M.\O?$%^V^>S2+";>;^7/_ ((2:)X8UC_@I#\)[GQ%>6-O=^'_  I\
M4=;\)V=[*J_VMXG7P+K&E1V=I"\4B75]::)JNN:Y;Q,T+0?V.]]#*+BSBCD_
MM+_;$_9I\/\ [7O[-WQ1_9[\1:DVA0>/M%MH])\1)9I?R^&_$^AZK8>(O"^N
MK:-) ]U!8:]I5@^HV<-U9S:CI37^FK>6PO&F7^$?XH?\$P?^"AO[/?CYM.@_
M9W^,?B;4-#U0S^'O'WP+\->)_B+H]V;.7S+#7M%UWP!9:CJ6BM*%CN;2/6;?
M0M;LW(CNK"SNXWB2\GJ4*F Q>#E6A1JU95;.32?)4I0@I*[CS<KC+FBFG;JN
M:Y&>4\33S+!8Z.'GB*%&-)M0BY6G2K2J2C+E3Y')2BXRDK-Z:\K1_HD27=I%
M<V]G+<V\=W=I/):VLDT:7-S':B,W+V\#,)9DMQ-"9VC5EA$L?F%?,7-76=8T
MGP[I&J^(-?U.PT70M#TV^UC6M9U6[@L-,TG2=,M9;W4=3U*^NGBMK*PL+.":
MZO+NXEC@MK>*2:9TC1F'\@/_  2?_9F_X*66'[;?PO\ V@_C/\./C9!X#\/:
M9XO\+^.O$W[0>MZSHVNQ^%_$OA/4[&WL=)T;XB:BOC?4'@UYM"U.*WTO1I;(
M3::L5[<V:9=?ZA?VN_@]KW[0/[,'QY^"OA?6(]!\2_$OX7^+?"F@:G<326]C
M'K.I:7.FFVNJSPQ3S0Z+J5VL.F:W)#!/,FD7EZT4$T@6)_'Q6$IX;$4Z/UFG
M5C)0=2K3LU3<IN,DTI2=XQ2EJU=-:(]W"8VKB\+5K_5*M&<7-4Z-6ZE4Y81E
M%IRA'2<FX)I-)IZL_/?PK_P7=_X)^>+/BW!\*H?%OC[1+.]UB+0M,^*WB/P9
M'I?PKU"^N;E[.TE.K'6I_%.DZ9<7(A4ZUXB\(:-I%G#<Q7NI7UE817EU:_LG
M7^<QX7_X)9_M^^)OBE:?"C_AESXN:!JDNMKHU[XM\2>#]8TGX8:7&L\<=WK,
M_P 39K4^"+W1[.%VN_M.C:YJ<NH11/#I$&H7ICM7_P!#[P-X<D\'^"O!_A&6
M_?59?"WA;P_X<DU22-HI-2DT32;33'OWB:6=HGO&M3<-&TTS(TA4RR$;STYI
MA,'A?8?5:WM'.,N=>TC4LH\O+.\4K<]Y:/1V]U))G)DV.QV,6(^N4/9*G*/L
MY>SG2NY<W-3Y9M\W)9.ZU5[2U:/Y.?\ @Y9^$O\ 9_Q,_9J^.5K;93Q5X)\6
M_"W6KF/A89_ ^MV_BKP\EPN #+?P^/?$0@D4R.T6D2QS&-(;82?F[X _X*2>
M)OA=_P $R/%7[%'@^;4++QOX[^+/C"+4O$T*-%;Z!\!O$>A>'+[7/#UA<$_/
MK?C'Q<_B73;N6/>EKX6O-9A>*"]OM.O5_J-_X+??LS^-OVEOV*WT_P"&/@W7
M?'?Q&^''Q0\$^.O#GAKPMI<VK^)-7M;HZEX'UZRTZPM4DO+F"#3?%[:]J$-N
MC;+?0A>S+Y5DSI_)Y\'O^"4'[<WQ/^*/@7P!KG[/'Q9^&>A>*?$>GZ7KWQ!\
M:>!=9TGPQX-T)Y?-UGQ%JEU?QV-O(FEZ9%=75MIPNH;G6+V.VTFQ8WM];HWL
M9;6PM;+J,<5.FOJM64K3DD[TFZD)<K=Y)1FE9*SM;75'@YM0QE#-*\\'3JOZ
MY1C!RIPDU:JHTZD>9+EC*4X7;;]WFOIHS]&/^"!'[ Q^+'Q+G_;%^)NB+-\.
MOA#J\NF?"C3]1@5K?Q5\6((8)I?$B6]Q#(EUI'PZM+N.YL[I!&C>-[O2I[&[
M:Z\*:K:K_9?7EOP2^#G@3]GSX3> ?@O\--*71_!'PZ\.V?AW0K0^6US,D&^>
M^U74IHXXEN]:UW5)[W7-<OS&CZAK&HWU](HDN'KU*OG<PQDL;B9UG=07N4H_
MRTTW:_\ >EK*7]YM+1(^JRW PR_"PH*SF_?K37VZLDN9_P"&*2C';W8IM7;/
MX\?^#E7XGG5_CE^SI\'8;L20>!?A?XD^(%Y;1.I6*_\ B3XG70HEN]G6YBLO
MAI'-!#.3);6U_P"=$D<6H%Y_O+_@W"^&'_"-?LF?%?XH7,/E7WQ0^,]SI=H^
MS'VCPW\/?#6D6>GS^:<%L>(?$/BZV\H*4B^S[Q(SS/'%^5__  5M_97_ &U/
MVC/V\_C1X^\"_LQ?&_Q7\/['_A$/!O@C7M%\ ^(-3TC4M&\*^#]$L+Z^TW4+
M>S-O=V-_XF/B#4+:6#]WY-VB!I65II/Z?/\ @F/\$=;_ &>?V$_V<_AAXIT&
M[\,^+K'P7/XE\7:'J5L;36-+\2>/=?UCQSJ>FZW;N!/!JVE2^(5TF\M;K%SI
M[6*Z=(D7V-88_7QE2G1R7"X>$X2G4]DYQC*+<;J5>?,DVTU4<4[]3Q,#2JUL
M_P ;BJE.I&%)58TYSA*,9./)0ARN22=Z:DU9[:]3WOXJ_M.?L_\ P-\6_#SP
M-\8/BSX-^&_B;XK2:S%X"LO%^IC1K779- _LU=20ZS=HFB:4PFU?3;2Q&MZC
MIO\ :]]=)I^D?;KU9+=.+^-W[%7[(W[3K?VM\9_@-\-/B%JE[:PJ/&$NCQZ9
MXON+(0H+6./QWX:FTGQ6]FD(3[+''K9MXTPT"J#D_P _?_!87_@EY^W;^TI^
MT-KO[0?PV/ACXU>"%\.Z#X:\'^ -%UBS\)^,O 'AC0K*6YNM*32/%VI6NCZ_
M'<Z]>:WKDM]HOB.XU?5]3UJY%OX8T^!+6RB_%#2/A1_P52_9WE/A_P )>"/V
M[OA)%$\T$-OX!TSXZ^&M%N?+6-K@:;>^#E@T7488Q=)YTNG7-S"K3;'<.Q6L
M<-EM*I2I5L/F4*6(<+U(J7+*,F[\J<9PJ0Y5:+O&2E).2:5D;8S-:U&O6H8K
M*JE;#*=J4^3FC.*27,U*$Z4^:5W&THN,6E)<UV_VM_X*>_\ !&7]CKX!?LY?
M$O\ :+^$?C#Q7\']6\$6EC=:7X%\1^*4\5^"/%=]>ZI:V5MX5TB3Q*)/&EOX
MAU);F5=+E_X2C6T9K8>=I31"YO(?S+_X(1>(O%6C?\%)_@]I?A^[OK?1_%OA
M;XMZ#XZ@M0YMK[PQ:?##Q3XHLK?4@ORK:1>-/#GA*\B>3"B_MK)%.^10?*+/
M]CK_ (*J_M?Z[ID/BOX6?M7?$:Z!:33_ !)\?;OQQI.A6D;D07%Q;>+?C5J.
MEZ0H58]DR6.HRW,@A,,<,LBK$?ZD?^"4'_!)RQ_83M-5^*_Q3UK2/&7[1/C'
M0SH,SZ&))_"OPV\,74UI>WWAWP[>7EO;W>L:YJEU9VK>(?$SVUE#Y%M#HFBV
MJ6"ZEJ?B'T*^(C@\OKX?$XV.-Q%6$X4XIJ4HJ<%!<SO*5H.\U.HTVU:.J1YF
M&PT\=F>&Q6%P$L!AJ$Z<ZDFG",W3GSOE5HQYIJU/DIII+WI.VWLO_!9CXG_\
M*N_X)R_M#W<$WE:IXWTGP[\,-+CW^7]I_P"$\\4Z/HNO0[QD_+X0D\27.P*W
MG?9_);8DCRQ_RN?\$+/A@?B/_P %%_A;J<UH+S3?A5X8^('Q/U.)T5XXQI_A
MRX\):)=ON^Z;+Q9XQ\/7<#KEEN88,8&2/WV_X+_^ ?C[\7_V?_@Q\+O@?\(_
MB?\ %6*Z^*.I>/O&47PU\&^(?&$VE6G@[PM>:)HUOJ]OX=L;ZX5-4N_'5U<Z
M?921.U[-HLUS!#(VEM)!\T_\&]?[(_QA^#WC?]I'XI_&SX/_ !-^$FJR>%?
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M-&LM$L3Y2LZQ?Z+8Q?NU=@GW0S 9/\)/_!./]@/]J*Y_;E_9DO/BG^S%\?O
M?@/PQ\4-)\>Z_P"*?'OP;^(OA+PEIR?#JVO?'NGQ:QKWB#PYI^CVL>J:MX<L
M-(M;>]NXTU2^O[72HTN)[V*WE_ODKHS^M3E+"T:4HRC3ISE[LE)+F<813:;V
M5-Z>?H<W#5"I&&,Q%6$HSJU8P]^+B_=3G)I2L[-U5KW6^C.?\6^)M*\%>%?$
MWC+7)OL^B>$O#^M>)M8N.OD:5H.FW.JZA-COY5I:S/\ \!K_ #'_  II6O\
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3LDDE]R"BBBD,**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img247211528_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_0.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %I X0# 2(  A$! Q$!_\0
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M&]7>U$\D2K"1]G8JV(95D();(!QG)J(X"E9-U.VGW7Z].H6/H_6/C[X=\/\
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MR\0>&M-N?-U'1?*,YW*4D$B[@8R"=P QGC@FG^++CP7XUFN? NN7NFZA=7$
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M:H_X7AX._P"?^[_\%EU_\:KN]H]*-H]*.:C_ "O[U_D!PG_"\/!W_/\ W?\
MX++K_P"-4?\ "\/!W_/_ '?_ (++K_XU7=[1Z4;1Z4<U'^5_>O\ (#A/^%X>
M#O\ G_N__!9=?_&J/^%X>#O^?^[_ /!9=?\ QJN[VCTHVCTHYJ/\K^]?Y <)
M_P +P\'?\_\ =_\ @LNO_C5'_"\/!W_/_=_^"RZ_^-5W>T>E&T>E'-1_E?WK
M_(#A/^%X>#O^?^[_ /!9=?\ QJC_ (7AX._Y_P"[_P#!9=?_ !JN[VCTHVCT
MHYJ/\K^]?Y <)_PO#P=_S_W?_@LNO_C5'_"\/!W_ #_W?_@LNO\ XU7=[1Z4
M;1Z4<U'^5_>O\@.$_P"%X>#O^?\ N_\ P677_P :H_X7AX._Y_[O_P %EU_\
M:KN]H]*-H]*.:C_*_O7^0'"?\+P\'?\ /_=_^"RZ_P#C5'_"\/!W_/\ W?\
MX++K_P"-5W>T>E&T>E'-1_E?WK_(#A/^%X>#O^?^[_\ !9=?_&J/^%X>#O\
MG_N__!9=?_&J[O:/2C:/2CFH_P K^]?Y <&WQS\&K][4;H?73+K_ .-TW_A>
MW@O_ *"5S_X+;K_XW78ZI&SQIM3=SV&:SOL\O_/%O^^*.:C_ "O[U_D!S_\
MPO;P7_T$KG_P6W7_ ,;H_P"%[>"_^@E<_P#@MNO_ (W70?9Y?^>+?]\4?9Y?
M^>+?]\4<U'^5_>O\@.?_ .%[>"_^@E<_^"VZ_P#C='_"]O!?_02N?_!;=?\
MQNN@^SR_\\6_[XH^SR_\\6_[XHYJ/\K^]?Y <_\ \+V\%_\ 02N?_!;=?_&Z
M/^%[>"_^@E<_^"VZ_P#C==!]GE_YXM_WQ1]GE_YXM_WQ1S4?Y7]Z_P @.?\
M^%[>"_\ H)7/_@MNO_C='_"]O!?_ $$KG_P6W7_QNN@^SR_\\6_[XH^SR_\
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M!?\ T$KG_P %MU_\;KH/L\O_ #Q;_OBC[/+_ ,\6_P"^*.:C_*_O7^0'/_\
M"]O!?_02N?\ P6W7_P ;H_X7MX+_ .@E<_\ @MNO_C==!]GE_P">+?\ ?%'V
M>7_GBW_?%'-1_E?WK_(#G_\ A>W@O_H)7/\ X+;K_P"-T?\ "]O!?_02N?\
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M5'_"\/!W_/\ W?\ X++K_P"-5W>T>E&T>E'-1_E?WK_(#A/^%X>#O^?^[_\
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MAXVFO;:^8_CA>:YK'[16E^';5_&UYI"^%6OS8>#]873RLWVP1^;*3)'N&TD
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MO+L"KR2,@8QQ1\%/ACKOP\TO5;76[C2;VYO=K2:C9I,;JZD"D-)<22L2YYX
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M!WT/Q[XM\1&Z65=<^RX@"8,7DQ>7R>^>M=;110 4444 %%%% !1110 4444
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M!_TXW!W[U\H1!!QPH4<#ZFL2P^"NBZ7>P3V=_K%M$ODFXM8KYEBO'B0(DDP
MRS;54'! ; W UZ!17YNJU1:*1B>9V/[/OA>Q\M&EU.ZMX;>[L[>VN+QFBM[>
MY4B:)%QPISU.6''.!BIX_@=HL,-F(M2UB*>&U6QFNDNP)KNW5BR1RMMY"[B
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M3_P-B_\ BJ9)^PK\:8L;O"B\^EY$?ZT?7\)_S]C]Z#F1X'17O/\ PPW\9_\
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M\4?">N7GB+29_"^IZSKUG;QZY;W\UQ! +N!/*2Y@9(F8AHPNZ-@,%>&YK/\
M#OP+\7?"G4--UOP?>:-K>LS6-Q;:U#K4DMI#<S373W;3Q-&DA3$LLHV%<;6'
M.1R ;5U^T@+G7K?1?#_@W6/$>HR&]W16TL$0C6VF$3L3(X'+$8JUJ/[3'A;3
M?!/A+Q.]OJ!LO$5V+58O)'FV07<)Y9QG"I"5(=@2!QC.17!0_LB7NJWND3ZY
MXGNX9XM+U)+N^T#4+G3[@7]W/YIDC,3+F-.@5R02H)7K5C3_ -EC5/$%C8V'
MBC7UTC3M-\-CP[:6GA5_+CD$C$W4THEC/,NR X'0HW)S0!Z3XN^,CZ+XIO/#
MV@>%M6\8ZIIULEWJ4>FM$BVB/DQJ6D=0TCA6*H.PY(XK+O\ X]W<GBK^P="\
M":YKEY'IEMJ=POF06K6Z3%PB.LKJ=X*-D#IBN6T7X.?$7PE#=26M[H.OW.N:
M;:Z?K8U"\NK0F6V5HH[J*6)"Y9XMI=#M^<95@*Y#P_\ LS^/O#FI:5J&HV'@
MWX@:A#H5IIEQ=^(-1O(Y4FAEE<NC>3*S*1(HRQW?)0![E\1/BQ-X$O/"NG6W
MAG4-?UGQ%)-';V%G+$AC,4)E<NSL%X (X/)KE]&_:P\&W6K-8ZW+_P (B8;*
M2XNGUR>*'[-/'=-;R6[?,065@&RI(PP-:GQ4^#,GQ7\2?#Z]U"ZDLK'09KJX
MO8M.U"YM)W:6V:)1%-"4? =LG)&0.G:L*X_9HL-/\2:K/HEOI]MHT_@^Y\/6
MT%T9)IEN)IY)9)G=]Q8-O&YB2Q(YH ]-F^)GA*#Q);>'I/$FF)K=R%,-@;I/
M-DW+N7"YY)7D#N.15:W^+W@B[_M8P^+-'D725+WS"\3%NH;:2YSP WRY]>.M
M>):E^SSX^OVT>TGU/2;VUTO5-&O[6XEO;B,10V9A:2V$"IM8LT3XD8DX?MC%
M4M1_9E\<:I9W6GVNI:;X?T*UN[?4[#1+?4)[F![N*Y\[/F/$)(8G4L"@+@$Y
M &.0#Z-T7QQX?\1:%-K6F:Q9W^E0;_-NX)@T<>P9<,1]T@=0>E9G@OXL>%?B
M =271-4,\FG!7NH;BVEMI(T<,4DV2HK&-@K;7 *G:<$XKF? 'PYU_P '^'O&
M-]&MA%XOUO=+%Y]Y+=6WFI#Y<!E8HI(X7=M7H.]5_@7X \7>$[K6-1\;6VCW
M7B#4HX5N=:L=3GNYKO9NPC+)!$L,:[VVI'P-QSR22 7_  #^T=X"^('@O1_$
MMMK]E866K7$UK:1WMS&DDDL<IC* ;N6) ( YPRGO6EI?QJ\*36>@G5=:TO1=
M2UF-9+;3YK^)W?<Y1=K*<-EA@$<$\#FO-/A3^SWXA\*WO@$:]_84]KX.N=9-
MM):M))).EX^Z.3:T8$;KD@@$^QKE]0_9C^($GP]B\)+JVCWMO'I%O9VLCWMQ
M;Q6<T<C/(?+2/]\'R,%S\O. .I /HOP)XV@\=Z;?WEO;26JVFH7.GLLA!+-#
M(4+#'8D9KI*\^^#_ (.UWP/:^([#5_[/DM+C6+F_L9K.5V=XYG,A$JLH"LI.
M/E)! SQ7H- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?BM^U1
M_P G)_$K_L-S?R6O+:]2_:H_Y.3^)7_8;F_DM>6U^V87_=Z?^%?D=2V"OHO]
MC^S\5K=:WJ/A"ZD6_2^TZSN;>2VCN;1+:1I6DNIT?^&(19##D%Q7SI7UO\$-
M#\&Z)X1L?$?C*V\/^%-/UG35T^VCOM5NTN-2,;N)KEHX>D<A(4YX_=\#FN;,
M)<M!QM>_E?SVZBEL>=?M::M;^+/&6A^*;&ZOY=-UC3R]I:WT:1_9XHYGC'E(
M@"K$^TN!C^(]:\-KV+]J*Q32_'6FV=OHECI&G1:;$;"72]1DO;2[MF+&.6)W
MY"_>&WL0:\=K;!I+#P2VM_6PUL%?JG_P38_Y-IB_[#-[_P"A+7Y65^J?_!-C
M_DVF+_L,WO\ Z$M>)Q%_N7_;R_4B>QZW\2?BY+X)\7:-IT$%M/8*$N=;FEDV
MO:6TDHAB=1W)<LQST6-O:M2Z^+%C%XDN]*M=(U?4XK&=;6]U&SM@]M:S%0^Q
MCN!)"LI. 0-PS4&L? [PKXEU#Q%?:W8KK%WK0"/-=HK-;QK&$6.(X^4#!;_>
M8FH-(^$)T'4 UAXKU:"SG:*?4+']RPOI4C6-I&8IN4NJ+OVD X[5\"OJSBEU
M2^_^M?P,="KXH^.VGZ=X!AU[2[*ZO;G4-*OM2T^W:,#=]G3<P?G@<@_0&FQ_
M'JPMM+L'O-'U(Z@VFQ:G?VL$<9-E$^<,^7&<[6("Y.%S52P_9WT^&""SN?$N
MK7UA96=[IUI9OY*K;V]TNV1<J@+$#&&)SP*?-^S[92&SGE\07DFHK8QZ==7D
MMM;,UU#&S&/Y3'M1E#%=R@$@\Y/-:6PEK7_/^MOQ\AZ%KXE?'#3?A\WA#4I9
MX9/#NLK/*]TH9G=%M_-C\H#J6X_"J\GQ<N?#::9?^*6ALH;W3KK4ET^QB,[[
M!) L,8D!PTA\Y5P!AF?@@"NRUCX>Z7K.K>&;Z964>'S*;6W55,;!XO*(8$=
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MI1=/K^'];B'4445S""BBB@ HHHH **** "BBB@ HHHH ^'?^"IG_ "(_@?\
M[",W_HJOSFK]&?\ @J9_R(_@?_L(S?\ HJOSFK]5R'_<(?/\SHA\(4445] 6
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 '7K7WM_P3R^,'C/7GN_!=]8W&K^&-/A,D.K.?^/ ]H2Q^\K=AU'TKY;_
M &?_ -G_ %[X_>+ET[3E:TTBW(;4-49<I;IZ#U<]EK]7OAM\-M!^$_A&S\.>
M'+-;2PMQ\S=9)G[R.>[&OD,_QM"-)X9KFF_P\_4SFU:QU%%%%?G)@%%%% "K
M]X?6NA7[HKGE^\/K70K]T4 +1110 4444 %%%% !1110 4444 %>._$_]H:/
MP)XPF\-Z=I$>KZC9Z>-4O%GO1:A8BQ")'E6WR-M; X' YYKV*N)\8_!_P[XV
MUJ/5[U;VTU,6QLI+K3;R2U>>W+;O*D*$;ESR,],G'6@#SE?VH[J]NKB[T_P3
M>3>%[/4=-TZ\U6XNT@E1KWR0C) 5W-L:X0,"1T.,U8T_]H[6=<M].73O DK:
MAK6IW>G:+;W.I1QK=+:M*+BXD8*?*0>5\HY9MP&!UKT.X^$OABZM=4MI+!C#
MJ5]:ZC<J)W&Z>V,1A8<\8,$? X..<Y-4-6^#/A*[T#2='*7.FKI][->:==6=
M]);W=O/*TCR&*96##=YD@(S@@XQB@#QW7OV@M?UV/Q9<Z<)?#]QI'AN]^TZ:
M[),;34[>\$3X<##@ C!'!!Z5U3?'+5]-\67OA_2]!O/%&L7>L?V?;PSW<5M!
M 4TRWNF;?M)$?SGJ"=Q/;%=')^S-X%DL;>T6TU"*&.RN;"7R]2G5KN.=B\IG
M;=F5BYW[FR0W-:?AGX4>#?#?B""6R>:YUVRE^V%[K49+BXWM;):^9)N8DYBC
M1<GN,]3F@#@-*_:BU3Q-I?VG0? <^H7%AILVHZU!)J4</V/RYYH3#&Q4^:Y:
MWE(^Z, <\UZE;_$K3_\ A5(\>WD,UGI:Z2=8FA(WR1Q"+S67 ZL #^->5?$#
M]FR:9?LO@RUL["VGL+RPDN)-6O;29!<S232&01$BYCWRNPB?;@D@-@XKU#P5
M\+[#PCX5DT&>YGUBPGLX;*:WO#N@V);K"RI'T57"DE?5C0!Y3+\=O&%KXPTB
MXUOPU#X:TR?PU>:M%8W.K1-'<N)+<1))+L_=2 2$8PP.[C.*H3?M+>*_$/B+
MPCIVB^';>TN#XI71=;MYKO*F%K5YD:)GC5N0"<%005QWS7<_\,J> I(HDN4U
MF^^SVILK1KO6;F5K2'<KJD)9_D"LB$8Z%%]*OR?LX^$)9I+EGUDZA)J=OJ[:
MA_:]Q]I-S#$8E?S-^0"C%2HX(/(H H>%_P!H :[\4H/",^D01V]\+HZ?J=C?
M?:8Y3 1N#XC"@D$GY6;!!!K+UK]J2STSQ9J]A!HQO-(T?5$T>^NUN?\ 2A.W
ME[FCM@A,B(94!.X$_,<?+SUWAGX!>$O".M:-J6GQZBLFBF?^S;>;49I+>S68
M$2)'$6VA3GICL/05<D^#/AIO%T_B*%+VTN[BZ2^N;>UO9(K:XN$4*LLD0.UF
MP%!)'.U<YP* /.[C]JU%M_$JVWA&\NM0\+W$%AK=HMT@^SWD]U'!# CD8D++
M()=PP NW/)P':]^U%/X/U27P[XB\*KI7C"2YMXK&Q.I+):W$4RRLLQN GR!1
M;S;@5SE1C.ZM'QU^R]X:UKPC<Z9H=O\ V??736Z7-U-<RL;N);Z*ZE\XY)D<
M['VNV2I?@@5MC]G'P:T-ZUQ'J=[J5U<P79U>[U.>6^BDA#"'RYV8L@0.X"@X
MP[9SDT <SI7[2FI>*KNWT3PYX,;4_%?^D/=64NH+!:Q0PLJ^:EP4_>*[, N%
MZYSC'.+/^T?XD\(^+/B'+XH\/QVVA:3'I$.GVBWD9G%Y>;$6!R%QAG?E^0H'
M0UZ3J/P$\,:E9:;$9M9MKW3VF,.JVNJSQ7Q$O^M5IU;<RMQ\I..!C&!4-Y^S
MIX*U"ZOII[6_D6^L+>PN(3J,_ER" @P2E=W^NC*@K+]\$=: .1@_:>N[R\M_
M#]EX3^W^,KN^6SM+*#4!]BF0P/.TPNB@&$2-]R[20=H_BK4^&/Q3UJ\\!>/]
M?\10QP7>C^(-1M(K*\NXXHXHXF58XC-C;C)X;'.X<9XKH;WX"^&-2T:*QN9=
M7FGAOAJ,&J'5)A?03A=FZ.<-N0;<J5!P03D<U+9_ GPC8^"=:\*K:W<NDZQ=
M-?W@GO9I)9+EG5S-YC,6#[T5L@]1F@#@--_:FO=1*:;!X+EN_$K:U%HXL+>^
M"P_O+9KA)O-DC4A J,&^3(QD9JRW[3EQ;PPZW<^$98O!-QJ$VDV^M+?(TCW,
M?F*28-N1$98GC#9SP#C!KM=%^!/A71?$ UQ4U"]UC[5'>M>7^HS3N\T<+PHY
MW,1Q'(RXQC&/05%#^S_X-@\3#61:WCJMX^I1Z7)?2MI\=TZD-.ML6\L.=S<X
MZL3U.: .9\0?M-VN@>"]&\0MX>NKA=2\*:CXI6UCG7>BV@MB8,XP6;[2,-T&
MT^M4[S]I/6M)U2[T#4? 4MMXJEGL8M*TU=3C=+H77F;6DE"XBV"%RXPW;&<U
MMV/[*_@"RMFMS;:I=P_V;<Z/&EWJUS*(;*<J9+>,%_E3*)@#IM%=+XN^"_A7
MQK=7EWJ5I.+^Y%KB\MKJ2&:!K=G:"2)U(,;J7;YEP3G!S0!A_!3QMXB\8:_X
M_@\16;:9-IFJ1VL.GF595@4P(QVR*!O4DD@D \]*]5KDO /PPT/X;MJSZ1]M
M>?5IUNKVXOKV6YDGE"!-Y:1CR0HSCKBNMH **** "BBB@ HHHH **** "BBB
M@#\5OVJ/^3D_B5_V&YOY+7EM>I?M4?\ )R?Q*_[#<W\EKRVOVS"_[O3_ ,*_
M(ZEL%?0-OXT^!?BCPCX4A\967C(:WH^EQZ=(=+FB6W.TDDJ&!/)8FOGZOHK]
MCGPO;^(=<U66#P[IOB?7(;JQB2SU+:_D6,CN+JXCB)P[IB(>P<FL<;RQI>TD
MVN7L[>6XF<'\;_&?@_Q.?"FG>![?5H-#T+36L4_MEE:=B96D)RO&,N:\QKU;
M]H+P5!X$U7PYI\NEVVAZ^=-W:KI]M,)-DGFOY;N 2%=TVDKGCCUKRFML-R^R
MBX;?\$:"OU3_ .";'_)M,7_89O?_ $):_*ROU3_X)L?\FTQ?]AF]_P#0EKP>
M(O\ <O\ MY?J1/8['XL?&'Q!\/\ Q.VDB>VC66\@N8IGMB^S2VC87,QP>L#H
M6/;:RYZUP7Q7\;:_KGAG5M1%[#HTM[H/]IV5Y#&5F@L_[2@6($[APT9#D\8W
M8Z"OJNYTZTO&W7%K#.WEM%NDC#'8V-R\CH<#([XIEQI%A=1-%/96\T;1>04D
MB5@8_P"X01]W@<=*^$I8JG3Y7[/5;^9E<^>K[Q-XET'Q%\0?$&C^(;&XL+&_
MT<2QFV$JWPDBAC?#!L1@A\C;GD5I?' 277Q8T.(^&KSQ?;0^&]0NWTJSU'[(
MP*SVP\P?.N]@&*@=?GKW*#1=.M;4VT-A:Q6Y"@Q)"H0A<;> ,<8&/3%6#;0F
MX6<Q(9U4H)=HW!202N>N,@<>PJ5BDI*2CLK=NB72P7/EOP[\5?$VD^'='TFU
MUB-4M]!&JP7LR).+LO+(5@:21U.(5"1,1ELC-=!K7QG\3Z+JE_+J=]::=OM)
M38:?:PQ7<9G6T:4QS.'\R-@R$\KM( '>O=KKPOH]ZL"W&E64ZV[%X5DMT81D
MG)*Y'&3S]:I:YX%T77K;4DET^WAN;^VDM9;V&%!/L=2IP^,YP:T^M492O*GO
M_7]?@%T>!>(/BMK#:/%:W.NZ/XN@U32X=2D2UM_+&GOY\(VMM?)5MY W8;<O
M3J*Z2?XD^)O[,FGN-?M;2XU'6KC3=,AM[&/;''"S[C)+*X4,57OZ< DUZ_HO
M@W1=!LOLUIIEH@:-$E<0(&FV  %R!\QXSSWJY>:%INH6OV:ZT^UN+;?YODRP
MJR;\YW8(Z^]3+$TM$H?E^5@NCY@T?XN>(KO7K+Q5-J]O<3V_A?5"-%B51'?W
M%O=>7\N&/S' ;Y02 "!P:V]6^,?BO0[.YMK#Q-HOBJXN--MKZ/4;>U"PV$LE
MS'%L<*QW*PD)7)#?+7T"OAO28Y+:1=+LUDMBS0,MN@,1;[Q4XXSWQUIMCX9T
M?38IHK32K*UCF<22I#;H@=@<@L .2#5/%46[^S_+OZ?UU"Z/++SX@>*?#WC"
M/P-=WEO?:]J%Q:2Z=?K:>6KV9!-T[("0"GE2*.?^6D?K6-\3M!OO%7QUAL+?
M2[?6X(M $KVUYJ4UJD>;C!=1&>6QQS7K?_"$6\GCX>*KFYFN;N&S-C:6[A1'
M:HS!I"N!DLY5<DGHH K?^SQ?:#/Y2>?MV>;M&[;G.,]<9[5DL1&FU*"UMKTU
M_K\;BN?/NL?%S4=%\76EAI^H6\^@#5_^$>ET^XCCC:(B!B=I+^:V&4?.1@@_
MC6+X.^)4WANTMKV.[L;-[L^'([F&1@(X;68B.5U5FRJ_-C<> 2,U]'OX:TB2
M^>]?2[)KQR"UPUNAD)'0EL9S3;CPOHUV'$^DV,PDA%N^^V0[H@<A#Q]W/..E
M6L52MR\G:X[GCH^+&O\ BKQY;Z%X?UK3([2;Q!=Z>UT(!/BWALHYL+AL%MY8
M9Z8SZ5!\._B_XJ\6>(M(DE$7DW]_<6UUHSQ1QM911[QN#[][.I5<AE (?V&?
M;[/0]-T_RS:Z?:VQC^YY,*IMXQQ@<<<4D.@Z9;ZE)J$6G6L5_(,/=)"HD;ZM
MC)J'B*7*XJGT_P _^!]PKE^BBBO/$%%%% !1110 4444 %%%% 'P[_P5,_Y$
M?P/_ -A&;_T57YS5^PG[5_[.2_M%:#H-@VN_V'_9MR\_F?9_-\S<NW&,C%?-
M?_#L*/\ Z*"?_!=_]G7Z!E.:83"X2-*K.TE?H^_H;1DDK'P?17WA_P .PH_^
MB@G_ ,%W_P!G1_P["C_Z*"?_  7?_9U[']N9?_S\_!_Y%<R/@^BOO#_AV%'_
M -%!/_@N_P#LZ/\ AV%'_P!%!/\ X+O_ +.C^W,O_P"?GX/_ "#F1\'T5]X?
M\.PH_P#HH)_\%W_V='_#L*/_ **"?_!=_P#9T?VYE_\ S\_!_P"0<R/@^BOO
M#_AV%'_T4$_^"[_[.C_AV%'_ -%!/_@N_P#LZ/[<R_\ Y^?@_P#(.9'P?17W
MA_P["C_Z*"?_  7?_9T?\.PX_P#HH)_\%W_V=']N9?\ \_/P?^0<R/@^BOOY
M?^"5Z,H/_"PGY_ZAH_\ BZ7_ (=6I_T4)_\ P6C_ .+H_MS+_P#GY^#_ ,@Y
MT? %%??_ /PZM3_HH3_^"T?_ !='_#JU/^BA/_X+1_\ %T?VYE__ #\_!_Y!
MSH^ **^__P#AU:G_ $4)_P#P6C_XNC_AU:G_ $4)_P#P6C_XNC^W,O\ ^?GX
M/_(.='P!17W_ /\ #JU/^BA/_P""T?\ Q='_  ZM3_HH3_\ @M'_ ,71_;F7
M_P#/S\'_ )!SH^ **^__ /AU:G_10G_\%H_^+H_X=6I_T4)__!:/_BZ/[<R_
M_GY^#_R#G1\ 45]__P##JU/^BA/_ ."T?_%U7NO^"7"6NW_BX3'=ZZ;_ /9T
M?VYE_P#S\_!_Y!S(^"**^\/^'84?_103_P""[_[.C_AV%'_T4$_^"[_[.C^W
M,O\ ^?GX/_(.9'P?7J/[/_[/^O?'[Q<NFZ:K6FDVY#:CJCKF.W3T'JY[+7U
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MV_\ W]7_ !H_M*S_ .?NW_[^K_C1I_*!"VJ.H8_8;H[5#<)USV'O0^J,N_\
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MR,_,8XQG@\]3C]16G11>/8#,_ME\9_L^\_U?F?ZO_P =Z]:&UEU#?\2^\.U
MW$?7/8<]16G11>/8#,;677?_ ,2^\.W;TCZY].>U*VL.I8?8+L[7"\1]<]^O
M2M*BB\>P&:-8?<!]@N_O[,^6/^^NO2A=8=BG_$ONUW,5YCZ8[GGH:TJ*+Q[
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M_P"_S?XT?;KO_G[N/^_S?XU!118"?^T+O_G\N?\ O^_^-']H7?\ S^7/_?\
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MD=2V"BBBND84444 %?JG_P $V/\ DVF+_L,WO_H2U^5E?JG_ ,$V/^3:8O\
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M!FJFN?&Y_"ZV%GKF@C1=<OY94MK6^U*&.WDCC56>43GC WJN-N=QQC'-&G_
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M38_"T,%&G5J)/7\S>+5CY8HKZG_X=P_%+_G_ /#O_@7)_P#&Z/\ AW#\4O\
MG_\ #O\ X%R?_&Z]O^U,#_S]17,CY8HKZG_X=P_%+_G_ /#O_@7)_P#&Z/\
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M=R?_ !NC^U,#_P _4',CY2HKZG_X=P_%+_G_ /#O_@7)_P#&Z/\ AW#\4O\
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M)UXT_P"B<77_ (-K7_XJO0**^J]I#^1?C_F?D1Y__P )UXT_Z)Q=?^#:U_\
MBJ/^$Z\:?]$XNO\ P;6O_P 57H%%'M(?R+\?\P//_P#A.O&G_1.+K_P;6O\
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M_P#BJ/\ A.O&G_1.+K_P;6O_ ,57H%%'M(?R+\?\P//_ /A.O&G_ $3BZ_\
M!M:__%4?\)UXT_Z)Q=?^#:U_^*KT"BCVD/Y%^/\ F!Y__P )UXT_Z)Q=?^#:
MU_\ BJ/^$Z\:?]$XNO\ P;6O_P 57H%%'M(?R+\?\P//_P#A.O&G_1.+K_P;
M6O\ \51_PG7C3_HG%U_X-K7_ .*KT"BCVD/Y%^/^8'G_ /PG7C3_ *)Q=?\
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M]K_C7<45V>TC_(OQ_P SS3A_^$V\6_\ 1.;S_P &]K_C1_PFWBW_ *)S>?\
M@WM?\:[BBCVD?Y%^/^8'#_\ ";>+?^B<WG_@WM?\:/\ A-O%O_1.;S_P;VO^
M-=Q11[2/\B_'_,# 7QSXSVKCX<7>,?\ 06M?_BJ=_P )UXT_Z)Q=?^#:U_\
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MM_Z)S>?^#>U_QKN**/:1_D7X_P"8'#_\)MXM_P"B<WG_ (-[7_&C_A-O%O\
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MO&G_ $3BZ_\ !M:__%5Z!11[2'\B_'_,#S__ (3KQI_T3BZ_\&UK_P#%4?\
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M/^$Z\:?]$XNO_!M:_P#Q5>@44>TA_(OQ_P P//\ _A.O&G_1.+K_ ,&UK_\
M%4?\)UXT_P"B<77_ (-K7_XJO0**/:0_D7X_Y@>?_P#"=>-/^B<77_@VM?\
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M3\,5<DJ^VH^]0EL_Y?)_H^OJ=)1117TY\(%%%% '0Q_ZM?H*=38_]6OT%.H
M**** "BBB@ HHHH **** "LW6/\ EE^/]*TJS=8_Y9?C_2@#.HHHH **** "
MBBB@ HHHH **** %7[P^M="OW17/+]X?6NA7[HH 6BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\Y?C?_ ,EB\9?]A*3^0KB:
M[;XW_P#)8O&7_82D_D*XFOY_QG^\U?\ $_S9_8F6_P"XT/\ !'_TE'J7P-AT
MJ&35K[4DFNOGMK#[+%>M:@I.Y5G8J06 P!CIS3/CIIZ:?/X;1=$;PXRV4D9T
MR6=I9(E69PI+,<[6&"![U:_9]L1>:K>FSL=/U+6UFM1%;Z@%8?9C+BX>-&X9
MPOX@<BLGXRZ:=*U#1X+T1)KRVKK?QQ3>:0!*PA+G)PYCVY'TKUFG_9J=OG;^
M]WM>_E?;7T^>33SQKF=UTN_Y/Y;VM_>M>^FG7SRBBBOGC[(*^X/V._\ DC:?
M]A&Y_F*^'Z^X/V._^2-I_P!A&Y_F*^NX7_Y&'_;K_0_../O^1.O\<?R9U,\*
M>)/%GB6'5]8O-,333&MI#;7C6X2(Q!C.<$;B6+#)R!MQ619^)]:TG4-=OK2\
MM=0T>'4K2)VN,M),DD40+(RD*OWMW0@Y/2O2M6\+Z/KTT4NHZ9:WLL0PCSQ!
MB!Z<]O:ISHM@R3(;.#9,ZR2+L&&9<!2?<8'Y"OTB6%J-W4K.[=];O>U_2_\
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M5"%W:9&I*$G_ $D'#=A]W]:/MVJ;?^09'GR]V/M0^]_=^[^M:E%',OY?S_S
MRVOM4"OMTR-B%!4?:@,MW'W>,>M$E[JB^;MTR-MNW9_I(&[/7^'C%:E%',OY
M?S_S Y_5KO4MN!IT9"R84_:1\R]VZ<=N/>L[[3J&[_CPCQYFW/V@?=_O=/TJ
M3XA>.-#\#VEI-KFH)81SN4C9U)W$#)' KB/^%_> /^AC@_[]O_A7)4QN&I2Y
M*DXI]F[?J>C1R[&XB"J4:,I1?51;7WI'9K<ZAE<V$8RQ#?Z0.%['IS]*1;K4
M3LW:?&N<[O\ 20<>G;G-<;_PO[P!_P!#'!_W[?\ PH_X7]X _P"AC@_[]O\
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MWG/'TS0M]JF%SID8/EEC_I(X;LOW?UK4HHYE_+^?^8&7]NU3!_XED>?+#?\
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MH 6BBD#!NASVH 6BBDW#=C//7% "T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'YR_&__DL7C+_L)2?R%<37;?&__DL7C+_L
M)2?R%<37\_XS_>:O^)_FS^Q,M_W&A_@C_P"DH]:^ NDP>((_$6FW.E:A?0R1
MPR"ZT^>*V>T=6.&\V1@%SR,<YK&^-'@^R\':_9Q64-_%]I@\Z0ZA?073LVXC
M.Z(D <=#S73:+>>#/"OPPMO[<T#6IK;Q$H$OE7Z+YKPL3YT:8RJY)&3P:X[X
MJ>'=%\.:EI:Z%IUW86-Y9)=JUU=+<"8,3AE90,8Z$=B#7JUHQA@8PT<E9^:N
M[K[/;KS'SV%J3J9K.I[T82;271\J2;OS[IK;EZ>IQ-%%%?/GV05]P?L=_P#)
M&T_["-S_ #%?#]?<'['?_)&T_P"PC<_S%?7<+_\ (P_[=?Z'YQQ]_P B=?XX
M_DR'Q\Q'B7QO,VE7%V84M$BU..Z$:Z<S1*!(1N#84D,2H/ -:MOJVNZ#?:U?
MP:C!/9IX@AMI;8P[FN-\%NK$/GY>H(P.]>MM9V[^?N@C;SQMER@_>#&,-Z\<
M<TU=/M5C*"VA"%@Y41C&X  'IU  Y]A7Z+]0DIN<9V;;?XOMOOU[=C\5_M:#
MIQIRIW226NNB44][V^%[6W[JYXS_ ,+1\42:+<:E!'$\CVUW*;5EC_T;RE8J
M5 ;>Q!4!@PYSVK;\2?$J]^VFUT6_L9':"P97P)%5YK@1L3@\C:1Q[BO1H]%T
M^&ZFN8[&V2YG!$LRPJ'D!ZACC)_&F6OA_2[)0MOIMG JG(6*!% Y![#U /U%
M-87$)6]KO_6GYBEC\%*2E]72MTT[IZ^EK>?4\UB\6>*+&ZOGNM5M+FUTK5X[
M&55M-KW,;JI))#':PW<8ZXKG?%7Q UC5-!URVBU'%M>Z-=WMO<>7&DD?E,F-
MJJY9<JY^_@C&?:O=?L-L=^;>+YW$C?(/F8=&/J>.M5HO#NE0M(T>F6<;2;MY
M6W0%MWWL\<Y[^M34P5:47%579W[_ .?;3\2Z.:8:$U4E05U;HEM\N^OIIL>;
MZUXXU6Q;5#!KUA&NCVD$T:RPJW]ILP))!#< D;1MR<]?2H=-\6ZC-K#Z?#>6
MGAV.XO[V62XN(M^YD\O$7S,!N^8EN>@XKTS_ (1O2?\ 1?\ B5V7^B?\>_\
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M2,+Y>1'\^T-G;S]WH<=:Z.S\3>)IO$4.@'5+4RQZC<6TU[]E&YXDMXIEPF[
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M\%[]/,NT445[!\V%%%% !1110 4444 %%%% !1110!\T?MN?\BWX9_Z^Y/\
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M** "BBB@!5^\/K70K]T5SR_>'UKH5^Z* %HHHH **** "BBB@ HHHH ****
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M^T>,_P#GTT;_ +_2_P"%=511[%_SO^OD'UE?\^X_<_\ ,Y7[1XS_ .?31O\
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M@^LK_GW'[G_F<K]H\9_\^FC?]_I?\*/M'C/_ )]-&_[_ $O^%=511[%_SO\
MKY!]97_/N/W/_,Y7[1XS_P"?31O^_P!+_A1]H\9_\^FC?]_I?\*ZJBCV+_G?
M]?(/K*_Y]Q^Y_P"9ROVCQG_SZ:-_W^E_PH^T>,_^?31O^_TO^%=511[%_P [
M_KY!]97_ #[C]S_S.5^T>,_^?31O^_TO^%'VCQG_ ,^FC?\ ?Z7_  KJJ*/8
MO^=_U\@^LK_GW'[G_F<K]H\9_P#/IHW_ '^E_P */M'C/_GTT;_O]+_A7544
M>Q?\[_KY!]97_/N/W/\ S.5^T>,_^?31O^_TO^%'VCQG_P ^FC?]_I?\*ZJB
MCV+_ )W_ %\@^LK_ )]Q^Y_YG*_:/&?_ #Z:-_W^E_PH^T>,_P#GTT;_ +_2
M_P"%=511[%_SO^OD'UE?\^X_<_\ ,Y7[1XS_ .?31O\ O]+_ (4?:/&?_/IH
MW_?Z7_"NJHH]B_YW_7R#ZRO^?<?N?^9ROVCQG_SZ:-_W^E_PH^T>,_\ GTT;
M_O\ 2_X5U5%'L7_._P"OD'UE?\^X_<_\SE?M'C/_ )]-&_[_ $O^%'VCQG_S
MZ:-_W^E_PKJJ*/8O^=_U\@^LK_GW'[G_ )G*_:/&?_/IHW_?Z7_"C[1XS_Y]
M-&_[_2_X5U5%'L7_ #O^OD'UE?\ /N/W/_,Y7[1XS_Y]-&_[_2_X4?:/&?\
MSZ:-_P!_I?\ "NJHH]B_YW_7R#ZRO^?<?N?^9ROVCQG_ ,^FC?\ ?Z7_  K5
MT.36I/._M>&SBZ>5]C=FSUSG</I6K151IN+OS-D3KJ<>7D2]/^'"BBBMSE"B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img247211528_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_1.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" /Y"-L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_AJ_BQ_\QE'_  _U_P""6'_1QEW_ .&K^+'_ ,QE?YT%%'_$MW G_0QXH_\
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MW<"?]#'BC_PORSR_ZDWD_O\ (/J5'O4_\"C_ /(_U=^5O]%__A_K_P $L/\
MHXR[_P##5_%C_P"8RC_A_K_P2P_Z.,N__#5_%C_YC*_SH**/^);N!/\ H8\4
M?^%^6>7_ %)O)_?Y!]2H]ZG_ (%'_P"1_J[\K?Z+_P#P_P!?^"6'_1QEW_X:
MOXL?_,91_P /]?\ @EA_T<9=_P#AJ_BQ_P#,97^=!11_Q+=P)_T,>*/_  OR
MSR_ZDWD_O\@^I4>]3_P*/_R/]7?E;_1?_P"'^O\ P2P_Z.,N_P#PU?Q8_P#F
M,H_X?Z_\$L/^CC+O_P -7\6/_F,K_.@HH_XENX$_Z&/%'_A?EGE_U)O)_?Y!
M]2H]ZG_@4?\ Y'^KORM_HO\ _#_7_@EA_P!'&7?_ (:OXL?_ #&4?\/]?^"6
M'_1QEW_X:OXL?_,97^=!11_Q+=P)_P!#'BC_ ,+\L\O^I-Y/[_(/J5'O4_\
M H__ "/]7?E;_1?_ .'^O_!+#_HXR[_\-7\6/_F,H_X?Z_\ !+#_ *.,N_\
MPU?Q8_\ F,K_ #H**/\ B6[@3_H8\4?^%^6>7_4F\G]_D'U*CWJ?^!1_^1_J
M[\K?Z+__  _U_P""6'_1QEW_ .&K^+'_ ,QE'_#_ %_X)8?]'&7?_AJ_BQ_\
MQE?YT%%'_$MW G_0QXH_\+\L\O\ J3>3^_R#ZE1[U/\ P*/_ ,C_ %=^5O\
M1?\ ^'^O_!+#_HXR[_\ #5_%C_YC*/\ A_K_ ,$L/^CC+O\ \-7\6/\ YC*_
MSH**/^);N!/^ACQ1_P"%^6>7_4F\G]_D'U*CWJ?^!1_^1_J[\K?Z+_\ P_U_
MX)8?]'&7?_AJ_BQ_\QE'_#_7_@EA_P!'&7?_ (:OXL?_ #&5_G044?\ $MW
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M?Q8_^8RC_A_K_P $L/\ HXR[_P##5_%C_P"8RO\ .@HKZ+_B6[@3_H8\4?\
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MA_T<9=_^&K^+'_S&5_G044?\2W<"?]#'BC_PORSR_P"I-Y/[_(/J5'O4_P#
MH_\ R/\ 5WY6_P!%_P#X?Z_\$L/^CC+O_P -7\6/_F,H_P"'^O\ P2P_Z.,N
M_P#PU?Q8_P#F,K_.@HH_XENX$_Z&/%'_ (7Y9Y?]2;R?W^0?4J/>I_X%'_Y'
M^KORM_HO_P##_7_@EA_T<9=_^&K^+'_S&4?\/]?^"6'_ $<9=_\ AJ_BQ_\
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M[_(/J5'O4_\  H__ "/]7?E;_1?_ .'^O_!+#_HXR[_\-7\6/_F,H_X?Z_\
M!+#_ *.,N_\ PU?Q8_\ F,K_ #H**/\ B6[@3_H8\4?^%^6>7_4F\G]_D'U*
MCWJ?^!1_^1_J[\K?Z+__  _U_P""6'_1QEW_ .&K^+'_ ,QE'_#_ %_X)8?]
M'&7?_AJ_BQ_\QE?YT%%'_$MW G_0QXH_\+\L\O\ J3>3^_R#ZE1[U/\ P*/_
M ,C_ %=^5O\ 1?\ ^'^O_!+#_HXR[_\ #5_%C_YC*/\ A_K_ ,$L/^CC+O\
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M#'BC_P +\L\O^I-Y/[_(/J5'O4_\"C_\C_5WY6_T7_\ A_K_ ,$L/^CC+O\
M\-7\6/\ YC*/^'^O_!+#_HXR[_\ #5_%C_YC*_SH**/^);N!/^ACQ1_X7Y9Y
M?]2;R?W^0?4J/>I_X%'_ .1_J[\K?Z+_ /P_U_X)8?\ 1QEW_P"&K^+'_P Q
ME'_#_7_@EA_T<9=_^&K^+'_S&5_G044?\2W<"?\ 0QXH_P#"_+/+_J3>3^_R
M#ZE1[U/_  */_P C_5WY6_T7_P#A_K_P2P_Z.,N__#5_%C_YC*/^'^O_  2P
M_P"CC+O_ ,-7\6/_ )C*_P Z"BC_ (ENX$_Z&/%'_A?EGE_U)O)_?Y!]2H]Z
MG_@4?_D?ZN_*W^B__P /]?\ @EA_T<9=_P#AJ_BQ_P#,91_P_P!?^"6'_1QE
MW_X:OXL?_,97^=!11_Q+=P)_T,>*/_"_+/+_ *DWD_O\@^I4>]3_ ,"C_P#(
M_P!7?E;_ $7_ /A_K_P2P_Z.,N__  U?Q8_^8RC_ (?Z_P#!+#_HXR[_ /#5
M_%C_ .8RO\Z"BC_B6[@3_H8\4?\ A?EGE_U)O)_?Y!]2H]ZG_@4?_D?ZN_*W
M^B__ ,/]?^"6'_1QEW_X:OXL?_,91_P_U_X)8?\ 1QEW_P"&K^+'_P QE?YT
M%%'_ !+=P)_T,>*/_"_+/+_J3>3^_P @^I4>]3_P*/\ \C_5WY6_T7)?^"_7
M_!*V&.2:3]HV[6.)'D=O^%5?%DX1%+,<#P62<*"< $GM7T'^T%_P56_8;_9<
MU/P!H_QM^+]QX1U#XH?#O1?BKX*AC\#>/-;&K^!O$$D\.E:PTFA>'-1CLFN9
M+>938WS6]_#MS-;(&4G_ #%-1_Y!]]_UYW7_ *(>OWP_X+V?\E(_8-_[1^_!
M_P#].&L5\[F7@)P;@^(N&,II8_B)X;.:>?3Q4YXS+W6@\KPF$KX=4)+*HP@I
MSKS57GIU'**BH.#3;B6#I*=.-YVESWU5_=46OL];N^A_3W_P_P!?^"6'_1QE
MW_X:OXL?_,91_P /]?\ @EA_T<9=_P#AJ_BQ_P#,97^=!17T7_$MW G_ $,>
M*/\ PORSR_ZDWD_O\B_J5'O4_P# H_\ R/\ 5WY6_P!%_P#X?Z_\$L/^CC+O
M_P -7\6/_F,H_P"'^O\ P2P_Z.,N_P#PU?Q8_P#F,K_.@HH_XENX$_Z&/%'_
M (7Y9Y?]2;R?W^0?4J/>I_X%'_Y'^KORM_HO_P##_7_@EA_T<9=_^&K^+'_S
M&4?\/]?^"6'_ $<9=_\ AJ_BQ_\ ,97^=!11_P 2W<"?]#'BC_PORSR_ZDWD
M_O\ (/J5'O4_\"C_ /(_U=^5O]%__A_K_P $L/\ HXR[_P##5_%C_P"8RC_A
M_K_P2P_Z.,N__#5_%C_YC*_SH**/^);N!/\ H8\4?^%^6>7_ %)O)_?Y!]2H
M]ZG_ (%'_P"1_J[\K?Z+_P#P_P!?^"6'_1QEW_X:OXL?_,91_P /]?\ @EA_
MT<9=_P#AJ_BQ_P#,97^=!11_Q+=P)_T,>*/_  ORSR_ZDWD_O\@^I4>]3_P*
M/_R/]7?E;_1?_P"'^O\ P2P_Z.,N_P#PU?Q8_P#F,H_X?Z_\$L/^CC+O_P -
M7\6/_F,K_.@HH_XENX$_Z&/%'_A?EGE_U)O)_?Y!]2H]ZG_@4?\ Y'^KORM_
MHO\ _#_7_@EA_P!'&7?_ (:OXL?_ #&4?\/]?^"6'_1QEW_X:OXL?_,97^=!
M11_Q+=P)_P!#'BC_ ,+\L\O^I-Y/[_(/J5'O4_\  H__ "/]7?E;_1?_ .'^
MO_!+#_HXR[_\-7\6/_F,H_X?Z_\ !+#_ *.,N_\ PU?Q8_\ F,K_ #H**/\
MB6[@3_H8\4?^%^6>7_4F\G]_D'U*CWJ?^!1_^1_J[\K?Z+__  _U_P""6'_1
MQEW_ .&K^+'_ ,QE'_#_ %_X)8?]'&7?_AJ_BQ_\QE?YT%%'_$MW G_0QXH_
M\+\L\O\ J3>3^_R#ZE1[U/\ P*/_ ,C_ %=^5O\ 1?\ ^'^O_!+#_HXR[_\
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M#_HXR[_\-7\6/_F,K_.@HH_XENX$_P"ACQ1_X7Y9Y?\ 4F\G]_D'U*CWJ?\
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M>7_4F\G]_D'U*CWJ?^!1_P#D?ZN_*W^B_P#\/]?^"6'_ $<9=_\ AJ_BQ_\
M,91_P_U_X)8?]'&7?_AJ_BQ_\QE?YT%%'_$MW G_ $,>*/\ PORSR_ZDWD_O
M\@^I4>]3_P "C_\ (_U=^5O]%_\ X?Z_\$L/^CC+O_PU?Q8_^8RC_A_K_P $
ML/\ HXR[_P##5_%C_P"8RO\ .@HH_P");N!/^ACQ1_X7Y9Y?]2;R?W^0?4J/
M>I_X%'_Y'^KORM_HO_\ #_7_ ()8?]'&7?\ X:OXL?\ S&4?\/\ 7_@EA_T<
M9=_^&K^+'_S&5_G044?\2W<"?]#'BC_PORSR_P"I-Y/[_(/J5'O4_P# H_\
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M4?\ $MW G_0QXH_\+\L\O^I-Y/[_ "#ZE1[U/_ H_P#R/]7?E;_1?_X?Z_\
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MRA*<:D(N$HG@Z48IJ4[\T(ZN.TIQB_L]FVO/RT/ZB/\ A_K_ ,$L/^CC+O\
M\-7\6/\ YC*/^'^O_!+#_HXR[_\ #5_%C_YC*_SH**^B_P");N!/^ACQ1_X7
MY9Y?]2;R?W^1?U*CWJ?^!1_^1_J[\K?Z+_\ P_U_X)8?]'&7?_AJ_BQ_\QE'
M_#_7_@EA_P!'&7?_ (:OXL?_ #&5_G044?\ $MW G_0QXH_\+\L\O^I-Y/[_
M "#ZE1[U/_ H_P#R/]7?E;_1?_X?Z_\ !+#_ *.,N_\ PU?Q8_\ F,H_X?Z_
M\$L/^CC+O_PU?Q8_^8RO\Z"BC_B6[@3_ *&/%'_A?EGE_P!2;R?W^0?4J/>I
M_P"!1_\ D?ZN_*W^B_\ \/\ 7_@EA_T<9=_^&K^+'_S&4?\ #_7_ ()8?]'&
M7?\ X:OXL?\ S&5_G044?\2W<"?]#'BC_P +\L\O^I-Y/[_(/J5'O4_\"C_\
MC_5WY6_T7_\ A_K_ ,$L/^CC+O\ \-7\6/\ YC*/^'^O_!+#_HXR[_\ #5_%
MC_YC*_SH**/^);N!/^ACQ1_X7Y9Y?]2;R?W^0?4J/>I_X%'_ .1_J[\K?Z+_
M /P_U_X)8?\ 1QEW_P"&K^+'_P QE'_#_7_@EA_T<9=_^&K^+'_S&5_G044?
M\2W<"?\ 0QXH_P#"_+/+_J3>3^_R#ZE1[U/_  */_P C_5WY6_T7_P#A_K_P
M2P_Z.,N__#5_%C_YC*/^'^O_  2P_P"CC+O_ ,-7\6/_ )C*_P Z"BC_ (EN
MX$_Z&/%'_A?EGE_U)O)_?Y!]2H]ZG_@4?_D?ZN_*W^B__P /]?\ @EA_T<9=
M_P#AJ_BQ_P#,91_P_P!?^"6'_1QEW_X:OXL?_,97^=!11_Q+=P)_T,>*/_"_
M+/+_ *DWD_O\@^I4>]3_ ,"C_P#(_P!7?E;_ $7_ /A_K_P2P_Z.,N__  U?
MQ8_^8RC_ (?Z_P#!+#_HXR[_ /#5_%C_ .8RO\Z"BC_B6[@3_H8\4?\ A?EG
ME_U)O)_?Y!]2H]ZG_@4?_D?ZN_*W^B__ ,/]?^"6'_1QEW_X:OXL?_,91_P_
MU_X)8?\ 1QEW_P"&K^+'_P QE?YT%%'_ !+=P)_T,>*/_"_+/+_J3>3^_P @
M^I4>]3_P*/\ \C_5WY6_T7_^'^O_  2P_P"CC+O_ ,-7\6/_ )C*/^'^O_!+
M#_HXR[_\-7\6/_F,K_.@HH_XENX$_P"ACQ1_X7Y9Y?\ 4F\G]_D'U*CWJ?\
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M^ACQ1_X7Y9Y?]2;R?W^0?4J/>I_X%'_Y'^KORM_HO_\ #_7_ ()8?]'&7?\
MX:OXL?\ S&4?\/\ 7_@EA_T<9=_^&K^+'_S&5_G044?\2W<"?]#'BC_PORSR
M_P"I-Y/[_(/J5'O4_P# H_\ R/\ 5WY6_P!%_P#X?Z_\$L/^CC+O_P -7\6/
M_F,H_P"'^O\ P2P_Z.,N_P#PU?Q8_P#F,K_.@HH_XENX$_Z&/%'_ (7Y9Y?]
M2;R?W^0?4J/>I_X%'_Y'^KORM_HO_P##_7_@EA_T<9=_^&K^+'_S&4?\/]?^
M"6'_ $<9=_\ AJ_BQ_\ ,97^=!11_P 2W<"?]#'BC_PORSR_ZDWD_O\ (/J5
M'O4_\"C_ /(_U=^5O]%__A_K_P $L/\ HXR[_P##5_%C_P"8RC_A_K_P2P_Z
M.,N__#5_%C_YC*_SH**/^);N!/\ H8\4?^%^6>7_ %)O)_?Y!]2H]ZG_ (%'
M_P"1_J[\K?Z+_P#P_P!?^"6'_1QEW_X:OXL?_,91_P /]?\ @EA_T<9=_P#A
MJ_BQ_P#,97^=!11_Q+=P)_T,>*/_  ORSR_ZDWD_O\@^I4>]3_P*/_R/]7?E
M;_1?_P"'^O\ P2P_Z.,N_P#PU?Q8_P#F,H_X?Z_\$L/^CC+O_P -7\6/_F,K
M_.@HH_XENX$_Z&/%'_A?EGE_U)O)_?Y!]2H]ZG_@4?\ Y'^KORM_HO\ _#_7
M_@EA_P!'&7?_ (:OXL?_ #&4?\/]?^"6'_1QEW_X:OXL?_,97^=!11_Q+=P)
M_P!#'BC_ ,+\L\O^I-Y/[_(/J5'O4_\  H__ "/]7?E;_1?_ .'^O_!+#_HX
MR[_\-7\6/_F,KWO]FS_@JY^PM^UQ\4K+X,? 3XQ7'C3XBZAHFM>(K30I/ OC
MW0%ETGP_%#-JMS_:/B#PWIFFJ;:.>)A"]VLTN[$,;D$#_,EK]T/^#='_ )2<
M^#_^R,_&'_TV:37SO%W@)P;D/"^?YU@\=Q%4Q>5Y3C<=AX8C&Y?.A*MAJ$JE
M-5H4\JI3E3<H^]&%2G)IM*479F=3"4H4YR3G>,6U=JUTNONK^F_*W]2MQ_P7
MN_X):VMS=6D_[15VEQ9W5S9W"?\ "K/BNWEW%I/);7$>Y?!I5MDT3IN4E6QE
M25()A_X?Z_\ !+#_ *.,N_\ PU?Q8_\ F,K_ #M=?_Y&+Q)_V,OB+_T]7U95
M?0Q^C?P*XQ;S'BC5)O\ V_+.J5_^9/Z_?Y%K!46D[U-4G\4?+^[_ %=^5O\
M1?\ ^'^O_!+#_HXR[_\ #5_%C_YC*/\ A_K_ ,$L/^CC+O\ \-7\6/\ YC*_
MSH**?_$MW G_ $,>*/\ PORSR_ZDWD_O\A_4J/>I_P"!1_\ D?ZN_*W^B_\
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MA_T<9=_^&K^+'_S&5_G044?\2W<"?]#'BC_PORSR_P"I-Y/[_(/J5'O4_P#
MH_\ R/\ 5WY6_P!%_P#X?Z_\$L/^CC+O_P -7\6/_F,H_P"'^O\ P2P_Z.,N
M_P#PU?Q8_P#F,K_.@HH_XENX$_Z&/%'_ (7Y9Y?]2;R?W^0?4J/>I_X%'_Y'
M^KORM_HO_P##_7_@EA_T<9=_^&K^+'_S&4?\/]?^"6'_ $<9=_\ AJ_BQ_\
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M[_(/J5'O4_\  H__ "/]7?E;_1?_ .'^O_!+#_HXR[_\-7\6/_F,H_X?Z_\
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MLQ/!4DGK4T7>/_R/]7?E;_5?HHHK^*CRPJ%_O'\/Y"IJA?[Q_#^0H FHHHH
MP/%?_(K>)?\ L :Q_P"FZYK_ ",IO^/BY_Z^KK_THDK_ %S?%?\ R*WB7_L
M:Q_Z;KFO\C*;_CXN?^OJZ_\ 2B2OZT^C!_"XU_Z^</?^DYT>C@=JGK'\I$=%
M%%?U8=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M .G#6*^)SS_DM> O^O/&'_JMRXSG_$H_]Q?_ $F!^#=%%%?;&@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^Z?QP_P"5?G]BO_L\
M7XG?S^)]?A97[I_'#_E7Y_8K_P"SQ?B=_/XGU\3QC_OG O\ V7&7_P#JGSTR
MJ[TO^OL?RD?A91117VQJ%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?NO_P $Z?\ E%#_ ,%I_P#LGWP@_P#1OB6OPHK]U_\ @G3_
M ,HH?^"T_P#V3[X0?^C?$M?%<?\ _(@P_P#V4_!7_K8Y&9U?A7_7RC_Z=@?A
M11117VIH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?NA_P &Z/\ RDY\'_\ 9&?C#_Z;-)K\+Z_=#_@W1_Y2<^#_ /LC/QA_]-FD
MU\3XD_\ ) <8_P#9.YK_ .HE0RK_ ,&K_@E^1^(FO_\ (Q>)/^QE\1?^GJ^K
M*K5U_P#Y&+Q)_P!C+XB_]/5]657VD/@C_AC^2-([+T7Y!1115#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVGZ?9VT376K^(=?U%D>+2/#F@:?'-J.L:G,K+!;1>7#'<7D]M;3_ +^>+O\
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MQ&P#1SVMQ')!-&P!26-E/(K]9?\ @G7_ ,$J?%?[:GAKQG\>/BC\2M)_9O\
MV1/AA)?1^,_C5XFALQ+K%YH\*7&M:7X0BUBZT_1TMM$BEACU[Q3J]U_96FW<
M\>FV=KJVJ)<VEIU9SG>5\/Y?5S/-L7#"8.E*G3]HXU*LZM:M)0H8?#4*$*E?
M$XBO-J-*A0IU*LW=QCRQDTY2C!.4G9+YMM[)):MOHD?DO17]+'AK]A'_ (('
M_&WQ!;_!KX,_\%#/B]X>^+FK7"Z%X3\3^-UM(O!/B7Q'-(L%K%:GQ-\+?!7A
M[4_MEQ^YL-/M/%6B2ZH\L<>G7-V[Q>9^,/[</[%OQ>_8)^.^L_ KXNI87UW'
M86_B3P5XST5+A/#OQ \$:A=W5GIWB;1DNP+FU<75E>:9K.DW#27&CZQ9W5FT
M]U +:\N?'R3C3)\\Q\LJITLURO-/J[Q=++L^RG&Y/B\5@XRC">*PD,92A#$T
MH2DE45&<ZM)/FJ4X1NU,:L9/EM*,K72G%Q;7=7WMUMMU/D6BOZS/VA?^"8'_
M  1$_9!7X8:5^TY^T/\ M+_#SQ1\3_ ]OXTT&P@U>XU^'4-/B6SM]3N8I/#7
MP@UN"SCAU"Y$*6]W<).5(*"1%+U\9?%OX'_\&^&E_"KXF:G\(OVLOVBM>^*^
MG> /&%]\,="UFV\3C2-;^(-IX>U"?P;I&J&X^"VEP#3M1\11Z=:7S3:GI\:V
MLTK/>6P!E3QLO\3<IS6&&K9?D'&V+PF+J>SH8ZAPKCZN!FO;.A*HL73<Z+HT
MZBE&I44G&')/FMRM*(UXRLXPJM/:2INVZ5[]M?P?8_ "BH8YD8B)I(OM*QJT
MT*NI>,D+DL@8LJY. 2,<CDY%35^CM-;_ ->?IYFX45];?L)_LO:I^V7^UG\%
MOV=;"2_M-,\=>*%F\;:QI@C^V^'OAUX>MY=<\<:W:O.DD$5[;Z%97%KI;W$<
MD/\ ;%[IR21RJ_EO]9_\%>?^"?'@G]@GXT?#FV^"VOZ_XS_9^^,GP^7Q-\/O
M%NOZQIWB6[?Q'X?OCIGC70I/$6C6&FZ7J2VXNM"UJQ:WM4>.SUG[-(TAM#*W
MS]?B;)\/Q'@N%:N)<<YQ^ K9EAJ'(W3EAZ,JJ<954^6%:I'#XJK1I-<TZ6$Q
M$TTH+FAU(J:IM^\XN27DO/Y/[F?DM115;[9:;MOVJWW>9Y6/.CSYO_/+&[_6
M?],_O^U?0)-[)NV]E<LLT5'+-% AEGECAB4@-)*ZQHI8X4%W(4$D@#)Y/ YI
MR.DB+)&RNCJ&1T8,CJ>C*RDAE/8@D'M2L[7MIM?I?L ZBJK7EKMN2ES;LUJC
MO.!-&?(V!B?/ ;,0!4@E]N,'T-?J_P#MJ_L"_#/]EW]B3]A?]J;PY\1_%?B'
MQ'^UAHMIJ?B3P]XB'A^W\.^'9;GP)9>+7C\-3V%M!?3Q)=W36L9O[FZ9[15D
M)23(/F8[-\%EV,RG 8N=2&)SO%UL%ET(T:E15<10PE7'583G"+C22PU"I-2J
M-1DTHJ[:)<E%Q3WFVEIU2;MY:)GY544F0!DD8QG.>,=<YZ8QSFH$O+25D2.Z
MMY&D!,:I-&Q<+]XH%8EPO\17..^*]1)N]DW;>RV]?N?W%%BBBBD 4444 %%%
M% !7TC^QI_R>'^R7_P!G._ +_P!6OX2KYNKZ1_8T_P"3P_V2_P#LYWX!?^K7
M\)5Y^;?\BK,_^Q?C?_4:J*6S]'^1_JOT445_E>> %0O]X_A_(5-4+_>/X?R%
M $U%%% &!XK_ .16\2_]@#6/_3=<U_D93?\ 'Q<_]?5U_P"E$E?ZYOBO_D5O
M$O\ V -8_P#3=<U_D93?\?%S_P!?5U_Z425_6GT8/X7&O_7SA[_TG.CT<#M4
M]8_E(CHHHK^K#O"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /K_P#X)[_\GZ_L6_\ 9T/P3_\ 4\T:O5/^"N'_ "DQ_;2_[+/J'_IA
MT&O*_P#@GO\ \GZ_L6_]G0_!/_U/-&KU3_@KA_RDQ_;2_P"RSZA_Z8=!KXF?
M_)R,/_V0N,_]:' F7_+]?]>G_P"EQ/SLHHHK[8U"BBB@ HHHH **]6^!GP6^
M('[1GQ@^'OP,^%>F0:O\0?B=XBM_#7AFRN[@V>GK=RPSW=S?ZK?"*<:?I&EZ
M?:7>I:I?-#(+6QM9Y1'(P6-NT_:J_98^,'[&?QHUWX"_'+2]*TSQYH.DZ!KL
MCZ!J9UKP_JFB^); 7^EZGHNK_9K3[=:MMN;&Y)MH7M=3L;ZRD3?;DMQ2S' 1
MS"&4RQF'69U,)/'T\ ZL%BIX*G55">*C1OSNA&M)4G42Y>>\;W3LN97Y;KF:
MO:^MEI>V]KGSK1117:,**** "BBOJ#XE_L;_ +0/PA_9^^#7[4/CWPEIFE?!
M?X_- GPN\26WB?1-3U#6FNM,O=7@%]X?LKF35M%,FGZ?=SC^T8(@#&(V(=U!
MYJ^,PF%J86CB<5AZ%7'5WAL'3K5J=.>*Q"IU*SH8>,Y*5:LJ-*I5]G34I^SI
MSG;EBVDVE:[2N[*[2N^R[OR1\OT445TC"BBO>/V9?V<?B5^UM\;/!W[/_P (
M4\/R?$+QTNN/H*>*-7_L+0R/#VAW_B'4?MFJ"VO#;M_9VFW)MT6VE:>X\N!0
M&D!K#%8G#X+#8C&8NM3PV%PM&KB<3B*TE"E0H4(2J5JU6;TC3ITXRG.3T44V
M#:2;>B2NWV2/!Z*_>63_ (-P/^"EB1NZ:=\!I75&9(E^+$ZM*P!*QJS^%0BE
MSA0SD*"<L0!7Y>?M5_L7_M*?L4^-K/P'^T?\-;_P/J>KVTMYX;URUN[;7_!7
MBZT@*BZF\+^+=,,FEZI)9-)&-0TYVM=7T[S(FO\ 3K9)H7D\'*N,N$\\Q2P6
M3\1Y-F.,<)5(X7"8_#U<1*$$G.4**G[2HH)WFX1ERI.4K1U(C5IS=HSC)[V3
M39\NT445]*6%%%% !1110 4444 %%%% !1110 45]3?L\?L8?M#_ +5/A3XT
M>-O@CX0TSQ/X<_9]\,V_B_XJ7NH>*=#\/2Z%H-UIGB36(+JSM=7NK>?6IGT_
MPEKTWV734FG#6B1%-]Q"&Y+]EK]G_P 2?M8?'[X6?L]>"M<T3PYXF^+.N3:%
MHNO>)8]0?0M-F@T;4M;>YU--+M[K43 ;73)HP+6VED$KQEE"!V'GU,VRRE'-
M)3Q^%7]BTO;YO&-6-2IEU)X5XV,\71IN=6CSX1/$4XS@I5*7OTXR35US1][5
M>[\7]W2^ORU/!J*^X=5_X)^?'R3]M_QC^P#X!B\,?$KXZ>$]<UG0XGTO6$\-
M>%]>?P_X(M_B!JUY8:IXK7339VUMX=FDD1=22WFN+BV>&!7,L)?Y7^)_PW\7
M_!SXD>.?A+\0=.ATCQW\-_%FK^"?&&E6]]:ZG!IOB/0KY].U2SAU&R>6SOH[
M>ZC=%NK662"8#?$[*0:,)FN6XZ=&EA,=A<16Q&7X;-J-"%:'UB>68QM87'_5
MY-5XX6O).-.M.G&$IQE"_/&44*47:S3;2DE?7E>SMO9]SAJ*^\?V\_\ @G_\
M2_\ @G[XE^$7A?XF>-?!'C:\^,?P\N/B/H=QX(BU^*WTG3+6_L]/ETW5AK^G
MZ?*VH^;>Q.#9I-;A%;=(&*@_!U5EN98'.,#A\RRS$T\9@<5&<L/B:2FJ=6-.
MK.C-Q52,)VC5IU(.\5K%VNK-D9*24HM-/9KJ%%%%=PPHHHH **** *>H_P#(
M/OO^O.Z_]$/7[X?\%[/^2D?L&_\ :/WX/_\ IPUBOP/U'_D'WW_7G=?^B'K]
M\/\ @O9_R4C]@W_M'[\'_P#TX:Q7Q.>?\EKP%_UYXP_]5N7&<_XE'_N+_P"D
MP/P;HHHK[8T"BBOIS]E[]C7]I?\ ;-\7WG@O]F_X5:W\0]0TD6S^(]926ST3
MP=X2BN]QM9?%/C#6I[/0M'>Y5))+2QDNI-5OHXY'L=/N@C8YL9C,)E^&K8W'
MXK#X+!X>'/7Q6+K4\/AZ,+J/-5K5I0ITXN344Y25Y-15VTFFTDVVDEJVW9)=
MVWHCYCHK]F_B5_P0&_X*;_#7PG=^+S\(_!WQ!M].LQ>ZAH'PQ^(NE>)?%\2*
M"TT=CX?OK31)]<G@4%C;:++>WD_W+.UN9"$/XU7MM=:;<WECJ5K=:;?:;<W-
MGJ-CJ-O-8WNG7EE*\%Y9W]I=)%<65W9SQ20W5M<QQ36\L;QS(CHRC@RCB'(N
M((5:F1YQEN;0H2C"N\OQE#%.C*=W!5HTIRE2Y[2Y.>,5-1DX.238HSA._)*,
MK;V:=B&BOU,_9D_X(R?\%!OVKO!=A\2?A_\ "&P\(_#[6;>.[\/>*?BYXEMO
M $?B>RF4O!J/AW0[FUO_ !-J&E7"X>VUB71K/2[R-UFL;R[C.ZO'_P!KO_@F
MK^V5^PY;V6L?M _":;2_!6I7D6GV'Q*\'ZM:>-/A[)J-QG[-IE_K^EJLN@:E
M=$,MG9^([#2'OI%>/3VO'1P.>CQ9POB,TEDM#B'):V;1G*D\NIYEA)XOVL+\
M]&-&-5SG7A9\]""E5ARRYX1Y79>TIN7*IQYMN7F5[]K7W\CX3HK[-_9J_8-^
M/O[6OPP^.OQ4^"<7@G7=,_9VT5_$7Q#\+:EXH&E^.Y-&&A:KXABOO#/AYK"<
M:Y%=V>B:M;6>V\MFN-3L9=.C!N'B$GQ?&ZRHDB'*2(KH<$95P&4X/(R"#@\U
MZE#,,%BL3C<'A\50K8K+:E&EC\/3J1E6PE3$48XBA'$4T^:FZU"2JTN9)5(/
MFBVD[4I)MI--QLI+JKJZOZK8?17V;^RY^P;\?/VN_!'QP^)7PLC\$Z9X _9W
MT&#Q%\4/%OC_ ,4?\(MH^F64VDZWKSV^GSC3]0;4+^UT;0+[4+RW5(EMH)+'
M?+OO85-?2?V%_CQK7[%VL?M[647@P_ #0_%+^#[Z6;Q*T7C7^V(_$UAX2;R?
M#!TXK+:_VOJ5MB3^T5E^QF2Z\D(A!Y*N?Y+1Q%3"5<TP-/$T<?@<KJT)8BFJ
ME/,<SI.ME^"G&]UB<923J4*+]^</>4;-73G%.SDD[J-K_:EK%>K6R/CJBOU,
M_9'_ .".W[9?[;7P<LOCK\#[;X5S> [_ ,1>(O"]NWB[QY+X?UG^U/"]Z+#5
M!)IL>A:@([<3L/LTIN2TT>)/+0%<^H?$C_@@'_P4[^'.BZAKT/P?\'_$:RTV
M#[1+9?#+XE:#KOB&=%7=(MAX=U=/#VH:C-& <6U@MS=3D;;>"61D1O,K\=<&
MX;'5LLQ7%&18;,,/7GAJ^$Q.987#UJ.(A/DG1J1K5(*%2,_=<)---.ZT)=6D
MFXNI!-.S3DDT^VI^,=%:>MZ)K7AG6M6\-^)-'U3P]XBT#4;O1]=T#7-/NM*U
MK1=6L)FM[[3-5TR^B@O+"^M)T:*XMKF&.6-QRN""<ROJ8RC*,91:E&24HRBT
MXRC)7C*+5TTTTTUHT[K0T"BBBF 4444 %%%?1W[*/[+'Q6_;-^-.B_ /X*IX
M;D^(&O:)XC\0:>GBS66T#1#IWA:Q74=5,VII9W[1W MV!MH5M7,SY!9%4L.?
M%XO#8'"XC&XVO2PN$PE&IB,3B:TU"C0H48N=6K5F](4Z<(N4Y/113;$VDFV[
M))MM[)+5M^A\XT5^\DW_  ;@_P#!2V.*62/2_@/<2(C,D"?%F6-YG )6-9)?
M"HC1G/ :1E0$Y8@<U^5/[3W[)'[0W[&WQ"'PR_:+^&^J> /$ES:-J.B7;36^
MK^%O%FEHXBDU3PCXJTUYM'U^S@F98;Q;6=;[3IV2#4[*RF=(V\/*>,.%<]Q+
MP>3<19/F6+5.57ZKA,?AZV(=.%G.<:,9^TG"":<Y1BU!:R:6I,:E.;M&<9/L
MI)O[CYQHHHKZ0L**** "BBB@ HHHH **** "BBB@ HHHH **:[!$9SDA%9B!
MU(4$G'OQ7WS^U)_P3X^)O[*/[/?[+?[1?C3QOX'\2>%_VKM$CUSP;H'AJ+Q!
M'K_AFWE\)Z3XP2'Q,VJZ?::<\S:?J\%N#I5S=H;F*4AC#LD;AQ698#!8G+\'
MBL33HXK-:U;#Y=1DIN>*K8?#SQ5:G3<8RBG3P].=63G*"Y8M)N5D)RBG%-V<
MG:*[NU_R/@BBBBNX84444 %?NG\</^5?G]BO_L\7XG?S^)]?A97[I_'#_E7Y
M_8K_ .SQ?B=_/XGU\3QC_OG O_9<9?\ ^J?/3*KO2_Z^Q_*1^%E%%%?;&H44
M44 %?U'?L2ZY=_LW?\&]/[:'Q^^&%Q<Z/\6/BE\1O$G@S4_%^BL4UC1=/;7/
M!OPNTP"[C*3V)T30=>\0WMC/#(LEAJ&OR7UN4GD+'^7&OZ#_ /@C!^U7\"M3
M^''[0/\ P3'_ &N];M/#OP0_:NM[V;X?^+]7OH-.T7PM\1]7TRTTG4='O-2N
MGBM=&O-:FTOPYXE\(:M>S0Z;;>+O#ALKLF;6[:OSOQ.PF(Q'#>&Q-+"UL?A<
MGXAR'.\VR^A!UJV/R;+,?"OF%"%#55W"GRXMT6FIQPLE9NR>-=-P3LY*,X2E
M%*[<(RO)6ZZ:VZV/Y[418T5$&%48 R2>N223DLS$EF8DLS$LQ))-=[J_Q/\
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M+:]^:VO;S/Z/?^",G[=7['5W\9O@_P#L?_LC?LDM\,=;\7?"+4?$/[0/QO\
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M$?%OQ,T7P)X>C#1(CV%[X?\ #?B_7]5TTHRMI_B+Q#]NB8,J"OY)T18U"+G
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MG_D@.,?^R=S7_P!1*AE7_@U?\$OR/Q$U_P#Y&+Q)_P!C+XB_]/5]656KK_\
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M!=-3BT&:>WO-6GT"T\&ZK%;PW&H:/<V\D$>GS>^_\$@?BO\ %?2/V5_VO_\
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M) "4<IM< E20#54 D@ 9)(4 <DLQ 4 =R20 !R20!S5)II---/5-.Z:[IK<
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M?V:+K]A/1OVQ_C;K7PUTGXA_$'XQ_'?QEJ>A>'K]-9OM3T::/PQI-MI^LZ?
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MA46.K5)JO[%PH05)-UH2<I-O#4Y/:VKLUMM?7_$[WV2^YO\ @KU^Q7)^S_\
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MM/A'\+_%/BZ^UKP'\,U^PM;^!=#N(8%M-"A:R5;$?97BFD4VBK$OFD)T)/\
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MOXALM)N9;=I$DC6YCM[EY(6DCDB$RJSQ.@*'^S#_ ()I?M%:;^V%_P %2/\
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M6/#6EZO:QS.D&IZ;HY^/.H:78WJ*0+BUL;[1]*O+>&3*1W.GV<P&^",KE_\
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M/?\ Y/U_8M_[.A^"?_J>:-7JG_!7#_E)C^VE_P!EGU#_ -,.@UY7_P $]_\
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M.K32>ZNG>WDV?7?[:O[;?QQ_;T^,+?&/XXW^CI?Z?I*^&O!OA#PO9W&G>#_
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MG5M7N]*U+[#?#Q/X>TW3_#>H^'='U73QKEL_ZG? K]DK7?\ @EUXUO/V]_\
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M!:V]OIOCB#1/$/@;5=+\06C0F1I-.NKGQ'K5_H\;3SQV]AJWEPN4P3[_ /\
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M>_U;XB^/-/LUFEQMBC>ZN8EEG<$11DNV53%?A/\  O\ Y+G\$/\ LLGPM_\
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MF15.Y5<J-X5OX@&R >XYI]%%?H9L%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!]?_\ !/?_ )/U_8M_[.A^"?\ ZGFC5ZI_P5P_Y28_MI?]EGU#
M_P!,.@UY7_P3W_Y/U_8M_P"SH?@G_P"IYHU>J?\ !7#_ )28_MI?]EGU#_TP
MZ#7Q,_\ DY&'_P"R%QG_ *T.!,O^7Z_Z]/\ ]+B?G91117VQJ%%%% !1110
M4444 %%%% !1110 4444 ?T.?\$OOV+?V OB?^P3^TO^V%^VMX2^(>NZ9\!/
MB/J=CJ5_X!\4>*+"_M_!=GX7\&7Z6]GX;\/WUBFJZ@NJ:_=2&1Y/.DAD2/*I
M;C=Z%X%^&O\ P;A_M(>,O#GP6^'^M_M0?!?QY\0[^/PQX(\<>*;_ ,:Z7X>M
M/%FKLEIH%IJ%YXEG\2^'$>_U*2"SLHM>L[;3+FZG2UFO[.2>&9/5_P#@DO\
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M2]I%')*4?:U%.M*FDH<J4U'=)O1[G,?MQ?\ !,/P_P#L=?M$?LI:YX!\8O\
M'#]CG]J?XA?#=_AIXTOFMWO)-&UWQ3X6FU+P-XEU+2#:VNJ_VKX2UN/4]!\2
M:?;:3_;>CSW@-E9ZAIERSY'_  7+_9P^"G[+W[<MG\*/V>_AUIGPX\$7/P;\
M!^((O"?A^76+^&Y\0ZMJ/B:'4+Z%=4O]5U"6ZNH;*T1XHIC'B!2D*LSEOTR_
MX*@^-/AC\!_"?_!*#_@F/X3\<:7\2/B-^SG\7?@+XD^+&M:5/'<1>';O0K_2
M/".EZ?>A99Y=+U#Q/J7B+Q!K%KX<NGBOM*\/Z?I,MW"L5Y9;OJ3_ (+$?\%
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MOWR:IJOP@^)'BKP%-JT<?E)K%MH6IS6^F:RL6 (O[6THV6H-$HV127+Q(65
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M(QDU:[48V;;6JW5VK*^C?\,E%?47[;7P,TC]F?\ :\_:,^ GAV>\N?#'PO\
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M;XEKXKC_ /Y$&'_[*?@K_P!;'(S.K\*_Z^4?_3L#\*****^U- HHHH ****
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MC/QA_P#39I-?$^)/_) <8_\ 9.YK_P"HE0RK_P &K_@E^1^(FO\ _(Q>)/\
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MJ2O4LJ:<7*41ARRG*]^>2EMM:,5;[XW/V=_X-]E5?^"J?P(55"JO@CXX@*H
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MTMVZG])/A993_P &OOQ%$) E/[16J^6QY"N?CIH*HQ]@^,\5]E_%GX:_M/\
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MGZ)I,K27%S;_ ,KWQ#\>^+OBEXZ\5_$7Q[XIUOQQXQ\8:U=ZSK_C#Q(4.O\
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M?1M&\:P:Q_:.IV%G/#IE]JWAWQ'?V$B6=H\?=_\ !.3]D[_@IS^SM^U=\/\
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M ,%I_P#LGWP@_P#1OB6OPHK]U_\ @G3_ ,HH?^"T_P#V3[X0?^C?$M?%<?\
M_(@P_P#V4_!7_K8Y&9U?A7_7RC_Z=@?A11117VIH%%%% !1110 4444 %%%%
M !1110 4444 >E?!GX8:S\;OB]\+_@UX=U#3-)U_XJ^//#/P_P!$U36C<C1]
M.U3Q3J<&E65[JALH;B\%A;SW"271M;>:<1!C'$[8!_?J\_X-F/VJM.G>UO\
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M?U^C66'I8NBW*492A*5.E*I)1.G4<JLHM>^Z5ES.+DH7YHN2UC=.UUKTZG]
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MJ223S6?&F3\6YUG-"C1RO"YSPC1P,/:Y/+B6KP_#,<RG6G*K/-I8?+L77QN
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M)L=6D?Z=\!?\'!/[=7A#Q-\0-7\3Z+\$?B[X7\>>*)?&-M\-_B1X0UJ_\*^
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MGXP_^FS2:_"^OW0_X-T?^4G/@_\ [(S\8?\ TV:37Q/B3_R0'&/_ &3N:_\
MJ)4,J_\ !J_X)?D?B)K_ /R,7B3_ +&7Q%_Z>KZLJM77_P#D8O$G_8R^(O\
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ME*MAJ<YRD8JE44::<5-1ARN'.X6GS)\UUNK:=6NBN?=O_!?"#4-2_P"">O\
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MKQ>(]9U%-$B^,O\ @H%_P4M_:&_;@TOP]\/;GX=6OP!_9?\ AS<P7?@+X#^
M]!U#3_#&E_V;#)8Z-JGC#6!I6E6NM7VCV,K6^E6=MI^C^&-#>6:73-)6[D-Z
M_P!/>%?^#BW]N[P?X4\*^#-)\&?LWMHO@WPYHOA;1%N_A_XDFGBTK0=,M-*L
M4=E\:QQ^8;6R@\WR8HHF=<I&BA57S7]HC_@NS^V5^TW\$?B5\ OB'X3^ EEX
M*^*GAJY\*^([SPQX(UW3?$%MIUU/;SR2Z3?77BR_MK:\#6R*DLUG<*@9B$WA
M6'Q65Y-QJ^(89WQ'PWEF=8R.8U)8+'5^+)K"</9;6KJG%9+D*R:>%I8FA@G'
MVV)G7J8_&5H3<L92C/DAE&-7GYIPC)J6C=1V@KKX(<EDTMW=R;6^R?XOT445
M^S'2%%%% !1110 4444 %%%% !1110 4444 %?2/[&G_ ">'^R7_ -G._ +_
M -6OX2KYNKZ1_8T_Y/#_ &2_^SG?@%_ZM?PE7GYM_P BK,_^Q?C?_4:J*6S]
M'^1_JOT445_E>> %0O\ >/X?R%35"_WC^'\A0!-1110!@>*_^16\2_\ 8 UC
M_P!-US7^1E-_Q\7/_7U=?^E$E?ZYOBO_ )%;Q+_V -8_]-US7^1E-_Q\7/\
MU]77_I1)7]:?1@_A<:_]?.'O_2<Z/1P.U3UC^4B.BBBOZL.\**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^O\ _@GO_P GZ_L6_P#9
MT/P3_P#4\T:O5/\ @KA_RDQ_;2_[+/J'_IAT&O*_^">__)^O[%O_ &=#\$__
M %/-&KU3_@KA_P I,?VTO^RSZA_Z8=!KXF?_ "<C#_\ 9"XS_P!:' F7_+]?
M]>G_ .EQ/SLHHHK[8U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *>H_\ (/OO^O.Z_P#1#U^^'_!>S_DI'[!O_:/WX/\ _IPUBOP/
MU'_D'WW_ %YW7_HAZ_?#_@O9_P E(_8-_P"T?OP?_P#3AK%?$YY_R6O 7_7G
MC#_U6Y<9S_B4?^XO_I,#\&Z***^V- HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%#O^AH_9L_\ #@^+_P#YW='_ !#1?\%#O^AH_9L_\.#XO_\ G=T?\11\//\
MHL,D_P#"KT_N^?X/L'MZ/_/R'W_UW_/LS^>ZBOZ$?^(:+_@H=_T-'[-G_AP?
M%_\ \[NC_B&B_P""AW_0T?LV?^'!\7__ #NZ/^(H^'G_ $6&2?\ A5Z?W?/\
M'V#V]'_GY#[_ .N_Y]F?SW45_0C_ ,0T7_!0[_H:/V;/_#@^+_\ YW='_$-%
M_P %#O\ H:/V;/\ PX/B_P#^=W1_Q%'P\_Z+#)/_  J]/[OG^#[![>C_ ,_(
M??\ UW_/LS^>ZBOZ$?\ B&B_X*'?]#1^S9_X<'Q?_P#.[H_XAHO^"AW_ $-'
M[-G_ (<'Q?\ _.[H_P"(H^'G_189)_X5>G]WS_!]@]O1_P"?D/O_ *[_ )]F
M?SW45_0C_P 0T7_!0[_H:/V;/_#@^+__ )W='_$-%_P4._Z&C]FS_P .#XO_
M /G=T?\ $4?#S_HL,D_\*O3^[Y_@^P>WH_\ /R'W_P!=_P ^S/Y[J*_H1_XA
MHO\ @H=_T-'[-G_AP?%__P [NC_B&B_X*'?]#1^S9_X<'Q?_ /.[H_XBCX>?
M]%ADG_A5Z?W?/\'V#V]'_GY#[_Z[_GV9_/=17]"/_$-%_P %#O\ H:/V;/\
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MO3^[Y_@^P>WH_P#/R'W_ -=_S[,_GNHK^A'_ (AHO^"AW_0T?LV?^'!\7_\
MSNZ/^(:+_@H=_P!#1^S9_P"'!\7_ /SNZ/\ B*/AY_T6&2?^%7I_=\_P?8/;
MT?\ GY#[_P"N_P"?9G\]U%?T(_\ $-%_P4._Z&C]FS_PX/B__P"=W1_Q#1?\
M%#O^AH_9L_\ #@^+_P#YW='_ !%'P\_Z+#)/_"KT_N^?X/L'MZ/_ #\A]_\
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M_P 'V#V]'_GY#[_Z[_GV9_/=17]"/_$-%_P4._Z&C]FS_P .#XO_ /G=T?\
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M'[-G_AP?%_\ \[NC_B&B_P""AW_0T?LV?^'!\7__ #NZ/^(H^'G_ $6&2?\
MA5Z?W?/\'V#V]'_GY#[_ .N_Y]F?SW45_0C_ ,0T7_!0[_H:/V;/_#@^+_\
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MH_XBCX>?]%ADG_A5Z?W?/\'V#V]'_GY#[_Z[_GV9_/=17]"/_$-%_P %#O\
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MS,Y5Z3G2:J1LO:7=]N90M?UL_N/XLZ*_H1_XAHO^"AW_ $-'[-G_ (<'Q?\
M_.[H_P"(:+_@H=_T-'[-G_AP?%__ ,[NOK?^(H^'G_189)_X5>G]WS_!]C3V
M]'_GY#[_ .N_Y]F?SW45_0C_ ,0T7_!0[_H:/V;/_#@^+_\ YW='_$-%_P %
M#O\ H:/V;/\ PX/B_P#^=W1_Q%'P\_Z+#)/_  J]/[OG^#[![>C_ ,_(??\
MUW_/LS^>ZBOZ$?\ B&B_X*'?]#1^S9_X<'Q?_P#.[H_XAHO^"AW_ $-'[-G_
M (<'Q?\ _.[H_P"(H^'G_189)_X5>G]WS_!]@]O1_P"?D/O_ *[_ )]F?SW4
M5_0C_P 0T7_!0[_H:/V;/_#@^+__ )W='_$-%_P4._Z&C]FS_P .#XO_ /G=
MT?\ $4?#S_HL,D_\*O3^[Y_@^P>WH_\ /R'W_P!=_P ^S/Y[J*_H1_XAHO\
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M^(:+_@H=_P!#1^S9_P"'!\7_ /SNZ/\ B*/AY_T6&2?^%7I_=\_P?8/;T?\
MGY#[_P"N_P"?9G\]U%?T(_\ $-%_P4._Z&C]FS_PX/B__P"=W1_Q#1?\%#O^
MAH_9L_\ #@^+_P#YW='_ !%'P\_Z+#)/_"KT_N^?X/L'MZ/_ #\A]_\ 7?\
M/LS^>ZBOZ$?^(:+_ (*'?]#1^S9_X<'Q?_\ .[H_XAHO^"AW_0T?LV?^'!\7
M_P#SNZ/^(H^'G_189)_X5>G]WS_!]@]O1_Y^0^_^N_Y]F?SW45_0C_Q#1?\
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M?_\ .[H_XBCX>?\ 189)_P"%7I_=\_P?8/;T?^?D/O\ Z[_GV9_/=17]"/\
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MV;/_  X/B_\ ^=W1_P 0T7_!0[_H:/V;/_#@^+__ )W='_$4?#S_ *+#)/\
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M5>G]WS_!]@]O1_Y^0^_^N_Y]F?SW45_0C_Q#1?\ !0[_ *&C]FS_ ,.#XO\
M_G=T?\0T7_!0[_H:/V;/_#@^+_\ YW='_$4?#S_HL,D_\*O3^[Y_@^P>WH_\
M_(??_7?\^S/Y[J*_H1_XAHO^"AW_ $-'[-G_ (<'Q?\ _.[H_P"(:+_@H=_T
M-'[-G_AP?%__ ,[NC_B*/AY_T6&2?^%7I_=\_P 'V#V]'_GY#[_Z[_GV9_/=
M17]"/_$-%_P4._Z&C]FS_P .#XO_ /G=T?\ $-%_P4._Z&C]FS_PX/B__P"=
MW1_Q%'P\_P"BPR3_ ,*O3^[Y_@^P>WH_\_(??_7?\^S/Y[J*_H1_XAHO^"AW
M_0T?LV?^'!\7_P#SNZ/^(:+_ (*'?]#1^S9_X<'Q?_\ .[H_XBCX>?\ 189)
M_P"%7I_=\_P?8/;T?^?D/O\ Z[_GV9_/=17]"/\ Q#1?\%#O^AH_9L_\.#XO
M_P#G=T?\0T7_  4._P"AH_9L_P##@^+_ /YW='_$4?#S_HL,D_\ "KT_N^?X
M/L'MZ/\ S\A]_P#7?\^S/Y[J*_H1_P"(:+_@H=_T-'[-G_AP?%__ ,[NC_B&
MB_X*'?\ 0T?LV?\ AP?%_P#\[NC_ (BCX>?]%ADG_A5Z?W?/\'V#V]'_ )^0
M^_\ KO\ GV9_/=17]"/_ !#1?\%#O^AH_9L_\.#XO_\ G=T?\0T7_!0[_H:/
MV;/_  X/B_\ ^=W1_P 11\//^BPR3_PJ]/[OG^#[![>C_P _(??_ %W_ #[,
M_GNHK^A'_B&B_P""AW_0T?LV?^'!\7__ #NZ/^(:+_@H=_T-'[-G_AP?%_\
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M]O1_Y^0^_P#KO^?9G\]U%?T(_P#$-%_P4._Z&C]FS_PX/B__ .=W1_Q#1?\
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M^"AW_0T?LV?^'!\7_P#SNZ/^(:+_ (*'?]#1^S9_X<'Q?_\ .[H_XBCX>?\
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M!\7_ /SNZ/\ B&B_X*'?]#1^S9_X<'Q?_P#.[H_XBCX>?]%ADG_A5Z?W?/\
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M4<3S5:]>KAIQITJ<>57G.4E%+J[F5:M2E2J)5(MN$DE?5NVWX_U9G\:NO_\
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M_P 'V#V]'_GY#[_Z[_GV9_/=17]"/_$-%_P4._Z&C]FS_P .#XO_ /G=T?\
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MY#[_ .N_Y]F?SW45_0C_ ,0T7_!0[_H:/V;/_#@^+_\ YW='_$-%_P %#O\
MH:/V;/\ PX/B_P#^=W1_Q%'P\_Z+#)/_  J]/[OG^#[![>C_ ,_(??\ UW_/
MLS^>ZBOZ$?\ B&B_X*'?]#1^S9_X<'Q?_P#.[H_XAHO^"AW_ $-'[-G_ (<'
MQ?\ _.[H_P"(H^'G_189)_X5>G]WS_!]@]O1_P"?D/O_ *[_ )]F?SW45_0C
M_P 0T7_!0[_H:/V;/_#@^+__ )W='_$-%_P4._Z&C]FS_P .#XO_ /G=T?\
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M_/[/X[_5:7+?X;.V[.S"T:=53<TWRN-K-K>]]O0_N5_XB@_V+/\ HB?[2_\
MX(?AY_\ /"H_XB@_V+/^B)_M+_\ @A^'G_SPJ_AFHK]X_P")?_#?_H!S3_P[
M8G_+U_I:]?U2A_++_P "?]?\._*W]S/_ !%!_L6?]$3_ &E__!#\//\ YX5'
M_$4'^Q9_T1/]I?\ \$/P\_\ GA5_#-11_P 2_P#AO_T YI_X=L3_ )>O]+4^
MJ4/Y9?\ @3_K_AWY6_N9_P"(H/\ 8L_Z(G^TO_X(?AY_\\*C_B*#_8L_Z(G^
MTO\ ^"'X>?\ SPJ_AFHH_P")?_#?_H!S3_P[8G_+U_I:GU2A_++_ ,"?]?\
M#ORM_<S_ ,10?[%G_1$_VE__  0_#S_YX5'_ !%!_L6?]$3_ &E__!#\//\
MYX5?PS44?\2_^&__ $ YI_X=L3_EZ_TM3ZI0_EE_X$_Z_P"'?E;^YG_B*#_8
ML_Z(G^TO_P""'X>?_/"H_P"(H/\ 8L_Z(G^TO_X(?AY_\\*OX9J*/^)?_#?_
M * <T_\ #MB?\O7^EJ?5*'\LO_ G_7_#ORM_<S_Q%!_L6?\ 1$_VE_\ P0_#
MS_YX5'_$4'^Q9_T1/]I?_P $/P\_^>%7\,U%'_$O_AO_ - .:?\ AVQ/^7K_
M $M3ZI0_EE_X$_Z_X=^5O[F?^(H/]BS_ *(G^TO_ ."'X>?_ #PJ/^(H/]BS
M_HB?[2__ ((?AY_\\*OX9J*/^)?_  W_ .@'-/\ P[8G_+U_I:GU2A_++_P)
M_P!?\._*W]S/_$4'^Q9_T1/]I?\ \$/P\_\ GA4?\10?[%G_ $1/]I?_ ,$/
MP\_^>%7\,U%'_$O_ (;_ /0#FG_AVQ/^7K_2U/JE#^67_@3_ *_X=^5O[F?^
M(H/]BS_HB?[2_P#X(?AY_P#/"H_XB@_V+/\ HB?[2_\ X(?AY_\ /"K^&:BC
M_B7_ ,-_^@'-/_#MB?\ +U_I:GU2A_++_P "?]?\._*W]S/_ !%!_L6?]$3_
M &E__!#\//\ YX5'_$4'^Q9_T1/]I?\ \$/P\_\ GA5_#-11_P 2_P#AO_T
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M_@3_ *_X=^5O[F?^(H/]BS_HB?[2_P#X(?AY_P#/"H_XB@_V+/\ HB?[2_\
MX(?AY_\ /"K^&:BC_B7_ ,-_^@'-/_#MB?\ +U_I:GU2A_++_P "?]?\._*W
M]S/_ !%!_L6?]$3_ &E__!#\//\ YX5'_$4'^Q9_T1/]I?\ \$/P\_\ GA5_
M#-11_P 2_P#AO_T YI_X=L3_ )>O]+4^J4/Y9?\ @3_K_AWY6_N9_P"(H/\
M8L_Z(G^TO_X(?AY_\\*C_B*#_8L_Z(G^TO\ ^"'X>?\ SPJ_AFHH_P")?_#?
M_H!S3_P[8G_+U_I:GU2A_++_ ,"?]?\ #ORM_<S_ ,10?[%G_1$_VE__  0_
M#S_YX5'_ !%!_L6?]$3_ &E__!#\//\ YX5?PS44?\2_^&__ $ YI_X=L3_E
MZ_TM3ZI0_EE_X$_Z_P"'?E;^YG_B*#_8L_Z(G^TO_P""'X>?_/"H_P"(H/\
M8L_Z(G^TO_X(?AY_\\*OX9J*/^)?_#?_ * <T_\ #MB?\O7^EJ?5*'\LO_ G
M_7_#ORM_<S_Q%!_L6?\ 1$_VE_\ P0_#S_YX5'_$4'^Q9_T1/]I?_P $/P\_
M^>%7\,U%'_$O_AO_ - .:?\ AVQ/^7K_ $M3ZI0_EE_X$_Z_X=^5O[Y/@O\
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M%)!?:OS-M!VCDX% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2-)^QKZV_P"8BIY7_7[_ ".I48M)ZZV?Y?\ !^_R/M__ (:<\&?] 7Q+_P"
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M/M__ (:<\&?] 7Q+_P" ^G?_ "PH_P"&G/!G_0%\2_\ @/IW_P L*^(**/\
M5')/^?-?_P **GE_D_O\@]A'N_ZM_D_O\C[?_P"&G/!G_0%\2_\ @/IW_P L
M*/\ AISP9_T!?$O_ (#Z=_\ +"OB"BC_ %1R3_GS7_\ "BIY?Y/[_(/81[O^
MK?Y/[_(^W_\ AISP9_T!?$O_ (#Z=_\ +"C_ (:<\&?] 7Q+_P" ^G?_ "PK
MX@HH_P!4<D_Y\U__  HJ>7^3^_R#V$>[_JW^3^_R/M__ (:<\&?] 7Q+_P"
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M/M__ (:<\&?] 7Q+_P" ^G?_ "PH_P"&G/!G_0%\2_\ @/IW_P L*^(**/\
M5')/^?-?_P **GE_D_O\@]A'N_ZM_D_O\C[?_P"&G/!G_0%\2_\ @/IW_P L
M*/\ AISP9_T!?$O_ (#Z=_\ +"OB"BC_ %1R3_GS7_\ "BIY?Y/[_(/81[O^
MK?Y/[_(^W_\ AISP9_T!?$O_ (#Z=_\ +"C_ (:<\&?] 7Q+_P" ^G?_ "PK
MX@HH_P!4<D_Y\U__  HJ>7^3^_R#V$>[_JW^3^_R/M__ (:<\&?] 7Q+_P"
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M *^KK_THDK^M/HP?PN-?^OG#W_I.='HX':IZQ_*1'1117]6'>%%%% !1110
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M=TGW2>NCU[KH+112$@$ D GH"1D_0=ZU&+1110 4444 %%%% !1110 4444
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M6X@N5BFDMY6@FCF6*XA;;-!(8V8)-$WRR1-AT;AE!H GHHHH **** "BBB@
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MHK^/S_B*IN_^C)Q_X?)/_G;4?\15-W_T9./_  ^2?_.VKW/^(&^*'_1-Q_\
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M@.#Q(G@Z;QMX1A\7RE!%X5E\2:-'XDD,B"2,)H;WHU-R\9#H%M260AERI!H
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M>6W\HD'_  =77<T$,W_#$P7S8HY=O_"\D.WS$#XS_P *V&<9QG SZ"OLN%^
M.+.,J.+Q'#F5K,*.!JTJ.*F\=E^$]G4K1E.G'EQN*P\I\T82;=-22MJTVD:T
MZ-2JFX1ND[/5+7YM']A%%?Q^?\15-W_T9./_  ^2?_.VH_XBJ;O_ *,G'_A\
MD_\ G;5]1_Q WQ0_Z)N/_AYR'R_ZF?G^#[&GU2O_ "+_ ,"C_P#)?U9^5_[
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M^7_4S\_P?8W^J5_Y%_X%'_Y+^K/RO_8'17\?G_$53=_]&3C_ ,/DG_SMJ/\
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M44I!&,@C(R,@C(]1GJ* $HHI<'&[!VYQG!QGTSTS[4 )112A6;A020,D $X
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M<E96[:!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% 'U__P $]_\
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MZWXLA-C>2_$K2IM3\'>%]2\1K)IND3VFM>&[B6*_/Y5?\&B7@/Q-\)/VOO\
M@L?\&_%GCG4?B-KGPA^('P]^&6K>,[^?5&_X2K5_ OQ-_:"\+ZKXH2UU:^U"
M\MF\0WNE3:JZW=U<7P%RB7ES/,A<_P!(W[,OBC]GG_@D'_P3N_8D^!7[8_[0
M/PH^!E[X-^$'@OX;7.M_$KQGHGA71-<^)MAX<A\0>/-%T#4=1O([34AIFM7V
MJ^0]O*_FZ?##=D*LF!_*W_P;T_MX_L7? 3_@HC_P6O\ '7QH_:B^"7PQ\'?'
M/]I!]:^#7B7QIX]T30-&^*&C7/QQ_:$U:#5?!-]J%Q!!KUC)IGB/P_?I-9L^
MZTUK3YPICG#* ?9'_!2'XB_M<?\ !7O_ (+$ZS_P1@^ 'Q^\5_LP_LH?LZ_#
MK2?B'^UOXW\ 7EUIGC'XA)?Z9X1UK7=(6\L+FTN=5M8(?'OA3P7X9\)WMU;^
M&CK=QXD\6>*;'Q'::7I&FP>$_P#!07_@BA\2?^")'P:G_P""EO\ P2F_:^_:
M&T'Q/^SA/X=\1_'+X7_&#QGI_BGPQ\3O ,FMV&DZK>7.GZ1HGAG1O$-E!>ZK
M'/XF\$^*M.U.PU#09[_4O#VI:)X@T>S74_L?_@I;^Q9^W_\ L6?\%0--_P""
MU_\ P3$^%<7[4&G_ !)^'^F>!/VL_P!F32Y96\6>+-!L-(\/:/<ZGX5T^U$V
MIZUIWB?0O"?A&^M9_"EGJ_BCPKXY\-V^L'PWXGT#6M2T^W^"?^"O_P#P4O\
M^"FO_!0#_@G[\?\ PGX?_P""=WQ>_P"">W[*/@OP9:^*_P!J7XP_M137FAZ_
MX\LM.\3Z!9^&/@E\)]/U_P )>#IM0O\ Q=X\N_#UKJ$^D6NJ:A>V4+VE[+X>
MTY[VWUH _L^_8=_:AT/]M3]D']G3]JSP]IO]B6/QT^%'A3Q[=: )7N%\.:_J
M5@D7BKPTES(JO=Q^'?$]MK&B1WC(AO([!;G8GF[1]4U^.O\ P;]^$=7\$_\
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MLL7.NJOE8Q4E4]SXW?VB7PW[^4G]I==W9WOT]%%%?@YR!1110 4444 %%%%
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MOXM?M,^*/VQ?CSX?_:I^'?A._P#%/@GXS_$/XB^'[)?B[\:+.WEU#1_ FA>
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M37_)L_[2'_9 /C-_ZKCQ)7MM>)?M-?\ )L_[2'_9 /C-_P"JX\25G6_A5?\
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M-HEYH[ZRP,6EW<MM=74?]G)?75I]L_\ !>W_ (*;?LI:M^PYXS_9:^!OQ;\
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MQ&E\4VUB\9UV'X67^E:CI]O90F*'Q%KEQX<BNA%87UY&GS#\(?V%/^"_NI>
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MX!TM?&M[X7L9VL+&;2[?4[6UM6U>:6_^+_"_[0_P\_X+,^-?$OQ4_P""D/\
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M]"\9ZZ\?@VZ\%^)=-OM.\6QZDHTF%X;*_$O[.?\ !;'_ (*A?$SX$?&'X/\
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MQ)_^8"C_ (AA/VX_^BR?LR_^#KXD_P#S 5_==177_P 3!^(__05E/_AIP_\
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ME;!_[RL3B>>].F_<VE)?:\E_=[_S>FY1117\V'$%%%% !1110 4444 %%%%
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M;4/%5A)X<M?%$NE3:_!9GPUX@T,21ZG+HFE23B[%QAK&$Q>7\^[XT_XAU_\
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M3]F7_P '7Q)_^8"C_B&$_;C_ .BR?LR_^#KXD_\ S 5_==17V/\ Q,'XC_\
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MGI2]V:=*M42OM)J2U2*A.5.2G'22O:ZONFGIZ-G\*/\ Q#"?MQ_]%D_9E_\
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M^GB'XB9_]3&OU8HK.> P-2<JE3!82I.;<ISGAJ,IRD]Y2E*#<F^K;;8N6/\
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M$M#38****8!1110 4444 %='X._Y&_PI_P!C+H/_ *=;2N<KH_!W_(W^%/\
ML9=!_P#3K:5CB/\ =Z__ %YJ_P#I$A2V?H_R/U-HHHK\%. *A?[Q_#^0J:H7
M^\?P_D* )J*** ,#Q7_R*WB7_L :Q_Z;KFO\C*;_ (^+G_KZNO\ THDK_76U
MY;1M#UI;]Y8K%M)U%;V2!=T\=H;.87+PKM;=*D)=HUVMEP!M/2O\^R3X6_\
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M+S_JZO\ AU17[B_\*M_X-\_^CI/V[_\ PVEC_P#.UH_X5;_P;Y_]'2?MW_\
MAM+'_P"=K1_KK0_Z)KCCI_S2>:];?].O/^M;'M/^G=7_ ,%R\O+S_JZO^'5%
M?N+_ ,*M_P"#?/\ Z.D_;O\ _#:6/_SM:/\ A5O_  ;Y_P#1TG[=_P#X;2Q_
M^=K1_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q[3_IW5_\%R\O+S_JZO\ AU17[B_\
M*M_X-\_^CI/V[_\ PVEC_P#.UH_X5;_P;Y_]'2?MW_\ AM+'_P"=K1_KK0_Z
M)KCCI_S2>:];?].O/^M;'M/^G=7_ ,%R\O+S_JZO^'5%?N+_ ,*M_P"#?/\
MZ.D_;O\ _#:6/_SM:/\ A5O_  ;Y_P#1TG[=_P#X;2Q_^=K1_KK0_P"B:XXZ
M?\TGFO6W_3KS_K6Q[3_IW5_\%R\O+S_JZO\ AU17[B_\*M_X-\_^CI/V[_\
MPVEC_P#.UH_X5;_P;Y_]'2?MW_\ AM+'_P"=K1_KK0_Z)KCCI_S2>:];?].O
M/^M;'M/^G=7_ ,%R\O+S_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_;O\ _#:6/_SM
M:/\ A5O_  ;Y_P#1TG[=_P#X;2Q_^=K1_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q
M[3_IW5_\%R\O+S_JZO\ AU17[B_\*M_X-\_^CI/V[_\ PVEC_P#.UH_X5;_P
M;Y_]'2?MW_\ AM+'_P"=K1_KK0_Z)KCCI_S2>:];?].O/^M;'M/^G=7_ ,%R
M\O+S_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_;O\ _#:6/_SM:/\ A5O_  ;Y_P#1
MTG[=_P#X;2Q_^=K1_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q[3_IW5_\%R\O+S_J
MZO\ AU17[B_\*M_X-\_^CI/V[_\ PVEC_P#.UH_X5;_P;Y_]'2?MW_\ AM+'
M_P"=K1_KK0_Z)KCCI_S2>:];?].O/^M;'M/^G=7_ ,%R\O+S_JZO^'5%?N+_
M ,*M_P"#?/\ Z.D_;O\ _#:6/_SM:/\ A5O_  ;Y_P#1TG[=_P#X;2Q_^=K1
M_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q[3_IW5_\%R\O+S_JZO\ AU17[B_\*M_X
M-\_^CI/V[_\ PVEC_P#.UH_X5;_P;Y_]'2?MW_\ AM+'_P"=K1_KK0_Z)KCC
MI_S2>:];?].O/^M;'M/^G=7_ ,%R\O+S_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_
M;O\ _#:6/_SM:/\ A5O_  ;Y_P#1TG[=_P#X;2Q_^=K1_KK0_P"B:XXZ?\TG
MFO6W_3KS_K6Q[3_IW5_\%R\O+S_JZO\ AU17[B_\*M_X-\_^CI/V[_\ PVEC
M_P#.UH_X5;_P;Y_]'2?MW_\ AM+'_P"=K1_KK0_Z)KCCI_S2>:];?].O/^M;
M'M/^G=7_ ,%R\O+S_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_;O\ _#:6/_SM:/\
MA5O_  ;Y_P#1TG[=_P#X;2Q_^=K1_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q[3_I
MW5_\%R\O+S_JZO\ AU17[B_\*M_X-\_^CI/V[_\ PVEC_P#.UH_X5;_P;Y_]
M'2?MW_\ AM+'_P"=K1_KK0_Z)KCCI_S2>:];?].O/^M;'M/^G=7_ ,%R\O+S
M_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_;O\ _#:6/_SM:/\ A5O_  ;Y_P#1TG[=
M_P#X;2Q_^=K1_KK0_P"B:XXZ?\TGFO6W_3KS_K6Q[3_IW5_\%R\O+S_JZO\
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M>:];?].O/^M;'M/^G=7_ ,%R\O+S_JZO^'5%?N+_ ,*M_P"#?/\ Z.D_;O\
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M_P"#AO\ Z-+_ &#/_#M>*/\ YK*/]1,5_P!%+P-_XE^3_P#R_P _S[,/8O\
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MMW_@X;_Z-+_8,_\ #M>*/_FLH_U$Q7_12\#?^)?D_P#\O\_S[,/8O_GY1_\
M!D?ZZ_GV9^\=%?@Y_P +=_X.&_\ HTO]@S_P[7BC_P":RC_A;O\ P<-_]&E_
ML&?^':\4?_-91_J)BO\ HI>!O_$OR?\ ^7^?Y]F'L7_S\H_^#(_UU_/LS]XZ
M*_!S_A;O_!PW_P!&E_L&?^':\4?_ #64?\+=_P"#AO\ Z-+_ &#/_#M>*/\
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M'_S64?\ "W?^#AO_ *-+_8,_\.UXH_\ FLH_U$Q7_12\#?\ B7Y/_P#+_/\
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M_P &1_KK^?9G[QT=:_!S_A;O_!PW_P!&E_L&?^':\4?_ #64?\+=_P"#AO\
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M\H_^#(_UU_/LS]XZ*_!S_A;O_!PW_P!&E_L&?^':\4?_ #64?\+=_P"#AO\
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M+_8,_P##M>*/_FLH_P"%N_\ !PW_ -&E_L&?^':\4?\ S64?ZB8K_HI>!O\
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M_P#$OR?_ .7^?Y]F'L7_ ,_*/_@R/]=?S[,_>.BOP<_X6[_P<-_]&E_L&?\
MAVO%'_S64?\ "W?^#AO_ *-+_8,_\.UXH_\ FLH_U$Q7_12\#?\ B7Y/_P#+
M_/\ /LP]B_\ GY1_\&1_KK^?9G[QT5^#G_"W?^#AO_HTO]@S_P .UXH_^:RC
M_A;O_!PW_P!&E_L&?^':\4?_ #64?ZB8K_HI>!O_ !+\G_\ E_G^?9A[%_\
M/RC_ .#(_P!=?S[,_>.BOP<_X6[_ ,'#?_1I?[!G_AVO%'_S64?\+=_X.&_^
MC2_V#/\ P[7BC_YK*/\ 43%?]%+P-_XE^3__ "_S_/LP]B_^?E'_ ,&1_KK^
M?9G[QT5^#G_"W?\ @X;_ .C2_P!@S_P[7BC_ .:RC_A;O_!PW_T:7^P9_P"'
M:\4?_-91_J)BO^BEX&_\2_)__E_G^?9A[%_\_*/_ (,C_77\^S/WCHK\'/\
MA;O_  <-_P#1I?[!G_AVO%'_ ,UE'_"W?^#AO_HTO]@S_P .UXH_^:RC_43%
M?]%+P-_XE^3_ /R_S_/LP]B_^?E'_P &1_KK^?9G[QT5^#G_  MW_@X;_P"C
M2_V#/_#M>*/_ )K*/^%N_P#!PW_T:7^P9_X=KQ1_\UE'^HF*_P"BEX&_\2_)
M_P#Y?Y_GV8>Q?_/RC_X,C_77\^S/WCHK\'/^%N_\'#?_ $:7^P9_X=KQ1_\
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ML_$6YK))M6M=*35][75]3=3LDN2;T6O*_+7;U^[S/$Z*]L_LOX _]#3XZ_\
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MR\W]WF>)T5[9_9?P!_Z&GQU_X*U_^5E']E_ '_H:?'7_ (*U_P#E91_:</\
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M?AF-U2;Q'XZ^%7C7PSH4#.VU?M.K:KHUM86RLV%#W$\2%BJ[MS 'P6OZ?O\
M@F?_ ,%GOVT_V@/VP?A;^S=^U#KGA+]H#X/_ +05[J?PS\0>&-1^%_@'0KC2
M#J>A:K>0ZW ?"^@:3;:MI<7V%[;Q-HVOVNIZ?=:#/>S1);7-LDC_ !-\9/\
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M]3&O\L[_ ()[_P#)^O[%O_9T/P3_ /4\T:O]3&OXY^DU_P C[AC_ +$^+_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"U\17L.G:9/KLA\=>,=#>ZDN[B"UM&O]&T;P]J>L7%EH4_B;0;W4+4U];_\
M!P#^V%\8M%_X(E>)_P!I?]A_Q+XDM='^-FF?!>\O?BMX.MKZ'Q/X,_9T^,D%
MO?ZSXXTR2T4ZEX>N;_3-3T#PW?ZI"UMJ7ART\3WUW;W>FZA9Q7UJ ?M[=_M-
M?LW:?X['PMO_ -H+X(V7Q,-T;$?#N[^*W@2V\=&]6=+8V?\ PB4VO)K_ -K%
MQ(D'V;^S_.\YA%LWG;7M]?RE_#G_ (-^?^""GB'_ ()]:)\1+]=$\4>$]8^%
M=K\0]>_;Y?X[Z_:^+/[5N-%&J:K\4?\ A+U\4GX?:(=/U2:>^D\,WGAZ30[&
MX@72];TB]OH;EI?;_P#@UO\ C?\ M%?&O_@F]J__  O+Q7XH^)G@_P"&'Q_^
M(_PI_9O^+WC07K>(_B/\"O"5KX?AT*^N+O4@VHZMI^A:[/K_ (?TK4[VXNYX
M+6P_X1PW++X=6., _I%HKXS_ &^_VYO@G_P3I_9=^(W[4OQUU-HO#/@JQ%KX
M=\+6-Q;Q^)?B3X\U-)H_"?PZ\(03Y%SK_B6_C,0E\N2VT?2H-3\1:IY6CZ/J
M%Q#X3_P1T_;X\8_\%,?V"?AA^U_X\\ ^&OAEXC^('B?XI:-<>#O"6HZIJVBZ
M;:>!/B+XC\&Z<\5_K(%_/<W=CHT%S>NZQQ&[EE,$4,)2) #]0J*** "BBB@
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MK6XA=)8+B"22*6-E>-V5@3_%I\#OV+_^""/[-/PH\':=_P %B?C5^SY\8_\
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M_KYN/_1\E15^_P =EZ+\COCLO1?D%%%%,84444 %%%% !1110 4444 %%%%
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M!K#XNE^&&GZ;H.K:I86EU\0P]YI,6HV=I)'X?98I9(YT,3?@O^QW_P $M_\
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MKZ79V!OYKBVL[O3[^?PGXGU+2]-N]3M]/OK/4]-U+2- U_39GN]$6QO?R/\
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MI#'] T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW5KB>U70["%&\6ZJ9+FY:.)F /["**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBO&OVB_#?Q,\9?L__ !O\'_!?6M.\-_%[Q9\)?B'X9^%_B35[
MZ]TS3/#OC_7_  EJVE>$M?OM1TZSU"_LK;1M=N['4I+FSL;RYA%KOAMYI J$
M _%K]JO_ (+5>+O$7QH\;?L2_P#!);]G36_V\OVN_"%Q/X>^(WCJWG&A_LG?
MLVZX;E-/DF^+?Q5FNK#2];U31;HW2WOA71=8TJWEOM.O=$7Q0/$-E>:$GI__
M  2)_P""4OBS]B?3/VFOCI^UA\1=!^/?[:O[=_B]O'G[47B;0]*%K\,K"*:?
M7[^W^&O@W1[NTM$U'0+*\\5^('U75;O2=+AU=+JSTNUT2QTK1K4W?Y ?L-_\
M$S/^#D#_ ()X? C3OV>?V:?C#_P2\T#P1;>(?$/BW5-2\1>'_B3XB\9^*_$_
MB?4'O]2USQ?XHF^&]M=^(-22,V^E65U=1A[31M/T[3HL0VD=?N3_ ,$\/"O_
M  6AT#XB>/KC_@IE\3_V./'7PRG\%00_#JQ_9N\/^*M)\2V?CS^W+)[B[\03
MZ_X;T.W?0O\ A'UOX4BADN9VOY;9_+C2)V< _'S_ (.:/A_X#^%W@7_@CUX'
M^&7@GPC\.O!>C_\ !3/X31Z1X0\">&]&\(^%]+0P$E-.\/\ A^RT_2;%"68E
M;:TB!))(R37T9_P=NV6O7'_!&_Q_?:)'<&'0_CQ\ M7URXABDECL=*3Q?)80
M7EWL5UCMH]>O]$0R3*8A/) I!=T!^)OV\_\ @EE_P<4?M_:M\(HOC#\=O^"<
MLWAS]G;X^VGQY^#4>@V/Q)\.:C:^(_#MW<)X7/B<Q?#?4TU6RCT\PC4-*\T1
MS3EP]W*%1Z_<#X%_LJ?MN_M.?L@_M-?LQ?\ !9[7_P!G'XKVWQN6[\(:&G[,
MFG^(/#^EZ5\/K[0[)UOKFX\0Z'I-Q;>./#_C2VB\2^&-3AL[R/3;W3-+NW>=
MX3  "C^Q9_P1\_X)]?#;]EOP7H'B_P#9Y^#/[2?C7XK>!=%\7_&WX[?&[P%X
M2^+?Q$^-OC;QSH]OKWBOQAJWC+QAI6L:I!IVK:KJ=U=>'M)T:ZLM+T'3?[/B
MTV);BW-[-^9'_!*'P7'_ ,$_?^"X_P#P4)_X)<_ K6M=O?V--4^ GA#]L'X?
M_#+4-6O-=T_X ^/?$.J?#VQUKPOH5SJ%S=76GZ/KEKX\N8_*N)Y+V]TK2? Q
MOI+R]M+O4KO8^&G[(/\ P<F?L.^";7]E3]E/]I']A?\ :1_9R\'V9\+_  /^
M+7[4.D_$+1_C9\,? EM+)#X?\/Z[I?AW3]0TC75\*Z-%;:;HR7=YXS@A5;>T
MB%MH=G::39_HQ_P2@_X)3ZM^P;>_'7]H/]H?XV7O[4O[>'[6>O6OB#]H;X^W
MM@^E:0;'3)'ET3X?_#[1Y4BDTOPCI$CB225K73?[0^R:/8VFB:#H7AW0=%L
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MT_26N]1.F7=_I.G266D:=9:78:QKMW/-K6NZU>:G'$*6+G@L%E,L'6ISPU3
MPK8I^S6%5' 5J-7V]&HIN4ZE>-&*C3]FIPE5E[3E4&V6ERQARNZ:N]+63O>^
MN_I_P?VI?;O;;]W<VW_=R<?I3:**^E-@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "NC\'?\C?X4_[&70?_ $ZVE<Y71^#O^1O\*?\ 8RZ#_P"G
M6TK'$?[O7_Z\U?\ TB0I;/T?Y'ZFT445^"G %0O]X_A_(5-4+_>/X?R% $U%
M%% &!XK_ .16\2_]@#6/_3=<U_D93?\ 'Q<_]?5U_P"E$E?ZYOBO_D5O$O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRL 000#7^6?-^V_^VJ)[@#]L+]J0 7-RH ^/OQ2 "K/(% '_  E'     X
M XK^F/H\QXEE3XM_U>KY%12GD?UO^VL)F.*<FXYM[#ZM]0QN#Y%%>V]M[7VG
M->GR<O++F[L'[2U3D<+7C?F4F[ZVM9H^F?\ AR__ ,%0_P#HS_QW_P"%'\.?
M_FRH_P"'+_\ P5#_ .C/_'?_ (4?PY_^;*OF+_AN#]M;_H\+]J3_ ,/[\4__
M )J*/^&X/VUO^CPOVI/_  _OQ3_^:BOZ2]EXD?\ 0=P+_P"&KB#_ .?7]6?E
M?M_?]Z7W3_S/IW_AR_\ \%0_^C/_ !W_ .%'\.?_ )LJ/^'+_P#P5#_Z,_\
M'?\ X4?PY_\ FRKYB_X;@_;6_P"CPOVI/_#^_%/_ .:BC_AN#]M;_H\+]J3_
M ,/[\4__ )J*/9>)'_0=P+_X:N(/_GU_5GY7/W_>E]T_\SZ=_P"'+_\ P5#_
M .C/_'?_ (4?PY_^;*C_ (<O_P#!4/\ Z,_\=_\ A1_#G_YLJ^8O^&X/VUO^
MCPOVI/\ P_OQ3_\ FHH_X;@_;6_Z/"_:D_\ #^_%/_YJ*/9>)'_0=P+_ .&K
MB#_Y]?U9^5S]_P!Z7W3_ ,SZ=_X<O_\ !4/_ *,_\=_^%'\.?_FRH_X<O_\
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M8N4\?P)&,4Y2E+*\_C&,4KRE*3SI*,8J[;;223;=@_?=Z7W3_P SZ$_X<O\
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MO^]+[I_YGT[_ ,.7_P#@J'_T9_X[_P#"C^'/_P V5'_#E_\ X*A_]&?^._\
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M_P" IK71/#N@^+],U'5]4N(;/Q7<W<L-E902SR1VUO-.ZH5BBD<A3_6?>?\
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M /\ .(+X?^6M_P"!0_\ D#Y-_P"'WO\ P2F_Z/3^&'_@N\=?_,E1_P /O?\
M@E-_T>G\,/\ P7>.O_F2KZR_X8=_8K_Z-!_9>_\ # _"G_YDZ/\ AAW]BO\
MZ-!_9>_\,#\*?_F3H]MX9?\ 0NX[_P##SP__ /.(+X?^6M_X%#_Y ^3?^'WO
M_!*;_H]/X8?^"[QU_P#,E1_P^]_X)3?]'I_##_P7>.O_ )DJ^LO^&'?V*_\
MHT']E[_PP/PI_P#F3H_X8=_8K_Z-!_9>_P## _"G_P"9.CVWAE_T+N.__#SP
M_P#_ #B"^'_EK?\ @4/_ ) ^3?\ A][_ ,$IO^CT_AA_X+O'7_S)4?\ #[W_
M ()3?]'I_##_ ,%WCK_YDJ^LO^&'?V*_^C0?V7O_  P/PI_^9.C_ (8=_8K_
M .C0?V7O_# _"G_YDZ/;>&7_ $+N._\ P\\/_P#SB"^'_EK?^!0_^0/DW_A]
M[_P2F_Z/3^&'_@N\=?\ S)4?\/O?^"4W_1Z?PP_\%WCK_P"9*OK+_AAW]BO_
M *-!_9>_\,#\*?\ YDZ/^&'?V*_^C0?V7O\ PP/PI_\ F3H]MX9?]"[CO_P\
M\/\ _P X@OA_Y:W_ (%#_P"0/DW_ (?>_P#!*;_H]/X8?^"[QU_\R5'_  ^]
M_P""4W_1Z?PP_P#!=XZ_^9*OK+_AAW]BO_HT']E[_P ,#\*?_F3H_P"&'?V*
M_P#HT']E[_PP/PI_^9.CVWAE_P!"[CO_ ,//#_\ \X@OA_Y:W_@4/_D#Y-_X
M?>_\$IO^CT_AA_X+O'7_ ,R5'_#[W_@E-_T>G\,/_!=XZ_\ F2KZR_X8=_8K
M_P"C0?V7O_# _"G_ .9.C_AAW]BO_HT']E[_ ,,#\*?_ )DZ/;>&7_0NX[_\
M//#_ /\ .(+X?^6M_P"!0_\ D#Y-_P"'WO\ P2F_Z/3^&'_@N\=?_,E1_P /
MO?\ @E-_T>G\,/\ P7>.O_F2KZR_X8=_8K_Z-!_9>_\ # _"G_YDZ/\ AAW]
MBO\ Z-!_9>_\,#\*?_F3H]MX9?\ 0NX[_P##SP__ /.(+X?^6M_X%#_Y ^3?
M^'WO_!*;_H]/X8?^"[QU_P#,E1_P^]_X)3?]'I_##_P7>.O_ )DJ^LO^&'?V
M*_\ HT']E[_PP/PI_P#F3H_X8=_8K_Z-!_9>_P## _"G_P"9.CVWAE_T+N._
M_#SP_P#_ #B"^'_EK?\ @4/_ ) ^3?\ A][_ ,$IO^CT_AA_X+O'7_S)4?\
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M_P /O?\ @E-_T>G\,/\ P7>.O_F2KZR_X8=_8K_Z-!_9>_\ # _"G_YDZ/\
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MW_@4/_D#Y-_X?>_\$IO^CT_AA_X+O'7_ ,R5'_#[W_@E-_T>G\,/_!=XZ_\
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M_P"9*OK+_AAW]BO_ *-!_9>_\,#\*?\ YDZ/^&'?V*_^C0?V7O\ PP/PI_\
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M&'_@N\=?_,E1_P /O?\ @E-_T>G\,/\ P7>.O_F2KZR_X8=_8K_Z-!_9>_\
M# _"G_YDZ/\ AAW]BO\ Z-!_9>_\,#\*?_F3H]MX9?\ 0NX[_P##SP__ /.(
M+X?^6M_X%#_Y ^3?^'WO_!*;_H]/X8?^"[QU_P#,E1_P^]_X)3?]'I_##_P7
M>.O_ )DJ^LO^&'?V*_\ HT']E[_PP/PI_P#F3H_X8=_8K_Z-!_9>_P## _"G
M_P"9.CVWAE_T+N.__#SP_P#_ #B"^'_EK?\ @4/_ ) ^3?\ A][_ ,$IO^CT
M_AA_X+O'7_S)4?\ #[W_ ()3?]'I_##_ ,%WCK_YDJ^LO^&'?V*_^C0?V7O_
M  P/PI_^9.C_ (8=_8K_ .C0?V7O_# _"G_YDZ/;>&7_ $+N._\ P\\/_P#S
MB"^'_EK?^!0_^0/DW_A][_P2F_Z/3^&'_@N\=?\ S)4?\/O?^"4W_1Z?PP_\
M%WCK_P"9*OK+_AAW]BO_ *-!_9>_\,#\*?\ YDZ/^&'?V*_^C0?V7O\ PP/P
MI_\ F3H]MX9?]"[CO_P\\/\ _P X@OA_Y:W_ (%#_P"0/DW_ (?>_P#!*;_H
M]/X8?^"[QU_\R5'_  ^]_P""4W_1Z?PP_P#!=XZ_^9*OK+_AAW]BO_HT']E[
M_P ,#\*?_F3H_P"&'?V*_P#HT']E[_PP/PI_^9.CVWAE_P!"[CO_ ,//#_\
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MPP_\%WCK_P"9*OK+_AAW]BO_ *-!_9>_\,#\*?\ YDZ/^&'?V*_^C0?V7O\
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M ,,#\*?_ )DZ/;>&7_0NX[_\//#_ /\ .(+X?^6M_P"!0_\ D#Y-_P"'WO\
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M^C0?V7O_  P/PI_^9.C_ (8=_8K_ .C0?V7O_# _"G_YDZ/;>&7_ $+N._\
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M!_9>_P## _"G_P"9.CVWAE_T+N.__#SP_P#_ #B"^'_EK?\ @4/_ ) ^3?\
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MX8=_8K_Z-!_9>_\ # _"G_YDZ/\ AAW]BO\ Z-!_9>_\,#\*?_F3H]MX9?\
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MW]BO_HT']E[_ ,,#\*?_ )DZ/;>&7_0NX[_\//#_ /\ .(+X?^6M_P"!0_\
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M>&7_ $+N._\ P\\/_P#SB"^'_EK?^!0_^0/DW_A][_P2F_Z/3^&'_@N\=?\
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M3H_X8=_8K_Z-!_9>_P## _"G_P"9.CVWAE_T+N.__#SP_P#_ #B"^'_EK?\
M@4/_ ) ^3?\ A][_ ,$IO^CT_AA_X+O'7_S)4?\ #[W_ ()3?]'I_##_ ,%W
MCK_YDJ^LO^&'?V*_^C0?V7O_  P/PI_^9.C_ (8=_8K_ .C0?V7O_# _"G_Y
MDZ/;>&7_ $+N._\ P\\/_P#SB"^'_EK?^!0_^0/DW_A][_P2F_Z/3^&'_@N\
M=?\ S)4?\/O?^"4W_1Z?PP_\%WCK_P"9*OK+_AAW]BO_ *-!_9>_\,#\*?\
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M_P"!0_\ D#Y-_P"'WO\ P2F_Z/3^&'_@N\=?_,E1_P /O?\ @E-_T>G\,/\
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MA_X+O'7_ ,R5'_#[W_@E-_T>G\,/_!=XZ_\ F2KZR_X8=_8K_P"C0?V7O_#
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MO_# _"G_ .9.C_AAW]BO_HT']E[_ ,,#\*?_ )DZ/;>&7_0NX[_\//#_ /\
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M_9>_\,#\*?\ YDZ/^&'?V*_^C0?V7O\ PP/PI_\ F3H]MX9?]"[CO_P\\/\
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MSXG_ /0GW_\ X$:?_P#)E>Y?V[K?_09U7_P8W?\ \>H_MW6_^@SJO_@QN_\
MX]1_;&;?R99_X*Q?_P T^O\ 2U.>?]WIT]+_ *_?]WAO_"G/B?\ ]"??_P#@
M1I__ ,F4?\*<^)__ $)]_P#^!&G_ /R97N7]NZW_ -!G5?\ P8W?_P >H_MW
M6_\ H,ZK_P"#&[_^/4?VQFW\F6?^"L7_ /-/K_2U.>?]WIT]+_K]_P!WAO\
MPISXG_\ 0GW_ /X$:?\ _)E'_"G/B?\ ]"??_P#@1I__ ,F5[E_;NM_]!G5?
M_!C=_P#QZC^W=;_Z#.J_^#&[_P#CU']L9M_)EG_@K%__ #3Z_P!+4YY_W>G3
MTO\ K]_W>&_\*<^)_P#T)]__ .!&G_\ R91_PISXG_\ 0GW_ /X$:?\ _)E>
MY?V[K?\ T&=5_P#!C=__ !ZC^W=;_P"@SJO_ (,;O_X]1_;&;?R99_X*Q?\
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M $)]_P#^!&G_ /R91_PISXG_ /0GW_\ X$:?_P#)E>Y?V[K?_09U7_P8W?\
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MO_X]1_;&;?R99_X*Q?\ \T^O]+4YY_W>G3TO^OW_ '>&_P#"G/B?_P!"??\
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MQFW\F6?^"L7_ /-/K_2U.>?]WIT]+_K]_P!WAO\ PISXG_\ 0GW_ /X$:?\
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M$3"5_P""I7[)!4D'_A*/&XR"0<-\+?&ZL..S*2I'0@D'@U^6-?J;_P $3?\
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M1J]SXD\&6M]J!4:;:>(HKJPT[6/#3:JSI'I5[J-BVC:E<.MI9:M->LMN?/\
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M5I;:SEND@L]8M[6\$EK#);ZA#=6KINA)/A],CCCB01Q(D:+G:D:JB+DDG"J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'QR_P#K
M)/\ KI)_Z&U-IS_ZR3_KI)_Z&U-K](.@**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *T]$_P"0UH__ &%=._\ 2R&LRM/1/^0UH_\
MV%=._P#2R&HJ?PZG^"7_ *2P/K6BBBOSHYPJ%_O'\/Y"IJA?[Q_#^0H FHHH
MH P/%?\ R*WB7_L :Q_Z;KFO\C*;_CXN?^OJZ_\ 2B2O]<WQ7_R*WB7_ + &
ML?\ INN:_P C*;_CXN?^OJZ_]*)*_K3Z,'\+C7_KYP]_Z3G1Z.!VJ>L?RD1T
M445_5AWA1110 4444 %%%% !7V__ ,$W/V@?A[^RO^VY\!?C_P#%5M<3X?\
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MG"N+J0I5,-4C4I.44Z3E5G-N44XQ490E9Z7YEZ/1ZKHC]7_^"JG_  4WT/\
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MI'[0_A>UFT+PJM]IIU&WTVZU:'4=887D1M-(M;V[&_R=C 'W7_PTS_P=/?\
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M@:VMC///>6^@>)_%GA_SIM,LO#-OI(!_8W1110 4444 %%%% !1110 4444
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MH]Q::9XZ\,:7XHL+6=X_D>:WM=4BBE9/E:1&*\$5Z30 4444 %%%% !1110
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M/%FNFXUX6GAO5M.T'5=7T%-8_HXK^*/_ (*D?M3?!#_@KS_P4L_X)"_LE?\
M!/CQ_H?[0&O_  !_:/MOVG_C;\:_A@+C7?!7PC^'?AG7O VK:A&OCRRA&FM=
M/I7A/4KW4XK&\>Q77SX"T)[M]=U6"P@_M)UO6]'\-:+J_B/Q#JEAHF@:!I=_
MK>N:UJMU#8:7I&CZ5:2WVIZIJ5]<O';V=AI]E!/=WEU<21PV]O%)-*ZQHS
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M^-NL:-?W_ACQ/I\.IZ1=7FDZC\8X+[3KB:SGB>6RNX8[BW9C%,BR*RC]1?\
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MTCQSHN@^#[30-->%'UO4=3U'4&O%N[S^T[2PGL]&TWX3_P"#:KQC??!35_\
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M*_.W_@DU^UWKG[=O_!.K]E+]J7Q;'9Q>./B7\,[9/B$-/A2VL9OB#X/U74_
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ME_:7AKQ=X8\#:CJF@:[IXGFMC>:9J$&8KFW^T6\\/F)QYD3KVKKQ_P $Q_\
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M?Z/J^FWD9AO--U72KN:PU+3KR%OFAN["^MY[2ZA;YHIX9(VY4U2K])_V5O\
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MNE64HN$<=B</)QE&=E"49-NK3C+E<DGL][)NUDW:T;W5KM'X5T5][_\ !/\
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MPGHUW\1O"WAG5(M5@U'0=!\736CZUI>DWT.N:S%=6-I=Q6\T>JZ@CQE;N8.
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M:-X0\$ZG?VMM'K EU?PUX$CLKF/:VHZ;HGC?7=.2?1[#2=1U/^EW]IG]@?\
M8M_;*ET.Z_:F_9B^#/QSU+PU$UOX?UOX@>"-(UCQ%HUF\AFDT_3O$9@BUVUT
MR29FFETR+45L))6:1[9G9F/L/P5^ _P5_9P\!:9\+?@%\*? 'P;^'6CM)+IW
M@SX;^%=&\(>'H+B946XO7T[1;2T@N=0NA'&;O4;I9KZ[9%>YN)6 - 'K%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?S=_\'89 _X(H_M Y(&?B-^S^!DXR3\7_"P 'N3T'>OH
MK]F+_@C-_P $HO%G[-?[//BCQ%_P3Z_94UGQ!XD^!GPDU[7-8OOA)X8N;[5=
M8U;P!X?O]2U*]N9+1I+F\OKRXFNKJXE9I)YY9)9&9W9C^M7QB^"7P?\ VA?
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M?$CX)>&9KHR&?XJ^!=/@T^WN8K?[5F_D\8RK)=3H18?&'Q'.L&BC^LS]FO\
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M/P%K5^L>CW^L:KI\/_!>3_@H_P#!/_@H9\$O!7_!)?\ X)N?$7PI^UG^T?\
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MM;W AN89$$T,4@&Y%( /@3_@C"_F?\$F_P#@G<V_>#^R+\$@K;MP*KX)TM5
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MVEV-_JU[8Z9+JW@O4](ENTU22QM;CZ#O_!^I:7_P=L?#S4=*\*:CI_@C2?\
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M0^%7B7Q_\5?$=MXNU'2]+U/5+?4PGA;^RH[2:+Q!IFHR66JZ!J&J?LM\>_\
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M@J#]G*7+"<9)6NG)PM>[6FFKN[;]-?YH:*CB5TBC21S(ZHBO(0%,C*H#.0.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /CE_P#62?\ 723_ -#:FTY_
M]9)_UTD_]#:FU^D'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]3\=_P!%[QST_P"8KASI;_JFO+^M;]OLG_S^K??#_P"5^7Y]V?N]_P ,V?\
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M_5->7]:W/9/_ )_5OOA_\K\OS[L_=[_AFS_@@%_TD9_:<_\ #)^)/_G*4?\
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M.=+?]4UY?UK<]D_^?U;[X?\ ROR_/NS]WO\ AFS_ ((!?])&?VG/_#)^)/\
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M_P!//+\7W/P'_P"&F?\ @X2_Z1N_LH_^)%:)_P#/.H_X:9_X.$O^D;O[*/\
MXD5HG_SSJ_?BBC_73 ?]&^X$_P#";B7_ .B?^KORL>UC_P ^*/W5/+_IYY?B
M^Y^ _P#PTS_P<)?](W?V4?\ Q(K1/_GG4?\ #3/_  <)?](W?V4?_$BM$_\
MGG5^_%%'^NF _P"C?<"?^$W$O_T3_P!7?E8]K'_GQ1^ZIY?]//+\7W/P'_X:
M9_X.$O\ I&[^RC_XD5HG_P \ZC_AIG_@X2_Z1N_LH_\ B16B?_/.K]^**/\
M73 ?]&^X$_\ ";B7_P"B?^KORL>UC_SXH_=4\O\ IYY?B^Y^ _\ PTS_ ,'"
M7_2-W]E'_P 2*T3_ .>=1_PTS_P<)?\ 2-W]E'_Q(K1/_GG5^_%%'^NF _Z-
M]P)_X3<2_P#T3_U=^5CVL?\ GQ1^ZIY?]//+\7W/P'_X:9_X.$O^D;O[*/\
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M_/.H_P"&F?\ @X2_Z1N_LH_^)%:)_P#/.K]^**/]=,!_T;[@3_PFXE_^B?\
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M  FXE_\ HG_J[\K'M8_\^*/W5/+_ *>>7XON?@/_ ,-,_P#!PE_TC=_91_\
M$BM$_P#GG4?\-,_\'"7_ $C=_91_\2*T3_YYU?OQ11_KI@/^C?<"?^$W$O\
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MO[*/_B16B?\ SSJ/^&F?^#A+_I&[^RC_ .)%:)_\\ZOWXHH_UTP'_1ON!/\
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MH_=4\O\ IYY?B^Y^ _\ PTS_ ,'"7_2-W]E'_P 2*T3_ .>=1_PTS_P<)?\
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M+_I&[^RC_P")%:)_\\ZC_AIG_@X2_P"D;O[*/_B16B?_ #SJ_?BBC_73 ?\
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M"?\ A-Q+_P#1/_5WY6/:Q_Y\4?NJ>7_3SR_%]S\!_P#AIG_@X2_Z1N_LH_\
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M.$O^D;O[*/\ XD5HG_SSJ/\ AIG_ (.$O^D;O[*/_B16B?\ SSJ_?BBC_73
M?]&^X$_\)N)?_HG_ *N_*Q[6/_/BC]U3R_Z>>7XON?@/_P -,_\ !PE_TC=_
M91_\2*T3_P">=1_PTS_P<)?](W?V4?\ Q(K1/_GG5^_%%'^NF _Z-]P)_P"$
MW$O_ -$_]7?E8]K'_GQ1^ZIY?]//+\7W/P'_ .&F?^#A+_I&[^RC_P")%:)_
M\\ZC_AIG_@X2_P"D;O[*/_B16B?_ #SJ_?BBC_73 ?\ 1ON!/_";B7_Z)_ZN
M_*Q[6/\ SXH_=4\O^GGE^+[GX#_\-,_\'"7_ $C=_91_\2*T3_YYU'_#3/\
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MBC_5ZA_T'YG_ .#<)_\ ,?K_ $M3V7]Z7X>7EY?CZW^NO^$F^"W_ $.NK?\
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M?K_2U/9?WI?AY>7E^/K?ZZ_X2;X+?]#KJW_@DU+_ .5-'_"3?!;_ *'75O\
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M-B>3EY_J]>E7Y.:_+S^RG+EYK/EYK7L[;.R33V:?H[D5%%%=(PHHHH ****
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M.$8E6QE5TQE&24HM2BU=2BTTT]FFM&O-#"BBBF 4444 %%%% 'U__P $]_\
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MXLIIX4OM+U&UN=/U&T9Q<65[;SVMS'%/#)&NK0 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSU%+#6-,E\C4](OFLYIEL]5TV?\ <:AIUR8KRRF_=W,$3D"F!?HHHH ****
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MUAI2A"4H4X4I)IN-XVG&*NTY))*ZNDWL]7HVSY\_8A_X)]?&/]NNZ^*-_P"
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M>^)LL\GC7X<Z/K"6_A_Q%]KL7TW4;=K>:&:YL;/5K&0VVMV.CW%A::U&D?\
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M6F3JRC1G*46IU:,N51MRWE%JTKN_G?OH]-?Y3:_N\_X)J>'_ ((_$K_@B3\
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MQ6"GA^&\@E%X9U90E"G5]HUB:4*D(UU&FJC:IQ0DWRX=*R;H2U:3:M"GM?\
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M2[B&<>*3XDTZ>XM?$EYXB?5+_P 01W%P=9NKUYY6< _F^OO^#H[X;_%C]O\
M_94_96_8Z^!&M_%K]GWXZ_'/P]\#-?\ VK/'L/BOX?\ AC5O$FK>(-%TS6U^
M#>BW>A+/XEA\(Z;K%GJ&IW'B271KNZFU+3D71;/3)[+5]5_HV_:\_:M^#G[$
M/[.7Q4_:B^/>O/X?^&/PE\.OKNMR6D<-QK&LWMQ<P:9X?\*^&K":>UCU+Q/X
MKUZ]T[P_X?T]KFWBN=4U&V%S<VMHL]U#_-3_ ,%M/ 7@;X7?\%*?^#;+X?\
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MX[^)%S'<6Q?3_#]_;W'W)^WU^V5X8_8O^&^@^(=&\#-\8/VF_C'K]O\ !O\
M92^ N@&VB\;_ !M^+>NCS-+\-V]Z5-QH7P^\-[_^$L^*?C2Z*Z'X(\'6-_K%
M\[7TFEV5_P#E_P###XS6'_!.KXE:U\$H/A#\8?\ @I9_P5X_:ET.S_:>_;9N
MOV?;#P7I,'A30%3^P_"MEJOC7XI^*_"'A'X5_ ?X>12)\-?V>?AO-K+:MJ6F
MV<VOW&CVFL>*[F[U, _9C]CS]DOX2?L0_L]> /V</@O8:A#X0\#V5S+>ZYKU
M[)JOBWQUXPUJZEU;QG\1/&VLS?OM9\9>-_$5U?\ B#Q#J#".)[Z]>"R@M-/M
M[2T@^FZ^+?V(?VZ?A'^W9\/?%WBWX>:+X]^'OC;X5^/-7^$_QS^!_P 7?#\?
MA/XN_!'XJ>'TADUCP3X\\/07VIV4=PL4\=WI6L:1J>IZ)K=@XGL;YIH;VUM/
MM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /PC_X*H_\ !>S]F3_@G%>^*/@E
MX6T'Q/\ M+_MMVGAPZUH/[,WP[TC7Y9]%M;KPW'XLM/%'Q0\6VNBZAI_A3PC
M:>&9E\3WRZ;'K?B.;18FN4TFSTYKC6;'Z_\ ^"3/[</B7_@HW^P9\%/VP/%W
M@+0_AEX@^*C>.EOO!?AS6+_7M'TG_A$/B!XG\&6[6FIZG:V=[/\ ;[?0(K^5
M)H%\B:YD@1Y$C61M/]NWX)?!S0_V7?\ @H#\;]&^%7P\TSXS>-/V-/C[H_BW
MXL67@[0+?XC^(](T+X&^+M-T;2=8\:QV"^([_2]+L+>"TL=.N-1>SMH(HXXH
M5"#'P+_P:_2)%_P1%_9!EE=8XXO^%UR22.0J(B?'+XC,[LQX"JH)8G@ $F@#
MQ7]H'_@LE_P49U/]O_\ :R_8O_X)V_\ !.KP1^U]I7[(</PNMOB5XVUGXUZ=
M\-KS3];^(WA"S\1)930>(;K2=)G$.H/JVD6\&F7M]>*=#O9[Z*WX1?N'_@GI
M^U;_ ,%9OCI\8?%'A7]O#_@G!X._8^^$^G?#S4==\.?$7P_\=?"_Q-OM<\>P
M>(?#ECI_@^30M#UC4KBUM;W0;_Q#J\FJ2QQ0P2Z+#:EV>]11_,7_ ,$F_P!O
M+]O*X^*G_!4OX[?L)?\ !-CQG^VGXY_:E_;F\>>.M>^+OB3XD>%O@S\#/"7P
MV\+7.NK\/O!.C>+/%;POXS\:1V_B+4[B_P##VE:G81Z#H\WAV5UO&U 1VO\
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M\0^%]>NAI6N*=,U2UM)9;5[G]%J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**_FY_X.(?\ @J;^V_\ \$W/A)X+F_9-_9UNM6T+XAVMS:^-_P!L77O#VI>.
M_AU^SQ<OJ2V%M9:CX*T:RNH_^$FOK(R:KI&M>-)5\) HEA;Z-XGU)Y;"U /U
MD_;G_P""CG['G_!.3X:2?$W]J_XPZ#X"M;J"Y?PIX*M9$UKXF_$*\MU8G3?
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M"?XL:IJ+:M?:_H(UK5-.D>'4/$$W_":V]VNH;],\60:DTEM<Z=XIU:$?H_\
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MPAX]@W7NGR^&!>^)QX3:TTW4UCDT6^U:^GTO1)/(O;#P_936=O!;_F-\?_\
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M="I]8E*O5J5:G+*(J,4U)N<FHRC>4F[QE:ZZ=M+6U;;N[6_?;_@I_P#M>?\
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M$^+_ /4YGFX[XZ?^%_F%%%%?S*<(4444 %%%% !1110 4444 %%%% !1110
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M3/;:5I%M:VOVFZDS/?7LB27E_<O)=7D\]Q))*P!^?O[('[$/Q5\/?M-?'?\
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M=T[1VLFH"WD-FES(J2-';M<^6LSJCLD99@C$8-ZB@#^)+]BO_@FU_P ')?[
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M@ HHHH ^#_VX?VX_@5^PV?@)XF_:(\$>)[WX=_$OXGR>")OC)8^#++Q3X-^
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MS+>XN?"UDZ0Z%::IIGC^VT\VT5G9WM]I-O8V,'](Q.3D^PX     50!@*JJ
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MK3/_ )=T?ZT\,?\ 12\/?^'O+/\ YJ#VD/YX?^!+_/S7WGP%17W[_P .I_\
M@I7_ -&0?'__ ,)K3/\ Y=T?\.I_^"E?_1D'Q_\ _":TS_Y=T?ZT\,?]%+P]
M_P"'O+/_ )J#VD/YX?\ @2_S\U]Y\!45]^_\.I_^"E?_ $9!\?\ _P )K3/_
M )=T?\.I_P#@I7_T9!\?_P#PFM,_^7='^M/#'_12\/?^'O+/_FH/:0_GA_X$
MO\_-?>? 5%??O_#J?_@I7_T9!\?_ /PFM,_^7='_  ZG_P""E?\ T9!\?_\
MPFM,_P#EW1_K3PQ_T4O#W_A[RS_YJ#VD/YX?^!+_ #\U]Y\!45]^_P##J?\
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M\,?]%+P]_P"'O+/_ )J#VD/YX?\ @2_S\U]Y\!45]^_\.I_^"E?_ $9!\?\
M_P )K3/_ )=T?\.I_P#@I7_T9!\?_P#PFM,_^7='^M/#'_12\/?^'O+/_FH/
M:0_GA_X$O\_-?>? 5%??O_#J?_@I7_T9!\?_ /PFM,_^7='_  ZG_P""E?\
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M1_PJSXD_]"3K_P#X#1?_ !^CZ]@?^@W!_P#A50_^6!SQ_F7W^G^:."HKO?\
MA5GQ)_Z$G7__  &B_P#C]'_"K/B3_P!"3K__ (#1?_'Z/KV!_P"@W!_^%5#_
M .6!SQ_F7W^G^:."HKO?^%6?$G_H2=?_ / :+_X_1_PJSXD_]"3K_P#X#1?_
M !^CZ]@?^@W!_P#A50_^6!SQ_F7W^G^:."HKO?\ A5GQ)_Z$G7__  &B_P#C
M]'_"K/B3_P!"3K__ (#1?_'Z/KV!_P"@W!_^%5#_ .6!SQ_F7W^G^:."HKO?
M^%6?$G_H2=?_ / :+_X_1_PJSXD_]"3K_P#X#1?_ !^CZ]@?^@W!_P#A50_^
M6!SQ_F7W^G^:."HKO?\ A5GQ)_Z$G7__  &B_P#C]'_"K/B3_P!"3K__ (#1
M?_'Z/KV!_P"@W!_^%5#_ .6!SQ_F7W^G^:."HKO?^%6?$G_H2=?_ / :+_X_
M1_PJSXD_]"3K_P#X#1?_ !^CZ]@?^@W!_P#A50_^6!SQ_F7W^G^:."HKO?\
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M1_PJSXD_]"3K_P#X#1?_ !^CZ]@?^@W!_P#A50_^6!SQ_F7W^G^:."HKO?\
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M^B,X2_\ $;R;_P"8O+\^[/H/_AK7]JG_ *.1^./_ (<WQ9_\LZ/^&M?VJ?\
MHY'XX_\ AS?%G_RSKY\HH_UEXC_Z*'/?_#OF'_S1Y+[@_P!1>"/^B,X2_P#$
M;R;_ .8O+\^[/H/_ (:U_:I_Z.1^./\ X<WQ9_\ +.C_ (:U_:I_Z.1^./\
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MGRBC_67B/_HH<]_\.^8?_-'DON#_ %%X(_Z(SA+_ ,1O)O\ YB\OS[L^@_\
MAK7]JG_HY'XX_P#AS?%G_P LZ/\ AK7]JG_HY'XX_P#AS?%G_P LZ^?**/\
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MK7]JG_HY'XX_^'-\6?\ RSH_X:U_:I_Z.1^./_AS?%G_ ,LZ^?**/]9>(_\
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M<WQ9_P#+.C_AK7]JG_HY'XX_^'-\6?\ RSKY\HH_UEXC_P"BASW_ ,.^8?\
MS1Y+[@_U%X(_Z(SA+_Q&\F_^8O+\^[/H/_AK7]JG_HY'XX_^'-\6?_+.C_AK
M7]JG_HY'XX_^'-\6?_+.OGRBC_67B/\ Z*'/?_#OF'_S1Y+[@_U%X(_Z(SA+
M_P 1O)O_ )B\OS[L^@_^&M?VJ?\ HY'XX_\ AS?%G_RSH_X:U_:I_P"CD?CC
M_P"'-\6?_+.OGRBC_67B/_HH<]_\.^8?_-'DON#_ %%X(_Z(SA+_ ,1O)O\
MYB\OS[L^@_\ AK7]JG_HY'XX_P#AS?%G_P LZ/\ AK7]JG_HY'XX_P#AS?%G
M_P LZ^?**/\ 67B/_HH<]_\ #OF'_P T>2^X/]1>"/\ HC.$O_$;R;_YB\OS
M[L^@_P#AK7]JG_HY'XX_^'-\6?\ RSH_X:U_:I_Z.1^./_AS?%G_ ,LZ^?**
M/]9>(_\ HH<]_P##OF'_ ,T>2^X/]1>"/^B,X2_\1O)O_F+R_/NSZ#_X:U_:
MI_Z.1^./_AS?%G_RSH_X:U_:I_Z.1^./_AS?%G_RSKY\HH_UEXC_ .BASW_P
M[YA_\T>2^X/]1>"/^B,X2_\ $;R;_P"8O+\^[/H/_AK7]JG_ *.1^./_ (<W
MQ9_\LZ/^&M?VJ?\ HY'XX_\ AS?%G_RSKY\HH_UEXC_Z*'/?_#OF'_S1Y+[@
M_P!1>"/^B,X2_P#$;R;_ .8O+\^[/H/_ (:U_:I_Z.1^./\ X<WQ9_\ +.C_
M (:U_:I_Z.1^./\ X<WQ9_\ +.OGRBC_ %EXC_Z*'/?_  [YA_\ -'DON#_4
M7@C_ *(SA+_Q&\F_^8O+\^[/H/\ X:U_:I_Z.1^./_AS?%G_ ,LZ/^&M?VJ?
M^CD?CC_X<WQ9_P#+.OGRBC_67B/_ **'/?\ P[YA_P#-'DON#_47@C_HC.$O
M_$;R;_YB\OS[L^@_^&M?VJ?^CD?CC_X<WQ9_\LZ/^&M?VJ?^CD?CC_X<WQ9_
M\LZ^?**/]9>(_P#HH<]_\.^8?_-'DON#_47@C_HC.$O_ !&\F_\ F+R_/NSZ
M#_X:U_:I_P"CD?CC_P"'-\6?_+.C_AK7]JG_ *.1^./_ (<WQ9_\LZ\+TK2]
M1US5=+T/1[.?4=7UK4;'2-)T^U0R7-_J>IW45E865N@^]-<W4\4,8) W."Q5
M02/3_C'\!?B[^S_K>D^'?C!X+O?!>KZ[I<FLZ1;75[I>HQW^G17364T\%WH]
M]J%F7@N5\N>W:=;B$/"\D2QSQ,_93S;C*K@\3F-+-.**N7X.I0I8O'4\=FT\
M'A:N);CAJ6)Q4:KH4*E>47&A"K.,JKBU34FM/-K<.^&.&S/ Y+B,@X!H9QF=
M'%8C+<IK93PY2S+,,/@8PGC:^"P-3#QQ6+HX2,H2Q56A2J0H1DI5904KOI?^
M&M?VJ?\ HY'XX_\ AS?%G_RSH_X:U_:I_P"CD?CC_P"'-\6?_+.OGRBN/_67
MB/\ Z*'/?_#OF'_S1Y+[CTO]1>"/^B,X2_\ $;R;_P"8O+\^[/H/_AK7]JG_
M *.1^./_ (<WQ9_\LZ/^&M?VJ?\ HY'XX_\ AS?%G_RSKY\HH_UEXC_Z*'/?
M_#OF'_S1Y+[@_P!1>"/^B,X2_P#$;R;_ .8O+\^[/H/_ (:U_:I_Z.1^./\
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M'_PUK^U3_P!'(_''_P .;XL_^6='_#6O[5/_ $<C\<?_  YOBS_Y9UZY;_\
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M[YAY?]1'DON1^@_ZB\$?]$9PG_XC>3?_ #%Y?GW9]!_\-:_M4_\ 1R/QQ_\
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MY-_\Q>7Y]V?0?_#6O[5/_1R/QQ_\.;XL_P#EG1_PUK^U3_T<C\<?_#F^+/\
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MY+[@_P!1>"/^B,X2_P#$;R;_ .8O+\^[/H/_ (:U_:I_Z.1^./\ X<WQ9_\
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M9_\ +.C_ (:U_:I_Z.1^./\ X<WQ9_\ +.OGRBC_ %EXC_Z*'/?_  [YA_\
M-'DON#_47@C_ *(SA+_Q&\F_^8O+\^[/H/\ X:U_:I_Z.1^./_AS?%G_ ,LZ
M/^&M?VJ?^CD?CC_X<WQ9_P#+.OGRBC_67B/_ **'/?\ P[YA_P#-'DON#_47
M@C_HC.$O_$;R;_YB\OS[L^@_^&M?VJ?^CD?CC_X<WQ9_\LZ/^&M?VJ?^CD?C
MC_X<WQ9_\LZ^?**/]9>(_P#HH<]_\.^8?_-'DON#_47@C_HC.$O_ !&\F_\
MF+R_/NSZ#_X:U_:I_P"CD?CC_P"'-\6?_+.C_AK7]JG_ *.1^./_ (<WQ9_\
MLZ^?**/]9>(_^BASW_P[YA_\T>2^X/\ 47@C_HC.$O\ Q&\F_P#F+R_/NSZ#
M_P"&M?VJ?^CD?CC_ .'-\6?_ "SH_P"&M?VJ?^CD?CC_ .'-\6?_ "SKY\HH
M_P!9>(_^BASW_P .^8?_ #1Y+[@_U%X(_P"B,X2_\1O)O_F+R_/NSZ#_ .&M
M?VJ?^CD?CC_X<WQ9_P#+.C_AK7]JG_HY'XX_^'-\6?\ RSKY\HH_UEXC_P"B
MASW_ ,.^8?\ S1Y+[@_U%X(_Z(SA+_Q&\F_^8O+\^[/H/_AK7]JG_HY'XX_^
M'-\6?_+.C_AK7]JG_HY'XX_^'-\6?_+.OGRBC_67B/\ Z*'/?_#OF'_S1Y+[
M@_U%X(_Z(SA+_P 1O)O_ )B\OS[L^@_^&M?VJ?\ HY'XX_\ AS?%G_RSH_X:
MU_:I_P"CD?CC_P"'-\6?_+.OGRBC_67B/_HH<]_\.^8?_-'DON#_ %%X(_Z(
MSA+_ ,1O)O\ YB\OS[L^@_\ AK7]JG_HY'XX_P#AS?%G_P LZ/\ AK7]JG_H
MY'XX_P#AS?%G_P LZ^?**/\ 67B/_HH<]_\ #OF'_P T>2^X/]1>"/\ HC.$
MO_$;R;_YB\OS[L^@_P#AK7]JG_HY'XX_^'-\6?\ RSH_X:U_:I_Z.1^./_AS
M?%G_ ,LZ^?**/]9>(_\ HH<]_P##OF'_ ,T>2^X/]1>"/^B,X2_\1O)O_F+R
M_/NSZ#_X:U_:I_Z.1^./_AS?%G_RSH_X:U_:I_Z.1^./_AS?%G_RSKY\HH_U
MEXC_ .BASW_P[YA_\T>2^X/]1>"/^B,X2_\ $;R;_P"8O+\^[/H/_AK7]JG_
M *.1^./_ (<WQ9_\LZ/^&M?VJ?\ HY'XX_\ AS?%G_RSKY\HH_UEXC_Z*'/?
M_#OF'_S1Y+[@_P!1>"/^B,X2_P#$;R;_ .8O+\^[/H/_ (:U_:I_Z.1^./\
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MJG_HY'XX_P#AS?%G_P LZ^?**/\ 67B/_HH<]_\ #OF'_P T>2^X/]1>"/\
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M %%X(_Z(SA+_ ,1O)O\ YB\OS[L^@_\ AK7]JG_HY'XX_P#AS?%G_P LZ/\
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M?_#OF'_S1Y+[@_U%X(_Z(SA+_P 1O)O_ )B\OS[L^@_^&M?VJ?\ HY'XX_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %>O\ [/7_ "<#\!_^RT_"O_U.M!KR
M"O7_ -GK_DX'X#_]EI^%?_J=:#7IY)_R.LG_ .QKEW_J91/ XK_Y);B7_L09
MQ_ZKL2?W(T445_L:?\SP5"_WC^'\A4U0O]X_A_(4 34444 9>N?\@76/^P7J
M'_I)-7\$TO\ KI_^N\__ *->O[V=<_Y NL?]@O4/_22:OX)I?]=/_P!=Y_\
MT:]?Q7]+S^+P!_U[XH_]*X?/]1OV;_\ N_C!_P!?N!/_ $CB\91117\9G^G0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML)P_6RR>%G@L#P[PG46/RC 9-56%C2SG 3J5ZV>TJ^*6/QKEB'*'[T_L^_\
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M9/[66%H8?)\OKXQUL74JUI3Q.8XW'8G$584Z-*G&C"$U4****_/C]F"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0V?_ ,T-?EE]GM_^>$/_ 'Z3_P")H^SV_P#SPA_[])_\31_K+P)_T;'"]/\
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M\.VO"'_1]7[+G_A0V?\ \T-?EE]GM_\ GA#_ -^D_P#B:/L]O_SPA_[])_\
M$T?ZR\"?]&QPO3_FL>)O+_IYY/\ IL/]1/%O_H_.._\ %9\#^7_3KR_'UO\
MJ;_P[:\(?]'U?LN?^%#9_P#S0T?\.VO"'_1]7[+G_A0V?_S0U^67V>W_ .>$
M/_?I/_B:/L]O_P \(?\ OTG_ ,31_K+P)_T;'"]/^:QXF\O^GGD_Z;#_ %$\
M6_\ H_.._P#%9\#^7_3KR_'UO^IO_#MKPA_T?5^RY_X4-G_\T-'_  [:\(?]
M'U?LN?\ A0V?_P T-?EE]GM_^>$/_?I/_B:/L]O_ ,\(?^_2?_$T?ZR\"?\
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M ,[/+\^[/YPO^'(OQ9_Z+I\//_"8\2?_ "31_P .1?BS_P!%T^'G_A,>)/\
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M(OQ9_P"BZ?#S_P )CQ)_\DT?\.1?BS_T73X>?^$QXD_^2:_H]HH_XEN\)?\
MH1X__P /V<__ #9Y?GW8?\3O_2*_Z*S*?_$2X:_^=GE^?=G\X7_#D7XL_P#1
M=/AY_P"$QXD_^2:/^'(OQ9_Z+I\//_"8\2?_ "37]'M%'_$MWA+_ -"/'_\
MA^SG_P";/+\^[#_B=_Z17_1693_XB7#7_P [/+\^[/YPO^'(OQ9_Z+I\//\
MPF/$G_R31_PY%^+/_1=/AY_X3'B3_P"2:_H]HH_XEN\)?^A'C_\ P_9S_P#-
MGE^?=A_Q._\ 2*_Z*S*?_$2X:_\ G9Y?GW9_.%_PY%^+/_1=/AY_X3'B3_Y)
MH_X<B_%G_HNGP\_\)CQ)_P#)-?T>T4?\2W>$O_0CQ_\ X?LY_P#FSR_/NP_X
MG?\ I%?]%9E/_B)<-?\ SL\OS[L_G"_X<B_%G_HNGP\_\)CQ)_\ )-'_  Y%
M^+/_ $73X>?^$QXD_P#DFOZ/:*/^);O"7_H1X_\ \/V<_P#S9Y?GW8?\3O\
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M (3'B3_Y)K^CVBC_ (EN\)?^A'C_ /P_9S_\V>7Y]V'_ !._](K_ **S*?\
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ML\OS[L/^)W_I%?\ 1693_P"(EPU_\[/+\^[/YPO^'(OQ9_Z+I\//_"8\2?\
MR31_PY%^+/\ T73X>?\ A,>)/_DFOZ/:*/\ B6[PE_Z$>/\ _#]G/_S9Y?GW
M8?\ $[_TBO\ HK,I_P#$2X:_^=GE^?=G\X7_  Y%^+/_ $73X>?^$QXD_P#D
MFC_AR+\6?^BZ?#S_ ,)CQ)_\DU_1[11_Q+=X2_\ 0CQ__A^SG_YL\OS[L/\
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M%_PY%^+/_1=/AY_X3'B3_P"2:/\ AR+\6?\ HNGP\_\ "8\2?_)-?T>T4?\
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ML\OS[L/^)W_I%?\ 1693_P"(EPU_\[/+\^[/YPO^'(OQ9_Z+I\//_"8\2?\
MR31_PY%^+/\ T73X>?\ A,>)/_DFOZ/:*/\ B6[PE_Z$>/\ _#]G/_S9Y?GW
M8?\ $[_TBO\ HK,I_P#$2X:_^=GE^?=G\X7_  Y%^+/_ $73X>?^$QXD_P#D
MFC_AR+\6?^BZ?#S_ ,)CQ)_\DU_1[11_Q+=X2_\ 0CQ__A^SG_YL\OS[L/\
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M%_PY%^+/_1=/AY_X3'B3_P"2:/\ AR+\6?\ HNGP\_\ "8\2?_)-?T>T4?\
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M  F/$G_R31_PY%^+/_1=/AY_X3'B3_Y)K^CVBC_B6[PE_P"A'C__  _9S_\
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M_G"_X<B_%G_HNGP\_P#"8\2?_)-'_#D7XL_]%T^'G_A,>)/_ ))K[/\ CO\
M\%LOV%_V?_BG\0/A?XAU7XT^/8_@K?6^F?M$_%+X+? 3XG_%WX)_LW:E.J32
MZ=\;OBEX*T'4_#?A'4=,M9%N]?TZVGU>^\-PB5-?M]-N;>YMX?U'\%>-/"/Q
M'\(>&?'_ ( \2Z'XS\$>--"TOQ/X2\6>&M2M-9\/^)/#VM6<6H:3K6C:K8RS
M6>H:;J-E/#<VEW;2R130R*Z,0:/^);O"7_H1X_\ \/V<_P#S9Y?GW8?\3O\
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M  F/$G_R31_PY%^+/_1=/AY_X3'B3_Y)K^CVBC_B6[PE_P"A'C__  _9S_\
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MGW9^F+Z4?C_9?\9Y@ME_S1G"OE_U+_7^FS\HO^'-/CC_ *.1^$G_ (*M7_\
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M^$G_ (*M7_\ D^OU=V)_=7_OD?X4;$_NK_WR/\*/^(*>%G_1,XK_ ,2'//\
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M=V)_=7_OD?X4;$_NK_WR/\*/^(*>%G_1,XK_ ,2'//\ YK\OS[L/^)H_'_\
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MD?X4;$_NK_WR/\*/^(*>%G_1,XK_ ,2'//\ YK\OS[L/^)H_'_\ Z+S ]/\
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M .B\P/3_ )HSA;R_ZE_D_P"FS\HO^'-/CC_HY'X2?^"K5_\ Y/H_X<T^./\
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M!EZY_P @76/^P7J'_I)-7\$TO^NG_P"N\_\ Z->O[V=<_P"0+K'_ &"]0_\
M22:OX)I?]=/_ -=Y_P#T:]?Q7]+S^+P!_P!>^*/_ $KA\_U&_9O_ .[^,'_7
M[@3_ -(XO&4445_&9_IT%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 >_\ [)__ "='^SI_V6OX;_\ J4:=7]N-?Q'?LG_\G1_LZ?\
M9:_AO_ZE&G5_;C7]U?1)_P"2<XN_['F"_P#5>C_)?]HQ_P EKX<?]DKFG_JX
M"BBBOZV/\YPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_'/]G2:+:I8VUH-), L38QBS\D6_R  _:RBBB@ HHHH **** "BBB@ HHHH
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M]O@X>_GBA_X7%\1-.#L"?LMI+8_#?1M1B4HSWGQ$TYCYEO\ +_59_P %HO\
M@FAHW_!5+]AOQO\ LY07>@^'_BKI>MZ%\1/@9XYU^*4Z?X0^(_AZX>W+ZC/:
M6MWJ$>A^)/"VH^(O"NM):12.MOJ\6H+!-<Z;:J/MC]DC]F;X=?L;?LT_!7]E
M[X462V?@3X*> -"\$:1(8EBNM8N=/MQ)KGBC5 A99-;\6Z_/JGB;7)@Q\_5]
M6O90<.  #Z*KX^_;E_9F^(W[6OP$U+X._"S]J?XQ?L=>++[Q-X;UZ'XT_ N]
MFL/'UC8Z%=2W%[X>M[FWU?0YUTO7TD6#4ECU&$O'%&K++'OB;[!HH _DK\-?
M\&P_QF\&_&+QW^T+X3_X+9?MX>&_CK\4-(T_0/B-\7]%A&F_$;QSHFE1Z7#I
MFD^*O%UK\1(M;US3["+0]'CM+34+R>&W32[%8T46T07]H_VTO^"6/[/W_!0/
M]DWX??LP_M1:QXW\9:[\+M'\*S^!OVB=+U2#1?C=X:^)7AGP[9:%<?%/2O$$
MMOJ=LNN^*9;1]0\6:5J%MJ6C:U+<EKBW-]9:5J5A^F-% '\NNG?\&UVL?%7Q
M#\/=(_;Z_P""H_[9W[=/[/'PJUK3]:\(_LY?$#5[KPSX/U:?1X8(]*A\>:M_
MPF'BO4?$$$,:SV-U<:?!H?B"XTV0VMGXATN*:XBD_IDM_!?A&T\'0?#RV\,:
M##X#MO#,7@N#P:FE60\,1>$8=+70XO#"Z(83IPT%-&5=*72C;FR_L\"T\GR/
MDKIJ* /Y?M:_X-M=3^%_BGXBVW_!/O\ X*>?MC_L$? ;XM:W?:YXR_9S^&^J
MW?B7P'I=WJT=Q'J:^ +P^,/">H^&H9(WALK.2^77-;M-.3[%)K]W:06=K!^N
MG_!-_P#X)E?LT_\ !+[X+ZC\)/V?+#Q%JNJ>,-:3Q;\6?BSX_P!3AU[XF_%O
MQIY,D1\0>+]9@M+&U$-HL]U'HNB:996>EZ3%=7DJ0W&JZCJ^J:E^AM% 'Q#\
M./V%_A]X,_;-^-_[<_BKQ;XN^*_QJ^*/ACPU\-?A]<>.SIEQI/[.GP<T.QM)
MM4^%OP<LK"SM8]%T7QGXNCN_&?C#59TEUW7=2GMK:]OIH+25[WS7]MC_ ()Y
M2?M,?%+X,?M0_ _X[>*?V3?VROV?=.\1>&/AU\>O"WA3P_\ $72M8^&_C#,G
MBOX3?%3X7^+)K;P]\0/ .KWH35+2VEO=*UCP[K/F:KH>JVMQ-.LOZ444 ?FU
M^P__ ,$])?V6_B/\<_VD_C-\>O%_[6'[8/[22^%M,^*GQW\7^%O#G@#3+#P1
MX%@G@\&?"_X6_#/PF9M"^'OP_P!!:YGNY-.@U#5M2US5#'JFM:G=7$, B_26
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X)?_ %DO
M_7:;_P!&O3:<_P#K)?\ KM-_Z->FU^42W?J_S/Z'CLO1?D%%%%(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6QX=_Y&#0?^PUI7_I?;UC
MUL>'?^1@T'_L-:5_Z7V]:T/X]'_K[3_]+B8XC_=Z_P#UYJ_^D2/N"BBBOU,_
MGT*A?[Q_#^0J:H7^\?P_D* )J*** ,O7/^0+K'_8+U#_ -))J_@FE_UT_P#U
MWG_]&O7][.N?\@76/^P7J'_I)-7\$TO^NG_Z[S_^C7K^*_I>?Q> /^O?%'_I
M7#Y_J-^S?_W?Q@_Z_<"?^D<7C****_C,_P!.@HHHH *_0[X-_P#!,S]H7XY?
M"_PC\7/!^L_#.S\+>-;*XO\ 2(M?\0:K8ZI'#;:C>Z7(MY;P:'=012FXL)V5
M8[F4&(HQ()*K^>-?M3\:[N:S_P""-G[,<L%W<6;GQUH:>;;7,UK(5;Q#\2B4
M\V!XWVMMRR[MK8&0<"OT?PZR/A_-GQAC>(\'C,PP7#7!^.XAI8/ YC_9=7$8
MC"YCE>&C3EC/JV+]G3E2Q=:[]A4M+EEROEL_Q'QKXKXPX=7AKE7!69Y9DV9\
M<^)65<&XC,\UR;^WJ&#P689-GV-G6AEWU[+G6K0Q&78=I+%TKPYX<RYKKP'Q
MQ_P2?_:V\&>&=2\36.G^!_'J:3!)=76A>"/$=S?^(YK>)"\C:;INH:5IR:G<
M!062PM;DWL^TK:PSS%(G_->2.2&26&:*6">"62">">-X9X)X7:*:">&55DAF
MAE1XIHI%62*161U5E('WM_P39\6?%J']K[X4:9\/];\2W>GZMJEU!\0M,2_U
M*_T6X\!1Z?=2:W=:Y:233621V)2VFTR]N$26WU;[$EM*))O+D[C]ICX!W7QX
M_P""D?Q/^#GP2ATZ*[\2>)[._P!<O9-RZ'X:OU\-Z1J7Q!UW4?LP++;:?J$\
M\]W;VX:XN]:NC81*+NYVKZ&:<*Y'GW"^4\4<$Y5G678C&\6QX-EP]CL?2SJ6
M/Q^(P"Q^#Q64X^&"RZI4OKAL9AZM"2I59T91JPAS<_BY!XA<5<(\?<0\ ^*7
M$7"V=8/*_#JIXFPXRRC**_#$,HRC!YM_9&98#B+*:N:YS1HVTQ^78W#XN+KX
M>EB:=2A4J<CI_F=17ZT^+?@]_P $N/@KXDN_A'\2OBC\>/'GCW1IQI7B_P >
M>!H+1/"7AK6U;R[NU%K8V-U;E],E.S4+2!/$\EB\<D%S/]ICFA3YB_:[_9$O
M/V;M2\%>(?"'BVU^*?P8^+%DNH?#'X@V*V\;7\CQ03_V%JZVCR6:ZC]GNH+J
MQOK0K::G9-)((+.[M+VS@\+./#W/,GP&/S!XK(LUIY/6I8?/J&19U@\UQ>0U
MJ]98:E#-</AY<U.,\5?"/$89XK"PQ2]A4KPJ2C&7UW#7C/PGQ-F^4Y/' <6\
M/UN),/B<7PEB^+.%\RX>R[B[#83#+&UZG#^,QL5&O4A@&LPC@\=' 9A5P#>+
MHX2I1A4E#XSHK]@?&/[*O[#'[)=CX(\+_M<>-OC+XK^+OC3PO;^++S1?AE:"
MRT/PSI]S*]DRA(X1<3QVNHP7UG#=7>HSW.H/92S?V1;1%(V^</&GP&_9@NOC
M_P#L\>$O@9\9M;^)GPS^-GB/0++7].N;5=/\:_#ZRU/7[?1YM-U+4WTZTMQJ
MMPKW;6MM>Z+;7]D;0W%Q!=V5U97<^V9>&V>Y4E2Q>/X:69PQ678/&Y#2XAP%
M3/<LKYI6P]#"QQV7*2G=5<50CB(X.>,J853Y\1"G3C.<>7(_''A+B%RQ&79/
MQR\BJX'.LQROBW$<'9M0X3SW"Y!AL7B\?/*LYE!TK.A@<5/!3S*GEU+,)4O9
M8.K6JSIPG\&T5^U'Q8_8P_8/_9:\=:VO[0_Q@^($VDZS<VTGPV^%?@^<ZMXW
MA\-K96D-UXF\9:CH^CFY$-WK::I'I\2P:);I9PPK%/J=RETEMXC^TU^Q/\+-
M)^"=I^U1^R/\0]5^)OP66\2R\6Z-K.+OQ#X,+SQV<M_)=+8Z9>+;Z9J$UO9:
M[I6M:;;ZGI27=IJ*W-[822RQ=>9^$_%654,YE6K9!BL?P_3KXK.,BR_/<#C,
M_P #E^&J<E7,ZV5TY>V6"C!PQ$FF\32PU6G6Q&&HPEIYV0_2(\/N(,5PU##X
M;B_ 91QA7P> X;XLSCA/-<LX0S;.L=152AD.&SZO#ZM+-9555P<(N*P.(QV'
MKX7!X[$U(+F^<=<_9/\ $^A?LF^%OVM9_%NA3^&/%7BB+PM;>$8K'45UZTN)
M=8UC1Q=SW[M_9TD(FT::8I&N_P N:)=V]7%?*=?HCXM_9V\*:1_P3C^'W[1T
M'BCX@S^+?$'Q"M_#]UX6N_%$LWP[M;63Q'XFTPW.G^%#;"&UU 0:7#*+M;DL
M+B6YDV?O,#Z"\)?\$Z_@CXB_9O\ @'^T!XK^*NJ?"SPKKOAV3Q=\<O%7B'5M
M,GTZRTTPM!INC>"=,ETV)K;5]9U9X;:![F;5VCMTG%O8WU]):6DW96\-\XSG
M%9?AL@RC"8"=+@/ASBC'QQ.>PJT\3A\RG2H5LZGB<9##T,OA6G7ABL5@IU(X
M;+,-2K5'B)Q@SS<+XX<-\,9=F^-XQXCS'-J>(\7.-. <GJ8'A2IAZV!QF2TZ
MV+PO"\,#EE7&8K.*N'I86I@,#FM&C/&9[CL1AJ2P=.I4B?C917Z!Z=\'/V'_
M !M^T%XRTC1_VB-7^'W[.'@SP/H/B*V\3^);&[N/%_CG6D<6OB?1= EU32-/
M^SW<=S);7%K /#M[>7,$[KI6EW"6\[P_1/@#]G'_ ()J?M+:W<?"/X#?%/XT
M^#_BU<:7J%QX2U3QW:RS:'XGO--MVN[@)I^H:5:0WWEVL4US-I]K=Z!?-9Q3
MW%HDIMRK>7EWAMF^:U9X?!YWP9/%5,PQ6697A)<5Y5'$Y]B\+6>'<<FI>U<J
M]/$UTJ>!K8KZE2QKE"6'G.$XR?OYUXY\-Y!0IXS,N%?$ZE@*.49?GF?9A'P]
MS^6!X1R_,,+#&QEQ+B70C##5\%A9^VS3"Y?_ &GB,L5.M#&TZ-2C4A'\J/AO
M\/\ Q)\5_'OA3X:^#HK*?Q5XUU>'0]!AU*]&G:?)J$\<LL:7=\T<PM82D+YE
M,4F#M4(2P%7_ (L_"WQ?\$_B)XG^%GCV'3;?Q?X0N+&UUN'2-175M-CFU'2;
M#6K86VH)% MR#8ZE:M*?)C,4QDA9=T9)^[OV%/ 'PX^&_P"VS:_#WX]W'BS2
M_BIX!^(]GX;^&EGX15;SP_?_ ! TJ\U:VU(>);L6MQCPY/IR6MUITX:U\T7&
MYIE9=A[?_@J%:_LKK\6OBQ<^%M6^*5Q^T])XP\')XLT>_LO^+<IIC>%M%CN!
MH]PNFQO)>G1O[%>W07\[/?R7480\+'VQX!PZ\-<=Q9B,QP."SK \6U\GK9=C
M,SHX>K#"X3+<54KY:\OG0]O_ *P5,;A_;8;">VYJN 3JJFKJ2\J?C!C)>.64
M^'F"R;-\SX6S;P\PG$F&SG+<AQ6,HU,PS+.\NH8/.XYQ3Q7U5<'T<KQKP^.S
M!864</FSC1=9V<'^2U%?KQI?[$G[,G[.?PR\'_$#]N_XE^+]'\7_ ! M!J'A
M[X/_  \#C6K&T\J"XDAU#[%I^H:M?7]A#<P)K,ZR:/H^G7L@TZ*[OKD*\G)?
M&?\ 8B^#?B?X&:S^TU^Q5\2=<^(G@+PA]HD\?^ _%2"3Q=X8M;***?5+F!SI
M^EZBESH]K,NH:AI&K6#/-I*RZEIFIWB1B*7GK^%7%F'P6(KU%D\LSPF6_P!L
M8WA>GG."J<5X/*_8PQ,L;B<CC-XB$88:<,15P\93QM*C)2JX6%[';@_I">'>
M-S/"86D^)89%F.=OAK*^/JW#.:4?#W,\^^LSP4<LP/%4Z2P=6=7'4ZF"H8R<
M*>5XC$PE3H8^I9-_EI17ZK_LN_L"^!?VCOV4=2^+DGC#4?!OCBQ^)>HZ!J'B
M/5=6T^'P#X:\!Z!+HM[XA\0:EIEQ:PRW-Y9:%<ZG);EM:M+:2^%E]H:"U6>0
M6/"GP _X)Z>.?VE/A3\#/ 7Q2^)/CGPYXN\-^+=(U[QQ:ZNFCJ?B?I\NF7GA
M6WTZ:_\ "=OI]SI&O:9;^);..+3;6>W;4!I'EZC/YH,RH>%O$M7!Y!CZN(R'
M X?B>&4RR)8_.<-AJ^93SC%PP>'HX;"24L54J8>I4HSQ\XT7A\'1K4YU*^LE
M&L5X_P# V'S/B_*:&#XOS3&<!U>((<6_V1PQCL=A,DI<.9?/,L7BL=F$90R^
MA1QE&CB:644ZF)CC,RQ.%KTJ&%LH3G^4%%>F?&KX9:S\%_BS\1?A5K4<LNI>
M!O%6J:%%(8RKZII\<WG:#J4*$+N76-(N-/OH2H"M]J 7C%?5'[8G[,WPY_9B
M\"?L]:)!?^)[WXY^/_!D?C;XGV6HZC:R>'_#]G+:VT,5CI>EQZ?#=VDTNN37
M]A&]U>W!,6AW;X+3?N_F*?#&;SPO$N+J4:>&I<)SP]'.EBJBI3HXO%9@\LH8
M*E#EDZV,GB85OW,;)4L-B*LI*--W^[K<>\.4L=P-E]'$UL=B/$6EB\5PN\#1
M]O2Q.7X')XYYBLTQ%1SA'#9=2P%7#7Q$N9RQ&-P>'A"4ZZM\>_#KP-K7Q/\
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M:NZ321P1//\ ?-?SO_\ !OC^S?8_L)?\$IK;]HG]HK6H/#OQ(_:53QG^W/\
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MU;6/A^ZTJ\N=<.H>(_#6CZQ\=?$+_@K%_P %AO\ @F/J?@?XB_\ !7;]C_\
M9T\6_L>^,_%FD>%?%O[0G[#^M^,]4U'X%7WB*X6#3I?'/A'QGKNL76L:?'<7
M$=I T5IH%KJ3VLMCIGB75?$-WI6C:F ?U:T5^%?_  66_P""K_B?_@GO^S;^
MR'^TK\#)/A#XS^'G[0?[2'PB\#>)?&GCVQ\3^(/"UM\"_B%X4U[QC?\ Q \*
M-X2\1^'+I[Y=!TVSU;2;ZX?5+!K":21M(O'>)!O?L,?MS_\ !1;]MW]HM/B.
MG[%WAO\ 9_\ ^"76M>'/%%W\+OBG\7M<N[+]IWXO!;>TD^'GQ"T_X<IKUJW@
MOP3XS5I]3M](U_P?/>KHMS8WEOXCO%D1Y@#]MJ*Y[Q=JUSH'A3Q/KMFD,MWH
MOA[6M6M8[@.UO)<Z=IMS>0).L;QR-"\L*K*(Y$<H6"NK88?D=_P0I_X*&?&7
M_@IU^PC9?M/_ !V\,?#CPCX\N?B]\2_ $FD?"S3?$>E>%5TCP;/I$6FW*VGB
MGQ-XLU7^T)Q?S_;)3JQMY=D30VMM\R$ _9*BOQ5_:8_X*._&OX,_\%FOV!?^
M"=WAGPK\-+_X,?M3_![XF_$'Q_XHUO3/$L_Q(T?6/!>E?$Z^TRV\)ZG9>*+'
MPW::=/-X,TI+V'5O#&KW$L=S?^3=VS- 8O,?VQO^"EG[:OB+]O;6/^"8O_!+
MWX)? OQM^T#\-_@_H?QL^/\ \9_VI?%/B/1_@]\)_"WBJZT./P[H^G>%O UU
M9^,?%OB"\L/$>@7\T]E=/#:-KNGP+H][!;ZK?Z> ?OQ17XJ?L<_'7_@M-H7[
M2OAW]G__ (*%?LH?LW^)_A;XN\)^*]?TW]L#]D'QGXFM/ /@_5?#-I;7-MX:
M^(?@/XE7MWXG&H^);BZATO19=-BT@2W#O=6EKJMCI^M7&E>-?''_ (*J?M>?
MM _M??%W]A#_ ()!? 7X1_%_QW^S;)9:7^U#^U3^TIXB\2Z)^S5\&?&-_=FV
M7X=:=IG@B2#Q=X_\9V4EIJ]AJEMI%]%)8ZSHVM6<.D:E9:'JNIVX!_0A17\X
MUE_P4[_X*%_L"_&WX,?"[_@LA\$OV<K7X&?M">.;'X5?#K]N']CK6O'C_";P
MC\3]9C4^&_"?QH\$?$V2;Q/X5MO$#QW;1>*DET[3+6""XO(=/U"PTO7[K1OZ
M.: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'?VA/C;
MX9_9M^!WQ5^/WC71?&'B'P;\'? WB#XB>+=*\ Z&/$WC";PSX6L)=5UZ?0]!
M-Y8?VI<Z?I=O=:C):K=PNUK:3M&6=51O8JS]6TG3->TK4]#UJPM=4T?6=/O=
M)U;3+Z%+BRU'3-1MI+._L+RWD#1SVMW:S2V]Q#(K)+%(Z."K$4 ?//['W[6G
MP9_;E_9S^&G[4GP UF_UKX5_%33-0U#P]-K-BFE:]8SZ/K6H^'=:T;Q!I"75
MZ-*UK2-:TF_L+ZR^U3JLD(EAFGMIH9I/3?C)\6_ OP#^$OQ+^-WQ/UA/#_PZ
M^$G@7Q3\1?&VLNHD.G^&/!^C7FNZQ/#"70W5V+*QF2SLXV$U[=M#:0!IID4_
MS"?\$#[_ %+]@C]N'_@I'_P11\:ZA<Q^'OA;\1;K]JO]D(ZK-B36/@5\26TA
M-5TW3&F9FN?[&T_5/A[>W=O:RRJ/$-QX[N=B_9[IQZ5_P<V_&3QMXQ^"/[,G
M_!+?X&W[I\<_^"F?Q]\(?"Z:*SDS<:+\&?"?B+0=6\<:]J,4/^DPZ,^OW?A*
M+5)"88;KPO8^,(WD>*VN(F /W*_8D_;'^%W[?'[./@C]J7X+:'\1=$^%OQ&N
M/$*>#C\3_"J>#O$>LV'AO7M0\-W>N0:,FIZL/[$O=5TO4(](O_M974;>W-W"
M@@DB=_K"ORL_:C_:B_9B_P""'_\ P3[^'MUJNA:SJW@KX1^&?AY^SU\ ?A!X
M-A@;QU\7O'5KH2Z-X-\$>'+<K)&=8UJ#1K[7_$>KO#=&RL;76M7^RZI?BVTV
M_P#A73/C5_P<X>*?"=O\?]-_94_X)K>#?#%W86_B&P_8T\8>/_C/-^T=+H-S
M90ZBNA:I\3[2_M/A3I7C\Q[K(6]Z-/T^QOIA;ZKI=M<03PP@']'M%?E-^Q1_
MP5'\%?MT?L<_&CX^>!O!6K_"SXW?L\VGQ*\'_'C]GGXCB27Q-\'/C=\.?#VI
MZE?>#_$GV8:7<ZKH%Y>6/F:5K4$&DS:E8I>V<]MI.N:;JNG:?^*O[$__  7<
M_P""F_\ P4J_9]\":'^PU^QI\%/B1^U+IVE^(]3_ &G/C+\0;SQO\,OV,_@5
M?7'B[7[3X<^ =)2]\4:IXW^(?Q(\0>!K+1_$^MZ+HGBUDT%-4M[EHKRSEO$T
MH _L#KY \+_MT_LX>,?VS_B5^P%H/BS5;G]IKX2_"_1OC#XW\'R^%M?MM(T_
MP)KQ\*C3M2MO%LUBGA[4+J3_ (33PZ9=.L[^6]A%ZWF1#[//Y?X^?\$OO^"L
M/[;/Q2_;C^/_ /P2_P#^"E?P(^%'PC_:V^%/PS3XO> ?%GP:O-<D^&WQ'\'+
M+H<=QBUU;7?%#2^?:>*-%US1M<TO6;>&[LK?Q#I&K:%H>N:(T5W^%WPAUK_@
MN+'_ ,'"?[8]_P" _!W_  3IN/VZ7_8X\#Q?$[1/$NI_&N/]G.'X,I<?!0>&
MKKP;<V>M1^.W^(,RIX)_M:/4;V72$$_B$P0I"EH8P#^O;_@H'_P4E^'/_!/7
M5OV4=(^('PW^(7Q!F_:S_:"\-_L\^%)O 8T(Q>%/$'B6YTZUMO$'BC^VM2T]
MO[#MVU&-IQIJW=\5BE\NW8A0:WQO_P""F'PQ^!G_  44_9+_ ."<.O?#WQ[K
M/Q)_:[\%>-?&_@_Q]I$GAX>!O"]CX(T?QWK-]9^)8[S5;?7WN[N#P%J$5J=+
MTR\A$M]8^;(J^>8OCW_@K!_P41_:)_8-T[_@E]IUA\/_ ($>+O&_[5/[5'PE
M^ OQO7Q5H/BKQ!H'A6?Q+!X;@\8:K\)I;3Q3H%[IMY::OJ&ICP[J7B ZVL=E
M%9->Z?<2B7=\2_\ !0O_ )6EO^")O_9O_P"T#_Z@O[1E ']85%?F;_P4._:1
M_;]^#=S\(/AU^P!^Q3I_[3WQ%^+USXLBU7XE?$+Q]8>!O@3\"K3PO;Z5/'?_
M !.FAN[3Q'J$WB$:I(?#^G:9>:5_:']D:G;VEY>:BD.GR?CY\6_^"H__  6B
M_P""7Y^'_P 9?^"JW[,7[(/Q#_8V\6>.] \%?$7XK?L7^(/B-'XT^!5QXNG^
MSZ7J?B'P_P".]4U9/$6E6,XDAC@L]*MH-9N8H]*7Q;8ZOJ.D6VH@']$7[7/[
M6?P1_8>^ /CC]IG]HGQ%J/A7X1?#LZ OBC7-*\/ZQXHO[1O$WB+2O"NCK;Z'
MH-K>ZI>M<ZWK6GVS?9K9Q"DK3RE(8Y'7V3X?>.?#GQ/\!>"/B7X.NY=0\(_$
M/PAX:\<^%;^>UN+&:]\.>+=&LM?T.[FLKM(KJSEN=,U"UFDM;F*.XMW<Q3(D
MB,H_EX_X.LO$O[5_B#_@F#XNUCX%P?L_ZY^Q?XG\,^ ]<_:#\2^+;KQ>OQG\
MW4/BW\++_P"#]W\%H=.NH/"MSI6IZC<12^+#XDL[B[329 ^FB*02,/T-_P""
M,>J_\%-;C]GWP G[<^@?L?:)\$K+]G']GYOV:-0_9VOOB7/X\OO#Z^";8/)\
M8%\<ZE>:';ZA'X2C\*S,WAF*VM/[9EUK ^QK:J@!^U-%?RVW?_!8/_@HU_P4
M+^-OQD^&?_!$G]F;X%>,?@7\!/%%SX#\:_MI_M9Z]XITWX4^-/&^GR.FH:/\
M*]!\(:EI&H:I9HC0W^G:DLWB6ZO=$FLM;U71O#5EK6AMJ'LO['?_  6$_:@\
M.?MK^'/^":__  5M_9K\$_LR_M,?$_0YM=_9X^+GP?\ $&HZ]^SO^T"ELEU+
M-HGARYUS4M:U#0M>F2RNK;38)_$&I2W>LVDN@:OIGAG6+W0;/6P#^BVBOYIO
MVZ/^"YOQ-_8G_P""IVJ_L43?!;3?C)X&UK]D/PY\1_@C\._AQX9\6:G^T3\:
M?VHO'/CJY\)^"?A/H>K6VO7OA;2_"5_:66H:QKNJW/@>YNO#^D:5J>KO>WOD
M1:9<?J?_ ,$Y_B3_ ,%%/BK\+_&WB_\ X*-? +X/?LW^/=0\<B?X6?#3X3^+
M9?&=UI7PPN?#^CW-O%\0];7Q1XITVY\:VNORZO97CZ3-I=E):P6[#2+1]QD
M/T*HK\C?^"X'[?'Q<_X)I_\ !/?XB_M8_!#PY\/O%?Q!\(^-?A=X<T[1OB=I
MOB#5O",UEXV\::;X<U26\LO#'B3PGJ\ES;V5Y)+8M#K=O%'<JCSQ7$8:%OTO
M^$7BW4?'WPH^&'CK5X+.VU;QI\//!7BW5+;3DFCT^WU'Q'X;TW6+V"QCN)KB
MX2SBN;R6.V2>XGF6%466:5PSL >AT5^+7_!+_P#X*-_&;]M/]IW_ (*L?!GX
MK>&?AIX<\)?L+_M/6_P7^%VI^"--\2:?K6O>%)-6^*-E+J7CZYUWQ/KUA?ZT
MEMX)TJ7[3H5AX>L5DN-0SI[(T'D_"WPG_P""D?\ P63_ ."G?_"R_C)_P2T^
M"_[#?PQ_8^\"_%+Q?\,? 7Q%_;(\1?%#7?B/\<;_ ,"75O;ZKKNE>&OA7?0V
M7@K0-0:XB$5GK-K-=6YG6*WUZ^FMKS[. ?U'45^6W['7[8/[6;_ ;]HCX@_\
M%2_V;_!_[&.M?LOWNL3>+?B'X8\=Q>+/@M\3? /ASPF?%^O_ !4^'[RW&H^(
M=+\,:5IZ^1<6NIWNKW$UZ9+"WN3K%CJVCZ9^;OPC_P""@O\ P6J_X*7:'?\
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M\3O@AJ7B2W_X1;Q?KOPZ^)?PY^(?AF_\!_%SX/\ Q)\,S+#KWP^^*GP_U?\
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MA5XF?PK'\>/VG_B3XA\1>(K*">YUM6T2ST?PS<>%Y?%.K0W4&G6NDS+86NJ
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M1\4^'K/Q-I]_=S^:;>V$6EWL<EZ7E"VKQS)*RF)\?C+_ ,$X/^"MOC#]J?\
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MQV7HOR"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\+/^"C_Q<\$> --^%OQ'\$?#7]H;P-H,5O;^'+#XMZ.^J:KH=M:1F*SM(=7
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MX9\)/I>N^)O#VD6%HH>8WG@?1-;TJTTNUC9[Q)DT^"&1IDB;\)?^"0/[/_\
MP5A_:(_X)Q_LK>/?V4/^"TGPJ^'7P:L?AII7@K1OA/:?L,?"KQO?_"#5/!@;
M0]:^&GB'Q)?>*[35-5U[PU>VS)=ZIJUG:7VMV]S:>(/+DM=6M;F?^SIT21&C
MD571U9'1U#(Z,"K*RL"&5@2&4@@@D$8-?S_^-O\ @W^^&'ACXM?$#XN?L'?M
MC_M=_P#!-VX^+VK3:Y\5OAM^S'XUTRV^#/BG6KID-SKFF_#K7M/GL?"VL2 W
M'V>72;W^S-*,X31-)TRVC%LP!\O>!O\ @FQ^T_XU_P""IG[(_P 7OVN/^"Q_
MP._:1_:&_8GL?$?Q#T?]G[PU^SQ\.O@]\6[GX3?$O3+OPYX@;4=-\'?$AM=/
MA?6)Q;+!JVL>'-5T^P#W*6Z0G66DFYC_ ()CZ5I=Q_P<P?\ !<O69].LIM7T
MSX>_!"PTW5);:)[^PL=6T3X<S:I:6=TRF6WM]1ETK3)+V*)E6X?3[,RAO(3'
M[+_L"?\ !*;]FK_@G[J?C_XB>#-2^)?QL_:0^,'E'XP_M4_M#^+Y?B1\=?B#
M'&UO,-*N_$]Q:V=OHGAP7-K;7']A:#86,%W)::<^KS:K+I>G2VNS^S__ ,$U
M?A-^SO\ MW?M?_M^>%_'/Q"UKXE?MDZ3X,TCQYX/UZ;P\_@?PQ#X)LM)L;"7
MPE'8:'9:Y')=QZ/;O=C5]7U--\DY@6(,H4 _''_@[3CC_P"&-/V,[K8HN;7_
M (*-? ,VUP!B: OX7^)6\PR#YHRVQ,E2"=J\\56_X.3)X+;]H[_@@Q/<S0V\
M$/\ P4Y^'LDT]Q*D,$,:>+?A47DEFE98XHT'+N[*J@$L0 37[/\ _!23_@F]
M\*O^"FOPJ^%_PE^+?CCX@>!-$^%?QR\&?'C1M1^'<OA^'5-0\1^"=/U_3K#2
M-3;Q%HNN6K:+=P>(;M[M;:WM[X2PV[07<05U?&_X*@_\$M/V?/\ @JS\$O#/
MP?\ CGK'CWP5J/P]\:V_Q$^&'Q-^&.KVFD>-/ OBV"PNM+FN;/\ M.PU32=2
MTS4K"Z:'4=-O[!F::VL+^PN]/U&PM;N, YG_ (+A?\HA?^"BO_9J7Q7_ /3!
M-7\N_P#P4#_Y4W/V/?\ L7/V4_\ U-M0K^B_X-?\$3?AA\*_V//VM?V1?$W[
M6/[9'QXL?VRO!L7@SXH?%'XZ_%2Q^(7C7P]96^@:CX=MYOAO!JWA^31_#)33
M]3D2:*^MM=:^%EI4=]/<1:;;(OK'BW_@D1^S1\0_^"8'AK_@E1X_U?X@>)O@
M;X2^'WA3P1H'C=M3T?3?B?INH>!M:A\1>%/&EKJ5CHJ>'X_$.EZS;0320-H$
MFC:A9FYTN^TV>QO+B)P#YN_X*U?\%&/B5_P3?_X)O? GXA? [0O"FK?&KXX^
M(_@9^SO\+-?\?K._PZ\ ^(?'_@VZU!_B!XQ2!HUO-.\/Z9X?O'L]/GGBM9]1
MN+6[ODO-,L;^QNL.7_@FU_P49\/> ]0^)7Q*_P""]7[2&A?$C2/"][XF\9Z[
M8?!#]G"Q_9X\/2Z?I\VK:[-%\.==\*%4\%Z/$EZ&O-0\16%[)I-NE[=R64B&
M&*?X2_\ !O?^SKX>_9:^._[)/[1G[27[6W[9GPS^.-M\-[>V'Q]^)MOK%Y\%
M+CX1#Q&/A_K7P&:#26;X>:[I*^)KR&^N(9M0TO7+&VLM'U31KC0EN=+NL#X:
M_P#!OYHMCI?A[X:?M(_\%'O^"A'[7'[,?A"738M#_98^*/QA71OA)KVA:(;9
M=&\(_%)/"UG9^(?B)X1T^WM8+5?"\NKZ%X?FMXUM9M,:R+VK@'S+_P &AD\E
MS_P2L^+4KZG'K0?]M?\ :!=-6MX1;VNIB7P7\)96U"TMD)CMK>^DD>[BMX_D
MB$^T=,G9_P"#1F>"3_@FY\<88YX9)K?]OG]H87$*2QO+ 9?#'PF>(31JQ>(R
M)\\8D5=Z?.N5YK];?^">'_!+WX)_\$T-0_:<M?V?O&'Q%G^'/[1_Q<'Q?M/A
M'XGU'2;CP%\&=4FAU*&_T'X6Z;I>E:8=,T*]COK2R==0-]J']D^'O#6G3WUR
M-)2>7\W?"/\ P;)_LL_#7]H_Q+\:_A#^U?\ MR_!CX<>*?BQIGQKU3]FKX4_
M&BT\'_"FZ\<Z5KT7B.SAU VGAR76=7\,6>I1A--TO5+F[UC3[ 1Z?%XC>VAB
M50#YC_X)X:WH7P5_X.<O^"O?PY^.=S;:'\7?VBO /PR\9_LXZEXBF2WE\:_#
M#3-,T#6=4\/>#;RY;;J,D6BQZ \NEV$CR%/AOKZF -X=O$M_T_\ ^#AWXK_"
M#X6?\$?/VV$^+^IZ+;V_Q%^%.H?#+X?Z)JD\"WOBCXI^*KJTA\"6&@V4I,U]
MJFC:W!;^+7-K')+IFF^';_6I#%!ITLT?L_\ P4;_ ."1W[*?_!2ZT\#Z]\6D
M\=_#/XY?"=Y)OA#^TK\#_$O_  @GQK^';&:6\BL=.\2)9WUOJFA0ZG(=5M](
MUBRNUTW46N+[0;K1KZ]O;JX^&?@__P &Y?P)M/C1X%^.7[:O[6?[7G_!2'Q%
M\)[ZWU'X5>$/VK_B,_B?X8>$;ZRG:>QO[GP9MNSXAN;:2.SE>TU+51X=U">S
MB;5M U"$100@'X8?\%.OAMXW\"_\&^W_  0=^&WQGTJ<^*+;X_\ [*5EXC\.
M^(H//GM=$U[P'X^U'1?#.MV-WYFU].\(ZII.B7^EW29MOLTNGW$,9B>%?[\X
M((+6"&VMH8K>VMXHX+>W@C2&"""%!'%##%&%CBBBC54CC151$4*H"@"OSK_X
M*0?\$UOA-_P4P^'GP;^''Q9\;_$'P'I/P5^.?A'X\^'KSX<R^'H+[4O$7@ZP
MUC3K'1M6_P"$AT37+8Z'<P:S<-<I9P6M\)(H&@NX@K*WZ,T <OXXL+G5?!7B
M_2[-/,O-2\+^(+"TCY.^YO-)N[>!,#D[I9$7CGGBOYB/^#0;Q#I-Q_P2Q\6>
M!([VU;Q1\,?VN/C?X<\7:2ES"][IM[?6?@S6[&6YM%;[3:V][:WS):27$:"Y
MDLKP1%O(D"?U/U_-_P#$G_@VW^"%W^TA\6?V@_V7_P!M']MO]A>U_:!UG4]?
M^.'PP_9>^*%MX+\(>+]3UN\O-0UN71W&G->>'H=2U#4=2ODL+T>(]-T6?4KZ
M'PW9:+ITR6$0!\A?M=_&KX8_$O\ X.Q?^"8_P^\!^+M+\5>*?@=\ ?C%X3^*
MECHTZ7T7@[Q7K_P^^./BNR\+ZK=0,\$/B"#PY?:;J^IZ5N^TZ9::KIWVQ8I;
M@Q1_HE^W3_P2/\%?MB_M0ZE^V9^Q?^VKXY_8M_X*!?"WP]IOPH\>?$KX-ZMH
M_C;1-8L8-&MM6\->#_CM\+QK%C(]W_8%_HKQVVH7]E'JWA9=#.JZ!KEO8Z)<
M6?2Z/_P;^_L-^ ?''[%/Q)^"M[\7O@SX\_8H^*'B;XJZ-XP\*^-+?4?%?QU\
M0^/;_0[_ .(DO[0OB?Q'H^J^(/'MWXW_ +"ATW6-1MM2T6:/0-0U7PY9QP:#
M<6^G6<O[5'_!##X,?&O]H3Q7^US^SK^TK^U9^P+^TU\0I(9_B=\1/V6/B==>
M'-#^*=Y;VYM(=0^(7@;4X[O3-7OEM]L4LFF7NB6][M:;4;6\NI9;AP#Y!_9N
M_;Y_X*=?L;_\%(_V=?\ @F+_ ,%.M1^ W[2VE_M7>%/&6K? ']J+X$:1>>#O
M&*7/@30=5U6Z3XJ^ %L-*TJ&WNSH-SIM[/IOA_2X[&^O8=3M=?\ $=C;ZG%8
M?C=_P13_ &?_ /@I1XC^+W_!3O\ 9Y_9]_X*2^#?V*OC%\*OVS_B%XD^-WP:
M\9_LL^!?C;XV\;W/B+4KK3;'XPV_B+Q?KVD:O+X8U6YTN;38(K"&]TRW9]/U
MAKE!XLL&O/Z<OV)/^"*7P8_9/_:(OOVR?BI\?/VD/VWOVOY?#E[X/T#X[_M2
M^.E\7:G\/_"^I6?V#4=(^'>@6MK;V'AP7UE+?V$EY<7&JW=IIFJ:MINDRZ;9
MZMJ\>H;O[;W_  1C_9[_ &O_ (V:%^UAX(^)?QO_ &-_VR?#NEPZ';_M.?LL
M^,(O OCCQ)H5O%;VL&B?$/3IK*]T?QK806%M%IL4UW#9ZLVFPVFE76J76DV%
MCI]N ?D/^WY_P2^_X*%_M!?"#0_V8_V]/^"]7[/-O\./CMX^\*Z%X)\)>-/V
M.OA#\*]6\<_$KPWJ=OXG\+Z-X%URU^)V@:]<^)8[ZPA9-/\ #]V;Z^MYGTQH
MY8M1-O/_ %F> /#U_P"$? G@KPGJNL/XAU3PQX2\.>'M2U^2%K9]<O\ 1='L
M]-O-8>W>:Y>!]3N+:2]:%KB=HFG*--*5+M^.W[-O_!#[X.?#+X^^$_VK_P!J
M;]HK]I3_ (*'?M'?#@$_";QM^U?XQM/$?A3X/W):&7^U?AK\-=+L;3PWH>NI
M=0K>6VJWK:O+IM\EOJ6DQV&JVEM?Q_MM0 4444 %%%% !1110 4444 %%%%
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M^._&7_!./PMX=\ 7%C<JCOXM\0_LRV.F^%9K.\BD559M8O+![>YCE"J2DJ2
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M3=>/M.-_822H[6EX=/U"_L3<P&.8V=[=VV_R;B5'_K(K\Y;_ /X)J?";4/\
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MX0?%KPMXBT'R/$VE^#/B--K$?A:[U7Q)::Q8:GKOAG4K*V>54M#;OK4,TO\
M4C7YN?\ !/\ _P""6?[,_P#P3O@\?>(OAI+\0/BG\=OC%<VM_P#&O]IWX\^+
M)OB-\>/BI=VJQ&.#7_%]W;6D=AH<5S$+R+P_H5CINGR70ANM174;VVM[N/\
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MVAN]4AU/5I]$U3Q%]CTZSUV;7=7\0S:'%<:1H_A_3M4U\ ']<G[7O[67P?\
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M32/ _P 0=5ETI;+5+^'Q!83Z_P"&3=:AY%G917<26:)#XK_P;3:5I:_M7?\
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MA=INMZ3X,UOX$7ZZ5*/ U[:V&NW=GK$-R=<TK7[%1IFI:9)I4UW8W.5\//\
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M9I^*$T/PF\<^*=;GCNM8\3W_ ,/->6:&SUS4;I7N9GL=8BTF">1GL='M, 4
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M^U%^TQXV;Q]\5-9\/PWD-^OAG2+I;2RLO#_A^6YL],>[@@ANM2U!='T:VO\
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M_P""1?\ P49\<?L8?&+XX>)]5U/XOP?#6\\/?&O]F/XM?$/1-<NK/Q1>^*O
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M%Q!;^=^RE\=K>$SS1PB:XET3]H4101&5E$D\Q!6*%-TDK?+&K-Q7ZK_L,_\
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M^H?L\_\ !/OXHZ[_ ,%;/A=^T3^T)_P6#^&_[7'[4?[%7PR\2>&_%GP$\+?
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MN+2_TC6+-9?[)\4>%M=T^6VU?PQXKT22>672=?T>[M;^U\VXMFDEL;N\M;@
M_)J__8;_ ."T>DZ;>ZUJG_!>'0--T?3+&YU34=6U#_@GS^SY9Z98:99V[W=W
MJ%[?7'BN.UM;&UM8Y+FYNYY8[>"WC>:61(U9ATO_  0R_8R\+?LQ_#/]I3XO
M>!OVY? W[>/AG]LSX[:E\>;[XI?#+PAX4\'^ XOB#.-2TSXA3:-8^"?%?BCP
MT+G5]9,(U*STW^RX])DTF&P-D#&-GC _X-R_ &J>&[?X+^._^"E/_!4+XA_L
MB69-K!^RCXD_:0M5^'EWX9665K;P'K6K:=X2L_$&H^!K.%H;2TT."?3Y8+:
M+%?H\CR5^\?P2^"'PE_9O^%?@KX(_ SP%X=^&/PI^'>C0Z#X.\$^%K(66D:/
MI\3R32;0S27-Y?WUW-<:CJVK:A<7>JZSJEU>:IJM[>:A=W-S* >J4444 %%%
M% !1110!\$O_ *R7_KM-_P"C7IM.?_62_P#7:;_T:]-K\HEN_5_F?T/'9>B_
M(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME<T_]7 4445_6Q_G.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7^\?P_D*FJ%_O'\/Y"@":BBB@#+US_D"ZQ_V"]0_]))J_@FE_P!=/_UWG_\
M1KU_>SKG_(%UC_L%ZA_Z235_!-+_ *Z?_KO/_P"C7K^*_I>?Q> /^O?%'_I7
M#Y_J-^S?_P!W\8/^OW G_I'%XRBBBOXS/].@HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#W_\ 9/\ ^3H_V=/^RU_#?_U*-.K^W&OX
MCOV3_P#DZ/\ 9T_[+7\-_P#U*-.K^W&O[J^B3_R3G%W_ &/,%_ZKT?Y+_M&/
M^2U\./\ LE<T_P#5P%%%%?UL?YSA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?QU_LQ_\ !P%_
MP44_;7\#?$'X,_LB?L7_  N^.G[<GASX]_%CPSKEU:/XK\!?LO\ [/\ ^S_X
M4N-$T3X?^//C+XF\5^.);O6OB'X_\2_\)A::%X.\/>+M%?4M+\,WVLPV48LO
M[-U'^Q2OY-O^#2/3M/A_9F_;^U2&QLXM3O\ _@HS\8;2^U&.VB2^O;33O"?@
M:33K6ZNU03SVUA)J&H264$CM%;27]Z\*HUU.7 /OK]M7_@JC\:OV0?#G['?[
M+'A3X#:%^TO_ ,%9OVLO!/AN32?V=_ NORZ+\*/">O6&B6X^*/Q)\8^+[N66
M[T3X1^'?$=IXECT&6:Y@N-:TOP_K5W=ZYH^GZ%J>K1?./Q)_:>_X.(?V)O -
M_P#M/?M,_ 3]@']K'X#>$-+/B_XW?"']D;5/C/X1^/?PP\#V AN_%&N^#K_X
MBM>^&?'4?A'11>ZIJMC!::Q?72V%R]L]OID<NJP?G)_P4&\!_M*Z'_P=#?""
M\^'W[5&D?L9ZW^TS^QI9?#_]G3X[^,?A#X6^,_AN^U30#JL/B?X/Z-H'C34=
M-T'3_$WB#7]-OIX+I;V#4TNO%&C:39PW$_C&VANOU7^)_P"R1_P5^^'7P[\:
M^./B]_P7L^%7@KX7^&?#>K:IX]\5^-OV /V?]!\):'X7AM)!J]]K^KZKXVM]
M/L=-2U>1)Y;J9(R'$8W.ZJP!]7?M,_\ !8K]G#X)?\$L+G_@JE\/HM0^,'PG
M\0^#?"VK?"KPO93)X?UGQ;XT\<:];>#]#\#Z_-/'?_\ "*ZAH/BR>[TWQ^6M
M]3N/#B>'_$/V6UU:ZL[>WN_A%?C#_P '0L7@2Q_:1L_@/_P3 \8^%]1T.#QA
M%^Q_X>\3?&BT^-O_  C5Y9OK-OH=E\1-3U:'X>77CW^S3!9DIXCN-'GU28"U
MTR7'V-NZ_9"_X)/?L=_#[_@D!I'_  3J_:&_:8\#_M/_ +-W[1/Q!U+6_A?\
M5]%U3PY\,;'Q#K'Q,UNU\??#RQ^"NHP>*?%.F7GBFS\1:/?>*?"/]BZAJZZU
M=27\!T._THWMA<?(GQ5_9+_X+-?\$:?@9X\^-G[)/_!1;PW^V-^RA^S?X#U#
MQMJG[,O[;W@Z.7Q;I?PK\ Z;-J>L:'X0^+.C7ZZM=W>D^&[!K?1M+M]?\!Z8
M4M4MM)TL3O;:5. ?9'_!4[_@L1\<_P#@G9^S;_P3L_:&\4? ?P[\/+O]I7XT
M_#;PG^T[\)?'T>L?$?QI\'/!FN>#I/&/Q"\/>#+OP'XB\+:?K7Q+\-06M]I.
MESW4.HZ->:K#';SZ3B1FC\<\8?M5_P#!S#\3?#D_[3/[//[#?['/PQ^"JQ7W
MB7P7^RG\=_%GC#4OVN_&G@:+[7>:5)XMDTKQ-X9\#>$_&VN:1':7$?@M=6T7
M5M&O[Q='O8KZ\MV-S^9?_!=O]N+PC^U;_P $VO\ @AW^WGXB\+WWPV\(^//V
MR_AE\6_&OA:[$NOR^%+?PMI'B-?'5I9NEK!/XATJTNO#NM2Z%=?8;>XUS1OL
M%RUE!->&W3^X+P=X_P# _P 0O _AWXF>!_%OA_Q7\/?%OAVP\7>&O&FA:K9Z
MCX:UOPQJEBFI6&O:=K%O*]E<:7<V$B7<=VLWE"$EG9=K8 /S<_X),_\ !4[X
M;?\ !4OX$^)/'&C^"]?^#GQO^#GBQ_AE^TC\ O%QD/B/X6?$:TAD,L,,UQ;6
M-WJ/AC6);34DT34+[3=+U.&]TG6]"U?3+/5=$O$;X6_X)W?\%>?VA?VK_P!@
M7_@IY^U/XZ^'?P5\.>//V+?B%^TUX6^&FA>"M&\8V'A+Q+9_!?X2V_COPW<^
M.K75O&6L:M>WNHZO(UIK<NAZOHD5QIJHME!I]SF:ODS_ ((5>(O#WQR_X+0?
M\%W_ -IOX#217W[,'BKQ]\-?!FD^*=&V-X1\=_$O2;W7!KWB70KR BUU9-0U
M#2?&'BJ/4+?S!<:=XXT_4GDVZM$TGRW_ ,$3/^4-W_!?K_LM7[?7_K.-G0!]
M<?LG_P#!;'_@J+_P4A^#_P  C^P1^QA\'O''CF+2M.O/VT?VA_B'>^*? /[,
MGPK\67WBJ[D/P@^$.F:[XOB\4>.O'NG?#C^Q/$/BB[M?$GBJR\-:AKEG83Z3
M="X2:#],OVS?C[_P69UK]HG7OV=_^">'[(?P#T#X?^&_#7AK6M4_;._:Y\=:
MT_PPUN^\26(NKCP_X ^'OP]G@\7WNK^&[A+C3]5N+R'6K>.YMR]WIEA:7FEW
M5_YK_P &Q.FZ=I__  1)_8R?3["RL7U&S^,&I:B]G:PVSZAJ,WQS^)$$M_>M
M$B-=7LD%O;P/=3EYFAMX(BYCAC5?E#P/\;?VY?\ @L!^W_\ M_? /X5?MJ>)
M_P#@G_\ LJ_\$^OBA;? N[\.? KPGX/U/]H_XU^-3J?BC1M3\;:WXV\=:9JI
M\$>$EU'P5KK:+%HFEE9+6ZTNQN;&ZOX=0U2@#U3X#?\ !4C_ (*%?LT_MS_
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M6I\W&I>%II]2T87MK+<:I'8V_B'PSJ>E^(O$FCZ_9ZDOYH>%?^"_?[:GQ/\
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M -@^#7?P?IEUX@FMI[J:W\-EM'CD>9--8V8CK>_X-Z_^5;']L#_N_C_U4D=
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M=Y7\I?ZL<$_]'/RO_P 13C#_ .=9_H3_ *^^*?\ T87/_P#Q8/AKY?\ 4_\
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M_9Q_\"K/_P"=Y1_P\$^"G_2/#]G'_P "K/\ ^=Y1_JQP3_T<_*__ !%.,/\
MYUA_K[XI_P#1A<__ /%@^&OE_P!3_P _P];?EYYD?_/1/^^E_P :/,C_ .>B
M?]]+_C7ZA_\ #P3X*?\ 2/#]G'_P*L__ )WE'_#P3X*?](\/V<?_  *L_P#Y
MWE'^K'!/_1S\K_\ $4XP_P#G6'^OOBG_ -&%S_\ \6#X:^7_ %/_ #_#UM^7
MGF1_\]$_[Z7_ !H\R/\ YZ)_WTO^-?J'_P /!/@I_P!(\/V<?_ JS_\ G>4?
M\/!/@I_TCP_9Q_\  JS_ /G>4?ZL<$_]'/RO_P 13C#_ .=8?Z^^*?\ T87/
M_P#Q8/AKY?\ 4_\ /\/6WY>>9'_ST3_OI?\ &CS(_P#GHG_?2_XU^H?_  \$
M^"G_ $CP_9Q_\"K/_P"=Y1_P\$^"G_2/#]G'_P "K/\ ^=Y1_JQP3_T<_*__
M !%.,/\ YUA_K[XI_P#1A<__ /%@^&OE_P!3_P _P];?EYYD?_/1/^^E_P :
M/,C_ .>B?]]+_C7ZA_\ #P3X*?\ 2/#]G'_P*L__ )WE'_#P3X*?](\/V<?_
M  *L_P#YWE'^K'!/_1S\K_\ $4XP_P#G6'^OOBG_ -&%S_\ \6#X:^7_ %/_
M #_#UM^7GF1_\]$_[Z7_ !H\R/\ YZ)_WTO^-?J'_P /!/@I_P!(\/V<?_ J
MS_\ G>4?\/!/@I_TCP_9Q_\  JS_ /G>4?ZL<$_]'/RO_P 13C#_ .=8?Z^^
M*?\ T87/_P#Q8/AKY?\ 4_\ /\/6WY>>9'_ST3_OI?\ &CS(_P#GHG_?2_XU
M^H?_  \$^"G_ $CP_9Q_\"K/_P"=Y1_P\$^"G_2/#]G'_P "K/\ ^=Y1_JQP
M3_T<_*__ !%.,/\ YUA_K[XI_P#1A<__ /%@^&OE_P!3_P _P];?EYYD?_/1
M/^^E_P :/,C_ .>B?]]+_C7ZA_\ #P3X*?\ 2/#]G'_P*L__ )WE'_#P3X*?
M](\/V<?_  *L_P#YWE'^K'!/_1S\K_\ $4XP_P#G6'^OOBG_ -&%S_\ \6#X
M:^7_ %/_ #_#UM^7GF1_\]$_[Z7_ !H\R/\ YZ)_WTO^-?J'_P /!/@I_P!(
M\/V<?_ JS_\ G>4?\/!/@I_TCP_9Q_\  JS_ /G>4?ZL<$_]'/RO_P 13C#_
M .=8?Z^^*?\ T87/_P#Q8/AKY?\ 4_\ /\/6WY>>9'_ST3_OI?\ &CS(_P#G
MHG_?2_XU^H?_  \$^"G_ $CP_9Q_\"K/_P"=Y1_P\$^"G_2/#]G'_P "K/\
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M_P 13C#_ .=8?Z^^*?\ T87/_P#Q8/AKY?\ 4_\ /\/6WY>>9'_ST3_OI?\
M&CS(_P#GHG_?2_XU^H?_  \$^"G_ $CP_9Q_\"K/_P"=Y1_P\$^"G_2/#]G'
M_P "K/\ ^=Y1_JQP3_T<_*__ !%.,/\ YUA_K[XI_P#1A<__ /%@^&OE_P!3
M_P _P];?EYYD?_/1/^^E_P :/,C_ .>B?]]+_C7ZA_\ #P3X*?\ 2/#]G'_P
M*L__ )WE'_#P3X*?](\/V<?_  *L_P#YWE'^K'!/_1S\K_\ $4XP_P#G6'^O
MOBG_ -&%S_\ \6#X:^7_ %/_ #_#UM^7GF1_\]$_[Z7_ !H\R/\ YZ)_WTO^
M-?J'_P /!/@I_P!(\/V<?_ JS_\ G>4?\/!/@I_TCP_9Q_\  JS_ /G>4?ZL
M<$_]'/RO_P 13C#_ .=8?Z^^*?\ T87/_P#Q8/AKY?\ 4_\ /\/6WY>>9'_S
MT3_OI?\ &CS(_P#GHG_?2_XU^H?_  \$^"G_ $CP_9Q_\"K/_P"=Y1_P\$^"
MG_2/#]G'_P "K/\ ^=Y1_JQP3_T<_*__ !%.,/\ YUA_K[XI_P#1A<__ /%@
M^&OE_P!3_P _P];?EYYD?_/1/^^E_P :/,C_ .>B?]]+_C7ZA_\ #P3X*?\
M2/#]G'_P*L__ )WE'_#P3X*?](\/V<?_  *L_P#YWE'^K'!/_1S\K_\ $4XP
M_P#G6'^OOBG_ -&%S_\ \6#X:^7_ %/_ #_#UM^7GF1_\]$_[Z7_ !H\R/\
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MN?\ $//"G_I('AK_ ,0'Q,\O^J;\W]WF?JO17Y4?\.\?C[_TD=_:5_[]I_\
M--1_P[Q^/O\ TD=_:5_[]I_\TU'^MG'/_1JLX_\ $IX._P#GO_5GY7/^(>>%
M/_20/#7_ (@/B9Y?]4WYO[O,_5>BORH_X=X_'W_I([^TK_W[3_YIJ/\ AWC\
M??\ I([^TK_W[3_YIJ/];..?^C59Q_XE/!W_ ,]_ZL_*Y_Q#SPI_Z2!X:_\
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M5^5'_#O'X^_])'?VE?\ OVG_ ,TU'_#O'X^_])'?VE?^_:?_ #34?ZV<<_\
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M\?C[_P!)'?VE?^_:?_--1_K9QS_T:K./_$IX._\ GO\ U9^5S_B'GA3_ -)
M\-?^(#XF>7_5-^;^[S/U7HK\J/\ AWC\??\ I([^TK_W[3_YIJ/^'>/Q]_Z2
M._M*_P#?M/\ YIJ/];..?^C59Q_XE/!W_P ]_P"K/RN?\0\\*?\ I('AK_Q
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MJ;\W]WF?JO17Y4?\.\?C[_TD=_:5_P"_:?\ S34?\.\?C[_TD=_:5_[]I_\
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M?VE?^_:?_--1_P .\?C[_P!)'?VE?^_:?_--1_K9QS_T:K./_$IX._\ GO\
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M_M*_]^T_^::C_AWC\??^DCO[2O\ W[3_ .::C_6SCG_HU6<?^)3P=_\ /?\
MJS\KG_$//"G_ *2!X:_\0'Q,\O\ JF_-_=YGZKT5^5'_  [Q^/O_ $D=_:5_
M[]I_\TU'_#O'X^_])'?VE?\ OVG_ ,TU'^MG'/\ T:K./_$IX._^>_\ 5GY7
M/^(>>%/_ $D#PU_X@/B9Y?\ 5-^;^[S/U7HK\J/^'>/Q]_Z2._M*_P#?M/\
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M %9^5S_B'GA3_P!) \-?^(#XF>7_ %3?F_N\S]5Z*_*C_AWC\??^DCO[2O\
MW[3_ .::C_AWC\??^DCO[2O_ '[3_P"::C_6SCG_ *-5G'_B4\'?_/?^K/RN
M?\0\\*?^D@>&O_$!\3/+_JF_-_=YGZKT5^5'_#O'X^_])'?VE?\ OVG_ ,TU
M'_#O'X^_])'?VE?^_:?_ #34?ZV<<_\ 1JLX_P#$IX._^>_]6?E<_P"(>>%/
M_20/#7_B ^)GE_U3?F_N\S]5Z*_*C_AWC\??^DCO[2O_ '[3_P"::C_AWC\?
M?^DCO[2O_?M/_FFH_P!;..?^C59Q_P")3P=_\]_ZL_*Y_P 0\\*?^D@>&O\
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MT_3-0L+NPO\ 3[>X7FO^'>/Q]_Z2._M*_P#?M/\ YIJ/^'>/Q]_Z2._M*_\
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MUTS3[^[33K07%]<PVL_V>VF*,M?R)?\ !J7^R;\.=9\<?\% ?^"GG@?X?3>
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M[_TD=_:5_P"_:?\ S35E_K9QS_T:K./_ !*>#O\ Y[_U9^5^C_B'GA3_ -)
M\-?^(#XF>7_5-^;^[S/N7Q5^SG\)_B%^SM?_ ++7Q,\,VWQ%^#>N?"ZU^$'B
M?PWXI"SCQ+X/M_#]OX=*:C-8I8M!J4EK:PW<6IZ8+"ZT_5(X=2TJ2QNK:VDA
M_#KX=?\ !N7\/?AGH]Q\'?#?_!1__@IIIO[';WUU/;_LC:'^T2GA?X>QZ+?7
M<][>^"I?$7A[P[I_BF/P5>S3%;W2=%NM#O;^/S#?ZM=7$\UP_P!P?\.\?C[_
M -)'?VE?^_:?_--1_P .\?C[_P!)'?VE?^_:?_--1_K9QS_T:K./_$IX._\
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MXU\$^*+%-0T/Q#HE\J^=:7ENQ5T>.1(KJRO;:2"^TV_M[74=.N;6^M;>XB_
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M:K./_$IX._\ GO\ U9^5S_B'GA3_ -) \-?^(#XF>7_5-^;^[S/U7HK\J/\
MAWC\??\ I([^TK_W[3_YIJ/^'>/Q]_Z2._M*_P#?M/\ YIJ/];..?^C59Q_X
ME/!W_P ]_P"K>ES_ (AYX4_]) \-?^(#XF>7_5-^;^[S/87_ -9+_P!=IO\
MT:]-IJ(T2)"\C3/"JP/._P#K)WA B>>3D_O)F0RR<GYW;D]2ZO/>K=U9WU7;
MRTTT\CW+):)W2T3U5UT=GJK[ZZA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6QX=_Y&#0?^PUI7_I?;UCUL>'?^1@T'_L-:5_Z7V]
M:T/X]'_K[3_]+B8XC_=Z_P#UYJ_^D2/N"BBBOU,_GT*A?[Q_#^0J:H7^\?P_
MD* )J*** ,O7/^0+K'_8+U#_ -))J_@FE_UT_P#UWG_]&O7][.N?\@76/^P7
MJ'_I)-7\$TO^NG_Z[S_^C7K^*_I>?Q> /^O?%'_I7#Y_J-^S?_W?Q@_Z_<"?
M^D<7C****_C,_P!.@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#W_]D_\ Y.C_ &=/^RU_#?\ ]2C3J_MQK^([]D__ ).C_9T_[+7\
M-_\ U*-.K^W&O[J^B3_R3G%W_8\P7_JO1_DO^T8_Y+7PX_[)7-/_ %<!1117
M];'^<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI'K'A7P_\4?B->>&]=\3Z+XFU#29K-;[[)J%_=6-Q=-]OB\+WJ3Z3I?[)?\
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M-,\0:0;DZ?K.GBXG%EJ-O<VPFE$6]NBH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#X)?_ %DO_7:;_P!&O3:<_P#K)?\ KM-_Z->FU^42W?J_
MS/Z'CLO1?D%%%%(84444 %%%<KXT\=^!OAMX=N_%_P 1_&GA/X?>$=/FM+>_
M\5>-_$6D>%?#=C<:A<):6$%YK>N7=CIMM-?74D=M9Q37*/<W#I#"KR,JD2;:
M23;;LDM6V]DEU;$VHIRDTDE=MM))+=MO1)=V=517S0/VU/V,R0H_:[_9?))
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MXRBBBOXS/].@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\=>(/&;%,>(M>\;:GJVJ:AXFU'41/-J,]]+&["W6**/^<K_@@W\?/A3^Q_\
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M?P[97UF-0L7\5O/J6FV&D7UYI[Q:E#H-O)J7B"/2[FUU.[TRUL+JVGE^"_\
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MZY_R!=8_[!>H?^DDU?P32_ZZ?_KO/_Z->O[V=<_Y NL?]@O4/_22:OX)I?\
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MA_\ D@'QR_[(]\3/_4*UNOQ%_P"#5S_E!Y^R-_V'?VB__6D_BQ0!_0W1110
M45\G_"G]M_\ 9B^.'[1OQZ_91^%7Q0TWQK\;_P!F6T\.7/QL\,:/8:M-8^"I
MO%#SQ:?I5QXE:Q3PYJ&MVL]M-::WI&E:G>W^@7\<NG:Q#97\%Q;18_[;O[?G
M[*/_  3M^$9^-/[6?Q6TKX:^$KN_DT;PU8&VO-;\8>.?$$=K)>'P_P""/".D
M0W>M^(M36VC,]VUI:C3]*MV2[UF_TZS87% 'V117X3_LB_\ !QC_ ,$ROVPO
MC/H'[/\ X9\=?$GX.?%3QK)##\.M _:(^'%]\+K/XC7-Y+Y>F6/A+Q!)J&L>
M'YM3UK(_L+2]8U/1]0UV=EL='M[[472S;T;_ (+!?M2?'GX)Z;^Q;^S_ /L\
M>/M)^!OC;]NW]KCP;^S'J'[2.LZ'I'B3_A2/A;6M'U?7==UCPGH?B.&?PSJ?
MQ-\16^FKH'P_MO$44^F?VG-<R" WL=I<VH!^R5%?SU?#OQM^TM^P!_P5,_9/
M_84\2_M9_%K]M[X$?MP_"'X\^,8(_P!H5?!VO?';]G3QU\ M L_$L_C!?'?@
M?PWX.35OA/\ %**^D\-V.@>(] ==%\1:7=MH&K1PVT^G7?O_ .TM^U/^T'^T
M%^VEX&_8 _8%\8V7@S4/@UXB\!_%W_@H/^TR?#^C>,-$^!WPT2]M_$'A7]G#
MPWI^N6M[H.K?'+X^VUH([[3[A&F\"_#:6]\130R7%\@T\ _9:BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOS<_X*
MT_\ !0/3?^"8W["GQA_:VG\+0>.?$OA--!\,?#GP9>7$]GIGB/XC>-M8MO#_
M (7MM;N[5DNH/#^G3W,^O^(/L<D5]<:-I%]:6$T%]<6\T?XP?"W]@#_@X _:
MP^%_A+]HWXO?\%HKS]F3XA_$SPMHWQ"\.? 7X,_ /POJ'PX^'%IXHTZVUG1O
M"FNWT.L>')=<GT[3[Z*'58[VV\3/;WRR6O\ ;^NK;IJ,H!_6%17Y0?\ !,G1
M/^"M?@.;XT_"K_@IOXI^ OQBT+P'>>$H?@%^TE\*;=/#OBWXRZ7JEKJDGB5_
M'?@;3K#1]'\/7'ADVFCVQE'A_P /WEWJ>HZA%"OB'3;6VU^Y_1#XI_&[X,_
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MO GPO\*QS"W?Q+\0_%V@>"]!6X9'D6W.K^(]0TW3_/>..1TA^T>:ZH[*A"G
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MCP3XCT?Q5X=OV@?RYEL];T*\O]-NC#("DH@N7,;_ "O@\5UE !1110 4444
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MTDG\4I,G*<#6R_ 4,,YTG44>>LW"I4;K5+2J+G==.48OW(-I>Y&.BLK?S?\
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MTF&ZN(1J-GYD:_:(MWKE?S(_\%O@#_P5"_X-SL@'_C-#XN?^D?P-/\P#]0*
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M"ZA+-?W=K<I]@U33-.U!+BU@ /WZHHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***^3O%O[;O[-W@?]KWX8?L*>)?'<]A^TU\8OAOJ_Q:^'_@%?#?B.YM
M]:\"Z%)XKBU+5G\3VVER^&=/DA?P1XFV6&H:K;7TPTUFBMW$]OYH!]8T444
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MIVE&ZD(CMAJ%Y'#:&XD(2'SO,8A5)K^%O]C+5/\ @O+^S3^TE^TW^VE\7O\
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MVA:EI'AZ#P]X#\&WEKI,UWXFLM<.M:^-5\3+:V5[J#N?P4_92_;3_P""4O\
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MBA_P4T^!?B[]A7_@D_\ L9_M<^*OC9^TOX;U'X5?$'XJ_&?X2W?PD^&7[/\
M\/\ QC"GA_Q[JGB7Q+>ZGJEA#K(T/4M0T8WE[<V&D:.EW-J5A=Z_JT&G:#?@
M'S9_P5T_;2\2_MV?\&O7[+?[77BG3]'3XD>-_C1\ W\=V<-FD.A77Q*^'_BW
MQ]X&\6:A!IJ.8[+1_$FO^&+S7+?2XI66QTO6(].$I\EC7[O?L$_\$>/@Q\%O
MB/X5_P""@O[2?B?Q=^TY_P %(_%^B3>,?'W[2'C3Q=XFCT'PEK7CCPI?Z9XA
M\&_!_P"'=AJEGX1\-?#?P[X=\07W@SPK::II.KZG;:!:PS6MQI(E33K/\BO^
M"U/[ FN_LA_\&XO[/_[$?PGT7Q3\8/$/P9^*OP$L]>N? GA+Q!XBU+Q/XHN]
M8\:^+?B/XLLM!T>QU+5[;0[WQ?KNLWE@EQ"[:=IMQINGSRF98P_]@_@:)T\$
M>#X9HWC=/"OA^*6&:-DD1UTBT62.6*0!D=2"KQNH96!5@""* /XO?^"9?[(G
M@#_@O[^T]^V/_P %,_\ @HC;:G\;O@W\-_V@/%O[.'['W[-NK>(=>T[X6>!O
M!O@FVL-5EUG4="T75K!M2E;1O$/A@O9M/#INO>+KKQAK_B*SU:1]&BTWPG_@
MXY_X)8_!S_@G_P#LM^'OBE^Q%J.L? OX#_'3]I7X+^"/VC/V4+/6=8\0?![Q
MAXJTZ36O$OPX^+'@K1?$MSK4W@3QEX<G\.ZIH&NPZ'?66E:]H&O1PI:6?]GW
M$.J?3/P-\<?M _\ !MQ^UA^U/\(?BA^S)\<OV@?^"77[4_QFUSX__ [XW?L\
M^"[SXC>(/@GXO\56Z1ZOX*\;^&K26UB@6VT?3-,\/ZC;WU]I5U=VWA'2O%WA
M?^VAK.N:1IGR5_P<.?M]?&_]OK]C'X8>*?AA^RK\8O@/^PSX+_:K^#S7?QB_
M:=\+_P#"L?B3\>OBIJ=GXQL_#&B?"+X4W,FHZ_:_#;PGI<?B;5?%'CW7KG3E
MUK6GT/1=(LD%CJ9N0#^D;_@LS\)O^"7?CCX8? ;QU_P56^-^L?#GX'?"WQ?J
MFL:#\+Q\5?%_@_PE\=?$5[I.FG_A'/$GPZ\!";QG\49?#PT^UU33;;PE;Q:S
MH275^)[^#2-7U&"Y_E)_X*B>-_\ @@9H/[,%U\<O^":$7B_]BS]O+]G[7O _
MCO\ 9L\4>&?@G^TQ\![KXEW6G^,="L?$'AU-6\>>$=-\(>)IAX2U#5?%-M?W
M]XFO2'1H;6>[N=*O]3TR\_9S_@L7HWQ'_9A_X*S?\$\_^"H'Q*_9P^(7[5_[
M#OP7^#/B7X1^.O#WP[\'#XE:U^SQ\2_$&I^+9X?C7#X%=9H&N)K7Q+X4NK+7
M9H;:,S>!Y;%=7TS7X/"+3<!_P5A_X*">+/\ @K;_ ,$\/VC/V=?^";?[&O[2
MOQFT?5/A_'X]^+7QU^*WP6\3_"/X>^ ?!7PUU;3?B3?>&OA?'XSM;7Q-\5_C
MCXMF\)V_AWP[X,\%:)>B.RU*\U.2_E6**.@#S?\ X.(OC'\3OC5_P3#_ ."*
MOQ^\)76D:5\:OB?^U?\ L@_%3PW?ZE86T>@:=\5?%GP)\4^)],O+W36CNK5-
M$M?&%[#<3V313P?8(S"T4D>4/Z.7O_!L[^P#XS_9^^)>D_M'Z9XQ_:4_;!^+
M/A_Q#K_Q*_;7^(_C?QE<?%C4/C!K.ES2_P#"9>%["UU^V\,>&?#FA:Z8Y/#W
M@N+1[G31H=M;:1K[ZVJR3-^3/_!12#QQ\?/^"+__  ;\ZIX$^$/Q@?4?"/[3
M_P"R3H_B_P (WOPZ\3'QCX4_X5-\/O&_PT\5ZOXB\/V.G7=_I&@G7_#5U=:7
MJU_#;VU]HU]I.H QK?Q)7]S&H FPO0 23:7(  )))A<  #DDG@ <D]* /YM/
M^#3_ .+'CWXE?\$B_!_ASQ_KFH^(+OX&_&_XO?!3PU>:I<R7EU:>#?#EWH?B
M+0M$6YFDDF:QT ^++O1](@9S'I^CV6GZ;:A+.SMXT_>[]H+]G[X*_M0?"CQ+
M\&/VA/AKX7^+GPJ\3-I=WX@\">,K)M0\/ZM<^'M5L_$&B37=LDL+M+IFM:;8
M:E9R)*CPW=K#*C!D%?S[_P#!I[X'\;^ /^":?Q"T3Q]X*\8>!-:G_;(^.6J0
MZ-XV\+Z[X2U>;3+[1?AVUGJ$6F>(;#3KZ2QN=DB0W:0&!Y89X1)YUO,D?]--
MR";:X !),$H  R23&V  .23V ZT ?Q*_\&N7_!.?]AGXY?LE>/OCW\7/V8/A
M5X^^,WPK_;M^)]E\//B-XAT:XO/$OA.S^']K\-M?\$VND7/VU8H(?#&M33:E
MI0,#M%=2M)(TN$"?7_\ P4#^'7_!O#\+?VZOB7\6/^"@7BW7?VF/VL/B-:^'
M;BV_9SUJ]^,W[2L?P?T/3/#NF0):>%/@A\*-)URW\!:3K\-E%XFNM,\=BX@:
M;5)]3\/6.FZ7>W!D[S_@U'\#^-_ /_!/[X[:1X]\%>,/ NKW?[<WQTU>TTGQ
MKX6U[PEJEUI5_P"'/AH;/4[;3_$&GZ=>3Z?<F.6.&]BA>V>:"X@$GG6\\<?P
M9^Q)^TQIO_!$G]M[_@I)X#_X*-_LZ?':?Q9^U)^U#XN^.?P9_;7^'GP7\5_&
M?3?B_P##+Q3J%]/X=\ OXC\,:?J6NVL6D><NI6GAW3Q>MI'B#6M?T77[#23I
M>ES78!\W?L[_ !\_X)_?LX?\%X?V$Q_P1_\ ''BCP9\#_P!LNP\??![]L?\
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M5N[R:38SZ7'+JD,=O>VGAU+S4[G4K;5VTV.\ATRRM],L+G4+V=+>!5G^CO\
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MRN5%14L11RV=6O1C&47..]_P3N_:[^(/P_\ C1X1^$'C7Q)JOC7X-?%S58_
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M=SN-)QC2S'+\;GGB#7AEF)<XRO#$8["X24(1<9SK4Z<8N[L_DW_@GU^R_P"
M_P!K#XM^+? 7Q!U;Q1H^DZ!\/+OQ;9W/A2[L+._DU&W\0Z%I*0W$FHZ?J4+6
MGV;4[B1D2!)#,D7[T('5MW]B#]C_ ,(_M2ZI^T)H>M:EXGM=6^&GAM;WP+;Z
M%J&FV$>JZ]=7GB6QT^UUR6_TZ^5[26YTFP23R/LA437#M*HV[?IO_@BGX,\3
MW/Q>^*GQ&BT>\_X0BS^&S^$'\1O$Z:;<>)-1\2:%JL.DV-RRB*]NH-/TNYN;
MY;=G^Q)):"X*-=PAI_\ @DS<SVNO?MK7EG/);W-MX!6YM;F"1HYH)X=3\>2P
MSPRH0T<L4BK)'(I#(ZAE((%<O W!^08ZAX-SS;):5:/$N9^)2S252$X3S7!9
M5EE"IEDFY-1G#"5O:RPLXKD51/FYTFCU/%CQ)XORK&?29I<.<4U\//@C(_ U
MY!3H5:52ED&:\0Y]6HY[!1A%SIU<QPLJ$,?2J2]HZ$HJ'LFU(^3?VD/V=?V9
M_@+\-+;POHGQVG^*?[5ECX@\/Z;XQ\)^&$$_@S1!<)<)XCTFR-II<Z27VF7I
MMK&!;SQ%)JLEPK+/I5G)*]K#[$/V*_V;?V</ 7@_Q9^W-\5/&>C^.O'EFFIZ
M-\%OA3;6UQXDTG3G17:36[E[+4+EY;1G6UU&Z/\ 8^D6VHB33K.\U6:&5T_.
MGX*ZUHVB_&'X2^(_%K+-H&F?$WP3K7B26[)E5["#Q1I]YJ5W=N^\R*@$EW<R
M.'9@DDC[B2:_=W_@HQXX_95^'GQJT75_CW^R1XJ^+E_XN\%:3)X;^)^G?$S6
M-!T#5-.TN>]BE\.V-E9Z]96%M=Z*]PMY<Q0Q)+=PZK!J#>:LPDK@X6P?"N>Y
M/Q7QK+)N#\BCD57A_),IRO.Y<38WA_ 4<>\;*6<YW#+*69YEF^:8E4:>!HU<
M1'"Y94Q7M*M6E&HL/AY>KQ_F?B#PGQ-X>^%\.)O$GBN?%M#B[BGB'/N%H<"Y
M5QAG&)RB.54X<,\*U,^Q&19'PYD6!EB:V:XK#X*>89[2P*HX>AB)4I8W&0_/
MSXP_L:?"S6?@CJW[3/['GQ,UKXG_  T\)SO%\1?!/BZSBM/B#X$AB\LW&HSQ
MQ6>G33VUC%(EY?VEYIL,RZ23JVGWVIVL-UY/YNU^V/PT_:D^!?@'X,_&OQA\
M!_V"?BWX<^&_C#0+WP!\1O'-IX[N?$G@RUGGTV\L;%-;?6M3UBSMS8GQ"(Y;
MNV@C=3?PV$UP9)X(#^)4*&*&*-FWM'%&C/S\Q10I;GGYB,\\\\U\9XC8#AO#
M3X=QV0U,LCBLURJM7SK"9%0X@I9!3Q5#%RHX?'Y-+B/ 8#&O!YG0]Z6'I+$8
M?"8O"XJE1K.FX)?I_@EG'&^.I\:93Q=0SZ> X?S_  V$X8S+BW%\'XCB^M@,
M5E]/%8S*.)X<%9OFV6+,\BQ;5.GBZ[P>-S'+L=@,3B<+&LJLG)1117YL?N9[
M_P#LG_\ )T?[.G_9:_AO_P"I1IU?VXU_$=^R?_R='^SI_P!EK^&__J4:=7]N
M-?W5]$G_ ))SB[_L>8+_ -5Z/\E_VC'_ "6OAQ_V2N:?^K@****_K8_SG"BB
MB@ K\[?^"NW_ "BN_P""C?\ V9'^T[_ZISQ?7Z)5_FX_\%[O^"R'_!7G]E']
MH;]L#_@G'\5=>^">K_ 3XN>"/&6@^"/$</P5L]-USQA^S;\<-!UK1M+N['6#
MK]U'%XFT31]0U?P7J^LPVW[CQEX9U6^M;:%%MT !_91_P0D_Y0]?\$[_ /LV
M?P+_ .B[NOUFK_,;_P""%W_!9'_@KO\ &SXP_L:?\$OOV>-<^"FD_"7PK9Z/
MX4U#Q!JOP7MO$&L^!?@7X"B;5O&WBG6-4.OV4=]J=CX=ANK32Y[I+5-4\3ZA
MHNG22)-J"L?].2@"C-I>F7$C37&G6$\SXWRS6EO+(^T!5W.\;,V% 49)P  .
M!7\F7_!'.PL)O^"^W_!P5!+8V4D,/C#X/"&*2TMWCA U#Q6,1(T96,$?>"!=
MY +9(!'];=?R7_\ !&__ )3]_P#!P=_V.'P?_P#3CXKH _IZ^+_Q6^%?[-_P
MF^(_QP^*FNZ/X!^%_P +O"6L^.?'GB>YA6"UTOP_X>LI;V\N6AM8C<7UVT:?
M9M.T^UBGOM1OY[;3["">[NH89/YK?A=_P58_X+<_\%!-#U3]H'_@FS_P3J_9
M[\/?LA_VQJMI\+_%_P"V/\1]>\/_ !'^.VE:+=7>G3ZYX5T3P[XK\):9H&GW
M=[;2V\<MS_:^@0:A;RV5OXSU5K345@^J_P#@Y\\(_$;QC_P15_:XL_AO%J-S
M<Z*/A7XN\8VFEM*MS<?#GPI\6/!VM^-)95B=7DT[2]+LVUO5T(>,:5IEY),G
MDQR.GZ,_\$S?B'\'/BE_P3Z_8W\7_ *]T:Z^%4_[.?PET?PU;:&T'V?0F\->
M"]'\.ZQX6O88 !9ZYX6UO3-1T#7[*55N+76=/O8K@&569@#Y!_X)7_\ !7BS
M_;T\6?&C]F7X\_!#Q#^R-^WM^S+-$OQN_9N\5ZB-7BET.6XM;.'Q[\/-?,%J
M^O>%7N[[3([Y'@D.FQZYX<O['5/$&A>(-(UR\^9OVD_^"S7[3GQ._;*^(?\
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M+0OB%XD&DZ_I-OH+06[^(=&M]5N]/CM;*VEBM=/:-0#ZS_X)J_\ !1[XG_\
M!1O_ ()W>,_C]X2^'O@;P7^V+\.KKXS?"?QU\#]8GUU?!7A3]H_X;+J!\/\
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M5;W3+F^T]8F@OI8Y #]+/B=_P4R^*OP*_P""S'P0_P""=WQ>^'?P^TC]G?\
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M@-4^%/B3QC::>Q#:5X?M=7GU:\LTL=&T9KZZ6!_S_P#^#A#2?CCX;_X+'?\
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M?_P6S_X*0_\ !0SX._#B^_X)B?L(?#7XI^-M/^%WA36?VEOCQ\;?%VO?#?\
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M[/1+7Q%?Z;XB\1Z?JWA?Q1HOB;PO?O'<S65I^#7_  2R\<_\%?-/_P""N/\
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M%#>.M+GUCQ!JTNIP>,O[0N-.M)+[2_$^FW81TF25_L;Q[_P3A_;Q^./[=W[
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M?1%N=9U\Q:/HFNWGA[25U*VUJ>*[\.+<1VLL>GW*P#\,O&/_  44^)_[:/\
MP0=_8K_X)]^$=2U"W_;?_:R_:!\-_P#!+[XI:5=-&WB;POH_P2UC0X_BAXR\
M36IGCNX;2\^&8^',/C2:X2(20>,/%*LPCL;IT /W^_8J_P""P6K>-?\ @E9X
MT_X*K_M[>#_!?[.GPA77_'WB#X;>'?!"Z]J?B#7?A+HWB&+P5X CGM?$>KS-
MKGQ)^(7C6WU/0_#UCI3Z5HVK+/H=_&+"QOI[BV\(^''[;G_!P1^UIX'TG]I7
M]F7]@K]BCX-_L]^+K"+Q7\+OAE^UI\7?B=%^T=\2_ =^C7/A_7F_X0=-,\&>
M![CQ3I;6VIZ18^+;?2OLL=W:W,EQJ>E307UU\R?\'0?[.][\$?\ @B%\"_A7
M\!](EL_@Q^RS\:OV:M)\5Z5#IG]HVEO\*?!?A3Q/\/\ P_?^(=-MV@@U"Q7Q
MGJG@RXUA;@B&]U*\26=TDE-Q']J?#'X(_P#!<CXG?#GP)\1?AA_P5U_8Q\0_
M#GQQX0\.^*O NN>'OV!M)DT/5/">N:5:ZCH-[I1@^(R1+93:;<6[01+'%Y"8
MA:*)HS&H!]F_\$S?^"G&A_M\:=\7OAQ\0/A-XB_9B_;)_9@\2V?@K]I[]EWQ
MKJ=OJ^M^ ]8U"*9]%\4>%O$%O;6,'C'X=^*EM;J70/$5M96^?*"R1SZ?>:'K
M6N_CC^SM_P '#'[7'[68^+/[/W[,/[#_ (<^/_[<GA3]HGXQ^ [/PIX=\0>(
M/ _[/WP@^ /P_P!3TG0/"_QE_:"^)?BJ\O$L=9\6^(I/$.DZ/X-T+4-,F\0G
M0;B:RNM+N)++3]0^I_\ @GE^P1^T!X0_X*C?M!?MV_'+_@HA^S?^U1\5KOX'
M6W[,'QW^&GP%^%ND_#C4?#^M:1JO@[6/!=U\1M%T/X@>)X]&\3:%IWA)M.CB
MUS2;/5[BR=;6*6&VL9(#\V?\&HVB:/;_  Y_X*F^(X-,L8O$&J_\%-?C#HFI
MZS';QKJ5_H_A_0O#]_H>F7=V!YLUCI%[XF\0W>GV[L8[6XUO4Y(@K7<I8 ]?
M_8X_X*__ +?N@_\ !2SPG_P3(_X*L?LK?!SX(?$OXX> M=\??L]?$GX ^(=?
MUGP-XKCT+3/$&OSZ1<G6_$_C*/4[6ZT[PKXJL(M3MM4T75=%US0(M-UCP[/#
MK-OJUO\ E/\ MC>-?^"K,7_!RW^R_JOAOX(_L>7G[0>C?LR?&K2OV7_"NK_$
MGX@0?#7QC^SFGB+]H>/3?%OQ8UR&*/6= ^*$NCS>([FXT'08WT5-1M-,MXC-
M%+,S?H7_ ,%=8UMO^#@3_@WUO[<&"]N=;_:%L)[F)F2:6R33]#5;5W4@F'9J
M-^C)T9+N=&RKD5K?M5LH_P"#LS_@FFI9%9_^">'Q85%9E4NPO?VIW*H&(+L$
M1WVKEMB.V-JL0 ?I;^V3_P %'?B%_P $XO\ @G7X4_:?_:R^$7AOQ/\ M.:[
M=^!_AE#\"/@CXFO)?!?BC]H#Q_=7UMHOA'PSXR\2V]UJ-GX3B@T^]U74-;O;
M#4M0AL=/NH;2QOKV6UAE^(M=_:L_X.5_A=X<7XW^.?\ @GC^PM\5_AW:P6NM
M>(OV<O@7\8?B3)^T[I'A_>;B_L=,U?6M0U7P#XE\6V5E+Y4NG^&++Q++J5[:
M^7HVCRO-Y3?JK_P4A_8D_9P_X*(_LY77[)_[1_B&]\*Z?X\\3Z9J_P ,/$?A
MSQ)IGASQ_P"'OBMX1L-6UK0?$/P]_M1;BWUG7]'TF+7KB^T5M.U**]\--K@N
M+>&%7OK3\$_C8G_!>?\ X(J_!7Q?\?7_ &K_ ('?\%.OV-?@580:QXT\(?M
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M9Y<?F>=Y:>;L\OS=B^9Y>[=Y>_&[9N^;9G;NYQGFGT4 %%%% !1110 4444
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MKW&DS>'/ZO**    8 P!P .@'I2          8  X  '  '  Z4M% !1110
M4444 %(0#C(!P<C(S@CH1Z$>M+10 4444 %! (((!!&"#R"#U!'<&BB@ HHH
MH *" 1@@$'J#R#^%%% !1110 4444 %%%% 'P2_^LE_Z[3?^C7IM.?\ UDO_
M %VF_P#1KTVORB6[]7^9_0\=EZ+\@HHHI#"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *V/#O\ R,&@_P#8:TK_ -+[>L>MCP[_ ,C!H/\
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ME*EC,!BHQ<H+$X+$4*_LY2INIR2E%_HC\<O^"F/Q\^,/@^\^'/A[3/!_P5\
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MJ]IJD5O#;Q_T!T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7^5O\
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MU32OA=XV\411^)/ MA/</+<1/;KJ.I>=*]Q?ZAJ5X\ET_P#1W10!\+_L$?\
M!.W]FK_@G'\*=5^&/[/6@:W+?^,=?N/&7Q7^*WC[6I?%_P 7?C+XZO9)Y;OQ
M?\2?&EU%!<:SJ3/=7/V.TMK>PT?31<W<ECIT-UJ&I7-[PO\ P3<_X)J_#;_@
MFIX6_:$\*_#;XA^.?B':_M$?M$^,OVC?$5UXYM] M[C0?$?C/3]&TZ\T#1AH
M&GZ?')HMI%HL$EM)?+/?-)++YDQ78J_I%10!^;O[4'_!-7X;_M2?MJ?L0_MM
M>*/B'XY\->-?V&]0\<:CX'\':!;Z!)X6\9R>.HM.BOH_%<VHZ?<ZM#'9KIL?
MV7^R+NT9O,D\TM\I'SY_P4[_ ."*?PD_X*2?%GX&_M%P_'OXZ_LL?M)_L_Z9
M=>&O!/QH^ ^MVFF>(3X1N]1U#5O[%N4N5BNK2YT_4-8UV72M7T75M*N(X=?U
MJQU2+6+"[BMK;]I:* /Q*\6?\$*_V<_BA^QW\-/V4_C1\>_VNOBSXJ^#GQ$\
M6?%_X6?M8^)_C5?I^TWX!^)WC"Y>ZU+Q%X;\;V>G1Z>EG!(R1V&B:QHNLVUG
M!$AMYX[R."\@^8?$?_!O1XY^..GZ7\-/VRO^"M_[?O[57[-&FZQINIWO[/\
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MCD-S.EV8H!&YE9 C8_@D^#/B+_@G3\*/^"AW_!0#0?\ @XK^#NJ3?M1?%/\
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MOBN[^(.HZKKTFBZ[+XLTW^V'F6RT328-&UB:QU+P]!I@LEM9OTZ^&NJ?"O\
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MNNZIJ=W!IESJTG@#Q NDS74]GI>O:!=ZII0MOM[VL0!_9GXR\<>"_AUX>O\
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M;'X,#7;>3XAS^$%@N;H^)/\ A'H]]S#HYMK2XG6\G\J-HX]RY\R+?\R>)O\
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MHHH ***YWQ=XO\)^ /"^O>-_'?B;0O!G@SPKIEQK7B?Q9XHU2TT3P[X=T>T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4]X]K&SW?A_4-EC);:A82/JUM^S'[:GQK\9?LZ?LH?'WXT_#CX>>+OBS\2/
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M]%\N\A_5S_@EY\3?C;^T:WQJ_:)\<_\ !.#X:_L3?!^6_M[7]CO2M>\%:3X
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ME_<^';F.WLM.TS3X;B]O;J:1@L5O;02RN3\JFOYL?VJ?V3?VH_B__P &U_\
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MQ+>Z]I\6@WK1L&?2]9OX?F64JW\VWQ+_ ."H?C?XQ_\ !OW\(/A'X8N=0O\
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M)'%N=2E3Y*<JM.*G3IV48SDXRDM)7]PL?^"]FE?"[QOX%\/_ +>_[ G[6G[
M?@/XG:I!H_@WXV_%;2H_$WPRM]1O)$%G:^-+_3M"T*]\-,(7:XU(V\&LWNDV
M\<M[?Z3;Z=!=7T'KW_!>#XU^*O '_!,SX_:=X"^!_C?X\>&OC=\(/'?A3Q'X
M\^'.J:0_ACX,^#[[PY::O9?%KQC<2Q7@U;P5=+)#%:R:/+&;C>LR7822'?\
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M065EX4T^ULK?6H+GQ"FKW]YIIGN+J..'0=0%RP:2W+_T%@$D  DD@  9))X
M '))/  ZU^97_!&#/_#I_P#8!!S_ ,FZ>&" <]]5US!Q[C&/:OO;XL:GXGT7
MX4?%36?!,,D_C31_AE\0=5\'PP@M-+XIT[PAK%YX>2%0K$S'5H;3R0%8F78
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M^O?%'_I7#Y_J-^S?_P!W\8/^OW G_I'%XRBBBOXS/].@HHHH **** "BBB@
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M#T]G\8/@Y?C3/B'X7&AZ[9:Q<P:+>FXM3%#KMK:S:)JFRXAE;3KZX\F5)0C
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MX6A[=\M2M/$P5.O5Q-:K7K5*23BJ3J5)2G&FDW:$'&*;<K<SN?@G_P $U/\
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M_P"J]'^2_P"T8_Y+7PX_[)7-/_5P%%%%?UL?YSA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\-?C;X!\+V\.B> 'UK6;>(1Z+KEGH%G::?<7[R3:YJ-C:V=YK_@_0]<>^CO
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MG@U*U^5O^"T'[#/[8>G_ +4_[*?_  5\_P""<'A73OB;^U'^R7I&H?#[XG?
M*\NQI\_QY^ ^JW&NS7NA:,_GVB:CK%A:>+?&6E7>D+<1ZQ>Z?K]EJOAHW.O^
M%-,TC5.8@_X+#?\ !0']M_PKJ7[/'[('_!)3]K3X!?M ^-M*G\&>+OC3^V)X
M:?X=_L[?LY2ZW:/8:YXVN=<OK'3]8^)M]X6L[BXU/P]X5L]'T'5==OXK#?H]
MY#]ITJ< ^8_^#=,R-_P;B?M*F9A)*UQ^W297"JJO(?AX_F,$5550S9(4*J@'
M 4#BO@KX-?MH?%?]B'_@T$^&/CCX%ZS=^%/BM\6/B[\0?@#X4\;:;-+::MX)
M7XC?&_XF3^)/$NB7D.V33]?B\)Z!KNG:'JT4D5SHNK:G9ZU9R+>Z?;FOT_\
M^"%WP#_:3^ 7_!(#]OG]BWXS?L[?&+X>_%7X5^*_VLO#GAF7Q3X.U33K3XWK
MX]^&UZ- UGX4Q26Y?Q5I][?VJZ?;76BRZK8ZA<7VG?V=?W371BAX+]B+_@DI
M\1OVOO\ @V;\*?L!_'?PAXS_ &</CO\ \)%\4/''@*S^+/A+Q!X0U[P'\3/#
MWQJ\8>*?A_JGBCPSJMC:Z]:>'/$VG74FDZG,-/DO!X5\37>IZ9;7%W':(X!^
ME_[%_P#P;]_\$V?@1^RSX2^%?Q5_9=^$?[0?Q.\4^#M,O?CG\8OB_P"%]/\
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M:1X@M+OP5#K$EI%ISW6IZAI5KHFH_:)+ZT3&CZCJ!B:=1*$PVW\*/^":7/\
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M.":>LW&]G9.S/Z%**^+_ -G7]N?X._M:?L:-^VE\!9+[7O!#^ ?'OBEO"_B
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M7T_Q!K'PF^+.@6D.BZKK/A9M0TRX\4>#[TKJ^E6-_#>QSW<,=TMM_9C\,/\
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MYXQ;ZC/<+'JMF98(_-P/B7_@GO\ \%3OAO\ MXWGQ8^%6H?#'QQ^S?\ M=_
M-)D^,?[+7Q7Q!XMT1XF%HNL^&M4DLM,;Q%X8;5Y+;3;R[DTK3M3T5M0TFYU+
M3_[.UC2-0O\ ^<7X7?M0_P#!2+2?^"\7[6WQ5\-?\$TM*\4?M,:W^ROX$\.>
M-/V8S^TQX3TRT\%?#^PT;X26^B_$*+XH3Z(VDZX^N66F>'KS_A'H;"&[L_\
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M_A_(4 34444 4M3@-SINH6P=(C<65W ))#B.,RP21AY#V1-VYSV4$U_+4_\
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MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OU4_P"'67B;_HZW]E?_ ,+2]_\ D>C_ (=9>)O^CK?V5_\ PM+W_P"1Z_*O
M[):?\^UO_P!^8_\ XFC[):?\^UO_ -^8_P#XFC_6+P__ .C:5?\ Q.<Y_P#F
M#R_/NP_U*\9/^CYX?I_S:CAGRO\ \SCU^_[OU4_X=9>)O^CK?V5__"TO?_D>
MC_AUEXF_Z.M_97_\+2]_^1Z_*O[):?\ /M;_ /?F/_XFC[):?\^UO_WYC_\
MB:/]8O#_ /Z-I5_\3G.?_F#R_/NP_P!2O&3_ */GA^G_ #:CAGRO_P SCU^_
M[OVI^!/_  3<\0^!?C;\(?&LW[2_[-FO0^$?B1X/\1RZ'H7BR[NM;UB/1];M
M+U],T>V:%5GU*\$7D6<3,!).Z*3S7W_>?\%2O#]G>7EF?V6/VIIC9WEW9F:'
MX=[H9C:7$EN9H6^U?-#*8S)$W\4;*W>OYU_V3K6U7]J3]G)EMH R_&SX;E2(
M8P01XHT[!!"Y!'8CD5_;Q7]1^ T*N?Y!GDN!*B\/*>&SFE',:56+XR_M2=3
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M>I>'_P#HU3]JK_PW7_W77ZL44?ZM^(O_ $<RA_XA&5?_ #P_J[\K'^N_@O\
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M^CF4/_$(RK_YX?U=^5C_ %W\%_\ HQF*_P#%I\0__.?^KORM^4__  ]2\/\
M_1JG[57_ (;K_P"ZZ/\ AZEX?_Z-4_:J_P##=?\ W77ZL44?ZM^(O_1S*'_B
M$95_\\/ZN_*Q_KOX+_\ 1C,5_P"+3XA_^<_]7?E;\I_^'J7A_P#Z-4_:J_\
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M_==?JQ11_JWXB_\ 1S*'_B$95_\ /#^KORL?Z[^"_P#T8S%?^+3XA_\ G/\
MU=^5ORG_ .'J7A__ *-4_:J_\-U_]UT?\/4O#_\ T:I^U5_X;K_[KK]6**/]
M6_$7_HYE#_Q",J_^>']7?E8_UW\%_P#HQF*_\6GQ#_\ .?\ J[\K?E/_ ,/4
MO#__ $:I^U5_X;K_ .ZZ/^'J7A__ *-4_:J_\-U_]UU^K%%'^K?B+_T<RA_X
MA&5?_/#^KORL?Z[^"_\ T8S%?^+3XA_^<_\ 5WY6_*?_ (>I>'_^C5/VJO\
MPW7_ -UT?\/4O#__ $:I^U5_X;K_ .ZZ_5BBC_5OQ%_Z.90_\0C*O_GA_5WY
M6/\ 7?P7_P"C&8K_ ,6GQ#_\Y_ZN_*WY3_\ #U+P_P#]&J?M5?\ ANO_ +KH
M_P"'J7A__HU3]JK_ ,-U_P#==?JQ11_JWXB_]',H?^(1E7_SP_J[\K'^N_@O
M_P!&,Q7_ (M/B'_YS_U=^5ORG_X>I>'_ /HU3]JK_P -U_\ =='_  ]2\/\
M_1JG[57_ (;K_P"ZZ_5BBC_5OQ%_Z.90_P#$(RK_ .>']7?E8_UW\%_^C&8K
M_P 6GQ#_ /.?^KORM^4__#U+P_\ ]&J?M5?^&Z_^ZZ/^'J7A_P#Z-4_:J_\
M#=?_ '77ZL44?ZM^(O\ T<RA_P"(1E7_ ,\/ZN_*Q_KOX+_]&,Q7_BT^(?\
MYS_U=^5ORG_X>I>'_P#HU3]JK_PW7_W71_P]2\/_ /1JG[57_ANO_NNOU8HH
M_P!6_$7_ *.90_\ $(RK_P">']7?E8_UW\%_^C&8K_Q:?$/_ ,Y_ZN_*WY3_
M /#U+P__ -&J?M5?^&Z_^ZZ/^'J7A_\ Z-4_:J_\-U_]UU^K%%'^K?B+_P!'
M,H?^(1E7_P \/ZN_*Q_KOX+_ /1C,5_XM/B'_P"<_P#5WY6_*?\ X>I>'_\
MHU3]JK_PW7_W71_P]2\/_P#1JG[57_ANO_NNOU8HH_U;\1?^CF4/_$(RK_YX
M?U=^5C_7?P7_ .C&8K_Q:?$/_P Y_P"KORM^4_\ P]2\/_\ 1JG[57_ANO\
M[KH_X>I>'_\ HU3]JK_PW7_W77ZL44?ZM^(O_1S*'_B$95_\\/ZN_*Q_KOX+
M_P#1C,5_XM/B'_YS_P!7?E;\I_\ AZEX?_Z-4_:J_P##=?\ W71_P]2\/_\
M1JG[57_ANO\ [KK]6**/]6_$7_HYE#_Q",J_^>']7?E8_P!=_!?_ *,9BO\
MQ:?$/_SG_J[\K?E/_P /4O#_ /T:I^U5_P"&Z_\ NNC_ (>I>'_^C5/VJO\
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M-4_:J_\ #=?_ '71_P /4O#_ /T:I^U5_P"&Z_\ NNOU8HH_U;\1?^CF4/\
MQ",J_P#GA_5WY6/]=_!?_HQF*_\ %I\0_P#SG_J[\K?E/_P]2\/_ /1JG[57
M_ANO_NNC_AZEX?\ ^C5/VJO_  W7_P!UU^K%%'^K?B+_ -',H?\ B$95_P#/
M#^KORL?Z[^"__1C,5_XM/B'_ .<_]7?E;\I_^'J7A_\ Z-4_:J_\-U_]UT?\
M/4O#_P#T:I^U5_X;K_[KK]6**/\ 5OQ%_P"CF4/_ !",J_\ GA_5WY6/]=_!
M?_HQF*_\6GQ#_P#.?^KORM^4_P#P]2\/_P#1JG[57_ANO_NNC_AZEX?_ .C5
M/VJO_#=?_==?JQ11_JWXB_\ 1S*'_B$95_\ /#^KORL?Z[^"_P#T8S%?^+3X
MA_\ G/\ U=^5ORG_ .'J7A__ *-4_:J_\-U_]UT?\/4O#_\ T:I^U5_X;K_[
MKK]6**/]6_$7_HYE#_Q",J_^>']7?E8_UW\%_P#HQF*_\6GQ#_\ .?\ J[\K
M?E/_ ,/4O#__ $:I^U5_X;K_ .ZZ/^'J7A__ *-4_:J_\-U_]UU^K%%'^K?B
M+_T<RA_XA&5?_/#^KORL?Z[^"_\ T8S%?^+3XA_^<_\ 5WY6_*?_ (>I>'_^
MC5/VJO\ PW7_ -UT?\/4O#__ $:I^U5_X;K_ .ZZ_5BBC_5OQ%_Z.90_\0C*
MO_GA_5WY6/\ 7?P7_P"C&8K_ ,6GQ#_\Y_ZN_*WY3_\ #U+P_P#]&J?M5?\
MANO_ +KH_P"'J7A__HU3]JK_ ,-U_P#==?JQ11_JWXB_]',H?^(1E7_SP_J[
M\K'^N_@O_P!&,Q7_ (M/B'_YS_U=^5ORG_X>I>'_ /HU3]JK_P -U_\ =='_
M  ]2\/\ _1JG[57_ (;K_P"ZZ_5BBC_5OQ%_Z.90_P#$(RK_ .>']7?E8_UW
M\%_^C&8K_P 6GQ#_ /.?^KORM^4__#U+P_\ ]&J?M5?^&Z_^ZZ/^'J7A_P#Z
M-4_:J_\ #=?_ '77ZL44?ZM^(O\ T<RA_P"(1E7_ ,\/ZN_*Q_KOX+_]&,Q7
M_BT^(?\ YS_U=^5ORG_X>I>'_P#HU3]JK_PW7_W71_P]2\/_ /1JG[57_ANO
M_NNOU8HH_P!6_$7_ *.90_\ $(RK_P">']7?E8_UW\%_^C&8K_Q:?$/_ ,Y_
MZN_*WY3_ /#U+P__ -&J?M5?^&Z_^ZZ/^'J7A_\ Z-4_:J_\-U_]UU^K%%'^
MK?B+_P!',H?^(1E7_P \/ZN_*Q_KOX+_ /1C,5_XM/B'_P"<_P#5WY6_*?\
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MC5/VJO\ PW7_ -UU^K%%'^K?B+_T<RA_XA&5?_/#^KORL?Z[^"__ $8S%?\
MBT^(?_G/_5WY6_*?_AZEX?\ ^C5/VJO_  W7_P!UT?\ #U+P_P#]&J?M5?\
MANO_ +KK]6**/]6_$7_HYE#_ ,0C*O\ YX?U=^5C_7?P7_Z,9BO_ !:?$/\
M\Y_ZN_*WY3_\/4O#_P#T:I^U5_X;K_[KH_X>I>'_ /HU3]JK_P -U_\ ==?J
MQ11_JWXB_P#1S*'_ (A&5?\ SP_J[\K'^N_@O_T8S%?^+3XA_P#G/_5WY6_*
M?_AZEX?_ .C5/VJO_#=?_=='_#U+P_\ ]&J?M5?^&Z_^ZZ_5BBC_ %;\1?\
MHYE#_P 0C*O_ )X?U=^5C_7?P7_Z,9BO_%I\0_\ SG_J[\K?E/\ \/4O#_\
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M /1JG[57_ANO_NNC_AZEX?\ ^C5/VJO_  W7_P!UU^K%%'^K?B+_ -',H?\
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MU5_X;K_[KK]6**/]6_$7_HYE#_Q",J_^>']7?E8_UW\%_P#HQF*_\6GQ#_\
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M %;\1?\ HYE#_P 0C*O_ )X?U=^5C_7?P7_Z,9BO_%I\0_\ SG_J[\K?E/\
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M -',H?\ B$95_P#/#^KORL?Z[^"__1C,5_XM/B'_ .<_]7?E;\I_^'J7A_\
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M .C&8K_Q:?$/_P Y_P"KORM^4_\ P]2\/_\ 1JG[57_ANO\ [KH_X>I>'_\
MHU3]JK_PW7_W77ZL44?ZM^(O_1S*'_B$95_\\/ZN_*Q_KOX+_P#1C,5_XM/B
M'_YS_P!7?E;\I_\ AZEX?_Z-4_:J_P##=?\ W71_P]2\/_\ 1JG[57_ANO\
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MS]U-R7*]/>2OTN?S,_\ !-+_ )3^_P#!<O\ [ _PF_\ 2SPI2?\ !-/_ )6
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M2I4:E6IB,'+DP]25L3./LJ]27-&BIQ@K7<YP:NE*WQ')X>_X+?R?LOO^QO\
M\.V/^"?J_ Y_@<W[/ \-+^TWJ/E+X!/@X^"!&'/B?R_MPLO^)C]M,7F'5?\
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MG2I*%.LG2G*=##THWJ4^6<JG-*G&W*C^;7_@JU\!O^"JG[)OPK^&6K?MC?\
M!3KXW_M,_L#?%3XE:)\*_P!KF?X*^!M!^&/C;X?^!_$E]9QI/<VRV.IQ^(-"
M\2V2ZK8I#?W,>C7&LVECX<U2PNSXCL@W]>?[)?P>^ 'P%_9K^#'PM_9:LM)M
M_@!H/@71;WX8W^CWJ:K#XI\/>(K9/$$7C>^UM41]?UGQG)J3^(]9UJ95FO\
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M#_TDFK^":7_73_\ 7>?_ -&O7\5_2\_B\ ?]>^*/_2N'S_4;]F__ +OXP?\
M7[@3_P!(XO&4445_&9_IT%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 >__ +)__)T?[.G_ &6OX;_^I1IU?VXU_$=^R?\ \G1_LZ?]
MEK^&_P#ZE&G5_;C7]U?1)_Y)SB[_ +'F"_\ 5>C_ "7_ &C'_):^''_9*YI_
MZN HHHK^MC_.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9C@*-*E6JXS#TZ5=<U&<ZL(JK&R?-3N[SBDTW*-TDTV[-'[NT5\J_LF?MO\
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M%%?J9_/H5"_WC^'\A4U0O]X_A_(4 34444 9>N?\@76/^P7J'_I)-7\$TO\
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M_##[)I$.J>(=%U/5?#31+XBUD?VAX7O='U)S=HTEVXMH%7]SZ_F0_P""YO\
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M** "BBB@ HHHH **** "BBB@ HKR+X^_"_4_C9\$_BK\(=&^(_C/X0:M\2?
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ME\8_ _A[5H=2UWX;WOBNRFU+PY8^+;>W#)I-[J]C;7%U:6<\@N6B@F+1(8W
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M_CK\5_@M_P $@?V3_AY\>/ OP&UV;PI\4?VL?V@?&5_X0^"EUXN@:6*7P_\
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MYS]?J5:E>6&G/!*-'ZK*&)JTZ;PE.*IJJJM)3Y8U%4=1UHOG3C)Q7TM^V/\
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MI[#3_B!X;ET[QQX;NK&5)H6TFYU.PGM'7<UBHV,?YBO^"EO[$/AS_@@YX_\
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MPN$Q.'XNPF68O)E#)_'V/%-:C'-\JP\(<.5\%4A0Q^#C5Q=*.,H2G5ITJ='
M^WK*;=-44Z<U#GX?Q^88#&^'68Y[EO$[J<1_1!GP!AL5/ASB#&5*O&V%S+#3
MQ>3YG4H9=6GEV+IT\-6KU\3FSPF&E34:[Q,HUJ4JF-^UEXU\8>"?^"L?AZ;P
M=XGUOPQ+XBOOV?\ POK\FB7\U@^L^'-3N-&.HZ'J+0D&YTN],41N;23,<IC0
ML"5%<!_P5K^*WQ0@_:8\7?"NU^(7BZU^&USX$^'&HS>!K?6;J/PR^HLM]?\
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MSP,S71OW^/OQ3LM5/A;X7W#62V6@J^L^)4NHKO2DU'10#\\/$VB_LP?M,_\
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MVVBV_B*PTN'4]#N+U-)GTYIFB6PU"&QU2Q_0K_@HM^QW^V+^S/\ \%&/A_\
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M7BZ[L(QXJ\4^,?$'BGX*ZQJ5ZFL:I)>W>GZ,+PZ3H-I/'8Z3;V\,6Y_Z#_\
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M)E;=/;^'8]3^'TM]%;-*B>)-6\829)AN&3]=?^";'CK_ (*3?%[1/C!\8?\
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M @  P  /0# _(4%5;A@"/0@'^=+119;6T[ )@8Q@8Z8QQCTQ2*JKG:JKGKM
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M'F"_]5Z/\E_VC'_):^''_9*YI_ZN HHHK^MC_.<**** "BBB@ HHHH ****
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M;;5_&_BRXAMFO38QW5U'I>D:79:3X?TK[5?3Z?I%M=ZEJ5S>??-%% !1110
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MT%Q?/X=T[QQI6F#3[#6I++7KO2H=(:_M;>R]V^+W[,__  46_:DU']FK7O\
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M 4444 %%%% !1110 4444 %%%% !6QX=_P"1@T'_ +#6E?\ I?;UCUL>'?\
MD8-!_P"PUI7_ *7V]:T/X]'_ *^T_P#TN)CB/]WK_P#7FK_Z1(^X****_4S^
M?0J%_O'\/Y"IJA?[Q_#^0H FHHHH R]<_P"0+K'_ &"]0_\ 22:OX)I?]=/_
M -=Y_P#T:]?WLZWSHNK@ D_V7J& !DG_ $2;@ <D^PK^#.33-5\V;_B4ZO\
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M!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\
MX*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,
MI45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-
M?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y
M&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S
M-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1
MJ_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X
M''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_
M ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@J
MU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D
M:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5
M?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/
MVG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?
M_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_
M /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0
M_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=
M_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'M
MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z!&K_ /@JU#_Y&H]G
M/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\ X*M0_P#D:C^S-5_Z
M!&K_ /@JU#_Y&H]G/^2?_@+_ ,O-?>'MJ7_/VG_X''_,I45=_LS5?^@1J_\
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MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
M X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO
M_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\CYK[S2HK-_MG1_\ H*Z;
M_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\  X_YA]7K_P#/BM_X+G_\
MCYK[S2HK-_MG1_\ H*Z;_P"!UK_\=H_MG1_^@KIO_@=:_P#QVCVU+_G[3_\
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M6XU/6]:OK_5]3N;G4+VYGD]+_MG1_P#H*Z;_ .!UK_\ ':/[9T?_ *"NF_\
M@=:__':/;4O^?M/_ ,#C_F'U>O\ \^*W_@N?_P CYK[S\FOCA_P12_9"^-?Q
M+^+'Q&M/%O[3OP,M/VB;P:A^TY\+_P!F_P#:&\:_!WX0_M)ZA(BV^HZC\7/
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M_P#(^:^\TJ*S?[9T?_H*Z;_X'6O_ ,=H_MG1_P#H*Z;_ .!UK_\ ':/;4O\
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M ,=H_MG1_P#H*Z;_ .!UK_\ ':/;4O\ G[3_ / X_P"8?5Z__/BM_P""Y_\
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MK[S2HK-_MG1_^@KIO_@=:_\ QVC^V='_ .@KIO\ X'6O_P =H]M2_P"?M/\
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M^*W_ (+G_P#(^:^\TJ*S?[9T?_H*Z;_X'6O_ ,=H_MG1_P#H*Z;_ .!UK_\
M':/;4O\ G[3_ / X_P"8?5Z__/BM_P""Y_\ R/FOO/AM_P#62_\ 7:;_ -&O
M3:<_^LE_Z[3?^C7P0>X/8TVORR6[]7^9_0*V7H@HHHI#"BBB@ HHHH ****
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M44?\14\2/^BWXD_\.>(_^2_J[\K'_$OG@A_T:S@G_P ,6#_^5GZ9_P##VO\
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M/_D2OU#HH_XA)X9?]$-PW_X;*'_R(?\ $Q/CG_T=;C?_ ,/N,\O[_DC\O/\
MAT1^R5_SW^,/_AS]4_\ D2C_ (=$?LE?\]_C#_X<_5/_ )$K]0Z*/^(2>&7_
M $0W#?\ X;*'_P B'_$Q/CG_ -'6XW_\/N,\O[_DC\O/^'1'[)7_ #W^,/\
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M1'[)7_/?XP_^'/U3_P"1*/\ AT1^R5_SW^,/_AS]4_\ D2OU#HH_XA)X9?\
M1#<-_P#ALH?_ "(?\3$^.?\ T=;C?_P^XSR_O^2/R\_X=$?LE?\ /?XP_P#A
MS]4_^1*/^'1'[)7_ #W^,/\ X<_5/_D2OU#HH_XA)X9?]$-PW_X;*'_R(?\
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MW^,/_AS]4_\ D2C_ (=$?LE?\]_C#_X<_5/_ )$K]0Z*/^(2>&7_ $0W#?\
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M_5/_ )$H_P"'1'[)7_/?XP_^'/U3_P"1*_4.BC_B$GAE_P!$-PW_ .&RA_\
M(A_Q,3XY_P#1UN-__#[C/+^_Y(_+S_AT1^R5_P ]_C#_ .'/U3_Y$H_X=$?L
ME?\ /?XP_P#AS]4_^1*_4.BC_B$GAE_T0W#?_ALH?_(A_P 3$^.?_1UN-_\
MP^XSR_O^2/R\_P"'1'[)7_/?XP_^'/U3_P"1*/\ AT1^R5_SW^,/_AS]4_\
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M,3XY_P#1UN-__#[C/+^_Y(_+S_AT1^R5_P ]_C#_ .'/U3_Y$H_X=$?LE?\
M/?XP_P#AS]4_^1*_4.BC_B$GAE_T0W#?_ALH?_(A_P 3$^.?_1UN-_\ P^XS
MR_O^2/R\_P"'1'[)7_/?XP_^'/U3_P"1*/\ AT1^R5_SW^,/_AS]4_\ D2OU
M#HH_XA)X9?\ 1#<-_P#ALH?_ "(?\3$^.?\ T=;C?_P^XSR_O^2/R\_X=$?L
ME?\ /?XP_P#AS]4_^1*/^'1'[)7_ #W^,/\ X<_5/_D2OU#HH_XA)X9?]$-P
MW_X;*'_R(?\ $Q/CG_T=;C?_ ,/N,\O[_DC\O/\ AT1^R5_SW^,/_AS]4_\
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MXA)X9?\ 1#<-_P#ALH?_ "(?\3$^.?\ T=;C?_P^XSR_O^2/R\_X=$?LE?\
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M?_(A_P 3$^.?_1UN-_\ P^XSR_O^2/R\_P"'1'[)7_/?XP_^'/U3_P"1*/\
MAT1^R5_SW^,/_AS]4_\ D2OU#HH_XA)X9?\ 1#<-_P#ALH?_ "(?\3$^.?\
MT=;C?_P^XSR_O^2/R\_X=$?LE?\ /?XP_P#AS]4_^1*/^'1'[)7_ #W^,/\
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MO^QY@O\ U7H_R7_:,?\ ):^''_9*YI_ZN HHHK^MC_.<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /@E_P#62_\
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MD_;^%_AS\2/CA\!/$?PMM]-^//PVA\51>-?BA#?+(FN^&;7Q9I&G6/A*WM&
MF^P072Q:O97S )<6LL)VAV:O@:+XQ?L<^./VHO@Q+:?LN>'?A[\(SK.N>"OB
MIX>UO43J]AKEYXKU2WT[1O&C/8SV[6DOA6_471+MM:SN[Y9%9=K1^[F/A]D=
M#@C@3,7G>595Q!G6<YQEF;0Q[SV,I5:6:Y5E_P!7J4W@*F#P<N&/K5>6<U%[
M"-6#E+"3S&=-)?)9)XR\5XKQ4\7,ECPKQ!Q!P=PMPSPSGW#T\I_U3E"GAZ_#
MV?9Q]<HUUF]',<SAQV\#A8\,TFL5+#U%".84LFI5I3E^<%%?7G[=_P ![7]G
M']I7Q_X)T733IW@C4C:^-?A];0K,UM#X4\0))+%I5D\SR2S1:#JMOJ>AQEY9
M9#'90%W9GR?<?VM?@]\+/V=OV7OV8? Q\#Z$G[1?Q)T<?$;XB^-9%NV\2:=X
M>=)+N'0R7N?LUO#)?ZS9Z& MJK/#X7O  KRSM7Q57@C-L+6XUHXZIA<%_J*I
M0S:I7=;DKXN>:4\JP6"P/)1E*K6S"M.=?"2J*C2EA*-6O.I",4G^IT/%;AW'
M8;PMQ.54,?FG_$6G"KP[1PD<-[7"9=3R*KQ!F>:9JJN)IPH87)L+3IX7,(T)
MXC$0S#$X?"4J56<VX_FE1117QI^G!1110 4444 %%%% !1110 4444 %%%%
M!1110![_ /LG_P#)T?[.G_9:_AO_ .I1IU?VXU_$=^R?_P G1_LZ?]EK^&__
M *E&G5_;C7]U?1)_Y)SB[_L>8+_U7H_R7_:,?\EKX<?]DKFG_JX"BBBOZV/\
MYPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF&U\1:+I,-MITTUMX@AM-,LO^$5O+W5@#]X**_BG_9T_X*(_\%F/VO/VJ/\
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MZ<_9A\&_\%ZOV//VQ/A9\'OCQ\3_  /_ ,%._P!B+XHVVKQ^,/VA9/#7P_\
M@%\7_P!G>^LQ!LU?7= 35X%\4::9[FW-MX?T^\\<ZAK^F)JDFFWGA[5-,CT_
M5@#^B:OS5_X*8?M/_MC?LN^!O@7K_P"QM^RM<?M6>)?'WQ]\)_#SXF^'[?3O
M%>I-\/OA=K.G:Q<:U\17B\)NMS!'I-_9Z;9/=:ANTRW&H&2Y5MJBOP'\1_\
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M4+8RZK:ZZL&CE[2[UWP3J_AJTU6]TT _K^HK\O/CY\:_VO?VK?V*_@A\9?\
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MO$6JMK'B?X_?%KQC;:?!XQC\!^ / GA[Q1J>K:+::V%UN]ETO1[&.VO+N%W
M/ZWZ^"O^"E_[>?A3_@FE^Q]\1?VP/&OP_P#$?Q/\._#K5? VE7G@WPIJFEZ-
MK>HR>.?&>B>#+6>WU#6%>PABT^YUN*^NA(CR26\$D<*F5D%?S&_\%$O%_P#P
M7]_X)!>"OA__ ,%#?BC_ ,%%_AY^U]\*=+^*G@OP_P#M _LWZ?\  GPK\.O
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M&OXCOV3_ /DZ/]G3_LM?PW_]2C3J_MQK^ZOHD_\ ).<7?]CS!?\ JO1_DO\
MM&/^2U\./^R5S3_U<!1117];'^<X4444 %%%% !1110 4444 %%%% !1110
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MQ?XON9I[=/ TNH:^MM:ZFLUCH^IZK_8/BNT2/2=/\4MX?^T_^"RWB-?V&?\
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MOJ5O-K$EFB6L]_-!#;I" ?RS_&SX2?L1?LQ?\'%G_!)#X,?LE_'/XC>/=,\
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M  3*_P""I_QI^ ?A3X8QZ'XBT/\ 9)^,GQ(T#XV_ 'XIM>ZW8V4'@#P-X?\
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MZ5XT\02Z9J7@WX.GPU-=:#X3U.RG6+5);%KRTM_'%GXJMKN>&ZQ&WZ >'?\
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M;*_6'4M,CTI%1H[6*1_4OVP_^"+W_!-O]O#4?AAK7[3'[.&E^,]=^#_A32/
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M:U<6EI-<7$UK;PR7$S2:/[9/[ W[(7_!0#X?6?PT_:Y^!WA'XQ>'-(NKF_\
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M4*7NG7ES;/+;30SQK*7AECD"N/(OV7_V7/@5^QG\%?"G[/'[-W@2U^&OP?\
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M*UTBPET'P]<WD-K=:CI7AS1M#TO3FU>XLK%]8U5=4U2*QL;2[MK.WROVHO\
M@WZ_X)+_ +7_ ,4=8^,_QC_91T9?B3XENY]0\6^(OASXU^(7PF_X3#4KME>\
MU7Q3I/PY\4^&]$UG6+Z13+J.L7.G'5-2G>2XU"\N9Y&D(!^8/PC^)O@/]N__
M (.@H_CM^R'=:?XV^"_[%O[%'B'X.?M*?';P9)%??#_QU\1O%6I^+[?PWX&L
M?%-D)-,\5W&D7?B>P%C=6-U=6EU)\._$CV-S/9:##/<<W^R_\7_!O_!+C_@X
M4_X*0?!S]JG7](^%/PU_X*90_#O]H+]FSXP^-+F+P_X!\3^*-(GUIM3\"3^*
M]4EM]'TO56USQIXVT"%=0N[>%M8\+Z;8F2*?Q5X<AO\ ^G']F#]DK]F[]C#X
M7V/P:_9=^#W@SX,?#FQN9=0;0/"&G&"35=5N%1+C6_$>LWDMWKGB?7;B..*&
M;6O$&I:EJ;V\,%M]J%M;P11\E^V'^PE^R5^WU\.K;X6?M;_!'PC\9/">F7EQ
MJ?AXZY'?:=XC\(ZM=6QL[G5?!WC#0+S2O%7A:^N;?9#>2:)K%DFH10P0ZC'=
MP0QQJ ?S_?\ !S7^V-\+OB3^R!I'_!-+]GGQ=X8^-G[87[;OQ7^$'P^\$_"3
MX<ZYIGB[Q!HOAZS\>Z'XJN_%'BB#1)]03P[IVHWVAZ7H&F/JSV<UVNJW^MVJ
M2Z5X=UFYM/W;O?V-/#NO?L(:7^QSK$_A_P#M/3OV0X/V7],^(6H>%K'Q+-X<
MF7X.Q?"Y?%6G6%_+;7$XLIXX]:CT^/5-/>Z>".(WMO(1<1^*_L2?\$7_ /@F
MQ_P3S\6WGQ$_9:_9H\/>$/B3=V=YIL?Q'\4:_P"+OB5XYTG3-05([_3O#GB+
MXA:[XDO?"]K?1)Y%^/#K:9-J%LSVE]-<VS&&OU'H ^#O^"<7[#?AW_@G]^R#
M\!_V8HM=T'XD^(O@QX0U/PI=_%JV\!Z?X)U;Q='J7BC6_$37,^FQZGXAO=/1
M$U:&Q>VE\1:GYPL8YWFRXCC^[V7<K+EEW*5W*2K#((RK#E6&<@CD'!IU% '\
M>O\ P;K?&#P)^P5\7/V]_P#@DE^U'KVA?"/]I/P=^UGXY^,/PT?QS>6WAFW^
M/GPV\;Z1H5CI/B/P5JVKR6UMXANWT?PYI/BJRTZ*Y?4;WPYXHMKJQMK@Z/X@
M73/Z /BE_P %3OV&OA'^U#\$/V-?$/QNTG7_ -HOX_ZH^C^!_AU\.-.U3XFZ
MGIUXQB^P-X\/@6UUU? %IJR-=7.GW_BK^S;)M/TO5M6NY[32=/N+Y;?[;W_!
M+C]@_P#X*+6.AP_M=?L]>%/B?K7A>VEL?#'CF"\UWP;\1O#^GS7"W4VEZ;X^
M\%:IX?\ %0T:2Y5KC^Q+K5+G1TN99KN.Q2[E><\?^Q'_ ,$?/^"=/_!._7=1
M\8?LI_LV^&O WC_5+.\TRZ^).O:SXI^(GQ$CTK4"C7VDZ;XP\?ZWXDUG0],O
M?+1;ZRT.YTZ&_14COEN8XXU0 _'/_@F2?^.E?_@N@.Q^'GP!/Y:!\/\ _$U-
M_P '8?\ R;O_ ,$\_P#M)/\  _\ ]1_QG7]!_P -OV*_V9_A%^T=\;?VM?AY
M\,K+P[^T%^T9I^A:5\9/B##K7B2[NO&5CX:@T^VT:&XTC4-8N_#^F_9(-+T^
M/S-'TK3Y)Q:QFX>5BQ9?VJ?V+/V:/VU_#_P_\+?M-?#*R^)^A?"WXC:+\6?
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MN;[3I6MZ-JVE75AK6@:[I5QF73]9T;4+'4+8230K<&WN+B&7Y._9+_X(\?\
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M_< >_?\ ! ?0-3_:L^-'_!1?_@L?XVM)Y+G]LKX^:S\(/V;IK]I99M*_95^
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M8CXP^#40DD*@B./S98H@[[5\R2-,[G4'^B?]J/\ 96^ W[:'P7\2_L]_M*^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_9Z_Z*9\7_\ P.\+?_,W7\X?\2T^*W_0LRG_ ,/>#/[<_P")Y_H^?]#KB/\
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M1_\ B+YC_7_#/RO_ #145_2[_P .4OV>O^BF?%__ ,#O"W_S-T?\.4OV>O\
MHIGQ?_\  [PM_P#,W1_Q+3XK?]"S*?\ P]X,/^)Y_H^?]#KB/_Q%\Q_K_AGY
M7_FBHK^EW_ARE^SU_P!%,^+_ /X'>%O_ )FZ/^'*7[/7_13/B_\ ^!WA;_YF
MZ/\ B6GQ6_Z%F4_^'O!A_P 3S_1\_P"AUQ'_ .(OF/\ 7_#/RO\ S145_2[_
M ,.4OV>O^BF?%_\ \#O"W_S-T?\ #E+]GK_HIGQ?_P# [PM_\S='_$M/BM_T
M+,I_\/>##_B>?Z/G_0ZXC_\ $7S'^O\ AGY7_FBHK^EW_ARE^SU_T4SXO_\
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M(W_B!<1?_,8?\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\
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M]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9__!6K_HVC]G;_ ,.*O_S94?\
M$2L#_P!$GXC?^(%Q%_\ ,8?\0/S;_HX7@K_XMS@O_P">9^I]%?EA_P +/_X*
MU?\ 1M'[.W_AQ5_^;*C_ (6?_P %:O\ HVC]G;_PXJ__ #94?\1*P/\ T2?B
M-_X@7$7_ ,QA_P 0/S;_ *.%X*_^+<X+_P#GF?J?17Y8?\+/_P""M7_1M'[.
MW_AQ5_\ FRH_X6?_ ,%:O^C:/V=O_#BK_P#-E1_Q$K _]$GXC?\ B!<1?_,8
M?\0/S;_HX7@K_P"+<X+_ /GF?J?17Y8?\+/_ ."M7_1M'[.W_AQ5_P#FRH_X
M6?\ \%:O^C:/V=O_  XJ_P#S94?\1*P/_1)^(W_B!<1?_,8?\0/S;_HX7@K_
M .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9__!6K_HVC]G;_
M ,.*O_S94?\ $2L#_P!$GXC?^(%Q%_\ ,8?\0/S;_HX7@K_XMS@O_P">9^I]
M%?EA_P +/_X*U?\ 1M'[.W_AQ5_^;*C_ (6?_P %:O\ HVC]G;_PXJ__ #94
M?\1*P/\ T2?B-_X@7$7_ ,QA_P 0/S;_ *.%X*_^+<X+_P#GF?J?17Y8?\+/
M_P""M7_1M'[.W_AQ5_\ FRH_X6?_ ,%:O^C:/V=O_#BK_P#-E1_Q$K _]$GX
MC?\ B!<1?_,8?\0/S;_HX7@K_P"+<X+_ /GF?J?17Y8?\+/_ ."M7_1M'[.W
M_AQ5_P#FRH_X6?\ \%:O^C:/V=O_  XJ_P#S94?\1*P/_1)^(W_B!<1?_,8?
M\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9_
M_!6K_HVC]G;_ ,.*O_S94?\ $2L#_P!$GXC?^(%Q%_\ ,8?\0/S;_HX7@K_X
MMS@O_P">9^I]%?EA_P +/_X*U?\ 1M'[.W_AQ5_^;*C_ (6?_P %:O\ HVC]
MG;_PXJ__ #94?\1*P/\ T2?B-_X@7$7_ ,QA_P 0/S;_ *.%X*_^+<X+_P#G
MF?J?17Y8?\+/_P""M7_1M'[.W_AQ5_\ FRH_X6?_ ,%:O^C:/V=O_#BK_P#-
ME1_Q$K _]$GXC?\ B!<1?_,8?\0/S;_HX7@K_P"+<X+_ /GF?J?17Y8?\+/_
M ."M7_1M'[.W_AQ5_P#FRH_X6?\ \%:O^C:/V=O_  XJ_P#S94?\1*P/_1)^
M(W_B!<1?_,8?\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\
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M]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9__!6K_HVC]G;_ ,.*O_S94?\
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M(W_B!<1?_,8?\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\
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M]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9__!6K_HVC]G;_ ,.*O_S94?\
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M(W_B!<1?_,8?\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\
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M]%?EA_PL_P#X*U?]&T?L[?\ AQ5_^;*C_A9__!6K_HVC]G;_ ,.*O_S94?\
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M(W_B!<1?_,8?\0/S;_HX7@K_ .+<X+_^>9^I]%?EA_PL_P#X*U?]&T?L[?\
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M/_1R/!O_ ,6IPCY?]3#S_#UM];45\D_V/_P5)_Z-[^!O_AQ-._\ FFH_L?\
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M &/_ ,%2?^C>_@;_ .'$T[_YIJ/['_X*D_\ 1O?P-_\ #B:=_P#--1_K5/\
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MVHKY)_L?_@J3_P!&]_ W_P .)IW_ ,TU']C_ /!4G_HWOX&_^'$T[_YIJ/\
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M^7_4P\_P];?6U%?)/]C_ /!4G_HWOX&_^'$T[_YIJ/['_P""I/\ T;W\#?\
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M*%:E*4)Q;*A?[Q_#^0J:H7^\?P_D*Z#C)J*KT4 6**KT4 6**KT4 6**KT4
M6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**K
MT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6
M**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT
M4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6*
M*KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4
M 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**
MKT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4
M6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**K
MT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6
M**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT
M4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6*
M*KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4
M 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**
MKT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4
M6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**K
MT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6**KT4 6
-*A?[Q_#^0IM% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img247211528_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_2.jpg
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M/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP #A"24T$!
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MK(MKC5'B\:8T[9%4 Y9DQZ##'C-C1XA16K/WL/\ ,_\ )/#RQDE_R0F87O\
M,3A>)Y%,F6IBIAOS+I_=IN#YIY97_#YC9$^-6:Y8_%0O*'MSBVAW_P &&:_K
MVOM]38/NY?X?UNV^F\KXVKNO\"K\(O=?/)D>G_Y(W'1?=KVW^@)2<L1^-_\
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M<;-R=LCK;<L2(TLNR^F\QHP2X(W$7!%Z\\3/6#ZG&Y0F7-YDRU;/S?F_EQ)
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M_P#4(<(N8G'/K XUYIJ(3$9%K<EMJBVGR@C1&C$?_:IQL-XG]#=OAM>SV/\
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M.(QYN*&27%D)D*78HXG]5"QC1@2I*2*386M:XN*I'J#Y@#;_ $WK%K>#/2;
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M; @@,(8K(=="(16L:Y[NG9J*NR:DX6'D<AF18&(N_*GD6-%\W=@JC734D"E
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M2">]I6M-1A_^8+R$TT;(DTF[U23&RKZ*;60@%BI59@C(+$;[$"QL#U-Q\_\
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M,K41[%\NX2;#8NQD5R[Z>3B.[8]PCY;<S,+;X]=$%["W2_7\])OXQAK P-O
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MPVCGD?%&TQD+TWD=K]SB215Y$LT;W?8\[E6M8&RK\Q-K*R[KJ Q(6UZO3?\
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M<:PJ9&N29?/R;&<@E)*J26+A3,B/B,M\V+,0,J76GA3"C<&:%5LW*X_-<1#
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M/,B+W?Z09^_TZAYS#+[NF/54V(/^%03^DFKIQ"#BO:W"4Z/.)9C_ ,;M;_E
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MJHW@%E!DS2H\AXX3LAI(BM*UOF422]SB@48RM$Q-E57)JU#F^\^7!/%X<6-
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MOP<=B=K]Z=_9^?W+#%ECB<))H,>4!XVEEE],2O&;K((0/E5@5#NK$$J*YT<
M<IYQ@/*>&%HKBWE0[_*L?H+['2SI4JOR"OOK>)4R GAF(42S@MF>+'.C4*(S
M$5'=*N1>3_97O?N;M[W!XW%P<C(EP<_,C@G@9V=)4E;86VL2!)'?>KBS#:;D
MJ2#W!^(;VZ[0[I]K.7S>1Q<6'D^,P)<G&R5C1)(7A0N$WJ 3%)M]-HS=3N!
MW!2.^Y6]#W;*CD8JM1??LJIO]2Z]17A<GPKQH5A;6FNMW=LGXE_7IHQM56X5
M(#M:R3-+6 M*P]G'1SCU@+"&6Q UJ;N4T 9W2Q(U$[>IB;>W49<G%DR&Q(YH
M6RT'S1AU+K_O(#N'U@5+;"SH\5<Z6"=,%S996C=8V/\ 1D*A&^HFI[4L, +&
MJ%< 6/6C2A@=!508-H*2JHB[+JJI,<@0?&C2U,IER[JOT=GY=%%)3O\ Q?GT
M4G[0_+SI6DIVD/[$^O\ -MHIQ6'2FE=U")')L2,9-C1RHA(Y4]Q0/1PB)_\
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M5E^4V8BM>_C)]FNR>V>WL/W"[3P\?C<YL]<7(A@41PSB5)'241+9$EC,9#%
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MF ]=-@V+(Y85A'E"<&1 D DHH90I 7JUXU1R.:O=IZ>#&G@?&S%23&E4HRN
M5=6%F0@Z,""00;W!JO"FR\/)3,P'DCS8'61'C+!XV0AED5EU4JP!# BQ'6M8
M:GT8>GBBR<.31L*F2#PY;)T*BMK^VL\7A2PE0P'LHIAGLDBC%:CAADO.!JHG
MP=B;:AXSV"]JN'YP<]A\6/O<<F]$>61X8W!N&6%V*?*=5#;E4VL-!70'-?BJ
M]].X>V&[7Y#FS_#Y8C'))'##%DRQD;65\B- Y##1RNUF!-V-S6T;G*N[G+NJ
M[JJK[5[?SZW'7/T5@+#RK"F2\$<=9EG29]ET&TRF>E:&K9CV0V\FUPD4:,]I
MHK@8G(3Y8,T>0CBINCF/(]SGM<Y45-?<K[9=J<]W)_Y-SL<V;D^D(Q!/(TF(
M%4W6V,W[L$-=O$%B68$V(VOP7O'WSVOVA_X9VS-C\=AF=ICDXT*PYY9@5<-F
M+^](9;)X,JJJJRJ"#D^1+H\;K K+E4V.4L)K(L;S,BOI*F(W;]W%CH5\6$!-
MD^$;=OH3692S\;Q&(OK/CXG'Q@*NYDAB4>"BY5%^ %OHK7^-B\OW!R++C1Y6
M=RTMW;:LF1,Y\6:P>1OBQO\ $UQLYJM\?]*_WFW#?.537Q_Y"]7^&R,-SS)&
M71IE [,:>PQS%;*WJHT%X:Z+8MQ],>EG(4DMD@<>21K!$1SUUESF7B=O=[<=
MW)C+$^!R@&-+,'+#4@(RE3L(OLN=0==0:T)WNR^WGNMQ7<63B^E'RA/'YDDO
MJ*\)8J(_W9VJAWB(OO4DK<BUJKOKWR"XQ+UZ?=OV@90X\ F09=6$1T&O,44N
M9G''5'9**>:(2:!)5#D90/8PB,Z7*Y$1_P 6I/?65DX7=7;TL3%8FS2C 6UW
M64@Z7M9O.WCUI_W1Y#-XKO;M":"1HX7Y4Q2 6LRR (5:X)M\W@1YUU\+WN;M
M^RYS?KV7;]&MI>%JWG&.M:T<_>F'#^=SUUS)MIV*9=5P_EH<@KHD>P%/JVE(
M<-?<U<@L9)8XIS/< HS!*+K<W=S%Z4TY[I^RG;?NFT.9FRRX7-XZ;$R(@K;H
M[EO3E1K!U5B2A#*RW-B0;5T)[*?B([O]E!D8'&P0<AVWER"1\69F0+* %]6&
M1+F-F4!7!5D<*I*AA>H\!^F3$.!WV=M$M9^59=<PVULO(K*+'KQPZIIV27U=
M-5QR2&0(\J2$9)!'F,8[A,17-8Q&Z?\ :WV;[<]K(9Y..EER^8R0%DR)0JML
M4W$<:+HB;OF;5F8@7:P #'O/[_\ =WO9DX\7+Q08/ 8;,\.)"69?48;6EED?
MYI9-ORKHJHI8*MV8GGQZZ[;(YG.!::W?*;0TV-4!L3AD5Z05BV,536EE&&O[
MHDF1<-,$I$3K3P&L5=FHFN/OQ59O,S^Y28'(%_X1!@PMBJ?L6<$S2*.A<R@H
MS=0$5;VM7?'X)>/[?Q_:&3D^+$9Y_(Y/(7-<6]0&,@01,?M",0E9$7[)+NUK
MDFKA^[^MLD!RIE%%7EDNQ.;A4RUR2*BO= C6L2TJXV.6*LW\(%C)4\H#7(G6
M8*/1=T&G3DWX0\WF%[DY7C(2Y[>.$LDBZ[$G]15B8#H'=#(#;5E76^T6Q#\=
MO'< W:?"<Q.(U[K'(-#$UAZCXOI.TRL?M-''((BM[A7<@6WF^WGK/Y%RGCSB
M>&[$YDJJGY7DL?')=W">X4RLKG5MA8RF0Y+$ZHDNQ2$@6E:J/:-7]"H[94WQ
M^)#N_GNT/;T2=O2/!EYN8F,TZ:/%&R2.VQAJCR; @<:@%MI#6(YK_"7V'VUW
MW[IF'NF*/)P>/P),M,:0 QSRK)%&GJ*='2+U#(4-U8JNX%;@\G^.>5<[XXS"
MIRC&[VW)+9:04L*LUA-E0LEB'F!%*J+2&4I1S4L1D4;'.:XHRN:\:H]$77"?
MMQWWW5VIWCA9_%Y63)ZV7%'-"TCNF0DDBHR.K$AF(;Y6MN5K$$5Z4>[/MKV7
MWIV#R/&\QAX<7W?!FE@G6*.-\62*-G22-U52JJ5 =+[&2ZL+=/0F15ZW-1KF
M;.<G2Y=W-[?V7*FR=3>Y?IUZV-8,0.@->(<*F50>A('Z:;<Y41/B7W=_?V:0
M5+L54+2$?]'Y?Z-)50%JCU]F^W;[M_Z-)?6WC3@2ZWI"D54V1-OIW_HTMJJ"
MV-Z;55]Z[?7JAF(-J=5"W2A%=[U_']6FJE*MNO6A5]Z_C713E8!]3OJ#Q;TP
M<+9?R_DXQV!*<(JS$<9\=H).:YY<^)&Q7$X;E^)J6,YJDE%3?RM>"0=?A$NK
M1SW-8G;_ !4W*YA CB70?SF/V5'TG\PN:QGO+NKC.Q^V<KNCEF Q<:,D+XR.
M=$C'Q=K#X"Y\*\ZW)_#.:8YZ)LH]5_,=E-G\Y>K3GGC%[9I5DPY,?!;"\GYK
M8&''ZV$B0\O7$8R18BITQZ"!!$B(CWIK0?*<?FQ=C\CWGS)8<URA38+D&. M
MN15M8@O8$C^:%^-<3]T<#S>-[,\_[M]T[T[S[D>(1BY5\?"9]\<:D$%3*$#6
M!%HQ'>VHKTV\91"UW&?&T"28IY,+CS"(LDT@I#2"R 8O5#,0YBN>4IGE:JN<
MY5<J]JZZ&XN-XN,QHG)+KCQ@DZFX10;DUW=V[!)C=O<?CRL6ECP,=6)-R66%
M 22=;D@WOK5^"Z>M.M[!,[>HI7(P8VIVN(1Z]C!L:F[E7L1$WU..G6KU&N]M
MI-JXVA^](Q*[R*FS^-B7)43CR1SZ'@G%G5]A2GQ'*<?93Y9:WF=7/F%A.;;V
M<*#"L:V*U"DBPV#1"[G-K6#^Y?&JLV2T$YPH<]<4.I4JQ87+^%@+BXU/E7/3
M_B*[>QTS.1DP>0/#8?/Q<6)D,312M(/FF%V!"Q[E+ Z@$;2;D5V:>BL<YJ.Z
MNERHCFJO2NR]CF[_ -5>]-;%UUOYUTV(]C7OTIQJKLG:O<GM^C0:KJ:;VHF^
MH;_:-'C4-U3NTE2%7<;5HC]YEQSS_P L^B_E7!O36:]7DBV/BAIM'B>0CQ/+
MLSX_@9##E<@81BF2F>,51?Y)CPR""YSFH=K7@^+Q>AV?^V/)=O\ $]Z8F?W*
M(_X:@D :1/4CCE*$122(/M*CV)\M&\+AG-@E,!$1U\? D>-C]%:&?=X>G3U>
MX9P1ZNZ4^.<E<&X3R)R%QO;>FCB+/LL-2YW@U;43ZN3RY)K".OI$O!Z?*H07
M1(D<TZ.^:0+RD</Q7')G_N'W'V?F\]Q$PEQL[.Q\>9<S(B0-%*S C'#?*!*R
M'YF(4A00 #;:(F+#DB-]NY8R1M%];>/Y?Z:Z*2N*_4K6S;G)L-SBQBV!TM&T
M.-Y7F$7*8-)76$SB"O!$CQIX'U4[(J?#\>R(,.1/ERHK9LUQBO*62IVZV/+=
ML2K'BYL"F,;=[QQE"Q R"22#N"-(\)8*JMM6P "[:E-%D@;E/S6\3]'7\QJN
M6V.^KU]8.5!S",7+*^+GL)RUI^/JW"KN5/=0&P"V!CMGCTNS@084"KEQ9PI<
M^3+BV5@^1'=(BL:/46')[.$A22$_=&,1U$K2J!O$JEU<*22RLI5 K(@5MKDF
ME*Y=[J?F%^G3PMX=/Y:NK+<4]1.4YQ6QV9+7T/&++WCNXMX5%<P(=C)JZ6?@
MEGDV/1IX\>!DAC3;&#D#)Y'G#$L*H\  !1RI*58V'E]MXF"SF)I.4,<RJ64D
M!F$JHY&\H  8M@L61Q(S%AMIYTRW>U[+?P/A^;\_P_.;?S7!?5#<7V71L:SV
M%2X;<9S53*ML2PJ 7<#%#3YLZZDQITC'YDZ#;5?RVK#"B-(L(P"2F21&\5RK
M(P<_M:&"%LK'+YJ0,&N&*EP %!&\ JUW+-]H$*5*VI&BRB2%;3Z?R_+K5G.X
M^]9;KN[G&S6GZ;VJI(<L;;^L%0B6MI9:W'@4S*%DVGO+3(B1_+2:XD4#8K#M
MD-=N!$F?Q'LL0)&('O&[$?(=_P S#;\V^S*J7NKAB6V[2/FJGT\S<+'P\]#]
M/QJZZ7&/5]'GX_53<YK4Q^+8UH,COYDC"K>_G4 \GB%N958Q<,&YN23JE):Q
MGR&>4#6/ !0_,!OD+$GR>S6CDF2!OO!5BB 2*H?8=H;]Y]@-MO;YBX9K^F0M
M5*N:/E#?G\K^&GY#\]5.TA^K]<+XVC4L_"VYM$E9>WDBTLI6/DC6L+S!8F''
M'7@I&5T&3(KC^=.. 0C(<P XSG2@O>9K43]F_?LEIEF^XD1^BJA[J; R"Y:Y
M (V@L!N4EOD8!:J/WW8NVV_6_P"FWA60^*:GG2LOLR_VL9749%CW35Q\); J
M:.)+<,8W/F6-C,J UQ?F!&N0<L#X8XZG;XD5S1+T:MW+R\#)CP?PB%X\GYC+
M=F(^  :^GBI#7MHPOK3D R0[>L04%K:5F_5AJ51HHHT44:**/=[=N[?2W\"%
M(^(O15+)4Q_$\Q%5T*1X@RO<#J8$[Q/>]GF0C<-2I^]>FR.;NCEUA_,=D\1R
M[_>(%7%Y(:I*BZJWB;7 -Q<=?&FY(DF4I* 0?A4=L@\K_G1>+X?RSYEXS.OR
M_D/)?Z-Y7_,^4_Y+??J[?$WU8?X+WYZ?\-]9/NF^WJ6%_3V];7ZW^-6G^$8O
MWKX;;VMX[JGK>SL;&SGA@M)TCD3X)K.4URL?&#<O4<4@C-52( ;"(-\4K7(C
MF[JFVFII^Y.X\Z7"XE!C<=&[(\\BL#H;$QC]HW&@%]-:MG'\5%Z:3R@'Y00#
M]%,1ZD(R^:EO?/F[N<DB2JO4;GR'R5\'K5Y.GQ"=BO<1VR)V]FLLX7LKB.')
MFG#97)O8M+(=PN+_ -6#JO4W\]/*I<I*(RIHGE54]WU_KUF0=@NR_P GEX59
M,E5L&MK>A>_[/TZJJRY/VJ>'W?C_ $:E1_U8^FK3E_9I?]'Z-/'[0^NK+D?U
MM&EJBA>_4A/LBH+?:-":4TR_A27=ZZ4=*BO]JH:6J:-%%&BBDN=LFWOTH )H
MII55>]=5T4:* ">E6/R5@55RA@>48!=%/&KLGK'P7S8J-=)KY(RBEUUE'8]4
M&4L"PC"*C';-(C5:JHB[ZQSN[MOC^\>VLWM?DV*X>; 8V9;;D.A1UOIN1PK@
M'0D6.E9IV!WCR?MYWCQG>_"A&Y/C<I9E5[[7 NKQO;4+)&S(2-0&N-17*&']
MWIS.7(VUD_(<&@XRDE&FR^+8SI<I8/7\4B%B[ZX,I;)PNU@3'8!I/VC.:FZ\
M+XGX2.]'YD8F?G\>.!#_ #3QF0RM'?7; 4%I"/!I-JG]I@-?3S/_ !^>V\?;
MASN)XKE9.ZS%\F+*L2P++;3?DK(=T2MJ2D6]E%MJDZ==L6QVIPK&,<P^A&\=
M+B]'64%6PKVD/Y*JB"A@?((UJ-))*P/61R(B.>Y5V3?7?/%<9B<3QF/Q6$NW
M"Q84BC!ZA(U"*#YFP%SXG6O*OF.6SN?YC+Y[E&W\GG9,N1*P%@TDSF1R!X#<
MQL/ 6%5X2J\K&N=LU[VM5=]MD<NRK]&R+JXA5JW7V@L!<@&O//Z@.1LPY"Y5
MS.9D]A8(VHR:\HZ>C(<XX6/UU-:2:^-!APE<T<<R,C(\Q.E"%,YSG*NZ;>2_
MNYW;W%W/W_R<O,S3!<7-F@AAW,$@CAD9$5$N K$*&=K;F8EB>E>]7L%V#VCV
M5[5<-%V[CXS-G<;CY.1D!%:3*ER(EDD>20@EE!8HB7V(BA0!K?I#Z!N0LNS#
MCO,*+)Y\ZXAX-D%778[;6)S2I;*^WJB3CT19IU>64*G(!I ];G/$&6T>_0UB
M)VC^%[NGG>Y>Q<C'YV23(_A^;Z,,TA+.T9C5_3+G5O2)L"22%95)T%><OXV.
MQ>U^SO='$R^V(8<7^+<=]YR<>)0D:3+,\9E6-;*@G W,J@*75F ^8UO2I%5=
MMNK;W?T)].NE=HKC[04A7JOLV[??JD^0JH GPKB5ZW\GR6ZYTO<>NCRDHL6@
MT8,8JR.>D!D*QIX=A(MPQU7P22;*<<K7FV5RH)![[,V3S4_$_P OS6=[GS\1
MR3..*P\>'[M&;[-LD:N\H7H6>0LI?4V0+>RVKV/_  6<!VWQ?LQC\]PR1GG>
M0RLG[[, /5WQ3-'' S?:"1Q!&5+@7D+V):]:5<H8)EG)?IWY>%1,G3A\ 5M7
MZCZ>*'Q2?*I.-6H,<S0-4C57R9\DXUO+@I1C1$DEJ O5%<%%U+]C$YOG^W^?
M[;C,C\1B8T67""25AR5D(M'_ #/5CWEE%@3&&M?6N4__ -5KVX[=[E]K\#G,
M:../OH3S!'0 2S0P1>KN>VK&%[!'-R/4*WM8#*WJMYC9R_B'W4O/K93)-G_M
M!OL<R:2)^_1D]%+XR)=N<YO[*S9.+OF-W7M&='=RZZ@[AYM>=X+MCG[WF&=%
MZGF)%9$?\[*Q \:\=N\^YQW/V9V/WF?Z\<OCK/\ ":.2-)@?+YXV/T,/"]>B
MB87HDF1$[$,9._W$<B:Z 8?,?IKKY5&YA;2]2KC[HB(U4]_;I+'SJO8*2A53
MOW1/_M*FCZ:<1 #TK'?(O%?'O*\"'$S[%8M^.M>5U;->69!LZU3[>8;!MZT\
M2?'#(5J>()">$]417-541=8GW7V+VGWQB)B]U8$.9#$Q*%@RO&3UV2(5=;V&
MX!K&PN#:LY[)]Q>]?;G.DS>R>2GX_(F4"14*M'*%O;U(I%>-RMSM8KN6YL1<
MT[@/'."\75)J3 <9@XY E';*GK&=(DSK.4QBC')M+.<638V)1#56L\4KD&U5
M1B-1534KMGM+MOLWCOX5VQAPX>"6W,J W=K6W.[$N[6T!9C8:"PION_O3NOO
M[E?XUWCGS\AR03:K2$61+WV1HH5(UOJ515!.IN:F\ZP_&>1L8LL/S&K9:T=H
MT2F!XCXYP2(Y/%B3X$L2H>%8PBIU",Q45J]B[M5S5>[D[;X7NWAIN [@@7(X
MK( #(20;@W5E8:HZ'564@@_"X+/:?=/<'9'/X_<_:V0^+S6,Q*.H!%B+,CJ;
MJ\;J2KHP(8'SL1KGQ]Z..(\ RF%EK39-E4^GECGT,/)YU::KJIX'^)%GK#K:
MJN2SFP2(CP.DJ\8R-1Z,ZVM<FINSOP[^W?9?.)W#AKEY?(0MNA^\R*Z0MX.J
MJB!G7]EGW;3J!NUK>_??XH/=3W![<?M?D&PL/B\A-N1]UB>-YU\4=WDD*QM^
MVD>T,/E)*W%;9J9?:O:OM5WM]J_2NMZ5SH$"Z 4RXKO?OMW+OM[-%5JIN#;2
MD)(555.WL3?]KLTEO"^M2 +]!4%,J_UMO^%OI>FE5!&/@0*@LC;WK]3M)8'J
M*D>B!J#>A#*OO^U=-2 7MX54(_A4/&<G>Y?JW_#WZ6R[=.M5*I+"X-J/&W]R
M_P#"3]6J:>V+Y5RP]1_IRY$]6_K+X]I,LM,>E>E+@G'*?(;ZCK+X/SJ1R%DJ
M6$JUHLAH4=YHEKD=570X@93$\&!1OE)NV1)V=KWN3MW,[GY_$@R7B/;.*?4E
MC#?.\G549?YI\?Z-_$UH_P!PO;SE_<CO?BL/D)L<^W'&VGR8%?\ >S9 ),<4
MB#]A]-2;! X NU67]\5+&O%'IIPP7@119'ZBX+(T,31@CCC8[QMF8P C 8C6
M#!%?:A:QC4Z6-Z41$3;5I]WB/_&(L0?VV9$@'32]B!\-:QK\5I'_ .-L3C%6
MQRN8Q8E4:#]H  >0OH!TKK[% V%#B06-Z6P8D6$Q$7N;$ ..U-OH06VMJJFQ
M0@Z* /S "NH(8%AB6*WV%"__  BW\E:3_>,<X2.#_23R9:T\]8&9<@QX_$&"
MF&1&R8][R"R36V5M'1%1_7C>("L['J;VL=%:ONUBG>W,C@>V\KD+VF],HGGO
M<6%OHU/U5K7WC[OC[$]N.3YY#MS?0,,%NIFF!1=H\2 2P^BN8WJ6].[.#_NM
MO3LP==Y#(\5YNXPY-R9.A&'A2N4*B_Q!D,[MD>UU/37M3"=OW/!K6'/=O-Q'
MM*D,B@9Z.F3(3X2.=QO_ +H*K]5<V=]^W<_:7X2H<.52O.0RP\CD-^U]XG8N
MUSYH&C3_ (+>5=_<!R!F48'@N2L<CVY%A>*7GB=6Z.=:T%?.([?V_&==;HP,
ME<KCX,L'26%'_P#B4'^6NV^!SUY;@<#E4.Y<K"@E!\_4B1[_ %WJ\6OV^GNV
M[?S:?=O(U>%'G3[7KV;+V>[31 /TU5MOK:GD7=$7\.Q=46-/1@AKFIEG[*?;
M^?5)%NM2@0>E2\\,N576,.OFK66$N!.C5]HV.*8ZLGR(A0PK%L,VP9;H$I[#
M()_P$5G2O8JZ<A9%E5Y%WQA@2M[;@"+BXU%QI?PJB3<5LNAK29/3AZD(TJXN
MH_/98-S8TU!"/.^?YT1K8V,ERJ1$I+0\N,4MG2SK7(&V$BP7RUO'$$M7&*&*
M9) LUD[D[:98X7X_= KN;;(NK^F"R@$;6"IL":QDD2L"R[3;CC3_ &E>QM;]
M-_\ 75XTO!7J$6+=SI_J3R*QNY4+(I>*6<59Q<8A9%/OL7L\;NI.*1PU\2;C
M8::KFP9%*67.BL%.5\8S7JKTM\_/=N[T2/C(UA#()%-@Y0*ZNHD-R'+,K"0*
MK$K9EMI2B">]_5UN?]7Y?[:D)?IVYUFS_ LN>KO*<;'R!2WR4U_97,;:@QW-
MJ#*,?<4=+5Q2%NH%+4DJ9-<:2:GM"E98E\*2-6/>7N3@4C+18"19)QV3<@4_
M.\;HWVF-E+,) X D0 QBZFXK^[37^=[C<#]7G^7TUD7'>,L\H.8[G(9O*YSX
MWD609/DL+C1LVQ&O\M64._B6'35E,V/*G5F37U$3Y@UJNBCAMCL>QID8ZW9/
M*<?D<,F.F(!DQQHAFL/M@J5^;J R+*-E_F+;B"5N*DQW20MON3;\P&OZ=?H-
M8>B^EWGJGIAQ<9Y[N<<LI-?B]5DDB->9C9$R*%B6+8-C$6>EQD0;N;2Y!/+C
M<Z<><P$@ZI,9">XT=BO2\-W5V_-,6RN/22(,[("L8V&1Y7(VIM#(-ZJ%N!\I
M<!6TILXLH7Y9+-8#K]'Q\:R;F_"'*%[ETW(:?F3(,5HI=5B46=%@6-S16$R;
MCRX]'M;*QGT:P(O1:TD*T8@F(, )%BIV,8YO4VV8/.\7CX:X\V%'+.&D()"L
M 'WE0 US\K%-=20FTDBG6QG9[^I?6_QM^7ZJL^CX7]0L8D6TB>HV1DMY6S*L
MU_!G6F1&QBU.&W+DDFJ-71O-@QZ)<X])K0=4:/X@XS7.8Q62'^),GYOMU@87
MXT10,K!"%0.HV[ US8N5<.;$V+6N;J+((9@=PDNU^G\GZJ=H^ O4C"FX8>S]
M2>16$.ML*N?FT2,:S83(),&[NI)"UDBUKK@4&M6B-"@%JO!'$G.&0QGL,UA'
M)/W!VU)'.L7&1J[*PB)V_("JCY@I6[;]S"2Y900H!6XJE<>==EY#H03KUU/Q
M\JW+=^T[LZ>U?A3?9O;W)ONO9K":N5)T44:**-%%&BBC114U_P"0_P#IO_J^
MDN;TS_\ 4?\ M_\ JJ9L>R?9;;)_&S-D[D3]\3N3Z=+"!98P%5 ;Z>)\S5MP
M_P#IXO\ <7]0J6=^A/S)J346;[+?EX&D^[ZT_3I1UJS9'V1]-"]_V?ITY5CR
M?M4\/N_'^C4J/^K'TU:<O[-+_H_1IX_:'UU9<C^MHTM44+WZD)]D5!;[1H32
MFF7\*2[O72CI45_M5#2U31HHH32&YT%%-O\ 9]OZ-. 6HI&EHH1-]4EK4Y&;
M7I:)MIHZM?PIVL;<H\KX1P_C2Y/G-LZO@DDI"@1(H'3;:WGJ-Q?)5< ;FOD&
M:)JO>YRL$)GQ/>U-M\3[S[X[:]O.(/.=T9'HXA;8BJI>660@G9$@U8V!))LJ
M@79@*V![;^V'>GNQW$.V>R<49&>(S)([L(X8(@0#)-*VB+N(50 7=CM16-ZQ
MEQ%ZI>)^9[DN-8U,MZG)6QSS(M%DT 5=+M(D5OB2C5)XTN="FOBB^,H4(T[1
MHK^A6-<Y,8]OO>OL7W)S'XS@I9X>61"_H9"".1T'VFC*LZ.%N-P#;E!N5MK6
M>>['X;O<_P!F^/BYKNF#&GX"601_>L24S11R-]F.8,D<D9>Q",R;&(VAMU@7
M(OJKX(D>J6[]&#\YBP?4?2\2X[SB+CVPC'B2,@XSR*SNZA+_ !>P<UT&Y-13
MZ(B6<1KF2H8C@,K'!(KV;2:>,R&"_P ]@?TUHQ89!&)P/W=[7^-4/E7TA<.\
ML9*?+[<.18]D-@X;[J9B=G$@!O"C:P:2K&#85MI$2P>)B-?("P1"(B*]7N3?
M6G.]/83V[[\YAN?Y6'(@Y5[>J^-+Z7K6  ,BE74O8 %U"L0!<DBNC/;3\4?N
MY[8=O#M;@LC$R>"BW>C'F0^M]WW$DK"ZO&P3<2PC8LBDG:%N169^/N.L/XMQ
M:'AV#5#*BDB%*?PW&++FV%A+5OF[2UL)#GR;"REJQO65Z]C6M8U&L:UK=D]L
M]K\)V?P\/ =NP)C\7#?:HN22VK.[&[.['5F8DGZ !6HN\N\^YN_^X)^ZN[LI
M\SG,BV]R H"J+)'&B@+'&@T1%  ZZDDGD?ZC?4WRK:<H99CV,Y9=X;C&(7]C
MCU;7X],+4R)AJ642#+M+:9&\.9*D2Y87N8-S_"$+I:C=]W+P#[S^]G?N5WWG
M\-P?(9/&\+QN4\$<>.QB9VB.UY976SL7<$JI.Q4V@+>Y/JK^'?\ #?[78?MC
MQ?<7<W%8?,=R<OA1Y4LN4@F2-)UWQP01M=$5$*AG"^H[[B6 VJ-Q/1;SCE_*
M^-Y;0YS*=<W>#R:-8V2$&,<NVI[\5FD<%MX+!A/9UTFG(GCHU''"1JOW>QSG
M=*?AR]Q^=]P>V,N'N1_6Y;C9TC,]@#-'(A9"^T!3(I5E9@!N7:2+W)X__%O[
M/]L^U7>>#D=GQ_=N!YC%DE&-N++CRPNJ2"+<2PA<.C*I)V-O53MV@9TY0X*X
MPYC2 3.\>=-L*L3X]?=UD^737D:(1ZE?"^802,=(@J55>@3-*-CU5S4:JJJ[
M,[V]M>RO<-(AW5A+//""(Y59HI44ZE1(A!*$Z[6W+?4 $DUI[VY]X/<;VKEF
M_P#!^1;%QLD@RPNB30.P%@YBD#*) --Z[6M8$D "IS"^'.,^.\4N,*Q7%8<2
M@R*-+B9,*8619S<E!/@FK)8[ZRG%/,L&$KI! HQ7((0WN0;6HY=[EVKV7VQV
M5Q1X7MG$CQ<!B2X%V:1B+%I'8EW:V@+$V&@L*M/?/?G=_N5RK<WWSG29^>8S
M&NX*L<<9O>.*) J1H222%4%B;L2=:\X_)V4^G/TVXSFOI=!PMF/*3_2MZML6
MR7%LAY.Y"F0TBQ,CKZ0!2PXN(1:0GR<]&&KIDCF\4,\<U)AT0S.AVH^6S^V^
MUH<[@(N.?)/&9<66/6D)4F5@&= +%0OR@+J#>^AZ\+]R\YV3V'B<MVAB<&^:
MO"YD'(;<F<^FYG==\L00;D]$A+(1M)()\;^F>FNXN34M)DD%_B0<BIZJ_A/1
M6N1T2[@1[.,O4Q$8[]S*;VHB(OLUT%%.F3 F3'K'(BN/H8 C]!KKC#R8\O&3
M+A-X98U=3YAU##]!JH+V)]*[[?7^+55[U,"DZZ6JS.1<K)@^ YGF3(S9Q<7Q
MJWNPPW[H.3(@Q"%CB,K-G(!3]/B*FRHS?6.]V<VW;7:_(]PI'ZKX.%-.$_G-
M&A95-M;$@;OA>LN[)[<7N_O+BNUI)?0CY'D(,=I-+HLLBHS"^FX*3MOH6M7#
M:9SMS+.R)V5%Y*RX%TLA9+'PK>5%KHR]74V-&I!O^3L@#3X4 X#AJSL<CNW?
MRSE]W/<V?F3W"W-YZ\D7W +*PA76^P07]'TQTV%""NAOUKVA@]B_9_%[>':R
M=O<8W$"/82\*MD-I;U&RB/7]4_:]02 AM186%=G^$,^G\F<3X1G%M&%%MKRJ
M+\T'&'X40EC66,ZGFRX@U5?"B3Y%<XXV;JC&DZ4[M]>GWM]W)/WAV3Q?<^4@
MBRLW#21U LH?57*C^:S*67R4@5X]>YO:./V-[B<SV=ARF7#X_.DBC=C=C'HZ
M!R.KJK!7/BP)^%90>O>J_9[]MU_7K,*PQ4**;T*]$[._ZNW24]3+G+[5]^V_
MYM'C:JU4L+^5,O=V[)]OT]B:+ ?33@T%J0BJG=[OU?KT>-Z?B\:3NGO32T[8
MU'3>\?&G$%FHZE3N7\VJ&-S>I%0557OTE%"+LJ+[E1=%%<?_ $,V(Z+UL_>5
MPK&<0$*+R=DV13SR2O>,,2+E)K%TLRO<O4V%6VZHU5[6B3I39NR:U5V>D[^Y
M//8<0+R2F#8H)NS%BH%O,E@!]-JYC]M<N#BO?;W ^_2^G@)CXV3(S'Y42,RL
M[F_@JEB3Y::"L5\F>H+D'F[+JS.#5>+66"8%EX<QXTX^RO$J'(*<)ZA) *RZ
MMWV=?(GKD%C!.]SSA,)8RE1!(GAM77J/A?AT]L\;MN'@>Z\7[YW%(BF;++,3
M!.;:XRW]-1"?E&Y6,ECN^T+>8???XX/>;O+W!;NSM:3$A]O\#-]3!XJ?%@EA
MGAB<B.3+>2-ICD9"#<9(Y(_NY<"(63<W:WC_ #6MY$P7%<^K$4%=E=##O6"D
M$:KX*R JZ=$E&<K6]=;+&4)'KLFXU5=DUQ)W%PF7VUS^;V]G:Y>'DO$Q'[6T
MV5P/)ULR^885[<=@=Z<7[B]B\3W_ ,/=>*Y?CXLM Q!,8D0,Z.W2\3AT=M!=
M">E<E_5[D/#'J>YZ],&.R.4YD/C#BSD2ZDYRU^)RIV$93:W)**# 6IR8-C&,
MDEPZ\]2Z8^(:L#%L3&:553XLA[F_"W[E=T=O8W<65'%#QN&_WJ3"9O\ -S1(
M-Y/IVLI"@DQLWJ%;V3<+'AWW2_$W^'3W%]R>!]MI^?R?X1B<V@GR8\0R<7/.
M'54A.9ZBL$+CTSD+"^, Y;U-OS5N_P#> <8S^7_2%S=A-/*Q^LO%IZ/)J ^2
M68:*@!<8/E]!ET*+*M2L("N\ZE,Z)'<K5:IS,9_6UIWNWCCS';^7QT9C5IH2
M%+V" W!%R>@_57<'NMVX_=GM[R_;J-%'-DXK*ID8)&&# @,UB%!MMO;QK,WI
MYQG)\*X(X@P_-&PV99C/'N-4UZ.ODOF0@S8< 8TC E$#'?)\I&\,3W^&U'/8
MNR;;:KX+$R^.X3$X_-9&RH<=$<KJI*J!H3J1\:N/MYP7)]M=B<-V]S+QR<K@
M\;!!*R$E&:*,)=20"18 7(\*S.Q57??V;;:NE9G3K?VE^K]6E%/+T%33/V4^
MW\ZZ6EJ8$J]WL[?T::?K3L?3ZZ;FQ6S84V$]RM'.A3(1'(I6N:.9&+&>YK@%
M =JM:5516$&]/ZKFKLJ+&YC<2#JI!_,;^-Q^<'Z*5U+"U:75'HU4#H\.RY2R
M*534;<*%C3&QF'()E3 GUV<F+3RC+1QBYO2)553O--N'!CU'G5>ZQEED,S3)
M[TO=X\6,32>KOUM]H@Q?,!N/I-ZDGR^G<R;+"- I@IB$@?,; C]'7\_3ZJF8
M?HAQ=L=\:=R'E<N.E92546'&CFK:F!"H<!-@M9#@48KXU)%@5:^#9P!LC-+!
MG,)T%5AG(UEN^LHMN3&A#;V8DV+$O*)22VS<2=48DV9;7%UJ@88W6W'P^C32
MKRS#TK0\MK^.J=O)N84M3QW69/3QX5?&C;W%;DQ[1IH,R2R;&.V!$J+-L%D8
MBR(Z B1W,8-['*Z)A]V/B29,WW6%YLAD8DD_*R;=0+$7+#<6%C=FN2#H\V&2
M1\YVB^GE<6TINA])]503,UDAY#R<W\VX#EO'T&5Y&*&_Q>ERN5BL@<&KR!LU
MYWX_BX\1 *KK?"$*,R3*W([Q4Z%R.[I<A(%.-$/1R(Y2+G8[1B079+6WOZA+
MO<EMJZ"VJC#LQ.XVVD#SUJQ,C]&TY[,7)BG(4D-K"Y%A9;>VMH%\.-"I(\&K
MCQJ'%:..*WCQJO%YE>X]' <<(H;"NBE,:(66*3/Q^](P91EXP,+8QC55-R6)
M8EG8[26<-:5[$M8, KA"M!PB%&T_-NN3\+=!]'A5]\>>DVDP1)B2N0,KRI;'
M%\SPR:EF(8V%QG,HAXQ*88Y$^TZ:ZC+)>:$%ZE8-VR*FR:@<CW=/GE2F/%%M
MECD&W^?&0=QL%U8"S$6)JI,$!=KL>EOJO>K</Z,J]Y8AX')MS2$BTN,U"!J,
M9A1ZUC\3K..Z^FF0:8EV:IKVQ3\=BF^70+PR94LK)B2H:)$62O>K@,LF*C@N
M[79R6_>-,6!;:&-Q,5O<$*H*;'^>D.$3:S6T_P!'^BI:9Z*85I(D2+GF'/;=
MJX_*QNOA276D&OK8;,4K<2J9S 4.64Q95RR%6M?9F*116[E1'! UJ;U)WP\2
MA8,.!#Z@<D;22?4:1A=XVLMVL@ O'X%J#@EOM.?']5A6Y-%6EIJ*DICV)[<]
M/35=4:WE1X425:EK8((1+*3$K@1JZ(>>X"E>*.,8!N>K6-:U$1,+R)5GR'F5
M0BN[,%!)"W)-@222!>UR23XF]3D7:@6]R!55TS55&BBC111HHHT45-?^0_\
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M8GI]#TUM3L#._B79?'9-[N,94;_>CO&?_P!VM]^S_+?QKVRX7/8WE^XI&_\
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M"N3'?T,:M5DL6CR2,(KW_"YKJ^ON$1J^Q[O>NNL?=>&.*7B.9;I!FB-OBDI
M(_-N%OB:\%_?R)<&;MWN=A\F)RR12'^[G(5A]!&ZLF?<T99*L_2[E6 SWO)/
MXFY5NL5EHYA$=&ER*NO^80#*Y-F2H]S6RW$&J];/$17(G4F\OVE:2#@\OB)@
MP?#Y&5-0>C6;Q\+[NE7?\/GWG"[7Y+M[)211QO-9,:%E(!1R)!MN!<!BP-M
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M#^[/;"MJF7]L#[ Z'JWVN@\1U\A58XN5!JR6/Q/^BEO\0;#.<!VP(\665&D
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M,X;Z@X?'L/';CE7'XV25^? ;&RN++@6"FQ6)@\V!'Q6:!V,0H*OC<BLCJL,
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M_;.9VYRTN&X(R\24%3;J!9XV'P92/TUU5VUR4>7 JR])4LP\CT;2K7XDN+'
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MMR*='FK+M*:WBV4_)[]M*C?E,FI7PQ"KG=?C.W(U.Q=$>^WX@N(]U^W</MG
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MTE,;'G&48E@-K#R:"%<55]R:OK/GC46-)5C&3(X8,BV4]=/(V-_TU3ZQO<6
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M:4V"?&H=:^_\B:IJ6L@8V\:;<]&HKG+LB(KG*NR(B)VJJJJHB(FD9E52[$!
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MJ*EF.07G.PC^M#E["YL[/LSG.EY=+Q&KBXX4<3'XTB/6'0HEE-... +;/GG
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M7V1R'9W//AO??&WJ026TDBO\K#XD JX\&!'E6Y.$Y*'+QO1DU5QM8'J"=?\
M6*Q_A%M8\8Y<;%K4ZDB];3U5@O8&QK2N58LL2_L]:M^$C$[6$1S=8-R&/'RV
M ,E-'Z,/$-:Y'^CX5=L.63CLOT7(*'H? J>A^'E6S=7Q;RCS3FK2\."H+"TI
MZ(%A?0+N]%0L)5RK(4 4R-*.$H#.AR2[D9NC^AV[$<O9J]^W?8'*]\)E\5QH
MC]7&"N?48)HQVW70Z V+>(%K FCGN53!GBR 6(8$&WPU'Y7KLK@<(?IM]/5-
M#S.>&WEX332I5X6H\3P+&^N[F78/K:=TMHB. ^SM6Q@D*UF[&^(YK4W1.X^,
MAQ?;#V\ABY)_5CXW%^<I^VY8_(E_YSN%4FVFI UK%>$X?/[T[FAXC "KFYL]
M@6^R@L6=V( -D0%C87-K#4UK3 ];V3LNVR+G"Z)^,*;^(A5<BP;>QH75\1(T
MZ29\.;,$+MZ' $PKDZ45FZ*FF<+W_P"0;DU;D\''7B&:Q$;.944G[6YCM<CJ
M1M6_0$5TQR?X9N,'$,.'Y');GE0E?55!#(X'V=JC?&&.@;>]M"0:Z&5]E N*
MZ!;UIV2:ZT@1+*ODMW1LF%/CCEQ#M1>U$+',UVR]J;[+VZZ.:1)D6:(AHG16
M4CH0=01]((-<CF&2*1H9P5F1BK ]0RFQ!^@@BICJ7M3L]J?H]^HTG44"-3>D
M[[*BIIANM-L IL*CU[+[-U3\VV^HS_:-2D4% 3Y4>(ON3\OZ]1&0%C]-5F-2
M+&]JCUK]'X?;J&=#:E'2M&^;O7-B7"MYFE3+XWSS,8>&KG,"9=XN%LF _(^-
M^),;YERZDDC'#DR8*1\:S:GBQ#=)EF6<DP&C10;DDXW"R92K)ZB(7*FQ\F<H
M#\=5)(\!8^-8[F]PQ8<TD7ILY3=J-=50.;VZ"Q%CXFX\*JY/5]Z6<OSG$.-K
MZ4P^<R<R;CL'&L]X[,*WP#/R9AD& T=5D<._@G/A^29%EV)3H5:02/0SP->I
M6"* A(QXKE((Y)DTA"W)5A9EL&)%CJ I!/E^>A>;X;,DA22QE8BP(/RM<A?#
MQ(('G]8JOY5ZON",3Y.M^-;N7D3^4J@;:^KHX6!V]CD>82IU_AE$_'L":*.M
ME?'-?YO4,79 0#^(\XS$#$E%!!CXC/FQAD(%^[,=3N "Z,;MK8:*WQ\+7(O*
MR.=XS&R6@EN)T6P^5KGI<#3S*C_4#:S,1]97"=UFLS"IV%7W'D>'G3^.85KG
MO'UGB'G;NGB<&7./R/DT[' &QZB%?\_UL+QK0D%U7;=/[M?-(09+P^:D G1U
MD)3=97#:'U =;ZFT1-A>Z_14>/F..,QA>-XT#!;LK"Y7TV6PM>UY+7-K&PMK
M5,R3U[>G.EC5\.EILORNVLH^!YCB^,5G',^KFY!5Y]FW%V.#S&@B74*$96TQ
M>9ZBTDS'@#XX3&\L8QQ2&B2/@N2DN79$0;E8E@0"JN=IL3U]-@!X>-@1>F;N
M'BHOEB5W8;' "D$[W4;A<#H7!O\ 3\:OR'ZRN)<BMJ;%,&C9QE.=YK!/:<98
MJ3!<IHO]H6/EILAN*//ZFYL:I8$/BJ_%C$UH<A-M':@%51JYP6%AR\)EI&TL
MQ1<=-';<IVFX!4@&Y<7'RC7]-I?_ )#A.1%$&.2_V%(8;@?LM>U@I\&Z?G%]
M@^-<^I.3,#P3DG&W&?CF>XKCN94Z2AH.8.MR&LBVP(TT2.<T4Z*R3X1V(JHT
MK'(BKMOJR9<,F'D/C2V]2-RI^D&VGP\JN>/,F9BIDQ7"2(&'GJ+BN//*%/>8
MSG^6UV6(2/;/OK:>Z1-<K&V<6=/D2HMK$,54;)AS %:YKVJJ-[6+LYJHG-//
MXF7A\O.F8&]1Y68$]&#,2"#X@C\W3PKTE[ Y;B>9[0X^?A60XT>)%&R*1>)X
MT"LCCJI!!Z]0=PN#>M^_1C19!3\?9'9VH)42JR;)A6>-QY;""<>'%J8L";<
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M?$G8J[KK8_:GN9BY\R<)W(OW/G;J@+?8FD.GRV%DN? FVO6K-F\6T.Z;'^:
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M+&AO>ZJY"W/B0-"?$BJ'R#SMQOQG8BI\DM)9K@@AG)54T!UG,AQS-Z@FG[$
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M_ J"^1_NS_$/Z-1)?2N/L=/[RD/WC^^_P*A_ _W9_B+3)]'^A_B4O^9_OO\
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J

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img247211528_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_3.jpg
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M/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP #A"24T$!
M    #QP!6@ #&R5'' (   (  @ X0DE-!"4      !#\X1^)R+?)>"\T8C0'
M6'?K_^X #D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$!
M 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,#_\  $0@!:@(< P$1  (1 0,1 ?_$ 0    $#
M!0$! 0             ! @,$!08'" D*"P$  00# 0$!              $"
M P0%!@<("0H0  $$ 0," P0%" ,)" T&#P(! P0%!@ 1!R$2,1,(05%A%'&!
MH2(5\)&QT3(C%@G!X4+Q4F(S)#5%%S=C-,2%-I9'EW*"DL)#4W0EQ29&APJB
MLK-4576E9G:&MU9S@T1DI)76)W<1  (! P(#! <"!P@/!08""P$" P 1!!(%
M(3$&05$3!V%Q@2(R% B1H?"QP4)R(Q71X5)BPC,T%H*R0U-S@R1$E#5%A947
M"9*B8[-'\9.$9288PW0E)]+BTU1D5;34-O_:  P# 0 "$0,1 #\ ^_C111HH
MHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT4
M4:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**Q[+LAC8CBF3Y9,:=D1
M,8QZZR&4PSMYS\>EK9-D^RUONGF.-1E$?BNJ.YYJ;9MN1N4H+18\$DI YD1H
M6('I('"LELNV2[UO&)LT+*DV7E10JQY!I9%0$^@%KGT5\V&3^M_U,91E;V6Q
M>3[S&&W9:RJW&\?^4CXY5Q%/OC0%K'HST>T!EGM%QR6CQO*BD2]=D^;^X>=G
MF5N6['>8MSGQ@7U)#%I$"+>ZIX94B0 6!,FHL>)/&OLCL_TT>3&R["O3L^R8
MV:PCT29,^LY,CVLT@E#!HB3<JL6A4X  VX^[WI,YIL.?.#L7Y NX;,+(BD6V
M/Y($1AV/7R+O';!ZMEV%<#J?=B60- ^@B1BT;A-H2]BZ]Z>6O54_6G16#U%E
MH(\V9&$@ LOB1NT;E;_FL5U =E[=E?*SSFZ$QO+7S)W/I#!D:7;L:56A9B"_
MA2QK*BN18%T5]#&PU%=5A>L!]8?JVB>F:DH8=121LFS[+OG'*2KGR'8]375E
M<3(3+JX*-M+>9\^0#3##2@3Q]RJ8""[ZKYO^:Z>6N!CQX<"Y.^YA;PD<D1HB
M6UR2:?>(NP54!!8D^\ IK>OI\\AIO.?=<N;<,I\+I;;PGC21J&EDDDU:(8@W
MNJ;*S.[!@B@#2Q86YT]+'\Q"ZY4Y&I^,.5L9Q^GG98Z]"Q3)<76?'A%=-QY$
MQFFMZRQE6#C?XBQ',(\EI[;ST%LV_OH::'Y4>?F;U?OZ=,=3X\$.;D!O EAU
M*C.H+&-T=G()4$JP8@D:2HN#74_/KZ4MN\O.DY.MNB<S*R-NQ&3YJ#)T-(J.
MP031R1K&&"NRAT9+@-J#$ BO5O7J"O$5&BBC111HHHT44:**-%%&BBC111HH
MHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT4
M4:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:*
M*-%%&BBC111HHHT44:**-%%&BBC111HHHT45AEGR-@-+G&*<96^9XQ6<B9U4
M9-?X9@\Z[KXN5951X65..6VU!1//A8VM?C99!!^==9;,(_S37>J=R:**S/11
M1HHHT4533(D6PB2H$UAJ5#FQWX<R*^".,R8LEHF9##H%N)M/-&HDB]%1=M,D
M1)4,4@#1L""#Q!!X$'T$<*DBED@E6:%BLR,&4@V((-P0>P@BX->0&5?RH(LO
M+WY&&<OKCN!RY;KX4]KB:WF14,1QSO&LK+4;R#!LVHXJH,.RH_F-@@HXCZHI
M%Y6W/Z6MFR=X.3MNYS8VS.Y8P^$KN@)OHCD+#W1R4NC%1:^JU>ZME^N7J/"Z
M>7#WG9<;,ZCCC"C)$S1QRD"PDEA"$ZCS<1R*KFY&B]A9^"?YBW /'/JYI?Y6
MV"<3<E0;W#,BR+!6,]L[+&Y=#8V=/C-KGMSD5D03@N'Y-Z\R^;A)''_*'N@
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MP+F?G+ N0\73CS%;J:=G>2*]Z_\ W5C32J&KARVICL:4XX,4RF6#S LH#1.
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M?%U=A>3?ZJ&G<VHX>&<C4>293R@,?BUMLRLY4>/\DY AMO-!3M/2RBK-B?\
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M4#=>]6-%&RXJ*NNQ?0Q#_P 0#DO/F*F&R8(<@/J:WPDV(]-0%R#G\ITF(H3
MR-1<.TQAJJ;5JHK5C-O.S8Y/-(^C[$8P=94W7$==<0%!=T'4@ZFZ^?<)XH\9
MF8)_-B.RQ B^H.?C;C>U^/=42X.TH@,S>[V'5S-^1MPM5 [FF1'$.P*VR5W"
MT?!H+AMLH]@MR;*D,/YAAIF8Y7B ;]![!>7M)>W9-8\[KYAOM_C SG&\2VOP
M[/?E:U@=/LM?MJPN)M&OP[+\W;X;^[;ON>%ZD2SY*>L8E2;]U'S66RS+JT>D
MLLU"4Y-$HN3HXD5?YXQV'/F!4"<60BDFR(FUU3YCON4(E:42NG #2$ MS?\
M-![P>-S2&+81 T@_F0;'G?5W#M(^ZOFD_P#B2Y=A9<%^EZ4XML$.-S-G%?*:
MMYKDI_\ &AP.*ZZ;8//ONMH+'<A$G:!JO1-T7;OWTXP=21]0[L=Z>9L80(JK
M(P:SA[DJ.P%2./(^L5Y8^J_Y!>E=L7%4"8Y<I)'\'PP!Q]?9V5X!<(AM7L[+
MX-)X>W9$_3OKZ-])B^.M?%[S/;_*V/I-:[;GR7.:LV)7$>1N_6,*/B+R"U'8
MCMMLCYB%V-MHG04V1-:\D[-U9E<B/'(%^-@+ #[C]M;ODXL,?EIM2*"M\,/[
MIM[S%BQX6N3VDUTEF#@.8=(,XT;O1ELA-&&^X2[DV(2VW0D7;;W:WW<W VPW
M5-(%^0[ZXGTZ''4B('>Q)%M1M;N]53-?\CY:>^OD>SV>2B_TZDBM^S-2\/=_
M 5%(?_J*/O\ &'XZ^YKA2!9,< <-9(4*%-I7N,>-Z?\ AWY@S2NF#Q[2*5Y)
M9\LHK!SX["$O8*FK1 8JO?MKXH=1]%=1R[GGSK,# VZY3#'U#2-4SD27Y:CS
M(K],?1FX8D72&U0."THVG#)?M(^7C]SU+V5MQ,2R7\7C8H$Z&ET_&:M8F:%,
MEJK\5R&Z8545]$*6ZJQV#C@G>@E&;,]MQ5-4UZ'ZH_::L,XZ_ (\;5[PU#W4
M YD+R![16P_M3 &)=HKH&/N6X<^?Y?75#'A6SM9,R-JJ89J*R3"KK+$V)2D]
M+FN;,Q[=V.@#$)8YR$;:[D(G>\T7[P(FJD?1?5:[9,PF B::XQ]0TGAIUEN5
MR?>L:>V;MYD\#B)F6XDM\';8=IN.'"JS\!R895+4E+B%-R-B'.QO(V[-\HV.
M1#)QZ-7QGS'S36'V?N4:V%XG!#VIJ<=%]9)E8B'-U,(K>-KXQ>A1S/=PJ/\
M:.U%3.L($*FS1V^,V^(GD.^H!@W_ )-U+;A.1XN,*$;+:UNP=^:R@AEFQY@
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MSU5^EKHO;)Y.E=IFO^H;:<07MV_+Q@C[;UN%+[&ER#^,DKIP8P]#6I\U'?\
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M-QZ@A$GA[9&/!':WPW[U4?<2?95OAVT6Z%[)87(3MO&:!V-(NJ#)J)JECI%
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M=AKXD^9;:LUQVZC6F,=V<Y7S<MTV/+KA=TWZ]L]T>B+X;*.M5P6+]19,I_\
MYA[^O4:Z9OB>%T)MB=VWQ?V@KIK.EVQ/M]BG$';VJA.@FRZW[<VT[:0>TK^,
M5Q#I47W\=]G/W&KC'_Y(2=__ +/D]-O;Y'NU;BX;=<<])JE.?_J".W]^4?\
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M].\0/*J3>H%)I2?0*\S6YY.UG&^0DJH;,E:N4O7[OSD="["]B;/Q]NNW5=>
M4F?]F;;G/_.0RB-N?#\PC[37NUXE_:.X82_S<T1=?[8'[!7KMP5G^53N+L>Q
MZGFRK!*E+2ILX-=$:_%*>CJ)BR&YL.4UVO"X]7O@T/F*1GOLUL:)KZ6>1_5W
M5N[>7N/LFUC5%@I)#J"^^J1N672;V+:&50.[EQKYI^=_3^#MWF/F9LY"C,$4
MX!/ M(@#W_QBN36?R#O[.H<R0V).08[\P5+1I92GGK*G>,D,Y[X*CTM&GI1H
M#9%O*3M 0^Z;>_3)-FZWWK"AR\B4A4D8#6VEU'+58 \SP'YW#NM7+/&VO'E,
M*+:6US;BK<.5_O[NRJYO&60O,<Q>ZR1B55R8\6TI+^K1L[.?;6#9G!?DDX\^
M01TFFI*[VFCRFTA]J.*29C'\N(VR@F\9CSX]M2E?=DUGG=^)L#\/,^J]02;P
MQQS)BQ*C7(8=EAW>S[*M80(=AC-W82G;:;D,:XJX29!5BZU%GQ)1N11JV <2
M&TVT3 H\ J1>8;["H0J9".2Q.A.G?V?X91Y9DDOXC,=36)]UN7N^OF;&FONN
M4)U16TXP6X7MO;G;OO\ =67,@$#*N.[N#25..E9U=3%D/B8.5;XO2W(1QX(-
MM/*LLX2@)&KGG-&^QWJHB[W;5#MVVP9L.7CX\,<YC U6%R.P ]X';SXUCFDG
MDQ)8VD9@'!MQ/V]P^[A5*R+L2+R'CKUG74KH(W8I2LBTL<5C6GS,I8+L@I()
M9E!\H&.T.HE'[OOMGL[YW;\(9&.\L431W8J"%M?B3;O/#UW%.=9)GAF"NUP!
M<CG;A]G.J$YD.1"PTH[EK93J$'AM,<>)Z&Y 89M6Y[DI )88-193?8,1G?N#
MRV$!5\DQ77LGK7IY<2#,BE,T>JQ"CBMCQ+CAI'=?F;"K*[=E!I%8 (_)N8^W
M[C^_43M]0P3R:ZCUWXECF3&_#CR)#R1K8+-R>U)9EOFK:NQX,:R;45V7S$:9
M9[P7RMRP4OF1M$.5.N- SP.K:23[S,0.2&YTW^+M%A4L6R96E8F<K(AN1^;8
M]Q[3;\=4,J]%&J[&IMA!A-4GG6,7)*MLFE;"6\,MBDV576(P-RF1> 5555&6
MNQ ($76*;K_>,O#6#&@".G.1+LH'8IX<.XC\5JMP[9 '.0Q#$@C0>'+A?T_O
MTPLBR&PDNWD?\0@Y?8(L<'(<0H52Y4.MMLE*(C!QEIU^+'!Q73)9 .B")]T!
M34_S?F'N&:F7BP38TDRD!3'>.P7B6[C;D>=[5:3;]NQXS#.5DQ@;@D\;]G#N
M_)4;$6Q\\/DJ9QJB9%"?QZTG#Y$JS-M6ELV6U*5&\YAA$;4R[>_?=$W3?38N
MB>N\[%EAD++9U(222R.3>[ 'X=-N7;<4WYC"MQ&B0_GKQ8 ?F\.QJ8./VIUS
MU7)=@I%GR6Y,EW=]Z; ; Q(84%T^X71CM-B#1DH]B=$3;9-99?*C>9YH)LO/
M%]/ZWW=1![ #^< +6I3ND'*.(*@X ?E]O.KE^#3'Y+$Z9</?.P65C5S\.,S&
M^78+H[YS9^>W*-\!$21>T4VW1$768A\H-I.O]H94SR\-#I[@MV@J.5ZB_:21
MFT<09&^('O'+U\:!QN$(&)R9[R2'4?L0*40-6CZ.*XKLUD11LNY51-@[$4$0
M5W1-9>'RRZ4C$):.<O$#?]9[C7(XNOYW+[*C;<\A^%@!V'^#ZJF6EH8K4IYZ
M/&;BA'>.2Y/D$L.#!8193Y([+>1BNAQD;5PS10%L1W54%-9W%Z-Z6Q#*\.'%
MXDAXZP'3D![J?F_N\:C.=..V]NT\_76EF88<VC%1B*M3P3$<[XQHP4"UYG47
M.]59,A:L*?B!YT=R/=N7E">UNM7>9E4V?:XEC2''QU\(^X= NO<1Z1V56^;R
M,SW6D;Y7[W__ '?O;U<]3>H/TN9/R?AO&G#W&E_QMAG!&-R9T[D'C:_H+]9.
M>2(4N+88) C9%CCOF5>,8M<N2[.96*P@W4Q(K,EW\/;E0YEL0@2^( GB6L6
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M5BV%_P"?AU1J>/:"Q;^Q]%>=N2U7X5 Y&H&54TQ'-9]A6D@[^95A;?BE9)!
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M?XI/_P!8<89ABV-74(X[)\FN-X&TCFC3YB!=Q([YJH CL"#3&_==;SE3X6%
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MOJ0KOW)MT+RVF=-_..MM,L)O_8D'V\"37F_ZH<-<KR]BS26$N/FBP'$$212
MW[OA%C7S><-*V-=&V<#?RQ7;O'KX;?VM>W.F"&@4BUN';Z1^_7P\\P]9W!_=
M-M1[#6@N.OWN=Y2XNVSF4W1>]%1;22J;+[=:AL=OVI.X/ SO_;FNL=:DQ],8
M*]HP81ZOU:UTQR,2CC#"+T59,%/<FROM(B]=;WOQ"8"$_P )0?M!KB71X)WQ
MO\&_]J:N[#C:8A*4G6Q0:^3NJN B)^Y]JJ6R=$U<1E&UEB0!H/;Z*Q\T<AZA
M32K&\P[#WU]VW!"+_J*X/545%7AKBOHJ*FW_ *AT'147JB]=?-K>"#NV5;E\
MU+_YC5^E7HV1EZ-V=6%B-JP^!Y_T>.MJ:QU;'XI[J-%'BGNHT4>*>ZF]Z;*J
M+O\ #JG]&BI$)87--\SX?;_5I*?1YGP^W^K2@V-Z4,5-Q3D<3;KT73]9]%.\
M5NZE5U%\5^S1K/HH\5NZHR-214VVWZ;II"=7,@4Y7)INR?E^?4B@*+"I+7-Z
M3ZE^S3KCT4[Q&[J/J7[-%_51XI[J3<4Z+NFD)L+BCQ&[J;WC[_L70I)'&IJ<
MBHOAIU%+OJ Q@FY-';>D4MO';\RZ3PAWU)XAIJGNFR==_;_4ND,0[ZD4EA>H
MU\=2@6C(]%.[*752BC0"R\4-F[Z*7?;PZ?1IFDBYU/W\^WO'=2@D=M,[1+NW
M$5[A[5W%%W%>BBOO%4]GAJ!T5U965"&%C=%+6_2/&GW)]%4;E36R&D8*&PVV
M+AN ,<%BD!FB"1"<96S1#1-BZ_>39%\-87*Z:V/+QUQ9<>,1!M1 %M1]-2AU
MU E1;N[*I)%!"<:6,+DMB&:^8L%B03<)) "*-R48051'0(4/;?M4TW5%ZZUK
M.\NNELF9ID@9+H5"AC8<.=3@(9/%TCB+6[+4?*VK<Z-:_B#,^QBLN1&OG8PM
MQDBN)N2(,=>X)/F;*KGM\-D1=:OD^5T)CMASD3:N<G !>/NC3S-[<^RHC$IC
M*C@2>?"_JJ@&-=P&'&H34=VR"9^(5]^CH,.5CHN+*^5A1W!<-AL'R(6A']V0
MFO>G5=8MNB^J]NR@<&=9'C4,K@DVXGW;=R_EJ.3&AE)$@O&5 *VX$]_#M[_5
M5[^:C_)_B7X=E'XA^+>;\WYLGYO\6^0\[YOO^8WW\[_PG^+[^OAJMX'5OR_C
M:,OYWYR]]7;HMJ_0U<?55#Y#]9X6E/!\/E_%U6_%6\,BY1AT;]N#%5)M(U(:
MQK&7'D, K4[RD<**U%/]Y(\A7&T<5%%44E[4)4Z]"WGKW;=ISGV\QR2RH#J*
MVL& Y'C<F_ @<>X&M4QMHR<E%<$*&XB_=WW[!6LIW(N2V@>2$M)E2W#6XO)F
M*QY4>=3Q1#L"*Z\W(??&&3Y;DJ=LC9LO .[;0Y>L.KM\QIH]M14B3WR\2N)%
M0<+<;W-SW:N'=69AVG;H-+9+?K"VFS6L3SN/LMW<:Q:?#O;.IB6]X(S*W)Y2
MQ862RWG'[3'JN$1BOSK<9HW0D-0F'GD0%\Q5$_-3O0DT?U9ZIWA<;*W.<F"6
MRZR3XJIS][@+'F>_OXU-\WMN-))%C J8Q\(^%S[>?8/Q5>THH!9):4EO;R+)
MVLHY!XO9T0C\Q7-) 6R&QFLQ"7SI3L9H6D'<6S7851$>:76PXWEOM:2R1;A*
M^1[I\(@:"@XV+6^)@.VYN>)'&J$F\3.BR0QHHU^^#R/\7CV?D]58#R#A$;/.
M#;VD_AQHY;S%_2_BSTH&9#CEK3_/P9=F^TDDD=6\)A&'G%!DB%HMVVWB%']7
M="['O_0.X=,&"()D84\(=@ 5=XF".6/(ARIN3:LQTGU1E=/=:8'4:.P;%RX9
M=(Y%4D76H':"FH>TUXW0Y[B!Q[DCB*#S1RL9M$)-E!PQ22R#B;[BK<B,Z.R^
M"KKXRQ2RPXF!ES7&1BSMCR]XXE2#_9"OK;(D<N5FXL)OCY4"S1]QX:@1_8FL
MEQ*#&2YRS#YCR1(+EQYK<@FO.^4K+T@<*:VT:BCBP6YIN#U3[S7BFVL]LB01
M;YE;7DDK@S."Q O:.8>'(POP)4,S <!<<:PF]R9,FQ8^Z8BA\^%&"J38-)#^
MLC4D#@&957ML#7JC)QS'I.(0^.\F=;N(>*5,.F-V0+I,YQ(@DX_!^:2$K#C:
M1HCC<7RF#%]&UV)PA$$3Z.IB0Y?0>%Y=9L#[ETW% D$C3*W^4^&VM 6ATZ--
ME TO?2+%C>OFO+U7N2=:9'7FT,FW;Y/D/*!'9A!K72VGQ ;D\22RVU&X K@+
MFC%PH>9\JIOPPZF)F>#4%JU )M!8:D!6.X[,;A_?-'(K;M./8O<JJB_>7NW7
M7C;SRZ=SM@\UYH=PQSCQ;IM$$L:$ZAIB0XXL>T!8E%B2P %S>O:/D7U"F_\
ME7%.)3+E;;NT\<C&UR9'$]S;@+F5CP '<+5E?H_N9AV\&E:E,Q7+S';K')AR
M&5?3OKT:GH -=X(4A!A.H/<O;NJ[IK-?2IC#>NM8.F99?"7)QLF$D\R8+3@#
MN8I&]O;6+^J/$5>CWWE5U'%R\>?^QEO"]_1J=+^H5Z#6]?3X[3I+M'[2RK:M
MMF+54_>V;ISI1-Q(<:$0HPZ[-D/.(#1&X@L;J2J@BI)]0=K\LNF-OG&3.9,J
M 1LIB?X58BP<7[1W@_;7SRDZDGDC+(@5R;$]I'8/5>M+9?D-=CV+9%F'(&00
ML/PG$ZFWR[))#4UZ-4X[14L%VRN+F^R4@.^L&ZVMB$[(> V&>QM>UG9$WS>#
ML&R[=A)@8^/$<>-]=V4,Q?GJ)-^/=W5C)MRSII?$,C*2+6!MRY<:UORGRYP'
MPQ!H;3E/)JBA;RL+%_'FWZC*,SOKR#30&+2^N(=)C=1E&32*#'*N4U)L[(HR
M0*UEYLI+S2.!W9C60=5['\.ZJ.F_/B?P[ZJ*GF+@>:]1IBO*&+N2LGS*NX]Q
M@\,RB8;N09I:X-4\G0*2A"@><9NG'..+Z%?./M ]!8J93<EYT&BWTX2N.34O
M&U@2!70M3F-M2OLL9!+2WI'GFHZW+C#,>VIS?<%EAZT2*VS$LJM73$3?%IE^
M/OWFCH=Q#:@GLUN3=_\ [:<LC*-#FZ_BK;Z[HJBJ;*BJB[^Q4_4NIO"7MJ:X
M!O>L3S:PB0<8NF7[5BIE6=7:5M2\X3A/NVDF ^U%:B18P.S9;R.F*J+(&0CU
M5$3KI&1 +V ILS:HF0-8LI ]HM7 #V;8U61S<O[6/C\Z(@-6%);$L6^AS-D0
MH*4Q#^(RY"G]UH6&W?/W3R^Y"333(K#@:YN^-/$_A,C:P>[G6_.$K_+\<P1&
M[7$G&SM\BRG)JRLG73-?:TU1D%J_.J:N=7/52LPI:LK\R^R<@B9>DFV2HHJ(
MPB91?GSK?=M>7&P8\>8$L!QXCA<WM[*U7%LY5X#D^8XZ=J+[S5RT\2K)@V[)
MJ-C$EINJLO,R>[HNVX[$FXJBK)K)'#E:M"R!(,F0S7\4N2;]O'\+5?>*[&?;
MQ)RD?G8">=Y$[A;J^8L&QO:BDQQJ]?@F2K'E5T:[<LW(BM_NBELRG W)M"2.
M0$*2.1-;AM)F&VHDEPFIBH]'"WLO>U>4G*N2^N"%BGK$YOPW/N3,2Q'B/DSU
MCQ&;JZY0JLDH[?C[!F<DH>.,6XM]/@\9NV>)7^+9,=9/9R4[D@D0:Z5NU+2:
MC;5%M?$WX<:REQP[S71?/'J*XPS7/:&T3U4YOQKZ7I'#O(,[#.5O3I>3V6\P
M]3%!E]=$=P6?D]'C.3OW^1XE@DJ-84&&.M)$RB7-D"ZQ8?+)'!Q/;?AWTECZ
MZOT?U!\\YU*]1/#%7$G\>Y;PGZ?;SDJQY<L./RCY;*8Y%PNFRGTSV%5@MPY)
MQ.LY+R.GJ<P'*ZPV9D2DO:,&V(R-. R0"3<=HI>5=I<)W-[=<<^G'*+E^7(S
M7(>/N*)M_*EMJS964S(\ I+3.?Q-A&F%#S7')$N0VH +4EH5[1)$35B'X@#\
M-N-.A9EG73SO;V=OL[:ZW7KU55U<T(>7*LMXS?POOHV_+K^O1X:=PH\9OX5:
MBSZGM,;M@Y;PZ!)L+BJKV:[/\7@!WO\ (.!02=D=D..FPO9SA"//3*5S]N2T
M4BN)5&2TK3611QI/$(?Q5-R!Q'>/W1V>T=M;.JK6LOJJLO*2?&M*:Z@0[6IL
MX9^9%L*VP8"5"F1RV15:?8<$D1=B'?94145-*$0\@+5<65&&H$6/IJN_+PT[
MPD[A2^(OH^T4;_EMH\).X4NL?@:3?\MM'A)W"D\0=WWTO5/'=/I';1X2=PH\
M0?@:U7RQRLUQ+55%U(XVYBY(@V5D[73FN&< ?Y'M\<:;BE)&WO:"NGQ;I*=T
MA\D7(;$QQ'51";0?O:L8>"N9(8U>")@.'BOH!] 8\+^LBL;N>[+MD2S-CY60
MA:Q$$9E9?2R@AK?H@_N\B\N<T8YZD^/<EX=J?0WZ@O4!6YG"&NGXSS;Q19>G
M_B%F0#HO5]EF/(?*3M':T<>FF $D9-# L;ADFT**'F]JZS.+M@V[(7+ESL6#
M0;WBD$TGI"HEP2>5F95/:;5JN\;GC=2[=+LR[/FYT,RV*9$)QH ?S6>64J5T
MFQO$KR"UU%Z\?IO\G/TJ>G;E3@5KU*<@<B5O%/)>&Y+3YGF^,YW(POB+'_4L
MN4UMSB?'TG([JLL;W".,\FP>=/JZ&9;6 2;"QJ@1^8W*E R6[1];[_N&#E+L
M19<V&5"B?%*V/I(=@%*J[JX4L%2X5C86!-<$R?IV\N-NW7!DZLC+[?/"ZR.I
M58$RM89(RSHSI$R%TC9WU,R ,P9K'E_UI?R?>1/2@]GG// G)?$N6>G8'I^2
MTU!GN=1L?Y%HXLQY7Z["J-Z>4BNY4M'WW1AU/X?)*UM7#:;^6-\]SV'H[S*R
M&FCP<B!_VD2 6"$H;?$[@6*6/%B;*HO<BN2^<GTK1O%/N6QY</\ 5^Q,<;2A
M94'YL2:AIE/YL=F#-[HTECQR7C[^7'RK59+C9_S"^/>3\/X&O,2;NQ+TUXAD
MW,V43,CFQG1@85FDWC6NR?(.*;2J-UF6ZXY3S6))A\J+P'YJCFNH?-S-Z@V]
M\#8SB+EB0@F5A%[H/QIXA"N#RX,".=K<]5\MOHVP>BNI(NH.OSGOM(@)5,:,
MY%W8%=$OA!WC9;AK^&R-\((YCT*]$O\ )V]-,2TROF+E+C;F2UQ=_/TE>G_B
MGU"9*XQ>0..J6JK8\3*>7\#Q^)1PG+S,<H&;/ATED)+ J?E6YL=9!N@/,=^Z
M\WQXHMKQLE=0C(G>*^AG+$Z48DW55LI8<&-RIM:O4_0GT[^7.%F/U!G;6SD3
MZL:/*"EUC"BSS(BHMV;4PC9>":=8)N*]^!V 1;;$&FVP!MIMH&VFFFFQ0&VF
MFFQ%MIIL!01$401%$1$1$USL1ISM7I=!;W>%AR[+#N'JIZ$J+U7?X;_;X:#&
MEN5/(%"FJ^'3\R_T:IE3>F7%"DJHB?#KT\?LTFDTM,VT:32AB. -&WY==&DT
MNMN^CPT6/=4B,3SI-T]JHGUZ-)J354?F;^S[?U>S4L:>]Q'"G"CS/A]OZ]/E
MC M;A1Q[*=YB;(NR;K[/N[IX_#4&D^G[*./>:7O395V3?ITV3=?#X>&FT7/>
M:C[R1?9MU]B[_#VJFE!L;U(C<[TBEOU]OY?#3]?HI^KU?;^]2?EX:/$]'WTF
MMOX0^VE153P5?S?U:/$]'WTNMOX0_#V4=ZI_:_/MM_=T\FW92AF)Y\*13W\5
M_1HU>@U8N.\4GCHU<;6IP>W(T?#?K].E/$6I=;=]+UTSPU[A1K;OH3Z=0.MC
M8"D+,>TT[4=3J00./&U&DTCNIUR*5%V^G44@ M:I%-QQI"W5.OL\.FHR!8GM
MJ16-P*C_ "\-16/=4]O52HF_U:@DN&/I'&G*H;G5P_T3MU_SM[^G^\?=MIEC
M;T?O5#I7YO3V>'_*JLS*!5!+=OX%5-2R@YG/CS3<_P HIKB8P'XC&D2P,F&I
M/RKS:-"SV*ZOEN- I.>02ZQE=-;%\RVZ-C@YJS^(6)X,Y.H$@\" >S\=:%#F
M9/" M:(QA?4+6^VKB^\M3G#QO3J_&X.859/-/Q!;EUT]Z=2(R,R6;[@13A1[
M4U(5-L21WM5/W<EW;*RY.%MLP\9XH?'/\5;G23J+7Y<+7MS([ZC5)LC&Y,YB
M-@.X=H_>[O56#@Y5CCSN/OC.=LI%\+^/37WC<I[IU8S=>^9DX+8L-,1X_F,.
M*RVX:"T?81HXAZ=F==;!!!)'&[/DACHN/<8@VOJO\-QSMW5DX=JRLB57L!%H
MXV^(<^ '?Z+^VIYF8/,W)6<<H6/WN.08\9YB*W\S79)9I#",J@P ->7'<A"R
MRK+0BZ.P=RDC32CJF3YA[KFO'-LL)4H &LOB)*XX:%-@%U6L.WCZJLC:\2!6
MCR74ACJXFQ5>?_:%6Z.EV\Y'&-!FQGSD?B>3P[!WR:2UF :R&F6@%7&%5)+B
MDWY8(VV(]II[-7X>F/,+>L[)Q,CQ,=-"NRN=,+EK$*&L;\";^[PL:;D9VSP1
MA7"-'IT*Z<77^-;AW<[\Z\BN8,7D8QF7-&*%%;B'69$F?4<5ESS&FJ^U-K)V
M@CNJ(=X S,?9W1$_94?9KY@^;O1>;T5Y@]2=&Y842AUS(M)NI6=!,I0D"X#$
MKRY@BOISY2]41=3>7O3G4J,79(CAS$\]4#&$ZK=I"JW'OO6-?- F4XM<BJ)%
MRB@.LDFB(B++@_>:7NWV4RC2EVZ?V-:#XP?+P-R'"/(B,3^LCA?TUOPA9,;.
MVX_'!*)5]0/&O8_BJV8O..L0L6FV6R.I9:EBV""B6=>IUUBXJ?\ CG9,4B(O
M%=_'7V\\E]RPNH?*O9-WQHHEDFPD$O"_Z^&\$QMV$O&Q]M?(?S0VJ;IKS#WC
M9@[K F:[1@<C#-::(>H(X'LKD?UG520LIX;S0 5!<<R3#)QHFR+YPP[RM$B\
M$ZM2MMU]JZ\B_79L1Q\SI/K-;-IGR<&1@+"TBI-$/M62U>G_ *.=X$^/U-TH
M3\<$&8@_C(6BD(]C1W]5<V<(6W\)<GH)%Y;-1G<&6J)L*)77,@6I";#T1OY:
MR/ZDUY&\E-['27FYMV<QTPP;QCN>P>%.W@27]&B1KUZ;\VMI_K/Y8YN(!JEF
MVN=1V_K(E\:/VZT6O5W.JB;:4X)6M+*GU%I$N(T%#!LK!(8R8\F"T;A"T$I^
M'+<5A35 \\0151%54^X4L#D,G#AR]E?(1) ;.*Y1YUP61SAP#SAQ/CMM J;?
MD[B?D;C6#9W+$Q(F/7698E;8[$D9#7L-%:QF:Z78"<AE&_F/+$NT57;?$NC"
MZMP:U7%8, 5XBM#O\8>J]<NP/FRI7TS4W,6(\6YSP-/Q:;D?+]_QA;<=99;\
M?9;5Y;!R=C"L>S*IS:AS#!4675_AKE=;U;R,E,C/--O WWN?"].L.58-Q;Z*
M<\XLY^LO4K$Y/Q_(N2LKS&'5<@0I--:T7'N0<'V_#7#>"YI483@$([*EX>Y&
M#DKB=O)*^12]T6=7D%/9O/L(TY$ "#J[:4G[*]")$*3D#CV,531R9U@RL><X
MV!.,4E;*3RI5E:."BA&[8Y%Y#)+YLAWM$!4>XAGBC+,#^:*B=A:W::Z 63%:
MF1:MR2RU.ELO.PH+[[83Y<6&K029$:,9B_*;B(\'G$ DC?>G=MNFLB187-'B
M)RXVK0/S*V-C9Y!8D/SSMA:US/GF*?A5;6V<J Q51>]42,&T7S9';L3SYD1[
M["@T)BS.1V"D#*H\1R #WFWXZYXB<PQV?5'R;QKE6083383A'IZX6Y3I+*V<
MJ(%O#L\SSGGJCS.P6ZFRP?E4T*CXV@&+30HD8@>-57S-DK_G6-2+:VI>(KS>
MC>N[GKD/T[>K;/:>^?X4Y&XLP.7ZK^"VLP]/=I BYIZ:,B9R"!AV*V5/RM%I
M&\QDXS<4L5R[RJC,XSOXW!;9-$-5)FHD'L//V4X@>RO5MCBRB<HZT.5I53R?
ME<6-\M>YY/Q>KPI_*C1Y\XJV>-8K(:I ;C1' 8%C]\V0-=RIN2HDRZB=(O>J
M64N(!\QE*EE',C\+ULW")^(3X#G&TMR,S51WH@81 'NK_E8D:(LD*O'I,;L&
M)(QV0RX4,&R%T(Y=@(3;:IJ^GP:)+:J3$W'"R@88V)/8""#;T>KL]%9')Q7*
MH#B'73X.0,-=J,+8NG27;(A_BP*5&C2JN8;:=$-&X>_M3VZB;%!-T-7-!)LG
M[E48M9H!D28U=HXO:)N1[S'C$T!=Q17EO&#4!5=TW%-O=J+Y:3O%.L_=Q]8K
M'<>XQD4MIE5SC^'8UB%MG5TQD>9WDNP^>M<CO(E;$IH=E:-U7S;LY^OJ834>
M,TLQAF.T':V((1;O&*>TBC0YX< *VO0XM%I7W+&1+?N+Q]HF';66VVRC,<S%
MQV)5PFB)FMBNN ).;$X\\HHKKA]H[3K#I%EJ=%5/2W?63Z7PSWT_4*-&AN^C
M4*<CG9L:;B0JBBHKLHDG5%1=]]T5-(RD"]*#>M+XZ@<<Y])P3;R,*Y#?NLKX
M\'9!CT.7->9;9_@3"(O8Q"M1<<R&J:381[K)H$0&6QTSU4@&EM(^$\1Z^T?E
M'MK<O<GN7;W[=/TZ4&QN:>.!X]E6^WNZ?'ZR9=W]I7T=-7-$_/M[>9'KJV$R
M*B*NR9LMQJ.R*F:"FY;D1(B;JJ(LFL>FIO$4"YX"K''RB9:6=,S08[-M,:MJ
M4;PL[<FUD.@C,RX[SE3$BUDB2F27,^8:-DXV,6.RPPXAD]W_ +O07%J;XHN+
M E>_\.-:KXDXISO!<KY#R?->8<MY"8RB=%3%L4F3;)G#,+K4C1I-I^"TEC8W
M$J/(G71.BPCTR2L6"VV"&I..;,4$F_9211LK%W8M?D.P>S]_A6_$Z=4Z+[TU
M-4U!*1;=Q*6W]\JK^G0+"IXY%0>]>]ZMEO3U&0U-E09!4U5_0W,1VON*.]KH
M5Q2V\!]$1Z#:5-DQ)K["&ZB?>;>;,%]J=-/222)Q+"S)*IN&4D$'O!%B#Z11
M,V/D1-!.@>%Q9E8!E8=H(-P1Z"#7+L?TD>B[B)V=R13^GW@WCJSI8LUV-FD#
M!\>@2<4>FL.0AGXV_,8.OQ>S5R4@,.PPBJCI"*$F^K^1OV]9,!Q<G+G?&(L5
M+FQ'<>5QZ#>]:_C=,])[?/\ .XNWXD62#<.L:@J>PKV*>XK;N%;\XQM<=L<
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M!Z$KZ _1]O[;CT5O_1\K7FP<J+-B';HF7PY+>@/$I];5P[VNL8;V'_OW <H
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MD3TPUTVUL(7!^!QYEW6V5-9O)%L' ?J+FBR7&KBK9C/63L2O@6U)FEPS)9C
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M C,H1DHF1M\- 01W5;QL>-/UB_%R!OV</P_]M=9?*R=O][O[;=V_E.?L^_\
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M1<:3;-^-W+N W_C<GXBFNY2R (FY/S<#N K,UABB=2"!^-*G795T_74BR/\
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M]OXM-M_E-O\ POY59=?]+JT7WS7OTZR^)QQT_1KS[GNPS91_'-6==E39=]6
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M8<BW,W'O@ &UK\3VKB/I]#BNPHY/'.)\5NO8;AG^KC$\US5,GNN4XG'J3!M
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M>$PVJ\:29*J\T!'-S?-#4D)#Z$;5NJCNJ)X O7IT155&P^=7F1DY*(V>H4L
M0L$ _D5%-],GDQAXY9=J=W':V5E$_P#FV^ZKPUZ!?296N-"?#D=_S9+C0_CM
MMEC>Z@Y&,QB;95*&;)#O(2979&FMU[E(=M=MGZOZI_;>T8HR<@8^1-IE BBL
MXTWXVX@?PB/A'&M03R+\I8,')D3:())42ZDSY#Z2>':X'JYW/"LYQST=>ES%
MIJ65'PQBD2:/:GG//7D_=!<%X1-BPN)49P$<!%[2!1Z>&NH29>5(-+.;>S]R
ML1@^5O0&!-XV-M6,LG>?$;EQY,Y!%[<+6KI9#1-A'[HBFR(FP@(BFPH*#L(B
MB)LB)T35>N@A1W"F/"W(9?C26694:0T;$B/( )$>0PXB@XR_'>$VGF7!78@(
M5%4\4TQE5U,;*"A%B" 00>8(/,'M!%/0NCK)'=74@@BX((Y$$<01V$<16.X]
MB&(8@DS^$L2QC%?Q!Q7)Y8[0U5*4XU)7-Y95T2,4@4<521"541?!$U0P=IVO
M:PPVS&QL8.;L(8DCU'O;0HN?766W+>-YWIT?><S*RVC72AGFDETCN7Q&;2/5
M:LA4^U-T7?X(7VZR%8X #E1YB;?M+OMX=?'W;[Z*< ;@]E1^:OQ_/_5I:FL#
MSKRJ]87+V7Y=R*7!N+29$.BKYM+36,"*^L4\JRB[2$XQ'L9'<"%502GLM-M$
MJ-*[WN&A;#V^!OJ4\Q=^W?JYO+#9I'BVB PI,JMI.3D3!65)&N/U,8=%"'W6
M8LS7LMOIC])'E3TQL/0X\X^H8HYMZG7(D@=UUC#Q<<NK21+8_KY#'(QD UJ@
M5$M=K\DKQC<V$N;!PR?5YX[3L6;MV% DJ"]5'4ONLRFBBY S5/SVI",..1'(
MJ._---F2"*BHZ\T?U9RYYGQ]F>+.:%7,@BNIC\,D,-,HC+ V)C* ZU!( L17
MK?\ KMM^-!%E=1Q3[6F0\8A,^EQ*)0"IU0&4(5U*LJR%?#9E!8@@U<7.%,^2
MTG546L;L'6'Y,> Y#EP56X)BV"E:D1X;\MBQ@UL^8CB1Y<IEF.ZK)H)JJ:L-
MT9OOS3XL40D=68*59?UEI/#!"E@ZH[7T2.JHVEK'A51/,?I8X,6=-,8HW56<
M.K_J@T1F*LZHT;R1II,D43/(NM25L:MI\0\E!$>G_P )3G(#!H)3H\FLE0W6
MRA1K$9D23&GNLSJPH<UDDEL*Y&[G@#O[R0=5STGU&(C/\HYQU/Q!D92"JOJ4
MAB&32RG6MTNRB]S:KB]?]'&=<7Y^(93#X&617!UM'H960%)-:./"<+)9&;3I
M!-/A\1Y]-B)+"D\I'X(6<%I^PJ&BEURHVX_8.$[9-C75T6*YYI2)/E,J@D*$
MIBJ(Z+I+?IHO%$%@R:U!>,:DYES=QH0+Q+OI7@0#<$4V?K[I7&R/ ;*N5E,;
ME8Y3HDXA8Q:,^)(S#2(X]3\0Q&D@G=WIHY7S#AOE2IXUO%EIBN3Y/"Q2\QI]
M\9#./WUR^W"J[^F5MYZ)'59\EE)21R5F9%=5S[QBV6N]_3UYA]0=(];0>7V[
M-(VPYTYA\%CJ^6R""8WB() 5S9753H8,''$7/F_ZG_+#I?KCR]G\T]C2->HL
M#'&09T71\WBJ0LD<P(5B\:W:-G D0JT9X&P]'_43RE,XBXLN<HJP:=OI$N#C
MU!YX^;'CVUJK_;8/M+]U]NNB1G7D;7[IN"(K]U5U[#\X.NI_+OH++ZAPE5MU
M+I!CAA=1-*2%=A^<(U#/I_.*@'@37ACR,\N<?S1\R<+IC<'9-FT29&25-G:"
M  M&A[&D8K'JYJ&+#B!7A_9W5C?W3]]DLZ??6,^:W+MYLV4;MA8#YHE(;64X
M7<V3C** ;;"WT041$1-?*S<-SS]XW*3=M[FFR]PFDU2R2,6DDX\1J/+AP4"R
MKP"@  5]E=LV?;MAVB/8^GH(,+;8(BD,<:!8X^%E.D?%QL6)NSFY8DDUT<U9
M<,7^1SG,XR:CF8FDNX=Q2JQ_$+W&YF/8[86=2W"J;"UI*NODOVM-3(_Y$0PG
M1VWVC<62X3_:O0$R>CL_<9#O>3"^U:I# D6/+"T43O&$C:2-%8O''JTQD2H&
M4MXK%[5R1\3S%VO:(UZ9PLF/??#B&5+/EP9"SY$<<I>6.*:615CFET:Y08)&
M1E3P5$=QDL//^!6'YDZ575<X[7'L<J+&O#'78((6%T;-8R[5S1J9 5=AFBSS
M69*::4QD0/./N5P=\E#OO0D<CSRQ1.9<>&-T$14?Y-$$!1O#.ALC4?$=5N'B
MUF^H7P^1TIYI2QQXT$T\2P9>1+'(<@.?\LF,A$J>*OB)AZ!X43-8I/H6P1K8
MPN7\1/09B.E5HU(G-VU35#BQ,RZ:GCS>*K.OPA^2Q7JT_(KV<<M:TY:.N#,$
MSD.'W2S1<9^UNDG@?68M+2"1$\&S1QJV"Z8Q8)8LHAGB+ZB) 6D9KRM6:'3_
M %]'DQ^'X_B)$8I93D@I-*R[G&^8%9[JLAR,7(6+2#$0L2+:!2.<ZF_NJ.[A
MY/1V4JBR*#+.PAVM2Y\I)A2G35UQ(RM[-_*FI*),$BL.-_<(5!5'6D;+O^\]
M/;M'O^R9#XN[Q/J62/A8DW*D#W60\C&P*$<"*ZEOW36P]3;)+TUU!C1YFR2I
MH:.4:K@"P8$^\LB\UD4AU;B#>O8#%O4<_9>F69S9:5L4LBHH5G3VE:P),UTW
M,:VS;H&'8[:&IL5=G+E1Y1!W;M-N&VG[*+KZ687FT,CR7/FE+ /FX\)BT(N$
M.4C^!I':(VFLW>$-KW%?)S/\EGQ_/H>3T&0WR<NX(J3FVL8;Q_,:R.1E2#4O
M<9!>UC:O(O+,MR3.;Z;DV6VTJ[NYYJ3\R4>Z-AONW%ALILU"@L"O:VRV@@ ^
M";]=?-;J'J+>^K-WEWWJ'(?*W28W9V/!1V)&O)(UY*B@*!Z;D_5[I?I;I_HO
M9(>G>E\6/$V>$6"*.+'MDD;G)*QXM(]V)[0+ 62'&.9,APFR$')LR+#;,]^P
M')<AN.!GVHI=@FXBKLBKMX:Q,49FE2%;!G=5'==B +^CC6:GF7'QY,AP2D<;
M.0.9"J6('IL.%;S=].V;M3:>!\S6.RLG<NXV(M,!/</)[#&XM_+NX-?_ )*(
M1E@-T/8KLDF6W'I30 I=KY-;NWE]O2S0P:HC+E&18 -1,SPK*TBI[MAI$5KN
M5!9U"DV<KS)/-OIJ3'R,K1,(,(0ME$E ,:/(:!(7D]Z[:S/?3&&95B=F U1"
M33V1TCF-W=C0/S(LZ942"@63L(9"16+2.B-V=>T<IF.Y(6LFH<<W1%&G3;4F
MU)M1(M1W'";;LV3 =T>:%M+E;V#C@Z@L 3H:ZEK68@E;J03T':-R7>-MAW6*
M-XL?(3Q(P^G48FXQR$*6"^(EG"DZE# . P(%KC29,*5&GP94J#/A/!)@SX,A
MZ'.A26U[FY,.7'-N1&?;)-T,"14TS"SLW;,R/<=NED@W"%@T<D;%'1AVJPXC
M\1Y$$<*EW#;\#=\"7:]U@BR=LG0K)%(H>-U/,,IN#^,<P0>->T'I7YAMN7N.
M)$K)B1S*L0NEQB\L&P%EN[%:^'9U-TK+>P,RI=?,0)(BB LEDS%$$T1/J'Y)
M]?9?F)T-#N^Y@?MF"9L?(*BP=XPI$@ X#Q$968#@'U6X6KY$>?7ESA^6/F)/
ML6U%OV%D0IDXP8W:..0L#$2>+>%(K*K'B4TWXW-=,[DOM7KT3JO5?<GQUUP\
MJXT 3RK#[W/,9QYUR+,L5DV+:+W556V5C8 OL1\&B2/"W_W=QK6Q[1TGU!OB
MK-A0:<0_W64^''_8D\7_ +!6KGW5GFGT+T6[8N\YJON8']&@4SSCT,B>[%_C
MGCK6MAS%9N*0U&/Q(8?V'[F<Y+>^E85;Y3(*ON^:+6_8/E9C@7W/-=F[5A0*
M/^W)<G_W8KA.\_4[EN6CZ:VB-(^R3+F+-Z_!@L!ZC.:Q23R/G,K=%OAABN_W
M*NJK8R"B^P79;-C(^OOUL^/T!TICCCC-*W?)+(?N0QC[JYON'GOYI9Y.C/AQ
M8SV8^-"MO[*43/[=561W)LH?_P =E62N;^/;;R8Z>._[,,HP(GT(FLM'TSTY
M%_-[?A@^F(-][ZC6K9'F5YC97&;?MU-_X,YC'V1!!5KD29DM^#*EV=S+E5;[
MLNLDR+JU>?KI3\.17OR8+QS".(^]!E.LF;:B1-.$"_=)4U8_8FS#EA85O\!%
M_P#L5CFZSZT9M1WG=BP/;F9'W?K.'LJO;O\ (FEW:R?)FUZ>%]:'X=?!V4X*
M_FU&_3VPR?SF!A'_ !*#\2BK,'F!U_C'5!ON[J?_ ,U*WW,S#[15VC9YF\1=
MVLJLG43P&>S66(+_ -E\S 5U47_L]_CK'3]$]*9 LV#$A/;&TD9^Y[?=6Q87
MG3YJ8!'A[S-,!V3Q8\H_[T0;_O5E,#F+*XZHD^!16X>!$ 2Z:2J;IU1QIRRB
MJ2__ +$4UKN=Y7;%*I.%/DX['OT3+]XC;_O$UT/9_J>ZRPRJ[YM^VYT(YF/Q
M,63[;SQD_P!@!6P:CE_%IRBU:A.QM]=A\RP )%8I*NVWXK!5UID57VR 836B
M[GY:]1X ,F%X6; /[T2)+?X)[,?4A>NU],_49Y=[ZRX^ZM/L^8W#_*5!@)__
M #,6J,>N41"MJL2&I+;3\=QI^.\".,R&'0>8=;7JCC3S2DTX"^Q154UH4@>%
MVBE5EE4V*L"&![B#Q!]!KN\,T.1 F3C.DF-(NI71@R,IY%64E6![""150BK[
M%_,OMTP2*:EL:<)JF^_5%3V_IWTQV!M:G*"#QJ02[DW\/AIE.JY[_P#F?Q_T
MKM__ $/AI/SO946D_-7MP\+^5689%_GVV_\ +'/T)K,;=_1U_0KSMN'].E_P
MA_'5DU9JK1HHHT44:*DB^+V4X=1/\7LJ8TNFTVC1132+M3\O?MI=)8<*6U4Y
M*I+O].WPU*. IU6BZ;4X*]HF9"Z"=C;8/.FCN['EM-N$"*X\3B BH0D"$I"J
M$B+K0/,W#^:Z0GFTJS8SQS<6*V",+D6XDV)L/RULO2,XAWR-&-DE5D/ 'F+C
MGRXCG6,S$04;D,,MMLD8.%\G#M8\-7!+S":%V6KSEB\**^(*8B#8MF:JA+UX
M7YE1#-QL+=X>*2PV+ -IYZA9B.5N7::ZWTW*L&0T#W!23M[CVU;K^GA9#36M
M%9 KU;=U<^HGBV78;D.RB/0Y'8YLO:XK+Q=I;+LNRZXO)&DL30RB\;*5([P>
M!^ZNJ[9FY&#F0Y^*VG)AF61#SLR-J4_:!7D)=^BGFNNR%RHHF,:OZ-9#@0,J
MDY#&J8Z0D-$9?NJIYIVWBRQ9)/,;C,RA(Q+L+94UR2;R\W,96C&EA.'?@S7#
M >E0#<CT&QKW?MWU.=&S;0,K<\;-CWL)[T,:!D9[<=$I8 (3Q&H J#:QMQ]&
M>)>,XO$_'M!A$>;^)O5J3)EO:C'2*-K>6TQV?:SFXR*:L1BDO>6P!$1C';!"
M)215UUK;<"':]OBV^ DQ1):YYD\R?1<DFU>1.K.I,SJWJ3+ZDS0(Y\N75H4W
M"* %1 >W2@ OVFY[:S\PWZ*G7Z/A\4\-M7:Q"2!N5,\L?RV_5HIQ?3Q-Z>@[
M]$'?ZM]_Z]+:H_'4]]:7S#U"<18)>.8YD&4(%Q'-&YT:LKIULE8ZNW[JR>@L
MNM1WA1=R;13<!/$47IK6\_JS8=MROD\J;_* ;,%5F"_I%18'T<2.T5TGI_RF
M\P.J=I_;.SX).WNI,;221Q&4=\2NP+ ]C<%/836W:*UI\DJ8%]064.YIK6.D
MJOLJ]X9$64RI*!*V:)NA-N 0F!(AMF*B2(2*FL_!/#DPK/CLKP.+JP-P0>1!
MKG&X8.=MN;+M^XQ209T+E)(W!#(PY@@_;W$6(N"*OX-[>*;[>Y.G7W_=U(S
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M/"M7S,F';]4N:?$SCQ"?P3V-SY7Y\^55+;(-[]B"'<X3CB VVVAF9*1$HM"
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M,J3A).3?T=_MJ]%T[ K 7N+]W[]4J-. $,$LIG;6CVUO83;10U\.]'&P$G5
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M_P#HU_OK^16CW_\ UB:>S]F?RZVOEYHF37J*O^DI*^"^\4]VVO9&#_1(_P!
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MX(FV8]$[3 D4"3Z4U2RT22(PR!6A:X92 586Y,IN"/013)462-HY &B86*D
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M&YULK@J%%XAYKY,],^0M1W\1LY2Y%Q^S9LC*AECN0OR;#'U8:>40)VFLGY$
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M76S*0-DV7+,_"+-R+<PWYM<!;/0S'R;.(&^RN13=V%X4VW0#7M5/V237E?\
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MRHJ+NB^W68!ORJA^.L=E95C\*]B8Q*N(<>]LFE>@U;I&+\MM.]?W)*'E$XJ
MJH'=WJB;[=4WUJ;JWIV#J!>EI<V!.HI$UICEK2,O'BH(L38$Z0=5A>UJR,6S
M[ID;;)O$,$C;7"X5Y +JC&W!K<1S'&UNR]ZO>WN368E))%ZQU/(FF6R>=,&6
MVP4W773%MML!3<S<,U0  4\5541-5IG6.,NY54',D@ >LGE2J&)LO%C38LN)
M.:\^#,BS6.Y0\^')8E,]X_M!YK!N!WC[4WW353'RH,R'Q\62*7'-QJ1@RFW
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M4XZ$]"L\+_A3/&&_O.&W0GY1V(-BF[TRI9\MTQ3[Q,L'MU3;7AWJ+>,SR_\
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MMT:**-%%&BBC111HHI=%%R.5'7XZ3A2W;TTJ?%>GT[Z#2J;GC01HG05W^/\
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M%%-VW\=1TM&VWAHHI=%%7K?_ -6]O_Q@_P#16NL6'_)2_;^W/Y%:!_ZFV_\
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M8?B/]&J7L_VKR%1^S_H[_+?43<_\VY4O_%*/^KKZM,;X?\VH_P"*4?\ 5YJ
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M/_9W^M__ (;X?_,K1_\ U _S_P#U=_COB_M*_]D
:                                   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img247211528_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_4.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *M!/(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFP)<6SWEIJENUH\;:CIMY;J);2:!T,B.-P1U9!]-:E^P'X<T;5K[0=6_:_\
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MLF?]#QK/_A'>)/\ Y K^::BC_B9CQ _Z >&/_#?F'_SV#_B3#PG_ .AGQO\
M^'?*/_G!Z_TM?Z6?^'DG[)G_ $/&L_\ A'>)/_D"C_AY)^R9_P!#QK/_ (1W
MB3_Y K^::BC_ (F8\0/^@'AC_P -^8?_ #V#_B3#PG_Z&?&__AWRC_YP>O\
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M_P#(%?S34C=#]#_*C_B9CQ _Z >&/_#?F'_SV#_B3#PG_P"AGQO_ .'?*/\
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M'>)/_D"OYIJ*/^)F/$#_ * >&/\ PWYA_P#/8/\ B3#PG_Z&?&__ (=\H_\
MG!Z_TM?Z6?\ AY)^R9_T/&L_^$=XD_\ D"C_ (>2?LF?]#QK/_A'>)/_ ) K
M^::BC_B9CQ _Z >&/_#?F'_SV#_B3#PG_P"AGQO_ .'?*/\ YP>O]+7^EG_A
MY)^R9_T/&L_^$=XD_P#D"C_AY)^R9_T/&L_^$=XD_P#D"OYIJ*/^)F/$#_H!
MX8_\-^8?_/8/^),/"?\ Z&?&_P#X=\H_^<'K_2U_I9_X>2?LF?\ 0\:S_P"$
M=XD_^0*/^'DG[)G_ $/&L_\ A'>)/_D"OYIJ*/\ B9CQ _Z >&/_  WYA_\
M/8/^),/"?_H9\;_^'?*/_G!Z_P!+7^EG_AY)^R9_T/&L_P#A'>)/_D"C_AY)
M^R9_T/&L_P#A'>)/_D"OYIJ*/^)F/$#_ * >&/\ PWYA_P#/8/\ B3#PG_Z&
M?&__ (=\H_\ G!Z_TM?Z6?\ AY)^R9_T/&L_^$=XD_\ D"C_ (>2?LF?]#QK
M/_A'>)/_ ) K^::BC_B9CQ _Z >&/_#?F'_SV#_B3#PG_P"AGQO_ .'?*/\
MYP>O]+7^EG_AY)^R9_T/&L_^$=XD_P#D"C_AY)^R9_T/&L_^$=XD_P#D"OYI
MJ*/^)F/$#_H!X8_\-^8?_/8/^),/"?\ Z&?&_P#X=\H_^<'K_2U_I9_X>2?L
MF?\ 0\:S_P"$=XD_^0*/^'DG[)G_ $/&L_\ A'>)/_D"OYIJ*/\ B9CQ _Z
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M_P#X=\H_^<'K_2U_I9_X>2?LF?\ 0\:S_P"$=XD_^0*/^'DG[)G_ $/&L_\
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M_P#H9\;_ /AWRC_YP>O]+7^EG_AY)^R9_P!#QK/_ (1WB3_Y H_X>2?LF?\
M0\:S_P"$=XD_^0*_FFHH_P")F/$#_H!X8_\ #?F'_P ]@_XDP\)_^AGQO_X=
M\H_^<'K_ $M?Z6?^'DG[)G_0\:S_ .$=XD_^0*/^'DG[)G_0\:S_ .$=XD_^
M0*_FFHH_XF8\0/\ H!X8_P##?F'_ ,]@_P"),/"?_H9\;_\ AWRC_P"<'K_2
MU_I9_P"'DG[)G_0\:S_X1WB3_P"0*/\ AY)^R9_T/&L_^$=XD_\ D"OYIJ*/
M^)F/$#_H!X8_\-^8?_/8/^),/"?_ *&?&_\ X=\H_P#G!Z_TM?Z6?^'DG[)G
M_0\:S_X1WB3_ .0*/^'DG[)G_0\:S_X1WB3_ .0*_FFHH_XF8\0/^@'AC_PW
MYA_\]@_XDP\)_P#H9\;_ /AWRC_YP>O]+7^EG_AY)^R9_P!#QK/_ (1WB3_Y
M H_X>2?LF?\ 0\:S_P"$=XD_^0*_FFHH_P")F/$#_H!X8_\ #?F'_P ]@_XD
MP\)_^AGQO_X=\H_^<'K_ $M?Z6?^'DG[)G_0\:S_ .$=XD_^0*/^'DG[)G_0
M\:S_ .$=XD_^0*_FFHH_XF8\0/\ H!X8_P##?F'_ ,]@_P"),/"?_H9\;_\
MAWRC_P"<'K_2U_I9_P"'DG[)G_0\:S_X1WB3_P"0*/\ AY)^R9_T/&L_^$=X
MD_\ D"OYIJ*/^)F/$#_H!X8_\-^8?_/8/^),/"?_ *&?&_\ X=\H_P#G!Z_T
MM?Z6?^'DG[)G_0\:S_X1WB3_ .0*/^'DG[)G_0\:S_X1WB3_ .0*_FFHH_XF
M8\0/^@'AC_PWYA_\]@_XDP\)_P#H9\;_ /AWRC_YP>O]+7^EG_AY)^R9_P!#
MQK/_ (1WB3_Y H_X>2?LF?\ 0\:S_P"$=XD_^0*_FFHH_P")F/$#_H!X8_\
M#?F'_P ]@_XDP\)_^AGQO_X=\H_^<'K_ $M?Z6?^'DG[)G_0\:S_ .$=XD_^
M0*/^'DG[)G_0\:S_ .$=XD_^0*_FFHH_XF8\0/\ H!X8_P##?F'_ ,]@_P")
M,/"?_H9\;_\ AWRC_P"<'K_2U_I9_P"'DG[)G_0\:S_X1WB3_P"0*/\ AY)^
MR9_T/&L_^$=XD_\ D"OYIJ*/^)F/$#_H!X8_\-^8?_/8/^),/"?_ *&?&_\
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MW_K*Y(?#^'7_ "2M/_LH.-__ %N.(PHHHKY8^X"BBB@ HHHH **** "BBB@
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MQJ9N"L0L[V Z?/%$(8YHSJ<$<F9(IU3RS]L=9+O]J[XSP&9$>?QXUDDTYQ%
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M5Z9-XFNM)ENHFNKOP5?32?:+AY+)PL4L$%Y" \L[Q0M:.)/1_P!M73[KQO\
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M_(\?&G_L5O"7_IVU:OU7P1_Y.EPE_P!A.8?^J?,3\,^DK_R8_C[_ + LI_\
M6CR<_<^BBBO](S_'(@;J?J?YT4-U/U/\Z* )Z*** /A+_@I#_P FH>-_^PKX
M8_\ 3Q!7\TE?TM_\%(?^34/&_P#V%?#'_IX@K^:2OX/^DS_R7^ _[)G ?^I^
M:'^I'T,/^349G_V6F:_^JK(PHHHK^=S^N HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BB@D $DX Y)/0#U- !171Z7X-\9:[:&_P!#\'>+M:L
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MG_8HX6_]97)#X?PZ_P"25I_]E!QO_P"MQQ&%%%%?+'W 4444 %%%% !1110
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M3D:UTVW6VM(Q;644-NICA4!G"!G.68DFK&O_ !<\=^)_AYX-^%FLZM#<^"O
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M(((R.001P: _K^OO0E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5^O/_!(S_D>/C3_V*WA+_P!.VK5^0U?KS_P2,_Y'CXT_
M]BMX2_\ 3MJU?JO@C_R=+A+_ +"<P_\ 5/F)^&?25_Y,?Q]_V!93_P"M'DY^
MY]%%%?Z1G^.1 W4_4_SHH;J?J?YT4 3T444 ?"7_  4A_P"34/&__85\,?\
MIX@K^:2OZ6_^"D/_ ":AXW_["OAC_P!/$%?S25_!_P!)G_DO\!_V3. _]3\T
M/]2/H8?\FHS/_LM,U_\ 55D84445_.Y_7 4444 %%%% !1110 4444 %%%%
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M(O?#UC;Z9!X[^&=[X[U&PM46*W@UG5=&U>PU&1(D 6.2]ETI;^XP!ON+J67
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MJ\-XW-<HQ6<Y)2Q^*Q5:>$SNE7HX2>#S"MA,)E7U3&5:=2C#$X6,I'Y\>-/
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M;%XXW/5D5C]64'^M/K\:W/Z)>C:[!1110 4444 %%%% !1110 4444 %%%%
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MY)+^Q?\ ]D*UW_U.KRODROJ>,_\ D?U/^Q1PM_ZRN2'P_AU_R2M/_LH.-_\
MUN.(PHHHKY8^X"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "CK110!^A?B"\7XK_\ !/#P=+9,UUK?[-WQ)N-.UVSC(>>V\-^*'OC::M=
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M1\-\GCPY0X9^N9E]2H<7QXSC7]IA?K3S&/&$N-%AY2^J^R^I/,I/#."I*O\
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M<H2=1117SI]<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?KS_P $C/\
MD>/C3_V*WA+_ -.VK5^0U?KS_P $C/\ D>/C3_V*WA+_ -.VK5^J^"/_ "=+
MA+_L)S#_ -4^8GX9])7_ ),?Q]_V!93_ .M'DY^Y]%%%?Z1G^.1 W4_4_P Z
M*&ZGZG^=% $]%%% 'PE_P4A_Y-0\;_\ 85\,?^GB"OYI*_I;_P""D/\ R:AX
MW_["OAC_ -/$%?S25_!_TF?^2_P'_9,X#_U/S0_U(^AA_P FHS/_ ++3-?\
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MX:.'I8/"XW$X;"8G'XS%SY\7FF,GAL-1J8B4*>%P]*E2YJI1117S!]J%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %(W0_0_RI:1NA^A_E0!]:?M&?\ ))?V+_\ LA6N_P#J=7E?)E?6
M?[1G_))?V+_^R%:[_P"IU>5\F5]3QG_R/ZG_ &*.%O\ UE<D/A_#K_DE:?\
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MB70JT[QJ.$:KIR@?#4\%Q:RM!=6US:3H%+V]W;S6MP@<;D+P7$<<JAU(9"R
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MV"Q#I4/;>RY^3VGL:7/:_)&]D4445X1].%%%% !1110 4444 %%%% !1110
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M#_!?7_BUJ/CFXU*WMO&/PDUOP;HATW3FU%Y-;OY=T$=RJRQ&WMRN2UP=RJV
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ\O^IEY?AYLJ?\.T_P!E#_H7O$?_ (5M[_\ $4?\.T_V4/\ H7O$?_A6WO\
M\15O?)_SUF_[_2__ !=&^3_GK-_W^E_^+H_U3\/?^B X:_\ #?@_+_J$\OR[
M:G^L_BU_T=WC/I_S,LQ\O^IEY?AYLJ?\.T_V4/\ H7O$?_A6WO\ \11_P[3_
M &4/^A>\1_\ A6WO_P 15O?)_P ]9O\ O]+_ /%T;Y/^>LW_ '^E_P#BZ/\
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M@_+_ *A/+\NVI_K/XM?]'=XSZ?\ ,RS'R_ZF7E^'FRI_P[3_ &4/^A>\1_\
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M_GK-_P!_I?\ XNC_ %3\/?\ H@.&O_#?@_+_ *A/+\NVI_K/XM?]'=XSZ?\
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M/I_S,LQ\O^IEY?AYLJ?\.T_V4/\ H7O$?_A6WO\ \11_P[3_ &4/^A>\1_\
MA6WO_P 15O?)_P ]9O\ O]+_ /%T;Y/^>LW_ '^E_P#BZ/\ 5/P]_P"B X:_
M\-^#\O\ J$\OR[:G^L_BU_T=WC/I_P S+,?+_J9>7X>;*G_#M/\ 90_Z%[Q'
M_P"%;>__ !%'_#M/]E#_ *%[Q'_X5M[_ /$5;WR?\]9O^_TO_P 71OD_YZS?
M]_I?_BZ/]4_#W_H@.&O_  WX/R_ZA/+\NVI_K/XM?]'=XSZ?\S+,?+_J9>7X
M>;*G_#M/]E#_ *%[Q'_X5M[_ /$4?\.T_P!E#_H7O$?_ (5M[_\ $5;WR?\
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MX=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\
MBZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_Y
MF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(
MJWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7
MY=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC
M_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O
M_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0
MO>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]
M9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E
M_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^
M3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6
M?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>
M(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#
M7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC
M_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]
M+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\
MV5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?
MZ7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.
M[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB
M/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?
ME_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*
M/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T
M?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_
MX=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\
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MX=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\
MBZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_Y
MF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(
MJWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7
MY=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC
M_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O
M_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0
MO>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]
M9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E
M_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^
M3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6
M?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>
M(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#
M7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC
M_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]
M+_\ %T?ZI^'O_1 <-?\ AOP?E_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\
MV5/^':?[*'_0O>(__"MO?_B*/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?
MZ7_XNC?)_P ]9O\ O]+_ /%T?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.
M[QGT_P"9EF/E_P!3+R_#S94_X=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB
M/_PK;W_XBK>^3_GK-_W^E_\ BZ-\G_/6;_O]+_\ %T?ZI^'O_1 <-?\ AOP?
ME_U">7Y=M3_6?Q:_Z.[QGT_YF68^7_4R\OP\V5/^':?[*'_0O>(__"MO?_B*
M/^':?[*'_0O>(_\ PK;W_P"(JWOD_P">LW_?Z7_XNC?)_P ]9O\ O]+_ /%T
M?ZI^'O\ T0'#7_AOP?E_U">7Y=M3_6?Q:_Z.[QGT_P"9EF/E_P!3+R_#S94_
MX=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\
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MX=I_LH?]"]XC_P#"MO?_ (BC_AVG^RA_T+WB/_PK;W_XBK>^3_GK-_W^E_\
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M_7>!?^1-5_[#Z_\ Z9PP4445XQ]F%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 44H!/0$XZX&<4 $] 3CK@9Q0 E%%% !11
M2@$YP"<<G Z#U/I0 E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5[A\$?^0AX@_Z\[#_T?<UX?7N'P1_Y"'B#_KSL/_1]S7H95_R,,-_B
MG_Z;F?/\5?\ )/YG_P!>Z'_J7ASZ(HHHK[@_#R!NI^I_G10W4_4_SHH GHHH
MH \Y^*O_ ")>H?\ 7:T_]'+7R;7UE\5?^1+U#_KM:?\ HY:^3:^0SW_?8_\
M7BG_ .E5#]=X%_Y$U7_L/K_^F<,%%%%>,?9A1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?SS_\ !?C]HSX\?L^?\.YA\#_B
MUXX^%7_"R_VR_#/@CQ\?!6MSZ,?%OA*[733<>']<\@'[=I<OF2;[27,3>8Y9
M2<%6?\' G[1GQX_9YUC_ ()Q0_ SXM>.?A1%\2_VRM/\$>/X_!.MSZ*GB[PG
M-/X:#^']=6 $7^EE;BY7[)-F(K<2[E)8%?&O^#EKK_P2N_[/T\(_^@:73/\
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MQ]/-?'Z55KQ#[E.Z3VND[>H4444#"BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _G3_X."_@9\9_C8?\
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MK_AU]X6?9_U_PZ^\=13=Z?WE_P"^A_C1O3^\O_?0_P :+KNOZ_X=?>%GV?\
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MK_AU]X6?9_U_PZ^\=13=Z?WE_P"^A_C1O3^\O_?0_P :+KNOZ_X=?>%GV?\
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M (=?>%GV?]?\.OO'44W>G]Y?^^A_C1O3^\O_ 'T/\:+KNOZ_X=?>%GV?]?\
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M (=?>%GV?]?\.OO'44W>G]Y?^^A_C1O3^\O_ 'T/\:+KNOZ_X=?>%GV?]?\
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M?_@!9_\ QBC^W+[TL_\ P L__C%8]%<GM)_SS_\  G_GY+[CU?J]#_GQ1_\
M!</_ )'R7W&Q_;E]Z6?_ ( 6?_QBC^W+[TL__ "S_P#C%8]%'M)_SS_\"?\
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M (Q6/11[2?\ //\ \"?^?DON#ZO0_P"?%'_P7#_Y'R7W&Q_;E]Z6?_@!9_\
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MKT/^?%'_ ,%P_P#D?)?<=;J.JW<-KH[I]F)GL7>0-9VK+N$Q4;%:$B-<<;$
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M (Q6/11[2?\ //\ \"?^?DON#ZO0_P"?%'_P7#_Y'R7W&Q_;E]Z6?_@!9_\
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M%'_P7#_Y'R7W&Q_;E]Z6?_@!9_\ QBC^W+[TL_\ P L__C%8]%'M)_SS_P#
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M*** "BBB@ HHHH **** "BBB@#<U;_CST+_L'R?^CS6'6YJW_'GH7_8/D_\
M1YK#JZG\27I3_P#34#&A_#_[B5O_ $]4"BBBH-@HHHH **** "BBB@ HHHH
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M_P!SE_V$5/\ TW1"BBBN0]8**** "BBB@ HHHH **** "BBB@ HHHH ****
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MYZ]/L+Y)7^:[%48JKBJU6RY:#="G967,DO:R7G=\G=*+MI)C:***Q.X****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#<U;_CS
MT+_L'R?^CS6'6YJW_'GH7_8/D_\ 1YK#JZG\27I3_P#34#&A_#_[B5O_ $]4
M"BBBH-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYW?\
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MI\K\WXG10_WO%J-N3]TW:UO:.G&^W7EY;_?U*]%%%9':%%%% !1110 4444
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M ;FK?\>>A?\ 8/D_]'FL.MS5O^//0O\ L'R?^CS6'5U/XDO2G_Z:@8T/X?\
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M+-%6JDXN4E)IRUD^^M]?GJ83PU"<80E3BX4DE3CJE%)*-E9]E;O8_GV^ /\
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MRW_\%UY1_:O@[_H;+?\ \%UY1STO^?\ A_\ PHH?_+ ]EB?^@/'_ /A!C?\
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M_H#Q_P#X08W_ .4#J*;_ &KX._Z&RW_\%UY1_:O@[_H;+?\ \%UY1STO^?\
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M_P#X+KRC^U?!W_0V6_\ X+KRCGI?\_\ #_\ A10_^6![+$_] >/_ /"#&_\
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M_0'C_P#P@QO_ ,H'44W^U?!W_0V6_P#X+KRC^U?!W_0V6_\ X+KRCGI?\_\
M#_\ A10_^6![+$_] >/_ /"#&_\ R@=13?[5\'?]#9;_ /@NO*/[5\'?]#9;
M_P#@NO*.>E_S_P /_P"%%#_Y8'LL3_T!X_\ \(,;_P#*!U%-_M7P=_T-EO\
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M (44/_E@>RQ/_0'C_P#P@QO_ ,H'44W^U?!W_0V6_P#X+KRC^U?!W_0V6_\
MX+KRCGI?\_\ #_\ A10_^6![+$_] >/_ /"#&_\ R@=13?[5\'?]#9;_ /@N
MO*/[5\'?]#9;_P#@NO*.>E_S_P /_P"%%#_Y8'LL3_T!X_\ \(,;_P#*!U%-
M_M7P=_T-EO\ ^"Z\H_M7P=_T-EO_ ."Z\HYZ7_/_  __ (44/_E@>RQ/_0'C
M_P#P@QO_ ,H'44W^U?!W_0V6_P#X+KRC^U?!W_0V6_\ X+KRCGI?\_\ #_\
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M\'?]#9;_ /@NO*/[5\'?]#9;_P#@NO*.>E_S_P /_P"%%#_Y8'LL3_T!X_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#M?%7_($\ _]BY<_P#IQ:N*
MKM?%7_($\ _]BY<_^G%JXJM\3_&?_7K#?^HM X,L_P!S7_83F'_JQQ84445@
M=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 4444 ."LV=JLV!DX!.!ZG'04!6;.U6; R<
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MMQ)I7AG2[C4I;*R\TK&VHZG)#%IFFQR$)+J%Y;1,0')'\Y_[,?PJ_P""K?\
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M)%M["V5+2TACC2*WMXTBC4(H%?-OQ=U7_@I+_P %"?V]OCE^S3\&_B[\4?\
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M25^%7P6_8&_X+$>!/B_\,?&/Q;_X+!S_ !7^&'ACQQX<UWQ_\,6^!OAG1/\
MA8'A'3-3M[O7?" U>WT"*?3?[?L(IM-:]AFAEMDN&FBECD1&'[K'&3@8&>!U
MP/3-8U:<:;2C6IUDU=NFJB47V?M(0=^NB:WN[Z';A,15Q$)2JX/$8-QDHJ&(
M=!RFK)N4?85JT>5-\OO.+NM%;42BBBLCJ"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *]P^"/\ R$/$'_7G8?\ H^YKP^O</@C_ ,A#Q!_U
MYV'_ */N:]#*O^1AAO\ %/\ ]-S/G^*O^2?S/_KW0_\ 4O#GT11117W!^'D#
M=3]3_.BANI^I_G10!/1110!YS\5?^1+U#_KM:?\ HY:^3:^LOBK_ ,B7J'_7
M:T_]'+7R;7R&>_[['_KQ3_\ 2JA^N\"_\B:K_P!A]?\ ],X8****\8^S"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _E_\
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M.7-[[WG[_,%%%%<QZ@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5[A\$?\ D(>(/^O.P_\ 1]S7A]>X?!'_ )"'B#_KSL/_ $?<UZ&5?\C##?XI
M_P#IN9\_Q5_R3^9_]>Z'_J7ASZ(HHHK[@_#R!NI^I_G10W4_4_SHH GHHHH
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M?G^ZW_?+?X4<_P!UO^^6_P *^F/[;N_^>.G_ /@OM/\ XU1_;=W_ ,\=/_\
M!?:?_&J/[,C_ -!+_P#!'I_T_P#7^MS_ %FK_P#0NI?^%\O_ )A_JS\K_,_/
M]UO^^6_PHY_NM_WRW^%?3']MW?\ SQT__P %]I_\:H_MN[_YXZ?_ ."^T_\
MC5']F1_Z"7_X(]/^G_K_ %N?ZS5_^A=2_P#"^7_S#_5GY7^9^?[K?]\M_A1S
M_=;_ +Y;_"OIC^V[O_GCI_\ X+[3_P"-4?VW=_\ /'3_ /P7VG_QJC^S(_\
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M /!?:?\ QJC^V[O_ )XZ?_X+[3_XU1_9D?\ H)?_ ((]/^G_ *_UN?ZS5_\
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MW_?+?X5],?VW=_\ /'3_ /P7VG_QJC^V[O\ YXZ?_P""^T_^-4?V9'_H)?\
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M 'RW^%?3']MW?_/'3_\ P7VG_P :H_MN[_YXZ?\ ^"^T_P#C59?V9'_H)?\
MX(]/^G_K_6_7_K-7_P"A=2_\+Y?_ ##_ %9^5_F?G^ZW_?+?X4<_W6_[Y;_"
MOIC^V[O_ )XZ?_X+[3_XU1_;=W_SQT__ ,%]I_\ &J/[,C_T$O\ \$>G_3_U
M_K<_UFK_ /0NI?\ A?+_ .8?ZL_*_P S\_W6_P"^6_PHY_NM_P!\M_A7TQ_;
M=W_SQT__ ,%]I_\ &J/[;N_^>.G_ /@OM/\ XU1_9D?^@E_^"/3_ *?^O];G
M^LU?_H74O_"^7_S#_5GY7^9^?[K?]\M_A1S_ '6_[Y;_  KZ8_MN[_YXZ?\
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MK?\ ?+?X4<_W6_[Y;_"OIC^V[O\ YXZ?_P""^T_^-4?VW=_\\=/_ /!?:?\
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MZ?\ ^"^T_P#C5']MW?\ SQT__P %]I_\:H_LR/\ T$O_ ,$>G_3_ -?ZW/\
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MW6_[Y;_"OIC^V[O_ )XZ?_X+[3_XU1_;=W_SQT__ ,%]I_\ &J/[,C_T$O\
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M/[;N_P#GCI__ (+[3_XU1_9D?^@E_P#@CT_Z?^O];G^LU?\ Z%U+_P +Y?\
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M?VW=_P#/'3__  7VG_QJC^V[O_GCI_\ X+[3_P"-4?V9'_H)?_@CT_Z?^O\
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MG^ZW_?+?X4<_W6_[Y;_"OIC^V[O_ )XZ?_X+[3_XU1_;=W_SQT__ ,%]I_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -S5O^//
M0O\ L'R?^CS6'6YJW_'GH7_8/D_]'FL.KJ?Q)>E/_P!-0,:'\/\ [B5O_3U0
M****@V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1117(>L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"_[!\G_H\UAU=3^)+TI_^FH&-#^'_P!Q*W_IZH%%%%0;!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<IX\\=^#/A=X(\6?$GXB^)M&\%^
M? F@:EXH\8>+?$-]#INB>']!TFW>ZO\ 4M1O;ADBABBB0K&F3+<3O%;6Z2W$
MT4;]77\Z_P#P53_X)O?M1_MV>)?CUK_Q_P#VK;WP3_P3N^#OPIU[Q_\ #+]E
MGX0PMI/BOXL?$'P=X U/79=7^,WBDV4"'0;'Q19I-I>G/<^(9C9@KIMGX:O
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M&%6":A4C92NEK\#;@[-IN+U;NQ****R.H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KM_!7^OO_P#KE!_Z')7$5V_@K_7W_P#UR@_]#DK?
M#?QZ?J__ $EG!F?^XXCTI_\ IV!Z#1117LGQQ W4_4_SHH;J?J?YT4 3T444
M <_XG_Y US_O1?\ HP5Y/7K'B?\ Y US_O1?^C!7D]>5C?XR_P $?SD?59+_
M +G+_L(J?^FZ(4445R'K!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5A^*?^14\6_P#8I^*/_3#J%;E5-0LX]1T[4M-F=XX=3T[4
M-,FDCV^9'#J-G-92R1[@5\Q(YV:/<"N\+N!&004E>,DMVFE\T?R^?\&H?_)@
M/[4'_9ZGQH_]0[PM7QS_ ,&Y/[!/[$_[5OP<_;O\;_M,?LK_  2^.WB_PY^W
MM\2?"^A>)/B;X*L?$NL:3X=/A_1-5&BV-Y=,)+?3EU*[O+U;9"$-S=SRL&9E
MV_TH?\$Z/^"<_P */^":GP:^('P2^$7CGX@^//#OQ%^*WBOXMZKJWQ%'A[^V
M;'6_%NFV&EWFF:?_ ,(YIFE61TJTM].@:U-Q;RW;2M(T\\@8 0?\$Z_^"<'P
MF_X)K>!_C5X#^$?CKXA>/--^./QOU[X[>([WXB?\(]]NTCQ'K^FV6EW&C:*/
M#FEZ7;_V);V]C"T!O8[B^:5G:6X?( Z75LZSA)IS<.5KJE>_]?K8\M82<HX*
M,X)QHQFJB;VO[*UMOY9=G]YZ-\"O^">7["7[+_CAOB9^SE^R-\!_@E\0WT34
M?#3>-/AQX&LO#OB)O#^KR6DNJ:,=0MG+G3]0EL+)[J @K(UK"21LK\/OV921
M_P '4/[?1!((_8]\'$$<$$6'P_((]P:_J&K\_O 7_!.KX4_#[_@H9\9?^"D&
ME^./B!>_%GXV?##2OA7XA\"7X\/_ /"O=)T;2H=(ABU+1C;Z;'XB_M.9-%M/
M-%[JEQ:*6G,<*[QMSA/^(Y-MR@HKKJIP=ONBSHK8?_=U2BE&G6YY+79PDF];
M[NWD?A7_ ,%,O 'C/_@C3_P4'\$_\%F_V=?#VHWW[,/QVUW2OA;_ ,%&/A)X
M;BE&GQMXBOK>&#XJVNE0(;6.]UF>*+5[:]\M3!X^TTPEH!XSO[EH/^#7/2?A
MS\:_@1^W'XKN]-MO%7AF+_@I'J7QH^'MQJ,$D:V^LZ?IK:YX(\3K:/C;>Z?'
MJ(O+>"X5TAN'#,ADBC=?ZE?C#\)/A[\?/A5\0O@I\6/#=EXN^&OQ2\)ZQX+\
M:>'+] T&I:)K5L]O.(W(+6U]:2&*_P!+OX<7&G:E:VE];,D]O&P^%_\ @F#_
M ,$M_@K_ ,$I_A3\1?A!\#O'OQ+\?^'?B1\0A\1-1O?B<WAN35-+U!-(M]$@
MTO37\-:3I%N^G165K$?,NX9;N28,[S?,15^U3HN+O[1<L5)=8*]D^MXW:OU3
M2,UA)1Q<9I1EAY>TFX-7Y*LE&]D].64HJ6U^:[=[GY@?MR> M=^(/QT_:-_X
M)6_#MY?#EO\ \%$?VG?V8/CEXU;1<VO_  C?[.FL^ -7O?VL?$ZPVWE!+'Q/
M=?LT7.FZI.K(9/%?Q 2=B]YJ2>;_ $J>&O#/AWP5X:\.^#/"&DVN@^$O!^@Z
M1X7\+Z'91K%::1X?T"P@TO2-.MXT 58[2QM8(A@#<5+G+,2?Q<_9_P#CWX5^
M._\ P7>_;D\&:1X2T62Z_9#_ &-O@O\ !=_'_P!F$NN3Z[XV\<'XD>*]&BOF
M)^S:= =6TW3'M%1)1?:)J+B1H+EU;]O:SJ-VA%JWNQEZN48ZOU27XFV&A%RK
M54[MU)TUVC&$Y7BNFDW):75DDGH%%%%9G6%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!N:M_P >>A?]@^3_ -'FL.MS5O\
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M$/B_\-_C-X/T$Z7XK6VUK4]/C\5>%?#]W?:P?$O@VQUG1K=EU75=,LD;^U-
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MI:G^K&'_ .@_'_\ EEY?]0?D_O\ (^@?[3\&_P#0WV'_ ("WO_QFC^T_!O\
MT-]A_P" M[_\9KY^HH_M.I_SXP__ )6_^7>O]+4_U8P__0?C_P#RR\O^H/R?
MW^1] _VGX-_Z&^P_\!;W_P",T?VGX-_Z&^P_\!;W_P",U\_44?VG4_Y\8?\
M\K?_ "[U_I:G^K&'_P"@_'_^67E_U!^3^_R/H'^T_!O_ $-]A_X"WO\ \9H_
MM/P;_P!#?8?^ M[_ /&:^?J*/[3J?\^,/_Y6_P#EWK_2U/\ 5C#_ /0?C_\
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M_H/Q_P#Y9>7_ %!^3^_R/H'^T_!O_0WV'_@+>_\ QFC^T_!O_0WV'_@+>_\
MQFOGZBC^TZG_ #XP_P#Y6_\ EWK_ $M3_5C#_P#0?C__ "R\O^H/R?W^1] _
MVGX-_P"AOL/_  %O?_C-']I^#?\ H;[#_P !;W_XS7S]11_:=3_GQA__ "M_
M\N]?Z6I_JQA_^@_'_P#EEY?]0?D_O\CZ!_M/P;_T-]A_X"WO_P 9H_M/P;_T
M-]A_X"WO_P 9KY^HH_M.I_SXP_\ Y6_^7>O]+4_U8P__ $'X_P#\LO+_ *@_
M)_?Y'T#_ &GX-_Z&^P_\!;W_ .,T?VGX-_Z&^P_\!;W_ .,U\_44?VG4_P"?
M&'_\K?\ R[U_I:G^K&'_ .@_'_\ EEY?]0?D_O\ (^@?[3\&_P#0WV'_ ("W
MO_QFC^T_!O\ T-]A_P" M[_\9KY^HH_M.I_SXP__ )6_^7>O]+4_U8P__0?C
M_P#RR\O^H/R?W^1] _VGX-_Z&^P_\!;W_P",T?VGX-_Z&^P_\!;W_P",U\_4
M4?VG4_Y\8?\ \K?_ "[U_I:G^K&'_P"@_'_^67E_U!^3^_R/H'^T_!O_ $-]
MA_X"WO\ \9H_M/P;_P!#?8?^ M[_ /&:^?J*/[3J?\^,/_Y6_P#EWK_2U/\
M5C#_ /0?C_\ RR\O^H/R?W^1] _VGX-_Z&^P_P# 6]_^,T?VGX-_Z&^P_P#
M6]_^,U\_44?VG4_Y\8?_ ,K?_+O7^EJ?ZL8?_H/Q_P#Y9>7_ %!^3^_R/H'^
MT_!O_0WV'_@+>_\ QFC^T_!O_0WV'_@+>_\ QFOGZBC^TZG_ #XP_P#Y6_\
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MI:G^K&'_ .@_'_\ EEY?]0?D_O\ (^@?[3\&_P#0WV'_ ("WO_QFC^T_!O\
MT-]A_P" M[_\9KY^HH_M.I_SXP__ )6_^7>O]+4_U8P__0?C_P#RR\O^H/R?
MW^1] _VGX-_Z&^P_\!;W_P",T?VGX-_Z&^P_\!;W_P",U\_44?VG4_Y\8?\
M\K?_ "[U_I:G^K&'_P"@_'_^67E_U!^3^_R/H'^T_!O_ $-]A_X"WO\ \9H_
MM/P;_P!#?8?^ M[_ /&:^?J*/[3J?\^,/_Y6_P#EWK_2U/\ 5C#_ /0?C_\
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M_H/Q_P#Y9>7_ %!^3^_R/H'^T_!O_0WV'_@+>_\ QFC^T_!O_0WV'_@+>_\
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M)M?67Q5_Y$O4/^NUI_Z.6ODVOD,]_P!]C_UXI_\ I50_7>!?^1-5_P"P^O\
M^F<,%%%%>,?9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@#QW]H3P#\0OBI\#_BA\./A/\ %G5?@/\
M$OQGX3N]#\%?&;0]..KZO\-M=GN+66#Q/I^F"]TYKZXMH8)[86ZW]FS)=.RW
M$;*#7\GO_!3OX#_\%<?^"<O['OC;]JT_\%K_ ([_ !:_X0[Q1X!\-GP1'X @
M\'MJ'_";^);3P]]K&NR>*M?6W_L[[5]K,)TR;[2(S#YD)82#^R2OP!_X.=/^
M4/GQM_[*A\!/_5E:57=@*LXXBA1M3=.K7IJ<9TJ4[J4HII2G"4HZ?RM=^K/
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MKX4O;T^.KP6EIKUG%+IMS<&TN?)AN'D6%G5<?A-_P1^C_P""O#W_ .W_ /\
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MS_Z<6KBJ[7Q5_P @3P#_ -BY<_\ IQ:N*K?$_P 9_P#7K#?^HM X,L_W-?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*I%Q<DFTFU>]FU?N>.?L[6%]I7[//P!TK5+*[TW5-+^"'PFTW4]-O[>6TO\
M3M1L? 6@6M[87UI.J3VEY9W,4MO=6TZ)-!/&\4J*Z,H_#:X^%'Q2/_!S3;?&
M$?#;QX?A(O["<7AH_%$>$M=/P\'B/^S[-3H!\9"Q_P"$>&LJZE#I9U 7NX$"
M X;']%1))))R3R2>I/J:=O;;LW-LSG;D[<^N.F:JG6=-U6HI^UI5*;UM95+7
M:[M6VZF>(P,<1#!P=24?J>)P^(BU%/G>'O:+N]%*^K5VNA^8/_!6C_@GGHO_
M  45_94UOX>Z7<P>&_CS\-+M_B;^S9\0UE-E?>$_BAH<2W5IICZI"IN;/0O&
M"6L6C:L\+;K.Y_LK7(5-WH]N#^3_ /P;&_#7]J#P+H__  4$UW]K#X;?$_P#
M\3_B!\;O!^O:QJ'Q-\&ZSX3O/&7B%=)\5IXIUO3)M3L+*RU])=8F>:]U/1&N
MM.FGNUF@G:.XB+?U.4YG=\;V9MHP-Q)P/09JXXJ<<+5PCBI0J2C*,G\5-QG&
M;4='[LW!<RT2:NM6S*IE5">:8;-8SE3KT(5(5(12]GB%*G*G3E45U:=*,YJ,
MTG)Q:@_=2M_-Y_P;G_"3XK?"?PS_ ,%&(?BG\,_'_P -9?%G[;7B+Q'X5B\>
M^$->\(R>)?#\UMK8BUS04UZPL'U;2)&DC5-2L5GLW9T"3,&4G^D('!!'4$'\
MJ5G=\;V9L# W$G ]!FFU%>LZ]655Q47)1O%.Z7+",-VE>_+?8WR_!QR_"4L)
M"<JD:7/:<DHM\]251W2;6CDUZ(_E4\<Z9\;O^".O_!5[]IK]L#_AGOXR?M#?
ML-_M[6%OKGCC6?@'X2N/'WCCX0?%.*^AUR^N=;\+6;0N;<^()?$4MK)>W>F:
M9J6C^*8H[?5$U;2FM9_DO_@HK\9_VZOVZ?BY^RM^WY\ OV._VB/ '[+W["7Q
MV^'<_@30?B#\.=>TWX^?%WQ!XW\4Z9J?CKXCZ5\*M&AU77+?P9X5TSPGX=T*
M*YC^WVL9UJZOX]2N(FOX;#^V$,RY"L0&^\,\-CH&'0@>A!I?-DR&WL"!M!!(
MPO\ ='H/8<>U=,,<HRIU)4(3K0IQI.I*4K3IJ'LW>"LO:.E^[<[M6UY>:S7F
M5<BE4IU\-#'UZ."K8B6*CAX4J3=*O*K[=<M5VDZ$<1^^5'EB^9*+J\GNE6UO
MK;5+2TU2SCN(K/5+2UU.TAO()+6\AM=0MX[RWAO+294FM;N*&9([JUF1);>=
M9(955T8">BBN ]]:)7UTW[A1110 4444 %%%% !1110 4444 %%%% !1110
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MN->^RVQ=;K3[G2?#SW T*#4X-5_O)::9@5:1V4]06)![\C/K2BXG  $L@ &
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M_P Q]?\ ],X;_-#J*;O3^\O_ 'T/\:-Z?WE_[Z'^->+==U_7_#K[S[2S[/\
MK_AU]XZBF[T_O+_WT/\ &C>G]Y?^^A_C1==U_7_#K[PL^S_K_AU]XZBF[T_O
M+_WT/\:-Z?WE_P"^A_C1==U_7_#K[PL^S_K_ (=?>.HIN]/[R_\ ?0_QHWI_
M>7_OH?XT77=?U_PZ^\+/L_Z_X=?>.HIN]/[R_P#?0_QHWI_>7_OH?XT77=?U
M_P .OO"S[/\ K_AU]XZBF[T_O+_WT/\ &C>G]Y?^^A_C1==U_7_#K[PL^S_K
M_AU]XZBF[T_O+_WT/\:-Z?WE_P"^A_C1==U_7_#K[PL^S_K_ (=?>.HIN]/[
MR_\ ?0_QHWI_>7_OH?XT77=?U_PZ^\+/L_Z_X=?>.HIN]/[R_P#?0_QHWI_>
M7_OH?XT77=?U_P .OO"S[/\ K_AU]XZBF[T_O+_WT/\ &C>G]Y?^^A_C1==U
M_7_#K[PL^S_K_AU]XZBF[T_O+_WT/\:-Z?WE_P"^A_C1==U_7_#K[PL^S_K_
M (=?>.HIN]/[R_\ ?0_QHWI_>7_OH?XT77=?U_PZ^\+/L_Z_X=?>.HIN]/[R
M_P#?0_QHWI_>7_OH?XT77=?U_P .OO"S[/\ K_AU]XZBF[T_O+_WT/\ &C>G
M]Y?^^A_C1==U_7_#K[PL^S_K_AU]XZBF[T_O+_WT/\:-Z?WE_P"^A_C1==U_
M7_#K[PL^S_K_ (=?>.HIN]/[R_\ ?0_QHWI_>7_OH?XT77=?U_PZ^\+/L_Z_
MX=?>.HIN]/[R_P#?0_QHWI_>7_OH?XT77=?U_P .OO"S[/\ K_AU]XZBF[T_
MO+_WT/\ &C>G]Y?^^A_C1==U_7_#K[PL^S_K_AU]XZBF[T_O+_WT/\:-Z?WE
M_P"^A_C1==U_7_#K[PL^S_K_ (=?>.HIN]/[R_\ ?0_QHWI_>7_OH?XT77=?
MU_PZ^\+/L_Z_X=?>.HIN]/[R_P#?0_QHWI_>7_OH?XT77=?U_P .OO"S[/\
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M_P"!/_/R7W!["C_SZI_^ K_+R7W&M_;%Q_S[:;_X+;/_ .-4?VQ<?\^VF_\
M@ML__C59-%'M)_SS_P# G_GY+[@]A1_Y]4__  %?Y>2^XUO[8N/^?;3?_!;9
M_P#QJC^V+C_GVTW_ ,%MG_\ &JR:*/:3_GG_ .!/_/R7W!["C_SZI_\ @*_R
M\E]QK?VQ<?\ /MIO_@ML_P#XU1_;%Q_S[:;_ ."VS_\ C59-%'M)_P \_P#P
M)_Y^2^X/84?^?5/_ ,!7^7DON-;^V+C_ )]M-_\ !;9__&J/[8N/^?;3?_!;
M9_\ QJLFBCVD_P">?_@3_P _)?<'L*/_ #ZI_P#@*_R\E]QK?VQ<?\^VF_\
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M59-%'M)_SS_\"?\ GY+[@]A1_P"?5/\ \!7^7DON-;^V+C_GVTW_ ,%MG_\
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MG_X$_P#/R7W!["C_ ,^J?_@*_P O)?<:W]L7'_/MIO\ X+;/_P"-4?VQ<?\
M/MIO_@ML_P#XU6311[2?\\__  )_Y^2^X/84?^?5/_P%?Y>2^XUO[8N/^?;3
M?_!;9_\ QJC^V+C_ )]M-_\ !;9__&JR:*/:3_GG_P"!/_/R7W!["C_SZI_^
M K_+R7W&M_;%Q_S[:;_X+;/_ .-4?VQ<?\^VF_\ @ML__C59-%'M)_SS_P#
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M "\E]QK?VQ<?\^VF_P#@ML__ (U1_;%Q_P ^VF_^"VS_ /C59-%'M)_SS_\
M G_GY+[@]A1_Y]4__ 5_EY+[C6_MBX_Y]M-_\%MG_P#&J/[8N/\ GVTW_P %
MMG_\:K)HH]I/^>?_ ($_\_)?<'L*/_/JG_X"O\O)?<:W]L7'_/MIO_@ML_\
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MJLFBCVD_YY_^!/\ S\E]P>PH_P#/JG_X"O\ +R7W&M_;%Q_S[:;_ ."VS_\
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M7DON-;^V+C_GVTW_ ,%MG_\ &J/[8N/^?;3?_!;9_P#QJLFBCVD_YY_^!/\
MS\E]P>PH_P#/JG_X"O\ +R7W&M_;%Q_S[:;_ ."VS_\ C5']L7'_ #[:;_X+
M;/\ ^-5DT4>TG_//_P "?^?DON#V%'_GU3_\!7^7DON-;^V+C_GVTW_P6V?_
M ,:H_MBX_P"?;3?_  6V?_QJLFBCVD_YY_\ @3_S\E]P>PH_\^J?_@*_R\E]
MQK?VQ<?\^VF_^"VS_P#C5=;X4O9+N:\$D5K'LCA(-O:P6Y.YG!W&)%+ 8X!)
M Y(ZUYY7;^"O]??_ /7*#_T.2M\/.;K4TY2:N]')M?"_,X<RHTH8*O*-.$6E
M"S44FKU()Z^FAZ#1117KGR1 W4_4_P Z*&ZGZG^=% $]%%% '/\ B?\ Y US
M_O1?^C!7D]>L>)_^0-<_[T7_ *,%>3UY6-_C+_!'\Y'U62_[G+_L(J?^FZ(4
M445R'K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDD]FTTGI?\5JNZU)A6I3E*$*D)3C?FC&2;5M'I?H]'V>CU/9Z***DT"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH W-6_P"/
M/0O^P?)_Z/-8=;FK?\>>A?\ 8/D_]'FL.KJ?Q)>E/_TU QH?P_\ N)6_]/5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% #XW\MT< ,48, W*DJ<C([C(Y'?H:_';X3_LM?L7?\$@-9_;&_;H^./Q
M^D;6/VH/B['XP^(7Q[^/%EI2:OX*A\17NHW&C_"3PEJV@V-]K%QX8DOYV&F:
M:EO)J%Q%IFG6;I+#I\"I^PQR Q"NY5'?9&I>1]B,^R-!R\C[=L:#!=RJ@C-?
MG!^R]^V)^Q;_ ,%7O"WQP\*>&O <7Q$TC]GGXQ2?#KXF_"W]H7X9>'YK[2/'
M/A\7L=GKS^!/$+>(;=;6&X35]/T[6)H1/:WUOJ5B3;W*SPUI!R2E\7([*IRV
MO:^FKVU773[D<]90<J=Y059<SHJ;T<K)7LK-V3T2:;N^ES\6?^"3NJZ!^V+_
M ,%NOVZ/^"A_['?AF_\ "7[!^J?"K3?@QXC\8'16\':)^T%\<E/AZXF\6:1X
M6F2TO3)9RV-SK%W?7>FVTA5K?4+XP:OK4]L.U_X)":7IW[5G_!7_ /X+,?ML
M_$BUL_%/C'X%?&G2/V2O@C>:Q;0:A_P@'@OPSJ/C#0+R;P@+F.0Z'/J6F_#^
MS-S/9&&23_A(=9;Y7U"[+^2^)?AK\./V'O\ @YG_ &/?AQ^POI=C\,_#'[47
MP;\37W[9/P$^&J'3OAKH^DP:7XJO=(\8WO@;3'30?"]S?/H>CZO;B"PM;;3+
MJ W.FVUF^M7;W?MO_!#W[+\%O^"EW_!=K]E7Q1*FE^/]4_:ITO\ :)\*:#=+
M]GO-6^''C34_'.LP:OI\+D&\MK;3?'W@UYGM1*(DOA)+M7!'1)>Y.4=I4(<N
MCYE!3C&7-J[_  K79K5)*]O+I?Q:5.:UAC)NHTTJ4JDJ4IP<$O=5E*7NW;4E
M9N6C,O\ X*>:7I'[)?\ P7+_ ."07[6WPRTZT\*:Y^TWXB\<?LU?M%2:+:PV
M*_$;PO=W'A[2-&GUVWMTBM]2U:VL/%-\LFJ7JS7LG]C>'E\T_P!E6QB_4_Q1
M^P%^SC\+OV]?BO\ \%=?C=\3=4UCQ%X7^!L7@S3=+^)5GH4GPN_9U\*>$;/3
M5U?QYX)OFCEU32-3?3=.U;[=<2HRP2>*?$M[:E+K4 4_,#_@L5%%\;_^"Q?_
M  0U_9E\*,-7\7>$OBAXW^/GQ#TZQ'VF\\'> -$U'PW?6?B#6;>(M+9Z??6G
MA3Q1+!/,J(?[*ER2&4C]@/"W[>'[*?[27[7W[2?_  36U#0M=U'XO?"/P9%K
M?Q-\!_%?P/IL'@3XB>#==31YKN+PI;:Q>:A#\0-"%AXAT6^OA-I*6ESIU[]H
M6"6&VN6BB3ER4FD_X<E)QW]FJEM7K9=%?1=CIA[)U\1&3BK8J$J2E=0=94(N
MRO[O-9RDTM6TF?S[>*_C7\'_ /@J1_P7S_8/^+'_  3<N(/&^B?L<^&?$'B#
M]L/]J+PUHU]X6\)Z_P" ]4-];:/\/&O]3L](U7QG)/82:OX6L+B2PE6X/BFX
MM[-YM&T.XN[?^PLXR<=,G'TK^.O_ (+T?!#X+_L,_M#_ /!,C]J#]AOP3X5_
M9_\ VRO%?[5&@?#B/P=\$-%L/ T/QE^&ET]BNLP>*O OA6+3]*UNTMM4N]-\
M+7E[<:4?[6L/&%UINJ2WJ0V@M/[&KI$2ZN$CYC2>54QTV+(P7] *FK9QI2C?
MEY7%*7Q)QDV[OJKRT:226EE;77".4:N*IU+.I[15)R@K4WS0BERK>+48KF3<
MFW>7,[V4%%%%8'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5V_@K_ %]__P!<H/\ T.2N(KM_!7^OO_\ KE!_Z')6^&_CT_5_^DLX,S_W
M'$>E/_T[ ]!HHHKV3XX@;J?J?YT4-U/U/\Z* )Z*** .?\3_ /(&N?\ >B_]
M&"O)Z]8\3_\ (&N?]Z+_ -&"O)Z\K&_QE_@C^<CZK)?]SE_V$5/_ $W1"BBB
MN0]8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS
MV_;5_P""<OPG_;C^*/[(WQ6^(_C+QUX7UO\ 8Z^)\WQ4\!6'A%])33O$>M37
MN@7[6'B?^TK.YN#IXF\.V:@Z?);S^7-<(7PX(_0FBFFXNZ=GKKZJS_!DSA&I
M%QFE*+:;3VO%J2^YI/Y'Y5_\%0/^"3/P=_X*G'X%3_%7XK?%WX2ZI^S[KWC/
MQ'X)UOX07^CZ9JYU3QHOAK[5=37VJ6-Y/:7.ER^%K"?2KK3GM[F"62=O,SL*
M_G&?^#9#X9DDG_@I;_P4J)/))^-B9)]3^YK^G"BKC5J12C&326RLFEK?JGU,
M)X3#U)N<J:<GRIM.2NHI*.S6R22_X:WS]^RM^S]IW[*W[/7PN_9ZTKQ[X\^*
M&G?"[0KG0[7Q_P#$[51K?CWQ,EUK&I:P;WQ)JH %Y=Q/J36<+@8CLK:VB'$=
M?0-%%9MW;;W>K.B,5&*C%644HI=DE9+Y(^$O^"AG[ 7PP_X*._!+PW\"_BQX
MM\9^#/#?AGXJ>#_BS9ZKX%;2TUB?6_!OVX6.GSG5[6\MO[.NEOYA<E(EN%98
MWBD4K7W/:0)9VMG:(=\=E9VEBAE"L9(K2VBM4,JD%&,D<0\Q2-C%F!&TXJ:B
MG=V2OHFVEV;M?[[+[A*$5.4U%*<DHREU:C>R?I=G\^/Q!_X-\?AK#\1OBKXO
M_9&_;:_;%_8/\#_'C5=0UOXR_!+]GSQJEG\,_$^JZN91JMYX?TZ:ZTZ?P@]]
M%// 1 ^J?8[:XFL=/:TTPQ6$/ZJ?L1?L/_L^_P#!/KX#Z-^SW^SEX;O=&\)6
M6I7OB/Q%K^OWPUGQM\0/&>K) FL>,_'&O^1;-J^NWZ6]O;H8[>ULM.TZVM-,
MTZTMK*UBB'UU15.I.2Y7)M::::VT5VM96Z7O8RIX:C2FYPIJ,FFD];13=Y*"
M>D5)ZM1M=A1114&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% &YJW_'GH7_ &#Y/_1YK#K<U;_CST+_ +!\G_H\UAU=3^)+
MTI_^FH&-#^'_ -Q*W_IZH%%%%0;!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 *"5(920RD$$'!!!R"#V(/(-?AY^TQ_P0T^$OQ6_:(\6_M9
M_LP?M-?M(_\ !/O]H+XF1-#\7/%7[,WB2+3?#/Q0:0[[C4?$O@R:XTVW&LWD
M^+N^N[34XK"[OE_M.32QJCSWTW[A4549R@[Q=KZ/LU>]FGH]5?4SJ4J=5)5(
MWL[Q>JE%]XR5G%]+IIVNMF?E?_P3]_X)'?L[?L ^+?'WQETOQ;\4_P!HK]J3
MXKV[V?Q(_:?_ &@_$A\8?$_6]/F>*6[TG2)Y%:'P]I>H2V]M)J0CFO\ 5=06
MVMK6[U>;3[:WLX<3]NS_ ()!_!W]L_XP^#/VH?!_QC^-G[('[7?@30U\*:1^
MT=^SIX@30?%6L>$T:3R?#WC/2Y&M[;Q)96D4UQ;6DHOM/NA9W$EA>S7UBD-O
M%^M=%/VD^;GYGS;7TVM:UMK6Z6MY$_5Z/L_9>SBH)WLM'S;\W,O>YKZ\U[WU
MN?E+^P9_P21^"W[$/Q,\?_M%:U\4_C)^U=^UG\3M+'A[Q;^TM^T5XA3Q-XZ@
M\,!T:3PUX1M4$EMX6TJ\6&WAOQ%=7U[<6EM!IL=W;:4GV U/V]?^"0'P%_;B
M^)W@C]HW3/B/\8?V5OVN/AQIT6B^$?VF_P!G3Q(/"WCQM#@\U;71O%5L1'!X
MEL;"&XNK:PE%WI>IP65Q+IDFHW&E-]@K]9:*/:3YN?F?-M?R[6VMY6MY!]7H
M^S]E[./)>]M;\U[\_-\7/?7FOS7ZGXH?LE_\$0?@Q\ _VB-)_:^_: _:!_:$
M_;U_:B\)VS6?P[^*'[3GB1-;L/AG%L>.&\\$>$$FO[33=7LXY9TTV^N=2O+?
M2'GDN](T^PU!C>G]KZ**4I2F[R;;_!>22T2\DBJ5*G1CRTXJ*;N^KE)[RDWJ
MV[;M[66R2"BBBI- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "NW\%?Z^__ .N4'_H<E<17;^"O]??_ /7*#_T.2M\-_'I^K_\ 26<&9_[C
MB/2G_P"G8'H-%%%>R?'$#=3]3_.BANI^I_G10!/1110!S_B?_D#7/^]%_P"C
M!7D]>L>)Y;*'1[A[^]BT^V#1![J96:-"9 %!"?,2QX&/QXKRK[?X2_Z&[3O_
M  'N?\*\K&N*K+FG3C>"LIU:<'O+6TY)V\[6/JLE4W@Y<M'$5/\ :*FM+#5Z
ML=84E;FI4YQOY7NKJZU5V44_[?X2_P"ANT[_ ,![G_"C[?X2_P"ANT[_ ,![
MG_"N/FI_\_J'_@^C_P#+#U^6K_T#8W_PBQ?_ ,H\U]XRBG_;_"7_ $-VG?\
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M^ANT[_P'N?\ "C[?X2_Z&[3O_ >Y_P *.:G_ ,_J'_@^C_\ + Y:O_0-C?\
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MO\)?]#=IW_@/<_X4?;_"7_0W:=_X#W/^%'-3_P"?U#_P?1_^6!RU?^@;&_\
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M![G_  H^W^$O^ANT[_P'N?\ "CFI_P#/ZA_X/H__ "P.6K_T#8W_ ,(L7_\
M*/-?>,HI_P!O\)?]#=IW_@/<_P"%'V_PE_T-VG?^ ]S_ (4<U/\ Y_4/_!]'
M_P"6!RU?^@;&_P#A%B__ )1YK[QE%/\ M_A+_H;M._\  >Y_PH^W^$O^ANT[
M_P ![G_"CFI_\_J'_@^C_P#+ Y:O_0-C?_"+%_\ RCS7WC**?]O\)?\ 0W:=
M_P" ]S_A1]O\)?\ 0W:=_P" ]S_A1S4_^?U#_P 'T?\ Y8'+5_Z!L;_X18O_
M .4>:^\913_M_A+_ *&[3O\ P'N?\*/M_A+_ *&[3O\ P'N?\*.:G_S^H?\
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M/^%'-3_Y_4/_  ?1_P#E@<M7_H&QO_A%B_\ Y1YK[QE%/^W^$O\ H;M._P#
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M_@^C_P#+ Y:O_0-C?_"+%_\ RCS7WC**?]O\)?\ 0W:=_P" ]S_A1]O\)?\
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M%% !1110 4444 %%%% ':^*O^0)X!_[%RY_].+5Q5=KXJ_Y G@'_ +%RY_\
M3BU<56^)_C/_ *]8;_U%H'!EG^YK_L)S#_U8XL****P.\**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX=JI2IU)J,JTJ<)T8U*KA#W^:')%0245%%%<!]"%%%% !1110 4444 %%%%
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M]#/#_=5_^5_U9^5_'J*]A_X4KXC_ .@KHGYW_P#\BT?\*5\1_P#05T3\[_\
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M+6GV'1-+DU2\EU'47M;8NY1KR^GFNIV+$O-(S'DU]9?\*5\1_P#05T3\[_\
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ME9=#QZBO8?\ A2OB/_H*Z)^=_P#_ "+1_P *5\1_]!71/SO_ /Y%I?V;C_\
MH%J_^2__ "7]6?E>O]9LA_Z&>'^ZK_\ *_ZL_*_CU%>P_P#"E?$?_05T3\[_
M /\ D6C_ (4KXC_Z"NB?G?\ _P BT?V;C_\ H%J_^2__ "7]6?E<_P!9LA_Z
M&>'^ZK_\K_JS\K^/45[#_P *5\1_]!71/SO_ /Y%H_X4KXC_ .@KHGYW_P#\
MBT?V;C_^@6K_ .2__)?U9^5S_6;(?^AGA_NJ_P#RO^K/ROX]17L/_"E?$?\
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MT/'J*]A_X4KXC_Z"NB?G?_\ R+1_PI7Q'_T%=$_._P#_ )%K'^S<?_T"U?\
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M_)?_ )+^K/RN?ZS9#_T,\/\ =5_^5_U9^5_'J*]A_P"%*^(_^@KHGYW_ /\
M(M'_  I7Q'_T%=$_._\ _D6C^S<?_P! M7_R7_Y+^K/RN?ZS9#_T,\/]U7_Y
M7_5GY7\>HKV'_A2OB/\ Z"NB?G?_ /R+1_PI7Q'_ -!71/SO_P#Y%H_LW'_]
M M7_ ,E_^2_JS\KG^LV0_P#0SP_W5?\ Y7_5GY7\>HKV'_A2OB/_ *"NB?G?
M_P#R+1_PI7Q'_P!!71/SO_\ Y%H_LW'_ /0+5_\ )?\ Y+^K/RN?ZS9#_P!#
M/#_=5_\ E?\ 5GY7\>HKV'_A2OB/_H*Z)^=__P#(M'_"E?$?_05T3\[_ /\
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M?]6?E?QZBO8?^%*^(_\ H*Z)^=__ /(M'_"E?$?_ $%=$_.__P#D6C^S<?\
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MKK6S?CY)8EF))8DDGJ23DD^Y/-?,O[37[&?[+'[9?AO2O"?[4'P-\"?&32-
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M%>P_\*5\1_\ 05T3\[__ .1:/^%*^(_^@KHGYW__ ,BT?V;C_P#H%J_^2_\
MR7]6?E<_UFR'_H9X?[JO_P K_JS\K^/45[#_ ,*5\1_]!71/SO\ _P"1:/\
MA2OB/_H*Z)^=_P#_ "+1_9N/_P"@6K_Y+_\ )?U9^5S_ %FR'_H9X?[JO_RO
M^K/ROX]17L/_  I7Q'_T%=$_._\ _D6C_A2OB/\ Z"NB?G?_ /R+1_9N/_Z!
M:O\ Y+_\E_5GY7/]9LA_Z&>'^ZK_ /*_ZL_*_CU%>P_\*5\1_P#05T3\[_\
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M6K_Y+_\ )?U9^5S_ %FR'_H9X?[JO_RO^K/ROX]17L/_  I7Q'_T%=$_._\
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MV_7_ .M1YGM^O_UJ )**C\SV_7_ZU'F>WZ__ %J )**C\SV_7_ZU'F>WZ_\
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M *U'F>WZ_P#UJ )**C\SV_7_ .M1YGM^O_UJ )**C\SV_7_ZU'F>WZ__ %J
M)**C\SV_7_ZU'F>WZ_\ UJ )**C\SV_7_P"M1YGM^O\ ]:@"2BH_,]OU_P#K
M4>9[?K_]:@"2BH_,]OU_^M1YGM^O_P!:@"2BH_,]OU_^M1YGM^O_ -:@"2BH
M_,]OU_\ K4>9[?K_ /6H DHJ/S/;]?\ ZU'F>WZ__6H DHJ/S/;]?_K4>9[?
MK_\ 6H DHJ/S/;]?_K4>9[?K_P#6H DHJ/S/;]?_ *U'F>WZ_P#UJ )**C\S
MV_7_ .M1YGM^O_UJ )**C\SV_7_ZU'F>WZ__ %J )**C\SV_7_ZU'F>WZ_\
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M *U'F>WZ_P#UJ )**C\SV_7_ .M1YGM^O_UJ )**C\SV_7_ZU'F>WZ__ %J
M)**C\SV_7_ZU'F>WZ_\ UJ )**C\SV_7_P"M1YGM^O\ ]:@"2BH_,]OU_P#K
M4>9[?K_]:@"2BH_,]OU_^M1YGM^O_P!:@"2BH_,]OU_^M1YGM^O_ -:@"2BH
M_,]OU_\ K4>9[?K_ /6H DHJ/S/;]?\ ZU'F>WZ__6H DHJ/S/;]?_K4>9[?
MK_\ 6H DHJ/S/;]?_K4>9[?K_P#6H DHJ/S/;]?_ *U'F>WZ_P#UJ )**C\S
MV_7_ .M1YGM^O_UJ )**C\SV_7_ZU'F>WZ__ %J )**C\SV_7_ZU'F>WZ_\
EUJ )**C\SV_7_P"M1YGM^O\ ]:@!C=3]3_.B@G))]3FB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img247211528_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_5.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 6D"#<# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 >??%KQ+J7@SX5?$WQAHS6ZZQX4^'WC/Q+I37D7GVBZEH7AS4M4L6NH
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M:>(M3LK&V9F!O-<URTU?4]0E9&C-[.L%G;,P_=6UM$WEGW/]D_\ X.1/VF/
MGCS2M$_:TT'0/BG\-[JZM]-UW5- \/6OA+Q_X9B,R03ZQ9#3S'I>N/9#S9KO
M1[[3[>:\"-#:ZA92A=_YUB?H]^(&'P$L9%9-B<3"DZT\KPV83ECTE%2Y(N>&
MIX.I5=W%1ABW&<HN-.<VXJ6+P=91O[C=K\J;OZ;<M_G;S/[B**_#W_@J)^V)
M^UK\'OV:OAG^V?\ L,^)O 7C3X%ZKH>E:MXX@U7P5'XHO(_#OBV.TO?"7Q T
MNZ^T030:*BW/]E^(K:=#_9LMQ87;^5$E^T?B/_!%W_@L1XU_;=\7>/?@?^T?
M+X7LOBW9V3>,/AYJ?AW28?#VF>(_#-E%'%XAT-]/2>X0ZQH<GEZJEP)4^V:9
M<W \G=ILLLGQ-+PYXBK\)XOC'#?4<3EN75:U#,L+1Q%1YKE]7#UHT<1#%X&>
M'@Z3PZG3K5DJDG##S5=KD4W')49NFZBLU%VDE?F332::MTNF_+4_HPK\+?\
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M(_X("?MV_M6?MA^'/CCHO[1WB*Y^(EC\.IO"C^%_B%>^'=*T;4/M6KK?I?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,I2MII+WK<R6VNR[MVZ'UO\ \&W?[)WPK^,?QS\??M"^/]=T37?%GP&729_
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M:.#J5+PE[2IAE-49SO3IOFE!RO3@[WC&RYI6<;OE>K5W9ONUMT7W'P3\=?\
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M6E7MS!;#Q/=IHGB[3K(S97[3J-GH=Q'JD-I#)L\^6TM+^5(BTH@8(5/Y"_\
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MB7D5]IFJZ;>^"99K:ZM;F%F5E=&&Y&VRQ2!HIDCE1T7\M?\ @F%_P5_^'O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG4;D]6;7<G@V]6U*[ZMN"O=[ZVN_,Z__ ((0_P#!+;]E3]H/]F37?VB_VA?
M5E\6-<\3>._$G@WPYX?UV[U*'0?#.C>&(+"WN;M+/3KNR^UZQJ6HWL\JW5P\
M@LK:UM!;*LDLYK\5_P#@KG^RCX$_8L_;H\;?"_X1&ZT[P#=Z7X3\>^$-+GO+
MB]N_#,'B;3DNKG15OKIGN)X-.U>WOCIDDTDLR:=)9Q2R/)"SM_63_P &YO\
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M#Z0/_)R,;_V*\H_]14<N+_CR](_^DH****_$SF"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/;XBC>GA:U&-?#2K3IQG5A.<82T^J24X)SBXR^TG:]MTNMVMFKJY^E'[$?\
MP6_\+?MW?M=6'[._PT^!^N^$/!TO@_QCXHG\;>,?$=C<>(;D^&DLWMHHO#>C
M6TVGZ='="[ G\S7-3>,H=K 8)^E?^"R.N?M+^'OV$?B/J/[*K>,XOB&-9\,6
M^MW/P]MKFY\86G@"YOWB\6SZ0MA'+J4(^S-!%J%SI:?;[?39;N2%XE$DJ?Y_
M7[(^M?M4Z#\8+>__ &/9/B!'\91H&MQ6[?#:REO_ !-_PCT@MCK@6VAM[IS9
M;5MOM;&(JO[O)!89_K4\!?&S]OCX=?\ !%7]J#XK?'_Q?\7O!O[2?A;XD:F?
M"?BCQO:_V1XTTWPFY^%]M9-IJ75C$XTJ6]O/$EO%+);DM-)?K$^Q8ROV?&/A
MAE?"?%O"V:\.3R&."AG'#>7QX;S3&8K%8S&8S%9A.$L9C:=6.(G+ U?<C6E3
MC*,5"7)0:2@]*E"-.K3E#DMS4X\DFVVW*UW>^G]6/G/_ (-UO&_[=7B#X[_$
M?3OB-J/Q=U_]G!?A_K5WKE]\3[CQ;?Z)8_$9-9T&U\/1^%]1\2M,#X@GM8=:
MAU*QLIVB72[>YDOXX[B'3R?[":_EE_X-W?VQOVF_VH_'W[3>F_'[XQ^+_BA8
M>$?!WPYOO#=IXEN;::#2;S5=;\3V^H7%HEO:V^R6Y@LK:*0DD%8EXSS7S;_P
M5J_X+L_%_3_BWXN_9R_8U\1CP#X=^'>M:AX8\:?%G3H;*^\4>*?%.DW,EEJ^
MG^%Y[N*ZM=$\/:3>0SZ=)=I;OJ>JW<5Q-'<6=G';_:/GN->!^)..?%7-<FP&
M79)EV(P> RRMF%?!5*ZRK"X>K@Z%:GB<37E@L/7KXJM]8A1M2P,9U902C!TZ
M52NHJTIU<1*$8QBTHMVORI.,6FW9-MW[*[]+G]EE%?YO.J_'3_@LI\.?"EE\
M=M<\;_MA^'?!4JPZU;^-]9'CC_A&8[?4E>>WU"\&I6TNDV^FW*'=#-J%LFGL
MLD*(<30J_P#0Y_P18_X+/>,?VJ/%T?[+O[4-QIES\5Y-)N+_ .&_Q(M;>'3'
M\??V7$\^I^&_$6GVT<-A%XDM].B;4M/U&QC@35X8+^&>TANK>*6[\'B?P1S_
M "#)<7GN!S;)^(\%EW.\RCE56I+$82%*WMZCIRBX5(8=-3Q$8U57I4^:I*C[
M.$YQFIA9PBYJ49J.ZC>Z[_=I?6Y_3517\0__  6>_P""A7[9O[/7_!0GXF?#
MOX0?M!>/O!/@+1-$^&U_IOA+1[ZUATBUFU#P5H6HZ@(HFLY'"WM[+/<S[WD+
MRSR9.PA%^./B/^VI_P %D?VI]$U3]H'1-2_:$TOX3Z3!,(KWX/>'_%'AOX>:
M/9:1:10:C<VUQH5N)-12);=KG6-3N[[45BO!>2236J1O!!V95X#9YF>5Y)G-
M3B+A[+\OSO 8;&TZF+K8FG5HSQM&C6PF#<)T(0K8FLJLURTJSBO8SM*3<(R<
M<).482<X1C**E=WNN9)I6LDWKW/]#^BOXR_^"(7_  5Y_: \3_M"^&/V4OVE
M/'6J?%'PM\3S=:3\/_%/BJX2Z\5^%?&%M92WMAIDFKM%]LUG1M<BLY[+[-J,
MTUS9ZC-;W%O<&&2:"O[-*_.^.."<VX#SIY-FLJ%:4\/3Q>$Q>%E-X?%86I*=
M-5(*I"%2G.%6E4I5:52*E"<'9SIRA4GA5I2I2Y96>ETULU\_Q7?ON%%%%?'&
M84444 %%13W$%K$\]S-%;P1X+S3R)%$@)"@O)(RHN6(49(R2 .2*P[CQ=X3M
M'CCN_$_AZUDE!,27&M:;"\@! )C62Y4N 2 2H(!(S51A.?P0E+_#%R_),#H:
M*YG_ (33P<>GBSPS_P"#[2__ )*KEYOC9\&K>>>UN/BW\,8+JUE:&YMIO'OA
M6*>WF0X>&>%]562&53PT<BJZG@@5K'#8F=^3#UYVWY:525K[7M%[W06;V5ST
MZBO);SX^_ K3[6>^O_C5\);&RM8VFN;R\^(_@ZVM;>)?O2SW$VLI%#&N1N>1
MU4=S7,#]K3]E8C(_:8_9](]1\9OAR1_ZDE;0RW,:B;IX#&S2=FX86O))O5)N
M--I.S6GF.S[/[F?0-%?*OB3]N?\ 8S\(_9/[?_:F^ EG]N,HMO)^*7@_4=YA
M"F3?_9FK7GDA0ZX,_EA\D(6(..6_X>-_L'_]':? K_PX&B?_ "173#(,]J14
MZ>2YM.#O:<,MQDHNSL[25%IV>CL]]!\D_P"67_@+_P C[3HK\\]3_P""L7_!
M.+1[^YTV_P#VO_@\EY:2>5.D&L7M]"K[0V$NK'3KFTFP",F&>10<J2&! R;G
M_@KY_P $U;6WGN6_:^^%<JP0R3&*VN-<N;B01H7,<%O%HK2S3/C;'$BEG<A0
M,FNR/"'%DU%PX7XBDI).+CDN9-24K.+36&LTTTTUHTU;<?LZCVIS_P# 9?Y'
MZ145^48_X+;_ /!,P_\ -RVBC///AGQB.P//_$A]QQUSD=CC \0?\%UO^"9G
MA^WM[@?'R77/M$S0^1X?\#^,=1N(=JEO-N(SH\'E0G&T.6.6(&.:ZH<!\;SD
MH0X1XDE*3LDLES'5_/#C]E5_Y]SU_NO_ "_KY,_7NBOQ9_XB /\ @F;_ -%7
M\8?^&Q\7_P#R%7':M_P<5?\ !-S3+Z:S@\3?%;5HX@A%_I_PPU46DQ=%<B+[
M9=6MP=A;8Q>!,NK!=P 8]4/#;C^;M'@WB2]K^]E.,@K:=9THJ^JTO?K8:H5G
M_P NI_.+7YV/W7HK\%'_ .#CK_@G(L;LFH_&21UC9DB'PSN4,CA<K&'?4PB%
MV^0.Y"*>7*KDCA?^(EK]AC_H3/C:?^Y?\/?U\1UTT_"SQ%J\W)P=GJY;7Y\'
M*EO>UO:N'-MKRWMUM=#^KUO^?<ON/Z):*_G U[_@YH_8PT^R2?0_AC\:]?O&
MN$C:Q:Q\,:4$@9'9KC[3/KEPC;'5$\H)N;?NW *<\?\ \10/[+G_ $0#XS_^
M#7P9_P#)]=,/"'Q*FN9<(YFE>UIO"TY:?W:F(C*W9VL^@?5Z_P#S[E^'^?\
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M!5H8C"XFBTJE&M3=X3BVFG9Z-23C)-QDG%M/.,G%J479IW371GY<_P#!/?\
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MP.O>NI@F#!3V)X'&>O7KT/\ G%>M"?,EZ:?U??N?G]>C*E)JS5GK]R?9=_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7UG=6<G[-.CPI=026[36GBSQU:W<*RKM,EK=0^)%FMIU',<\+I(AY5A7F_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\1?V0-0O]:UV6%A<VOAC0HS%/JTMJOVB>>[L--M3'/?)+%_#K_P4"_Y2G_M
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M OCK2K;3]09] \7>(]*M[C9;ZC;WMFMQ)974UG=13P226ERDT3*LL3 ?RF^
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M25OS)Z***T.8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/NFM+I;V\S_/+_X*!*?^'IW[0+ $J/VE+L9QW77+-2,=<Y& ._&,Y&?Z=?\
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M2C).,D_[:QVCBTFGY-"@9('O^G>M"W&3TSS_ (?TS5%!SGT_J#6E;+^O/?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2+S_ /U<\&..\;&7+6Q.51RF@NLZF;8JA@)P6JU^KUZ\G;51C)V=K/;"X/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ>H /"'@\\=>/Q)%??O@VU ACW Y*(,^F",CIP,'/?@FOD/X2V!6W@.!A54
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MR_U]_P [?(NT445R&04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]5;KHGY:ZOJ57PWLEI;9V[]-.E]UJ^YZT.0#ZT4R/[O/7//Y"GUXYQ!1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYD**** "BBB@ HHHH **** "BBB@ HHHH **** # /49I,#T'Y"EHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ I" >HI:* $"@=!_.EHHH **** "BBB@ HHHH ****
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M[) LT$L5I<:9+.=6CGCN$:*Z@N5E;^.-S@8]?Y?_ %Z[#P-C^TKHX!_T,C!
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M=-V7:***Z#RPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*0ZG7=5N=?UD))_#%)I^C+;W*C:7%P@)9-RU^1^/.?\ ^K/@]X@YK&?LZO\
MJ]BLNP\KM-8C.94\GI.-DWS1ECN=-;<M[JUSJP.$_M#'Y?@+)K'9A@<'-._\
M+$XNC1KNZM\-&=23U6B?6Q]1?!73I)(;228/)--*)9I';+222Y>61F)R6=W=
MF8CEB2>E?IY\.['R[: !2 =F?7[OMGV/!QS]17P3\&]+"V]G@8&4Z-@D '&?
M?)YR?S.,?I!X$M%C@CXY 7'S=!CG&,<<YQG.?T_QGR6DHPB[+97OJ]5'O\MN
MY[OB;CO:8FNK[3EIMIS+MLK?"K6[+73W71(RL*KSDC@'V'/8=\FNNA_F#_,"
MN?TM (P0/X0>>O.>G)P,Y[YQUKHXP O'K7V%-6C]R^Y?\$_G'%2YJC:ZN[\^
MS^[^MB2BBBM#F"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M(9C\I'T/ZXKD]7DPD@(X4-SGT)/I743N #GC'7Z G^O:N%U^X"1N1P0I.?H?
M;WR,X[X]JQK.R^3_ !LD=N"@Y5HI=91_!IWW_P"&/G3XB3*+6;_<D[G'.X]<
M>XK\O_C9<1BWNLD#_6 \\ ;FYSCG'I@=^>Y_1OXE7ZI:W'S@81^"P!&2<9^N
M._)XK\OOBTUWK=];Z%I:&XU+6=1M=(L(D!9I+S4;J*TMP O)'FS*S8!(4,<]
MS\5G<_=DEJ[62MNVXZ?-VZG].^%N&:K4*DO=A"2G.3=HQC&TI2DW:RBDVWT2
M;>S/$OCQ:06W['_[/4NLO<IX@O?BC\6KWPE Y4P2>!I/L4.I7.%+,G_$^@M$
MMA(4W*;AE0CD?!-?<'[>VM:?:?%KP[\'] G$GA_X#?#_ ,-_#Y%BVB"3Q(UJ
MNK^*[LA&;?=R:G>"VO)'VRFXM94<8537P_7^R/T=^'<7PMX,\"97CIU)8F>4
MO,YPJ7_<0SC$U\SHT(Q:3BH4,53YHO55'/:]E\?F&/CFV99IFU./)2S7-,PS
M&A"W+RX?&8NK7P]U=VG*C.G.IKK4E-Z7L%%%%?M1RA1110!U=E+<K\(?VK;>
MW:?9>?LQ^/([F" .PN8H==\)3JLL: F1(64S<@B/:TA( )'\]E[_ *I?]P'U
MZ@'WK^E[X' '3/VD 5##_ADC]H'Y6 8'_BD<C(8$<$ @XX(!&" :_F=G_P"/
M2W_Z]X?_ $6M?@?%TE_KUFM-12:RO(*KDK7DZGUZG9I+5Q5!>\VVTU&R45?]
M'X(FI9-G]+E7N8[#U>;>_ML%&'+9+[/U=.]]>:VCBK\G==_I_1LU]G_L6G_3
M/B'_ ->NC?I/(*^,+L_>.,<XQ]<BOM/]BV&7S?B%<^6WV<QZ-;"7C89_,FE\
MK/7=Y:,^,= ><BOY0^G%.$/HK>)_/.,>:EPG"//*,>:<N-^&N6$;M<TG9\L5
M>32VT9^H_1SC.7CSP4H)RY9Y]*7+%NT(\,9O>3LGRQ5]6[6NM1W[9UFPN?A_
MJ7F#:8=9T_R=IW!ED@N?-W]"")=FW ((SDYX^-[3J/J,?F?_ *]?:O[9Q_T/
MX?#_ *?=</Y067^-?%5F>1D=<8Y]<G/X=*Y?H-UZE?Z+'AHZLN9TI<6T(:)6
MI4N-N(E"/NI7Y4WJ[R?5L]'Z0].%/QXXQ4$H\\N'JLK\TKSGPWDW-+6]KNUD
MK)6T26C^Y_\ @G[X<M/%O[:'[,/A^_O9=.L[[XO>%Y+B^@CCEEMDL99+_>J2
MD(0S6X1RQ&U&9AR!7Z>^))EN/$OB2X0JR3^(M>G5E.5*S:M>2*5/&5(88.!D
M8.*_.W_@F9I<^L?MT_LRVELT4<B?$-+UC,6"&*PTC4KN9 55CO:.)EC&-I<@
M$J"2/T"O>;[4#ZZCJ'_I9/7]G^&FO$/$_O/W,HX;7)9>[[3&<27G>U_>]E%6
M;:]W1)WO^'<>SOF654^:ZADE&:A9+E=7&XU.6BO[ZI13NVOW:M;6]:BBBOV8
M^'"BBB@#J? UEI6I>./!.G:]<K9Z'J'C#PO9:U=O@);:3=:[80:C,Y) 5$LY
M)B[D@(N7/"FOTT^+%UJ;?M2_%I=8LAI]Q!XL:UL+<.9(VT*SLK2VT&YAD91O
MBO-*CMKE67*CS,*6 !K\H6!*D X)!P>X/8CW!P1[BOUD\>ZLWCWPK^SE\?5V
M3W'CCX?0^!?&5XDCR2GQU\.)/[&NGOW=F"W5]IB6TRC"^:MO)+EB23_!/TZ\
M@Q^)X?X$XEHU9RR_*,WS#+<90M>G3K9M1PU7"XBZU4I++J]*5]+*"6K9]SX=
M8REAN(ZV%JQ3EF^2YA@,+4;:E3Q5"6'S-4XKX6L1A\#B.:Z<N>A24;)RO]L_
M"F9/+M>>"4QTR25&0/H1U[YK[O\ ";JUN@SV7UZ85<]/7M7YS?"/4T:&URP(
MWIC:<=OQ/;VX'H:_0#P9=+);@D@Y$>!D @@#CZ''^1S7\'Y5-.$-M4NO^'[]
MM_,^#X^PTH8FMH[*I)>>Z_1?+[V_<[5LH/<G\,9K3!!Y%85C(&C!!&>#CGON
MX'3CI@>GKUK;3[H]L_SKZ2+NE]WW'XK45IM:_/<=1115$!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>)BUJG1OHM3\PO&?BO4O'GC#Q5XWUF9KC5?%WB+6?$=_,YRTESJ]_/>.>@X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTE)R?UU_P24(/_!1']E$ <CXCQYX'/\ Q*=0'7K7Z&_%WGXM?%,_]5(\<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKI=V^Y?Y]2>BBBM#E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;?4M"\0:'>V^I:3JNG72;X;NRO;5Y()XG!ZHY9&#(X5U91Y_XNA+0R9Y )Z
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M]!SSC\/QK]6_V5N/@EX9'_3]KW_IUGK\G)GR3W&,GUXY_P#K_CVK]8OV5/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-6M;VV'J7]G-I72FK.%2*;2J0ERMQLV4445XIXH4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW*&S][@#.2<'&,$<'BOT@U#0DF# IG!Y..?7(.>OUQCW->?ZIX0AD+DH/XF
M/;YAZ=3],#.!T.:\C$Y?"K>\5KUT\M[K;Y;GZ-DG%^(P;A:LX\MMF^\?->EK
M[?,_/?38?BAX-LVTKPKXQ\3:)IBMOBL+2[;[-$V"&^SQ3*R0J,9\N(*F<G':
MN<U?3OB=XE+QZ[XU\8ZK%)(9)8)]9O4@=F(SO@BFBB*\ ;%7;P.#Q7WS=> 8
MI"P,0()XXS@D\D<GMR1G P<C')II\/(@01%NQV*D  $9/('M_AQFO.EEM1Q4
M.>K[-))0]I-027+IRWY=D]E;I8^OH\:X.$WB?J> ^M2=YXIX3#?6)2T?/*MR
M>TE*]FY.;;T=]K?!&B?!>.-PYLSYDC!FD:++,6+,S/(3N8EF!9F8DDDL<Y->
M\^&OA6L'E9M<$<'"@<A5 YSCG'N><=1D?3-EX&CC90T6 "#Q^)P<$X&._K@8
M[UW>G>%H8]A"9(Z XQP"<=/8="#SC'KMA\JIP>L5I;I;;E_.W5V/.S;C_%XJ
M/*Z\GH^KW=M7KIVZZ/3K?R_P[X&2!8P+=1M(R<# P22<]3WSSG/2O9M'T)(5
M3]V!A<;MN/?C(  P/4GN#TK>L='$(5=@'0[1QQZ_-R<]^@]>AKHH+55"\=,9
MQ[=,_3GOVQ]/:HX:,$K+MZ;):_Y+\4S\QS+.:N*<G*I?F;OKZ7_*UK?(9:6J
MQJ/E!R,@'!ZCWS@8Z ?C6K'&!SZ?AW!QCT_SFA(\#T'^<8XQC_.34X&.!7:D
MDOZ_KH?-SFYN[_S_ *V7R2"BBBF2%%%% !1110!\(_\ !2OQG?>"OV-?B[=:
M<T\=WKUCI7A)+BWD\J2UB\1:M:6-S-NZE#;&:*15(9DE8 \FOS@_X)Z_L^_!
MKX9_LY>)OVT?C=H%AXF;3K37=5\+V&I64>I6OA[PYX8GDLA<66F749M9O$&N
M:I;O;V]Q,LJ6\'V=(F02R./T)_X*A>'=3\1?L7?%/^S$61M"?PYXEO4(8N=-
MT;7;.:],2J"6D6)MP!X"JS$@#-? G_!/#XQ_"?XU?LS>+_V)/BKXBMO#>KW=
MCXBTOPS)>7T5BVO>&_$<TM_"VBW5Q-%#<:WX>U:5YSIK.DES#]F:**6$R[?L
M,MIU?]7:U2C[3V:S6"S"6'NZ\<#[.C[5Q4;R25TY6LN5N[Y>=/\ 7^'ZN)I>
M&V+^I2Q,*<^+*2S^6!<UC/[%6%PGM^1TVIJ*O!2Y=/9RJ<W[N509_P /3_V9
M_BSX<\>^%/C?^S=):^'&T*^_X133K>+1?$4OB%CF.VT>6=+*PE\+:E+"T4L.
MJ6\K0V<D<A5@40M\ _ ;]D#P;\>?#/BKXLZQ\=_AW\ _ACIOC'4]"M-'\8ZM
M!J?BS3(D6*_L[6ZGOKC2K&X"Z?=(EO<YDDO?L\TY5 KBOO*S_P""/GP^^'VD
M^,=?^.O[15IIGAJUT:[_ .$>URRL[3PVFD7L):5=8UHZO=O;ZBL-L@#Z-:2+
M]H=W6.X!\O/I'[$_P)^%\O[)/C/Q9\!O#/PI^.OQV?7_ !9I5MJWQ2TZ)]&D
MO--UR?3]!6?2M1CNY?#VEWOAR*UUFVC6&W?4I+HBXNI8541?24\;D^7X/$UL
MBQ&,IJIC,!AYUG"I4P5.553]Y5,PBZ%'2,_;5IQJ2A)1M!TVDO;GG?#>39?C
MZO!^,S&C&OCLMPU2JX8BOE]!UH37/3GFR>'PSDH2^L8BJJM6$^51INDTX_G9
M^T7_ ,$[_'/P%\*>%?BUX+\9>&OCO\--?USP[I^GWNA6C+<W%QKUW%%H:SV5
MM=75EJNCZU=[-/:YT^]&QKF.*0*959?OG]ISX*V'AO\ 8V\1:E\0_P!E#X>^
M$O&K6^E:EHJ_ _2I+B\^%6AV#Z;-XAU[QIXSU"2WAN;T0"ZCM["Q2Y@=Y([:
M=KKRI+ROI3]JO3-6\3?\$[/&=G#JOPYT/QG\/=%T35?$]K\)KI7\'>'?%/A/
M6K'4]3T3PZ;!A)I=Q9S.K1*5C>UO,N $*O7\RFI_&3XN:[IUYI.L_%'XA:MI
M.J6YM]2TS4_%VMWNGWMM)M+V]W:3WCP7$+$#?%+&R,0,@X%>WD%+-.)Z6&Q%
M3&4:=3)\WJPK3Y*].KB:,'AJU%-X6K0H>_'FYIJDU4BE%.$)554XLOQ>;<2T
M<-B<3CZ*K9/F]:%6:C6I5L30@\-5HW^JU*&&49Q4N::HOVD5%+EA*JJGW1\4
M?'G['OP\^-7[*/CW]C\:S!J/A;5?!VI?$9UBU-+(R"\T^&:"YCU=(Y9_&,T$
MNI0:[)9!M(D26 6DA&XU_6:CB1$D7.UU5USP<, 1D=C@U_!]\*O#=WXR^*7P
MU\(Z>)1=^(_'GA32(&@@-Q+&UYK5G$TRP KYOD1[YC'N0%(VW.HRU?W@1)Y<
M<<8.1&B)G&,[%"YQVSC.*\3Q,R^EET.'J"Q&)Q5:-#,%.OC*OML3.C[>C4I>
MTJ<L>:,9U*\:>B2BFM;-OY'CJE3H/*:*KU\34I4L7&5?%5'5Q$Z<JM.I3]I4
M<8\RC.I54--(JW0?1117Y6? !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%1O($^HY/?CGTYYQQ69)JB1L5W \D?E^!S346]DWZ#LWLFS7
MHK-AU".7HPSC. ,_7WR,]A6B"&&1]/H?0T--:--/LU80M%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\^YL4445XIPA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0858Y.">G(_^O2?9T]!^7_UZGV<;W_17Z=?ZZ=M=5BJJ27,]/-?Y>2.?CTU
M02,>N0/?U!_0U>BLU7&!Z\XQ_P"/8S_G%:OE^_Z?_7IP51T _I^5-0BK=;?=
M]QG*M.6[[?A;_(K);XYX ))QSSD=1G^E6 B@#C/^?3Z5Y-\;OCM\)_V<_A]K
M7Q0^,GC32/!'@[0X'DGO]3G N+ZY"%H-+T73X]][K&KWC 16>FZ?!/=3R,,(
ML:NZ_P IO[6?_!QC\3O$.H:MX9_9*\#Z7X"\-QR75G:_$'QW:0Z_XNU& I-
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M^-7A/?%#<^+-"M-.\*_$*RA+ 27+1V,-IX8UR0;F;[/+8:.Q5 HO5)K^L?\
M9D_:K^"'[7?PYL_B;\#O&5GXGT23RH=6TU]MIXD\+:E(C.=)\3Z([M=Z3?@(
M[1B4-;W<:--97%Q"#)7R^><)YWP^E4QV&YL+*2A#&X=NMA7)_#&4^6,J4I?9
MC6A3E.SY%)*Y^.<7>'7%'!<E/-\'"I@I35.GF>!J/$X"<W\,)5.2%7#SE]FG
MBJ-"<[/D4DKGT51117S9\,%%%% '+^-O".D>/O!_B?P3K\(N-%\6:%JGA_4X
MBJL3::K9RV<S(&!7S(UE\R(D?+(B-U%?Q)?'3X-^*OV>OBSXL^%GBJWN;/4_
M">JR'1]0^>'^UM"ED:70/$&F7";&,5[9&)UFA8/#.LL3%)$91_<K7Q!^VI^Q
M)X&_:Z\(0K/);^%_BAX<AD/@SQW':^:\"L3))H>NPQ[9-1T"\?EXB3/8SG[7
M9D,9HI_K>$L^IY/C)4L7?ZCBW!59).3P]6-U"ORJ[E!)N-6,5S./+)*3@H2^
M_P" N+H\-8VO0Q?,\LS!05=Q3D\-7IW5+$J*NY0Y92IUXQ3DX.,XJ4J:C+^0
M'4/$'B+6XD@USQ'XCUNVC8/%:ZUX@UC5K6-QTD2VU&]N85<<8<(&QQTP*FT;
MQ1XG\,-=OX9\3>(O#;W\+VU\= UO4M'^VP2(T;Q78T^YMUN%,;,@,H9T5BJ,
MH)KU3XX?LY?&C]G77KO0_BMX%U?0HH)GCL_$UO;RZAX0UB!7*1WNG>(+:-[+
MR9N,17;VUPCGRGB$@(KP1ID;I(A!_B# C\,=OI7] 8"EAL51A4P\J-?#U$G"
M=)PJT9)V:LX7A*3[='HTFC]MJ8W#XNBJE"="OAZJYX.E*G4H23L[QY;PELG+
MS6JTL]NV\3>);'2]3T&P\2>(+/0]:D2;6]'MM:U*'2M7FC<R+-J=A'<BVOI?
M,)=I+F.1Y7P9"Y"D8)/15'].G<_T ]_<EID7>D2,#)*ZI'&N7EE=SB-(XD#2
M2R.2%CCC5F=B BDG%?HU^R9_P38^-O[1VIV&N>*M*U3X4_"=+F-M2\3^(+)K
M/Q#K=O'LDEM/"N@78CNI#<HQA&KWJ0V5JQ+1K/(GEGU,5B\MR7"SQV8XBA@Z
M$;R<ZC2G6DDER4X+]Y7JM)*,:<9S>R7*CYK,\TPN!IU*V(JPHP;YFY64JD[)
M:12<ZD[))12E)I+>R2]E_P""0O[-5Y\1_C//\=M>T^X3P7\(A(OAZZD4QV^L
M_$"_A,$$=NQ&9X?#VGO/>W3I\BWL]A%O.)4']0E>??"SX6^"/@QX"\._#;X=
MZ+!H/A3PQ9)9:=91?/+*V2]S?7UPP\R\U&_G9[F]O)B9)YY&;Y4"(OH-?S)Q
M;Q%4XFSFMC^65+#0C'#8&C*W-2PM-R<>>S:]I5G*=:HDVHRGR*4HPBW^'9UF
MD\WQU3%23C325*A!VO"E%MKFMIS2DY3E9NSERW:284445\R>2%%%% !1110
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M3=5:>XT*?7+AG@TN^@OKFP%]Y%E<I;F[AD7\N/\ @YL_Y/A^%O\ V;]X8_\
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MZG;_ &W6K75IDB>[TZV\&VEOJ*>))%M6FM=2M[;3/+6YO[<'R[_@F!_P4_\
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M6+S38T.CZ/H4FH6XDN+5&L]5GM&9$-TY#-7]/5?YWVD_\I[=*_[2$VG_ *N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI.\I2DVY2;>[;;;?5L_FAMR;E)MRDVVV[MMN[;?5MZMA1114B"BBB@ HHHH
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M/6/#VAZ=H]S-X7U3PWK-U)H5TVGP6RS:?;WFF6=W:0R(XMI8R(#&DLJOW/\
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M:Q%+:7^FWHL);"3QB^F#3'U;3O%%C<,FJ6D&C^(M.TA]4@#W-B+5VLU^X?\
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M*L.K-X(DT_4-/F-G8ZAJ"VCR6IG_  )TFPOO^'\^E7(LKLP#_@H3:$RBVF*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%/$6O>%M9AC>*'6/#6L:CH6J1Q2C;)&FH:7<6MVL<BDAT$H4@D$<G,MGXO\
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MHBE>\FM'N&EB"J(Y&D+(%7:1@8Z"ZM+6^MI[.]MK>\L[F)X;FUNH8[BVN(9
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M** "BBB@ HHHH **** "BBB@ HHHH **** "B@D#J0/K2 @]#GW'3_)[?C0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12;AG&1D=L\TM !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!^=_P#P46_:]N/V7_A3;Z=X-N84^+/Q$:[TKP>\
MD<=PN@64$:_VOXIN+=SASI\<B0Z:DBM'-J4L18,D,BG^3S4M2U+6M2U#6M:U
M"\U;6-6O+C4=5U74;B2ZO]1O[J1I;F\O+F4M)-/-(S,[N3UP,* !^K?[<.D^
M,?VJ?^"B\?P/T:X^R_V2?#7P_P!'FG:1[71=+_LN'Q-XIUYX7RH=6O[B4QH
MMU]CL4)RQQ]+^//AS_P2S_9.UW0?@M\6/#&K>-/'K:;I=SXA\17MKX@UNZMO
M[3VPQ:IK<VGZA::=HR7*E[Q=/TJW8VEJ!*8BQ$DGZ)E'L,JPV%IQPN(QF.QU
M!8RI2PE)5:RP\K.,IMRBE1@G%*-[RJ<]U9^]_3?"6+RK@;(<HPE++<?FO$7$
M. AG>,HY5AH8G&+!5$I8?VLIU*:I86A3G&G""G)RQ+KS4+SNOY_68#Z]?I[G
MW'8'ZGM55G)) Z=_>OT$^+/[,7P]^*O[2=W\+?V#=1N?B3HS:*=<UJWOM6MX
M/#OA.=9XTN(=)\6:S<12ZWHL4<T1:607$]K=DV2W%XV'7GOBY_P3H_:@^#W@
M?4OB+K7A[PYXC\)Z)%+/KU_X*\26FOW&BVL!Q/>7EC&L-T]G;$,;R>UCF6T5
M2]QY:X)^ZPF/RV^%IU,33PM;%0ISIX;%2CA\3^]TA&=*;YH2F](I_$O@YDTW
M]=4XLRBJL&JV,IX'$8ZC1JT<!CY1PF.BJ^E.%;#5)<].<G=13TJ[TG.+4I?"
MS@2 H0"#][/08.1^.0,>AYXP2/Z#O^"2O[9NKZ_.O[+?Q)U.34+K3M+NM2^%
M&O7\Y>\GTZPS/J?@^\N9Y'EO)K&%Y+_1I'/F)913V.76*U6/Y8^"G[)'P ^(
MO[*OB/XJ>+/!_P <_ NJZ1X'U'6X_BIJ][IL_A'6O%UH;N/3M)\"^$K&-M9\
M1:)J#1PF>YELT5)1+;1ZA&<3#R3QS\,OAA^RRG[(/QT^$OQT3QQXX\0:IX8\
M5:[H,-F+=[>'[98C4]1M/+FW:-ID)N+C1KK1=89[^60FY$X@C=:C,5E?$.&Q
M63.GB%C8UJN&PLWAISA1Q]"A.O"2KT?:TZ<'&#A-5)TYN$VJD(W37Y]Q+F&5
M\2T,9DU2%>.*IXBKA\+.>'<XT<?0H3KQJ*O1E5ITX2A"4*BJSI3]G-J5-*2:
M_KGHJI87D>H6%E?PD&&^M+:\B*L&4QW,*3(0RDJP*N"&4D$<@D'-6Z_!6FFT
M]&G9KLT?SNU9M/=:,****0'B7[0_P,\*?M&?"3Q9\*?%T86SU^S+Z9J:(C7>
M@:_:!I='URQ9E8I<6%V%9@N#-;/<6S'9,U?QN?'3X!?$[]G'QU>>!/BIH$^D
MZA#+*=&UB.-Y- \3Z<LLB6VJ:'J84VURD\:K+):"07EE*S0SPHR9/]R%<%\1
M?A;\.OBWX?G\+?$OP9X>\;:!<9+:=X@TVWOXHW(QYUM)*AFLYUX*W%K+#,I
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M)CTV&-BC&"2]N(V!M&KXQM;:>\N8+2VBDFGN)4AABB1I)9))&"(D<: N[LQ
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M+1):)'^$,I2G*4YR<I2;E*4FY2E*3NY2;NVVVVVVVV[L****8@HHHH ****
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MHJ*">&YABN+::*XMYXTEAG@D26&:*10T<D4L99)(W4AD=&*LI!!(.:EK/;<
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M2S6\HPP.4D;@CU%:E1*,HMQDG&46U*,DTTUHTT]4T]&GJ@"BBN-\3?$7X?\
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M_@I7_P!'M_'G_P 'NA__ #/5^?E%>[_JMPQ_T37#W_ADRS_YE*]G3_Y]P_\
M 8_Y'Z!_\/7?^"E?_1[?QY_\'NA__,]1_P /7?\ @I7_ -'M_'G_ ,'NA_\
MS/5^?E%'^JW#'_1-</?^&3+/_F4/9T_^?</_  &/^1^@?_#UW_@I7_T>W\>?
M_![H?_S/4?\ #UW_ (*5_P#1[?QY_P#![H?_ ,SU?GY11_JMPQ_T37#W_ADR
MS_YE#V=/_GW#_P !C_D?H'_P]=_X*5_]'M_'G_P>Z'_\SU'_  ]=_P""E?\
MT>W\>?\ P>Z'_P#,]7Y^44?ZK<,?]$UP]_X9,L_^90]G3_Y]P_\  8_Y'Z!_
M\/7?^"E?_1[?QY_\'NA__,]1_P /7?\ @I7_ -'M_'G_ ,'NA_\ S/5^?E%'
M^JW#'_1-</?^&3+/_F4/9T_^?</_  &/^1^@?_#UW_@I7_T>W\>?_![H?_S/
M4?\ #UW_ (*5_P#1[?QY_P#![H?_ ,SU?GY11_JMPQ_T37#W_ADRS_YE#V=/
M_GW#_P !C_D?H'_P]=_X*5_]'M_'G_P>Z'_\SU'_  ]=_P""E?\ T>W\>?\
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M]_X9,L_^90]G3_Y]P_\  8_Y'Z!_\/7?^"E?_1[?QY_\'NA__,]1_P /7?\
M@I7_ -'M_'G_ ,'NA_\ S/5^?E%'^JW#'_1-</?^&3+/_F4/9T_^?</_  &/
M^1^@?_#UW_@I7_T>W\>?_![H?_S/4?\ #UW_ (*5_P#1[?QY_P#![H?_ ,SU
M?GY11_JMPQ_T37#W_ADRS_YE#V=/_GW#_P !C_D?H'_P]=_X*5_]'M_'G_P>
MZ'_\SU(?^"KO_!2L@C_AMSX]#/<:[H>?_4>K\_:*/]5N&/\ HFN'O_#)E?\
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M(C'ZSA:^(HSJ.I*A:?)&%.G##$2A+D<9<\[/GGR.'-:UG9VOU3:[:]+?$O\
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M/%X@\/07;R2Z/):R6D)CAO#:VW9I_P &YT;HLD?_  4+_:+=)%5T=-,W(Z,
MRLK+XZ(96!!5@2"""#@UZ5^P7_P2&^!?[.W[7EQ\</!O[:>M?'SXF_!T:EH?
MCGP=J%EX<O-6TN]\6>&[G3;6'Q1?VGBC6=6T^=+&Y,UM'<0%F>W^SLT;12(G
M1F'%>0YKPSQ7E_$/'];CB5?+:N*R>G7X0S+ U\GSNG.'U+$8;,/9RA@L+7JR
M6#K4)>SP\E5A",J<9U(56YPE3J1G6]M[MX_NI)PGI9J5M$W[KOHT[*U['S1\
M&/\ E9F^-?\ V(?B;_U37@ZO+/CE_P K,OPN_P"PK\+_ /U4$E>I_!C_ )69
MOC7_ -B'XF_]4UX.KRSXY?\ *S+\+O\ L*_"_P#]5!)7N83_ )&Z_P"T;:7_
M *AP*C\7_<BORB?V!U_/C_P<F2R1?L%>&VBD>,GX[>"5.QV7<ITCQ,"K $!E
M/]U@1G!QD U_0=7\]W_!R?\ \F$^&O\ LN_@C_TT>):_$_"C_DY'!O\ V/,)
M^<CEP_\ 'H_]?(_F</\ \%,995_X(+?#"5)95E/@3]F1C()'$C%K31=V]PVY
MP^3O#$AP3N!S7QS_ ,$[O^"+-C^VS^S5\-?VA/VPOCE\3->L/$7A"31?@KX$
M\,ZU:M:^"/ .DW4^DZ/+<7NKVFJ1P2R75A=7,6@Z99V5K';M%-?W%W>SR&+[
M#_X*9?\ *!/X7_\ 8A_LQ?\ I)HE?I!_P1X_Y1H_LB_]DUE_]2?7Z_1Y\29S
MPQX88S&9%BWE^-Q7BCGN#GC:5.E+%TL.\NHUZE/#5JD)RP[JSI4U5G2Y9SII
MT^90G-2W<Y4Z#<'9NO-7ZVM?1]+VU^X_GV_9&\$?%/\ X)0?\%D/!_[&NA?$
M?Q/XX^!'QOAL=/@L=4"VEAK6E>+]!O=1\/>(;K18KB33+/Q3X6\2Z3)I=]J^
MG06S7ME!J$*1):WB0Q_1G_!32:9?^"XG_!/&)9I5C:V^'Q9%D<(2?''B ,=H
M8 ;@ 'P!O4!6R!BH_P!MPG_B(>_8>&3@:/\ #? [#+^/<X],T?\ !3;_ )3D
M?\$\/^O;X>_^ISXAKZ6AB)YGQ'PQGN*C2EFF=^#&>XS-<53I4Z,L=C*>!S7#
M?6JT:48P=:=*E!3DHI6C&,5&$(0C:?-4IS=N:6&DY/N[-7Z).W;TV%_X+LS3
MQ?\ !0#_ ()CK%/-$K^)+3>L<TD:MCXL>#ADJC*"=I*DXR49D)*D@_U43?ZJ
M7_KF_P#Z":_D]_X+_:U8^%OVX/\ @FWXIUEFMM$T35FU'4;UMJ0PVUA\4?!U
MU=L99&2-?(MU,TI9@L<>'<A2*_JHUOQ'H6A^&=5\6:MJMA8^&]*T2\U[4-:N
M;J"'3;;1[2QDO[C49KV1UMX[2.S1KAKAY!$(AO+;>:_*.-*<Y<"^$;C"4E/*
M>(J<>6+?/47$-6].-OBG:<?=W]Y::G/5_@X;_#/_ -*1_+M_P;@3SS?$G_@H
M-YT\TH7X@^%@HEEDD QXB^)(R [$!B  6QN8!0Q( Q^5'[,_[''Q-_;P_P""
MB/[8OP*T3XP^)/A1\)G^(7Q&\2?&J]T+4+F2]U_P_I'Q'UFW\/Z%!HQNX+/6
MKB36-1\VVCU83Z7I\44]W+;S216\$GZ@?\&TFJVFN^,OV\];L"QL=8\8>"-5
MLR^W>;34=8^(E[;%]A9-_DSIOVL5W9P2,&N;_P""(7_*4[_@HE_U\?$'_P!7
M)=5^RYIF>-R'B+QMS/ 2A2Q^7\-\'5,-.K1I5U0Q'U?+:4:RI5HSI.K0E/VM
M%SA)0K0ISY7RV?1*4H5,3*.DE3I6NKV=H*]GI=7TOU.V_;T_X(W?#[]FC_@F
M9\4].^"WB/Q=XU\0_"SXBV?Q_M]6\3K;+K-KH]KHT/A?QCI.F1:!;VL3P-HA
MCUAA+"Y$VG22@H69J_7+_@D!^TX/VI/V"_@UXQU/41>^,?!.ER?"WQXTUU'/
M>C7_  *L6FQ7U\!-++"^L:)_96KI]I(DD2\\PY!W'](?$?A_2/%OA[7?"NOV
M<>H:%XET;4] UJPF :*]TK6+*?3]0M) 004N+2XFB;@\.:_B/_9A_:,O?^"3
M?C+_ (*K?LL>,M2?2IM-\(>)?$'P5@E>2W75?&Z7$?ACP3-I\@9F\_7/#7C#
MPYJ7G0AF,.AR3$[+<!/S?*:^:^*/!V>9+C*]3,N*LFS[ <0Y;7JJ+Q&*P.;U
M</D^;8>*@H*-+#U9X7'5.6*C=N32?-(RBY5Z4H/6I&:G%VUM-J,EHNCLW]Y]
M+_!>XN?^"E7_  7A\<_$R*\N=4^"?[)$\[:,5FEMK62+X=7#>&?#JK;>:ZRQ
M:[\0Y-4UL30%!>Z?:1R2[E4H?Z\J_G[_ .#=O]FBZ^%'['FJ_'3Q/9NOC/\
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M*L^:21,I1BDY.R;45YM[+YGYL44U&#HKCHZJP^C $?SIU>CL4%%%% !1110
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M73A[SA6J1UYK'ZI_ K_@AA^QO^SO\%;3XM_\%"_B#!J>N_9--U'Q+%?^,IO
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MWQ%+"8BJXQ<8RKSP].-::BW+E]I4A*HX\SLYM7;U91117YD?"!1110 4444
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M9\)_V-HU_P".99+/PA!N2#3;&T5-.O1"T*1P1V/]NV\4$3_9_M'V="I^V?\
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M!6,&A>([Z%GAT6'3/$.IRZ[K,X=X5BBO$TVYOW&;:U6.>(-^/7_!27_@FO\
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MK>(K**RN_.@T.\T3P_;S7T^HZ5IEU8_;K_4CH]I=ETFM);@2,Z^\_M+_ /!
M#]K/X$_#OQ!\4O WCCX=?'[PUX4T:YU[7]-\'V^L^'O%\>F:?')-J-UHVAZD
MVIV.MQZ=;1RW5S';ZW#>F".5H+.9HV2OO[_@G7_P34\/?#[]B'XE_&K]K[Q!
M\=K[PM<WWB_QKXK_ &6OAGXI\0Z9HZM\-'U#0;F#Q1X>\#WJ:CXZ\8W_ /9-
MW:'1XM0_LM;;[!$\%S<PQRVOZ[?\$L=8^!WC3]E[Q'<?L_\ PB^.?PC^%&I>
M-/%5OIO@#X]C5;ADNKNVA76'\')XBN;Z]/A"]FD\M[5Y7T]+Y;R.W3#39][.
M.,\WRS%8[%Y7C:>-RW*\QHX"I1>64OJ4U./O4IYG4QOURKBDX5%ST,/]7FE[
M53Y7&,NWBOQ.S_ 9CFF*R?-*68Y/E.;4,NJ8=Y-16!JQE'WJ-7.*F/ECZ^-3
MIU;U</AHX6HDZJJ6<(2_GQ_X(I>!K?XA^!;^VF_X)_\ PB^*?ARP^(MR?BA^
MUE\9=3CL_#VA_#M=.\S6_#>B:;JNFZL^M>+_  \K[[73=#MK33X[>[:37+NU
MF\N8=!\,?@1_P2:^+O\ P5,^/_ACQ7+:^!?@G8>$],O?A9\/_%":MX%^&'CS
MQ9_9LB_$7Q!I6LZM%I0T30=$NTLYO"-F^H:=9:W/<:A)I27D$(BK\^/#O_!3
M;]O7]A^X\<_LQ_#C7_"/PT\-_#?XF_$BQD\&:S\+O#^H:OI6IWWB_5K[4X-6
MNYIP]S<^=/L3>-L=JMO;H3%$@'PM^TY^T]\8?VPOB0/BQ\>M9T7Q)XV7P_I?
MA@7VC^';'PY8?V/HWG'3X/[+L6DM_.B-Q+OGSNDW 855 K]%PO".?9AF^=8[
MZ_\ V5EV<8"IA\#B\IS?'U\714ZN'KT<74PN*HRPKJU(4_9Q>#Q.&IX:A4J4
ML.I3FL1#JQ&3YSC<YSW,'F#RW 9Q@IT,'B<KSC'U\12C4JT*U'%5,-BJ<L-[
M6I"G[.*P5;#4L-0G4IX>,IS6(C^]/_!''Q9\+_A%_P %:_BY\'?V<_&][XX_
M9^\=^%O'7AWPWXCUNWN-+NM47PO:V/BVT2&RN8K!I!I.M:?K.B:;=/:,][IH
M%S 7CNC,W]GU?YZ__!"CPC+XK_X*2?!;RKLV:^&=.\<^+)2L#3"XAT;PAJH-
MHQ4@0+</=1QB9CM5BB8+.JG_ $**_(O&O TL!Q5@*<:TZ]:?#V6_6:U51]O7
MJT:F*PL<17E",*<ZU:E0INHX0A&ZTC%62_&_%"G3I\0X;EJSK57E&!CB*M3E
M]K6J476H*M6E!1C.K4ITX.;C&,;I)125D4445^/GYP%%%% !1110 4444 %?
MQ=_\%3K[2)/^"V?P2C^+PG7X96/B/]G5)OM*6MK9?\(]_:4$ZRM<7BBSDTQ?
M$DLC:K-<LR?98[V$E-BX_M$K^07_ (.5/V?]6L?'7P6_:3TVUFET#Q%H%S\,
M?$UW&97_ +/\0:#<W&M>'FD*1[+:/4-*OM26WD:8,]QIDH0!@"?M> 72GGZP
MM2?LWCL#C,'3J+XH5*E-33IOI4Y:4E#NWR[NY^R>!F,P]#C:I@\15^KO.L@S
MC)\/B%95*.(Q-&G6C.C)N/+6=/#U(TVFFYR44_>.V_X.8[WXSP?\,TC1KKQI
M;_ F6S\8/K\F@3ZE;^%Y?B)]ITW^PQK]QI3INO?[ -^VCQW[BU:,WK6P:</C
M\'K;1/V\?'%_^Q]H'C?PG\8OB-X/U+6_#ME^S%X/^)UMKEU\-?%UJWB"*Y70
MH6U8IIUWINJ36T\6H2:S.;M-(662)UM(@:_27]F'_@X$^*?PK^$.F_!W]HWX
M-:-^TMI?AVPLM)T#Q3J6L6MAXCO=*L,1V5GXRM=8T[4]*U^XL8$CAMM85(;V
M988S>I-/NN#YK^T]_P %Y/VC_CCXX^$^J?#SP/X1^#WP[^#WQ \/?$71O Z.
MOB2\\6ZUX::5-/M_%FKR6EM'::4EG=7EG'IOA^VM1$+@SO=SM'&B_K7#F5<4
M9;A\-DJX>RRM3P3QSAF];'4XTJRJQK2HSI4*=.6+IUZDJL:-5OE;HIP<Z2;G
M']GX>PW&G#.58#A-\*9%7P^3RS7V/$=;-*,:.+CB%BZE"O0PE*C+'T,75EB(
MX>O*7)*6'C*E*=%2]I#^FCX;:]\1="^/O@/X%_&G5O\ @GAX*L_&/A6^U&W_
M &5/!6@:O=_%JST&UTPC[3HVLZE=6VA^(+2VNHG>^@?P3IUK=67G-92LL)E;
M\,/CGJ?_  3S_P"";?\ P5"_:$U'XK_LZZ[\1='U'PW\-_&'PC\">&K'2;OP
M)X)U7Q5IJ:YXTO+GPYK-Y;:;<2S:W;VEQH5H\%UIFE1B8P6D5QY4L7/_ !"_
MX.!O"FN>-? OQG\$?L+_  WTK]H#1HM(TCQ7\5/&.H:1KVM?\(A;W1DUKPSX
M(U:TTB+6]/75+-[BQM=2U*XCETZ&XD7R)T;RZ_-+_@J%^WMX;_X*$_&[P7\7
M/#7PKU#X4Q^%_AO9^!]1T_6-4TK6=4UW4(-7U'5I-5N+W288H6MX%OUT[3TG
M,EPMK;(9!%N\M:X1X'XA6:^SS3+L9EV49GD]?!9I]2S'"X=T\72Q-.O2G#ZE
MB*E>5.M&/U>G5G.KB:E.I7=>HH2:E^>Y#PUG^&S&<<UP6*RW*\TR6M@<UA@L
MQPN'2Q='%4Z].I%8'$U:\X5(P^KTZ]2=3%U:<Z_UBJHS:E[%^T!_P5;^(FG_
M +3'Q&^.G[$_Q)^-/P_L?C+X#M?#/Q-L_B]<:'XGNI]4M!=V6GR^%-+B$^D>
M%[3PSH\\=IX3GTM(+O1)C<3VQ5I7S^K?_!L1?WU]'^V-/?7EW>3WFH_"C4KR
M>YFDF>[U&]?XARW=]<.^1)>7,A+SS',DA.6X(K^1<G' ZGH/ZGV_G7]U7_!N
MO\ =3^%O[&?B#XI:_ISV&J_'KQ_<^(=*,\<D=Q-X*\*V:>'= F*O\IM[O5%\
M1ZC:2Q\36M[#)DKMKZSQ/RS)^&_#G,,-A\/2HUL?/)<KH5I1I_6\5]2Q5+$4
M(UZRC&I76&PF%KQI\_-[.%HQY5H3Q_'+<JX4Q6#PM*G3GBO[,P4*CC!XFO'!
MUH5:$:]9152K&A0HU(TN=M0A:$>5:'[_ -%%%?R$?SP%%%% !1110 5_GM?\
M%F?A!KOP!_X*'?%75=/:\TJV\<ZQHWQD\%:Q9O=0R6TFN"*_DGL+UH8%6]TG
MQ/8:CQ;O+]E>. -*^0:_T):_#;_@N-^P+J7[6/P$L_BU\-M+EU/XR? :RU74
M[+1[2+S;WQAX N-M[XET"S15:2?5=+:W_M[1;6+Y[V2*_P!.B#3W\ K[;@'-
MJ&59_2CBIQIX3,*<L#6G.RA3G4G"="I-O10]K"-.<G[L(5)3E[L6?K/@SQ7A
M^%N+X+'5(TLNSO"SRC%5)NU*C4K5:57"5JK?NJFL12A1J3E[M.E7J5)>[%GP
M=^RQ_P %^_@3XY^#]C\*/^"A/PZO];U_2].@LM1\9:9X,TOQWX-^(/\ 9HC%
MCJ6N^$[MUET?Q#,$\RY>WMKVPFO5:Y@-B)=B7_VE?^"\O['_ (&^"?B3X2_L
M3_ ]-;U+Q5I6J6")XE^'.@^"?A1X>GU>#R9]4U/PJAEE\77L>3(^FS:?:6<T
MT5N+F\N;=6AK^1FXCF@FEMYXWAF@D>*6&1622.6-BCI(C ,KHP*LK*&4@@@$
M&JK-C('4>O\ G_#^E?NU#PSX;GC%BG0Q<:?MUB7@(8N<,N]LFI*7L(I32NM*
M<:T8)>Y;V?N'[]B_"S@F&8RQU/#8ZG1>+6->4T\?5IY.L3S<RG'"1C[2$5+5
M4H5XTXK]W&,:25,_JY_9(_X*Z?L+_$+]AF#]C_\ ;XT'5M$MM!\'#P3K5EH_
MA37-3\'?$GPWI]XE[HXTH^#BVH>']9_=V\=QIEQ#8:7'+:K+!J*PS&WB]Y_9
M'_X+9_\ !-'X8>&_&/[/^C_#WQ#^SA^SYX"@>R^#T5SX5UCQ(GCC2M52YG\4
M/KFD^'U\0WFBZSJ6LW5S<QP:A-=6][:79DO-3BN-T(_C(/<GZFHF?/ Z'K_G
M_/6O7J>%'#N/^NPJ5<XI4,=BWCGA:&8.&$PF-E*+J8G"X>5&=*-:I#FI.5>&
M(<*,Y4Z2I^ZX?.YKX><-8AYBG6S:E1Q^,EF+PE',90P>$QTY1=7%X7#2IRI1
MK5(\U)RKQQ#A1G*G25)*/+U/CW4=$U;QWXZU3PS;K:>&=4\;>+M3\-VJ0"T2
MV\.ZAXAU*\T.V6T!86JP:5-:1+:[C]G""'^"N1)Q^O?_ /7SR.WN?<+ ?Y_'
M\_\ '/2O4O@E\&?B!^T%\5/!?P?^&.A77B+QIXWUNTT;2-/M8W=(S,VZ[O[V
M5586NFZ7:)/J.IWLG[JTL;:XN)"1'M/[#0HT<)AG5K5(TL/AJ,JE6O7FHPIT
M:,.:I5K3E91C"$7.<Y6BDFWIOZ>-QU/#TI.=10IT:;E*=25E&%.*<JE2;:LH
MQ3E)NUK-O74_J5_X-E/@5?VFG?M"_M%ZI:>79:LWAWX6>%9I[1E=VL'F\1^)
M[FQNV^5X6-SH-I=*F")H-K$X(']8=?,/[&_[,OA?]D']G'X9_ 3PN;>Z7P=H
MD?\ PD.M00"W/B7Q?J)^V^)O$,J!58G4=4EF-N) )(K&*T@8#RL#Z>K^"N/.
M(8<4<69QG%'F^JU\1&C@E)-/ZEA*<,+AIN+UC*K3I*O*+UC.I)/4_E/B3-?[
M:SK'9A&_LJM50H7T?L*,8TJ3:Z.<(*;71R:"BBBOD#PPHHHH **** "BBB@
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MM>_SM;I>Y]VT445X9 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !15'5-4TS1-.O=8UK4;#2-)TRUFO=2U35+NWL-.T^SMT
M,MQ=WM[=R16UI:P1JTDUQ/+'%$BEW=5!-<5\,OBU\,_C/X=N/%WPH\<>'/B#
MX7M=:U3P[+X@\*ZE!J^C_P!M:+*D.JZ?%J%JSVUQ+92R(DKV\DL6YALD85JJ
M%:5&>(C1JRH4YPIU*ZIS=&G4J*3IPG42Y(SFH2<(RDI249.*=G9V=KV=EHW;
M1-[*YZ'11160@HHHH **** "BBB@ HHHH **** "BBB@ HK\B?@7_P %+/$?
MQQ_X*5_&_P#8@LOAKI'ASP9\$-!\3R7OC*YU>ZU#Q+XFU[P_=>'[0R0V44,&
MF:7I$K:Q+)#$7N[TI%'YTB,[1Q8;?\%/O%6L?\%4=-_X)ZZ'\,M&T[PQI,&K
MS^*_B%JFKW5YK>K2VO@5_%=I#H6DVT4%CIMJ)I;:">:^GO+F81SA(;=?+:7Z
M_P#U%XE5?$8>6"IQJX3AJ/%N)B\7A;4<CG1A7AB9255J52=.I2Y<-3<\0I5(
MQE3BU/EU]C.[5E=4_:O5?!HU\W=66^J/V2HHHKY R"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10!7N_\ CVG_ .N;?RK_ %6_V*_^31/V8_\ L@GPH_\ 4+TFO\J2[_X]I_\
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M'VE"I"O)*+G3CO3HQG:+H2C&4?XDIVFG9/FY+I6;T2Y7=.ZZI?T%_P#!8?\
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M&QJ*:6%IPC0E)J#Y8+GSM2J1JJ-/D=.+E&7/)M\K2?,GIJNUDNG5O]JO"O\
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M2'MI-4*<9S<HMP5'VJCS6E&V\6TWJM==5JMSZ)U?_@XJ^-7P[O?#'B#XR_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M22.*-)))IG6.*&*-Y)I9&(58XX45I))&8A0B*6+$ #/%=%GV8Q**[+6/AO\
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MM">*#&-"^#7Q(O\ S1*R-'X.U]8V6%E61A+)IZ1;59E&[?M). 2<X]V\-?\
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M>\&VA93+IGAFUF\5:R5 #.OVF5]*TBW8D^6LBRZBJD&0Q.H"/_1J
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MIW>FNGH?R*?\%"?%_C3_ ()M?\%J/!'[:^K^&O$/B+X._$W2M,N]5GTN-/\
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M&G-J/B+5? VH0:1J<^HZ/:Q[IK]_">JZ3'JMSID$%Q<7.GWE_/!#(UJT<G]
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M/^']9\6^(- \)^'+.34/$/BG6]*\-Z#8Q*7DO-8UN^@T[3K=5 .3)=7$8.<
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M>ZTLE>[_ !L>P?L4?\' ?Q _:E_:9^''[-?[27[/_P %+CX4_&W6I?A_;?\
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M%GQIXCT^XTV?QO\ $6^\BZ\3-I]IX6^P3(EE.WV";6-6O+Z>\GB86]K;V=O
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M%ULIS6>'O[-YAA87IU):*]6=*%2$ZEN6M"G0JPE-5.>7VS1117XL?C04444
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7B_P7X/\
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M7A36-7M+?_B<I$\FENP +RQ,L4?P9^R-_P %)OV=OV3_ /@HM\:/VN_!_P
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M&AWDIM=+UO2+G>+((LWDLC&7Y1M?^"@'[*/P_P#^"FGPK_;*^!'[-OB/X6_
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MF<*F$RW+U).I4Q4\7**M=4Z%*5&#:W2E*O)1U5^26]F>@4445_+!^(!1110
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M8TL1AZ]%U).JJ5:,)N;A[2>I1117P1^?A1110 4444 %?C__ ,%U]3U73/\
M@FY\8'TJZNK5KWQ%\-=.OC:AB9],O/&^CI>6T^U6_P!&F4(LQ.U=H&64<U^P
M%?%?_!1;X2:C\</V)?VCOASHT<DVMZI\-M9U/0[>&$7$MSJ_AH1^(]/M(H]\
M9+WEQI26JE7#+YV5#_<;T\EJTZ&;Y76JV5*GF&#G4;V4(XBFY2=T](J[VZ'T
M_!6-H9;QAPMC\3RK#X/B#*,17<FE&-*ECZ$IS;:DK0BG)Z/8_&'_ (-E(O#O
M_"C_ -IF>%-._P"$K?XM>'8M4D4Q'5SHJ>$H6TA)LDS+IPG>^:WVJL+3F?.Z
M1>/YE_\ @H'K'Q#US]M;]IV_^,DFH?\ "=VWQ=\6V=\FLM)'/IND:=J,D7AJ
MVL$ED?[%I-KH<=@VD+:.+1+7RI;1MA#5ZQ_P3B_X* >-?^">WQSG\>:9I$OB
M[X<>,;:T\/?%?P$LZ6MUK.B6MP\MGK&A7,I$-IXGT&266?3FN/\ 1+R*6?3[
MO9'.)XOZ8_$O_!0/_@A'^T;J^B?&?XRV'PXN_B3';64KM\2OA#K\OC6TDTQ8
MI;*RUIM/T74;#5FL'B2&S%Q>ZE;@1".)_(P#^T2HYEPWQ/F6:K),?G."S;#T
M(T:F74G7Q&&JTHTE*A4@HRE"$I4W=M*,HJE*+E.$X1_JO-JV><">)'$_%,>&
MLSXFRSBK!8.%#$Y-1>*QF7U\-##PJ82M"*G.E1G+#W;;C"=..&G"4YT:E*/\
MFGAWQ;^TMXS_ &F?@G?>*M'\<_&+XV:3KOPXM/A_X%^*&G7^OWWB71M*GLKG
MPSX:CT/Q-#Y%UX6U/2XU N?)-A/9.^HS7,AB,X_N1T[QE_P4DTWQO\-]3\1Q
M_L/_  7^&^M>(-%TT?L\ZEXH\0W7Q,N_# >W368O#WC2%=,\+W/B6R@N3)!I
M.C:+=6"36Z6XE=)UE/XM?M2?\%NOV6O$_P"U?^S+XT^$_P ";/Q1X%^!/CF+
M5O$OQGU;PM9:3\1+OPU<Z+J/ARZ\._#;3YHX;RPT:PM]2_M*7^UIE_M%K&WM
M-.LK##3S_3_[8/[9/_!%;XM^*?A3^V9XY^('B3XR_%[X-Z=;W_PN^&'@C6_&
M^DZCJFIZ3JG]LZ9INO>$9H]/T&PO+;596EDO=:N+&"6.+;+-?0101-&>X?-\
MWED,<3PAB<)2K8#&4U&CEW]L5J&)J2DJ.%=%8C!8; TZBA2JNMB%3Q&&A4J2
M@XJ%1/X3C3$9SQ%/AMX[@:MEE&IE>/I*G1RU9W6PN)JU)*A@_81Q. PN74JJ
MIT*WML1"GB\)"M4<)15.HGYW_P ' _PF_9Q^'GQ2_8P_:.\>?#F?5++5_B7K
M.@?&K2/!BZ=I.M?$SP'X9@T?Q#'H]S)*+:SGU26:>YT]M4O9//.G7DENTVV*
M';\Q?M+_ /!8_P#8*_:)^!%S\!KK]E'X]>%/!.F>'-5T[P=X,\(>+/"?@?P#
M9:X^FO#X<OM>T#PGJ]E#K.G:)J4=E?#3[N*ZLR86E:SGN"&KW#_@L-^W]^P?
M^V=^P/H!^'GC[PYXC^-\?BSPCXD\$>#;W3]3B\=^!KF6>V@\=6=WFSCM]/*:
M1+/8WLDEP=/U46T<EDUP8[=T_DI9B3[=A7VW '"4,XX>R>7$.%SK"9EP]C<=
MAL)&MBL;@)4[8A5Z=>A3C.GS1C"JL-"M9Z494X24($\)Y+',.'<G6?T,XP^8
M\.XK&X;"1K8K&8-TE]8]O3JT:49PYHQA5AAZ=75J-!TZ;]G&*/:_%'[2?Q]\
M<?"#P-\!?&/Q6\5^(?A'\.+N_P!0\'^![V[B.EZ3>ZG++<7SM<QP1ZMJL#7$
MTLMK9ZWJ&HVFGLP.GP6NU O]S7_! IV?_@G!\/,NSA?'OQ,1=S%MJCQ&YVKD
MG:H))"C Y) YK_/W'S.J+U8@?F<9SVP.<\<8.<=?])?_ ()1?!>\^!/[ G[.
MW@[5K%M.U_5O!X\>>(+1V!>/4_'EW/XE0./+B9)%TR_TZ.6*13+%*CQNQ*8&
MOCE3P67\'8#"4J5'#U,;Q!#$0I4:<*/M)PPV-J8S$2A",5*<ZE:G*M5:<IU*
MJE-N4CQ_%/$8:GD>&PE*%*E*OFJQ"IT80IQG-4L1/$5I1@E><YUHRJS:<ISJ
M7DVW=_HE1117\F'X$%%%% !1110!\H_MB_LM>&_VL?A!J/@+4YX])\3Z;*^M
M^ ?$[(SG0/$L,3)$]PB O-I6H1YLM5MT&Y[=Q+'F6",'^17XT_ OXH_L\^+;
MSP7\5_"]]X>U.">6*RU-HI9?#WB&")F"7_A_60@L]0M)T7S419%NX4.+BWB8
M8K^YBN:\5>#?"7CG2I]"\9^&="\5:-<HT<^E^(-*LM6L94?&X-;WT,T?S8 )
M"@D #-?8<,\75\@OAZM!8S SGS^QY_9U:,W;FG1FU*-I6O*E./+*6JE!N3E]
MKPSQKCN'Z,L#.G]<RZ=256-!SY*E"K.W/.A-J2Y9VO.C*/)*?OQ<)N4I?P32
M3H<_O$ QR=P'?H.>GOW]?7UKX+_ CXL?M#>*[/PA\)?"&I>);R>XCAO-6CAD
MA\-:!"[()+[7]=9/L-A;P1MYS1-(UU.%VPPNY"C^O _L(_L?&;SC^SW\-]_F
M^;@:(!'NWF3 A$HB$>XX\H((POR!0O%?1OA+P5X/\!:1#H'@GPOH'A+1+< 0
MZ5X=TFQT>Q3:-H/V:Q@@B9@OR[V4MC S@8K[W$^+&$I8:2RS*:[Q;34*F.J4
MHT*4G:U1PH2G.LT_L<]%/^9+0]O,?$*%:G)8+!58U9*REB904(ONX4Y3<^ON
M\T%Y[W^>?V.OV6/#'[)?PBL/ .D3QZOXEU*==;\>^*1$8G\1>)98(X))88VR
MT&F:?!''8Z7;'!CMXC+(//GF)^K:**_&\;C,3F&+Q&-QE65?$XJK*M6JRM>4
MY.[LE91BE:,(12C"*C&*44DOS2O7JXFM4KUYNI5JR<YSEO*3_!)+1)644DDD
MDD%9VJ:OI.AV;ZAK6J:=H]A$0)+[5+VVT^SC+<*'N;N6&%"QX 9P3VK\H?V[
M/^"ENF? 34-5^$OP<M[#Q+\6[5$BUW6[Y5N?#?@5YXO,6"6%25UCQ$B/'(=-
M8I:6(;_3GDE!M:_G9^)/QF^+/QAU:?6_B=\1/%?C*]GD>3R]5U>[.FVP8Y$%
MCI$,D6G6=M& %CMX+=8T &T9R3[>6<-8O'PA6JS6%HSLX.47.K4@]>>-.\5&
M%MI3DF[IQC)-7_4^%?"7.<_PE',LPQ$,ER_$1C4PWM:,J^-Q5&24HUJ6%4Z4
M:=&I%WIU*U6$IJTX4ITW&4O[0X/CA\&;F_DTR#XK_#J6_B,BR6J>,O#YE5H?
M]:"/[0P2G\0!)&#Z&O2[6ZMKVWAN[.X@N[6X0207-K-'<6\T;?=DAFB9XY$;
MLZ,RGL:_@=>&!>?+4-UW9(8>^X'.3]<_U]\^#'[5/Q]^ &JV^H_#+XCZ]IUE
M%-')<^&-5O)]:\*:G&C9,%]HE_++;;7&5\VV\BXB!_<RH:]^? 52=.^%QR=6
MVE.O1<(R?;GA*;A?SA)*ZNTM3W<T\&8T:4GEF>^VQ$8Z4L;A%1I3E9:>WHUJ
MKIW>UZ-1=&]&S^VVBOS^_8@_;T\%?M;Z+-H-[:1^$?B_X=T]+OQ+X2,C2:?J
M-HLBPG7?"]Y+M>]T^1V4W5DX-[ICOLF\V'9<O^@-?#8W!8K+\34PF,HRHUZ3
MM*$K.Z:O&49)N,X26L9Q;C):IGXOF.78S*L96P./H2P^)H2M.$K--/6,X23<
M:E.:M*$X-QDG=/<****Y3B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^$!XD_^3*/^(S>&?_1587_PBS7_ .8//\^S#ZS0_P"?B^Z7^1_*M17]5/\
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M &R/@)?W5E\2?V>_B7I,-M-Y2ZQ8^&K_ %[P_=+E5$UIKFA1:AIDT#,P4/\
M:4()&]4R,_-$7PV^(5Q?R:7!X'\63:G$9!+IT7A_5)+Z,Q<RA[5;4S)Y?5]R
M#8.6P#7]'Y;5P&+HPKX7%X3%49)2C5P^(HUJ35DT^>E.<>J;UTO;=GZG5SC"
M8JG[;#XO#8BC)7A4H5Z56G))IW4X2G&W5ZW[ZV1Q1/4GK_G_ #Q^ [4Q5>5U
M1%9F=@J(H)9V)P% '4D^@..^>*^^/@5_P3"_;D_:(OK*#P%^S[XYM-,O#$3X
MF\9:7/X)\,6J2LH66YUCQ*FGQ; K>:4M8[J81!F$)+('_J;_ .">W_!!#X3?
MLWZKX?\ BS^TGJFE?&KXMZ/<6FK:'X8L[>X7X8^#=4MG2XMKHVU\L5UXSU6Q
MG57BN-7M+71K>XC6:#2)YHXKP>7Q'XA\)<)8:I4Q>8T,=CXQ?L<JRZM3Q6,J
MU++EA5=.4Z6$@W\57$2IJ,>9TX59I4W^=<0\:93E4*GM,73Q&(2?)A,-.%6O
M.5M%/E<HT(]Y57&RNXJ<O=EY%_P0?_X)<Z]\&X(_VQ?V@?"[:3X^\2:']G^"
M_@_6(BNI^$O#>LPM_:'C35].F0-INO:_8/'::';3A;[3M#N;RXG2"?5A#;_T
MZT       8 '  '0 =@**_BWBOB?,N+\ZQ.=9G**JUN6G0P]-R]A@\+2NJ&%
MH*3;Y*:;E*3]ZK6G4K3]^I(_G;-\UQ6<XZKC\6USU+1A3BW[.C2C?DI4TVVH
MQNVWO*<I3?O284445\X>8%%%% !14+SQIG++QUR0/3U_'WXS@BH1>PDX$D9/
ML1Q^&<Y^GZT[/>SMWLPL][:=S^>W_@X^\/:W=_LF_"+Q;:3&30/!OQPTZ?Q)
MHY:X6+6(]4\.ZO%IUO,$_P!&9%EM+B/_ $H$ W ,7._/SW^W1^R+\0_^"O'A
MK]CW]HG]B?XF^!-7^'_A7X=V/A?Q)X3\2>,)?#C_  HU^*]MKV;7(-*L[*_D
MMO%>F8FTC4K!TTZ_$7A[39+"[:TFCEK^@']L;]F[P_\ M>_LW?$_X"ZU=6^G
MOXTT-AX>URX@%POA[Q9ILJ:CX;UH1@-)Y=IJ=O"EWY2F9]/FNXHU9I-I_P W
MSXL_#[XW_LM?$CQK\'?&<OC7X:^*O#NJRV6O:/I^LZUH=KJ.P,EIJT'V&ZM;
M?5M-U*T*W&F:FBR1W=G*K(P/F1I^Q^'N$_MK!X>C@,PHX'.LBQ6,JTHU\,L7
M2K8',J=.G4E+#JK0G-PJIQ52G53I2Y(U$X58H_I?PKQ*SGA[*\+EN;T,HXFX
M*S#.J^#6*P4<PPV*RGB.C1IXJ=3">WPE2=2G7IN$:]*NI4&J=.JI4L1&)_3?
M^P1^Q[\<OV=[_P#;XN=!_::U7XY?%7PEK_@>QOO"W[,GB;P#J7Q4^(U_-I\&
MJ6=]K/CSXKI?CPC=3"_^SZSH5Y?W%LRZ/(;N\-_;6MO5W_@KM\6/$O[)WQ(_
M8D_;J^'?PM^%'B[QGKOPT\3?#77_ !#\2++P]XRU'_A-8=.T+5[*YU.\\,,N
ME:IXK\-6]IX@LX?$NES/;6EY]NM=/>*!H%C_ )(-,\2^)-"EO9]"\2>(M#FU
M$;=2GT?7-4TR?4@2Q(U&:RNH9+W)9C_I+2\LWJ<TKS7M=O["STN_UW6]0TG3
M6D?3=*O]6U"]T[3GF+F62PL;FXEMK.24R2&5[>.-I-[[RVYL_KN7^'&(KYY0
MS;'YEA<92<)4,9A5E?U66-PU;*X9?6PU6IA\9"FJ;JP6(I)T:CCS.E*4XQI\
MOO9APM6GG_\ ;>8YMA,P<J4L/C*$<IA@GC,-5RBEEM;#UIX7%PI>Q]I1CB:,
M)4)RI\SI.<H0I./TO\</VM_C)^T3XO\ %M]J^JW7@KPS\2O$VF^*?%?PI\":
MUXB@^'6M>-X(X[9_&%UX?U34M0-YXCU*14N+V>:1XIKI(Y5@#QQE?]*SX':=
M=Z1\%OA'I6H7%[=7VG?#+P)97EQJ0C&H375MX7TN&X>]$*1Q"Y,J/YPCC1!)
MN"J ,5_!?_P1L_X)_P#B?]L+]I7PQXU\2Z#<#X!_!O7=,\5_$'6+R*X@T[Q!
MJ>F2+J'A_P !Z;<!%2\OM7U&&TGUJ"*7-GX=CO'G,4EY8>=_H0*JJJJJA54!
M550 JJ!@*H&      , <"OSSQTQF48>OD/#.60HPJY31Q&)QT*%K4)8NGA*6
M%P]26LWB%0POM*BJ2<U2GA^9NZ4?Q_Q.S+!5:^6Y1@H4X1RZ%:I5C22M3=>%
M"G2IREK)U%2H)SYY.?(Z7,V[66BBBOP$_*@HHHH **** "FNJNK(ZJZ.I5T<
M!E96!#*RD$,K D$$$$$@C%.HH _SY/\ @L9^PEKG['?[2^O>(]#TRYD^"WQF
MU;5_&'P^UB*VD%AI6H7UU)?>(/!%Q.H,$5_H5U<&:RMP8C-H=S92P1;;>Y,?
MY!DYK_41_:@_9A^$W[77PA\1?!KXPZ$FK>'=:B,VGZA"$CUKPOKL,4B:=XD\
M/7K*S66J:>\C%&&8;J!IK.[CEMIY8V_@[_;[_P""3/[1_P"Q!K6K:W-H]W\3
M/@?]I9]&^+7AC3II+&TLYIF6TL_&FFQF>?PMJZKA)O/:72+F12UAJ4P=8E_I
MCPZXTP.<8;#Y5F6(IX?.:$8T*?MI*$<QIQ2A3G1G)J,L5RJ,:U%OVE22]K24
MXN<:?]>>'?BEAL^RS"9+F^*AA\^PE*&&C.M)0CFU*FE"C6I5)>Z\9R*,,10;
M52K->WI*:E.%+\K&;.0.GKZ_Y_6HS@9. ">O3G X'3ZXZTYP4.&!4XZ,"#[X
M! SSGI^M0,V3[>G^<\U^Z87"K32R5EV[:/7:_P!_I=GV^-QOQ).R5T^[OT_)
M^NN^J0G)S@#/^1GUJ,GL.O7.> /4^W\^_'53N8[4!8D= "3_ "/&/Y\XQS^F
MG["'_!*O]I7]N3Q'IMUH/AV]\ _!];J)O$7Q?\5:==6V@0V(V/-#X8MIC:S^
M+=6EC95MK72W:T1W66_O[.%&->CB\;EN28*KF6;8S#Y?@</%RJ8C$34(:6:A
M32]^K5EM"C2C.M4E:-.#;27Q6;YQAL#0J8C%8BGAZ---RJ5)**5E\,5\4YRV
MC""E.3]V"9N_\$C?V$]>_;6_:A\-1:EI,S?!?X6ZEI?C/XM:W<1R+87&G6-T
M+C2_!MO,%V2ZKXLOK=;,6P8M%I$>JWTH"6RK)_HIV]O!:6\%I:PQ6]K:PQ6]
MM;PHL<,$$*+'##%&@"1Q11JJ1HH"JJA5   KYO\ V3OV3_@_^QK\'M!^#?P<
MT)-.T?342ZUW7;F.)_$/C/Q%)"D=_P")?$E]&BM=ZA>,@6&$8M--M%AT^PBA
MM8$2OI:OXH\2^.I<<9ZL1AXU*.3Y=">&RK#U-*DJ<I*5;&5XIN,:^+E&+<$V
MJ5&G1I-RE"4Y?S1Q5Q#/B',?;14X8/#Q=+"4Y_%RMIU*TTFTJE9QBVE\,(TX
M7;BVRBBBOSD^8"BBB@ HHHH **** "BBB@ KY"_;D_:%?]FO]G?QAX[TN6%?
M&&H+!X6\#12KYF?$NN%K>WO#$&#,FE6RW.I,Q#1B2VA24%)"#]>U^#__  6M
MU>^NX_V=/ L-Y]EM-:\1>(K^4SF)+&.Z\O3=)M;NZD(,JK9_;GE8\1)%YC'Y
MJ]/)\+'&9EA*$U>G*ISS3V<*49591>CTDH<K\F?6\"Y5A\YXKR; 8N,9X26)
MEB,33E=QJT,'2J8RI1DDG>-:-#V4EI>,W9IV/Q \+_#[XL?%O4-8OO"'@SQQ
M\2-6:[FO_$%_H.BZEKTYO[^5[FXN-1NX(I$6YN99'F*S2^:P;=MVX)Q_&G@/
MQU\.=1ATCQ_X-\3>"=4N83<6UCXHT:]T>XN+<$ S6RW<2+<HK<,T+.$/#8[_
M -#_ .U/\8K[_@G'^SI\#?A]^SYX>\-V>L^*FF@O/$>L:<NJ6DKZ/I%C>ZYJ
M]['%-:OJVM:[J&HQ/#/<RO'!9QS)&%2.W1?RK_:&_P""@'C']JCX>?#[X8_$
MKP9X0L9=%UVTU'QCXWT+31/XEO3]K$2R>$[2=I/^$;SITT@O;.*>\&K7$<,?
M[N+"5^GY/BLPQTJ.(HY?1>65*U6G&L\1RXF-.DY0]M[#EY'%U(N,:47S7>Z7
M[Q_T;EG%^>Y[.CCL)DN$APY7Q&(P]'$O'<N8PP^&G4HK%RPOLO8JG.K1=..&
MIR]JFU'FY5[5_GZS%C[?YY/O4]EI^I:K<?8]*T[4M5NBI?[-I6GWFIW111EF
M%M8PSS%%'+-LV@ DD &OW[^''_!/3]CCXC3Z9X4TGPG^U6_]IZ%-<67QCUS2
MK_PSX,OM0BLUOLQ)>Z;%!;R20./LD<U@MC=7$;V4-S),%+>;_LE_#JV_99_:
M*^/7@3Q1^U1X*^%O@WP/XJ\.:9<6>L0>%K;Q5\3+1;8Z[IK6D_B."['AFPCL
M+J+3/$5]ID=S->R326=LL1B$\7JTN(\$Z6,>%HUJF+PE"&(^K8BG5I.K2G6A
M0O3="EBZEU4FHN$J,9\S7M%3@ISAXF*X]P%:CCXX&CB98S"4(XCZMBZ-:A*M
M2G7A04H?5Z6-J)J<DO9SHPG%RC[14X*<X?CU\-OB3XI^#'Q#\*?$?P??3Z1X
MK\&:Q!J=FI,EN]REO(HU'1KZ%@K-:ZG:>;87MM.A4I+\Z;D&/[;_ (.?$[0?
MC/\ "[P+\4O#3EM'\;^'-.UVVC88DM9+J!?MEC,N24GL;Q9[256.0\)SUK^<
M_P"-_P"UQ\*O"NJ_MA_#W4/A/\'_ (C:]\8I],NO!WQ ^&[+K'A%([O1M/@2
M'7=7OFTK4'O/#XA-]'=:!IL?G>(WNQ="2T".?TR_X) >(;S6?V.=%TZ[NIKH
M>%O&WC#0;3SHF0P6BWT6H1P*YXF4/?RR;EX0R&/^&O#XXPU3'Y)ALYK9=/ 5
M<+B<+AX3G5A5^M8;'818F33A&,HK#XE>RBJBB[NI+E3DXQ_-..9SS3+L+FE;
M 2P=;#UL/1A.56%5XC#8O"QQ$]8QC-1H8ENE!5(IW]H[)R<(?J11117Y(?E8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2.O:O+K4:E"3A4BXM=SEG3E!VDFOEY7+5%%%9$!1110 4444 %%%% !1110
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M" HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+CG>QR<*3_%^9P2 ,5XKX.^$FHKJBN]G*J[F)R"&'4?Q+R<C(P>A X#&OV;
M5,O67)2<+^S5_AO>R^=U_P &Y]GAWAOJJ3Y;\L;WM>Z>W?MYL_3OX#^)[K4K
M.WWRN^]8\ELGID>I)Z=ATZ5]G6C;X5;^\ >N1W''UQ^/7V'R%\#_  ?-I5C;
M%HI%V+&O.<]1N.0%S@\D]-OK7U_:ILA5<8 4 #OZ_P!:_*<Z=%XRI['X>=OI
MY=N^GJ?)XWD]M+DM:[VVV5K6[]?\[WL4445XYQA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444QY%3&>Y]1Q[F@!]%9DVJVL)97
ME16&< D?GR1_+KD5%'K-HW'GH3G .5R3QQ@,*KEE_++[G_D.S[/[F;%%0Q3K
M*!@C!&<@Y'7 Q]>M35(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&:%95PP!XQ@@
M$$?C_GTK@]:\%Z?JJRK) K!@?O >AXSC) )XSV'Y>A4TJIZ@'OTJX5)TW>$G
M%[Z%1E*#O%V9\RZE\$](NI"XM(078MC&5'J#T R,Y/'/X4W3_@EI5M(3]EA&
M""<+P1S@#J"!W'X&OILQH>H_4YH$:#H/U.:[EFN,4>7VLK>K\O7L;?6J]K<[
MM_P;_P!=>MS@-"\&6&DQJ(XE&!G 5>3@#.?0< <YSD@X//>11+&H  XX P
M/;'TS4H4#H,4M<52K.J^:<G)]VV]?F8RE*;O)W84445F2%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 44$@=2!]:;O3.-PS0 ZB
MFAT/1A3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBVHIN3MHK:N[V/VFHHHKPB HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N&\6Z*-3L9TP"64K@X Y!Y(!#$#OZYKN:BEB60$'^0/;'_ .OUJZ<W
M3G&:WB[Z%1DXM-=/^'/R_P#BA\$I]2N[F2.TW&0_>\K(;+ 9W'@GC Z9')KS
MOPA\ KJUO@S6@YE##]SC&6 YXX.!DXY')R,\?K'>^'K2\9B\"G<#R5!&>N<>
MN> 1D=.@JI;^%;*W;<D*]<XV@'MSG!]QZX-?4TN*,13PZHW>BMMII:WW+S[]
MSU(9I4C3]GTLM7?LET?_  ]MTFCSCX:^#CHEI%&5V8 R5! &<#! [Y&!_LXS
MCC'N<*;$ Y[?D !4-O:QP(%50H'& ,9^OZCL<5;KYK$5Y8BHZD[W;;U\TE^A
MYE2;J2<I;O7O^+U"BBBL" HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-9E1
M2SLJ*,99B%49( R20!DD >I( Y- ;[#J*@^U6W_/Q!_W]C_^*J*74=/@C>:>
M^LX84&7EEN88XT&0,N[NJJ,D#)(&2/6I<X)-N44EJVY)));MZZ%JG4DTE3FV
MVDDHR;;;2222U;;2275HN45FQ:SH\\?G0:KILT62OFQ7UK)'N&,KO24KD9&1
MG(R/6K4%Y:76[[+=6USL +^1/%-M#9P6\MFV@X.,XS@XI*I3E;EG"5]K2B[^
MEGK\ARHU87<Z52"B[2<H2CRN]K.Z5G?2SZZ%BOYB/^"Y7_!7_P 2?LYWEY^R
M/^S1K4FC_%R_TJTO/B?\2K"1?MO@#2]5A%Q9>&/#3[76#Q5JEB\=YJ.J ^;H
M>G7-M%:A=0O#-9_TN>)M<MO#'ASQ!XEO$,EIX>T35=<ND5TC9[;2;"XOYT62
M0B-"T5NP#N0BD[F(4&O\ICX\?$GQ1\?_ (^_$SXF^(;FXU;Q-\3?B)K^OS/)
MY7G2S:YK$TEC9HL06%5MK:2UL+=(P(TA@B1/E45^^^ G!&7\49_C\USBA2Q>
M7</4L-4IX2NE*AB,QQ<ZGU5XBF[QJT,/3PU>M.E43A4J^P4XSIJI"6^$I*I-
MRDKQ@EH]G)[7[I)-M=[7TT-?X.? 7]HW]L#XB7GA[X2^!_'GQE\>ZG*^J:]=
MV:7FL7$9N'?S=7\3^(M2F%I8I,ZR%M0UO4H/M,B.B2RS?(?T*\1?\$&?^"EW
MA[0+O7A\$+;6S:6ZW!T?P_XR\*:EKLX(#-%:Z>FK(UQ/&"=T,;F0D%8P[84_
MVU_\$W/V-_!G[%/[*WPW^&>B:':V7C;4_#^E>)_BMKKVD<6M:]X\UFQ@O=7C
MU*YPT[6VARS'1-+LS(;>SM+%?*C62:=Y/O:OJ>(_I'YOA\XQ.&X9RK*99-@Z
MT\/0K9C#%UL1C:=&?)]8BL-B\)3PU&JH<U&CR5)P@XN=1R]V.D\;)2:IQCRI
MV3DG=I==&DK]-&?YLW_!.S]D7]O'Q=^V)I_P[^!<WQ&_9_\ B/X U6SN/B;X
MXO;?6O#4/PTT&WND::?Q;93);KJT5VH8:3X6O8KB+Q/*R116\ED;B[@_TA]'
ML[S3](TNPU#4I=9O[+3K*TOM7GAAMY]5O+:VBAN=2FM[<+;P2WTR/<R0P*L,
M3RF.(!%45+!ING6MY>ZA;:?96]_J7V?^T;Z"U@AO-0^R1F*U^VW,<:S77V:)
MFCM_/>3R8V*1[5)%?-7[9'[5_P .?V+/V?\ QO\ 'SXE2O+I?ABUCM=#T&VD
M$>H^+?%FI%H/#_AC3FV2^7/J=Y@3W;QO#I]C%=ZA<#R;9P?RWCKCG-?%7.\G
MIT,DP^%Q$(4<OP6#P<8XG&XO&XJ5.-3VF,E2IUJM.==*.$P\K4L+3;;<JDZU
M:>%6K+$2BE!)Z)):MR=KZ[VOLNB/J(D $D@ #))X  ZDGL!4:30R':DL;MC.
M$D5CCCG )..1S[CUK_-@_:O_ ."M7[<7[9WC2[CN/B1XJ\">#]1O9K7PS\(?
MA-J&IZ#HEE:W;M%;:=,^BFUUSQ;J+)((6OM:GN[FYD8K;6UK$T=K'\WZEJ7[
M<OP;CT_QWK.H_M+_  ]@ADC.G>)]6O/B9X?MHY9@AB6+4;Z2VMU>4% D9ES*
M"%"L#BOT3!?1MS:>&H/-.*LIRW,<1"\,OAAJF+2G9-4OK#Q.%]K.+?+4^KT*
MT(O^'.JG%RV6"E9<U2,6^EK_ "O=7^X_U,Z_$/\ X.%/^4:GC[_LHWPO_P#3
M^]?CK_P2>_X+R?%BQ^)OA']GS]M'Q4?'O@/QKJ-EX;\*_&/6A;0^+O!'B#4;
ME;?3$\9:JOD1^(O"M_<S)9W&I7T;:WHLKP7+7E]IZRV]M^Q/_!PD0W_!-/QZ
M000?B+\+R"#D$'7G(((X((Y!'6ODLLX&SS@/Q4X*RS.84IQK\0937P..PLI5
M,'CJ$<=1C*=&<X4ZD9TI-0KT:M.%6E)Q;BZ=2E4J91I3I8BG&2^W%IK9J_1^
M75;KTLS^8S_@WD_Y2<?##_LG_P 7O_4%U&OH3_@YL_Y/2^&O_9#=!_\ 4E\3
MU\]_\&\G_*3CX8?]D_\ B]_Z@NHU]"?\'-G_ ">E\-?^R&Z#_P"I+XGK^A,7
M_P I"97_ -D'4_\ 3V8G;_S&?]P?_;C];/\ @V._Y,D^*W_9Q&N?^H!X K^D
M"OYO_P#@V._Y,D^*W_9Q&N?^H!X K^D"OY8\6_\ DY'%W_8UE_Z8H'GXC^-4
M_P 7Z(_ ?_@Y"_Y1X ]Q\:/A^0>X)MO$ )!ZC()!QV)%?PV_ 7X"?%G]IGXE
MZ/\ "'X*^%KSQI\0=>M=5O-+\/V=U9VDUS;:)IUSJVIRB?4+FTM$6UL+2>X<
MRSI\D9VY; /]R7_!R%_RCO/_ &6CX?\ _I-K]?S7?\&_7_*3WX,_]BQ\5O\
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MGN .?FX(S]3_ !1_X*__ +>WQ4\)_#'P[J_QY\;Z#K'PVT[7=)G\7>$=<O\
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M5'&M>+@.% S@ *,]%  X %?M5_P;10PR_L&^-3+#%(1^T#XNY>)&;_D4_!
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M.GJ\=Y+IM]&A@:5E>##HJN&K^B^BJP7'>9X'CF?'M+"8&>9SQ^/S%X2<<0\
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M13K4XT>>G6CB.:$ZE56=*I.D[6)J1JRJI1O))2CKRNR276ZV[Z79_F;>&/\
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M'*\5;'U:<7:W/3PL\7RIIWDE4JU87M>+2:>KQU2VD()]W=J_I?\ !MGYZ_\
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M],EB2)O(LO$&AZE82228BVJ][I]]J$4:9\XL5LR>8\ 8:OFS7O\ @F-^W/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXZ><X51UNZ&$Q&!<;**<+-']Z^C:_H?B*SCU#0-9TO6[&50T=YI-_:ZA;."
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFKJ+:[V?]=1V?9_<:]%5H[A7&00P]>GOSVJP"" 1WJ1"T444 %%%% !1110
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M@UT/AOQAXI\'ZI;:WX6\0ZQX?U>S=9+;4M'U&[TV^A=<X,=W9S0W"XW$860
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M\!^,/$/A74[>2.6.[T35;W3Y"T.?*$HMYHTN(X\DK!<++!DDF(Y-?J9\$?\
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MRK0C3Q-%W7+7P\ZM&::<:DDTQU%%%>P?-!1110 4444 %%%% !1110 4444
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MF_ILRS1117.9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"JMC.!\W68THJ4UD^<RIX?&VO?DPV8TXPPF(E;2,<31P:27O8B;9_H1X8?M
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M (QU&+2_#GA;2KK5=2NI64,8[="8[:W0D&:\O)C':V=NOSSW,T42\MD?SP_
MS1_&'_!2O]L?4?BA\0K:XA^$GPZEMM4.CE/-TNPT2QOE;PSX&MW(6"6YUZYB
MFO-=G!EDN+>'57;*&Q$>S_P5;_:HO?B+X\L?V9OAW>M>:!X7U&U?Q>^FR-,=
M?\;RDQ6VBJ(V"SP^'UE$7DJ)!+K5Q*H=9K!%/Z^?L0_L[6/[-OP"\*^$9;.&
M'Q?K=O#XG\>7:*/.N/$>IP)(UE)*0K20Z):F#2;8,!A;9Y-H:5R?YLS/'/Q>
M\3H\)X>3J\!^'U>GF/$<H-O#Y[Q#1JRA@\NJ.+Y:N$PN(A5@Z;O3J_5LPE+F
M4L)-?W'D.51^C=X#S\0\;36'\7O&7"5LEX(C4BEC>$N#,11I5LRSNC&7OX?,
M,?@ZV'J1K)*MA_KV3PCR-9C2E]<Q11011PPQQPPPQI%%%$BQQ111J$CCCC0!
M$C1 %1% 55 50  *?117])I)*R5DM$ELEV/X=;;;;;;;NV]6V]VWU;"BBB@0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?"'[8W[!_PU_:IT2XU6*&S\(?%BRM&31?&]I:C;J!B1S;Z7XJMH
M=AU/3RY"1WF#J>GH3]EF:$-;2?RJ_&/X+_$3X"^.=3\ _$?0KG0M?TMU93GS
M;*^M9-QMM1TJ_C @O]/NE5FMKN [7VNC+'/%-#%_<S7S-^U#^RQ\./VI? =U
MX5\8V,-IK]I;SOX2\9VUM$VM>&=192T3Q2D*]UI<TNT:CI<L@@NHBS(8;E8K
MB/\ G?QA\"\NXWHXC/N':6'RWBV$95*B2C1P6?<L?X.-22A1QTK*-#,++F=J
M6,YZ;A6P_P#:7T:?I9YWX4XG!<(\:5\7GGAS5J0HT92E/$9GP@ZDTOK65RDW
M4Q&4PNYXK)FWR*^(RQTJRJX?&_SP?L6_\%'_ (@_LZ7.F^"/'3WOCOX0O<")
MM,N;@RZYX4BGE!DNO#5[<O@VT):2230[F1;&53BT>PE7=+_3W\-/B=X&^+_@
M_2O'?P\\067B3PUJ\0:WO;-_GMYU1&GL+^W;$UCJ-H76.[LKE$FA?&5*LC-_
M%U\?O@#\0?V<_B%JOP^^(.EO:7MFYFTW4X5D?2=?TIW86NKZ/=LBK<V=PHPP
MXFM9Q):721W$3I7?_LJ_M<_$O]E7QK%K_A.[_M3PU?M%!XI\%ZE/<'1==L58
M9(CCD'V+5+=<_8-5A1Y;4DI+#=6S/;/^#>&'C;G_ (=YA_JCQQ2QV)R/!UW@
M:E/%0J2S?AJI2E[.4*<9WJXG T;6G@9-SI4TIX"?+%8:O_77CU]%?@_QIR?_
M (B1X45\IP7%>982.;4*N7U*,.'..:->"K0J5YTW&A@<VQ"=Z>:Q4*>(KN=+
M-Z?M)RQN%_M#HKP[X _M"?#;]I#P'I_COX=:Q#=Q311)K>A330C7?"^J,N9M
M*UJS1V>"5'5S;7(!M=0M]EU:2212#'N-?WKE^88'-<%A<RRW%4,=@,;1AB,+
MB\-4C5H5Z-17A.G.+:::T:TE&2<9)232_P A<XR?->'\TQ^29YE^+RK-\LQ-
M7!YAEV.HSP^*PF)HR<:E*M2J)2C)/5/6,XN,X2E"49,HHKY _:J_;0^%/[*^
MAJ?$5XGB#QYJ2(?#_@#2KJ$:M=K(P4ZCJDK%HM&T>!297NKL":ZVB#3X+F9P
M%Y\ZSO*>'<MQ.;YWC\/EN6X.'/7Q6)FH4X](PBM9U:U25H4J%*,ZU:;4*4)S
M:B^WA?A;B+C3/,#PWPKE&-SS.\RJJEA,OP-)U:LWO.K4EI3P^&HQO4Q.*Q$Z
M6&PU*,JU>K3IQE-?7]%8WAS68?$7A[0?$%OL^SZ[HVEZQ!Y4BS1^3J=C!>QB
M.5"5E0).NV125=<,#@ULUZ-.<*L(5*<E*%2$9PDMI0FE*,EY---'B5:52A5J
MT*L7"K1J3I5(/>%2G)PG%VTO&2:?F@HHHJS,CEY7C_/!KQ;XC:1->V-RJ#DH
MV<C@Y0C@8.>23Z<9Z;37MIY!'K6+J5A'<Q.CJ#D9!Z@G&.1Z#![8^E;X>JZ-
M6,UT:_-.[]+>9I3GR34NS7X-/?IL?B]\6?AQ>7%[>,(6;=O/"-GJI[$#OD8&
M._->%:)\,;\7L9\A\%P,LA&,%<GKZ#CCGMZ#]J?$GPWM]3>1_LJ-G@ J#P>W
M"X[]QG\*XVR^#]K'<;OL<8^;CY0<$=. @]/;/2OT+"<5*EA53=KQBE>^NB5]
M-+;?U<^BHYJH4U'32-MTNWSMKMVMI8\9^"/@FYL$A+PXP.I4D[<#D\^_7CDU
M]]Z%:F"TA4@E@F#G@C@$'KC!'T/M7*^&_"<&F1QJ($4* <$#<!M"X.!N/;J<
M9]J]&MXA&@X ) _08_#CM^E?&YKCWC:\I]WKJGVMM_EKOTL>+BL1[:;EWW\K
M/\.B[[WW+%%%%>0<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 (0&!5@&5@0RD @@C!!!X((X(/!%?"W[17_  3S_9W_ &A4N]3N
MO#D?@'QO.AV>,O!=M;:?-<3!-D;ZUHH1-(UD)U,LD%OJ#'_F(  "ONJBO&SS
MA[(^)<#4RW/\JP6;8*I>]#&T(55"35O:49M>TP]:/V:U"=.K!ZPG%GTW"G&?
M%? N;4<\X0X@S3AW-:+7+B\KQ53#RJ034G1Q-*+=#&8:32]IA<72K8>HM*E*
M2T/Y)?VC_P#@FC^T#\!VOM:TO2?^%E>!;?S)5\2>#[>XN[FSME!?=K&@D2:K
MIQC0HDDT:7UCO#L+T1J6'YV21R1.8Y4:-UZJX*D?@>Q['H>HK^^P@$$$ @@@
M@C((/!!!X((ZBO@']I3_ ()R_ ']H.VU35K318/AQ\0[Q9)H?&'A:TC@M[J^
M8QGSM?T"-K?3]6$BQB*6X3['J0C9O+OE/!_DOCWZ+EE7S#P_Q[=E.H^'LVK7
MO;54\OS22O=ZQIT<Q33;3J9A%(_T7\(?I^7>%R;QDRE)-TJ,>,N',+:UVHNO
MG.00=FE_$K8G)7%I)QHY/-M'\AU>A_#GXL?$?X2:];>)OAQXQUWPAK5JP9+S
M1KZ6W$B@D^5=VV6M+^V))+6E_;W-JYP9('Q7TG^TI^P7\>OV:);K4O$6@GQ-
MX%CE5+?Q_P"%TEOM"VR,5B758]HO= N)&!41:G"ENS%4M[VY9A7Q4RLA*L"K
M#@A@01]0>:_D[,<KS_A/-OJF987,LASG!352$:BK8+%T91E[F(PU:#C*4&U>
MEB<-4E3G;FIU)+4_T2R7/N#_ !%X=_M#),PR3B_AG-:,J%6="6&S/+L3"<4Z
MN#QV&JQJ1A5C&26(P.-HPK4G[E>A"6A_03^S5_P6)L[H:=X7_:/\/-;SG9;#
MX@^%+8-$[$[8Y=;\. J5))19;K2)7+-ND&F(N0/VW\$>/_!7Q*\/V?BGP%XG
MT7Q9X?OXTDMM4T2^AO;<AU#B.81L9+:<*07MKF.&XCS\\:U_!]7M7P8_:$^+
M7P!\20^)OACXPU/P]=K)$UY91RF?2-7AB8,+76=)F+V.IVK8"F.ZB=D7_420
MMAQ_0G 'TE^(LC='+^,J,^)<KCR4UF%/V=+/<+35H\TIODP^9J*2NL0Z&)F[
MRGC:C]U_QIXP_04X*XLCBLY\,<33X&S^?M*SR6LJV(X2Q]67O<E.E'VN,R&4
MY72E@OK6 IIQA2RRC%.:_N&HK\AOV6?^"L?PS^*3:9X1^-UM9_"_QK/Y=K%X
MA265_ NLW)PJ--<3[Y_#,\YQF/4)KG3?,("ZG$72W7]<K6ZM;ZW@O+*Y@O+2
MYB2:VNK6:.XM[B&0!HY8)XF>*6)U(9)(V96!!4D5_:7"O&?#7&N7K,N&\UP^
M8T4HJO2BW3QF#J25U2QN#JJ&(PU31\OM::A42<Z,ZE.TW_ESXA>&''7A;G$L
MDXXX?QF2XJ3F\)B*D8U\MS*C!I/$99F5!U,'CJ-G%S]A6E4H.2IXBG1K*5.,
M]%%%?4'P(4444 %%%% &7J,'G02IP2RG /< D]>WIT_QKXZ^-/@]M0L[EEC5
M\B0$ $XPI.#[] !^>:^UG0,#[C';D'J#GCIFN$\4>'8M5MW5@&R#E0HQRI7K
MC/3MZYXR:]#+L6\)B(5%=6DG^*Z;MZ:?/U.C#572J)]$[_BM+?)?=U/P ^)G
M@::TO+AQ$552Y'!PN7R>@/ //(Z9/H*^>KG2)HFPP .3Q]WL2 ,X(Z@$=B/2
MOVN^)'P534A,T=L"65B"% !^8C#?+U&0<G) !QG S\H:Q^S[=&9F%J"=S< +
MR.HYV<<''0="!7[!E?$F&E1BIU$FE;5K?3I?7SZ=^A]AA,QI2@E*2NM-];JV
MFW^?D?GW%I<K.%&,D]NH.<?7C/;'ID'FO:O /@ZZN[NW/E9_>  X) STP,<\
MY'&3VSC-?1NF_L^W7GINM22#W521R,')3'KW]L$\'Z;^'?P-%H\32VP!WCDA
M>H [;.,^GY<5KF/$>%C1?+43DT]FFNUM_/2UB\1F-*,/=E=O];?YW[?.QV_P
M0\(RV-G;[HPK*J'OD\(03P,C&1CVXXY'W/I,/DV\2[<80$G([CT'O[?X#@_"
M7A6'2;>&(1XV@8X&20!ST'   YX(S@<$UZ=$@51P!UZ9QCZ?A7X]FF->+KRG
M>ZN_NTM;5[V^7GHSXW%5G6J-]+_HDK=M%M;U\I:***\LY@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW)9)%U$J$ETG0KA&Q_8D3M-=+@ZG.06L(OW6_8@\3S>+OV3_ (%ZQ<O&]T/
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M9SGKSC)]SDFIZ**P,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%_P3IUCX]W&G?%7XJPW6A?"&SNX9]-T]DD@U3X@/;REI8+!B4:ST ,@AN]8
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MY]NV:DE?8I(QT]<?3GL.N?8'I7E?C7Q5'I%L[%]AVL>?4+C/. <D#KR2,XY
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MVWNV^K84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%M2L;N;P]HGB&[NA:>%O$DN/+U?3C"'E-I*2S:EHRR6]K?R+'.LUI<>=-/\
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M10HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG.4ISG.3E.<Y-RE*4I-N4I-MRDVVVVV[L****9(4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M$ @@@$$8(/((/4$=P:** /X?/VD?"'_"!?'GXN>$-LRKH/Q!\6Z?%YZA9&@A
MUR^%JY 2-2LEJ89494"O&Z2*-KBO%%=D.49E.""5)&0>H..H/<'@]Q7Z&?\
M!47PH?"_[8?Q&<$&+Q'!X?\ %$6 1C^UM$LUF7YF8G%U:7!+#:I9B%5549_/
M&O\ (KC'+/['XMXGRGDY(Y?G^;X2G%K:C1Q]>-#356=%4Y+LFC_I!\,L]?$W
MASP%Q"Y\\\YX.X;S&K.[;>(Q.48.IB;MI/FCB'5B]%[R8I))))R3R2:_2W_@
MG#^U;\'_ -ESQ?XOU/XE^'?$=U=^+;'3M&LO%&BM:WL6@:;#<R7-_'-HLQM[
MB?[;.+)Y;FUNI)5CLUB6T;<6;\T:*QX9XBS'A//,OXARCZLLPRRK.KAOK>&A
MBJ"E.E4H34Z,[7O2JSC&<)0JTVU.E4A4C&2ZN.^"LD\1>%,YX,XC^O/)<]H4
ML/CEEV-JX#%N%'$T<72=/$TKM<N(P]*<Z=2%6A6C%TJ]*K2G.$O[@_A)^T=\
M$?CG9"[^%_Q&\.>)YE@BGN=(AO%M/$%@LHR%O]!OQ;:K;%6RC.UJ82RG9*ZE
M6/MM?PC?#S2O'NN^+=%TCX;0>(;KQC?7D5KHD'A@WHUEKNX80H+)K K=1OAR
M7EB9/*B#RR.D4;NO]>_[&/PS_:!^&_PRB@_:%^)^H>.O$^J+:7-EH-[]FOF\
M$V:P G2Y?$03[?K=_+(Y>]:YGNK>T=%M[2YN$5I6_OGP>\9<Y\1Z]7 8_A&O
MAI8.DY8S/\MJJ624ZO)S0HUJ6,G&O0KUKI4L/A\1F-9J7M:D:5!2J1_Q]^DK
M]&+AGP0PF'S?*/$?"8Z&9XA0RS@_/,.X<55J'M%"KB<+7RVG4PF,PF%]Z6(Q
MN,PF2X=./L*4Z^+E3HU/L*BBBOZ"/XV"BBB@ HHHH **** *%^Q6,D'!VG^M
M?(OQKOKJ*RN/+W A">,\GY^>G'3Z9YZU]?W48="",_*<#_/'?_\ 5UKY[^)W
MA9]5LY0B%B4?D @\XP.1Q@Y[=_4UZF55*=+$PE4:LI)M.VVFU_T.K"2C&JG*
MUKQW];_\#YGXG_$?6-0:[G7<X'FR]7)S@KCL.>W4'FL3P+JNH'4X#E^)$[MQ
M@XX/KC)[GKBOJGQY\';V>YE(MV(,DA) '<C'3)&<?4[<'(/-+P1\&KR'4(7-
MNX'FH<[1\VTG<3E02,Y[C.<?3]?CF>!6!M>%^3KITOY[[Z[;*Q]A'$T%02NK
M\M[I[VY4]]==_+7;4^SO@G=74EE9,X8_ZG!8$_PY[C\"3Z5]OZ>6,";LDXQS
MQ@<5\X?#'P@^EVMJK*0 (Q\PV\A.IRO7KQ@= > 17TI:H40+V P.<]^N3U!Q
MP>F.G&*_(\XJPJXF3@U;F>WHM_/^KL^2QLXSJOE75WV\OZ[?=I;HHHKR#B"B
MBB@ HHHH *:Z[T=-Q7<K+N7AEW C<I]1G(]Q3J* 3L[]M3^9W1O^"GG[2'[/
MOQ-\8_#[XA'3?BMH?A/Q=XB\.W%MXB*6VO0KI.N7E@SVOB;2X%EE<1V^(Q?V
M6H1#/RA5VJOTW\9O^"N/PU\6?L\^++;X;:;XF\,_%[Q'8?\ ".6FDZO;I-!H
M,&L6[P:KK]CKU@S6EY)IMLT\>GK+'I]VU_);W!MDBB<'\M?^"C'@_P#X0W]L
M+XS6J6DEK;:UXAA\56OF9VSIXGTVRUJYN(<@'R7U*[OT4=%:-T7Y54U\05_F
MSF/BWXE<(X_BSA"'$.(QF#P^.SO)*;S6/UW&X&G3Q.(P<*^!S"KRXVE6ITDI
M8=U:U:A3?+.-"ZBU_N-DOT<O SQ(RGP[\29\&8++,SQ>4\*\5U8\/U)97E>:
MUJV!P.9SPN:Y/1Y\KKX:M7DXXM4,-AL56CSTZF*:E*_1^&?#^L>-?$^C^'-'
MMI=0UKQ#JUEIEA:J7:2YO=0NHK6VBW[9&'F331QF0JP0-O?Y58U_;;\ OA3I
MWP1^#OP_^%^FA67PIX=LK*_N (]U]K,J?:M:OY&C1%=[O5)[J;>%&59>.!7\
M4/P_\>^)_AAXR\/>/?!M^NF>)_"^I0ZMHU^UK:7@M;V .(Y?L]]!<VTFT.P
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M;W3-8T^[TV_M98V*NEQ9WD4-S RL"")8DY'%8%?W-_%#X'?"3XSZ=_9GQ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7"_%#_ ))K\0?^Q)\4
M_P#ICOJ[JN9\:V<.H>#O%EA<;Q!>^&M=M9C&VUQ%<:7=12;&P=K;7.TX.#@X
MKEQT'4P6,IQMS3PN(A&^BO*E-*[Z*[._*JD:6:9;5E?EIX_!U)65WRPQ%.3L
MNKLG9=6?P<,2'R"00000<$$8(((Y!!Z&OJG]G;]LOXY_LTZHL_@/Q3/<>'IB
M/[1\%ZZTVJ>%=07*_.VER31_8KI0I"7VES6%Z \@:=TDD1_E:08=A]/Y"F5_
MD!E6;9GDF-P^99/C\7EF889J5#%X*O4P]>G>W-%3IR3E":5JE.?-3J1O&I"4
M6T?]*/$'#V0\5Y5BLDXDR?+L]R?'1Y<3EN:82CC,)56\9.E6C)0JTW[U*M3Y
M*U&:4Z52$TI+^K[]F3_@J!\#OCI]A\.>-)HOA+X_F6&#[!X@OH?^$6UB\95!
M70_$4AB2)YI"1#8:S%97)/[JWEO64R-^E\<D<L:2Q.DL4J+)')&RO')&ZAD=
M'4E71U(964E64@@D&OX$U9E.58J>>5)!YX/(YY'!K[Q_9P_X*(?M _LZPKHM
MCKG_  G'@R.TFMK;PCXRENM3L--9DE^SS:/="XBU'3/L\KQ$6L%W_9QMX%MQ
M8J#YB_UIP#]**O05'+O$'!2Q,%RPCQ!E5&,<1%:+GS#+(<M.K_-.O@/9R2LH
MX&HVY'^=7C#] 7"8J6)SKP;S.&!JR<JLN#.(,5.>#DV[^SR;/:OM*V'[4\+G
M'MJ;=W/-J,4H'ZE?\%7?VRY/!6B3?LW?#O4E3Q'XFT]9?B3J]G,IFT?0+Q";
M?PK$R$M#?:W"RW6J.-LD&DF&V5E?4G,7\XC,68LQ)9B68GDDDY))]2>374^-
M_&?B'XA>+-?\:^*M0GU3Q#XEU.[U?5KZX=I);B\O)6FF<LY8A 6V11@[885C
MAC CC11RM?SQXC\=9AXA<4X[/<8YT\)S2PV3X&4KPR_+*4Y>PHI)\OMJMWB,
M747\3$U)V?LXTHP_M#P1\),F\&> <KX2RV-*OF+A#'\29M"'+4SC/J]."Q>)
M<I+G^JT.6.#RZC*WL<%1I<T?;SKSJ%?7?[&O[*OB;]JKXK6'A:Q$UAX.T:2V
MU7QYXC$9:/2M"6;#06Y(\M]5U1HWLM+A?*&4S7,BR06<\;?-W@?P9X@^(?BW
MP]X)\*Z=/JOB#Q-JUEH^DZ?;*6EN;R^G2")!@-L4%M\LK I#"DDTF(XW8?V5
M_LE_LV^'/V7_ (0:'X!TJ.VN?$-Q%#JOCG7H(]K:[XGGB'VN1'8>:=.T[<=/
MTB*0YCL84=@)IIBWU_@GX73\1.(77S&G4CPODDZ5?-JBYH_7JS?/A\HI5%9J
M6)47/%S@^:C@XR2E3JU\/)_F_P!*CQ]I>"W!BPF2UJ4^/N*:6(PO#M%\M3^R
ML+%>SQO$>)I.Z<,%SJEEU.HN3$YE.#<*V'PF,IGM?@'P'X5^&/@[P_X#\$Z1
M;:)X8\,Z=!IFE:?;(JJD,*@-/.X :XO+J3?<WMU+F:ZNI99Y69W)KL***_TH
MH4*.&HT<-AZ5.AA\/2IT:%&E"-.E1HTHJ%.E3IQ2C"G3A&,80BE&,4DDDC_#
M/%8K$X[%8C&XW$5L7C,77JXG%8K$U)UL1B<37J2JUZ]>M4<JE6M6J2E4J5)R
ME.<Y.4FVVPHHHK4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _FT_X+4^%/[.^
M,OPP\716L<<7B?X?W&GSW*F,/<7_ (;UNY602JH$A,5CK.G*DCY#*2B8$)Q^
M+5?TC_\ !:OPE_:'PC^$WC**S>:;PYXWU;1;B[3>5M+#Q%HHNF$H!V".:]T"
MS0.P+"0(J$*\@;^;BO\ ,OQ^RS^S/%;B=1CRT\?++\SIZ6YOK>6X5UI+1)WQ
M5/$7:NFT[R<N:W^[OT/,]_MWZ/? CE/FK9/'.<AKZ\W(\MSG'+"P=Y2::R^M
M@WROELFN6*@XME>W_ ?]GKXG?M%^-+/P5\-O#]QJ=U(T4FIZI(K0:-H&GO*(
MI-4UG4&4PVEI$=V!^\N+ET:&T@N)@8Q[Y^QW^PG\2_VJM;CU"**?PG\,-.O!
M#KWCC4+23R)3%O-QIWAZ"0(NL:L&00ND;&TL9) ]_,GEFWE_JB^!_P !_AK^
MSUX)L_ OPST"#2--BV2ZCJ#I%)K/B#4%38^IZYJ"QQR7MVXRL8(2"UBQ!:PP
MP@)7L>$O@;F_'U2AG.<_6,GX2C+F6)Y5#'9PHO6EED*D6H8=M.-3,:D)4EK#
M#0Q%13='YKZ1?TL>&_""CBN&>&'@^)?$6<'3>!]HZN5<,N<;QQ.?5:,TZF,2
M:G0R6C4AB)+EJXZIA*$J*Q/A?[(7[$/PR_92\.P2V$%OXI^)E_9B/Q'X_OK2
M-;HO,(S<Z;X=AD#OHVB!HT01)(UY?"))=0N)G(2/[7HHK_0;(\BRCAO+,+DV
M1X##Y;EN#AR4,-AX<L4_MU*DFW4K5ZLO?K5ZTIUJTVYU)RDVS_&KBSBWB3CG
M/L?Q-Q7F^,SO.\RJNIBL=C*G/-I75.A0IQ4:.%PE"-J>&PF&ITL-AJ2C2HTH
M0BHHHHHKUCYP**** "BBB@ HHHH " >#6+?Z?%=(R.@)VX!(&.N!U'89'<D&
MMJD(!ZTTW%IK=.Z&FT[K1H\@U3X?6EZ2S0Q<D\M$%W=^FT' ([D@\?C!IOP[
MM+20/Y,74Y(C';DX&,=. 2?7GDU[&8U/7/YT") <C/'O73]<Q"CRJ;MZ[;?Y
M?CZWT]O4M;F=K6W?EY^2_P"&,;3]+AM%5$0< 8^F",<#@=S[]<UN*H48_/\
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M7Q8_:8TN.23$%]X:^%5R-ZJ&4LE]XX0J!NY1K?P[&[I@%]6=BPL8OK;]B/\
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M$DEHDELC_.)MR;E)N4I-N4FVVVW=MMZMMZMO5L****8@HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5BC!^9SZX[#.6. *]9T_PQIT8AL[>P%[<SR1PQ[T\ZXN9Y7"1HB\@,[L%5$
MY.,\FM3X<V>E>'[[3I=?L8[^POY4M]<@; D2RNAY+-;2CYH9[+>+B*52")5.
M<J,5]-> ?AN?#WQQT_1=1=;W3=-L[GQ1H]Z5S'J6GK"LFF7(&"C/%YRM,#MV
MS1*P S@=/BQXTY5P%1XF>-AB(5<CX$X@XXR:BIJE0XGI\-0Y<UR_"5X2]I'&
M8'$8G*%B:%2"M@LWP^-PSQ$:./C@_P"W?!KP5^N8/)\9C,-A,3F.=YYEN38^
M6)H1KRX>IYLXRP//1JQE!+$488N52O'W_K.$K8.HZ<?8/$?.OCWX8Z3X:O;7
M0[AE77H].@NM<%F56#3;V\19H-.51E99K:U9#=,P \V0*G"DUXEJWAV^TO=(
M1]HM1C%Q&#\N>TJ<E,=-W*D]QTKZ#\7ZK-K?BOQ'JL[%Y+W6M0DR23A!<.D2
MC.2%2-551DA0 !P!7.,JLI5@&5AAE8 JP/4$'((/H>*^HX#S7B;"<+<.2XEQ
MJS//*^48#%Y[-QC3H/-<;0AB\PI8*$%_L^#PV)K5<-@*3=1T\)2HQJRK55.K
M../O#G@_/\QS7^Q\!#(U3Q>(I99BL%3C&;P]&;HX:>/H)PI8NI6ITX5<54M2
MK2K3J.E5I0:IKP"OV"_X),_\%5?'7_!/OXF6GA/Q=?:AXD_99\>:Y;_\+$\(
M.TUY-X&O+MX[>7XC^";<%FM[ZSCV2>(]%MPMOXBL(MY1=4M;2XK\P-=\*!@]
MWI:@-RTEH. W<F#L#_TS. ?X3G@^>D,K%6!5E."K @@CL0>0?4$5]_F. R7C
M#)\7E>8X>&+P.+I^SKX>I95:,[7IUJ4E>5*O1G:I0KP=XSBFFU=/^4>)N%<T
MX:Q<L#FM!<E3F>&Q=*\\+BZ<;>_0J-*THW7/2FHUJ3:YX)2A*7^MWX$\=>#_
M (G>#O#?Q!^'_B/2?%W@KQAI%GKWAGQ+H5W'?:3K.DW\0FM;VSN8B5>-T;#H
MP2:"59()XXIXY(UZROX*?^"'_P#P5BO?V1_'.F?LR_';Q%/+^S-\0=:CMO"N
MLZI<[K7X)>,]8N0#?+(8)KB+P+XEOI(XM8LEDBLM!U.X.OQK%!-JQE_O1@G@
MNH(;FVFBN+:XBCGM[B"1)89X94$D4T,L99)(I$97CD1F1T8,I((-?P'X@\"9
MCP%GE3+L3S8C+\1SU\IS'DM#&852MRSLN6&+P_-&GBJ*^";C4A>C5I3E\-6H
MRHSY7JGK&7=?HUU7Z6):***^$,0HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J2ZGIKW)LE
MU"Q:\4D-:+=P-<J5^\# )#*"N1D%.,\U_%G_ ,%S/^"MGQZ_X:"\;_L??L[>
M/]9^%OP[^%PT_1?B5XI\'W#Z1XR\:^-;JQMM4U'18/$4)_M#1_#GAZ*[MK22
M/2I+2;5;]IWN)GM[:!3_ #5P?%7XK6NM/XDM?BI\3;;Q')))*^O0?$#Q;'J[
MRRC$LK7PUCSC)(/OONRV!DU_0W"WT?,WS[)<'G&8YYA\G>88:GB\'@E@:F.K
M+#UX1J8>>*E]9PD*,JM*2J>RI^VE",HJHXU.>G#LIX.4X*3FH\RNERW=GM?5
M6OOUL?ZUM9<FN:+%<"TEUC2X[LEU%K)J%HEP6C*"11 TPE)0R1AP%RI= V"R
MY_S$IO\ @IK_ ,% Y_AZWPNE_:X^,[>$'18#"/$\J:W]C2.-%L!XF2-=>6R4
MQ)((EOP_G;I/,R[9^/;KQMXXOM4?7+WQUXYO-;>X^UOK%SXR\33:F]WN#_:3
M>OJAN/.WJK%PX)903D@5[.#^C/F,_:_7^*L#0M)JA]3RVOBW.'V95O;8G!>R
MD^L(>V2Z5&6L#+7FJ)=K1;^^[1_KAT5_%=_P0^_X+"_%'1OBUX1_9!_:D\>7
M_CGX>_$"<Z'\*/B)XQOWO?$W@KQE(I?2_"NM^(;R0W&K>&O$CJ]CIT^JSRW6
MD:LUI$EP]G>.D/\ :C7XCQOP3FO F<RRC,W3K1J4UB,#CJ"DL/C<+*4H*K!3
M2E3J0G%TZ]"=Y4JBTE4IRIU:G+5I2HRY9:Z736S7_ V84445\<9!1110 444
M4 %%%% !1110 4444 %%%>?_ !3^*?P]^"?P_P#%/Q2^*GBO2/!/@'P7I5QK
M/B3Q+K=P+:PTZQMP,LQPTL]Q-(R6]G9VT<UW>W4L-K:0S7$T<;:4J56O5IT*
M%.I6K5JD*5*E2A*I5JU:DE"%.G""<ISG)J,(13E*322;8)-NR5V]$ENWV/0*
M*_GJU?\ X.6_^">^GZE?V6GZ#^T%K]G:7$T-IK.F_#K2K>PU6*-B([RSBU;Q
M9IVI16]P &B6^L+2X56'FP1ME1^ /_!0#_@N_P#M0?M7ZMJ'A#X):KKG[-WP
M/ADN+:VT[PIJSVOQ)\8VC2 QWGB_Q79,)-,5@B-#HWAN2UA@!(NKV]D)8?JW
M#W@KQYGF-AA\5E57(<(HJI6Q^;1=&G3@]HTJ$6\17KOI2C"*C_R^J4DU(Z88
M6K-V<7!=92_RW;\OO:/] 7^T]-\T0?VA8^<9C;B'[7;^:9P2# (_,WF8%6!C
M W@J05X-7J_R1(OB#\1(=9'B.'XB?$&'Q"MV;]==B\<>*4U9;]FW->K?+JPG
M%T6^8S!M^[G.:_?O_@FY_P %]_CC^S]XD\/?#3]KC7]9^-7P%N3::.GC"_CB
MO?B?\-H]T%K;:F-5)BG\8>'+& #^T-+U-I=5M[:(3:9>,Z26MQ]EQ%]'3/LL
MR^IC,DS>AGU>A3=2KE[P<LOQ-515Y+!MXK%TJ]3?EI5)T)3M:FYU'&$M)X*<
M5>$E-I:QMROSMJT_1V^_?^\"BN?\)^*_#?COPSH'C/P=K>G>)/"OBG2;#7?#
MVOZ1<QWFF:OI&IV\=W87]E<Q%DFM[FWE21&!R VU@K J.@K^=9PG3G*G4C*$
MX2E"<)Q<9PG%N,HRC))QE%IJ46DTTTU='$%%%%2 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP!R3QCH.I)&,=\X[US-IV^O_ +-7H/A>W6XU ;@#]GMKN[ (SS!$S*?<JV&
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MM+U.QGCN;*_L+V%+BUN[6XB9HYH)X9$DCD1BK*P(-?Y]6I2Q%'&T$,".@Y&
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MW8_?JBFQR)*B2Q.DD<B+)')&P=)$<!D='4E61E(964D,"""0:=7XD<H4444
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M;4X*?U>>,P>$Q\::J<OM/8RKTJJI\_)#GY''FY(J5^56_',PRW&9;BZV S3
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MK=)X:TF]\::5XD2Q9UW0P^*KK5]2T^2[CCW^7-+X8CAED(#Q1KR/Z5_V;?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$6"VND\X^'_"TQL/">F7UN@$J6U]KUQ<:B$E9H+DZ9&QBWV\,E?UB5_FP?\
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M\L[N<;23T[Y%>;6\F-I]<#N<<\?7VXQG&.*Z&TF*E2K;65E92#@@K@J<^JD
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M%TE#ZQB,'6DI;IJE;SO9/R>@%E\W8\L?GPM;3^3++#]HMG(9[6X\IT^T6KL
MSVT_F0.P5FC)4$>BR_#/74_U=Q82<G ,CQG;V;YE[^GYX/%0?\*V\1_WM/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2VO;.6:TN(WAD85_?/\ \$U_V\?#/[=_P%L_&)%AH_Q8\&-:>'/B_P"#[:0
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ME+VF8XW%R<KNZYI)\OK.O>(-?F2?Q#K6L:U/&<QR:O?W5ZT9(Q^[%Q(RH<<
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M9;7?:[T5S]TOVY_^#?GXMZ-X9T/X]?L<^'YO$NE>(_">A^)_'O[.4]^C>,/
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M&NI>"O$-AX9M;F]++:)/J]WI\5I$MPZM%%*T@A:4"+S/,*J?-NO2O[4/$_\
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M/KJ>U_#R-;+0-0U%QP\\TN2,?)9P9&.,E3(>H[Y%>-7$S7-Q/<-]Z>:64_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_>CO\+Z:]5L_3KN%%%%?GYB%%%% !1110 4444 %%%% !1110 4444 %%%%
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M2CYIZW^;OZ6MTN%%%%?BYRA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCB-Q+IVH16X 8W$ME<QP!2<!C,\8CP3P#NQFO'_%FF_8[_[5&N(+S+C'19E
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M$GB'Q%XDGV>=XC\0Z]X@F$9D,0EUO5KS5'6(RLTIB5KLB+S6:3RPN]BV2?\
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MC5J_BZPTCQ+X8_:&\"ZYX.UVQBU/2M;TSP[JUU'?6-RR/;3VQCU4PR![=F+
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M,=S.UQ*MMI]_)I^GGS7 )C;3[6U:!,;8;<Q0)E(EKQSX<_$OQK\*?%VC>-_
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MEE\*:C'/';9GEC-MJ[2!$5CYD<;[3LK_ %#Z_P U7_@C?^S]KG[0_P#P4/\
MV?\ 2-.MKUM#^&7B%?C+XSU*T7"Z1HG@4K=:<\UP5>.WDU'Q)-I-C:"0'[0[
M3)$K.AV_Z57^?SK^5/I)U\)/B7(:-)Q>-H9+4>+Y6G*-&KC*LL)"=M5*\<1-
M)OX9QE9*5W^"8YKG@NJB[^E]/U"BBBOYQ.$**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **XOQY\1_A_\
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M1JT:]&I*E6I5(-2A4IU(.,X3C))QE%IIJZ8TVG=-IK9K1KYG\/\ _P %&/\
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M)D!*?0N"5]SM%>IUX%'(\4B2QL5>-E=&!P592"I!'H17MNEWR:C8V]VA!,B
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M.&2UTV'+R75\UO;0QR32QJ?\V@AU+)(CQ2(Q22*12DL4BG#QR(P#)(C JZ,
MRL"" 17]I_1J6#7">=NG.G]>EG\WB8*4?;+#0P&"6$E*.D_9>TGBE"3O'G]J
MDT[H]7!0DJ$JG++D=:4%/E?(Y1A"3@I6LY)24G%.Z33:2:;V-%A#W#RG&(DX
MS_>?C/X 'GWKJ*YO0W423(2 S(K*.Y"DYQ],BND)P"?3FOWW$MNJ[]HJ/I;_
M #O\S]KX/C3CD=%PMS3K8B55IZ^T51Q7-V:IQIV3^S9]0HKHO$&CQZ'_ &38
MR;_[4ETJWU+559B!;2ZD/M%G9"(@;'@L3!),3\S33NI.$7'.UY.6YCA<VP5#
M,<%*4\)B?:2PU645&.(H0JU*5/%4;.2GAL5&"Q&$JI_OL-5I5;1Y^5?8XO"U
ML%B*F%Q$5"O1Y%6IIW=*I*G"I*C/1<M:BYNE7A_R[K0J0N^6[***Z"VTV$>&
M=4UN= [_ -J6.C6 W<QRO$]]>7!7N1"D,*$9"B2;</F6C'YA0RZGAZE?F;Q6
M.P.7T(02<ZF(Q^*I86DDI.*Y:;J.M6=[QH4JLHJ4HJ,EAL-4Q4JL:=OW.&Q.
M*J2E=1C2PM&=:;;2;O+E5.&EG5G"+<4W)<_1117<<X4444 <AJJE;V7/<(WX
M%17MW[*7B#5?"W[3?[/^OZ+.EMJ>F_&3X;SVLTD<<T:'_A+](21GCE!1E6)G
M8YQC&[(Q7B>K_P#'Z_\ N1_^@BNV^#9*_%OX8LI*L/'_ (1(920P/]O6'((P
M0?<'-=F)IQK9?7HR2<*N"JTI)JZ<)T)0::ZIQ=FNJT/PG.HI9MF<5M]>Q2UU
MWK3_ ,S_ $7/^"U>O)X>_P""8'[7%T;J[M)+[P)HNB0RV?F"5WUOQUX4TUK9
MVB*LMM=P7$UM=Y.QK669) R.5/\ FL@8 'H *_T;O^"Y?/\ P2G_ &D\DD_V
M%\.,DG)/_%QO!W))Y)]S7^<E7X+]&RG&/!><37Q3XGQ49/3:GE>4\MM+_:EN
MWOH>#@?X4G_T\?X1C_F='H:CRYV[ET4^F I(X^I/YUNUAZ'_ *J?_KHO_H-;
ME?NF(_C3_P"W?_28G[MPRDLBR^RM^[J/YNO5;?S84445B>\%% ;80^P2!&5S
M&Q(60(0QC8CD+(!L8C! )((-=%XJTN#2=:F@LT=+"[M=/U73D?=N2QU2TBNX
M(R6)8F,.R$DYX'7K7!5S&A1S+!Y74YXXC'8/,,;AY>[[*5/+:N7TL33;YN95
M?^%*A4IQY&ITX5Y<R]DT^F&%JU,)7QD.5TL-7PN'JK7G4L9#%3HR2M9P_P!C
MJQF^9.,Y4E9\]USM%%%=YS!2$!@0>0001[$8-=%-HZ/X7L_$5H)"(=4ET364
M9MPAO'B%WIUP@_@BN[7>A7HL\3#/-<]7#@,RPN91Q4L+.3>"Q^,RW%4YI1JT
M,9@JKIU:=2*;Y54@Z6*P\K_OL)B,-B(^Y6@=.*PE;"NC&O%6Q&%P^+HR5Y0J
MX?$TU.$HMI7Y7ST:RM^[KTJU%OFIR.%N(_)GEC[)(RCZ9X_3%?47[$'Q@O?@
M)^US^SQ\6;*ZCM/^$1^*W@^YOYYFD$ T6]U>VTS74G$9#/%)H][>HT?(E#>4
M58.5/S#>N'N[AEZ&1L=.W';([5[+^S5X O/BE^T!\'/ =C-;VDGB'XD>#+.X
MU&\N;6RL=(LF\0Z>;K5KZ]OI8+&UMM.A5[HO=S1Q2/$D"L9)$4^KFBPDLHS"
M.8RA3P-3+L53QLJLHQA'#5L-.G7YY2]U)TYR6NC;22;:1_.^+I1>+Q5&A%SI
MJOB(4HP3FW2A.=G%1NVE3CS.WV4WLC_5[MKB&[MX+NWD$MO=0Q7$$JYVR0S(
MLD4BY .'1E89 .#R*FJCIEHEAINGV,<OGQV5C:6D<QVYF2VMXX4E.W*_O%0/
M\I*\\<5>K_+%VN^6[C=VOO:^E_.Q\L%%%%( HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OXZ_^#@C_ (*EZU<>(/%7_!/[X)7UI!X?L[*P@_:)
M\71+'<W6I7]TL.IP?"_2'D1XK2WLH?L5YXKOXC]L^UM'HL+6_D7K2?V*5_F5
M_P#!63X1>/O@W_P4)_:<T?X@QZE-=^,/B-K'Q)\-Z_J, B'BKPGXQE&HZ3K5
MM+&B6T^U6>PO1;%Q:WUI-;2E94(/[IX Y%D^<\88BOFBI5J^3X!9CEF#JZQJ
M8R.)HTUBN1Z5'@5-3A%WY:U2E62;I)KKP<(RJMRU<5S13ZNZ5_.WYZ]#\Z^G
M2O9?A<P:TU6(KD&YMV)SU#0NA7'T)Y[Y[8KQJO8/A<ZF+54W#>)K5RO?:=RY
M^F>*_L7B=7R7%6O?GPSTZ?[32U^2/Z ^CS4Y/%KAM<R2JT,[I-.WO)Y+CI<J
MOU?)>RU:3Z7/*;]52^O4485;NY50.@ F< ?@*_4O_@CY^W5JW[#O[7?A74=1
MN(#\(?C/?Z'\,OB]9SV\,CVFG:EJ(M_#?BNSNF43VEQX9UV\@GNE218+K2;B
M_CG4LL3I^7NM8&KZG@8'VZZXQC_EL_:FZ-!<76MZ#:VD<DUW=>(?#]M:PPJ7
MEEN9]:L(H(HD7+-))*R*BKR6( YK;-,KP6?Y%BLJS*DJV#S+ ^PQ$)6;4:E.
M+C4BW\-6A44:U*>\*M.$TTXIGY#F]",,RS/#:<M/'XV@K)1C:GB:L$U%:12Y
M4TM>71=#^^'_ (+,?':]\KX=_ S0-1D31]1T]/B!XI%JX\C5/.GDM?"MK-(
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MUA9RW$LEM9M>O')=M;0NYC@-R\43SF)5\UHT9]Q4$?U&?MR>#OV.?VGO#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%>7^-?C;\'?APBOX^^*/@'P?OE\E4\0^*]%TN5IBR((EANKR.8R%I
M$4($W%F4 9-1.I"G%SJ3A3BMY3DHQ7JY-)?>=&%P>+QU:.'P6%Q&,KS=H4,+
M0JXBM-O91I4HSG)OLHL]0HKX/U__ (*9_L/>';B\L[OX_>%+N[LHXI'M]+BU
M74#/YKA!':306!MKF5,[Y8XYRT<8+N !7,Q_\%6?V')&11\8(5#LJ[FT/5U1
M-S!=SM]F^5%SEFYPH)QQ7BU^)^&\-/DQ&?9/1G_+4S'"0:L[:IU5;7N?>X3P
MA\5<=06)P?AOQSB,/+6-:EPMG<J<E92O&7U*TE9IW5UY[GZ+45\=^&/^"@'[
M''B\R_V/\?O B+"X2275KZ?0X 60NK"XUBVLH#&RJ=LGF;"V$W;V53]0>'?&
M7A'Q?:I>^%/%'A_Q):2+N2XT+6-/U6(KZ[[*XG QW!P1W%=N#S?*LQ_Y%^9Y
M?CK;_5,9A\3:SL[JC4G;70^:SCA/BGA[_D?\-Y_DEVDGFV3YAER;:NDGC,/1
M3;6NC9TE%%%>@?/A15>[O+33[6XOK^ZM[*RM(9+B[O+N>*VM;6WA4O+/<7$S
M)%##$BEY)9'5$4%F8 $U^$?[;G_!;KX7?!TZKX _9FMM,^,/Q'M9KBPU#Q=/
M)+_PK7PQ<P_NW$-W;LDWBV_BEWJT.FR1:; T>9;Z<,(CG4K4Z*3J34;NT4]Y
M-]$EJ_DM.I]GP1X?\6^(F;1R;A/**^9XFRGB*RM1P. HMI/$8_'57'#X6BKZ
M>TG[2K*U.A3JU91IR_8WXQ_'/X1_L_>#[OQ[\9OB!X;^'GA6T$@.J>(M1BLQ
M=311-,UIIUL2UWJ5X8T9A:V,$\^WYB@7+#^8?]L/_@XLUBYDUKP9^QMX"AL+
M1EN;&'XO_$>V,MV3O,8U'PUX+C?RL-'N:WDUNX*@M%<B)MC6[?AC^T#\<_BY
M^TUXPN?'/QO\=Z[XXUR>8S6\5]=R1:+I* D0VNBZ'"RZ;IEK:QL8K9+:W1XT
MS\^68GYMU30;5XI/LR&*9%)3#,RR%03M8$GJ!CCH1]17U/#M+*JM:E/&4YUY
M.2]R:7L(>\K.45*]3SYE*%GK#J_[(R/Z)2X>PLL;GN*P'$F9TJ4:OU2E4Q%'
M+H5(Q4YTJ%"I1IU,;.+O!3QDZ5&K9?[+!M'=?$GX^?&O]HO7[WQG\</B?XP^
M)6O";;;2>)-7N+K3M,4B1BNDZ-&8M*TQ<2R1J;2SB=8V:(.4^6O+;VVCN8)8
M)4#JZ, ",X;!VNN,E65AE2""#CO5'0942:[MG(5I LB@D#<4R'4=.03TQDC.
M*UYRL2O)(P5(U9W9C@*JC).3C@ $_P#ZQ7[/@YNCB5&E%4XP=+V,*:C",8*%
M/EC3C%624F](I)-/K<_=N$<'EL>#<%@Z.'PM'!PIXS#XO#TZ=*G0BGB*RJJM
M3BHPCS47!R32M2<5\*C;S33/$'V/S+/47DDC5W6.Y.9)(\$KLE!^8H ,@\LN
M#D$8JQJ'B6V$,L>EB6_N]A"^3$YBCW<"1WQU7.0H&=P'.*SM+T^VU35;EI%+
M6B-+<>62P,@=SY:L1CY<Y9AW'%=M';V]N"EO!% O3$:!>!PH) R<#\^M?K-.
MI@:.(IRE0G.LXTZM6BIQIT.:7*[32A*3DTKSC!QCYW<C\DX8I<9YOD>)H4\Z
MP.$RF-?&8' YE4PE7'YQ["C*5)SPTY8BCAO9TYM1P];%1K5X\CM!PC29X?9:
MC?:+>M<HK"4Y$\,ZLHG1VW$.#@@ECN##H<XKL[;Q1JNLM]FTC2XH9\9DNII2
M\$"]V/ 4=<!2<D].A(T_&-A#<Z3+=,BBXLRKI*  QB9]KQDY!*MN# <X(Z4_
MPG%%'H=JT2J&F:5YF'5Y!(RC<>N54  'H!Q7WL\9@\5ET,QG@H3Q4:JPJ4I2
M]G"2@JD7-1<%6@HZQC-.S?*_=6OY=D?"_%/#_&>)X'P_%N+PW#U3+9\0RGA:
M.&CC,1AZF)IX*K2PL\12Q53+<5/$MJO7PU5>Y#ZQ!>WJ1Y,G6K;Q<UG(6O+6
M>(+^^AT^-X9F3'S?>R[@?Q",@D>O0\YX-BB?7$\X8>&&62%&!!,RC&,'!5D4
MLPR.HZ<5ZX#CD5YQXQ3^S]1L-3LV^SW4H<NT8"DO$1B4@  [@=CY!## .>]9
M;C7BJ=;+/94:$\52JQIUJ%-4HJ:IMVJ0@K.+C%KG6J6EG>ZWX]X1H\.XW*?$
M#^T,TS?#</YCEE3'Y7F^-JYA4EAGC:5-5,OQ.)J)TZD*M2E/ZK4O2G42J\\5
M&5.?H]<[XHOK>TTB[@DD3S[N+R880P\T[F4ER@Y"*%Y+8!R,9K"M=5\8:C:E
M[:R@573"W118G;(Y>)9&VL2.C!2H)XY%<-<6>HR7XM;I)A?SR!,3[C(S2-PV
MXY)0G+;ERN!D<"EE^3I8GFQ.*PR^JSC5=*C5C4J-TFI^_JO9P32YFTY6334;
MJ17&WBE*KD'U?(N'<\J1XAPM; 4<RS3+<1@<'%8^DZ$882\:BQV*J0J3]C"$
MX4K\M2,Z\>:!VG@VSU>$/=((4TZYP'2X+!IBIPLL '(*\C<WRL,@=LZWB'Q!
MJ.D*J1V$:^<&6*\>3S8@0/F"H,$2 '(#\<$C@5T]K!]FM;:V^7-O!%$=GW-R
M*%8K[$C\:KZEIUOJMJUI<[A&9$D#I@2*4.3M)'&X?*?8\5Q2Q]#$9C]9Q6'I
M5*#G:48*:?LUI"<N6:]I.*2<E).,TN7E2M;Z["<&YQDG 2R'AS/,PP><T\)[
M>C7KSPTZ:QM:,:N*P=/VV'J/ 86I5=6-&6'G&IAJL_;^TG)U.?@/#?BA;:2X
M@U21VCNIFN!=$;C'.^ WF #)C;  *CY/3;T])MM3MXBE]::G%"T!6:.\M[SR
M)8&4[EECFC=)HG4@,KH5=2 001QSEQX.T::$Q0126\VTB.<2NYWD';YBL2K+
MG&0 #CG->4FTG^UM8JI><3FW"KSND5R@Q[$C(/IS7IK"9;G-2K6P]2KA)P47
M6ISIT^1PM;GBE.T5:+3M*R>LH*]W^>2XFX]\*L#EV49[@,NXDPN,=>EE6+P^
M-Q?UF-?FC4J8*O5EA?;8F4:F(C*G&>'52I&3IT\3.,%&E^U/[)__  70_;!_
M94UG3/#U_P"(%^//P:T]HK:?P3\1;F>YURVM$W!V\,>-F,NL:84#8@M+_P#M
M+3L1Q@6\0#;_ .O?]A?_ (*U_LF_MV6UEHG@GQ,_@/XMR6YDOOA#XZEM[#Q&
M71RCMX?OU8:;XFMC\KQ_89(]1*L6DTR-$+U_G6Z?X,TVWB4WX>[N2H,@$C1P
MH2.50(0S;>FXGD] !Q5MM$DT>>'7?"E_J7A[7])=;W3M0TJ_N;2Z@N+<K*DE
MO=0R)<V\RNBNDD4BD2*A[ C\SXM\-N >*%RX:A5R3-N50AG. H4XT*]7X5/,
M,$IPIXE3D^:I7A3H8F6[Q'*E$^(SSP;XWS:GF/$V)P^3X?&XN>(S*MD^$KRI
MXFG[2]:5"E0AAW@E.$?=C16,E4E)<LISJMW_ -86BOXV?^"6_P#P< >*M"O/
M#'P$_;<N+[Q5X=;['HGAOX]QI)<^(M 0,EM:Q_$N$!Y-=TX%U6;Q1&PU6S2,
M/?Q:IYGF0_V'Z!K^B>*M$TKQ)X:U;3M>\/ZY86VJ:-K6DW<%_IFIZ=>1+-:W
MMC>6SR07-M/$RO'+$[*P/!SFOY1XQX(SW@C,GE^<T(\E3FE@\=AY.I@\;23:
M4Z4[*4)K_EY0K1IUJ>C<'"4)R_!ZV"Q="C3Q-3#UXX6K4J4J.*=*HL-6JTE&
M56G2K.*ISJ4U.#J4XR<Z:E%SBE)7UZ***^0.4**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "JM[?66FVD]_J-W;6%C:QM-=7E[/%:
MVMM"@R\L]Q.Z0PQJ.6DD=54=2*^.OVKOVY?@W^RCI+0^([[_ (2GXA7D)?1/
MAQX?NK>37;C<A:*\UF0F2+P]I!ZF_OTWSC*V%M>2JR#^:;]I7]NOX_?M.75_
M8>*/$LWA?X?S3L;/X<^%)Y]/T/[,LC/;KKMRC)>>(KJ-6 >6^=;4L"8;.!3M
MK\6\1O''A/@!ULOC-Y[Q%"+2RC 58*&%J-7@LTQK4Z6"5[-T(1Q&-47&3PL:
M<XU#^H_!+Z*'B)XQQPV<SIQX1X*J3BWQ+F]"I*IF%)22J_V!E:=*OFC2NHXJ
MI4P>5N<9TUCY5J<Z*_4O_@J7^W5\#O''[-/QG_9J^%/C2W\7^.OB9H,W@74-
M;T*VFU#PQX:TS4)XEUN[FUJ)XK2]O5M(Y;6TM+&6X5[B;?*_DQ,K_P QW@+P
M7H7P[\-V?AKP_"XMK?,EQ>2J!>:E=LJK+>7CH-K2L%"JJX2.-51  .?2M598
M;$HJJ%+HH PJJ 3T &/H!BN5\P^WZ]OQK^3^*?&?CWQ'R5Y'F^84\%PO#-Y9
MK2X=RRFL/@)8^&'IX>EBL95DZF,S"O0HN4**Q=>="A*<ZN'P]&=1M_ZQ^#/T
M=?#GP4H5*W#6$QF89]B:+H8WB3.J\<3F56G/V3K4<)2HTZ&"R[#5)T8.5+"8
M>-:<8QAB<3B5%,OEXS(DQCC,T:LD<K(IEC5_OJDC+O16Q\RJP5B!D$XKQ+XJ
M?%UO"QD\/^'RDGB"2$&YO& >+1TE&8RJ$;9KUT.]$8&.%<,^6(%>O^8?;_/X
MU\[^/O@]J>N:W?Z]H=]:LVHR+-<6-\SQ,DX0*QAG"NC1-M7"R!2A.,D8KZ7P
M R_PMK^(&%K>+>-H4,@R_ U,3EN%S&-:63X_.*>*PSPN$S>I3A54,OA3J8O%
M.A65/!XJO2A1Q=25"=3#XK]"X^?$\,@J4^$J,YX_$5X4L35P[@L90P<J<E5J
MX12DFZ\I1I4N>'-6ITY2G12J1C4I_+MW-=7UQ/>7L\MW=W,CS7%Q/(TDTTCG
M<SN[<DD] .   H  %4RA'0XZ<'OC\.?R]:]O@^!OCB9]LJ:1;*?^6CZBDB@Y
M QMA#OTR1\I'&,=J[71_V>075_$'B$-&IR]MI-N06 /075UM(RO4+;DY.0V!
M@_ZGYC])WP2X:P<74X\R3$TL/2A"A@>'J=?.)^SI0C&G0P]'*</7H48QC%4Z
M<:M2A2@E%.4(H_EBCX7<:9G6:CD.-IRJ3<JE?,)0P<>:33G4J3Q52$YN[YI.
M$9SE>]I/0^7K>UN;RXBM+2WGNKJ=ML-O;1-/-,Q. (XHP6)]<# ZG KZ5\$_
ML]220?VW\1M170]+BB%P^EP7,45V(Q\V=1OG)ALH]N"T<?F3<[>#Q7T+X3\%
M>%_!\030M+AAN&7$NH3#[3J,_7E[N0-(B_[$?EHO9>IJO\0?".F^-],ATK5O
M$EYH5G!*UU+%;75I#'>,JDJ;V*Y(\^.'ED7.%.YOO8(_DWCSZ;>:<:YY@N$>
M",;C_##@_&XGV&=\>U,I?$'&<,O2;JU<FR/ RKT<NJU8I4:,H5<;CE4J4J\<
M7EWLZD3]*R;P.PF2X*MFV<T*'$N<4::J8+(88O\ L_)Y8B\5"&,QM90GB(P;
MYIJ4:-!QC*FZ6)<DUXOK/QI\%>!XFT7X4^&=.E:%7ADUN>%X[9V7Y0T3-F]U
M#)RS2S21QN0"HP01XWJOQD^)6KO(T_BF\M4?.V#34AL(H@2"5B\I/. R!C=,
M[#D;N:]9N/V:XKRW$OAKQQ87TIBWI%<P1M')G=M;SK*XF:.-L  F!^<L2!P/
MG_Q7X.\0^"M2.F>(=/DM)6!:VN%_>65[&.LEI<J/+E XWH#OC)PZ@U_17@;E
M7T2N(,=5P/"=?*./N/\ V<L5F^9^)F$QN;>(.:U:3Y\3F$H<9X"A6ER-N=;^
MPL)2PV'@U[:,7>3_ #+C?$^+&748ULVIXS(,AYXTL)AN&JU'"</X6+M&EAU+
M)J\H+F=HT_KU6=2I--0;TBKJ?$?Q^C!O^$R\0/@Y*2ZA)+&XZ%9(I T<B$<,
MCJRL."#7(W-Q-=W$]U<,'GN)7FF<(D8:1SEF"1JB+D]D55'8"H:*_KG*^&.&
MLCJUJ^2</9%DU;$4X4L15RK*,ORZK7I4Y.=.G6G@\/1E5A";<X1J.48R;E%)
MMM_DV*S+,L=&$,;F&.QD*4G*G#%XS$8F-.4DE*4(UJDXPDTDG**3:23=D%%%
M(2 "20  22>  !DDGL .2>PKW#B_#UT7S?0\U\;R@WUI"#S';,[+G@&20[3C
MU(4_A]:_L._X-:O$MK/\%/VI_"+:D'O]-^*WA37HM((?=;:=JOA%+3^T$;9Y
M>R\O=/GA9?,+A[3)0*03_&CK=[_:&IW5RIS&9"D7IY4?R+CD\'!8>QZ"OZXO
M^#6 DV_[8HSPE[\*,#TWVGBK=^?EK],''4UY/C#A%#PGS:G4NIT/[(K6LKJK
M+-\%S)W3M;VLD[6?2]F[_P #<?YI3SKB3B',J,E*A7S"<</-:J>'PTJ>$H5%
MOI4HT(5-/YNVA_7C1117\&GP 4444 %%%% !1110 4444 %%%% !1110 444
M4 !&00>AX-?P&_\ !P'^PF_[,O[48^/7@708K#X,_M*7-YK133+;R=.\+_%J
MUC6;QAHTD,,206,'B:-H_%6F*"D4UW<:U;VZ_P"C,B?WY5\D?MQ?LB^!/VWO
MV;?B#^S_ ..E2V3Q)8"_\)>(@A:Z\'>.M($EUX5\4V913)NT[4=J7L*<WFE7
M%_8\?:<C]$\,.-9\#\4X7,*LIO*\8E@,XI1N[X*M.+^L1@G[U7!55#$4TES2
MC&K1BTJTK[4*OLJBE]EZ27D^MNZW_#J?Y9U=UX,U'9--ITC?+,/.MP>@D7_6
M+G_:3# 9ZJ<5H?&3X0?$#X ?%3QW\%_BIH=QX>\?_#GQ!>^'?$6FSQLB/-:R
M'[)JFGNP"W6CZU9F#5-(OHMT%W874,T3LI->>6MQ):7$-S$2LD,BR*1['D'V
M894^H)K_ $&Q%.CF> ?L:E.M2Q-&%;#5Z<E.E44XJK0K4YQ;4J<TXR4HMJ4)
M:73/N>%L\J</9[EV;TVY4Z%:*Q,(M_OL%67L\53235VZ,I2IWT5:-.37NGT-
MIMY'I]];WLEC::D+9Q*EG?"1K.25>8VN(HV4SQHP#& LJ28VNVTD&_XA\2ZW
MXKU ZGKU^]]<^6(85VK#:V=NO"6MC:Q@0VEN@P%BB4#C+$GFN9LKJ.]M8+J(
MY2:,.!W4]&4^A5@01[5:K\KJY'E<LYHYY7R[#5,\P6$KY;A<QKTU5Q>!PE>H
MIXO#8*I4YOJ4,74A3>-^JJC+&>PP\<5*M'#8>-+^W\/FE>KEL<-AL9-Y7C94
M<>Z5&?+A\7)TD\-7JJ%E7]G3FWAW5<U156HZ2@ZM1R^G?!.K6_Q&^$^M?#"Z
MFC'BC0H'U+PNDS /J$%G(UY%#;%C\]Q;'S8#$I#F!XPJE5-?,6&!*NI1T9DD
M1AADD0E71AU#*P((/((JQ:7=WI]W;7]A<SV5]9RI/:W=M(T4]O,ARLD4B$,I
M!Z\X89# @D4M[>7&H7EU?W;K)=7D[W-S(D:1+)/*=TDGEQA44NV68* "Q)ZF
MO@>!O#Q\ \1\>ULGQ5*7"7&^>2XSIY/-3CB<AXNS"G3P_$OU-J+HULGSWZOA
M,TA2<J5;+LRACJ4(5\-C*+PGTN?\1QXARSA^&,HS6<9%@5DDL;%Q=+,,GPS=
M3*_;IM3AC,O]I6PKFE.&)PSH2DX5:,_:]!X)\37'@[Q5HOB*W=E6PNXQ>*IP
M)M/G817L,@Z,C0,S8/0H#@D8/Z0>,=%L_&O@K6-+CV3PZQI#7&GR@Y F\H7=
MA,K $@B14Y W<D#!/'Y;=>M?HK\!/$+Z[\.=($[F2ZT.:;19B6!=H[1@UJS<
MD@FV=%R?OE"1Q7\6?M N$<3E.'\-_''AY?5>(.#>(<'DV+QE%*-5TI5YYYPW
MBJDHI2<<MS? XNC!MZO-U!Z**7[=]'?.:6+J\2\"9C^]R_.LOK8ZC1F_=YU3
MC@,SI13ND\3@J]&;T5E@V]V?G6R/&SQ2J4EB=XI488*2Q,8Y$8=BKJRD=B"*
M9M7^ZOY#_"O1?BQHHT#XC>*["-!'!)J+:A;* 540Z@HN<+D#($CODCC)/T'G
MH!/09K_0/A7B/"<5<+<.<5X.488+B3(<HS[#>\DH4,WP&'Q].FY-I<U..(5.
M7]Z+1_/&;997RK-LSRBK&4Z^69AC,!4M%MRG@\14H2DDKNTG3YEY-,T=(UK6
M- NH[[0]3O=*NXW619;*XDARR]/,C5O*E7L4D1E*DC&#6CXI\1R>*]4_MJZL
M;:SU*YMH5U:2T CM]0U"+<LFI+ H"P274?E_:$7AID:0??P.=P?0_E2<]NO;
MZUI+(L@JYW1XH67X%9]A\%7RY9S1A&ECJF6XB5&I5P&*Q-%PGC,%[7#T*]/"
MXMUJ-#$4H5Z$*=9.;7UW,Z>!EE,JV)6 K5Z6(^HU.:5!8FFIPIUZ-*HG&C7Y
M*LZ<JM%0G.G-TZCE#W44N#Z'\JV=/TM[HJ2I.2/3\ .O.3_/CTZL>%I3&&\L
M].F.,8/OTXR>GMZ5\IGGB7D62XKZK7K4^?G4&Y34==/S_+8^IRO@3,LQP_UA
M*44XJ22BW;5;MK6RNM.OEJ>$>,[,36,=XH^>UD"MZF*8A?3G#A>XZD]J_L"_
MX->OC@^O_ W]H']GO4;TR7/PS^(.F>/O#MHYD9XO#GQ$T^2&^$99RB6\7B'0
M+SRXHU7#W$CN29%K^4+7]"+VEU;,G$L,B#/9@I*D9!Z,.,#KSP:_5;_@W6^,
M5S\+_P#@H;;_  ^N;IX=(^./PS\4^#KBV:]-I;3:]X7>'Q9H$TL)#17MS%#:
M:W:V=O)L=3J$SPOY@\MO2XDQF!XY\*N)(8.4:M;+*-/.,,DXN4%@JL,55E%N
M[N\/#&0TLW&I9/4_CWZ0?!N)X?S_  ^/G2M2S7"*,YI63QN7N-*HY=$Y86>&
M7]YPF^MS^_\ HHHK^+#^;PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHI&Z'Z&@#^(C_ (.5?VP?%OBO]H3P=^R!X9\0W^G_  _^%7AO
M0O'WCO2=/O)(+;7OB'XGC>_\/G5E@9!>1^&O#[6L^G6\YDCM-0O[JX5%G*LG
MX*:'XF^$OQ+6VTSXK6=QX-\6N$MH_B5X<118ZFVQ8HI_%NDD-$;K*@W&IP*G
MGN3)/ERS5]&?\%=?$,_B;_@I?^V1>3W]YJ/]F_%R^\-02WKR/);6OAW2]-TR
M'3K?S"2MC8^4T-DB_NEA \L!37YT(N]U3KO95P>AW$#G\Z_OC+?"_)\U\/\
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M+.&Z%J&98G(.!\!@:N33\0^'\/6>(S'*Z_$>7Y53G3AFV'R^OE<E3J_VME?
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M-JYME> RVGF.3YEEN&HT%D]3-*6:T_K&*H'VG"7 F1>(%+"\+9S6S?(L3D.
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M'/A*/6M;TZZN867PMK6GK);^*=(N[KS&C$>C:G:7L0N)'4M:1Q7$HC9V1?\
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M^647F6)HX+)Z>#P\H4_88;#YE3J5G5Q%2K5KU:M6I_09^WL?V3OVP=-TB_\
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MFN:$XVOS1DK=[IJQ^58:JZ&)P]=/E="O1K*5[<KI5(S4KV=K.*=[/T9[#\4
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MJ><O#9I2E)))RK4H4<39V2N\70Q$VE_.FW=GD5YX7EBCW>61A0?NX[GKW)'
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M3Q=#!Y'0KQ>DJ5'%UJF9NF[QK2RV-"I&5&I4B_#V8L2S')8DDGN3R37[Y_\
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MB(N&*P^0Y/F>'CQ+/%9A1E/#_P!IXW)\OP>'PM6=7 UL17J4Z^$_J1K^1/\
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MRA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML[.>"A4 D?,S*0  <]<CH.WKBO/M,&N1A8V\H(%&TW!#[<#@?*<GC'!SCCG
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MYNW;'GH#YLH:1^YRH P?<53B\=+,K?:M&LC"3M94?+E>^ \>W/;KS^E?,83
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MS)+24-/:-SN 9 ,N,==??LT_!R_F^TW_ (,>:0!5#OJVMHJJO10!>A5&<DX
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M[.4;[G\*XQVHV_FDE]UW^A^O-%%%?PV>4%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5YS\7?A/X"^.GPR\;_"#XH>'[3Q1X!^(7AZ_\,^*-#O5
MS%>:;J$>UFBD +VU[9S+#?:;?0[;BPU&VM;VV>.XMXG7T:BM*-:KAZM*O0J3
MHUZ%2%:C5IR<*E*K3DITZE.<6I0G"<5*,HM.,DFFF@3:=T[-:IK=/N?YA?\
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M%G&+'>(O%==-24<QCA;IIJ^!PN'P4EHWJI4&FKZ--/:Q_).-5L77C_+4<?\
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MO!W#[C%^]4P5#-Z-+/\ -HV4O?I9;@\+\,J>+K7<%^=GBSX:?$/P%-%;^-_
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M-8BA"M/DE"53G?+Q'XC>(O!?#ZHYOD."HX[-\)4RN6=Y=FCJ8*<YPC4E3Q6
MI4%)8B7LU7^K?6%@J\Z3E#FITIT5I:#KT^AR2".));6<@S6Y.P;ATDC8#Y)
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M2],M])LX[2#<>DDSL2?-G95#N ?N@X  '& *T>E>/B\UQ%7'2Q-"O5C3A/\
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MVU^MKZV['\KNUWRWY;NU[7M?2]M+VWMI<****8@HHHH **** "BBB@ HHHH
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MPOHNJ^(_$6J66BZ#H6GW>JZQJ^I7$=I8:;IMC ]S>7MW<S,L<-O;P1O++([
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M5*I*C5PU>"=H8C#5DO:4:BZKFC"I!VO"K3IS6L4>_P +YCALJX@RG'8ZG[7
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MTF\UB_C)$D=LF8K>$\B:[N&VP6L(!.7F=!@<9[^[Q_"OX>^%?^2G?$VQM[]
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M))4<94A.T^2;<;-FFX^3/3@?XXY_'ZYKZ,\/>*]-U+3+;2O$UNTWV=%CM[]
M7<!0%C,A!\V-U4!6D0MN4#>O&:^:-.F'RDD\$=/0]\=>O'T_*O0=+NE&.<8
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M7OAR+33Y($<1"E=N[)'<@9(X.,^WIFO ;+3KS7-3\RU+'=(2H4G&,]..F?\
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MM[+\(?VE_&^C7TP0V]A\0?"^B>)=*C=$PS276BMH.K-YSY)!F81#!C4X*O\
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M?AZ^+QM3ZI+$TI4*"E&7MDI)-U%!)SO?E:2C=)7E9.)W<?9W7XUSK*>&N$,
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MIXA*@XK#?V?+%0Q$JU*=.JTXQG>LO&FF2VT9O?/M[E442!())HY"HP7C9%;
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MIIVGVT%E86%M!965G;1I#;VMI:Q)!;6T$,85(H8(8TBBC10J1HJJ  !5JO\
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M1V-]H]Q/;QO-<6U^L'E2%8BG\_MW&8KF9#VD8CZ,=P].QKZ#_9$^(.H_"O\
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MNXN2?\2\<9^X4<13I59*6)BZ#49-*<7*%1J:BUS1A*$)VE=*<8-*ZBU^C:
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M>@].]?''@SP'<WUPL81O-<DY .=Q/'&._;CCC&3G/HWB+PUJGA>++&2-@@(
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M +*P-*A@L.L3!N+HU,/12J5::DG[M:=5:)JS5SY6\8Z7#I%PQ9DB42>62Y5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7E7Q5^!GP;^..A3>&OC!\,/ _Q)
MT.=)(VL/&'AO2];2,2IY4C6LM[;2W%G*T?R>=:2PS!0 L@P,>JT5I2JU:-2-
M6C4J4JL&I0J4IRIU(26THS@U*+71IIE0G.G)3ISE3G%WC.$G&47W4HM-/S3/
MY^/V@_\ @W*_8C^*1U#5OA%J?C_]GOQ%=-+-%:^&=6'BCP,LTCRRG/A;Q*+B
M\MD=VCB$>FZ_9VEO;)Y=O9*V#7Y&_&+_ (-Y/VSOAVMS-\)O$/PR^-6A6<)>
MVM;75)? GBAX88O,D4Z9KR2:3+-P8X8K7699KJ485$+H#_;S17W67>)?%^7Q
MI4YYE_:5"DVX4<TIK%6O9.]>]/%O2*2OB&DKV6KO^A\(^*/%G!M:O5RW$87%
M1Q4:4,13S/"QQ;J0HN4H16(4J6,IQ3G)M4\3",GRN<9<D.7_ #*/C;^Q!^UU
M\*=-U6V^)7[,_P 8="6S5V%_#X,U+7=,62-CY<T6I^'X]4M/)F"LT,AD59XP
M<#Y2%^!(HM>LI6L6M]:TJ5SB6"_LM2TCR\D@O,+Z"U6!>#^\DV XP&)XK_70
M=$D5DD19$8%61U#*RD8*LK @@C@@@@C@UPNM_"SX9>)5D3Q%\._ VO+-!%:R
MKK/A/0=3$EM#CR;=Q>V$VZ"+ \N(YC3 VJ*_5,B^D+4R["3PN/X7HXJ4IJ<:
MF'S&5*E&:BE?ZM7PF(=KQ4K?6$V[KF3?,=7%/B36XOSO+,XS#+5EE3"8:&"Q
ML\DQ=2ABL7A_K$ZM1TZ]>-5T9^RJ3I4E4]O"%[SYXOD7^4GHN@Z8LC3ZQJ.G
M7<SL!%;1:A#+N9NK2LLFZ60M\J(NX,3GYB0!W4/P@\4^-MUK\/?A]XU\2ZTJ
MM)!IWA3PEXBUV:Z$8!DB6'3]/N%\P+AN""N?F 4\?Z@T7[-_[/,$B30? GX.
MPRQNLD<D7PT\&1R(Z,'1U=-%#*RL P((((S7INE^&?#FAHD>B^']$TA(C(T:
M:7I5C8+&TP42E%M8(@IE"J)"H!<*H;( QMB/I$5G6CB:&1XAU(N+5*IFD:6&
MM&WN>RIX2=X25U*_O.]^:]FO?J^(W M'A[$9#@/#U3=>C7BLRS',<+7S*.)J
MJ3IXQXV&6?6)5:$Y*4(TYT::C!4U%0E)/_.O_9D_X(?_ /!0K]H34]'U"[^$
M/_"F?!,]QIMQ=^+/C%>Q>'6&F73"7[7IOA> W7B'5L0JS&%+2WV.4CG:(2!J
M_H_^#7_!N7^S5X<\(WL'QM^)'Q ^)7CG4M-GMUU/PW=0>#?#GAR_ECVQ7>CZ
M9'#>WFHM:28=&U:Z,4X_=RV:@!J_HLHKX'BGQGXRXEJP=.MA\DP].ZIT,KA*
M-1IR4OWN*KSK5Y2NDI>R="$DK2IM;_GN4\;\39#A,5@LDS.IE5'&UZ-?$SP=
M.E#$U9X>,HTH_6I0EB(4H<TG[*G4A"3E+F4E)I_Y=_[=7[/?B?\ 9*^//Q _
M9S\8N][J_@OQ"LVBZR;?[.GB;P=J,!O/#'B:"$9")J^FW$)GBC9E@OX;NWX\
MK ^>_"":E9VTEK>:?<16\DAG@G90"I9?F1HR=^U\ JV!@Y4]17]R'_!=#_@F
MZW[3WP[TK]ISX4^''U;XZ? [1;N#5=$TZU>XU'XA?#%99;^]TNVM8%9[[7_"
M=U)<ZYH4.UI+JUFU>PCWW$MC%7\4>XL23N#!F5E8%71U)5T=6 9'1@5=& 9&
M!5@""*_HS@OC;"<4<(X*-.,9XZE%4\YC-\LZ&8P=W4HTX-*-&O"*K49.\'&<
MZ+3G3J']->&2Q''6;3\1,9FU/"YI@Z>'R6KE67PHN,Z=#!4:=>MF2KTYR5/,
M:G/B</3H1I^RE&U/$7H\D,*^\2:1I\ZVUQ-*9<XD$<+D0CCE\XSR<83<001]
M%E\3:'#"9Q?QS8&Y88@6F<C^$(1P>F=V,9YJQJNCV>L0&*X3$ZJ1;W*C][&Y
M' )_CC) !1LCN,5XF;67[6UDHWS"X-L .C2"0Q\>Q8=>PY-?>9;E^79A2NYX
MBE5H6>(BYP<9Q=VIPE[-<L79IK>-M;Z3??Q[QQQWP3F"A'"Y%F.6YNZD,EQ$
M,'C88G#5J2I1GA\11CCYJK7BZL)PUG3Q#DY0]FHRP\)[S4);K4;C44+0RS3M
M,I1BK)D_+AEQR !G'7FMB'QAKD*!/M*2@8 :6%6? &.6&TGZG)]Z[:R\'Z3!
M;JEW$UU<E<32^:\:!CR1$JGY=I. 3DD#GFHCX(T<N[&:\56.4177]V/0LP)?
MU!)SZUZ$\VR6HE2JX>52%%1A2E/#QFG&-HI4VY.<4EK[RC=)WUT?PV$\-/%G
M 2GF679O2P6,S6K/%YC1PN=XC!U8UZ[E7G+&PA1IX2I5YYRC+V$ZZA4=H-07
M.N2@U74O$.HV-A>W!-K-<QB6")1'&Z EF#@<N"!C#,>":]="K&JQQJ(XXP$1
M$&U45> H ]/U/->/ZCIT_A;5;2XBD\V$2+/;RE<$JC 21R#IO53@] V00!@U
M],_#/X9?$;XT^(K'PG\(_ OBGXC^)=2"-::+X0T>[UF[*R;?WD[6T;6]G;QL
MX$MU>S6]M$"#+*H.:\K/YX>%+"8FC*C1R_V-2<9>[1HTY*2=6=7FY80?+R<T
MIM-<LK[-O[WPEQ&-PE;C+"\58FO_ *S9=C<&\RQ.:8I5JD,L^JMX11Q=6K./
MU.G56)K)TYK#J.(HU(MJI&WD/B:Z_LZ*QU2,*;JVO%C0'K-;RJ1/ W<H0 W0
M[6 85^B'_!/']@3XR?\ !0OQU;V7@G1]6\)_"#0M1M8_B/\ &#5;'R]!T6V+
M%KK2/"\DY2+Q/XIGCCDA@LK$S0:<SI=:F\<4;1O^R?[%W_!NO>>)YO#OQ"_;
MGUD6.D6K6NKV7P+\%ZFWV^\D813"R^(?BN! D-J4+17N@>'6$ID5HKG67A:2
MV/\ 5=\//AQX"^$W@_1/ 'PS\(>'_ O@KPY9Q6&A^&?#&F6VDZ1IMK$BHD=O
M:6L<:;BJCS)7WS2L-\LCN2Q_".-/%_)L!E[RSAM?VGG:=6G+-/\ F6X"$I72
MHIW68UH^]*G91PM.<W*52O%.C+\YXX\8<QR;BK.J?!N8Y;B\MQ>'P<*M94/K
M=".8TL+'#U\9AZDU3A+%1C"E0<Z<L3@ZM/#X>3]I-2C'SW]G#]G#X4?LJ?"?
MPW\'/@[X<M_#_A3P];CS) JR:KK^K2JIU'Q#X@O]HFU/6=3G!GN[J=F(RL,(
MC@BBC3W:BBOY?Q&(KXNO5Q.)JU*^(KU)5:U:K)SJ5:DVY3G.<FW*4FVVVS^=
M,5BL3CL37QF,KU<3BL35G6Q&(KSE4K5JM23E.I4G)N4I2DVVV_P"BBBL3G"B
MBB@ HHHH **** "BBB@ HHHH **** "OG7]KCQQ/\./V9OC?XTM9!%=:+\.O
M$<EM(9A 4N+NR>PB:.9@0DRM=!H#C/G! I4D,/HJL;Q#X>T+Q9HNI>'/$VDZ
M?KV@ZQ:O9:IH^JVL5[I^H6DF/,M[NUG5X9X7P-R2*RG R*\W.,+BL=E&:X'!
M8B.%QF,R['87"8J<92AAL3B,-5HT*\HQM*4:-6<:C4?>:C9:GM\,YA@<IXCX
M?S7-,)/,,MRS.\JS#,,!2E"%3&X'!8^AB<7@Z<ZB<(3Q.'I5*,937+%S3EHF
M?P06TD;QJJ3I.Z*JRNLBR,9,9=I"K,=[MEF+'<6))R3FOWE_X(K_  6FNM:^
M)GQ]U2S*VEC;P_#OPC<R94RW,ICU+Q1<P*T9#Q(ATRQ,JRIMECFCVR#<4_4/
MXZ?L$?LW_'#P3-X4N? .@^!M6MK*.V\-^-/!&C:9H_B'PW) Q>%[=X;9;:_M
MF)*7=EJ45Q!=Q-B3$B0RQ^Z_ OX,>$/V?OA9X2^$_@B.8:'X5L!;"\N_*.H:
MO?S.UQJ6LZD\*1QR7^I7DDMS.4140NL42K%&BC^5/#;Z/.=<'^(.7YUG6-R[
M,\FR;"5,=@L3A'4A.OF\XRPU"A5P==.K26$52IC%74YTY3AAE"7/*K"E_H3X
MX_30X7\2?!O..%N%\JSO(N)N)LPHY3FN!S%4JM+"<-TIT\=B\9A\RPKC0Q$L
MRG1HY8\(Z5&K3HU<<ZD'2C0JXCUNBBBOZ]/\VS^2[_@X'\5SWW[1?P0\'O#Y
M=KX:^$^JZU#.)I&^T3>*/$[V\Z& J(HC;IX=@Q*C,\PEVR;5ACS^(FALNTL3
MS\BY! ]V].F.V1R*_73_ (+Z6\UK^V9X*N9+@RQ7_P $/#\EO"=V+46WB7Q+
M;R*NXE#YLBF4^6%&3A@6R:_'G1IP+=2,<NQZ]><#'H#W![\GH:_!_$+!U*V*
MQD[/WZB2::UC&$$EZ6@E;2R^9_LO]&&-"EX:<"4:;CRT\AGB6H\W\6OBZ]6M
MH[N_M\3-R^SS*3BE'E1ZCI\X!7G'IT].<'KG'I^''-=;;7RJN-W5?4?0\\\9
M.1Z'UKS&VN\ <CH>O!'Y<\GTXY)] -B._./O#.![8_\ U]^.U?S'GO#4\35;
ME%M)]5V:_'UWMH[ZG]<8;&1C%:VT7;R^>J5M_P +'67UXLBD$]F&<CW['D^O
M&*\^U&?87()SD!3GGCHP^I&1ZUHSWQ((R.A!Z>^>??U]L&N5U6X &_/'1_Z$
M_7./7@=ANKT>&>'Y8>I"'*TFTEIUNG9:V\K:=D]3R<^Q'/AI5HM\U+635U[N
MGO+SC*TK[)<S['0>%[H2W-[&Q 811N1P WSLI;VQT_R:\_OKJ6PU2XN;8A);
M>\F9??;(P*-_LLI8$'H#GC&:ZSP5F2;4[HG"(D,62#G/S2'&,\@8R!SW/OYI
M?7ZWDUW*N%8W$Y9<YQF4GC."5(QR0,#((K]*X.RN%;C+BO#NE&MA5E^38;&4
MY14J4GB,,^:E.#2NI4E.#3YK)N+=I)'F5\R?^K^0RJU>3%UJ^85,-*_+4G#"
MUHQ<XM+XH-P;U3>LK>[)KT;Q'!#XF\,#4+09FMHS=Q <NK(,75L<<@[02.N2
MJ>I-?/%R0<X/7I^GU]#^5>W?#^_,DVH:5(VZ-X_M,:DC&?\ 4S  GD,C+N&,
M#!)')->*ZS%]EO[^W[07EQ$IQ@;4E8#CL,'N>,8]J_7?!S#5\ASSBK@BI.=3
M"91B<%F^32J-N4<MSF,YRH<VS5"M32D]'*O/$32L['D\7U(8_ 95G2C&-;%T
MZN$QB5DGB<&X1Y[7WG"4FNBA&G'2UCG9C@G\_P A_P#7K&GZ?0,/SR1^E:DQ
MR6/T'Y__ %CBL>=LD_4#WQU'M7]BY%3:Y&^T='M>T7KKK9;_ -(_&\PGN[K9
MK\4[?CZWLM=;8NHVT=Y;3V\H!5T."1G:X7*L.X*G!XKQ&X&UBO4JQ4_52P/\
MJ]OO)TM[:XN'("QQ.Y'J<'"CIR20/_KUX=</N9W(Y9F<@=!G)(_#.*_?^"H3
MY*R=_9J5+E\IOXK>=E"]M]+G\A>/WU.-?))14?KTJ&-C6:5IO"PGA_JZF[7:
M5:6)5.^S=2VESO?@Q\&_'W[0OQ<\ ?!+X7:6-7\>?$KQ%9^&_#ULY9;2WEN6
M:2[U74IE!^SZ3HUA'<:GJ5P1A+6V=5S(Z _Z8?["/[%WPV_80_9X\)_ SX>Q
MI?75E'_;'COQC/;0P:MX[\<ZA#$=<\1ZD\:AQ%),@M=)LGDE32])@M+")V6$
MN_\ )S_P;,_!"/QI^UE\6_CAJ-GYUA\&OAC'X?T.YDB5HXO%/Q"U!89S&SJ1
MYL?A[3+OYX\21>>%+*)L-_<?7Y!X^\68O$9KA>#\/6=/+LMP^&QN/I0=GB<Q
MQ,'4HJM:UZ>%PDZ4J4-E5Q%6<DW&FX?Q5G==SQ4J:TC!)NSWE))J_=):KS;\
M@HHHK^=CQ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *R/$&M6?AS0=;\0Z@ZQV&A:3J.L7KLZHJ6NF6<U[<,78A5 BA?YF.!U/%
M:]?!?_!2[XO6WP9_8V^,GB.2Z6UNM2\.3Z!9N91&Q?5"L$L84J?-6Z1AISQ
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M8A+GSW+\TJ-\S;O@Z^#NG?M];U?6]KOE3?14445\,?SJ%%%% !1110 4444
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MXL^)?@%-9W-FHO;*]AM/!M[XCU/-Z^YHE\R*%HIL^;*ZM&6^:0'^'BOZMO\
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M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY[?4#;RAP2RXVNI_B4GDCT/4CJ> <#)KV+XJ73O!I^DVK@"+==R1DX#*J^3
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M%Q#IU93HM1EJG[LI12E==8MKU:/O\QR"MDV54ZE&M=3IKDBIZI-)6>EU\_\
M.WF<E_<WK%2S-_#@\=>!S]#G\>!QFF_V#/,I=D8EN3P<9/TZ#IGU/Z[.B64<
MMT 0,;AU'K[^OY5]':+X)@O-.DG 4".,$\ =!U&<<8X[^U?H?''BUEWAHL-[
M""PT*LJ=-RA'EM.<HQ2T5M6[7?5_,^8RKA.KQ%[6.(?M%&[2D^9O1?$]-$FE
MHGWN?(%[I4ML#E-I';&!GGC)Y['.<=..V?/=9(M=1LKD@C>C1,?]I&W =>NU
ML_YY^H_&.CQ6CRJ@ QN[8R<'([9Y'T%?,GCN$I9I-']ZVNXV#=PK@HV.?XN
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M"BBBI("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/!]WI5BEQ/ & 3<#LV.0!U'&&(Y()![D^H\V/B.WTV4J\KP,I/#?=R#QAER
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M1^S[\._''AOQSK?Q"\6:9-IEKXF7PMJUKJ\.@^"[#48XKCQ#/J=Q9QV4]]#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"2-M88DV[3GG_09'0?2OY0/^#>W]@CXL>%O%OBG]M+XY^"=9\"VM[X1D\$_
MSP]XLTTZ;XCO[#79X;KQ3X]ETB_@&HZ+8WEI:VNB:*UQ'97FH6ESJ4Q3[&T?
MG_U?U_)&+X3RG@'#8+@S)YT*E'*7B<3CWAIQJ48YKF$X/$483@Y0;P^$P^ P
M]91;5/$TJU)VE!GXKX[^)$_$_CRMGJJ.IA<%EV#RC!S=_P!Y3PTJV(K5$GK:
M6*Q5=1;NW",7>S211117G'XR%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M00S(ZR022(=U>Y5^$W_!N]<0VG_!,OPQ=7#B."V^*/Q9N)Y""0D,.I6<DCD
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M6$/:X>LHR=*M3YJ=2SY9.S!IJUTU=)JZ:NGLU?=/H]F%%%%<@@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\HKG_
M (*R_"JV_P""@</_  3W;X8^/6\?S>(X?#8\<K>:%_PBBW,WA(>+A<FU-S_:
MOV869%L2(M_VCG;MK]7:_C"U/_E9KLO^RGV/_JDXZ_1_#KAS*N(GQBLUHU*W
M]C\%9UG6 ]G7JT/9YA@GAEAZD_9RC[6$?:RYJ4[PE]I.R-Z$(S=3F5^6E.:U
M:]Y6L]/78_L]HHKQ[]H/XIR? _X'?%CXPPZ,/$,OPT\!>)?&B:$UU]A75F\/
MZ9<:B+ WGER_9A<^1Y1F\M_+W;MIQBOS[#T*N*Q%#"T(\];$UJ5"C!RC%2JU
MIQITXN4FHQYIR2YI-15[MI79BDVTEJVTDO-['L-%?EQ_P2T_X*,77_!1SX;_
M !/\?77PRMOAF?AWXYL/!J6-MX@EU]-4^V:#;ZRUX99K#3WMC$9Q!Y7ER*X&
M\/G*C8_X*@?\%!+K_@G9\'O!7Q4MOAO!\2SXM\>)X+?2[C77T&/3U?1-2U<7
MYGBLKZ2<DZ?]G$*Q+@RARX537T$N#^(8\3K@YX&/^L+Q,,(L"L5A''ZQ.@L1
M&G]:5?ZIK2DI<WM^1/W7+FNBO9S]I[.WOW2M=;M7WO;;S/TOHK\^+_\ ;BN;
M+_@F_P#\-[GX?1&Y_P"%%6?QE;X<G6SY2M=003G1#KBVK$K&)O\ CZ6T)8+Q
M%DXK\T7_ .#@_P  2_ #X:>*= ^"FM^//VF/BQ>>(8O#O[/_ (#U2X\1-H^F
M:-JUQI=IK/B;5['39]2MCK MI;K2]#LM&NM6N[:*:X=+2VB:8]F6\ <6YQ'$
MRRW*9XM8/.*F18IT\1A$L/F-&C5Q%:%9SKQC3P]&C1J3JXV;6#@HI2KIRBI5
M&A5E?EC>TW!ZK225W?79+5O;S/Z-:*_EB^$?_!Q-X\L?C_X3^$/[77[*LGP,
MT7Q/JNE:3>:O#=^*+/Q#X737KEK+2]>U'0/%NFZ>U[H"W;Q?;KFWD@:&TCO;
MJ W#6S0'^CCX[?'[X5?LW?"/Q5\</BWXIM/#GP\\(Z6-3O\ 51B[GU!I]JZ;
MI>A6D+>9J^L:U<20VFD6%J2]W/,AWQP"2:///^!>*.&L;EN S3+)+$9Q%/*E
M@J^'S&GF#E4A25/"U<#5Q$*M7VE2G'V47[3][3:BXU(.2G2J0<8RCK.W+9IW
MN[*S5]=OO7<]EHK^4FR_X.&?VCOBYXK\3R?LP_L$Z]\3?ASX<N;AI=4\WQGK
MFOQZ9;2,_P!HU;_A$=#OM'TN^N;$Q7,>G">[DC+D+)=(A8^G?$O_ (./_AOX
M:^$WP]\5^$O@EJEW\5;_ ,5:]X/^+?P<\9:Y<>&M>^'6I:-9:?<6M]93G2I7
MUO2=9FN+VU@GGM-,N-.O+"?3]3MX;I"&^AGX.>(<*N&H+(X5*^(G&$J%',\J
MJU<'*=&=>FLQA3QDG@(U(0E&%3%>RISJ\M&,W5J4X2OZM6NERJ[MHI1;5]N;
M73Y^G8_IHHK%\-:N=?\ #F@:\8/LQUO1=*U<VP?S!;G4K&"\,'F8&_RC-Y>_
M W;=V!G%;5?F4HN$I1DK2C)QDNSBVFOO1@%%%%2 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R66."*2:9UBBAC>6
M61R%2..-2[N['A51068G@ $FOB*Y_P""EW_!/FSN)[2Z_;._9MM[FVFD@N+>
M;XM^#HY89H7,<L4D;:H&1T=2K*0"""*^R?$'_(!UO_L$:E_Z135_!%_P1Q_8
M)_9\_;S_ &@_VH/"G[0.G^+-0TKP%HUEX@\.KX5\3S^&I8M0U/QAJ.FWANY(
M+6Y:ZB:VCC$49\L1.&;YMWR_IG W"/#V>Y+Q;GW$>89M@<#PQ3RFI-930PN(
MQ%:.98C$89_N\4X1DX5*=)I*I#W93;;:2>]*E"<*DYRE%0Y?A2;=[]_D?V)V
M_P#P4O\ ^">]U/!:V_[:'[-DUQ<S16\$,?Q=\&L\LTSK'%&@_M7EG=E51W)
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M/PSI.L7JM]BL[B?S)+=(<1E?,WE5/\BG_!"S]N+]EG]E;QI^UIJGQX^*FG^
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MD%S:IJ6B:S9Q7^FWJVU[#;W< N;6>*417,$,\>[;)&C@J.JKY$\._%K]F_\
M9@_8]^'GQ&F^(/\ 9W[-W@;X;_#^Q\-^/]7@U349+KPE>VND:'X0U"ZBL]-;
M4[BXU;[7IJ9738Y&FN0SP1+N"\OXW_X*1_L5_#OX*>#OV@?%?QV\+Z?\-OB)
M9W=]X!NS%J;^(/&4%CJ%[I5T^@^$?L*^)KE(-0TZ]MIKB73(+2%X&,UQ&A5C
M\#_8&:XNO4_LO*,XQ>%J9I7RO!SCE^)J5*N*IJ56.!G[*BX_VA'#)5:V%BE5
MA%2FZ<8)M8\DF_=C)IR<5HV[[\NB^)+=;^1]QT5^</[-/_!6+]AG]K'Q_;_"
MWX1_%Y9O'VH023:)X;\5:#J_A.[\0F")I[BVT*75[>*SU&_@A1Y6TZ.X%]+&
MDCVUO.L4I3]$=2U/3M&T^^U?6+^RTK2M,M9[[4=2U&ZALK"PLK6-IKF[O+RY
M>.WMK:WB1Y9IYI$BBC5G=E4$URYGDV;Y-BHX'-\LQ^68R4(5(87'86OA:\Z=
M1M0G"E6A"<X3DG&,HIIR4HIW32)1E%VE%Q>CLTT]=M&7:*_(WQ]_P7)_X)M?
M#[Q3J'A.[^.<WB:\TN9K:\U/P3X1\1^)_#PN8Y/*G@MM;LK);&^,$@97FL9+
MFU;:QBN)0,U]Z?L]?M2? ']JKP@?&_P"^)_AGXCZ% T<.I#1[IDU;0[J52RV
M>OZ'>1VVKZ-=$JZHE_9PI.8Y&MGFC4O79F'"W$V58.GF&9\/YSE^!J\GL\9C
M,MQF&PTG42=->VK4803FFG!.2<D_=3'*G4BN:4)QCW<6E][5NI[]17SM^T9^
MUC^SS^R;X6M?&'[0/Q1\.?#G2=1FDM='AU26>YUG7;J)0TMOH>@Z;!>:QJC0
MAD-Q+:V;V]H'1KN:!'5C\*> _P#@N9_P37\?>([/PU;_ !TF\,7-^4CMM2\;
M>#_$OAK03/*ZI%!/K-U826=F\CL )+Q[>V4G]Y.F1EY?PIQ/FN#GF.6</9UF
M& I\ZGC,'EF,Q.&3I_Q$JU*C.G)T_MJ,FX?:2!4ZDE>,)R7=1;6GFD?KI16;
MHVM:/XBTK3]=\/ZKIVN:)J]I#?Z5K&D7MMJ6EZE8W*"2WO+"_LY9K6[M9XV#
MQ3V\LD4BD,C$'-:5>"TXMQDG&46U*+3333LTT]4T]&GJF0%%%%( HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2P];VSJ2<9*;E%Q2<;:W.V<J2I4/:4W-\CLU-QLK[:)_>?R??\$S_@Q\??\
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MWC*T\(Z]\9+6WE\):;X]/C.];7A#<^((FT;2YKS04M8O!U_J*Q60T(+;:3-
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M]M-M.I^@_P#P4QN_^"*_[1O[/?C_ %OX/?%3]G7P3^T9X/\ #=UK_P ,]?\
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M++9^)OB3+>+H.BZEJ_V2.33/#"QM='3[:X%N)6#"+S2AD*/L#;'Q]M_MS?\
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M=<;\.E9?A]X$5E967P;X85E8%65AHEB"K*0"K @@@@$$8(S795_+&(_WBO\
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ME*26RDTO1,\\****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MANTU#5]4ALI=5OI]2U!Q?:[J&J:I.US?7,]PYN;V8AI"J;4"J-SXH?"[X?\
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MDIQ4I,TIU(4X3:YO:RBX)Z<L8NVO>_RZ=#ZJHHHK\Q, HHHH **** "BBB@
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M/J1V\$5K!#;0+LAMXHX(4!)"11(L<:Y8DG:B@9))..234M%%?DV^YSA1110
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MU2&QDU?4;K5]2<7VO:AJNJ3M=:C>7-TYN;Z8J\I6/9&%1?'_ -HO]A#]D_\
M:S\3^$?&7[0GPATWXC>)? EC+IGA35+WQ#XQT:32;";4%U26V2#PUXBT6UNH
MWOT6X/VZ"Y;<-@81DI7UU14T<WS7#X^>:X?,\PH9G5G6J5,QHXW$TL?4GB5)
M8B<\9"K'$3G74YJM*51NJIR4W+F=SFDFY*4E)WO*[N[[W=[Z]>Y%;P16L$%M
M @C@MX8X(8P20D4*+'&@+$L0J*%RQ).,DD\U+117G[[DA1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBL_5-6TO0[&XU36M2T_2-,M$,EUJ.J7EMI]C;1@9,
MEQ=W<D-O"@ )+R2*H Y--)R:C%.4FTDDFVV]DDM6WT2 T**_,KXV_P#!8?\
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MP3_\F4?\0<\3/^B3QO\ X4Y;_P#-OFOO#ZM7_P"?;^^/^9_4717\NG_$4?\
MLZ_]&S_&7_PHO!/_ ,F4?\11_P"SK_T;/\9?_"B\$_\ R91_Q!SQ,_Z)/&_^
M%.6__-OFOO#ZM7_Y]O[X_P"9_4717\NG_$4?^SK_ -&S_&7_ ,*+P3_\F4?\
M11_[.O\ T;/\9?\ PHO!/_R91_Q!SQ,_Z)/&_P#A3EO_ ,V^:^\/JU?_ )]O
M[X_YG]1=%?RZ?\11_P"SK_T;/\9?_"B\$_\ R91_Q%'_ +.O_1L_QE_\*+P3
M_P#)E'_$'/$S_HD\;_X4Y;_\V^:^\/JU?_GV_OC_ )G]1=%?RZ?\11_[.O\
MT;/\9?\ PHO!/_R91_Q%'_LZ_P#1L_QE_P#"B\$__)E'_$'/$S_HD\;_ .%.
M6_\ S;YK[P^K5_\ GV_OC_F?U%T5_+I_Q%'_ +.O_1L_QE_\*+P3_P#)E'_$
M4?\ LZ_]&S_&7_PHO!/_ ,F4?\0<\3/^B3QO_A3EO_S;YK[P^K5_^?;^^/\
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M9?\ PHO!/_R91_Q%'_LZ_P#1L_QE_P#"B\$__)E'_$'/$S_HD\;_ .%.6_\
MS;YK[P^K5_\ GV_OC_F?U%T5_+I_Q%'_ +.O_1L_QE_\*+P3_P#)E'_$4?\
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M_P"%.6__ #;YK[P^K5_^?;^^/^9_4717\NG_ !%'_LZ_]&S_ !E_\*+P3_\
M)E'_ !%'_LZ_]&S_ !E_\*+P3_\ )E'_ !!SQ,_Z)/&_^%.6_P#S;YK[P^K5
M_P#GV_OC_F?U%T5_+I_Q%'_LZ_\ 1L_QE_\ "B\$_P#R91_Q%'_LZ_\ 1L_Q
ME_\ "B\$_P#R91_Q!SQ,_P"B3QO_ (4Y;_\ -OFOO#ZM7_Y]O[X_YG]1=%?R
MZ?\ $4?^SK_T;/\ &7_PHO!/_P F4?\ $4?^SK_T;/\ &7_PHO!/_P F4?\
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M?;^^/_R1_4717\NG_$4?^SK_ -&S_&7_ ,*+P3_\F4?\11_[.O\ T;/\9?\
MPHO!/_R91_Q!SQ,_Z)/&_P#A3EO_ ,V^:^\/JU?_ )]O[X_YG]1=%?RZ?\11
M_P"SK_T;/\9?_"B\$_\ R91_Q%'_ +.O_1L_QE_\*+P3_P#)E'_$'/$S_HD\
M;_X4Y;_\V^:^\/JU?_GV_OC_ )G]1=%?RZ?\11_[.O\ T;/\9?\ PHO!/_R9
M1_Q%'_LZ_P#1L_QE_P#"B\$__)E'_$'/$S_HD\;_ .%.6_\ S;YK[P^K5_\
MGV_OC_F?U%T5_+I_Q%'_ +.O_1L_QE_\*+P3_P#)E'_$4?\ LZ_]&S_&7_PH
MO!/_ ,F4?\0<\3/^B3QO_A3EO_S;YK[P^K5_^?;^^/\ F?U%T5_+I_Q%'_LZ
M_P#1L_QE_P#"B\$__)E'_$4?^SK_ -&S_&7_ ,*+P3_\F4?\0<\3/^B3QO\
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M9?\ PHO!/_R91_Q%'_LZ_P#1L_QE_P#"B\$__)E'_$'/$S_HD\;_ .%.6_\
MS;YK[P^K5_\ GV_OC_F?U%T5_+I_Q%'_ +.O_1L_QE_\*+P3_P#)E'_$4?\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D)"@LQ 4
MDDD   9))/  '))X I))$B1Y972..-&DDDD8(D:("SN[L0JHJ@LS,0% )) %
M?QA?\%F/^"W6L>-=4\5?LJ_L>^*[K1_ EBVH>&_BI\7M$E>UU3QG>1R-::GX
M9\$ZE'MN=.\+6YCFM-0UZS:&\\0,TL>GSPZ2JSZC]EP1P/G7'>;QRO*:<84Z
M48U<PS"LI?5,NPSER^UK2BFY5)M..'P\/WE>HFH\M.%6K3UI4IU9<L>FLF]H
MKS\^R6K]$VOU _X**?\ !>WX#_LHW'B'X5_ >VL/CQ\=-/\ .T^\N+.^1OA?
MX'U)0R.NNZ[83-/XDU6QE!2?P_H+QQQ2YCO]:LI8WMG_ (Z?VJ/^"B'[7'[8
MNLSW_P :OB]XCU70S=37&F^!=&NI?#_@/1A,JQF+3_"^F20Z<?W2(C7%\E]>
MR;2TMW(237Q*S,[%F)9B<DDY)/UI*_NG@OPOX4X)HTI8' T\;FL8IUL[Q].%
M;'2J6M)X;F4J> I-W4:6%49<MHUJU>2<WZM*A3I+W5>5K.3W?>W9>2^;8K,S
M'+$L>F223@=!SV'8=J2BBOT5MO5N[[LV"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ5)2]JC25*"CU>LGW?\ DME_P0HHHK[DU"BBB@ HHHH **** "BBB@ HHHH
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M<:4ZML3C:V"IX7#.<*<E25>M3=6=J=/FG*,7G"O3J.T&V_\ #)+YNUE\WJ?
M-%%%?>&P4444 %%?IM_P38_8/^#O[<'C75O#_P 5_P!KKP#^SE'I&JV6G:=X
M0U?^SU^(7Q!6]M4G%SX,D\17>G^&1;PW<D>ER17%Q=:K/>.4LM/EP'K]1/\
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M*+4HR2E&2::<6KIIK1IIIIK1IW1L%%%%, HHHH **** "BBB@ HHHH ****
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M[IWO;$TZ+VZ=-UOAH\U:%^C<O_ 4VOQL?RL4445_H<>R%%%% !1110 4444
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MDU=77,K*W6]GI:VKW_@2I%S)-#;1+)-=7#!+>TMXY+B[N') "6]K LEQ.Y)
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M1C:K",(UJ-25&M",_9TIJI1JPG3BE"52J56-5/1QE%VE![I_Y=.FJ:/]!/\
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M&"L<[6(R <]<=Z_ OHZ*W"&=)62_ULQZ[))8#*[;=%^'0X\#_"E_U\?_ *3
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MC=--NHY*[U=O=M?LNR1\!DA068A5 )))   ZDD\ #N36EIVC:[K$;SZ-X?\
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ME:QS75PY)'RQ1.1U.!S5K5=+U30M0N-)UW2]3T75[29+>ZTC5M/N]/U6VN)
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M54F@D'>.:-''=:6O[_OBC^QK_P $^_\ @M?^RY:?'/X':9X7\"?$S5]-O?\
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M0K*K&STJ1TG%Z.ZT;2[7^:>CZ-_IM_P1)_9'C_:Q_;N\ +XAL6N?AI\#HO\
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M1C%K>ZWDTKJSO;;35'^?C\:P%^-GQH"@*!\7/B0 J@*H'_"8:Q@    #L
M.!7]+/\ P:P?\EI_:[_[)O\ #K_U(M3K^=[]I7X9_$CP/\;/CC)XR\ >,_"U
MM:?&CX@:?/?:[X;U;3--6^O/%&LW=E:IJ5U:1V,TU[:*UU9QQ7#M<VR/-"'C
M1F']$/\ P:N@R?&7]KR9%=X!\._AU"9U1S!YP\0ZFQA\\+Y1F5?F:(/YBK\Q
M4#FOU/Q6JTZOA)Q!4I5(5:;RO*+3ISC.#OF&5-6E%N+NFFM=FGU.C$?[O/\
MPQ_.)^8?_!<U5'_!4C]IDA0"TOP^W$  MCP%H0&3U.!P,]*^/_V%P#^VI^R:
M" 1_PT+\*>",CCQ=II'ZU]D_\%V+.[L/^"I'[1HOK6YL_P"T(OAY?6!NH9(%
MOK*3P'HJI=6;2*JW-N61U\V$N@9'4D,I ^._V#H9[S]M[]DJRLX)[R\D_:"^
M%TJ6EI#+=7310>*+&>>86\"O+Y,$$4LTTNWRXHHWDD944D>[D#7_ !##*))J
MRX"P;YD]$EP_3N[[633N^EBH?[O'_KS'_P!(1_4K_P '3_\ R17]DS_LKGC3
M_P!0L5_%U)]QOI7]J/\ P=.:?J$GP$_9:U>.QNY-*TOXP>*8M3U*."1['3Y;
M_P '.EBE[<JIBMFNWAF6W\YD$K1.JDE<5_%:QW^7%&#++<,L5M%$IDEN)9"J
MQQ6\2!GFD<LH1(U9F+  '(KYSP':?AGD=FGRXO-U*SO9K,\3)I]FDT[/HT]F
MB<'_  8>4G?_ ,"/[[?^"JJJW_!"-PP##_A37[-IP0",A_ Q!P?0@$>]?P+5
M_?U_P53TC5S_ ,$+K^P72=4;4--^"W[/,FHV":?=O?:?'IY\$'4'O;18C<6J
M:>L<C7S31H+58W,^P(Q'\ 0DC9/,5T:,9RX92GR_>^8';QWYX[UY7@ T^%N(
M$FG;C3.-FGI+"999Z7T=G9[.SL1@_P"'/_K[+_TF!_<W_P &OO\ R9=\9/\
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M6'C3:E"I*4:D9.Z]I*'5:I*45OH]+Z^EOV7^"'_!Q/\  []FWP';_"_X%_\
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M,E[:W%FU[KGA6^LA=0R0?;+*7PAI'EWEIYBJ+BV?:P6:+=&2K#.0:Z>'VO\
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M-ZS;)-9:CXK\#26*K?W=KP'MM;M[32?$%JY8EI)F#,9(I /XX?\ @MK^U/\
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M2K4%5K/EIJR;=J<G!XM*4:<%_$E47+W2U3?>VJUVT\C\._\ @W_^&_A;5?\
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M597&Y6##)4D'.&4X93Z,IX93@J>" :<2 "2< <DGH!ZFOZ!.P_L?_P"#5O\
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M8*G6G2G%WC.G]8]JJ<XO6,X*,XO5-.QTJC2B[JG!-;/E3:]+["*JJ J@!1P
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MQL=*^+WC.^^!EP- 7RK&[L?B?+9VVJ^*(=/LID,\8TG.M17UK %-M$3 TH0
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MC=+L[;3M,_9<^!NG:?9PI;V=C8Z[XJM+.T@C&V."VMK>..&"&->$CB144<*
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M?:Z3I7[+'P*TS2K&WCL[+3-/UOQ19:?9VD2".*UM;.WBCM[>VC0!(X(HTC1
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M+!4?885UFVXMT:+<(\L8W3;ES2;92C%.4DDG*SD^KLK*_HOUZMG[_P#[/_\
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M*K2KQJU(JU2<KN]RIPG%1E%22V3Z:6T>^WF?TT>,/^#F3XP75I?7GPP_8_\
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MH*;3G&CBL/4HXFG";2<Z<*JA-I.46TFJG3A4LIQ4K;7W7HUKZJ^I_2+\<O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2G4@Y0J4YQ:E"<&XRBTXMIW/3WV"BBBK **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?P?0_D:,'T/Y&O\ 3L_X=4?\$Y_^C/?@I_X3'_W31_PZH_X)S_\ 1GOP4_\
M"8_^Z:]7_B9?A?\ Z)[/_P#P/+O_ )I]?Z6M?7J?\D__ "7_ #/\Q/!]#^1H
MP?0_D:_T[/\ AU1_P3G_ .C/?@I_X3/_ -TTO_#JC_@G/_T9[\$__"8_^Z:/
M^)E^%_\ HGL__P# \N_^:?7^EJ?7J?\ )/\ \E_S/\Q+!]#^1HP?0_D:_P!.
MS_AU1_P3G_Z,]^"G_A,?_=-'_#JC_@G/_P!&>_!3_P )C/\ .YH_XF7X7_Z)
M[/\ _P #R[_YI]?Z6I]>I_R3_P#)?\S_ #$\'T/Y&C!]#^1K_3L_X=4?\$Y_
M^C/?@I_X3'_W31_PZH_X)S_]&>_!3_PF?_NFC_B9?A?_ *)[/_\ P/+O_FGU
M_I:GUZG_ "3_ /)?\S_,3P?0_D:,'T/Y&O\ 3M_X=4?\$Y_^C/?@G_X3'_W3
M2?\ #JC_ ()S_P#1GOP4_P#"8_\ NFC_ (F7X7_Z)[/_ /P/+O\ YI]?Z6I]
M>I_R3_\ )?\ ,_S$\'T/Y&C!]#^1K_3L_P"'5'_!.?\ Z,]^"G_A,?\ W31_
MPZH_X)S_ /1GOP4[_P#,L>O_ &\_EZ=L4?\ $R_"_P#T3V?_ /@>7?\ S3Z_
MTM3Z]3_DG_Y+_F?YB>#Z'\C1@^A_(U_IV?\ #JC_ ()S_P#1GOP4_P#"8_\
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M  /+O*__ #$^OX?,^O4_Y)_^2_YG^8G@^A_(T8/H?R-?Z=G_  ZH_P""<_\
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M_P#1GOP4_P#"8_\ NFC_ (F7X7_Z)[/_ /P/+O\ YI]?Z6I]>I_R3_\ )?\
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M:_T[/^'5'_!.?_HSWX*?^$Q_]TT?\.J/^"<__1GOP4_\)C\?^?G_ #TZ4?\
M$R_"_P#T3V?_ /@>7?\ S3Z_TM3Z]3_DG_Y+_F?YB>#Z'\C1@^A_(U_IV_\
M#JC_ ()SYS_PQ[\$_P#PF./R^TX_2D_X=4?\$Y_^C/?@I_X3/_W31_Q,OPO_
M -$]G_\ X'EWE_U$^OX=M3Z]3_DG_P"2_P"9_F)X/H?R-&#Z'\C7^G9_PZH_
MX)S_ /1GOP4_\)C_ .Z:/^'5'_!.?_HSWX*>G_(L?_=/Z]3WH_XF7X7_ .B>
MS_\ \#R[R_ZB?7\ ^O4_Y)_^2_YG^8G@^A_(T8/H?R-?Z=G_  ZH_P""<_\
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M/C'_  Q[\%/_  F.?S^TYH_X=4?\$Y_^C/?@I_X3'_W31_Q,OPO_ -$]G_\
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M .2_YG^8E@^A_(T8/H?R-?Z=G_#JC_@G/_T9[\%/_"8_^Z:7_AU1_P $Y_\
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M?Z=G_#JC_@G/_P!&>_!3_P )C_[IH_X=4?\ !.?_ *,]^"G_ (3'_P!TT?\
M$R_"_7A[/_\ P/+O+_J*]?P#Z]3_ ))_^2_YG^8G@^A_(T8/H?R-?Z=O_#JG
M_@G/_P!&>?!/_P )@?\ R32?\.J/^"<__1GOP4_\)C_[IH_XF7X7_P"B>S__
M ,#R[_YI]?Z6I]>I_P D_P#R7_,_S$\'T/Y&C!]#^1K_ $[/^'5'_!.?_HSW
MX*?^$R?_ ))I?^'5'_!.?_HSWX)_^$P/_DFC_B9?A?\ Z)[/_P#P/+O+_J)]
M?P#Z]3_DG_Y+_F?YB6#Z'\C1@^A_(U_IV?\ #JC_ ()S_P#1GOP4_P#"8_\
MNG_/X"C_ (=4?\$Y^?\ C#WX*<_]2Q_]T\?A1_Q,OPO_ -$]G_\ X'EW_P T
M^O\ 2U/KU/\ DG_Y+_F?YB>#Z'\C1@^A_(U_IV?\.J/^"<__ $9[\%/_  F3
M_P#)-'_#JC_@G/\ ]&>_!3_PF/\ [IH_XF7X7_Z)[/\ _P #R[R_ZB?7\ ^O
M4_Y)_P#DO^9_F)X/H?R-&#Z'\C7^G;_PZH_X)S_]&>_!/_PF/_NFD_X=4?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img247211528_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_6.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %S >P# 2(  A$! Q$!_\0
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MHHH **** "BBB@ HHHH **** "BBOP#_ ."L/_!1G]HK]D[]J[]E7]GOX/\
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M>+/%FEZSXLUKPY\./#<GCO3[6'P[X5\.P^'(6\.V^JW&K:S?R\UX[_X*\_\
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M%,UR8X9/CCXI_P#!Q5_P3B\._L;_ +0G[7OP6^(6N_'VT_9_?P'I6K?"[3_
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M?&RVDIO_ /AHE_@0OPQ7P1/X?2W:-K>-_%0\5#Q?YQ96TD>&RBG4QY+\-_\
M@KK\#M0\6?&;P[\;+>#X2V?A+_@J#HW_  2U^"VL:1/XG^)D7QG^,_C+P'X3
M\:?#^XNH_"_@TQ^ %\32:[K.E3R:U<77A;0CH"W>J^,+<ZG#:P 'QO\ \.DO
MVY?C-#_P4K\2?M>?M6_ 'QI\2?V]OV*/ 7[*_AB[^#_P=\4^!/ _P7N? ME\
M08;5(]"UKQ+KVO>+O#EYJWC.;Q+J&M:IXF'B*YU76-=LK+3M(\/V'AW2+/\
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M@^'^F^(/@QX-EU*^M[2W^(/Q4TWPAX'GECU18]?)\.>)AHP!^T5%?G#\9?\
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M[T;PYJM_XDEU+P7JLGB[6-8\.Z%J'BGQ,VJ>+9-)L$UZ.UA_7.B@#^1+XO\
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M.@:E#;:W_P (4NGZ;XHT_1=8N;:W>ST2'2].U%$N;B=!]4?L&?L,?$KX<?\
M!&GX:_\ !/KX[7[_  ^^)4_[+7Q*^ 7C[6/ ?B&+5+GPA??$2U\<Z'+KGA7Q
M)H]Q DVHZ1I_BB#5-,O[&Y@E@OX8C'-#-%N3J/V_/^"DUI^QE\;/V2?V<M'\
M*_"W6?BI^V+'\<(_A=J'QU^,^J_ /X5WGB;X.Z!X0O-)^&8^(FF_"GXLVUM\
M1/BSXI\>^%O"7@:T\0Z9X<\-&>74!+XDN_%EQX*\">.#Q/\ MT?'9_VW]._8
MM\%? GX0Z+KT'[#OPV_;#\8^(/C1^T!JOA"Y\.ZM\0/BYX\^%%U\)+#2_ 7P
MC^)VC>([OPO>>!KF]U+QA9>*X=,NY+E+?3=/NK4QZE( ?F[^Q]^P1_P4LG\;
M?\$K/AA^U7\,OV3O@_\  _\ X)):-K=OI7Q9^"_Q0\3?$CQS^T_KEC\"=2^
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M@CQ;\#M"^%F@Z_XHTSXL?&B,^(;#7]3@M/"^A6)\##Q9XZ3]AOC1_P $I?\
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M/\=Z Y\278^P"22ZB/S6S;O4O@5^P_\ &GX<_MV_L2?';4/#/A?2_AC\"O\
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M[-'Q'\8?LQ_L5?";X(W7@&'Q5J&D_ #XB_LN_&_XQ^-?$6J>%K_3=!\%7?\
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MGK\GB:TUZ.[T_7IH?"T,B);V%VLO]4E8&G>%/"VD:[XB\4:3X:T#2_$WB_\
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M MUH?C;43K'C/1;CPCH$^D^+M79;16U3Q/ITNGM9Z]J++86*F^U6&[N2ME:
MRXMH=F?^JDW0K49XRG-U\%0PU:I*C5<JU3#Y7++H5*_^TOG@I*GB(P3C*+YX
M.<FX3CU?\1\PL<URS,J'#F,PM/*>(\USG+\'0S+ 1HY;@\WX[PG&6*PF6/\
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MW\./"MCK-UX5\"^%].U34;6YU0Z5!<WMP6^WZ "BBB@ HHHH **** "BBB@
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M&#PH\EO\0/%?C?0= \37>EKKDEQ$ ?VJ]>E%(HPJC@X4#(Z'CM[4M !1110
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M (:Z]^SG\0OCW\5/A3)\0_\ @HMH'@_P?J?@3PS\._'>H?\ !3#_ (*[0?\
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M9^B7_B[]A;3_ .UU?XW?\%7+J73_ !;HG@S1H+#]L7_@ME>S_$74_$/C#7O
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MW"_!Z7-)RLO]5<GT5V[?(PPZ2A.RM^_Q'_I^84445\J;A1110 4444 %%%%
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M,^(='N;S2->\/Z]I%Y9ZIHVLZ7>76G:IIUU;7UC<SVT\4K?H_7P!_P $T_\
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M/GC'226EK^9Z)1117\WGL!1110 4444 %%%% 'RO^R!_R3?XA?\ 9U'[9?\
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MW@7X@^!],O[)=4\5ZWJ\7BS7KR]\>7&K:K;ZQ!K#PV\Q>"=C^Z] !1110!\
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M_P!G;6/"VC_#;XC?"OXB?LM?M!>+]7^)FM^#/%7P9^$/QD^+?P \8?%SQ_\
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MHE!^R998X8Y)II$BAB1Y99976..*.-2SR2.Q"HB*"SNQ"JH)) !-?&UQ\-O
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M^7C^SKXNT-H6^'?[4/[0OA*VM<F/0O$FL>!OC)H5X<$+'JVH?&'P-XS^(]Q
M#M+#3?B+H]V^W!O!OD+)_9G[9GAD7#VGBS]G+XP0(=VGZ=KGA#XB? C57C"*
M!!JWB[1?$_QWTNXG:022'4=.^'&EPK$\=N-':2%[NY'BZ\/XV7XJ*CI.K1EA
M\1224>9SIPA76,JPO[D5'"*M*6OL5'42X>RS$V_L[B[(:M2LD\+@LQIYQD^.
ME*==488?%XC%99+AW XCD:Q%6I5XBEEM*C=/,954Z9]145\N_P#"Z?CGX>-O
M%XZ_9+\<W^3B_P!:^"OQ(^%?Q*\-Z< C,9S%XZ\0_!7XA:E;EPL*+H_PYO\
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M&\OJX:M3QL<7+/L#26%EA9PC7CB'5:IJBX*ISM1Y>;0^G]&_Y ^E?]@VQ_\
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M#J7Q.U+XA)XY^#&K>)_VHKV]U[6M$;XS^'OZJ%SM&>N!GMSCFEHH \8_:/\
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M'WP.UCPS\4OA#XT\ 7?C;XD_'7Q[\/\ 7?#FL>-_#VO^&+FYM_!'A?\ 9O\
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M=CKNI7DNN^/[[2O"_KFN!?VB?%FH>"X"T_P(\!:U-I_Q'ND_X\/B_P".M'N
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MIE,<;1R+WNBBBNL^?"BBB@ KY^^)OB;Q#XN\1Q_ [X;:I<Z/KNH:=!JOQ/\
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M^AZ/X;T'2[>.TTS1- TRRT?2-.M85"16UAING06UE:6\2*J1PV\,<:*H55
M%;%%% !17YS_ +77QI_:"^&/[6/_  37\#^ ]<\(>'_@?\>/VE?'/PQ^,5N^
MGIK7CWQNMA^R/^U)\5]#\-6S:KHLVE^#O"&C^(?A=X9\1WVMZ!J3>,_$>LPZ
M=HT=WX<\+:;XBL/'OSS^PC^UQ^T3\1/'W[0VF?$*_P#$WQ[@M/V3?@/^V)X)
M^'6@:#\(/"GC/P=XR^,WQ<_;;^'NK_LO?#_59!\)/!UWH%CI_P"S%X(M/A]>
M_'CQ@GBVS\8Z_P",[OXD?&.3PM=Z7'X( /I__@FG_P FZ_$;_L__ /X*Q?\
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M],HHHKY<V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\P/#O@WQ'K?\
MP6'^/OB[3/BQ\0/!^@>"?V ?V"3XE^%_AW3?A9=>!?C /$?QR_X*H:9HX^(N
MH>+?AIXH^)FF#P#>Q2>(?"7_  J7XB?"XWFL7,T'CL^-= 6WT.W_ $_KX ^'
M?_*4W]L+_LP#_@FY_P"M%?\ !5>OO^@ HHHH 0@$$$ @@@@C((/!!!X((X(/
M6O-_#?P:^$'@WQ)JGC+PA\*?AMX5\7ZX2VM>*_#?@;PQH?B36&(<%M4UW3-+
MM=4U D22 F[NIB0[@_>;/PC_ ,%??VV?%?\ P3__ &$/BS^T;\-[GX<O\5/#
MM_X"TKX>>'_B89KG1O%&I>(?B!X8T77].LM%L/$'AO5]=U.R\'WWB'6;:UTO
M43)8_P!G-J][:W>FZ?>6\O\ &1IG_!VO_P %&Y]2TZ"Y^''[*BVTU]:17#2>
M!/'Z1K!)<1I,7=?BE$R((RQ9A)&5&6#KC(_L/P!^@OX__26X)S/Q \+\IX=Q
M?#F4\0X[AG%5LZXBPV2XF69Y?EN5YKB5A\-B:4I8C#1PV;X2,<13DXRQ"KT+
M*=&5_G\UXFRK)L33PN-J58UJE*-:*IT95%R3G.FN:47:+YJ<G9]+/JC^\+]N
MF#]GBY_8S_:CM_VM;JYL?V99O@3\38OCK>V(U@ZG:?#)_"FIKXLNM&7P];W>
MO/KL&EF>70TT6UNM5?5TLDT^VGNVBB?\0/\ @E7X@\.>,_VQM&U3]HN7_@L2
M?VC-%_9W\=2_LF)_P5/^%_PL^&WA\? GQ/XE^'3?&:+X7W'P/TJT\/:S\88;
MW0O@\?B_I_Q4N[?XC6>AR>%+K3-"CL_^$DN;;]POVH_!$'[4'[''QM^'GP_T
M+X5?&JQ^.OP0\6^%?#6@^-?&GB/1?A#\1-,\>^&;G3;>VUCXA?#!K[Q9HWA?
M6K#46>/Q?X#DGU[3(Y(-7\/3_;H+64?DA^Q_\/\ _@H#X'_;Y_9>T3]M']EO
MX)R^'_AS^P[\6OA%\(_VF_@M\;OVJ_C_ &/@K2?#'B;X&0:QX*^)6N?%O0="
M\,V7Q@^+\&F>&M>O/B)XRLKSQW\1-*^'VNV^F^*+MM/\3:?+_']2G.E4G2JP
ME3J4YRIU*<XN$X3@W&<)QDE*,HR3C*+2::::31] FFKIW3U36S7<_H8HHHJ
M"BBB@ HHHH **** "BBB@#E]?\$>"_%>J>#]<\4>$/"_B36OAYX@N/%G@#6-
M?T#2=8U3P-XJN_#FN^#[KQ-X/U#4;2YN_#/B"Y\)>*/$WA:XUG19K+49O#GB
M+7=$DN6TS5]0M;C&\"?"3X5?"VZ\;7WPR^&7P^^'5[\2_&.I?$3XCW?@3P9X
M<\(W7Q ^(&LPVUOJ_CKQM<>']-T^7Q7XQU6WLK.#4O$^NO?ZW?0VEM%=7TJ0
M1*GH-% 'P!_P33_Y-U^(W_9__P#P5B_]>F_MD5]_U\ ?\$T_^3=?B-_V?_\
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M7Q#J'AF^UC2M>TBS\06>D:[>7&C76J:'K.G6^HQVTU]I6HVR2V<WS!_PQO\
MM%?])8OV_P#_ ,-S_P $LO\ Z6G0!X%'^P]H7QW\-_$J]_:Y^#.DV_B+0_@S
M\"O 5]-\&=$T+PGK?CGXC>%='^'W[0GQK\?> =4\,0:5+K>F^+_C-IG@3P1I
M&B^(H1IYOO@<8(-.MM.UF[DOOF7]IS_AH;P'^P%_P6!^"/Q"_9_M/!WPOT#_
M ()R_M,^,="^-MGXL_MV#QUXOU[]CP?;/"5HUUC4-7T3X<QS:S\"_"%S>1Q>
M(-(\$_L]^&M8\6SW[?$;PY+!^B__  QO^T5_TEB_;_\ _#<_\$LO_I:=>?\
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MB=K=_HNA> --9&9=0U^_U?1+33M+6Z9M8T@;=0MOYL/^#>WXN_$WXQ?M#/\
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MJ7C"^L[+39OY+;;;;U;=V^[9[Q_8O11_GT_G12 **** "BBB@ HHHH ****
M"BBB@#\X/^"4]SXJO/V2_$-YXZT;P_X<\;77[;__  5)N?&/A[PGXFU'QIX5
MT+Q5/_P4\_; E\0Z-X9\8ZQX3\!:OXL\/Z7J[7ECHWB;5/ O@O4=>TZ"VU2^
M\)^'+FZET>S_ $?KX _X)I_\FZ_$;_L__P#X*Q?^O3?VR*^_Z "BBB@ HHHH
M *\W^+_Q-T7X-_#'QO\ $_7[:]U&P\&Z!>:M'HFE1^?K?B;5@%MO#_A#PY:
M,^H^*/&&O7&F^%_#&E0I)<ZKX@U?3=.M8I;BZBC;TBOC_P")BK\9OVD?AO\
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M(N$%3A&$?AA%15]79*VKZON]V]6%%%%<904444 %%%% !1110 4444 %%%%
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MCZ)_:_\ 8WAW3](\/V&F:59>@?\ #&_[17_26+]O_P#\-S_P2R_^EIT ??\
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M!_PQO^T5_P!)8OV__P#PW/\ P2R_^EIT?\,;_M%?])8OV_\ _P -S_P2R_\
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M?]%? '_#&_[17_26+]O_ /\ #<_\$LO_ *6G1_PQO^T5_P!)8OV__P#PW/\
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M\,;_ +17_26+]O\ _P##<_\ !++_ .EIT ??]%? '_#&_P"T5_TEB_;_ /\
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MUO<PR03Q.,I+#,C1RQN.ZNC,K#N":Y7X?^ /!7PJ\#>$/AG\-_#&C>"OA_X
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M_",?\)GL_P"$'_X0;XH>=_PDW_""_P#$Y_X1;_A(O^$=_M+S_P#B5?:/L/\
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MG].:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img247211528_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_ 6P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6\$ V\+B52W9BV"1WQGM0!WU%%% !1110 4444 %%%% !1110 4444 %%%%
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M=F=[17GS:CX?B6XDGU(P6\)C'VB74&$;[UW+M._GBITN- EU!=/CU97O&^[
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MBNC!D89#*<@BO$?'*:?HOBS5(U7PU:%K9;M&UC36N9;R1BVX(Y)R 0!@=,@
M8KMOA8X_L&]@^QVUL8+O:PM8WBC+&-&($;$["I;:P'&Y30!W5%%9D6O6,VLR
MZ5$9Y+F$[9"MNYC0[0V#)C:#@CC/>@#,\1W?_$\T"S^S7'_'^LGG[/W7^KE&
MW=G[WM735A>(_P#CZT#_ +"B_P#HJ6MVKELA!1114#&32I;P232';'&I=CZ
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MQ;S2!;!Y6#WHMXRBBY95+\'ZCUXQ0!U%%%9\>N:7-JTFEQWT#7T8RT ;YA@
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M B.=%).3L\Q25'MG [5MZ)HXT6S: WU[?2R/YDEQ>2[W9L =@ !QT  K2HH
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MWT:Z\)[SG0_F6GJM5^J^9M6]Z$:GR?R_X'Y'8T445SF04444 %%%% !1110
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MRQ?8R=;G/FQW+LD0D9B5.5!QR2,X[U[K_P )#XAM?^/_ ,(W+*.KV%W',/\
MOEBK?I7N9ID]7"U^56L]5JE\M6KV>ASPJ*2.HHKE_P#A/M%AXU!-0TUO2]L9
M8Q_WU@K^M:MCXBT74P/L.K6-P3VBN%8_EG->5/"UX*\H-+TT-.9,TZ***P&%
M%,BECF3?%(LB9(W(V1D'!_48I]&P!1110 4444 %%%% !1110 4444 %%%%
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MWV>)< #GE>>]>E5T8[-*6*KNM0@DGO=)Z_<1/#5*#Y*NC.8&G^-"26U_25]
MNFM_66D&E>,2#N\3V()_NZ7P/_(E=117)];GVC_X#'_(CE1R_P#8OBTK@^+X
M@>Y72D_^*H.A>*#C/C)P,\[=-A!KJ**/KE3M'_P&/^0<J.8_X1[Q$S MXSN\
M#LEC /\ V4T?\(UKA)+^--3]@MM;C_VF:Z>BCZY4[1_\!C_D'*CF!X5U,YW^
M,M;))_A6W'_M*D_X1"[*;6\7>(#ZGSHA_P"TZZBBCZY6\ONC_D'*CF#X-=@
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MV[6- HHHI >;SZA=3?$**Q?QE93Z:;EEETXB(2(<<0E2I+<XYR"/UKT9$2-
MD:JB*,!5& *YO7;+Q-'JL=WX9_L94DC(NDOD<&1QC8V4&<@ CD]ZATV/QY)K
M%J^KS:#%IT98S)8B4R2?*0H^<8 S@_A0!UE%%% !7*1:*+3XE-J-O9LL5QIS
MB>XP2&E\Q< D^PX%=710!QVIV.J6VJ:%)>:RUY$=24"(VR1X/ER8.1S7.>(5
M'B'XNPZ6&/E6EHL+X[>82[_^.*!_P*NN\1WUO_;>@6&]OM/V]9=NQL;?+E&=
MV,?AG-<Y\-(?[6UOQ%XID&X7=X\=NQ_N*<<?@JUU+2E*;[67SW_\EY@3233Z
M]ST@ *H4#  P *6BBN4 HHHH **** "BBB@ K,\11S2^'-1C@C625K=PJL,@
MG%:='6@J$W"2DNAX%X:U&\T_Q#;7%M.Y)<"199=JR*>H+'^=>O?\)+-!/Y%Y
MHUY'-C.V%XYCCZ!L_I5RS\/:787;75M:*DI! .20H/7:#P/PJZUI;/<+</;Q
M-.GW9"@+#Z'K6=/VJ5IZ_P!=]/R-IXRM6M[9*5K*[;O:VNJM?6[5U=;79E#Q
M9I"G%Q/+:MZ7,#QX_$C%:%MJFGWF/LU];39[1RJW\C21Z790W$]Q'"$EG!$C
M!C\V?;IFLR3P=I,EE+;F(LSG(FD DD3Z%@:N[ZK\?^&(YZ3WBUZ-/](_F;Q
M(P0"#7"_$;P.?$FBQQZ5:V$-ZLXD>:10AV '(W $]Q6C)X,$-G%'INIW5G<(
M?FE61\/]5# #\*RO%^B>(4T:5;35;F\L=H,\+@&5L'G! &5]145''E?,G8UH
MUJ=&:JQDU;75?HF_Q:7F<EX(^%-Y:ZZMWJTUC<V"QLI%I=ONW=N5Q_.O1_\
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MK?VMXJ7[WA>V;C^#4U_J@H_MSQ&OWO"$Q'^Q?PG^9%61K>H<[O#E^#[/$?\
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M4 %%%% '_]D
%       !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img247211528_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #Y =L# 2(  A$! Q$!_\0
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M/^ARU;_OW!_\17944 <7_P (3K'_ $.>K?\ ?N#_ .(H_P"$)UC_ *'/5O\
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M10 44S?3Z "BBB@ HHHH **R?[6":\NG^5]Z#[1O_P"!;:UJ "BBB@ HHHH
M**** .(^-'_)*/%G_8*N/_0*Z;P[_P B_IG_ %[1?^@BN9^-'_)*/%G_ &"K
MC_T"NF\._P#(OZ9_U[1?^@B@#1HI,TM !1129H 6BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"/S15%M8LHI/(>\MDF_YY/.H;\JJ>)?#T'BC0[O3+F>[
M@@NDV2/93O;RA?\ 9=/F6O@/4AX!?QSXCT6V\#?"C35TG4?L#/XR\4RQ:M/_
M --?XV^;_>H _19'W4^N'^&/@K3/!7AR.TT@3I93*LZPM?2W<46Y?^632_PU
MW% !7GDG_)=(O^P(_P#Z-2O0Z\\D_P"2Z1?]@1__ $:E 'H$K[%KRGQ5=SW/
MQ:\)0-_JH)Y=OR_],J]3N/N5\?\ QO\ !^M:5\4-)U>VN;9Y8KKY+CS;A+A4
MV?.Z;?EW;: /L-/G2GUD:)?0:EHUE<VUS]MAEB5DN/\ GK_M5KT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !14#W"0)ND943^\S5B7_B!6MY?[-A;4
M;H+^Z2)?DW?[_P!V@"WI6J_VHU[^ZV?9YVA^]][;6IO^6O,_AWJ?B"\GU7SK
M..%?M+,SW7R[)?XU^6NVDBU-D^;4((?^N4'_ ,4U &MOI&<*FYOEK*&B-*G[
M^^O9?^VNS_T&G'PY8;MS0><_]Z5F:@"P^M6,7W[N%?\ @50?\)!;/_JEGN?^
MN4#-5JVL+:U'[B".'_<3;5R@#RM_%FII\141=(N=OD>5]G\KY_*W_P"MW;]M
M=Z=>A3[T%W%_OVSU7^S2_P#"7I/M;R/L.S?_ +6^MS90!03Q!IS#B[B'^\U6
M8;R"?_5S1O\ [K5*T:R)M==R_P"U5)M$T^4?/9P_\!BVT :-,WUD_P#"-VB_
MZHS6W_7*=UH&CRHG[O4[Y/\ ?9'_ /0EH 9X@U.6QBLGBVXEO(HFW_W6K93[
ME>;>/](UN2;266^:\M%NXE\E6^SOYN[Y7W+7>:7%/!IT$=W,)KM4VRRJOWFH
M YCXT?\ )*/%G_8*N/\ T"NF\._\B_IG_7M%_P"@BN9^-'_)*/%G_8*N/_0*
MZ;P[_P B_IG_ %[1?^@B@#A?BA\;/#7P:LK"Y\1S30K>2M%%]G@:6O.W_;L^
M%Q_Y>]1_\ 7KS[_@H6R?V/X3]3=R9_[XKXFF==J?-_%7S^+Q]2A5Y(GZ[PYP
MCA,WR^.*JRES'[!^"_%^G^.?#5AKVE222V%[%YL+2KL?;_NUMN#N?YNHKRW]
MF(X^!WA/;_SXI_*N?UWX+ZWJ7BCQ5XBL+_\ L[4C=>?I3VL<2W+?Z(D7SW'W
M_*W;OW7W?EKVJ<N>,9'Y7BZ,</B9TH_9D>^#I2U\^VNB_&#3=2UM[.]:_M[5
M]^G17TT6R]7>FQ7?[R_)NW?(OS46'AGXLRZM<6FHZW=C3_/1&OK22!':+?\
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MAHJ)I4C:C;(NK-ML=\FS[0VS=\O_  &FIX[\/O/;P+JUH\UQ_JD67[WS;/\
MT/Y:.:/\H>SE_,<YJ/Q$UG1K&6[OO!]];6L7,LOVF)MJ_P#?5>A0_.M<C\70
M!\/]8/\ TRKK85_=JW^S3ER\HJ?-&7*3)3Z**@Z3G_%?AC3_ !?H-YI&KVOV
MW3;Q/*GM][KO7_>7YJ_.'7[/P/;?$GQ%H<%GX)\*V^DZG]EBM[Z#6]2EE5=O
MS^; _E?\ _AK](?$E]K%KHEW+HUG;7FJ*FZ"WNYVBB?_ 'GV_+7QW/X-\:Z9
MXKUB_P!/\(_%O0+C5+S[9=6GASQ)I?\ 9C2_Q,F]=VV@#[&\-%5T&PVE6B%M
M'LVJRK]W_:K;KC?AW=^)K_1"WB?2(]%NE^6*W6^^U2[/[TKJB+N_W:[*@ KS
MR3_DND7_ &!'_P#1J5Z'7G;?\EUB_P"P$_\ Z-2@#T2BBB@ KR[XC^'KS3;^
MT\4:,O\ Q,[-_F3_ )ZI_$G_  *O4:K7-NLT4J/\R.OS)0!X1\5_VE]+\)^%
M;6?2&6\UJ_BW06[_ /+#^_YO^[7,:;^VOX?AL;=;G2=4>Z\I?,9$3YF_[[JG
M\:?@S:3:R^[;9Q7C?NK[;\EO+_ [_P"R_P!UJWM._8Q\+2V<#WEYJ<=UM7S$
M2==F[_9^6O'KQQ?MOW7PGVF"EDD,)'ZUS<Q&/VV_#(_Y@6K?]\)_\77K_P ,
M?B+9_%#PS#KFGVTUG;RLR[+C[]>9_P##%'@H_P#+]JX_[;I_\37J7PZ^'NG_
M  R\.1:+ILL\UJK,RM</O>KPWUN,_P![\)YV92RJ5/\ V'FYO[QV"_>J2H<C
MUH>8;:]4^8NA]%9.E:U8ZU \]C<QW,*OL9HV^ZR_PU/?ZE'8P/+)]Q?_ !YO
M[M/8<9<X:KJL>FP;FW.[_)'$GWW:L/4M'G_L34+F=?.U">#^#^#_ &%J_IUG
M///]MO$_?M_JX?\ G@G_ ,56R_R)NI%E&&5+/3HGG;R4BBW,[_PURWA+XL^%
M?%]M<7.G:O;?9X)WM]\LB)NV_P!W_9JA\=? ^J_$?X<ZAHVC:M)I5_*NY2GW
M)_\ ID_^RU?"7A+]DGXE>++.ZGMK&TL_(G>WEAOI_*=67_@%<E2K.,N6,3RL
M7B*]&48TH<Q^CG_"8:,/^8Q8?^!*5-8Z]IVJLT=I?6]XZ_>2&57K\]S^P[\4
MPO\ JM'_ / [_P"PKV[]D_\ 9[\7?"#Q/JVH>(UL4M[JU6&/[+/O?=OI1J5)
M2Y91(H8O$U9<LZ7*?5R4^F4.^VNP]@S%URV.N3:1N_TQ($NF3;U1F9?_ &6M
M:O/OM<'_  N.Z@\^/[1_847[K>N__6R_PUWV_P"6@!]%,WT;Z 'T4S?1_!0!
M0O\ 6+32EB>[N([9)95B1I6V[G;[JU?1]U>>?%[=_97AW_L/V?\ Z'7H$/\
M%0!-1110 4444 %%%% '$?&C_DE'BS_L%7'_ *!73>'?^1?TS_KVB_\ 017,
M_&C_ ))1XL_[!5Q_Z!73>'?^1?TS_KVB_P#010!\>?'K1-0UOX*_#--/L;F\
M=+6)V^SP-+L_T=?[M?.LW@/Q+\G_ !(]7^]_T#I?_B*^\M%^*OA7X6_"3P1/
MXIU>+2(;K3+>*!YE;YV6)/[M5F_:_P#A!W\86?\ WZE_^(KZ7#9Y++X>P43\
MUQN1X;&U8UZM7ED=/\ K.XTWX1>&([F*2WN$LD5DF38Z_P# :R_$/P(T[Q!=
M>)[N\O)Y9]6NOM5NCRO]GLV\E(M_E?=W_(_S?[5>A^%_$6F>,-!LM7TFY2\T
MV\B\V"X3^-:V$*XKYVI/VLY5#] PU*-&A&G$\/F_9Z6;7(6:^MDTJ.\^T?9$
M@;?=1>;$_DW'S[65?*VK_O52C_9SGM(%@M=:@6V^S16[^; W[IU5=]U%\_\
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M2=J6B@#!\6>&;7Q+HTUG/&K[E^7?7(_#CQ'<VTLOA759&.H6:;K65_OSP?\
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M7;5;3?#NFZ58VMG:V-O#:6J[8(DC_P!76O10!32RMD;<L,:MNW;E7^*KE%%
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MU]_S\1*[?^._[2UGM;?':W\1YN;R[=99;6XL_L<2/;Q*S;[B*7_<^9?G_P"
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M)2C_ (2O1MO_ "%K#_P*2@#9HK#C\6Z),F]=<TUU_O+=)_\ %4__ (2K1O\
MH*Z?_P"!*4 ;-%8W_"5:-_T%=/\ _ E*/^$JT;_H*Z?_ .!*4 ;-%8W_  E6
MC?\ 05T__P "4H_X2K1O^@KI_P#X$I0!LTRL;_A,-%,C*NKZ;O7[W^E)3_\
MA*M&_P"@KI__ ($I0!H3V_G0O'N9-R;=Z_>K@/%/PGT[7OAN/!EC<R:19K+
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M=Y8O-_OI]UJX6/\ 9EU2QBU%;[7]-3^T8K6WBM/-EB1I8OXTV;/F?_=;_@5
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M?2H]9LOLY6]\VWE1W2!Y_N>4[)]Q?[JJE 'TD8[/S?+VP^<W\&U=U3_8H/\
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M$&JZ5=+N@N[=LH] &_1110 4444 %%%% !1110 4444 %%%% !1110 4444
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<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>img247211528_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_9.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $. R0# 2(  A$! Q$!_\0
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M;>73*^:HRN.!R:OP?'_P8VO?#J6^US5=0CT?3-:T;5-1?2$BD(NT98[E8HR
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MR&RH7^\6%=QK_CCP/IEK\8[71-=O]:C\8P0RV4D^F-:[9OMXG>)@6. J?QG
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M/<U3S7ZZ?\,F?!S_ *)WH_Y2?_%T?\,F?!S_ *)WH_Y2?_%T+BC"+:G+\/\
M,7,C\B\T9K]=/^&3/@Y_T3O1_P I/_BZ/^&3/@Y_T3O1_P I/_BZ/]:,+_S[
ME^'^8^='Y%YHS7ZZ?\,F?!S_ *)WH_Y2?_%T?\,F?!S_ *)WH_Y2?_%T?ZT8
M7_GW+\/\PYT?D7FC-?KI_P ,F?!S_HG>C_E)_P#%T?\ #)GP<_Z)WH_Y2?\
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M_P 6^+]%T;2[=KK4;V\BBAA09))<<_0#))[ &OU<_P"&3/@Y_P!$[T?\I/\
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M.DO>SOI<,S7,5F7/E)*P"LX7H&( !/L*_6C_ (9,^#G_ $3O1_RD_P#BZ/\
MADSX.?\ 1.]'_*3_ .+H_P!:,(]Z<OP_S%S(_)?3=:O]&%V+"]GLQ=V[6MQY
M#E?.A;&Z-L=5.!D>U4\BOUT_X9,^#G_1.]'_ "D_^+H_X9,^#G_1.]'_ "D_
M^+H_UHPF_LY?A_F'.C\B\T9K]=/^&3/@Y_T3O1_RD_\ BZ/^&3/@Y_T3O1_R
MD_\ BZ/]:,+_ ,^Y?A_F/G1^1>:,U^NG_#)GP<_Z)WH_Y2?_ !='_#)GP<_Z
M)WH_Y2?_ !='^M&%_P"?<OP_S#G1^1>:,U^NG_#)GP<_Z)WH_P"4G_Q='_#)
MGP<_Z)WH_P"4G_Q='^M&%_Y]R_#_ ##G1^1>:,U^NG_#)GP<_P"B=Z/^4G_Q
M='_#)GP<_P"B=Z/^4G_Q='^M&%_Y]R_#_,.='Y%YHS7ZZ?\ #)GP<_Z)WH_Y
M2?\ Q='_  R9\'/^B=Z/^4G_ ,71_K1A?^?<OP_S#G1^2^CZW?\ A^_2^TN]
MGT^]161;BVD*.%92K $=BI(/L:I8&W'&.F*_77_ADSX.?]$[T?\ *3_XNC_A
MDSX.?]$[T?\ *3_XNC_6C"7O[.7X?YBYT?E'XG\9ZYXTN;6XU[5KG5IK6W2T
MMVN7SY,*_=11T4#T%8^17ZZ?\,F?!S_HG>C_ )2?_%TJ_LG?!U&##X=Z-D'(
MRLA_]GI+B?"15HTY+[O\PYT?F9\/_@#X\^*.AOK'AK0)M1TY)VM_/7Y5+J 2
M!GKC<.1WR.U%?L#I&E67A_3;?3M+LX--L+==D-K:1B..,>@4<"BO)GQ1B')\
MD%;I>]Q<Y:HKE[_Q??7FN7.B>%]%/B#4K3;]MFEN!;V=FS %4DEPQ+D$'8BD
M@$$XR*D\CXE?] #PQ_X-KC_XQ7R:H3:OHO5I$'245S?D?$K_ * 'AC_P;3__
M !BCR/B5_P! #PQ_X-I__C%/ZO/NOO7^8'245S?D?$K_ * 'AC_P;3__ !BC
MR/B5_P! #PQ_X-I__C%'U>?=?>O\P.DHKF_(^)7_ $ /#'_@VG_^,4>1\2O^
M@!X8_P#!M/\ _&*/J\^Z^]?Y@=)17-^1\2O^@!X8_P#!M/\ _&*/(^)7_0 \
M,?\ @VG_ /C%'U>?=?>O\P.DHKF_(^)7_0 \,?\ @VG_ /C%'D?$K_H >&/_
M  ;3_P#QBCZO/NOO7^8'245S?D?$K_H >&/_  ;3_P#QBCR/B5_T /#'_@VG
M_P#C%'U>?=?>O\P.DHKF_(^)7_0 \,?^#:?_ .,4>1\2O^@!X8_\&T__ ,8H
M^KS[K[U_F!TE%<WY'Q*_Z 'AC_P;3_\ QBCR/B5_T /#'_@VG_\ C%'U>?=?
M>O\ ,#I*SO$7B"Q\*:'>:MJ4P@LK2,R2/U)] !W). ![UF>1\2O^@!X8_P#!
MM/\ _&*\/_:EU;Q;:Z%HNE:[8Z9I]M=7#S#^S;R2?S"@& V^-< ;LC&?TKS,
MRJ2P&$J8G1\J[K=Z+\6>UDN7K-<PI8-NRD]?1*[^=EH<)X^_:+\4^+[R5-/N
MY= TK.([>T;;*1V+R#DGV&!7&:?\0O%&E7(N+3Q%J<,H.<_:68'Z@D@_C5CP
MSX5TK7]-OIY=9GLKBRM9+J=#9;XE5>%'F;QRQ*J..IJ]%X+T?3=0TE-1UA;V
MVU*Q%S#):*Z*9#*8S'DJ22 K$?+\Q '&<U^/3J8W$35:=35]>;_)Z=O70_I2
ME0RO!4WA:5%66EN1N^E]VM7;6[>VI[M\#OVA)/&%_%X?\2>5'JT@Q:WL8VK<
MD?P,.@?TQP?K7NU?GWK=@W@[4+&6U:Y%U _V@73)L0LKY41^I4 9.2,D@=.?
MOS2[HZEIME=$;6N8(YB/0LH;^M??Y!CZV*ISHXAWE"VOD^_FNY^+\99/AL!5
MI8O!KEA5OIT35MNR=]NGX%BG^4_]QORKY@\+?M'>+/B_\;?%/A?P;X>75?!V
MFVTVGO<12^1,;C)7[29SQ&@(8 8).,@$].?L?V+OC#:WEM<-\2[^412I*8I-
M=N"&P0=I_=]#C!K]&CEO)IB*B@[)V>N_Y'YU;N?7P1F&0I(]A1L;.-ISZ8KY
MK^*W[,OQ;^)GC.XUZV\7_P#"+Q2Q1Q#3=+UNX6!-BXW >4.3U-377[-GQ:N?
MA+9^"AXK6.YM[]KX^(%UJX^V2 Y_=,?*^X,^O:H6!I<L6ZRN]UV_SMY!IW/H
MXHR]5(^HI?*?^XWY5\W_  H_9K^+7PQ\0W6J7/BP>*4GLY+06>J:U<-'&7Q^
M\'[H_,,<?6N.B_8K^,,=RDI^)VH,%D#[#KEQ@X.<?ZOIVJU@*#DT\0K=[;_\
M,&G<^P C,,A21["C8V<;3GTQ7S=\6/V:/BU\3O%G]M6WBT>%HOLT=O\ V?I>
MMW"PY0$;\>4.6SS3S^S;\6C\(QX(_P"$K7[2-0^W_P#"0?VU<?;-O_/'/E?<
M_&H6!I<L6ZRN]UV_SL&G<^CBC*,E2![BE\I_[C?E7S;\)_V:?BU\,?%9UJY\
M6CQ3&;:2W^P:IK5PT.7 ^?\ U1^88XKD'_8K^,+W+2_\+.U!0TA?8-<N,#G.
M/]7T[5:P%!R:>(5N]M_^&#3N?8 1FZ*3]!1L;.-ISZ8KYP^+'[-?Q:^)WB.V
MU6V\6#PM'#9QVIL]+UJX6)RF?WA_=#YCGGZ46_[-GQ:M_A)=>"3XK62YGU 7
MP\0-K5Q]LC Q^Z!\K[G'KWJ%@:7+%NLKO==O\[!IW/H\HRC)4@>XI?*?^XWY
M5\U?"G]F7XM_#+QE!KUSXO\ ^$HBCADB.FZIK=PT#%QC<1Y1Y'45RMY^Q;\8
M;N[N)Q\3;^$2R-((TURXPF23M'[OH,XK18"@YN+Q"MWM_6P:=SZ^",W12?H*
M-C9QM.?3%?./Q5_9L^+7Q,UC3;ZV\5KX76SL8[)K?2]:N%28KG]ZW[H?,<\T
M:=^S9\6K#X4:KX+;Q8MQ<WUZEVNO2:U<?;( NW]VA\K[IQZ]S6:P-+DC)UE=
M[KM_G8-.Y]'%&49*D#W%+Y3_ -QORKYG^%O[,'Q;^&WC:R\07'C$^)XK=)%.
MF:GK=PT$FY<98>4>G4<5S>J_L8_&'4M1O;I?B7?6RW$SRB&+7+C;&&8G:O[O
MH,X'TK18"ASN+Q"MWM^ :=SZ[",W12?H*-C XVG/IBOG'XH_LV_%KXD76B36
M_BI?#(TW3TL733-:N +HK_RV?]T/G/>DT7]FSXM:1\+M>\'OXL6\N-4N8[A-
M<FUJX-W:!=OR1GRONG'//<UFL#2Y%+VRN]UV\_U#3N?0>L:K9^'].FO]3N8[
M"RA&Z2>=MJK_ /7]J\8UK]K;PQ87+1Z=I>H:JBG'G96!3[@-D_F!7RUJVB:W
MX2U35- UGQ/J/B2:SNFBDDN[Z2XB#KP=F['0Y&<53K\HSCB"I0Q4\/@9)QB[
M<UMVM[)]/SW/V_(>!\+4PL,3F-Y2FKJ*=DD]KVUO\U;8^S/!G[2GA'Q;>16<
M[SZ'>2D*BWP'EL?02 X!^N*]8V-QP>>GO7YM9!&."*]T^!&F7/Q'\#^._![^
M*M9TJ_O?L\\%]#<,\EG&N%/DY/RY(&0#WKMR+/'C:RPV+:3>S2^^Z]+O3M8\
MCBC@^CEN'>.P+?)&W-%ZVOI=/??=._>Y]8F-E&2I ]Q0(W(R%;\J\#^'/[+F
MI^ ?&VE>()_BMXK\0Q6,A=M,U"3,$^5(PXW'CG/3M7*?$[]FN\MM0U#6W^+W
MCB&75;YA9:-I;[G>:0DK!"I<# &>3@*JDD@"OT>.%P\ZG(J^G?EEOVL?D]D?
M4X1CG"DX]!048$ J03VQ7SGXZ_9F^+'Q(T;PM#'XX'@XZ/8BT9+:_N)9[H\?
MO+AT"J9..<9')Y-.\+?LM_%GPSX$\4^&W^)%OJ<FN! NJ7<UTUS8[?\ GB=W
M&>]7]2H\B;KJ]]K/OO?;;7\ T[GT48V R5('N*!&Y&0K$?2OF'P)^Q]\6_!/
MC#2M=?XK'6TL)O..G:A<7303\$;7&[D<_I57Q7^QE\6_%'B75=73XNR:6M]<
M/<"RL[BZ6&#<<[$&[A1VJ_J&'Y^7ZPK6WL_NL&G<^J C$G"DX]J"C @%2">G
M%?.OCC]EOXL^-/#OA72D^)%OHK:%:FV:\L)KI9;XG'SS'=RW'ZFCP=^RW\6?
M"7A#Q7H3_$BWU9]=A6)=0O9KII[#&?FA.[@G/Z5'U*CR<WMU>^UGWWOZ:_@&
MG<^BC&X&2I ^E C<C(4D?2OESP9^QQ\6_"'BO2=:?XM/K"6%PLYL+ZXNF@N,
M?P.-W(-'C/\ 8X^+?B_Q9JVMI\6GT=+^X:<6%C<72P6^?X$&[@"K^H8?GY?K
M"M;>S^ZP:=SZC",20%)(Z\4%&!&5(S[5\Z^,?V6_BSXM\'^%-"3XD6^DOH,+
M1-J%E-=+/?YQ\TQW<D8_6CP/^RW\6?!?AWQ5I3_$BWUIM=M1;+>7\UTTMB1G
MYX3NX;G]!4?4J/)S>W5[[6??>_IK^ :=SZ*,;@9*L!]*!&Q&0I(]A7ROX4_8
MQ^+?A?Q+I6KO\79=46PN$N#97EQ=-#/M.=CC=RI[U:\=_L??%KQMXPU778_B
ML=$2_F\X:?I]Q=+!!P!M0;N!Q5_4,/S\OUA6MO9_=8-.Y]/!&)("DD=L4%&&
M,J1GU%?.OBG]EOXL^)? GA;PVOQ(M],?0PX;5+2:Z6YOMW_/8[N<=J7X?_LN
M?%GP)I?B>SD^)%OKIUNR^QK/J,UTSV1Y_>P_-PW/7V%1]2H\CE[=7[6??>_I
MK^ :=SZ),;@9*M^5 C9AD*2/85\I^'/V*_BYX?U[3-2;XP3:@ME<1SFUNKFZ
M,4X5@=CC=RIQ@UI?$+]D3XM>/?&>J:_'\5!H*7L@<:=IL]TMO!A0,(-W XS^
M-7]0P_/R_6%:V]G]P:=SZ:",20%.1VQ049<94C/J*^=?$/[+?Q9U[X<^&_"J
M_$BWL)-&DDD;6+::Z%W>[L\2MNY SQ]*7X<?LN?%GX?1>(4D^(]OXA_M>P:Q
M5M3FNG-H3G][%\W#C/7VJ/J5'D<O;J_:S[[W]-0T[GT5Y3C^!ORKGO&OCC1_
MA]HK:GK5SY$).V*-1NDF;^ZB]S^@[U\W:'^Q+\7-&U?3[YOC'<7HM)XYC;SW
M-T8YMK [6&[H<8/UKS?XJ>(M0\3>/M;N=0N8YY$N7B"6SN;9-GR'RE<Y53MS
M^-?-\0XFEDV'4Z-15)2T6C5O-WZ?K8^NX9R)9[C'3G*U.*O)K?R2\W^29ZUK
M'[8&H/<L-)\.VL5L#\K7LS.[#W"X _6NB\$?M8:9J]Y':>)-._L8R$*+V!S)
M"#_M@C*CWYKY8I,@]Q7Y7#B#,(5.=U+^32L?MM7@S):M'V4:/*^Z;OZZMW^:
M9^D4<B31I)&ZR1N RNIR&!Z$'N*6O!_V4/'$^L^']0\.7<AE?2]LMLS')$+D
MC;] W3ZU[Q7ZG@L5'&X>%>&E_P 'U/YYS7+JF58VI@ZCNXO?NGJG\T%%%%=Q
MY(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6FN:59:E83K<V-[!'<V\Z=)(W4,C#Z@@U:IL,,=O#'##&L4,:A$C10JHH&
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M* "BBB@ HHHH S?@%_R1WPM_UZ_^SM7H%>?_  "_Y([X6_Z]?_9VKT"N^O\
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M\,)7[I1",*1VP.*\F_:,^'<'C/Q'\,[FYUK6; VOB*$6T>F7AMTBE\F=O.(
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MM*_\)\__ "12-I_Q G4QR^/+."-NKV>@HLH_W2\K*#]5-'+3_P"?B_\ )O\
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M>DQZ#HFG:7#+-/#8VT5JDMP^^5U1 H9V[L0,D]S5VD[7T)5[:G!?'#XS:-\
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M'D C@U\G?#_P&+C5O@UIWA7X3:Q\/O$_A6\CE\3>(+[3UMHC;K Z74)N@?\
M3S<2$$<M_>)!%4?!O[/[>'/@A\(=2M/ LMGX]L_&UK?ZA=_8C_:4$!OIA*TC
MD;UB\EERN=H4CBJY5S)7ZI?>[7]/\OF3=V;MTO\ @]/73\3[1HISXWMCIFFU
M!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=<^&=6D'B[P5\06\3R:%!=$3WNFI;6RS)+%G+QR1>;M+ @N@(Y%))7L^U_\
MR9+7T3=_0>MM.]OP?YM+[SZU\0>)K#PNNFMJ#3(NHWL6GVYB@>7=-)G:&V@[
M5X.6. .YK6V,,_*>.O%?(LOCW5O&3:#\1].U[48/#WBSXEZ3IFBV\5S)'"^D
M0B2+.S(&)Y!([#'S )GI7+ZA'KEO\'O%?Q.;QUXI.OZ'\0;FUTZ :M(MC!:K
MK"P-;M #ME5D=@?,R1P%V@"B,;Z/O_\ (_C[VO\ 5TVEJNW_ ,E_\B?<01B,
MA21ZXIM?#GQ0\86;:!\==6\4_$S7_"?Q2T2[U.#0M L]7EM%M[)(S]C\BS7Y
M;A)D^9I=K$%F^9=O'V3X&GDNO WAJ>9VEFETJTDDD=BS,QA0DDGJ223FDM8\
MWI^/]:CEH[>OX6_ST-JBBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 '6LK4_"6AZT"+_1K"\SWFMD8_GB
MM6B@#SO5/V>_ &J[BV@):L>K6<\D1_0XKD=4_9%\+7638ZKJM@QZ!G691^!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 7.*&.]2K?,IZJW(/X4E%
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M** "BBB@ HHHH **** ,CQ9X0T3QYX?N]"\1:7;:SH]V )K.Z3<C8.0?4$$
MA@001D$5Q=K^S7\,;/PW=Z%%X0M!87=U'?3NT\[7+W$?$<OVDN9@R D*0_ )
M X)KTNB@#SA/V<OAHFBZ]I \(63:=KRP#4X7DE;[6T))BD=B^[S%)R) 0_3G
M@4VS_9M^&-A::A;0^#K(1:C:I9WF^25WN8TD\U#([.69U?YA(3O'9J])HIW
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M%'LZW\R^Y_\ R0<^%_DE_P"!+_Y \S_X3O1/^?F?_P  I_\ XBC_ (3O1/\
MGYG_ / *?_XBO3*K:EJ5IH]A/?7]U!8V5NADFN;F01QQJ.K,Q(  ]32]G6_F
M7W/_ .2#GPO\DO\ P)?_ "!YY_PG>B?\_,__ (!3_P#Q%'_"=Z)_S\S_ /@%
M/_\ $5Z5'(DT:R1L'1@&5E.00>A!IU/V=;^9?^ O_P"2#VF%_DE_X$O_ ) \
MS_X3O1/^?F?_ , I_P#XBC_A.]$_Y^9__ *?_P"(KTRBCV=;^9?<_P#Y(.?"
M_P DO_ E_P#('F?_  G>B?\ /S/_ . 4_P#\11_PG>B?\_,__@%/_P#$5Z95
M#6]>TSPSI<^I:QJ-II6G0 &6\OIUAAC!.!N=B .2!R>]+V=;^9?<_P#Y(.?"
M_P DO_ E_P#('!?\)WHG_/S/_P" 4_\ \11_PG>B?\_,_P#X!3__ !%;>D_&
M7X?Z_J5MIVF>.?#6HZA<ML@M+35[>665O145R6/!Z"NQI^SK?S+_ ,!?_P D
M'M,+_)+_ ,"7_P @>9_\)WHG_/S/_P" 4_\ \11_PG>B?\_,_P#X!3__ !%>
MF44>SK?S+[G_ /)!SX7^27_@2_\ D#S/_A.]$_Y^9_\ P"G_ /B*/^$[T3_G
MYG_\ I__ (BO1[JZAL;:6XN)H[>WB4O)+*P5$4<DDG@ >M1SZC:6NGR7\UU#
M#8QQ&9[F20+$L8&2Y8\!<<YZ8I>SK?S+[G_\D'/A?Y)?^!+_ .0///\ A.]$
M_P"?F?\ \ I__B*/^$[T3_GYG_\  *?_ .(KT.#4;2ZT^._@NH9K&2(3I<QR
M!HFC(R'##@KCG/3%)IFJ66MZ?;W^G7<%_8W""2&YM95DBD4]&5E)!'N*?LZW
M\R_\!?\ \D'M,+_)+_P)?_('GO\ PG>B?\_,_P#X!3__ !%'_"=Z)_S\S_\
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M )^9_P#P"G_^(KTRBCV=;^9?<_\ Y(.?"_R2_P# E_\ ('F?_"=Z)_S\S_\
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MM>E"3DG?=:,SK4U3DN5W35U_7EL%%%%:& 4444 %%%% !1110 4444 %%%%
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MUWP5)X@UG['I\,[S30WD41\DR!A'O!(.=P"L<<X88'[/_P 4-=_X39/ 5O\
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M7SM.WGZH@^$GABV7P.([%P/!:E-$_P!(D/V<&V:VYY^?]TQ7YL^O7FN.T_\
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M:>KFUW_R1WXG14XO=17XMO\ )IA1116QQA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "@X
M-8:^%4LY)&TO4M1T6.1B[V]E,!"6/)8(ZL%)[[<5M/(L2,[NL:*,EG(  ]R>
ME5O[6L/^@A9_^!"?XUE.,)?$=%&I5IW=/KOU7S6Q1_L74O\ H:M:_P"^H?\
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M;_R5?Y%'^Q=2_P"AJUK_ +ZA_P#C5']BZE_T-6M?]]0__&JO?VM8?]!"S_\
M A/\:/[6L/\ H(6?_@0G^-'LZ??\7_F'UC$]O_)5_D4?[%U+_H:M:_[ZA_\
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M_P"AJUK_ +ZA_P#C5']BZE_T-6M?]]0__&JO?VM8?]!"S_\  A/\:/[6L/\
MH(6?_@0G^-'LZ??\7_F'UC$]O_)5_D4?[%U+_H:M:_[ZA_\ C5']BZE_T-6M
M?]]0_P#QJKW]K6'_ $$+/_P(3_&C^UK#_H(6?_@0G^-'LZ??\7_F'UC$]O\
MR5?Y%'^Q=2_Z&K6O^^H?_C5']BZE_P!#5K7_ 'U#_P#&JO?VM8?]!"S_ / A
M/\:/[6L/^@A9_P#@0G^-'LZ??\7_ )A]8Q/;_P E7^11_L74O^AJUK_OJ'_X
MU2-H-_("K^*=;9#U"RQ(3^*Q@C\#5_\ M:P_Z"%G_P"!"?XT?VM8?]!"S_\
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M\XVWW7(];VMUVOROB3Q8NM:/HFDVEE_9VFZ7&^R'SC*99I"#)*Q(')(   X
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J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>img247211528_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_10.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $+ T4# 2(  A$! Q$!_\0
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MK72E))Z7>YSA1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBGR3J6>5X2_)3?+4G9X3X(.+4Y;1::DT[BYI>6G]U=+>72R^X\2_X9T\4?\
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MHTH4H3J2FHIL$YMI)7=K_#'9).^VR44V]M#KO^&=/%'_ $=7^TY_X.?@]_\
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M^ Q\O+R1\Q_\,Z>*/^CJ_P!IS_P<_![_ .<Q1_PSIXH_Z.K_ &G/_!S\'O\
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MV]Y)K6_Q22WL?CNW[#GQ8U+X5?"?]I'1?@'X[\5?M8_%K2OCO^T%KGB+34^
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M^)_"D&@6FJW$WB^V^->H:+\+;?4]6\/6^IZ01X<\0OJ\X@OK-S^_'P5_:<^
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M(PU>="O]:I5*C]K6MK334DGI&35GRN.TFEHHV375-IWN?A!\$/\ @G]^U_\
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MTE&SNI;VBD]M;J2NK+\5O^"BWP'_ &E?C1\3;KP_X:^"6D?%/X/ZK^RUX_\
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M%S\+Y(=?OO$5EJRFTU'P;8W",TM[X'?\$W_VFO"UY^Q'\%OB/XF^#B_LZ_\
M!/WXO>+OBIX \?>$[WQ-/\6?C,9E\6Q_#?2/$7A2^T"TT#P(^C6_B^['C^ZL
M_$VO)X@N[.W&E1+#-/<#]VZ*C_7S,J.6X7*<!A<%A,)A<+5HT^:$\35IUZU+
M,L/4Q=&I5DN2I'#YQF5"C&<:JA#%RJ5)5:]'"UL.O:R45%)))66EVF[W:_\
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M75?#_A#2/B'?:?%IMXVKS7#:;I6L!#H%WJ$4EDFKFYAF5/F?X._\%7?@Y?\
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MS7WGZ+T5\H7/[6G@/7]+_:ZM_AHFH^(O%7[(=CK>G^.?[4T;4],\(S^/-/\
MAU)\0H/"VF^(618M;DL;&738/$K:29&T:>^2TE871"C\_/@'_P %/?$?BCX
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MSQ,(NA"M/ZO*HJ\9TXQ*$HI.224MGS1=]$]+-Z6:UVOINFCNJ***\$@****
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M:/'/%F'I4:-+.L2H4,30Q493C0JUISPU&EAZ-&O7JT9U\3@U0HT:4\!B*E7
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MI5OKV'G4HT*>&A.IE>5SD\/2Q5?&TZ%1O!WJTH8K$XBM"%7GC"=5R@HRA3E
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M3/!"C5#=3P6D=C?6=Y8K%"[RF83&-/D*X_X(SW.@_P!F_P#"'?'VV\63>)/
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M0]/N+FU$OD7T$<EI=));S2(UW[;>_P#/Y=_^!,__ ,<H^VWO_/Y=_P#@3/\
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MZ*\@^VWO_/Y=_P#@3/\ _'*/MM[_ ,_EW_X$S_\ QR@#U^BO(/MM[_S^7?\
MX$S_ /QRC[;>_P#/Y=_^!,__ ,<H ]?HKR#[;>_\_EW_ .!,_P#\<H^VWO\
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MWO\ S^7?_@3/_P#'* /7Z*\@^VWO_/Y=_P#@3/\ _'*/MM[_ ,_EW_X$S_\
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M;>_\_EW_ .!,_P#\<H^VWO\ S^7?_@3/_P#'* /7Z*\@^VWO_/Y=_P#@3/\
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MKU(0H1G4CVO"48NTJLT[)VLMG)1T[ZW7=:-Z79_;A_P\<_X)]_\ 1['[,?\
MX=WPK_\ )M'_  \<_P""??\ T>Q^S'_X=WPK_P#)M?YKUCX8\2:I8W&IZ7X9
M\0ZIIEF91=ZGIF@ZKJ&FVAMXA/<"ZO[.SFM+8V\#+/.)ID\F!EFEV1D,?J;X
M$_L+?M!?M%_![XR?'GX=:3X/3X8_ SPSXE\4>,]9\2^--&T34;VT\(:9;ZQX
MBLO"OAM3>^(-<O=,TZ\LIKBY.FV>A1RWUC92ZU'?7EM;2=^,^COP;E]%XC'<
M8YIA*"K4<.ZN(65TH*OB*D:5"C>=)7JU:DU&G37O3;5E:]F\%26KJR2NEM'=
MV27J[NWR/[^_^'CG_!/O_H]C]F/_ ,.[X5_^3:/^'CG_  3[_P"CV/V8_P#P
M[OA7_P"3:_@DU[]@3XK>%OAG\+?B)XD^(_[/6A:Q\;_AQX6^*7PA^">I_$^:
MU^/OQ$\,^-KZ/3/"D/AGX</X9W7NM:[?R?9[#3CJ\:2M'-_I0$,FWJOCU_P3
M.^/_ .S]X ^(WC_6_$_P2^($?P-U?PAX>_:*\(_"?XBIXP\:_L^:]X[BCD\-
M6'Q,T@Z1IUM;P74UQ:Z7=:GH>H:Q96&N2R:5<.'M9YU\]>!?A[*K0H+CK,?:
MXFO/"X>/)EZ5:O3Q%'"3A3D\.HR2Q>(H82,^;V<\76HX6$Y5ZL*;2PE!M+VL
MFV[*R6KO%.WS;2>UVEO<_N]T[_@H9^P5J^HZ=H^E?MF?LV:EJVL:A8Z3I.FV
M7Q7\,7%[J6J:G=0V.FZ=96Z7A>XO+^]N(+2T@0%YKB:.) 68"OL1U9&9'4HZ
M,5=6&&5E)#*P[%2"".Q%?Y8WP*5?^%[? K@?\EN^$'8?]%&\,U_JAZC_ ,A"
M^_Z_+K_T>]?E_BWX<9=X=XG(J&7YCC<P6;4,PJU98V&'@Z3P=3!P@J?L(034
M_K,G+FNURQM:[.?$4(T7!1DY<R;=[+:W;U93HHHK\A.8***559CA5+'T4$G\
MA0 E%2>3+_SRD_[X;_"CR9?^>4G_ 'PW^%.S[/[F3S1_FC]Z_KJOO(Z*D\F7
M_GE)_P!\-_A1Y,O_ #RD_P"^&_PHL^S^YAS1_FC]Z_KJOO(Z*D\F7_GE)_WP
MW^%'DR_\\I/^^&_PHL^S^YAS1_FC]Z_KJOO(Z*D\F7_GE)_WPW^%'DR_\\I/
M^^&_PHL^S^YAS1_FC]Z_KJOO(Z*D\F7_ )Y2?]\-_A1Y,O\ SRD_[X;_  HL
M^S^YAS1_FC]Z_KJOO(Z*D\F7_GE)_P!\-_A1Y,O_ #RD_P"^&_PHL^S^YAS1
M_FC]Z_KJOO(Z*D\F7_GE)_WPW^%'DR_\\I/^^&_PHL^S^YAS1_FC]Z_KJOO(
MZ*D\F7_GE)_WPW^%,(*DA@01U!!!'U!YHLUNFOD--/9I^C3$HHHI#"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:M6AX<<<5J%6I1K4N&,YJ4JU&<J56E4C@JSC.G4@XSA.+2<91:E%I--,_6_
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M .%KK/\ \DT?\-0_M)?]%X^*_P#X6NL__)->%44?ZR<1?]#_ #S_ ,.V8?\
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M8W#T<93IT,;4JQ^3P64>$6/QF(X?PGA-2P^;N6/PE/*<RR[+\-2Q^,P&.RC
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MX  &223P  23P!FE961F1U9'4E61U9'1@<%71@&5E/#*P#*000"*_07P59?
M#6+?POXYT7P=\(+#QU>Z7\'-9U7X<>)OB7K6@>#/!]K#XT\66WQ*\1:/=ZWX
MJM-0E\6V&EZ+X/U Z!JFN:E-:VNK7NJ:?H%]"Z00_*'QXU'2]7^./QDU;1+Z
MRU/1=3^*7CS4-(U+39X;G3M0TR\\3:E/87EA<V_^CSV=S:R136TT/[J2%T9
M%( PS/AW^S,MP^82S/ 8U8NM3C0I8+ZQ-.A4AB9*M4J8BCAW"HO80<L,J<JU
M&.(I?6EAZDXTI=F0<:K/\\QN2QR+-LL>786M4Q5?-/J=-K%T:N IRPU&E@\5
MC8U:+^N5%3QSJPP^*J8/$K O%T:=2O3\HHHHKYL^X$;H?H?Y5_6E^P;_ ,F?
M? 7_ +$Z;_T^ZO7\EIZ'(SP>/7VK]NOV6OV-OVM_&_[/_P -/%W@S_@K1^UC
M\'/"GB+2]3U70/A9X/\ @K^R!KOA?P'IMUXAU=[?PUH.L>,_@UK7BO4=-TX$
MQ6UWX@U?4M4F3#75W+)EJ_J?Z)J7^N_$;NK_ .J59<MI7:>=9.W)-1<;1:2:
M<E)N<>522DX_Y_\ [1%O_B%7!<>633\0L/)SO'EBX\-\1)0:<N=RFI2E%QBX
MI4Y<\HMP4_W/HK\KO^&#?VW/^DV7[:O_ (C_ /L-?_.'H_X8-_;<_P"DV7[:
MO_B/_P"PU_\ .'K^^3_'\_5&BORN_P"&#?VW/^DV7[:O_B/_ .PU_P#.'H_X
M8-_;<_Z39?MJ_P#B/_[#7_SAZ /U1HK\KO\ A@W]MS_I-E^VK_XC_P#L-?\
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M_A$#_P!! ?\ @*?_ )(H_P"$0/\ T$!_X"G_ .2* .,HKL_^$0/_ $$!_P"
MI_\ DBC_ (1 _P#00'_@*?\ Y(H XRBNS_X1 _\ 00'_ ("G_P"2*/\ A$#_
M -! ?^ I_P#DB@#C**[/_A$#_P!! ?\ @*?_ )(H_P"$0/\ T$!_X"G_ .2*
M .,HKL_^$0/_ $$!_P" I_\ DBC_ (1 _P#00'_@*?\ Y(H XRBNS_X1 _\
M00'_ ("G_P"2*QM7T@Z5Y&;@3^?YG_++R]OE[/\ II)G._VQCOG@ Q:*** "
MBBB@ HHHH *VO#W_ "%[3_MM_P"B):Q:VO#W_(7M/^VW_HB6@"#XK_'/X-?
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MAU?Q_P"//%-E\3I;G2_B=IOA6,0V_BGQ ERMG^R^D_M'?L]:]:^-[[0_CO\
M!O6;'X9Z;8ZS\1[W2OB=X*U"T\ Z/JEI)?:9JWC.YM-;EA\,:7J-E%-=6.H:
MT]E:7<$,TMO-(D,A7YF\$>'_ /@FW\)M:O/VN/!?B3]FSPK-X^M/'>I6OQG7
MXI^&7\(W-GJ&LVNK?%&]\#ZGJ?BRY\%^'(=3U]K.^^(LW@>'2%U'5C;2^*6G
MNS$: /S'N?VD/&5O#XG^'W@+]LGXD>,_V&4_:+_9V\%>*/V^KGQ+X1UWQ5\/
MO#'Q#^%'Q0\5?$WP18?'.R\*6OA Z3'\3]"^"'A;4/BG)I\S?"@?&?4O"5UJ
MVF7VDV$OAOWN#]JO]H[1O^">>L?$_P $^.T\4>)(_P!KWPI\ O@+\>_'G@^V
M\12_%3X!^,?VK_!GP6\%_&G7_#FG6_A?3_$TU]X)\3WTUOK^EP:#I_CB'0[+
MQM9RVUKXA6[/ZS>+?&O@GPI\&/$WQ&TG3-*\9^ =(\ ZUXXM-,\)7G@_^R/%
MWAY-'N=?\O0M2UK6-$\#2VOB&U9I+34M6U[3?#MP+Q;R_P!6M[&26[7"MOVC
M?V?!JFG>#[[XQ?"/0O&,^AZMKA^'NI_$CP%;^+-,T[PEIRZGXK:Y\/PZ_-<1
M1>"K..2;Q)<6Z2V.AP6D]S<W,5K TX /QY\6_MC_ +9_A+]HGQ[\)+7Q/X;U
M+QK\)OBE\-?AK\.O@]XXU;X(> IOVK?!.I>"?!NN>(OB;-H\FB3_ !677/'^
MJ:YXQLO VN?",Z?\,/ 6K^#8-&\=:/J*Q>)+NSY!?V^_CMI_[.C_ !7\-?M3
M>#OB_P#&GQAH7PEU+XP?L_P_"_X?^&;O]A&T\:_%OPSX/^+/B/Q%>J\&I:#9
M? [3=8UOPKJ&B_']]8NKW6]&_P"%D:CJ$/@G2-=T:;]TO&7Q9^"'@.U/B_Q_
M\2?A;X0M-+\/6NO#Q-XM\7>%-"AL/"NO7L=A9:PFKZMJ%LMOH&M:BL-E:7R3
MKI^IWRQVT$L]P%09$GQQ_9RTZ_\ !5G)\7/@O9:E\<DM+OX>6Y\=>"8+OXNQ
MWZQV>GW7A!!JBR^.H[Y9(;.QGT@:HEV9(K6W>0ND9 /P@F_::_:V\8?$GX:3
M^"M0^%OQ9\7>'/!/[;VM_ CXKFT^&OQ*\6>.K3X7^$_V;O&.J?#/6/$/PBL-
M%^%6G:SXCU+4/$OPXNM?^'5E;Z5K]G-X6U*6QTGQ#X>U2"3G?VE/^"@OQIUW
MPKX3_;%^"UEX-/AGQ5\./VT_%_[(FK>-/AA)J>N^&_!7PWT7]G/P99^)-362
M>RU@1?$GQOJ7CO5M7T6Y^S2W7A:S\,VEA+"UL;Z;]]?A-\<?AAXZ^&6G^.[*
MZ\/> =*TZ"R@UOPWK7BCX>-=_#^;5;M;;1])\277@WQ1XC\*:1=:TLUA=:3;
MVNNW$5_;ZEI_V=GFG$0ZWPU\7?@[XV\7>*/AUX/^)GPW\6>._ >8O&7@CPYX
MP\-:YXJ\(#SUM7C\1>'=-U"YU70PMT%M95U&TM@ER%MY LP"4 ?C7\2_VF?V
MH/A#\8O$7[/?Q(_:JTCP=\.V^/GPWT/Q#^V7X@^$/PVT%O@_X4\?_L_^*/B3
MI'@";3[^QN/A-I5OXR^)?A:#P=X2^(/Q%TS5(M#TS5IO#>MWVO\ C'4O#&K-
MZ#H_[9GQYD_X)V^-OCS;>./"WC'QIHO[3_Q)^"MW\=K#X9W-IX3\%_!SP_\
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MM'_#H#]H'_HH7PF_\"_$O_REK^B>BC_B6;PJ_P"@+.__  ]XG_Y#^KORL?\
M$]?T@_\ H;\,?^(ME_\ \EY?GW9_.Q_PZ _:!_Z*%\)O_ OQ+_\ *6C_ (=
M?M _]%"^$W_@7XE_^4M?T3T4?\2S>%7_ $!9W_X>\3_\A_5WY6/^)Z_I!_\
M0WX8_P#$6R__ .2\OS[L_G8_X= ?M _]%"^$W_@7XE_^4M'_  Z _:!_Z*%\
M)O\ P+\2_P#REK^B>BC_ (EF\*O^@+.__#WB?_D/ZN_*Q_Q/7](/_H;\,?\
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MJ:=U'FC:TM/S'Q4^D=XG^,F28#A_CC&Y/BLMRW-:><X2&7Y-ALMK1QU/!XO
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M+9:CJVNSG3;6[D;3-/L+RYNHHY(H[:8G80#[@\$_$3X?_$S27U_X<>.O!WQ
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M6M!U>\0 _I+HK\@/VX$\7>!O%'[/FC>-_'GQ=\6?!70_@A\4K+7]+^$OQ_\
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MX5T6"QU3PS<Z+I-H==UVSNI(M+ /7_!?_!,O5-%\;_!/QAXDM_@GK=Q\/?\
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MOV(OV/\ _A>'P,/@Y?'C?&/X:> PWCKPU)XKT$:%XLC\2/JY_LB+5=&8W_\
MQ*+46EW]MVVX,V89=XV_I]7X1_\ !QE_RC@3_LY;X'_^B/'%?3\%8/"YCQAP
MME^.HPQ.#QO$&483%X>IS<E?#XC'T*5:E/E<9*-2G.46XRC))W33LSJP48RQ
M-*,HJ2;;:DE*+M&35XR335TM&FGU31^$W_$17_P4D_Y[_LV?^&.O/_GA4?\
M$17_ ,%)/^>_[-G_ (8Z\_\ GA5^%E%?WG_Q"+PU_P"B0RSI_P O,=TM_P!1
M?]U?B>KRT_\ GSA__";#^7_3KR_JRM^Z?_$17_P4D_Y[_LV?^&.O/_GA4?\
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M44 6[#_C^LO^ONV_]')7KM>16'_']9?]?=M_Z.2O7: "O/O%/PJ^'GC;Q?\
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M71K?4K*+P'9Q:6_@F*18+GPI';6D&EII_P!FCBCFT/\ 9$_97\,3>.;GP_\
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MX_\ 29/_ (*J_P#A7_LK?_0P4H_X)J?'$$$?\%D_^"JF00>?%W[*I''J#^S
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MNUXW#*T,T4R@%H9$E4-G:6C8. V"#@D#."#CH171_P#"5ZA_SQM/^^)?_CU
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MND?\]Y/_  'G_P#C='_"2Z1_SWD_\!Y__C=>:T4 >E?\)+I'_/>3_P !Y_\
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M-_\ @B3_ ,HM/V2_^P!\2/\ U='Q&K_/(K_0W_X(D_\ *+3]DO\ [ 'Q(_\
M5T?$:OYM^DQ_R2_#G_905/\ U6XHY\9_NC_["*/_ *;Q!^J-%%%?QB>.%%%%
M !1110 4444 %%%% !7@O[4_QCU3]GC]FGX[_'G1/#=KXRUCX/\ PP\3_$#3
M/"5]=WMC9^)+W0+47$.D75[IUO=W]K!=L=LD]G:W%Q&!F.)SQ7O5''< CN&
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MZ,@UMB?\\8?_  'A_P#C='^O'AE_T9S"_P#B;9[Y?]0OE^/K<]K0_P"@9?\
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M %MXJ_Z*;B'_ ,/69>7_ %$^2#ZYB_\ H)Q'_@ZI_P#)>7Y]V?D[_P ../\
M@EK_ -&OK_X=WXV?_/#K]#_@E\%/AC^SG\+?"7P5^#/AA?!OPR\"VVHVGA7P
MRNJZSK8TNWU;6=1\0:@G]J^(+_5-9O#<ZQJVH7C/?7]RZ-<&*-D@CBC3U.BN
M+'9UG.9TX4LRS?,\QI4Y^TITL=F&+Q=.G4Y7#VD(8BM4C&?(W'GBE+E;5[-W
MBIB*]6/)4K5:D;J7+.I*2YDFD[2;5TFU??5]V%%%%>88A1110 4444 %%%%
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MWPAX9U;Q%\1=3\+_  ^\&^(/^$6.M:'\,/#5]XTN-"^&$6H2>"?"4\]Y\/\
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MPH FHJ'>WK^@_P *-[>OZ#_"@":BH=[>OZ#_  HWMZ_H/\* )J*AWMZ_H/\
%"B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>img247211528_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_11.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %8 Z # 2(  A$! Q$!_\0
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MQ)9)H'B;PWK,5]8F+4_#NJZI;PO?6:730O<PAP#Z0HK\_OC_ /\ !4C]A/\
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MY-?\%9_VGOVU/V9O^":_Q8\!?$3Q3\#/'_[7_P"V-XZ\.?L>_LGZ3^S#X/\
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MQ7XWU3^V_%^M:?>^,=$NO$FK^68AJ6L#1?$^GP7MXL3-&DTT3.BO(J%1(^X
M^,_^"W'C;]H']DC_ ((0_&/Q%X/^._C6S_:$^$WP]_9>\-7GQ]\*:E/X=\9:
MYXFC^-'P6\'>,_%=MJ%LWVFSF\96UWK:Z@ YEFL]8NH97+2NQ_-3P3HO[2'[
M87[:7_!9GPYXM_;K_:\^&WPP_90^!_[/OB_X0?#?X/\ Q4O? ^F:5\4O&7[(
M?AWQJGC6^U6RMWUBZTC2-;TN_P!3F\!PW=KX:\2:SK^H:IXAAOGAM8D_J8^(
M'[)7[.'Q6_9X_P"&3OB3\(_"OC?]G3^Q/"7AU_A-XDBOM3\,2Z+X$U;1M=\(
M6-PMQ>O?W":#K'A[1=2L99[Z2X6[TVVFDED93N3PE^R1^S7X$\4_&KQMX0^#
M?@OP_P"*_P!HO1/#?AOXX:[I]A+'?_$O0?"'A1O _AG2O$TCW#K=6>B^$G?0
MK**)(!'8NZ-N=F<@'X^_L;>.M*_;W_X-V_ ^N?MZ?'1O".@_'?\ 9/\ 'O@+
MX\_M">(_$&C>';O2='.O>*_ALWQ \0>)-?\ *T*'5OL>FZ;?:M?ZOLL=2U)Y
MVO@5O)<_'WBC]I/]M#_@BO\  /\ 8Y\,_&U?V/?^"C7[!L/C[X-_L[? _P >
M?"+3+OX7?M.:(EWI<UC\'_$EAX.>]\<_"3XB2:=I6CPQVFK^!KRPURZG0:E<
M:HDFH?;:_I5\!_LO_L\?#/X#:?\ LO>"O@W\/](_9WTS0]4\,VGP:E\/66K_
M  ^_X1[6M2OM7U;1KKP[K::E8ZAIVHZGJ5_?7=KJ$=S%-<74KNI)&/E7X7_\
M$@?^"9GP8^(?A7XJ?#3]C/X,^&O'/@/5KK7O >JKI&HZM9>!=:O':6XU7P3X
M=UW5-3\->$;]IV-TESX=T?398;Q4O(&CNHXYE /Y=O@-\</^"@?[87[$G[0_
M[:VG_$S]L;P[^UM:_&?XLQ>"_B+I/[3GP*^#/['G[.NN?"_QS<:%X1^!GB[X
M%_$/QGI%A:^ ;BQ:RT_X@#XC^%+_ ,5ZW)XA34+/499DL;FX]E\3_MQ?MS_L
M=^ /^"BG[+7QM\=^)I_VR?VI?AW^RU\8/V"/#Y\;3>+IO"GQ'_;;;2?@U\4O
MA=\(?$#-<Q3>$/V;_C7>ZOJFAS:3<WEAHWA>'3K^WD:)ED;^D'QG_P $I_\
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M#Q+XK\2_%RPN(_%VM:'\-K2!7/AW0;NW87VF3W6K-<6,FH(W].'Q!_X);_\
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MV@?V3?'O[>T>M?L2>%M'\%^*OC7;_MC^!_@?\ ?@Q\=?AK\/M(UWQ+I7PT^
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M>#O$4W@U;5?"][XS\"Z7K=GX,\<ZEHHLK8V>J>,="US4-T>^6YE=G9@#Y_\
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M#U_IZ'U%_P#/Q?\ @+_^2/\ 6*HK_)U_X:1_:0_Z.,_:"_\ #W_%'_YJZ/\
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MK\)_X9ZWE_U,/ZT[Z'U%_P#/Q?\ @+_^2/\ 6*HK_)U_X:1_:0_Z.,_:"_\
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MTA\?Y &9"4^./Q0<!U.&4E?%A 93PRGD'J*?_P -(_M(?]'&?M!?^'O^*/\
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M'_1QG[07_A[_ (H__-71_P 2QX__ **_!_\ AGK?_/#U_IZ'U%_\_%_X"_\
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M^&D?VD/^CC/V@O\ P]_Q1_\ FKH_XECQ_P#T5^#_ /#/6_\ GAZ_T]#ZB_\
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MGA*>'PV(I2;@JT91BVW&\Y2>Z24I.*BVOM<T;IZI0=K)GY:T445^K'0%%%%
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M[?L-^Q[^P!^R5^SE^U[\>_@'XV^-=[\<OVD/A?\ L;_$S7O&GPL\4_ S2?\
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MXT8TI3H1A&E4ESP59*TM%:2M>-U[L>5IJ[OS<RU;5K>3/NS]J#_@EE\--/\
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M]H7A^/XC)I,UV]A?)H4.FW.#]OM)?):T:Y]8U/\ X+D-K5K?>']1_8E^%J^
M+SX)?"7X&)\/[#XM^-H-$M?"WP/\<W_CKX<Q0W-QX:NKMK*RO;_^S=:TZY^T
MMK>GVT*W-ZHDN8IN8^(G_!9P^,K#]I]]+_9GN=/\2_M<:;X0D^)&L>(_VCOB
M%XLT/P=XE\#-IMQX:G^$_@C4/#Y\/^%_"UEJ6DVNKW?A\(MQJ]U)/:W.I0:<
MD-LJPM/Q7A4Q<JF$Q%.MC\UPV+JUOKW#5;#4\"Z60X&M@XX:=>I/"SI83#YM
MBH5LOG2C+&NE*='$U,5.=%)8C6Z:<I1=[PLHVA%JW1V4G=):ZN[>GU[\>_\
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M *K+6:_T3Z_A_P"DA_R7F7_]DOE__JSSD\K&_P 9?X(_G(****_G\Y HHHH
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M_B&E_P""C'_0>_9D_P##G^-/_G5U_?/11_Q,/XA=\C_\-D__ )K#ZY6_N?\
M@/\ P?ZN_*W\#'_$-+_P48_Z#W[,G_AS_&G_ ,ZNC_B&E_X*,?\ 0>_9D_\
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M56I"4)<O+*U[*ST:DNO>*_$****_)3G/PB_X+A?\$X/VAO\ @H?X=_9MTKX
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M![]F3_PY_C3_ .=77]\]%'_$P_B%WR/_ ,-D_P#YK#ZY6_N?^ _\'^KORM_
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MKXGZW^UYXQ^)^C>&_P#@GUX9^(G[1G[._P"TY^QC\%/V8_&>G?$D?LL?M _
M?PWJNC:Y^T%+]J\-Z)\,;OQ+\76U7^S?&?@;0M";P]J_AVVDAU.^6]FMY+4
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M\,:A+<++8RQ)+^/'[)__  6&_:D\4?\ !+S2?"WQ)\5^'?%__!4GXDZ+\/\
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MCL]'T:#3]-T[38+/Q/P-_P $+O#^@:-^SQ\#?''[7?QD^*?[#W[)OQF'QP^
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MWXG76C:II-U\,M:T&*.?3=6^&VNZ%IVN^#O$LY;54OX +\W%J\UO+\D_!O\
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M",NI:WXC^%_B#]IG]M3XN_M,?\,X?L_?%']G[]EO3==^'_PY\!67PGM/BKX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQQ_;0
M^%-GI7_!13_@F)\:W\>_%/4-9\0_M">/_A]8^!K[Q[JD?PG\,:%#^RC\==4U
M>?P_\.]/%CHLOB'Q+J.FZ5=ZWXAU\:[JH&E6=MI4^EV:R02?L=7-:WX,\(>)
MM5\*Z[XC\+>'=>UKP+JUSK_@K5]9T;3M3U/PCKE[I-_H%YK/AF^O+>:YT/5+
MK0]5U/1KB_TR6VNIM+U&^L))6M;J>)P#\7_C)^R#^RU\3O\ @H]\#O ?PO\
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MMY+EXDFN8(RTJ '>UX5^TU\&=2_:(^ ?Q2^"&D_$SQ9\';KXG>%KKPE+\1O
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M9A1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_BS3K2T\3Z3;71D>'3]7MHUFGC5)I/I>J,=[ID2)%%=V$<<:+''''<6Z)&B
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M$****H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O\]7_@XT_Y2L>,_P#LU_\ 9O\ _3_\<J_T*J_S
MU?\ @XT_Y2L>,_\ LU_]F_\ ]/\ \<J_8O 7_DYV1_\ 8+G?_JEQYTX3^/'T
ME_Z2S\.:***_OX]<**** "BBB@ K^BK_ (-?O^4A_P ;?^S+?$7_ *O/X25_
M.K7]%7_!K]_RD/\ C;_V9;XB_P#5Y_"2OR?QQ_Y-?Q/_ -T;_P!7^5'/BO\
M=ZG_ &Y_Z7$_O&HHHK_/<\<**** "BBB@ HHHH **** "BBB@ HHHH ****
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M  :_?\I#_C;_ -F6^(O_ %>?PDK\G\<?^37\3_\ =&_]7^5'/BO]WJ?]N?\
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M_P"AL^,7_B0O[0/_ ,\^C_B;/@O_ *)KBO\ \ R;_P">OK_3T/\ BG9XG_\
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M<[_]4N/.G"?QX^DO_26?AS1117]_'KA1110 4444 %?T5?\ !K]_RD/^-O\
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MMKGP&\#ZCI_Q*&NQ7VF^#K/P/K7VO5O"#>%KV_U?Q/86^IMXLM-.N=4T6_\
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M** "BBB@ HHHH **** "BBB@ HHHH *_SU?^#C3_ )2L>,_^S7_V;_\ T_\
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MX<:_]C#@[_UL,C/ZJ****_TN/\+PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH *_SU?\ @XT_Y2L>,_\ LU_]F_\ ]/\ \<J_T*J_SU?^#C3_ )2L>,_^
MS7_V;_\ T_\ QRK]B\!?^3G9'_V"YW_ZI<>=.$_CQ])?^DL_#FBBBO[^/7"B
MBB@ HHHH *_HJ_X-?O\ E(?\;?\ LRWQ%_ZO/X25_.K7]%7_  :_?\I#_C;_
M -F6^(O_ %>?PDK\G\<?^37\3_\ =&_]7^5'/BO]WJ?]N?\ I<3^\:BBBO\
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M1\^%%%%4 4444 %?R;?\%F?^4B>B_P#9E'PF_P#5[_M$5_637\F__!9@$_\
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M $M>GZ[5_EI_=+_Y,_RP_P#AWY_P4(_Z,#_;._\ $?O&O_R-1_P[\_X*$?\
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M>_X;U^'?_1"?VX?_ !!K]J/_ .=A1_PWK\._^B$_MP_^(-?M1_\ SL*^X:*
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M*'_SUZ/^(5W]J_\ Z/+_ &<O_#'?%#_YZ]?V]T4_^(S>)W_16XK_ ,-^2_\
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ME;^67_AR#^VW_P!'%?LE_P#AIOC1_P#/3H_X<@_MM_\ 1Q7[)?\ X:;XT?\
MSTZ_J:HH_P"($>$?_1%8+_PXY[_\]?+\^[#_ (FV^D;_ -'2S7_PR\)__0__
M %=^5OY9?^'(/[;?_1Q7[)?_ (:;XT?_ #TZ/^'(/[;?_1Q7[)?_ (:;XT?_
M #TZ_J:HH_X@1X1_]$5@O_#CGO\ \]?+\^[#_B;;Z1O_ $=+-?\ PR\)_P#T
M/_U=^5OY9?\ AR#^VW_T<5^R7_X:;XT?_/3KU+]G_P#X)+?MW?L]_M!_#C]H
M;0?CK^R!XAUWX;:'\1=#T_PYJ?PO^-EAI6I0_$?1]+T;4+F[OK?XEW5W!-IL
M.E12VB102QSM-*DHCVI(/Z2**]3)?"'PWX>S3!YUDW"N%P.:8"<ZF#Q<,;FU
M6="I4I5*$Y1IXC,*U&3=*K4A^\IS2YFTE*S7@\3_ $C_ !OXSR',>&.)_$#,
M,WR'-Z5.AF675LKX=H4L52I5Z.)IPG5P>38;$P4<10I54Z5>F^:"3;C=/X-^
MR_\ !3S_ *#G[!O_ (2O[0?_ ,V5'V7_ (*>?]!S]@W_ ,)7]H/_ .;*OO*B
MOT@_$3X-^R_\%//^@Y^P;_X2O[0?_P V5?3GP>C^.$?A6X7X_P!U\*;OQO\
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M17N=*T&QTS1=0T+PWX TS4CJFKW9C%KIM_ZE\,_^"BO[3_[3GA_X,Z-^SO\
M!GX-^%_BOXG_ &<_B)^T/\3=/^.GBSQ?I_A?3XOA]\9?$/P(M_AYX1M="L+#
MQ+::QXN\9>$]<U.X\2^+(+?3?AYH8L(-=TK6]7N_LJ?;>N?\$\_V0=?\7Z_X
M^N?A3>:;XQ\3?$/7?BIJ^O\ A;XF?%OP5?2>.?%NBV/A[QKJUC_PA_CS0H='
MM/'VD:9IUK\0_#^CQ6'ASX@-96MUXSTC7+R&.X7'UO\ X)H_L/Z]X!^&_P ,
M;CX#Z7I7@OX1Z/XS\-?#[3O"7C'XC^!M0T#PE\1-9N/$'CGP2WB3P7XQT#Q/
MK'@/Q5K-U-?:WX%UW6-3\(WTOE)-HIBM[>.( ^(_C!_P5'_:"T+QIJWASX1?
MLNW_ (ZN?A7\"/@C\9OBQX8\.:%XZ^,J^(M=^,'A_5/%D_PM\#_&7X16]]\(
M/!(\.Z%HE]]@^*_C[4;_ ,$>++V5)[.TT[0+&]UP>977[9G[5OP,\=?\%/OC
MC8P>#?B5^SE^SG^U%\*KKQ/X,^)7C?QE_P +(T?X=^)/V>/V;=0\4^#/@=8V
M8N_!WA"?P[+XJU+QG9Z9J3:GI_CCQ=K.JZ/96VE7MQ_:]W^IGCW_ ()^?L=_
M$JZ\-7/BKX'Z 8O"W@#PY\*++2?#6M^,/ OAO5OA9X0D$GA3X9^-O"O@;Q'X
M<\-?$7X>^&V\Q=#\%?$#2?$WAK2XKB\@LM,AAO;N.?-\2?\ !.?]C#Q=\4O$
M/QF\1_!'3M3\?>,/&WA+XB^,[J7Q?\1(?#/C;QCX!TO0M'\#ZOXU^'MKXO@^
M'OC!?!]EX9T,^&=-\2^%M4TG1+VP35--L+;5);B\F /ECXP_\%!_CCX"U#]I
M+XN^'/AE\*]1_9:_9$^.?A'X#_%6RUGQ+XD7X\^-=3UAOAE%XL\8_#^VTNWG
M\&:)I_A2?XK:*NC>$_%$5UK'CB'1-4GM]4\/_P!IZ-'+^P%?*/B[]A[]ECQW
M\5I?C3XJ^$NGZIX^O=>\*>*];E'B/QI8^$/%GBWP*EK'X*\7>.?AGIOB2S^&
M?CWQ;X32PTU/#OB?QGX0UW7M&72])%AJ$ TK3OLWU=0 4444 %%%% !1110
M4444 %?S1_&'_@H[;>&_^"HT7BF+X]>.M,^#/P1^.?PR_81\5_ ?3]-\>/\
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M; ^ G[%'PQM_BQ^T%XNN?#?A[5O%6@> O".CZ)H.M^,/&_Q ^('BJX:T\,^
M_A_X)\,V.I^)/%_B[7;A)$T_1M'L+B=UBFFE,-O%)*N-^RA^VW^SY^V?HOQ
MU'X)^(M?;7?A'XPF^'_Q>^'/C_P9XH^&GQ2^%7C.*!KI-!\>_#_QKIFC^(M"
MFO;5)+O2KZ2TETG6;6*>XTG4+V*"9H_B[_@J5^R%\>_C+IO["OQI_9NT+PW\
M4_BG^P3^U-X$_:"B^#OB[7['P7:_&CPOI/A_4?"7BSP]HOB[5C-HGA?QQ%IN
MH_VQX1O]>(T:/5("EY>0D1-)\]_LL?L[_MS^"?VH?VW/VZ/B-^S#H&@^)_\
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M@_91?Q'\8_@M\._V\_C=^W3X[^)Q3Q_X"U*WO/"GB7XA?!?P!I_PC^('Q/\
MAUH_Q7\">+/AW!XWTZ+Q=#XCT467PUT)M.;4B ?T%_!O_@H/^Q7^T%\16^$W
MP;_:.^&_CSX@R6NKWVD^'M*U*Z@?Q;8:!(T>N:A\/]2U.RL='^(VGZ/M>74K
M_P !ZAXBM+*V22[N)H[6-YEYOPM_P4R_86\<>.['X:^#OVA_"_B?QEJ?C.[^
M'NGZ9H>B>-=2M+OQGI^OW/A:_P! @UZU\,2>'GN[#Q%97FC7L@U7[+::A:W-
MO<3QO!*%_/7XF_\ !1K]F_6?BQ_P3L\/_LP:E^R/\6O"'B;XV_"[X76?POU'
MX<^+K_X_?LY3>.Y;_P !WOB31(=#:WT3]G"]\(>&+B]\'7V@?$;0- U;4=4N
M9_"5B9/.>T'9?\$?_ ?[2C?LZ_#CQBG[07A5?@2WQF_:\EB^"[?!6P_X2..P
M7]J[X\6?V)OBF?%Z7KRG6DFUC[6?"X8P3#3?+*1BZ< ^V_"'_!3']@[QY\0M
M)^%GA3]IOX=:IXWU_P 9:I\.]!TUI=:T[3M=\=Z+J.IZ1J/A#1/$VJ:19>%M
M6\10ZOHVJZ3'I.GZU<WMWJEA=:?9Q7%Y$T-?=%?QT^!;S]I?6OV$?V7_ (7_
M !GLO@)X+_X)T?%#]NCQGX;\9_'SPY'XY\1_'[X10Z+^W3\2_&?PZU#Q1HVL
MV>G> _ ]I\0/C)X;T;X6S?%;2-3U>+X;6OB[2==GL/-N'N;#]Q_^"L7CWQSX
M*^!_@^W\ ?M7Z)^RUJ>O^.(H=7.L>%/'%X_Q@\+:=:&]U_X8:7\4?AQX8\:^
M,_@+J.KVP1HOBKX>\(>)-5T9=\5GI-P\Q:, _3;Q'XC\/^#] UKQ7XKUO2O#
M7ACPWI=_KGB#Q#KNH6NE:+HFC:7;27FI:KJVIWTL%GI^GV%I#+<W=Y=3106\
M$;RRR*BDCP;]GS]L#]FC]JM/$Q_9^^,'A;XE7'@V6P3Q/INE'4M.UO1H-7BD
MFT75+K0=?T_2=:.@:[##/+H/B.*PDT'7(X)WTG4;Q8)2GYZ_\%#+#Q7XQ_X)
M#Z7)\-=-O-)TJX\)_LD>)/%]G]N\2?&N[\,_!;3O'_PEU_XFZI>7>M6%IXH^
M,5GX+^'MMK'B#76\1:5;ZC\0]'T34F\1Z6#JVH6!^!/BU\;OB;KGAG]O#PG^
MQ9^T_P"+/VW_  E:_L*Z!XXUO]HGP=I_PV\4_%?X-^*[SXL:9;>(/@W\/OBU
M\&_!_A2UUB3Q-\"]7^*WQ.\'?#../5O&7PP\0>'X]1T>:WO/%^F6\@!_4E%/
M!<"0P313"*62"4Q2)((YX6*2PR%&8)+$X*R1MAT8%64'BI:_ C]B*']D_1OV
M_- T;_@F1K.B:O\ LT7?['^NZI^U9#\,_$>M>)?@_;?$Q?&/P]A_9NU;6;R]
MO]0L+?\ :*UKPP_Q97QM'=SQ^/;_ ,*6EC>>/+=KN+39SY+^U_HOQ1\>^.?^
M"W_CBV_:7_:2\ 3_ +&WP9^$'Q;_ &;/#OPT^+7B[P3X3^'?Q,T;]DNZ^*-Y
MXGET'0M1M;+Q?9Z]KOAC3(-7\$^)H]2\#7L%QKUQ?^';W4M>N;V( _H2^*GQ
M0\"_!3X<>-?BW\3M?M_"WP]^'?AW4O%?C'Q'=PW5Q;:+X?TB!KG4=1G@LH+F
M[EBM8$:1TMX)I2 0D;'BNP@U33[C3(=:CNH5TN>PCU1+Z5Q!;C3Y;<7:W4LD
MVP0PBW83.\NP1IEGV@''\J_[6V@^.?A[X)_:3\.I\9OCS\3M+_:*_P""(WQK
M_:"^*OA[XD?$+Q+XZ\-WGQ>\)>+/AO$GCWP5X+O)9_#_ ,,7;0OB%XETW4_#
MWP]TW0?"QT*RT>(Z,KZ*MY)^C_QA^+-A^W-#\&?V%/V:OB!9Z_\ #GXE?"SP
MA\3_ -L;XV_#3Q';7VG^#?V6KI?[*L_A=X8\5:/)<6T/Q$_:@U;2M8\#:>UG
M=#4?#WPOTKXD^*DCAO8] FE /U9^%WQ3^'GQK\!^'OBA\*/%VC^//A[XLM[F
M[\,^+_#\[76AZ]96E]=:;+?:3>-'&E]8->65REM?6X>TO(T6YLYI[:6*9^TO
M[ZVTRQO=2O9#%9Z?:7-]=RK')*T=M:0O//((HE>60I%&[".)'D<C:BLQ /XK
M_&_X1'XI?M^VO[)=G\4?C5\'_P!G3P;_ ,$T(/%^C_#'X _%#Q;\%]+A\3Z+
M\;;KP'X,U.UU+P'J.CZMHZ^"= M(H=&LM!O=*BO/(L+37#JFB6*:1+\.?LO:
M[\:;/P9_P2,_:-\3_M,?M$?$#XH?M7?#/]HCP=\?%\6_$SQ!<?#SQIH_AO\
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MBSX?V<VE7D>J7OP^^'VI^&OA[J/B'3-&O[WPS+9:9'ID_P!!?L ?L^WWQ_\
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M/I_B?XMW_B^'Q'%X4\+_ !"\4FR\%>)_$WB"YUOPDOB631-+\06EOJC6TO\
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ML484@(N-".-(D2*)$CBC18XXXU")&B *B(B@*J*H"JJ@!0   !3Z* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
H* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>img247211528_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_12.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $F S0# 2(  A$! Q$!_\0
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MA$?$O7I?#$5E>?#_ ,/>']=OM*T7P%X4TKPEH^DV0B@T_P"SH;C[1Z7\5O\
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M6\=5$VQ?G#XQ6T7Q*_X+2?\ !43P-X__ &8OVL?VSO"O@G]GK]C;4/A]X#^
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M*_\ P2<_9<_8^^)OPX^+'PFU#XKW'BGX7?L9V/["OAJ+Q?XST[6M'?X*:?\
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M'Q1\2_ :W_;G_:M_9P_99^*G[1'A:].F>,/AK\-_&7AN^UWQ+;>"_%$BR_\
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M^+_AOX+?#KXU?$CPUXN\ Z#X#^-_PHO/@SXY^'=UX>T_X?: EWX0N?!E]/\
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M/%5[HD]S(4N[&YMP(0 >P?LS?\%0OAY\;/@A\ K&_.K6?[7GQ<^!7PU\3?\
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MFF@?\$U_VJ_BS\&?VD9?BQ^RC>?M+?#3XN_"_P"'K?"/Q=X2UOPMXD&A^+_
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M#^O3/<QM-::G:P22VD@!U/\ P2M_X*(>,/V]/!G[5>C?$OPEX4\-?$[]D_\
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M*$?]'P?M4_\ A[O'?_RWH_XEEX@_Z*;)?_";'_\ ROU_IZ'U&?\ S\C]S/\
M4AHK_+>_X>/?\%"/^CX/VJ?_  ]WCO\ ^6]'_#Q[_@H1_P!'P?M4_P#A[O'?
M_P MZ/\ B67B#_HILE_\)L?_ /*_7^GH?49_\_(_<S_4AHK_ "WO^'CW_!0C
M_H^#]JG_ ,/=X[_^6]'_  \>_P""A'_1\'[5/_A[O'?_ ,MZ/^)9>(/^BFR7
M_P )L?\ _*_7^GH?49_\_(_<S_4AHK_+>_X>/?\ !0C_ */@_:I_\/=X[_\
MEO1_P\>_X*$?]'P?M4_^'N\=_P#RWH_XEEX@_P"BFR7_ ,)L?_\ *_7^GH?4
M9_\ /R/W,_U(:*_RWO\ AX]_P4(_Z/@_:I_\/=X[_P#EO1_P\>_X*$?]'P?M
M4_\ A[O'?_RWH_XEEX@_Z*;)?_";'_\ ROU_IZ'U&?\ S\C]S/\ 4AHK_+>_
MX>/?\%"/^CX/VJ?_  ]WCO\ ^6]'_#Q[_@H1_P!'P?M4_P#A[O'?_P MZ/\
MB67B#_HILE_\)L?_ /*_7^GH?49_\_(_<S_4AHK_ "WO^'CW_!0C_H^#]JG_
M ,/=X[_^6]'_  \>_P""A'_1\'[5/_A[O'?_ ,MZ/^)9>(/^BFR7_P )L?\
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M-XSUV]^(,7G:0_@'3--DOK3X@V>G636]YXEO-'U":#1+.[MFN'=G:-,J_!F
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M?1L_Y+G-?^R5QW_JVR0[,#_%E_U[?_I4#\@:***_MP]0*K7O_'G=_P#7M/\
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M*R_"R]?2]3B,IB:= 6/\J=]\"]6M/@MH/QHN-:\&R6WB#X@W/PXT_P"&8GU
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M<?2OZ\O^(5*7_H^1_P#Q'J'_ .>_1_Q"I2_]'R/_ .(]0_\ SWZ/^(W^%_\
MT5$?_#/GW_SK_JS\KGUJA_S\_P#)9_\ R)_(=UZT=.E?UX_\0J4O_1\C_P#B
M/4/_ ,]^C_B%2E_Z/D?_ ,1ZA_\ GOT?\1O\+_\ HJ(_^&?/O_G7_5GY7/K5
M#_GY_P"2S_\ D3^0ZBOZ\?\ B%2E_P"CY'_\1ZA_^>_1_P 0J4O_ $?(_P#X
MCU#_ //?H_XC?X7_ /141_\ #/GW_P Z_P"K/RN?6J'_ #\_\EG_ /(G\AI
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MWFUJ/0;&PU>5K;2K2""Z=8?L;_B%2E_Z/D?_ ,1ZA_\ GOT?\0J4O_1\C_\
MB/4/_P ]^MY\1^!LL3B<3#BS,:,L7C(9A.G3RW,71HXZE5Q%6AB<+"MPW6>&
ME0>+KTX4Z4E1E3G.-6E4]K6=9\^%YG+VDM7S6Y96O=NZO3=K-OY-]V<GXL_X
M*9?\$WM=_:(\%_M#^$?B+XXT;Q%X+^+GP=\0>/\ 4?B-\*_C=KDGCOX:_#?X
M5^'_  E96WP/\">%O'&D^$?!7CP>(=+GMO$.O^/]'U&:XT5I+B-]6TX6FDR?
MF7_P5 _:G_9:_:G^%_P*7X+?$CQ1>>+O@OX\_:;@F\%:]\)_$?A:UU_PC\=/
MCAJOQ1T7Q1IWB2ZNFTK3!H.D-IVF77AR\MEU.YO;N<PK!!8,9?U@_P"(5*7_
M */D?_Q'J'_Y[]'_ !"HR_\ 1\C_ /B/4/\ \]^KR?BCP5R3,,JS'"\;9U4K
MY/&G2P:Q6"S*O35"GA,7@50J)\-1J3I?5L?BJ:C&I#V2G%89T8TZ:1&>%@XM
M59WC9*ZD]$FK/W-K-^:Z-$?[5?[5'P(_96_:GU'XJ_$OXW?%+QKK@_X)U_#_
M ."UM^Q"W@;Q1/\ #CXBZC\0OA;I]YHNI:QXMN]4D\ 'X;RMJ$FH:_,-/M?$
M5GXML;VV1KJ%$BNO#/%O_!5S]G5?CIXV_:6\!_$;2]%TGXQ>&_@5X*U[X"ZE
M^S_\7/%_C'PYX;\)ZUX)_P"$ZT'Q!JVN?%BV^!.D:1X"L= OM;^$OBCX:>!I
M/%%QJ)MX;?2["=-0FU;Z%U#_ (-9M:U>=;O6/V^M8UF[2""U2[UCX&W&JW:6
MEJ@BM;1+G4/C/<SI:6L0$5K;+((+:(".".- %%'_ (A4I?\ H^1__$>H?_GO
MUY^#SKP4I8?"1QO&F/Q>+HY=1RO$5H9/F%##8C!4IX:M]5^I_P"KM6E&E]8P
MM.M'$3=7,U;EEF,U"CR)2PME>HVTN5ODDKJZ=K<EK75[ZRU^)Z'Y_P#Q4_X*
MB^$/%_@W_@JE9:-\8?C.WBC]J+]I7X.^-/V;+N2+QC9OI_P9^'_BQ+Z[T"2^
M-Y%_PKNSL_#\,%O;^&5^QF_$/V62"5KBY-?27CK_ (+%_LV:E\;_ -M+XCSZ
MK\3?BSX$^)__  P!J?P>^&OBKPSKMKHGB&\_9S\?>%_&/Q;TR\TG7)+K0_ T
MEZ=-U:?3KV^M(K;Q#J%SO>9MX+>W?\0J4O\ T?(__B/4/_SWZ/\ B%2E_P"C
MY'_\1ZA_^>_7=/B+P&J*,9<1XM1BL/%*&79Q2?+AEPM&G%3IY#&I#W>$<L4I
M4YPFO:Y@X2@\32=!\^$_G?3[,^GL_P"Y_P!.H_?*V^GSTW_!17]BF7XN?%6_
M\=_%[7?'7P$_:>_:#T3XI>._!G@KX/?'_P /_%+PAH.A)KFO>#?$/BOXE>*/
MC9<#P=XY\'>,GT?PYKVF?L]:-91^+?AF-3L8;W3;/4K33-+]&^&__!3_ /8F
M\"?#?X:_#O6_CMJ]CXK\%?#W]LCP#=^/O@K^SY\9=,\-^&;S]HD:"O@W6OA_
M#XU\5:SXPO8?"LVF'4]2O+K6=(EU+7+;[;::?I,4D$Q[_P#XA4I?^CY'_P#$
M>H?_ )[]'_$*E+_T?(__ (CU#_\ /?KEK9WX'UZ<*53C;.W3A&DN58#&J,IT
M,!B,KIUIT_\ 55TW66 Q+PLZG(G6I8?"0K^UCAJ22<L*[?O9:6M[LND7&_\
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MY]_\Z_ZL_*Y]:H?\_/\ R6?_ ,B?R'45_7C_ ,0J4O\ T?(__B/4/_SWZ/\
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MU?A0OB;X:2?$672X--\1E=!M%^V6]D)%[G_B%1E/7]N1_P#Q'J'_ .>_7?\
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MF>XN[V\NI_C%)/<W=U<223W%Q,[RS32/)([.Q)K_ /$*E+_T?(__ (CU#_\
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M _PK^%GB3Q]X6_:HL_%'P,^)7[;7@W]H#]GCXA>*O@SJVL:'XI_9_P#V+/\
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MM(_$KPY\6DO/VCOV7_VJ?C!X^M/CYHOP1NOAK^SSX-\7>.?"UMX^^&/Q@M?
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MTXVTEM-\VQ?ME?LB^%%_95_X*<:E\$?'FC^$[)O /[)7P&^&G@'5_A?+X1^
M?AK]LZ\3Q_\ $KXIZWX-\.^&?#E]HNHZ?I7PTT:3QVK>)_$MOINC0ZPOAG2U
MGO=:O+C[!^ G[?'['/[??QB\2_#[5?V<H=1GU'XA_M7?L?\ A;Q]\6/!'P^\
M2Z7\6="^ ^G_  B^(WC_ $31GN/[8U2;X5?$_P .>,_#GQ"\-Z5J:#2_$MCX
M3.KZCIL<T&E2N ?'/@O_ (*<_M6>+/VE/ASX'M?#/AGP#;_&GXR_![PQ\3_
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MAMX=F\'Z%X.U[4_ W@_0;&)O$?A=#HFOZ#I&M:UI=YSEU_P1<^$UQ\4?@_\
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M>&/"KR:%X_O?VX9OVZ/"/C_4M*DW66OP>%O'#Q^"+[PC=-!I_B3P=]HFDO\
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M/O"_A?3H9M9\?V>E^(+W6;RRT^UT6( _8BBBB@ HHHH **** "BBB@ HHHH
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M&OV]IHUF989['49IX+S3-0OGN-:T6YE\/:W<0:A;2ZEH1_L^X=D+NW,_$_\
M9(^$7QB^*7@CXK_$ ^-M;U;X>:GIWB+POX7;QWXDA^'MAXPT71O%GA[1/&T?
M@J.]&C0>*]+T;QOXDT]-5LXK3^T;>\MEUR'53I.D&Q^G** /SQU;_@F+^S/X
MH^"'A7]G+QW/\5?B'\&_ FGG1_ W@SQG\2-7U.U\(:/_ ,*E\=?!*/3-$O;:
M&QU.*UM_A]\1/$&FVK75Y=75M?)I6KP7$>HZ7;7"L^#_ /P31_9]^ 7Q8^%7
MQ"^$EKJ/A;P[\)KKXM^)M"\!RSW&M6DWQ#^+/PT^#GP7O/%PUS5+N>_T^#0?
MA3\'=/\ "UAH%E$MI>W'B+6=:OYY+X1[_P!$:* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YR_:$_9RT']
MH"Z^#.I:EKE_X=U7X+_%:/XD:/>Z?;Q7+:KIVK>!/&_PL\>>#KY99(G@T[QA
M\//B)XHT=[ZUD2\TO4)--U2 3&R:VG^-[+_@BY_P3YTZUUBTLOA'JMNFOZ))
MH>L2P^./%,%U?1_\*M^'OPBL]2DNH=0CGCUK2_#'PO\ "-_IFIPO%/;>*+:_
M\1DR:AJNH//^JM% 'YP:K_P2I_9"UWQ_\,?BAKN@^/M;\=?">#0AX;U_5?B3
MXHO+B\U'P[<?$VYT_7-=BENS;:AJSR?&#Q__ &@\<-K9:F-6LC?V-P_AWPXV
MDU/$/_!)C]BWQ3\,[CX0ZWX*\4WO@.]TGX0:!J.CR>._$+#4="^!WPMN_@WX
M"TN\G>Y:1X[/P#>W.G7%[&8M5_M)X_$%AJ&GZ];6NHP?I510!X5XR_9_\+>-
M/'/PS\>W7B/QWHNI_"5=O@[3?#^OV]GHUJ989+'4'N+>[TR_O9)=9T::7P]K
M,T&H6TNHZ%(^GSN4=W;FOBY^R5\(_CC\0O _Q$^(Y\;:U=?#[5M"\2>'_"4?
MCOQ)9_#Q?%WA6/Q)%X5\9W/@J"]71F\5>'H_%NO1VFL6T-K/?075O::X-6M-
M-TRWL_IJB@#\_I_^":O[.&K_  2\(_LZ>,+CXH^/_@U\/QH</@'P5XT^(FJ:
MM9>#=/\ #OPW\:?"?2M)T*[A@LM1CTVW\$>/-:TP17EW>2^?!I&H"=;[2[:<
M8WP4_P""8O[.G[.WQ1^$WCOX.V6J>%/#?P@'C[6/#O@2:]N]<M)/'7CGX,_!
M7]G?_A+6UK5KNYU"U&B_!GX(Z%X5@TFW40:C?:SK7B#49Y=2N'>7]&J* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKY[^"_[2
M/@OXZ>,OC;X/\(:/XML9/@9XQTKP3KNJ^)M$FT&S\0ZEJ>BQZR;_ ,,6M\\>
MJW>APAWLXM5O+"QM]3EADN=+^V:>T%Y-[5I?B3P[KEWJ^GZ+K^BZO?\ A^[&
MGZ]9:7JMCJ%WHE^P<K9:O;6D\TVFW9$<A%M>I#,1&Y"?*V*49-2DHR:@DY-)
MM13:BG)K2*<FHINUVTMV@-JBBBI ^;/VR?AKXU^,G[)/[37PE^&]]_9WC_XE
M_ ;XL>!O!EU]I6S7_A)?%'@?6]&T>WDO7=%LH;V^O(;*:]+K]CBN'N008A7\
MZ?Q'_P""%_[17QR\;^+OBWH7Q!^&GP?\(_&KQ-\'/C1X@^!^OQ^(8]4T7Q]\
M%?"_P&T_X!R>+9- T#5-%C\3?!RQT[XZZ%?Z?HMYJ6A7CW/@*TM[Z\T]M6DT
MO^K^B@#^8'Q7_P $@O\ @H;?_ OQS\,]$_:JTR_\9^.OB=J/C+7_ !]XH_:"
M^,R7^I>(K?P5XVT?PU\:-!71_A/'8?#_ ,2/XJ\2:+K'BOX80Z-XR?4=.\/6
M1T?XUZ/KUAIVK0^H>-/^"2W[8.O:=\=;G3?VCK.T\3_&^R^/X\0ZI:?&OXVZ
M?<WM[XU_:D^&OQF^"P\S4O#7BCP]IEG\.?AUX;\:>"+K2X_!]_X>FC\33^%9
M-$UGPGJVH3V?]%U% 'XW?%+]A#]H7XA?LH_L-_!KQ9XK7Q_\4OV:-6^$OB_X
M@>,?"O[4GQO_ &>=+\4^*?A.='NK.WM]4T3P%\4?$WBN/5IM/-FGB_7AH/BK
MPY+ _B'PVNEWVK3:=I_K7[87[('Q@^-GQG_9C^+OP=G^&7@OQA\')],T_6?B
M7XK\4^+-3\0V7@FY\?>!/$_CSX>ZE\.K_P $>+_A]\</!/B_1_"K7EA;^)I/
MAIXZ\$_%7P_\/_B/X/\ B+HTVEZKI]W^F]% '\U6N_\ !'/]HGQQ^RIHO[*/
MB'Q!\/=$L?#O[1#?&JW^(LG[27QW^)&@/;V7Q-^+?Q#\,R^!O@1XF^%ND>$/
M@_XGT"_\?>'-3:3PIXBN[+5=9\.7!O;EH;F*>NF_8D_X)>?M%_LG_M!?!/Q3
M\0==\)_$K7O$'[07QC_:I^/?QH\$37UI:7WC7QY^QKX%^#/Q.TS6K37;'1-2
M:X^+O[05]JWCWP_I6EV6I:=;^$_"%E>:M/IFKV<%@O\ 1?10 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YJ_M&_\ !0B3
M]G[XY>(?A3/\*9?%&@^'/A1=^.[SQ9;^)KBP=_$C^'_%GB/1_"S(?#5YX<L6
MO+3PI(LUGJ'BBV\9S6=\_B+1/!NL^'-'U;48/.=3_P""H5YX;N+M/$7P9TYK
M?P?8^)]%^(CZ#\2HM0EC^(VCP_M%3:79^ A=>$["#Q-\/;T?LT>,%UCQIJL_
MAV_\/GQ'X<$OAN[-EKXLOTMUOX1_"OQ+XH;QMXB^&W@37O&#^'+[P>_BG6?"
M>A:GK[^%-366/4?#;ZM>V,U\^AWT=Q<17>F-.;.>&YN89(6CN)D?*L/@-\#]
M+F\.7&G?![X86,_@_P *ZIX&\*S6O@3PQ!+X<\&:V'&L^%-%DCTQ6TWP]JPE
MG&I:1:&*PO1<W8N8)/M=SYH!X;\.OVR/!NI_#5/&/Q9LC\/];L?&/Q*\":[I
MWABU\7?$SPX-:^%FO3Z%XCU+1/$7AWP@ES=>'IVCBO-.O=8T;1+J>.66$6;2
M6LS5]8^'/$&C^+?#VA>*O#M\FI^'_$VC:7X@T/4HHYHH]0T?6;&#4=,OHXKB
M.&XC2[LKF"=(YX8ID60++&CAE'D_C?2]'^#OP.\1:+\+/A:LFB^'_#&K66A_
M#SX:V7A/PM!9VMW;77VB32K/4=0\->'K*"U:XGU&[5;J&:8B9X8KF[D$<DO[
M-/\ R;C\ .,?\63^%7!QD?\ %":#P<$C\B1[UW.A1>7QQ48U(U8XI8>;=>E.
M$U*G.HG&A&E&K1Y4HQYIU*D*CYN2SC*,<^9^TY':SAS+1IJS2LY7:=[WLDFM
M+[IGME%%%<)H%%%% !1110 4444 %%%% !17YR>,?VO?BQI'[5'C+X#^#/!/
MA#Q[;>'7M;.U\*Z3;>,H_B)#;7OP+U'XI0^/=?U^2(^ M.\(#QA;:+\-8=-,
MJ:W>ZEXJTZ[BEC:V%K?^<?$/]H?]J!/&7P)_M7PQXA^$'B#Q'K&E6ND?"FRT
M:/Q-H_Q.U.Y^,?@+PKXQTCQ/XG32=5&CVOASX-ZUXK\=Z=##>^'W6[LVU.34
M+E-*%J.A8:H^6[A'FBIJ\E?EE%R3MO:RNW:T5K)I"NOQM\[I?J?K%17YO77Q
ME^+&J_MM:+X(\,>+M<D\"ZI%IJ:9X.?P&T_@;4OAA=_"+QSKFM_%=_%GV%+F
M?5-!^-.D^%_!KHOB#24,%TOAM=+:?5EUB/O?V<O"WQ"^)GA']G_XN?%GQ/<Z
M]\2?AMKW[0>C:]JU]X?E\)2^([/4O&GC'P5IEQ;>%-/EMM&T> :5HVAW5GYE
MG>S?V;%"+:_E%W/=74RHN$5*4XV<8R27,Y>_&HXIIQ2WARRU?*Y)ZJ]B]]$N
MK7W-7_,^Y****Q&%%%% !1110 4444 %%%% !1110 4444 %%%% '*>._$%Y
MX3\%>+?%&GVNCWM[X=\.:SK=K:>(?$5KX0T">;2]/N+U$USQ5>VUY9^&](S#
MG4M<N;2Z@TJR$U[);3K"8F_+,?\ !3W7]-T#X8^-O$_P+?2OAYXR\%^//$NH
M^/[;Q)K4WAS6=4T34/B;:_#32/AS#JG@S1O$M_IWQGTGX7ZMXQ\&>)O'/ASP
M3I$?A2^TZ_U.2U:YMEN/U<\2^&O#OC+P]K?A+Q=H6D>*/"WB72[[0_$7AOQ!
MIUIK&A:[HNIVTEGJ6D:QI6H0W%CJ6FZA:32VM[8WD$UM=6\LD,\3QNRGS;1/
MV=O@'X:G\,W7A_X*_"O1KKP7HVL>'/"%SIO@+PQ:7'ACP_X@:X;7-#T&:'3$
MDTK2-5-Y>"_TVR:&SN5O+M)(62ZG60 \3^%?[9?A3Q%\.6\7?%73#\/]=T_Q
MOXS\ ZOIOA6#Q9\4/#LFK^"ETRZU"^T3Q#X<\(1W=SHTFGZUILD=WJVB:-(U
MY]NM(89Q9F>3ZR\+>)]"\:^&?#OC'POJ$>K>&O%FAZ3XD\/ZI%%<01ZEHFN6
M$&IZ5?QP7<-O=0I=V-S!.L5S!#<1B0)-%'(K(O!:GX*;X=_"J_\ "/P"\)_#
MCP8=*L+E/#/AN;2[CPYX#TY;FY>YU)CIO@VQ6YMVE2:\N4&GV@DGU"19)B=\
MCGGOV5-__#,/[.WF;?,_X4?\*_-V;MGF_P#"#Z'YGE[P'\O?NV;P'V8W#=FN
MWV-%X#ZQ'G5>&*A0FG6A*$HU*=:HI*BJ,9T[>SC%2E6J*H^>T86L1S2]IRZ<
MKBY+1IIIQ5KW:>[;T5M-SWRBBBN(L***\0_:+\0_$WPO\)-=U7X/6UM<_$)]
M;\!:/HC7OAZ\\5V=A:^(OB!X7\/^(=9N?#]CJ&E7.I0Z'X:U/6-8DB74;..(
M6/VBXF6WAE!<5S2C%-+F:5WHE=VNWT2Z@>WT5^57AKXV?MH>-?B9\/OA;KOA
MBY\(>&OB!\//BGX:\0?$/0_A7XAM=5\">./"^N_%[PSH/Q1OIM=U";PM9:#X
M@C\'^!]=T+1;?4M6N+27Q59V.J:;-9^)M"UC2_TE^'VA^)?#/@;PEX?\9^+Y
M_'_BW1O#^EZ=XD\;7&E66AS>*M;M;2*+4M=;1M.)LM*&HW:RW*:?;/+':1NL
M/GSLAF?2I2=.W-*#;U2BV]+M7O:V\6K-WV:33N)._1_/T3_4["BBBLAA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MG'A3X5^$_!GCKXH_$318]27Q)\8-1\+:IXRDN]1GN[*6Z\'>&+3PCHG]F64G
M[K3(H]&LH([B* E;BX#7#X9L5X%\+K:>W_;#_:0,WP]TSP+'/\)/@--:ZCIU
MWH=S)\0H7\=_M%LWC34H]'MX+BROYYS+ISV^N-<:J4LEE:8P/&H^Q*^,/A+#
MX;B_;(_:=;0--\;6%U+\+/@))XEF\7Q>/(]/U/73XT_:'#WO@=O&DTNG2^%/
ML@MX8W\ K#X/_M&.]6*/^TQ>L?7RW_<L^]V3_P"$RC[RC-QC_P *^6:S<:T(
MQ3^&+G2KIR:48TYM584MI_X5_P"E1\U^OIU7V?1117D$A115'4X]2FTW48='
MN[.PU>6QNX]*OM1L)M4T^RU)[>1;&[OM,M]0TFXU&SMKHQ37-A!JNF37D"/;
MQ:A9O(MS& ?GS^WWXX_;*\'6_@!_V1[#4+F6R\)?'+QYXS33_A;#\3'\2ZS\
M./!^D:Y\,OA9*+B\M1X<C^*/B&XU#0#J.GK)K\XA:+0GM[R,R5/^PU\3/VL_
M'/B_]I[1/VG-#UBWTKPC\38H_A'XCG^$^K?"WPWJ/A75KOQ*TOACPT/$<&FZ
M_P"*U\%VNGZ'9ZIXD%IXE\-:K=:A'J?A?XF>-;'4);;P[TFH2_M9:1XCTWP?
MJO[9'[&6F>+=96-](\+:A^R]XULO$>JI,TJ1-INB7/[;T6IWRRO#,L;6MK*'
M:*55),; =9_P@_[=G_1RG[+W_B'?Q,_^C2H ^O:*R]#AUJWT31[?Q)J&FZMX
MA@TNPAU[5='TJXT+2-2UF*UB34[_ $O0[S5_$%WH^G7EZL]Q9:7=:]K5QI]M
M)':3:MJ,D37<VI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?%?[<?[>_P$_X)\_#30/BA\?)?&,VE>+O$\O@GP?H/@/PXGB;Q
M3XK\8?\ "/:UXCL/#.BV%SJ.CV,NL:U!H<^FZ+;7>J6@O]7NK&S1U26:>#XX
M_;+\#_M >$OVJ/ASXSE_X* ?M(?"+X$?'OQG\-_A+X&^$?P=\"? O6K'X?\
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MXO\ DR;X ?\ 8L:Q_P"IAXCK[;H **** "BBB@ HHHH **** "BBB@ HHHH
M*^.OVV_VY_@5^P#\)],^,/Q\N/%G_".Z]XKA\"^&]*\$>'3XF\3>(_&%YX>\
M1>(]+\.Z/ICWNFV\VIZS;>&;ZPTF"XO[87VL7&GZ=$WFW:E?SR_;^^&W[3?@
MCXM^-?BGX2_;5^*GP\L_VG+OX7?LL?L\?#;0K&?5_A%\)-3\7^"_%UM\1/B'
M\6= &JZ/<>'K'1M<T32/&OAGXY^"M1B\7>$/$&K_ /"*>)-)U_PA?VMI'?\
M^"X%[\5?"7[+'P"\6?"WQQ\+_#GCOX??M%>!/$4.H?&/XB?LK> O .OW.G_#
MOXAV!AU*X_;"NK3X7>(+Y;R]CUS1;"PD3QOI^K:?9^)O#EQ9OH=W=P@'ZT_
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M:XLY)8FC2ZMUNH;BV::W9A-$MQ!/ 9$42PR1ED;Y%'[,_P 70 #^W)^TPQ
M+'0OV; 2?4A?@(!D^P ]!7V%10!^8'P2^''Q]^(OB3]H72-=_;>_:%CMOA9\
M<M2^'/APZ?X6_9RM99- M/ /@#Q/%)J<DGP/N1>:@=2\3ZDC7,:6R&UCM(Q
M'C=W^R?A=\(O'/@#6[W5?$W[1?Q=^+]C=Z:UC#X?\?Z9\);/2K"Y-Q#,NJVD
MO@+X9^#-6-\L<;VH2YU*XL3#/(6LS,L4L?F?[*T4L?C?]LQI(Y$63]J_6S&S
MHRJX_P"%/_!QLH6 ##:Z-E<C:RGHPS]A4 %%%% !1110 5DZMK^A: M@^NZU
MI.BIJNIVFBZ6VK:E9Z:NI:S?EQ8Z38->30B\U.],<@M+"W,EU<F-_)B?8V/S
MY^,'PM_:*\=_MFZ1K'@34?%7A/X:>'? /P*OW\>/\1/$6D^$--N-.\=_':;X
ML^%=+^%]A:W&@^/?%'C?PC>>"-"U/5=8N]'F\*V$NAZM8W<MW9VJ)YW\6_V(
M_CWXI\-^$M'O?BEH_P =]2@N_B7H=WJWQ/GUOP\_@33?B3HO@O3M,\?^&(I9
M_'HU/Q-\-+[PG>ZKHFGAM'N+J?Q%/]BU?2W@GDNNB-*FW'FK0CS)-JUVKQ<M
M6O=5G9-2<97O96LVKOHOQMV\O-[7V[GZE76OZ%8ZMI>@7NMZ19Z[KD5]-HNB
MW6I6=OJVKPZ9&DVI2Z7ILLR7FH1:?%)'+?26D,RVD;H\YC5E)YG7_B7X,\-7
MOAG3]1U=9+KQ;XQ7P%I"Z;;W.K1CQ4;2ZO7TO4[C3HKFWT:2&&SE69]5EM$C
MG>"V+?:+B&-_CWXN_LY_$SXB?M%_"GXE:=IW@RT\/Z!J7PONM<\7ZCKM[_PL
M#PC9?!WQ]XR\53Z5X:LK?0YK/5=+^,ND^(;#1?$4":OH3:,D5]_:(U^!+*$>
MH? ?]G'3?AKHGCG0-<T?1DTR[_:7^(?QQ\#V>CWVH2QZ>GB/5_[3T6]OY)?(
MFDUCSKG4+C4K>>2]MVN;AG::<E2LN%.,8R<^9N*;C&U[MM/6[M;31J[LWHG%
MLUO_ %Y?GKJM$?5U%%%8C"BBB@ HHHH **** "BBB@ HHHH ***_GU_X+GZG
MXVTK4/V4YM+U7Q5HO@J\U#XK:5K=UI_AK]J#QEX7O/&&I6G@BW\$:/J?AW]E
MSXT? GQ/+XGU '7O^$4N]=\6:U8;8-8L;'PS)=WCZK8 ']!5%>'WWQ5^''P0
M^"OA3QQ\9O'?AGX8^%-+\+^%++4_$?C[4YO"&G6VHS:-;!+*Y/C'4[G5[;49
M6AGQIFK:EJ.NQF&=+ZXN[J"YN&[?X9_$WX??&7P%X5^*7PJ\8:#X^^'?C?28
M-<\)^,/#-_#J>A:]I5PSI'>:?>P$I+&)8Y894.V6"XBFMYXXYXI(U .YKY.M
M_P!J[0I_VFI_V<O^$0UA/+U"[\*P^.CJ%DUC/X^T_P"&NE_%Z]\.?V"(_P"T
M8]-B\!:O:WL?B5K@VTNL)<:,+%/+6]D^L:^;O%?[)_P5\9>/?$'Q+U71O$-I
MXQ\2Z>+34M4\/^./&/AKRK_^S-+T"7Q/I4.A:U81:+XPN?"^BZ9X3N_%&DK9
MZQ<^%[4:)-=-8S7,<P!F?L\?M0^'_P!H77/B?I6CZ;IFACX?>*-8T&SL;CQ0
MM[XOUK2M(\4^)?"B^+=2\)-HNG2^'_#^MWWAJYG\.WD6IZ[!J5O(Z2SV=W:R
MVQYKX4ZEIVH_MB?M*KI_Q.MOB*VG_"CX#V%]I=O<^#;D_#&^A\=?M%^=X G'
MA33[&]MY[7(U22W\92ZCXG0Z@1+>FR^RPQ>Q?#SX!?#CX8^+?%7CKPU9Z]<>
M*?%UI%I5[J_B;Q9XE\77.F>';?6]:\2VWA/PX_B35-3/A[PK:Z_XBUK5;;0=
M+-OI\%U?N(XEA@M8H/)_ADVMG]L+]HP:Q)X(>W7X0_ 1="7P@+P:A'I'_"=?
MM%,J>./M4CQGQ5]J:=G-D([8Z>UIE/,W$^OEMOJ6>WM?^S*/+=0;_P"1MEE^
M7FIRFG;?V=2D^6_,YPYH2I;3_P *_P#2H_UI^1]?T445Y!(4444 ?.FOZ7I=
MS^U;\,[ZXTS3I[ZW^ OQFDM[V:QM9;V!XOB'\!UB:&[>)KB,QB641[) (_-E
MV8,C[OHNO M9_P"3H_AS_P!D"^-/_JQ/@'7OM !1110 4444 %%%% !1110
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MC5%\V1(]W_"UK [=[!<X_P"$%&<9SC(SZU^9OZ0O@^E=\7I)*[_X0N)=M/\
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M2_\ \Z.C^Q\V_P"A7F/_ (18G_Y4'++^67W/^NJ^\POVY;[XHZ9^R)^T#?\
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M^%HHK32[NWU/5I9H+,6LUSXADM4B3[*9+CZ0_93W#]F#]G4,PD<? [X5!Y%
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M%K_91_Z.4_:4_P"^?A3_ /._H_XA:_V4?^CE/VE/^^?A3_\ ._K^GJBOO_\
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M\?7[-/\ UR^+'\_A]7\Z?2'_ .30<6?XL@_]:7)S^H/H8?\ *2/AY_@XN_\
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M _"+X@_!C]D#X;?$?]M;X2?LA_#J^U7P/<>&O OQC^'/@/XT^$_B]XHT;1]
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M %IK\KGU[1117D$A1110!X'K)/\ PU%\.1DX_P"%!_&DXSQG_A8?P#&<=,X
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M)X95:.:&:-FCEBD5DD1F1U*D@^/#]G#]GE0%7X#?!@ #  ^%W@<  =  -#P
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MH8;#PPU!5:N#R7!XJ4J<(1DI1Q$.:<5SJ47*,OO/_@F-_P GQ_!#_?\ 'O\
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MM[7X;E9X8?#)^U16\L:ZY*D@YO\ X(_6\/@KX-^/?A=XAT&Y^'/Q$L?B%?\
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MN%/\.>_^LYFQ_//TT/\ E&WQ#_Z^<(?^MQPV?O;1117^FQ_A&%%%% !1110
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MXPLKC7M+L[1M?UK3HO"GB2VU/X>67B6]M_[+EMK77M. .N_: ^$'Q?\ BO\
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M-0HHHH ^;/V<_P#C]_:'_P"SD_'_ /Z8?!E?2=?-G[.?_'[^T/\ ]G)^/O\
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M]PVHG4I]KPI;BT;SO-C]XHH **** "OY_O\ @N-_Q]?LT_\ 7+XL?S^'U?T
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M]C%?V]]$[_DA.(?^RPQ/_JCR(_RL_:(?\G;X/_[-Q@?_ %I^*0HHHK^I#^!
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M\R_XAMP\YXK+\LP$J7]N9ERPCEN)S;$QJ*7U6[E5>;3A*+5HJC!IMR9_#O\
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MP9^*?B>WT>^^//QBT?Q#X<\'VZ:]H6CZE!I%MI$M_P"+[ZRM_#XO+&WN)I'
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M/OSM\_\ <Y\SY:_S=_U1XL_Z);B3_P ,6:?_ #)_6O9G^WO^N7!__16<,_\
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M=6=+!8>GAJ<ZKAQ5"#J2A2C*;C",7)MQC%62_F6_8B_8;_:N^%O[5GP:\?\
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MVN?5-5EEU_4)]5UB^N;Z[EU/6]7U;5[F_N$66>YN9V1%J_\ LV>'] E_9U^
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MG"$(U(>TYJDIQG34,O\ E\O^O<M-/YHZVMS:VW;:=M$FI7]_HHHKS#4****
M"BBB@ HHHH **** "BN8\9Z;XHU?PMK>F>"O$]GX,\57EB\.A^*;_P /1^++
M/1+XLA2^N/#DVIZ-%J\:('4V;ZI9*Y<,9AMVM\OK\)/VS@RD_MC>!& ()4_L
MJ:2 P!R5)7XP!@"."00>>"#S0!E_\$ZO^30_AO\ ]C+\:O\ U>WQ,K[;K\[?
MA#^R?^U1\%/A]HGPU\'?ME>%Y/#^A7?B6^M)=7_9=T.\U&2X\5>*]<\8:D;B
M>W^*]G RIJ>OWD5JD5K$(K..WC?S94DGE^M?A-X5^,'A:UUN+XN?%W1/BS=W
MEU:2Z'=Z+\+[7X9KHEK%#(EY:W%M:^+?%:ZNUW.T<Z7#R636JQF(1RB3>H!Z
M[1110 4444 %%%% !1110 4444 %%%% !7Q1\>?V%_A]\>O&VH^-[GXJ?M!_
M"F;Q?X=T_P '?%OP[\%/BE<> O"_QK\):2E_!IVA_$?35TG5+B1[73]4U+1!
MXA\(7WA+Q=+X?OIM#G\02Z=%90VGVO10!FZ-H^E^'='TGP_H=C;Z7HNA:;8Z
M/H^F6D8BM-.TO3+6*RT^QM8AQ';VEI!#;P1CA(XU4=*TJ** *E_+=P6-[/I]
MHFH7\-I<RV5A)<K9)>W<<+O;6CWCQS):)<S*D+7+0RK ',K1N$*G\^/$5[^T
M5X;_ &H_!WQA\1Z3\6]6^%47[./Q&;Q#\$OAX++Q;X7\+^.]/\3^"$T>UL)]
M/&@IX\\>^*;*75[[3+C5DMAIFEV-WIVE1P#[9-=_HE10!^>/[(UM\;;#XR?'
M5?B-H/C:_P##VOZCK_BRW\;^-;/Q]X9_L76M4^)/BV/1?A7X5\/>)?'/BOP=
MXB\*Z#X"A\/ZII_C+X>:7X<TV$7/]D:I%?WTBM:^O_#^#Q1!^UY\>CXD\0:!
MKMO-\%/@+/X9@T/P[=Z!/H'A]_B'^TB(-%UZ:Z\3^(U\0ZS%.LLTVNVEOX:M
M;B&6*%?#\#0F>;ZOKXT^%&B_V3^V-^TS/_PKOPIX$_MOX5? 35?[3\-7EC=7
MGQ&#>-OVB+<>-O%D=EH.BR67B.;R3I3VU_<Z_=_8=/M9#K#1E;:'ULN7^QYY
MK%6RVD[.-%RD_P"U<M7N2J3C5BTFW+ZO&<G%-5%&ESSBUM+T_P#;H_UI^1]E
MT445Y(@HHHH **** "BBB@ HHHH **** "N#^(WPN^&WQ@\-2>#?BMX#\(_$
M?PE+>VFHR>&O&WA_3/$NAR:A8%VLKU],U>VN[-KJT:20V\YA,D)=C&RECGO*
M* /S5_:$_P""=?[,>M?#6YTSX4_L6?LR:QXME\3^![U+:\\$>!?!4*Z1H7C#
M1/$6N*-<C\':Q(CW^EZ1<Z0ML+)DN#J6V=TMEFS[MX'_ &*/V2/#EUX5\9Z9
M^R5^S]X'\<Z)/I'B&QNM!^&O@<ZGX5\2V$D%_;SZ1X@L- L9OMFD:A$CV6JV
MB6LGG01W,*PMM"_6E% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M$9!'(R,9'4?3WH \N\0_&[X/^$O%<W@;Q1\3/!/A[Q?;>&[OQ?<^'M9\1:9I
MVIVWAFPM[R[N]:N+>ZN(C!906>G:A>O)*48V-A?7JJUK:7$L>/9?M'_ '4?[
M#^Q?&7X:SCQ+X8UGQIH;#QCH:+J'A7PZ-4.O:[$\EXBII^C#0M>_M.:8Q?8?
M^$?U\7 C.AZK]C^4/C#^P/>_&OQS=:KXS^-WB?6/ -O\*/&'@#PEX1UK1K34
M]5\)^+?'":C'K?Q6DU^.]L;7Q;XLCT^XT_PIH4/BK1-0LO#'@NVU71?#XL+G
MQ)J^I2^?:E_P2[T?Q"-2_P"$B^,VL7!\76OBK5?'ITOP)X9TL:I\0-=C_:)C
MTOQ#X=A,UU;>&_#NC+^TIXP^T^#GAU:VUXZ'X?.IZBS3:TVH 'W#XS\2VGQ<
M^!7B?Q%\%_B;H$5CK7AO6I=(\>:/INF^.M*-O8Q746K6T6GRZA96<]RPM[O3
M9DGNHY=/NMYEA,T!BJW^S1G_ (9Q_9_R<G_A27PJR<8R?^$$T')QVSZ5Y-X'
M_8[T'0?AR?!/BCXD?$S4M2U+Q?\ $?QUXGUOX>>,_%OP6L-<U_XH:Y/KGB")
MO#OP]\1:?:G1[.286FC6.IW6K26, F=;DRW=P6W-!_9!^'GAK0]&\.:-\0?V
MD+'1] TK3M$TFR@_:8^.$,%GINE6<-A8VL,,'C>*&**WM8(HHXX8HXD1 L:(
M@"CU:53!2R_ZM5Q%6G5>*CB&H8*E422IU*3BZWUBG4J)IPE&,ER0;GRI.4G+
M)J?M>=137)RZS:W<7?EY6E;6]M79?+ZJHKYJ_P"&6_!__12OVE?_ !)WXZ?_
M #=4?\,M^#_^BE?M*_\ B3OQT_\ FZK#V67_ /0;B/\ PAC_ /-A5ZG\D?\
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M8:_'JT'PB_:%^#>I^)]2L-&U[QMJ?ACX]Z9I=BUHWBBYM;>ZCTCP-<Z?/?\
MA[P]+!<:7)+>RK<QA]\TOAVH_P#!,+2?$<E[+XI^,NK7C^+V\1ZU\2?['\!^
M&-&77/&.I:A\>-1T'5/"RF6]3P?H>AS?M ^*$O\ P]MUJ/Q/'HFA'5;P2RZK
M)> 'WA>?$>U\?_";5?''P(U'P1\4$O;"]30+D^+FT[PIJ,MO,UKJ4=SXBT?2
M?$DUG+8QK<L85TJ:5KF*.WE^SK*9X\3]E,L?V8?V=2X59#\#_A49%5BR)(?
M^AF1$<A2Z*^Y4<JI=0&*J3M'F7PV_8YT;P?\/7\'>(OB9\2M3U?4O&WB_P ?
M^(?$/P[\7>*/@C;:OKOC&+2[2]@;0_ASXATZ$Z3966C6$6G6.HWNJ?9;@WUW
M#+$U]+&N[X>_8^^'?A;0=$\,Z)\0/VD+'1?#NDZ=H>D6,'[3/QOA@LM+TFSA
ML+"T@A@\;Q00PVUI;Q0Q10Q1Q1QHJ1QHBJH]2C/ O 2P]:O5I5IXJG7;AA?:
MI1ITZ]/D<WBZ::_>1G'EI1:<IJ4I)0MDU/VBDE%Q47'65G=N#O;D?9W]Y[*R
M5W?ZMHKYJ_X9;\'_ /12OVE?_$G?CI_\W5'_  RWX/\ ^BE?M*_^)._'3_YN
MJQ]EE_\ T&XC_P (8_\ S85>I_)'_P #?E_<\W]WF?2M%?&UC\)/@5J<FK1:
M;^T1\8=0ET"WFN]=BL?VQOBQ=R:+:V]P]G<7.K)!\29&TZW@NXY+6::\$,<5
MQ&\#LLJLH[-?V7O!KJKI\3/VE'1E#*R_M/?'1E96&596'CL@J00002"#D<4>
MRR__ *#<1_X0Q_\ FP+U/Y(_^!OR_N>;^[S/I:BOB7P%^RW??VG\23XV^)G[
M29TX^/[K_A7NW]I[XQ';X&'ASPV+8.-/\:12A_\ A(!XA8_VF\U^4:,-)]G%
MNH[FR_9L^'^HK<-I_P 6?VB;];2[N-/NVLOVIOC==+:W]H_EW=E<&#Q]((;N
MUD^2XMI"LT+_ "R(K<5=3#Y?3ER_7ZL_=A+FIX.,H^_",[7^MK6/-RR722DN
M@E*HU=TTM7HYN^CM?X/5KR7F?4-%?-7_  RWX/\ ^BE?M*_^)._'3_YNJ/\
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MD?\ X$_\O7^EK\M_\-36'_1!OVI/_#&^)?\ X[1_PU-8?]$&_:D_\,;XE_\
MCM?4E%'UG+/^A7/_ ,+ZO_RD+P_D?_@3_P O7^EK\M_\-36'_1!OVI/_  QO
MB7_X[1_PU-8?]$&_:D_\,;XE_P#CM?4E%'UG+/\ H5S_ /"^K_\ *0O#^1_^
M!/\ R]?Z6ORW_P -36'_ $0;]J3_ ,,;XE_^.T?\-36'_1!OVI/_  QOB7_X
M[7U)11]9RS_H5S_\+ZO_ ,I"\/Y'_P"!/_+U_I:_+?\ PU-8?]$&_:D_\,;X
ME_\ CM=KX!^.-KX_\0#P_#\+?C?X1<V5S>_VQX^^&6L^%/#X%L8P;4ZM?.T
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M9\-37?@5M/B2^TJPT7R[)IO##6,%ZEYI]K8_83;17:7%M&B3AW /S-_X)_\
M_!1KQ[^U[\6M7\">+/ O@31=*U?X'/\ 'O1(O ^IZW?>)O@NB?''QY\'3\"O
MV@8-3EN;2W^+P@\)1>(VDTZ'PQ&MS8>--#/A80>';77=6_7:N8T30?!>@:MX
MA'AS1?"^B:[K]S%XD\5C1-.TK3=6UJ\OGN;>#7O$(L88;S4;F\DM+R"+5-2\
MZ6X>VN8DG=H957IZ "BBB@ HHHH :S*BL[LJ(BEG=B%554$LS,2 JJ 222
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M1/M%]J,&FW=I%HUYYE[-'9W-M'IT_ERPK"OJM !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 >&_M->!K?XF?L]?&CX?W?AK1_&-GXO^&_BS0;SPKK_B
MO7O ND:_9W^D7,-WI=[XR\,:-XB\0>%TN[<R1)KFE:#K-WILQCNDTN^$;6TG
MX!0_LZ?'J/3/#/QU\&R_#&)QX/\ VO- \&"^\?>+_A_XPTSPIXZ/[,,.N7GC
MOQ!\!/A9\*M"^)/Q"@TWX4?%:RT'X@77A+0/%5I!J?PR@\4:UXW.B7]Q9E%
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=>EU76=0\.Q7E[^XM%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>img247211528_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #^ A0# 2(  A$! Q$!_\0
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MI8$N#LE^ZTNUOE2IKO\ ;/L[":[EE\)WR:9$MUY5P]RB.SP112NK)_!\LO\
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M T >ZT5YE^SYXJ\1>-/A+HFM^*6MCK5\LLLL=HNV)%WML5?^ [:]-H ****
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MW[MF_P"[_!NVUS%C^PIX*L[""SDU35IK>&\ENO)4Q10[Y8?*^1$157^]\O\
M%0!Z#-^T]\-K:UBFE\41(DLODK']FG\[=LW_ .JV;MNWYMU>DZ'KECXBTFTU
M/3YX[O3[J)98+B+[KHU>(Q?LEZ&FMVNN7WB+6=5UNW^074WD)OB^S_9T38B*
MORJU>P>!O"=MX$\(:5X?M)I+BUTZ!;>.6;[[#_:H Z.BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#YO\ !O[2WAGXB_$"Y\/-X9@EN?-NHFFBEBNKB+R/
ME9[B)%WQ(W\+?-6Q-^T7\*HO$,%M^["RZ==2SZH-,98K6*!MLL4K;-R?[M;,
MG[-?@J-/W%G>VDS+=I+/9WTL4TJSOOE1W4[F7=]W^[4'AG]F#P1X3ABBTR+5
M(?*6X3>^HRNTJS_ZU7W?>^[0!TQ\1>#-2\#?\)5]GAN= =%NA-_9[-NV_=?9
MLW5Y?XF_:M\ Z1XGM+./0;K5],O%LV76+&P\V)VO'V)M^7YO]JNU;]G'P<?A
M@/ R+JD'A\W/V[_1]2FBF\W=O_UJM]W_ &/NTV']FOP5;:#;Z1%;7L-I!':Q
M0,EV^^(6S;HMK4 9UG\:/@X]K<16>HZ-+%87T<+6]G8[]D[[E38BI\WW'^9?
M[M:'BKXI^"/ _BB6WUZVMM*2U@BNHM0EME^9YW9=BKMW;FV4OAS]F7P'X5*I
MIVGW$*)J*:E&KW3?NI5W[=G^S\[?+6[XU^#?ASX@MJ<NL13[M1M5LIVAFV;H
MD=F7_P!"H YKQ#\6_A[X'CU7[-':2ZKIUC+JK6-O9^4WR1>;MW[-J2[/FVO\
MWS503]HWX2ZOIFDZYJVMZ=9W#2^5$FIVW^D6LNU6;ADW+]]?G^[\PK4C_9E\
M$HEQ!$NJ165S8_8KBQ35;C[/.OE>1YKIO^:7ROEWU5OOV4/AUJ6KQ:E+IER=
M0BN5NEN/M+[_ /5)%L_W=D2_+0 C?'SX20:S=V;ZM8273W>R=_L+;6E27RM[
M/LV_*SJN_/\ %5W2/BKX#74;(2G3].NIM0GT6QN88-R-+$[)Y7F[-J-\GW:5
M_P!F?P-+!/$]E=>5<-*SK]K?_EK=+=/_ .146LJ\_9*^'=YK<6K/!JR745U+
M>JD.IRK%YKRM*S;-VW[SM0!PUU^UCX6'C5M&;P?%++/+:Q;)IX$O;S[2^S=%
M;LNZ7[NYOF^ZE>E?\+^^%EZ^I;?$>FWDVFLEA<;8'E=?,?RMB;5^97=&3Y?E
MW+4UU^SGX+N;GSVLYTNMUF\5VERRRP/:_)$T3?PMM^5O[VZL"_\ V2O",6DW
M%CX>%WH/VO58-4EFBG;>GE2M+LB?[T?S/0!<B^,GP5N)=/THZUX>G^VP?;;>
MV^S+M^XW\.WY7VQ/\K?-\M5;?X_^ ]5\>66@VVG%]-NM.BO4UNXL7BMG^TS>
M1#$NZ+YO-:K&D?LD_#C2-4BOK32KF&Z6S:RE?[4S?:%^?YY=WWI/WK?/71ZY
M\!O">NZ>MK<17L.VUL[2*:VNWBEB6UE\VW967[K*_P#%0!SMGXR^$WB7QWX7
MDT_48+OQ!96UU_8]I;I*L4";WBEEV[-B?-$Z;V_NU8TGX\_#77I=*OI]2TTZ
MK+:>;%(8VE\I6A:7RA/L^^T2,VS[S*OW:6P_9?\  MC;>&(H(M2=?#D\MQ9[
M]1EWO*SNS-*_WF^9VJO9?LF?#ZP-I''9WXLK>-42R?4)6MVE6!H$G>+[OFK$
M[+OH ['X;_$CPC\0;:[3PG?PWD%AY1EBB@:+RUE3S8OE95^5D;<OUKO:X;P'
M\*] ^'=[J%SHT$\4U]#;6\YEG9MR6T2P0_\ CBUW- !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 >9>,?BU%X8^(FC>&/[*DN5O/(\^]\\((/-E
M\J+Y?XOGJ+PA\8++Q9XB\4:>PM;&QT.=K=KJXU&+>SH^QM\76-=WW6[XKH-<
M^&VA^(]:L=7O[1FU*S7;%/&S)MYRO_?+?,O]VJMC\+/#>CZEJ&H1Z7%<W5[%
MY-Q]I;S$=,[F^5OE^9E5FH ZG2=8L=7@:33KRWOXE;:TMO*KKN_X#6G7E_P7
MC:*+Q8KZ5'HC?VT_^@PLC+%^ZB_N?+7I^:JHN67* M%%%2 4444 %%%% !11
M10 4AI:\9^*6A:AI>MV6H>%DU3^U]6N4BO'L;I%9XD7Y?];\JK_NTH@>OS3)
M FZ1E1/[S-09D2159E#M]U=U>'Z[\/\ QA<V:SZPR^-=SHTMBEU]E1?D^[Y3
M?NOE?YM_WZMZGX.\17?B'29(]*V7,%K%%!K$URCK8,J_/\F_>^[_ -EJ^4#V
M/[3$)5C\Q=[?=7=5FOGKP5\._$NA>(=(MM;TE=1^QW,MPWB2SG17;<WW=CR[
ME7^]MKZ%H8!1114@%%%% !1110 4444 %%%% !7GWC'XAW7A/QEX2T.+1IKN
MWUVZ:WDO?-5(K?"[O]YFKT&L35_#.F^(I;*6^M(KB:SE:6V=^L3[=NY: /+_
M !Y\?E^%VN:JWBK39;'PW:Q![:[B7S9;K^^Z_-_#_<^]5/6_VDFBNK!--\/3
MO::EID5_9W%[*J>:TLOE(FU-]>CV_P +/"EOK$NJ_P!AVDNH.NUKBX3S3_X]
M3M8^&OA?7>;[1+2;%M]C'[O;LBW;MB[>GS<T 8'A#XH7/B"PM-8OH;32M%:Q
M^T7,LKM^XEW;<;_N[:[#PWXKT?Q9:RW&C:C;:E!$WE.]K+O16_NU9TO1+'0M
M&ATS3[:.VLK>+RHK=/N*M<'\)/M_]I^,O[0M;.SNO[5^>*RE>6+[B?Q,B?\
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M_-_X]7U[7R1^SQX;\&:!\8KNTT-M/AN+73Y);6+3M*M[=Y;65]V^XEB=M_\
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MLRHK?W?FJ^8#T>RA:VLX8&D\UXU56<_Q5;HHK( HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /D.W^&7QHL/C!+J5HL]GHDVL+=--#XCVV[1?:M[
ML]GL^;_1?W6S^_\ -7UY7R1\7YQXY^(\]MHWB1+8RSV^FP:A'K-Y9PV5U$_S
MV^V)/*EEEWJOWOEKZ<\,6=]8^'=*MM2G^V:A%;117-P6W>9*J?.W_?5 &1KO
MQ&T3PYXJTSP_?7,B:EJ&WRMD>Y$WOL3>W\.]OE6K-GXXTC5/%VJ>&K:Y6;6M
M-MH[BZM]ORQ++]S<W_ :YWQE\)+;Q;XWTSQ*-4N;2XLEB#1)&KI+Y4OFQ?>^
M[L?YO]JJ>B? S3M$\0Z_K,FLZSJ3ZS!LNK::?8N[?NWHR;77_=W4 7?@_'?(
M?%HU&"TM[O\ MI]ZV+.T7^JB_O5Z.:\K^!"6B67BA;&#4+:U_MA]L.IK*EPO
M[J+[WF_-7JAJJGQA$<.E+2#I2U(!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5G:M:'4=.GMDEEMS+&R>=%MW+_WU6C6#XO\3V?@
MKPOJ>O7Z2-9:= ]Q*D2[GVK_ '10!XW^SSX/\ ^ M9UNQ\#ZUK]Y#//+<727
M=@ZV3R[OG=)_LZ1-_P  >OH*OD?]F^:ZT3XN:AI5]:&'^TK%M4L;K?.SW43O
MN^9?MLL2?]^DKZXH \\UCXS^$_#WB34-$U6__LR;3;>*XN;J[7RK>)7;:O[U
MN*S-5_:%\(Z->_9HKFXU)FL4U")K*#>DJ,VQ$1OXF9JT/&?P8\->.]8OKO7+
M66_@OK!;"XL7DV0RQ*^_YMOS50UKX!^'=82Q2*2[L8K#3ET^S6&7=Y2H^Y'^
M;^)6H W/#OQ+L/%S60L+.[\JZL_M:W$J*JQ_-LV/\WRONK.^%/\ :/\ :WC7
M^T_LWVO^U?\ ETW[-NQ/[U;.C_#[1]&\*IHD5JTMHD'D2.[?O95^]]Y?]JN6
M^!UI::?+XRAL=.NM+MTU9]MM=;MZ_(G^VU:1^&1!ZU111698445\G_M]^"OC
M5X[^'&D6GP8U.YM-16_W:C#8WBVEQ+%_!LE^7Y5?[WS4 ?4&H7]KI-C-=WL\
M=M:Q)ODGG?8JK_M-2:9J5GK-G%>6-W!?VLJ[H[BWD61'7_99>M?+GC;X1:Q^
MT#^R_!\(/%?CW3K+XG_V?!+J303I*XE7_GK$K;MM=]^Q]^SM<_LP_!RR\&WO
MB"7Q#=13O<2W 5DA1F_AB4_PT >[4444 %%%% !1156ZN8K.!YIY%AAC7<TK
MMM5: +5%96D^(=*UT2?V?J=IJ7E?>^R3K+M_[YK5H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ^6#X!\7)\5C?GPAI?V9O$*W?V?R%_L
M_P"S[T_TKS?M'_'U_'_Q[_?_ .^J^IZ^7;/X>VW@_P".=^VEZ7;>*)K[4XM5
MU&6[TAB^DM+]WRKA6VK]W=MV-7U%0 5#(&,3;6VMM^_4U03?-$_R[_E^Y_>H
M \Z^#HGQXM^TZA'JLW]M/NNX8O*1_P!U%_#O:O237F/P4A^S1>+8O[(BT3;K
M<O\ H5OLV1?NHO[GRUZ<:JI\81'#I2T@Z4M2!&[JB[FZ+7B/PZ_; ^%OQ/\
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ME7]U9GX=>-+SR)-GVBTL8'BE_P!M#]H^[7Y:)^V=\9IHO-3XE7[I_?2*W_\
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M (-I_P#XNOV%_:H'_&.WQ"_[ ]Q_Z!7XN_P5]WPW",Z$K_S'3 W?^$_\5?\
M0VZ]_P"#:X_^+KR3P#JVH:5\2-3O;/Q7?#4&W^;<V]Y*DMQ_O/N^>NN?P]I4
MS.SZ9;.[?>=XDKE=%\)>%D\177DSQWDZ]+)_F2*O9Q=!2J4Y<D?B_F+D;>K^
M$5UWQ@GB&\U2]FU#>LK.\[.[.OW7W_>KV+X:>//%#_$;PTK>*-;=&U&WW(^I
MW#H_S_[]>7VVCZ?82^;;6,$,O]](ME=E\,?^2C>%_P#L)P?^A5U2PM*E"<HQ
M^(1^Z4?W$IYZ4R/_ %*_[M//2OR!G.?&?[:'_(\Z+_UZ-_Z%7SY7T'^VA_R/
M.B_]>C?^A5\^5^(9W_R,*I_4_"7_ ")J'^'_ -N.?\9>!]&^(.F?V;KEM)>6
M7F^;L25HOF_X#1X-\":-\.],?2]!MI+.R:7S7261I?F_X%7)?M"IXI?P)_Q2
M/V_^TOM*[O[,W^;M_P" 4W]G=/$Z>!Y?^$N^W_VK]L;;_:>_S=O_  .H]G5_
ML[VOM?=YOA.KV]#^U?8>P][E_B<O_DO,>GU]%_L6?\C=K_\ U[)_Z%7SI7T7
M^Q9_R-VO_P#7LG_H5=.1?\C"F</%_P#R)J_]?:/L6BBBOV@_EP**** "BBB@
M HHHH **** /D[]G/Q#>VOQDUWPP=3DFM+6*>6YTE]1\U-+E\WY$1?-;<KK\
MWW5VU]8U\I?LV:]JNG_$G6_#37-I=:.JSW$%I;Z8L5W8?OF^6ZEW?>?^&OJV
M@ HHHH C?=GY:\Y^%+:@^I>,O[36V2[_ +5^9;1G9?N)_>KT9^C;NE>6?!&*
MT@N?&2V5E<V$']L/^ZNT=6^[_M54?AD2>K'I7G/[0G_)$_&W_8(N/_0*]&/2
MO.?VA/\ DB?C;_L$7'_H%5A_X\/5%H_$M/N44)]RBOW!;'8%%%%,!Z?ZU/\
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M<:JI\81/*?VJ./V>?B#_ -@>X_\ 0*_%+4OM/]G7'V/;]K\K]UO_ +]?M?\
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M^G^M3_>K]X/#'_(NZ3_UZQ?^@5\-Q/\ #2^9A4-'L:^9OVV?^0'X;_Z^9/\
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M2O)/#^@_$W1+K6)U7PG+_:-Y]J;][=?+\B)M^Y_LUM;_ (I?\\/"'_?^Z_\
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MH'Q TVQ@M4U?0'6*)(E9[&7^'_@=?*9WCJ..4/92^$B4CT(</GUKYG_;8_Y
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^F* .&/@'P1J(MAH_C%M(MK>=DE6WE1$G;[WS;O]EOE9:LWGPO\ #VL6-O\
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; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>img247211528_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_14.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &E Q8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"&?[@_WA_(T43_ '!_O#^1HH FHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M AG^X/\ >'\C11/]P?[P_D:* )J*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (9_N#_>'\C11/
M]P?[P_D:* )J*** "BBB@ HHHH *XCQY\3?AO\*])@U_XG_$'P1\.-"NKV/3
M;;6O'GBO0?"&DW.HRQ2SQ6$&H^(;_3K.:]EA@GFCM8YFG>*&618RD;E>WK^)
MK_@N1X(U?_@L+_P5_P#V5/\ @COX*\5W6A_#SX#?"?X@?M%?M!^(M(:TD?PU
MXL\0^"[J\\*V]T9$N0EW;:7_ ,()I""XM9#9P?%=KJ!7=9HR ?VH:%KVA^*-
M&TOQ'X9UG2O$7A[6[&VU/1=>T+4;/5]&U?3;R)9K34-+U33YKBQU"QNH72:V
MN[2>6WGB99(I&1@3JU_+[_P:L_M0^*_'O[$'Q!_8E^,+W-I\=_\ @G;\6_$G
MP+\2:1J&];V+P#>:QK5YX(4":"UD>'P[JNG>,? \"" /;Z5X8T26Y827Z;OZ
M@J "BBB@ HHHH **** .>\7>+?#7@+PKXE\<>,]<T[PSX0\':#JWB?Q1XBU>
MY2STK0O#VA6$^IZQJ^HW4A"6]EIVGVMQ=W,S<1PQ.V#C%?AK\&?^#DW_ ()7
M_'#XS^"?@SX:^)/Q1\.R?$_Q9%X%^%_Q0^(/P9\:^"O@W\0?%ES>G3;'1_#_
M ([U:T2&WDO]0"V-K=>(;#0[!KN6&"6[BDFC5OTR_;ZN?A!:_L4?M32?M ^'
M_'7BCX'R? WXB6GQ8T7X9:3-KGC^Y\ W_AV]L?$]QX2TJWF@EO-:TW2KBYU2
MT19,1M9F9XYDC:&3^#_Q3^U?X<_9!_8\_9TG^'G[>?[ _P#P5T_86\ ^./A)
M/\&?V _VBO@[X8\._MJ> + W>F6VF:;X,L/!S3:[IWQ/^&EQXDDEU/4/%"$:
M?;B2**/4[2XM[&Y /]"YOC)\*U^+</P%'C[PQ)\9YO MW\3?^%9P:I;S^,+?
MX>V6LV/AZ;QC?:-"TEUI_A]]=U*STFUU&^6W@OKZ1[>R:X>WN1#Z77\5VI?#
M?]GOX>_\'&7[8/[1GC%?B9X:F^''_!-"Q_;6TO28_BKXGTSQ@?B;<>3?ZYI6
MC>'M5\0G3/$SV6DBXCT7X3WUEJW@.QUVR@NSX9:*R9!^;W[/?QT^/'A[]K;_
M ((N?M*?#_XT:]X,\/\ [=/[6R>&O$WACQ#^W/\ %;]J#]HWXR_"#7/'>@Z!
MK5]^T]X)UZ'0?@SX(MF@U:[\/:/H/@#P+8?V5>"*=[Z#6=-MC9 '^CE17\#W
MQ=\;7'QX^'?_  <2?M1_M(?MG?'+X,_M2?LG_$OXZ? K]FKX8>'OVB_$WPQ\
M/?#7X9Z%X=NM-^&_A#PY\+;;7+/1_$MI\=-34>$M0U"31KZZU6_:XUOPW>:;
MXENGUD>>:O\ &G]K+XYW7_!%O]CV[UZZ\7? SQC_ ,$C?!G[1>I^&OB!^V7\
M0/V.M"^.'QO-UXAT?Q%J/C#X]^$+'6?%_BOQ!\-?#NAZ'K^A^"Y;E8)+C5K_
M %S4[@P)+%< '^A)7XS_ !C_ ."\7[ /P4^*'Q3^'6O:K\;?%>@? 'QKI'PZ
M_:+^.?PW^!GCOQQ^S]^S]XWUN_&EV7ASXJ?$_2+%]/TR_CU$M8W_ /8=GX@M
M]+O(I[/49K:ZADA7 _X-_/B/\>_B5_P3VTF^^/GQG\,?M"7GA?XQ_%GP/\,_
MB[X9\<>)/B6/$WPI\,ZU;6F@:=K7Q#\5>#/ ^J^.=9\%ZT_B3P.WBPZ7=PZY
MIOAS3;U=6O99)O*_++_@JC^U+>_\%#/CY\3?^"''_!/FS^&/@/0=?U;3=8_X
M*7?M8:LGAGPUX/\ AOX9L]=T6ZU[P=HKB73CXN^(UW=:;IND>([T_;-2O-0B
M3P7;-#:6_BC6=% /ZS=8^(GA/2/AMJOQ934XM9\#:7X'OOB(NL^'WAU:#5O"
M=EH,OB5=3T22"86^I17VCQ"ZTUX9Q#>)+"T<VR17K^=_1?\ @ZK_ .":OB33
M+;6_#OP\_;@U_1KT2&SU;1?V7-<U73+L12-%(;6_L?$<]I.(Y4:-S%,P2161
ML,I _9_QG\/?"OPC_80\6_"KP+<R7G@GX9_LE^(/A_X1O)KJ&^FN_#/@WX/W
MGAW0KJ>]MPL%Y-<:9IUM--=0JL5Q([2QJ$< ?PS?\$E?CA^W%X1_8!_9[T7X
M5?\ !=;_ ()O_LI?#S3M.\3G1OV?_C;X.^&FJ_$WX=VY\<>()[W3?%5YKRP:
MM<3ZE=/=:U:B:4,NF:I:)'<K@&( _P!"CP-XOTSX@^"?!_CW1(-2MM&\;^%O
M#_B_2+;6;&32]8M],\2Z3::S80:KIDQ,VG:E%:7L4=]8RDR6ETLMO(2T9-=3
M7\E'QI\4>#_VU?\ @MI\7_@9^U)^UW\1?A'^R5\#OV!?AG^T)^RG9_"S]H75
MOV>/!_CO6?'T?A[4O$G[0UAXQ\,:]HT'CRZ\*)J.KR:'=2WVI:+:6.FV\MQ8
M7>F:+J45S^._@#]H'XLG_@AC^RS\3+[]H?XH>(KR;_@N_H>C:]\8M9^(7B*#
M5_$/P[_X2V^FGE\3>)#J<1A\*ZG; :I>Z9=7,6@1^:1]F2$*@ /]#KQGXF3P
M7X0\4^,)-#\2>)H_"OAW6O$3^'/!ND2^(/%VOIHNG7&HMHWA?08)(IM:\0ZF
M+8V6C:5%)'+J&HS6]I&ZM*&',?!OXFP_&7X8>#/BA;^!_B3\-8?&>D+JZ>!/
MC!X1N/ ?Q,\,AKB>W.F^,?!]W<7=QH&KH8#*]C+<S,()8)0Y608_D[^./[0&
MK^)_^"S7_!8/2?AU\;=3\0>!_!7_  07^*&MZ1IG@OXC76J^%/"7Q&TJ'P3=
M#6-,M-%U:?1]$\::9%J:7']HV:6^M6:ZB&::,W&#\Z_#[XY?%/\ 8Y_8D_X(
M%_\ !7?Q3\3/BAXD^$'@GP%XA_9O_;@TB]\4>*O$]MXB^&/QAN_'#>!?B/KN
MCW.HSV^L:[X+\86$UC9ZQ?+/JMSJ^K^#M*6X:U0H@!_<U7A'[3W[1?P[_9'_
M &?OBS^TM\6CKH^&WP7\':EXY\9GPSI::UK_ /8>E^6+G^R=*DN[%+Z\)E01
M6[WELK<DRJ!FOXQ+[XO?%?X>?\$E_AI\>/CWXI_:)O\ ]H/_ (+6_P#!1"S\
M<>#_  [X6_:7UO\ 9]\)^%/ 7Q*U;Q+=?"/X8>./B[<VGB/4_A9^SY>>!M-L
MM<US2OAW;:)XBU/0-?TZR34;.VTG48)/EGP+XZ^-_A?X ?\ !S/^R-XU^+VB
M>-OA9\#OV6_AGKO@WX??#[XU?$G]H+X.?#+Q?XOT>>?QIH?PU^)GQ@U'6/B'
MJ\>G7G_%/>+)M4OX$N?%&B:@&TVS-I!!  ?Z!GP7^+/A/X\_"+X9?&SP&=2;
MP3\6O GA7XB^$CK-D--U8^'?&.BV>O:.=3T\37 LKXV%] ;JU$\P@FWQ^:^W
M<?3*_P _/XH_$C]ICXP?&K_@GO\ L:PZCI9_9T\%_P#!&']G[X\^%/AQXJ_;
M+\>?L+>#?%?C[4?"6G:;XD^*MS\5? >DZGJOCSQ/\.+>QC?0O ]QC1]&M[/4
M-;O();>'4[>_Z#XF_%O]K/XH?\$]?^"$FE?$K]KSQ=XF\4_$K_@J5:_!9_VD
M/@/\4?&I\0_$/X/)XCUOPQH=]>>.]>\+>"=4\8>(/#\"7GAU_$6N>&KZSUG4
M/#MMX@>35)K@W#@']\&HZCI^D:??:MJU]9Z7I6EV=UJ.IZGJ-S!9:?IVGV4#
MW-Y?7UY<O%;6EG:6T4EQ=7-Q)'!!!&\LKI&C,.,^%GQ4^'7QN\ >&?BI\)?&
M&A_$#X<>,[*34_"?C3PU=C4/#_B+38[NXLCJ.CWZ 17U@]S:W$<%Y 7M[E8_
M-MY)8621OXS/'GP5MO G[2O_  < _P#!.M_BK^T)X\_96T7_ ()Q^&?VH_!?
MP_\ B%\<?B/XTU+P;\4X_!FG^*]2O-&\7ZSKU[XPDT[Q!XBB%SK^E3ZN^GZ]
MI4TGA[6[34M+2*(?LK_P;<_#+X9_#W_@D9^RKJGP^U/4-0U7XD^!M.\>_$F*
M]\>ZUXUBT[QU?QG3+RQT_3]6UG5;;P-9)IVEZ<X\(:)!H^EV<[S7@TR.[O+F
M:8 ^G/V]_P#@K_\ L4_\$V?B1\!OA9^U#XM\5Z#XH_:&N[M/"!\->%SXATO0
M-(L==T/PY=>*?'=__:-B/#7AF/4]>@0:AY5[++%8:O-#:R+IL^/H#]M/]N'X
M'_L%?"/PY\:_CM)XL;P1XJ^*'@'X1Z3+X(T&+Q-J3^*_B3>7-EX;>6R?4=-1
M-):2UF>]OTN)&MX@K1V\[.J'^%3]M'X[ZA_P4!_;D_X*V^/K7]@G]KC]M?X9
M77P:U/\ X)T?LI?$S]G+P!+XS\$_!?Q3\-[^V\6^(?'-YJTVG74*:W=?%:VT
MCQ6+;2'6_E\)ZKJ.FW#I%J-HZ>Z?MG_MB^.?VT/^#9?]E7Q)]L>W_:9^#'[9
MG[.7[-GQ(L?$D4%OJFB_'/X-ZGKWAO2IO%5A>"=[2\U6P'A/Q'J<6JP><\FI
MW+7L!?SHZ /ZY?VB_P#@J!^S'^SC^T[\%/V,M5_X6+\5/VH/CNJWOA;X._!+
MP</'OB?PYX<>811^,OB,[:KI&E>!/";(E[>_VKKFH1,-*TO4]6:V&FVING]3
M_9X_;?\ @C^TY\9_VK?@/\,F\7GQW^QM\0M$^&7QB'B'P_'I.C#Q+X@TZ_U.
MP/A744U"\.N:=]GTVZ6>ZDM]/>.54 @=)$D/\M/[ /@OXJ_\$8O^"O%I\.?^
M"AWC/P]\?O&'_!6#X:^&=0\)_MT:SHS)KVF_M->';H_\)K\ (O$M]NGTOP-K
M>HZKI>G:/9+%HEA<R0_"X6.CZ59-/INE_HG_ ,$:?^4G'_!P5_V>/\+O_4-\
M74 ?TAT444 %%%% !1110 4444 %%%% !1110 4444 <]XJ\7>%/ N@:AXJ\
M;^)_#W@[POI$:3:KXD\5:UIOA[0-,BDEC@CEU#6-7N;/3K*.2>6*%'N;B)7E
MDCC4EW4'Q"/]LC]D.:1(HOVJOV;Y99'6.../XX_#%Y)'<A41$7Q06=V8A550
M2Q( !)K\R_\ @Y!57_X(N?MOAU5@/!/A!@& 8!D^)?@QT8 @X96 93U5@"""
M :_AA_9\\#?\&K]W^QO\.M1_:2^+7[5^E?M;R_!^UNOBAI'P\LOB7=16OQ8&
MF2R:A8^$XKSP!-\/YU_M,)%IT=]K7]@/&R+=ZE"ADN4 /]5BQOK'5+*TU+3+
MRUU'3K^WAN[&_L;B&[LKRTN(UEM[JTNK=Y(+BWGB99(9H9'CEC971F4@FU7\
MRG_!I]X,_:%\*?\ !+73K[XR^(=5U;X>>,/BUXR\3_LSZ7XAUBUUG7]!^"UU
M;:3;62W)MM2U(Z'I^L>([;7-7TOPS</:3:;'=37D=A;V>J6LD_\ 370 4444
M %%%% !7\@GQ._X*T_\ !3G]J/\ ;^_:_P#V2_V&?B+_ ,$]?V4=$_8]\7/X
M!M]%_;0\1ZM;_%?X^:_#)=V3:QX5T==L$/AZ?5;(PRKIEEYND:?J_ANXEO\
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M>K:=:7%K87NF:MH,#Z7<XFLKSP1JNFP+.=/N)V_,G]@W_@B#??$__@BKI?\
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M,6@G%M>130B:%B6BEV;XV)*,#6BB)&BQQJJ(BJB(BA41% 5555 "JH "J
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M:6M[\K^/O^#F'[/K/Q>^(OP&_P""</[4O[1G[$WP$^*(^$OQ-_:Y\%36%CH
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MSPSJWP]T_4(=6M?A!JNEV]CI$=M9:B/$$5QID&M1F#[7<:1']_?\$Y/^"?\
M\5?V:?BO^V!^UO\ M2_$CX=_%']KK]MKQIX)UOXF:C\(/#.O^%?A1X)\'?"[
MPPO@_P"'W@/P)8^*]1U/Q/>6=CI"+-JFIZY<?:KJ[2W5(\PSW=[^LE% '\V'
M[6__  2M_:P_;%^$_P#P5!^('C74_A]I'[2W[3WC+X.?#[]FOP/J'BBZU#X?
M^'/V./V5/BMX/^)W@?X/^*/$EAI7FZ-J'[1GB32/&7BSXJK#I^M:=I6L>)M$
MTZYDU/2-'GM%^Y/^"/O['7QD_9 ^#'[0@^-_ACX<?"WQ9^TA^U[\8_VG+'X
M_!W7SXF^%?[/GASXB6GA32=(^&'@_6TT'PO8W\-I'X5DUS49M'\/Z/HXO]:D
MAL[%9(KBXN?UKHH _FD_:)_X);?\%4--_P""G7[4G_!0/]@/]KS]F#X(P?M+
M?#GX0?#;5O#_ ,7?AEXA\?Z]9Z+\,_ O@SP_+OBD\.:SH4%Q<^(?"\^J6EU9
MN6.GW,%K=1>8DH9/"7_!OOK'CG]CK]OSX<_M@?M3ZE\;OVSO^"C&H^"_$OQD
M_:8TKP?9Z+H7A#6?A'JD.M?!_P .^"/!L;6$;>"?#=_:HFLZ<L>@Q:KI5U_9
M.G:;HD.CZ1+%_2Y10!^ O[#O_!*3]HWX<?%R7XE?M@_$+]D>[\,>&_V=;K]G
MKP?\)/V-/V=M.^#GAOQ?<Z_ITN@^+OC;\7?$VN:?/XJU+XF:QX<EN-%CT[PQ
M<:5X3M8[^>X@L8/LZV]UYU^RE_P2G_X*6_LK>&O@E^Q_X&_;\^&_A;]@'X#?
M&V\^(VAZSX&^&?B'1OVQ_'?PO_X2/5/%UK\!/&?BFYU&Y^%UGX7U/5=5N=/\
M3>)-$T0:Y?:6R&U2W\J.R7^C^B@#\:/V(O\ @EQKG[/^F?\ !4WPA\:O&GA3
MQQX&_P""BO[1OQG^)\&F^!X]<T[4_"_PU^+_ (6O?"5_X6UN[UBUC4^)+?2M
M0N$:\TPW5BLQ\^*0[O*3X1_8H_X(7?M-?LU^+_V9?ASXY^.'[(FL?LL_LE_$
M#7?&_ACQ#\-/V6]+\.?M9_M :<FN7VO>!/!'Q]^(GB/^W=(M]!\+ZG?OJ%Q?
M>#IQK-^UI86;WA:UM=0M?ZA:* /X]/CO_P &ZO[9'CGPO_P41^"/PV_:>_97
MTWX*?MQ_M">(OVEY?'OQ!^"7BS7_ -J2UU_5/%&F>,=.^$&M?$JTU7^R]*^%
MMCK6GP^9J&DZ?K&N>5;3&ST^TAUW4[.+[5_;P_X)-_M<_M766C>&K:Y_X)L_
M%GP!-^SYX,^%]OH/[67[,WB7Q/X[^ 7Q T?PBOACQ%XV^!/QE^&VH^'/'.K:
M?>337^M^']*\>S,-#U2:.6$&)'A?^C:B@#^8/Q[_ ,$"OBMH_P -O^":/B+X
M3_M!_"KXO_M/_P#!/3X?_$#X7:EJ7[:GPKU'XN? SX_> _BA/KVH:KX;\6^%
MH=5NO$.AVGP^N?$=_IGPQN;:YU/4-,T2WT5)KRVO-$M)G_6S_@FM^QEX\_8R
M^"?B/PY\7_B-X)^*'QD^)?Q"\0?$GX@:[\,OAEX=^$OPR\.R:NZ1Z)\.OAIX
M.T&QLYK3P%X'TZ,Z?X?FU^2[URX6XN9;N6)&AMH?T0HH _GW^/\ _P $?OC#
M\7_VC?\ @KK\9])^+'PUTK0_^"BG[$'A[]ECX=:/J-AXH?5? /B?1_!MMX:F
M\2^-);:REM+G09;J*:XCCT-KO4/(DC5K99(F$N5XI_X(W?&37OA'_P $*OAU
M;?%SX9P7_P#P2D^)GP;\<?%;4+C3O%+V?Q.L/AKI?@NPU*R^'RQV8FL[O4#X
M8N_L#^(TL84-W:RSE!%+"W]#M% 'QA_P4!_8=^$__!13]E7XE?LJ?&&ZUG1O
M#OCJ#3-0T3QAX:>&/Q1X \<>&M0@UKP?XX\.M<JUN^HZ#K%M#++:3A8-4TV7
M4-*FEABOGFC_ )YOBG_P0J_X*L?M<^#_  [^S5^VO_P4F_9]^)O[,N@66E^%
M[OX@Z-^R;X)U#]KCQ!X!\/:Q::UH^@+\3O$OAL:GX9U&>[TO37U76]-\8WMQ
M?RBXFUQ?$IGN8[G^NBB@#\7M$_X)9^)O!_\ P52_9H_;<\+?$#PS+\#?V=O^
M">EE^Q)8?#_Q#!JE_P#%#5K[1M<\2W&D^*KC5;;3;;PO/92:+JVFP:@RK8W4
ME_;Z@T5@EM=0I#Z9_P %>/V /'7_  43_9@\#_ CX9>,_!/P[UGPM^TC\&/C
M9=ZMXSL=7N=%NM%^&>JZGJ.IZ/!;Z!;7%S_:FI"^B6T>6);0^7*EQ+%O61?U
M5HH _$O]MS_@EK\0_B#^VA^S+_P43_88^(G@3]G[]J7X1:LOA7XW0^*;/Q!:
M?#K]IGX#WBO_ &CX%^(UGX)MS?ZEKMD&FM-"UB_AND@@O+:XN&-YX8\-26?C
MW[%_@+4_CC_P7=_X*;?MH6^F:A;_  V^"7P=^#7[!_@S7+NQEL[#Q5\0-,@T
M/XC_ !A;2)9HT;4(?!6IV>C:,^I1%K6;^WV@B:5K=C%_0K4<4,,(988HX5=W
ME98D6,-)(=TDC!  SNQ+.YRS'EB30!)1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?S(+I&H_!S_ (.I[O7?%%K+;Z!^UQ_P
M3E2S^&6MR".&PO?$?PGU[3;?Q5X<BD=Q]KU.RTWPT-8F@C_>Q6FI619-DJ25
M^>7PL\ ?$#]F#]H7XF_&32_^#<;]JS]JGXX7OQ0\<:Q;?M._M$?'SP/\6?%.
MH0S>)]<FTK4? .F^*]$N?#_@#05L[TOX>MO#^CVNI6>FO9Q76J7MQ;K<M_6S
M\=/V/?@E^T+\5/V;OC;X^T?58OBI^RCX]U/X@_!OQIX<U5]$UC1[[7]$G\.^
M*/#VJ3Q0RC6O!WBG1Y_LFO>'+Q3:7C06MRC07-O',/J.@#^0?]OS]G/]NG]H
MCXR_\$S/^"SWPW_X)ZR>*/C=^SEI7B[P-\>/^"?WQ(\6>%7^(MKX/D\2>+)/
M!FO^&]>O(X?#6JZKH?\ PDOB/Q%:1I;S:IIFI:GX:N[+1M2^SZE]B\I^ '_!
M'K]LC]K_ .$__!;+XL_'OX+^$/V%O%?_  4UTCP'I_P-_9M?5])UV+P-K/PC
MU2Z\6Z'XM^(+>%,:3ILOB[Q!'86=S<0P1ZU:W&L^,M=N]#MUN;"UN_[3J* /
MX1_AI^PY_P %./VL]=_X)-_LF_%C_@F]X9_8J\(?\$S?BGX'\:?$[]L"R\9^
M!KJV^(^B?"2;2XK72_A[:>&9'UJ^F^)PT:VU;7HH;S6;6\\271U?4+K3(+69
M;C^BO_@K_P#\+8^*GP\^%7["?P!T#Q5:_$#]OCQLOP:^*/QB\-:!J+VGP6_9
M8T.&/7_V@/%^O>+[2RET_1=1UCPB\G@?P5I&KWT!US6/%5XVGV]W_9M[&/V-
MHH _A7_;@_9?^.?@#]NCXF?#GX3? S]K&/XM^%?B'_P3;\,_\$F_'/P6T[XH
M0?LX?![]F?X6?\(_HOQ\\.:[K7AG4[/X?^&[;3--TS7_ /A8-KXP5SJ]O>Z3
M.3'$)GF_M[\8V5_?^!/%6G0Q&[U.]\):Y9106Z\W5_<Z/=01Q0*S9S-<.$B5
MFZLH+=ZZVB@#^'/_ ()<_&;_ (+'_P#!,[]C;5OV3/"7_!%3XX_%OQPGQ1^*
M_C/PC\0=>^)'@OP?X&EO/'WB ZCI(\0:;)/)>1:9IQ&Z\F37=/6[A" 7=AO:
MXCHZS_P;O_M@:G_P1L^*7@W78O OB#]OWXL_MFZ+^W[X]^$L.MV<'@OQ'J&A
MZ=XGT.+X$KXJ2^M=)@UA]"\8^(=9&J0:I%HBZ_>R>&K?5TLV'B(_W-44 ?R'
M_P#!,_\ 8U^('Q#_ &L_ _Q%^('_  0S^&G_  3X\&_";P#XB75/CC\0/CSX
MY^(WQ?;XE^)/"VM^%;[3?@3H;^,-6LK'PW<#6;I[N^UW3GT]-$DNTBU.[U2Y
MMHHO$/V6M%_X+J_\$EOA#\9?^"=_[.'_  3G\/?M'I/\=O&'C3]FG]KW_A8G
MA>/X06WA7XB>)+36;O4?B9X7U#6-#UN2?28UFG>TU/6_#6KVUW=W=DBWUGH^
MEWFJ_P!K]% '\PEU^RC^VUX@_P"#@;]A7]KSXJ?"%-0\'^#_ /@G!!\.?CU\
M8/AU:LGP:T'X]7<_Q=NO$GA?PW_;.K7GB2#3?MWB+3QHXOENYWL=0M&FO'<S
M;/D+_@I__P $U_CYX&_X*L_$7]O;P[_P3P_X>C?L]_M)?"/PGX2\0_"OP]\5
MM1^%GQ#^"GQ+\#Z'X?\ #UCK%G=:7K^CW^JZ)K%OX9L9UN4M]3L8[+6M8L;J
M/3;G2--NM1_LXHH _C*^+?[#7_!2/P-_P2?\/:=^R'^Q[I'[#GQ4^*G[5.B_
M$S]JW]EK]B+XUZM;?&KQ'^SG+H2^&[W1]-^*GC#Q-J=B/BU>6R)-XFM]"UVY
MM);"/18S%J=UIVJZ=/Q?_!//_@GM^T!\&?\ @LE;?M)?#/\ X)__ !V_9G_9
MD\<?L<?$SX=^%]=_:=^*TOQS\37WQ3E@B:S\0_M!:B?B'\1/$/A8>,M4TK['
M;^$;75YQ;>&ETIUMM)N=1ETVP_MIHH _SO?CK_P2$_:+\6W[:E^R[_P2R_:-
M_8"_X*3?\+ALQ!\;?V6OVE] T_\ X)ZOX9C\7_:[OXD66J:WXRNO&WA/1V\/
MQI<V/@CPYI&B:C:ZLHF?0YX)'T<?<7_!0?\ X)B?M1?#7_@H_;?MO:I^P<G_
M  5G^%/QI_9I^'/PN^*_@KPM\4;OX0^.O ?QO\!^'?#6A7_CS3X]-UK1K^?0
MO$UQX8CU""*%=4TB&T\0ZW:ZE#I]]I&C7EY_;!10!^1'_!&;]F3Q)^SO^S+K
M>J>//V+_ (,_L(_$'XP>.;WQYXB^!/P=\:^)?B NE6BV%GI6A7OQ \3>(-;U
M^WO/']Q86I_MA=#U">PA@6RCGE;4!=QP_-WQ4_9@_: UK_@XQ_9H_:LTKX5^
M)[W]G7PA^Q!X_P#AUXE^+4,5G_PBNC^-]3U3Q7<6'AN[F:[6\&H745]9O$J6
M;Q,+A!YH(<+_ $$44 ?R)_L,_L,_M;_#;_@D/_P6+^!WC7X">-O#'Q@^/?Q8
M_;!USX0>!;^WTR'7_B'I7CWPM;6/@Z^T7R=0>"6'7KB-[6Q-Y<V[97$BQ1E2
M?V__ .".?PC^)7P%_P""87[%?P>^,7@[5OA_\3OA[\$/#GASQIX,UU($U?P[
MK=G+>&YTW4$MIKB!;B(.A813R)AAAC7Z6T4 ?RM_'#]F3_@HS_P3._X**_M0
M?MM_L(_LTZ/^W1^R[^W>F@:U^T5^SG8>-](\ ?%3P!\2]+M[F#4_%_@VXU>2
MWLM8T[6#<ZO?R+:6VM7U[<^)+G3;[3M/72['6Y_B+]@__@E1^T;\3/\ @JY^
MS=^W9H__  3!^'?_  2@_9R_9NF\<:GKG@O6?BG_ ,)]\3OC;K_BKPQXHT>T
MU-]"T^]U'^QM2M;GQ((I9KN#0M-M-+M)E@&I7-Q$J?W T4 ?S _\$P_^"8T!
M_;,_X+#?$C]M;]C;P9KOAKXN_MB3>-OV>O%7QI^'7@KQE#XI\"WM_P"/+F^U
MCP7<:S;ZS<6FDW1OM'GNE"6)GDFMC-$\D.(O1?\ @OQ^PU\0/CK^R+^R!\"/
MV3_V=4\9^%_AQ^V1\%?$>O?"[X=^'=!T_P ,^%OA-H?]NQ>([B3P\'TW2+?P
MU:PWPAO;*VA*/%=.HMG1GK^CFB@#^3W_ (*)_P#!,3XS?L2_M:_L[?\ !4C_
M ((Z_L\:#>_$#PWK>G_#W]JS]E'X8^&O"VB:5\7OA7JTA;5?$?AG1K@Z=I.A
M:^]A%/H>N76@-IU\+QO#'B.*.Y.FZ[%J'8?\%,[_ %C]HS_@KW_P0%^'WA?P
MIXBT7Q1H.I_%S]JCX@^&_$%I#:>)OAOX#TGP[X8D\CQ?I$=S.EA>G6-*U/PW
M<.ES/!#K%JT-M-=H?,']25?+>C?L=_!'1_VN/&?[;QT?5]7_ &@_&7PH\-_!
M$>)=<UB;4M-\)_#+PUJ=SKD?AGP1HLD:VOAR#6M>NYM:\17%L9+K5K\J\LR0
M@PL ?4E%%% !1110 4444 %%%% $,_W!_O#^1HHG^X/]X?R-% $U%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3? ;X>^"=,L_ =W\+?B?;^--/T+4ET'PK%IOB[QI<_$"ZMM0Q?@WXYUOP/\
MLO?!&?\ X)O?%7XJ_%/QG<_\$S_BCXA_:-TQO%OBOXEZWX)\?>&_ OPMB^#6
MN7_@#Q'?:CI/PP^,=GK5S\0M*\">!=$TCP_-X@T#3KO9X<UK3](TG4*_J\&G
MV"W4]\ME:+>W,*V]S>"VA%U<0)]R">X">=+"F!MCD=D7LHHM=/L+)YY+.QL[
M22Z9'N7M;:&W>Y>)!'$T[1(C3-'&!&C2%BB *I"\5=3Q/P<N;EX9IJE*K1K3
MRZ>80JY1B/9K-HQPV,P4\M=2O@L'',Z<LIPRQ-.GEU3 8?D4Z,:-##"P4EO6
M;=FN?E:J+6F[QDIV4I>S_>.WOJ3ZW<OQ_P#V,_$W@X?M@:GX1_94^*WB_P",
M?[*]W^R?HGC+XIZ[K7Q*\6?%[1M#_:1N_']E9^'&N?%/B_6=>N_"OQ0\7?#Y
M]?U#XB_#JQO-,72_[(T34-6\)^'KZ>%M0_8NJMI8V5@DL=C9VMDD\\EU,EI;
MPVR37,V/.N)5A1!)/+M7S)G!D?:-S' JU7Y[GV;0SG&PQ<*%6BH87#X:4\3B
M(XO&XJ="+B\5C<5##X6%?$3NH<ZP]/EH4Z-.7/*#J3ZZ5-TXN+:=Y.5HIQC&
M_P!F,6Y-1ZVN]6WI>P4445XAH%%%% !1110 4444 %%%% !117C_ (;^//PI
M\6_$WQC\(?#_ (ML-0\=^!-.\*:IX@TR/>+9;?QI;Z_=Z#%IFJ,HT[6;V6V\
M,:Y/>6.EW-U=Z;%8R/?Q6ZE26HMIM)M15Y-*]E=*[[*[2]6@/8****0!1110
M 4444 %%%% !117YF_\ !76\_:&TC]@[X]^(_P!GCXLV'P6U?PG\/O&'BCQG
MXUATK4=0\<#P=HGAO4KN\T+X;7UEJ&G0^%?%FNWBVEC'XQN6NI?#MB]U>:99
M2:E]FF@ /TRHK\I?VI_C%\2/AG_P2+U3XL>"_&VK>&OB/#^S5\))8?B*;K[?
MX@\/W7BZR\#Z%KOC1=1U0W6_6M,L=;U'6(]7U(SK!J$2ZC>._ENQ\/\ V1?B
M9X\_9C\5_P#!0WX.^%G_ &E_VU/AU^S7XP_9QO\ X4^'+GQWI7QE^.4]S\:_
MAEX=\1>//"^G^-OB!XD\/)KEAH^K:A)XX%EX@\40/H.@W]Q8Z6DD*:?9OI1I
M3KU:5&FHNI6J0I4U*<*<7.I)1BI5*DH4X1<FKSJ3C"*UE))-B;44V]DFW9-N
MR5W9*[?HDV^A^Y5%?G?\"/\ @H(/B_\ M!:7^S=XV_93_:9_9P\?:_\ #+Q;
M\5_#DOQPTCX:V&DZ_P"&/!>O>%O#NN?V;-X)^)/C2[>[M]1\7Z4H2>T@BV&0
MO,I\I9/T0KIQV7XS+:L*.,I*E4J4HUZ?+5HUX5*,Y3A&I3JX>I5I3BY4YQO&
M;M*$HNS31,*D*B;@[I/E=TXM-).S4DFG9IZK9IA17,6?B_1+[Q;K?@FWENFU
M_P /:/H>NZG"]A>1V<>G>(KC5K;2WAU)X5L;F>271-0$UK!/)<6J)%)/'&EQ
M"S]/7)*$H-*<7%N,9I233<9Q4H25]U*+4HO9IIHNZ>SOT^?8****D HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** (9_N#_>'\C11/]P?[P_D:* )J*** "BBB@ H
MHHH **** /@CX7_LS?&?X(2_M<>(/AQX\^'<WC#]HO\ :D_X7IX=E\5^']?O
M="\,>$]3TGX?>'/$'AG6;73[^SO+_79-$\*ZQ_96HV5Q%8V]_J&GRW$$T-M/
M%+X'\(O^";WQ$^&_[4OAWXA:E\:_#6K_ +-GPJ^-/[07[1'P7^%.G>!+G2_B
M!HWQ(_:0TG4-,\7:7XO\<-KESINN>#_#4GB/Q??>'([;1K;5;N77+>'4YUBT
MJ#S?USHH _GG_P""JG_!./\ 8L^%'['7[2/[0WP[^!NE>%?C-INI>&/&EAX\
MT_Q7\07U.U\3^*?C+X/.OZO%:77BVXTD3:C_ &YJHE@.GFT1;R1(;>)%C5/Z
M&*_&#_@N7X<^-^I?L3_$37O WQ-\'^%_A%X?TWPVWQD^'VL_#J;Q)XH^(T-[
M\6/AG%X9B\)^.D\4Z5%X DT2]2YN;^27PYXE_M>*:.W4:>8?.?\ 9^OK<WQ>
M,QO#/#U?&YE6S*K_ &MQ'"+Q&(Q>(K82G#"<-QAA9SQ44HI6=>$,/.K0C"O%
M\ZJNK3AR4H0AB<1&%-4U[+#M\L814VY8AN24=_Y6Y).\7HU9OPSXQ:[X<L[[
MX9VNI3ZM/=V?Q2\+ZC)!X?\ &.G^&9-%MUL-<4>(/%]O<ZA9R:OX(M=_E:KI
M!2=;ZYN-/D6"0VVY/;H)X+J&*YMIHKBWGC2:"X@D2:&:*10T<L4L;-')&ZD,
MCHS*RD%20<U^;'[:G[+/P)^(_P 1?@-XU\9>!K[6?$WC;XW>"/A]XGU2W\9^
M.]'@O_""^$_&TXTJ?3]$\4:;IEJIGL;-DO["RMM4\^&+-[L:57_0KPCX3T#P
M)X8T'P;X5L3IGAOPSI=IHVB:<UY?:@UEIMA$L%K;&]U.YO=0NC%$JKY]Y=W%
MQ)C=+*[$D^!B/J/U;#1H8O%UL1",95J-;+J6&H4_:J4JBI8J.;XV=?V=:+IP
MO@,'[6G:O)4YMT5]3F.6Y?A<GR3,,-6QD\5FD<7+$TJ].A&A1E@ZRPTE0J4Y
MNI452?OQ=2,7&+Y7=J[Z*BBBN$\$**** "BBB@ HHHH *XOX@_$#PQ\+_"FI
M>-?&-U>V7A_23;"^N-/T?5]>NT-W<Q6D'E:7H=EJ.IW&Z:9 WV>TE\M29)-L
M:LP[2BHJ*HZ<U2E"%5QDJ<ZD'5A";3Y93IQJ4I3BG9R@JM-R5TIQ;NNG!SPE
M/%X:>/H8C%8&%>E+&8;"XJG@L5B,-&I%UZ.'QE7"8^EA:U6FI0I8BI@L7"C-
MJI+#5U%TY?@1^U3_ ,%C_%7PK^*\_A'X*> /!?C7P3#X?T;4%UWQWI_C_P ,
M:[)JM\D\E[;?V1=1Z)/'9VP6)8)WLL3L9&25U Q^@?[*W[=WP_\ C]X+^$R>
M(/MFA?%GX@Z,EQJ?AC1_!OCV7PM8:TB7LUU:6'BN^T1]%EL4@LG>*\FUAX7<
M^2)VF(2M#X__ /!.[]F;]I?X@R?$[XI:#XGO/%LVC:=H4UUHWBW5-%M9;#2O
M.%EOLK4F'SXDF:,S*%+H%# D$GZC^%/PQ\)?!?X<^$/A9X$M;JQ\'^!]'@T+
MP_:7M[/J-W#I]N\DD:7%]<DSW4N^5V:64EF)] *^&RG+>.*&?YCB<SSG 5\F
MJRF\'AUAYU'&#Q%*2C3H1E0GA)>PC4A&=3&8]4W*TH5M)+^I_$+C3Z+69^$?
M!F2\#^&G%F5>)>!I8:/$><U<XPV%C6KPR?&4*U7&9K4H9IA\_H?VK4PF)JX;
M!\.<*U,7"FY4L5ER3H3[]V5%9W941%+.[D*JJH)9F8D!54 DDD  $DXK^=[]
MEC]N^]\7_MR^'_B1K'QIUGQ!\(/VV_'GQR^!?PW^$U_<>)H_!WPOB^!5R\G[
M-_COP_;ZEH\'AZQU;X_Z!X3^,E]XAGTG4YE\1OK7PL>"2]>%Q;_OK\0/!UE\
M1/ GC3X?ZEJ>N:+IWCCPIXA\(:AK'AG4/[)\2:78^)-)N]&O-0T#5?)N#IFM
M6EO>23Z7J(@F:RO8X+E8W:(*?"?&?['WP:\9_ GX4?L\O9:]X:\"? [5O@KK
MOPIN?">LMH_B3P9K'P U70-5^'-_I>LBWG82VI\/6NFZP)8'76M'O=7TZ['E
M:C,U?MW#&:9!EV$S7#9OA:^)J9S!99*M2C0DLMR^>'Q4IXV$*U&K+$8BCF;R
MO'4:-"I@ZK663HRQ2I8J=.7\CUX59R@Z<HI4WSV=_>FI1M&Z:LG#VD6VI+W[
M\MTF?(O@;]OKXL?$KP5^PQ>>&/AKX$L_''[9EG^TW9PV6N:SKZ>'/!_B;X*_
M#[X@^*_"$,D]K"VHW.D^(M8\'V&G>()63[78:??W=S81RSV\<;^7_#+_ (*L
M>/OC%\//&7Q"\&? /3+!-'^.GPF_8C\/^'?%'C..WNKO]MCQ'XJA\(_&K0M<
MU;2(=4@L?@K\%-6OK:VM_&-AIU_K'Q(%AJ5UX=L;2UFL7?Z4M/\ @F5\%M-U
M_P -Z[I'Q,_:'T=?A[>_'N^^#VB:;\3X[;1/@O-^TCH/BG0/B4?AW OAXWUM
M(L?C#5]0\(7/B/4/$EUX,OUL1H$UII]LUA-=M/\ @F!^RGH>B:_X:\%:'XN^
M'F@:_P"#O@KX?;3? _BR[T1-&\9_L[W@O/A!\<_#T_D7-QI?QU\+F.TMKWXA
M++-=>+K73M.B\8V>O&V9I?I99CX8Q=1++,14]I5I5:+6&QBCAJ<^)<RQM?#5
M;9M2E5Y>':^59="45.U;!8V%.I3GB:69+!0QNEYI65G[T=7[&G%->X_^7JJ3
MUZ2@WI%TW\_^,?V_OVE- ^,N@_LH:7\*O@Y>_M"2?M'^"?@UKWB>]\1^+K?X
M13?#[XC?L]_$3X[^'OBKHEA!!-XMAU32(_A[JWAK7OAWJ5XTT]U;I>:9XK:T
MU*&2RIZC_P %1];\._M$^!/A9K?AKX<:GX9\5_M<V/['FK6?@Z[^(/B+Q'X6
M\2ZU!KUAX;^(.N?$&U\-2?!VR37?$^@264OPABU_4/&OANPU*PCU_7+?Q-!J
MOANP^N_"/[ OP:\+^,_"?Q-U#Q#\4/'7Q4\,_&$_'#4/B9XY\6VNJ^+?&GC.
MW^%/B3X*Z':^+9=/T32=)G\*^%/AYXJU/1_#'AC1-*T/3-+F\O4?+GU"2^N+
MSB]2_P""9OP*U;Q1X&UJ]\;?'.3PQ\,/VG%_:]^&_P *5^(D,/PP\&?&^7QG
MK_C_ %+7=-T.#0(M5O\ 2M7\3^+?%VH7>@:_KVL:;;/XHU@Z5%IS26K6BIYG
MX:RG"G7RNJJ<,G5'$5J%#$TYXC.JE/$PQF,PZJ8JLX8;V\<'6R_#2AA/8T*E
M=RJT9T?J>+;AC-U-7]I=)M-1IIQ<8NT5=VYE-^]>25KI\R_1*BBBORD[@HHH
MH **** "BBB@ HHHH **** "OR(^ 7_!(SX6? +]MWQ=^VMHGBRUU?7O&&H?
M$BX'P_N? NE67A;P+:>)I[1?!9^&(M]1DD\'Z[H&F7GC.Q\;^(H8[JZ^)4GB
M^\N;^WT?R/)G_5S7?$WAOPO!:W7B;Q!HGAVUOKZWTRRN==U6PTB"\U*\8K::
M=:S:A<6\=Q?73 K;VD3/<3L"(HV((K8DDCACDFFD2**)'DEED=4CCC12SR2.
MQ"HB*"SNQ"JH)) !-:PJU:4:BA)QC6@Z<[)6G#K%W3T]-1-)V;6VJ\A]%<S9
M^-?!NH^'9O%^G^+?#-_X3MXKJ>?Q19Z]I5UX=AALG=+V:;6X+M]-CBM'C=+J
M1[E4MW1UE*%2 ZY\9>$+/PVGC*[\5^&[7PA):P7J>*KG7=+@\-O9W3(EM=IK
MDMTNF-:W#21K!<"Z,4S.BQNQ90<[/L][;=>WKY#.DHKG=6\8>$M!L]+U#7/%
M'AW1K#7+JSL=%OM6UO3-.L]7O=17?I]GI=S>74,.H75\GSV=O:/-+=+\T"..
M:Z*E9[VT>S[VW **** "BBB@ KB?B3\./!'Q?\ ^+_A=\2?#UGXL\ ^/= U'
MPOXO\-:A)=166N:!JUN]KJ.F74EE<6MVD%U;N\4C6US!,%8E)%/-=M7)^-?'
MO@;X:Z!<^+/B+XS\*> ?"UG+;P7?B3QIXBTCPMH-K/=R"&U@N-8UR\L=/AFN
MIB(K>*2X62>4B.)6<@4 >1ZE^R;^SGK6KV.MZS\)_#6L7NG? N^_9GMHM6.I
M:GI3? K4KW3=0OOAQ=Z#?7\^AZAHMS>:/ILSSW^G7.JC[(D::@L32(]S]G;]
MES]G[]DSP3<_#G]G3X6>&OA3X.OM9N_$.H:1X>2]E?4M:OEC2?4M4U/5KS4=
M7U*Y$,4-M;M?7]P+.SAAL[18+6&.%?9%\0Z ^@CQ4NN:.WA@Z5_;H\2+J=D=
M!.A_9?MW]LC6!.=/.E?8?],_M'[1]D^R_P"D>=Y/SUE>"?'_ ($^)>@P>*OA
MQXU\)>/_  O=37%M;>)/!/B31_%6@W%Q:OY5U!!K&A7M_ITLUM)^[N(H[AGA
M?Y)%5N* /SD^(/\ RF._9H_[,'_:;_\ 5T? 6OU(K\6K+X#?"7X-_P#!:SX?
M>)_AKX/@\,:]\;_V/?VG_B-\4M0AU77]1?Q9XSF^,_P0$FM3P:SJNHVFEN?M
M]Y_H>AV^F:=F<_Z)\D7E_M+7T?$*HQI\/*A.I4I?ZOX>TZU*-"HY/,,S=1.G
M"MB(I1J.<(2563J0C&I*-.4W2AS8?FOB>9)/ZQ+1-R5O94K:N,7JK-JVCNKN
MUWY;HNK"?XP>/-%_X2_6;XZ?X,\!7Q\$7'A_[+H7AT:AJ'C&/^W=.\2_9U_M
M;4/$7V+[-J6E_:I/[)BT2QF\F/\ M+<_J5>6:+JXG^,'CS1?^$QU._.G^#/
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M]XET?4M UW2;M6:TU/1M8LIM.U/3[E596:WO;*XGMI@K*QCD8*RG! !^6?\
MP3W_ &G_ -J;XE?$;Q9\(OVJ]1^$/BCQ'JG[.OP$_:S\"^(O@_X7UWP?IGAW
MP;\>I_%UG_PJW7]-U[Q%XDGUO5?!5_X59+3Q?#/IIU^QNA<W6DVDICC7P#X.
M?\%$?VI[W_@H\?V:OC9X1L?"_@/Q[\4OC/\ "[PG\-YO@;\2_"FJ>!-(^'/A
M*\\=?#;XIV7[1FMZE+\,OC7:_%_PSI-_?WOA'P?IEK?^#DN+>6>8K;3Q2?:'
MP=_X)D? +X#>#_'/A3X9>-_VBM#OO'=S\.+:Y^($_P <_&&J_$WPWX&^$NLI
MJ_@#X1^"_&NI27.I^&OA/H,9O-%7P;9YM[[0=5U/3=1N;M;KS(^Z\#_L!? 3
MP%^TKX@_:FTZX^*&M>/=7U;QAXDT+PMXM^*/B[Q/\*/AOXM^(MK9V7Q$\7_#
M#X;ZI?3>'_!GB/QQ96%O9^(+_3XF5[3SK;3X-/AGF1P#\L_^"J__  44_9P^
M)G['7[27P$\,0?'-?']_J?ACP=;R>(/V:/C]X5\%_P!M>&?C-X/74S-\1/$?
MPZTSP-;Z4S:->_8-;GU^/2=4!M3IMY="^L_/_HEK\P_^"R^?^':?[3^/^@1\
M.1^!^,GP[!'T(R#[5^GE?4YI4P53AO)'@<-B<+36<\0QJ0Q.,IXV<ZRP'"_-
M4A4IX/!*G"2<4J3IU'%IOVLE)*/+24UB*WM)1F_8X>SC!P2CSXFR:<YW=[W=
MTG?96U_EC_X+L_\ !2OXN_L\_M#_ +./PC_9W\,:SXDUOX&SVW[3GQ4DM=*O
M+O2M8OH)DT/P5\+9)UMY8C/K?A74?&.L:KY<<L]M'J'AJZL9/M%O>0I_2K\'
M_BAX:^-GPK^'GQ=\'&\_X1CXD^#] \9:+%J-NUIJ5I9:_IT&H)8:I:/\UIJF
MG-,]CJ5JQ)MKZWN(2S;,G^5C_@L=HEUIG[9?B_Q-?7VGVFEZKX.^&5M 3->R
M7$*KH[Z<]Y?1VUE-%:64=RCJ9))S.R O%;R94-_25^Q)HU[X?_9)_9\TC4&M
MWN[3X8>&_,>TF^T6TBW%K]JADAF*1ETD@GC<;HT==Q5T5U91AF?&^,S[)<@X
M3Q'@C/@2CP?#'1H>)4EGT:_B%2S6M#%4:F8SS'+<-EN)A4Y:V8Y#/+\5.&%R
MVKB,-2>-H*.)I_U'XH^%' 7"7@MX0\=</>*6%XLXBXNHQ6<\'4<1DM67#=?$
M9:LVS>BJ6!QE;'TIY-F5>AD^.CBZ$)QKU*/UE4:\HTI?4E%%%?.G\S!1110
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M<UK\S8TK?=;UV^[_ (;L6J***YAA17Y"_M0_\%Y?^"3?['_BS4? 7QH_;&\
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MB9XP_;%@^,CZ%^S]9? /QE;6_@'P#J?Q)\&?%[Q-\0O!L'@C4-1U7Q+"-4\
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M%'>.ZM[_ ,/QNVKVU?NGR[XPUC]LR#X/>"[WP%X$_9SU#X]7$EG_ ,+!\/\
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M06L<\AH _I^HHIDLL<$<DTTB0PPH\LLLKK''%'&I>2221R%1$4%G=B%5022
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MOCBSNLLW@ZSU<_"GX5!EYCC_ .$(^'TFESWZ0Y:+?J^NWPO("5OX)R[Y\_\
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MMKJ_\,^,_P!M7XO>%M?M(=0B%U9SW&C:S\=[&_MH;R!UN+5WMDCGA99(BT;
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M5V/C EIX(>3P[X&\4Z7H6L>'HO$.J2Z7K6F:V+&&^\+K'=O):_T)_P#!;/\
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MT/XA^";_ ,">+=%UV;PK/#X@TN_AL+JVU'1-2L5N$CNK66WN(/+N1/!][44
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MH4X04J33<>2S@V[)JZ5O>IVTZP3V46Y****^(.D**** "BBB@ HHHH ****
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MW!OBMA9.\</D'#6<PCK_ !L)QMP_E$)]K1H\08B-^\TNI^DU%%%8GYX%%%%
M!1110 4444 %%%% !156]OK+3K6:]U"\M;"RMHVEN+N]N(K6U@B12SR37$[Q
MQ11HH+,[NJJH)) !KY%\4_MS? ?3-6G\+> -0\2?'KQM"QB_X1'X#^&]0^)-
MU%,=RQC4=<T=3X3TFW,RF&>ZU'7H([1@YN FPBN/%YA@<!&,L9BZ&&YW:G&K
M4C&I5E_+1IW]I6F^D*49R?1,^CX>X0XIXKJUJ7#>09MG7U:*J8RK@,%7KX7
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M^(_PK_:B7XO>%M0U#Q5X"\0Z5XU^'GC#X8_&#X1ZK_:7PY\3^%]=T2WGBO\
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MU[1TN+SP];:8+G3FT75%E=KY;=S:2>5-(&C+_P!#-?69OA<=@^&>'Z..P%;
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M%DY8+*(U8X/(LN<MUE>0X&.&R;+(/_GWE^!PU/\ NA1117>?*!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%?(</[=G[,EQ\2Q\'HO&7C!OB0
M;V.R/A@_!+XZI.HEUJ3P]%J<E^_PU728_#LFM0RZ>GBF2_7PVTT4A753$C2#
MVLGX:XCXB6-?#^09UGJRS#_7,R>3Y5CLS67X1<U\5C7@J%=83#KEE^_K^SI>
M[+WM';.I6I4N7VM6G2YWRP]I.,.>7\L>9KF>JT5V?7E%%%>*:!1110 52U*S
M;4=.U#3TO+S3GOK*ZLTU#3Y$BO[!KF"2!;RQEDCE2*\M2XGMI'BD1)D1FC<
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M+>(?$.F>-O'MMI?C%=3OM1CNM&_ML.FE)I5ZUK";S! /TZHHK\FO^"E27_Q
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M45&3C?1RBI346U9N*G))Z*4K791110(AG^X/]X?R-%$_W!_O#^1HH FHHHH
M**** /Q'_P""VGP3^ "_LW_$?]K[XW:Q^U1<I\%O@_JWPZTCX?\ [-/Q=U;X
M9:IXTN?B?\0_ =OH=BKV=O<V5KK]WXRM/#FDP>++R&;^P= U#7%-M=17,D#_
M (:_\$I/V5OVF_ /[?7[/7C+QY_P3._X*:? OPEH^J>+YM5^*OQU_P""CO\
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M1I;1-'&ILIKG1O"WP]\57$BSR,1+#%?Q; C*MSAED /B%_P6M\1OC2/V;?\
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M-2OH_M7^A>&F\3^+;J0V0S<+##X7\.ZNTQ4$;3'N60$&-F7)KXG^!W_!8/\
M9)_:$_X+'6?P)^%?B>]US3/%?[*D7@3PWX]U+3-;\*Z5J_Q8\/>-M=^(M[X$
MMM&\5:9HNLK=R>#+R:[L[ZXLH([O4[*?2;=9;B6W$G[_ .D^$?">@6_V30O#
M'A[1;7<S_9M)T73=.M][@!W\FSMH8]S!5#-MRP4 D@"OYA+'_@G5_P $S?\
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M*_AY=\-2=[*G3O>]^;EES7YG4JM^TEO'9ZW]Z7_I3TW?Z>BV"BBBN<H****
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M8HR;/0-"TY(X]/T72;".)56*.STVSM4C55V*L:P0HJ*J@*H4 !?E  XK5
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MFT9*X?QW^TS\%_ S*OG-'([P10^)9_D0QS(D:2/*ID"[?+#2-_X6G_P5+U[
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M2J_9AOB3XR\0_M)?$K?DW ^(?[3OQJ\0"Z+HBRFX5?%UFK^<T:32@!0TJJV
MJA1^/O[0'_!N=I7Q!^/GB?6_AE^T+HWPM\#^-7UGQ'X;\#W?PX\2>,[GPK9:
M5_PCUE+ID_B75OB8FHZ]+=W6IS7K:A>O%,A#1&.0%&7XSC;,/%"&7827"V09
M2L4\?15=?VM0QU7V"4G#FHX[!Y5AH1>)5%.I3QE:K=J/L>24ZD/Z6^C!P?\
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M*BL[LJ(BEG=B%554$LS,2 JJ 222  "2<5RO@3P'X)^%_@WPS\.OAOX2\.>
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M^)&BWJ>'OB5);ZOXDO75TN_#UW+:H/"=L\<BVM[8>('.!<%6_A(_X)K?%O\
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MHH121^>8_.,VS2I*MF>:9CF-:?QU<?CL3C*DO\4\15J2E\VPHHHK8\X****
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M&974AE)!!J6HXHHH(HX((XX888TBAAB18XHHHU"1QQQH B1HH"HB@*J@!0
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MWQ;K7C&.^TGPO++X>T"^.G6<UOJO[#44 ?SO?\%6/^"<7[)/PP_8Y_:2^/\
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MOB74KGQ"OQF>PA\'ZG\.M:^ 5YH'PYT_X<)K,][;ZY''H;>$[?5-,EOX//?
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M8RCAZ2HRA@Z5:K4<,'3@ZCH04'2Q$5&4HPJ6C&E4KQC^[DU[5I-7NOJ75/\
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MXIUKPMHOC;2M&U&6^^,UI:75S>^$_$6AZY%)I5QJ%JMIJ5NLEPEP)((_1O\
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M\76.J^ HO$%DEMXR\*:?I'Q6U(^#5O=/U>ZO-)O]$UO4?#\&I-J5S:R5_K5
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M=> OVI/C/^V/X9_X(U?M?V/QX^/G@+X:_#GXD>)_^%@_LC[=2\/_  L75(-
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M?8CQ/XGMXK34K'7+;7;'PUK^AWK0Z;<NW^HE7X%_LP>)_&G['UU\?+GX%_\
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M7QB\.VOA+XG^$-&\;>&[+Q+X4\8VNC:[;M<V4'BCP/X@T_Q5X1UN.-7C(OM
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MI3;E)123DW)W;;!))MI)-[M+5V5E=];+37H;6L?L]Z9?_M@>%OVOI/'R6O\
MPA/[/OC3]G^X\$-I=HUC/_PE?Q \*^.)/$MSXG;5D>QN=-E\.)I7]BMI,BW
MOOM3W\#0K;S?4ZLKJKHRNCJ&1U(965AE65@2&5@0002"#D'%?P>> /%_A?X@
M?L6ZS\#O$/BW7M5N]0_X+"?$*\\2?$3]M_0/'?P?_9]\?6VI>&O$FL2Z7^U9
M>V\OAW5K6?41823ZW\.]/U#3=6\)>.$T;3];2Q%OM/\ 3I_P19U5=3_X)Q?
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M\%Q/C#+^W5XP_8O\,_L7^$=9U[X/^+OA/X#^+&@ZW^U?X!^'_P =_$6I^/\
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M/I]CI.EV$*6UCINFVEO8V%E;QC$<%I9VL<5O;PH.$BAC1%'115ZBB@ HHHH
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ML+.VCCM[2SM88K>W@C2*&-(U51IU^$FO_P#!8O7;#6?^"Q5KHGP@\,ZSHO\
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MFZ^%G[*'[$?P-^)?P;\$:I?M>^$_ GQ \2?#SQB\-]H.D$*EO<^(O%\>@C4
MC/)=RE5 8^6@_$CXH?M)?$WX;_MD:Y^SI^W3_P %M?VK_P!AJR^'?[(7[(7B
M2UU3P7#K7C./XB?&3QW\,[#7OB^UW96FF7\FDFVUN\^W0R2HADCO%MU?%H$
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M;:>-HI[>X@E5XIH)HG:.6*16CDC9D=64D'S?7_@C\%_%?@K2OAKXI^$/PO\
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ML+2;P+:Z0OQ6B_:&NXKJXUV]EC\1WQ\+-X8\O9#80)K(U,[6DNK7#!_VWHH
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M]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\
M8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?
M_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^
M/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\
MV-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%%
M !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_
M^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X
M]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\
M8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?
M_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^
M/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\
MV-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%%
M !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_
M^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X
M]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\
M8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?
M_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^
M/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\
MV-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%%
M !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_^Q_X]_\ 8T>?_L?^/?\ V-%% !Y_
F^Q_X]_\ 8T>?_L?^/?\ V-%% #'EW@#;C!SUSV(]!ZT444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>img247211528_15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #  BP# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W74-1L])L
MI+R_N8[>WC'S22' '_U_:O/;WXUZ)#*4M+"]NE'\>%C!^F3G]*X+XF^)9]=\
M4W%HLA^PV#F&*,'@N.&;ZYX^@KBJ]6A@8.*E4W921[1_PO&P_P"@'=_]_DH_
MX7C8?] .[_[_ "5XO171]2H]AV1[1_PO&P_Z =W_ -_DH_X7C8?] .[_ ._R
M5XO11]2H]@LCVC_A>-A_T [O_O\ )1_PO&P_Z =W_P!_DKQ>BCZE1[!9'M'_
M  O&P_Z =W_W^2C_ (7C8?\ 0#N_^_R5XO11]2H]@LCVC_A>-A_T [O_ +_)
M1_PO&P_Z =W_ -_DKQ>BCZE1[!9'M'_"\;#_ * =W_W^2C_A>-A_T [O_O\
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M7OGFB;QOJ<D]F\-O86L5I/\ :5M[:#9&\G]YAG)/XUS?:BM_90[ ;EAXJO\
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MS+?;($MY_P!ZPW1I]T=>,>HHNA\LNYS&I?$*[L]4MQ;QV4]HT\,,D2)*SH9
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M[Q=_T ;K_OI/_BJ/^%?>+O\ H W7_?2?_%5],T4?VC4[(.8^9O\ A7WB[_H
MW7_?2?\ Q5'_  K[Q=_T ;K_ +Z3_P"*KZ9HH_M&IV0<Q\S?\*^\7?\ 0!NO
M^^D_^*H_X5]XN_Z -U_WTG_Q5?3-%']HU.R#F/F;_A7WB[_H W7_ 'TG_P 5
M1_PK[Q=_T ;K_OI/_BJ^F:*/[1J=D',?,W_"OO%W_0!NO^^D_P#BJ/\ A7WB
M[_H W7_?2?\ Q5?3-%']HU.R#F/F;_A7WB[_ * -U_WTG_Q5'_"OO%W_ $ ;
MK_OI/_BJ^F:*/[1J=D',?,W_  K[Q=_T ;K_ +Z3_P"*H_X5]XN_Z -U_P!]
M)_\ %5],T4?VC4[(.8^9O^%?>+O^@#=?]])_\50/A[XN)Q_8-S^+)_\ %5],
MT4?VC4[(.8\-\._"+4YKA)]<406ZG)@C<,[^Q(X KUN*Q:"%(88-D:*%55Z
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M_P !S_\ %5K]0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P'/\
M\51]0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P'/\ \51]0J^0
M69]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P'/\ \51]0J^069]!45\^
M_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P'/\ \51]0J^069]!45\^_P#"X/%G
M]^Q_\!S_ /%4?\+@\6?W['_P'/\ \51]0J^069]!45\^_P#"X/%G]^Q_\!S_
M /%4?\+@\6?W['_P'/\ \51]0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@
M\6?W['_P'/\ \51]0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P
M'/\ \51]0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4?\+@\6?W['_P'/\ \51]
M0J^069]!45\^_P#"X/%G]^Q_\!S_ /%4H^,'BL'):P(]/LY_^*H^H5?(+,^@
M:*\F\.?&,7=PEKK5K%;,YPMQ$3LS_M \CZUZ2+]V ("$$9!'>N6M"5%VFBE3
M;V-"BJ'VZ3^ZGZT?;I/[J?K6/M(C]E(OT50^W2?W4_6C[=)_=3]:/:1#V4B_
M15#[=)_=3]:/MTG]U/UH]I$/92+]%4/MTG]U/UH^W2?W4_6CVD0]E(OT50^W
M2?W4_6C[=)_=3]:/:1#V4B_15#[=)_=3]:/MTG]U/UH]I$/92+]%4/MTG]U/
MUH^W2?W4_6CVD0]E(OT50^W2?W4_6C[=)_=3]:/:1#V4B_15#[=)_=3]:/MT
MG]U/UH]I$/92+]%4/MTG]U/UH^W2?W4_6CVD0]E(OT50^W2?W4_6C[=)_=3]
M:/:1#V4B_15#[=)_=3]:/MTG]U/UH]I$/92+]%4/MTG]U/UH^W2?W4_6CVD0
M]E(OT50^W2?W4_6C[=)_=3]:/:1#V4B_15#[=)_=3]:/MTG]U/UH]I$/92+]
M%4/MTG]U/UH^W2?W4_6CVD0]E(OT50^W2?W4_6C[=)_=3]:/:1#V4B_15#[=
M)_=3]:/MTG]U/UH]I$/92+]%4/MTG]U/UH^W2?W4_6CVD0]E(OT50^W2?W4_
M6C[=)_=3]:/:1#V4B_15#[=)_=3]:/MTG]U/UH]I$/92+]%4/MTG]U/UJY"Y
MDB5SC)':FI)["E!QW/F;QUK$NM>,M2N)')CBE:"%>RHA('YG)_&N=JYJ_P#R
M&]1_Z^Y?_0S5.OIX)1BD@"BBBJ&%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7N?PSU674O"JQ3L6DM'\H,>Z]17AE>O_"#_ ) V
MH?\ 7=?Y5P9E%.A=]"Z?Q'HU%%8MCJ&MS>)+^SN](2#2XE!MKT2Y,Q[C;VKY
MXWN;5(651EF ^IQ2UY]\7(#=>']-@%F+PR7\:_9C)Y8E_P!G=VSZT)78I.RN
M>@ AAE2"/4'-+7AN@WUUX3L_$NIV&F1Z2\)BMO[',[SF%RW^M;=C(^AQ70GQ
MCXIMM+:&Y-ND\MY%;P:C/;HBJK]2T:N0".V3S5<I*J(]1R"< @XZ\T5XWIVM
MZGH>I:[+_:%I<3RZU;V\]S'&!&ZE<' R0I_&M:;QQK$L]S:6MW9QF76/L,%X
M\0=((]N<D9 8_4TN5A[1'IU (/0@_0UY;JUQK=QK?A5)/$NG2N+N6-Y;.(&-
MBH_B&[&['&.U5="\2:K)!8Z/IL^FZ0UU/=R/=O; Q_(WW0N0-QZDYHY0YSUR
MCZUY?!XR\2:P-%@LKFSLY[M;A9IFMO,1S$>'0$]#]<5OZ=KEUK'PQN-3O4A>
MY^S2B0!/D<KD?=]#Z4<K!33.QR",@Y^E%>1Q>)_$:62PZ5=6%G!::+'?&-K,
M.">ZCD8!KL=9\475AX AUV&*+[3-'%C>#Y<;/@;C["AQ8*:9U=%>6:AXR\1Z
M5!JEB=2T^_N[9;>2*]AMPJ#S&P49<D<>N:L:KXC\36-]=V UK3HI-.TX7DDT
M]H +IF_A4;OE _&CE8<Z/2Z*\GOO'^M1Z3;WEK=I)/#;02W4*60* R'G>[,,
M9[! 3ZU8UCQ=XFM[W6KBTO+..RTR2#-N]KN:0/C(W9&.O7K1RL/:(]0R ,D@
M =S17GWQ5BN;_P +:9%#<B&.YOH$E0Q[P^[IGD<#T[U4'BO4=/U_3["QN8Y]
M-%\-/=$LA'$N%Y <MN+#V&VA1T!SLSTO<O\ >7\Z6O&;6]>75] F6*"%HM3U
M *(8]H)5>"1W-:]GX[U6XMM%/VJV::ZLKJ>X58UR&C!V\=NE/E#VB/3Z*\G/
MC#Q4FA:!(]]"]UK99UDBL%;[.JKG:%+@.Q]21BN^\*:CJ6J>'K>ZU:V6"])9
M75"-K8. PP2!GKC/%)JPU*YM4445)04444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6I;?\>T?TK+K4MO^/:/Z5I3W,:VQ\I:O_R&]1_Z^Y?_ $,U
M3JYJ_P#R&]1_Z^Y?_0S5.OK([(R"M7_A&]6/APZ_]E_XEH?9YNX9SG&<=<9X
MS6=;V\MW<Q6T"EIIG$:*.[$X%>S(VAG53X.&LY3^S_[,^Q_9FV^=]XR>9G&<
M^W6L:U5PM;^D#/%<TF1ZUZMH^B7=UH_A**&V61]-U:1+\_*/*P_\6?I^HK6T
M6-/[5UT:I'9BS&KL-*-RN/\ 2N>%Q_#T_&HEB4KZ;?YV"YXGD>M&1ZUZIIT?
MB"+1)&T>WAD\0G5'75@T:,X7^$8;I'].U2:E?V^BZ9XON] ^SQ[;VW19(D5E
MC=AA]F01US5?6-;)?C_7R"YY/D9QD5?TW2+W5A=&SC5_LL#3R[G"X0=3SU^E
M>NV&G7(\,36MYLN[271VEC,=O$D'F$9X/+M)W)X%<?\ "SSS?ZS]F"-.=,?R
MQ(!M+9&,YXQGUI?6+QDUT"YP88$9!XHR,9R*]IT^&.2]T-_$<$*^)/LMP1&$
MC61B,>7D?=W8SC-1PS!_&&FO<Z/=6UZEA<&22_6'?< +P66/C(]P*7UGR_$+
MGC61ZBK-A97&IWT-E9Q^;<3-L1 0,GZFO4](N+37+7PEJ.O+;O,]S/'O,2(&
M(4E%( QC.,9]JO\ VV>+Q3H"SZ9?VMZUU)']JNU@#2Q$'*8C[9Q@X_&B6):N
MK:Z_K_D%SRZ[\+ZG9RK"XM9)GF$"Q074<CESVP#G\:R[RVEL+R:TN5"3PN4D
M7(.".HKUFUU*?[#:ZA-,@G_X24Q-,44'9]W'3IBM2T;5?[;UI+JPN_,:\'E7
M=JD#R+%_"&1N3'UY^M3]9DMTA7/#:EM+>2]NX;6W ::9PB G&2>G-=#J-NEI
M\19(5^R7ZK>J2J[8HI#D$KZ+Z'M7HGB""2=]-NI_.M#'J<02UO(8MQR1Q$Z=
M4'O6LZ_+;3<=SQR]M)M.OY[*Y4+<0.4D4,#@_457R,XR*]=U6\75K7Q9#JBP
MM:V-[%Y6V)5,8)^8@@9R>^:EU:.XQK4>HV]FGA-+0'3Y$1 N[ V^6PY+9S4+
M$/JOZT_S"YX[D8SFKM]I=WIUO:3W2*D=W'YL)# [ESC\*]:329[C6[75XK>-
M].&@[/.&W:7V'(]S53241TT#8D+Z@-$E-BLH!!EW<8!XS1]9[+^M0N>8W&E7
MEMIEKJ,L:BUNBPA8."21UX[52KT+QY_:?_"(^'O[8C6._,DGG*JJIS[A>,UY
M[6U*;G&[ *]?^$'_ "!M0_Z[K_*O(*]?^$'_ "!M0_Z[K_*N7,?]W?R+I_$>
MC445BV+^(SXDOUOHK)=%"C[(\;'S2W?=7SIT7-JL_5AI'DQ2:PUHL44@>-[I
MU55<=""3UK0K@/BQ!)<Z+I<$4%M/))J,:K%<Y\MSZ-CM0MQ2=D=3':>'M9FG
MOH8].OI)8_(FFC*R[T_NL1G(^M$/A?0+?39M.AT6Q2RF.98%A&US[CO7D=C<
M7_AB/Q3?16MAI6LPK%"VG646V**,M_KQN)#?7IZUIKXLU^+0I<Z]"UJ][%#_
M &F)H)I;9&^]O\OY![$BJY69J:ZH]#M_#OA9K6[TVVTO3&@9E^TVT:*1N'3<
MHZ&IE\+Z FGS:>NC6(LYF#20"$;&(Z''K7D]AKDNDS:Y>V>OBZA;6[>.;40$
M DC*X.X@;<>XK3E\:ZC<)=F'7!#ITNL_9?[24(RVT.W/RDC')[FCE8<R['HC
M^'/#RV=M9/I-@MM"^^"$Q*%5_51ZU&N@>&-3TP6J:;IMW8K*SA%17029^8\=
M#GK7GFISK=:IX3N&\9M>PI>S1"^1(XUR!P"2,%NV1P:@TSQ-?FUT^RGUU-$L
M;BXNVDU%(HERR-\J<C:/7IDT68^9=CU@:/IJO;.MA;JUJAC@*Q@>4IZA?04+
MI^FV6ER6BV]O!8;6WQX"Q@'[V?:O,[;Q#XCUH:!;C6)K(W4=SON(84S.J?=<
M!A@9]JZ31]9O=2^%D^H7<PEO%MYE:4HOS%<@$C&/TI-,%),Z"#1-"D@\RWL;
M-X98!!NC *O%V7(ZK5W[#:?8?L)MHC:;/+\@J"FWTQZ5Y&NM^()K8K::[-91
MVFA1WHCAACPS_0KP#[5V'B+7K^#X6'6K>Y^SWIMHI/.50=I)&3CI3:8*2-Z#
MPQH-M8/8P:/916CN)&A2(!68="?<5C^+/ P\47,4AU"*W1(_+VO813LH/78S
M<J?SKD(_&=W:#48/^$FGU2T\NW,=]!#$7BED/,>[A%^IZ5'#XK\07&D-!'K+
MQS)KBV2W ,<SB)AT+ !6^N*+,7-%K8]"7P5X=-K;07&DVMT8(5@66>,,Q5>F
M35Y]!TB5+A)--MF6YV^<"G^LV_=SZXKS-_%6MVV_2KO7W@@CUA[*;6)(XP\<
M87(SQM!)XR16BFJ:GJ&J^'=-L/&,MU;W/G>=>VT"*90AX'((SVR*+,?-'L>A
M7>G65_#%#=VL4\<3K)&DBY"LO0CW%4Y/#&@/?G4'TBR-WO$IG,0W;A_%GU]Z
M\WTKQCX@G\1LT^IQJL=S-%/I\TL *Q(#@I'Q(7XSZ&J\/B?4]7N+RQ76+J2S
MO=&N+@>:T)D#+G&%0?NP1QM))Q1RL.=/H>G1:9X>BN[98K>P6Y5GN+=5*[LM
M]]U&>_<T0^$_#MM</<0:)813/NW2)" 3N&&Y]Z\JTS6[W2M/T5],O5U&2/0I
MYE#)&Y1P1\N0,@+Z9[<UW'@C51>S.A\8KKDCVZ3/;^4FZ!CU^9 !CMM/(H::
M!23Z'1S^'M&NM+CTNXTNTEL(L>7;O&"B8]!VJW:6=KI]K':V=O%;V\8PD42!
M54>P%>8:SKOB"#4]?O(-=FBMM,U*&&.T$2%&1\9!)&<<U'%XN\1W/C.6%-0A
MA,>H"W&FSSP1J\..H5OWC,>H(XHY6'.NQZU17EN@^)[R_G>ZO?%RP7[O<HVA
MF!#LV [<8&Y2,9R>#56WUW78O#7A^ZOO$UQ!%K$Y6YU"2.,+9JH.%7*X!;U:
MERC]HCURHFN;=+A+=YXEGD!9(BX#,!U('4BO)9O%6NS:'&R>(H5MH;^:!;T2
MPV\U]$H&UHVD'EG!SGIFIQXGNK^;1;JQU,;I-*NF%WJ,$:$2*<;F(! 'NIP>
MO-'*'.CUBBO/_A[XBFU*_O+"[UBZU"YCB24[G@FB7/4I)%Z_W6 (KT"DU8I.
MZN%%%%(84444 %%%% !1110 4444 %%%% !6I;?\>T?TK+K4MO\ CVC^E:4]
MS&ML?*6K_P#(;U'_ *^Y?_0S5.KFK_\ (;U'_K[E_P#0S5.OK([(R%!(.02"
M.XHR<[LG=USGFDHIC%W-S\[<G)^8\T%F/5F..1DFDHH 7>VXMO;<>IW')J7[
M+<K9"Z\B86K/L$NT["P[9Z9K?\":59ZQXF2WOHO/BCADF$&<>:RC(7C_ #Q7
M:V26NL>&?#4=QHD-C;7&ME9+1 P1QM(SAN?;Z@UA4K*#M;^M?\A7/+(;:\FM
MY9X(9WAMQF5T4E8P?4CIFH02.A(SUP:]&*Z9-9>,'AT>TMH]-*I#'%OPX$A&
M7R>2<5)J_AS1+'3;G5TMX%M=7-O'IJDY$&\?O&'N,&E[=7LU_6G^87/-223D
MDD^I/-&YMV[<V[UR<UZ9XNT;PMIMCJ=A%'##=VB)]F:&VG\PMC_EK(?D;=ZC
M%8O@O3();&ZO[S2[&YMUFCA$UWYC[23RJQH,L3GJ2,52KIPY[!<XW)(P2<#H
M,\5-<V]W:2JMU%/#*5#*)05;:>A&>U>E:OX?T?03XAO+;18M1:WNXH(K64NR
MPJZ@DX4YZGCTJ]XBTVRDU+4]5N-,6[FT_2[<PZ?(6*C.<E@.2%J/K*=K+3_A
MO\PN>0[FQC<<=<9I\8FEE"1>:\K< )DL?;CFO4+'P[H]QJ-C>OH<8-YI4MS)
MIF6VJZD;2O.1FI_#5O8"^\-ZU%HMM875Y)- ]NH?;A5)#J"<@\8_$T/$I+1?
MUK_D%SRM[&ZCM1<R6LRVY<QB5D(4L.JYZ9]JA+,2"68XZ9)XKU.VT;3M>L].
M-U9QVOVC69DDCA+*&55)"@$\9(Z^]5;?2=*UBVFN9O#\&EO9:G%;HL88+<(S
MX*L&/) YR*?UA=4%SS;<W/S-SUYZT9.T+D[1T&>!7H^N:;HEQI7B@6NBVUE)
MI,Z+!+"S;F!/.[)Q7F]:4ZBFKV 4,P& S #H 31N;CYCQTYZ4E%:#%+,>K$_
M4TE%% !7K_P@_P"0-J'_ %W7^5>05Z_\(/\ D#:A_P!=U_E7#F/^[OY%4_B/
M1J**Q;'_ (2/_A)+_P"W&Q_L7:/L@CSYN[ONKYTZ+FU5+4[O2[*W2?5I[."%
M7&V2Z954-VP6[U=KSOXP;!X<T_S9;:)/M\>7N8]\:CU9>X]J$KL4G97.QL;_
M $/6I9)]/NM.OI%79)) Z2,%/8D9X]JMI864=LUM'9VR6[?>B6)0A^JXP:\G
MT[6[#2_#UU]CUK29)I[F.(RZ!9I9[0>SNXPH/][!Q45GXCUW5++2+,:_<0-/
MK4EF]Q!(DCF(+D#=MPWUQ5<K(YT>GM/X>A6:V9]+C7S%AEB/E@;S]U6'KZ U
M>%A9+#) +*V$4GWXQ"NUOJ,8->0S7-QIFLZXMO<.S_VY:Q,\FUF<;._'4^M2
MZ+XI\0WOB&3S-8C$AEN$N-/FN8QY:*#M,<07>".#DGFCE#G78]9-A9M#' ;.
MW,,9RD9B7:I]AC JK VAW_GV$']G7(@?,UN@1Q&W^THZ'ZU@?#TZA?\ A./4
MM0UB]O)[Q6_UA7$."0-F!U]SFO/M"GGT71(=FMW-A9ZAJ\\5[J.$W0JI.,-M
M^4L>I.:+ Y=;'MIMK<NCF"(M&-J,4&5'H/04);01P&!((EA.<QJ@"G/7CI7D
MZ^*M5ETVQAN?$$UMI$FHR6YUY457DB4?*=Q&T9/&['-,C\5:K/:Z9#>^(Y[+
M2)+N:(:VJ*C3HOW,DKMY]<<T<K#G1ZE:KI5W$TEHEE-'@PLT2HPP.J''8>E5
M]6TBQ\1:!+IAEVV<H"[K8KQ@]!U':N1^&RBY^'FH+%=R/ON+G%P@ 9N3\PXP
M"?I7)Z#J[V6BZ)IS>*[G3M,E$S7-Z'0M#*IXBR5POK@\FBP<RML>P+;Z3:)'
MI;)9*9UXMV1 9L#D[?XO?BITTZPC4*EC:J P8!85'(Z'IU]Z\C_MS6+J3P_J
MLH,^H1VEX8',>#.%^Z^WW'-5K?Q9XA/AG5KN'Q"+@K9+*2;J.2:WE+ <*JC:
MO;:<D4<K#G78]G:QLWCEC>TMV24[I%,2D.?5ACD_6E6TMD,12VA4Q#$96,#8
M/1>./PKROQ/K=_H6GPVD?B+4Y+Y;#[899KB*%68X[[<OCH$ QZFF:GK>O7MQ
M?RV_B"[LUM-%@O@EN$VO(1SG(/![@4<K#G2Z'JXL[471NA:P"X(P9O+7>1_O
M8S3(].L(9/,BL;6-^?F2%0>>O('>O,&\47-UK)_M7Q;-H*Q0VTEK#'$K+=;P
M-Q*D$OD\8'2H8?%/B"X\;20_VO'!)'J @73[BXCC22#U$97>6(Y#9Q1RL.='
MJT5A90,K0V=M$R@A2D*J1GKC [TZ"TM;3?\ 9K:"#><MY483<?4X'-345!I8
M@:RM'\S?:P-YC!GS$IWD=">.3]:#9VK7*W)M8#<*,"8Q+O ]-V,U/10%D0"R
MM!</<"U@$[C:\OE+N8>A.,FE-G:FU^RFU@-OC'DF-=G_ 'SC%344!9%>2PLI
MK9;:6SMI(%^[$\2E!] 1@4[[);90_9H<HNQ#Y8^5?0>@]JFHIA8@MK.ULU9;
M6U@MPQRPAB5,GU.!4]%%( HHHH **** "BBB@ HHHH **** "BBB@ K4MO\
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MG5DFM#__V0
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>img247211528_16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $$ AP# 2(  A$! Q$!_\0
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MJN#HH^KT?Y%]R"QWG_"_/B9_T4'Q+_X-)O\ XJC_ (7Y\3/^B@^)?_!I-_\
M%5P=%'U>C_(ON06.\_X7Y\3/^B@^)?\ P:3?_%4?\+\^)G_10?$O_@TF_P#B
MJX.BCZO1_D7W(+'>?\+\^)G_ $4'Q+_X-)O_ (JC_A?GQ,_Z*#XE_P#!I-_\
M57!T4?5Z/\B^Y!8[S_A?GQ,_Z*#XE_\ !I-_\51_POSXF?\ 10?$O_@TF_\
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M_P#B*/:0_F0'/45T/_"N?%W_ $*>O?\ @KG_ /B*/^%<^+O^A3U[_P %<_\
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MPRDY\V-2>6 &1C//'AO_  KGQ=_T*>O?^"N?_P"(H_X5SXN_Z%/7O_!7/_\
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M/D0&6*(QQ(OF#/RL?+)V]0",\Y%>%G&(I0PUI26K1,GH?8=%%%?E!SA1110
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MXF\<ZA)9:;<7L5C$MO$99I)')^Z@Y8*H9FQR IP"< _*G_#+O[9__1S.G?\
M@M'_ ,9KY#UZZ^)MU\1_%'C?XZ>(=4\=>$O@KJ&RTM[[3VM8]5U1W'V:%(C&
MN(G=$D>1A_JD 'WUH _6SPQ^T+X \8_$_4OA[I/B"*Y\8:=8PZC<:6T4B.D$
MBJRGYE W .A9?O+O7(&:]&K\K/@#^Q+^T]+:WGQ4T?XK:;X#\3>/4_M35(;B
MR,MWB1VE57+1MMSOW;%QC(!^[QZ[_P ,N_MG_P#1S.G?^"T?_&: /O:BO@G_
M (9=_;/_ .CF=._\%H_^,T?\,N_MG_\ 1S.G?^"T?_&: /O:BO@G_AEW]L__
M *.9T[_P6C_XS1_PR[^V?_T<SIW_ (+1_P#&: /O:BO@G_AEW]L__HYG3O\
MP6C_ .,T?\,N_MG_ /1S.G?^"T?_ !F@#[UVCCCITH(W<'D5\%?\,N_MG_\
M1S.G?^"T?_&:/^&7?VS_ /HYG3O_  6C_P",T ?>U%?!/_#+O[9__1S.G?\
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M .CF=._\%H_^,T ?>N!UI:^"?^&7?VS_ /HYG3O_  6C_P",T?\ #+O[9_\
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MM>L1<VQ8 ,8Y(I%VR12#[R.O\+#T_'H0: +]07EC;:A:S6UU;Q7-O,NR6&9
MZ2*>"&!X(^M3T4 (JA0 !@4M%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!EZIX7T;7+*2SU'2;&_M))EN'M[JV22-I5(99"K @L"JD-U! ]*U***
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M7"JJYP/^FAQMP*]>HHK>CAX8>_)U_K_ASCQ6-JXSE]K:Z\OP]%T[!11174<
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MMX?O#T\0ZD/^ V__ ,:K:HH PCX<O3_S,FJ#_@%M_P#&:3_A&[[_ *&;5?\
MOFV_^,UO44 8/_"-WW_0S:K_ -\VW_QFC_A&[[_H9M5_[YMO_C-;U% &#_PC
M=]_T,VJ_]\VW_P 9H_X1N^_Z&;5?^^;;_P",UO44 8/_  C=]_T,VJ_]\VW_
M ,9H_P"$;OO^AFU7_OFV_P#C-;U% &#_ ,(W??\ 0S:K_P!\VW_QFC_A&[[_
M *&;5?\ OFV_^,UO44 8/_"-WW_0S:K_ -\VW_QFC_A&[[_H9M5_[YMO_C-;
MU% &':^%4CU"&]O;^[U::WS]G%YY>V%CP65411NQQN.2 2!C)SN444 %%%%
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M:WO:]4?]L1_C3&L]0[:@@_[=Q_C6A10!F&QU/MJ:#_MV'_Q5,;3]6[:M&/\
MMT'_ ,56M10!BMINM=M:C'_;D/\ XJFMI>N=M=B'_;BO_P 56Y10!S[:3X@[
M>((1_P!P]?\ XND_LCQ#_P!###_X+U_^+KH:*8'/?V1XA_Z&&'_P7K_\71_9
M'B'_ *&&'_P7K_\ %UT-% '/?V1XA_Z&&'_P7K_\71_9'B'_ *&&'_P7K_\
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M-O9/,81A@#(22(\#[I!-=S\$=$A\,_&SPU+H%XL]C?1WD%S#YX>555&<AP.
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MD5Y<,RI32?*U\OZ_KYGOU,CKTY.//%V6Z?X>O3_@--]W_97B/_H/VW_@N_\
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M)9SA0<A)%!<%2_*CZ>HH ^6+7XC?'"#5+>1="N9(-0N[65X;[29%%JIM;0&
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M9C)_B45G2S"C6:235_Z[_P!?<;XC)L3AXRE)I\O17O:[\EV_III>&>%?B_\
MM#ZPW@:VO/!XL1>WDMOJ>H7FCSK&V)X5SL'SP1B)Y75Y53<T>/\ ?MQ_%O\
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M@.GAK4C_ -M;;_X[3F\/71_YF'5!]!;_ /QJF'PU=G_F9-6'X6__ ,9H /\
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M&75ORMO_ (S0 ?\ "1:A_P!"SJ7_ ']MO_CU'_"1:A_T+.I?]_;;_P"/4?\
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M#8/_ (NC_AEWXF?]"\O_ (&P?_%U\K_9N-_Y\2_\!?\ D?H/]N95_P!!5/\
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M_1?_ *],:^*_\NUP?H@_QH M451;4RO_ "YW1^D8_P :8VKE?^7"\/TC'^-
M&C166VN,O_,-OC](A_C3#X@8?\PK43_VQ'_Q5 &O28K&;Q*R_P#,(U,_2 ?_
M !5,;Q4R_P#,%U8_2W7_ .*H W,#TJEJNCV6N6?V74+:.[M]ZN8I1E25.1D=
M^16:WBYU_P"8%K!^ENO_ ,53?^$P?_H ZS_X#+_\52<5)6:*C)Q:E%V:.BI*
MY[_A,'_Z .L_^ R__%4?\)@__0!UG_P&7_XJF2=#C%-"*,$  ].E8'_"8/\
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M;S"((88W\A07;S@QP,*??V\5,O\ S!-6/TMU_P#BJ8?%SC_F ZP?^W9?_BJ
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M4GENY[:&&+4I=\[*URK1O*2 !N;(R?FKZ#_X3!_^@#K/_@,O_P 51_PF#_\
M0!UG_P !E_\ BJ /F[2_V.?%6GZ]X1U:'Q?I^GMH^J_;FT^TMYWL[>+%N'2W
MBDE;#2>0[,QP0\[$$C*MTGP7_9A\2_"_XG:9XFO/%\6J6D.@PZ5=P-%+)+<R
M)%%&&#2.?+4&(MA3@EON@Y9O;?\ A,'_ .@#K/\ X#+_ /%4?\)@_P#T =9_
M\!E_^*H Z*O!/C=_R.:?]>L?\VKUG_A+I6X3P_K#.>B^0BY_$N /Q-9;?#^#
MQ--+J7B&$"^F;Y((9,K!&  J;OXCP23TRQ X JEH)ZG;4445(PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;I;8<^:8I<':[(?X>I9' '\6QMN=IQ>N/C!X0M=0-A-K"Q7PD6/[,]O*),L
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M,9GAW]FKP?KF@SF]_M"=VN;JW#M.,B%+J4I'C;@J' ?Y@22.21Q110!V.B_
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+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>img247211528_17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_17.jpg
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M/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP #A"24T$!
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M>\U)<"XL5A/=-DK/(GN?6>7WG7@#<0,;)[H#>X5L(+R61@#G.]?LHHBS92@
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MF@^\"-0&*D I@NM^CO@-KEW/;7N?;QA7M=BYK5Q<"$5H^\"% Q4A:O=GL/\
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MZBO;0;8YT4#[5]S.)WM$@N+R618KF...2/X?0T:M):6QOD<UK7@:BWRGN&G
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M,VA>WGO;>PQF'B4C!L&D0;RGVI6B'<RZ^)77#];,8KHM@_,A&2@C;[-U!-=
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M7;BNRC-,&6Y/C4N-0I+"W9*67")OFC[?I_JCXJ.ZF9/YK7R,C+I?RX77-A,
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M$._1;Q!81R7$5C=SRN,4DQ?-;VD$C)8W%X?)XIG^;;N_$<X1RQMU'RR AKU
M9 G)<@/HF=19M9OMM7AOIVQC&K3^&[C<W"JK?V1B5=F6WD+/JJ@RG</=OTGS
MJ2YA0\HHKO%'+6;MQ@F6I#[S3J8Z4*;6$NOL!1/=-DW2\ZAEN8O,9MLSK42&
M.4Q.<R*"^#FDL<U^D2RP8 A<\FN1SF.+R1D4]@/VD5.DGU(^E%JVO;VMQ+9M
MJ>QO=8T>*1T^GC&UU$#TVGU-8%>0(K-++PMVI<L1L0<AB"7+:>R$1)"XQ?\
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MU[=-=.*RGV59XUIGL][+P'7N</N.I.G#F8::JSQ$L<N551WFQ!O+L1S#%'D
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MP-6D.L/\/_K*(MWJ^&+]"=U:HG\NA].^P6'40]_8,'O ;6O>-;\J2G^VAO\
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MCC%7MM);.='+Q) KH^T7L&XV\=Q Y=1 3BTYD'NRJ0L;CIGVBY2M"Q6H2&R
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MEDG_ )19^!"0? :GA+3P"#2E*0=?,6>8T[6P0-#R^)9U6KD>@TX]TNIZ&OI
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MK0-/$<"KT"*S=(_WG*@YUHMI/Q%^QF>ERD=E3]6KDQ'D3(,EZ++"1J\VK0+
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M)Y\BF,VT-=->K[R#I]W%.?J6STK"P^VC$/RJWDD>?/!$U,5*GT)2!W<N0O\
MYK03%ZZZ*?FLM)]W)MITZ??Q2/4[]*MA!Y*M%/\ E7;@#XC<6M/)K<_738]G
M>3OC_#55=%!U!4\Y(E$#KK\)8!/%=_4][(C8X6M=1&#Y<=-1$?$W-Q(\<&@!
M>_"F&5<Y;/(4]/:C!)[DF'$::4/ A+BPXZ 1[^?%=^\[MBTR%IY ##N*4=MN
MC^C("AMA*>3RY?8X"AJP8GS4K1/LY\II:>Q33TEWREI*2%)4VAQ*"D@Z=.G
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M4?F1ZLQ$I$6?.= 3.L8Y;"4.,(2D,M+&H4.]0)"@>#-C;RV,1^))-[(5)7$
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M\3I' MJ,<GOX5-"=E2EE0 (;8:279$IUPAMF-&CH"G'WWW%I2A"02I1 XK2
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MPQH >KO=3'T5<$WQ&#4U8"K%855M0J^/'T"G"@N2'#U<D+<6'>?]E.H"1X)
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M4I(U'$EM8JY6 ''%<A45U?ED(GN"/+=@UB^)SN2?L]M*J9N9&8+SDAF(])*
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M=J0:^AK KI)J1(G4?[6O^@?KX$S_ )8'8/JK5V.:451_P ^P_P!2O]/ V8H
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MEI 0DH.OX^S34=>6O%2YD5QD9D31"W:8XF-*J!4@Q(<B+V-^:5QAH-.Q'F-
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M.2'W25K6>:E$GC.W-Q+=3NGFQ>?9W5L+&PM]OMV6]NH:SMQ<3^UAC3D[IY9
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M*,-N[@"276NY%78+6AS2,\V4_8_R ^;^W]4[.WY5]?!O\9$!@@\_W+ZWTZ3
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M7N)HQ<SO50#I&"8*5[/JKM]GT7;LMD<A&D$@^]CCBXUUGVEWIAY:W1T>3_\
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MW:'(S 5KHF,N&ATGO =U?$FK?2CX?+D)YD?LK ]I"CV$C[>',E8"-2@KG2=
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M1VV7@2G:/UT2,A[3XU2BGWH;3RT_9['%<N!]$F(F&O56Y6O+0R >?[*"/O\
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MSA4JSA4J_]D
%       !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>img247211528_18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $# F8# 2(  A$! Q$!_\0
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M$M;Z[FV3W%Q+"ML4YVQG!?.>F>.E:/A+1=*U32=?NM1ED62SM=\6U"P7/\6
M1DCTJWAL.H\UOS"R.Y_X7E;_ /0 G_\  A?\*/\ A>5O_P! "?\ \"%_PKB)
M/ S)');#5(FU>.S^V/8^4W"8SC?TW8YQBMK5O EO=WD<MBIL[&'3;>:<PPO.
M[R/GH@Y)..?2I='"KI^861N_\+RM_P#H 3_^!"_X4?\ "\K?_H 3_P#@0O\
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M%H+35[F"RMFD@O4LXXV@E"(2>GW\DG/WNGM4.GA;Z1O]X:%W_A>5O_T )_\
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M1(>I^@Q[U#XGTG3K/QG;V,2?9;-XX"^P%L;AR<9H5##.7*E^861W/_"\K?\
MZ $__@0O^%'_  O*W_Z $_\ X$+_ (5@>)O"6E#5KXVTT.F:7IJ(DTJP.[,[
M=!C<=Q]QBLN3P(MHFH37^KQP6MJD<J3) 7\U'^Z0,@@^U*-'"M7M^861V?\
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MI76+X,L)_#LT&FW,=_J)U%;87!C:/R_48)Y'O3EA\-&UU^861T?_  O*W_Z
M$_\ X$+_ (4?\+RM_P#H 3_^!"_X5QJ^ ?M<BC3=8@N46Z^RW#O$T8B?\?O"
MB7P#+_;EOI5O?.TSAFD\^T>(QJO5@#D,/3!I>QPO;\PLCLO^%Y6__0 G_P#
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M.WAM[M;7<MLS[RP!!P#QUI*CA>WYA9'8?\+RM_\ H 3_ /@0O^%'_"\K?_H
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M[Q[V:'2K6UNKU4CN)XY&)=%Q\N#P.G6DN?B#>7,]U*UA;J;FZANF <_*8L8
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MW2W+%6)PP&,#VJ>;QW<74]S]KTVVN+2YBCCEM6=@"4& P8<@U[9_PKSPE_T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%6'_ "$;;_KJO\Z]U7[B_2O8RK:7R/FN(/BI_/\ 06BBBO6/G0HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PKXU
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M -^A2=:HU9R87#^W-*_Z"-M_W\%0)K6G:M8WHL+N*<PJRR!&R5.*G_L+2?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$C&:SD\/6J.'$DAD4@AB<]"3^/6K=A8+8K(%D9][;CD8 ^@H N4444 %%%%
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M[L')V@(22!W^G(J>W@A'VB2)B?M#[F/O@+_2L]-$@@N%,=Y+'</G!4@97C(
M_*@"W)K-E$[I)*59"!@KR<G Q^/%2#4K8V(NPS&(G'W>0<X(Q]15-/#ULMRD
MQEE8HVY03_M!OQY%3R:3$]NL2R.NV9I@0>[$D_A\QH ?9:G!?SSQPAB(@AWX
MX8,H88_.L_QG_P B;JW_ %[M5[3M*BTPD0R2%"BIM8\?*, _E5'QG_R)NK?]
M>[5=/XUZ@;@^Z/I10/NCZ45 &#XI_P!7I'_84M__ $*M^L#Q3_J](_["EO\
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M\B;_ )XR?]\&CR)O^>,G_?!KW+SK'_GI;_\ ?2T>=8_\]+?_ +Z6C^RG_-^
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M:/@R+[&NAHH Y*'2M3AM@-C_ "D%8Q)D$^]3'3+V>-XYXG\UI%9Y1+\I&X'
M'TKIZ* .7EL-620)"&V1R$Q/YG.W)X/X56GAN[1XH6>>2X81[")#\IW#=GU[
MUV-)@$@D#(Z'% &%I=EJ<4DS3RL',97<3E6?LU5[?3=1:>$/YL<(93,#+DR$
M9R1[=*Z:B@#G[VQN9;R]C2T5EN-FR8L/DP!SZYXJI*FJV;2W95E*@;4#9#ON
MQCZ$&NKH(!ZB@#G-6MKB*RM0=\["-E*\_?(X;COFBQT^_2_ADG0^8&WR7&_[
MRE<;<?7^5='10 4444 8*_\ (]R_]@]/_0VK>K!7_D>Y/^P>G_H;5O5<^GH
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MFE>22$,7!#9Z'(QG'KBKE%0!0.C6)P3#R.^3DU)%IMG ,10*H!4\>J]*MT4
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M:)_^>TG_ 'V:/M$__/:3_OLU'10!)]HG_P">TG_?9H^T3_\ /:3_ +[-1T4
M2?:)_P#GM)_WV:/M$_\ SVD_[[-1T4 2?:)_^>TG_?9H^T3_ //:3_OLU'10
M!)]HG_Y[2?\ ?9H^T3_\]I/^^S4=% &AI4\QUBR!FD_UZ?Q'U%?45_\ \@:Y
M_P"O=O\ T$U\LZ3_ ,ABR_Z[I_,5]2Z@0NB71)P!;MR?]TUY>8[Q)95\+_\
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M2RRQ&.59DDB;:RLIR"#5#_A&YO\ H.ZK_P!_ZWJ*I3DE9 8/_"-S?]!W5?\
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MZ"B@#G_(\5_\_P#IG_@,W_Q55;&#Q'#I6K_V[=6TRE7, A0@A<=ZZJJ>J_\
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MM_*KE-DC26)HY%#(PPP/<4T[,#Y#/4_6BOIG_A7_ (5_Z EK_P!\T?\ "O\
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M!Z"C SG I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH __]D
:                                   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>img247211528_19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #U 1T# 2(  A$! Q$!_\0
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M/-/(X +LW7@ #% '):1XVU=/#7]N:K:2S1OL6.*.V6%69GVC:YD;(^H%.O\
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MX^[@_B<' R:YBUUOQ#/IFN+?6LMULMB-D<(A5"0PRK-C<,8;U&?PH [/1?\
MD!V/_7!/Y5>JAHO_ " ['_K@G\JOT %%%% !7DGQ!_Y&E_\ KDG\J];KR3X@
M_P#(TO\ ]<D_E7=E_P#&^0UN<M1117N%E_2/^/R3_K@_\JJCH*M:1_Q^2?\
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M03S_ ,"JY_9_B+_H/V__ ( #_P"+KVJ,'"G&+Z(^6Q-2-2M*<=FV;M9VO?\
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MW4J_#*5V95\2!F7[P%HI(^OS5\]G4'C*D)4NBZGM97F%'#0DJE]6<717;_\
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MAE$LA4K@<D$=ZHP^&]5-K>175XK--=+,CQR,I"A<8SV.?2L&(ZT *H4#  P
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MRMO<$8"D8XP>?PJ)/"_B":-([R^)560AH[IU(4-DC'0D]<UT'$=U17 MX?\
M$PDN+B[OP85CR([>:3+E1QGW(]*M^$M+UV&[2^U"YF%L\)"V\LI9D^8X!SWZ
M<T =G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9
J

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>img247211528_20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "@ @\# 2(  A$! Q$!_\0
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M_)^E'_"2:Q_S_P GZ4?VE3[,/['K?S+\3U6BO*_^$DUC_G_E_2C_ (236/\
MG_E_2C^TJ?9A_8];^9?B>J45Y7_PDFL?\_\ +^E'_"2:Q_S_ ,OZ4?VE3[,/
M['K?S+\3U2BN$\+ZSJ-[KD<-S=/)&48E3]*[NNNA65:/,C@Q.&EAY\DG<R/%
M'_(MWG^X/YBN+\)32+KL4?F,L95R5W8!.*[K7;66]T6YMX0#(Z@*"<=Q7!_\
M(GJXZ11_]_!7%BXS]M&<5>W^9Z6 E2>&G3G)*_\ D6=.A%SI_P!I%LE]=M<^
M5()6SLC_ *?6M:>P@GLK>RLDMY($NW!+\A0/Q_"L$>%-87.U$&>N)12#PIK
MZ1H/^V@K"+J)6=-_U\CJFJ4I755+^O7IT.@M[&WB:.XA@$<TD,T; +LSQQ\N
M>*P]"D^RZ9JYD16V",/&W<;B"/RS3#X5UDG)1"?7S12?\(GJ_P#SSCY_Z:"D
M_:734&K7_%6"*H\KC*JG>WX._<VQ8V<FD6ENI6=/)G>#/7)Y'XU NFVEGIGV
MB:SB:6.SWE7_ +^>]9@\*:P""$08Z8D%)_PBFL'K&G_?T55Y_P#/O^ON$E36
MGME:]_ZU-@6NGO>20):0Q[;=+@.IY#DCI[>U6+RRM+W4KW^T+>*"W4H8[D'!
M<G&1GO7/_P#")ZO_ ,\X_P#OX*4^%-8(P40@=O-%'-4M;V?]?<+DI7NJWX^G
MGY&Q'IVGM>^5<62*JS;8BJ[59<=#S\WUK%T^.TO_ ! Z2V\4<0#>7$#A6(Z"
MG'PKK)QE$..G[T4G_")ZOG/E1_\ ?P5$E4;7[O8T@Z44[U=U;?;\3=TV*&W"
MW$EK#;7DD,FZ)>.!T.,\5C>'95(U221S$&MR28^HY'2F'PIK!.2B$^IE%)_P
MB>K_ //*/_OX*;]K=-0>@DJ-I)U%K;\'ZFK!);:K''*L(G6W"PEI4W2/GOC/
M ]ZO-:0QI%9P01M"E[\PSRBD=<YKG1X4UA<[409ZXE%'_"*:Q_<3_OZ*I2J)
M:T]2)0HMZ55;^O,V;K3M.CE&RW6>!RYF<+N8$'^]GC%->RTP2FWCM(=GV/SQ
M(?O%NW>LC_A%=8P1L3!ZCS12?\(GJ_\ SSC_ ._@H;G_ ,^QJ-/K6_'_ ()N
M7<$=Q?M)+8JX:%!'*J;E!/J,\UGZ-$MIXCOHF9$"1,"8CP..V:J#PKK(Z(@^
MDHI/^$3U?_GG'_W\%)NHY*7(]QQ5)0</:JS5OZU-N."TN[.SCDD-TBQO)%+*
M<EG_ +I'MZ57^PV?V5YH[%'U%8\B!EVJW/4+FLP>%-8'2.,8Z?O!2_\ "*ZS
MNW;$W>OFC-%ZCWIB4:2VJK^OF:$-A;BV,QL(A=&4++!CS-B^PSQFK,MCIDEM
M#:Q1!?/9UC,C9*-V[UC#PKK SA$&>O[T<TG_  B>K_\ /./_ +^"A<Z5O9_U
M]PVJ;=_;?C_P3?L]/TUTDMC#&5A=$?YN';')JO!9:;=6J7)M(%F5Y$CA!P),
M= :R/^$4U?\ YYQ_]_!4UMX;UFVDWK! V1@J[ BJ3GHG3_ AQIJ[5;7U_P"#
MU&:W9JEAIT@M$MKB<D.J# S6J8;9[0Z$)5,B0APNW^/J>:HWFAZ]>K$DD4"Q
MQ#"(C  55_X1/5\Y\N//_705%IJ3:@]32].4$I5$FKO?ST^XUGT:W26]D2S1
MD6!#$,\%N^*E.DZ8'CQ;1'=DR+YF=KXX3Z5B_P#"*ZS_ '$X_P"FHI/^$4UC
M_GG'_P!_!57E_P ^OZ^XFT'_ ,OOZ^\UX["Q%E]KNK&".Z$3L8,X''0XIEMI
M=M/8GSK:#+P&56B0@ ]OFSU]JS#X4U@G)1"?>44?\(KK&,;$P.WFBE[_ /S[
M_K[@M3M_&_K[S"HK<_X1+5O^>4?_ '\%'_"):M_SRC_[^"N7ZO5_E9W?6J'\
MZ^\PZ*W/^$2U;_GE'_W\%'_"):M_SRC_ ._@H^KU?Y6'UJA_.OO,.BMS_A$M
M6_YY1_\ ?P4?\(EJW_/*/_OX*/J]7^5A]:H?SK[S#HK<_P"$2U;_ )Y1_P#?
MP4?\(EJW_/*/_OX*/J]7^5A]:H?SK[S#HK<_X1+5O^>4?_?P4?\ "):M_P \
MH_\ OX*/J]7^5A]:H?SK[S#HK<_X1+5O^>4?_?P4?\(EJW_/*/\ [^"CZO5_
ME8?6J'\Z^\PZ*W/^$2U;_GE'_P!_!1_PB6K?\\H_^_@H^KU?Y6'UJA_.OO,.
MBMS_ (1+5O\ GE'_ -_!1_PB6K?\\H_^_@H^KU?Y6'UJA_.OO,.BMS_A$M6_
MYY1_]_!1_P (EJW_ #RC_P"_@H^KU?Y6'UJA_.OO,.K%]_Q]O^'\JU/^$2U;
M_GE'_P!_!4UUX6U62X9UBCP<?\M!3]A5M\+)>*H\R]]?><[16Y_PB6K?\\H_
M^_@H_P"$2U;_ )Y1_P#?P4OJ]7^5E?6J'\Z^\PZ*W/\ A$M6_P">4?\ W\%'
M_"):M_SRC_[^"CZO5_E8?6J'\Z^\-'CMETB]NIK>*:6.1%02=!DX/%3ZK8:1
M#J%RC2&$@ HB'CE0?YU!_P (GJ__ #SC_P"_@H_X1/5SUBC_ ._@K;EJ<BC[
M/^M3G<Z7.Y^UW\_3_+\32GT9;^QTS9:Q6>=QG*X!"CISW)K/\3V<=K)9-#;K
M CP<@8Y(/?WQBF_\(IK&,;$_[^BI9_#FNW/E^?L?RUV)F0<#TJIQE*+7LW?0
MBG.$)I^U32O^/S.>HK<_X1+5O^>4?_?P4?\ "):M_P \H_\ OX*Y_J]7^5G7
M]:H?SK[S#HK<_P"$2U;_ )Y1_P#?P4?\(EJW_/*/_OX*/J]7^5A]:H?SK[Q_
M@W_D8X_^N;_RKTJN)\-:!J&GZTEQ<(@C","0X/6NVKU\#"4*5I*VI\_FE2,Z
MUXN^A!=_\>DGTKB]7\30Z-KNG6%S$WD7B.S7(/$)!4#=[$MC/:NTN_\ CTD^
ME<C?:*FH:S#=7&Q[9;.:VDA89W[V0_\ LM=,]SGHWY=!;7789K^ZM)L1/%>_
M9(N<^:WEB3\."?RI9_$FEVRYDNLDN\85$+,60@, !UQFL&U\(7^FQ*UM?I<7
M$.I?;(6N03E/+\L(Q')('?VJ[I7ANZL]0@NKFXAE:.:YF.U,9,VTX'TP:C0T
MO(L_\);I4\4GV.Y$TGV=YXAM(60*,D XP2.X[4[3?%6F:A;HYN!%(;<3N'4J
M-N!DJ2.0">U9\?A*6/2])M!<1 V,,\3L$^^9%*Y'TS4$_A"]U.S@LM1NX%@M
M+0V\#6Z%68D ;F_+H*- O(W/^$ETH6TMQ)=&*.+:7\U&4@,< X(Z$]ZLSZM9
MVVGK?33%+=L;25.6)Z #KD^E<Z_A.YN[>3[3) +@F)592[#:LBNP.XGKMZ5N
M:WILNHPV[VSI'<6LZW$/F#*%AD8(],$T:#39FZEXOMX;2TDT_$\EU<BV D5A
MY;=3N &0<=JLZIJ^HVVI6=A8VEO--/$\K&:8HJA<=./>JL'ARZ-XE_<W$/VE
M[Y+N98U(0!4VA5_Q-6M5\.V^L:Q9W=VJR06\3IY9R"2V.?THT%[UAMMXLL'T
MZ&ZNO,MR^X. A=4*L5)+ 8QD=:8_BF W6I6T8"O9>6?,D#;&#>^*JZUX5GO@
M]O9R01636OD)$P8"$\_,H!P<Y[TDGAF_=+N 7-MY-U# K'8=RO& ..>AQ1H%
MY&V-=T\WGV7[0?,W;-VT[-_]W=TS5-O%VD%)##<F5UC>10$;#[<Y ..2,=*H
M6WA.6WNRADCDL_M)N!N9]P).[&,XX/?%/C\*RI8:7;&XCS9F<NP7[WF!AQ]-
MU&@7D7K;Q1I\VGV5T[2(UU'YBQB-BP'<XQT'K5F_U1K:XLH((O.DN22!G&$
MR3_GUK"F\-ZI-IMC 9+(7%K%Y2SH'5D Q@@@^W(/%;=QIT[W>F74<H::URLA
M8?ZQ2N&_'/-&@TV5M/\ $$]ZPB-D5N&< *"0 O<G([58M]7:6SU"1XMLUD[J
MZ9X.!D'\152XT2_DF2XCOL3LQ,C<@#GC '8#L:LVVE2I9ZDLTBFXOG8E@.%&
M,*/RHT#4H:;XFO)9K$:E9V]O%?1F2%X9R^W W?,"...]:"^)=*,<DANBB1KO
M+2(RY7U&1R/I6+;>!H+1(U@=4#V;6MSP23D?>7T.:HZGX8O8= GW".:>&$10
M&/>S'D<X)/8=!1H*\D=3'XDTJ2"XF^U;%M\&02(RD ]" 1D@^U,'BC2/LIN&
MNRB"01D.C!@QZ#;C/-9=SX:U#4KB6\O+FV2Y1$2W$2'9\K;LL#US@4\>&[VZ
MU :C?36XN#<1R-'$AV!4SP,]^>M&@7D31>+(+B6^BB7RVM)DCW2JP#!L<].O
M/2KT7B32IKU;2.[S*S,H^4[=PZC=TS[5F77AR]GN]0V7$ M;N>.X&5.]67''
MICBC_A%W%E:0-,I\BZEN'*KRP?/ ]^:- O(T[3Q)I5[=);071:61BL8*, ^.
MNTD<BII=7MK>^%K<>9"SD"-W7Y')[!O7ZUR>DPW\NL:+;E-UOIN\%S;M&0NT
M@;B>"?I6Y=:5>S:XMYLM)H4(\L3ER8_4J,X!]\46!-V+VGZNFH7][:"WFA>T
M90QDQ\V>A'Y51@\6Z>_VXW#M;I:3^0693ACVQQ4FFZ?J5OKVH7UR]J8+K;A8
MPVY=N0.IQWJE)X<O)+FY4SVYM9;Q+M04.X$=0>U&@];&J_B#3HY5C>=@6 )/
MEMA,]-QQQ^-(_B#3UN)+?SG$JJQ ,; /M&2 <<UE7?A:675+R:.2-K:\D$DJ
MR,^5(Z@ '!_&H4\*7W]H6\TES"RP3,X<[B[*1C'7 Q1H*\B]9^,=,N-)MKZ9
MWA\\,5B*,6..N!CFK5KXFTB\F$4%X&+1F0,5(4J.N">.*SM-\-WEM)8FYGMW
M6SBEB38ARP?H3GO2-X2,FGV-H\ZJMO'*CLBX)WYY%&@7D::^)-*,4DK71C2-
M=Q:1&7*^HR.15.]\9:;;61N86DFVSI"Z>6P(W=#C&<5GCPA<S6AAN)8-R1K'
M$X+MP",DY/&0.@JYJ?ANYNY;J:WGB221H6C#J< Q^N.QHT"\CH7N(H[<SR2!
M(E7<6;C K/'B32S!),UT8TC +>8C*<'H0#U%07_ANVU&VN3+F.[N8]KR([;0
M?89K-_X1.YGMF6XD@$H"*K NWRJ<G.X]Z-!MLTE\7Z(S!1>,&WB,@Q,-I/3=
MQP#[U;;7=/2\^RM<'>&V%MIV!O3=TS6;=>&Y+@:OMEC5KYXF4[?N[,=?RJK%
MX1EBNI$\V.2SDG\\[V?<#UQC..O>C05Y&J?%&D?9C<"[+1[_ "QM1B6;T QR
M?I3QXCTM[83QW)D4N8PJ(Q8L.HV]>*Q+G29=%TS27B<-<64KD,(2Z,&Z[@.?
MQ%4]/\/7U]%_:1(BN?M4LB(X:-71O8'(Z4607D=)/XHTBWC5WN\[DWA51F;:
M.IP!D8[TEIXCM;W7I=+A#-M@2=90#M8-5*S\+M;2O+YD0:2U>%@H)^=B3GD]
M.:ETO0KS3-3BG6:!X3:I!*"IW97H5HT'[QH3:Y86]W]EDG(D!"L0I*H3T!;H
M#3QJ]BT4<@N5VR2&-3_M#J/PQ6%/X4E;4KITDC>TNYA-*LC/E3W  .#T[U,?
M"N_5;R5[C_09HW$<(',;N,,V:- NS07Q)I;+(YNBB1J7+.A4,H[@GJ*I7GC+
M3+>QEN87>?RI$1T$; X8X!Z=*S?^$-N9=/>TGFA)2'RH9,NQZCD@G X'05>U
M+PU/=RW<L$\2-+# D89> T;9Y]C1H*\CHXY!+$LBD[6&1D8IV34<'F^1'Y^S
MS=HW[/NY]JDI%ADT9-%% !DTYR=YIM.D^^:!=1N31DT44##)HR:** *DVJV%
MO<+!->P1S,P4(S@$D]!BK>37*ZAX<GNCK;K'"9;R:%X68\@+MS].AKJNU DV
M4-6U5-)MDFDC:0.^P ,% X)Y)Z=*?9:G%?L1"K[5169B, %AG;]0.M/OXYYK
M4QVX3S'(&YQD(.YQW-9VE66HV5_+')(#8@-L&1R<C:1QQQG/J: UN;631DT4
M4##)HR:** +-A_Q]#Z&M:LFP_P"/L?0UK5K#8Y:WQ$<P#0L",@BJ/DQ?W/UJ
M_+_JFKB=;N=1@\;:4NG0)<,UA<EHY)"B\/'S]?\ &G):B@VD=/Y,7]S]:/)B
M_N?K7":5K][I8OKW4U2.T.L3PW0#;O))C0I@^F1CZL*LIKFMW-TEHUY9V$IT
MU;\F5,XW.X"\]@H7/XU/*5SL[+R8O[GZTGDP_P!WI[UQ">*]4U&REO8);6P6
MUL8KIH9UR9RP)('HO&/QJ+3/$=Q_PD=Y;B-K>*ZN8I))YAE(\PJWE#_:/-%@
MYV=YY,0&2OZTODQ?W?UKSV]\37MQ:WMNTPEMKS3;J:%P@0KL7@C!ST]:MMXF
MOU>2"T(5+*U@8 H&$Y9,\L3P.W'>CE#G9V_DQ?W/UI/)A'5>O3FN*NO$.O%Y
M[BW:UBBAOXK3R)$R3O"YR?;=^E+)KE[;:A%;:E)!,]KJ9B,ZICY3"SYQZCI1
M9!SL[7R8O[GZTGE0YQM&?3-<OX=U^]O=<^PW4BRQRVGVJ)]@4XR!T!Z$$5GF
MY<:S!<RR$3'6)$="W15C.Q?Q'/XT60<S.Y\F+^Y^M'DQ?W/UKB[7Q#K,PT^<
M7%I+_:?F+':JGS6Y"L1GUQC!SZU!'XWOI[Y[:%(B[PHL*E>?M!(5HS_N\L?;
M%%@YV=WY,7]S]:/)B_N?K6'KNHWMI?Z586]U;P/>%U>:5<@%5SP*Q[;Q)JFH
M31:='=6MM*K3*]ZR927RR/NCIDYY^AHL'.SM/)B_N?K1Y,7]S]:X*PUZ]NM>
MM]0N;R."!=-F:2,+E7*2;=R_7K4UOXFUAWO+9#%--]E6XMV=53J<8ZX^E%D'
M.SM_)B_N?K2"*+LO3WKBG\2ZC]C1XKH&.*1UN9/)7S(R " 4SR.>2*ELO$3C
M74B!@%O<W:H\N,;AY18'GIR*+!SL['R8O[GZT>3%_<_6N,A\1ZKJ;6\%G-;1
MM-+<J92N["Q],#UJ71-<UFYN]'>^DMFAU!) 8XTP49<\Y]\46#G9UODQ9QMZ
M>]+Y,7]S]:XF\UN;2=4UYH26D>[MXES\WEAEQNQZ5.OB>_L?WU\%:PAF$<L[
M(%.&!P2 3C!Q^=%D'.SK_)B_N_K2>3#G&W]:XN3Q-JS3Q6Y MY&MC=!A$&#
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M*-%7O*C_ .>8H\J/_GF*.5A[1%&BKWE1_P#/,4>5'_SS%'*P]HBC15[RH_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<[*WV=_44?9W]15FBBR#G9!%$R/DXJ>BBF)NY__9
;

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>img247211528_21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_21.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %D X0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **_,[_@H=^VM\4?V3?$'[+O@WX4^$?@UX@U_]H[XB^*_ ;:[\=OB+J_P
MQ^'O@U?#GA9/$D6JZSXFTC0M?DM;>ZQ+9EI;%QY[6T42O), )-$_X*$>%_A'
M\,_ASK_[9GBKX,Z%X[^+GC+QSX8^&VG_ +)^K?$S]I3P7XP;P;:65[-I.BZU
MH/P]@UFZ\8K!<2K>: NBC%Q&+>QGNY4N%A^CI<)YY7R[+\RPV#^M4LU==8##
MX6I#$X_$QPM3%TL14A@*+GBO9T98'%2J3=)*-.C*J_W?O%^SDTI)7YK\J6K=
MKWLEKI9].E]C]+:*^!=5_P""G?[%.E?"OX5?&$_%R?5?"?QLUW7O#/PUT_PW
MX"^(GB?QUXCU[PG<3VGC'3%^&_A_PMJ/CRPN?!MQ;3Q^+!J7AZT70/++:BT"
MLA;YY^!?_!8#X$>*?@?X9^,7QUO[7X=Q_$SXV_';X5_!W3? OA[XB?$J3XB6
M/P>U9(K*ZTNP\.^%-1UO_A)/$>BW-C?6WAYM.6YN;ZX;3M-2ZGBD1:I<'<4U
M</5Q,,@S5PI8OZ@X/ XF-:IC(_7?:X>A0=-5:]3#?V?C/K<:4)O"NA45?V;3
M0*G4:OR2M?EV=[ZW26[M9WMM;4_8"BOA'4/^"EG[&.G? _PG^T&WQ=^W_#_Q
MUXLOO 'A&QT7P7X\USXC:]X^TF2XCUOP-8_";2?#5Y\2W\7:#]DN9-=T!_"R
M:AI$$)GOH88I(7DYA/\ @H=\)_'?B7]D:?X'^./AUXS^'/[2/CCXN>#-3U+7
M%^(^C^,]-U'X4>"+GQ3KF@:#X;M?!%Y%IGC'1+FV>/Q1H'Q,N_ \EE88;3GU
M#498+*3"'"_$4U4E+)<SHTZ4\=2J5L1@L30HPKY=AL3C,9AY5:M*,(XBA0P>
M)E.@Y*HG1J1<;QDD>SG_ "27Q+6+2O%-M7:W23NNG4_16BOSH^''_!5K]B#X
MM:K:Z'\/_B?XCU[5=6\'^/?&GABT_P"%3?%C35\;6/PQL+O4_'>B^!+S5O!E
MC8>,O&'ARSLIY+WPAX=NM0\0[S#!%823SPQOY/\  O\ X+$_LU?$KX >!?C;
M\0;3QW\--4^(_C7QOX0\(_#&S^&OQ0\=^--=D\'R:AJ=S<^%],\+^";O4?&M
MAI7A""SUOQ;X@\,Z;=^'_#=[->:/?WT-[83Q#H?!G%<8593X=SBFZ-;#T*E*
MI@,33Q'M,5'&SH\N&G3CB)P<<NQO/5A3E2I2P\XU9PERIGLJFON2T:33BT];
MVT>OV7KLK:GZWT5P_P -?B/X,^+W@/PK\3?AYK2>(?!/C72+?7/#FLI:7]A]
MNTZYW!))+#5+6RU*QGCD22"YL[^TMKNUN(I8+B".6-E'<5\Y5I5*-2I1K4YT
MJM*<Z56E4C*%2G4IR<9TZD))2A.$DXRC)*49)II-$;;A1114 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFP:SX$T_6&GOM$L-0MW9M/U1H%TF75'BD1_W/_X6G^U;_P!&F^'O_$C?#?\
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M[*__  ^9+_\ / .5_P!W_P "C_GY_GV9]6T5\I?\+3_:M_Z--\/?^)&^&_\
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M ,P5'_"T_P!JW_HTWP]_XD;X;_\ F"H_L?%_\_LK_P##YDO_ ,\ Y7_=_P#
MH_Y^?Y]F?5M%?*7_  M/]JW_ *--\/?^)&^&_P#Y@J/^%I_M6_\ 1IOA[_Q(
MWPW_ /,%1_8^+_Y_97_X?,E_^> <K_N_^!1_S\_S[,^K:*^4O^%I_M6_]&F^
M'O\ Q(WPW_\ ,%1_PM/]JW_HTWP]_P")&^&__F"H_L?%_P#/[*__  ^9+_\
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M+_Y_97_X?,E_^> <K_N_^!1_S\_S[,^K:*^4O^%I_M6_]&F^'O\ Q(WPW_\
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MD%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^,G[%VA?"34]+\0?"C]E#XO-\,?BSH?QHN->GO+'XB:MH5IXH\#ZO\1=*L=
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MFWUN>M?$7_@G=^RU\2H?A@=1\)^*O"VK_"+X:V/P8\'>+/AS\2?'WP]\:?\
M"H;'3K321\-=?\6^%/$&F:]XF\)W%A90Q36FNWU]=1S-<7UG>6FH7,]W)S_B
M3_@F)^QKKFD_#O2-&^&^K_#-/A?X"O/A3X9U/X/^/_'7PNU^?X7ZG<37NL>
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MX*=&4YN4)*G1I4E)._LJ5.E?V=.$4N>6CYG>/PZO3T^Y?))=#\4OV;?^"/\
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M46TY==VWNFK[[ZNW:[MN?G])_P $P?V-(/ ?P\\">&_AOJ_@5OA3XC\4>+_
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M+"WU'Q+K=Q=W5A90P6UA'#%Y7Q]^T]^WW^TW^U/^RK_P49\4_LX>!OAOX1^
M?P \$ZC\.]7\3^+/%WC+0?CQKGB*^^'.E>+O&7B7P&?#@70/#*>"-/\ $VEW
M&C0ZXQN_$<]M<QVUY92ND<7BG[-7_!0?QS\*O'E[\'OAW\,M-\8?'SXW:_\
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M'/A/2+F=-:M+.SB\/^(_">E7FG'2;+3_ "U?4XY!*-6U$W'U[HO[-?PE\/\
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MK8Z;C6K;*^(/[5D9Y&_*W]HO]MK]JG]G#]L?]FKXV?M:>%/"_A7P/X1_8O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP?\ XY1_PD^J^MM_WX/_ ,<KGJ* .A_X2?5?6V_[\'_XY1_PD^J^MM_WX/\
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M_A)]5];;_OP?_CE'_"3ZKZVW_?@__'*YZB@#H?\ A)]5];;_ +\'_P".4?\
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M_!_^.4?\)/JOK;?]^#_\<KGJ* .A_P"$GU7UMO\ OP?_ (Y1_P )/JOK;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9M_X!@?+_J#\D'_$JWT>O^C6</?^#<V_^>)^MW_#X3XY?]$O^%?_ 'UXH_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME^8TZ]=976EE,<10R'/<PA5P%'%4>',7C\3#FK4:/-\>O:7*3/"(99F2\EL
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?D+_ ,%T_P#E'-XG_P"SHOV"/_6U/@=7Z]5^0O\ P73_ .4<WB?_ +.B_8(_
M];4^!U '[#ZE_P A&_\ ^OVZ_P#1\E4JNZE_R$;_ /Z_;K_T?)5*@ KQSX]_
M!3P[^T+\,=7^%7BO5=9T70M;O]'O[N_T#[)_::OHMX+V"&%KZ*:W2.:4!9F,
M9<(,(0237L=>!_M-?'#_ (9S^#NO?%H^&_\ A+5T+4]!L)-"_M(Z2URFM7XL
M3*E]]FNPCVQ82B-H2LHRI=#@GQ.))Y+3X?SNIQ'&$L@AE>.EG4:D*]2G+*XX
M>H\<JE/"J6(G!X?VG-"A%U91NJ:<FD?4\$4N)Z_&7"U'@J=6GQA5S_*:?#$Z
M-7"4*T<^GC:,<JE2K8Z4,%1J+&NBX5<5*.'A*TJLHP3:^&_^'0'[/W_11/BQ
M_P!__#G_ ,K*/^'0'[/W_11/BQ_W_P##G_RLKR/_ (?+VG_1OMQ_X7L7_P H
MZ/\ A\O:?]&^W'_A>Q?_ "CK^7_[7^B5_P! F3]-\FXP\O\ J%_J[\[?WG_J
MW^T4_P"AAQ-_XDWAQ_\ / ]<_P"'0'[/W_11/BQ_W_\ #G_RLH_X= ?L_?\
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M-%^+G_:0_P#X*-?^M8?$&OU\TW_D(V'_ %^VO_H^.OR#_P""*O\ R:+\7/\
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MQ53'5L6ZM&M4HUN(<OQ6&H8>%#BF<(_5>'?[6RSGG*,JN->7XF22]M.E[/\
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M;]N3X*_'[1;KP_I7@K]H3P3X/T#46T+2?#>L^!/"]SX$D\+^+M2\5:/;> M
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MCRR>44Z='**5&.%J4Y3Q-1^RE2>-J5L3#"4Y5$E\4-XW^!'ASX=W=MI_PO\
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MOQ@\3Z5>PW-GX4\#6'B2RU+P]\*+?5+9FA6>9[9/%?Q*\F21(KB'1O#TSO\
MV;?(?JSQK!^SGXK^)'Q$\6^!+GX:>,;I]/\ C?K]A-\2[FW6UU7XS)KUE=:=
MJGC*0WJZ"OP4D\+7-U<_#?4+J[L= N/$D1@\5WGVRYC@?WX?\$9X0,#]H&0
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M8.G4SKAQ5,#6S2EE>'H8FC##YO2P]+&9=1RW_9*E*FHT9XS%**<5"RPWC_\
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MPI\,+.Q_9VTN?Q)K_P 3]4_M*;Q-X/T_X@ZQ9?#2:PT76H]3\/\ C"Y8V-@
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M^\8G3M8L?$VEZJL-LD'SU9?$;_@HOK_Q#AT_X_\ B[Q3\'/VCKW3_P!E^X^
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M>K?^CFKO%5454151$4*B* JJJ@!550 %50       !BN#\6_\?MK_P!>K?\
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M%5E\;++Q_P#LW_%_XLMK/P ^%/CGQQIWCN/X:_&'X3VFD^"K6;4CX4M-:O/
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MGI_QL3_: ?\ ]&:VQ/X\^]?K_10!^0'_  Y>^!H^Y^V%_P %3$_[R%?'1O\
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M9=F.5\8X2IP\^%J>*JK/<ZQJQF)XQQ.*P>1X+*L)ED<=F>88[$XO"2P[PM#
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MT>_^A/Q-_P")7F7]?\._*W]%?_#WW]GO_H0/BO\ ^ GA[_Y:T?\ #WW]GO\
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MZ\N[=8I-4N[2PBN=3OA+>WLLTTW[O^H33?\ D(V'_7[:_P#H^.OR#_X(J_\
M)HOQ<_[2'_\ !1K_ -:P^(- !_PY=_9=_P"B^_\ !2G_ ,60?M3?_-K1_P .
M7?V7?^B^_P#!2G_Q9!^U-_\ -K7ZWT4 ?DA_PY=_9=_Z+[_P4I_\60?M3?\
MS:T?\.7?V7?^B^_\%*?_ !9!^U-_\VM?K?10!^2'_#EW]EW_ *+[_P %*?\
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M^GAO;;[/Z3XX_P"">7QB\9>-/%D#_%;X;VOPKUK]K_\ 9=_:XTF(^$O%$OQ
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M_M*'>.,!O-\32?=YQMQU.<\8B_X<K_L[?]'4?\%1_P#Q8]^T=_\ -%7Z^T4
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M*TDZ]:>&[3PS9^!M"\&>,_%WANV\%:9X1L=!DM/$VNWUQ:S:WJM[JDW.W/\
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MM_J,OAS6=*&I:@MS[9_PD>L?\_$?_@/#_P#$T?\ "1ZQ_P _$?\ X#P__$T
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MO=7>#QCX2^/&BZQ>VG@_X;Z?G6;>WL;"],7AW3K;PY+H=S)XDMM?O-9CO)#
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MS/%XNO2P=:OB<OP<<JKSP^%QE>GC\)6SG!T:F"E24,MAB)1D\/03;]W(\XX
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ML^?U3/L+]2PG]BYWAW"5/'Y/[3&O!U/<>-K-,^0?^'EW[0W_ $A<_P""H?\
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M_P""*O\ R:+\7/\ M(?_ ,%&O_6L/B#0!^M]%%% !1110 4444 =EX0^_?\
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MGC/5=4F\(?#K2-0F%U!H.F,C7DUMI\FK7>HMI>FFT /KJBBB@ HHHH ****
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M'/UW_P 1"W_!,_\ Z&[XX?\ AB_$?_RQH_XB%O\ @F?_ -#=\</_  Q?B/\
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MX'%X%4ZM7%YOF%.=!T,95E[.-*$_:1IR511C*,_7Z***^W/YV"BBB@"[IO\
MR$;#_K]M?_1\=?D'_P $5?\ DT7XN?\ :0__ (*-?^M8?$&OU\TW_D(V'_7[
M:_\ H^.OR#_X(J_\FB_%S_M(?_P4:_\ 6L/B#0!^M]%%% !1110 4444 ;>C
M:NNE&X+0//YXB VNJ;?+,F<[E.<[QC&,8/7/&Y_PE\7_ #X2_P#?^/\ ^(KX
MV_:)_;!_9D_9*M_"%U^TC\8?#GPDM_'UQK5IX.E\0V/B2]77[GP[#IT^MPV8
M\.Z'K31MIT.K:=),;L6RLMW&(6E82!/F/_A\A_P2_P#^CR?AO_X(?B5_\PU>
M[@N%^)LRPU/&9=PYGV/P=;G5+%X+)\QQ>&JNG4E2J*G7H8:I2GR582ISY9OE
MJ1E"5I1:5JG4DKQA.2[J,FOO2L?K+_PE\7_/A+_W_C_^(H_X2^+_ )\)?^_\
M?_Q%?DU_P^0_X)?_ /1Y/PW_ /!#\2O_ )AJ/^'R'_!+_P#Z/)^&_P#X(?B5
M_P#,-75_J3QG_P!$AQ3_ .(_F_\ \Q^:^\?L:O\ SZJ?^ 2_R/UE_P"$OB_Y
M\)?^_P#'_P#$4?\ "7Q?\^$O_?\ C_\ B*_)K_A\A_P2_P#^CR?AO_X(?B5_
M\PU'_#Y#_@E__P!'D_#?_P $/Q*_^8:C_4GC/_HD.*?_ !'\W_\ F/S7WA[&
MK_SZJ?\ @$O\C]9?^$OB_P"?"7_O_'_\11_PE\7_ #X2_P#?^/\ ^(K\FO\
MA\A_P2__ .CR?AO_ ."'XE?_ ##4?\/D/^"7_P#T>3\-_P#P0_$K_P"8:C_4
MGC/_ *)#BG_Q'\W_ /F/S7WA[&K_ ,^JG_@$O\C]9?\ A+XO^?"7_O\ Q_\
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MH_\ #Y#_ ()?_P#1Y/PW_P#!#\2O_F&H_P"'R'_!+_\ Z/)^&_\ X(?B5_\
M,-1_J3QG_P!$AQ3_ .(_F_\ \Q^:^\/8U?\ GU4_\ E_D?I=5FSN!:7=O<E2
MX@E60H"%+8SP"00#SU(K\R/^'R'_  2__P"CR?AO_P""'XE?_,-1_P /D/\
M@E__ -'D_#?_ ,$/Q*_^8:C_ %)XS_Z)#BG_ ,1_-_\ YC\U]X>QJ_\ /JI_
MX!+_ "/UE_X2^+_GPE_[_P ?_P 11_PE\7_/A+_W_C_^(K\FO^'R'_!+_P#Z
M/)^&_P#X(?B5_P#,-1_P^0_X)?\ _1Y/PW_\$/Q*_P#F&H_U)XS_ .B0XI_\
M1_-__F/S7WA[&K_SZJ?^ 2_R/UE_X2^+_GPE_P"_\?\ \11_PE\7_/A+_P!_
MX_\ XBOR:_X?(?\ !+__ */)^&__ ((?B5_\PU'_  ^0_P""7_\ T>3\-_\
MP0_$K_YAJ/\ 4GC/_HD.*?\ Q'\W_P#F/S7WA[&K_P ^JG_@$O\ (_67_A+X
MO^?"7_O_ !__ !%'_"7Q?\^$O_?^/_XBOR:_X?(?\$O_ /H\GX;_ /@A^)7_
M ,PU'_#Y#_@E_P#]'D_#?_P0_$K_ .8:C_4GC/\ Z)#BG_Q'\W_^8_-?>'L:
MO_/JI_X!+_(_67_A+XO^?"7_ +_Q_P#Q%'_"7Q?\^$O_ '_C_P#B*_)K_A\A
M_P $O_\ H\GX;_\ @A^)7_S#4?\ #Y#_ ()?_P#1Y/PW_P#!#\2O_F&H_P!2
M>,_^B0XI_P#$?S?_ .8_-?>'L:O_ #ZJ?^ 2_P C]9?^$OB_Y\)?^_\ '_\
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M;F>505\?$A9)6< E/!+*2 1DJS+G[K$8)K?\/Y?^".7_ $D)^!'_ 'S\0/\
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M^.E&Y<[<C=C.W(SCIG'7&>,]* %HI,C)7(W  D9&0#T)'7!P<'VI: "BBB@
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M/AYX&NO#&IW'QG^,FH^(EL;7P]\/;O4-*TWQ):B?3[<6NHRQW,.M^Q]^S?\
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MB%]9Q4X.O7]C[.G[2HW:<W*I.XSA%6=2#UWYUKHE=WD]7:[MI^9\'T5]X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB3]AB:U\5_&C4];F\._LU^*/']]\3+[P7X0N1HUG+HM_9^+=2O;O2?$<IO\
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MY/\ GI%_W]C_ /BJ-R?\](O^_L?_ ,57\0/VV_\ ^@AJ/_@PO/\ X_1]MO\
M_H(:C_X,+S_X_1_Q-Y#_ *-]+_Q*E_\ 0X'_ !3>J_\ 1XZ?_BOY?_1KZ_T]
M/[?MR?\ /2+_ +^Q_P#Q5&Y/^>D7_?V/_P"*K^('[;?_ /00U'_P87G_ ,?H
M^VW_ /T$-1_\&%Y_\?H_XF\A_P!&^E_XE2_^AP/^*;U7_H\=/_Q7\O\ Z-?7
M^GI_;]N3_GI%_P!_8_\ XJC<G_/2+_O['_\ %5_$#]MO_P#H(:C_ .#"\_\
MC]'VV_\ ^@AJ/_@PO/\ X_1_Q-Y#_HWTO_$J7_T.!_Q3>J_]'CI_^*_E_P#1
MKZ_T]/[?MR?\](O^_L?_ ,51N3_GI%_W]C_^*K^('[;?_P#00U'_ ,&%Y_\
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M\=/_ ,5_+_Z-?7^GI_;]N3_GI%_W]C_^*HW)_P ](O\ O['_ /%5_$#]MO\
M_H(:C_X,+S_X_1]MO_\ H(:C_P"#"\_^/T?\3>0_Z-]+_P 2I?\ T.!_Q3>J
M_P#1XZ?_ (K^7_T:^O\ 3T_M^W)_STB_[^Q__%4;D_YZ1?\ ?V/_ .*K^('[
M;?\ _00U'_P87G_Q^C[;?_\ 00U'_P &%Y_\?H_XF\A_T;Z7_B5+_P"AP/\
MBF]5_P"CQT__ !7\O_HU]?Z>G]OVY/\ GI%_W]C_ /BJ-R?\](O^_L?_ ,57
M\0/VV_\ ^@AJ/_@PO/\ X_1]MO\ _H(:C_X,+S_X_1_Q-Y#_ *-]+_Q*E_\
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M%Y_\?H_XF\A_T;Z7_B5+_P"AP/\ BF]5_P"CQT__ !7\O_HU]?Z>G]OVY/\
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MXZ?_ (K^7_T:^O\ 3T_M^W)_STB_[^Q__%4;D_YZ1?\ ?V/_ .*K^('[;?\
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MAP/^*;U7_H\=/_Q7\O\ Z-?7^GI_;]N3_GI%_P!_8_\ XJC<G_/2+_O['_\
M%5_$#]MO_P#H(:C_ .#"\_\ C]'VV_\ ^@AJ/_@PO/\ X_1_Q-Y#_HWTO_$J
M7_T.!_Q3>J_]'CI_^*_E_P#1KZ_T]/[?MR?\](O^_L?_ ,51N3_GI%_W]C_^
M*K^('[;?_P#00U'_ ,&%Y_\ 'Z/MM_\ ]!#4?_!A>?\ Q^C_ (F\A_T;Z7_B
M5+_Z' _XIO5?^CQT_P#Q7\O_ *-?7^GI_;]N3_GI%_W]C_\ BJ-R?\](O^_L
M?_Q5?Q _;;__ *"&H_\ @PO/_C]'VV__ .@AJ/\ X,+S_P"/T?\ $WD/^C?2
M_P#$J7_T.!_Q3>J_]'CI_P#BOY?_ $:^O]/3^W[<G_/2+_O['_\ %4;D_P">
MD7_?V/\ ^*K^('[;?_\ 00U'_P &%Y_\?H^VW_\ T$-1_P#!A>?_ !^C_B;R
M'_1OI?\ B5+_ .AP/^*;U7_H\=/_ ,5_+_Z-?7^GI_;]N3_GI%_W]C_^*HW)
M_P ](O\ O['_ /%5_$#]MO\ _H(:C_X,+S_X_1]MO_\ H(:C_P"#"\_^/T?\
M3>0_Z-]+_P 2I?\ T.!_Q3>J_P#1XZ?_ (K^7_T:^O\ 3T_M^W)_STB_[^Q_
M_%4;D_YZ1?\ ?V/_ .*K^('[;?\ _00U'_P87G_Q^C[;?_\ 00U'_P &%Y_\
M?H_XF\A_T;Z7_B5+_P"AP/\ BF]5_P"CQT__ !7\O_HU]?Z>G]OVY/\ GI%_
MW]C_ /BJ-R?\](O^_L?_ ,57\0/VV_\ ^@AJ/_@PO/\ X_1]MO\ _H(:C_X,
M+S_X_1_Q-Y#_ *-]+_Q*E_\ 0X'_ !3>J_\ 1XZ?_BOY?_1KZ_T]/[?MR?\
M/2+_ +^Q_P#Q5&Y/^>D7_?V/_P"*K^('[;?_ /00U'_P87G_ ,?H^VW_ /T$
M-1_\&%Y_\?H_XF\A_P!&^E_XE2_^AP/^*;U7_H\=/_Q7\O\ Z-?7^GI_;]N3
M_GI%_P!_8_\ XJC<G_/2+_O['_\ %5_$#]MO_P#H(:C_ .#"\_\ C]'VV_\
M^@AJ/_@PO/\ X_1_Q-Y#_HWTO_$J7_T.!_Q3>J_]'CI_^*_E_P#1KZ_T]/[?
MMR?\](O^_L?_ ,51N3_GI%_W]C_^*K^('[;?_P#00U'_ ,&%Y_\ 'Z/MM_\
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MQT__ !7\O_HU]?Z>G]OVY/\ GI%_W]C_ /BJ-R?\](O^_L?_ ,57\0/VV_\
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MZE865OK5G%XH\2Q>$4@GU6U*^'-'T3P_I:7M^\L\]Q?.\%JD3Y\E_:I?V2_
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MX5:SI]CJD6HZW:%WGM_$LMI<S1300O)!;ZA \4$DMN/,/TW_ ,$U]9U?P_\
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M2RVE0IT98J6/P]#%RQ[_ -NE5HTXRQ+HQ]D>'/P<X,G5EF"?$$.(I9M3SO\
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M\<:IXH^"?C[X9>*]/T;XH^#-"O[N^NE\(>++:.]@T3Q#8HM_<0"6VE:-O/\
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M'Q8'Q^(_MB7P/'XI\/)\(F^(0TC^S?\ A-FU!H6\1LC/ME^PK$ LRB]-@]T
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8L-@]3^G^%%%% )O35]/_ &S_ #?WL__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>img247211528_22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_22.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %2 WP# 2(  A$! Q$!_\0
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MAK?_  4U;RM4U[4;CXA3VGB6/XAKX6DL_#>BW4%\^HF>RT^TN?O'PG_P5_\
MVT_A_P##O]E#]I3QC>>'_P!K'PG\9[KPWJO[3?[./P,_8T_:&\ ZU^SC\/?B
M1X=N/%6B^//A=\:?$Z7GAKXE:'\+('T[3?B!<^*4@LO$=O--JGA;4H[66"\3
M]QOCU_P39_9?_:._:*\(_M/?$30?$0^(VA?!_P"(?[/GC*QT#6K?3/!OQO\
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M4\>KXTOOBQIGQFG73_%'_".M#::0/&.DV@CLSI,LZZ7YMK]L-S)]M4 ^'/\
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M&M;/0/ O@7PWI-O/=BRT+P3X1T"T)NG:]^VO%;M#]54 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!^;?\ P6-_Y1/?\%(O^S)?VE?_ %4OBFOY
M7?@!^SWHOQD^"W_!'#4?^";G_!/?X^_LV?M=_#?QC^S!\0_CK^W/J?[/.K_L
M]_";4/@OI?PX=?CY-XA^*FHW-A8_'?0OBNT]L=/T.SAUO_A+[:5[F%K2*_\
MLUW_ &R?M"_ WP3^TU\"?C#^SM\2FUE?A[\</AMXQ^%?C9O#NH1Z5KP\+^.=
M!OO#NMG1]3EM;Z*PU(:?J%Q]CNY;*[C@GV2/;S*IC:Q\#/@OX._9[^"7PK^
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MOQ ^(>J>(9+V>'6M,^)'Q9T[6--\("SMK"WTRPTNXM9(WGC>5OR?_P""2_[
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M(J>RIN<W"'+%RERMO^I?_A\?^R!_SP^+O_A 1_\ R]H_X?'_ +('_/#XN_\
MA 1__+VOY:**\7_B:#Q0[\-?^&>M_P#/'^KORM]3_P 2$^ O;CC_ ,23#?\
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M@2+R7\PF3:O+_P##X_\ 9 _YX?%W_P ("/\ ^7M?SO?&S_D#_L^_]F^^&/\
MU,_'U>$$@ DD  $DDX  Y))/  '4UZ&:?27\2\)C9T*/^KOLXT<'47/E%:4N
M:O@L-B)W:S!:<]626FD;*[M<\7A_Z"_@9F>5TL7B5QI[:>)S*C+V?$6&A#EP
MN9XO"4K1>3R:?LJ$.9W?-.\DDGRG]3'_  ^/_9 _YX?%W_P@(_\ Y>T?\/C_
M -D#_GA\7?\ P@(__E[7\L8GA(+":(JN-Q$B$#)P,G.!D\#/4U+7GKZ4/B>]
MGPT_3)ZS_+,>OZORM[3^@1X#+=<<+UXDPR[=\F\_Q7S_ *E_^'Q_[('_ #P^
M+O\ X0$?_P O:/\ A\?^R!_SP^+O_A 1_P#R]K^6BFEE!52RAG)"*2 6(Y(4
M$Y8@<D#-'_$T'BAWX:_\,];R_P"IC_5_2Q_Q(3X"]N./_$DPW3?_ )DWKZ?+
M7^IG_A\?^R!_SP^+O_A 1_\ R]H_X?'_ +('_/#XN_\ A 1__+VOY:**/^)H
M/%#OPU_X9ZW_ ,\?ZN_*Q_Q(3X"]N./_ !),-_\ .;U_I:_U?:#_ ,%8OV5O
M$>D^--:TZ'XI_8_ ?A^U\2Z[]H\#)%,=-N]=TOP[$+&,:T_VJY_M#5[0O"6C
MVVXFFWGR]K<Q_P /C_V0/^>'Q=_\("/_ .7M?SN_"7_DGO[3'_9(M#_]6KX%
MKPJO0Q?TE_$RAA<IK0?#O/C,%7KUN;**SC[2GFF882/(EF"Y8^QPU.ZN[RYI
M75TEXV6_07\#,5F/$6%JKC3V65YI@\)AN3B+#1E[&OD&39E/VC>3OGG]8QV(
MM)*-J?)&SY6Y?U+_ /#X_P#9 _YX?%W_ ,("/_Y>T?\ #X_]D#_GA\7?_" C
M_P#E[7\M%'/0#<Q("J.K,3A5]!DD#)X&>>*\_P#XF@\4._#?_AGK_P#SQ_J_
MI;V?^)"? 3_JM_\ Q)<*O_>-IU_I:_U+_P##X_\ 9 _YX?%W_P ("/\ ^7M'
M_#X_]D#_ )X?%W_P@(__ )>U^+7CS]A75?!>@_$:UM_BKX>\0?%_X.?#?PO\
M5OBG\(K;PQK=B_A[PAXDBBN)Y=)\;7%S+H_B+4?#]M<VL^L6<-C8H%F9;6XF
M9%\S@M:_99'A/X&>!_C3XR\?WFB-\1?!^I^,O"_ABP^%WC?Q)8_8K;5I]*TB
MTU_Q[I$<GA;PS=^(O+AOM.75I86%K<*7C8QN:^KQ/C3X\X.IB:>*RSAF@\%@
M*V98N=7#X&-'#87#8Y99B57Q+S[ZM3Q>'S#_ &*OELJJS&CB;TJF$C-67YW@
M?HO_ $1LRHX&M@,^XYQ<<SS?"9)EU*AC<UGBL=C\=E*SW!2PN"7"7UROEV,R
M;_A4PN=T\/+)<1@6L11S"=-J4OWB_P"'Q_[('_/#XN_^$!'_ /+VC_A\?^R!
M_P \/B[_ .$!'_\ +VOY:!G R,''(ZX/IFBOE/\ B:#Q0[\-_P#AGK^7_4Q_
MJ[\K?HG_ !(3X"_]5O\ ^)+A?_G-Z_AVU_J8'_!8[]D!F51!\7<NZ(/^* CZ
MNP49_P")[TR1D]AS73>-?^"L7[*W@+Q=XA\%:]#\4SK/AG46TO4C8^!X[JS-
MRL$%P?LUP=:B,T7EW$>'\M,MN&.,G^42+_70?]=X/_1J5[A^TY_R<-\8/^QQ
ME_\ 37IE>C3^DMXERRC&8UOAWVU#,LLPL/\ A(K<GLL7A,WK5N:/]H7<N?!4
M.62:Y5SJSYDX^-6^@OX&0XBRW*XKC3ZKBLBSW,:M^(L,ZOUC+LQX9PN'Y)_V
M1:-/V6;8OVD7%N4O9-2C[-J?]$G_  ^/_9 _YX?%W_P@(_\ Y>T?\/C_ -D#
M_GA\7?\ P@(__E[7\M%%>=_Q-!XH=^&O_#/6_P#GC_5WY6]G_B0GP%[<<?\
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MDPW_ ,YO7^EK_4O_ ,/C_P!D#_GA\7?_  @(_P#Y>T?\/C_V0/\ GA\7?_"
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M:E>'-&R;YE_1#_P^/_9 _P">'Q=_\("/_P"7M'_#X_\ 9 _YX?%W_P ("/\
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M_P 23#?_ #F]?Z6O]2__  ^/_9 _YX?%W_P@(_\ Y>T?\/C_ -D#_GA\7?\
MP@(__E[7\LSN(T=V^ZBLQ^B@D_RK[W\3?L(ZSX>\/^,+.W^*GA[6/C1\._@Y
MHGQT\=?!N#PQK=J^D> ]6\J:Z_L[QS-<OHNM:[HEA<6U]J.F16%M&4F$=O=R
MD!V]G*OI >-&=T\95RO!\.8N&7PA/%-9="BXNI2Q->E1HQQ&;T9XO%UJ&!QE
M6A@L)&OC*]/"XB=&A-4IN/S'$/T._HP<*5LLH9_F?&V7U<XJSI8&+SJKBHR5
M+$Y?@Z^)Q,\%PYB:>79?A\5FN6X?%9IF,L+EN%K8_!T\1BZ<\124_P!HO^'Q
M_P"R!_SP^+O_ (0$?_R]H_X?'_L@?\\/B[_X0$?_ ,O:_!W6OV64\*_ /P/\
M<_%7Q"GTT?$?P=JOC'PGX7TSX9>-O$=G);6>HOINEV'B'QWI<;>%_"MWK\OE
M26#:Q)"@BD9MLJQ.U?)58YG](GQAR>>%IYE0X8PU3&8+"YAAZ?\ 9].M4>#Q
MM&GB,+5JT\/G%:IAG7H5(584L5&C7<)J3II6MU9%]"WZ-?$M/'ULDQ7'>-H9
M;F>.R?%U_P"UZV%PZS'+,34P>88?#5\;PYAZ..CA<51K8>KB,#/$X55:<H1K
M2:U_J7_X?'_L@?\ /#XN_P#A 1__ "]H_P"'R'[('_/#XN]0./A_'W.!_P Q
MWWK^6BCNO^\O_H0KS/\ B:#Q0[\-_P#AGK?_ #Q_J_I;W?\ B0GP%[<<?^))
MAO\ YS>O]+7^K_QM_P %8?V5O /BO6_!NO0_%(ZQH%Q;VU^;#P/'=69DNM/L
M]2B^SW!UJ(RK]FOH=S>6N)-Z8.W<>7_X?'_L@?\ /#XN_P#A 1__ "]K^=[]
MIW_DOWQ._P"PMHW_ *B/AVO":]'-_I+^)>"S;-,'1?#OL<)F6.PM'GRBM*?L
ML/BJM&GSR681YI<D%S225VV[+1+QN'/H+^!F:<.\/YIBO]=/K699%D^8XGV7
M$6&A3^L8[+L-BJ_LX/)Y.%/VM6?)%RDXQY5=VN_ZE_\ A\?^R!_SP^+O_A 1
M_P#R]H_X?'_L@?\ /#XN_P#A 1__ "]K^6BOI/\ 9E_9ON_VF/&-]X+TWXD>
M!O >JV^E:EJ6FV/BB2_N-;\3R:7IEYJUU:>&M&L(2U\+.RL9KC4[NYO+*"QM
ML.GVJ<I;/.5_2-\7LYS#"97EE#AO%8_'5HT,)AUE?L76K3^"G&IB,UI48RFU
M:*G4CS2:A&\I10\_^A/]&[A?)LPX@SW%\;X#)\JP\L7F&->??68X;#4[>TK3
MHX/(,1B)4Z:;E4E3HS]G34JD^6G"<E_0)_P^/_9 _P">'Q=_\("/_P"7M'_#
MX_\ 9 _YX?%W_P ("/\ ^7M?@-\'_P!G*P^(/@+QQ\5_'GQ.TSX3?#3P5XR\
M-_#K_A(KGPMJ_C34-<\;>*+M(;'2-/T+1KNQGBM;2UDCU#4M1N+I4@MY$6*"
M=Q($\X^./P?\2_ /XK>,/A)XNN-/O=;\(WEK$VHZ4\CZ;JVFZG86NKZ+J]EY
MRI-'!J>DWUG>+;SJ)K8S&"7<R%FZL3](#QHPF587.\1@^'*>68R=*%#$?V="
M<V\1+'1PSK86GF\L9A:>+>5YC]3JXG#T:6+6"Q4L-.K&C)QX,#]#OZ+^9<0X
M_A7!9GQM6SW+:>(J8O!?VU6I4U'!T\GJ8Z.&Q];ARGEV.JY?#/\ )?[1H8'%
MXFOETLUP,,=3P\\13C+^D#_A\?\ L@?\\/B[_P"$!'_\O:/^'Q_[('_/#XN_
M^$!'_P#+VOY:**\;_B:#Q0[\-?\ AGK?_/'^KORM]/\ \2$^ O;CC_Q),-_\
MYO7^EK_5^G_!6']E9_!%SX_6'XI?V#:^+;/P7*#X'C%^=9OM&O-=@*6O]M8:
MS%C8SB2X\T%9]D7EG=N'+_\ #X_]D#_GA\7?_" C_P#E[7\[MO\ \FP:S_V<
M'X<_]5KXDKPJO0Q_TEO$S#1R]TWP[?$Y?1Q-3FRBL_WLZM>$N6V8*T;4XV6M
MM=>WBY/]!CP,QU3.8UUQI; YSB,!0Y.(L-']Q2PV#JQY[Y1+FGS5ZEY*R:Y5
MRJVO]2__  ^/_9 _YX?%W_P@(_\ Y>T?\/C_ -D#_GA\7?\ P@(__E[7\M%:
MV@Z;:ZQKFCZ3?:WI?AJRU/4K.QO/$>N&Z71M"M;F=(I]6U4V-O=W@L+&-FGN
M?LMK<3F-"(XG8@5PP^D[XI3G"$?]6>:<HPCS934A'FDU%<TYYE&$(W?O3G*,
M(IN4I1BKKUJOT#? *C2J5JG^O/)2ISJSY.(:-6?)3BYRY*=+))U:DN6+Y:=.
M$ZDW:,(RDTG_ % _\/C_ -D#_GA\7?\ P@(__E[1_P /C_V0/^>'Q=_\("/_
M .7M?AC\0?V/=3\.Z;\$=9^'_P 1-+^)>F_'KQM<> ?!*7/A+Q+\/=9NM8@U
M&UTZ/6;;0_$R27^I>";R2Z2:S\5VRK:S6^V7[.J2QLTOQF_9!B^&?@_XB^+?
M!_Q<T+XJGX+_ !!TWX9_&32-,\)Z[X8NO!7B'5H&^PWEC<:K=7=OXD\.RZC%
M<Z0-7M_L)^UVTA%H5R%^GK>-?COAZ>.JU<LX:5/+:%'$XJ<,-@JT94*^7/-X
M5<&Z.?369P651EF-9Y9]<^K8)2Q.(]E27,O@L+]%SZ).,K910H9YQTZV>8K$
MX+ 4JN-S3#3AB\)G4.'*V'S..)X3HO(JDL_J1R7#+//[.6-S.4<%@GB,0U3?
M[D_\/C_V0/\ GA\7?_" C_\ E[1_P^/_ &0/^>'Q=_\ " C_ /E[7\M%%?+?
M\30>*'?AK_PSUO\ YX_U=^5OT'_B0GP%[<<?^))AO_G-Z_TM?ZPO G_!5W]E
MCXB^-O"7@'P]#\4AKWC/Q!IOAK1CJ'@>.TL!J6JW"VUJ;RZ&M2FWMO-<>;,(
MI/+7+;&Z5^EU?Q&_LI?\G._L_?\ 97/!/_IX@K^W*OZ=\!/$;B/Q&RCB#&\1
M_P!G^WRS,\-A,-_9^$GA(>QJX.->?M(SQ%?GGSMVDG%):6ZG\&_2\\$^"?!/
MB3@_*^"?[8^JYWD>-S#'?VQF%/,*OUC#YA]6I^QG3PF$5.G[/XH.,VY:\RV"
MBBBOWL_D,**** "BBB@ HHHH _C+_;[_ .3S_P!HS_LH'_NNZ#7R'7UY^WW_
M ,GG_M&?]E _]UW0:^0Z_P A>-?^2SXP_P"RJXB_]7&-/^D3PK_Y-=X:?]F]
MX)_]9G*PHHHKYD^\"BBB@ HHHH **** "BBB@ HHHH **** /=OC9_R!_P!G
MW_LWWPQ_ZF?CZL?]GW3[#5_CW\$=*U6QM=3TS4_BU\/-/U'3;ZWBNK+4+&\\
M5Z7;W=E=VLZO#<VUU!))#/!*C1RQ.R.I5B*V/C9_R!_V??\ LWWPQ_ZF?CZO
M&=)U;5-!U73=<T34+S2-:T:_M-5TC5=/G>VO],U.PG2ZL=0LKF,B2WN[.YBC
MN+>9"'BFC1U(*BOHL=7IX7B'#8JK3=6EAIY'B*M)*+=2G0P67U9TTI>ZW.,'
M%*7NMOWM+GP^48.MF/!6.R_#UEA\1CZ?%.#H8AN<50K8K,LVH4JS=/\ >)4I
MSC-N'OKEO'WK']('PWTW]G>[_:F\??";XFZ-^SKXK\7Q?&;Q/#\!/ G@#X=Z
M'_:?@OP7H?A+Q#+XFLOBQ)9^%]-T&Z"VL82STC6)M9O[?5H[2]M& 031?#?P
MI_X)Z>$OBQI?]AZQKOB/X7?%76_ATWQ8T?\ MWQ7X-U;1Y- U;Q=)I^DZE>?
M#_2=%37/#_A'4M*FAFTS5-0\6KJ"RHWGZ1!#M0?F59_$OXB:?X[E^*-AXX\4
M67Q*GU*\UB?Q[:ZO=0^*YM6U"*2"_P!2DUF-Q=/>7L$LL-U,7)GCD=)-RL0?
M2[O]K']IN^LI-/N_CQ\39K::QO-+N<^)+A+B]TF_\S[3I%]>1JMW>:2WG3F'
M3)YGL;4W$[6L$+2N6_4JWB5P7G2IQXFX1K8JE@LSX@K82C@H86,L9EN<U,NG
M1IYGCZN*I8V.98%8.I1PN*P=2-+"8-X;"8>E[+#I2_ L/X&>*/#$JT^!/$?"
MX"OFF1\&X;,<5FE3,)4\LSOABEG%+%5<CRC#X"OE=3(\V>8T<5C\OS&E.OF.
M91QN88RO]8QC</M'PW^QI^S[XY^/OC7X!Z!J?[0/A[4/A'K'BE/''C+Q-;^#
M;CPMXLT;P5H2WVK6_A>YMM)L/^$8\1ZMJ$L$VC6>KOKL,?AW[7JLZSFUV/Z[
MX%_9W_9>\*_LT_M&?$+^U-2\>Z/??"*QU37_  [H.K^!_'WCWP#J'ASQ>ZC4
M/A]\28?"UEX?6S\36LT5O>ZE!HL5QI,-GJ,=\MR(D1?S&U#]J+]I#53X?:_^
M.7Q-F?PK?6FJZ#(GBG4+:2QU>QMI;*SUAY+5X7OM6@L)7T]-1U%KN[-AMLWE
M:W18Q8C_ &K/VE8=5DUB'XX?$2"\FL8]*EAM]=D@TJ32(KN>_71FT**-=%_L
MA[RYN;BXTT6 M+J2XG-S%*)7!XL!QKX>X"IB:U/A.<J]59[1H8B668)K#8?-
M<"\'@(QPCSET)RR>E/$4)QG)T\WIUYXG$+#8R%"K1]/-O"WQGS>A@,-7\0Z,
M<+AGPEB<7@XY]F:^NXSA[-8YGF\I9A_JQ]:I4^)*]#!XJE4I0A6X<K82G@L$
M\=EE3%8?%?=WCG]AGX"_#?X8^ _COK>L_'O7_ 'Q?U;X2Z#X)\ Z/:^%M*^)
M/A"^^(T=P]_=^-[^_P!#O-,U&VL3;E=%M--T?2Y]5D<1^<JA9'_/_P#:0^$$
M?P#^.?Q)^#\&O+XGMO ^NQZ?9ZYY*6\M]8WVF6&L67VR")Y(H=1MK748K34H
MHG,27]O<+'A  +.G_M0?M&Z7K^O^*;'XW?$B'Q#XIBL8M?U5O$EW/<:@-*B,
M.CR%+@RV]M<:)$=FBW-G#;W&DC!L9(&&:\8U35-3US4M0UK6]1OM7UC5;RXU
M#5-5U.ZFO=1U&_NY&FNKR]N[AWGN;FXE9I)9I79W8DDU\KQ7GG!N9X*E2X<X
M;JY-BHXG#U)U9\BBJ=.GCXXU\T<7B)5O[5K5\#BH82<(4<BC@7@<#6Q='$3K
M'Z%X=\)^)V09IB,1QMQQ0XFR^>!QE&EAJ?M92=>O6R>>5QY*F78*GAO]7\+A
M,VR^IF%*I4Q/%<LTAFF:X7+\3@Z6'/9OA+_R3W]IC_LD6A_^K5\"UX57NOPE
M_P"2>_M,?]DBT/\ ]6KX%KPJOF<Q_P!PX?\ ^Q9BO_5[G!]WDO\ R.>,_P#L
M>Y=_ZR/#04A&1P2#U!'52.01UY!P1P>17V/^Q?\  _X=?''Q=\5+7XGKXJF\
M.?#GX,>+_B>MIX/U>VT35+Z\\,-:RK9-?76GZE"D-S!)-$ 8!B9HW+X4J?N;
MP;^PC^S%\5=5^'7@_P +P_%OP1KGQB_9@L_VD- \2Z[X[T?Q#I/@**?5?#NE
MMX;U32QX6TT^(X@-7NKR759;S3DC2*")80)&EC^HX?\ #7B+B;+\+F&65,KY
M<?6K8?!X7$XRK0Q>)JTL52P7+!+"SP]/VN,KT</3E6Q-**G452K*E0C5K4_@
M>,O'/@O@3.LPR7/:&?\ M,IPV&Q>9X_!9=AL3EV#H8G 5LUYZDGCZ6,JNAEN
M&Q.-KPPN!Q$_9T)4:$*^*J4,/5^.]8_;S\=:Y8ZO+J/PP^%EWXS\;^&O!_@?
MXN>/[BU\3-KWQ8\">"Y[=[7PCXAMXM?AT_2[#Q#9VT>F>+;SP_!I^HZK9!5M
M;G3G7<>Z\+?MI_#CPAX(UV.5OC-JFMZW\$?$OP8L/@=K7B+1;OX >%SX@F)M
M-?\ # NKAM8MO#WARV6&TT+P]J&E:IX@M9DS)XEGB9I#Z#\1/V+OA7+X7_:?
MTCX6?#7X[67Q-^ _Q!^&_P -O!<_B?Q)!J^D_%?5?'&L6>E_VA8:-%X6TP6H
MF$K7=O;V>J7MM!IU_IM]).J,RO[5\"=%\$^ /B9+^Q;X'@\&:_X@\+?!KXQ>
M)_C;\3M3TC3KQ=4^.5YX*EM+/0=.U>ZL[Z[T_P (_"T72V2O92%9]52XNY(#
M=VT@/Z3EV5^(E/.J%+-^(L#2>-@LLP&9RP/]H>WS7&YYFF5SP.'H5*.3U,5F
M+S'+<[S#,JN+=7"U*="KF6,>-KXS _6?PW.L^\%\1POBL3P[P5FV(655/[=S
M?(XYM_8_U7AW+.%>'\]AFV-Q='$\1T,#DL<ESOA?)\CP^7QP^/H5L70R/+XY
M7@\MS58'\+XD\N..,L7,:(FX]6VJ%W'KR<9/)Y-/K]9_%?[%WP3^%?@'Q=XX
MUSPS\9?BU:^!S\&/#-LG@CQ58:=%\3+KXH65GJ%W\9O#UW9>'->.F_#59;J7
MP[X9TXQW=U>ZOI]V=8N[2Y86T7QI^V/\'O"7P%_:(\;?"WP*VOGPMH.F^"+_
M $U?%-Y#?Z_"_B7P3H/B2^M]2NH+:SB>:VOM4N( B6T?DI&L1WLA=ORO/N <
M^X9RYYAFGU&%.GB<'A*N'HUZU7$4:F.EG5/#2DWAH8:K2G5X>S6G[3#XFLT\
M/3J<OL,3AJU7^A.#_&#A'CK.5DV0+-:M6K@<RS*AC,3A<+0P6(H95#A:MCH1
M4<=5QU#$4Z'&?#U=4L9@<->.,JT>98O!8W#8?YFB_P!=!_UW@_\ 1J5[A^TY
M_P G#?&#_L<9?_37IE>'Q?ZZ#_KO!_Z-2O</VG/^3AOC!_V.,O\ Z:],KQ*/
M_).YE_V.\C_]5_$9]9B/^2SR7_LE.+/_ %=<#GAE%*HRZ+V:2-3]&=5/Z$U^
MR'CG]D+]DCP&GQKM+KPU\;]6U#X$_ 3X=_'/6+F#XEZ+8VWB[_A-(;Y)O"=E
M!)X/G;0XX)[2*8ZP[WDL:2SQ):O]G5Y?0X<X1S+B:EF%? XC+L-1RWV?UFIC
MZ^(I)NI@LTS&U&.'PN*E-PP.39CB)\T8+EH*$'.K4ITY>)QMXD9'P)B<FP>:
MX/.<=B<]]L\%1R?"X3$.,:.:9!DG-B)8S,,OITHU<UXGR7!TN6=1\V*E5J*G
MAZ%:M#\[?V>/V@-2_9R\5ZEXV\/^ O!/C+Q)>:-?Z!8W_C*3Q,!H>EZS87NF
M:]!IT/A[7=&BE;6K&\$-S)?K=O!]EMWLC;N9C+Z1X?\ VPH_#6BZOX/3]GWX
M*3?"^_UGPIXUM/AE*_CQ/"^C?$CP8TATOX@6U[+XNFUZ35=0A,%GXDLI]5.F
MZM9VD$2P6CM-))][_$__ ()]_L[_  DO?A1>W'A_XZ_$K1OCM\4?!/@K1+#P
MOXHL+&X^$>C^*-"TV]ENO%&HV_A74F\1:B;Z[N;NT6[MM'MWTFTN6,JM 6;P
MJY^#/@?]CKQ%\>OCOXITG^WM&\ ?$/QA\)?V3?!7C2&UU5O'_CG3D>UNO'_B
M"&6W$&J^&?AW;/+<2S-8"QU'7%6V!2>"W#?H[X2\0N%(T<OQF:Y7EF693B,;
M+,JM/#X7'T\FP>8Y>\7C\;BY5LLC''8?,\NHT*=/!QQ>(ECL2\JRJM1HXU87
M#T/Q!>(O@QXAU,1G.7</Y_GN?\18/*Z>1X:OC<PR>MQ+F63YQ3R[*<KRZ&%S
MR<\IQN19UBL54K9C/+L%3RK!1X@XAP^)Q.5/'8W%?GC\3_BAXF^-'Q"\7?%'
MQG?6NH>*/&>KR:KJ\UC&D-E%((8;6UL;*!'D\BSTZPM[6PM(GDDE6VMXA+))
M)ND;A*_?#XP?LB>$OC9K_P ,/&?B?4YX[GQ5\,?V7?!<.E^!'T70A\.AXWM-
M6F\3?&;XAZ5'81B[T;5]6C/ACP_96,<=O>>);NU?5]2LK*"*%OB7X\_L[?!;
MPM\#/BW\1? O@3XR^ _$GPL_:.L?@?&GQ(\3P:QIOBC20FJ?;/$%M8KX9T5[
M6]N39V\WV>*YNK>RAGMS'-.+@E/$XD\,N)\#5S?-<;CL-C::69YJ\;BYUZ>.
MS6&&CB,;C\6Z5.&-HPKU(4ZF(DL1CTZLJBIJI+$JO1H_5<#>// 6;8;AKA_*
M\JQV5UIRR+A^&5Y=2PE;*>'JF.J8+*LHR[V]6KEF)JX2E5K4,%&>#RF2H1HR
MK2H0P,L+BL3^=->ZO_R:[%_V<6O_ *JZ^KPJO=7_ .378O\ LXM?_577U? Y
M1OF?_8FQ_P"=$_7^)?\ FG_^RFRK_P!V#PJBBON_]G#X(?!'Q5\ ?BM\:_B[
MI'Q!\0S^!OB;\-? FD:'X)\6V/A.*YM_'=_9Z9/<W]W>:'K)+V,EZ+I&C12_
MDI;% )S+&\BR3%\08Z6 P=7"T*D,%C\PJUL94JTL/1PF68.MCL95G*C1Q%9\
MF'H5)1A2HU*E224(Q;8<6<5Y=P=E,,WS+#X_%TJV:9/DV&PN64:%?&XG,<]S
M+#93EU"E#%8K!8>*JXS%T83JU\51I4H.52I.,8MGQWX$\5GP)XU\*>-5T#0/
M%3^%-=L->C\-^*K6:^\-:U-ITHGAL=<LK>>VFN].DE"//!'<1&38JE]NX'ZC
M\5_MH:]XL\>-\5[GX0?#*T^*UO?66JZ!\0&U7XG:OJOA'5=,U*TU/2[SPMIF
MM^.+[0-)ATZ2T%I::3%I9T9+">>U-@RL"/T2\._\$V_V:O'7COXR^!- O?C#
MH<W[/WQ!\,:+XCU"Z\4Z)K=Y\2]'U_P/+XQ?1/#FE#P]8Q^'M9:XFLM&T^^-
MUJ$EP(GNS:>9<I GRW<?L8>#_BS\/_@%XF^"W@SXG_"W6_BI\4/B%X3\:V?Q
M4\1)XATWP-X&^'L-U+K7CR>ZD\.^&I(=-L[>UDN7DN5*W%]MTJW+R/$[?J<.
M /$GA[ U,)@<1EM2CB,9B<70P.#=/&XC&9CDV;8/AK%5\%/$Y6_88S*\TS"A
M@Z=66)P<^:I5Q673K4(U<2OY^J>,7@=QGF]',<UP6>4L3@LLP.78O-<S5;*\
M'EN2\3</9AQSE^%S2E@L^C];RW/<@R;%9G6PU/ YG3<*6'R_.J.%Q<Z&"/FW
MXR?M>:_\6O"FM^ [#P#\-OA?H_C7Q[_PM'XDQ>!(-674?B#\0/LA@&JZQ<:U
MJNI2VFFVS/->V&@Z:L%G;7,\DKM-MCV?*M?NS\--.^%O[2_PQ_:3^"GPTD\'
M_#;X*?#B]_9Z^&7@WXD:QI&F0ZW?Z$?B&LGCOX@:IKL]BE_/XD^(US%=1:7!
M<W=M:M%=:;:326]O-<Y\YT_]B3X V/BCX'^'_$OPW_:"FE^/7Q8^(/@,VEEX
MUTVWN?@II_@.].E16WC>XM?"FH6NL>(=9\B7Q+>;9=,L++0IGDTN2_M[:.ZF
M6<>'7%/$53+LYIY_EV>X;'X6G2CFM2G/ X*G7CQ)BN&WA,#1P-#%>UP4\X=*
MIA\;'"8*&.69RS#ZNHTLUQ&%?#/C7P!P70SKAJKP=G/"6-RK'U<1+A^C7IYK
MFN(P<^",OXVAF6:XG-L5E_L,SI\,1Q%+%Y7/,<SJ92\ACDWUUU,1P]@\?^-E
M?2G[&W_)V'[.W_96O"'_ *<%KQ/QSHUIX;\=>.?#>GM,^G^&_&OB[P[I[W+B
M6Y>PT+Q%J6E63W,JJBRW#6UI$T\JHBR2EW5$#!1[9^QM_P G8?L[?]E:\(?^
MG!:_-^&J4Z/%O#]&=N>EQ)E%*=G=<]/-,/&5G975T[.RNNA^X<<8BGB_#CC'
M%4N;V6)X'XBQ%+F7++V=;(,94AS1UY9<LE=7=G=']KE%%%?Z_'_-J%?QI_\
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MA:5/#T9U:,*E2=>O2@E.K3BN9N4XI-GR"RAU9&&592I'L1@_I7W+??MX>/\
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M5&IE55U)4<URO%X.$L-0Q56CBJ5/$QC'#I8R'X;FOC[X5\49=_JYF^3<5XO
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M>(/_ )2U^Q=%>=_Q SPN_P"A1G7_ (D.(_\ F;U_I:^U_P 38^/G_12<+_\
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MG_#FS]I+_H?_ (-?^#CQ!_\ *6C_ (<V?M)?]#_\&O\ P<>(/_E+7[%T4?\
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M!OQIX8^'7CG6_$8\;^,-&;Q)HGASPIX \<>/=0_X1U=<B\-?V_JR>#-!UM=
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M\3_^"8G[:7QC\3ZEXK^(?QF^%_B&_O\ 5=9U6VLKSQ/XLGT70&UZ^:_O]/\
M#.DW&FS6>A:4TQ15LM/CAB=88FF$LJF0_:'@']IGX'_$CX;>-_BYH/CB/3O
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M53J>WPU&7M5*3Y8RARVFVOP__P"'-G[27_0__!K_ ,''B#_Y2T?\.;/VDO\
MH?\ X-?^#CQ!_P#*6M#PC_P6+^"OC']GG]N?XY6?PU\:Z;KO["6K?%>#QC\)
M]7U?2;/Q!\1_"WPP\6ZSX*7X@> -<-HVGW7A37_$6@:QH<UT]E</X:U_3;G2
M-5#R26,]Y]<W'[?G['>BZCHOAKQK^T+\,/ WCC4O#7@_Q!JG@WQ!XA*WOA:Z
M\;>$H/&FC>%_$6L6UG+X>TSQ9<Z)+)<V/AN^U2T\0:M# 9]-TF=)H5?\=EX
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M#B<16PTH\'X2,85*N Q6$J.<?KS51.A7J1479*4E.]XV?XL?\.;/VDO^A_\
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M\1-.M+B_^(GA7PXA7?<6?PJA_L_3O&?BB:[CTFW\2W6H^'K=9+GP_JTT-_\
M$"/#&S?]C9VN6,9._$.(7NSY>5J^&5^;F3C:[:::NDV9_P#$VWCQ>,5Q1PJW
M*4X1Y>#<%*\J:;J1;6/:3ARM3YK<LDXNTG9_G-_PYL_:2_Z'_P"#7_@X\0?_
M "EH_P"'-G[27_0__!K_ ,''B#_Y2U];^)_^"@_[+WACX<:#\8X_$GCSQE\(
M/$?A#Q%X^TWXI_#7X1_$;XA?#]/!WA34-2TS7]>U+Q1X8\/WVFZ39V,^D:C,
M&U"6!KG3[?\ M&V$MG+#+)]:>$O$^D^-_"GACQKH#7SZ!XP\/:-XIT-]3TV]
MT;49-&U_3K?5=+EOM(U*&WU'2[J6QNH))]/O[>"\M'<P7,,4R.@<O ?PR@E*
M>29Y%-N*<N(,2DY+XEKA=UK=;KKMJH?2X\=ZDG&GQ3PI.2C&;4.#L#)\DDG&
M6F/?NR5FI;/HW=GY*?\ #FS]I+_H?_@U_P"#CQ!_\I:]+^'_ /P2<_:!\+Z#
M\7=,OO''PFFG\=?#:3PCI3VNJZV\5MJ#^*/#^LB>_+Z2C1V@MM*N(R\2R/YS
MQ+LVEB/U K=T?_CS\2_]@)O_ $OLZWP7@EX9X?$*K1RG.%4]CBJ:<L_Q$ERU
M\+6H55;ZLM72J5$G]EM25W'7DS/Z4WCKC<&\/B>(N&ITOK675N6'!V$A+VF%
MS'"8J@^98YZ1KT:4I1M[\5*#:YVU^*__  YL_:2_Z'_X-?\ @X\0?_*6MG1O
M^"2'[6GAQM2;P[\7_AKH#:SI5WH6L-HGBWQ=I3:MH=^NR_T74S8:9 ;_ $F^
M0!+S3KKS;.Y4!9H7 Q7ZY45ST_ _PRI34Z>5YY3G&_+.GQ'B835U9VE'#IJZ
M;3L]G9Z7OUU?I6>.]>G*C7S_ (3K4IV4Z5;@C U*<U&49)2A/&RC*THQDKIV
MDD]S\K;7_@EU^VO:76G7:?'OP9(^E:"?"5E'+\0O'YBB\&/+%+=>"5$=M')%
MX/O_ "4BOO#MO)#IEQ%\K6X8*R_5?B']ES]MR?P!XD\"> /%GPH^&/\ PF5S
MX>GU[7M*^,OQN\2:EI%MX:6,V&A_#9?%%YJ(^'.A2S+(]S;:)*]XUN\=BE^M
MK"J'U_XH_%_X9?!70]%\2?%7QIHO@C1O$GC3PI\.?#MWK,[1MKWCOQSJD>C>
M$_"FCVT22W.HZSK6H2^7;VMK%(T<$5S>W!AL[6XGCYOXO_&O3_A7K_PJ\"67
MA^^\<?$WXR^-E\*>"O FD7]II]\=&TB)=2^(?Q$UJ^NXYX-)\#?#7P[G5?$.
MJRPR"XO[K1/#=@LFL:]I\;>[EWA=PAEM/$TLNI<28=8^E4H5JD>(JLJSI.A4
MH5HT,76P<\1A%/#5:E&M+"UJ$IT9*%64H1BE\GG7CUXDYY6P&(SG$<#XR648
MBCBL+0GP90IX6.(CC*&,PM3%Y=A\TIX/,'3Q^&H8G"0S##8J-+%0=6A&-6=1
MR_/_ $?_ (),?M>^'M9E\2>'_C/\/-"\13B_$_B#1_&?C+3-<F&JB0:IYVK6
M6G0W\G]I"64:AON#]L$D@N/,#MGW?X1_L"?M;_#+2[C0=5\9_#OQGHT9L?[
MCA^-OQL\"ZCX4M[2_?4KO1-$O?"%Q8V\?A?7KN1KC7M!EL)(+N[5+R&6WN#(
M\GK_ ,9/VMO@A\%%^,NG:]XFD\1>.O@5\#V_:&\=_"_P=;'6?'MI\,I]6N-
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MNI:SXX\(>)_"NL:,_AGPW;ZG)K[6S7VC74MB&F'M/@S_ (([?L^_# ?#F_\
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MY5.9>]3E144I^TM[-\%OVR_AA^T#\9?%WPA^%NF>(?$5KX(^!WP2^.6O_$Z
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M(\*>)[#PS^S9XWL_#7Q=MFT3P_XNT[_A-]1O+O7/#.O>.[J^UGQ-?:WXRM=
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M%G[%?P<\8_'K2OV8%U72/"VO>%_B1XL;Q5J-G9>)_AK\4O&-KK8E\/:_\.O
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M:->> ;3X>?#>]T?PC\0)='_X132;OX3^*;_QAX4E\$JC6-]8:E9VEK;W'/\
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M#Y!\=:?J$OC#Q!)%87LD;W^Y)([2X='7[/ ,JZQE6&01D$C((ZBN3_LO4_\
MH&ZA_P" 5S_\:KZ)UZYN4UG452YN$59\*J3RJJCRX^ JN !GG '6LC[7=_\
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MY_\ C5>Y?:[O_G[NO_ F;_XNC[7=_P#/W=?^!,W_ ,71_8U+_G_4_P# (_\
MR7K_ $]#^W<1_P! U'_P;/\ ^0/#?[+U/_H&ZA_X!7/_ ,:H_LO4_P#H&ZA_
MX!7/_P :KW+[7=_\_=U_X$S?_%T?:[O_ )^[K_P)F_\ BZ/[&I?\_P"I_P"
M1_\ DO7^GH?V[B/^@:C_ .#9_P#R!X;_ &7J?_0-U#_P"N?_ (U1_9>I_P#0
M-U#_ , KG_XU7N7VN[_Y^[K_ ,"9O_BZ/M=W_P _=U_X$S?_ !=']C4O^?\
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MP;\&:#<66B>!/".L6%U>W=OJUSXLUGQ9\0]>\767]ESZEXJU^">+3+2+1-/
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M1)W>MDM=%;X6^&W[&_P\^%_CG1OB)HUM\0M=\4Z!I7C33],OO&.ISZV+>_\
MB"WABV\4^)DMXM+T^SA\1WOA[P;X<\'0ZA;6L MO"UE<:='&9-2U"XN/IO\
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M_@3-_P#%T?:[O_G[NO\ P)F_^+J/[&I_\_ZG_@$?+^]Z_AWTU_MS$/?#4?\
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MO[=^K8;D>3\GU>AR<RQW-R>SI\O-9VYN6][==NA,O@;QDC*Z^'M35E8,K"-
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M#X\\#?\ !-WP!X)TWQ?87.G_ !N^(ESXW\/>$? FM>(/BM\4O$7CGQ1'\*/
MFIRZMX7^#.F:[>S6]WIWPKMKR>Y;6/#4),_BQ+JZ7Q7J>L^>].\8_P#!-WX;
M>.-:\6ZOJ_A/X@0VWCC7)-<\2>%]/\0?9?"-VVK>(_!_B7QSI4&C);A[?0_B
M5-X$\-Z3XVTEKR>QNM @O=*TF#2;?4;D'[ ;QKXQ4X;Q'JX. 0#<8R",@CY.
M01R#T(Y%'_";>,#C_BI-6Y(4?Z2.6.2%'R\L0"0HR2 2!@&M/K&!YN;VF9<S
ML[\V'Z<OET44EY)=V8K!YJDH>PR%16G+[/'=6KK>[3;FVFW=N^]B5O WC%F+
M'PYJ(+$G"PQJHSV55<*JCHJJ %&   !3?^$$\8_]"[J7_?I/_CE,/C;Q@,9\
M2:MR 1_I'4'.#]SH<'!I/^$V\8?]#)JW_@3_ /85C_PE_P#4P^_#_P"7K_3T
MZ/\ A?[Y-TZ8[^[?K_B_JQN^'?!?BNU\0:)=7&@ZA#;V^J6DT\KQKLCB24%W
M8AR0JCDG'2OK.ODGPYXP\57/B'1+:XU_4Y[>XU2TAFADGW)+$\H#HXVC*L."
M,]*^MJ^JX?\ JWL,1]6]OR^UCS>W]G>_(K<OL]+>NI^?\8_7?K6"^N_5.?ZO
M/D^J*LHV]IKS^V;?-?;ETMYA1117OGQP4444 %%%% !1110!XYK,7G^(;N'=
MM\Z]CBW8SM\Q8DW8R,XSG&1GUK\"/!W_  6A\0ZGX/\ ^%Z>-?V4#X;_ &8(
MOV[]8_8#U'XC:%\:=)U_XA:-\1K;Q]'\.=%\;W7PNU'PEX?&J>#=3\075E]O
MMM \3ZEXATFSEN+T:=>6MI-*/WXUB40>(KN<J6$-]%*5! +",1.5!.0"<8!/
M S7\S_A;_@W]L/" \,>.],^,GA"\^.OAO]N;XY_M.7FOZWX8\<:K\+O&GP;^
M/?\ :NE>(/A'XC^'5SXL?3K#XD>#_#^NZI=_#;XR:!:6>L^#_%KQ:M9K-&3L
M\>U)SK>TWYY<NK3^)]M/5M.V]F?:R>+5'!?5U[OU>BZCM%K2G3Z/5OE;M%6O
MT::NOU.F_P""H7_!/ZWE\2?:OVH_ %EIWAC2_B%K=SXFU#3_ !GIO@C7](^$
MM[_9WQ.O_A]X[U#PO:^#?BC#X#O T7BA?AMKGBJ72!'-+=QQQ03/''X1_P""
MH?[!7CZR\3WW@?\ :'TKQ<?"4'@N\U32O#O@+XLZMXFO],^(UU=6/@36_"/A
M&S\ R^*?'_A_Q9=V5W;Z+XA\":/XCT.[DMY0NH#;7Y W_P#P;\>,=;_93A_8
MVU[XN? +5_A]\,_AY\:/!GP&^*^N>"/C?KWQ;TO5_B0-9L?"/BO6] N?BO;_
M  M\":EX3\.^(M8T/QA-X \,WG_"PQ-'<O::&7FW^]_&3_@D%^T%XF^/7P?^
M.WPG_:I\,>$;3X;?LP?L?_LU^.?A!>:3\2/"OA+X\^'/V9]1\8W_ (C\/^.O
M%OP[\3:5XNT/X?\ CJZ\2Z;JEEHNA2S7=I?^';2WUD:C8R&*CV=#_GYK>VKT
MMIK=1>ZNK/9[@J^8)J^'3CR)RY5JI-6:UFD^65VVKJ26B5TC[!\#?\%/_A+\
M8?VT?@#^R[\#8- ^*WP^^.G[/_QO^,X^..B^)]1T^7PCXD^!WC*+P9XC^%VL
M?#K5?#%IK%EXA@U"1DUV#Q!?>'];\.W2K:7GA^0N)!^G5?SK_L3?\$6/CK^Q
M_P#M;?#[]J0?M#? WQ:=#\1_M6R^+_ VG_#;XFZ9:S^#_P!JGQIH7CS5]/\
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M7;+(WA[6_#<FGZO<>&;;4)?*CQ/@S^VW\=_CEI6@R>,?VE_@3^R3)X"_9_\
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M;4?^?M+_ ,&1_P _-?>4**O_ -DZM_T"=5_\%M]_\8H_LG5O^@3JO_@MOO\
MXQ1[*K_S[J?^ 2_R\U]X>VH_\_:7_@R/^?FOO*%%7_[)U;_H$ZK_ ."V^_\
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MO9NE.IBJ$ZD7^\;J2J*2<G*T93J)Q24DJ::DX-W<JEHHNT5?_LG5O^@3JO\
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M5M+E$,EL)-,U*R@O-/D%O*J2V^^TFA;R)422'/ENH92*OU?_ +)U;@#2=5
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MWC;2[NMT^EG%ZBQ7L\11G3CB:<.:,HVYZ;C/F25IWO*RZ<DEK*\E-6B_Q4^
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M=J__ (+A_P#+0_L;'=\+_P"#ZOE_U"^O];^E9'J/S%&1ZC\Q7FO_  G'B/\
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M?7W<-[S3DWBL1S-KEUO]7O?1W:=_PO\ )NJ?L,6<7PT\$_#+PA\5-?T?P_\
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MU"=.-/FG!)QO_8?_ ,+5\;_]!&U_\%UK_P#$T?\ "U?&_P#T$;7_ ,%UK_\
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M2;;O'Y&^(GQ+_:R^!/P]^$&L:Q=^*G^/7[5WQD\1>*?B?IV@?"7Q?^TMX?\
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MX$>$OV6?A/?>)/AC^SS9^ O"^I7ZS>./$WA+PGK>IZI>7D>G:O<>!;OQ%/\
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MTBWDLM,T#1Q(OWQ\)_V4_P!FS]GEM,G^#GP3\ _"UO#F@Z[H&B7&@:?<6O\
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M^%OA-] 3Q@BHG_"6&U.E;I/$\D4:03Z_+*^JW-L/LUS=RVY:,_<O_"V=9_Z
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MODL+:WM%G$$,<:]3S_=;_OEO\*]3_P"%LZS_ - 3PY_X!3?_ !^C_A;.L_\
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MT-;JZ72?L8N9Q)ZYR>H;_OEO\*]3_P"%LZS_ - 3PY_X!3?_ !^C_A;.L_\
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M_A!M=_O:3_X.+'_X[6M;!XN51M8>LURT]5"72G%/IW,,/F&!5)7Q>'7OU?\
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M@VN_WM)_\'%C_P#':V#X,UK_ (1X6V[3/,&N?:,_VK9^7Y9TYHL>9YFS?O\
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MX5_Y&?P]_P!ABQ_]'"OMJOB7PK_R,_A[_L,6/_HX5]M5]9PS_N^)_P"OT?\
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ML%N?['\$^'O!O@JUU.ZM[;6+O4/R[^&7AC]KGX<R3?"+]BBU_:-\3SV?@?\
M:%F^+7AK_@H3X$T_P+\"_!?Q5\0^-;?Q1\+=9^'?BG3?!<^C^)=<U'7M=\8:
MN;/X?:I\1/!6N^&8])U;QO?6^K"">YN,(RTN[I)MW26K[Z[+39W;[&$Z]6#4
MG"T)-J"Y>:>FW-%-64OBO?2*LTFS]I?@]\=_@[^T#X>U/Q5\&/B%X?\ B%HF
MB:W/X:UZXT5[R&]\/^(;>VM[V31/$.BZK::=KF@ZFUA=V>HP6>KZ;9376FWE
MIJ-JLUE<P3R>LU\7?L5?";XB_"_PO\2=0^,/P]MO"_Q9^)'CFR\8?$/Q]=?&
M^V^.OBWXR:];>%M'\.1>+O%.MZ=\.?AAH?A&/2-+T>Q\->&O 7AGPW;^&?#N
M@Z?;0:1%;QO(C?:-9R24FE>R[V_-:?UT.FE*4J<92M=I-V37X/9]UJET;6K5
M>H^H_G5[5/\ D)7O_7=O_05JBO4?4?SJ]JG_ "$KW_KNW_H*T='ZK\I _P"-
M#_KS6_\ 3F'*%<EX[\>^"OA?X1UOQ[\1?%.B^"_!?ANV2[UWQ-XAO8[#2M-A
MFN(K2W\^=\EY[N\N+>RLK2!);N^O;B"TM()[F:*)NMKP/]I^V^/]Y\#O&MI^
MR[8?#Z_^.=T?#\'@K_A9U_#IOA33$D\2:2OB+7_M5WH'BC3QXC\/^&?[7U?P
M;#JV@ZEHT_BNTT>+5H&T]KBA*[2[M+MO]Y4Y<L)2U?+%NR3;=E?96;]+KU1T
M'PY^/OP4^+?P]U;XL?#KXG>$O$_PX\/2^(;?Q/XNMK]['3?"=UX1@>Z\56?B
MV'5H-/U'PM?^';1#>:SIWB"QTZ^L+1H[FXMT@EB=_$]-_;S_ &:X_"'PI\7?
M$+QJOP7;XY:9J?B?X2>$OBA!-I?C;QGX$MO$4'A_1/'EMX<TJ+5KS3/#WBW[
M?HFK:'_; LKU-.\0Z.FI6]G?3RVD/S!X/_8^^,/C+P!X=^"_Q*\ ^'/A?\*_
MB%\:/$GQK_;1U"7X_7?QV^*W[3^J6-KX9G\.>&?$GBJV^''PZTZWT#XCZ[I.
MF6WQ+L=/TO2M'TGX;^!--^''AO2H]%\23I8<_P#MW>'?''AGXU:_\6?@C+^V
MAI'[1UY^SCH'PW_9SMO@9\,-&\6_L[^)_&6B^-_$'B?2_!/Q5UM/#OB&W\-Z
M#<:W=Z0_CVS^(][X%\%P^"HDU?P[J]YK&F7#V&BA#F<;O=]5HE9*[LUJV[]D
MEW..5:NJ<9I127)&6DGSN5G)PB^79;)O63:T6K^U+?\ :]\)ZI\<-0^"_AGX
M:_%CQ?9Z!XT@^&GBOXL>'-&T"\^'_AGXAS:59:S<Z!>6<GB&#QSJ.CZ#::C8
M6OC#QUHOA/4/!OA/6+V#2=7U:*Z2\^R_6?\ GU_E7XGV_P"P%\7[;XD:E]B^
M%?P)T?6?&7[6_AC]K^__ &U=/\:ZFWQP^&UO=:QX<\8_$KX&^&/"TN@7&NWT
M5_K%GXL^'7A]['QS8_"N^^&?BRYO_$'A6;Q';2"__;.1@\DCJH17=V5!T0,Q
M(4=.%!P..@J9J*Y>5IZ:V=];+S=M;_U9O:A.K-U/:0<4I/E].BM9.]K/JM=T
M[I,K0/\ R"1_V$A_Z2/6?6@?^02/^PD/_21Z4?M?X7^AI4^Q_P!?(_J9]%%%
M2:'@EU^U+^SI9?&.S_9]O/C)X'MOC1J%XNEV?P^FU*5-7GUR32O[=A\,B[-M
M_8T?BVXT+&MVOA&75(_$UWI#+J5KI,UFPF,GC+]HGX?^"OBQI?P?U%K^YUY?
MAEXJ^-'C_7+8V,?A7X._"GPP6M8/&?Q,U6ZNH6T>U\7:Q#>Z-X-L+:"[U'6Y
MM&\0ZA%;II6@:E>0_''B;X3?M<^,_P!KG_A._B3\'?A?\1_@%\,_B;8^./V<
MM)TO]H:+P#IGA/6-'\&_V5I_Q@^(?PV@^#^H:U\0OC0=3O=9TC2[C7/B!/X4
M\%^'9M.N?#FC+K-O<ZA+IWO[*>OV/['7[4^E_&"^\8^-/V@_VKO"OBC7?VD_
M$WP'M=,UGQO=SZSI!T*P^%_P*M?&#Z=977A;X3> G/@7X9:3JGV9M5%OJ?B*
M33I/$/B>[M)]>6"Y;MW:6ET[M]59K1:WO;6UFUJ<?M:TG448JT9R:;33486]
MUIJW-.ZLTWIS-I.R/>[/]NK]C[4/ 4WQ0LOVA/A]<^ H?$=CX/3Q%'<ZKY-]
MXIU/2Y]<L?#^CV#:4NKZ]JMQHEM=:PMKHFGZ@Z:7:W.H2^7:V\TJ?17@SQIX
M0^(WA/P]X\\ >)]"\:>"O%FEVVM^&/%?AG4K76-!U[2;L$V^H:7J5G)+;75O
M(5="R/NCECE@E6.:*2-?R&^&'Q8^)W@[1?C8-6T_]O3Q#^S5,_P_\+?LU_'#
MQ+^S7_PEO[57P;\>:GX'\66_Q:UW3/A?J_PX7QK-\*M N[/PGX>\'>(=;^$V
MM06_B37/$&@PQOX*AM-1M?L#_@FYX!\9_"[]B'X ^ OB#X+U'P!XK\.Z)XLB
MO_#VN6\ECXHGM=2^(OC#6](\5^-M)EO]4.@>/O'VDZG9^.O'?AR._G@T#Q;X
MCUC2;=;6"TCL;4G!1C=/K9:WNFK]E9KJ.C7G4G&,HZ.#<GR.*3323UE*ZEK9
M/E=DG;6Q]OUIZ+_R%]-_Z^XOZUF5IZ+_ ,A?3?\ K[B_K4T_XE/_ !Q_]*1M
M7_@5O^O53_TB1[;1117NGYX%<7J/P]\)ZK>W.HWVEB:[NY/-GE^T7*[WVJN=
MJ2JJ_*H&% ''2NTHK.K1I5HJ-:E3JQ3YE&I",TG9JZ4DTG9M7[,WP^*Q.$FY
MX7$5L/.4>64Z-2=*4H\RERMP:;CS1B[/2Z3Z'GW_  JWP1_T!Q_X%7?_ ,>H
M_P"%6^"/^@./_ J[_P#CU>@T5A]0P/\ T!X;_P $4_\ Y$Z_[9S;_H9X_P#\
M*Z_E_?\ )'GW_"K?!'_0''_@5=__ !ZC_A5O@C_H#C_P*N__ (]7H-%'U# _
M] >&_P#!%/\ ^1#^V<V_Z&>/_P#"NOY?W_)'GW_"K?!'_0''_@5=_P#QZC_A
M5O@C_H#C_P "KO\ ^/5Z#11]0P/_ $!X;_P13_\ D0_MG-O^AGC_ /PKK^7]
M_P D>??\*M\$?] <?^!5W_\ 'J/^%6^"/^@./_ J[_\ CU>@T4?4,#_T!X;_
M ,$4_P#Y$/[9S;_H9X__ ,*Z_E_?\D>??\*M\$?] <?^!5W_ /'J/^%6^"/^
M@./_  *N_P#X]7H-%'U# _\ 0'AO_!%/_P"1#^V<V_Z&>/\ _"NOY?W_ "1Y
M]_PJWP1_T!Q_X%7?_P >H_X5;X(_Z X_\"KO_P"/5Z#11]0P/_0'AO\ P13_
M /D0_MG-O^AGC_\ PKK^7]_R1Y]_PJWP1_T!Q_X%7?\ \>H_X5;X(_Z X_\
M J[_ /CU>@T4?4,#_P! >&_\$4__ )$/[9S;_H9X_P#\*Z_E_?\ )'GW_"K?
M!'_0''_@5=__ !ZK$_PW\'W"6T<VE;TL[<6UN#=70\N$222A.)@6^>5VRV6Y
MQG%=S136!P232PF&2:LU[&GJKIZ^[W2?J)YOFK<6\RQS<7>+>*KWB[<K:?/H
MW&Z?=-K9L\^_X5;X(_Z X_\  J[_ /CU'_"K?!'_ $!Q_P"!5W_\>KT&BE]0
MP/\ T!X;_P $4_\ Y$?]LYM_T,\?_P"%=?R_O^2//O\ A5O@C_H#C_P*N_\
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M * X_P# J[_^/4?\*M\$?] <?^!5W_\ 'J]!HI?4,#_T!X;_ ,$4_P#Y$?\
M;.;?]#/'_P#A77\O[_DCS[_A5O@C_H#C_P "KO\ ^/4?\*M\$?\ 0''_ (%7
M?_QZO0:*/J&!_P"@/#?^"*?_ ,B']LYM_P!#/'_^%=?R_O\ DCS[_A5O@C_H
M#C_P*N__ (]1_P *M\$?] <?^!5W_P#'J]!HH^H8'_H#PW_@BG_\B']LYM_T
M,\?_ .%=?R_O^2//O^%6^"/^@./_  *N_P#X]1_PJWP1_P! <?\ @5=__'J]
M!HH^H8'_ * \-_X(I_\ R(?VSFW_ $,\?_X5U_+^_P"2.&NOAOX.O;B6ZN=*
M$D\S!I'^TW0W%55 <"8 855' '3/4FJ__"K?!'_0''_@5=__ !ZO0:*;P.";
M;>$P[;;;;HTVVWJVVXW;;W8HYOFL8QC',L=&,4HQBL572BHI)))3LDE%)+LC
MS[_A5O@C_H#C_P "KO\ ^/4?\*M\$?\ 0''_ (%7?_QZO0:*7U# _P#0'AO_
M  13_P#D1_VSFW_0SQ__ (5U_+^_Y(\^_P"%6^"/^@./_ J[_P#CU'_"K?!'
M_0''_@5=_P#QZO0:*/J&!_Z \-_X(I__ "(?VSFW_0SQ_P#X5U_+^_Y(\^_X
M5;X(_P"@./\ P*N__CU'_"K?!'_0''_@5=__ !ZO0:*/J&!_Z \-_P""*?\
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M/3[6REN8]7\4W6F:C+I>A>&4U*X_3U9-C*ZL R,&4@\AE(((]P0#7Y>?&/\
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M'&\5_P#RTH_X:1_:)_Z+S\8O_#C>*_\ Y:5XO17\%_V[GG_0ZS?_ ,.>-_\
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M@JOQN/VF?V@6W;?V@/BX=B[GQ\2_%!V+_>;&J_*O(Y.!2I^TO^T'+GROC_\
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ME_71?<'M:O\ S\J?^!R_S\E]Q3_L^P_Y\K7_ +\1?_$T?V?8?\^5K_WXB_\
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MR\\<3?#[X(R--XT\8^!O 'B/7H+#QSX@T;[''H+M>_V5H^KVNE7,@_-WX2<
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MIAH588B&'S'#</8ZA"O34HPKPHXK)*M.-:$9U(PJJ*G&,Y)22E)/Y?\ A?\
M\$T?V7O GQ*\">-]!^*WQ3U/7O"GBS1_$.DV6I-HK65_J>G7B7-O!?-'X=AF
M:">90)V6>*1@Q/FACFOV8KXE\*_\C/X>_P"PQ8_^CA7VU7Z)P%P_D'#^#Q]'
MA_)<#DM'$8JG5Q%+ JNHUJL:*A&I4]O7KOFC!<JY7%6W3>I^*^+W&/%_&.99
M/B>+^)LUXFQ."P%;#X.OFLL)*IA:$\1[2=&C]4PN%BJ<ZGOM3C.7-M)+0***
M*^]/R$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY#^)#,GCG677[RR6++
MD9&Y;*V(R._(Z=Z^O*^1_B'_ ,C_ *I_U\:=_P"DEK7SW$G^XTO^PF'_ *;J
MGVO O_(VQ'_8!4_]2<*?F#KG_!-O]D;QA\$_VEOV:O$&C>(/$7P__:L^+WC#
MX^?%#3+WQU%=^+-+^)_C!M)EU/Q+\/=4CM!?^"_[,FT6TDT:WAM+Z*P274+.
MZ-[8:C=VDO.^ /\ @EI^S9\)?$#:I\)_$WQZ^&7AS4M;^''BOQE\./!'Q5DT
M'P1\0_&GPNT33?#N@>+_ !<+301XJ&JZ[I.DV$/Q"L_#'BCPUH?Q!N+=+KQ+
MI5V[7"W'\PGB&ZU@WG[9NH:;\/F\!>)-?_X+O7?PZ\+?\%(9?B3-I+_LL3V%
M_P#"KQ$G@36M%TD-XEMO"WC6VMM3\&Z;?ZQ=I\,I=9^($MEXACT^6RCN)?O/
MX8_\%._^"@/Q*\+^'_B=9_$[]FSP-X_\8?%C]IWP%XP_9P^/FL?!KX?>#_@Q
MX=^&D'CG3O#.IP6FD7C_ +1L?B?X;SZ+X4\<?$.Z\<PW7A+Q5X4UN_FT:+2[
M1-*DO?$GA,9&%X8OFA)WG&;Y5S2IPE=*+J1=_9VO+DE!TXN2CS0<OJ:68Y;4
MJ6J9<X5*:2I2I1527)&K.#3<HT)1C&56]H^TC4C5DH.?)54?UH^)7_!'K]AW
MXL_$CX@?%/QGX/\ 'ESXC^)?Q:\(_&3Q)I^G?$*_T[PM#XA\,3W]]J_AS0?#
MT5@]KHGP]^*&K:C)KOQ?\'6C_8_'NN6]EJ=W<6D]ME_JO]I+]ESX-_M2VWP^
ML_B2_B+0?&?PH\9V_P 2_@]\1/AEXPE^'WQ:^&'BRSA-C<:WX$\26$=S=6=E
MJ6G.VC>(=*NM-U3P[K.EL+#5=.N$CA\K^;:+_@J[^TG;_&7]E']E_P 6?ME:
M1\./B'\0?BGX.\ _M4?$S6_AK^RIX_\ A7X @\7_  BU/QEH_B+X%_&CX>W4
MWPH\0>%_&FO649\-Z?\ $#1['QCX!LK[2HO'%OK)N)HE^(_VA_\ @K_^UMX,
M^,$WC?PQJG[/WQ \>_!/PI^TG\'?A%^V;=_!?PZT?QO\">'?VJOAI\/]/\9^
M&XXI4T?3_#NL:5XHU+2O%6G^"91X1UW7M);5]"DAE1Q&X8#,*LZ3>(3E&-Z+
MYZCY5)<B:E*"CR35-*7*Y.4+2Y)1;;4\WR:A3K\N#DH3FHXF/LZ*;<91J24H
M0JSFJE-UG*/-&G"-6\/:0FHH_JA\.?\ !+']D_P]X\\#?%J:#XK>+/C'X)_:
M#MOVG;KXP^.OB5>>*?B3\0OBMIOA6]\$:%+\2?$%YI:)K?A#PQX6U"YT?POX
M)T6R\->']"MI)!8VT9N+HS\KXH_X)(?LR^)_ 'Q+^$O_  GO[26B_"7XU>-_
MB9X^^+_PRT?XO6-SX)\?ZU\6O%%OXP\8_;-(USP?K:>')WUBTMXM)UWP=+X>
M\7:3HRR:(GB"2REVI^7'[8O_  4N_:7_ &3M6^(^B>$_VHF^)'CS]EKQ_P#L
MK_#_ .,%A\4OA3^S5\*_!OQ#U?X\:GIE[XAG\(>#X)Y/B_XJT[3O"VMOJ6E>
M+? YT7PEX3_L%+36CXU9=9U(?/O[&O[87QD^&6G_  ._9FTS]L;0OAYX;^/'
M_!03]OK0/C3^TA\0M'^%OB_5/@1I'PR\3>*]9^'O@V&T\50R>%O".L?M%:K9
M3-X?U3XDV<_AZPM=/ETWX?6,<:2PQ3'#Y@Z:K?6ENG#6H[QC"5?FLZ?-%0BU
M*G%0;;DE37-:)4L;D\*SPWU!JT9*M945)3G5IX7V;Y:SC4E4J<U.M*51)*G*
M55N#E(_H!^%W_!,G]G#X)Z\)_A-KGQL\ ?#<>.=1^)A^ 'AKXHWFG?!63QUK
M.CC1=;U>YT:+2_\ A+[G2=:B5=2U3P5-XU;P1?:^9M9N_#\]Q.Z5T_PN_P""
M?7P3^$'[,VL_LC^#O&O[0MO\'+VX@G\,Q/\ &OQ!IGC?X6QVFJ_V]8V/PK\>
M^%+3PSXA\*:?9ZZ7U9;>6XU5KRYDEBU274+&62T;\(_V0?\ @H/_ ,%*_P!O
M']HWQE^S;X!_:&^&7PUA\$_LT_'#XE?#;XO:%\ ?!>NZ7^T[JOPW^/'BOX2?
M"CXIZ7I?BR6^M?#/PY^*=O;:#?Z__8275C-!:7LGA&?2VO\ [1:?IM_P35_;
MB^./[=7Q5U_5]1BT[PG\*/@)^SS\)?A]\>/"!\+VMOK$W[?GB*ZU2\^,7A>/
M7+B'[98Z-\*]%T*UA?1M)D&GR7WBV(799K6U5<:]#'4HU)5,1&7L_9U*EIR<
MHM-JC)N4$W.3E)1:;E=M5&MCJPF*RO$3HPHX2I#V[K4:+=*$83C*,/K,(J-6
M2C2A&$'.+C&#M&5)2NF^V\7?\$E/V0?B9XZF^*/Q0\>_';XM_M!VUK\.[#P#
M\?/'_P <[#Q%\:/A'!\+-8F\1>$K?X4ZA8>']+T/08AJ\]S>>)+:^\*ZVGBU
M+B[@\0B^@N;D2=[\7/\ @F=^S#\:O@M:_!#XZ>*?C1\0=#?XL7GQ>?QGXO\
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M=^-[_P ,ZSJ&@7NCS>%-?BNYM*U/P5XA\/ZWH6HZ04M-0ANY(TN5_ 7]FO\
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M+7B*)[S0(O&DZPVV@^']3U/P]X;TS2+*[>)?JVOQ2^/OQ$\3^#OCI^TO-?\
MQ)U7X.3^)_VDOV+_ ()^-/C)IMYIFD:Y\%?V)?%?PLOM?B\8>%]>UVUOM*\&
M6'C+X^?\)QX#U;X@7%J;?P[K&K0ZI--;W6B:;=P]6'56KS4H590BHN5K-IJ4
MHTY+36UIMV5[NZ2YI'!BWAZ#CB)T(U)RFH<VB:Y(3JQDV]-)4HJ[MRV4G*T%
M;]#/C)^RSX/^,WQ6^#WQ:\2?%7XX^$M<^#>LSZGX"\+^ _B)H_AGP)>:YJ6D
MZOH>NS:UX9U#PIK,WB*Z\3^$=8UCPKK]J-2C2\\,W,]O;P6=PAOAX^/^"</[
M/0T_Q/X6G\8?'.;P_JOPZ^)?PP^&_A"7XP7::?\ L\>!/BR83\1;#]GFW334
MU+P3/J]M]GTF#6-5N?%5]X=\,F'POH<^FZ!*UC/\7::8OC)H?B.]O?C'XX^.
M<OP?_:*^(?P8_9(\<&31_%&N?';P=H</PO\ BEKWB9O&=CI:6L5Y\&?%'AC7
MO!7BC]I+PI:R:E??#VP\2^&X;C5/$>N0-==UX.^*OP^^('C']CWQ%\.]5\:Z
MQ\=K[]I_^T_&7B'Q&FAG5_B'\/OC)\!_%?BGXIZFVG^'/$/B'3O#WPWTSP=H
MG@%[;P1=W&F:Q\+[_P -?#W0O$&D6FMW<;ZOTJ%>$;*O)*$&K1@URI)SC>]G
MRMN2DVDXN4XV=YHX_:X2M+GEA8-U:D97G5<G.4W2I3Y8I23FO=<8Q?+4C"G-
M2C>FS](/@%\ =(_9Y\,R>#_#WQ)^,'CSP[%;Z78Z#I?Q4\4>'=?L_!FEZ1;-
M:VNC^#++PUX-\&:?H>ER1LK75J+.Y,\T44OF(P??[Q117G3E*<G*3O*6K>BO
MTZ61[%.G"E"-."Y815HJ[=E>^\FV]^K"BBBI+"BBB@#>\*_\C/X>_P"PQ8_^
MCA7VU7Q+X5_Y&?P]_P!ABQ_]'"OMJOLN&?\ =\3_ -?H_P#I"/S+CO\ WS ?
M]@U3_P!.A1117TQ\(%%%% !1110 4444 '3K7\D7B']KKXR_\$X[G5_VF?\
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M;#PG^T?>:C)XF7XFNVG:E<:AX>\<7]Y-/?QWWFV9OK2:ZACBFTZ:>%NBTO\
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M3XSU'Q59_'&U\4^-_AY\*_"GBGP1I4OA[X=>*=-^&6CZ-'XJ\:^.8M>\/_\
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M>D\)IKFJ>";F^E\#ZKXJ3PQ-)X?7Q?J7ARZ\4KH[?V<NL"U58@ ?C?\ %O\
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MPFWBCQ!-X3\.V_Q5\2:AX"M]#^#MWK/BB";P_8VOQ3O_  A/)JL9MGC0LC.
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M/#5[X[UK5;^RTFWT6"^TW1YM;U.TD\ZUT:,2Q?VE>11?:&QO#'_!0/\ 9?\
M&?AK7_$_A;Q)\1M:M_#UQX:AFT*T^ 'Q^7QQK,'C.#4KOPCJWA#X?S_#*'QM
MXUT#Q)9Z-JMYH_B'PGH&L:+=VNGW<ZWPCB8T ?,W[(O@7XZZ7^WC^TAXK_:<
M\,^!/#'Q&B^ WPB\&_#?4_V?/A_XO\.? #XF_"*#Q/XK\0WOBK5_$OB>\UJ^
MO?C3X5\>:IJO@[4_!NKZM;3>&?!,>@:[H%MJ6G>,M1N[/XV\&_M&_M0>)_#7
M['OPL;7OVL_#WQ2\ :U^VIX(_;#\8Q?!?XA>)'\%>(+'X2_'2#X,:IXB_M'P
M]'X;^*,L7B"R\*^-?AA9:!J.N:-XDBTO0U>^MKG5=(M+_P#4;Q+_ ,%,/V)/
M"OAOPWXHU+XV07ECXN\!:_\ %#0=-\-^!?B7XO\ %=UX"\'^(=0\*^./$ESX
M*\*^#=8\7:7:> /$.DZMI/Q @U71;*^\$7FEZA!XHM=+DM9576N?^"BW[&5O
MXUTWX?Q_&W2M2\0ZCXF^&_A&270_#7CC7_#>B:Y\8_#_ (9\3_"6+Q7XST7P
MS?>#_"%A\2]'\9>%I/ ^M>)]<TK1?$EYKECI>F:A<:FTEI& ?ASI'Q9_:D;X
M<^&=$T&]^-VJ_ WPS\:]"TS]J/\ :+E^(/[<=WH7Q'TQO@SXH?2=1\&1>*?!
MMM^UC\#?#5W\6K'PY;_'G0?A>=:\->%=<U32K'0/&.D>&KSQ-;:5]]2:W^U_
MI/\ P3/\6:WX:\9_$WQCXRE^)=E)H7BGPYX2\?']H'P_^R5??&'PY;>,[CP;
M9?%;0+/X@>._BKX3^#$OC2Z\ >*_%'AR'QAXHL[;P_K?]G7_ (N\D7WWA\2O
MVR_@IX)^$5I\4-%\8:-XB?QG#\7](^$&E.-9T^'XD_$+X.>$/B3XM\3>";2\
M.CSR:7<V=O\ "GQK'>7VH6L-M%'HEY):M=R-:0W7#>!?^"@'P5O_ (;?LY>+
M?BE>:M\.-?\ CW\+/@;X]N(H_!GQ(\1_#7P)KGQU\/Z#?^$_"GBSXR:?X+'P
M\\+W&KZ_K:>&_#4OC/7/#-QKUY]E$-G#+>P0L ?D%K7@+Q7\>?$O@OPY\/?$
M'[8OQ*_8V\(?M]_L3>(_@YX\^(NM_'W3_B18>(8/#_Q/?X_WVB>-/&L6D_&7
M4_@UX/OF^'U[9>+_ !Y(VG>&/B)<^);3PAKD>F6%NMI]:_\ !1;Q-\>_#?Q_
M^&6BR>(OB#X4_99D^ OB==(\0^ M>_:1T35=2_:57Q=86]C9^(_$/[,WASQ)
MX\NM<T_P#!%JGPUT#Q@J?#OQ5K\_B6+Q!9Z_?VNGZ8WUY^UO^VQ-^S;J7CO2
MO#W@.U\?7OPG_9+^-W[7/Q'AN_$$WAX:7X/^'%H=-\!^'M/G32=4CN-8^)?C
M.'6-/BGG$-MHFA>$O$>IRK>70L+*X\X^-7_!3GX9?#?0/A]JG@0^ ?C%J?BW
MX'?M!_&?7M \%?%;PSJVI>$XO@5\!=3^- T:]M]#&M7#Q>);O36\)1ZK-!:6
M^GW4T=T8[J1H[-P#\M_%&C_M&ZKXOT7Q+^USJ/[0'B;1_@E^V%_P3E\87OC#
MX=> _C-X4TM]/O/V7=;M/B3XQLO!O@'1Y?$MSIL?CZ_T>T^(=M:6>JP>$/$^
MI:O9W:Z):7%[;Q;/P0^$_P"UM\'/A3X#^)_P+U#]HB+XR^-OVK?^"F^B6_PB
M\;WOB[3_ (&V_A?Q+XE_:P\<?!VY\2?"F\TVR\+Z)I>H>/=(^'GB/PQ\3-<L
MX]:U:[\1+:-XFO?#_B.UTH?6/B/_ (*K?%GX9_LT0_M0^-O@G\%?BEX:O-?_
M &;=$M/AS^RK^T'-\:/BM'/\??&WA_PW<V-YH#> -"LT\0^&]*UFZU#2-#CO
MFF\7ZQI%QH-G-8O,EXGT=\3/^"G/PB\!OI7B7P]I5U\4OA;XI_95@_:0\!>+
M/ >HV]]J_C[6/$?QD^'/P3^'?PL\.Z%=Q6L*>(O&WC/XE:'H\<^JZGI_]@ZP
M9=/URTM&MKV2T /R!M?&7[<-]\"_$VH_"+XM_M#_ /"8/X(_9\\.?'/3XM&_
M:G\7_$C1/B]XL_:#^#GAOQ=XJ\-7'QO\$6OA7X<^.O#/A>^^*D/Q \!_":PU
M#X4R>$1INO'0+/1]"BU'5_T__;F_9_U[6KO_ ()E_#'PIK7QRU;1O"'[:6EW
M'B_XE:3K_B7Q+\2]#\*0_L\?M"VVI^)?%'Q(>VU+4] CUJ^U*U\,7OB^YFTV
M73V\0VUEH.H:1J<NCO!Z+XO_ &N/VKO@UX/U_P ?_'S]D?PWX/\ !'A>Y^'G
MB3Q#XJ\!?&ZS^)6G:/\ #[Q-XYT?PEXZT^]L/^$.\+:^_P 1/AMI6MP^,I8-
M/TC4/!/BC0M,UR.R\4:;?V5M;7WTU\=?VMO@'^S?/X:L?BQXSOM-UGQ?I^N:
MWH'AOPKX+\=?$KQ7>>&?"Z6,GBGQA+X5^&WAKQ9XAL/!7AA-3TT^(O&&H:;:
M^&]';4+**_U.&:[MXY #\"O&6K_M]^!)=7\"^ ];_:QUSP?\/=)_;*\#7GC6
M?2/$_C?XQ-\"?"?[?_PCT+3O$/@_QCXGT>\U+QY\;-,_9?N_'#?!C5;J[U;Q
M9XNTBR_MK0T\1ZO9P7TF9XSTG7_C-\??#GP<^$7Q1_;,\=?!'P+^V#_P3F\9
M^&M6^($OQ2U#X@?"WP]XC\#_ +5:_$GQ/X<\2?%'P^?BIH7AK49-/T?2M=\;
M^/X/M^C:K<20:-K=JEOHDMK^YFJ?M"?L;_M*:\/V7)/'7AWXLZO\1O GA;QX
M?!_ANV\6:M9W7P]\6Z%?^.? _CT^,O#%BNE^'-%UFP\.W&I>$?%R>)M):37+
M*TL]%U%?$+65LWDGP>^/7_!.[X$?$_Q'\#/A3XPM=)^)GC;XV3?"WX@7]U8?
M%_QK>W_QWT3PY:1Z7X!^)/QG\76'B*PL/%LOAFTM[?P'X=\6^.+6+4["-K3P
M5:W"S&&4 \(U+X>?%75/^";'_!2_X'^)M1^/?CFX\-M^V]\./@K=>,=:\=>(
MOC#XE^'<'@[5-1^&^D:3XRO1)X\^(=M<7FIS^'_#>L2WNMZIX@TA+?0CJ.J+
M'A_A_P 2>'?B[^SU\3?BUX/\":=^TKX9\*>-?@Y_P3 _X6!X_P#!^@?%;QE\
M5;/]E_X?7/Q:T/\ ::O?AQ\0$T3Q!=Q^.? DOB#PII.M:)I^H2?$[PSX*U?5
M=5^'_AXWFF:=+9?LUIW_  4E_8HU*;QKY?QQTNRTSP)X5\:>.=1\4ZUX6\=Z
M#X(\0^#?AO>1Z?\ $/Q3\./'&L^%['PE\5]!\"WLL4'BO4_AGK'BRUT3S$FO
M9(K9EF/JWP+_ &M/@#^TGJ_C;0/@YXZD\3ZU\/;;PKJ7B;3;[PIXS\(W:>'_
M !S:7][X*\7:+%XS\/>'V\4>"?%L&DZO_P ([XS\,_VOX8U:?2=4M;/59;K3
M[N&( _&BU\;_ +27AWX9_&;XP_!_Q!^V/\2?V4? 7Q>U;X??!W3]?@^(^K?M
M#?$+X/\ QD^"V@^"_%'C+PA;^.=*3XL^+=-^!_[45QX>\5_"?Q[XTL[KQ':^
M $^*ZM=ZWX4L]$NS]7_\$UY_VP_%]]>W?[56J?$_3]9^ ?@>Z^"7C:T\5I=Z
M=X;^,/[1_B'QG?>//BS\6?""M#96OB3X5^&?#9^'O@?X*:E9VIT?3=)N_&EA
M937%\M])!]->+OVYO@W\)_B;\5O!'QF\>^ O!]AX/\=_"_X;>"[?1[OQKXJ\
M>>(_''Q&^%&K_%6S\(ZUX/TOP2ZV/B?5M%T#6;WP1H_AK4_%4_BC3+-<_8-<
MN;;1)>M^'_[</[+'Q.T'7/$GA+XMZ5+IGA?X9^(/B_XI77=$\5>$-3\+> /"
M/B;Q1X,\8ZQXET7Q;H6B:QH5WX-\5^#/$GA_Q=H&IV-MXB\,ZGIRV^M:59&^
MTXW8!]7T5\M6_P"V?^SM-\0?"_PSG\8ZWI/B#QM%"OA+5/$7PX^)GAKP%XBU
M:;PC+X]'A/2OB=K_ (0TWX=77CF/P;;W?B&X\#)XH_X2RVL+&_,^CQSV%Y##
MY)J?_!0OX*ZO%\--1^&WB.RU'0O&OQ1\&^$9=9^(GA'XS?#BP\5>#/&'AKQ[
MXATWQ9\#+W5/A9/8?&>?5XO M_)X8;PQ=GPIKEC;:C<)XK@GCTVUU, _0"BO
MF?6?VQ_V9/#_ (8\->,M5^,/A>W\->,?A+;?'/POJD:ZI=IKGPKU#4?"NBZ1
MXJT^WL].N+N9-?UWQOX3\/\ AK1Q;CQ!XE\0Z[9:#H.DZCJQELX]GP3^U!\%
M/'O@KXC>/='\57^E:-\'XM6F^*^F^-O!_C3X>>,_AO%HNA-XHO9/&OP^\=>'
MO#WCKP\C^&U_MW3WU'P]"FL:45O=):]A(:@#W^BOSHN/^"L?[ MM8ZSJ3?'*
MXGM-$\+:=\0)FL?A5\9M1FU3X8ZC'/*?BWX8M+'X>W%YXO\ A%I26EY_PD?Q
M2\+P:OX#\,-:3Q^(-?TV0(K^WW?[:O[--GX_L?APWQ&:ZUF]UKP?X8?7],\)
M>-M7^&ND^+?B%I&F:_X"\'>(_BWI?AR[^%_AGQ?XTT76]%U+POX8\0>+M-UO
M6K76M&:QLIFU?35N@#ZHHK\P_C]_P50_9Y^&OPD_:(\:_"_6/^%H^-/@3\/_
M (C>-[31-0\/?$3P7\.O'S?"F]CT[Q]I_A#XSZGX&E^'GBQ?!U\TEKXIF\$Z
MSXHET6:&5;FWQ#,8_:O"_P#P4!_9@\8Z#XUUGPWXN\7:_>?#S5?"6B^*/"N@
M_!SXT:MXY>]\=Z;=:MX-O?"O@*T^'S^-/'7ACQ7I^G:I>>&_&'@W0=<\+:S;
M:5J<MEJ\HL+L0@'VE17PKXD_X*6?L4>%O#/ACQ7J7QIBN[#QCX(\2?$?P_IG
MAWP)\3/%GBR[\%^"O$-QX4\>:W<>"?"_@W5_%^EQ_#[Q#9WVE>/[/5=$L=1\
M$W=A?1^)K/2S:3[*LG_!0/X&:#K'Q(G\6^/?!MYX/T?Q)\(/#WPM'PMB^(?Q
M9^(_Q#N?B[\(;#XOZ';1?#CP;X!U'6KW4M2\,7%SXFT*U\#'QK!/X'M_^$EU
MJZT/9=6=L ?>E%?'.J?M\_LKZ-H/@;Q9J'Q UN'P;X_T_3]5TWQLOPM^+,W@
MOPYINJ^);CP9I]Y\3?%<7@=]!^$<-QXMM+KPXQ^*%_X1-MJ]K<6MX+=H)2N=
M\'OVS/#/B_X-_M _&_XK6%A\*_!/[/WQX_:'^$WB;5DO=4\36<7AGX$?$35O
M!$OCG4!8Z)'?VB:G:Z8-:U.PMK&^AT2)Y@;^[MK9[N@#[7HKYR^(7[6G[/GP
MOU#5M&\6?$.V'B#2+3P!<OX8\.:'XF\:^*-5N/BK=>(;3X<:'X8\.>#=%UW6
M?%OBGQFWA3Q#=:'X4\,V6K>([C2M*N=;?3(M&"7[^6>(O^"CG['/A71?#VKZ
MS\6+I+SQ5IWCW4M$\%V'PY^*>L_%&Y'PLU"VTSXF:;/\*-&\%7_Q'T_Q!X O
M;N"/Q=X;U'PO::]H<3BZOM.BM/W] 'W!17Y<^*O^"H/PJ;7_ (P>'_ARVAZM
MI_PZ^"W[-GQT\-?%7QI)X]\._!7QMX-_:*\81Z!H\\'CS1_A[XCM;79I=WI%
MUH#6D>IOXCUK6H=&6"P&D^(+O3.V^'/_  4.^'NH_"SQ?\3?B[X?\2^!+7PY
M^T!^T_\ !NVL/ W@OXG?&>>3P]^S9\4O%'@#5_B'KL/PZ\!ZUJ'AG0Y-)\/P
M>)/$5[JUC!HGAM;U[636KN. 74@!^B%%?F-XP_X*8?#BT\:?'3P)X+M]'NY?
MA#X0_9:\=Z-\2/&,OCG1_@SX[\-_M,>*=)T?2KC2_B%X>\ >)]*,JZ7K>D2^
M$CITFKP>,-<U:VTJ*73K;3M>U#2O=E_;Y_9-;XC:[\+3\6((_$WA[4/'&AW=
M_-X2\=0^!K_Q3\,]#U3Q)\1/!/ASXF2^&%^'7BSQ[X(T+0];U+Q/X&\,>*-6
M\5Z1!HNLI=Z1'/I.HQ6H!]AT5\H_ ?\ ;>_9?_:9\32^$O@C\3XO&VL'P#I'
MQ3TEE\*^-] TCQ;\-];NXM.L_''@/Q!XG\-Z+H/C[PU#JD\&DZIJO@[4=;MM
M%U2XM=/U=[*ZNK:*7XB^)/\ P5Q\,?"#XA?#,>/?A3J]O^S_ /%/]H[X^_ V
MQ^-.E:G/>_\ "#^$OV>M#T+2O&/QV\>>'AI)2R^%J?%VYU_PAJ&M6FJ/'X;\
M'Z=;_$#6&2P^WV-H ?L717YX>,OV\5\*_'2V^#<'PZ35;>[_ &K?@9^S3;^)
MXO$Z)%-;?&C]GOQ=\=HO&\5FNERK+#HZ>%TT"+2TNV74X[]=434($B%M)\B^
M%/\ @MY\-/$O_!,V;]O9_@]XKL_B9#J[_#P?LH+J\$_CVZ^,$\1UG2?"]EKK
MZ9;VMQX7U+X=M%\9%\<?V8FE0_"R+4/$&R273YK4@'[DT5^<5_\ \%!++PY\
M$?VI/B#XK^',MI\2OV;?&>F>"+3X3Z5XA74;[XF:G\3]*\':O^SA<>&]3?2K
M>6"R^- ^(/A71[:5M,O#H>O1>)K"07[>'[DOZ'X1_:^>V^%O[5'B_P"+_@EO
M"_C7]CW5_&EI\5O!W@F\U+QJFHZ1H7P_TKXM>%=<\(3?V-IVJZE;^,?A]XBT
M2[M;>?28;BVU8ZC:NCVUM'<R@'VU17Y9?"+_ (*D?!JX^"OPL^)'[2FNZ'\)
M_%WQ3\!VGQB_X0GP?X4^.'C6/X9?"+6VMUTCQE\7]1N_A1HEY\._#=G=276D
MZG\1?%^E^'_AEJEYIFH:AX7\4:OHMM/?0?9O@O\ :E^ OQ%^+?B_X&> _B#9
M>+OB?X M8;SQQX>T'2?$.H6WA*"\TW1]8TPZ_P"(X-(;POITFM:3K^E:EH,$
M^M+/KMC<O=:3'>0VUT\ !] 45XQ\,?VA?@Y\8=?\;^#_  #XXTS5/''PTU67
M1_B#X OX;[P]X_\ !EVMQ+;V\_B'P3XAM=+\3Z=I.JM#)+H.OS:6-"\0VH%Y
MH>HZA;$2U[/0 4444 %>4Z\0OB&=F("K-:EB>@ BA))]@.:]6KRGQ'"S:S>,
M)+=03#Q)=VL3?ZB(<I),KCIQE1D<C@UQ8^_L8VU?M(_@I,]?)6EBJEVDGAYJ
M[=MZE+J^NY_/!9> _P!HCQ+^S/\ M4?L)6_[)GQPL_&OQQ_;)_:0\4^'_C+X
MXT'P_H'[/'@OX=?$S]I*?XE>&OCA%X_;Q/=:CJ6I>%/#:P^*_"WAW0/#\OBN
M\\6P:986\-DWGWUL_P"'G[$_Q(\<?$_2?&7Q\^"OC'Q5?:+\.O\ @K#X>TWQ
M/XWU2YO=0MY?B?\ M/>$_$'[.>F"XB\222I%XQ^'C>(=3\&V'SV5KHGGVUVM
M@T%I;I_0#]G;_GK:?^!UE_\ )%'V=O\ GK:?^!UE_P#)%>8ZT]+0MU?Q-M\O
M*_D[+2VEMSVXX6DHM2JJ5[K[*]WG4XZ7=Y1LUS:;W25C^9S4OV,/CCX$\"?L
MR^"KWX0^/+KX2:3^P/\ !GP7X;^&W@3X9ZU\5=:^#W[9$.CL_P 8/$&JV6E_
M&/P&GPT^(VLSR>&(O"OQEN;S4?#OA:?PSK6F1ZCX?@>9]:]"\4_L>?MCW/@S
M]L'Q6]Y\7/%?QAE^-/[+FD:!XDUS7[R?5_BM^RYH'P6_9TM_VG]"^%?@K0?B
M#I'A"Q\1_$/Q-X5\7V/BV+1]9T'4_&VM:5KVB:5XDBM=<M[NZ_HA\AQTEM.>
M#_IUER/3_CXH^SM_SUM/_ ZR_P#DBG[>?\BZWNG9W:?;3;77?70/JU*W+[5V
M]VS4DFN6/+9OF::VV2:2Y;O<_GR^'_[('Q2\9_$W]FO3=5\&_&G3_P!D;4?V
MEOBMXB^(/PBNO".L?L[>!?"O@&;]ES5O#D4M_P##6V^*WBCQGHOPL^(OQ6;1
M_.\ ZY>V&FWGC/3+O7;/PU;:+K]Q<7F#X<_9M^('A!?!&A?M2_LP?M/_ +17
MP*\'_#7XG?#_ /9R^&OPM\0^(-;\5?!OXA6'[1WQ0U#P[JGB)[3XD>&M0T.X
M\5_!NZ^%]G\)OC-KNO7=I\/= \/RZ/=:EX>EE:2Y_HK,#GDRVA/J;ZR_^2*/
M(<=);0=O^/ZRZ>G_ !\4>VG?X-+6V:?77F25GKJTM;>8OJM.SM6U=K-N+BK.
M#MRM[/E>C?VO+7^?CP?^SM^U5<?M0WVL^.M,^+6B?$Y_VJ++XA>"_CAI/PZ;
MQCI/AW]E^WETF\T+X7ZI\>+WXTP>$8/"%GX(T^\^&'Q&^%+^#]5U?5_%5_?>
M--*L_$6K7=AXE7^@)R"S%1A2S%0.0 2<#) / XY ^E2^0^,>;:8ZX^W66,^O
M_'Q1]G;_ )ZVG_@=9?\ R164Y2FU>-K)+1=DEVVTVUMKJ=%*,*2E^\4G*3DV
MY+KWULWW>[T[$%%3_9V_YZVG_@=9?_)%'V=O^>MI_P"!UE_\D5%GV?W,UYX?
MS1_\"7^9!14_V=O^>MI_X'67_P D4?9V_P">MI_X'67_ ,D46?9_<PYX?S1_
M\"7^9!14_P!G;_GK:?\ @=9?_)%'V=O^>MI_X'67_P D46?9_<PYX?S1_P#
ME_F05?O?]5I__7DO_H^>J_V=O^>MI_X'67_R15Z\@8Q6'[RV&+,#YKRT4']_
M/]TM, PYQN7(SD9R"!23M/1_"NC_ )HD2G#GI^]'>7VE_*_,RJ*G^SM_SUM/
M_ ZR_P#DBC[.W_/6T_\  ZR_^2*FS[/[F7SP_FC_ .!+_,@HJ?[.W_/6T_\
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M#_6O OA6._NOB5\1O&OC3QM_PCS:]JFL*^HZ_I$:#4;G1],M=/L8X9!^CU%
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M7B[P3I?_  D5CXBTB]GM(/U#HH _(+]FS_@F%XC^!'B36=?U+XQ>&_$*W_P
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M#VHV.K7VE:M(E[I6NO9J]D^_J'_!,KXJ:MX;TG]GV]^.O@E?V3OAS\4?B_\
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M@S\+=%M],FN[>XU2;PCX!\.Z!/KMQ]HL6UG7Y=6:![>U>UD7[3HH _(C7_\
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MX$\:>&/& TW[1G[/_:!\/:GJ/V,3X/DM<^6)<'RRU=T(U) " DD  *"23P
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M+;UA5K7_ (];_K[4_P#2Y'/A&_JF$U?^ZX?_ -,TQNQ/[J_]\C_"C8G]U?\
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MXXT^QM;C3[OP)I%VVH:8=2EOI=&M=;M;.Y@_>LG )P6P"<#&3@9P,D#)Z#)
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M]OXYT[_@IQ\9_B/\'?VN_B_X8_:O^%W[)?[3/[2?Q1U7XT?LNWVG?M$CQ/\
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M_P#&*/[#UO\ Z VK?^"V]_\ C%>Y?:+C_GO-_P!_7_\ BJ/M%Q_SWF_[^O\
M_%4?V51_Y_5?_ 8_Y^O]+4_U@Q/_ $#T/_ ZGEY>OX>9X;_8>M_] ;5O_!;>
M_P#QBC^P];_Z VK?^"V]_P#C%>Y?:+C_ )[S?]_7_P#BJ/M%Q_SWF_[^O_\
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M?_XJL_[*H_\ /ZK_ . Q_P _7^EKK_K!B?\ H'H?^!U/+R]?P\SPW^P];_Z
MVK?^"V]_^,4?V'K?_0&U;_P6WO\ \8KW+[1<?\]YO^_K_P#Q5'VBX_Y[S?\
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MEX3\#7&LZ+J$>EM=ZA<>,+C2Q9ZY/X0M=/U"U>3]93G!VD X."1D XX)&1D
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MH>$]:LAX4^%MS;Q>$-'T.3X:^ DD\+P0W%]=KK-_]FTRU@ /W"_:&_X+5_\
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M;\./&D6J2>%?&>MZG;W$EI:Z!KAT36;:QOO->-[_ $K4=-;9J%E<6T>/H_\
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M%Z[8>'?&HM?BCXN\.77ANXTCPAJUZ;#Q)X@\/V/B:ST6]CCM=2AM))U*>/\
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M"^)_A;\9?A#XC\0>(+M/#?PB^)IT6/PS)"UP?%^H2:A.T'3_ +-'_!,SQ?\
M!#Q]\+=$\3ZYX7\;_!CX!?%/XC?%CX6^)-2^*GQ[U;XCWNN>,K_QIJ.A_P!I
M?#*\U:Q^$OA+7M#?Q[K-CXC\5Z9J'BBV\;V,+-+X1T*ZU>XEL #]"/'W[7_[
M,GPM^*?A[X*?$'XT^!_"GQ0\3MHR:7X2U749([J&3Q)=/8>&(=<OHH)=)\+3
M^*;Y'L?"T'B?4-(F\37@^RZ$FH7!$9\9_9^_;S\$_'K7?VK[^WTS1?"/P@_9
M6\9^+_!&N_$76/%6L'7-4O/AO_:$7Q"\0:QX)NO >E6/A3PCH]WI&L1Z/J</
MC;Q-J>L6NEW5]J&B>'HGLEN_G3X_?L ?';XA:_\ M>^ O 'C?X.VOP$_;T\3
M^ _$_P :_$GCS2_%6H?'#X52>&_!/@;X<^)--^$\.GVEQX9\6V^H^&?A[H^I
M?#NX\4:_X4_X5+XQU/5]?TZT\2*+:S'W-^SS\ [SX2>$_C)X2\7ZCHWB[3OB
MA\=_CC\3HK>.VNI[<>$OBOXHO=8LO#NO)J@<ZCJ5OI=T;+79\/:7]PT[Q[XY
M#D Z;QC^TW\ _ .G1:IXJ^*7A;3K2Y\!6/Q0LA!<SZM>:EX!U75=,T+2/$^D
MZ;HUOJ&I:O8:SK.LZ;IFBKIEI=7.L7MTMOIEO=2)*L?F7B']N/\ 8X3P!X6\
M6ZW\;/!EYX'^*,?B;2M$D@@US5YM2MO#]XOA_P ;IK>@Z9I-YKOAJP\*:C=1
MZ+XUO/%&FZ-9^%-0N8M/\1SZ9=S1PM\(^$/^";O[2'PW^%?C+P]X;^/7AK7O
M&5K\1?A1X,^&\4M[XY^'5AJ'["7P(O?$;_#/]F'Q;\1?"JZO\0/"&M2)XTU[
M4_%/Q \!6\MQJ&H:?HFG1V9TQ[N1/.8?^"9/[57A/0/$3?#?Q?\  WPQ\4-9
M^*OQY^(7@7XS:)\3OVCO"OQ*^!,7QT?P!JM[I^E^(TA\4I\=_#.DZYX12;Q%
M\-_BWIEMH/Q%DT70-8U'7/#US=7NGV0!^G/@C]HO]C/X8^._"7[&'@'XE_#'
MPEXQ\(:5I'@GP=\']#NC:V6@0Z9H,5YH?@#3;J* ^';/Q);^&8H=0T[P*=67
MQ2VA)'J,&C/8;9Z9X;_;_P#V+_%]_KFG>&_VD?A?JT_AWP#X@^*&IW%OKH72
MQX#\(VLM[XP\1:?K4T,6CZU;>#K2":X\7VVBWVH:AX5BC=]?M-. KXJLO^">
M?Q^MKYO@[J'Q'^$6K?LT7G[9>E_MMZW\17T3Q+8_M-7WC.P\?Z;\9+[P';:?
M:VG_  @UE%J?Q+TN/3T^*,/BE==TWX67$W@>V\'/+%;ZNGQ-\$/^"?G[7/[3
M?_!/W]G+X)?$>X^$/P7\&?#OX9_M':IX0_M#PKX\TSXY2?$?XK^!OCA\*/"/
MA7XB>'M1TRVTSP;X%T*U^*E_K?CV^T#6=;UOXG6VFZ-"-"\,13W1F /VRU;]
MO?\ 8[T3PYX?\77OQ^\#2>&?%-_XALM UK2Y=4URQU*#PEJ$>E>*/$,4NB:;
MJ'E>"?#VHS0VFL?$"X$/@?3YIH1=>(8Q+&6ZZ;]KS]FF#XD2_":3XQ^#O^$X
MMM'NM=O+-+JZET/3]/LO"0\?W7]I^-(K1_!6F7\'@1D\:OI%_P"(;;5QX2E@
M\1BQ.CSPWC_ 7Q=_X)R_$K4?'O@'XD?"OQ+X/O-2M_V0_!/[(WCOPAXF^(_Q
MF^%'@_3]%\"ZAJ^K:7XO\)CX0B6Z\0Z=?W7BC7K/Q-\,_$-MHFD^(+*TT":#
MQ1H=W;WK7.3HG_!.?XR^ /'T6E?"'4/@;\-?@;/X5F\,_$;P_I_B#XW:YX=_
M:*\.VOP-7X1:/X)^-/[._B?4=9\ M*OV+P];7_Q=\,_$JT^(,W@OPUI?AI[.
MZVF=0#[EB_;U_9!E^'?B'XKGXY^%;?P'X8U_1_"VI:S?6GB'3I[GQ!XCB-SX
M;TKP]H=_HMMXA\6W/B6T26_\-?\ "*:5K4?B#3H+K4=&>]LK6XN(MS3OVU?V
M4-7E^%=MI/Q\^&^IWOQPMTNOA+IMAKT-YJWCZ'_A(CX1N_\ A'])MTDU*ZDT
M?Q0LF@>(X&M8Y_#.JP7-EXACTR>UN4B_-CP1_P $]_VO?!NH?#'XC:?\0O@_
M'KW[./Q-L/%O[._[./BCXA_&CXL_ GPKX7U+X1^*?@_X^\.P?%+QWX9_X6UX
M434=)\26NM?#>SA\/>,[#X57>@G2--.MZ7XDU;R?7?V4_P#@GK\1?@M^U+:_
MM3_$?QI\-/$'BCQ1\._VEX_B#X?\%Z!K=CHN@?$[]HSX\^ OBU=P?"XZUYUS
M8^ ]!T+P5'H.IWVIR6WB/QEXCGN_%FI6=E+J]Y86P!]M?$[]K_\ 9D^#'Q#\
M-?"GXI?&KP/X)^(/BQ=,ETGPWK6HR17$%OK>H-I.A7GB"\A@FTSPC8:_JR/I
M>@7_ (LO=%LM<U*.6PTF>\NXI(5ZKP1^T1\#_B3\0?&WPI\ ?$_PEXP^(GPV
MEO[?X@>$O#VI)J>J^"[O3-7?0;ZP\31VRO%HVI0:K&]K_9M_+!?RA&N(;>2U
M4SC\\/VC?V#OCS\0?&'[96C?"OQG\%H/A'_P4&\*>"?"GQQU;XI:/XIU;XF?
M"*+PU\/[;X2ZO??"*PTNTNO#WC2*_P# UO\ VIX0T7Q9K7@ZT^'OQ(GOO%]E
M=ZW%?W6DO]7?L<?LQ:I^S'8?M%66JZWH>OO\9_VJ/BU\>M*O=*MKV/4+;PYX
M\C\.6N@Z1XJOM007&L>*=,L=!$6JZH'EM[EGC-N^U2  <+X<_P""E7[*%OX#
M\ ^)?B_\:_@S\+?%/C;2_#FK3>$K'XH:;\0K'1K#QAK]]X>\+ZS+XLT+2K*S
MD\(ZM?V:VP\:W^G:/X8LM0F&G7^HV\ZH9?:[_P#;&_9@TSXS-^SW??&OP1;_
M !D23[(_@<WT[WR:NVE-KL?AA[^*V?14\9SZ(IUBU\$MJ8\6W>EE=0MM%EM'
M25ORK^#G_!(WXG?#;]G?]IGX0:K\2/A5J_BCXX_L/_"_]E30?$EMX=U[[#HF
MO> [SXY7M_K>L?:X3J-QX4OY_BII$UKIEDWVM9](OYIX_,>T8>QR?\$^OCJN
MNZK\(K?QS\(3^RUKO[;>D_MQZAXSNK'Q;-^TY;>*-.^*VC_'2;X9V#K9IX2,
M$OQ#T*RT&S^+DGBA/$NG?"AYO!$?@Z9X[;5(0#V'PC^WM^PY^U3\!-'?X@^+
MO!UEX(_:$U?XH_!JT^%WQ)$\>H?$A_#'C5/A?XJ\,Z=X>N;&WO?%5OJCZ[X>
MFNK/2;.[-OIGBJQ2_$+1WOV?LO$?[3?_  3Y^,GA[XP?LX^)_BW\(/%GA'P3
MX&\2P?%GP+J.KRVWA>/X?>!5CM/'$7]J,++1O$GA_P %BV33_'2>&M6U>W\,
ME6TWQ.+%G>W;YZ^!7[ _QP\'?&#]G;Q?\4?%GP;U+P=^S'<?MW:/X(?P5:>+
MQXS\0>&/VNO&O@WQKX?UC46UVQBTSPMXM\)RZ+K6CZS%H=W?V%S:7%C<:??Y
MFNK2#XK_ &C_ /@G#^TMHG[$VI?!_6-7^&'C+X:?L7?LV?M3:9^S@GPC\+^,
M+_\ : ^.'B/QY\&?'OPR\&Z=\1M!O;"/0-#EA\-^,-0N?&NC^$=5\92_%OQ]
M!I&O73^'4BDT^4 _5Y/VZOV9?^$ UR3]G_QY\(_'P^%WB?X-?#[4O!\7CG3_
M (9Z-X=T/XE>.O#?PW\*:CI5_J^B2V5WX>E353#X#FT#3[SP[XWU?3K?PAX>
MUJ*]NA-:^O\ @O\ :_\ V9?B)\7O$'P&\$_&CP5XD^+?AF;7;75?!NG7TS7;
M7WA6:.V\6:;I.H2VT6C>(=6\)7$BV_BS2?#^I:IJ7AB=9(==M=/DAE5/RU\:
M_P#!//\ :?\ VG=,\!>+OBOXP^!G@#5OA[\*?V;/AM\.M'\!:1XY1O$'AKP1
M^T3\"/V@_B-KWQ0;6-.TZ]\.^(38_!BQ\+?#;P%H?_"1:-X+UG7/$NK7OBJ^
M756M;3[(_9(_9W_:9_9Q/@_X,:KK?[/OB#]FWX5W/Q*?P;XP@TGQQ=?M">+-
M.\9>(M4\0^';+Q):W*:9X(\(ZWHLNN7L/C3QAINK>,Y_B1);0WSZ%X4O+^^E
M ![OKW[9?[+_ (8\<>,OAUX@^,WA/2?%?P]T3Q)X@\;6UVVIII'AK3_!WAX>
M+/%D.J>*1I[>%8-9\->&&7Q!KOAS^VF\1:5I#IJ%[I<-LRR'JO'O[3'[/_PM
MNKJS^(WQ?\!>";FR\,^$_&EZGB7Q!9:2MGX3\=>,8?A]X/\ $-U+=R1Q6^D^
M(_&]Q!X7TJ\F=(KG698[-6\Q@*_-;XP?\$\_V@/BG\2_VA[3PSX]^&GP,^"O
M[0OA[X_:1\2XOA]XD^*NO3?%^Y^+?PAU?X;>%=9^(/P'\7PW7PM\,_$#P=JL
M_A?Q'KWQ7^'WB^PUOQM;^#H=(N/#^E6^NW;V/RW^V'^QU^VYX@\/GXW>/[CX
M*>)/B3?>%OV$?V>M'\!?!3PG\1O'6@:%=?"C]NOX6_%F]^*&N?\ "06F@ZSK
MWA&ZTV7Q'K7B[14L-(_X0S1M+MK:WU3788-1UZ4 _7NS_P""@/[&5]X'7XBP
M?M#_  ^7PHWBO6? BW-U>7]AJ[>.-!\.ZAXNU#P:OA6^L+?Q6?%3^%M+OO$6
ME^'AHAU?7=&A74=#L]1M9[>66WK_ .WG^Q[X9^%_@;XS:Q^T!X!A^''Q+N]3
ML? NOVEY>ZK-XCO-"\S_ (26VLM TFQOO$B3>$&BDC\:I=:/;GP7*C1>*O[(
ME^2OR?\ C=^RO^V5!^V/^SA^U%>Z5\%]6^,WCC]IW1 WA/P-I7Q#USX#^ /A
MO\'OV3?VD/#WA[5_BAX]N/#6G^+U\7^//$7CZXT'_A8C^#%M/!4<W@[PUI6C
M>)Q:/)?>T> /V OVL?@[\5;S]K?P/XN_9O\ %'[2WQ(U#]H4?%7X:^,8?B+I
M/[/'AK2/CGXC^'/B'3I?A)J^BZ-J/C2V\0^%9OA9X?7QOJ^K^&=/E^-#:OKL
M^J'P7<P:3/; 'V3\=/\ @HU^R3\"_ OC[Q;J/Q@\%^+];\$_![5/C;:^ _!N
MNV_B#Q/XK\%V_@/7/B'H&IZ)#H\>I1#1_&&A:!>GP]XFN3'X<NIC&K:DI.*^
MK_AG\0O#7Q9^'W@[XE^#KMK[POXX\/:9XDT2Z>WN[5Y;#4[9+B+?;WUO:7<;
MH6:-A-;0L60L%VE2?R'^!7_!)_Q)\%/@[^V+\)X?BCX4UZ;]I3]D#P/^SIX=
M\7/X9OK&]\->*-+\)?'.R\7:Q=:6L]PFF?#V;Q5\8(KKP=X*T74[@:#X<T:/
M2Y9YKB&WG;]6O@;I'Q*\/_"/P!H'Q?7P,OQ%T+PW8:+XE/PUNM?O?!,EQI4?
MV"UFT*X\466G:\\$^GV]I/.NH6<4D-Y)<0QM-#''-( >K4444 %%%% !7E>N
M(LGB.6-QE'N+1&&2,JT<"L,C!&02,CFO5*\H\0N\>O7,J#YHY+>1<C(W)#"P
MR.XR.1WKAQ]E1C?_ )^Q^>DOT/7R9-XFJEHWAII/L_:4K'\:&G_\%3?VO!<_
M&WQOX=_:_@^(_P"T1\-?^"MFH?L@?"S_ ()T1_#?X7BW^,_[.L_Q%A\/S/%_
M97A9/BM%K6D^&+KQ!K,?Q=L_$*>%_#1\"MIWB*SN[N]E\_\ 87]M/]KC]K[]
MFKP]\.?VG/'7PMTWX&?LV? []H+P/8_M2:7I7Q \*_'.Z^(_[./Q$N=7\#ZW
MXN@AT3P9I.O^!KSX4^)KCP3XODN=.NY&U'1]4UJUNEE73PDGWU^SM^R=\&/V
M7+'Q[9?"C0+R!_B/\7_B?\;_ !#JGB2ZC\1:[!XW^,&MIXB\<)HVMWEJ-1TK
MP[>ZJBSV>@VTXL[)0(XPR@$?1SQ)*CQ2PQS12+MDBGB2:&1<@[9(I5>.1<@'
M:ZL,@'&0*\Z56ES1Y:47&/5VNUII:UM-4KI[]6KGMPPU=1GSXF:E):).347W
MYFU/5VYE%Q3MHDFT?QO?'#_@JC^VY\.OV?\ Q5X]UWX^^,?A9^TIX4_9AM/V
MWM$^'GB[1OV>_ /PDU7P9\;/BOKVJ? GX-^'/"_BCP!XD^*/[1&N^'_A1::%
MX=^(.G^"-:\$3>%KJZN=6U/Q3<:TEQ!:>8_\$S?^"@.H? _XZ>$])UKXL_#W
MX3?!W]HS_@J9_P %$_B#^V'#KR^'].T31].\2_L]_#?XB?!"_P!:\0ZXAO?
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M1VT#PC8:AK%Q!96XT_PUHTDMAID5O80S,D\\^H7%]=RO<$ ^DJ*** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
>HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>img247211528_23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_23.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %( V<# 2(  A$! Q$!_\0
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M  %?_)'^LW_PT?\ L\?]%Y^#'_AT? __ ,O*/^&C_P!GC_HO/P8_\.CX'_\
MEY7^3/\ V5I?_0-L/_ .W_\ C=']E:7_ - VP_\  .W_ /C='_$L66_]%ACO
M_#+A_P#YY!]17_/Q_P#@*_\ DC_68_X:/_9X_P"B\_!C_P .CX'_ /EY1_PT
M?^SQ_P!%Y^#'_AT? _\ \O*_R9%T_1W:1$L=-=XF"RJMM:LT;$9"R*$)1B.0
M& )'(%(EAHTGF;++3'\IBLNRWM&\IE&663"'8RCDAL$#DBG_ ,2PY=_T5^/Z
M?\R6AUV_YF76ZMW#ZBO^?C_\!7_R1_K.?\-'_L\?]%Y^#'_AT? __P O*/\
MAH_]GC_HO/P8_P##H^!__EY7^3)'IVCS(LD5CILL;9*R1VUJZ, 2"594*G!!
M!P3R".HI_P#96E_] VP_\ [?_P"-TO\ B6++5OQACO\ PRX?_P">0?45_P _
M'_X"O_DC_68_X:/_ &>/^B\_!C_PZ/@?_P"7E'_#1_[/'_1>?@Q_X='P/_\
M+RO\F?\ LK2_^@;8?^ =O_\ &Z9)I^CPH9);'38HUQN>2VM409.!EF0*,D@#
M)Y/%'_$L66O;C#'?^&7#_P#SR#ZBO^?C_P# 5_\ )'^LW_PT?^SQ_P!%Y^#'
M_AT? _\ \O*/^&C_ -GC_HO/P8_\.CX'_P#EY7^3>_A^WCMK>]ET%(K&[:1+
M2^ETCRK&\>';Y\=G>26RVUW)!O3STMY9'@WKYH3<N1/#T$MM-?1: LMC;210
MW5_%I!EL;6:?)@ANKU+9K6VFG"L8(IY8Y)@K&)7P<+_B6/+-_P#7'&VO:_\
M8V'WO:W_ ",M[Z6[Z;A]17_/Q_\ @*_^2/\ 60_X:/\ V>/^B\_!C_PZ/@?_
M .7E'_#1_P"SQ_T7GX,?^'1\#_\ R\K_ "9_[*TO_H&V'_@';_\ QNC^RM+_
M .@;8?\ @';_ /QNG_Q+%EO_ $6&._\ #+A__GD'U%?\_'_X"O\ Y(_UF/\
MAH_]GC_HO/P8_P##H^!__EY1_P -'_L\?]%Y^#'_ (='P/\ _+RO\EQH?#J2
M&)XM%256V-&T=BLBOG&PH0&#9XVD9SVJW_96E_\ 0-L/_ .W_P#C=-_1ARY6
MOQ?CU?:^2T%?T_X4@^HK_GX__ 5_\D?ZS'_#1_[/'_1>?@Q_X='P/_\ +RC_
M (:/_9X_Z+S\&/\ PZ/@?_Y>5_DS_P!E:7_T#;#_ , [?_XW1_96E_\ 0-L/
M_ .W_P#C=+_B6++?^BPQW_AEP_\ \\@^HK_GX_\ P%?_ "1_K,?\-'_L\?\
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M &>/^B\_!C_PZ/@?_P"7E?Y,_P#96E_] VP_\ [?_P"-T?V5I?\ T#;#_P
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M^)\T;+=\RLM4'U&/_/U_^ K_ .2/]8O_ (:/_9X_Z+S\&/\ PZ/@?_Y>4?\
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MW5_\2Q9;_P!%ACO_  RX?_YY!]17_/Q_^ K_ .2/]9C_ (:/_9X_Z+S\&/\
MPZ/@?_Y>4?\ #1_[/'_1>?@Q_P"'1\#_ /R\K_)G_LK2_P#H&V'_ (!V_P#\
M;H_LK2_^@;8?^ =O_P#&Z/\ B6++?^BPQW_AEP__ ,\@^HK_ )^/_P !7_R1
M_K,?\-'_ +/'_1>?@Q_X='P/_P#+RC_AH_\ 9X_Z+S\&/_#H^!__ )>5_DS_
M -E:7_T#;#_P#M__ (W1_96E_P#0-L/_  #M_P#XW1_Q+%EO_188[_PRX?\
M^>0?45_S\?\ X"O_ )(_UF/^&C_V>/\ HO/P8_\ #H^!_P#Y>4?\-'_L\?\
M1>?@Q_X='P/_ /+RO\F?^RM+_P"@;8?^ =O_ /&Z/[*TO_H&V'_@';__ !NC
M_B6++?\ HL,=_P"&7#__ #R#ZBO^?C_\!7_R1_K?^%/BU\*_'FH3:1X'^)GP
M^\9ZK;6;ZA<:9X4\9^'/$6H06$<T-O)?366D:E>7,5FD]Q;P/<O$L*S3PQ,X
M>5%;T"OX/?\ @V L;*V_;U^+LEO9VL$A_95\5(7AMXHG*'XI_"DE2R(K%20#
MM)QD XR*_O"K^??$?@ZCP)Q-5R"ACZF94Z>#P>*6*JX>.%FWBH2FX>RA6KQ2
MA:RE[1N6[2..M2]E-POS:)WM;?YL****^#,CF?%?C3P=X$TV/6?''BSPSX-T
MB:\BT^'5?%>O:7X>TV6_GCFF@L8[[5[JSM7O)HK>XEBMEE,TD<$SHA6)ROGW
M_#1_[/'_ $7GX,?^'1\#_P#R\K\,_P#@YYMX+G_@GS\/H[B"&=!^U7\-7"31
MI*@<> OBP P5U8!@"0&QD D \FOX/K#PTFJW<.GZ3X<;5]1N6*6NFZ1HDFJ:
MC=.JL[):V%A:W%Y<NJ*TC)!#(RQH[D!%8C^@?#GP4P7'/#,.(,1Q%B<LG+&X
MS"O#4\NHXFG&.%=/]XZT\;0?O*;;3@E&V[.RCA55ASN;CJU;EOMYW1_K&_\
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MRY*:EF:<Y\L92Y8IRY8N5K)M'U&/_/U_^ K_ .2/]57_ (:/_9X_Z+S\&/\
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M[ZY?Q NH:W:Z_P",WFD\:ZOH'B34[6\\0>%K[QFUQ,/%4WAK4M*.N*Y%\),
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MO_JK- K_ $4J_P ZW_@X'_Y2J?';_L2?@;_ZJS0*_H'Z-W_)=YC_ -DMC_\
MU:9*=F!_BR_Z]O\ ]*@?C#1117]OGJ!1110 44^*.2:6*"&.2:>>6.""&)&D
MFGGF=8H8(8D#/+--*Z1111JTDDC*B*SL =?Q%X;\2>$-9OO#?B[P[K_A/Q'I
M<B1:IX=\4:+J?A[7M,EEBCN(HM1T;6+6RU*QED@EBGCCN[6%WAECE53'(C&>
M:*DH.45.4924+KF<8N*E)1O=QBYP4FE9.44VG)7#%HJ_I6EZEKFJZ7H>C6-S
MJFLZYJ>GZ+HVEV49FO=3U?5KR'3]+TVSA',UY?WUS;VEK".99YHXQRU>H_$?
M]GOXZ?![2X=;^*WPD\=_#S1[GQ?XB^']OJ?BO0YM+LY_''A (?%/A..:1F5M
M<\/B1#J=F/FMPP;<PR1G/$X:E5I4*F(H4Z]?F]A0G6IPK5N5-R]E2E)5*G*D
MW+DC*R3;LDPNKI75WLNKMO;T/UM_X(V_&'XPVB?MR>#[#XI_$BU\(>!O^"</
M[4'BCP?X6M/&7B&'PYX/\1V>FV]]8^(O#FC17XT_0M9M-3N9+RTU33X+>[@O
MKAYXIEGE+'[Q_8!^ GPO_:^_8U_9O\>?M<:;\1?VB[G4O'7[7NM>([;QY\8_
MBY?0ZM)\,OAC%?>%'M($\8IIVD:K9FR6S@U:PL8KRXCC2WU![^WC^SU_*UHW
MB3Q)X;;47\-^(_$'AQ]8TN[T+6'\/:YJFAOK&A:@H34-#U9]*N[1M3T6_0!+
M[2;XSZ=>( MS;2J *[7PYXB^-VE^$+W4?!WB/XQZ7\/O"5V]KJ5_X3UWQ[I_
M@;PI?^+8_L4MK?W>AW<'ASP]?>*HC]BE@N9+*X\0Q-]E=+V,^6?SWB'@>KF.
M(S3&Y=FU/(\7F6+RVK#&86A.ABJ+P^69EEU2G'%8;$8:LZF+Q./H8I2A4A)U
M</!/GJN$X8SI7YG&7(Y2B[I6>B::NFGJW?IJEULU_2W\!/V8_P!@?XQ:1_P2
M^UW5?V%/ VCS?\% ;_X\>%/B!;:7\4_CH-(^'B?!W3_%<UCKWPUAN?'5Q<RZ
MWJUW!I<NJW/B*]U338[33FB@TN"2:2:N$\.?L+?L4^!-"_8[\)ZW\&M3^.OA
M_P#:$^$?Q*^(/Q4^*?A7PQ^T]XX^,UCJVF7FN6FK:5\)-2^$=I=_!#PG=_ S
M[!81:YI/Q#M[B]O<W5QK<"M/9>=_.#8_$3XB:6OAN/2_B%X^TN/P9)?3>#(]
M,\:^)]/C\&S:H&75)O""6>JPIX7EU-7==2ET(:>]^'<7;3!VSZA\--:_:EU_
MP/\ $WPK\(/$_P <K[X<>&/#][\2/B]X:\">+_%\'A'1O#"W9L]5\8^,=&TS
M5[?3X]+N+S4C!K%]<6[IJ,UU_P 3-;KAEX\1P3G=&5:K#C?-<-A*E:NW2K9G
MF:5-8C&Y_P#4>7&8K,,1.G/!8;-LIPE.E!0IXZME%&=9PKU*%?#)TI+7VLDK
MO>4MG*?+JY=%*,?/E76UOU>_X)CO8Q?LI_\ !9;PEX,^%5C\<YH?@YX.?PIH
M.LZ+XUNO$OQ!\.6_CSQ7I.C:1JGA;P3K&GZV8([2&W\4WFFZ$L&LVNLSW-G+
M?R6,<=JOUQ:_\$Z?V78?BMX4_9>N?V5=8N?@QK/["U[\=_$O_!1Q_%/Q1M;_
M ,,_$FW\(:CXGO/%TTLVJQ_".T\&Z7XALH?!;^ +W0&\16TU[&M]<$02SU_.
M_P#![PA^U)<07WBS]GGPK^T=+;7'FZ!J?BKX%Z!\5FM[@Q&&YFT+4/$'PZLS
M%,T)>VN9-*N;QGA+P3M;H7C<[@/[8%Y\)/B=HKZA^T2?@?\ "C6]-L_C)X=O
MM>\>V?@'P#X@\9Z@MCI6G>/_  SJ.HV]GI-_XEU:810Z9JVF@7VHS&>:V-U(
MTQTS3AC'5LWSC&9?Q9#+?[1Q>&G5HPQ>+HU\/C9Y7E>28/$3CA<PPU.OBL-7
MP2J8'"5Z2P>,K9@\+BL/65'"H4J;YI2C4MS-75VM>6,$WRM7:Y=$]&Y6?0_7
MK_@D=XE^'/AK]AS_ (*30_&%;:_^!_B_XB?LH?"_XMZA]F9VTWP!\3;WXD?#
M^?QOIA*N;.^\&ZGX@T/QW93\/&="6%9H7D2XC^_OA1\!OV9O%?[%>I_\$[M-
M^)GASQ1\&_A_^V;^QWX,^-_[0OP_U[3&TCXL_%#XDZC_ ,+!\>W/AKQ6AN=*
M73)V7P1\*/#>I1//'8SP(T4 U"(I)_(;9^(_$>GZ/K'AW3_$6OZ?X=\1/92^
M(O#UAK>J66@>(9=,=Y=,DU_1;6[BTS6I-,EDDETZ34[6Z>PDD>2T,+NS'M_!
M_A;XR^(OA_\ $F]\!:;\0=3^%OP^@T+QI\6AX:O-77P/X7B.I1Z=X8\5>--.
MM+R'2([B+5A%:Z'JU[9SWMI>*GV*6$Q[U,\X!J8['YIFL.)*V5RQ^?9-F^'C
M&E36'PF.R["Y/EF!Q*YZM/VF81^KXVC0]Z-&O/'X.%2A.K@<.Y.5%N4I<[CS
M3A)=DXJ,5OUT?DVU=:(_IC^%'[ /[ WQU^,NI?#'XC?!37O@)/X._:NUKX;^
M!;KX:^$OVH/"7@WXG:?X8T;Q!J-S^SU\7?B#^T*EOX<_X6%K\6BV.H:!XE^%
M]U:2:T;RXT^P9%U+3)6^I_V&?ACIGCGX _#WPCJO[%?BS]B[0[C_ (*@PV6J
M^!?#'BSXZ>';W5]-\-?!SXF6EGXLMO$GB#Q'%X]T2\TV>&P\*Z]K6@>(++P_
MK&H:65M%A%Y>6C_QX^+/C3\9O'W_  CO_"=?%_XI^,_^$0^QMX3/BKXA>+M?
M/AF;3L?8+O03J>KW)TG4+3"^1J=D8=239'_I9\N/;NZK^TG^TAKMZ-1UG]H?
MX\:E?A;%5N[KXP_$1IE_LV(P:>R,OB- DEE$62VE15EBWR,K[Y9&?S,Q\..(
M<PPD\-5XMQ52,XX:5%8S%9KBUEV(PRQ,9UL(HXW#0Q+QCKTJTY8ZG5JX*KA8
M+!U$JLITY=&;5O:.VF[D^6W;WE>_][:VF[9^WGQF_8\^&7PR\.? 3P5\&/\
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MQ Y3^=+_ (.<_P#E'W\/_P#LZGX:_P#J!_%>OY@/^"*^_P#X>B?LB^7NW?\
M"9>*L[,YV?\ "N?%_F9V\[?+W[^VS=N^7-?T_P#_  <Y_P#*/OX?_P#9U/PU
M_P#4#^*]?PHZ'KVO>&-5L]>\,:[K?AG7M.=Y=.UWPYJ^HZ#K>G2R1O#)+I^K
MZ3<V>HV4DD,DD+R6MS$[PR21,3&[J?[=\%\NEF_@_F&4QJJA+-*O$N71KR@Z
MD:,L;AHX9594U*#FJ;J\[@IQ<DN52C>Z]3"KFP[CMS<ZOVOH?U%?LW_$_P#9
M<_:.\>^!/^"=7Q3^,_Q@_;Z?XT_ML^*_B'JMY\7?!GCSX>Z'\&O"'@+P#\1M
M1U+P9X4UW6_'&I^-;B?5]<T6%)G\,ZEI.CM9PS27$"02S07GBNG? O\ 9?\
M$/P'\*?M#?!K_@FYH?Q\\2>._P!M76/V8?$_P0\'^/\ ]H#7M.^#/P_\$:Q?
MZ187]S/HWBU/$$/Q2^*$'D:K<^,?$-Y_P@&GL]E!8Z)9+;S&Y_GBT?Q%XB\.
MZU;^)?#WB'7_  ]XEL[BXN[/Q)H.M:GHOB&SN[M)HKN[M-=TRZM=5MKJZBN;
MF*ZN8+N.:XCN+B.9W2>57ZOP5\7OBW\-7UZ7X<_%3XD_#^7Q3#)!XFE\$^.?
M$_A:3Q#',Q>0ZU)HFJ63ZE,SLS"ZNC+=HSR-'.IED+?<5. ,3AJU6ME6?YC0
MIU7@JU;!SQ>,P.%Q6*IU,?\ VA4JTL@KY1AL.L91JY4HSP6%H5XRRF,:E2K#
M&8ISV]DT[QG*VC:NTGJ[_ X)75E[J3T\W?\ J)_:&_X)Y_LK?LT^$_ 4?P*_
M8;/[=%SXG_;G\5? GQ=XCG\8?&:[O_A[X!GO],FA\)7Z_#;Q1IEDOB+PU>W]
M]X*TSQ;J5G%I]A-HLTOB47MW*SKB_&?_ ()P_LH_LT:WX"TOX*_LI:E_P4"M
M/BM^W#XG^!WQ"N#XK^*9NOV</!.G0Z0T'PYM+OX<Z[I&F:;XUTN+6-0O9_&G
MCX7NDRQ>')!<P_-*#^$S?MZ?'+3OV8/A1^S-X'\0>*?AI;?##Q_\5_'5W\2_
M GQ%\9>'_&/C]?BXRRZ]X>\6IIEY917-C;7:_;H;U[VZO;F[Q._D3F6:;YN\
M)?&;XQ^ (_$D/@/XN?%'P3%XR,C>+D\)?$#Q9X=_X2>66432W6O-I.K6C:I?
MRRC?)J-VTM_(2ZO<E))%;R<#P1QFJ<?KG%V.E.ABLRA4C5S'.&\\P\\35A@,
M5C)X3-8?V6\/15/%X?#90\*YRFL)F',J;;B-*KUJ/1O1N7OKHW:7NVW2C:^T
MKH_J+\=_LV_L0?L%?%/_ ()[6/PO^ 7@SXX^-_B[_P % ?%OPTTKX]>-_B%\
M1S=>#=!^%_QV\(:;IM_8Z/X8\4Z3X2\0^-/!USX@M?#5KJ=[IP\/R3^$M0N=
M6TG4Y[XB+Z;U#]C'X1_M3?%+]KWP_P#'_P %^)_@YX=\3?\ !4BUTNVLM*\6
M_$SP5H7QOT71_ASXA\0:+J::)XE\2R>#]2\0?%_Q%I<'AI?&FB:,I43/8>$I
MM,EX'\64OB_Q?<6>A:=<>+O%=QIWA:]N]3\+:?/XEUR:Q\+ZGJ%U'?:AJ?AF
MSDOVM_#^I7]]%%?7U_H\=E=WE[%%=W,TMQ&DB]-K_P 9?C+XLC2'Q7\8OBUX
MHACOM/U.*'Q'\3/'&NPQ:GI#F32-3AAU37;J*'4M)D9I-+OXT2[TZ1GDLYH7
M=F*K^&N>U(T*L.,\?_:L:&+HU\[KO'UL7>IG2S/"5<+AY9E]5PRP]"%'#/#4
M8TL/STO;4X0E-V'0FTOWKYM4YZW?OJ2:5[*R25EI?5)']-_[*'[ '[+/[2E_
M\&?&GQL_87N_V5-;N/VM/C=\"KCX"?\ "7_&"PTWXU?#CP[\"OB1X\L_$"V/
MCSQ')XZC\0_#'Q)X:TVVO_$OA+4K/PYJ-U9W,=[:2PSR6L7Y<?M<?"W]G/Q)
M^P5\!_VM/A!\!?#W[-OB?Q%^UG\;_P!GGQ/H_A?Q?\0/&?AS5O"7@J+4[GPU
MXEU?_A.==UR\'B+3[;1MVIMH[:=:W\DFI>59(#;QVWYRZ_\ '?XZ>*M?T;Q7
MXF^-GQ?U_P 4^&[-]/\ #GB75OB9XUO=?\/6,UA_9=Q:Z#K$VMMJ&CQ7FF9T
M_4/[.N+9M2LVD@U!KE)90_"3^)/$EUH=MX8NO$?B&Z\,6>IW6MV7AFYUS5+C
MPY9ZW?*RW^M6F@S7;Z3:ZQ?*\BWNJP6<=_=K(ZW%Q('8'Z#+.$<\PF:4<QQ/
M$^.K4J.)PM6&6QQN<5\'1PU/^W/KF#_VW,J_UZ.*>8Y=..(S"E6K499;"%+D
MHJA3HW&G-24G4>CB^6\G&RYN9:R?->Z:<KM<MMF?TY^(/^"?7[*6C_$WQ/\
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MZ@NH6\%BSVJW#7]W=_S0_M2?M>?%K]J[]H"^_:+\8W5OX.\91V7AK1O!]EX
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M\'E?WA_\'.9 _P""??P_R0/^,J?AKUX_YD/XKU_!WD>H_,5_>/T?/^3<T/\
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M\2_]%#GG_AVQ_P#\T![2?\\__ G_ )^2^X^$_P#AV!_P3J_Z,E_9E_\ #/\
M@O\ ^5-'_#L#_@G5_P!&2_LR_P#AG_!?_P J:^[**/\ 6?B7_HH<\_\ #MC_
M /YH#VD_YY_^!/\ S\E]Q\)_\.P/^"=7_1DO[,O_ (9_P7_\J:/^'8'_  3J
M_P"C)?V9?_#/^"__ )4U]V44?ZS\2_\ 10YY_P"';'__ #0'M)_SS_\  G_G
MY+[CX3_X=@?\$ZO^C)?V9?\ PS_@O_Y4T?\ #L#_ ()U?]&2_LR_^&?\%_\
MRIK[LHH_UGXE_P"BASS_ ,.V/_\ F@/:3_GG_P"!/_/R7W'PG_P[ _X)U?\
M1DO[,O\ X9_P7_\ *FC_ (=@?\$ZO^C)?V9?_#/^"_\ Y4U]V44?ZS\2_P#1
M0YY_X=L?_P#- >TG_//_ ,"?^?DON/A/_AV!_P $ZO\ HR7]F7_PS_@O_P"5
M-'_#L#_@G5_T9+^S+_X9_P %_P#RIK[LHH_UGXE_Z*'//_#MC_\ YH#VD_YY
M_P#@3_S\E]Q\)_\ #L#_ ()U?]&2_LR_^&?\%_\ RIH_X=@?\$ZO^C)?V9?_
M  S_ (+_ /E37W911_K/Q+_T4.>?^';'_P#S0'M)_P \_P#P)_Y^2^X^$_\
MAV!_P3J_Z,E_9E_\,_X+_P#E31_P[ _X)U?]&2_LR_\ AG_!?_RIK[LHH_UG
MXE_Z*'//_#MC_P#YH#VD_P">?_@3_P _)?<?"?\ P[ _X)U?]&2_LR_^&?\
M!?\ \J:/^'8'_!.K_HR7]F7_ ,,_X+_^5-?=E%'^L_$O_10YY_X=L?\ _- >
MTG_//_P)_P"?DON/A/\ X=@?\$ZO^C)?V9?_  S_ (+_ /E31_P[ _X)U?\
M1DO[,O\ X9_P7_\ *FONRBC_ %GXE_Z*'//_  [8_P#^: ]I/^>?_@3_ ,_)
M?<?"?_#L#_@G5_T9+^S+_P"&?\%__*FC_AV!_P $ZO\ HR7]F7_PS_@O_P"5
M-?=E%'^L_$O_ $4.>?\ AVQ__P T![2?\\__  )_Y^2^X^$_^'8'_!.K_HR7
M]F7_ ,,_X+_^5-'_  [ _P""=7_1DO[,O_AG_!?_ ,J:^[**/]9^)?\ HH<\
M_P##MC__ )H#VD_YY_\ @3_S\E]Q\)_\.P/^"=7_ $9+^S+_ .&?\%__ "IH
M_P"'8'_!.K_HR7]F7_PS_@O_ .5-?=E%'^L_$O\ T4.>?^';'_\ S0'M)_SS
M_P# G_GY+[CX3_X=@?\ !.K_ *,E_9E_\,_X+_\ E37U9\+_ (4_#3X)^"M*
M^''PA\">%?AKX!T.34)M'\'>"]%L?#WAW3)=6U&ZU;4Y+'2=-A@L[9[_ %.]
MN[^[:*)3/=W,T\F9)&)] HKEQF<YOF%)4,?FN98ZC&:JQHXS'8K$THU(QE&-
M14ZU6<%-1G.*FES*,I).TG=.4FK.4FM[-MJ^U[-]M HHHKS20KY3^*/["_[&
MOQM\:ZG\2/B]^S!\#OB5X_UFVTVSU;QCXT^''AGQ#XCU&UT>RBT[2K>]U;4M
M/GO+B'3K"&&SLTDE9;>VC2*,*B@#ZLHKJPF.QN7U77P&,Q6!K2@Z<JV$Q%;#
M573DXRE3=2C.$W"4H0DX-\K<8MJ\59IM.Z;3[IM/\#X3_P"'8'_!.K_HR7]F
M7_PS_@O_ .5-'_#L#_@G5_T9+^S+_P"&?\%__*FONRBO2_UGXE_Z*'//_#MC
M_P#YH*]I/^>?_@3_ ,_)?<?"?_#L#_@G5_T9+^S+_P"&?\%__*FC_AV!_P $
MZO\ HR7]F7_PS_@O_P"5-?=E%'^L_$O_ $4.>?\ AVQ__P T![2?\\__  )_
MY^2^X^$_^'8'_!.K_HR7]F7_ ,,_X+_^5-'_  [ _P""=7_1DO[,O_AG_!?_
M ,J:^[**/]9^)?\ HH<\_P##MC__ )H#VD_YY_\ @3_S\E]Q\)_\.P/^"=7_
M $9+^S+_ .&?\%__ "IH_P"'8'_!.K_HR7]F7_PS_@O_ .5-?=E%'^L_$O\
MT4.>?^';'_\ S0'M)_SS_P# G_GY+[CX3_X=@?\ !.K_ *,E_9E_\,_X+_\
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MR7W'PG_P[ _X)U?]&2_LR_\ AG_!?_RIH_X=@?\ !.K_ *,E_9E_\,_X+_\
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M4:+;:_I]M?65CK,&G:K;W-M'J-I::EJ%M;W:QB:*&]N8T8+,X/S5_P .P/\
M@G5_T9+^S+_X9_P7_P#*FONRBO3PF=YS@**P^!S?,\'04I35#"8_%8>BIRMS
M35.C5A#FE9<TN6[LKMV*4I)64I)=DVE^#\E]Q\)_\.P/^"=7_1DO[,O_ (9_
MP7_\J:/^'8'_  3J_P"C)?V9?_#/^"__ )4U]V45T_ZS\2_]%#GG_AVQ_P#\
MT#]I/^>?_@3_ ,_)?<?"?_#L#_@G5_T9+^S+_P"&?\%__*FC_AV!_P $ZO\
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MP[ _X)U?]&2_LR_^&?\ !?\ \J:^[**/]9^)?^BASS_P[8__ .: ]I/^>?\
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M_P##/^"__E31_P .P/\ @G5_T9+^S+_X9_P7_P#*FONRBC_6?B7_ **'//\
MP[8__P": ]I/^>?_ ($_\_)?<?"?_#L#_@G5_P!&2_LR_P#AG_!?_P J:/\
MAV!_P3J_Z,E_9E_\,_X+_P#E37W911_K/Q+_ -%#GG_AVQ__ ,T![2?\\_\
MP)_Y^2^X^$_^'8'_  3J_P"C)?V9?_#/^"__ )4T?\.P/^"=7_1DO[,O_AG_
M  7_ /*FONRBC_6?B7_HH<\_\.V/_P#F@/:3_GG_ .!/_/R7W'PG_P .P/\
M@G5_T9+^S+_X9_P7_P#*FC_AV!_P3J_Z,E_9E_\ #/\ @O\ ^5-?=E%'^L_$
MO_10YY_X=L?_ /- >TG_ #S_ / G_GY+[CX3_P"'8'_!.K_HR7]F7_PS_@O_
M .5-;/AS_@G%^P/X0\0Z#XM\+?L>?LZ^'_$_A;6M+\1^&]?TCX4^$+'5M#U[
M1;V'4=(UC2[ZWTQ+BRU'3;^V@O+*[@=)K>XACEC974$?:=%*7$O$<XRA//\
M.YPE%QE&6:XZ491DK2C*+KM.+3:::::=GH+GG_/+_P "?^?DON"BBBO$)"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRM(UI<0SJT<;QE)!A\Y  /:Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ9_P3#/BV^U7XE?&O]H[XJ#]H+Q)^T!J?[16L?$#]G=[#X-^&--\6-\(=(^
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M_P"*H^UW?_/S<?\ ?Z3_ .*K^//^)N,Z_P"B)RO_ ,/6+_\ G?Z_TM?]+/\
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M.,8J-DO5AA:#A!N#;<8MOGFKMI-NRDEKY*V_<_I=_P"(I?\ ;._Z-3_9:_\
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M +^/_C7WQ_P2>=W_ ."D/PLWNS?\8X?M._>8MT\1_LZXZD^I_,^M? 5???\
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M_P#(OK=7_P!!^,/:P_\ !I_X?U8_S)/^>C_]]-_C7U%^PL[M^WA^PD&9B/\
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M^3:\??\ 9'\1?^JG%'ZWX!_\GP\(?^SD\%_^M#EY_/O1117^39_T2A7Z%_\
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MHK]I/Y?"BBB@ HHHH _SJ/\ @X._Y2U?'3_LCG[-G_J*>)J_&:OV9_X.#O\
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M%% !1110 4444 %%%% '^15XK_Y'KXG?]EA^-'_JVO&M8E;?BO\ Y'KXG?\
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MB"*_D]O+&Q^V77^A6?\ Q\S_ /+K!_SU?_IG7]8G_!8O_E&1^V/_ -DHD_\
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MKD*_U#X6_P"27X:_[)[)/_57A3W:?\.G_@C_ .DH*RM>_P"0%KG_ &!M5_\
M2"XK5K*U[_D!:Y_V!M5_](+BO<EL_1_D6?ZJ_P"P=_R8Y^QE_P!FH_L[?^JA
M\'U]75\H_L'?\F.?L9?]FH_L[?\ JH?!]?5U?Y0RW?J_S/GPK\)_^"]7_)%?
MV2_^SP+7_P!9H_:3K]V*_"?_ (+U?\D5_9+_ .SP+7_UFC]I.OA?$[_DV_'O
M_9'<2?\ JGQA^K^ _P#R>WPA_P"SE\$?^M)EI_//1117^3!_T4A7WW_P2<_Y
M20_"S_LW#]IW_P!2/]G2O@2OOO\ X).?\I(?A9_V;A^T[_ZD?[.E?KO@-_R=
MS@O_ +"\S_\ 5!FQ_-_TO/\ E'#Q0_[%^0?^MAPZ?UZT445_J&?X'A7\+/[0
M/_)W'[;W_9X7QA_]$>%J_NFK^%G]H'_D[C]M[_L\+XP_^B/"U?S3]*K_ )-O
MEO\ V6&5_P#JISX_N7]GW_R?#.?^S;9__P"M#PB>:T445_GJ?[-DUO\ \?$'
M_7:+_P!#6OZI_P#@C!_RC0_9F_Z]/BK_ .KR^)M?RL6__'Q!_P!=HO\ T-:_
MJG_X(P?\HT/V9O\ KT^*O_J\OB;7]<_1(_Y'W&7_ &*,K_\ 4W$'^<7[1K_D
MD?#'_LH^(/\ U68 _4.BBBO[G/\ )P_);_@MO_RC]\8?]EO_ &3?_6H/A+7\
MO%?U#_\ !;?_ )1^^,/^RW_LF_\ K4'PEK^7BOX-^EK_ ,E=PK_V3-7_ -6V
M,/\ 7/\ 9T_\FZ\0/^RYH_\ K/94%%%%?RB?Z&GT1^Q1_P G]?L+?]E\\3_^
MLR_M#U_;17\2_P"Q1_R?U^PM_P!E\\3_ /K,O[0]?VT5_HK]%W_DV$_^RGSC
M_P!1<K/\4_I\?\GZC_V0O#7_ *F9X%%%%?T6?Q6%%%% !1110!_G4?\ !P=_
MREJ^.G_9'/V;/_44\35^,U?LS_P<'?\ *6KXZ?\ 9'/V;/\ U%/$U?C-7^C'
MA#_R;7A+_L7UO_5AC#VL/_!I_P"']6%:OAC_ )'WX4_]EE^#_P#ZL?PU656K
MX8_Y'WX4_P#99?@__P"K'\-5?C!_R:/Q4_[-MQW_ .LMFI]=P/\ \EMP;_V5
MG#?_ *N<$?O8W4_4_P Z2E;J?J?YTE?\H<=EZ+\C_HX'Q_ZR/_?7_P!"%?U2
M?\$7/^4;7P _[#O[0?\ ZTS\8Z_E;C_UD?\ OK_Z$*_JD_X(N?\ *-KX ?\
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MNO$/AFZD.F:]!:$QVFIPW%O&\T21W$P!ZG1110 4444 %%%% !1110 4444
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MZI/^"+G_ "C:^ '_ &'?V@__ %IGXQU_6OT2O^2EXN_[$>!_]3Y'^='[1?\
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MN]#U_3[?5-*NKK0_$%CI>N:3-<V-U!,^GZOIUCJ-J7\J[M()E>->HH ****
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MG[&7_9J/[.W_ *J'P?7U=7RC^P=_R8Y^QE_V:C^SM_ZJ'P?7U=7^4,MWZO\
M,^?"OPG_ ."]7_)%?V2_^SP+7_UFC]I.OW8K\)_^"]7_ "17]DO_ +/ M?\
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M _\ R6W!O_96<-_^KG!'[V-U/U/\Z2E;J?J?YTE?\H<=EZ+\C_HX'Q_ZR/\
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M^(O#OBG1M8T+7O#^K65M?:3JNGW5G-&?*#OZ]0 4444 %%%% !1110 4444
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M]+#_  T/M>OX3_CE_P G4_MJ?]GD?'[_ -22VK^MG_AX_P#L(?\ 1UOP6_\
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M>#SR-25&.,KT75C3<X*;@I*+E'F:NCO**\\_X6Q\.O\ H9D_\$WB3_Y34?\
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MM(?_ #LZ^P/^"=[^/O@G^V[X ^*_Q1_9U_:_\)?#W1O@C\>/"FI>)+K]C?\
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M5-5(3@Y<T6ES%%=/_P *V^.__1JO[8__ (B#^TA_\[.C_A6WQW_Z-5_;'_\
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M;_B,_@[_ -'8\,__ !/.%O\ YZ^?]69S<?\ K(_]]?\ T(5_5)_P1<_Y1M?
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ML_\ ]!#]KG_Q5IXE_P#G-T?\-L_\%G_^@A^US_XJT\2__.;K_,W_ (BKE/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4R22.&.2::1(HHD>2661U2..-%+/)([$*B(H+.[$*J@DD
M $T^JM]8V6IV5YINI6EMJ&G:A:W%C?V%[!%=6=[97<+V]U:7=M,KPW%M<P22
M0SP2H\4L3O'(K(Q! ,C1/%OA3Q,TZ>&_$WA[Q ]J%:Y71-:TW56MU<D(TZV%
MS<&$,00ID"AB"!DUM_:+<7 M#/"+IH6N%MO-3[0;=76)IQ#N\PPK(Z1M*%V!
MW5"P9@#^6?[%7[/_ (&\)>-OVK_VJ/A3^SQX$^#$WCR^N?@U\#/ WAOX=Z-\
M)UU?X5? JY\066G^*=>T?2M#\.W-O=_%_P"+-]XO\16]UK&G"^7P#:?#]T94
M1S+^7^C?'+]HB#XBP?'Z_P#&_P"TIXQ^* _85T'P?\5=>U']F6V\#6'[-_Q>
M\??M9? ^#XL?#WPY+)\&+W2&T#X>:(NOR74NK>$OCIXB\)>'-"'Q#5_B-87B
MZ?0!_4E17\_8_:R_;B\(> _A4FI:UXEU[6_VC/B)\6OV//A/K/B3X9:)8:EX
M:^+K?$$^(_@?\>/$"7'PY^'(\0>'[GX!VGQ0OM8U"?P)X6\&^)=4^'/@B\@\
M&:4_BS6BWTK_ ,$]/CA^TCX\^+WQD^'WQO\ &/CWXGV/A?PU:ZLOC34OA*GP
MS\$:'XK/C_Q9HDW@N#2=2^$_PM\3>#/%T/AFST2[U#P+>:W\<=)GM;:3Q7I7
MQ2@AU0:" #];Z*** "BBB@ J&XN;>TB,]U/#;0JT:--<2I#$'FE2&%#)(RH&
MEFDCBC4G+RND:@LR@S5^;G_!4[X.:=\5OV8K?4/^$3\1>,_%GPZ^,_[.'C#P
M/I&@2>*+YK36;3]I#X0&_P#$,WA?P[<"V\02^'] BU74(I]:TW5+3P_:)J&L
M(EIY,UW& ?H[+<00O!'-/#$]S*8;9)9$C>XF$4DQA@5F!EE$,4LICC#.(HI)
M,;48@GN(+9!)<SPV\;210J\\B1(TUQ*D,$0:1E4R332)%%&#NDE=(T#.P!_#
M?]HK0?VDO$__  4J_9 ^)'B_]G?XOZG\-/A9^TW?^!O@MXF\'^*/A;JWPOTK
MX=>*OV5_C1'\2_BWXZTN#XC0^-=)\4^(O&.H:3H,/_"4^#-.T?P]X1\"6>E^
M'=0U7QEX_M]+U+G?VU/&WQL\9?M Z]\+/$6O_&6ST/PI^UY_P3\U3X*_!#P5
M\"F\3_#SXI_!O3OBQ\"/&_Q*^+_B3XJVG@;4]7L-6\*_$%?%VCW_ )/Q \,Z
M)X.TWP/80:SX:U2+Q5_;D !^^%%?SP^ /VO_ -MG5+'XM?$U=:^)5SX.^'?P
MO7]HGQ-X2^(OPKT'0;O0H_A-\:M,?XQ? &.Y/P6^'MCX7\2:W\!+O7X(/"@\
M8_%O7M'\7:+H6OZ5\5[W3;S4HKO8^&W[6'[9_B/X_?L[^)?$/C#Q_?\ PQ_:
M*UKP#X]\)_ _PY\%;#2[CP?\&/BUKWC?5])G\7>)KSX1ZQI7CK2/"OPT;X>W
M7C#7=,^-_P ,/&GPKUZ'6Y=9\*?$B+4[33(P#^@:BBB@ HHHH *SKO5])L+O
M3M/O]4TZRO\ 5Y)H=)LKN]MK:[U2:VC$UQ%IUM-*DU[)!$PEFCMDE:*,AW"J
M0:T:_#__ (**-^SMXJ_:/^'WPN\1>%-7T+XR>)])^$NLZW^TUKWP\^+_ (KT
MSX'_  R^'_Q6F\7:/HGP"USP_P"%]?\ #6A?'?XA>(SJ.E7UQX8O_#=SIWA<
M1^(_B5J>K:7H'@[POJP!^W0N;<W#V@GA-W'#'<R6HE0W"6\SRQ13O"&\Q899
M()HXY64([PRHK%HW )+BWAD@AEGABENG>*VBDE1)+B2.)YWC@1F#3.D,4DSI
M&&98HWD("(Q'YR?"GX-Z5\/O^"GG[3GCWP[X2\06%E\5OV3OV>]7\4^-=1D\
M4:MI?B7QMIWQD_:/CFTBSU[6[B]TNTD\.:!=Z0+?PAH=Q:6F@Z9J%I<)I5M%
MJ<<T_P"<'Q7^+W[16J?M+_#_ ,8^(=1_:!\4?$?X$?M!_MTZQ!^S_P"&_P!F
MM-1\!_#+P!X9_92_:7T#]GCQGX.\;P>#]$;QKJOQ*TJY\,ZE9S^(_B?KVC^/
MO$7BUO#6E:3X3O=&73)P#^D"BOYX?#W[;?[6WPF^$GCG]H[QQKWCOXK_  =^
M#/Q ^%EQKFFZ[X TFS\0_$CP/\<?AI<>#QI_AWQ#:_ KX$OJ\WPX_:/OO!-Q
M(OA[P+IEUH7AS5_%VA>(-9\7'1M-N&]E_94^,O[:^G_M?^&_@I^T+\2?&?Q5
M%YH'B$>.K/0O@QIO@;P)\/)],^&/A;Q'8W?B*23X1>'D-C?^-KC7]&\*_%#P
M7\;O&^A>-I+S3O#5W\*_"MU9W/B"$ _;FBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KX$_X* _M%>+_V=O"_[/%SX3\=^%_AC!\7/VF?#/P>\6>/_%7P
M^UCXGVWACPMJOPL^,'C>6[TWP?HFL:)>7VK7>N> M!TF*X:ZDM[*SU"^N9K:
M3RU>/[[KB?%_PY\%>/=0\!:IXNT"VUO4/AAXVA^(W@.ZGGO(9/#GC6#PSXG\
M'1:_:"TN;=)KE?#/C/Q/I!@O5NK-K;5[AGMFG2"6$ _,OX2_MQ_%R/0=7\1_
M&71/#BZ=H'PBUKQ1H=U>:/?_  0A^*4J?M!:M\)OAQ\18]+^(M]?ZQ\.-'^*
M?AV+1]<LO"&LMK&KPS7+2Z%'K2ZCH]C<]YX%_P""BS?%NT\)Z1\&_P!G[QG\
M2OB=>VOQ)UGQ]X TSQMX'T.V\%^&OA-\18?A?XIU?1_&?BF]T;0O'$VN>*)\
M?#RPLETC_A)=-M[N^UJ[\(K (Y/JKXL_LK_ GXX^)=+\8_$WP7<Z]XFT70[?
MP]I>L6'C+QWX4N;/3[#Q3I7C?1Y8AX/\3Z#"=8\.>,-$TSQ+X3\1/$_B'PEK
M5NVH>&=4TJXN;IY_.M0_8 _9-U/3H-.NOAIJJB'Q!XW\2S:I9_%/XP:;XEU3
M4?B5<:3>?$.V\0>+=.\?6OBGQ)X?\<7^AZ7J?BOPEX@UC4_"NO:K:C5=3T:Y
MU&6>YE /F_QI_P %//"4FL_&GP;\/_".KW5QX%?X^_#GP]XY=TU>.U^-_P #
MO!7B_7=>L?%O@6TM5U#1?A[;:]X1U3PS9^.I]9EL-6\16L.GO8Z?I>JZ?KD^
MKIW_  45UO0[3PAX)^(7[/?C72?CK\2_#OP?U/X)>!8O%'@E[#XS'XKVNMI;
MW<GB*UU&XTOX9S>%[OPKXBO_ ![I'B07<OA[18["XT*X\775ZE@GUK+^R1^S
MY+XB\7>)CX!DCNO'<'BJ+Q7HMMXO\=6G@;5KCQSX8;P;XRU=OAO:^)H?A]:>
M)?$_AJ2;2M<\56'ABU\2:C'<W<]SJLEW>75Q-Q&C_L _LDZ%X=U_POIOPHDC
MT_Q"/ B27UU\0/B?J7BGP_;_  ONI[WX<6/@#QMJ7C6[\9_#'3/ MW=7EQX4
MTOX<Z]X6T[0I;[4&TZUMS?WGG@'J_P  ?C;8_'?P1J'B5/#&L^!_$?A;QGXN
M^&OQ!\#Z]<Z;J&H^#_B#X#U:71?$^AC6-%N;S1M>TY+F..^T77=,N#;:OHU[
M87S06-S-/86OM]>?_##X6^ ?@UX-T[P!\-?#MOX8\*Z9<:G>P6$5WJ.IW5UJ
M>MZE=:SKFLZQK6M7FI:[K^O:WJ]]>:IK6O:[J6HZSJ^HW5Q>ZC?7-S*\A] H
M ^0_VW/C_K/[/7P-N];\$:IX(TOXN_$'Q1X;^$GP3D^(_P#:#>!!\4/'-U+;
M:/J7C&+2)8=6E\)>%=+M-;\:>+%TR1+T>&_#>JM;ND@5U\G^&O\ P45^'/C[
MPGX8URU\.ZU?7&H_L?\ Q(_:LURYTN6P_LK3_P#A37BS3_A]\2OAW#)<W*3'
MQ'I?C:75-,M9I -.:/2YI)KI-\>[[<\1_#;P/XN\5^ _&_B7P[::QXG^&-UX
M@O\ P'J=Y+=N/#>H>*-%D\.:YJ%G8K<+ITFH7FA3W6DI?7=I<W=E8WVH06$U
MJFH7HG^=_&W[ _[)/Q$-_P#\)9\'[.]CU?4?BGJ6LVUAXL\?>'K+7!\;I=$N
MOBQH^O6/ASQ5I-GKGA3QWJ/AS1-9U[P7JT%YX0N-?T^+Q!'H<6MM+?R 'B^M
M_P#!3;X3^&/$OQ(\*^(O GC^PU;X/_!^']H3XC0P1:/>C2?@KXA\,66I_#/Q
M?I+QZA'#KVH_$_Q?=W7PX\/>%[>6#5=.\1^'_$U]XD_LCP]IMKJVHZ$'[?&O
M6GC/1/@WXH_9F^(6B?M ZS\4/!OP^'PNL/&7@#7["RT7X@?"[XM_%KPU\1[C
MQ]:ZK;>'W\)V_A_X*>.]+\3P6\4NNZ)XBTS[%::7K5A<V&J7ON\/[%O[+T3Z
MA+)\'O#U_/K&G>)M%UVZUB\U_7+WQ'H/C#P5H_P[\0^'?$U[K&KWUWXD\-7O
M@[P]H.C0^'-=FU#1--71M,OM+L++4[&VO8[_ ,/_ -DO]GCX3W&DZSX2\!_9
M=9\.>,6^(ECXL\2^,/''C;Q;'XIA^'/B/X3VVJ:EXS\=^)_$7B;5;31_AMXL
M\3>$M$TC6=7OM"\/:1K-^NBZ=I\LIF !YC\#/VW_  A\;/C_ .._@!8^&Q8:
MMX;\*ZWX[\->)M$\7Z!XW\/^)?"?AKQK;> -<?5KG00+?PMXCAU^^L)['05O
M-?AO]%NC??VO;WMI>Z7;<E\&?VX-?^)?Q:^'OACQ#\*;3PE\,/V@+KXZ6/[/
M/C*V\8MKGBS7+C]GO6Y=)\5-\1_!R:!9V/@R#Q=IUGJ?B;P<VG>)?$,MI86$
M>D>)H=-UW4(K6#N?V=_A'^QGI_C"'XA?L[1:3J/B/1_ <B:3J.A_$+Q[XGT;
M0?AE\9/$5QXL@LO"FBZUXHU7PMH7@7Q?XB\&7.N:)IGAK3;/0([C1Y+K1;:U
MA<M-U^C?L6?LS>'O%WC/QSHGPR33?$GCR'Q-!K5Q;>+O'BZ=IJ^-M8M_$/C=
M_ WA\^*&\/?#*X\;Z]:P:SXTNOAOI7A2Z\6ZHAOO$,VI7,DDK@'CO[,'[<L'
M[2WQV^-7POTO3/A7HWAWX6^(_B9X8T@VWQ>?6/C!XDD^&GQ%D^'5YXGOOA1)
MX+TJWTKP3K%]8:E?V&OZ7XQ\1_9+:?P[#JMK8W.OP10?H/7R?X/_ &5XM#^-
M^F_&SQ=\6_B%\3+SP/I'Q#\/_!WPKXGLO VFZ+\+M'^+&I^'M6\?06M]X3\)
MZ!KWB^ZU.7PIH-AI=]XQU/5I=%T>S>UA6XO+F;46^L* /S1_:X_;NC_9V_:$
M^#/PVM=7\ 67@VR3PUXT_:8N?%<M\NNZ)\+_ (H>-!\&?AO=^"'LKA;>WUNT
M^(=Y=>./$[:S;S6<?PQ\ >,I;=5U*73=_L^G?MBZ#KMQ9:7X?\ >*-2\0:Q\
M=_V@_P!GS0-&DO\ 0].;5_&G[/NA>/=:U2XCO;R\2UM]*\5'P%>V.A7$[!K>
M:_M)]46UMH[F6/V36OV??@SXD7XRIK_P_P!%UD?M!Z59Z'\8O[1:^NV\;Z-I
MWA4>"M/TN]::\=M/L;'PV'LK.VT0Z9%;7-Q>:M J:Q?7E_/Y"G[!'[*$?C"X
M\>Q?"ZYB\5SWGB'4XM3B^(GQ2C33-6\7^"F^'GC#6M TU/&RZ3X;USQCX/8Z
M3XPUO0+'3=6\5.%U/Q!>:CJZ)?J > >#_P#@IKX<^,6E>#)_V??@EX\^*6N_
M$[Q)\0_#7PVT'4=?\*?#]?$5Q\"[+2D_:(N]0U7Q!>36GAZU^$7C/6+3X63&
MZ2XD\6_$);FV\/)+X4MI?%PZ+3/^"C7A'Q3I6M^)O!_PN\42^"] ^#WPS^*>
MJ>-O'/BGP1\//#>GZK\7-:\1^%O!OPSO9]6UB]OG\:+XJ\*ZSHNO1:18:QI]
ME)#:_P!D76OW>IZ587WL^I?L)_LH:CI,&B0?"*Q\-V%GJ.EZMIA\!>*/'/PW
MO]%U#2O!4/PY6X\/ZOX \3^&M6\/?VKX&MK3PQXJBT2^L(/&>E6-A#XNBULV
M%F\"^-?@#^R+X3\(6G@KQ;X0\'^#/"_CJX^#GPV\/Z9::UK7A"XN]5^#=QJ/
MB?X*:+X'O- U?2]9T+Q-X!NM/U/Q+X5U'P?=:9X@TN;3+G7!?AM.:[@ .;\
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M?P7^SA^RSXE^'?QO\'>%=%N?%?@GXWZCKG@GXYR:A\2/B?XHU?QKK7A/3?\
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MOPI:V[?U"4PQQLZR%$,B!@DA52Z!\;@K$;E#8&X @-@9S@4^@ HHHH ****
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M ^,OCGQ)^TCH_P"R)X/O/A-X"\7_  S_ &1/A)8>+#\>]+^-O@+X0^(9M?\
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M:!\.]6\4_#_P%X4MO&'AC0?!D>O:+;ZO\*M9\9VNN7.J0_T.TP1HKO(J())
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MT+]HSXT:QX?\0>$_#-KX&^'&HWDFE3:KH^E>*-4L[[QAK,MSI'BS48/#>EF
MPZ?X?:"YU2+5-7T'3]3 /O.BOA'X*_MP6GQG^*]MX"LO@_XQ\->#M<\6?M'^
M!?!OQ-U?7/#$]CXG\4?LS?$(^!?&,0\*V5Y)XCT?1]<A#:[X:U;4X8I)HX+K
M3=2T_3KM+=[OY0OO^"BO[07A7Q%#JWB;X!Z?K?A#0O O[>GCSQGX<\(>+_#L
M&KP^"?V2_CMX:\!Z7XTL->U^^MK2YO[KPA<>(4N?!]K#+<:UXC@@GAO=(TT,
M8@#]G:*^"_@E^WIX3^.GQ7@\ ^%OAOX[A\):UK7Q+\->%OB9/9S2Z/J&N_"B
MX^R>)X->TY+!#X4L;NY@U.W\.WU[J5W)J5QIZV]Y9Z7/J&GQW'FN@_\ !3#1
M]6GT/4-0^!7CK0_ _C/Q/K_A'P#XONO%/@FZ;Q)JO@[]K_X?_L=>+9KOP]9Z
ME)JOAW3;'QC\1-+\5Z-=ZJ%DU[PUINKQQ6UGJ45G;WH!^GU%?F+\4O\ @I5I
MW@#Q5\0_"_ASX">/?B1+\*M*^(GB;QM=Z!XI\#Z8EOX6^&7Q/T'X6^(;G18=
M:U.U;6?$-SK.OV]SHWAD26DMW%:7UK=ZAI]Y%'%-RNO?M\?&L_'?P!\,/#?[
M/DIUFWTW]JRP^*/PKU+Q_P" H-8.N?!;P[^SIXW\&:UX:^),NJ1>%3I.J>%/
MC(ZZCI\UN+F'7+VWLKZ:QL-&OM5< _62BOR3L_\ @KM\)=<\/:_\0_"GPG^*
MGB?X3^'[#4EO/&FG:6XOH/$6F?!2U^.$^F:AX?>S,6EZ*N@WEMX?E\47>N"U
MB\2W-K$+&32;F'5F^H=?_:L\3:5X1_9[GT_X%>(]4^*_[1]QK3^#?A+-XX\%
MZ7+H^C^'_"NK>.]2U/Q+XWFNY_#-O-%X2L+&Y32]+?5KJ75]7@TM&-K8ZIJU
MF ?9=%?FW^S-^UUX^_:.^)7QB\=:5X>N[']GKP=\$/A+XO\ AUX7MK;0;GQS
MXI\2^.M$U_Q+XD.NDWTEU9ZUI5UH5QX0T'3;"\3PU?K;SZN=0OEO]/NHI/"/
M_!1CPMKGACQ/K?B+X::SX3UOP=\(/C#\8O%/@BY\4Z%<>+O"&F_!WPIX*\6:
MOX2\=Z%?0Z+K'@7QM>V7C:QB71?$VFV"6R0QZLMW>:#JFDZI=@'Z045^.G@3
M_@I#XXGT?XJZS\0OAS=6G@^;]H;XW?!7X3_$+0+OPU))I.K^%?@J/C1\/_"O
MB?P/<:L=8O\ 4[G0],\3V.I^)5DM])&L:7:K=VMKHU^FK1]-I?\ P59\"?V'
MJ7B"Y^%'Q.UOPCHL?BSPPGC72M.MD36?B;X#TVQAUGP]J>G2I!HO@W2M<\82
MWO@_0O%&K^)_[$76(K2XU-M+T+4['5I #]9:*_/7Q/\ M9?'OPE\1/"/AWQ!
M^S)>6FG3_!K]H[XE^+?"_A[Q[X9\>>/KG4_@]%\-;CP=HO@:W\/S1VNKS^-F
M\<'2UT_4+73]5CU&>S:&V:VBCDU/M])_;+T6\^!FE_'2_P#",%MH8^(UO\.?
M'-EIOC?0=43X8W]]J@\.6FH>/+^Y@TB7PO'IOBC4/#>D^-M+\2:9H>M^ +76
MYM<\4:?9:5HNH3  ^TZ*_'#4/^"J$'CWX>^!/'?P;^&_B:%_$5[J-E)8^*)/
M#:V,/BU_ _Q^\4^'OAMXON1JB7/AG5Y])^#UEXTU][%+S4-#T?Q+X?TBYMTU
M&]U%=.C\%?\ !2/XFZ-X^\9?\+C^$B'X8Z'X1_8EU#Q#KG@O5-&:X^%?B/\
M:6^&&M^)/$MK>Z??:DVM_$#3M,\66.FPV[:!9Q7.GZ#?_:PNHW%M<VX /V3H
MK\]O 7[?-IXD\6_"SP/XR^"_BWX=^(_C-%\,?$/@&VN_%G@OQ1:WOP\^+&C_
M !"U3PWXKU2_\-ZC=VNE:E9S_#ZZTS6?"[/<7"W&KV%QHFI:[96^J7%CO_LY
M_M;>)OVA?CCXY\*:7\/[/1?A%H7P1\ ?$'0/%EQKUI>^([WQ;KWQP_:4^$6N
MZ7>Z?8R361T*>/X%)JN@7EL_FA7O6NY)1>VL-F ?=5%%% !1110 4444 %%?
MG'\7/B5^TSX-_:H;P3HGQ2\ 1_"J3]GGXO?M$)X<O/A/)=^)H(/A+XC^%?AK
M_A"?^$J7QM;PS6_B%O'6I:C-KIT1+O3WM+2UALY8S)*WQOX7_P""H'[0WB?P
MM^SEX?D^%O@[1/BY;+9_\-GW%SIWBH>!?"/_  F/PA\8^-O@B_P>OKJ:"/Q
MOQJ.DZ=\1--%QJ&J-X4\!:5K^AZZ(_$L]BZ '[R45^.%K^V/^TE:^$?'7[0>
MH:S\,+OX:?#?XE?LK?#K5/@XO@G5+;Q/XO@^.7P._96\=>)[_P *>/5\6$P^
M+[/Q9^T'J9\*:!-X8U.PO=+\/VFD79-Y?MJEO[-^U9^VMX]^&FK>./!GP=^&
MCZY=?##Q_P#LM>$?B7\2?$&M^'+/P[X4G_:%^*?@OP]:Z7IWA"[U&W\2^+9F
M\'^(#-/JFFK;6FEZEK&G+9KK4^EZW:6 !^E-%?C=XT_X*9^+/B)\*=3U3]G3
MX3>(M/UWQM?_  OM?@_\0/&$<'_"*7GAGX@_M-_#7]G;4?$NKQ:C8V>DZ+XM
ML(?B/8^+_"7@[5-0U*WUF&&Z35+BW?0M:TNM[X9_\%*[^[MK[1M:^$_CKQM#
M\-_$7A#1/C)\41>^ /"]CX;L_B#\?_B!\ _#FI6/A*RUB\O/$UWI_B3P1/<Z
MQI^@)&3H$D6L0'[;<1Z,P!^N=%?E9X:_X*C>'_&3^$K3PM\!?B3JNH_%[5-$
MT[X"^;?:9I.A?$'^V=;U?3\^)/%>KV]EH'P]O+70]$O_ !:NFW=YKMWJ.F0O
MIFE"\\2HVBCJ_A3^VMXUO/V:;_XP_$CP/IDOQ"O/VEOC)\#?#?PQTK7;*TU&
M]OO!GQ:\=^#]$\+Z5=:/!XIF\9>)].\.>#[R\OH_!^E:S>ZVFE:IJUEI<%E!
M=FS /THHK\X/AW_P4-M?BK??#NV\'? _QA;6WQ4^$ND_$/P#?>.?$_AKP):>
M-_%FK>'O$>L-\*O ^HZT?[!\3>+M!O\ PW<:-XILXM;L]6T1;B'7SH-WX=BN
MM3@]N^,7QO\ B#X6^*N@?!7PSX(@TI/B+\&OC%XP\+?&_6]?TBZ\->%_'?PZ
MTW1[BRT'5_ B+_;6IZ9MU^SU34]9GU#1]-C@@_LZVDN[JYD>S /K&BORT^(?
M[<WQ6\*:'^PU\4]"^%^GZ_\ #/XV_!SQ+\:_VD/#=L-1N?B)X"^'NG>!/AKX
M@NO%/PUL[1I(_%-SX!U3QW_:_B?PP]K<:IXB\$:?J\WAD2>(+2PT_4.?\$_\
M%.[34?AWK'Q#F\!+\3?!/@FV^)'Q&^)7Q.^&WB?PO;>%?#GP.A_:C^-7P2^%
M/BSPKI.L:N^L_$C4]:\'_"34_&&L67AT1(]O8,FF276M:YH_AV0 _6NBOE/Q
MQ^T?KVD_%[7_ (1^ _A1JOCE_ GA3P9XL^*/C)O%_@_PMI7@33?B)?\ B2P\
M*M9Z1XCO[75/&5WY7A36]6U2VTI;6WMK&VAL[2]O]<NXM(KX,^!O_!2CXB>*
MF^%G@S4?A?K/Q7^,?Q7^$WP'\2Z/X7\,2>$/AWX1@\3_ ! ^#?QB^,&O7K>)
M_$VN2SV6A7&C?"R]AQJ%I))I]_)IMKIL>IIJ%Q):@'[/T5^3OP5_X*37GQP\
M1W?AWX4_!_QC\1_$FO:-8?%'2_">JZUX ^'">"_A+)\*?@1XSOKJ^\2:OK=U
M8>(=:BU_XUZ+H<-@HM97OC?S75UI^@V5MJES0^,O_!2?4-(\07WP]^'?@EK/
MQ"WQ#^%UCX2\>74R>,/A_P"-O!1_;*^!/[,?QA@T[4=.@T_3!XDTEOB_!:Z=
M%H>L>*+?2]:2^LM<GT[6M"NM&E /UQHKX1^,G[=7ASX3_&O4O@M8_#'QY\0-
M2\(Z/\*->^(FI>%+26YE\-:;\9O%>M^$O!;Z5I$=A=3>)ITN?#VK:IKR)=Z5
M#I6D6IFBN;Z])L5\(^(O_!4?X?\ AO3/ OB.'P[XUTG1M-\86&A_&:"WTOP_
MKU]X/\3+X1_:+UG6?@]J<,^KV!@\6:=)\ ]:U2\U+39)A::;?^#+^:"/1?&,
M&H0 'ZRT5^/4/_!2;XB>&/C-XV\ ?$WX&W>@:IJ^G_L]6?P;^&6G>*?#WB+5
M[S6/B;X2^,GCKQ7JWBCQYX5.NZ5::98^'?AU:I:Z=;Z-=Z@NI0W"6*ZGIU[%
MJ4/6V?\ P51\)W=_=73_  %^*NE^!O">H_!S2/BKXOUVY\/:/>_#_4OC1X7U
MWQ!H5O%X*N[I?$_BL:/<:&++6Y='M4C^PZIINN:2=3M7N(;8 _5BBOS=U?\
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MR;R+]I?_ ()[_&#4]1^,GA'X%R1WN@_M4V^M6OQ/\3>(M(^'%QX=\,)XA_:
M\5_%]8;:#5M6L?%WA2+PMIWC+7[;[=X6T7Q^GCW4)=.FO- \&ZY9'Q1< 'W+
M^U3^T7\%/ LVO?"GXP_!OQY\4_ ^B?#G1OCA\3KO1O NC^+_  #X"^'_ (=\
M:R2:9XN\7V^HZS8W<J>&=>\'7'BQK;1M(UF_TW3_  S/K<5L[621EV@R?\$^
M_!VG_&/P_I6K?L[:/IGBVWM-.^-VG:AX@\+FUUK3->O;S0['1_&*ZWJ$J3:#
M=ZMX@U#0K;1KAAHT&LZU>Z-':0ZEJ%Q:R]'\4/V)_@G\;/CUI?QS^+.A1>.I
M] ^&^A_#[0_!NKRZLGAJV.B^--8\:'6-4L+'6;32_%$=]=:G;VEQH7BC1]7T
MD1Z=#*L>;BYBD^3;[_@E='XA^+GA[XJ^-/V@-8\877AWXFZ#XZ$&L?#ZSNM8
M\3:+X:_:,\&_M$Z#X2\7ZO?>+K_2+M=#OO!>F> ='U+PUX4\)V5IX-2W6;P_
M=ZQ9Q:DX!Z78_#__ ()8/X=^'^B6&F_LJOX?^)OB&_\ %?PYAAU;PDP\9:T$
M7X7ZC<Z)>?V@;S4[-#Y?PYN=,^T/H\=P(?!K62W"Q::-J#P[_P $RXH;K4X3
M^R]<V'CG3+SX1RRG7/".I:1J&E6</AC3M3\(64$FHW.F:7;Z<+/P?9:HNGQ6
M/]G7=MX?@OIX+V.P42^&/V'-8^'7Q(U7XA?#+XR67A__ (3?6]=N?B=H_B+X
M1>&?&B:[X=U+X[_$'XYZ?HW@V\O=:T]? FHV-_\ $WQ/X=U#6)+'Q18:U;_V
M7K[^';+Q'IL>H/XM%_P2;\$Z?X.^"_A'2_B;/<0?#?X%7_[.7C:/Q)X,FU/0
MOB=\-=7\:?\ ";:PTWAS0/&WA*U\/^*]6O+K6;'4]9N[GQ3INJ6>J@ZMH&H3
MV%K* #NOB_9?\$O_  UX+7PK\3-!^ ^O^'/@[JK^!KCP=)#IGBK4O"[?&+QE
MI_@C7](UC1Q<W>IZAH/B'Q;K%K9>-+;5AJ&E?VE$/[:A.HV,,<:_$SXG_L'>
M.?&VF^"_B1\.O!'C+XB? S0O$^J^$/#VLVG@N^?2/!G@;XI^$/AAJ?V+6+K7
MX_#,6D+XON/#-VG@[Q)JD%UMT^UN+[0(-4MK:U;D-2_X)CZS=^)_$OC&#]HJ
MZD\2W=AK^G>%==\0_#$>)=3T^WF^+O@CXN>"(_&9N_B';Z=XM@\ W/@BQ\'6
M%KX=TWX>6VK>$)(8+^)=9LQK,]OQ3_P3(E\2-XQCC^/5WI]E\2M3^+^K?$",
M?#'2;F]U"[^*?QY\#?'^V_X1N]_X2BW3PY'X;\3>#7TEUNK3Q =;T?5?G;3;
MZPBNIP#[*\ 7/[*]W?>(M<^&]W\'YK[X7^(OB5XI\3:OX9N_#I;P7XB^)6L:
MCX@^*WB/4[ZTE\O2[GQAKUGJ^I>+]8EE2+4M4L=3>_N'N;*[$7@6DWO_  3L
MD\>Z1H?A?1O@OX@\5_M::E\=?!TUWX<TW2=>@\<ZAK>@Z+XJ^.7AGQ-=6[7$
M5@_C+28= U7Q)H]ZELOB1I-.O[BVN#=PW4VM\/\ ]B[Q+X!\-?M)>&-'^/FO
M^&=-^.GAO6]$\(Z=\-O"4/@W0O@KK>NOXSN-1^(G@W0M8\3>-;1?'NIWWBRU
MO=9GTA_"_A&[N?#FFW-AX.TB\N+Z[GXOX0?\$_=8^#_CGPY\0=$^,VDOK%C\
M9[OXK>)--@^%ETF@:Q8:[\%_#WP7\5^%M$CUKXF^(_$/AZYUC3?"/A_Q#9^)
M=0\2>*)=)UC^VH?[*OM-U*SM-( .L^'/C+]EVQ_:7^*?_"L/@;J=CXS\.:QJ
MG@#XO?'?P_X2T73O 'AKQ+IWA+2O&6N:-XIU1M>M=1T9FT6TT--5\4GPK!HV
MJZJEA87&O7MS&6CN6]Y_P3C\>^"-,\+6FK?LO>(O GB:Z\;_  ]T32+?6O T
MND:MJ'Q+\6:+\1O'/AO1(H[Q?.O_ !CXPN?#_C[4(M-/VK4M3DTKQ7"[D6VH
M#@_C7_P3L@^/7QDU;XB^-/BEI&D>'=43Q';S+\/_ (0>'_ GQPU#0_$'P]UW
MP"/A_P"+OCQH7B*$^/\ X5Z<NOW&MV_@OQI\.M:FGOK+3+>ZUV6UMI4N-5OV
M"M5\::CX*U/XX?&:Q\>W'@CX??&3X6Z:G@CX.^%?A/"/!_Q@^&?AOX97LENU
MCK/B>[L?$^CZ?H5SJ-MK4-VUD)]4?3]+T/0](MELI@#H?#.E_P#!.'PWX.\2
M^(O"L?[,]AX,NFD^'WBG5].NO",MCJ;^)KW3?$,GAS4[E9Y9M6E\47WAK3_$
MS12-=2>(9=';Q&7O?LUQ?B+XKZ9_P3G^)6O+H?Q(@_9N\?>.O$@UGQEI6@76
MM>";KQEXINO$7@#0-4U&_P!*9=4MKZ[?QE\._"7AEI)OM<=EXD\+Z)IJSRW>
ME6(,7@.F_P#!*+3M.TGP)J*?&2!OBG\,-6\-_P#"%^/HOA[KEGILWA#PU\.O
M%?PVMO#'C'PK;?%J.\UNZDTKQGKFJQZSX>\6>#+?3M9DB&EZ'9Z,]_HU]WOA
M_P#X)A?#GPMX>\3>'M \8R:/:^)/&'P)\8;M.\&:3'_95Q\$_ !\%G3K![G4
M;N^;3_%5]=:QXCECNK^>30YM8N],LGN;9GEE .XT>;_@G5X\\31:I<0_LXV_
MQ%\<?"F_AU[PI?Z]X!&MCX?2?#FR'B32/$FA:7K-SH,MOI'PTFBL-6NPMU%!
MX,M9OLVH2>&K5ID].U*?]BS]J/X87>F7NK_!#XO?"OX6)I>NWWV7Q!X>U;0/
MAO%8:#=R:7J=W?Z??HW@Z)?"AOFBGFN=.2Y\+W%UYAFT6\E\[XVU'_@E'X-T
MK]G#Q3\&K+QEKGC"XOO&%W\1!<V>F>&_ _B'Q#J5O^RW;_LUZ;X7_P"$F$6K
MQ:/;RV=A:>(AJUW:ZC%%*7T*XL)M(9W/2_ +]E3]H?6+/]MSQ/\ %SQG-\)O
M&O[5/AOX6>!_"WB'P9X?\':'XQ\%6WPS^%U]X&?QE<>'O"?BCQKX1L;W4=6U
M>\NM.TNS\:ZS<KI=I&'U'1#/9:=I !]*VWQ=_83^'_A#4/$%O\1?V=?!7@KQ
MGHR^"]3OAXD\&>'=(US0_ASIEKX8/AB[C:ZLTDLO!&BZ[9Z;<:5)$B>'M(U6
MW:XAM+&ZCD?P#QCX6_X)D>'_ (D_"7]F&^^&7P6\8>/O&_Q1\1>'M(\!:39^
M'?%6L^'/%.L_!?Q+XSU[4/B#9W.JRZS!H.M_#+X>Q:->VNK1ZI:7-G)X.T^Z
MTI=*ETV>WY_P?_P2L\->']?\>>)-7^*,&JW?CWP1^TMX4N-,T[X;V]CH6@:C
M^TQ\-_V??AIXBUW08?$GC+QKK<::#I/[/ND76GZ=J6OZE-?S>*/$%K?ZJ;+[
M- G=>#O^">4W@KXH_"SQ;IGQI>7P!\)/C]XJ_:.\/>!+CX9:$WB34/'?C_X1
M>-OA5XUL-<^)G]O'4KWPS=GQWJGB/P_91Z#;ZKH<MOI^AWVM>(-&L;&&T *7
MQ ^#/_!.O6]=\?>"= \;_!?X)?&)_#'Q @\8^)?AWXA^%VB?%'POX7T_P_IF
MD_%^[ND\4V'B'3?#UY_P@ M-$\9^*+W0XO$FC>#[F&;^UM.LE@N4ZJSE_P""
M9_A7P_<_%!_$7[-%MX?\:^%=9^&>J^,-9\5^%+C3O%^@Z+H/AKP]XK\/ZNVI
M:D]EJ^H1>'4\+6WBTW5M)K$VDR:9/K<CV4\4K\EXT_X)D>"/&NF_$&PO?B3K
M%E/X\_: ^/7[0CZE:>$?#<MYIOB/XU^!K7P;;Z-(M\UU;:WI'A&33M-OWAU:
M":'Q7I]JWAS6+6/3)B4UK/\ X)YPZK\29_C)\2?BM;>,?B3K%E\8[3Q)=Z/\
M+M#\)^$KEOBI\)O!'P=L9_#WA677_$DOAZ;POX8\%1S7=W-KNM:IXMO-6NX=
M6U*#2[33-/M #TGQ3^S]^P3\,O 'A+6?&?@7X(>#_AYH%_XCG\'>(?$=UING
MZ/%J7Q3T*'3?$/\ 9?B'4-05M1NO&V@:796AA%]=R:I::7IB6<;G3[#R<+0?
M'G[ T7PKU'X(_#.Y^ OQ!^%_C&_\)Z!XR^&?A'Q'\/?$6AZKI7Q]\46_@Z'7
MO&5AJVNBWU_2_$>JZB;/5IKZ;5-7U66,:-:VFH:J;/3)+<O[ WPS&B?!.QL=
M<UR#6OA-\0?@'\0=9UN_N=6\06?CJ_\ @#X<N/#VA6B^%-=UZ_\ #'@9=6$X
MO[NY\'Z=8RVUU$A"7+8D'D]W_P $P/!;VWPAM]-^)%YI"?"66UN+5+/P'X;^
MSZ_-;?M?>!/VNMVI6AN5MUCGU_P2?"5Q 4N(9K#7-0UB16O2UO, >R66M?\
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M_-,_V"QM++SBGEF;[+;QP>:4W/L,GE[RF]]N<;FQDWJ "BBB@ HHHH ****
M/XT_^#K?_DH/[ '_ &*?[5__ *=?V;:_D[K_ $LO^"BG_!*'X!?\%+M2^#NK
M?&CQ]\:O FH?!*S^(-AX6F^$'B#P1HRZC:_$B7P5/KL?B"+QI\/O'<5T;>7P
M'HS:7)8+ICVXEU!;AKI9XA;_ )N_\0M'[#O_ $<-^VE_X6_P*_\ H>J_I[PN
M\9N%."^$,'D&;83/:V-H8O,*\ZF P>!K89PQ6)E5IJ,Z^9X6HY*#7.G124KI
M.2LWWX?$TZ5-0DIWNWI%-:M=Y+IK\K'XE_\ !MW_ ,I2-*_[-3_:#_\ 4R^
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M"5>>G0Q&)II.K1FX.-:3<'%M1;<5S8BI&K5<XW2:BM4D](I/9OJNY\,^!?\
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MR[(,1E6'KY=FM3'8B6;8C%8:E*C/!U<.E2EA<#CIRJ<\XMQG"$>6[Y[I1?\
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M'X2\/Z-X9T:&>9KB>+2M!TZVTO3HYKA_GGE2SM(5DF?YI7#.W+&N@H ****
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MO]0N/$<.FZ_J.EW6F_;9M/\  =WXNNTT+4=&\0211Z3K&GW-P >;_M;?%/\
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M#GBO4/%7B:]T;Q+=^'(_![KXU\%:7%?Z-XAU74KK6/$EEH]MIC:C'=PVO*?
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M9?\ &*?"2&TBN/ EYXSUC0_B1/X@U]-7LX]0D^*?@1-8N+:XCTVVL/M?Q/\
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MX7_#'Q1\4O'FJQ6/AW5-2M-8\3OIN@6.A^'M-TW5KZRN-1UV'46GNM-L+G<
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MD,ECX>U31XK[0(--GGNVN"B@#TSQ;^S5\&/'&@?%3PQXG\(MJ.B?&KQ_X/\
MBA\2;,:YXAM/^$A\;^ K'X:Z=X5UD7%GJMO<Z6-,L_A#\/HC8:/-8:=>?V$7
MO;2XDU+57O>7\2?L:_LW^,+#7]*\3_#:UUO3/$_B3XK>+M=L+_6_$DUK?^(?
MC7IT6E_$?46A_M@+#)K=K! UHEMY,6@7<$-_X>32[V*.X4HH YO5?V%OV?\
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MM_$OP9\"Z?\ #;X<WL%@^KO:QPZ#X-TNRTF2P$7V'6'C?4=;M]1U.>>\D**
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AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>img247211528_24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_24.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #? V8# 2(  A$! Q$!_\0
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M?]"S%_X$G_"OG*BLO[=S+_G[^$?\CI_U.R/_ )\?^32_S/HW_AL*;_H68O\
MP)/^%'_#84W_ $+,7_@2?\*^<J*/[=S+_G[^$?\ (/\ 4[(_^?'_ )-+_,^C
M?^&PIO\ H68O_ D_X4?\-A3?]"S%_P"!)_PKYRHH_MW,O^?OX1_R#_4[(_\
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M ,"3_A7SE11_;N9?\_?PC_D'^IV1_P#/C_R:7^9]&_\ #8<W_0LQ_P#@2?\
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M&PIO^A9B_P# D_X5\Z10R3R!(HWE<]%12Q/X"FT?V[F7_/U_='_(7^IV1_\
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M_D<=7_>*?_;WZ',4445SG8)UKUCX4^+]>.B^.8SKFI&.U\.R-;I]LDQ"1)&
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ME0C"%\G@?," 1^.:JZ1H?AIO#VK^,-3T^\_LE+Y-/L=&M;K#-*R%V,DQ4D*
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M6M6C4HM*HK7.;#XJABDW1FI6_7;[^@ZBM+3_  ]>ZIH^K:I;HC6>EK$]TS.
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MA9;AF9BN,; #G=FJGAJST[3HM:\2:?KVA+XGN[VXBT];^]2+[!$7;-P >LC
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M)O$UDMWIVF&6%W:.,R31Q-*Z\%45V!8@\8 JQ!X5ME^&>N:M<P2Q:O8ZS;V
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M=H4T[.SL^S4VT_DTF?0=]X4N/&'@[0OAZERR:WH#VDVL*V/EAEW;@3U_T<.
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MKZBC>OJ*+@.HIN]?44;U]11<!U%-WKZBC>OJ*+@.HIN]?44;U]11<!U=.?\
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M*&D8*"3VY[U#<EJ_T-ER2=DW][-C^V[/_H7])_\  9?\*/[;L_\ H7])_P#
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M\!E_PK)HHYG_ $D'(O/[V:W]MV?_ $+^D_\ @,O^%']MV?\ T+^D_P#@,O\
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MUB_WQ_6I:.=_TD/V<?/[V:W]MV?_ $+^D_\ @,O^%']MV?\ T+^D_P#@,O\
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M_20<B\_O9K?VW9_]"_I/_@,O^%/D\06TI7?H6EOM4*-T . .@''2L:BGSO\
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M9$J^>Q&"SX'S$@ 9.>.*IWGA30M1L+>QO-#TN[L;;B"UN+&*2*'_ '$92%_
M"LU-I)=E'\(M/[[_ -;ERI)MOOS?C)-?=;^MCB?V<?$>D>+/@MX:U+0=%N/#
MVD/')';Z;<W#7!A"2NIV2L27C)!*-W4C%>E4V.-(8TCC18XT 5410JJ!T  Z
M#VIU3)\TFS6$>6*3"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .$7M/\ GI-^8_PK6CZ&J6O:[I_A?0]0UG5KN.PTO3[=[J[NICA(8D4LS'V
M!K"<8W;9Z=&<U!),K?\ "+VG_/2;\Q_A1_PB]I_STF_,?X5)X6\3Z5XV\-Z9
MK^A7T>IZ-J<"W5G>0YV31,,JPR ?P(R*U,4G3BG9HM5I-73,?_A%[3_GI-^8
M_P */^$7M/\ GI-^8_PK8P<XQS1BE[./8?M9]S'_ .$7M/\ GI-^8_PH_P"$
M7M/^>DWYC_"MC%&#Z4>SCV#VL^YC_P#"+VG_ #TF_,?X4?\ "+VG_/2;\Q_A
M6Q3FC91DJ0/4BCV<>P>UGW,7_A%[3_GI-^8_PH_X1>T_YZ3?F/\ "ME5+G"@
MD^U#*5.""#Z&CV<>P>UGW,;_ (1>T_YZ3?F/\*/^$7M/^>DWYC_"MC!]*,4>
MSCV#VL^YC_\ "+VG_/2;\Q_A1_PB]I_STF_,?X5L8HZ4>SCV#VL^YC_\(O:?
M\])OS'^%'_"+VG_/2;\Q_A7/>+_C;X,\#3>)H-5U@"\\-:1_;FJVMM"\TEK9
MDD*[;1@%L'"9W$#(&*[+3[V+5-/M;VW)>WN84GC8C!*,H921VX(H]G&U[?U_
M2?W"]M*]K_UI_FC._P"$7M/^>DWYC_"C_A%[3_GI-^8_PK8P?2BCV<>P_:S[
MF/\ \(O:?\])OS'^%'_"+VG_ #TF_,?X54\6_$#1? ^H^&;'5YY(+GQ'J0TG
M3E2(N)+@QM(%8C[HVHW)XXKH\'FCV<;7L'M9WM<Q_P#A%[3_ )Z3?F/\*/\
MA%[3_GI-^8_PK8 S0!FCV<>P>UGW,?\ X1>T_P">DWYC_"C_ (1>T_YZ3?F/
M\*V*,'TH]G'L'M9]S'_X1>T_YZ3?F/\ "C_A%[3_ )Z3?F/\*?XK\3:?X)\,
MZKX@U>5X-+TNV>[NI8XFE9(T&6(1068X[ $U>L+R+4["UO;<E[>YB2>)BI4E
M&4,IP>1P1P:/9Q[![6?<SO\ A%[3_GI-^8_PH_X1>T_YZ3?F/\*V,<XHH]G'
ML'M9]S'_ .$7M/\ GI-^8_PH_P"$7M/^>DWYC_"MBBCV<>P>UGW,?_A%[3_G
MI-^8_P */^$7M/\ GI-^8_PK8HH]G'L'M9]S'_X1>T_YZ3?F/\*/^$7M/^>D
MWYC_  K8HH]G'L'M9]S'_P"$7M/^>DWYC_"C_A%[3_GI-^8_PK8HH]G'L'M9
M]S'_ .$7M/\ GI-^8_PH_P"$7M/^>DWYC_"M@ L< 9/H*5D9#A@1]:/9Q[![
M6?<QO^$7M/\ GI-^8_PH_P"$7M/^>DWYC_"MBBCV<>P>UGW,?_A%[3_GI-^8
M_P */^$7M/\ GI-^8_PK8HH]G'L'M9]S'_X1>T_YZ3?F/\*/^$7M/^>DWYC_
M  K8HH]G'L'M9]S%?PI9OMS)-P<]1_A3O^$7M/\ GI-^8_PK8HH]G'L'M9]S
M'_X1>T_YZ3?F/\*/^$7M/^>DWYC_  K8HH]G'L'M9]S'_P"$7M/^>DWYC_"C
M_A%[3_GI-^8_PK8HH]G'L'M9]S'_ .$7M/\ GI-^8_PH_P"$7M/^>DWYC_"M
M@*6. "3[4K(RG!4@^XH]G'L'M9]S&_X1>T_YZ3?F/\*/^$7M/^>DWYC_  K:
M:-UZJ1]17EVM?M.?"KP[XU;PEJ7CC3+37HYUM98'+F*&9L;8I)@OE1N<CY68
M'D<4U3BW9+43K22NV=O_ ,(O:?\ /2;\Q_A1_P (O:?\])OS'^%;%%+V<>P_
M:S[F/_PB]I_STF_,?X4?\(O:?\])OS'^%;%%'LX]@]K/N8__  B]I_STF_,?
MX4?\(O:?\])OS'^%;%%'LX]@]K/N8_\ PB]I_P ])OS'^%'_  B]I_STF_,?
MX5L44>SCV#VL^YC_ /"+VG_/2;\Q_A1_PB]I_P ])OS'^%;%%'LX]@]K/N8_
M_"+VG_/2;\Q_A1_PB]I_STF_,?X5L44>SCV#VL^YC_\ "+VG_/2;\Q_A1_PB
M]I_STF_,?X5PGBS]J#X8>!O%MQX;UKQ5%9ZG:ND=XRVL\EM8N^-BW%PB&.$G
M(.'88R,XS7J<?[U \9$B$!@RG((/0@^E/V<;7MH+VTKVOJ8__"+VG_/2;\Q_
MA1_PB]I_STF_,?X5M+&[C*J2/84T@J<$8/I2]G'L/VL^YC_\(O:?\])OS'^%
M'_"+VG_/2;\Q_A6Q11[./8/:S[F/_P (O:?\])OS'^%'_"+VG_/2;\Q_A6Q1
M1[./8/:S[F/_ ,(O:?\ /2;\Q_A1_P (O:?\])OS'^%;%%'LX]@]K/N8_P#P
MB]I_STF_,?X4?\(O:?\ /2;\Q_A6Q11[./8/:S[F/_PB]I_STF_,?X4?\(O:
M?\])OS'^%;%%'LX]@]K/N8__  B]I_STF_,?X4?\(O:?\])OS'^%;%/$,A&0
MC$?2CV<>P>UGW,3_ (1>T_YZ3?F/\*/^$7M/^>DWYC_"MH1.<X4G'7BD",QP
M 2?0"CV<>P>UGW,;_A%[3_GI-^8_PH_X1>T_YZ3?F/\ "MEE*G!!!]#24>SC
MV#VL^YC_ /"+VG_/2;\Q_A1_PB]I_P ])OS'^%;%%'LX]@]K/N8__"+VG_/2
M;\Q_A1_PB]I_STF_,?X5L44>SCV#VL^YC_\ "+VG_/2;\Q_A1_PB]I_STF_,
M?X5L44>SCV#VL^YC_P#"+VG_ #TF_,?X4?\ "+VG_/2;\Q_A6Q11[./8/:S[
MF/\ \(O:?\])OS'^%'_"+VG_ #TF_,?X5L44>SCV#VL^YC_\(O:?\])OS'^%
M'_"+VG_/2;\Q_A6R5( )! /0TOE/C.QL>N*/9Q[![6?<Q?\ A%[3_GI-^8_P
MH_X1>T_YZ3?F/\*VA$[#(0D>H%"QNXRJDCV%'LX]@]K/N8O_  B]I_STF_,?
MX4?\(O:?\])OS'^%;'2BCV<>P>UGW,?_ (1>T_YZ3?F/\*/^$7M/^>DWYC_"
MMBBCV<>P>UGW,?\ X1>T_P">DWYC_"I+?P_;6DR3(\A=#D!B,?RK4I&^Z::A
M%/8F52;BU<BHHHKH/*)(^AKYQ_;)\727%MX+^&MEI&K>(I?%.I)=ZOIFA0">
M[;1[5UDN,(648=_*C.2!AFKZ.CZ&L"/P!H,?C^;QM]AW>)Y=.723?/*[;;42
M&3RU0G:N6.20 3QDG%1]I-]/TV_&U_*YVQ3=.R_K^EMYGR1X-^).I^"O@_\
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M\F2=D("G !7 XQT%4Y1]I*4=%T_'?^O6Y/+)TXQ>K6_X;?UZ'(_&;28?BO\
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M/8R_Y^/_ ,E_^1-/K:_Y]Q_\F_\ DC'_ +4\0?\ 0"M?_!C_ /84?VIX@_Z
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MM?\ P8__ &%']J>(/^@%:_\ @Q_^PK8HH]C+_GX__)?_ )$/K:_Y]Q_\F_\
MDC'_ +4\0?\ 0"M?_!C_ /84?VIX@_Z 5K_X,?\ ["MBBCV,O^?C_P#)?_D0
M^MK_ )]Q_P#)O_DC'_M3Q!_T K7_ ,&/_P!A1_:GB#_H!6O_ (,?_L*V**/8
MR_Y^/_R7_P"1#ZVO^?<?_)O_ )(Q_P"U/$'_ $ K7_P8_P#V%']J>(/^@%:_
M^#'_ .PK8HH]C+_GX_\ R7_Y$/K:_P"?<?\ R;_Y(Q_[4\0?] *U_P#!C_\
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M]J>(/^@%:_\ @Q_^PK8HH]C+_GX__)?_ )$/K:_Y]Q_\F_\ DC'_ +4\0?\
M0"M?_!C_ /84?VIX@_Z 5K_X,?\ ["MBBCV,O^?C_P#)?_D0^MK_ )]Q_P#)
MO_DC'_M3Q!_T K7_ ,&/_P!A1_:GB#_H!6O_ (,?_L*V**/8R_Y^/_R7_P"1
M#ZVO^?<?_)O_ )(Q_P"U/$'_ $ K7_P8_P#V%']J>(/^@%:_^#'_ .PK8HH]
MC+_GX_\ R7_Y$/K:_P"?<?\ R;_Y(Q_[4\0?] *U_P#!C_\ 84?VIX@_Z 5K
M_P"#'_["MBBCV,O^?C_\E_\ D0^MK_GW'_R;_P"2,?\ M3Q!_P! *U_\&/\
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MC_\ 84?VIX@_Z 5K_P"#'_["MBBCV,O^?C_\E_\ D0^MK_GW'_R;_P"2,?\
MM3Q!_P! *U_\&/\ ]A1_:GB#_H!6O_@Q_P#L*V**/8R_Y^/_ ,E_^1#ZVO\
MGW'_ ,F_^2,?^U/$'_0"M?\ P8__ &%']J>(/^@%:_\ @Q_^PK8HH]C+_GX_
M_)?_ )$/K:_Y]Q_\F_\ DC'_ +4\0?\ 0"M?_!C_ /84?VIX@_Z 5K_X,?\
M["MBBCV,O^?C_P#)?_D0^MK_ )]Q_P#)O_DC'_M3Q!_T K7_ ,&/_P!A1_:G
MB#_H!6O_ (,?_L*V**/8R_Y^/_R7_P"1#ZVO^?<?_)O_ )(Q_P"U/$'_ $ K
M7_P8_P#V%']J>(/^@%:_^#'_ .PK8HH]C+_GX_\ R7_Y$/K:_P"?<?\ R;_Y
M(Q_[4\0?] *U_P#!C_\ 84?VIX@_Z 5K_P"#'_["MBBCV,O^?C_\E_\ D0^M
MK_GW'_R;_P"2,?\ M3Q!_P! *U_\&/\ ]A1_:GB#_H!6O_@Q_P#L*V**/8R_
MY^/_ ,E_^1#ZVO\ GW'_ ,F_^2,?^U/$'_0"M?\ P8__ &%']J>(/^@%:_\
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M?5(_\_%]TO\ (-#TJBO-?^%->*/^BP^+/_ >S_\ C5'_  IKQ1_T6'Q9_P"
M]G_\:H^J1_Y^+[I?Y!H>E45YK_PIKQ1_T6'Q9_X#V?\ \:H_X4UXH_Z+#XL_
M\![/_P"-4?5(_P#/Q?=+_(-#TJBO-?\ A37BC_HL/BS_ ,![/_XU1_PIKQ1_
MT6'Q9_X#V?\ \:H^J1_Y^+[I?Y!H>E45YK_PIKQ1_P!%A\6?^ ]G_P#&J/\
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M7^0:'I5%>:_\*:\4?]%A\6?^ ]G_ /&J/^%->*/^BP^+/_ >S_\ C5'U2/\
MS\7W2_R#0]*HKS7_ (4UXH_Z+#XL_P# >S_^-4?\*:\4?]%A\6?^ ]G_ /&J
M/JD?^?B^Z7^0:'I5%>:_\*:\4?\ 18?%G_@/9_\ QJC_ (4UXH_Z+#XL_P#
M>S_^-4?5(_\ /Q?=+_(-#TJBO-?^%->*/^BP^+/_  'L_P#XU1_PIKQ1_P!%
MA\6?^ ]G_P#&J/JD?^?B^Z7^0:'I5%>:_P#"FO%'_18?%G_@/9__ !JC_A37
MBC_HL/BS_P ![/\ ^-4?5(_\_%]TO\@T/2J*\U_X4UXH_P"BP^+/_ >S_P#C
M5'_"FO%'_18?%G_@/9__ !JCZI'_ )^+[I?Y!H>E45YK_P *:\4?]%A\6?\
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M  IKQ1_T6'Q9_P" ]G_\:H^J1_Y^+[I?Y!H>E45YK_PIKQ1_T6'Q9_X#V?\
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MR#0]*HKS7_A37BC_ *+#XL_\![/_ .-4?\*:\4?]%A\6?^ ]G_\ &J/JD?\
MGXONE_D&AZ517FO_  IKQ1_T6'Q9_P" ]G_\:H_X4UXH_P"BP^+/_ >S_P#C
M5'U2/_/Q?=+_ "#0]*HKS7_A37BC_HL/BS_P'L__ (U1_P *:\4?]%A\6?\
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MK/J=O<B;R?LL D7RV0E3DG!S6A\7?C&?A%KW@%+[2EN/#GB365T2\U?SRO\
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M(I?K8TJKDE)+IK_Y,X_H>J?M$_&S6/@S8^#4\/\ AB#Q7K7BC7HM!M+*YO\
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M"[C.6S(RGH,U[Q^UZV_]ESXKMZ^';L_^.5%23]C*777\OPZZ%T[.JETT_/\
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MA;P7TIC4/':[?FB#RHI.X,1E@I KT'0?B/'XI^(6N^'M)T^2[TS0D$.H:Z)
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M5NGC$95\L%VLYDP$YY'&<UZ-J.HVFCV-Q>W]U!865NADFN;J18XXE'5F9B
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MV;MY[=/D>@>!?B5\5Y_%^F:7X[^%EIHNEZJKF+5/#VM#45TZ15W"*^4QH4)
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M7B/]G'X4>,=;O-9U[X:>$]:U>\?S+F_O]'@FGG; &7=E)8X Z^E>>_9/B?\
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MK^\6OE+_ .1"VVNW]?H>V>$?!/AWX?Z.ND^%]!TWPYI:L7%EI5HEO%N/4[4
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M (EL/$5UHMA<>(+"%[>TU66V1KFWC?[Z1R$;E4Y.0#SFO$/LGQ/_ .BLW/\
MX3UE_P#$T?9/B?\ ]%9N?_">LO\ XFGRTO\ GZONE_\ (A8]=\6?"KP3X^U&
MQU#Q-X0T+Q#?V/%K=:IIT5Q)",YPK.I(&><4MY\*_!>H:5K6EW7A'1+G3-;G
M%UJ=E+81-#>S  "25",.V%49(SP*\A^R?$__ **S<_\ A/67_P 31]D^)_\
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MDA4O:%EV,8CCY,K\IQCCBO"?LGQ/_P"BLW/_ (3UE_\ $T?9/B?_ -%9N?\
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M)/ NN^++?Q3J7@S0-0\36^##K%UIL,EVA'0B0KNR.W-=822<GDU\\_9/B?\
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9JG=M_>QL****Q **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>img247211528_25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $3 <X# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH *YO49O#D>I,NH1Q?:FV99XF.X9.WGIC@Y[#O72=JYO4X/#DNJ@ZC)";S*
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M_P!_7_QK3HH S/\ A'],_P"?=O\ OZ_^-'_"/Z9_S[M_W]?_ !K3HH 0  8
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MYY_*J?C=0^C0J<[3=)D D9ZUQOV"V(&8P2.1R>/UH$>J0Q)#&L<:*B*,!5&
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MX]*YO4=.U2ZO[B2W8QPD*$ N6&_CG(Q\N#C&/?UH Z-.G7-.J.%66-0S;F
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M!R.K^#IM7N+2[EU69;J%B20#Y:Y !,:Y^4_*.Y^E=:O"BEHH **** "BBB@
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M]/NQ_P"[6AH?_(T:1_U]Q?\ H0H&?:5)@4M% @HHHH **** "C%%% !1110
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MIHO%%A=-=*8)@J?9B77<%)R"0RC!+ XZDKZ5W]9FJ:%::M/;S3M*LEOG88V
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MC<<E7< T 6:*I_VMIW_/];?]_14\-Q%<1^9#(DB$XW(V10!\O?&;_DJ^H?\
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M3+\].G(K9/B'2XRH>Z(+G"YB?D^G2@!;V&-=2THK&JG[0_08_P"63UQ?QO\
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MW4#0SQK)&WWE89!HHH 9%:P0.SQ1(C,,,P') Z5.*** /__9
A

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>img247211528_26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_26.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z "@ H * "@ H * "@ H * "@ H * #.* $R/6@!<CUH
M3(]: #(]10 N1ZT &1ZT &10 9'K0 F1ZT +D>M !F@ H * "@ H * "@ H
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M92NCJ4E*-SZ,T?;_ &-8E1A?(3 ]MHKS7N>/+<O4A!0 4 % !0 4 % !0 4
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M0+&QLM5TVUU"]&+C;E_WAX/<"N5R<966QYTYR3LANM031:,SV,322QC"C=G
M]QWXH@[L(J\M3S<VZ6VF7&I3Z>L<WF!(,9"EN_&>PYKK=CL3UL8TDSW'S2Y)
M]Z%?H=\(+EMT+.GVC+=PL[I;J3G+GJ/I3,IM6Y8D5Q*K3R-]GB4%C@+G'7ZU
M-[%QC[NK&O;27!_<0LV?NK'R1^%#8FHP6NYOQ:)JUQX>GBN;:4>60\._CZ_I
M24D<CJ)2N0:39F739H=0@)2&0=7V!1WPU$M-@<M;F?=6 6\FCLI(IH<_N]LJ
MDD?G2>NYT0KM+FD=#IH:P\/FVU)T@?.Z-0WS*Y/<CIQ3:OL<TKU'S,O:-JUU
M.;Z*YF\@>8,3*/NMVYZ5$XK<56E:S9L7]M]KLGGBAB?4RH4W! _> =3CIG%2
MFT<ZO&6NQZ=IBE-+M%.,B)0<=.E<CW.27Q%ND(* "@ H * "@ H * "@ H 0
MT <[J1O#K43*[K;)\IC4 ^83C!/H!S5=!Z)&9XOT[^UM,2QANHHKDR)(@;D\
M'TJH.SYBH-IW1Y#XJL3;>))6GLIE20ELRDIYA'5N.U=L7=:'JT8>U5C->[N(
M@5!"QD<+&@3!^N*M:Z&DJ/(N9&E<ZW'J=E:V]\\IV-O(+9VX&/E.._'!]*2C
M9Z'.HN+OW(4U2274;-II EF@$;1*, IZ$#N?6BQ<J;<4R!+>*^NH[6/9:^8Y
M'S9*@=A]:3=C>2<:>AHZ7J&ER:X99[9HK*1!;W";MRGC YZCD#FD]$<33<=#
MO+;1;'PCI#ZGIUM*M[/"0QD</Y?&<9Z8]^]<_,YNW8YTW-VD>71WAN+I[BX8
MM)<,2X(R375;E2/6I.#C9&C82M:+-#;O),UY'Y36WE'YP>F?<=JFUG<B<8UG
M?L9XTZ2;4HK&RC>1W<+@I\RG/.:;DUJ*I*T=3NO#/@VR%XU]=322VZLRI"Z%
M3D=S[5C*I961R3KSE[J.-\0:M?:[K#3Y14M6VVRJ.  >N.]:Q5D:PI7C>1'<
M7GVR1EO5D+CYL*_ <]>#QBK:ML:4XZZ%RRDMDT*Z5[UH+MFS&N"58>]2:UXO
MH4];FMWEM?(F$V8]TDD:;59\\T]D94E>=V>P_"0[O!Y/(_TA^HQZ5Q5OB.#%
M34IZ'8:N,Z-?#G_4O_Z":RCN<\-T>$-;I;^3<*=R@@%\$<]Z[UL>]%NUD()2
M;EECC?RV;(=NH'O3L)V6X^24>0,+O3[Q&.OXCG%"):UNR"W>".\60DQ1@!B2
M,*!3>PY)M:&S;W]U97$5S;PQM9H/W<*,,%>_TK-Q31SNG%QY7N=G8^(=-NI4
MMXYEAN73B&0'./KT-<[@UJCAG3E%&7XET*WU.TN(K6Y9KV0B6.$MA 1UQZ$B
MM*<[;FU.;@]3S.]T?5-/!-]92P+G!9AQ^'K71%\VJ/05=25BG)=2SNTSDF3H
M,]@.@JC2*TT)5C,UFMR"BR [63=@GW J6*E.4=&2:>98]1@59%@9SM)=PHVG
M@\TK605YKE-B]N?$FEZJUM9&9K:+B%1B3*^I]<U*2ZG)%1:NR34=4,T$>D:C
MD%SO=E0+L)'W<=^:OEOL."UNCEGA:*8VWE[GW;5"\Y/;%*S;U.M2BHW9IMJ<
M,8AMK^U:>. ;5*RD$'OGL>]%K;'.H2>JV.H@UC1_L4D<&I^2ES@RQS6^0"!_
M> K.SN)QF]6317&FZ;;1W%_?_:&4_N5MY".#ZXH:OL82YI.R1['ICQOIEJT0
MQ&T2E03T&*X[6/.=[ZEND(* "@ H * "@ H * "@ H 0T <IK>I_V3/>:G>N
MJVEO'M1!]YF_SBM(QOHBXQ<M$>+:GKVJZE=3WINI(WF;Y5C^7CTX]*[U!)61
MZBP]HIEQ=8EOM)M(?$R?:+!6(BF0XF! YVD=<<9S6;CRNZ,N5I_NRSJ?A_3+
MC1$U'PQ-+?F/'GQL,R(#[8J5)IZFD:TU*U0YZWTS4;S:(-/E?GYCM*@#W)XK
M92MN=5:I!131:_X1G76N%MAIDC#?C?D%<9ZYJ'-)7,98E<ES2U#P=/HUP;C4
MIO*T]9,^<AY89X '7-3&:EL8+$<ZLCE[EK>2\G2/<$9V*@\$C/%:MI:G5#D4
M6CUZZU 2^$[>S\B2[GDC%O+$N0P;9SUZX]JYDESW1YC2Y[GD:E$*M@HZ# SD
M$>U=.Z/7A[/E3%:_NHWA>&9C-$?W9!Y7Z4=!5&HK0]-\">&UM;<:Q?R>=>3C
M='Y9^X,]_>N:I/2QYE6K)Z+8V_&=T#H\UI;WL=O>W*%859@I?U SZ^M123;,
MH)MZGC.P"WF$S%9%("A6!'O799H]>+4E:Q?71[_5[."]T>UEN=Y,<RGDJX'7
M/H014\]M#DC5=/1DMGX4U>298=35-,W+O'VCC*#J?0?C4N:1;Q5XV/0=1T_0
M?!_@V2;3;>*ZE \R+S0'+N<?-]!Q6',YR//C*;=C>^&=Y>:AX5^V7P0333LV
M$7:,<=JBKN355G8Z?5R5T>]([0O_ "-9QW(A\2/!7N72R,3$M"YW8QG.>]>@
ME<]Z,4M2&VC6X;SMA+G*9SC '%-Z Y)JY9"R6TD2M'+LVX"D<Y'O2N*.JU"X
MC$F%F4!/?@@TKC@[1N.>+S+81(Y4KT-"T$[7NS.O+VW@9$#S&]A4@,I "D__
M %JKS(:YW9;!I7BJ?2<1RQFXB9MQ#.=P^AJ7%2(KTDGH>EZ1X@TKQ/IS&>W6
M-\^64D8=QVKG<91>APSA*+T.#\9:+;:+>QK96)17Y;<Y('T%=%-W1TT)R>BW
M.;D6=X([J2-8XV)1=HP.*N2['92:3U&+")Y8T'4L!4(VG%-$UPTB:M-*D[@J
M^$96Y&.!3\C&-&^YT-B+75[47,\/FW<'^N8R;=X['ZTKM;'/).$K$VBZCHM[
MJL]K;6:VUPR-Y,SMN.[&/PI.YG.ZW,&;P_JT!=9[)PH;#.6 'UR33B=?MX.-
MB V$:[_.U"&.)3_RS8.V/H*:$ZC<>5#)C:W5PD=L\D*H@4&X88.._ XIHR7/
M'4^F-%79HEBN0<0(,CH?E%><]SR);E^D2% !0 4 5KN]@L(&GNIDAA! W.<#
M). /J20 />@!L.HVTUW]E60BXV>9Y;H5;;D#.".F2* += #&D"R!-PW$$@=\
M#_\ 6* '9XS0!5M]0MKF]N;2*8-/;;?-3!!7<,C\Q0!;- 'E?Q=N6\BPL(U)
M,\Q) [\?_7KIPZLVSLPG+&?-(\TN 8HF@GC,<B';@'OWKK6FIZ^DE[I&V+BU
MM8 24M@>3_#D\T[7,J4>63)+;4KC2)4?3KIH'D'S.K??([4G%,SE%.;YB35-
M4U+5;Z0WUT^5/$>=JK^%2HQ6Q5&C'5E6:.ZC@@W7$R!OG4!ST[4WV&J/-Z'4
M:5XH2#PW';^(HY[VS9RT(;[^!QD-[<UER26J..=+5N/0OZGJG@2WO?(CTB2X
M(4,\L9(V]"*BTGNR(4JDES'3'6M-U"YLKO3KB*Y6V/FRPQINF (QTZCWK-)J
MZ[F#IM;GEWBE9%\1ZBCL&"SLR\8X/(!Q753;Y;'IX>"E3-7PEX;>[>/4IF6.
M-A^Z5ASG^M*51+0RE5O=GKMK:K86+>6H^0?*,8_"N%^\['FR?,['B&HZK>>*
M]:EG>-GN$RD42)]T ],5VPM%6/5I1I0AJ;<'@%6M[:;4=2CTNYN 6:VD +8[
MD#M_2H=1=C'ZRX2:AL>A^$Y+&'3+BTTRYM)K>W)\OR) S'CJY]37/-)M71Q5
M$Y/5'C^L>(-:\3PYU.?]RCD*D6 @/H<=_K77&"BM#T*%*#B7](^R-X4N([J:
M2:\B=D@&3A%8#)].U-KWKD.G*%16/3OA0Q;PA@ONVSNH]AQ7)5^(PQ=U4L=;
MJXSH]Z!_SQ?^1K..YSP^)'@J1( HDG$<JMP&&$(KO5TM#W4VMCH7LK>W6WN-
M.N59>LNY0>/7V^M1?N<_M)2T91OKGR[B0,S,8SN4KZ=JI(J$5RE-[MK^,F>!
M"XQ@]SS_ #IVL7RN+T)?L\+7*%9]MNK'S"IR1^';%*XI<[.0NH(K:ZE2&X\^
M/)(DP1NJ[-HJDU3^(B,6\!PC,/7'%"BT:2<).Y+/)<61A1)MIXDPK< FJMI9
MF,[3D>@(USXO\*6IAEC>[MW*S*WWBN."/TK%/DD<EU2FY,Y6_LIO[,6(2&5X
M92)(57E!V/XUK?6YUJ44U=&;;-(EW$(A^\## QS1:QO.JK:#;F*:)Y$>-ED#
M$$$8YHM<%6]VQTGA[0+C^RKF>Y7;YR 0QE]K,<]1Z5#E9V.&52[LB[I'A*&#
M4([KS0MR 6\DDD*>WS"I;%*J[&-XMN;F2\BM_/,UM&"DA'>3OG^GM5174=%*
M^IAQI$@7=EAT([_G5)V/0<%%7&$1_=VDD].>M+=A4:Y3ZAT,$:%IX(P1;IQ_
MP$5Y[W/G);E^D2% !0 4 8'B:.0G2KA8)9X;:^269(U+';M8!L#DX9E/'I0!
M'KE](;*"YT^&>1A*B2210MO2%G7S-O&<X'89X['% %.!M5DO# SW:Z=]O*0.
MH.YH/LY)W-C('F<!CS[]* ,.=-928WJC4C=)H=RD+^6['SED&P8QC<0!U&3@
M'L* +\LNN1AH7DU!8SI8GMY5C)<W7.58 =1\N%(QR>N. "[X134?[<UB?4[5
MX;B>&T+MY9"-((<.%/0X;(X- '7&@#R7XISZ3+>16\PFEO8!OC2-L $^OY5U
M4;H[*$)-7/.G>V\V-OL[F,_,VZ3)4UU)V.^,9..@2V;_ &Z6.U'[EUWI)GY2
M#3N33FXW2.AMM)MC9QA;<7#I\X !89]>.U92DQ3LHW8[7_"!-Q<:E#*\,6-T
M\;*<HW?;ZCTI0J)I7,(5GT9S=I%/K$[-%$SI"F" <84=*UNCH4VE;N5;JX><
M&69]Q4;!CHN.P':E8VBHQAH7-3A%L]M,@81W4*L#COC!%):$8>>CYD)INJ-H
MNI1ZC;R>686&X==X[@T./,F@Q*A**<3I_%?A#4=1UZ*_TB#S[:_VRN^X?)GJ
M?RK*,TH\IQPKN*L=UI6F"*[CM%P]I;1 (<<Y%8SE<RG.T+K<Z)&0)Y>>2,D>
MU8''U,4:7INA3#4+;2$6:;)EE0CY!UR<G^5:*3?NFBDV>?\ CWQ#--JD-O9*
M$6ZMQ]H9@#)R3\F?X1["NBG&R.S#TDY79F_#YIK;Q:(K1L1F%RT?]_ .*<UH
M;8E16QAK8W+6]U=6:2S6H?,_R\1GMDUOI<J#4)6$@DD@D.W&""7Z<+WQ3V-Z
MVFJ/9OA"ROX,+*A0?:'X+;O2N&O\9X]9MR.RUCC1KW!Q^Y?I]#6*W,Z?Q(\&
M+B4C>K #GGH?K7>EH>ZGRH=;WA\QO,01 G;A,@8[#FFT2D^44+//;SO,A&P
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M*OL!2:L;QIP4;GTKHA)T2P).28$_]!%>>]SPI_$S0I$A0 4 % !0 4 % !0
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MDJ1EE/N#_2JL;=;,^D-&=I-&LF8@DP(3CZ"O->YXTU:3+U(D* "@ H * "@
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M!MNH[U1)$WFQQ_,-N&'H:::"R>J()(TF8-+RP.03US0F5:YJV\$5[!&;JX6
M0$!'/\2]_P C2>AA)N#T+HT^UL"CM>L8=P=3TY'UI<S(YY3O;<S9U2]>=V'E
M2H_R[A@,OK5;&L'RHRITN(+PIN$D6WETY5?QJT:*78C,\?V7#S1F7:<J >*%
M>Y2BY:E.(QNJ0E'=">NW S5%25B^8[1[A(+E.'ZL5SM'?I_*DKV,Y;:&:+J>
M"2Y5P'C5MH9EX*@\8JK:"O'=C["P.JW+I';.L;G?B(XP!0W9$NZ5RY=Z=#%9
M7.FQQ+&L4V^,LQ+2\?Q>A&:A/J9P4F[LQH+&ZB?'E$2;,@$\?0FJNCH<H]1D
MNGWMM$99K5U3/4C^5.]QQJ*)=2U2XLX26>*\09'F?<9<\8]Z39@[MW1]$Z0"
MND68)R?)3)'T%>:]SR)?$7:1(4 % !0 4 % !0 4 % !0 &@#/NN9&6BPF<[
MXKMIKW0+C3XQF6XC*J-IP<<GZ5=-*^IK2:C*[/"[O3Y+"Y:"8$MMWH",9'J?
M3Z5Z$7IH>FJCJ*Q=OKV]UN"U2]B5#:Q[$*\#'O[\41LF:*@U[RW'Z#J;V.N2
M7D2QNRV[*8G;&\' P#ZTI*]B*RU5C($3JC@C(!..W%,Z:</=-;0;"_GT/54L
M-/;4!(RK(BD@Q]2",=:B4DCSZC49:FGH'@/4;F6*YUI#9Q1N"L7\3X]?05#J
M+H.>(YE9'5^+;Y]&\.S7$"JSN/+3)^[G_P#54P]YF<6FSS&QTV]OUWFWDBLT
M7?)<,A"JOU/4UMS+8[/;W7(A084B8F)O+QMC!;!'N?6FSHC'E5V;WA@QZ9::
MA?RRQP$!599P1YB'LOO4O4X*S3E9%F/3[#6[.:6"X^S6THW%?]9)O' &/2B_
M*2I26EBO;>"+H3M<+?P?8X(3,DC<-(0.FWKC(ZTE.P.L^5*QRT5T%"-PI4C@
M^QK3<[O:J4+'HFH>.+(^'9)--4"\O<QS(^3L.!N;^6*P47>YY].F^:QP<+&
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M!#'9LI5MA4\$$T;#3ML9K>'=#9MQMH@?9B*KG9?M9=QS:#HK  P(0/\ :/\
MC1SL7M&AH\/:&%VBWCV^F\XHYV/VLA6\/:$ZD-;18[_,::G(?M9$;^&-!D@:
M!K9#&>J[S_C1SL/:SO<:/"?AX# M8_\ OL_XT>T97MYD4OA'PR$)DM(0HYR9
M",?K3]I+8/;395_L/P67*#[&7/! FR?YU:G-;%*K4Z%:2V\ P,T,MQ8(R'#
MS\@CMUIWJ#YZKU6P)%X  *K=V!SU G_^O1>H)5*KT0-'\/XW4-=:>K#D?O\
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MNR%T:6YAUJRG,81U<$*1GO2EL#BW&Y]41',:G&,BO+/,V'T % !0 4 % !0
M4 % !0 4 (:0'BWB'6[C1/BEJ$UG,JW+PHJB1<ITYKKA%2C9G5&"E&QYE?W4
MU]>M=O&D1)P O2M4EL=D8N"N5B'DW%7*@\-CBJVT"SEJ@BA26%G+-@OL]C@9
MH>PH).5F:IU6./23!-;QW,J$1QO)]Z,?U]*%L.:2EH)HFEV^IF]GNKIH([./
MSGVKG>,XP/2DV1)N+L5!='4=4!GD$: !4S]U5'0"FAQML126K!E=%,D1;:C
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M?'4?G0KIG)?WA-/#MJ]NP.&\U< ]^:4MCIJ-*!]11Y\M<]<5Y9X['T""@ H
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M0U?Q3++H\5I<Z?;RV\)54"Y5UQZ-4<MM48SI^RV90?4ULKUWMM/C:!XP!%<
MME3SDGCGWILR;<C<DU5H_)N-%BL("T*^<@0%HVQR,GJ*23V",')V9FG6-32=
MI%O'!/!08"G\*OE2.B5)15T4M1U"ZU7[+]HVQ1V_RJH'ZGU)H2,>3JR>R;.J
MVHV@8D7@#WI2V.F<8J)]2P_ZM/\ =%>7U/(9)0(* "@ H * "@ H * "@ H
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M_A1[2/<N52"V-;2?A_J[WUA>^7<6Z*RM-'+;."ISSCCD5G.HFCD=34^AT&%
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M^5%QW8;5'\(_*BX78;5_NC\J+B%H * /_]D
7                               !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>img247211528_27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_27.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #F 7,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HIDLT5O$TLTB1QKU=V  _$TVWNK>[0O;3Q3*#@F-PP'Y4 2UYI=ZS?
M1?$\)_:,JQQWL5H+/S,1F%K=Y&<KZAA][VKTNJ4NCZ;/?_;Y;&![ORS%YS(-
MVP]5SZ4 <,=0N4^*44LE_P#:-/N76WM8;:^)$;>27R\0X(///TK>\1^,T\-:
MUIEE<Z9<R6M]((C>IC9$Y.%!'O6O!H.DVU['>P:=;1W,<0A258P&5 ,!0?3%
M<E\5?^05H?\ V&+;_P!"H [ZBCM10 4453M]5LKK4;JP@G#W5H%,\8!RF[I^
M>* +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '->.T\_PS+:FVDF
M69TSB'S4&U@P#KD$J2,''/-9?P\T*/3DN]1AEM0MW@-!:V[PI&X9B1M?GC<!
MSZ5N>,83/X6NT#%6RC*PNA;$$.I!$AX4Y%5/ 5W)=^'F,LLTLD=Q)&S378N2
M2#VD  (H ZBBBB@ K@?BK_R"M#_[#%M_Z%7?5P/Q5_Y!6A_]ABV_]"H [[M1
M1VHH *XCPW_R4WQ=_N6O_H+5V]<1X;_Y*;XN_P!RU_\ 06H [>BBB@ HHHH
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M4+E+GP[IZZ=*]M)J<$C7@8;$8/PI'J:]%33K*)K9DM8E-JFR A1^[7&,#T&
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MH **** "BBB@ HKFKW6[R#X@Z9HR%/L=Q9RS2 K\VY2,8-=+0 4444 %%%%
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M69UWY')X/';@58\"^$;WPNM]]MOVNWN)-ZDR,0F>2,$^I//4]Z["B@ HHHH
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M_P"A4 =]VK%\7?\ (G:Q_P!><O\ Z":VNU8OB[_D3M8_Z\Y?_030!\-T444
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M_P#030!\-T444 =#X#_Y'[0?^OV+_P!"%?;M?$7@/_D?M!_Z_8O_ $(5]NT
M%%%% "-]QOI7PKXD_P"1HU;_ *_)?_0S7W4WW&^E?"WB3_D:-6_Z_)?_ $,T
M 9=/@_X^(_\ >'\Z93X/^/B/_>'\Z /NW1O^0%I__7M'_P"@BKU4=&_Y 6G_
M /7M'_Z"*O4 %%%% !1110 4444 %%%% !7SI^TG_P AC1?^O=O_ $(U]%U\
MZ?M)_P#(8T7_ *]V_P#0C0!X91110!])_LW?\BMJW_7Y_P"R+7M=>*?LW?\
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M7_T,U]TM]QOI7PMXD_Y&C5O^OR7_ -#- &73X/\ CXC_ -X?SIE/@_X^(_\
M>'\Z /NW1O\ D!:?_P!>T?\ Z"*O51T;_D!:?_U[1_\ H(J]0 4444 %<MXT
M\%6WC*WM8IYS!]GDWAU0$GV^GK74T9H AM;=+2TAMXP L2!0 ,#BIJ** "BB
MB@ KYT_:3_Y#&B_]>[?^A&OHNOG3]I/_ )#&B_\ 7NW_ *$: /#**** /I/]
MF[_D5M6_Z_/_ &1:]KKQ3]F[_D5M7_Z_/_9%KVN@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH R-?\,Z3XFMHK?5K;SXXF+(-Q7!((/3V)%6-'T:QT'3
MUL=/B:.W5BP4N6P3[FK]% !1110!YQ#K>I-\33";^4VYOVL?L6X;!&+82A\>
MN[OZ<4OQ-_M?4KW0]'TK1Y;IS>1W1N"^R%-ASAFP<9]<5W T73%U<ZL+& :@
M4\LW&SYROIFKU '/_;/&'_0"T/\ \',W_P BU0UM?&&I:'?6(T31%-Q \89=
M7E8C(QT-L,_F*Z^B@#Y/_P"%">./^?>R_P# C_ZU'_"A/''_ #[V7_@1_P#6
MKZPJO%?V<]U):PW<$EQ%_K(DD!=/J.HH ^:?#OP6\;Z/XCT[4FM+!Q;7"2E6
MN]H.#GDA21^1KW[[9XP_Z 6A_P#@YF_^1:Z"B@#G_MGC#_H!:'_X.9O_ )%H
M^V>,/^@%H?\ X.9O_D6N@HH YXW?C J1_86A]/\ H,R__(M?/>J? _QQ?ZO>
M7@M;%1/.\F!=9 R2>NT9_(5]2T4 ?)__  H3QQ_S[V7_ ($?_6IT?P&\<)(K
M?9[+@@_\?/\ ]:OJ:2_LX;J.UENX([B3[D32 .WT'4U8H Y>PD\86NGVUN=#
MT0^5$J9.L2@G  _Y]C5C[9XP_P"@%H?_ (.9O_D6N@HH Y_[9XP_Z 6A_P#@
MYF_^1:/MGC#_ * 6A_\ @YF_^1:Z"B@#P7Q?X)^*.M>);J_L;B.SMY"-L-OJ
M3LB_0E%_D*Y^7X6?%>8H9=1+E&W+F_;@^M?35<QXX\96G@W16NYF!N'X@C9&
M(<Y&<D=.* /$/^%9_%S_ *"K_P#@P:O7?"D'CG1_#5G87FFZ5=7$*8>:?5Y5
M=CZD"W;^9KI]"UJT\0:1!J-E(7AE'4H5Y[\'FM*@#G_MGC#_ * 6A_\ @YF_
M^1:/MGC#_H!:'_X.9O\ Y%KH** .?^V>,/\ H!:'_P"#F;_Y%KS#XI^ ?&GC
MJ^L)X].TN#[/&4(AU!I<Y.?XHDQ^M>WT4 ?)_P#PH3QQ_P ^]E_X$?\ UJ/^
M%">./^?>R_\  C_ZU?5-Y>0:?937=RQ2&%2[L 3@#V'-<KX*^(&G^,)[ZWA<
M>?;S.$58W&Z('"L21U/I0!R?PM\)>,_ VD7MG)I>DSF>?S<RZD\1'R@=%A?/
M3U%=U)J7BJ(J)-'T!"YPH;6Y1N/H/]%KHZ\P\9C2$\87#>)[6XN+-K&-=-6%
M&8F7<=P0KT?.WGCB@#K_ +9XP_Z 6A_^#F;_ .1:#>^+P"3H>A #J3K,O_R+
M7GM]XM\40ZGK4%K,T"VZLD,#Q;FC4,@1P-O)()SECG\*MZCX@UFSN+G0I[^>
MYF,JIEK?!DA:U9F.0,??_P * .U_M#Q9Y?F?V+H.S&=W]M2XQZY^RTX7OB\C
M(T/0B#T(UF7_ .1:\KA\1>(H["7300+:'2BJ6LL1.]!;!@^-O)W<<MCMBNHT
M'6M??Q+9I-=R&PDO);3[-]G 546)75LXSG.1Z4 =9]L\8?\ 0"T/_P ',W_R
M+1]L\8?] +0__!S-_P#(M=!10!F:;/KDLSC5-.TZVB"_*UK?O.2?0AH4P/?)
MK3HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LZUT'2;'5+G4[73X
M(;ZY&)IT3#R?4_@*T:* "BBB@ HHHH **** ,ZZT'2;W5+?4[G3X);ZV_P!3
M.R9=/H:T:YB_\=Z+IWBFVT*>\MEFE5B[M.H\IAC"D>ISQ73T %%%% !1110
M50UC2+77-,FT^\4F&4 -M.#USP?PJ_10!'!"EO D4:@(BA0![5)110 4444
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MHH **** .<OO!6D7_B>UUR:UA,T*,&0Q*1(3T8G&<C'%='110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '__9
8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>img247211528_28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_28.jpg
M_]C_X  02D9)1@ ! @$ > !X  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $$ X0# 2(  A$! Q$!_\0
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M+WB:S\)^#9M6TBWNHKS3M"GU:^MQ?:O.GDVEJQN-DH 4_P ^>I_L&?$"WO\
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MDDM=%HM$K*\?Y?\ R9GRA_PU6W_1MG[5_P#X:"/_ .:6C_AJMO\ HVS]J_\
M\-!'_P#-+7O?A_XC> /%?B7QEX,\,>-/"_B#Q;\.[K3+'Q[X9T;7-.U'7?!E
M[K5C_:>CVGB?2[2XEO-$N-4T[_3K"'48;>2[M?W\"O&-U=I3J5\!2ER5<EG3
MGRTY\M3&8J$G"K"-6G/EE%/EJ4Y1J0E:TX3C.+<7%A>/\GXOKL?*'_#5;?\
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M-L_:O_\ #01__-+1_P -5M_T;9^U?_X:"/\ ^:6OJ^BN7ZWEG_0I7_A?B/\
MY'^KORLKQ_E_\F9\H?\ #5;?]&V?M7_^&@C_ /FEH_X:K;_HVS]J_P#\-!'_
M /-+7U?11];RS_H4K_POQ'_R/]7?E8O'^7_R9GRA_P -5M_T;9^U?_X:"/\
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M-V-]=?&#P/X%U/P9'>_&:]\?^*)(+77/#^L^%=1?1);F\T%?#>DVQA2U\_\
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M2Y<OJXB%*GC\;/&4NCZQ=34H*TWS73U3M)7U33=G%7LOAOHW=?R[?L@?'/\
M:_\ VROVAOV7?A+\4?VH/COX$\ ZU^S=^T!XT3Q!\,=1TKX=>)OVAO"/PO\
MCUJW@[X6?%*_2;0KR70+SQ?X=>P;5-<T;3[*7Q#8Z?&UG]DBU"6Z/C_[#'Q]
M\"_!;]DCP;\$;3XO?&+1_BO\9?VZ_C%X.U3P[X3^/_AGX2:5\-K3PUXF\574
M%W\3_&/B;PSXLU#X3Z%X[%M=-=W&DZ9IWB+XA>*+%(+._4PW:U_8/#IOA>WN
M[._M[#0(+[3].&D6%[#:Z=%=V.DJRL-+L[E(UFMM.#*K"RA=+8,JD19 QS&H
M?#?X2:O:ZM9:KX"^'.IV6OW,5YKMIJ'A;PS>VNM7D%P]W!=:M;W-C+%J5S#=
M2/<Q3WB32QW#O,CB1BQSJ^).55XXS"OA>GA,LQ-? 8JG@,OQ&%PM*EB<#B,]
MK1JU71R^D\0G_:V%?*G0E%Y93HT:F'P]6,* ZZ:DG32BVFHQ:5FG)W=HJ]^:
M_3X4DTM%_)#\(?VM=:\?_M*?L:ZC\=_CAH/BG0/V<_V_/VT?AGX7^*'BKQWH
M/B);+X?R? ?3+_P;'KOQ0BTOPQI_C*-[JY>T\.>,KO2=-N/%%JL4\44P*X\\
M_8QUG5?C'^TI^PEXZ^,?[3GQ$^'_ (R^,O\ P3O^/&B:#\8#\1+'P3>R^/H?
MC[?^%O#'AKPQ>0VNGZ5<QW$CV6M7O@ZP@=M=UNTM[^>*24;6_LIE\ _"V>W%
MI-X+\ S6@NH+T6LOASP[);B]MH!;6UV('LS$+JWM@+>"X"^;% !%&ZQ@+3KW
MP5\/[JUT^&/P[X,MYM"CN/\ A&;K_A'_  [<-X9N9V,HN]$AN+.2"PE2ZV79
M6W2-)9XU:4-S775\4LK]CB*."X:EE\L1@*N71JTL7@Y+"T:W^LE:I*A3>5\J
M5;&\0+$8FC;V598&FI1E*IS4QUXZVI\MXM:-:74MO=ZRE=K9V\]/PU_8=_:#
M_:<_:7_:$_9]^!WC7XA^-]&UG]A3X7?$S3?VZ8[5O[-@^*WQTB\5WGPK^%.D
M^*Y?L[#5+/Q!X:\/:A\96BMGM()+F["&/R)(L?T#5\??LI_LG^"/V6F^,>O6
MOCSQ%\3OB7\?_B9??%3XM?$SQLWAZVU[Q-X@GLX-,TRQAL/#FGZ3HVDZ!X>T
MNW6QT72K&S2&UCDN&W,9B%^N/MMG_P _=M_W_B_^+KX#C#-,MS3-W/)\/0PV
M6X>A&E0C0H+#PJ5J]2KC\PJQ@Z=*K[!YCC,73P"KP5:EEM+!8>:BZ*C'*I*,
MI7BDHI)*RMJ]9=%?WF[7UY;+H6:*K?;;/_G[MO\ O_%_\71]ML_^?NV_[_Q?
M_%U\L9EFBJWVVS_Y^[;_ +_Q?_%T?;;/_G[MO^_\7_Q= %FBJWVVS_Y^[;_O
M_%_\71]ML_\ G[MO^_\ %_\ %T 6:*K?;;/_ )^[;_O_ !?_ !='VVS_ .?N
MV_[_ ,7_ ,70!9HJM]ML_P#G[MO^_P#%_P#%T?;;/_G[MO\ O_%_\70!9HJM
M]ML_^?NV_P"_\7_Q='VVS_Y^[;_O_%_\70!9HJM]ML_^?NV_[_Q?_%T?;;/_
M )^[;_O_ !?_ != 'R'^V_H/[:OB+X0:18_L'^.?A=\/_C+'\1/"=UK.M?%K
M21K'AR?X<0G4!XJTZTMVT77XTU6XF?2I4<Z>LTNG6^I6ECJ&EZA<VM_;_ O_
M  40\0>%/"/[=?\ P2"UKXO^(?!&B:-IWC#]I8^*=>\47>F:)X/AO&^#>BP7
M%P\_B*X%G964^IR(MDE[<LZ/+;1F5IMK']MOMMG_ ,_=M_W_ (O_ (NN?U[P
M_P""O%4<$/BC1/"WB2*U,C6T6O:;I.L1V[2A!*T":A#<+"9!'&)#&%+A$W9V
MC'U&1<10RJKA/;9?AZM##87B+#2JX6G1PN9UEQ!D]?*9.OCW2JRKT\#[98C"
M4:L'"G)UX0</;RG'2$^5QO%-+GU6DGSQY=7K=1W2MWVO<_E5\4_'SX??#_\
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M+*[ VBZM$OXKA;:X"\":$)(!QNQ5SX_P<LSH8^ED5/"*EA^*,#*."G@\-5>
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MD6:*K?;;/_G[MO\ O_%_\71]ML_^?NV_[_Q?_%UX9!9HJM]ML_\ G[MO^_\
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M?;;/_G[MO^_\7_Q='VVS_P"?NV_[_P 7_P 70!9HJM]ML_\ G[MO^_\ %_\
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MISPV(<)IQGRMODE=*0J]*C&@ZD()-\C3N[VDUW;Z,_I@HHHK^1#S@K)U/7]
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M_P Y_7^EJ?\ %.'*?^CM9C_XAN&_^B3U_IZ?VP?\)YX#_P"AZ\$_^%=X=_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,9PJY?3>+S6I4K0Q-'FP_P A#PW^COC<!FF#I4<^Q&$Q&78_!YQ@WC..*/\
M:=++,;PY2Q.2XE8U4(RS>GCLBX-H4,EI5,/G%99=D%&CAJF"Q2CC/I'X0?MO
M?"+X=:W>>,[[X5>)8O&3?M!^-_C%=ZOH=CX U;6_'/AOQ9>:I=Z-X*\0^)O%
M-K-JGA<^$'OXF-SX6D5-86V$2R6K3S3#\\/'>M:=XF\<^-O$VD6^H6FE^)O%
M_B7Q)86FJM;2:G:6VOZU>ZNEK?R61-I)<VQO##));$Q/L#KC) ^E9OV>_P#A
M-_A=X2^,/A'2E\&>%=?O/$FAV]O<7<^OW>J>-M:^,>M>#_A[X-B#W4+V5GIN
MAG2+;Q+XSU#[+HE@$MYIC=ZOJMK83<A\2_@+H/@KP1XT\8^&_BG:^.&^'?Q1
MLO@_XQTI?!>K^&6LO%]SI^LWMS-I5[J.H7::MHEM-H5_9PWC6]C=W+QB:33[
M2*2$R_*9_/C/-,IP6'S*GA*V58#"QSW!5:,<!@)5\/C\!"O4QM"A5>$QN*<\
M)@U+%*CA&W/"U,56A*M6JXG$?H7!T/##A_B/-,9DE3,L-Q#F^/EPEFE#$3S;
M-X83&9/G$\'1RO%XO#QS'+<![/,<SY,"\5F$5&ECJ.7X>I3PV&H8#!_-]%??
M%[\)_@]K^KQ_"/2? E_X>\76_P"R_H'QLM/B=9>,=9U$S>*(OA98?$'6[#Q3
MX2O;>;2AH&M2O=Z5I[:7/8WFG7MS821O=H'MI.2U#]C[4K>T\/S6OCE%O_$6
MH>,O"EEHGB#PS'H6KR_$+PKX(/CFQ\*QVD'B;69+6W\3V<%_H^G:AKZZ%JUG
MKEM!8WWAF,WT3IX]7@G/5[26#IX?,Z=&N\)B*N"K\D:&-C7I8>>#G#'PP-:I
M7C5KT(\V&IU\/-58NG7GRU%3^FP_BKPD_8PS.MC<AKXK"QS#!X?,\*JL\7E<
M\)7QM/,X5,GJYKAJ&%GAL)BINGC:^%QE)X><:^$I<]%U?C2BO=$^#^CZ3\6/
M ?PQ\=>.T\+#Q+IW@>Z\5:M%X:U'5KCP9J_C:PL]2M/";:5;7 EU36K:+4]*
MLKFY\ZST^SU.]EBOC!%I]RQ\_P#B3X4@\!_$;X@>!;:^DU2W\%>-?$_A.'4I
MHXX9[^+P]K-YI4=Y/#"SQ0SW*VHFFAC9DBD=D5BH!/AXC*L=A*%7$8BE3IPH
M8Z66UX?6,-.O1QL*7MI4:N&IUIUZ=H*2]I.G&E*K3K48S=6A6A3^MP/$64YE
MB\/@L%B*M:KB\HAGN%J?4\;3PN)RNIB%AH8G#XVKAZ>$KN525.3H4JT\1"A6
MP^)G2CA\5AJM7BZ***\X]L**** "BBB@#^FK_@E5_P FCZ9_V43QQ_Z-TVOT
M>K\X?^"57_)H^F?]E$\<?^C=-K]'J_U<\)/^38\!_P#9+Y1_ZB4S_GE^D5_R
M?;Q;_P"R\XA_]3J@4445^B'XR%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >G>'U4Z19DJ
MI.)N2 3_ ,?,U?"6M?\ !2_]F+3/C#XY^#.D6WQH^(&J_"KX@^&OA/\ %OQI
M\+?@)\5/B1\,?A9\3?%D5C<:3X&\;>-_"'AC5=.L-?BM=5TJ[UJ&P34K7PW!
MJEA_PD-UIDMPL8^[O#__ "![/Z3_ /I3-7\VW[67[+/[:ND?%C]H/XB?\$[O
MV9_CO^RQ^U-\1?C7X-\1Z/\ '+X=_M7?!S5?V)?CO92:II>E^(_B]^T]^SQ\
M0]<;4X/$%IX%CO['7-!\(_!Z\\7ZOK%KI%[9^+];BMBDP!_2#_PE'A0:CJ.C
MGQ%X>_M;2+9;W5M+_M?3?[1TNS8*5N]1LOM'VFRMF#H5GN8HHB'4AR&&:TGC
M7P1%]C\WQ;X5B_M#4Y]%L/,U[2$^W:Q:E1<Z39[KL?:=3MBZ">PAWW4)=1)$
MI89_C7\1?\$O?VL/^&$?CI^S%XB_X)N:?\:O^"A&OV_[6MWK'_!1RU^-/P:\
M(6'Q+UOXKZ_JFL>#/&NA^)_$'CFV^+'B*^\8^&K^Q\&3?#3QOHGAOP]\.8O#
MMHIU*&UDLIZ]!^(O_!';XM^!?B;XNT_3/V5]0^)W[/OQ2_83^#7P:^''@3X-
MR_LZMK?P#^/.G:2T?QXFN=<^.7BS1D^&GBWXE>*9+'XB3?M1?#:3Q;XSN->\
M.6UKJPU":TT.*\ /Z]IO$'ARWUJU\.3ZWHD'B&]MI+RRT&;4K"/6KNTBW>;=
M6NEO,M]<6T>Q_,GB@>)-K;F&TXX/XA?&#P7\/O!OC?Q@WV_QM-X$\(:KXUU#
MP3\-[2W\9_$36-(TFWEGDB\->#M.NAJ6LZA>-$UKIUK"(Q>7C);I*':OY'O!
MO_!'S]LK0_$GQ@^&OQNTK]H/XX?$+QK^TE\(/BE\'OV\/#'CW]FR+XG>!?AE
MX&\*^#+'PV/$WQW\<W]I\8O!WBCX42>']8\)>)_A_P##[X;W_A+XNV.N:AK%
ME! ?$&KWEE\_:[_P0]_;GTK]C#]D:Q\ ?LV:7I'[7-GIO_!5K0/VIO%&D_%C
MX::1XR\0^'?COX?^)^A?LR^'O$OCC_A/$M/%GAO4;6Z\!PZ/X?T_6-1TKP-+
M'#?ZM9:%?0ZE<* ?V[>$/B9X/\8:#X*UJ&\7P_>>.]!TK7M(\(^+&L]!\;6H
MU32K35WT;5_#%S=-J%AXBTB"\C@UW1RLMSI5ZDUM<X:,D]%#XH\*7&J7.AV_
MB+P]/K=E-';WFCPZOILNJ6EQ,C2107.GI<-=P32QH[QQ2PH[HK,JD*2/XF?A
M#_P1*_;3T#]G'X@ZWXB^ &E:%^V':?M]?L*?$KX0?%"?XE?#?6_''@3X"_"K
MPU\';'XO:UX4\71>-KNW\.V6EZEI_P 0GUOPS:7]AKGC:.-XX]+UZ"31@WF7
M[.7PXTGP%\?O^"(GPUE^$_P^\6_M3:)^W7^T)K?QT_;.^$_QM^$WQBU']JC0
M-*TWXG:GXI^(VOKX,\;:U\:O['GNY])O_$T/QO\ !GA*/X8:CH4'A>P+2:BU
MJ@!_>EL3^ZO_ 'R/\*-B?W5_[Y'^%.HH ;L3^ZO_ 'R/\*-B?W5_[Y'^%.HH
M ;L3^ZO_ 'R/\*-B?W5_[Y'^%.HH ;L3^ZO_ 'R/\*-B?W5_[Y'^%.HH ;L3
M^ZO_ 'R/\*-B?W5_[Y'^%.HH ;L3^ZO_ 'R/\*-B?W5_[Y'^%.HH ;L3^ZO_
M 'R/\*\?N/\ CXN/^OB?_P!&O7L5>.W/_'S<_P#7Q/\ ^C7H AHHHH ****
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MJOV+_P ,H_\ !9'_ *3&_!W_ ,5;_"?_ .?E7KG_  2J_P"31],_[*)XX_\
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M+&2[L;FWOK/[19SQ3N ==_PB5[_S]6O_ 'S+_P#$T?\ ")7O_/U:_P#?,O\
M\37G?QB_:A^#7P#O[6Q^*NO:WX:2\@\'2P:JG@?QOK/ATS>/OB;X8^$'A+39
M/$FA^']1T*'6=7\>^,?#^F1:++J":I!8W<VOW-I#H%C?:E;?05 ' _\ ")7O
M_/U:_P#?,O\ \31_PB5[_P _5K_WS+_\35KP_P"/_#WB;Q3X[\':6-<&M?#B
M^T+3O$QU'PQXBT?26N?$>A6WB/3?[ U[5=,L]$\60#3;N$7]UX8O]6MM*O\
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MO_Q-=]10!P/_  B5[_S]6O\ WS+_ /$T?\(E>_\ /U:_]\R__$UWU% ' _\
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M:W)KFI:[:W/A\>F?$#_@F!=>.OC3?_$J;XO>%6T4?M(?"O\ :.\.#Q/\&_\
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M>+=3EU+6]=BM=-L]'T?1M.L0 >0^%_\ @I9\-SH.F^,/&^C>)FTKXIZAXO\
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MIDD44H"RQQRJ#D+(BN 1T(# C(R>>M=Y_P *O^)O_1./'O\ X1_B#_Y7T?\
M"K_B;_T3CQ[_ .$?X@_^5]+^SL>]'@,8T^CPM?R_Z=^?]68UG>3IIK-\L36S
M6881-?/VVF_Y]F<*         !@ #@  <  =!2UW/_"K_B;_ -$X\>_^$?X@
M_P#E?1_PJ_XF_P#1./'O_A'^(/\ Y7T?V?C_ /H!QG_A+7\O^G?G_5F']M9/
M_P!#?+/_  X83_Y=Y_GV9PU%=S_PJ_XF_P#1./'O_A'^(/\ Y7T?\*O^)O\
MT3CQ[_X1_B#_ .5]']GX_P#Z <;_ .$M?_Y7Y_GV8?VUDW_0WRO_ ,.&$_\
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MQ_9B_9QM]2\->'/C%^U%\2?VJ/V;OBYX8\-^*+OQ5JE_^P1\3_BKK?[0NO\
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M^TA#XT\#_';1_AC\ OVK?#'Q:M?"7P4_9^\-_LQ^%_!4?Q4UVT\'Z;\8-/\
M%/C3Q3#\18?BM;ZEX+M_@YK^F>/[V/1_#>H:K'I<FHWFF_T#^*I?@+\"K?PM
MX\\1Z5X#^'JV4/@7X >#/$-OX9L;*^L=-\;^+_#WA;P%\*/#LVD:8^H66@:O
MXQNO#=AI?AC3UBT6&^2PN9+:WBLA<0:/P?U[X-Z_H?BV'X*?\(G_ ,(]X?\
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MCZ\^*&LZKJ'Q)^)'[+^@_$/Q,OP6U?5=9\0K_;7B":^\%:=++X0UCQ%,NO\
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M_@B7K]J>N=1_X*)?LJ. &^ZI^PV<QWID>81E" WE[CC/ZZ44 ?D5_P -=?\
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M_P"?S]KO_P 5_P#[9G_SF:_8+^TM1_Y_[W_P*G_^.4?VEJ/_ #_WO_@5/_\
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M/P?X@OO"GQ0\.ZOI6HZ&VHZEX4N8+K7+#38-4O/"6E^%=+$=M?1:Q>77WO\
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M/];+_P!=9?\ T8U,I\G^ME_ZZR_^C&IE !1110 4444 %%%% !1110 4444
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M^--#L)M%G\*Z/X7TJ[D\57MWXLU%GGFTN-8OCG]H3X2_L6Z7\*_VMC9_#O\
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M.0**** /R7_X)_\ _)]W_!<7_L]#]GO_ -8R^$E?K17Y+_\ !/\ _P"3[O\
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M-X(\7:_I-EX3T9;CQOX3O]:T;4-7:[\.>"O#FAKJ^B^*/#7BK11I&DZQX?\
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MD2J#\S'& .,?6K/_  E6I?\ /.T_[]2?_'J /0Z*\\_X2K4O^>=I_P!^I/\
MX]1_PE6I?\\[3_OU)_\ 'J /0Z*\\_X2K4O^>=I_WZD_^/4?\)5J7_/.T_[]
M2?\ QZ@#T.BO//\ A*M2_P">=I_WZD_^/4?\)5J7_/.T_P"_4G_QZ@#T.BO/
M/^$JU+_GG:?]^I/_ (]1_P )5J7_ #SM/^_4G_QZ@#T.BO//^$JU+_GG:?\
M?J3_ ./4?\)5J7_/.T_[]2?_ !Z@#T.BO//^$JU+_GG:?]^I/_CU'_"5:E_S
MSM/^_4G_ ,>H ]#HKSS_ (2K4O\ GG:?]^I/_CU'_"5:E_SSM/\ OU)_\>H
M]#HKSS_A*M2_YYVG_?J3_P"/4?\ "5:E_P \[3_OU)_\>H ]#HKSS_A*M2_Y
MYVG_ 'ZD_P#CU'_"5:E_SSM/^_4G_P >H ]#KQVY_P"/FY_Z^)__ $:];_\
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M" R,R-@]1N4@X/<9P: /9J*\>^U77_/U<_\ @1-_\71]JNO^?JY_\")O_BZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_(A_P=!?\E _8E_[
M$#X]?^I5\,*_KOK^1#_@Z"_Y*!^Q+_V('QZ_]2KX85^H>#'_ "<WA7_L(Q__
M *J,P.W ?[Q_W"K?^FY'\[WP\^&7PW\6?!KX]?$'Q1\7](\%>//AC:>!I_AS
M\-+W3]4N=1^*DWB/7WTW78+"ZM=+N[6$Z18J)8O]-MFM;@_:]8^S:.5NS]R_
MLT_"7P+\3_V<O#G@'P7\,?AM<_M+?$&7XWWL4_[0_P +/B^V@_&'1O#6CW>H
M>#8/@!\>/"6IP>"/A_X@\!VVGZFVM:7XDL;73]>\21Q1Z]KG]E/':I^4) )!
M(!*YP2!D9X.#U&1P<=:]+T#XS_&/PGX4OO ?A7XN?%#PQX&U-;]-2\%^'?'_
M (LT3PG?KJL9AU5;SP[IFK6ND7*ZI"3#J2RV;"^B)CNA*I(/]Y9ME>/QM&K'
M"YE6I598^EC,/SN-.CAH4L$L.L,XT**J8K"O$IXZI2K5(UIU9M4,9A*E+#5Z
M'H2BWM)K5/7I96MHM5?7O=[Z(_59O@3\*CX]'[,R? 'P['\%O^&/T^.$O[7\
MECXJD\?V_BP_ IOB>_QB?XC+K/\ P@3^ 4^(B+\+7^'T>C_V(\0DT@3KXQ=K
M@>-?M,^"M#^'4GQ#^!OPW_9&\->)/ASX)^#/PY^(6A_M*6=AXZF^(,D&N>&/
M"7B/5_CUJOQ(M-9F\%:YX*\1ZGK&H>'+3P<FCQ^%[&(V^FZ?*OB*PO))/@$?
M%7XI+X$_X58OQ-^(8^&&[?\ \*W'C;Q*/ .[[:-2S_PAPU/_ (1W']H@:AC^
MSMOVX"[QY_[RG7'Q8^*MWX%MOA?=?$[XB7/PRLVB:T^'-QXW\33> [4V]V]_
M;_9_"$FIMX?A$%]+)>P+'IZK#=R/<QA9G9SYN&R#,Z.*P]>KF3Q-*BJ4*F'J
M8G,HPKUX5:52IG,W#%*7U^M"G*C/ 1:R]0J/EER\\*B4&FFY7MNKNS=T^;?1
MZ;?#J<!1117V!H%%%% !1110 4444 %%%% !1110!_<C_P &W?\ RCU\4_\
M9TOQ:_\ 44^&%?OO7X$?\&W?_*/7Q3_V=+\6O_44^&%?OO7^:/B)_P E[QE_
MV4V=?^K#$'E8[_>JGI2_]-0"BBBOC3D"BBB@ HHHH **** "OAO_ (*.ZG^U
M=H_[(GQ O_V);7Q5>?M(1>(?AXG@ZW\%Z5X;UOQ&^C3>,=,C\9M9Z=XM@N=!
MF@3PRU^UZ]U"TL-L));0K<+&1]R45W97C5EN98#,983"8]8'&8;%O X^E[?
MXQ8>M"J\-C*-U[;#5^3V=>G=<].4HW5[CB^62=D[-.S5T[/9KL]F?QD_\+#_
M .#G7_H7/VEO_#9?L_\ _P I*/\ A8?_  <Z_P#0N?M+?^&R_9__ /E)7]FU
M%?K/_$8,/_T:_P ,/_$:C_\ +SI^LK_GQ0_\ _KLON/XR?\ A8?_  <Z_P#0
MN?M+?^&R_9__ /E)1_PL/_@YU_Z%S]I;_P -E^S_ /\ RDK^S:BC_B,&'_Z-
M?X8?^(U'_P"7A]97_/BA_P" ?UV7W'\9/_"P_P#@YU_Z%S]I;_PV7[/_ /\
M*2C_ (6'_P '.O\ T+G[2W_ALOV?_P#Y25_9M11_Q&##_P#1K_##_P 1J/\
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M_/BA_P" ?UV7W'\=?_"P_P#@YU_Z%S]I;_PV7[/_ /\ *2C_ (6'_P '.O\
MT+G[2W_ALOV?_P#Y25_8#X$^)7P\^*,WBBV^&WCCPMX\N_ ^N0>&/&]EX3UF
MRUN^\&>)[G1K#Q%#X9\665C++=>'?$3:#JNF:PVB:M#::E%I]_:7,MLD<R$[
M'C/Q+H?P[\'>+/B!XUOCX>\&>!=!UCQ/XNU^ZM+Z>UT+0= L9=3UG4;N&QM;
MJ\D2PL();J6"UMI[IHT(B@D<JI/^(P8?_HU_AA_XC4?_ )>'UE?\^*'_ (!_
M79?<?QS?\+#_ .#G7_H7/VEO_#9?L_\ _P I*/\ A8?_  <Z_P#0N?M+?^&R
M_9__ /E)7]EVDW4.NZ)I7B32#)?:#KFEZ=K>DZI%;W"6M]I6KVD%]IM[&TT4
M;I'=VMS!,BS)'*HD"2QI(&0:3V-['L\RTNH_,=8T+V\J!Y'.$C4L@W.YX51E
MF[ T?\1@P_\ T:_PP_\ $:C_ /+P^LK_ )\4/_ /Z[+[C^+_ /X6'_P<Z_\
M0N?M+?\ ALOV?_\ Y24?\+#_ .#G7_H7/VEO_#9?L_\ _P I*_K?^%OQS^$?
MQNUCX@Z%\(O'6D_$34?A3XHO_!/Q"_X1>'4K_3_#/C#2KJ>QU?PS=:R+%-&O
M-:T>^M;FQUBQTN_OIM*O8);34!;W"-&/7FMKE8O/:WG6'<5\YHI!%N#%"OF%
M=FX."A&<[@5ZC%'_ !&##_\ 1K_##_Q&H_\ R\/K*_Y\4/\ P#^NR^X_C"_X
M6'_P<Z_]"Y^TM_X;+]G_ /\ E)1_PL/_ (.=?^A<_:6_\-E^S_\ _*2O[0?L
M%\2@%G=DNI9!]GFRZKMW,@V991N7)&0-RY/(SYUHWQ-^'_B+XC^.?A!H7BS2
M=5^*'PRT7PMXC^('@:SEEEU_PAH7C:/4)?"6J:W:^4%M;3Q!'I6I2:<_F.94
ML;EF5!&:/^(P8?\ Z-?X8?\ B-1_^7A]97_/BA_X!_79?<?R!_\ "P_^#G7_
M *%S]I;_ ,-E^S__ /*2C_A8?_!SK_T+G[2W_ALOV?\ _P"4E?V>FUN0D<AM
MYPDQ58G,,@25G^ZL;%<.6_A"DENV:E&GWY8J+&\+* 646TQ90V=I(V9 ;:V"
M1S@XZ&C_ (C!A_\ HU_AA_XC4?\ Y>'UE?\ /BA_X!_79?<?Q>_\+#_X.=?^
MA<_:6_\ #9?L_P#_ ,I*/^%A_P#!SK_T+G[2W_ALOV?_ /Y25_6CK7[1/P*\
M,_$)/A1XH^+'@KPM\1KCQ)X-\&Z=X1\3:NGA_5-;\9?$2QU74_ _@_PV=72S
MM/$OBKQ1IVA:S>Z5X=T"YU'5Y;?2[V1[2,0M76?%7XF> /@;X$U?XH?&#Q7I
M7PZ^'F@/I4>M>,/$\DMCHFFOKFJV.A:0MS=>4^TZAK&IZ?IUMM1@]S>0(2 ^
MX'_$8,/_ -&O\,/_ !&H_P#R\/K*_P"?%#_P#^NR^X_D"_X6'_P<Z_\ 0N?M
M+?\ ALOV?_\ Y24?\+#_ .#G7_H7/VEO_#9?L_\ _P I*_L*\">.?"GQ.M/$
M5]X U=?%%IX3\7:[X#\1W%A8ZG''I7C#PS+%#KVA3?;;*U:6YTR6>%)IK836
M;F13!<RJ<U9\>>,/"7PL\&^(?B-\3?$^@_#SX?>$M+GUSQ5XX\:ZI:>&O"?A
MO1;8H+G5]<U_5I;73=+TV RQB:]N[B*"/S$W.-PR?\1@P_\ T:_PP_\ $:C_
M /+P^LK_ )\4/_ /Z[+[C^.S_A8?_!SK_P!"Y^TM_P"&R_9__P#E)1_PL/\
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M445^"G(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM_\ A[OC7_\ -W1_PXC_ ."6W_1NNM_^'N^-?_S=U^N]%'^MW%G_ $5'$?\
MX?,T_P#FH/K>*_Z":_\ X-GY?WO)'Y$?\.(_^"6W_1NNM_\ A[OC7_\ -W1_
MPXC_ ."6W_1NNM_^'N^-?_S=U^N]%'^MW%G_ $5'$?\ X?,T_P#FH/K>*_Z"
M:_\ X-GY?WO)'Y$?\.(_^"6W_1NNM_\ A[OC7_\ -W1_PXC_ ."6W_1NNM_^
M'N^-?_S=U^N]%'^MW%G_ $5'$?\ X?,T_P#FH/K>*_Z":_\ X-GY?WO)'Y$?
M\.(_^"6W_1NNM_\ A[OC7_\ -W1_PXC_ ."6W_1NNM_^'N^-?_S=U^N]%'^M
MW%G_ $5'$?\ X?,T_P#FH/K>*_Z":_\ X-GY?WO)'Y$?\.(_^"6W_1NNM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8XM4@LX=7ABOD^^:* /RA\#_ /!$W_@G?\-=*T33_ GPT^(WAG4_"4GPNN_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>img247211528_29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_29.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MN0_DW_Q5'UZKY?U\P_LRCY_A_D'_  FFJ?W(?R;_ .*H^O5?+^OF']F4?/\
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M_P#%4?7JOE_7S#^S*/G^'^0?\)IJG]R'\F_^*H^O5?+^OF']F4?/\/\ (/\
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M\$^J"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MR?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\
M_M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/
M][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\
M:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\
MOR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!
M-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I
M_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'
M_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_
MR?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\
M_M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/
M][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\
M:/J/][\ _M)_R?B'_"'I_P!!-?\ OR?\:/J/][\ _M)_R?B'_"'I_P!!-?\
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M_P!MMC '^IR/RZ?ATH^J/^;\!_VDKW]E^/\ 7^8?\(>O?5%_[\G_ !J/J/\
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MJ184 % !0 4 % !0 4 % !0 J]&^G]:!,S[F_FM]4L[7[(3#<,4,Y< *P1F
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M,Y_$G)-*S*YH]R3R9?\ GD__ 'R:+,.:/</)E_YY/_WR:+,.:/</)E_YY/\
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MC:S[1G:#F@+DUAXAL=2DCCM"TK/G_5E755 &6+*2,9..N<@^AP!<U:0!0 4
M% !0 4 % !0 HZ&@#(OO$%M8ZC]@$4L]R(UD9(R@P&+!1EV&2=C8 R?E-,+F
MA+=P02VT4L@22X<I$IZLP4L1^2D_A2 S[GQ#;6^J-IR0RSW"!2P0HN-V< ;F
M&XX&<+G''J*87(8O%>GS7,EM&LKW*2&+R5VER^YAC ;Y?NL?FQP">QH%<W*0
MPH * "@ H * "@ H * "@"U;_P"K/UJT9SW):9!'-_JC2>Q4=SF-5\-P:S=S
MO=,R*8XA#)$Y66)T,F6![9$F/<$@U)I8R#X8U:QUJZN=--H-/FFR+3SG@ 06
M\,2G*+QM,3?+T(;U H"Q!9^$=7M_#MOI$DEJ1'800-*D[@[X'9DXV\JV0#R"
M!D<]: L=+I%G=P-=7%W;P0SRE0%CN9)LJHXW,X'.2>@_.@93.E:TLT,RWB//
M(T;3R&0J$ ?+*J8(92I*C.,=>I)H$=#2&% !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % #A]TTP,:ZTR34/$5K<7()L;&/S(4)&UYR2-Q
M'^PHXS_?/I0!A:7X5U:QFTN"66T:ST02FR96;S)BR,B"08^7:K')!;<<'CI0
M*Q=&G:]+XF-U=VNGW%E%,9+9VO)0\(V%1B/R]N[DY.2?F//:@-2:#2M9AU)+
MF2[CE\U8S,0Q38P=BP50/F4J0H!(QMSU)- '0TAA0 4 % !0 4 % !0 HZ&@
M#C?$7A.XU#6+J^L[73;G[=9K9S"^!/D[2Q#I@'=]\Y7Y<X7D4Q-$<7ASQ%:>
M(=/NC=V=[;V\JHLLX<S10B/:P'.,L1DG&22,\   68S6_!]]J-YJ$L4&FL=5
M@BCGFGW%[1U&-\7R_-Q@CE<%0<GH &C8O=,UB64W,<\;R!F2.+SFB5(]I"G>
M%)+%MK'C';M\P!O1*ZPHLC[W"@,V,9/<TACJ "@ H * "@ H * "@ H M6_^
MK/UJT9SW):9!!>,4MF93@\?SJ9:(TIJ\K&*^J1QEP]U"IC*JX+*-I;A0?3.1
MCUK*[.GEB1MKEHJ!SJ%OM._!WKSLSOQZ[<'/ICFB[#EB2SZDMJ(S/.D8D<1I
MNP-S'H![FB[#EBAT-]]HA2:&9)(G&5=,$,/4$478<D1MSJ<=E 9KJZB@B! +
MRE54$\#DT78<L42"[<L5$BE@ 2,#.#T/Z&B[#DB.^T2_WA^0HNQ\D0^T2_WA
M^0HNPY(A]HE_O#\A1=AR1#[1+_>'Y"B[#DB'VB7^\/R%%V')$/M$O]X?D*+L
M.2(?:)?[P_(478<D0^T2_P!X?D*+L.2(?:)?[P_(478<D0^T2_WA^0HNPY(A
M]HE_O#\A1=AR1#[1+_>'Y"B[#DB'VB7^\/R%%V')$/M$O]X?D*+L.2(?:)?[
MP_(478<D0^T2_P!X?D*+L.2(?:)?[P_(478<D0^T2_WA^0HNPY(A]HE_O#\A
M1=AR1#[1+_>'Y"B[#DB'VB7^\/R%%V')$/M$O]X?D*+L.2(Y9Y/+8[NX["G=
MD\BN-^T2_P!X?D*5V5R1#[1+_>'Y"B[#DB5/[;M?MDMF-0MOM42[Y(?,7>B^
MI7J![T78N6.P^#5H;J!)[>\@FB<[5>-E92?0$478<L2Q]HE_O#\A1=CY(A]H
ME_O#\A1=AR1#[1+_ 'A^0HNPY(A]HE_O#\A1=AR1#[1+_>'Y"B[#DB'VB7^\
M/R%%V')$/M$O]X?D*+L.2(?:)?[P_(478<D11<2X;YAT]!1=BY$5;K6+>Q\K
M[9>P6_FOLC\UU3>WH,]3[478<L46?M$O]X?D*+L?)$/M$O\ >'Y"B[#DB58M
M:MIDE:*_MY%B;9(5=2$;.,'T/M1=BY8EK[1+_>'Y"B['R1#[1+_>'Y"B[#DB
M'VB7^\/R%%V')$/M$O\ >'Y"B[#DB'VB7^\/R%%V')$/M$O]X?D*+L.2(?:)
M?[P_(478<D0^T2_WA^0HNPY(A]HE_O#\A1=AR1#[1+_>'Y"B[#DB:%@[/ Q8
MY.[T]A6D'='-524M"U5F17OO^/1_P_G4RV-*7Q(X#Q-!>I<DVMJ\\6H6[6<A
MC7)BDSF*0^BC<^3VXK)'3*YF66F7$WAV^6;39+>ZL=-?3XAL)+2%29'CSG<K
MG9@\YQ]:?426A?U6VO[:_BALC>R6S7-HS$N\F 7<2?,<D#:%SSQUXS20W=;'
M.Z+-J>E^'M#MCI^H^1;6I@N8W^TQ%;@!<?=1F*X!P5^3)/.<53(5TD=C':SR
M>&K-=9B:[OH@I_=DAC(?E!RH&.#R< #GM4]=#3IJ&@--%/=6<]G(CP!5\]L[
M9 ,X"@C 4=@I/'7#9R,(]C=I%!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@DD' &>G.*+!<W]+U&#5M-@O[4GR9EW+NZCMC\Z0RW0 4 % !0 4 % !0 4
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M(_O+^8H&&1_>7\Q0 9']Y?S% !D?WE_,4 &1_>7\Q0 9']Y?S% !D?WE_,4
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M2V::ZD)DDD9U(9B!TPN/P Q3N+D.TJ30* "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * 'K_JG^HHZ">Z.9\26-YJ3VL5M:W.8+J"7=YB"!PLBLV]
M2V3@ XXZ@$4UH*2N1:9IFNQ7&JM=6^FQ17LL>U8)W;:@4(W5!@[5R/<X]Z-!
M)/431-!U2#4K&YU66U(TVS:SM_LV?WH8IEV! VG$:_*,@<\T-@D[ZG4TBPH
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MN,(+)F0LV[!&%7/6@1W.G2-+IEI*\4D+O"C-'*270D#@D\DCOFD46: "@ H
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M''"SMYA17V@ <_*P.>@&<]#0.Y;L[R&_M5N("VPDKAE*L""000>00012 GH
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MHX^;([YH"QOZ78OI]BL,LHFF+,\DBJ5#,3G@$DCTY)/'4TAER@ H * "@ H
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MV_\ OH?X4<J#GD'V:'_;_P"^A_A1RH.>0?9H?]O_ +Z'^%'*@YY!]FA_V_\
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M(/(?T'YT68<R#R']!^=%F',B:%"B$'UJEH1)W9)3)"@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _
L_]D                                                        !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>img247211528_30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_30.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M^9!]4K_R/[B1_#G@!S,3#:#S3$V%G91&8QA#& W[LC_9QGO1]8I?S(/JE?\
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M?S(/JE?^1_<;2S>&X[V^O$NH$N;Y52>19R&8*"!CGY< GD8H^L4OYD'U2O\
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M'%92CRR:[&T)<T5+N1TBPH * "@ H * "@ H * "@#US1_\ D!Z?_P!>\?\
MZ"*^DH_PH^B/C<3_ !I^K_,NUJ8'%?$#_F'?]M/_ &6O*S'[/S_0]S*/M_+]
M3#2:QE:.&4Y18U8[S\NX)C:,8QDGGD=*Y%*#LG_6AWN-2-Y+N_SW);M=+!6&
M)T%N&P9%8EP"RG'O@9[=JJ?LMEL33=;XI;]NFS%V:()$S&N&EC1AO.%0EMS<
M$_[/?TXIVHW^:^[45\39Z]'TZZ66R\RNGV&4L94B4>0BJP8_>"\DC<.<_P#Z
MCFLUR/?LOR]?Z[&K]I'X6]W^?I_7<R:YSL"@ H * "@ H * "@ H GMKN>U=
M6@;:P.1\H/;'?KP351G*/PF<Z<9JTBR@U55FM%@G^<[Y$\K)Y!YZ9]:T7M5>
M*3^XR?L':;:TVU%AN]1G4JDB-AAC>$R"?3/3.WM1&=26WZ"E3I1W7Y_C;U&Q
MSZE;6J!%D2$'<K>5Z'/#8]10I5(QTV]!N%&<G??U_0F%UJ]WYD2Q%R(]K!;=
M<JIR>PXSD_G5<]66B7X$>SH0LV^O=[_>4KJ_N;T*+B3?MSCY0"3ZG'4_6LIU
M)3^(WITH4_A17J#4* "@ H MB:]O(&@17DC5O-*I']WC&>!P,?A6EYS7*MMS
M'EITY<ST>VXZXFU$L+N<2J9,8DV;<\[A@X_'BG*53XG_ %U%"-)+DC;3I^!8
MDDU;S$ 4;DEX$*)PXSV4=>OUJVZM_GTMO\C)*A9^G6^WS&C5-5@F9LE'&"08
M5&,$C.,<<DBE[6K%_P# '["A)6_5_P"8][O6+:W2=AY<! 5?W2!3GD<8P3Q3
M<ZT5?IZ(2IX><G%:OU=S*=VD=G<Y9CDD]S7.W=W9UI)*R$H&>G^$O^18L_\
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M_,BOKI+N97CA,0"A<%LDGUX 'Y"IJ34W=(NE3=-6;N5J@U"@ H * "@ H *
M"@ H * "@ H * /7-'_Y >G_ /7O'_Z"*^DH_P */HCXW$_QI^K_ #+M:F 4
M <G+XV6*[E@$%M*4NTM@L-X&==URD!+KM^0_O-P'.<$9% &RGB#3))9(H[AG
MEC<(T:Q.7!(8@;<9Z(WY&@"O<^*]+@=8DG\R9IU@"!6&6+ ,HXY8#)V]?E([
M' !9.O:< Q\YLINWKY3[H]N,[AC*]1UQP<T :5 !0 4 % !0 4 % !0 4 %
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M.<M]T#G/ Q0!IT % !0 4 % !0 4 % !0 4 % &%!X4T^&[DGW3D'R_*43R
MQ;5*_*P;/(8_G0!:/AW26MX(/L2".W\OR@"1L\L$(!ST&3@>Y- &G0 4 % !
M0 4 % !0!4O]/AU&.&*X^:%)5E:,]'V\J#[!MI_X#0! N@::MPTZP,'9G;B5
M]H9_OD+G"D]R .I]30!/9Z796$T\MK;K$\^WS-I.#M&!QT&!QQ_2@"W0 4 %
M !0 4 17%M#=1>5.@>/<K;3TRI!'Z@4 4[S0M-OY4DN+;<T84+M=D "G(X!
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MBA8=%M;O5!F26UBN7:"/:BB0@*O+$YR<9Z=^*+#OIJ31>+-/EGAA1)B\K!
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MCQ*;M+&.RMRES?PK-#'.5#A" 2S)G. #CJ.<#(SFG85RQ!KT9TNXOI?+=;=
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MO'*MYWW=N(B3QGJ!S@>X -6'XC>%)E5UU7;&PC(>2"5% ?.PEF4 !L'!/7%
M"ZIXZTJR\-:GK%F6O180)</"%:,LK_=(W#H<'GV/I0!HP>)]'N+]+*.[(N))
M7A17B= TB#+("0 6 ZC.>#Z&@#DK/XM:?)K?V&\M/L\)FN(?-CF\UHS$P7,B
M!<J') 7KDG% '2P^-/#]S<3V]O?F::W&9TCAD8PC.,N ORCZXXYZ<T ,A\=^
M&IGC1=3"M)!]I3S(I$W1;6?>-RCY=J,<]\&@"O\ \+(\);8S_:X(E<QQX@D/
MF." 57Y>3EAP.?R- &I9^)=(OY1#;71:4W#6OEM$Z,)%4LP((!& #STXQG-
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MT*.:/<.278/M,'_/>/\ [Z%'-'N')+L'VF#_ )[Q_P#?0HYH]PY)=@^TP?\
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M% '%?$#_ )AW_;3_ -EKRLQ^S\_T/<RC[?R_4XNO+/="@ H * "@ H * "@
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M02,+C)&%8Y'H?0T>RI_RK[@]O5_F?WL@N-0\,6P^861^95^5$[E1UZ<!@3W
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MAV;LAAGYBPY((Q@  2S\+I9ZK:7ZZK?2-;I*ICD\HK*9&W.S83=DD+T( V@
M 9R ;U !0 4 % !0 4 % $<XE:WD6!T28J0C.NY5;'!(R,C/;(H Y>T\)W-M
M>27)N+<O+=BY)57#1#*Y526.[.TY+?WSVPM &W!I(@O_ +6+Z[<E</&T@V.>
M?F(QUYQQ@?*..* -&@ H * "@ H * .;_P"$'T>**U^R*]E<6\WG?:;=4660
M['0[FV\_+*_N,Y&#0 Z#PC!:KNM]2O8KC>S"X00AP&50RX\O;@[%/3.1UH $
M\'6<1F:*\NTD8@Q/^[+6X$BR$(2G0LBYW9Z"@!6\'V;R!WO+MM^PW*[D NBK
MEU+X7CYF)^3:.<=.* .AH * "@ H * "@ H * "@ H YB'P7' )=NMZD6E>9
MG8^2"5E.YTXCQ@GG/4=B* +>L^%K363(6N;FU\ZV-K+]G*#?'R0#N4XP22,8
M]\CB@"M+X11;:]CAOKEWO#&'>1D5D"N3E2J@EL$\DD].: -#3] MM+U&>[MI
M9$250OV=518EP% ("J"2 H&6)P.* -6@ H * "@ H S==T===TPV+7MQ:*9$
MD\RWV;LJP8??5AC(!Z=J *EKX82WCU59-4O;A]1G6X>27R@T<BJJJR;4 X$:
M=0?NCU.0"G>>![>_LYK>ZU?49!.SL[;HADLJJ> FW(V9!QD9/.#B@!R^$_-3
M4DFNY+9;FZ$T/V8J6A &>"ZG!+M(_ X+\'B@#I(8A#!'$&=PBA=SMEC@=2>Y
MH ?0 4 % !0 4 9$>OQ?;[V"X@>W@@*B*X;E9SD*VT#GY6(4Y]: )7U_3([C
M[.]T%DRX 9& )7[V#C'&.?0<GB@!%\0::US#;"603S\QQF"0,PQG."O3 //3
M@^E #8_$>E36T\T%[&_DN8BI.UBX4-MP><X9>/<4 -M_$>GS627#O)%^[C=P
MT3_)OQM&<=22.* $N?$^E6\2-]HR\JNT*%&'F%0Q(''7Y3Q[4 *?$VDQ0^9<
MW0M]L?F/YBLH0!-YR2,#"\T 3Z?JJ:C<WD4<3HMLRKEU92V5#?=8 CK0!H4
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M#VQ2L"9KTAA0 4 % !0 8YS3 *0!0!&L$:W#W 7]ZZA2V3T&<#VZFF!)2 *
M"@#2B_U*?[HKH6QRRW8^F(H:C<0P>6)9DCSG&Y@,]*QJR4;79T482E?E5RC]
MOL_^?N'_ +^"L?:0[HZ/95/Y7]P?;[/_ )^X?^_@H]I#N@]E4_E?W!]OL_\
MG[A_[^"CVD.Z#V53^5_<'V^S_P"?N'_OX*/:0[H/95/Y7]P?;[/_ )^X?^_@
MH]I#N@]E4_E?W!]OL_\ G[A_[^"CVD.Z#V53^5_<'V^S_P"?N'_OX*/:0[H/
M95/Y7]P?;[/_ )^X?^_@H]I#N@]E4_E?W!]OL_\ G[A_[^"CVD.Z#V53^5_<
M'V^S_P"?N'_OX*/:0[H/95/Y7]P?;[/_ )^X?^_@H]I#N@]E4_E?W!]OL_\
MG[A_[^"CVD.Z#V53^5_<'V^S_P"?N'_OX*/:0[H/95/Y7]P?;[/_ )^X?^_@
MH]I#N@]E4_E?W!]OL_\ G[A_[^"CVD.Z#V53^5_<'V^S_P"?N'_OX*/:0[H/
M95/Y7]P?;[/_ )^X?^_@H]I#N@]E4_E?W!]OL_\ G[A_[^"CVD.Z#V53^5_<
M9NM16NIV92*_ACG17"'S!@[D*D'VY_04U4@NJ$Z-1_9?W#6T_2);D7-S>_:)
MEE296:<+M91\O"X!'7KFCVL.Z#V,_P"5_<+%9Z=';R0?VH722%8#NDCX0!@
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MAY-Q_P ^[_\ ?2_XT<LNP<T._P"8>3<?\^[_ /?2_P"-'++L'-#O^8>3<?\
M/N__ 'TO^-'++L'-#O\ F'DW'_/N_P#WTO\ C1RR[!S0[_F'DW'_ #[O_P!]
M+_C1RR[!S0[_ )AY-Q_S[O\ ]]+_ (T<LNP<T._YAY-Q_P ^[_\ ?2_XT<LN
MP<T._P"8>3<?\^[_ /?2_P"-'++L'-#O^8>3<?\ /N__ 'TO^-'++L'-#O\
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MYFC&"(D!&" ,BMUL<SW'4Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__9
J

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>img247211528_31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_31.jpg
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M/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP #A"24T$!
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M/&,RJ>#3VW:7][VK_'U4]+8ZX:)=*8=G,G=I\/-/^@\8S*IX-/;=I?WO:O\
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M.$3"+] GV3O_ $ W;_K;F?\ DO4L_<W[L7_D>L_M29_F9"_F%^^Q_P!3L/\
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ML$O_  @O.%TW,^N-:D:P"ZFQXD5Y,:X2?39V&$60KR$U,2",M.(D6:-G4@A
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MZQ7L>62@V[=1%FW3([3(D_BT6KHX)@ '3*14>'Y7E]1M7C.%N$QKZBG=,E
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M;=C=)"2NS2133VSJ6K<QK3)(_9Q<PRGB9%AWRX0]UYSV3&3&N<^_"^ Y:_%
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M7B99.I#$H]]>1#478_T3I5GRK/#($K)GRA=:]HR&WQQ&IEV5EJ:*I<'3&O=
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M;FWE4;I,6N0:AV8.#L46 .VJ8 +Y18I%E=CTP;6M_2S=M-S]S?MW&X9VQMY
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M1U[ I&6.118R6QD4S+*)D*DFHL8E2 RITTB@4HFXB4H  >0 #'$-*N0R<['
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M#11DP1-&&Z?[":/%(&YF@)BS&@"W$@-3BD <O $Q$OP#PRW/$O+O=='^J5?
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M3")A$PB81,(F$3")A$PB81,(F$3"+J<Y$R'44,4A$RF.<YA "E(4!,8QA'R
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MHP_H6HSB7P:=QG%_Q)29I-X9/O>:U[B;)XXA_0F.]/A_0M1G$O@U'<9Q8?\
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MFL7LIU?;EC(QHYD)*1NT<QCV#-$[AV]>NJ_ (MFC5!,#*+.'"QP(0A0$3&$
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M '#F#XPPB<Q?Q_@X_P"=R@81_K 4>/\ 6\N(A3:N0$! 1#B(!P$1 !$  1$
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ME:UA&_F:' OB"73G$0+B"/VQ#8B+6M: <L?3P'0G"M',0&(8<YX=Q82"TB7
MM#*=@=$,#@Z%,USH&#W/>7#)#&.<VNQ3")A$PB81,(F$3"+LI^6?_5F_[XY9
MWK%5E^HWP!3FM[&LM481D9#K)(,XVW)7(Z?%P3SF^0)"E2CI3L5TN\PY5(%!
M040Y1,H B(CP+P]G#](,0PR1+IZ4ALJ75"?"WTW#>X-? B,O]FTW=4VG4AS>
M+Z)X3C=3.JZYI=/FT)I0;/V;"9L7RXM-V;"<]MZV#; !$QG2>^9A%"M-V]2J
M[9*J+5YS%)(*S9$>\UY]+OT^]I><1!XQ?JS[P5FJ@F2 ZA%"\#I%$?:&FU4Q
ME.R72TS6TIE%@!F 1E.>X7A?])KC,?>88B)#A M!7-N[-*&9,JYLVNK'OK1/
M;,)$HF[/9*8;IWOT7L$F5=F-@Z <TQ:\A4WMUM(L5(U5DV=-'*<DU>B]E9QV
M^<,9$+042I2"KX7#&7;$MKDI)%'E="1-$HCR$,4^,Z:8D9!IW,:Z6X/:Z\^8
MYQ:_?LCBZ+7C?W@36P? -&0$'-\-L'%0*MDQS)["QS+DN2UC7LXOE8&77RG&
MFEDR'1EQ<\@7G MLP;=LIW9UG32+<,75UL-YEH8@/&4=,R-B\T&68ORM'2:A
MXR.<PC=PU3X\2." H<5!  #4ZTX@9M^8V6Z2ZLFU#Y?I-9,?-N1:ZZZ-QIEM
M<P:CQ>=>@%Z'47"FR!+DOFLJ68?(HY<TW'S)4N1OD'L+FD;X]LU[)AU6&ZVY
M$J6K=15L6E'$KYFA4EW9'Z;D$7,T15,'[V]/^UBW0OQ6AGC1UL%X=-9#@?BD
MB(^4IN;U':>XDZI=4B3*#W7HP,R(O.J718;T9;@ZJF$.;;8R.0Q\.7V58++H
MV4?&*ATN6678ME0-QE&R$QMR$UKFT4H.8^(@Y\,HA;&>^KFV;"T53:N$RDB2
MMUBO9AN\:*PPTD[1RW< ^5+SJ+41JJL0Y#I++++&.4W, !K2M-L6ER][<&N;
M!D#>>' R^+W2#>.4T['.!!#G%Q(,;-R?V9X!-F[\PO:\F;>!9*<UPF\;#FN;
M<%@%9,:T@AS&M8UI$#'$<O(GF):3EU&K-DI*/W<@HSCT>[L6RCQ<ZYT6B "(
M(MR&./*4/( ?  !Y,Y:KJ#5U4RJ+6L,Q[G76B#1>,8-&H-8+NJ"D;04,FA:]
M\QLF4U@<\WGN#0 "XZKC"TJW_P"D#_TA_P#R$LP_Q?&M@>N? /I7&55DPB\U
M#]FFHIPX\A#GX?CY2B/#_/X9#C=:7:P5F-O/#=<@+8:0T*X<2Z\/4[&VE',2
MV9GLGG1!5NE$+R*\8G&IG=Q*,HT3<239\LZ(S6,D[(V:*&$IA,0![R?H2]]4
M:3"ZALR9*:W?;X(#"XL#!>8'MB\.<\2W$/#&$P,0OE=+VE2I=$VOQRE?)E3W
MN$C>R'&8&"87F[-,MQ;+<QLMTQ@=*,R:T1$'%6,VC+2*4>NE(UU%&3=$81YW
M\FJU/*/$SB+\\:V!D=X9JP:&(X."J9%^Q$P@F(D,4-,Z&XB6RWMF2 R:X-;>
M>1?</6N"Z776M@XQ ==C9$$+T6]HV"A\V6^55.F26%\P,EAPEL/J"8Z^&WGN
MBP77%E^ +@""J"9T[9(2+=RZDG7WR#2#4L@MX]S(G?.(0CQLV(_:-G44T.LA
MV#PCE4?(+5 >*X)B( ."KT3Q"CIG53IDA[&R3-@TO+C+O 7@"P1$'!Q_(;Z]
MTV+:H-/,*Q"M91,DU4M[Z@2+SVRPQLVZYQ8YS9C@#>:9;?:/LEWQ:L49RZ[=
M,(F$7Z!/LG?^@&[?];<S_P EZEG[F_=B_P#(]9_:DS_,R%_,+]]C_J=A_P#8
MDK_Q%2OJ+GZ07XZ3"+\N/5[,.J]UE[>GF7_KL3=F;UF8%5$3(O$JO"]U<IK)
M?TB2S1<Q52&+Y0.0,_F[VIU<R@[6<5K9/^&E5@<VTB#A*EP((M!:8.!&J O[
M'=AF'RL5[!,"PZH_F\_#GL>( @M-1-O-(-A#FQ:0=0E8^#?DN9L_;*5F%1[T
MWFNYK19^YJ1$A8PK#FQ2$>F^92S1(;',UU1V^3!,.T"0713,DF5+D\+KQ5F6
M^6ZGDB\V9=+#=+'3=Y,US;S7@;[,E%\P0MWU[&EK0V'3GLRHA-ES65E0ZXZ5
M>$P7A-9(XPV0QY8Z4X[Q*GMER77O1,B7,<'N+X^LCO-N_!-L%#8(Q9&+.-"/
M-.KNCHM6D+/5\BC:27B1D#/B1$\9%,[H[Q)/L$S]D*I>TR\_31DZ$OB4MM,&
M-9<WPF#6RYDJ(>67KV]S+H+R\"ZTW;PO*E+V;S:8F<<2F.K#,?,OB2&@N=-D
MSR'2Q,N7#-DA[A+$ISK[VWPPW52+[SD%@ER$K$2Q2DHY&/038N"E!D0LY-2[
MLAN^1CU-PUEVLT+1V0A$%54VK<Y52"D 9A?IG/?OH;32V-F2PT!I]7]I,F.]
M9CHM>)EQX%TD,ED.%V"V)?9Q32S(+JR=,?*FEY+VGTSO,J4WU9C"UTITK?91
M)>UKIDUI8X/BKBKU$V%TE(IO8-BJH[:.T&+Y-Z(R$$LY>OW@.8A:2CY5JAQ3
M=I-%B"B(+,6Y4N)/FF)L.T^KIC7MFR6$N:X-<'>E+)<YT6%[7M%C@QPN^E+:
M&1%A&HSLJPR2^4^GJ9C6L>USV%GH3@UC&W9HEOEN=:UTUIO^A.>Y\#:'1FS;
MAE+36).L/8ANV;OEXA5LNRD'1 8HPRP*M([NJB)TW$6GSJBFCS)@DJJ*@#QX
M@;SL0TKJ<2PZ9ATZ4UK'EA!:X^B)9BUD"""P1=!L1!QO#5!]?"- Z/!L7DXO
M3SW/F2VS0X/8TWS-$'3+P(+9A@T.=!UYK0TZA&(,Y1=XF$3")A$PB81,(F$7
M8WY7_BD_N9<L_+X@H;D\9^<J^U6P+U.S0%G:MD'KB E6DLBT<F.1NY59J H1
M%<R?SRI'$.!N'EX9N897/PS$9&(RVA\R1-:\-.0EIC PMAX%YF-X7+QO"*G!
MYKW2Y53)=++F^LT.$(B-D1J+*<!O*1BXTK2:K<=:WZ,0I!H2,F_<-T!BSR1Y
M(D<[A&S48E>-:BDU100(1$$$&A2)F(!C!G34.F<^FD"764\NIG"498>]Q N%
MY?==+ N%@@QK6@-NM8 T@$KC,3[.*6LJS/P^KFT5.Z>)SF2V!QWP2Q++VS7.
MWQLQT9CGO)=??,+GAQ *J6N]Y!@5%)C#/FJ:3FV+'<$LXC+KA9TI!)%RM->8
M2R!IB"2DU&[=R!P2%D5)$R'%,%,R2M-)L@!LF2]K0Z<8B=Z9WX. )F;U>ORP
M\M:^,#+#6%GHARPSNS:GJ7.F5-1+>]S*87>+_L@:<L):)6_7-ZG&6U[Y<+PF
ME\P3/2+502.[9!_*PDP2K0+-S#R$S) T;\P17:S%9=5A5I&QPH=G%Q9T'(NW
M#?F6(Z?<5#< $2Y@GZ83YU3)JQ32&3)3YC[H]2+Y)DEK6P]!D#?<WT@^9Z1A
M$A;-+V>4U-1U%":RIF2I\J5+O._PD)50VH#GOC&9,!;O;'P:9<KT6Q(#E60V
M]I",@$HEW7RR\FHO).Y>?<SSM)Q,N9 2%$RK(&"S9BT!JT:-E&R D;*-VI2@
M0@CS!EI--)]-0BFF2-]J2YY?-,QP,PNAE;=(:V#6-+&P86L @V,1KU_9M35F
M)FMD56\4@;+;*DMDM+9361R/OASW7G37MF/!F-?,)+G 0/*V^Y<3I&:5V+8I
M%C6$8LQ0<%3CNQ;"8'Z;-%M'-7*#2P)E3%\@LLZ(JJ4QP$H'$F':;54094B6
MP"6UA:#!L!ZP: UI#9HAOC7.>'.!(@"0DOLSH@UPGU<Z8XSGS \MB^+H7"XN
M>YKG23'>7M9++6D-,2T.43O^RG%^0:I.H@C)1M,2<P5R:0._< >61;$=L4S@
MR8\S'O#<%4^W[PND'!,B@)!RCYF.Z13,<8ULV4&.;.?,O7KQ_: 7F@W6^C$1
M%Z\X6-#@T07N:+Z(R]&)CWR9YF,?(ERKH8&-_9%Q:\B^_P!.ZZZZY<8ZU[F%
MYBL99SB[!,(F$3"+(E8H 62JS]E-.-XPT3))1#)DX;%5+*R:\-(R[-@FL#U%
MR#N458@S:I-V[M4[A8HF*1(#G+[^&X&,0PR?B)G-EF5,#&M(C?>9;GM:#>!O
M/+0Q@:QY+W"(#07#D\9TF.%8U380*=\X3Y)FO>UQ&]RQ-9*>\BX6W98>9LQS
MWRVAC2 7/+6F]GT7?DG)F!F\8K("155)LUE6JP%;-W,,DN_?**G;&91Y6\VD
ML4_*HH)0,!B$$H\-UVAF-M?O);+,^TAK7@V RP7.)(NMA,:X&!, 8M$##SF]
MHVC3Y0J0Z<VFB 7.EN'I%LTAC  Z^^]*<TB+6@D0<Z(5'[&[GW%Q(BI5P:-6
MKIZJL%IB54@9MU9I!!V5P@JJU,TDUJZ]!HKVG9J@@)C"0HE,;!U4Q?>75$:;
M>6M<XG?F$709@#H@D0>94RX8P-TDD @G9.GNC_&&4H;6&>][6 <7F WG"42V
MZX!UZ6)\HS&W;S;X #G @0.P04E6)N3KTPD5"3B'1F;U,G:"F"I2D/S(G521
M,J@H0X&(<"\JA! Q1$H@(^+7451AU9,H:L7:F4ZZX6PCL1 B#&(,($6B((*Z
M7"\2I,8P^3B= XNHY[ YA,(PR6P) ((@1&+3$&!! M&:BWTPBRC_ /0O_P"]
MG_9UG3?^B_\ \Q_NBXO_ .2?_;W^_+*G4'JG:DCOC<LA':PV-(,'VS+BZ9/F
M-'L[MF\:K33LZ+EJZ0BSH.&ZQ! Q3D,8I@'B B&=+IWHQI-4:;8O/I\.KWR'
MXC/+7-IYSFN!F.@6D,((.H08%<;V7:;:%TG9M@%+58QA4JIEX12M>Q]73M<U
MPE-!:YIF M<#800"#85A_P!CNX/=+M#]W]L]$YRG5+2OHO$<VG[A=UU]T$Z;
MP?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A4]CNX/=+M#]W
M]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)
MU^T$Z;P?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A4]CNX/
M=+M#]W]L]$XZI:5]%XCFT_<)U^T$Z;P?/:;A4]CNX/=+M#]W]L]$XZI:5]%X
MCFT_<)U]T$Z;P?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A
M4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A4]CNX/=+M#]W]L]$XZ
MI:5]%XCFT_<)U]T$Z;P?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;
MP?/:;A4]CNX/=+M#]W]L]$XZI:5]%XCFT_<)U]T$Z;P?/:;A5S['=P>Z7:'[
MO[9Z(QU2TKZ+Q'-I^X4]?=!.F\'SVFX5=E-.[?YS\-3;/$.8W 0U_;. AQ_R
M1EG:):5EQ_\ M>(Y>33]PJ,T]T$# #C>#Y.6TW"KI['=P>Z7:'[O[9Z)RO5+
M2OHO$<VG[A6Z^Z"=-X/GM-PJ>QW<'NEVA^[^V>B<=4M*^B\1S:?N$Z^Z"=-X
M/GM-PJ>QW<'NEVA^[^V>B<=4M*^B\1S:?N$Z^Z"=-X/GM-PJ>QW<'NEVA^[^
MV>B<=4M*^B\1S:?N$Z^Z"=-X/GM-PJ>QW<'NEVA^[^V>B<GJEI7T7B.;3]PG
M7[03IO!\]IN%3V.[@]TNT/W?VST3D=4M*^B\1S:?N$Z^Z"=-X/GM-PJ>QW<'
MNEVA^[^V>B<=4M*^B\1S:?N$Z^Z"=-X/GM-PJ[^QW;_('_--L_CSF'A[/[9Q
MX"4@<?\ %'XRY;JEI7=AS7B.7DT_<*O7W06^3SW@\(#^FTVS_C5T]CNX/=+M
M#]W]L]$Y7JEI7T7B.;3]PK=?=!.F\'SVFX5/8[N#W2[0_=_;/1..J6E?1>(Y
MM/W"=?=!.F\'SVFX5!TYM\0X#J39X@/D$!U_;. A_P#I&.J6E?1>(YM/W"GK
M]H)TY@^>TW"JZMM=;^9B[%G0=TM/.'9><!:U6^-Q?]W*8B'?118$%WV!#F G
M:<W( B < '-J7H_IQ)O[U0XNW?(7KLFI%Z&2]!HO0&2,8:BT9VE79E4;WO\
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MZH5G>UV_23I9](5>[/7B_)VSEQ6I]14_9)E12*(C'\ (DBF4A"@ %(0H%
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MI3MS%O7=0J[IY!R*4O"NW%?B5G,/+($?)H2D6NHT,K'R**<FY*1=(2*E*X5
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M*>X1,(F$3")A$PB81,(F$7FL90B*IT4NV5(F<R2(G!+M5"E$2)=H8!*GVA@
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MQ[U_6W-@KZ[61*H@Y2CGK1K(LEC).TEA AB5-7/(@2/X1!69A5,PQ$;I $/
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MH)M.YY?,!A=$ /%'5_A64T]>R4V7)<V)<22=:V&H=?S!2"[:0W-=9.OO64S
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M^ROR,L8PV(9=5:7-F$\Y7.<I5SBT;V\3X1WSU878QU8Y/&O_V0
B                                              $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>img247211528_32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_32.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * *NHF[&G7'V PB[V'RC/GRPW8MCG'TH \UU'Q]
MKFEVZ6S16YN[;[3-<F6)TW1PA&"A=Y(9@XY)(Q@]\4 =7=>.=)BO$T^U>2[U
M!W,?V>)1N0B,O\Q8@#Y0>] &3H7Q%AN=+T@7EM++?WT2L5MBA 9LX&"^X9QC
M)X]Z -W1O%EGXBT^>\TV.<1Q1!RTJ@ ,03LP#G<.X]^M '!:1\3M4NCHD=RE
MLK$F;4'4/M2)P&BV_,>2">#G[M '86_C_3[E4$=E?"66"&Y@B94S-'+((T8?
M-@?,PX8@XH +OQS#I5K?W.I6,\,=M<^0B!XC(^(E<\;^3R>!GC'O@ S?^$]E
M-CJ.H11>9##-(8$"X+H+03#<2V%ZG.,\<8SS0!JZ'XUM]4%K:S6\\.HR)"7C
MPH7]Y$9-Z_,?DPK#UR,8H =_PE'D^)-0TUHIKAHY888HXHPI#/$TGWF?!&$/
M88]^M %;Q#XJGC\(6FK:8K1-<W44 $L+2N@9]K?)&V6(YX!YH K#QS)H7AN.
M_P#$5M,':614\N+RGDC4C#^5(^\=>1SZ\9% %F3QNEM#<7E[%)!:6]W/&2J;
MC(D<;-QAL@_+W'<?4 $]AX\L-3MHWL[*]EDDF,*QA4!SY9DSDMMQ@'OUXH R
M+7XHVTCZC=RZ?<C2[:*VD25%!<>:I/SC=P!Q],'/:@#M=)U*#5]-MK^V.8)T
M#I\RGCZJ2/UH O4 % !0 4 % !0 4 % '.^--?G\.Z +FUB$MU//';0A@2H9
MVQDX(.!SW':@#D[KX@ZE;6]I.HM91:HK7RA'&_=<F#:F6^5@58G.X9Z$]2 ;
M]_X[T][#4#HS-?W%M!/(WE ;8C$!G=N*D\LO R>M #8/'UD9OL9M[B>\2V,S
M+;M&^2J!F48?(// ;!_J 65\6P:CX;UO4],20I81R;))1A)'5-W&#D@'@].]
M ',:1\36O]0M$E1!#;:>\NH^6"66=<@HH)_V"><_>'- '2R^-K>#6(-)DTR_
M&H32^6L(\K^YOSG?C& >_:@#+TSXEV[Z!8ZAJ5E+%)=O( D+(V%638&P7W8Z
M9..Q]L@%:#Q[>A-4=X%EDM7N1'$BXR(YUC!+%_\ :Y&.>Q% '26/BZTO_$,N
MAQVMVE["T@E5U4",($.XD,>&\Q<8]^F* ,U?'4%MK%_I\L%U<RQ3SA%AC50J
MQ1QLV2S\_?Z\>F.,D C\9^*;S3K?0VTMMJZC+M+&VDG8+LW#"(02: %MO'<N
MG:3I1\1:=-;ZE=A0\,.T[-TFQ259MR@\'GIG'7B@"II7Q&$NEQ:IJD+6T)MI
M9C&BAMVV<1+AM_\ M '('.3D#J :,'Q$TVYCE>"ROW\F&:>4!4^1(B QR6P?
MO C&<YH K7'Q&ATRXU+^T]/N4M[:_-FDL8#+Q&K9<[L+G/&?;WP =M!*L\*2
MH0R.H92"""#]* ): "@ H * "@ H 3('>@"AJ[:<UG]DU,*;>Z/E;64D$X)Y
M(Z<*3DXZ4 85OI7A'6R+>*&.\>)1=;F9W9EE& Q<G+!@F,$G@#MB@ \4:SX3
MMKN"RU^4">)/M,8$4A\M3E"VY!P#\P/(XZ\4 6[3POHD5K"^G0)$JA7@9)&9
M 0/D<+G!('?TH D\.>'8M TJ>S:5;A[F>2XN)!&(P[N<G"CH,<?A0!3ATCPI
M8W?V6*QB299(8"HC9L,J,8P3Z;2W7CUH OV?A71+ ?Z-81I]P#))VA'WJHR>
M%#<@# H AU;0O#\DHN=2M06GG"@[GYD=1%C@\;EPI[$=: )XO#&BP6[01Z?&
M(CG<I)(.8_*/4_W!MH HZ?X-M;#Q.FL";<MO:"SM(-G^ICX/+$DL>N,] 2*
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ML>A())XQC:#DT =6!Q2&&!0!&+>$7)N/*7SBNPOCYMN<XSZ9H EH * "@ H
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MOQC& ,4OJ]3L'/$Z_2=?TO74E?3+Q+E8B%<J",$].M9SA*&Z&FF:52,* "@
MH * "@ H * "@ H * "@!& 92#T^N* /,KG^T=+\?6MM;V172VN%2.622[E=
MSM1GYW[ /F)RPQA6[C% 'I6>,XQ0!Q]YX1NKU9Q)+:PE[HR+Y*$#85=2"/[P
MWEL]SG\ "+5DBC^)GAM4%UYC?:'8R,[1\Q'A<G:#QR![5?V6+J=P*S0Q:8$<
MLAC1F5"Y R%! )]N>* .>@\2WUPVF-'IUN(;V0Q8>Z(D0J6WX4(00%7.2PYX
M],@"W_B:XM-3DM(-.,Z)E ^7!:3RRX480CIC^+//3ID M:5KZW]P;:X2*VN@
MN1 9,N>N3M(!VXVGG!Y.0,4 ;0Z4 % !0 4 % !0 4 % !0 4 % !0 4 % $
M5Q"D\#PR;MCJ5.UBIP1ZCD?A0!YOX6FUB/QL+>YTTV]DZ3-$VZZ=@%<KAB[E
M,\#M_$N.#F@#TP=!0!S*^%"P_P!(U&25GDWRN44-(,J=I/U1?H.!BA;@1Z>D
M$7CN>*(7F4LSN:X:1E;+J?D+$@CG^'BM/L$]3JQ62*.2^) QX!U;']Q?_0UK
M?#6]HB)['SIM/]YJ]Y7>AR6#9_M&GR!H&S_:-/E2W%H(5X/S'I19!H>O_!$?
MZ)J^23\\7\FKRL?S<R.BDCUD5YQN+0 4 % !0 4 % !0 4 % !0 4 (W3B@#
MB(8;.V\7SV$\5]+-+<)/!G5,J5")\QB:;<<,K?P'H.M ';+TH 7 H XG67/_
M  M#PTGV]' 6<_90%W1_NV^<GKST]/EJEL+J=M4=!E74K^+2]-N;Z?<8;:)I
M7"C)(49./RIJ+EHA;:G!?\+H\.=[+4L_]<D_^+KL6#J=S/VT44X?BIX1MY(7
MBTS4%:!76,^6GRAR"W\?<@4_J53NA>VB)_PM3PEYRS'3]4+HP;+ 'D#;D@R8
M)QQDT?4JG=![:(V+XH>#X+I+B/3-1$B,S [%/S'.3@R=3D\]>31]2J=T'M8G
M3^&?B'I/BK4GL+&&[CE2(RYF10" 0#T8^HK"I0G22;*C44GH=A6)H% !0 4
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M')L.H * "GYBW.]^#O\ R.UQ_P!>;?\ H2UY^-^!&M+1GO->2=(4 % !0 4
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M@9)P.: . \*ZIH%]XVNUTVZ\V$1![*(^?^[8EC,0K_*F?EZ8[T >C#I0 UN
M:2W YJV>,_$&X1$N%=;([S(6V-\RXV9XQZ[>_7FM/L$]3IA6:*.4^)'_ "(&
MJ_[B_P#H8K?#?Q$1/X3YUKWUL<H4 % "'H: /7_@E_QYZQ_OQ?R:O*Q^\?F;
M4>IZN*\\V1R/Q*_Y$N\^J?\ H:UC7_AL]3*O]YC_ %T/$5^Z/I7F'WHM !0
M4(3/4?A'_P >>J?]=%_D:[L+\+/D,]_BQ]/U/2ZZSY\* "@ H * &2D+&2=V
M/]GK0!YCH_B2TU;Q/IMKHAU&:.1G>22\U)QM6,C</*R3GYA@-M_*@#U!3D4
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MUY)TG/\ C?\ Y$[4?^N?]1657X&=V _WB/S_ "/ 4[_6O+ZGZ!'9#J"@H *
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M /(G:C_US_J*RJ_ SNR_7$Q^?Y,\!7O]:\OS/T&.R'4#"@ H [SX4\>([O\
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MOBO1;7QE->O?WCQ&V,1#6TA6-@PX4!.AP3WK94I<FB)V9L?\+"\-_P#/W/\
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MT>SEV/%N6++QKH5_>16EM<S--*=J@VLJ@GZE0!4N#CN.]SH :D!: "@ H *
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M4"L 7% Q: "@ H * "@ H @FLK:Y>)YX(Y6A;?&74$HWJ,]#1L!+L%"T 7%
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M@ H * "@ H * "@ H * "@ H PX_#>GI>WUZ8@]S=,Q,K*"T>4"D*>PP/U-
MBF?!UNZSI+?7<D;Q[41F&(_F5LKQZQKP>/:@!T_@^UN;B*::ZN&D6/8_W0)2
M-Q#$8P""[=,=: &2>#8G=96U"Y-PH,8EVIGRRH4IC;CH.N,^] '2Q((T5%^Z
MH % R2@ H R-1T&UU*>66X:7>R*B%7*B/:200!P3NP><]!0(H+X0MPMU&;J<
MPW =3'A<*COO90<9Y.>>N#Q0 LGA&&5;=);V=XH5C!3"#>8R=A) XQGM@''/
M>@"67PO#))IQ%U.D5@(MD2D;6,9.">/<B@9T Z4 % !0 4 % !0 4 % !0 4
M % !0 4 9>H>)="TBX^SZCK%E:3;=VR>=4;'K@F@#261'4,K J1D$=Q0 NX
M9SQ0 V.:.5%>-U=&&0RG(/XT .W#UH 9)-%#&TDLBQQH,LS' 4>Y[4 0:AJE
MAI-H;O4+R&UMP<&25PJY],F@"6VN[:]MH[FUGCF@D&4D1@58>QH ER* #(H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 ?_V0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>img247211528_33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_33.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_M&__P"@4W_?P?X4 ']HW_\ T"F_[^#_  H /[1O_P#H%-_W\'^% !_:-_\
M] IO^_@_PH /[1O_ /H%-_W\'^% !_:-_P#] IO^_@_PH /[1O\ _H%-_P!_
M!_A0 ?VC?_\ 0*;_ +^#_"@ _M&__P"@4W_?P?X4 ']HW_\ T"F_[^#_  H
M/[1O_P#H%-_W\'^% !_:-_\ ] IO^_@_PH /[1O_ /H%-_W\'^% !_:-_P#]
M IO^_@_PH /[1O\ _H%-_P!_!_A0 ?VC?_\ 0*;_ +^#_"@ _M&__P"@4W_?
MP?X4 ']HW_\ T"F_[^#_  H /[1O_P#H%-_W\'^% !_:-_\ ] IO^_@_PH /
M[1O_ /H%-_W\'^% !_:-_P#] IO^_@_PH /[1O\ _H%-_P!_!_A0 ?VC?_\
M0*;_ +^#_"@ _M&__P"@4W_?P?X4 ']HW_\ T"F_[^#_  H /[1O_P#H%-_W
M\'^% !_:-_\ ] IO^_@_PH /[1O_ /H%-_W\'^% !_:-_P#] IO^_@_PH /[
M1O\ _H%-_P!_!_A0 ?VC?_\ 0*;_ +^#_"@ _M&__P"@4W_?P?X4 ']HW_\
MT"F_[^C_  H /[1O_P#H%-_W]'^% !_:%]VTMO\ OZ/\* #^T+X?\PMO^_H_
MPH /[1ONVEMGT\T?X4 ']H7_ /T"F_[^C_"@ _M"_P#^@4W_ ']'^% !_:%]
M_P! MO\ OZ/\* #^T+_MI;?]_1_A0 ?VA?\ _0+;_OZ/\* #^T+[_H%M_P!_
M1_A0 ?VC?#_F%M_W]'^% %JRNQ=Q,VPHZ,4=.NUAVSWH LT % !0 4 4=0L3
M=R6SK+Y;0/O&5R#2 S=7L!;^&]8WW$LK212RY)VD'9C'RXR..],#H* "@ H
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MI0(J#19'$"O:C:$8. X!)[<YZ_=Z>_M0!!_8]Q%,Y: "!6<Y+@DKLX/J/FH
MU?#I)M[AB<YF))/7[JTP-F@ H * "@ Q0!E^(A_Q3>J#_IUE_P#030!J4 %
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M1_K=0_Z^G_D* -.@ H * "@ H R_$7_(MZI_UZ2_^@F@#4H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#,TC_6ZA_U]/\ R% &G0 4 % !0 4
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M^2NT?<Z'.?3FF)'0T#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M S-(_P!;J'_7T_\ (4 := !0 4 % !0!E^(O^1;U3_KUE_\ 030!J4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!F:1_K=0_Z^G_D* -.@ H #
MP* *D=\)+^2T\J0,B[MY7"GIT/?K0!;H R_$7_(MZI_UZ2_^@F@#4H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@#,TC_6ZA_U]/_(4 := !0 '
MH: .8T98Y/$ES=):&!I(VWDPLH8[EQ@E1GIS_7K0!TXH R_$7_(MZI_UZ2_^
M@F@#4H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#,TC_6ZA_U]
M/_(4 := !0 'I0!@6M[)=:_-#%/.$49,;(/+*@ <'KG)_3&.N0#>7('- &9X
MB_Y%O5/^O27_ -!- &I0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 47 * "@
MH * ,S2/];J'_7T_\A0!IT % "'H10!S^G0I'XIO EL(0D>/D;Y3D@@XV@#/
MU/\ .@#H,XH S/$1_P"*;U3_ *]9?_030!J4 % !0 4 % !0 4 % !0 4 %
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MH6MM+Y4LRI)@-M/7!Z']#349/8",:O8X_P!>/R-/DEV /[7L<?\ 'P/R-*S
MJ*^IWMLLT%S!$IEX!A.=@?UW=P/3OVHT M"/4L?\?5L/^V#?_%4: +Y6I?\
M/W;?]^#_ /%4: 'E:E_S]V__ 'X/_P 71H!%<6=]<PF&:Z@,;$;@L!R0#G^]
M1= 7E@BQ_JT_[Y%( %K N=L*#)R?E% "?98-VXQ)D#'W10 +:VZ A84&22<*
M.M.X#OL\/_/)/^^12 1K6!U*M"A4C!!44 )]FA#*PB0,O0[1Q0!2TC_6ZA_U
M]/\ R% &G0 4 (>AH R+:Z9_$MU;&XR$B!$0=3MZ<D=1UXZ=3UH U\4 9GB+
MCPWJG_7I+_Z": -2@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M: #.* $S0 9H A-Y;+(D9GC#N,J-PY'M2N.Q3TC_ %FH?]?3_P A3$:= !0
M=J *Z6-O'=-<I$JS,NUF'&1]/PH L4 9?B+_ )%O5/\ KTE_]!- &I0 4 %
M!0 4 % !0 4 % !0 4 % "9]J $)YI("G;0--:Q2-<S;F4$X;OCZ5=[ 2_8S
M_P _,W_?5',P'V]LEM"L,?"*,#/-2!+B@ Q0 FWG-(!U, H * "@ H * "@
MH * "@ H * "@ H * "@ H 0G% #/-0G 8$_6@+""5#GYEX]Z MY"?:(@P4R
M+N/.-U [2[$3WT*6\LP<,L0.[:0>1U% 6:W0U&O6F!*P>3GU.[%("#9J,YN8
MIUA2)LJC+G."HY_,FC4?NEP6L6Z-C&I:,84XZ4"NRII'^MU#_KZ?^0IB-.@
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MV[RB"\'F9X.PXQ^= M!LL5Y+;!!-&DA;YF53T]N>M(-"6.RMD)9;>-6.<D(
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M8U0F)?E P!QTQ0#+84>E,5V&Q?04#N&Q>F!2L%PV+Z#\J+!<-J^@_*G80H
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MEYUNT,D\A5A@GC)'Y4A7+&P"F(-OO0 ;?>@ V"@+ %QWH 7&* %H 3% !B@
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MYP&VX/'3N:2*;L:'%,D7% !@>E !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &9I'^MU#_KZ?^0H
MTZ "@ H * $) ZT 9GB(C_A&]4_Z]9?_ $$T :F<4 )D4 5+N]-O+#%' \SR
M9P%(&,=>IH2 C^VW73^SI?\ OXG^-/E7< ^VW1_YATO_ '\3_&CE7<!U@DB/
M<S2Q^7YTF\*2"0 JKSCZ4G9; 7-P]:0% 0I>W-R+A"PB<*F"1QM!_F33*V+R
M($4*!@#B@G<<* %H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * ,S2/];J'_7T_\A0!IT % !0
M4 4-0:\26U-LI*>9^]  SM_'^GM2 R=5;4!X6U=IHT+^7,/WC;<1X/(P#V[&
MF!K7&HQJ ()K5SW#SA?Z&D"11EO9;F*6"1[)$?Y0PNN0"![?6@K1%E(]'0DA
MK4$@KG<,X[T$BJND*C()+8*WWAO'-,8!=)6(Q"2V"$Y(WC!/YT!<7_B4^2(?
M-MC&#NV[QC- 7!O[)>)8VEMBBYP"XP*!7)8[FPB0)'<VZJ.@#CB@+DGV^S_Y
M^X/^_@H /M]G_P _<'_?P4 'V^S_ .?N#_OX* #[?9_\_<'_ '\% !]OL_\
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M^_@H /M]G_S]P?\ ?P4 'V^S_P"?N#_OX* #[?9_\_<'_?P4 'V^S_Y^X/\
MOX* #[?9_P#/W!_W\% !]OL_^?N#_OX* #[?9_\ /W!_W\% !]OL_P#G[@_[
M^"@ _M"S_P"?N#_OX* #[?9_\_<'_?P4 'V^S_Y^X/\ OX*  W]G_P _<'_?
MP4 4]%=9'OV1E93=/@@YSP* -6@ H * "@!" : $:-6&& (Z8/- &+-;:7_;
M=K&]DAE5& 8(NT;N<'USL/Y>](#2_LZR_P"?2'_OV*8"_P!G6/\ SYP?]^Q0
M ?V=9?\ /G#_ -^Q0 ?V=9?\^D/_ '[% !_9UE_SZ0_]^Q0 ?V=9?\^<'_?L
M4 ']G67_ #YP_P#?L4 ']G67_/G#_P!^Q0 ?V=9?\^</_?L4 ']G67_/G#_W
M[% !_9UE_P ^</\ W[% !_9UE_SYP_\ ?L4 5[RVL[6U>8:='+M&=BHN3^>!
M0!7TR/3+FW*16**(<)^\C7)&.#^(_&@"_P#V=9?\^</_ '[% "_V=9?\^</_
M '[% !_9UE_SYP_]^Q0 ?V=9?\^</_?L4 ']G67_ #YP_P#?L4 ']G67_/G#
M_P!^Q0 ?V=9?\^</_?L4 ']G67_/G#_W[% !_9UE_P ^</\ W[% !_9UE_SY
MP_\ ?L4 ']G67_/G#_W[% !_9UE_SYP_]^Q0!D:K/HME/';36T32G]Z$1%W8
M!SW_ ,\&D!J1V-A(BNMI"589'[L=*8#_ .SK+_GSA_[]B@ _LZR_Y\X?^_8H
M /[.LO\ GSA_[]B@ _LZR_Y\X?\ OV* #^SK+_GSA_[]B@ _LZR_Y\X?^_8H
M /[.LO\ GSA_[]B@ _LZR_Y\X?\ OV* #^SK+_GSA_[]B@ _LZR_Y\X?^_8H
M /[.LO\ GSA_[]B@!DMEI\,+RR6L"H@+,?+' % &7HR:3=-,MO8J 6+DR1K]
MX\D>V,C\Z -;^SK+_GSA_P"_8H 7^SK+_GSA_P"_8H /[.LO^?.#_OV* )HH
M8X5"1(J*/X5&!0 ^@ H * "@ H * (#:PO=)<M$IF0;5<CD ^] $] !0 4 %
M !0 4 % !0 4 % !0 4 5[RT@O;<P7,*RQ'DHPR#CI0 MM:6]HC+!"D89BS!
M1C)/>@">@ H * "@ H * (HKF"?=Y,R2;"5;:P.".H- #_,3<RAURO49Z4 0
MVM_:7H9K6ZAG"'#&-PV#[XH L9H * "@"O<V5M=D?:+=)<# W*#_ )Z4@+
M' &*8!0 4 % !0 4 % !0 4 % !0 4 (RAE*D9!&"* *]M8VUJY:"WCB8J%)
M5<9 Z"@"S0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 )D4 +0 4 %  >E '.-X5'G/+%J%Q$Y+;=K'"Y(.,9Z<?X8Q0 Z'
MPY)!J9N1>W#B0YD+2D9 .0N/KCD8X!'<T ,?PQ+Y*JNHS*R$']U^ZWJ"S;20
M?5CS^E): ;%A:/:6RI)*TLG5W9LY/]!3 N4 % !0 F10 M !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M * "@ H _]D
%       !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>img247211528_34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_34.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MD(D51"583'NWF;>O/!- ':>  1\/O#H/_0/A_P#0!0!TE !0 4 % !0 4 %
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MF+PHH 6@ H * "@ H * "@ H * "@ H * "@ H :SHGWF ^IH ;Y\7_/5/\
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M_!UO;VNL^(8[7'D^?$5P<@YA6FF979U]4 4 % !0!@3_ /(^6'_7A<_^AV]
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MIHIM^6E9 Y*\Y&3]:7,-3TV'^%+5;+7/$-NKEU2:$ G_ *XK5IDMW.KJA!0
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MX5/+RLB-.TM7H7-!\%QVUY'?W-P+A_D:*1&.6PO5NQYR:3G?1#E4NK([-4
M( _+%08VL+CN*86&,K^8I4C8/O#'-(#(T'_D9_$W_7>'_P!$K6D1G1U0!0 4
M % &!/\ \CY8?]>%S_Z';T ;] !0 4 % !0 T]<4@,^XU.*VNQ!,CJ-N?,(&
MTG^[]>*&4HM[$,>N65S!,]M.DACA$W)VC:02#D].GX4EKH*SZG+AC;:C+J$*
MQF66/S?)A57$AVG)5@.')P.3R#WQFG)WT['0N:44F4=(UD1:MJ%Y?6\A%E;>
M>B!09$0+]PYY)^;..,>U)+5(VJ0M321=T:9KJ>R\N^BN/*@G9&N#BX920 RC
M)^7(QG-:WY=#CK4[1)9+99;J*W W/("Q"GT[FNGF]WF1Y*@O:<LD;EY<)=VY
MTR!Y(&N8BL<P'^K."0<9R>!G^=<=[ZGI07+9'-L5T*.R%L]E8ZE*IC;SG)!2
M(98+@$*#@Y./S--.^YLDI-DCWD5W+=;;<RZ8%^UF0,3&Y*EB <9'S8.>O&,<
MTUW*4=?,V/!US)=Z.UPS.8I)"T6^7>4']SD# !&!GKUXZ4GN14C9V)9O$;RW
M4UMIMFUQ):RE)S*WEJ, $A2>IY&,\>XI J>FI)8>(EO+Z&S>V:.:16+8<,J[
M>O/<=<'VH"5-Q-U3QUH,P8 @@T@&X#(0: ,-+D1ZB]L99-L9+9<+LQ_=SUXX
M_.A1+46]BG#XJMFN%L3:,UQ(&W+ V]02!LRPP/F!'/09&2,U7+H5R69)IW]G
M36]C<K')ITA/%L90"1@DJ1G!'S$_E2;LR7S;/4NZ)(LTMT5LIK?RI3&IEQAQ
MUW+CL:;=R.3EU1MT@$/0T 9_A_\ Y%O2_P#KUB_] % &C0!B>,%W^$-54;>;
M=A\W3IWH&MSS[38I['$8LHWD23>98F'EDYQTS[ \^O2IEU-I>\KGH4ME9WQW
M2P DCY@1SZ5FFT87L] L=$LM,.ZWA4-C[S'+?G2=V-ON6VGVQ.R*Q"CMW-%R
M6<';2W\NMZG--+^_^R@L%R F3@ ?@#^5;Z#F[1+$BS6T#)YC+((]Y7.&52<
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MKFY;3M.>2]D9?-C&WGA!QG&W ZY/8\'ZT+5V$TKG>>'=-%]H=K+>R23JW[U
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MRQXGT2>^DLI+601_9F+ ?>+L0 !ST' R?:G%I*R(@^5EFYLK-=2M;R^90\2
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M#<FV->%'TJ)8U!< 3F/S-IR#TSGV/Y4IN[-J3Z]Q98!(5U5HWC6:-7E\DGS
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M35C0M[Z%[7S@C)\V"C=0:;BXDWL9GAN7S?$GB5LYS<0]^G[E::&CJ*H84 %
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MR5GN7#$Y<GOVP*3;8.5]C3DL[2:2-I+>,O&VY#LR5/3(]Z3)NR? !5=C$^M
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MFG\C;@CF2>TM[7S(FA*K(" T:1J3ALXP7*A5QG(#9Q4VZF+:N[BZ[=QSLD:
M,4!)4N5/MG!!_#WK:C#1L\ZM*TE=:(KZ!I92:ZNM3*K;Q',6X_*B8_OGKWZT
MZD[*PXPIRFYQV-*[T2!-2>X2SL!:S1L6$@VEYB1@G P00#R<G-<U[*QW1=E9
M&OI=E'9V4<:%6;&7<8^8^N1UH;);N7QTH$% "$X'% $4D\<8;S'5 HR23T%(
M=BGX?_Y%O2_^O2+_ - %,1I4 8_BO_D5=2^;;^Y;G.,4#6Y1T"&Z:R#7%P)2
MS9+ YX] :QEN$GJ8WB;58Y)WT^VE'DHFV;8Q!&?NCCJ#S6D;1M<F,;F)*P^V
MV-H=CI' LA8Q\G)) R>V3FB,7&)LM-2SJ2K>W;VUM DP6%9#+U!8'E<>IZT^
MS)C91*6BZ6^KZ4U_)=2V_P#9L[NGEKD,0 3M7'!R/SH>DFC1R2U14TNXN=1F
MFFU-9[M]Z 2+C>"?NL,\#CG YISTV')))-'IT!D@OH8"S2 0 .??U/O_ (UB
MU[ISW]X8Q$FH/-=%46!=N=V!R2?Z#BGLB2>'4+:66*&&5<N"=I.&(SU /OWJ
M4A[E[E0<\@4# %L9QGZ4 "J"OS#\*!V(WM89)5=XE9EY!89(/UIBNQYAB8@E
M,D>M/4>H[RT!R!^=( VK_=% #=JCM^M AP55^Z *8"DA1DD#WH 8TJBE<7-T
M.-\4>)C8I):1JZ2,,^8?DRO?:?4548W-(0;U.)N+M+W:8&N(IW5^9,,LISG)
MSZ\\Y&*VY>4ZE>.Y<M)DMKB& QW%L -V4E98V?C^[P>1CW J;7W(:<HW(+B]
MO[NX+R3NRI(&1"3G@_.<=!SZ5459E<BM<Z,>+KJ4M;VL/GD6SL/,8[F8=,#O
MT/:LG&Z;,E3U.,%ZZ:B+UXU4LOF3GDL"5QN.>G.3VZUJDEH='+=6.BT/1M1U
M'RYV@;R[@[C)*2#C/ /0M_A0W8YZTTM$=CX5MTM-<\0P(,*DT('_ 'Y6IO<Y
MD=504% !0 4 8$__ "/EA_UX7/\ Z';T ;#R %AP<#I2OJ!A6EI=74KWNH8B
MB>17%O(,F/;D#G..>#TI/<VYTHI1W-)-4MG*BWD68>9L8HP.T^]#=M"'"25V
M703GI^-!%@W$KR,>H%,-E=G.RZE/!J4PO9UM8<LD"E02X !)'<D8)X]>G%%C
M56MH1Z=JS- $L9)+NXG<.K2Y*A22#@X&,!3P>Y[]*!RC;<ZE&)7FF8@P!4@\
MC% ;&'<VEY)=VD83;;1NSLZ-M  'RC:.3_\ 6HLD:QE%*_4YN'P;<7-Q=7%T
MBP7 .Z"?.]3\S,HV-T(..3SU&>M7S613J+0EU&UGMM.G22Z?,H4,5B)PR#/R
MKG@$@@8.>1@U2BFKHQC->TY3G]'N=/O]1DDN+1IDG<Q1%#\T?0YP.F,YXZ8S
M5..QVSNE9#[Z]M[[13;OJ92]@7RP6W1J-Q&3DC<01SZG'([4FK,S7N@MK=3O
M+;VB3((XF9Q$0QN2ORY5B.'Z9]230VHEWLKG1:MITU[IT!N;:X>W%J,0AF\Y
MG(^9& &.<\G/X5G'25S!-7U)-!TFXBN+9[VW$'V<KY*RJC,1L((#*2>,CKZ=
M/29:L4II*QTE_81:C;K',SA5D612C;2".E";Z&:=G=&-I]DEO+<6MA(TADE+
MW%RZY9GXZD<9QC^=:+179$YN>QI72);1);P0H6DSDLN<#N3Z]:E/J2^B1B&*
M"76+FU:Y=[<6XMXXEF0HSX+-E<<$#!^;\J&S=)1@DD6=,TUH+"S1&N9"[R&2
M:8LC\DDG:1@<]OI4L&]3H[:&.WMXX8E"1QJ%51T '2@@FH ,XH 9DT@ZG-:W
MIADU&*\%E-.CQO%.JLK+LQP=IZGT_6FC1-6-7P[QX:TH=/\ 1(O_ $ 4$&G0
M(R/%*>9X8U&,]&B(I,:))0EG:R&( "*(XP/2LEJQ2?4\D74SJ,Z&\EC P^98
M"3@Y(4=?3GFNAK4Z%3Y5H;T$.G&TCN+60.T5N(3R!AE& OUZ5,6UH9RNGJ<Y
M:W\ZZK:275Q+;E'SYB_+'C'0COD#J2:N2TLC?ECRV1WFCW::';JEWJ0GLY1Y
MD,TA&^0'!X Y(R3UK#66K,96V,_6];TZY;S[8,S1@'&652RG*_7FJ2>S&J4K
MV.FTV1YH8KB8%+IXE5T'9NI'X9K)_#9&+24WV.7\6ZE'&\EK;2%A&.1@C]YG
MJ>,8]Q6T59:ETHJ5S$U75+JR\9I=Q&!TBB4H0VYE'E@$;<YZ\8Q5)1DM#513
MCH>@:'XJT[6(UC\]([L*"\+9!'OS63BXZ&,HN.YN+)&3@."?0&I)6NPZBX:!
M0%F(KJPRK9 .*+CN@Z4"M;<3( )/ H#0JS:E80G]Y=Q*?=Q]/ZBBPTKE.7Q'
MID,JQ-=+O8@*%!8GZ #FJ46T))LHWGC#38+Q;)'DGNB#^[C0_*0.A]#[4<KM
M=E*G)[G&7'B;4[B_1//>,EA+P,*N"3M(')^7)QWQ6G*DM#IY(Q1+'?W6O6\F
ME1^5>01;FD:X^5RF>6W'!7DG'IBAKE(^'4N3>'?#T<=K#I=]-]JE8>7Y4GF@
M#@M^''K4J4K781G)_$<_?Z;JL,Z0W$<=X"?GC20%N#Q\HYZ'/'7-7&29K&2Z
M%.\34)(#)<6!:% 0"\97:3@CC(IZ#OTN:>GVFN2:A$YL"PC&Y7C3 7IC)/'K
MQ1)JQ%244M#MK'PG907C7<J^?<2MN<L@"@]<@8Z9R<'/6LG+H<CJ2:L;<V+=
MD$5N[%3QA2<?X4MR&KF;X:D\WQ'XE8*P_P!(A&",8_<K5HI'44QA0 4 % ',
MWTL<7CK3_,D";K*Y"Y.,G= <#\ ?RI/0=KEB+5C/>/%';2B!0<R,-IW#MS[4
MG9&CIN*N8%S?7&HN]O%#YL<K';+(Z%7"\XP!]W@]\T]$;12C9LBT<6UKJD-O
M)-;?:S(73800V3\PS_>!7G'' J&C2I+FBV=G>7T-C$))=V"P7Y1D\G&?IZU:
M1PI.3.7U'5=4U:.9+"06L(8(RM&PEPP&T\<J<GTZ$>]/1'1&G&+]XE71]]TU
MQJ$IDAB#2/YZD@(5(&UCC9WSCM@4K]A2GTB16NHW+Q26^DSV3HD2LL5L1* 2
MW)S[X('O37F"4;WF=58"6*QC%S,\DN,LT@4-^..*5^QC)IO0N'H:9.Q0?5+&
M&5HFNHA(IVLFX%@< X(^A'YT,?+)ZE2]U=$=K9#MD*;DYY;OP!S^0[&A(?(]
MWL<A-K<IMY$,Y^U21B=K>3(*'=P%W8QGT/(S5Q;B]-C1TH26J*IN+BWD7RHD
MAFD?*P'#'+?=8=^5S[_G71S)Q,G!J5EL:UM:S-9RS2PK+*JXDMA&/F8\<*W&
M3[]C^%93;!<M[(O:>UWI[R'[#+!#F241$Q[I"S$@#!ZG&>?SK&3;-)69-#%J
MNI7=G?QW"10(VX(SEL*>"I5< D#(SD\\CW'HK"?*E9$]]JUUNDM]-A03QI(6
M>Y!55(!Q^!;'X4U&PE%=1= NVN]'^W2Z@MXL[9W1XV+@XP/ZT[7=D34:C\(6
M.K0V]JT*P3O.&9BFP@'+''S'BJ<'U,^>*5T6;=+C,EQ,%,[ A%/0>@]A4NRT
M*BN:2;*OA(QS:09S'"MS)*_GF+NX..?? %)JQI/25CH0!2('  =* $H S-6N
M;J"-1;@\YR57<PP,X Z$GIU%(I*YF6&J3R2W(B,DQA3_ %;X#,_4J>  1D#K
MCGKWINR+DDD-L_$Z0S?9M5FC26279$\<;"-@>5 8\$XZD&FXZ"=/2YK^'_\
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MGGGZ^].[(E=%MHVAMD2PBC4 @ =%49YX^F:-17NBV >] A=OZ4!87% "]*
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MBJ9Z8BQD#J,XIIV.K#R47JRWX6L[^(1OJ-I:P1Q.9&82,60!%P1G..ASR/\
M&'JRJK3^%FJ=2NI=2:YLI(I;'*JP$RE2,CYP<\#!;CC.VI>CL8J-HV9K2ZE9
MPHKR7*+&V-C!MV[/0\=N:"%%WT14M!*SLTJPO<>:RQ2*"=@ [Y[\GIZU<4*;
MZ,P_%-K/J$6EW!C1V5I(R0A=%9OE!."/ES@=#P>U6M#6B[1:8EMIU[;VT42(
MD,%O-)&YB<ON4A0"02=QZ]>1@?CGOL:*4=BNE@VNPZC)&\L41_T/!VM@#:&(
MYZ<-GG-:)V:02FJ=@OM;U'3H[?1=/5)+J&/:R)V51QG=S@C'(S@YS3LF[R%"
M*;YF94DNK17D$E^]PEPDI:*65ML2C&%$@Z9()X _^LI<JTB6XQ^R:FJ^)TU+
M1;J.*Y@C:(E9UR&#+P%8$'('*_3GVRHQL91C:5RL([2QU73;J,6\P:,2S733
M,<L!SM3//RG.<GJ,^Y=ZE2OJ;D5QI%Z\L<%DT$UHAV+;* \D> 2%QVW$Y'J/
M6IU>IC[R5V17]JL.I2G38(S=B%(3++(SEDSG:1D8.-V#UX]J:>PXM27O$]R(
M=7TZS76)$C99/F$8! D7/'S ]@<YZ52W8)N#?+L1V\5U=)>VL,[VDD,+Q1Q/
M@F09.V;/4YSR3WS4N-F.Z5F9VFPW$ @N(DDAU"%UB<N3+^['WB#_ !+CC/J,
MTS1M/3H=MIETU]I\%S)%Y3NN2F[.WVSWI'-)<KT+PH$+0 4 % !0 =* $H ,
MT '>@!'^Z><4 4/#_P#R+>E_]>D7_H H T: ,GQ-@>'+XG@>6:3 E>=HV#*/
M,A('('(K.XKV&7UM;:I9-'*@E3T-$&T#N]4<!9Z9<Z%>S6:VKQVR.2C'G<F1
M@KR3@=^/RK=NXYM-&U:WEG#9B2!BK3J2N1A2P&,']*CJS-?RLP='UVYGU%UN
MV,B >9Y@ !7!'Z5>S.C$4(0BI1.UTJ.UN,3;A(^2 6Z]>>#TK&:<7J812W-.
MXM8+A<2*<XP"I((_*IV+L<]XA\.6VHQ0^1 PD64,2,X*YY!]J:DP6A5?P[;6
M%V7M&FDD*8>.,D)T[@=3GU[5<6PG*5K%42ZQ:W%NICMQ:@,SB8*)$Z\C/^>M
M.5FQ0A!1LD5C%8317$UOEFN1N=XCN7G@%1^9SQ5ZK<.9O1&&-#U!;I+=;?>N
M0%D4_(0>GTH;N>@J\5'7<Z2\2/3=+.FV]P#-'AW P"Q)YX;'^126K.&4Y3E=
M['/2V!N;PF,+&KCDAPQ%;<K-(XI1I^99N9S81):Q 'RURRF0!1G@$^I)[XJ9
M6,Z3<U=E>[EN+&86\<RF54^<+AC(3D;03CICK]?2H-$ENS12_DMG-M!,!)$@
M;D<\]LX_SBI8J=*+UL6],UU[>8K.IN(F5LQXR6XZ =S^%2[]#6K1C'X3GX-:
MM/\ A*HW;2MBJ=@"$MY8QA65<X  ZYJG"?+8)1?)H;6C6UE%J=S<3?:DA9)-
MMTR[8Q'C .[L,'C-2[I61-23DM"PFHZ9HQC33+<3%%R;R0!W=",G!Z^E%F]R
M5%RU9BW]Y/?SR2SLY@D4%%\LD[^WX>U5RV-%:!TO@O2KJWMY-1N&D5Y@%192
M0,=FV?P_2E-F-62D]#K!'ND7<6PO0#I]:R1GY$K;=F"./2F JX &*+@.'44
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M,:!V'$9%,8@4"D 8XI@)D@CC(I"%I@*.U S$T+_D:/$W_7>'_P!$K5(#HJH
MH * "@#F-2@6Y\:643JK(;"YW*_0C=!UHO8#1ALK*)((C;1;+?+0C8,*2""5
M_ GGWH?<=R](=L#%$R0/N_TJ0MJ9PN)$@42JRLP+L<8V],#'^>M5N%DA(-/,
M$5M-)(_VQMJN6?[WJ,=,?X4[]!,TDR >,$\GM4B*.IQH+9I)I(TM@I$FY<D>
MX_\ U4UN4M'H<C_8DDED\D$5I*8VVAT^4L,Y.1D8/ Z^]4VD=/M%HF6HM+NF
M*(ULWE2KMWG:64Y&<\<\"DY=2742N0WWAZXL;&1_M$ES+(1\J*0 Q.3GKP>G
M?K5QE<7M4[7*LK^(-0N7L#&T<87J) D9' P1P>>O'IWS1>,=65>$5S(Z:#0V
M%M!:S^8\2(%$GF'<O0C'MVJ>:^J.9N[YK%ZYL+8*$5Y+8R9!:'@DD=2<=>.I
M]JARL5&Z]Y&+_8=EI^GO!9ZG) TB_NF+!@BD\[0, ]3SVR:+IZV-.><G=(K/
M<76FV"#10;^:67/FS@;#\O(7D =/7L?:J3N5;F=Y(JV,=@([=WMKUK]993L5
MS(K@,V0S$8VG&<>M-MHMJ2TZ%9]4N(;N8R) +69%C+V\;"15+*&RZ\[LD\#(
MR.<4636A/LXOJ;EM)<S6CPA<7CG=! Q93&O&X&4#J1SGW%3:QG*RT'6^FZS&
M(GN/GGG41R,I5A%QU((&[IC\>!UIWTT);UT-UK4P:=*ELJ&X,9 +@ ,V.IQ2
MN]+D*U[G-W-K>WI&GK)NEM[=(YFMV* MP<@\;2.<=>O;N=;FJ4$[L9=:G::;
M86ZNK3R3J4 ER0S$^O+8[]^V*M1L]"XQ]K)]D1C3].UC4V%W]ICE>T1A;B3(
MVCC((Y[D8/-*[L"DU&RV*4&HV9OI%M;B2)70S_9)2ZEIG^8*YP1M(/([?2FU
M9;&CC9$][9Z5;:;"US#+/+<()&SA6F4JP"8 R=J] !Z?A+NB%>3(]+CN[*/5
M=2N+9K-/)VJYRI;!.,AN,#(.>/YT].H:)I(AC66\LH)7$=PJ(CNYD_<.5Y*C
M![8^@_6JNMD&URQJ?B!K#4)W>.-[*-R/*M_W9!900Q8\$G)_0]:F*;5V.,';
M3<[#P]SX:THCI]DB_P#0!2V.78U*0&5XE./#M\1_SSH YSQ28;6YM9&N9()W
M+QP8)VEB!\I'<?I4K5,<=7H8,VL3WFGV:3VXBM6=M\I8H8T&%!(]\'(''%)I
MK0U<%?0W/%=E<G0K287/V5[;;YC+(4&.A&1['C\*(M,F,GS&!>W,5U%-<V]T
M(Q @%T%A+%XR2,(<]21^&*I7+L[Z$%WJD%Q$]K:V[-'M0N5<.\@55/*D=3G!
MXJE<:@D]34TF:>:>\DAO$E+[3D#!1<8&X#C/^%"2LKF-:33MT-1/)FM4EOX%
M=58E6,08JV>O './IT_)/W7H9Q;M8S-=.JV]R([8O+;8:1FB0,JX_@DR#D8]
M^?2B"5KF\%%:2W*^B7Z1:_8*^FP0QO)Y<<L3;=I9<D,.^23@<5,DU'<IP5KH
MH/?W-MXGNHX;=X)_M.QDD(9#&6P,C/0X_#<*N44]1J*Y+FG=IIUVTIL',.OR
MQ.T4<9 9ACHIP!V/7GDT+5VEL1%M:K8S$LYK.TE?4[2>.\%NI:1V)8KYG*GC
M;UQ^%&M[1V-$U)^ZRQIKSK;7FC@P7EM-#(?(C3;O.,###@'/%2UK="G&+5RA
MO^R2'3WLA9S&.)EWR M%C /7G[H_'%/S96^JU+ODW:>&'-J#<M;W),RQC"_=
M!Y'5CW_$4TDY:"DUS6D2B^2YL?*E\J/<Q\N-LKG/09SG.!^E39HEQUNBUIVA
M7$TUN+2/RH&8,[Y."N<D9/7VI]-2>=)'9+H-@MRMP8 9%.1SQVYQT["HN8I6
MT1H%U)VA@#4C'*NT9!YH =3 .] !C%(!*8!C% K!@T#% Y% &)H7_(T>)O\
MKO#_ .B5JD!T54 4 % !0!R6M:K::3XVTV6]E\J)[.Y0-M+<[H#V^E("P_C'
M0=P'V_(/K"_3\J8%.3QOI+WFQ+Y?LX'.87S_ "HY4/9$EWXOT=;:1K>^S,2"
MJF)\9'3MTHM8-Q+OQCH9N[0B^/RDD@1OZ 9Z>YIK836I;'C301P;\\?],7_P
MJ0*FJ>,/#;:;<)-=O+'MR46-P6QR #CUI7MJ..YS-M\3-,AGE 98K< .=RR2
M2,>.2>F.<8[;?I5+7<Z/9IJY4U3XDXO9)=.U/_1P%80M!S@8!P2I_O ]NGYW
MRK8J,(+1D>F_$%M1U *UZB02Y=EGC8L$'105'49/Y"FDHDU*<>1M'71^*-#C
M<R+?8D8@D- 2,Y]=N:&<"=B4>-](*)''=B)A]XF)R !Z<5%D6I,D_P"$MT5U
MR^J;UY!5H'(QW&,<T-(:9$VL^%)+>. W*B*/.Q5@=< G.!A1@5-^4OG:"#6?
M"]L/*AO-D2J5\H1/MY.<_=^O?N:+WU'SN^A5AUCPKI]NLLFH/*;8,PS$X &#
MV"@=&/YFB[+O)E;1_%FD6XMA:1PV^G-D N)&F7.2,C&,9XP":=PFNY>/Q!TU
MM9BLEDS!@F6?:PV]P N,FE8FVAK?\)EH'_/^?^_+_P"%&Q!DZYX^TI+1X;#4
M46[QN!DADVA01NZ+UQG%"U+@M3F;;QOIT.G3W'VVY5@&M+9<NS'YBP<DC'3'
MN #UXQHEJ:;NQ2U7Q;92VEFWVKSI4@7<%A91%(<%B,]2#L]L9]>&G:YM!6-7
MP=XAT2.\U)O/,,)4!)&C9I"V3N/ P!P#T],YQ2D]$957JA;B?P_LFB?5;F2#
M"2-(X9BX7/R8VC''?_$TKC55RLF<[H^NP7FHAXIH+62V)DA\Y9)$' 4+CG!'
MR\X_E5O5&U3E2L:>H>)A*TEH]\'MYYOG^5V.Q@020PQ@$# YZ?C22L9IQ1:D
MET:[L<)J%O,=F]7FMGVLPSM#+MZ!2W/TX[4-D^T5REJ6L6UQ!#923+"T=V$C
M?:S!XS\Q+#'(SDX(QSTXI%1J;V/4O#N/^$:TK'3[)%_Z *@Y+W-.@#.UZ":Y
MT.\AMX_,F:,A$R!N/ID\4F!R.M)XAU.:T,?AR9%ADW,#<P\],8^?KQ0D.+L,
MDL]:N]0EN;KPU<%> L:W4/('0-ENG'ZTN@^9EN>?Q#>2S0W?AAY=.E3:83<0
MDY]<[J$AW,J;0M53319VOAVY<?:!.?M%S P/7C[W'6JN+G92;P[X@C@D@M/#
M2VR#:(B)868#^($EN.V#UXJDRU-CM.TSQ=IP55T $%3YA:XB)+9)&/FZ#-#U
M')J6YHWEGXBN+9(8O#LT0!);%W$0??&[K4HQ6C(M+T_Q1I]Q%++I5Y/\FR5#
M=0A7YY.-W7M0S64KED6&K)K<.H+X8G&QMS*+B ;C@@'[W7GMB@F,K(S[C0-=
MEO;FZ32+X2R,TB,]S VUS@@_>Z CIS3!5K*Q5BTCQI!<QSKH*,4(/-Q$",>A
M## )ZTFB^>+Z'17$_B:]46MQX:>2RD4K*IN8M_3^$A_7UJ4K&;T=S(M-)\06
M5Y$8/#3/:1/N0/<Q;^O0G=SW_.FU<OGYEJ;&H64VJEVO?!<CNR>7Y@N( P7T
MSOH6AFI<NQ)9QZC90301^%;@QR-G!N(.!@#'WN1Q2!NY+;F\M$1(/!;HJ] )
MX.#_ -]4"+@U;6UP!X6N !V^TP?_ !=%K@+_ &QKG_0KW/\ X%0?_%TN4!/[
M7UH_\RM<_P#@3!_\71R@ U?6U_YE>Z _Z^H/_BZ+ *-9USG/A:YQ_P!?4'_Q
M='* ?VSK?_0K7/\ X$P?_%T<H"_VSK?_ $*US_X%0?\ Q='* G]L:W_T*US_
M .!4'_Q='* HUG6_^A6N?_ J#_XNBP"?VSK@)_XI>Y_\"H/_ (NBP =8UL_\
MRM<C_MY@_P#BZ=@%\.V]^NJ:Q?7UBUG]LEC9(VD5SA8PI/RDCJ*=@.BI@% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 ?__9
2

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>img247211528_35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_35.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MXR"3T)SCB@"SX;\5'Q%+=7$2,EHMM#*D;+\Z,3('!]>4Q0!0T[Q%J;^'-/\
M%-_J5E!I\Z-<3VYCX2':2JHP.3(,#.>#@X H HWWQ%GGT:2XL;1[.X1L[9P'
M!0PR.IRIQNS'R,\?B* -F^UO4QI7A^6W< WNUKIHHQ)*J^46)2/^+YMN< X!
M/% &9!\1DM/L]G> 7UT@+74UK&8UC3S61?W;_/O^0[D .-I]L@%^X\=&*"2[
M@T:[N;+S_L\,Z.@$TGG"(K@G*_,3@G@@'I0!!+X_F\VZM8]'D2YA1U^:9"HF
M6,L5./X1@KNXY^N: (]"\<7NH::A:P>YU)_('D(Z(I+6ZS,0QZ#![\Y('O0!
M8MOB!'=7BQ)I5VMNLT$$TS,@\J2; 52N<DAC@XR!UR: .S'2@!: "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H HW^F6VI-:&YC+_99UN(L,1AU!
M /ZF@"KJ?ARQU><RW8G.Y55A'.R*X5BR[@#S@DG\: (%\(:.MM';_9F\N**:
M% 9&R%E8._.>NY00>HQQ0 ^T\*:593W$Z02237*,DTDTS2-(&"@Y)/HBCV H
M B;P;I+P+$PNF9)!(DK7<AE4A"@P^[<!M9AC/\1[T )9>#-&T^!+>WMW%NB(
M@B:5F0A#\N03SCI].* +.C^&M,T,LUE#(&,:P@RRM(4C4DJ@W$X49. * ,V+
MX?Z#';B![>:>!8)+>..>YD=8D<$/M!;@D$C(YYZT 61X.TL1,I^U-)YJS"=K
MF0RJZKL!#9R/E)'T- #5\$:+'%'%##/"D15HQ'<R+M95*[@<YW;6()ZG/- %
MO1/#>F^'HC'IT+1(45"#(6X#,P&2?5VH JKX(T-9@YM7:)6D=+9IG,",X(<K
M&3M&=S=N,G%  /!.BFS-K)#/+&0%S+<.[!0C(J@DDX"NW'O0!<N_#FGWEI96
M[QR(+$@VTD4K))$0I7A@0?NDCWH I1>"-$A*&*WF0A=CXN)/WR[R^)/F^?YF
M8\Y^\>Q- #G\%Z+)>"Y:WD++-YZ)YS[$?S%D+*N<#+J">/7U- %AO#6GO>SW
M+)-F9F=X_/?RRS)L+;,XR5)_//7F@"M;>"M(LK;R;5+B'#HXD6X<.I6,1+AL
MY^X,4 26_A'1[2 PP6K(AD@EQYC'YH2#&<DYZJ,^O>@#?' H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@!,T +0 4 % !0 @)H 6@!,T +0 4  H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M! P,CF@#T5&#H&!R",@T .H * "@ H * "@ H J2:C9Q:A'8/=PI=RJ72$N
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M?"'AYK!;$Z)9?95D\T1>0NT/C&['KCCZ<4 23^&-$N0JSZ1:2(LIF"O""-Y
MR?QP/R'I0!KJ, "@!: "@ H * "@ H * ,#5/#4=_KD&KK<21W%NF(U !7<%
M=03QG@2MQ]* *_A[P?:^&-(O;&UNKEX[DEB[/AU^4+\I'3@#I@#L!0!7^&.H
MWFJ_#[2;R_N7N+ET=6D?[S;791D]S@#F@#KZ "@ H * "@ H * $/2@#*DU2
MZ3Q#%IHTNX:V>(N;P8\M3_=/?/\ C0!JKT% "T % !0 4 (>E &7X=L)M-T:
M*UN !(C2$X.1\SLP_0B@#5H * "@ H * (+M&DM)D099D( _"@"GX?M)K'P[
MI=K<)LF@M8XW7.<,% (R* -.@ H * *+K<K=-(MQNB*X$/E@[3@\YZ\\4 <Y
M!?\ BV?3[&XELH8O,53<)&F)D)89PK$@87ZG^5 #;B[\5M$FV$Q2[$+;8T90
M=@W#KUWY'7 '/O0!UUL[O;1-*FR4H"Z9SM..1F@"6@ H * "@ H * "@!"0*
M #<,4 &1G% "T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 4IM7L+?4H=.EN EW,,QQD'YN">O3^%N/8^E $=KK%CJ,-T;:5C]G8QRAX
MVC*-@'!# =B/SH YCX0_\DPT?Z2_^C6H [B@ H SH-<L+F(2V[S2QGHZ6\C
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MU)YDVZ16;:%SM=E' XZ 4 :] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % #=V#0 ;O:@ WT 9%_X>M-0U:'4W>5+J!<1LC8"D!P&QCJ!(_Y^U $
MT.BV5KIEU9",O!<F5YE<YWF0DMGZY/X4 <S\( %^&&C@<#$O_HUJ .YH #TH
M Y[P42?"-ADYX;_T,T =#0 4 % !0 4 13@^3(58JVTX([4 5=#FEN=!T^>>
M0R32VZ.[$ 9)4$].* +] !0 4 % !0!E^(N-#G^J?^AB@#37O0 M !0 4 %
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M<Q01&X$4IDGFC!4]OW?)/R]_?UH W?"DC3>$=,D6[6Z)@&)QOP_O\Y+$?4T
M>>Z7IUKJ/Q+N].O[PSRP,;EXHK62)1)F-RV3*Q +(O5<'& ?4 ],O-#TZ_NA
M=75I&]RL31+*1\RJV00#VZG\SZT +I^C:=HUO/%IUG%;)*Q=UC7 +4 <U\(?
M^28:/])?_1K4 =Q0 4 % !0 4 % !0!%/<0VT?F3S)$@XW.P4?F: *DNL:68
MG U*USM/_+9?\: *'A_5]-3PYIBMJ%JK"UC!!F4$?*/>@#9M[NVNT+VUQ',H
M."8W# 'TXH FH * "@ H * "@ H * "@ H * $R* %H * "@ H * "@ H *
M"@ H * "@ H 0CB@#F_$F@7.K:GH]S;K;*;*<R-+(6WH.,A0.#G'/([=1E2
M9OA7P=JV@Z/<VC:OY,LMPL@>!0^0(U0D[P?F<J7/N>IZT ;/@X,GABV5Y#(P
M>8%R "Q\UN<#B@#>H * "@ H * "@ H * "@ H QIO\ D<[+_KPG_P#1D5 &
MS0 4 % !0 4 % !0 4 <=\1(H)_#T,=SC[,UW$)6,!E5%YR6 (8#W4@C/UH
MU?"CI+X3TQXK06:&W7; (S'Y8QTVDDC\: .:T2QU6'XG:Q=_V>#ILJ[3=R0(
MC[@!\BM@.R_F.* .EN_$=M9^([31989C)=+E90!L4X=@IYSDB-^V./>@"OH'
MBVR\0Z7>WT<,MK!;%@QG*@E0,[L G QZXH R_A 0?AAHQ'3$O_HUJ .XH *
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M<4 % %*,8UBX_P"N$7_H4E %V@ H * "@#R[X_?\DPE_Z^HOYF@#Y1/6@ H
M^F?V;_\ D2=4_P"P@?\ T6E 'LU !0 4 % !0 4 % !0 4 (6VT )O3^\/SH
M HZ8Z 77S#FX<]?>@"]O7L0?8&@!0<B@!: "@ H * "@ H * "@ H * "@!"
M<"@"":\M[>6&*:>*.29ML:NP!<^@]: %@NH+I"]O-'*H8J3&P8 C@CCN* ,G
MPCQX=@_ZZS?^C7H W: "@ H * "@ H * "@ H ^=-6'_ !/=1_Z^9/\ T(T
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M;EY_[*TO<Z*A^23&%)(_C_VC0!L^&?CWXCUKQ1I>ESZ;IJ0W=S'"[(LFX!F
M./FZ\T ?0HY% "T % 'E_P ?O^282_\ 7U%_,T ?*!H * /IG]F__D2=4_["
M!_\ 1:4 >S4 % !0 4 % !0 4 % !0!SOCT?\6_\1'O_ &?/_P"@&@#XD\Q_
M[[?G0 OFO_>/YT >I?L_LS?$O!8G_0Y>_NM 'U2HP,4 +0 4 % !0 4 % !0
M 4 % !0 4 (>!0!S?B'0+K6-5TN=)K5+6TD\R6.6 LSG(QA@PQC&>XR 3TH
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M "@ H * "@ H * "@ H 2@#$\(_\B[!_UUF_]&O0!N4 % !0 4 % !0 4 %
M!0!\ZZM_R'=1_P"OF3_T(T 5*  =: /I-?NB@!U '*?$'CPY;_\ 82LO_2F.
M@#JZ "@ H * .6\<W-[:^'C+974UMB9/-DA1F81_Q8(1]O;YMIQSTH T?#D\
MUSX;T^:XO8;V62%2UQ <I+[C &?R'T% '':-'?1?%._1$OGLV,DCF55\N,D#
M&TE=V#@]#V- &_J^LZKI_BJS@2V9](\AI+B00,VW"N2=XX!!5!M[[_:@!GA;
M5=;O]-U.34K=C-%*1;A[=K8N-@."&)Z-D9!(]S0!3^$&?^%8:.3P<2_^C6H
M[=_NF@#X+U#_ )"5U_UU;^9H K4 =%X!_P"2A>'?^PA#_P"AB@#[=% !0 4
M>7_'[_DF$O\ U]1?S- 'R@: "@#Z9_9O_P"1)U3_ +"!_P#1:4 >S4 % !0
M4 % !0 4 % !0!SOCW_DGWB+_L'S_P#H!H ^(J "@#U3]G[_ )*9_P!N4O\
M[+0!]5#I0 M !0 4 % !0 4 % !0 4 % !0 4 4KS5K*QO+.TN)U6XO'9(8\
M\MM4L3] !R?IZT 5]&\0Z;K]O+/IMQYL<4GEL2I4YP&!P1G!5@0>X(H @\)?
M\B[ /^FLW_HUZ -R@ H * "@ H * "@ H * /G75O^0[J/\ U\R?^A&@"I0
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MWB+_ +!\_P#Z : /B*@ H ]4_9^_Y*9_VY2_^RT ?50Z4 +0 4 % !0 4 %
M!0 4 % !0 4 % !0 E &'X2_Y%R#_KI-_P"C7H EUWQ-H_AF"*?6=0CLXI6V
M(TF>6ZXXH \^\2>,_A]?:;JES;Z^#J+V[^3Y=S,GS[,+@ @=<4 2^'?&_P /
M=.L[&Y;7U6^%NHE,EQ,_S;1NR"2,YH [W0O$ND>);>2XT:_CO(8GV.T>< XS
MCGZT :] &;K&MV>APQRW@N"DC;1Y%O),<^X0$B@#%B^(>@S,1'_:+E6V'&F7
M'#=P?DH ZP=!0 4 ?.NK?\AW4?\ KYD_]"- %2@ '6@#Z37[HH P-=_X^8_]
MW^M &50 =J .HTC_ )!</X_S- %Z@ H ,#TH ,#TH ,#TH 3 STH :^!&V!V
MH XKX0_\DQT?Z2_^C6H [9_NF@#X+U#_ )"5U_UU;^9H K4 =%X!_P"2A>'?
M^PA#_P"AB@#[=% !0 4 >7?'[_DE\O\ U]1?S- 'RB>M !0!],_LW_\ (DZI
M_P!A _\ HM* /9J "@ H ^3/CSQ\4[S''^CP_P#H- 'F= "CK0!]X:+QH6G_
M /7O'_Z"* +U !0!SOCW_DGWB+_L'S_^@&@#XBH * /5/V?O^2F?]N4O\UH
M^JA0 M !0 4 ,DSM(!()'!'44 -MHWBMHHY)FF=5 :1@ 6/J0.* ): "@ H
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MVTZ+';)@Q%B"Y"R#;QQ@EU)_W!QZ "Z1X>GT?3]9MH[V3_3)Y)H9&8R/$&0
M9+YR0030!D_" $?##1LG/RR<_P#;5J .W;[IH ^"]0_Y"5U_UU;^9H K4 =%
MX!_Y*%X=_P"PA#_Z&* /MT4 % !0!Y=\?O\ DF$O_7U%_,T ?*)ZT % 'TS^
MS?\ \B3JG_80/_HM* /9J "@ H ^3/CU_P E3O/^O>'_ -!H \SH 4=: /O#
M1O\ D!:?_P!>\?\ Z"* +U !0!SWCW_DGWB+_L'S_P#H!H ^(: "@#U3]G[_
M )*9_P!N4O\ [+0!]5#I0 M !0 4 % !0 4 % !0 4 % !0 4 -==PQ0!5L=
M*L=,B:*PM(+:-FW%8HPH)Z9X]@!^% %K9SVH -H':@"EJEO;7FEW5G=.8X+B
M)H78$ @,-O!/?F@":QLXK&PM[.+)C@C6-2QR2%&!G\J )P@![4 +M'H* *][
M=6VGV<MW=S1P6\2[GD<X51ZDT 5='6Q-D;K3YO.M[QVN ^<@[O3VH T0H]!0
M NT>@H :0J]1UH J/;V\FIQ7>X^?#"T84'C:Y4DD?\ 'ZT 7 HQP*  (!V%
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M"&RA=][)"NT%L8S^0% &E0 4 % &#JG@KPUK5ZU[J>B6EW=$ &66,%B!T&:
M**_#?P63C_A&-._[\B@!W_"M/!6<_P#",:?_ -^10!U$<:0Q)%&H5$ 55'0
M=J '4 % $-W:07UK+:W,2RP3(4DC89#*1@@T <T/AKX*48_X1G3N/^F(H 7_
M (5KX*_Z%C3O^_(H O:5X-\-Z'>?;-+T6TL[G:5\R*,*V#U&: -L<4 (6Q0
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MGY@V2?2@#LXHXXH4CC141!M55&  .U #Z "@ H * "@ H * "@ P/2@ H *
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M!MCH6HR&WAC\<"XO L3LR,"T@CD?>< Y*DN%QR!C'I@ ]#7WH =0 4 % !0
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M0 A&1Q0!AR^&8IO%D&OM=W(DAMS"(%F<1G)!R1NQVZ8Y//4"@#<' H 6@ H
M* "@ /2@"M:VOV5ICYTLOFR&3]X^[9GLOH/:@"S0 4 % !0 4 97B'0X/$>B
M76EW+R1QW"E2\3%6'OQ_*@"]:6R6=M';Q;O+C&U=SECCW)R30!,: ,'5/"&D
MZQ>27-Y"[M*BI*HD(5PI)7(]1DX/O0!1_P"%<^'2-IMI2H4*!Y[#&&#9X.2<
MCJ<]_4T 6]&\&:3H5Y'<V,4J-'&8P&E9@1DG)!/)^9AGT- '14 % !0 4 %
M!0 4 % !0 A.!0!S&K^,K2QNUM+6,7LWG?9W\J>,"&4C*I)DY4L <9'48[B@
M#G= \/:GKNMOK?B) ]MD_9X9X0LJ ]8V R"H8 CN&7@D'+ 'HZ($ "@ #M0
M^@"M?R30V4TEM!Y\Z(S1Q%MN]@.!GMGUH \HT]=8\7^)I+>:^N;&5(&>[CM[
MK?';2AMJ?*&95DPN"F65EW$[2>0#U#2-'L]%L8[6RACB1>6V+C<?4_YXZ4 :
M% !0!@:]IUY=:AI]U J7$%L7,EH\AC5V(&U\@'E<'@C^(^G( OAC03H=E)YC
M(+FZ?SITA)\I9".=B\8!ZG@9.30!O4 % !0!2O-)L-09#?65O<[,[/.B5]OT
MR.* +:H%Z#% #J "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H 0C/:@#D(? UO'XGEOR(&L'9I#;/#O9G8$'+LQ^3+$[ H&<'M0!UP0 8
M P/04 .Z4 % "$ T ((U'08[G'>@!PX% !0 4 (5!ZT &,4 +0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!__9
,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>img247211528_36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_36.jpg
M_]C_X  02D9)1@ ! @$"6 )8  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" =)#'0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD%6I)5?9UJD&XPE[_P"S_P#Q$)_\%?\ _H[K_P P%^S!_P#.5H_XB$_^"O\
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MRRE""@YS;_T9****_HD_QE"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_!(?]A[]K#]FGX9S?%']NC]J;]H3XZ_M(?$O0K>WO?AAX]_:$^(_Q1^$_P
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M_!R9\%]/^+7_  28^-_B-? &O>/_ !C^S_XT^#?QY\ Q^&XO$]YJ/@^Z\/\
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ML-0L]0U+Q3-J>JZO;7^D6>A]E_P<^_\ !1_6/@W\-/#7_!/#X5RM:^,_VF/
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M*?QSXNTG]H7XU:_I_P )?A?'K.F6?CKXN>*;:]^*WA72CX?\#:3J!U!=-O\
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MXX'"/%8Z6/S'V<*W\?[*KJR.JNC##*P#*P]&4Y!' X((K]+OV'/^"N'[<O\
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MVHV^KZ!XA\/:WITUMJ>BZYH>K6EKJ>CZMIMU;7^F:C;6][97$%S#'*O])/\
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MOA+XAT.YT6Z\5:-H!T3Q3H&E^)=#\6_$"R^+NBZMXX\/_#7P[^]_[7G[,?\
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M^(/$GB3Q!J]S9Z3H>@:'I-G=ZIK&L:I=VNG:9IUK<WM[<P6T$LJ_TD?M+_\
M!UO^S'\/?&6G^'_V6/@)XV_:C\+1)</X@^)?BGQ5J/[./AFY6YT;POJFAO\
M#_0/%'PS\;_$?Q BWFJ>)_#WBY?B#X(^$5SH6L^%H9?#=MXYT#Q!;:[9>5X=
MYSE>2\*8C$9IC:.#ISSG%J'M'*52HXX3 .2I4:<9UJKBFG)4Z<G&ZO:Z/OOI
MF>&W'7B9X_Y-E' G#.9<1XZAX9\/U,4L'"E3PN"IU>)>+H4JF89CBZN'R[+Z
M=6<91I3QN*H0J.$U!RY)6_JSHK^-?0?^#NG1+CQ#X=MO$_[ ^JZ1X4N=>TBW
M\6ZSH'[3%GXD\1:+X7FU"VCU_6/#GAC4?@/X4TSQ1K^FZ4UW>Z/X;U/Q?X/T
M[7-1@MM,O?%?AZVNI=7L_P"HC]CS]L'X&_MT? ?PE^T-^S_XDDUOP=XD5K'5
M]$U6.SL?&OPY\9V5M9W'B'X<?$?0;._U.+P]XW\-&^M#?VEOJ.IZ-J^F7ND>
M+?!^N>)O _B/PSXGUG]$RGB7(L\E.&5YC1Q52FN:='EK4*Z@FDYJAB:=&M*F
MFTG.,'!-I.2;5_XT\0O!#Q5\*Z&&Q7'G!F8Y%@<745"AF*KY=FN5O$2BYPPU
M3,\EQN99?0Q52$9SI8:OB:=>K&G5E3IRC2J./U!117YF?\%!?^"MW[&7_!-B
M#1](^/GBWQ)XA^+'BGP_'XM\'? /X3>'X?&'Q:\2^%/^$IT_PK<^)I+?4]4\
M->!/ _A^.ZN-9O-*UCXI>._ =AXTA\%>/-*^'D_B_P 4^%-4\/1>Q7KT,+1J
M8C$UJ6'H4H\U6M6J0I4J<;I<TZDW&,5=I7;6K2W9^=97E6:9YF&$RG)<NQV;
MYKCZJH8++<LPE?'8_%UFG)4L-A,-3JUZ]3EC*7)3IRDHQE)JR;7Z9T5_&GKG
M_!W5I4'B/Q%;>&OV ]1U7PC;>(-9M_"6MZ]^T[:^'?$FM^%8-0N8_#VL>)/"
MNG? 'Q3I?A;Q#J>E)9WFM>&=+\9>,M-T+49[K3+'Q;XDMK2+5[W?^'__  =Q
M> =1\9Z+8_%3]ASQAX-^'DYU'_A(O%'P^^/.B_$SQII:Q:1?SZ2=$\!^)/A9
M\)="U]K[7H]+TW4%O_B1X:&EZ1>7^MVSZO>:;;^']5^47'W"#K>P_MJCS\W+
MS/#XU4;WM?ZP\-[#E_O>TY;:WMJ?O_\ Q*-](O\ L_\ M/\ XAEF/U;V7MO9
M_P!L\,?VAR<O-;^R?[<_M7VMM/8_4_;<WN^SYM#^PVBOB?\ 8>_X*$_LL_\
M!0SX=ZC\0?V:?'LVO3>%E\,6WQ)^'WB32;OPQ\2?A7KWBKP];^(+#0/&GAN]
MWP3JN[5=#MO&?@[4_%OPQ\2>(_"OC+2O!/CKQ0_A37)++[8KZNC6HXBE3KX>
MK3KT:L5.E6HSC4I5(/:4*D'*,HOHXMH_G_,\KS/),PQ>4YSE^.RG-,!6EA\=
MEV986O@<=@Z\+<U'%83$TZ5>A5BFFX5:<9)-.UFC_(W_ &^_^3_OV_/^S[OV
MSO\ UIGXI5^TO_!JE_RDN^)O_9C'QG_]7[^R77XM?M]_\G_?M^?]GW?MG?\
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M_8Z_X."OV-?VW/VD?AK^R]\)_A?^T_H7C[XHOXP70M:^('@SX4Z5X-TX>"O
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M&G3G.32BV?J_17\XGPZ_X.=?V(?BU\0? OPK^'?P _;1\2?$#XF>,?#'P_\
M OAQ/!O[.^D/K_C'QGK=CX<\,:(FK>(?VFM(T'3'U;6]2L;!-0UO5=,TFS:X
M%QJ.H6=G'-<1_P!'=<V6YOEN;TZE7+,92QE.C-4ZDZ+DXPG*/,HMRC'7EULK
MV35[7/<XT\.>-_#K$X'!<;\-YAPWB\RH5,5@</F,:4*N)P]&HJ52M"%.K4:I
MQJ/DYI<JE)24;N,K%%%%>D?%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAG\-AK6A>&?!UEXEC^&'PR\/>$/A\GBR;PWI6K>,#X;?Q7X@@D\0:UJEQ/\
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M729M!L=-_9C\:V?B*[O=:L-1M=4U?PG;Z7I6L6VH:O=Z'^R5.&_]7_#_ #;
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M>I6GAVRUKQ!?0Z)::IJVL:E;:<MO!>ZMJ-Q&]U+_ %_?\0B/_60?_P U/_\
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M/Q*^&O@GXK_'7P]KG@WXL:UHG@GQE\4O^$4\7O\ #CX)S> _B=J?C/X:>&O
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MX;\=Z+X'^(WA[XI:G\8KOPMHNA:UI/PZN8_A_I5EX*^*7@KXJW/CG5;*+3_
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M1+)=5M=,UG2=0GL3/%9ZE8W#1W47]&/_  =$?M0^#?VA?C=^P)H?P\TXZO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2]1&C:O]CT_5-,U;2]?\%^,]#\)_$3PEXQ\'>'O[@O\ B*U_X)X?]$:_;/\
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M3C,'0CE$LN@L8ZV*R^K0QN'@J=^:KA:U.M%:PFGJ?U4?\1=W_6/C_P VP_\
MR:J/^(N[_K'Q_P";8?\ Y-5?&'_$*5_P4/\ ^BR_L8?^'#^.'_T.M'_$*5_P
M4/\ ^BR_L8?^'#^.'_T.M?6?VAXN_P#/O'?^&S)__F3S_/LS^?/]4/V=O_07
MPO\ ^)QXC?\ S_/YYOCS\3/^%V_'WX__ !Q_L3_A&?\ A>?Q[^-GQP_X1?\
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ME=;"8:KAZE.K)SPL<9*K*I7FC_)V@F6XAAG0,$FBCF0, &"R('4, 6 8!AD
MD9S@D<U^PG_!/?\ X(I_M3_\%)_@YXM^-WP,\??L_P#A3PIX-^*>L?"/4]/^
M+'BKXBZ%XAG\2:)X/\"^-KJ]L+3P?\*O'>FRZ')I7Q T:WM[FXU:UOWU"VU.
M*338K:&UN[W\<]-_Y!UA_P!>5K_Z(CK_ $"_^#3_ /Y1[_'?_L]SX@?^L_?L
MS5^+\#Y%E^?9[6P&81JRP]/!XBM%4JKI2YZ=:C"-YI-M<LY7771]#_3+Z47B
MKQ;X4>$N7\8<(5L#1SK$<0Y'EM6IC\%#'8=X;'X#,L1B$L/.4(J;J86DX3O>
M*4DE[QZHGQ/UG_@WX_X(F> O"OQOU;P3XS_:&\)ZC\8/A?\ !+3O >E>-?'W
MPT\=?M!_&/XA?'3XR_"C2]9GOK7X5:Y;_#[PYX:FNO%WQ:U+4KWP3>0>%_!?
MC+2/!%_KWC.[\$Z1XG_S[/BM\5_B?\=_B5XU^,WQJ\=:Y\3?BU\2-:?Q'X]\
M?>)'MFU?Q'K+6UO8Q.UO86]GI6C:1I6F6=AH/A?PKX?T_2O"G@OPKI>B^$/"
M&BZ'X6T/1](L?ZH?^#MC]H"/6/CK^QY^RGIFJ>/+,^ /A9\0?VC?'.AF^^S?
M##Q)-\5/%-G\+OA#K2Z9;:ZYUOQ_X#@^$WQWT[[=K7AJV'A?PY\3&M_#.N7Q
M\8>++#3?Y?OV>OA&_P"T#\?_ (%_ .+Q,/!4WQR^,WPM^#<'C)M&'B-?"5Q\
M4?'6@^!8/$S>'3JV@C7UT&;7DU5M$_MS13JPM#IXU;3C<"\A^@\0\97Q&;Y;
MPE@IRA@\!2P&&A2E-VJXO$0IPH3K2TY_94)T8P;3Y7.K)?'9?CWT-N',JRW@
M'C?Z0O%%"C6XDXNS3BS.,5F-/#1O@.'\KQ.)Q>:TLNI:O#O'9O0S.MB8TII5
MJ6%RZ@[+#MS_ &'_ ."?7_!OC^V7^VYHGA+XK>-9]&_9A_9V\8Z)9>)?#GQ'
M\?61\2^//''AW6;'Q=_8VM_#KX-Z5JNE:O?:7+JVA>')Y]3^)?B/X3:7K7@3
MQSH7Q!^&E_\ $C3 ;";P;_@HG_P1=_;-_P""=$>N^/\ QUX?T3XI_LTVGB&R
MTC2?VB?AE?\ VS0]-C\3^*?$.@>!-.^+'@;4Q9^-?A;XHURVTO0)-6N3I_BS
MX.Z7XJ\=^#OASH7QK\7^-=<T_2[O_3O\,>&/#7@GPUX>\&>#/#VA^$?!_A'0
M])\,>%/"GAC2;#0/#7ACPUH%A;Z5H7A[P]H6E6]II>BZ'HNEVEKINDZ3IMK;
M6&G6%M;V=G;PV\,<:^1_M0?LY?#+]KO]GKXP_LS_ !BTU]2^'/QI\":YX&\0
MR6MGH%WK>@/J=L6T7QKX0?Q1H?B70]*\?^ /$$.E>./AWXDO=!U1O"GCKP]X
M>\36EI)?:3;$?<2\+>'7EKPL5B%F'LK+,W7JN?MU'XGAN?ZK[%SU=-4E4Y/=
M5;F]\_ENG]/+QE7&\<^JRR:7!_UZ\N!HY5@(X=94ZVM&&>O#//?[46%T6.EC
MG@GC/W[ROZO_ +&?Y3/[(G[7GQT_8=^.?A;]H+]GSQ4/#GC;PZ)-/U/3-0BN
M;_P=X_\ "%]<6D^O?#WXB>'[>\T__A(_!7B+[#9O?V"7MAJFEZI8Z/XJ\*:S
MX<\:^'?#7B71_P#5 _8N_:B\)?MI?LL?!']J#P59C2M)^+G@JVUO4?#RSZQ>
MIX0\9Z7>7OAGXB^!H]7UWPUX/OO$47@7X@Z)XG\'Q>*X_#6DZ7XMCT1?$NA6
M[Z'JNG3R_P"05X:U*36/#VAZK+CSM0TJPNY]NW:+B:VC><#8%7 F+@ *F,8V
M(?E']S7_  :1?%;Q'JWPF_;5^!EQI^@0^#?A]\2/A!\7M&U*VM+]/$]_XL^-
M'A;QEX)\6VVLWTFJS:7<Z'I^B?L_> W\.6EGH>G7]G?7WB>;4M5UFWO]*L]"
M^/\ ##-L7@LYQ7#N(G*6'K1Q,J=)R<HT,;A'>JZ?2,:M*%55+)<TJ=*6Z=_Z
M0^G/P!P]Q7X89'XSY/A:5+-\KJ9'#$YC&E&C6S3A7B)1IX*EC4K3JUL#F&+R
M^I@G.4GAZ.*Q])7C5BZ?\)WP\_Y$?PO_ -@>T_\ 0*]O^#WP2^(OQ]^+?@_X
M4_!7P!K/Q'^,/Q,U*S\)>$/"GAR"&76-;N8UOM2,37-[<6FE:+HFCV2ZIX@\
M3>)=<O\ 2?#'A3PWIVK>*_%VLZ/X:T/4M6L/$/AY_P B/X7_ .P/:?\ H%?V
M9_\ !H]X \&ZK\3?VXOBE>Z,TWQ!\">!/@/X \,^(?[2U:)=.\&_%CQ!\4_$
M7CG1CH\-_'H5\VLZW\&/AY?#4M1TN[U;2QH+6NC7^GV>L:];ZG\IE64?V[QC
MB,KE6J4*&)S#,'BY4I<LI8:A6JXFI36Z;J.C&,.:,HPJ<E1Q?(?OO&OB#'PK
M^C5D_'M++<)FF:9#P5P7_8.'QM)5:%+.\UR[+,DP6+GK&I"GA%F56OB?8U:%
M>MA(8C"TZU-XBYXA\0_^#4_]L?PO\ XO&_@CXW_!+XG?M":<_B"_\1? ;38_
M$GA?PGJ6AZ5;>*[O2-/^&?QN\56VGP>)OB!XG73_  =IVGZ!\1?AS\'? NGZ
MSXGUJ+6_BGINB^%+?7_$W\O&I:;J^A:OKGASQ%HFN>&/$_A?7=9\+>*_"OBC
M1]2\.>*?"?BKPYJ5SHWB/POXH\.:S;66L>'O$GA[6+*\TG7-#U:SM-3TK4K2
MYLKVVAN(9(U_V;:_SF/^#H#P%X+\"?\ !5@ZKX6T=M*UGXS?LF_!#XN_$:\.
MIZQ?KXD\=V/C+XR?!&+71::G?WECH9A^&OP;^&7AO^S/#UOI6D3_ /"/'69]
M/DU_5-<U75/N..N \FRO))YKE%&IA:F!G06(INO6KPQ%*M5IX?G?MYU)0JPJ
M5(2O3E"FX.HG3ORN/\K_ $5?I8^)/'?BCAN O$3,<%GV#XHP^:2R?&4\IRS*
M<3D^8Y;@,5F\</"6587!T<3@,3@\'BL.XXREB,8L2L'*&,2]O"O^@?\ P:T?
MM\>(++Q7XR_X)U>.K[P^W@O4])\=?'/X$ZUXC\>:A9^)=/\ &4-[X3/CWX)^
M _!^N7UYI.MZ)XDTF?Q7\=(-#\#0>'+_ ,,:OX=^-/CG7M-\:#QUJNL^"/-?
M^#H;_@H9XA\:_'+1?^"=GPQ\7:[I?PZ^#NA>&O'?[4&E:7=ZAIFE_$#XM>-K
M;0O'?PG^'GBJQO?">EW&L:+\(O B>&/BS9-HOC3Q/X \3>*_B[X8N=;T'3_B
M+\"M#O=+_"O_ ()9?$/QK\,/^"DG["OB;P!K/]@Z]J/[5'P3^'E[?_V;I.JF
M7P5\7_'FC?"3XF:,+;6M/U.SB_X27X;>-_%OAMM2AMH]6T=-6;5] U#2-=L=
M-U:R_P!-+]HK]E_]AGXE-JOQR_:T_9W_ &3_ !\_PX\!WIUOXP?M%?"3X/\
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M\N/_  :L_LRW_P -/V0?C#^TUKMKKVGZC^U!\3;#0_"L-QKOAC4O"^L_"SX
MIXB\-Z-XKT72=(CGU_P]KMU\5?&7QJ\(^);;Q9J,5S?V?@?PSJ&D>'=,TN:+
M7/%?]1U?4>'V5_V9PO@.:/+6QZEF-:ZLW]9M["_73"PH:/9WTU/Q#Z8O'3XW
M\=N*84:ZK9;P@L/P;ERC+FA"63>TEFZT]WG_ +?Q.:P<E=NG3I1<GR*Q1117
MVI_+@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?
MD7_P7E^*OB?X/?\ !(S]MOQ'X1T_0=3U/Q9\-_#OP-O[?Q)::A>Z=#X2_:5^
M)O@;]G7Q[J4$&F:KH]RNNZ/X&^*7B+5_"]S+=S:?9>)K'2+S5M*UW2K>]T34
M/UTHK+$4YU:%:E3J>QJ5*52G3J\O/[*<X2C"IR<T.?DDU+EYH\UK<T;W7?E>
M*PV"S/+L;C,'_:&#PF/P>*Q> ]M]6^O8;#XBG5KX/ZQ[*O[#ZS2A*C[;V%;V
M7/S^RJ<O(_\ &'HK_9XHK\8_X@[_ -5%_P"8C_\ "A_IC_Q4B_ZLS_YT3_\
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M1\#+KPYJW@Z"#P[XBT&W^#'@3P%8Z/XKL7OIO%FFVMMXDU/6-<U;5;[6;_\
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MZ1HFFG4-0N/L.D:5INFVOE6=C:PQ<G)_P3<_X)VRJ4E_8(_8MD1@0R2?LM?
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MF^"_CZ#P9X.\,>%O@?I?A_XJ^,AX:^ >@:EI]OX8\0_##6OAWX3\*^,/&7Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLO[9_P#X</X'_P#T.M'_ !"E?\$\/^BR_MG_ /AP_@?_ /0ZU_)'_P %2O\
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MXR?%S2IXH? ]IXY^'=WX-L]*^$?A_P 5Z6=_Q*^(7@?6_'D>C>);6[U;P/\
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M/C?3M-2S35+WPOK]QX0U^#0O'OARR@\8>$_#FIV'^FK_ ,%4_P#E&!_P4?\
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M (2'_A*+;QF?V=!X432O)T(Z-_9-WXR.O_VCJPOO^$:_L6S.O?B+_P $P/\
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MSI47"ME^)J1A.7LXNK3JX?&0A%<]2C/V<9)PC*3HU7.$922@^_QUX2_XFG\
M,@SKPXQ&%QV9K%9;QAD>"JXO#T%BL33P6,R_-N',3BJLXX?!YEAECL51DL3.
ME1AF> AA\16P]&I/$4_]4>O\Y;_@Y_\ '_@SQY_P5;?2?"NL_P!JZO\ !?\
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MPS;AW+<SSB$XQC'&XWA'*<;@,EP\:B:;GCY8G"X%1=OWKC)S?/[G^BW^Q%\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X1^U+\$_\
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M%EE']@<+XN]#.9XBIF5/Z_C\DQ69KZS/%XA\RQO/1]I;#RI*$%$K\3/^"O\
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M0^)G@+XPG7]*MH-9O]4^%%Q\1? 6B>#?B%<Z]IMKXGG\>^ M5\/V_BG6M?\
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M,-_P4 _X-P?^&Z/VQOC?^UG_ ,-E?\*N_P"%R7OP]N_^$ _X9X_X3;_A'/\
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MC@G?/,JS)T/8K'8I6PSHJI[7]ZJCA3Y/R]_X)-_\$V_^'7OP ^(OP,_X7/\
M\+Q_X3[XZ:Y\:?\ A*?^%=?\*S_LG^V?AG\*?AU_PC7]B?\ "=?$#[?]F_X5
MC_;']L_VO9^=_;?]G_V5%_9OV[4/R%_;D_X-:_@Q\7?%_CCXJ_L8?%N+]F_6
M?$B>-O%'_"@O%7@^#Q'\!&\:7>C:3)X1\,?#?5?#-SH/BO\ 9^^'5]XIL]?O
M?%5HNA?'/2O#%IXKMK+X3^ ?!_@_P1HWP[U+^KRBM,5P_DV-R[#Y5BL!2KX'
M"TJ='#4:DJDIT(481IT_98CG^LPDJ<5!U(UE4DKJ<Y7=^7)/%_Q)X<XSS;Q
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M,/SV_P""9/[$OC?_ ()\?LP6?[,?BS]H(?M#Z%X5\=>+=>^&FMCX4:3\)/\
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M]Y\-OB;X/^#'@VZT+3[BTO-<N;_5/$_B""34-'TK0[WP3K&E:[J-[H_[!?\
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M_"J?B)X;\??\(W_;G_#0FL?V)_;W_"/?V3_;']CZM_9?VS[?_9>H_9_L<_\
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M-8\0>*M3M=7\>ZUI5IXA\<>*/$GB;Q1XMU^ZM-"T&?7X_!/@KP!X5\*?4O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!_+_HW_!IK_P3HT/2K#2+3XT?MJR6VG6T=K ]
MQ\1?@8\[1Q#"M*T7[.,,;.1U*1(I[**_47_@G)_P2?\ V=O^"8<WQGG^ GC/
MXT^+G^.<7PWA\6CXO>(O VOKIR_"]_'[Z ?#H\&?#GP ;1KP_$;6_P"V#J9U
M<7 M=*^Q#3S!=F^_3NBO%PO#N28+&O,<)EN&H8V4JLGB81DJCE7NJKNY-7GS
M2YM.KM:Y^FYYXR^*/$O#,.#<^XUSK,^%X4<OP\,DQ-6C+!1HY5*C++Z:C&C&
M?+A)8>@Z7OW3IQNWK<HHHKVC\R"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR;XZ_ KX1?M,_"+QY\!OCQX
M#T/XF?"3XF:')X>\:>"_$,=Q]AU.Q^T6]_97=I>V%Q9:OH/B'0=7LM.\0^$_
M%GA[4=*\4^#O%.E:-XJ\*ZSH_B/1]+U2T]9HI-)III--6:>J:>Z:ZIE1E*$H
MSA*4)QDI1E%N,HRB[QE&2LU)-)IIIIJZU/Y+?C[_ ,&F?[/?BSQ'#J_[-'[5
M/Q/^!6AWVO\ C+6-?\&_$_P+I'[0VC:9IFLWUA=^#O"/PTU6R\6?!;Q?X>\/
M^"+<:SI3WGQ+\2?&?Q?XHL)]"EU3Q3!JNCZKJ?B?Q0?\&B#8^;_@H0"><D?L
MG%1UXX/[2[$<8SR<GGCH/[/:*^3Q7 G"6,JRK5LEPZG)MR^KUL5@X-MMM^RP
MF(H4E=OI!']"9%]*[Z0G#F!I9=EOB;F]3#481IT_[8R_(>(L3&$$HQC]>XAR
MG-,;)1C%)<V(E9>KO_(-\+?^#2'X2Z7XEU*X^-_[:OQ+\>^"Y_#][::7HOPB
M^$/A3X->+M/\42W^EO8:W=>,/&WB_P#: T+4=%L]+BUJTN?#B^ +&\O=2O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKYC_:=_;2_9+_8N\*+X
MS_:L_:*^$/P$T:ZT#QEXDT&W^(_C?1-!\3>-]/\ A_I]EJ?BZV^&O@F:Z;QG
M\4-?TBVU71XCX4^'>@>)_%-]J.N:!H^FZ/>:MKND65Z >_>*O%7A?P)X7\2>
M-_&_B30/!O@OP;H&L>*O%_B_Q5K&G>'O"_A7POX>TZXU?7_$GB37]7N+/2=#
MT#0])L[O4]8UC4[NUT[3-.M;B]O;B"V@EE7^$7QE_P 'R'A33O%WBBP\!_\
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M^D7%YI.N:!KFDWEIJ>CZQIEW=:=J>G75O>V5Q/;3Q2M_AD?MI_L?_&7]@?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGPQT#3/%5K':1:C>^&+O6++2-4T+5KBRUO3OUC_X/6?^4GW[/?\ V89\./\
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M\-:!8+<:KKNK:=I=I=7D/^4EXG_X*=_\%*/&WAKQ#X,\9_\ !0O]N/Q=X/\
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M?6/]HZ-J>HZ3>^1]ITZ^N[.6&XD_RD?^'L7_  5-_P"DEG[?_P#XF1^T5_\
M/&KY5^)'QW^.'QD\::U\2/B_\9?BM\5?B)XC_L[_ (2'Q[\2/B'XN\<^-->_
ML?2;'0=)_MKQ3XGUC5-<U3^R]#TO3-&T[[=?3_8M)TZQTZV\JSM+>&/S_"W$
M^"^'S7,O^(UY-XGYODD\OC_9'_$+>)>%.'<UP^:QQ-+F_M+_ %LX3XHPF,R^
MK@Y5^7ZK]1Q.'Q-*E?ZS2KS^KWCHYBX0_LVI@J=13_>?7J->M!PL_@]AB*$H
MS4K?%S*2;^%K7_=.^!_QP^$W[2?PF\"?'3X%^.]#^)7PG^)6AQ>(?!GC/P]+
M,]AJM@\T]G=6]Q:WD%IJFBZYHNJ6E_H/B?PQKUAIGB7PGXETS5O#/B;2=)\0
M:3J6FVOP#^TC_P %LO\ @F-^R+\:/&?[//[0W[3/_"OOC!\/O^$=_P"$O\(?
M\*9_:"\6?V1_PEGA30O&^@?\3_P1\*?$OA>_^W^%_$NB:I_Q*];O?LOVW[%>
M_9M1MKNT@_R/?#'_  4[_P""E'@GPUX>\&>#/^"A?[<?A'P?X1T/2?#'A3PI
MX8_:R^/>@>&O#'AK0+"WTK0O#WA[0M*\?VFEZ+H>BZ7:6NFZ3I.FVMM8:=86
MUO9V=O#;PQQKX=\7_P!I[]I7]H/Q+8^,_CY^T-\<OC?XPTS0[;PQIOBOXO\
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MO;#3-*O/$-]H7@S2-%TN[UR[TO1=&TVYU:XM9+^>PTG3+.6X>WL+6.(Q&+\
MGX5T,/A<@\7UXVOV<<3F^(XOX+EX5PY<Z<ZU:APY3X(CQ;5]KP[&.%IX:IQ3
M1^KYU6>.EB\3@<,LNQ8HYK]>;E5R_P#LW7EIK#XGZ\_W:23K/$_5U:M>3DJ#
MO32BHJ4N>/AW[8O_  4 _8]_8"\->#?%?[7/QNT/X0Z7\0M<O_#W@FUN-"\9
M>,_$OB>_TBP74M:N-)\&?#OPYXN\87.AZ!;S:='XA\3KH0\->'[_ %WPQI6L
MZM8ZIXJ\-V>J>5_LA?\ !6K_ ()]?MY_$K7/A!^RA\?_ /A:OQ$\.>!M2^)&
ML^'O^%5?&SP-]C\%Z/K_ (9\,:CK/]K?$CX;^#]#N/L^N>,/#EC_ &=::G/J
MTW]H_:8+&6SM+ZXM?L7XO_ GX(?M!^&K'P9\?/@W\*OC?X/TS7+;Q/IOA3XO
M_#SPC\2O#6G^);*PU/2K/Q#8Z%XSTC6M+M-<M-+UK6=-MM6M[6._@L-6U.SB
MN$M[^ZCEP_@S^S%^S7^SC_PDG_#//[/7P.^ _P#PF7]C_P#"7_\ "F?A-X"^
M%W_"5?\ "/?VI_8'_"2?\(1H&A_VY_8?]N:W_8_]J?:O[,_MC5/L7D?VA=^<
M9?B_ *'A?C:&:9!XOU_&A_68Y=FF7\7\%X3POCSYA!X.MC<BQ'!&-XKG]6RJ
M558G#4.(X?7<PI0E2Q> PV(E'#$XYK]=BX5<O67:<\)X?$RQND?>4:JQ,:'O
M3VDZ/NQ=G&;5V?M(_M(_!?\ 9%^"_C/]H;]H;QG_ ,*^^#_P^_X1W_A+_%__
M  COBOQ9_9'_  EGBO0O!&@?\2#P1H7B7Q1?_;_%'B71-+_XE>B7OV7[;]MO
M?LVG6UW=P?#O[-W_  6R_P""8W[77QH\&?L\_L\_M,_\+!^,'Q!_X2+_ (1#
MPA_PIG]H+PG_ &O_ ,(GX4UWQOK_ /Q/_&_PI\->%[#[!X7\-:WJG_$TUNR^
MU?8OL5E]IU&YM+2?]&_B1\,?AK\9/!>M?#?XO_#SP-\5?AWXC_L[_A(? 7Q(
M\)Z!XY\%Z]_8^K6.O:3_ &UX6\3Z?JFAZI_9>N:7IFLZ=]NL9_L6K:=8ZC;>
M5>6EO-'X=\-_V%/V(?@WXTT;XD?"#]CC]E7X5?$3PY_:/_"/>/?AO^SU\(_
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M7-5FXKEC/FNY+P[]C+_@I%^Q=_P4'_X61_PR%\9O^%N?\*C_ .$/_P"%A?\
M%N_BOX!_X1__ (3[_A*?^$3_ .2G>!?!?]K?VM_PA?B;_D!_VE]@_LW_ (F7
MV/[9I_VH_;-_X*1?L7?\$^/^%;_\->_&;_A4?_"W/^$P_P"%>_\ %N_BOX^_
MX2#_ (0'_A%O^$L_Y)CX%\:?V3_9/_":>&?^0Y_9OV_^TO\ B6_;/L>H?9?H
MWX0? GX(?L^>&K[P9\ _@W\*O@AX/U/7+GQ/J7A3X0?#SPC\-?#6H>);VPTS
M2KSQ#?:%X,TC1=+N]<N]+T71M-N=6N+62_GL-)TRSEN'M["UCB/B_P# GX(?
MM!^&K'P9\?/@W\*OC?X/TS7+;Q/IOA3XO_#SPC\2O#6G^);*PU/2K/Q#8Z%X
MSTC6M+M-<M-+UK6=-MM6M[6._@L-6U.SBN$M[^ZCEZ/K?@;_ ,14^L_V!XK_
M /$$OK'+_8O^M_"'_$5/JO\ 8OL?;?ZT?ZD?ZI?6/]8O^%+ZM_JA[/\ L7_A
M%^M_7O\ A?%RYG]1Y?:X'^TK?Q/J^(^H\WM+V]A]9^L6]C[G-]8O[3][R\O[
MH^5OV.O^"I/[!/[?GB7QEX,_9,_:'T/XI^,/ 6AV'B?Q+X4N/"/Q'^'?B6'P
MUJ%^VE#Q#I.A?%/P;X)U3Q/H>G:HUCIOB'5O"]KK-AX6O]<\,6?B2XTJX\5^
M&H]5]Q_:G_:X_9R_8G^$UY\<?VH_BIH?PD^&5IKFB^&(]=U:SUS6K_5_$OB&
M:2/2O#WACPIX4TK7_&'B[7)K>VU'6+C2?"V@:Q?Z?X:T7Q#XJU&WM/#7AS7=
M5T[<^#/[,7[-?[./_"2?\,\_L]? [X#_ /"9?V/_ ,)?_P *9^$W@+X7?\)5
M_P (]_:G]@?\))_PA&@:'_;G]A_VYK?]C_VI]J_LS^V-4^Q>1_:%WYW<_$CX
M8_#7XR>"]:^&_P 7_AYX&^*OP[\1_P!G?\)#X"^)'A/0/'/@O7O['U:QU[2?
M[:\+>)]/U30]4_LO7-+TS6=.^W6,_P!BU;3K'4;;RKRTMYH\,ZQ/@O+Q+PE?
MAW)O%"CX.QS#)/K^5YUQ+PIB?$NKE2I81<1_5,]P/">$X6P^83KO'/)/;<.8
MG#4J2PD<=[:<JTHNE',?J<E6J8)YAR5.6=*C76#52\O8\U*5>5=P2Y?:6K1D
MWS.-E9'YR?LW?\%LO^"8W[77QH\&?L\_L\_M,_\ "P?C!\0?^$B_X1#PA_PI
MG]H+PG_:_P#PB?A37?&^O_\ $_\ &_PI\->%[#[!X7\-:WJG_$TUNR^U?8OL
M5E]IU&YM+2?[^^.'QP^$W[-GPF\=_'3XZ>.]#^&OPG^&NAR^(?&?C/Q#+,EA
MI5@DT%G:V]O:V<%WJFM:YK6J7=AH/ACPQH-AJ?B7Q9XEU/2?#/AG2=6\0:MI
MNFW7E?PW_84_8A^#?C31OB1\(/V./V5?A5\1/#G]H_\ "/>/?AO^SU\(_ WC
M30?[8TF^T'5O[&\4^&/"&EZYI?\ :FAZIJ>C:C]AOH/MNDZC?:=<^;9W=Q#)
M]&^)_#'AKQMX:\0^#/&?A[0_%W@_Q=H>K>&/%?A3Q/I-AK_AKQ/X:U^PN-*U
MWP]XAT+5;>[TO6M#UK2[NZTW5M)U*UN;#4;"YN+.\MYK>:2-M^.L3X&U.-,A
MK>&F3>*^#\.Z>'RO_6C+^.N)>$,SXTQ6+CFN+EG?]@YQD'">4Y'@,/7R-X"A
ME?\ :&19E4PN:PQ>*Q?US!U*.#I3A8YFL-56-J8"6+;G[">%HXB&&C%TX^S]
MK3JUYU9M5>=SY*L%*GRQCRRO)_DA\,?^"_?_  22^,GQ*^'OP@^&_P"UE_PD
M?Q$^*OCGPG\-_ 7A[_A1'[2^C_V]XT\<Z_I_ACPMHW]K:]\&M+T/2_[4US5+
M&Q_M'6=3T[2;+S_M.HWUI9Q37$?[%U\K?#?]A3]B'X-^--&^)'P@_8X_95^%
M7Q$\.?VC_P (]X]^&_[/7PC\#>--!_MC2;[0=6_L;Q3X8\(:7KFE_P!J:'JF
MIZ-J/V&^@^VZ3J-]IUSYMG=W$,GU37/XI8GP7Q&:Y;_Q!3)O$_*,DAE\O[7_
M .(I<3<*<19KB,UEB*O+_9O^J?"?"^$P>7T<)&CS?6OKV)Q&(JU;?5:5"'UB
ML"LQ5.?]I5,%4JN?[OZC1KT::ARJ_/[>O7E*;E?X>5**6[;M^'?_ !$A_P#!
M%W_H\O\ \UW_ &K?_G&5^U'ACQ/X:\;>&O#WC/P9XAT/Q=X/\7:'I/B?PIXK
M\,:M8:_X:\3^&M?L+?5="\0^'M=TJXN]+UK0]:TN[M=2TG5M-NKFPU&PN;>\
ML[B:WFCD;XY_X=B_\$V/^D>O[#O_ (B;\!?_ )@:^XJ]3Q5Q7T?<12R1>"&1
M^,>4UXU,P?$E3Q5XJX)XAI5:3C@UE<,DH\(\&\,3P]2,_P"T)9A5Q]?%1G'Z
MG'#T8/VTR,#'-4ZO]IU<OJ*T/8K T,32:?O>T=5XC$5KKX5!14?M.3V1^.GQ
M._X+]_\ !)+X-_$KXA_"#XD?M9?\(Y\1/A5XY\6?#?Q[X>_X41^TOK']@^-/
M VOZAX8\4Z-_:V@_!K5-#U3^R]<TN^L?[1T;4]1TF]\C[3IU]=V<L-Q)^J?P
MQ^)'@OXR?#7X>_%_X;ZS_P )'\._BKX&\)_$CP%XA_L[5M'_ +>\%^.= T_Q
M/X6UG^R=>L=+US2_[4T/5+&^_L[6=,T[5K+S_LVHV-I>136\?SCXG_X)V_\
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M?K$<5A\35KOW_?=&5+$T::_=Z1C.#M-7<G%VC]4U^'?_ !$A_P#!%W_H\O\
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MSXB>'/"/C"VT/7[>'48_#WB=M"/AKQ!?Z%XGTK1M6OM4\*^)+/2S]L7_ (*
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MVR4815VV^9))/\K/VD?^"V7_  3&_9%^-'C/]GG]H;]IG_A7WQ@^'W_"._\
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MH/**V=Y%F/!&-XFG]6KRQ*S+#8'B.'UVE2H2PN+P$\14CABK'-7C*;H5<O6
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M5\<^$_AOX"\/?\*(_:7T?^WO&GCG7]/\,>%M&_M;7O@UI>AZ7_:FN:I8V/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>]U?2]<TFWO=%U"7HF^R8XJ[2[M+[V?XT=U*9[FXF/\ RUFD?OT9R0.>< 8
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MLO\ UT?_ -"-?[@/_!5'_E&#_P %'O\ LPS]K_\ ]9[^(=?X?TW^ME_ZZ/\
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M'[1]JTW4+.]BAN(ZDKN2[MHF#MR/MRO[K'^")7^V#_P1<^*'@;XO_P#!)?\
MX)U>+?AYKG_"0^'],_9"^!_PSO[_ /LW5]*\CQQ\%/ ^E?!KXG:)]EUNPTV\
ME_X1GXD^ O%GAO\ M."WET?6O[)_MCP]J&K:!?Z9JMY_CC_M;?LR?%']C3]I
M7XT_LN_&?23I'Q&^"GC_ %_P/KQAL?$-AH^NQ:9=L=%\9^$O^$JT+PSKVI^
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M?\.G?^"67_2-/]@#_P 0W_9U_P#G<U^ /_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "OYZ_P!A/_@V/_X)>?L&?&?2
MOV@O"_AKXM?'_P"+7A#Q%H7B_P"%OB3]I;QKX;\7V'PE\5:%%KR0^)/!GA#X
M?^!/A?X)U'7FN=9L=9T[6?B#X<\<:GX,\3^$_"/BSX=77@WQ/I,FKW?]"E%&
MVO7OU _@,_X/FO\ CS_X)@_]?/[9W_HK]E2OY_O^#6W_ )3J?L1?]<?VF/\
MUD3X]U_0#_P?-?\ 'G_P3!_Z^?VSO_17[*E?S_?\&MO_ "G4_8B_ZX_M,?\
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MWPOYM[IEM!J?_",^+M(_MO1Y=0\.ZS]O\/ZOJNF7O^FW_P $.OVO/C+^W?\
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M'[1_[-__  D__"$_\-!? 7XP?!'_ (3/^Q?^$D_X1'_A:_P]\1> _P#A)_\
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MG]L/_P"B"H ^_P#_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:C_A[%_P2R_Z26?L
M?^)D?LZ__/&KX _XA<?^"%'_ $8S_P";,_MA_P#T05'_ !"X_P#!"C_HQG_S
M9G]L/_Z(*@#[_P#^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P2R_Z26?L
M ?\ B9'[.O\ \\:O@#_B%Q_X(4?]&,_^;,_MA_\ T05'_$+C_P $*/\ HQG_
M ,V9_;#_ /H@J /O_P#X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\ A[%_P2R_Z26?
ML ?^)D?LZ_\ SQJ^ /\ B%Q_X(4?]&,_^;,_MA__ $05'_$+C_P0H_Z,9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M04?L,_\ =S/_ *V'^T%7X _\'SG_ #BZ_P"[V?\ WT>OW^_X-<?^4%'[#/\
MW<S_ .MA_M!4 ?O]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X _\'1W_*"C
M]N;_ +MF_P#6P_V?:_?ZOP!_X.CO^4%'[<W_ ';-_P"MA_L^T ?@#_P8Q_\
M.47_ +LF_P#?N*_O\K^ /_@QC_YRB_\ =DW_ +]Q7]_E !1110!\ ?\ !6+_
M )19?\%+/^S /VR/_6=?B-7^(-7^WS_P5B_Y19?\%+/^S /VR/\ UG7XC5_B
M#4 ?Z+G[$7_!W7_P3;_9K_8O_9$_9S\=?!+]M_5O&WP!_9@^ 7P4\8ZIX3^&
MWP&OO"NI>*OA7\*?"?@7Q#J'AF^UC]I70=7O/#]YJ^A7EQHUUJFAZ-J-QITE
MM-?:5IUR\MG#]/\ _$:M_P $LO\ H@?[?_\ X:S]G7_Z*JOW^_X)._\ *++_
M ()I_P#9@'[&_P#ZSK\.:^_Z /Y O^(U;_@EE_T0/]O_ /\ #6?LZ_\ T55'
M_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JOZ_:* /Y O^(U;_@EE_P!$#_;_ /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!_ '_P?.?\XNO^[V?_ 'T>OW^_X-<?^4%'[#/_ '<S
M_P"MA_M!5^ /_!\Y_P XNO\ N]G_ -]'K]_O^#7'_E!1^PS_ -W,_P#K8?[0
M5 '[_4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5^ /_!T=_R@H_;F_P"[9O\
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M?_6P_P!H*OP!_P"#YS_G%U_W>S_[Z/7[_?\ !KC_ ,H*/V&?^[F?_6P_V@J
M/W^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_@\D_P"DL7[ '_AN? W_ -+3H_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ_K]HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!_ '_P?.?\XNO^[V?_ 'T>OW^_X-<?
M^4%'[#/_ '<S_P"MA_M!5^ /_!\Y_P XNO\ N]G_ -]'K]_O^#7'_E!1^PS_
M -W,_P#K8?[05 '[_4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^ /_!T=_R@
MH_;F_P"[9O\ UL/]GVOW^K\ ?^#H[_E!1^W-_P!VS?\ K8?[/M 'X _\&,?_
M #E%_P"[)O\ W[BO[_*_@#_X,8_^<HO_ '9-_P"_<5_?Y0 4444 ? '_  5B
M_P"467_!2S_LP#]LC_UG7XC5_B#5_M\_\%8O^467_!2S_LP#]LC_ -9U^(U?
MX@U '^BY^Q%_P:*?\$V_VE/V+_V1/VC/'7QM_;?TGQM\?OV8/@%\:_&.E^$_
MB3\!K'PKIOBKXJ?"GPGXZ\0Z?X9L=8_9JU[5[/P_9ZOKMY;Z-:ZIKFLZC;Z=
M';0WVJZC<I+>3?3_ /Q!4_\ !++_ *+Y^W__ .'3_9U_^A5KT#_@GM_P<>?\
M$8_@=^P+^P]\%/BE^V3_ ,(O\3?@_P#L@?LT_"WXB^&?^&>?VJ];_P"$=\=_
M#_X+^"O"?B[0O[9\._ W5_#^K_V1X@TC4-/_ +3T+5=3T>_^S_:M,U"]LI8+
MF7Z__P"(H[_@A1_T?-_YK-^V'_\ 0^T ? '_ !!4_P#!++_HOG[?_P#X=/\
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MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M??_ /Q%'?\
M!"C_ */F_P#-9OVP_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#[0!\ ?\ $%3_
M ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7W__
M ,11W_!"C_H^;_S6;]L/_P"A]H_XBCO^"%'_ $?-_P":S?MA_P#T/M 'P!_Q
M!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7W
M_P#\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\ 0^T
M? '_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK
M_P#0JU]__P#$4=_P0H_Z/F_\UF_;#_\ H?:/^(H[_@A1_P!'S?\ FLW[8?\
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MXC_XISQ_X>\*^+=._L[Q;X5U[2?^)MH-A]L^P?;[#[5IEU97MQ_3]_P8Q_\
M.47_ +LF_P#?N* /[_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *_DB_X*P?\'5GA7_@FA^VU\1_V+O#W[$OB#X^:O\(_#_P[N?'7CW6?C[IW
MP<TYO%7Q#\#Z'\3;/1O">@V/PA^+USKGA_3?!/C'P<USXFUC4_"VHS>*KGQ-
MH<7A-=(T'2_%'BC^MVOS _;%_P"",'_!,#]OGQW9_%+]JG]D'X?_ ! ^)MO]
MH_M#XB^'=;\?_!_QWXM\W1_#'AVU_P"%B^+O@IXO^'?B#XG_ -@^'_!OAW0O
M"/\ PL74/%'_  A6CV4^F>$?[$LM3U6"^ /\T3_@N=_P7._X?1_\,N_\8N_\
M,V?\,V?\+M_YK;_PN+_A-/\ A<7_  J/_JD?PL_X1S_A'/\ A5G_ %'?[7_M
MW_F%_P!E_P#$Q_O\_P"#7'_E!1^PS_W<S_ZV'^T%7\@7_!UK_P $N/V$_P#@
MFO\ \,&?\,4_ S_A2_\ PNC_ (:C_P"%E_\ %S?C%\1O^$E_X5S_ ,,Z_P#"
M&_\ )6?B#X[_ +'_ +'_ .$[\5_\@#^RO[0_M7_B:_;OL.F_8_Z_?^#7'_E!
M1^PS_P!W,_\ K8?[05 '[_4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^ /\
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M_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:_ '_B([_X*F_]*Q_[?_\ X,?VBO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117YR_P#!4_\ X*6?!O\
MX)2_LD>)OVI?C!HNO^,IWUVQ^'7PF^&GAI9[74OBE\8O$6B^(=;\*^"9_$QT
M[4])\"Z%)I?A7Q%XA\5>-]<MKJWT'POX>UF30]%\8^,YO"_@7Q0#2;=ENS]&
MJ*_P[/V]/^"CG[77_!23XQ:U\8OVJ/BQX@\823Z_X@UCP-\,;+5=;L_@U\%]
M-\0PZ%8W7A3X-?#J\U;4])\$:$VE>%?"NGZI=P/=^*?&EQX>L?$OQ$\2>,/&
M<^I^);__ $)?VE?^"OFC_P#!.?\ X-MO^"?WQ1_9]^(O@+6/VEOC+^R%^R_\
M ?V>+BPN? WQ#M?#/CWP7\'?!WAOX\^.=4\*7?BJT&I#]GP^'/$_@[73_8GC
MC1_ O[0VI?#+P1\5_ ][HVKZYH['V7+LTO/5/\=+=?4-Y)+JGKT5K7?5V2UO
MV6Q^VO[8G_!9G_@F)^P1XXM/AC^U3^U[\/?A[\2[@3F^^'>@Z1X[^+GCOPJ(
MM(\->(+4_$'P?\&/"7Q"\0_#4:[H/B_P_K?A,_$'3O#(\9:1>3ZEX4_MFRTW
M5)[(_8[_ ."S/_!,3]O?QQ>?##]E;]KWX>_$+XEVXMS8_#O7M(\=_"3QWXJ$
MND>)?$%T?A]X0^,_A+X>^(?B4-"T'PAX@UOQ8?A]IWB8>#=(LX-2\6?V-9:E
MI<U[_BAR2/*[22.SR.2SNQRS$]R3_D#@<4B.\;K)&S(Z$,K*2&4CH01R#0O/
M\.G^>GI?R$[=/QZ_G;\?PU_W]J*_EJ_X->/^"P^H_P#!0W]EW4?V:OC[XMU[
MQ+^V#^R=H6EP^)?&_CKQ;X7U;Q/^T%\']:UW6K/P=\2+*SB_LOQIJ^O?#&U3
MP]\,/C#KVM:1XCFN]3N_AKX_\6?$KQ'XX^,6K:7H?]2M-JSMZ/U35T_FM>_<
M%J%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^ /_
M (/G/^<77_=[/_OH]?O]_P &N/\ R@H_89_[N9_];#_:"K\ ?^#YS_G%U_W>
MS_[Z/7[_ '_!KC_R@H_89_[N9_\ 6P_V@J /W^HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#Q_XU_M"_ +]FOPKI_CK]HSXX_!_P" /@G5O$%KX3TOQC\:_B7X
M+^%?A74O%5]IVJZQ8^&=/\0^.M:T'2+SQ!>:1H6N:I:Z-;WDFHW&G:-JM]#;
M/;:=>2P_S1?\''G_  4)_8%^./\ P1C_ &R?A;\%/VX?V0/C!\3?%'_#//\
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M%_[LF_\ ?N*_O\K^ /\ X,8_^<HO_=DW_OW%?W^4 %%%% 'P!_P5B_Y19?\
M!2S_ +, _;(_]9U^(U?X@U?[?/\ P5B_Y19?\%+/^S /VR/_ %G7XC5_B#4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M89_[N9_];#_:"H _?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP!_X.CO\
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M3_\ Q#B?\%3?^EG#]O\ _P#!=^T5_P#1_4 ?U^T5_(%_Q#B?\%3?^EG#]O\
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M_$.)_P %3?\ I9P_;_\ _!=^T5_]']0!_7[17\@7_$.)_P %3?\ I9P_;_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ZWX2L-=^('A#P-X+\;:Q_0S110W?^NBT7W(2T"BBBD 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!_ '_ ,'SG_.+K_N]G_WT>OW^_P"#
M7'_E!1^PS_W<S_ZV'^T%7X _\'SG_.+K_N]G_P!]'K]_O^#7'_E!1^PS_P!W
M,_\ K8?[05 '[_4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$%1_Q"X_\$*/^C&?_-F?VP__ *(*@#[_ /\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ/^'L7_!++_I)9^P!_XF1^SK_\\:O@#_B%Q_X(4?\ 1C/_ )LS^V'_ /1!
M4?\ $+C_ ,$*/^C&?_-F?VP__H@J /O_ /X>Q?\ !++_ *26?L ?^)D?LZ__
M #QJ/^'L7_!++_I)9^P!_P")D?LZ_P#SQJ^ /^(7'_@A1_T8S_YLS^V'_P#1
M!4?\0N/_  0H_P"C&?\ S9G]L/\ ^B"H ^__ /A[%_P2R_Z26?L ?^)D?LZ_
M_/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&KX _P"(7'_@A1_T8S_YLS^V'_\
M1!4?\0N/_!"C_HQG_P V9_;#_P#H@J /O_\ X>Q?\$LO^DEG[ '_ (F1^SK_
M //&H_X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ^ /^(7'_ ((4?]&,_P#FS/[8
M?_T05'_$+C_P0H_Z,9_\V9_;#_\ H@J /O\ _P"'L7_!++_I)9^P!_XF1^SK
M_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ^ /^(7'_@A1_P!&,_\ FS/[8?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_&/]JCXKZ_XPEF\0>(-8\"?#*SU76[7X-_!73?$,&A6%UX5^#/P[O=6U+2?
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M?^4%'[#/_=S/_K8?[05 '[_4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M25@,E8T9V ]<*"<4Q'^H#_Q&G?\ !*S_ *(C^WK_ .&I^ 7_ -$]1_Q&G?\
M!*S_ *(C^WK_ .&I^ 7_ -$]7^=W\3_^">?[?OP1\#:Y\3_C/^PY^V#\(OAI
MX8_LT^)?B'\3_P!F?XT^ ? WAX:SJ^G^']'.N>+?%?@K2= TG^U=>U;2]$TW
M[?J%O]NU?4M/TVU\V]O+>&3X_P '.WH<XYP,'..2< 8[YP!WH _V0?\ @EU_
MP7U_8=_X*U?%#XD?!G]G70_CUX%^)7PV\!6_Q.NO#?QO\!>&/#O_  D_@=?$
M.G>%=>USPQK'@#Q_\3- '_")Z_X@\'V&M:;XFU7PUK%Y_P )AI-UX6T_Q'9:
M;XKN?#?[;5_G)?\ !G5^R5^U1\(?V[OB=\</BM^S7\>OAK\%OB9^P5XF/PY^
M+_CSX0^/_"7PN\?#Q;\8_P!F[Q=X4/@OQ_KOA^Q\)^*!XG\)V-]XG\.G1-6O
MO[<\/65YK6F?:M-M9[F/_1MIM6?R7XH-=;_+TLF%%%%( HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?O]7X _P#!T=_R@H_;F_[MF_\
M6P_V?: /P!_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\ ?N*_O\H
M**** /@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J_Q!J_V^?^"L7_*++_@I9_V8
M!^V1_P"LZ_$:O\0:@#_4[_X)[?\ !QY_P1C^!W[ O[#WP4^*7[9/_"+_ !-^
M#_[('[-/PM^(OAG_ (9Y_:KUO_A'?'?P_P#@OX*\)^+M"_MGP[\#=7\/ZO\
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M_P#G<T ? '_$4=_P0H_Z/F_\UF_;#_\ H?:/^(H[_@A1_P!'S?\ FLW[8?\
M]#[7W_\ \.G?^"67_2-/]@#_ ,0W_9U_^=S1_P .G?\ @EE_TC3_ & /_$-_
MV=?_ )W- 'P!_P 11W_!"C_H^;_S6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\
MT/M??_\ PZ=_X)9?](T_V /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\
M9U_^=S0!\ ?\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V
M'_\ 0^U]_P#_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T?\.G?^"67_2-/]@#_
M ,0W_9U_^=S0!\ ?\11W_!"C_H^;_P UF_;#_P#H?:/^(H[_ ((4?]'S?^:S
M?MA__0^U]_\ _#IW_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@EE_TC3_8 _\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%XO^#A'QO_P5Z3P?\$?AW\+7^"'[(_PL\?ZGX_T#P]XEOM'\3_%+XJ^.=/\
M^$O\*^"OB5X[U:RTV.R^'Z:7\-_$UY96?PE\&ZMXATG1O$7B?QC=>(_B)\4(
MH? D_@R7Y=U^>OX7]=@75NUK:KOY?\'IN?K_ /\ !F5_P4=\=Q?$SXK_ /!,
M_P"*7CTZI\-=4\ ZQ\;/V7](\8^.-(M/^$*\:>&O$4$_Q:^%'PJ\-ZII3:_X
MB'Q,T+Q;??&6_P#"VB>*(](\%_\ "IOB5XZTSP3/=^//B-XJMO\ 0TK_ "K_
M /@S_P#V7_%7QC_X*OZ;\?+1M?TKP1^R%\'_ (F^/M>UNW\&ZCK?A;6_%7Q3
M\*ZK\"?"7PTU?Q=%>V&D^"=?UW2/B)XU^(WAQKT:QJ/B/3OA'XITK3- DMEU
M?Q%X9_U4*N73NXJ_XI?>K/SO?J2NO9/3[E^M_3;H%%%%2,**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH _.#]M[_@KG_P $ZO\ @G'XJ\#^!?VROVF/#_PA\;?$7P_J/BSPKX.M
MO!?Q0^)GBJ?PKINHKHY\3:SX>^$7@?Q[J_A/P_JFKK?Z7X9UGQ;9Z'IWB[4=
M \66/A:YUBY\'>*HM'_FB_X+U?\ !>K_ ()/?MH_\$GOVK/V:/V:/VK/^%E?
M&WXE?\*,_P"$*\%?\*,_:2\'?VU_PAW[2?P=\?\ B/\ XJ/Q_P#!WPKX2T[^
MSO"7A77M6_XFVO6'VS[!]@L/M6IW5E97'ZO?\%M/^#>CX-?\%BO%7PH^+\7Q
MM\0?LU_M!_#/P_'\-K[XC6W@N?XN^%?&_P &K?4?%/BC2_!.L_#6\^('P\MM
M+\0>&/&WBK6-=\,^.?#WB739VT[Q%XLT#QCH?C2.;P+?_#S^2+_@J/\ \&I7
M_#M?]A/XY_MK?\-Y_P#"Z/\ A2__  K+_BVG_#+G_"N?^$E_X6+\8OA]\)O^
M1R_X:*\=_P!C_P!C_P#"=_V__P BIJO]H?V5_97^@_;O[2LP#[__ .#&/_G*
M+_W9-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** /@#_@K%_RBR_X*
M6?\ 9@'[9'_K.OQ&K_$&K_;Y_P""L7_*++_@I9_V8!^V1_ZSK\1J_P 0:@#_
M $7/V(O^"^?_  4D^#G[%_[(GPB\"_\ !N[^V_\ &SP3\*_V8/@%\./!WQF\
M)W_QY3PK\7/"O@?X4^$_#'A[XG>&4T?]B'Q9I"^'_'ND:79^*M&72_%7B73E
MT[5K86/B#6;81:C<_3__ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #7[_ '_!
M)W_E%E_P33_[, _8W_\ 6=?AS7W_ $ ?R!?\1'?_  5-_P"E8_\ ;_\ _!C^
MT5_] #1_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 U_7[10!_(%_Q$=_\%3?^E8_
M]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\ _!C^T5_] #7]?M% '\@7
M_$1W_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M%?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M::UIWA34==\+67B>YTBY\7>&(M7_ $8H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /X _\ @^<_YQ=?]WL_^^CU^_W_  :X_P#*
M"C]AG_NYG_UL/]H*OP!_X/G/^<77_=[/_OH]?O\ ?\&N/_*"C]AG_NYG_P!;
M#_:"H _?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^$&O?L5_!O3-?BTOQA\3?VI?"WB/P#XL6WLM1\'-X@M/AY\"M5L]-^*?CGQ
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M&D:A/)_:\TLFNZG_ %>_\&,?_.47_NR;_P!^XK\ ?^#H[_E.O^W-_P!VS?\
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MN;"TEB^GJ;U^Y?@DA6W\W?\ !+] HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M'P^^%ECK&B_\(N^I^$Q\5_BAK_@KX;WGCVUL_&GAK5S\/;#Q3=>.9?#^I?\
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M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
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M /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?O]_P]B_X)9?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'ACX:ZI'-_I*4VNVS5U^OW.ZOUM<2_%:,****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#^ /\ X/G/^<77_=[/_OH]?O\ ?\&N/_*"
MC]AG_NYG_P!;#_:"K\ ?^#YS_G%U_P!WL_\ OH]?O]_P:X_\H*/V&?\ NYG_
M -;#_:"H _?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K!\
M5>%?"_CKPOXD\$>-_#>@^,O!?C+0=8\*^+_"'BK1]/\ $/A?Q5X7\0Z?<:1K
M_AOQ)H&KV]YI.N:#KFDWEWIFL:/J=I=:?J>GW5Q97MO/;3RQ-O44 ?X2/[6O
M[,WQ2_8S_:6^-/[+_P 9M*.D?$GX)_$'7O!&O-!9>(;#2=<33+MGT3QIX2/B
MG0O#.OZEX#\>:#+I?C7X?>([[0-)_P"$H\$Z]H'B6ULXK+5;;/\ ;U_P2>_X
M/!_A_P"$OA9X'^ G_!3KP;X__P"$D\&CX3_#/P=^T]\)]*UGXCQ>(/ ^F>'M
M'\&^(?B/^U#8>.?B1J_Q,U/Q_I=[I+^/_'/CSX96OC[5?B6?$>MQ:/\ ";P_
MKWAJSB^('[??\%W/^#?;P!_P5]B\'_&3P-\4/^%'_M;_  J\!:KX"\,>*O$-
MAJ_BCX8_$[P/8_\ "7^*O!OPR\?:-9ZG#>^!(].^)7B:\O[3XL>#=,U_6-#\
M/^)_&=MX@^'?Q1FC\"VW@S_.A_;$_P""'7_!4C]B+Q3XYTCXL?L@?%[Q7X(\
M!Z#XG\;:E\=/@CX-\2_&;X#R_#;PMJ'B6VO?B-J'Q)\#:/J>F^ M ;2?"NH^
M+[K1?BQ!\/O'WACP=/I>O^.?!OA6VU.T61)V5G:W3\D[]'K9K9M;.RLW9NZZ
M[KLWOZKMNTM'Y_Z+7Q0_X.O/^")7@#P+K?B[PK^TCX\^-VOZ4--.G_##X7_L
M\?''2O'7B?[=J^GZ;=#1+_XS>!OA'\-;8Z-97EQX@U+_ (2;XA^'?-TC2M0@
MTC^U=?DTO1-2_A&_X+I?\%X_BA_P5_\ &^@>!= \&M\(/V1?@UX_\7^)/@UX
M$DU3Q /'GCIM8T?0?#NE>//C_96GC#5_AIJGCK2+/2O$EYX%L?"OAZ$_"K2?
MB?XX\"P>,_B#'>7WC'7?Q!^&'P<^+OQN\<Z'\,/@O\+/B/\ %WXE>)O[2_X1
MOX>_##P1XF\?>./$']C:1J'B#6/[$\)^%=,U;7M5_LG0=)U36]3-C83_ &#2
M--U#4[KRK*SN9X_Z'?\ @G?_ ,&KO_!2K]L?Q7X5U;X_> -?_86_9[US0?%N
MLWWQ2^,WA[2;WXGPW_AW4+OP]IGA/3OV8KKQMX/^+UEK_B+Q% +JVN?B59?#
M'PR/ %IJGC?2O$.O27/@CP[XY=K[Z6UUT]'Y^GX,+M?=\[/U_P"!ON?H%_P9
M8?L=^*?&'[5O[0G[;WB'P+H-]\*_@S\)+_X)^ _%_BGPSJ-SJ%M\=OBAK?A7
M6;_4/A+K][X:NO#L.O>#?A#X>\6>&OB?=Z1XJTKQEX=\,?&_PAH\FEZAX7^)
M>J2P?Z25?,?[&G[(WP;_ &#_ -F/X1?LE? &PUVP^%/P9\/WFB^'6\4ZY/XC
M\3ZQJ&N:]J_B_P 7^*O$FKRQ6MM/K_C+QKXB\1>+=9@T;3=#\,:?J6M7.G>$
M_#GAKPS::3H&F_3E-N^VR5E?\7\W=VUM>Q*_/5_UY+0****0PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?O]7X _P#!T=_R@H_;F_[M
MF_\ 6P_V?: /P!_X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C'_SE%_[LF_\ ?N*_
MO\H **** /@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J_Q!J_V^?^"L7_*++_@I
M9_V8!^V1_P"LZ_$:O\0:@#_4[_X)[?\ !N'_ ,$8_CC^P+^P]\:_BE^QM_PE
M'Q-^,'[('[-/Q2^(OB;_ (:&_:KT3_A(O'?Q ^"_@KQ9XNUW^QO#OQRTCP_I
M']K^(-7U#4/[,T+2M,T>P^T?9=,T^RLHH+:+Z_\ ^(7'_@A1_P!&,_\ FS/[
M8?\ ]$%7XP_L1?\ !?/_ (*2?!S]B_\ 9$^$7@7_ (-W?VW_ (V>"?A7^S!\
M OAQX.^,WA._^/*>%?BYX5\#_"GPGX8\/?$[PRFC_L0^+-(7P_X]TC2[/Q5H
MRZ7XJ\2Z<NG:M;"Q\0:S;"+4;GZ?_P"(CO\ X*F_]*Q_[?\ _P"#']HK_P"@
M!H ^_P#_ (A<?^"%'_1C/_FS/[8?_P!$%1_Q"X_\$*/^C&?_ #9G]L/_ .B"
MKX _XB._^"IO_2L?^W__ .#']HK_ .@!H_XB._\ @J;_ -*Q_P"W_P#^#']H
MK_Z &@#[_P#^(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\
MH@J^ /\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H :/^(CO_@J;_P!*Q_[?_P#X
M,?VBO_H : /O_P#XA<?^"%'_ $8S_P";,_MA_P#T05'_ !"X_P#!"C_HQG_S
M9G]L/_Z(*O@#_B([_P""IO\ TK'_ +?_ /X,?VBO_H :/^(CO_@J;_TK'_M_
M_P#@Q_:*_P#H : /O_\ XA<?^"%'_1C/_FS/[8?_ -$%1_Q"X_\ !"C_ *,9
M_P#-F?VP_P#Z(*O@#_B([_X*F_\ 2L?^W_\ ^#']HK_Z &C_ (B._P#@J;_T
MK'_M_P#_ (,?VBO_ * &@#[_ /\ B%Q_X(4?]&,_^;,_MA__ $05'_$+C_P0
MH_Z,9_\ -F?VP_\ Z(*O@#_B([_X*F_]*Q_[?_\ X,?VBO\ Z &C_B([_P""
MIO\ TK'_ +?_ /X,?VBO_H : /O_ /XA<?\ @A1_T8S_ .;,_MA__1!4?\0N
M/_!"C_HQG_S9G]L/_P"B"KX _P"(CO\ X*F_]*Q_[?\ _P"#']HK_P"@!H_X
MB._^"IO_ $K'_M__ /@Q_:*_^@!H ^__ /B%Q_X(4?\ 1C/_ )LS^V'_ /1!
M4?\ $+C_ ,$*/^C&?_-F?VP__H@J^ /^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^
M@!H_XB._^"IO_2L?^W__ .#']HK_ .@!H ^__P#B%Q_X(4?]&,_^;,_MA_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?YI_\ P>T_"[QSI7[=?[)OQIO]
M$,'PT\>?LEK\+O"GB3^TM(E&J^.?A-\8?B5XL^(.B?V1!J$FO6!\/Z!\:?AE
M?C4M2TJSTC5O^$E-KH>H:E>Z+XAMM*_TL*_FL_X.@_\ @E]XI_X*(_L%V?CK
MX)^"]=\=_M0?LB:_J7Q(^%WA'PM9:CK?B?XA_#KQ8FBZ1\</AGX;T!?%NAZ3
M=Z_?:/HGA3XGZ.\'ASQSX^UW4?A%;?"_X;Z#)K7Q,NH[I/;YI_)--_@5'>W=
M-?-[?C:[/Y(/^#-CXJ>!/A__ ,%9O%?@[Q=K@TGQ#\<OV1?BY\-/A=8'3=7O
MO^$G\<:)XU^$_P 9M2T(76FZ?>6>CF#X:?"?XA>)O[2\07.E:1*OAQM(AOY=
M>U71-+U+_4RK_ I\*>+/%GP^\6>&_''@;Q+XA\$^.?!/B'1_%7A#Q?X4UC4?
M#GBOPEXK\-ZE;ZOH'B3PWK^D7%GJ^@^(-!U>SM-3T?6-,N[74=+U&UM[VRN(
M+F".1?Z8OV9_^#NG_@K5^SS\+M)^%_B>[^ '[4/_  CXL;+0_B+^TAX!\:ZS
M\4[;P_I7A_0_#^F^'M7\6_"_XG?"I/&WD#19M;OO&7Q TOQ7\3_$GB'7M=U/
MQ;X\U\S6$.G4VFEW2MZ]FOEHUIM>[;=HM9OU_2WZ'^KI7^>;_P 'Q/Q4\":I
M\1_^">/P2L-<^T?$WP)X(_:(^*?BSPU_9NKQ'2/ GQ8U[X3>$OA]KIU>;3X]
M!OO^$A\0?!;XFZ>--TW5+S5]*_X1AKK6[#3;+6/#]QJOY_?%/_@\G_X*S^/_
M  +KGA+P?X4_9#^!WB#5O[.%C\4/AI\(?&^M^.?#'V'5]/U*Y.A:?\9?BU\5
M_AK.=8L[.Y\/ZE_PDOP\\1"+2-6OYM(&E:]%I>MZ;_+Y\5?BY\5?CKX]U[XJ
M?&WXE^/OC!\3O%']F?\ "2_$3XH>,/$/CWQQX@_L72-/\/:,-:\5^*M0U77=
M472- TG2]#TM;V_G%AH^FZ?IEH(K*SMX(Y:O;U3?RU7X[^12LK][67SWO][^
M?EO_ $#?\&G'PN\<^/O^"UO[/_B[PEH?]K>'_@C\.?V@_B9\3[_^TM'L?^$9
M\#ZS\&?&/P:T[7/LNI:A9WNL_:/B3\6?A]X;_LSP];:MJ\7_  D']L3V$6@Z
M3K>J:;_K85_&7_P9U_\ !.'QU^SE^S9\8_VW_C5X"_X1+QA^UN? ^A_ BU\6
M^!](L/'-E^SGX3M+WQ(_Q T#Q5-JMWXKTWP)^T%XK\3:;>0^$K_0/"EMXCT?
MX+?#SXHVTWC/PKXJ\ ZQIW]FE7+2R[))^KU?W-V^5R5U??7\$OTN%%%%2,**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _@#_X/G/\ G%U_
MW>S_ .^CU^_W_!KC_P H*/V&?^[F?_6P_P!H*OP!_P"#YS_G%U_W>S_[Z/7[
M_?\ !KC_ ,H*/V&?^[F?_6P_V@J /W^HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M .F64?\ #9'_  >2?](G?V /_#C>!O\ Z990!_7[17\@7_#9'_!Y)_TB=_8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\4> O$_A7Q5KGUY0&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'X@_X1__ (2#_A']>_L3^UOLG]J_V)J_V#[1_9MYY/\ 3]_P:X_\H*/V&?\
MNYG_ -;#_:"K_.#_ ."K?_!%3]J?_@CY_P *%_X:7\??L_\ CC_AHC_A:/\
MPA7_  HOQ5\1?$W]E_\ "I/^%=?\))_PE/\ PG_PJ^&7V+[;_P +-T'^Q/[)
M_MO[3]DU?[?_ &;]GL_M_P#H^?\ !KC_ ,H*/V&?^[F?_6P_V@J /W^HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)*K?V5U4=?FVU^#7Y$KKZ_DDOS3"BBBI&%%%% !1110 4444 %%%% !1110
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M[)O_ '[B@#^_RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_AL_X/7?VPO%
M7@CX)?LH?L3^!_'6@V&E?'+Q'XW^,GQX\(Z/XFU"U\?W?A/X53>%=+^#&G^*
MM TGQ+:VTWPD\9^-O$/CSQ';VOC#PKJNG^(OB1\#_#FK^%-4T_5?AKK<4_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M $8S_P";,_MA_P#T05 'W_\ \/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+O4/[4J**&[O\$NR6W]=7J 4444@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /X _^#YS_G%U_P!WL_\ OH]?O]_P:X_\H*/V&?\ NYG_
M -;#_:"K\ ?^#YS_ )Q=?]WL_P#OH]?O]_P:X_\ *"C]AG_NYG_UL/\ :"H
M_?ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_/1_X.\O^"?7
M[<7[2'[=W[.OQF_9U_9/^/7Q_P#AL_[).A_#&Z\2?!#X:>)_BU_8OCCP5\8_
MB_XJU_1/$^C^ -/\0Z_X3QH/Q,\'W^BZEXFTO2=(\4_;-6M?"VH:S>^%?%EO
MHG\GW_#I'_@JG_TC6_;U_P#$1/C[_P#,!7^W?6#XJ\5>%_ GA?Q)XW\;^)-
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M^[)O_?N*_O\ * "BBB@#X _X*Q?\HLO^"EG_ &8!^V1_ZSK\1J_Q!J_V^?\
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M_P#G<T ? '_$4=_P0H_Z/F_\UF_;#_\ H?:/^(H[_@A1_P!'S?\ FLW[8?\
M]#[7W_\ \.G?^"67_2-/]@#_ ,0W_9U_^=S1_P .G?\ @EE_TC3_ & /_$-_
MV=?_ )W- 'P!_P 11W_!"C_H^;_S6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\
MT/M??_\ PZ=_X)9?](T_V /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\
M9U_^=S0!\ ?\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V
M'_\ 0^U]_P#_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T?\.G?^"67_2-/]@#_
M ,0W_9U_^=S0!\ ?\11W_!"C_H^;_P UF_;#_P#H?:/^(H[_ ((4?]'S?^:S
M?MA__0^U]_\ _#IW_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@EE_TC3_8 _\
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MC[_@QC_YRB_]V3?^_<4 ?W^4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8/BKQ
M5X7\">%_$GC?QOXDT#P;X+\&Z!K'BKQ?XO\ %6L:=X>\+^%?"_A[3KC5]?\
M$GB37]7N+/2=#T#0])L[O4]8UC4[NUT[3-.M;B]O;B"V@EE4 P/B?\5?A?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /QH_X+@?\%</"G_!(;]D8?%NU\/:#\1?C[\4]>N_AS^S
MO\+=:U[3]/T_4?%B:+>:KK'Q(\;:/#K>E^--7^$?PPMTTR7QJ/!%O+J&H^)O
M%'P[^']WKW@)/B';>/?#O^1'^TW^UA^TC^V9\4]6^-/[4GQH\?\ QO\ B3JQ
MOX5\0>.]>NM4BT#1[_Q#KOBK_A$O!.B!HO#_ ( \!:9KWB;7[[P[\/O!.E:!
MX)\+_P!JW=KX<T#2[.3[./[ O^#WGXX_V]^TS^P]^S7_ ,(T;3_A5?P*^(GQ
MQ/C'^VC.-?\ ^%__ ! MO 0\,GP[_9,(TO\ X1#_ (9I.JC6O[=U'^WO^$W-
MC_9.B_\ "-_;->_'[_@VL_X)S? C_@I7_P %%KKX7?M,:;_PE?P4^$GP#^)/
MQO\ &7PS-WXOT1?BB]EJG@_X5>&_#+^+_ ?C7P-XK\&+H7BKXKZ)\2/[8TK4
MM0&IGP(/!]_I$NF>*+W4-.25V_+[K)*5[=[Z+;6VVXV^5+I?=]7=V2]+6T\W
M?HE^/O[,O[5_[2/[&?Q3TKXT_LM_&CQ_\$/B5I1L(6\0^ ]>NM*CU[1[#Q#H
M7BK_ (1+QMHA:7P_X_\  6IZ]X9T"^\1?#[QOI7B#P1XH_LJSM?$>@:I9Q_9
MS^LO_!93_@O7\>/^"P?A#]FCP%XQ^'.A? WP3\$_#MQKOCCP=X#\<^,];\+_
M !7^/FMV%IHVO_$^]T'5Y;/2M%\.Z#I5E>:?\'_!^J6GC/QC\-=.\:_$FSOO
MBYXVM_&DD6E_TO\ _!R-_P $ ?\ @GY\!/\ @GUXV_;9_9+^&\7[-/Q"_9I3
MX.Z1XB\*>#KSQ'KW@;XT>!=?\2?"C]GG2M-\1Z1XH\3WZ^&?'GAE-0T7QK-\
M3] +:S\1=9/Q!U#XO:=\0/'GQ M_B-X2_P [N&/SIHHAP998XP?3>X7OQW[T
MU>34>MU;7Y+7M?IW7WFRYNC37ILWIWMHGKHWUV1(I9 QCCD<*,L41F"CU8J#
M@?7%(CO&RO&S(ZD,K*2K*1T((Y!K_<[_ &'/V'/V<_\ @G=^SGX,_9A_9A\&
M#PI\/O"@DU'5M6U&2UU#QQ\2O'&H6ME;>)/B=\3O$EM9:=_PE/C[Q3_9UDNH
MZBMEI^DZ1I.GZ)X.\':)X8\!^&/"OA70_P#,K_X.P/V//@)^Q]_P4^T33_V=
M_ GA_P"%O@WXW?LR_"WXRZQ\-? _AGP=X)^&W@WQ5!XE^(GP;O+/X=^#? _A
MKPSI/AS0M;TCX0:)XNURVN(M4U'4O'_B+QGK\VJ?9M8M-+TP;L]-KZ/9^7I]
M^]EJ"5T^Z5[;I[)_=>_FNW7^SG_@UY_X*A^*?^"B7[!E_P" _C;XTU[QW^U%
M^R#XATWX;?%'Q?XIO=0UKQ/\1/AQXN36=8^!OQ-\1Z\WA/0])N]>OM'T3Q7\
M+M96?Q%XX\?:]J?P?N_BA\1]>?6OB9:R77]*U?YI_P#P9+?$_P <:5^W7^UE
M\%]/USR/AKX]_9+;XG^+/#7]FZ1+_:OCCX2?&+X:^%/A[KG]KS6$FOV']@:!
M\:_B=8?V;INJ6>D:M_PDOVK7+#4[W1?#]QI/^EA52M?3JHO3NXIOTUOILMB5
MM\W]UW;\ HHHJ1A117\Q/_!1;_@ZS_X)P_L5G4?!7P)U<_MY?&VU^R@^'O@5
MXKTJT^"&BF;_ (0O5?\ BJOVDCI_B?PC??VAX5\3ZO=Z,/@UX?\ C4]GXN\(
MZMX$^(:?#K4G^W6X!_3M17^57^U!_P '?W_!6/XS>*%NO@+JOP>_8^\%:7KW
MC*XT70?A[\,O"GQ6\5ZSX8UO4;&7PEH_Q*\8?'K1_B)HVOZ]X)TFP-DOB/X=
M>!/A#I_B/4=8U[4]5\+);2>'M(\-?D#XM_X+'_\ !6+QKXG\2>+M8_X*0_ML
M6>J^*]?U?Q)JEIX2_:3^*_@'PQ:ZCKFHW&IWMOX;\$>!/%'ASP9X-T""YNI8
MM(\*^$- T/POX?TY;?2- T?3=)L[2R@ ^?\ 7]?UW_VTJ*_Q2_A=_P %L_\
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M !$=_P#!4W_I6/\ V_\ _P &/[17_P! #7]?M% '\@7_ !$=_P#!4W_I6/\
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M_:'@30L:/XHT];7^T[(6VL:A_5[_ ,&,?_.47_NR;_W[BOP!_P"#H[_E.O\
MMS?]VS?^L>?L^U^_W_!C'_SE%_[LF_\ ?N* /[_**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6,7B'4_J#_@V#_9<_P"&G?\ @L=^S3-J_@?_ (3;P!^SM%XO_:=\?'_A)/\
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M]G_WT>OW^_X-<?\ E!1^PS_W<S_ZV'^T%0!^_P!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_26+]@#_ ,-SX&_^EIT?\,;_ /!Y)_TEB_8 _P##<^!O_I:=?U^T4 ?R!?\
M#&__  >2?])8OV /_#<^!O\ Z6G1_P ,;_\ !Y)_TEB_8 _\-SX&_P#I:=?U
M^T4 ?R!?\,;_ /!Y)_TEB_8 _P##<^!O_I:='_#&_P#P>2?])8OV /\ PW/@
M;_Z6G7]?M% '\@7_  QO_P 'DG_26+]@#_PW/@;_ .EIT?\ #&__  >2?])8
MOV /_#<^!O\ Z6G7]?M% '\@7_#&_P#P>2?])8OV /\ PW/@;_Z6G1_PQO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA8:@=8^'GB70_#]A\:/AE=:=X?T#X>_%?PSX$\,>&_"&D_W=_P#!:S_@VC^
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M%% !1110 4444 %%%% !1110 4444 %%%% '\-__  =#_P#!$[_@HC_P4/\
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M _ '_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:_?[_A[%_P2R_Z26?L ?\ B9'[.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^S
MK_\ /&H _ '_ (@J?^"67_1?/V__ /PZ?[.O_P!"K1_Q!4_\$LO^B^?M_P#_
M (=/]G7_ .A5K]_O^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '
M_B9'[.O_ ,\:@#\ ?^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\
MHOG[?_\ X=/]G7_Z%6OW^_X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ/^'L7_!+
M+_I)9^P!_P")D?LZ_P#SQJ /P!_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_
M !!4_P#!++_HOG[?_P#X=/\ 9U_^A5K]_O\ A[%_P2R_Z26?L ?^)D?LZ_\
MSQJ/^'L7_!++_I)9^P!_XF1^SK_\\:@#\ ?^(*G_ ()9?]%\_;__ /#I_LZ_
M_0JT?\05/_!++_HOG[?_ /X=/]G7_P"A5K]_O^'L7_!++_I)9^P!_P")D?LZ
M_P#SQJ/^'L7_  2R_P"DEG[ '_B9'[.O_P \:@#\ ?\ B"I_X)9?]%\_;_\
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M^[V?_?1Z_?[_ (-<?^4%'[#/_=S/_K8?[05 '[_4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445_/9_P=
M!?M=:E^R7_P2!^.\'AJ^U_2?&W[4.L^'/V2O"NL:/H?A?7=/L;'XIV>O:Y\5
M[3Q3'XIE:/3-"\4_ /P/\6O!-MKF@Z9K'BC2/%'B;PW=Z'%HERA\7>&TW9-]
ME<:5VEM=I7]3^0+_ (+N?\'-?QC_ &TO%?Q+_98_85\:Z_\ "?\ 88N="USX
M9>-/%MIHT&A_$O\ :ML+_4=/;Q#KFIZEJ^EIXT^%OPBU:WTJ7PYX<^'^AW7A
M;Q3XY\ ZYXJ3XY"ZT_Q[)\'_ (=_R,,S.Q9F+,QR68DL3ZDG))]S7W'_ ,$V
M?V'O%/\ P4@_;;^ W[&'A#QOH/PVU/XS:]X@BU#Q[XCT_4-9L/"GA/P-X*\2
M_$KQSK%KH6F&&X\0^(+?P9X.UX>$_#DVHZ!IWB'Q2^C:+K'BGPEI-]>^)M)_
MUG/V9_\ @@Y_P25_9<^%VD_"_P ,?L.? 'XJ&S%A=ZY\1?VD/AGX)_:#^*GB
M_P 0V_A[0O#^I>(M7\8?$_P_K[Z%_;YT&'7+[P9\/K'P5\+]*\0ZEKNI>$O
M?AK^VK^"9VLDWJWUZ_\  7;T^8F[_+2WR7WO:[/\7_ITK^D;_@CY_P '(_[8
MW_!.OQY\-_AO\<?'OC_]IK]AK3S:^%_$GP;\6:E9>*/'OPO\(C2/"OA;1M8_
M9^\<^*Y1X@\/Q_##0?"6EP>$/@=J'BVP^"&I:-+XGT"QT;P#XF\56_Q0\+?Z
M/?Q3_P""+G_!)?XQ^!=<^'?C#_@G5^R'IWA_Q!_9OVZ_^&GP0\$_!3QS;?V5
MJ^GZW;'0OB?\&M+\!?$OPN9;S3+:#4CX9\6Z0=9TB2_\/ZN;[0=5U33;S_+$
M_P""X?\ P2S7_@DA^V_J/[.NA?$4_$[X7>._ .D?'#X*^(-4B^S^.M.^&/BO
MQ7XU\):=X5^)\5KIFFZ#/X\\,:_X#\1:3>ZWX6C7P_XOT:WT/QG!I/@R^\0Z
MA\/_  D)V?KIZ];>6WX;CMH]=M7^"T^;^[7O;_8T^%/Q/\#?&[X7?#;XS_##
M7!XG^&GQ=\ ^#_B?\//$HTW5]&'B'P-X^\/:=XK\):X-(\06&E:]I0U;0-6T
M^_&FZWI>FZO8_:/LNI6%G>Q36\??5_'9_P &8_[7>I?&#]@;XS?LG>)+[7]3
MU?\ 8\^+UMJ7A"6YT/POIWAC1/@[^T6GB/QCX=\*:1J^D2P^(O$.OV?Q<\(?
M'CQ5XCN/%VF2SZ=IOC3PIINB^)-4TJWBT'PC_8G3:L_N:]&KK\&2M5^?JM&%
M%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?
M@#_P='?\H*/VYO\ NV;_ -;#_9]K]_J_ '_@Z._Y04?MS?\ =LW_ *V'^S[0
M!^ /_!C'_P Y1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%%
M 'P!_P %8O\ E%E_P4L_[, _;(_]9U^(U?X@U?[?/_!6+_E%E_P4L_[, _;(
M_P#6=?B-7^(-0!_J=_\ !/;_ (-P_P#@C'\<?V!?V'OC7\4OV-O^$H^)OQ@_
M9 _9I^*7Q%\3?\-#?M5Z)_PD7COX@?!?P5XL\7:[_8WAWXY:1X?TC^U_$&KZ
MAJ']F:%I6F:/8?:/LNF:?9644%M%]?\ _$+C_P $*/\ HQG_ ,V9_;#_ /H@
MJ_&']B+_ (.Z_P#@FW^S7^Q?^R)^SGXZ^"7[;^K>-O@#^S!\ O@IXQU3PG\-
MO@-?>%=2\5?"OX4^$_ OB'4/#-]K'[2N@ZO>>'[S5]"O+C1KK5-#T;4;C3I+
M::^TK3KEY;.'Z?\ ^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%50!]__ /$+C_P0
MH_Z,9_\ -F?VP_\ Z(*C_B%Q_P""%'_1C/\ YLS^V'_]$%7P!_Q&K?\ !++_
M *('^W__ .&L_9U_^BJH_P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55 'W_ /\
M$+C_ ,$*/^C&?_-F?VP__H@J/^(7'_@A1_T8S_YLS^V'_P#1!5\ ?\1JW_!+
M+_H@?[?_ /X:S]G7_P"BJH_XC5O^"67_ $0/]O\ _P##6?LZ_P#T55 'W_\
M\0N/_!"C_HQG_P V9_;#_P#H@J/^(7'_ ((4?]&,_P#FS/[8?_T05? '_$:M
M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154
M??\ _P 0N/\ P0H_Z,9_\V9_;#_^B"H_XA<?^"%'_1C/_FS/[8?_ -$%7P!_
MQ&K?\$LO^B!_M_\ _AK/V=?_ **JC_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /15
M4 ??_P#Q"X_\$*/^C&?_ #9G]L/_ .B"H_XA<?\ @A1_T8S_ .;,_MA__1!5
M\ ?\1JW_  2R_P"B!_M__P#AK/V=?_HJJ/\ B-6_X)9?]$#_ &__ /PUG[.O
M_P!%50!]_P#_ !"X_P#!"C_HQG_S9G]L/_Z(*C_B%Q_X(4?]&,_^;,_MA_\
MT05? '_$:M_P2R_Z('^W_P#^&L_9U_\ HJJ/^(U;_@EE_P!$#_;_ /\ PUG[
M.O\ ]%50!]__ /$+C_P0H_Z,9_\ -F?VP_\ Z(*C_B%Q_P""%'_1C/\ YLS^
MV'_]$%7P!_Q&K?\ !++_ *('^W__ .&L_9U_^BJH_P"(U;_@EE_T0/\ ;_\
M_#6?LZ__ $55 'W_ /\ $+C_ ,$*/^C&?_-F?VP__H@J/^(7'_@A1_T8S_YL
MS^V'_P#1!5\ ?\1JW_!++_H@?[?_ /X:S]G7_P"BJH_XC5O^"67_ $0/]O\
M_P##6?LZ_P#T55 'W_\ \0N/_!"C_HQG_P V9_;#_P#H@J/^(7'_ ((4?]&,
M_P#FS/[8?_T05? '_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!5^ /_!\Y_SBZ_[O9_\ ?1Z_?[_@UQ_Y04?L,_\ =S/_ *V'^T%0!^_U%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117S/\ MI^&_C!XR_8X
M_:S\(?L\W.O6?Q^\5?LS_'CPW\#KOPKXJ@\"^*+7XP:Y\+?%6F?#.Y\-^-[K
M6/#UMX-UZ#QI=:)+H_BJXU_0X/#VH+;ZO+K&F1V;7L !_ET?\%NO^#@C]J?]
MOC]H_P"*O@/]GWXX^/\ X._L.^$V^(_P9^'O@;X/^-?B'X TO]H;X9ZQ=7'A
MSQ#\2?CK;&W\$>(/'"?&/0K.&ZL_ACX]\/6_A[X:^!]2C\"Q^&I_$M[\2?&/
MQ _FZ,LI))DD)/))=B2?4DGFI%A>:[$!($DMP(2Q' =Y=A)'' 8YQQ^%?ZS/
MP _X-/?^".GPO^#GP_\  WQA^ ^N?M)?%3P_X?AMO'_QP\5?%[X^?#S4_B)X
MIGGGOM6UFW\ ?#+XO^'O!/@S08;FY;3/"OAK3+*_O]'\+V&CV7B3Q3XV\3Q:
MSXRUX2]U2?7KUO9-_FNW1+;1O=K9+3Y?UJ_/U/\ )A\R3_GH_P#WTW^-'F2?
M\]'_ .^F_P :_P!@#_B%\_X(6_\ 1B]M_P")&_M<?_/[H_XA?/\ @A;_ -&+
MVW_B1O[7'_S^Z>GG]W_!]?Z>AIY_=_P?7^GI_(+_ ,&4[,W_  4__:$W,S8_
M8+^(V,DG'_&0G[,G3-?Z=]?F1^Q;_P $;_\ @F[_ ,$\?BAX@^,W['?[-\7P
M=^)7BGP%J?PQU[Q)'\6?CGX[^W^!]8\0^&/%6HZ&VC_$WXF^,] M_M&O^#/#
M=^-2M-+@U>#^SC:V^H165[J%O=_IO0]?N7X)(5M_/7\$OT"BBBD 5_,;_P '
M<WP,;XN_\$;?'OCE?$QT%OV9OCK\#OCD-)&B_P!J'QM_;6NZC^SF?#'V[^UM
M._X1O[*/C^?&?]L_8]>-Q_PB/_".C283K_\ ;NB_TY5P7Q5^&/@;XV_"_P")
M'P9^)^A_\)/\-?BYX"\8?#'XA^&SJ6KZ,/$/@;Q]X>U'PKXMT,ZQX?O]*U[2
MO[6T#5M0L/[2T35--U>Q^T?:M-O[.]BAN(T]4_P]>@T[--[)I_B?XQ7_  19
M_;)\!_L!_P#!3[]DC]J;XIVGG_#'P-XZUOPS\1M1\_6(_P#A$? OQ>\">*_@
MWXK^(OV3P]X9\8:_KP^&>A^/K[X@MX2T/P_>ZQXR7PTWA33)M.OM9@U.S_V5
M?@+\>O@[^U#\'?A]\?\ X ?$'P_\4O@]\4O#\/B7P-XY\,SS2:;K&FR33V=U
M!/:WD%IJNB:]HFJVFH>'_%7A77[#2_$_A#Q/I>L>%O%.CZ/XBT?4],M/\>S_
M (+"_P#!'K]HW_@E?^T9\2- U_X;^/M3_9/U3Q_=Q?LZ_M%2VEUXH\#^+O _
MBFZ\5:O\./!_C#XC:1X5\,>%--^/.F^%/#&L6WQ ^']SH_A?5CJWA?7_ !5X
M5\/ZA\,M0\)^+-<_-GX*?M$_M ?LU>)[_P ;?LY_'/XQ? +QGJN@W7A;5/%O
MP5^)OC7X6>)M2\,7NHZ7J][X<U#7O VMZ%JE[H-YJVAZ)J=UH]S=2Z=<:AH^
MEWLUL]SI]I)"T[I75FOP\GZ7;OU]+,35F^SU]>S^[=='IHTS_=X\5>*O"_@3
MPOXD\;^-_$F@>#?!?@W0-8\5>+_%_BK6-.\/>%_"OA?P]IUQJ^O^)/$FOZO<
M6>DZ'H&AZ39W>IZQK&IW=KIVF:=:W%[>W$%M!+*O^1;_ ,'*O_!1CX$_\%*?
M^"B]M\3_ -FG4E\5_!3X2? 3X;?!#P=\3%M?%^BK\4)++5/&'Q4\2>)5\(>.
M_!7@;Q5X,70?%7Q7UOX;_P!CZIIVHC4V\"'Q?8:M)IGB>ST_3OQZ^.?[6W[5
M?[3X\,K^TM^TS^T#^T,O@K^VO^$-3XX_&7XB_%A/"7_"2?V3_P )%_PC*>//
M$>OKH/\ ;W]@Z%_;7]E"T_M7^Q=)^W>?_9UGY/L7[!'_  3E_:V_X*3?&;1O
M@W^RQ\*M?\822Z_X?T?QY\3;O2M;M?@[\%=-\0P:[?VGBGXR_$.RTK4M)\#:
M))I/A7Q3J&DVERMUXI\:S^'K_P -_#OPWXQ\93:;X;ORUVOO_P""_);_ '/H
M.]D_-6_'I;>^B^_3J?W0_P#!D7\##X=_9/\ VUOVDCXF^U?\+<_: \!_!4>#
M/[%,']@C]GWX>R^./^$H_P"$B.K3?VI_PEW_  TJ=*&BC0M.&@CP2+_^UM:_
MX27['H/]N5?,?[&G[(WP<_80_9B^$/[)7P"L=>LOA3\&?#UWHGAU_%6N3^(_
M%&L7^M:[JWB[Q=XJ\2:O)%:VT^O^,O&GB'Q#XLUFWT73-#\+Z=J.M7.F^$O#
M?AGPQ::1H&F_3E.3N]-M$O1))/YI$K;7?K\_\N@4444AA1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU=[;POX<@TL_K^OZ_4?]=_\ @?+[S]/_ /@L/_P0<_9<_P"";FH>+[WX=_\
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M#O"MUJ6OZ]K>JWGAK5OB)XI^.'@[XV^*?&$'A=H[/6O#?B/Q)K_BV[_1\?\
M!CK\2?\ A59U4_\ !1#P.?C=_P (%_:(\"#]G37A\*Q\3_\ A'OM/_"''XLG
MXN'Q<? 7_"5_\27_ (63_P *6'B$^'O^*G_X52-2_P"*1K^/W]NS]A/]H_\
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M/V__ /Q,C]HK_P">-1_P]B_X*F_])+/V_P#_ ,3(_:*_^>-0!_M\T5_B#?\
M#V+_ (*F_P#22S]O_P#\3(_:*_\ GC4?\/8O^"IO_22S]O\ _P#$R/VBO_GC
M4 ?[?-%?X@W_  ]B_P""IO\ TDL_;_\ _$R/VBO_ )XU'_#V+_@J;_TDL_;_
M /\ Q,C]HK_YXU '^WS17\T/_!K'_P % OVG_P!OC_@GIXEO/VI9_$'CWQ3^
MSK\8+GX$>&/V@]<D\/SZC\7/"NE^ ?!/BO3M+\<ZBGC/5/&WBKXP?#RV\3VM
MCXV\?^)/ OA/3O&WA77_ (;:H_BGXG_%9?C-XBL_Z7J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /\97_@MW\*/V ?A[^W'\4_%_
M_!.3]I_X=_'+X-?$;XA?$7Q'KOPU\!^!_$/A'3?V</B!#XLG;Q+\/_ VMV_P
M_P#"/P9^)'P%NM5O;JZ^ ?BOX+:OKVDV7@FQ?PKJ=O<Z7X=\*_$OXJ?UZ_\
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M'1W_ "@H_;F_[MF_];#_ &?:_?ZOP!_X.CO^4%'[<W_=LW_K8?[/M 'X _\
M!C'_ ,Y1?^[)O_?N*_O\K^ /_@QC_P"<HO\ W9-_[]Q7]_E !1110!\ ?\%8
MO^467_!2S_LP#]LC_P!9U^(U?X@U?[?/_!6+_E%E_P %+/\ LP#]LC_UG7XC
M5_B#4 ?[?/\ P2=_Y19?\$T_^S /V-__ %G7X<U]_P!?PQ_L1?LH?\'8'B/]
MB_\ 9$\0_LY_\%-OV(/ 7[/FO?LP? +6?@3X%\6> ?!MYXJ\%_!K5/A3X3OO
MAAX3\37EU_P3Y\:7-UX@\.>"9]#T?6;FX\8^+)Y]1L[F6;Q-KLC-JEU]/_\
M#&__  >2?])8OV /_#<^!O\ Z6G0!_7[17\@7_#&_P#P>2?])8OV /\ PW/@
M;_Z6G1_PQO\ \'DG_26+]@#_ ,-SX&_^EIT ?U^T5_(%_P ,;_\ !Y)_TEB_
M8 _\-SX&_P#I:='_  QO_P 'DG_26+]@#_PW/@;_ .EIT ?U^T5_(%_PQO\
M\'DG_26+]@#_ ,-SX&_^EIT?\,;_ /!Y)_TEB_8 _P##<^!O_I:= ']?M%?R
M!?\ #&__  >2?])8OV /_#<^!O\ Z6G1_P ,;_\ !Y)_TEB_8 _\-SX&_P#I
M:= ']?M%?R!?\,;_ /!Y)_TEB_8 _P##<^!O_I:='_#&_P#P>2?])8OV /\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/ =SX8\>:C\0]5MO#WBV+5OACXLT:3^]*BBFW?\ !?<K?\/^@@HHHI %%%%
M!1110 445^8__!2/_@KS^Q!_P2Q\!KXI_::^)2WOCO4/^$9F\)_L[_#*Z\*>
M*/VBO&VD^)]7UG2;?Q5H'PVU?Q5X8:Q\":?_ ,(QXMN=3^(/B[5_#'@=;GPO
MJ'A:P\0ZAX[U#PYX3UP ;_P5&_X*S_LM?\$D?A1\/?BM^TM;^/\ Q0GQ1\?2
M^ O!GP[^#\'P\USXI:NUAX?U+7_$/C&T\)>/?B/\-Q?^ _"'V;0]%\7>(M+U
M&_'A_P 0>.O 6G7UI'_PD]G,OY_?L$?\'/W[ W_!13]K#X6?L=_!/X1?M?\
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M +(L[KQ-XBU>]B^TGW^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\4G[<FV2-V1U_P"&9_VPCAE)5AE?V?B#@@C()![$BF?\11W_  0H_P"CYO\
MS6;]L/\ ^A]K_(X\<^"/&?@?QKXO\%>-?"/B?P?XR\'^)]>\+>+?"7BG0-5\
M/^)O"_B;P_JMUI.O>'?$6@ZM:6FJZ)KNB:K:7>F:OI&IVEKJ&FZA:W%G>V\-
MS#)&O+?8;W_GSNO_  'E_P#B*2U2?=('HVNS9_KX?\11W_!"C_H^;_S6;]L/
M_P"A]H_XBCO^"%'_ $?-_P":S?MA_P#T/M?Y!_V&]_Y\[K_P'E_^(H^PWO\
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M4 ?N)_P;#?MY?M7?\%$/V OBE\;?VP_BH/B[\3O#G[6_Q ^&.C>)1X'^''@
M67@?0_A%\"?$^EZ'_8WPP\(>"] N/LVN^,O$E_\ VE=Z5<:O-_:7V:XU"6SL
M["WM?Z-*_$K_ ((%_P#!/[X7?\$[?V'M;^&GP7_:_P# ?[<7PT^+'QZ\>_&_
MPU\>/AEH'AW1/ ]_]N\,> /A/K'AC1+GPI\4_C!H'B+_ (1S7_A%JL&I:U8>
M+4\G5Y[_ ,/W6DV=[H5S+=?MK3E:[MM_P "BBBD 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?@#_P='?\ *"C]N;_NV;_UL/\
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M=?\ Z%6@#^OVBOY O^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\
MHOG[?_\ X=/]G7_Z%6@#^OVBOY O^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K1
M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5: /Z_:*_D"_X@J?\ @EE_T7S]O_\
M\.G^SK_]"K1_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6@#^OVBOY O\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#^OVBOY
MO^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z
M%6@#^OVBOY O^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^
MW_\ ^'3_ &=?_H5: /Z_:*_D"_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q!4_
M\$LO^B^?M_\ _AT_V=?_ *%6@#^OVBOY O\ B"I_X)9?]%\_;_\ _#I_LZ__
M $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#^OVBOY O^(*G_@EE_T7S]O_
M /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6@#^0+_ (.CO^4Z
M_P"W-_W;-_ZQY^S[7[_?\&,?_.47_NR;_P!^XK^4+_@LS^Q3\+/^"=O_  4G
M_:0_8Z^"FO\ Q \4?#+X/_\ "G_^$9UWXI:KX<UOQW??\+ ^ OPN^*6L_P!N
MZGX3\*>"?#]S]F\0>-M5L],_L_PQIGDZ/;Z?;W7VV]BN=0N_ZO?^#&/_ )RB
M_P#=DW_OW% ']_E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_(7_P=9?\
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M^</RE_7S'+XO_ OS1^_=%?YX?_!PY_Q$+?\ #S_XJ?\ #(O_  \__P"&4O\
MA7_P>_X4)_PQ3_POS_A5G_".?\(!I'_">?V__P ,R_\ $L_X6!_PNW_A:?\
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M ,H*/V&?^[F?_6P_V@J /W^HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 4444 %%%% !1110 4444 %%%% '^ /7^OU_P:X_\ *"C]AG_NYG_UL/\
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M:\,:;XN^UZQ\'_%'CKQYJFLZ#J'@;X>>"_B;XF\>^(-)UE'B\-0ZCHOBK3=
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M[1S<U[7ES\ND;K6R9_JK1^A_]'A_LTY?2JJ8/B-^):X7K5%C/]9<0LD7$?\
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MBZ\X8*M7]G"A-U'%I)_2-%%%>B?&!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDK_;\_\ $Q/VAO\ YXE'_#V7_@J?_P!)*_V_/_$Q/VAO_GB4 ?[>U%?RV?\
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M]N;_ +MF_P#6P_V?: /P!_X,8_\ G*+_ -V3?^_<5_?Y7\ ?_!C'_P Y1?\
MNR;_ -^XK^_R@ HHHH ^ /\ @K%_RBR_X*6?]F ?MD?^LZ_$:O\ $&K_ &^?
M^"L7_*++_@I9_P!F ?MD?^LZ_$:O\0:@#_1<_8B_X+Y_\%)/@Y^Q?^R)\(O
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M=_\ !4W_ *5C_P!O_P#\&/[17_T -?U^T4 ?R!?\1'?_  5-_P"E8_\ ;_\
M_!C^T5_] #1_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 U_7[10!_(%_Q$=_\%3?
M^E8_]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\ _!C^T5_] #7]?M%
M'\@7_$1W_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M
M%?\ T -?U^T4 ?R!?\1'?_!4W_I6/_;_ /\ P8_M%?\ T -'_$1W_P %3?\
MI6/_ &__ /P8_M%?_0 U_7[10!_(%_Q$=_\ !4W_ *5C_P!O_P#\&/[17_T
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M+DVV@>--4N],^P>)]-\G5[>PN+H7ME%<:?=?T=T4+2]NN_W6_+0'KOT_SO\
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M .^CU^_W_!KC_P H*/V&?^[F?_6P_P!H*OP!_P"#YS_G%U_W>S_[Z/7[_?\
M!KC_ ,H*/V&?^[F?_6P_V@J /W^HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _P  >O\ 7Z_X-<?^4%'[#/\ W<S_ .MA_M!5_D"U_K]?\&N/_*"C]AG_
M +N9_P#6P_V@J /W^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /YG_^#GGXW^(_!/[)_P "/@;IMKXL
MTKPE\?/CWIM_\3?&7_"*^'[WX77/A;X)Z8WQ"\,?"CQ+XYULRW?A#XE>,?C"
M?A=\3?AII'AJWM]>\8>&/@9\7(WUBTT#0M>TG7OXQ04D3(*O'(O!&&1T<>O*
MLK*?<,#W!K_6:K\5?^"M&L_\$QOV;/A9X_\ BW^T_P#LM_ GXN_';]H+0==\
M#>#?#]GX(\(>'?VB?C=K&G>#]/\ ",MU!\;M&T/_ (6E\./#/PW\,7/ANT\0
M_'?3]:CU3X/Z4W@_3_ LNI_$W6/A3X$\5_@OBUX7/BW%/B?$<5T,EPV4Y6J+
MH8W N>#P^'H5*V(K8B6+IXNG.$YRJR<O]FJRGRTJ<7[L4?ZT?L]?IW0^CUD<
M/ _)_ '-?$O//$+CN>94\TX7XHIX;B;-\VS7!Y9DV69-1X?Q?#^*PV*P^&HX
M"FJ+>>8&AAY8C'8NK!*M7J+^!/6KO7?$VOZ%XC\4>+O&OBF^\*_#CPU\(?"5
MOXI\8>(O$VF>#_AAX*GO)_!G@#P9INO:CJ-KX.\%^$FU+55\.>$O"\>D>&](
M75=1-GI4<EW)(>[\.?%?XJ>#? _Q(^&7@[XE>./"'P[^,46A6OQ8\'>%/$-[
MX:TGXDZ7X?T'XA^%[3PUXYET1['5?%7@6_\ #_Q4\;:9XE^'&MZC>_#SQ>FH
MZ?>>*O"VLZEX;\-7ND>=7MQIM@-;U46MCX=TAK[7=?.EVFI>*=2T/PMIMW>W
MFK'1-'U'QUXE\9^,Y/#7AJTE_LO19/%WC'Q9XF71;"T;Q#XH\0ZP+[6;VQX:
MUO1+M_#WB-=.TCQGX=DN-'US^Q]1O_$UAH/BO2$GMM1.D:GJ/@OQ#X0\8VFC
M:[:H;#4KCPMXJ\,>)(K"ZN#HVOZ+J0M]0MOY!>99O',Y9E#.LRDXU/[*7$*G
MCHUGA/8O"**KM_6XQEER<%A>=5G@[X=PY+P/^C*EP5X>5N":?!6)\,N":-+$
MX5<>5O!^>$X6K9;'B!9C2X@J59Y3&F^'Z]>AQA*EB)YY#"RRU<1\F<1Q#Q3A
MBG#;6UO9P0VEG;PVMM;QK#;VUM$D$$$2 *D4,,2K''&@ "HBJJ@   5_9+_P
M; ^-+_4/V?OVJ? -MX(OK;PIH'QZ\/\ CN'XJK?S76A>+_''C?X:^'_!_BOX
M=V=LNCQ6%GKGPP\-?"7X>:_KGE>(M4OYK+XK>'Q?Z+H$$.G7OB/[=_X)2ZG_
M ,$R/VCOA=X!^,'[+G[,'P(^%'QJ^!.B:-X,\5:)<^!?!FM_M#?!76+[PEJ?
M@^.XO?C)J6C/\3?'>B?$'PQ%XEL]"^->H:W+JGQ9T=_%MGXRGL?B#I_Q-\&>
M&_V<K^M/"KPH_P!6LQPG&%#BZAG%''9?6@J6!P,HX7&8;&QC.,WC:V+E5GRU
MH4JSB\)2FJE+DJ-/FBO^>WZ??[0+_B-7!O$GT;\U^COFGAQF?#/%N5XFIF'%
M?%5&KGW#6=\,XBK0J4*?#&7\/4<#1=?+<3CLMIXFGQ!C<+5P&9/$82-2DZ%6
MH4445_0A_CN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %Z?M+?^LE?'6OT@_P"#GK_@@Y^S!_P3E^'?PE_;!_8TM?$/@+X8_$?XOO\
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M4UNKZ)JW6_>]^J>W3IW7<6J;OW5O2R^3UO\ \-8_*7_B"P_X)6_]%P_;V_\
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M\8+*X_MOX967@SQ%J?D_$7Q%Y6L:OJ$$G]D312:%IG]7O_!C'_SE%_[LF_\
M?N*_ '_@Z._Y3K_MS?\ =LW_ *QY^S[7[_?\&,?_ #E%_P"[)O\ W[B@#^_R
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *_@-_X/=_VHV2T_8C_ &+?#WCC
M'GR_$']IWXM_#<>&_O)$L'PL_9[\;'Q?>Z!R-[?M,Z'_ ,(UX:\4=5&J>-]
M_P"2?:C7]^5?YM__  >X_!7Q3HG[8/[&W[15W?:#)X*^)O[-?B'X+:#IEM=:
M@_B>S\4? OXH>(O'/BV_UBRETJ'2K?0=2TG]HGP3;^&[JRUO4-0N]0TKQ7#J
MFEZ/;66D7>N)[?./YH<>OH[?=_E<_G\_X(J_\$S-0_X*N_MX> _V9[[6]?\
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M6J3:M9Z9HNK_ .LA5R^SWY?R;2O\DOE8E=?7]$%%%%2,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _@#_ .#YS_G%U_W>S_[Z/7[_ '_!
MKC_R@H_89_[N9_\ 6P_V@J_ '_@^<_YQ=?\ =[/_ +Z/7[_?\&N/_*"C]AG_
M +N9_P#6P_V@J /W^HHHH **** "BBB@ HHHH **** "BBB@ HHHH _P!Z_U
M^O\ @UQ_Y04?L,_]W,_^MA_M!5_D"U_K]?\ !KC_ ,H*/V&?^[F?_6P_V@J
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MOAR_\<?%S0?%]KHL%EINL?!7P/\ $?3-)G\2^$=3\77GAKPQXALO$!_TOO\
M@H9_P7O_ .":G_!-'Q/XF^%_Q\^+VN^*?C_X7T#PCXDN_P!G?X,^"]6\>_$Q
M].\9ZC:PZ9!?:Q<'0/A%X-UV#P[<_P#"?W7A?XC_ !1\%^)IO +:7XBTK2-3
M3Q;X(M_$WR!^S!_P=B_\$?OVD/%;>#/$7Q#^+7[+.L7VO^#?#7A6Z_:=^&UM
MX?\ "WBW4?&.HWVEF>/QU\*?%/Q?\$> M"\*W,&G2>,?%/QB\0_#7PQHVGZ[
M8ZM'J][I6G>*+WP_2]+OM_P%K^/;YII^G]?D_P#AC]'/^"4__!*C]G+_ (),
M?LX67P1^"EK_ ,)1X[\2_P!E:Y\>OCUKNDVNG>.OC?X[L+:YBBU+4H(;C4/^
M$8\!^&#J.J6'PQ^&-AJFHZ/X$T;4-1N+G4O$_CSQ-X^\?^-/TZHHI-WU_K^O
M( HHHH *_ W_ (.?_P#E!?\ MT?]>O[.G_K6OP%K]\JX+XG?"KX7_&WP-KGP
MP^,WPW\!?%SX:^)_[-'B3X>?$[P?X>\?>!O$(T;5[#Q!HXUSPEXJT[5M U;^
MRM>TK2];TW[?I]Q]AU?3;#4K7RKVSMYHTU=-=U8<79I]FG]S/\$2BO\ <"_X
M=5?\$OO^D;W[!/\ XA]^SU_\[NC_ (=5?\$OO^D;W[!/_B'W[/7_ ,[NJT\_
MN_X/K_3T-//[O^#Z_P!/3_#]HK_<"_X=5?\ !+[_ *1O?L$_^(??L]?_ #NZ
M/^'57_!+[_I&]^P3_P"(??L]?_.[HT\_N_X/K_3T-//[O^#Z_P!/3\ _^#++
M_E%9\;?^S]/BM_ZH/]F*OZ\J\C^#'[/_ ,!_V</"]_X'_9Y^"?PC^ W@K5-?
MNO%6I^$/@Q\-_!OPN\+ZCXHOM/TO2+WQ)?\ A_P/HVAZ3>:_>:5H>BZ9=:Q<
M6DFHW&GZ/I=E-</;:?:10^N4-W;?<04444@"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K\ ?^#H[_E!1^W-_P!VS?\ K8?[/M?O
M]7X _P#!T=_R@H_;F_[MF_\ 6P_V?: /P!_X,8_^<HO_ '9-_P"_<5_?Y7\
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M_P#GC4?\/8O^"67_ $DL_8 _\3(_9U_^>-0!^ /_ !#B?\%3?^EG#]O_ /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGB+PC<6VN:_X/AU_PII/B?1_%'A_Q+X(O]=M_&OA75K'Q+X?TJX3\K/V$/\
M@E+^W;^R'^T;X:^,?Q3_ ."R_P"T;^UO\,K30_%?A[QO\ _B_P"#?&^M>&O&
MEAKNAW46BW%CK/Q$_:3^+5OX'USPQXP@\->*[;Q/X9\+Q>);RPT74_!1U:T\
M->+_ !);WG[P44<*>-GB%P5P)Q5X;</8OA>CPCQI_:'^L6&S/PZ\.>(LXQ?]
MIY;0RG$?5.+.(N%,UXMR;V.$PU*>6?V+GF7?V-F#JYOD_P!1S;$8C&U77RW"
M8G%4,95C7>(PW)[&4,9C*-./)-U%S4*->G0J7DVI^TI3]I"U.IS4XJ*\._:1
M\!_&CXF_!?QGX(_9Y^/?_#,7Q@UO_A'?^$0^./\ PJWPI\:?^$(_LWQ7H6KZ
M_P#\6S\;WEAX7\2_\)+X7L-;\(?\32[B_L;^W_[?LO,U'2K2)_\ .>_X.#O@
MW_P4 _X)5>!?@=\./&W_  5L_;)_:Z\'?MG^&/VB?!_BOPUXC^)7QP^'7AS3
M?#G@#3?A9I&M:#XBT'4/V@_BOIOQ"\/^.M.^+USIVMZ#J<6DZ7)I>E7>EZG;
MZY8:_<067^FE7\ ?_!\Y_P XNO\ N]G_ -]'KHX#\=?$;PUX6XEX,X1Q'!^&
MR'B_ZW'B.GG/A=X7<6YKF5'&Y<LJK8.?$?%W!N><1X?+Z>#=98/+L'FV'P&7
MXG%YAC\!AL-C\RQ^)Q,XK+,'C*]'$XB.(E5P_+[%T\;C:%.#C/VBE[&AB*5&
M4W))RG*FY3481FY1A",?X"K62"*ZMI;FW^UVT4\,EQ:^:\'VF!)%:6W\^,&2
M'SHPT?FH"\>[>H+**],E\>^%YHI(7^'.C!)8WC8Q3VD$H5U*L8YX-%CFAD )
M*2PR)+&V'C=7 8?I7_P05_9<^!/[:/\ P5B_93_9H_:7\#?\+*^"7Q*_X7G_
M ,)KX*_X2;QCX._MK_A#OV;?C%X_\.?\5'X \0^%?%NG?V=XM\*Z#JW_ !*=
M>L/MGV#[!?\ VK3+J]LKC_1\_P"(7'_@A1_T8S_YLS^V'_\ 1!5IX8>/?B7X
M/9?GN6<!XWA/!X/B6IAZF=PX@\,O#'CNKCEA:-?#T*#Q?'G!W$N+P^#A2Q6)
M7U'"UZ&"G+$5JLZ$JM6<Y&-RO!YA.E/%1KRE135)TL;C<*H\SC)OEPN(HQ<K
MQB^:2<ERI)I)'^0+7J'_  G'A7[+]D_X5UI/E>1]FW_;(?M7E^7Y6[[;_9'V
MSS]O/VK[1]J\S]]YWF_/7^M5_P 0N/\ P0H_Z,9_\V9_;#_^B"H_XA<?^"%'
M_1C/_FS/[8?_ -$%7'X7^-GB%X._ZP?ZAXOA?"_ZT8?!83.O]8_#KPYX^^L8
M7 ?7?8X;#?Z_\*<3_P!F8>K]?Q'UZCE?U*GF?+A?[2CB_J&!^K5C<MPF8>R^
MM1KR]@Y2I^QQF,PMI2Y;RE]4KT.=KDCR.?,X>]R<O-*_^0+7I&F>-?#FGZ?9
MV4G@+2;Z6W@CCFO+F>VFGNIP,SW#M<:1<2KYTI>18C-(D",L$1$4:*/];+_B
M%Q_X(4?]&,_^;,_MA_\ T05'_$+C_P $*/\ HQG_ ,V9_;#_ /H@JY_"WQBX
M]\&<US+._#[&\/Y?F>;9?'*\;B<]X%X#XXO@%B:6+=#"T>.N&N),/E_M,10H
M5*]7+Z6%K8CV%&%>I4A2A&+QV7X7,80IXN-6<*<^>,:6*Q6&]^SC>3PM:BYV
M3=E-R4;MI)MG^09=202W5S+;6_V2VEGFDM[7S7G^S0/(S16_GR 23>3&5C\U
MP'DV[V 9C7?:3XP\-:78P6C^ ]-OIDCB^TWEY>1W4MS<K#''-.OVS2[M[:.9
MXS*+6&46\+.WEKEF9O\ 6U_XA<?^"%'_ $8S_P";,_MA_P#T05'_ !"X_P#!
M"C_HQG_S9G]L/_Z(*M/#OQFX\\*N(<VXJX(K<)X#/,YIUJ.*Q.:^&_AOQ7A\
M/2KXB6)K4LFRSBWA//,KX=IU*DN24,@P661^K1A@DE@Z=.A%8O+L+CJ-.AB5
M7G2IM.,88S&4&VDDG4G0Q%*=9JU[U93?->7Q-L_R%]8O+34-2N[VQTZ/2;6Y
MD62/3XIC/%;L8T$PC<QP@1R3"29(DBCB@6001(L4:"NLT#Q9H.CZ;%97?@O3
M=8NA)-)/J%Y/ \L[22$H%2YTR\,$<4(BA$44HB9D:?8)9I2W^MY_Q"X_\$*/
M^C&?_-F?VP__ *(*C_B%Q_X(4?\ 1C/_ )LS^V'_ /1!5IP=XV>(7 /'>?>)
M/"^+X7P7%W$?]L?VEBL;X=>'.>Y/3_M[,Z.;9E_9'">?\*9IPEP[SXNA"&$_
MU>R/*_[,R^5?*,L^IY3B<1@JIB,MPF*PM+!UXUY4*/L^2,<9C*51^R@X0]I7
MI5X5ZUHN\O;59\\TJD^:I&,E_D1>(M4T_6-0^VZ=HL&A1-!%'+9VTPE@>>,N
M#<(J6]K%!OB\F-HH850O$T[%I9I&.MX:\2:+H=K<17_A2PUZYGG$@NKV:(^5
M L:K';Q07%A>QQ[9#-(\L1C>;S424,L$6W_7'_XA<?\ @A1_T8S_ .;,_MA_
M_1!4?\0N/_!"C_HQG_S9G]L/_P"B"HR;QL\0L@\2\?XO95BN%Z''F98C-,7B
MLPK>'/ASCLF6*SFE.AF>*PG!N/X4Q7!>78C%4ZM92KY?P_A:M.6(Q-2C*G4Q
M.(E4*F6X2K@H9?.-9X6"IQC!8O%PJ<M)ITU+$0KQQ,U%I:3JR3M%.Z2M_D1>
M(M4T_6-0^VZ=HL&A1-!%'+9VTPE@>>,N#<(J6]K%!OB\F-HH850O$T[%I9I&
M.EX;\0:'HD4IU#PK::]=R22;;F\N\11VSK!M@6QGL[RU\Q)8GD%T$6XVS-"&
M$>0W^N7_ ,0N/_!"C_HQG_S9G]L/_P"B"H_XA<?^"%'_ $8S_P";,_MA_P#T
M051E?C-QYDWB3CO%O 5N$X\<YCC,=F&)QN+\-O#?,LDAF&9:XS'8/@S,N$L7
MP5EN,J3<JL,5EW#V%KX>O5K8C#3I5Z]:I,GEV%J8.. DJ_U:$80C&.,QD*O)
M#X8RQ,*\<3.*5DU.M)-)*2:22_R+?$VN:5KDMI-IOART\/O!'+'<"SF1HKM6
M9&A+00V=G#')"?.!E$;2S+*J2/L@B4'AG7-*T.6[FU+PY:>('GCBCMQ>3(L5
MHJL[3%8)K.\ADDF/D@2F-985B9(WV3RJ?]=+_B%Q_P""%'_1C/\ YLS^V'_]
M$%1_Q"X_\$*/^C&?_-F?VP__ *(*K_XC9XA?\14_XC1];X7_ .(@_6/K?UW_
M (AUX<_ZN_6O[%_L#ZS_ *@_ZJ?Z@?6/[/\ WOMO]6/:?VO_ ,9!S?V__P *
M8?V;A/J/]G<M?ZI;EY?KF,]MR^T]KR_6O;_6[<^EO;V]G^Z_A>X?Y''B7Q)H
MNN6MO%8>%+#0;F"<R&ZLIHAYL#1LLEO+!;V%E')ND$,B2RF1X?*=(@JSR[LG
MP[JFGZ/J'VW4=%@UV)8)8XK.YF$4"3R% +AU>WNHI]D7G1K%-"R!Y5G4K+#&
MP_UW?^(7'_@A1_T8S_YLS^V'_P#1!4?\0N/_  0H_P"C&?\ S9G]L/\ ^B"H
MSGQL\0L_\2\O\7LUQ?"]?CS+,1E>+PN84?#KPYP.3/%9+2A0RO$XO@W <*87
M@O,,1A*=*@HULPX?Q52I+#X:I6E4J8:A*FJ>6X2E@YX"G&NL+-3C*#QF,E4Y
M:CO.,<1.O+$PC)MZ0JQ2O)))2=_\CCQ+XDT77+6WBL/"EAH-S!.9#=64T0\V
M!HV62WE@M["RCDW2"&1)93(\/E.D059Y=V+H6H:;IE\+O5-&CUR%(QY-G+=R
M6D27*S0R1SR;(ITN(U2.2)[6>)[>99CYJL%"G_7A_P"(7'_@A1_T8S_YLS^V
M'_\ 1!4?\0N/_!"C_HQG_P V9_;#_P#H@JSS[QFX\XG\1L)XK9Y6X3QO&N#J
M9=6IXI>&_AOA<AK5<IP\<+@*N8<$X/A/#\$9I4H4*=*FYYEP[BY5E0P\J[JS
MP]"5-TLNPM#!RP-)5XX:2FG'ZYC)54IOFDH8F6(>)IIN[M"M%*[M92=_\D/7
M_%F@ZQILME:>"]-T>Z,D,D&H6<\"2P-'("X9+;3+,SQRPF6$Q2RF)6=9]AEA
MB*_UH_\ !K1\9OVUOVC;C]M;_@E_\+_VOO'GP#\$>-OV0Y?B5\*/B7(GBWXH
M:I^S#K7@K]HOX?:9XWM_V?\ P-J7Q)\*>$?AO'\:/#'[0OQ0A\?:[X/C\.^-
MH/'/_""?$WPUXKT7Q1X,#ZS\7?\ !T#^P5^R=_P3M_;Z^$7P4_8Z^%/_  I_
MX9>*/V0/ /Q2UWPS_P )U\2?B!]N\=ZW\:/C_P"$]3UW^V?BEXQ\;>(+;[3X
M?\$^&-/_ +,L]5M]'A_LS[5;Z?%>WNH7-W]?_P#!E3_RE-^/G_9@'Q3_ /6B
MOV5:TXQ\;/$+C[CO(?$GBC%\+XWB[AO^QO[,Q."\.O#G(LGJ?V#F5;-LL_M?
MA/(.%,KX2XBY,77G#%_ZPY'FG]IY?&AE&9_7,IPV'P5(P^6X3"X6K@Z$:\</
M6]ISQEC,95J+VL%3G[.O5KSKT?=2<?8U8<D[U(<M23D_ZQOV:/\ @C-_P42^
M 'Q^^$?QE\0_\%W/VJOC3X7^'WCG1->\8?"#XD>"_B-XL\%_$_P7'<BV\9>
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M;_A97_"U_P#B(:_:J_X2C_A.?^%A_P!E_P#"HO&/_"M?[?\ [?\ ^$D_L_\
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MCQS^W%XHL/'/B/7O#'Q?^)'A*Y\->--(\%Z];:1<V_@+6M3U;Q]\3?%'C?\
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MZ''X1\/:/X6\26^OZ3X0_P"$<U35O#,VG7GCCQ2EY^Q=%:9-XV>(60>)>/\
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MK3C&T4^2,E!2YI**E*391117YV=84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445\D?M_?$[Q
MQ\$OV$/VU_C-\,=;_P"$9^)7PC_9(_:0^)WP]\2?V;I&L_\ "/\ CCP#\'/&
M7BKPGK?]C^(+#5=!U;^R=?TG3[_^S=;TO4M(OOL_V74K"\LI9K>0!:M+N?Y0
M_P#P79_X*X_%3_@II^V1\91X9^+7CZ\_8F\$^/[?0OV</A /$WB&U^%]UH7P
MVLM;\(:+\<7\ WWAOP)M\=_%%M:\9^/4U7QYX2NOB=X'\/?$7_A4EYXFOO#O
MA'2K:'^D'_@V1_;]\#_L+_\ !#O_ (*3?'#XC> ?'TWA[]E[X^:U\7K#7]2T
M76-'^%_Q=\:_%KX4_"/X<_#+X%^#OB)HFB^,[RV\>7/Q*\&>%=!^(]U-X+O=
M'^%7A_XS?"OQSX@FNM!UK4VTC_/_ (%%Q?0K)R)[N-7]Q), W7/4,>N:_P!)
M_P#X.M/%/P=_8&_X(^?LY_\ !._]F.V\/_!#P7\7OBWX=\)Z-\%/#7A6:_TW
MQ)^S[\#;.]^)/C^>?Q9K&CZW)9Z[9_'G6O@#XT\5>*=1\667Q6^)7B?6]8UO
M5=7\76NJ?%"XN!:4^;=S]U>MX._XI>2OT5BK7FD_ABW?T2>UO*[;ZO7=MG^<
MW\7_ (K^//CO\5_B9\;OBEKA\3_$SXP>/_&/Q/\ B%XC.FZ1HPU[QMX]\0ZC
MXJ\5:PNC^'[#2M!TE=3UW5K^]&F:'I>FZ/8"?[+INGV=G%#;QM^(/PA^+'PE
M7P4_Q4^&/Q"^&B_$KP%X=^*OPZ;Q_P"#/$?@X>/OA?XO%X?"?Q'\%GQ%ING#
MQ1X#\4#3[\^'?%^A_;O#^M"QNSINH7(MIMG2_LX?!/Q1^TM^T+\"OV=/!%_H
M.E^,_CU\8?AK\&O"6I^*KG4;+POIWB7XF^,M&\%Z'?\ B2]TC2M=U6ST"SU/
M6K6XUBZTS1-8U"VTZ.YFL]*U"X2.TF_T8?\ @\L^%'PN\)?\$K?V53X4^&W@
M+PQ_PJG]KCX;?"WX7_\ ".^#_#VB?\*W^&.H? #XVK?_  X\!_V9IUK_ ,(A
MX"OE^'?P^%YX/\/_ -G^'KD>!/!OG:<__"+Z']A&DHIKORV[)<OS=[_AU$O>
MDT^V_F[V^6FOD_+7QK_@SQ_X*I?&/X\:/\3?^";7QV\2:_\ $*+]G[X2:7\4
M_P!F7Q;JEC!?:EX0^#/ASQ/H/P_\:?"'Q1XQNO$2ZMJF@^$M7\<_#63X&Z.W
MA?4Y_#/A67QUX2NO&&G^#/"WPI\%Z/\ W*5_D8?\&J'BOQ3X>_X+?_LJ:/X?
M\1Z_H>D>._"_[1GA7QQIFCZQJ.F:=XQ\,67[./Q3\;V?AKQ59V5S!:^(= MO
M&G@[PCXOM]'U>*\T^'Q1X4\-^((K=-5T+3+NU_USZJ71]UK\FU\[VNWW;)75
M=GI]R?ZZ>04445(PHHK\2O\ @X9_;EUG]@;_ ()5_M"_$OP'XQ_X0GXU?%*+
M1OV=_@7K$,7CB'5[;QW\6)+NU\2:QX3\1^ [W2-2\#^// WP:TGXJ_$OX>^-
M-2U[1='T3QQX)\/M))K6HSZ9X5\0#T3?8:5VEW:7WL_FB_X+M_\ !U=XH@\5
M?$O]C7_@EOXL\/1^$K;0=<^'_P 5/VU]$GU"\\2WWBFZU#3X-9M?V2=?TK6;
M32-%T70M*M-<\*3_ !XN;#Q%?>)]2\07OB7X$R>$(/!W@/XS^./X7OBI\7_B
MS\=/'6N?$_XV_$_XA?&#XE>)O[._X23X@_%'QGXC\?>-]?&CZ1I_A_2!K7BK
MQ5J6JZYJ@TK0=)TO1--%[?3BQTC3=/TVU$5E9V\$?KW[%O[(/QE_;X_:B^$/
M[)/P#M- N_BI\9O$%]I.AW'BS7(/#OA?0],T+0=7\8>,O%WB75I8[FYBT'P;
MX+\/>(O%FKVNBZ=K?BC5+#1I]+\)>'/$OB>]TC0=1_TWOV9_^#23_@D+\'/A
M=I/A3XW_  S\=_M:_$QA87_BCXM?$+XK?%3X:FYU@^'M"T[6M.\&> O@EX[\
M!>'/"_@*77]-U;Q)X=T/Q+-\0O'.C#Q'>:-K?Q/\766GZ3)9EFDF]W_3LNBO
MI?K;JT[#>]MO^&W_  =MK[)'^5%X0\9>+_A]XI\-^.? 7BKQ'X)\:^#->T?Q
M5X0\8>$=<U/PWXH\*^)_#VHV^KZ!XC\-Z_HUU9:MH>O:'JUG::II&KZ9=VNH
M:;J-K;WME<0W,,<J_P!D/_!'S_@[4_:+^#/CSX;_  %_X*8^)!\<_P!FN\-K
MX1E_:/F\-W%Y^T3\(+=-(\*^'/">O^,KWPSY2_'+P!X>_L+4=2^(5WK/A?7/
MVB->NO%_B#QZ?B%\2-8\/:3\,?%']/OQ3_X-1_\ @B9\0_ NN>$?"W[-WCCX
M(:_JO]F_V?\ %#X6?M _&S4/'7A@V.KZ?J5T=#L/C%XU^+7PUN?[9LK*X\/Z
MD/$WP\\1+%I&JZA/HXTK7H]+UO3?\V'_ (*L?\$S/C%_P2@_:W\0_LO?%O7-
M!\:V-UX?L?B1\(/B;X<:"TL/BC\'?$.M^(="\,^,;OPQ_:.IZKX$\0C5O"OB
M+PYXK\%:W<W4VA^)_#^K#0=:\8>"[CPOXY\3B=FKJZ[7^;]&]=NVN]A6OMTU
M]-EKW5W;_(_VMO"OBKPOX[\+^&_&_@CQ)H'C+P7XRT#1_%7A#Q?X5UC3O$/A
M?Q5X7\0Z=;ZOH'B3PWK^D7%YI.N:!KFDWEIJ>CZQIEW=:=J>G75O>V5Q/;3Q
M2MO5_*7_ ,&A_P"W/K7[4'_!-_6OV>OB%XQ_X2?XF_L2>/K?X;Z7!>1^.=0\
M16W[._CK3)?$?P.N/$?BOQ1>ZMH.K'2M;TKXM_"[P=X?\(W^FVO@?X8_"OP)
MX>N?">C6<>BZOXF_JTIM6=O1_)JZ?S3$G?\ KKU"BBBD,**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OP!_X.CO^4%'[<W_=LW_K
M8?[/M?I_^V+^WY^QM_P3_P# EG\1?VP_VA/A_P# [P_J_P!H_P"$9T_Q%>7V
MK^._''V#6/#&A:S_ ,*Z^%OA.P\0?$WXD?\ "-7OC/PQ/XN_X03PCXB_X0_1
M]7@\1>*/[(\/Q7.IP_RA?\%ZO^"]7_!)[]M'_@D]^U9^S1^S1^U9_P +*^-O
MQ*_X49_PA7@K_A1G[27@[^VO^$._:3^#OC_Q'_Q4?C_X.^%?"6G?V=X2\*Z]
MJW_$VUZP^V?8/L%A]JU.ZLK*X /G_P#X,8_^<HO_ '9-_P"_<5_?Y7\ ?_!C
M'_SE%_[LF_\ ?N*_O\H **** /@#_@K%_P HLO\ @I9_V8!^V1_ZSK\1J_Q!
MJ_V^?^"L7_*++_@I9_V8!^V1_P"LZ_$:O\0:@#_4[_X)[?\ !N'_ ,$8_CC^
MP+^P]\:_BE^QM_PE'Q-^,'[('[-/Q2^(OB;_ (:&_:KT3_A(O'?Q ^"_@KQ9
MXNUW^QO#OQRTCP_I']K^(-7U#4/[,T+2M,T>P^T?9=,T^RLHH+:+Z_\ ^(7'
M_@A1_P!&,_\ FS/[8?\ ]$%7R!_P3V_X.//^",?P._8%_8>^"GQ2_;)_X1?X
MF_!_]D#]FGX6_$7PS_PSS^U7K?\ PCOCOX?_  7\%>$_%VA?VSX=^!NK^']7
M_LCQ!I&H:?\ VGH6JZGH]_\ 9_M6F:A>V4L%S+]?_P#$4=_P0H_Z/F_\UF_;
M#_\ H?: #_B%Q_X(4?\ 1C/_ )LS^V'_ /1!4?\ $+C_ ,$*/^C&?_-F?VP_
M_H@J/^(H[_@A1_T?-_YK-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\ ^A]H
M /\ B%Q_X(4?]&,_^;,_MA__ $05'_$+C_P0H_Z,9_\ -F?VP_\ Z(*C_B*.
M_P""%'_1\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\ H?: #_B%Q_X(4?\
M1C/_ )LS^V'_ /1!4?\ $+C_ ,$*/^C&?_-F?VP__H@J/^(H[_@A1_T?-_YK
M-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\ ^A]H /\ B%Q_X(4?]&,_^;,_
MMA__ $05'_$+C_P0H_Z,9_\ -F?VP_\ Z(*C_B*._P""%'_1\W_FLW[8?_T/
MM'_$4=_P0H_Z/F_\UF_;#_\ H?: #_B%Q_X(4?\ 1C/_ )LS^V'_ /1!4?\
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M_P""%'_1\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\ H?: #_B%Q_X(4?\
M1C/_ )LS^V'_ /1!4?\ $+C_ ,$*/^C&?_-F?VP__H@J/^(H[_@A1_T?-_YK
M-^V'_P#0^T?\11W_  0H_P"CYO\ S6;]L/\ ^A]H _S@_P#@O5^RY\"?V+O^
M"L7[5G[-'[-'@;_A6OP2^&O_  HS_A"O!7_"3>,?&/\ 8O\ PF/[-OP=\?\
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M*#)_XA6O_P!%E0!_(%_P]F_X*G_])*_V^_\ Q,/]H7_YX='_  ]F_P""I_\
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M\H*/V&?^[F?_ %L/]H*@#]_J*** "OX _P#@^<_YQ=?]WL_^^CU_?Y7\ ?\
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M  7?M%?_ $?U'_$.)_P5-_Z6</V__P#P7?M%?_1_5^_W_#V+_@EE_P!)+/V
M/_$R/V=?_GC4?\/8O^"67_22S]@#_P 3(_9U_P#GC4 ?Y<G_  <+?L4_'W]A
M#]M#X8_"+]HS]NKXP?\ !07QMXC_ &8/!?Q'TOXS?&N'QI!XJ\,^%=7^*WQJ
M\,6/PQT]/'7Q?^-6KGP_HVK^#]<\56K6_BK3]..H^--5$/A^UN1>:CJOZ/\
M_!E3_P I3?CY_P!F ?%/_P!:*_95KQ__ (.Z_P!H7X!?M*?\%)/@EXZ_9S^.
M/P?^/W@G2?V(/AMX3U3QC\%/B7X+^*GA73?%5C\>?VE=8OO#.H>(? NM:]I%
MGX@L](UW0]4NM&N+R/4;?3M9TJ^FMDMM1LY9O8/^#*G_ )2F_'S_ +, ^*?_
M *T5^RK0!_I]T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P7Q4^&/@?XV
M?##XD?!GXG:)_P )-\-OBYX"\8?#'XA>&_[2U?1O^$@\#^/?#VH^%?%FB?VQ
MX?U#2=>TG^UM!U;4+#^TM$U33=7L?M'VK3=0L[V*&XC[VB@#_!2^,/PL\>?
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MO^SK_P#.YK\ ?^(CO_@J;_TK'_M__P#@Q_:*_P#H :/^(CO_ (*F_P#2L?\
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M_LZ__.YH_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:_ '_B([_X*F_]*Q_[?_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 445_-3_P=#?\%0O%/_!._P#8+LO
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MT?V;9^3[_10!_G!_\'E/[)W[+'[+_P#P[C_X9H_9I_9__9W_ .$X_P"&OO\
MA-?^%%_!OX=?"3_A,/\ A&?^&7O^$;_X2G_A /#GA_\ X2#_ (1__A(->_L3
M^UOM?]E?VWJ_V#[/_:5YYW]/W_!KC_R@H_89_P"[F?\ UL/]H*OP!_X/G/\
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M^Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBO,?BI\;/@S\"M%TCQ)\;OBY\,?@YX=\0>(;;PCH.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M .EIT ?U^T5_(%_PQO\ \'DG_26+]@#_ ,-SX&_^EIT?\,;_ /!Y)_TEB_8
M_P##<^!O_I:= ']?M%?R!?\ #&__  >2?])8OV /_#<^!O\ Z6G1_P ,;_\
M!Y)_TEB_8 _\-SX&_P#I:= ']?M%?R!?\,;_ /!Y)_TEB_8 _P##<^!O_I:=
M'_#&_P#P>2?])8OV /\ PW/@;_Z6G0!_(%_P='?\IU_VYO\ NV;_ -8\_9]K
M]_O^#&/_ )RB_P#=DW_OW%?RA?\ !9GP;^V3\/\ _@I/^TAX1_X*!?%CX?\
MQQ_:ZTC_ (4__P +;^*7PMTVQTCP)XH^W_ 7X7:GX#_L+3]-^&GP?LK?^Q/A
ME>^#/#NI^3\.O#OFZQI&H3R?VO-+)KNI_P!7O_!C'_SE%_[LF_\ ?N* /[_*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO?&?B+3/.^(OAWS=8TC3X(_[7FECT+4_[O/^&R/^#R3_ *1._L ?^'&\#?\
MTRR@#^OVBOY O^&R/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'
M&\#?_3+* /Z_:*_D"_X;(_X/)/\ I$[^P!_X<;P-_P#3+*/^&R/^#R3_ *1.
M_L ?^'&\#?\ TRR@#^OVBOY O^&R/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R
M3_I$[^P!_P"'&\#?_3+* /Z_:*_D"_X;(_X/)/\ I$[^P!_X<;P-_P#3+*/^
M&R/^#R3_ *1._L ?^'&\#?\ TRR@#^OVBOY O^&R/^#R3_I$[^P!_P"'&\#?
M_3+*/^&R/^#R3_I$[^P!_P"'&\#?_3+* /Z_:*_D"_X;(_X/)/\ I$[^P!_X
M<;P-_P#3+*/^&R/^#R3_ *1._L ?^'&\#?\ TRR@#^OVBOY O^&R/^#R3_I$
M[^P!_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'&\#?_3+* /Z_:*_D"_X;(_X/
M)/\ I$[^P!_X<;P-_P#3+*/^&R/^#R3_ *1._L ?^'&\#?\ TRR@#^OVBOY
MO^&R/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'&\#?_3+* /P!
M_P"#U;_E*;\ _P#LP#X6?^M%?M54?\&5/_*4WX^?]F ?%/\ ]:*_95K\X/\
M@X6^)?\ P4N^*G[:'PQ\0_\ !5']GKX/_LU_M!V?[,'@O1O!W@7X*:UI.O>%
M=6^#5O\ %;XU7WA[Q9J%YH_QQ^/UM'X@OO&VH_$/1[JVD\8Z;.FG:%I4K>&;
M..:+5-9_1_\ X,J?^4IOQ\_[, ^*?_K17[*M '^GW1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?,_[:?P
M9\4?M'?L<?M9_L]>"+_0=*\:?'C]F?X\?!GPAJ?BJZU"Q\+Z;XH^*'PM\5>"
M- O_ !)>Z1I>N:K9Z#9ZKKEI<:Q=:9HFL:A;Z?'<2V6EZA<I%:3?3%% ;'^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC^H_XAQ/^"IO_2SA^W__ ."[]HK_ .C^H _K]HK^0+_B'$_X*F_]+.'[?_\
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M77ASX676K^-_B/X?^)\/@S^B[_@NK_P5V\?? 3Q7>?L$?LW'Q?\ #?XL>)?
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M8/\ ;^A?VU_97VO^R_[:TG[=Y']HV?G?PU?\'-/_  <0?&+P?\8O&7_!./\
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M^D:>-;\%?M ^,_%7B?4[+^Q]-\2^)KW3#X!^)4/Q ^%?VCQ"^B:OXI_X0/\
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M%_[LF_\ ?N*_O\K^ /\ X,8_^<HO_=DW_OW%?W^4 %%%% 'P!_P5B_Y19?\
M!2S_ +, _;(_]9U^(U?X@U?[?/\ P5B_Y19?\%+/^S /VR/_ %G7XC5_B#4
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M_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?:^_\ _AT[_P $LO\ I&G^P!_XAO\
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M_B&_[.O_ ,[FC_AT[_P2R_Z1I_L ?^(;_LZ__.YH ^ /^(H[_@A1_P!'S?\
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M&G^P!_XAO^SK_P#.YH_X=._\$LO^D:?[ '_B&_[.O_SN: /@#_B*._X(4?\
M1\W_ )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^A]K[_P#^'3O_  2R_P"D
M:?[ '_B&_P"SK_\ .YH_X=._\$LO^D:?[ '_ (AO^SK_ /.YH _RA/\ @O5^
MU'\"?VT?^"L7[5G[2_[-'CG_ (65\$OB5_PHS_A"O&O_  C/C'P=_;7_  AW
M[-OP=\ >(_\ BG/'_A[PKXMT[^SO%OA77M)_XFV@V'VS[!]OL/M6F75E>W']
M/W_!C'_SE%_[LF_]^XK^<'_@X\^$_P +/@=_P6<_;)^%OP4^&GP_^#_PR\+_
M /#//_",_#KX6^#?#GP_\">'?[;_ &5/@;XBUG^PO"/A/3=(\/Z1_:_B#5]5
MUW4_[/T^W^WZQJ>H:G=>;>WMS/+_ $??\&,?_.47_NR;_P!^XH _O\HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&4W_ "D__:%_[,+^(W_K0G[,E?Z>%?,/P4_8D_8Q_9J\4:CXW_9S_9%_9A^
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M/[8?_P!$%1_Q"X_\$*/^C&?_ #9G]L/_ .B"H ^__P#A[%_P2R_Z26?L ?\
MB9'[.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&KX _XA<?\ @A1_T8S_
M .;,_MA__1!4?\0N/_!"C_HQG_S9G]L/_P"B"H ^_P#_ (>Q?\$LO^DEG[ '
M_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&KX _XA<?^"%'_ $8S_P";
M,_MA_P#T05'_ !"X_P#!"C_HQG_S9G]L/_Z(*@#[_P#^'L7_  2R_P"DEG[
M'_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\ \\:O@#_B%Q_X(4?]&,_^
M;,_MA_\ T05'_$+C_P $*/\ HQG_ ,V9_;#_ /H@J /XHO\ @[K_ &A?@%^T
MI_P4D^"7CK]G/XX_!_X_>"=)_8@^&WA/5/&/P4^)?@OXJ>%=-\56/QY_:5UB
M^\,ZAXA\"ZUKVD6?B"STC7=#U2ZT:XO(]1M].UG2KZ:V2VU&SEF]@_X,J?\
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M_$1W_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M%?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^[F?_6P_P!H*@#]_J*** "OX _^#YS_ )Q=?]WL_P#OH]?W^5_ '_P?.?\
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M_HJJ_K]HH _D"_XC5O\ @EE_T0/]O_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\
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MZV^,/@WX;^)]=T^:^B3PY!JOA[Q1IFB?JS_Q&K?\%3?^B!_L ?\ AK/VBO\
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M^(YS_K%U_P";L_\ Y(]/2R[ZW_0D_O\ **_@#_XCG/\ K%U_YNS_ /DCT?\
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M .F64?\ #9'_  >2?](G?V /_#C>!O\ Z997]?M% '\@7_#9'_!Y)_TB=_8
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M-_ZQY^S[7[_?\&,?_.47_NR;_P!^XH _O\HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*BU:\TO6]&_UD:I]/-?=9M?I]V@K[^3_ $3_ %"BBBD 4444 %%%% !1110
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M\@7_  QO_P 'DG_26+]@#_PW/@;_ .EIT?\ #&__  >2?])8OV /_#<^!O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0_$?BS4K:T\,>&M?U?3?Y0OVH/\ @]>_9"^'?BE?#W[*7[)_QA_:9TK3=?\
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M],M+33?#'@/POX!\!>#9OK;^EZ_IW*MU^[S?;_/M\T?ZV9_X*P?\$M VT_\
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M67_!2S_LP#]LC_UG7XC5_B#5_M\_\%8O^467_!2S_LP#]LC_ -9U^(U?X@U
M'^BY^Q%_P0,_X*2?&/\ 8O\ V1/B[X%_X.(OVW_@GX)^*G[,'P"^(_@[X,^$
M[#X\OX5^$?A7QQ\*?"?B?P]\,?#+Z/\ MO>$](;P_P" M(U2S\*Z,VE^%?#6
MG-IVDVQL?#^C6QBTZV^G_P#B'$_X*F_]+.'[?_\ X+OVBO\ Z/ZOT?\ ^"9/
M_!3;_@FWX"_X)M_\$^? OCK_ (*#?L0>"_&W@O\ 8@_90\)^,?!WBS]J_P"
MWASQ5X3\5>'/@-X!T?Q#X9\3>'M8\?6>KZ#X@T+5[.\TO6=&U2SM=1TO4;6Y
ML;ZV@N8)8E^W_P#A[%_P2R_Z26?L ?\ B9'[.O\ \\:@#\ ?^(<3_@J;_P!+
M.'[?_P#X+OVBO_H_J/\ B'$_X*F_]+.'[?\ _P""[]HK_P"C^K]_O^'L7_!+
M+_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"DEG[ '_B9'[.O_P \:@#\ ?\
MB'$_X*F_]+.'[?\ _P""[]HK_P"C^H_XAQ/^"IO_ $LX?M__ /@N_:*_^C^K
M]_O^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\
M\\:@#\ ?^(<3_@J;_P!+.'[?_P#X+OVBO_H_J/\ B'$_X*F_]+.'[?\ _P""
M[]HK_P"C^K]_O^'L7_!++_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"DEG[
M'_B9'[.O_P \:@#\ ?\ B'$_X*F_]+.'[?\ _P""[]HK_P"C^H_XAQ/^"IO_
M $LX?M__ /@N_:*_^C^K]_O^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P
M2R_Z26?L ?\ B9'[.O\ \\:@#\ ?^(<3_@J;_P!+.'[?_P#X+OVBO_H_J/\
MB'$_X*F_]+.'[?\ _P""[]HK_P"C^K]_O^'L7_!++_I)9^P!_P")D?LZ_P#S
MQJ/^'L7_  2R_P"DEG[ '_B9'[.O_P \:@#\ ?\ B'$_X*F_]+.'[?\ _P""
M[]HK_P"C^H_XAQ/^"IO_ $LX?M__ /@N_:*_^C^K]_O^'L7_  2R_P"DEG[
M'_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\ \\:@#\ ?^(<3_@J;_P!+
M.'[?_P#X+OVBO_H_J/\ B'$_X*F_]+.'[?\ _P""[]HK_P"C^K]_O^'L7_!+
M+_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"DEG[ '_B9'[.O_P \:@#\ ?\
MB'$_X*F_]+.'[?\ _P""[]HK_P"C^H_XAQ/^"IO_ $LX?M__ /@N_:*_^C^K
M]_O^'L7_  2R_P"DEG[ '_B9'[.O_P \:C_A[%_P2R_Z26?L ?\ B9'[.O\
M\\:@#\ ?^(<3_@J;_P!+.'[?_P#X+OVBO_H_J/\ B'$_X*F_]+.'[?\ _P""
M[]HK_P"C^K]_O^'L7_!++_I)9^P!_P")D?LZ_P#SQJ/^'L7_  2R_P"DEG[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
MEW?\':G_  2LT[]D#]K+1OVV/@SX<U^#X&?MJZ_XS\0?$Z2:]\4>)M.\$_M9
M76M:EXN^($<^KWWAT:3X1T#XT:3K"?$#P%X6U'QSXAUK4?%7A_X[1^&M'\+?
M#KPAX:T#2_Y&*_WN_B=\*OA?\;? VN?#'XS?#?P%\7/AKXF_LW_A)/AY\3O!
M_A[Q]X&\0_V-J^G^(-'_ +<\)^*M.U;0-6_LG7M)TO6]-^WZ?<?8=7TW3]2M
M?*O;.WFC_E,_X+G_ /!M>_[=%M^S##_P39^%O[ _[(C?#&;XS2?&9G\#'X"#
MX@KXQ3X5K\/!_P 6%^!?BP^*SX4/A;QR?^*J^P#0O^$D/]AFZ_MC5_LZVV[Z
M+LO^!J_P0V[[Z:??9:??HG]Y_E[T5_H#_P#!+'_@TM_:F_96_;J^"GQU_;1U
M;]@;]H;]FKP7#\2XOB/\($N_B+\5SXM;Q-\)?'7A3P>?^$ ^*_[.7A_P#KXT
M#QYKGA?Q-_Q/=7M#I9T8:UI?GZSIVGVTW]?G_#JO_@E__P!(W_V"O_$/OV>O
M_G=TQ'^'Y2JK.P55+,QP%4$L3Z #))]A7^X%_P .J_\ @E__ -(W_P!@K_Q#
M[]GK_P"=W7TS\&/@!\!_V<?"]_X'_9Y^"?PC^ W@O5=?NO%6I^$/@Q\-_!OP
MN\+ZCXHOM/TO2+WQ)?\ A_P/HVAZ3>:_>:5H>B:9=:Q<6DFHW&GZ/I=E+</;
M:?:10@'\0_\ P:)?\$=_C-\*O$UY_P %2?VC?!^A>$?#?CSX1:SX*_9,\">-
MO",%]\2[_2_'6H^&K_5/VF]'N=3*77PMT+6O!FE:S\/?AQ>0V9\5?%7X?_$7
MQOXAB;P_\+-5\)ZG\7?[U*^!_P!G[_@J)^P#^U;^T5X\_94_9I_:>^'WQU^-
M?PT\!?\ "SO%VD?"Z/Q'XQ\$6W@=;KP183ZWH_QET;0KKX,>+39:E\1?"6E:
MEIGA'X@:YK&F:O>ZAI.H:?;:CX=\26ND_?%-N]NEDDEY?\&]WYL+6^>O]?*P
M4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /X _P#@
M^<_YQ=?]WL_^^CU^_P!_P:X_\H*/V&?^[F?_ %L/]H*OP!_X/G/^<77_ '>S
M_P"^CU^_W_!KC_R@H_89_P"[F?\ UL/]H*@#]_J*** "OX _^#YS_G%U_P!W
ML_\ OH]?W^5_ '_P?.?\XNO^[V?_ 'T>@#^4+_@C/^Q3\+/^"B7_  4G_9P_
M8Z^->O\ Q \+_#+XP?\ "X/^$FUWX6ZKX<T3QW8_\*_^ OQ1^*6C?V%J?BSP
MIXV\/VWVGQ!X)TJSU/\ M#PQJ?G:/<:A;VOV*]EMM0M/[O/^(*G_ ()9?]%\
M_;__ /#I_LZ__0JU_$%_P05_:C^!/[%W_!6+]E/]I?\ :7\<_P#"M?@E\-?^
M%Y_\)KXU_P"$9\8^,?[%_P"$Q_9M^,7@#PY_Q3G@#P]XJ\6ZC_:/BWQ5H.D_
M\2G0;_[']O\ M]_]ETRUO;VW_P!'S_B*._X(4?\ 1\W_ )K-^V'_ /0^T ?
M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*
MM??_ /Q%'?\ !"C_ */F_P#-9OVP_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#
M[0!\ ?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?
M[.O_ -"K7W__ ,11W_!"C_H^;_S6;]L/_P"A]H_XBCO^"%'_ $?-_P":S?MA
M_P#T/M 'P!_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\
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M]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K7W_P#\11W_  0H_P"CYO\
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M6@#_ $^Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.B_\4]_PD'_"JQXG_P")D?"-.6G*_*WWRM_PQ,=>9=W>_:T=/EKK^'8^7?\
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MH.I^*[J*[BTZ^\47FL7ND:7H>E7%EHFG_DX)YEB,*RR+$6+M&KL$9R NYE!
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M=O+S1OLWQ(^$_P 9O&WBSP[::!HGAV+5O'T'B2PO-:U_Q5XK_LS^S.OX"/\
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M]L/_ .A]H /^(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\
MH@J/^(H[_@A1_P!'S?\ FLW[8?\ ]#[1_P 11W_!"C_H^;_S6;]L/_Z'V@ _
MXA<?^"%'_1C/_FS/[8?_ -$%1_Q"X_\ !"C_ *,9_P#-F?VP_P#Z(*C_ (BC
MO^"%'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]H /^(7'_ ((4
M?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\ H@J/^(H[_@A1_P!'S?\
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M^U9^TO\ LT>.?^%E?!+XE?\ "C/^$*\:_P#",^,?!W]M?\(=^S;\'? 'B/\
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M/;YI?>TG\^WF..^U[)NWIM?RO:_EVW/Y/OVF/^"AG[<_[8[ZO#^T]^UI\?\
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MPBM-9\/^&_AI\/-3^%OP[\*_UY42W^2_):^CW1*ZOOKZ:)6_ ****0PHHHH
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M)9?](T_V /\ Q#?]G7_YW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<U^ /\
MQ$=_\%3?^E8_]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\ _!C^T5_]
M #0!^_W_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T?\.G?^"67_2-/]@#_ ,0W
M_9U_^=S7X _\1'?_  5-_P"E8_\ ;_\ _!C^T5_] #1_Q$=_\%3?^E8_]O\
M_P#!C^T5_P#0 T ?O]_PZ=_X)9?](T_V /\ Q#?]G7_YW-'_  Z=_P""67_2
M-/\ 8 _\0W_9U_\ G<U^ /\ Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 T?\1'?_
M  5-_P"E8_\ ;_\ _!C^T5_] #0!^_W_  Z=_P""67_2-/\ 8 _\0W_9U_\
MG<T?\.G?^"67_2-/]@#_ ,0W_9U_^=S7X _\1'?_  5-_P"E8_\ ;_\ _!C^
MT5_] #1_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 T ?O]_PZ=_X)9?](T_V /\
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MU_\ G<U^ /\ Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/V6S^U'_ ,$<OVH(-'\$?\)MX_\ @#%X3_:<^'P_X23_ (1S_A$G^$VN1/\
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M5XETY=.U:V%CX@UFV$6HW/T__P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\ 0 T
M?O\ ?\.G?^"67_2-/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3_8 _\0W_ &=?
M_G<U^ /_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]O_\
M\&/[17_T - '[_?\.G?^"67_ $C3_8 _\0W_ &=?_G<T?\.G?^"67_2-/]@#
M_P 0W_9U_P#G<U^ /_$1W_P5-_Z5C_V__P#P8_M%?_0 T?\ $1W_ ,%3?^E8
M_P#;_P#_  8_M%?_ $ - '[_ '_#IW_@EE_TC3_8 _\ $-_V=?\ YW-'_#IW
M_@EE_P!(T_V /_$-_P!G7_YW-?@#_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\
M0 T?\1'?_!4W_I6/_;__ /!C^T5_] #0!^_W_#IW_@EE_P!(T_V /_$-_P!G
M7_YW-'_#IW_@EE_TC3_8 _\ $-_V=?\ YW-?@#_Q$=_\%3?^E8_]O_\ \&/[
M17_T -'_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #0!^_P!_PZ=_X)9?](T_
MV /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S7X _\ $1W_ ,%3
M?^E8_P#;_P#_  8_M%?_ $ -'_$1W_P5-_Z5C_V__P#P8_M%?_0 T ?O]_PZ
M=_X)9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S7X _
M\1'?_!4W_I6/_;__ /!C^T5_] #1_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\
M0 T ?O\ ?\.G?^"67_2-/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3_8 _\0W_
M &=?_G<U^ /_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]
MO_\ \&/[17_T - '[_?\.G?^"67_ $C3_8 _\0W_ &=?_G<T?\.G?^"67_2-
M/]@#_P 0W_9U_P#G<U^ /_$1W_P5-_Z5C_V__P#P8_M%?_0 T?\ $1W_ ,%3
M?^E8_P#;_P#_  8_M%?_ $ - '[_ '_#IW_@EE_TC3_8 _\ $-_V=?\ YW-'
M_#IW_@EE_P!(T_V /_$-_P!G7_YW-?@#_P 1'?\ P5-_Z5C_ -O_ /\ !C^T
M5_\ 0 T?\1'?_!4W_I6/_;__ /!C^T5_] #0!_&%_P ''GPG^%GP._X+.?MD
M_"WX*?#3X?\ P?\ AEX7_P"&>?\ A&?AU\+?!OASX?\ @3P[_;?[*GP-\1:S
M_87A'PGIND>'](_M?Q!J^JZ[J?\ 9^GV_P!OUC4]0U.Z\V]O;F>7^C[_ (,8
M_P#G*+_W9-_[]Q7\H7_!9G]H_P"*?[6__!2?]I#]H3XU_LQ_$#]C?XF_$#_A
M3_\ PDW[-_Q2D\1R^._AS_PBGP%^%W@C1O[=D\6?#_X7>(&_X2_P_P"&]*\>
M:9_:'@30L:/XHT];7^T[(6VL:A_5[_P8Q_\ .47_ +LF_P#?N* /[_**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _%_P#:R_X(5?L=?M??
MM'>-OVG_ !IXN^/W@'X@?$O3?"%O\0]+^&/C'P):^%/%^N^"?#6G>!]$\8WM
MGX]^&'Q!US2M='@3P_X1\(7.G^&/$.A>#9-/\)Z;J\7A2#Q;JWB[Q'XE_G+_
M ."B'_!$S5/^"?7[,E_^T%JO[9OPA^(NI6'BK3O#5AX#\8_#/Q;\#=4^(FIZ
MKH7B*_TKP3\'D\/^+OVB=3\<?%G6]4T:V33O"FJ:5X1\&Z/X,C\:_$[X@_$O
MP)X$^''B36J_M,_:P_:>^&'[&?[/7Q,_:6^,1\22> /AAI>F76H:=X-T*;Q)
MXM\1:UXD\1:/X,\%^$/#.D)-9V<NO>,_&WB/P[X3TF\U[5- \)Z3?:S!JWC+
MQ/X7\*6.L^(M,_SGOVT_VV/CG^W[\;[KXY_'&ZBTB'3[34M ^$?P=T+5;G4O
M 7P&\ :G=V5[<^$O#-Q/:Z<?$GBSQ#/I6C:E\6/BM?Z5INO?$_Q%I&D[=,\)
M_#OPA\,/AG\/?Y]\9:/AKD>#JYCG/#F!S/B?-5-X##T:^+P&)Q-6$53>/Q];
M+\1AJCPM"T>>=1RGBJD50IN[J5:/^O\ ^S7S'Z;OBEQ'E_!?AGXS<5<$>!O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?L ?^&Y\#?\ TM.@#^OVBOY O^&-_P#@\D_Z2Q?L ?\ AN? W_TM.C_AC?\
MX/)/^DL7[ '_ (;GP-_]+3H _K]HK^0+_AC?_@\D_P"DL7[ '_AN? W_ -+3
MH_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ /Z_:*_D"_X8W_ .#R3_I+%^P!_P"&
MY\#?_2TZ/^&-_P#@\D_Z2Q?L ?\ AN? W_TM.@#^OVBOY O^&-_^#R3_ *2Q
M?L ?^&Y\#?\ TM.C_AC?_@\D_P"DL7[ '_AN? W_ -+3H _K]HK^0+_AC?\
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M\0]8NKF3P=J4[Z=KNE1-XFO(X8M+T;]'_P#@RI_Y2F_'S_LP#XI_^M%?LJT
M?Z?=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6#XJ\5>%_ GA?Q)XW\;^)-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX1/P;I!:77O'OCW4]!\,Z_?>'/AYX(TOQ!XY\5'2KNT\->'M6O8_LQ_SJ?\
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M\<?L)^-[+]NW]NVR70_VKM$7QCX=^!OP-\.^,='U_1O@GHNOZ/KG@/Q1X_\
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M]4^&G@GQ/X732?BCXD\.:EJ_AG1/$O\ L)452=NE_7;[NO?MW30C@?A3\+_
MOP0^%WPV^"_POT(>%_AI\(? /@[X7_#OPT-2U?61X=\"^ /#NG>%/"6A#5_$
M%_JNO:J-(T#2=/T\:EK>J:EJ]\+?[5J5_>7DLUQ)WU%%( K\ ?\ @Z._Y04?
MMS?]VS?^MA_L^U^_U?@#_P '1W_*"C]N;_NV;_UL/]GV@#\ ?^#&/_G*+_W9
M-_[]Q7]_E?P!_P#!C'_SE%_[LF_]^XK^_P H **** /@#_@K%_RBR_X*6?\
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M^_\ #WP^\$Z7H'@GPQ_:MY:^'- TNSD^SCY[ ). "2>@ R3^ I*_5+T^[?\
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M!!QZ\UZ%\*?B[\5O@3X]T+XI_!+XF>/_ (/_ !-\,?VE_P (W\0_A?XQ\0^
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MJT?\05/_  2R_P"B^?M__P#AT_V=?_H5: /Z_:*_D"_X@J?^"67_ $7S]O\
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MSN]+UC1]3M+74-,U"UN+*]MX+F"6)?M?_AZK_P $OO\ I)#^P3_XF#^SU_\
M/$JVM6DG;;9W>V_KIILM"4GO9W?EM=+1?A]Y][45\S?!C]M7]C;]H_Q1?^"/
MV>/VM?V9?CSXTTK0+KQ5JGA#X,?'GX6?%'Q1IOA>QU'2](O?$E_H'@?Q5KFK
M6>@6FK:YHNF76L7%I'IUOJ.L:792W"7.H6D4WTS4@%%%% !7YD?\%C_VT?BC
M_P $\_\ @F]^TA^V%\&- \ ^*/B7\'H?A1)X:T+XGZ7XAUGP-?GQU\<?AG\,
M]7&N:;X4\4^"]?N1;Z#XSU2[TW[!XFTPPZO!87%U]LLXKBPNOYIO^#LCP/\
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M;Z=-B5_G^>G_  .^X4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG^SK_P#0JT ?U^T5_(%_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\9SZ3XSO?#UA\/O%O^MM^S5^P%^Q%^QRFDR_LN_LH? +X':YI'@*Q^&(\<>
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M ()@_M#_  %\;_LI:(/ G[.O[3G@7Q1'I'PLOO''B[QSJO@3XI_!NX\,:?\
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MY_SBZ_[O9_\ ?1Z_O\K^ /\ X/G/^<77_=[/_OH] '\P/_!!7]J/X$_L7?\
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MF@#X _XBCO\ @A1_T?-_YK-^V'_]#[1_Q%'?\$*/^CYO_-9OVP__ *'VOO\
M_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:/^'3O_!++_I&G^P!_XAO^SK_\[F@#
MX _XBCO^"%'_ $?-_P":S?MA_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?:^_\
M_AT[_P $LO\ I&G^P!_XAO\ LZ__ #N:/^'3O_!++_I&G^P!_P"(;_LZ_P#S
MN: /@#_B*._X(4?]'S?^:S?MA_\ T/M'_$4=_P $*/\ H^;_ ,UF_;#_ /H?
M:^__ /AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\ P2R_Z1I_L ?^(;_LZ_\
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MH\W]I_9;?4);VRU"VM/K_P#X,J?^4IOQ\_[, ^*?_K17[*M>/_\ !W7^SU\
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M&_Z. _\ ,5?!+_YV]'_#VS_@H-_T<!_YBKX)?_.WK]'/^(?S_J[7_P P-_\
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M5?!+_P"=O1_P]L_X*#?]' ?^8J^"7_SMZ\X_81_8^_X;8^+OB/X5_P#"Q/\
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MZHT445_H(?ZBA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\36HSK86GC,5"A.$<164RBBBMCS@HHHH **** "BBB@ HHHH **** "BBB@
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M1U&VMO!_C/P]X>^*6M^.?"WC>_?POJ_A*VU'P]XS3PS^?G_$:I_P2P_Z(/\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^
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M/[8?_P!$%1_Q"X_\$*/^C&?_ #9G]L/_ .B"H ^__P#A[%_P2R_Z26?L ?\
MB9'[.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&KX _XA<?\ @A1_T8S_
M .;,_MA__1!4?\0N/_!"C_HQG_S9G]L/_P"B"H ^_P#_ (>Q?\$LO^DEG[ '
M_B9'[.O_ ,\:C_A[%_P2R_Z26?L ?^)D?LZ__/&KX _XA<?^"%'_ $8S_P";
M,_MA_P#T05'_ !"X_P#!"C_HQG_S9G]L/_Z(*@#[_P#^'L7_  2R_P"DEG[
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M_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'&\#?_3+*_K]HH _D"_X;(_X/)/\
MI$[^P!_X<;P-_P#3+*/^&R/^#R3_ *1._L ?^'&\#?\ TRROZ_:* /Y O^&R
M/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'&\#?_3+*_K]HH _D
M"_X;(_X/)/\ I$[^P!_X<;P-_P#3+*/^&R/^#R3_ *1._L ?^'&\#?\ TRRO
MZ_:* /Y O^&R/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R3_I$[^P!_P"'&\#?
M_3+*_K]HH _D"_X;(_X/)/\ I$[^P!_X<;P-_P#3+*/^&R/^#R3_ *1._L ?
M^'&\#?\ TRROZ_:* /Y O^&R/^#R3_I$[^P!_P"'&\#?_3+*/^&R/^#R3_I$
M[^P!_P"'&\#?_3+*_K]HH _D"_X;(_X/)/\ I$[^P!_X<;P-_P#3+*/^&R/^
M#R3_ *1._L ?^'&\#?\ TRROZ_:* /Y O^&R/^#R3_I$[^P!_P"'&\#?_3+*
M/^&R/^#R3_I$[^P!_P"'&\#?_3+*_K]HH _QY?\ @X6^)?\ P4N^*G[:'PQ\
M0_\ !5']GKX/_LU_M!V?[,'@O1O!W@7X*:UI.O>%=6^#5O\ %;XU7WA[Q9J%
MYH_QQ^/UM'X@OO&VH_$/1[JVD\8Z;.FG:%I4K>&;..:+5-9_1_\ X,J?^4IO
MQ\_[, ^*?_K17[*M'_!ZM_RE-^ ?_9@'PL_]:*_:JH_X,J?^4IOQ\_[, ^*?
M_K17[*M '^GW1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7\G/_!=S_D[KX=?]FX^$?_5F_%^OZQJ_DY_X+N?\G=?#K_LW'PC_ .K-^+]?
MR_\ 2]_Y,UC?^R@R'_T_5/XW^G;_ ,F!S'_LJ.&O_4FL'_!"/_D[KXB_]FX^
M+O\ U9OP@K^L:OY.?^"$?_)W7Q%_[-Q\7?\ JS?A!7]8U'T0O^3-8+_LH,^_
M]/T@^@E_R8'+O^RHXE_]2:(4445_4!_9 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7XE?\'#/[<VL?L"_\$J_VA/B9X$\
M8#P3\:OBG'HO[.WP*UB&/QQ!J]OX\^+$EU:>)-7\)^(_ =]H^I>!_'G@?X-:
M3\5?B7\/O&>HZ_HND:)XX\$^'V>36M2GTSPKX@_;6OYZ_P#@Z#_9$U+]K7_@
MD!\=Y_#-CK^K>-_V7M:\-_M:^%='T?7/#&A:??6/PKM->T/XKW?BF3Q1$J:G
MH7A;X!^./BWXVMM"T+4]'\3ZOXI\,^&[31)=;N7/A#Q(GL_0<?BCMNM]M^OE
MW/\ (>)>5R26DDD;))R[N[G\69F8^Y)/K7Z!I_P25_X*HNH8?\$U?V^ #V?]
MD#]H&-OQ5_A\K#\0*^PO^#;3_A5?_#[/]A+_ (7#_P (#_PBW_";_$/^P_\
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M_*_@#_X,8_\ G*+_ -V3?^_<5_?Y0 4444 ? '_!6+_E%E_P4L_[, _;(_\
M6=?B-7^(-7^WS_P5B_Y19?\ !2S_ +, _;(_]9U^(U?X@U '^BY^Q%_P=U_\
M$V_V:_V+_P!D3]G/QU\$OVW]6\;? ']F#X!?!3QCJGA/X;? :^\*ZEXJ^%?P
MI\)^!?$.H>&;[6/VE=!U>\\/WFKZ%>7&C76J:'HVHW&G26TU]I6G7+RV</T_
M_P 1JW_!++_H@?[?_P#X:S]G7_Z*JOW^_P""3O\ RBR_X)I_]F ?L;_^LZ_#
MFOO^@#^0+_B-6_X)9?\ 1 _V_P#_ ,-9^SK_ /154?\ $:M_P2R_Z('^W_\
M^&L_9U_^BJK^OVB@#^0+_B-6_P""67_1 _V__P#PUG[.O_T55'_$:M_P2R_Z
M('^W_P#^&L_9U_\ HJJ_K]HH _D"_P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55
M'_$:M_P2R_Z('^W_ /\ AK/V=?\ Z*JOZ_:* /Y O^(U;_@EE_T0/]O_ /\
M#6?LZ_\ T55'_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JOZ_:* /Y O^(U;_@EE
M_P!$#_;_ /\ PUG[.O\ ]%51_P 1JW_!++_H@?[?_P#X:S]G7_Z*JOZ_:* /
MY O^(U;_ ()9?]$#_;__ /#6?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"B
MJK^OVB@#^0+_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154?\1JW_!++_H@?[?\
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M^<HO_=DW_OW%?@#_ ,'1W_*=?]N;_NV;_P!8\_9]K]_O^#&/_G*+_P!V3?\
MOW% ']_E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$?5L=@Z]#%X.O[/V6)PM:EB*,YTJD)LHHHKH/("BBB@ HHHH **** "BBB@
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M0HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /X _\
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M  7?M%?_ $?U'_$.)_P5-_Z6</V__P#P7?M%?_1_5^_W_#V+_@EE_P!)+/V
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M=?#K_LW'PC_ZLWXOU_+_ -+W_DS6-_[*#(?_ $_5/XW^G;_R8',?^RHX:_\
M4FL'_!"/_D[KXB_]FX^+O_5F_""OZQJ_DY_X(1_\G=?$7_LW'Q=_ZLWX05_6
M-1]$+_DS6"_[*#/O_3](/H)?\F!R[_LJ.)?_ %)HA1117]0']D!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_!'[1W[7/[37Q]\%Z-^Q3X^\5:1X0^,_QV^*'Q/\+Z9XHM/CI^SOI%IXDL-
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M5H=?AU7X>ZU/=6MOHUWIR:?<Z7-#JDUS/=V=C^ZM#M=VVZ?TQ!1112 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OP!_P"#H[_E
M!1^W-_W;-_ZV'^S[7[_5^ /_  ='?\H*/VYO^[9O_6P_V?: /P!_X,8_^<HO
M_=DW_OW%?W^5_ '_ ,&,?_.47_NR;_W[BO[_ "@ HHHH ^ /^"L7_*++_@I9
M_P!F ?MD?^LZ_$:O\0:O]OG_ (*Q?\HLO^"EG_9@'[9'_K.OQ&K_ !!J /\
M1<_8B_:O_P"#L#PY^Q?^R)X>_9S_ ."9/[$'CW]GS0?V8/@%HWP)\=>+/'W@
MVS\5>-/@UI?PI\)V/PP\6>)K.Z_X*#>"[FU\0>(_!,&AZQK-M<>#O"<\&HWE
MS%-X9T*16TNU^G_^&R/^#R3_ *1._L ?^'&\#?\ TRROW^_X)._\HLO^":?_
M &8!^QO_ .LZ_#FOO^@#^0+_ (;(_P"#R3_I$[^P!_X<;P-_],LH_P"&R/\
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M'&\#?_3+*_K]HH _Q1O^"S/C+]LGX@?\%)_VD/%W_!0+X3_#_P"!W[76K_\
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M=^%_$G@CQOX;T#QEX+\9:!K'A7Q?X0\5:/IWB'POXJ\+^(=.N-(U_P -^)-
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MY*>'Y'391117Z(?QJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 %%%% !1110 5_)S_ ,%W/^3NOAU_V;CX1_\
M5F_%^OZQJ_DY_P""[G_)W7PZ_P"S<?"/_JS?B_7\O_2]_P"3-8W_ +*#(?\
MT_5/XW^G;_R8',?^RHX:_P#4FL'_  0C_P"3NOB+_P!FX^+O_5F_""OZQJ_D
MY_X(1_\ )W7Q%_[-Q\7?^K-^$%?UC4?1"_Y,U@O^R@S[_P!/T@^@E_R8'+O^
MRHXE_P#4FB%%%%?U ?V0%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^-I_#+:CIND^.M"BTOQ3XB\/>*?!.N7-K!KOA?Q#K$>A:WX-\9P^%_'7A?\
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MC_@I=^TN?V./^%1#_@G;\"H?C4?!7_#0O_"??\+?$OPZ^.WC_P#X1K_A)/\
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M^#H[_E!1^W-_W;-_ZV'^S[0!^ /_  8Q_P#.47_NR;_W[BO[_*_@#_X,8_\
MG*+_ -V3?^_<5_?Y0 4444 ? '_!6+_E%E_P4L_[, _;(_\ 6=?B-7^(-7^W
MS_P5B_Y19?\ !2S_ +, _;(_]9U^(U?X@U '^BY^Q%^RA_P=@>(_V+_V1/$/
M[.?_  4V_8@\!?L^:]^S!\ M9^!/@7Q9X!\&WGBKP7\&M4^%/A.^^&'A/Q->
M77_!/GQI<W7B#PYX)GT/1]9N;CQCXLGGU&SN99O$VNR,VJ77T_\ \,;_ /!Y
M)_TEB_8 _P##<^!O_I:=?O\ ?\$G?^467_!-/_LP#]C?_P!9U^'-??\ 0!_(
M%_PQO_P>2?\ 26+]@#_PW/@;_P"EIT?\,;_\'DG_ $EB_8 _\-SX&_\ I:=?
MU^T4 ?R!?\,;_P#!Y)_TEB_8 _\ #<^!O_I:='_#&_\ P>2?])8OV /_  W/
M@;_Z6G7]?M% '\@7_#&__!Y)_P!)8OV /_#<^!O_ *6G1_PQO_P>2?\ 26+]
M@#_PW/@;_P"EIU_7[10!_(%_PQO_ ,'DG_26+]@#_P -SX&_^EIT?\,;_P#!
MY)_TEB_8 _\ #<^!O_I:=?U^T4 ?R!?\,;_\'DG_ $EB_8 _\-SX&_\ I:='
M_#&__!Y)_P!)8OV /_#<^!O_ *6G7]?M% '\@7_#&_\ P>2?])8OV /_  W/
M@;_Z6G1_PQO_ ,'DG_26+]@#_P -SX&_^EIU_7[10!_(%_PQO_P>2?\ 26+]
M@#_PW/@;_P"EIT?\,;_\'DG_ $EB_8 _\-SX&_\ I:=?U^T4 ?R!?\,;_P#!
MY)_TEB_8 _\ #<^!O_I:='_#&_\ P>2?])8OV /_  W/@;_Z6G7]?M% '\@7
M_#&__!Y)_P!)8OV /_#<^!O_ *6G1_PQO_P>2?\ 26+]@#_PW/@;_P"EIU_7
M[10!_BC?\%F?!O[9/P__ ."D_P"TAX1_X*!?%CX?_'']KK2/^%/_ /"V_BE\
M+=-L=(\">*/M_P !?A=J?@/^PM/TWX:?!^RM_P"Q/AE>^#/#NI^3\.O#OFZQ
MI&H3R?VO-+)KNI_U>_\ !C'_ ,Y1?^[)O_?N*_ '_@Z._P"4Z_[<W_=LW_K'
MG[/M?O\ ?\&,?_.47_NR;_W[B@#^_P HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _BE_X./?VFOVJ=2^
M/_A_]D3QGH%W\*_V0GT;P]\1?ALEA?S7-G^V%XJT"#P]KFO^*_%NMP1V]A)H
MW[/OC>]L]#TKX ^9<WGA[Q98^&?VA?B##K*^+_V<I_A]^$/[/_P'^)/[3_QI
M^'?[/OP?M- OOB;\4]:O-#\)V_BG7[?PSX=BDTK0-9\6:_J^N:Q+#>74&B>%
M_"/ASQ%XMUV/0]*\0>*+C0]!U*+PKX8\3^(6TW0-1_TY?C;\$OA5^T=\*?''
MP0^-W@K2?B'\+?B-HS:'XM\)ZR;N&"^M5N;>_L+_ $_4],N;#6_#OB3P_K%E
MIWB+PEXN\-ZEI'BOP;XITK1O%7A36=&\1Z/I>J6GQ=^P_P#\$K_V8OV /'WQ
M@^(?P/E\?:MJOQ9ALM)L[?XF:GX2\82?"GP;9>(->\0MX ^&'BR+P5I'Q'M_
M"6J2ZEX<L_$<7COQOX\UOQ5%\-OAWJGB76]6\3:'>Z]JWX'QGX.X_B_C? 9[
MC<^GB\@=2G''9;B$Z>)P.#P\746"RQT(*C*ABZJ<*E2:HXB@ZTZ\IXRI=G^N
M'T9/VD/"/T<_HO\ %WA9PSX2X;(?%NEA,;7X6XSR=T\;DO%O$F;5H83_ %FX
M[IYGB)YG1S3A[ U(XG"X3#SS+)\TIY9ALHPV'X<P<HTU^'__  6X_P""37AK
MX6_LN_!#]HK]FNP,>D_L5?!C2_@M\;?#H\/:M?>,/B1\#H?%B:UIGQHFM/A]
MIEC\/M,\7_"SXA>-OBI\8?CWXBM_AUX*TWQ;X0^*WQ<^+7CCQM8+\)?"WA36
M_P"6WP=XXUWX8>,?"'Q.\+:G:Z'XJ^&?BWPQ\1_"FO7MAH^J6WA[Q7X"UW3_
M !=X9\12:?XALM2T*[;P_KVC:?K,,6KV%YIWGV,;7=M-"K(?]5CQ5X5\+^.O
M"_B3P1XW\-Z#XR\%^,M!UCPKXO\ "'BK1]/\0^%_%7A?Q#I]QI&O^&_$F@:O
M;WFDZYH.N:3>7>F:QH^IVEUI^IZ?=7%E>V\]M/+$WYB?LM_\$6O^"??[)GBQ
M_'/@GX1W'C[Q5I?BNY\2_#G5?C;K4GQ2'P=L[?7O"_B3P9H'PUT[7;8:3977
MPPU?PAI-S\//BIXFL/%/[0&D&751J/Q@U@ZQJ)N#C_P9EQ-Q'DV=\/8W#\/R
MIPHT,UK4X5(5*,,OA3CEN,RZE0Y+XRC2IPPO*ZV'A"G0PTX5(RIS4Y^B%^TM
MAX'>#?B9X8^,/#6=^+M#'XC-,WX"P&,Q&$Q&%S#%<7U\74XTX:XPQ^;/$N'#
MF9XW&8G/IUXY?G.)KXS-,]PU?"5J>.H/#?3'["GQ\^,W[27[-W@[XG?'[]GO
MQM^S7\5+B[UGP[XI\">-='O/#7]L:AX8OFTB[\=>$_"OB&[;X@>%_!7BF^M[
MN?0M"^).DZ-XGLS;7;:9/XY\!R^#/BKX_P#L&BBOW3"4:F'PN'H5<35QE6C0
MI4JF+KJE&OB9TX1A.O6C0ITJ,:E62=2:I4Z=-2DU&$8V1_E3Q#F6#SC/LZS;
M+LDP'#> S/-<?C\%P]E57'5LLR/"8O%5:^'RG+ZV:8O'9C5P>7TJD,)AJF.Q
MN*Q<Z-*$J]>K4<ILHHHKH/'"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "L'Q5X5\+^._"_B3P1XW\-Z!XR\%^,M UCPKX
MO\(>*M'T[Q#X7\5>%_$.G7&D:_X;\2:!J]O>:3KF@:YI-Y=Z9K&CZG:76G:G
MIUU<65[;SVT\L3;U?S$_\''_ /P6F_:E_P""/UM^QU-^S3X"^ /CA_VA)OC_
M !^,Q\<_"WQ$\2KIB_"I/@JWAX^&!X!^*GPR-D;P_$?7/[:_M4ZT+@6NE?81
MIWD7GVX>GX?B[#7EYO[M3^</_@L#_P &E/[17P:\=_$?X\?\$S?#B_'']FR[
M-UXMA_9PB\27-Y^T/\(+=-(\5>(_%>@>#;3Q+Y2_''P!X>_L+3M,^'MKH_BC
M7/VA]?NO%_A_P'_PK_XCZQX>U?XG>*/X_/BG\(OBO\"_'.N?##XV?#'XA?![
MXE>&/[-_X23X>_%+P9XC^'_CCP__ &SI&GZ_HYUOPIXLTW2=>TL:MH.K:5K>
MF&^L(!?Z1J>GZG:&:RO;:>7_ $ /^",/_!SY^WQ_P45_X*1_L\_L>?&SX1_L
M@^%_AG\6H/B]+XCUSX6> ?C/HGCJR;P!\#OB3\3-&&B:GXM^/_C?P_;"YU[P
M=IEIJ8O_  QJ1FTB>_@M397DMO?VO]VM%K)6^76RO:WX>?Z"O=OOU]=_UZ?F
M?X%7A'P?XM^('BGPWX&\!>%O$?C?QKXRU_1_"GA#P?X1T34_$GBGQ5XH\0ZA
M;:3H'AOPWX?T:UO=6US7]<U6\M-,T?1]+M+K4=3U"ZMK*RMI[F>*)OZ8?^"8
M?_!K-_P4 _:\^*7PQ\1?M;?"CQ]^QQ^R/J7]K>(O'GC'QXWAGPS\=M8T?PMX
MA;0KSX=^#/@CXAO+GXE>!O'GC6\MKM/#WBWXN?#O0_!6A^$8KSXE6UMX]B_X
M0SP1\1/]72OY#?\ @Z>_X*J_\% /^"9EO^R%8_L=_%KX>_"_0?C_ "_%2[U[
M5Y?@QX<\<?%#3M7^#">$H-1TU?$GQ,U+QQ\-;OP%XVL_C'X;NCHEK\&='\<>
M&_$/PX%_;_$[5- \8:AX5TLO;6U]M]=WVV?SNO(+-]>_X*^_W_\  W/ZE/@)
M\!/@Y^R[\'/A[^S]^S_\/M ^%OP=^%GA^#PSX%\#>&H9TTW1],BFGO+J>XN[
MV>\U;7->UO5;N_U_Q5XJ\0:AJOBCQAXHU36/%/BG6-8\1:QJFJ7?KU?PE_\
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M!^_U%%% !7\ ?_!\Y_SBZ_[O9_\ ?1Z_O\K^ /\ X/G/^<77_=[/_OH] 'X
M_P#!KC_RG7_89_[N9_\ 6//V@J_U^J_Q1O\ @C/XR_;)^'__  4G_9P\7?\
M!/WX3_#_ ../[76D?\+@_P"%2?"WXI:E8Z1X$\4?;_@+\4=,\>?V[J&I?$OX
M/V5O_8GPRO?&?B+3/.^(OAWS=8TC3X(_[7FECT+4_P"[S_ALC_@\D_Z1._L
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MD_Z1._L ?^'&\#?_ $RRC_ALC_@\D_Z1._L ?^'&\#?_ $RR@#^OVBOY O\
MALC_ (/)/^D3O[ '_AQO W_TRRC_ (;(_P"#R3_I$[^P!_X<;P-_],LH _K]
MHK^0+_ALC_@\D_Z1._L ?^'&\#?_ $RRC_ALC_@\D_Z1._L ?^'&\#?_ $RR
M@#^OVBOY O\ ALC_ (/)/^D3O[ '_AQO W_TRRC_ (;(_P"#R3_I$[^P!_X<
M;P-_],LH _ '_@]6_P"4IOP#_P"S /A9_P"M%?M54?\ !E3_ ,I3?CY_V8!\
M4_\ UHK]E6OS@_X.%OB7_P %+OBI^VA\,?$/_!5']GKX/_LU_M!V?[,'@O1O
M!W@7X*:UI.O>%=6^#5O\5OC5?>'O%FH7FC_''X_6T?B"^\;:C\0]'NK:3QCI
MLZ:=H6E2MX9LXYHM4UG]'_\ @RI_Y2F_'S_LP#XI_P#K17[*M '^GW1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\G/\ P7<_Y.Z^'7_9
MN/A'_P!6;\7Z_K&K^3G_ (+N?\G=?#K_ +-Q\(_^K-^+]?R_]+W_ ),UC?\
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MTC5X_P#_ (IOQ%_^AP\S^W<D_P"ASE7_ (<<)_\ +C]Q**_#O_B)#_X(N_\
M1Y?_ )KO^U;_ /.,H_XB0_\ @B[_ -'E_P#FN_[5O_SC*/\ B4_Z4W_2-7C_
M /\ BF_$7_Z' _MW)/\ H<Y5_P"''"?_ "X_<2BOP[_XB0_^"+O_ $>7_P":
M[_M6_P#SC*/^(D/_ ((N_P#1Y?\ YKO^U;_\XRC_ (E/^E-_TC5X_P#_ (IO
MQ%_^AP/[=R3_ *'.5?\ AQPG_P N/W$HK\._^(D/_@B[_P!'E_\ FN_[5O\
M\XRC_B)#_P""+O\ T>7_ .:[_M6__.,H_P")3_I3?](U>/\ _P"*;\1?_H<#
M^W<D_P"ASE7_ (<<)_\ +C]Q**_#O_B)#_X(N_\ 1Y?_ )KO^U;_ /.,H_XB
M0_\ @B[_ -'E_P#FN_[5O_SC*/\ B4_Z4W_2-7C_ /\ BF_$7_Z' _MW)/\
MH<Y5_P"''"?_ "X_<2BORL_9Y_X+<?\ !+#]J;XE:7\(/@S^V%X&U3XB:]]B
MA\-^'O&_A;XG?!O_ (2O5M4U_1/#&C^%O"&K?&;P/\/]#\6^.==USQ#I=CH'
M@+PWJ>J>-->\R[N='T&]L]+U2XLOU3K\PXS\/>/O#C,J63>(? _&' >;U\/'
M%T,JXSX:SKA?,JV%D^6.)I8'/,%@<54P\I:1K0I2IMZ*5SMPV+PN,@ZF$Q.'
MQ5-/E=3#5J=>"E_*Y4I2BGY-W"BBBOCSH"BBB@ HHHH **** "BBB@ HHHH
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M7RKVSMYH_P#!/L/^/ZR_Z^[;_P!')7^_;5OX5_BE^4"3X&_9\_X)<?\ !/\
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M:;LTK;JWS2E?Y/?1B2Y6[];_ )67DUUO?TN?V@?\&,W_ !X_\%//^OO]C/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?@#_P='?\
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MV'_]#[0!\ ?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
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M ,Y1?^[)O_?N* /[_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M</BG^UO_ ,%)_P!G#]GOX*?M.?$#]C?XF_$#_A<'_",_M(?"V/Q'+X[^'/\
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MW_I9P_;_ /\ P7?M%?\ T?U ']?M%?R!?\0XG_!4W_I9P_;_ /\ P7?M%?\
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M_@_7/%5JUOXJT_3CJ/C351#X?M;D7FHZK^C_ /P94_\ *4WX^?\ 9@'Q3_\
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MK2P>88_#XF-*M%-TJCIJ%1)N#:1^CE%?G'_P]L_X)\_]' ?^8J^-O_SMZ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KX'_X*??L/+_P4A_88^.?[%K?$X_!I?C3'\.8V^)*^"Q\
M0CX;'@#XM^ OBD2/!Y\5^!QJYU<>"/["&?%&F#3_ .U/[4_TW[%_9UW]\44
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MO^'3O_!++_I&G^P!_P"(;_LZ_P#SN:/^'3O_  2R_P"D:?[ '_B&_P"SK_\
M.YK\ ?\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H :/^(CO_@J;_P!*Q_[?_P#X
M,?VBO_H : /W^_X=._\ !++_ *1I_L ?^(;_ +.O_P [FC_AT[_P2R_Z1I_L
M ?\ B&_[.O\ \[FOP!_XB._^"IO_ $K'_M__ /@Q_:*_^@!H_P"(CO\ X*F_
M]*Q_[?\ _P"#']HK_P"@!H _?[_AT[_P2R_Z1I_L ?\ B&_[.O\ \[FC_AT[
M_P $LO\ I&G^P!_XAO\ LZ__ #N:_ '_ (B._P#@J;_TK'_M_P#_ (,?VBO_
M * &C_B([_X*F_\ 2L?^W_\ ^#']HK_Z &@#]_O^'3O_  2R_P"D:?[ '_B&
M_P"SK_\ .YH_X=._\$LO^D:?[ '_ (AO^SK_ /.YK\ ?^(CO_@J;_P!*Q_[?
M_P#X,?VBO_H :/\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H : /W^_X=._\$LO
M^D:?[ '_ (AO^SK_ /.YH_X=._\ !++_ *1I_L ?^(;_ +.O_P [FOP!_P"(
MCO\ X*F_]*Q_[?\ _P"#']HK_P"@!H_XB._^"IO_ $K'_M__ /@Q_:*_^@!H
M _?[_AT[_P $LO\ I&G^P!_XAO\ LZ__ #N:/^'3O_!++_I&G^P!_P"(;_LZ
M_P#SN:_ '_B([_X*F_\ 2L?^W_\ ^#']HK_Z &C_ (B._P#@J;_TK'_M_P#_
M (,?VBO_ * &@#]_O^'3O_!++_I&G^P!_P"(;_LZ_P#SN:/^'3O_  2R_P"D
M:?[ '_B&_P"SK_\ .YK\ ?\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H :/^(CO
M_@J;_P!*Q_[?_P#X,?VBO_H : /W^_X=._\ !++_ *1I_L ?^(;_ +.O_P [
MFC_AT[_P2R_Z1I_L ?\ B&_[.O\ \[FOP!_XB._^"IO_ $K'_M__ /@Q_:*_
M^@!H_P"(CO\ X*F_]*Q_[?\ _P"#']HK_P"@!H _?[_AT[_P2R_Z1I_L ?\
MB&_[.O\ \[FC_AT[_P $LO\ I&G^P!_XAO\ LZ__ #N:_ '_ (B._P#@J;_T
MK'_M_P#_ (,?VBO_ * &C_B([_X*F_\ 2L?^W_\ ^#']HK_Z &@#^,+_ (./
M/A/\+/@=_P %G/VR?A;\%/AI\/\ X/\ PR\+_P##//\ PC/PZ^%O@WPY\/\
MP)X=_MO]E3X&^(M9_L+PCX3TW2/#^D?VOX@U?5==U/\ L_3[?[?K&IZAJ=UY
MM[>W,\O]'W_!C'_SE%_[LF_]^XK^4+_@LS^T?\4_VM_^"D_[2'[0GQK_ &8_
MB!^QO\3?B!_PI_\ X2;]F_XI2>(Y?'?PY_X13X"_"[P1HW]NR>+/A_\ "[Q
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M_GC5\ ?\0N/_  0H_P"C&?\ S9G]L/\ ^B"H_P"(7'_@A1_T8S_YLS^V'_\
M1!4 ??\ _P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_ ,3(
M_9U_^>-7P!_Q"X_\$*/^C&?_ #9G]L/_ .B"H_XA<?\ @A1_T8S_ .;,_MA_
M_1!4 ??_ /P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\ $R/V
M=?\ YXU? '_$+C_P0H_Z,9_\V9_;#_\ H@J/^(7'_@A1_P!&,_\ FS/[8?\
M]$%0!]__ /#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU? '_ !"X_P#!"C_HQG_S9G]L/_Z(*C_B%Q_X(4?]&,_^;,_MA_\
MT05 'W__ ,/8O^"67_22S]@#_P 3(_9U_P#GC4?\/8O^"67_ $DL_8 _\3(_
M9U_^>-7P!_Q"X_\ !"C_ *,9_P#-F?VP_P#Z(*C_ (A<?^"%'_1C/_FS/[8?
M_P!$%0!]_P#_  ]B_P""67_22S]@#_Q,C]G7_P">-1_P]B_X)9?])+/V /\
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M^"=O[?7PB^"G['7PI_X4_P##+Q1^R!X!^*6N^&?^$Z^)/Q ^W>.];^-'Q_\
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MP2S^%7_!)3]MWPU\ ?@E\1/'WQ#^&'Q$^ G@CXW^&G^)\7A^?QQX3?7/%?Q
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M]I_V9U<M_E&_KRJ_SO>_F0MM//\ /\NWD%%%%2,**** "BBB@ HHHH ****
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MT<K\X_\ @K9_RCY_: _[I5_ZNWX;5]!XL_\ )J_$O_LW_&7_ *SF9'U'C?\
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M^31?B+_V<=XN_P#59?""OVJK\5?^"$?_ ":+\1?^SCO%W_JLOA!7[55\_P"
M'_)FO#S_ +)^C_Z?Q!\O]&'_ ),#X6?]DOA__4G$GXJ_\$P?^3NO^"KG_9QU
MM_ZLW]HZOH[_ (*V?\H^?V@/^Z5?^KM^&U?./_!,'_D[K_@JY_V<=;?^K-_:
M.KZ._P""MG_*/G]H#_NE7_J[?AM7Y_D'_*+_ !O_ -D_XY?^M!QV?E_#'_*&
M_B+_ -DO](__ -:CQ*/XJZ_T<*_SCZ_T<*_'_H+_ /-TO^[(_P#?N/P?]F[_
M ,WF_P"\=_\ O]!1117^@!_J %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!_*S_ ,'>O_*-CX(_]GQ?#7_U0O[2]?P[_P#!,7_E)/\ \$]?^SXO
MV3?_ %?7@&O[B/\ @[U_Y1L?!'_L^+X:_P#JA?VEZ_AW_P""8O\ RDG_ .">
MO_9\7[)O_J^O -?]/?[-[_E7+QCZ^-G_ *JJY^+<7_\ )88?URS_ -+B?[%U
M%%%?\PA^TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHM+AN8;N[O?S<_X@J?\ @EE_T7S]O_\ \.G^SK_]"K2[^NGW(;:=K=DGZG\
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M_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6@#^OVBOY O^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5: /Z_:*_D"_X@J?\
M@EE_T7S]O_\ \.G^SK_]"K1_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6@#^OVBOY
M O\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX4\"^(_[%U""'WS_ (BD?^"ZO_1\$?\ XC/^R#_\X*C_ (BD?^"ZO_1\$?\
MXC/^R#_\X*A:>?K^MK!^']>I_H#?&O\ X)R_LY_L*_\ !OM^V%^QUX(\!> O
M$?AWP!^P+^T)XO\ '7B.]\$6L1^+W[0_A#X#ZOXIO?VB_$>D>(M5\9WEOX^N
M_B5X,\/>.O!TEYXEUZY^%1\->!/#/@/5],T#X=^#+;2/\MW]@O\ X)Q_M=_\
M%)/C'HOP<_97^$_B#Q?+/K^@:/XY^)U[I6MVGP:^"VG>((-=O[7Q5\9?B+9:
M3J>D^"-";2O"OBG4-*M)TN_%/C6X\/WWAOX=^&_&'C*?3?#=_P#HY_Q%(_\
M!=7_ */@C_\ $9_V0?\ YP5'_$4C_P %U?\ H^"/_P 1G_9!_P#G!4=6WK?Y
M:W?^>RMZCO[JCLDVU\TE^%C_ $V_^"5__!-+X-?\$I/V2/#7[+7P?UK7_&4\
MFO7_ ,1OBW\2_$K36NI?%/XQ^(]%\/:'XJ\;0^&5U'4])\"Z%)I7A7PYX<\*
M>"=#NKJ#0/"WAW1HM<UOQEXSE\3^.O%'Z-U_";_P:_?\%E_^"D?_  44_;O^
M,?P9_;%_:,7XO?#7PI^R1XU^)V@^&U^$/P)^'_V'QQI/QC^!?A73]<.L?"_X
M8^"M?NOLV@>,?$EA_9MYJEQI$O\ :7VJ?3Y;VSL+BU_NRIOS\OQ6A*MTZ?\
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MZ_[O9_\ ?1Z_?[_@UQ_Y04?L,_\ =S/_ *V'^T%7X _\'SG_ #BZ_P"[V?\
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M_P!FX_ __P!5EX8H_;%_Y-%_:G_[-Q^.'_JLO$]'['7_ ":+^RQ_V;C\#_\
MU67ABC]L7_DT7]J?_LW'XX?^JR\3T?\ -J_^\?\ _ON!_P V6_[Q?_[ZA\X_
M\$D_^4?/[/\ _P!U5_\ 5V_$FOH[]L7_ )-%_:G_ .S<?CA_ZK+Q/7SC_P $
MD_\ E'S^S_\ ]U5_]7;\2:^COVQ?^31?VI_^S<?CA_ZK+Q/7S_"7_)@>&?\
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MOQ&K_$&K_;Y_X*Q?\HLO^"EG_9@'[9'_ *SK\1J_Q!J /]AK_@F3_P %-O\
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M $8S_P";,_MA_P#T05 'W_\ \/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\
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M_@A1_P!&,_\ FS/[8?\ ]$%0!]__ /#V+_@EE_TDL_8 _P#$R/V=?_GC4?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU? '_ !"X_P#!"C_HQG_S9G]L/_Z(*C_B
M%Q_X(4?]&,_^;,_MA_\ T05 '^>'_P ''GQ8^%GQQ_X+.?MD_%+X*?$OX?\
MQ@^&7BC_ (9Y_P"$9^(OPM\9>'/B!X$\1?V)^RI\#?#NL_V%XN\)ZEJ_A_5_
M[(\0:1JNA:G_ &?J%Q]@UC3-0TRZ\J]LKF"+^C[_ (,8_P#G*+_W9-_[]Q7\
MP/\ P7J_9<^!/[%W_!6+]JS]FC]FCP-_PK7X)?#7_A1G_"%>"O\ A)O&/C'^
MQ?\ A,?V;?@[X_\ $?\ Q4?C_P 0^*O%NH_VCXM\5:]JW_$VUZ_^Q_;_ +!8
M?9=,M;*RM_Z?O^#&/_G*+_W9-_[]Q0!_?Y1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG?M$?_0MT?\ $%1_P5(_Z+_^P)_X<[]HC_Z%NO[^_P#AZ]_P2V_Z24?L!_\
MB8W[._\ \\:C_AZ]_P $MO\ I)1^P'_XF-^SO_\ /&H _@$_X@J/^"I'_1?_
M -@3_P .=^T1_P#0MT?\05'_  5(_P"B_P#[ G_ASOVB/_H6Z_O[_P"'KW_!
M+;_I)1^P'_XF-^SO_P#/&H_X>O?\$MO^DE'[ ?\ XF-^SO\ _/&H _GG_P"#
M>G_@WM_;,_X),?MC_%+]H7]HKXG_ +,?C;P7XX_9F\6?!G2M,^"WC'XJ>(?%
M%MXHUWXI_![QO9W^H67CGX,?#K28M CTGX?:U;W-U;:W=:BFHW.EQ1:7-;3W
M=W9?V*5\Q_!7]MG]C+]I/Q1J'@C]G7]KC]F+X^>--)T"Y\5:KX0^"OQ[^%7Q
M3\4:9X7LM1TO2+SQ)J&@>!O%>NZM9:!::MK>BZ9<ZQ<VD6G0:CJ^EV4MPES?
MVD4OTY0]?P_!6#]0HHHH **** "BBB@ HHHH **** "BBB@ K\:_^#A'XU^*
M/@#_ ,$9/V_?'GA"QT'4=7UCX.V'P;NH/$EMJ-WI\?AG]HSX@>#/V>O&M_;1
M:7JFD7*:_I?@WXH:]J?A2ZDNYM/L?%%IH][J^EZYI5O>Z+J'[*5_(9_P>??%
MD>#O^"8OPA^&&E_$C_A&/$'QA_:X\#Q:M\/;#Q@-%UCXG_##P'\-OBGXC\3#
M4O"=OJ-M>^-/ 7@OXCS?!O7-<^TZ?J7A_P .>.+CX8ZG?_8M>E\*SLGL_/3[
M]"H_$F]D[OT6K_!'^8YX0\(>*_B#XL\,> _ GAK7_&GCCQMXAT;PEX-\'>%=
M(O\ Q!XH\6>*O$>HVVC^'_#7AO0=*M[O5-;U_7=6O+32]'TC3;6YU#4]1NK>
MRLK>:YGBC;]W/^(7'_@NO_T8S_YLS^QY_P#1!5^4_P"Q!\;?"/[,W[7G[.?[
M2GC;3_$.MZ-^SM\6_!GQYM/#'ABTTZ?4_&WBKX.ZQ;_$7P+X N+[5=5TJU\+
MZ!X_\;>&_#_@SQ7X^CC\2:A\.?"^NZQX]TCX?_$S5O#EE\._%']K'_$<XF['
M_#KQMF?O?\-K#=CUV?\ #)6,^V_\:K2R[ZW[6Z?/>_E;N1U?]?TMOG<_G_\
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M -#[0!\ ?\0XG_!4W_I9P_;_ /\ P7?M%?\ T?U'_$.)_P %3?\ I9P_;_\
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M.N?_ %9O[.-?M57XJ_\ !3[_ ).Z_P""4?\ V<=<_P#JS?V<:/'C_DV6:?\
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M7_R7]6?E?_1JHK_.5_XB]?\ @I/_ -$1_8=_\-K\>O\ Z)>C_B+U_P""D_\
MT1']AW_PVOQZ_P#HEZ/^*1'TR/\ H2^'_P#XG>!_^9?ZL_*Y_K]P]_S\Q?\
MX2R_^2_JS\K_ .C517^<K_Q%Z_\ !2?_ *(C^P[_ .&U^/7_ -$O1_Q%Z_\
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MOW#W_/S%_P#A++_Y+^K/RO\ Z-5%?YRO_$7K_P %)_\ HB/[#O\ X;7X]?\
MT2]'_$7K_P %)_\ HB/[#O\ X;7X]?\ T2]'_%(CZ9'_ $)?#_\ \3O _P#S
M+_5GY7/]?N'O^?F+_P#"67_R7]6?E?\ T:J*_P Y7_B+U_X*3_\ 1$?V'?\
MPVOQZ_\ HEZ/^(O7_@I/_P!$1_8=_P##:_'K_P"B7H_XI$?3(_Z$OA__ .)W
M@?\ YE_JS\KG^OW#W_/S%_\ A++_ .2_JS\K_P"C517^<K_Q%Z_\%)_^B(_L
M._\ AM?CU_\ 1+T?\1>O_!2?_HB/[#O_ (;7X]?_ $2]'_%(CZ9'_0E\/_\
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M^W__ .&L_9U_^BJH_P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55?U^T4 ?R!?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^0#_ (.B/C_8
M:YXD_9%_8XTNY\/W\WAN_P!>_;"^)NGW6A>*1XF\/RP:7XM^!W[/-SI/B-GM
MO!,^@^,)-?\ VEYO$&BQQ:WXIL]6^&WA'49G\+:5=VR^,/YB/"/C#QA\/O$^
MD^-_A[XP\6_#[QOX?_M(^'O&_@+Q/KG@OQIX=?6='U#P]JTWA_Q9X8O]*\0Z
M%<:EH.K:KHM[<:3J5G/<Z5J5_I\LCVEY<12?ZAGQ;_9L_9U^/UWX6O\ X[_
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M?R_RN#TM?K;\78_'BBO]?K_B%Q_X(4?]&,_^;,_MA_\ T05'_$+C_P $*/\
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M_@J;_P!*Q_[?_P#X,?VBO_H :/\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H :
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M^7_3O^KOMI^'?_$(5_P4G_Z+=^P[_P"'*^/7_P!#11_Q"%?\%)_^BW?L._\
MAROCU_\ 0T5^XG_$7K_P38_Z(C^W%_X;7X"__1+T?\1>O_!-C_HB/[<7_AM?
M@+_]$O1_Q'W]LC_T97_SG&1>7_4Y_J[[:']E>'O_ $,O_+RKY?\ 3O\ J[[:
M?AW_ ,0A7_!2?_HMW[#O_AROCU_]#11_Q"%?\%)_^BW?L._^'*^/7_T-%?N)
M_P 1>O\ P38_Z(C^W%_X;7X"_P#T2]'_ !%Z_P#!-C_HB/[<7_AM?@+_ /1+
MT?\ $??VR/\ T97_ ,YQD7E_U.?ZN^VA_97A[_T,O_+RKY?]._ZN^VGX=_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX=:]XX\'>!=6\4:'I>K/K7@77=6M_#\6G67C_P '^,O#,-U=W'A^[E/]@?\
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M/^#R3_I$[^P!_P"'&\#?_3+*_?[_ ()._P#*++_@FG_V8!^QO_ZSK\.:^_Z
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M .<HO_=DW_OW% ']_E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!POQ1
MU[QOX5^&?Q$\3_#/P"GQ6^)'ASP+XNU[X?\ PND\6:9X#C^)/C?1] U#4/"G
M@&3QSK=K?:-X,3QCKUO8>'6\6:O97FF>'5U$ZQ?VMQ:6<L3_ .8!^T-\?/CE
M^U!\=?B1\:?VFO$%]K?QUO\ 6[_P5XRT2]T+6?!UK\(4\$ZSJ]E%\!/#'PY\
M133:[\*_#'PIU:ZUO2!X UUF\6V_BFY\4^*?B3?>(?BMXJ\=^+-?_P!3FOSK
M_;E_X);?LD?\% I=#\0_&KPSXE\/_%3PKH4?A7PI\;?A;XB'A+XE:+X4_P"$
MFL/$]UX6OA?V'B#P)X[\/RSP:U8Z1IGQ/\#^.(/ L/C;QWJ_PV'@OQ9XJU/Q
M')^8^*?!&:\<Y##+LJSJ66U*%5XB6!JJV7YK.*BZ-+&U:4'B:7L)Q=2A*/MJ
M"J-2JX:=2-&M0_N7Z!7THN /HK>+.(XSX]\,Z'&F$S; 0R6AQ5@9N?%_ &'K
MSJ1S+,>&,!C:\,FQSS/#5%A,TI5/[.S:>"A+#X#.\-A,1F>6YK_,I_P;Y_L+
M7OQR_: E_:Y\;Z/H.I_!?]F_6M2T?PS!?:CX7U:YU[]I1-$\,ZWX:L[SP7J?
MA[Q)=II/PO\ "/C&S^*,/B=]0\ Z[H?Q*N/@OK'@35/%,&F^/++P]^<7_!2_
M]@O5_P#@G;^U-K_P>LE^V?!+Q[;ZY\4_V9-:M--\;)IMA\)+WQ5J5A%\&-2\
M1^,[G6W\2_$/]GTOHWA#Q5=VWC3QGJ^L>!=:^$'Q0\8WN@>(?BQ-X2T+_0Y_
M9[^!?@3]F;X(_"_X!_#2UDM_!?PJ\'Z1X2TFZN['P]8:SK\]C!OUKQEXI7PI
MH7AGP]>^-_'.NS:GXR\=:WIGA_2(O$/C'7=<UZ2P@N-2F0?/O[=7_!/']F[_
M (*&>!/"O@_X\Z)K5EKGP]UZ;Q#\,_BMX"N]'T3XJ?#FZU065KXNTWPQK^M:
M#XETF;PSX_T6QM]%\;>$O$?A_7_#.LBR\/>)DTFU\>>!_A_XM\*?,X_P8RZI
MX;4N$L(Z']N823S6CFDTXQKY].G&.)]I-1=2."Q-**P$5RR]E0IX:O*G5K8=
M<W[EPO\ M,N,,-]-G&_2$SV&:KPKSZG#P^S'@2A.&(K99X38?&U:N3RPF&E6
M6%K<49-CZM3BVM4C6I1QV;8W.\JP^+P.69M+V7\8_P#P1@_:S_:"_9G_ &HY
M_#/P0^!WBS]HOPY\;8?!>B?&GX5?#KPO9ZEX_?PEX>\5CPYX8^)FD>*KA;+3
MO!EI\+_$/Q7N4O=7^(WB7PO\%/L/CC4=/^(WBCP)_:FB?$OP1_H.U\V?LV?L
M??LR_L@^'=2\,?LW_!KP?\+;/7#!_P )+J^DVUWJGC7Q@ECK'B77-'A\;_$3
MQ)>:UX^\;6WAJ]\8^)8?"%KXL\2ZS;>#M(U:?P_X6BTC08[?38?I.OMO#CA#
M,."N'*.2YAG-3-ZL:DJT8J'+@\O]K[T\)E[G%8F6'51RJ.5:45*I*52GA\-S
MSA+^8?IJ?2,X0^D_XT9CXE\'^&F$\/,%6P6'RRMB9XAUN)>,/J*]A@\_XNIX
M6M+):&;K PH8*G1RRE7JT,'0H8/&9SG,<+A*U$HHHK[X_D8**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBO(OCU\>O@[^R]\'?B#\?_ (__ !!\/_"WX/?"WP_/
MXF\<^.?$T\T>FZ/IL<T%G:P06MG!=ZKK>NZWJMW8:!X6\+:!8:IXG\7^)]4T
M?PMX6T?6/$6L:9IEV >NT5^!?_$4%_P0M_Z/HM?_ !'3]K;_ .<+1_Q%!?\
M!"W_ */HM?\ Q'3]K;_YPM '\@G_  >L_P#*3[]GO_LPSX<?^M"?M.5^?_\
MP:T_\IT?V*?^O3]I;_UDKXZUZ'_P=#_MY_LG?\%#?V[O@U\9OV//BS%\8OAM
MX6_9)\%?#'7O$D7@SXB>!?L'CC1_C'\=/%6HZ(VC_$SPCX,U^X^SZ#XS\-WX
MU*TTN?2)_P"T3:V^H2WMEJ%O:?'O_! K]J/X$_L8?\%7_P!E_P#:3_:7\>1_
M#/X*?#JU^.*^,O&LGAWQ;XL71V\8?L\?%?P)X<4>'O N@^)_%6HG4?%7B?0]
M+QI6AWQM!>F_OOLVFVMY>6Y'>7S_ /21SUY;:Z1_,_V;J*_ O_B*"_X(6_\
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MJ:QX6\4Z/K'A[5]3TR[_ &A_;#_X.9_^"K'[:?[.=K^S%X\^)7P\^&_@+6?
M5Q\//C1K?P1\ #P+X\_:+T:^M?#5MJLOQ2\37NM^(O\ A'_[?_L'4T\4Z!\"
M[#X->"?%FD>./&W@WQ-X4U;P%JEAX4TK^[_]L?\ X-8/^"2/[7_CJU^(ME\-
MO'O[)_B-_M'_  DMI^Q]KW@OX6^"O&!&D>&=$T@WOPQ\4_#SXB_#/PB=!LO#
M;S0-\+/"'P^;Q!J_B/Q+X@\<GQ9KU_;:E8_':?\ !E7_ ,$L%8%OCS^WY(/[
MK_%3]G@*?8^7^RQ&W/LP/H:>ZL_1KIKOIV%L[J^]T]GZ_+]#_/$_82_83_:-
M_P""C/[1_@S]F']F+P:?$_COQ07U/7=<U)[K3_ OPP\!Z?=65MXE^*'Q/\26
M]EJ \,> _"XU"R2]ODLM0UC6]9U#0_!G@W1/$_CSQ1X6\+:W_M-?L:?LC_!W
M]A#]F/X0_LE_ *RU^R^%7P8\/7>B>'9/%6N3^)/%&L7^M:[JWBWQ=XJ\2:O)
M%:VT^O\ C'QGXA\0^+-8M]%TW0_"^G:CK5SIOA+PWX9\,6>D:!IO._L>?L#_
M +''[ /@.[^''['O[/G@#X'>'=5\@^)+[PY9WVJ^./&QL=7\2ZWHY^(GQ/\
M%=_K_P 2_B.WAR\\8>)8/";>._%OB$^$M'U6;P]X9.E:!%;:9#]>T[Z66U[^
M;?3[M;>K^2\W_P -_G_7G<HHHI#/X _^#YS_ )Q=?]WL_P#OH]?O]_P:X_\
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M_M3_ /9N/QP_]5EXGKY_A+_DP/#/_9G\F_\ 6+PQ\OP/_P HQ<(?]F'X?_\
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M/W]$#_QI_P +/_GS_5GY7/\ 6&C_ -"OB#_PRX[_ .5_U9^5_P"J:BOY6?\
MAK+_ (.R?^D8O[#O_A?>#/\ Z851_P -9?\ !V3_ -(Q?V'?_"^\&?\ TPJC
M_B3CB+_H_?T0/_&G_"S_ .?/]6?E<_UAH_\ 0KX@_P##+CO_ )7_ %9^5_ZI
MJ*_E9_X:R_X.R?\ I&+^P[_X7W@S_P"F%4?\-9?\'9/_ $C%_8=_\+[P9_\
M3"J/^)..(O\ H_?T0/\ QI_PL_\ GS_5GY7/]8:/_0KX@_\ #+CO_E?]6?E?
M^J:BOY6?^&LO^#LG_I&+^P[_ .%]X,_^F%4?\-9?\'9/_2,7]AW_ ,+[P9_]
M,*H_XDXXB_Z/W]$#_P :?\+/_GS_ %9^5S_6&C_T*^(/_#+CO_E?]6?E?^J:
MBOY6?^&LO^#LG_I&+^P[_P"%]X,_^F%4?\-9?\'9/_2,7]AW_P +[P9_],*H
M_P")..(O^C]_1 _\:?\ "S_Y\_U9^5S_ %AH_P#0KX@_\,N._P#E?]6?E?\
MJFHK^5G_ (:R_P"#LG_I&+^P[_X7W@S_ .F%4?\ #67_  =D_P#2,7]AW_PO
MO!G_ -,*H_XDXXB_Z/W]$#_QI_PL_P#GS_5GY7/]8:/_ $*^(/\ PRX[_P"5
M_P!6?E?^J:BOY6?^&LO^#LG_ *1B_L._^%]X,_\ IA5'_#67_!V3_P!(Q?V'
M?_"^\&?_ $PJC_B3CB+_ */W]$#_ ,:?\+/_ )\_U9^5S_6&C_T*^(/_  RX
M[_Y7_5GY7_JFK_'1_P""G7_*2?\ X*%?]GQ?M9?^KZ\?5_<1_P -9?\ !V3_
M -(Q?V'?_"^\&?\ TPJOX(OVQ-6^+.O_ +7/[4VN_'SPQH?@GXZ:U^T;\;]6
M^-/@SPQ<0W?AKPC\6=1^)GB>\^(WACP]=6WB'Q=;W.AZ!XPFUG2M)N+?Q7XG
MAFL+2WDB\0ZTC+J5S_K1^R7\#\S\*/$3Q:S''^(O@IQM#-N"\DP5/"^%GBSP
MAXBYA@94<\E7>(S7!<-X[%U\NP=1/V5'%8F,*56NG2A)ST/@^/,RACL)@(0P
MF989T\15DY8[ 8C"1E>DE:G*M&*G)=8QNTM=C^]W_@T*_P"4;'QN_P"SXOB5
M_P"J%_9HK^J:OY6?^#0K_E&Q\;O^SXOB5_ZH7]FBOZIJ_P E_I^?\ID_2$_[
M+_%_^H& /O>%O^2>RG_L$A_Z5(****_D ]\**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2;.X6Z\5>-I_#U_X;^'7AOQCXSFTWPW?_P"IWX2_X-G/^"'?@KQ3X;\8:/\
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M!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?P!_\
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M ,.G^SK_ /0JT ?U^T5_(%_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\
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M\%W/^31?AU_V<=X1_P#59?%^OVJK\5?^"[G_ ":+\.O^SCO"/_JLOB_1X_\
M_)FO$/\ [)^M_P"G\.'TGO\ DP/BG_V2^(_]2<,?M57YQ_\ !6S_ )1\_M ?
M]TJ_]7;\-J_1ROSC_P""MG_*/G]H#_NE7_J[?AM7T'BS_P FK\2_^S?\9?\
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M'K_Z.&O\$_\ B!7T9_\ I.+P_P#_ !2/TA/_ * O7^GI^H_VGG/_ $36+_\
M#EE/_P U>O\ 3T_JFHK^5G_AP+_P4G_Z6*?VXO\ P ^/7_T<-'_#@7_@I/\
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M]?Z>A_:><_\ 1-8O_P .64__ #5Z_P!/3^J:BOY6?^' O_!2?_I8I_;B_P#
M#X]?_1PT?\.!?^"D_P#TL4_MQ?\ @!\>O_HX:/\ B!7T9_\ I.+P_P#_ !2/
MTA/_ * O7^GH?VGG/_1-8O\ \.64_P#S5Z_T]/ZIJ*_E9_X<"_\ !2?_ *6*
M?VXO_ #X]?\ T<-'_#@7_@I/_P!+%/[<7_@!\>O_ *.&C_B!7T9_^DXO#_\
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MK_Q6I^BS_P!$#X__ /B+>'7_ --4_P \VBO]#+_AQI_P2T_Z->_\S9^T3_\
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M^"6G_1KW_F;/VB?_ )[=?J/_ !+?QQ_T->%/_"[-_P#YQ'\(_P#%:GZ+/_1
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M*\F^"OP(^#?[.?@6P^&GP,^&WA+X7^"=/^RR_P!B^$])@T_^U-1M-'TK0/\
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M&G6^HQW$5EJFH6R17<WK=( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Y _;%_;\_8V_X)_\ @2S^(O[8?[0GP_\
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M_P#_ (BCO^"%'_1\W_FLW[8?_P!#[1_Q%'?\$*/^CYO_ #6;]L/_ .A]H ^
M/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z
M%6OO_P#XBCO^"%'_ $?-_P":S?MA_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?:
M /@#_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M04?L,_\ =S/_ *V'^T%0!^_U%%% !7\ ?_!\Y_SBZ_[O9_\ ?1Z_O\K^ /\
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M_P#T/M'_ !%'?\$*/^CYO_-9OVP__H?:^_\ _AT[_P $LO\ I&G^P!_XAO\
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M_B&_[.O_ ,[FC_AT[_P2R_Z1I_L ?^(;_LZ__.YH ^ /^(H[_@A1_P!'S?\
MFLW[8?\ ]#[1_P 11W_!"C_H^;_S6;]L/_Z'VOO_ /X=._\ !++_ *1I_L ?
M^(;_ +.O_P [FC_AT[_P2R_Z1I_L ?\ B&_[.O\ \[F@#X _XBCO^"%'_1\W
M_FLW[8?_ -#[1_Q%'?\ !"C_ */F_P#-9OVP_P#Z'VOO_P#X=._\$LO^D:?[
M '_B&_[.O_SN:/\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[F@#X _P"(H[_@A1_T
M?-_YK-^V'_\ 0^T?\11W_!"C_H^;_P UF_;#_P#H?:^__P#AT[_P2R_Z1I_L
M ?\ B&_[.O\ \[FC_AT[_P $LO\ I&G^P!_XAO\ LZ__ #N: /@#_B*._P""
M%'_1\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\ H?:^_P#_ (=._P#!++_I
M&G^P!_XAO^SK_P#.YH_X=._\$LO^D:?[ '_B&_[.O_SN: /\T3_@Z!_;U_9.
M_P""B7[?7PB^-?['7Q6_X7!\,O"_[('@'X6Z[XF_X07XD_#_ .P^.]$^-'Q_
M\6:GH7]C?%+P=X)\07/V;P_XV\,:A_:=GI5QH\W]I_9;?4);VRU"VM/K_P#X
M,J?^4IOQ\_[, ^*?_K17[*M>/_\ !W7^SU\ OV:_^"DGP2\"_LY_ [X/_ 'P
M3JW[$'PV\6:IX.^"GPT\%_"OPKJ7BJ^^//[2NCWWB;4/#W@71=!TB\\07FD:
M%H>EW6LW%G)J-QIVC:58S7+VVG6<4/L'_!E3_P I3?CY_P!F ?%/_P!:*_95
MH _T^Z*** "BBB@ HHHH **** /G']L7_DT7]J?_ +-Q^.'_ *K+Q/7\#M?W
MQ?MB_P#)HO[4_P#V;C\</_59>)Z_@=K_ #?^F_\ \E5P/_V3^8_^K&)_DO\
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M.O\ LX[PC_ZK+XOU^U5?BK_P7<_Y-%^'7_9QWA'_ -5E\7Z/'_\ Y,UXA_\
M9/UO_3^'#Z3W_)@?%/\ [)?$?^I.&/VJK\X_^"MG_*/G]H#_ +I5_P"KM^&U
M?HY7YQ_\%;/^4?/[0'_=*O\ U=OPVKZ#Q9_Y-7XE_P#9O^,O_6<S(^H\;_\
MDRWB]_V:_C__ -93-CZ._8Z_Y-%_98_[-Q^!_P#ZK+PQ1^V+_P FB_M3_P#9
MN/QP_P#59>)Z/V.O^31?V6/^S<?@?_ZK+PQ1^V+_ ,FB_M3_ /9N/QP_]5EX
MGH_YM7_WC_\ ]]P/^;+?]XO_ /?4/G'_ ())_P#*/G]G_P#[JK_ZNWXDU]'?
MMB_\FB_M3_\ 9N/QP_\ 59>)Z^<?^"2?_*/G]G__ +JK_P"KM^)-?1W[8O\
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MO]?Z>GP[_P 1(?\ P1=_Z/+_ /-=_P!JW_YQE'_$2'_P1=_Z/+_\UW_:M_\
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M?\1(?_!%W_H\O_S7?]JW_P"<97W%_P .Q?\ @FQ_TCU_8=_\1-^ O_S T?\
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M_!/PW,= TG^;GX6?%OXK_ CQ[HGQ1^"GQ+^('P=^)_A8ZF/#GQ"^&'C#Q%X
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MV_\ @GSXZ\=?\$^?V(/&GC;QI^Q!^RAXL\8^,?%G[*'P&\1^*O%GBKQ'\!O
M.L>(?$WB;Q#K'@&\U?7O$&NZO>7FJ:SK.J7EUJ.J:C=7-]?7,]S/+*WV_P#\
M.G?^"67_ $C3_8 _\0W_ &=?_G<U_+%^Q%_P7S_X*2?!S]B_]D3X1>!?^#=W
M]M_XV>"?A7^S!\ OAQX.^,WA._\ CRGA7XN>%? _PI\)^&/#WQ.\,IH_[$/B
MS2%\/^/=(TNS\5:,NE^*O$NG+IVK6PL?$&LVPBU&Y^G_ /B([_X*F_\ 2L?^
MW_\ ^#']HK_Z &@#]_O^'3O_  2R_P"D:?[ '_B&_P"SK_\ .YH_X=._\$LO
M^D:?[ '_ (AO^SK_ /.YK\ ?^(CO_@J;_P!*Q_[?_P#X,?VBO_H :/\ B([_
M ."IO_2L?^W_ /\ @Q_:*_\ H : /W^_X=._\$LO^D:?[ '_ (AO^SK_ /.Y
MH_X=._\ !++_ *1I_L ?^(;_ +.O_P [FOP!_P"(CO\ X*F_]*Q_[?\ _P"#
M']HK_P"@!H_XB._^"IO_ $K'_M__ /@Q_:*_^@!H _?[_AT[_P $LO\ I&G^
MP!_XAO\ LZ__ #N:/^'3O_!++_I&G^P!_P"(;_LZ_P#SN:_ '_B([_X*F_\
M2L?^W_\ ^#']HK_Z &C_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &@#]_O^'3
MO_!++_I&G^P!_P"(;_LZ_P#SN:/^'3O_  2R_P"D:?[ '_B&_P"SK_\ .YK\
M ?\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H :/^(CO_@J;_P!*Q_[?_P#X,?VB
MO_H : /W^_X=._\ !++_ *1I_L ?^(;_ +.O_P [FC_AT[_P2R_Z1I_L ?\
MB&_[.O\ \[FOP!_XB._^"IO_ $K'_M__ /@Q_:*_^@!H_P"(CO\ X*F_]*Q_
M[?\ _P"#']HK_P"@!H _?[_AT[_P2R_Z1I_L ?\ B&_[.O\ \[FC_AT[_P $
MLO\ I&G^P!_XAO\ LZ__ #N:_ '_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &
MC_B([_X*F_\ 2L?^W_\ ^#']HK_Z &@#]_O^'3O_  2R_P"D:?[ '_B&_P"S
MK_\ .YH_X=._\$LO^D:?[ '_ (AO^SK_ /.YK\ ?^(CO_@J;_P!*Q_[?_P#X
M,?VBO_H :/\ B([_ ."IO_2L?^W_ /\ @Q_:*_\ H : /W^_X=._\$LO^D:?
M[ '_ (AO^SK_ /.YH_X=._\ !++_ *1I_L ?^(;_ +.O_P [FOP!_P"(CO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\QG_!W/\ '(_"
M3_@C;X^\"CPP=>/[37QU^!WP-_M4:U_9?_"$_P!BZ]J/[1A\3_8?[)U'_A)/
MM8^ !\&?V+]LT'R/^$N_X2+^UIO[!_L+6OZ<Z_GK_P"#H/\ 9$U+]K7_ ()
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MW3-,UO31?V%P+'5].L-3M1%>V5M/%_J65_@D_"OXN?%;X%^.]$^*/P2^)GQ
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M^(CO_@J;_P!*Q_[?_P#X,?VBO_H :/\ B([_ ."IO_2L?^W_ /\ @Q_:*_\
MH :_K]HH _D"_P"(CO\ X*F_]*Q_[?\ _P"#']HK_P"@!H_XB._^"IO_ $K'
M_M__ /@Q_:*_^@!K^OVB@#^0+_B([_X*F_\ 2L?^W_\ ^#']HK_Z &C_ (B.
M_P#@J;_TK'_M_P#_ (,?VBO_ * &OZ_:* /Y O\ B([_ ."IO_2L?^W_ /\
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M_P#0/4?\/^O^"D__ $KK?MQ?^!_QZ_\ H'J_JFHH_P"(Z_1G_P"D'?#_ /\
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M>K^J:BC_ (CK]&?_ *0=\/\ _P 7=](3_P"CWU_I:G]F9S_T4N+_ /#;E/\
M\R^O]+7^5G_A_P!?\%)_^E=;]N+_ ,#_ (]?_0/4?\/^O^"D_P#TKK?MQ?\
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M)3'?^K?(C_I[_;4_\HL\ _\ 9_\ A;_UW7BJ?K-1117]KG_,(%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?YEWC?_ (/6_P#@H]+X
MO\52> OV:/V)/#O@N3Q)KDGA'0O%_A;X[>-?$^B^%WU.Y?P_I/B/Q;HWQX\
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M17C7XI^#=*U]+G1[2*U\5:7H-GXHL=/FU72++6+?2M=UNRU#]7OAA\*OA?\
M!+P-H?PP^#'PW\ _"+X:^&/[2_X1OX>?##P?X>\ ^!O#W]LZOJ'B#6/[#\)>
M%-.TG0-)_M77]6U36]2^P:?;_;M7U+4-2NO-O;RXFD!:_P!=^I_ 7_P:%?\
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MD?BMX>T[7O#6IZ1X ^.GPOU_XT?''0OA[\2+[X7_ !-\/ZA\,_C9X#DM-?\
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MH _K]HK^0+_ALC_@\D_Z1._L ?\ AQO W_TRRC_ALC_@\D_Z1._L ?\ AQO
MW_TRR@#^OVBOY O^&R/^#R3_ *1._L ?^'&\#?\ TRRC_ALC_@\D_P"D3O[
M'_AQO W_ -,LH _K]HK^0+_ALC_@\D_Z1._L ?\ AQO W_TRRC_ALC_@\D_Z
M1._L ?\ AQO W_TRR@#^OVBOY O^&R/^#R3_ *1._L ?^'&\#?\ TRRC_ALC
M_@\D_P"D3O[ '_AQO W_ -,LH _K]HK^0+_ALC_@\D_Z1._L ?\ AQO W_TR
MRC_ALC_@\D_Z1._L ?\ AQO W_TRR@#^OVBOY O^&R/^#R3_ *1._L ?^'&\
M#?\ TRRC_ALC_@\D_P"D3O[ '_AQO W_ -,LH _K]HK^0+_ALC_@\D_Z1._L
M ?\ AQO W_TRRC_ALC_@\D_Z1._L ?\ AQO W_TRR@#^0+_@Z._Y3K_MS?\
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M-U#Q-/#::'H=I#H-KXMM=!\;6]OXV\/ZAX?1+O\ &?\ X?N?M=?]$Z_9Q_\
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M5T[P5_()_P %T/\ @A9%_P $7X/V8IX_VH9/VD!^T?+\98MC_!9?A#_PAO\
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M_%B[TO3?'VAKHW@/X;>+/C#I^GZ/KO@;X@VGPX\!_%6#5O$O\_7QK_X.W?\
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MD%_;(;]H?_A//@+XD^"!\&-^SV/A-_97_"0?$+X8^/!XG'B(?&_XE_;?L?\
MPKDZ4=%_L*T^T?VS]N_M:#^SOL=__3M112_K[@"BBB@ HHHH **** "BBB@
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MP!_\'SG_ #BZ_P"[V?\ WT>@#^4+_@C/X-_;)^('_!2?]G#PC_P3]^+'P_\
M@=^UUJ__  N#_A4GQ2^*6FV.K^!/"_V#X"_%'4_'G]NZ?J7PT^,%E<?VW\,K
M+QGX=TSSOAUXB\K6-7T^>/\ LB:*/7=,_N\_X8W_ .#R3_I+%^P!_P"&Y\#?
M_2TZ_D"_X-<?^4Z_[#/_ '<S_P"L>?M!5_K]4 ?R!?\ #&__  >2?])8OV /
M_#<^!O\ Z6G1_P ,;_\ !Y)_TEB_8 _\-SX&_P#I:=?U^T4 ?R!?\,;_ /!Y
M)_TEB_8 _P##<^!O_I:='_#&_P#P>2?])8OV /\ PW/@;_Z6G7]?M% '\@7_
M  QO_P 'DG_26+]@#_PW/@;_ .EIT?\ #&__  >2?])8OV /_#<^!O\ Z6G7
M]?M% '\@7_#&_P#P>2?])8OV /\ PW/@;_Z6G1_PQO\ \'DG_26+]@#_ ,-S
MX&_^EIU_7[10!_(%_P ,;_\ !Y)_TEB_8 _\-SX&_P#I:='_  QO_P 'DG_2
M6+]@#_PW/@;_ .EIU_7[10!_(%_PQO\ \'DG_26+]@#_ ,-SX&_^EIT?\,;_
M /!Y)_TEB_8 _P##<^!O_I:=?U^T4 ?R!?\ #&__  >2?])8OV /_#<^!O\
MZ6G1_P ,;_\ !Y)_TEB_8 _\-SX&_P#I:=?U^T4 ?R!?\,;_ /!Y)_TEB_8
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MHHK_ $ /]0 HHHH **** "BBB@#_ "L_^#D/_E-%^V9_W;O_ .LI? RO<?\
M@W_^$W_!63XH_P##6G_#KS]IWX'?LX_V'_PH?_A>/_"YM T;7/\ A,O[3_X7
M-_PK/_A&_P"U_P!GKX\?9?\ A'O[/^(']L?9_P#A%?/_ +<TOS?[<\F+^Q_#
MO^#D/_E-%^V9_P!V[_\ K*7P,K]Q/^#,S_G)!_W9_P#^_1U_U5^+'&6)\/\
M]DUP-Q=A,@X/XGQ&4> 'T7?9Y%Q[POE7&?">.^OXKPGRR?\ :W#6=T<1EF9?
M5H8V6,P/UFC/ZGF6'P>/H\N(PM*<?P[ 8=8OCO$X>57$4%4S7.[U<+7GAJ\>
M2..G^[K4FIPYG'EGRM<T'*#TDS[B_P"&3?\ @[)_Z2=?L._^$#X,_P#I>M'_
M  R;_P '9/\ TDZ_8=_\('P9_P#2]:_JFHK_  3_ .)Q^(O^C"?1 _\ &8/"
MS_YS?U=^5OU'_5ZC_P!#3B#_ ,/6._\ EG]7?E;^5G_ADW_@[)_Z2=?L._\
MA ^#/_I>M'_#)O\ P=D_]).OV'?_  @?!G_TO6OZIJ*/^)Q^(O\ HPGT0/\
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MQ#_:13]LAOVAU\>? 7Q'\$!X+;]GH?"8Z3_PD'Q"^&7CS_A)SXD'QP^)8O\
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M'$_X*F_]+.'[?_\ X+OVBO\ Z/Z@#^0+_@Z._P"4Z_[<W_=LW_K'G[/M?O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;O\ @T@^-/BGX7?\%G?A3X$\/V&@WFD?M(?!OX]?!OQQ<:Q:ZA<:AI7AC0/
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M*/\ H^;_ ,UF_;#_ /H?: /@#_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JT?\
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M'S?^:S?MA_\ T/M'_$4=_P $*/\ H^;_ ,UF_;#_ /H?: /@#_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JT?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6OO_ /XB
MCO\ @A1_T?-_YK-^V'_]#[1_Q%'?\$*/^CYO_-9OVP__ *'V@#X _P"(*G_@
MEE_T7S]O_P#\.G^SK_\ 0JT?\05/_!++_HOG[?\ _P"'3_9U_P#H5:^__P#B
M*._X(4?]'S?^:S?MA_\ T/M'_$4=_P $*/\ H^;_ ,UF_;#_ /H?: /\^/\
MX.%O^"7_ , O^"3/[:'PQ_9S_9S\7_&#QIX)\:?LP>"_C7JFJ?&O7_!?B/Q5
M;^*O$?Q6^-7@6^T_3[[P+\/_ (<:1%X?BTCX<:'<6MK<:'=:BFHW6JS3:K/;
M3V=G8_H__P &5/\ RE-^/G_9@'Q3_P#6BOV5:^0/^#H']O7]D[_@HE^WU\(O
MC7^QU\5O^%P?#+PO^R!X!^%NN^)O^$%^)/P_^P^.]$^-'Q_\6:GH7]C?%+P=
MX)\07/V;P_XV\,:A_:=GI5QH\W]I_9;?4);VRU"VM/K_ /X,J?\ E*;\?/\
MLP#XI_\ K17[*M '^GW1110 4444 %%%% !1110!\X_MB_\ )HO[4_\ V;C\
M</\ U67B>OX':_OB_;%_Y-%_:G_[-Q^.'_JLO$]?P.U_F_\ 3?\ ^2JX'_[)
M_,?_ %8Q/\E_VB__ "6GAS_V2^:_^K:)_?%^QU_R:+^RQ_V;C\#_ /U67ABO
MSC^.'_*<#]CK_LW'Q/\ ^H_^U/7Z.?L=?\FB_LL?]FX_ _\ ]5EX8K\X_CA_
MRG _8Z_[-Q\3_P#J/_M3U_4'''_)">#?_9P/!;_U<Y2?V1XC?\FU\ O^SH?1
M\_\ 5_DA^U5?BK_P4^_Y.Z_X)1_]G'7/_JS?V<:_:JOQ5_X*??\ )W7_  2C
M_P"SCKG_ -6;^SC7T'CQ_P FRS3_ +*#P_\ _7A<*GU'TEO^3/YS_P!E1X7_
M /KT^"S]JJ_%7_@I]_R=U_P2C_[..N?_ %9O[.-?M57XJ_\ !3[_ ).Z_P""
M4?\ V<=<_P#JS?V<:/'C_DV6:?\ 90>'_P#Z\+A4/I+?\F?SG_LJ/"__ ->G
MP6?M57XJ_P#!=S_DT7X=?]G'>$?_ %67Q?K]JJ_%7_@NY_R:+\.O^SCO"/\
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M$^V?8_\ A7>B?V/_ &7_ &/]G^U:I]M_M#S[3[#X=_P<A_\ *:+]LS_NW?\
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M_P#H:*/^(0K_ ()L?]%N_;B_\.5\!?\ Z&BON+_B)#_X(N_]'E_^:[_M6_\
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M5\!?_H:*^XO^(D/_ ((N_P#1Y?\ YKO^U;_\XRC_ (B0_P#@B[_T>7_YKO\
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M>:YA]<Q,L'A/J67XA4\7BOK>+IU,+AO84:GM\3"="ES58N*_KY_XB5_V%?\
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M/:!9ZAJVH?V?I.GW^J7WV2TF^R:=97=]/Y=M;32I]#?\,#_MU?\ 1EG[6?\
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MLUCQ'@,NSK(,/1J2HXRIB*EL/Q!F%">!=-3EB)T795*48O\ KB_XB5_V%?\
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MQ-XRM= BU[QA\#O%+)X-^//P^AAT_P '76OGQ/\ #'6)DUC4-"\*ZMXZ\/\
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M5]0U#^S-"TK3-'L/M'V73-/LK**"VB^O_P#B%Q_X(4?]&,_^;,_MA_\ T05
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M[X0U>ZTBXNKRRM]5MM-\06&GWL^FSWNGW]I#?10M:RW5C>6Z2M+;3(G[#_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#']HK_Z &@#]_O\ AT[_ ,$LO^D:?[ '_B&_[.O_ ,[FC_AT[_P2R_Z1I_L
M?^(;_LZ__.YK\ ?^(CO_ (*F_P#2L?\ M_\ _@Q_:*_^@!H_XB._^"IO_2L?
M^W__ .#']HK_ .@!H _?[_AT[_P2R_Z1I_L ?^(;_LZ__.YH_P"'3O\ P2R_
MZ1I_L ?^(;_LZ_\ SN:_ '_B([_X*F_]*Q_[?_\ X,?VBO\ Z &C_B([_P""
MIO\ TK'_ +?_ /X,?VBO_H : /W^_P"'3O\ P2R_Z1I_L ?^(;_LZ_\ SN:/
M^'3O_!++_I&G^P!_XAO^SK_\[FOP!_XB._\ @J;_ -*Q_P"W_P#^#']HK_Z
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M0_:JOQ5_X*??\G=?\$H_^SCKG_U9O[.-?M57XJ_\%/O^3NO^"4?_ &<=<_\
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M^'__ %WV$/G'_@DG_P H^?V?_P#NJO\ ZNWXDU^CE?G'_P $D_\ E'S^S_\
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MO_6@X[/R_AC_ )0W\1?^R7^D?_ZU'B4?Q5U_HX5_G'U_HX5^/_07_P";I?\
M=D?^_<?@_P"S=_YO-_WCO_W^@HHHK_0 _P!0 HHHH **** "BBB@#_*S_P"#
MD/\ Y31?MF?]V[_^LI? ROU3_P"#3+]F+]FO]H[_ (;\_P"&AOV>O@=\>/\
MA#?^&5_^$0_X7-\)O 7Q1_X17_A(?^&C_P"W_P#A&_\ A-] US^P_P"W/[#T
M3^V/[+^R_P!I_P!CZ7]M\_\ L^T\G\K/^#D/_E-%^V9_W;O_ .LI? RO<?\
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M](]?V'?_ !$WX"__ # T?\.Q?^";'_2/7]AW_P 1-^ O_P P-?AW_P /^O\
M@I/_ -*ZW[<7_@?\>O\ Z!ZC_A_U_P %)_\ I76_;B_\#_CU_P#0/4?\2U?3
MK_Z*/_S[#P>\O^KR>GX>0?VSPQ_SY_\ ,%F'E_U+O3\/(_<3_AV+_P $V/\
MI'K^P[_XB;\!?_F!H_X=B_\ !-C_ *1Z_L._^(F_ 7_Y@:_#O_A_U_P4G_Z5
MUOVXO_ _X]?_ $#U'_#_ *_X*3_]*ZW[<7_@?\>O_H'J/^):OIU_]%'_ .?8
M>#WE_P!7D]/P\@_MGAC_ )\_^8+,/+_J7>GX>1^XG_#L7_@FQ_TCU_8=_P#$
M3?@+_P#,#1_P[%_X)L?](]?V'?\ Q$WX"_\ S U^'?\ P_Z_X*3_ /2NM^W%
M_P"!_P >O_H'J/\ A_U_P4G_ .E=;]N+_P #_CU_] ]1_P 2U?3K_P"BC_\
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M%H_'SX%6'_"=_P#"M/\ A:/_  GG]A?V;\1M3\W_ (1?_A8'@S^T_.\CR_\
MA(M/\OS=\GE_TY5_)G_P=$_\V-_]W,?^^_5]3FOAQPYX0X"OXB9)6SO,\SX>
M]E]6P.:XW / 5_[6K4\CK^W6$RG#8C]WA\SK5J7LZT/WU.GS\T.:$OPC@+Z:
M'C1^T6XLRGZ&WBAEGAAP/P+XQ?7O[<XHX"X8XKAQ9EG_ !#[+<9XIY9_9,N(
M?$#.LG7UW..",OR['?7,LQ/_  FXO&+#^QQ7L,12_H9_X;X_85_Z/3_9,_\
M$C?@]_\ -C7\>'[3?_!(W_@H)\>_VDOVA/CG\'?@9I/Q ^$?QH^.'Q8^+'PL
M\>Z!\</V>YM"\;_#CXC>/=?\8>!_%^BRS_%:">72?$OAG6=+UG39)H(97L[V
M%I(HW)1?PIK_ $Y?V!_^3%?V+/\ LTS]G+_U3W@VO*R/-<-]("M7R?B7!U\E
MH</THYEAJN1XVFJM>KBI+"SIU_K^"QD/9Q@N:/LXPES;R:T/N_%/@#.OV0N
MRKQ'\$^),K\3,U\7\97X)SO ^*?#6+GE^69?D5&.>X?%Y4N$N)^',2L96Q,W
M1K/%U\30]@DH4HU/?/X\/V9/^"1O_!03X"?M)?L]_'/XQ? S2?A_\(_@O\</
MA/\ %CXI^/=?^.'[/<.A>"/AQ\.?'N@>,/''B_6I8/BM//%I/AKPSHVJ:SJ4
MD,$TJ6=E,T<4C@(W]A__  WQ^PK_ -'I_LF?^)&_![_YL:/V^/\ DQ7]M/\
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MO_9A?Q&_]:$_9DK_ $\*;T?R3^]7%??R=OP3_4****0PHHHH **** "BBB@
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M:GJ%E913W,?^6'_PZ=_X*F_](T_V_P#_ ,0W_:*_^=S7W%_P3&_X)E?\%(_
M/_!27_@GSXZ\=?\ !/G]M_P5X(\%_MN_LI^+/&/C'Q;^RA\>?#GA7PGX6\._
M'7P'J_B#Q+XE\0ZQX!L](T+P_H6DV=WJFLZSJEY:Z=IFG6MS>WMS!;02RJTK
MR2?5I-^KU)>B=NBT1_<+_P '87Q<_;Q_9Z_8)\ ?&O\ 8T_:%^+GP3\'Z9\7
M=.^'W[1]A\&/"WV'Q1=>$_&JV.O?#WXDW_Q\T1%^('P,T'P1\0?A_I_PWNAX
M4U3PUI_Q.U#X[:7X-\3Z_):FP\*^*O\ /_\ V>/^"U__  4C^#W[0/P.^+_C
M[]MW]MOXV>!OA;\7_AM\1?&?P:\5?MA_'1/"OQ9\*>"O&.C>(_$7PT\2#5?$
MOBG1UT'QUI&G7GAC5CJGA;Q'IRV.J3M>Z#J]N)-/N/\ 8U^/?P$^#O[4/P=^
M(/[/_P"T!\/O#_Q2^#OQ3\/S^&?'/@;Q+#/)INL:;)-!>6L\%U93V>JZ)KVB
M:K:6&O\ A7Q5X?U#2_%'A#Q/I>C^*?"VL:/XBT?3-3M/\DS_ (*=?\&[?_!0
MC_@F]XKU34(OASXA_:C_ &>1H/Q \=V'[0G[/G@+QWXL\.^#O '@'4=0FU._
M_: T&ST.^N_@5KVG>"X](\;Z_P#V[J6N?#:WT[4M3M/"?Q6\<2>"_&]QH"3L
M[[JZ>NJOV?D_SOW13UC;9J][:771^;5W>_2UM$[?Z?/[,/\ P5D_X)]?M8?L
MQ-^UK\//VH/A#X8^%&@^'_!NL_%M?BM\1? ?PX\3?L[ZAXZUZ^\(^'?"G[0>
MDZ[XG2V^%OB#5O&FE:MX3\-3ZUJ1\,?$'4;#^TOACXC\;>&-2T37]4_RY_\
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M#K'B'Q-XF\0ZQX!O-7U[Q!KNKWEYJFLZSJEY=:CJFHW5S?7US/<SRRM]O_\
M#IW_ ()9?](T_P!@#_Q#?]G7_P"=S0!\ ?\ $4=_P0H_Z/F_\UF_;#_^A]H_
MXBCO^"%'_1\W_FLW[8?_ -#[7W__ ,.G?^"67_2-/]@#_P 0W_9U_P#G<T?\
M.G?^"67_ $C3_8 _\0W_ &=?_G<T ? '_$4=_P $*/\ H^;_ ,UF_;#_ /H?
M:/\ B*._X(4?]'S?^:S?MA__ $/M??\ _P .G?\ @EE_TC3_ & /_$-_V=?_
M )W-'_#IW_@EE_TC3_8 _P#$-_V=?_G<T ? '_$4=_P0H_Z/F_\ -9OVP_\
MZ'VC_B*._P""%'_1\W_FLW[8?_T/M??_ /PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^
M=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S0!\ ?\11W_!"C_H^;_S6;]L/_P"A
M]H_XBCO^"%'_ $?-_P":S?MA_P#T/M??_P#PZ=_X)9?](T_V /\ Q#?]G7_Y
MW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T ? '_ !%'?\$*/^CYO_-9OVP_
M_H?:/^(H[_@A1_T?-_YK-^V'_P#0^U]__P##IW_@EE_TC3_8 _\ $-_V=?\
MYW-'_#IW_@EE_P!(T_V /_$-_P!G7_YW- 'P!_Q%'?\ !"C_ */F_P#-9OVP
M_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#[7W_ /\ #IW_ ()9?](T_P!@#_Q#
M?]G7_P"=S1_PZ=_X)9?](T_V /\ Q#?]G7_YW- 'P!_Q%'?\$*/^CYO_ #6;
M]L/_ .A]H_XBCO\ @A1_T?-_YK-^V'_]#[7W_P#\.G?^"67_ $C3_8 _\0W_
M &=?_G<T?\.G?^"67_2-/]@#_P 0W_9U_P#G<T ? '_$4=_P0H_Z/F_\UF_;
M#_\ H?:/^(H[_@A1_P!'S?\ FLW[8?\ ]#[7W_\ \.G?^"67_2-/]@#_ ,0W
M_9U_^=S1_P .G?\ @EE_TC3_ & /_$-_V=?_ )W- 'P!_P 11W_!"C_H^;_S
M6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\ T/M??_\ PZ=_X)9?](T_V /_ !#?
M]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S0!_E"?\%ZOVH_@3^VC_P %
M8OVK/VE_V:/'/_"RO@E\2O\ A1G_  A7C7_A&?&/@[^VO^$._9M^#O@#Q'_Q
M3GC_ ,/>%?%NG?V=XM\*Z]I/_$VT&P^V?8/M]A]JTRZLKVX_I^_X,8_^<HO_
M '9-_P"_<5_.#_P<>?"?X6? [_@LY^V3\+?@I\-/A_\ !_X9>%_^&>?^$9^'
M7PM\&^'/A_X$\._VW^RI\#?$6L_V%X1\)Z;I'A_2/[7\0:OJNNZG_9^GV_V_
M6-3U#4[KS;V]N9Y?Z/O^#&/_ )RB_P#=DW_OW% ']_E%%% !1110 4444 %%
M%% !7^<?7^CA7^<?7^?_ -.C_FUO_=[_ /OHG^7_ .TB_P";,_\ >1/_ 'Q3
M^U3_ ())_P#*/G]G_P#[JK_ZNWXDU\X_\%W/^31?AU_V<=X1_P#59?%^OH[_
M ())_P#*/G]G_P#[JK_ZNWXDU\X_\%W/^31?AU_V<=X1_P#59?%^OV#B;_E$
M;#?]F?X2_P#5'DQ^\<7_ /*#&$_[,/P/_P"L[P^?M57YQ_\ !6S_ )1\_M ?
M]TJ_]7;\-J_1ROSC_P""MG_*/G]H#_NE7_J[?AM7[!XL_P#)J_$O_LW_ !E_
MZSF9'[QXW_\ )EO%[_LU_'__ *RF;'T=^QU_R:+^RQ_V;C\#_P#U67ABC]L7
M_DT7]J?_ +-Q^.'_ *K+Q/1^QU_R:+^RQ_V;C\#_ /U67ABC]L7_ )-%_:G_
M .S<?CA_ZK+Q/1_S:O\ [Q__ .^X'_-EO^\7_P#OJ'SC_P $D_\ E'S^S_\
M]U5_]7;\2:_1ROSC_P""2?\ RCY_9_\ ^ZJ_^KM^)-?HY1X3?\FK\-/^S?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/BKPKX7\=^
M%_$G@CQOX;T#QEX+\9:!K'A7Q?X0\5:/IWB'POXJ\+^(=.N-(U_PWXDT#5[>
M\TG7- US2;R[TS6-'U.TNM.U/3KJXLKVWGMIY8F_&+XI_P#!N!_P1-^,7CG7
M/B)XN_8(^'ND^(/$/]F_VA8?"WQ]\;?@;X'@.E:1I^BVQT7X8_!3XG?#[X;>
M&C-9Z;;SZF?#GA/2CK6KRZAX@U@W^O:MJNI7G[=T4 ?A)X1_X-FO^"'?@CQ3
MX;\8:-^PAX<O=6\*Z_H_B32[3Q=\:?VEOB!X6NM1T/4+;4[*V\2>!O'OQG\2
M>"O&6@3W-K%%K'A3Q?X?USPOXAT]KG2=?T?4]*O+NRG_ &=^%_PH^%OP0\"Z
M%\+O@M\-? 'PA^&?A<:D/#/P[^%_@[P[X \"^'1K.KZAX@U@:%X1\*:=I.@:
M0-5U[5M4UO4AI^GV_P!NU?4M0U*Z\V]O+B:3OJ* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _@#_X/G/^<77_ '>S_P"^
MCU^_W_!KC_R@H_89_P"[F?\ UL/]H*OP!_X/G/\ G%U_W>S_ .^CU^_W_!KC
M_P H*/V&?^[F?_6P_P!H*@#]_J*** "OX _^#YS_ )Q=?]WL_P#OH]?W^5_
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MZ6</V_\ _P %W[17_P!']0!_7[17\@7_ !#B?\%3?^EG#]O_ /\ !=^T5_\
M1_4?\0XG_!4W_I9P_;__ /!=^T5_]']0!_7[17\@7_$.)_P5-_Z6</V__P#P
M7?M%?_1_4?\ $.)_P5-_Z6</V_\ _P %W[17_P!']0!_7[17\@7_ !#B?\%3
M?^EG#]O_ /\ !=^T5_\ 1_4?\0XG_!4W_I9P_;__ /!=^T5_]']0!_7[17\@
M7_$.)_P5-_Z6</V__P#P7?M%?_1_4?\ $.)_P5-_Z6</V_\ _P %W[17_P!'
M]0!_7[17\@7_ !#B?\%3?^EG#]O_ /\ !=^T5_\ 1_4?\0XG_!4W_I9P_;__
M /!=^T5_]']0!^ /_!ZM_P I3?@'_P!F ?"S_P!:*_:JH_X,J?\ E*;\?/\
MLP#XI_\ K17[*M?G!_P<+?L4_'W]A#]M#X8_"+]HS]NKXP?\%!?&WB/]F#P7
M\1]+^,WQKA\:0>*O#/A75_BM\:O#%C\,=/3QU\7_ (U:N?#^C:OX/USQ5:M;
M^*M/TXZCXTU40^'[6Y%YJ.J_H_\ \&5/_*4WX^?]F ?%/_UHK]E6@#_3[HHH
MH **** "BBB@ HHHH ^<?VQ?^31?VI_^S<?CA_ZK+Q/7\#M?WQ?MB_\ )HO[
M4_\ V;C\</\ U67B>OX':_S?^F__ ,E5P/\ ]D_F/_JQB?Y+_M%_^2T\.?\
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M^/\ _P!93-CZ._8Z_P"31?V6/^S<?@?_ .JR\,4?MB_\FB_M3_\ 9N/QP_\
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M6?\ ADW_ (.R?^DG7[#O_A ^#/\ Z7K1_P ,F_\ !V3_ -).OV'?_"!\&?\
MTO6O\$_^)4.'?^DPOH@?^)KXI_\ TF_/\^S/U'^W:W_1/\0?^$V!_P#GCY_G
MV9_5-17\K/\ PR;_ ,'9/_23K]AW_P ('P9_]+UH_P"&3?\ @[)_Z2=?L._^
M$#X,_P#I>M'_ !*AP[_TF%]$#_Q-?%/_ .DWY_GV8?V[6_Z)_B#_ ,)L#_\
M/'S_ #[,_JFHK^5G_ADW_@[)_P"DG7[#O_A ^#/_ *7K1_PR;_P=D_\ 23K]
MAW_P@?!G_P!+UH_XE0X=_P"DPOH@?^)KXI__ $F_/\^S#^W:W_1/\0?^$V!_
M^>/G^?9G]4U%?RL_\,F_\'9/_23K]AW_ ,('P9_]+UH_X9-_X.R?^DG7[#O_
M (0/@S_Z7K1_Q*AP[_TF%]$#_P 37Q3_ /I-^?Y]F']NUO\ HG^(/_"; _\
MSQ\_S[,_JFHK^5G_ (9-_P"#LG_I)U^P[_X0/@S_ .EZT?\ #)O_  =D_P#2
M3K]AW_P@?!G_ -+UH_XE0X=_Z3"^B!_XFOBG_P#2;\_S[,/[=K?]$_Q!_P"$
MV!_^>/G^?9G]4U%?RL_\,F_\'9/_ $DZ_8=_\('P9_\ 2]:/^&3?^#LG_I)U
M^P[_ .$#X,_^EZT?\2H<._\ 287T0/\ Q-?%/_Z3?G^?9A_;M;_HG^(/_";
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MB_\ K0Y2?W]^RY_Y3K\#?^\F?^N>\03^>;]AK]EW_AM#]J7X7?LT_P#"<_\
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MY?[0RC$8#-&\:_R9_P"(HG_JQO\ \V8__)^H_P"5DS_JS'_AC'_NXK_A9/\
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M/C9XD_ZS?ZZ\:_ZS<8\'?VU_J=QCQ!P#PY_QCG /$'"O"67?V=PEPKD.4_\
M"3D. ^N?4/K^/^M9GBL9C,1_69_PX8_X;A_XS4_X:K_X5A_PU_\ \91?\*U_
MX4;_ ,)K_P *\_X: _XNQ_P@W_"9?\+A\)?\);_PB7_"6_V!_P )-_PBOAG^
MWO[/_M7_ (1_1OM?]FVQ_P .&/\ AA[_ (S4_P"&J_\ A9__  R!_P 91?\
M"M?^%&_\(5_PL/\ X9__ .+L?\(-_P )E_PN'Q;_ ,(E_P );_PB7]@?\)-_
MPBOB;^P?[0_M7_A']9^R?V;<_P!#/[ __)BO[%G_ &:9^SE_ZI[P;1^WQ_R8
MK^VG_P!FF?M&_P#JGO&5?M<?"S@/^PUQ)_87_"U_9*SSZ[_:><_\C3ZG]?\
MK7U;^T?JG^]_O?8>P^K_ /+OV/LO</\ ,*/T]/I8?\137@K_ ,16_P"-9?\
M$0%X7?ZM?ZC>&W_)"?ZQ?ZI_V%_;/^IW^L'_ "3_ /PG_P!I_P!J_P!L?\Q7
M]H?7?]I/YYO^(HG_ *L;_P#-F/\ \GZC_E9,_P"K,?\ AC'_ +N*_P"%D_\
M#17_ (8K_A#_ /A#_P#A17_4T_\ "0?\)3_S _[$_P")O_)G7]9G_!KM_P W
MR?\ =L__ +\#7XIP1QOQ1XC\499P9QGF?]L\-9S]=_M++?J679=]9_L[+L7F
MN#_VS*L)@<?1]CC\#A:_[C%4O:>R]E5YZ,ZE.?\ I[]*/Z+G@5]"[P*XY^DM
M]&G@;_B&WC9X;?ZL_P"I7&O^LW&/&/\ 8O\ KCQCP_P#Q'_QCG'W$'%7"68_
MVCPEQ5GV4_\ "MD./^I_7_K^ ^JYGA<'C,.?\0NW_5\G_FL__P"4#1_P_G_X
M8>_XPK_X94_X6?\ \,@?\8N_\+*_X7E_PA7_  L/_AG_ /XM/_PG/_"&_P#"
MGO%O_")?\);_ ,(E_;__  C/_"5>)O[!_M#^RO\ A(-9^R?VE<_UF5_F-?M\
M?\GU?MI_]G9_M&_^KA\95]KXEX'"^#^"RS,O#JE_J[C<XQ5; YE6YZF;_6<+
M0I+$4J7L\]GF=*CR56Y\]"G2J2^&4Y1]T_F#Z$7%.>_M'.*N.."OIFX[_B,G
M#/AOP_E_%/!>6?5<'X>?V-GN:YD\IQ^.^N^%6'X&S#,?K&7QCA_JN:XO'8.E
M;VM'#TZ[=1_T,_\ #^?_ (;A_P",*_\ AE3_ (5A_P -?_\ &+O_  LK_A>7
M_":_\*\_X: _XM/_ ,)S_P (;_PI[PE_PEO_  B7_"6_V_\ \(S_ ,)5X9_M
M[^S_ .RO^$@T;[7_ &E;'_$+M_U?)_YK/_\ E U_/-^P/_R?5^Q9_P!G9_LY
M?^KA\&U_IRT_#3 X7Q@P&9YEXBTO]8L;D^+I8'+:W/4RCZMA:]'ZQ5I>SR*>
M64JW/52GSUZ=6I'X8SC'W1_3>XISW]G'Q3P/P5]#+'?\0;X9\2,@S'BGC3+/
MJN#\0_[9SW*LQAE. QWUWQ5P_'.89=]7R^4L/]5RK%X'!U;^UK8>I72J+^3/
M_E6S_P"KSO\ AL[_ +MU_P"%;?\ #.O_ (?7_A,/^$P_X7K_ -2M_P (_P#\
M(M_S'/[;_P")0?\ $43_ -6-_P#FS'_Y/U'_  =$_P#-C?\ W<Q_[[]7\F=?
M$\;\;\4>''%&9\&<&9G_ &-PUDWU+^S<M^I9=F/U;^T<NPF:XS_;,UPF.Q];
MVV/QV*K_ +_%5?9^U]E2Y*,*=.']/?1<^BYX%?31\"N!OI+?26X&_P"(D^-G
MB3_K-_KKQK_K-QCP=_;7^IW&/$' /#G_ !CG /$'"O"67?V=PEPKD.4_\).0
MX#ZY]0^OX_ZUF>*QF,Q'Z&?\%+/A=_PB'QU\)_&K^W?[0_X;F^$NA?MY_P#"
M-?V9]D_X5=_PTUXP\>>+/^%5?VS_ &A<_P#";?\ "$_9OL'_  G/]E>$?^$D
MW_:O^$/T#;]F;]#?^#:?_D^KXK_]FF>.O_5P_ BODS_@J_\ \XU?^T3/[''_
M +T:OK/_ (-I_P#D^KXK_P#9IGCK_P!7#\"*\/ANA2P_C1DU.C#DA+.\)7DN
M:4KU<5@8XFO.\W)KGKUJD^5/ECS<L%&"C%?I_C7FF/SC]F3XC8O,:_UC$4?"
M_.LKIU/94:/+@,CXJJ9+E=#DH4Z4']5RS+\)AO:RBZU?V/ML14K8BI5JS_M_
MHHHK^\S_ )-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\5M6\4:_J&K>!/!-OX<NK/7?"NG>'M.M_%,.IZ5XJN?$&DW?A3^E>BBC^ON
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OP!_X.CO\ E!1^W-_W;-_ZV'^S[7[_ %?@
M#_P='?\ *"C]N;_NV;_UL/\ 9]H _ '_ (,8_P#G*+_W9-_[]Q7]_E?P!_\
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MAS7W_0!_(%_Q$=_\%3?^E8_]O_\ \&/[17_T -'_ !$=_P#!4W_I6/\ V_\
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M_P#!4W_I6/\ V_\ _P &/[17_P! #7]?M% '\@7_ !$=_P#!4W_I6/\ V_\
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MXO\ ^4&,)_V8?@?_ -9WA\_:JOSC_P""MG_*/G]H#_NE7_J[?AM7Z.5^<?\
MP5L_Y1\_M ?]TJ_]7;\-J_8/%G_DU?B7_P!F_P",O_6<S(_>/&__ ),MXO?]
MFOX__P#64S8^COV.O^31?V6/^S<?@?\ ^JR\,4?MB_\ )HO[4_\ V;C\</\
MU67B>C]CK_DT7]EC_LW'X'_^JR\,4?MB_P#)HO[4_P#V;C\</_59>)Z/^;5_
M]X__ /?<#_FRW_>+_P#WU#YQ_P""2?\ RCY_9_\ ^ZJ_^KM^)-?HY7YQ_P#!
M)/\ Y1\_L_\ _=5?_5V_$FOT<H\)O^35^&G_ &;_ (-_]9S+0\$/^3+>$/\
MV:_@#_UE,I/Q5_X(1_\ )HOQ%_[..\7?^JR^$%?M57XJ_P#!"/\ Y-%^(O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***^1?VX_P!N/]G/_@G=^SGXT_:>_:>\9CPI\/O"
M:QZ?I6DZ=';:CXX^)/C?4+6]N/#?PQ^&/ANXO=//BGQ]XH_L^];3M.:]T_2=
M(TG3];\8^,=;\,> _#'BKQ5H@&^Q]=45_F&?M2_\'F__  44^*;^.-!_9D^$
MOP!_94\(:X?#8\%^)9]'U;XZ?'/P,-+_ + O/$+?\)AXXN=+^"WB7_A*-2T_
M7+'&K?LXK_8GA#Q#_95B9/%>DV?CM_@'_B*5_P""Z7_1[-M_XC1^R1_\XBA:
M^7K<=O-?U_7^5S_7QHK_ "#O^(I7_@NE_P!'LVW_ (C1^R/_ /.(H_XBE?\
M@NE_T>S;?^(T?LC_ /SB*?S7X_Y?U9^5SYK\?\OZL_*_^OC17\*'_!L!_P %
MF?\ @I%_P46_;O\ C%\&?VQ/VB(OBW\-?"?[)'C;XG:#X;C^$/P,\ ?8O'&D
M_&/X%>%=.UQM8^&7PT\&Z_=?9M \8^)+ :;=ZI/I$W]IFZN-/FO;/3[BT_NO
MI/3\/Q5Q?I_E?]0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH _@#_ .#YS_G%U_W>S_[Z/7[_ '_!KC_R@H_89_[N9_\ 6P_V@J_
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M_MA__1!4 ??_ /P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\
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M /\ Q,C]G7_YXU? '_$+C_P0H_Z,9_\ -F?VP_\ Z(*C_B%Q_P""%'_1C/\
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MGR'P?'F(S.MA, L?EU' PCB*KIRI9@L8YR=)7BXK#4.1):\UY7>EEN?WN_\
M!H5_RC8^-W_9\7Q*_P#5"_LT5_5-7\K/_!H5_P HV/C=_P!GQ?$K_P!4+^S1
M7]4U?Y+_ $_/^4R?I"?]E_B__4# 'WO"W_)/93_V"0_]*D%%%%?R >^%%%%
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ME?9/[9U+[3_0S_PWQ^PK_P!'I_LF?^)&_![_ .;&OQ _X++?!;QA_P %0/\
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M_"KO^$*^,/P,^'/@_P"$OQ3\(?\ "2_&?X=^#_$?_"+_ !!\ Z-X?\6^'_\
MA(/"7B#7O"^M_P!DZO:?VKX=UO5]$O\ S],U*\M9OXV?^&^/VZO^CT_VL_\
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M ';-_P"MA_L^U^_U?@#_ ,'1W_*"C]N;_NV;_P!;#_9]H _ '_@QC_YRB_\
M=DW_ +]Q7]_E?P!_\&,?_.47_NR;_P!^XK^_R@ HHHH ^ /^"L7_ "BR_P""
MEG_9@'[9'_K.OQ&K_$&K_;Y_X*Q?\HLO^"EG_9@'[9'_ *SK\1J_Q!J /]%S
M]B+]E#_@[ \1_L7_ +(GB']G/_@IM^Q!X"_9\U[]F#X!:S\"? OBSP#X-O/%
M7@OX-:I\*?"=]\,/"?B:\NO^"?/C2YNO$'ASP3/H>CZS<W'C'Q9//J-G<RS>
M)M=D9M4NOI__ (8W_P"#R3_I+%^P!_X;GP-_]+3K]_O^"3O_ "BR_P"":?\
MV8!^QO\ ^LZ_#FOO^@#^0+_AC?\ X/)/^DL7[ '_ (;GP-_]+3H_X8W_ .#R
M3_I+%^P!_P"&Y\#?_2TZ_K]HH _D"_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ/^
M&-_^#R3_ *2Q?L ?^&Y\#?\ TM.OZ_:* /Y O^&-_P#@\D_Z2Q?L ?\ AN?
MW_TM.C_AC?\ X/)/^DL7[ '_ (;GP-_]+3K^OVB@#^0+_AC?_@\D_P"DL7[
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M9?%^OV#B;_E$;#?]F?X2_P#5'DQ^\<7_ /*#&$_[,/P/_P"L[P^?M57YQ_\
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MW'Q/_P"H_P#M3U^U5'A/_P C'QB_[/!G?_K*\&AX(_\ (V\>O^S\<1?^L7P
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M -FX^+O_ %9OP@H_X+N?\G=?#K_LW'PC_P"K-^+]'_!"/_D[KXB_]FX^+O\
MU9OP@K^'_P#G,K_O('_NB?YS_P#.?G_>4/\ WFG]8U%%%?Z@'^R 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_$:M_P $LO\ H@?[?_\ X:S]G7_Z*JC_ (C5O^"67_1 _P!O_P#\-9^SK_\
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M?_K17[*M'_!ZM_RE-^ ?_9@'PL_]:*_:JH_X,J?^4IOQ\_[, ^*?_K17[*M
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M_P F6\7O^S7\?_\ K*9L?1W['7_)HO[+'_9N/P/_ /59>&*/VQ?^31?VI_\
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MU5?/^ '_ "9KP\_[)^C_ .G\0?+_ $8?^3 ^%G_9+X?_ -2<2?BK_P $P?\
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M>7_YKO\ M6__ #C*^XO^'8O_  38_P"D>O[#O_B)OP%_^8&C_AV+_P $V/\
MI'K^P[_XB;\!?_F!H_M+Z W_ $1OTO\ _P 67X,?_2G]?Z>AR<4_]!'#_P#X
M1YC_ /-_K_3T^'?^(D/_ ((N_P#1Y?\ YKO^U;_\XRC_ (B0_P#@B[_T>7_Y
MKO\ M6__ #C*^XO^'8O_  38_P"D>O[#O_B)OP%_^8&C_AV+_P $V/\ I'K^
MP[_XB;\!?_F!H_M+Z W_ $1OTO\ _P 67X,?_2G]?Z>AR<4_]!'#_P#X1YC_
M /-_K_3T^'?^(D/_ ((N_P#1Y?\ YKO^U;_\XRC_ (B0_P#@B[_T>7_YKO\
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M*\)9=_9W"7"N?9M_PK9]@/KGU#ZA@/K69XK!X/$?UF5_F-?M\?\ )]7[:?\
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M5_0S_P 11/\ U8W_ .;,?_D_4?\ #AC_ (;A_P",U/\ AJO_ (5A_P -?_\
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MFJZ)KVB:K::AX?\ %7A77[#2_$_A#Q/I>L>%O%.CZ/XBT?4],M/\;#_@K/\
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M ! \'?9=>UWXS>'-6T_4?^$>\.>/O@AJ=A>I_P )5>0+_(%^WK_P= _M]?\
M!1+]D[XK?L=?&OX1?L@>%_AE\8/^$%_X2;7?A;X!^-&B>.['_A7_ ,2?!WQ2
MT;^PM3\6?'_QMX?MOM/B#P3I5GJ?]H>&-3\[1[C4+>U^Q7LMMJ%I_JM?&O\
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M  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?O\
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M5_\ 5V_$FOT<H\)O^35^&G_9O^#?_6<RT/!#_DRWA#_V:_@#_P!93*3\5?\
M@A'_ ,FB_$7_ +..\7?^JR^$%?M57XJ_\$(_^31?B+_V<=XN_P#59?""OVJK
MY_P _P"3->'G_9/T?_3^(/E_HP_\F!\+/^R7P_\ ZDXD_%7_ ()@_P#)W7_!
M5S_LXZV_]6;^T=7[55^*O_!,'_D[K_@JY_V<=;?^K-_:.K]JJ/ ?_DV65_\
M90>('_KPN*@^C3_R9_)O^RH\4/\ UZ?&A^*OP/\ ^4X'[8O_ &;CX8_]1_\
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MJ'"/%F1Y'3P^#<</BZ6&HX+'8G$1G7Q-;$TZM.GA_P [XHP/&&*S!/**N)6
M5*'LXX7'4<#*-3EM555O$4*M5N7O1<G*,8M**33O^'?_ !$A_P#!:+_H\O\
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M**_*#N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *997]?M% '\@7_#9'_!Y)_TB=_8 _\ #C>!O_IEE'_#9'_!Y)_TB=_8 _\
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M3+>+W_9K^/\ _P!93-CZ._8Z_P"31?V6/^S<?@?_ .JR\,4?MB_\FB_M3_\
M9N/QP_\ 59>)Z/V.O^31?V6/^S<?@?\ ^JR\,4?MB_\ )HO[4_\ V;C\</\
MU67B>C_FU?\ WC__ -]P/^;+?]XO_P#?4/G'_@DG_P H^?V?_P#NJO\ ZNWX
MDU]'?MB_\FB_M3_]FX_'#_U67B>OG'_@DG_RCY_9_P#^ZJ_^KM^)-?1W[8O_
M ":+^U/_ -FX_'#_ -5EXGKY_A+_ ),#PS_V9_)O_6+PQ\OP/_RC%PA_V8?A
M_P#]=]A#YQ_X))_\H^?V?_\ NJO_ *NWXDU^CE?G'_P23_Y1\_L__P#=5?\
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MXW_[)_QR_P#6@X[/R_AC_E#?Q%_[)?Z1_P#ZU'B4?Q5U_HX5_G'U_HX5^/\
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M(.^'_P#XN[Z0G_T>^O\ 2U/[,SG_ **7%_\ AMRG_P"9?7^EK_*S_P /^O\
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M_P#*=?@;_P!Y,_\ 7/>()_)G7ZS?\$-/^4I?[+W_ '6S_P!9V^+=<E_P1N\
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M /PSC_P[_P!&^$O[*_\ PO'_ (6__P +:_X5=\ _@58?\)W_ ,*T_P"%7?\
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M^!K^LROYC?\ @LM\:?&'_!+_ /X9Q_X=_P"C?"7]E?\ X7C_ ,+?_P"%M?\
M"KO@'\"K#_A._P#A6G_"KO\ A _[=_M+X<ZGYO\ PB__  L#QG_9GD^1Y?\
MPD6H>9YN^/R_P_\ ^'Y?_!4O_HZ'_P PG^SM_P#.DKU,J\1^'/"' 4/#O.Z.
M=YGFG#WM?K6.RK!8!X"O_:U:IGE'V#Q>;8;$?NL/F=*C5]I1A^^IU.3FARSE
M\'Q[]"_QH_:+<69K],GPOS/PPX'X%\8OJ/\ 8?"_'O$_%<.+,K_XA]EN#\+,
MS_M6/#WA_G63KZ[G'!&89C@?J>9XF^6XO!O$>QQ3KX>E\F?M\?\ )]7[:?\
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M_B-6_P""67_1 _V__P#PUG[.O_T55'_$:M_P2R_Z('^W_P#^&L_9U_\ HJJ
M/O\ _P"(7'_@A1_T8S_YLS^V'_\ 1!4?\0N/_!"C_HQG_P V9_;#_P#H@J^
M/^(U;_@EE_T0/]O_ /\ #6?LZ_\ T55'_$:M_P $LO\ H@?[?_\ X:S]G7_Z
M*J@#[_\ ^(7'_@A1_P!&,_\ FS/[8?\ ]$%1_P 0N/\ P0H_Z,9_\V9_;#_^
MB"KX _XC5O\ @EE_T0/]O_\ \-9^SK_]%51_Q&K?\$LO^B!_M_\ _AK/V=?_
M **J@#[_ /\ B%Q_X(4?]&,_^;,_MA__ $05'_$+C_P0H_Z,9_\ -F?VP_\
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M>$_%?C;P_;?:?$'@G5;S3/[/\3ZGYVCW&GW%U]BO9;G3[3^KW_@QC_YRB_\
M=DW_ +]Q0!_?Y1110 4444 %%%% !1110 5_G'U_HX5_G'U_G_\ 3H_YM;_W
M>_\ [Z)_E_\ M(O^;,_]Y$_]\4_M4_X))_\ */G]G_\ [JK_ .KM^)-?./\
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M7_\ OJ'SC_P23_Y1\_L__P#=5?\ U=OQ)K]'*_./_@DG_P H^?V?_P#NJO\
MZNWXDU^CE'A-_P FK\-/^S?\&_\ K.9:'@A_R9;PA_[-?P!_ZRF4GXJ_\$(_
M^31?B+_V<=XN_P#59?""OVJK\5?^"$?_ ":+\1?^SCO%W_JLOA!7[55\_P"
M'_)FO#S_ +)^C_Z?Q!\O]&'_ ),#X6?]DOA__4G$GXJ_\$P?^3NO^"KG_9QU
MM_ZLW]HZOVJK\5?^"8/_ "=U_P %7/\ LXZV_P#5F_M'5^U5'@/_ ,FRRO\
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M[..\(_\ JLOB_7[54<*?\GE\7_\ LG_"O_TQQF'!/_)_O';_ +)?P6_]1O$
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MT4:'I^'XJX=_+_)/]0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#GC4 ?@#_Q#B?\%3?^EG#]O_\ \%W[17_T?U'_ !#B?\%3?^EG#]O_ /\
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M^C:OX/USQ5:M;^*M/TXZCXTU40^'[6Y%YJ.J_H__ ,&5/_*4WX^?]F ?%/\
M]:*_95KQ_P#X.Z_VA?@%^TI_P4D^"7CK]G/XX_!_X_>"=)_8@^&WA/5/&/P4
M^)?@OXJ>%=-\56/QY_:5UB^\,ZAXA\"ZUKVD6?B"STC7=#U2ZT:XO(]1M].U
MG2KZ:V2VU&SEF]@_X,J?^4IOQ\_[, ^*?_K17[*M '^GW1110 4444 %%%%
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M3_LH/#__ ->%PJ?4?26_Y,_G/_94>%__ *]/@L_:JOQ5_P""GW_)W7_!*/\
M[..N?_5F_LXU^U5?BK_P4^_Y.Z_X)1_]G'7/_JS?V<:/'C_DV6:?]E!X?_\
MKPN%0^DM_P F?SG_ +*CPO\ _7I\%G[55^*O_!=S_DT7X=?]G'>$?_59?%^O
MVJK\5?\ @NY_R:+\.O\ LX[PC_ZK+XOT>/\ _P F:\0_^R?K?^G\.'TGO^3
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MS^S_ /\ =5?_ %=OQ)K]'*_./_@DG_RCY_9__P"ZJ_\ J[?B37Z.5]!X3?\
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M_2/_ /6H\2C^*NO]'"O\X^O]'"OQ_P"@O_S=+_NR/_?N/P?]F[_S>;_O'?\
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M'P9_]+UH_P"&3?\ @[)_Z2=?L._^$#X,_P#I>M?U344?\3C\1?\ 1A/H@?\
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M_P#.;^KORL?ZO4?^AIQ!_P"'K'?_ "S^KORM_*S_ ,,F_P#!V3_TDZ_8=_\
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MS!X6?_.;^KORL?ZO4?\ H:<0?^'K'?\ RS^KORM_*S_PR;_P=D_]).OV'?\
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M!\4^&L7/+\LR_(J,<]P^+RI<)<3\.8E8RMB9NC6>+KXFA[!)0I1J>^?RP?\
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MO]FW]H3X&?!W]J3]F+X@?%SXT? _XL?"?X6> M _:)^#,VN^-_B/\1O 6O\
M@_P/X0T6*?QO!!+JWB7Q-K.EZ-IL<T\,3WE["LDL:$NO\'O[?'_)]7[:?_9V
M?[1O_JX?&5'[ _\ R?5^Q9_V=G^SE_ZN'P;7RR\<<R^MK@_^P<#]1^L+AKZU
M]<K_ %OZI[197[?^%['ZQ[&]3^'[/VGV.5<K_=U^RQX+_L!?2._XBUQ1_K3_
M &.O&W^P_P#5W*?[ _M_ZDN._P"R;?7O[1_L?^T;X.WUWZ[]2T^M>W7M7]9_
M\.-/^"I?_1KW_F;/V=O_ )[=?N!_P1I^"WC#_@E__P -'?\ #P#6?A+^RO\
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M;X_85_Z/3_9,_P#$C?@]_P#-C7\>'[3?_!(W_@H)\>_VDOVA/CG\'?@9I/Q
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MC?\ ]9U^'-??]?PQ_L1?M7_\'8'AS]B_]D3P]^SG_P $R?V(/'O[/F@_LP?
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M .F64?\ #9'_  >2?](G?V /_#C>!O\ Z990!_7[17\@7_#9'_!Y)_TB=_8
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MNX^_[/!XH?\ K58T/ '_ )%/B=_V?CQD_P#6TS _%7XX?\IP/V.O^S<?$_\
MZC_[4]?M57XJ_'#_ )3@?L=?]FX^)_\ U'_VIZ_:JCPG_P"1CXQ?]G@SO_UE
M>#0\$?\ D;>/7_9^.(O_ %B^ #\5?^"[G_)HOPZ_[..\(_\ JLOB_7[55^*O
M_!=S_DT7X=?]G'>$?_59?%^OVJHX4_Y/+XO_ /9/^%?_ *8XS#@G_D_WCM_V
M2_@M_P"HWB ?G'_P5L_Y1\_M ?\ =*O_ %=OPVKZ._8Z_P"31?V6/^S<?@?_
M .JR\,5\X_\ !6S_ )1\_M ?]TJ_]7;\-J^COV.O^31?V6/^S<?@?_ZK+PQ1
MAO\ D_V<_P#9G^&?_6TXM#"?\I.\0?\ 9A^$/_7@\<'\X_\ P7<_Y.Z^'7_9
MN/A'_P!6;\7Z/^"$?_)W7Q%_[-Q\7?\ JS?A!1_P7<_Y.Z^'7_9N/A'_ -6;
M\7Z/^"$?_)W7Q%_[-Q\7?^K-^$%?P_\ \YE?]Y _]T3_ #G_ .<_/^\H?^\T
M_K&HHHK_ % /]D HHHH **** "BBB@ K_()_X*^?$CQI\5?^"HW[?7B?Q[K/
M]O:YI?[57QC^&]C??V=I.E^1X+^#?C'4OA!\-]&^S:-8Z=9R_P#".?#OP-X6
M\/?VC-;R:MK']E_VMKU]JFN7NHZG=_Z^U?XZ/_!3K_E)/_P4*_[/B_:R_P#5
M]>/J_P!M/V(V$PL_%[QIQT\-AYX[#>&^3X3#XR5&G+%4,+C>)\/6QF&HXAQ=
M:EA\76P&!JXFC"<:=>I@L).K&<L-1</S;Q)E)8#+8*3498NI)QN^5RC1:C)K
M9N*G-1;5TI22MS._P[17^C5_P:%?\HV/C=_V?%\2O_5"_LT5_5-7]4>/W[7;
M_B!OC)XA>$G_ !+Y_K1_J'Q!6R+_ %@_XBQ_8G]J^RP^'K_6O[*_XAKF_P!1
MYO;\OL/[2QEN7F]L^:R\3*N ?[3R_"8_^UO8?6J*J^R^H>T]G=M<OM/KE/FV
MWY(^A_AWT5_N(45^/_\ %<S_ *Q=_P#.V?\ Y(ST/^(9_P#4[_\ ,;_]_G^'
M?17^XA11_P 5S/\ K%W_ ,[9_P#DC#_B&?\ U.__ #&__?Y_AWT5_N(44?\
M%<S_ *Q=_P#.V?\ Y(P_XAG_ -3O_P QO_W^?X=]%?[B%%'_ !7,_P"L7?\
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M05 '[_4444 %?P!_\'SG_.+K_N]G_P!]'K^_ROX _P#@^<_YQ=?]WL_^^CT
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M_$:M_P $LO\ H@?[?_\ X:S]G7_Z*J@#[_\ ^(7'_@A1_P!&,_\ FS/[8?\
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M_P#R6GAS_P!DOFO_ *MHG]\7['7_ ":+^RQ_V;C\#_\ U67ABOSC^.'_ "G
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MUUTO:3G*$8_OE3Y;R5Y\L5=M)_N)_P 0A7_!-C_HMW[<7_ARO@+_ /0T4?\
M$(5_P38_Z+=^W%_X<KX"_P#T-%?<7_$2'_P1=_Z/+_\ -=_VK?\ YQE'_$2'
M_P $7?\ H\O_ ,UW_:M_^<97^.?_ !$O]K=_T+?I?_\ BI^-_P#Z#?+\^[/T
M'ZGP%_/P_P#^%^&_^:/+\^[/AW_B$*_X)L?]%N_;B_\ #E? 7_Z&BC_B$*_X
M)L?]%N_;B_\ #E? 7_Z&BON+_B)#_P""+O\ T>7_ .:[_M6__.,H_P"(D/\
MX(N_]'E_^:[_ +5O_P XRC_B)?[6[_H6_2__ /%3\;__ $&^7Y]V'U/@+^?A
M_P#\+\-_\T>7Y]V?#O\ Q"%?\$V/^BW?MQ?^'*^ O_T-%'_$(5_P38_Z+=^W
M%_X<KX"__0T5]Q?\1(?_  1=_P"CR_\ S7?]JW_YQE'_ !$A_P#!%W_H\O\
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MW%_Q$A_\$7?^CR__ #7?]JW_ .<91_Q$A_\ !%W_ */+_P#-=_VK?_G&4?\
M$2_VMW_0M^E__P"*GXW_ /H-\OS[L/J? 7\_#_\ X7X;_P":/+\^[/AW_B$*
M_P"";'_1;OVXO_#E? 7_ .AHH_XA"O\ @FQ_T6[]N+_PY7P%_P#H:*^XO^(D
M/_@B[_T>7_YKO^U;_P#.,H_XB0_^"+O_ $>7_P":[_M6_P#SC*/^(E_M;O\
MH6_2_P#_ !4_&_\ ]!OE^?=A]3X"_GX?_P#"_#?_ #1Y?GW9\._\0A7_  38
M_P"BW?MQ?^'*^ O_ -#11_Q"%?\ !-C_ *+=^W%_X<KX"_\ T-%?<7_$2'_P
M1=_Z/+_\UW_:M_\ G&4?\1(?_!%W_H\O_P UW_:M_P#G&4?\1+_:W?\ 0M^E
M_P#^*GXW_P#H-\OS[L/J? 7\_#__ (7X;_YH\OS[L^'?^(0K_@FQ_P!%N_;B
M_P##E? 7_P"AHH_XA"O^";'_ $6[]N+_ ,.5\!?_ *&BON+_ (B0_P#@B[_T
M>7_YKO\ M6__ #C*/^(D/_@B[_T>7_YKO^U;_P#.,H_XB7^UN_Z%OTO_ /Q4
M_&__ -!OE^?=A]3X"_GX?_\ "_#?_-'E^?=GP[_Q"%?\$V/^BW?MQ?\ ARO@
M+_\ 0T4?\0A7_!-C_HMW[<7_ (<KX"__ $-%?<7_ !$A_P#!%W_H\O\ \UW_
M &K?_G&4?\1(?_!%W_H\O_S7?]JW_P"<91_Q$O\ :W?]"WZ7_P#XJ?C?_P"@
MWR_/NP^I\!?S\/\ _A?AO_FCR_/NSX=_XA"O^";'_1;OVXO_  Y7P%_^AHK^
M"+]L3X0>&OV?/VN?VIO@'X,OM<U/P?\ !#]HWXW_  @\*:EXGN;"]\2ZAX:^
M&OQ,\3^#-"OO$-YI6F:+I=WKEWI>BVMQJUSINC:383W\EQ+9Z986[QVL7^E_
M_P 1(?\ P1=_Z/+_ /-=_P!JW_YQE?YKG[=?Q(\%_&3]M[]L?XO_  WUG_A(
M_AW\5?VJOVA?B1X"\0_V=JVC_P!O>"_'/Q<\7^)_"VL_V3KUCI>N:7_:FAZI
M8WW]G:SIFG:M9>?]FU&QM+R*:WC_ -,?V9_%7TSN(>.?$VC]*#"^->'R'#\)
MY15X7EXI\&Y_PSE\LWEG$H8Q957SC(\IIXK&+!).M1HU*TX4??E",7S'QO&5
M#AVCAL$\EEEKJNO45?ZCB*5:?LU37+[14ZM1QCS;-I)N^MS^\'_@T*_Y1L?&
M[_L^+XE?^J%_9HK^J:OY6?\ @T*_Y1L?&[_L^+XE?^J%_9HK^J:O\3_I^?\
M*9/TA/\ LO\ %_\ J!@#](X6_P"2>RG_ +!(?^E2"BBBOY /?"BBB@ HHHH
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M%_87_$L_M/\ MG3OR9_X(:?\I2_V7O\ NMG_ *SM\6Z_K,_X+E_\HM/VH?\
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M?[1X2XJS[*?^%;(<?]3^O_7\!]5S/"X/&8<_XA=O^KY/_-9__P H&C_A_/\
M\,/?\85_\,J?\+/_ .&0/^,7?^%E?\+R_P"$*_X6'_PS_P#\6G_X3G_A#?\
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MK?VC]4_WO][[#V'U?_EW['V7N'^84?IZ?2P_XBFO!7_B*W_&LO\ B("\+O\
M5K_4;PV_Y(3_ %B_U3_L+^V?]3O]8/\ DG_^$_\ M/\ M7^V/^8K^T/KO^TG
M\\W_ !%$_P#5C?\ YLQ_^3]1_P K)G_5F/\ PQC_ -W%?\+)_P"&BO\ PQ7_
M  A__"'_ /"BO^II_P"$@_X2G_F!_P!B?\3?^3.OZS/^#7;_ )OD_P"[9_\
MWX&OQ3@CC?BCQ'XHRS@SC/,_[9X:SGZ[_:66_4LNR[ZS_9V78O-<'_MF583
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MYZ].K4C\,9QC[H_IO<4Y[^SCXIX'X*^AECO^(-\,^)&09CQ3QIEGU7!^(?\
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M)^S)7^GA5/?Y1_)$+>7K^B"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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MFO+K_@GSXTN;KQ!X<\$SZ'H^LW-QXQ\63SZC9W,LWB;79&;5+KZ?_P"&-_\
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MW_9G^$O_ %1Y,?O'%_\ R@QA/^S#\#_^L[P^?M57YQ_\%;/^4?/[0'_=*O\
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M]/C0_%7X'_\ *<#]L7_LW'PQ_P"H_P#LL5^U5?BK\#_^4X'[8O\ V;CX8_\
M4?\ V6*_:JCP:_Y%W'W_ &>#Q0_]:K&AX _\BGQ._P"S\>,G_K:9@?BK\</^
M4X'['7_9N/B?_P!1_P#:GK]JJ_%7XX?\IP/V.O\ LW'Q/_ZC_P"U/7[54>$_
M_(Q\8O\ L\&=_P#K*\&AX(_\C;QZ_P"S\<1?^L7P ?BK_P %W/\ DT7X=?\
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M7[67_J^O'U?[>?L1/^3J>-__ &;_ (>_]:.9^:^)/^Y99_V%5O\ TRC]X/\
M@A-_P0F_9&_X*>_LC?$7X^?'SXB_M&^$?&'A']HWQ=\(--TWX0>+OAGH'AJ?
MPUH'PS^$/C.SOKZS\9_"'Q_JDNN2ZIX_UFWN;FWUFVL'L+;3(HM,AN(;JZO?
MVH_XA"O^";'_ $6[]N+_ ,.5\!?_ *&BOSE_X-Q_^"M7_!/K]@S]B+XI_"#]
MJ_X__P#"JOB)XC_:J\;_ !(T;P]_PJKXV>.?MG@O6/A'\#O#&G:S_:WPW^&_
MC#0[?[1KG@_Q'8_V==ZG!JT/]G?:9[&*SN[&XNOW\_XB0_\ @B[_ -'E_P#F
MN_[5O_SC*U^E;Q[^TIRSZ17BW@/"3 _2;J>&^%XLQ%/@^IPAX<<69MPS+*%A
M<(Z;R;,<%PMC<)C,'[9U>6K0Q5>FY\\5-M-(R/"\'3RC 2Q\LE6,E0B\0L1C
M*$*WM+N_M(2KQE&5DKIQ6G34^'?^(0K_ ()L?]%N_;B_\.5\!?\ Z&BC_B$*
M_P"";'_1;OVXO_#E? 7_ .AHK[B_XB0_^"+O_1Y?_FN_[5O_ ,XRC_B)#_X(
MN_\ 1Y?_ )KO^U;_ /.,K^?/^(E_M;O^A;]+_P#\5/QO_P#0;Y?GW9ZOU/@+
M^?A__P +\-_\T>7Y]V?#O_$(5_P38_Z+=^W%_P"'*^ O_P!#11_Q"%?\$V/^
MBW?MQ?\ ARO@+_\ 0T5]Q?\ $2'_ ,$7?^CR_P#S7?\ :M_^<91_Q$A_\$7?
M^CR__-=_VK?_ )QE'_$2_P!K=_T+?I?_ /BI^-__ *#?+\^[#ZGP%_/P_P#^
M%^&_^:/+\^[/AW_B$*_X)L?]%N_;B_\ #E? 7_Z&BC_B$*_X)L?]%N_;B_\
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MVQ_:G]L?:/LNE_8O[/\ (N_MWAW_  ;>?\IHOV,_^[B/_64OCG7W%_P<S_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_Z6-5+=6V:5ONM\[--7TNU=)$KKWOKZV6OS5F%%%%2,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _@#_ .#YS_G%U_W>S_[Z/7[_ '_!
MKC_R@H_89_[N9_\ 6P_V@J_ '_@^<_YQ=?\ =[/_ +Z/7[_?\&N/_*"C]AG_
M +N9_P#6P_V@J /W^HHHH *_@#_X/G/^<77_ '>S_P"^CU_?Y7\ ?_!\Y_SB
MZ_[O9_\ ?1Z /P!_X-<?^4Z_[#/_ '<S_P"L>?M!5_K]5_BC?\$9_!O[9/Q
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M_9O^,O\ UG,R/J/&_P#Y,MXO?]FOX_\ _64S8^COV.O^31?V6/\ LW'X'_\
MJLO#%'[8O_)HO[4__9N/QP_]5EXGH_8Z_P"31?V6/^S<?@?_ .JR\,4?MB_\
MFB_M3_\ 9N/QP_\ 59>)Z/\ FU?_ 'C_ /\ ?<#_ )LM_P!XO_\ ?4/G'_@D
MG_RCY_9__P"ZJ_\ J[?B37T=^V+_ ,FB_M3_ /9N/QP_]5EXGKYQ_P""2?\
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M^P_[<_L/1/[8_LO[+_:?]CZ7]M\_^S[3R?RL_P"#D/\ Y31?MF?]V[_^LI?
MRO<?^#?_ .+/_!63X7?\-:?\.O/V8O@=^T=_;G_"A_\ A>/_  N;7]&T/_A#
M?[,_X7-_PK/_ (1O^U_VA?@/]J_X2'^T/B!_;'V?_A*O(_L/2_-_L/SHO[8_
MZN_$3(\]XD_94^'^2\,\9</\ 9WC/ #Z,7U+B[BGC3!^'F191]6J>%>+Q/U[
MC#,,7@<)D_U_"4*^687VN*I?VAC,9A\KI\]7&PIS_"\)5I4>.<54K8>KBJ4<
MUSKFH4,-+%U:EUCHQY</",I5.234Y6B^2,7/:-S^_G_AV+_P38_Z1Z_L._\
MB)OP%_\ F!H_X=B_\$V/^D>O[#O_ (B;\!?_ )@:_#O_ (:R_P"#LG_I&+^P
M[_X7W@S_ .F%4?\ #67_  =D_P#2,7]AW_POO!G_ -,*K_$+_B"'CK_TF-X
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M_ 7_ .8&C_AV+_P38_Z1Z_L._P#B)OP%_P#F!K\._P#AK+_@[)_Z1B_L._\
MA?>#/_IA5'_#67_!V3_TC%_8=_\ "^\&?_3"J/\ B"'CK_TF-X ?^-H\'>7_
M %5?]6] _M++/^B>S7_Q',1Y?]./ZMZ'[B?\.Q?^";'_ $CU_8=_\1-^ O\
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M?\1Z_M'_ (A/_P D%Q1_JU_K7_Q$+_C#_P#DK_\ 5[^PO[7_ .:D_L;^S_\
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MK_QG_9GD^?YG_".ZAYGE;(_,_H;Q%^H_ZFYQ_J3]4_UG_P"$_P#LS_57V/\
M;W_(TP'UWZA_9'_"A_R+OK7UKZO_ ,P7UCVO[CVA_CE]#/\ UJ_XF3\./^)G
M_P#6#_B!G_&8?Z\?\1Z_M'_B$_\ R07%'^K7^M?_ !$+_C#_ /DK_P#5[^PO
M[7_YJ3^QO[/_ .%3ZB?A_P#\/R_^"I?_ $=#_P"83_9V_P#G25_8?^S)^R_^
MRY\>_P!FW]GOXY_&+]EO]F+X@?%SXT? _P"$_P 6/BGX]U_]G;X,S:[XW^(_
MQ&\!:!XP\<>+]:E@\$002ZMXE\3:SJFLZE)#!#$]Y>S-'%&A"+_'A_PXT_X*
ME_\ 1KW_ )FS]G;_ .>W7]A_[,G[4'[+GP$_9M_9[^!GQB_:D_9B^'_Q<^"_
MP/\ A/\ "?XI^ M?_:)^#,.N^"/B/\.? 6@>#_''A#6HH/&\\$6K>&O$VC:I
MHVI1PSS1)>64RQRR( [?GGA#_K/_ &EF_P#Q$G^WOJ/U&A_9G^O']H?5/K?U
MC][]1_M[]S]8]E;VGU?][[.W-[I_8W[17_B!O^IGAS_Q)-_Q"C_6C_6C-?\
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M'_"CO^%0?\*E_P"%H_ /X%7_ /P@G_"R_P#A:/\ PGG]A?V;\.=,\K_A*/\
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M *P?\0,_XP__ %'_ .("_P!H_P#$)_\ D@N%O]9?]5/^(>_\8?\ \EA_;_\
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M];Y,H_M7V7]G_P"R_6/[5^N_VAR?O/[0^M?6?]I]L?V_T445_?9_R.A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '^8A_P>L_\I/OV>_\ LPSX<?\ K0G[3E?R,^$/&/B[X?>*
M?#GCGP#XJ\1^"/&O@_7M'\5>$?&'A#7-3\->*?"WB?P[J-OJ_A_Q'X<\0:+=
M66K:)KVA:M:6FJ:/K&F7=KJ&F:C:V][97$%S#'*O^YS\:OV)OV,_VE/$UAXU
M_:+_ &1_V8_C[XRTK0;7PKI?BWXU? 3X5?%3Q-IOABQU#5-7LO#EAKWCKPIK
MNJV>@V>JZYK6IVNCV]W'I]OJ&L:I>Q6Z7.H7<LWX2?'3_@T4_P""-GQ<_P"$
M:/@3P)\>?V8FT+^VO[5;X%_'/7M;_P"$T_M7^R?L/_"2I^T?IW[04=I_PC?]
MG7G]B_\ "&IX2\_^WM6_X2+^W_)T+^Q4M&_6Z^Y?Y#;O;I9)?\$_SI?&W_!8
M+_@IC\4?V8OB3^QU\7?VQ/BW\9_V??BYK6CZ_P"/?"WQJOM'^,'BG5;_ ,/Z
MYX-\3:);V'Q<^)&D>)_C%X:T+2_$/@#POK5IX6\,>/M&\+IJ5MJERVC,_B;Q
M.=9_-ZVE$%Q;S,"RPS12D#&2(Y%<@9XR0,#/&:_O=^/W_!C[XAMM/\?ZW^RW
M^WQHNL:JVO37/PM^&?Q]^#%]X:T^'PQ>>)X%M]'\?_'+X=^,O%ES<Z]X>\&3
MW,LWB3P[^SS:Z?XQ\3Z9!;IX4\"Z5KDEUX>_'[XU_P#!I'_P6@^%?BBQT'P)
M\)/@[^TII-WH-KK$_C;X+_'WX>Z!X:TO4+C4-4LI?"NH6?[15_\  3QB^OV5
MMI]IJUU<:7X4U+PN^GZYI4=EXDO-5AUO3-'I.S36ZM^#NK]P\KZ:O?K97W]%
MZM:7/ZOO@#_P>4_\$MOB;J/@#P[\9/!'[3O[->K:_H,-QX]\7>*?A]X=^)'P
M?^'WBB#PO/J^JZ/;>(/A5XQ\3?%[QCH$WB*U;PEX5\26'P&TS4-7GO\ 1]:\
M2^%?!&DRZS+H/\I/_!T_^V?^R_\ MY?MN_LW_'K]DCXP^'/C1\++K]BKPGX5
MFU_0[;7-%U+1/$_AW]HK]IB+5?#?BWP?XNTGP]XU\%Z_#;7.G:U;:-XN\.Z)
MJ.I>%];\.>+=,MKSPQXET#5]2_#OXV?L-?MK?LU^%['QO^T5^R#^T_\  ;P5
MJ>O6WA73?&/QD^ GQ3^&?A34/$][IVJ:O9^'+'Q'XS\*Z+H]WKUWI.AZWJEK
MH]O>R:A<:=H^JWL5N]MI]W+#\LD$$@C!'!!Z@^AJ79_UV?\ GN";5_-6^3/[
M"/\ @RF_Y2?_ +0O_9A?Q&_]:$_9DK_3PK_,/_X,IO\ E)_^T+_V87\1O_6A
M/V9*_P!/"J>_RC^2)6\O7]$%%%%(84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_&%_P '27C_
M /X+AI\4_P!G#X6_\$Z/!7[7]K^S+=?#^]\?^*?B+^PQX<^+-_\ %/7/CM8>
M(_$_AW6_!7Q1\7? N]U'X@>%?A_X5^'^H^!]=\$^'-1T_P '>#O'WB/QCXNU
M.[O?B5K7PUTB#X4?QA?M1_\ #_3_ (43XY_X;6_X>_\ _#,O_%,_\++_ .&H
M_P#AL_\ X43_ ,CCX>_X0W_A.?\ A;'_ !;_ /Y*!_PBG_",_P!O_P#,X_\
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M%>+/%VN_V-X=^.6D>'](_M?Q!J^H:A_9FA:5IFCV'VC[+IFGV5E%!;1?7_\
MQ"X_\$*/^C&?_-F?VP__ *(*@#[_ /\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ/
M^'L7_!++_I)9^P!_XF1^SK_\\:O@#_B%Q_X(4?\ 1C/_ )LS^V'_ /1!4?\
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M_P 0N/\ P0H_Z,9_\V9_;#_^B"H ^_\ _A[%_P $LO\ I)9^P!_XF1^SK_\
M/&H_X>Q?\$LO^DEG[ '_ (F1^SK_ //&KX _XA<?^"%'_1C/_FS/[8?_ -$%
M1_Q"X_\ !"C_ *,9_P#-F?VP_P#Z(*@#[_\ ^'L7_!++_I)9^P!_XF1^SK_\
M\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:O@#_ (A<?^"%'_1C/_FS/[8?_P!$
M%1_Q"X_\$*/^C&?_ #9G]L/_ .B"H ^__P#A[%_P2R_Z26?L ?\ B9'[.O\
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M/[/_ /W57_U=OQ)KYQ_X+N?\FB_#K_LX[PC_ .JR^+]?1W_!)/\ Y1\_L_\
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M'J/^):OIU_\ 11_^?8>#WE_U>3T_#R#^V>&/^?/_ )@LP\O^I=Z?AY'[B?\
M#L7_ ()L?](]?V'?_$3?@+_\P-'_  [%_P"";'_2/7]AW_Q$WX"__,#7X=_\
M/^O^"D__ $KK?MQ?^!_QZ_\ H'J/^'_7_!2?_I76_;B_\#_CU_\ 0/4?\2U?
M3K_Z*/\ \^P\'O+_ *O)Z?AY!_;/#'_/G_S!9AY?]2[T_#R/W$_X=B_\$V/^
MD>O[#O\ XB;\!?\ Y@:/^'8O_!-C_I'K^P[_ .(F_ 7_ .8&OP[_ .'_ %_P
M4G_Z5UOVXO\ P/\ CU_] ]1_P_Z_X*3_ /2NM^W%_P"!_P >O_H'J/\ B6KZ
M=?\ T4?_ )]AX/>7_5Y/3\/(/[9X8_Y\_P#F"S#R_P"I=Z?AY'[B?\.Q?^";
M'_2/7]AW_P 1-^ O_P P-'_#L7_@FQ_TCU_8=_\ $3?@+_\ ,#7X=_\ #_K_
M (*3_P#2NM^W%_X'_'K_ .@>H_X?]?\ !2?_ *5UOVXO_ _X]?\ T#U'_$M7
MTZ_^BC_\^P\'O+_J\GI^'D']L\,?\^?_ #!9AY?]2[T_#R/W$_X=B_\ !-C_
M *1Z_L._^(F_ 7_Y@:/^'8O_  38_P"D>O[#O_B)OP%_^8&OP[_X?]?\%)_^
ME=;]N+_P/^/7_P! ]1_P_P"O^"D__2NM^W%_X'_'K_Z!ZC_B6KZ=?_11_P#G
MV'@]Y?\ 5Y/3\/(/[9X8_P"?/_F"S#R_ZEWI^'D?E9_P=F_LQ?LU_LX_\,!_
M\,\_L]? [X#_ /"9?\-4?\)?_P *9^$W@+X7?\)5_P (]_PSA_8'_"2?\(1H
M&A_VY_8?]N:W_8_]J?:O[,_MC5/L7D?VA=^=^5G_  ;>?\IHOV,_^[B/_64O
MCG7N/_!P!^W[^TI^W+_PR7_PT-_P3J^./[ G_"K_ /A?'_"(?\+FG\>S_P#"
MV/\ A-O^%,_V_P#\(W_PF_P.^#.W_A!/^$1T3^V/[+_X23=_PF6E_;?['Q:?
MVIX=_P &WG_*:+]C/_NXC_UE+XYU_M[X=\-<=\'_ +*GC_ASQ+Q/UOC;+O #
MZ3O]M8C_ %LR?CCVGUNIXJ8[+?\ C*<@SGB#*,TY,HQ6 A_LF;XOZER_V=7^
MKXG"5L+1_-<76PN(XYPE;!1Y<-/-<E]DO85,-;E6!C/]Q5ITJD+U(R?O4X\W
MQJ\9*3_U3****_Y1#]T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
MFK_X.,_^"U_QX_X(]>#_ -E./]GGX3_"/XA>-/VBO$GQ<DU/7?C./&6K^%_#
M/A?X0:9\/EO=)L/"/@?Q)X$U;4-?\4:K\4]$O+7Q'<>-K?3O#VG^%-4TR7PM
MX@N?%5IJWA3^E2OY"_\ @ZR_X)>?MT_\%)[3]A.+]BKX'?\ "Z)/@U<?M,O\
M25_X69\'OAU_PCB_$&/X +X0.?BQ\0/ @UC^USX)\3C&@G5#8?V9_P 3060O
M=/\ M:?EW7YJ_P" UY]G^3M^)^ 7_$:S_P %0/\ HWO]@K_PW'[0O_T3E'_$
M:S_P5 _Z-[_8*_\ #<?M"_\ T3E?GM_Q"X_\%U_^C&?_ #9G]CS_ .B"H_XA
M<?\ @NO_ -&,_P#FS/['G_T05,1^A!_X/6/^"H6#M_9\_8)!QQGX;?M"D9[$
M@?M/+D>V1]17\_G_  4._P""G_[9/_!4/XI:7\3_ -K?XF)XI3PA_P )39_"
M[X<>&='LO"?PL^$7A_Q9XAF\0:CX?\">$].#,S$#2-#O?&GB[4?%?Q/\4>'O
M"?@W3/''COQ2/"NBS6?WW_Q"X_\ !=?_ *,9_P#-F?V//_H@J]D^"7_!I'_P
M6?\ BIXIOM \>_"/X/?LU:/9Z#<ZQ#XX^-'Q\^'?B#PUJFH0:CI=E%X5TZR_
M9VU'X\^,D\07MMJ%WJ]K<:KX4TOPLNGZ'JD5[XEL]5FT33-8+7[?.WZCN_Z_
MKR/1/^#/_P#9A\4_&3_@K#IOQYM'U_2O!/[(/P=^)GQ \0:W;^#=0UOPOK7B
MGXJ^%M6^!'@_X::QXMCO;#2O!.OZ_I/Q"\<?$;PXU[_;&H>(M.^$'BK2M,T"
M2V75O$7AG_52K\Q/^"4W_!*?]G'_ ()+_LX6?P2^"=H?%'CSQ.=*UWX]_'O7
M=)M=/\=?&_QY86MQ##J>I00W.H#POX#\,?;]3T_X8?#"PU34-'\"Z-?ZC<W.
MI>*/'GB?Q_X_\:?IW3;6B6R5O7JW][=O*U]25U\]?T_0****0PHHHH ****
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M_P!WL_\ OH]?W^5_ '_P?.?\XNO^[V?_ 'T>@#\ ?^#7'_E.O^PS_P!W,_\
MK'G[05?Z_5?XHW_!&?\ 8I^%G_!1+_@I/^SA^QU\:]?^('A?X9?&#_A<'_"3
M:[\+=5\.:)X[L?\ A7_P%^*/Q2T;^PM3\6>%/&WA^V^T^(/!.E6>I_VAX8U/
MSM'N-0M[7[%>RVVH6G]WG_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#^OVBOY
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M _[I5_ZNWX;5^CE?G'_P5L_Y1\_M ?\ =*O_ %=OPVKZ#Q9_Y-7XE_\ 9O\
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M4?/[/_\ W57_ -7;\2:_1ROH/";_ )-7X:?]F_X-_P#6<RT^H\$/^3+>$/\
MV:_@#_UE,I/Q5_X(1_\ )HOQ%_[..\7?^JR^$%?M57XJ_P#!"/\ Y-%^(O\
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M@ HHHH **** /\K/_@Y#_P"4T7[9G_=N_P#ZRE\#*_<3_@S,_P"<D'_=G_\
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MCHRM4KSA2CR0<JCYY+F4'&-Y-)_Z;=%?RL_\.!?^"D__ $L4_MQ?^ 'QZ_\
MHX:/^' O_!2?_I8I_;B_\ /CU_\ 1PU_@G_Q KZ,_P#TG%X?_P#BD?I"?_0%
MZ_T]/U'^T\Y_Z)K%_P#ARRG_ .:O7^GI_5-17\K/_#@7_@I/_P!+%/[<7_@!
M\>O_ *.&C_AP+_P4G_Z6*?VXO_ #X]?_ $<-'_$"OHS_ /2<7A__ .*1^D)_
M] 7K_3T/[3SG_HFL7_X<LI_^:O7^GI_5-17\K/\ PX%_X*3_ /2Q3^W%_P"
M'QZ_^CAH_P"' O\ P4G_ .EBG]N+_P  /CU_]'#1_P 0*^C/_P!)Q>'_ /XI
M'Z0G_P! 7K_3T/[3SG_HFL7_ .'+*?\ YJ]?Z>G]4U%?RL_\.!?^"D__ $L4
M_MQ?^ 'QZ_\ HX:/^' O_!2?_I8I_;B_\ /CU_\ 1PT?\0*^C/\ ])Q>'_\
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MOHS_ /2<7A__ .*1^D)_] 7K_3T/[3SG_HFL7_X<LI_^:O7^GI_5-17\K/\
MPX%_X*3_ /2Q3^W%_P" 'QZ_^CAH_P"' O\ P4G_ .EBG]N+_P  /CU_]'#1
M_P 0*^C/_P!)Q>'_ /XI'Z0G_P! 7K_3T/[3SG_HFL7_ .'+*?\ YJ]?Z>G]
M4U?XZ/\ P4Z_Y23_ /!0K_L^+]K+_P!7UX^K^XC_ (<"_P#!2?\ Z6*?VXO_
M   ^/7_T<-?P1?MB> /$OPG_ &N?VIOA9XS^(NN?&#QA\-?VC?C?X \5_%KQ
M.M^GB7XH^)?!OQ,\3^'==^(OB%=5USQ/JBZYXVU33KKQ+JRZEXE\0WZW^IW
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M$9_X2KQ-_8/]H?V5_P )!K/V3^TKD_X?S_\ #</_ !A7_P ,J?\ "L/^&O\
M_C%W_A97_"\O^$U_X5Y_PT!_Q:?_ (3G_A#?^%/>$O\ A+?^$2_X2W^W_P#A
M&?\ A*O#/]O?V?\ V5_PD&C?:_[2MOVN/BGP'_8:X;_MW_A:_LE9']2_LS.?
M^1I]3^H?5?K/]G?5/][_ '7M_;_5_P#EY[;V7OG^84?H%_2P_P"(IKQJ_P"(
M4_\ &LO^(@+Q1_UE_P!>?#;_ )(3_6+_ %L_MW^QO]<?]8/^2?\ ^%#^S/[*
M_MC_ )A?[/\ KO\ LQ_)G7]9G_!KM_S?)_W;/_[\#1_Q"[?]7R?^:S__ )0-
M'_*MG_U>=_PV=_W;K_PK;_AG7_P^O_"8?\)A_P +U_ZE;_A'_P#A%O\ F.?V
MW_Q*/Q3@C@CBCPXXHRSC/C/+/[&X:R;Z[_:69?7<NS'ZM_:.78O*L'_L>58O
M'8^M[;'X["T/W&%J^S]K[6KR485*D/\ 3WZ4?TH_ KZ:/@5QS]&GZ-/'/_$2
M?&SQ)_U9_P!2N"O]6>,>#O[:_P!3N,>'^/N(_P#C(^/N'^%>$LN_L[A+A7/L
MV_X5L^P'USZA]0P'UK,\5@\'B/ZS*_S&OV^/^3ZOVT_^SL_VC?\ U</C*OZ&
M?^(HG_JQO_S9C_\ )^H_X<,?\-P_\9J?\-5_\*P_X:__ .,HO^%:_P#"C?\
MA-?^%>?\- ?\78_X0;_A,O\ A</A+_A+?^$2_P"$M_L#_A)O^$5\,_V]_9_]
MJ_\ "/Z-]K_LVV^U\2\=A?&#!99EOAU5_P!8L;D^*K8[,J/)4RCZMA:])8>E
M5]IGL,LI5N>JG#DH5*M2/Q2A&/O'\P?0BX6SW]G'Q5QQQK],W _\0;X9\2.'
M\OX6X+S/ZU@_$/\ MG/<JS)YMC\#]2\*L1QSF&7?5\OE'$?6LUPF!P=6_LJ.
M(J5TZ:_GF_8'_P"3ZOV+/^SL_P!G+_U</@VO].6OY,_^'#'_  P]_P 9J?\
M#5?_  L__AD#_C*+_A6O_"C?^$*_X6'_ ,,__P#%V/\ A!O^$R_X7#XM_P"$
M2_X2W_A$O[ _X2;_ (17Q-_8/]H?VK_PC^L_9/[-N3_B*)_ZL;_\V8__ "?J
M?AICL+X/X#,\M\1:O^KN-SC%TL=EM'DJ9O\ 6<+0H_5ZM7VF10S.E1Y*K4.2
MO4I5)?%&$H^\/Z;W"V>_M'.*>!^-?H98'_B,G#/AOD&8\+<:9G]:P?AY_8V>
MYKF,,VP&!^I>*N(X&S#,?K&7QEB/K6583'8.E;V5;$4Z[5-G_!T3_P V-_\
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M55,ZRNOST*E6"^M99F&$Q/LI25:A[;V.(IT<13JTH?V_T445_>9_R:A1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_$4=_P $*/\ H^;_ ,UF_;#_ /H?:/\ B*._X(4?]'S?^:S?MA__ $/M??\
M_P .G?\ @EE_TC3_ & /_$-_V=?_ )W-'_#IW_@EE_TC3_8 _P#$-_V=?_G<
MT ? '_$4=_P0H_Z/F_\ -9OVP_\ Z'VC_B*._P""%'_1\W_FLW[8?_T/M??_
M /PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S
M0!\ ?\11W_!"C_H^;_S6;]L/_P"A]H_XBCO^"%'_ $?-_P":S?MA_P#T/M??
M_P#PZ=_X)9?](T_V /\ Q#?]G7_YW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\
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M_P#G<T ? '_$4=_P0H_Z/F_\UF_;#_\ H?:/^(H[_@A1_P!'S?\ FLW[8?\
M]#[7W_\ \.G?^"67_2-/]@#_ ,0W_9U_^=S1_P .G?\ @EE_TC3_ & /_$-_
MV=?_ )W- 'P!_P 11W_!"C_H^;_S6;]L/_Z'VC_B*._X(4?]'S?^:S?MA_\
MT/M??_\ PZ=_X)9?](T_V /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\
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MO^\7_P#OJ'SC_P $D_\ E'S^S_\ ]U5_]7;\2:_1ROSC_P""2?\ RCY_9_\
M^ZJ_^KM^)-?HY1X3?\FK\-/^S?\ !O\ ZSF6AX(?\F6\(?\ LU_ '_K*92?B
MK_P0C_Y-%^(O_9QWB[_U67P@K]JJ_%7_ ((1_P#)HOQ%_P"SCO%W_JLOA!7[
M55\_X ?\F:\//^R?H_\ I_$'R_T8?^3 ^%G_ &2^'_\ 4G$GXJ_\$P?^3NO^
M"KG_ &<=;?\ JS?VCJ_:JOQ5_P""8/\ R=U_P5<_[..MO_5F_M'5^U5'@/\
M\FRRO_LH/$#_ ->%Q4'T:?\ DS^3?]E1XH?^O3XT/Q5^!_\ RG _;%_[-Q\,
M?^H_^RQ7[55^*OP/_P"4X'[8O_9N/AC_ -1_]EBOVJH\&O\ D7<??]G@\4/_
M %JL:'@#_P BGQ._[/QXR?\ K:9@?BK\</\ E.!^QU_V;CXG_P#4?_:GK]JJ
M_%7XX?\ *<#]CK_LW'Q/_P"H_P#M3U^U5'A/_P C'QB_[/!G?_K*\&AX(_\
M(V\>O^S\<1?^L7P ?BK_ ,%W/^31?AU_V<=X1_\ 59?%^OVJK\5?^"[G_)HO
MPZ_[..\(_P#JLOB_7[54<*?\GE\7_P#LG_"O_P!,<9AP3_R?[QV_[)?P6_\
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M+[P9_P#3"J/^)..(O^C]_1 _\:?\+/\ Y\_U9^5S_6&C_P!"OB#_ ,,N._\
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MHWA.7Q]K.C>(=>TG^UO[)_M9+#PU9Z=I7C;'CO5O"=UXF\%:MX MO&-SI_\
M!-_PWQ^W5_T>G^UG_P")&_&'_P";&O\ 2B^+'PG^''QT^''B_P"$?Q<\(:3X
M[^'/CO29-%\4^%M:CE:SU&S:6*ZMYH;BUEMM0TK5M*U"VL]8T#7]'O+#7?#F
MNV&FZ]H.I:;K.FV-];_BMXY_X-R_^"?OBWQ3JGB'0-9_:&^%^DZA]B^R>!O
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M(WXP_P#S8U_69_Q#4?L*_P#15_VL_P#PNO@]_P#.(H_XAJ/V%?\ HJ_[6?\
MX77P>_\ G$5^2_\ $'O&#_H8?^;+7\O[_P#5O0_T*_XJ/_LY/^B/_P#.)97Y
M?]0_]6]#^3/_ (;X_;J_Z/3_ &L__$C?C#_\V-'_  WQ^W5_T>G^UG_XD;\8
M?_FQK^LS_B&H_85_Z*O^UG_X77P>_P#G$4?\0U'["O\ T5?]K/\ \+KX/?\
MSB*/^(/>,'_0P_\ -EK^7]_^K>@?\5'_ -G)_P!$?_YQ+*_+_J'_ *MZ'\F?
M_#?'[=7_ $>G^UG_ .)&_&'_ .;&C_AOC]NK_H]/]K/_ ,2-^,/_ ,V-?)E?
MU/\ _!.#_@A[^RA^V!^QA\&OVB_B7\0?VAM#\;?$3_A8?]M:7X&\6?#;3/"U
MK_PB7Q6\<^!M-_LNQU_X3>)M6@\_2?#-A<7WVO7+WS-1FNYH/LUM)#:6_P">
M<)9;QMQKF5?*LBS;&U,7A\%4S"HL3G&*P]-8:EB,+AIM3E5DG-5<51M"UW'F
M:^&Q_8_TA>-?HP_1BX+RSCWQ4\/N%\)P]F_%&"X0P=3)/#?(LYQ4LYQ^59UG
M.'A4PM' TY4\.\#P_F$IUW)QA4A1IV;JQM^"?_#?'[=7_1Z?[6?_ (D;\8?_
M )L:/^&^/VZO^CT_VL__ !(WXP__ #8U_69_Q#4?L*_]%7_:S_\ "Z^#W_SB
M*/\ B&H_85_Z*O\ M9_^%U\'O_G$5^A_\0>\8/\ H8?^;+7\O[_]6]#^./\
MBH_^SD_Z(_\ \XEE?E_U#_U;T/Y,_P#AOC]NK_H]/]K/_P 2-^,/_P V-'_#
M?'[=7_1Z?[6?_B1OQA_^;&OZS/\ B&H_85_Z*O\ M9_^%U\'O_G$4?\ $-1^
MPK_T5?\ :S_\+KX/?_.(H_X@]XP?]##_ ,V6OY?W_P"K>@?\5'_V<G_1'_\
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MS4L9/%5:I1117U9^ !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK-^V'_\ 0^T?\11W_!"C_H^;_P UF_;#_P#H?:^__P#AT[_P2R_Z1I_L ?\
MB&_[.O\ \[FC_AT[_P $LO\ I&G^P!_XAO\ LZ__ #N: /@#_B*._P""%'_1
M\W_FLW[8?_T/M'_$4=_P0H_Z/F_\UF_;#_\ H?:^_P#_ (=._P#!++_I&G^P
M!_XAO^SK_P#.YH_X=._\$LO^D:?[ '_B&_[.O_SN: /@#_B*._X(4?\ 1\W_
M )K-^V'_ /0^T?\ $4=_P0H_Z/F_\UF_;#_^A]K[_P#^'3O_  2R_P"D:?[
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M /X,J?\ E*;\?/\ LP#XI_\ K17[*M>/_P#!W7^SU\ OV:_^"DGP2\"_LY_
M[X/_  !\$ZM^Q!\-O%FJ>#O@I\-/!?PK\*ZEXJOOCS^TKH]]XFU#P]X%T70=
M(O/$%YI&A:'I=UK-Q9R:C<:=HVE6,UR]MIUG%#[!_P &5/\ RE-^/G_9@'Q3
M_P#6BOV5: /]/NBBB@ HHHH **** "BBB@#YQ_;%_P"31?VI_P#LW'XX?^JR
M\3U_ [7]\7[8O_)HO[4__9N/QP_]5EXGK^!VO\W_ *;_ /R57 __ &3^8_\
MJQB?Y+_M%_\ DM/#G_LE\U_]6T3^^+]CK_DT7]EC_LW'X'_^JR\,5^<?QP_Y
M3@?L=?\ 9N/B?_U'_P!J>OT<_8Z_Y-%_98_[-Q^!_P#ZK+PQ7YQ_'#_E.!^Q
MU_V;CXG_ /4?_:GK^H../^2$\&_^S@>"W_JYRD_LCQ&_Y-KX!?\ 9T/H^?\
MJ_R0_:JOQ5_X*??\G=?\$H_^SCKG_P!6;^SC7[55^*O_  4^_P"3NO\ @E'_
M -G'7/\ ZLW]G&OH/'C_ )-EFG_90>'_ /Z\+A4^H^DM_P F?SG_ +*CPO\
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MK_ZNWXDU]'?MB_\ )HO[4_\ V;C\</\ U67B>OG'_@DG_P H^?V?_P#NJO\
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M\G=?\%7/^SCK;_U9O[1U?1W_  5L_P"4?/[0'_=*O_5V_#:OS_(/^47^-_\
MLG_'+_UH..S\OX8_Y0W\1?\ LE_I'_\ K4>)1_%77^CA7^<?7^CA7X_]!?\
MYNE_W9'_ +]Q^#_LW?\ F\W_ 'CO_P!_H****_T /]0 HHHH **** "BBB@#
M_*S_ .#D/_E-%^V9_P!V[_\ K*7P,K]4_P#@TR_:=_9K_9Q_X;\_X:&_:%^!
MWP'_ .$R_P"&5_\ A$/^%S?%GP%\+O\ A*O^$>_X:/\ [?\ ^$;_ .$WU_0_
M[<_L/^W-$_MC^R_M7]F?VQI?VWR/[0M/._*S_@Y#_P"4T7[9G_=N_P#ZRE\#
M*^XO^#9G_@F[^Q=_P4'_ .&V/^&O?@S_ ,+<_P"%1_\ #-__  KW_BXGQ7\
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MW_HS3_S8C]JW_P"?G1_9OT!O^BR^E_\ ^*T\&/\ Z;'K_2U.?BG_ *!^'_\
MPLS'_P"8/7^EK]Q?\/.O^";'_20K]AW_ ,2R^ O_ ,WU'_#SK_@FQ_TD*_8=
M_P#$LO@+_P#-]7P[_P 0WG_!%W_HS3_S8C]JW_Y^='_$-Y_P1=_Z,T_\V(_:
MM_\ GYT?V;] ;_HLOI?_ /BM/!C_ .FQZ_TM3GXI_P"@?A__ ,+,Q_\ F#U_
MI:_<7_#SK_@FQ_TD*_8=_P#$LO@+_P#-]1_P\Z_X)L?])"OV'?\ Q++X"_\
MS?5\._\ $-Y_P1=_Z,T_\V(_:M_^?G1_Q#>?\$7?^C-/_-B/VK?_ )^=']F_
M0&_Z++Z7_P#XK3P8_P#IL>O]+4Y^*?\ H'X?_P#"S,?_ )@]?Z6OW%_P\Z_X
M)L?])"OV'?\ Q++X"_\ S?4?\/.O^";'_20K]AW_ ,2R^ O_ ,WU?#O_ !#>
M?\$7?^C-/_-B/VK?_GYT?\0WG_!%W_HS3_S8C]JW_P"?G1_9OT!O^BR^E_\
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MQ#>?\$7?^C-/_-B/VK?_ )^=']F_0&_Z++Z7_P#XK3P8_P#IL>O]+4Y^*?\
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M[WA;_DGLI_[!(?\ I4@HHHK^0#WPHHHH **** "OY,_^#HG_ )L;_P"[F/\
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M'V7U;'9K@L L!0_LFM3SRO[=X3-L3B/WF'RRM1I>SHS_ 'U2GS\L.:<?\XN
MOH7^-'[.GBS*?ID^*&9^&''' O@[]>_MSA?@+B?BN?%F9_\ $0<MQGA9EG]D
MQXA\/\ER=_4LXXWR_,<=]<S/#?\ ";A,8\/[;%>PP]7^-FO].7]@?_DQ7]BS
M_LTS]G+_ -4]X-H_X8'_ &%?^C+/V3/_ !'+X/?_ #'5_'A^TW_P5R_X*"?
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M5_PA7PI\<_$3PK_:EO9?"ZRN9/[#\;>$O#?B2R\JZBV:CH]H[[XU>-_ZG_\
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MPJ#_ (5+_P +1^ ?P*O_ /A!/^%E_P#"T?\ A//["_LWX<Z9Y7_"4?\ "O\
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M1?\ NR;_ -^XK^_ROX _^#&/_G*+_P!V3?\ OW%?W^4 %%%% 'P!_P %8O\
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M_P"@!K^OVB@#^0+_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &C_B([_X*F_\
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M_>1/_?%/[5/^"2?_ "CY_9__ .ZJ_P#J[?B37SC_ ,%W/^31?AU_V<=X1_\
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MX^+O_5F_""C_ (+N?\G=?#K_ +-Q\(_^K-^+]'_!"/\ Y.Z^(O\ V;CXN_\
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MG1R#$XFE##14*\,?EM.-6/,[35.KB(5(IZZ3BGIYG]4U%?RL_P##@7_@I/\
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MM_X:ZO\ \G_5GY7/^*1'TR/^A+X?_P#B=X'_ .9?ZL_*_P#;_17\0'_$2O\
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MR_U9^5_[?Z*_B _XB5_VZO\ HE'[)G_A"_&'_P"?O1_Q$K_MU?\ 1*/V3/\
MPA?C#_\ /WH_XC_X=_\ 03FW_AKJ_P#R?]6?E<_XI$?3(_Z$OA__ .)W@?\
MYE_JS\K_ -O]%?Q ?\1*_P"W5_T2C]DS_P (7XP__/WH_P"(E?\ ;J_Z)1^R
M9_X0OQA_^?O1_P 1_P##O_H)S;_PUU?_ )/^K/RN?\4B/ID?]"7P_P#_ !.\
M#_\ ,O\ 5GY7_M_HK^(#_B)7_;J_Z)1^R9_X0OQA_P#G[T?\1*_[=7_1*/V3
M/_"%^,/_ ,_>C_B/_AW_ -!.;?\ AKJ__)_U9^5S_BD1],C_ *$OA_\ ^)W@
M?_F7^K/RO_;_ $5_$!_Q$K_MU?\ 1*/V3/\ PA?C#_\ /WK].?\ @E[_ ,%S
MO'?[8'Q\\,?LR?'GX->$M#\;?$3_ (3>\\$?$+X17.L:9X6M?^$2\&2>,U\.
M>*O!'C+6_$VK0>?I/AGQM=GQKI'C:]\S49O"WAT> ;:VDU;Q;;^GDWC7P%G>
M9X+*<+CL=2Q>88BEA,)]:R[$4J57%8BI&EAZ'M(*HH3K59QIPE44:?,TI3BF
MF_A_$C]F+]+3POX'XF\0L_X6X7QW#W!^3YAQ#Q"\CXQRC&X_ 9%E&$K8_-LU
M6#Q$L%+$X?+<#AZV*Q-+"3KXQT:<Y4,+6<6E_2-1117ZR?Y\A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YD
M?\%EOVPO&_[!/_!,;]KS]JGX96?VCXD_#SX>Z3H7P\OOM&D1?\(KXY^+7CKP
MG\&O"/Q!^R^(/#7B_0==_P"%:^(/B#I_Q _X1/6_#]YI'C+_ (1K_A$]2GTV
MRUF;5++]-Z_DN_X/,_%GBGPY_P $G/A[I/A_Q)K^A:5X[_;4^$?A/QQIFCZQ
MJ&F:?XR\+6OPI^/?C:U\-^*K*RN(;;Q#H%MXS\'>$?%UOH^KQ7FGP>*/"OAO
M7XK=-6T/3+NU3V?W+U>B'&W-&^UU?TN?Y;3NTCO(Y+.[,[,>2S,223[DDFOZ
MJ/\ @E1_P:H?M;?\% OA#X6_:8^,?Q7T#]CCX'^/]$NO$/PD/B/X>ZW\2_C'
M\0].6Y\.3^%O&L?PN;Q%\-M(\.?"7QQI5]XCU#PKXRUOXB0^*==M]"T?7M#^
M'6K?#OQSX7^(%U_*]9*KWEHK %6N8%8'H5:5 0?8@FO]^^K7NI-;WLO+EL].
MG5=-+>>BU;_K5_U]]]3^(S_@]3_;+/@7]FG]FK]ASPGXB-OX@^//Q!U/XU_%
M>P\/?$HZ7K%M\+/A#:_V/X(\,?$+X9:;$U[XC\!?$_XE>+)O%WA36?$E[9^'
MK?QO^SA<2:/I/B+7M&DU+P7_ )OB(TCJB L[LJ*HZLS$!0/<D@5_2+_P=<_M
M+C]H7_@L9\8/#&G:MX#U_P )_LO_  ]^&'[-_A76_ =__:HNGT71)_BA\0]*
M\9:E!KNM:;/X^\$_&7XK?$OX>^(K'38= /AO_A$K/PGK>A0^*] \0:AJ7P!_
MP1/_ &:/^&N?^"K7["_P1N=*\!>(?#^H?'GPQ\0_'?ACXG6)U;P/XN^%_P #
MXKWXW?%3P9KFBOH7B2RUX>,?AS\//%'AC3?#NLZ3)X=\0ZOJUAHGB2\TG0;_
M %'5K&8I-W>S>OHM';Y)NW=]QRT2]%\W+5?FD_0_M[_8V_X,[OV&(OV.?#FE
M_MEWOQ\U/]K?XI^ /AKX@^(OBGPC\2?#'A4_LU^.X[V7Q5XN^'OP>T7PY:>/
M/AGXE6&SU*W^%/CSQ9\3#\;M)\6#PO<^.OA7#\+IO$$-OI_\('_!3_\ X)X_
M%+_@EY^V3\3?V2?B=JA\71^%ETCQ+\./BC:>%O$/A/P_\7?A;XLLEU'PGX[\
M/Z?X@@QO4C4/"/C2ST/5O%?AWPO\3_"GCOP/IGC+Q5_PBTVM7?\ MZ5_F'_\
M'K./^'G_ .SWTS_PP7\-_KC_ (:$_:<_'&<TF]4^[M9;:^7E;[K@MFNRNF][
MW7YKIWL>N?\ !D=\;/%.A_MC_MD?LY6MEH,O@KXG_LS>'_C7KFI7-KJ+^*++
MQ1\"/BGX=\"^%+'1KV/58=*M] U+2OVC?&=QXDM;S1-0U"[U'2O"LVF:KH]M
M9:O::Y_I*5_D(_\ !K03_P /T/V*A_#]E_:5)XXR/V2OCOCGZ%N._/I7^O=5
MO[+[Q_)M*WR27JB5U]?T3_-A1114C"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /X _P#@^<_YQ=?]WL_^^CU^_P!_P:X_\H*/V&?^[F?_
M %L/]H*OP!_X/G/^<77_ '>S_P"^CU^_W_!KC_R@H_89_P"[F?\ UL/]H*@#
M]_J*** "OX _^#YS_G%U_P!WL_\ OH]?W^5_ '_P?.?\XNO^[V?_ 'T>@#^4
M+_@C/^T?\4_V2/\ @I/^SA^T)\%/V8_B!^V1\3?A_P#\+@_X1G]F_P"%LGB.
M+QW\1O\ A*_@+\4?!&L_V%)X3^'_ ,4?$"_\(AX?\2:KX\U/^S_ FNYT?POJ
M"W7]F61N=8T_^[S_ (B._P#@J;_TK'_M_P#_ (,?VBO_ * &OY O^#7'_E.O
M^PS_ -W,_P#K'G[05?Z_5 '\@7_$1W_P5-_Z5C_V_P#_ ,&/[17_ - #1_Q$
M=_\ !4W_ *5C_P!O_P#\&/[17_T -?U^T4 ?R!?\1'?_  5-_P"E8_\ ;_\
M_!C^T5_] #1_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 U_7[10!_(%_Q$=_\%3?
M^E8_]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\ _!C^T5_] #7]?M%
M'\@7_$1W_P %3?\ I6/_ &__ /P8_M%?_0 T?\1'?_!4W_I6/_;_ /\ P8_M
M%?\ T -?U^T4 ?R!?\1'?_!4W_I6/_;_ /\ P8_M%?\ T -'_$1W_P %3?\
MI6/_ &__ /P8_M%?_0 U_7[10!_(%_Q$=_\ !4W_ *5C_P!O_P#\&/[17_T
M-'_$1W_P5-_Z5C_V_P#_ ,&/[17_ - #7]?M% '\@7_$1W_P5-_Z5C_V_P#_
M ,&/[17_ - #1_Q$=_\ !4W_ *5C_P!O_P#\&/[17_T -?U^T4 ?R!?\1'?_
M  5-_P"E8_\ ;_\ _!C^T5_] #1_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 U_7
M[10!_(%_Q$=_\%3?^E8_]O\ _P#!C^T5_P#0 T?\1'?_  5-_P"E8_\ ;_\
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M%_\ DM/#G_LE\U_]6T3^^+]CK_DT7]EC_LW'X'_^JR\,5^<?QP_Y3@?L=?\
M9N/B?_U'_P!J>OT<_8Z_Y-%_98_[-Q^!_P#ZK+PQ7YQ_'#_E.!^QU_V;CXG_
M /4?_:GK^H../^2$\&_^S@>"W_JYRD_LCQ&_Y-KX!?\ 9T/H^?\ J_R0_:JO
MQ5_X*??\G=?\$H_^SCKG_P!6;^SC7[55^*O_  4^_P"3NO\ @E'_ -G'7/\
MZLW]G&OH/'C_ )-EFG_90>'_ /Z\+A4^H^DM_P F?SG_ +*CPO\ _7I\%G[5
M5^*O_!3[_D[K_@E'_P!G'7/_ *LW]G&OVJK\5?\ @I]_R=U_P2C_ .SCKG_U
M9O[.-'CQ_P FRS3_ +*#P_\ _7A<*A]);_DS^<_]E1X7_P#KT^"S]JJ_%7_@
MNY_R:+\.O^SCO"/_ *K+XOU^U5?BK_P7<_Y-%^'7_9QWA'_U67Q?H\?_ /DS
M7B'_ -D_6_\ 3^'#Z3W_ "8'Q3_[)?$?^I.&/VJK\X_^"MG_ "CY_: _[I5_
MZNWX;5^CE?G'_P %;/\ E'S^T!_W2K_U=OPVKZ#Q9_Y-7XE_]F_XR_\ 6<S(
M^H\;_P#DRWB]_P!FOX__ /64S8^COV.O^31?V6/^S<?@?_ZK+PQ1^V+_ ,FB
M_M3_ /9N/QP_]5EXGH_8Z_Y-%_98_P"S<?@?_P"JR\,4?MB_\FB_M3_]FX_'
M#_U67B>C_FU?_>/_ /WW _YLM_WB_P#]]0^<?^"2?_*/G]G_ /[JK_ZNWXDU
M]'?MB_\ )HO[4_\ V;C\</\ U67B>OG'_@DG_P H^?V?_P#NJO\ ZNWXDU]'
M?MB_\FB_M3_]FX_'#_U67B>OG^$O^3 \,_\ 9G\F_P#6+PQ\OP/_ ,HQ<(?]
MF'X?_P#7?80^<?\ @DG_ ,H^?V?_ /NJO_J[?B37Z.5^<?\ P23_ .4?/[/_
M /W57_U=OQ)K]'*^@\)O^35^&G_9O^#?_6<RT^H\$/\ DRWA#_V:_@#_ -93
M*3\5?^"$?_)HOQ%_[..\7?\ JLOA!7[55^*O_!"/_DT7XB_]G'>+O_59?""O
MVJKY_P  /^3->'G_ &3]'_T_B#Y?Z,/_ "8'PL_[)?#_ /J3B3\5?^"8/_)W
M7_!5S_LXZV_]6;^T=7T=_P %;/\ E'S^T!_W2K_U=OPVKYQ_X)@_\G=?\%7/
M^SCK;_U9O[1U?1W_  5L_P"4?/[0'_=*O_5V_#:OS_(/^47^-_\ LG_'+_UH
M..S\OX8_Y0W\1?\ LE_I'_\ K4>)1_%77^CA7^<?7^CA7X_]!?\ YNE_W9'_
M +]Q^#_LW?\ F\W_ 'CO_P!_H****_T /]0 HHHH **** "BBB@#_*S_ .#D
M/_E-%^V9_P!V[_\ K*7P,KW'_@W_ /\ @KU^S7_P2H_X:T_X:&\$?''QE_PO
MC_A0_P#PB'_"F?#7@+Q#_9O_  J[_A<W]O\ _"2?\)O\2_AW]C^V?\+$T3^Q
M_P"R_P"V/M'V75/MO]G^1:?;O#O^#D/_ )31?MF?]V[_ /K*7P,K]Q/^#,S_
M )R0?]V?_P#OT=?]5?BQFO!N2?LFN!LT\0.$,PX\X1PO@!]%W^U^$\KXJJ<$
MX_-?;8KPGP^ ]AQ/2R;B&>6?4<SJX+,JO+E&+^NT<'4R]_5UBWBJ'X=@*>(J
M\=XF&$Q$,+B)9KG?LZ\Z"Q,(6CCG.]%U*2GSP4H+]Y'E<E/7EY7]Q?\ $7K_
M ,$V/^B(_MQ?^&U^ O\ ]$O1_P 1>O\ P38_Z(C^W%_X;7X"_P#T2]?U345_
M@G_Q%7Z&_P#TB'X@?^-3X[_Z3/\ 5WY6_4?J/$/_ $/\)_X8X_\ SQ_J[\K?
MRL_\1>O_  38_P"B(_MQ?^&U^ O_ -$O1_Q%Z_\ !-C_ *(C^W%_X;7X"_\
MT2]?U344?\15^AO_ -(A^('_ (U/CO\ Z3/]7?E8^H\0_P#0_P )_P"&./\
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M_P \?ZN_*W\K/_$7K_P38_Z(C^W%_P"&U^ O_P!$O1_Q%Z_\$V/^B(_MQ?\
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MPR[ _4\LPULMPF#6(]MBE7Q%7\W/V9/VH/V7/@)^S;^SW\#/C%^U)^S%\/\
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M_P"%:?\ "T?^$\_L+^S?B-J?F_\ "+_\+ \&?VGYWD>7_P )%I_E^;OD\O\
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MO_I:=?U^T4 ?R!?\,;_\'DG_ $EB_8 _\-SX&_\ I:='_#&__!Y)_P!)8OV
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M?V'_ &Y_8>M_V/\ VI]E_M/^Q]4^Q>?_ &?=^3^5G_!MY_RFB_8S_P"[B/\
MUE+XYU]Q?\',_P#P3=_8N_X)\?\ #$__  R%\&?^%1_\+<_X:0_X6%_Q<3XK
M^/O^$@_X0'_A0O\ PB?_ "4[QUXT_LG^R?\ A-/$W_(#_LW[?_:7_$R^V?8]
M/^R_#O\ P;>?\IHOV,_^[B/_ %E+XYU_O9X3T^ :/[)KCBGX7XWC#,.!H^ '
MTHO[#QG'N69+D_%E:^*\6)9G_:N7</9MGF3X;V></,*6 ^IYIBO;9;#!U\1[
M#%5:^'H_EV/>*?'>&>-CAX8K^U<D]K'"SJ5*"]W <GLYUJ=*H[T^1RYH1M-R
M2O%*3_U3****_P"50_<0HHHH **** "BBB@ K_/-_P""Y?\ RE+_ &H?^Z)_
M^L[?"2O]#*O\\W_@N7_RE+_:A_[HG_ZSM\)*_G[Z2'_)#Y5_V5>!_P#51GI_
MK[^Q6_Y2FX^_[,!Q3_Z\7PJ/)?V#/^":?QU_X*(?\+5_X4KXL^$OA?\ X5!_
MP@W_  DO_"T==\8:+]N_X6!_PF']C?V%_P (GX#\;?:?LW_"$ZK_ &G]O_LS
MR?M&G_9?MOFW/V0_;S_X)I_'7_@G?_PJK_A=7BSX2^*/^%O_ /"<_P#"-?\
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M*A7E5IU,TI48TG"M4G3_ #R_XAJ/VZO^BK_LF?\ A=?&'_YQ%?SS5_;_ /\
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M7,*3C7IXO!.,5&K"M4E3G43GSKFE"+T>FA_3_AC]./PGR#@#A;)OI*>+'!G
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M5]9_LN_\<\'_  G/_#:G_%S_ /AK_P#X1G_A6O\ PR[_ ,5K_8?_  S_ /\
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M\0_^R?K?^G\.'TGO^3 ^*?\ V2^(_P#4G#'[55^<?_!6S_E'S^T!_P!TJ_\
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M[,/P_P#^N^PA\X_\$D_^4?/[/_\ W57_ -7;\2:_1ROSC_X))_\ */G]G_\
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M!_\ G=Y?GW9_*S_PUE_P=D_](Q?V'?\ POO!G_TPJC_AK+_@[)_Z1B_L._\
MA?>#/_IA5?U344?\37\._P#2'OT0/_$*\4__ *<GE^?=A_85;_HH.(/_  IP
M/_SN\OS[L_E9_P"&LO\ @[)_Z1B_L._^%]X,_P#IA5'_  UE_P '9/\ TC%_
M8=_\+[P9_P#3"J_JFHH_XFOX=_Z0]^B!_P"(5XI__3D\OS[L/["K?]%!Q!_X
M4X'_ .=WE^?=G\K/_#67_!V3_P!(Q?V'?_"^\&?_ $PJC_AK+_@[)_Z1B_L.
M_P#A?>#/_IA5?U344?\ $U_#O_2'OT0/_$*\4_\ Z<GE^?=A_85;_HH.(/\
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MARD_O[]ES_RG7X&_]Y,_]<]X@G\\W[#7[+O_  VA^U+\+OV:?^$Y_P"%;?\
M"R?^$V_XK7_A&?\ A,?[%_X0[X=>+O'W_(N?\)!X6_M'^T?^$6_LG_D/6'V3
M[?\ ;_\ 2OLOV.X_H9_X==_\.7_^-EG_  O+_AI+_AFW_FBW_"L_^%._\)G_
M ,+A_P"+!_\ )1O^%@_%/_A'?^$=_P"%I_\ "6?\B'KO]K_V%_87_$L_M/\
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MQ=_X65_PO+_A"O\ A8?_  S_ /\ %I_^$Y_X0W_A3WBW_A$O^$M_X1+^W_\
MA&?^$J\3?V#_ &A_97_"0:S]D_M*Y_K,K_,:_;X_Y/J_;3_[.S_:-_\ 5P^,
MJ^U\2\#A?!_!99F7AU2_U=QN<8JM@<RK<]3-_K.%H4EB*5+V>>SS.E1Y*K<^
M>A3I5)?#*<H^Z?S!]"+BG/?VCG%7''!7TS<=_P 1DX9\-^'\OXIX+RSZK@_#
MS^QL]S7,GE./QWUWPJP_ V89C]8R^,</]5S7%X[!TK>UHX>G7;J/^AG_ (?S
M_P##</\ QA7_ ,,J?\*P_P"&O_\ C%W_ (65_P +R_X37_A7G_#0'_%I_P#A
M.?\ A#?^%/>$O^$M_P"$2_X2W^W_ /A&?^$J\,_V]_9_]E?\)!HWVO\ M*V/
M^(7;_J^3_P UG_\ R@:_GF_8'_Y/J_8L_P"SL_V<O_5P^#:_TY:?AI@<+XP8
M#,\R\1:7^L6-R?%TL#EM;GJ91]6PM>C]8JTO9Y%/+*5;GJI3YZ].K4C\,9QC
M[H_IO<4Y[^SCXIX'X*^AECO^(-\,^)&09CQ3QIEGU7!^(?\ ;.>Y5F,,IP&.
M^N^*N'XYS#+OJ^7REA_JN58O X.K?VM;#U*Z51?R9_\ *MG_ -7G?\-G?]VZ
M_P#"MO\ AG7_ ,/K_P )A_PF'_"]?^I6_P"$?_X1;_F.?VW_ ,2@_P"(HG_J
MQO\ \V8__)^H_P"#HG_FQO\ [N8_]]^K^3.OB>-^-^*/#CBC,^#.#,S_ +&X
M:R;ZE_9N6_4LNS'ZM_:.783-<9_MF:X3'8^M[;'X[%5_W^*J^S]K[*ER484Z
M</Z>^BY]%SP*^FCX%<#?26^DMP-_Q$GQL\2?]9O]=>-?]9N,>#O[:_U.XQX@
MX!X<_P",<X!X@X5X2R[^SN$N%<ARG_A)R' ?7/J'U_'_ %K,\5C,9B/T,_X*
M6?"[_A$/CKX3^-7]N_VA_P -S?"70OV\_P#A&O[,^R?\*N_X::\8>//%G_"J
MO[9_M"Y_X3;_ (0G[-]@_P"$Y_LKPC_PDF_[5_PA^@;?LS?H;_P;3_\ )]7Q
M7_[-,\=?^KA^!%?)G_!5_P#YQJ_]HF?V./\ WHU?6?\ P;3_ /)]7Q7_ .S3
M/'7_ *N'X$5X?#="EA_&C)J=&')"6=X2O)<TI7JXK QQ->=YN37/7K5)\J?+
M'FY8*,%&*_3_ !KS3'YQ^S)\1L7F-?ZQB*/A?G65TZGLJ-'EP&1\55,ERNAR
M4*=*#^JY9E^$PWM91=:O['VV(J5L14JU9_V_T445_>9_R:A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?R!?\'2
M7_!*G_@I_P#\%&O^&<-3_8S\2?\ "Y?@EX!^VV'C#]CK_A+_  !\*/[$^*<_
M_"3W%K^TO_PD_P 0O%?@[PE\2OM7A*_B^%O]@^(M=@\1_"79_:'PRTG7-,^,
MOQBO/#7\07[4?_!!7_@K#^Q=\"?'/[2_[2_[*?\ PK7X)?#7_A&?^$U\:_\
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M8E^W_P#A[%_P2R_Z26?L ?\ B9'[.O\ \\:@#\ ?^(*G_@EE_P!%\_;_ /\
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M^'L7_!++_I)9^P!_XF1^SK_\\:C_ (>Q?\$LO^DEG[ '_B9'[.O_ ,\:@#\
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M3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6OW^_X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
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M)WB#_LP_"'_KP>.#^<?_ (+N?\G=?#K_ +-Q\(_^K-^+]'_!"/\ Y.Z^(O\
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MO1_Q%Z_\$V/^B(_MQ?\ AM?@+_\ 1+U_5-11_P 15^AO_P!(A^('_C4^._\
MI,_U=^5CZCQ#_P!#_"?^&./_ ,\?ZN_*W\K/_$7K_P $V/\ HB/[<7_AM?@+
M_P#1+T?\1>O_  38_P"B(_MQ?^&U^ O_ -$O7]4U%'_$5?H;_P#2(?B!_P"-
M3X[_ .DS_5WY6/J/$/\ T/\ "?\ ACC_ //'^KORM_*S_P 1>O\ P38_Z(C^
MW%_X;7X"_P#T2]'_ !%Z_P#!-C_HB/[<7_AM?@+_ /1+U_5-11_Q%7Z&_P#T
MB'X@?^-3X[_Z3/\ 5WY6/J/$/_0_PG_ACC_\\?ZN_*W^9)_P< ?\%>OV:_\
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M2Y=2TJ:6.+4+-)K221$F+#\T7@CQ3_:2XL_M/AS^R_KJXBY?K6:_6_[/]O\
MVER^Q_L;D^L?5]/9^UY?:>[[2WO']LK]J+X#_P"I:^CY_J-XS_Z^?ZKKP;]M
M_87 /]@?ZW?V5_J3[7^T/^(D_6?['_MGW_KO]G^W^I?O_J?M/W!^U-?R9_\
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M\9[70KOPEXI^(GC+0I-6D\>^,M4U"?Q%#:P:LUG!8:9'<16<5Q'=?FY^P/\
M\GU?L6?]G9_LY?\ JX?!M?A'%E:CCO$S#YSA:BJX+/\ -,GSK 2Y:D*BPF,Q
M%"-*->G4A%TZZ=*7/"+J06G+4E=V_P!9_H^9=F/"_P!"/-_#7/<%4P/%'A%P
M)XA^&7%=+VV$Q6#GQ#P[DV95L=6RG&8/$XB&,RNI#,*'U7$U8X7$5&JBJX2C
MRQYO].6BBBO]!3_CX"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@#^ /_ (/G/^<77_=[/_OH]?O]_P &N/\ R@H_89_[N9_];#_:"K\
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MVCXM\5:#I/\ Q*=!O_L?V_[??_9=,M;V]M_]'S_B*._X(4?]'S?^:S?MA_\
MT/M 'P!_Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G
M^SK_ /0JU]__ /$4=_P0H_Z/F_\ -9OVP_\ Z'VC_B*._P""%'_1\W_FLW[8
M?_T/M 'P!_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\
M.G^SK_\ 0JU]_P#_ !%'?\$*/^CYO_-9OVP__H?:/^(H[_@A1_T?-_YK-^V'
M_P#0^T ? '_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7W_\ \11W_!"C_H^;_P UF_;#_P#H?:/^(H[_ ((4?]'S?^:S
M?MA__0^T ? '_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__
M /PZ?[.O_P!"K7W_ /\ $4=_P0H_Z/F_\UF_;#_^A]H_XBCO^"%'_1\W_FLW
M[8?_ -#[0!\ ?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
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M6UI]?_\ !E3_ ,I3?CY_V8!\4_\ UHK]E6@#_3[HHHH **** "BBB@ HHHH
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M ^/7_P!'#7[B?\/.O^";'_20K]AW_P 2R^ O_P WU'_#SK_@FQ_TD*_8=_\
M$LO@+_\ -]1_Q,K].O\ Z)S_ ,]/\'O+_JS?I^'D']C<,?\ /[_S.YAY?]3'
MT_#R/P[_ .' O_!2?_I8I_;B_P# #X]?_1PT?\.!?^"D_P#TL4_MQ?\ @!\>
MO_HX:_<3_AYU_P $V/\ I(5^P[_XEE\!?_F^H_X>=?\ !-C_ *2%?L._^)9?
M 7_YOJ/^)E?IU_\ 1.?^>G^#WE_U9OT_#R#^QN&/^?W_ )G<P\O^ICZ?AY'X
M=_\ #@7_ (*3_P#2Q3^W%_X ?'K_ .CAH_X<"_\ !2?_ *6*?VXO_ #X]?\
MT<-?N)_P\Z_X)L?])"OV'?\ Q++X"_\ S?4?\/.O^";'_20K]AW_ ,2R^ O_
M ,WU'_$ROTZ_^B<_\]/\'O+_ *LWZ?AY!_8W#'_/[_S.YAY?]3'T_#R/P[_X
M<"_\%)_^EBG]N+_P ^/7_P!'#1_PX%_X*3_]+%/[<7_@!\>O_HX:_<3_ (>=
M?\$V/^DA7[#O_B67P%_^;ZC_ (>=?\$V/^DA7[#O_B67P%_^;ZC_ (F5^G7_
M -$Y_P">G^#WE_U9OT_#R#^QN&/^?W_F=S#R_P"ICZ?AY'X=_P##@7_@I/\
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M^K-^GX>0?V-PQ_S^_P#,[F'E_P!3'T_#R/P[_P"' O\ P4G_ .EBG]N+_P
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ME<R?V'XV\)>&_$EEY5U%LU'1[1WWQJ\;_@E\#/@9\4_VD_BGX7^"OP5\+_\
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MNG_$$/\ B8C_ (@AQI_Q"'_6C_4/_B-']J_V+Q7_ *@?\0W_ +6_XSC^T/\
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MS_LSR?/\S_A'=0\SRMD?F?U-XB_4?]3<X_U)^J?ZS_\ "?\ V9_JK['^WO\
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MW^H/^JG!7]E?V1_Q%;_C(O\ 4_\ UA_UI_L_ZE_PB_VS_K!]6_V[^T3]P/\
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MXC> M \8>./%^M2P>"(()=6\2^)M9U36=2DA@AB>\O9FCBC0A%_CP_X<:?\
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MC\.OB'HNK^#==U_3UTGQ7I]C<7VFVU]<6>K"S$-U=:=;P75J\WZ1_P#!M/\
M\GU?%?\ [-,\=?\ JX?@17\R\)?6_P#B,V6_7OK'UG_6BMS?6O:^W]GS5_8<
MWMOWG)[#V7LK^[['V?)[G*?[B?2&_L#_ (IH<:?ZL_V/_8__ ! C)_8_V%]2
M_LSZWR91_:OLO[/_ -E^L?VK]=_M#D_>?VA]:^L_[3[8_M_HHHK^^S_D="BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *_ '_@Z._P"4%'[<W_=LW_K8?[/M?O\ 5^ /_!T=_P H*/VYO^[9O_6P
M_P!GV@#\ ?\ @QC_ .<HO_=DW_OW%?W^5_ '_P &,?\ SE%_[LF_]^XK^_R@
M HHHH ^ /^"L7_*++_@I9_V8!^V1_P"LZ_$:O\0:O]OG_@K%_P HLO\ @I9_
MV8!^V1_ZSK\1J_Q!J /]3O\ X)[?\&X?_!&/XX_L"_L/?&OXI?L;?\)1\3?C
M!^R!^S3\4OB+XF_X:&_:KT3_ (2+QW\0/@OX*\6>+M=_L;P[\<M(\/Z1_:_B
M#5]0U#^S-"TK3-'L/M'V73-/LK**"VB^O_\ B%Q_X(4?]&,_^;,_MA__ $05
M?C#^Q%_P=U_\$V_V:_V+_P!D3]G/QU\$OVW]6\;? ']F#X!?!3QCJGA/X;?
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M_P#^(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\ H@J^ /\
MB-6_X)9?]$#_ &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_ (:S]G7_ .BJ
MH ^__P#B%Q_X(4?]&,_^;,_MA_\ T05'_$+C_P $*/\ HQG_ ,V9_;#_ /H@
MJ^ /^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%51_P 1JW_!++_H@?[?_P#X:S]G
M7_Z*J@#[_P#^(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\V9_;#_\
MH@J^ /\ B-6_X)9?]$#_ &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M_P#_ (:S
M]G7_ .BJH ^__P#B%Q_X(4?]&,_^;,_MA_\ T05'_$+C_P $*/\ HQG_ ,V9
M_;#_ /H@J^ /^(U;_@EE_P!$#_;_ /\ PUG[.O\ ]%51_P 1JW_!++_H@?[?
M_P#X:S]G7_Z*J@#[_P#^(7'_ ((4?]&,_P#FS/[8?_T05'_$+C_P0H_Z,9_\
MV9_;#_\ H@J^ /\ B-6_X)9?]$#_ &__ /PUG[.O_P!%51_Q&K?\$LO^B!_M
M_P#_ (:S]G7_ .BJH _B"_X+U?LN? G]B[_@K%^U9^S1^S1X&_X5K\$OAK_P
MHS_A"O!7_"3>,?&/]B_\)C^S;\'?'_B/_BH_'_B'Q5XMU'^T?%OBK7M6_P")
MMKU_]C^W_8+#[+IEK965O_3]_P &,?\ SE%_[LF_]^XK^4+_ (+,_MK?"S_@
MHE_P4G_:0_;%^"F@?$#PO\,OC!_PI_\ X1G0OBEI7AS1/'=C_P *_P#@+\+O
MA;K/]NZ9X3\5^-O#]M]I\0>"=5O-,_L_Q/J?G:/<:?<77V*]EN=/M/ZO?^#&
M/_G*+_W9-_[]Q0!_?Y1110 4444 %%%% !1110 5_G'U_HX5_G'U_G_].C_F
MUO\ W>__ +Z)_E_^TB_YLS_WD3_WQ3^U3_@DG_RCY_9__P"ZJ_\ J[?B37SC
M_P %W/\ DT7X=?\ 9QWA'_U67Q?KZ._X))_\H^?V?_\ NJO_ *NWXDU\X_\
M!=S_ )-%^'7_ &<=X1_]5E\7Z_8.)O\ E$;#?]F?X2_]4>3'[QQ?_P H,83_
M +,/P/\ ^L[P^?M57YQ_\%;/^4?/[0'_ '2K_P!7;\-J_1ROSC_X*V?\H^?V
M@/\ NE7_ *NWX;5^P>+/_)J_$O\ [-_QE_ZSF9'[QXW_ /)EO%[_ +-?Q_\
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M*?\ ].3R_/NSV?["K?\ 10<0?^%.!_\ G=Y?GW9_*S_PUE_P=D_](Q?V'?\
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MZ_WL\)^+,-QQ^R:XXXHPG!_!_ .'S3P ^E%[/A+@+!9KEW">4_4L5XL9=/\
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MA;4]*U"YTFYU#2M+OI]-FN'LYKS3;"ZDA:>SMWC_ (\/^&^/VZO^CT_VL_\
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MM_5/:+CW_5W^U_J_L?K'L;Y9_:7U#V?M/]J^I\K]BOROK^LS_@UV_P";Y/\
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MBBBO]"3_ ([ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!4W_I6/_;__ /!C^T5_] #1_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\ 0 T
M?O\ ?\.G?^"67_2-/]@#_P 0W_9U_P#G<T?\.G?^"67_ $C3_8 _\0W_ &=?
M_G<U^ /_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]O_\
M\&/[17_T - '[_?\.G?^"67_ $C3_8 _\0W_ &=?_G<T?\.G?^"67_2-/]@#
M_P 0W_9U_P#G<U^ /_$1W_P5-_Z5C_V__P#P8_M%?_0 T?\ $1W_ ,%3?^E8
M_P#;_P#_  8_M%?_ $ - '[_ '_#IW_@EE_TC3_8 _\ $-_V=?\ YW-'_#IW
M_@EE_P!(T_V /_$-_P!G7_YW-?@#_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\
M0 T?\1'?_!4W_I6/_;__ /!C^T5_] #0!^_W_#IW_@EE_P!(T_V /_$-_P!G
M7_YW-'_#IW_@EE_TC3_8 _\ $-_V=?\ YW-?@#_Q$=_\%3?^E8_]O_\ \&/[
M17_T -'_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #0!^_P!_PZ=_X)9?](T_
MV /_ !#?]G7_ .=S1_PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^=S7X _\ $1W_ ,%3
M?^E8_P#;_P#_  8_M%?_ $ -'_$1W_P5-_Z5C_V__P#P8_M%?_0 T ?O]_PZ
M=_X)9?\ 2-/]@#_Q#?\ 9U_^=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S7X _
M\1'?_!4W_I6/_;__ /!C^T5_] #1_P 1'?\ P5-_Z5C_ -O_ /\ !C^T5_\
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MJIA\075R;S3M*_1__@RI_P"4IOQ\_P"S /BG_P"M%?LJT ?Z?=%%% !1110
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M=<_^K-_9QK]JJ_%7_@I]_P G=?\ !*/_ +..N?\ U9O[.-?0>/'_ ";+-/\
MLH/#_P#]>%PJ?4?26_Y,_G/_ &5'A?\ ^O3X+/VJK\5?^"GW_)W7_!*/_LXZ
MY_\ 5F_LXU^U5?BK_P %/O\ D[K_ ()1_P#9QUS_ .K-_9QH\>/^399I_P!E
M!X?_ /KPN%0^DM_R9_.?^RH\+_\ UZ?!9^U5?BK_ ,%W/^31?AU_V<=X1_\
M59?%^OVJK\5?^"[G_)HOPZ_[..\(_P#JLOB_1X__ /)FO$/_ +)^M_Z?PX?2
M>_Y,#XI_]DOB/_4G#'[55^<?_!6S_E'S^T!_W2K_ -7;\-J_1ROSC_X*V?\
M*/G]H#_NE7_J[?AM7T'BS_R:OQ+_ .S?\9?^LYF1]1XW_P#)EO%[_LU_'_\
MZRF;'T=^QU_R:+^RQ_V;C\#_ /U67ABC]L7_ )-%_:G_ .S<?CA_ZK+Q/1^Q
MU_R:+^RQ_P!FX_ __P!5EX8H_;%_Y-%_:G_[-Q^.'_JLO$]'_-J_^\?_ /ON
M!_S9;_O%_P#[ZA\X_P#!)/\ Y1\_L_\ _=5?_5V_$FOH[]L7_DT7]J?_ +-Q
M^.'_ *K+Q/7SC_P23_Y1\_L__P#=5?\ U=OQ)KZ._;%_Y-%_:G_[-Q^.'_JL
MO$]?/\)?\F!X9_[,_DW_ *Q>&/E^!_\ E&+A#_LP_#__ *[["'SC_P $D_\
ME'S^S_\ ]U5_]7;\2:_1ROSC_P""2?\ RCY_9_\ ^ZJ_^KM^)-?HY7T'A-_R
M:OPT_P"S?\&_^LYEI]1X(?\ )EO"'_LU_ '_ *RF4GXJ_P#!"/\ Y-%^(O\
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MY_P1=_Z,T_\ -B/VK?\ Y^=?#O\ P_Z_X*3_ /2NM^W%_P"!_P >O_H'J/\
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M_P!?\%)_^E=;]N+_ ,#_ (]?_0/5_!%^V)X_\2_%C]KG]J;XI^,_AUKGP?\
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MXMU_69_P7+_Y1:?M0_\ =$__ %HGX25_$!^PU^U%_P ,7_M2_"[]I;_A!O\
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MF_UUX*_U9XQXQ_L7_7'C'B#C[AS_ (R/@'A_BKA+,?[1X2XJR'-O^$G/L?\
M4_K_ -0Q_P!5S/"XS!X?^AG]@?\ Y,5_8L_[-,_9R_\ 5/>#:/V^/^3%?VT_
M^S3/VC?_ %3WC*OYYO\ A_/_ ,,/?\85_P##*G_"S_\ AD#_ (Q=_P"%E?\
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MS^S_ /\ =5?_ %=OQ)KYQ_X+N?\ )HOPZ_[..\(_^JR^+]?L'$W_ "B-AO\
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M#0\$?^1MX]?]GXXB_P#6+X /Q5_X+N?\FB_#K_LX[PC_ .JR^+]?M57XJ_\
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MB7-LOSO#4O:\;9)A5BOK&3XKGR>IB,!2]C4G2Q5']9O^'Y?_  2T_P"CH?\
MS"?[1/\ \Z2OQL_:L_X)8?%W_@JG\?/'O[>G[)7QJ_9YUC]GWX[_ /"+_P#"
MO]1\<ZC\:_!7BFX_X5?X,\._!KQ5_:GAF]^!]S<Z9Y/C;X>>)(++S9W^VZ=%
M::@FV.[1%_E@K_0R_P""&G_*+3]E[_NMG_K1/Q;KT^$N*L5XXYE7X3XTR[+*
M65Y=@JG$6'EDBS# XMYAA,1ALMI1J5L1F.-A+#O#9OBW.FJ49.HJ4E4BH.,_
MA_I"^ 61?LL."\L^D']&;C#CC'\><8\48+P;S:CXH5.#^*L@CPCQ!E6=<;8^
MI@\ORC@[A?$T<X6<^'F0PP^-GF%:A3P4\PH2P=2IB*5?#_SS?\0U'[=7_15_
MV3/_  NOC#_\XBOZ&?\ A^7_ ,$M/^CH?_,)_M$__.DK]9J_R9Z[N,<31\!/
M[._U'P&$K?ZU_6_[4_MV>.Q_+_87U7ZE]5^KXW >RO\ VQB_;\_M?:6H\OL^
M1\_R_P!&_)LQ_:U_ZY?\33<6<09?_P 0 _U=_P!1?^(4X;A7A+VW_$5?[<_U
MG_M[^V>&N*_[0]G_ ,0WX>_LOZM]0^J>TS'VWUKZS2^K?VT_MP^/O@1_P6[^
M$_A[]E+]A/\ :%^'FO\ Q<^'WQ#TG]H3Q%9_$OPE\>OAUH47PX\*>&_%OPWU
M>YM-;U'X,WD%UJR>)OBQX0B@TI(EEGLYK^[60)8NK?E?_P 0U'[=7_15_P!D
MS_PNOC#_ /.(H_X-I_\ D^KXK_\ 9IGCK_U</P(K^W^O3X7X5R+QDRJ/&O%V
M"=+.*]>METXY/B<7@L%]7R]QIT'&A7KXRHJCC-^TE[9J3U48GP?CKX^^*W[-
M?C_$_1A^CQQ+3QOAOE6699QEAJ_B-D>0<2\3/-^+J4L9FL:N:97EG#F$G@XU
M</36$HQRR$Z,')3K5FU)?SH?L/>/O@1_P1$^$_B']E+]NS]H7X>:!\7/B#\0
M]6_:$\.V?PT\)?'KXBZ%+\./%?AOPE\-](N;O6].^#-G!:ZL_B;X3^+XI]*>
M)I8+.&PNVD*7R*OV3_P_+_X):?\ 1T/_ )A/]HG_ .=)7\\W_!RQ_P GU?"C
M_LTSP+_ZN'X[U_/-7Q6=^+O$/AYFN.X)R#+,@GD_#E9Y=E\\PP^:8C&RP\(Q
MJ1>(KTLWP].I4YJDKRA0IJUERZ7?]0>&/[.SP>^F-P#PM])[Q;XW\6\-XD>-
M&5T^,N,*'"&;\"9-PS2S?$U*F$J1R;*\;X>9OB\%@_98.DXT:^9XR:FYMUFI
M)+^ESXN_\$+/VH_VN/BQ\3_VK?@[\8/V8KWX1_M.?$/QK^T)\++S7_$WQFT+
M7;OX<?&CQ)J?Q(\#W.M:)/\  N6?1]6G\,^)=+EU+2II9)=/O'FM))'>$L3X
M1?\ !"S]J/\ 9'^+'PP_:M^,7Q@_9BLOA'^S'\0_!7[0GQ3O- \3?&;7==M/
MAQ\%_$FF?$CQQ<Z+HD'P+BGUC5H/#/AK5)=-TJ&6.74+Q(;2.1'F##^HG]@?
M_DQ7]BS_ +-,_9R_]4]X-H_;X_Y,5_;3_P"S3/VC?_5/>,J_2EX1<%_V:N+/
MJN._M3ZBN(N7^T*_U3^T/8+,K>QOS_5_K&GL_:\WLWR^TO:2_B1?M$_I-_ZZ
M+Z/G]O\ "_\ J'_K0O!OVW^J.5?V_P#ZH_VLN"?:?VAR_5O[8_L;WOKOU#V'
MUU^W^I^SM17R9_P_+_X):?\ 1T/_ )A/]HG_ .=)7YY_MY_#GP?_ ,%W_P#A
M57_#O_X^?"7Q%_PRO_PG/_"VO^%HZ-\=?AI]C_X7C_PA_P#P@?\ 87]I?!:]
M_MK[1_PJ#QG_ &GY/E?V;Y&G^9O^WQ[/XV:_K,_X-=O^;Y/^[9__ 'X&OSSA
MSQ,SGQ7SG!\ <49;DE/(L_\ K'UZ>54<SPF/7]EX6OG6&]AB*V:XJG3OC,NP
MZJ\U"IST74A'DE)3C_8_C-]![PU_9_>&W$GTN? KC7Q/Q?BKX2_V/_JMA^/<
MPX(X@X3J?Z^9_E?AEGG]K91EO 60XW%\G#G&>;SP/L<VPGU?,HX/%5/;TJ,\
M-6^3/^(:C]NK_HJ_[)G_ (77QA_^<17[)_LI_MA?L@_\$K/@'X"_8+_:U_:/
M\):/^T%\"/\ A*/^%@:=X&^'OQ_\:^%K?_A:'C/Q%\9?"O\ 9?B:R^#MM;:G
MYW@GXA^&Y[[RH$^Q:C+=Z>^Z2T=V_>RO\\W_ (+E_P#*4O\ :A_[HG_ZSM\)
M*^HXMR7*O W+:'%G!>"A5S3,<;3X=Q$<[KXS'819?B\/B<RJRIT</B<%..(6
M)RC"J%1U915-UHNFW.,H?A'T>O$OC_\ :G\:9G]'SZ3/%&(P' ?!W"^-\9,I
MK>%^5<.<*Y_+B[A[-<DX)P%/&9AF^2\48:MD\LF\0L_GB,%3R^C7J8V&7UXX
MRG3P]2AB/ZB?B[_P5'_X)]_M<?"?XG_LI?!W]IC2;WXN?M.?#SQK^SW\++/7
M_A1^T)H6A7?Q'^-'AO4_AOX'MM:UN?X02P:/I,_B;Q+I<6I:K-%)%I]F\UW)
M&Z0E3^%/_$-1^W5_T5?]DS_PNOC#_P#.(K\F?V!_^3ZOV+/^SL_V<O\ U</@
MVO\ 3EK'A##8'QVPV,S;C; T*6*R&O#+L"LCJXW 47A\33^LU'7AB,7CI5*G
MM%:,HSII0TY6]3U/I%YSQ1^RBSGASP^^B_Q5FF89#XL99B^,N*)^*> X9XLQ
M]/-\EQ<<DP<<JQ&3\/\ "U/"8-X*;=:C6P^*G.M:I&M"/N'\I/[#W[&FK?\
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MQ]FO81<6Y?Z<M%%%?Z&'_'*%%%% !1110 4444 %%%% !1110 4444 %%%%
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MOY O^&-_^#R3_I+%^P!_X;GP-_\ 2TZ/^&-_^#R3_I+%^P!_X;GP-_\ 2TZ
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M *LW]G&CQX_Y-EFG_90>'_\ Z\+A4/I+?\F?SG_LJ/"__P!>GP6?M57XJ_\
M!=S_ )-%^'7_ &<=X1_]5E\7Z_:JOQ5_X+N?\FB_#K_LX[PC_P"JR^+]'C__
M ,F:\0_^R?K?^G\.'TGO^3 ^*?\ V2^(_P#4G#'[55^<?_!6S_E'S^T!_P!T
MJ_\ 5V_#:OT<K\X_^"MG_*/G]H#_ +I5_P"KM^&U?0>+/_)J_$O_ +-_QE_Z
MSF9'U'C?_P F6\7O^S7\?_\ K*9L?1W['7_)HO[+'_9N/P/_ /59>&*/VQ?^
M31?VI_\ LW'XX?\ JLO$]'['7_)HO[+'_9N/P/\ _59>&*/VQ?\ DT7]J?\
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MT3_$'_A-@?\ YX^?Y]F?U345_*S_ ,,F_P#!V3_TDZ_8=_\ "!\&?_2]:/\
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M "OY,_\ @Z)_YL;_ .[F/_??J_K,K^3/_@Z)_P";&_\ NYC_ -]^K\I\;O\
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MPLRS^R8\0^'^2Y._J6<<;Y?F..^N9GAO^$W"8QX?VV*]AAZO\;-?Z<O[ _\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\P/^#&/_ )RB_P#=DW_OW%?W^5_ '_P8Q_\ .47_ +LF_P#?N*_O\H ****
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M:*_D"_X8W_X/)/\ I+%^P!_X;GP-_P#2TZ/^&-_^#R3_ *2Q?L ?^&Y\#?\
MTM.@#^OVBOY O^&-_P#@\D_Z2Q?L ?\ AN? W_TM.C_AC?\ X/)/^DL7[ '_
M (;GP-_]+3H _K]HK^0+_AC?_@\D_P"DL7[ '_AN? W_ -+3H_X8W_X/)/\
MI+%^P!_X;GP-_P#2TZ /Z_:*_D"_X8W_ .#R3_I+%^P!_P"&Y\#?_2TZ/^&-
M_P#@\D_Z2Q?L ?\ AN? W_TM.@#^OVBOY O^&-_^#R3_ *2Q?L ?^&Y\#?\
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MK_@FQ_T6[]N+_P .5\!?_H:*_.7_ (-Q_P#@K5_P3Z_8,_8B^*?P@_:O^/\
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MGW9\._\ $(5_P38_Z+=^W%_X<KX"_P#T-%'_ !"%?\$V/^BW?MQ?^'*^ O\
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M2'_P1=_Z/+_\UW_:M_\ G&4?\1(?_!%W_H\O_P UW_:M_P#G&4?\1+_:W?\
M0M^E_P#^*GXW_P#H-\OS[L/J? 7\_#__ (7X;_YH\OS[L^'?^(0K_@FQ_P!%
MN_;B_P##E? 7_P"AHH_XA"O^";'_ $6[]N+_ ,.5\!?_ *&BON+_ (B0_P#@
MB[_T>7_YKO\ M6__ #C*/^(D/_@B[_T>7_YKO^U;_P#.,H_XB7^UN_Z%OTO_
M /Q4_&__ -!OE^?=A]3X"_GX?_\ "_#?_-'E^?=GP[_Q"%?\$V/^BW?MQ?\
MARO@+_\ 0T4?\0A7_!-C_HMW[<7_ (<KX"__ $-%?<7_ !$A_P#!%W_H\O\
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M_P"*?@)'J$.K7NH?&C5-*GLX5-G'9Z+831GS[BX ]#_XAJ/V%?\ HJ_[6?\
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MV9X6\8?M.^-_$W[(^DZE^TYX=\&:_P#$;X5:?H7B[7?@)9S?%32/#&M7^G?
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MHMA#&/(N+@CW#_B&H_85_P"BK_M9_P#A=?![_P"<17Y,_P#!M/\ \GU?%?\
M[-,\=?\ JX?@17]O]?8>&^3Y3XD<,TN)^-LLP&?Y[5QN+P=3,,1A*&'J2PV$
ME"&&I.G@:>%P]J49-)JDI--\TI'\X?33\1_$'Z%7CCC_  -^B]QOQ9X2>%.
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M&P5)4E[##4N:?-_IRT445_H&?\@ 4444 %%%% !1110 4444 %%%% !1110
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M%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M7_!*/_LXZY_]6;^SC7T'CQ_R;+-/^R@\/_\ UX7"I]1]);_DS^<_]E1X7_\
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M3NO^"KG_ &<=;?\ JS?VCJ^CO^"MG_*/G]H#_NE7_J[?AM7Y_D'_ "B_QO\
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M^5_ZIJ*_E9_XA"O^";'_ $6[]N+_ ,.5\!?_ *&BC_B$*_X)L?\ 1;OVXO\
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M^5_ZIJ*_E9_XA"O^";'_ $6[]N+_ ,.5\!?_ *&BC_B$*_X)L?\ 1;OVXO\
MPY7P%_\ H:*/^(5?0W_Z2\\0/_&6,=_].;^K/RN?7N(?^A!A/_#Y'_YW?U9^
M5_ZIJ_QT?^"G7_*2?_@H5_V?%^UE_P"KZ\?5_<1_Q"%?\$V/^BW?MQ?^'*^
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M_9OQ&U/S?^$7_P"%@>#/[3\[R/+_ .$BT_R_-WR>7_3E7\F?_!T3_P V-_\
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M7X=?]G'>$?\ U67Q?K]@XF_Y1&PW_9G^$O\ U1Y,?O'%_P#R@QA/^S#\#_\
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M"MG_ "CY_: _[I5_ZNWX;5]'?L=?\FB_LL?]FX_ _P#]5EX8HPW_ "?[.?\
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MJ^G7_P!%'_Y]AX/>7_5Y/3\/(/[9X8_Y\_\ F"S#R_ZEWI^'D?N)_P .Q?\
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M']L\,?\ /G_S!9AY?]2[T_#R/RL_X.S?V8OV:_V<?^& _P#AGG]GKX'? ?\
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ME-Q]_P!F XI_]>+X5'Z&_P#!N/\  /X%?''_ (;'_P"%U?!;X2_%_P#X1?\
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MG_XCE\8?_F.KZ#QU_P":6_U,_P"IW_:7^K'_ '1_J?U[^RO^YGZM[?\ Z?\
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M7U_T6G^JO^JO^NB_[I'^K_\ 9%O^I=_9UO\ F&L?PI_\-\?MU?\ 1Z?[6?\
MXD;\8?\ YL:_H9_X(,?\9P_\-5_\-J?\9?\ _"L/^%&_\*U_X:B_XR _X5Y_
MPFO_  N'_A,O^$&_X6Q_PEO_  B7_"6_\(EX5_X2;^P/[/\ [>_X1GP__:OV
MO^QM-^S?SS?\,#_MU?\ 1EG[6?\ XCE\8?\ YCJ_H9_X(,?\8/?\-5_\-J?\
M8@?\+/\ ^%&_\*U_X:B_XQ__ .%A_P#"%?\ "X?^$R_X0;_A;'_")?\ "6_\
M(E_PEOA7_A)O[ _M#^P?^$F\/_VK]D_MG3?M/\N^%G]N?Z^9%_K)_:W]B_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M._X(4?\ 1\W_ )K-^V'_ /0^U]__ /#IW_@EE_TC3_8 _P#$-_V=?_G<T?\
M#IW_ ()9?](T_P!@#_Q#?]G7_P"=S0!\ ?\ $4=_P0H_Z/F_\UF_;#_^A]H_
MXBCO^"%'_1\W_FLW[8?_ -#[7W__ ,.G?^"67_2-/]@#_P 0W_9U_P#G<T?\
M.G?^"67_ $C3_8 _\0W_ &=?_G<T ? '_$4=_P $*/\ H^;_ ,UF_;#_ /H?
M:/\ B*._X(4?]'S?^:S?MA__ $/M??\ _P .G?\ @EE_TC3_ & /_$-_V=?_
M )W-'_#IW_@EE_TC3_8 _P#$-_V=?_G<T ? '_$4=_P0H_Z/F_\ -9OVP_\
MZ'VC_B*._P""%'_1\W_FLW[8?_T/M??_ /PZ=_X)9?\ 2-/]@#_Q#?\ 9U_^
M=S1_PZ=_X)9?](T_V /_ !#?]G7_ .=S0!\ ?\11W_!"C_H^;_S6;]L/_P"A
M]H_XBCO^"%'_ $?-_P":S?MA_P#T/M??_P#PZ=_X)9?](T_V /\ Q#?]G7_Y
MW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T ? '_ !%'?\$*/^CYO_-9OVP_
M_H?:/^(H[_@A1_T?-_YK-^V'_P#0^U]__P##IW_@EE_TC3_8 _\ $-_V=?\
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MJ?\ [-Q^.'_JLO$]?P.U_F_]-_\ Y*K@?_LG\Q_]6,3_ "7_ &B__):>'/\
MV2^:_P#JVB?WQ?L=?\FB_LL?]FX_ _\ ]5EX8K\X_CA_RG _8Z_[-Q\3_P#J
M/_M3U^CG['7_ ":+^RQ_V;C\#_\ U67ABOSC^.'_ "G _8Z_[-Q\3_\ J/\
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M1?B+_P!G'>+O_59?""OVJK\5?^"$?_)HOQ%_[..\7?\ JLOA!7[55\_X ?\
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M ,IHOVS/^[=__64O@97W%_P;,_\ !2+]B[_@GQ_PVQ_PU[\9O^%1_P#"W/\
MAF__ (5[_P 6[^*_C[_A(/\ A ?^%]?\)9_R3'P+XT_LG^R?^$T\,_\ (<_L
MW[?_ &E_Q+?MGV/4/LOP[_P<A_\ *:+]LS_NW?\ ]92^!E?JG_P:9?LQ?LU_
MM'?\-^?\-#?L]? [X\?\(;_PRO\ \(A_PN;X3> OBC_PBO\ PD/_  T?_;__
M  C?_";Z!KG]A_VY_8>B?VQ_9?V7^T_['TO[;Y_]GVGD_P#57XL5. :/[)K@
M:IXH8+C#,.!8^ 'T7?[<P? 69Y+D_%E:^*\)XY9_9.8\0Y3GF3X?V></+ZN.
M^N97BO;9;#&4,/[#%5:&)H_AV 6*?'>)6"EAX8G^U<[]E+%0J5*"]W'<_M(4
M:E*I*]/G4.6<;3<6[Q33_HU_XB0_^"+O_1Y?_FN_[5O_ ,XRC_B)#_X(N_\
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MO_B)OP%_^8&C^TOH#?\ 1&_2_P#_ !9?@Q_]*?U_IZ')Q3_T$</_ /A'F/\
M\W^O]/3X=_XB0_\ @B[_ -'E_P#FN_[5O_SC*/\ B)#_ ."+O_1Y?_FN_P"U
M;_\ .,K[B_X=B_\ !-C_ *1Z_L._^(F_ 7_Y@:/^'8O_  38_P"D>O[#O_B)
MOP%_^8&C^TOH#?\ 1&_2_P#_ !9?@Q_]*?U_IZ')Q3_T$</_ /A'F/\ \W^O
M]/3X=_XB0_\ @B[_ -'E_P#FN_[5O_SC*/\ B)#_ ."+O_1Y?_FN_P"U;_\
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M#?\ 1&_2_P#_ !9?@Q_]*?U_IZ')Q3_T$</_ /A'F/\ \W^O]/3X=_XB0_\
M@B[_ -'E_P#FN_[5O_SC*/\ B)#_ ."+O_1Y?_FN_P"U;_\ .,K[B_X=B_\
M!-C_ *1Z_L._^(F_ 7_Y@:/^'8O_  38_P"D>O[#O_B)OP%_^8&C^TOH#?\
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M4_\ ,#_L3_B;_P F=?UF?\&NW_-\G_=L_P#[\#7)P1QOQ1XC\499P9QGF?\
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M/^$3_P"1\T+^R/[=_MW_ (F?]F?V-J)_Q"[?]7R?^:S_ /Y0-?DS_P $-/\
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M%G_9IG[.7_JGO!M'[?'_ "8K^VG_ -FF?M&_^J>\95^UQ\+. _[#7$G]A?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OP!_X.CO\ E!1^W-_W;-_ZV'^S[7[_ %?@#_P='?\ *"C]N;_N
MV;_UL/\ 9]H _ '_ (,8_P#G*+_W9-_[]Q7]_E?P!_\ !C'_ ,Y1?^[)O_?N
M*_O\H **** /@#_@K%_RBR_X*6?]F ?MD?\ K.OQ&K_$&K_;Y_X*Q?\ *++_
M (*6?]F ?MD?^LZ_$:O\0:@#_4[_ .">W_!QY_P1C^!W[ O[#WP4^*7[9/\
MPB_Q-^#_ .R!^S3\+?B+X9_X9Y_:KUO_ (1WQW\/_@OX*\)^+M"_MGP[\#=7
M\/ZO_9'B#2-0T_\ M/0M5U/1[_[/]JTS4+VRE@N9?K__ (BCO^"%'_1\W_FL
MW[8?_P!#[70?\$R?^"9/_!-OQ[_P3;_X)\^.O'7_  3Y_8@\:>-O&G[$'[*'
MBSQCXQ\6?LH? ;Q'XJ\6>*O$?P&\ ZQXA\3>)O$.L> ;S5]>\0:[J]Y>:IK.
MLZI>76HZIJ-U<WU]<SW,\LK?;_\ PZ=_X)9?](T_V /_ !#?]G7_ .=S0!\
M?\11W_!"C_H^;_S6;]L/_P"A]H_XBCO^"%'_ $?-_P":S?MA_P#T/M??_P#P
MZ=_X)9?](T_V /\ Q#?]G7_YW-'_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T
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M=S0!\ ?\11W_  0H_P"CYO\ S6;]L/\ ^A]H_P"(H[_@A1_T?-_YK-^V'_\
M0^U]_P#_  Z=_P""67_2-/\ 8 _\0W_9U_\ G<T?\.G?^"67_2-/]@#_ ,0W
M_9U_^=S0!\ ?\11W_!"C_H^;_P UF_;#_P#H?:/^(H[_ ((4?]'S?^:S?MA_
M_0^U]_\ _#IW_@EE_P!(T_V /_$-_P!G7_YW-'_#IW_@EE_TC3_8 _\ $-_V
M=?\ YW- 'P!_Q%'?\$*/^CYO_-9OVP__ *'VC_B*._X(4?\ 1\W_ )K-^V'_
M /0^U]__ /#IW_@EE_TC3_8 _P#$-_V=?_G<T?\ #IW_ ()9?](T_P!@#_Q#
M?]G7_P"=S0!_E"?\%ZOVH_@3^VC_ ,%8OVK/VE_V:/'/_"RO@E\2O^%&?\(5
MXU_X1GQCX._MK_A#OV;?@[X \1_\4YX_\/>%?%NG?V=XM\*Z]I/_ !-M!L/M
MGV#[?8?:M,NK*]N/Z?O^#&/_ )RB_P#=DW_OW%?S@_\ !QY\)_A9\#O^"SG[
M9/PM^"GPT^'_ ,'_ (9>%_\ AGG_ (1GX=?"WP;X<^'_ ($\._VW^RI\#?$6
ML_V%X1\)Z;I'A_2/[7\0:OJNNZG_ &?I]O\ ;]8U/4-3NO-O;VYGE_H^_P"#
M&/\ YRB_]V3?^_<4 ?W^4444 %%%% !1110 4444 %?YQ]?Z.%?YQ]?Y_P#T
MZ/\ FUO_ '>__OHG^7_[2+_FS/\ WD3_ -\4_M4_X))_\H^?V?\ _NJO_J[?
MB37SC_P7<_Y-%^'7_9QWA'_U67Q?KZ._X))_\H^?V?\ _NJO_J[?B37SC_P7
M<_Y-%^'7_9QWA'_U67Q?K]@XF_Y1&PW_ &9_A+_U1Y,?O'%__*#&$_[,/P/_
M .L[P^?M57YQ_P#!6S_E'S^T!_W2K_U=OPVK]'*_./\ X*V?\H^?V@/^Z5?^
MKM^&U?L'BS_R:OQ+_P"S?\9?^LYF1^\>-_\ R9;Q>_[-?Q__ .LIFQ]'?L=?
M\FB_LL?]FX_ _P#]5EX8H_;%_P"31?VI_P#LW'XX?^JR\3T?L=?\FB_LL?\
M9N/P/_\ 59>&*/VQ?^31?VI_^S<?CA_ZK+Q/1_S:O_O'_P#[[@?\V6_[Q?\
M^^H?./\ P23_ .4?/[/_ /W57_U=OQ)K]'*_./\ X))_\H^?V?\ _NJO_J[?
MB37Z.4>$W_)J_#3_ +-_P;_ZSF6AX(?\F6\(?^S7\ ?^LIE)^*O_  0C_P"3
M1?B+_P!G'>+O_59?""OVJK\5?^"$?_)HOQ%_[..\7?\ JLOA!7[55\_X ?\
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MB_L._P#A?>#/_IA5'_#67_!V3_TC%_8=_P#"^\&?_3"J/^)..(O^C]_1 _\
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M3AZT\/.M0K4U*I1IRYJ<O=LKG\F?[?'_ "?5^VG_ -G9_M&_^KA\94?L#_\
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MESX^YCXQ_1KX.SCQA\,,;PQPUD&$XTX0ITL3DU?.<BPM6AF^70JXNMA*WUC
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MF[NW^G+1117^@I_Q\!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ!XZ\/":^\0V.D:['IMT$UOP9XM'A37?#.O:GX"\>^'YM5\%?$'PY8Z_I/\
MPE/@G7]?\-W5Y%9ZK<$_[J?A7Q5X7\=^%_#?C?P1XDT#QEX+\9:!H_BKPAXO
M\*ZQIWB'POXJ\+^(=.M]7T#Q)X;U_2+B\TG7- US2;RTU/1]8TR[NM.U/3KJ
MWO;*XGMIXI6;6B:ZW7S5K_)W7SN2NW:WW>?G=,WJ***0S^ /_@^<_P"<77_=
M[/\ [Z/7[_?\&N/_ "@H_89_[N9_];#_ &@J_ '_ (/G/^<77_=[/_OH]?O]
M_P &N/\ R@H_89_[N9_];#_:"H _?ZBBB@ K^ /_ (/G/^<77_=[/_OH]?W^
M5_ '_P 'SG_.+K_N]G_WT>@#^4+_ ((S_M'_ !3_ &2/^"D_[.'[0GP4_9C^
M('[9'Q-^'_\ PN#_ (1G]F_X6R>(XO'?Q&_X2OX"_%'P1K/]A2>$_A_\4?$"
M_P#"(>'_ !)JOCS4_P"S_ FNYT?POJ"W7]F61N=8T_\ N\_XB._^"IO_ $K'
M_M__ /@Q_:*_^@!K^0+_ (-<?^4Z_P"PS_W<S_ZQY^T%7^OU0!_(%_Q$=_\
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M ,&/[17_ - #7]?M% '\@7_$1W_P5-_Z5C_V_P#_ ,&/[17_ - #1_Q$=_\
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M _[I5_ZNWX;5^CE?G'_P5L_Y1\_M ?\ =*O_ %=OPVKZ#Q9_Y-7XE_\ 9O\
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M4?/[/_\ W57_ -7;\2:_1ROH/";_ )-7X:?]F_X-_P#6<RT^H\$/^3+>$/\
MV:_@#_UE,I/Q5_X(1_\ )HOQ%_[..\7?^JR^$%?M57XJ_P#!"/\ Y-%^(O\
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M /B[OI"?_1[Z_P!+4_LS.?\ HI<7_P"&W*?_ )E]?Z6O\K/_  _Z_P""D_\
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M-11_Q'7Z,_\ T@[X?_\ B[OI"?\ T>^O]+4_LS.?^BEQ?_AMRG_YE]?Z6O\
M*S_P_P"O^"D__2NM^W%_X'_'K_Z!ZC_A_P!?\%)_^E=;]N+_ ,#_ (]?_0/5
M_5-11_Q'7Z,__2#OA_\ ^+N^D)_]'OK_ $M3^S,Y_P"BEQ?_ (;<I_\ F7U_
MI:_RL_\ #_K_ (*3_P#2NM^W%_X'_'K_ .@>H_X?]?\ !2?_ *5UOVXO_ _X
M]?\ T#U?U344?\1U^C/_ -(.^'__ (N[Z0G_ -'OK_2U/[,SG_HI<7_X;<I_
M^9?7^EK_ "L_\/\ K_@I/_TKK?MQ?^!_QZ_^@>H_X?\ 7_!2?_I76_;B_P#
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MOY,_^#HG_FQO_NYC_P!]^K^LROY,_P#@Z)_YL;_[N8_]]^K\I\;O^37\3_\
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M99B/$C"5\\APO#/,1Q%5P5'"364QS6OG4Z$5C*F.<OZ<_P#@C3\:?&'_  5
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M^/R_V_\ ^&^/V%?^CT_V3/\ Q(WX/?\ S8U_/-_P7G_XSA_X94_X8K_XR_\
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M_P"467_!-/\ [, _8W_]9U^'-??] '\@7_$1W_P5-_Z5C_V__P#P8_M%?_0
MT?\ $1W_ ,%3?^E8_P#;_P#_  8_M%?_ $ -?U^T4 ?R!?\ $1W_ ,%3?^E8
M_P#;_P#_  8_M%?_ $ -'_$1W_P5-_Z5C_V__P#P8_M%?_0 U_7[10!_(%_Q
M$=_\%3?^E8_]O_\ \&/[17_T -'_ !$=_P#!4W_I6/\ V_\ _P &/[17_P!
M#7]?M% '\@7_ !$=_P#!4W_I6/\ V_\ _P &/[17_P! #1_Q$=_\%3?^E8_]
MO_\ \&/[17_T -?U^T4 ?R!?\1'?_!4W_I6/_;__ /!C^T5_] #1_P 1'?\
MP5-_Z5C_ -O_ /\ !C^T5_\ 0 U_7[10!_(%_P 1'?\ P5-_Z5C_ -O_ /\
M!C^T5_\ 0 T?\1'?_!4W_I6/_;__ /!C^T5_] #7]?M% '\@7_$1W_P5-_Z5
MC_V__P#P8_M%?_0 T?\ $1W_ ,%3?^E8_P#;_P#_  8_M%?_ $ -?U^T4 ?R
M!?\ $1W_ ,%3?^E8_P#;_P#_  8_M%?_ $ -'_$1W_P5-_Z5C_V__P#P8_M%
M?_0 U_7[10!_(%_Q$=_\%3?^E8_]O_\ \&/[17_T -'_ !$=_P#!4W_I6/\
MV_\ _P &/[17_P! #7]?M% '^*-_P69_:/\ BG^UO_P4G_:0_:$^-?[,?Q _
M8W^)OQ _X4__ ,)-^S?\4I/$<OCOX<_\(I\!?A=X(T;^W9/%GP_^%WB!O^$O
M\/\ AO2O'FF?VAX$T+&C^*-/6U_M.R%MK&H?U>_\&,?_ #E%_P"[)O\ W[BO
MP!_X.CO^4Z_[<W_=LW_K'G[/M?O]_P &,?\ SE%_[LF_]^XH _O\HHHH ***
M* "BBB@ HHHH *_SCZ_T<*_SCZ_S_P#IT?\ -K?^[W_]]$_R_P#VD7_-F?\
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M_P#[JK_ZNWXDU^CE?G'_ ,$D_P#E'S^S_P#]U5_]7;\2:_1RCPF_Y-7X:?\
M9O\ @W_UG,M#P0_Y,MX0_P#9K^ /_64RD_%7_@A'_P FB_$7_LX[Q=_ZK+X0
M5^U5?BK_ ,$(_P#DT7XB_P#9QWB[_P!5E\(*_:JOG_ #_DS7AY_V3]'_ -/X
M@^7^C#_R8'PL_P"R7P__ *DXD_%7_@F#_P G=?\ !5S_ +..MO\ U9O[1U?M
M57XJ_P#!,'_D[K_@JY_V<=;?^K-_:.K]JJ/ ?_DV65_]E!X@?^O"XJ#Z-/\
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MXJT;PU<K<>&KZ_%AX1TPRZY<VYM;#3/VH_X<"_\ !2?_ *6*?VXO_ #X]?\
MT<-?COTS/"#P$SWZ4?C7F_$WTN."^!\^Q_&>)KYIPEF'A-XUYWC<BQ+P>"C+
M XC-N'N#<?DN.J1A&-1U\NQF(P[4U&-1R4DO1X=S#-:629;3HY!B<32AAHJ%
M>&/RVG&K'F=IJG5Q$*D4]=)Q3T\S^J:BOY6?^' O_!2?_I8I_;B_\ /CU_\
M1PT?\.!?^"D__2Q3^W%_X ?'K_Z.&OYD_P"(%?1G_P"DXO#_ /\ %(_2$_\
MH"]?Z>GL_P!IYS_T36+_ /#EE/\ \U>O]/3^J:BOY6?^' O_  4G_P"EBG]N
M+_P ^/7_ -'#1_PX%_X*3_\ 2Q3^W%_X ?'K_P"CAH_X@5]&?_I.+P__ /%(
M_2$_^@+U_IZ']IYS_P!$UB__  Y93_\ -7K_ $]/ZIJ*_E9_X<"_\%)_^EBG
M]N+_ , /CU_]'#1_PX%_X*3_ /2Q3^W%_P" 'QZ_^CAH_P"(%?1G_P"DXO#_
M /\ %(_2$_\ H"]?Z>A_:><_]$UB_P#PY93_ /-7K_3T_JFHK^5G_AP+_P %
M)_\ I8I_;B_\ /CU_P#1PT?\.!?^"D__ $L4_MQ?^ 'QZ_\ HX:/^(%?1G_Z
M3B\/_P#Q2/TA/_H"]?Z>A_:><_\ 1-8O_P .64__ #5Z_P!/3^J:BOY6?^'
MO_!2?_I8I_;B_P# #X]?_1PT?\.!?^"D_P#TL4_MQ?\ @!\>O_HX:/\ B!7T
M9_\ I.+P_P#_ !2/TA/_ * O7^GH?VGG/_1-8O\ \.64_P#S5Z_T]/ZIJ*_E
M9_X<"_\ !2?_ *6*?VXO_ #X]?\ T<-'_#@7_@I/_P!+%/[<7_@!\>O_ *.&
MC_B!7T9_^DXO#_\ \4C](3_Z O7^GH?VGG/_ $36+_\ #EE/_P U>O\ 3T_J
MFHK^5G_AP+_P4G_Z6*?VXO\ P ^/7_T<-'_#@7_@I/\ ]+%/[<7_ ( ?'K_Z
M.&C_ (@5]&?_ *3B\/\ _P 4C](3_P"@+U_IZ']IYS_T36+_ /#EE/\ \U>O
M]/3^J:BOY6?^' O_  4G_P"EBG]N+_P ^/7_ -'#1_PX%_X*3_\ 2Q3^W%_X
M ?'K_P"CAH_X@5]&?_I.+P__ /%(_2$_^@+U_IZ']IYS_P!$UB__  Y93_\
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M  =$_P#-C?\ W<Q_[[]7\\W[+O[<O[4O[%__  G/_#-/Q1_X5M_PLG_A&?\
MA-?^*)^'7C'^VO\ A#O^$@_X1S_D?O"/BG^SO[._X2G7O^03]@^V?;_]/^U?
M9;/[/_0S_P $N_\ C=!_PO+_ (>6?\9)?\,V_P#"L_\ A2W_ #1W_A#/^%Q?
M\+!_X6-_R0/_ (59_P )%_PD7_"K/ ?_ "-G]N_V1_87_$B_LS^T]9_M'\TX
M6XDP/%WAS@/!O+:6+H<3YA]:]CC\=3HTLAC]4SW$<4U/:XK#U\3F$>;+\-4H
MPY,KG?&.%.7+0<L1'^WO'KP5XJ^CO],WBO\ :3\:YAP_FG@9P?\ V%_:?"G"
MV*S'&^+%?_6#PJR?P%P7U'(LVRK).#ZOLN,,[PF98KZQQWA>3AJGB,92]MFD
M*>3U?Y,Z_P!#+_@AI_RBT_9>_P"ZV?\ K1/Q;H_X<:?\$M/^C7O_ #-G[1/_
M ,]NOYYOVY?VY?VI?^";/[4OQ1_8K_8K^*/_  IC]F;X,?\ "$_\*T^&O_"$
M_#KXB_\ "-_\+%^'7A'XL>,O^*R^+'A'QWX_UC^V/'_COQ5K_P#Q/_%6J_V?
M_:O]E:5]AT6QTW3;/U>&^&\=X#8ZKQ?Q?5PF99;F6$J<-T*'#=2MC,=#'8RM
M0S2E5JTLTH9/AXX2.'R?$PJ5(8FI65:I0C&A*$JE2E\!XU>-7"O[63A7 ?1T
M^CIE_$'!?&W!?$&%\:LTS3QJPN7<.<*XCA7AS+LUX%QV7X#'<"YKXCYO5X@J
MYOXCY'B,+A<1D>%RZ>787-:U;-:&)H83!X[^W^O\F>OUF_X?E_\ !4O_ *.A
M_P#,)_L[?_.DK^LS_AQI_P $M/\ HU[_ ,S9^T3_ //;KKXG_P".@OJ/^IG_
M  F?ZH_6?[2_UG_V+V_]O_5_J?U'^RO[:]K[+^Q<5]9]O]6Y/:8?V7MN>I[+
MY_P,_P"//W^M'_$RW_&<?\3#_P!B?ZE?\0,_XR7^R_\ B$O]K_ZQ_P"M'^OW
M_$,OJ7UW_B)N0_V)_9/]M_6?JF;_ %_^S?J^#^O_ ,\W_!M/_P GU?%?_LTS
MQU_ZN'X$5_;_ %_,;_P4L^!GPL_X(_\ P*\)_M+?\$ZO"_\ PSQ\;/''Q:T+
MX&>*/&O]M^(OBU_:GPL\2^#_ !YX^UOPO_PCGQSU?XF>$K+[;XM^&?@C5O[;
MT[0;3Q%;?V)]@M-7@TS4M7L[_P##_P#X?E_\%2_^CH?_ #"?[.W_ ,Z2O0X?
MXVRKP5RZ/ W%6'S#,,VH5JN93Q'#]+#8K+G0S%QJ4(1K9CB\JQ+JQC!JK%X2
M,(NW)4FKM?'^+WT7^/OVG7&5?Z5'@)F_!_"/A]FV P'!6&R?Q>S#.L@XRAFO
M!U.6#S/$5\OX,X?X_P DCE]>KB(2P%6GQ#4Q-6FIO$83"R2C+ZS_ .#EC_D^
MKX4?]FF>!?\ U</QWK^>:O[)O^":?P,^%G_!8#X%>+/VEO\ @HKX7_X:'^-G
M@?XM:[\#/"_C7^V_$7PE_LOX6>&O!_@/Q]HGA?\ X1SX&:O\,_"5[]B\6_$S
MQOJW]MZCH-WXBN?[;^P7>KSZ9IND6=A^AG_#C3_@EI_T:]_YFS]HG_Y[=?*Y
MMX2\1^(^8XOCG(\;DF%RGB6K_:6 P^:XG'T,QI4)QC34,71P>6X[#4ZJE3DW
M&CBZ\+-6J-W2_H#@']H5X+_0MX-X>^BOXI<,>)^?^(/@CE]/@KBO.. ,EX4S
M3@W,,UPLYXRIB.'LPXBXUX5SO%Y>Z6-I1A5S+A[*<2ZD:BEA(Q493^L_V!_^
M3%?V+/\ LTS]G+_U3W@VC]OC_DQ7]M/_ +-,_:-_]4]XRK^-KX^?\%6/V^/V
M8/CK\:?V:?@9\>?^$'^"?[/'Q:^(WP,^#W@K_A5WP8\2_P#"(?"SX2^,-9\
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MXW\%9K^USS3(_$7Z-V(R_@G)/"' 8G@KB7"^-]7$\-YKCLUSS$1SW"8C(Z'
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ME%_\TF__ "N* /XPOV"OCC\4_P!F[]K'X4_&GX*?M)?#_P#9$^)O@S_A.O\
MA&?VA_BEX'\1_$CP)\/?^$B^&WC'PIK/]N^"_"?P3_:*\0:S_P )9X?UW5?
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M]_Q%'?\ !"C_ */F_P#-9OVP_P#Z'VC_ (BCO^"%'_1\W_FLW[8?_P!#[7X
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MM7_P;>_\.?/V6/ /[2__  V7_P -$?\ "<?M >%?@7_PA7_#._\ PJ3^R_\
MA)OAU\5?'_\ PE/_  D?_"\_B;]M^Q?\*R_LG^Q/[!M/M/\ ;?V_^U[?^S?L
M=_V<0Y)A.)<@SSAS'U,12P/$&3YGDF,JX2=.GBZ6$S7!5\!B*F&G6I5Z,,1"
MC7G*C.K0K4XU%%SI5(IPEW\5<.X+B_ACB/A/,JN*H9=Q/D.<<.X^M@9TJ6-H
MX+.LOQ&6XJK@ZF(H8FA3Q5.AB:D\/.MAL12A54)5*%6"E3E_8G^S7_P<P?\
M!$GP!^SI\ O GB[]M;^R?%?@GX*?"OPCXGTK_AG#]K:__LSQ#X;\"Z%HVM:?
M]NTSX#7NFWOV+4K*YMOM>GWEW8W'E^=:7,\#QRN?M*?\','_  1)\?\ [.GQ
M]\">$?VUO[6\5^-O@I\5/"/AC2O^&</VMK#^T_$/B3P+KVC:+I_V[4_@-9:;
M9?;=2O;:V^UZA>6EC;^9YUW<P0))*G\=G_!%3_@V]_X?!_LL>/OVE_\ ALO_
M (9W_P"$'_: \5? O_A"O^&=_P#A;?\ :G_",_#KX5>/_P#A*?\ A(_^%Y_#
M+[%]M_X6;_9/]B?V#=_9O[$^W_VO<?VE]CL/U_\ ^(&/_K*+_P":3?\ Y7%'
M]B83^P/]7/:8CZC_ &/_ &)[7GI_6_JGU+ZA[3G]E['ZQ['WN?V'L_::^RY?
M<#_5W!?ZL?ZI^UQ7]G?V#_J[[;GI?7?J7]G_ -F^U]I[#V'UKV'O\_U;V7M?
M>]AR?NS]*?\ @G=_P<9_\$:?@5^QU\'_ (5_%3]L;_A%O'OA;_A8']O:#_PS
MW^U1K?V'^V_BEXV\1Z7_ ,33PY\#]7T:Z^U:-J^G7G^AZC<>3]H^SW'E74,\
M$7M?[2G_  <P?\$2?'_[.GQ]\">$?VUO[6\5^-O@I\5/"/AC2O\ AG#]K:P_
MM/Q#XD\"Z]HVBZ?]NU/X#66FV7VW4KVVMOM>H7EI8V_F>==W,$"22I^-?_$#
M'_UE%_\ -)O_ ,KBC_B!C_ZRB_\ FDW_ .5Q7'EW"^7Y9PA@>"J%;&3RK+^&
M\+PO1Q%:I0EF$LOPF5PRFG6JU88>GAI8R6&IJ<ZD,)"@Z[<HX>-.U-<&5<&Y
M7E' F6^'N&KX^>2Y7PE@^#</BJ]7#RS2>5X+)Z>24J]:M3PM+"2Q\L)2C4J5
M88*GAWB&YQPL*;5)?I3_ ,$[O^#C/_@C3\"OV.O@_P#"OXJ?MC?\(MX]\+?\
M+ _M[0?^&>_VJ-;^P_VW\4O&WB/2_P#B:>'/@?J^C77VK1M7TZ\_T/4;CR?M
M'V>X\JZAG@B^U?\ B*._X(4?]'S?^:S?MA__ $/M?@#_ ,0,?_647_S2;_\
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M4,9.%6=;\J?^'D7[%W_19O\ S'?Q7_\ F%K^U3_B*._X(4?]'S?^:S?MA_\
MT/M?@#_Q Q_]91?_ #2;_P#*XH_X@8_^LHO_ )I-_P#E<5\WX4>"G"O@]_;_
M /JSF'$&._UB_LOZ[_;N*R[$^R_LC^T?JWU7^S\JRSDY_P"T\1[?VWM^;DH^
MS]ERS]I\EX)?1YX+\!O]9O\ 5#-.*,R_UK_L7^T?]9,;E.,]C_87]K?5/J7]
MEY)D_L_:?VQB?K/M_K//[.A[+V/+4]K^_P!_Q%'?\$*/^CYO_-9OVP__ *'V
MC_B*._X(4?\ 1\W_ )K-^V'_ /0^U^ /_$#'_P!91?\ S2;_ /*XH_X@8_\
MK*+_ .:3?_E<5^P'[P?O]_Q%'?\ !"C_ */F_P#-9OVP_P#Z'VC_ (BCO^"%
M'_1\W_FLW[8?_P!#[7X _P#$#'_UE%_\TF__ "N*/^(&/_K*+_YI-_\ E<4
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M'#PQ$(?O9125?F</=G*<7)2^5_\ A^Y^WE_TL/\ [#O_ (A/^TC_ /2<Z/\
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M (?N?MY?]+#_ .P[_P"(3_M(_P#TG.OJC_B!C_ZRB_\ FDW_ .5Q1_Q Q_\
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M]U30M#\9ZI?77B/2=&U+P#X'O]+L-2M[*\\'^&KB"31;+^OG_B!C_P"LHO\
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M^(&/_K*+_P":3?\ Y7% '[_?\11W_!"C_H^;_P UF_;#_P#H?:_GF_X+S_\
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MGF_X;#_9S_Z*)_Y:/CK_ .9BOZ-/^(&/_K*+_P":3?\ Y7%'_$#'_P!91?\
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M9D_SBO\ @J/^PQ_P[7_;L^.?[%/_  M'_A='_"E_^%9?\7+_ .$)_P"%<_\
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M(OK2VN8Y84_:[_B!C_ZRB_\ FDW_ .5Q1_Q Q_\ 647_ ,TF_P#RN*^HXXX
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M1X5\+:=K7BS4[[PSXH\4W?@KQ#\/OZG: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /YB_P#@[=_:8^*/[.O_  2/UG0?A?JW]@/^TY\>/ '[-/Q
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MDC/0/^#&/_G*+_W9-_[]Q7]_E?Y0G_!M[_P6K_98_P""/G_#9?\ PTOX!_:
M\<?\-$?\,[_\(5_PHOPK\.O$W]E_\*D_X7G_ ,))_P )3_PG_P 5?AE]B^V_
M\+-T'^Q/[)_MO[3]DU?[?_9OV>S^W_T_?\1JW_!++_H@?[?_ /X:S]G7_P"B
MJH _K]HK^0+_ (C5O^"67_1 _P!O_P#\-9^SK_\ 154?\1JW_!++_H@?[?\
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M_IEE'_#9'_!Y)_TB=_8 _P##C>!O_IEE'_$:M_P2R_Z('^W_ /\ AK/V=?\
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M_9U_^BJH_P"(U;_@EE_T0/\ ;_\ _#6?LZ__ $55 !_PV1_P>2?](G?V /\
MPXW@;_Z991_PV1_P>2?](G?V /\ PXW@;_Z991_Q&K?\$LO^B!_M_P#_ (:S
M]G7_ .BJH_XC5O\ @EE_T0/]O_\ \-9^SK_]%50 ?\-D?\'DG_2)W]@#_P .
M-X&_^F64?\-D?\'DG_2)W]@#_P .-X&_^F64?\1JW_!++_H@?[?_ /X:S]G7
M_P"BJH_XC5O^"67_ $0/]O\ _P##6?LZ_P#T55 !_P -D?\ !Y)_TB=_8 _\
M.-X&_P#IEE'_  V1_P 'DG_2)W]@#_PXW@;_ .F64?\ $:M_P2R_Z('^W_\
M^&L_9U_^BJH_XC5O^"67_1 _V_\ _P -9^SK_P#154 '_#9'_!Y)_P!(G?V
M/_#C>!O_ *991_PV1_P>2?\ 2)W]@#_PXW@;_P"F64?\1JW_  2R_P"B!_M_
M_P#AK/V=?_HJJ/\ B-6_X)9?]$#_ &__ /PUG[.O_P!%50 ?\-D?\'DG_2)W
M]@#_ ,.-X&_^F64?\-D?\'DG_2)W]@#_ ,.-X&_^F64?\1JW_!++_H@?[?\
M_P"&L_9U_P#HJJ/^(U;_ ()9?]$#_;__ /#6?LZ__154 ?PA_P#!9GQE^V3\
M0/\ @I/^TAXN_P""@7PG^'_P._:ZU?\ X4__ ,+;^%OPMU*QU?P)X7^P? 7X
M7:9X#_L+4--^)?Q@LKC^V_AE9>#/$6I^3\1?$7E:QJ^H02?V1-%)H6F?U>_\
M&,?_ #E%_P"[)O\ W[BOY0O^"S/[:WPL_P""B7_!2?\ :0_;%^"F@?$#PO\
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M"8S"UE%RBJN'Q-*I1J)2:4X-)M:GZI_\$(_^31?B+_V<=XN_]5E\(*_:JO\
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M<Z-IMO\ M#7.@W&FK+\1M$:6:]\2Z?=+':ZJ4LW:"T2^_0K_ (C5O^"67_1
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M_AYU_P $V/\ I(5^P[_XEE\!?_F^K^"#_AXG_P &B'_2+?\ ;_\ _"U\1_\
MTQVC_AXG_P &B'_2+?\ ;_\ _"U\1_\ TQVOPC^S?H#?]%E]+_\ \5IX,?\
MTV/7^EKZ?/Q3_P! _#__ (69C_\ ,'K_ $M?[W_^'G7_  38_P"DA7[#O_B6
M7P%_^;ZC_AYU_P $V/\ I(5^P[_XEE\!?_F^K^"#_AXG_P &B'_2+?\ ;_\
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MO_B67P%_^;ZC_AYU_P $V/\ I(5^P[_XEE\!?_F^K^"#_AXG_P &B'_2+?\
M;_\ _"U\1_\ TQVC_AXG_P &B'_2+?\ ;_\ _"U\1_\ TQVC^S?H#?\ 19?2
M_P#_ !6G@Q_]-CU_I:G/Q3_T#\/_ /A9F/\ \P>O]+7^]_\ X>=?\$V/^DA7
M[#O_ (EE\!?_ )OJ/^'G7_!-C_I(5^P[_P")9? 7_P";ZOX(/^'B?_!HA_TB
MW_;_ /\ PM?$?_TQVC_AXG_P:(?](M_V_P#_ ,+7Q'_],=H_LWZ W_19?2__
M /%:>#'_ --CU_I:G/Q3_P! _#__ (69C_\ ,'K_ $M?[W_^'G7_  38_P"D
MA7[#O_B67P%_^;ZC_AYU_P $V/\ I(5^P[_XEE\!?_F^K^"#_AXG_P &B'_2
M+?\ ;_\ _"U\1_\ TQVC_AXG_P &B'_2+?\ ;_\ _"U\1_\ TQVC^S?H#?\
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M?_!HA_TBW_;_ /\ PM?$?_TQVC_AXG_P:(?](M_V_P#_ ,+7Q'_],=H_LWZ
MW_19?2__ /%:>#'_ --CU_I:G/Q3_P! _#__ (69C_\ ,'K_ $M?LC_@[-_:
M=_9K_:._X8#_ .&>?VA?@=\>/^$-_P"&J/\ A+_^%,_%GP%\4?\ A%?^$A_X
M9P_L#_A)/^$(U_7/[#_MS^P];_L?^U/LO]I_V/JGV+S_ .S[OR?RL_X-O/\
ME-%^QG_W<1_ZRE\<Z^-_^"F?[77_  1U^*/_  I/_AUY^RI^T=^SC_8?_"R/
M^%X_\+FU:ZUS_A,O[3_X0+_A6?\ PC?]K_M,?'C[+_PCW]G_ ! _MC[/_P (
MKY_]N:7YO]N>3%_8_#?\$E?^"CWP/_8,_P""@OP _:O^+_A7XK>(_AW\*O\
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M?LZ__154?\1JW_!++_H@?[?_ /X:S]G7_P"BJH _K]HK^0+_ (C5O^"67_1
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M#4GA7PO/JEOK_CK6?"O@G3O$/BK1?ZG: "BBB@ HHHH **** "BBB@ HHHH
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M:_%*Y_ )_P &EW[4'A7]G+_@KWX)\*>,1H%EI/[5GP?^(W[,UCXH\2^,M/\
M!VG>%?%FL7WA3XM^!S;#4[*>U\5>(/'OC+X0:'\'O"G@V/4-#U'6_%'Q)T=M
M'OM1U:TL?"WB+^V#_@Z8_:J\"_L^?\$A_P!H'X<77QD_X5I\:?VFHO!WPM^#
M7A71->U?2O'/Q-TNW^*7PYU7XYZ'IUMX?/\ :1\!_P#"F#XJT+XGZEK#6?@>
MZT;Q9IWP\\27\VH_$GPUX;\2?Y3W[0/[/OQH_94^,OQ _9^_:#^'OB#X5_&+
MX6Z_-X<\:^"?$D,*7^EZA'#!>V=W9WUE/=Z3KWA_7-*O-/\ $'A3Q7X>U#5?
M#'B_PQJNC^*/"^L:OX>U?3-3NN>^(/Q<^*_Q:_X0O_A:OQ.^(?Q,_P"%;^ O
M#WPJ^'?_  L'QIXD\9_\(%\+_"/VS_A$_AOX+_X2/4M2_P"$6\!>&/[0O_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7\@7_!ZM_RBR^ ?_9__ ,+/_6=?VJJ_K]K^8+_@[2_9
M5_:._:R_X)E?#[PS^S-\%_B!\=_%OPU_:_\ A=\4O%G@GX6Z!=>,?'</@2/X
M8?&_X;7.NZ%X&T877BWQC]@\6_$KP?;:GIG@[1M?UC2]'O\ 4/%FHZ?:^$O#
MGB;7-' /G_\ X,J?^467Q\_[/_\ BG_ZSK^RK7]?M?S@_P#!K7^PM^T=^P=_
MP3*O/"?[4'@S_A6OQ ^._P"T!XN_:0T;X;:G+=1^._ O@3QC\,/@YX&\,Z/\
M4M#N;&U_X0[X@7__  K6^\3:AX(>YO\ 6/"FCZ_H6C>-(_#GQ M?%G@GPO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY%?[.'PP_:E_9U^,O[.NA?M;_#CXR^ ?$'[-/B#P#J7Q0M?C1-KUKH/@73/
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M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
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M^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R
M_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R
M!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_
M /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I
M_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=
M?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^
M?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$
M%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7
M]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#P
MZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%
M6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '^*-_P1G_8I^%G_!1+_@I/
M^SA^QU\:]?\ B!X7^&7Q@_X7!_PDVN_"W5?#FB>.['_A7_P%^*/Q2T;^PM3\
M6>%/&WA^V^T^(/!.E6>I_P!H>&-3\[1[C4+>U^Q7LMMJ%I_=Y_Q!4_\ !++_
M *+Y^W__ .'3_9U_^A5K^0+_ (-<?^4Z_P"PS_W<S_ZQY^T%7^OU0!_(%_Q!
M4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_
M7[10!_(%_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M?U^T4 ?R!?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_
M $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R!?\05/_!++_HOG[?\ _P"'3_9U_P#H
M5:/^(*G_ ()9?]%\_;__ /#I_LZ__0JU_7[10!_(%_Q!4_\ !++_ *+Y^W__
M .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\
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M^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\
M$%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\
MPZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""
M67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__
M /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P
M2R_Z+Y^W_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M%
M '\@7_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.
MO_T*M?U^T4 ?R!?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B
M"I_X)9?]%\_;_P#_  Z?[.O_ -"K7]?M% '\@7_$%3_P2R_Z+Y^W_P#^'3_9
MU_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K7]?M% '\@7_$%3_P2R_Z+
MY^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M?U^T4 ?R!?\
M05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M
M?U^T4 ?R!?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_
M  Z?[.O_ -"K7]?M% '^*-_P69_8I^%G_!.W_@I/^TA^QU\%-?\ B!XH^&7P
M?_X4_P#\(SKOQ2U7PYK?CN^_X6!\!?A=\4M9_MW4_"?A3P3X?N?LWB#QMJMG
MIG]G^&-,\G1[?3[>Z^VWL5SJ%W_=Y_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5K
M^0+_ (.CO^4Z_P"W-_W;-_ZQY^S[7^OU0!_(%_Q!4_\ !++_ *+Y^W__ .'3
M_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\ P2R_
MZ+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?R!
M?\05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T
M*M?U^T4 ?R!?\05/_!++_HOG[?\ _P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__
M /#I_LZ__0JU_7[10!_(%_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@
MEE_T7S]O_P#\.G^SK_\ 0JU_7[10!_(%_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?
M_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M?U^T4 ?R!?\05/_!++_HOG[?_
M /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M?U^T4 ?R1>$_\
M@S"_X)0^'/%7AGQ#K'Q0_;?\>Z1H/B#1M9U3P+XL^+GP?L_"OC33M+U&VOK[
MPGXFO/ O[/?@OQM:^'_$=M!+H^LW/@[QCX3\50:=>7,OA[Q-H6KK9ZI:_P!;
MM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXI;?^$-_X9V\!_VO_;'_  A7]A9_X2K3/[/_ +3_ +3Q??8O[/N_Z]Z/U#]
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M/BCPU\)]$\40^/\ XB:?X.\4_P#"*:;<VGA[Q!J.C_ZZY_X)/_\ !+0MN/\
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MI.D^+(?&-YKWA[PS_H.444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'XE?\'#'[<VK_L"_\$K/VA/B9X%\8?\ "%?&GXI1Z+^SM\"]7AC\;V^KV_CO
MXL2W5IXDU?PGXD\!WND:CX'\>>!_@UI/Q5^)?P]\::EKVC:1HGCCP3X?9WUK
M4I],\*>(/\<%5EN9E49>:>0 9/+22-U)Z#+'))X')/%?Z,/_  >^_&GQ3H/[
M._["'[/%G8:#)X+^*GQC^+_QC\0ZI<6NHMXHL_$_P&\&>$?!?A"PT>]BU2+2
M8- U+2_VB_&UQXDM;W1=0U"[U'2O"LVF:IH]M8ZO::Y_%#_P230/_P %4O\
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M'CL^+/[:G^'OQU\9ZYX*\$>*[6#P_P"%O&WPC^%,&M:Q\2?"G\H?_!)- _\
MP52_X)K ]!^WM^R&_P",?Q_^'[C]5'_UNM?[>%5:T5T;;U\E9*WSO^ M;W>J
M\^KOK?K^*W?R_P  L&2WER"8Y89.HX9)$;'YAA]/PK_:\_X(T?MB>-_V^/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO+X;\+7+S^'-+_1BFU9M=G8%JD^X4444@"BBB@ HHHH **** "BBB@ HHHH
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M5*+$I\ ?V E3/"M\+_VB7;&>[C]J9 3COL'/..U?J)_P37_X/,_#'Q%\=_\
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M?);^=^B/U<C_ .#U?_@J2&_>_ #]@-U[B/X8?M$1M_WTW[4LH]/X3_A_6_\
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M0+_P2S_X.K_^'EG[<_P5_8N_X8._X4K_ ,+@C^),G_"R?^&H?^%C_P#"._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%?L]W-CXJAO=+T^VL=>E\8_ ?Q;J=M:Z1=ZYITGA;4?#=]+JD.K7FJ:)H_\
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MJOI_+>_;3KMI?O<)*UFM+I-_?;SW25KZZZ:'^V?1112$%%%% !1110 4444
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MKW3])TC2-/UOQCXQUOPOX"\+^*O%6A]!^V7^US\&_P!@_P#9C^+W[6OQ^O\
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MORJDK2DNS:^YD+9>B"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M^'YH] TG3;:'ZZKXD_X)W?MW?!O_ (*0?LD_"?\ :K^#&M:#<67C;P_I=O\
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M'P#8_&C]JKX?>(_V<O@S\./%L>K:GK'Q!TSXDMI/@?XYZKX=T/P_>V.I6_\
MPKGX,>+_ !5XEB\9ZO<6W@?PSXVD^'^D^)'U?4?%WAKP9XN_Q_XXWED2) 6>
M1E10.[,<#]37V+^WA^WA^T=_P4;_ &CO&'[3?[3?C#_A)?''B79IF@Z#IB76
MG^!?AEX%T^ZO;CPW\,OAEX;N+W4!X9\#>&1J%Z]E9/>ZAJ^LZOJ&M^,?&.M^
M)_'?B?Q3XIUO^MO_ (-4/^"&/BKQ=\2O"7_!43]K#PMK_@_P;\)M=@U#]E/X
M-?$'X8:CIUQ\6/$^N?#_ $;Q+X6_:8N6^(WA-=*U+X2>%M(\=Z1XD^ ?BWX>
M2:AJ/B'XOZ+%XXT[Q?X1MOA-9:?\2"*N^9K32ZVTZ+U>NVMM>C"3LE%:V;?S
M=D_DDEVN_5']W7[%'P6\3_LV_L:?LD?L[>-K_0-5\9_ 3]F3X"_!;Q=JGA2Y
MU"]\+ZEXG^%OPK\*>!M?O_#=YJ^EZ'JMWH%YJNA7=QH]SJ>BZ/J$^G26TM[I
M>GW+RVD/^-7_ ,%9_BS_ ,+Q_P""G7[??Q/MOB1_PMS0/$?[7'Q[B\"?$*'Q
MA_PGND>(/A?H7Q(\0^'?A5_PB?BR/4-5LM6\!:3\.-)\+:)\/?['U"X\/6/@
M?3?#^F^&_*T"STV"/_;1\5:QJ'A[POXDU_2/"NO>.M6T/0=8UC3/!'A6X\+V
M?BCQEJ&F:?<7MEX5\-W?C?Q)X-\%VNO>(;F"+2-'N/%_B_PKX7@U&\MY=?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOB%XBL- TG_A*?''B#Q!XENK..]U:YS[W112WW **** "BBB@ HHHH ****
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M_;!V^GW?^&@=OZ=>>M"[/;K_ ,-MW_IZ/3=;_EZ/?^NNY_ED_L(?L(_M&_\
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?XR/\ P<!_ W_AGO\
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MD?#G27U#5](^&6K^(-,\6>!M5TGQ!\?M8\/2?"_PVWA#Q&_C_0]-U+Q9\4=
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M>_\ !./P7\$OB\PMOCQ\3?'GBO\ :!^.?ARR\3:/XM\.^!_'OC?3/#/A;2_
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M*_S)ZOY+[M;_ (V^04445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX9T_PW8ZC^S/HUIJ7]E>--9\0_"NW36O'_P[LX+KX@7 ^#L?C3P_$GP]\ ?
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M,\8_'O2/B-HWB#7O!.E6!LE\2?#GP'\']/\ $>H:QKVIZKX56VD\/:1X:_F
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MM/#_ ,3?&'@R^\$7'\7_ ,5/^#VC]O75_'6N7_P1_9/_ &0_A_\ #2?^S?\
MA&_"?Q4A^,WQ@\=:5Y6D:?#K!USX@^$OB?\  [0-?^WZ['JFI::MA\,O#?\
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M<W%Y>7$UQ-)(T];+U?\ E\]?2WH5:RN];NR7FK-W^37;5^5G_7YXO_X/8/\
M@H_>^*?$EWX"_9G_ &(_#?@FZU_6+CPAX?\ %_A7X[^-_%.A^%Y]0N9- T?Q
M)XPT;X]?#_2?%6OZ;I36EEK'B32_ _@[3M<U""YU.R\*^'K:ZBTFSZ#X6?\
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MJ^'?[G^3[/I;1KR%OM_5OS_IG^EY_P $C?\ @N%^R/\ \%>O"?B&V^$J:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHK \5^*_"W@/PMXE\<^.?$N@>#/!7@S0-9\5^,/&'BO6=.\.^%O"G
MA;P[IUSK'B#Q+XE\0:Q<V>DZ%H&A:39W>J:SK.J7=KIVF:=:W-[>W,%M!+*H
M!OT5\ ?\/8O^"67_ $DL_8 _\3(_9U_^>-1_P]B_X)9?])+/V /_ !,C]G7_
M .>-0!]_T5\ ?\/8?^"61Z?\%+/V /\ Q,C]G7_YXU>Q_!7]MC]C/]I+Q/J'
M@G]G7]K?]F/X^>,])T&Z\5:IX1^"OQZ^%?Q3\3Z;X8L=0TO2+WQ'J&@>!O%>
MNZK9Z#9ZKKFB:9=:Q<6D>GV^H:QI=E+<)<ZA:13 'TY1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445^8G[8
MO_!9O_@F'^P/XXM/AA^U5^U[\/OA[\2[@3F_^'6@:/X\^+OCSPH(](\->(+0
M_$+P?\%_"/Q#\1?#0:[H/B_P_K?A(_$'3?#(\9:1>3ZEX3.LV>FZI-9 'Z=T
M5^ :_P#!T7_P0I<X'[<R@\#YOV:?VP$'/^T_[/ZCZG.!WK]?_P!FO]J?]G/]
ML7X6Z3\:?V7?C/\ #_XX_#+5C90#Q/\ #_Q!::RNB:Q?>'M"\5'PEXRTE6CU
MWP%X^TS0?$V@7WB/X>>-]+\/^.?"O]K6=KXE\/:3>R?9@ >^T444 %%%>1?&
MG]H'X"_LW>%;'QU^T3\;OA%\!/!&IZ]:^%M-\8_&GXD^#/A;X5U#Q/>Z=JFK
MV7ARQ\0^.=:T+2+O7KO2=#UO5+72(+R34+C3M'U2]BMWMM/NY80#UVBOP%D_
MX.B?^"%41*M^W/&2#C]W^S7^U]*/P:+X .I'N"16_P"$/^#F3_@AWXW\4^&_
M!^C?MW^'++5O%6O:/X<TN[\7_!?]I7X?>%K74-<U&WTNRN/$GCCQ[\&?#7@K
MP;H,%S=12ZQXJ\7^(-#\,>'M.6YU?7]8TS2;.[O8 #]VZ*X'X8?%;X7?&[P+
MH7Q0^"_Q)\ _%WX:>*!J1\-?$3X8>,?#OC[P+XB&C:O?^']7.A>+?"FHZMH&
MK#2M>TK5-$U(V&H7 L=7TV_TVZ\J\L[B&/OJ "BL#Q7XK\+> _"WB7QSXY\2
MZ!X,\%>#- UGQ7XP\8>*]9T[P[X6\*>%O#NG7.L>(/$OB7Q!K%S9Z3H6@:%I
M-G=ZIK.LZI=VNG:9IUK<WM[<P6T$LJ_#_P#P]B_X)9?])+/V /\ Q,C]G7_Y
MXU 'W_17P /^"L/_  2R)P/^"E?[ !)X '[9'[.N2?3_ )*-7W#X5\5>%_'?
MA?PWXW\$>)- \9>"_&6@:/XJ\(>+_"NL:=XA\+^*O"_B'3K?5] \2>&]?TBX
MO-)US0-<TF\M-3T?6-,N[K3M3TZZM[VRN)[:>*5@#>HHKY"^*?\ P4'_ &"/
M@9XZUKX7_&W]M_\ 9"^#OQ+\-C33XB^'?Q3_ &E?@S\/O'6@#6=(L/$&CG6O
M"7BWQII&OZ4-5T'5=+UO33?:? +[2-2L-2M?-L[RWFD /KVBO@#_ (>Q?\$L
MO^DEG[ '_B9'[.O_ ,\:OH#X&?M8?LL_M0#Q0?V:/VEO@!^T0/ _]B#QJ?@9
M\9/AU\6QX0/B7^U_^$<'BC_A /$?B#_A'_[?_L#7?[$_M;[)_:O]BZO]@\_^
MS;SR0#W^BBO(OC1^T#\!?V;O"UCXZ_:(^-WPB^ G@G5->M?"NF^,?C1\2?!G
MPM\+:CXHOM/U35[+PW8^(?'.M:%I-WKUYI6AZWJ=KH]O=R:A<:?H^J7L5N]M
MI]W+" >NT5\!+_P5?_X):.VU/^"E7[ 3L>BK^V/^SLS'G'0?$8GKQ]:^W_"O
MBKPOX[\+^&_&_@CQ)H'C+P7XRT#1_%7A#Q?X5UC3O$/A?Q5X7\0Z=;ZOH'B3
MPWK^D7%YI.N:!KFDWEIJ>CZQIEW=:=J>G75O>V5Q/;3Q2L ;U%%% !17S'\:
MOVV/V,_V;/$UAX*_:+_:W_9C^ 7C+5=!M?%6E^$OC5\>_A7\+/$VI>&+W4-4
MTFR\1V&@^.?%>A:K>:#=ZKH>MZ9:ZQ;VDFGW&H:/JEE%</<Z?=QP^?>$?^"F
M?_!-[X@>*O#?@7P'_P %!/V(O&WC;QEK^C^%/"'@[PC^U=\!_$GBKQ7XH\1:
MA;Z1X?\ #?AOP]HWCV]U;7=?UW5;NTTS1]'TNTNM1U/4+JWLK*VGN9HXF /M
MVBBB@ HHKYC^-7[;'[&G[-GB:P\%?M%?M;_LQ_ /QEJN@VOBK2_"7QJ^/7PK
M^%GB;4O#%[J&J:19>([#0?'/BO0M5O-!N]5T/6],M=8M[233[C4-'U2RBN'N
M=/NXH0#Z<HKX"7_@J_\ \$M'(5/^"E7[ 3L>BK^V/^SLQ/;@#XC$]>*^W_"O
MBKPOX[\+^&_&_@CQ)H'C+P7XRT#1_%7A#Q?X5UC3O$/A?Q5X7\0Z=;ZOH'B3
MPWK^D7%YI.N:!KFDWEIJ>CZQIEW=:=J>G75O>V5Q/;3Q2L ;U%%% !1110 4
M444 %%%% !1110 45\1>+O\ @IG_ ,$WOA_XJ\2>!/'O_!03]B+P1XW\&:]J
M_A7QAX-\7?M7? ?PUXJ\*>)_#^H7&DZ]X<\2>'M9\>V6KZ%KVB:K:7>F:OH^
MJ6=KJ&FZA:W%E>V\-S!+&OT]\+OBO\+?CAX%T+XH_!;XE> /B_\ #/Q0-2/A
MGXB_"[QCX=\?^!?$0T;5]0\/ZN="\7>$]1U;P_JXTK7M)U31-2.GZA<"QU?3
M=0TVZ\J]L[B&, [^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKP+XY_
MM7?LM_LP+X8?]I;]I3X _L\)XV.LCP8_QS^,?P[^$J^+CX<_LG_A(1X8;Q]X
MC\/C7CH/]O:'_;(THW9TO^V=)^W>1_:-GYWGWPL_X*#_ + _QS\=:)\+O@G^
MV_\ L@_&'XF>)1J;>'/AW\+/VE?@Q\0?'7B!=%TB_P!?UEM$\(^$O&FK^(-5
M&DZ#I>IZWJ9L-/G%AI&G7^I77E6=G<31@'U]17P$W_!6#_@EHC,C_P#!2K]@
M%74E65OVQ_V=E96!P593\1@00>"" 0>#7OWP,_:P_99_:@'B@_LT?M*_ #]H
M@>!SHH\:'X&?&3X=?%L>$#XD_M8^'1XH/@'Q'X@&@'7QH.NG11JWV3^U?[%U
M;[#Y_P#9UYY(![_1110 4444 %%%% !1110 45\P_&O]MS]C#]FKQ1I_@?\
M:,_:Z_9A^ /C75] MO%>E>$/C7\?/A3\*_%&I^%[W4=4TBS\2:?X?\=>+-!U
M:]T"[U;1-:TNVUBVM)=.GU'2-4LHKE[G3[N*+H/@9^U=^RW^T^OB=_V:?VE/
M@#^T.G@DZ,/&;? SXQ_#OXM+X1/B/^UO^$>'B=O /B/Q - .O?V#KG]C#53:
M'5/[&U;[#Y_]G7GD@'OU%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWP/^T9\,?%GB3^TM7E_M7P/\)->^$7BKX>Z'_8\VH2:!8_\ "/Z_\;/B=?\
M]I:;I=GJ^J_\)-]EUO4-2LM&\/V^E?PAVA(NK8C@BXA(^HD4BBG\:7134?D[
M.WI:5O0<]5?^ZOO2M?UTOZZG^_A7\5?_  <+_P#!S1??LB^*=7_8H_X)Q^,/
M#^H?M,^%M=@MOC]^T*NC>%_'?A3X$ZAHFH1S7WP:\$:)XHTSQ#X,\:?%ZXN+
M5M*^*NHZ[H^M^%_A-ISZCX"@L=3^,=YK\_P._H\_X*X_M=7_ .PG_P $V/VQ
M/VI-!O->TOQG\.O@_JFE_#+6_#>A^%_$NH^'/C!\3M3TKX2_!OQ3<:%XTE3P
MQJ>@^%OBGXZ\(>(?%5OJ]MK$!\,:9K#Q>&_%%RD'AS5/\4'Q?XO\5_$'Q9XG
M\>^._$NO^-/&_C;Q#K7BWQCXP\5ZQJ/B'Q1XK\4^(]1N=8\0>)/$>OZO<WFK
M:YKVN:M>7>IZOJ^IW=UJ&I:A=7%Y>W$]S-)(R=V[=+7;_)?/77I;ST+65^[L
MO56;?RNM'O?R/1/C=^T;^T'^TOXIL?''[1GQT^,'Q[\9Z7H-KX6TSQ9\9OB5
MXR^)WB33?#%EJ&JZM9>&]/UOQKK.MZE9:#9ZKKFMZG:Z/;7,6GP:AK&J7L5N
MESJ%W+-XXDDD9W1N\;<'<C,AR.ARI!X[5_HA?\&N7_!"[]CGXF_L;^$?^"A/
M[7GP;\ ?M&?$7XP>._B%)\#O"GQ!GO?&WPO^'OPM\"7WBOX+ZF/%?P>UO1-/
M\!>)_B!XI\=Z?\1=4NW\<0?%70-#\/Z+\(O$O@/_ (07QY:>*))?ZFOV_O\
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MEIIR^)O GBDZ?;7C?M!^+I+_ ,;>$_'.HZMK?QM\4>)_ ?BB_P#'7P<^PO\
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MZWTCP_X;\-Z!I%M9Z3H>@:'I-G::7H^CZ7:6NG:9IUK;V5E;06T$42_Y%/\
MP:V@'_@NI^Q"3VB_:8(]C_PR'\?!_(D5_KZU3VBO5_>[?DE][(6[\K+\+_K^
M05^(O_!;K_@BMX#_ ."S'PI^"7@_4_BW_P *!^)?P*^(&O\ B3PA\6AX"U?X
MJ-%X'\;^'DTSXB?#P>!8?BE\,-!8>+]=\._#'Q&?%FI7.KZOH)^'XTC1(+6S
M\4^('G_;JBI:3W[I_-.Z_%#_ ."OOT/XJO@I_P &2?[%/A_PQ?6W[1'[8'[4
M'Q6\:OKUS<Z9KWP;T?X6? 3PK9^&&T_2X[+2+[PAXR\,_M%:QJ.OV^K0ZU>W
M7B2W\=:7I]WIVH:5ID/A6QN='N]7US^QCX5?#'P/\$OA?\-_@S\,=$_X1GX:
M_"/P%X/^&/P]\-_VGK&M?\(_X'\ ^'M.\*^$]$_MCQ#J&K:_JW]DZ!I.GV']
MIZYJFI:Q?_9_M6IZA>7LL]S)WM%5=[= /\0W_@K5_P I4?\ @I5_V?Q^U_\
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M6L^,]<L/#=EJ^J:YJUIH-IJFM75OH]KJ>M:QJ%OI\=O#>ZIJ%RDEW-_L-?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV(OB1\/?#?[-/@"+]H3X1_ 2[T7]C3Q%\,M%^'OPK\<^$/$7PD\*>*KSX%_
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MZCKGVCX:?#WXB_L]_$SPAX;_ +-TB+^R/&_Q=\-_%CPQ\0];_MB'3X]>OO\
MA(-#^"OPSL?[-U+5+S1]*_X1K[5HFGZ;>ZSXAN=6^@/^#V#XI^!]%_X)_?LO
M?!B_US[/\2OB'^UU9_$KPEX;_LW5Y/[6\#_"/X/_ !-\,?$/6_[8@L)-!L?^
M$?UWXT_#*P.F:EJEGJ^K#Q-]JT33]2LM%\0W.DDU:Z[I6_[>2M]U]1PNFF];
M.[\U'5_>E?R/\SFBO1O@]\*_&_QT^+?PO^"?PST/_A)_B1\8/B'X+^%_P_\
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M[9V_A_33X>^'VO"+5]5L)]8.DZ!'JFMZ:+78#^KFBOS$_:8_X+-?\$Q/V1?
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M_F11RND;Y!W*K$ Y& >/X@ #U P::;3MY7[KI??Y=.S]"VE_-+SU3_#1_P#
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M_P")WQ/O]+T_5O&^KZ?IMG9Z9X7\!>&/ /@'P;]0_P#!#?\ X(9_&3_@KO\
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M;:>VGEB;\(/^(H[_ ((4?]'S?^:S?MA__0^UZ5_P60^*?Q3^,7_!#O\ :/\
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MW_!MM_RBY_X.7_7_ (81TW_UGC]O.OY =5_Y"5[_ -?$G\Z_OR_X,9/^/?\
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MQ/\ L?:1JO@*^/C;XA^/OVCO'^A_;_M/Q0\+I\-?#T/PU^$>J_V9;:ZG]B^
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MJ^E'PP;30[_3+/6?$-OJW^AE5R5G_P!NQ?WQ3(77U?X:?I?YA1114C"BBB@
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MQ\VE^'=+UC4G\6>";GQ-_J-_\$=?V&=$_P"">'_!.C]F?]G&/P=_PAOQ'M?
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M7ZM?H?N'\)_^#<'_ (+/?&OX9?#7XS_#+]C7_A)OAI\6_ G@WXG_  ]\2?\
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M_@T)^!7_  MK_@L5X3^(9\3?V"/V8/@!\<?C8NE_V+_:G_":OXCT73/V;O\
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M.K'P'\1K_P &^(KC0KGP%\,/$!TZS\1:=\(_#&L/-(W^AY_P<,?\$ROVH?\
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MQMX6^,Z7/@+PW^T/X-V>$?VG_@MX-U;5[H_#/QXE]K%KH6O6>F>);:WUZT\
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M>*/%&M?K'_P;R?\ !%;Q5_P5'_:<T;XA?&'P!K\O[ GP1\033_'CQ:OB#4?
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MJUYJ/Q2\#^(&\+^%;O0?"FGZQJ_CGX/^&M1\3^(/%UY\'/$7B*]ENY/]1?\
M8:_;E_9R_P""B?[.7@O]I_\ 9@\9CQ7\/O%@DT[5M(U**VT[QS\-/'&G6UE<
M>)?AA\3_  U;WNH'PMX_\+'4+)M1TY;W4-(U?2=0T3QCX-UOQ1X"\4>%?%6N
M?XL_[:O['_QC_8'_ &HOB]^R1\?+30+7XI?!O7K'2=<G\*:Y#XC\+ZYI>O:#
MI/B_P=XL\-ZM'%:W,VA>,O!?B'P]XKTFVUK3=#\3Z98ZQ!I?BSPYX;\36>K:
M#IW](7_!G!^U[J?P8_X*2^+OV5]1OM?E\$?MF_"#Q#IMCH6D:'X7O=.'QC^
MFF:Y\6?!7BKQ3KNJ2V?BC0]!T;X5VWQ\\/06WA:YU"#6/%'C3PVGB#PW>6UC
M9^(_"3C9I][77RW3^5_.ZMU!W3U_J]K/^MT[G^HE1112 \D^/_QF\+_LX_ C
MXV?M"^-[#7M4\%_ ?X2?$CXS>+],\*VNGWWBC4?"_P +_!VL^-]?L/#=EJ^J
M:'I5YKUYI.AW=OH]KJ>M:/I]QJ,EO%>ZII]L\MW#_A4?&#XJ^.?CK\6OB?\
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MX@Z+<ZYIME,?#7PT\"_&7PSX4\16ND^(_$6BZO\ $&;1;"RL- \6>*]6LO\
M4RK_ !;O^"$?QH\4? 7_ (+"?\$\O&_A"PT'4=5U_P#:7\"?!>\M_$EMJ-WI
MT?A?]HZ>X_9\\;W]O#I>J:/<KKVE^#/B=K^I^%;F6[ETZQ\46>CWVKZ7KFE6
MU[HFH?[2-6]HORL_5-Z/T5OE9$+KZZ?<OUN%%%%2,**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=7U#Q!K']A^$O"FG:3H&D_VKKVK:IK>I?8-/M_MVKZEJ&I77FWMY<32'RO\
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M%'.O^YQ\<?V4_P!EW]IU?#*?M*?LV_ /]H5?!7]M?\(:OQQ^#WP\^+*^$O\
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M/?67A[X;_$7PM _C?PZ?#FH6'C_X=_#3_72HI6^7ZKM_6WWCOT>J_7R_7O\
M)6_P2?A;\6OBM\"_'6B_$_X)_$WXA?!WXF>&?[37P[\0_A;XS\2?#WQUX?&L
MZ1J'A_6!HOBWPEJ6D:_I7]JZ#JNJ:)J8L=0M_MVD:EJ&FW7FV=Y<0R8'B[Q?
MXN^(7BOQ'XY\>>)_$?CCQQXSU_5_%'B[QAXNUK4_$OBOQ7XH\1:C<:MKWB+Q
M'X@UFYO=7UW7]<U:\N]3U?5]3N[K4=3U&ZN+V\N)[F>65O\ ;Z\7_P#!,_\
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M -7[X_K_ &[:*FVM_)K[[?Y!??S5OQ3_ $/\P[_@RF_Y2@?M"?\ 9A7Q'_\
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M&G^(-'.L^%O%.G:5KFF#5M!U;2M;TQKVQA%_I&I:?J5J9;.\MYI/[(?VB_\
M@[I_X*X?LS_M!_'/]G+QQ\$/^"<VK^,?@%\8/B1\%_%NJ>%?AU^TQ>>&M3\2
M_"_QCK'@G7K_ ,.7VK_M(Z)JEYH5[JFB7=SH]WJ>AZ/J%QI\MM->Z3I]RTMI
M%]@?\$N_^#PWQW\<?VG_  7\#O\ @H?\,/V9/@O\+/BGKEGX<TG]HGX>:Q\2
M?AKX6^#NIG0?%<MC+\2]$\<ZU\9;7Q%H/C?QG_P@?A)/%<WB[X3^%_A+I][K
MWC?QWJ^K>&8+JX\.RE?;KK;\?Q5_GKZDG;1[K2]_.UGW2Z/HNMDDOX7?V9OV
M3_VDOVR_BEI/P7_9;^"OQ ^.'Q)U8V,Q\/> ] NM4CT+2+[Q#H?A7_A+?&NN
M,(?#W@#P%IFO>)M L/$7Q"\<:MX?\$>%_P"U;.Y\1^(-*LY/M Z?]M/]CSXO
M_L%_M"^*/V6_C[:Z#IOQB\ ^&?A=KGCS1?#>N0>)=-\-ZI\4OA9X,^+5KX4F
MUVRB32M2USPGI'CG3O#?BFYT"YUCPPWBC2]9'A;Q)XG\.KI?B+4_]M+Q]^U7
M^R]\*?A=X-^./Q1_:1^ GPV^"OQ%'AX_#[XO^/OC#\//!_PN\=CQ=X>O/%WA
M,^#?B!XA\1:=X3\3CQ/X3T[4/$_AXZ)JU]_;7AZQO-:TW[3IMK/<I_CU_P#!
M<[]K[X,_MW_\%3_VK?VG_P!GR_U[6/@[XZUKX<Z%X(U_Q%HDWAN^\3V'PN^#
MOP\^$][XKM-#O)6U73?#_BG5O ^H>(/"D'B"VTCQ.?#&I:1)XH\.>%_$+ZEX
M=TMM[)=7KWLD_P +V_#4%;WK_P NGKS1_&U_E<]^_P"#97Q3X8\"_P#!:O\
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M:_%H/C'X[^+DD\%_ ;P!+!J/@ZV\0+X@^)6LPQZ7J_B#PKI/CKP_XNU?X:>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_$/@CPGJ]Q9:EH<&G:?K5QJ6I^)/#6E6E]K^F_Q/?$__ (/B_BAJW@;7-/\
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MG5_"_P#L]_L]_&;]JOXS_#W]GO\ 9\^'VO\ Q1^,'Q2U^'PYX*\%>&X8'O\
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MVH7&DZ]X=\1:!K$%IJNAZ[HNJ6=UINK:1J=I:ZAIM_;3V=[;P7,$D2?UM_\
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M)%_PO+XF_;OLG_"N?[*_L7^PK/[1_;/V[^UH?[/^QWW^<)_P]H_X*H;V<?\
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MA;H.B2>)V_:$&F&[\;V_A?6?B1HWP9TBPU?1_!/BGQ1\,_&VC:IXD^&MI_
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M\/\ 1=.\'>'O"]WXEN_CQJ/B3Q?-XS\7^"= UWV+_@\1_P""4FC^)_A]I_\
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M +%G[9'[.W[3_P $O!OP_P#$&@_%_P#9EO/CW^S]^T=X TZ32O'$^K:;\;O
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M[_Z_R&G\U_7]=O(_P#)(9HB1+#+&1U$D;H1VY# $<^M,5'<X16<^BJ6//3@
MGFO]_:BF(_QS/^"</_!OG_P4<_X*'^._ )L_@?X__9\_9R\1MX'\1>)_VGOC
M;X*U3P9X+L_A=XWTC5/$ND>._A3X;\63^%?$/[0AUS0-'?\ X1:U^%:ZKX;F
MU?7_  2?'/C3X>>#_%5OXUM?]9C]C3]D?X.?L(?LQ_"']DOX V.O6/PI^#/A
MZ\T3PZ_BG7)_$?B?6+_6]>U;Q=XN\5>)-7EBM;:?7_&7C3Q#XA\6:S;Z-INA
M^&-.U'6KG3?"7AOPUX8M-(T#3?INBG?2W3?U?GZ:V[7?F!_FF_\ !T/\/?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M75_X-</^"ZS$ _L.*@_O-^TS^Q\0/KL_: =O?A3^?%?Z_%% '^?9_P $QO\
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M'\(/"/@_PC;^&O#7P:T^ZU*77K3^M>BBW]?U^07/\P=_^#*C_@J2"?*^/_[
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MUT77)-'A\9^#O OB?PO_ )XG[47_  :!?\%8O@SXJ6U^ 6D_"#]L'P/JNO\
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M_P""IO\ T7S]@#_PZ?[17_T*M?Z?=% '^8)_Q!4_\%3?^B^?L ?^'3_:*_\
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MKK5_AAK=K;Z3X7O;&_\ ">@_[-U?R&?\'>'_  31_P"&GOV,]!_;>^%WA/\
MM+XW?L7_ &J7Q]_8.A?;/$?C3]E[Q/>P_P#"81WO_"/>!=>\6>(O^%(>*7T_
MXGZ2-;\6>%_A]\-?AEJW[1WC/4OM&I:C#E/H^WY=?\_D4NL?YK6]4]/OU7SN
M?G[_ ,&0_P"U&&M_VWOV*_$'CCYHI?A]^U!\)?AN?#?\$JS?"G]H7QL/%]EH
M'0/'^S+H1\-^)?%/5QJG@C0!GX@:C7]K?[:OP8\4?M'_ +&W[6O[/'@>_P!
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MG_"53:)9_N!_P9\_L<^.OC?_ ,%.6_:LL;K^R/AE^Q'\/_%6N>*M0^SZ1?\
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MW?EHEZ))*_G9:^9*T7Y^KU84444AA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#U=WO_7^04444 %%%% !1110 4444 ?S4?\ !47_ (->?V#?^"B?BCQG\;?
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M@7PY^TAI.J:#;Z3#HE[:^);CQII&H7FHZAJFF2^%+&VT>TU?7/&Q_P &5/\
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M]?<?@+_P6\_X(L?%/_@LG%\$/!H_;?\ ^&:/@I\&'\0>)7^&&G? ;Q#\4O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
A10 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>img247211528_37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_37.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MK\ V>K6=P"X0>5.K98]!P>O!H#8DNM:TJQ65KO4K6W6)@LAEF5=A/0')XS0
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M6(,J^5M [D9)P.A&><Y[4Y:2L@CKN=19&<VD+7)!FV#?M7:,XYXR<4WHQ(M
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MV#CFIC\(/J>D:/#-'8@W%G':3%CNCCF,H'I\Q _E5$1U6II#I04% !0 4 %
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MUH 6_P##VCZK*LNH:7:7<BC:&FA5R!Z9(HV OQQ)#&L<:A44!54<  =J 'T
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MUH&:FG_;5LT%^83<9.[R00OMC.30(L[J ,7PK_R#;O\ ["-W_P"CWH VVZ4
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M/?Z4,>YT6B?\@'3_ /KVC_\ 017 >F7) &7:PR#P128(XS0&TR/7IET_1Q"
M[QF=[D,01U C)R!^%-; ]#M=PH S]</_ !(K\=/W#_RH ?K'_($U#_KWD_\
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M1G\Z ([+3M3BU"_E@UZR>:XD5YE^QD[2%"CCS..%% &A!_R.%Y_UXP?^AR4
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MMM RAK@QH5__ -<'_E2 DUC_ ) FH?\ 7O)_Z":8%F#_ %$?^Z/Y4 5]6_Y
MU]_UP?\ ]!- $UM_Q[1?[@_E2Z <+I774?\ L(7/_HUJ[*?PG!6^-FA6AD7_
M  =_R!)?^ORX_P#1K5Q3^*YZ%/X$;S#BH-#B(/"%Q+J=Q?2VVCKNNGD!FL-\
MV-V0=X8=NG%-:#9VX&5% A<8%(#%\(_\BU:_[TG_ *,:@!/!W_(LV_\ UTF_
M]&M3 W: ,_2?^/.7_KYG_P#1K4=0.4B_Y&#7_P#K\'_HF.NFC\)Q5])%NMCG
M%\,_\C1K/_7O;?SEKEJ[G;0^$ZT]*Q9T'/\ B/0[G5Q!]GO$@\K.[<91G/\
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M*)%*7\ND3LT>Q);<^4%QM8*5^8Y(R<ECDYH$V=[I\#1:5:P38+I$JM]0 #2
MEMK2WLX1#;0)#$.0B+M _ 4 2/&DB,CJ&5A@@]"* (X+6"U@6&WA2*)>B(-H
M'X"@!^Y?4=<=: ([B%+BWDMWR4D0HP![$8H D7:J#!X'?- "[10 QF2-@I8
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M9QNR72FQO=IQB%B#N]B,'_OJ@"J8?$=U?3V\X$-C%<QB!(H_F1%E7# D8/R
MY'/T% #-)D\1QWTSWT$T44MR \T4"EW C4*2,'@G=DX].@H DT$^)H=;^RW,
M0ATQ99&3<F2ZDL>H!P=Q'4CCM0!I:]8FZU>Q:]M'O-)6.020JF\"7*[6*CJ,
M;A[9H Y2\TK7[>]EAL[&5[%[P7R<XV,LNP)]"N&_ T ,32_$DJZC_:.FNBS7
MOVAE0B99&\KY5QW0,!^F?6@">32KN]O9KJ[T>6 ?N4NK:&,[;D!@TC$]&P>
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MUTYLY;:)[>$2^9_RTN!N\QA^8Y[T =@.E !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 )B@ VT &* #% "XH 3%  1QB@ Q[F@!>E !0 4 )B@ Q0
M8H -O- "XH ,4 )B@ Q[F@!: "@ H 3% !B@!<4 % "8Q0 8H ,>YH 4#% !
M0!__V0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>img247211528_38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_38.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@!,BD HI@% !0!1UEWCT2_>-BKK Y# X(.TT
M <&=<UNTLO#EU?1HEMY;NS07+2238@8_,I4#MGDGFD/J58-;N[?1M8TVZNY7
MU%K?SUD2<E IQ@A\Y!.3D <8IL6QUOAB"2-IFE:+>0,"/47NN/<,!B@2.G'
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M>%'(63<Q#Y'\6!GZ4 ='9:H+O4;^Q\AXGLV4%F(PX89!&#0!HT % !0 4 %
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MDT4\CN S&)<B)2P7<WH,F@":[U^VL]8M]->.4R3#.\#Y4SP,_4\<4 5M)/\
MQ56O_P#;#_T"@#?H * $9<C':@")[:*1 CQ(R 8P5R* )$C6, * JCH , 4
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M $"@#>H * "@ H 0]* ,32_$D&IZI=V*Q-&8C^Z=CQ, <,5'H#Q0!MCI0 M
M!0 4 % "'H: .4U^_@T_Q!:22WT-DSVSJ)+B+?&?F''!&#^/-(?0T=+T^VC\
M.)9V\ZW$+*Q$C+PQ))S@=LGIFG(E'GVAK9?V]8-]GQ/YX)NHK!E23);&'9\
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MV^W7/[N7&>96/;TSCZ@T#/-OCA_R'--_Z]F_]"KIH=29'E@Z"NLDZ?X>?\E
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M<#]U(2I?/W/1B.I7U(Z5+U&<_P"#;O4)M3N1<2WCJR_O8[C<5B<'JK$8(;/
M7@ #UJK$G;T#&NP12Q. !DFD!PVJZU_;+VK);WJ6,:M<.J2&-IXON[UVG/RD
M@X.,Y!H0&OX3U#[9;SQ)J*ZE!;N%BNUYWJ1G#'NP[GWJA'24AA0 4 % !0 4
M % !0 4 % !0!R_C"YD&G?8XI1"\[JH(,>6'.1A^.@ZF@"'P.VFPV][8:=;R
M0/:R*)PT@<,S#.00=O0]!0!K:CXCL-+NTMKAW\UE#D*A8*I8+DD=.2/_ -5
MB2?7+.VU 64COYORY(4[5W<+D^YH&5-(_P"1JU_ZP?\ H% '"?'#_CQT;_KK
M)_(4T853QNJL8(W_  -QXZTG_KJ*5M!P^(^G34G8<7KO_(8D_#^5(XJWQ&?0
M9'1>%^ES_P !_K3.FAU.C%!TH6@84 % !0 4 % !0 4 -8X4XY/I2>@''W?B
MQW_TJTL;HP6LGE7'F,L:HY_A<'D$9'/3YAVY# CT;2&U+3[0 K]ACN6F+.&2
M=CEOD<#N"?O9YP*-@.T555 J@  =* *>J:G;:19&[O)/+A#JA?'"[F !/MDT
MF".-@U2XM-9O3=O#-/%(K^7-(6,B,2$: =%&TX]20<^M%@9M^&O#]UI,;F[O
M#,P9A'&A(15+ELX_O$GD_A]:$CI!T%(8M !0 4 % #6Z4 8FLZ[%8W,>FM:7
M$US=C; J$()#@YPV>,#K]12O<#G-,_M'5;^[EB6)_.MS"7E+!H"I(P>"5<;L
M$9PV,@TT@N=II]BFG64%K%G9&H49)/\ /^5 %IC@4 >?:QKO]IR3RPVTN--D
M>">&4D%22 )PH/SJ,,<5*U]X"32K/4M:FBFMK^W6RMU>V^U00F,S1DHV8QT'
M0J3[<>U;:B.]50@  P*-QCJ "@ H * "@ H * "@ H * "@#F/&>G)>Z?$5A
M0SB4*)?LZRL@(.,!@>,X_6@"C\.Q>I87T=Y;R1A95",\2Q!OD&X *!T;(SWH
M MZ_X:OM1U9;JSGACCFB%O<"0$DH'#97WZC\: %O/#MY=:VMUYD*V\Q0W"\[
MOW;93;^F: -!O#EFU]<7@ENXYK@@R&.Y=0<<#@&@"CJ?@?1-:6-=2%U=+&25
M$EU(0I/IS0*R,J3X1^$6DC9+*5%0DLHG?YACIUH)Y$6K7X8>%;.YCN;:QFBF
MC.5=;F0$'\Z!J*1M_P#"/6H_Y>K_ /\  R3_ .*H**<_A/1V+37$EUGN[WD@
M_P#9J"'!,BC\#Z/YDC[[ME?!"_:Y,+].:!<D2W!X3TRVSY+WD>>NV\E&?_'J
M"E%+8OV>EPV,C/%)<L6&");AY!^3$T%%Z@ H * "@ H * "@!DDB11L[L%10
M22>@% '.:KK4NZ".QDBE@U"%X[>>-@0)P"5&1ZC/XBD]=![&1X5TF[N-0GOK
MBWN;2'[K13LQ,AP048-G<H&TAO4G'%,6^IW2*$4*  !T H S==UVTT#3FO+H
M2-&"JE8EW-R0,X]!GFE<#B[K4[O4-1U"/3[];NPNECGCC>,LT!#*#A>IP0"R
M''#9[XII!?J=;H?ANUT:V\I&:?Y_,5I0"4) SMXX'&<=J8C; Q2&+0 4 % !
M0 =J .9U77U>.X32[D&]T]_,GM67#R1C[P&?T(]*5P.=M['4]4UT17EG.T3L
M7,[2,8S&3E9$;HC#@ #GDYI[ >@6]LD"#&&<@;W( 9R!C)QU- $Q8*.>*3T
M\W\2>)X-4%WI\HO='NM.G66*<D!)<9QRIZ,,XSP>E&O0>QK:3X7COM0DU74H
MS]J699K>2&3]V/E&63'.&QR#_P#7I[*R$=D%P.,4 .H * "@ H * "@ H *
M"@ H * "@#D_',<$&D&](2.8$)YS*S;!R>@/<\?C0!'X O7O;&Z<6ZK;JZ".
M9<XF)0%N#Z,2/PH ["@ H 2@#"U_5+NRCMX]+C6XO9&W+"5)#H,!N1T^\.:
M.=\-SZ[?Z@;U7W6WVAD9VDSF/)X*D\,#M P,8S0!WR]* &R2I$A>1@B#J6.
M* ."UV[O]8N[:W-M'':?:)&2.0D>=Y8Y5\\;6!.#V(% '3Z!:O:BY"B=+-RK
M01RL&\OCD+@GY>GZT ;6* "@ H * "@ H * "@ H 0J#D'I0!BW_ (4TJ_EB
ME,3V\D<BR;K=S'N*D$;@.#T[BE8#: Q3 "..* .,OKRQT[4-1BU2P::[F8M:
MRFV\T2J5P$4XX(Y&#@<^](;+WA;0/[/T^WFOH(C?X+;B@W0AAR@;KC.>.V<=
M!31+W.E48H&+0 4 % !0 4 % %2ZTVSOEVW5M%,.V] <?3TI 26UI#:6L5M
MNR*)0B+G. !@#FF!.!@8H YWQ5#.;>SN%M7N[:WG$EQ;H,F1-I'3^+!(./:E
M'XM1E*T^P^(]6@:QCDCL+*/[ZPF(,Q/^KY'*XSD8QTH0CK418T"JH50,  8
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M5#/*,EB&#CY2<H?DXSV- '6H@10JC '0#M0 Z@ H * "@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H 0 "@!: *U_90:C8S6=
MRF^"=#&ZYQD$<T 8=MHVHS7%FFIS0RP61+1L@(>0XV@MV''7'6@#HT144*H
M51@ =J '4 % !0 4 % !0 4 ?__9
2

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>img247211528_39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img247211528_39.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M0 F: #- !F@ S0 N: "@ H * "@ H * "@ H * "@!,XH ,T &: #(H 4&@
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MCXAUJ6TE26]?;L8%5 &>/:FI-,PE&*6QU'P@Y^'EGD\^;+_Z$:[#ST=[0 4
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M% "O96LC[WMXV?IN* F@!PMX0K*(D 9MQ&WJ?7ZT +'!#$ (XD3!)^5<=>M
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MF@TJ\U.!;Z2*U52 _DCN2W4 @B@#I/#VL+KVBP:DD#PK-GY'.2N#C^E &I0
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MV9^SUN>DOJUA#<BUENXHY\#$;MM)_ UR<KMHC2Y># C@TMABT % !0 4 &:
M$R* *NH:?;:I9RVEVC/!*,.H8KD>F1S0!5NO#^G7J0K<V_F>2I12SG)4]5)S
MR#Z&@"AXW39X#UE0, 6KX'IQ0!J:%_R =._Z]H__ $$4 :% "9% !D4 +F@
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M!S'P^_Y$NR^K_P#H9H Z>@ H * "@ H * "@ H * "@ H * "@ [4 -*CTI
M<!XN\#/<W$NK:, +H@F:W/2;Z>AK>%5K1B.)26YMK]H[VWDMY$.T))&4(';K
M79&2DM";:G22ZPEAI;M"<3",PKSW/?'M6:@F]1[&9H^F),RAH\@<G^E.<FE8
M45J==:Z:EQ9'3Y4Q&%VQ*BX8CO\ 7''YUR\R6IHU8T[7PC9(JFX8O(.Z?)CV
MXJ74DQ%'QFMW8Z= =,DDM\$EI$.2,#@<]JNBHM^\1/571/X#U>_U;3;AK^82
MO%)L5MH!(QWQ55X*$K((;'65SEA0 4 4M1BC33[N0+&&\LN2X^7('!/Y#\J
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M:G]H6,2%,1YVYQG[WK0!M:9J$U_"[S:?<614X"3[<M[\$T 7Z "@ H * "@
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M %UD_P#0C7:<9WC9VG'6@#S?7/[2CU&ZM85E$,UPOF%[] CH7!VHG53CC_\
M70!W.D"X72;87:%)MO*$Y*^@/N!B@#A+:TCAU)2EYIKK]OR-NF/OYEZ>;TS[
MT ==XIUN30])$UO#YMW/*D$"$=78\?XT 0VWB:T336F=KRXDBF-O,JVY9TD
MR054<#_'K0!#\.V#>"+!@",[SS_O&@#;U>[?3M'O;V-0SV\+R@'H2!F@#Q0?
M'G5\\Z/:_P#?;4 45^,VJ+KCZF-*MM[0"#9O.  Q.?UH O#X\:L3C^QK7./[
M[4 >YVDK3V<$S !I(U8@=LC- $U !0 4 % !0 4 % !0 4 % !0 4 (>E &3
MK7AW3->@6+4+?S-G*,#M9?H151FX/031Y/XAT2;PIK;J%/\ 9\_,$I&=I]#Z
M&NR$^=>8MC+U!A>7T$4F2T:9  &TY/UKHI>[&YG-W9TVE6C&U55^4ORWT["N
M>H];FD5I8ZK3X&TU99-F\3#@=6'J/QX_*N>3YG8M*P_2]0N)=8@2:,Q!BXVI
MR#QQDG\:)*R)U.O'2L1BT 4]0L(+^U,,X;;D$.C;60CN".0: .?MM,TF\F2(
M^(+J_0DX@>\#(^T\@@#Y@.XYH ZI %0!0 !T H Y;7O$CV&N6VEPAU7R6NKJ
M9(]YCB7C@8/)/?L,T 4O&^O:</ UTBS22_;;-C!(L3,&&.I(&!^.* .HT/\
MY &G?]>T?_H(H J>+_\ D3M9_P"O.7_T T ?))ZTAB4 "_ZX?2@#ZHUC4+_2
MO L5YIJ![B.V0XVDX&SD^G'7GBF(HWNO^((?!0U1;0+?9),7EG*KCKGIGH<]
M#^- '2Z#=7MYI44^H0B&X;.Z,*1MYX'/7COT- &G0 4 % !0 4 (>AH \O\
MA=J-A81^(4NKV"!FU*0@2R!21^)H ] _M_1O^@M9?]_U_P : (+K5- O8&@N
M-2L7C;JIG7_&DTF-.QRVHZ+H,B,;'7[2)C_"\Z$#\<YK)TS6%2VZ,J/P];.-
MLWB330N>TX/]14>R9HZZ[&I!HNB0PX7Q%8JX[HR ?^A4_9$.K?H4=5L+9-*N
MVCUO3YML;D*)U!/'UIJG9B<]+&G\'^/AY:8.?WLG_H1K=&)W9/% 'GNH:-IL
MFO-?1K*TXO0SR+IQ8<."1O/&0<C=Z<=LT =^S!0,D#)QS0!P]I]NCF\DP:VH
M^WD_*D8@V^;G/3=MQ2 Z[4=-M=8M5AN 2J.LB,AP4=3D$'U!I@.L-+M].680
M!MT\IEE9CDNQZG]* ,7X??\ (EV/U?\ ]#- &CXG_P"15U?_ *])?_030!\B
M=*0"4#!/];^ H ^R--_Y!=I_UQ3^0IB+5 !0 4 % !0 4 5K^6:&QN98%#3)
M$S(I&<L!P/SH H65_J>Z)+NS21),8GMV^4?56Y'X9H UQ0 C$J,TK@58=2M;
MAI5MYEF,3;7\OYMI]#CH:;36X+4>;K:I9HY  ,DXI/1@,L-3L]3B>2RN$G1&
MV,4.0#Z4VG'1H2=RYB@9FZUH]IK6G265W'OB<<'NI[$54).+NA-7/%/$/AR_
M\)7L'GRB>WE&U)57T/ /H:]"E6C-<J,W%IW-S3-2ECCP% (X.1G'^>*SDDT:
M([FSNHYK'EQYBG<"*Y>5IZFEKD.GW43:U;1_<8EB%<8.,5<KV)9UHZ5@A"T
M5M1$9TZY\TL(_*;<5Z@8.<>] 'GN@0>9?:8(+R)M,M[@M'##;>6\<A0@"3)R
M.#V&#UH ]*7[O3% &-J/A^WU#4/MOFRPSF!K9V3!#1GJ"#W]#0!G>*[&#3?A
MMJ=E;*4@@LFC0$Y( % &WH?_ " -._Z]H_\ T$4 5/%__(G:S_UYR_\ H!H
M^232&)0 +_KA]*8'UD;Z\L=!TUK/2I=0+PH&6-U7:-HZ[B*!&:/&&I-J+:</
M"UV;I(Q*4\^+[A) .<^QH Z'2+V[OK=I+O39;!PVT1R.K$C'7*DT :- !0 4
M % !0 A]* . N?@[X4O+F6>5+LR2N7;$V.2<^E $/_"D_"'_ #SO/^__ /\
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M6W8D+*A0D=1D8XH YVP\)Q65XET9X6E$B'(M@I"(NU47GY1U)]<F@#IU^Z*
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MRN"I0,(VQY@^7H>OM0!R=KHUMIM_!<FY@O[AIE3:ZX6V!.<1@$[/7!Y/KVH
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M@6'49Y% #B>#0!Y+I?B#XA^(YM1?2)=.%O:W3P8E3!X/% &CL^+'_/32/RH
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MK$ 8 +\?\#- &EXG_P"15U?_ *])?_030!\ATABT"!?]9^% 'V/IO_(+M/\
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MH * "@#F/A]_R)=E]7_]#- &CXG_ .15U?\ Z])?_030!\A]Z0PH 5/]9^%
M'V/IO_(+M/\ KBG_ *"*8BU0!B^+O^10U?\ Z]9/Y4 6M!_Y%_3O^O:/_P!
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MV1@BA.PY+0@ND17;;&%7J,4V[FL%H9C1^9G Q46-D8GB3>/#]ZISA87X_P"
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M^V_QH /^%8>#N^AQ?]]M_C0 ?\*P\'?] 2+_ +[;_&D #X8>#ATT2+_OMO\
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MUCC7*,QRQZ=#6E36)F]#UP=*XB!:8!0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 AZ4 94]AJ45W-/IUU;H)R&D2XA+@$ #((8=@.* +EG;R6MHL<LOFR
M99G<+M!8DD\=N30!P7PCXM?$(_ZB<E(#T8]*8'-:[X434)'NK9PEPWWE;[K'
M^AJ'&Y2E8XZ;1-3M79'LI>.ZKN'Z5DX,U4D/L=+UHMA;"8[>A8;?YTE!E.2-
M';?*&BN+62)AW(X/T-3R#YT8'B"&;^QKYBIP(G_]!J4K,IR3B=+\'O\ DG=G
M_P!=9/\ T(UV+8XNIWM,84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ,>%)%VR*'7T89% $?V*U_Y]HO\ O@4 (;&U[6\0_P" "@"9$6- B*%4
M= !@"@!U !0 4 ,>-9%*L 5(P01U%&P'-#X>>&5OC=C3E#DY*AB$S],U?/(+
MG21P1Q1B.-%1!P%48 _"INP*LFCV$E['>-:Q&YB.4DV\@T*3!ZEX#%( H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H 0]* /GK2?&NK^#[O5[6R
MM;.>.>]DD)FW9'/M0!I_\+C\1_\ 0.TS_P ?_P : #_A<?B/_H':;_X__C0
M?\+C\1X_Y!VF_P#C_P#C0 ?\+C\1_P#0-TW_ ,B?XT -?XO^(9%*MIFF$>AW
M_P"-+0#&O?'>JWD%W$;*TC%RC(VV20@ C' )J>5#N>I_".,P?#^T1B"?-DZ?
M[U6([N@ H * "@ H * "@ H * "@ H * "@ H * "@ H __9
A

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>59
<FILENAME>ck0001534133-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-26T21:27:54.9229+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.calcimedica.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ck0001534133="http://www.calcimedica.com/20241231" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" namespace="http://xbrl.sec.gov/stpr/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2" id="DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2">
        <link:definition>100020 - Disclosure - Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>100040 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100050 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1" id="StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1">
        <link:definition>100060 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100070 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100080 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995455 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1" id="DisclosureNatureOfBusiness1">
        <link:definition>995465 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>995475 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions" id="DisclosureMergerAndRelatedTransactions">
        <link:definition>995485 - Disclosure - Merger and Related Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>995495 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses" id="DisclosureAccruedExpenses">
        <link:definition>995505 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants" id="DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants">
        <link:definition>995515 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit" id="DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit">
        <link:definition>995525 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1" id="DisclosureStockbasedCompensation1">
        <link:definition>995535 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>995545 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits" id="DisclosureEmployeeBenefits">
        <link:definition>995555 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>995565 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>995575 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>995585 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995595 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995605 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>995615 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables" id="DisclosureAccruedExpensesTables">
        <link:definition>995625 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" id="DisclosureStockbasedCompensationTables">
        <link:definition>995635 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>995645 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>995655 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>995665 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" id="DisclosureNatureOfBusinessAdditionalInformationDetails">
        <link:definition>995675 - Disclosure - Nature of Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995685 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails">
        <link:definition>995695 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails">
        <link:definition>995705 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails" id="DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails">
        <link:definition>995715 - Disclosure - Merger and Related Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>995725 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails" id="DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails">
        <link:definition>995735 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995745 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails">
        <link:definition>995755 - Disclosure - Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails" id="DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails">
        <link:definition>995765 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" id="DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
        <link:definition>995775 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails" id="DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails">
        <link:definition>995785 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" id="DisclosureStockbasedCompensationAdditionalInformationDetails">
        <link:definition>995795 - Disclosure - Stock-based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" id="DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>995805 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails" id="DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails">
        <link:definition>995815 - Disclosure - Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails" id="DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails">
        <link:definition>995825 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails" id="DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails">
        <link:definition>995835 - Disclosure - Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails" id="DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails">
        <link:definition>995845 - Disclosure - Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>995855 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails" id="DisclosureEmployeeBenefitsAdditionalInformationDetails">
        <link:definition>995865 - Disclosure - Employee Benefits - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails">
        <link:definition>995875 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>995885 - Disclosure - Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>995895 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails">
        <link:definition>995905 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" id="DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>995915 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
        <link:definition>995925 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>995935 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="ck0001534133-20241231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="ck0001534133-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="ck0001534133-20241231.xsd#StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1" xlink:href="ck0001534133-20241231.xsd#DisclosureNatureOfBusiness1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions" xlink:href="ck0001534133-20241231.xsd#DisclosureMergerAndRelatedTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses" xlink:href="ck0001534133-20241231.xsd#DisclosureAccruedExpenses" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants" xlink:href="ck0001534133-20241231.xsd#DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit" xlink:href="ck0001534133-20241231.xsd#DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensation1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits" xlink:href="ck0001534133-20241231.xsd#DisclosureEmployeeBenefits" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="ck0001534133-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables" xlink:href="ck0001534133-20241231.xsd#DisclosureAccruedExpensesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="ck0001534133-20241231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureEmployeeBenefitsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:href="ck0001534133-20241231.xsd#DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2" xlink:href="ck0001534133-20241231.xsd#DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerTransactionsMember" xlink:label="ck0001534133_PostMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreMergerCalcimedicaMember" xlink:label="ck0001534133_PreMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MergerTransactionCosts" xlink:label="ck0001534133_MergerTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureTable" xlink:label="ck0001534133_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedClinicalTrialCosts" xlink:label="ck0001534133_AccruedClinicalTrialCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheOneMember" xlink:label="ck0001534133_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidClinicalTrialExpenses" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease" xlink:label="us-gaap_WarrantExercisePriceDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfChangeInOwnership" xlink:label="ck0001534133_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheACommonWarrantsMember" xlink:label="ck0001534133_TrancheACommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureLineItems" xlink:label="ck0001534133_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheTwoMember" xlink:label="ck0001534133_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RightOfUseAssetOrLeaseLiability" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromFollowOnOffering" xlink:label="ck0001534133_ProceedsFromFollowOnOffering"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DirectorsEmployeesOrConsultantsMember" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseExecutedTermPeriod" xlink:label="ck0001534133_LeaseExecutedTermPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityDisclosureTextblock" xlink:label="ck0001534133_TemporaryEquityDisclosureTextblock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiability" xlink:label="ck0001534133_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxRateReconciliationWarrantLiability" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnderwritersOptionPeriod" xlink:label="ck0001534133_UnderwritersOptionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FederalResearchAndDevelopmentMember" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlementShares" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AvenueVentureOpportunitiesFundIILPMember" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeemedDistribution" xlink:label="ck0001534133_DeemedDistribution"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="us-gaap_DerivativesAndFairValueTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_InducementGrantsMember" xlink:label="ck0001534133_InducementGrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MaximumNumberOfAdditionalSharesIssued" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExpectedPerShare" xlink:label="ck0001534133_ExpectedPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedOther" xlink:label="ck0001534133_AccruedOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredAndCommonStockMember" xlink:label="ck0001534133_PreferredAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfC2WarrantsToCommonStock" xlink:label="ck0001534133_ConversionOfC2WarrantsToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExerciseAndConversionOfC2WarrantsShares" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerCalcimedicaMember" xlink:label="ck0001534133_PostMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ContractualObligationOfContractInEffect" xlink:label="ck0001534133_ContractualObligationOfContractInEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfWarrantCoverage" xlink:label="ck0001534133_PercentageOfWarrantCoverage"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RelatedPartyTransactionsPolicyTextBlock" xlink:label="ck0001534133_RelatedPartyTransactionsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingBasic" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantsLiabilityMember" xlink:label="ck0001534133_WarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommissionsAndOtherTransactionExpenses" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BaseRent" xlink:label="ck0001534133_BaseRent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreFundedWarrantsMember" xlink:label="ck0001534133_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentsAssumedInTheMerger" xlink:label="ck0001534133_ShortTermInvestmentsAssumedInTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ChangesInFairValueOfFinancialInstruments" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsLiabilityMember" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnpaidCancellationAndOtherRelatedCosts" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredStockWarrantsAndCommonStockMember" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeferredTaxAssetsAccruedCompensation" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CompanyRecordedExpense" xlink:label="ck0001534133_CompanyRecordedExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NonCashInterestExpense" xlink:label="ck0001534133_NonCashInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonWarrantsMember" xlink:label="ck0001534133_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember" xlink:label="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NumberOfContractCurrentlyInEffect" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaIncMember" xlink:label="ck0001534133_CalcimedicaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" xlink:label="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OfficersAndDirectorsMember" xlink:label="ck0001534133_OfficersAndDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PatentsCostsPolicyTextBlock" xlink:label="ck0001534133_PatentsCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsMember" xlink:label="ck0001534133_PreferredWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="us-gaap_EquityFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock" xlink:label="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseAmendmentDate" xlink:label="ck0001534133_LeaseAmendmentDate"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SaleOfStockRemainingSalesAmount" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationPermanentDifferences" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:label="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MD" xlink:label="stpr_MD"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlement" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="us-gaap_EarningsPerShareDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementAvaliableForSale" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantMember" xlink:label="ck0001534133_PreferredWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RentExpenses" xlink:label="ck0001534133_RentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidExpensesAndOtherCurrentAssets" xlink:label="ck0001534133_PrepaidExpensesAndOtherCurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RainBioIncMember" xlink:label="ck0001534133_RainBioIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesCTwoWarrantsMember" xlink:label="ck0001534133_SeriesCTwoWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnrecognizedTaxBenefitsNet" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiabilityPolicyPolicyTextBlock" xlink:label="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PriorToMergerTransactionsMember" xlink:label="ck0001534133_PriorToMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaCommonStockMember" xlink:label="ck0001534133_CalcimedicaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePreferredStockAbstract" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodPrivatePlacement" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PlacementAgentWarrantsMember" xlink:label="ck0001534133_PlacementAgentWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TotalNetProceeds" xlink:label="ck0001534133_TotalNetProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConfidentiallyMarketedPublicOfferingMember" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedSeveranceExpense" xlink:label="ck0001534133_AccruedSeveranceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugVisionIncMember" xlink:label="ck0001534133_GraybugVisionIncMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetDeferredTaxAsset" xlink:label="ck0001534133_NetDeferredTaxAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AuxoraMember" xlink:label="ck0001534133_AuxoraMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaPreferredStockMember" xlink:label="ck0001534133_CalcimedicaPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LoanAgreementMember" xlink:label="ck0001534133_LoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExchangeOfStockForStock" xlink:label="ck0001534133_ExchangeOfStockForStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementMember" xlink:label="ck0001534133_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AtTheMarketOfferingMember" xlink:label="ck0001534133_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TransactionCostsAssoicatedWithWarrants" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrivateCalcimedicaMember" xlink:label="ck0001534133_PrivateCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PostMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Post Merger Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PostMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Post Merger Transactions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PostMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Post merger transactions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average Pre-funded Warrants Outstanding Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average pre-funded warrants outstanding basic.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average pre-funded warrants outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short Term Investment Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total short-term investments, Aggregate Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term investment fair value disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investment Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax computed at federal statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax computed at federal statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards expiration beginning year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carry forwards expiration beginning year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carry Forwards Expiration Beginning Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total short-term investments, Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term investment fair value disclosure accumulated gross unrealized gain before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche A and tranche B common warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche A and Tranche B Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche A and Tranche B Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreMergerCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Merger CalciMedica</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreMergerCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre Merger CalciMedica [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acceleration of stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Acquisition Related Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of business segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger and Related Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Note Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Promissory Note Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in the fair value of convertible promissory notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustment of Convertible Promissory Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of expense (income) related to adjustment to fair value of convertible promissory notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Sponsored Entities - Mortgagebacked Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mortgage-Backed Security, Issued by US Government-Sponsored Enterprise [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MergerTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MergerTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Merger Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MergerTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Merger transaction costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of information about income tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Reserved</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement By share based payment award number Of additional shares reserved.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in number of shares reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consideration Transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Business Combination, Consideration Transferred, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedClinicalTrialCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical trial costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedClinicalTrialCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Trial Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedClinicalTrialCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Clinical Trial Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Other Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock from ATM Facility, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche one.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Trial Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical trial expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical trial expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease in warrant exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant, Exercise Price, Decrease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options, forfeited</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of options, cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Chief Financial Officer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Chief Financial Officer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Proceeds From Issuance Of Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net proceeds from issuance of private placement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuance of private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of change in ownership.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Change in Ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of change in ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds of Convertible Promissory Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCredit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCredit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits, net of uncertain positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheACommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche A Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheACommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche A common warrants member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheACommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche A Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of information about income tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued payroll and other employee benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Payroll and Other Employee Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Payroll and Other Employee Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche Two.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Separately Recognized Transactions [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, stock issued during period, shares, conversion of convertible securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock as a result of Merger, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use asset or lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset or Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-use asset or lease liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Follow On Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds From Follow On Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromFollowOnOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from follow on offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty equity incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Placement Agent Warrants Outstanding Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average placement agent warrants outstanding diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average placement agent warrants outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Directors, Employees Or Consultants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Directors, employees or consultants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Directors, Employees Or Consultants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche B common warrants member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche B Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TrancheBCommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche B Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of options, Assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested and Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested and exercisable, number.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of restricked stock units, vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock and warrants issued during period shares common stock and warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock and warrants issued during period shares common stock and warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants granted during the period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseExecutedTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Executed Term Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseExecutedTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease executed term period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseExecutedTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Executed Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-1Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C-1 Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C-1 Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury bills</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Bill Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of options, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of options, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options issued and outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total common stock reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, options, granted, intrinsic value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityDisclosureTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock, Common Stock and Stockholders' Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityDisclosureTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [TextBlock]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityDisclosureTextblock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, forfeited/cancelled (expired)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options, vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transfered Cost Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination, consideration transfered cost incurred.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Placement Agent Warrants Outstanding Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average placement agent warrants outstanding basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average placement agent warrants outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options to Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Rate Reconciliation Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax rate reconciliation warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnderwritersOptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriters Option Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnderwritersOptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriters option period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnderwritersOptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriters option period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Equity Incentive Plan Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty three equity incentive plan member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in Fair Value of Preferred Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public combination multiplied cash price paid per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Combination Multiplied Cash Price Paid Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public combination multiplied cash price paid per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants converted to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants issued to purchase shars of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current and non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in prepaid expenses and other current and noncurrent assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal research and development.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Federal Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of restricted stock units, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock units net settlement, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units Net Settlement Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted stock units net settlement shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable interest entity ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Avenue Venture Opportunities Fund II, L.P. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Avenue venture opportunities fund II, L.P.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Avenue Venture Opportunities Fund II, L.P.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeemedDistribution_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deemed Distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeemedDistribution_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deemed Distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeemedDistribution_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesAndFairValueTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesAndFairValueTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivatives and Fair Value [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of restricted stock units, outstanding beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of restricted stock units, outstanding ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_InducementGrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inducement Grants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_InducementGrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Inducement Grants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_InducementGrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Inducement grants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fixed assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss and comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of options, exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issued on exercise of stock options, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from exercise of stock options, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of preferred stock to common stock as a result of the Merger, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, stock issued during period, value, conversion of convertible securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document financial statement error correction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Segment general and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Segment general and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Number Of Additional Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum number of additional shares issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum number of additional shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on available-for-sale securities, net of tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrealized gain on available-for-sale securities, net of tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from the private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross proceeds from the private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Proceeds From The Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExpectedPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExpectedPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expected Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExpectedPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expected per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total asset measured at fair value, Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets fair value disclosure accumulated gross unrealized gain before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued during period upon conversion of units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued other.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of warrant liability to equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-Term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other prepaid expenses and current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, options vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance and termination benefit expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred and Common stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">preferred and common stock member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred and Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions in connection with the reverse merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance and sale of equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance or Sale of Equity, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series D Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series D Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series D convertible preferred stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Units (RSU) Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiaries [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfC2WarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of C-2 warrants to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfC2WarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of C-2 Warrants to Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfC2WarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of C-2 warrants to common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Convertible Preferred StockMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary equity, Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary equity, Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise And Conversion Of C-2 Warrants Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise and conversion of C-2 Warrants, Shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Series C-2 warrants into common stock, share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment, Principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance or Sale of Convertible Promissory Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares used to calculate basic net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted-average number of shares used to calculate basic net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total asset measured at fair value, Aggregate Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PostMergerCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Post Merger CalciMedica</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PostMergerCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Post Merger CalciMedica [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ContractualObligationOfContractInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual obligation of contract in effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ContractualObligationOfContractInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation Of Contract In Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ContractualObligationOfContractInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contractual obligation of contract in effect.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total asset measured at fair value, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets fair value disclosure accumulated gross unrealized loss before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfWarrantCoverage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of warrant coverage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfWarrantCoverage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Warrant Coverage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfWarrantCoverage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of warrant coverage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Policy Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party transactions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Common Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted average number of basic common shares outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares available for grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares available for grant (shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average exercise price, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards weighted-average term of recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Common Stock Reserved for Future issuance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of schedule of common stock reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Adopted Accounting Pronouncements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Gain</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible promissory note warrants liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Warrants Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note warrants liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commissions and other transaction expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commissions and other transaction expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commissions And Other Transaction Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commissions paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of restricted stock units, forfeited/cancelled (expired)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturities, Repayment Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term, options vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate grant date fair value of RSUs vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2024 Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award Number of Shares Unvailable for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of shares unvailable for grant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares unavailable for grant (shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrual for interest and penalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock from at-the-market offering (net of issuance costs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Notes Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-2 Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C-2 Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C-2 Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Base rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Base Rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_BaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Base rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credit carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Segment research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Segment research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Funded Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Pre Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of options, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of warrant liability to equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentsAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentsAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments Assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentsAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term investments assumed in the merger.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Changes in Fair Value of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Changes in fair value of financial instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of financial instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the Stock Option Grants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total asset measured at fair value, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total asset measured at fair value, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure Amortized Cost Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets fair value disclosure amortized cost basis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred warrants liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Warrants Liability [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred warrants liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance, Initial</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate initial number of common shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares reserved for future issuance, initial</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax, net of federal tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Series A, B, C-1, C-2 and D convertible preferred stock to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Amount Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of warrants per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise price of warrants per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock To Graybug Stockholders As A Result Of The Merger Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock to Graybug stockholders as a result of the merger, Shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty three employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unpaid cancellation and other related costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unpaid Cancellation And Other Related Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unpaid cancellation and other related costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Reduction for tax positions of prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Warrants and Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock, warrants and common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, Warrants and Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities Available For Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Accrued Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets accrued compensation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and Stockholders' Equity (Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of ownership of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Consideration Received on Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants in connection with the private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Warrants In Connection With Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of warrants in connection with private placement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision or benefit for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average Pre-funded Warrants Outstanding Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average pre-funded warrants outstanding diluted.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average pre-funded warrants outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Forfeiture of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value measurement with unobservable inputs reconciliations recurring basis forfeiture of warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeiture of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CompanyRecordedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Company Recorded Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CompanyRecordedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Company recorded expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CompanyRecordedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company recorded expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Fair Value of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees Contributions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NonCashInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NonCashInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non cash Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NonCashInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible promissory note warrants common stock converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Warrants Common Stock Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note warrants common stock converted.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agrgregate intrinsic value, vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Adjustments and Reconciling Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Segment reporting adjustments and reconciling items.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments and reconciling items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of C-2 warrants to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of preferred stock to common stock as a result of Merger, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of shares vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common warrants member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity of investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale, Maturity and Collection of Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale, Maturity and Collection of Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock Series A, B, C-1, C-2 and D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Series A, B, C-1, C-2 and D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock series A, B, C-1, C-2 and D.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value by Liability Class [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carry forwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended and Restated Certificate of Incorporation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended And Restated Certificate of Incorporation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and restated certificate of incorporation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Issued for Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from at-the-market offering (net of issuance costs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of contract currently in effect.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Contract Currently In Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of contract currently in effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value options, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of promissory note warrants into common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Promissory Note Warrant into Commonstock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of promissory note warrant into commonstock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock, shares converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total short-term investments, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investment Fair Value Disclosure Amortized Cost Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term investment fair value disclosure amortized cost basis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CalciMedica</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CalciMedica Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CalciMedica, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued liabilities assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities Assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounts payable and accrued liabilities assumed in the merger.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Addiitional convertible promissory notes and Convertible Promissory Note Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Periodic Payment Principal Additional</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument periodic payment principal additional</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Shares From Private Placement Net Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common shares from private placement, net, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares from private placement (net of issuance costs), shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock from at-the-market offering (net of issuance costs), shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized tax benefits gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized tax benefits gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Aggregate Number Of Shares Of Common Stock Outstanding On Last Day Of Preceding Year Added To Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OfficersAndDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Officers and Directors</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OfficersAndDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Officers and Directors [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_OfficersAndDirectorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Officers and directors.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patents costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patents Costs Policy Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of convertible promissory note converted into common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Equity, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Graybug</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Graybug [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Graybug.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Costs Policy Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Shares From Private Placement Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common shares from private placement, net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares from private placement (net of issuance costs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock issued for services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseAmendmentDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Amendment Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseAmendmentDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Amendment Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LeaseAmendmentDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease amendment date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining amount of available for sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock Remaining Sales Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of stock remaining sales amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net proceeds from private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Proceeds From Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total cash equivalents, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents fair value disclosure accumulated gross unrealized loss before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares outstanding used in computing net loss per share - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions for tax positions of prior years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merged date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Date of Acquisition Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross cash proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock, net of issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible promissory note warrants convertible</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note Warrants Convertible</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible promissory note warrants convertible.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation permanent differences.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Permanent Differences</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent differences</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Permanent differences</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of promissory notes into common stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Promissory Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares conversion of promissory notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Costs and expenses related party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses, Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Offering Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Policy Acquisition Costs [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand and Twenty Four Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty four private placement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets obtained</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MD_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Baltimore, Maryland</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MD_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MARYLAND</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Transations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Shares from Underwritten Public Offering, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common shares from underwritten public offering,net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares from underwritten public offering (net of issuance costs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase related to current year tax positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Costs Included in Accounts Payable and Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing costs included in accounts payable and accrued expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing costs included in accounts payable and accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted stock units net settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock units net settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units Net Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted stock units net settlement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible promissory note warrants to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Convertible Promissory Note Warrants to Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible promissory note warrants to common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in the fair value of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustment of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available for sale under Shelf Registration Statement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shelf Registration Statement Avaliable for Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shelf registration statement avaliable for sale.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PreferredWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred Warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rent Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of rent expense incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Shares from Underwritten Public Offering ,Net Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common shares from underwritten public offering,net, shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares from underwritten public offering (net of issuance costs),shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Consolidated operating loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated operating loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued, price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Separately Recognized Transactions [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Postion, Minimum Percentage of Tax Benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax postion, minimum percentage of tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax postion, minimum percentage of tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to common stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares used to calculate diluted net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average Number of Shares used to Calculate Diluted Net Income (Loss) Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average number of shares used to calculate diluted net income (loss) per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted-average number of shares used to calculate diluted net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and six equity incentive plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2006 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Six Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets assumed in the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses and other current assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RainBioIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">RainBio, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RainBioIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">RainBio Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_RainBioIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RainBio, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesCTwoWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C-2 Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesCTwoWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Two Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SeriesCTwoWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C two warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, and Short-Term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrecognized tax benefits net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PriorToMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior to Merger Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PriorToMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prior to Merger Transactions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PriorToMergerTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prior to merger transactions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Calcimedica Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Calcimedica Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Calcimedica Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Conversion of preferred stock to common stock as a result of the Merger, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of C-2 warrants to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible preferred stock [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred stock [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested and Exercisable in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested and exercisable in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, vested and exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value By Balance Sheet Grouping [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment to 2006 Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment to Two Thousand and Six Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amendment to two thousand and six equity incentive plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of promissory notes into common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Promissory Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value conversion of promissory notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders equity note stock split exchange ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Stock Split Exchange Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stockholders equity note stock split exchange ratio.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash equivalents, Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents fair value disclosure accumulated gross unrealized gain before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of stock description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of promissory note warrants into common stock, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Promissory Note Warrants into Common Stock share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of promissory note warrants into common stock share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total short-term investments, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term investment fair value disclosure accumulated gross unrealized loss before tax.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquisition of stock of Graybug, net of cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Acquisition of Businesses Net of Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments of aquisition of businesses net of cash.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash equivalents, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Fair Value Disclosure Amortized Cost Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash and cash equivalents fair value disclosure amortized cost basis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible promissory notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConvertiblePromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and other Risks and Uncertainties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued during period private placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period, private placement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Placement Agent Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Placement agent warrants member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PlacementAgentWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Placement Agent Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TotalNetProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total net proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TotalNetProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Net Proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TotalNetProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total net proceeds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average exercise price, outstanding beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average exercise price, outstanding ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payables and accruals incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards limitations on use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards, Limitations on Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Confidentially Marketed Public Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Confidentially marketed public offering.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Follow On</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedSeveranceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued severance expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedSeveranceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Severance Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AccruedSeveranceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued severance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugVisionIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Graybug</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugVisionIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Graybug Vision Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_GraybugVisionIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Graybug Vision, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercised in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercised in period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of restricked stock units, exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation and Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetDeferredTaxAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net deferred tax assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetDeferredTaxAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Deferred Tax Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_NetDeferredTaxAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible promissory notes to common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Convertible Promissory Notes to Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of convertible promissory notes to common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AuxoraMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auxora</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AuxoraMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auxora [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AuxoraMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Auxora.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 500,000,000 shares authorized at December 31, 2024 and December 31, 2023; 13,481,917 and 5,754,505 issued and outstanding at December 31, 2024 and December 31, 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Calcimedica Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Calcimedica Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_CalcimedicaPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Calcimedica preferred stock member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_LoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total cash equivalents, Aggregate Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Company's Financial Assets Measured at Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 9)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Net Asset (Liability)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value, Net Asset (Liability), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average number of shares outstanding used in computing net loss per share - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Disaggregated Amounts of Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExchangeOfStockForStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange of stock for stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExchangeOfStockForStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exchange of Stock for Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ExchangeOfStockForStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exchange of stock for stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercised in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercised in period, weighted average exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Promissory Notes and Convertible Promissory Note Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shelf Registration Statement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shelf Registration Statement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ShelfRegistrationStatementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shelf registration statement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for services, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Issued for Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse Stock Split</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At the market offering.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ATM</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At-the-Market Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Merger transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Merger Related Costs, Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Series C-2 Warrant into Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of Series C-2 Warrant into Common Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Series C-2 warrants into common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion of discount on short-term investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction costs associated with warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Costs Assoicated with Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Transaction costs assoicated with warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average exercise price, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average exercise price, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrivateCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private CalciMedica</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrivateCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private CalciMedica [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_PrivateCalcimedicaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Private calciMedica.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Common Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted-average number of diluted common shares outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from loan agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Repayments of) Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from (Repayments of) Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock to Graybug stockholders as a result of the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock To Graybug Stockholders As A Result Of The Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock to Graybug stockholders as a result of the merger.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary equity, Ending balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary equity, Beginning balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities measured at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of convertible notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible note payable, net</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PostMergerTransactionsMember" xlink:to="ck0001534133_PostMergerTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" xlink:to="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" xlink:to="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreMergerCalcimedicaMember" xlink:to="ck0001534133_PreMergerCalcimedicaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:to="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:to="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_MergerTransactionCosts" xlink:to="ck0001534133_MergerTransactionCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncomeTaxDisclosureTable" xlink:to="ck0001534133_IncomeTaxDisclosureTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccruedClinicalTrialCosts" xlink:to="ck0001534133_AccruedClinicalTrialCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TrancheOneMember" xlink:to="ck0001534133_TrancheOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PrepaidClinicalTrialExpenses" xlink:to="ck0001534133_PrepaidClinicalTrialExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" xlink:to="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PercentageOfChangeInOwnership" xlink:to="ck0001534133_PercentageOfChangeInOwnership_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" xlink:to="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TrancheACommonWarrantsMember" xlink:to="ck0001534133_TrancheACommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_IncomeTaxDisclosureLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" xlink:to="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TrancheTwoMember" xlink:to="ck0001534133_TrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RightOfUseAssetOrLeaseLiability" xlink:to="ck0001534133_RightOfUseAssetOrLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ProceedsFromFollowOnOffering" xlink:to="ck0001534133_ProceedsFromFollowOnOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:to="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_DirectorsEmployeesOrConsultantsMember" xlink:to="ck0001534133_DirectorsEmployeesOrConsultantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TrancheBCommonWarrantsMember" xlink:to="ck0001534133_TrancheBCommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:to="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_LeaseExecutedTermPeriod" xlink:to="ck0001534133_LeaseExecutedTermPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:to="ck0001534133_SeriesC1ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryBillSecuritiesMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TemporaryEquityDisclosureTextblock" xlink:to="ck0001534133_TemporaryEquityDisclosureTextblock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WarrantLiability" xlink:to="ck0001534133_WarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" xlink:to="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncomeTaxRateReconciliationWarrantLiability" xlink:to="ck0001534133_IncomeTaxRateReconciliationWarrantLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_UnderwritersOptionPeriod" xlink:to="ck0001534133_UnderwritersOptionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" xlink:to="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" xlink:to="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_FederalResearchAndDevelopmentMember" xlink:to="ck0001534133_FederalResearchAndDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RestrictedStockUnitsNetSettlementShares" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlementShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AvenueVentureOpportunitiesFundIILPMember" xlink:to="ck0001534133_AvenueVentureOpportunitiesFundIILPMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_DeemedDistribution" xlink:to="ck0001534133_DeemedDistribution_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesAndFairValueTextBlock" xlink:to="us-gaap_DerivativesAndFairValueTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_InducementGrantsMember" xlink:to="ck0001534133_InducementGrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_MaximumNumberOfAdditionalSharesIssued" xlink:to="ck0001534133_MaximumNumberOfAdditionalSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:to="ck0001534133_GrossProceedsFromThePrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:to="ck0001534133_SeriesBConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ExpectedPerShare" xlink:to="ck0001534133_ExpectedPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccruedOther" xlink:to="ck0001534133_AccruedOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreferredAndCommonStockMember" xlink:to="ck0001534133_PreferredAndCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:to="ck0001534133_SeriesDConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SubsidiariesMember" xlink:to="srt_SubsidiariesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfC2WarrantsToCommonStock" xlink:to="ck0001534133_ConversionOfC2WarrantsToCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:to="ck0001534133_SeriesAConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ExerciseAndConversionOfC2WarrantsShares" xlink:to="ck0001534133_ExerciseAndConversionOfC2WarrantsShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PostMergerCalcimedicaMember" xlink:to="ck0001534133_PostMergerCalcimedicaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ContractualObligationOfContractInEffect" xlink:to="ck0001534133_ContractualObligationOfContractInEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PercentageOfWarrantCoverage" xlink:to="ck0001534133_PercentageOfWarrantCoverage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RelatedPartyTransactionsPolicyTextBlock" xlink:to="ck0001534133_RelatedPartyTransactionsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAverageCommonSharesOutstandingBasic" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WarrantsLiabilityMember" xlink:to="ck0001534133_WarrantsLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CommissionsAndOtherTransactionExpenses" xlink:to="ck0001534133_CommissionsAndOtherTransactionExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryNotesSecuritiesMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:to="ck0001534133_SeriesC2ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" xlink:to="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_BaseRent" xlink:to="ck0001534133_BaseRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreFundedWarrantsMember" xlink:to="ck0001534133_PreFundedWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" xlink:to="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShortTermInvestmentsAssumedInTheMerger" xlink:to="ck0001534133_ShortTermInvestmentsAssumedInTheMerger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ChangesInFairValueOfFinancialInstruments" xlink:to="ck0001534133_ChangesInFairValueOfFinancialInstruments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreferredWarrantsLiabilityMember" xlink:to="ck0001534133_PreferredWarrantsLiabilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" xlink:to="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_UnpaidCancellationAndOtherRelatedCosts" xlink:to="ck0001534133_UnpaidCancellationAndOtherRelatedCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreferredStockWarrantsAndCommonStockMember" xlink:to="ck0001534133_PreferredStockWarrantsAndCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_DeferredTaxAssetsAccruedCompensation" xlink:to="ck0001534133_DeferredTaxAssetsAccruedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:to="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" xlink:to="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CompanyRecordedExpense" xlink:to="ck0001534133_CompanyRecordedExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_NonCashInterestExpense" xlink:to="ck0001534133_NonCashInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" xlink:to="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CommonWarrantsMember" xlink:to="ck0001534133_CommonWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember" xlink:to="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" xlink:to="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_NumberOfContractCurrentlyInEffect" xlink:to="ck0001534133_NumberOfContractCurrentlyInEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CalcimedicaIncMember" xlink:to="ck0001534133_CalcimedicaIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" xlink:to="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" xlink:to="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" xlink:to="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_OfficersAndDirectorsMember" xlink:to="ck0001534133_OfficersAndDirectorsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PatentsCostsPolicyTextBlock" xlink:to="ck0001534133_PatentsCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreferredWarrantsMember" xlink:to="ck0001534133_PreferredWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityFairValueDisclosure" xlink:to="us-gaap_EquityFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_GraybugMember" xlink:to="ck0001534133_GraybugMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock" xlink:to="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_LeaseAmendmentDate" xlink:to="ck0001534133_LeaseAmendmentDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SaleOfStockRemainingSalesAmount" xlink:to="ck0001534133_SaleOfStockRemainingSalesAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_NetProceedsFromPrivatePlacement" xlink:to="ck0001534133_NetProceedsFromPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IncomeTaxReconciliationPermanentDifferences" xlink:to="ck0001534133_IncomeTaxReconciliationPermanentDifferences_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" xlink:to="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:to="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" xlink:to="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MD" xlink:to="stpr_MD_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:to="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RestrictedStockUnitsNetSettlement" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" xlink:to="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShelfRegistrationStatementAvaliableForSale" xlink:to="ck0001534133_ShelfRegistrationStatementAvaliableForSale_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PreferredWarrantMember" xlink:to="ck0001534133_PreferredWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RentExpenses" xlink:to="ck0001534133_RentExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" xlink:to="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" xlink:to="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PrepaidExpensesAndOtherCurrentAssets" xlink:to="ck0001534133_PrepaidExpensesAndOtherCurrentAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_RainBioIncMember" xlink:to="ck0001534133_RainBioIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SeriesCTwoWarrantsMember" xlink:to="ck0001534133_SeriesCTwoWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_UnrecognizedTaxBenefitsNet" xlink:to="ck0001534133_UnrecognizedTaxBenefitsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock" xlink:to="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PriorToMergerTransactionsMember" xlink:to="ck0001534133_PriorToMergerTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CalcimedicaCommonStockMember" xlink:to="ck0001534133_CalcimedicaCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePreferredStockAbstract" xlink:to="ck0001534133_ConvertiblePreferredStockAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" xlink:to="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" xlink:to="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" xlink:to="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" xlink:to="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConvertiblePromissoryNoteMember" xlink:to="ck0001534133_ConvertiblePromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_StockIssuedDuringPeriodPrivatePlacement" xlink:to="ck0001534133_StockIssuedDuringPeriodPrivatePlacement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PlacementAgentWarrantsMember" xlink:to="ck0001534133_PlacementAgentWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TotalNetProceeds" xlink:to="ck0001534133_TotalNetProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConfidentiallyMarketedPublicOfferingMember" xlink:to="ck0001534133_ConfidentiallyMarketedPublicOfferingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AccruedSeveranceExpense" xlink:to="ck0001534133_AccruedSeveranceExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_GraybugVisionIncMember" xlink:to="ck0001534133_GraybugVisionIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_NetDeferredTaxAsset" xlink:to="ck0001534133_NetDeferredTaxAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock" xlink:to="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AuxoraMember" xlink:to="ck0001534133_AuxoraMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_CalcimedicaPreferredStockMember" xlink:to="ck0001534133_CalcimedicaPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_LoanAgreementMember" xlink:to="ck0001534133_LoanAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ExchangeOfStockForStock" xlink:to="ck0001534133_ExchangeOfStockForStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ShelfRegistrationStatementMember" xlink:to="ck0001534133_ShelfRegistrationStatementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_AtTheMarketOfferingMember" xlink:to="ck0001534133_AtTheMarketOfferingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" xlink:to="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_TransactionCostsAssoicatedWithWarrants" xlink:to="ck0001534133_TransactionCostsAssoicatedWithWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_PrivateCalcimedicaMember" xlink:to="ck0001534133_PrivateCalcimedicaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_SubsidiariesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiability" xlink:label="ck0001534133_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePreferredStockAbstract" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedClinicalTrialCosts" xlink:label="ck0001534133_AccruedClinicalTrialCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidClinicalTrialExpenses" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:to="ck0001534133_WarrantLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_ConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="ck0001534133_AccruedClinicalTrialCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:to="us-gaap_Liabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ck0001534133_PrepaidClinicalTrialExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC1ConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC2ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="ck0001534133_ConvertiblePreferredStockAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesDConvertiblePreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC1ConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC2ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesDConvertiblePreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ChangesInFairValueOfFinancialInstruments" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="ck0001534133_ChangesInFairValueOfFinancialInstruments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeemedDistribution" xlink:label="ck0001534133_DeemedDistribution"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExerciseAndConversionOfC2WarrantsShares" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MergerTransactionCosts" xlink:label="ck0001534133_MergerTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlementShares" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlement" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_35"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_36"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_37"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_38"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_DeemedDistribution" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ExerciseAndConversionOfC2WarrantsShares" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_MergerTransactionCosts" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlementShares" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlement" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_35" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_36" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_37" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_38" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember" xlink:label="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentsAssumedInTheMerger" xlink:label="ck0001534133_ShortTermInvestmentsAssumedInTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidExpensesAndOtherCurrentAssets" xlink:label="ck0001534133_PrepaidExpensesAndOtherCurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" xlink:label="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TransactionCostsAssoicatedWithWarrants" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfC2WarrantsToCommonStock" xlink:label="ck0001534133_ConversionOfC2WarrantsToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NonCashInterestExpense" xlink:label="ck0001534133_NonCashInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" xlink:label="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" xlink:label="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlement" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_ShortTermInvestmentsAssumedInTheMerger" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_PrepaidExpensesAndOtherCurrentAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ck0001534133_TransactionCostsAssoicatedWithWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_ConversionOfC2WarrantsToCommonStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ck0001534133_NonCashInterestExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromOtherEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlement" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="us-gaap_DerivativesAndFairValueTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DerivativesAndFairValueTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityDisclosureTextblock" xlink:label="ck0001534133_TemporaryEquityDisclosureTextblock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="ck0001534133_TemporaryEquityDisclosureTextblock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock" xlink:label="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PatentsCostsPolicyTextBlock" xlink:label="ck0001534133_PatentsCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" xlink:label="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiabilityPolicyPolicyTextBlock" xlink:label="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RelatedPartyTransactionsPolicyTextBlock" xlink:label="ck0001534133_RelatedPartyTransactionsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_PatentsCostsPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredPolicyAcquisitionCostsTextBlock1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_RelatedPartyTransactionsPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaIncMember" xlink:label="ck0001534133_CalcimedicaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LoanAgreementMember" xlink:label="ck0001534133_LoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredAndCommonStockMember" xlink:label="ck0001534133_PreferredAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugVisionIncMember" xlink:label="ck0001534133_GraybugVisionIncMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConfidentiallyMarketedPublicOfferingMember" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredStockWarrantsAndCommonStockMember" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TotalNetProceeds" xlink:label="ck0001534133_TotalNetProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommissionsAndOtherTransactionExpenses" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_CalcimedicaIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001534133_LoanAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreferredAndCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_GraybugVisionIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_ConfidentiallyMarketedPublicOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreferredStockWarrantsAndCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TotalNetProceeds" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpenses" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_GrossProceedsFromThePrivatePlacement" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_NetProceedsFromPrivatePlacement" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_CommissionsAndOtherTransactionExpenses" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrivateCalcimedicaMember" xlink:label="ck0001534133_PrivateCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AtTheMarketOfferingMember" xlink:label="ck0001534133_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RentExpenses" xlink:label="ck0001534133_RentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RightOfUseAssetOrLeaseLiability" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CompanyRecordedExpense" xlink:label="ck0001534133_CompanyRecordedExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_PrivateCalcimedicaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_AtTheMarketOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_TitleOfIndividualAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_RentExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_RightOfUseAssetOrLeaseLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_CompanyRecordedExpense" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidationItemsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DepreciationAndAmortization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaIncMember" xlink:label="ck0001534133_CalcimedicaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugVisionIncMember" xlink:label="ck0001534133_GraybugVisionIncMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodPrivatePlacement" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_CalcimedicaIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_GraybugVisionIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodPrivatePlacement" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SeveranceCosts1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantsLiabilityMember" xlink:label="ck0001534133_WarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsLiabilityMember" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_WarrantsLiabilityMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_PreferredWarrantsLiabilityMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsMember" xlink:label="ck0001534133_PreferredWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantMember" xlink:label="ck0001534133_PreferredWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantsLiabilityMember" xlink:label="ck0001534133_WarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_PreferredWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_PreferredWarrantMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_WarrantsLiabilityMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrivateCalcimedicaMember" xlink:label="ck0001534133_PrivateCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfWarrantCoverage" xlink:label="ck0001534133_PercentageOfWarrantCoverage"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExchangeOfStockForStock" xlink:label="ck0001534133_ExchangeOfStockForStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExpectedPerShare" xlink:label="ck0001534133_ExpectedPerShare"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_PrivateCalcimedicaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_PercentageOfWarrantCoverage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ExchangeOfStockForStock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ExpectedPerShare" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedSeveranceExpense" xlink:label="ck0001534133_AccruedSeveranceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedOther" xlink:label="ck0001534133_AccruedOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_AccruedSeveranceExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_AccruedOther" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PriorToMergerTransactionsMember" xlink:label="ck0001534133_PriorToMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaPreferredStockMember" xlink:label="ck0001534133_CalcimedicaPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreMergerCalcimedicaMember" xlink:label="ck0001534133_PreMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerTransactionsMember" xlink:label="ck0001534133_PostMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonWarrantsMember" xlink:label="ck0001534133_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaCommonStockMember" xlink:label="ck0001534133_CalcimedicaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerCalcimedicaMember" xlink:label="ck0001534133_PostMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OfficersAndDirectorsMember" xlink:label="ck0001534133_OfficersAndDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesCTwoWarrantsMember" xlink:label="ck0001534133_SeriesCTwoWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DirectorsEmployeesOrConsultantsMember" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementMember" xlink:label="ck0001534133_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreFundedWarrantsMember" xlink:label="ck0001534133_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AtTheMarketOfferingMember" xlink:label="ck0001534133_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PlacementAgentWarrantsMember" xlink:label="ck0001534133_PlacementAgentWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease" xlink:label="us-gaap_WarrantExercisePriceDecrease"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheACommonWarrantsMember" xlink:label="ck0001534133_TrancheACommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementAvaliableForSale" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="us-gaap_EquityFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SaleOfStockRemainingSalesAmount" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromFollowOnOffering" xlink:label="ck0001534133_ProceedsFromFollowOnOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnderwritersOptionPeriod" xlink:label="ck0001534133_UnderwritersOptionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MaximumNumberOfAdditionalSharesIssued" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="ck0001534133_PriorToMergerTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_CalcimedicaPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001534133_PreMergerCalcimedicaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="ck0001534133_PostMergerTransactionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_CommonWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_CalcimedicaCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001534133_PostMergerCalcimedicaMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ck0001534133_OfficersAndDirectorsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesCTwoWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ck0001534133_DirectorsEmployeesOrConsultantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_ShelfRegistrationStatementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreFundedWarrantsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_AtTheMarketOfferingMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PlacementAgentWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheACommonWarrantsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_GrossProceedsFromThePrivatePlacement" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheBCommonWarrantsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_TitleOfIndividualAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_ShelfRegistrationStatementAvaliableForSale" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_EquityFairValueDisclosure" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockDescription" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_SaleOfStockRemainingSalesAmount" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_ProceedsFromFollowOnOffering" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_UnderwritersOptionPeriod" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_MaximumNumberOfAdditionalSharesIssued" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_InducementGrantsMember" xlink:label="ck0001534133_InducementGrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_InducementGrantsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AuxoraMember" xlink:label="ck0001534133_AuxoraMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RentExpenses" xlink:label="ck0001534133_RentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MD" xlink:label="stpr_MD"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseAmendmentDate" xlink:label="ck0001534133_LeaseAmendmentDate"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseExecutedTermPeriod" xlink:label="ck0001534133_LeaseExecutedTermPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NumberOfContractCurrentlyInEffect" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ContractualObligationOfContractInEffect" xlink:label="ck0001534133_ContractualObligationOfContractInEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnpaidCancellationAndOtherRelatedCosts" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BaseRent" xlink:label="ck0001534133_BaseRent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="ck0001534133_AuxoraMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_RentExpenses" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MD" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_LeaseAmendmentDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_LeaseExecutedTermPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_NumberOfContractCurrentlyInEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_ContractualObligationOfContractInEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_UnpaidCancellationAndOtherRelatedCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_BaseRent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationPermanentDifferences" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxRateReconciliationWarrantLiability" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ck0001534133_IncomeTaxReconciliationPermanentDifferences" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ck0001534133_IncomeTaxRateReconciliationWarrantLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetDeferredTaxAsset" xlink:label="ck0001534133_NetDeferredTaxAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeferredTaxAssetsAccruedCompensation" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ck0001534133_NetDeferredTaxAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="ck0001534133_DeferredTaxAssetsAccruedCompensation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureTable" xlink:label="ck0001534133_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureLineItems" xlink:label="ck0001534133_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FederalResearchAndDevelopmentMember" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfChangeInOwnership" xlink:label="ck0001534133_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnrecognizedTaxBenefitsNet" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ck0001534133_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureTable" xlink:to="ck0001534133_IncomeTaxDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="ck0001534133_FederalResearchAndDevelopmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_PercentageOfChangeInOwnership" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_UnrecognizedTaxBenefitsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="us-gaap_EarningsPerShareDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingBasic" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheOneMember" xlink:label="ck0001534133_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LoanAgreementMember" xlink:label="ck0001534133_LoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AvenueVentureOpportunitiesFundIILPMember" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RainBioIncMember" xlink:label="ck0001534133_RainBioIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheTwoMember" xlink:label="ck0001534133_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_TrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001534133_LoanAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ck0001534133_AvenueVentureOpportunitiesFundIILPMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_RainBioIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_TrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentTerms" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_SubsidiariesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiability" xlink:label="ck0001534133_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePreferredStockAbstract" xlink:label="ck0001534133_ConvertiblePreferredStockAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedClinicalTrialCosts" xlink:label="ck0001534133_AccruedClinicalTrialCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidClinicalTrialExpenses" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:to="ck0001534133_WarrantLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_ConvertiblePreferredStockAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="ck0001534133_AccruedClinicalTrialCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="ck0001534133_PrepaidClinicalTrialExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC1ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC2ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="ck0001534133_ConvertiblePreferredStockAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesDConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesAConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesBConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC1ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC1ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesC2ConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesC2ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesDConvertiblePreferredStockMember" xlink:label="ck0001534133_SeriesDConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC1ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesC2ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesDConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeemedDistribution" xlink:label="ck0001534133_DeemedDistribution"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" xlink:label="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" xlink:label="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" xlink:label="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExerciseAndConversionOfC2WarrantsShares" xlink:label="ck0001534133_ExerciseAndConversionOfC2WarrantsShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" xlink:label="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" xlink:label="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MergerTransactionCosts" xlink:label="ck0001534133_MergerTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlementShares" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlementShares"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RestrictedStockUnitsNetSettlement" xlink:label="ck0001534133_RestrictedStockUnitsNetSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_DeemedDistribution" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ExerciseAndConversionOfC2WarrantsShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_MergerTransactionCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlementShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_RestrictedStockUnitsNetSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"/>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaIncMember" xlink:label="ck0001534133_CalcimedicaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LoanAgreementMember" xlink:label="ck0001534133_LoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredAndCommonStockMember" xlink:label="ck0001534133_PreferredAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="us-gaap_ShortTermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugVisionIncMember" xlink:label="ck0001534133_GraybugVisionIncMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConfidentiallyMarketedPublicOfferingMember" xlink:label="ck0001534133_ConfidentiallyMarketedPublicOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredStockWarrantsAndCommonStockMember" xlink:label="ck0001534133_PreferredStockWarrantsAndCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TotalNetProceeds" xlink:label="ck0001534133_TotalNetProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommissionsAndOtherTransactionExpenses" xlink:label="ck0001534133_CommissionsAndOtherTransactionExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_CalcimedicaIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001534133_LoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreferredAndCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_GraybugVisionIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_ConfidentiallyMarketedPublicOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreferredStockWarrantsAndCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ShortTermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_TotalNetProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_GrossProceedsFromThePrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_NetProceedsFromPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ck0001534133_CommissionsAndOtherTransactionExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrivateCalcimedicaMember" xlink:label="ck0001534133_PrivateCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" xlink:label="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AtTheMarketOfferingMember" xlink:label="ck0001534133_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RentExpenses" xlink:label="ck0001534133_RentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RightOfUseAssetOrLeaseLiability" xlink:label="ck0001534133_RightOfUseAssetOrLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" xlink:label="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesRelatedParty" xlink:label="us-gaap_CostsAndExpensesRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CompanyRecordedExpense" xlink:label="ck0001534133_CompanyRecordedExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_PrivateCalcimedicaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_AtTheMarketOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_RentExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_RightOfUseAssetOrLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_CompanyRecordedExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails">
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" xlink:label="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_DepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails">
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:label="ck0001534133_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaIncMember" xlink:label="ck0001534133_CalcimedicaIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugVisionIncMember" xlink:label="ck0001534133_GraybugVisionIncMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockIssuedDuringPeriodPrivatePlacement" xlink:label="ck0001534133_StockIssuedDuringPeriodPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" xlink:label="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_CalcimedicaIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="ck0001534133_GraybugVisionIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="ck0001534133_StockIssuedDuringPeriodPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantsLiabilityMember" xlink:label="ck0001534133_WarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsLiabilityMember" xlink:label="ck0001534133_PreferredWarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ConvertibleNotesPayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_WarrantsLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_PreferredWarrantsLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantsMember" xlink:label="ck0001534133_PreferredWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreferredWarrantMember" xlink:label="ck0001534133_PreferredWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" xlink:label="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantsLiabilityMember" xlink:label="ck0001534133_WarrantsLiabilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_PreferredWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_PreferredWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_WarrantsLiabilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:label="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrivateCalcimedicaMember" xlink:label="ck0001534133_PrivateCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" xlink:label="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" xlink:label="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfWarrantCoverage" xlink:label="ck0001534133_PercentageOfWarrantCoverage"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" xlink:label="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExchangeOfStockForStock" xlink:label="ck0001534133_ExchangeOfStockForStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ExpectedPerShare" xlink:label="ck0001534133_ExpectedPerShare"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_PrivateCalcimedicaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_PercentageOfWarrantCoverage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ExchangeOfStockForStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="ck0001534133_ExpectedPerShare" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" xlink:label="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PriorToMergerTransactionsMember" xlink:label="ck0001534133_PriorToMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaPreferredStockMember" xlink:label="ck0001534133_CalcimedicaPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreMergerCalcimedicaMember" xlink:label="ck0001534133_PreMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" xlink:label="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerTransactionsMember" xlink:label="ck0001534133_PostMergerTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonWarrantsMember" xlink:label="ck0001534133_CommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CalcimedicaCommonStockMember" xlink:label="ck0001534133_CalcimedicaCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PostMergerCalcimedicaMember" xlink:label="ck0001534133_PostMergerCalcimedicaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OfficersAndDirectorsMember" xlink:label="ck0001534133_OfficersAndDirectorsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SeriesCTwoWarrantsMember" xlink:label="ck0001534133_SeriesCTwoWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DirectorsEmployeesOrConsultantsMember" xlink:label="ck0001534133_DirectorsEmployeesOrConsultantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementMember" xlink:label="ck0001534133_ShelfRegistrationStatementMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PreFundedWarrantsMember" xlink:label="ck0001534133_PreFundedWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AtTheMarketOfferingMember" xlink:label="ck0001534133_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PlacementAgentWarrantsMember" xlink:label="ck0001534133_PlacementAgentWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceDecrease" xlink:label="us-gaap_WarrantExercisePriceDecrease"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheACommonWarrantsMember" xlink:label="ck0001534133_TrancheACommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GrossProceedsFromThePrivatePlacement" xlink:label="ck0001534133_GrossProceedsFromThePrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" xlink:label="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" xlink:label="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShelfRegistrationStatementAvaliableForSale" xlink:label="ck0001534133_ShelfRegistrationStatementAvaliableForSale"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityFairValueDisclosure" xlink:label="us-gaap_EquityFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" xlink:label="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_SaleOfStockRemainingSalesAmount" xlink:label="ck0001534133_SaleOfStockRemainingSalesAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromFollowOnOffering" xlink:label="ck0001534133_ProceedsFromFollowOnOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnderwritersOptionPeriod" xlink:label="ck0001534133_UnderwritersOptionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_MaximumNumberOfAdditionalSharesIssued" xlink:label="ck0001534133_MaximumNumberOfAdditionalSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="ck0001534133_PriorToMergerTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_CalcimedicaPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001534133_PreMergerCalcimedicaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="ck0001534133_PostMergerTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_CommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_CalcimedicaCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="ck0001534133_PostMergerCalcimedicaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ck0001534133_OfficersAndDirectorsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="ck0001534133_SeriesCTwoWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ck0001534133_DirectorsEmployeesOrConsultantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_ShelfRegistrationStatementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PreFundedWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="ck0001534133_AtTheMarketOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_PlacementAgentWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheACommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_GrossProceedsFromThePrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheBCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_ShelfRegistrationStatementAvaliableForSale" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_EquityFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_FairValueNetAssetLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ConversionOfStockDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_SaleOfStockRemainingSalesAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_ProceedsFromFollowOnOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_UnderwritersOptionPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="ck0001534133_MaximumNumberOfAdditionalSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_GraybugMember" xlink:label="ck0001534133_GraybugMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" xlink:label="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" xlink:label="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_InducementGrantsMember" xlink:label="ck0001534133_InducementGrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" xlink:label="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" xlink:label="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_GraybugMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_InducementGrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" xlink:label="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" xlink:label="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AuxoraMember" xlink:label="ck0001534133_AuxoraMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RentExpenses" xlink:label="ck0001534133_RentExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_MD" xlink:label="stpr_MD"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseAmendmentDate" xlink:label="ck0001534133_LeaseAmendmentDate"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LeaseExecutedTermPeriod" xlink:label="ck0001534133_LeaseExecutedTermPeriod"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NumberOfContractCurrentlyInEffect" xlink:label="ck0001534133_NumberOfContractCurrentlyInEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ContractualObligationOfContractInEffect" xlink:label="ck0001534133_ContractualObligationOfContractInEffect"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnpaidCancellationAndOtherRelatedCosts" xlink:label="ck0001534133_UnpaidCancellationAndOtherRelatedCosts"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_BaseRent" xlink:label="ck0001534133_BaseRent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="ck0001534133_AuxoraMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_RentExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MD" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_LeaseAmendmentDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_LeaseExecutedTermPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_NumberOfContractCurrentlyInEffect" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_ContractualObligationOfContractInEffect" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_UnpaidCancellationAndOtherRelatedCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="ck0001534133_BaseRent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureLineItems" xlink:label="ck0001534133_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxDisclosureTable" xlink:label="ck0001534133_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" xlink:label="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FederalResearchAndDevelopmentMember" xlink:label="ck0001534133_FederalResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PercentageOfChangeInOwnership" xlink:label="ck0001534133_PercentageOfChangeInOwnership"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_UnrecognizedTaxBenefitsNet" xlink:label="ck0001534133_UnrecognizedTaxBenefitsNet"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_IncomeTaxDisclosureTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001534133_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="ck0001534133_FederalResearchAndDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_PercentageOfChangeInOwnership" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001534133_IncomeTaxDisclosureLineItems" xlink:to="ck0001534133_UnrecognizedTaxBenefitsNet" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheOneMember" xlink:label="ck0001534133_TrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_LoanAgreementMember" xlink:label="ck0001534133_LoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AvenueVentureOpportunitiesFundIILPMember" xlink:label="ck0001534133_AvenueVentureOpportunitiesFundIILPMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_RainBioIncMember" xlink:label="ck0001534133_RainBioIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TrancheTwoMember" xlink:label="ck0001534133_TrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentTerms" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_TrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="ck0001534133_LoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="ck0001534133_AvenueVentureOpportunitiesFundIILPMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="ck0001534133_RainBioIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="ck0001534133_TrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="ck0001534133_WarrantLiability" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="ck0001534133_PrepaidClinicalTrialExpenses" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssets" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="3" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="ck0001534133_AccruedClinicalTrialCosts" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1.00" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="6" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WarrantLiability" xlink:label="ck0001534133_WarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PrepaidClinicalTrialExpenses" xlink:label="ck0001534133_PrepaidClinicalTrialExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedClinicalTrialCosts" xlink:label="ck0001534133_AccruedClinicalTrialCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="ck0001534133_ChangesInFairValueOfFinancialInstruments" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ChangesInFairValueOfFinancialInstruments" xlink:label="ck0001534133_ChangesInFairValueOfFinancialInstruments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromOtherEquity" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001534133_TransactionCostsAssoicatedWithWarrants" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001534133_NonCashInterestExpense" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="12" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" xlink:label="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_TransactionCostsAssoicatedWithWarrants" xlink:label="ck0001534133_TransactionCostsAssoicatedWithWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NonCashInterestExpense" xlink:label="ck0001534133_NonCashInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" xlink:label="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" xlink:label="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:to="ck0001534133_ShortTermInvestmentFairValueDisclosure" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_ShortTermInvestmentFairValueDisclosure" xlink:label="ck0001534133_ShortTermInvestmentFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="ck0001534133_AccruedSeveranceExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="ck0001534133_AccruedOther" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" xlink:label="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedSeveranceExpense" xlink:label="ck0001534133_AccruedSeveranceExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_AccruedOther" xlink:label="ck0001534133_AccruedOther"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="ck0001534133_IncomeTaxReconciliationPermanentDifferences" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="ck0001534133_IncomeTaxRateReconciliationWarrantLiability" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationPermanentDifferences" xlink:label="ck0001534133_IncomeTaxReconciliationPermanentDifferences"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxRateReconciliationWarrantLiability" xlink:label="ck0001534133_IncomeTaxRateReconciliationWarrantLiability"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" xlink:label="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="ck0001534133_NetDeferredTaxAsset" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_NetDeferredTaxAsset" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_NetDeferredTaxAsset" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="ck0001534133_DeferredTaxAssetsAccruedCompensation" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_NetDeferredTaxAsset" xlink:label="ck0001534133_NetDeferredTaxAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_DeferredTaxAssetsAccruedCompensation" xlink:label="ck0001534133_DeferredTaxAssetsAccruedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingBasic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:to="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingBasic" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" xlink:label="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" xlink:label="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="ck0001534133-20241231.xsd#ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" xlink:label="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" name="PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" name="StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_UnderwritersOptionPeriod" name="UnderwritersOptionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_LoanAgreementMember" name="LoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PercentageOfWarrantCoverage" name="PercentageOfWarrantCoverage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_GraybugVisionIncMember" name="GraybugVisionIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AuxoraMember" name="AuxoraMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PlacementAgentWarrantsMember" name="PlacementAgentWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_TotalNetProceeds" name="TotalNetProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_BaseRent" name="BaseRent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio" name="StockholdersEquityNoteStockSplitExchangeRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TrancheBCommonWarrantsMember" name="TrancheBCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis" name="AssetsFairValueDisclosureAmortizedCostBasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember" name="ConvertiblePreferredStockSeriesABC1C2AndDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" name="IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" name="StockIssuedDuringPeriodSharesConversionOfPromissoryNotes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes" name="StockIssuedDuringPeriodValueConversionOfPromissoryNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_PatentsCostsPolicyTextBlock" name="PatentsCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TransactionCostsAssoicatedWithWarrants" name="TransactionCostsAssoicatedWithWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_WarrantLiabilityPolicyPolicyTextBlock" name="WarrantLiabilityPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare" name="PublicCombinationMultipliedCashPricePaidPerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_AtTheMarketOfferingMember" name="AtTheMarketOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_NetProceedsFromPrivatePlacement" name="NetProceedsFromPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred" name="BusinessCombinationConsiderationTransferedCostIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_ExchangeOfStockForStock" name="ExchangeOfStockForStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement" name="IssuanceOfWarrantsInConnectionWithPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_SeriesCTwoWarrantsMember" name="SeriesCTwoWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" name="IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear" name="OperatingLossCarryForwardsExpirationBeginningYear" type="dtr-types:gYearListItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_SaleOfStockRemainingSalesAmount" name="SaleOfStockRemainingSalesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" name="TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_RightOfUseAssetOrLeaseLiability" name="RightOfUseAssetOrLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ShortTermInvestmentsAssumedInTheMerger" name="ShortTermInvestmentsAssumedInTheMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_FederalResearchAndDevelopmentMember" name="FederalResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PreferredWarrantsLiabilityMember" name="PreferredWarrantsLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic" name="WeightedAveragePreFundedWarrantsOutstandingBasic" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional" name="DebtInstrumentPeriodicPaymentPrincipalAdditional" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_PreferredAndCommonStockMember" name="PreferredAndCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" name="FinancingCostsIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement" name="NetProceedsFromIssuanceOfPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" name="ShortTermInvestmentFairValueDisclosureAmortizedCostBasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_DeferredTaxAssetsAccruedCompensation" name="DeferredTaxAssetsAccruedCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" name="WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit" name="TaxPostionMinimumPercentageOfTaxBenefit" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TrancheAAndTrancheBCommonWarrantsMember" name="TrancheAAndTrancheBCommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible" name="ConvertiblePromissoryNoteWarrantsConvertible" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_RentExpenses" name="RentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_StockIssuedDuringPeriodPrivatePlacement" name="StockIssuedDuringPeriodPrivatePlacement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_DeemedDistribution" name="DeemedDistribution" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_PrepaidClinicalTrialExpenses" name="PrepaidClinicalTrialExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic" name="WeightedAveragePlacementAgentWarrantsOutstandingBasic" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial" name="CommonStockCapitalSharesReservedForFutureIssuanceInitial" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_SeriesDConvertiblePreferredStockMember" name="SeriesDConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ProceedsFromFollowOnOffering" name="ProceedsFromFollowOnOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" name="ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_OfficersAndDirectorsMember" name="OfficersAndDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" name="CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ExpectedPerShare" name="ExpectedPerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" name="AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_TrancheTwoMember" name="TrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_NumberOfContractCurrentlyInEffect" name="NumberOfContractCurrentlyInEffect" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_UnrecognizedTaxBenefitsNet" name="UnrecognizedTaxBenefitsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_CalcimedicaCommonStockMember" name="CalcimedicaCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConfidentiallyMarketedPublicOfferingMember" name="ConfidentiallyMarketedPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember" name="TwoThousandAndTwentyFourPrivatePlacementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PrivateCalcimedicaMember" name="PrivateCalcimedicaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted" name="ConvertiblePromissoryNoteWarrantsCommonStockConverted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ProceedsFromIssuanceOfConvertibleNotes" name="ProceedsFromIssuanceOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_WarrantLiability" name="WarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_NonCashInterestExpense" name="NonCashInterestExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_MaximumNumberOfAdditionalSharesIssued" name="MaximumNumberOfAdditionalSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash" name="PaymentsOfAcquisitionOfBusinessesNetOfCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_ShelfRegistrationStatementAvaliableForSale" name="ShelfRegistrationStatementAvaliableForSale" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_WarrantsLiabilityMember" name="WarrantsLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ShortTermInvestmentFairValueDisclosure" name="ShortTermInvestmentFairValueDisclosure" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_RainBioIncMember" name="RainBioIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock" name="ConversionOfSeriesC2WarrantIntoCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_GraybugMember" name="GraybugMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PreferredStockWarrantsAndCommonStockMember" name="PreferredStockWarrantsAndCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember" name="TwoThousandAndTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember" name="AmendedAndRestatedCertificateOfIncorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AccruedClinicalTrialCosts" name="AccruedClinicalTrialCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_ConversionOfC2WarrantsToCommonStock" name="ConversionOfC2WarrantsToCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" name="AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes" name="FairValueAdjustmentOfConvertiblePromissoryNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_UnpaidCancellationAndOtherRelatedCosts" name="UnpaidCancellationAndOtherRelatedCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_AccruedOther" name="AccruedOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_AccruedPayrollAndOtherEmployeeBenefits" name="AccruedPayrollAndOtherEmployeeBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock" name="ConversionOfConvertiblePromissoryNotesToCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted" name="WeightedAveragePlacementAgentWarrantsOutstandingDiluted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_AvenueVentureOpportunitiesFundIILPMember" name="AvenueVentureOpportunitiesFundIILPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ShelfRegistrationStatementMember" name="ShelfRegistrationStatementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet" name="IssuanceOfCommonSharesFromPrivatePlacementNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted" name="WeightedAveragePreFundedWarrantsOutstandingDiluted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PreferredWarrantsMember" name="PreferredWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" name="CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_ConvertiblePreferredStockAbstract" name="ConvertiblePreferredStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" name="Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TwoThousandAndSixEquityIncentivePlanMember" name="TwoThousandAndSixEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PriorToMergerTransactionsMember" name="PriorToMergerTransactionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares" name="IssuanceOfCommonSharesFromPrivatePlacementNetShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" name="IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_InducementGrantsMember" name="InducementGrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_WeightedAverageCommonSharesOutstandingDiluted" name="WeightedAverageCommonSharesOutstandingDiluted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_AccruedSeveranceExpense" name="AccruedSeveranceExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems" name="SegmentReportingAdjustmentsAndReconcilingItems" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" name="Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" name="IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_PreMergerCalcimedicaMember" name="PreMergerCalcimedicaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" name="WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_SeriesC1ConvertiblePreferredStockMember" name="SeriesC1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_MergerTransactionCosts" name="MergerTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_TrancheACommonWarrantsMember" name="TrancheACommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" name="CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_CompanyRecordedExpense" name="CompanyRecordedExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_CommonWarrantsMember" name="CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_CommissionsAndOtherTransactionExpenses" name="CommissionsAndOtherTransactionExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_LeaseExecutedTermPeriod" name="LeaseExecutedTermPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" name="AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember" name="TwoThousandAndTwentyEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_PreferredWarrantMember" name="PreferredWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" name="IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" name="Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" name="Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PostMergerTransactionsMember" name="PostMergerTransactionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" name="ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_ConvertiblePromissoryNoteWarrantsMember" name="ConvertiblePromissoryNoteWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_SeriesC2ConvertiblePreferredStockMember" name="SeriesC2ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_GrossProceedsFromThePrivatePlacement" name="GrossProceedsFromThePrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_PostMergerCalcimedicaMember" name="PostMergerCalcimedicaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" name="IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember" name="ConvertiblePromissoryNoteWarrantsLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_RelatedPartyTransactionsPolicyTextBlock" name="RelatedPartyTransactionsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" name="ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_IncomeTaxRateReconciliationWarrantLiability" name="IncomeTaxRateReconciliationWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_LeaseAmendmentDate" name="LeaseAmendmentDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_CalcimedicaPreferredStockMember" name="CalcimedicaPreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ChangesInFairValueOfFinancialInstruments" name="ChangesInFairValueOfFinancialInstruments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_NetDeferredTaxAsset" name="NetDeferredTaxAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_RestrictedStockUnitsNetSettlementShares" name="RestrictedStockUnitsNetSettlementShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember" name="TwoThousandAndTwentyThreeEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ContractualObligationOfContractInEffect" name="ContractualObligationOfContractInEffect" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_CalcimedicaIncMember" name="CalcimedicaIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_IncomeTaxReconciliationPermanentDifferences" name="IncomeTaxReconciliationPermanentDifferences" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember" name="AmendmentToTwoThousandAndSixEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" name="ConversionOfPromissoryNoteWarrantsIntoCommonStockShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_DirectorsEmployeesOrConsultantsMember" name="DirectorsEmployeesOrConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock" name="AccruedResearchAndDevelopmentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_TemporaryEquityDisclosureTextblock" name="TemporaryEquityDisclosureTextblock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock" name="ConversionOfPromissoryNoteWarrantIntoCommonstock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="ck0001534133_PrepaidExpensesAndOtherCurrentAssets" name="PrepaidExpensesAndOtherCurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_RestrictedStockUnitsNetSettlement" name="RestrictedStockUnitsNetSettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="ck0001534133_WeightedAverageCommonSharesOutstandingBasic" name="WeightedAverageCommonSharesOutstandingBasic" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_ExerciseAndConversionOfC2WarrantsShares" name="ExerciseAndConversionOfC2WarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="ck0001534133_PercentageOfChangeInOwnership" name="PercentageOfChangeInOwnership" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 21, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CALC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CalciMedica, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document financial statement error correction</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,481,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2120079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">505 Coast Boulevard South<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">952-5500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text"> Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">                                                                              </span></p><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive Proxy Statement (the &#8220;Proxy Statement&#8221;) for the 2025 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission not later than April 30, 2025 are incorporated by reference into Part III of this Annual Report on Form 10-K</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (and subsidiaries)(the Company) as of December 31, 2024, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#8217; equity and cash flows for the year then ended, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2024, and the consolidated results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (the Company) as of December 31, 2023, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#8217; equity (deficit) and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Moss Adams LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">659 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,935<span></span>
</td>
<td class="nump">$ 5,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">10,734<span></span>
</td>
<td class="nump">5,708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PrepaidClinicalTrialExpenses', window );">Prepaid clinical trial expenses</a></td>
<td class="nump">748<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other prepaid expenses and current assets</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">19,665<span></span>
</td>
<td class="nump">11,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">19,794<span></span>
</td>
<td class="nump">12,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,998<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccruedClinicalTrialCosts', window );">Accrued clinical trial costs</a></td>
<td class="nump">820<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">866<span></span>
</td>
<td class="nump">1,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,684<span></span>
</td>
<td class="nump">4,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract', window );"><strong>Long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WarrantLiability', window );">Warrant liability</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,384<span></span>
</td>
<td class="nump">4,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 500,000,000 shares authorized at December 31, 2024 and December 31, 2023; 13,481,917 and 5,754,505 issued and outstanding at December 31, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">174,166<span></span>
</td>
<td class="nump">154,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(159,764)<span></span>
</td>
<td class="num">(146,064)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">14,410<span></span>
</td>
<td class="nump">8,157<span></span>
</td>
<td class="num">$ (71,304)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 19,794<span></span>
</td>
<td class="nump">$ 12,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccruedClinicalTrialCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Trial Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccruedClinicalTrialCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PrepaidClinicalTrialExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical trial expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PrepaidClinicalTrialExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">13,481,917<span></span>
</td>
<td class="nump">5,754,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">13,481,917<span></span>
</td>
<td class="nump">5,754,505<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 14,478<span></span>
</td>
<td class="nump">$ 15,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,726<span></span>
</td>
<td class="nump">22,216<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">24,204<span></span>
</td>
<td class="nump">38,075<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating loss</a></td>
<td class="num">(24,204)<span></span>
</td>
<td class="num">(38,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ChangesInFairValueOfFinancialInstruments', window );">Change in fair value of financial instruments</a></td>
<td class="nump">9,490<span></span>
</td>
<td class="nump">3,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">1,014<span></span>
</td>
<td class="nump">550<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">10,504<span></span>
</td>
<td class="nump">3,718<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (7.66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (7.66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of shares outstanding used in computing net loss per share - basic</a></td>
<td class="nump">11,245,915<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of shares outstanding used in computing net loss per share - diluted</a></td>
<td class="nump">11,245,915<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ChangesInFairValueOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in fair value of financial instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ChangesInFairValueOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain on available-for-sale securities, net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (13,698)<span></span>
</td>
<td class="num">$ (34,355)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Gain</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2022</a></td>
<td class="num">$ (71,304,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 40,402,000<span></span>
</td>
<td class="num">$ (111,707,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, Beginning balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, Beginning balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,820,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">12,039,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,039,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock as a result of the Merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,442,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock as a result of Merger, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,820,880)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock as a result of Merger, value</a></td>
<td class="nump">62,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock as a result of the Merger, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (62,071,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger', window );">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001</a></td>
<td class="nump">29,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares', window );">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet', window );">Issuance of common shares from private placement (net of issuance costs)</a></td>
<td class="nump">10,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares', window );">Issuance of common shares from private placement (net of issuance costs), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes', window );">Conversion of promissory notes into common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes', window );">Conversion of promissory notes into common stock</a></td>
<td class="nump">3,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ExerciseAndConversionOfC2WarrantsShares', window );">Conversion of Series C-2 warrants into common stock, share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock', window );">Conversion of Series C-2 warrants into common stock</a></td>
<td class="nump">442,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare', window );">Conversion of promissory note warrants into common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock', window );">Conversion of promissory note warrants into common stock</a></td>
<td class="nump">841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_MergerTransactionCosts', window );">Merger transaction costs</a></td>
<td class="num">(4,545,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,545,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RestrictedStockUnitsNetSettlementShares', window );">Restricted stock units net settlement, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RestrictedStockUnitsNetSettlement', window );">Restricted stock units net settlement</a></td>
<td class="num">(297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(297,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Reclassification of warrant liability to equity</a></td>
<td class="nump">216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock from at-the-market offering (net of issuance costs)</a></td>
<td class="nump">246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock from at-the-market offering (net of issuance costs), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on investments</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(34,357,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,357,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2023</a></td>
<td class="nump">8,157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">154,218,000<span></span>
</td>
<td class="num">(146,064,000)<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,754,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from exercise of stock options</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from exercise of stock options, Shares</a></td>
<td class="nump">12,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger', window );">Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet', window );">Issuance of common shares from private placement (net of issuance costs)</a></td>
<td class="nump">7,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">7,903,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares', window );">Issuance of common shares from private placement (net of issuance costs), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,985,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet', window );">Issuance of common shares from underwritten public offering (net of issuance costs)</a></td>
<td class="nump">9,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">9,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares', window );">Issuance of common shares from underwritten public offering (net of issuance costs),shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement', window );">Issuance of warrants in connection with the private placement</a></td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RestrictedStockUnitsNetSettlement', window );">Restricted stock units net settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock from at-the-market offering (net of issuance costs)</a></td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,000<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock from at-the-market offering (net of issuance costs), shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on investments</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(13,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 14,410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 174,166,000<span></span>
</td>
<td class="num">$ (159,764,000)<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,481,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of promissory note warrant into commonstock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of promissory note warrants into common stock share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of Series C-2 Warrant into Common Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ExerciseAndConversionOfC2WarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise and conversion of C-2 Warrants, Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ExerciseAndConversionOfC2WarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares from private placement, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares from private placement, net, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares from underwritten public offering,net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares from underwritten public offering,net, shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock to Graybug stockholders as a result of the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock to Graybug stockholders as a result of the merger, Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of warrants in connection with private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_MergerTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_MergerTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RestrictedStockUnitsNetSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units net settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RestrictedStockUnitsNetSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RestrictedStockUnitsNetSettlementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units net settlement shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RestrictedStockUnitsNetSettlementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, stock issued during period, shares, conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, stock issued during period, value, conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 17, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,313<span></span>
</td>
<td class="nump">12,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in the fair value of warrant liability</a></td>
<td class="num">(9,490)<span></span>
</td>
<td class="num">(1,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in the fair value of convertible promissory notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TransactionCostsAssoicatedWithWarrants', window );">Transaction costs associated with warrants</a></td>
<td class="nump">776<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_NonCashInterestExpense', window );">Non-cash interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discount on short-term investment</a></td>
<td class="num">(608)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets', window );">Prepaid expenses and other current and non-current assets</a></td>
<td class="num">(228)<span></span>
</td>
<td class="nump">2,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">601<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(868)<span></span>
</td>
<td class="num">(1,837)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(21,146)<span></span>
</td>
<td class="num">(25,730)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchase of investments</a></td>
<td class="num">(29,002)<span></span>
</td>
<td class="num">(6,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Maturity of investments</a></td>
<td class="nump">24,587<span></span>
</td>
<td class="nump">15,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(4,423)<span></span>
</td>
<td class="nump">8,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">27,905<span></span>
</td>
<td class="nump">10,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash', window );">Acquisition of stock of Graybug, net of cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Merger transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from issuance of common stock from ATM Facility, net of issuance costs</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">27,974<span></span>
</td>
<td class="nump">20,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">2,405<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">5,530<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">7,935<span></span>
</td>
<td class="nump">5,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of Series A, B, C-1, C-2 and D convertible preferred stock to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger', window );">Issuance of common stock to Graybug stockholders as a result of the Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentsAssumedInTheMerger', window );">Short-term investments assumed in the Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PrepaidExpensesAndOtherCurrentAssets', window );">Prepaid expenses and other current assets assumed in the Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger', window );">Accounts payable and accrued liabilities assumed in the Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfC2WarrantsToCommonStock', window );">Conversion of C-2 warrants to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock', window );">Conversion of convertible promissory notes to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock', window );">Conversion of convertible promissory note warrants to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses', window );">Financing costs included in accounts payable and accrued expenses</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RestrictedStockUnitsNetSettlement', window );">Restricted stock units net settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1', window );">Reclassification of warrant liability to equity</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts payable and accrued liabilities assumed in the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfC2WarrantsToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of C-2 warrants to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfC2WarrantsToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible promissory note warrants to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible promissory notes to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of convertible promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing costs included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in prepaid expenses and other current and noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock to Graybug stockholders as a result of the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_NonCashInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_NonCashInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of aquisition of businesses net of cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PrepaidExpensesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PrepaidExpensesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RestrictedStockUnitsNetSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units net settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RestrictedStockUnitsNetSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShortTermInvestmentsAssumedInTheMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investments assumed in the merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShortTermInvestmentsAssumedInTheMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TransactionCostsAssoicatedWithWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs assoicated with warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TransactionCostsAssoicatedWithWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in equity for down round feature triggered for warrant classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybersecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk management and strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and maintain information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and our clinical trial data (&#8220;Information Systems and Data&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending on the environment and system, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: an incident response and disaster recovery plan, disaster recovery testing, data encryption for certain data, asset management, system monitoring and multi-factor authentication for certain systems, employee training and cybersecurity insurance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use a third-party information technology consultant to help identify, assess and manage the Company&#8217;s cybersecurity threats and risks. This consultant reports to and works with our management team, including our Chief Scientific Officer and President and Chief Operating Officer to identify and assess risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods and tools including for example by subscribing to reports and services that identify cybersecurity threats, leveraging certain system monitoring tools, and leveraging tools provided through Microsoft Office 365.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment and management of material risks from cybersecurity threats are taken into account as part of the Company&#8217;s risk management processes.  For example, our senior management works with our information technology consultant to evaluate material risks from cybersecurity threats against our overall business objectives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use third-party service providers, including cybersecurity consultants, to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use third-party service providers to perform a variety of critical functions throughout our business, such as hosting providers, application providers, contract research organizations, contract manufacturing organizations, and other third-party service providers. We review the cybersecurity risks associated with the use of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of assessment and due diligence designed to help identify cybersecurity risks associated with a vendor, as well as the imposition of security related contractual obligations on the vendor.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including &#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our information technology systems, or those of our CROs, contractors, consultants, or other third parties with whom we work, may fail or suffer security breaches, loss or leakage of data, and other disruptions, which could result in a material disruption of our product candidates&#8217; development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governance</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></span><span style=""></span></p><div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors receives periodic reports as needed from management </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.</span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board of Directors addresses the Company&#8217;s cybersecurity risk management as part of its general oversight function. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div></div><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors is responsible for overseeing the Company&#8217;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors receives periodic reports as needed from management </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p></div><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Audit Committee of the Board of Directors receives periodic reports as needed from management </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">concerning the Company&#8217;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> considerations into the Company&#8217;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of Business</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CalciMedica, Inc. (&#8220;CalciMedica&#8221; or the &#8220;Company&#8221;) (f/k/a Graybug Vision, Inc.) was incorporated in the state of Delaware in February 2015, following the conversion of Graybug, LLC, which was organized in May 2011, and has its principal operations in La Jolla, California. The Company is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory processes and direct cellular damage.&#8203; The Company had a wholly owned subsidiary, CalciMedica Subsidiary, Inc., incorporated in Delaware in October 2006, which survived the Merger as more fully described below. The CalciMedica Subsidiary entity was dissolved and combined with the Company as of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Merger Transaction</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 20, 2023, Graybug Vision, Inc. (&#8220;Graybug&#8221;) completed a reverse merger transaction in accordance with the terms and conditions of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended on February 10, 2023 (the &#8220;Merger Agreement&#8221;), by and among Graybug, Camaro Merger Sub, Inc., a wholly owned subsidiary of Graybug (&#8220;Merger Sub&#8221;), and CalciMedica, Inc. (&#8220;Private CalciMedica&#8221;), pursuant to which Merger Sub merged with and into Private CalciMedica, with Private CalciMedica surviving as a wholly owned subsidiary of Graybug (the &#8220;Merger&#8221;). Additionally, on March 20, 2023, Graybug changed its name from &#8220;Graybug Vision, Inc.&#8221; to &#8220;CalciMedica, Inc.&#8221; and Private CalciMedica changed its name from &#8220;CalciMedica, Inc.&#8221; to &#8220;CalciMedica Subsidiary, Inc.&#8221; At the completion of the Merger, the prior Private CalciMedica equity holders and the prior Graybug equity holders owned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively of the combined company, in each case, on a fully diluted basis using the treasury stock method and excluding out-of-the-money options and warrants.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger was accounted for as a reverse recapitalization, with Private CalciMedica being treated as the acquirer for accounting purposes. See discussions of the transactions in connection with the Merger in Note 3 - Merger and Related Transactions.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has experienced net losses and negative cash flows from operating activities since its inception. The Company has an accumulated deficit of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2024, and a net loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the year ended December 31, 2024. Total operating expenses for the year ended December 31, 2024 were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Substantially all of the Company&#8217;s operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects to incur significant expenses and increasing operating losses for the foreseeable future as the Company initiates and continues the preclinical and clinical development of its product candidates and adds personnel necessary to operate as a company with an advanced clinical pipeline of product candidates. The Company expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of clinical development programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From inception to December 31, 2024, the Company has completed financings from the sale of preferred stock, warrants and common stock for total net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, including the 204 Private Placement and 2024 Follow-On described below, and has issued convertible debt for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In connection with the Merger, the Company received approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of cash, cash equivalents and short-term investments. As of December 31, 2024, the Company had cash, cash equivalents and short-term investments of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">closed the 2024 Private Placement (as defined in Note 7 below) on January 23, 2024 and the second closing of this private placement occurred on February 5, 2024. Gross proceeds from the transaction were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in commissions and other transaction expenses. The Company closed a confidentially marketed public offering (the &#8220;2024 Follow On&#8221;) in October 2024 of the Company&#8217;s common stock for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and transaction costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On February 28, 2025, the Company entered into the (&#8220;Loan Agreement&#8221;) with Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P. for an initial $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of gross proceeds (see Note 13).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to seek additional funding through public and private financings, debt financings, collaboration agreements, strategic alliances and licensing agreements. Although the Company has been successful in raising capital in the past, there is no assurance of success in obtaining such additional financing on terms acceptable to us, it at all, and there is no assurance that the Company will be able to enter into collaborations or other arrangements. If the Company is unable to obtain funding when required or on acceptable terms, the Company may be required to scale back or discontinue the advancement of the product candidates, reduce headcount, file for bankruptcy, reorganize, merge with another entity or cease operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the Company&#8217;s current operating plans, management believes its cash, cash equivalents, short-term investments and additional financing in February 2025, will be sufficient to fund its operations for the period of at least one year following the issuance of these financial statements.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Update (&#8220;ASU&#8221;), of the Financial Accounting Standards Board (&#8220;FASB&#8221;). The consolidated financial statements include the accounts of the Company for the year ended December 31, 2024 and the Company and CalciMedica Subsidiary, Inc. for the year ended December 31, 2023. All intercompany accounts and transactions have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#8217;s activity from March 21, 2023 through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and assets and liabilities at their acquisition date fair value. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the merger exchange ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0288</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">   </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accruals for research and development expenses, valuation of warrants and valuation of equity awards. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk and other Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to concentration of risk, consist principally of cash and cash equivalents. The Company&#8217;s cash is deposited with major federally insured U.S. financial institutions. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract manufacturing organizations (&#8220;CMO&#8221;) to supply products for research and development of its product candidates, including preclinical and clinical studies, and for commercialization of its product candidates, if approved. The Company&#8217;s development programs could be adversely affected by any significant interruption in CMO&#8217;s operations or by a significant interruption in the supply of active pharmaceutical ingredients and other components.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Products developed by the Company require approval from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance the Company&#8217;s product candidates will receive the necessary approvals. If the Company is denied approvals, approvals are delayed, or the Company is unable to maintain approvals received, such events could have a materially adverse impact on the Company.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of readily available cash in checking accounts, money market funds and commercial paper. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company invests excess cash in commercial paper, U.S. treasury bills and U.S. government sponsored entities, such as mortgage-backed securities. These investments are included in short-term investments on the balance sheet, classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Realized gains and losses on the sale of these securities are recognized in net loss.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The financial information is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7d54053a-642e-4e39-bfc6-b012d14346a8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s singular focus is on developing highly selective calcium release-activated calcium channel inhibitors to improve outcomes for patients with acute inflammatory indications. No significant revenue has been generated since inception, and all tangible assets are held in the United States.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment focused on developing and commercializing innovative therapeutics primarily in the U.S. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the chief executive officer, who is the Company's CODM, in assessing segment performance and deciding how to allocate resources on a consolidated basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.</span></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about reported segment loss and significant segment expenses for the years ended December 31, 2024 and 2023:</span></p><div style="font-size:10pt;font-family:Times New Roman;">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.08%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:15.84%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.28%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment research and development </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(a) (b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,607</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,380</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment general and administrative </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,226</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,598</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation (see Note 8)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,039</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense (see Note 2)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of profit or loss</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments and reconciling items</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
        </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">840,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">2,449,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">1,473,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">9,590,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">31,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">29,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Option</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As permitted under ASC 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has elected the fair value option to account for its convertible promissory notes due to certain embedded features within the notes. The Company recognizes the convertible promissory notes at fair value with changes in fair value recognized in the consolidated statements of operations located on the change in fair value of financial instruments line item. Changes in fair value as a result of the Company&#8217;s own credit risk is reflected in other income in the consolidated statements of operations. As a result of applying the fair value option, direct costs and fees related to the convertible promissory notes were expensed as incurred and not deferred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space with an original lease term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">twelve months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and does </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have a right-of-use asset or lease liability recorded. The Company's policy is not to record leases with an original term of twelve months or less on the consolidated balance sheets. The Company recognizes lease expense for this short-term lease on a straight-line basis over the term of the lease. The lease is accounted for under ASC 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has been classified as an operating lease. Rent expense recognized for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs consist primarily of salaries, payroll taxes, employee benefits and stock-based compensation for those individuals involved in ongoing research and development efforts, as well as fees paid to consultants, external research fees, license fees paid to third parties for use of their intellectual property, laboratory supplies and development of compound materials, associated overhead expenses and facilities and depreciation costs. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. All research and development costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates preclinical studies and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers,  and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. The estimates are trued up to reflect the best information available at the time of the financial statement issuance. Although the Company does not expect its estimates to be materially different from amounts actually incurred, the Company&#8217;s estimate of the status and timing of services performed relative to the actual status and timing of services performed may vary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to executive, finance, business development, legal, human resources and support functions, including professional fees for auditing, tax, consulting and patent-related services, rent and utilities and insurance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs related to filing and pursuing patent applications are expensed as incurred since recoverability of such expenditures is uncertain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Offering Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes costs that are directly associated with equity financings until such financings are consummated, at which time such costs are recorded against the gross proceeds of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations and comprehensive loss. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had deferred costs associated with its ATM Facility (as defined in Note 7)  and expensed these costs in the Company&#8217;s consolidated statement of operations.</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Private CalciMedica has issued various freestanding warrants to purchase shares of its convertible preferred stock. Prior to the Merger, Private CalciMedica adjusted the carrying value of such convertible preferred stock warrants to the estimated fair value at each reporting date, with any related increases or decreases in the fair value being recorded within other income (expense) in the consolidated statements of operations and comprehensive loss. Pursuant to the Merger Agreement, the Series C convertible preferred stock warrants became warrants to purchase shares of the combined company's common stock. As a result of the Merger, the warrants no longer meet the requirements for liability accounting and, as such, Private CalciMedica adjusted the value of the warrants to the estimated fair value as of the Merger date and reclassified them to stockholders' equity (deficit).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the 2024 Private Placement, certain warrants to purchase common stock were deemed freestanding warrants and are reflected in the Company&#8217;s balance sheet as a liability as of and for the period ending December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense represents the cost of the grant date fair value of employee stock options recognized over the requisite service period of the awards (usually the vesting period) on a straight-line basis. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model (&#8220;Black-Scholes&#8221;). Forfeitures are recognized as a reduction of stock-based compensation expense as they occur. Equity-based compensation expense is classified in the statements of operations in the same manner in which the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified. The fair value of each stock option grant is estimated on the date of grant using Black Scholes. The following summarizes the inputs used:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the closing stock price the day prior to the grant date for the fair value.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Free Interest Rate</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free interest ra</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">te is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities similar to the expected term of the awards.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses an average volatility for comparable publicly-traded biopharmaceutical companies over a period equal to the expected term of the stock award grant as CalciMedica does not yet have sufficient historical trading history for its own stock. CalciMedica will continue to apply this method until a sufficient amount of historical information over a period equal to the expected term of the stock-based awards becomes available.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company used the simplified method to calc</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ulate the expected term for all grants during all periods, which is based on the midpoint between the vesting date and the end of the contractual term.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend Yield</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has never paid and has no present intention to pay cash dividends.</span></p></div><div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources which are excluded from net loss. The Company&#8217;s only element of other comprehensive loss is unrealized gains and losses on marketable securities and short-term investments.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s board of directors reviews and approves transactions with directors, officers and holders of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of its voting securities and their affiliates, each a related party. The material facts as to the related party&#8217;s relationship or interest in the transaction are disclosed to its board of directors prior to their consideration of such transaction, and the transaction is not considered approved by its board of directors unless a majority of the directors who are not interested in the transaction approve the transaction.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beginning in November 2020, Private CalciMedica has paid consulting fees monthly to a consulting firm affiliated with the Company&#8217;s interim chief financial officer in connection with its consulting agreement. CalciMedica recorded expense </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">521,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during years ended December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company granted a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to a consulting firm affiliated with the Company&#8217;s interim chief financial officer. The Company recorded expense of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> general and administrative expense for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net loss is equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. The Company calculates diluted net loss per share using the more dilutive of the (1) treasury stock method, if-converted method, or contingently issuable share method, as applicable, or (2) the two-class method. For warrants, the calculation of diluted net loss per share requires that, to the extent the average fair value of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to net loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the warrants for the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In all periods presented, the Company&#8217;s outstanding preferred stock, stock options, preferred, common and convertible promissory note warrants, and outstanding convertible promissory notes were excluded from the calculation of loss per share because the effect would be antidilutive. Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per share.</span></p></div><div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU provides guidance that simplified the accounting for certain financial instruments with characteristics of liabilities and equity. The new guidance reduced the number of accounting models for convertible debt and convertible preferred stock instruments and made certain disclosure amendments intended to improve the information provided to users. The guidance also amended the derivative guidance for the &#8220;own stock&#8221; scope exception, which exempts qualifying instruments from being accounted for as derivatives if certain criteria are met. Finally, the standard changed the way certain convertible instruments are treated when calculating earnings per share. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this ASU as of January 1, 2024, which did not have a material impact on its consolidated financial statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">entity&#8217;s financial statements. The Company adopted the new accounting standard retrospectively for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements related disclosures, however, we have added additional footnote disclosure as part of the adoption.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued final guidance in ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (ASC 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> requiring entities to provide additional information in the rate reconciliation and disclosures about income taxes paid. For public business entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company has adopted this ASU No. 2023-09 effective December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which requires public entities to disclose in the notes to financial statements, of additional specified information about certain costs and expenses. For public business entities, the guidance is effective for annual periods beginning after December 15, 2026 and interim periods after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact that this guidance will have on the consolidated financial statements.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger and Related Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Merger and Related Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Merger and Related Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 1 - Nature of Business, Private CalciMedica merged with a wholly-owned subsidiary of Graybug on March 20, 2023. The Merger was accounted for as a reverse recapitalization under U.S. GAAP. Private CalciMedica was considered the accounting acquirer for financial reporting purposes. This determination is based on the facts that, immediately following the Merger: (i) former Private CalciMedica stockholders owned a substantial majority of the voting rights of the combined company; Private CalciMedica designated a majority (five of seven) of the initial members of the board of directors of the combined company; and former Private CalciMedica's senior management held all key positions in senior management of the combined company. The transaction is accounted for as a reverse recapitalization of Graybug by Private CalciMedica similar to the issuance of equity for the net assets of Graybug, which are primarily cash and cash equivalents, short-term investments and other non-operating assets. It was concluded that any in-process research and development assets that remained as of the Merger would be de minimis when compared to the cash, cash equivalents and short-term investments obtained through the Merger.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under reverse recapitalization accounting, the assets and liabilities of Graybug were recorded at their fair value, which approximated book value due to the short-term nature of the instruments. The Company's consolidated financial statements reflect the issuance of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,571,433</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares to the former stockholders of Graybug.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding share of Private CalciMedica capital stock (after giving effect to the automatic conversion of all shares of Private CalciMedica preferred stock into shares of Private CalciMedica common stock, the automatic exercise of certain Private CalciMedica warrants to purchase shares of Private CalciMedica common stock in accordance with their terms (the &#8220;Private CalciMedica warrant exercises&#8221;), the conversion of Private CalciMedica convertible promissory notes into Private CalciMedica common stock and the closing of the 2023 Private Placement (as defined and discussed in Note 7 - Convertible Preferred Stock, Common Stock, and Stockholders' Equity (Deficit)), was converted into the right to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0288</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock, which resulted in the issuance by Graybug of an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,946,540</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock to the stockholders of Private CalciMedica in a transaction exempt from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on Section 4(a)(2) of the Securities Act and the rules promulgated thereunder. In addition, Graybug assumed the Private CalciMedica 2006 Stock Plan (See Note 8 - Stock-Based Compensation), and each outstanding and unexercised option to purchase Private CalciMedica common stock and each outstanding and unexercised warrant to purchase Private CalciMedica common stock (excluding the warrants which were automatically exercised pursuant to the Private CalciMedica warrant exercises) became options and warrants, respectively, to purchase shares of Graybug common stock. Immediately following the consummation of the Merger prior Private CalciMedica and Graybug stockholders collectively own approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company, respectively, on a fully diluted basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the reverse recapitalization, Private CalciMedica received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of cash, cash equivalents and short-term investments, net of transaction costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Private CalciMedica also obtained prepaid and other current assets of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and assumed payables and accrued expenses of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Private CalciMedica also incurred transaction costs of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is recorded as a reduction to additional paid-in capital in the accompanying consolidated statement of convertible preferred stock and stockholders' equity (deficit). The Company also recorded one-time charges of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the acceleration of the Graybug stock awards and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in severance charges that are recorded in the consolidated statements of operations and comprehensive loss for the for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 17, 2023, in connection with the transactions contemplated by the Merger Agreement and following a special meeting of Graybug&#8217;s stockholders, Graybug filed an Amended and Restated Certificate of Incorporation effecting a reverse stock split of Graybug&#8217;s common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, at a ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:1.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's assets and liabilities which are measured at fair value include short-term investments and warrants for common stock. The Warrants for preferred stock (&#8220;Preferred Warrants&#8221;) and warrants for common stock related to the convertible promissory notes (&#8220;Convertible Promissory Note Warrants&#8221;) were all accounted for at fair value prior to the Merger (see Note 7 -</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock, Common Stock and Stockholders&#8217; Equity). All assets and liabilities recorded at fair value are revalued at each measurement period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Common Warrants (as defined in Note 7 below) were valued using Black-Scholes utilizing the following inputs; (i) a risk-free interest rate; (ii) volatility based on the expected term of the Common Warrant; (iii) and an exercise price and stock price on the date of the transaction. Several different scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the Common Warrants can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following three levels:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. </span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.333%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.222%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,229</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.353%;box-sizing:content-box;"></td>
        <td style="width:1.112%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.362000000000002%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.918000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.918000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are highly liquid investments which are actively traded. The pricing information on the Company&#8217;s money market funds is based on quoted prices in active markets for identical securities. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial paper and U.S. Government sponsored entities - mortgage-backed are classified as Level 2 with in the hierarchy and are carried at fair value with unrealized gains and losses included in other comprehensive income (loss) as a component of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stockholders&#8217; equity until realized. The Company estimates the fair values of these securities by taking into consideration valuations obtained from third-party pricing sources.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, there were no transfers between Level 1, Level 2 and Level 3.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.24%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.24%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> fair value liabilities existed as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"></td>
        <td style="width:1.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Warrant liability</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Initial Fair Value of Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,190</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeiture of warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in Fair Value of Preferred Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,290</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company&#8217;s financial assets measured at fair value on a recurring basis (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,571</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,225</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,730</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,342</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2023, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2023.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Accrued Expenses</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">531</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">935</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">286</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">345</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Promissory Notes and Convertible Promissory Note Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Promissory Notes and Convertible Promissory Note Warrants</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Convertible Promissory Notes and Convertible Promissory Note Warrants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2022, the Private CalciMedica board of directors approved a convertible promissory note financing pursuant to which it could issue and sell up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of notes convertible into shares of common stock (the &#8220;convertible promissory notes&#8221;) and Convertible Promissory Note Warrants. The funding and issuance of the convertible promissory notes for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and Convertible Promissory Note Warrants to purchase shares of the Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share took place in multiple closings through October 2022.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2022, the Private CalciMedica board of directors amended the convertible promissory notes and Convertible Promissory Note Warrants to issue up to an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (for a total of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) and added the automatic conversion for a &#8220;de-SPAC&#8221; business combination or reverse merger transaction. In November 2022, Private CalciMedica issued additional convertible promissory notes for gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and Convertible Promissory Note Warrants to purchase shares of Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The convertible promissory notes accrued interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum and had a maturity date of December 31, 2023. Immediately prior to the effective time of the Merger, all outstanding convertible promissory notes and unpaid and accrued interest automatically converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,487,104</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica&#8217;s common stock at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a conversion price based on the equivalent valuation of the cash price paid per share by the private placement investors purchasing shares of common stock in the private placement multiplied by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Such shares of common stock were then converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">590,031</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug common stock at the effective time of the Merger in accordance with the Merger Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with each purchase of a convertible promissory note, Private CalciMedica issued to each holder of such convertible promissory note Convertible Promissory Note Warrant to purchase shares of the Private CalciMedica&#8217;s common stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Each holder of the Convertible Promissory Note Warrants had the right to purchase up to a number of shares of Private CalciMedica&#8217;s common stock equal to (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (&#8220;Warrant Coverage&#8221;) of the principal amount of the convertible promissory note purchased by such holder concurrently therewith, divided by (ii) the cash price paid per share by the investors in the qualified financing or an initial public offering, as applicable, or in the case of a &#8220;de-SPAC&#8221; business combination or a reverse merger transaction between Private CalciMedica and a publicly traded company (a &#8220;Public Combination&#8221;), the equivalent valuation of the lower of the cash price per share by the investors purchasing shares in the publicly traded company in connection with such Public Combination or the cash price per shares by the investors purchasing shares of Private CalciMedica&#8217;s common stock in connection with such Public Combination, in each case, rounding down to the nearest whole share and subject to the terms of the convertible promissory notes; provided, however, that any holder that purchased convertible promissory notes in excess of the holder&#8217;s pro rata commitment (as defined in the convertible promissory notes) received a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% Warrant Coverage on the principal amount of the convertible promissory notes that is in excess of its pro rata commitment. The Convertible Promissory Note Warrants had a five-year term. In connection with the Merger, the Convertible Promissory Note Warrants were automatically net exercised in accordance with the terms of the Convertible Promissory Note Warrants. Immediately prior to the effective time of the Merger, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,308,047</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Convertible Promissory Note Warrants were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,308,047</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica's common stock, which were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152,875</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug's common stock, based on the principal amount of the convertible promissory note.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, the Convertible Promissory Note Warrants were not deemed equity and were classified as a liability on the balance sheets. The Convertible Promissory Note Warrants were valued using a series of Monte Carlo simulations and Black-Scholes to determine the fair value, probability weighted for difference scenarios. The Monte Carlo simulations determined the liquidity event price. The Black-Scholes warrant value is discounted from the respective event date using the risk-free rate. The Black-Scholes valuation included standard assumptions such as exercise price, expected term, risk-free rate, volatility, and a dividend yield of zero. The Company estimated initial fair value of the Convertible Promissory Note Warrants utilizing the following range of assumptions for the difference scenarios: exercise price ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.01</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), risk-free rate (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.02</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%), volatility (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%),</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expected term (</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.1</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> - </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.6</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years). As of the date of the Merger, the Convertible Promissory Note Warrants which were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">152,871</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock were revalued, using the price of the common stock of Graybug of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock, Common Stock and Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TemporaryEquityDisclosureTextblock', window );">Convertible Preferred Stock, Common Stock and Stockholders' Deficit</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Convertible Preferred Stock, Common Stock and Stockholders' Deficit</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Authorized Shares</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's current Amended and Restated Certificate of Incorporation authorizes </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the effective time of the Merger, the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,820,880</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica preferred stock were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,820,880</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> outstanding shares of Private CalciMedica's common stock to be exchanged for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,442,852</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug's common stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon completion of the Merger on March 20, 2023, as the accounting acquirer, Private CalciMedica is deemed to have issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,571,433</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock to Graybug shareholders.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Private Placement of Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immediately prior to the consummation of the Merger, Private CalciMedica completed a private placement financing pursuant to which certain investors purchased approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares of Private CalciMedica&#8217;s common stock (the &#8220;2023 Private Placement&#8221;) for gross proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In conjunction with the Merger, immediately prior to the effective time of the Merger, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,706,997</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Private CalciMedica common stock were converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">596,363</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Graybug&#8217;s common stock.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 19, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited investors, in which the Company sold the following securities to the accredited investors in a private placement transaction (the &#8220;2024 Private Placement&#8221;): (i) an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,985,610</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock; (ii) to certain investors, in lieu of shares of common stock, pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306,506</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock and exercisable at any time; (iii) Tranche A Common Warrants (the &#8220;Tranche A Common Warrants&#8221;) to purchase an aggregate of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,058</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants); and (iv) Tranche B Common Warrants (the &#8220;Tranche B Common Warrants&#8221; and together with the Tranche A Common Warrants, the &#8220;Common Warrants&#8221;) to purchase an aggregate of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,058</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants). At date of issuance, the fair value of the common stock was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in equity at December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company issued placement agent warrants (&#8220;Placement Agent Warrants&#8221;) to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67,908</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the initial closing of the 2024 Private Placement and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,839</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the second closing of the 2024 Private Placement, at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75,746</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Common Warrants.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The initial closing of the 2024 Private Placement occurred on January 23, 2024 and the second closing occurred on February 5, 2024. Gross proceeds from the transaction were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with net proceeds of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in commissions and other transaction costs. The Tranche A Common Warrants expired unexercised on July 29, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Underwritten Public Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, the Company closed an underwritten public offering of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,720,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;2024 Follow-On&#8221;). The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In addition, the Company granted the underwriters a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30-day</span></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> option </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to purchase up to an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">408,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at the public offering price, less underwriting discounts and commissions, which option expired unexercised.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Shelf Registration Statement and At the Market Offering</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2023, the Company filed a shelf registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;). The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities and warrants having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in one or more offerings and in any combination of the foregoing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Shelf Registration Statement contains two prospectuses, a base prospectus and an at-the-market offering prospectus, as supplemented on March 29, 2024  (as supplemented, the &#8220;Original Prospectus Supplement&#8221;), that covered the offering, issuance and sale of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of common stock pursuant to an at-the-market offering agreement (&#8220;ATM Agreement&#8221;) with H.C Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;), acting as sales agent (&#8220;ATM Facility&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 1, 2024, the Company closed the 2024 Follow-On and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,720,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of its common stock at a price to the public of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share pursuant to the Shelf Registration Statement. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Follow-on, on October 30, 2024, the Company suspended sales of common stock under the ATM Facility pursuant to the Original Prospectus Supplement, and until December 20, 2024, did not offer for sale any shares of common stock. The Company filed a prospectus supplement (the &#8220;Current Prospectus Supplement&#8221;) with the SEC on December 20, 2024 for an aggregate gross sales price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,450,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of shares of common stock to be sold pursuant to the ATM Facility.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to use the net proceeds from the ATM Facility for general corporate purposes, which may include research and development expenses, clinical trial expenses, capital expenditures and working capital. The ATM Facility will terminate upon the earlier of (i) the sale of all of the shares of our common stock provided for in the at the market offering prospectus or (ii) termination of the ATM Agreement as permitted therein. The ATM Agreement may be terminated at any time by either party upon written notice. During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,950</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares sold under the ATM Facility. As of December 31, 2024, the Company has sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101,522</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock for net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">319,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, after deducting $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of commissions and settlement expenses paid under the ATM Facility and approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available for sale under the ATM Facility. As of December 31, 2024, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.5</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million remains available for sale under the Shelf Registration Statement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred and Common Stock Warrants</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognized a change in fair value of the Preferred Stock Warrants for each of the years ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2023 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">795,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The change in fair value for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 was due to the conversion of Preferred Warrants to common stock warrants as part of the Merger.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In November 2020, Private CalciMedica granted a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to a consulting firm affiliated with its former interim chief financial officer in connection with its consulting agreement. The warrant has a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-year term, an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.19</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and vests ratably over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months commencing on the effective date. At the date of issuance, the fair value of the warrant was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk-free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which has been recognized as general and administrative expense over the vesting period. In conjunction with the Merger, the warrant converted to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,520</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants of CalciMedica at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In October 2022, Private CalciMedica granted warrants to certain officers and directors to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">496,970</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. In conjunction with the Merger, the warrants converted to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,313</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants of CalciMedica at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants have a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">-year term and vest ratably over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months. At the date of issuance, the fair value of the warrants collectively was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants are classified as equity, and the Company expensed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to general and administrative expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the 2024 Private Placement, the Company issued Tranche A Common Warrants, Tranche B Common Warrants and Pre-Funded Warrants. Tranche A Common Warrants were exercisable until July 29, 2024. The Tranche B Common Warrants are exercisable upon the earlier of December 31, 2026 or 30 days following the Company&#8217;s public disclosure of topline results from the Company&#8217;s planned Phase 2 clinical trial in patients with acute kidney injury. The purchase price per share and accompanying Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.827</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3915</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for directors, employees or consultants of the Company participating in the 2024 Private Placement) (or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8269</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant and accompanying Common Warrants, which represented the price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.827</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and accompanying Common Warrants minus the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share exercise price of each such Pre-Funded Warrant).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Tranche A Common Warrants had a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.36</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, were not deemed equity and were classified as a liability in the Company&#8217;s condensed consolidated balance sheets. At the date of issuance, the fair value of the Tranche A Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">0.94</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of the balance sheet date of December 31, 2024, the value of the Tranche A Common Warrants was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">nil</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with the change in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">being recorded in consolidated statements of operations in other income as the Tranche A Common Warrants expired unexercised on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 27, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Tranche B Common Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are not deemed equity and are classified as a liability in the Company&#8217;s consolidated balance sheets. At the date of issuance, the fair value of the Tranche B Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million utilizing Black-Scholes with the following assumptions: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.69</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, risk-free interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of the balance sheet date of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the value of the Tranche B Common Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, with the change in fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively, being recorded in the condensed consolidated statements of operations in other income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Pre-Funded Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are deemed equity and included in the equity section of the Company&#8217;s consolidated balance sheets. At date of issuance, the fair value of the Pre-Funded Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in stockholders&#8217; equity at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Placement Agent Warrants have a strike price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, are deemed equity and included in the equity section of the Company&#8217;s consolidated balance sheets. At date of issuance, the fair value of the Placement Agent Warrants was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million using the relative fair value method and is included in equity at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company granted a warrant to a consulting firm affiliated with its chief financial officer to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. At the date of issuance, the fair value of the warrant was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">twelve months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, risk free rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, volatility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and a dividend yield of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrant is classified as equity, and the Company expensed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> general and administrative expense for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TemporaryEquityDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TemporaryEquityDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Stock-based Compensation</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Equity Incentive Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company adopted 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;), which became effective at the closing of the Merger and replaced our 2020 Equity Incentive Plan (&#8220;2020 Plan&#8221;) on the effective date of the Merger. As of the effective date of the Merger, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock available for grant under the 2023 Plan. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 Plan of up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of shares of the Company&#8217;s common stock outstanding (or a lesser number determined by the Company&#8217;s board of directors). As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">228,475</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">options have been returned of whic</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">223,743</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(granted under the 2020 Plan) are unavailable for future grant. Effective January 1, 2024, the shares reserved for issuance under the 2023 Plan was increased by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287,725</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares. Effective March 28, 2024, the Board approved an increase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares reserved under the 2023 Plan. This increase was subsequently approved by the stockholders of the Company on August 27, 2024. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">820,266</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> s</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hares were available for grant under the 2023 Plan.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2023 Employee Stock Purchase Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company adopted the 2023 Employee Stock Purchase Plan (the &#8220;2023 ESPP&#8221;) which became effective at the closing of the Merger. As of the effective time of the Merger, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock reserved for issuance under the 2023 ESPP. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 ESPP of the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total number of shares of the Company&#8217;s common stock outstanding on December 31 of the preceding calendar year, (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">195,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock, or (iii) such lesser number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s board of directors. An annual increase of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,545</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock was automatically added to the share reserve under the 2023 ESPP on January 1, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares have been issued under the 2023 ESPP.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option transactions for the 2023 Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.435%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.152%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.353%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.466%;box-sizing:content-box;"></td>
        <td style="width:1.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.687%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Contractual Term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate Intrinsic Value (in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,739,270</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.99</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,326,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,852</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">228,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.51</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.15</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,350,852</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.46</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.09</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">210</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,852</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options exercised and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,326,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> options granted during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024. The weighted-average fair value of options granted during the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. The total fair value of shares vested was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (which includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the acceleration of vesting of the Graybug stock awards at the date of the Merger) for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, stock-based compensation not yet recognized is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which the Company expects to recognize over an estimated weighted-average term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.8</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.46%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:12.6%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:14.06%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.15</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.56</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.01</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.25</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Units (&#8220;RSU&#8221;)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of RSUs is determined on the date of grant based on the market price of the Company&#8217;s common stock on that date. The aggregate grant date fair value of RSUs vested during the year ended December 31, 2024 was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">nil</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes restricted stock unit activity for the CalciMedica Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.183%;box-sizing:content-box;"></td>
        <td style="width:2.158%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.61%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.799%;box-sizing:content-box;"></td>
        <td style="width:2.158%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.093%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Restricted Stock Units</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited/Cancelled (expired)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation Expense</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,449</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,590</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The stock-based compensation expense for the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, includes one-time charges for the acceleration of vesting of the Graybug stock options at the date of the Merger of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in research and development and general and administrative expenses, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock Reserved for Future Issuance</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common stock reserved for future issuance consists of the following at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,352,621</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available for issuance under the 2023 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">807,414</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available under the 2023 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,107,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues liabilities for such matters when future expenditures are probable and such expenditures can be reasonably estimated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has historically entered into contracts in the normal course of business with contract development and manufacturing organizations, for the manufacturing process development and the preclinical/clinical supply manufacturing, and its vendors for preclinical research studies and other services or products for operating purposes. These contracts generally provide for termination on notice of 60 to 90 days. As of December 31, 2024, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">seven</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> such contracts, with one CMO related to its development of Auxora and one acquired as a result of the Merger with approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of associated costs, respectively, still in effect for future services, and there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unpaid cancellation or other related costs.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may also, from time to time, become party or subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. Some of these proceedings have involved, and may involve in the future, claims that are subject to substantial uncertainties and unascertainable damages.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Lease Agreements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has an operating lease for office space in La Jolla, California. In </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, an amendment was </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">executed for a twelve month term as of January 1, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and therefore qualifies for the short-term lease exception. Since the lease was amended and renewed in December 2024 for an additional twelve month term it therefore qualifies for the short-term lease exception. Base rent for this lease is approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,500</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> monthly.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rent expense for the years ended December 31, 2024 and 2023 wa</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively, which is included in operating expenses.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Employee Benefits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2007, Private CalciMedica adopted a defined contribution 401(k) plan for substantially all employees. Contributions made by CalciMedica to the 401(k) plan were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Income Taxes</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The effective tax rate if the Company&#8217;s provision (benefit) for income taxes differs from the federal statutory rate as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax computed at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,877</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal tax benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,993</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">665</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits, net of uncertain positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,050</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">705</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,534</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating losses and tax credit carryforwards. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of deferred tax assets (liabilities) are as follows (in thousands):</span></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,407</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,535</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,356</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carry forwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,506</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,403</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,596</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provided a full valuation allowance on the net deferred tax asset because management has determined that it is more-likely-than-not that the Company will not earn income sufficient to realize the deferred tax assets during the carryforward period. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has federal and state NOLs available of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">296.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">nil</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to offset future taxable income, if any, for federal and state income tax purposes. The federal and state NOLs expire beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of post-2017 federal NOL carryforwards that carry forward indefinitely. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Tax Act the amount of net operating losses generated in taxable periods beginning after December 31, 2017, that the Company is permitted to deduct in any taxable year is limited to 80% of taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Tax Act generally eliminates the ability to carry back any net operating loss to prior taxable years, while allowing post-2017 unused net operating losses to be carried forward indefinitely.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has federal and state research and development credit carryforwards available of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Federal research and development carryforwards expire beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. State research and development carryforwards do not expire.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) specifically by IRC &#167;382, the Company&#8217;s ability to use net operating loss carryforwards to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% within a three-year testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly reduced. Any limitation may result in the expiration of a portion of the NOL carryforwards before utilization.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the Company&#8217;s unrecognized tax benefits is summarized as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,506</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions in connection with the reverse merger</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">847</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reduction for tax positions of prior years</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">334</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,482</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertainty in income taxes in accordance with ASC 740 Income Taxes. Tax positions are evaluated in a two-step process, whereby the Company first determines whether it is more likely than not that a tax position will be sustained upon examination by the tax authority, including resolutions of any related appeals or litigation processes, based on technical merit. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more likely than not recognition threshold to be recognized. The Company&#8217;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrual for interest and penalties and has not recognized interest and/ or penalties in the statements of operations and comprehensive loss for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. Uncertain tax positions are evaluated based upon the facts and circumstances that exist at each reporting period. Subsequent changes in judgment based upon new information may lead to changes in recognition, derecognition,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and measurement. Adjustments may result, for example, upon resolution of an issue with the taxing authorities or expiration of a statute of limitations barring an assessment for an issue.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, unrecognized tax benefits associated with uncertain tax positions was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million respectively. If recognized, this would affect the effective tax rate, subject to valuation allowance. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not recognize any interest and penalties associated with unrecognized tax benefits. Due to net operating losses incurred, tax years from inception remain open to examination by the Federal and State taxing jurisdictions to which we are subject. The Company is not currently under Internal Revenue Services (IRS), state or local tax examination.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.94%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.98%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,357</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,886,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,486,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average pre-funded warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">288,082</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average placement agent warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,913</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of shares used to calculate basic and diluted net loss per share</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,245,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,486,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share - basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.729%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.976%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.976%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,739,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,970,368</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">276,437</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,794,811</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,016,184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Subsequent Events</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 (the &#8220;Closing Date&#8221;), the Company the Loan Agreement with Avenue Venture Opportunities Fund II, L.P. (&#8220;Lender&#8221;) and Avenue Capital Management II, L.P., as administrative agent and collateral agent, for growth capital loans in an aggregate principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Loan&#8221;), with (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> funded on the Closing Date (&#8220;Tranche 1&#8221;), (ii) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials (&#8220;Tranche 2&#8221;) and (iii) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#8217;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval). </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Loan bears interest at an annual rate equal to the greater of (a) the sum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% plus the prime rate as reported in The Wall Street Journal and (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The Loan is secured by a lien upon and security interest in all of the Company&#8217;s assets, including intellectual property, subject to agreed exceptions. The maturity date of the Loan is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 1, 2028</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Maturity Date&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Loan, pursuant to the funding of Tranche 1 on the Closing Date, the Company issued to the Lender a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">641,163</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock of the Company (the &#8220;Warrant&#8221;) at an exercise price per share equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.32</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Stock Purchase Price&#8221;). The Warrant is exercisable until </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">February 28, 2030</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Expiration Date&#8221;) and upon a change of control, the Lender would be entitled to receive the shares of common stock underlying the Warrant without payment of the exercise price.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Update (&#8220;ASU&#8221;), of the Financial Accounting Standards Board (&#8220;FASB&#8221;). The consolidated financial statements include the accounts of the Company for the year ended December 31, 2024 and the Company and CalciMedica Subsidiary, Inc. for the year ended December 31, 2023. All intercompany accounts and transactions have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#8217;s activity from March 21, 2023 through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and assets and liabilities at their acquisition date fair value. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the merger exchange ratio of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0288</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">   </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the Company&#8217;s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accruals for research and development expenses, valuation of warrants and valuation of equity awards. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and other Risks and Uncertainties</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of Credit Risk and other Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments, which potentially subject the Company to concentration of risk, consist principally of cash and cash equivalents. The Company&#8217;s cash is deposited with major federally insured U.S. financial institutions. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract manufacturing organizations (&#8220;CMO&#8221;) to supply products for research and development of its product candidates, including preclinical and clinical studies, and for commercialization of its product candidates, if approved. The Company&#8217;s development programs could be adversely affected by any significant interruption in CMO&#8217;s operations or by a significant interruption in the supply of active pharmaceutical ingredients and other components.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Products developed by the Company require approval from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance the Company&#8217;s product candidates will receive the necessary approvals. If the Company is denied approvals, approvals are delayed, or the Company is unable to maintain approvals received, such events could have a materially adverse impact on the Company.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and cash equivalents consist of readily available cash in checking accounts, money market funds and commercial paper. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-term Investments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company invests excess cash in commercial paper, U.S. treasury bills and U.S. government sponsored entities, such as mortgage-backed securities. These investments are included in short-term investments on the balance sheet, classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Realized gains and losses on the sale of these securities are recognized in net loss.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The financial information is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;), in deciding how to allocate resources. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7d54053a-642e-4e39-bfc6-b012d14346a8;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s singular focus is on developing highly selective calcium release-activated calcium channel inhibitors to improve outcomes for patients with acute inflammatory indications. No significant revenue has been generated since inception, and all tangible assets are held in the United States.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment focused on developing and commercializing innovative therapeutics primarily in the U.S. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the chief executive officer, who is the Company's CODM, in assessing segment performance and deciding how to allocate resources on a consolidated basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.</span></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about reported segment loss and significant segment expenses for the years ended December 31, 2024 and 2023:</span></p><div style="font-size:10pt;font-family:Times New Roman;">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.08%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:15.84%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.28%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment research and development </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(a) (b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,607</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,380</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment general and administrative </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,226</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,598</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation (see Note 8)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,039</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense (see Note 2)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of profit or loss</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments and reconciling items</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
        </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">840,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">2,449,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">1,473,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">9,590,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">31,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">29,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Option</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Option</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As permitted under ASC 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has elected the fair value option to account for its convertible promissory notes due to certain embedded features within the notes. The Company recognizes the convertible promissory notes at fair value with changes in fair value recognized in the consolidated statements of operations located on the change in fair value of financial instruments line item. Changes in fair value as a result of the Company&#8217;s own credit risk is reflected in other income in the consolidated statements of operations. As a result of applying the fair value option, direct costs and fees related to the convertible promissory notes were expensed as incurred and not deferred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases office space with an original lease term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">twelve months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and does </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have a right-of-use asset or lease liability recorded. The Company's policy is not to record leases with an original term of twelve months or less on the consolidated balance sheets. The Company recognizes lease expense for this short-term lease on a straight-line basis over the term of the lease. The lease is accounted for under ASC 842, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has been classified as an operating lease. Rent expense recognized for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">274,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock', window );">Research and Development Costs</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs consist primarily of salaries, payroll taxes, employee benefits and stock-based compensation for those individuals involved in ongoing research and development efforts, as well as fees paid to consultants, external research fees, license fees paid to third parties for use of their intellectual property, laboratory supplies and development of compound materials, associated overhead expenses and facilities and depreciation costs. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. All research and development costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company estimates preclinical studies and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on the Company&#8217;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers,  and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. The estimates are trued up to reflect the best information available at the time of the financial statement issuance. Although the Company does not expect its estimates to be materially different from amounts actually incurred, the Company&#8217;s estimate of the status and timing of services performed relative to the actual status and timing of services performed may vary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative Costs</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to executive, finance, business development, legal, human resources and support functions, including professional fees for auditing, tax, consulting and patent-related services, rent and utilities and insurance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PatentsCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs related to filing and pursuing patent applications are expensed as incurred since recoverability of such expenditures is uncertain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Offering Costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes costs that are directly associated with equity financings until such financings are consummated, at which time such costs are recorded against the gross proceeds of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations and comprehensive loss. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had deferred costs associated with its ATM Facility (as defined in Note 7)  and expensed these costs in the Company&#8217;s consolidated statement of operations.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WarrantLiabilityPolicyPolicyTextBlock', window );">Warrant Liability</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Private CalciMedica has issued various freestanding warrants to purchase shares of its convertible preferred stock. Prior to the Merger, Private CalciMedica adjusted the carrying value of such convertible preferred stock warrants to the estimated fair value at each reporting date, with any related increases or decreases in the fair value being recorded within other income (expense) in the consolidated statements of operations and comprehensive loss. Pursuant to the Merger Agreement, the Series C convertible preferred stock warrants became warrants to purchase shares of the combined company's common stock. As a result of the Merger, the warrants no longer meet the requirements for liability accounting and, as such, Private CalciMedica adjusted the value of the warrants to the estimated fair value as of the Merger date and reclassified them to stockholders' equity (deficit).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the 2024 Private Placement, certain warrants to purchase common stock were deemed freestanding warrants and are reflected in the Company&#8217;s balance sheet as a liability as of and for the period ending December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense represents the cost of the grant date fair value of employee stock options recognized over the requisite service period of the awards (usually the vesting period) on a straight-line basis. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model (&#8220;Black-Scholes&#8221;). Forfeitures are recognized as a reduction of stock-based compensation expense as they occur. Equity-based compensation expense is classified in the statements of operations in the same manner in which the award recipients&#8217; payroll costs are classified or in which the award recipients&#8217; service payments are classified. The fair value of each stock option grant is estimated on the date of grant using Black Scholes. The following summarizes the inputs used:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the closing stock price the day prior to the grant date for the fair value.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Free Interest Rate</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free interest ra</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">te is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities similar to the expected term of the awards.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses an average volatility for comparable publicly-traded biopharmaceutical companies over a period equal to the expected term of the stock award grant as CalciMedica does not yet have sufficient historical trading history for its own stock. CalciMedica will continue to apply this method until a sufficient amount of historical information over a period equal to the expected term of the stock-based awards becomes available.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company used the simplified method to calc</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ulate the expected term for all grants during all periods, which is based on the midpoint between the vesting date and the end of the contractual term.</span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend Yield</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has never paid and has no present intention to pay cash dividends.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources which are excluded from net loss. The Company&#8217;s only element of other comprehensive loss is unrealized gains and losses on marketable securities and short-term investments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RelatedPartyTransactionsPolicyTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s board of directors reviews and approves transactions with directors, officers and holders of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of its voting securities and their affiliates, each a related party. The material facts as to the related party&#8217;s relationship or interest in the transaction are disclosed to its board of directors prior to their consideration of such transaction, and the transaction is not considered approved by its board of directors unless a majority of the directors who are not interested in the transaction approve the transaction.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beginning in November 2020, Private CalciMedica has paid consulting fees monthly to a consulting firm affiliated with the Company&#8217;s interim chief financial officer in connection with its consulting agreement. CalciMedica recorded expense </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">521,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">during years ended December 31, 2024 and 2023, respectively.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2024, the Company granted a warrant to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to a consulting firm affiliated with the Company&#8217;s interim chief financial officer. The Company recorded expense of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> general and administrative expense for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss Per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net loss is equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. The Company calculates diluted net loss per share using the more dilutive of the (1) treasury stock method, if-converted method, or contingently issuable share method, as applicable, or (2) the two-class method. For warrants, the calculation of diluted net loss per share requires that, to the extent the average fair value of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to net loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the warrants for the period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In all periods presented, the Company&#8217;s outstanding preferred stock, stock options, preferred, common and convertible promissory note warrants, and outstanding convertible promissory notes were excluded from the calculation of loss per share because the effect would be antidilutive. Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per share.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt with Conversion and Other Options (Subtopic 470-20)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The ASU provides guidance that simplified the accounting for certain financial instruments with characteristics of liabilities and equity. The new guidance reduced the number of accounting models for convertible debt and convertible preferred stock instruments and made certain disclosure amendments intended to improve the information provided to users. The guidance also amended the derivative guidance for the &#8220;own stock&#8221; scope exception, which exempts qualifying instruments from being accounted for as derivatives if certain criteria are met. Finally, the standard changed the way certain convertible instruments are treated when calculating earnings per share. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this ASU as of January 1, 2024, which did not have a material impact on its consolidated financial statements and related disclosures.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This guidance expands public entities&#8217; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#8217;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">entity&#8217;s financial statements. The Company adopted the new accounting standard retrospectively for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial statements related disclosures, however, we have added additional footnote disclosure as part of the adoption.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued final guidance in ASU No. 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (ASC 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> requiring entities to provide additional information in the rate reconciliation and disclosures about income taxes paid. For public business entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company has adopted this ASU No. 2023-09 effective December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which requires public entities to disclose in the notes to financial statements, of additional specified information about certain costs and expenses. For public business entities, the guidance is effective for annual periods beginning after December 15, 2026 and interim periods after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact that this guidance will have on the consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PatentsCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patents costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PatentsCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RelatedPartyTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related party transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RelatedPartyTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WarrantLiabilityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WarrantLiabilityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsTextBlock1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsTextBlock1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Disaggregated Amounts of Operating Expenses</a></td>
<td class="text">
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:64.08%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:15.84%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.9%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.28%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment research and development </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(a) (b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,607</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,380</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Segment general and administrative </span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(b)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,226</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,598</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation (see Note 8)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,039</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense (see Note 2)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Reconciliation of profit or loss</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments and reconciling items</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consolidated operating loss</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,204</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,075</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         </tr>
        </table><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">840,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">2,449,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">1,473,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">9,590,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">b)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">31,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">29,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.333%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.333%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.222%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,229</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:43.353%;box-sizing:content-box;"></td>
        <td style="width:1.112%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.362000000000002%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.918000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.918000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.334%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.34%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables present information about the Company&#8217;s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.24%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.24%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"></td>
        <td style="width:1.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.88%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Warrant liability</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Initial Fair Value of Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,190</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeiture of warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in Fair Value of Preferred Warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,290</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Company's Financial Assets Measured at Fair Value</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company&#8217;s financial assets measured at fair value on a recurring basis (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">746</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">749</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,571</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,573</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Treasury bills</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,225</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,227</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. Government sponsored entities - mortgage-backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,730</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,342</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,346</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="font-size:10pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.34%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.18%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.236%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;">&#160;</p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized<br/>Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized<br/>Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,738</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,372</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,211</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,213</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S Government sponsored entities - mortgage backed securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">495</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total short-term investments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,706</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,708</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets measured at fair value</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses consisted of the following (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued payroll and other employee benefits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">531</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">935</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">286</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">345</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">866</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Transations</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock option transactions for the 2023 Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.435%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.152%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1.111%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.353%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.466%;box-sizing:content-box;"></td>
        <td style="width:1.178%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.687%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Options</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Contractual Term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate Intrinsic Value (in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,739,270</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.71</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.99</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,326,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,852</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">228,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.51</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.15</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,350,852</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.46</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.09</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">210</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the Stock Option Grants</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.46%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:12.6%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:14.06%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.15</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.56</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.01</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.25</span></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Units (RSU) Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes restricted stock unit activity for the CalciMedica Plans:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.183%;box-sizing:content-box;"></td>
        <td style="width:2.158%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.61%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:3.799%;box-sizing:content-box;"></td>
        <td style="width:2.158%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.093%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Restricted Stock Units</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Exercise Price</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited/Cancelled (expired)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,449</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,473</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,590</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common stock reserved for future issuance consists of the following at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.22%;box-sizing:content-box;"></td>
        <td style="width:1.48%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,352,621</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options issued and outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available for issuance under the 2023 Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">807,414</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares available under the 2023 ESPP</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">122,545</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,107,023</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of schedule of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The effective tax rate if the Company&#8217;s provision (benefit) for income taxes differs from the federal statutory rate as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax computed at federal statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,877</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,214</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State tax, net of federal tax benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,993</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">665</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits, net of uncertain positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,050</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">705</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,534</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of deferred tax assets (liabilities) are as follows (in thousands):</span><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62,407</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,535</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,356</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,865</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carry forwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,506</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,403</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,475</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,596</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88,460</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82,575</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Reconciliation of Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the Company&#8217;s unrecognized tax benefits is summarized as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,506</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,846</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions in connection with the reverse merger</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">847</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;word-break:break-word;">
        <td style="background-color:#cff0fc;padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reduction for tax positions of prior years</span></p></td>
        <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,080</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">334</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additions for tax positions of prior years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,482</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.94%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.3%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.98%;box-sizing:content-box;"></td>
        <td style="width:1.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.78%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,700</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,357</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,886,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,486,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average pre-funded warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">288,082</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average placement agent warrants outstanding, basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,913</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average number of shares used to calculate basic and diluted net loss per share</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,245,915</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,486,258</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share - basic and diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.729%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.976%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:17.976%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,824,443</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,739,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,970,368</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">276,437</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,794,811</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,016,184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents and short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,764)<span></span>
</td>
<td class="num">(146,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,204<span></span>
</td>
<td class="nump">38,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,905<span></span>
</td>
<td class="nump">$ 10,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ck0001534133_LoanAgreementMember', window );">Loan Agreement | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Gross proceeds from loan agreement</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_GrossProceedsFromThePrivatePlacement', window );">Gross proceeds from the private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_NetProceedsFromPrivatePlacement', window );">Net proceeds from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CommissionsAndOtherTransactionExpenses', window );">Commissions and other transaction expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ConfidentiallyMarketedPublicOfferingMember', window );">2024 Follow On</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember', window );">CalciMedica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2024 Follow On</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PreferredStockWarrantsAndCommonStockMember', window );">Preferred Stock, Warrants and Common Stock | 2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TotalNetProceeds', window );">Total net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_CommissionsAndOtherTransactionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commissions and other transaction expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_CommissionsAndOtherTransactionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_GrossProceedsFromThePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from the private placement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_GrossProceedsFromThePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_NetProceedsFromPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from private placement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_NetProceedsFromPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TotalNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total net proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TotalNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001534133_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001534133_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ConfidentiallyMarketedPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ConfidentiallyMarketedPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PreferredStockWarrantsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_PreferredStockWarrantsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio', window );">Stockholders equity note stock split exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RentExpenses', window );">Rent expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121,000<span></span>
</td>
<td class="nump">274,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RightOfUseAssetOrLeaseLiability', window );">Right-of-use asset or lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit', window );">Tax postion, minimum percentage of tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Variable interest entity ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CompanyRecordedExpense', window );">Company recorded expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_PrivateCalcimedicaMember', window );">Private CalciMedica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Costs and expenses related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,000<span></span>
</td>
<td class="nump">$ 521,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants', window );">Warrants granted during the period | shares</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_CompanyRecordedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company recorded expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_CompanyRecordedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RightOfUseAssetOrLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use asset or lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RightOfUseAssetOrLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock and warrants issued during period shares common stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders equity note stock split exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax postion, minimum percentage of tax benefit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_PrivateCalcimedicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_PrivateCalcimedicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Segment research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (14,478)<span></span>
</td>
<td class="num">$ (15,859)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Segment general and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,726)<span></span>
</td>
<td class="num">(22,216)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems', window );">Adjustments and reconciling items</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(24,204)<span></span>
</td>
<td class="num">(38,075)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Segment research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="num">(13,607)<span></span>
</td>
<td class="num">(13,380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Segment general and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(8,226)<span></span>
</td>
<td class="num">(12,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,313)<span></span>
</td>
<td class="num">(12,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Consolidated operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (24,204)<span></span>
</td>
<td class="num">$ (38,075)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">31,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">29,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">840,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">2,449,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">1,473,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">9,590,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment reporting adjustments and reconciling items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">840,000<span></span>
</td>
<td class="nump">2,449,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">1,473,000<span></span>
</td>
<td class="nump">9,590,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger and Related Transactions - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 17, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockIssuedDuringPeriodPrivatePlacement', window );">Stock issued during period private placement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration Transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid and other current assets obtained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Payables and accruals incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and termination benefit expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acceleration of stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Shares issued during period upon conversion of units | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,946,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember', window );">CalciMedica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares of stock issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse Stock Split</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acceleration of stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
<td class="nump">$ 10.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination, consideration transfered cost incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockIssuedDuringPeriodPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockIssuedDuringPeriodPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_CalcimedicaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ck0001534133_GraybugVisionIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 7,612,000<span></span>
</td>
<td class="nump">5,372,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">10,734,000<span></span>
</td>
<td class="nump">5,708,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">18,346,000<span></span>
</td>
<td class="nump">11,080,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">6,117,000<span></span>
</td>
<td class="nump">3,634,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">746,000<span></span>
</td>
<td class="nump">1,738,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">6,573,000<span></span>
</td>
<td class="nump">5,213,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">749,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">3,227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. Government Sponsored Entities - Mortgagebacked Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">934,000<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">6,117,000<span></span>
</td>
<td class="nump">3,634,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">6,117,000<span></span>
</td>
<td class="nump">3,634,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">6,117,000<span></span>
</td>
<td class="nump">3,634,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">1,495,000<span></span>
</td>
<td class="nump">1,738,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">10,734,000<span></span>
</td>
<td class="nump">5,708,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value</a></td>
<td class="nump">12,229,000<span></span>
</td>
<td class="nump">7,446,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">746,000<span></span>
</td>
<td class="nump">1,738,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">6,573,000<span></span>
</td>
<td class="nump">5,213,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | U.S. Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">749,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">3,227,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2 | U.S. Government Sponsored Entities - Mortgagebacked Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">934,000<span></span>
</td>
<td class="nump">$ 495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3 | Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShortTermInvestmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investment fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShortTermInvestmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ck0001534133_WarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ck0001534133_WarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details) - Fair Value, Recurring - Warrant Liability - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Initial Fair Value of Warrants</a></td>
<td class="nump">11,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants', window );">Forfeiture of warrants</a></td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in Fair Value of Preferred Warrants</a></td>
<td class="num">(9,290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliations recurring basis forfeiture of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ck0001534133_WarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ck0001534133_WarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis', window );">Total cash equivalents, Amortized Cost</a></td>
<td class="nump">$ 7,612<span></span>
</td>
<td class="nump">$ 5,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents, Aggregate Fair Value</a></td>
<td class="nump">7,612<span></span>
</td>
<td class="nump">5,372<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis', window );">Total short-term investments, Amortized Cost</a></td>
<td class="nump">10,730<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax', window );">Total short-term investments, Unrealized Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Total short-term investments, Aggregate Fair Value</a></td>
<td class="nump">10,734<span></span>
</td>
<td class="nump">5,708<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis', window );">Total asset measured at fair value, Amortized Cost</a></td>
<td class="nump">18,342<span></span>
</td>
<td class="nump">11,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax', window );">Total asset measured at fair value, Unrealized Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total asset measured at fair value, Aggregate Fair Value</a></td>
<td class="nump">18,346<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis', window );">Total cash equivalents, Amortized Cost</a></td>
<td class="nump">6,117<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents, Aggregate Fair Value</a></td>
<td class="nump">6,117<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis', window );">Total cash equivalents, Amortized Cost</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents, Aggregate Fair Value</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,738<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis', window );">Total short-term investments, Amortized Cost</a></td>
<td class="nump">6,571<span></span>
</td>
<td class="nump">5,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax', window );">Total short-term investments, Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Total short-term investments, Aggregate Fair Value</a></td>
<td class="nump">6,573<span></span>
</td>
<td class="nump">5,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis', window );">Total cash equivalents, Amortized Cost</a></td>
<td class="nump">749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents, Aggregate Fair Value</a></td>
<td class="nump">749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis', window );">Total short-term investments, Amortized Cost</a></td>
<td class="nump">3,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax', window );">Total short-term investments, Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Total short-term investments, Aggregate Fair Value</a></td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Government Sponsored Entities - Mortgagebacked Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis', window );">Total short-term investments, Amortized Cost</a></td>
<td class="nump">934<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShortTermInvestmentFairValueDisclosure', window );">Total short-term investments, Aggregate Fair Value</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets fair value disclosure accumulated gross unrealized gain before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets fair value disclosure amortized cost basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and cash equivalents fair value disclosure amortized cost basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShortTermInvestmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term investment fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShortTermInvestmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term investment fair value disclosure accumulated gross unrealized gain before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term investment fair value disclosure amortized cost basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
<th class="th"><div>Nov. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare', window );">Public combination multiplied cash price paid per share</a></td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PercentageOfWarrantCoverage', window );">Percentage of warrant coverage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 3 days<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PercentageOfWarrantCoverage', window );">Percentage of warrant coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Private CalciMedica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of convertible promissory note converted into common stock</a></td>
<td class="nump">20,487,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock | Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of convertible promissory note converted into common stock</a></td>
<td class="nump">590,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Issuance or Sale of Convertible Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds of Convertible Promissory Notes</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible promissory notes | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember', window );">Convertible Promissory Note Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Issuance or Sale of Convertible Promissory Notes</a></td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional', window );">Addiitional convertible promissory notes and Convertible Promissory Note Warrants</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible', window );">Convertible promissory note warrants convertible</a></td>
<td class="nump">5,308,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted', window );">Convertible promissory note warrants common stock converted</a></td>
<td class="nump">5,308,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ExchangeOfStockForStock', window );">Exchange of stock for stock</a></td>
<td class="nump">152,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ExpectedPerShare', window );">Expected Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember', window );">Convertible Promissory Note Warrants | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember', window );">Convertible Promissory Note Warrants | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember', window );">Convertible Promissory Note Warrants | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible promissory note warrants common stock converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible promissory note warrants convertible.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument periodic payment principal additional</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ExchangeOfStockForStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exchange of stock for stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ExchangeOfStockForStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ExpectedPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected per share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ExpectedPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PercentageOfWarrantCoverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of warrant coverage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PercentageOfWarrantCoverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public combination multiplied cash price paid per share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_PrivateCalcimedicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_PrivateCalcimedicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ck0001534133_ConvertiblePromissoryNoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccruedPayrollAndOtherEmployeeBenefits', window );">Accrued payroll and other employee benefits</a></td>
<td class="nump">$ 531<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccruedSeveranceExpense', window );">Accrued severance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_AccruedOther', window );">Accrued other</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 866<span></span>
</td>
<td class="nump">$ 1,468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccruedOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccruedOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccruedPayrollAndOtherEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll and Other Employee Benefits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccruedPayrollAndOtherEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_AccruedSeveranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued severance expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_AccruedSeveranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 20, 2024</div></th>
<th class="th"><div>Nov. 01, 2024</div></th>
<th class="th"><div>Feb. 05, 2024</div></th>
<th class="th"><div>Jan. 19, 2024</div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 17, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShelfRegistrationStatementAvaliableForSale', window );">Available for sale under Shelf Registration Statement</a></td>
<td class="nump">$ 89,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000<span></span>
</td>
<td class="nump">$ 246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">13,481,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,481,917<span></span>
</td>
<td class="nump">5,754,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,490,000)<span></span>
</td>
<td class="num">$ (1,146,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 3 days<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,726,000<span></span>
</td>
<td class="nump">$ 22,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of stock description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of 75,746 Common Warrants.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_GrossProceedsFromThePrivatePlacement', window );">Gross proceeds from the private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember', window );">2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 3.827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,839<span></span>
</td>
<td class="nump">67,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_GrossProceedsFromThePrivatePlacement', window );">Gross proceeds from the private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,985,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Commissions paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_UnderwritersOptionPeriod', window );">Underwriters option period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ShelfRegistrationStatementMember', window );">Shelf Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance and sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_AtTheMarketOfferingMember', window );">ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Commissions paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_SaleOfStockRemainingSalesAmount', window );">Remaining amount of available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Issuance and sale of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ProceedsFromFollowOnOffering', window );">Proceeds from follow on offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember', window );">Amended and Restated Certificate of Incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants', window );">Stock and warrants issued during period shares common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.96%<span></span>
</td>
<td class="nump">4.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=ck0001534133_OfficersAndDirectorsMember', window );">Officers and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants', window );">Stock and warrants issued during period shares common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=ck0001534133_DirectorsEmployeesOrConsultantsMember', window );">Directors, Employees Or Consultants | 2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 4.3915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.3915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Officers and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Officers and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="nump">101,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,950<span></span>
</td>
<td class="nump">92,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Fair value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_MaximumNumberOfAdditionalSharesIssued', window );">Maximum number of additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_CommonWarrantsMember', window );">Common Warrants | 2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 3.827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 795,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PreFundedWarrantsMember', window );">Pre Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PreFundedWarrantsMember', window );">Pre Funded Warrants | 2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 3.8269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceDecrease', window );">Decrease in warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PlacementAgentWarrantsMember', window );">Placement Agent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheACommonWarrantsMember', window );">Tranche A Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expiration date</a></td>
<td class="text">Jul. 27,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 27,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheACommonWarrantsMember', window );">Tranche A Common Warrants | 2024 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,646,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheBCommonWarrantsMember', window );">Tranche B Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 7.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Warrant liability fair value</a></td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheAAndTrancheBCommonWarrantsMember', window );">Tranche A and Tranche B Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,646,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PreMergerCalcimedicaMember', window );">Pre Merger CalciMedica | 2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,706,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PreMergerCalcimedicaMember', window );">Pre Merger CalciMedica | Calcimedica Preferred Stock | 2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,820,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember', window );">Post Merger CalciMedica | 2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember', window );">Post Merger CalciMedica | Calcimedica Preferred Stock | 2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,820,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember', window );">Post Merger CalciMedica | Calcimedica Common Stock | 2023 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of Stock, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,442,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=ck0001534133_PostMergerTransactionsMember', window );">Post Merger Transaction | Chief Financial Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=ck0001534133_PostMergerTransactionsMember', window );">Post Merger Transaction | Officers and Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants converted to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_GrossProceedsFromThePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from the private placement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_GrossProceedsFromThePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_MaximumNumberOfAdditionalSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of additional shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_MaximumNumberOfAdditionalSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from issuance of private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ProceedsFromFollowOnOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Follow On Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ProceedsFromFollowOnOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_SaleOfStockRemainingSalesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of stock remaining sales amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_SaleOfStockRemainingSalesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShelfRegistrationStatementAvaliableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shelf registration statement avaliable for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShelfRegistrationStatementAvaliableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock and warrants issued during period shares common stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_UnderwritersOptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriters option period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_UnderwritersOptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the entity's equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ShelfRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ShelfRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ck0001534133_OfficersAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ck0001534133_OfficersAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ck0001534133_DirectorsEmployeesOrConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ck0001534133_DirectorsEmployeesOrConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheACommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheACommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheBCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheBCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheAAndTrancheBCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheAAndTrancheBCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PreMergerCalcimedicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001534133_PreMergerCalcimedicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=ck0001534133_PostMergerTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=ck0001534133_PostMergerTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,107,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,481,917<span></span>
</td>
<td class="nump">5,754,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock issued on exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acceleration of stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,326,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Aggregate grant date fair value of RSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">840,000<span></span>
</td>
<td class="nump">$ 2,449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,473,000<span></span>
</td>
<td class="nump">9,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acceleration of stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,500,000<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember', window );">Graybug | General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant', window );">Number of shares unavailable for grant (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember', window );">2023 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">807,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan', window );">Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved', window );">Increase in number of shares reserved for issuance</a></td>
<td class="nump">287,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">820,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember', window );">2023 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial', window );">Common stock shares reserved for future issuance, initial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 2.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Total fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock issued on exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan', window );">Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved', window );">Increase in number of shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Stock Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards weighted-average term of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,326,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate initial number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement By share based payment award number Of additional shares reserved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares unvailable for grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ck0001534133_GraybugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding</a></td>
<td class="nump">1,739,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">1,326,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options, exercised</a></td>
<td class="num">(12,852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, cancelled</a></td>
<td class="num">(228,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding</a></td>
<td class="nump">2,824,443<span></span>
</td>
<td class="nump">1,739,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of options, vested and exercisable</a></td>
<td class="nump">1,350,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">$ 15.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="nump">4.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="nump">1.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, cancelled</a></td>
<td class="nump">75.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding</a></td>
<td class="nump">5.51<span></span>
</td>
<td class="nump">$ 15.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, options vested and exercisable</a></td>
<td class="nump">$ 6.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term, outstanding</a></td>
<td class="text">8 years 1 month 24 days<span></span>
</td>
<td class="text">6 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average remaining contractual term, granted</a></td>
<td class="nump">$ 9.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term, options vested and exercisable</a></td>
<td class="text">7 years 1 month 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="nump">$ 316<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue', window );">Aggregate intrinsic value, granted</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Agrgregate intrinsic value, vested and exercisable</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options, granted, intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 3 days<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.56%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Restricted Stock Units (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, granted</a></td>
<td class="nump">$ 9.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock units, outstanding beginning balance | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock units, granted | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of restricted stock units, outstanding ending balance | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, outstanding beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, granted</a></td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price, outstanding ending balance</a></td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,313,000<span></span>
</td>
<td class="nump">$ 12,039,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">840,000<span></span>
</td>
<td class="nump">2,449,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">$ 1,473,000<span></span>
</td>
<td class="nump">$ 9,590,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Common stock warrants</a></td>
<td class="nump">3,352,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options issued and outstanding</a></td>
<td class="nump">2,824,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,739,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="nump">7,107,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember', window );">2023 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="nump">807,414<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember', window );">2023 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for future issuance</a></td>
<td class="nump">122,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Contract</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_RentExpenses', window );">Rent expenses</a></td>
<td class="nump">$ 121,000<span></span>
</td>
<td class="nump">$ 274,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_LeaseAmendmentDate', window );">Lease Amendment Date</a></td>
<td class="text">2024-12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_LeaseExecutedTermPeriod', window );">Lease Executed Term</a></td>
<td class="text">executed for a twelve month term as of January 1, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_NumberOfContractCurrentlyInEffect', window );">Number of contract currently in effect | Contract</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ContractualObligationOfContractInEffect', window );">Contractual obligation of contract in effect</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_UnpaidCancellationAndOtherRelatedCosts', window );">Unpaid cancellation and other related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_BaseRent', window );">Base rent</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ck0001534133_AuxoraMember', window );">Auxora</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_ContractualObligationOfContractInEffect', window );">Contractual obligation of contract in effect</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_BaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Base rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_BaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_ContractualObligationOfContractInEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual obligation of contract in effect.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_ContractualObligationOfContractInEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_LeaseAmendmentDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease amendment date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_LeaseAmendmentDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_LeaseExecutedTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease executed term period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_LeaseExecutedTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_NumberOfContractCurrentlyInEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of contract currently in effect.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_NumberOfContractCurrentlyInEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_RentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_RentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_UnpaidCancellationAndOtherRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unpaid cancellation and other related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_UnpaidCancellationAndOtherRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ck0001534133_AuxoraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ck0001534133_AuxoraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employees Contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax computed at federal statutory rate</a></td>
<td class="num">$ (2,877)<span></span>
</td>
<td class="num">$ (7,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax, net of federal tax benefit</a></td>
<td class="nump">611<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxReconciliationPermanentDifferences', window );">Permanent differences</a></td>
<td class="num">(166)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxRateReconciliationWarrantLiability', window );">Warrant liability</a></td>
<td class="num">(1,993)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions', window );">Research and development tax credits, net of uncertain positions</a></td>
<td class="num">(1,050)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">5,475<span></span>
</td>
<td class="nump">8,534<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IncomeTaxRateReconciliationWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax rate reconciliation warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IncomeTaxRateReconciliationWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCredit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IncomeTaxReconciliationPermanentDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation permanent differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IncomeTaxReconciliationPermanentDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 62,407<span></span>
</td>
<td class="nump">$ 58,535<span></span>
</td>
<td class="nump">$ 194,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">10,356<span></span>
</td>
<td class="nump">9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry forwards</a></td>
<td class="nump">13,506<span></span>
</td>
<td class="nump">12,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">2,026<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_DeferredTaxAssetsAccruedCompensation', window );">Accrued compensation</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">88,475<span></span>
</td>
<td class="nump">82,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_NetDeferredTaxAsset', window );">Total net deferred tax assets</a></td>
<td class="nump">88,460<span></span>
</td>
<td class="nump">82,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(88,460)<span></span>
</td>
<td class="num">(82,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_DeferredTaxAssetsAccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets accrued compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_DeferredTaxAssetsAccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_NetDeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_NetDeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 296,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 62,407,000<span></span>
</td>
<td class="nump">$ 58,535,000<span></span>
</td>
<td class="nump">$ 194,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards limitations on use</a></td>
<td class="text">In addition, under the Tax Act the amount of net operating losses generated in taxable periods beginning after December 31, 2017, that the Company is permitted to deduct in any taxable year is limited to 80% of taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_PercentageOfChangeInOwnership', window );">Percentage of change in ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrual for interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_UnrecognizedTaxBenefitsNet', window );">Unrecognized tax benefits net</a></td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear', window );">Operating loss carryforwards expiration beginning year</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credit carry forwards</a></td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear', window );">Operating loss carryforwards expiration beginning year</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credit carry forwards</a></td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=ck0001534133_FederalResearchAndDevelopmentMember', window );">Federal research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear', window );">Operating loss carryforwards expiration beginning year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carry forwards expiration beginning year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_PercentageOfChangeInOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of change in ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_PercentageOfChangeInOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_UnrecognizedTaxBenefitsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_UnrecognizedTaxBenefitsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=ck0001534133_FederalResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=ck0001534133_FederalResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits gross</a></td>
<td class="nump">$ 11,080<span></span>
</td>
<td class="nump">$ 7,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">2,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Additions in connection with the reverse merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reduction for tax positions of prior years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits gross</a></td>
<td class="nump">$ 11,482<span></span>
</td>
<td class="nump">$ 11,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (13,700)<span></span>
</td>
<td class="num">$ (34,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAverageCommonSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic</a></td>
<td class="nump">10,886,920<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAverageCommonSharesOutstandingDiluted', window );">Weighted-average common shares outstanding, diluted</a></td>
<td class="nump">10,886,920<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic', window );">Weighted-average pre-funded warrants outstanding, basic</a></td>
<td class="nump">288,082<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted', window );">Weighted-average pre-funded warrants outstanding, diluted</a></td>
<td class="nump">288,082<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic', window );">Weighted-average placement agent warrants outstanding, basic</a></td>
<td class="nump">70,913<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted', window );">Weighted-average placement agent warrants outstanding, diluted</a></td>
<td class="nump">70,913<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare', window );">Weighted-average number of shares used to calculate basic net loss per share</a></td>
<td class="nump">11,245,915<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare', window );">Weighted-average number of shares used to calculate diluted net loss per share</a></td>
<td class="nump">11,245,915<span></span>
</td>
<td class="nump">4,486,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (7.66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="num">$ (7.66)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAverageCommonSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of basic common shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAverageCommonSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAverageCommonSharesOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average number of diluted common shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAverageCommonSharesOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average number of shares used to calculate diluted net income (loss) per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average placement agent warrants outstanding basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average placement agent warrants outstanding diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average pre-funded warrants outstanding basic.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average pre-funded warrants outstanding diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001534133_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">5,794,811<span></span>
</td>
<td class="nump">2,016,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">2,824,443<span></span>
</td>
<td class="nump">1,739,747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">2,970,368<span></span>
</td>
<td class="nump">276,437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - Subsequent Event<br></strong></div></th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 32,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">12.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Sep.  01,  2028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Loan Agreement | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Tranche 1 | Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued to purchase shars of common stock | shares</a></td>
<td class="nump">641,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share | $ / shares</a></td>
<td class="nump">$ 2.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expiration date</a></td>
<td class="text">Feb. 28,  2030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Tranche 1 | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Tranche 2 | Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 7,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms', window );">Repayment term</a></td>
<td class="text">The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#8217;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Tranche 2 | Loan Agreement | Avenue Venture Opportunities Fund II, L.P.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ck0001534133_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ck0001534133_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ck0001534133_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ck0001534133_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ck0001534133_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ck0001534133_AvenueVentureOpportunitiesFundIILPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ck0001534133_AvenueVentureOpportunitiesFundIILPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>119
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  N >UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  N >UHL&:-&\0   "L"   1
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MA;C?"BXYEZ)ZGUQ_^%V%73!V9_^9<?W-^"+8-O#K+MI/4$L#!!0    (  N
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MXO*Y;F)=R=9Z8(]!2:0-]M0":&: MMA$L0'9F=1 R+,MY-D)??QPT\XL!<R
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MW;# /Q8H&X#?%U*:[<0F:/^!Z5]02P,$%     @ "X![6IY[C>*/"@  ZF$
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M9%7SK_/<'NN.G-6^$L6V+2QKL$WSP]_D<WLB3@H0>J& UQ;PS@IXLPL%:%N
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MLMC[_+3"YPRT2\#]4BG[$K@&.#Z0Z1]02P,$%     @ "X![6F<W"]H+"
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MWF2A7Z?H.E\W4;RVW6;/E>Y==ECJGP4($Z"?YYRKX\1L,/Q^DC=02P,$%
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M=Q=/&">KEO(0;2=J!]7>4,L(\A$Q3RB#.G] _+E2!T 3/_*J+6@?&O #O3S
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MV6!4Q8YG"ME.QJZ&Y@S9.MT4R>"^GDJA^/A]T_&[;ELHB"0L)-G-N7?CPTW
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M->G_3XI>%S@;BN_(%-<!I1TRKQ?X15OQFXM*3,2Q^$W&RBOAEJ()XT#<>?T
M$>)6FDQ_5KG.I"A(08YBCFLAQ6;MC-D>NXW%MU M@LXU((#$_.KE=E&M!#KT
ML_39&EGF3,/(W]>J,70C QHX<Y4E4X%%@CX %1Z4#PI_,UGJ*(W^+Z=35*@]
M+[X.[X?BU^OKN^%>&TEH!F\UUD)JA+I:A[8K//Y1:0\II&V).K&9E@:J2N=Y
M05GYT@45R%!-\8K*%W4]"7P@L,C)+Q*\1&0#GF0<"%T4, #6F"V$&^ BB8NM
MM^>BKX](+8*XUW"@0O8-(87=0:2@2@YKE+ =1A;R/\[KR $FN0^.+?8$4:'Y
MF''Y8R\>2FFW'_;J0AGHE>4*D4]R^TM@*0D*R( ]:D1JJY-^52S8MO1YX:3/
MZ25'0+/H_"LV4$D>=OUM@$:KD9%"6@P-C(<HULK .&/$-[452(E.-8RR?;GV
M@-Y4;/&I!2B!/U)PG4I>;/<G31?:2"^B2Z$*H4))<1 5*BUN60O]9#&+90@J
MI:H6.T 3:;2'1/>57F.":I1/)L.:0\8/).=!&OB)K@QKU.DQU20B\:!")/\#
M+W;0XH5U]AC#W<M4[JQP*#[%IB\R4^7<%A+FV"VD')?>982<!'+<K"0M1TR,
M*SF\M=F\QRLB!50W;;J;;G85,K90V$HS#8$)\$[9E WNQ10D\FKPPC?6>L ]
MMXA):5Q[5ZW6';5#\951X6 .GYI_D, @.4/:C)8+;5!8JIL3L0%PD!SG*5+P
M&=LTT$+B/QA;J39K)4+WB*Q1-1%'23^+'/]J7SL.V19D4U-A,%7L7BK3VU2S
M;Q-Z.:-S%ON$4<"!J%(\P'&( +THN<G@Y'0RF,]FT(N(A\:*NO5V$:9UN DA
MK21+GR?V>N45*]X%.=2K:PM?+9>*J9B(8'>[ @9"240+Y)&@+*>Z9/-HU;Z>
MJA.8S!5]N8118J4?:&/2TVB5%9@4TIQ1S"C_==,2;-01.* #$WVI/!5ETJ(M
M1+Z^!65<0#RO'SQ3KQZ5SW1@ES+EJ5H/#"</-(J<&$R:;(UI\@-J"?VHGGW.
M&><YG(HSY:U/5OW\T]ET.O[PBOK6W,!K)Q^.!C5^=H.XWQA:$?7"$%XYM'AP
MF/@61"*D&'[7!6H\5F: Z<AH72I$#MK-=P:TBZ&G+VD&+Q/B$"SI /X<.OSE
M%/SEMF/679O9^Y2IVZ2]?B,A]YT^>"M^23C=_P@UF8Y'"$:-E223-=7EQI.6
M4@=P4%3KX^%X>G;626 #(;NUDM "2W"H2);O-"Y&2\N74+M(\0H=MZ) X'TV
M>#]_-SB9C[^CID6<9TV^+R%41CMS$051E%$LD5+8N=)$FCN4B^3>JZSR"2NO
M,QZYD_>SV8 G*%)%4-DMO]WE3W6FZ=0'X&7$LB25]<S[\J@_;2G',V5-S?C*
MX L57F56#(\T\Q0;B2$'K_*<><*@#1'@'BB;MN\+!9US4T%0U5G1OU<J%=89
M"HM_.+YASD< C7,KQ^4H%=(+7*./E6W:"S.Y9.^ZW?ZG&N2[@IM._B')??5(
MX[_AI2T8I?KDL=="&B!T*Y[T00E5:XN\?PI=CL &,DGCH$SDC;QHM ZH(<HT
M-,QV<  1]U4Z,GV0:]/LI)N(AKYUQEB:5_L,)[,:13OM@W.X:2PD2MZ=^/AR
M.A5_X<W3,SS4VNHY_MP]8B)B65%4<VTJ9@PR: Q_G,I CUH2>XC([#^1U4B4
MBS=B^GXX!_$RIG;]AVG6@#DJF=%!ALP%8BA[PV:">Z)FF*BEU'F'BJ*%?8<^
M$K;MA \F#R>MQ;2O:=92;N6"6IT_9IFO\%$]4ONI X)FC:!7;-663<I?.KA/
MYGSXKI'90+@.'5Z83@YYE34MWH /J M%XAA0UU"9&O)I=G-U4+GNT+R6W''F
M=J;L+E'A].W,K_J<T<_K^;5#)Y/CK='.JF,F:.@S- 7[_49,QL.3-@_->06V
M*J/\3B?M-(F0:.4\Y>B-.!F>MB+XC 8/&.0;3>G$T676=5#VQX%-JP\R#710
M\+Q:T^4AAB_X0VBM;?YN<8(1:1I]1&O0@;6Y99H-Q=^;ZXC):?K$\P@&V'H,
M-8RJ6R%,!6!4F6Y4,*WW<>/ZB-M@$4Z&:/YT:E:QYCEU^&@83DX_A)T\/DVL
MI39,=L1U/5;3?0Y'!E.("@.)KMG!)XM@EJY.4\W"67^#(RE7H<0Y9Y\-NTP%
M0%2?8=X0N1F/)Z*D@P/A\8".0I!+JGC\S\7Y9+CO*FS4N;GD*R.ZGR55.(>E
M2\SV:WL%?)UN/I^6I_MCI&N%HY(P:HFMX^'I22_1L.8ENI+O01<N8G+QXUI)
M1)06X/>EPRRO7TA!>S%^]3]02P,$%     @ "X![6O<(.=!I"@  0"(  !D
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M;6'#[Q7"PILE_T9@:KPW*5\N%.912QOP?&8P1A8+8E#]:.3VWU!+ P04
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M%6:CT=*D../M-CHR0$SHFCIG-P*"I2PET+ZV*F27&RV,#;CH'SYND"?8:IL
M!P+ZTDA@S0. S*SIN+P48/3TQ5HE4/%1P&CYL4CWT4-R?38+J38KN-'EGN5,
MABWG.7LJGT&T9GP#HFUL8IAXR\74FXV&HO\+V 7;@,L#;R!Q$RDJW#.8.[0X
M7U>4GW9< ^,0(CIXP_/WYODO]GD#.!Q:.]P!WV,PO&DP&SB7DI+X)'0D"XX)
MA9<,58%63!*!2#_!85#0L\LZ[OS2Q]_@JI.XK')\''JSR<P+IHLA;I^"Q_4
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MJ_8@*I0))D0&NXPDST';4MC@6Y81\%Z4$3 1L:(GXT_$^ NT]3[B1D3C9$[
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M8[0SES,I(#]OP/-)EN75#3.H/RY=_A]02P,$%     @ "X![6GF"^%MK!0
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M&Y.D4R\ME]P"Z;)A?]])\=8AGR-Q(XV&A-5R+-[8^V;@1A <JY"P5*5RWL
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MN$+]*T<+\'QA;:B_T '-B^.;_P)02P,$%     @ "X![6@X6_$*N P  F@@
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M8$#@2-3=<W?/O9 \7EEWXY?,@>X*4_J3P3*$ZM5X[+,E%\J/;,4EOLRM*U3
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M2\[8Y%/9'C4622A<UYW^R'?!=*+F;EF;-*1QPF_0U6%:;'2Q)M<.=1K;FST
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MSY\^X@<1W ?@*/HC/,NFZYJ*?L2F9MWB /@>=:+[@!OX/\OT\O\ 4$L#!!0
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M&@%:GPNAMR_&0'V5'OT'4$L#!!0    (  N >UIFXJXT!@4  ,T,   9
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M84$?1RB- >UO!&G93TR X7-K\0-02P,$%     @ "X![6J/J]%$@!@  12@
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M)%_<41)2K@]0^S=,=7OEBDY0S1Q<_ M02P,$%     @ "X![6JU0=?J9!@
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ML#(<6)P5^EYX0-,B%L3>(+)SC5NN<2?7;4ILXD%=V3LH'X%;KVLGV'NOZYG
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M=6%Y/1C7+Y(MS:CXR*0:/,UC#B0%K@74_H(Q^?JB#VC_/3'Y'U!+ P04
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MHO:%S$5QJ0H:P\3!FT"!W((S??',[WNOVZ+0$=E>3*(Z)M$I=HPQDL:,VAL
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MR@;@^Z649KNP!/5]&_X#4$L#!!0    (  N >UH1BD% " (  "L$   9
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;(5446^;,!#^*Y8W39VTQ026=LL
M*2FJVH=*4:-V#],>'#B"58.9SX3NW\\V!$53VKT$GWW?=]]W/B?NE7[&"L"0
MEUHVF-#*F';)&.85U!QGJH7&GI1*U]S84.\9MAIXX4&U9&$07+*:BX:FL=_;
MZ#16G9&B@8TFV-4UUW_6(%6?T#D];CR(?67<!DOCEN]A"^:QW6@;L8FE$#4T
M*%1#-)0)7<V7Z\CE^X0G 3V>K(ESLE/JV05W14(#)P@DY,8Q</LYP#5(Z8BL
MC-\C)YU*.N#I^LA^X[U;+SN.<*WD#U&8*J%?*2F@Y)TT#ZJ_A='/PO'E2J+_
M)?V0N_A&2=ZA4?4(M@IJT0Q?_C+VX000AJ\ PA$0>MU#(:\RXX:GL58]T2[;
MLKF%M^K15IQHW*5LC;:GPN),>L.%)D]<=D#N@6.GP7;<(/E,5D4A7..X)'?-
M</NNC1<9&"XD?HR9L?4="\O'6NNA5OA*K0SR&8GFGT@8A!%YW&;DXOT_-,S*
MGSR$DX?0\T;_]Y )S*5R-I#\7.W0:'OMO\Y)'2B_G*=T3V&)+<\AH7;6$?0!
M:/KAW?PR^/Z&X&@2'+W%/@@^>,%2\)V0MM& YU0./%>>Q[VO0QK$['!:FIW<
MO7M&]USO18-$0FDQP>QJ08D>1G,(C&K]..R4L</EEY5]S:!=@CTOE3+'P$W8
M]/^0_@502P,$%     @ "X![6KIB6*%$!0  @AX  !D   !X;"]W;W)K<VAE
M971S+W-H965T-# N>&ULQ5E=3^,X%/TK5G:T.R,Q)';:I&5+)2@+.](B(0JS
M#ZM],*W;1B1QQW;;87_]VFF(DS@-:1O$"\W']?4Y)[;OP1YL*'OF"T($^!F%
M,3^W%D(LSVR;3Q8DPOR4+DDLW\PHB["0MVQN\R4C>)HTBD(;.8YG1SB(K>$@
M>7;'A@.Z$F$0DSL&^"J*,'NY)"'=G%O0>GUP'\P70CVPAX,EGI,Q$8_+.R;O
M["S+-(A(S ,: T9FY]8%/!NY2#5((KX'9,-SUT!1>:+T6=U\FYY;CD)$0C(1
M*@66/VLR(F&H,DD</]*D5M:G:IB_?LU^G9"79)XP)R,:_AU,Q>+<ZEE@2F9X
M%8I[NOF3I(2Z*M^$ACSY"S9IK&.!R8H+&J6-)8(HB+>_^&<J1*X![.QH@-(&
MJ&D#-VW@)D2WR!):5UC@X8#1#6 J6F93%XDV26O))HC59QP+)M\&LIT87N.
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M$%RM[N^W^^/^=T&Z//SYW6IQDQ7K_QV$V6U^G6^"_P@^W-SDNUTW701Z^9Q
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MJ@+R^_NBJ%_>J "[_P?A\C]02P,$%     @ "X![6KJ!]1N7!   (!4  !D
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M0NAOLFO'.A9):R%9V8(Q@S*OFE_ZM17B . &)P!>"_#.!?@MP#\7$+2 X%Q
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M/YC& Q*"L3U,>W"3:V/AV)GMM/#?[VRGH; 6[6$OL<^^[_-]E[O+-DH_F K
MDL=:2#..*FN;"TI-44'-S(EJ0.+-4NF:633UBII& RL]J!8TB>,S6C,NHSSS
M9S<ZSU1K!9=PHXEIZYKIIRD(M1E'@VA[<,M7E74'-,\:MH([L/?-C4:+]BPE
MKT$:KB31L!Q'D\'%;.C\O<-W#ANSLR=.R4*I!V=<E>,H=@&!@,(Z!H;+&F8@
MA"/",'YWG%'_I /N[K?L7[QVU+)@!F9*_."EK<;1>41*6+)6V%NU^0J=GE/'
M5RAA_)=L@N\(G8O66%5W8(R@YC*L[+'+PPY@<'8 D'2 Y#5@> "0=H#4"PV1
M>5ES9EF>:;4AVGDCF]OXW'@TJN'2_<4[J_&6(\[FEW4CU!, F8*$);>&?"*3
MLN0NQTR0*QD*Q67\> Z6<6$^H,O]W9P<'WT@1X1+\JU2K6&R-!FU&)(CID7W
M_#0\GQQX?I"0:R5M9<BE+*%\24!12R\HV0J:)F\RSJ$X(>G@(TGB9+@GH-F_
MP],WPDG[_*:>+SW =PN6:\"RM\\9_CE9&*NQ@'_M2UC@&^[G<TU]81I6P#C"
MKC6@UQ#E[]\-SN+/^\3^)[(7TH>]].%;['UI&3+#7ZSYHG5EM+=( M'($[FY
ML\[CC*YWA?SM,3J/XV>O$"'=:80:],K/!T,*U4H;2J@_#2-HBB/(M^JK<QQ-
M$]^1])DFS+5KIE=<&B)@B93QR>@T(CK,BF!8U?AV6RB+S>NW%8Y7T,X![Y=*
MV:WA'N@'=OX'4$L#!!0    (  N >UH^#AV'AP,   L*   9    >&PO=V]R
M:W-H965T<R]S:&5E=#4R+GAM;*U66X_:.!3^*U:V6K529W(!$IB%2#-#J_:A
MT@AZ>5CM@TE.B-7$SMH.,/]^CY.08<!D^] 7B)USOGS?L<]EOA?RI\H!-#F4
M!5<+)]>ZNG-=E>104G4K*N#X)A.RI!J7<NNJ2@)-&Z>R< //"]V2,N[$\V;O
M2<9S4>N"<7B21-5E2>7S Q1BOW!\Y[BQ8MM<FPTWGE=T"VO0WZHGB2NW1TE9
M"5PQP8F$;.'<^W>/OF<<&HOO#/;JY)D8*1LA?IK%YW3A>(81%)!H T'Q;P>/
M4!0&"7G\VX$Z_3>-X^GS$?UC(Q[%;*B"1U'\8*G.%\[4(2EDM"[T2NP_02=H
M8O 24:CFE^P[6\\A2:VT*#MG9% RWO[30Q>($P<_O.(0= [!N</XBL.H<Q@U
M0EMFC:PEU32>2[$GTE@CFGEH8M-XHQK&S3&NM<2W#/UT_)DGH@3RE1Y D1NR
MQFN2U@40D9$5)((GK&"T"3CN?(04)"W(6E-=:R&?R8L[65$-1 OR(<N@.9N+
MEV^7H"DKU#O\T+?UDKQ]\XZ\(8R3K[FH%>6IFKL:-1EF;M+Q?VCY!U?X^P'Y
M(KC.%?G 4TA? [@8C#XBP3$B#\$@XA*26S+RWY/ "\860H^_[CX:H#/J#VC4
MX(W^]X#(DJFD$*J60/Z^WR@M,0?^L86L11S;$4UAN%,536#A8.8KD#MPXC__
M\$/O+YO<WP3V2ORX%S\>0H^-:I1?U1I20C7)N@NH^@LH\6+90M#B1@VN*66[
M^":81M'<W9UJLUA%@3_NK5Z1GO2D)X.D379@)M##>\*Q#F/>'&GC'MD AXQI
M&^<6=G+")O3],\:7-KZ=;=BS#0?9/@$60PY<DY1AYDK@"5CS,+SX\HT?AF?T
M+HTFGIU?U/.+!OG]H%)29(=E:(.U2#_;N$46;K/9Z(R<Q2H,)W9ZTY[>=)#>
M"N\\E4E.L'QA^]AA7ZQ*$TUSUHF$E&G5WX,:8RNQ!')2"<5,5;5&>FI1XYW$
ML55CL8J\*VIFO9K9H)KOM*C;:D\+;/ 4^=H(SBY/>1Q-SOA=&DTGHRNIY7LO
M[<H;9-B50Q-=.. LHZP$.Y#3Q#X/G\7D/)/<D[9:@MPVTX;"@E1SW?:3?K>=
M:![,1&/:\MD^3CKW37]W7V#:,>D+E5O&%2D@0TCO-L)XR7;R:!=:5$WSW@B-
MHT#SF..T!M(8X/M,"'U<F _T\U_\'U!+ P04    "  +@'M:]CSNQ^ #  #9
M$   &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RMF%V/VCH0AO^*E595
M*[6;;P@4D+9$5?>HK5:E/>?:! /6)C:U#6S__1DGV0")UTL1-TN<S+R99SP9
MVSO:<_$@UX0H]%CD3(Z=M5*;H>O*;$T*+&_XAC!XLN2BP J&8N7*C2!X43H5
MN1MX7L\M,&7.9%3>NQ>3$=^JG#)R+Y#<%@46?SZ1G._'CN\\W?A!5VNE;[B3
MT0:OR(RH7YM[ 2.W45G0@C!).4."+,?.K3],_4@[E!;_4K*71]=(H\PY?]"#
MN\78\71$)">9TA(8?G9D2O)<*T$<OVM1IWFG=CR^?E+_7,(#S!Q+,N7Y?W2A
MUF,G<=""+/$V5S_X_@NI@6*ME_%<EG_1OK;U')1MI>)%[0P1%)15O_BQ3L21
M X":'8+:(3C7(:P=PG,=HMJA3+5;H91Y2+'"DY'@>R2T-:CIBS*9I3?@4Z;G
M?:8$/*7@IR9W+.,%03_Q(Y'H YI!72VV.4%\B::\V'!&F))ZE)(E$8(LM"FZ
ME9+ ;<P6Z"O%<YI31<'_;4H4IKE\!TJ_9BEZ^_H=>HTH0S_7?"O!6HY<!4'K
M5[M9'>"G*L#@F0!3DMV@T'^/ B^(#.[3\]U#@WMJ=_\'LQODE>Y^<NKN0J:;
M= =-NH-2+WPVG#J+"K*(RRP.33FI5"*SBNX%0[G!&1D[\+%+(G;$F;QYY?>\
MCZ8,75,LO9+82?;")GNA37WR'?H@=#R!%64KE',I48:%^ /M;X^%N;HJQ7ZI
MJ)O@;M(+(J\_<G?'*>I:Q4D<QJ=6:=?*'T1]SVO,3JBBABJR4MTQA=F*SN&K
MJRK"A%%)Q,>O]L*XU\+H6@V27IO"&LV%,Q@WK+&553>/#.J?JFKFD&WJXBYS
M&'MM9H,53'#8@K:&=2%TKX'N6:%GBF</"/HL+-82Z^7.1-OK<$#+:L-VC?SC
M^JM8K=%<R-IO6/M6UMLL$UOH;R_1]KL@28MCVK49M*?5&LR%J$F#FMAKF2N<
MZSU&NZ.;>),.2Y)$_=:G.358!?&@502I-:P+H0<-].#\!2P_K/TFYL$U%[%K
MBJ57$CO)H.\=MER>M7 ^TT=(X/.U4KL?E\$'OUTJ)J/ ;U6*/9!+08_VEO[?
M?B$OE$PM^ *ZP:B+;@WM4O3#/L^W;H1J= 8;EC,;1*W7ZA"]=D\TF05QNY&D
M]N@NI3_LTWS[1NTKD7*(=CC?XNITE\/Y$K.,&,G#[G0:T4UV)G9K;)>R'W9S
MOGT[][TUY\\4>M392W9X7S1)[:'\+:I[=(S4A_YO6*PHDR@G2Y#W;OJ0>E&=
MHZN!XIOR9#GG"LZIY>6:X 41V@">+SE73P-]6&W^FS'Y'U!+ P04    "  +
M@'M:4 W1<TH%  "1'   &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6RU
M65MOZS8,_BM"=L$Y0!=?<N_2 &V]@W78V8IVW1Z&/2@V$PO'EG(DI6GWZT?9
MB1TWKMIT:A\:7\B/Y&>:(JWI1L@O*@70Y"'/N#KKI%JO3CU/Q2GD5'7%"CC>
M60B94XVG<NFIE02:%$IYYH6^/_1RRGAG-BVN7<O95*QUQCA<2Z+6>4[EXP5D
M8G/6"3J["S=LF6ISP9M-5W0)MZ#O5M<2S[P*)6$Y<,4$)Q(69YWSX#0*"X5"
MXD\&&[5W3$PH<R&^F).KY*SC&X\@@U@;"(H_]W )66:0T(^O6]!.9=,H[A_O
MT#\5P6,P<ZK@4F1_L42G9YUQAR2PH.M,WXC-S[ -:&#P8I&IXC_9E+(#%([7
M2HM\JXP>Y(R7O_1A2\2>PMA_1B'<*H1/%(+^,PJ]K4+OM0K]K4*_8*8,I> A
MHIK.IE)LB#32B&8."C(+;0R?<?/<;[7$NPSU].R*QR('\@=] $5^(.=)PLSS
MH!FYXF56F:?S(0)-6:8^HLC=;40^?/MQZFDT;T"\>&OJHC05/F,J",EGP76J
MR$\\@:0)X*'?E?/ASOF+T(H80=PEO>"$A'[8;W'H\O7JO1;UR*[^"^5=XA?J
MP=@23:]Z%+T"K_?BHR 14W$FU%H"^?M7%"-7&G+U3QOG)6:_'=-4C5.UHC&<
M=; L*)#WT)E]_TTP]']LX\LE6.0(K,%EO^*R;T.??8($)"8QQ\J)-5)B&O,E
M04H5B:F4CYC:&RH3U<9HB3PJD$W9O)^%D^'$-W]3[WZ?+JL/Q]+E"*Q!UZ"B
M:V"EZU93#6\BJ\0=[)'UE"2KY6-)<@36(&E8D32TDO3;&^@9'N32,.S[H\-4
M.A0<C >]P8%@="@83/JC9G8VPAM5X8VLX?UN"8UD+&>Z6 L4P?5@K: M6KN!
M*USEM\O+"5GC$B")3LMZ=Q[KXICF8LV1Y45++N+ZM 1NKD!"&">:/M!Y!@2%
MF$ 7Y[!DG!MINM"(C=4=\CD>E!4^&)V@"5K:N13YBO)'PI11Q] ,IA;8,"1K
M= 71S=V=A4>@TH@6))2"8_\[X^5.@I6E&_74.DX+A1.R20'K]U,1A4:TL<D1
M:<-TBLT8-E!+I-D &^]:WL/2,;,4,XU-TZ+;5KVM]!_[ICD":Z3BN$K%L353
MKD'&P#7VG8;D.*5\69 K-OC\5<I6;<E70@;^?BGJ#IZ\9E:[QU+D"*Q!T:2B
M:&*EZ#R.Y1H7.'Q#D1E,*% :DS;!?,;F33-H+4>3@^+QM Y-7JKGD=6O-T8=
M^'6[ZEOCON,28K'D[%_S(F+IF&--6.!+8=Z:UI[4/RR8P;AM-6^1G 0M@I'=
MQ;=2L->Q!Z_I;5J#M6H>VPTZ18M<H359"VO6PG?HKK>@K@AUB1:Y0FL26D\K
M@;6!M_<+\+!BLIP=ZW79+(NM)-L-X70V;&73Z;3B"JW)9CVO!/:!Y08QJ<3>
MP=3P!.XA$ZL<UT 22\">J:27V%K-X'!N"7J]UD+G=&YQA=8DKIY<@E>,+JU\
MN!P\+IVB1:[0FIS5@TPP?(]::!V/CB;4)5KD"JU):#TZ!?]C=CJN%MH-/5L+
MG?;^KM":;-;=?V!O_QW4PO%!+>RUM7*7=D^.YNT])H*@'@D"^TRP^^@EG^&O
ME2E'[?R63I=HD2NTYK?E>M0(_7>HDJ&CX6#[ =LE6N0*K4EH/;B$]L'%795\
MP1!6R5$KFTX'&E=H)9O>WAY.#G)9[(4A2>:#6+F=4UVM]MO.BUTFKQ8O-^L^
M4XD$*I+! E7][@B[#5GN?Y4G6JR*':&YT%KDQ6$*%(N'$<#["R'T[L08J'8A
M9_\!4$L#!!0    (  N >UJ4@VGH- ,  ,H)   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;*U6;6_3,!#^*U:8$$AL>6V;C;;2NH'8!Z2I8_ !\<%+
MKHTUQPZVVV[\>LY.&OJ25H#VI;4O=X^?Y^P[>[B2ZE$7 (8\E5SHD5<84UWX
MOLX***D^DQ4(_#*3JJ0&IVKNZTH!S5U0R?TH"/I^29GPQD-GNU7CH5P8S@3<
M*J(794G5\P2X7(V\T%L;IFQ>&&OPQ\.*SN$.S'UUJW#FMR@Y*T%H)@51,!MY
ME^'%U;GU=PY?&:STQIA8)0]2/MK)33[R DL(.&3&(E#\6\(5<&Z!D,;/!M-K
ME[2!F^,U^D>G';4\4 U7DG]CN2E&7NJ1'&9TP<U4KCY!HZ=G\3+)M?LEJ\8W
M\$BVT$:633 R*)FH_^E3DX>-@+!_("!J J+=@.1 0-P$Q$YHS<S)NJ:&CH=*
MKHBRWHAF!RXW+AK5,&%W\<XH_,HPSHQO1"9+(%_H$VAR2N[PE.0+#D3.R!0R
M*3+&&74)1\N]4&B;"_8+<AM")B!@QHPF;Z[!4,;U6\2XO[LF;T[>DA/"!/E2
MR(6F(M=#WR!=NZB?-=0F-;7H +4P(I^E,(4F'T0.^3: CSI;L=%:["0ZBG@-
MV1F)PW<D"J*D@]#5WX?'1^C$;>YCAQ<?P#N<SN]3R3G!<[JB*O_1E;H:.>E&
MMJ5_H2N:P<C#VM:@EN"-7[\*^\'[+MDO!+:5A*1-0G(,?3L)!I/PL$["7$G=
M>6QJP($#M%UJ.0[#( V&_G)3U+[7H!?T6Z<MLKV6;.\H6:P6;)4:L']Q:BQA
MB46J% A#GH$J)Z"2FMF*Z>1>X_<V6,5QLL-\WR=*DP/,^RWS_E'FEWE>DR+8
M^;=IVLJN%$.SE=#)NK_'J)_ND-YWB<)NRH.6\N O*6,?P58DFLZ_8J8@IK";
ML 2%FU&"FH/JXGUT@7^MDL&>PC09=$M,6XGI48E3;+:UJ/_9E:/8_ZHNW5-W
M&B9!M[SS5M[Y2]?V>4=M)VFT<]BZO#8[0,W6W[@6W1FQKP6-1VDA3'UIM-;Z
M03+!!XF[N'?L^%"Y=/>S_P>F?N5\IFK.<+,XS! R.!M@ E7]<J@G1E;N\GV0
M!J]R-RSPL07*.N#WF91F/;$+M,^W\6]02P,$%     @ "X![6KREJ3'Z P
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M0@O ^Q7GZFV@/]#^MV'V#U!+ P04    "  +@'M:#$7;HBL#  "V"P  &0
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M@BY=SRK<.T 8E<5$PX/<ZF./87U@\OW#Y/>)8]*#;>FR^[D6,L1SC!99:/4
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MC6?(_CS UG1?AF CQ3,1&RD^UX#8YPT8461?;2P.,+!5P'('XMOC0$[9.4$
MJXIYPZY@'(DB#(%<M.=H&"*S$\+'OC[851($461' +,[" (,@:L11S 'X %#
M@J!\#NX\C[SZ.>5M_J4>_P%02P,$%     @ "X![6I>*NQS     $P(   L
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M96QS+W=O<FMB;V]K+GAM;"YR96QSS=J[3NM %(7A5XG\ $SV+< 1H:*A1;R
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M*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM!'K;9+.$0&]#O8U
M;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]G4!O1[V=0&]'O9U
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M>@502P$"% ,4    "  +@'M:1L=-2)4   #-    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  N >UHL&:-&\0   "L"
M   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   (  N >UJ97)PC$ 8  )PG   3              "  >,!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ "X![6D9Z"ST%"P  P$0  !@
M         ("!) @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   (  N >UJ; 9L']04  (8?   8              " @5\3  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  +@'M:$,XTL9D"  #8"
M&               @(&*&0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ "X![6BBE:9WI P  > T  !@              ("!61P  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (  N >UJWWSG*NP(
M  \'   8              " @7@@  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    "  +@'M:GGN-XH\*  #J80  &               @(%I
M(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ "X![6LF)
MKZID @  + <  !@              ("!+BX  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    (  N >UIG-PO:"P@  )4D   8
M  " @<@P  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  +
M@'M:8V[:*4T"  "D!0  &               @($).0  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ "X![6BQU:+Y# @  B@8  !D
M         ("!C#L  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    "  +@'M::9A[/*4+   "/   &0              @($&/@  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (  N >UI6)AX6LPH  (P;
M   9              " @>))  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ "X![6L&^20,/'P  5U\  !D              ("!S%0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  +@'M:HU'.
MO,,(   D%P  &0              @($2=   >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    (  N >UKW"#G0:0H  $ B   9
M  " @0Q]  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M"X![6O-$!_:B @  V@4  !D              ("!K(<  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    "  +@'M:":(.<Q (   :&@  &0
M            @(&%B@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    (  N >UJ13Q:O"P\  )HW   9              " @<R2  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ "X![6NJ2R8,("0
M:!H  !D              ("!#J(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    "  +@'M:>8+X6VL%  ";#   &0              @(%-
MJP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (  N >UH6
M$V1+C (  )\%   9              " @>^P  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ "X![6KU/"8(^"P  1!X  !D
M     ("!LK,  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  N >UJ$!KYRE@4  "04   9              "
M@2+M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ "X![
M6G(=DPFN @  VP4  !D              ("![_(  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    "  +@'M:%"DES[P%  !6#P  &0
M        @('4]0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   (  N >UIFXJXT!@4  ,T,   9              " @<?[  !X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ "X![6LKT^TWB P  >@D
M !D              ("!! $! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    "  +@'M:H^KT42 &  !%*   &0              @($=!0$
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (  N >UJM4'7Z
MF08   HB   9              " @70+ 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ "X![6AG^8UUT!   JA   !D
M ("!1!(! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  +
M@'M:U&R46U8#  #,#   &0              @('O%@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (  N >UJX<%%9FP4  $(A   9
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M970T,"YX;6Q02P$"% ,4    "  +@'M:V!YL.TP*  "7=P  &0
M    @($6,@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M  N >UKK4] <;@(  *H&   9              " @9D\ 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ "X![6L*%X.Y'*0  #_4" !D
M             ("!/C\! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    "  +@'M:_[([O]<)   380  &0              @(&\: $ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (  N >UJZ@?4;EP0
M " 5   9              " @<IR 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ "X![6KYJUS^A P  ^0\  !D              ("!
MF'<! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  +@'M:
M>]*J91L#  !V"@  &0              @(%P>P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    (  N >UHN'Z+6. ,  *\+   9
M      " @<)^ 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ "X![6M;)U4JQ P  YQ,  !D              ("!,8(! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  +@'M:5,CO5*L#  #D#0
M&0              @($9A@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    (  N >UK)A'?#9P(  +P%   9              " @?N) 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ "X![6CX.'8>'
M P  "PH  !D              ("!F8P! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    "  +@'M:]CSNQ^ #  #9$   &0
M@(%7D $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (  N
M>UI0#=%S2@4  )$<   9              " @6Z4 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ "X![6I2#:>@T P  R@D  !D
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M<R\N<F5L<U!+ 0(4 Q0    (  N >UJ*J2]YL 0  -4F   /
M  "  3RN 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  +@'M:$R?LNN\!
M  "E(@  &@              @ $9LP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    "  +@'M:8B/G&-@!  !((@  $P
M@ % M0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     0@!"  42  !)MP$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>185</ContextCount>
  <ElementCount>383</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100070 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100080 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Cybersecurity Risk Management, Strategy and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Merger and Related Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions</Role>
      <ShortName>Merger and Related Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants</Role>
      <ShortName>Convertible Promissory Notes and Convertible Promissory Note Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit</Role>
      <ShortName>Convertible Preferred Stock, Common Stock and Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Nature of Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails</Role>
      <ShortName>Nature of Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Merger and Related Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails</Role>
      <ShortName>Merger and Related Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails</Role>
      <ShortName>Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails</Role>
      <ShortName>Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Stock-based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails</Role>
      <ShortName>Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Employee Benefits - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails</Role>
      <ShortName>Employee Benefits - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ck0001534133-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ck0001534133-20241231.htm">ck0001534133-20241231.htm</File>
    <File>ck0001534133-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img247211528_0.jpg</File>
    <File>img247211528_1.jpg</File>
    <File>img247211528_10.jpg</File>
    <File>img247211528_11.jpg</File>
    <File>img247211528_12.jpg</File>
    <File>img247211528_13.jpg</File>
    <File>img247211528_14.jpg</File>
    <File>img247211528_15.jpg</File>
    <File>img247211528_16.jpg</File>
    <File>img247211528_17.jpg</File>
    <File>img247211528_18.jpg</File>
    <File>img247211528_19.jpg</File>
    <File>img247211528_2.jpg</File>
    <File>img247211528_20.jpg</File>
    <File>img247211528_21.jpg</File>
    <File>img247211528_22.jpg</File>
    <File>img247211528_23.jpg</File>
    <File>img247211528_24.jpg</File>
    <File>img247211528_25.jpg</File>
    <File>img247211528_26.jpg</File>
    <File>img247211528_27.jpg</File>
    <File>img247211528_28.jpg</File>
    <File>img247211528_29.jpg</File>
    <File>img247211528_3.jpg</File>
    <File>img247211528_30.jpg</File>
    <File>img247211528_31.jpg</File>
    <File>img247211528_32.jpg</File>
    <File>img247211528_33.jpg</File>
    <File>img247211528_34.jpg</File>
    <File>img247211528_35.jpg</File>
    <File>img247211528_36.jpg</File>
    <File>img247211528_37.jpg</File>
    <File>img247211528_38.jpg</File>
    <File>img247211528_39.jpg</File>
    <File>img247211528_4.jpg</File>
    <File>img247211528_5.jpg</File>
    <File>img247211528_6.jpg</File>
    <File>img247211528_7.jpg</File>
    <File>img247211528_8.jpg</File>
    <File>img247211528_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="555">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="12">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="44">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>126
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ck0001534133-20241231.htm": {
   "nsprefix": "ck0001534133",
   "nsuri": "http://www.calcimedica.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "ck0001534133-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "ck0001534133-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 280,
   "keyCustom": 103,
   "axisStandard": 29,
   "axisCustom": 0,
   "memberStandard": 32,
   "memberCustom": 34,
   "hidden": {
    "total": 11,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "contextCount": 185,
   "entityCount": 1,
   "segmentCount": 73,
   "elementCount": 733,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 555,
    "http://xbrl.sec.gov/dei/2024": 44,
    "http://xbrl.sec.gov/cyd/2024": 12,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100030 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:PreferredStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "longName": "100040 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:ChangesInFairValueOfFinancialInstruments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss",
     "longName": "100050 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1",
     "longName": "100060 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_980a3e42-f670-42e5-8f84-d7c4be19f842",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
     "longName": "100070 - Statement - Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "shortName": "Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "100080 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R11": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995455 - Disclosure - Cybersecurity Risk Management, Strategy and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1",
     "longName": "995465 - Disclosure - Nature of Business",
     "shortName": "Nature of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "995475 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions",
     "longName": "995485 - Disclosure - Merger and Related Transactions",
     "shortName": "Merger and Related Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "longName": "995495 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses",
     "longName": "995505 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants",
     "longName": "995515 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants",
     "shortName": "Convertible Promissory Notes and Convertible Promissory Note Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit",
     "longName": "995525 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit",
     "shortName": "Convertible Preferred Stock, Common Stock and Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:TemporaryEquityDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:TemporaryEquityDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1",
     "longName": "995535 - Disclosure - Stock-based Compensation",
     "shortName": "Stock-based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "995545 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits",
     "longName": "995555 - Disclosure - Employee Benefits",
     "shortName": "Employee Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "longName": "995565 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "longName": "995575 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "longName": "995585 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995595 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995605 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "longName": "995615 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables",
     "longName": "995625 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables",
     "longName": "995635 - Disclosure - Stock-based Compensation (Tables)",
     "shortName": "Stock-based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables",
     "longName": "995655 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "longName": "995665 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
     "longName": "995675 - Disclosure - Nature of Business - Additional Information (Details)",
     "shortName": "Nature of Business - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "995685 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:StockholdersEquityNoteStockSplitExchangeRatio",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:StockholdersEquityNoteStockSplitExchangeRatio",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
     "longName": "995695 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails",
     "longName": "995705 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:Depreciation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672",
      "name": "us-gaap:Depreciation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
     "longName": "995715 - Disclosure - Merger and Related Transactions - Additional Information (Details)",
     "shortName": "Merger and Related Transactions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:StockIssuedDuringPeriodPrivatePlacement",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:StockIssuedDuringPeriodPrivatePlacement",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "longName": "995725 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_0e263a22-52cd-4e60-a0a1-c92ee05526be",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
     "longName": "995735 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)",
     "shortName": "Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_eb167185-a0eb-45f5-beb2-ad40dbc114b5",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_eb167185-a0eb-45f5-beb2-ad40dbc114b5",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "longName": "995745 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_0e263a22-52cd-4e60-a0a1-c92ee05526be",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R40": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails",
     "longName": "995755 - Disclosure - Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3",
      "name": "ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3",
      "name": "ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
     "longName": "995765 - Disclosure - Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details)",
     "shortName": "Convertible Promissory Notes and Convertible Promissory Note Warrants - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719",
      "name": "ck0001534133:PublicCombinationMultipliedCashPricePaidPerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719",
      "name": "ck0001534133:PublicCombinationMultipliedCashPricePaidPerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
     "longName": "995775 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "ck0001534133:AccruedPayrollAndOtherEmployeeBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "ck0001534133:AccruedPayrollAndOtherEmployeeBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
     "longName": "995785 - Disclosure - Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details)",
     "shortName": "Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3f53ad55-92a4-4198-b148-88d91cc0fe54",
      "name": "us-gaap:ConversionOfStockDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ck0001534133:TemporaryEquityDisclosureTextblock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
     "longName": "995795 - Disclosure - Stock-based Compensation - Additional Information (Details)",
     "shortName": "Stock-based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f00c8c38-7ab0-4fba-aebe-dc2c92350193",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails",
     "longName": "995805 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details)",
     "shortName": "Stock-based Compensation - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_0e263a22-52cd-4e60-a0a1-c92ee05526be",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
     "longName": "995815 - Disclosure - Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)",
     "shortName": "Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R47": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
     "longName": "995825 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Units (Details)",
     "shortName": "Stock-based Compensation - Summary of Restricted Stock Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3c08a61f-703c-4719-8fb8-4579c9288562",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
     "longName": "995835 - Disclosure - Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details)",
     "shortName": "Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails",
     "longName": "995845 - Disclosure - Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "shortName": "Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "995855 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:RentExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:LeaseAmendmentDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails",
     "longName": "995865 - Disclosure - Employee Benefits - Additional Information (Details)",
     "shortName": "Employee Benefits - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails",
     "longName": "995875 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "995885 - Disclosure - Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "995895 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails",
     "longName": "995905 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_0e263a22-52cd-4e60-a0a1-c92ee05526be",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_980a3e42-f670-42e5-8f84-d7c4be19f842",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
     "longName": "995915 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "ck0001534133:WeightedAverageCommonSharesOutstandingBasic",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
     "longName": "995925 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5c21d041-cc6f-4faa-beac-30a23e6d407a",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "longName": "995935 - Disclosure - Subsequent Events - Additional Information (Details)",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ck0001534133-20241231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities assumed in the Merger",
        "label": "Accounts Payable and Accrued Liabilities Assumed in the Merger",
        "documentation": "Accounts payable and accrued liabilities assumed in the merger."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r63",
      "r67",
      "r953"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Current, Total",
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r733"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion of discount on short-term investment",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ck0001534133_AccruedClinicalTrialCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccruedClinicalTrialCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued clinical trial costs",
        "label": "Accrued Clinical Trial Costs",
        "documentation": "Accrued Clinical Trial Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AccruedOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccruedOther",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued other.",
        "label": "Accrued Other",
        "terseLabel": "Accrued other"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AccruedPayrollAndOtherEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccruedPayrollAndOtherEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and other employee benefits",
        "documentation": "Accrued Payroll and Other Employee Benefits",
        "label": "Accrued Payroll and Other Employee Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ck0001534133_AccruedResearchAndDevelopmentCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccruedResearchAndDevelopmentCostsPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Costs",
        "label": "Accrued Research And Development Costs Policy Text Block",
        "documentation": "Research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AccruedSeveranceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AccruedSeveranceExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued severance expense.",
        "label": "Accrued Severance Expense",
        "terseLabel": "Accrued severance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r80",
      "r147",
      "r539",
      "r566",
      "r567"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Gain",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r13",
      "r21",
      "r442",
      "r445",
      "r484",
      "r562",
      "r563",
      "r883",
      "r884",
      "r885",
      "r890",
      "r891",
      "r892",
      "r893"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r578",
      "r890",
      "r891",
      "r892",
      "r893",
      "r963",
      "r1025"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of shares vested",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r344"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of warrant liability to equity",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r42",
      "r101"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r793",
      "r803",
      "r836"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r785",
      "r796",
      "r806",
      "r839"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r831",
      "r840",
      "r844",
      "r852"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails": {
       "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "verboseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "netLabel": "Stock-based compensation",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r387"
     ]
    },
    "ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AmendedAndRestatedCertificateOfIncorporationMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended and Restated Certificate of Incorporation",
        "label": "Amended And Restated Certificate of Incorporation [Member]",
        "documentation": "Amended and restated certificate of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AmendmentToTwoThousandAndSixEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AmendmentToTwoThousandAndSixEquityIncentivePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment to 2006 Plan",
        "label": "Amendment to Two Thousand and Six Equity Incentive Plan [Member]",
        "documentation": "Amendment to two thousand and six equity incentive plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r123",
      "r142",
      "r169",
      "r206",
      "r211",
      "r223",
      "r226",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r435",
      "r439",
      "r469",
      "r534",
      "r620",
      "r698",
      "r699",
      "r733",
      "r760",
      "r918",
      "r919",
      "r982"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r148",
      "r169",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r435",
      "r439",
      "r469",
      "r733",
      "r918",
      "r919",
      "r982"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total asset measured at fair value, Aggregate Fair Value",
        "totalLabel": "Assets measured at fair value",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r455",
      "r724"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total asset measured at fair value, Unrealized Gains",
        "label": "Assets Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax",
        "documentation": "Assets fair value disclosure accumulated gross unrealized gain before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AssetsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total asset measured at fair value, Unrealized Losses",
        "label": "Assets Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax",
        "documentation": "Assets fair value disclosure accumulated gross unrealized loss before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AssetsFairValueDisclosureAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total asset measured at fair value, Amortized Cost",
        "totalLabel": "Total asset measured at fair value, Amortized Cost",
        "label": "Assets Fair Value Disclosure Amortized Cost Basis",
        "documentation": "Assets fair value disclosure amortized cost basis."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At the market offering.",
        "terseLabel": "ATM",
        "label": "At-the-Market Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ck0001534133_AuxoraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AuxoraMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auxora",
        "label": "Auxora [Member]",
        "documentation": "Auxora."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_AvenueVentureOpportunitiesFundIILPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "AvenueVentureOpportunitiesFundIILPMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Avenue Venture Opportunities Fund II, L.P. [Member]",
        "documentation": "Avenue venture opportunities fund II, L.P.",
        "terseLabel": "Avenue Venture Opportunities Fund II, L.P."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ck0001534133_BaseRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "BaseRent",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base rent",
        "label": "Base Rent",
        "documentation": "Base rent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Principles of Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r430",
      "r716",
      "r717"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r430",
      "r716",
      "r717"
     ]
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merged date",
        "label": "Business Acquisition, Date of Acquisition Agreement",
        "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acceleration of stock awards",
        "label": "Business Combination, Acquisition Related Costs",
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ck0001534133_BusinessCombinationConsiderationTransferedCostIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "BusinessCombinationConsiderationTransferedCostIncurred",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "label": "Business Combination, Consideration Transfered Cost Incurred",
        "documentation": "Business combination, consideration transfered cost incurred."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate purchase price",
        "terseLabel": "Consideration Transferred",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Business Combination, Consideration Transferred, Total",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r12"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger and Related Transactions",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r431"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid and other current assets obtained",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and accruals incurred",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "documentation": "Information by type of transaction recognized separately from acquisition of asset and assumption of liability in business combination."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_CalcimedicaCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CalcimedicaCommonStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Calcimedica Common Stock",
        "label": "Calcimedica Common Stock [Member]",
        "documentation": "Calcimedica Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_CalcimedicaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CalcimedicaIncMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CalciMedica",
        "label": "CalciMedica Inc [Member]",
        "documentation": "CalciMedica, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_CalcimedicaPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CalcimedicaPreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Calcimedica Preferred Stock",
        "label": "Calcimedica Preferred Stock [Member]",
        "documentation": "Calcimedica preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r140",
      "r688"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": "ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total cash equivalents, Aggregate Fair Value",
        "totalLabel": "Cash and Cash Equivalents, Fair Value Disclosure, Total",
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": "ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash equivalents, Unrealized Gains",
        "label": "Cash And Cash Equivalents Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax",
        "documentation": "Cash and cash equivalents fair value disclosure accumulated gross unrealized gain before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CashAndCashEquivalentsFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total cash equivalents, Unrealized Losses",
        "label": "Cash And Cash Equivalents Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax",
        "documentation": "Cash and cash equivalents fair value disclosure accumulated gross unrealized loss before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2": {
       "parentTag": "ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash equivalents, Amortized Cost",
        "label": "Cash And Cash Equivalents Fair Value Disclosure Amortized Cost Basis",
        "documentation": "Cash and cash equivalents fair value disclosure amortized cost basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents and short-term investments",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "totalLabel": "Cash, Cash Equivalents, and Short-Term Investments, Total",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r88",
      "r166"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r88"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "totalLabel": "Cash Equivalents, at Carrying Value, Total",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r880",
      "r992"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ck0001534133_ChangesInFairValueOfFinancialInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ChangesInFairValueOfFinancialInstruments",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Fair Value of Financial Instruments",
        "documentation": "Changes in fair value of financial instruments",
        "terseLabel": "Change in fair value of financial instruments"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefFinancialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefFinancialOfficerMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Financial Officer",
        "label": "Chief Financial Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r144",
      "r145",
      "r146",
      "r169",
      "r194",
      "r195",
      "r198",
      "r200",
      "r208",
      "r209",
      "r249",
      "r276",
      "r279",
      "r280",
      "r281",
      "r285",
      "r286",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r469",
      "r571",
      "r572",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r629",
      "r647",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r876",
      "r887",
      "r894"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of warrants per share",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Exercise price of warrants per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants converted to common stock",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants issued to purchase shars of common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock warrants",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r275",
      "r754",
      "r755",
      "r756",
      "r757"
     ]
    },
    "ck0001534133_CommissionsAndOtherTransactionExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CommissionsAndOtherTransactionExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commissions and other transaction expenses",
        "documentation": "Commissions and other transaction expenses",
        "label": "Commissions And Other Transaction Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 9)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r115",
      "r535",
      "r607"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r266",
      "r267",
      "r672",
      "r907",
      "r912"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total common stock reserved for future issuance",
        "terseLabel": "Common stock shares reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ck0001534133_CommonStockCapitalSharesReservedForFutureIssuanceInitial": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceInitial",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Capital Shares Reserved For Future Issuance, Initial",
        "documentation": "Aggregate initial number of common shares reserved for future issuance.",
        "terseLabel": "Common stock shares reserved for future issuance, initial"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r750",
      "r751",
      "r752",
      "r754",
      "r755",
      "r756",
      "r757",
      "r890",
      "r891",
      "r893",
      "r963",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock par value",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r608"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r74",
      "r608",
      "r626",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 500,000,000 shares authorized at December 31, 2024 and December 31, 2023; 13,481,917 and 5,754,505 issued and outstanding at December 31, 2024 and December 31, 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r537",
      "r733"
     ]
    },
    "ck0001534133_CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CommonWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Warrants",
        "documentation": "Common warrants member.",
        "label": "Common Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ck0001534133_CompanyRecordedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "CompanyRecordedExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Recorded Expense",
        "documentation": "Company recorded expense",
        "terseLabel": "Company recorded expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r153",
      "r155",
      "r160",
      "r528",
      "r547",
      "r548"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk and other Risks and Uncertainties",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r128"
     ]
    },
    "ck0001534133_ConfidentiallyMarketedPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConfidentiallyMarketedPublicOfferingMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Confidentially Marketed Public Offering [Member]",
        "documentation": "Confidentially marketed public offering.",
        "terseLabel": "2024 Follow On"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r173",
      "r435",
      "r436",
      "r439",
      "r440",
      "r486",
      "r677",
      "r917",
      "r920",
      "r921"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r173",
      "r435",
      "r436",
      "r439",
      "r440",
      "r486",
      "r677",
      "r917",
      "r920",
      "r921"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r121",
      "r173",
      "r206",
      "r212",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r698",
      "r699",
      "r918",
      "r919"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r121",
      "r173",
      "r206",
      "r212",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r698",
      "r699",
      "r918",
      "r919"
     ]
    },
    "ck0001534133_ContractualObligationOfContractInEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ContractualObligationOfContractInEffect",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual obligation of contract in effect",
        "label": "Contractual Obligation Of Contract In Effect",
        "documentation": "Contractual obligation of contract in effect."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfC2WarrantsToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfC2WarrantsToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of C-2 warrants to common stock",
        "label": "Conversion of C-2 Warrants to Common Stock",
        "documentation": "Conversion of C-2 warrants to common stock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible promissory note warrants to common stock",
        "label": "Conversion of Convertible Promissory Note Warrants to Common Stock",
        "documentation": "Conversion of convertible promissory note warrants to common stock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfConvertiblePromissoryNotesToCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfConvertiblePromissoryNotesToCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible promissory notes to common stock",
        "label": "Conversion of Convertible Promissory Notes to Common Stock",
        "documentation": "Conversion of convertible promissory notes to common stock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfPromissoryNoteWarrantIntoCommonstock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfPromissoryNoteWarrantIntoCommonstock",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of promissory note warrants into common stock",
        "label": "Conversion of Promissory Note Warrant into Commonstock",
        "documentation": "Conversion of promissory note warrant into commonstock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfPromissoryNoteWarrantsIntoCommonStockShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfPromissoryNoteWarrantsIntoCommonStockShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of promissory note warrants into common stock, shares",
        "label": "Conversion of Promissory Note Warrants into Common Stock share",
        "documentation": "Conversion of promissory note warrants into common stock share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConversionOfSeriesC2WarrantIntoCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConversionOfSeriesC2WarrantIntoCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Series C-2 Warrant into Common Stock",
        "documentation": "Conversion of Series C-2 Warrant into Common Stock.",
        "terseLabel": "Conversion of Series C-2 warrants into common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Series A, B, C-1, C-2 and D convertible preferred stock to common stock",
        "label": "Conversion of Stock, Amount Issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ConversionOfStockDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockDescription",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Description",
        "terseLabel": "Conversion of stock description",
        "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of stock, shares converted",
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r288",
      "r289",
      "r299",
      "r300",
      "r301",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory notes",
        "label": "Convertible Notes Payable [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r112"
     ]
    },
    "ck0001534133_ConvertiblePreferredStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePreferredStockAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock",
        "label": "Convertible preferred stock [Abstract]",
        "documentation": "Convertible preferred stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r317",
      "r754",
      "r755",
      "r756",
      "r757"
     ]
    },
    "ck0001534133_ConvertiblePreferredStockSeriesABC1C2AndDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePreferredStockSeriesABC1C2AndDMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock Series A, B, C-1, C-2 and D [Member]",
        "label": "Convertible Preferred Stock Series A, B, C-1, C-2 and D [Member]",
        "documentation": "Convertible preferred stock series A, B, C-1, C-2 and D."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note [Member]",
        "documentation": "Convertible Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConvertiblePromissoryNoteWarrantsCommonStockConverted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePromissoryNoteWarrantsCommonStockConverted",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note warrants common stock converted",
        "label": "Convertible Promissory Note Warrants Common Stock Converted",
        "documentation": "Convertible promissory note warrants common stock converted."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConvertiblePromissoryNoteWarrantsConvertible": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePromissoryNoteWarrantsConvertible",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note warrants convertible",
        "label": "Convertible Promissory Note Warrants Convertible",
        "documentation": "Convertible promissory note warrants convertible."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConvertiblePromissoryNoteWarrantsLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePromissoryNoteWarrantsLiabilityMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible promissory note warrants liability",
        "label": "Convertible Promissory Note Warrants Liability [Member]",
        "documentation": "Convertible promissory note warrants liability."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ConvertiblePromissoryNoteWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ConvertiblePromissoryNoteWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note Warrants",
        "label": "Convertible Promissory Note Warrants [Member]",
        "documentation": "Convertible Promissory Note Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate Debt Securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r715",
      "r724",
      "r734",
      "r748",
      "r1021"
     ]
    },
    "us-gaap_CostsAndExpensesRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses related party",
        "label": "Costs and Expenses, Related Party",
        "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r291",
      "r316",
      "r485",
      "r495",
      "r532",
      "r689",
      "r691"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "auth_ref": [
      "r136",
      "r177",
      "r182",
      "r189",
      "r250",
      "r251",
      "r257",
      "r417",
      "r418",
      "r425",
      "r427",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r483"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "auth_ref": [
      "r136",
      "r177",
      "r182",
      "r189",
      "r250",
      "r251",
      "r257",
      "r417",
      "r418",
      "r425",
      "r427",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r483"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r863"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r863"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r867"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r865"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r858"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r859"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r859"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r857"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r857"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r857"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r860"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r862"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r862"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r863"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r866"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r864"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r861"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of convertible promissory note converted into common stock",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r30"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Notes and Convertible Promissory Note Warrants",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r168",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r274",
      "r275",
      "r287",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r303",
      "r310",
      "r311",
      "r313",
      "r477"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r62",
      "r63",
      "r112",
      "r114",
      "r173",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r732",
      "r888",
      "r908",
      "r909",
      "r910",
      "r974",
      "r975"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r477",
      "r478",
      "r706",
      "r707",
      "r732"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r306",
      "r974"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r289"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r312",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r732",
      "r888",
      "r974",
      "r975"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r705",
      "r967",
      "r968"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r173",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r732",
      "r888",
      "r908",
      "r909",
      "r910",
      "r974",
      "r975"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Issuance or Sale of Convertible Promissory Notes",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ck0001534133_DebtInstrumentPeriodicPaymentPrincipalAdditional": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "DebtInstrumentPeriodicPaymentPrincipalAdditional",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Addiitional convertible promissory notes and Convertible Promissory Note Warrants",
        "label": "Debt Instrument Periodic Payment Principal Additional",
        "documentation": "Debt instrument periodic payment principal additional"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r44",
      "r45",
      "r59",
      "r99",
      "r100",
      "r173",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r312",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r732",
      "r888",
      "r974",
      "r975"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities Available For Sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245"
     ]
    },
    "ck0001534133_DeemedDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "DeemedDistribution",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed Distribution",
        "label": "Deemed Distribution",
        "terseLabel": "Deemed distribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "ck0001534133_NetDeferredTaxAsset",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross",
        "totalLabel": "Total deferred tax liabilities",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r113",
      "r410"
     ]
    },
    "us-gaap_DeferredPolicyAcquisitionCostsTextBlock1": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredPolicyAcquisitionCostsTextBlock1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Offering Costs",
        "label": "Deferred Policy Acquisition Costs [Text Block]",
        "documentation": "The entire disclosure for deferred policy acquisition costs."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ck0001534133_DeferredTaxAssetsAccruedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "DeferredTaxAssetsAccruedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Accrued Compensation",
        "documentation": "Deferred tax assets accrued compensation.",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "ck0001534133_NetDeferredTaxAsset",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred taxes",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carry forwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development credit carry forwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Fixed assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employees Contributions",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Total",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "verboseLabel": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r40"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total",
        "terseLabel": "Depreciation expense",
        "negatedLabel": "Depreciation expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r40"
     ]
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesAndFairValueTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Derivatives and Fair Value [Text Block]",
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109"
     ]
    },
    "ck0001534133_DirectorsEmployeesOrConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "DirectorsEmployeesOrConsultantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Directors, Employees Or Consultants",
        "documentation": "Directors, employees or consultants.",
        "label": "Directors, Employees Or Consultants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensation1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r346",
      "r378",
      "r379",
      "r381",
      "r719"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document financial statement error correction",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789",
      "r832"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r191",
      "r194",
      "r198",
      "r199",
      "r200",
      "r205",
      "r428",
      "r433",
      "r451",
      "r452",
      "r529",
      "r549",
      "r692"
     ]
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r194",
      "r198",
      "r199",
      "r200",
      "r205",
      "r428",
      "r433",
      "r451",
      "r452",
      "r529",
      "r549",
      "r692"
     ]
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDilutedAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r202"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r201",
      "r203",
      "r204"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards weighted-average term of recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options to Purchase Common Stock",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r136",
      "r157",
      "r158",
      "r159",
      "r174",
      "r175",
      "r176",
      "r179",
      "r184",
      "r186",
      "r188",
      "r207",
      "r250",
      "r251",
      "r257",
      "r322",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r432",
      "r433",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r450",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r479",
      "r480",
      "r484",
      "r546",
      "r562",
      "r563",
      "r564",
      "r578",
      "r647"
     ]
    },
    "us-gaap_EquityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Fair Value Disclosure",
        "totalLabel": "Equity, Fair Value Disclosure, Total",
        "terseLabel": "Fair value of common stock",
        "documentation": "Fair value of the entity's equity."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965",
      "r970"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r424",
      "r877",
      "r878",
      "r879",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Ownership percentage",
        "terseLabel": "Percentage of ownership of common stock",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r246"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r782",
      "r793",
      "r803",
      "r836"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r800",
      "r833"
     ]
    },
    "ck0001534133_ExchangeOfStockForStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ExchangeOfStockForStock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange of stock for stock",
        "label": "Exchange of Stock for Stock",
        "documentation": "Exchange of stock for stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ck0001534133_ExerciseAndConversionOfC2WarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ExerciseAndConversionOfC2WarrantsShares",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise And Conversion Of C-2 Warrants Shares",
        "documentation": "Exercise and conversion of C-2 Warrants, Shares.",
        "terseLabel": "Conversion of Series C-2 warrants into common stock, share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ExpectedPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ExpectedPerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Per Share",
        "label": "Expected Per Share",
        "documentation": "Expected per share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_FairValueAdjustmentOfConvertiblePromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "FairValueAdjustmentOfConvertiblePromissoryNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in the fair value of convertible promissory notes",
        "label": "Fair Value Adjustment of Convertible Promissory Notes",
        "documentation": "Amount of expense (income) related to adjustment to fair value of convertible promissory notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of warrant liability",
        "terseLabel": "Change in the fair value of warrant liability",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Company's Financial Assets Measured at Fair Value",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467",
      "r726"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467",
      "r726"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value By Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r465",
      "r466",
      "r468",
      "r490",
      "r491",
      "r492",
      "r706",
      "r707",
      "r713",
      "r714",
      "r715",
      "r724",
      "r728"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r455",
      "r456",
      "r458",
      "r724",
      "r967",
      "r972"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r326",
      "r331",
      "r455",
      "r466",
      "r490",
      "r713",
      "r714",
      "r715",
      "r724"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r326",
      "r331",
      "r455",
      "r456",
      "r466",
      "r491",
      "r706",
      "r707",
      "r713",
      "r714",
      "r715",
      "r724"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r455",
      "r456",
      "r457",
      "r458",
      "r466",
      "r492",
      "r706",
      "r707",
      "r713",
      "r714",
      "r715",
      "r724",
      "r728"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r467"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r464",
      "r467"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r455",
      "r456",
      "r458",
      "r724",
      "r967",
      "r972"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Option",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Initial Fair Value of Warrants",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r467"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total",
        "verboseLabel": "Change in Fair Value of Preferred Warrants",
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r969",
      "r971"
     ]
    },
    "ck0001534133_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Forfeiture of Warrants",
        "documentation": "Fair value measurement with unobservable inputs reconciliations recurring basis forfeiture of warrants.",
        "terseLabel": "Forfeiture of warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r467"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r465",
      "r466",
      "r468",
      "r490",
      "r491",
      "r492",
      "r706",
      "r707",
      "r713",
      "r714",
      "r715",
      "r724",
      "r728"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r972"
     ]
    },
    "us-gaap_FairValueNetAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueNetAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability fair value",
        "label": "Fair Value, Net Asset (Liability)",
        "totalLabel": "Fair Value, Net Asset (Liability), Total",
        "documentation": "Fair value of asset after deduction of liability."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "ck0001534133_FederalResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "FederalResearchAndDevelopmentMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal research and development",
        "documentation": "Federal research and development.",
        "label": "Federal Research and Development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_FinancingCostsIncludedInAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "FinancingCostsIncludedInAccountsPayableAndAccruedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Costs Included in Accounts Payable and Accrued Expenses",
        "documentation": "Financing costs included in accounts payable and accrued expenses.",
        "terseLabel": "Financing costs included in accounts payable and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r840"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r840"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r840"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r840"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r840"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "General and Administrative Expense, Total",
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "verboseLabel": "Segment general and administrative",
        "negatedLabel": "Segment general and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r631"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ck0001534133_GraybugMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "GraybugMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Graybug",
        "label": "Graybug [Member]",
        "documentation": "Graybug."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_GraybugVisionIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "GraybugVisionIncMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Graybug",
        "label": "Graybug Vision Inc [Member]",
        "documentation": "Graybug Vision, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_GrossProceedsFromThePrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "GrossProceedsFromThePrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from the private placement",
        "documentation": "Gross proceeds from the private placement",
        "label": "Gross Proceeds From The Private Placement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "verboseLabel": "Public Offering",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r766",
      "r789"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r39",
      "r93",
      "r725"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r94"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r264",
      "r265",
      "r460",
      "r464",
      "r467",
      "r559",
      "r561",
      "r632",
      "r685",
      "r727",
      "r994"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r265",
      "r460",
      "r464",
      "r467",
      "r559",
      "r561",
      "r632",
      "r685",
      "r727",
      "r994"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r395",
      "r396",
      "r404",
      "r415",
      "r721",
      "r957"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r395",
      "r396",
      "r404",
      "r415",
      "r721",
      "r957"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about income tax.",
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IncomeTaxDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncomeTaxDisclosureTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about income tax.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r390",
      "r395",
      "r400",
      "r401",
      "r402",
      "r408",
      "r414",
      "r419",
      "r421",
      "r422",
      "r423",
      "r576",
      "r721"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision or benefit for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Income tax expense",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r133",
      "r187",
      "r188",
      "r206",
      "r213",
      "r226",
      "r394",
      "r395",
      "r420",
      "r550",
      "r721"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r392",
      "r393",
      "r408",
      "r409",
      "r413",
      "r416",
      "r570"
     ]
    },
    "ck0001534133_IncomeTaxRateReconciliationWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncomeTaxRateReconciliationWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Rate Reconciliation Warrant Liability",
        "documentation": "Income tax rate reconciliation warrant liability.",
        "negatedLabel": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r721",
      "r955"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax computed at federal statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "negatedLabel": "Tax computed at federal statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r721"
     ]
    },
    "ck0001534133_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCredit",
        "documentation": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCredit",
        "terseLabel": "Research and development tax credits, net of uncertain positions"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IncomeTaxReconciliationPermanentDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncomeTaxReconciliationPermanentDifferences",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation permanent differences.",
        "label": "Income Tax Reconciliation Permanent Differences",
        "terseLabel": "Permanent differences",
        "negatedLabel": "Permanent differences"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State tax, net of federal tax benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r398",
      "r721",
      "r955"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current and non-current assets",
        "label": "Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets",
        "documentation": "Increase (decrease) in prepaid expenses and other current and noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r831",
      "r840",
      "r844",
      "r852"
     ]
    },
    "ck0001534133_InducementGrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "InducementGrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement Grants",
        "label": "Inducement Grants [Member]",
        "documentation": "Inducement grants."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r856"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r856"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r856"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment Type",
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r592",
      "r593",
      "r595",
      "r597",
      "r650",
      "r652",
      "r654",
      "r657",
      "r658",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r752"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r592",
      "r593",
      "r595",
      "r597",
      "r650",
      "r652",
      "r654",
      "r657",
      "r658",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r752"
     ]
    },
    "ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonSharesFromPrivatePlacementNet",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Shares From Private Placement Net",
        "documentation": "Issuance of common shares from private placement, net.",
        "terseLabel": "Issuance of common shares from private placement (net of issuance costs)"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfCommonSharesFromPrivatePlacementNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonSharesFromPrivatePlacementNetShares",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Common Shares From Private Placement Net Shares",
        "documentation": "Issuance of common shares from private placement, net, shares.",
        "terseLabel": "Issuance of common shares from private placement (net of issuance costs), shares"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares from Underwritten Public Offering, Net",
        "documentation": "Issuance of common shares from underwritten public offering,net.",
        "terseLabel": "Issuance of common shares from underwritten public offering (net of issuance costs)"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares from Underwritten Public Offering ,Net Shares",
        "documentation": "Issuance of common shares from underwritten public offering,net, shares.",
        "terseLabel": "Issuance of common shares from underwritten public offering (net of issuance costs),shares"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock to Graybug stockholders as a result of the Merger",
        "terseLabel": "Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001",
        "label": "Issuance Of Common Stock To Graybug Stockholders As A Result Of The Merger",
        "documentation": "Issuance of common stock to Graybug stockholders as a result of the merger."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001, Shares",
        "label": "Issuance Of Common Stock To Graybug Stockholders As A Result Of The Merger Shares",
        "documentation": "Issuance of common stock to Graybug stockholders as a result of the merger, Shares."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_IssuanceOfWarrantsInConnectionWithPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "IssuanceOfWarrantsInConnectionWithPrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants in connection with the private placement",
        "label": "Issuance Of Warrants In Connection With Private Placement",
        "documentation": "Issuance of warrants in connection with private placement."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_LeaseAmendmentDate": {
     "xbrltype": "gYearMonthItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "LeaseAmendmentDate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Amendment Date",
        "label": "Lease Amendment Date",
        "documentation": "Lease amendment date."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_LeaseExecutedTermPeriod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "LeaseExecutedTermPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Executed Term Period",
        "documentation": "Lease executed term period.",
        "terseLabel": "Lease Executed Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r62",
      "r63",
      "r64",
      "r66",
      "r67",
      "r68",
      "r71",
      "r169",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r436",
      "r439",
      "r440",
      "r469",
      "r606",
      "r693",
      "r760",
      "r918",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r116",
      "r541",
      "r733",
      "r889",
      "r906",
      "r973"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders' Equity (Deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r139",
      "r169",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r436",
      "r439",
      "r440",
      "r469",
      "r733",
      "r918",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value liabilities",
        "totalLabel": "Total liabilities measured at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r964"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesOtherThanLongTermDebtNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesOtherThanLongTermDebtNoncurrentAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term liabilities",
        "label": "Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_LoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "LoanAgreementMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Agreement [Member]",
        "documentation": "Loan agreement.",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentTerms",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturities, Repayment Terms",
        "terseLabel": "Repayment term",
        "documentation": "Disclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r44"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r908",
      "r909",
      "r910"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r41",
      "r908",
      "r909",
      "r910"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r273",
      "r388",
      "r704",
      "r913",
      "r914"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r273",
      "r388",
      "r704",
      "r913",
      "r914"
     ]
    },
    "stpr_MD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "MD",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Baltimore, Maryland",
        "label": "MARYLAND"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r341",
      "r388",
      "r458",
      "r496",
      "r558",
      "r560",
      "r568",
      "r598",
      "r599",
      "r651",
      "r653",
      "r655",
      "r656",
      "r660",
      "r683",
      "r684",
      "r703",
      "r710",
      "r718",
      "r728",
      "r729",
      "r730",
      "r731",
      "r744",
      "r922",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "ck0001534133_MaximumNumberOfAdditionalSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "MaximumNumberOfAdditionalSharesIssued",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Number Of Additional Shares Issued",
        "documentation": "Maximum number of additional shares issued.",
        "terseLabel": "Maximum number of additional shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ck0001534133_MergerTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "MergerTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger transaction costs",
        "label": "Merger Transaction Costs",
        "documentation": "Merger transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r341",
      "r388",
      "r458",
      "r496",
      "r558",
      "r560",
      "r568",
      "r598",
      "r599",
      "r651",
      "r653",
      "r655",
      "r656",
      "r660",
      "r683",
      "r684",
      "r703",
      "r710",
      "r718",
      "r728",
      "r729",
      "r730",
      "r744",
      "r922",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Government Sponsored Entities - Mortgagebacked Securities",
        "label": "Mortgage-Backed Security, Issued by US Government-Sponsored Enterprise [Member]",
        "documentation": "Debt security collateralized by real estate mortgage loan issued by U.S. government-sponsored enterprise (GSE), including, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and Federal Home Loan Bank (FHLBank)."
       }
      }
     },
     "auth_ref": [
      "r903",
      "r904",
      "r905",
      "r924"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusiness1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r134"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89",
      "r90"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_NetDeferredTaxAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "NetDeferredTaxAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net deferred tax assets.",
        "label": "Net Deferred Tax Asset",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "verboseLabel": "Net loss and comprehensive loss",
        "totalLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r90",
      "r119",
      "r137",
      "r152",
      "r154",
      "r159",
      "r169",
      "r178",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r187",
      "r188",
      "r196",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r428",
      "r433",
      "r452",
      "r469",
      "r545",
      "r628",
      "r645",
      "r646",
      "r758",
      "r918"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders",
        "terseLabel": "Net loss",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r180",
      "r181",
      "r182",
      "r183",
      "r191",
      "r192",
      "r197",
      "r200",
      "r433"
     ]
    },
    "ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "NetProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Proceeds From Issuance Of Private Placement",
        "documentation": "Net proceeds from issuance of private placement.",
        "terseLabel": "Net proceeds from issuance of private placement"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_NetProceedsFromPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "NetProceedsFromPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds from private placement",
        "label": "Net Proceeds From Private Placement",
        "terseLabel": "Net proceeds from private placement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_NonCashInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "NonCashInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Non cash Interest Expense",
        "documentation": "Non-cash Interest Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r797",
      "r807",
      "r831",
      "r840"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ck0001534133_NumberOfContractCurrentlyInEffect": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "NumberOfContractCurrentlyInEffect",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of contract currently in effect.",
        "label": "Number Of Contract Currently In Effect",
        "terseLabel": "Number of contract currently in effect"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r897"
     ]
    },
    "ck0001534133_OfficersAndDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "OfficersAndDirectorsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Officers and Directors",
        "label": "Officers and Directors [Member]",
        "documentation": "Officers and directors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total operating expenses",
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Consolidated operating loss",
        "verboseLabel": "Loss from operations",
        "terseLabel": "Consolidated operating loss",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r694",
      "r896",
      "r898",
      "r899",
      "r900",
      "r901"
     ]
    },
    "ck0001534133_OperatingLossCarryForwardsExpirationBeginningYear": {
     "xbrltype": "gYearListItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "OperatingLossCarryForwardsExpirationBeginningYear",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards expiration beginning year",
        "documentation": "Operating loss carry forwards expiration beginning year.",
        "label": "Operating Loss Carry Forwards Expiration Beginning Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards limitations on use",
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r698",
      "r699"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "totalLabel": "Total accrued expenses",
        "terseLabel": "Accrued expenses",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets",
        "totalLabel": "Other Assets, Total",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r141",
      "r533",
      "r699",
      "r760"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized gain on available-for-sale securities, net of tax",
        "verboseLabel": "Unrealized gain on available-for-sale securities, net of tax",
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r13",
      "r107"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain on investments",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r546"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "terseLabel": "Other income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r795",
      "r805",
      "r838"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r787",
      "r798",
      "r808",
      "r841"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r787",
      "r798",
      "r808",
      "r841"
     ]
    },
    "ck0001534133_PatentsCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PatentsCostsPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent Costs",
        "documentation": "Patents costs.",
        "label": "Patents Costs Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ck0001534133_PaymentsOfAcquisitionOfBusinessesNetOfCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PaymentsOfAcquisitionOfBusinessesNetOfCash",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of stock of Graybug, net of cash",
        "label": "Payments of Acquisition of Businesses Net of Cash",
        "documentation": "Payments of aquisition of businesses net of cash."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Merger transaction costs",
        "label": "Payments of Merger Related Costs, Financing Activities",
        "documentation": "The cash outflow for financing costs associated with business combinations."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commissions paid",
        "verboseLabel": "Stock issuance costs",
        "label": "Transaction costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of investments",
        "label": "Payments to Acquire Investments",
        "totalLabel": "Payments to Acquire Investments, Total",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureEmployeeBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefits",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r715"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ck0001534133_PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan",
        "label": "Percentage Of Aggregate Number Of Shares Of Common Stock Outstanding On Last Day Of Preceding Year Added To Plan",
        "documentation": "Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PercentageOfChangeInOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PercentageOfChangeInOwnership",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of change in ownership.",
        "label": "Percentage of Change in Ownership",
        "terseLabel": "Percentage of change in ownership"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PercentageOfWarrantCoverage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PercentageOfWarrantCoverage",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of warrant coverage",
        "label": "Percentage of Warrant Coverage",
        "documentation": "Percentage of warrant coverage."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PlacementAgentWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PlacementAgentWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Placement Agent Warrants",
        "documentation": "Placement agent warrants member.",
        "label": "Placement Agent Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ck0001534133_PostMergerCalcimedicaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PostMergerCalcimedicaMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post Merger CalciMedica",
        "documentation": "Post Merger CalciMedica [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PostMergerTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PostMergerTransactionsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post Merger Transaction",
        "label": "Post Merger Transactions [Member]",
        "documentation": "Post merger transactions."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants",
        "documentation": "Pre-funded warrants member.",
        "label": "Pre Funded Warrants [Member]",
        "verboseLabel": "Pre Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreMergerCalcimedicaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreMergerCalcimedicaMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Merger CalciMedica",
        "documentation": "Pre Merger CalciMedica [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreferredAndCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreferredAndCommonStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred and Common stock [Member]",
        "documentation": "preferred and common stock member",
        "terseLabel": "Preferred and Common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r750",
      "r751",
      "r754",
      "r755",
      "r756",
      "r757",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r314"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r608"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r314"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r608",
      "r626",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r536",
      "r733"
     ]
    },
    "ck0001534133_PreferredStockWarrantsAndCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreferredStockWarrantsAndCommonStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Warrants and Common Stock [Member]",
        "documentation": "Preferred stock, warrants and common stock.",
        "terseLabel": "Preferred Stock, Warrants and Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreferredWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreferredWarrantMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Warrant [Member]",
        "documentation": "Preferred Warrant."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreferredWarrantsLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreferredWarrantsLiabilityMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred warrants liability",
        "label": "Preferred Warrants Liability [Member]",
        "documentation": "Preferred warrants liability."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PreferredWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PreferredWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Warrants [Member]",
        "documentation": "Preferred Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PrepaidClinicalTrialExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PrepaidClinicalTrialExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Clinical Trial Expenses",
        "documentation": "Prepaid clinical trial expenses.",
        "terseLabel": "Prepaid clinical trial expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other prepaid expenses and current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ck0001534133_PrepaidExpensesAndOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PrepaidExpensesAndOtherCurrentAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets assumed in the Merger",
        "label": "Prepaid Expenses and Other Current Assets",
        "documentation": "Prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrimeRateMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate",
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PriorToMergerTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PriorToMergerTransactionsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior to Merger Transaction",
        "label": "Prior to Merger Transactions [Member]",
        "documentation": "Prior to merger transactions."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_PrivateCalcimedicaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PrivateCalcimedicaMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private CalciMedica",
        "label": "Private CalciMedica [Member]",
        "documentation": "Private calciMedica."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "terseLabel": "2023 Private Placement",
        "verboseLabel": "2024 Private Placement",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds of Convertible Promissory Notes",
        "label": "Proceeds from Convertible Debt",
        "verboseLabel": "Proceeds from issuance of convertible notes",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "ck0001534133_ProceedsFromFollowOnOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ProceedsFromFollowOnOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Follow On Offering",
        "documentation": "Proceeds From Follow On Offering",
        "terseLabel": "Proceeds from follow on offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gross cash proceeds",
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ck0001534133_ProceedsFromIssuanceOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ProceedsFromIssuanceOfConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of convertible notes.",
        "label": "Proceeds from Issuance of Convertible Notes",
        "terseLabel": "Proceeds from issuance of convertible note payable, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance and sale of equity",
        "label": "Proceeds from Issuance or Sale of Equity",
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r571"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from issuance of common stock from ATM Facility, net of issuance costs",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from loan agreement",
        "label": "Proceeds from (Repayments of) Debt",
        "totalLabel": "Proceeds from (Repayments of) Debt, Total",
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity of investments",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "totalLabel": "Proceeds from Sale, Maturity and Collection of Investments, Total",
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r17"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r497",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r686",
      "r711",
      "r743",
      "r744",
      "r745",
      "r747",
      "r749",
      "r915",
      "r916",
      "r923",
      "r993",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1022",
      "r1023"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r497",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r686",
      "r711",
      "r743",
      "r744",
      "r745",
      "r747",
      "r749",
      "r915",
      "r916",
      "r923",
      "r993",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r152",
      "r154",
      "r163",
      "r169",
      "r178",
      "r184",
      "r187",
      "r188",
      "r249",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r428",
      "r433",
      "r434",
      "r437",
      "r438",
      "r452",
      "r469",
      "r530",
      "r544",
      "r577",
      "r628",
      "r645",
      "r646",
      "r722",
      "r723",
      "r759",
      "r885",
      "r918"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, Plant and Equipment, Net, Total",
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r482",
      "r531",
      "r543",
      "r733"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r129",
      "r132",
      "r542"
     ]
    },
    "ck0001534133_PublicCombinationMultipliedCashPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "PublicCombinationMultipliedCashPricePaidPerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public combination multiplied cash price paid per share",
        "label": "Public Combination Multiplied Cash Price Paid Per Share",
        "documentation": "Public combination multiplied cash price paid per share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ck0001534133_RainBioIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RainBioIncMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RainBio, Inc. [Member]",
        "documentation": "RainBio Inc.",
        "terseLabel": "RainBio, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r324",
      "r341",
      "r372",
      "r373",
      "r374",
      "r388",
      "r458",
      "r493",
      "r494",
      "r496",
      "r558",
      "r560",
      "r568",
      "r598",
      "r599",
      "r651",
      "r653",
      "r655",
      "r656",
      "r660",
      "r683",
      "r684",
      "r703",
      "r710",
      "r718",
      "r728",
      "r729",
      "r730",
      "r731",
      "r744",
      "r752",
      "r911",
      "r922",
      "r967",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r324",
      "r341",
      "r372",
      "r373",
      "r374",
      "r388",
      "r458",
      "r493",
      "r494",
      "r496",
      "r558",
      "r560",
      "r568",
      "r598",
      "r599",
      "r651",
      "r653",
      "r655",
      "r656",
      "r660",
      "r683",
      "r684",
      "r703",
      "r710",
      "r718",
      "r728",
      "r729",
      "r730",
      "r731",
      "r744",
      "r752",
      "r911",
      "r922",
      "r967",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r800",
      "r833"
     ]
    },
    "ck0001534133_RelatedPartyTransactionsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RelatedPartyTransactionsPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Policy Text Block",
        "documentation": "Related party transactions.",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_RentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent expenses",
        "label": "Rent Expenses",
        "documentation": "Amount of rent expense incurred"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r291",
      "r316",
      "r485",
      "r495",
      "r532",
      "r690",
      "r691"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Research and Development Expense, Total",
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "verboseLabel": "Segment research and development",
        "negatedLabel": "Segment research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r685",
      "r698",
      "r990"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r780",
      "r791",
      "r801",
      "r834"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r781",
      "r792",
      "r802",
      "r835"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r788",
      "r799",
      "r809",
      "r842"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ck0001534133_RestrictedStockUnitsNetSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RestrictedStockUnitsNetSettlement",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Restricted stock units net settlement",
        "terseLabel": "Restricted stock units net settlement",
        "label": "Restricted Stock Units Net Settlement",
        "documentation": "Restricted stock units net settlement."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_RestrictedStockUnitsNetSettlementShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RestrictedStockUnitsNetSettlementShares",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units net settlement, shares",
        "label": "Restricted Stock Units Net Settlement Shares",
        "documentation": "Restricted stock units net settlement shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock Units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r101",
      "r540",
      "r565",
      "r567",
      "r575",
      "r609",
      "r733"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r174",
      "r175",
      "r176",
      "r179",
      "r184",
      "r186",
      "r188",
      "r250",
      "r251",
      "r257",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r432",
      "r433",
      "r441",
      "r443",
      "r444",
      "r447",
      "r450",
      "r479",
      "r480",
      "r562",
      "r564",
      "r578",
      "r1025"
     ]
    },
    "ck0001534133_RightOfUseAssetOrLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "RightOfUseAssetOrLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset or lease liability",
        "label": "Right-of-Use Asset or Lease Liability",
        "documentation": "Right-of-use asset or lease liability."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SaleOfStockRemainingSalesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SaleOfStockRemainingSalesAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining amount of available for sale",
        "label": "Sale of Stock Remaining Sales Amount",
        "documentation": "Sale of stock remaining sales amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r53",
      "r430"
     ]
    },
    "ck0001534133_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Common Stock Reserved for Future issuance [Table Text Block]",
        "documentation": "Tabular disclosure of schedule of common stock reserved for future issuance.",
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r721",
      "r955"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r424",
      "r877",
      "r878",
      "r879",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Disaggregated Amounts of Operating Expenses",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Units (RSU) Activity",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock Option Transations",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r103"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the Stock Option Grants",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r720"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r591",
      "r594",
      "r596",
      "r652",
      "r654",
      "r658",
      "r661",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r687",
      "r712",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r746",
      "r752",
      "r923",
      "r993",
      "r995",
      "r996",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1022",
      "r1023"
     ]
    },
    "ck0001534133_SegmentReportingAdjustmentsAndReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SegmentReportingAdjustmentsAndReconcilingItems",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Adjustments and Reconciling Items",
        "documentation": "Segment reporting adjustments and reconciling items.",
        "terseLabel": "Adjustments and reconciling items"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r697",
      "r702"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r696",
      "r701"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r229",
      "r231",
      "r695",
      "r696",
      "r700"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Costs",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ck0001534133_SeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Convertible Preferred Stock",
        "label": "Series A Convertible Preferred Stock [Member]",
        "documentation": "Series A Convertible Preferred StockMember"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SeriesBConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesBConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Series B Convertible Preferred Stock",
        "terseLabel": "Series B",
        "label": "Series B Convertible Preferred Stock [Member]",
        "documentation": "Series B Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SeriesC1ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesC1ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C-1Convertible Preferred Stock",
        "label": "Series C-1 Convertible Preferred Stock [Member]",
        "documentation": "Series C-1 Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SeriesC2ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesC2ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C-2 Convertible Preferred Stock",
        "label": "Series C-2 Convertible Preferred Stock [Member]",
        "documentation": "Series C-2 Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SeriesCTwoWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesCTwoWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C-2 Warrants",
        "label": "Series C Two Warrants [Member]",
        "documentation": "Series C two warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SeriesDConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SeriesDConvertiblePreferredStockMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series D Convertible Preferred Stock",
        "label": "Series D Convertible Preferred Stock [Member]",
        "documentation": "Series D convertible preferred stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance and termination benefit expense",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercised in Period",
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercised in period.",
        "terseLabel": "Number of restricked stock units, exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Exercised in Period, Weighted Average Exercise Price",
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, exercised in period, weighted average exercise price.",
        "terseLabel": "Weighted average exercise price, exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested and Exercisable in Period, Weighted Average Exercise Price",
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested and exercisable in period, weighted average exercise price.",
        "terseLabel": "Weighted average exercise price, vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "Share-BasedCompensationArrangementByShare-BasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested and Exercisable, Number",
        "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested and exercisable, number.",
        "terseLabel": "Number of restricked stock units, vested and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issued for services",
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of restricted stock units, forfeited/cancelled (expired)",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average exercise price, forfeited/cancelled (expired)",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of restricted stock units, granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average remaining contractual term, granted",
        "verboseLabel": "Weighted average exercise price, granted",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodStartLabel": "Number of restricted stock units, outstanding beginning balance",
        "periodEndLabel": "Number of restricted stock units, outstanding ending balance",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodStartLabel": "Weighted average exercise price, outstanding beginning balance",
        "periodEndLabel": "Weighted average exercise price, outstanding ending balance",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Aggregate grant date fair value of RSUs vested",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ]
    },
    "ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Reserved",
        "documentation": "Share based compensation arrangement By share based payment award number Of additional shares reserved.",
        "terseLabel": "Increase in number of shares reserved for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "verboseLabel": "Shares available for grant (shares)",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award Number of Shares Unvailable for Grant",
        "documentation": "Number of shares unvailable for grant.",
        "terseLabel": "Number of shares unavailable for grant (shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of options, cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "ck0001534133_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Intrinsic Value",
        "documentation": "Share-based compensation arrangement by share-based payment award, options, granted, intrinsic value.",
        "terseLabel": "Aggregate intrinsic value, granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value options, granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of options, outstanding",
        "periodStartLabel": "Number of options, outstanding",
        "terseLabel": "Stock options issued and outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "verboseLabel": "Shares issued",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price, outstanding",
        "periodStartLabel": "Weighted average exercise price, outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agrgregate intrinsic value, vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, options vested and exercisable",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, cancelled",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r357"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, granted",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r350",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r382",
      "r383",
      "r384",
      "r385"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockbasedCompensationExpenseRecognizedForOptionsAndRsusGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stock-based compensation expense",
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount",
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsingBlackScholesToEstimatedFairValueOfTheStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual term, options vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued, price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance, Shares",
        "periodEndLabel": "Ending Balance, Shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ShelfRegistrationStatementAvaliableForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShelfRegistrationStatementAvaliableForSale",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available for sale under Shelf Registration Statement",
        "label": "Shelf Registration Statement Avaliable for Sale",
        "documentation": "Shelf registration statement avaliable for sale."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ShelfRegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShelfRegistrationStatementMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shelf Registration Statement",
        "label": "Shelf Registration Statement [Member]",
        "documentation": "Shelf registration statement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r908",
      "r909",
      "r910"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Domain]",
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r908",
      "r909",
      "r910"
     ]
    },
    "ck0001534133_ShortTermInvestmentFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShortTermInvestmentFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": "ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short Term Investment Fair Value Disclosure, Total",
        "verboseLabel": "Total short-term investments, Aggregate Fair Value",
        "documentation": "Short-term investment fair value disclosure.",
        "label": "Short Term Investment Fair Value Disclosure",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": "ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total short-term investments, Unrealized Gains",
        "label": "Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax",
        "documentation": "Short term investment fair value disclosure accumulated gross unrealized gain before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": "ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total short-term investments, Unrealized Losses",
        "label": "Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax",
        "documentation": "Short term investment fair value disclosure accumulated gross unrealized loss before tax."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_ShortTermInvestmentFairValueDisclosureAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShortTermInvestmentFairValueDisclosureAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails2": {
       "parentTag": "ck0001534133_AssetsFairValueDisclosureAmortizedCostBasis",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total short-term investments, Amortized Cost",
        "label": "Short Term Investment Fair Value Disclosure Amortized Cost Basis",
        "documentation": "Short term investment fair value disclosure amortized cost basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Short-Term Investments, Total",
        "terseLabel": "Short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r881"
     ]
    },
    "ck0001534133_ShortTermInvestmentsAssumedInTheMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "ShortTermInvestmentsAssumedInTheMerger",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments assumed in the Merger",
        "label": "Short Term Investments Assumed in the Merger",
        "documentation": "Short-term investments assumed in the merger."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r167"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePromissoryNotesAndConvertiblePromissoryNoteWarrantsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r144",
      "r145",
      "r146",
      "r169",
      "r194",
      "r195",
      "r198",
      "r200",
      "r208",
      "r209",
      "r249",
      "r276",
      "r279",
      "r280",
      "r281",
      "r285",
      "r286",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r469",
      "r571",
      "r572",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r629",
      "r647",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r876",
      "r887",
      "r894"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r74",
      "r77",
      "r78",
      "r136",
      "r157",
      "r158",
      "r159",
      "r174",
      "r175",
      "r176",
      "r179",
      "r184",
      "r186",
      "r188",
      "r207",
      "r250",
      "r251",
      "r257",
      "r322",
      "r417",
      "r418",
      "r425",
      "r426",
      "r427",
      "r429",
      "r432",
      "r433",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r450",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r479",
      "r480",
      "r484",
      "r546",
      "r562",
      "r563",
      "r564",
      "r578",
      "r647"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r591",
      "r594",
      "r596",
      "r652",
      "r654",
      "r658",
      "r661",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r687",
      "r712",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r746",
      "r752",
      "r923",
      "r993",
      "r995",
      "r996",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r207",
      "r480",
      "r497",
      "r569",
      "r589",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r647",
      "r753"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r207",
      "r233",
      "r480",
      "r497",
      "r569",
      "r589",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r627",
      "r630",
      "r631",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r647",
      "r753"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r794",
      "r804",
      "r837"
     ]
    },
    "ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock and warrants issued during period shares common stock and warrants",
        "documentation": "Stock and warrants issued during period shares common stock and warrants.",
        "terseLabel": "Warrants granted during the period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_StockIssuedDuringPeriodPrivatePlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "StockIssuedDuringPeriodPrivatePlacement",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued during period private placement",
        "label": "Stock Issued During Period, Private Placement",
        "documentation": "Stock issued during period, private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of options, Assumed in the Merger",
        "terseLabel": "Number of shares of stock issued",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r101"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversion of preferred stock to common stock as a result of the Merger, shares",
        "terseLabel": "Conversion of C-2 warrants to common stock",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r44",
      "r74",
      "r77",
      "r101",
      "r304"
     ]
    },
    "ck0001534133_StockIssuedDuringPeriodSharesConversionOfPromissoryNotes": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesConversionOfPromissoryNotes",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of promissory notes into common stock, shares",
        "label": "Stock Issued During Period Shares Conversion Of Promissory Notes",
        "documentation": "Stock issued during period shares conversion of promissory notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued during period upon conversion of units",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r44",
      "r73",
      "r74",
      "r101"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issued",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r73",
      "r74",
      "r101"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for services, shares",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock from at-the-market offering (net of issuance costs), shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r73",
      "r74",
      "r101",
      "r571",
      "r647",
      "r667"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of options, exercised",
        "verboseLabel": "Stock issued on exercise of stock options, Shares",
        "terseLabel": "Issuance of common stock from exercise of stock options, Shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r73",
      "r74",
      "r101",
      "r356"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of C-2 warrants to common stock",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "verboseLabel": "Conversion of preferred stock to common stock as a result of Merger, value",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r74",
      "r77",
      "r78",
      "r101"
     ]
    },
    "ck0001534133_StockIssuedDuringPeriodValueConversionOfPromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "StockIssuedDuringPeriodValueConversionOfPromissoryNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of promissory notes into common stock",
        "label": "Stock Issued During Period Value Conversion Of Promissory Notes",
        "documentation": "Stock issued during period value conversion of promissory notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Issuance of common stock from at-the-market offering (net of issuance costs)",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds",
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Issuance of common stock from at-the-market offering (net of issuance costs)",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r73",
      "r74",
      "r101",
      "r578",
      "r647",
      "r667",
      "r759"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r74",
      "r77",
      "r78",
      "r101"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r78",
      "r92",
      "r610",
      "r626",
      "r648",
      "r649",
      "r733",
      "r760",
      "r889",
      "r906",
      "r973",
      "r1025"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureMergerAndRelatedTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse Stock Split",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ck0001534133_StockholdersEquityNoteStockSplitExchangeRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "StockholdersEquityNoteStockSplitExchangeRatio",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders equity note stock split exchange ratio",
        "label": "Stockholders Equity Note Stock Split Exchange Ratio",
        "documentation": "Stockholders equity note stock split exchange ratio."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r488"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r488"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r488"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r488"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r488"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r489"
     ]
    },
    "srt_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]"
       }
      }
     },
     "auth_ref": [
      "r925",
      "r978",
      "r979",
      "r981"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDisaggregatedAmountsOfOperatingExpensesParentheticalDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "ck0001534133_TaxPostionMinimumPercentageOfTaxBenefit": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TaxPostionMinimumPercentageOfTaxBenefit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Postion, Minimum Percentage of Tax Benefit",
        "documentation": "Tax postion, minimum percentage of tax benefit",
        "terseLabel": "Tax postion, minimum percentage of tax benefit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r43"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Convertible preferred stock",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r279",
      "r280",
      "r281",
      "r285",
      "r286",
      "r386",
      "r538"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Temporary equity, Ending balance",
        "periodStartLabel": "Temporary equity, Beginning balance",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "totalLabel": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Total",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r169",
      "r249",
      "r469"
     ]
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TemporaryEquityDisclosureTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TemporaryEquityDisclosureTextblock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock, Common Stock and Stockholders' Deficit",
        "label": "Temporary Equity Disclosure [TextBlock]",
        "documentation": "Temporary equity disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock, price per share",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r43"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary equity, shares issued",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Temporary equity, Ending balance, Shares",
        "periodStartLabel": "Temporary equity, Beginning balance, Shares",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ck0001534133_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities",
        "documentation": "Temporary equity, stock issued during period, shares, conversion of convertible securities.",
        "terseLabel": "Conversion of preferred stock to common stock as a result of Merger, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of preferred stock to common stock as a result of the Merger, value",
        "label": "Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities",
        "documentation": "Temporary equity, stock issued during period, value, conversion of convertible securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityValueExcludingAdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par Value",
        "documentation": "Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r43"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r980"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TotalNetProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TotalNetProceeds",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net proceeds",
        "label": "Total Net Proceeds",
        "documentation": "Total net proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TrancheAAndTrancheBCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TrancheAAndTrancheBCommonWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche A and tranche B common warrants.",
        "label": "Tranche A and Tranche B Common Warrants [Member]",
        "terseLabel": "Tranche A and Tranche B Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TrancheACommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TrancheACommonWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche A Common Warrants",
        "documentation": "Tranche A common warrants member.",
        "label": "Tranche A Common Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TrancheBCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TrancheBCommonWarrantsMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche B common warrants member.",
        "label": "Tranche B Common Warrants [Member]",
        "terseLabel": "Tranche B Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TrancheOneMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche One [Member]",
        "documentation": "Tranche one.",
        "terseLabel": "Tranche 1"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche Two [Member]",
        "documentation": "Tranche Two.",
        "terseLabel": "Tranche 2"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TransactionCostsAssoicatedWithWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TransactionCostsAssoicatedWithWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs associated with warrants",
        "label": "Transaction Costs Assoicated with Warrants",
        "documentation": "Transaction costs assoicated with warrants."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ck0001534133_TwoThousandAndSixEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndSixEquityIncentivePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and six equity incentive plan.",
        "terseLabel": "2006 Equity Incentive Plan",
        "label": "Two Thousand And Six Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TwoThousandAndTwentyEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndTwentyEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Employee Stock Purchase Plan",
        "label": "Two Thousand And Twenty Employee Stock Purchase Plan [Member]",
        "documentation": "Two thousand and twenty employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TwoThousandAndTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Equity Incentive Plan",
        "label": "Two Thousand And Twenty Equity Incentive Plan [Member]",
        "documentation": "Two thousand and twenty equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndTwentyFourPrivatePlacementMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Private Placement",
        "label": "Two Thousand and Twenty Four Private Placement [Member]",
        "documentation": "Two thousand and twenty four private placement."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Employee Stock Purchase Plan",
        "label": "Two Thousand And Twenty Three Employee Stock Purchase Plan [Member]",
        "documentation": "Two thousand and twenty three employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_TwoThousandAndTwentyThreeEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "TwoThousandAndTwentyThreeEquityIncentivePlanMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Equity Incentive Plan",
        "label": "Two Thousand And Twenty Three Equity Incentive Plan Member",
        "documentation": "Two thousand and twenty three equity incentive plan member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasuryBillSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasuryBillSecuritiesMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfCompanySFinancialAssetsMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Treasury bills",
        "label": "US Treasury Bill Securities [Member]",
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_USTreasuryNotesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasuryNotesSecuritiesMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Treasury Notes",
        "label": "US Treasury Notes Securities [Member]",
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one to ten years, are interest bearing, and are backed by the full faith and credit of the United States government."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "ck0001534133_UnderwritersOptionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "UnderwritersOptionPeriod",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Option Period",
        "documentation": "Underwriters option period.",
        "terseLabel": "Underwriters option period"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "ck0001534133_UnpaidCancellationAndOtherRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "UnpaidCancellationAndOtherRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unpaid cancellation and other related costs.",
        "label": "Unpaid Cancellation And Other Related Costs",
        "terseLabel": "Unpaid cancellation and other related costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits",
        "periodEndLabel": "Unrecognized tax benefits gross",
        "periodStartLabel": "Unrecognized tax benefits gross",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r405",
      "r720"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reduction for tax positions of prior years",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r720"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrual for interest and penalties",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r720"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Additions in connection with the reverse merger",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r720"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r720"
     ]
    },
    "ck0001534133_UnrecognizedTaxBenefitsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "UnrecognizedTaxBenefitsNet",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits net",
        "label": "Unrecognized Tax Benefits Net",
        "terseLabel": "Unrecognized tax benefits net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r126",
      "r127",
      "r130",
      "r131"
     ]
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable interest entity ownership percentage",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of warrant liability to equity",
        "label": "Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount",
        "documentation": "Amount of increase (decrease) in equity for down round feature triggered for warrant classified as equity."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r321"
     ]
    },
    "us-gaap_WarrantExercisePriceDecrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantExercisePriceDecrease",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in warrant exercise price",
        "label": "Warrant, Exercise Price, Decrease",
        "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "ck0001534133_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liability",
        "label": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WarrantLiabilityPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WarrantLiabilityPolicyPolicyTextBlock",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "label": "Warrant Liability, Policy [Policy Text Block]",
        "documentation": "Warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfAntiDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to Purchase Common Stock",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrant",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r750",
      "r751",
      "r754",
      "r755",
      "r756",
      "r757"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of warrants",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r966",
      "r967",
      "r968"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "terseLabel": "Warrants expiration date",
        "verboseLabel": "Warrants expiration date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r966",
      "r967",
      "r968"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureConvertiblePreferredStockCommonStockAndStockholdersDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r966",
      "r967",
      "r968"
     ]
    },
    "ck0001534133_WarrantsLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WarrantsLiabilityMember",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueUsingLevel3InputsDetails",
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liability [Member]",
        "documentation": "Warrants liability.",
        "terseLabel": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAverageCommonSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAverageCommonSharesOutstandingBasic",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Common Shares Outstanding, Basic",
        "documentation": "Weighted average number of basic common shares outstanding.",
        "terseLabel": "Weighted-average common shares outstanding, basic"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAverageCommonSharesOutstandingDiluted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAverageCommonSharesOutstandingDiluted",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares outstanding, diluted",
        "label": "Weighted Average Common Shares Outstanding, Diluted",
        "documentation": "Weighted-average number of diluted common shares outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average number of shares outstanding used in computing net loss per share - diluted",
        "verboseLabel": "Weighted-average common shares outstanding, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "terseLabel": "Weighted-average number of shares outstanding used in computing net loss per share - basic",
        "verboseLabel": "Weighted-average common shares outstanding, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of shares used to calculate basic net loss per share",
        "label": "Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share",
        "documentation": "Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share",
        "totalLabel": "Weighted-average number of shares used to calculate basic net loss per share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of shares used to calculate diluted net loss per share",
        "label": "Weighted-average Number of Shares used to Calculate Diluted Net Income (Loss) Per Share",
        "documentation": "Weighted-average number of shares used to calculate diluted net income (loss) per share.",
        "totalLabel": "Weighted-average number of shares used to calculate diluted net loss per share"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAveragePlacementAgentWarrantsOutstandingBasic",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Placement Agent Warrants Outstanding Basic",
        "documentation": "Weighted-average placement agent warrants outstanding basic",
        "terseLabel": "Weighted-average placement agent warrants outstanding, basic"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAveragePlacementAgentWarrantsOutstandingDiluted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAveragePlacementAgentWarrantsOutstandingDiluted",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Placement Agent Warrants Outstanding Diluted",
        "documentation": "Weighted-average placement agent warrants outstanding diluted",
        "terseLabel": "Weighted-average placement agent warrants outstanding, diluted"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAveragePreFundedWarrantsOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAveragePreFundedWarrantsOutstandingBasic",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average Pre-funded Warrants Outstanding Basic",
        "documentation": "Weighted-average pre-funded warrants outstanding basic.",
        "terseLabel": "Weighted-average pre-funded warrants outstanding, basic"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001534133_WeightedAveragePreFundedWarrantsOutstandingDiluted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.calcimedica.com/20241231",
     "localname": "WeightedAveragePreFundedWarrantsOutstandingDiluted",
     "calculation": {
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails": {
       "parentTag": "ck0001534133_WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.calcimedica.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average Pre-funded Warrants Outstanding Diluted",
        "documentation": "Weighted-average pre-funded warrants outstanding diluted.",
        "terseLabel": "Weighted-average pre-funded warrants outstanding, diluted"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-30/tableOfContent"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3A"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5D"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-7"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>127
<FILENAME>0000950170-25-046035-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-046035-xbrl.zip
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ML"C$9SDE+'&<""\8L;EAVL42_DZ^>"JK9)5;SBA/%<G@-82Y%/2H-[!T-$Z
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MLR*AZ=V/D.CFCI!<!ORB#"5>.TL82S.PP7(POQRUEGHGI.Q#3X<MR9),Y%R
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ML%4.V^(PQXC+8\EXSF7.^GL\_B25YWV2QT\3ULSC++8VSX$$TPPC!:A-L>*
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M Z^ 4Q\J#;%(+J$_W#2^\'/\0W?9K1?</+[N0G2WVXMO&&MW97<D%R>:)%T
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M$Y9%/KU%XL?I#A/QCHSS&^5^/[EXDX<A:_G8%A=K<D>^U$=*$YO&@BHBE61
M+!DGFAE&K,ER:5)#F7PPTEUW^% ?CDT)BB'4#?YR"4]SE1L;]QX>_<L(B.A%
MY, \F*#/7,W:P]IB/'-V?WK7L7Z(MYQB^+ NAQLGD5='![__]OKM^Y/H\.W!
MT?&[H^/]]Z]?1;_\=W3\^LWKX]=O#UXOI^9]0RL3;?2_E?S&JQXSL.2CBJ+
MRBUSJ&7)?U<&Z<4&O<.<E19=[ 8GK<,@ U/S';A;E]%)=T 3?8>WM/A@5WYK
M<<&^GX-O!^V]/X;% A_.N9#" B\-BJNSK)>AR4.^Y!44<C3+YW%E5'Q%7>/*
MHWT\4M,0N(9%W0>_<]3YD3P<*Q5+4@\]@*J3>YC74T;OP#F.#@\/YVBJ[4"/
MY_E$;T!11C$E?UT.V2QO_\-=H4WNZXUH:X&:B[&%R_;8+M@A?[J:(AYW@]@
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M);CY9:<('[ET;M#8) @YAGH$C$_\UC5&$^B14UP6T"[@_C=P?R&8@/GQ2^H
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M*<W<S ,E:G=E\^4A"F?P%L.6RJ%RXU/X@VMFR&Z[2M*/U(G,RV;)5<RG@MY
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M.)]Z63K^\0?ZRW#_:#@8' R/_QSV_EI,?_#\*&_^107I<+#?7UR_T/;-\&!
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MG.59=@5=@Z=,FO]Z]4];'\%WX2,8M#Z"K;_KOEIN];8%Z* OCT6R7C@9A&V
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MP^I$&(R!YA60L5MPJ2_+9O/?>8[@Q 5TM'3$RM=I%2R:5X^ATCKS6;A?V&2
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M*(.;C=2HD:&?H""M ?"LK2NQW='_9PUS=<SA$""D7G#KK3@U![-TR3<T!P7
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M* +W/46$2'&I5;[+15K;HJ'&E'$#&&<).;-:^#9?5W@ZZ3B]]D_G[H<C<5>
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MHU1!8V!0$(Q'L0H[23PO@[(U!A-MG1A"!0&?7X>_Y=)Z(_<!I4'%83%YK?@
M5H.]7<Q,AE'RN@/L7=<@(.E':FR!8;2S#W[C*PE1FS='RSQ7+'X;J4*DR=K
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ME<5A/ON(7I%W=/6HSLKMRC\]$,] QZ%.,"J*5-3I"/FR=%B/D7&4/?*1IS)
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MUWAM:/(%#JB>2JC+#@M1TUX\G.@SNB'-<XQP3 3I!4?R2_.0Z_[CO GR0QX
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M*>:<S/ (799$J3&P>*L_"\G]>36IN[#FH^F7Y160P@Y1T@P-CE)BUU.>]=8
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M]@JU62E.>8T./,!W'539KXR4Q#%%?'?EG-D9>3455XMI,/^+W@6F^C15!R8
M-6O#.-_ENL@"ZLN ]W+"L]UW/-O9A&>;\&S_-J?-3^Q%>OJ_V-2SKRF<9^ T
M^:5#_43!;!8;2V#H.K;:L,<^DW#!PKD1%X9.+!2VT"/#_HLT[PB+P;"7;,=/
M^_^S]W9-;AM)UO!?0;RQ$R%'H'LDV1Y[QE=M2?9HQQHI)'L=[]4&2!;9&($
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MZ9&EH>4! .99OVOJP4'HK]C2=Q_:=W--)[/9(_QT=5Q-4.M'Q;WLEHN/KE"
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MUS]O.ISNG)<5V!^/QUXW:N1*0-(VO6!9@O;45.YB>$F]+S1RJ<+?W5IQ=;;
M-*R8N":K#I-[U7X)XH*E]]T!SC*U;_]VO(+F5W9[1IB=,\>@3ZSNSK7_WZ L
M0^4(LN3'W_XI+9H-['BR.H9BSG>PV#/ZQ>YO-+%$Y9R1;<=70]OFFS_=J6#Q
MJ_-OOO9)[+=_^>JOC[_\YJMO'G_]I^^NO>_E,M3?WCJW\[=:A062DA76Z<3"
M4+GEV\>/_Q+J+:9VQ3_\Z.'#/PVN>E="YJ=NTN;.LU\Z3<=6TQ_)3<-*FC=<
MX@8M:;GM*^^?'<:ODB2>]A8SZI*+IBJ\WV$O.-I R] DUZ/M$QC>#FXOR@51
M0@Y!R&%T.2FQ[[,5#]1C"YKIM#@>=/->C"=&6@>=]^2\)W^W/?FBWQ/DD^"1
MF[I,#]S0C-Z>^!!UIC6L9ITO&IY+=\K$QLNG2AST6R%%-7BR1G@30SG%MBA+
MXN427J]CQ3S0/E+;G 81A%F-#VM[XC)U6HQAKX6LA.M$^B&:7/0K2]$_4;$R
M  4+(R*BR&YTFN3227F% +[AV8[<Y[$=_P>.%6]=SZ/\$=EJ2+E03=%D3&=I
M_)MMA,#8MOM!KFJDKI,<*U=DHDS5^0QJ4S?0#U]G5;EV9TR&XA0$O;QL&V0A
M_@1:.4SU*$^3L,)U(J% ?TGG0#R$2$24#.W1P]PO8K9SS:X*&0H-*26C5L<>
M5>P9"T)[C"T-'RN-P"TC6>@1LO=^!#/?R4T,&N,AE X=5F"M4WI3D$D>>(LR
MPJFQ]Q/'1./0IH6%BK%)BD:AK7#)Q.$E>97AHN?9RR,+ ]%WPG6'B)G7AE/2
M6F/TSG^Z8W+8@Q#4)Q 5Q3.L@S%P]9?-A)<0]F/KR.&=T6]R@J[7AJ"=5'Z#
M@H!]N=H8H73?I,*L2L/H6299[8X_>ZCN-%#Y[6M&;9$1K,E3-<('Z59G(G(+
M#(%, 3"/&/V#$>]8-T>=JBU!6MRW?S;O1M)/I@/JW@J%#)S9C(G:P+U;5GU'
MGSJ8>A(>,:K,2X[.ML\:1FP?CQ[+!>EEW[*>#DY@PZ7MS[""AAA'Z161MG.I
MP][DCOM;8=*.JTE0J'QG;@9^R.S;UOM,?X,BW9M53;VA<\OM4QI\V"NV5W=)
M+!^APQ; <IW91=4AT&96'+*:;86) \?#_9/K_1E5)FZ)?])RU5'4(:'SM *7
MA _/BH[F,Z1,FF<_D8?(+K;^G2\+VH 775GD$7RIW9H[T)0J-MY0YM[4'\&"
M69?\!LCPNBBKT9Q5?'<*]#WR#G,S9APAU=/ :+!KT(;IB#1/@BSZO55;7'.S
M;**'9FS=Q]?>4.D2KOP/2)K7ILPN0U"8Q#!CZ&#6:R$GAV2B __TB='^/]P8
MQ>V\71BZ^E1#$?,(Q&]1"0*3DD@L4QMC]>^^:/?@$J+9RF8IG*[^",K^FS9^
M;K@R\\AN4H&S )ON7;GEH<C'^;=?/\PZNJ*CB! G$0;EN,(5O CUSFC.RZJT
M%7I)"JY8+/Y7XB^K2G<EA#7DEH+$LYWZHU*W#D4&-IZ&FD2.G9+('%YTPFR&
MWN#UX/)=+Y&0H3GP'_PS)4.5C$]26V<'@MH@]1DSAH0#!WRPBLG!F&A!= 1@
M&'<M->W+=4A69NWE^XY _7I&H'Y>"-0_\N'^+,Q@1R7Z)P4FL+/7CI6\YG/_
M/IW[/-(2A)QDRN8K'(*7Q2I[])4_MZKJ#.QU800_1X>Y9KYZGPU"%<QG7?ZY
MB6O/U1OOGU9,3"3#Z$Q/'BNHEB?N0BC',-C?VU%_'L"KLQ?G3\_S[-6E_Q\*
M]E\18);^>^4H*CC/7HAJ9?KM6T0NY]D_J9LP^=6 )V%83\%Q2M;70::#V=R@
M/I5\/^IA"FYCT]#\D([^\_I@6K0!-7_=H>.HG<+B_[*:LX&/ EL9C11'U:JC
MRAKDF5Q[9D WP&(Q:\V5N)-)7'S\U/I84/Y;B$OR4,)F0A>6E=B[C22127#*
MPLHAB@SVQO5 J5M0?LFL+%TPS'_WS+4BQ7)6?H2A4(B\!_.#WA0/A#5[)MD/
MJGAF]UJ+X^EA"@W!%&KTX= -D,':;M\LWRK;*PT/U)W48J^#J-NRZ"[E(SZ%
M!@<Q570634V-='SN(R?+4W'$G3F*GH1TZWDD;)X/SWOD6WZ-S5C&CFS93;\H
M#I 0)V?R8UL<%KWW$C_]]"1,K:#,6U^YED\F9+F&#HBN\8-;M!B,\1?Z^CR[
M97[N#X^O'WZ=/6E("^+[IJ?QD7:5O6GZ_66>O>EI-O_+A]_D]BR\R/[Z^.&7
MW_")!E)2[S%VEW0LUCVB@K++'GS[];=?9'_]^O'9UU\_?#B\GVNWX+'_U:K%
M>(H_N??[7?>W/_]Y653+DJ=3S[WC^/.YM7;%1U+SBCM=AJ977%&.>])?Z(AQ
M#RV)A0-_$!8PW(FN)H_/T,>*P%0,X> +IC-][:!/[._@!]+.>O3P[!_\3-R&
M*9?LT%B0E (!TL@90.>$84;N+)>>V)I( =L-GR1=TX!3,N3XU%@!U1C7$Z F
MNBY)F ;1 15 >Z%\#&O:H>U7,'&4<"&35Z;B"N;0O8V>"?XT46FI@Z3FKCJ@
M#T0U6;JV$3ZTA-*,^#<TW#\499L]C1^F=GA?;8J]J@6[[,VS)ZI=&Z\:JR!R
MKEIRH^?HAS7T0QHD=<*7(Z==>/1]5K;G PO"0JE2)5_;?@?%EI,OVK^5"E1=
M'<]4""J7W RC4C#_O(QXJ;O@:F;7.U(UA[9K1O/[K#T;/"V-$+ZMJ<WI7_$3
MLAY6/<R]Z2W/<R%HW0M=P O74LL4>^.5"!,E7SH"+$*Q3AMX<I$+K5'F >PC
M__*F7_A-W&[40TW^TK%[R/R>NF+2^'BBA*E&GX'1\>.?UU\\\,4=SK-7IHHZ
M?9-RJ8RYD%<R([IUHD&5+MR\'7ZGR/(#[(6)!'[*CBCP\%ZZX]E1UHK:+D1N
M[=0[G\O/][3\_)=[4GY^-!>?/W7QF9\[*U>, __?1\7_DG[>_S*LK;NK:73V
MG+A.'UW<Z<SY/'OME]+'TUC*WU(%^60NZ8.OS>OG;_Z1_7#QY.>7K]_<Z9?X
M^P0=_Y<W>>=G[CBW8QIC46?:;HDRE\J'REI!"2VITTCU'G@=OSO.L_^_Z0F?
M2*A>XLZBQL,A%M@!<F-!SX1KGW4L5:MWX:KF.C)."0ZIJ@)ZG@=2)VL0-^>.
M%E5)CQ<%O#%LG,+15+VR;E1N&$-SDNONRSU-U"L'6%'[,Y6^'^)ZRKM[GHBF
M[U[41740$/D/X6>?!'@U?>9UE U_&:B<<V4B7I!0.&:BF 47I+'TOJ9>%E>D
M;[G> C]E2"GPT@T-15\[0F,XJUM^](JJ4\%Z'%0M)L- 34C_2<HQU2' ,_1G
MM122\R@7]5@6SC^-$](52H+D&),."]#T6=^AFK L:I2*.A0Y#MX*^4-UF+D
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M(4BU2&N8ZWS3FP1'N-3PN>P37]VMLM0H70K?=,(C81%,"*H7RA-N'?^//@-
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M2@'<WW4):EER@4>NXY_#.\.KF?WB3N_WB_W>$;D%%Q<U1SU6.00#K7?DKN4
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M-4L>Q2AEZM">W=:?:QA==B8XX=M2=&.<QFL$D(_IZ@YPGQ!I  !(5/@&B+S
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M9?/^F??/QTM2N)(J&#L?AU'O70:5+!4'SWQ6):G\G&C9A_,CS-"70G*K4:'
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M%-3"N$@!J  ;!K97G[Y$3E1R/8R+%#"?@)R2^J32@$]AU!C\Q[!58/,:\C1
M)Q-9Y99(X-OS[&G@DH=G2_"M8-!(?=UQEF*@OP*Q/2/Q.N)?(5[T;-5<UT>D
MORT^&]R02BSA_V>IG-8,#J6@0NW6/U;D11Q2:H./@O#D^G.1"WY('S_D7XG<
MFN$- 9\&4"1(%87-,+>LB[)X^%$&QK<W@(6#!N>-/(F6L,02)=X_9L1YJF*
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M:UMZT$J*IB=R=3#/'<:S["+C2]<N[-M*7#K-T@[>V>A]\13DX%K=I4Y#BN=
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M1HR)[+* /DE\2<C*I:<K7)&#\G=GAL34?TT3#B<LP\7 66LXHKX.%Y^^G1&
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MY;WW52,/ZJ3-G@I0 E*SXRD%R&&D>H(Q,8 IUMYA\@3.U+ZV,_ZTM]$R3?9
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M%'$:^+?3 Q?8J>B-4##HK '-?U(HU'<U#:'^UIF6#%D\/;,.HH2I"QXD)1P
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MZ&+=.=1-Z;KA$7Y7K#@"_>+S;/'DLR=?LJJ#!H>??PD4V@5,H,O2MB!E@?9
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MTI'^"9(U]TV6[L*BI5Q': (WR4B&R%5U'W)*Z&/?2<\3$@L3X$BR?P9V\5H
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M*,P]IS&?ZKP+D8G5?3KM<S ]J?,!XLY4@B;>XV!>IUC-W2!='J(WZ'PG\;9
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MNT7?P91X45AQ;L2D^0A9SSM_*C$3?KWLT;ABYXE/;1';Y. 42!X^Y0G=D G
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M*=R8HB"&;^W"3)/B8SCTZCW_'-9P6 H7]>9"7Z?<CIX//0<%99X*R0+IW^)
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ME_+E:].=X%&6)^N7T/?5 KJETLT3XA"2,LF:IM:E(^=0&O+%*D\*: %&QNQ
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M%NAK*O=+TEC!U?%%>T2KTKK[&]4)Y>D2?A9I14JN;L/#A=7=YQS!H+Q%XLK
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MJ)<2T1(MC'[]96G2F64ST95-:>Y)AV"*3QOL9+<\BMCSS3SA&0LDBX.WZ0'
MH[^@91!@5^XY YS,!(<VE"A+"?1^#_C4#(S_X+OYAP'0<*T(;,\S*&ALUK,A
MX#E%(^6>LG]-#58&]281,ZVC;&<2]\G!(AUX$^>+<!4(R8^8XW\+7_Y3'UFF
MT)PKC!=-0Z (MLU8]4:L%P40(<H^GH9L!,ZD( >(4^MM!\=\(:24RZ;.U[OC
M&3-P_[T=/7ZI/@,C99W(OE:</"-?)A;'8OAMLZ@\2YE,9*8 ?Y#;"M?#B3HV
M']T8\'" @_X!5=^3*)=IN.AIR1Y%DJV_/.03S^5GPQ#V%[LP/1<BC(AAA&?\
M?P9I/TIXD5UY\LU_IBG9@569S+XB6?@M[,<%W;']"TD(4KIP9&GB,Y 1^_H_
M'Y3I^?+RZZ^>?/[U-W_Z\L]/OOCZRZ^??/6?W][687\AS?F7UT5Q"$/=V01)
M2A3S=&9B**'WS9,G?[*,GLN-\HV)GVYPU8=B@'V5[XI\S_\M5Z^7Q++ZRA!/
MV**J"LSJ2"R% ?$0TO8[(@B<K@N^KNI;@$N,!)#/?0*OK\I.:N@44^/'FMQM
MT? *%H\KYQ3^[OM*T">9B9$L!):JTB3DO\BO5_(SD_<2<0<^NWA=$N:%2M45
MY'[0D82PORAEW(ATBZ;A?B; Q13Y2I8_*MDP"!;0\K7*""5GD'R=&JFBX+2%
M/62+,X97T#'&XR-;K^QDN;V:<8T\6Z@J6%)BB[7(,B80V#YV1;/7@JB?3D7/
M&E1$3PQ'\< 3)@B^ZHAW2T^'KOF4HF]R%>'B*(KC#H,KYV"JI1_\H7$B:!GT
M$/#93RG)K<*?Y-1?1HB(O*@&>07^@KUK.?C"Y_ <#7NN7B&6X6T48A9O5L4A
M<FVXX+/--S2"9DF>BBKWD8 VU?YH39!'8BUNFJ.I6R!:6!U/4V^#FR17QE$5
M9JDFE/&ZR6\KRIRIV&EDP=GMBFN>6Z'J0$(IKGJ=(FPYG9YVO();D<VV-Q]C
M2HJ? 9 A1KE-;K@?7A/&@ND"$8,:L?;G4:D3T:2V.4I&+3X_]DQ\^B$AUM@(
MK8DLCZY8%?RTHN0+92BR0[MB?6V*X89:=(B4DB5KPU=ORAI=BB4+.F*#ZQ5I
MAAC8D<OGPHAB02<MP<W']7Q<_V['M1I9[B6"U]^@-R*<3,&\%K32RGVKQ#[N
MA.!O?(\//>4/>0*;[Y]>Q0XY(1\*CPMZ(K0Q 2:D664ZM_]95-&-YZO_UI>+
M+M]KVDL:X:SM"5)L'+H?V5M7IR+I+=']K';R+K>";!FW_,-8D3JBE)Z6A?Z1
MT@N8(&+N6M'%:R8%0RC4[T#HRK.R8<=#F\-TQBDG+T\4;[W/7^.V?,?1S?>D
M5P=U )@*?D-D8!L0YR!]R&EWY:2A,U ^-S$X_/FF)NJB=:&D,I!&6!6HFCCQ
M8R!SJ$D;_6:2/M2'B8F>03?1R01ATCJ 4\L -,"L/;V"GU57E2 (*:R=>G."
M$=43*KA[%[M\6>RT)9J])BD"%-5U?BWH)C0U4P, :4WW.XZT1X'T0;.C(.S!
MO##K:HG.).*P:A5\K;4=OH'3737<GDR;RXO1ZCB=)J.C%(@Q@Z;><!UT0RAV
M#5R]#GKL\.8:G+P[*<3YSS'U$N5 4J=PD2 GK:0;JU$IO68N?$TK)8(*2U2!
MAT@+/'-MB_00+U7+P1H//OLSG;Z\(JU<+':$??7?>NISKQ64KA[F!FQ1M!Y%
M*1.JF;9%$V(LOT23<S_U_\1(;0L0N2*[D:Y**D")IH1S.>X^JV?HTR. /OUY
MAC[]8:!/LY_\._K)A"#FK.=?MB7)R?P^GO-C=)GY-%?OSC)'A%)PY[@0ODA@
M2B?JNB#]9?J<'&V0W=:C# $D71GN!!S%4UY;>[GX,03*-;33TW,3GD<49!;6
M 3ZL2Y46<C&FX;+/YEK(06*\67O6FX2G*PZ+7CD<F7,@.P>R[[[P]_S%U=6Y
M5E5MO;#X-M*C;Q"Q('/&45<>G/7]H8N 0PI/"">UVH;52;];%UKS2AA>N+V_
MBSE5IZ4MH>Y4!>Y42IM0(?_\YTY&U782?,@N/G??>(UZV79-S\G#/#Y]K MJ
M7ME?CY+F55M(P VIA]:,1)Q!*Y!9W'WJ2<AHA&6'X-:%49I7IY_[@R=3W>3,
M[L41,>99_R:7.Q=ZQT@8&4B)""39'Z^*4%HOSW;MMBEU%:SK58]KR$.QC<[W
M!@L&O\:_,;#PG^8X$>;B1NM@F%BI;[-P&01:J^,73^M[:/8O%Z]2K,\=99DY
M_SD?&Q_GL3$D#OOA^<_/GOZ@'"EE<X8&5&1RY&R!C2?@4ZN<WV"B"M.[VKJD
M3DRJC9FU8^*2"F; +V\X#6&\.#&QA X[[3[3'*<_=!3//@'Q,."'-G]&R!Y3
M_U&C;+C&-A@QS3_Q;$0U+<<TVK;UJC0^0QU3\&C1/P%P?[!(.K-4N.-C90TL
M?1@W<W),)G>9PU'>#Q_T8::(7G$J;VW?B;ZYU]NIIP;-CW=-MHA[B(,'4#=5
M<33](PQ3*=&/3""QL_L++!-=T_D^O^;25UG]VE>1FR%1@%G5?2.<9YP?2TPT
M/Z0A9MJB>!V'),W5X<,VVVWGGF8MF4OB,H&[D.;X>4"S=9VMZWL%@R3(Y 05
M'?.K=T"1,[,9\2N3E%-LE>4F[70\H*9QFD*0"B+PHC(C$A39:V A=JR&6R*X
M%LSYL&$\,]R$ 3R>;LO=.LR T2,(4^!SXSK3UF40VC =8;UX^N.KQ.PCX<<.
MF57/G78#3?1&'H95" R\3M^P@L;B$U5T<V",X/0R4A!'#]A?ZP.5#+J&_W6H
MU\'(X!]L?$(\4Q_$PG^:C7%_"?1[\8G6$&T<9+A*(''Y@A5-Y@)71'XS/ DW
MT'=TC";<05P4L0M%83!NQJ$(!TZS,N4F9R,&<O=7N!2P!$A4[V3OK]S3>J #
M@_>* /EGZSI;U_=7NX^<-*AD$G?3(27+[2O@::CZ6O"F4D0\<Y@)/LN8M!VC
MH@<9 0\5_\F1O].CHUJOC6'> _,>> _)>/;6J[61WA,U,1W\X>136!G"+TE2
MY,O:*0^GL!;T2KW6Q @N.L; &""<@S[KG50-3$V%E4Q-!9KZ"%X!DES1B5.9
M>G,FZ,2ICHOP]!<)O]94_G"<953NZ&_IKO-&G#?B!]F(<D:((WX:#,1$7[SR
MI'\+WG!D,N-VKY@=/4%Q;H[93;WK*Z00W.5("@W++?+?!E>ZN,G3NYIB&B&(
M^MUUWD4^^3'@B9W[FMQN,1KBN%/3I8R\J-K80\0.L@=,G_+/AVTTBS2!\^TB
M3OJN7B4)>9UR?L;K2-E+Y!7IW#&GN4^2!R?X6^=53"2>)-$E)A'"=.'"PI+&
M#:XH4K#E96JT5. ,VC=XP W106G+#"U2*KUH(@[9N6[;M_)$2-;'%GOWUD0A
MXO*$L?O8&^-4!QIX&Z5W]<@W>MVKDO.-*Z(%+5O"H2]K:F4XAXN;[O::)'T%
M>/UV6YN0W29$I\H1+*0ITQU9+&<NS B2JV3R1Y GK%55/!=IWS;==QM_R/K=
M1NJ1?RU0B5</ 6NJ>"/G?W/1:-A9Y6BV,TT27OR^89R82\B>T2FO)(ZM4#YJ
MCC"/*-5B,+'L6A"[VE)\AQYY"4X@@.J;F4CX%TG3H"DI.GP\OQ2_ZV*?*^EJ
MVW>&)+"T/C:33V:-%@,FU[09CU>(]5_2&X?'E+QOE("D[0-!2GNJ'6_P\K4)
M(84QN!PO)!P?<L?=QVZ,OA]%KE[;8EFO#2%L*UYJ#];R$=XXUJ)N*VWN2<2+
MQFP$0]ND/++!NV>#D HLN1HYR&.MOX;1P#>E;FHDZ;MN)SM9P,!>^\5$6%X6
M[:&NE,THO8?"3XDYZ4+4V\!F><%AM5KJ\+&'O+YGV.NC@KU^\]D,>_W#P%X?
M-'_)[ST/:X+(4#JFRMF)BHI-'?*2Y/NI[K76?1T9\@ %U3@C/B6VS(56I;*Z
M)1(Z1L14=RAQSM[( UY$SRA7QOBN?"#2.HY[D'YC%KJB3=(2S@&]B_4"S".[
M\G4!*D(LJ]T1/#=T]ZB*@+!X4_?5^I33RYY0C$<60B+'KK]2A=2F$YZD$N]@
MY- T9<_4.1/]MUZ+GL %641AL Y,5 NZ*3R80T 2!)2K\.^RO:X;GFB6FPS1
MIZ17BC<A?&QM)_O>*::UF^![CSG=R4;V;*&H% *RV6":XM!WRKA%21(:&!YA
MR^QYFU)JE#*;18[E1;E=+\@QA?-!D$PF GR%)1B-QDS.^<+D\^#>7C.(B/BT
M%33(;S;^"I7BMM[=2)>VW"^L"DH=NP2)YLXL<M4<6%@E75[N(EQ2 T\)SM(U
MF2V2; ];R50",;S-IC]T@R]B?<<%ZS,(4^2 3JK']6_B(4(\N:?Y4Y;)FKJP
MHK!RFVP9RBH!8IE.Q"!<S!BG/U[CNJ S@<_0_DJ7=9M7FN&/F0Y;M.U;K-K'
M<4H\Q"/A S!O>2JF:%^+L,KJ8\%2(V$YE(<Q!Y-DW0SP$"DK<:X0( $+$<VJ
ML/E[I'Z0%;&M8NVK7N@X+L"IS>_I)1+2X 2.PT ($/]2YHJN-K.B/6X/1SC\
MF,;+VF+#&?L:C4;H9+"%Y1;;\@@;_CLMZLO%C\FE^2R*KI2XVX A,6Z<#]1-
M.)R8'K@>U8&\YZ(=1Z1'0]Y'M/"T&8"^M!W V1PZ8$BNJI<#-Q8X9(KN>RT_
M+*^W->!%FW2X3HJ"Y\!E9%I/BLE6/U @3KO<GH+)BBA7O -E6R68U7\6*7:#
M4]_/*T>HG'$I*//,<P1?GG2&3V>XAG21407XQ.-',ADE <:\96XE9@LMR[?@
M<=M<K*6#)!8?:(KA9BI]C0J@3-Y6*)!-1=XZ6/+P%L.JP*,RU;OH,JG4)OZ1
M3I%1#<@4<D,#,&]9%%0C-<2*/6%MKH^CGYSER\4K<F/=CN1= OQTV(#P^CIF
M8N;#0.H8R0H1=F-]980\YD\926!'W2N6#>5[1'[HA)6H<AE/+INTI,K7MXS^
MH:I#WSA/6I67R WC_,\B&*&V%"RV(-P9*+\N2 1%K4WR^M57#2LDW%6BJ()U
M;-".17 G)6O"&H*\DZQX=NQH"$N-T%D37MG]L93ZBEI:L*7ZBE,*:QA)N*!A
M.[4*Z_:$3/W(PQMV5SG_5K/5=+VP*GN*)]JNV.]=6Y>8NPEKYV*\(3^J:;Q:
MF0D[4MHVPXJYSNE?B.58FTD_R&^;TQAI]IMU70>9#.]CR,J3A!R8K>:(\%^/
M"!]7'/@1!RM3N=_WX0W?:RI>PF"]C!!Q"E1([&-'B@>TNE\(4<J'<NH?X!M]
M?.'G%">V$ <SSK#D_M2VWY#>N$+:;1$XMAR#"A.@X*I_$\Q.=I[9V+-WTX6:
MDMNU.A6?*9G]6)B/F?-/FD17X;[JJM\YHNB[L <1GX8RI^P><V*>D<W$N< '
MFB==3C4A3$W-(3?9#5DQ81;Y1_*$*=EO.$&([LEHQMU%?[]I2Z .IH4RQ&?,
M$?GCCLA_ZO\O>^_:Y+:1I O_%83C3*P=@>[3-]W&[]D(C6S/>H^]<EB:,Q\=
M(%'LA@4"'%R:XOSZ-Z]560#(;EDWMH4ONV,U"0*%K*R\//D\5JI$+8L; [E#
M'4_E;M4 S)).3^QSC!C6BZ(**+\,?ZHE2OX<H_1E0]JZT6  W-!*17*B"$.E
MLSLEY9[>JF82Z6,XCFGJ?WE\&N.7I^>'M4\WG*O]H+=G6-W3070<LG3,781B
MS I@1X5TBB'I'M5O$<N?IQ/ D'/6I3GJG8Q4Q6I^)A-:%'47I-AX3FT/^AG.
MMAMPR/"Z@P"93*-A.-]Z1"+IEJ8&IID*2)%W)9'D^=3"LR\+LQ"E%E3M0S:]
M"MGI?>.;DGR2SB()W(CCCZ7GBK;M,7M(^0!/<;"P //>I0K=$O^4#JM_/(&H
MP$Y>*%%FPVT]?'+6.)#/2=DM5&PP!@B%"7%QHA6%MXBSS\HN3J[K8VW[Q&,O
M?3FA#")6="FI"]@X@4;R=0@+2S?V!\0;B-JVERBL&*8+23.;&"S(SDCR$+"A
M<1D8)I=T:%0%G$>]Y9)/;';'[$EFU-C#0HV=SZBQ&37V$(]L/3?PB(1HMQ%F
M^YRK;1/=&"[ZTIC+[WU3M+GB?NN^PT:IYK/1MTZ3%S=8R:=>B=&"D+--*[D>
M41\*=O83>[M#@O#!CD2C,P=:FZ2O1 ?O9/@.Y_P2N:.)L(OEL5"&EJ9P\!'W
M'"Y6I=.3>2O]L2RM_8P<S!Z'%YWJ6V<TVBFDW\62GXF4Y.$K2$FFES$H+'-8
M%J+U)W<1Q)3,!0P7(T18&,;(C+0/9)"X>I!R#60EP]7P<R;0.S!2,4?Q1^P2
M3!1OS!-WRE(P1:8Z7^%\.[:\N#G$UB/QJY 5<4F]<0KHAR@N:Y7D0Y5?%:O'
M6U2B>.Q%ZDR];@%8E3);8#O ZY812DG+48.6U(<+>@/I$Y) $1Z ]A,W1-W*
M\1P#?HQW#\T@\^[3]NN>1?*M?MKJ-0:L^):.>9/, ]-_<%GG@>EI;J1_O/KE
M]4O:&K<9-]%U>#KJ)JMCTB$\'>X=81J-QA!YKAP<3IEZ(DO8WBFRAGDRR<@#
M(,4SGLAY[P7?0UEM2<4M_#=XJ.'O!GD/(RJ]@(MSPY:[W9M6A=_YHO54EB\U
M,3S7V15RZ0/B,FR_F]A(*@A>J5&FN&UT-O./S+OX$Z42=Q6J;$QJBU6SB<XF
M^LFRW8F43/YK>8.($4A5\U13HHP4CEC9Q1$&\;9^@_]C631PF&"5DR20#-!^
MF$!Q+A<FI3BQ%,QEM8L*H9 M@?N& V[>$?..^.@[8H 8L 0F]9JA</% RS71
M3C9^&KMED4)L5-;2AAU>@'20QL/D'CPKOX^!EDFXN.-/=*^R?QB85V(19A?@
M$-&>EFFR=8% .:PFK3#Q9+TLG)TI"8 G8L>FIH$$NFFB>LVDCDP]&I]]CI/&
M>7O.V_/C;T_.2&0NP&^"W.%V(LX4.G5H%W-%DH3!J"^'E5Q;P+"'GH(5ZB9N
MPC%D&1:B0]!T&GX1&9YSW8A$]SP5[BFM6\Q'(]^2_XXW+.9VD!")U-ZJQ%(K
M)5+U=.LSU?+Q8L=/'(D1X+.8QO,:)Y\;> K7W=1Y*T0QZS E$5]&RUK\-;X_
M05#5QFT,.MRS'YC]P$?W X)IUQIGO?%FC@AIDU(AB2_QA86ZO) [>3 @$I8A
MQ13N$*D=5 ZOC"7/(''(DR-:D8T\B7S&W)#M"403V1YA6$^Q&?GRKX$3S/MI
MWD\??3\MA.=LZA#;VV9<UVTWZC4RNU* #K+2-NK'%'5.S5"XR83:]WAN4K<@
M=!<QXQ28DVZ%K1.NPE71M)U75PB;/.K*?!348=SJF#?DO"$_P0$7\C7A&UTZ
MQ\(MW#;$>@G679A_/G2]=XP<\.-=PD[*_029AVO6*)N W'M;D>SVFPMS42K_
M>S*&01BH^BUR7=F#&FU+O]+ZCY7T,NTVY9Y$90;NV!<PT&+AL->1_)PURYOD
M_'&:7)R=7\[;;MYVGZ+SU@0Z&\N.V3CLT;NDKJ9THP64"_NCTI' J$TGO(6P
MOZ@8$X^[C!'J8$ W0K0@PR:,)1J?PRN>Z"8:J@Y+488NE"9%3%3*6E:ZC_&'
M^P7LR#%P%*R@S&G46<F%49:OJ6;*\'D??II]&.))5>;)IJ)07UNQL+@243FK
M[!:"/YD*X;\ZK<WRD'._4?46VLLLNI4R/)I&KJ7=;N?',N02I<VSP;'=OE((
M&!6!TS#XP84?Y $PU=R)?*_0N_$//)-4WSU+$;A6+0H+*9^(3")ECE1/B^KG
M#G!2@O]#4FQ).=1.,+$(5*[:J-(IJK(T=0$J*[8%F]ADZ:^C,8FLK7DX:4G)
M$H%%,[H_5 2"I,<U2H- S V! $'3'ZS@X]Q_1(G OT@7SF1&2$(O9&JGN(E9
M$\@>&6G1=YN^T]BJH)_L:CB02'G6CTZ-#J/3Y#D< 75_35S2!#-GAG"<'1<R
MD5Y&Y@_,C#'OLQ1N,?(4O5!Z>WZ/_H$G"M/[ SZ:,"8?8>12?YH:3O/!)U[\
M^K(-8_^Q#EC$9Y,J&WJDLF41J&D2$?'9TK6(/_+MAY6BQU22%E:BBEY=-I7W
M(K,9EJ13QA:"5_O=U1L\SVFR9#BMBEVD<=A!5.CA!XD#1KD*1K#7B4G#!P+0
MFR=('L $R<4\03)/D#S$0"6,#1C,B^]'\ !WBVGD]L;YP0\61L%*3Z"KY]D,
MK,;X7B)W(@HLJ#0=AZK#CS'@QIRFF(;&7_1#$2A*E4H6&$9,B,P*A=>=K_V:
MDQ+</TXIL]H%RK.4V37\XDTAMZ<T.>$B"MQ\A\HRGZ/Q/ T6EKO=!B<52X[<
MZ,:);0>IM\KD_"FJ W<W[:"\S%$7"8PL,\2J$^$4K1\!T1LZ5]^Y#$TBPSS_
M[E>?RF \\F+@^]R$\BVI!LF-\@"''S1TZ^:NVO<J &0M(<8J$%=7#XB'YPM.
M:'*'81^-7OL&A0W&1//$=R44VMR:<7!MW= $>+)V)+M#RK?@9&"G4,&)&:DL
MO8.F/UGN_M4S.: .1E/0S;]$MMI@Q:HGUW(M U-8E(C852*DGG(SY/6AGYBF
MC9!1YW$C9I=&J;C2GTCJABOP81L^#KY*<S@5$F8=P"5J,HD)3<R3)\QI2MJP
MAPA^@A9"* DGF"' =R-NZVV&R>P\$3/7 [^,>J"P)@PV/9W A''J,::B4Y,8
M1H6]R3>!F6#PD%M(%GT7+H!>:]#GBAM<<I;//:G9]C^Z[>/Q0CR0:)5TI'CN
MEL.Q:#!@,MG],>=LQK,9'X49[P72"@ROM08^6^ULM9\R\, 4%9VH(SX*)7LR
M3)%9*?W_(7T3-HMZMF9GZP+V0[,US];\26#3\7R09T'1>H".X?6M@K3VI+VS
MQ<X6^VFB!K%,3]L;V-/W%G!\)A<*X;.YSN;ZJ<=')>)5A8Z]2 :COD+SGPI^
MVA(<,512+=8I5&CY4^.&0($L5]D;[1Q55"3E)#%(@)0H2Z 47%XF(DC!Z*ZS
M9X ?8B' 0%82-1H^^CK[O8[(BQD#-1\5\][[)$>%M.]<18@D/@1"N.UIKV-R
MK8/-N&(EA @I([&4F4K*@; AB>1*P+R&4=]P9!OE^GDGS#OA<^T$!1.: OH!
MU0)KM-BIRBSO 9A[AE#)2)! X&D1Z=(HV=A6B-,L&O<M[,)Y+\Q[X5-PJ7GD
MQ2HQ]9QWE.>>\=BQ2@4O9"!#2&4&QO*SDLHU:UD'>/5$>9>A0@$B+VBGR8Q.
M"FZI$6:99&U@!MTUXO0S/H^CUYK\<R_:9\]HJ1\ECZ?MR*>&X!Q!5HB0)=C5
M9"F;F"/@,OT ZZ/7(2UOHO>GY;1C@*F=="=8DW+MFP'!5CTQS34@@$%E*95>
M#X,4-Z.#CGE[[;=.TXR6K$L8N]3+$8)F?TP;-IOTQB4:WM\:UZB!M 9RZBD:
M?*&=+TUEC&82V9<*OTALA3(WH-\*4S<Z#Q.#%?&J3(^]8D3?Z N:*VOT/8&?
M$@57HD@A"5*=S/#_RI,9B0S'Z@].\'A':AA2K(*=BC<#WX\G"&M8+GYKAI"7
M2P'*EKL?%Q4-%Y:[>?,>\>9%:%_;@<>^9G)TW9EB87?JOZP*5^;M'I$79N0*
M@-Q8VD6&PXUFRC1]=1R2$XF1S!@%:LJ!7Z%V@.5Y)T=R?X3- ?K\B5W__:VK
M6/D2)5L4/3U(6>@.TWC@AA[&TQ;23^+)W;0WQ>:0-@V6LBB)IP&:>J50/E$#
MEC6);H?Y.JNL:5!194"0"->C <.(^Q <QB'F&E.EF*2G$753))/:1U1S%PG-
M?5_7P.\Z>1WP+SO1W++4D/;&[T"63KJW(+FMCX@Q31 =O/N0(CZ=L<0.,X.1
MHQU2@Q%*-9(Q:.)=&RJI<G,#T@,2$;BIX2U-*XK=?=,X@G=#LZ,5V8_GUR)-
MI=P9)2@1#-(Q-1K3QE_M;956 DJ^XD&=@O2^]S@?-$=\T" 6V$;VP^D* 2.+
M\%-#XYM%5S(_3A:2E?VL&YC5?78FDF,VP7FN\&'-%5[.<X7S7.%#]/5_G(W)
M#IZ-SPD,22&:"X09==\M:5:.0A$5E. X8TE$,UA#N]9"/].MA7RF)MP]WMUZ
MTS'C#<LA2<CJM9XP7,N8]8E."Y9WU )=D$MBH5,5B1Y^"W("F>BK<802[S,+
M"DR5B7K*G>5CP*.G545)2!R6Q<8+7AXX\GRF! %2B(HMQ\XP7PA-$Z2 \./]
MS"S 3?,*O,= =,/S&,SQUQ'OR8/Q%WZ,]9!0@1EW9,(MN1""^0!L3^S%=%20
M)2C+>(EQ/N[KH)?D-=$"!PX1-[QR&]B"*/D"USKGRME/+KO9G;Q:8^+P'+8%
MW"M\]):\P_-E1^G#Y+]C<"84R\3]03^"E86)3VN/O(U$9VPI;"GB=W ANWIP
MT52^++T U9WALCSW9_ YX&R=7'*M5'H*E]S/.A*[BEQ"?\^KW/*S<&!:M)I-
MX4TT[MK3(\MH(FGG\-TSQQ?//>>DK]<U/M/NII='R8$B@CWV$;?.+DU8%=0'
MJ\&%X?-0TG?PTB(.7BQ[:I/@9ZE_!^>_Q=G3OYU_:Y8YY7EC5V5+XL*N!O:(
MJU3((L?' A6'X?W^&]_N=2WT2=NLR?49B?637+\'\,N-4-ES-<UJ@H^SP.EX
MV/R.B/+U&Y-@#9SA8A$*7,^ETT-$"P.]G#[PR' VE;L#%],VH!FF1IJ>QB'7
M"8W?(G *$A<PS )R=#',J>U ZT7-(>&.\].<>D"'IM3SEBI,Z=Z+T0O&4B)6
M!(E<CB[$SPE[IV$FN!LW4%3C*CN>/VW?4"7$"SD9-J58BGE$98X?EV*6BC=1
MZ;H-6I)1R9#8M%C[X%V'8GT80"K6XPG9AW$L'N,9N.7\8E&7^3NO!OW47XL.
M;F3Y#NOS"]L3A5Q>9J;2^N 0*A4A#7VSL[*(%%M#8WI17VU,LC46D95I^+WL
MY#,LU1QAC5LI:#?*GPXK4-P6>1^D[PRCBC@L#._QU)2XB)L*.X')FDB)XJH,
MU8HH8)IH6/JZ+_HQ8KER%6G;K9Q070N3VR8K$ "A5X;#"EP\9APW1+FI3W!Q
MENS@V)!C"/VX/>TL!2X.^6=-":Z[\Z0BV,?WIS6UB?SG3Y/OL8_9>I$Q!'EA
MGD2+ =X>4T7I(D<G9"J#SXC36,4J?)3A+.L&Z]IUI4K <F1XC'$G9!-4S!:N
MB="]"?,EH:TAW>?I[8Q=%YD*9'>!=U26XZ]G_LN,)TOC8X/7@/)8H\[J70NN
M-A?4QZAF&X/2BT2*5/G;:?+WXE;N+W8T&A'EOA-C -ZP;-BD4RI""2IK[$B[
MVP*V!;5C"$F7T8%9P;]-+8XN@VD@4T?*^$/J0-.2:%:!?8V;NNE(<)C:TH.O
M,&>[Z0[D@\9V(+'!&_4Z"E[YH^E6=5G4>X>(#"XVM."ITX,4&Z9=8^\BP@.9
M,;N ^Q&@SQP+/*!8(&*&B3DGR4LZ]6.F^S>YMWT$25X62T2G\]D9+?5W3F%
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MG2=@+K##>\Q.?D:N/2SDVM6,7)N1:P_Q:.FBHT6/E.$I@F IB)4;G"XG?JG
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M0P-DW_Z!,P"2AY9*W%%&-_TL-NZ.;H?W/->R&(H2P_4P^HC1>H$S*'8N$#.
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ME8.UQ9T-[PI6\Z;83.YM[N[\3//<%]+C2NEC\):6/244TC^ED)K;JA+&BG'
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MV;4@'\;PY+F>^+!/$JPG3N/.ES*$/[(63CY5U,X8EWCVR/R8T2[^RT@2CD9
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M[_PR/NR"G)U?@4T^<R?9LZO\Y.KRV>)D<0&FO7J</;N$XW^175U]1IM\ *"
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M'MYR/Z!Y+C:E=>7LH"NG;UTY.TYVC^O*::D$^WKZ[0_GTZ>;ZR7W&38:7?#
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MDBGO%U^OFPO]7M\=#0;K%L:3U&7VJV'_F/:[*J"'ZAPF=Z&>B6N01_?(*'4
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M@+8?"FP'XSIG7NP%7EF38;XQ%;$?"NW<PLEZ'@:%?5654>7]E1\=.=IXY:M
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MUPNN_.6FH5F9-+4N(Q9K"D$WI0K6>HT>>0V6>A4121Y(PX89IUQN",G]6 ,
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M.G2:4!,3G!2I;%Z/9-](C92I='V#7]GOPG0BS$*NLFYHO,^=,#AS=KO/JDD
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MO0W2F!(5 ]*RX=8/,.8$]5^D^6!9W9@L/<];=3"L]00S?JF/=.-:',,:KD-
M>Q%P0,_*I+<_R'>H/BJ'Z47A=Y3,:@9!^6NM(Z<TIE%D-MG3N#PA>K583U\+
MH2#;T I3:]*:'/C2Z4OF<4BW3[_Q!&GQ0[HU,5!$=G@1R:^>?SBKB5TV#V6U
M1X)COLG-D(&,C:E3GYB'Q5SU1\ &;M3T4P7 ;C1#SXK@#0R:KO\3#9A^:MEU
M%] ]A.#2@QO1QZ_=:WOAFW(R-TD%[<PW9GXK%WUE.'LR#P%C@?!H%/L[^!1\
MBU_71=ZKWZ@/"\?<,EH87H?W>9=PF$[)7WC/]S"/^][@^;=Q^G:]=M0Z='KP
M,5MRG)8Q8PO8VHL SRT9%<XE T4F*_O(_HN$^P?JB/!>^&(^!CH8]EUGT!OL
M$X' ?PRM ;'3!L0?%"518?],<'-BS+9EIXLB(D/5VB-."D8_H$#VIM[JZW8
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MQ,)+O5PHL)!FP*_]5'>)7X99. ZC,%^>J/<;?-V\VJC7'1[B<C\02+@S>4H
M_(]W/[U=\UJ_.QC<XJV;OW+<[1\]SDKV2,_X2/!:[]KW-H27CC:F2C?QG5N%
MG+J]?K@RDGA-@$G]B3F!?+59WSEZ5DIB(Y#6JX0O DYZ@OQ!\P3Y&\+L^IR0
M1JANIWW?%Y3OIGQ?,6&/DRBXP37\"U0FYP-H.,'?QNG;_WXO?#$?B]09]MV'
MQ.%MLD=:>R.60[2*0XPLAWA(#G$V\^)I8_F/52]:1Q26>=R0>0PL\WA(Y@%&
MRLTJCZP>85F!907/E!4,+2NPK,"R@A?/"D[G8!7DEAE89M!B9F 9P,,Q@!84
MPS"H[U /<P,BV)TBF:^I\*,PQM/#]XL@A)UA.%W_,4]# $PJ(B\7@>/Y>7@9
MYN$-AU5M#_M[X4'/+*=H%7HWS5AK"^P>)Y/RP;#M&69/'KB#X]LX;)X#-CXR
MT5J6]Q*1S+*\MK&\D7L\/'ZAV&A9GF5YEN6].)8W'-VLT?KSP47+\':(X=T_
M 3^3$IJ#>_*?W:4SLO6?-2=+B7F8Y>G2=6 KQ<3S\R*%M]B)!H^E261]95:+
M>BF2ZQDJ3P-WV+<NLEU"0LOI=@IVNXEDSY#3]=U>[V8]12T26DYG.=TS1[)G
MR>F&O9OUB[=(:#F==8FUQR76'_9L4EE+G6)?19HE<2RB=B#_"V4=5CY9)>FN
M0W4& XN$.X2$EM/M%.QV$\F>(:<[='LW'/MLD=!R.LOIGCF2/4-.MS=TA_LO
M-?OU<5K%6Y[7=F)^)BZPO?W#S8V5;6+8$R:&)7%61+D7YUQ0F>0SD3I^DN4V
M'6R7-*A;EG1;'>O>0/D,M;"!V]]_[/#CK3MD6%2V'-5RU%:BH>6H94+'T?YM
MNHU9CMH25&X+H"Q'?=%H:#FJCO[V'KMFU/)3RT_;#+WGYT'L'[8FA\Z<O$6+
M/*1#44*=9EO18N;J\L)VS-_X1Y)[D9->-Q*M'93T0OG00\S#;0M\=Z?IQZVA
M^@R5O/Z^NW_XM)[(=?-SVX+8NZFK6 YK.:SEL&W@L"/W:/38"3>6PUH.:SFL
MY; O@L/N]=WAT6-G;^\6A[6)C[O(:JW;<AW%'V_.>X3_Q='T])_ZJ*:+;[\[
M&@Y?;_#S'< _;WG^?Q=9'DZ6MP5 N9U-ZV\/JV_7>02=*Y$*YU4?8.+ 6E&8
MQ,XD29U\)IPE#@L6."S8,0<%.SCESW7\9+[P4O@M3^#]4??X)N\/NX[S!SP2
M"#\57B:<9 (?Z>[K;UQYF1,4PEFD(4 ;@(#+>.7S8>PL5)VQ.@Q]9-@=ZH\$
M:7@I8F>\A#<!2IT<X.CX,[@]H3?I^;Z(1.KE^ )\X%+ !<93_,\L3_SO3K+
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M\BXH?!=0W%:47Z*V)JZL&*\. 24-NT%8"V?F!<2WW1MQ;[($CDI1OI:KOE"
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M\1: L#_#P0LJ:5-Y5(Q."*H3K,[UDX_@_"-,,UW31*\.CX'&%_8D&##ICS2
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M$C7AE],0]7Z6G7&-$Z.035()-4./P&]JB2]*E<'QP]0OYLCM?"$U= .!&!]
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M;2F&JS7)M$M#Z@^ 97V("'#+<H+5&74>SMFZ..?F6/C6EW3J@?TL30,I6__
MQH=7H-[36]SM,XS;K(G93+ =RP3;MYE@+RD3K/W<_2XI/H82V\$_3#DD_3'U
MYH+:0>P->OUA^6_0A]K$3 TS+LPJ.<4UH=5LF*T1=MO++_1BEO:6T1D *QV4
M2+-VUJ9>#J5;<6>LJI;Y,OX@5S+9_G%B^FEOALO;S3'?5U7&F>[HA HWT0#&
M'[!<(#.G89 G?,F=66O/WY#:=L.A]OS%YT,?]VX*WX,G(7P]_?:'\^D397OV
M^^^<+W_\_<,WY]/O'[]\^WSZQZ<OOS]QSLGX@CJ\7ABAU[:"<@<RMG[N.E^H
MW/53"<XGCQ"U6['\G<8P<=./P4CYM3\+06+FO6JI\TVV4'L/%COU-7LA4+V!
M,Z;:"JH>(Z B8)2>,4709T ')% )ZK)X>BZAKB:7XD/8D7(//RWSU1MN235F
M<;@DF^/:5-J,.C*^@(W%T:5*'MG,Z,4P[&'[#&SM..&_81Z";+/0T"A#CMB[
MR6;WUVQ6=:Y I9SJMS%[LIAB%\O!(2LO+X5RMW;(CY>1=Z6;B[-N1TW22_B#
M4JG&K&4J1V><8$=]N"?V0&&W58RO$Z/$7)LDPW0$3F<J.Y)10"J^YK;E=%9C
M_3G>(#; 4BD[/.>-4RAPL%KL7&%9!(\38)>A3*[&DHE44-:\AP.@(S_\+(+0
M]USL<-9UG5%O!$]C#Y6?DR(2EWBL<T#VF>N<%W 1@,Z .L9 RE/G>- ;'EI$
M,JUPF;I1[US7Q/YORRO,;VN^4?VV6[8:K6 O(POA(B.0ZX0Y8Q6E?40A!V(W
M(\_FP$O&/6]E/R$ZW.@$1Y!VYUWG ^ 7P-%!"*L.?_W>*)]1HZ%* _QKP.=B
M 1NPN+[L&^3J!!:4I5LMS \:'8^.>TT;:;H[;,XA&_-0@F)EMJ3\/*($?Z[:
M*8E:*JE&/KH!55DR7K]C"MS-2Z29A&F6\\2 \=(I@$V<PGXCYU")HU/SUG7,
MMKS]=5=+>% &';Q,-]B7&7=UA&+^QFW^QF0R&^C;!+9\0WF*44(&C%AGQ3!;
MW@V#]R5RO$HFX2IRH/#+BC&%K:H=C3G4O.]UCM9D'\G.XZH!&C?CY7XI+$"U
MAE?#,L7/='=E(I-J @BE]4ILI:XL0$#,UY(?98?NLF5SPSIE3SO555,EL$K.
M=*0XDYQRDY5D728V4SX+1N-#XJ&\OHX$(Z,X]V<B8&"=ZA'&C4R?&[YM/BGW
M%F4GU,W/;"0U4YYHXWVOP)]59X,WK.&97BZU:'R>4**N-G$/#C\J9#CSYG?6
M6N;HW@-WM QI/4/*@ P3PTC,*!N7!AW\"-E+C-.#*:^IU.99Y1="C4$DM8+'
M)LN_$V(HJX&S+$*M:U%;JW)N\;K;U;RP?XS-#YOYX5-70OH79=[=A<Y^N4"<
MAN>M8^W6CK6SKEF$]$WG%7UDR#J_%FF8@:EFC"W]2JW@<C#=N*=\PV2B%\T$
MJJ6/=FC3CB>:C&RBR8Y'RFZ4:/+,XV6?;B'([T#,=4'>[UUH7^6%]MY<R,37
M]M9CMUZ0]WLHR"5DW=6B"3F71QL7OV!X'V/[MFU!58%O5I)E:R#MYS/28VEB
M-E4'CH7Q=YGSG$D-Z9%\2+>,%;8JFRSA:<="Z9QA'L$EM!N 7Z4#POD]Z3I]
MYT,D9]6"-7>&RI[SJ:3.-L':;3E<W^.L+1X2<2Y!VC_8.WTC8Z_M@F6[0>G\
MK**%&A.E3)")_3K6W?!@F^ ,FVXYI!ND;YL B/_EJ1*L:WS AL_WVFP&]IAB
M!XR@V@*C%AGCD-&PQR[J2E[!5UI>]UW3"1"F\_X7+C!"_T.>%E)*_+(WI)9]
ME7;C=^KQ]1+5'Q54\&0C< ^X0T#.\C-C<..'?!;ZJKD*C5+,9#\/5<$&&FA0
M83)BOHB2I< F&O=31.=NK*!#E[\<[2K0?<^!3?Z(H.S8!6R2Y]F@PH>OJL[T
MDR*63BWG5+=Y\9.%CG]O  EFO^ON_3(4VZ1S*[50A=&OQ!A'=V)@:9;GB^SD
M[=LP[?J8*#&G1(FNG\S5* ,:4$L1$-"2L$$9%1D#N01RD$!RW3;A_%,>$$>#
M ;R04GUQ2(''WF35.N":[^"EXUB4^LW1M#KEQ-8]>-;VUS&)&]D%-;.AM"I2
MJV%'\P6VIU=OT+9BCQIJR$WJX^/2\D"R6[F"+45OL'%%I7./KO ^,EH%/(V3
MN]\W+&)S6H&UBF]M%?>[AC ^VV8"Q$MD^]MU[NSWKS=SG6;CK>561C.*M$EE
M:[N=]GL2=SY(&:_-A@HT'^T$V]H0+8>H"3NC^)JJLR)0NEFO^L39"<Y7LW5!
MJ[ERJ]"@8@DA'ZO9'SO2*+@_N,BX*?GR(KD"ZPB;L5FMX=9:PZ"KFKPOG2\*
MGJ0#RVYS/U/S.VX\1+\3HGPVNC,8E17G1F+.9\K7L?'R6V@?@]MJ'^WF\W?$
MM#9Q4Z?]4O4#H!: ^E.,T5I4^+Y&7ES14ZQ\>@#Y-+R0?3HOS':A-MQ[>Q$U
M[&H6\<T$:47R_(&#FSU?]@CE1O=2-?\$,F:!V<W6!7HK:31\IM+H6J3JH*FQ
MK*!6FSCF#LB@1AIL%0R?B]C9O]!!@HLR2' Q$2V>_-#Z"4G]_2[@@XJ]&'-1
M/@K9@OX<VROZ+9B/OH-R9?]:N;(;<J22$#/ ^74TJ%H%O4K6EV/2.8YL0EA\
MY8I$$ZG"=/XB>*/-"]^QO/ #FQ=N\\*?2U[X/Y]84QM=J#& 3?,LVPJ['? 3
MC#  SI!UFR9;Z@K?%6W-$$AX1QV<J]@1//^23K$0Z4\U-H?WBAK=X.AU50;5
M]+E&<4/,\1TA2 =7S$ZPDR.RQQ54*D^,ZN/AZ_8H??O=P]&@?WATL'\\&![N
M'PY&K]]= 8-EGG[R78@%[#/2T)'\GX"T 2H__?>>]T9=D"$$>-%^K_>Z]L7V
M]J5ZG_B%;#1.F8(>M6OW4MU[@A-S3C0Z5D7KK='RN-L[&+U<M#P^.AX<'O5&
MH\/1?K]W?%]8V7\F6-DT]+=-=@<V^A)&,Y?&SOT8-UIMKI0G4T'UXSHG5Z6^
M39S/298YIX$WSYS??OO*N7UIG.7.__7FBW?.O\ ,F^(OF+996FQI:;&I'C*E
MQ38):0!=+=N/:=W,]$,_HO/IDZO& C?/_,7$03TM6&94EE! ;3E;QRD6:X33
M9G?#<U%N$0(YY:$V0(%,C:J%B8?!QSM K4DA']&$W 52EL_[V()KD8F3C$=)
M:#:8DCI#[_V$R\/ZV@S"E%*>4'&BWI</P5-!E6\<#[K'@]>FA2*/R2;*VS6O
M'79[1]>]];>W>5K?FC*3\"[&GO]]F@(F!QU)Z!/ZOV9"-S@H6VSXAX9C52VU
M'AIDI@=L #@):U\*3.'Q(HE.\S ((K%BO*,Q)__$\)8?-"TW\Z;EQ\WU>@^)
M_9XS2\7DOW[Z/\QC+I+)A<$Y+IA=H#,VOY@#[UDO#]8!G=8,<* F.9-.J%\%
MRA9JJA'<@&2^:2YX(V^4\_7L],O/SJ?W)\[!Z%A3G"=-RCS8YOYKE\T0W?JR
M&ZW+A[1A:?5[O=Z-PG,[B=T9K .^)?/VD/EN4_C^6AQ[I@3^@.1Z%W5ZJR6&
M%=^>Y06/S0MP(*V(,Q%<C+T(RYPNLID0^9,*^3,<5 6O4!CF9]Z6<T[;6C=]
MA*P@^(^A)?V=(?U]2_HM(?W2'7'!X] Q0Z@U'."\XBSYHC>H*N%A_1F< S-#
M?T/7B&KG^"_AI=G:62R68>P<PQA9AM$2AN$;]&ER#VXMT%+. 3_1A:!_[2OE
M=*2JTH-3H(R^"++1JR-SS_?>4T)__N9FS,7D+3>$R!TU:,N]6L>]#BWW:@GW
M,AB6[V6SBTF47+55W3F##3H?<8-6KWFNG.'8<H8GY0QQDHOL(D\N2A;1D-#T
MI!SB=]PB1F KK&)3 -S2?>OIOM_;1/CPOQC;M6'Q]1# ]*##1X/ 4Z61X. @
M(N!65P]LSE-L587N[_#CO:#7,RESP39\;4<OQ_DMS"@LJ)*.5WO]'O3Z^, W
M,2VX$-(Y-QJ$M0'2SKD0G#>)8SNH#?':@JL;L?I[QL2=9/8O  8OI? .J6,'
M6)+*TG_JJVMYN8H$$R5T_'C$:>@R"[IEA-V>!,^U+H05M+A)*NCAS=- ^S=_
M9;_W*,N,'F65_FW>N<4K@^[^HRQTT!W>(AGX=B<:W"6!&,OA[L]?=A,WBB[@
M5/6]BUPZA1I$<@.3/&IGI>--Y('I_'AF)_R]0*?\C0)SJ\@#?[X1YCB2??>&
M#XPS-].6;UOG>W. 66IK'L>1^6FX,)N,6H2T"/ET"(FMVRTF6DQL 2:&8(G]
MGG0M-EIL?'IL?/YJ,= ;UNN\]W)A2<Z2W-,CY/,G.2O=+*FU A%1UPK>?BS@
MT6Q6MD)\AB3W=Y$*;-NQ;5;?0SH@UQ#O=NCVP.W4VD"K:^#3JIYZ%AH6&JV%
MAN4D%ELLMEALL=ABL<5B2YOA\T*Q97UQTO-&F.OJQUZJU7FO%3R#;A]N8#BR
M)/M\&)@J"U1#W:^NKKJ9\+O3Y/+M:>K/PDN1O17!U$O?!E[NO>V/AOO]X? M
MH%._?SSL#T:#8>_PX+"__S;8/QKM#T:!^#'H=V?Y_"DK"$^GJ2B'7= (/>PE
M*]*I2.6LJ"2=>G'XEQS]RR6&W&_I]^22RXP'7&8\<+'H M_RYDD\=7Y)O>6X
MF#K_I"GTJHGMF0?@3M0:Y\68?^"^+:L];[&I])S+FFF^BL#&;EGNG*HY\6I/
M'\4X+;QTZ?1[[NUJG=N&<SM"@<^/@1]U_F>GF95%G"="'&#VG>'Q:'ADT<>B
MS\VA]=D#3<)!.5J17Q:'+ [=Q/BPB&,]!0_B*7BIWH$VX*&E2@L-"PW+22RV
M6&QI 7PLMEALL=ABL<5BB[4T;4RZ_6ZAH74+/2/6]2#1Z"%'H]7V._#!#BR=
M>GY^(MOK;4#11XA5RS PAZ6I V_@G.&U3.!B<L'3P6"AA5RK'$.,8\)2+\Z[
M-B;\@E0<&Q.VB//TB&-CPA9];$S8XI!5_I\-XEA+W<:$VX"'EBHM-"PT+">Q
MV&*QI07PL=ABL<5BBX6&A8:U*VT$N'U.H($EUF?#NAXF CQH=P2X%NQ=*0&6
MOG)9_XN#46W,>'<HY_FQ7!LSMHAC8\86?6S,V.+0KN&0-1>L;6]CQCL"9$N5
M%AH6&B](U+<8/A9;++98;+'88K'%0L-"P]J5-F:\RTX@ZSU\/JSK+C'CT<'^
MZ+@WZ/5&P]'P^.TT]98=#!A?]'NC=@>-==CWYV7D764VP/NRM=M[Y8_]7N=_
M=YHE6,RQ$5Z+/KN'/GKT0I^#O#V+1A:-;)#WJ1''&N,VR-L&/+14::%AH6$Y
MB<46BRTM@(_%%HLM%ELL-"PTK%UI@[QM<P+MV^YPSY1UW2N:?!,3D8K8%TZ8
M.7,O$%A?^X$#O)D"V8ML3.V8_16]![P"UWE8.+>\_-OT5C\DF)D+8,GX?8![
M=S,GS.R?AX1W]]DPW!:+GU;H+2V&C\46BRT66RRV6&RQT+#0L!XMFRFQNT"V
M5&FA8:%A=;\VP,=BB\46BRT66RRV6&A8:%B[TF9*['*FA"V7>3ZLZPY!W=[Q
MJ-<_[ WV>\.CWL'^6S@2AF[W+SB"_H0QV_<B\]-PH5J9?]-5[O_W_QP-^H?O
M,N<LF<_AQ_,\\;_;RO<7I,C>=^6[[6UN,<=6OEOT>9+>YD=4]K[_C*%FL>HY
M:/:M %4;4,D:YC;@VP8\M&J#A8:%AN4D%ELLMK0 /A9;++98;+'0L-"P=N6M
M[$KX7V\<"?K/(+QT_,C+,H3:5, VTT"DM#JL!#O#!^3&_NJ$<2!^G'2&[R:1
M^-$)PE3X%'SRDZB8Q^^",%M$WO($?UT!;W<$ ,9-JQ@S_//?19:'DZ7:/;W8
M$7'P;I%D(7TY%9&7AY?BW3CY@=#'X\L]PE^VO*#^ /[]))ZD<CN;EK]!#*5_
M6+E9N!WY__$R9]I=( \4QA@1[&2YE^8G7I$G[ZH_ *CYSWSWY$/P)G#>$R^Z
M\I;9NY_>:BQIHBVZ4P,M:M=[O[?X2'SHOJ^L@1[5?1$9UJX,-\MW4B5%/!(^
MW@$"2PKY"*_7[_6ZO=?J>4#-R%MDXB03"R_U<J% D]*]T'L_U=U+8\__/DV3
M(@XZ$K4G]']\SBN^TG$2!>\NPRP<AU&8+T_42@T>)][8X6OSPO\?>U_;W39N
M;OM7N'+.],Z<*\@$WVG?=BV/D[0^39RL..VTG[)  +38D4B5I/S27W\!4K)E
M6TYLF9)(:L]J$\<B16!S/^_ @SDD]1L_>.(6^O);'',KCW&W\A2ZSCUKW&(-
MG:T\R!O:UK9F9 4_NNT[2YZ"#:]XJA73*J?C5A$N[.2TG*_A>)X[$K2B9K*L
M(YZO'.?-0):U8\]F>#;33;<WX[\_R1QCKKY->\.<::N+#VG[P4HO$!*$W#TA
MWV?Y!$P$$UO Q$1%8F?9AOH*@8U@(]SB!_*FKC'>LE)"Y"!RNR=D_T4.U@VB
MU@HB:E]+'+R?J4N+D10]%KF_R%Q>)>4(VR]WMD@;IQ'W9R%! RV,3<L)7=<[
M$'[H!285\MII>:MHG2/1^S*7-V$:)_JUQ.K%++G/V)#9!XYO3!6>$WIPW!MH
M6DR4_EE1V[:)Y00>Q:D/X,\ZJD=.R_KL88MN\NSA5B '9N$@FLZJI'U?&HLM
ME^W@(:02:  -:!*P!6QI 3Y@"]@"?( /M UB3_3A[6:B:$.-W_946#M?"'Y\
MEFU7"L&+!KU5P]XO6D\4QO%%+N5$73<PU(2E,,ZRRWL9=VM@1#>&/J"63;+T
MPCAA8YY\E$*]TH%QFO)A]5DY4L.2ZE6SL3&=*2!9(?/"*!3VK,SR&WU!+LNE
MA60H.O??56I4$0=H @SBH DPZ+.;)L!690TWM"BP%:B!5:@_=U8=(0> ^G,;
M> BI!!I  YH$; %;6H /V *V@"U  V@@KD1MN7U)(!?"VAO5U4!MV5$_^79P
M(-0?MNT+>4U-JP?%Y>>6D*<R+[*T,*8L+U$SWDOW&#5C$&?WQ$'-&/1Y!5K_
MR](9RV\,R]GDT;%@4;]91,U-G12[I\Q!,(\B<1MX"*D$&D #F@1L 5M:@ _8
M K: +6 +V()($V7C]N>%G*$'8>V-ZFJF-[5I.M9R;VJ[W57CWUB>L[0TRLSX
M/-\N?*]/]6(W\EO)Z]W(M-J-3,/;W<B1+*^D3*NR\:+VK+Y0?W3^9^/M\9GQ
M[M^SI+PQ_I*-]9LM!L:'#R>H)>^37]1T&^Q.ZQD09T?$01-L\*>9)MC.)GM@
M@T;]IA%.M$&(CV)R1T"&5 (-H+%'IK[%^( M8 O8 K: +6 +V()($\7D?J6%
M? AK;U379OI;=V0+\JJB\OF(Y0I$]>FYS!/UTUOC)$NK=Q:-I?%9H27S7(KY
M\<CZN.2'NY-1,MXC[P?;CT&<W1,'VX]!GY:WK :'^LTA!WN/$<2C7-P-D"&5
M0 -H[)&I;S$^8 O8 K: +6 +T  :B"M1'.YR$@@9Z/ZHKLT4ASN^TWB^T9A5
M->+;PX_#>J?5P$B*8J8^CFY6=*U67ZFW&JN)8:OQOCO-J!N#.+LG#NK&H _J
MQN 0MAGWACB([U$W;@,/(95  VA DX M8$L+\ %;P!:P!6@ #<25J!NW+PD4
M0EA[H[HV4S=VNETW'MPK''_B95:UJ0ZJW+F%PG$'Q*=_>A>%8Q 'A6/0!X5C
M<*AK''*&."8; 3X*QYT &5()-(#&'IGZ%N,#MH M8 O8 K8 #:"!N!*%XRXG
M@2B.M^N/[MI,Y=C=Z\KQNSSAZ@VH>\H"I>)]\I-1*@9Q=D\<E(I!'Y2*P:&=
M1@DNB(.0'J7B+H ,J00:0&./3'V+\0%;P!:P!6P!6X &T$!<B5)QEY- E$):
M>Z.[-E,J]OI8*K;<P;,JQ>_UN<8?*QU<9BEJQ?OD**-6#.+LGCBH%8,^J!6#
M0SL-$SP0!S$]:L5= !E2"32 QAZ9^A;C [: +6 +V *V  V@@;@2M>(N)X&H
M!6GMC>YJI%8<FF%@Z5JQ93JAKA6'[:X5O\_RB:X"KZH9GX]8+JL:\;G,$_73
MK\9)EE;O+!I+X[-"2^:Z&EP?>:RN>U0P1G5XCUSC1I7K.4%I!L19 RW;MHGE
M4TJQFP_\60.MXVF>C T'U6%0" ?5M(,XB.)1'6X##R&50 -H0). +6!+"_ !
M6\ 6L 5L 5L0::)>W(6T$$5"L3^ZJX%ZL:-^\NW@0*@_;-O7]6*K&_7BKSE+
M^4A6)>%J9_&\@(R*[SXY,-@/#.+LGCC8#PSZO *M_V7IC.4WAE77?'%>+%BT
MEG./M:"(Q%'S[03(D$J@ 33VR-2W&!^P!6P!6\ 6L 5L 5L0::+FVZ^T$$5"
ML3^Z:S,U7[L;-=_/ZJO?ZZ\1J/;NH^N":B^(LWOBH-H+^J#:"Q;MV*W'2D[$
MX*CV=@)D2"70 !I[9.I;C _8 K: +6 +V *V@"V(-%'M[5=:"%TG>Z2[-E/M
M=3I2[1VK!TS4[XSC"_TG2KY[Z+^@Y OB[)XX*/F"/BCY@D4[]NU!' 3B*/EV
M F1()=  &GMDZEN,#]@"MH M8 O8 K: +8@T4?+M4UJ(FD/Z?R&NO5%>C9P"
M['L^=?0IP*YCN4)>4Y.VN^C[*8YE;GR0I1(7(Y+EE93IX]-\#98*XWAH?&%\
M),?J\I%,;P;&Y]'P[7!@*#BD,#ZR&\,RJT2[B5KQ/CD^J!6#.+LG#FK%H,\K
MT/K(E(TW+ O'_X)#KPD)P!P$\"@5=P%D2"70 !I[9.M;C _8 K: +6 +V *V
M@"V(-+<>::J_6326U8\BN33XF!6%1NU"JF'F0N;5T]63U,CT!?.!_8<DJ9#7
MA\0^BL?RFH@DE[RJ2?%L/)ND1R(IIF-V<Z@_?03OT%4 ZT$OJM/JG_^:%642
MWRQ&7]U(9"J.IEF15-^<RS$KDTMY%&77&GT]_?D8U6^>^8*HI?Z]DU32W7"^
M]_@79)WH_92W>COS/_7+'-TF$.832E)=*"1%R?+RD,W*[.C^!PKJ^M?UNZ^R
M"BQ6\SUDXRMV4QR].;AER2K9JM[I$BT>O-YFW^*6]%#3KVR%/"[>5R6&#UZ9
M'FS]3NZ+HIZ2OIPH <MF\TOJYU'3')H_+:Y7U!RS:2$/"SEE.2OE IJ\>B_5
M?6\>)IPBQG^_R+-9*LB<VG'U7SW/J_J51ME8'%TF11(EXZ2\.5P\:44.JAZ8
M_]/R"Y]#4K_Q@R=NH2^_Q3&W\AAW*T^AZ]RSQBW6T-G*@[RA;6UK1E;PH]N^
MLU@JV/!:J5HQK7(Z;A7APDY.R_G2CN>Y(T$KBB;+.N+YRO%=O2QF63OV;(9G
MLTDD\\WX[T\RQYBK;]/>,&?:ZN)#VE9!^U86/$^FVB4#(4'(W1-2MZ$!$\'$
M%C Q49'8638$&\'&W;.Q_VZQDC=UC?&6E1(B!Y';/2'[+W*P;A"U5A!1^UKB
MX/U,75J,I.BQR/U%YO(J*4?8N+F[5=H6-F[V9RG!AC9N6KW9N/DN3[B",U(O
MK<!NS7U?>X3=FB#.[HF#W9J@#W9K@D,[C@/ '*RAQ6[-+H ,J00:0&./;'V+
M\0%;P!:P!6P!6\ 6L 61YDXC3=2'F\\+V:@/]T=Y+>K#_'==\:V+OT17>+_9
M58FW&T7<\YE@>3%2 _V+C"*6#XR/2\UWCV<7LZ*<'W1'W8'!"H--I!J80'47
MODHK\ %;P!:P!6P!6\ 6L 51\T:#N'^@4 OQ[)9X @V@ 4T"MH M8$L+T !;
MP!:P!6SI<\B)0FV78WQJ#AT4:ONCO)XNU#H=*M1^3/B(R;'Q=I:F#\NS856>
M=5">A8?2.GS %K %; %;P!:P!6Q!K(SR+,03X@DT@ 8T"=@"MNP<'[ %; %;
MP!:P95]"3I1GNQSC4W/HHCS;'^7U='G6[5!Y]J\R364Y,HZ'QGG)9NJ):OH#
MX_-HQ6Y:E&OAL;05'[ %; %;P!:P!6P!6Q [HUP+\81X @V@ 4T"MH M.\<'
M; %;P!:P!6S9EY 3Y=HNQ_C4''HHU_9'>3U=KO4Z5*X]+^5TI#[]E>4*QX'Q
M\=?C197V++N4DTA]@U^= NB@- OOI!7X@"U@"]@"MH M8 O8@C@9I5F()\03
M:  -:!*P!6S9.3Y@"]@"MH M8,N^A)PHS78YQJ?FT$=IMC_*:U&:'97EM#@\
M.+BZNAH6D@\OLLN#XYR/DDM9'$AQP?(#P4IV,*_>'NA"+@UM:KF6;?J>3YT#
MX02N8[E"%W8IK0J[BPD0]95$/3QGO#R4UZ,D2AZ]BZV6?4^RM)B-2W6=<7R1
M2SE1OUX4<UEA9+'QB9>9KNA:7E72-0=&=%.5@1=%XG(DGR@4OV5IG.5Z8Z^X
M3(HL+P;&AP\GJ GODUO4J-(-R%\[K61 G!T11REI8H>N'8 ^H,_+T?K(E =@
M6%9E 6UP"!Q:*V"@%-1!?+^1^'Y?8_HV\!!2"32 !C0)V *VM  ?L 5L 5O
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MQ;H>/95YD:6%,65Y>:-_D\LR,WX^R7+=KUJ*7U UWB,7J%$%&Y"_'AQW6J6
M.CNBCE+)Q Y=.P!]0)^7H[6PAE:]']D!B\"B]?8C_P^H@W@>E>,N@ RI!!I
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M8+")5$]9%&XMT[)1M(4+T@I\P!:P!6P!6\ 6L 5L03"\T=CL'ZB_0CR[)9Y
M VA DX M8 O8T@(TP!:P!6@ C?X$F*BV=CFBMVQ46WNDNYZHMEIV"ZJM65KH
MYLY9;)RJ+YGJBJKZYQ=YD12*Y5(8GV?1..'&,>?9+"UU_?5]DD\,8GS,BL(X
M%FQ2Z/VT*+W"5VT%/F +V *V@"U@"]  &OL>!Z/0"M6]S^()-( &- G8 K:
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M^C\0U]XHKZ?JMU:'M]_2P/C;\'QX,KRMM%+;-7]8C@U-#^78UO"_%:JSQ?B
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MT  :>QN:HJC9EUP )!3&'?0 /4 /T /T: L:H ?H 32 1O\BQUX6-9]@8"L
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MF>U+%VUT0ST2$FU2(EVBY<L@W$&>=-W]O1")-HE$'P%#4K,;-K0M;.]V!@6
M 3  UBK D-3L;J)()S6_9)$"SC@;&K\EXR)#6K,GNJ9_;%VD-5F2J\&T1'F#
M@OU%#'G,MB:,UHO!MFGJ]B8! <  & !K%6#("7;#'K6%[=U.0  P  ; 6@48
M<H+=S;)4N[;'ZLO_/$[X[^K_(V0$^Z%I^L?5.D&#W=F=H6#7$4-&L%\9P?N&
M;F!\'+X=8GUCAU4)  -@  RI0:0&D8< 8  ,@+4,,*0&NYMNT:G!][E4:"3<
M^/-,YBP72 [V0]?TCZU(#G:,@EU'#,G!?B4''YHZW<"1Y1/T<.RL+@%@  R
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MA']Z?=CT0H%?:9HWJ0*JIV\T%_>>+(O<1AYA=6G51==-0,^UO^6XD<6I3?S
M5^J(A2%AML<(4RJ/Q;$3>I[Y4/N[W*+"="CA7)D )V:,1$IK$=MDEBT]X9C^
M=[3_#O%TK!]H\1>.;!V=RZ!>6ZY>;:C7QM2K0E7IK$**;Q$;LY3+;\5(RG*G
M/O5)EE:WJ!!/&+_6PS+.JV$9K-#:]JWD<A+)W+!IM=+#,5@J] \VQ+@S8NQ
MC#<@QD6IQ&:B$"Z^95-9RV)[I/G\=G1:C#_=#M"(L]PH1]+XIV1Y86A'2D#*
M^R#E+UV$!RG_KI3?BM*=H.O8B&<3!<=(J8#D4K94VD^6QVA\R(I:ZB'Q/9-X
M#Q*_ ;N^6O8+]6/&?Q^U5N33"F]=#?JL9B3SO+I&#;F2[.JG4396CR[^\%^!
M1?TCX]V_9TEY8_S\5L8)3\I?X!KT55'X4!2;#0 X*T;?XG%VU=8 X$0-T'BO
M!P@I[ZN4AY#RQJ0\S4I9?"NS;W?B'B<I2WG"QDN"OTMI/]-#-,K,N"?V[Q>C
M7%( D.'.R# UL1!UY4(G3+?/T\4RXTXM,WZ=(FQ\T3.6/'=<!6QWR7.UWN.Y
M"QX78]V-6F[->FQCQ_:I-4"LN1"I(_#M*VV:GO?7K$JQG(]8+N=9URJCHG_Y
M:\9R4:VMF/=LT0F:/<7IA(UY\E$*%68.E$#Q89O\BGTE[\-Y+[DZ+WC>F]6K
M+%T[IK&P F*%?DP<RDT24-,BU W#F-D!=^*@H566GZ9)JERMK^J+?AUG_/<W
MABPXFZJ+RGPF'ZV]?\[(JN7H;>7!QFW?'%!#_4\KLN^FFJ;MQ6F3\K(WD_Y-
M&B-V*0VF94W6EDVYS=E$C>U&>SW+951CON31J)8\UO6(!XK?^%G;QV(6%8E(
M6)[(XI>?]7>>U-_XRU/K$0?5DZMH2CWGWD.+>Q60NS5: ^/>(@YCK!Q]_;N[
M"NKTMH):W%90BQ455%E74/7'N@)DQ/<*+#>253^D=9%E<.L!+$9;)9F-G_5V
M.9W!N)3C&^/VR66FIZPOOS>IVRSTTO1^&2H(C6R6JTE6$CIXWGUZGH5V7V.6
MY..;@9&D!AN/C8FZ(->7JH^G:F3%=[]O$=)JD)?>V-,O; '#O>]3CYJ-ZS>5
MZ+_N%JSIR_6OGH.PFH#Z5O7Q1+^7JZ0<5:2<.^+3/%%#GHX5Z!<R50\8*\#5
MYW*J1Y#46NUO:7);/JN&<UR9+S:\%Z\^7#2_C?BU3>+?%=]HXS;Q5U8D-2'G
MUK$CP.PK(1J/]$9*A3Y#U:I <*[[BZFZ>+Y5^H'.G-N50FG@E%U4=PZ-3TJO
M/[@KJ>I^\EKK;ZT@%WI_X9D]_+H?#R]BA?HHJZU(9=.'AC+Q>M3,J+-BRYHT
MUGNK\KND1Z5I]9/GV8^%#5C*@GQ2UK70PC@/@'^^IVA_,7ZNMFK]4JE[_=A<
M&]>Y(8RDL92EJY\VMTWZXV6KHTV8>F@N*G_C=EQ_&YX/C5@*K?2-0O)9KFR6
M>N5C=G47F;/I5 V^VE&?S[25T!^H6<[&<U,T?UOG=_?K*]Y=\Q%++ZHQ3)*B
MT"]B\975I(9[*AO[JA-^JQ2"F''-[UN!>HJ:2@I3H23BEEXU9XROHZQ8_G0N
M$.H2ID1 .:FZ;:?FF7*5M,=34[AZDI*)+"J9>F N69&E%:594<SRZM$LRF;J
M*T92W9$_TU74(AGG4NI!WOJ'FNV+2P:W7RAFLE)/>:ZLHOI?G*M1Z?DL26FA
MG=][,JZCB8'Z;:[FIIZE)BC3"Z4$JP_G4]2^XWR*<S\QT2G]5 U%HY]G8R-3
M:F9I!G6:7[VQH7&L_%U6IV[OWLF5?*1LYLBI)U5K,ZH7H!68?N)SGV9$"F ]
MPX6G.IWE4_TZU9?,U;:^ZK'FEG%<AP*IUNQ/6(>73+HBG/I1N_<:T[G-2#,5
M:_'1XO'04/LU[T]+2HF/9WH)X%S$ZC@IXU+,\GIYD=(;FC&5\Y(4OQ=/:H %
M77^H3'Z@*@;+6NWQ>&I?2-2&7\M4-:JA<:[YO'3I[<SDM8)+8S+04L8,Y6Z4
MVN%)U$#D9:)<"JXUP 6K!*56HQ/MMM3F720%'V?%_#N?-\/::ZL19N,B6QK,
M)1OK'A.+!ZV,3F?:&:N2#HHX2:Q\$H6N&G4RJ8+2"1/2B&Z6O,2!CK:OI(K=
MU=\/'J&5@X[JY\$^6X[5MY1NK[[Y,"F5(/ 7L'09YE85!E:_<F7V(SE.Y.7<
M1M]9&<5*S;-VHUULBPW/&@U;=EVBVR![*<D%F[5?\]8'LJQBZ.MK4K8569;)
M3,)B7Q#'II0P+W!(:$N7>ZXEK(@VU/?I3/VB)7A^U/L"CP6;%,:'#Y]_U-1I
MO[BV:QE[/:>]T(J%5'0.+=\BCL\LPE@<$C=@8>RS*'9#V1"G/V2\<BI:\N[.
MU1#>)O(B&^@J4Z*L1IHPT/N>Z#]U>,L^@;!K&=]UY;:0^:4.,XJ5.096R[:*
M0'1TI MWN_:WL"(?T\5TL=\"^RUV/!JTF.^Z"FCC?HO5HF97_[5OP?]WY+$-
M0^[';H1EH!YL1BYF4T6MN_%Z0[^3@<'<%+;%T"SV+2RM=?S^OH7'"SG;9*GV
M^$TVN8A_1>_V72V6]]2MS8'>\Q7SS8+5_A7DSU@O;K=AO?C/8M%QZWLKQU=W
MYK'77D:N!V&91S^L75?7T:,M+2I_QCKR\OL@K+MN_$E\5RPBKY8/KE@SOK)\
M_VBE^(.3)3;D>W=,-6YYX72[=6&]BGC]A</_I_$EPYM=)5R=RM#GE;YM(-6&
MO=]V2U3WUN!N:-GM1I?Z-;VZ3\/:@O5]75[2M^;:-(5%JU9<M4R=;&[Q41P+
M[H;"(5;L<^*HGTGH10[Q8N:9=B!L)PP;VA#?HL5'[_)4">D?V&1Z9/Q3B<M%
M.]8@M8QU>YR_^NV)!0K_YVYI0IQG$Q6RF8$V%=M>H? $7#TN8S\QX]=K0!K%
M@>^*@-@^BX@3J#\"SAW" RI\CTMJ.4Y#&A!+U3JH"N:KU8*Z?\#^XB"O==;I
M-HEU+B\J5_RT2E75/F!1K\S0OJ!N#VQ8E1>IU*,:):]#'9VY,Y)BCP+5-K_3
MG:W$;!D.J\I56*"$!4IKC<;& B4L4'KI B6]-_Q;TM9JR>?C+U^-TRH[;QV]
M/ST[/CLY/?[PJAU[&Q_SZ=G[3U\^'G\]_72V"\-6O=67'=JP8[S4^ PZ7+E*
MX%6%A5YU!WZ=X=LX%"?''TY./[Y[>WIR/#!.STZVF9.XI\_XB\\;WC%P#6WV
MWCS9[Q^4#.HO@/FYJIYDLX*E0I=>ZG!5V55#5R]D7?T85<7BNOSRR\ZQVW&Z
MKCK-Y8$_JCVQVN&\'_/HZ>C+B8IDLMG\DOI)H3DT?UI<KI<!L6DA#PNIH%?2
MM$"E/IVGNNW-PQ.A+I/%0H'#Q?U'CT]UJI_F></0\W]:]E/GTZP=U8,G[J-#
M)UCCKC5NL8>FO<X ]W%.WSD?+)CN[GBP6H37.6QJ$<FL4";!CG3)NC'06L=T
MO1"YS2+ULK"R"9P42_4G?WQCO6D"L]L(?)$L4A:M<E.,A<%M+1_7]@N>]1J6
MUTW^OR@_^-.#W'SC[/W.FZA5DFFW]UU -T WM(F/V]<--G3#MG7#*M<._MSN
MWPMT]NYT-M@&Y%J!'.04;(.<;LS/^6X*BRN',.:;=GG4)RW6!IN- (Z+XGYI
M!$JUK4JU;Y@!)^ $&02W6HY32^MN_7!:GK?@9);G>OT\@Z_2%3VY,L;8((K5
MP_NA.@$=)!62V@6Z]1NZM9,UZ[LXU5R3JJ%,O:)OY>0:<H265_%5#UM^NGG4
M13])]\^Z;52F&Z!<LO'#SG7/E(SG(+_GVOEYX*59)Z&[3\SG8_;?[>#:<U5S
M8ZN65^KF^Z^J45F?[\]_GS.^U.S3\@,SHM0BG J/.*'EDE!PC[!0.C%70(6^
M>+A!7WHF=QDW21Q)01S']DAD^38)I2F$&<L@U.?/U!OT9P6Y8&QZJ#7-<2KT
M7^_NU,QQ><+R7'>$_+M>1O[&F*5)_92_??O;^5OEPZCWJ;[%?F,(R9,)&Q=_
M?$/4O^IMT7]\DUR7A^EL0D16DOD5;_[D#T+;7>RQ7\SW3_LIE5O675#\^T<Q
M*/XN*GZIW'$>.A8).+6)(WQ* AI+90)<.^2.S4T_?JCX36EY-K,LXEI<*7YE
M!P@S&24\M*0T7=?RHITJ?G?@VB84?V.*?^U$-@*Z'05TYZ,L+XE28A,C22]E
M43[J0PZC#J/>6[]Q3VUY)!PN;)^1**8N4;:;$19+3F+;\6+'#1R+1DT$<95V
M^:J4R^F=;FG(=%-SX-L.;'>'A0_ZO4/0=9-B>ZK?3<NV0DDI$9$9:%WMDHB%
M 7$C9E$OYIQ&;A.QV@;UNSOPS0#J?7>A&6IM.P[-/N=RRA)A\'&2:H",LFJ]
M+Z^GNI4/8C38<-CP'MMP&9K"]5Q..&4><7@<$.8QD_@V=WD0A[&T7A6C\=_5
MT*EK.]2V#^>ZYF2N:KYJ3?-NKFB:*K(Y,.==%D-H^@Y!UTV*[:FF%T[D>)+J
M')QPB!.$'@EMR8AEAY'CVX$;.?9KHK6M:WH*18^2VM[&;9^J\\ZF\^AM$:[5
MJR9?N\T$=GU'=GW-_D[=U#D;)>'K.V7MDV_@"E=(Q_6)'UN,.+;O$!9ZC)AQ
MQ&+;<GP1-K+<<NX6S#V!XU146JS>NC_?'->0=V#M/@Y<NT48Q!DV!3:E?22$
M37E19M&-7!%8RB!$W"*.$#YAU(H)C6+?L96=,7VOB>K@%FU*Z,&FM#LL;;:<
M:&TS++5Z$99^S4HV1@3:66^A)="UWA> I5]:!\3-,.8F(Y;KQ\1AW%5!( T)
MLSS7]RV?6X\M_3K1XR9L.@T'GH==>5V6.BCV#D'738KMJ6)G(369[7'B.K&G
MPC&F0CC'8D3&T@[M(+"M@#41PFU$L=.!9T*Q=[I$N,G0JX.QU><\FZK)WU1%
M/MT59:J70@^,5);M4).PQ!V"#I:X0Y;8MAGUJ"\)]RDG3A3&A$5!0"*JM\1'
MGC*V5C,%NEK%?!ZSM#Q.Q;N%ECF3S1GF$%:YPQ(()=\AZ+I)L3U5\BSV8LJ%
M36R/ZA6:;D2BP ^)+4TJ?,NW',:;J9AM7LE[/I1\E\M@"+U6K+9$.:MK9AB+
M7[#X91>F/+2LP'29()1Y(7%"+U9A5R2)<,W0C0/N4%,V$:\MK75IK./)K@WW
MGJUQ@>F Z>@W"6$Z7F(Z8CMRI66:Q/==21SA"!($%B61HW[ON4',HD=K\=>)
M ILW'0ZU83O:'1@VNVT/ZR/77!^)0++;WH UM+1F$=DL&LNV^0/=:7R]-JA[
MZAKXW'68-!D1?J2BRMBQ5'"HG 13NG'LN3QPPT8::C8;4(8#/]QY"\WO4JV/
MK@$,"0P)# D,R>KTI!\YE'E,[\WSB1.H/X+ $X1ZW/8C*_)D^&@YR?H+.YLR
M)-: !CM?T;EWAF3MXB..#?ZQ#%_50$;96+Q J#\D+$K&29G,&[Z<EQG_?:2^
M0^;%'_XKL*A_9.BB?GF#DTMQ<NGS;!!.+MTSZ""IH!LD=5=G#"\2\7"2FCHS
M>-YR8'SG&T&E0J5"I0(Z2"KH!DEMD?.#0U]V["P=<Z[>1UD84W;#HK%$ :D[
M!:260->=XA */TNMFDQI>I&M#]7V;.(PUR.!$X7$]#GWN>G%OFTVLH)@KF ^
MU_JEX=8>@S#<>7??EH@AE@I TT/30],_;K_K4\?5B\==RXV(8U&'A+XM2!QS
MQ_&%[]+'AR^O5>+?K*9WT"VB/^O%$:FM$ZGE,_GH>$Z>%5@_#EN^)^[BGIKP
MV'*Y&TM&(L<.B6.;#F%4F7 :AK%+W<B+HU=M(KYW8MM<T=P[L>U$:YF&3'E@
M[7QC,62P4SA!S>\9Q?94S7-I!W$41,3TJ4L<[ILD8#8EIHBX4MTB9.:K(K6M
MJGDZH X.YFS!ZFM$;#N.V!9'<K9#M\)\=P@ZF.\.F6^'.Y;T71V@.<I\NXY'
M C,R222I&?$HLD+A-M?JJ58N2QM FDVX!M[.CSB##'8*)ZCY/:/8GJKYB,6F
M95HVX<QUB!.RF(1>S(@(/>$&OLM\'C?7EFG#:IX.' \K*'I35T,?IE>>4_FZ
M32.PX\^U4//-\S5V3[<!A(+9'(CP EX5[,74%I'#B*34)$[@!22P9*PL>AR'
M)F66PX,F@KV-67Y[X 4O;\;T%.4>];N Y,)VP':TEX&P'3OLWA?XC/EVJ"9@
M,^(PX9(P<"61 7.I;=*(>W83$>3&;(<S,*V71XVP'6B]M+OEZJ^4Y ^91D+F
M$_05P&[E%FVYQ6[E=D('207=(*F[;JJ$M4\[<I=^8WG.EO+IZ_2?1$8$5?'N
M)=WV-*<1F2;5QPX0,X@<XOA<'U84<_43-3VJHE$F'N4TUMZB,M<NB_S&36/%
M<-_$WI0N"Q_T>X>@ZR;%]E2_N[$;,.[:Q.6<$H>;-@ED+(D5^]1R[<@*'_>+
M67MO2C/Z/4ZNE5GYC\PSS:# HM81E/ON4])8Z;33E4Y8X=3'*G6'#A-J%] X
M8FC3G@.+)75<%JLXRXJ(XWD>"0,>$8N'(7,B)J5+&UXIU5 \Z [L#BR1VKMS
MB&"B6J$Y8:)@HGIBHKA08%AQ0&S;JOKK,!($H8I< I<YE'H>8V'#"[+V:B76
MWIFHWIX"TYC@/XG\[?M]\"$I)"?)-1DE0H7@A^^_4<_VJ6_[))#<(8X;,R6
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MIRKN6U7JJTS9?6]*3T9?3I2/E,WFE]1/"E48_-/B<JZ/"9L6\K"0*I10XK3
MI(Z8J]O>/"R97B9%4F4:;@X7]Z\HAM9/\[QA&-H_+5O ^31K$WCPQ'UTZ 9K
MW+7&+=8PM-89X#[.:>T"^BK)65U5?RR#S\@DM3F7_M+0<[/9="!U'RG%4_W)
M']]X;YI K97+X1KV YX%^S\ERXUWRL>\?]#1)AG;TL5,6V8U5'3K7Q&06D]%
M6U#13:IH?1(=]#&$O55(0=@W)NPVA'V'SE?XW1W-SW>^UG&VUEU/?O<^PJXL
M&)\G6M,+0UY/=8*[.&R)5MXDA)W2R:]:&]84BBN7AG73"0!TD%1(:A?HUF_H
M7NS\]+7M:&><I2^RD"SGHZK<*N2E'&=3O1*@S5L<NJN<-[,0NB70=6?[0B>V
M)H3;V9I 7=\,';W=C84V<1CW"0MCF]B!RYD?N;;E/CH'R^46%:9#">=>3)R8
M,1))QHEM,LN6GG!,GSUN+UXKFN-4O+U3,^_J"*W!MBQ^ET[ VJ0X;EEI0>/O
M'\6@\;NH\4W'=@.'>TIO6@YQ/,\D 3,#-1]E!GCH^F$0/-3XW#?=P&0.,</
M(HYMAH1%040LP5TIX\CU*=^)QG<'@1M"XS>^Q^S%Z6M$<#N*X/XL4ZGW@>D
MC@EU55*4>;7GH!U:%A9]ZU7*MBL9-%%KC3/ /1'Y8:2"/L_CQ#$Y(X$M*1$\
M#BTKMCS*[2;"O[F64K[ \3T=U:P[$ Y\:^<'WC=<!]]K86X)3K H^TQ"6)07
M]3KARH@$CDE\WV/$B6QE42RAC(7M^W[DA)ZT'AT_M$YXN1V+8ED#B\*DM#P(
M[6N3SLX$H763SNS1RBLX#' 86JEBX#"TQF&(:21#AUK$5* 01TA&0B]R571I
M16%L1538C_IOKA."WJX+G7L(15,N@C.PS)8UW.R]BP C B/2;Q+"B+S$B(1>
M:#,GC$@LXT!%D-(D0:3,"5-_QK8C8FEZ342=FS(B=C P_9:UU.R]$=E!L7.3
M864'XT9]A*<1Y]G$R%:U1X*YA[EOC[J N7_*W+^H)62XZ)'UO!9AJUJ[;3]&
MC3WABL@D@HJ0.*[P26B'OL+/=!P_M$T9/SKU^%4QZMT)Q\]W, KU?M1/"%?;
ML<KQ%Q@R&#(8,ABR-ADRB_LT=)4ADU2JF)=;=FV45*QL4X]S:<M'AR:^*D[>
MG"%#R+Q+0[9VC19]+IKJ<U&.9&XDE7QAVSRVS3_/PF';_)Y!!TD%W2"IN^[N
MA>U1._*23D8LO9#*33)BEN3&)1O/I#Z.X>YLK"0MRGQ6'7^!C$UW,C8M@:[U
M^9@69UNVG_WP8\N*6$QBH7<[15%$&(M]PNQ8V#3V5YW#^9(T/O]=#9VZMD-M
M^[#6/,5I^EXIGK]KO?,I?K_0.J=W2J>QO4].:.XZ&P*A[!1.T/M[1K$]U?LT
M\F/'=4+B22F)XPM. L?S22@=&="8QMP-7Y/UWJ7>MP?40\^CWFP^0HBW[40X
M+#EJ[AVW]9VNN6_=&V"Q9UNQ18DG:$0<YD<D9*Y#W,"S>&0%L70:Z7E1Z:6S
M+,WNU\(;[H U,"E6<_5(EEN"$PS*/I,0!N4E!B7R3;T"6!!A>Y0X'I<D"H5'
M3,L)[3!V8\N,&EE4M0V#XKH[SR+NF3G!-J1=1Y#S]A6((V'VVZXL8/9;8_8I
MC:D=2$$L-_")0[V(,"<*2>RZDC$9"FH_,OOKQ)$;#R'-@8L=07V2XY;@!&.R
MSR2$,7E14M*V>.A;(0FC,"0.4]%D$$N=GE1!HNMP%1 ^2DJN$T-NVIC8 Y_N
MO!RY9[9D!R5+!)#WWLV9+(UQ5F !:6<MO36TM)80V2P:R[;9^NX<M+,VJ.TP
M^[W?_^M8++"9=(D9N;;N]^\0)N*(N#:/+"DH=]Q7K8"]=3-DN;F=OU0Y&6;+
MLM0/J-XV-P--+&#18-%@T?IGT2*+61&W/&)3IBQ:)&(2>LJV>7&L@N/(,EGX
MR**M%3AOTJ+9SL!V?5BT75DTE&#;$D$;4ZG>P(CETB!&Q(J$UT>3)^-9*06\
M$7@C+=(E\$;@C=SW1@+;<2W'CXB(!24.9Y(P3V\\"B+A.);-X^C13J-UXNMW
MK!IB\5GFYUI9_JHUY7VO1/THQ7G)2EE\BH\G,E<$>YN-QRPOJEMN?19SV6>Q
MGNNRK)Z_+QESI6L1%MJ2.);%2.!0J9PS87+3<5UI-5(3?SC_M[5]V"H"=&A9
M*UPV^'#(2L /@!\ /V"/_8 PHI&R]B&Q8\M5=C"V24"9(/I (]-F 75MT416
MHJU^0!Q(VW=Y3(0C;.(XD9J_YS!BRXCYD1]$-M_(_'?A!_A#;]4)D? #.I++
MP6J(AG,YOU5H2T&8PH!=2$.)3"1SW7:KRNP41C8KBY*E>N;&K)#"2-+_%^4'
M<P=E^4^>3::SZDS)]%&&Z __%5C4.D*6"-YA5Y9JP2ELT9I+DWJ2N\H_";C@
MQ&$\4@Y'S(D74N:;-H\MRII(5BSTX7&M#L\J;?@IKGR/XM.=*GSLO-7J<MDK
M,==RQUS7$V8HF'*M>$ </_!)%/F,N#*D9N X@6\_.I2[P9G.O;)'$W[E7"D=
M6(X[".FJ+O!PO_JCV%ZEM+K9:18FMQ/,A,E]X6H-'@MF63%AGF?I;0XN85P$
MA)L6$W$0^EXS6^5W;W*E[5H>Y8*XGJM&';B,A+YM$E,;4<=R \^G&YSIADRN
M,W ";Z!&#XN[:[VVR'.HOYF:9/7C)A7(G9IZG@&LGVXMDK=/// 52.QFPB]*
M75=C:6;Z7T?28%RG0UAZ4^5#LE)]E5XHHP:7J,LN<C8VIBPO=:*E',E":O52
M[7MB2A4LM3PO="ZT:D(Y7)4MW]44C0<O5R27!A^SHM#*XD*2N8CKH6A-]J?J
M@OF8_U.U,+P^)/91/);71"2YK/30H9K-;)(>B:28CMG-H?[TD?X8NDH-Z&'-
M$X5:*_QK5I1)?+,87W4CD:DXFF9%4GUS+L>L3"ZETCW7&@P]P5LU=/U,@_Y#
M">D,0]^3-I')O:<S%5/F?VIBC6X3PW-PDW2<I&I<I9*>0S8KLZ/['ZC77O^Z
MYF&5'F:QPOZ0C:_837'TYN"6L2O-F^;7$D4?4*U91FTII]CT"UMAZ1;O:QM:
MOG+;EO7EMULM^2V+OVG%F\N13 OU>M84N*OZC4?96&P&PI/C#R>G'U\CA1L?
MXKNWIR?' ^/T[&38&5.^^?>V;*;/;XVSMN,GR[PS/MS?8[KGL/V<I,K/R6:%
M"FV*7[:(2\L4):;;]^E6$=X#GZ7JX%TY)??]8CT9?3E1WFXVFU]2/RFTA^9/
MB\NY7@$Q+>1A(570H'3. I,Z-JYN>_.PD'Z9%$F4C)/RYG!Q_XH2>?TTSU/A
MM?W3LB\SGV;MS!P\<9\:I$=??MLZMUA#SUMCA.L\:NAU>TK?6581-'3@ZV,9
MW-'IB,&.4B9M/MBO?TC=GB3I-7*29*.=HS:+Z]H>W+-@_Z=DN?%.A;K">"NY
MK);^V'2P2<8VW/"GHZS>@HK>@DI>X8GUYQ4!N694=C.'_[Z^1=W.<-ZL"K=,
MRVFEOFX#]-U4#IM%JO/G@$,5/*T*;*B"%KER5:ZINQTI-IJFZU)3QY9#V<65
MC6W!KCO[2%N\-K%165ZY*W0+ZQUCY4A;(F#$8MPDCLLHB:S0)<*,PR!TI&F&
MCU8!OKK?XO$E2\:Z!/ U.\DFDRP]+S/^^TC9?9D7*W:(]J4C8]?%O]5M#6!L
M6HH=C V,36ULK#!RA*<WW;/0)XX4E+! 2")B)@*]GXV&C6RZW[&Q:4>SQ*Z+
M_TOWSC\1=G9E\WQWPLZ_I0K L1JS,"Y8DAI*O-E"QH@2#%(PO19$\EF>E(DL
M!L836^?UAGF]$IQ=(X+MBE/1:!%YH^AN&<@].W]H&RV*A+ \UW&)XU@.<2S3
M)Q'S5'SJ6<+S(H]2OY%6?=6IM?>6L=;.PZWCH'2:5FGGMQKM6.B]%WH)K/(T
M/L5?V?7G+-<C/R[+/(EF9>UN?&:YNJ2A<XM6=?)KB^2OLX1AOV6_+4#MO0EJ
M^R9*6*#6; WG 35#CUI$!$(0)Q0Q8;9PU!^>Y3J.+9C?2"-_V".<H8>":QLC
MW_M[G5!Z[:[7\.JF,JU,F:'-[SYFU6W&F(Q,%>1&TB:.ZSDD]&.+Q,*4L1EX
MRD?A3<3)*UR2A;NQ@7*M%[;LE-X&.K:T4FF@J LSUBY&PHSMHQD3IB<]'JKP
M17"I0F5/DM"B,?$]7T:1,F+,-YL(K[=HQJI"\*K>G^U1&?TV8]MN0=;"G?GM
M;;^!!F1H0(8&9+L;C=>1!F3U9QUN0;;!%I/;;4'6TC9+=5>QW3;N6G1G$\JO
ME.+;ZCYMA?I1KSUL+9 KVGRUNEG;;0^RM/*&M4?[.9>QS/-J @KKZMB5Y16?
MU9DL_I'Q[M^SI+PQ?GXKXX0GY2^MGN=#N[_'PGZOI]K D-=<ZL)?=2 SFV0S
M18EM=EIK.5H/B=-4GRZZS3Y=MC<,G.TTIWKY+?[0W-+8AG0[';J\H>N9R_^Y
MF%^7YN</K6TQTM[.@X)AN*7F=-M[1X'5S1YX:+"$'BI[U@&O#7S<; ^5>F-<
M'2>AEPI40A=40C-ME5K+MLT*_+&:M<ZFLG&U-^\S2P0Y3=$0$&(-L>ZR6',^
MF\S&;+TSIKN/;C=EN?_(0;J;EFYMM:N-0M5/]]8T@;^=D7Q8\6ZR;;-R_C4K
MYW[YBL(EI!L=Z??J%4$!H^ETZU1T?6PU4J50!E &>Z\,CJME1U &4 90!GNO
M#$[8--'A&[0!M &TP;YK@_GJ<FB#7FF#_B,'_; =_?!GEFQTU064 UP%J().
MJ()Z0QJ408M*0&BL^/K&BNL)PZ]LS%(NJYJG=;1\2K>QYGF/:%GU&I/8AX-(
MM@P3CA]Z6?\G%EF.I&9,J",#XIBV;O=O44)--W9L:C&/.P_[/U'NQ0&S N*'
MZDHG=CT2"#<@PHD=ZHC09]Q^V/^I+MU]FI5%R5*-][VN3]5&XF*YW=/IV?L?
MM'ER![[K#%QSYYV>(&G=ES1H^'UH.-AB FY!U<O =?T@H$12SR$.EX*$- X)
MMZ+(CEU+NM1O1-4O+9^KPZN&FM]3:'IH>FAZ:/I.$W ;9WA%8<PC6Q(O,$WB
M2"LF84SU&5ZF;PIAQ]2/'VIZYIM^X(01"3W+(H[EFR1@5-L)'D>693M1Z&U/
MTRO/WJ([;T7>%KF#OH>^A[[O* %[T2:<VD):?NP2+O2ID%'DD" (8A*XD6]2
M:H;"?'2&M&U2V_24'7%"?8]I*P,4"4K\@//($G%L6E:3%N69AUPXWL#T')B6
MUXEX2\ZO:(>(P\; QO3'QCQQ#J/';<<7(7&$]%1,X>ES&*5#7"H=[E#FV?31
M>4?",4-NV0'A/%0WFMQ2(8CCD]#W(H^;?BQ-<VLQQ<Z/3FR+Q"&:@*:'IN\H
M ;>@Z1TF;-NU7<(LGQ,G<$(24&:2R#5-QW-BSXP?98],:7DVLRSB6EQHZV 2
M9C)*>&A):;JNY45R:YH^&%#7A[9O3MN_?+'68L/^^HNUJFGI@RG2^4,VN7IK
MN2=W];#EI\]?1WL6=SUOK[26+A*Q0NK%I).I3 M6";F\UC^OTZ\&B[GVW83#
M=6R)Y9XOT00-04-$,.!=!W@']0<:MH"&4'_@7>?5W^J\363[7N1Z,3%Y[!(G
M="1A3LA(S -/N);KLMAZF+>19N P[ON$R\ CCL4=$OFA2ZAT7=L4/([=\&'>
MYECH(TBKD_6^9L=BT=)<=S,_3>>-.*KE_E7P>;(4>WZ1_YXEA9KZN<PO$RX_
MRSS)Q!?)LXNT^I:_L_%,-I7O']C41A8(H@N3 =YUD7?PF$'#%M 0Z@^\@_H#
M#?>4AE!_X%WGU=_JA($IA1.%D4GB(.#$88X*_CT1$BMR7#?F;B2D]S!AX'*+
M"M.AA',O)D[,&(DDX\0VF65+3SBFSY P@.CNJL</EHV\3E.<%L5,]P RLE@O
M&]'GD];-.8PXSR;&-$\N62F-Z5A]OY9HX^=4EOKB9'$CSXJR:,GV "POZ11V
M\!?:[2_0(')$;!)I,9,XKFD3QOV8>#*,J&^'RGZ;#_V%R+2%X\8^\4*F_ 7?
MHB3D3DQ\'MFN*SRF1KCP%_CO:NC4M1UJVX<+1?0IKH])KAL(O5=*Z'.M@SXO
M5-"9+,_G_8->V5+(&82!._"H"2\  HG $;SK(N^V8 B$:0>69SDDC@*A D=F
M$18RJ:)'EU';]7@D'G42VHXAP%XQ"&);!!$& +SKJ0%PJ1O8@<M(+&Q)'#OP
M2,#T/E_3CTP6QVY,'W4-?<E2HYT; '\0FL@%0AAA!,"[3O(.U7/0L 4TA/H#
M[Z#^0,,]I2'4'WC7>?7W1$?(T/?C:H^1]$/BJ%B=,)L+8C'J1\*R3).SURP>
M:D4* &>+['0Y$+K(M&DYT!7+<Y:6A9&D6JY36:N#JZ0<&>5(/EX;U Z-C#5
MG<(.9K\E9A]1#VB(J >\ZP[OH/Y PQ;0$.H/O.N\^EN=]+&X+=W_S]Z[-K>-
M).G"?X71[\Y[>B)8ZKJCRKV[$1IU]QR?Z+8=;?=NG$\3=;4P39$:@/1E?_VI
M*H 4)5*V+%$2(.5<;)H$"2#QU/-D9F5E.>Y1506.>&527&XP1U:1**2F)@1Q
M#W4?_]U'GB_G)YNX\[]3V'DU^7.@S(^44  .XQ%T ' W2MR!&PPP'  ,@?X
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MD_>FGD_RT)]_".TR;[<&%2V@Z:#IH]5T"&G&!T/@NE'9;IP@ ZX#& (,@?X
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M6!1BLE'9#J1ZT%)=>6YQI!%%J17B7%;(5I0AX20.1'AM0SQ$3+;-(P<2:*%
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M0LY-%3GU&$6:]+C4FYJH/))$>Z.Y%T0?;G(P,<M)(I:7/:_\W-$*S '"8!O
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M42N1YHP0236)H3K$-,<;\[FPU+O%L?O7JF["X?O24CW%F$)U!DQ%#-_O>@8
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M[C03;NE <+9(=+W1F9-$K,UB?7&)F];,>"VE;LG4QK877[\X7S[9]7+\)JE
MELI=64Y?/5\U[2I7^:3PK./=BQ-TSZAGQGR.>IZ.VO-ST^Z0/9_T+)YE*YOV
M1C>Z8^+UU1Y-CGWW_$WZD6E^0M?!TIV:>;[TLJ0F/=%);!9GD\OPO(3=M:.2
M;G#7B[E\2$':GEO]XCFO_;6])]R1S_71Q\O>DRD#JO=D+@1R6EXG]R3Y6_LN
ML:O>FJ2'X-,@+'=R\86U6:X<U#VK??3]#5SS #-^3G)O@\+($^<0)YXA+2A#
M0AAIN*?:5_1J"*T)22&MC\C;2J7HEABDI9((<\<M"5)7E%T-H;N)O-_"\G3A
M7R:'LEWFP?\Z6:EI3^OS-Z')N9OD0EV:Y$OC+&QF^1#=GN:C7UNF?_TN+$,0
MA[\4& T?'UCJ0*BHD*.!(8X32"P+&CEF!0M!,"5WRI&H-@P3:Q$7-,\(^PII
M7J5_)I"$2F-/R4Z*Y<'Q0:]OXS (?$R3YK?G>58HA3"?UX2U\;O[8"<'")-@
M$IL[TX9"[F;MY]>S559M:]H4/^5$01?/Y; GZ<OG?@'E63%Y06/XE)<QY^,6
MJR5:1)0.1TF-0SK]>>= Y,/6W6_WN_3/U-E[=Q%NY6BI[ZV4YS$732?B:Q<N
MQ8WFO'C6:^_J6C? AO+0<IS:N5_+,JV:ADJ3SE-^N3M//BR-A?-%"D^/)F]#
MR.%:BH+;;:]ORVDL<7>Z^'DWZWCA-?:WD#[-Z><)FZ#+;N&L7,E6@'(-"H;X
MR!\A'OJU3L_*7RG]AJ&RG1MI2ZNQI@XI>O%E(?=LL<FRS,/[,KN8V>UT$F>+
MCVWG'_89I.P@9X8L.XQ/$L6E"*CNVIR%PEA'DZMG,R5<6IVM.BC[$&M7ER*$
M?QN^&@L=3+01(U(QF3PO3U&288F8(Y6.S ;MR54U#A([81Q&T0:/.$^'6UHE
M-R]@[W$,2NMP58U_#TN39>9G4RZU/;ZPV$^=P:ZMQ9*7:K'$3=<0$:&/AJW(
MD_3]67X4UV2XNH#2;" \$DAI;7E%RRZ_)L&C2J& K:1 GA,6%9%!ZYV2OUO-
MH85E"LD69^'79)N#HX<=7;\$;5#@B7U._W,PS:1+F>SF2B?O%LN+-'DBN74W
MQAM]??(Q-&$,T!.&*!P3,_&@<K" -=+&8\2"L"Y%H<39'3:[#?1>K^WXU28\
M._#[<@C!CX8=9*Y1=U0R(\ODM-<Y!S1)?ZR=PJU))5+]V&YAKI?A%(6L9L61
MS;J[ 6)2V%73=',25QW)K,#I:Z%DF<ID23<-4S*.Y\WB?6/ZU&3YS?<A!7D)
M[H4^?;J7NETVO>R7IJ6F;1>N+G*]^?V+*:3!%@6"H[?E>F7@N&['E *=0NQE
MX63"Q 957;JT%'^7,/0J&-?TE_Y.^ JE:VU<E0*"/CK:3!FF 9XALTF!E_*,
MMD_<A?5D8O?I^A_;.$WCHYNT7/A5GNA+!Y82G+;'J4^?I7@N0W^6-#]/#>:4
M;+J_[JI#%_6M)R7[;'#ZX@=3/-W-2<_K\Y"+]O(9=\]VV8'=6#'/7VX-@PL+
M?4PC/CG*Z4=6^1JVK)S&?1EN_UJ99AF:A#74ORQWE!4EOU>4Q:]"OI-E?58>
M0]QOHO50AA$XU!'X2W[@FV H/](];NOR2H1T,>\4UUWN^JBK%! DH>R@&F(H
M"E#R2-.+39'Z^>'-KDC=J"T>3?:-RSQZ\&/QC[$+@N.@D' 539Y*H$AKPU'%
MN2/1,BO5SB[E,5V-YE@@3GWZ0U*!C @:B<K$]']'7 Q[6S<4OR]YRF]Z&QW(
M42$<C\0_GO8=RM?)2HKY)C/V9I:N8S-K63S=7TJE"GH]OUK5L%5YTK:KDB^]
MV,[+![LLH!PA')WG1OIHD%.R2G#$"8Y"!,28K["U"9I4[ZS0XL)+G)QD)31#
M7+D*:9O0:3BEF$C!-:NN^LQK!&8&V=JRX:=DN@.!4AU=OPQK2) \FKS\4J[T
M,G\FSR*4\AMSGH#U*=WI,F?O1P L2I6(S%ND0J41=RPBS0E'RGMG R."L'B(
M8&Q=LGA29C**"Y\+G&O?^_,EM]PIR_4+_KXQ3M-'?!10*YZ6:4^G7;XS3RE_
M2/>[%M7V=-$L42[L2"RYGB)+'N+Q=0FIR\KNO_VW\^^.#LDN)I7%AB0D!XMX
MY3W2D6$4N)/:*UUQMD.1MTF2GB0[YO__?&'*X[E_FPWY+MGQ8A;S8#*N1J+B
MEX.6(5VA2V%27QQ9'(A=W^+[7.L88IED74^#59U3\=<\O?I_S+PKE65]MFU=
M#M*&7&@UR6?H@Z;E:5VJ7LL9SC=G6+@^=;)=*R76J;^_-SEWO/%*-G[W=LG7
M6!)\A''!M* HJ0%.CD=,+HAG!)'H>$*U3O[S3O$ 5IBF09A&H@G9P5$"*>H\
MRN\')J+%RN[UG8OAMMV6A,'^\6Z>[J$$!8]%4(JS<M7-'1VC4^ZM)+A"+#<C
MX)[BA",:$K='@V6E$S)V&/W6.-H*OS**[@E"1!_A<4"HK!M-MY834YG81H"7
M(*,SV*3'KI3+,7MZ]L%X1/,4:8K!G0@[,?NM\9)WJZN[2HLD_Z_S.H.M^H@#
M3SF0L1!/F1;8&*:(Y"*;YI*.K?.^E_V%7J-S[G0>ZYRRZV8MSDSS9TE+G:_L
MK':)R5*8D!&Y7?NZE1:8O)YO:JDOK99(1UPS^[&3MGI_68W'D2.HM-<F2H,J
M265R9I,7;+G%2 9<T4JZ*,0._(4B6@DMD=(DA7\LIE?"I#]2+&<)PY$Z]:4<
MP<LV%T2[D#=X_/KNC=\(>CR2>;;.%]P">#=_-1+4$.MX\LN0MSQGB3!'1E"+
M"&;$>*H<S01X -28SR4H>AT+1M; *1NI' @P^$B/ R_=Y&KFL$10(\Q&RD!D
MXA2#2$).PHP02%M.D!5"<(,C=V&W6>$M,/,V@:#'RZ5DT>]]NNWU?$MR#P0B
M?<1& :*CI'-;*SA5"23%Y>1/:8L0^J4H^8/U*I=?%^E&=M;B=&'#\8<P7X7)
M?Z4/\@3KZ_/S1;/,ILVU=K^L$M6]?#F=_'KTYJCP7G_X25?<.OG-S,W[+N#=
M'%8J5N?]W.QL# "/55)/XBV*/"_DIU@A:RQ'"</64AH$,[NS/S+(D.>)F*EB
M^DX2XMQ6#7$GF2*4,9Z]S^NE]/=POJ'( ^;;DXJ.).)(W'?%[_J^#:%+Q1#V
M5Z@[OZ;&(K?5FOM28Y'L]6<N4NC7?4UB&J[=G%JS6+T_7;O0>=RN$U07D[W3
M?H9LZPV7%VC;1<>Z$[,FC/1)J=4)[_./I:>7E;SS]M//)]^^5.ANCCZ:',^6
MI^4"KDXZVQ"2+5<NUU'$U2SK86/J\OV^7'Z]@OW<M,O";GD1=#N9+W)]T*HI
MJQ\3<OK?R$<O;*YBS3^1WCR]9([-MLAY5KQ;*>GR+'FI*$GV6Z4[JY<3L\QW
M-5WG^/:<L5M)OG4SI0##ALGZEPKU=L1[R8AYR7P?$I6)\_=K$[V,EPM9VC3\
MUS_6W='F:7X\#=F'*.L!?/F]^:7[R#=V60C.S.=\<9OO9*AD,IGD=O'Y%_*Z
M@;Y8IEMMT-6KK$MBNO*9JT4J>:U*>BM,3E.4718D3).)9Z5.)_WR_,]F=;YT
MG_-AZSX!TVZ9Y+HNIC-$O]P\?<GE]H^C*/+ZX5)CFGTMH!Z)F8JB]<_27)*T
M&_:F&8*I_V;Z3@Y[H_6<1L^XW!1!G<^2%YB@=>%[V#"KPX?0=:#8/_\UO6[R
MJR_TVB6-RRTSLK.U'O7M*N;R^- M#<[C]$JUXJ:$+:]Y6/B2CEU.9@GNZ3[F
M?6'OY08<=1\A731*_&)OQ!^N//9A:?QUS< >6;X?S@)[&X-"[TCH'7F7-EH8
MFD<^H>:1Y?GMZW<G.'.!NPH%27W>L[!"-BJ"#*XD5SRJZ _2[^[M1=7P\6:!
MZ9O%+"M;^R[]]M]F);O[Q1YX-[G8F_; &^>BT1OA@.;%&6=G?3N/+<M/+DP_
M6=M^&RX'[:3((K>&A I%GF?,I Q(8\<1$89$9;4R_""[COPM+T9_':^@ZG/W
MYW7(>L(0N>6ZXF+&C)<W>1W$?-F'Y5V+E=QD;1;*QQ>M0[=Z24':I$N;?+7=
M^.34? A=9B)=S;FY6.Z4$VVE,5J.7O\X>GNT7L24%U>5 #Q/8&ZMS;]X*NO,
M:_G6WX^/WVSUZ2D%I#$TH:QCGO?>_GS="-:<GR>8E-#^_:KN^CTE&)R%OA-1
M^>ZDS_ F!4]13;WL%E)MSI97I<1%B4NZH&J+9=XN$X),X]N$&W^QJ=GZBH_?
MGEQNGK3WJW^<9X-N?>F/BR_U"81?-K;>^PM_6Z2_-C_PR_';OUV8Z&;/K:LA
M[Q,8W2G:*U.^-UM)N:[MVC2WN]PR:J?AT$U^E>4LV*PDZYKUZJ#-15Z90-R&
M8 IDSW+![ :$%R-[N-F1Y\XS;TM+@GV]/4I/Q9!S#J74,(U:>PFP76^#OM7'
M%[MU3 OJNGQ"VW>EZDE@NT3]Z\.FE!5NF*ZTDLF+1GTR;4Y-=(UDXC5-LKJF
MF#ZSU:7QM^E84Y)[>>JH[]A0\GP7U[$."KJUJN%?JSZ'\NVWT:W/+\M+;S+&
MUQ>[U7ZO9)<VEUE*,/N6:?T0WN31=WYN2".Q[TC0MF&YSLEW>U*6IU#2UG73
M@:RS?>GS-XDFO?O!S%;A:/*_ZW:95"2O_&M/N]T[?(9:_Z]8OU\UH?=$=C%Q
M05Y-6#8+LVYFE+ZR-'UOHHOT7M_;,'SJ6L)-2L8L__3PIPE=#$YQCI'G*B3W
M&;M<?!X0<TZIX(U0VAQL,_DR#=[WF>O:9N69L?+NV^0@+'_N#?A[MM_U[;+P
M]NPA_VI%!:9JV/TYCKZ:E3]LR.2PD(9:CJ3T,:^J2CP97$3:.\6H\E*R@W0O
M^*,-K^//2=5RO>[5QO,0&EV%P1]M291O##:V#KH3\)^NQ&F=1[+98'E_W>;7
MG()^QK/=GAM*WL69^3.D$=5C9:V7J[.^W5VWSCZ=RW63O.E*%DV)[<XV046G
MK]/+XEJZZ6TU-<A?SE.KLT7;[W;09<O>E^6L^Q6ZOF;6Z^L.T-SOV7RK"Y[.
M%NWR<N^%S<W?^GPEC5OFI]-9FU42E.)Y7=L"9&V9:?$RKNZ<W5W_I4_ZWJJY
M\;GO[J/]TE/+GLG&LUA/$L;T#-,93R\<FHN^8_T9NT;PW51T/GS1M.OYP[6#
MGCM3++KI^!1#A\Z]='7C5F?957:AGV_O"OL*/KK^P%E=RR<77G3"7GXX_USY
M]_USLXM5WZDVF:(\N>*&;<%LUXWKP=6$W *Z7WBT@5[!;S9']LK3M?LZ)RC.
MLX.?35(ZJ97;;1>KQF6,'.?&$;/-]>=Z 5_G0NM)MG73]X\I$Z.EG>&ZJ\3R
M\C/)+8S*=25F*4.M%$_D*UG_3/^SH12,V+#\F-W$\HW+S_72]4SW(K3O +)E
M\ZWYUDT]1CJ;2Q!^:#>!>"LPLP%)03CBP6%D2'(8,!515X%S?9C]G$\6\SQ%
MUM=%UNV?)RF(2YY?>@4^P]<VY=BV7<F;%MM-LO&VEB[D?W:H_",=W^12G.65
MI/QSU^N+U%X];Q/:^B*QC@//%\O-8HYV9?\9W.72J5(B=>5)-,GFTZ)!B;@O
MMA#I.N*62H[2;N1*2<>E!2472I:/JG/:I20;UNVDSLP_<R8B^#Z!FZY\E1,@
M)6<:+]U0O5QUY4@[;27G.5*-R)I92<NVIR$L+]]-(2;7 :N[JZXJK8A!POQ:
MJMSGBQ X&[;IA*OKP'OQSD7YV&GP[TNV:+N,#$!Y38UD>?RAV&"R9<_L%ZZR
MZ*_*DJ+M[0\N<O8GO[W>E$CGRKG5^?GL\[H>[BM.S[7]I+9;GES;F:I=I@/R
ML>NT5EZI%)H,S/XJOWB"?LUG\F/VCXR]#=K<8C7S13HW4K\6T6ZOAL^7',F2
MT,Z%?OWRK]Y8VUWE^JK'_.4O?K4LI^Z,FSV?DC::7-GM)YDKCZ6-P]N-A>ST
M)BC "+@\ MZL(=H_Z.X)7FY<4N*C'B>YVFV]\/R7GXXON*8\J:YK1_'*WN>F
ML'EWI!13S?,,]47^^0*AI6=4QYE-]FWG&517JFAW,;FG\UKQY?H6*^4[%WW7
MUM>]MX V/>YZW9,E'S.]>%E\4I\"F,_!3]<;;NVMO3W+<I^K;R^^N^[VTE-Y
MLFU&8S=N2N[37/*:NV&TCB<O%S4^N%L:G57<!11,E5=[28I,E5ZI@&T,/'*)
M#^.6)LT]GOLK?3)@OO\;'=2UHU->;!D22&Z/D78:W*S=Q^Q/KH/@#Z:>E:'=
M>87)$S@-[L]NUJV;C)U.NKT/NG7'I9CWHKE=SVSG";7-E>7+_0*UMK19/4U8
M2:>;E4;PEZJ+UQTA%TV=#)Q^ZRSOA%GFQ3*!-2$G:^;+TR*9L[RD84/)OM_#
M[SP%[:>Y4+Y+3NQXP0_,*51;5RE'$',R+[LG#!GNTRNGM>-:$8UW5Y#>@E-^
M*P\D/[RWP663)=WI& 6(Y&OST1>5[EO]B88TC0/I[VM7=^7GE;=+*.N;-K1U
MA8RF7=RZV>7%)I^I3UJ4.J44!#3SXNBWYSFSVVQ-S5^$I&<))N]+^:]Q?^8>
MGYN!MDZ_7EHH4?:C+-/HI3CENF9B\SX#NA4C3[NZ]Q0)=#N<;'@9I2@'E6:C
M^=HO$N_+K?GICD-7\W2OL[+WZ/ODG_4YTJX=[O95;6_[<!$M-.$TKU-+SEK^
MRM'D]VM_J[_\=0/4+N-Y89ABA9R&?;_9!W6]%<!PZW.N585KYCP)43)&AX)W
M*G>6\$@9J=(?D6!C:65P.$@!<B@I\=_+4[]AE>C5^N.;7.O3KC^^K49TQD\"
MT94$0.GHM9S<32:V5]=XE<[?>>WJ+!-$9\W-NJ]^FZ;UG$Y;UKBF[Q9CKR>C
M^KFABY5MN1*CO4@];J<E-T\IQZM=2-Z4(IL/=?AX$>F[TSK$/;]8YD";BQS7
MZY]^NZC8K.?EN)*<.EU\+'-\LS3XL@/:A,VLT;Z<4OZA?$79-G>LX+GRY%$B
M751_0J>U3^![\<L_*B\X%LP@R7-7L+RNT48GD<6$>L(9ET8-!3[=8PB?DFZ4
MM-8B+Q@,S6:$7?IK"!>\_^EFU):-K\MNV_DY7]YNNX][VC#KMK!+_LK,U:NS
M/%F<U_:BDM4K6KS^).>\<S/]>GY:V[K,ON;= LY*XC)O29=WC^FRK.<)PEM!
M5#)EN+Q9=Z*EOGPYH?/5XE*V,6_$EI<W;Y:==[7;^5+Z':36#=/[ KH4QBW-
M_'WI';V>AFWR8N?9IHKZCWF93WB[+).?0)?[Z;+?&:$0Y/"+^JR3FE'MD,(Z
M-[?Q$5D5*,)5X(0IJB0[2(HLN5@V-*_C9IN:7H O=T/JW]PNVGOYZI=+97N9
M%W/IWL=%X]LP_^X_TST/NF1O2XTN9#+125>YL<4FE[,N9:%@&GGSQ8=N=4-V
MYI,CF&<&2@(ZC8ZZ3.1U8S/'/>\N5U:?]PNJU@5%Z]/G<=TY^6?]EB))J[>:
MRV\F)S8KMK:99<\);I"#N;:# *P*AE7!=UD53&!5\!-<%;RGI<<-E]K>:H4N
M_>YN6>(]E_OMD?DS]9T@%WK%D5POF-I4/&S";-MO*[%1\GHS[9/_M5DR=4TU
MZW84_;40>B=VR_5-BWS"K?G<_]4%P"6"O@CSUQ=W-=S_>HS=+<>Z=/6EDG20
ML<;=IY*\#)$Q:U&*WZOD1\> E*X(XI71SE C<=QM87N 1./)PI^]:18)>7F;
MTM]*#CW\[\7'/]J\\VWV DM@.* A4=(L.8737N2()EUKT8*<-9:Z<+8@,;27
M -B[P.L1U 6]9XMY%X+;E7\?EI-<NK!JKY3C]KO*UV5?UTL;,W=Q]WHGW#K/
MA;:+7 [16;0OK&\WDZ6=:]V?-/_FET[;5[+W/Y5]\+7WW@7G)0W6SQ?T2?LK
M V=K J($H]WN9)<.ZG[K4E>E2T[ZGE'W0-[(L-3HB=]T2;9>M.,J%0/G7=.%
M]I)J=,7[&]RM(5GP7S;8V8H3UQ_NW=:W_>)J]+SZ],6]M0$)@D4A=4#.Q$2A
MECND<2YK==JX2DC/#K.F[:T[#7Y5>OI>(>"M28>_?>X_O+9.*+G%W7_^O7LP
MER.:#*,N9+D<.&>PE1G&% ZG9]8=TCU[38_P7]:'EW:-YVUXT7;KC\(:LTV)
M6LK7MJXA7<0FIOJ0>+@LT?C\8OTKEPY-Q_I-<%'.+/D15G_9#GEZ#'8QSP]?
M_#(YTK?^ZJV_*(X4?_BS/L:=TB-Z^T=SLR_^^P_+9C^4^AA9I0&=Y^+?-[EY
M!^KI,);_[*?#G 7LXO077;2>W]A#L_NO_G+LCDD*T,L>@,[,^J]WS+V32LJ1
M?/]6TT?WY=O[PW9U(,G8GP>Z8UIX3S"^]&"ON]DK(3=_7KI7'\!VF\30.I%Y
MGN0U.W&3M:\P&.O>>LK_1L;_O\5U^'G'=;A_^'[A$73\A-EP'L(]0QQX?(0/
M#>QU%QZGP..'Y/'M)D+ V3#\!VHO&/[W-OP9#/]!N6QZK\OFDI&BN\8[^P9O
M;'NJIJ3M]M[NE2>;OG\K!MK.C)63;9\=;V50]0!2N=]4K'SMNNL[563<KH#Z
M>_/7R??VK[<>QC=!P$%DZ#Z?\N.*]O;9YXM1&O R2&]NN7\;$N[VDOM]SAV5
ML]]I\DBOITYN-M:_7,>:?^P!2E6%C;:2D2+-C$/<>XU4Y0-BE24Q>B:(VYFW
M\39HJ52%*,8<<6L]4EHQQ#%5SK"HE:57YVU^[UGV>.Y_NN#8?H_C:_>I8Y?V
MJ6-?VZ>.326NKJU;!2JX.5A @D""0() @AY"@@CU0FIID5!.(JY#*1T02+%(
M%,&:*K6S6H(2JXB/N:S+><1S.Q)-O4-841H9PU91\D@2Q-3UFZ4"%1Q$@FX9
M>*_G2B#P'D3@W6]\TO<$34?794?87![[&*$WA-W@\]S)@(]B*W!U1N7J6!FX
MYA(Q$I+O8C1%5JGT3X-Y\,+3Y,X<(MK^>T>MR=,YOD2LAW5VU/3_L?>FS7$;
M6:+H]_LK$(IQM!S!9",7;%)/1]!RVT\WVDM8=D_<3QVYDA@5J]A E23ZU[^3
MB:50"RDN11)5=?K.M4ABR<3)LZ^,I:CK')JY?5=>L"M ;F4%*(U0&J$T>EII
MY$3""\L$H6 V$\%]SK[-&+'2VD1HF6>,[\+P?AYI1-E)4MP\:.@8><!X3&^,
M>8_#]/:COD@SX<2WL /R:R=UUM9&?AA8E(]*%T$S>.\ B(H'*AY?43R*.)9Q
MGGL_OXE]X5]&BF 5<\=<*JS*-OLC/<0,/FN+X<T'/W/R.\_VW@VXWKWU#U^)
M"3]]11%A)YQRU$/0+$:S>'RHB-()I=-7I)-D*LVU42"3TIP(K0N24YV1N!#6
M#^CU\VQW81:_C'0",SGF!8JG49K)&*$>A9G\O?7CM,K&-&Y;;0Q,9#8JO01-
MY+T#("HAJ(1\10GA$JQ;+11Q.7=$4"F)Y(836R3&9EG">;&32/&0U7D'O1_?
MT<X%W)%?/D&?_,'9PBAS]@Z *'-0YGQ%YN1"9S;))>&*@R5+60;R(P$[F,:9
M+%C&$IWNPO!%F;/_,@?CP/MLX/8#(T*7R3&Q>M0L]@Z 6.N%*L9=58R8%X6D
M'&S2Q)NH-L])$1>,:+!."Y%3T"4V?.L/,6M[!O<^=)CV+;EW'N85)RP6J&>@
M;8L2:$_Q#B70\4D@:YSDN7,DYH:!!%()48F*X=>,":%,FE*Y"R/W&200ST_B
M+$$)-$I+]_Z-61]C_AZCI?O 0M_?+/RLRTG9CP*Z"F-;HEGU.&MXWVAE#YL]
M8F(> G"$ $3:1=1#VGTR &*L8:0:V)U.]\SX67]A+'5H]5)U^I>?_S:WEQA^
M0.</)C:\I,_GV7TP*M-:IVE!7)H((I+<$!D[1EA>2$'CF%D1/V98G/X(6Z<)
M%Y3SC4&= WYT-C6_+;G1>\^,'I: X,HOUI _;37S6)8SRMZB6^;(:'2?-2S$
MP$/ P$.3$HH;+E)!<J<2(EC!2&X21HI<)8Q2H?)DHS6USN(DCZ4@<1%:FL0%
MD2KWPZ!U8BV\)Z,:I<3!TRB67^VSQ?AN.$U[AJEJJ 6\='@0$P6.+U&@8-S$
M-I=@G_*4B-QR(DWN0!OQJ@>3U";%+B::8ZK:/G$"3%5#"802""70<T@@'2MG
MTB(C(#R\-!$QD5F2D)A*GH P$5GA'F, 8ZK:/G*".Z>JP6]23>S?_V;*3Y&>
MR!I.S ?<R*2LY\1.K/=N!$R%\W^US9P4IPG+OWEKROIJ(J_?N(G],@1'"M#Q
M7I+277?["_>0>BZK^=OPZ22$^-[XEI.3TG_5&I"67PF+\>R;(=3:=S^*[@,+
MNNW4[I=*)DZSA-$L3P6HAYG(6/+-T%WPT=HKV/RD!UDY]5]- N1N =6KO\O^
M6/UI==(VK$GC^)NU%[8LP\UF\ZGO2!+XQ<^__UMJQSBUCG"M8R+2+".%8!RH
M/TU=%DL9%^95].5R\F8BI^?__<I.R1\?1@3>.W8K[5JRS%ST7[=SZJ_N[XF3
M#;<S=L:<2(V-B2MB8-*9T\#8C2!Y;H4UMC!ILM'<(8\SIS)NB.72@CE""U*8
M3)-4<RD3Q6B:[:S_X9+#QU\; 2#B$P#<C8Q]G(@5\A#V$G-2.&<-\I^ 84J)
ML*FOGXHY,3&E0C-_.=NHGTJ%S=,\]PW,P)!E64ID;%.P43.>F#07)ME0"9X>
M<]B)$,4>XLY)5-E)\$S.9S?/#MY;!(M3+8HX<22U&G3.F"9$"J$ 64#N.1FK
MW+%U!(N36!<\SHCBS.N<H'WF0L4D!1D)_,P/)M]9\[N[(Q@]$1G?0P3;7]PQ
M6:QE5@AB5:% ^Q 9R5DJB,JI8YJ"':(W<$?E/ :DHD3%!3 G1SDI.*<D2S*I
M$LL<I]GSXTYQDA3[*-A6F---\]7@O"[D)QLI:[TJI2<+ P\ /*+YA8VN@:'5
MD9WZOWUOM;U4MHHX/8F C$5XEZ=GOU!]9;4?XS"Y/NU-DH%2"K^!*MO]%VV0
M\=L@:B<V2*P :X3.0+GE@@A-8R)S9HB6.>@KB7,FSO?'!MG:"G)O[0YG4BE
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MS8M-R[J>UV=3TS5T'NJ5CQKVEA>C'_:V+]/^,EY(7G!!:%H +E#-2$ZM(EH
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M_[-/.EM45<-BO,.F[I.]6A6Q[=<U5"I#KZZ@X,VVC*?>J@#?I7/.+:Z1L5F
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MP!( M.,Y]1H@" ,1,V630J;QAAMR)*@ZO-"$6>M?F_/9&8J./*S6HNCVK)S
M9\MI8*=F4U#L);9::S6USA$N4T$$58Q(KC+"M 7\+6B>>.5C1T[SNVHM@)
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MR*NK:B9AJY6M%Y-Y>(/?A9[(NBX=/-3LS?F_UG;P@DC6T3\M?%E$V\N#&"%
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MT=D=35*?\3F:I+N8).&I!L]#H10B1EP)BFP*&B7AI#!!>L$[-0:/;9*^ODU
MHXT:;=1HH[X>?(XYL#$']L(@W5_ CBIWQ.?H%MS-+:!2<::-139H@KBC&EF%
M+5))J<!4Y#(=;BSA$V]J@N<9.?]PLF"'W_@T9L'NF06S=1V7=74:;5Z0H;++
M*L%"K3[EE=H?UC$FP^ZG@^@QS4HHS%=N&OM&,G;A?'O9_N\>L(T["/8KY1M*
M),DPUXA8DGL1:8DL%0J%1(.RBCIBV,'XQDE18T^9#"/D"*L>LHY+P'RIO&-T
M?$>K-%JET2K=/3DF)<>"(H,I!0NC"')1.229X\8P+Z)73V"5OO9\V&BE1BLU
M6JG12AW*2HWIL5$#CQIXU,"C!A[]A(/X"4%*2Q*U*$;K$>?PDTN2(*TXPS8Q
MYTFGD_9]!DE?Z2(<,$RE\>@ ]" ]!C];^+)_+2\C7V R6]GV;83)IRO_#J?_
MI7Q^Z>/U>)#H.(=WC"AAX-&&P)!1R:,HG,:1AABC^F^^+<+MU!4_%HQ]^_H1
MUO$_5_5RDLYO;YDN;G_='1_R9OHA@=MJKT/+XZ2NYJGZ,?IXZN*B8N2HHIBR
MHVKY,19-EI7#RDXKT"9M>\-\@IU.*_O)3J89O B4#:I!#VWOF:L^QT6LIK&N
MX5+P/0FM3N%R'^OCZG>X])OY*7S[\^HL+B;SD'7%]+Q:Q$^3^+DN]]YS=?BA
MFL-G"Y2OB);Q]&R^L(OS:@+7FBQ*JT;0DY?N\-&&*[;UP<^@3]=!ENJ#A=_/
MYO4DKZ.ZLOLE<[RSJJ]>G(]I#>^6FGST);2MB^#,OZ].X:7Z]2YKZT#;8(^<
M"01QK#1RW"MDE=,Z4N59[+3-%9Z2@#E!WDNPF<F"G<T6%XPL!9L9X"KVLLW\
M,;KEA:'\'2[VPW3N__BFBF BS_+R7JS:&\';BN%D>=NG^V]R.W(C;Y#P(^7U
M/S=%%6X^#8_SOL4QK*59,>G9++]?S$\G=3V'=??W^1*N:6?AN@.J_[*+A;VT
MB_9^2O<!$NZ9VGT[JT[.%I-I5BFT4;;O%Y-/%L3UQD[]Y)>8=6+EYG81LAH*
MDT7TR_D"I'UVMIA_RD49&<L;H9]="'V6A9XF,SOS\!S5V6I1KT#^U7)>P1?T
M'ZO)$DY=34,%)ZQB>7]U!(6^.LO';%R1_53[1B$\ 0\G7AA8L!9I[S#BAG-D
MM(@(:ZF<L$FH;M5:D)P$PS2RF#%@1#XAPQE'7G(N?"16,K5/I[R=U: YLKUX
MWYJJ]_:\_+J8@(#/@$]?1<KE#BD7-Q6L'5_-R/L V0K.G^9W '"<E86_C;_)
M#*!3?[2+AA_X^2E8>WAD4,'5=QG>.<1%\>MK,%N70\CK[V^M41I#GU:S[!V4
MLS*B ?<Q/T/+8*Z\7>$3'W*F)7_D8PSET0> ?VL95S(ZY+ 58+4,188:A@B7
MD5-J"'?I$/A_WXKE9Y#<UOO(R^) H&?'5W<JZ17H;PO)K$%!X_J/MHY;Z^$*
M!5_BONIUO;M>[!)N5\4O>;9KG7$[:0 ] &2:8 !5D2+KB45<1(-T4 QIK9(Q
M5&*).VR/6@^L#O!(B="(6YIR3QV%HC6!"6:XR>?L(O/-U-;UN]1*_=WBU\R!
M?FHE]CX+;/-AW7Y:DUW,PH\Q_+:$-P(7.BF4U?XXGT[MHOXMO[<-HO$VHND-
M@,[!B7XC&CRN!I@ U?D?U=D4[ID]H=/5=#DY VAG"@V7R6[88K[Z\+%Z!\PC
MNT"9JQR/+&Z'Q?T=N-CI6CAW(W) (@+PN!O-U%U43\/H&B('\LEQLXQ \-\'
MH#R$(]3[9) CCB/NP2/3U!F4,'4:^R25]1U7429@?02C@ 68->ZS Z<)BM*:
M%+0*-NTOP[@=MSO9"/!K,WC?979D 4>Y(!R .QCGP!I-C+ 68>Q")CH>60>4
M1_I$L:7.1B(?@J)G<0[T0&#3<'=0.ZUBLRO0X78Y\:V*J_-[:I#5.@0AHM_>
MG[QIN7_E5F![<M 0&)$#'[:\6#A^$?/9L0([_0&T[1(T7MW(X;CJJN%]*KBH
MQK"M$E^F<R 5%I@*AY@'0'."-3@'GB+AA3":81I8IZUATIPI#CR-,^!A/$:+
MC)%PMN7$&^NDP<_@' S&(WZ@<_ U. ;!2D<=\XB[  CC@$\;0<T: ]BC6GMM
M.R$;90T5U 9DF /'0 J!3. *!8K!YU681NM&Q^#PCD$35KF>DWJ_R-ITDI/_
ML5X6:%:+C&+ 8__A**DG/#"*L+< +4$->*S4P:_,"J+ 98WV$$IRER2\;:7U
M*\CIQQ50A \-;=C!W]EJ"V*(W@5C5_=AZP/ OBT(LS-X[*(Q<V+.KO.*YU5H
MP=/-N%5O3T]!*\+GT_.L], R@R+-]"*F!-[4Y!/XLO!8ZT#++X4C')4DY7RU
MK)>V"1#>Z&6M9F=V$AH*TP'XFLF43&5[J>: ^0  #Y18YEGOB"L%_U#0Q"X!
M@I5EGJ<8#>ZFX0Q/*AB+D?<9\ E.M-:J7/B2)%%*1[.7%;_94+TW:S%=K(&B
M0NNWA8SM*M[&(&[C'=]4PXZ/N%9'!/-> _^>IKY/7\%N\_>&=S@@,:&"7\M"
M_)\5?+%ISL#G3<(M;6]C\+;^V)Y3EM=% ,J=EP/.6J&44%3)XC=)^APE:>E2
M7KY79!<FLRLNT@:T)O"4<*/^+U'%@E<DQT&=XCD.ZG*+-HDLL<Z*&(E5G:B^
MA57-<L14IPB&R9"RK/,Y"6-8HDD1LS?\\7[EIA/_YL+)^F4CK3?PO@I3>@]O
M"PQ42WJ>@B+I?GNYQ]5O*__Q*B"6@A> XFQXU@%<0T>9C8";W I?8H4TM1QY
MH9CRU$8<.S$3F;#Q1H--<!Q(4&0)61XYB@ Y+I0PBIMGM0["X"/,>DZZ+[#T
MMX4]=ZL/'3-P$\_)"A#8RGP12N+S\V3Y<?O3DP^+6/3A&+G?C=S#+[/8+((B
MLVAA:6^\\USC=AUAO#;&!&N^7.WC?!K@%<"UZJPWKJO7N$7XX"M/+3*<.-4&
MS"/.16'!$*1E-(@Q$[$@(?C4::J-@1I*+!52 C035]$A+> 2*23).7$8>S)&
M$!XC@O#3+OZ7'V\%\;HXA?G@4NJ]@_@VJ56!7%R[J.Y.JX&GVFF^SG>3[P=@
MEZ,FFM&,6@\@YM8E9!SE*'EA!.7*B: O8SYRYY0/ 6$G/:P3H)$Z<H:DE48R
MGSSV8C\E!(C#P]@/%P!_DV>@PQ\.%: @_>9WWU;?M5F)M<I="V!3FM1B^6R=
MWZGLZ7P%!]Y<;[1!<G%'BD%HUP><Y%>+!3S#M#A$BY@-TE$5)I\FH3G\NPG@
M]5;.U(7KU#I&&?&3E+V@BYK G( !C,$[G<!7."N^ 'R%%'-,ZBB7/MLS\ 5\
MKK\^RD>WU_(;TWBW[(V])G]3N;C\'($U[S.H)133/F 6SL)F@?BVM/N[S7,T
M[DRUY<^LW]C1C?[I=/[Y0DEMR_=JT7:]TK47>L633KI\HR"@^]Q97%<]2'V;
M)[F+.KS]8QWE8PNIR1@XJDKKMGS7,/\\6X?C9M&66-EG '9+49KJTI7[)]QC
M?5BNPZ]O4Z'W.O^EK($C6"N?,X3RZRPDYGR]>LKO%VOKVB!?_@Y?? 9H>_?F
M&AOAP DYB&V+E"9EEP" K 8-!VNGN',W/O/W '4?)TV%;O\M# U2NI0D2B9[
M<3I[?MA*) +64N"H'#.'"SH\OH7A_4X9?EM=MBSK"-H]+$K=8']R"=>3Y5X@
MKW?%W)*$63 7GR(ZAR5=%FQ)LU]6%MO1]EM3O!(GV0VGS^)RXY2$JQS:';5Q
MN_+@>R8.^K]L#6-)1XQ1X")GH Q&1AB)9)"P$D/07G?2J7=QAG:6[9:L+T2=
M);T6]-8!#XW9'#&LCS!7O5[%=\#YX$*!P5K,C='(, _N@_ JE^,%E)2/1%)#
M27=0R&,B*[.5WS)9V40+OPZ(7<OF_K3+XX[:C3W#1)S0-($S:X!$,'!RHQ%(
M&Y80@,T3RT+RJD-![HVXG[X 3YQE E) ]?-\4?[[0$P108^TZK=SVPTU=U"T
MD]*[!R$Y[M7W'>/=%\)XOTU^[L?8X 7#BHA J(HWO3POKEVC<G+(M(DQY-!!
M-9U8-YGF0UHL.3LM7*[^&..RO@,3+9<O;:=#M2I>KJWJN&AWH?^2OQ_HQ<5T
M7M63TCNOV;H-#_;#U/H_T&\^NZ*E\"[$3"#!C2M/=-'/^BBCV*T?N-E-FX,E
M(*\PR2&16)X<'!<+0FP?_JH[;V[21#&G$Y!4R-<%WQ664/'GFROL/M_GUBLH
M3Y09?9C4/J^Z_"0@G"8F&NNSEK4VERLE,XU8FIAI_0=*BQA+(=:^VUS$/F!M
M3U<Y0E&J8_+F!'B%J].SYFN4( "\RMU$P1'\GA\@?SGXED>7;GA4?9IG.60Y
M'K61FR:$!3^>3^*T;(#X5US,=S?H1U@II[8Q6$U ZN+EW"EVO,KW_M=:&FD^
MG<X_Y]\66>&7L-765TQMG&7?.WYU.4/RW0#R(S'2('(3RT02>.5>N%PW*9#U
MVG/'>**\T\1RS(\\I1+^_O**J;[K/ZRH(59)8U&@,2"N4T+6!8MBHE3:0()P
M'4_3 '1(R'M-4^YY1'%"VA&@=3'::)2PC'=V])47_T,F(%DOQ%E=]-3)HBS>
M'+_XX?SBD':7Q0FHS;!IDW1RL;I_!3'_#%+>+KB\;82)W[B#!U_=.[4/,/NV
M0@-@_1H\21-U0"$PP!6+##G)'?SJN59*N4"Z>_@UIHQ1C?)^,,2)5LBX:)#E
MB@9FI7"Q4Q ^&%SQ8]KSV.7WVQ9^"+K+IB2"!8P9(4BCNQR7'!DBG#,F1*KZ
MI[M^:CG6?VY$?1>4W5@BSOJ-L4'H+HD9:!KID:!:YW)H#RHH"*!-3 LB192\
MDY9_=MWUR+CJ=S@-=%>?'F<G-O'GG;99N_W]&M<ZMUW\$%';+#$_(-P!P)D/
M:+_)OTI0X\LKQ%ZG:?R"FGWF\!I>P7=<G<Y>@T-Y-K7GK_*GG4Z,QV(R*P_;
M3NAJ_M#&,-;/74Y%X,R]7C=)>[6(&4N?XFLW_Y*%E+_XIJ7CEULV!27T_F&6
MB^ZC?7BM/Z,^@8SH'90UW237V/JX&<K62G<RFTYF\&!+NUB^RMFYU[L?P'MO
M_MQ L8QFLPF$_\I./]OS^O4W?]Z =F^OT(RH+91VT'984#UI;[V; 'S[=[:G
M<>BV-KB[-?SFJ@ZA/>E\U[,X:8Y:]6D-[P3<'DRYO]G?HE%'+X-G"OB+I4!-
ME$3.PJ_!J<2T<<RK#IVY-TUV-],9=Q<ZD^>)DAUR@NKH7X75(I<N] 16_)AL
MUO1E:]\?L#V<>U\!L!0DX,DDQ*B-B"N9D+$T A6. HO@+)>'X\M?*<#D$ "6
M)59_?UR=;.IXUKM^[Y>7&G#6VP?GA,,4:9L[I=D@D1%4(B6<T=)S,,V=-:$T
M-](1BEB"A<$9CL@$(1$))C"*@XXL]:;.HLF)]SLB?^U6OD5L$H]'6RFVS8:9
M)A.^=<K6#JYA[*=QTF*&J4%1Y.VF#M2S5J">F=#,"YRTYYW]-/<&X%J9/N5V
M4G$L^AU0[6^YQ/5#!PY'#$*44F&<J28)B'L'>.))(VV4-4+ZY'BG].<^S<%/
M?$FFUV#S\Y:&DUDX:?H[_$=;J3")]<W-P[_J+N 2K';;$R,OYED==QIZ'Q06
M#'M#K1((*Y=R@7E +B2*J*01O!&L5.S$[>\#B]_\QQA6TPA*YQ8 ^3U_<@ML
M?*4E1FMTQ!8=^?W4DSI3LM9>7E1D?%<V4LQ7-?C;]?>O^EBI];SS%)JI.QEP
ME\)T64<T<;C=:'#^3F5:QM2>SU?M(<W=##O&WZX/]]FLGM7Q51W/;*Y!6(NF
MF:U33OOF8E+-<A,F_#2I)TV-U*OU-;8.W!X1U-Q5RF-CV+?;0;SV*S=1O#]?
M<RXYEO2>9][S-'JL-<,7_[OO=<;OVSUM>]S1-J+:Z*^&A>2L_^-#V5*&6O75
MS'[:K[X^ Y2;"/2K)@Z=_[#'D-YR?M7#)OOM9P7Z0-'H_?F-YQSD-TJK*RW
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MOG&(86W8N+=DOQHZD6*2F"N"N*/PCU"9&AB)C"6:N,C!(#S(*5W'H0N%Z+9
M.VP<6LM>Y!RO1=V+I1>CDSJ:F-'$C":FVYA:>\RMQB@H0Q'WVB#C%4>)!A;
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M&RB6D6LE]O'*3C_;\_KU-W_>@';O@(&,J"V4=M!V6% ]:</\FP!\^W>V9]C
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M9/ IVS)R,0 Z>F5OQ7;,4_%D+J^U[878+P4]:NBKVK[D/X;2(795Q_(6=W:
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M1MAW@1F[*2/=]\8JWS8E,U68Y+)N^/%\$J=A&'CS"LPO ^P$(&2 -W!FC7*
M(N9I9(E1Z0]GFP^-MQ];@=\%;;1KRP%Q&UO^K[B8]QILZPT2.=#F8ISM9'GK
MS<Z*@L@ %VF+#<#]:(N_&O\WL\)/C1^8=PN (UCZ(<-]_KF:7=I^UX3_CW;<
M$;^><#:,J?-!&\T55J!,<[LISP"RB5D$*#:4>F--Z(0."4]))AZ0YB)O($O
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MC86\YK:7+[&GX_-E&,G<EYGA*MCS>FN;S98D<@=^HE[7Z\$[>9[)=%ZO%DT
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MW?./-N=!:O!5_QB6Q<(Z&BRI1IA1T!6"*&0=SRWCE0X\"@G:H\.HM+;4@P<
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MB20V6G.A!3@IA]!R=YR?\K)=TW7E5Y\>;C#3R/OT,#OQ[ R]_-%DUFP1@[\
M[_GK_U=5?X'_-I&T__^;,_LA(@<Z+B[*(V9U^==R0/M=_E5"X5]>(?8Z3>,7
MU"3JX7IP\>GJ=/8Z3.JSJ3U_E3]]?69#UKB;>/>QF,S*XWYL!L\U?V@CW^LG
M+Z<B>-FOS^;UI%Q[$:>E.O&UFW_)8LI?O7U*^$M6'[>8L4?H_8/S/N=G%WV)
MS?^,^@0SBG=PEE%U@:V/B_7CM=*=S')]' )CO%B^LJOE_/7N!_#>FS\W4%Q$
M^P<JLY%?V>EG>UZ__N;/&]"V5UZC++_D!E%;*.V@[;"@PO=%U+ZQC3>]LYL
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MSJD(IB/&!B,G$Y@CL$+(&N90Y,Z8H"Q\WN$QQD;GI>)()@H\)H$E,D1J9$/
MDABP5BGT)J?RHG9;-UF5;D8%ENITM;7FVX_JMN_7;N.46Z=4;IM.V;<B!D+C
M1:*,>ND0D=GB1@PH)DXAZ7UNI.*T2YU(XWW@_^B)%-SS".%%(J5>MU=;EV-M
M(^HT+C_.0X/I>@?697S;Q_DTQ$7=(GBS I;]-MBC";UL0M=]F:J3#_G?EV!'
M@R!:VH \SBU)K-7(>8V1HD)3BAW6NM.<!!A]DAZ.S',2@+K+A*S6%/@[\UH"
MY?>J,X9CM*,OV(Y>M2P&8DR#%HF0*) W%/!,5&XJ("0RW$K'!(G:=9+0]UD#
M3V!,>P[DAQK3T7 .SW"^G56_V/.M?8+K/HCKV<IVW3L^-WRVZ\Z)&2!ID@?[
MI01KI.BH$D>=Y(%7'R<QP<<S4$NY"6T[BGE@LY>9STWIO$?620NVER6D8Y1
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M67@GK7]SV8]\Z,+3ZDC1GAO YFMM@_87NP"?#8SW%F9_*&RU\<UR'F^V >1
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MU883CIETFFP5$]Q5Q8AU#3D#UXRM&5JS7KQ*U:Q ,TK)B!\H&;'<\;\XAA>
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MB& Y#)/:R! #T6H7"7P?0 '7PN8?)NU\%N;-K*LK!#X&O/,-4OD>:[#O1HI
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M#_]K1LMFI2;5?3<PN?J#^(5>[+L@72$@^ZKO]U@HRB5IO()KJDA /FWIX2H
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M^&KL?YN AFSKS9FVO/O][8:ZH#:XI#(IX-F&\;._C)M1KW5E -C;3@,\V%=
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M-DQ-BD^NAJ%+1\JG/;MH+\G7IFTZ:_UB=8U+=HET=U5X2%F=[OL]C4=ZQ*5
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M7+V#-9RTH@6T!C%"S EN)H$. >=1F5<56@0[A\GL"$[O[5R.=B[9R@:^S78
MN5NMZ\_) ]/V-M?TF7J?KOS=/NYT*D<:JN%,%LVZU6<R.R,XF2V.(TZ,X,S(
M)\+G]G8@QW6T=59JNU-I.$9%$W+U,7I[/$V<B?[(1^U/S( Q&LY3T;BM'5SI
M[=B92BGI(O5K'*GA"!8-]:.DHKQ=@#KC%111/ON'BN/5M7O#F2G:_@LQ#CG1
MOA "\78(3*8L];Z*QANEX4@5O0,CI#J]74(&8G"ZG*T>%!K.38F!ORI>Y^TP
MZ#\,J2D=_KS:X?9"90Z$?NIP)MH0JC\:_U9B3*\^&JJ='2\5/B218[X=DA$/
MB6J(W&]QH2,TH)QZEOT[^S.C$MT'%U'L;L$NG5HDU_=/5#D1GU'6[':P- W>
M<!B+YO>ZPYBUBLI9"B,3SA,;P4Q)')!DKESC>^8&TC6)GVCV-/,IOYUE#1?>
M+8WBT+5C(2P]L(EW/)AM*#6<LJ+IO=V5EPXIS@L.^G9.=#V,A3\+Q0A,SQO?
M_0>[=8*0?[-@ +B-]A%^NM09\(@.'[3A]'6(G2X^N">GQ59B@B2=(6%2F[C,
MN"WB]NXA(F*:;^=5QQNMJ'VR+!D[)Y=["/:[8H\3(.KU?(&[D&XX>T7+?,OW
M-:-)REG@,>/S('(B;Z=+1\!_9Y].7UH-YZ<$6[(V.>!-F=0)]-#%IM"I;\,I
M*!K#"P 1;SNO*V$D?1?R,0&7U*&AY0&F[SX.PD/2Z98I/4Q56Z\I5O_,_+[B
MN.@?L.&,%8WGF826[.M4C$404R/)W)3N!*:!"J&<8.&/;X=TK$,*,D7@<]#J
M<V&>9DW*8JNZ',4>9!L.7-&T7G/@TN$QBE2:W>'\5,1GO9VH$:!S.HM!;?LV
MG(VB^3QW-M[>.L-OW8,?)MHN:RK%CB&O60/)^B/R<]&,WNF]4@?':R01I-[.
M4)_TOVPR9KKI$ )KL_?AW/7V,75R[:H2 H=1:S@Y19MW20YH]OS@N/C$B)%+
MTT;?#LXX2;^*+X3IMKCB3&:\X_44V-M^\<WV]@YU+L-@>Y:N J3 -!ZR249N
M.)!%\WCC@83IG3AB?B2=()$S)&LV1:+,D6??O!W><7/#LNAGG6(.NO1M.$ E
M%NX\JMH?7F:"_P&K*VZ#Y_]>6%,KM*'G+5T3\:-Z/I("RZX?OW?<[7O1YKWE
M>=^1;TCA*:3K]L7J_TGI";6Q__)=Y&YW'N75FD>8&?L9:N,%_@E;.VOOQ3WG
M64E']ZR#K>7ZPR>=(:-GSCC$R99N'VG8=\)E-+3,]HD1#>W](SU)%JGGG&LH
M#9DY#$RCK?6.[L-@!__!D=^S&V>=</'B.C0\\:TP#%[:++H7ADE?('XB_L&X
M^?!O)Q\^G'S$ZNK_5$ZW-SO%XNQR$A%X&N$^.W%CNBTRT+H@_#^54ZJ?LIQO
MV=JKF_XS?_-\GK%[;3W2%M<=K+7:#4[,SR<?/IY\^!><<!FUD:<;=Y]J7)QF
MK'.*N ;W06QYXRYKD63_B7>2YP-[#WXI^5^FIUTP,34^*-)&EDG[=ZCX_M.G
M/WWX].E$DD96.A/4SF*+TO8M>6M/:09,Y4IOCL5A*=EIV!VC^NV 91EO^"-=
MOO%.F)ZIS&!9TUJE8ZU.GJ)V)I5(B<[E.]LQ/7P$@XO0#2ZMZP+TH6Y(1A@5
M,*R++*%A8(/G13,T5M<#9F0Z1[^\Y2!/\UCKNKD97/C^\$1=EW'H2 8713,F
M3]>5,S*=J9=W+&B9419WW,F8?ME'!\3H]<QKFH5)05DCS$-GD5K[7*9:V!$3
MU@<MZNCS,"D^]<C [BP&]1YC\H70EE@ZSAIJGM[TR]\J%W*DM>PPUGP69JSD
MOY'7<-QI3;_<_7+7QO[(>PQN6H+LG9C52U(<.)KIQ6D=GMUK,3I2-\V\H4C!
M7DMG=&Y&C6-=HMRZF[>Z4^_'_-J*'M&/'H4QYY']<$*ILWU_\2V&\!4FB%_X
M^RV:RB#.+,H[=3,1'1EZP-U[ZL41$@7J$7*,W,(8,W+3"6,@^^MH#J4BR>G9
MA.<OI$^PL<\4/J41G8L5E"?T(+7V0K<@,4]?D%9_S\QLW^/:MV=E"1S3GC?!
MKN6@*;MO5 6!HS$LFC8>3KU G0QS)HV LU%L>SP]#81FI'".KU1.L&]Y,(KN
M&U9%84+M=[B&.Q,M=AQ]<SKA+:O ]1;3RLG,4Q8U(I-.*)NVFZ"LSJHGI"5+
M?1:R:S>&NU.<3H[MNY6U9":73'H?T!;49B2C##J6K>D:W,V2>MU=M["2Q,2/
M_:"]JJ4UBQM2@TNB]SC3W:;-A3 &WK-M!YC\!FZ%O*[#;UP[U(2JU[C>DS[4
MI[G'=<'H#7@7]$YIZF7N P0WRF+V'WCJ)>L*>J7E[+4;U*2G:2"V4V>WU"CC
M31U0WC_4^.-8(?K#9U"_B![DF%^SGT1K6);*M/=/?-6@84+=C:%#0B8[*@6?
MO$,=!:@E&3BP,TW9ORUV3;?QU>^CDXUE[11_O?A-ZJT7O_A;XO%E<Z-7[,?D
M;.&,__)=3</W/2==O=GJ7_YV$T0Q=_BI;KXO&>P0,<GV_?K.>?!"*P]">A)3
MR?<QBD,VTXK%;]EY,N;.Z6-\Y;-9((3!E1_3D$8QR@M[2(9AUY<;.!7,M>RL
M^;3]2MW-$V23/3.A: -NJLL]?)G20[?:QU%L^8Y([;'K3F!G6C/9N.4WM^KS
M+VDXRJ0C:K_;!,_O[8/#Y\M^2*?)_O&W0J+S:6"%#D20,1&"$8]6;)4C6/![
M=IN>LB%_S^]-3RJ:3]S=4Q"RT<+ME?_,#CRL:\G'77?.6E*8['3=>);_U=K2
M\PPZ5>YDY1I--ME4S<G(JLFOA?%!B*I,GJA3GRIX'7>,43] A[I\E=@/Z>*P
M?_R-P]$PI9M=RQ$\KI;W?]S=6>#DN6QHK/ES2K)_05X^8S?MX3((7]A''K%5
M=7G@WBG=N+[/VOR56K4R1'=BD]Z&W+P=4[H*[_:/MOS7+8V8DHHAGY _T/^>
M[$M_%C?HTK;WVSW&BWT.V7:"[FEYH'E^9A?.*5T'8&3^-ORB;3N0YE4!J9>I
MDTNF1(H?3WF8C10_FD7HMB1T:P RXN\LU59;R/_5O8S>F'!9A[N 7Q:H/IV!
M\S<\U%Z=];TF>QUE^"P[!H],P^9FY[_OW0@ML2(<\RQ0@LES3U\' I,Q^74/
MIT0!DKBCFTP(9HZGZO9SVJ?T@JJZ^#MVUOS5-P9+-E\!;4E,MDUHS%/UP"JK
M2Z'=9%-.'KS30_+C?[KLX(?VTP&1&6K4QY:=#=W/R[WC,AJ@=93<P^I?-1_U
M9"V6SO_=<[DBA^J6B22N._)=24UVCN[I%IZW\,!1Z?@)AYQ,6F4@JNLQ_>?
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MFWWJ>AR'%T-((WK\&-7$==<KD^64\>EED\-JM86*\&G2706BT$A$9U0RK^%
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M\>35LA.1WSC9X]LL1Z!5XKLI&-QR!F.%^#O='U'])2HM+$..HC+"GX^3&Z_
MR(( >8+T23H ^4T.H?WRJT9 5MVH/3D%XB2EOB"2/H$!"!^!\"&,?'DY.^%-
M2"_WOD,=Z?105$=$'>[)MQSFQ.+C$#;0R1I'(G(HHHQ%<+!7L0*Y^ZBP$KMT
M)5[D2@3*2CS"H-IN*Z-+H5Y>7==AP1?"[-</!N1QOG1V@3%:^E[3,@7K- !_
MU/K<#:G-A/%HA=YJMNJ)#:(G;YF1" Q%<"P2K$DR&DF&([_!@ 1'-"-/M -
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MKUY\-NLG=S?4(YK0QK"=!&$FD/0-^43'9%%\P%G64O"<A.[Q<99Q]S;MG,F
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M6N/YBVXAU!K268>'HZOU@1*RQ\B45\./N8!T^XDZ>X^NU@F+/$:0/=526<+
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M'</UI32RG5-NKI+2W 2J9I(PR_Y+W@YIN(#WB/R79A4;L[/*>RT7Z7?&QC^
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M@,CPNR*E**)GCH@/KX(%L_;!<7@IA*8G/&%XCGX'NY+4HB B5H)3#WI?W6\
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MYX$B)6A7"/J^LU +_>\_O@-&%T)E?[7+Z>56<K4F&<O%?;J2Z@3(DOT?X7.
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M.(A?_2R">!)(>1F0J<"[H7DU=D!IZNZYTPKLSEIH>"PB;%<)'F_^BN*V (]
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M)B;U&$B( ;4K#4KE(7UZUS^\LE=FA#L'4N+9J-#(F:.*E [/NR[7V[$B^7&
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MVUZF;8.FLRF5YPVKU!R**R#[:#2W-=@:U*ZM.;%'(BJ>EQZQ[RB<VPBQN79
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M[_2U$ZNF@?>]3^,H.-+_M@7K=OK6"4*O_0R@)G(LH'!OG0J)U-C0G8TY!"K
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M3>T=.DC&NYH'5&$A2XX6;PZJ/JT[=]BA":^:H-K6J*.XPSPN%RF%=U8;'N^
M("YEM8&KU.RL[MR%.V1W?R)VD&'R#XI."T*Q6;P:T*<3E^7@P@G<-#A?Z89>
M,W""Z9*MG C;+'>ADW&]_H%#!\R$N=067M'\G1-K)HZT9"_]@GPXVN$*$- /
M6<:*\^$'('W*4?9"+>I89E++*6DM?5..XP0#+U-BL:/1G("[?(DIB@KXFV'+
MFYK/KILN#W@F:7838<% P6"K_7+VG F6!%H_@+5?.K))&D*RC(W<N0$-UI;.
MI:<[?N_$6G7)O"OEGT8/U8E=N;/N8F66S_@_'7-BFCZ:_>(H#0/4VO0%%5O
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MB?W*"(IA8$S'[?"9$^35\L#,QAX=F3T^=X+<A@1<T_M@:.X$.6*784&8\%]
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M.@^].6Z^PV=.D%>S!,&DJ501Q^EW6+Q.!J3Z9TZ05X%V[>0?;OO&"<+$_B)
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M9AE3=05CR+U,Q?.^S="&TI%C0LCZX4/^V^?TY7<AB@@5\)</\)??_LC#_\\
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MO%W_^4]8$3CD>'+IG@+JP^]87-$=Y85QVF3.-)QB7NYT<:XW<8?[M-\:?_2
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MNW$<2Q-^E[JOS,FLZN[*?TU?R*<HSSA"7K8B<M5_$XLF(8F=%*D$28=53S\
M3^(!1Y(@ )(7E16V 1#XL+&QL8\]!S/MR2@NJDL,8 *[&':ORXVJ^GE90IP)
M?_F!P]!3WQ;E8YCYT.P]Z%H[OM<!+$CG+OH1OB"$O0> ;4*@^U I8AHR-P.:
M5T+/P<SP<Y9W;NTF21S#J714?_+?<H?D$!SPN\PD)_S^3J9UQ_*ZU^8B8A=$
M/$"GKJ)J4K0"NS3O,-_)11!8?^_*QKEDNBLNA,6-Y>K8+2I-]Q9<!(V.4:YU
MMAQ0I?]B)XD'P=UO$138WUVP);WP_.\6@68_T5O"Y6\11:S'D:C5L(\E;X"L
MZ-3'W7,1^(XI3RDI4K24A)!4L:L/"UH$Z4XEE#6=AQ="E\.$L=[>SJ.B:^XK
M5H%P)N54O8C2]./(;C);M618ARJS&'[PH\)J+E/@QGDV=%8$G6R)TT^SU<,H
MDU9%8QD6<<)[RZ1,'K (Z*:223F1*8O >GQ](24P9LEH2M*E3$Q.F9MZ5%@C
M))!9 *NDM"03!;0(6)4) F)!2DHP-HTC]!8#F!QX$="I%@.&Q:0M8@M&D@YD
M8]]&Q=;<MZHR_MLW+J_ ?2'%?*@<>>J@/B6PFR9L3,K-16,(%T'P8UHA!&,:
M%X&K,O8M%'%90+R0:L-J>+5T/)@*T/-"4&BE,#$)^DGY-2UP=!%$/KX*KA&Y
MN@@,I^'%HK&V!>0+*6-N!&_^_I]J8#>RF.%4!I*^$<"C;H2Y[_=Q&+=,I+$2
MQF+:2U$O+V>+VZ,62K64I0_;FT4 J8R$!\2V%\"/6L1V.< +A-D7 /\V\UM/
M1?!@WV#_TM-U@B@D/06[KO#=7M[PO-PLY.+%C__X[(3.(2.]5X1K @XX$.-3
MA&XUO E7[CUY 2\TR9\.T?O/[L7+$SV@?USS.Z ?OG?6<A,YT,.")00N&CS>
M9O?TX9CLT,QN D(JDIZCC)+.HN\"L4#A)PD 6_B:OKGE3XBUG-$+!HLB#Q$<
ML/2^X^L"A4/!3Y2ZV\/&TK_83%.#7?;1;F!?B#A&'//10W_Q]Y><D6:-T3]W
MZ-L.DD5E2&&<#^F'B;B/E!H7@X8R=*FD F3]Q]&_R(H:L9;W@"?J/03.H2=)
MMP;1M;QB/NB /8;[")[045+-ZL?^I)&4,93CD4;2M="7"->HO4Y2:FWTSOKW
M;7?TH??LP.1R'Q[0[WJ<9_(0^I?V'!5EA+>P.E=Q_2C)<RZ1$74M_+H-%8-
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MUXC8Q40-U>E?;(]:[?4OP<[ )_%+V'734QH@&<1#C#Y&# T")\"W\B=$0C<
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M^H:-ZT+T4L$8A#&(7]TC\-( W4BM/UB9DZ'2W'6(@!:D]#0X X!H!9<<7G2
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M=5H7LX[)EQ1/"AUCX*8P=S!R@@!X-Y<VE<L<&(E153NA)+LC^.S /T"";F&
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MMOO-X0#! 4EES=C13*%0'HV:F6L;/CDQDN(N.$</< '^W;_0FQ;= ,#;19C
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MF/S[8+HH;ST*ZA?TG]K]B1'RD_QZ#!'VZ!V   ]='\0;S_/S]3Z&^PB><@.
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M&S)L>?=)++SO%PS"X?K@4H<$\QMF: 68C[7Z4[[U-)IUI(7D&ZL.$_4=LTC
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MW?ULW74\>AB2+<U0*O<($9='+(=#^'E"MK];OGKIUPC?P&\Y(F*O$5&7@?F
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M6K,-<O2@6$F8),3N8XHK7C.-VV-8F(6>(YB)TXVT;C@I3Q0F2-Q#$SH\A@E
M^T/-KZ_@0\941V!N/*6Q*3NNW?ERBC3^[),IW%^O;)P_AN]2B,\)0*]!K_Y(
M?HC@*X#OODLM'20YB&F+S91" ]=*&</(I69_VV9/_/C^ T#7CZG>:O+CF+;D
MG I'6#-K((T"P_^D1>;+7421!+*)OSEHGI@!(>[CX$8O +';V$] 0:SY(E^
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M(AON:L_SQXF/#T'THR&*33:].S_&I)!"<'M!QS#.7]N7%S_^X[,3.H=<OYE
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M5X8&+#3+NR48,.EC( B6$(0 "V6[5S2+?Q!=&$P&0+S<!S%2A*BA(0OG)J/
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MI">042:LKZ0O,*&_B-+FJ7-Q>S7P#+>T 7-!>H(SK*->B Z'UA$5")K+[NE
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M7G]5031TNP:X(%J;RF4.C,2HJGT_DMT1Y'7.T14&ZC5OZ5M'[Z2:S,H'P^:
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MFLEKH,AB&8ZLPJ4F #FGLVE^^=.)1,">B:<KKL[*=&-Y+4@YU>N@O#J6(Z5
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M:@;KIK(ZDZ%3P;4$?5DMK9 IR;=Z^L5:#HXB9>74/K8F[X(93(_Y1+>\.N4
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MYW5LFC5(ISLTC>^NP<YKL+,-3SB]Q:8GP)TB;F'P""*/T8MDAOT0A:1RE0T
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M"-=;],$T*'QSLJ; :PVG.]@:+\)C+R(ZG=.D6,2] [&\5DV_0Q?M9/EC#6]
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M9',6U?XUU5"DB^!'DAA:;5G%<!YF8.HI;(-[5+OLCB!GM3N_LAB@(MB<J^
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M?R/]^7I;246G'X8T>ELPQ2(X7I;]_2NIT/F]*:A!.['<2X\7$=1R\),7H>D
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MF,_Z'21^"!:VN*9WDX8^VWAA4(<')<N/'J=Q7_ G1/P7JQRUG)?^'Y9&@ZT
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M8]+\.B&M4*LE3Y_'/:VH3=&>?KN(VQ>+M$/0_0%J)U"JLLM43?PCP5U>^/S
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M9I5V>!OD($[M4EO([/C]1GV/=;\5[OMK@4]=\K2@2\0<=/O:9<]S,7DZ>H$
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MBFR!=IJ=\?COC0'O=J]_$FW>Q>))3_9;".Z-0LM:%@M5%I7D,:M+'ZPG0*;
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MMU^.]F7>C$EKI?N Q=L2K+:%,4D[<=S:8[,Q-[%WH1OBEQ,J2'2@Z,GC^A>
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MD/%U[3"G<)  .WN8I$<-V(75#AA0\]ZB[Y?P#D7JG&?L')W )>XK%<Y6\6R
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MA!=]*VY9-8:3<X/UGH70 A3[4>U8BPRTK][.;MUW/O"!E]4 ,U"-6&\?8Y9
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MH<AA92B^P/I3Q958KJPP':)@G57'FSMK$G5 $'NVMXBYII)SI_W>?G]0^_O
MIKG&'QWU709GPUEA+5N5)>L3^T)G-SXL31&<'8"_)JY=@18T5T+&OHPJ@E$.
M&H/F&GID]:(H 1#R?<*,T(* T&]9([GY 3]SX5S -E%7./-:#:0X.%PCI5>8
M%PV/3/':@I9$^HH-;G=Y1O'\E/+ *QLW;JII=:[-\ZDPD5GCY4^K,&P7SVVW
M3W%*K0XQ<H/%44D420)0@FW9.':/WZV>JMYZ(1H^JBH;JQ%FX8-*,.J@7UE$
M"T*3E$(@6I:#BIVT^W4J7_W.#9S5%*"&.1P42="R_@H;W,P89P+_*XA<.=2
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M!*'>W[+ZW".'[0K64BX/_]14W0E?A,]LUJJ[_U7O2:4Q-R3=U/HHJMIH,8E
M5=Z>T)U1"#?DY]]RK"QWV7K1 WC<F&[KX>.*IKI\W.M#U JDJ+BJXK7>;"'[
MIZI=5D\U&MP=Z&XG!C$(OXS&?B'P1]?JHA:U]DD#+%E$%$+'U)8^:2MDB!DF
M]2QH5]G3RRF.=$?E**DNLZWQFP(@B;XH1TIL-HK]."8K0"2G0 !A1?6^4Q'E
MG(H,0U=KI>2J=7)'6&@J0\5#U]SX#A53K,_D"S69QF6T^5S<-8"M P56R3&I
MALH\\A(6I9$RVR.O]09$+J^RTC;H+>% >:I6A:^ZX[@2U;-:N:P;GMHRC+-
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M"2C"::6[?80_U$<&9$^ 38"B$XE/.$+%%)IW!#=>-/5 EJJDQ!'M;IR&->>
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MI@C.$,!?$Y>^0 N;JT!C7T85P2@'C4%S#3VRBE$4 0CY/J%&:$% Z+>LD<(
M #]SX5S$-I%7./-;#:0X.%PCI=>8-PV/S/#:@I9$^HH-?G=Y2/'\E!+!*QLX
M;JIIE:[-\[$PDGGCY8^K,&P/SVVO3W%,K0XS<I/%44L4:0)0@FW9.'>/WZV>
MK-YF*1H^K"I;JQ&&X8-.,"JA7UE,"T*3E$(D6I:#BIVT^W4J7_W.#9Q5%:"&
M.1X4:="R_@H;W,P8AP+_*XA<.=2 >V.5S#"3S5D&*3Q/PE!7HUQL+2)O"VZH
M[%<I /FQ:YG.2MO8F&#-M7<?&$ "_ ( 1YF;6YOA5:C^%59!*P@GM59M%6&N
M40\C6H6CDZ$\?0QS6FA5;LK@7;R2+?'Y9H2KC*?IC!^PS]E$[-#!S'-)Z7.B
M45:P69_*A]9< V8*V[G.AA"OO<?IDCWK8UI"F",-T388R)15!-^3-(&S(H:@
M&Q=9CJL:9(O.6>YC&3=&85&RA"'VC:R;O!)_E/B<:0&G12# [LA"\\4(XJ]J
M"G+[EEA+/2F#:G!1Z(5-SN!1S*1/CT1_C//%X$D#&Z;@()MS\NEK@4,"DA:%
M9+:YC&Q-KIZ5GRH/";YPYTGGMVW3"<@<[L8K9#" !6\=97L!V]HY0TH48\G>
M6(O;)VYET"2--Y)"&UH7SMCSE=Y9OQZ4QEE6KD"8+5<^.*P61(:?-V])/8?+
M!A&2-;**K7-<*@V1EI^Q3\\$O.$S#FALQ#>V^..7/'6N>TP85N%J7K'X&D<4
M*)SY6;^RL\(</L)JQC,>T9N6Z:YQ7D:7RR_99T_?* ,_:"WC-=*^ZT%]3<00
M('4XNEB2<G09 W7Q^'U%1"+.H3J')Y51+0^XEZ_F<0X>?HU!N9'EG0*275V8
M6AT03S\3#3(]"F<75>5<5FP4 W8(VF@&R^>:;8%+F$%M "^0IRA1D,90I;^'
M0C0ND/3)&%"HXA4QZ8]"_T;L_#(1Z^ QP6CK%=QJQVSI,H>K[3,D_:V9B82J
M+\5A"Y\D4/2H+)-)M)RAX#@#0% $;L0A_2%0(8#Z&;C(<*?A>YA0JBI*'@JO
M+7IS0OCN)V>MYDJO@-[X0@5N"%>B)U<V3 %ULW 0)07N(LGUZR&J8H6X;WU?
MO[5AM;;GFE%O;W1X>-2PZ<%GXZ.'8=/;'[$/@'^U4MQ!7(RJ5]C<!AL!3N6D
MRHPJM";V*7M)!AB;B5<8DXU5:J\<A3[N$N_X&(3'#0@WI[N]Z);.(W4?/%+[
MG4>J\TAU'JE=Y%ZWG-H\'DWV3[Y6_.#>'52#_9+4YKW1P7BROW]T?'CR9._@
M^.CXZ);B!P^^8OS@K;=4J>HM6S.%*[L<O$94G@@SD6 >$(-RR5V"2E/QLPX7
M9^'] ^0HYUO0DCQ]K<IB$, J=T>PD7OUZ.H"/II_%J/ZK8JXB-@[SL<^FR[<
M%1$8UZ[>X?[13I  6L>MW/K#^WSK:[?0.>R#-0.T'C+\N!R#!)5LH9%,&.>V
M@NMHHS(C@SN91RB52P(6\,RFHU("@'^Z4 OG@Z/7(E\,SN=J\C+#5U0?#>B!
M=6)]L^M^RS+!;<<J=[?^Z]_Z)_\UM]Y?MR_)%(YN+ED.\P+T]<CM.A/%!@VD
MQ57Q@BR!KNBV9_$W9<=Z:_.(G:'[EM8&9"CT_S&4$&7*]3ISWGLWD;><4H(J
M; 933ZT+/&68HV<M-H"V2[_$7<EKWP41XD'Y.1A[]9K]^NK#Z_/W[QFUQWGS
MLMZ+A&S^9'F_$E5$E<8KYFE+^GHOAW,,D!<@Y#ZC[7W7;8,/%,<^H^W$+4/H
M/]?^[)S''+O5?O?==U^XKET \>/WCW<.JO?G[._B9_=)PQW"]-EV>J7C[%_X
MP>'\SSML8).QG\528!N4M\O1BV_->OXK\=?_?,"V%1;\SY=2S-EY:,7ZQK:7
MZ1A_M^=NS]V>NSUW>^[VW.VYVW.WYV[/W9Z[/7=[[O;<[;G;<[?G;L_=GKL]
M=WON$D"Z!)"OB+0'70)(EP#2)8#LHM]R-TJ2?>L[>FW8[_[AZ/C@JV%"!X8.
M#!T8OI \?IUJ-&=OWYZ_?O'JW^QL]R"U4PBS8]AQAT$_6.SI_I13>H[!QCL7
M_M?HHH*%U:G#^=4(?BS7,2]MY[(5!RF8&JAPF96ZUF$%@ZG#]VE)T=94=LLV
ML*,<PIXMZT;-3EP9M&48RW9+Q,A^JCHI\X2C@EEL?0^?]7)KJ+,=-;G+"_@7
MK V+G-B6EJ'(G1\1FQ+F+@4R@2DI/U&C/HI-$6M59Z@,S )KIE ?3"Q!1B58
M0L$B/Z;/MN"NH&543#649(2UNGFNO@H3]";C/IMAW52LSY*"1A&_(0O75O;Z
MHXB@3S4DMS89(\[UN@#LL#'LF5C@@5@U_*+J3/1,<0U0L E=$<1L97P'I5!\
MOWW957D<7SP+86G!6)6Q<N'R-\,5)@F@Q"RT CX?U"OTX=A8A IST]9KI8LR
MI[)<"NO,ZF:56P()IKP9@=5H!/;^.77M=:GFC.UP$RK<I=(L 8)P.0> @+P$
MV(C53/SY9^;ZFR%HI='"C>4J9&*%)-P?):%4>R:H4O76WTHM56E\BHQ?'R[E
MHNV0X8Y>R,076L7ZFYG@^,]%*3/;I2H'RL'L7<;RD00!EFC;WY0*B_JL'JPI
M-!>9<F7-L*.G;3F*J'J!U9)L^\X;7H<]IP+I W;YS"]4=F'[:6('H:+4:W@P
MQ4[(K9L)!*'>_K3ZW".';1K74BT1_]14W M?A,]LTK*[_U5K4J4Q!RC=UMIL
MJMIH,8E K=Z>T*U1"#?DI]]R+"QXT7K1 WC<F&[KX>.*IKIT[*M#Q/5QXF:P
MO@*EI<17VOB%C*^JC%T]O6QP>V"\F3#$X/P\>ON9!S&Z4B*WJ'7:&F#U*J(6
M.J:\]$E;34M,-:HGQ+LBKUYF<60\JDQ*);IMN><4 $FT1CFR8M.2[,<QB0&"
M.0-B""NJMRB+J.A,9!BY7*LJ6*V3.R)#4QFJ([OAQC<KF6&I+E^SRS0NILWA
MXZY7<!THL$J.V554\9.7L"B-5-H>>:V-)')\E96VEW,)!\I3M2Y\ 2;'H:BT
MV=JE7_'45N2<!\(^5W7^$\.]:KJ))+M<-8#Y:3!>8),_"V1;E/D3H+/CWH).
M+;EE"&!YV/NCD$1M*^^%6H(WBRK]A@K%Q+]\?\TL4QO;J3FW-0T2K/:8@M05
MM25H[1+J*6:+H.TX$U4\SHLIJ4:1U +4O+344[9Q "2 S/ ,"RWW''6O4S[W
M934.<)N%YJM8>EF('-LT9MN&'!/MQ:>DF+[3&9"F9JJJT]_"G0 NB5QCI<:,
M6W#&O4U=L1ADK4CBZH2MC\2Q:E<);%(#9>_M W^%PQ>N74!+N^RER(?V (N/
M+$"NL'TYP)FHMJLL2FIBM#&JO5^UI:@5S?5MTT.Q4L>"_K1D?J/T[U@44.$,
M_5@?:,I<C0;(31&L*K[N8%0K2.B$K/:GV^J;?TSL<NI"  EOR>ZWE4%K+<>:
M"?^H*%>K\E6^DS!4BY3@.?C *?4#2OI'J<8W"QU8,1PU,NHM5VA :A0(8G6_
M@$,&G4%+U%:7@"VU(_.J?;:ME/ML]WK/=KVZ[KEC_+!SC'>.\<XQOHM"]&XX
MQK\I"(+)F[K3H QA*B/';-MHO=UW%J1^)00_#+& ?2:<!D%6'+"EVN#>!ZQJ
M=^9*$;F6*4TW1"P#SD2B5A;,IIP9"8(J]L<%7'6RG694_P)DO&!O(GF/\017
MIW28-A$B-=<*]N%MJI5.31=@UX41V9P,*4RC9 MO1[K<J()<PG-\QY>J;ZO+
M%(G<:$*)QO'FJ'H[W"!M-XQV#1.KDX7%)77:JOH[)%(GY0J[%V%%>#L8 G*A
M59D#(,B,4U76O[*FT .XTCC(D.>&EZ[916U>.EP_04.<KGP)!<.Z^,75H</I
MV\K_N2^4AZ.ZS4M3:XZ7(');E*IMMW>_^K\\QVV\I0X-.R> 1SU>7E7:+4N5
ML&I?A?(W(/AUR%1YLT2>!M6W@H;MK13W0&SM*+'AU)_EAL9GU2K;EA8758MQ
M>.2[9X066+ TZ_.*AP!@V::+W@9R91?QT]1ABI9/X'-;<.:6*TT8.GWGGND[
M3SI]YZ[UG:>/T>WXX]^>/EX6J^S'_P=02P,$%     @ #(![6@I,5796&@
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M18S3+;S00JYFI0:0&%@##5E\D(04L 7-"KA$K&2YLE(98&/M\? '\A/:4JE
MNQ&E/WUOFVCEJ!'[@" VC(-,[0!]J+<X*(SV1P*&<%K9;A_1#_66@=D34!-@
MZ$3P"5NHE$)SC^#$BZ8=R%*5E-BBG8VSL.8<.-T&P55IG<@$T2OB65="#U@
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M5>S(LPZ1A.,)@$64":HL=+*^P-3F_O.,[8Q_I$"<]9?'B.Q['][?6J^I+;1
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M)AQYWBE%VA5JJ17F\/(ST8#I$9R=5[5L67&A&*A#L$8S&#[7; -:P@QJ#7A
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MU'YG1-VU$?7T,<8=G_WEZ>-EL<J>_3]02P,$%     @ #(![6H>.>J9E)
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M,Y-9MA1R/B\T/$\;  EOB@R692Q.IEJ-Q0\ZEWFB92;>CL<Z@552L$D2M&/
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M*&$&^-RID_"IK3(N#^13LD:5U83#)3W4%DN7E!&7R:C<4WBR@2#A-1E"G5K
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MU 4\91A-94,Z%T6%;>UMUPR&L 3]<'QJQ13FU",#5/,F8RLD;*VIG@=CCG>
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M<37KD!HA*@T4>\O >&QS=5 G?B]26(C#>ZO;;+4V*\BN1QX\=:E%)HMO!2>
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M1C-; T)N-+.-9M9A+KKVFMF+QQ@)]/T?7CR>EK/L^_\'4$L#!!0    (  R
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MT6_WP P,XYN=%M@&-_(:M%?A@X69RH!]UV0@LPX]361#6R?5WC:E,52BLJP
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M>UF[JH=\*+Q64+P,8Z@6L5%+5:0V$C\G*<>T;10=6,2$+6.P6Y&B[CJC(#O
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M_4B)\E3XN<:_6 =WV=_%K=N]1!7U)\U@D=#&T&A?4JBP;U:MX2R<";^0EWJ
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M&4%=57V/F7+W-X1L(=@V"?NL#OQI4R&1(%#ZCH4%%TO?B9<EDJ1"<Y]KZ8;
M?:X30K!A*OA2I2\32F>4QD5"!H )% ^I42VBTM!U(Z@P?R!S5!>BI<!.C\%7
M:I+$:8YIS3D5(9!EB6QOB*U5RT^SJ#=-. T!4CGLNF&CJP>G,=2K%T1<$92
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M_3*(@^FO__'NEW$^"7_]_U!+ P04    "  ,@'M:#YI_KJ$#   !$   %P
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MNIQPRY0RA@DC)*SEKVMF94[L1]4DN:5<A*AK=N\R;%I.!JZD9#MN?>-BW^G
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MV[7P-Z5@3S%5G:E/%?P:@OGD=&>N3C)S>MI557Q)F@Y-X[J663Y?K%JDG3N
MO7#J>F6Q!O)X>QS[GN/8T[)*>N=KJSE4A3!7[O(5@?D':%I_VZ^U<[H\0:*&
M7([YQ#CGV]VG<_>O?^KNNQ/[_P-02P,$%     @ #(![6@Q0//K_"   T3\
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M6B6JRXE1A@$+W^ZLH]*5 =EJUG':&'PF&MU%#4T>G'M#T+@WY"6Z:CZ:$]E
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M->#-60 Z@_Z8J,AY$' /9*%8*CS^D?G<HS5R&GOF@N:])$II/"N4KA%8H7B
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M._2K1I'+[TX XV*XV)3.2[ID<:B8T)G4^:FSAU\X.WK=V=-?5?L'4$L#!!0
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M;&P#>&[V_LG3 ZG4@\2DL;2<+ %G;YN7<9?N#S_,!6&G4R'G4',+:DV&K_!
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M/Z]<%8_=L^X&\I@X8XU!PR<E%S))SUJZI,U ]EG[(YT@?C[LB-V6N6!M#X5
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M'EK>#[-*2JW];)5M9FF;%28<NGR1?%3V$2.QQ6+#^XSZLR:?6WAN37 VH/'
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M3X[(V9KEU >%.4</PB7'0I]:OTZXQ]Q=ZA<S 0]F6RHT*N(LV&HC+!@N_[T
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MU?_ \#GG%#H\O3HL8JIJ?1K9=)QE^)QKXC5_Q]:22-^M:",QJ!@AZ1:CQ/&
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M%?6,/]#^"-XNM,<Q+^7E9#"JPN9/[*\/J\L[G3\]#_37"^.&I_A" '" _ B
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M /R%/!RAV"8\6P#PA)XXX-T.OA?Z)R[\)^0OO8$F:5@0ON_XL&V'D3\A,]?
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MMK%Z@@7Q=CHI9XB]3 P=DXP[F20 9D=.3Q65YA%C@^U9/!Z&&<C:]:-8CWQ
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MS";R\]S/5T2OT4>>E 7,_\UQ]&W%31+%HN_ "W4Z9YUG/]&RF1'E[+5?);3
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M-DHG4^3S*X_\LK"-U?K^A$^<J>?  B^TC;*?I;#7#H*UZ_)F9T\\#S:9KU8
M2X4P00^';R*3@CR^&^FOO9DU:2]6N-(.%53W$(\)4V@F$[]S+\E1!37;'*&K
MA+% ;F@1 ._? 6F["L#ZD[/K@X:M&\Q*=KSA#RH1%UZJMR^*#*X#SSJK/%)
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MJ!L$>=>23!:/C2Q-8UJ:XH:W/=6WVK.$B5#:>SV3%%M=7K4Q"*<JH'2]5^A
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M)*Y= DMH&MR7TZ'A8=//;K$51.=B@&H%5SE[(.<8H'VKD$#<;VZ0I^M1C5F
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MJYF0G1>&5%(J&L3U_L"YC;6CSVM6>1G5CZFTC =)@POT5Q)3J+*+738[6_$
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M"(!OGW;@;B2M)(/CW@ ^FI,D<_;JO3I$QOVA,;]%/Z6-7&W1*6C+=Q,BX3U
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M2'<)GBY?L.6K$)/,_V*<OFXN*7EBM"RJI0XJRU0Q)5(VHYA_E0%ZX@P4H%>
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MI35<9O;SF!=#@=/;@?16K0[,0K8<$Y]QKQ \!%O'\B^9X*VM3Q(D;/U]="/
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MU+R(ZA=Y'JSU#J<=>?:;3]B,RI)^1D*YW"<Y 5G'M(5<4S.?=#]CGXZ(R,A
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M2>5[=[1T0WU?I88D@1:$&S@Z8=LI_K7ZC5V7:/5J5M0+SMY)*IQW!,V&;&F
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M<^L ]=M8+,*&KB&WM+6:C'-[C\8F=$QKCFR(' 'ST,,KIQJ&0\H(+I]>6([
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MN*LU.GRK?@!A#7_B@Q=ARI,*V_R"IQ6 N>E*;=*>P84Y5*^;O,CQF6W(X=-
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MEP@4X5'7F#>0SDG?4LT@5:&N50\NK"_*B%D%!PL0IJ_<4F'_+1;\ 5!E"7X
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MTL\PY047I--@J2G3*=U,?N6SNC:MR)VQ#\K0TXIQFP[#AQ,RHN+O3;M([R:
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M09 W<Z-Z.R=9.(:ZE:P;S>3U_G(<TZ/ ;*[U%D[.WHO[R+6K*4_G,#:.<*8
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M%$%RS*Q4<_0X1Y#;Y476K4Q7:,D-(>UK>,3I>+7MP6Z;Z#M)!N^6?]_J;MQ
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M,2!D<]?+K6TM4A%+2#O8:6(Z;7'1U B!V%D20#Z%-9%@-=!%_3JHX>N_N5>
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MM"^8:;TKUF]L'9B54*#7T0V],?A>8V%TQ+5WK6MN??T+JI@(K# Z#[!M\H@
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M9@&XU)*E'9T@/_&:<2>G%KQW^3:+U0]#GT=$#[I'=#F@+DUNZ=O[EQR"GK@
M99/.XZHLBU,UK46Z!/=+T6N:;WXYI&>9C#GLNNLG;?^\KL>_"TE"^Q^"9O2H
MH9$^- ZRU70+XS6]^+7:1W,7(B<B@HJ)VPDVWW@P=MEY?EKBYLF#RG;>K1UW
MA/>]PN'_"B-^_+K@T/XP4%/!GKQ0C8AK]$%J.@-^ F4>.:-MDB&7%*U#3>=2
MXYLM]R]"M;)-\750K?J7VO5] 9U*927VQ^S_MK<'*94(@XZU@YZ"%LZ=5+W@
M>/__"J3;]O8@$?R==@AZ1&3JS/\#V<>S9"':CB/@FF)6KM1FYB'(1X_&=0AR
M($:6#_83O]N_/P1])8H=@DK&C50Q!:SD7Y CD&!5Z8-*(#M2I-^<67EH IKG
MN\)??D>2_HJ^XR'H<D,L>O-8!7JM>9GX7R\< )H.057E50<**<1)[2[T#V5$
M)KM=M(>=70EC)7PZ!"7'8_;WFP]!(['*^Z.K'2PUS:/S/Q@<@@I73 I>31=7
MH!5YAXT$#AZ$_D_NO_^W0S/MBE)01%(.0J?8VK@=;00YBUY8A,]$3S,I5:15
MMCB['_/U[;KA*=K?.02I1<C6\4+\=BIE&?,%(JG:V*;UQ/M</?78TV<7>8])
MH.K0'=[HA2HTCLCB_\G(I'$<C?NOYW@ S4H TB5U8A?])BMQDLS#@TBUFY">
MA+/\%^'G^D]BN^.I.>?&-99J:%L);[MD"U/CWZN)#_RW)H[NXB!A?BL<P0-X
M,P\0.@39M%XF?IP'='ZRK>H6=@ZRB-'$7WY(NZJ.GQB>1B7,&WVQS%$*H?:&
M2H\2]9NEWMG2,<:#,N"&][7.\;+6HF\E9GC'4UEU'RK?]^EJM.)E/XN9VOF[
M&$_*5A(JV3\79LUZ_B>P]P)[@JU*]XEBR=,RI!*>2YW!)9JX#F^&?#X"4"VI
MDPC!_=&_D_8G%LF9;1<;LQW#!OEFQ,K1^"LI?#\_ON9R OUP,V>?*64^ F",
MAY-'G;]*@*46TS'_%T$],,^RN2?N%Y-;FCQWJ78"Z5@$.)I.L+075OA@H<TG
MM_%ET$.0][AZ_L@$\QZ&:6N9M-WWI&=WA<V=>B>5\1/($8^K$L?4R<=;#[=[
M!\.E6 8.#C:GO;UEKEQ\?>:$)_$:,4!])H*1>5"*TF;=BZ#Z=$D)J),.]*C&
M310,)TMB**3?Q!BPIJAS(6R[4M8,)89VYT]"?TZO-N1WSMRMR;4P=ZAK'0OX
MI3"0)[.AGE83[L CA;%=%'<\]?3@;+PZI4VBK]&'7\<Q+[XTMNA55_AC@6>;
M DH/LH*7''FMN/MN"SB5(81M4G/$73=NVN(5F29FG+R1TA;K.9L[B**0<O/P
M G_;)TQS-I<T>&N%[K5HM5E.(4X7+Q23I+A8%N,HP6\ ?&$P$NQ3Q0N;YZMD
M!16L&\J,4DT(^"RW6RP@:\<!!G,QT+,T25J7>W$>G/&E4?+\$76'$Q>*46JT
MG.(X#,6'M'/: NTO,9L9B?2GV_X]@GPX?/<5.70Z/%*T#5,X&P4VR,@K(P5Q
M_95I/=.H!+8@+C1*G3.\@70Z(* 7WK>=.,CF.T#I^J%/6QR"2&XF5FUN2E;G
M@ C2W)51UDVIN&T\E.\N#GN]<V+_T?YV*5K#MDL@*F%U8O+Q39CVEWE1\".I
M:/8IH*Y4>PM^"#JYD]PY7V\<4WZSU._((TQ#R$3!-0P/P;FF!RV G8\-WA%P
M<0&<W>1N^QEC5#.CI.L;[),6[]0D1E4#K)@X.@YA$D'[;:Q]\3^8YX\O/1*V
MRIU/>_CHAG(72GV$O^@KW>^[EF#O#(A7!D4>M&F+N..*W@1%2ZH:FXG<*F $
MI[E>7!+\;2>O7;B)%6XI:6B!5[748UX11=LX6$X'']AR,.)I0VV$D L00A?K
MW'.X[4";:[EPRQ86>C'5:APW,^,4H''@<WO<PS:P"*;K-CZ!08-4SRZEW+%:
M%6*?LWT,CYVO_OSXL3P#,O8@0R:EG\K-'\07E/&$NZ>T?2#0#<,23Z5LZ2X:
M_5F6C#1KI$O&+\Z+()(IZF\(!E5("]H!OK4MDRYD55,#A%1-(7+_ZQRI@^I^
M*JKPV]^..=:4*Z9G@:(\?,[?\B?$+<>1'_AL<1 -WIS$\QS<U7#>Z06BBP56
MW'E6\*LV).K5=_#S'K%%)M-,8>K3!V;"G#\^EA<Y7_ ;)YEAE4+@#NFZ;XMM
M;#_(RBV"H?HJTW6!V##W25-YV :L&+:.UKQ@;82:"_G_=)5'AQ3D3[ZY0]#W
M [3G/%-7ZC5Z/]=W?!U#<^3Y;9J\571DO9C[AZ#1<Q'N?Q([[AV"4G\=Q*,W
M5U%G#D'K+PH<R] =KN E.7!]YD%&^.U#T#U=;N2]H_J^>QR"-J.ZT1NW7UT[
M!&5NL%O!!VKR*][_9P)P_1#T%TJ^@V:U^&<G5(*V).<02AK=64W_%+^8#3F!
M^!36!S^'B+&C;;6/:<#\_5Q  ?U1E5CNC (5WG+542?9BO6)GV;%O0H5Y</%
ML04N/,YJP8$7RNZ7"^AT]*;[FN7<+1U-4[K9RP>U_+!X8S[K6D**K]]:Y;Z4
M,VJ&6"]/1L\T,*+H\EL\=#V+$7UPQ8:S=@Q2LQ"P(C6(1@W&$!0I\V>_AF<,
MFHW(CGU/8=QI:LNVF=A9_A"-L1N'BRL9+1GGHIG7V$/N-P[2#0V1J@=Y;>+Q
M3@076AUY:(/A'%"@.J9K2?22Q0]D8P$?9YC(Y19V#_U<8EAXD9^4S]O'26(8
MP[_DH^4@7/F-:]XBWF?+="14!(2]S[<?.?P3V7F_.&Y2<D6*Y15OV8D5:ROJ
M#&S;9&<_>U8@('FG=>;93.]$P[?P%3J8S<E+C^B"U"\7,,.0LB,XJZG)1</2
M\*+UO0PB3V55")I[#J8U+=L0\XN98]E'5E1:WP]-W)VY(4U_'%-BI(4IO3O)
M_V\#_QG/@SOX(]<3CWP6L(4,KV!W$&L#ZIBWG*'#SL4]@@UCJIH9Q-=3_GEC
M%J5#:BQK/J6R5"]_^BD!.U6X?Y#_,3O(RN4X6M"YORAG)S+^2O)(\:#S]EVQ
M^_'M0FN;5OI+IW#ADI'V,?(0>83L^?1?ZUJ29]ED0:CBLR!+BR^EMBEF]ZW2
MGV'=1K:"1V&?&_8PT TT[3YZNHJ,KC\5SPR"0<ZS9^E'_NOE4F7I1[]KT-7<
M"\,XV VU36G:.0SES;)Y&/K8YX)UT:34D'RN"(/OHHF_?LVRIEN_-,>C/K&.
M##;B#5L5D:/.\E@ ?UUAN '>S%M^+_5\?Z*&N8H^+X+%U^XR+(KC!WD2'6^.
MPK>V5?W=\FH:)I&F5 -=A=<W@[S# G)MT7J[#N]CCC]-@NF?H$^=.U772WO;
M_M#KI".W6=)??+9)IX*OX'VMR0^]9);$)95RGEQ[EFV76FKH:5?:.QD)45IR
MXW.&>C^:R-;#[K: [_[/7BC%XJ[!&2F&#\#%-$1ZT7PB-=7/LTY/R(QA43HF
M027?D#?I6$*6T=Q;S88W#PE)+C"7'&L?_)B^T8M/\[)M#670#"'XIVG<WSS%
M1Y8*!M3@W>"I*H8W+7.SE0J?VEA(WCI)X8E.%00@9<A[HI&ADD+X^/O-8[LM
M!E:F$59C%?I_STDVM1&2_QY;2/U[?%.E*&EXIU+P]'>I&)PMF08^LWBM^86:
MM$SGH'+!N_'^$@]I?0MACY^<OY3MR]^0!A)?AE2S?E8Y[Y:,19T432D6-<OY
M&&.6G:S\>LEFV=P>JC4[GE6/7<6MP:0*T2#B0ND\;F5SAFG.\C@H;!,V6;!0
M18&!%ENZ3S?/:]5\=W1G.OU1,_9@(D^VT%!"].T83J="EC@F9#J!V[(/<7F
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M]@K.D.L9_VJ-CV(W!34%6,QAUW=)1P+?4NA81'G*?;MKS?;5 ,=MWJ1.ZA4
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M6OI293 ^^R7!W#0P)% F=5":;\1<NH7OBP7J'Z@4[?Z@U.HAB&8%YD5WZ%*
ML(6U-BE$<H\M8GN1*I.55-]VK;XMNUO4)R$Q0==/FR'MC%U^+_%OAM%/B\):
M'<FG-F"P O;J;_?CUQ_<6*0-D2M.@;FR'HY]H%8#K M%*FIRD@-/":N]SP(3
M?I>V3-]/J5X2[OW6RTA)^9$RQ4J>JOI:Q^8"TY495PZRL$3O W5&,*!(CVFG
M 43RW-6L#:IW-S%(=6DO%G\7#U6MQ(4%8TPR)+36A?O3L%QFG!6)]4;<[GN5
M1[*F&X/KCXG!NRDO)&].,I58QR=^A07!M1/TY2D2CH[CJH8A@9J5[X-"BE9#
M^=4Z:D*RN9V_WC@W\<7>"&U@Y_C%DW!C ?E<F__=XHU0CMBNQ4#;;NJ*<^6U
M(A5+I<*T=7ML5(8B14GGL[R"6<0GQM.EH?ZAPIG4U_XM+0V/F?@P%$<079WJ
M0U9/:-.CJY,/07%S5R<):#I'MV[$>JXLW2<6GGL(<AA7BZL(5.Z=\:JOK6NX
MNZ4QJS6@'*YWKS9:3(_KR-129"DE^6T#Z4K!T-$"XQQ=#>BM"Z4V1:='B\QR
M;I3<RM%]:AVIV*EH?#[..L$FP<94VJW>\+^#F$/0$[U#T-=4ZD0=W<L*,*#U
M+#Z9'GRM*76B(9*M/&4>3IFY\4O"\>ZX90-47&N/1Q(;,'UKVNCBW]Q%2]^\
M_TGE8'#=/W(U*6W*Z_MRJ90<"$/J("T$PNVKDIB/"+LO*4,8U@@2AW-*R)LU
MX[-(%H^B32\9X^KC'SW3/5;SWNHGS A9&=).D"??&'^WHJ.I\ESS5LZ-R5QE
M*3/K1(7&T:5H*2'C#]["O=8K"1>^N=BD7L\1#4*.)LZ'X>MG-%#C[ YPG?QF
M'Q.Q2L2=D&;$I#(>_,G5XH<6#)&*11]+*J@RIX"C%CN=Y_+"*B (QXX&78N)
M]]AO<SDNCBTC>/7J>1Y^(,QBE*5= H2:C ?3*UW ZZ'M55/*;D?UN"$F?C+V
MCKX4HR9%I;HPO"Q)6E7L)OCQ3D2&%#_+AZY'GI.AMQ&+7'TQT\XGW T$&V#E
MKFLV@_FKC'W)1-E/'YJ[)HC4<"^KAE'I6.*_QD;^1?_(2CPR7OU\6;SP#6G9
MQ+:W^=_>%R=$LUX4MZ3+M30U$;)ND*TM7@09?*NY(W#?1#R3SXS>S<NK=<E^
M.JZQ\Q_]A(W70??F>1,_-I;SQE!8 U<+$GJ7TA_2=:+.7EBU(2U>VRS0S[GK
M>6WSG&ZBSJU6'8\:VPBLNUV9HF.VG%V1W"3.C\=$TNY[>DI@PDYP#MXAK,5Y
M)0_I 110X4E2@FQYY&-ZJC2BBMJ0C+2E'X<\^/:9NRV/FNBY81\F%GHQH'ZT
MH#'>JO[)7Q.,FAI0JOL*DYL]R58]B +[5IUC#[-/TV)B]$.HZN<005US8@VT
ME;@=33UNP>69KGW/M=#,ZZYK9QL^&WPP7W91XA=K4E:8@4A;0_QC^ZX($^KK
MK=YTCI9F.';TJ9='[%','B@.[Q.J^U*L/T"94K.5IMW6R229D<>5BEU=52&5
M#H0L?-OB"%N#93G6IG7T!,7T5*>130T++VH#F4< >6M<PU_))7:W7_D^_7%5
M2(4;=!\Y&56Y5(O+6LMK2%G*"HT5*)*-K;KZ]L2;_RR/GWWTO'C8S0YJ2QHI
MN)5@KVNG:%M@S+EU*UW!..>&O-R,=:37A1G_&8>Y K/>/N]\PX,# GCA8YO!
M0>L*P ]..O)[X'8+FAAE=H64PXV4+8$Y_S.)8_8,Y?R2L-M0Z9[;OOZQG4\,
M_(U*]2=OW9-OYP$4Y)/1/H-3'(P/!\D:/#%S/'2>2+0?+T+?8I';Z_X$EF5*
M>15&8:KS@!D2.:G<UW;Z&FK-W['GP),MY0$)"E+'AMTU;OA<BK:/_'PI8]C)
M@8/?1"2R(VB2$1QX PG[XCN>D /W6SH+0T06VU@_0U:J2:Y)#HB7'?&[QLC$
MY^*0/0.KED.0!QI0*-[B9H(0!>27R9UZ&!Y$=CO*,'IND@KI. 2]$;1=/P3Q
ML )/XJQ@W+/]6 )C+\NPA3NR;HV^H?NH=_3K/88H]E.Q9\V,_)PSAB5D3C;D
MHNTEY!VD@#WFIVP9-X'81:9>-@\ORQ4(RW>!&:K%B7W!?YF6): NT'(Q/L%R
MEY>'_ I<1_T#I*.#BOHUKM[%1(PY2GIWZ"MG+Y8]=DHRCR8O*I<I"UB/D4>*
MDQ[ PDZ^H_@Z%D5^21<0[LSJ&2*7C"9 JYY=C;,ILK3HO6_1 @GW;[C66@0+
MN;=/8E@?U+%OH'KF<0$Y3$N6U@1UTO!B=DXP8D!*]'-8^1J1#U<EZ(;=B0^N
M$KF;><5/*+G2O<POQB%ZW<",Y!(]8X_/'(CLD5_GZ!X$U(G=4N*KDC>2%^";
M1*8^NV^>WU >FA6=OKB3+,DQZDD7ZNHWFW>,^3P>H('A=44$D1(]2MTOR?B]
M_(^NNE78J=>G\W'L8C0=?'RU_ MP/>KG!Q)/UO)[-7Z19))U<4RQ<P%6>)#'
MN*#<.%J>Q[+BRM=IC3)MI>":M, +"[,%%W!B198V-FG\4.?]S9S-D>>PSY^2
MQXC3H6S.<KH>HQ1(9$JP7.C$3JOH:76RU)1@N.#VO.M0 #Z!9=<XA"=RP^JM
M$86STI U4<]YQ'.GQ=$GFF( 5@V_%; \<)>[DVP8>-!T-!J !=FS\SC+%J8Q
ML-C!%J?)OPG9.8+ISCH@J#.S.3>OX":,PJ4<+V9>4HE_!L^BTM5$MNT/0<\3
MRBX+?P9?LG83"3W[2.<>S?[:9GT2WXL ?K%_VIM#KO+MU_-<Z3:12B"-VBM;
M&@[4J_%BH8JZ 4H7/BC*@A(NB3WK_E;:!<]/M8&AL/*_?8\$.=V+S<FS> B*
M1U=GMEM]578 PA>VI-N)('TG?^HL1T_6\SQL/W46M3ZM+D&N?]D:U7<(\IJ9
M::1O,?6FJK*;.P<#C@]PHDA@VGVX)+O3.72+ZQ,@3=F+8(5*;?'3&*.49:)Z
MW"\)F!7ZW%>G&43&E":W./2$:O],56RE\UVX26KSQ#?%^R,^"Z**?='/%)<:
M-_-?^(MX-V5HU7LE=>I,,A )_LA'USF_QGZVMY=67(22SB^>Z>8,-#6Z1?>1
MT7%]X:B2G>HV$PK?&=LW9Y@<8%&Z*#)8 %>5 *G;BQ<BS<G7C;K<G,#UVTPR
M;3O;M&CDVMN:@]%(K[SW#Y-M1Y8;&U[_F+OK\V=QUZW3(=QR[(%U\%6B#_Q(
M+U*3WVBI5B+Z*(.;ZDQYI [PBZK'E>WFN!B2F+Y<A+5X$2[B,FMF+AS,+>1*
M3'$,?>>\(:DU]C&=;%XB<4OF4>KOH?RFZY6<%/?+73U2'[XWNCZ_IE%PRWY)
MW^C,9)Y(4'>T^CI^U43LUC7 UTO@I;5%28>BQEBI;38A/QM?53:R5U?GZ&ZY
MNE_7+E4OW[7#A?HJR7=0CX25H#OG@![*8*P6FO^7<K+HG&L'E)KHUWO&WQ_'
MG!R9D!_9A9EKQ_58C.Z^P6X%EW.9FRL+7VZ(LJD!PP:G'<GH>J$M,?IUQELZ
M/!H'Y@#BJ>';,>&E )P4JKV7)?=N7RAJ%\+U=X:V;AYLS8$Z>2=ZV^OILP;^
M+S6O^#Y*:5N[XU4PRGE)!>^M.^X7))*6XN7RG%/2-4V4[->H7J^*C/D23]]/
M]+-;.2EJ=O]^@K3LR5Y'%5L;4[F"7NR(MN5G?W\ARYAYS!')';EV0V"<R8,:
MQ%2WU=&.-.*^^FNT3^+C&:>C'TG!K;>=,5WNE[(F^KJTE$_5>#U?N5L?NTAW
M&TN:,"=^P35P14%OKK:!_T1:,;S""@$,F$(LA08:,<90>(Y-&BQP1ZH",0O]
MCLZ97<[1>,H!QZUAC42X;;R-NH=7V&.V5-W8^!/>CV'%&?*WGR#K?I., FTI
M**DB%8V\]"&K,^\>.U5*9=D7B[Z(#N3<K=,WD5GOY4?T(K)HY9:%/D;&A6F*
M)'-92\Z)N!&;E'EJ^F_,P";[GQ BH)[42C]N12/&&FJBVB$U*]W)R7/G1SQ&
M@]%)AII#[M3OKL[)NV[&$$ZKCY!9LE?:9T3PK%YWAFBP4)VY5N:Y3+$W)OWS
M.'66X&U&TD'Y(<B;1Y1]9'4XH4B4).+'3A>83Q5UR?<0)+B(PQC3Y5][X>AG
M7_ZJBD;J4/Z[U#B,Q1WHSF^YBXS@3P=L:8JAST)<U_:J2BUD&FS8)L/NC_E)
M<V?;)TB>5YK.B:8_$52+UCYN/=D]AA WEBS'FB[8N]H;O?Y8UJ"S0"M+.E?5
M7#;TP>NDB!U4+NLUP1DZNSI1-KU*R,B]:73!<4HT"K7&>GH(2D>A/8^<-21V
M?I :CA)TW,;T\/QV7/FSN+BN"\AAL>4GR?1DYLI?AZ"IP,Q#T#K&X%IYJ_H^
M4ZK7A/)_9K3_GP?:>)[VQ+.</8L6(.4W'H*BO>E2Y\K:I8 '1!X=L5<=>\(W
M_EN]6\Z6/=+&:<0 58YNE/RP#&#-O+HAJO5J48K7]U/G3F>N;D.J[<BN&XII
M:1X6_Q\A].+KL')S>R>U OQ;Z?<)G>-#+U3-V=QQAZ#43:#J$/2XCPH^.+J"
MTF0L^)$5H+T.$47D,LD8FJU5@OF+(UXQ>D%5Y1OM?-E:9U)B7C5OA84*3M8@
M3S>E'.->='M "N(?O*RD\K9/.BKM$&3H,W;#AACKZLC&/1WP(@=&FW96G3Q+
MO/SE9ZF'>.DRY$$0NS\R5V#2NF!SR?F^O9M(F(Y[6M9B2D25;2X?IHGK6:<M
M=(-5.KW_7.P(8X,./J#.(/T/CDC%2QU0A&R.TW[>!6Z&,]UA[OPT>3(ZNE[9
MI\@W$P6FCV/G6=+[^R0?@;9L6.G7C7VU!LH@GQ]#2^OY]%;L".OF"ZA@GL#W
M3 R7RY']"( 7\AOF)4*2IS;N 3KY?G,:M/DHI/:B^@4@U8H^D#1_5E^] *CW
M#Y#X:]Z)OO7=X;DT6>@(2I/]@N2C@S<L3%Q=[C2TP2YYAPAT[%NQ.47^)W6T
M+-,$:&&H'+P]NMVJLW[N@@=OB8_58R&<5%K_-M8CM, =6"0[N%\>TM<IFIN!
M"@V$B*%Y@##3<)/-S.FQIS#4I8D0K/F#MH8HA[$^QB!+_#WS(2N4%MI]" *A
M^C \2#B6I0MXE2%51M@RP)(^?ZD;(L@-B*E:1UV>U'#3&B3O,U)E<[&!E"-U
M]16! E>O!LZIIL_.;NZ)QKFIMB8XS#J=\^IQLE?CH3Q1/:O&5QEJ$E^#""'3
MNZCTWX*FF<O"NN\U59[X>JZ-=U&KIP)4*>PB)5I6SCU5I:]9YSLG(IZ&Y)=V
MR#2E&S=M?Y,6,4DWL)].P,+O;+X%8$P?=,=U-&SPJU)?Y_[*%L>"O^ADI^0U
M8JKQ$"%H </G C1T8JMZ8*IK-$9I*'=K^G)\1;_/R?[QJ+8BCQ.B.:U%,VN3
MVNK0H N&WDQ%%!F"V]NJHV+-.R%UZ,Z#V]T_?94#V/)TV:6EXA@D#T63<'8B
MG@H67!\\E^T3\OS-#V>HPR>F<W.49%BXU@/>[Y"Y$_25^#8M=$?M/&\(.NXE
MNVH1"Z= >L14CW>*[L2&<&%A;G6C^MKTL(Z".PVICF/>C6-JV9:C!*LRWXS:
M;]\L-)PUWJYMR$]1[T!J\@YR-0Y!Y] =@N!'X @PYY&D@41(5;.SZ4SSX;:+
M+"^@E,[A@"$Y5W7UFW3-2371W8D456FRENA\S/;$]CHUW+#'D7?.H \!)FE-
MG_4._AE<&S)&E]9I]Q:XTI3P#$_6 !:O+C2\M^UX;/_LC4T?;>PG9].7'U]D
M[QE[.5AWV"5(9PY5YMPSMPE9NY]HKNT>F%C46[SEIO8H.S'%9F7)$6[<.K/.
ME/[-/"@ +R2@:?>EIE(IV\5T2#>:*YA'E&4P=#%K@[Q_".KD$?[*NIG96?^\
MO'GO_B1.SQRF^EQ"C;3,1!5[%:\+9KTT4>W^R'A>\WYC.7GJ.N/BP4>B?SDQ
M5@M2QWA+47V,CIP3J*-C$L$417I49B2U?DB]L"UI>M$B8WMZ*40Q'MK@_NCJ
M[UNRO-=[3_1!AH58_.@%G@CT0TBR,R093#D:YVJ2$U%G-QC3GV+I,0N]B%UN
ML9Z76GF?9DD^H7#O<H#*-*ZC:[TMT\R9S:AF&+]0B2XHFM6?</QY*PP,R!1'
MH_@ ,&/G")^[ =B"&IXR?QXI5D^3F9P_^XOGC)]#<T^,5.?^=A[5[=DTZ2:Q
MQ@?7,K+K@K59N5T79I)R.J\Z;O91D(B\N&.LS@"' C73\A.'=M>CW\\=WR^]
M7]*/T?M<R[IW]<4 OTKWP\#? =Z.T[8]'@Z7-4O-SR25WVKE',JV6[F%U9%W
MA]HYV@0F>(N4F)TIELD*S+0/^Y23!?O"_CO837>#+%H?FP^-%UN7O#2AD<-U
MS[3P_&VY NRZUK1[;NJ7A8KSK4O?E%6V.4DBT ?^MR'>R#]919&H44C=RI8B
MK85A#F3G 6JD1<=N'0(_QRM<JW2/**J&,O/>\!+BTT9'F[!H0ZP7_O6DB=.O
M&1UJ*ZR$YZO_7^Z?FT6$P,I()8=#4%0Z+>=Y_0[@= CBS@PXXS]/RUZ]'3!T
MO47?2V10N!]MBZ$=G?7;"L[BWV-WHFLA;)QD*R2,[&J4W-L8H=Q+JR&9<R=0
MME7Z8;ICZY9EY.]IS]86%L\8XV]T)Q3%E6]1%Y8T\O-T_;48'[X]SL?Z6!;B
M=R1=0F8<@WZ@.\&TVX<@0&$R$:6&O WH%")E:6/.59U-2 /8(ES,SU!O5(4M
M/+7N+D];3J7V:QL-$YQ4R_JHB<\D.%Q'=C3]]6Z.P%V,8(WYXW)XZ*6?R @J
MFL57SJ !%LR_$5P,'SI'.];1!<BCF\W<'S.4D#KI]Q(=JR]%;54V_N%"UL43
M$ZPW=Q,ODSJ'7:?[J>_UC?<ULBX(/0^:[?D.>6 >LA]Q".(00$T0)>89PYF,
M9[05LKH P$\Q(5G]!?"3:8BP]KE+XP2E-@5Z<0*N5--E7O"HU6\UCV[_"C>Q
MJ!9%Q>;=#@W4K$^%>:MV%4)#PC4B-N>G]Q@S!Q_U)0Y!)Z0.XMEJON[7B'7
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MS/%Z >NL4CCB+R!K7G(B2"#QDU^HOPT**7+_]:;X-!]KF;@#(+)]NNMN(5S
MO&/-,^;CFRT11M]B'5>UO5IIENJO@ .#KL1B[0%]^P92,RU2=TTC]RQ6S9QY
M^6I-L.R)&T"Q]C8H<(5E+:WXO0%^"WW1+-ER,M2T]BC5J\?6X\W'\,LG3>O"
M6]*[SKW*.W.]QOVCKNT(YV/^G==?'[>B.SE)FC63F*<HO#Y/2EFP7XMKC+ :
M$6C!R0R]E'F("!S9Z^38(X_:UW$M;!X+I9C'=;@8K957 9':5A8!+<,;0&EB
MU/H&3-?;PM3=\7E9ZIB6)K20)(OLPN '>V<GB;VSA*AN(0Z7 W4!ESFPVC)&
MG) 581"8N\24*Y^/@+FRG O+OLXHL&0)1;TUS'U&8NOI2'DB(7_,4]IH8*D
MR]GWS883+HRQ3,$DJM'H5]8Z:3\BAFV'+K886ASJ.%L&C,4##QG+P6@OM/[!
MRW!4[X]O2DYY61&*-QR=[FA[MR0E/6_W_XK#5I[6WQ 5ZJ9Z8',>,KD-$NR]
MST4B/Q5+-'_2$QR%J\_W427E@9 KH?8-K4.&ZXKA@=* =E0%D!*K070R0*41
M(KR,^/I.F715<XL!ZV&ZZ56":\9L\=*+I.[?EV!!D-$7L_+I3&O5]S\^V"GE
M0O1RS^3"LB[?NB(>?P"+"#AE=,UD[[4&_.F6%E.GD9K[[I7];A^]JOH"'4Q,
M[70UE:LL#&D1MIRPSDT_&$^ ' 6S7*+H.([.)Z04C(R'_K,Q*/*.W>84.?M&
MH$)#.%7 :WK.<?_*.U^P#;HT'IL#FK&O6,DF'1TN)300.T:.M[0^6Y67=[-4
M_X9*);/.X@ M'^J@2%B@<1[#Y;XU>.H;IRKA)0!C8JC)X"Z!T<BK B.T;"'%
M,:(ZX.M/IUVU-:'8_FM5YTQT%W)JZFCK$-;Y <=>2',:3U:TJ_@4OPIY##XX
M'X]CM;\A'T2>@@=*9@B.CUIZA!=;-#XZ-Q2+=;PP'&>1@2\ZAM<<<VX-BRB=
MF/#WGPTSMWU__L#S6U4;DJL8KC1QU99[B7<)Z&1[",0@7/!-TE&H"G"/UBT0
M:V=_K*D$WZ?KY=1.^]Z<$1DR!#J20RPAR8STB"#\Z!*>V$3N&&>01W!7<,=#
M L5I.3'?VXU+* J?Q]7[FW3TO%R,/AJ@$294Q=X#Y0'Q!M+B(OX%P9=UH,3*
M_:;AEA,=2 N5SAK'B6OS;A]E1JH''#QNW\O/,RPK,3L^]2M(H3)9;I6(3!<D
M0FY*3M+F$[XWL.7=  _N7PCS<:02?,F%Z+] ,RJ[!].%.N3;9TK$4- +#\;]
M3-+Q%AGJ^::;5D<Y*]/''73KQ.6C'7<FL[G6J*Y#J+E7LWC4/?R?,PGD :MR
M0+JK;;3,1  >(9V"UPV^,4]+U]%[E0O3M7%D?>;0T](+G4FIGNCWVR /FN%4
M4LL538(!1>.VR?(@3V81^J#85!@4_@@%EGP>Y%;>))?SCM\@ "%<66MWYP95
M$#IL[^=U0J+O@TIV0&M=&%G876[#=@VU0);_"+E^;4-T7&_&SLG#D]7[K":@
MM1/-=."1F0G?S>9Q^WF6@,F?4M@_&XX[7+BF\'R7-#]93/?Z),?DSYGB4G!P
MUY95K5]D6ACN)DEQ;*/_YB*->C!LJX!P(.WUT1F_SW1BEI'C<U^T4D#RL_G;
ME]IJ3R>&.#SW&8BY5-=81>EP*/;^,.9=Y?*-9T8!+C.:_"8LG90V3AN%![4&
MW4V!7O/V@ME>/(?5E*V]IJEE.R.K.= ?=>>%;'D(&LGIMT\J93_BM/S9M14V
M.P'K4?))(8>YI(ZKB:,.3@5, _[4ML#24*$=AC=:*# *W=(H)*WAR=JZ30E=
MO8B/E64!Y078Z\2#CE:9_@,R@WP'WA'A-/V00T(%RK*951)\Z&=Q&3>V0?@T
M*AE,82MWF1C GY]-"K.4P@&TKL!3PU]:V?-A9QS+IR%I.KA+Z-OKIRQ0H1F^
MFF8_):=JNF;D2<+K[?PJ)KEZ]J6 /@;=AS2#7P2GSN+E,$%Q:A5T4S9_/)7!
MJL/J$5&UL']A@2HL06<RP^I:5)QDLU5YYV-YJ5=G91R9D'T=/LP__5@_\F+&
M^C)Y[D;]D#QZ3E%QLZ4#5B+\XT=P%O3 *J.I:32%-1)QBT$,(6:.B3U=91)#
M[JI??EKR&[&4WB0XR5A3H+I3%R94D/[,7E_*1/7LI._C4\"'>'E9T<*04V^"
M3L,OQ8M)O//'J#ZY_KE!5E/3P:>;"TDR\RRZ<+;B<6EZ-KA=X[DS.S["0=L(
MWDZ<!@NQ;&PI]N<-$O\)\N2?^AOKO;R]@",+W(>$L""4@5U=L_@4#!6:_FLK
ML'".KS8VWI?@ARR?4_6W+7@/E@Z7$"FM4[X;?9!(S!][;WP9G2#)2> I/^,J
M(_[J8.FO[N&>!TJ[!'O&D=*\,. *A#*8DM#6N9A7^TUW7JAIGU/IR+9" ;BS
MOJ60,O8N6D?KP,L?]9T/-(JA!0UH]BQ@XBS8!GD6"O9#7Z\4_J)7E"8*(6P'
M&[#WZ&@=,1)[AX9DW:UH[^PH@-4\>WI"0N?'NR.@G7T['PDD2L>,"MG0U:YR
MZZ8:TI-*Y$>E8XO/RZVKD/3 HL3H.CBV3M]PU:Q.HBAGFG(2_\O[7QO+#]7!
M#]]7*;*G$;V^45F7PUVT*==_ /#8GY>Z4\7DE7[C87,LTI"13J\KY6*!UC#<
M?H^1XQZE%K\AJE>5BM>9FHCK\FTOKJB%::QK]YI\"PZMIMF6DI:6O)]Q905T
M*,ME<&J>8\+"I?.D6*1?G/ML*)6\#_YS+NW!(GLK7"#"/HX+8B['8M4HO6I'
MAK$;W")1Y_;1.5A27WKR*XNH&<KQ]<=>0CQF 1 A/Y1 YLIF3%CV/9C[)&4P
MH3(W0J"\[($X#DA5SP)+E!][K<%?5QGLDA5Z"K6I#2,VY;^"WNPMB=M3D.Z^
MN7X<3R \I+V'S+V8.<*63Q?:T-)M4/WJ8#K/!@?D+LYRBH&@/83!]+A.CRNM
M1**UEJ]$9V=O34*"X4'%??]2I,OLS@54,)V0<SPD'RN01U*% 1<=127GS"K&
MKIZ;9WQ#F+'R_MGLC+I "QXS@N[9!G5?8SWJ8OD#C>..Q('I3>R+YNM]OO>Z
MS0A2I2ORCR;]IQU%)_6L^PT^--7B,H/V% :W"IT>P_+,H,%^TVPU2?G[V-R>
M3X.GLB0+K[UV/-53?=E\S;/</<WHEI<?RSGWZ/[PA[7E)P89V8NOG:://P]W
M&]+N5%ZN(0V6_%Y]C>H2"GN61XWD_D&F+0!C];N-1-2*E.K?Q9.S2"JM[&=9
M[W[FU+HZ233?-WY5>IK_T.BGRJ/[LIT?J"6HWG59P(,JV,V&I%O*SD=)PM0.
ML=-2C))6=U$%"FR)!UN!K2]A?K?6(U#E*VW)[\LXA05-I1H/WW9DFQOT?EWE
M0^!$P;Z';,EY:,^LO%# LRZN UJ#*21C@!;(#B2R]5U8'"S;PYVUU#.@MN0^
MICE&K@<'UH]$,3IH^/%.)^/9"^Q?#WCZ%3V5O>B02JD<I>,"F, HC"QGF)<-
MEC&<S3L(+YB:OT+,_=-<1LP;HM#NR$QECVP]_F5]N&4L5/]HP.?IF0^_'.(B
M- I,C&EGC3'J$YVMUN1=T7HF5C4YY3F#C9<^8L6-U;"(=K'\Q1>0HF#3ZGS"
M+6L+O8'3+=6$4_^BVLNS7,L6_,YDM46KGLQ-<(Y^Y'#EQ$7IK)47-Z;'0RL_
M_#QYXA79UN1_'Y#XG^._G\J(E!]?2^,I"P&G9<9"\1]BLB%;MX9A3(3#-BA_
M5S;J>]$ :O-0R1/4W*A0XI'5V=+_XW!&O[9M$"\[4&,;U%!(A6[=(=56<R_\
M:2PNCM((4RU\Q;N7>:):P<U6!O1_AL_&E)!^)UX9$X1DMVLF'> 7\\[8;7AW
M<>USVR)%%=?,5<27=I*?G124D.<F^-;]WNS!55IYN-\_P[&K+G-Y=S>X?*_L
MBX;]VM,>O?'C?G=A]PZ[A>[.#WAT6FJ'V@T+$Y_%&?UW-I3B8X\Z2UVT'S5&
M3(8F!L5?7&V/=2 VVBD4AAL@_]X&#3.1]J@NDS\;Y(O5^2V"H[ [:1EQ3:P^
M3B!@M@NHX60!LU5.!YZ5 ?X4N=-.U0%PV/G1J'_JK4^-X:=@&8<<Q.OA41>D
M@33WG (+,2>;3ZBY"C!Q&Y1*OLE@N$QB.$&?/!C0[XI<RQY^&BOM#=H6CXXM
MAI"'F>CW+IG%IU+>=':TD0]=<6$\E_!V6-=ED#K8(O7#0&' B-HL9XDQF$>^
MYC*%F]/O(P/JHM]1U=\PN[]W2+SR@VV#FH@]L.FP6CR9WM2G)OJ0@%*#61LV
M-Z?VN8YO\!.H!0W3*\U*#1TM;/D'SRQ]RY;;(G /OALZ1GV!,O\L("@A3K#S
M<@0*/'O66@D##(:+^H]V:#.W01+A#Y^NQR;'.#Q975O% ,?OOL?VY'PYMDH0
MV[>*PVKDTQ>UE M3&Z(R@1K5O,'ZB=IV58J@&R?!ZKWFX%YUK]] Q5)53PM[
M()$B_2Q$9;3>>5S0Q3%J_'V"N3)6XW:6>S'7P\G4/__YLJ)V=9[WB^(:EWL?
M]?V)7*&!V%/"]EG%,*'2R'YIY"1&G"2!.#."G[U'3R%V R1)8-"3G8-+1RAS
M^*IU<7DR3E6?/ZN:7/XY-J#>3-".THDRT(H!JT"[(,"1/)Y,UCR9DFS"+$RS
M/@@D=<VHCF\ <5#Q9;(,+ZH24.XI/DRKNY[+?+\E*1% #UQ1<JHHB=*)F7!@
MGBYUBA;3F0V]H*9U@_^3WX:4 2SFH3Q9"\%>,DLH^C@%YH4/ZI RX0+-4<,(
M9].E^O%RUK'':@;#>(OV1*]7;03RZ(;CCKBPD_@$[P:7J*./']:P(0(Q%#<(
M^0DJE*HO48I(Y4&V:%^Q!)#$A<#S*6\P!Q#R#)P,C*0X7/NEZ1,^Q\.-C:__
M.HZ.@0)IU#NYI;J?S0>&T(N#E_)<ZFF+J3-3OS &W2H.F!#?J/U_CXLQ?JCD
M=P;<-V#J],NF=\TWP,7E1#!208T=QM)Z_6-!=IT!=OKRSN4!3A>!7\XYFF8V
MLX^U7E>:O?-X(*.^]OYVA$/9X\_NF8M.S6O3"\'#X_9?];MG[T-DR:$XP&1)
ML-^1E33O<R]N, TEA3C"OA^8%L"J:U>!6>Y+KD:(M3:.W(J,"&FA$2+ /DTW
MZS8&0B^VM=/B++P=(NJ"]W=!=B)5D6]F":(]N$G2$J<*B)A+ BOP=-.8N<]8
MX6.4\V/S)""OEG=^S&C] !#E/&0(WN%/=Z@*KXFN!FKL/>(DNLN,(Q)?.S=,
M3@R>$*1:JR&'MD$*D# H8"+-Z1LG&<.;U_M(.@"J9IIWBH8(JEW%4+?(*0@(
M<_W!5D$*.-/(@\M/\*))![30:)<[]5$)07LJIRI:VAPB0\K_-$3DEUB&<751
M720,GMPGF<I:3F-*/D!:(6R:68'E-;Y3*W("%;9HICY2#NX\V./J.VUKU-E;
MRN@96QC=>!N2\S)?,#:MY[6*OCF;IC,(/$IC(;S22U+>PY8F\[)-+?.DTV*H
M]CI8C]/]M^_(JJGAT=1K56,OKIG'U"AMGOKT>M[TNJ;8V^REO2-A]L^8GDIC
M@\\\G*>]M@(Y9'_PTS8B[R!8L#^A%&%" G)B6$G=\F?"MLZCI_LH ]I,:!H!
MFJ$;+-'0CJ;3SC?ZQF;Q(TWOG_P:'WBXF,.,,VZ^QUPM):+>07?RK-FS?UIK
MPE$,(@4G"F3U8@XBO&KT[C/61>!)CJUDMEQ535.;5;92^&&TF6ZVAQ6O\.A>
MPZ]76S"N!?2]QQ]"X.2YNT+I/MBW#9(6*E,7GE6IT*A*4O-4)A!A+/V>)K;2
M5"_RS#C/,8*I:G..U3.>'5MT/<G*;VOE_:QG_>A&N;]%NW92**&QHY.V2HWW
MD=R#?"J\D(ZU"&#012;8\^0H\]"TN*@] (3IT@W.)$L+P @]]F!N[<L65F6W
ME2:U<%8*$5$-K_%N_@ )_A2QJ6IA)Y@HH"\.+++64]<W?FOFSC 1W-^%:FSY
MO2/,%YJ'[#4'HA-#'/-#S9P":L1R^UF;FD4AA#.V#WH]L)D?M)-4C,T\:E:K
M'*<\NZN+EYJK]KI7>1=!;E:4:BK814<[:_UTS/^XYJ<5-UVSI=\KS.?WD:BY
M2BU&$!,,>$,DP#Y7#%<&6%N0[$#I*%7^8W]^Z5M_ R)EM2J4K_P]B!KHUJYV
M<>;T8<P@ZCZF8;!O-F<6'\9_9&G&2(9T@\'>2]3X0X TL[?.6F7:?T4@6U_H
M.6:HM32Z>FP?5L)<+&O5^NUYBB?^GN-SQ8H'/1KD>F'^[H*L70?J,6"&4'FR
M!>_(K/9>$DD/F@EA-6YZL\\7'^5>Z)3'W4$>>7CLOLN#"-F'^!#:("=T MF5
M=6<##.C,]N%2K.6 ;1!W)Y(.:1KO ]]#R9'#!G>$Q3]$W!I'[@72[(2TED2=
MW5_.0M:\"M\J*GB4F!Q3N1RH&>'?6ZS8D':Y%<WH.,7Z^F%<CAX_5.';^^)L
MYH?77_#1O[T3,@9^?!^8BP:<Y9F7"B7RETPOR;#A?F;9!A>;*G/>-[@_^$JC
M>E"OG8ZNV;/_<2$A*T.I*<(>?>9V=NVH68^=PY68& M30I.3Q5KM$.\;SPL(
MFH?>PT@CDEDHIG6^H3X8<88=V#1'EE_>%ZWZQ=AO+2V60\R")4FN17W7I!?Z
MQ9>(KAE)6#/I''&*N=(OL)R@!PJVW,?5XIGSFWA7R@"/\X R.Y1J3P%+ZD7R
MKEPGF;*-7^H;<2'X">"P_S;H9I&Z0*LH\!?7H6ZWS:7,*=<3ASL)9Y#=J*Z;
MY) I%-V$D\O/087/3O:[**6EH.;*D;) %*-(SU$F\WPST/;IJY]5XRS_J4[T
MBC0 \1G.K:ASFQ$^M.(C!><T[JU<_#D(Z$-[P!)?(;+;H-#9"75&RH@CB\A1
M!0P8T/V?Z7Z&T)!6((_I(AEV] ?SR]D?UJ45@(4+"V@+<W0Y4(6#92X<1R_X
M3[YOH2D7DT0H"QLWW7M#/0W$4=+N6.>8 J_4M\M\>R/*.72-HAO.(SU\J)\U
MJFV>:;@\]KS2K>[F2/C[P'<:.,,%#U2<C8-&^T^2Y_36%JX7?!?U(T"P]\NN
M;9#\(T;4[IV2/!\_R=UJ>S=%[\^0XR%S"ZK&R1Z"_=JL?KOZ7*G$6N0@66(C
M:7?\A2-)?'^F?IXAUP@=$)%ITM::$5S4)67GV.QU^L^KEYW;H"^MO(-"N?F.
M)=1%'ITBY&34'!/W^Z+\&RCW&'07>?,VO*XX01,L#3>^.)XGSG[\A-.6:.#3
MY#SNM])IKS]/VP;AXB"FX#U"WMG]I_@J(X"7.((*=;*8XZ35PK^=8R6D(1*8
MR2A']L>'FA3(?@#5D]"VFOL/^E=>)+.Q/BUP)(0U@]6P5F@@C!@M-J4J;];#
MM,:B%\C-43QI24XW_[YAG@0<P_F'I9<A>@_A6[4-NA9F;<Z"9$1T7&' .\Y%
M5'1F4>@#'[PY)G0U;&)81$)T1=_KR[:P:MM0N([>$IH.#^(+M?']1^1;T%SD
M'J"3-<OQ R+F54,99,H BI%221U,]PG<-ZK'LV#JIZ.QO](WBT1MASILZ\+T
MPZK)J1UF82\=HB-*>^XTMZ6LE6NTY0?8!@?+!$8Q($IP\CR9IVS!)OUD%F;$
M8117,*)(D[Y7< ,_]C'^QU8L_:9  2ABT3R&:H^/$K0BH]8.]8+E84JV943I
M?J/F/ T_Q"7=EQGRBV=RC>?O_+;?S;8+/:":ZD9M_>B2?_W,!SUY57Z)0@@A
M?&X>W:=L&?O: ]WCSJGO'Y.K3I7[.^>2TT6>8-!TM*;_8H1-P>T' >Z(L:)"
MH]]8\F1SQLK4%&,V#ZG#Q]=!YK)0C>147A)K<&[F$5<A#'5HHQ^70CZTH:\4
MGB#,UQUGF::;+ID__";@F*[\:>-G%<NO5N9[:C0X8^]T3OLN1_9(L,\@%+EV
M2 H9K_F]BO5S#M*CGXTV23$<%!4,(Y6CY'A:K:Q?6;4\^]?A2B>_6BNQM9X'
MT+!8[,*G2L$[=F36X7L)F#@JT;BKG]X*:2(3,+P:'^Y^U.1-(88VV&PZ 377
M=G.)HR($D?$'J6SU.:GL]R)!AR!=N+L',CH0[47J"6XO&DM/,9QB_UZ2OOXZ
MI#7$-^7-0LLEO02F9OID_-77;E2M$5\[L&Q.:69V]?7J$_.G33-/%^C%QX8?
MG[=+D5#2&D&\U[([Z55C6U;<T7#;Q?O[E-^4BP;RA. #N;YO59)[1:@ETW(%
M>[_.'!I%F'$MX/']/1"9XVS-;)T.@Z1KI=!E:ZVQU8JA6Y'8.HVQ17/4?<)X
MP0DE*?$A/QN-N[BC1S%=+A.%G%1^"7(W+XA?*A2G4;9L48K+71-O;S7K0_![
M%E$*1H+RRHEP/R2&$;6W+S3F-5"\M:7J_%[,PE'>86U]4<YX66<^C"_T /=1
MPO"<0,WAP)RS"+-M4/44Y]XV:/\WU%PJ5-Z(_ ^&Y3@(:&%Z\\27T78X9E2J
M4A$NQ](H".>ONYB+L"U!'*5%Q6ICSPW=E3\51L?'W\GX1R8,/1KD>RU$6C,0
MU6?&\4^?#S=5,8:F8R27.B0*@F-AY["06@_FQ<38AL=LK]$$6;>1'F>%<':E
MPC5:=K4[[OU(=5Q()S8_4KI< 8L;?!<[R^_XOI6(>9( 8=E!I[XYC%OO!GQZ
MR)(\T3E).<'0>* F32 />/1!I7F05[!"O\H'"'W];$*$,O6@?U^5_TVE*>#.
MS,I:WX7BE:3?B_B61K0RC/I#<JFRAYQ2; JHLFV$Q"(B.+:L58+X"PAB8OV[
MBO6'K[?E;LW0_(<J3WU6U@;^NN]&JW/M2:P(/R6I[DI;B\ =YH\L!_;%<*.0
M(UM+?9 T,KXPS]J(=QYXPC9A8*BJ\LR$U$@$E%GDX3J,YT==(!,["_IM6=P
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M!L_5=XZ6LZ(HVD\9;:.;(O[:>[.-::>+&0^NOG:_W4WR H3N2(2%ZOHK$FG
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M)!55C.DC=*L=XU[!<;:TN.?]RWC=<R*98XQ2]%K2;"%D[CF* %U]-#<XN>0
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M4-D'N4BE#M1T$587P>PK!VEODA5K&K7^NY-2L&#"_'-P4\+:.E.)]:<$SS/
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M^4C1<9NL'ZD;2O(;1T-Q7B)MW^29ZT%E:$_"5%XOIA:]?H8VS4@'P@XWE>
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MEX1:RUZ!Z85;@ /=@6I'^ A. =?_(&8<0IT=YYQ'FG7O-2>C+.D'38;QYUP
MJBZZON%R=4##RYV H%OXH5\[;AK7FWW#E'"OXJ\@#C_GF'+![ QG!O[7/N@N
M.@,F2F67!H;I"U#">V%QN1B!'8%3?JW>)3A#2I2#Z?CBJ)KL^)K6S>I&[!#$
M'&8]5O4+PJ<^L$GMHJO*9AX(DJTG LU&80Y<\J[0<P?(.II"\CE%V*D\FCF_
M=<M>1OR:(VE32@VJ?53\1L.%[-'@AZ&O$[MM*WE&5ZCBE[ \ <,!0RDVYI^8
M1J+R<WBJB=8P^3H98[@KWNW<S!(*8L#9]6@/<A*X=H(TF H^V:Y!FV"DC;"B
MF%>1$[VM!BU1E'65C\[1N')_9T%::L#\!H]_1-Q2XJ>*SG"$SROW.?)D'R(X
M)%SMNVGF+N;,G_HJ@'P&:0-0-EZ7H&<PGM# J0;ZG,]D2;PH(/-16H1.B,,U
M[H,$D"44='+#QG$ ;CF*/^MG(-:J)]\1%57NYB<>852T)BS'*3A43_[F)SD3
M;NWDL,4V<IYW%7DWTG,W!"_7L[#\W1$/YHQ4OAPI>=''F]JON#3<7>4NP!M?
M82EA*'RM" I=WKR=+J8BX"#@S._@G]D::!-PM8LUGF5AZM!J,JN5N1P@Z;/=
MR[RRC*9=&YS$+*#C]D&(C;^B9PG2!FH(,E_^1K?!(4"C#&4PH8JR,BA'E\+]
M:G_.R8W=I8'CU!H!W/J.[GR>!7ZL'59J%IHDCPL+\Y'JTZ DK*<PK\]RQC&-
MXJ2-*;V-:_N@6+=H%6#J!WP$I3TA.&?YVE<L5YOK(;3ZIB<]XT_WFTY?&V[8
M&?WU.NE<P6T=C6,71;Q_5R>O??I@)I"]]")U0[# 1_=7 %RC/+OW3.%$YVA%
M?)^2 Q(;0QSY>.?A'H]PMW.C<Z.?78WU@[05[)?2:YFIA3-8W<MOMTQP,I'?
M9#/'5C;"ET2LC**<7OU_C\XZ_'=Y%VAX0BAL?A;\VV0P9A^TELKRV >->&?!
MA:F6K'^DN!3GWB_$/NAMSHG*?="1&D#N-S@Q_[]D7QCC<N/O=^D*[%3\>>[M
M8SM>#E.&\QF YV^9FVL=XM^Y[W.[*UGQU5__]T5X")M/(O^'YI[Q1S?N]*X?
M7G"I.4*DP^<9"12-@XU<Y;XAB$:L/K)!5E3CSH2J\"YXU8:9J662>2,?0\?_
M\EALC#X]Y*XA>.^R@?RGVA9I#Z@15%K78\R/HF!1?!YFWW.;9,,(J31MO#Q7
M+<WC.EJ.U)7S'LT>X"EUE8N\$H!/@Y#?Z66 D#](<%Z4'T4CD3M)H89OD<:]
MQ0?I_!AJS3%D@4DV\:UO/N/Y(_5MYL]3J#KEUM\.]G7QS1WUN=3/*[IJU?)I
M! _T/);<,+$6R42SA $KIM7/UF&6&IO0,'OP)LUX_2 M&<:SND!$BZAJC06H
MPT1_1JLVO\^ZFG%[2/KRCMI1IBD[J!HE\_83I>B&93. ,$-@>I25/#>EI&&0
MSYKET!OBFI_*G6[W>"A8%-9>5KUEW>.%7+3.<:0^9%TOL:@O'?4?ZK8N3^P:
M?VUG^E!*.-OK77:0=VMYN_MNRGJK_W(9^F\,S38#4-+HV@<EP1K$U_CH3(8.
M$*.0B((SU5"P.D3?NF77'B/%IPSH,QL/=9EL,&/J/^RSR+(?;D2<=C.\-2[4
MW1^@7106$L1XYBVZ;=FKD0:G74<#RB)[ NO"S!LL>Z""*1H]7$%AG[X!E+]!
M1AJ.[J2@3S<E>:NM+S2U-] TTECZ5!/5]:'0#0'@C=97"+%,+K>H>CDKY;1O
M "%/66610FFRBN_\_@+5K#GX,#7PJJ%$[,<?3H\T><TTBWG!*15I/7>"TZN/
M-!T5C\T]7U)ID>,J'.IS:A2KV#^:<XL=:YVA6B[.BU5LP/I=:6"/Y^,_X?0#
MT;;E')[#7-Z%+> <9S,]T9WZ',&:;O0S-+_XQ_Q4PN%V.#5*P'&,!6=>1QEI
MYQ;+8[J=V5_TO-_F\U=4 TSBE'0:U$ NYGH:2^&\JR/QM6$0_\LRU#E: J./
MC4%I<%N^PGZ%]CR#)CEHHQL<,J(UW8$^H@%/!K%UIP?+2("E&(BO)(5R9))[
M&GAO?4,BG/(^M8P*S>O77?>8A1H1A'PKNY#!F1Y*%MD7O\TB1ZFHRI05,_%T
M;#+.YLKGUS<,YG 1'YSL*DZ@?G8U&0@5A%24B2&=3;6HRA=-9T;0[6GFSD'Y
MVN,,IKT%/,9X.9PE),Q( <R8BAPRF"=:%Q5,EYH3!A 4-"_+9B2LZ!&?C-V$
M5V,[7>?)3H# C42_?#4LH^1"ZV@UY6GQ:3^ADW/W>LZ?6-W^\3$(4$;'P[P&
M <5]T/I3>LFM(77.!<XG6*-/-P;LS+I.2_[&3K"FBS]I))Q<:2Z6H*=GO4%T
MS1T9WZ[D@]L\6R6V3DWU5OV,(%64# 9[ALCA1L'Q#0Z5^0^\30H7ZF\]\K(4
M3'I,,HJGL+PEQE(OD*V[/"N]+T>,1A5=IBHN^-U=C;QY5R:QX8R>=:S,Y9#6
M'$4+"VOSK:M7*Y>]U.]-V(Z,75GV\MP3: &X0NS(UCZH*V0?Q/N.S!@ ^HYV
M;47@5<%U=C5$2U&,".D6.<C@KX0>:Z26OZ#O>3205UT89CSJ.8+^*DZ2^(L5
M;<F9V@=)<(ZA'K-?HUP6-KX-SH.YKL$''(,[G)XROP\"(8,LZD?4@W!:!%TO
M.CI9=;LW2GZD&R^3:Q,<4N[G5#>\]J:V%I%VC:$R:[JUR--69NX3\,[/02^M
M C\2$.:F_</FO?WDQ%Y QT[[5-PSO(.G^S=9QCMFGD>V]B+):%'JTF85?*)6
MZFIWRTZ$H\D=6NU ,!#1\&#RL6GATNN$C_.;>Z<*S1U,\XMUP"?L+YDJ*=.M
M,5=2==UF?B@@U+VK<HO.ORD80J@0])W8">C.$UP-;?@G:AF%LA[?!_ER!6EU
M_;P (+\/ZG$+68!W"4BMRJ8$B%'W090?*="KD:]\=?B9Z;64EY!]D*!:8W[5
M/P'TN:<G@CNZQ6J)K"R6&X"E9J3#1#ER*!]ZU48(E9P\ITO7R&C<?:2V" <*
M;#^,XGLD9*GD6\WY?)>&(5?.-]0_4^PB)9<PC!G_<E^D&G687KX6$\+DB^[$
MU+%WUSIIAB2#\RG=!)%?D#3KSPOV=#$([YG C;]'UK78QBX?<O4]'4="1ZI7
MI^8Z'H<]YG+L?#EL&C;K7QF62DW!O &XVZ/>0I5:%6T'E^L.EO?I?_*YUN[G
M1/>=2Y^M[!"V;]^/T4^A]%%DS<KD+\%(?TCYL5&&^:>.^I(C6.O2-]0?:N>G
M B^27;2SL@L"0E<KYE#*X]OD$R@[P(T:X/^H<0@%H2M\C#X_'IBKI( (4#"D
MNV>]\W?@/60Z//#5R7E0F2C44)<M2*I:.\ .Y/;O,V<27<]=)R',,)8<\(UV
MFN1@H &$4() +-6OC;.!"\2I7T_ERLHIF"3WLW3^^D,1@2V>'F]G<-49:+^'
M=3WW/8N^^Y[S>7[*@8H395QNCSF<.K YPZFBJYS.F0^!$@2.6>03/\<C=H*J
M/C?(F=K)V</LRM>\>-ZG!AD@;5L7QWIT21%SRE9N./D" K;A]]R/M4&6N RC
M'3C.](L>ESX$8)E7D%T_2'C>H>AC/XOY1G?,:@16BT]'H@6=@+:>_"J&B=>?
ML#G&/3,^:U)00V_0=_&<-PX^297E@"ZWB8'B$__AM\/PVO)$5E"(!_,JL ^B
M+N&H&[Q(*#($7CRP>^T#W:$+9ZHRG2%$O#,G_=[0BX*[>\.E_X:2M1F2XAOC
M^A%.X^!_LF/1@45HABB]/ -J4XH2 C3HO;> '(H+[ A02<2(;TLT0MSX!ZTE
M:YN^-EZ6]"@S0C_ZQZ#&+ZQL)5?R9=U(Z8?&K5"FCV4AZ<$C\8-=+]5-<CUJ
MO^537!_9Y'N=,EFZ#.57.)WT.1CC]-I,-*/R6;&8%KFA0CF7.,1(%BR7S';M
M>#-@NVYQ,?DA(U H><FD^4B^^=1<J\JN"Z8&UMC1, ZC!0RN\7I5&*JE]>^#
M2/I"F^/C=,FII172AA5 B0H*/R1\*-<E,N4XI2/^WK5,9TN^S\(G$G_8?"0T
M$EC"&HQM[DA%10^BZW;7F70TB5P?WK,/^N8\0#2D)61 ]5\A] KUYHI>+_-2
MH@R8USZ,0)46S+4WB7!:K*1;0F+[E6K'Y=VF_*7GHHRB1W?,=+U816S"GR,_
MX#-_-HV=!Y]Y $FE2$/*!%$C_N2,,6V5(D!LB_P7JO+*S<W9L'P&H3/AL F9
MJZ\JTIY34Q^PX8LO*/5[@S"7,:MSZ5MJ8:W5G%:<YP&J,O,8<S+BF3Z5*9K5
M&ET._]8V^"1_JM4ER0@JW?%(K8FMB2,9KN04G?#1%OR*DU\XK'A-L_!:RG?7
M_J[H83OAV,:4/+.&D1%C[$MV8/2_:)I5$" ;OM9?CG)A)^-/?:*K?-P'U8=W
MP^/<->KIS>MN"T'\_E/-W> 4F$B[B:="W*\T4A'VI_5*A'K,&^#:TB;L2%\8
MQ45-RO\2.__,:<N$=?&]'TN[:VK,.]%<,QQ SQ?":=:8;\TDCAY^Q. \*SS/
MN1;0*,'PK;8^I7L7%A].(#H;C2V5E_L-+SMK[8:+T5.R1W^I7C\\=?N9Z@$@
MR2@BNQWR2<E8,Z7W1^-BH6?=B9$+E<F]5MT3W=Y0_92]);#8REB7J2FR-?DD
MR2;%5C]-+_1!Z/L'L=8$3W#D'*:=HN16_OAJ67'%K^&.AJ:D<V]YWAP<58[9
M 1V$3S:S3F8M&,=R\7-2ACHVN ZF>(T;2*$[]:)5X:P(P'RAR".QGL9>)#]A
MN5'-#:\/^63:J54A[0,LNQWL<Y/KKC;WYE_G2=.R'S)F14Q^"N#C8/37COPB
M\=WHBF3^/<VW&"O^3U^D-UC&T\VY=)RRJ2UQ\)XGA%G$A.^#.AWP!Y"5#(-1
MM,?@I K#C<!^$7T"V'!/Z :+;H3A[$FK]O2_"F9A#J-::GI31*OQ7SZ2<^58
MOUI$/J>YVM75]6<$2D^MN #AIYD83%>1ZPTV@.<\F.-5ZQYWB@^(JTD>6+ZK
MZ/&3QN$];I_?2W7%NA?+EZE(Y%$OOE!5!PO<J$+<J#YGEP,YI?2.'F+U+&6W
MM"#ST6V3RHZ1@+)AMS"85+0FRHD.Z\6DD(4YVL"P3T$/7 P:3H6#$2Z3S=]^
M08TK!J..%$E'KS<]]Y2KSO*3I)QKK(O_C__H]WU#,"JYD2N=IJK/$XR]%J<<
MZCO\K$')"GO8(N>R6K;',=)%,R.13!T3V<PAN7MMLER1X?M_'N.XR2%A-I'H
M.CB[<..C!MN9(U134+D,GASA6 HPS+ASM C@$L1*>)?=CR7RIO(7KOZ!I^V#
M1OW?Y X.<8SW:H:,1#D.Q2!;C=T,"BO._'\'5XL<@(A8_7U*6F4?]-REF\
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MN'?N8E,;+2\6RO<&Z4SNB?CU/(R/JUT"-.',@$\-+VW,XQ%N,-ZP8$_6/]^
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M[8M)SCG\E?J7DPZ=3:]K_.4.QE^?-0O:H*6!I'<6)'L&*- !]QRGH,QDA20
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M/AE[)_U.G2L*,5&GJA_,E0U&NX\_[AZA$*)VBO8\QY+-94>;J,\8X2@^$EP
M63K9UD((2UII3E'2)D<,A:WSD"LM*(I9\1_LI_1W-[?X/7DW;Y[G^"C@FO?@
MXO+Z#\K^-ST8N^\V#9N&'Z$C=LR#HV#T1P"C[^B[&%GPVWO(..IK(,$17XL0
M)C@NF>F),;_W*B1WN!L-H'2\,X>=JI>38C0<'QG36K?-(Q6^E9];NK]Q+( :
M\QASXA[HDV+T-RO'I9"IE5%7XN8+NBR90(IJ88<>GA.Y3,X)4A"H!JQ)=<<:
MJ\\DISE7.Q"(TD\WC6-,]G-<5.W+^YRG760U;R[@\_1QWKTA;IS?<Q(<4 Z@
M?JGM*?]6#Z/#&+'U',!4<P7\SB!:$F CIN8S+]4X_FFYDE+.@AR93_IS"'\J
M^8WUC??]TDM%AZ[%=TV?&IA1$VO^5G#1@HR")QAUG:]5BK-_(W*F7;D4]OKG
M$W5YZ+,,O2.&\A;WC^?-( ]?5!T9:NKSQPGU\^:I\-H;]=_+ZW>Y&/BD7Y3/
MR#16C#_:@&J[K5]165V?8CCH#IQ!-+GO1@D .YV7_1C^"IA]@"<UCS+4  NW
ME:J)(L)?;!Q *<*7]I&9[ON<^=&"/1MGRD-N\&^:"Z!%:LCQ[^/C$U3\L"_M
M*TO?:+CG_P&=9@O"/%CYAFW#<GE%!3!!LN!_!"4XR!0'0IIO $H&@*\;:4D?
M92G^\H$[O#0RS#N]G;PL.:8R/[*"LGI>'SHB+7>R*G5;#RG]\S7\%!.*[L>6
M03\B(GJ8/01V]%D@X0^@<[NH$+<@HO#A@U#'4)@C9=\,->1%H9JK8UY8F"S?
MG.W)NI;.XNQY<I>[ATJ+)U=E=65%5<@&SH0%"0@& 7CP7;\WEI/.Q7B%XJ-X
MFO7!2\NAD=5LC6ZZB!>;4I0#CG7Q^N;-0R/VS;WOCE;45];V=0>:E<6+K8[(
MW6)+G2R]/PK3WB<B]F1):O^9;#&/Q[Z-[GM2;K23@>/>*#,>B;SCZDJR+0--
M;8)Z\^1()<ZW9(_ /*WP[CF#"['1U$A=)73OS:73T6ZY94ENB+JBJ)TTT,GL
M PDRR%3@43".6D$*CGH+7I+0C!A>(_ZHWU]#EF*J%E,VEH9":C6\[?#(!X\'
MO-HE70^4S1:<Y'&^*K@2,5:^.7J8>#I<J0%>HK180Q&@=C#2T,+,3@Q[TI>^
MYG$UP@>EI\OY)?411-AA)VKT/%J<\N#]JR,*@U9GXO;V:=OOD>[,R=6QSQJ]
MT.5[3#8"H+6-*P(Y4PA>E#;PFI3BV#JN1BDJ]L8#N!;TR5K?)3OK ?Q1P:+E
M91ADGV;D^,C(WM#>+[U'I18G_0</W#%,^UM7;R4285&4$CDS%=60(M]@E1,A
M@^(K0O)\H8R_]BMT(CLQ3Q)Z%(_1PGQMX#=[94[UUX[M[SS[0'/8M")^F?_E
MH&=4S\,M _B)R>G8ATN'Z^-=_;_@C-MSJZLJXTTZ)+6R+ WDVX9:[40X[' W
M"P_<=1W,G;-Z.^W&_T6&]X-S;M[9$8F5.)V5F@=#;O.CL^@98)0:Q0C%3$8)
MM;U 0]&-\-+E-)H!\ULJ;S"M$<.%<8T*2^+$Y2$]&VTE+.H_XYW17/ZMW7[I
M^BHK714UW?0#3.'NI6'KZX-J-J0G[VI ;JN"V'E08PU,4_1:)@28EURK69"7
MS#, "V*L,O2B?(+K6WNVX6.20EE919_7S\KRBCX%:9G. PH=QW3[W$A]9>WL
M%O>7,DQ?S%#;F*<,&(1'AO23\-*+.J>Q@#E:[//I:!T6)'0B6N=T:F:T/MH.
M/3I1:=YJ.+I&4@IDBM-=>U%[,H"PAIT:&8$".@'$Y1#?=W./9MNL"$/A0X.;
MVT5XQ=8TZIB6%T]8H&:%1?J1W5E1[60MO>9+9G>DM+R;JK2C6HFWY&TEFRFF
MU]>46SJ33,^!$CK_'J""O+YW8;COXV0^D?S&J379*[\S.KDS5ES@28,-_FE&
M[LR9@;+2T)*Z=7VQ["0;NAVHB^8=__B+0R40\V4"G2>'::0!YI@<%J3$CPSJ
M22T@GG!(<A/!/ A"_VS:3D-XD.>J[[RDSD#I(?A JK-Z8D=$&#8@MK_]</!&
M@SP8<98%F?L&"]JI,9;WEX=8-KI^^=Z[;X;.9\YDUZ2T4^49Y;6^-#@2-LFV
MV#ZUPHET;V!!.#9&$3QT/7)7V 9<8.P[$M]D-#\4/S24I!VF@#LH+95MMS_U
M];=6RNBSDMK"->P/>:)X,X&++@#DD:>FV +O]LFHF9)K6NN%*3/!DX.%F;4]
M/P?I<GE7\IU[YN-?Z[M+#P1\'TT?NR+<#)72?&U_U0=JNE,1T*7K):8"WX;@
M8G9/"-ROE<X!%II'Q(,5.*X.-51[_XPCKI>0X^.K#>('!\VW@W%>"5"7M*(?
MT53->%NC4W]PH3V;U:!!I =R7]:N3^T*_'I!38#3X:B@$=ZJ0$);OO#-).7H
MT]<Y6C>GSTHIR,EY>E^ZF9D@ZJ9CIZ+K?6J:=S)-#$<S,'+5_)&XOODW%NW$
M*""X1W$Z$:#U9[Z#+'JS\3+G:I=I %&IT09FU(TZE[>@@A0U[*=K>N+F1P8K
MBS .%\5Z%=I3KBCX79Q1>F5QK(&O&;'3*&ACK!].?@"Z_D'OL>07A>Y,,:2]
M;&%&TI_^%.DR%B0BX?%G;^[WD43I95+P/%_<+4T/7I,3EJ):L*\I?L44.)4*
M#%%<J7! FL:-Q.J33\/8F'L6'C\%D;+!(:G5+UWK[.EWQXT4=DW@UL#/@2(I
MF:6OMC(#UXM'YA[KBV8ER\>P/TGZB1(,R9 YV/3P)^)9^^JX""G7T>+K93&A
M(U38\'"P4):%C*4>3V@<2E_@W,T8G'*1\TW4"S$=]-Q5N= @ X?X)$4WU9I-
MN!UA\AL>2PUF%*8]%!'$.(RI=KQ\YO2C+?+$'Z?#IV_MB]9LVGVQ)C+\RBH"
M. -;K*-=<B*\GUCR \UY&I@@J\-'*INQI6 L>[NSTU4!-HS'.7)=6;4T-DA1
M6*,E]4SO;?\-1>7F^@O^V_-^AH;]!5YP=J2K):&L]P%^)M+7_2OA6PAU$QBF
M[4*VM8TK R>S 1[C0;0H<!&ZQ[4'V-3L5\0=+?/U,U)$_NB;!)GU26*MTK6T
M'TF61.2CB%W*=_ T3DR#%L99%A#?#%4S*:!S]]<J%2#-VQHGF/QLC1,OA&PZ
M*R>A GH.XGJJM&0]R24EDU[O, N9(JD$TYX-=LMEA3FK1H:L]"!?2$M7E?;+
MXDM1Q^U6D]:="JBW>-2DSSHHKFX/Q_.<C#QS:=#47#@HH'D:@\BPO#-W=[;R
MG)9Q8)9!;+[.GW/]CW!GRU>JS6YURN@*_ R+'E0R&+):G\?\@2%?PX[.NX^R
M4P?)YL$*>.#,YF("J,\-R*G/IX0?3$TE?,2$)(4$*ZX$C-Q#"_9+29F;4;C
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M16)(#P+<B+)A3]V#X:52TF76[:XK7,Y)^&"ZOH**3=U;.22N224J1%%UHJ1
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MA.IF(@@ZL]L2KV(PIY.WY(':?U5+E_[6TK\A_SOK_H;@;PC^AN#_+@CBQZ"
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M6)!4/LSA?B,6A)L%(1(8D)]8X'$S"Y* 7R]7S]/8LF=!GL,7F,);UK1$,(1
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M@M%M2_2;U&V0NO 9%%4*76O-/%*_LS;;3'OJTZN73364\8 Z_9*+_=-+PTG
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M_;*,$BM+"Y', LMV@O(MRRAU'G0:KV<<#^N0 6XNR!6X@7%CF-/@UZ307V6
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MHVJ,_Y#!D^A%A;KV:IDU)A^JE1<^^/&6KARX%#SIZ+W(2NS_WN56_KS\V<R
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M1A1^ZYO;,LHO>_\L<-&H=MOXAU\-"37A0>(\1.!)NWIUK]X/,)6D?IV]Z\4
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M[V/NE=ZNXFC'+Y_A]ZU?KC)]J\&7T<5F0:H65@9?/KBBV2)3F ]+VMG^ANI
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M)E%,(!]NC^I'B,0)NTG%4KOQF!&J!I3%%5]0QZV%BAT%-;7<++Z<GHYSU=X
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MAD44JJ2EN=0E\]]5#S6&CDID)(D$3H4'T-HSJBW\1Y('! 3+'%WABR]NPUO
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M?)!V??K;=U3!^.[KI50"G+67NDF'"2)3UN!^A("X?S:01P4WF86.F+)/\I[
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M#"V+,LO\2CH>EI5YH<0QMJ(:K2TD[=Y]#4;"(N^76XX7)TQ=.0;!=O?\#LW
M5?(A7'%O<'<(1QUSE9G<GBS(\VQ#((S915^YES^@PL0GKOE[M ]E9D?K4G(7
MC10&E*LB75C8HH+*"9_,ZGSBQ;Z12PXB'^KJD\XG6"? F><1@"#,VU?B% V
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M]D/#!G; (5KZ;T'WW(6Z 3!(N%-:\2?2V[F[(7A_Q"!"\%"<( VSD,'V1D&
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MG8MY;?OOC4>6M0 _](A9\!N5-CBG/%"45/1OVU MUDE0O?%ZXF 2,JZMM?'
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M:WWM(VTIFXK(H]+\Y*?Z)J_R%#,+T3$A=%E_6*G'X*)FWLC1&";$M%I;E\S
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MTKN_'?++E#BK_!Q4\D2":KHL/ ?W1OP4!8F?->CA1\N?EQ'3N91XMVFG]*9
MVM[)4'7I-U<"%E,H*]K?!E6GRN,A:LO) LUF[/F;X#@L-2YT)/H*$.UP\RZ=
M3<%7F2;":B(\1'L(&0NTH)L^86S@.F8M=CUF>T %L8#<#2M7YQP&G[+\J?:U
M?1>K_4+5ST1_MNP[5OWZE:HH-VG) EZTITNDCJS[8TATOQ$!</_RE*!^?J.-
M=0V'X<6/1([@,@X0APV474K4XZ3R%)\2B9](3J R(S>HWHI-60NE"BT7]SP#
M!37,O*I0:>.B[90K/Y*=3YZJRR,Z3)U.=J/+SN&@_>Z"\"&3,O316,%JY#)/
M7&U+I^JNIBM./!)NZ2*<\3<L#)>Y&V9:24O^XA>T.;RY5E[_RNZC*>TI;W3$
MM>(B>L#L<)]@+^1:*O(74S%&1&/V5T:RW$9;&I%^.J77TV'AXK<0_-IOW?'S
M78I0PFQA5FR]*34@NY/SKK;BCOWP7YA;1;;Z)RVV]5FK[62H=NA7U+4IV%L6
M?DZS5KMUK&>)[]4MIP^=W[PT\-?F?CJ!#NF&B92$COT-&DA(U#-?50XW <_*
M.K^,17,E*&A':IN!$I?!]4T->5&09F !^+)661ZO2?-TY^K9BE=."9VJ<WNJ
MC31$>_M[9O3F)2A8:@OB UW\6)&"[!MT)>'-ZV#!"X@.Y@BB0-FXQR_$5)(,
MR#V43TP7/ :+<C@Y@7:JAP;K@]6G QK0<L2<XS>$]C79!X./]9=6=WK]F&HB
MK/?'J/1?^ MK46^$E-U#*28C%&FB'I?%,-I(S'YK0S _P $T(.=F%=[#6H>?
M.;F:U@,7YU<OUY6V\:G%&1SR9:X,S!,7T/U2;R%EH.\;"I+A@#:TO/8M6)&T
M&<Q[-"Z[,=!2Z=5+6U6#.VZ3=:=O^?CTS_."'?(ZCB I:LF&J;JQ_#/4-T=K
M=UC]6(,$\S)D3K<"C;L!=AX>Q'6ID3^R*J*IB71O.M-9</4UB"D!;;G86PTF
M(JLL/)^:8F3NF>]_-6]]'EH1JG6A. Z9>&*F'?O+3&37 ;Z!S$#_W0%7/ED_
M' X0! \@77^#^V%3?I9(3AM>@WY"'F227Q79"9U(?XMOF^.$[GY,I5P#>AR2
M3M=\ ]89PII$P8<1QAWIJRJ4.%I^G_F1H(=/1Z0-0O<(CRIQ1T__A1D%G46*
MJV#I8:$-M)[<3ZF@BN3=V;WD]D4Q5:2%E29MX3/&[Y*5Q0487=+!G5&O</R]
M=PII\2$&&RQSFIEGRR:N!P(<8=S%7L&@W;KQEJN[F0'*].<4T X16_@;=*12
M0X5B$[-7,0AQV!6D,%""XLK&-\B0KD!Z?%.;U\_Y5DV4)*\UPHU\WYM%_=2^
MN1'\^A&7G&GGVH$@ _WO"C8"E;'T1X$U$2FI/K^.%(K^0M9[>H..Z.!S:%Z(
M)2DB-HF".^G2V,H]8AS[Z\P1?B%9,P"K5@3Y!!%D19I>:"AVW&YWD&HC>1U_
M]&LLISH^9#7!W.3,P]'.=932Y*WND2\,,"]^G_B+>+A'_1JA$_P.7:W=PE(E
MJ=2+<P$_PL=L?/QE\C"^,D."RM#(9]/BO%:!LW'F]N4! M.R0.^]CQX3VW%K
MH>@+H>H.RP>"YJ/0'KWS.K0/.4J53U'DVW WM@8]4RC<P9QTIE31>:J@,_MH
MA.#$3>467+R& GA:\")^QPW7D"!3SP']>76GU=NW'LA)E':/,W#A<H^5]),W
MB4Y#9_C41B:^&7>3)4>2Y3N^,>.^96*3R>I$VA$^-3H4JW/C?8V9!!5+J%8W
MG#BF]BM,SB*DU[WCWL2IVXKHMXC#6,%K"D$\+)4#YK2A0:=_'5]P0Q\;T)7"
MJI:@FHW0G6PDS5N_&C#!QF)7860AXY8ZZBWS@QQ@)61S8#K*;&Q'J(RR4W4/
M>3#KI%^#8E4WI_=A93_-1,AS/&()F>8#C=( NXY>$=N4.ASQ$P]VS:@BZ\&K
M5^3+1JHF<I>IRD1A"83ET-MHJPRJS)P3S&64GD>&7_:6#XA@72\K2_K9%4YX
M2*2TY*%_%O7IUQL3"JX!WB'_*V>T.2)3ZH>DQ-0X%FB'_KB*Z\N[#%(;\Z3X
M"TDB.2XM)D(F-J9A<^XEXMFID59X7X_(Z DN#"E8OU,+ HHB#]A9NB?NDA'M
MRKF%VV>M\9GP/G4E>9@%AJQ*(2ERL'%C*O\ZO>^-&RM:Y,T)6M6:O?R2B/RR
MS^2@\R&^1KI_V>3A??.XY/5M9R)#J6-O6@_^95G3^]SZC:Y%A*](/5J"VF$O
M?DB?>0QW25"+M2(#O"7\'@!="9"6433V/&UXFJ&AB5SA)KD] AMGOA\TYAC&
MED\J2U#*(@,"4!BPB+MFCO4NGJRMZ?4JK5G(-,W\Z3;J_K9$W[AEF\/6MZ4/
MEPZ)Y--A*;X1C\>EIZ KC7C2H*:;^ Z68#1\8PKQ'T30Q(42>#GNO*53W ,[
M2)'(^G3)9/9&.3-N"")7A^Z0PA^A6I03O>W[JF?EOC5H]IGX X%ZT!=D6(#H
M4#>BDPJ08NH*CF> S/4*<9:\T$5\&Q$,PV$X\8-J=+*]7]WO6Q&(H#7B5>4<
MB)21C^P@;AL<=Q17/W7S^+3M"BW&7)63[,0=&QSQ0"[.I!?-CA $#.B0<#G\
M'JT$!-!25)Y^)*IR?&-]^F-R9%KJ5;J22+97I\]P<$N)YP_$2(=R<<K30TIF
MAO?7.Z>,?C_73SAN%I3,>[\9G0> IRE(!FO&#ZMR"3-TH0K<2E\K4A8>)K,H
MU;7)%V;J5X&TUJSL3QIK0:.F:6N")E^[!1_OK+&QOF(PA";;J)4!/KM_,8CK
M:?07GQ+GZU]6KZ<5D]\,-/HCY%1LM:]H@R.'-G,:_68V!KV\83<I0$R%]WYC
M+0FU,VU+Y?)D$95\;VI1)J[B)=CG/Z;;2]B3?,"![\,<:=&."TW\C$A&3=-T
M:_TKH[+(M-Z0A]OPRB* 2TA$@VZR(S2;,/%S^L4G&^PA5[;8;<PW41 LSBSO
M;<>C(#V&$C/.-$*K*Z%*^N"Z\/5M!(# [CS >(Z_5]T9V6H_*J(C18 O]*&+
MTQJ/Y-P'4.R32;/OKZF0+"PES<%M8OF1E9[! _R]E;Z<2#L]C[I>TH'"7[<E
M*/_ NB0E(]\"E_">J,J3V6.L]SCC2ZC%O^ ^-!@BP(D"P^ UWZ+:>$O";\YV
MM5X#=LI6DW^?'(LE(2MGQ5+H.IC:HD(7*?BRPQI3KU$V&9"W3)F%W1+I@-C6
M*Q"+H4)EN(@.<')R39O-\@J-XDFG@DRF4S=X$DM.9#>&;CO55S6Z]S.S>4C_
M!XRCB]1ZA&9Z%1(4 \%AEU #=W^&V])U]FV[0FUS=6S3#5]ULY=^B20C/"DR
MX%O-M+%GF7VMSEFLI60%(I63&<UW/ITUWCLI0:V=3XW-4Q\**8ER#<)HCDRK
MQ#\#:RJ+K*YD9A<FMQ;NJ*7+!*KU[;=CHRUZ\.UM+7C(@,)S1H!DH)M<[/!-
M>+4.:(:+9PV[W<I3@[+^]4+?(SPQ6! $'7L_4VLZ)OU\J-0;4)[>Q2S(,CN>
M_2$G*CSBN+.;$0.O/.E07D I]-+[O6K(0_!NY*?+)/X93X(2*1AQ+=.%)P($
M2UG<+%YAD5^M,7&HY1F4PSU/'0?BLI7N*S!G5+Y?+QR#")X-4"2GT]9J:"[7
MT:Z[JG/+%EN9@]^K?%!B@Q<0!W3K:LE_8PHHP\IN$*\<\[9!Z@5?@KK%Y@=Z
M_LIS'HZ-U1K(<C'5('P7W?&="*=L'_WD_,3Y1P=_ 99)1D9D3#(4W\'H!8QM
M!MN212NX-!1I+]\W>5Z6R6I!JYI?-FHVD&YFKHP-*Z'$D3='\JZRWBB79N=6
M!"@S-X,911G$7NN@,X&^D2:O^[T.(!Y7A_1Y%^YE(:J(/8R-9]5TM;[&N4*Q
M?+3@MPQH!=:(UO%CFU?5#9C(JDVJK'Q92%1E?\_G>EJ=)-1 Z7;@0BKI,$D]
M."KT8,L\G,C9XG\Y-#A*H?+8$K&V*%B,='^6-9S:'(&[B:@W9JV !.EP>9?<
M,5D<0CQ%J5X.R3IR'B-C:FZLO?%ETT[9&0WW]W,/.DPQU?<_ WI?[%L\PM#0
M^8UZL(!8VYBGV4WRY.#6NS"*OV&V@ZTTZC2L,3@W<KV.=;+7I$R7.VO77^J+
MSU9]I7>_[(M:09+>K]_'1EHBCB]-]^Y*8CVG,9#P-0U+R8$-#$&[N!P( M9^
M)'=3E,C;21?[YUER4RJGL!O* ,Y6D!5K;KK<K:RL)AF3P\FULH4'!GB:GDZ>
M/M_+9@A!>PRP1_OVP'KP&@J'M1YHW ZP:RE(+F7?;EC+]TTTMQ9N@'LDJ&7:
MXE()RJ=K);'2M6[($",-Y0U&OJMWY)3)"T_F!=Y\/+7F$5%XO-_%V#/@'8>^
M/& Q/LO-#,XO1@%.@#RL2]H%&;%YSEQTJVQ<WBHDPAC(R,VGJI".\IUBV5U2
MDS<.'STLQ/,5!;F%(^;O"S>GN!>FA6/#Y%_=IG9(4+]KXF6"4^*2()- UC!5
MD 09\,?4EU^G68$TKE6T>6#DHQ*;OQ/L?$]T5]MV'K&Y$7[(UG^6%\2ITQ1K
M6%N9B.JF6"OG")!AJD@9*W@.G18ZC$Z3M<4W$<Z[F1IRH.\MK&]D5/#I'I$F
MWWB\*S'-+Y2N"$T8J,#M@1![8 ]ADYM7N.GZT4]^;K*W]FCJJR#%6GSI_'%9
MR( JVH!C(ZGO%0=_#<LNQX.V]!4NY':*&G .%S>VA!"7)P\%AS[UI\O .Q&!
M2TNH8JT)]%+EIT9OZ]_^+$UGWA-OV5==4)DR-N(%UA26N4]E#D44YEU_XG\-
M/5RM.,%:V:#E#VQJ6$_2A1H?N]OY/!8Y0P0V(=[-(K<C_Y.;?YX9V)K%391V
M'</>F:BM'MB:X(3+*+#4:U2<W(/ZCU\<^B\\EC21'/B>L]<Q&T66_-:<H,#(
M)Y#IFSPCOF=T[N1=5\\Q*)*Q&$,+#+KZ][D';ET''USVV.BI)7?@UP7:#6R:
MT<<26(J%9 19Q&'_:ECZC5)%F>D4HLB->3J0/5<FK#E/M2\T.9+;%4_2?-)1
M0L0Y1&FZ)7AN\()>^Q8?4E!^7F>A?WOYBT,3S:Y2Z6(WN ?[@\!2!V922"<D
MJ'YM=]IG BSS^Q#X>T C%GL>#6G),G!(355EQ$M$=#H2,JDD)VB@)$!C!723
MC_X+9,67AHP&MF8I9]OQ!C.>?&($JS?DGW\7ZKOKB!IH5K?KP(UKY%CX+:(N
MW(R8>&MQ=;WR[T]2(E>H(+=%X&:\D5_'+=/WE@C-1$=!=#*;W_6&E63Z3#\6
MEE/'>GC:>M;TU1\)UWK=DI(99.Y:GI-,=",2G/JJU)V=NQU=X!0]*!_IK(#<
MSUJ.9=.PH$,7M,UH!M'XRR$^'"O\*U""0@%^0@(3&">TTF.6CGN"SDW86/*F
MH7J9D@ Y6JK^(Y5 3TP&YZ#-@F-"*W_&&8]9VIW'FQ]UDEZ-K<HEN/>(3!Y/
MP9K\=<5G'ONIK,P"RJ:S!TM"96*R"OP63Q?4,O.*B_$>]5<%5U6B[FX8'?/T
ML%;;*^!;[RE_GK\3)?J%#(\*-%I@U(#&7?1S:'6X!S:NJ>4;)04KW\2L)ADJ
MR[<\);E";=R-%S7!V)NE9ZM=C3[DI3$PM=R<D7T^%#NP(:/$T]WJ(/2\JNX7
MG4OEO1->A#O1H"4A#JAMXZ'!6#8]1H(*Q*T4:=5 U6&@L65B:P\) ][UVLPW
MC/[7N5C5L_6VH=QPD6,AD> : VRT\BYECKA !:-^@U>L_:DY(_0.X*/PZ"#
M;D"#CD&VL-1^OO;Q?BUD\ 'D-QI& PT:Y$9 5G3$U]P,V]J5S+3[4C"F"8F?
M3)KN>(YW\3=+SKQ/8^8\:4L/#P2G&2G)X1R<*M.37 XT-N%_Q*"A'6CQG4!
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MTPR!<C]R59[P9XT-5/_X^>#,K%3SLLV;&V"TCJ,Y]MF;_K.S]<)?S_@[;UI
M+':<O'GVKZOCU5X'O]YPG_OU*HKER1E\-U(W"/JY)BTH/6Q%17Z[+49*(D2)
MZ]_W:X)"%]!#8+N6 &>W)=4$X84,CN39%GQ,9ZM^RI(MQ/WY]!4CKW[_N[\N
M3<#B]Y9_'D4%PLRG>K3E&\$=RMY4P#?"(HUV!Q*4CJ'?@;Y:R('O'2TO!=B\
MGONVM4O<+/BNQK>^23:!=,V6=)B3)+'VF/VI97NR^;L7TV\>LL]E<L^F8O>R
M<#TPBP=7#FP_PW9D\ _X!^##J2\G>_316ZJN3+-JC]<Z'HEP#G\TW>I_B[J?
M66+PDM%Q /_XG.2O?S]<J-!C/L_U;1UYA[M60PV(JH^JX#F_:_L5KR?)^],S
M+CX^>D-966T;SJYK9.2?J@U4:MN!U(?8K(PO_PWXN(?$YMB%_@&Y*"2GD;80
MM\]JXQ,%?K=EH<!"I\YH5U5["7Z68<!.ICYN&L\PR]0\:7THZ-7+=P^[$_XH
MWELWI+/^(>,P9G?89\@P28O4?HBXB[!+"6!D/%;B#(K%N7QH>S:2H6]L!%8_
ME:'$Q$H.B8$V!N-/L1>S?1C-Q49M(W5-& &;$.Q,_996,?7K8>U2\;O+"15-
M#BF['@HE+@JM77*RS$&XD&'P7>2>*#TGTP"NO0-Z)4F HJA"\8EHSJZI51P
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MJ8W'[PP+-C&\3="J:$@_L1])GV:00\!R)K%U-UD^F*WR3GDG^_,D%9";(IR
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M>& B:KYO? "7ZCA(/O&=3 C(S??PI'VLI/K&T-N%,&\<I*G>% ]<DQ#G_-I
M]0^ALY98M? .L<'@-4^''1M;?B6*97E'2TN.=0)N?3GPI:]1AB7UO/OG0LBG
MQ54L_I8_%M6SU5>>LU9#5/2'/__5B>C>6\%'8F7L.V0<NG*%)Q7%N<R&O\-2
M$AU3,6,FT#);Y3P7W0)_A<(&%5:M'>IBP>5#H\ZS-]9DAP1C_IW.7(EC].$/
M!I0AJDA2XPX9<W;X_D7; [E-81DQV.@CSN1K1KM3\JWC1Z^+K5'0$BF?)Y]8
MQAVIGDAP7@M+ETL[\X'AN+W@D/,S;?FS-Z,2DMU3+^2;#==\HW$R4E1LG2;3
MR1^M"6Y&P85>/^C0 <<,9H,XQU8TYQ5?PO908A-M+Q2?"UDQ+X'P;1C"3FC<
MZU_Q,*/WJK4>A\3_KGU\AN7L>&R]X>Q0%QJ\CN(1?5J07%$8D!;"IH/!Q4:T
MZ$3G1330LE&.0!U$5J&; =IZIE.<0(,GQB_ 'RGP)>A6@]&?"WFJ===IA R6
MI.28V8&"W&*,>/$/FB@#YUD#WOC!NM:8$J^0C:31O-3=:HM\.$.>)U/.,>,G
M(QG/#8$J]"R1>P0:?T>L5!)=ZRZ(:T.*ER_/**0H>KI;%[6^],#_W3UOH!2"
MKA'TI/\\V[UGP7* =QKM$$/C\2MM<T(W1!Z;E&3+.D,5J9<7KU-W"RHG5J]I
MJG^^ %IO3"S.N!I&V%0F57WVR1NGPI3R..K@A2GC[<_>ND\Z[L@^9ENXA5)J
M;H'*.1*8GHY_]< U8.6[/R:?&/2)PDB%+SY%WZ5S/$R-@6E-MBMY02!^F:W7
M#I=&,G*%L&H43XVPMV%P'X1EK9HJ09MZ7?*X\O?)ZLPD!52DD6TWR86F="R/
MDC/CTJ^CG:Z!6\[J2%P=SCL2)RAJX#?^>K8.V":BUL,AG'_Y:13OE$2X.$\3
MS&VERY.]V*7NT\;^7?&FZM-P*9,C)9@UXQ^9MJ1QF]LC*)P$-K,S]T:':7G^
ML)+NFINU@OGAO]L7ASAT:(2Y0 ,X+_G/&T^$(L\.ZDM*\"ZQQTI8#>*6[/W#
M9;4B-BPG=_OAR'1'H?O8L/;'#P'S,YC@P%T6YP_<WC T>#74A(!,!O&HQ/<5
MPY[R_%/Y:69<VUWFB<U>S);0A+0;?<[7;0_I3P\V';P"A-C1)1T/OV3:=3Z^
M=>\F:<^CJ >1&9K?J_LFZUV-ZH9L<\+AW2L\^;YQ>$MBRI=8P98LD,]S$,7V
M9@0;S20DCM/CY=9-W\!C6(CM>%THT#31*.[J3[UBUR]T*-5QP+%W\E.,AZ,S
MXKN+>F5U*+E#L(4>%%@.-*T'&,6F,@.%Z3^I@MV#>+<27^.KK_7<,$[E#.)?
M4(+%ZP>/TME699CTNF?_M+Q,"O5YL[?#Y 'A5^'J5*#IM*F\@ 9L0EY!Q(S!
M0'2*B7:)X!-\V\@[ 8+"#O>U*L2NM#<)UH'3HZ$XKLJ%_@#EG@">>N1QTURE
MQR1<,"9.ZM2A."'LZ@)TT(@J>0<.VI:/.'&.LHWN\4)*H9^<IZENP)90HIG-
M%O*!YQ*HIC5$K'9[G"?W0O7 /]2P IM (PZ!&-E(.S-@^%X!KAG%-*%+,#O-
M'_=]5#?3IP;62!JU7+Z\YS#)-DGG2'%"Z-1'/;N;,?;%5C8V_<Z^S9F."?<^
MZG\K.FW2N%B4-YA16]T@8C;P=_S7('!7Y/TT* PZ:CB$2MPCA/DBX^B5/DWP
M.$_-J/-0Y3CNONE6,KN@9!RIY$<P8(^VMD>1<3[Y4%"K'NU'B$"E=W8O.6>^
M;6QL&B<! 6?>/C,/42*UMQ!?>V?P=B9RD/SG! 51=B(NRJ.!JI:<@U!8R8<(
MTQA1:CJ40*HJWQ4:P!K$ CNAXRVB%'7_/<XX-7/LR4_+8E5;$G;"K.@=Z#Y\
M*E"^#0ZB%B -3AI7CZ<&17%5!'W )G\ 4_ZEG44:^,RI![]CW_N;6#-(;O:/
MQCS<[$'\2J^9=\CE(@_7$:R>[R+:MY8&Q)'V#_&0Y9B0Q;$#]#Z!E$BW]W]5
M"P6\-K*-6E!?5#AZ$(E%I,'1H*#DWU!L&[)J*$YE '\ [*1[U$1$FNN/ZN*D
MH1<_[6M\O[J-NCG3IM9R:J^E%(Y"!8-M$7'S1TMN=.WT'@BE',S>KO_I8.#V
MD&?7=B%FM5!;[=[K:2E'&&CT=5:$-7HDMD^\>6"B;J*F&[POX<&/GD(MB6.M
MI]=Q@A*+Y5Y^L+7'/NP[_RB[K.!;E@U>NWX*7++\ >=)C;-P[XA)<- C9<2-
M)83-#K^LJ05C63[O;%!MF6HO:7+ES(K(<JSQ2E,\&7<KT[#!I]"OIB1X_,#@
M_/!\J7]CGW9+[>%]]YQ'*>D+-+%QRQ9Z(K+:J 6>)#C!#B@IXYU[ W44SQ@V
M'LB9'I\S5AQ39I?2P0=?H"#=BNXEXK96+V__?Z?J(LS\"T]A=T3_'6,%GT=
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M$,W9XS!\"?=&=*XM;S)$Z >F%SZV5Z?PH-R5"XM"6&$..G&>L%YDSN=^-65
M+R71AT6\4TKS;Q':LBUY^ET\1='ZSHSR'P/L_54H0=@ EVT.GRE8+TA:60<P
MC40364+Q/5:=.14B.Y(A3.>@EWYVL".[W@&_$5W1[Z5,(1S,Y=]Z!_0T,E \
M-19:('JWA**I/(C\R4H9=>@0Y(01$&\AR=]+#OX;(3LMM,H OU&\%ZU=@+?C
MO@P#^KH0K2O(OX2PWT@N][<RYD,BM]0G.L*">Q<)9L4#:^J",EYIA+-H"0G(
M8!1B+6P":IQD('\CM7[@MP)&4V3L!'67D#_H-]0%TH$((4ST]@ ]+>4///_
M\P\\_\#S#SS_P/,///_ \P\\_\#S#SS_P/,///_ \P\\_\#S#SS_P/,///_
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MEJH\/?^3*(4PAU\MD1],_'_4$MG2MGIA3)&?*H3Y$7?YNCHEF*AP=0G=C8?
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M@'<_US3.[$W;>R^O9-WABX__^7CJF^S>>Y*BG_V/2O^CBM9('UZ/Y7^MW6Y
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MCC:.ZM<.N(ZX)+7;'Z==6)WME;-[9W#1_W"5\/^N04:R@+EC7$.\%%LRAG>
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ML)SV%W'">\_^^H_]A[(&IX6P4 '\_?D-_2)G<2FT7&".$_&E+^N=A;"^X,_
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M6QZ)*<;X<[)-K3Y\03KIBP);+H<Y:*K/^QNZ"(\32&)RI" O+V8QV8P]XC&
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M93;Z//(9T[D&=:J^NPR^40R0Z S]FM8AH>AQ/44GQR6N9-G$M>U"C%3:V6-
M_ZOB@4]^;P8?Y'H&OGC_UJ)@ORU&=9Q\J_Y^F&<R)V'E>O9$Q-CDJ!,1# #F
MW [$Y%YFHFB:' MV>ZNVYME4^P;(Z'GHBGML:T7'-O-O?=%S\W'I-SJ^_W6]
MMBZ[[&G!:F=!1$GH^G.4[4#3<9[8."*: EX$ABV9M2THB6F")'OR+N"'% _U
M:1V3'[SL''Q"TKT/H?.<7%%W(6Q_9.F&?]Q'.@Q($R("1D,95/6<%<)>$%^W
M-^,@E7)J"FV<X5D(H@1;%;BHKSQ?<*@-L84H'LH42%E)WC'='_IHLL6P1H4:
M-)T^)EW=WQ5+OM7G[BL_-"1BMC[_!VMO'M3$]K4+QQ$!-3(K"#G*$52&J( H
M0N($J @1$9 Q1Q$98LA10:+$M,H\YB@*1Q"B,HD,$1FB3!'"<!01&2-!R,!1
MQDA');8D:6[[>[^JK^K6O>]WJ[Y;1>>/KK"SA[6>]3R[UUY-/#V##ZUOS!JX
MGSNVB");&+OU<82?"<//R3B^60@BT>38F?I'R3HKAIXLX&H+7E\1'8PUS]*W
MS-/.N/3EC]5OCXHWM?M(?!L/<%_6F>K=/R/]J-*VMT-OP]]_YMO&7:1>@^Q<
MUGB@"6N2'TP%[8@J/3M^4N<L7)U81A@^B]M3MSTSXD3F);>[A;DEV\DVI#+;
MI]'-.24%>&N.\,723QQA!;-F\W"C^U@=&W2\4)CG<L!PAH:%J!:_YZE@ET>;
MF-Y7L="LSSC">B_@'Y*Y*U\VXX$63^ <8RE]B&F(#Q[&;:/B1?B;S3;4Z';<
MNGZ:LY"RK OD(I2A<R^K&#S"YCR3DW^TN?KYV56'+5WEQ+1IK.NMZ2W7U%'\
M1+QH!'@3 "-^_Z$;Q"RB/-G<%.6OZNE?'^,5.C&PZH"AYRLP9%;Q:L?RE9B:
M'TD[]CMT!O$?Q]-<NAJWO3JS)9;KW0&1\M[D!_EA'Z6W_U&2*&J\Y4X-\3IQ
M=]N@+/ULV,%"XP"GG"?\$NW?!9:&9B:3+EZ9X>]+:A=11DJW:GCM1F6L(D0\
ME[2(TOBU#XC#*@S[[?7 'F$)MPGC#KF7SMCE* *']+GMWO6G>-?6)NMD?O#G
M'S5-.=,0]YIZYRCES!,R86>0MV*]\CE""YD8'>!LCZH"!26*>_1I>$2NCLON
M@&G-EM#E<58"B^7RJ''G%-^R)L>I.$IBY9J_QFO"D5=NXQ<J.OHH:Y2R[LB6
MZOLJ B)XZ; [!MIVX&Y'@J>2V:Q+_NOI'$:Z2_JWJ.K%GP3Z+A(/"'')_G_*
MIVK@[."WV5NB@(Q?A1O3+Z%3%U&JOYW1SNDH 3O6S^?1#2W_:8[XE.*PDI@T
MIJYQ^%R:#3-.\L]!B\/>K7LSKG+]546?PY+>/AF_9#?X]:T1V?'3P(X>B]??
M'MB8K_5S%Y\Y63AMSMI]3U6\T]4C:W/"KC]+W79R.RX43ZB=.O>):JNSY4VV
M^?F[09]_!I.:2YNLO11_*U,X?S!2\.PET,@3JG$[O *Z+%Q$#<M%,S1GB#'.
M29*PG$5->)>1)Q^=BU\MK,PM_=A<9IE;0/*M>QV4LFHV\F7^T4-=2SG<\'_&
M:83/A]O^+N2__MR>^>F-QJM(31/>*J%=@IIPQV_ H?YI53GB\"LBF^S&#A31
MSB-3PE0X,3UN9]+TR_%+(T^?6?'AUO.B>Q.Q-;E;C3W^+F2(TULVN;S6@*EE
MWYOUNZM^#F&3+T9M<3WWP7^ZDG#GH'7!AH$,]V-[_$<,ML_X?I=NX P]^ZY%
MJQ'=^N$Y8?*CQ-3677G/=OTB:J1TV[[YQLKL.S^?IVQEE5G_VM?'<9#?CUE$
MO5Z VSFR2/SR1=2\?6^9\CA)4<T1YB^BOM(Y511E'KH%KR18AR^B//3AO0NN
MP#_R!/PL 5FV@<]77\QE,"'B9VUW1V#7@TW_B_J<_^^E,P[4V+81#&F_0X92
M;S&%BXW+0?R.E81;"3HUB8DJ"GVPKB2X@)HJ=FLJ&CYZ\8S(P?C4P*:7M=5-
M@R;NJT_65OS;>;?V>6-]*#D8]9VI">5RZ:O?VP Z$+=-WS3>WD(D5T_W)DJQ
MR5%^:]3WO__>L.<M^UH6JSP\6[?^2NX9DF9-MEXV>X=?RWJL><K#' 6L?/#K
MM0V_JM%ZBIC\!K%S"S/U3VJBD#T;^B\M&)JZ7#P6QE$+JJT"LRK&*9K3L+94
MYTTJ0XL:TQJ(Z:W\,M]$[W%SM?3\.M$;87,=1XJ9XC XPT0Q(PD0B@%^?P=>
M!?F!<DR=Y]QLM8B9@-M#QK<(P",]RWVA,N%YEG3MG(O9U65063O=(M6-(RUF
M%;N:U_G6I?7/X#7'[[R;.0'"V>#,T3O\SQ/R'(@L-Z&_742MPBWKEN^@64,;
MP'Z$J59_$B1$453"F:K63+6I,F$WP,W_K;^HC^980BUP>9%P49PI=K6+225J
M!E*3YUT64>N<+_X9E5O&R_?Z$_UY00ZOS8 HTB#9(DIY#Q],^3 C=&)+2;+K
MT(RTARM89K.(XE=W/H-8"$@FV% TP\=^ZXWL)M/73+*O:?:(3].,BV=TKR64
M7!0?C20UE-9:[-5SK.XW?3XX3YP<D34JR^AKZ6WXZNQV C]U?*P1QD!!8#:7
M53ESR==Y34=5^=A'_Y9B*M#:K/\L)^;T/%8+8@4V]3?B14J'2K+XY:"-P9G+
METFAU:.'% ,(?)#M5P@I\0+P)!/:W85TB4M8"?F)YF[:V\H#H:%^[I@ZZ)SX
MG:4&>1]$8#..([N\4G $A!/#@HK">@U37UI8;/;:KK[4B=2+K(QD&$N4+54^
MB)1XWL=I(1;.9K_RPZ15GLO:=TC8_YAVX'[08%IP$/R/[5_E_0;%?E'-L6ZT
MU'BV]9(.ZB%8S6<1I6) ?[^(6GM&6<4)(4 FV%E!$;U+O_G^Q7%\(K 29Z(X
MP.N1V$@/B:I+9!FWQ6O6=8KG5ONF'PKL]<'6F$6#@7F[7]SA=XM&#0+K&OI+
M!O&!P!\4:)M> B!\BM@E V=%?W?M^B*JE9618WEOO"?!" MYCE]]F-V&7\X)
M=;7B1AN[]C;N_^H[<KWA<(#OG,N0-3E\PJ7_75&15?N3,-_SK*"RR05@>G<R
MN6!XLMZQ)/%Q5>S^VK[O<O+:-3L.UU^PL]?]J[W8L:0<\\)O_6S6\IIU\.1^
M8PW%WZQ/A^!5Y;''$8P0 2TM? PW_@BL5M+.C+?++R$7_DN-&!'/CRZB,H*E
M.VZ9_7EA\] 67HAT.CQ5XVC;4/?&)X?W.RWY229?1>3>(JJ?(T2H\CK.V454
M"G.)O3-R=T7/H U&/ZR>Q95XB+"I-IP1=CN175PPWN3A#A([T6B:'_O]G,*Q
MG&HF]YIQE$8PI09.TA'J=GSB^X^3J=>"<P+LYA9LE(^!T![^A"N$EV\'6JR;
M5T+/N9Y(GXL4T<I\W$9.)R=MQ\]K@D3..5;B0DA\#78UC:JL: P'Z6+7\_+V
M&=8D<:D]_L^ABG%.LM[.CWYZ_0H\0+GXPU0R+P^F!LFP$.4AE.@$6M'^4!;#
M.V<0-UFYB K&WJA?4I?:L8@RH%O,%+SM4]A2KIWZ&$I$-]IR8,V>%+IUO=DC
MR+AER':A_5OM]YR >XNH3XBUHM.&?E5S3_;EM6S%K5,@ OU6%M 2B \/6-LC
MRU?617!"1M KIG90/?:?@KE@15;9.#&%;@8FQM%U%"K05>UDD">["E%V/^?7
M%14/=[,^ALIR.E.^1,SO0 \S/GR3N4!'Y>O@GD"4\@%._4/X.NC0*YGWKK&9
MG/G9'%8J+6I\3?AT@%\'H&%/+N^62T(Z FVE.H.+J"3[0T]V9)@V-U'-'];T
M2R06ORU$-%LHDX (9AS #N$*]*ALT>?4<4%B\V[(>[R;*,)WXF\NHO1H>$P<
M;*G0@$I%WQ-<@UIP]N!W/7[>W6AU;>GHE&_'[=+I:R;L/\0Q!I]S#$;\"#7_
M5Y),EH$,6*W@/Z_PN8\7/O!NW@IM$9%5VA91-1P).TS$K0C%5]MRFXR)6==U
MAV:X%Z'G_>T8;7L_TN-I?2#>WCA,=#^[[4=7<6<%E$'6-7GI:M+C1DH_WSFS
MB()^[Y%PQ41HJV!V ^@A>R6-OE&#3PC\#7HR9N<WA["#TQQ>S7536 .=9&0*
M!C?XAE_+J\B;1;0_^_UFSCV3F[3DRG,WC0ZGGR/C1]C"[)9NM"P 6>@;"DIO
MLP[-OA]G1>V764/R H@M;L^.K5$'DF#C/FOLS6;+_DBRZ6EI^15U\3XEUN49
M^U9?I]N+@<!W_%4%&5M/_=;YB@.2OB?K*33T9 >RO$^/I\)Z_G>._+M]LVDG
M-NGME[=4M:>J9ZDHS=!E[4 H!C+/5FB'>"B10$_"?N# JB.(-TZ#SI+K1?1_
M_E18UD'WQLDAXX%Y(/\;80@VIA[L:3L:;&VTJ;XO\GZ;7>PTW[%1/U@R+\Y;
M*XN9K( <Y8FPZI3\5Q:O3[,=[8S4.1Z@H"%3E5A.T%S<0C2WVSD G&@CHA51
M(*=M1'*Y\QDUD9ME!\3^^[[&(>CDB]K:IO<4Q:&RUT]=-IYHL4Q=4WHE9L!=
MT?XK+1B9/^S(FW%QB4('.\Z>W8)T]8.4*2D99_*S99^E$QFU<ZG-OT.W1918
M_#+[+>!(*\]N6H$#W=+%/3J-V'&\OC-%;.$F1KR,[U5RQBBVH%LT'$ Q.*'!
M7T0Y"4 $R2"+W??D8;0(B"'7A?N8U<P,SEG,2+_(Y#8VB>8*JHC7EA@U%%.K
MN5Z/WPJHJ2)>*KXZTGOH474"W.GQHO]37ZM_J/=0_8_$*$ K5#IMR_]3Y4O
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MEHC1)E"W_T$JA+*=Y)Y%_\28C1YR&8B4C^R3X&#JIZC46;O_W_F<"L3H;Z4
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MR,GLJO3<;]ZO!%J%RF38V#:!=A6<Z$34*$:APY2U@PNT\Y!4" PK[7<N!];
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MY$;;TH_A5D0HYVB-BU_N=;\3,>EUJ0IN;Z ^R$ZXMWU]<(H8^T1X,7+G,"[
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M(3(*%! BWT#[#?HD7T7SA%Q%Y.W]HA^M<WRY^""U>60\Y!:\T<_W4-'D\^E
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MFYF^/%:4A5=H0<9>BJ&QXPDTC94 "(L642N;\?1>S+,0B2-H+ N4KDP5$3,
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M[>>'#JY]9GS$'(%Y+$5J7VT#REWPD,B(7@K-@**?H"U%LVXF3T?(:[F3EGB
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MRC,JN*AG9.7.)MN>^>^;517LGV]C&A_:ZO]#;/5_$<J31U/U]P>Z4;NW5C!
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MX<GJ0*>K%A-2X[XJOF;=]C^H]S)2O&<+Z=\+U1.=E3_9.<CH_Q;R=L$,)JG
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M-WCS+!/T*P?;N-1S>#ZJ#D++6Z>RL-5@>U#TLP3[G\G"^'FT$JD*]L$_T&=
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MP"AA!H![!<V=W-2-GI4F;E85YOMH3KT,]G0A^,5D'4_P4JWU(Z1G&;>65*K
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MCO]\NY( 7*4X*>DNT5^C,80]LL^U[H3F<)%3?.(ER_X5TX@N0IK7Q8&Y3D1
M[V5"KD2'1RZ4\D@I 9&@V+'\@#C/SR,_4),-<Y#+Y4?(@4^3<W31_8I"*E91
M27(K1S33USWKRXD9,.&OL0]CMLPV#EA&.P\4'FC0',C5/3F>U"+ CP");C\S
MM:FE6[4$6#I/U8>$V[S^;.")T9W<#-)09H*X;A2N4;_=V[.#[G'9BX09Q]G/
M7HW34=]>BL4T!G=9LZ;S-P@(J2]&11VJS8]P,!EO%UAG*#<V96YDY:0S,JM6
MA4?B*Y\58X+SO_VPWSVK_^B\?'#1:K":]8 <V*>54IA@R'U=XN.%L]\O=UY(
MT3K[7<-/0<!-- PM7VOC_V4Y_L<Z(B]FX&U;G32^70C-=><MX^( HL5')->M
M.;XR?%JFKG.\4,Y*5$Q+G$,>R4@7-FV7^A30W3MN^?,4] EB?D5[I#FUFW$5
M([K\KN^()U+4(L.J*\2,C4!N@W6?[%.JCHUFYWDY/;ACU[MTNSJN6__DT^72
MC1J+]VK&^U)TUHC#9]NS;_)0@JWH>33V@^OA&F3,D[80]X)U<9G6*6%Y^ZZQ
MQS#3QO&JO26P-U6SH3TUS!WEXLXV7[.T:*?+1F[V?S2U?2QAE 'I.5!&Y%-A
M]'PFZ"_,S!)1(2; C\QRJ4*',\L02_;81@\*-B[HL<1!F#.E0%'/5^36F.2D
MK\>G3/.Q[ME[\JX9&5=&O'Q]5*9WI(P%=6M#N&I<B9\_+'_6&+9UR-B^(9I=
M<_/O!R:*;T3#\Y_6^R="(1?[[K.+J5<_Q"3:\8/5AY6RRW'WFH[&$Q-5?:.)
M\77$4WT"L7WCPXI[^8F%&5:E44FBR4GW?&U)M9Q<4976;27CK\O-"]"IY;N>
MQ(V1Z&:?:/687MJZ2L<#?K68VC8VG4SV+S-(\*5JG.V@W/:\Z>.8_!>WNRG6
MLESIA#5W=0TW?\!1FU\POOD=H=8V#M(,(QO !!"R#D#8@5'XZ2DM\R*$6P^6
M.[#U*A;LL-:DZ#!4XI6%B=Q#<:W9"-]3&@!-*-1K?/>]#[UW)W-3:G%9X_FQ
MRR-R<'E$*IX__> HX]<2I.]YQ*WX13X@JF@&,8#+E:<D_8B6[VFBG>>W!\?5
M'X0U8,>G+2>#('*KP9?*;UP;Y#=Y4+-PW>_8FX4B6/:+8^5NRS?>"3[X@,N7
M/6T5XUH "?VCC%/Q:$!V79"'1.OEKVCI%#/+=;@$],R#/81EU!5-FH9.57 G
MXN7D!T3J@:6 J?*#O8 LN\E[VM*249)1/::51G#KH#57RRCV(=-L[\6'='%,
MA.T@+-;YG+\U3U(M LE'@1TQ!O>T\= C,JUSI85B"/'SEZ-Z\,VYE<')'99Y
M.DW3&<(9'$95,EKI91.XYO&8W9R#^XP>\1/THK903'TVK+[I2;@ /H(\;3IF
M;SR>O[2:.2W,XV,SJSN50WQ$X<O-%,LH"5*)_EH0O797*V7JXX.Q6!)MD\Z:
M:MPP,]/4UX!$GCU"C?3]%=YL-LSP_91-+_(L!=?)!)WX7B?:DAA7,'=W]EXF
M__2TIE-#_)^^X8:$GRI""H49A" 3,=$_:I$N@I]*$DLNE_/;#M_T[A-R3_S*
MESPYP'9L4Y2L6!'?S6_E6BQC<*STFE'NZUR@)U1C)39;-I<B%LX$\1&*'%2R
MQOH4SG5-$^6([V_B1)+*GU6PXC$!P4\,7(^+MXM4R6,'L'-V">ERH(].@;<N
M#D<P8PO_@Z#-T?4@^FB?UG9V,XHGK9VKCZ .C2;7/[Q7)Y/WTL79.,=]4L85
M.U5Q7#O9Q9#8WIK891TM+3] L;5/\S;/*J6?0WZ$U555L]1OMYV"Z8',BE#?
MD$W0K,.'Y5P9)U"?$L6\23H309>@\O=?3PD83?,/.^0\7!3QJJQ/4L-ER>U'
MK5!S.G-)WH*0GPR@FC@'AM L@732>VDS7UDC2C&ZS8E8J602:/"EMF:Z86[3
M='C1EO13(N?.N\3A6".Y7EUX&@?>W3.GNZXMM?\U6TJ(N!?(/.K(5\\[?$@K
M$,'FZ=,>242;0Y_@O0/)#X"GU ?4)$/\@[_@AH< )URM9Z5YMGFPTS+)N\$?
M:+$-,HT\9Z(7#>:*SM<['21C,I&=_W%/6PQAB2:(7R*V:Q&1\DR0(V(@H2;$
MVBZ9A2I8@:!5#L[XBS%E:R\8CH%6)P;5!LE,I5$TDM7$XKJMHC252WL3SZG<
M>A,ONT.BWOF?S'[]_ZI2#:?G8K_@D4>9H!DOP(8)*IV*<+[NC#VXAOK806-G
M:<PXF64WEI7'WVNE,O3M8/2DAUOTFV\0HJS/7FCB9H(^1Z@S09./+C"^W'T3
MSQIE9C]S.:(8%!KL[](R@8,^,D/GB12KI=\RBD\TCP=Q!LCH2->V1@Y=ZO8_
M>>?YJ;>BB1=<FMY]Z(KX4/TUG37=O$*>N6*P1%Z OUT9DJM$ P9RVVH&@[>9
MH!Z=$$?\S@2D$&7Q#[>-N>?F?HXSB)"]'29HX (3E%O-&$))T:7KM&(42CN-
MKQ)"'?76;\0Z"TT,!V@5KWEGOS6[ES)0"*EX[):;3F^@9]8Z9MU^R8A[?/2A
M.'2X!/$:<$"7DXUP5OC)Y"1QP0_-"0>&DVB>-J74X3SIB/TWA4Z2T6^K]S(W
MJS>\,*5P\F;U"=3H'G(  ]R:88)V;NC3KOIT078?LTZ!P:N*HGV:_IHYL\D$
MK43"?JS"@"SM$3\F2.L<$X0U9(*ZI[<S]P<Z,+OW'KR'+=<2_:#[(5^8H**1
M70C]3XH? SU\E24=F*,_4>/5T+XIU@7"_D\V.,IX2Y:FBXA"S7Y6(%X-,')#
M8*LU3)"YE@,3E+^3S"+MV<& [ZX/4/:P:W[_>.A?291FR3%TB,W&.R8HBHLE
MK,HJ/]VI8:B?!#!]WXPAA:Z;8X)&3J"VQE 4951%VTDF2*^/<YSA(RZUS005
MYYKMWX--F/$S0=]H)"S%C@S+I&MNTQ[[[;_Z%X=61N$:VU@]UY\\4$ 1;G@R
M04-<2+O'N4L,Q TF")G*_"_LO7E0$U_7+AH'1$"(,@HH41%!F50F12 _!T1%
M0$%!0(B(""$"(B!!8EJ9D2$J"@I"1$1$ALB," D0(#]%0.:9D* R2Z(06Y)T
M3O.>4[?NN>];][Y?W>^K4^>4?W2JNJOHM?=:SUKK><+.WHCXG#D>[(1&%'^1
M++!!S>JO!CI+&A=%B'1&?"UM>C(%RD NR373EM$'%@2.!.17$<*VEH9RA5Z)
M$/_\;M0_.1>3BO&N@D&U481@OA0AV#Y\<YJ $PL)-44(.:M_%3KZG\#]"=R?
MP/T)W)_ _0G<G\#]UP7N.^R:M0S.]ZHWTS7&3_D!Q#:7U-PW8\/896)F[DSE
M<DP>$!:ZAQZ S1LXRMYD-/^U*;%D>*B9_^&EU[$O]W@2P'@<66%M\C9P85QB
MA_BO /THP=$-B52*+,;V]>U4)]3\3<HG_4&+L55\>V+[E:,;U2>\Z3?6)ZT2
MAV23T/>/?$$%8H8K@"-X ]:O&'<M+^<^]-:&Q_O3G[I[Q#8T;G;7[.#N*Y*L
M/N_6[E^YBZQM_\O^;*A+58$=.#QM,H%*'EOM+=!_])6HV<7>XPS9)'QZT_OI
M@%+47GMZ#]TS5=%PFHZ\6]2A;!ET\)1O6\7'7T"[DN"@$KM#J&072P9/X^')
M/_01(6)W")Q%B!?3')C]2I!D@1\V@%6YTQR9JSL&L_//*V>BQ\Y-BA 99C2+
M.<@+!A-SV1+H='X$QUF#CA',K?QV^'?COWH1BO,%DX!>=+-0 UC[V';02<H4
M[QZ:[5JK(4)DJZ%%".1@APAA'$:\/0 T+0AWT*8*/P)<618%NKFR&Z2 != ?
M$'5$B,Y@,$R$B&+$HW_O(H$W])O)RWID))KSA OC:V?_8K@EZE^.%LT.A1Y@
M%AV]T&#\]7X1XM _IG"=QOJ;I@A,U1#,1(A&SR:R(,7JGQR#6S9_00)3%R2
M*2O2RAGO03#RLS#DFR@N#-D3E&7M_63!L6J<")&Y\A0X@/E_SC4'VI+ ]882
M\N@=@EUF,#8_& G5.JT$UJ%1M$5UA@C!XA\4(;YUZ'>\1X*9(L1+)Z'"4SMH
MQT4C$:)]Y2GZF?X_S76ELEBN["YIV<V:A.348+7R)1TB^>1 &N\;,<N;)D0(
MCO 9G#;>:9.CL0);$:)+&[KW*4^$V*2G N?,RF/R?P '9T4(V5&6OG ]5X0
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M,F<^-3J0:W>*N[9R.;-TEKH[M7,)J8AUB:[,S<'9CZ165YGTN3CF>BQ[6B(
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M&SPW8N6733 H+>7:EFSY6ZWC8G_MZ=:-6&>[=,'*6I,$N!!?1H_G&9OVMU#
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M*AYM9E<\^'+_Z!15K:\"=^'[FHK:--.;&4%AJVU+:F\8ZNOL*8W[8J5U0;O
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MTZG9^229&?=MID,,+X44]^E?LO&A!&MX@%(BQ.-<VG@\C0</NQP)/:>5>R&
M"^><O@4(Y _Q'@AI1.D1P38PA(\@-IL"\^9<)?921\*.7J(&X0AW*?8N=:U
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M0N^6$7FA?"O!U6[&2>"]SP._L(+ ][?**U],LF_C9AFB8*QRNZ3V*NV"J7[
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M500>)V(:#E19'/1V]WN2MN65G.LA6PAD\]ZGZ]Z2OC1P8]=+-X>N0N2-Q*=
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M&?BP1=UQ['[05Q2#^R^?:E,'QG%1&?;,@[14\0Y!;P=4)20_ '@CV/!\=K?
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MYE9];GZ,-1ROO367RT?067*WQ_0,*&-+8=4D,WC')OE%)PUQ-U9-0D%P6J&
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M_W/W?"E=&#LZ5LL)9GJIK#C$5DREPI/+T";VI7\WF1E(9VJ:+[ /(_D_:9O
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M7NZ+,JD58(\M-Z4P+YTU2*])*]UB&S9]P$-H>_-CQ<*7,HX7T-KU/C3UC\V
MZ-!_;U!*]!U!-@8=TU@D7; AQ!=*]Y/#)_<?S#23[='"\N-_WC1H(3>FTB^@
M+T0WO)N]@*/<J[CW:M[KVHJ(>Z2KCR1629I^W)27X(CHTIEPR=L19(UV)6E@
M[3-X'WQ.> )NZZW:F:=/QQSO5TL]L4MZ#,0SM7N2*1*%+IQN:X(2GJ'](9^G
MNU5HO4_8TIB5L+4D^&#PW;_.3_2TQ6)Z2_^J[I"H/9..%%L#LL$T\]CC?X\Q
MBC6)G7J'!,9@\2J$&;_>>Q627#[ZTPWI.*+47I*]'$MJ2%_2.==3='$O]?38
M>ASO'LUZMN!R:4V$/RZK]%/@7 &U)B&R?/962+)Y3.++.:T&T_:BK**V?]X>
M&1G^<;]SRU^#)^<R#COAHKMW'DOZ\!)0@I4W&I[+AG*>YN_I\B_R]]XW YK@
M0H*BZ:U&7OGSMC<]:YS\8VYD7L_*YQ=K S="Z&".UKQ 3V<C<F,W?'^TC>8_
M=O7JARRC=]H]N?1'<^N_@I4W ]\PBI?0W'JE4^KY5L@;\?B/.3EPR'=V(X*_
M6:0F':'N&!Q$$F3\'^MPL09[Z7CZ5/_I$:E&@.X-)81W_N/I7'?:7?S&DX;7
M+@6JN/CHW!&G2"APJZ8>F7^%\G*8.@FY,=RE438=I[0K5Q5TI3LM)9IA?&,.
MF%59VA1,\&UOQAE=>9 A<0<3:[ >DDP$)U_O2"%OWTC;_FE:.FZ_P# ):.UL
MF:RK'\/NH]J=)!,>!O@]#O+_K."@K J.1Y8=';W@&KI?YWRK<D>R>\;+9M8K
M]4L/K\G)N;PU&G[H BM&+XH#^_8/OGMMHG[MT?6%7UG[OT[M$C2JUEB=B&WP
M?^*VLV*=X[C3_L$*?PKL%RQ/N\6[<N1#\('[]Q[>PT-7;  )UGF;X'(XK%>Y
M^%I%RG(#21YK]OZE=YYAL3[ANV"K?EK,%=3HWJ](%91"2@W]\W[%&RJ]2D$$
MQ>$L;<KN_:=0)Z4]J)\W\ VADCSB.OSLCRF:(X)32J,0^ 8 24@1]-RE[A1?
M$N0GB8TJP)B.)A][N0?1%W53:CZ4<B<2JF:?NRQ<OG]DA&$Y.'-BX]M=^W@T
M(]QV\+<7Z"N =A#58@,<=)W/ ?(9Y"C-V1O:SY[.-C6Q3%E! 1.H3+_@9NN'
M_]VY_-,P(S!Y(0XV%BERPF($-GQCP<4 L)TG@3I^C)N,/_.1/%%DP;@+AA]D
M/ L?F&T</&IE7-A+.QQV414Y<V;NDM$_WCRJS;YI\X6HK3&GDTS[8F -B.[H
MXL#"H>+  *VDF'=U?ZS-Y0.1.BF5KMCSWQ%5IZ*(C\Y^Q::3AC"Y#.@RL7L*
M.JWX:]=_#3^4>[&'/[RY46,RKY1_.2)_&P\DFKROBRE[-/U]C&:&<M3,LY8!
M<AS?R+DHP:>LH@KK"O:)O-8*L))P^\7NHV*_^)>8JE- #F$9I=:+MH3KH':@
M[7V>X.-5CVU\_OIAXU#OSGNG^6C%4V];K5;L1*?!*F&0)$D<62;^"R NW %^
M\:@-Y:"7HT ^G:HOCBQ:=NA7^1PQ:Y<1N-MHB+(NC;7C1*EA,>MJX<8A!85$
M1%S5Z57(O8_((]5 H'^_5<U(-3#I/QEP\N-GV<]3N1/G)]XGPVPT?YW(=3RP
M3? N8\YQG]5* GH5LM$#+'T)HOX>E!J(U4$5 6&ML5WVQ-]@RC1;L3>AFO[Q
MY4\2Z<JV]NJ6._=-?O67?0ZK/W]^7Q&?R7P;*-;IVN$$TU+I/?+!(#\ZZ"+*
MN.HV;V%L5T4WY>)M^M_M)C=\%V*4:WSHO$,NG$E8[/[AZZ4I*V7^;VZ=,@MR
M3F];SXR+@6^JH,,.(1V 7P;TT$]7V(QL/=X*5<L]+_+Q*-WW7<PJI/K+XCK"
M^X,WL:5/3E"]/2D&2+4<Z6 IH9NG>Y(QCV!5G!N"N?[/&10TW;(_61.ZGBR)
MXCFGQ"4BN*-$(6V!O\=A46/^:YSN?BN% .-6-'2;/K4^7(?5 >^KW)_NO\/[
MBP#!(DD]7$4:^$^,BZN0<J2>[_^\%>YNAHP'E !)O/Q.=OHUT+';WY?)]S1U
MBYMH-TO0#>CT8,2733+*,&=8'[[&]B8>'B _]D*Z5H77\I7ZEKI_W*QU-?\7
M>USR"A8N,!+&@=XBJWF]G4![?C)<=:HKX3FZ #/BG$:QVT,>66#>JGS3GG_F
M)^M(Q-?"A1MY?.J^3;9;=>; ?*:9QOM5R.AFCN#-W.![L<$[C'T2\]+P==8C
MB^J&(PS?PLKDWJ\PVF9'M21&XG7CS>:5W/;J:_>QPW]\OV&5.#UI=FJ<%;]B
MWT?!)?<E>]XD,=][=@JLC6!ER)1?4VK=P>&O=J3&;+'KOIC1,8-A+[ >OM>7
ME&8)U=Y']#PD68CZI5MX.<*H3Y-W[7Q!\ZH#CT[\T[<3OBD<<D!Y7VWU*F32
M1_&:716*<J(HKF85TGE@%7)A46VVKC>F% QP'ZA>[GUYO\T_FGA2 +]KU/K@
M>J.PM]JO<+UEJ_OY_BBUPVT9RJD!:T_1I5:(SDQ$DG07H$7/T:(2.1,TR#AF
MD>D/KXCFG<0ZQ)<6K>M_$/7RV#]6T65I)8FG-.Z8?;GKD-GK,C.UR)2^IP'N
MR(Q52 .*,;^8_ #CVXE0EVZ?//]YR@_T[1G]?;WV@=6O/[\!OR!_BQ<K(7Q.
MP!]RWXEW/S>1%'_Y696>[RV*V7J8 QM*?].ZPPOV_F4(=3>0JF/</793*7R$
MBQTSKV ,TD^T;^<];<!:^8\?B4LKEG\PY+W_1&&5EOU'A@'0V_4YZ4Z;=6\8
M4.Z<V0_;+C#2(7Y][-3UZ5PP^)OPJT <K/BN7$W-RSP+OK.;"WQV3L&<LFNH
MXA?M=#KU*GG:52F ;P[J(VZ+ _1*!+]Y5U@&?-J=1?'Z4([$'/4F]:3)<B).
M9Z+&_V>_RTT-/%GKS.MSA>YO&G_M;LR;&Y7'VY\X_HW&>?3;@B4VD[2;\<T,
M&IN;P$AA9D!5N-X._C<"@ZAR*15C>*^JR]+SP%OUM,Z!$;^3N[2!, 3G%91<
M5,&4*/0(_>,9DPZ,(.V/%/S6,/:FV#[5WV? !'0%VCS<M*^W*QRO23*K5Q_5
MS E_J?,E@[6W>%3!MH9T=3J_&ZXJ'9^"@0Y&_*U3.@#^KMES2>F8'U+=?ZJK
MRC&2^X:2RT-:0Q4<*]C^/8K653PTF9+QY^K%XXUDSS*?H\NY@OZ_+EG!;!G_
MQ)QFJZ5RFC%)SM"LKI##C+,]KND_L\^;(3:GEJ0QWZ7JSECD:>9IU_CQ*C]6
M[/0Q&(J)G=[IPG7.Q*)<N]MPD?>O32GH\N(0\M%^)WSS!>J'R-=?7H.J_GTS
MU>/)Q6C,:?5HS*<OP\$YI.P20FG^:)=W\?H-5:\BJML(PG\$\@3Q?L$JA*.5
M+CXW8)1*-L\(@HQ8C==>^^@8O+7YPM#DYQ_OR#X?>N,<7'YN2/_RX&YJL"A8
MED250(+(7&P"+@H7LQ'U@;^[LI#=\.T?2614ICPOB/1L%F?P>JBFH&L)[7K2
M0-,Z/TCWD@HR5$T^3Z$J\62WSU*S]):JP4G/OVR>=]=OZ]!]]TI-\5#2?;OM
MG6^G-59T@0;I%H0@IE,/,H33%#L#S@P42Z>#I>@CE.ZL YM*J96OOM\8??"X
MFK][I.--P'S"OAL3X]2RX#@\&KWSQGVV:5OT<RR>\#DT[^M.N^)KY6C4YCSG
M0^^O+WPS_Q#=9IX7C5-0RNH,G@\VYD;_@8<0NH*RC91\)84Z=TI-@E3;+C>'
M.JKXFR^1=L#,^S$Y61@DTPQ*G[%;^'FZT([[=#[U,!76C[7MB_X3%'Z//F-[
M'H=D-AM:_%6:T7FQKG^^.0B=EHIZ$ASJ]NK?^L<P4Z=E^53:VN&R=*ND$&>%
MR>14B-5^=4LW@"X"5Z<1*A1#X^F2F"YQQ$UF]?#<^&>S^?;)MYA:Y6>'S-J<
MU!5B@G=ZG/_\WG*Q4>??GURQ9]:I$VE][8\T7&,_>Q\U39H[@==>684([TDH
MU(.X0?L3#SA]U]GTJ74@BCN?]F,)E<+>&EO^4;Q_X^<M/JP?DB"_VCB[ZMY>
M@W\/P^SC[@WU'RE+]G*94;X_3Y_^85A&Y/UL,U0X>#/;]\'7187DZC?Q>[E8
M"R:ORE7C"7+=OU\>GX<=_)-XQ<O[&M!M_ZG'SJ?&Y^S7H+/3RU3E:X9&23^E
MN]XWG"^V,TOLNLF,460HF%GRBF'=/>OSN>%?_QC V&EO2J%95=D?#H+;[6U;
MFB\='(\HVVFFH[RECDZOSMCWG+I!DKQV,O1[%3*.D)[)$<:N0EZ/ >Q5B&>6
M/:U)6ZI/^W]Z:8^HZGON*F3O-RW\IU\;5R&OEO /5R'DBU)7U%;$PJ,^Q/(U
M=0\G? #TF^W_[44+Z_ZLD_GSF"3-2-).XQ0@R/)TDM*Y]OZN?LBL"O8&J!83
MT:=9A18$<"U]<;L'JRTSTX;[(E]B6H_I[0&LV@9@;@I@4>BO;?3M> NH"CZR
M*@<T9Z<@.&E0X Q?V<^^YAMSX@TBS!S<;U5+O$X+_TBFC:<&NG92=W\4._]%
M>E(!36LJA@J:,LB9#J/'M>#[P7!,_9DQGZ\(:H08([E+XZ3C7YN+U1C"JK6>
MB.BHNS9Z5NV"?OZAF.I23 )S$+P>M45L "RF8T.BIVG;0%?N4_N@.^5S>?::
M%;5*NV%%*,\10\H0[,B+<.'/:H\S0Y!8&A" 3\79"/K%JO+"'V ,$'JR.9=)
M!#[H[=(V(F"/7.V-B>$2-\/S:\%"!LLIY3GA\10&>GQTJ<K-;-0Z@?G$$MS]
MH/QD(9 OW;Q>A)"AV3E\6 YH!%VHF6:/.TH57( J[EAG%32UP/<N.2I92*SK
MH9-TV.)=([#M.HZC5&T,@9D_94P>L0I,8/@VOL^_55X3&IY8,_&9A4GJ?3CF
M0VDFBNQC751*'W@/C#P8&#YL?_# NW<=J3X;4CTW[;I_0@F/D%JO0I+PU.V8
MB[PQIG(FL2Z>G_,_==$V5^'F$4-HH@95!_<>9S5D2E4$*_Q;+MG8SQ0"\T%#
MW^J!QOI=-M#0?)=VZ?O!>UQ+-Z/3C?<"#LKW3LG)*- 5W)#42O:['/??*D2+
MALX!3? =BRQG8:HD?0'K+%!VEA#;K$0PK#UX1'#U&]>&V7YXD5&\*]+9#8AG
MIHXA4Y;3NUYW5J'U=H[$BB"_]U^]7Q3RHO#Q6F.=6?_ 'O'.3IG']8Z&#E67
MCRSU$V@;3"PG/0/"BJ7T'I\!^,Z^5_Y^DX>?1/*7=\36'';]]#PD@#"T\+ZD
M+;EG@;:P64;\RB4%- ZQA9@CW8.Q\ 3S!0W"^V#G5^@]! 7)5^;]P>W%QH%)
M.R.C#@[6BI'1Z-"HYYAKYUD3Y_'!8=::!P/?AE? 2=959OD5KNB&_]D_*YS:
MVFW.IG@^7H3#H'H0VRBD=%3CF5Q.GWY/L?)8.? +A#*V@8:]+O5U^72/3V$W
M_+]<#^PIG6C_-+*<Z&;SUN[.!<62HXB=> [?=GH5DFHIN?>C<5\S13;K+.QZ
MZS'(A3 %$,7S^:68-'.OD?G6<S.K3>!-XWQYRVF4E-(X26J?^Y3:MLG&<@:G
M]];RM^J+@X[:F":NQTV# I]SO"QYLQ_O7JTS.;IA;&$5(E;/E6YN!ZJD6] R
M3\/349DX6_ .QTV-B^HQE\-B!BA0PG40I^OE+H#>C97@S]0-6ED+-#-K_1LS
MX^73KD[Q(VOXB\EU$V2MZ(UQV"CP@+)8=4B(7;OO*U8%^F4;E'VK)P>K\5)\
M1%!#8R)3H6JX[7/" N<LF +ODXD9N;GVBBR_+%BY&7D.61DKE!,\AJ(6=A2@
MT0HBA7:$1QVE]=[Z)S)S7/R[W7C.<YHP J6Q"EGJM,*;K4( =\0?KQCAD55(
M?8S0:Q4R/.%.^D[CC(E5;+@$.NW3+R%%\@#K)CHG'8?JF>"OD.2Z./T94'6<
MO?ALO4RHH)3] KYKYQ B9\ HN1KN'TN\XK]#RW:J8:0:RBA5T_]L_-!GI_*)
M/2L]F7C. VB#,Q,!&LI B/-(#S$BW84IY$0ERV#'JU-;/FO":V")G;YRM803
M&0%5P7AUY[4\RLXHAN8P[8,:(C<,'F5M*+ NN7PUMI5OG:#3F_9T_<PB:.PK
M5K_(\Q6KX=>VP8BGU<%7H!<T=9.RX?K@#I&#V&1,C&N@,4@0D- C56H9AO+D
M[WG*9459+BK/%D/;$H[ ;_(H1(\WE%:J:]_A;FGW_%84:#@F5@]E3*T?AAM@
M3\G6;ADWJ*W%S-*G_Z8:"HI;@P%'X;5Z23'LB!FQHJ\*W> $? L$2LX"03FJ
M0:EMPS"GX 3#W*OY3=?]3J9NKP!E$DGNM_0#54^21W60OD600_D&H@#<.%%1
M:CN!M6EJA$)QAA/S6L2-9G 5994<PLI8Q^4DE\O@S=I98Q[ZOZC:W87N@\N]
M.FA3Z-F!6DN#YL$?=7!MF8?2"DRS\[F+J41RCE@]0;I%171>EFFVY;ME.DKR
MX/O$P8$Z7,/VDK#4\=BH36)/I(+?.$C@&27'BA+.F?K2?\ZM:!%FFK(B+P]I
M_]=>=1O;*QMI*M) EHX;>,.DRIX:>8DL;L*TW/RG5*+0E>E8+2#/9]C4]/YC
M?LWBBP<_>$TY7]*0Y-BWX[(4>"+T+A(T_-:S_6+Q#L,F"14?%AR]Q56G=UT^
M [JY>+=E1!?OL%'_]@>^M[#SCV9H 7A.,72MRQ,><%-R%#ZER))9L$ 33T"0
M\5V= MP0%YJ^K&LXW8&2BW,I&2ZA?<1ISK8$/2K7M?B[/7ME\.V8NPV+($02
MVJPJD(G7+?\M1O6Q-\D6Y37^=;^,IR&8-&WI-NF(+)F8=^80]/:#]>58] CB
M,BD%H6T*@P+E\SWV/NU::0O<8:4*@L%H'%[1;\XC>2BVW7-F\=S0PH9;V"#]
MA+ +WI _.=+-W)KOJ(UXSC=ST)C-(&;'6[.@76R6<0="L2U49#L7M.>)Z5<!
MB:%D<?JC59$78TJIK3FRY=Z#L/KORF;YP?K_>7&IU'+(E&Z;*WYH%0+:QO-H
M=.44(N#</Q$,-Y^[9=I.8Z)2[ D,<\**825,(8&7DX$[T$(F=.1I*_W[HB_Q
M51CKLZ;4- :]\^%L010A:KE2T3U\L _:()OR"1ES?L!^312KMPQUK/SN>B%@
M,Q#9J,U3+M1MTD':>K',!3<9==,(5R[G_336=6"FAR9&O0ISG[NNZ\,^.6I2
M.^8V[,\3'6L9()&BKM;"=ZQ5>\M]%6\F@P,<5#:JD<0/%07A.T]BG8#B%;8'
MZ,U59M%X%B"12TB.JJX(7XCZ@=W1N "FSK!.+GQ-<'/UUM,=-FI(IT2N=T]V
MVK +F@H%O$BI4S: N5B'+T,.73!20#SU%'P^L?:NE[(0'F(KF*$,3PA4"P*@
M.11=+8;]9!;["65I<=-<P9ET?-FD822USXP8K7C9* 5/L]UU=W139$U)QA1K
M:A^GJ>FN9>JF72D;HAT5/5*R]SW/\M;/TO!0^?OE%@CI PW<+R]6"^#:B-49
MW&^=- )4$QLED.^XA>Q$9>-4P%_<^7["8?"6 M^5&;2U;M1R7E?'9Q623#@^
M9II-B)%KN#:V/W1C#?!PG[;"F[NOF[[W0:Y+;>N:1[ :/(E9'ZRWSY4NW55'
MSLFESOQR:6VZ<]#.H>R!5O9-'NUQ#FBIP[1WZQ&K]G05;\@6CK1Y #W"-R";
MVZ\5OC]&86JVJ6D4ISBZ$-),]A&YU;3S:WX9O,A7>=;\\!UP/."_^T;+"%3?
MVDUQT)K-26'S=PM"A4F2_%5()'0B2JA%D3R+*T*B0"[ $ :!)9$<VB8,S6MT
MT=Q*Z6J@;O?3L6(]@N>PE>ZI/R;FSFE+DYJ)IU:@2N-A+;%O@[?)_X>BL+M)
MJ0A5F?LLR-(>@K&X#FQU%?AFX.2QZ\ N+B(CS]YR-E$KJ<V7)(:#T[Q6<X6Y
M)G>+3N6T7<!786'5W"V?1?)L7D%MD; K(R!)'?\<U804JR(Z48WF?,=*68ZK
MQ_.KIHF?FJ1;-@)-#%84/4</>PJTJ0J36@]896ZW1$<&,(*403[0AM8\?(0M
MW"C-$$Q$: D]YJ8T Q7G6N2:HRX^/^^WU((0ZXA$2J!\#[0>R23>;:)IR>C4
M+^$^L(07E=%B<P]F/.V:Z-R%U\4Z3D](MJY">'MI9/-TL7/I''67@,_.6H74
ME0S%99V8\!RXG'-TV JUU:]'+BDZJL*O5W06WZD(5\2B)24P7]%YZ0<:F<3W
M$_TE'4)M>Y&*3V>K($)RTL>"=GZ4[I\*F"@\&:><%B0W/-TZ9)7PM6E"_75X
M?HM!^X_10@]*6TM>  'R1UYX598!.16H>II8/4<8)T.1"VN4@@*]S28WYHM\
M90#GW]0!965R3CRXR5G<7M9_QU+7U[L%F4&%!"@9GTJ=6OAN8Q^YL!)%6'JS
M$$4*'N;+C*A\FIB+/H>SP7>J_^]=!?<[ITG-\9UG9)^(X[^E6UPY[$]5TUIT
MT@2"IY4.M\%J"X@+#1Q4%M5:T-Z?1C&NL>Z95J*EM:%(X=IMU.TC5V.;R9_V
MU*7^/MT4.K2<VGR,URO7)GU*NX $]^1W_F_LO6E44]G7-QA'1,2(""@(*0=
M14RI#"532E$1$:(@LQ GA! Q*B 10U**@( 0AU)**(C*)")$(!!E2(  42E%
M9@A"!DH9(_<*A"M)+GWS_]+]].KW?7IU]^I/[X>3M2!9Y]Z[SQY^OWO.WIO1
MCY/?X:K*:3NH5%4>+F)*"!-6!T.XWZ$IA2<T1@TJ4N( ;GZH7-OE"!3S-$ X
MT$>Y3/!WHY\Q_=K<4AQ#+ C/K,K*:RWH'Q?6QB9.R>H0VS^GRD'XPP(J+=-
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M^M(<P7OO__W"GV9S9KP8WFDZ9#8WV8Q<_5] XPX"TI;\#B)D-YF[B;2E&6/
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MNF?/_&7=W:%G-?L#TV\+K]!6."FU5,^CT,)I>;KJ*8ZHOI ,*X[74EI#28I
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M9]&JO4U3"L:+,;DAEQF7'_[XFC#]25'_('$^G7EC:8Q-3(_!:\?*K]F#M1_
M4X%!@>H]PQWLJTU31L46:^A/ZC1@[7A(&Q )G'"I8@T98DW+EJBRZ!=8*<%;
M,IJXOZD>T592+YJ@@>7YIO^D7)JQB C7WN/NB4.[A>4>.=0ELV:L-;M[SP^7
M7*#?\Z-ET31AD@=F29@M(L@^2U[=S=6#*MS JC0QN<]*B057<YY]RJAV"+8%
M/,J  $&ST#HG=XECI3)G8_?W\Y^MB279DLI>M@I_+'1OOQLA#.[  2X6;2D\
MMJ"9.3 %:ZJ[-JX Z9-!"G?EH9Y+5%M00M6R20*3Y#2H<)BW>+ A=WR>W,18
ME';B%9NE/V;[>*^0\KAQ'K?&.9_T;>*XDVYGY4#=V>$3\\42K%)GB?Q753:/
M1.AGR*M46<_ J?JT2'D(9,RBM67&\#&+)GJN**V@;+'V9<J'V6]04<1+8FQ2
M"M5;RH!<:Z^\I/"]0./>9+A?BEW;-QI;4,WI#7!G\QMI%O0&GDA+HP5_!V=,
M/TL>,)?_@UAK%$4@E?.*():4ETB_P$S1=0:R!$[;>T;2)_Q A%OS/UZ_D-AV
MJNO2H^\7;AB?M333_#>TK%WVZS+4]9'))<B3J\NZWB)B@./,.R+@B C:OCH9
ML$?0E4D4HQ^>&IYJ9 E#Y=%!+NX *[7V%TY/YDF+8=:R<7WYN8/=W\UJWKSA
MY+2Y "\#3XUA"ULEBIJ@P".]N^@K$2!SBUDQIUPG:,[9J.+00Q=0_0/PRA Q
MJX\GI=>W#6A)CT!S"AS$EQ\%D(?"!$.%_NY[#R/DN2A.RM2G)!WM+8W"KQ%!
M!$]@-O]EX)>Q'H-@H\?C%KFJM[IX58#ZO3QRD7MT%.XT!D/U@&;)H.XP6;9/
MX4LEODYU@;+473=,;,@8ZLD>*D[[7]L)2?;FL8B=KVIQDI^7+LX(:FZMN%1I
MN3\JSE"X@/)^6]YA-1#H8?\?J5I0EZI>T!P':+T+*$T82XU5W<%=/-]YNCV:
M*327GP3O.FF!&@RVVXTC45 4*WG(I+JB]K,R=-4U_2J;P]_]9E2>WUL].G=&
MVZL."(YURDI^QVU=0)&QD"E3N<Y ?@]PX9,1]5!7_YM6HDR,H4K0A8]<:H52
M3TKOFY.8-[:M@P:DA3?]*X,,19)/A>= ^P/@ZGRI^S[KQ4D>GT,SI6/6OT7]
M/)VA.&QQ?0%5FK:X9<[M,SMH[XDNC&^7E<S<HXS7?9[Q/LY#WO')Z$;)?JD(
M^^=<1<N<)>:)&7]3T%2: !3(U=OF9E0#:(OB]S!FI4AF $[+4]7[K>%,#>$I
M/Z4M5*;PHWP8: X@-UK<>"%))]+6*7&=KTH<K"7NKK5O38P#0KI9,_V7S)B'
MLXZ]B7FR@"+^CU_%L?X=@34U%E 6R^D-]3RY(;1)61D.EQ5/\^7JRIDDJJ[J
M+]Q%QH"!? # ICJ936#6X2)NL%8.*CV0\)4235@U"!GQ?U!<9)C^5O$-;6QC
MYN&WIQ^J\N$>Z[8UE)M_+5MCA3*NQ\33 5]U:L4P7JF[1%[6R1/7,@$\'HVG
MGSNS,Y:L7!<ICVSWEK$QJ1BM2HL:*U"C6:=0>&CKE5/O[@U\@0:\$CNN*^VE
M$3B^2*])]Q!I^&TIQ(1LXH<%-W'A_^DF9^ BOPMY1Q;Q^ NH=,QZ> W5#8BJ
M[LF<OU 6D0OQO:&!XOZ!\.J+I0C[ZHJ:CKHX=<8_Y&9IQ+]AYIF#N8\64&4E
MOD<[9@>QGNW6=39\O_;H+*V/%KX=UH'V<<['NJ/J#@^YN3N[(WQO.+-GOG&^
M@QA!WOG][..A;T/^FS)MT_KQ7WE*W5QXQ;1B&[UA%_P+K3/X-U7&)>Y6XGR,
MS)%%(0?T4A=)ZVX<[*$: /+>Q@P8RVNGV@-#%EAMHMUL8OP%:NB+_F9T<K1(
M5V2:D//D$K8UL-6R7N,'LOA+MZN8ZMW^S+D[//%S>@6N 0]MISU1K*.>A[8K
M0JFN/5PKJD8O+P27(-K@$"*]P5CC&O(\0'EN 76;(8CMR9)J,=$3,5R3-^W/
M.66)TX<ZX?>%X:E1A<T]C.OSMNI8H$X4@/LP&-@008>^*BY/S,5I/04(@JED
M$Z,.V@;( '% 95/UC(2A35 "B&O,Z)F?2IKAH<*%H4V66DTQ.9O8-:2+_:.V
M]+!J-RCJ;<^A[BU5;U6G554X,<+%*W"R!+#XL.HEU798E,XK1\OHSXBOP\IH
MG;QR B.)CTXV^:6]Y"RGJJK#X6I)07@U-E7V2WEE5:?G^'RC\<4QGY[,8YDU
M8]=L;*XI>R?5;ZZ=53GP<F7<9\2OI_,,Z43RP( \#Z#J!BH=H!K%6>H1PIU<
MR<G(0^0-#R5)\1=GZLSY)NOK[O"W5MG]+:^NRL_[>,5JWGHH^S)U' 6-P%K]
M $E J!AI)/=EP"NS@7RLD@#R8$V"^N68H"GN\(<O Q,87?H%W@9MHWJF$3M[
MO^=8_@_RL:KJA$8WQX]<QC/2T-ZZ^__0J (P"]8Z]X*$X-:3:.%$$[/28#+Z
M.60A#>6CH2W8R2S 7/X2/%P1\[SPSD78!F)*&>D.IB! W5Q=749\^J:]=A^
M=>6!5;EY1X6WJWSGZ7=K[2-#E@V]W9BLDE"]H1 Q+PVWBKN)^@N4EKM?BD%1
M3P"$9"X&ZG1^N_)L-W6W5&8X?:!G,CGDBE%;H>C45J]EV*7Y9HRUA_.HZAJG
M0\AJX^%6.G ,US\B8%;0&Y:!&>E44]"M.5:4 F]![GP]EKI/BM.G-%0RT<0A
M71-,SR[$23-6$O=2$%+P_>_J"QFY!>GWZS.$KSK>6\T_^N?N(HBG[OITBR?F
M$ !O-&366X]$CKED*:]O0GX"VBYF0-M[9<O//!:=:(\F)&/6S$3LF99'0T'2
MO7K\ )LZR31"7.<_I46C_AH+W@P6,!VK3XW%G&A0A?=^+53J&L":VHKM] 9S
M-B[-#CO9:=ZD'4Q.#[;JI/I*LV.DERJ>4>()G6P>NG^PGX*OSS1Y]IP2R@_V
MC5?NK,ZI<,H@OV@N"N\("I^K"#>L_&;Y&-U5C8+5AZDK##_% T:P5ALB&$=5
M$<V);1@SR3O+7$?3PZPGY6\&R#?A7TG'*2EM_/E/=2].E8_-;T_R 5E\U?5H
MHY^6PU5E0#[\NOPOME8&!RZF_:(\ J ;VY*&=D+%H%%S-3H>-E)W(V.F*@.'
M+6\<YY0#<+(DS:S%W?EX#Y;UE;[IHJ0B+7]5OI":=WEG>:LA+@WNI9>INS!%
M*U>#N,DI!5[Y6P?7E+H;W)\X-C/1^Z:L6XDK[=_:FD]A-9K\\OJ!-J$1WM'^
ML0EQL<*AA]'DJZ^_!/6=4A4>X_'*JI7FE0NH^"#>!56 I:YDKID^D NOM >+
MY4% LZI.A*#]$ R&UKX8?QOP[_O'K-/*:'2&N9HXUQ&6&7@HK#HJ8/=G:R.K
M2N>(HN9-T^N6@'.P9IU$=G4$UOZ*:!%$)75&N3OS"4MP81@C6O^0DXK))DUX
M%?X.:W"@Z_H/(Q$H=>'@M<=:T4M-#*XLWFGQ O* V]V,MC#&^+#V NJU.AJD
M$0#\7U8*^\#U(9#V&?I.FWN'R!LYPHQDAT,OPFT?;#WZ<LYW;L[6EO/P]9XO
M@U_<K^QU*+?'5,#;X6;<8NX6N!G>I[HU$[&(JT-KXUI!V!*J1N5G)]V!4=CX
M+4"X:5VG'['2K_:7C'F?LCS_<9NJBO<.MK$Y#U^6-"O>WRARCKOBR&_MI+W#
M56C<I)^=ZF>*>R?+@#9?T(,GQMXRT:X$\ FS3*-@8@QLT655XU9<\^:[]<!'
M@R.?HXI3OSWX<2CF=?N,(B[E9D37K2,:TPV*E0W:/*6QH[J+Q8\M?@F]D]F
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M4=XI#T&]H('"SM6L['5W[;$HU:Z>5I>J'.?+48,6[A4&O;N%@R3=\!@?'Z]
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M%?-)D].("BJ@7(1V-P0Z&=#:<6QSI3Y:PI-=49R FPFK:ETE/'WJ4H!3CT_
M:'(WARV@-+F64&33M=B(C'2K*13T;<3[]>=_>QQ(Z&2KUD$RGW/:W;JRKO9Q
M\<N\!S=,D!M?/DW5!W ,ATCI5!]#_E%5S1-G#QE"N:].D7AK:&C:!_J&"(10
MQ7MVLX(^?BN2B%:0,E>74C>]J#UF^8KIQHO#N52F:SEBW,O*.+=Z<)^Q?0C5
M2%7LI#?LHSH.NY%O!IBG*)U!(VG!LXA7RO/03S"FV8"@X[1/&=03014DSK7
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M3]U ZHEU"AA:[/?\+'!_Y)Z0Q/(HFS'\ 62[%V&G;5OS/E&_WE2$R-VG8(X
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MQOS @8O /RO%OO:*5WHP*/VKEV$4.7:P_4>RIJQ*(1^"L<\HFD]%PH&;Z'.
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M>J.IA_^C'MG>\ 18)$7_]F#=P^)41-\8^F_5&N -ZKABD-VJ(:-<V17%#Z<
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M]W-CR2B?G__.#,WE9KZQ]H2,^<C;>?VY/03TR<?0.P%S?+X#K20D[RHBI0F
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M0N"I&1]IOFMJZ>':G7<KSR_I@L5$Y?;'3Y^TIZ/>9?QYZMB]6*Q:8()?4EF
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MIJ-/(Y56N:?<08C0W7.K [:<!/Z4O/D.FZ<(R%>B$[-[ !4F-Q]6S_8?;75
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M?+XSYI)[RJ>K0XZ)AI><R_N6T[-X&_+<@J7?I#VH^H,4/A*P:6=ISK<JXVZ
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MJ[7Q+F?&:(%VL23AT-_^\K+?G>?.&#XHL=/MK)7I\>&5[?]+<8E&V&;0WTE
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M([B^@Y8SY2^D=",TYLSLLXNF?52!\6NAU>^>S_V:^%QY_3-(/%?S*A@_](G
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M9F6!>5O!#DG1O]2-CCN&784P2%MD]+!_?,Q[^$!<9R.^B&UI:SUDH5Z,S65
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M0P2 \!F I\'[#02R:)'$'K'9G7QKTD%A(GD;N?\B20.DII#P8-_R.7@14G2
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M$%E@K4>)JWZR<6Y339D](R HO QW$A\5LM[CZ_B8JXN+I[_B\K[M^]164>7
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M,GC'T_T^C_5E>E^;7ZR/U^[Q-MTWTG5-MJ._TU=IZGOX@;^3N".<@T:OWX0
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MB8KO746-DI6_%7<,O3:N6$6YB'KZA$]]MW;(Q.4M^=J-OTF]Q$ORS]1UO1%
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M3=?F:KL9H)GF-S-YRS<I"D4AWR95A?'&M,\SHBWIR"U>0=$]<Q&@+X_^"1M
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M,#MA8QIG+HPZ]EKRR</KBW>,GITF!Y[AFGHA4AL\U8YE\['@=?A+ R(*"L'
MV"\FTL:$Q&?_-;R3.+WUG_8'ZW;<_P\]B(/W,1 XY<3/9D->O,O"-. :]786
M;DZ33Q!]KB,; /=$DE!\TBJ*O06^PF)N@67;:C#;!?_ R;2NU!-!!G:U22L_
MF*<&@XW>T<K"/"*_UV0?F0TL"\?)P=[\M4/Y460Y 0$^PL9-R/'$A9D6AP2R
M<#,D>1(\3(<,>*IP.M=RE+RABV,SFDC"0>@.JJ+!MW0'$!>G]VC!>,[&+OY<
M]=WWFX_3&*5?\>.([&X$VL[160@,2@"LY[F'8$.N@22YW]-$^ @(6AB+F[@
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MKH"(=1VB&;OEJ'I09YUNKM@^;=D#B4TLV>"-I&Q)1SFJ.:K6(\?B11*W$*(
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M:+/0@YC)30[@#^4,WUO_&K#T?#LR%61,$\:GJL;&$JXJL%%B[Y +A!%2L $
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M0Y6JCZ3W+7P2^\WC'A8Y3U?0[&;\=\:.""7K>9%89!>AL:);>8(?Q8+&SVH
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MN+D!43=!Q7HAP"S.9H\Y-5ILZ."J$O\J!DJKP;IT>>U4Z\E3C;8X:1A7'MA
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M.C:XCSL<^#CX?B[=H_/#:CRZYO;VL9H7;C,SNU+O)9;:!X#B0(J-@"C<P=<
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M60S/Z<(0A*Y+FWM&"1(B@R:JX'<(A^[P(\$EGCY^F- H?!;&K-_&#P"AM?3
MPGT(^?;1,!D/GLH70V>]:ML"Y.5QDZG06I35&*DZD3FQ5JUQQ>!&]W>]8 S=
M_9 81Z^7")RA3-%8"<OAP C7$1SBK'+;P$96?0Q1WL*-0V!N+C43TEP6>'8B
M%PU/-?1:NL)1C>=C_"NL*\J>*QRU]BX.5C-L1/MO.X_^FO[C.'SOGX0> H"Q
M3L<?7UA'4>VG]822<SR\< S5>"Z_)K"M8'5Y \)"R0?@Y8<[?-#%'[AI6A?
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MIB?,C GKO]P^&?%HK-\H]K/B"^>"3='Y<S_#';8/U6W?^P;P"IT'#B*Z8ZI
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MW&.\TJ5[K>^J+Z8&FB= ,-L$%O),Z68H?]:1X_$;7E:Y+ :YK=@4T2PFPW/
M&ZCDI$1QE@^-3OQMN&/-?9+;[;GVGXP]F0>1'CRXOQ/>8#G>B4;4AYM*"IPG
MYZ]$6ME/V8G(IC"\@3KZPD,U$\I)#$9+4.IWLQO=6O6N1E^9":7%90-4S(;T
M#O_!8:PHJN[G3M=?9!.3MMAJ=N]_=D/\ZXVFRAJ0]+%PS%=X@RC.0.#KG\H(
M6"YA8>@IK<0JK&*5E)6HU6B_W%H"!3776W_A@S.MW3)Q!F.3)D/63EE-K8\H
M3EN+F/69_Y.!<N]04?Z=TJ:01W_.T90SA_AX6_$ 1^FJ><BTXK;0=!C;(" 9
M6:P.Z$$,Q_*W]SGM*/8+8!QZS\3!913PP)TB7_BAS,2QQ:]'U'IS@3 GN<6[
M*KQ9Y.,B/+_BMI6$ J_S5ALLF5;V:3OJD [3[? OU2X& 4Y3^<-B5YA52I\6
MX,[4@6.[(/4[.DU&NS89;__]IS0E:4-W9-2_"J=-)=]NDK>8FE0F^'LG'KG]
MU_#BTW"!U)_NB"S)F<4L[($=Y&1%J21OGIS;0ER _&<6@T?6C>3_!KVX>5SL
MISX#KY)T7D.+CM-6Z,SBB! N$;Q#*@DM+PT<39D[<;@W>L?G1,VZ[%*@B2-^
MVC^>^1!HV@$$30RZ[X472$R(RD?]ZJW038\^Y __@4"@^7SIA^-J'_B*U%?Q
MG6;.B_.\0:=Y/GWO_[KJFB:YUVQUR.U/&.2.^CPT[R6PM-$Y6C:1YF(/L@3B
M);X>!MX\2Z@MS9:V&([M\GWE8U;?5S,VJ&<_[)'^-&U#G=L_I8L6+WS*6ZT.
MA1VA*H^Z?IZ>VAN.@$)V5V5O)-BQDGD[P+:LJ/8=7]UNK+:9:-SZ.#R[K^IU
MZL3:[>UKGSSZM&G)!\2%'XP?^"E F?-7M<%NI4Q3!$2:D%N&G309_%/X+#_N
M^'O5%N2U(6+9[T0$O\]B L#/PD]^7UGJB)#[X<>\O:=GLNZ4C#!_ZS4<GM$M
MC_&" GBWXQ_A=6%W\KM(K0!3"]#DB)@ 349J*PD+MNI4KRP[\$)S1QT&6LK<
M!9IYRBOP.BE[.9P.).+7\E; _2T7F6N?=S7ND@9X'^T)J@84#0HS4L^6LZ;6
M-A$.WFS*T^INIZ/WPV*K+@.GAM?#+/!G,VXZR<E*UFE*W]Z,6**,LS5/0EM&
MSQ#B3-,X],Z#-<MK>E.2;./WS0P>A%8I*C_ZW\T(,!W^0=\#WC$[M#GR$\-;
MM9LQ!S3YPB^!Y?*<IHF%%-A+94Y_V"8$])V,I(.=>GF7AIV74I4B'C?$GJ6I
M_#92B&:I(JXRHZ"<?>_(%74FT 0P#D$.\J\*;]3-?L+M2G_H3 [(E;';V";T
MYI^2KRUX@Q'[&351KP+9'CJ+F9M\7:8JWW3[?L\485$88AYP\77[OS;1Y3:O
M]EHE$/?6 +"#OM(2Y(^[JP*9G6*L[2P&1^_47A^\]8WGI"GBV<*J%MY..%'.
MRL@W[$EA\?#TZ4!<\0/+Y*@=X\AFGP]4T=5\XW?5@V.9+M0AQX,]=AN+KA=B
MD)3R[];?%9+ZFGSCN_[_GGI>6\>];<%]SKUCN#<D(72@('M-4/"-34%G/%;<
M?I_^#QE/@PC2#G'6!&(HHFN?>%/TH\IQA!7A[&7EZJ,/R/(7#H*?-96[*\2P
MFY426I"?N7W8M]"OJ)5M<BTSYFSICNTM>' 6@^B!&FXDSUDK5FRK9R:O*)W%
M+)IH97_8-RT$JG049CIID=?\2I*_PFM"3[ROF<6L7--VUW BY>+,$;^W#ZSV
MW1R;T4ECW>ORWW]=/82:^ ?=RTM3RML(-/V%0MXJRG+;.J\ #1=QH6HEN4)&
MHO_8@$M.4A$8J_D9@GR3FF=Q5[UK:_H(U9E&@IG"Y?_D.(B76D]LT#/+O(_O
M<?X;A4'B*X@Q_6]5*WX%(UA*QL"D_=33/8U><LKR$=-5X)?\:>Y67]]R);=B
MV"<L.S/FDI-A=OOYZ#7Y7T+OISI5KC=]S,\GPCN9MCG(HINJHT]2*XP"8>SZ
MY(,OG2@F+G@/X\LO+_]G],F3'<>T(@CWL<,HZTL3ZT6]\&H2691 NB]G+E9!
MRR-AH)""<K:J7J<H?K#18*/)R?./W&-DYY7K"=L?NC)<7KNVS13P[D)8&4M
MO,K$ X:,8W":A)8<:)AUB&:9YO(;S-T%1B;D+&5M?BGBI];H.9+UJ\__9PPK
M<FK=<_'H.@]\YU>UOBZRZ!>8W[U7<Q>0%,UB:H%T]2&5!W,(39*ZB+&:!'(S
MH[&&])P]L*_*A1X^)JW)Y";PUC!,X(@'HSN]4]:#$U<8>H_\OUT(@&]T^@>$
M'/<DMSP5?0BD5*> )*6[IE([444,'F*+')7_:.K1=[7$ZGY!1,S!IW"=C)S,
M?\8:#X;\9C&MTY0E3%W&(G#FSQG:-8+3@@=A#OEK()TTIQ-VB\IM*J;\,WH:
M>ZMIRZDSY9F];\L>S&).80#&+$:/9\/8!+<_<$A#EJL]X7C(2Q"V;9"?ZK(6
M;A?P[-\'/:=G1W-O'@'["DH'W,^=C+KUY\\G/'^K<=&N<FN2C"!0&+>:XN%+
M3^AC32)OEMHW)/X1[/U2E),V2<*OIN>0NU?ZVEE-8.$SHS/65-^J[H+D,$)%
M]9C5O]8K-P5*Y3X?69(8Y7O-4T#R#_$I5DB^@I;'68QZA9<R&_:2L-+S5\%L
MB7@^TBVNM&QJ@WAWP1+E;4U>XRY@2Z UE8\9C8UD2P.,A;R5>R5U736>&\.>
MOHST"O A<FU)'C0M>4@0P_YRG=9.V,9=*P\H;1L?@/X>DP LEQT,#-PKB2-D
MQMH5O6A+9\P#OPK[$.L<64A:X\KI!8;MK6-@";)21=,1%S[M#.)0!CHB+H2Y
MM#__DUCN25;F:NY.4E(O\A=-L40ZDOR;D)\2LATC)L?F",ES/\#(UT/7'_I4
MPT[X"Q5"V1I:49AT^4#QO<@-VS9FV7?$Q0-KB: W'G:XBRQ^ >H@B[U5;@QO
MV A%4OF&V@E0(804+M_8%B_"'X6OR_DKU%X0.U6][I$_E6?5 "<^&JV?S+5I
M(&38BA4I=\Y6>UKH&?ODMAT&)W$G*OU]^0=XN%'V$A2OTN#?O%_B#9@?V=5&
MUY!%ZAUPCFJ3>B5DU,9GX2R%2?!NF0]%L$E:"VWX7@0M_%Q8ZT\S'?4S$!%3
MMT1;Q>]R\@J16778D(S+.MS,?\,_,137\,=+X^0 ?.PB4-TY/HN)@58/N9]P
M6A !W91^1+8Y_#RNN_>)3O(I2'_,8H94[!]597CF<_'I:WM\;^%O Y)*IA/$
M;9[%P!M8"BFD*VW+<-HM(9O 1.4Y^$H%[-UJJM_+L26LI,?X5G:W9.<69SP)
MZVJ*+Q8/UNYWN'C3U6E/=I;KV17J:H8'R%7C\+*)R_F;80<T/^X'DO_&ZHWB
M*%< :AY>:J2X;D:/:;,_5C48ZK*5:#)%63B:&\A54E;X^Y%0.^9XYQOU!(94
MWWBU_E8\>X 8W"E*D?$57FAFO(;T(>9PITQ!;D-LX0#06\F"U^8[]-N4]-B)
M5]*#I#,^1!3<YQW^[LNQB],0!3O[[CQP*0/,1G%7=^YWV'F5ZU!Y/.# ' T.
MS=7&ZA@Y)6T6 Y(('X@RHQ; D)[2%N@(I8P/@3\#(.]K3MYE@52>.618%5=\
M*2>VN.9)^+;.^%+*1WZ'\]#'KDXK1I>CO8=F"^<U *_CJ!_J(HL'4.Y3!;;/
M8CS7\_<@O]-I?T*L9EK:,,IR,Z)9&)C2(L:J@^[#-]M<3*$]^3K]C6ONCPZ;
M]IR-!E:%#F]/I\: Q272L<7?[:CX%6E2G'5'86S&WK)(3\RYX6U:9A7,3PFT
M)L]A[-(4HN3 N&W;WE/DA;! -HL13.C1"U\O]_B<-\\7TLM^7&D0'.Q><^R$
MV[N_K884%1&<B/*)+=]_:ZAJ2+"ZZU\6%I0O^B*B]_G86']-R]]T/]?28WVV
M?>BGS-OO[_CHJQU'3%$VG?B7RUHZM070B79VD2O_[?EGU,^]A2_R1I:S1.WR
M+]QHV8X]-\-Y&WJ9S@PGL&8B*2K3Y\Z@%](-KIV)3%ZW8DBP-OLK@W\":'I"
MQ)M!"U&4O6"%YCI#!^+X:>YK;ZH-F"G_Z8X@GB:FUFN$FBDU?Y[+^@XY?]QD
M_?#/H[5/>^3O)8E-QW#"K)SS)0.N)>&X+[6UV<<,*X4GS\[1_#4"K.%AQYB&
MD&66+24=S9O1P +ZSEG,H:Y&BER/T!9HQ >Y2=&>9J^1OFZ&ATS7\W" Y6Y^
M%_)>1YF97Q)#/1_\U57YK^RG?C0A26SJHL.@I1RK@PEHQ%"$@_%S/Y^=&D#6
MH"PUA[7^?63>Y[V**5\GZ[+1LI(.JUV_ISM6Z9(^[PU::G!=O05H6@)(<G-U
MU 99V$%[L;(&XJ<W'E(M9\S][_&*\^QF?*5[$L.UC&[9Q#=P(8YQ<3;E,B"5
MC>,T$N**X$3A3N\DI]_RY[UO7'&_N"@L/,<!-_;*]A@5""K7N,NQ'WY*..J5
M1&09NKV$,('*(!3':N(D4K@. DJ&&,NS5O_VGK&+$\Y<UM#3:'>?FJBPMZ__
M7EHZU%1\?+2+/J]%M[ CVCD_AQ-J%%M\RYHWK'R& <XPMT%M"8@)/786(Q0O
M9U"DP%RZ%^E(!+D%V08MO"EE8</:K5)E5 W5O^%9]]D^CS5!N\]?6!USXC%I
MN17T$]'%JKR^Y?!!=V P1QXSGJ/ZZUML=IU$G-1W 8Z3E;PDIXF.E<=+,\/4
M(=*-/B,\:]#^V<49MV*E@U=SL_$'&V%-RV/[LIN4:RZ6\!^ Y 4 !A!$ @E%
MX2PC&P8 VM&,V?8('BR^KG(*#33K;71\P#@*MY7O%YUY4$Y_';%2V:KH4K7@
MW#,I!WO&(T_T/03;DAF6TKR=$_L3O2$]82>*61>@5"B!P&P75[+4^@+E4TTQ
M<"(NP$OY)[3P"IC<CN8\8V0-K./;;X=-!*IIS;H31O#?KU7-/&>0D%IC$M[<
M)N3A^77/(/=$I^C[>H['JOMLN36]+D.&C_I%=)U);6OM+8ASS<4<:-HZBSDA
MQC-V06XOY+2U=('2%]XAPQO2^4)<7E^-C+B2*BI)C&HO)_GV35%'-C3V1%NI
M[I@_;VBLR_8HN2/R,/GW)N5!S2\4J\P_,8NYY0DT[>2/OV,NG,6,ZA;VCQ3]
MMR^/L7(6,[9A%E/1#7SK+^YF:T[SIT0T#6Y2I'[HS_?^Q7X'#<02_K/Q8?KN
M)5:),!LB2?E-Y#ETEHPMG%A+ITFY D!GT#\0+FLS)?0\[')RD*I(0W]U[ZM^
MWAN]:18335WUM@0(/JE+%-?7)ZS[N==*EDJ45(A!DG_:PP0BO!$_7FA^I\]V
M.\/OG?6#I6V85^<OF-N#)=.%N3[R0^V_KRK<V/?H7FE7V>%- \^];MV(#?WH
MY3%:_3/@S6;9N1[S O\5;K<**PH./UEGP:$6;;+H_<ZIZ1[O?+_3*AV^A$+R
M-J%XR0=X3$ILP<]7D\%CA7N?0C3!A,$W'@%4=&?Y;9R*6*B<>7.@((=[XTC>
M0MV6^XD!Y;L][7/#RKN/47NWA[[>MN]0^*'PT4-AQ?D==@6!H?\UQ?^AM\DQ
M@6(4>J#92^(J%Q/U4H@OG$A!#.!VZ*)N&3M)K#LE7O%A!+&#IE[<''*/=DBV
MW7$O(/Q\FW7F^+J'&))=T9O??]WX:[1BZZV[AZX5=D4\*A9Y!-3>GB0=4Y+^
M#OYCE^4.M\6OMQ[P=-WA\:AU4VW-K5R/R$$/4Z'KJD^F\S7WF3J,@_ 5B"@E
M"]@9I@LA;@L_(4>92Q&*Y\(7CG-[&)Z@^# O=U3TMETH.DWA==G81&ZAK4NR
M5/T0O;W\/3-IR;9P3]>:59=L[Q[R++R7.V#?U3#:-91X;[U\S;ZMMP8/9MPX
M$&%I\?!N8VYZ1-'%&[33L1H#;Q8\K4R$C<&J-OY2%T/&7KA*0IFG]H '@+@B
MQCK0(<VN/=ZAA;\RVMJ>:ARGPB\*JT2FO>NJGO=,?HLT2_SWTXO:W6_*]@1M
M<G2S.= AVL0]?3>R_:%'[8SYX+L-?^RZ<.#05=KJ84_7"_OV;?6^Z'TK-]V_
MMLNOZL-&#@YL4^B#^%:VD3I.1:2346"@W@6U2R/9M#*&&TPJIO9UTZ>;8H^*
ME6&U/2@]PN;E9%_<7E%5Z!2S*]#0\W"SI\KFX1FEWX8UKD4;G]?>NG$C['E-
M5.^T9WA^1WC"]JO=Y^Z=N55D*-]@7F38\U 4L<FUN)#K:=O;G X- *&4*P<9
MYY]I[A3!-1)7S8,:XE*'S+/,I7H7A\FI%^!=)^KJ7<QG,5=CG:=___9%U"6+
M;F2_SBQ@_?WU30;P)M\"31UHV6VR;5PC(R^G$X5\+GF\4]JYBD[V[V78R6C8
M<)3/3=YU]OX+6I@$N.0\^2;**V0[USXH&K7GVCO43OS<=6'^,X<WR=692[HO
M)N$J(S=[N-W[]#$X>DTHNUX4YIR75[LMWTK/,[!X_54CQY)+O26K.@WN/8C9
M,.'JL<,]*C?"O),?RNGLT$66:'M=VR&WN@)ZB(#-!<9?E<,I+7ZU>0]"=]K?
MA1P\ZGKLXD.\&U/(79/MNE&_2AKYO.<)77VK?A7E^[S[NYF_R]=WS?4KQXYM
M?DU?=TN2X+QK/NY.5^F^UT4[NFE'2A;_-5;_99^JO.'VOA=+1NI7E1X[5'FS
MZ+#^9]H1MM5%_K^BC0_O]VS\KQQIG=B(SF]F8D#>"SE@ M_]"PQ)=+(J/DX-
MM(1"TNU(GOH"GLE[!8;ZPMNO=^)S<KMGM^)V(CDFVO9<RR(;N:WYH(?%X$6/
M\,$X\_I:BR[/VAL>M8.5Z'O:GAM#>:M6== =6YE8.$T:H--&P:J]I&B*ABV%
M?E%^_&0GBM3S6&< *$ZMOC/094)R[;/]%?*LYTDP_9//]_(S-XQ"/UJM+#&Q
MUK,5A17GY<;:]HU49,X-*^SVM,T-&[*=\K0K\ S/_8AN9.'_[4#9,ZGXUVI;
MO$HOC#)#H?E,_:_O_=XASO@9%7D60TK+,M,,\S674-<HW*M*2-_(Z>G\^NX1
M90(O^+4D]P'0"& _;9P;CF:;;5.=O^:.X96Z/<3)&^'(8I21!A U,>Q9C-L+
M(&[G5_65:)9JP2A^QL,.F-^%YG0VTM YBRD(Y*<C.6RA!#LS+<3/>&/9HP[C
M8BVH3T3XYRR1ZT(YN@-D.['[_O_7XJ3H:Q[Z2:=G,;]V$@>ZD7:* -#LLQU%
M/E+A+,W-6<RG;]K!(RIK0&\6,[6QNTQUGO.=\Y"LOGDO8!83],8(*7N/D)#W
MK%_6C#]F,97>MK.8WI>'7%=IS@+WI*[_JPSK_]]>.K^4:#;X H">XF?A $KD
M),4H[(Q:;SUUH8"AJREB-D5N-2VBS1>#);SUX2Z^;PE;[O/@\T]&MV_<$X=/
MR?V;>^?O>?%"E,O$ DT.Y)>L 6HKP!6WQ.N,\_6)X6_@$*G[H**6$DJLFDZR
M.S-4ZG_IRIE:O+XZ(LBF_#>KS\-P3'/@LI[RO/L]J_E38:K#S [*$N)9\L!/
M&7^\'>*[W@V$ U#.X3V\ CJ:=V\DI'2PZ1P4$#;S-@4P-[(JH2<*9FK*DQON
MAU-"V"JB3_>3"O4=!MOZ!4'Z];*3&5CRTF4Q?%)B8M@I8"Z$8Z1$+-VL"<$_
MS3Q5^9ZQ71JQN7O/N\D&GW>;G]COC+A=4W_^AMG'@5,>F''JKQ24+V2Y+%2'
MPAUR#FR^JK\9?Y6_ MDXR'#4MB_0]5M-79[#@&0($#Z%K9JS8SF)A?6097K1
MNW&"UZYWY?+:NAL1WE[V?5LW-':8CYK9:9P._;D:60<B2;*A><=!3KIM_/:6
MP#60_?52.M 2B.][4CYEC3_^KN;NCFJ%OWMO]=CSS]7\[FA'W;L95F-6CXJX
M]36Y/A:9\NNW9C'Y+(6.]JB IAPXB86MQ&I]E0!?E9/L\COCA/9(92 B%B_B
MAQ&39]R3)ZV!UAGL^(N*4;P^T\1?[?NND78I).0126IB17HW:6WQ72#,+>K-
MORVC+ R=.2TJZOB:YK25<YPUZ?;P,C&?#&]I&S=3D>EWY>+Q*RC^)&LNJ[<6
M,-PTY;.8DV-#5'=(YV5'W*':]PH@E'R99X:[EF\&VM]^/.RA5U.2'O7-CF,X
M,&+_@SQ/+*)W>C4\S8X _GH7U4%*@+!JHQ0YO@6[\"/C#\T=U/NRM,=L.[R4
MG7U18WGZ^[4*W1(<8R=, %6ME:*/_A5E\EG,M9GB9Q%%[9(7^EXKAHP%Q=_P
MX#\^PD^D2]+D.FH9>>14.N:77'FX5E-X2I.'K&(-+N"M>J7:%T _UO=5/I^X
M8'+(^P <%B;+J+/(#; 2O!N+S2Z/CS;-"=I0?/?1J,7$N%]^:41\7+&_:.2F
M:!<>>G9)VZ>FX513X(V45'25_\0Z-.-Q@*"(9\$<'M:.-+T]2C2,J"8L!YKK
MNUR,0GEK^%!.&O',POZWV<BJFJ>]R*:P0%.PVL5DY^6^$W7OHB@K=I^)F%H<
MR9H.<,4 2RE<FEJ_6]E#&Q3+B6I]*PF^N1.W"_U4$7KM1\QN\1SB6<HUBI'3
M)NF+:*=5X,YV@3[5CZ78)5D\U6'ZGK%5JNI,=3$#8U(:3YXL'O7>>?Q&>Y D
M'NN9_MTDZ*"9Z@I*(ZKQ"^E4P3 6K,T)>0 '->>:WI1REH76,T@+DEGWOQTS
MG F\7O3AY>4M]K%,-I46%K'R\C/!DO77-I:_WCCO"W;02^D'TA15JHUJAN86
M(_[2A2(X2,X6Q,>]G,8-W?(X'R=]<?B'>0/8G_Y$44B7-32 W+0GDZP5_KYO
M1A9\G#E]L;M2:)6+!!%/ _#&3L44NKN+L)64]<%2^0O=Y5EF/[[Z(+P@V%(@
MOHROYH]?D.3 ? DA@ZT75;HT<%[7E"_.T]Y$W^M]5#;W?41A'3^#XFDZN*^Z
M7[VN)+PVQT'$46Y ;;F%^-1RO$T5KI7&Y4M*+O)!7^R@7!)9@BY\)VP%BH_
MWMI>:]ZV.Q5,BS!<2&I$=)DS6>;=DK%&<38R*L#-'VL YW\=GZG-*1@SFOE2
M=[HVUS,Y2:*Q.@AAM1V+S3 >8K\4@VAU@*U1H@G@U)9PAI20C#?PE^2HK2BI
MJ/M?Y!?0K=K$ Q>7Y++4ZX8M>K983P(KXY.>-R#_:6Q0;5W-;H^TFCF+QM<=
M-KRC6\)JI67AYQ!/!EA*^,U *M\PFKQ$NP6793"_929&P-*A#F_C@1-)MD,Z
M0H@"Y_C7O#M+*^ZVM=I187V_OC>RR\KJ4N0ZWV+R[SB5&%FBHZ(B'RG/0H1
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M7/L4:0?./7\XIC[ [ "HO%,<MK."XY(F5<0(AS="1_O8SL.)T@'B&:)D&#N
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M%O/1#DT5HF]\[<V3*^)JRZ;_,)<@3>QG1(47E*+,A-R3=*XTFJG^H!*K(NO
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M1]ZD6X%N++2]0!Y<Y%5M^(NG#2\A3C^U0!_&$)W/OOU=DWOY7%.ZJ^NE^Q]
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M&#$64YMNY;I^N>$,-?!Q9MK2BV7/"WGGR@ZMV.<%LGU#)=.>!B47G52W$9#
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M%C.K?KF+<?J-ZHAG57E(/]C?39OK>H!,#TZH18]%9H:M+51@*G%0E!<KAKX
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MUCK2=#S*4[%RYTQJD44Y[K[SE^7?^NTF/4G97;(3ZQNU[V;=#%8-N%*J; -
M /7[V;H@A_,[9LS&\'@N*[W]XM(.*C%K(K 0R$X)2;W6V]4FQ')VUCG=A()B
M.HU'0BW*+BT\V5SSKRP_ "07_+X+,4370KG2HOS#!GL!B: J SJ5RV8+R-\9
M.P6K0^$1!Y;8L,-\,>PPN08:\PVL!2CS@7]':0<>3:0+3Y)R,<\BM!J]_G6B
M^FS+;"I3OQ5X^'F%5X'(ZQ3%':./T!G8E 9?!+672N*B'H[J>(N7S_5A!=X
MS5B+73@@9XXKQB+@F1-MA[CR%D86<6U(L;JR64,QETZ6A73W6D1^;3F8;C^N
MI7M3-\_ NB6?UKES;U)@ 6F'^0(/^ %WT(4ITXF>)O!%AE@Q;-[8@RAC9K0&
M,[M7(%6J9;I@,XXW&UD'B>]<5YH6,A=[:(H^.RDYY0[I7WCY?8%"[FX^&@'5
M \6NKLK9!F/8N"BA9/YA 7X*_<X3K"OZFQS3]62@_R.R&OH4Z5/U#'8,>Y+?
M0SYT+\8>J<B7,YV''?2;4W +GE=-U-R<U(A6_V91H:GRO@4HQL_+-+:PQ,9S
M]..+J$O44(%*P@%_(L&S0[V;H*KCVAN@GR_2S_K!%]DG^&^'6GD%9*\!I#.@
M'5_,>\T76IZ[#.JQ,CXQW3RLQ[@/$&JX@"7LB1$[1\,,*),@E8R76'KT1;3J
M6.HM7LG/W%-0Y%X$.N)<U&E@D2OMQ3^<Q]'F][[@F@'$M:NE(/(CLLZ@8S.&
M( E7FX?M6R$?XD8'!3$4A'OY,!* ZA+UPTF! <J3</2[)1OCQTD-6$6@(39[
MH"VN9Y"->HFCQ\. /VG/8 *CD4(#;'8AXEB*\_-:EAT[ -R[*R<';K[C7N%E
M+$SHN4DRXAI9O=U-1>/N2F G2W_F>LM8 -<OO #4-@.&8N$R;WQE @M]@"]@
MI07'XF6HCC^2MI<G,$X@^V&_X=JC!(8!1T6S!WEIW*O M@6OA7POVLAAE&L*
MC%J0%;DP4%CU:2#\"%P'"&9J=QNY(:!'5Y 2=4.BX,%^4Y;&[2_=!PN8LU:B
M55#G+V $>XY)62*#!E V#EP&3N#:[<B,QUP%\!6 YQ]'<J503,)S/DPP._\!
MJ(2HD[L0D:JG6]H&'&0W]CB?]OX]?PY8_V8Z'9JGLVX8W6.:_O#G/E8@5^H'
MG1W/\1? A!N.GD<&KE6<L2 \0[^7:<?][4"N,^U&/J-! RKA*@4@Q1AP:TA:
MCX(![#ZQ<Q^'EZA'8^G1DIV&(DF>..AUYBY$8C4"EUVVW.39A:R&U65SCZWR
M1;:8@4\EI[G[0$FZ]C1T/K##3=B.9;#&XYA@AQ"*=6 X"\5 X^LTU3?F.W?6
M*0DMB/H<PO.?9EHCFEP71M6)63_]_+,CE7JB%HFGVO+%S"D+@:"F\)H.Y\[R
M+H2$7!.PGY!@I)\^Q#A:@;D<&_ZG"),W (<9]E&COYHXQ%JD(\J"*@<BWW@/
M+5+/%)3?=L8T]#C;S_W3(+XJTX0E>Y:"WE]6^5)CNJEV+V/XHF+_LQG0P-4H
MP0[!:H2Y$G;L.E"(\P<X8TYHS]<"QSAW,3Y\!?X@K3:C:;9@RB]?OY&B71["
M\V#Z;\>6;VCI(:$8AR'3X5"WQWP-L9TK7Y$^HT3(+SQ?;.RB 5<ND6/^ZJ69
MABMV]HSCX=*JTR"&[W' WMYZ($U*_9WPOC^8;8=!/8YWE",O 4<?1L4A+H$R
MY;.@';.A&Y],/H:%@'8]U >C5-\Y$70"38Y_!L5$22QE_[.>CJ(P@?PGE<M4
MQ0JI%ZY+3?5$KPJG_QJ:HANK!!H$/!WV$4E%T66X$OO9OWC)6!WL(.U$FR+7
M'G1DDJG]G?DGL[L11R=T5U&IJ_.T.$K!'Y-8J6Z51IRTSW8#NXPXX^9=LU)O
M&-O-SN/EX4(H)F<QVE/)?!$UEAR[;:]6+U>-LX\;!L2G[$*\H'M7@%Y$6;-Z
M_R[GGP,MNA2/45J$63J=--F6.TQ"_ XQ":Y3.D5=G<R79^GGA9Y)+_FL^TM;
M.#;*,JQD.8LB$T15^AN;S=^+H RD<26]Z*9KM0SM6)PTSI/V#%<'Z]J4 HW^
M; 476<F"%R_VYRY$$</I)1S3:SY+@AY?R<$ED3*:)EHTBWHK9MU5X_WAFI%%
M^@1/:=+G;(.(S]E4TN)B(%?"SY*"I+^" <Y5,\+\0_/TH1.8@FYT]6(*7XR*
MI:!K39]Q+<MI?MM(H< M#8+8 %-;V*>!FM(@<\''@+7:M)XZT]*]Y0A4Q6W-
M,,ZTEOEE-W!H0CAZ'1*PIDUM,I"QN/O0F63^H5T(YQ'7B5>"D%G2QT%U48FP
MVL"G.,9=KCP(PK5]<[1BY_?-5_PNAD*-!(9R-,YJ<:\&OU5-/NU7WS1.^7/4
MLQ$A_WZ; "H;K%ERG+_P)V D+^YQ%/^P&\-?E6&Z?IIC"MI"]W$UP7W%L[L0
M_WX.G#^4 V7K47V<O[)3,9)=83MASUHNW,WQ;[8H-_8O]I.M;!8K;F;.K N;
M0N9W(3X)_C]IH&$G7V0VG%X= #=C0D'5Q9YD6+*XR\6N4?!,Q^J\?6^<%LE.
M> C>ZQ)W:3T+%)JY4_SKQLM_;7C7*#]$!8SK!Q"3< %5,ZML@59].L6] =23
M&56_@?QO@=/[V7+#46YOOWA'+) _PF)SNDGXE);0H+<K#[M+EK;=S[%,X\^]
M$7?M%5O(:C3H<OL]Y/O=Y+"?6W\(2=G\_VRP ^2=3[C5.MJ.WG+=XO]ZKD@^
MF[4YP??Z"7_LGOS], M%E6,G@08<M2A5EG O$C]W 1V_"SD<I1;Z=AK$=W]?
M:N*W^A4,,#4=9FZ,Y'SO[72^7U5:U/JM(MSG#KNP.M);2^M?&8FN&@V87Y4"
M[TW;08P!.Q<4%Q U!HSY#47?3(5!X2C@A\MCZZ&_\D^/W2>]GUQ/[.G?A*[0
M_J*$_,HH_X?F,_F]9VFI7)U0R_Z'W3(WE(\8>U&D95$9X##F2%H/F?BO?*74
MWDU(V,DNM[!4S3#@;?)7.YN,>\P%3RTGXYG[#49#0IBA#K(X5XZAG8 5HCR
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M9Z_ #0FV$4CF'"2W*X&N-/$UO.@MY V56,^.N!= Z]Y96^F.SH,#3BZ#WLP
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M 8MM!%OX,'2]!!]VBL%ZY& .["4M#OQ7S" 18+$2X&8C5A;Y,%\*G0KERX8
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M3#\9+;&+/CI6=F0HWPXY7&28M]TRL-O^9/E8*>>O>.ZV:CXL*I,Z\W#X8X>
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M_?># (<^H)D6\ 1:C>7J7I;<;'\,=::4#V.>04U03[(^-\NG=,W4M1#OWU@
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M-9!J@N$L4/A)ZY3FISW,H^:$MT:2]729DJ;86<:FOR@6&HL]8'N9LK><6!^
M6$E4!0D6N[NWR5B NYLUD9%0,5%97S!]A./:T$_YI^'.O@X;A\][O=Z^3$@]
M</[U,451E1V@AWI1+%&CB1Y(*W$7EA"CD:(GD)%$BRM; _#QZR@QL#8X):A\
MS<_1F%*MBB@(]"I.E9B?KR0$69_I^I,XMDA4WC!O,#9$+%7Y6'7TY?$SG\J6
M$)[6&C!1% GK\5. 9)1F03H;6(W="!..0+0.4@IU:]]O]\'-8&Y<<6#DY$'H
M3U)M=+G-KF'7X4I3H#:B^<B/&1W#@?FO)/.].S89--M1KTOTY5%2#[28XP*1
MB74L):JJ[!.AFI8FVSIC=91]%,QX"&W])]854@%#=4?)?N+C1#W2>M_C;:M-
M*3ALH<V;_YZFV:VD]>Y"[&!TTY*7$* [ =Z.?L--T@96,TVH$ZAJTFWFUNGZ
M\J)9K-: ;-OW,%\R< I=]1SC%%;<=:.8?$FD_=^5"DMQEW6T[1("M:>=$$UV
M;6=J0M_B?Y-T8%3;) K*O$.Q]U,MY<^OA]T]^YML^5V1)UZM;"D)7)R\%Q99
M-'/='''"_;J[><MVU7>J*HAPB^'PNPKW!M>_W&36<OB&OE_J,L/E?<=F=='N
MU\^<]+AY%>,MX*B0Y0IU.\2YN]!\D.V+! ,2:AE:9$9;5'.KYS06!0XGA(_G
M^/D,+3B^7ITV[-Q7TWBP7#R>L'E3W6U/':$KX8U5.WVL7*8DE/L'\:\-J4,H
MD N )U-0"* %(T\&'$4RJI7^TNAVTS9H^"3LSL.E3**'Y^8,H<PV%9Q'_TA=
M<T3QS-AUUO8*H*BBJ!2CG:M<37-Q0MEG=/]>(54H8:0RE8((U0%SV\1_5SVZ
M3]WJ7T)<8MV1K:AMZ)%94GMP6B&6 ?26AL$N3N+O&.\VNH;$,ZQHC#N.5ZC6
M9-Z\&!VXI<_=L<^BW$-846&:&0\KR3OK\7>F23: Q2;P ]Z@QQU%,?!CR$!8
MZ&/>HJO=IK(+I3[+4-[U/E>O+\*]_T>3XQ:2V\6>K0/T]Q_'*84!"-33T^X)
MDJ/20NIRRF8X%:3QM=N1*0;*(*J-08NJ+,RCZ("12;7DFF8_@6]]045Z<)3]
MG?Q7R@85I6,JCGAUCY:=#:;1P:4:-9!"[11C;"LODHU*8BDQUTILX4+>O +%
M!9X/$^BA8ZFK(:T*U<>5% <FF'-7-S-QCK*-%%9E211NZ?@Z]O7'^TG7\*I/
MAUR,S(_JK!@M8>B :*$&:"6(;..FX!2H!A(7,/(N<Z=D]6MP(;,#MP*.=DMP
M&:;J3<*5[T,<V1E8T_KZM5E./QA^(:$100&8VU_R;U_HW9SZIAS\)LJ$5T'1
M GP[-W8)H2PS)1MWTC6HRV:B+B5!]);<#4.;!R,8\5G=+]%ICY_!=7KG>J>]
M'G)%E_*W5F41:HT])@SO;6W94J+XJM>.&DXAR$W> +3LD2V3V#%A!P@0?9$^
MP2 AE$.C-?4UWPDO.)H26@*'G73;N9TN2.C?QJP!VR4F>T+]!<HY^[Z.G/MD
MI[.I1_%[L^974'(>/A,)5DY-I65#R);%X99Q@E*PKTVZ@)2P(#W8AE5*;XFR
M21TJ+B/G]K=Y&?Y9#!&E^)WWCXP(C?$/#5UC%W)@XM'(&M1*JK5$7_I,IDN.
MG#)Z@T_"JLE%3;7<I6W9N0=!;%5()3G,/01UNJG7TD.(%GK>*^I?",'^P3?&
MM3JNZJJI>IM\Z*UB>:_OABGN6( (@'T@ A_WAI%(T,:H\=%WZ?H7A[; .+#?
M8^A<; =N'2>![YT:*C'/-Q-_@"U*]+J9KSV&)B>W/?S\P&3O@XZ_2SJ)G-%H
MT2&PEIZ*"T;2Z&MD*V&2ZZO[_?8L.'U*'\5VF:V_>L?<BQSMU/S:R;U-^Z3)
MO>;VNE3_&(Q:PSN+H TJAU!'3Q&VRSX"]9%S(>* <:(5ZF6]T!0$II[G;OPG
ML\V:(,^G&Z:]6(GA>C>\]O,;AYKV7DIHL_:Y^]-IXTD"(>BJ)\?\QA[GG[=C
M>YM"Q<<HBG"0_*ZLWK!0%#>0<(>Y6W(=NP6E2-TX&]6VC[H+3J-LO9A%2TJ(
M"^^4_BB6)OAM\0G&NDNB6V>$+>N7"1^X?P/2 %X%"SQ!CV=I*;Z9UZ=.$*JM
MXF6[ME<A$Q@8HQC(E>VT+Y6!W^M=E"JP<1G[&8-D6^=SMMC:T!(M;?9^'7/S
M^+$UJ=OX"Q=&9PI?\QDC8IG2:VCV-/A'J%U,493FR;9(,(.;I8\C5,S;3\%
M)]4$NG*K$L;.>Z;PV\#Y5\T#EVML?*T:H[<^>EYK".S1\K^Z3.QO1ST M&P
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MHU?#0!M]!25F";&:SJ:AV%..-NK=XQWXLC&X0<4,G:B;42'0J=4__JO=VJU
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M[*W/D4NHGT_"4'[Q!2EI/LZQ#_:<\;%;+5649WLS:35UKV07_$6 NHU2B'@
M^Q1X!_FB(/N[3?;\V8-:D'LJQE808C!IE_7-K;FN(1-?U5]##,&=B%?>EBRX
M'C<6G5&?UK?:4J9*\8?K<+S[@#Z%C#6$/Y+'6^7]1\51/*6O(Z3-_ G=#VW
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M1[=\2B?'=L@,Z\YK>. W FD$T!Y0]OA?:[W;8:1,23A%2,Y"IN$NL>"M 6D
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M%BN SP5 9\*J8)E5S]&'XD.R@27$*&&CS"R[!--,L.VKC=D#\-TDF,9/)UX
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MJ5GZ)9?$O[^CC$<-U)[<:;'KK^J_ORB.LYK=&4L4>YBCHF>!4SH\M"!.<D.
M(F08JI"U,/=W5^_7&&Y!5E/4"R9'>#<OX0O=?( /UG?7W\XV6K'60O3S7QBB
MVUBY1X>_ T 3X%;2BZ3X5O*ZL5P-P"+.UMBCS00/TI(CC4(M?@2^)%7YNM+F
M_"YX]?',4H1OV]M[-@3F7O4[<U)[=^NROP<5BSKC>!4'VN9UK6DW' D%+.X^
M 8A376*W\-8Z? LYC:/SY=WL46(0Q-AZ^4DSEWY7,ACG&>Q$*H3<<5-CGEKA
MK7?>MX7'7C6__7L:Y0BHE9&^9('ES Q;%# L<3YS,?UP$?(FBE7U12!*S-T-
M>3ST89P ,UN^ /S;D=9J9P8X)X'0PNN15TNX@TEA-A%@0*2R47=-ZR_?>WQ=
M7Z],?I1.[MGQ'R>3\5YU05OYL.[H)*)Q@*4(&CH+&]Z0K%+>08&*MH'9^?25
M&ML,Y,,6=R!WZO.DU(]>0&8"2[(Q73'UZ'8BE\MM@K5\8E\0RR+^8W$OQ8"U
M^,0XC): RE'\$+6#55W;WHAM1TRA*$#A 5R\5Q9,U)Z=-CT#^K5UW&90\NAX
M5ZJF=;@O(,\V.Q&2]2E_L)-0&M;MG?_M8.5?):LYAR&JM/:&TP& +6 9T2)]
M*:N@9:U$;!4Q.7W29'=C;Y4F11OR.@O,%25G?&\=G(^Z<:QGG5NOS8";IS3F
M>\#%\_>SQA^1;:]%.^L!+E,Q*&;M0>&?QL+!L5",P@+V3)7.?9D:+J:3CD.I
MTC1-YWX98-S?D89--NTN!,BW:-8_]SC1"K,YZE1Y90ABG#5_+-@J@^HX7&]9
M2BI!YO_[)X'P-[+$8M[?ARQ@70/D7S&LB0L2'^5MWE\<R$9-0+S)V4 4WQ75
MJ@EP\<@JT*65=;-I-T00>L7#6'&CX7PK83MH4K!(3Q*_IMU.?3S^M(M5/))*
MC4EE5PH%5NW;?@DX(G3&T% /T5=A/JU%N0%>L8=]C;/ J_+Y]U/0XK'H3%CW
M.Z*9JMB"?FMSDRF]J#4+.T4%ZL5IHNE8Q0&ZP8_]O(A#8&WKE2C")AJ6?L'S
MQ;,8W_M57#O;KM7C ST=OP;T<!ENLOTNQZFA5U IV3&?C:CO$N,-%Y^5Q/W"
M;.9H$\SH7OZ /;L!J]@!ZP,=MQC&TIS=DT= 7"+#.0\R=:WHCW"CN3;=-NIT
M].C]*DT?_?9V8MN7VON&^T[Z'<7]*0)^PKT_).>C2I3*&KJ+:"P^-AL&!I)!
MG+Q(^2>\KYBQ!WJF($SZQ!O:4JHL7L8><[M"RE$[RG^>VS- U@FN&=T..E]_
MECMA-)D=2SHZX$0TJYN)GU5:>&,6ULF'T'IJHLVW)P:QAWS;%J?BU!56\#IH
MA6QF-63JF2G.;,??&%WR#N7/\Y+!V[:A/XS2R3YU(#&AS%9);8L^&UV=$$=/
M)8'. Q5U-5GS9>F^5*W@)T*68S2*B7CYLSZ^>("/99#8[0MO*-4&R00GE*@O
M!S-E%'E"#_U953PUYQC-1(6AM8XRF+8OH),T;-P7,$J8Z>F@;.NX];@1$9UY
M@7M,-":*RXG &>PP44),9@7PWO.053.* &87I<JK;;_)%\F79,2.V1N]#EHF
MGG\YC--Y7W-7RM8;(^P9L(TU((,V1?D^_ET629&.A3TF0TU=Y4(HQO]%G.A@
M_8*%EPIS@\' $N$U?W4@ZJZ%T$(+/B7Z\$X&Y2GT;B#S3M!OS/Y=(;WT\B^M
MZ=XW/_5) .N1_OXO@C__\FUZ$0@L!/%."=VN?#C\$G<<Z1 !/\XL;L(4*?#T
M0#'EUN(VG3BB,8/R!'(Y?D-FW]:5FKL4F&<CF^##8-LG=K:4&SW<-KKE6>.@
MT_8BM](1"JN%6$ _IG"N[8[HKSAZJRX^RC"MZ[,+O)9XK!]E^]F+3Y"';Z##
M0DS4A[);1<^0>H!-4I:K,($T->BN9\/@5FA["36<[B!K96)[>/B/N9_WFR/X
M]93Q>6NS:?-")PM)8\C<Q4$[ZZ@3?!&$TOP5":@C%"*O1)JPHV(/,D0$CK"&
M'65%T_N 8><:0#L5#)?_^FZX@[B"^0.KQ?%B%N&ZS.U"AX/-75ZP__J&05EE
MXDQK9E:$</:(JTUD1O>L>0Y,/#=;"^N\EJLKN5,J3#!'F(EH=*&7VM0]2UR!
M#/*KWV870!8O59AE$5H'M<YWR.F03CZ!;7-?K% >'/URHDJ%B8^3#PK\U_1J
MI94_B@DO'&\RBAD)0R@Z]**SO54/L6,LWVY;RKJ@.GZ2DTM^,',3,'_3MEZY
MSO]=9+VFFY?SP*R?9X^OEL?1_MEZJ-PJTAI_ZMGSW+=(RS=U+M[:/&-4NGWS
MG6Y^&A8RHTW%*,SH*!P<0&LX"47)V$.!\LL@YQIA/8,$;0T$>E^.6D*;@:Y6
M?RP4%5SL!EI':I*70H%>0-OG5(EEZ(\^/K%U6DM?DU-FIC)&HU]]=*Y5'.1]
MYB'J^Q1.<-3BBH$5;+23)QD^4!IP0VIQO6D](P2Z UQ4820&;-A#XD9Q!C);
M2XU-:#<[G_A!EGZ--:ED4*\Z+F0O-FKO?;O6*])O'X[]JV?%0^Q?(F@[?_H0
M"BF+J0@F@E@5[.F%42<69-$UM02P:&'B@:2I(6!88M'*2B9H0,_ F;9H7'SU
M?O-Y*?9:DSX]YJ<LLAK]@H"PLZ)W]GWU?D=$)YM*4W.6%!M:$HVH"\RB<5'M
M_+2;"K,21@8YE914Q)A.$L^TLFZ(-C!V26)&/.27(0$0A:A_ ;]+*&QD+>,$
M,%<K+Q),DP1-%D!4\XSVR'!0#;+E:8^D;]8QM:\GL#?K8O(ENU67(DFX=SQH
M6^U4E.(\\D:% 4[^>]+3FPU99 H.* [3TVD) &.ELHKU2[;;%9& :0F] AX/
MQ&PNI%=*VA]=3?558?3'K@@#DS;,>AG8)[/$M%6H4-[+7]%U,^*[5P<+\!*A
M;&/:53+&U$;!S1$=-'=5F)K %I90L[76P?-^"?R+LI&P[@#@)6= IJLS/7NH
M"_+2F.*)P738)=N]TF"G][CA]NJZY]\O]'$OV5W=DG2X"0.QI.79"E=6\TFB
M^ /G&JY&N[&07K082Q*8+0[%RL=..M*<P!_[(C@;J;G[E?<:*&5!358#9D_K
M:GII!7PH%>C]D;"SH3*E3TC-W=<[FY&R3D/P21&X>&Q$*AIQO=&JKF/]T@59
M#K;,Z(P1L)! L8_AJLPF4BG7UWYX==F, SP_#[Y-$N-OBI;PWP4X),Q&">=&
M&Q]."$_;C!>/T&UZJ!4U5[[Y'5(>IYN2P @6EK$]CW&F#]XG%1GCXVW][*7F
M/(E2.]2@Q=\4=)$[-]:F\*HHVB'VPL;V^Y)IC].*B#KF'59QR![A>*]S<&1D
MY!974Q5&CXCAB__DUU 26>(\D_5HBR] V1+R+31PQAU!.G&UE%2B&(W&6DT[
M_(.RG@.XY(A2ML9[*DN='^@8R_I7DB"+6Q3/-)_<7<B3W'#*[#W;(=M_<4*
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M* 'L2HP@ZT$=S>L@LK0@4^#H1FGQ-Q^TXLWQM*GV37K [=2B$)]R=DP@J_A
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M] =TCH6&5>L^W\'^S >\8BTD[*D1M-IH7>((R"BKBIO("5#L&84\.OB5 X]
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MR\+,/6$7,)A4C[YF-9_[_,TIG'3DQAFK-??"*'U3\06KGC]C_=8Q;A)2I?W
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M;F NH2662-^C*QSB+QA"KYF+IZ/AVE[B4OO,,,;NW*5H3U2$CW2\QWOHB_#
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MB\&*JBB;5<3YS 6PY1%S@85OQV#'1(Z#3U=5Z,I:HRFM1&LL+XQ[>3MY5$&
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M>LS-H5/W[/W059!9H9SR).0&?/'-Z)'GCV.HE-YQ[1.>CZPRQ'_S3WXE2BH
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MGF1:H3T:W'SSFL<@N[E=!S'N*G=V*CD2\&'8;"'DEZ[Z!3;Z!6)?C;A;]JO
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M=5H-L)5QZGMGB,=8L83%B [8Z0<;8!(L3A0YTB>AX1'K3D8X@P_>A:.#NB,
M,_<\^@H1'/%M(MI$.^7EN%V7:'/D1=#FI;C"I@D/6Q8CAN+=V%JF$N+8515
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M%-O+&=Y3=:GS[?6&+T/4W]7].B#Q?K]"C 8[K&*3B\Q.F<WQ%V@B@XR-2YA
MC=@*VH[>!C-<XIQ3 )=]$.0E[()CC8?<(U[ 4:*QFF=O?5S1?]T(%]Y8G1E;
M%-AY9T'[ZKJO^ZXT1T2H_+M.KJO0A+.$!-AV);*^"YH2N\1%:/S4)@_RI?<2
MJAC<[E4D9PN6S(5+W#A!UT%AZ=V1 .M?''7RC#[TSKLI#:^O"@O.TW-?>:4&
M%_3&NYJN4."7,#'!'&'R$D:-;3Q".]>SA+F1BKT\9-UXV3W #5Q(I1LI/" !
M=TKUZP?O-W\I\%!D:G7ZNG&OT:ZM_N/<BWVST^<T;Y #4D*8O.X4SD_X330
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MDT_<CZ@I>CF9MP.LX91\7TS+*7K]%U^6E@4P@6J>0C,265<OI]"<B2DD0R"
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MO3"""J;TP)8U*K)H^.^UVS<>@</%AX^H;']T<'N*9G-9E.RA$M79_DQ^5KL
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MJ3N%(2(E*4P#Q.3_VDK63%T<E%I&N+6GV38T?@A\M?\!_6?D$_ ^2Z$UN[P
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MNY[YE7Z>RB:)[RZ7%#9#IU$*&F?6^RJV]!"$"7R[F"5,(%GNQMG0!DW.RF)
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M$5EYLME6^AI0I4.05H=+>>Q%6S\;A8VO(NI>I7+/)9YWU3T.RHJ-][L=Z#
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MBYKDR)?$5T</)UJ+;KW]Z0%]/^JO%8N,YM'TT6Y$-:M(H0:_E9!22!N8#9?
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MJZ946OYZY'U%8S3KN'[F<$MTY76_[=@T#AB1H(*L?29WO[F2U4ZHA*X^N,N
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MQODVWZL_GRFPO6WQP5\$$C;81352C?^/&FWI4TU*PB>'#5"R]V]02P,$%
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M3^[T0?>R\55&$]TWV 'S<'+7[Z(_@*-E\'04!D0V#U-D4>H"-63&[D8+J>=
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MU03Z9.<(W5]JD,3($_K EU\LX_310DS\2!O7E+P@#G$W9HQV?O;Q\3D#4*
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M^W&%I0+5\A7IVU@YA-(=(=61<6B9DT_TV5-Y<_O&X>KB3^SGRYSN5 TER%4
M3UJ',3!4$T02A8EH1E-QNT,7JQ#MA=L@)O#3NP8,S>:K$]QB_/H9)[QPO1.#
M),13;YOHH*!+K-\"!K32U&(&XI;FY_BK&E-C6B Z$;EA.)#4NL+]0#PM@\[\
M;!9O-8D^C*#FN@3[''<X.E>U+8L=S3>7PC_HBL;T&$2:KYF-C<6$ZM_:]Q>]
M;(K&L'ZSAF_%[41I%XL<@=)R 2:+O'. I2G2[%U<^\-[C+C\)M8R.:]\VD>_
MQWGKK8">*KW(JH,Q)I)89?CHW&.KF">RP^\O/[1L4VX,]7X@6)#DUT![,<)"
M.5GI70&GX6:_>V2$6AAQSCW[CMF6EN%]Q;9XMMRYA3]MI?'A+K@G]UJ!U82V
MU#'6I;D#KU]7C)25B!KO0U(Q&YOR<ZVT"N6WBB8/L$Y 8=$"@B+4(:#.&8$T
M82UD-)X#[0/E6LF[H'20/HO%M'3YM328MDV9(!)Y>RY"+N/Z<I908%?X4U89
M?\TLKBJ@Q?W/C4#9"LD;VJ99!^4: +(ZVRB[Q3"+6N 9Y>,W83H@OC'.R[ P
MA$S!G>C$=9@*Z[#(8RAR#<Y?3C8F;)]:@2<Q3B@B9(+K5PI3):@,<YXD<7-(
M^-D^8\(>(XYT^2K"=&YY50\K\F1"1O'@SG68/>B_#FOUXB6J1E54$-4Z8MTY
M<QA!74'@<#UM%X.7FD]-GFO<1A%\][5V>L*%;GI>?I5E9QZ5.Z<JVRWZ?1UV
M,YO\EJ?$TOZ.VTE2F2B(\O9JSQ_.1)D"G6W8CNNB@$<D8^BU $YUME/*,L8E
M4?:8A"@.MVB8#I#, &^U!_&:YV[1_1BO:3;BWIMCGDI<FB)$U=,*/9]<IY%Q
M;:6/F*_B@S_INY _:&3O@/0_)M#<P7]^M^;8M$=PG_!VV8V6AFL/RWO:WE6M
MV@Z1)VRL(U5T3XY]CK)A%#8@W=9AFR/0T$'V7!$?1\7642O)[X4^*#"Z=1XZ
M4)B^JG5^.FH,!1T=1NQBF4]ANS,F[D'9KL,B]Z"#15(0%@,/[('R6OIF##\%
M+3\/&E:ZY>7AO2.>PD&_L)[K!1ZT6I@!;];NZZ&\@%H!LGU^Q$^ :T4H>/RC
M8TD8\&C>.#J)]V(YD:PTTQ#00M]*<A^N1J$1;3*Z @N:/F.EO:HX/HW7HAC;
M-$R-]"QE,V(H?N1]8AYE)TM9W,.39>V&AF:L 2J'?F,C]=5 N0E>!T()/_68
M:,V?; +]VHYN%#0:@/X0NAPMKB:V&);CH_,(T4$!Q4&]4Q=/AQTMW<9VP:_#
MMDFOI8:*% 3=*37B/IZ4+Q!P?8DM28QKCYT3ON1>L5 >),6%*]!N/AZ:8TK%
M><U9C+:Y&[5I))2?QY;>+_^!Q,?LUWRQY#[A:-9Z>M2=;Z]X)-G?#F[>UQE.
M<E $F=?>._H\?CJI$,0'=QTC-91*R)BH..9JROA$Z*X%Y]AF<X?J&/W.-E,J
M)@'O)ACYV$,C)H-'"WZ0=Y/^^7.40A[>\"TL+?+[#:.-<EE%?B)F_P$=7[TH
M_B@^8;&1GXFCPK@F4)LJ5B#W:.P$'I-^'S:N"(Q<0_*7&!K28%5NN4#=I06[
M-S:D+E6@[,\"QI(5A;IO35'[-NKSQ]K3D$8U0&J\B3T[44+4G: U8[@(05X;
M(1U1W\;.%&T+1[:SMQ'OD:Q>X_&2_,$[ D)J)#T]GY+"@$M U.8QH_Z0QA/\
M8\:)-*?&5?C'F^(Z*$Z\,WH5>1[*%OCSTBV,1;( KP4C$\R66D3 H!5T2K1I
M+#M]B9W"4AI&66ODT8E6,YS\D.%$NI8&8L"]I4;M\SGH10O7:Q6A1;IW>7$#
M/J79DN++4YD12P/UR>@@=E)L1PKK-RB1:-V"/5'W<BJ^'*J9KX[X2-(W=AG]
M,X*VYSQOY/.HYW?LV_XEN[?Z7U?UG[Q+[&\/HZ2@^LN]DOR4'&\^J#BMWZUE
M=;M">O3W!/HL.'CHG%#^)=6P4%,BW?50_6&\(6>P<*?LC<,Y]1$K^N<"_(OC
MYQ[?"3&OKC)'Z(K?K,.>X[+$6\1ME-IY#AXCBT>_0+?KZ[;4=H)<>&*^TIM_
M;HN0S<$,;LYL;K2%"8A+(2F F^&RYP/=CMPSQA<8G5,41N7]_-C>/G;H0@*_
M.QL!V.,R<7M(+JOGWVXPF':+Q<%>U@8O-)]F^ZW#TAH4BR,K1";]!)([L*6Y
MSD<U?8)%C^@-=E/"&ILN1W&[A$Q^M+>1*Z@EZA\+:G#X4FNY;ZVZ?QT62AA1
M.@?"4T4Z_N"&6)DM_ T@9TY@=L\T1#0\J:O22 <FS5,;XYX&Y2E%]6")-^$[
M3N/#D2D4/H)V+M[ /*9P2M/C8=)&QET3_TUC(%(-&O<!7L(;4#BHU!I%WO,*
M_,0-H$8FH*C-0^Z*BGGB _6%Q-\8C7T1,TW.+?W.#8S"B/[JZN+ZIH6#G]+Y
MOM"#K!>BSJ/=Z[ :4&-4!7M,%!D[8F7Q\/?IZA#J!QU;8D-HKDZ/1\;>0[Z%
MIDHIYYZG100Z'OV643Z446+A'O7K05ANX4+NBGG@[=>Q@=EMM'0TX,!.?4[R
M77O1>-1"8H:WVT)1W-O0P7&#%"I):NG""T#R X#^IG!OS^*<(F6S@P"35JC.
M!O/>N$'>3T^'"]C;>!LT29]ECK[.?<5\@=LC^7=[/WL\GX>H0EF#Z?SHUG68
MI @+T<M%I]>>BO1!0@N/&9 HLEL]&J2QG_HFUIN7&!J!5B92!>NP;)3.,U$X
M0&TE)*<_8MT*&Z=O"WP16'BHKF'@ <=IJL&MYMF=E9^K%N(Q']C:HPTN(ZB+
MY( 2UOVG4!0BD06'Y@&TH)[*[*\B>DU$MS3AO09("H(N_!GK_BL'^N914J"$
M_1T.MJ H5ZSVD1 QY];W;79YG_58),LTF\C6SM%C&[ZY<!5*&;\V4H+-VG\L
M^3O_R/?QFFLYJ(M"CZ=]G0#8UIM6)AY4703O:J9PG,H2U(-K7MQ.(]5\_]'G
M5-N0*TS#A(0^J:YD*[#''_,VK<."<)D(N=!&-)]^$VO=ADY8V8C4Q 9O$-&M
MA:K \.S\4]&9>FA*X/5V7[8ME"K@9=7U^1"U^7I<^=^G$YPA@H3P 92&'%.F
M4VI/B2,@N%@2LVH-I8]GS^5MV*U:813P+=7"A-@MEER'K9X@R4-RSZ#:=MPN
ME),  9VG2#=NJ@S,GV-E"]S @V5*2=5SS#7=%OT@P9S5.LQ1R>UW[O[@*H*"
M2'<-U^MSV5W@&'WG*Y%$1[;X1^CPQV0J[77\= 33* W?Y/?N)[ >TU<W(%4D
ME6&4.AW,!LZ//SS1L4WU9\:YBX]OU]5%]]EZ_8P,PC7TB&U8ARC-Q]=A^)#3
MPJBU*K(DE"<T[4<'XKCH"78V2@+$\9?G\$]%-I"KS#PUX@3R)" /'W?PPH&4
ME$J2YV-B K]#*)%"TGP2J'JDDX^4\\+W!^L\,WAHH'5GJ4PXM4:ST!%90[15
M:=)5)K0?'3B?Q*L55TS@>>FT%U\GF>/?F;IS7NWB+0E_ /6M,D9V(+DL"%AN
M;QAN6?,/E0KDYCXK/3/OW]A3=J^R#SF3I'",+EN;X:.);'5M_MI;N&FRZS#F
M2&)PY8QV\Q?B]S;4.YP3=>"J,;E"FCYMV.(>7G'R%)@H1S_8'VP63C$=34M8
MQ0;)#^M7_ABL0_]%E]G CB;PMD-L)^@&0!>>@?S&\4VZ@NRYX0DZE;8+%3-!
M2RPTA@B/B(2)>0Y[VW<<7*19/J58N*^Q=DCO:[K#L+%YIJ+7MI[*I3.510.Y
M:.EZ[H?E5@2DO3Q7(6#O(3F#T=?1 4C%J4(%$'=C'>:G;C7,:1"_6C40&0XV
MGIZ@C_R<(-^:P*EQ$-=9\G@S^$V&W=/&(RL%V3>79%Q5EYU>,.)"K#WKLKR-
M,)@9G[0E7OHO484+78^^+P=[MLS6J$#Z0WB.JN==(P^7"N=2O-E@3-C52><<
M=]USS[YV.=L^P<\8B3TBI@QN.[N3AF/I;4L#XLO[(60TB!#OW"+@?5R'60*E
M]Y^*N],GXC?,4![HPK]B\5NOQBI_N9TF"TFY 5C2)M"M^-'Y:99Z;Z1,W,3=
M#3FE,%'8LK(P-N81><*J]PO3ZWAW'C%/+/EK];R/2 Y*6+4@J:W=H]E#]B@U
MH(J!@'SF5TTXX"J'M]L8SB7PAUN[98D2'/1>"W6\<!FAQ%+P) 8X@$HI!B17
M\*BZN>< H3)B],2))75_9=,ES<>09C-9=2-<="B\14.IQX2GY&/]E%B+[8V0
MT;4=;,10=KZPC!>HV[;W274%+QR(/O,C4J?ZLN5EUZO*"?W#9B#:B./:W+GE
M1O.[W#W)]K\,YQ6\7=\OE,T%Y-O*AYW37*JT]+3=$/CA;792.R.>73SXU7,
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MM0G+G2>5+V4O=3=3 !?$B!0.L@3R!,,9+#UB.#^ROHVV>6K,O!98SM!F4YV
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MW.!J9PP+JZ#5<5ZR!KRG40E-)<L&8:EIXD-0=&NA]G.P/I50O0A+5__BH[;
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MGZ":<;GAR.2;MJ;O,;'APYT%'?[/AX_7TR,+LYV$*'U6!!8R8BTYB89VS&W
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MP% RO[&P9[LPI\(O/'\05V=_$%6M)0>]E4DV&E#MQ^A!?TD<@4(Y!!X#M.3
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M"(IVAALPD2:C?E[LJNS:822@P_W>62LK_K#>-5\K(F\Q.:F3V&MWOOT8"-=
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M.@(%[R7.EZ)J)L-NKT24^OK/?3&-O9O7'$?S,1.=#=G]91JSPP*8^%.>LH$
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MFZ.(B BH=(J8V $"8A0$I,WA(")$B I(P) <10A]CB*@($2D$Q "TBE-(DF
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M=+:_(:RY!:S,' -4DBH(FGWTM=,2O:8>T;$F\00K5E>=<KSVSGO4-F\\]LQ
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M'$>>6CV.M^=3D^J4!*AX*4PE@T54:86JA)JD.,+1<0Z"LJZ=QU@7HOL[J%L
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M<:PO'S/OQI_QT__ &J_=YZP=MO/BQ<L/E\@%F_V4Y9Q&>) W[V@]A0U/EBA
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M ;BL;7BN )%&,.91Y-K#BX:<!%15;%-8'!^:7Q*?X#I^F*-Z]%>%/E>+#;A
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M4&DD*'W-&89WQ"#+QA$*(@/0BC7C', D&@(ZW0W9JX<AJ]=>VO3##2!W]C-
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MPA;"H;UT?1G3+):S%,8! ]Y=31OH45"$V@L^ K%L1")H%S G8BYI6C<6OJC
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MLW>+ERC_OI>/Z7J0:;LH%4R"Z2B[&S 7S.R8N,$K9%+09,(8'MDP )NY3;)
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M1,1+5X"?7SK>+H<8:\J)D"U;G#R]A*VSA>Z 5IG"GDJ>&(Z0$8H!'>6,]5;
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M%A-]2,?L?SYOZ[_.0O4[Q-&2D3TJCFI(B]GK]Z-U(7J/3J&@!9]J&$LV=+E
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MS [L552%4;/SI6+F$HBI$#0+5DD8HCL"8\2.IE+*!9FP#\!M1JS(6-I7U2D
M?\U^AKR*;@AM4V9[M9PWS2.O=L:OBJWG7$F(=B$NUV)BPB2TEB_F+GI#8S]C
M-"\&!)&X09;(*3H7RE,E0]LJW\K?VK5*3%,V50!#+6Y3#T>+G/M/@;BLZF1L
M]=CV9<X"0^AJ<G9RZ-,?'1(=?KDPZ_&HI/&.[U!'DR/RCOG,YMH,+EU@Q7"
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MV_'?=TUK_X?Q<R82SZ20H(UL,?G[BEO8<$)TGK.:>8::1:R.A1I4Q=#)"Q'
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MY;Z%7V+6^IQUWK&2\^)6^<NURV=E<Z_OP,11D%75[L@4"MHS/J(#B (:/>\
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M(JM%HHDZG)>2W!=M1][V!I"%E89UGVZ)O3/XI)YW<>!M.MD-E>W2?X-L\B,
MBO^@&>H,'H])7^5:JF]UW;+:U;5TU*IV1FIK,.F/X]]K,-_74UFEK1%NZ@NY
MZH5HLK<2^.Y/C-[]'^V/,CG^]PW_?^ADEQB,M!*&&<BO*(SA&-NSYD);;SHZ
MY$-M+_4S]N^ZFT*>4WFV:>6&5>6[2I>GO<I^^' K"D=_"-P9T=>VDMX6=G1/
M_9HW0HL_7M%3U).57)E[VNV]I^LCK_+BE-5'+OLF[KS<_&JI8[/:.!!H_KFQ
MU(<W_#C^;J\&4_T5X/]KW_LX"<:HM1V5!Y@M;$.&=QEC=8=M)?D"TQKR:N:%
M*2WIOQ>GR4;F2.C<Z_O'IK; T3*[</%>J#AQXBOMV-,G[;83CZZ:1'-?.<TO
M$OOW%>>IBI@",=>G3DEE+.NH7T-/5,3#%4K"0&!"OF-;O548V/<63O+$7IMN
MO1!MZ52=7R%]?/CQLI8 M_93\^B",X$%SEJOF?-1E'308$*PR6(]A*S<1A_?
ME:M(4MTET&3:/ -ZKIS2U.>I$S[TTK?VRMFM$KS6-7:C6JM](C,Z<4_;K4>5
M-9TC#GV;?4G<0X(%ZJ2*BINO7PDQQ])78=9B6K=H819A) L/T'.;"7J"ESJ+
M3*4;?]BPP.&3NP&[=N_*FWN\B_?JWO<X?"/IB_YO#RM.]*YKL6F(]"G8&7EY
M1USE@X#+-XN.Q?;W]_B5))3FUN%CQ][$/\ZPYOR:_<._Q<3_JP=GOJJ0=)QV
M$<<MYD>"F8I$<#>R!:8S/ I@GEI7(:IUE];2,_E')D*KTSH1FY+0ZB=.;OOJ
M<,>-&KO/;%+N63+"HM7L\V\O#=#QOVJ.]2\SJS/Y2\G.N@57BORS_,_N3]Y]
M,.S)ZYN[/%9O.WWYIZ-7,KTL#UA9>^Q=\I.5$?V%7;/'E)=?X><8]?(S&LQL
M+@J 5"JRF;>,]%7ZK8KE1I2-^Z/!BL-1FXJSV @X/)F1H=!@N@?6:#"W\](
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M34D>RE\%QTNP%]F&:E>X5>J>YGA,=0LY)ADUDJ8V4G40,U#!@3*%[$6UBZQ
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ML</!L2P9&1L!+//> KO+.$L'JWE\E8U,+UR-A3?(M?M),G(&PZ*H=Z@=#J9
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M>@3E@=+X7WS-+_*_NH:&N@VEMT0C0/.NIL9:U (]#4T]#74G"H-":2SZ;Q]
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MQU<;)HGUFZ^CE-CBZU"35+543[$!Q\4(#"33J;0-QRE?VH6/^)TO@D5"_F%
MT1[J M[DB++2YW15&663M&5DG8^CYH_!Q:U54<[NJ_O8[Q#N^L"H"O+0Y;X\
MM__8D-T*+<&18V<RJ@(GY]QS:L>[8LHG@\)3:DZ=(Y77/]EVZ7:U?VZ9Y.7$
M]EI2Q'?[4X*):25%VLZ>CE%K'V6Z('I;!^(J?& =2$."3J0905S0Q O IN$B
ML>EF\1V8Q$MG*DE5Q_'2GG27!COW O'.30TO7.96.ND\SL[?Y+3#]FRZAMEX
MR&U\RT$-3PH#T;%>(C2O!T/UA@*!9BF&RTQCK% M[RD+@@\#>8EN_O<I.0'
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MJU^/HJ]C+%1]1QLF-!$0Q2PJ$1K,D,UI;_.U>/0K.$OWK51MR($.U,M+($\
M+Q).72V!]>J"\<DUH%<;1\_M_-T02'AD\'U=(ZC513"E^O7.%)#-QW^:P!=W
ME[_\TFTB(W0Q1TSX#$V.Z$;10DBHH$ZH4?IL#'P)G.9.IPAU68&5--ZH+8"%
M;7V)4N>LQ@HW)['N83'ZYJ?PUVQ3"HV>IN]Y4K*)NBLF'I?DA@NKB=83O'4T
M'CS)?@GQD*9M0"I+I=*A.TSJ"8BCV Q_!Y9W8DUTEU&D0:V-@XXC^#0OKK]V
MO/B;^SHHWN-U0\\R>$^>U^/=.?B"KKEM'+NFSH"W:S=GE;+M:2^%FNYNL,4@
M/4)X [.4JB=%ULZ79Y9#]$-0>.W'8S]1O!LNKQ[9EAD17CI2R@K:]S$K/&)#
M^K9;9VL=+]K9E?:O;[RUY X*EXG+9#209?<4&-K O!<<(DGQ@C Q-I&5@$0<
MKZREN;<#0JFS+%XL%#"Z.&C5=]2U@-;U1D3.G  PG19F/HP5L.O@] ?@3;^3
MQ>(/LH8,V0]"OR%'G'OO5$F=3T\:HPD[=4>Q'>%17=RYG5;R/Y35]$A")J%)
MJY.)H@1+4[FX-*'>M%-6DE"?A07-Q8M;)1PT!>T-A4612<61LY:FJF>/>J><
MNG?G=(:N>_WIDYM7;;2_V9V&8/QX_0](XN[(VHYN.^+/5T8)'VEUC#=6"9=
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M#&>*+.[)=-=ZS=8/"H4RI!9==RK@?>"Y5J ??UV!$,R@F\/.QK+;9.<,S/?
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M/Z;R0PT>-M;7-S6\HIYQDFW32?")M&H..)%I\@9V4%BJNMDZ4(V(G*E"0R;
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M<.P?-\1?;=K_L"$V*$OID9WA7O/,7>(NNRY<1;.N<N_-%93SKC3U=I]8M?S
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M7?(D\W]O?\8I\GT%&;H'QX6I3A U9+G1M*3 C=!%?O]M;]@F&WPRR:P)BA'
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MLRI*\MM0?YI G25_VB/?H@G@>&5"<YZB;(IYL(59R0&I&10'F(D?#A!W3VV
M;@K4M#&$++X:JT#9S=AH4&Y**/88)@8(.(;8YEL%#W-U[,-'I@IX0D1'[L"S
M>L],(?$]2;?KKVT74UG.QRK36(/OCK==2GKS!7K=1KSV.FOTY4 Q>H-3VQQ*
MT^+U]""3%WGM2YE9JEMGNV/TV\M:^/X;Q?%[=$47)WTGID;K<BF,$#(W1*HN
MZL TV242-X AXN.RTJ4L;:DV3(-X"9"(_QV3'Y9:)O!F,D@J3*YH:Y8>BA^
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M#)O:!^KE?>5<;#VBLVM ..W\8&Z\)L(Q[!52&Q=\U']]V!4MW/FB[#_;\37
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M#YP3,S(((5W>4NKS?D((41?.[,#_"E&?BG*&%HN]$Q2K &\5LPV:/:U]"G>
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MG^:+%,WE<.H^PV4-(L(O(?6A3E\K[E(N?';Z/8!"/A(ZG=?^1V!"55'DF="
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M>.PL_#KY'=:R<"6J)K@5F]KDDE6'-40\Y ]^!?6R%=:3WGJ.*O.?(EC&5'M
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M\Q-[=&'@XVP&^I$H%R*C(T]CJYOR1Y=I)5C=%K.-I+9Y*S,EI0MEU!B&+AA
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M2R4A/N0.>B3H)YV.K=64.+FH-UOV-=[CO!;H$LPJK@R;>#^+/+D%6_\"+7C
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MCBQ!MS475=$3SZ2/32;K[T73?/$W#56Y)1_,])@#PU8E3_1XZ#QZ$J'BP00
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MEP\5:JY#QU,*!06%985G&@"_7UOZO\K<XLPRP%;2"EN7^<LWCKEVY=&8B8_
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MW^K!I^XGSEAH2?N7'K@:O"L>_)R9RH70/!=)R/?;-%!SB6.#"A6BOBK83S[
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M*:YSJCJHV,T^+EY^&M+L5+R[:8DHNJF:A;Q8NQTN(&C^_/>+_X46P$,"_\*
M<>@*+I:*6VI)Q0XX_UL&SQ ?V(430:^7@ZSWQ-73.R_]_@*8UUM*H9>HS%6Y
M3W--2_*GM%(WP54I22&,*,H4S ?1<8>3[^>(;P>TSQ/ 7U/L^Q]?C\C=U]U:
M]B[%[ZSC#UX.32K?.\ZE"S\EU(?JFG)T ,S80%F=U+Y2DZ(E'?F0L8*"0H!Q
M<=9<+>GM)&=1EBIU1'^1HGU:QXN..U6KOU LTP_/V0#OX*\WW2M?<"'8<YZH
MA[7?=<D]9.8NY<T496)*:GU1%S9!9AQOOFC7VR4P><IA5G*ZF]-"IWK65D^O
MF#VK%8JX9'U[(#\(M73P7;75C?O48\;N(^_D'V9"#Q-&^%Z:6W<1:O_>#BVI
MU:_*?$5ITPF:,;80L13RHRE3TUQCI"ZP5[Q@;N"94' &;='*)_:3']MS9[+2
MA/LH,:73,UTL;ATAQV#.@?))N18E5ZOVQ5Y%"0=+KM8\!;L(2WU$B@$,8VA$
M6/=G)R6O"1 ,AE/PQ/TZ^+1. .L#"'J/=U>Y@'6/WH%PMQ# ,/P1QE=?1@*5
M9U 1 LJH_528ZZ-Y4.!CM04=>$2_CZ[9/VH/J/K^^%R4"H/[&^STC*L!O6"S
M]?0FFZ/(QKS'W87M2]W7R#>^^&&?-/9QJ8_9V\);9YR<,X4.9Y$URE 82J*-
M;\.FP(D!#/VALG'"8G(T;M[;)#"J+]T< 0OIM<?[@ZW,W%XFM^:)S*/EN985
M=1^[?0T1YT=(C_DLZ'EA4RZMSCFND#>BUI)B%9QF:"B0*.(!G$)H2TS6]1<G
MX[IE5(W1<S(V[QTXTDQ!%D.;^"K[&V+<;!51#3Q>(^^ZEL0(IC>/<X%Y(O%D
MM@OL5SD+6P[[511_%XK-O+')3V&+]*-:4G0TG-E1^ (V?:FZQ$,6!3YE! CT
M\V!:@;+,NT)/%MBF850JC51IK&<-VUXTVA$RJ+85]P%EJ+20JC$A! 8A,F)[
MY=^UI%5AP)^?E3NRW BD?DS ^:33//R,#K:%66^%)QT]3?S1-J*P.SN'_3Z#
M/4L2<.^3HWMA2 O-;MW_J.#4\)YAB0&!IX.[('/!TIC@PN@O1W9*QXZ-.?+C
M&*>Q&P-55IJ;M"4?V6<TZ9QQ;*:@S@:S#4>N=H@J!A**TN?D0U<]"F"-I!(8
MU\59^KS.IF!SKO7"][E#606Q3V)P;]W%U 5%WK'YA0%3%P_?I(K8"ZLA7RW)
M(Z^4%J1)&V;RPZ?,:@6\5-(B59%#$]S,808.'\,$XO3VMX,_MSM@ URV!6):
M,7R=!LCV^^E9#_3F+%&U6UE7:D+5#CT\7R78TMS'M&S$H0N=RG9Q6INH9?";
M.*6EZVZ"JF'PR?^6-U^MD$%\"M(AGN5PCD.XHUI\%?L(O)+706_E*S?4BX1
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M<[Q:0I!,;&8@OJ-?'4KHEU3.>XKJ'CO(@WP)D'._$$;,^N-_FS[("H"^Z35
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M ^ZOEW^^NFO'+L.=]^8LG+70RN>^55=#KT61#S<6DI5QS(B:GJQY#B(3H6,
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M!$1K_.=".DGC+H%7(THS07F>)HU1BSBPND)^9/,B*0<ZQTG 3QVG7<'"!.(
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M?.>M&$P:$G0)'@T[R<0BPOM<#,*1(1AC=']8 #"2@,3*;1Y:!E2*$VRQ9I"
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M';[=>7G:B_&*L/)]0M&)N^K!CO_N^]*"L\([\"4)(86J#V*S*5%2':OFPN7
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M>9^GG4WW-VT&O6W0T0A$*F)X-7=68<%%^+SKP[U;[ZD.#"M]+M<6;CDJ9#W
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MCV42[8@MR]B78_PWA3_'0FG]1V2^N@(^;#O6+CE*)\LP0SDH+[90G+]]E.:
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M9L)K.*O('>9*_,:B7C>7C@N<V";C3^"5VM!'&CJ)1I*M<A0'<K:@O87-5M<
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M1,^IL!:SA_9JE4 0$P="[)G9GHX"C<):<B[@\_$[,46>FG']43"Z^L!(:>G
M&]?B:74^WVR9@BN)%JC!@+LWA9-ZST*9-H[QI1;*Z48>2<OGD/MQ5TQ[.%\"
M@2DJA>^<)EXXQ(5><>>##R0/<ZPQOR_1PS5)P?G$XA2?N5W-'C= WIZL\!U\
M:0;USNB +_] 3^W-CH^.U<9,DAWRN+[<URX<3Y0EO>IB_,[\:S,K>.Q)-9YA
MOD9/P0:D.HB'SXG7"9Q ETQL@_);56?%+N"@D>6DVJ?:JI& ;?@&'=6-G6T;
M$$'=D[/EP?T>8=G618^(<_[(-[R<8KYP4*;H_\9/X&FAM.K()=.'X+K@ O^8
MN'J&/4^CR..$9VAK&5E^&SV_:*['EG8;#N__N%58>.>P4+9KN&/M3_L9<\$A
M,@5!YF(Q94AEXV),! ],.XD7Y0RP#I6W0=.Z=%"K(9_K*0*7,#\-M0!/N<LF
MD*EX%.*,PQ@U&V>E:20N*<KB"G7$=V"U7%;N^"@EK"LPM?B[=@K=BK SD8B[
M GXW?<OM0^R00ZJY7(62UF+0\_KB=7ED5RJ(.%$>1+QDD0BU)CX?DMB[FS2I
M%DK^&#UX\1,T3"Z>VQOPZ<%D>,PK?$WJO>TEA_\X*7I]8 [W&"")QOJNN0E)
M5%U 'EHH8V8T7MT[UE(%#,9+X&_RHC/8?TS+.^_!GR71N %2I[\6M9VRSKVB
M.WF\UB.V< _&J+P%3IEVIC*E01.37_<$BKKB'W;7>T$-$1XC)46(^A(RC;ZU
MEJL@/D=%<EC9KTEK,_09-%$7"=LDR+MY#O8P(E(7QA-[X-M?Q<@8:] )F<2;
M$XH:+J8%FIH,+EN_UT;XQCX0=0:R[)-[EQ-S^-N$]9VUQ]_'&_>3>WTA(8<?
MD+U9<-I"<66XI"#>[X7\/DFL^68@"44EZR)C<0Q;M*GK/9R<2MO822Q1CCJ<
MU/R2KC_QJD1J+)F<VWBQ:45EZNTW+-9(:>Z#Y:-_4[A[AF'T !,L.7J5M&I=
MQC:09UI'_!$=W*+HJS"JNB0'#<HUTA!J@=@W6;P>4YRO92P?1APX&=@ZC7_W
MY;9*-DTZ,/>R;, ];S,I,,>:]]]FY^TLB>U>V!V@#VIO)1O&:QJB)M/=4'S'
MM B/)<.H9E/5S#'L+M+"X+K@WV,V9^>!%/)K\F)8R"PBI@ 7;39G*29J?PO+
M-H_0<LN]L2]ZV@8$U_%EK^AK3P8H_8M:#[#Y^O;? VD=62S"5F-:.,JJH\JA
MOF6&2" GM[_2QEC["CZ">,?&L'7;"MMZ+!2/0.1\^1QP-=TF3WA9$R;LHL\7
M+T3+B^\/U25E].97"]\XW%G_I_8]O*X749]C/3 VG=0*9HB*)$G>?D86IFHO
M1)0V[9+[1#Z6=%S5%TYBT:7BE9Z^*?/[6^QEL*.H<!YZ5*B-\6.ZC"*.QPUS
M]X'%)IE[CTCUNF-3JMOMT]RC0$389YBRWN)4,@N%W-<2>ZXM]P_/O$^'8J89
MS94?H;.]03XK>HAET9PX\+=ZB+Y!O??G^BW+:2Y2";5YDT8UE01+^Q.D9G05
M.X>)3:_+2K^95+JBO/'+AZH3%HJ-1'W32BI>9&Y* "F^8TVFM>QG^SY9HC84
M"6\&OW]OVLSY"K-I3UG/5"MR.:FW4P@[L!XU[,;""O%8++FS?U=G:C6:<+H6
MAU#3CLY9HU'=1X\L+ECT"MXE9(&%S+'K=[@O+!21S5A;H*HM)BV7);)0V@WN
MG"R@;F#0.E,_OJ6UEZ_BM[B,[(4<T^3G2A6D5!)^XLEK&RJ'>I5'&XTGLO_I
M'HB8>;]24OP&:7%$ONVGGE_#20"9.H-R@29*'H,H(1E4+\AEK 9^\@&2JLY*
M6\H#23?E#6FH19SUUZ-'B6ED2\M00QYL:./]^SW-Z[1,ZFC7^C]3 ZNJ4Z;]
MI-PRI9NT$7Z(^H;/2O,3^AS3GB'5+'R1ANG V6&^;*$D(N[X%(PA1 FIO!$Z
M(_ZL+TFY^.H]D"8OM3DG7C)<RI0QISV_NR]YUJ;;8%U;\3\CC=X?R_S>/O=N
M7<[Z/6/L[5TV3RO 79Y))R5C%=5(RY?T3R?VLA&EJ!W]= Y8W6.^]Q'*1J.'
M6,*XQX?]B<7X9LSQ>O!870UG?B?#<?^;(?&:CO1U3;_H'HDB@B;_3&X0+8;U
MP49_LEPG.=[F7!J2&!NEX5UD!($/,>9J8EX?'@5$]_ 4S"SA?7P2KW6-]DML
M%.3K P-0HC ]-5.[[X^!E.\C%KW]L3%7Z>W3OZ53GSH^9/8RKC%?%,_BMJHH
M]4B?1"U47*")O8>XOB!/^\P7>R=*T=*<O,.U&44?#1 H7OK1;[W?9M%/OZ4,
M+.C>S+>]O_6SAZLVT7LC[Y:L/LV%\&_(]?7B+."FD^1-_EGN9^;!B?P<TE _
MP+U-"]G/F,!*PU*>&/T*/8V=$%+/0NTG($BHHM*>,CW8BM:XQ8>1.?C2SH0B
MO?_LI-*P@H\.&Y7OM?"? FNB$ZD?/,WX]&_K4 [3M"T9HB+)D"W()!QM6*>5
M-F?I$=HTI<VV)A3B^0*#NG;^Z"[446C3%LR7JJR;_0[^L!@DH:4#FQ]T?'1K
M)-YDQ6Q_%#2+>)\,H5\8^G:30J64UO(+-YAX'>([-J%&+G9R.U0S&!0VHB6%
MTG$+)9<_0[R4J7O,7?![#3O9CNL]P.;MZZS%]YR\,S#L"17AH=K:=:$AQKIC
M5:%I=V+EMS=TLNL(VUB3+VF=D#D?_50%B'#O5;6%<I$O+!+IZW2TLR%A;4_<
MJ>?V6BCU![AK7N(GLW1%+E\TH]Y$3?)D>],UY:*//[][<BNF/^DGQ<&*>_^I
MFC./@G_((^Q'2?I#J.*5W&Z6'6Z/NK1)IHN].,>QJ#-T-]/R#3?Q]!XX15 $
MV7*]V1\(I[39P$*1$GXOZ[<2[B!%N^+NC\D,/S1-ZO?<(_I^JJ-\+&2PL#;=
M[U;E=@OET^/D5$1];0UG+EG-(FZ/:B8QC?N,:EI#7J CB4EBK^00F"=,*U F
MM",7RF>%\,]4-G>-CSHPAA)AQ^98#6S''MSR2A@;>: PINOC\Q_^B;!AO@PP
MC&4V-:EZ]%Z$G3\:TS*P&BLB%P5=1(0E+:2Z43EQ V&]G8[9Q],PVP^J!=F>
M\C:OM\F0,SOWGS^\UTA#M6'GZ MT_B?<>N@LU-2".-/7JLTI._\>O[7\0O'J
MQ%$^NI76QY)!4^&C@KX!TTYP7TPA(\CE',;"Y"S>#_W@V7:>S#TN$#M".#UZ
M]1G(JH%S%XG0=]D\]=4YJ0%O-TM9/RU1&I?2%F_5[?L"=H,3F,H/Q QO=$(G
MP3UT.E[V>!FD'%&I[XE0J(T_@W0[>A]:86EQLU+$8S@,,1:AT_/0BNW-6*[D
MH(;ED.CCV$L+-%Q@>*&JW/="!<0NV]#4C)8-IQX[=!@AE9*Z5-4@OX <F4W/
M3-?2BE@/?4G6M$\<H!8;-@*72CP.?(_Q-*(+@?N.*@KH\[ *-;]]:QJ'J5D7
M&_+.5H\':Y?>N[NH]^C\5V/5+X_<[(QX_FZ["@V3G#%"[MQ@\NN9IE"NDF6=
MSE=Z1*#36"[':=D6"A2CF<C[B,S"::CC%73PZ<"Z<_42.\GY:Q@CY_J0,6KE
M%P/SREI%GC6/224NC2HN<?A&/&I:25:?0<PAGK,\Q2N)SCI\&^C >HUYX&]-
MVC2VBQSQ8 2SRZ2E]QH&K,'Q%7EG\077$\MMT+PS] 4522?2CO=FU+5I_A6F
M[C9O>O[NYNCY+VP&CN_:1''];]ZL05) 6^\S/T92X5P$W84HNYXBCI(4IG+!
M4W)"A2QVOES*I:+\-I['4)S7R^6'0*:Z:?C(>-$"9O?UNOL-/QG?C^@UHGSG
M>T<3?LG^9Q6<J9F@Z#@;GW__>*\-=.[9R-</AP^ON5-8'7W3=\?G=X/<N@HJ
MYFQEEKG-B572'R1/)"J+/*)W%_S$6WZR+./]S_4?X9>G2$'I;P#L"=QU <'+
M,=:0F7FKDQ Q'18*U8=$V5FD ^6^@D%F,VD"GITR'R,6E9R'AZI^1] RR$+Y
MPXQ45X=UDUX-7C"QQKPE4?#/ ,DK/*1E(SP$X&0^OGY@G87R]Q,(Q0Q@29@9
MLM%'D@.:Y @NJOAOY[K^<8Z%HOC-_*>%LMO3#Q=)-#H5NI,WR: JJ\D595RT
M4/Y-"\/IF<0,9PLEK,7TE86B>8^IR"B&2#E\2$N=7/J0A2\F3<H_$M;P4-9F
MY,,_\#&X._=_,%!8NY^=0Q0<*;%0[$CQB0MZ)T]!N_@XSGNC^#COAN19)N&S
MGBRGK852H3;?1M )-NG*B\<1J5RBO@Z-<R AD_ Q>)/K&."!XKC/+)0;98M(
M W($L5#\/A+E>?\G:?\G:?];)HTUY$4*^Y^QP2+"%VGY7/*MQ ??@B'Y]"P=
MWP5?[9F73X_7FN,^Q&$K)+>0UDWW^LVBJ)Y N\/-DL:5H3,79^;'XH\JMNMW
MVK2P<S3N"1KCGAR2XL2L7R+;#SL]TX7;A;OLN.E+#UHPZ_;6G@O?J"MR_Q/-
M+/VG4"@X<N=@Y>9E.[9M?5;\>\#[KJRL.9-+-[E&_96P<M<FA,)'HRR4_DSC
M<T#:2NL%YEN<*>@SXSWS-0)B>TA++933:I3LV!QO+*IM $)?Y#L86M.F)&=<
M2HIF7*W9<"C>NZ<R\R3RW8]?%OK__:I-FK/PGOP]SE#3$\ZO%=.6M,2CC[,.
M+(Z)7/WSD=B05TM?7*7O=9DQW+9KQ[:C^QX]#WI\\N#"M\K BJT]EPN2_3?]
M88@MW=O531!#_R-%$?1*_CMX.6[^K]&W4D7YOYA[SZBFMG=]-'MC \1(KQ(5
M 0$A*@20DFQ!0$! >B<;D2Y$1"1"2%2:]"U50<A&FDB)])Y(C8J(]":$)"+2
M)%$(2Q+"/YY[[QGGCO$[8]R/]^M:(S.S/._S/L]<<[V+.X=G.-@D$Z$C//5Z
M8:\*=VL?]-A+GRDW-@?@NA>. 35,")*IU 2KJ9Z:LEUIMTJH@$V,--<WMW:T
M7BAV"5G,#92VY:]%_=[/2^1E2)-&=1N[D0C2G#VK?A26!KE.&H7%J-D!(_0Y
M0^-K$W<[*F]%&&IS)V-<E9J[QC;_+AK]L>#HJO[]5*8*R/=T ]*T>F/BKK/X
M3>M&;YGZ%R_IGBYCS\N...3 O2*LPROLSA=87,RY-*#>^N[*;C8!%2B[&:P_
MU\9],>[\*P0/J$ARQ(Z"R"SZ7N6CEGEE>F+Z7ZAB[G0W1\69*W"9MY2'O-MP
MH9#9XCS\,ZP.\"U=[P<L-6RA\;_"]%BG51:4G4OF\&:48O7_AK">&J=9E"M@
MR6OBCR?)9NQP['@Z_9(#L$1/\$X'\[DJQW9O&<CL0.(IC?X<"2@=FU6UQO.;
M6#WN E)42XC/H?G3]E!D-T68>R9H5CNG9L'UW4NW@*GV%T&5/L>JPKS%\NI6
MOH;?#3G^62KNR@6R\%;(Q_/9\[>0$@RN1*J'0]6-0-HWNY3GV3?*[*J]#RPI
ME8A]:2L==>O@ZS97:__'LL-*84_])>'GZSH4 )U@5:!*W]%X@$A(NQ_I&_ER
MKB49?@:@]-RSFW&=]@@*]Z@MH=F(!.;"[:?=/#Z[76CM9SPF^_GGY,C2",!]
MWA0>K[,!0A&S!>@SXCQK2J47SAQXI+T/NN7_"!Q$YM^Z]^'"]Q=OF(2C=$^I
ML1S'V BF=790VZL[+U^&_S MJ7"T#Z\OJ("[_QC,.2<:[1B[U<')V#[#HR=O
MQ&(IB7%=6JH4UZ*S<?6[9HY-NI>NG]0B Y:)-H 8=_.8H?<M:?'?9VK[("$R
MVSY4^CV/G1C,CZ:'K,U8 Z:'E3^%>^*9YYX;M^P.9B&C8YPAS;Q@!$\Q-DMV
M4_=!RU^P7W&5BN)<=Q^N@!EOK?A47;"?\4T7;+N]F;UDQ<M;RFP?/N:_N.ZK
MO'])V\'Q!OFL59U,!LOALR-"8>FQ;=_._C^4?0>%8-W"Y>WI<QLW_R<4+-0X
M8QP=MC&NV[O3=W$S$0MG1&X(LX.!EAZ2!/=D$$6 *(U$!],ETV!5)#F,R:?&
M7S!/]QXX9.06[-=VU9#;F'5"=#-R?>N12\WWHZ)O/UE4TF8S.&*67 '%DE6=
M77@5.Y@[L1M:4X9<6'$K*HAF$LBY.[/8BO)Y2Y^7*SNYHT%K9R1S=9I_SGK^
MM7HF@29]^O:)(U)VNSI?@:3Q"N.4UJ@NBXO9P?8E1SU=1[-5K5/I=L?MLA4%
MQE=',_.M88'6!8U4F/BVBHZOG5#-1"$;&P59U33!/9,H8//<:[?==D9\$128
M*^=.(9IRIGI((*"DUTN0F9CJ3)]*5J@?,;"E'WS"@97:^.LD*4SX%SBZE :4
M-[QN;8J#[CHP?,.7!7DS?^IWB2+X/>QG7).^3RTE7?[2K9BP:CDL["XWS77>
MV=&.5IU<4FP_/>GPC>[W;=)AQ?'NJY?=[1'BJN.OHB_]&)P9+]._,YZ"6K6+
M;+JJKV\HG]&POFVVFVF+7&KCK?A_-1\ZPX-)/]M^D[O,@8+EOJ_@._;JBIYO
MK5SE 0W)N*ZM[_R;"9ZU+V)N,]_I;K^9U'3#]=4S#^^)S6A/[8/ND3<H0#1J
MSQ#\<IB+-?ON_[OYK\Y4Z"R=*U!''TY$B,$UT @>[]=N;R90#F;UWL'8,R/R
MR @)(9WN0!I[9Y2C%7&EH,_6\]U>S4N%N;_.U=0FZ^4^OX*'W>$>V6OG^9MR
MB@C'M1@-IDYMA+-O &L#W+,D&61"IP(5F4(ZWD00#MXM,(;UK.Q:Y_F^&HR(
MOO?)??C\(S'_"\9J]""1"SPPAGZ4Z2-M=R1NQ&:E7V ;>+[.= BD>81!<Z?O
MGS-T0R>\^@$S*M.K48U04"*6J>/N"^F,K)1M;Y38>*4O[V)Y _*LX4[B&8[#
M0ICS=< P#3Q;Q2*.<*56$2(8,T;46#]/6\AAW \V8*P9\8U36&6&QZ00#;H1
M'.)CG+! WU@+]Q;OM.O6^I-:D58B[T1AV"& LS(QFW,9K'+[U =87?07$<._
MN-/O(!9WB6GW)T]9..@23M5(.12JO$\[Y^LHT%CVSBG[N8*B3'89>CRVL5AQ
M\$SA*,XN:[84:56TE[&M^((T1/Q)/\R10%DSEH93"/N@@(PYD>'>7#R?UO"L
M6XP=G<YJ$;-DJ+E.:F@)06FJ1EP-2<U Y_;^LJ%L[>N]2@WM"FHK57SG:I8H
M_#R:(@"J-F2;QUXR@"TC@]6V5],9SA0=D+2?!H)[VGEW),BX*D]WU\^KDL+&
MZKQL=VO]Q8];-1JAGM]#O5/-!#G]KRN.Q)QH$,@.DTK&!/;"S@,F*C?6NFG*
M9H)2QK,.Z/RZSK-G[:U+YUTOFPH6.:7-(NWOH69[!B-K\@BH9]SG6LZ_(H(0
MC.L\!B[/>KDJ8UWV.Z*;HW)S<-%EJ]J9G%#F<$'@R\"IBS,+LX,M+KX_U;\7
MYTK.?NCX9\-/2@G_'Z7D6DV,= ,KR\,FLW$TL!I^J;PP/_"':WESS-W_R7U"
M/.ZC_"<QL#G&/?*3>9B,%\<M%D#J27W@I 5-)J(/<0+(ZO%2:6=*IG+\JQ>
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MNVV:N$IXFX^"%J5CD%_I^TB-C'7C<WO;( WGJ/71YJ**'8()+G?G?Y/T_T&
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MX2.WC;(OGOR;_*#,TO\,X]#%X-UVRXP94D^1^EXA[B9* FW,4B0RX"4\M%0
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MQ^,<HW.79RR/3(C;*AR^\>+560&0?!!CR,]%9ISQW/=QD7M*[D6Q^:-$F*^
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MS[2%]E"53/QTFFCY'BD[+AWIY.J-U#YD?]#;^ #=+7QA 7?4VZ:C[/QL+K/
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M*CUKVH:]&3:WBZ<G2AO!]*LIXQMV51XY=+#SG9$;35^M[UR?7OCC_9F!4$G
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M=?GA_!(<^:\UEN=B3UO*7]B$_!(KEEZ98A]4A)L00;@NJTB!&VXS<95*_!+
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MPPUX&3_&Z8-7C<WWHB,G3]J.G!\6J#(I?'FQL]<&=*CX1(K,&B6#WI:9PE<
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M]0OVEX+^%#2@_WD$)$N6,)@YFC4R_$3D"G)G9>@ES2&. 0]92K@;A%LJX6,
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MV9P\[W4\B7P":L!UCW-,"0TS+7Y%Y1'Q-(U!9S\MK[P_WXL-$C^!OS%^Z@K
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MG#'Q&6(US6H=^MV22,%-0SG<F]!CPS)D @?XHG=8 R"#R'J2?50LLU]AANQ
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M[OM]KG[/66Q[#IM#SG73YV8\%)VDM 01WSV#X:7Y.BZ4W"[:+!JB="$6P-\
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M;"57=SG]_GO'GAUG?TE_FUD-<+"LCA/,K73_+M0XB:R1D82#!8;]C+/0[IM
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M3I+'7Z"J8EK0#U!J F^ PX55N;1 %=!\U^37\7L2L]-#LIVQ#_2.IY,K!.<
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MYB8R%UH+$:J8EH@1,:XL,>*I50H*TE7+UNLYC[F19$<<EC'A -5E.T?G%$_
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MZZ\?W^DZU\K6A>E7><>N6V:#CPMGUN271ZS]#D9_/5?2//G54NY3:H'_IIR
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M[H)HYL]MS/&7ICL!W?QU28'!9X'C.$42KN40N!T448;J!& ZT#+$F\#7L7W
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M_,?6@Q&/<XXOMQ'K@;YQ[PY*#*[29#&RG![(Y42&& SA=AM?,);PSK, @RP
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M:#C^S&+*^+O_=7^Y5;@7$?<7C3'(=LRPR;*.A3-A"?,'T1XT3.Q=ZQP?&,L
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M48S] @R@^% ?WX@_RFL%:LJY\R2;NV,==CTYB]CZ2GQ"@M=:Z.D]%E&F,)\
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M!$\@E5UN;6:0%>@+'6&]P<FE$66"5:=_/G(.]1VC_@WA?_O#Z!_:S *;?,D
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M;8(F*[N+&(F ;G*46MT@#RK^;/Q)Y>=@I5RY)\9@T3H!-&P3J1JB&D:91EJ
M/L!#YNRG)-&(TP5E$2\QE\ 4"<IZ7?T(8ZQ.J0F\@Z4I""3GF\8[EVZ'7H-*
M?#>+17^30X4R0]U]AG\YW&+9)K8S_E3[$(C2QVZ$'S297.N+!U8YET%-=JD3
M2(UBV:/D1<$;2RH,RITT)!5[!>;AXGZ5GRWX]HEU:FA-:NKM3XR%2'6MYCHV
M-#**U8XKP 1]GDC $Y:X@AU$UD(7EQC]?RK'1;#'ICH)=:9Q47RC#B5:'8?
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M!OX5[^<[)AD=)S!K'C*5QB3-'R#)M&@\M *V-4Y4J8#9?T]B6T%(>29:;*F
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M4- ._XBMGKK^%!\LHRQD-[G>S:%LAE?(@Y"]J#?1G52]Y0C["V-.EVA]M<>
M+$DJ9%\-4<\]&6Q:- PGZD%?'F&O685-[FEM:FFCG )L7U&=%3 RPWF?KD'
MG<F7+0?)?!NF494"UGF 3M5\D6B=23PTQZ4():!Q$VB^:O*<J#=8$ #F5%01
M\",Q1CY=+T,Z4"HS"=OY='CF5B7-FHBMDJ*,,TJ-? &/_;5F4RJ3NE1-,8$$
M%)T'^YYGNW6::&V5="W;J.4*IX<9%E7]48?]YKS?0EEN0P1WV_O-!^OZ]="G
M"WU;,QWCB:\:[HFZ97?[_]7-T?X)N5ZNK:]]H6$7^?F*_FW-W\_-T%J]7U;'
MKLNL=G2[1["3Y<1$J4B=22KX+&%H=QT*/<*(4&J?"43^E[[60LH-.QZS7:1'
M;_=X8^@"10N-'+:5CU\,&]/$CCED+U1+_%.2XM2?VBX]K5\DLX(7R42=US$H
M]1GJ%B16S4B7W>957#JK<X XC#04W.CW&+HB>/*$?D//*4IK"SL"&Z5UT%7=
MNV=[6/7VL,P:Y].'GS,V/%FN':WPP]?$3J3I\BH,8N:'WT?CV["TR9-7_ZS0
MN?^HPL),[:<1V<,[WE>]KX[YQD5NEKQ/*I9]:&A QZTT_[>1K=;D'\$A-:CR
MDYL"MIZ(>?N9%'=OJ4X;;*)TH9+][A?2_:+$FB#Y;,%W+86+@9E]DE[H:=SN
M+%S4SY(X78>&8^#ND\-U4^TY'A<?,;;T:7='K6]X^;BL$3.>V%E?,ZO$E;LQ
M(>J/6?0O?2=]??5]?8T==U1OV')L1\KM'N-^:P7LP5LW^98^I6)_]8_P6D7+
M(&Q4FA(25NJ.L(/NK;H7'X'D\W+M!3XO4:0Y,75)P-'(^D&$ LO/D96H=1V?
M2I$4#1"]RS3,QWO:<J;[)5<@4E4=&ZN Z9#"BI;I[<^&%WC]DD?0NYCF%@GE
MSW?C 7I.23O2%L90=X2\XXW'%;!]Z74]@6<0&*\ %J86>6WKM%+MRQ:[#C?)
MFYLH]OL*W"WVWSA7-?K.IBGA:/N,F)0R2C.;3G)Q)8S^C9"K_@[2SO_CI%7^
M&94','^+Y5 (2T4!&SPMJR"!YD0'TN=8MX9^!6S&7E,Y]8/*1YYWH-Y3Y)ND
MK-9I^>+A63_+/W]CA:+(N@;%TQEK:>R\K1&AJ.9F!FMHIZQ&;ONB^@TOZ)[.
MJ[E/G4Y$[K4Q;H3Z0U[\PU.5!T_M#-WS9O!OT?B_MOS;H:.K5G-LP70F8I_T
MC*S<O^_AEVX^3ZPK=@9OEC8JO[/67_D3IW(2K&#>/P5P)$>B=IHE/9>5=W!+
MQ+/\OYLWO3:M?_9\M<?J\3I4Z+F?)7>?7"VV^.3>5W)?WMQ:_?+MZ[P"&[]K
MZ*UY)W/?GYYU/$H?';J&RSU9O]!.6Y/!-.UOY"8]Q$]12JZ".,2"<EE&R+_:
M'LO^)W8^@<3FI/FYL<-L_9/,NTF:C.-M# EW&ZL;F:'<K]G.97X]NTX5?B^W
M&5NNIO]F=M$CH+.R@X$^]_B75W?<#0Y]\"W9?" R?V_3Z<RW3TIT;!XNNT_B
MMGG76C8M.#9%_(U-&?G/;(J6=P _*[=W:YAN]90C5>,B]. OY'B+\?ZGH[96
MZPXZ71:)FQ/LRBK"#RTT?_8UV;EBU/@;SQ-,.PF;2).\$N**$A/;L0O[BDT9
M-_2%^3BW/*??AZ9W7<,;GY+'7#RO5OG'@QS<YP^NH(0*S$OJ98]LZ4"H6%.X
M2(=4IC938RO=!#0M_-BQ..LL5M@]KU)@\4QK6]X5IN&NJ[N.!VI'+(6,#4Q=
MV-C_4HR3A$*V:S4.Z'UB73!:"&=KP 5IN<*FK"X^_(I4M1HZ)V(3+0$Q)7T9
MKAE.VB)-X%TKL\YLHF4&V8.;GI*J37&\A#>0>5>SI$1_N,GY>&+M7Z@1Q&8(
M4S=CHLTTD_J \!R3'EW$D4$G$X&SBDL6^YK!QH(4J>E41VA?PD+!HZ;1IC_%
M_/0F"QJ#5*/6\2,P3FYI:LBT_/J"YRYFO7\&6S S?;L[L5_S1L5)K:-SPWGQ
M;@<[?]RN53U4_?6GX=*CK>?S;%J3^O;F'(C5N9.W4EY7PV)00R=^_[S6A T'
M7]G!;S*7Z_&5A@WD(075CY$S*<01*A1,\%# ^G!SI_<2&_-)K^M)$$:I5G=S
M +D2=).1GY;E^2PKI3'TN4 :W+06#-P+*>$Y9ZWYE.<E!>R$H43IK;,-A1BY
M(^:<M]O8+YP5;8X"IC:G@'WZE8%4\OXIE+2#5$'K)P$C8R9+QUCA*.E!IID"
M)J*3_OFMW)&[WLOW&^6IT4H&M<*2EEO#WY.@;0J8-686]XDOM;4ER[9$\=:B
M-Z,R2)#8Y)]?V;1LII44ND\!*PU0P  F30&S4&/_92+?H(#U<U?\I"U_\]EN
M_^&U2>ZN)A?[D3-HI-2Z5@%[>?S_"^._+PPN;LHDQXZ)!&& %*E&M(=<!_*4
M?+V/PM3'(;0 2*?W0(17'4$,ZZ#^,=#4;/_'UN.LG[DM@]X^F@4O[XM0^XN/
M/FOZAF)X+GSKK+F*NX5_8[CL=5$V/9N:V+*2D*KE'13_[7]]%G)6Y;.+( HR
MK^Q)7MWD*DHB=68]DF*!EH_SX*I ]Z9<';(7A $ME-@9Q$'"M4&I3Q4*]/E>
M/LH:=4JLF4U I2QENW3YJH64SZY<*7Q$J]]W. BS@,&"4=U*5;( H<K5X[3K
M3J9@>'_7)SQ2Y*K4XL./\6HG1AXS#L9/4;.I:G3DQGGJ9D(@@E()106!R%OR
M#7R"*UC YFCT\CKR>LLT\HN$,I<+H&WEFSID4M@#>#<_G6@I:]O6RU*UH=WP
MZQ-O1':UVLB\(DQZJ3I,W=G*GH0/E )1'+G.?!"Q'Q_-EG]-/H<AJP*%GI>D
M5M50IDDJ.GHV.ISX[:C3L3BAANZIIPR@V' M"R"+L&<$X3!+;42G,,W85VOP
MB_)O5$7%45T*V!:IB6 >0_XUFR3,+Z 1O@))G58^/L-+GX4H(WQU+$H_W,[
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MT6CH$QQ_YG(F3'IXB*!TG#:N:TL1Q(R]6#U]3!@]93+NA_IJUG@WE#CE@='
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MUB&/PN3[GC:,$EPLBKRP2U6/;DS_61=T@C90M CMC1.S5_<2D+)R,3),'"R
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M*YV R.P@B[9!&]97[H((XV'79_0VT#>9Q@E>-Q2SFK1[_N335G!S7A7]X(4
MK&]N^%E7LUM6.LLE14#HA1PE0Y28J,>>8A[RGRV)[ C%"?S?R/?RQK%H@[3L
MZ?!?W?9"TY/#+BUMS&%[5(W;IKR-/0/U_4?>Q\*DO\KR2%.52!WF6G[(=[&T
M-RU]*R:=GIA30P1K<.'5?"]?HZB[1)]+7\S$-#8W =&GP?JLV"F*/L0* K]G
M:K4CM2X;H-)I#,<'86V/VP@^>+=NA,T3LF_;$UD';2\0);6 ;\-%2X]!20K8
M-[7=QJ;<*<8J*EMJJ(!]G5-;-^_;YOE'PN;2#U#!B5572=FFHCBL3G;\=-"
M4?$ /2%&'O#DL>4<_3^+"O]_::P3L.C<Y#KY;B('8X P>0?AW,!L:I;<$&H\
MQ@#J6<*.Q.=M)UFAI/( =ES%)-3/-E""UC%!3'O+H1.%TWD/YNT3KO0ZE@\M
MWHR(,)_20C96]E4M<=2EL< 5EOJ/5Y5.!N_S=\ /3/!+EMP$8I\!*G,H']F;
M6^-%K"V$#=!%H/8XE M^HV$O<.O!6:D(-W)OTN':?L>JI8=2>@RXV:\R2%<O
M*]GA=\1^3 --O''*.HW:M$S+05B$%U:N-;6C-J"ZX&KC! SPI2\J0S?H2/,8
MPGA<&@6,UC]V\A#28!@E4@8T#,9:PSF/(/YIX-'3ZH"YLY.(2H%D55W7H;*'
M:B@WD?.H&UF7K4)%G&R$W1QQ)X!)8\)_YP,4O(DD&UJ>HFQ'"2T[=$4=K,[%
M]!;B4<K)=G!38Q7A:/N8D_/C.=+F)N<8R+2;=S,J8I^$A[HI=;R4H/SJIZ3F
MS;=!1V'!1XK D*(Q]\7.CJD/+MXTAVB">>LLQ%$(724]#V@TWWL,(4CPRA[D
M.BCN>S JM;(59'9,\4W"=<;:/)=+.K "1_XFG/WAF<D=K'NLG0Q[!6Q#/E0L
M;)%1]\M-(;+@50>-8#:(^!J?V%40*G3K6>TP[)(P-:#DU0-SY]@5>%_^=\ 7
M<FP$PLCQN7SO!1NQCV=3RQAMOQ/2N&K?L&ZAJBLLT5R)"./VDD]<A.%DV!=6
MTX><7>!BVA*-A_9L!*]5@(M"X[+0M6,D^$W^9H)%A?2[E-.OB7K0;@LGO1(G
M<F^0^3 !+EP&QVY/S2[[([=@#:Y5DIRGLU1\ )$D2-:XW&Z=5G+P-2G<V@C;
MXG<R8VH1\CT'U4JN0[E"@6 F=C&'K\W)-.PE&@\1C2&33N2VU#YVG3^[32<O
M2D35P!5<LWJ4O=7Y\AZ;"-/N7[3.;C!6A<Q7,9-0N^2[41L%+%MN!V!2Z"Q]
M5!DN:$N#K!:QAW#R&:C;;:**ISU'*V!:3A%"Y%:I%V1=-\<T RC=UG!\:!_O
M/+7+L:PR;-*@*/#7&>.=@V7@^8\EV^986.1XI:09-!$?7O6?)\&(A_RE^B-.
M48(^L!NQ?UB^G^#6HLO26&(E$S<"&]<NZF@WGT"ZYZ!$ 4>?3S@^W 37QI(,
M/^Y?5L ,\=&G[73RKWVQFYK)K]!:)Y+KR[*5T$LUQML+35)88=::4&(/1I.H
M3M"%HFC0%S_9 X091.Y]0M@^RMQ+'"Z\7/VH@TD%N&SC;5Q&R%349@(*.B^$
MI_DM+V1<BE=)EYH(G>'H45_GTRC]>6<&OS%*JH5&0P53M>]E3YHPFY4NI=MS
M5GK"9+9.,NC8@S;1(!I)3W&76-EQQF9A4D,A)K50S,]F6$34X8<%Z_'.Y6-2
M_2K\C_#U[P*QU^R"O8:7ZGYX>-T<^G;5ALA-2+L-6/<.RP?Y6_:O!<8%S;1Q
MTF*HFL0AJA;!Q<:1%!ZUGM05C1/2/J+(QAM>RW?-KG#8SI9"$[)-(%)HG"P\
M7*Z =?EO3M'^Z!?;D=_X\++\#<)8]L@:&9F-F5I(!LF]A1LYXHT/"5Z@-7M1
M$XJ6W( ZIK)5V":J3HY D2 RU83MR$]C;A_BI#$LA%;;^G186Z2X<JD/4/RJ
M3/C.+TI_G\&MPO@&^JIR;\<RS:!CJS]*CT)DL+:'N17JB$]\*-T#M0HZ$@->
MQ_)Y'J+4GH(>ZW7X7.'NIFK"MP##P9<VM:B-9:EPNJ@IB%U#"&-\VC ;">3S
M")?&;/!2'U%6W]A4XVC97Z&=Q VRI_)O,?+73/5<22J47091IE W(YQLP;A>
M7IS8$;S*[VV+EFZ5%<<:1JFMA=OV)2^S-N.=;2A&/&BBMP"SS;2Q&?R0-07N
MKQ5X'C<R1('."Z4/M<ZJC&/H H@#]$N.RHH9GB*J?@>W&[Y!WH=I^JYMC&$F
MLC;@!XY+PTCC-:(@*!&$'P=)6<Q!D5J=?Y?!_A21A@.WM_#/D4FKAA&"NZSR
MFR#.U;A=2:R/RZN'UEK%,52GD.D\M#A*A+F)@<>:;(=R>TN,H>,$?]!$-%D*
M9Q=C?(;,&X&X=(0U--%-W #N;HJ7R!R[N3]Z^K,31IFI6.$1NO,AX6?W(:L=
M2B[WB7J3VD#JL=XL?T&E1W6Y_PA=?(B!YD\H*:?XH]1>:)2 4<<7G9/E$G0%
MRC4KL0+[/0&1Q_<C"AC6V:6+5T?+"6X"QEIVWRL+O_HVG,MT9":VQWVP)4'F
M:+$5:.XN*R!@!$K<9VUDK"N]8"]VKH5P D_632=LW0Q_HQ4I'*DF'^1-4034
M6U>6*6H7<8U8O]!N!6P]9'"JB99:8IQR N#?C%3 !/KXF/X,AE6M4LCUQ![D
M-XPXX',OOV'A7E4@E.B9AMI&'$'LH:><'+$9\/B^0+ I%^ (W-@63OI")9+@
M28*H+@_D]OE?I)>&(QA7*][Q\>9G#*Q3Z!QU*"$0?7'$R5'[S\4%JW\Z$E:,
M_R]02P,$%     @ #(![6A]=RN40/P  $48  !,   !I;6<R-#<R,3$U,CA?
M,3,N:G!GS;P'5%-IUS9\%!45%9&FJ$2QH+2,CL ,8J(S8@$QHE)CR"A28\BH
M0"@ICHX%$!E48(2!*(AT(B6))) H111$I$M"$A,%I(0DE!32OO@\;WW>=SWO
M^_W_6O_Z#]F+E7-RPKWWO?>UK^N^ST+W4?<)6.MYY/@18-&B1< O^A] QP%^
M!@P6+_[VTA]+]*^ERY<N7;)DZ4I#PV7+5ZU<M<IHI9'1ZC7KUJY>8[+&R&BM
MQ5H34S-S<_-5QI;K+<S6KS,S-_OV)8L,]/<L6;IBZ=(59JN-5IO]7Q^ZEX#)
M<D"[V,Q@D0VPV&21@<DB70L  H!%2Q?][0#^Y5BT6#_&98;+5ZPTTG^ LA98
MO,C 8/$2@V^CUE_%ZZ\#2TR6KMNZY] R4Y_SAC:7S?;^EO%D^;:?JE^9G^Z6
M;/_^PI7K*U9:6*[?8+5CI^VNW7;[G%U<?_C1[>?#'D>.'CON>>:LKY]_0&!0
MR,70L/"(R*BK,;%QV/B$Q!N_W[QU^TYRROT'#S.SLO]\E%-0^+3H67%):5E-
M;1V%2GM13V]J;FE]W?;F;7M/;U__P.#'(;9 ^/G+R.C8U_$)Z<SLW+Q,KE N
M?/-K$6"PZ%^/_]8O$[U?BY<L,5AB^,VO18NQWSY@LF3IUCW+UAWR,3Q_V=1F
M[V_+S7[*>%+]:L6V[T]+S"]<Z5YIL7V?8(?TFVM_\^Q_Y]CU_T>>_9MC_^X7
M&UAEL$@_>08F !30G"E(V07\4VLP_HQ-BUUM*_2[\60X_OI8$].*Y-G 0C$L
M4G:3G0J&:KBAV2/(["21UI'R*MY0>#19:X\[(EGXFCA:B1?<$'PEAR84I[3[
M$RGN,/N"0GM-UR=EA,%DCKU0_#O(TAU5H3[_81]'%.[GY=49$I1"%&%J-;=F
MEN^(3;%'E#,ZD0^TB].#@L9$WL).(R$TQ7U_4<0"7EK#;/# GYQ E)M9I$([
M*-"4:Q!6 3- P96&!^<,"K*>%.UD85!5D8.6\ASB[27>V!FVLE2N U[TM[$)
M'ZWDM_9U 9&6>\>9MGWS27 D-6JWO+\8&T#ZHL3N[,IST8CX<=<@@P7,O8K+
M*D1\=2SQ]H)K\I.>V #*N'MN7CB,F+<#=3O9)B)[VJ]-M%IU2)']BK2ASAYD
MW'55!RSONNV>RC<K:B3EW&_=/W4VDCB2U<_3 1(K8&$@19&(81L+76_BL"51
M_FXR4ID"/Y_FN:NN+34\=XG%N(//81W Q\]SU,Z:8G6HU/*<Y%D6$_3!(3>0
MCI?_.N'X:VHT58N1Z( .I.!CWZ)Y7S.?@TO_)S.7(D6.JK,*E0#<0C:/L-ID
M=4F&'+J\,UV6ZA\.E\&<&_AB\,-T1%BZZF+KZLP*JZP;E[$X*I^5SQ;N2(BV
MX'<2YX@-U43CW(.@LSY(\ 2(NG=\0%Z.%?QXB6*T.W16\*)/>*RAZ#>G-6\)
MDUX4YMG2*AUP2;5_1=5(=A/V[;/#M&#?YN&"_>XF'O;EMA)<C0[X7+=HKM]\
M%D>B3*<GE3;>(STUZJ1AT#):_Y84;@:N4K4#DTF2LR980U78)BC5^QUO'W'E
M1+YU?5\5WY>>*HK;?^&8HY] >)3-3[I [CP("O1!_A ?+J/72IF%+H\$&I/8
MY)/5%IGFK90%?%Z&<!;'G2)QM9LI9"$FQ8V.\^NK6R*U2!88;=YKM/L7[R#C
M/?,N>5IT6CT$^4F)Q?4M$IOYO_77 =0#\COYH^ U\7&37G"P2="X,;&D;*\G
M^==NSUS(G/=,M'(RZ5.;Z'B"L-.KR<HX.89<&V4UG\[>TI_9CZXJ4@X)DRVO
M1GL@A9R#(*]NY/>*7%E5;I/U#NG)''?GV,IG:0=ZVSNNFK,REX#"_3D:\;P.
M4(C.:@J)$; -ZN_U(T0+TBP._'R2U1W:1ZX:22?*SGDY>,I/YM(\J^UKISR!
MA7LIBDGA45$J]A,7_-J%?CANX75Y,;S+,;\<'[NTLO"IWW.O>NA8.90-"6#Q
MJE+]-35GFOSD6+?BWS'!/<O![@P&/),(@8?2^"JR #EW4\GZ&/7M6Y6]GIJR
M 2UR)>>< GJJ=][8U$N&W[LS$Q&>&3X$?<=ZF4Q%\+F5&)"VQX6P4I&"LZ%O
MHMUWH,:)H>S,#45T_DB"#W[<-PXW1<)J#0Y:3WHD9$\IA623^%Z!4W*EHJCR
M'@57T^$0ETK=CA!5^VL-J(TNUU;N*OB?31+/BG($GU:0DCYMMO7*]9$>R'HZ
M0/-+W0L>$OF99XI#M5^0D%9D0V>P--@<J[*+#X99(13,US+5<2GB?;6F;*&R
MK'6T1GG<E U]._NRG729U7C0G&+,%K_R6[#(O(J)H]\K)!YH.%[\L=9KI(*&
M##^:$(=&YL'%Q,OEA;6:8N9Z?N"$948\L]MQRGPD;^1>P/-4\$,.MKA+Q<\>
MJ3(^JKF+@SZ&P\?9Q.3Y-W4:60]O:'09_#6-CKKSB.G=0<G+'FF%^N@_M?NR
MX,]]R<Z(X&.5O[RXM>*OEG=DQS$V3721K4)<IC 1=8LXQ":) BY4;:Y!T8.K
M(\C+SN> 74>SD+LAWJRD3B5QJ(3"OY>_6F)\EU*Y#1&PS^09/- N6(F<5,O0
M&39ETUICQKF'R%K39ND9@;;>?!C\-#YXQ4C^I>W^5FG-U#F^F<]VSSLZ8.^@
ME]15=N$#83=_4IYXKPAKA-H3U.SNM>ET"^X6GK2]1 ?P'AOE\%_#;B=N/29L
MK&EHO,=1^;'9/([JS7N22V?U][LPC;=&ZUG+M3TZ8*6[_Z=4HB6"&[FP$>%A
M5LOA<8A/"]^S;/"=/=-L_9_3 5<JQY$ULD>":D=JII"UEAU)R\$%$0I1HZU@
MSA*?O?:U-1@NA76[I[J*& ):=6Z<?=:H(BJ#&QE'M:!B,6;K1"HG4874\UX:
M*REZN&Y1CY?*6[V5]H*2JEV'=O&_:P,_CC;P9#5ZO[G33DKH5?@5I'_V;VK)
MFE"2CFH[:ZC7IXTFDS#.5*_&#*H#_,&T<UB0MHUGF3)C_V8>X;,A=KWSEN01
M&V7U82EQ)7Z02Z_!Z(#SXE7!@8YUP3:#YWUIU_NO__EH\X59PD(-&C-?>="*
M!U:,"=)7*M*;9?D@R>O<*N;3=? #QVVO#W#=^R*) W0U(Q/K2S+2]O)7Q7)-
M3S &R([NKDGD[UMD5H^\WU_(;E<^(OAYZP [FO3R2:KF#S5(<_-)Q,)#FE5_
M5K;-"Z^19/4\'/N;KQ8VS?"+I4TE%01P([#?H8)N0!Y$[5/<'V4/(/?V(W$^
MF C:SJ[Z1A<J&_BZ52&67!$:U4.I=3&W3W)C>+&TS/3<=K[%%R6'V#'C%\90
M>>)L);=O\@-ZG+;VNZ?^&&N/.K"N-=\?H0)-@]_.XBKI]0A#V<ZZ/K4M)N0S
MR(3'1W+:'/SLHZKQ^6VQO5TS]AXJOD 'P!E%<=W:=U:KK,(*C:+\:YRU=Q8<
M9IZ>\IBI8Z(ZJDU\X;% M!ZCKTONT1Y_1 9/F'R57U7?'SHWS5W"],^MSL7(
M(5%EI#K^-8Q-]W2,)K%]S+LO/(LONM_>;2-*[>3.@CMG!G[49-:Q%%X% P]:
MK-KA3UD1V@[-8.:HAO2&SPC3 0SU1NK@GA#5RGB[]TU&/SI[!Z'B,3OH,V=;
MS?:/W&Y7FICX$AMG=( YD+B*7R=O1J$"GF6WFMAX@>]7:W*(^^,Z=< $-9I#
M&^4&/W@RF06QZ4$['X#$3\^I2K("G&Q456G!VRRGLI\\HZ&JD/&I@?VQ#.(?
M".\O.Q7,+EF,]YT4EATER?"W!EOT)]CRR&!078Y7*L)M*>U>(%-E+"LQ*/PG
MC,M@5 <LT_;P-BA2I8O'FCL%?^ZHGXTNB"S(LB^_TY">F2_<CI!N(QKA^JM=
M19:2,O#:5VC5\YKQP=-=9:OW9-D'/$;7M-I?&B9-#[PCU2*O%\*& WGL$QUQ
M][O"\0YG/&N92A_NR5$$'ZNB&-XBAADOB3^YOJ#7IG_K3); E5EH7U<.7>C'
M\Y.F/QB>P'E\ZO1ZR9=DXO,WYBWJCOZ=/S3%H6H&AVIC$XC)K"@^,&YM6U>;
M?HC>/]?16ALZX'#)_6,>&70!K21@9.44S%#;JS;!-<E>IU+#VYU='%;W_.Z"
MW$XN2Q-%X^J D.G>\YH<M3GZ,6?<!![<'+DDKOK@VSB5T**3[EAY<,, T0JR
MYD!EBU_BO30'/\ONI@%9W'[9256FBTUQIQPTBIP>N)W"W*W8]E*[*XL?3*7V
MW!]87E70MX.*?#06ATAA8*/1#YF;-(]PAH+3I<61\K4%4;M+CY!C^/1,K&A(
MV_6>[QBM&/S$OPW90BUVJC9343;ZUN0]R0W[FC&4K0-^>KP&U0*UT%HKK _X
M3W6SO<K&!_9.5(9@PD=<WUKFT@B=I4Y=N2@UW_D4C.TJ<"(_BW0;K:P<'\"N
M!F>NBXKCCUO4B/RB-[B"^4C2M+J)LDT_E'7)EY=XE7F$7@V1V:>:]4=#NMR4
MP4=SQEFC^N+']L/%0S\+!HK*6TN]GIW+^\D^DPY/KV/J@/GC%EWRN,,L1V ;
M#J<XOJP6&[9 ^3T;AJW!JHS0D:>1]DF03I:]6Y5:G]B('HB=8G7LQJV[>^<F
M2RDKYN ;__QE.,WAY-N1!(9+(8X4EZD#PH@&7DND!S(',W_MJ26S^=H@KF.O
M#OAR-JB]07.?N9F'NAS5M:PBVP?AE5BZIMBN=;2ATMZEDT.8I0"_#B(IZ3=O
MI\&/8 Q;'6H[4!9OBW\#8R ]*E>/Z XZDE'/Q- SQY$2%M,BF%E$:TE$?V&C
M=MQ\_=':'[E'79E,(81BC\"R1X8ISH-38Y\8N:0#%6->E0,8<_:YF@X#MCIC
MG[?:D3:"$4=7&.F (?NF/9&N%A!KRT1C]GR \_&PE#A>_ME*IS<D\='9 \"Y
MU,^VK^#),9I=D\'6)-%S/)7'F>J@3;M*1$KD)=@,K7.F'TY,UQKTXQ)"'W,B
M6^<XE6[V?0/3#L'VX:H3O,-[G+XR,<YEKS-4V]4_]#@?(U?N*_\S.JNSHHA(
M^1[_A$#,1_ 383Q:%\*Z7K*Q*7$ZGTHS"6ZF#KSOV5U9Q=M] 1Z(X\3Y(>GM
M.J#UX"81Z2[3-#Z[C6#Y -;W"T.Z-),R*#M01/>L/IC+VQW*J;V ZW;#8*;[
MTVP_=S4C$A%V"W@O;[<*:OZET^O9R-U!%MGMIE,JT;KO+ZG>E<LC+T%#=<#B
MCYSX"[ML^O)P/[K3+)+F-V ;*J;?];!XF$?L\B'"6Y)QQ>JGEX?XJ?;Q_>O>
MSJ\(XA8%6"W)$ZJ842U3C*\&U0J,=%L3="VZJK<)*^$=.C^RX4+*LM2.P#.=
MJ2.AR,P,&GB P18T&$K(!Q78I))S7S_ S 8_<.#O0_-RK\ //_]9!]QSQ.X#
M?#S,_IDM&@W>HZ!8WH+81/#6:]OOCV#<TR'RKN5;9D-G"I3$U+&2AJW2ZQVM
M^3;2(_E- Z_;?LZK9$]\]DE-<H.\YEL&#&*YT8JJ&^<4Z">*]*#J?K%H \7>
MF6,FK=W)N\*2=^ Z-.SR$$EM<R*DJ"3*9/SR.6YPZY=A?%%#2\S[425\1/G(
M-^>:6YYM0'7_I\A]DQU)BDQJ'76FO$JL6!TYF*VV3"M(;4U9.)NXC8B&+JQR
MN%M-F !/XRCCRK*2^M#VQ=T>YEO,?#R ?[-;60WAPJR;)9&)W*PG@HO]4,H\
MZF&*="HZ(U#HH20.J,M8TSUWK%G[WBZ.SL@T5;WKVY"QW3?LE$CN'QM/8.C%
MVFM+%Q3D><=GQ/LTQQ0$/M/RBXIYAC Y0LPE\LL323<:/+#"S3N/S55F?Q?4
M:F;5,KAK\I=V%O0M*VE:G_U1RH,R:%W+C@!U*X\?B_7-44Z^0JY1>SV)OWV,
M.C"7V4=HN^K8''__?8P_NE,>Y\[()#92F3>?7//Y1T_T9C[&VZ.X'2N ;HCW
M^CGU2,XT'T%')8!Q_<<J)0P6+XQ\J,(;V>R&N5-4D[708Y]<,1*)SEMH4<5-
M!P'ZKFF-(R!OLD?+>':]H=42;L4A4940Z0(GB^EJ?K.FJ_'L/(M]O(#^W-NU
MN;?Q6=$S#V+XY22[XIR>CA$;M/?\5YD.,'+?C:GP*M.3*;97B9L(E?K[+$Q[
MX.0 Q$J!1(RJ#M?E6O!#0 Q.C2.'ZL0CN>Y;])O .,42LN5YW0#X25U/G5^U
MRN-=#8,@1' NLZ9%5<W-!/MN=2#*\75:"2?JU&'>F<8*1C=<10GWZG:(<;3:
M_#V,>H_=S@/;V<>H4BBOU-M51!GI+JO.\=+4-(M"B*\H2KB@2E:?2-8!C_N/
M[!EY>&U>+S.>+D[9]?C_E3W.Q?S!H=FAM5;Y3]"JC1B^=G/?HE&0 <^R1GIF
M:)C'@Z=%(6HF-JK'-'W(I,1I\MG-]N\AZYR>;&*"$;Z5^7)5I)Q2X-:J+0.+
M_0OO9?I"]H8\K_/Q.'[(P^S4HG^U8"]I2+/6MH_"72=OKN'#$TP\TRZCW(]E
MU.+YSB"QK8HR>?:4X:WX"Z -BMJF7[D3EMC3[W-:@D^S/3,2J,\A@]FCAU4Z
M@%O&EM\BV/[\>;*X.W8_ V/<%=,CCDM!"K2?B:LO:KF@.FJCR@EGG=K*L^ZI
M</:2,U,&V_OD"7"XILVOA'@>QH8':TJ9)@A%;4MB6%[1Q-JH=4/XW!/'#^_W
MQT#W._M_M[FMZ8#I:VKB\"!A-VIP=:0L-K+*)@9?HZYZ0XJ5#3[W\3CVWR]?
M?&*"%$72U<RMP^.UBA]CR88:\I0.X.QQ8_/8^@+)I^9R'Q$Y2BB7G/BWP"]'
M3KN(U7$-C$\%03O&[C);:..6,H::GNHUJNE:0,WZET&Y:OMW6N/&C@EK9U0J
M!Z4D4OAR:FDU1$BD]C\EK%B7B#?S"7SXC\5CYA=C5?E7;^<J_^\:)"Y#%P(M
M8XCB,\ZK0V ]+2OP>'2D+-F]9&E+67Z(#HC%@AZ5&)Q.>=4HC4XK=I[#)E(R
M:X=L&MN]KI1^L<</X#3L%.+&"!?,K_=1+FLI#)LNYHAE1Y@JE\5[O.;>_R*]
MC"%]S.\5KD>9+VCU@V:-Y7MA=APO!Y<I5D*PK[<^E1='34V)1?-&QZ;118&/
M\RR.%1T9KJJ4!S'WURE^J_BH[:N)^"Z>[-<]-T[9>5ME[Y6M7;<_B4\:G25^
MW:P=F-<!OPVRSP)G344NHGI</T=.;#S39THL(^9V* ER>83!.\)2.#P@,+[
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M*/ZJ3530+;[]Q:0,5V8+C]_<R/0M=R'HN2S,,BK?BEH?2*ET8>]/+<>S'+S
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M&,L(XY:0>&0\^7<=$,+BW!"&BXC@Y,(>M;, 9DR\D+ T;5A^6ID?I@/T\\M
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MJ-7(E$'9AQ2QPEUJE)"X-DI.M?@^^""5'OOZ/NO PXW]7 0BKG:_^IT^38N
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M6+IJ11E=0Q4>QA(SH,DF?UL<,PZ:)_^H>0+]DJS@:%]9@A:6)KI6)G2)5NB
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MS+J6=*_+K+;]J$Z%S$;E_9HT?/32N0INP:E26=9ABTV%SV-&^3ELV#7HD@<
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MU_-%#1]OFQHZA_3/GJJS)M]O ,)497@R6BEXSE@'(*J7X 6.T#E(/$6&#';
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M.!SP$P;W/@@QK56(X<,H"])57>?AZ#TLO=FN;F#W0,UQ<"SOS&?$28;3":)
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M^KH;BLXON^5^0]Z;? L[>5/&:/4SE05=I-M3=W6&#?"64S-DEA=F^1IH"?;
M*0Y\AK\#-5Q\H,^Q[YOJN,!_#?<"\7!"V?+2Z5F_I4U7HZ)BAJ,V9E9L8WS/
M'P(D[X$1&_G)1SF@LZ(!]?@%$J&ZM8 Y5NHDBRF$[*/AX/NT5>#'ZY";+'TT
MH_KN_:-WD9WPT_D/"Y@<VG:S>W-G)_U?W*=>]3.O*I@,?)HE>]T^S?< )-?X
MG(_U<O8(4>'2WV2.(LQ[=,)U\ M8EAP;@C']K;@6/^U6@>S&Z=!73O@[O7GH
M,2G.Q-<&LE.EDX &S@[!1PF7?B(MCU 8=\H(V.W8RX_.N']/P1JQG]*6JAX
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M(Z3$WPE6 1:+0;-$U?Y+VP((&3@D1O,KC3*JCX[6V$,'#>ZB?,QP(T=U>'E
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MN(;PT WA+F@9M&@=EX P$_1HN(07P"T%I?00!KZEPQ"*B=I!<"6%%OAZ*C:
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M^(_'B6,HP-Z=E,02:X(3=$5$)'D=YDT9$>>' I.3/DS4SGFZ"%.NK\/(Q(-
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M3M5-5:<JE:KN7OUVO\_S]'J[7XK57M#XHJ>/P&84T?$BU^IA  <!GUJ'!9S
M]4],"*O\4'T(:!]Y\17ISQU@X@%&U ;>$_]-@O:ZY9>+1J)IBE=-D"EHX$Q?
M,D$&7+IGA9C FP*6ZS"90%1ZD\%#CJ'FO 7VMN!T:&%?Z2PSK4!K ./EH?2S
MJ\S7UA\'$NJ(;>)U>I7X68\7 ZRVD1*F*$L+_J VKQ90[L1$B[K?RN"PK/TY
M8"K=(B9CT7-RI(]^*$0M?S$M5[L#(>OI[6B85)^O%#!JVFO6Y1IZ*E==[S'J
M/HV50VQ$".3JS@I+J-I #,]4W'5G0C^Q%MN!2EV'C=\X2%+"._,U4,#,R<&%
MR/R-SJ#^EZ1DPG[TU)QG:5)1B,QW8D#*^["BP:65Q$']DH1J+4H 3%14F0\2
M4^H-_\*Y=DR:@8Z"&^A$/((M#&1H[A[ZMHE1]CUW2WYXQ1RE=O/FIYB7F, G
M%;=[Y$-N=TA]K^PE&..-!@BF^-U0$4#T?5/0?1HJ ?B="'B#U_AE#X.K"Y9^
M_X:H;1Z>D&W6M3-]:;YDZ=RL>P:L,#ZP[R;\"=)?W.W1/_SJ3@6.3F<:TK&I
M4UNIKNP,:4B9XY3/)J415%\!(U5<P[M(A4O#@5 4:$L_',SLK-DYJ0$>O&&Z
M9EJUG.W9^#A*C1FBY'R6X3PEO0[#PC?C?82%>$< T38E23@RB2/2FY8R\,J(
MQ8WKL*UG(_#;AUMWXPVRF7!-G-EXQXAG_DB)GU5Z>*3)_/$8C_[ZI1WSS.'2
MDJ(@9OX786K'.LQ(U/WGY6@#H+O:25001('2O%!PJO.=: ?A([I.@NYP7.(4
M]/#/:>)^@1RD2IY7]LQ(IEZAN"L3=F.36P\,4ETYTM\/1IJAI6=OU-_ /,^>
MZYCH]HWA6Q+;]%JU\!N%U"@D4YDNLH3""_$[,SCF7:A[8,8V%&B#2"/*+A#,
MVTPY BVHI#3$=]=KR-GP%D$35R'B=XC4AZG(HO'YG!P>\_+H(:\OCN6]AR1>
M$]LN6]JQY\G0_M7%8V7,>:8^@Q],@^_V.F#JH(I5"VHUPA__Y><5-!.<5K-P
M#;QK4**BN$E->($\TR>2:A$CV[PPB:!*8(C9<5D7#2;J04M9ZH#98KG9WGJX
M#DHO@O!>N()QAN9^,4$=&5WY3.[X6OV\HK&NPG1B?.NC*>^ :U_=EU71KKFV
M&W>HOU?ZJ]6@Q?P9*%U^\(K2?;GPJI4=RC-W=]NJIJ?-:GW@NKB6F4UDE2@J
M3'?;#>%R)P<.I?*.Q%VW=W&,X$2%G4O(7RIT]/PH5'Z$/[_+$: ;@K+&(+J=
M!4_J5[T4P=.(D.0N6)OG  LKHR56Y[P8 [;/\EY-*1+;3'Y4+PJ0?'><_=*U
M==A=!]XGB/>@Z)H+4AZZ;:B\(>V9A(CYZV\6_K>&8WPEZ#R\'_)[*MK=1N-T
M)7R")_%$>->:FM&M=[K*WN6]@W"0/MG[BD9.<C&Y( ^84B&T4_JM0?%PF;,C
M=4ECB(;<4%GK-(MQ*(=-O%WZ"PZ[&E<IW7!6?E7R[;Z9F</X[LTY1P;2R$\[
MC2M6RQQ9QN6>ACGN%@]*<UO[L249@SC;U0EU3J.2$TC_NM/T6;O%.DQ=LG,"
M^>AD?)6:Y8E[Z?Q>@[)94P7GB_\?46B*;KRU;J>&W-5SU(97M8WI):^;6UZG
MC(QL?>A@F>7M!#(4@OZM.]94\2<! ?DAWI4?@9<8- T6Z+.V6W>0-*D8:14:
M6Q:"LUNL.8Y#KAK=*D-1O1JHN\MY$49/ IN&HK[OK?_G&VM_NUZ&\I-_KLFF
MU3QI4@F+"0FO=#E<[H;NMLD7E@2W/BA1?;]\=LU*D[U#A]/44'YM\D1>(-HM
MI3RM\F:;.SGAK<N-.'R7VO.5L[3M"$IRY^CSD](>0RE#?+E_WS0UUM[VJNR^
MIZ__C_6^57.CKDTRG2V^'B67[YMHC'T^\".4O0(B%_O!:QO8I T"<V&VX'"D
M0C4%U'-!IR(4,B=/VN9C6#2I"0^<]IFAW9V.U34<3)C$]COUMYY6$?U(6Z *
MMBF*J<UQ9Q@R75TG [+LP-7D_?T$-?I>C6_'$ F3< OS!-&[S"S]EM;&W.4'
MA]LG'FNA)'BEAO*E7H\X(8S%E!ZO#Z]:"=,A%R+,^*;9%1&S%[1[XM%KJ?0Q
M_>E.*C'S'SUKZ*GVEI,DQ$PEA>_F<;_MVBEY*,3&.P2,U!@"#)ROQ<-3:6'H
ML778R>%I@'RGH1?+C;F_-T(&0+\E[YA#*Y@&/%*R\>I>A\%MD4DFC-OG]E(Q
MMEZ-H7L<)HJ#JMV?BN=P%X\+U4M!Q]AE]+ZQ++KYKJL@G-%[$6\/9>N/-5J.
M^&X$ H:LY >PCXG$33=F4AJ"4D1S<Q^U59#_X%!MOG! \^&.6ZP,:5Q<NYK6
M:V>E+'85 M5OLJQ[:Z,PQXE"22C1_=>D.EV/:[!@9SKHNI88D$(;_>4Q4+I*
M#S!I+=E2 (JM:>EDAHFL3*B\B?TM0ZRBRCXLT51@[;0ZIBQ]?:9@US<YCO>I
M$-L0R$JC^_MEJN')?,?I6WW7=KIO#<K6Q40@DQ;787[KL!U0>] *@HGDT!@H
MYLEU6(^QW7.(XDN4Q!O<=^><KX>\6&)GBM1_=M-@7I^ E6F7FC9;)K\4J+,,
M-PJ.#>SY9+F9#=^.,SZ=L#O=A+8M*#<Z^?)IZJ4#N6=,YN,B<T^E87Z5PO4"
M4H\9'SZ.41R^^^&G8%O^63.E1WKO/7%/?[EU7O B\%5]+QR^4#^P$NI(0G;L
MC&4(G$]F2UOTU;Q.(\,-\/MM$R-K/VJ\?=],R;GVS=UA\\. ]RV>;Z<AW)N0
MX14Q=VG9^/7D_^WT65U#XM"@W;#ZJ?M,GX#(^6\#>ZB7LC-#+C%=_30&R3W9
M?9%[/,9B+Z;*OJM2>UY16K3_Z8NNHEX,IO*]'R[7A[& ,LUO+1SYJ9\V>JW3
MS0Y3^.:PG:5S+?6A7N&##C78.LQ<WY]#;OMB[=7\6LP'FD2C-.":>=O2^$^L
M BYWBJ-,S[BEA&5-W2[0&-H%6CV72+IJM7G6DY!0Z1'B*VF&'".SA2A4\T5L
MQT/]VOA\_;*\-4A<CQR.Q'L)HA?0+^?0]3]*P*D.M8-$=9&6)Z&GX*"PPN0B
M_AC? :KC!=R>>XL_.FIE_!WXA>5X3%M0W;*^7/KYZTQBYW1=J%:>^3=#NF$:
M#8BT[5BZCZA'OSU#M17#RQ)@*V8L@409Z/H ]QS8UXY(9<8D$ [@##MSHSZ6
MLQ')2&F!0X I[R$'#@\Y[.ES,63-U<>:@Y8,5>IR! V>^A]G/">M+O$D!XFL
M?W,#VS-DVM9AF]5 Q,)O#C8M@^LU9FD:SS\2[+MGP%)5^>;'G)*JA-82+.<?
M0Y*OCT]4K'8V<D+]Z,$A_/?E#:L:A!C1Q#I,570<\NJDU78M@'QS7%$;;0=A
MGVA($PG^2"3H0-QV(QS? 3!,;%416 Y1XZOL_%GL\F"WM<ZZZO=8OV+F<2%G
MS,.K.^Y:?[WXT<2B[)3>UPQF-^\4,+/H7BRP>BK:)T!!.J >&Y%"QJ.!.BZB
M[8N_?;\@EM6"\OBTA#_,<?"R&:V/)YX:,LF0@V+.-0VL8)#. V&R;QN:*)G2
M>6<*;EKM!V@"A3M=3)) [J]5WF\JT)6 8N3+O_7=5S\4&<L9KJ)*:G=@M^%M
M:9"=%4T__Q&EB8.SX7K7:![,.S/XK7DXQR'34?.C!_:Q"GE!3+\V;ZG!WD+6
M2W1,,>F\3, \;3GC%DF&:OPOE,2P0"_P07]66095V9^;;T[_&>3IWD&\O9;]
MN#HT.[D\U/,#Z:]YD>8=YT80?M<@<M'?W<R]DO! N*%L'=9FWBH_2]MDTC=&
M&.\B*<CS,+5"4L/4K56:9&)584DIF3P_>8@"]JS#-*H%9W+5H!1XFEOK'H=>
MFSZWFI;&3WNI0]4_O.@_VK4R^I&7R9^[Z5.U#:,,M,($WAUJ &<XM,Y>+/T&
MI8.42E,S39>_ ":^"661=HQ#J#;/;8=QH2> R:2R[R*U3_K9(V/ZR[1&7^_>
MJ+@7OM[=N@<MG".+W/+(4H\/Z#Z(*N^O5%,,M+,[VIX?W-]Q\K&=S9RBULEZ
MO_W%L^?M&&5Q5FZ/7BXPK]LM8[251B.+R5\0!>NP[<A0Y-@OWI]$5TUX.*B\
M\!N4,KQW WD'Z4=CZMF ^E]]U<"<1%J=J;X79^GM^*+5V+]@3A+^6'@4+\_+
M(?E4XZ$O)Y0?N<3N><AU%PZ2NXGWD#^?+(T5B7H0O+QUV' _H$1ST?O^.O-B
ML.WN;+G'-U0"'_3SSM<<2<%5 &BF1VY(Z9YL=0FGRHAOF>%T%WO]T^5'WG3G
M;2LNV.W8Z;)&;T[SWK,.BW((>N-8=>S]//GA] V#EU<@!G=1723W17/Y(F3X
M5GD*2!C_CKPRLHR@A&@:I?)C7$#$ Q*S44P^QJRZ2X-)023^?D<UT3\/B$$D
M\V&]#\N.[A__U($0R;7(_:F#+5P5[,YFJC2"6Q)XB]:=X<2PD-;=/\_/Y4:W
M\%!UP1;!N=B%-Y'Q-O\\6(<%74&?)TO(5;E(_=E]:&^^_G,2"G'B\<YCXZ;R
MLKU'_[-)&MBO2>/DD-R%LQB* _%@]&D%9^_I_\9V".&BT748X& XYLZ;@FX5
MXL]"[$#N;ZKSO[A+4^UF1CCW3I?O2MJV#4.&*P>40O?ZQ:E[:WTLB3X+/NDN
MJFBB9!<3[CO[1@<_"G@Z*7=QV]2&A)YK+L]T';:GEJ@-!;AD?2LSERQ]]N]*
MZO=XT@8HN<M7&=QN<!!82OGU<1O'4\7;3>I^+'TL 4\Q*KO;V>;*8!<ETS^8
M*NX\;5+DICR=:S]_"A>X,,ZWQ!\5/K;:!EFS;-MQ42\L-[,R%LD+1Z@G*NVJ
MYC[@3Y#G"K2&<N==,@^H88TOC!B6)+NI#*CD[T[_RZ9A82WA9<Z(\LBYR2_!
M=3YC$TS&B\^_$9A7F1SEE&/CJ ;K" ROTBW\.(VI/W.G-]WR>T!&).9ZRGR[
MW_=_KD%7]^](/VBE+&F3C=B>5+*U,UU*8;=:9-!@:<Z^X,&[>[>V3U3HZ%T$
MC">6S#E7Y\TY5KMZ:IYVQI.^X19F+'I_2?WJX/XZ.VK<,=SY33717-:YZ3&(
MZ_$)^9QV.IABT5#A=#W,Y2I40/QLS!)[S9JKR%?C(2(KQ/9_@$E2,9U[>M1D
M&BHMV#]H>0'#Y:.3_3M""],/XH2$74P&-V9XR\V#"-^IW0.B#]^8K^.M19(,
M8&X=UED#/2<8"K UGS"TH'0DK^X5%!'X$H<0R70CF$J3'[Z-NH(+-O-O8WRU
M<KO1S<TDGR%+^2B.*E4QF*-:-FSB(^T0E^R/[9?2FWT!NLM\6NNKZPW7F\>]
M##LFV[<PI_NDI^MS?(QBR*-O1?<Z#IJJ?*P_&G*]K=,H+=#44/53\6_LYA^=
MA^_/]2?\]B\:\QE#]B-RU0P%<B1>8+^),*3]N#7G]+C@%!3*)2:A$2M>)+G@
M&MP=7D832$ZY#$X0Y5H-YD?4MF>7QX'N;00SZC#UM%@%%ZB^ 7IG[GZLB2V\
M:"T6GE\MPA[Z?YJC 4[()"LCT?BP2%?@#8V!_IPM#2_P$LZ@'H-)N[5(115#
M2%XD5!X*IK*7Z$*U+KKFID^66@%L/EG-JSN>ZW@*AQ%X<?<WQ:Z097MC0TLG
M/HN2G+T<TEX7NO)J/]9D5E2<K*C2.7FAZ(A[R;W4A$ )%]FH0Y OSL9>4><?
MX+RNS?E#%STC ^>&]+&!ZAZ5H1C7^Z,-"Y.-3=<?Y;3HF/]^#Z[#1)*5P" O
M@9BA9D,#B5S2G58-PD".K^QHJZ'@,*#4P/+1HXOV@>1;"U3S4BB.43.?6W;3
ME+9S=D _Z8[ &%N)NS+(L&-]N1;LW%C&_LT,)9DONXQ\P6"J%IWS1YA;,<-?
MQ[]9T-4Z57FZ^WE2TE=/^W0L7E#YZX9>3^?,T0+_Q#86^/K-*/V?HZWE-N=*
M5 8> 9\M=W[[<N3D!=T^Z9Q_#@U47OCX\@4+&)J8.-!F>V;PKI:.C8X]47[D
MQT>7QF:#8+LQ#U]'YF*"@K.OG]]_2UK]_RZ;C/\K&$W[OS(&;##]+V^#$+-N
MP'EI;)7W6%AHJ<5&20IT@-6%!#&,FSTM#RXX!&4 9%[AG_#U(5.X(DZZP\(]
M72S.Z>R,3OC=&V1>#ITD#Z%]^O5G4M9ASL!(S96V)[VF+97>7082"RO\"-&0
ME2%4QR+>0=;#%\RFX%_!R+7I'($!Z1:M?J8-RT2P&M/-4HNGYJ('H'1W%P#!
M^++C^+797O^R9"NU$(RBL)<:\XN^(7M1E]B&Q>_E$C7%X*N_#@M%;198 $D,
M\CU- ]#PCL"\)'AR,Z2UF='7@5 9]Q;SD_; BP CS<UVD6LS:G)^*+)/T;&L
M>'2D5?7-<%@5)FPZ 7-%=(/&RIK:( :U3:()6EU!"T 1;3TM9@W*PH<$[=E:
MZ&DDF0GGHI*I42\%^A V3EO\M%XA%(+VZU&!_0@SO[$F6&LF,7*^NTKNZ ]3
MQROMK,^>Q\S'WB(;UPZ0#T.CX+&SD X0PRGKU+@R$"K49@?2::J"DT-7]<>[
M"];ZVD2:0Z:_%YYG72[PS@G_K![YH&M7>O$.Y]N/=VGFGR9XB-H0#5V+^F .
M!YXB4A -%<A#QD6XVB46_.T4D\06E0$GN8REYUYX4VA1.P5S$"_/>4T-#(^(
M"^<:;ITK4&JN:QZII]RQ'<%<OO]#^IC;,7B"8*\8T]/P6'!5H!#7B:BS35L4
M(  RJXK"(*<@I0GRY#0K28'_X,I2^BAI&UX#\W*.!-P48 M$AG>;LEO#[E=R
MX-#IHL&\<\2M09Z/ #O]#CD+6"0)\'X$K4W5:'?$0/$1P&W#V^5EN%"1\B--
MHSKPV92"P2ZD$D%5;)3]5@I?@G)>X5P&+M/XSN &,*J$8Q>$Z<R?/KO/GW\4
MW6<N4 P525GS903GA.G$8.08_RVZWO NW@Z\_V>"4>X<%$@&EN&J]5VX#$T5
MJ)<U/5H?^9H*K#0^,8C\UA]U^C'S-V:":3?MN"M(K#6M35>>MBIKW&$7((KN
MOW5[>]Z#(FO_*%S%_K7]ZQ3C]FL31?<R*[?:-WR=MC?-#+]6HK+_]PY[US)+
MISWGYVP*>1>C##S*7[QWD'D3B;%U,*,TTUS?BW3M]^2Q;YJ39*HLIU(UE>_!
M89YY3ZJ[+\ZG'13@\,FMO0#/IWEE_&7[7FJ&'>JX92\96(<M/,=HWN+'$=ML
M+2WM[*+T75D2Z1V6?ITMK*JPH]H;A<64>A=BZLZ"S?%TT"5\T]2V#4-6NS['
M3BE9'H9I;J@U?XA6?C6Z=5 0?4I>F,%>YL?,4XK?[J$F_6G@"QE M<V6#B)9
M5<A&S2=?[U%=^4<%DN!.7:>-\!WUGAO/2."MBF=?KVX^P>*V54KVZ3X;^AW,
MFDGH_&"("K9XFK\M6[8YI<G!XMF 2TZ+8@6$&CPBL?H$+@\X>/@+CG:T2]=]
M@&BWH<SK]OR*HXKGEP?D\GY,S6'$W$5[INT_3N;<L"G&T/I5TW!4E0.J?[GY
M0$%<K\-Y*F5P07_7WQ[?FJC-F>IQN(<G C,]9!7^LH.Y=ZVM+HX!*+[+/!TI
MM0<D+2IRU=UQ"/HZ["^J81S7ZUC<<U'U<=?.D*M4Z:*VP^\<OEAW/& *RHPB
M)5*5G[ .[:1Y,S[1/Y0^*A\J5_2LIV4G*'SQ_!6_VUX^[_O3Y8GC;<_<&9ED
M4?4U46C>0+O6P6A#R;N5!YL-2A?Y@CZCW$1TMA\W<B:YBW-M:%?^C(N>Z\):
MV8L0"T)68/B+.<K(C2ND8'7'J/@7/B<" S%2.H'9G&_3W-LJ_2>NQ&I<."]W
M!C;:D>0JI%KI/Q0^?B[0$SX2Z%_SCZ*!^G1\"$3F!4L\N9^K]&3-G"[<,]/=
MX1[MSBRM'QDT>E(=N'4N[**HG;0]BM\<'\@=32-HB0:8RT;Z[1FIFCJOL]JR
M<W0YY^/UV)0DY5. 8^:) \@KYFINSV-V>OGG\ECET6S18"<GLOOZLU,<7L>W
MS%@WC>K&$I?'5WL;FER[9P=S[%M0+]9A+D?\]X5X!W*V."=5J<=Y9]WZ3L\P
M?D&I<.TY]&2"<HOKA-XVG<3=&:9[E]QW,\N[=A!$+/8#!N/G273$MA^6KOP3
MT(!R$"I!M D7L@[CP+..?F (2SBILO#;]:D>6J[ROG.:>Q,GMTA\O/SAQ\PH
M6MA,,+@<Y"L+^?/U<)Y?2WO17>8TX'6KGE9=6C(+("?-#.(W%D]V7L_R",G]
M\4;EMX?VU=J,6L%1-G$;=,R>\HFJQ5Z$MZ]IE1)ZBZ XNU?]D<WXFY*)=*?;
MS!&CM]L9>S:_,G(,&Q3U]81[<G]YOKHS)?U(_*MX]&>?H@['6%F+4D^_],I[
MG']D(6.%?N?ZZ>YVRPVW.R[Y X$%N_R)(PN1NJ?)4W[7#UJI[V=+G:_P7-K\
M["O>86%P>FW:K:6X=7>],(& @'+GMOOS;H-3'4M,+X_DCJG+4!XG=I&Z 7/H
M82!J82I14TG-\,Z_B9)MF<-1>OJ^<XI67K[VTCEKJW1-68!\._*)"7P+))9G
MI<DA,,J Y='BST%-5X^<:\[L=KH].7%4:B,RIP7,OA1;G2CFLP%/MDD_ EY[
MGJ_H]2S=7>:JZ#GU:QVF>*%/WN?W<*7Y-_R,#-BG''Y!]\A5/K+G\!A!R>GB
MP4)3_SOO:F?T1]P?L/P3W]>^0_Y>S6%=&UJ'-2DXGXXA'1!_P_[/!;V;SH\F
M].0@Y+K:OE,#N%N@!UC_6BL5Y*96B^(YK9%B8-GS6<X2,!SY1'!L?\.VIANX
M4H<58-Q1(2'*5<[D#O,]%'H/2O9'P[^JCMRH[4&.&FMG35]<Z V 3O?BW4Q9
M+]POGK68SEF:YUOX+K0L:M25>SXV0(>ZY1O$=,.#C] +T-V:5]X45)Z.CH\]
MK>">$O2G7XH.+G486Z<ADV4J=;!@[<-<K^EVJU,IHK;J?S(W4VNRSTR?(>L[
M)"\6XXI//97--8>5-Y^;\/8:&^^+B;$T:VQ\U1T>$1&N>P*+Q?YE4H>R'*CM
MVG:HLVI?[;L/#POKFC=ON@GG9O&88@"\A>.+)!%@+ORF/+$M2$ $4SE;\MD.
M6*4O A5A*<U/7YN73AU8H/[-F:%CN$OI-)@I_$ZK[J>\<S6,WOOYF.<AE,'@
M@=,OO&VO9HT)*WEYHJWOQ;1! PP4*-!X6)#"F%*=)6QH&*%*@.XN4(!9'=!'
M1\KCU=EPA?1C=-^=H_??E.+0G(%NCE#M*-HGR.I]1'D(:/MUL_*24>].8NI4
M@^VB*_^" ";N;+9H %V_NK 9E!9M'>5F)*#K2>W$L=530RM$ICIO '(MQ)4Q
M1M'2 N,7%X-%>HVWI[CP!-,6):;R2!1R>U=P\:0=VX?H^&DY/LS!SK3X#94X
M:0AI!2X>YI\C#)'^HOIQ2<QJY&<&/KQ88#=D>?0Y<L$:S$!!@\  >IO7=[7M
MR_H<A,QL@1FXV)C#51Q::E#Y48]=?#5;LO_QC9%7>3TR\,&* ^3W9$C'!2WX
M&RKG2Q-ZF*,,Q#V:9"N<\(FH2-#[+/ <M5+"6X\0Y"":9R,4!]SQ_'-J4Q\+
MJM-7<Z,;_OTL=B<IQT_^''08.KAD&CV@OSCB1DGYI@-#>@21VVBWB/6VG2@5
M,?F3;$"G$G2@LB*(R(4+#I#2)A7[K0X+G$&?KL2K+L?ENS0/0UZLC'N3^F!Z
M%75T+=AGS^ I:BN(2[$K&_(7?8F[.>J+XZS#6+FMAN*^ZN*1PEHK>=P=]CJL
M \$LX[J_)<G@_QI9.0T=XSOB_Q86R7,^YH&!;6J.(SD1K-0E9D27DAD2WH#=
M/GMER1,L2ZRR1)4$-94T5=,*9^F+(TJK%LXE%BO!SF7=BWKG$PY$#)79[US9
M5Z1YHR% ZCPW^DV9R[6[BM-';73J\YP=F\?V?\D*>^\SMF\\/M.Q)?/JJCH\
M(7>*3H;T V^:5GEQE1G(%+<I>>)E./-.IX5Y$F%/B.;.ED^M<A<=P#R6F.?>
MW<M^Y E/,E%OAF\E,_T9E'MA NN*==B_'F'#)/]$81FY/2-A';:3&@L.BJ2X
M@+4[.+/0#1;Q+C?_H27'^*=GF=')8"DV*2+$5Y_2 KT!#+YQSW^"T\GJN,GW
M5^O+=]\?$(3$9"O;Q'5CZ\8=E'Y+_&B)-U>TEG7R4#CLE-IAO8M^LNBYI;Z]
MU8]CA]..:M]Y]&I0R$PR*;=W)QGG1<5^]-Z;ND9/^.V[QS%"1[O*PO&+TX#G
ME$WCN(/FA<*01&P:P6H R=8!A*Q:P)W.[V?Q?62\H!QK\Z:D-([%))G\VS[J
MN*$W?U=C_S+W(&TL*]BB^+D?G[@4[T:M/#740U,1Q!<3VU'L[IH %CEIE0;<
M8P9-!8).*=@HN&J7L*XJM-5S'18<;#$U=KHUN>QWYCKL2E])R #'D"+Z-1PZ
M$ZX[O+N$]I_ MF9V^;'Q,9>6)4*81P0ZCSE,:R"=OS$?C_8:]Z$0HPM2_RE,
MT7OV?Q-<_W-1_-EW'QE(2A0KJZJ BE [;E$$1Q_>T51:M2,'].)$WRE%Q95.
M0/8?/@9%ILLS&M4P.5G8B&N%Q]1#@WQ*,VW3BR_-Y"B[R]H\"T@LLJ%^\8R<
M"+VDG9AR87]YN0Y]>PJF_(-YZEUW/6SNK/8/0+1Q?T]XU/<9CX* Q^QR5CBN
M(NIG#VE[OENYNZ3]Q63G G7Y_,O72B0_E7ETUH>;7J[HS#>WS2RN&%C+3;D]
MPE37\PH]=FU^<[&LU\E:AX,_M_Z;[I]F^8N:U<-6V)(=O"_;IOO=PM>:@J;'
MB]7"JS_(\P%$+T-K>H[NHT?JCUSQU<[.6>G+UU,>#7FYA>E>M_M>HN?SR/GT
M7_]S2(3 5NSOF'AY"$:K(W80F7QN= W_O'=9&_;.&H5>M5>\1A<&P1@W** "
M-S##(78@-XQ_C];E1:^:N34)I]*JQ'C;QNE^=T74]LET>[ACPY"[T=_KL$0:
M8(\:\^+E ?#%%?YQ7'<7"3B[!.F4O:5)!JV5I7X;)N@*HL1-BR5&^QQT@:WR
M0Z0!-7YDSG2BI1'LI20TPXV9\*5#[7C"TZ%+F&->0Y%?_NE8+&43_T5 AAG)
MH^U_HBG&75U)##(K3YJ6=,,PJ2$_&B%9EFZP#F,C0-L,2QWVDDRP9W3J066S
MV<IYID%)?.'W-<80.N!3E /_^!5.W)F7N3_@,X8BR8U@C$@RCRR:1-<9)EEM
M$+N\/W<"54_5&W;PDP6.6-8Z;(S+2Q'+ P? H6,Q%* Q,B>_MQZI;08^ T-*
M5CO[6:W#]8]\+EZT)@<Q3T6[4Q#?Y\5\/O2BE2[0F<3%;L-EM+5J#W*&J::<
M+]+NP.@]DS?=]Z+TY7U>O1Y8\5(]>S7S8$RTN>O;1?7*BG?V1J\V89W_1CQ#
M;_KC-$D[D(%"B2XEY Z1.6% %JKK=$-+475"060'6F9Y'2:'_QL(;"?>4://
M^6Z$S%E"+U=@HC&7>//@RQ]1&G#GQJ;!I:AX+X>AI<W?7JY>47_2A/J3I/N8
M2"X(65^5LZA7CC\!S7+3K>E6QB"M@Y1(DA+$@^;.H'N[X5V:+&%?4 Y!'2Q+
ML]*$0IT;XFUM6X:6-6S/#[PT&5MI[I6FC]SH).^X4S([CV<3?A?>1(H-P*IM
MS"Y?AVT:$9;]"0O,X>NQNV-3M_FMFG>BD^+R<#[C]YV<KE^/)0_9"]+^3$"<
MSDK?9PDN-E4B#1]>2+ZS3-MBC/,Z.<*N 3)2D0U6!@+SF]II]3F#/P)&_ >I
MM&..%[%7':D#]CT#21N(WO/?PT/T$G[:JOZB%(3OS9T.'>N>LSSTR& YIZGH
M6!<J+@=75V"^-HQ!3G=J3H:2Y,G9%+3>BB6)4_*.(A:6%J2,Y;YZ_$6@Y97F
MQE?\2,^'F5W>V(4^#<0>["OHKQF_^.OKL$.QRM=F[6;(>0VBC9D_D#N(;9?3
M"YOV0'R>\F#UC-;MI-?]!%TH<8/J^PW%9TPNHC<IR3X^#AM?G6$XU(2:TV%1
M1,U99 A4PX[[NW7S(*U^[_#91C4N\3)NXK?\.BP0DIKO_A758GLHON#'E(-8
M8BZ2!6]$7Q#UY&1+93'3D8<><KU06W!PEU;(U1_9OFA$=ZL9_C8@.%$TIW8\
MNS&**$?'5'KV151[3(3FG&,Z!(0'!C4"XP>SR7LL,\"=[@P/HA2P,,=E'R6&
MH#;>HE_7S;[P:L+ZT8QB@(XK?0@3C])CG(ZPG_BH]]2N(D)4L'80LB/AZ)U4
M+_J8HN?YLB1@)BV$,WV!O; .J_]9_O6HIW/'):#F<5W/J-ZS-X&X=J-G0\$V
M)2'$46W?QT]?AGJ:)]7/5_FCA^M[X6=J[O7&580J\YJNY =*"6?#R.2 V\Q)
MK:5] X7WO[5N!DXO+0Z"76T$F>$]5 C)-\ A/8'.6T3%CX^#8\ [',?I=%%6
MJ$6?7RB>:7@;;[I]FOH^W%^1'LI,?."#^9'YX\RVC/'OI%<9[>I5]J,=)-45
M$D(T0-"G1.9'H=,+=)K '0F8R)=V.780L:SZ,4M_O[*+;!5&8 DTP?9-_KUW
MZY4G"U=W'Z3H5"W,V1C?US,I%^8G36<Z <\7YK\99;8,A;"N ?GU50J#2*L.
M0%OZVLA>>>MT_-_=16GM[I4G&ZW?OC;OC*T/=2X_<.22,:IJ>J>JS:-G6I(C
M;\-M(I+I=I.Q46[/U!MHX\VLKVOY4XFM.V8+C@N+\3ZA^[)_?I_:2-6+X>3O
M'YDSSDYR [^,SQ+^&E#N[JG4GTE6O)SQY&[^E@@4'X?W0GQO)$D1 Q#;O&63
M&R2RN#$,8MVK=U'UC1@)-N^A2;^5FDZU:6JZQ:QM;_2]-E%_?_UQ>7IN5'4&
M>Q'A\"DR]4"VNKZ>S>"B28O%@(+*&<S5JWY_K+#S8/BI>T7_*I9?$.9E=$SQ
M;<VJWJVV3Y^+#9#06#QXLOQ>S[/LCR4[H]6,//DJDYV(^3+)R]G>&FR1U\H]
MO.J,)J>H<^Q9B)ZVA:KEJUC4YI-I"R4[#0+IJM,A^J\/QE^(=>#$:_,4(/=R
MM%?HU$Y+!U"=EPWJUS^<.!T#YC#</<F)5W\479LU>PS,G_91?WOCVM^6)1M/
MO'[X;T=$[U'U^7GA1GJ!)E":@RG$H4_T4\T+QZJ[C^_]>V A,MY@V#@_FTG(
MW]Q0+)WI]+GP1,%PW>EHMM'$E@T?+I[54C/5W5<QXORMPXWB"3W]Y4XV^%GI
M<AWKUI?+,3#G3.J=#P8E9*YX9,M+C;^=;M!K.FKE21(T?_CI;?3\T72DRX")
MD4!3+<WM86GV+;%F"O_9]O^P"NMSPY$M^[_\6/&QIY^MSPC*G#]'I=113BXH
M;NR-V!=>_6VW>\3VGK]5M17/W9VS/U0FZ70]Y/#=/=,Z=LU:*@RS\1O[LC#?
MMY=41ON,$5( FHQH"%F'O(N?@NS784&D6P25GYO2S07[D,J6&PI_ZRF4JGJB
M%PUEO&(O';V5<A*2/'"X$9$"D!6(;4YB=YM?L$T.(2,:1]=ID!_S2(<\!/Z
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M[XAD<4:_W)I&L?6HK;.+H4K/7_IBY.?4TK]T4"P2GT=,%Y[8./GEHS[&__[
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MPG&XN,=N;[#68UD?Z2WJR^<D@.WP131?&=I0C!TSY^T1CU4N[9())?';E-,
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M;OM<$J%)<D69>QP_26C8@J0AKJ,FYKM0.ZD!I!2\#J 0B]<]VM%L;@'$=$;
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MXED<9.^%ZR<N:W::VER=-W)Y] 40*RWJ=0BI]'_A 'ORX81K\'N3DCOPA'C
M?:^,<F)EEVQ=9+/MXSTWE![=#FPV<XM#*9QW"X[,I ]5V0S%*37X]>ZO_%#\
M_,VCN^ECHLPW\=KY <7-3<W))Y\5BDJ[W8B_+"G[VD[Q>J:F5/9\AF+V2+S3
MF5UE%:SD8T?2=ZNF[[^:=B1^?X9/\K&2BQD]!_RWJ?D_TSIR[\6SG1"(ENV2
M:^U;<E!0P^;T.[9Z;Y^>0["#7V]?<+ GQ1OM'NHQ7MNP%K0M^=ASFSU;D%N$
M-D1&<9* L07!$E0M(?;_<XV7R'J&,'[4@J>$ V4)_,.UVX)TF MVX4=)M>7=
MY*E>S@-P>9XDA3,";9C]L;,(H/]^&>C)3EJK5]Z"I%(5<4$F,1MO=:Z 5NV<
MGP&191MM;+O3HV4O2U)FS,8^?;-!0!$,H@ JQ$\?,$H@YLN^,2V4/YZ,"*MI
MI;P&C3?@5^$4N"KXD9:F54? @E5.(Z5 ]Q'\P@"3&(HVZ#37,37V+,S.WI&G
M4J@^NL.,1%)/ZV[3E"@;GG-;.BX,DT*;XXR<6.:\ >, '\X-?C.!08+K@9ZE
M^'%H;4UY%TG$DLV=CU7*Y6F1T^9$X'J3 1>QO>V1L^22C$ILJ.?PAJ[DA7%S
M@Q>='$[G'W6N[^JK!W,?_UAP_N7'4QE%)"7$3=)]:$,$3U:!^7NE@*N'@_'3
MQEEKB7_]^R2:8^LRJAL^ESJG@CL5SI1,G).''\4^L^*<O.+O&IG6'4^Z&J+6
MM#E;LJLD"A-TNF!ELT+D5[BW)]##3"NG4Q]L0>0IDBC4^S)WGC,8-(]):%)Z
M:KNFD:^0BC.IQ$:3!U5S%-70)PB<^TKV,C9?5Z0U5FDC%<\DZ;!)).<:OTT@
M'JAB +X'%&SY3WB6 ,D!U.0:"-X3)'C*3-@!(3@B04(-[@AXD!44C)+".0-^
M24:([7TUWRG&@$H6:Q7M.LB3>OY]ZF6N+Z'<_?MXH2HZJG$DJ($GR;;@_&P5
MWK;$65X(V,"NXEP=H_H%B7L "0EXL4 E*[KD@2EPFE%.FPFU')%Q!?!$]O-I
MIF]3# X)$%F-#;LRA'PAO^Q](IUKPVZK!:/^I9B%/QW;)*\8R?[#6R-TN" 8
M3U&U2)KDQ (G$Q0J^=Q.+(O&2HLO9Q(4IY85A($=;@;&G$?N _/G36*FW5H(
M.\$$%KR245GC%X2^>#S &8NWUZ+U)09P7(K'!L[P]XVSA$-+ >8&KOER97B6
M0[SM#$*"QUK'6T][-@/\^ZLT=MY]H"V<\2Y(H(,S((A1[YD?]F5ZN=H 3UL*
MN%=H53W5V"R:^'//[CUC?17F-6+X =>Q;V UWB >&TFYFEY#?%H7?"1-<9QN
MI^@2M_NJ:;!4$3PR^VC\UZ=^IA=)JE\JQ083U-T^7'ETU6'_T[/E#H;CM;0W
MMSO.V#JX)?05VWH8/FT8-9T% NZ:= =="@C%Z3FS^J6PKEPD:SSNU[-"%:$Q
M;!SOWO6-YI4ED#H=W?:$\!IWJO(/U'_$Z&,WYV1UT)'UW%53C#M9 ZRIDM#"
MQ'W >9&Q2*ZPF[A?#_-4XOC-%"T3%Z4O)';B<M!7&W[2LR6*U12LX7,/1U-'
MMWC===5->'3>"VI(_)V&T:"[07V!Q-6H8Z&>&-98XW@Y^Z#VW4CR^[O4][C?
M8O."0^#O3JHX3H(UER@P'54=Q!UF$"67"C4 ^7*UVY^"#&N.#-GU/H^?FE%[
M\[8UX\C/F]6Z1_)^"GY:ZZPP\[YAB_&=U%,$3($)2Z0[GSCYF^,%AI=->MD
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MK!.,B.Z'-!6NKG!-@>%NLBCJ;_[8CM!A)+K\,_(2&YIT',!$+* /\OX!8FN
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M/W1X-EQ#X+P5*RXY!G9CTDH0],09Q2-SWP(.#<9$5N5-.\!E/13[T]%7AH6
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M>=XK?3&'+\W."6L8<S W9&[E6Z%,>'J[.9\7#(S1MNU[T:*0A<<"(9;!,Z\
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ML*]RA%O7'&@2Z4&/"&?TDYO&66%*2BQ.:73=BD\ERQL9T=I>)"]F//IU[8*
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M:12D_>SJXA!J5V!"8URML2O0S(CY[:,M6?KUV1BGUO#!XUG>HMD!_5MYFA(
MSELK*,+_R8)KX(X#4CV$7=@0%KZ7N1\%EP(3ECJ/6V+V@^[G'A.;LV5=<IST
M<P9[]SW0-(W-0P5=:;_Q(N<!<4,9#.D36P-#3X4:[!$#6C#0FMFLC>S3T1_;
ME/ZS19.6MBF"<YQG8DN^//;2+RVO#OHP]V%0PZ7OY&M=6R+#^#W9?[KP6%R$
M<\<;NPFB\7OO4!_/SW&A'JTV'B/OWKVSM87?EH"P_ON\C^1W=XCH@!G&S,2\
MWV>A/LO](%:IEZH).#[Y%H^0Q[KT,/;ELC"R7^QB;YLC+@!;:=\$":8.$V8W
MS09/GSGMUMS2U)+5I)RJ[#FD48]G^_:2TI#J':?1+%BZ^-!X1R2K':8(>@U:
M4ZS;H^C65[#EW>(CDT)OEG;4J6G.,<%//-6":K1F;,G3#/ZHQOZW0=5C1M6:
MTZ_\;Q[UJ4._*9WVS7:ZV%@[,L)5N3 U[8:)?^%24A+XX?!-NJG3X,Q'5,"\
MY,$(O+X\T095P)F#\6RFEF3_G[&1,N';M!RQDA.[)E$++./OR_<&8DMMQO/[
MJ.8)JC^OM'!)7YY5_?HZRO'OR*M'& _JMS/^=;7&V>WJ9[N[/]>XOE=\_CU?
MV\3[^H> *!646^R*(^N%[7M%MQ.H;,-RI]KJ-]2:*L(;E.6V9?$4FG(Q6R_K
M]=.Z]?4>#X6SMV_?/F+R>D^3(@22][/I1X*L>-3'SI ;PW/DMS\9,KR"3-^!
M[(:K"@_#95UUYLPLX_&IP<;@8W8LSQ)NF.M=0-XWXYY3.AIDVUP;7J?F$IA,
M?6?CKJP3N0/9"Z. NV\(U''7I[HB8.DZ5F (8.A,!L1$GI07&$^"I77XLXFF
MEWD6!0EJ?6?LO@Q^71S@G?BZ.-_CNVW5Q!BI0VV/C)9BZFZ4HMOPQ315G,>4
M6$%"C*R$H0!^Z4\Q'-CJ)3&&AA#-L'["H5GQ>R>)3P>HK9T'+! RC @=55$Q
MS!X#S'P>> CMHZEB9Y!KL;RJ5S41,_##()[%#1EL/'OK=M+IH9E4$ZKFJ7]Y
MU/QQ.%B;%2U;J,A_KAU@M7!Z]$2TB+O?Z].3+-%H<)2_DY71X+5Z9V'CIQQB
M@)-5@@[%NFZ=/"L>"\FS+7>Z\4P_P\$WQV\AV%;AD<F7%6?*VR.UQD>2I/5\
M95BT%(*\_5$.\BE!H>,D2QOJP*,-E!#D@H1.O#/9[8YOL(.?>QB'$S6!#L;4
MP%P4],+8S5SG!I/TCXPCY]N$TU^EA(I#@]N^_5#0\/Y: EM;RYUG41*JUMWU
M YA %/JR%MQ[MW\K*E6>. +,O(K'5*V,#\7!TUXC4;YJU,,SOYPI>AJK\8U[
MWZTP4/O<XD4!OS';^9?L2[TQR>BS7K7J[SVR R(J3%Y?=:H\9=)<,^51P'[C
ME<P=D6YFN(U4,.Z[UL[-U=:/CM369Q-+]O\M(1B$_51MG!8P13T(!K'DM'IT
MU G]<"/>-89!2E1DW2T>-!MW]C58._"P[R+MJ UEXRDYTL6W*_^>?D='Z4]O
MM,*_[3?R-KGXV_+%BFF3O.05+Z^\:ML)KZN?3QD.&WMYFQ@Y.[69Y'N@BWW-
MZE\43*!.1^23)^(KUDB+PPVC8%\O7).W TD6NB^Y:WR9"=8%\-GV9^I KX%@
MZ%3Y211C(\W^?/6U9<W%7/RAT!-S$0&1"R,OIFX\[U"R2]WSERLK5RX<?@!@
MI@F/LH),)L\#0RFQ0; ^JO;X'=WC?LN:.IFA^THJ4871BH.G [6TPLTCQYI4
M,O0\W4X&/O?@FL0C0FF(T-&5>#@J'A'.+OO\1V+P?>6RCU%15PO6)&*H@(N>
M#\2@-]"K(<E@"3#4#=7 2;&1J5#E#N,*+.?[WP1W?"_S'),WO\C-/"/.ZO^I
MEHE*^*'CMI_/RLSBSZ_H6\^.TM3K%]5OMJ::8A5"4J4GU$,\4G*,GNN%ES>6
M&5TYL]?)X6"EHYOE;Y^6S\74[(_RC.5X5J &*SBR7P?C=)V?A^D]K]2,G2JY
MDIUINOB>J[= 1@55)JR51%H4)= 0O*'>KC2\(JEC;PWX=Z\=(@,C5@-G:&R;
MOE5BP+Y2I SXV7UB,U)UN'_[O.G+)]XM$^2%X%[CV5.!"><^6FO_H_/8 ?=
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M3WET"G&]RK+]S+E%MI:KQ; +M?2;B[34MTH'O-U])G#-/>N$>"'X1U&F\*1
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M%=T,2^]+'(>K%ZZ\@4!\.8;"0VB./#>;-\P_T,RC<XMJP*$!RAI3C:J+8OY
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M6+4+&BV,S3ZWN+ZH_>8&M2DO//3I\?Z8$Z8AQ<*CH)?$)L?PNY&)HU"9#HP
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ML^,.$)W_FOROR?^:_']F\OC'1<A\UN%-VLTS4D1ECY^@.W/_#5!+ P04
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MQ(1$L]COZ"(\/XCH(LPCFF#COEZ+J'AC;+#GK=0=/FMHU%\PPE6+.VC*%IJ
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M?;KQSX[OV; ) OQ[GP!((_\P^G]!]1\D*[[K94FH&8L] 3I6$-97!P$G9$^
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M4D%*!Q4#,4,A[^@>WRX(02"G<Y"T!RM1*)_-_;Z!VQ:QXZ.3ZQGXDL&/;R]
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M&3PG(KXLCY>==G1C#X[?(W1YZ4BP9 E28!_4H<+EC!F/_X@7+_2"1^F5G,B
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M5VU%+'J$4*TT$PP"_N_U+U!+ P04    "  ,@'M:O33_F&51  !+90  $P
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M)W43 G1[SVMJ:\(9(I^L6"4X)9'CV-SUZ048EX.,:4Z4!74<+[9K1K;Y23'
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MP>]/*!Y/P:(3S$L]/JF6CY?E5HQM?N#O'E RR7E";02 U-3("=1M/W6F7YU
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M5[;=:Y>*]/0C&W0K6##5WZ;<F%*O;:*#B(ZI;A@1]^,#M$^87>U9B=OFC:O
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M#/$[4AQP!9Z%MSR+*-"=(?/2H<$YDO-(6'4/.@F!=;W9*NDTM[&S39E+<:U
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M &I7-I:@KLRI+XZ+FA/ 58UZ8G++:',<K$PC($F?73E0[N'&6DB"5OOC4/F
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M?0^/ //A(]J;'LR[][!P[^'AWR-\_(0$\R:!@T=' )"Q88AA?E S)<?ZZ!C
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M-H-#9#,<HBZMMP %I2MIKXR%WZ?9YM4>)]9**--,6F@P,]')/3%C9:-PK;$
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MWED0H_DMT9K$+% T<$PQ4PJC 3H"#3'EPX[;F4RYI)I>Z<58!C=>SR((/,D
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M256]!Z#0*7@OK-PEWM4?^:8]>ES*&C9K),SJQ4HBW@^XQ:\^!6[P5Q@.&<G
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M*3Z:G2[L,Y2I &:?UMX.4Y57EX,-D7LQ>3&0P"Q,W]9#$F-VKG2IAPFE3 (
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M":U70)]2^DZ1^#C2%\8V(/[69J$YO;A?3Y&\?\5^I1>;S+UA9IPI[T/"KH>
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M_;NT+EKB%L8K2EV-0J/D58 -7#.HG4SPTV/[4J.TXSIXASC8=/70M]QB>?\
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MVNWN:C GF$ZCXW%#\2]/<.75ANM!TC*K%O:LF=J>,*^9;,<$A3#14.I#:0-
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M;#:L<\!S=1!R3-%J*(_TCF\J70V.3;XNX\TQ0WD"VQ3!=I<=Q3$(LK*L#SC
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M*D?"KE[.T:_I/CQ[Y;:B$L@XUL+'8D!)\?'E[?#GPX  (,J:7O<54UN;Y$I
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M4I(U'$EM8JY6 ''%<A45U?ED(GN"/+=@UB^)SN2?L]M*J9N9&8+SDAF(])*
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MV#_N$V;0!]=T)8MTVL/DW< 3BB@6$7V&"0>B<U\P-*T1<?2[_M .A)[]V?\
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M,FN9<L0"1(GQ K)S'%J/+O'M2HUS9!]D;QHPCB*5!O\(F?Z8"1,Y$9Q2555
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M5D-S&K+YR9N_=$;[BW:-QFZ GQZ^U.O52(N)) Z)2Q::)0[E*^3<I6W.Q->
M?QX 'W]2F<XG'QY(^ G,WF)!X97T O>G9YLBQV(.2NY+(B9K 2KI$OQ1Y0IQ
M&TY1K)&C@[(;$I/V94^!VN4&.L:WU%NQD4I\24^6N7=37HYI-<!S<BQH*,N_
M'0>MZT_D%A(J+5&KK]!4COP5!$SP8IG60'2<M;+DS-MS6ZE\WU>W6TYY%XBS
MJIJ"<T4F3G^[*\R?>F8BF).C6I]YSL CS-[H\5YQ+V*'QYZ06N8"V58 "H#.
M'N*$KS-R?$1>SVAPAS*9*P@8U"03?#IZ,.' +(BJ[ML"5"HNT3K&<J?'*..'
M1F'[>IJMI\BGO$U-O-BO+5E  7 GG73G0I>^#A!7 &N0KNZ,=@M7JQ3G"@L,
MESE':V_2*E 2@L=Q6@B-0%&]_K' V8R]:(<,I.W@:=OE/7#I!F#RJ,*!<>P[
M?%_6;CVP6F%WHC:%+OLBW/&?FF\]AEG?6KG;$GBD8&2%K^'B7?:4V?WXU;P=
M1K,2]RKJDY<-#)4:4A(P"PLUFBLI"S@DH[2-UC0$XP0'P6-K:?S9K/L9#_ ^
M?T>^=-1WJZ]] "9Z-"<]H/;X"5)-V&4RX,1E'Y_+JBG[3YJJQVJQY_!0 FN;
M51^;9DNZC@Z5=1'"Y(UE 6P?97 -+.N[UNJ!O3?QRFB_;"/<<55.^E/:,C@J
MPGN%QKR7\GJM["<R5<JWFC7K:90#TQT50147>_T,FPG@K+A89_43(OGWQ+>$
M"Q.2EPAEAH!QY:*7FA8?+U*K^?.9Q'?3;N.TX!.?RW,9WHXYWS$&9<0V?.:G
M>..$U,35Z+)9S&4!5Z@<Y7;BB*LQ3O_UM">+&(X/G.$BGA#>)UU-AIZ) (6!
MO8:5&G-JZBVSG@K%;,0R*$1?H+4K7%% 2X)8JL*WM6K47IJ41UW+56,J8ECF
MV9E9C&7_QDVQ=4AWL=>FZN IL9;=IFFI.H\.@]=R:ZV@2)2Q2?CL?+CQS Q]
MG_>++IR+>1?#XMZ5H<%*A7;RRR-/S#!V\N*8I):6."E.*?A7[&%._:R5+-.:
M(!D%P">"<7SU]>YX<HJW>VI]?00K2,F1)"6!!RM'+\;1KBY3:X4'EZ=6#N!=
M)2.9RP!1>1K/N6!*C_=41I:R:%DDY?W'CC6<:O9 5KKQT%#CUM6:((8(V%X@
MVX]!(&(BC%V4#*^@5A+V"TR2H/L5UY8XZ*7EQOF5'O6(T2] NN9WRD2S[Q"F
MOC?BR]Q#L(: M3QUI\NA3$2\H8L!JK(F4D)CI?44]B@2Z%[*/#CI&J\"MXI;
MA0I;_US,LR=HGU.>WTH>$O04W2C^.P\V/#L2DJ=IP[U7(S$<@FBFUH.?Q/G'
M@4&<4AHKG\A:)A!N_!>2VW&%@Z!J+G<=Q["-CZ1?]Z5L7+?PXUT,'8[F&K6[
M<TUZ4?E]2!7Y1FWU?)S5I 3)2Q(WI!7-?V:P](CR[VOW<C@(%Y&+W7_LE\4D
M.1^5DZ (OEU*.?4WO,$Y[F-]ZJMR9&MFF+=8[IUO)+9?T@(8)I W=&P[KI=B
MKEY.O8W6CZG+.A33F'DEA<A#']*.LV$43]4MJ)L,1H#R_TYJ,)5 >S+F,,IX
M>]T'^^OL<C(1W,_L!M[JNY6TW*6%314ERNY83%ETFJSJ R5H1Q-/UM VV7P%
M%<R_Q'\YA3YQFRKIMG9B)J+Z*B>.X)!<#@7QLKGKK)U*T8PS)?5=>1&7M_.C
M?Q'EC?ZV]VG1 GC_K"5.@BB[TCQ6-\Y'I/.HT>NHS'PAY-K<T:S7@QIB_SD)
M[L&0"[Z@.US@UW*C#(L,=3F7Q!MFI)_ 7#(/%+>QH-&[NE*CI/'N'[J-X#4R
M\K$*9>]AUK8!>T5R5QBU-5,LIQA V@1J0.^B\/=<3Z9,4LM-W1YG"ZP^DHN$
MG/N W["&*^CCT8^:*\;=6(6RW4Y'W2D^A\AXDJUZR>A@<%MBM.9C  GV+& Q
M?7;*SU(F+NGW.K2:E_!)VXG;753R=<=M/?E2;VX=\!D?S1H(A6ZRE='X3,/?
M4Q%:N%(^.#EZBWVW)M=1>' 4<O_#WQF%&D$9#%R5Z?(4P*JCU][[O>E<=D+]
MX.*09]Z8G^"-JRWE_$TZH,N=ND(%[X$AK 2<MHTP$5E4BX?W==*&SQ RY40U
MM4B*G$A#!U47ET.&#%* IE=YH!<[=/LB%]JN5>?I'.TY>43VF<(8=8+O07]1
M):M.]<!>6NS6K-!,_SW_@O>@P4>_*UW;SDGMKK^>XY6-:A3P@[[QC8WY8N#8
MM+'9DX29S'B3:N=YC,\-*;G4IV4M,Y\I7YER5Y@D._SFNQ_#,^^UM( 2<H)H
M;N<*C7-79M79:"^F9#=4J&]VE2+70,!9N&)>Y\LHX!Q]J#TYCKJ9_CX47" 8
MT)].XG*$6:I@>\+22 TX+:+\YQ=RYR08#?W_,2N4I6:5A4[2C:X<HIQ[0<;<
MNTNPIWE.9+#*KVFS-H0JUN<!(K\A260W%!URR%>,AKDZXR*TNH#$1BBU$EK%
M^$Q'J)X!PFZA3">12\3,#B.#+0CQ8K/P&#*:%SD? ,TF2-[^6CMH_-VDQMB*
M[,ASR'8S[[%"Q.Q1IM/M:=E'4[1ZN8GN?V(_=E -@SNW@'^V@,7JR2]A>:3<
MD.> F8&$ESN2GC2?BIY]Y]GC7)D>U'+GHNJ\"VQ5;]"9-C%:U5Z[$1>HKZWY
M]=_FYJG4;_U#@6?;]/>D.T?<Q,^5K?WUM5$U[<Q/S+;G@F!P!.FO\E=GZ9W<
MQ#OML0T6<Y;'LCZ0'?C]JCH42!^>22TIKL)U 1=GXE%,]$S46YUD(QTU%]!4
M\XQXLOG] Y"&^..Y4MLL4TTCH!>C]@, [('T+D4#!&86V,WT#<0]$^>P954:
ME(V$'P-%)D<24G8(X#@1L7H?;LI<J?\:A>[$+]1N'QMDD(TV4_-JO*$5R[-,
MFKKQ E'285RRSO4P>1PUT5#P+H].6[P.')/YP@UI;(1EJ758(.#BYH11AS4M
M%WX1XB"S(%4]+QY<S&S7<N<HN^HF?-OYLFV.E"VQVA2:\KF;?\?!Z+EK(J^6
MN['G;=>F%$DWQU4#VFB/CM')7QL%1OL/4XFUZZ^M)C0:"YCJFU)!6"ET31R;
MPFFK%L$YW/I1227E-E=J]S!_CWZ1H[IA2\%J&<%0M+F6]$\EC WL$")A_)S+
M0:!NM!V)'SR7@P/W&''-XOPIL6-1>/3"4MP7C_BQK$:;L"EW#NHM:;ZAN3D'
M[=\ZU_NZ"9*3>DG*LMO8A$Z@B]Q9VNJ4FF!H[K-3MUZ6+;Q@U#OO+JJO-&8D
MSBR&VQ.HV2@B,QJ/C21_+OB)0+;+-@9,\B:5H Y>6$D1Y)[&&3<<(.GZ[Z9M
M]S_6]:?JTT)^PBP&<U.%[*ZM29L\K^!^JT@!2@%I"%'BR"5004,;++01"?B)
M90IW9R=@>%U;FR-B5^*FQK>9WX1X9P53G=W!=/IK?/+D/D'4-,,Y*/TCD^-7
M)FT"G'_F.3AR@J>B0.EF9:P*.:)F<?P0>=+A!'EX%\$X)$4SVC\RDGV+&.U*
MGYK6\OP_  S7WLG'L^+]9+XVW0ZY##T)+5:\XQS9Q-X/L-($K7XMX!-F+F_K
M6I&BP4T-^[U&WQN<-6:J&Z:J/R/V+E6C-Q8L7-:G/;RQ)GKC7"<0&*CI]E??
M#P#F@:DVAJRGYS^H1G,TG!6),I';/KKMQOAA$XR9;LM\A3"CF4^$K!1*Z;2)
M3H2UGYAX0RQA9^:SI5!ZZXTGUHFC)RF!U<A@6=%W&Q3/*B&2.HS&MJA?\I,9
MCYCR15C=!'VPL6 AD8'G])&I4Q/)H>O6#ND8ET*NI<\QKA#XV"4T+MMFI@#:
M >?##+9+\374"D7F5'P>+:Z2?_TN7]S,9=PY])*Q@E75Y4GOG%OT@CG&$-G
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M?HP S(-OO\FFB)(O01(15:QP/O&&B:I3AQ2/J,YWZ7K9<).6SWD$8BC+JA5
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M4F( T#CLRWWLKA@YUU(=?5"AG#TL-3!KH$C\RP"'J/PS9C>! 8=XSEK.W/,
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M34*<SOM^VQ57B80),FD>+2-2"+QXYQHH]QH&5K3@@"BK!N=)=EV:5/I2R_W
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MP<V1V)Y.V\]A0Z@&(@DCT4N<G5;Q)T;^ALXU8V^Q<LM1"E8:B1]5M_L,8\.
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M]SN^+6$$OC#2Y0P*,U)=QB\49H*SK\)>:E3LX3N#4:2AH;PK( 5B<60Y@/,
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ML(]UJV=3$T$LQ1\Z^G41L2N<O41#X26SVK+CZ]6S^8N2]/DB@_NBQZU#^C\
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MGSSF"5>:6DE4*ZAPLIP9PR:(7X1MZEEF,3Z9\!"EL9*$Q!V)ZQ1LFUP&4 1
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M"$MNA\K@K=ZK<%%Z'6W_ R#U1NJI(7MH-,Y7;*D"&*LX) N2*VAN*#FW].I
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MIYY:7'$NGF5[I6E)TBX\ED@12H-+:R[AHRB*";IP1T" #*U5R&7'V4.3Z%[
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M_#Q5NYF+5EN6DX8)"]+5*I9GGN\A^#$2*>8%+Q?"8/@0*Z:]%=Q?AIV;@Z#
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M'-?>WYV7E"E<S+/Z5>V7,\!A[I.%KR7D'CH"FIT?UYX_*!A2K5)>;-\M!7=
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MRC8]D&E%2)^ @PH&5RO*]_H  0O]^#GDM.5+\/TC^8W&GO6X& V5?V.0X#]
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M]@(NRN>O>3RN.Q>0POH"5E5)GH+R5T;UQ_^WTN%_^+<,^/^]_A=02P,$%
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M]-C>YN%< =Y;%3(28UMH\_<3G=_JO*Y%9#!6XYOINZH(YH>+JQK<?1T#C'"
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M"03^IZ^#PF 12/,K SB@W7#-8^FL'6F7-UN>'Z4K_<'LX<SR XF73/47PW"
M1CSV!I$"=D9;C*[*XH1&*N\^XA3$PP^S?%W4#L$^+SH_PYZ>*"]&ZXNW,J8L
M[:82'O 9N/T2Z?Z*_8H"5;0+2^2<I#&-1FJ+% 9R^;ZKAIV3BX&CV:+:[@)[
M<4?W _J8CNROHDN8;P?6BX@BF(^+C>FEK:KN)5:=Y#MEFGETU)14%7\2MT-I
M>2 _K?EFX81G"DJ- KM7504'8O"@N7'CI_[EN5GT,@X!:3YO=8\L6"I3>VT;
M,!M6G#_"JL!'67G3:4QG&,4GE"J(:2P4)_1J;;XK3\EE_^( @:' #)J[GE%*
M($SK*+UETELXY7O\?B?A;44%EU+HJU>B3UJ#\JD.6JFJ5E0Z.VQ.^.>FL(^U
M5G$Z^;Z[:T8>W3P2G/;HYKWD8\.^%'3GL;)[X47KKQ?98:,D/"";[>-)^VUW
MNB'C5:4UC7LQ!5T])R]MLJOWVF6(JGRLRLS[.$BDIY?C6>;'Q>B'U):>>+V=
M;=3S7?%G01:Z'1AC'PN62F&OQ=<T<RI[&93YS>OBW"WN1SH:*\W8H:Z,QHR$
MIPB$?99" 35SS*5Y*^B+4G@0=M+YS:TEU[JU.6DL,D55)7[^)%""%R\DDC5)
MRE&E1T.SJ;R"T("40X#[J[);'4F,94.?OQICH@@!.T*,6L'4JZ-&DN($KV/^
M6;A4B^! 6'#EC9W.NO96@Y5[]*(RZ.AN!4)GN=#M694]MJ'ZH%QCU]"X);S
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MVK$1WX[I;QP+8;ZFSD4_MQ<VFQM(FKN[%87,)2V8!F),16'2H5$G*)M:A(2
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M:YQS<CX!5>:VN!M'BF*(*I[S<P:409V6N/<?39],B!.\E9)QLHZ0?=CCPY+
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M52&,97E@*1VV9XP@;/__)@/1  !02P,$%     @ #(![6L \-Y"L)   3"D
M !,   !I;6<R-#<R,3$U,CA?,3DN:G!GK7D%5%3M]O>AI4$ZAP9)*0F! 964
M5#I5%*2[P2$$I 8!$0EII$&Z00%) 25EZ.[N89CY!N_]WON^]Q_W?G=]SZR]
MUIPYS]EGQV__]CYG4+]0\P"9FI*J$H"!@0$\07\ U!1P'[B!BXN'BW,##P\/
M'_\& 1$E,1$A(1'=30I22B9Z$#,3/2,C"X<@-PL;/SLC(X_$+?[;PF)B8B!N
M*5E)$1E!43&1:R48^/CX1(1$M,3$M"*LC*PB_\\+]04@OP&<8#!A8; !F.08
M6.08J$X !  8.!B_%_#WA8&)A8V#BW<#GX 0O:&&#,#$P,+"Q,;"P<'&1I\-
M0)\'L,EQ;K(**^!2Z#S%8W.A% F*R[K!?J_B*]6CG_L<HL]<@_$)J&EHZ>@Y
MN;AY;O&*B=^1D)22OO] 44E9157ML:Z>OH&AD;'E\Q=6UB]M;-W</3R]O'U\
M0UZ'AH6_B8B,3WB7^#[I0W)*=DYNWJ?\@L*BRJKJFMJZ^H;&]H[.;UW=/;U]
MPR.C8^,3OR9A"XM+RRNK:^L;FP>'1\<GIV?G%_!KOS  +(S_N_Y;O\C1?F%B
M8V-AXUW[A8'I=;V!'!N'51CWIH(.WE,7"C:1H!N4]^*R*K[BLXL^VJ=ZYOJ3
M@)I#;('SX-JUWY[]>XX%_T>>_>'8/_R" 418&.CD89$#8. ,SE,D/7!IX\MY
MFAD700_#>\<J2:1+$3VBMMM#.&H0B0+:]T?!ZW@.*""(& 5TCD8<%.N]LP*3
M=,Y[J9JB ,ZR\D+]G?.LR?0!1>\ZA!#Q?62@_MPYV1Q" VOI578WUKU:CF-,
M3Q2P^!*>Z#CWQBA]1-&[#2$XHQ*/&X3!7G T%8OP3$#2>.;5>9T2MTXOR?E9
MH@"%G$V]IE<\_$,VV<T&2)JP+!0@?]<)<<,)R15[;DX??@7LM.VSMIVGR.58
MU"U26]?HF/.A ,(.;120R52'Q)9  13*?S/&\V_&@'3*IPX(16$%Y50H('2A
M /*#9 H%8#*@@(@\,$,-YR6,N'ZH9!M\:BR79W*MLOJGN6 &@X<4@[TO-LEL
ME"@%7(#XH.Z1$@R.T_AYD]X3[T]6OLQN-O1W&C5<<&?P9/_\,1;9K_I?K!DM
M]D3<^WY:Q/<-LN!M"SK&JD$!7\*NX_+/]N1LBE^^8K7RTZ-:4EY2*J-QV9]^
MZI*6#*)% :VVP@=-CYR:,J?2/#JW(7\W-OC[:<H?:FO_M=K%N?VFFIM-82&.
M!I_\3[N1(?^;M6U_56MCL>283]>Q3L:Z%98<?O2' 9%\WR:6'#_-><D'-;F(
M@J[>O_5W'(6Z_#9TIQMY][=&[=_9;T?8CCU_U+OPZZ/RH\H&$)Q8 IW^7$KA
M'P[MZ>%#]B"$9^PUI#*K9#]%'EC\/=V0W^D&_Y./\)A7UY :4[3R]M(-<.H8
MIT^+X]=RN_&V*Y_5;4H\W[14;+N3*F9Q[X*B)@-^F(3.F7B5$7PGNC$]J,#P
MB^Y#%\<#5K= _$>X 85?8:J?Y728^'XB;JU(!-LOINK6C[S7L)%/85YSO%?'
M'C(B,P)9>'B>!#HX^80"YB;^'F/A15/+'5]'69GK'^Q@A<;18PU1C6*K^S&?
M\MV*S&R-310\1*<;:3FMR"D9';LHK<O]UVHXVUX?IYH94T-G[=B)WL?@]'P\
MNBO97]#;I5RG-H16*K$8>X$<N=BZO "?IS04^0L>A%5XUQEX-1K%Z5@R<'@
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MQ"]Q3/,YY/B\+=1^-'K*=TYN8ER7?!7KSQK*G;1]:!\QP;MFTQXWS9P8-#_
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M W-%%"SI5MR?IUR5;@1U+^$UNQV<M_!<Q3]&CG'QMIZ/9]&0597+_MZL> &
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M3W]EBK/9'9VL7+]OE_X5M*-U;?7J2I!,>VD@")2\<T4SJT\P<O^FI2H%G71
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M' -9WXRNI;;>*O:I7._\&!"X/4C//L:'H/VP(<->M2":P7-5@89&+3J<PN'
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M- 6DI#/G_[Z]1&)Y6YNH5F9Y>A#?.<FVRB?G^[K7'7A#^X13V_T -2+]\_)
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MYH98[_:)&G^7KX[2T6VO@+$R!#%1^JJ&]@^_2\>IT=6:Q<FE2LG6232'@ _
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M>4/PRN'0(==H4$M'/H8 =5^*!E#['0TH+"J2(=^.5WBJLV!P_Y#VH-H\)6:
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M]Z1)HVFMC,G[UM+#H6M;K#RL.SKZ-IS.+1[!T+@PB<VMFOZ#@R';TN^'T)4
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M4^Z-4R?'1^,,C/TC_%0XA+"&KZ]6M?N(M8,3XI 8/5]$R7T7<\/GOKX'O7'
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MC5>;#JP61U&42WE*!'JR4NY0[F"WFA- N3WDNQ6-AD9/<>4?#3W26,:37*E
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MC*4"]Q/J*GD9C*6JUM1MQ'%FV5(R9L^IS TY6TL"<61MV>NX$F?8_0G&KB_
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MXL\=25\M=PN;GSJ5!(O=WRA!%\ \U2C=_@/RO#AG[VW/FL!]@(Z[OPEQ\3N
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MEQH:1HZ[QI))(\SQ:9J3Z1G\9?!<?3CA;*TEBDJV**^*'O5)0:DR]5!=PZT
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M*M:'%RO)IS1NR[)F;.!*97SL1=P-JO$W3@(QEJ]-7,*V#.!E"VJUG<DFL6_
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M0KP[*W<;Y&R* :?NR1FMK2VU=:RO G]_<A YOIQ&[1X YY7?#1%$*<WO#^3
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MVY%NLXR)P\>X;M\T^Y=\#\5VG#J"CW03YB[(06N#?7^U@5[?:UE)#NT6P=7
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M<5A4/?+=<C(5.0\XBO*C+<F+9O([8-=.F5,3PIHU$*WQ4_PG #FI.\BMIGL
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M<EX+;K.1/)U4(U7<@X\V'4S;+<(4@[^(3CU4F"%[3L,)64'F$!+J[+[SD)(
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MSL;FXO[(U1>,377DF ("5)-\HMRHO5%O6NL$&<F/@W)[B=#]OU$Z_/RV7N\
MWNH]14+\R4IL"8/TJ3ZP<3$VZ(&5BN5XFIYX9.%V89184K9FN&U>RWP1QY,0
M-7-5_\W1T<HV,S(%QDG9W+2L_XE1C^LQ O\<8NQ91@CE,(6)O@/ZUKUJC!)C
M/R-@*9I*81R=S\ $W#RF#%"/]3-O?9,N(150GYM_"4/[@DD/?;&"."?*+HL[
M+F4FQ$K5PTR__^KF9O%QQJ7H"UW/=9CMD-1QVBE:I@/%V"+;>] #]CUE'<T\
M"32<OPUN]VP4]_Y7$_EYY/A3CU=&)$,4[3;^Z"WSHU.0WRO ^!_<[@G7\I%7
MK1]?"K:)<E=0K\SZN9Q=)\B!U(+YA762N[."Z.B[@'VP4@^OPSM@ VZ0^S%P
MAI#?A.>J_FETH*QHN/Q3BDY$3! AD9B11*9D+,M<%15KUXFZ$)TG*Q#DREFP
ML) 'W1"X)N_)A,B8:6;CX(%#$)RDAX_$@9[('>MMK\OG%QRKY=.R?,JL++^(
MZ$Q"X1%XHW[8M]S!JL:/#XF'+VM0=C#$>>SX++(F*78U%HMJ4QZ30OG(X.)I
MX541R*_\BATQ5 (CYER7.AE6;;K1<3D2MCD%7A9D1B+)L4=.BD'!?X22896)
MK;F$C*L&T7T>]URPX9$M6)T$*S4]<6$<_5P2*@% /Q%M[ QH<']GWU*3_FNV
M^K7DJ4<S37UT2F-6W$)L<Z)#5S<+I]:SL?7&NNQ4&3)[6GHP8+>D;B(Z,CT1
MSH5-%J/97O2+J#[_H T);J7:&JBJ+0$6!QW4C,229JW)"54@7Y,^K 4X!<1H
MJ?7.E\Q3Q&M@)F*.IC4P:\S9]X;'<]9GN:"F?V%<M&+X+%+TF<STX"8:J''!
MLQKY050V3ZMC4,><FV?X0F%]=R!.B;&R1\^_$,/H"VEB\49Q 4>9*\,HRA1S
M2%98\#4IO+BLT>3L24560)2S!\3/>BTR?30A/2U=U60PP68E"ZO<"=>X.6E+
M->9A+MD86!MJ!;"+F_F7V^N&KVU%J^/P-/*YG?//1W!6JFE_5Z&:@MV:_#Q1
MJJ6>OH%-< 2_GO/E$\],+5O?3)-(2T]"Q>IP>_AG%?(%\QO8MM9@/'C 0=%7
M)AMCF"V'Z#P8IW"\3H<HED8(GLZ3,]27K"8Z<CTQFD%QTSW\8,C<5%Z<E6']
M:STA&S\! ;]E.]71M4F*[(1'[/&^LSUS!Z7\K08NMP[UGDCNYG@;IAYDRL*;
MZ$_/P+%+NW95\+_*(5+>PP#QV$1L .C4CQJ-FVYD+0&F_L=%N$,_+%B9Y]OT
M4((:NX>P#!VA>7-K3[D">-B^\G<+Z,M9/Y1OY>OU0I5BXG3382,A _.0VC=;
M]&03B]:6EF _@:D*VG^5B221^$4)K%XP$,P['2I*ADQ&$]';P:SX,SR#F1OV
M///%@MCK;^_2("^0GS[:5&?IG#Z7M\079P$#ODVRB8P&SUZ<[S3ULE7BQ@MX
M#\E/M?XBE972CL ZD@$A'+L<KK"DC@\?=&6*C/MNDB#UK)Q]PC7L_0?I1//C
M*DWI<#E9HJ=*OD:IB*I]AN"'S<-!B34[0DWX,>EH4"HBTLJ9C]X)^&1-O(CE
M/H-ZR\5^G)IF9I<7A23.$L]G01RW:K?CR3K).MK#)OMN0)P\QC'S:Q>7A0(K
M UWYSV2"[_>50:,,+ +LYQXN>O?QG,9Z/\V<.?76L$!H=H'Y2=NXMKQ-[P#9
M)Q9=J\(LS10ZN?8#LKOURL21P=-M>?=BDJ<ENP%69Y9?8TB8.HHZ6FSANHO+
M6<6J>NVJ9%B\%6#YS4\XX:&8B&*_761FY&])9 B]5D8]&@ <E,$VF*B.38>0
M6VW-O6G-C.R8E*P[QE9145X#U>I]V7 <8(6M<0@V6W%_#:+-463^%K,ATR[1
MA\-*[85F;%STH72K(>]T2=;.+S_DT5V4@NE2D,Y=Y,48;@4);9# 0_C 65[@
M__6,UUA\^_8.*'T'G#RID%B] \K? :OO@'GEY7> M7;@VTW/.V#B52-457-(
M3/]GU#M@O_8$GR5QU=P0VG\V>TO(M(Q*KL1<(\O1VMC:JASTH=DBMT#1J/J$
M=?,N((]#MV'O%>1<(Z64&>AX-/??U9642KHN;T-E_N\ F<W81N6-/4I28 [M
MT^B#*JBB,X:P1Z7L?^>/RTM!/&/Y>.$71HW_.X&LP1!C'Q\^("MOHN' LYK7
MZAG8LUS&%^2XJ[R1/:^A!AS:>'UV4_T!PUWKB5PM9OFDZT%=4?0_9F0X-GFQ
M^RJZ[?7W$<;M[NN62#ES$GFV\3O_NJN&O@$^I#V9Z5%T*+*V<P8E^MI.+#G
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MCU\*&%+P;S7\^<,"?* J?^*FO ^+'5# )EVF?;T2L8H^G=4;CA]SN(D-RUA
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M*\XV>.MZ)Z_N!XP71#=PISG9K]97''3._A];;+4*!K:' @J\97@7Z.$39W_
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M!V*_2\K!0?V14>\RN*VAKB1.VE8?W?+H_ZUV_.!C]6$@G):_%K:K18F,#JG
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MW?LDL=^"3 <XK[M"%G_-95M[_.=)8=#2]^4K<M5&S<VCXSZD]6UN*!8S86^
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M^7-ICUOK-C6) OO(A(A@U\2[#P[6M\&=+G@E/U8BLVI3!4**(QO52%+(TUI
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M^/;L/SF['Z5H924*) KZ L5N@4T*7Z>_=8J$T-/]X-!Z+@$IW=>N(VV]-65
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MHC60#C&WX_;,SIM6'@R0$%)V8#.E4">CAP;M%,#<9*1@.LG(B&7[UK7BO@(
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MCK5^U84B%G[!,OVB7PT,:7$U7QO!1OB5Z"5U;2%'FLVC9?]LR*MRVWC94P]
MC]!]=3>YU ^CPH2;5T2X1Y;9G9**HH.9)!;T7"[5)Q[3>O,G)^MVG\>L$XF
M ^1UR+;?/%O40;YVQNKG+\Q.ILI%K-%FW_:'T3$'#_73-U%B0IZ&9]CM"ZAZ
MYB>DS'45,ZO8$L=8YZ;%7#E.@7QMS;G>I,V*M+1VU=SUE\Z\5T7C.TL%.V;Q
MT16/M=[/"YV_@PN[+.:)&KUJ!TTV'1=Q-BY8XB_B^\KQ"H.\W,CM[-!H!_YK
M9=X9B0;&UZ5V_LX]#7@.X[0:><O?YZ;'DO?C+B^6E]8,81/<%/M#!%]H\M\?
MEK<$S*ZJ"1KNW)8+)NZ(HB/1)7,LD1MH9N^F?W+364PL??@,N _ :MRO;A>B
MT"8_E?P4U8NL_/G?6*E1*>M )4L)&;HP?<F4 EU/$^O2O:_((N:LGZ%FQ>&'
MU3GB^GJ[-P!#?M?WT;&_UHH9M">G+^C_X[W+'ZR''GU=.1\7K@[);P@.[U_X
MBHI.91[? #P'/X]4N-J6?]^H/(EVY?*C2OM^J4IBX:QA87?0;FO[MI3A.'M3
M5CIK8YL5<=_0S\YSY@ O]WSR-V",X?N_?ER7(B=^T?C9-7V7$-&:[=_%P<QO
MNI^A)#N-E3B[. 9]%/R<T3N&_5*WMP[EQ/QI@M2]NY:F49,$6",BAZAAAX=^
MD<-/P*B^O:?BV,TKN 715S-'6$?LO-UG"93.(0GDR&W]RXJ29J6X+H8N<."T
MS_H$',*=;,UL,+?-HZ08:Y+?EIZ#R-@[,[-494Q13 _[[D^*[WM[M]Y1[3\Y
MLSF]K#?WS_.D<\V>]Y[<:.L-@+94/W6=8K^6;NW]!E!\JJX\JW2C"W?R!B]$
MU8"K+O*5HL;\^-J(0ZQP%>)ZTFDG<?3K9409@ IHL_<:_4M=6,L']IP,X#5!
M:@YS.%\-'==]79!?GBOUAZMB6,N*'SGLZCX:R!D1D\9FY>!=!D-WWOK\-P>/
M)6Q([&3@V=*$Q2=A6K<*C28S"?27TI*'PEFPA"&G%H 6;N&C;)JS)=R%)V@N
MJZ_-NPKF1&<:&(^/52!>CM0)\"+ZA_*,($CWC97AY+MM6V_[!;ED:. [J@J0
M$EL0GP6E)J=3GPL]YN]_*M?EDU@3%]F?!U?CC=UH6W\N4$D&;R;PM<Q+?2!D
MM36FK! 3YC@RN88).%/%VL#*HDH]?'XR,O[DY:)00'(1YZ>NDYK%W<(T>3YS
MN%QM')'$GI1>?"@UD:I%P0;*$6NK<UH@1P6)!+%&/A!V-"FY0UP3**[L*Q@5
MV.,97<5Z$[?%"\,K. X1>IU!*GBT?"J6BK1V50Z3&72L KI7"L)R<JM^OX-<
M[A'^8J-KY[=C85/V_VAIH6 I<[1&]/(6X4E"ELBQZKCC)4^F3S00NX:Z^[OV
M?7G8+!B%JB6LJ)M>?8+M<)?2H':<Q/ZDA>U#=<UIE=6$-;UTZ*F>L/7;ZNMX
MZKS]2'F&.=!9$KU_:9@+BOM4;Z'\F.P NQ,.>(>EO,,KB1=S5*!E0E"WU!\"
MD*'_VT'7J9VNGM#>Q^",(/U.=<&HNZH3.&VBIE&#G5[S-Y8X.]D:!</#$:P%
MJ]!F:8^UN6Y4(U1[=6ZY?WVOZ>0N\24JY//[YC08 /T?Y^PU&5GC+6=3Q_!Z
M)5NF:B$6,B-DG)D&"=<WDH!7=+DO@.UW3!_80$QS_/X[AX 'D\^+W9R.+HLO
M9G>W\'B(]$=]"1I3D@M+Z2^P"N_4G1_9>_G+:T7E99NP9RPG!A_I'E#3CAW)
M]]SIC> ][!D;AP[?SE..GN%8#C,@ _W==5%X(GE2T^Y#4%T+,F4%/^JA?$>]
MHA]UC*M7!>&AD1WHUKZL(^)D_=S@$]<.-*\!/54<;';_:NX0=?'\0:I[T!9;
M6V1MB]06:FGZ_O#]211E73XB/<FESF;CZ+PT*R&\D1!?;R;[S*?]J]3Y_2QT
M)J*I7H@=%O8-0-M-R3D+[VE-@4^:",5:-FWL>Q?9YK1;R-#',NF:X@XLYUJP
M]&<EC]L12B%I..OC'UQEX*<YPC5TM =+AR]*U6@-94(N)3KE;9%-YI<7:%:N
M0O">2W^>=TS^B"2VW><?-S#/:AN/=4?>X0D9DEL^Y"=N_$,\W^=Y/:N5>2=9
MDP-_W304_F1]/Q;NJT-OA'2"H1G?/>,EJ,Y&0BA _-%R;EZN@]4@@#6YLU*8
MD3UCV*U%J)*-Y:+"C/ +BBTS8P@KLW,Y[5+VO'O 1:MI9CV.,9"EQI:Z)TMQ
MUT!\7:S*VVE\D+7=(YYE28K.T=AI8+Y+'_T?^[Y!X3&CU0_<6Q_?43:<'6=2
MIQ'TUO+4!$&FVJ(-:=^L">!8?^AX *&?%^=.=&<O0\?VJ+[P@LZ_"T]A0H<Q
M,S+K?Q:?&\L#SF42W'$JJNHIBZTT1P9(F/9H726]%YJ?J^RUJP,3QNFYR^J2
M!5F=I/2S;+T"-TUM_G3A=N3_<;0.7,DTXS:U-)LX'ZDMD?V%O%9GIX]Y9%+1
MC?DG^>XCV6JVRE:VY%ZTM!S^L,XYCYA'(NTB,K98J@9K)8U']M?YLI'WIA-5
MM9$SXI4?LR/_I]2<*?:J_#."HX9,,\$-V.@>/CYHXE)4KJ.E]/%""72-_3>/
M$.KJ0D-$0ZZ:+93M1?10O9%02Q/!L=I/SVVM_9KE71S?'KYVN(Z;9G:".P7E
M]?:Y*Z5@8RY,+52T&*C;-('$F.-#9'C^66TG]L1_UU71-:")*?3;+ JD=6%R
M$M3H+LT]U1R?-@V%-A6M"=K=I1MCTC<EYI=]AHF64'H#9^.G)[9L$M1Z22DZ
M<?3_(MB7S=.6E;7U7U"XHR,,;M/JY)FZ-15",[AGGSEL,B.*QQP9]-,HT-&O
MJ3__)TGX0-VVIIJWJ*C&:OD<=^V[@-+<E"7X^K5WXM<*J*.3URQM^0:+9\&A
M[)FFP8RYRI2W:))H$K$O6#/C.#BW9(#/C@2=3$K,,? X-L0#_#Y(WD^X3^B(
M6W:;BA5A:OXLV)4\I7!MO'EV11EV3H\=W6_KBJ3TS$JRZ^W']I.GUVB[>$8U
M[1UCE7P[(]:7P@ -2SDS#WY^U\IHI^?D]XHF'Z8F51</;,3=#F2]DQ[AS_Z"
MP:L>K -.]N)*=LC+AW(=$,.]33/'-.JV%LBAV&&@(X:S6ZTZF\FDOA)@O)ZI
M1U_>$8WDHCOIMZE/YF!><[Z+#*,#I'E=_9YJ:^^E?1*,$9K(VK0:D[R]LP*<
M* B>Z3,</S]2<^:Z>)#'^ M(@]AG2R)IY:)^[NAEI>+A-7.FFH,LEX6W"9?7
M-;I]MV_5P!;$CAL$M[]7M]7Z-V*/V?IBVN>A]?'?1=,P I88,UDBZ#^&^M_/
M\/Z#)UE"C3> VAM@YONM6_KK^AO X0V@R1FVH"F6^ 9827D#/-O,O'KXRO[G
MEXJA+_TOTFG^U$6EP;<O"@\+JK/:1P\^+-:QQW"81MO!-$CP$"+OJ^P45D1!
M+%;-R7>!\M,[J;O/B@Z)KKJ?I3J+G'QTY[+B\%AGE.&USB#:M&=;N<AY"T\X
MCQ:]%\B6EH=+.TF/MMZAW_BSZ:HSRP_Y#="47R9_9"9 _ 8 /LH:UWK%7OLG
MC8[Q8"S,A "6M@EA20.R(G*2@\Y5$$>T)=\LF><$E[0'%/SB93,86W*ZF$B*
MCF&_[H3G(.FX5[EADS!]G0WG[O0;0%O/^F*_:^21W//F#6 YIU[[ /TKP>LP
M^>/XWB3^O!;\[[)X\1WQ( _M3I/0LTT[BW/-?6$&YB]N[G(/^E!=+(0XVY^H
MRI"@_7P4U<J?;:,<@8W_[.72/:S/S^?SO4B!UM@+!T07"Y?W6D/G.N)<EPUC
M(VT$UR<*P<N;./FFS81I KB!@XS#"H[#/NI6A/3]9SPV>[.H\-@ZLGP4-.0X
M0$,6\ON0%X6POPE/WQ#Y!)&VQ#AW9(&I*CCDF7$^$??4NZA- N^P'=DU3_S4
M] <\^/T4-"'6GOK>V!1E41"\TVL3E,82BQHD6IW%&F5@VDC5JDB\&KPJ?7+D
MS]8%_8[32 %.N2@EYV]8LU*B?3:_G!BI<'T5&WU*?%#@9NGTZV<M#9UJ+:;=
M_&T>M4^S;(D]&$-(#?@]5K5TB@3)[>_B!'V 7_\T"L(MRHJ%G,"QWV'@P P^
M/DH8E([DG<K6!MXM/7?+8SNKO:.8EJ#=-L1RQTRMY8;Z? 6,/30[5F"KHVY
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M,7YZ6)+2=;[9]TP@)3L=$'@P?OQ!ZZ: MN#$A=(M0I.\F+;5'F7@:.'2':@
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MC0I3"YW'I;R#KTN_JHR?R9;(&"F]9GA<4]!GX'F?(<]"5IVUM\81XXI6'J$
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M7R%PQ=QO<!0PZ?&MZ7#5OJBVR^GBO8__"':IBCQ2B*EKMEC0ZZ<Z,9#7K.-
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M9B<R565IZ%LW2)7BAM^(QC#T!?#*)WVV2"71VC:JE.)XIZY0]=);8F6FYAK
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M]UR9#WNX,3.K+4/VA;N?224T]@K0IRWI>_^Z'4LK#VXS#C\<AEQD0FO#GN
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M<3XG/<C8?N5Z'/!?/OX'4$L#!!0    (  R >UK0Q;.PKL\! ! 5 @ 3
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M7(Y[S,GY9]$Q2#69&1J&=)2W$?H;\'@@( ]Y! ?G)4IA/<IC<Z_O+NIOA\;
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M=!IK94>P2&W(@@($I%/Y0P:W[)/Y)Q*/QCLLMWR:UQH(G'J?JBM1\!.>Q:>
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MEAJZ\P/&;8LFL,M6Y(].JT+1SJ4?]NM['O?^>O.=PO-G%C[VSGP+?+OKIM#
M)%'#_J<0]5+CE-:4#\91C?&N7NW+V.Y)]%#"P ;)D: -)4D4PL B'KF+]JL4
MUA#[.CI%X ^5@W?YQUO!6+\1AH%%'EC"0NUB[!&=A,Y4?OJ\J..<AU2!<KV&
M&$88HC9=R7L!&X@W2.:E!"LZV&T=^:OE%;TT'6X5R6DRZEH9MQ3\$.?BK4'%
MG^H!3]F'P%69TQ5$F,0*2N)RLM:$M(S0$R#B5^1N$9*=4*""NWFR-7UX;L#B
M.]5_*G IL:=UQ![U]$WJ3ILIW&K 4#EW--DH"]=\1G[G\8"'LR-AQO&7RM/?
M 0_I0=8UO]2T(0WS]L98&G6% Z6!G52=%U7^5#G7A-(@WXC1MP/74P==_5L&
M*F>T]!=3@MB2AY&TF44!3"R;D1C$N/QTW4- 2W >.@^H<9>K.FACLF%)ZYJ7
MX;&*KYP3-D+OS[JYGEL)]-Z6Z$05(8\PP)"\8LQQ&ZT@9EY;="U4;B4.PBU-
M#\E1VB*G:, 6GE'W)%RB]/$N+R"M+2ZY0N0^R(R0P@J*!\"RAI1GV);E>S?(
MZ@PCQVI&(=6Y>GSAZ*)@W-4SG%L:XU8]/80X,/1U?# %F]A,757>9;GW11OP
MZ?T-U<R#XBMO7M[03G[IT6X;<>W]PO3JSJM'Z. 1UNF$8U! OG[I69]2>U?"
MF.O=.Q/EA[^,>XX[E38R&97#I25NT?3/DMRGM#E%@1'T1N@"V2EGD.NKEOJX
ML6-+^#-I@I-0G/"2" T]!*,\\XKS23PMJ)2[HCRO+P]\)5>^ ;?XL&/;8FL=
M*FW(N]MB=S$Q7-NZ\&)WTXZFI)/+E!59@X-,F,L(X0T<S0.Z*#PB,H/V3RMG
M(>4A+2K> YHA@CU26*^.3"K(YWWG9 7)1OI)Y<VB(^AM44B]]F$K)9]@8.8#
M%9&_EO(N-\3&M37G36-NN^OH&:1M_ZZ&8K7>8=9HQ^B[%S.N3:9Z:)4SVX&7
M9@&CJ ;PY>=CU*QJ$N6!.*BBTTF5YAU06=-SK]8GU^-.^^RC"V'8IL'&T$%,
MN]H\DU?P97..))48@8!,>I>/"I.A&F42O$&YDWP[=!.(N$V,P#!,\#$O(6X-
M-!0X& %V]^8D$N4"<;K<=(GB<,)Y#FN].#\[*1653W^Y4CYD]G5YF>/<TM(<
MEL3C;"4<PO\RB)J>1&4S5=N.\I>Q+*9:(UH>3QQUSCO$3EP^T]7B^0EI 57'
MDDAX]^B:L87[X^W4Q^_"N)/HY6,38\>"704^$]7--BBEU3N'RDE]1[7MF4?*
MB*P?ZL]5:W>Z7SW)4UZV(?5<HF16VPY55A2E!%TCT>\?*,3UN9)-\IR7#A6U
M#8?W;[^^$I,RUFH33MGX+'GTA=9)NPVG<Y:+>">EL+$(P4\0!OZ:HRJ*8(@S
M1?N%/J)S4#=X?X@7C(M:[)3L/ZZ_%TKE4DU/#XB\[=UXB+T+[!<3G_'_ /-Z
ML_*+L$?;VQL H=6H@,15@DL4;CW#<AKS'PJC<0T=-WN*F?+,Z1)T8SIQ-V$G
M+J+;ALU0&9&8BO3$3V(9^@N6$.&;8PK&'O4,FQ<N)O-REX_QSPVVH>)// I5
MU+31R "&[+O]NH>J A2]/E).#.0I/*\-5O&N[74V27_J0=G#K9Y=L>AJLPYJ
M3BC7]E3Q**8ZCQLXQ0@CZYX-Q:S/#+D;1$0,F$<G$A=5<R1)R$-26(>?%':5
MEL:1KY.88&4Z3:0$*KJ,,B/0FO@ .HA*8RA(AO6W T8=1#A$/#TD\J/@ GCD
M+*11$$;',Q^OQ2L]]BU5S1$DW[;F*+]!92]'\T*./K-.M;NQQE$A3*'IZQDB
MO>D.VB+\A49S3ZP6?OLP,7(5B.\@[F1&H7*G#@Y(X/V5P5'Z>TFA4EBZ_OI2
MF?[0H=:DP41REMU4><03(N9MTX9-9J)BROG8V9DBT@7'[0./[LO?50EM5["P
MK?*/+],T"7QHIU[MVS5(.477*<1Z56VE>#R^7A&4$42J+RN)&@\2T">I"87K
MV'ZLC3!/-L6EL%TR,U+#:=):-J@-.@,H<B.6EKFI%HA/:BQFTWVF47>VY" V
MX+Y=QH<*7JFB#Z#_@*'!3CB\YI8:' Q\[=/U?>E^Y,MX?%]B=9XW_TU#S+I
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M'%WR GT\E>A(<)9\XNP6I88)KQ([]C?VF0:#5;<:"[*D,'6"K7*6_M8&4$]
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M]^L7$@['^SUY7*Y36&H[RA+B\HP,;@P6F-Y-::0:-@[Q9C#8V>^HVB!3H%E
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ME;SGJ,IFH!*.[ >LR"Q['2Z%:P;?9$&'PT1GP?5?O\KDL_](M$3FNGJ;0[7
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MI_WPD+73F,@2 5Q!I&S)-&?'1ZQ,Z&%2T1J0$2)M7 1!<G2R!6V&S6&D3!\
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M&LN6ZF?=YM],#<+,($ _"R4"6 Y:'I"*,E.'A8;.@0[=K+U0JJ!?#NKWH"I
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M!$;O>QQ>4U;P'R\NYP$-:MR@DF9%OP!A*>*C97/L^AY.&$SR(5=+)BQ=:QO
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MAR55VBI:G%=TXNY?L.CJ]BZWT^$2FM^&II[V+%DAZM'\1)/M6S(O:4O\&<=
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M]ZHF#-+/1X[7ER='[B]V,S(.^%&J4VUTM>A^6\'HI'=S&>/\+?4PL?)VD2?
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MI^A])-'/C;,,;<IL0=4)\@74^?6NZ63![%!(J%FFZM<OL08%R<R__Q?7NAP
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M91G!7R%LT/ZG0"4=-=?SC7N>(,K@!;*IB6$X?A14E?6>HQ:; ]%0'A-)N""
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MOS=U=,]\F$O+(U/Y2)7V';-" .ZE_4#9RFI D>UJ4'PVB^#CM9UY(*E))CN
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MW%ZE%+V=BX>N&A ;1VIWC1W=27&KRE/IE-'.UK.O?J^:93HK.:(*.^(><!&
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M,Q*=SJFO.>6%V89;Y1-%;ZY5*N?NES*VOSWVK4 ;G.T#?L(&W2),_NSAIB7
M^1B>0'<LG=@#%F@50<OOPBGK8;=W^6*Q0L718/N19GWG<7$2)?8'I4?T_L-S
MZA5LD&?DP/G[*3T;KYC-.&340AIU>!Y:7M3G$XPL<U+/H.#WVF8;V-4VQ$SZ
MKUTOCA#9DGB =H[VVM*N3UOXHB?Z;M;!+"\P(GS7@.%->T>[&L35&>]R'<S;
M;$ EG "$3M9^*H"*TF438+7679E=S]\,N:E\K,(A/6ZO*.JNI3W+>M_Z'N7U
M\/X/-F@,<?!LB'FVY*$/=+_YJ*Z;/59=3;7(F_GV40\85J(1DH*:1=Z)H^B
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M2PJG+,<;*E9K@0XB]/Q+$--IC/C\0.I+[*3J(C6E<3(C: '4.C&46*.$9;7
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M]2')US>!19]]I429IIS92,EWX[UNQ60V_\EJ6.!23!7O%4B*R"K-"DCD,-V
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M_>@RW0C)1==1J1^IS4]O1O490OX(\PW<1!MZLDWMZXI?73NLJ/P::< O2HA
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MB6_ZUH]J$7\T*LW,OQ7?GD7$QU!$VUXI:LB#YY/1DDOR?,#6('$<NI+Q"K4
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M,F-JT'$-"C/Q8>A5'I#IB>RVG.R8+K;!(,%OA'@4;(^[@--D0I62,:\;"OB
M\!^#?#*L/-CNM2*!_PH>(K<\AD_Q61 BC:9513Z4 DZ=TX>E'Q5 KZ ^N6DO
M":+85=);L,&/ W4(]+7P86" (5"PB*CO>>01;=_"=6^LKJZUW*@C!BWGYYH
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M>_=<Z;OILU.8>BFJG: T<25/ SQV"WC)D<A]%  ]D.7KAK'8BUB<.:^,(7O
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MW@#HDA0K"$A0TT?&@)^.^[*&\S;)LI2Z#E)H]U7J39YNWMZ[\/+,LU_>+0C
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MO"PAB.LD,@C)-:\7&8LI)+_N>%3-)--1AP^/JX&KBER'"$CA)8@J8Z2+9%+
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M^01EE1T2VJ"%]GAJV["^RI!D#S7AKY%M!$QD\?C'Z<.:PPCF,RC3A;>A9NO
M\GHQXO$-U';K53*S_<0I-GH0JGUB59\?]+,""N] /$<FH<XE51+<P0*7H2_
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MH13A18@D^ P5\.93] W ]!2A_AB4P8N9***J$2*+? @[FJ&H<+\8C;2@Q_@
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M F!FV<+5!'?( L3P[6[]I%(F-(&LV7F>T7GP\[?BF/R9ZV060ZGRYD>O,_@
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M>/B"VOXBFA\^>3RPJ$A]6EKG\VPV.?J?3^Y35ZD';:D?V.VV$<J*Z/!ZF("
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M3O0[2Z=91\N>EE.F9,5L4N%U%XVI*UG/BQV.-LZG-V;Q;A_H S*[_>F7#Q.
MBD 4_)0)-^^]-4:M6D;&,70W\TP5:N$[:P:TE,WU"KC)E$46,WI_WI5C(U2C
MYI 0]NF0GU6PL^/YIX\4DNOE:;B/!>HU$6>;86K+'5]5,&67UL!>LB)8M'\N
M;<S#)D<6#E$A*-EUFUW[F(U*3! ;J> RZ8@D[J_\BEV6A8K97DX@URF"6!6E
M2^-&_8).8(]:MF)8:?SGXD/]&_XI$>]Y-I>AO?:VWO%5/]C-F#6].C7N.OD$
MQ>$LK[FBE[R<*00OO$L#)T%ND@*>.WWN%H$%QI"W/:!33\!JNQQSSFK)?A&H
M[W=0?/$]6 ,5O!3>>O2A1YR[=G2/W"%AV7^I);KL6(RQ*+RT=<KD1@,/Y(4B
MM";]$?;+F&2'0219 YTP:1KMR@DDWIW]M>EHE,7I,K]ZQ&EYOS.-4.D\YY_\
M(\6ZHV,_\P6R&=1OGD)$LH?=G'@1TR9EP]#_<B75'EB/BB)-@."VV)+K']%I
MJ,&<Y;RF@C4GJGK.KU?\-/F6.\*S(UU^?AU2N6';T?R4X"!2@;VB7^ZJ7=WQ
MC=K\\0KA_)&O+!:T"S>E!K[TSV ]9X(OQ1'%TYK"0^7UV'(O=-<:B#AR7I2.
M##[ZU_-MN)E. XZN6_PC,H8UF%_B6H4QM['"P)ILUO)668KRP;Z\QDV=TE>U
M-D5-7_,] 42FR%NRJO\UB.[]%L[T6HNJ/S<,HU%PXT/=D\)N/FKBX0L@^_@V
M4$96'P98CV\!L22U1-)6V]-F8'[V3A=ZLG5;&FO:^\JG];LQ3CCG6Z B2G?#
ML')!JO#N4#[$EB*QM4_%V #<5$O*TM:L)\5Z4N\?A %1CQ<^<6;HB5=I>K4D
M<Y%OKG5ZW*U9.R,C8[<W^#\-WJ6DN*+1*VG$\L&M;3*9KD/FX/_;;N1 I2HI
MP5)^+U)=]%E#L;%\ HRCI.W&\OK#'#T'K?6.Z4RB]G=9Z\W)= <U7S-]BUQ@
MKK^S+=!<8<""?'&YAL:AY8"\[!Z2&$]*]D:'"!?=2^B3'^F5YBNBV5M)/DPC
M@N:&N),&EC=',F0N&Q4Q0/6]$Z0UG*G1//MWS?_-A)L,KJH5$(_-J)HI#5OU
M[_Y[DO'<D6!ZU<\OZ;%K@79I#B7\S^NDU=[8D];H2P@5@(46KL>-T.XAAOLM
M783?Q%;3)&QGPJVF2SN!E]5?%<MJYG_2AOS\VX3#X^L.8[?P56$=';E"HKI-
MWX_*:"&@E#S7YO8MS5,F-LKAA[/(MS5_F71#^./F*1,O DK]"71P2F+9W16,
M7IX_99JG&%H7W55L8[^&R1R>*%E^)J29F*-L-ZYZAK&:UX-! 1PW<:3FG%@\
MQ$:V/C!V)%C0 5X4K:HX, 77R7\[4K=B,6B)G:Z %H_PY&7B&&H6A.8)#E5$
M*K@,TH[[9J.A)1K(#9E@:A2*XA(?HET B=DRO_'L7-1K'OVYO&[ :<++6PH5
M,N9VGK*HO1A]<>.(JX>TF;_5;?C.KU>L)Y>O,X6 T]&H*EV$^H_3%$9M"E"H
M"ESNF/Q#7#NKR.U)0RG?%4I0I_51#C5U^4G\\6WZ_9/2@!C?S'DY%P#I355=
MKL\CG^A30''=X37P-;.IUM*HY]4;2O8;XE=:"S9MF[YLKV!D#/<4EDV]_-I<
ME<O=?Z$#YP(/$<#4L:X#W?4DMQ0H)F5>LD>$4#']A"40PI+XZ^2);B3$N1:F
M(YU7GS@50''F>WU0J^ "OY(5S-?J$)\ZL%=1-P0"$OZ,R[%:*A%\EVLL<D37
M^%X2E.V^053I7B*)M)!^KZD$%C::W1/_:SXF)E]WO5,JZKG@*4VU)DA7NC&7
M$('V2R5M+P%F?-G\,E:08T&7L-?MZ0(B!-,]\BS'M)[F^,]*B%[04=OG4+>[
M;1;I4/NBH=(;RGR[@L/0=4Q,SF3Z8,S2[(N:(WN/K1T1C KKD8$VQN\$HA5,
MCL+:FAN;V].$%!5W=AYGL,,?".3:6CVXQZ?7\VXSFI]X8,X)Y-V;5@-=^AG1
MO#Y/3*YUO.==O>X0)[A?=P;$OZ'/\]MOP(LN/,#J^AVR8%TOQKA+O(I!+PUD
MOICRDQ!"@U)[V6E+V,C 7@6#6I_M96T]68,ZF/!AX?(Q\H((&-U?OI%QJ'/_
M* <]==8!-_A_CFEED&E2M(F^F!?B-_]WTC"S"+!$HU@ +STKZ#S 9FE%#^9%
M@_^[7J)_MR%S'?A=!?JDNVWPV'%&JG%* :WM%:_V84>J\Y\MQ=Y":JV2G7"U
MUY]K]Y<X2[RT;?3B(>.%A+V/D9J@5>V=H!9YQU(!8[Z757G6E2M&ZE1KAVIA
MP8+F*HLIJNVDB'1DFQ@A :C)XZ1TF$N3.<H$'*^B."CZ*!S=XS4UCQ.2#;;K
M-+[\8LS/.TQV4# O;LSGAD6)W%^)\0ZR[91K?$?! EOQU,S##,":A$S1;^9=
MU/RL[J,G P22;'&9"?J7U1U=N;_#HW_C;0]MCB)2PDZ9N.T=YMC3%<>''K1-
MUR_O+6QKW-X<@?H1#/@F8!);4\=<$O,L#,%%4V_*6Z NH_=23'IR]<_4Y3]Z
MUPLE/^BE02[X1U2^%E9[*A=Q.-804VB@Q.2;N3I%'4JJB;)I(#;+PD7'*^T3
MAU4=.@NJ\KR_=G]WUZMX-;)I\JJ&]K!$@-N8FR.<@Q/"Z6N6JU?/;WV]IF0[
M4+Q#-G/V9Y1!JNSJG)CHKA >HF]PY7!NZ>)*]TUYGK%0I[-$PN&!'0)7F2OW
MNP>%A]2Y^-EJ8-WY$.\3](I%H:5_@D^9+KJ>&732)8E+,23!67W2>9UU:@<M
M\Q!QRD3-D.!ACT$7LQQ;!LYAT-$CG!-??T?VW@6GG7.:B>Z&6QXZ9BTLFR<P
M!!"W: WI+A<QRV4V2W]#[$FZ+*YW(9QJT+)[G$NIK5'2CD(N2W@!C7[FMMIK
MH^]%['O'#W=&'NO&9VY%'G.=];K6JC2,QR[7AJO8D^CK=C\9US&-P,M0%(P;
M;H!]1GQ;85CO"/<R_6<.M=BKAE(ALX+1]I/7T>P8O7&PG"]!HE2"M85^7V78
M;6,%D'T;.Q("D%J*!G,%^%R30DWL"EJ;Z\1DU?Q"3:IF:BPK:TWT1LJEFM1A
M_8/>J>!RUXN/:M8:!]WVBR8SS#IBM4MN)JCX&^F?BUO>2NC].T-2?Y0F6&<F
M=+N8+[/,H05K5-9@5"[. G)Y7WP-& \K=@Z;(3K>F[$U?)[9+-TZ'[#W<^*I
M"N=[W\&_JGJ^7GG9YIBM)8LEC!1YSV[W-NGW![ P6'7+[.%E ZZ7PDTE[P+?
MZWQ4YGQZY:;\=U>!ELIO\(*Q;@.^K2./082 =%-@<*AXW".!U9&[;IHN[KD-
MFK2\K9?4<R1-;$Q\M!2-!=LP;T#13(2$4_>P>!?%DW>][)L%7&4DUW.;S\JO
M/IURHZHY/"GE'*O,JJ@H"?"P;31"I]5E0^$N4G9+;/ML8=3P9OJ"//Y+'MMC
MA&F!55U3:TR+3<2-AV6)Q;*"$&?8Y\/&(H_,H 3^M!O3M?D3X,3F\ ;9HW]_
M'-2L:OE3$E5',7P2E^"U+YN%!;USR#'M^C.^5F>?*T#G:S<!C/V"/W%!:1.N
M6]=0:.IRGTNS)L?EY.\K+67Q6LWJ>QY;?V[,@M4QC_4UY:YX0-_ZQ]4KG 6_
MY&1%J1=&^U)W!K-497G>"2=@Y'S':JN\_2H+HF$HX2UB9NG).8$Q/CGUL.+R
MHL?U#3##C8*YJIIG2N]3K@M:&/(R_7]>?VTOM03B U27 X=<$V($U-,E+69;
M)_[VV_/3+-#+5B@7SJ$'5+I^K=/(6KK']_ZN5/<]NXFK-S(T'_2G%."!-1K;
M%'EVT#4%>;EU4\'XWB3C'V#-E>:9D5G]S5A]IQ!6YUR87Q<H3+277X1;;;]9
M4.V[^T?HQ5BD,]]Z-T5\SXYZ7"NQU;':,IX#\C1''M^NY"KY.SRJ'8P.AOL^
M2&P./815J8M[S2TK"@U3\*H4]=M5AR=F$A58'OSS9^/9PS]7K4-]P_@%D!L;
MY<$S&]9' Y6U'6C3L:F4E*-9LO&V$.F4233Z4\PYC-<"F&,S5_P?P)QLSKWY
M$9F\LQ,VIR;FKA!\<)C!J4%D=;1,N'NAX8G4L=/UN'YEXT 5)8P5+(;ZX)3I
MKW6& B!'U@3\*# %!G\TH43^!'D@]WBZ6T=F!HWA7@#,!!&&52U.2>0OJ 7L
M;(":@)&N@<#3 :W'2F.8O;-7@0@D.5F^P$%L1,2,^$I8$E5V8(\:0UVM2.:U
MITSNV%PKAU7LB4-F:_43A+'<X5[Q=X:<*M4#2U^ZT"BXU2!@R]%BIC9N)5FP
MJE9Q4DIF(9XR$5.Z?]&X\Q0U-SLR/4P8$\SCO=7"3DWMLZ[,,3"Q<R3OK9;C
MN]$3\YD)ZF..C@"Y@&==_.K4CMK7L "68_'QR;GQ6N;IX0_0U9ZNCU$)0KW&
MU@%IK U>@/EQA(\$6[0H8Z27IQT(KO$[FM@ZH('Q+FJS3]39OTOK2N*>F:>T
M8GAA OR+XOX3D96;1'[&U8S5P3W&7$#6QJ2AM[*9L/[8D9QH5Z96X0W[B&GE
MZ9_0&R/5/[ZRGIBS/K12XNUX)6IN)M%3IOZP/+0@"">+YEU=[JU?>/=-PBR<
M)/!W,/OX*1-ZKP;HH($N$<F(18EY^WA!]Q:$,<OTLLG,P]+D\I]?D)S6U:^.
M>E@M*X2;C[YYB%IY6$<WPR4/)TYRHR\#2 HFN?O:<LP\=- A;YOO';P02HNN
MH.@+ G?;$R1IRCV=49JW&B.E&=//H=^-2&;MM8OW@CEST/&HM(?_MG/?V[/=
M!AT; !$43:S^'+)/1R8!O<U%6=;$>E+%41_\-'4>'R[^4W(S0'8._ O7F+/R
MZMLID_?=G;QJCHX"=3N&D<P*V\7SC_8X PK@L3C[>EO':RCYCPGV+GSK$ZRO
M"$KY=GOD4"?%"&?9QLK-Q7I87$7*FS6;T*YB]6M&+F,A/_0XJ;8@[Z\N,@-3
MX\&1ASSU/&C(D-I$J&C4/:L^*N-F?&-&F*R-G:&P$)>;ZU]L5M1?ZR&#.9&6
MN=+(MI@._C-H0^RIK@Q69#F\C&R<L /1I&7:3B$\CB$([NF#UHY&VF,D*SVX
M&E8P7OT!E?ZUO3=CDG!O*I \I7[1_H?CQ=;:3]\<%R^6TZVI.UUU -3Y<[<Y
M"74[2M*5.EY;M?F,O]KW]D351H$U+L)&TR*X-;\RF=VH;TC^.?GU_2<C8713
M"E($/G6L!!\:%)>AV7V1=Y\*>TSC;__@2UO707 /<6@X^$>T$,2*NX/PO";_
MR7IIE1E=L_AWI0;>GEI#XT.\=,L%<\:1NK/EAZD\.)L*^7"'#N$'Z4X3W+:<
M9F_X%;NKOU0)&1=40!1!S";6-6:9K<_@H22\./M ,*)IC]#T)U.$9A.)B^R!
MB MWJ]3IB:@WV-@A4ID3AVQP5I%/>(K]36%3U<-&;?HJHYM8SMNY,E^'?D4,
MQ;0N;272*'@=$#XF4Z)E%\\'-(BAXEST8TFN:73U,KH>4!A5^6_NX5%&IR?*
MX*2]ZNV[]O;VKLQ[':T?LQ;XIY9<ZY0_:2+^M^TA[\*Q!68H4 *A4[#;IP,>
MT+]$%P6BJ-D# FT:Q&@^:DF%8I:_O&?W-"<*/3(LCM0BUB\G" E.^#&G?VAI
M?,7])]4PK($':!;\X/&!'$+74%[-AVP*)0_\F+,1;@LH>*1=(B!09)+!(S&O
M4O6PPNE.M3MOXT%PN"]%]DN)[),F+/@<!%*=-SW2I"6_)I([=&44[B'?1P$*
M]8?<@(@K8SU%P7\B.+%\^=8,?/PSWB#@.EGIB>"(T%/Q!,=$W&2?9898= U"
M $!38[ --)%^3.-:/RA59W:;F3;;OWB%.IZ[Q$VW7*:4T=6HWT=Y-G1V$^DB
M4IK"]C-CJ%:C-?./TSO,VUN'PO=!-T5L6[N.C"E+VS(UC*'>&R=)=?B*S"2$
M^3)X;HS.3NLBE3\;:^I-O4NL@\AYAI8O^A;XMY]YSR2%<(4+J_NF3W/OJ,Y%
M9DO:.P]IT\438-N5*>3YR.TG_P1+"6BT0 -"SZ?^?OR*S)+A\]B5E*5IZS)Z
MO0!6[Y5+7HW<J?<.E?JM:0D-#84DUF4[F>V9RB>> TNVB(;X?>V'HPI7_J@C
M^%E YN#1',0Y0K"V?Y @1]EU['(+0N/Y0[A35H*C[UR"6SYI<L@]&+X!^'Z5
MX1#N-TH7O/.G;N+G ;9SZ#(I]/ZLF*/FL+B AOTJ^\V2P$*:!+>'JIXHGEHL
M#-^YCE_+@CLA98:# U:T1+MN#%""YM[7OB6H5Z?@B(7'E*$S#RBS!92 :(QB
MZOS2835-)J4[PI?Z4Y5N!0Q7SP-^)$B$Y:??2C^?N@@0>[^34_/_*8#>?$K\
M43!(_FS N7A@CU^R((/G,P_=@-^5="6:Q+8^M8M<_!NO'^\B.$F7B7A.[7*@
M+B))R-0"\;2M^?#,E/<S63=/>![@")$:2'DSF]4CXOBAEN*5E(G])RG4&/(_
MWN-V22,94$OFE-+;&9*RU5F/9%=R%@4$+,42<-98JPIM:[P;S=IW//U9CO?U
MA]40GE.F1]D#^O4NG-0W,+=K'*Z\DV-*@G4V<BPX7GB59FD)R2.3\-/3;HM?
M0LR8VTQ-A?[DW/]JCM4H7B<\F+=Z-?V4R?^V]JL3$<#UV)8Q\4PB-L97(G91
M%M"G-%RD"P$'M? 8.RHCGHK!S4>7DL&L"W O.T7)S^4SW5Z*[[*<??WD9+(M
MH)$!:MAK6Y?F\CGKFOZW=A0\GST@K@7</-9&R)WEG1AA0#9P;@G'D)L-4PC%
M'=6G5W\C7*BN/F7R ?P-]-X,2Q7D_N>!/D;L+SCV!\L_%(PMSY?@L;"?I2Q>
MQ7EFCWA;_F4.L@17YYA4BL@1J/GY*VA5@*86I.;GUOBK1(330#L5[U;MEB/X
M.:V8S5>-]P;67R:6SA<[41W,IR.$]P\074R($=;:.F72'%52'?])3>L0MJ^4
MX<S D_DU15)(N8V"&\ <V3OU#;]L2ZZLM9_5"?])K?Z3=#E*>RP$3)I(=#E/
MU!/R;7>]),\ (^QGGH!;CY/HKC35>]35Q'<_"^K?J!TGYNIJWH]2]/OZ;MHC
M>=YSRC.#/3*@<E^7!8]I.V7J.V5**\#$Z\D@7+_$P)Q!9+/8]^LZMJETD;-Q
M#XL6 YQIMS?O.><>Y9!-8P(^ $[W,1]GW*?<,\BK$YZMJJU4U ],#J^MI_EE
M>%OO3>4A=QH<XM]BM[+DA'5OWA*EJJ)RGMN^P$WU#^3HJ 7S>B?AK:MU+.*"
M0P<]]+HX[BM;E^JK9+Y@B))4ZK)E"<UT@EPBB*!C[Z7_5_%J6(LO_,D_\/#"
M93^O4)PUWCT(7F GWQLO'+[VL-(9JD!PL;5EMOTKOA;Z4U\8<0?0I;ART@VG
M%7O%@<4A\D02(I2K:MGTJ6N2<'LR1($$2J3U-)\R#4A6RR2A15"!SM,>;=".
M=],['CGN,!3Q.RI@FYYWD#D'.BP GE-!6*0X_0I-HI^A1;.)IPWUV_1>_)C7
M5Y"9V+KM>'=J?L&I97K'O1!GB&+^EGO4I\%S4K)SW2N^@#QO=<4<]\8V\16Y
M;D%Q/*CS\/(&;ZB\@JCSQ>FJW$=7C+J#IYM:E4/Q)-CG!(G+-FB.Z*MI-3.5
M:\(N@T6B;K?3W XB&Q*+;A8'#;H-"&6/T>S%W5((P2%EMKIC->2@')64/RYR
MBE5YE WRAH>2'4)#3J:?['$['3Y5(KFI7G-C!D_VM/PE@Y5 N_9ESITR]8O?
MG(SQ-(]#<O]")I\A1S^8)&9,7AI$\@%^..%3IH1NU6?*D9XD9_" 3E1"'C,.
M(U\=],5!?YZ$_MCM1X,Q=V3,'N:<(*/!" G E#IU^($J@=O\'K-L\U8Z=ADC
M@9">^<4>8(S7XTQS0&%B$?:!9*E0=O6>.G[D O^@O:02YZW'[3T=79H22"O;
M"G%]\L6I#.ZZ&OO[0:H$3*.+:9[QU5SA2HT,#VVH0L7M8B'WBDSL9SQ!_)1I
MH<(F78O \W-H3ER4+KH\/)/["'G)(*FBT/+,#!(!FD:XGD*&3H9]\C#,2&@%
MX>Q_7^4HTDA5( ][/84Q',]A"L,RB]XY^7C"#<0?.]$%  K- -H-5%&10T<"
M_4M_T74F>T41W%_T1. ;8G*#&-9LDPYTKKY W6_N8CF<S@_J?+_/X:PF)W-.
M17$!;CY]-" HRFN7P6;J1CT<6M9,U.."N?) 0CVH@7B'\<Y:^!IEI[-RHU>'
MEA#?\-57V*ML>1,Z)K/- ].YVSPC=?>)8D7G6^G)5J,]+ZA-EOFP@UQS9HJH
M1P(J8]"MZ:N3AG?^;)4C7Z';WC=FCH'@TM0S, "!?B9Q-Z(<.5V9XS-XBCZ,
MV-U78(.+RO]<SL9B;EY>EDC(_Z9AF4L)J<.*O'Z<[P#XLX \0D<7!+(?EL@I
M#JW8C7I@R<K6<B<1$O%CJJRKZJ4I<:JBT8KU?AD526.BP:]/KM*0V[>.-3[I
M_0,4]L]+;%NB@(:A7(=:'Q=V&F:P&'H?\*.VV,^4JT)CRB=(4;Y@;K\O=D[#
M4A^O%>VCT.A&?DTA9IG,%8FY6O(BDJI)F<!FI@D?YM3 L[#].BO$I@^P9TZ'
M3;X?WW9,HD4XV_8W>(Q]I567Y/?4<80>GEN8T4<SI##;S'0*QYI(P4HD+O<<
M9]HP[<T^!VBZ>4M:^(UR(WYJZ/FS5I+IB1OAL@G/H?6*#F]U0RVI^@'VFF&4
MM"T)R;&"T$=2IUV",PCP/(7:[%7,_%NB1P9NFB"[,A/24..V:5W76R6X[&=5
MN4ER@PHDHV32AMR5[8@T\.Z9_)?:>C)?GC+!0)D2/.HQ++X,.4#L^(ZOBYIK
MDO[% _:%&X&!8?K<A,C@<M[(^@NIXEUET!#JO5"1.LOUWYK$+Z:BZ8$0D47F
MDX9H@:K^A=VYKB$;I)@:*$%<D#983<Y\%:T'>))[](V LN4Q-L;.T3KB"IG@
ML_OH"\3 /34FF"EWWB:]^Y1)>?E>P/::^;BL7!<[68+7[2I)U$4<?<-JO-A$
MJTA<'*63'_U/@[% P;+4'TD;+0ZCFR!C"2BG2876,HT&[SXS>FL/0_9:0,P=
M+$IO? F*@V[!O#^I.!_W1NT239!#@FIL8WY:5^+^,YAU,>LJ<+]6(&EXDU+[
M!04A7/_0_&U<:U1,5@UVTD[.S,"TQ*2<179M=4P\4@1A2'V.U>.;;G4$$,:T
M%H?I:.G-:/GN9+<6X(WTQYXN:MM;U#I;G"/,P?^IC6VM<M2M'U _O[\.VK'F
M\P12&UJS3W\NDU2 "*2MY)8=WT.HTIX#ITR4'4R9G\/OQ/=3!\=R2?2;)+D
M\$3)_-)H6\;W\BR[1_RS!5G](NQ-O!+I,^H]^+%RZG?[;]_FOB_<S79TGOMF
MZA<>H.8=%NKHM- =VJ\6D)!A]_@>]PO/1T9^57(T$5V"<GZ:U0W/X*.#9S'S
M/ ,K]M&@RX[@7AZMM+9B7T'X0(DXBD-,)VSE88YO!VP$A= U":\ER]@FZE.-
MX_:_M;"^J$V>6&TN4O#.MARB70A^NQS4.9*A9P?9ZQ402"_:H"A]K1M ^S:6
M)@T\&'J8SB&MDN.O>)D%"CKVH%$HR*U8:NSA I!#\[ %#&@>UL 2=18_P=F6
M6 5/Q#8A%&G&J:C6F]>FHO]Q04^[+A1XE3)7?&]V@GUYNRV\-ZY@)N*8_"]H
M_UK5=MER3)H^"!%.S3MLI<:DH#.Y@#QR92?M^8">*F 16O857M6G=X7&O+W-
MJ*C 5VVFA)W8&L("G[B_^"3L(;8R\/W6%>B],V^AL[,+5F=_NQLN0A@S.EJA
M+]1NW]X@'QUN.#'O/PE4_%&P2G:NJ7E<8!M54]O%QM3@;)^7 KF5.K1J'106
MTGW!^NVJ]N)-@:RI$:K$PU&;2"WY^Z$?L"!3+VM&@S&GJ?OC#^/%#NP""78(
MJS4;EVCC9186SSDCP\31)FU&($Z(RW2@T\L9=]!")WE%2@$V;Q:YG)0?UJMT
M-]\7&717GEEY&=?$NTFBF2L.085>5!B#0$2)_QTR<$=/'*%-6]HZ**?K K84
M,<G#R).2UB6A&"^XRV^G+^&@I&AEFGFJFK/EO9C+?L]B6X45,'-(RZZ/_/^-
M<Z ^;)QG]V$,>0?L-_3ISY=AD2QG4=<"7FA)12:%I\9D]IZGK<6IR05HK)ED
M4+!Y+F#B@8+#Y&][OSE2PNKBX,VO[S]"S\DWW^--$!Q1:03>I^S7 )GXG":A
MI]+P+9T2RQ2\^]Y(V!Z=3UZ/F=SL+WY+7D\"9!;G,S5@,1)"EQ;@3'AP:*6;
M7<N\O6%5K>\'6LY,A/OSA[ZLRO&X9I[43+_@6F*#*O+*3_/R$\4DMR@J):B*
MI*%2JI-1^61XJL;0JN"WL)KG"-MV.QAAH]7G2]61+?7<8=%)GMX%WQ)6()&$
MY&),N[#1,N/#ONN >1!JU!A<\1DS2?JXXJ<+IL><ATVHMI855T./FON[SR,K
M)F#-FG?+FNZF&=W[%:#_9.DBXAX058^0![Z7(RRITNF!-%5\#'>T,-!^&$%3
M:$]$3UR8@S?8S:!KE\[Y?@R8)O([,%)%Y_'?;-K-NK#=MJJ.QNIU(9A5,;XV
M$5RO3/_RNN?7>ROY_LV\359-0D\D9/L_]U&(&B4\)=)VW;K7;ROGF']XM#&T
M$6.5+FIXT?V#4:Y,06OC("#49Y_AF33>PA:Y<Q-2[0K&/=H?]8K))^_[O[>W
M=AJHOZ#]5/6R3=T*F^M\9SH;<AZJ7"+#DEK[ F_6RY+-"2K%^ 2FBE\$"NN
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M$1CMVHSD",;,T=(A1@(@2VYS%B@K5#E'ZVSX#82JCW+(H 7OY;7!F^:)B[+
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M![=1F,6>M(9'V\2--M70J#N[G?W4;,9<<&N7=#N&&6R4>WN5(BH<GV_XL'H
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M4_.[2-7/U?Q6!NBIQ0V3I%I<&V_(574'ROC$U.+"\7.1X'IPI%3M@;X&=(
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M7<Y($M>Q,/6;/#('?E=,#9#4UDE\,4YZ Q>W.>;O'+A,F@NWJF5!30]A=LN
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MW<?O$ P68&81DV&8_. X!UO?R)8))U)#H6-=4OL8QY2 WD;KU<#B:EN@C4O
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M3D37S9ENT,7(-U7YT\W;@Y%^CAD,R1-R9=VU1C\97C?\#7)\IR YRJQG<E6
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MVA8%EQ:!WMF1? 4^3?>F%AS84)TSSW;,N8\P#6>>[ 1C4>13OEVG _K%@:C
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M)=.MJ:L'\470;*B(Z1\ SY(K@FC3U0,HU0!\WS?LW1$K9.)@46)3"UD:]KH
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MKP_%G9WM%VL#:,9ZQBB2Y&)(.S3%NM8#T4O!<S:-]7/SWCLQ)V@SUUYO'>,
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M^\S\&KI-=C;Z^XU0'//L,P@SY!O]J.T;V[8:]#/A!X]H?FAJ*]&.-C)X%SR
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MN!,/;R(HGH--*L9KFQ/QP<(7I'@+;D;<KK-O>J_@(*Y@$^.A)],6YA]C)10
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MNI*-=2DA$ALK(.K7YK(37;1SFP^$]_Q7SL%==2PCPRJAGI:HFH!SJTL$A/T
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M5E7>.L1MZ+.8AZ=R!R)!P#'V=I9\Z5W;2M]D!OF@Y4;)'<9^Q$HCSL'@\#I
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MV^P7OO,&5?'VW8'Z(/'%@[F98Z1?IV=7UR@L+L(/[V$[UG7(P@80VH#MV9<
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M)VX57=.R$>;<O-0'M9Z^8[ZKZ2N_/>3]T:-'M]O9V:O17^68BZ6-UG7"Q(K
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M(T&C010*E?"I9#?H;8+&Q\*^908RDAX0,5$8_\0I-/JAWU1OM-)0,UMLTTC
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MZ*S3XIUGC[)\]U:^RLLCN>1+=AVK/+SO;*K@>8CQY;E>VSYC-QSU3)]S8@!
MYE&R8TC9F[#=S#!JCN8!@)E%-,"NN10 7'X+2KEEK!*@]6"2+8[Z1,03]PX%
M3US,G!4Y@XK];C/0J,#N\>T&\T$<'R?+<4)E\1/,BK[[20:^&\[A=M_, . +
MD=7B(6IS?H?KK:X3LU1%";E/'Q/(4GKAMSK(;*0J5#CJ!P4)T,D=\:G+5(D
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M[F?GM(@/5*W@-AZV,J?B5RYOY(J/XG5/ =Q;L90LKH(5=MUU#B7U3PQ.QH<
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M?Z>396N4K)/E_6#.Z3ZF__[>O#37W"!*C%=V$.70\9$8+]^5>.)7/V!%E&!
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MA_?X)_VSAT)M&[\2;@DO2.?UN' =6",-+U <J?VDZ?R&XL]">W!TG,WRZB1
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MT/:/TFLW#.QP]82E-C1[+:H%)M<8>.:V:]HQ<@M/\J]']'JY#UMP,Y4Q8EG
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M/=9':R15<B20JNCM-H,M=!@YTY0BB*3OI\#J^\::BHKXF4,$<NSJXJ"9F(1
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M:J0#+7<1SHK;V8!59@9=ZGWF@X U00FTP?0M6[5 H9U(ODF# <>+@!%N\.-
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MQOSJ+$_/68(1LR%:T_JG]H.YL&$8;*?FN M\L:V'%?H6K40X(CPC*C!P:]_
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M$DNJC\AU>)<2G([4.';Q4SM-$>N8!-BL& IJ<&2AN]B@POAD(NE:/QF9(DW
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MX^V!-5/IX#4]-MG,YA'& )5ARZ\0:-!G/; MB4LJ/$N^J+ZOJY91)3&[T>;
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MM;Q]M??0]L471[WMY8G*/7Y-O2/Y[X2@S4'&#R9[=P(M+ARE>)%&9%(5>5;
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ME-R93Q8PSK5Q-1'(P\D<Z[I<GL/0GCZ*^DRF92T#O&5LPA.5TG'NS8:(6IL
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MM+U $^O,(@_&"(1NG[F#!5L:H*I:-?5K@43&DN0,G3SDHR8BA?9$F0E/'AA
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M]0N/&2I3XLPN"D&+GHZ-?#-*UW]HYB@+T@*61@<#5AS8Y$1"80Y8"NW"5DI
M;RW[<K$RL<L>*C>CY.&)\ @VE^R.3NVX^P?U_?([40?34X7_%Y#.O0:<7DR/
M*'=?_,6='31%*1V2,>@1T!UQKYX@HLL?H<25=-'W>4'</W@(SF!&J\,?K#4<
M^UL, THO970T8[=@1N]Y$YL?E,T)0;M(V%@?Q:I?C]6(<HD":> XXH/8'>>
MXDG[ V0])A<FBT)VF&'^?A"&W^EY(2"@%U+(<^>G6AK-"2RRF,0F/%VN20B2
MP.Q!13$TJ5P3H.O<,&6G$-0<DM?-5D3(S@JT@#"E6*,TSE"403K'A7&Z7M"
M+ "(+I0A"T,F?B&QSL*6L>.T8HC5ZN^DVE[$+ZGQA^!XOP?WX6N.V??A?\)'
M7AO2B=Q :0)GI0_J:S>T@/0/C@7/CD5&?C$ETU)193:&@1F>?)_UOC$"MED(
MVC^+?]WV B%I(<?N:@8K&//!(HVPE;>#W<"8?E>^5Z!QP@B_\[JF6*0V^8X
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MB#O]\,<0&Q/G?@'>B/!"E_>\$WB]2M"38VVPS@5,G[V"<1YK'G!3J>C!+)=
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ME#/NFBN85RJOK/OUEO\RN6')7'<B,.7G-NA+FDL-2G;QS($0%F?)XL6%[8\
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M$3SRBOFHDL.21YL2ZE[/JH4VO7C_KM\PWFYT%DFGOI1QPBR0QV/:;GS<3-O
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M'F$/("+\*4,=UX' R'HS(*XIO2OF7F&?$,W-/(($+3&&(GO!90$L^C87Y3Z
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M#0$X2YH@O2'LY!ES=A)=P6D&9C>',$CP%=-W&\%9,.%BA Z[.1OT!@K@(%1
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M^B;-6&&4,%;EAULRN,SWDA[IP1G^/B=QI68C"Y;4R>;>Q^ZP(ABPB)Y4Y*5
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M$DWY$*DN7,H<'S*-8FZ\8GM\R]_[:K32!_2MQ$\@)00J%+8< X1_Z9F+Q)D
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MXTN@&T8NIM<:.2)=0EP?_N:^."_WAT?=#2(LNT\*=F$50>\#ROK/C1P-D--
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MJ:E*\PY3AE7CTQ!5A.,QULC.@]MH=.(A3A_+"IY*W.TDES"$72K<GI-.-6G
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M=GXF4(1.$V+X:6Q3PB])P!_@80!*L%M%X2&3,;7^;9S5LL,#"E3D]=#9U#"
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M0!'G-DT-;3%Y'9=AQJX#NKFT]#@)7T/!D=_.\]M[,"+!_'98+W\)-J-+JQ
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MA>@I/Z5O"U2/5N+U@@V!HAR-Y#L-]?VQEBVX$_V7;!'K(ON<?E1O0VM#G5'
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MVR!\(%2@TS*UDSPHA-U:LW+=P97GUQ$V)[6NO'QP"G?O@^*MDN)=E:%5=F"
MO=V>2QO&<1664*P(F4'6JK.P=0H\DM16M!)TO67Z ACJZ$8XCWGXG,+ 9;NK
M"&[CO$%]5RK1/4S8;)"E)L6E:/C]'/P!J<!D/ P02!OI\X26C6'XWIB/>"YM
M/<E YB8OHLP<M1JZ.4U"0M>Y8YW<K@W2-H4YZ)\LBQ()-DVN"\=LF#]%@N.;
M&E*O(A R1W>$.C*#:/4T/" [W68JR_Y$\URT(;GU"MN"0)54]2[!PI##(V-#
MMXBN8YP,A!%ILS+&J4@/1/+C>8A4MB'HDB3%$+6!SG8:58$DPV1[E<I&VM-8
M"^9ES'&6$4R<@6P&7CNW7G\VW7;&S\!I3\*1)9@/<8O44)E ',BA57BJ@=*1
MPUJC4_1=VYV61R?Q+U56XZV0*9=DEN A1<(P6T>&>@GZ-3\AD+E%^N"WTFM.
M;P D=\K#Y"BXMI>9Y-;TVO+F$]*_RG4^EF@N.04Y"G. H3%,\A(LE);BT)67
MK5@QA38<P@C7_QD=(SL,JAQ_)35/0V^4N0#OF\L)&6Z#Q-@G4$F"7S,PFU;:
M A[+?]WWS7[2)FYN&=3Z5'F<2H2]:+2")]B(LA=C/]);<6L+)%[R?XA7I*=)
M'P;1=J!*^TG983%.78:"JLC \\. WI$D[N"0RB&(GG!%6(AO0V^#DC4?L-?T
MT$&SH0SF9T\/34O\$JP/\]%5\EO^E(21G03L;RCV*]XWQ5''HC/(M1>RI <@
M5S&"BU23^0$+MV0:(O7AN;1HDCHT)O-]49?#T_L5SI^OJ!0BT]'J^4AU0C6S
MZ]R'<(=CM[HJ%O.$T=/7EF KI8!N,J(#E\Q915H^P=896H)=F$3#L> *C[ZY
M!*HZ@2(Y.S#[#;JI]'6\/^=58X]M-PSOO]" WC'(B*4W!P7]J(G5"%9\#7TX
M\AYS ;F6W&J%"1.HRHY"D])=4YQ:3K+,:(RS-H($AZC@8:Y JYJ(+9.A  3E
MA]*"B ;QHJ $7L <&<Y:1N^.,?N6+/2P&S\,/! 8O7](WV.Z9[O*SS< 5Z%F
M)G6;L"LR (TSP ;)$(B;P20NP59YR^DR<WH 8>KT8!UF&"%2F<Z0.A$:<*!_
M!^)V7%+':O**[VA[H+MUQO@'<B4!UXH/!>W(VI\B+H>O_KGQDH@Z'RCLENF2
M)0JH , +*7]&DP+8FZ# 65ZNT"1Z*V4UY#5Y[5DH3SB#$]+26/M#8ZIE>X%9
M7G1JD5/O,R(<M'<&1[,N+9**&42+)/=7/;+P*):MYOT$#3F[AE.%426',:!M
MR$Y!BA;!?HQSDQR&2^>L16V1'H+SK1--7B_P<6D74>92U]'(/82'I&W-$?S[
M'<7"64/<J(>3+'XTZB&;F?]]HZC ,Y\06*)LM[$\'("5ZQ"]=!]*K63V];7@
MI3013D,000INM,LHF4#O 5>B=X">]\><-,6G\HY H6$UT-U1C1BO#"$O+_FO
MQ4>[/]_==N#UBI\A7 YP"LZGBNQGUDMWDSH%JG/487@[QPCM-(4QO(HU'(5&
MCLC+V.L^D;KUQULY*<&:4,$599=SEA.C*P)E1WJ(5RHG%5LXM;T[K5 >Y%)"
M[OO1SO: 2W6AH:C<V-_O,#+#PV#%D'BAG;&>D""Y^K*?9$NPY^)4,!?(FP@K
M?.5TM.DHZ;]XLMY\] A2>?)F19@-,@>@FIV&I%C9-&=AN8,!WQZ"3C;[B2%D
MH7008-?7<LM=311?94>5G:JKZ%#LDY=CPA!9U[%)<^2U!,18KXPPH-2@_0?%
M1MAV@0'J&IC1JH #) JHU2[0MR9>YFA9$?T!$;=5\F)"_UE^!_V)@642/4 0
MD?MA,[DR"C.6\^>JBAR-U&BEDSJ4'6(S030I)2 . %^NDY-YZ9/Y_ERR021B
M U%GY;G!;TAT%+RSJ;Y<].]L#4LJ_7QI\=N"=Q/KKI_IBE]:(HQ,5TN2 [F"
M>UO9FOVL_=*]Q(@/-1@\=86B%:-#/ A@N0)F$">9M$G12]K78YKRHS<ZG633
M]PP%?Q9,= (?272+=D/8\@R:-I*"DC+!W$+1\L55>5W*8_2D0A;=,FT#$:*-
M\[%/<J$N;XS,F^7CQ7EML_P^2>8@>S_I0T!GNY56FQU-E;U&%J5DAZ"];3E<
M(<]=H$,\,"#S#GE^Z]<15N\<;B71L8\Y$QC09UNU\*!+Z@[.2I3F>>L,P=47
M=)UQE!Z2Z4.VP@@L#Z=!C  15&)H521?+T4,"5<7EWXDQ(BN!FP<JD99JO"B
MW+V9/<PYT"^OQ%6T!%M_>LW%2[.V)I=!=UN.; -9H5H@HJI-3I8KWM+4"[@!
M->75T/CA%F!NU/S#UYOLK1]/([0;*+:)\';]N,IB**SS.JDZ9@FFZII\-; +
MT\8VOR7QJIYH&#W[&,[C) D '&T$(VGJ(>V%2I6*2U6H!0TKWN->*IO#2W8,
MH+8S4A7[\WBCNP9LL 9$=T#OS\PQDV:@YI9-5&QT+":9;3+ 6B'V<'U3R^G-
MP=8W]B!MK;PW1BW!_)7.M@2#ME]@2"_@%'P^M;5%Q:5._HB]4ID>0Y WT':3
M?-Y,9QHQ#*2)R*_+H&$139,__%?2L=XMT%$A31M:WN<GGUY\ **;S9@E\.G?
M)8QK +TU^N/LV$(:VVQ2B9:Z5*D#45=>?)%M1+23YYLVO>QA#FNU2739F_I9
MKL!>86<J"T['DQ#V_"#VG9@$D9-Z6VY>0'!QS>2%'U^M/V_ZH??G1D40J7,)
MMHQ\?O9C E=02VFCIA890+^%)Y4)C81(YVA=3= P\.Q5F!)]AXA71$[V8E76
M!QF&_&3206O2>&N2%[!S=!.3_8 0U\W])]Q[S[LSWQ\C* + D\QO%B-N8<8>
M"99C+L&I 9TSW@JG(;16H'4:."0IE=/KR*F<6G@')@.S#J4T*[7Q-F.#>D@#
MJ%7V)<2MPBM,7PWX#;U>-,2HV4PU$@^7MYGU,RF-%'^&$L7&BA%  (-OSKLL
MPT%&E9"/R/PUC;H$6TYTDL9"NLATS"J%M0P/J3^VG4U9@H5T(<2N-XDQE3*=
M_DLYIPMX^F&2Q\P7/:CXZLCNL9: C:A30H^(BO[EA^6I00H>YF7APO1P.:ES
M ;=<IFH^W?/XXV2NODK;^K-7]%)LUC ]KA%]2DY/6&GT7Z_(>!K.-OUKB)F%
M/]8?%9N%]/N+\X+=T.C\#Y%60V[=Q1F[NP2#L\)*\,9[Y _9RR,4:*BG"J(+
MV1F5T*+X^" +"[JWLU%0C*@%T8$V#NS6F^+G%HL1VA!#F&ELW3!4WIAS?"@V
M&GXJ4FOTM(=QT<O7RWY7EY-;PTD[E=D@C7QI"8; XS19MN)N'7+KOC]/@T+;
M?M253I%LP9HF6W(VVT1>^>?79,PZEGLEM.!U=[_U=%U&8@QOZ J_B^XT,]J\
MS][>?&;OOZ4Y $VF%R-A@O%)K/UB B>,?/-Z\'VP2C('CLNTIL:<"XOH(+FC
MZ2LE6Z$?V51$%\,S<!OFJ)KAE<JPEW(.\$M[<@KR%Y)OE1=T*':#Q#MOC!M*
MPG/SMF'[HV(4JEBE)%+[6;X5Q,V@WG0KX"+E!8QSP[_40?BGWX.WO'H%8K@X
M"O_E9%,<XRG!4]S.B!85P"E\6L98C\Q>9!39Z<T&3EQO2;GS.%+?]\'+.BJ?
MZ"M5BDTK2H&0&?>2PVBZ,B/(?JS[-DV;A!Z&&MH4:OVAB<N=$B1YH-77SK0Y
MS@:"N:^BKP[4+ 0O*68/L :8B8%M_#I*VA:'V$_Y%X%.P[$;2M%X'C9S6.I!
MZM62^;V %@"]8]!^1!MR$T01SI%,TH<ZKQO1.RRK J>L#G-QZY6Y.[!CT;>F
M03B[\GNP+AN/6 >1>?Y]! 87;==7,S<4==@]GZ_@Z+%7*@8YZ^=HVK+=H-F?
M@KT4E2"V*Y<&D#[F4]I#(9JR#+ 2#RA-NDO1S=%!VWZ6'0?RVGC@*180QQ C
M5(@6P#AE)]LH'*>YH;-#S+N>X&;2"+R_+WI3K,@@;5#\1ZO%37/IHY$T-9(A
MP5486T0KA5*GBC;?^O;#,:/0T6^P#,Q+KZ/I$7).]U^:K6N>DI^S&ZSC:$$%
MQSD#Y3^U/W^_,/C9A/H&K1I >HTPDB%+(->QG8*5;%,H3*C2GH"A+AIGC46Y
M=?OCELE<0(Y2PT3-B+3<*_P@VQ_W$\3(=9'!J/[J^>/OSHJ.V,+7M=&B>FM^
M"/]9\:O/4RDWC<K@P]::Q!FRSDH=E>!+4!<-M6D@1*YMM<60JXAS\RHYA60"
MOJ\;BT((\Y+8-C)/\$?NJ#:(368=(6V-V(/'Z9(,(W+S75-JF$Y_]V+7"H8_
M33JPEF '9<'R%Q@\>5B$O:VTK!V0XQ@VE;2?2(8*:@CNPLX,M :4(*909<N$
MLVJ0JS"[$MS+6QS*8FN?'#D*;I6VV^V>^$4@M[$12I#/4,8,O3V$W&]+L#8_
M?70QW?YCD8Z<PCG?O8I./0,LO.:L"IP4;) Y/8,P/+YQL68I@Q YWJK8VI0P
MD]"ZB$RQE1_V 19N$TV>X?:Q^HE(H<;>0Q]J?I34ORK 7JNV*C(TLE2HSDL-
M)]C+!MCZDYP51 P\)9:C-:&PZ;<^/\@Z&R^V W&4BZMSA)^O=XM\QU-_H$TF
M\_,H5V.VI0DGY[IUA@OAAXNFG'N3*_+B8R-VJ7QS*5!"[5:H\2P8W6%L#=)?
MS^J%Z]/:,,/B-N/M4&,QCE @\DP;JPX4D@JDP9]E.Z$[8(Z0VF9T_;T6/B84
M6 P4I"UZ5HLR-J(NV&2I>T$QU5U;)^L7;_?]F9L%^)!U92A0@Z[$&E6B?;0N
M9,!%P^4M2)(ZCRX+ ,TI,C.0<D#^2'98"2KH :*'B ,_>1B9'#L2O8%X&"1G
M,0648!-6"@2%' *FIA;_:EA'&)S7F^=R<2^QT\-CT(\00 F*JR)*%H1VQ0#2
M*[;O2R/-#_*HF@J@I\[35N'M[7,^G<;K7ZIC3%WOJ*W&/G6/?_)]L8B>D% 9
M_/GTZ7<F9R-Q+_2F\ZH@%>%XVV?W,02WF4.AJ2HV3I%7HPT)+AZ&609M"'6B
M6]$Z[#J"N6O#T7O<DBF3UVB-*!?S:]N:\K@2+?>];B]1-Q K(*I$(G\FTU*J
M,Z96+QVM3^K6D!Z$&D2,Z84Q<A)Z6R_+2SP/696$+\&,28:R&(@:C^%9V#I:
M8K0B^>,W;)9@P^)._6!:A#"C<"719V!>L&9X8I"MG>_AZ7BILQU7U\V+"I/8
M*7LBCY GHM^6[2XA+,$D:,PFMO%IVBW,!B*N>)C0*#.0HB$346:P*2#(ZAWL
MX_V97)CE1S9PCUH9YS(; #AWE1VWIE=&QFW 8><1,WNEA@0]\1"%=;(I^";
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MB$5JTISN;>>$1:K43\'W5KPA.=36@=W)5Z>H*47;(0TEZP8O TWU%EY,H;=
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MWUX+EFQ88:"W4"=;JDC.W9G\:L?.;L%U9A9KD<8N2E";DW85)\.)*"MIC2T
M>!@-C;UN,SY+Z<Q?#OEGE T0"5$23MRS96RCL2_CSO$^SZ#%U5#JIR$1T04L
M'_RY:+2M8-%P6T6)QT5JQ*4ZP<!^.EF*AS>63U(A4JLS?P6(:PNB&$;&Y^9
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MP*0VHEW7M!/>FGZNAW1&)5CMTISC-S[M!X5E<;+P4]7Z!,_*P>9$V[#LF4)
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MGC:M[]53(M.ZAP>^D+=<*-FFL>6=!GOD9>4RRA!PN$^S# X54A;R(M A26X
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MU%(OB%5*,^T*@WP>?<Y_=#LZKY_KY^C6B$I@JAQAI+%?/?9Y'E5#N &$*)D
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M @,I:VA['T$75!$\MY*(Y?G)4WEZU5N9#\%IQ385 ;:IKZ^&LD!&4[#.LR=
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MXYY)7WT:K=G+\7WR(:80HZ] \2J [0@H&1:LK[37J9(*^2VPO_3Y^B.Y"D*
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M_S'YN&/7;6U'M9%=UY3?Y%!4VR3E\2G="Q_^)^;__]M_U504$W\#4$L#!!0
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MA3 B--400L!*L(X-L\*H)CH4?W1D)[BW2Q] !<;- S"BUU'ZP$6._$1D+70
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M;1H 7ZJUAL755VF7=!W'<##Q &=F07;ZPXN]'>@?RDFHN2)4 YDH!Z7*)]<
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M&:.8-0$WODU^6.Z(N^6YY&^MTW.MAS+_*,Y9L'[CF(4@?<S'&CQD/>UP7\G
M^V.1]1:VR'&AEMQ57NC<T&#I&AAG;[%!WCGYQZ<-AE954'3_OE)9J'<L?LK!
M_16[UM0 >? 5P,]C5U2?@) !S9F /L0Z"#R@#4 /:Z#1QA;*664,, $B@H#;
M-.,96O=Q:M!#009.T=JS)&O!=3?BS[ =#Z0&^S'+DG?(?+R AY'[Z%LKTU24
M</P$2I8+\B\5_<:19*!ZP=) N!.]X-ZSL>](/:HGC"-:'.W1(7]\=+4IF%04
ML(IQ([\]43'O>E2?,1U_>YD+DN,8(JIAPQW.U-#,4LE-+D@,"!GD<?TA1($3
M\(CF/H,B3.BXH'P_NWTS["5-!\D8.Q?Z1; O[!A2IW!J^ME"Y^KL72_0<X"<
MW@(WN98DS0X+JBQ6T'4IVFVF("DD<M">1LB/F5EO("\[%0I.AI:3EB7?K6M\
MK][W.'H+KE!+[+W["?)DX(R%<8]?;O@16U%:M7U9:L]XDON1D# 8GX60[4[X
M\D,H\_,[_&19VITLSS-4G8/7JNWRW0_8?WGVW*$L#*.GI&SWC?HS5%E6,\2W
MIE3O>^'M=H_FJ=+1TA3H7"FL(1_-,.#-B<8RSML6'>1^^N2*-&15FH\EYK9&
MY(+$?1+L&3.8A)N,=$2.2V>.5P+%9HVP&NV49KO/<JY6TKJ9<<1.?6C_TY Y
M+PL&AB4)IIZ=[$#MG$0<'^B1T4K4S80RM7D<Y!W(3J@!YFLX_5B$U:HZ4@V<
M'(D778J7:OG(.KD8T7:H++CL O71OO'WAA/M52^>8;X(DB4YFAZ(@UJ)!A#Q
M>"5;>MO^!\^ 8(.L#EOEWSY:SQ<D<X25QP\E350\RSIW@ZEQ,^=HB5%DT6EY
M6W<&)(5E&P:/IH8*(Q)Z)Z,,(TO0/M%4DU#'R;J:B#@3P9CX![YAU9ZS-H$5
M@8P<N:2B$,:4J[FKQI-4R_VW0P3>U[M^<"_ZVLI&DEQ]!:_)Z%8[OE=5Q3%T
M T9J'^)K?:H)X!3B"[M\!;YDS)%]DE8%XRH.!4V/4T:R<WU56F]7YOW$A4SF
M-T2%?%AT4[-6V.%GOT(%AB;!]D.#L22?U_(FP"(#1OW>R5AF^@!P.A\!4N^'
MG5MU&I@S-C4%,'.E?(ORHHRU/SYKB>F5E!<8KHUHKYIGR,TS[U+:Y5!7VKJZ
MH(%M74E'6<D$K4]JS-@_WJ9-9_G&T<$4GI3AZ,;W0G'@E?#*@5K6F7KV<PU3
MN649?!H+19$3Z).1P-&@F6[T88XJL=RB+K!$LX4!O:N.A.Y_4*O_D%1<4ZBW
M6INYL&Z+113T=JF-WYSD=;^M, +C56CD4CG985.WU'5L4BFM3_%>GTIDYHWO
M6_;91E(*6;)BL?GN9WRRU+S%PIZAW1D&1#0IN==4<)0GA*185]E/-]')DL>,
MI<OA\<<9^-YI;/+6$*51;@FX,>30-3:4N*FVRE\[UY5SV?5[I)#):NV:<I9!
M2Y(+ZR3"/_/U_)0?K"!,7V&?U@O?3^JDIN/T^O=*=[/VIU58\]_-%TETTZ-+
MW8H7[A=?_;'_95"S@C:QQK"<<C4LPT<F,U!<&1Y^>]I:[42AO=NLV[*RS_84
M[-,:)735CO&#<U"(@B8)=)<H I"Y(6$NJ-O*]# BJF_!AB%)A.Q#H&@A#R23
M<!IN)J$[!AX,4<0%& \N,T$"M@>G@1:;D1"-C1&&*V"F.]!_PC8?[P_[E,Z4
MXAUO*27Z/N=8_$!,*:'X"HU9#%33N\"'>&8#A5NXSQ$%%GKD)8! 6J>_$W"'
M1A9CW8H3M4^GMA""W<_73_@PP'=Q\#@%MZR^_\7>FP<UM;SMHG%$!8R"@#)%
M11EDB .#,B0J B)"! 04A&Q%9(@8%9 ((5$0PB"P%0$%(0(",D:!@(P1PK 5
M$9DE"!G8BDRRED!8FTPG?G7JWN^<^IVJ\]VZ]X][[Z\J':BLI+O?[O=]GN==
MJWLMWO"BD][M]XC%2%"V"UOSX/98 %59&"(X;H/*P[^ 2KMMH6S>0@+0'14H
MEQS.Q>X8G289#CZJK.!F*#<"(_&&\Q.ZA0F5-=D=C^2BXQK!Q<G>1),<>#MI
M/S0)IOJ \%BN !UG,N_!HR0OF%#EVZ^CJ_[61 Q^&Y'_GKR_\UD.ZM>D4Q:+
MM]J3*SMZ0^L1T\",TF2#D?7)4$F^]33([=?,SDL(?A0Q6'7GEB_7<U,NJKOI
MEI^?0,ZZ%IQI=G.IT+OLME/D]#*HE^42]'#>S^TE+[_>J[_/N<%CF-\R,ZY9
MAQVN$RI4<U?F>LHA&C]25-*RC?11$PZI_5Y]$2"B,Z[9AT;)=K(5+7V#R5S,
M.N*1$:$]M_ETW4-+3(ELJAJ;!?G5- ?AU+PB]1L=FF\[R!\8ZFBJQ6X0FHE2
M6A2(5R",3EPH_ O-%C";IU3:"<X0SX'4& DL,$>-7PZY<A';"2H.(_1GQ#VO
M2!^Q2C45[N0U 7=\UO1SJU2RS#KBIQH80]]#2F?F ^\65XPLSK\DVD))W"]+
M;XE6(+QK A%S<KA2Z)#7F@<-M+-L6A)XCB<G<%;6[1&G5$DEP5N?T6:4P\U,
ML^+H5_X,"A_.5%$>\7 ]8?F&T6=>62R(M %^MDUZ@/#YX'"@CM<;1Z?&N]]V
MY#$25Q=B+<,X/6NG!&KMI$/UOTR";=486Z;K7)/-L$-AA[;^J1G &<P9/KW8
M[+.QY^#=C",:UDFXR]^>NK4-M$7A$5FB*SD&&W50'9_?N56X'B[!&K<-,*]5
M=,L>J,'IW$L^L[-\_WB07=7C]"&/.T-IMQN<G[Q,_R?[\1F,73 M='QDFBI4
M1*VV=8DWITMEC$:FNRA/B!48! X0;XD>7S<B'860UJ!=?!A5!I57:?( 8Y3#
MZ<$='T%7+?STKQM8SI[U=CIZW7@V 7]C3WVTXGKJ2PFL%CX' AY=54("Q "3
M6OTGL1V8400_2/18O /"=))WA+(3)[2 A?G-+PBYLF/C6/Y[4#M6<,QDH1T?
MOVK[FA4-Z9QJ&%BNL!9(TP]FW2_HP[3+:1?DWUL&VDE[WGQ>QLA](23Y5 $M
M#)/DX49NF2'>E0Y,-(<4FXH.3WE]KOA9T!^6E'P,6 U=32[\6(M9]+1T[(FD
M) BM!1Z_MSUL,^Y1ZY@P@I:!2%[X Z+.RPL!+%+%)%:5$-F!4@4TFWV5B_,"
MS2^1QWSN9'(U,)@L-9&934U 38BBS2VEQZ=?=0]DW3325Z3R%J\CMEMNU$>D
MECUU:>LO=)!/6*TYV&08T^%<F,)\=<U(J<1/Z>;;KF-77H<&?G\:\00X1SN#
M4_UF7U^O][;>8O2BQ7Y'"X>H\ZJ1M+L!62,KC;RZN3$);/T2I"4X2OI,K;%]
M)MB-TS0&B^,LPP5:A$M"=:C7;'X#\'LAS&:B!UC;ZU0+QF5S_PJ+(K?]SM/L
M@7[Q,!^Q@^#8=#'8GY>$JS@YT;_Z?=-\817>!7HFK7M&]*AE-S%0JI#OD=Y3
MUZ+]X)LALRYT->4!VB]57;@'BJ41?2%J8 G.1Q\"RW\T?'_#8>_RQFGN:0)^
M)@$S W;#>4!']=BT"DFO^G7UH,DF$Z\>ETB;F'^N#8IW"T\,3PYSA\6["0M>
ME/;5BHQF7D 8=1<ATXW2WO#SZ9NB9Y6$1'V1"\\JW'- 8:>KXQ#=K7'00&&G
M2_]WI<2#U1A0G^?6\[.QY)+0'DJX50+EL\_6@+;%Z!2AAVDA+])1\8.XO0;4
MSM.N',E:KDWZ^X0H&5_F>'=KNO2_W SQV<C3 &*;JT\_575*H</V3.&!MP_O
MW/)\J.-4)^?T((A[.>MS04+!F137W,LSKL\O&YP_,NK6/E@2GS\S:/5$&@%W
M]1?N?)O(J7R2/I=G/+3L.C3N+8'YD*LE,*$B@Q\X1,1R&(A Q,8\R V4Y>#G
MOQ4*Y4#-,@ C5F5RBRDF%3L"5">2>3W*(^T,Y29G1*+PN.4Q7FA=&@;*XSCT
M;O7"XE/Z+[CH2V![FBHQ7\;X.]Z*\LB7L:.-[=@JIW0>>AMI3'.=J""L%T&\
MS(">@02HF]FR'\ *#:RLF;E[/AN_F50L& ]B!/2A!GAJR5>&5S5.[ESB&6H]
M"I--ZOV.<1>]) ?,1WS7[\'QXZ"%4N\3RMER1R:(?T 4K;:LPWL#M0]:VI8^
MGNY65;,?LFD_3,NM^F>NWTR=I$T\:YX;6T%-P&YWJN,&5'* VEIB.*^Z'/*1
MM_XD_AS#]*3Q&7P*A<M0,=N[:KB7]\FB->2VD;OS+5.Q*DGSEG5%? 4VY8A1
M( <T/O@A1=\D]JQ5X+=_T@TT['F!OL#R(>/7=W/-<_VV*/U1TCL#%!Q].UHX
M%Q0T?M&GQ]"O*(55HMV?AO&>]V]$ER-8W7PW4;I87OQ> E,@!Y#CI;)UN7=>
MAD<=G>*;BU*01$4_T()7UYDGQ9L@PL %,#PN+,9RV.=HRNQ9@#Z7<:<A5;B7
M95QK[OBR=MJ_P*Z0:3 G]A+8B-^AJS);T0^D^IX1B+S/>/-1 JMA)S79X01:
M,Q$R<T5$-S#<O0\%(^A/HN])8-S=(#H9U<W!;F>"6AUW6"L)UZ4)Q4N?F8C"
M;[F/(B-VGAQFA?&HW^W.0U30XM( TM@QA(=OC\*?&KP^9SQO=VJX*9(W[F4[
M&#JO;:_='SIO?6;0)"D')<#T7\NX6-.H5G8W.'3:+\-+]\5=C>SIWGN(6IN1
M-EGT#A9AA5LXTCG;NZTN5FM &!@)CDRFME$3?7;U->V]YH5<-\W8WJ).J!JX
MT CYA\G],NRZ1YO_N[_BIZE/8-6H@^IN9\X-W>Z;-3/G>,2Q(S2'@\E!T):=
M7^\HI%@8/:DR$U$W#??>)! 5BCW6/.7Y)[:-M/%TU#LK5,QK<CQWQLZ5VNC,
M[]?.+3EC?U20^&'1'9>!>6;,-JEM(+]B(\A^M&CT!C*GFO&:W$J+I<J:H*-;
MUH(=*W-T'E(16G<&I*:H8#\3;2:MG'@8Q;&.R5U-QR>0_?0R>U\OO3!YE8L#
M.C7UU8'E\FEIJ0W$*($:J;4602^>\Q98$K+YM@-"KW(Q:T4"HRL*K:'Z<J$'
M]&'"!!#3.,&^O/U=<4+K?*_WD_8&R+"A3+M$_#;L[)L9V5=>K5=Z@^KDR>'A
MPL_B02I]JH/&:N3?:Q'E"WW#\)R%779^W JU5KX/K'DX-!)+F4  P5E?"!YG
M@9;RU0>YN^,6'.Z?_37;'Z1?.C'C\C4(;G#XC%9JAS:4!YZ<=.LSF4U-8"O<
M,%F0RQX&/C6C4YN\3>NY18-9_H/9S(;V!F:0N6(0)N3VZOW^RF#YQ:]?3?J>
M%3]AN')2]G7]<7O7E;<%B'M=G+=7BCR>&IBBC=//C%:<U?131YE7FL==/EF)
MG-DY=T-%8=+'S5W[PJ:23\[/+V&KLL\UV]N4$JNJT[]F1;"?^?2PO28^"*8%
MF5(<3ZU6E6%B( ,[9L41;F4Z&'ZICWR-H1#(PE+PUYN<R94$_@B3M \DQXVT
M&19 &+<W@S]K>CP)+YH:8ZP3#8--U)YR:P=Y"?FQ+<O0&$#F1T KH!>'/#<*
MEO%O5]=#]_VDK7@#[(XQ1(HY)8FT;UH3#87Q\!34^D>6>MP*E=:(.S0_;L 2
M'CYC:OZU8;FE^05.M:6PE)WD'K"AK!7YRY=+U20LMIK3OS,X5 W"2&L$/V]#
M1V5>)63=T;(;Z*Q[Y>5SML[LS@JKEO+J2Y#*S?%+^=Z7.FZ%[,7<3KBE&YA^
MR:<>*@!M%R^@]C9)XTM[L=W.)IMIU^Y!0H%APRU$D]O[5%!JYE]7V[.*A5IU
M>R_:=,;R:7,E[54)P>JG!0U'G&!=OM5"IB5S*OV@R9N;;KKGF=T:UMLIG5VZ
M[[[=+/U&Z>PO='G@%[WZ\8=Y4 X^Z-7P ZYMMOJK.C.C2+-JCP;BF^2AE^G-
M8_1@O/]7<1+I\.\%EK2V;NHNXNY&R)XG[_\N5T.40#0#JYU$16)U@A8_#ZSK
MZ(4<Z-2M)VBCQ*M#EE(>1L^U1@'%YT8*,YGA8O6J@U\O?!F+2K&(I_O>'I;
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M<OY2SN _GIF'JP)G>*S@,_,F&NGTP*5J<<T2^8L*_S;XJ9D,EO;R_2&52(Z
MMI$T$+$PER/0GQ BH5;!8>)-J!%,XTX\'_C!7D<Z2D2!M.1E>717@T?,?%Y3
M5E=[RYI!0YF$, <LFWW)Z].?7=\0&]!U4I_MH@+G&(D(-30G&[U%O-:P=RX*
M8+:K(#96NG;EJD#A8"<.GA31DQ++8R@+#PX*O:)X[ U?ICU?9AR>,3=0K4V7
MP#9?4@TYF#4AF_^9?(35E=ITEV?HY3329#W)5L.Q^"D9CWZL?J^63L"VH*S.
M/S.V%38_GO;,^5E@]3.;[T68C%;T,]ZPQR9>XY[A^2$AEL?>A@UJH,9;8GD5
MX<XCA!$DG::(BRB<J(GV>&Y3UAM%MLQZHG]K7]I+E63C0Y\6#MA6'3GT 87X
M3@\T,+W<3K\%A2=\F/6LZO'%PJWU>PJ>EFNJ$HBS\K%I':ZQ1]V[AEL=E-3/
M:AYXXKL_-D5.ZLY.!4%@Q**W[GL+?7O#ZVG!V%(OK]5&D#$G#UC; 5-,!JO@
M';6J]]VXW3OT3M)&\5^L7#J@?Q;:!?I/KB1:HD%77N'/\H8A=IL$1B&I0A5<
M?:PL85T[OQN/IQ'J.K(R\E>-^<X2F-_77?L8S^T%%TF=U-<C<V0N(BD-/=<+
M5*V<!M'"'?[<\#D)K A:X3TG(8?]("T /XEL1<1.&(.&[ =C3J#V8R/7UKHL
M1KP)?.W76=<@Y0G-3-=,Y^9@=S8F;HWPY72N%3@1;]29)!WW']+A/HV'3R0C
M.S7W#G0,W_M8&7I,_+[$AF&WM?1]$6+IZ%\?3M9?'\(H$1Z,7_3&XCPS&C+,
M<^(JC=F*06;BO7UXO/$P98[IUF_BU9AM>&;\Q7T#HSWUR0]9EZ/0$6.FK3D(
M^-OHHUF*[6"+'U;FI--AILN%.:NS-IO.O^O=?*8B+,O)J4CYJ.=2<[-?_&K[
MK9"PDMN",V&/"_1GW1W#W(.F;X^:]338ES5.K$11EYG^@DWBWH:N=@RDBV0B
M$Z6:\_=.JWOD:IUWTJB' HAK16\,EM@JS KVCXCTSAC?R,D\WKA_1S@+D;J,
M8VR=P!*FQ H5VA\F>MM6E!\'1OR9_O,D]0DZF#U*X7M!_ESX6!HS0:#K \FT
M83>$2F ;O$B]"+66G<2M(#\)E4;#)B&@4\OP>*HZ$0=>6VAE:UCJ@R%GZ[W&
M;2?;?-2RG?N,;CS^*:OK,CI$/DP,EE:@!_+K =JD3!N-@EY/DA%NJ!*]J&G6
M8DI@N\*D;+ 97(MC*Q)\SUS-Q6XA^)Z0HE63-1<=IZDZM.!620_6>F=NE(H+
M4:^ZL,%ASPYGHFP)U-6Q.O&H (KT!"F)RS0X%*$=<_RS"5D1YYE+R6M;-&':
MO)Q6&1F87B62(HU+:VO!]7>N.=:;]#ZZZ:%DK8+9]0S<:K'9#NYA]/ P-'GH
M:>KUUQ>(Z;PWR^K5UZ/,+SPGZ2 [VRJ4$BI.%AI<GSU?8'.^\X]#5_7.-W\[
MAJ0XU)6><R$K5J<ES0P5UH+D2JI&$X:'WBH%\[UH3D[#RCO\=D):6XMR/PI)
MZFM =XDPK:H_:2]FW-F(L&0WHYI-EOY1+[Q'OYE@*+6EXNVIYY]\=2@8LZT%
MX_/6D"_L U/;+=C0T4C^=> !R@PD]'T7/1?"7WE")/(V7#A)D^*=S3>%DFXW
M?&Q1SUBN*<MN']2@5?H]_MP=<C"]^%&NO916]KTF%+3?F5 ?)&H$\PR#X)MP
MJK54VLR$$L6M*969E=O\<NPK*S!BG)]8G6P^ZS$0C#2:OQZF5S'Q:Y@UP]MT
M[71AF FC3OKJ*DV.O*3:=*C\X.PZK\%.FIR>HM?+@S/Y"X*3.UW&L\;WIGSS
M=0@G*)TR^"NJW'^-W2[K@P4&84H&/K*I-T-G!]^5+ON*&W@ Q HK^^#&F>G6
M+7&B;[GIA+[ ;+#'R$V:' B]D=4PY(:5,E;\0G@IPZB[H;:$^J58J"B!\53F
M\JGTB4+P"">NF5L1,MDU/\^E/?1<Z%B@F.-.:%<(#K.(.I!_Y2Q"B6AE6.[;
MVS\V*=.5'8E6)A#>:]2_!=*C#9ON !U;,-9G^UNT9AF 8Y(5@NN=FAR&B?>D
M"+>OXU^O S)R..N'KX')$Z](2(CR5Q*S[\>^H 4R_Q RPV#3<Z_-,-'PC-BR
MPD1-A)J:;[A32"Z:F$\GC1>QQZ=7QOPW^&-K+_9L^#0Z],P?:W9]YF,51>[$
M0+64-VN^Q_Y6X31''"Y@KB+;";1M_".X_,JU@.N&R45YF^M>QX[FJNG>\6S_
MN:!^YF,[!%&W#()]G9][@SZ=J_ASV/GC3?*E)YGPD2[+_5O2]R0R]<Y=4+=5
M1+H7E?[Z(W=O\UE;+47WJU'8B>^N8D=5QKL%87=8@# MW)^_7:"CTXF4^R)U
M2*,F#8'[5]R\X#3!?8K?"F(Z+>")67\R0'8TFD/U0&]MLE.N*!)_UG)YO-#N
M#'F<&X93T-RM T3L[7VU@_E]BG^9*5.ZQ>9T_X&7PR;UQGC=@'Y<1/>/_ VC
ML#[J^<9@W>-OU?X0]YI.G.$$)_TQ[^49GDH,*>CER3;K=VDB!Q8L+^;Y$+PZ
M/&I;=(;S6T!DG(F<K 2V%3>2#XW/L)1^N*E$."X-7/@*6__:=,/M>NPYU--U
MO^:Q%YF6ABA$Y[6W[WD_/.X^#_1)4=ELH*SZ0 *CAWQEE190PD#-3XDEN0[P
MDX_+=+9<\',)>3)K;^T9^H]ZSL#W'^F/5PH-E<8SFW%WL97_*<%7XFM'_^=S
M960[]+]>?<L&KA^2X?^"ZJ/APBN,Q C$:BEV2YF@GL99>(D0/K^.$24>IHJ.
M''G?2=XE13#TG\XV2M#]#V1S+!!"%18L<"4P40Z&B14=%^N/ '>Q$PBA^O??
MNZBCA.CWZ\2'B[DT'_1W:XB&;9WXW1,R081 __WULP3VYA-.FK"?L[J. #R@
MPG_^<^<%=P?_]\[Z_0\'2!,GR, 6IGA3@L 2/2_+I3Z<T 6ZQ2P)K,;S1RUU
MHZ4WIW?3K/+J6^!ESSY6!3NYR8SGC9K"X!"U77+*M<,K>A&S^F<_E[^IXRG_
MKO$B;K:K.M7IL9CO:+KK93WE[./5;TM_W?!3NU9/<;J;_,3L"++;I/VF07^E
MN]T?MWQ,0YZ0I1;YZ224Q5Z\@;<VOIUWX,\*-^<VW]<M;3E!;GH8N)[E%6IM
M4DZZV5;;8L+'@I[NLDM5+@,5:>[-0W4C/V?(?N@Z[#MJW(0>D)J(0A,/B;)"
MR6-'^'\"=G.S@BT0\AT9AMHW[;,7;)I8"^GSO,VP;QO!97:,I6(E(6BQ4[6E
MX.Z^"8V6D3G?5,QGH_RW3<K@N[KM5/,A">PR<E3E-)3-^WV]3)Y\-4J[=U*F
M ZTLA#L@MA&=H(N@&C]#]$2\AN@(ZC!Q^&U$6VF^:E<B/ Q6IO*HL>8YA<L?
M??9J'AMT*O8K_A)4RS^"#02F72P1[UO2)\FJ/SQ+<0V(Y";? MRC"[69FG6%
M!)K/P')H?ZY.;$W-X'S8)IK'V5^%&28#[1*8[ZE';2<;4Z[V-=V=I$G91,J<
M;5:3O:H_9-I?.^)XMGU$+$]#3VBS@:GUU:ZR.:5PW0SO3LH1_2#YF[_N!NR*
M/Z>_6&X6]\\$7$9.&?'PUJ/BDVFQFVUWKCK2Y:J,=8?SU%D$O<L'W0ZO#OWH
M2]F.V;8HYVCIZ/[-A4Y4VKSO<>G2Z&Q=H]^-:^7U-]+IW\/'ZT3G"?Y\)0!+
MF2-S<C6WUDB]]X90!F(7$@-!":Q3 ELC_L)07E("Q8TOA98#31I@>(?/CC0L
M0&O'X57&O A>IP$&Q< D"L]$Z8)R*G4^6@--R.)IA]LKC2_QKUODA;LA&\#L
M'6LD1@*[QI#Y05;= X8+%:WY,S7 M>)2^#;"@@?4'<Q!IT3XW.<B-D\WG!M)
M3BG,AR8=&?2D=D^=V/+015Y)14TC/4O[A)8$MI>ZG7$=(95$VU%;Q+T2V-J>
M$>&>%B41E;B&AX];)>5Q>K=!U?9#I+U0>+OX$+5S$=E.</42=P_]/4!/2B!7
M\Z(_R(;9W?6W+W[T5<CVYV$5 GO]M+-YJ0K358&O'7!%+3D\PVL=2]T7); 1
M5F!%8)1L(+_Z^:[Y\H\'S[XS?E,-LS/$RK^-,65^.%:L.)2?@3Y4#F1\//24
MZ'?LVK&AZQN(+F4Y3CN^R9F:;5 ]?[#T8<!EX'6>UYA[L6W1SE!_9&*!S^*=
MH>(%^X[&7GJ->Y7[DKBX91>YU92DT0WT=J$WHRS$']%;@TE[+I#>Y>J(\J\W
MA0 4CD?'_-K95H;"_MI!$^JF@"S*_&8>.L$\XWZ9\-3KEC>#-?!MQ /]EINR
MO)N+LJ[/Y>X;*'X\NQ@CEJWFDI4OD,;QDX[^S(9/.5RJNG"SB#K61MK?-/#3
M< FIY/"": ",T^*[*'2];9XS!:=:FFOI0_+/JY+TD^*O/"UKB/G'4*<=$^\:
M6&MNP-AN&:6=6N00B<IYR4@6.K&"'[+2;@SZT:O,::.<M',W\#Y'6^OW_=.Q
M8GIS63[$<VBXSR0YW'/8=X K,,W1?%,^8UX:.,PV"EY:&C2J=._\^N#X9?KV
M4R=MM_R9D%KT%X0^VOTV^MCWR^U8UJ,4M4/,J#.$,T"Q@\"6L(4>Q-6QC/*+
M^UZ2P7W^2G"@I U(/Y.^MZPA5D^OY -QV,6]NJZIX$[SO$G*,*DH[#^= /YA
MR_NO7U89&42\EL"$N75S=R4P?WM 2FGNU-BR;W._3Z^NQO 16F(U+[[EW^3W
M_<2U/]$_2B#/IH^SXE.C=:*D0Q+8:M+Y9T(%"4R.H4TN3=[AC/WVB!.[P_GX
MAM_E&B["Z!'/4<T#^,DH&L69;V4487\T3#QZ-=857CS38%N",TPI+&*S/E;(
M]Z0O/U_T'/?Z4*'^V6'?C<(+,<4V1S\X/W[B]3!_L$"WMG"73NB 9U%N287K
MT!H@D=R*)'.>@_EVB#D[P:&7MTKS]PHU@7/G;=:XG9?767,>!E.''7*29F9_
MD%O-&3_>DZ]AA4?$4MN^.4:-VD229]'2/O=9YY*Y8P@)K&>#P%X"LY3  !TQ
MR>$G2O%?_A !S,$A'0_1+N1<MY0HR:UD80FM4;= ) VN5=V07J&%KP3VSPNK
MEQ)8+AF2UH'>OX+8+($Q7__>YK%TE5&-%$L9=H,$]JLH%;HC(U0L$S_,Y/O]
MWHG+88C/CXP_<197@TC1CF-38HTWTDGYK-E/[D4+I750'PM2I;C._8( G&BK
MA[&CF=(AEZ*8M$%7.Z'%.O%F*0/8.@@.2[]#!; 2V '<SP^Z$MA%*%.<J+XH
ME2E2"24.@ >BIZCB]1)8[_NHKC;ROS"H0*QQ__?"(PFL8+_H&1GHA9 26+K)
MBM\.<KG000*SV2IU$\IUL@1F+%-#7?R-3.2IOULFN>A_85&?M%UI)A<=1NY[
M+/[(@/R%*A+8ARQ!52)ZF+1? LNG2,><68N6P++6L3#_3$E@]]&+O["W .J_
M-"G@?S6?B/]I.M?,ZPBE-K^C_O,/\BV$^9<F&9/_U;RTS.6G+E,3R#_R>M'
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MS]: J1T!UYM.O/C'8(U(D6#&IT"*H&*;)@)<N4]""BU _VBA!^^O)ADN33$
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M ',6W,!.7&)'(S94$)W#P^!,=JRIYK[&X&MPV<#N ]E?##5Q]8]9^W8TW97
MUN>+GK1H"=& ![-7D9K8SR)X=5"5I%"(4?PB=!B2QJ0:T1>M23QQF8=-%JM#
M0SR' /?)K@D5J*SDQX0F5FDZ\]#%CPWDN":KPA_A6:8YA5YC,'C_D]!'"J?'
M?8XI>6OL/&Q^4*ZR?+-<^4NE/T[OCMZJ-_C7Y.F"T_DV*4<?^:88KW';ON/
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MC;"=+ZI7F?S]HF>59%_V:"H7.S<;!DKSEYW:4'"^?:%92M.5VILS$?$9OWB
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MB6XPL40%<0/^+U#^!;:ESJEBT&).=T\\:,G'APT&&PLWP'7=R"M671K*3.&
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M_9X$B^I :=#^TRG1R9.U?/0,+3+F?]@O=ZW;>UT^?>.#UKB@BD]86,G(<XF
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M0Q>$S7X0>)8G3..4B%WJ1P;L/H_KW_3P^-O'I]RJPK"S2RT622%Y GZ',0
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M.A#U]&ID-+FZYEL-$#P\%8[14)13Q$)5ZXE:XN3$ >X*._[V1(6**M(E7=D
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M;>0,-P4D7]8<-6B[)8M7I:%H;S!V^Q6U+AVDTB[I<GJ--!0!<U:1)7X&B^R
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MTJYH;JA,I'TLPU^$VQ=]_,YU?IAS:^FUJI+6U28TM("?^^FO71L$VAC+*>K
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MN4AGFFQ0/:<#V&N'\5HUP/'.&%1.OKL]<1MZ0TU#(H#;5]2A RM$ O@XH[7
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MBC"1FB*QQ->A<RS1R;4 KUT'E<FC2GS+72>?6I2X"+ <OBK1O/,-=)'W:^L
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M5X:QD4L\Q;"FJX<8=6&]X2*7@<OSNQ'?=J,A8VQV+%*5V- 5J :M%[%U2#H
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M)XROQQR1?A4ZSN6+;25^0[$T%2)?\-X[T'"X^O]B[4VCFKK"N-\H*B)BE%%
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M+,L?7F.)V9IU*?*7L U*E+R,N"4U&I!+&1@#!2-#2UMY;953I1N&%@@,K"E
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MH\=C;05,/8T>92W8?!OVEYDGQ%40<9:-T9JM\!;0$][$[.R3AD"IKUE@D!]
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MNI&--.L\E9GSM*R6'A&:[AI8BBQ6I4/C0) <)W)8.2<\X_-X2F,"[<$Z47
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M.HHGY*DDZ5-VJ/.-!"YQ'I\9**%5L@B'G&\-B_G<@;&4!VLM,HI\5+-$ )W
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M=[".79>S^"O/,E7D-I(](WMYW[=[S]BY5C#&=Y51R0G(-H,ONX_3ASW+*<[
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M7'4K92@- H2SRI1SW-T[RY]-$*M)M>V1/P-=-W4N:2>#-DZ.H4''L5O@2XW
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M%7%/HF\L_M0 I!0\;:$$XD9';DR@[BR2T>'/3Z/3<1>[P^4CHMP@A9D0G5.
M1RTC[DI#1ZY1;:,TVR O.=-B9ZM\W%?)%Z'RDJBYLK&N<:(_866,BZNV0%+\
MY>.>Y^]W=IA:#/%5>)[&JAZT+K8NTSB8P8:D=C=:*D\?\O:%BCU$* /-:H+F
M+=Z%(2I=7QS0R[.E. ]]:]VHU_1\@!QW$&R^RZ+@%&TA_TX'OQA<*&YE&D^V
M5)8^V\ JBS%Z%_(GPIV=K2( OLL( [(#Q0[<?PA"LJ$XV>=GFC4O@?A?)DOW
M#'(=I9NY$570=D*_<^Z6"^-32>FI"I3IM&D3WJEI*+V\DA9]!-=4[I:;LU?,
M-\+::MHG#H!-Q3)^)FH#=Y,2G<'4<4(;3?$V JJ&:%GKQWZ,N8R41=T(7:Q6
M9Y]O&5$"?X4<AGA*H6NT;,XPYI>PV('9:^C&M<Z^1&+@/\YH:">V(5%!,X2T
MJ+-GRM]P_!UQ,3$M0;H1WFMM,SB_=)/G"&U7?+RS'7S8"M%)5>0F).)O:%MG
M^[ ISVJ :AT:,['Q_F:T(NS*7\3]8Z _;+2-8.B:$\Y0#DTP(T"[ (A?0SF8
M0]G;?XV4H,_/HEE3#$#-F&93JQ0Z[C @O >11!,&*3;#4P,BW="^!4))X]CT
MVKHJQ)+=:S-<?=OXUPQ.3_I7FNX''D10H#/QNT$7MKR8OZ$ (&3P;(@6C RL
M'9D1P&LL[.K_3+G(#IY:+,Q>R(PXQG$XTQF0O$1_5=^ZB6R:GZP-O9G\SI:C
M='F*I8R?@0E:"HDA6%&LG*5TIW%;?&JG6WISV2?>'NB]G&D4%LH1!2*5#CNM
M=,Z!.QE)!5V*H_DG^2^;7KK^-.[' I81*D<0?8OBO.1##O>&_F-#D7[0I+R-
M= 3(*P'&!*<@U\.0'6N:K73/]5;8IL8[A(LFG!L)UE.)$_:<MN'(?I1 .P:O
M@ _%<1=EL]O^52Q^IJ+ENK#1U_,03LG<0#G4A]T?C:X]#T>V0BR%GPLRK="G
MC&AJ,==.0U+,0$):X[$%=B9O.XBDUR7DN@JP*-" F9F -"0_"K,]KY'0E_8L
M^0W6SCK=VM @[\GA1XRA) 0%$[9#WFXI8>3 !VIC2A%0&R@5:@S[XN<09**H
M)?%N(]N<6.2:E7!TA)5@95[LU=@[< [T 6HM7&J>5::EB=N2X\RC/H=.T-I_
M@)-EN?L%PT7-,VW?VC,638N7$<AXOVW2$,"IY2CK*<47O)(-6G9B+?NVY8&4
MZ6]MP04?A1KLX+8!?PG'X:2?7<=/K?=BGVY *@FP43V203!W)F7PG*#*Q]'6
M5D-&HAM?T$)M:ENC -M. T]/4%<XGOAZNU:FLWF8*/RVNUK7*L?_WJ(6-Y-D
M? N*V_"3TL6N$\TM(Q&<I@>.SJ&J=4.4Z*>0-@;E8%%G9[/U6B@%S)=?*RI=
M"[G+"7<!AB[\HY9!^>E!]:&<O 9%<BO*Z-,B-2WNZ1CQU#CG%^;9%)QO[[S'
MMM&K3Q"?*/N_[4'X@>*J320H6_!"\Y?*>GU+-!9%K@H:J.-N=\A[HMG9-D#Q
MM*4[NS\H#>9$4TZGR%DX4;=Q;H)M1D3?F"ABCMI]G;H-8C^AM1_0V!"[RN%C
MJ:IKX-<\[C%GIGETR.IACJR8;4Y^,BW"(WJ=_8XN(XY'##FPZZ1BP@;81EYP
MG\3IU)9[_4]%,3T.$P\NK<?K/-'>U:[&67<?8.<CIOEWI"S:>F>2P3)"8*;\
MQ+.>+DBZ.K$1&!&R36"7)J SAV(7"\:X=U^;\K,3)WVHL6Z0SYF2]TE/#E_.
MB$ZR*LWYNNC\-5D[R-!.,R%3GYPLFK#NQ83O9! 5_ILI>F#ZK'M[T0G::!!J
M%8R@F,9/Z[X:O#97[ ^>6QA^H3@0WL(O]=L0>VGN1'UR\96;$8C/3C?YLA(\
M!G0*J13A&G+Y(L(6RFX^'0]4:MIDFU@,>C_E0+WUCGZ,3WET4O?;5 ?>/: _
MJM:9^+SY]"%95S"O^ZF/O";PH8?[&:;*7OU4LSELLK"%WX[,EJ[3F.XLK).F
M%(JLK8<:D>G@^2C7GZ.32L8U3*WL?RH4I/_WJ)18<L"1@KZ>\,&\,?0-92Z7
M@X)L4*GQ[%%A!VY-+3>BCBQ0+(G-:)M6=Y<^E/-U(+K([0%_IIFTY#S)TX+L
MW=^\:CHJQKHB+T8KMM:$2:;V>NU.6:<0Q&XMZ?$%]%5GU>4+V;BQ."U)FF$B
M704D"\T0UA(*EM'TR?3V4A1P@ZY$K0ZE[(?"4F21X(-..M=6P;" CHJ_GA[B
M)'>QW'T;P+J&GUO"'E]<L-K8$U$5C4 ='Z.$J>]JJZSG*7"U=LA&1]KQZ\#2
M')[^X!P]$V,N']]^H5>S9;* MQF[N36WKK;?%[TJJF6VM/AZI8^A+;TQ-W"\
M;FOCBY8\;P"Y&0K5Z-W33FDF3H]VQ7(NG;":>U$Y9PF?!LWHC8P5T2Y4*S!0
MJQ+&T[C5L*_2(_D4E!H9]ZRKMKUL6HN-UAT5>,E4WU1!H<O/9'?_EO["XX5^
MI5(F0(,-&X1XU A\4^%'4.18L*0,RJ8E7_(9Y8D!GN78NT\A:RJ63E!<U4RJ
M!3D[K/<B:)O#);+$11ORE["39B'4DFKBXJ\C7\@5(M/FQ>KZ)2>]<;*[1N^]
MZQW>+M@>O/80K'P/Z K\&1-[U!5<#YDO(SW$B)Q_"I0R-)O(8_*@W*O./9G,
ML<XS;4#W*#A1K< A1[W+QJ9:MC0M4NDI+'+JT1<OTGM7%HJ0J3C@9!LI#/QZ
M)QYI"9M!-F FO!=<J1V=0KDT@VH6Q32FH.4I..'BE7R0^GD2$W!18>4J'&$"
MM_3]C,3476V]"G!GKFSIMRN:X8': OU?IVK?:ZDH$@H2?L49HT2$!J]F.DR4
MAT7*2VN4!I$=5..7 UQ"V:<69#K70\%'3LU6Q_A'U$QM(B=@'&(5 PFQ.U^X
MY.]\B&W>/NIOS'Y#'M!.DXQA,<G?>!5-W3%M&@!]4=V"%I8.8RNCY2B#KIM/
M((:2<)M%L215'&ON3HAE35IORC\Y0)JP"M$K!_',F(DMPP[A SMMG&NUR%_Z
MTQ3?,!)Z ]HJ.,TYWWZ0L'D6XY-8 3OVPK9RNP*H&BAN1^E>C02^ID6,P#YH
M^A. GXXQV3*2&$=L^3^H>O>H)-,U[M^.9J:DEI8F5%9.F3)-'AI%J)PR,Z.R
M-(]L<\H#$=.H28E0GO"0,DU33KJ5*5,R4RI!2Q%44/?LMJ&BDIIRFLD\Y?.4
MAWOD$5]ZU_JM]7O_\!]E"<]]7=?W^GYN[D-_I6:H,_23?=B9='^^W%5W$.4'
M$R<7=2N1[R#C# %G,[!1L=+UZ%@;O0.G960;;-]?S/T(QY,VS'R3J%R_9'01
ML$[U;A38\>QB;2/N/<P@1?SY-#3NQH60]E'B\\\_\3%H1G,WW:F7L0;9_QJ8
MPL9JYFTJXO@'[8V:DT'WA>:EH>BJ<GHJ?$2<_E AO!A517ZD)/4@OD_'=\F"
MBA8H@<%]%V_']M<593V]//.G\QO="OI^6\<6+SO[A/#T4!  &ZLP4ON8,/'K
M/N&A&&W5DM%-_)97T%QFK&B#(NGKR@3:YJ2H V)#'V:41#L+>H\=#J_;@28F
M&[Q",Q0V1-]6+V?LB(PS@>Z'A>6=K84P67H9KY.B(]&LYAJ&*T/M[M6?'U4@
MEO2=5Y?Y9U]ZKG SNW"$W-/_Q2AEYWV!X;_,I!^L;Y+/$@=*L68D)*@/\2<[
MEX^F!1YO!(W5-'>*:1B\Q61=V@C58CQR>2^7+^[7!MF@;<37+S90W#^^<72#
M>J;U)M-JK]05S0WF=Z$5ZHH7-4#<&FD%S4NFB$& :9/CEL]4S><B/JHEH\Q]
M@V-SAL"YS32@7Y2-7V,89?G]W2B/N9-XGC(IB-I5:',GU- M]M.)T>H\^Q7'
M%Q]C)/6AQGF/#;VUR;?5," ";WO\RK%:D' 2FIUE32YN$%M/SV)9R8.M(<,D
M\M7X!L5M$2;>:J2Z@>XJ>%&;]6X&CS(4013 MOY$C\K7[XH?;%.T#?NHA__N
MKTQ232U7GNN* DS="4,J_U;0W[HP\E? -WVS5/MP\'/<BE#GWZZMGZA[D2JZ
ME+85Y0LYMA+!KB6C_,(.P@J\+:#.46'7><_APFPA!9IO4>AM>P5D2IAZI'Z'
M;>3#G05WF;NJ'@\!&ZE-\HUKO[MVU,KI^YZ&C]\(^/7\^\XGH?7=(R:+Q?AE
MB#N\B_5UC:32!&>F$EO2R*VA]3=G[,,DGALK\JZ6@_WA<!!7FQ\H<:_\U_.#
M16ZRO-DFLO3"?Z1=+57Q"^7#+R6['EZ[!$SGCB[^)CJ >"X^0K!:JOWYT(\$
M4[P)?25@0X[JDJR'%)4C?/)AM)::B[: [Q>.DO5K^MQV(]%1CV+1EFG]\^UX
MQQX]>B+T0U7R7+%L60UW5W7U,$/0]?_?KV#\EK$#W-(Y#2/GB::@JEV\NAQT
MZ2UAED3]QP1^._0*'J1ASSZ7XRA:JLD;[G"D69"9S>D>Y/L*4'9>OBOW@,O,
MXJJD.(=?A_R+: >:PC3)D]\G0Q+)0H% RQE8(&7HUREF2&MIEPP#$@&QD>T+
M-MDS')-QVV36C/<6_Y^VY9VIA7;V/TDL#CL79]-J.3)N_<?'TJ3_P$M&N4M&
M4(",I=SDALH+1N^ WS9&DV&6=I'50;!@1L46'2VI"74NG%14ZCL-K\P>&W%
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M,?9I5UWAV7OZ&^">;B-XHR[,P6]!SH-5<\H-8**Y@2DAF,0M>/-8^BT5][B
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M$?(7IENJ,L"PFF+5S$1-/BS6H%IDEO0MA1T8,_U>4*$(A/JYC\'=\_)GC)W
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M6,3X:MD;;':4KM&0_H7-V+4!5'?6$UJZIC[+66CFT8;93#.$7_\@1CMMA'B
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M016+LXNRKIQE_/1D=B'^9"L<#*Y[Q]6.Q#70.''(GK:NBO!QVIH VKN48L#
M_0/T40D9G)FDCN'( )D[YS>9BEZ5;@M+X0"H\IQ,"GWP O&F><IN:^731L>
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MIT6QC41-DW/?G >HNL1"0-X ,E^2I#'9/)A[;\+H4;. )7"- 4 L)N;GG[M
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MEGW6BSG_>2;U?P9A8_I?4$L#!!0    (  R >UJ'<:W,LIL  (O)   3
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M?>V@5)J*?RVG7)^1S 6<=N>ATS6$65P,F?)=Q?&()9DWLO=/AGI3"\>_@$F
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METY:$7-=0R^=2D3%D3/31?B@[LGJ1C5S\3S-AN7CP?WJ)$9T:755;<B\ 7?
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MG-RJ_=\&D=>?:ILK#;[4EDAGZWS9XAI%<:%<JN^&@Y]Z^!;J*^QF3Y -B]=
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MC2EAO+YF,!9@.[SN>47&T%Q&/=GT^[-Y';"ISNC5\ M%I9.Q-=*; &GYH?B
MNT/ 6%J\UE%SBLUFH7\AN$?Q5Y338R%QU?8'$I1/=J%?!Q0HYX3]#C<'FE5K
MJZK*'9/O\HPO2+NB.AL,T]LJ/NW\3)G:['GN/+*F,WS@O_KCEIY@H:Y6OY:,
MCG0B:A&REF->DC#H2-,?H%JK=V55[D:-;;*WE;>G\,++N8ERG/;-9BE^[QM^
M2R7YK8Z:\5/0-$EU[/#&[+5')9-CQ\D:;QS-XKU*]1ML#:!,"DS(^L+ O"M<
M>P2U5H7NR$?T>]9F;^,Q?M]7UDS6B>P^Q4^'G2NZ'2EVH6LW HOX'A*"U1Y8
MIUX(E$QIDVBMO9L_!L$='L,=AQT\>M/!"6ZNFP?FC@B"HFC_BG^2E-X'&9QN
M:(KBR-=<*"Y HN*PWV%DRGLLQ[G.^F8PF4*B+-N&48#=O/FC]I1$##$O:<W[
M2ADXN3*RFT'0#B)X_R)YC)@8)=.5Z>"#-4Z5KJ9Y];H(XI&R+4HL0]I,W#!D
MK?F",K7E-;R0^7:6RDE]HJLU8TN)6P>9FM6P]P4U]7SPA^[K@@'E6$&T[KAE
MO[PH#]BEH:VL4*<]'81*J:T_!*V.5$["/<7MLR+F%!_EDP I8.PAI_/_P\Y[
MAS6YI>VC05 4%41Z5T!!$%"**"V*(DV(@( $(0)2([U%"(0B*%U 0&J4CI30
M(RVA(R @O??>$VJ D!SV?#/?[-DS>^8[\YOOG.N<:__Q7A>\65G/O9YZKZQR
M?!V\(/RW_V6BAW>4N3G6R8"@DVG!BY9_>&17_S^\16)*:G.RG.\T7CG0R9'D
M^\LI'.0^*AO5+-%UP#JP"XD"YL#428]@]LID0,;M/AUW5'::QV$P;L/+8>5&
MU6"?5HV7$@O%?[\7I<S.W(1H/=[=97Q!K:4Q@4D-6UT1_$:;FGC2CN.DN0.7
MDO1).VE4=NJ43+#=23M[B)92K2OC^$F[D^8A/O]FMW^SCCR/1F47?*XD ^KS
M=2+)@*N_.A3]_,^'HCO^(K%BPRW\_Q0>M<YO-^N[D$Z[;A&UOI,!'_[KU?1@
MWU^VZS_[TW;]_P:O+]_9#7IHC)U%!H-3PNRG#468]T$) T"ZX;S/(W4.K:+U
M;.KB46=)&S 4SPD$GQ79X)6,H&16-<;QBORO7BB2Y1F^T^I,=S6+-1X?2KFB
M<E8FV(MZ(OPEH>TZJ9/&>5NM.62 [8H]1?'5YMX+:JL?GEDZ!?+C@Y?DW/.7
MG<;AN@D7%7NL4!LN58EFC&T3'AL7FAX[J:PH:TU47REF2 KMKI!7<LUKB*6A
M]X.0VB-6$3J=L5I=AB-M:1Z39(! Z#IV_W5>;(H'\O[*0OWB#"3B&=1#!8VW
MB!2R1ION7C D US:B@N!E0)F%^X(102LY\F)3'?16._+;,0X>EK/GO=L'UHO
MZ.^9$$]\,)ETBW6NX/[W5M2%MI<["V&M*\)*\8)=(X+0U=Y$Y#9189MG37^M
M7\QFW;P;VLZM>V)RDM"1E:? 6Z*YF4"$G'="V9@TPZHC"&KYQM-I^9R"VS2'
MVCO!\#2[*<=>.3U(V.[9'0BEJ$]L E-\98UAFF6FC3A$3I;1]_K6CZ J_I><
M2<[&)C6.H<'WO\M<4HCIV!V646C-?]U_.%QUN+FX)9,6HQ-@KJLZ[+2<CV(R
M'QAG45XIX_F+QZ 4%K_)_-UN=8Z3#X=PT!Q\N/^),T3\B1SF_T(..0E_(H>/
MN*^>A&G(R6P8-4P&[)CITE3-L$ (*F7>RD3OD\A-8\\^<4$=8%"<.L%QY^%?
MXH")1>K?<]53OZW]\R$GL9+64I!J3[<%G/NO=TOO<%E;=T]X%_>?&$'''4TM
M3&#8G^.ELW<$<YUPB=#5K*SGWVC,5=J=65*F7YFH][;:Q$0)WIA><<6_EBT-
M@D^)G)$7F[E27*7RNBDE)FN(PX]9_?V40^;]&I!B(ZW/8+"%W.)\A^BN?)-'
M24O6C;9+:%G;52]PU%:W,[ ?*7_A2[9.@%K<GHV0#+A537Q0W^U &S.A7$Y(
M$0&">\KR+1OU903[ E(3O?05^]%W<GC7SS/&QO.?T6JMG^42 K(9 $/DS%QG
MN02:*^UB4CL 5NE1Q";G5ZE7L!:7Q+HB_=*LZCJ=C84K*#H?6XW%=S[VLDJ1
M?U;IL+9?4HDI&,"0,.XU_7)?>JR;"W(D2RNUX&C5.^NX7*\8M$BI/$<3B=<,
MMSG=%):9[@B]V%ABV"!]6WW/3S>)LL%VSK+,74$LY.$@47E6=O7<CJV9;IQ.
M&*8]9\5;Z0MZ2U_B^J!NY/X<3R)?(8IB(NU;>IL9IVF&67+"1WM/>#ZWD1CB
M>X6Y\+A#8HBF_6"*C=V>]4[YTJ& /EXI+"4W9X7=N\B,$37UP)IQ0-^ #%!1
M/FOVV SK4-?L;7H+^K;;C= P+<?-U;L;(B^K5]PW7U-9BJTV-/'D2'WKL';?
M]!.?];U%WNH6)X_@I5(Z]C .32^%5>4>URKFN,[G9:SGK"99KQFI%5)11"8Y
M&LHYH:37732D!O,J,. #><E[ ]JXTK@B>(^FB/&DN=2@%X]K04ZFI]7@FIQT
M#NR.B*4.&@/M.CMFW6V#DDQ1:^N]^^+[-X>W%Q-;[#ST+\Y4#57?F])XJ*PN
M1C=4GN7(P*$A_2R*]& ^ZE'MYBO0!AD "RR@:S(6J\&'IW&-']WW8]6;F!@9
MN<UY!R\V'L;H0GDX(/B*ZRRCJ3,/M(,U7TIUMV2RBNBQR\QP?>]%F9"Z869/
M34'Z7'YQSW&EM<G.7WP>7^#UH.]O=WK:0PBZP4[ N3_=Q-)^$E)&3)BNU+N%
MD_;$)Z[_YY6A_S>_*=:>M#TIU'K4LRP!#B=S1+5?7H[[D@&>:21!DM66!.*
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M9$L,6)- !OP*HO*OE*TG_$(Q3432YLYFJX,"9--+_E!/(+0:! S8<70W2^]
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M7[?H9^EHLK).#;JW].B5.,C55:B%44TFUO3^J1+XU5GL1:)BSZ@V#H/-)(2
M]&^7=<:[1*>B]U6U';S"%"R/KSHU62.:R(#XX7\6G :2VB>X'_['!S=(!KP-
M'YG<L)(!'R"K; LI/GARW^/4_LVW334&Q/9;=G.L%D\P[#G^#[V.Y3_HGI\O
M)/Q+K](_/4T&!"M<P-O5>*9:>=_L=@VS: =:]Z[9I\7""AW<>9/PDSV5'O .
M1,.YQV*6!.SVOW*FJUO_EA<G)>SFV154TL;F95W)_T;%TU:TE/5+#OY3O!:,
MK.<66?R43&V<B[83!\VK_ELA]N(_$H?Z2.M)YFJZ/%@QZ/P0K$6Q!L__*M?Z
MSN%;D-/9E3N421&:99WCI-Y)ZC71Q;(*PI=I=<]/7&FQ;%(J_GPW&FZP3?F=
M_5J-!-4F/K C UA(ED7_M+XTIO#UO,1M0WM6](JLH+9[S7VO/MX\=;&JNGXQ
M[-NBE-/ "L?J<SO;>=7U!:6H&V;W]!^SZ5%_N^*O'H\BF&0WK?TBPF+RGV4G
MT9,<IO#OYCJ=.?SIT@SW);#A^M,T%\ 4K8]C3U%V5N=?#/>O/%G]/YV2"WB:
M>3@QG$2% =KHF0@N*V[N?BKHC>(^5 ^;HO2X;?HB-35C7V*WMZ)C<#_VEPRR
M_+MVEAO)C[)6?@;]QJ!QR2M[0M+GT=71JA\BO783SLLO[,.];RVG7.Z1 SIF
M#!O!6K3Q_'[R=.K=;.P:#^>V+P2O*=Y40TJHM #H5P2K4?8_[YG&;)X$CSSH
MGZ'?1K[S!E;AJSV2V)$!4DAJ*/NK7*8!9"[O+=DXIVJ=QT^<OG#US7&?/5-%
MPP$%;9UF;36"_(O:\W_;NEU$?N8)_9CC@(P#3_3KK3,2H9:LJT_^KCWR?U@A
MX_Z#E;09UM"2PD[PS,S\,A-QR3J%J\A]JV=6IU*%/O$G,Y_ LC8PE"C/$JC\
M?M*X5Z>A6>RN38>;7U_6?O6/]9994/S(R5RSPLP3@D<LN/XN0])GF>;A@9G-
MG(FYGC4=06_M?:4WU33*R!IM+6E5^RI0"#:;8H-]2Q* R;:@XP92V/!Z83/G
M<QE"LB5'AQ9A;UI^,$;=V]3<&IGTR>?ZQ>"R7?\DUZ2<#%K_WW?^&WO[Y7'[
MY45AW/7] T]71:JO&JE0?\NSJ4A#?-<>/=Y<LDF[/A?-ZSCO;UV#U'/MTU+R
M>->1M!]$!LS.3!XW$%?G(R(NP5(7]Y()0!Y_U(Z7] N9.]^TO=P&#!/MQ8YY
M8#<XTNQ:'B;1'"(;R0 \WIXT37+M:C6#BHQ).QD^N#8FU,[4T)BITH_!Z?$)
MT9ZY+S>;L&UQ8+/MAIU). 9YA+[)%B0##,<../8""08H@OO4?A,=-V&VD9E]
M/]B5PTBT-IFW=?WFZ]<O:\+V4JLDH@SBA^.Q:FB\92/I-*$$;[Q5;S+%D2@B
M\=!O@<NYF3VI!SS9)*R@%.JHDNW&='5>V_ NZPRFL*+,;V_B),F:5J!CU%0O
M?.?B CUM@_$-#3CBPGVZAYI=N 0S(H@>-PK?A]@Y'WU!SRTBXYB$/ QVR !A
MA-&NE$M9Y2K)G811KB<#:*N53&8VSQ(92P@9N?$DUL\#>5E1>RN/BJ.U_>;R
MDUB*;U\L,[E8J/98A6VALBNX!":K3#"00M9S*0G@!(C7F2-A1:;82MOK(^,?
M-A[%RC>)A!QXVT>IL-UKUO!Z=]TW0\/,V?QZG-FUF/;2DI&:/(L;24DE,O2!
M_%NJ;%(BF7%F6<NK)M9F4.N77Y^"'YQ2/JO3]QH@2I<I-*Y>-9I_[(JI.?(P
M+"_.+LWWCMWI&7';7/4^A#NG6E\:AD4T79SV4J\%6R!Y_'<%!DHAE!-CXR/C
MS2]-[&_&<S]Q$MZY1]MF>"4<^A8-"M";+*'V<T6<@])WX9M$2G=ZP#V'R@.)
M6J<I?+^,?[O/XA0CQ'>N=P!SU%LMFVZUYVRP?*B)S!KN0-Z9Z.FYFQ;-1^WT
MU6>8T^E&.8F].V^7"HON+AWUW E]%.<PW!@M1.'C6[]!0\W:>5LQUW+?^R)V
M\'!(,V!0$QNLOD-"*V@E3$ZG8/&@&311[&CTO)=;VSJ+:OG 9L((AY? =\6H
MYQ?;V$)3+!:>8*9.>^RO8:3L&;P[#_D51%GB6MVY^JLUOIX2M9/LO1GTNM<R
MN>/,C^C6J11H7QF(SEIF+G;+QD,C,.-:Q?CYB1%EB4=>3PME$30_!:02HQSF
MH>A,9.[JME0HIV4G$F&$4.J='R(>$M[:OU[? 0&,1'8'TG #GI_@JHX,,=+&
MERZ/MK*917PJ9FVF!GZ+JJ)[GP<WP?DW\3!EW@R:Z6*Q^F!5&X71B["%1X[:
M<KU]]R-N$H8JGE0OCO(,FFCK7ZQX_T N_U1<PNTDOB3SN.BMI' -_H3'2)%0
M/3$3J[W;MEOK8*K;RNB/(Y]&[DR9488Z@IOS*PS')8]=-8[WB.9CK3^QXJ#'
M"41VR$FZ.KNG .HF782!9@*Q1RJ3A,Q.(^NUZ@=O+GZ4&%>Y6FQBQA!OJO22
M6=MQ>[?>YW:'T_(Q<A8"@#,/5#^8B3@+9<]'^YM95POCSQRJ&\KV.U&/S"9Q
M86#T'Z_YXSPN+&!&0S1+?<8^Y8O,2#\QGGVEAO&D]^ORW;X,8+LW&YSU9EKC
MO%8ANJCZYTY5%8?=E;)O1<$J7\@ 1S852"U-AT9ZG#E/O0@00P8,S+=%V6*(
MDZ'1$%=L?KC GB.>.W*FRV^"O:^4BWFV8>1A"[_;H6U'PPM61;45-[7&N- /
M:M*N?$S+SX9F5<Q49I7")2ETZ16_^OX$R-#9N#Y!2B9*O7UC&DTCF)K^^7]X
M62EE'1#ZP/("ST6Q:E76Q.G=N&"3Q,807A9?TZTDP^K5"::D+Z]Q=SO,B?)]
MU1(SD)%![7YO#HTL8Y@3D.: FP_S<X_C',K[9V:WN_*67"Y/?)2XXH>+7FR2
MM\<:^"4>1S_D_0B;>]JVXN%'1^7)CLI8.O0.L!"1[%#H?5)*58@N1JN84>W*
M/J5(Z!&?AR!F\H_A56R:G)TDI'^%7;!@7H=BL.#G4R?/V<Q5EJ/9P[XRQG%3
M,@". ,?&::?4*3'J\ NF!@.$N[!6ZO*>3PE,LZOVYX,BWE_K+M#KL V_9C'D
MQ,#3J._ 34 ]^,S)&5Z:4%G86U*!ST05P,7PU^-PPD\(CT<>$MJZP+US9>CN
M6=V:PI)'9 #HZ+E6I=1PQ0O5_4_AF9@?<'O;&HDFRV$K=KUX+V=/\XSG!A/C
MB):FCK(\QW;IHXW/S$35W-W2Q8Y]]/XH$2M!XW*@,(=9)0,^:2DQ11;^=J5(
M6_R=GK9XWEF^/G;PZZ*\;CD[:;X</;;F!ZR2*0W*;<A2:;]\(ETV_$XI&A?X
M;AH9,*(?5+H:)+7.1KV7G-_Z\2U(S&J4X7L;ZHJ%*>N<ON[1 ZL]'@:XUW2$
M_P"[ZT=H#G9O,=CN2OE]G/73UDCZE^+L;^Z#]G5SG36.8XCW++.7(;9X@1#7
M<4K5*O5UV08PIF"0W:OZ^VB:;8;[W8=MN464E/GN)$Z"8QK!K%GA!EX#/6(Y
M**?*+^+EZB[]29=7HZCA4NTP^Y;;=JN 5&64JFN)_589"6H<J[?2J7].6D3$
M)6[1$YZ2;+?Y\T!ZKXK0,0UDX>$DRO3+W4_AP)$!@9+Q(<L3+XI:\VV\5>\,
M+.DZB$S+/I_SZ2IUT8'HP%GPHO$SFV\GZ/MV0AJQ15ZB$]=2I%Z>Y[<)OU7+
MS:9"%'9N]F8JPF_Z[Z(NK&"L>W8][[VV>TM7#!)2$AHUI*:F+A#:B,Y\F&I]
M1\:V?+/$P+#%EN63TRB]8@'(V>=>CO:+<'F78SL(?TUJS,[@3C$1F!N[E!K\
MXY=-6X!?/\(+7(8-2"8XV^QDB+=L&4[_;5D'[\J*\+<K QNM-55%9>5GF2]F
MM]+?=>/HXM^B!A]Z5'LV(4ILLX)V15XWS:)8K2K/U/"IY\(\05A(\;C$!16F
M9+"*;FW#S=<4K<N:(IGKH[N0N4?]/5N(!1BHA6?$L(Z'>0=!4"HHV\.A_--Q
M,U!W_)C236>;X@[;!? R_J,VE8V:9/X'6B9JJ@'7_,V :J-T4D?"1M7,C=<*
M7$K356'46GTB&_PEOO:-MV9&W@3V7KX7]C')9_3.1AVJ)!,7&"/@9X[[>&?2
M["=$T_:&;;YFE]!8L]G(NR0338I,*P6:$XH^E2]6[PC.WWB79:!DPH3YG.O
M+=@G%$1YX78M9^1 N4ZH?5LE&;"EOH7H+ZOK24IP\@(>L!R@Q+;PJ.%>K2)0
M$/92*8AJ55J&#*@?/?MZI/F-&/?6R*"6+1E@A2Y+#F$)%0Q[?T&QJ%9N\*<N
M!-2;+YEX=_VFB,B:""]K^,3 M6#)0R$?ZBFA)DN!'_9GMT[RF-#YWQY4E:.>
M40HA /?>%>,7WU<+Y,"JZFVG\1E#8]8)CGV0QU4,$FW-8Z>&XFGH;C]H_L%)
M::P^'?%^@AX'#"0)CQ%RZYZ.$FSA[C88#EPX:D[QPV2[+:>/]"=X+N)3/$2
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M 3)I._>") 9U84+AF)!3<R\#UOO2[KV)>6"7\IO'M-3GU>&UYN[A O0(9W-
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M2UGU30_Y6U^3M/R!SI->*H*RE5)#X?^T]IS U<TN[+!1/T8D6-/\ZN'[Z"S
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M".'W@[7G7#OU6N8Q,%_#A0^?VQ&$$SC5OS].* NX#OFUG.P\9#!F0:4F23@
M"-Y?W^0CV5WKW =_=CHNU-U2XE%/*$84&#X);FHRA,0Z^3F4LX 6Q0*/K @M
M%I'<)D4-#AWR\V$K',0OX.;$C_[HY/Q22?4S,(2I!C55._%+7 D*?/:SD Y0
M8\@=86//_7WB,R"%+Q,2_K34500=-U@"U8"YD'NL?)OO-\2NK9G%#U;;?A#"
MG:6BL\IW_6>\D[F+&0-&'^&(AK?RSGGK]80V5TK>+_+=I/1.ETI55L#O=<O
M$J^1-7NDMW?1.T]>W=X%,=;?6D\0B0R=N&CWT6(+'OHOQ&=S29/3MJ:X^ZU2
M HDCU5.(+M<24(N)+'@&0O8A0Q276'/BIT]VZA)$/3_@(&'$[YZ>@;+^TBAK
M/;%E_P?55;_/F'/:]PPP"*QX:C!+;>/2BM/.5T3&]V=^)^;H)"NA+41+L,\
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M9T#L&*H+)H\.*C' V#/P-N3-,Y#G_0STU$%X0KZ(EX9,=H2L+SX#Q+.%8"P
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MC5.BX',9319PQ_;?+M']&6A8R'C_H\[$PF>R[>7)@]MBB=.MQ<95V=NKH:L
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M=79$CF *;6K'B(YT?"S5!2-MRN/!F,=$C53U"X4);<^@1DVL*%&,WP2;3<Z
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M916WOKF9.AC3T/,&7U-E@:708?RB_;3-VO#+8W@"%'=.BA/U;%=!H<87S"<
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M8" )(_FC(/V#G@ )A0#I[SH !P7IGPT* > MX.D%P XH0 [&^I<1C 6H)9H
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M=WM/BS]4)HAMZ(G-AX(I.MWB/BI(_06LV:VLBTCTIPS@>.<@C9@N!8AYDYB
M/!M(>F,EC3,C774.6.)MPVY^<P2(/8I7SI;L73&RW93'Q(G^TK!3,E\E%_O%
M\5/,F[H^R>D$-XCF1P@5W089#KY4+V^Z^3A-?+HX_Z:3-#[-V07!G3!5[C2&
M;CM.P![UW'GA:KJ*,(M#88/OV6 %N0A<T/N(N"='@DH)7V.]6!&?W+EU'2<K
M=[C:_8*+G-Y<I/)R)'&\<"'AD2]7W#V]()8T3_2&/,76U<J47 /;.I1SB1W6
M@L%:XU\WP&.AM?R1ZQ&NLCTC]B43"OC #TL?TV>^%^,<4CCVRISW$P\<+&Q-
M4P3>[S8I:B\53]<)!SQ=CY]>;[8;VSHDR]*'8E)(_C1H4,V:/(LG:SD CJP(
M9^JG7J1DF/,Q,^5/=P*9/+I6=35U!D[])]BRWD#XPB1'9>A,3!M8^K%MY#ZJ
M>Q&%B^=<0I\D^T7I3*1RWE64PV.8;TA+!2X3M7(_F9/DQ%MO1: **W)Y&H:9
M+\G#.YW(<'E%4VR921[+=@A^BKE96F@M71QQB93Z4->LZ=\U\L/V6JB3V3+>
M%$Q<O3[E4PD1!D9]EM9B8=[W0LG3;,&D/RAOB<V"P'<#+DSE2:NYH.D"0/VG
MF:^<I>0;UD!%?I-B:]WEDH7"SLY [WWU/[7L$P>V$(&!6:P(XD?%#Z">^!\?
M93_5,\.K3'EW<J<X^E[TQ6@^)D%&TS^:>4G&0=Y<JLVDD(,B]IYU'ITK\;+B
MWJA7G[HYHR9OF0YU2@<%]O(@;M9+Y419"70XP#^*]3[,FINK-R(@K*P2T4_5
MGKO A7 ONK(?&<Z;TC*=N5?KV#L48\.(GSKI0C$'K:T<FKNY5ER12HNL-B&M
MK&O\[?8IFG"=<BHR2FW("5GO#M,212IE>"FQ%_YZ<0J39T$ :RY#JD:K-Y"'
M,B70MY:MI,9/H-%;H0KSWY6BO#(>Y8QV>\>/!/C:& X734_F&&/BYWT8KK,S
M\Q1EL_;PB:"O%3Y.;4*UTZO=+1][(E<QPWM4SR$W$N9+-SSG38C?8VDY-I!R
M_>/S^WR>$<X]R=?^E$N""RJ$Y78!.0G^'SFLL!JZ O0,9"0N2,9K2B[]1&+S
MNJC=8)X;N6_[3#Q=D 75LU/)OTUO(<U 6DJ!;$Q5X4LJ"4W1]2UY?[1Q:]29
MTJ<!M;4V;1)5>MJPLM+(?(]R^0I-;D+AJ4XFX2[6#Q*1?P' "E<I@B'Q-F\N
MS5U7@YV0UO:?C)P1RA?#2R@GFNGOML@AMH4$28A350]O0\\"$!/[B-18T;)P
MN"UYTSM?78,H[=BG\^-9>'^S3>O\6<XE2H\F_XA.FT03XZ+G<N<B6WOH.5O6
M4+B/Z\%7CZOU+$<F%:_UA&C[6;OFIJR G\&LY(QBGX%,'6R22!I7A9^V#)H5
M3;<4; 5DRX97^/I%OI0F H&G4M+-#E\RN3(.*"Z+[3<\4#*TVSQ:J?++.!_H
M>)J%A6:P-[]SJ5*KO8^5&GG+>WB/NCC^L0N]^8-IN5(5#=%/G)-,RB*3F::G
M#_2(["BYD1P#T%@3ZP57CEE+4HI"!*^K718(-0"3_OW3V#>XFXTS9\[ZUZB.
MCR(+A?/=?*X,^=-K$J]<2V4@8K1+ _I;2KDF*CH="Z>^?R8Z1T=OLYFNA7-\
M%*&;M/9BX/S(UD]&,KA['\H!'X?;$H>]=;VK/)PY!V_Z:0RA.\K3.^#BV9Z)
M?,?N0,X ,OYS[_Z1-K1>2H/E??=:YV).*B\C1%+VWB@;G<]&5NM47<4-HVOB
M."=)%#?BYCMQ1GA/9%MFF\AYO\+/!(2_U>?:EW2*6EX[HJT_)T;(-DG;.5[?
M?G$N*/JH*B=/5?5)#4(5")F5OS.[9,?YWZUDI=,H;A?3@$IN<&^=5%DB5_=,
MF:%#E#F/?3.LU<DFAQK8:4'1-:4!2CZM6 S92*_IDHUL4G\<EE$285.\6-6T
M\?>Q&K"@,_\J5*K55"D[]QP;YE*? FVWI8+  5(I,X<VS=9<L*"XVY*\-@'W
MKJ?PIO;(#<V4.9NIY7/8)[V'5VDMMNXME85!6&O'ZHW'$U A<[O5S(.-O*,S
MW8 N\HX.M7V=G7A^EN'?!?GIBOQ@*;QH,/0/1#*)GI>85L!?^]@TLVF.4 5U
M.M'I,CE\D]Z=C/HE*]*2=2O^Y:T"E2<8*6<7]6CE@.1(U6,\X^ E1>Y?3=WK
M>931!_S7:S_L=\W;O*#$M;P\&6\R5\*>#=6L/6'CGK8ZHN=^E70V5K4)!);M
MU:QX^,N=D!?:%O(!C_H?03L34O[ V@?E+6=G('I2%PQ),GE$^]MN0R6OOHU?
M>PS[5$5>EUM#\9;X/=-\!]V7(Y$K*ZJ#MHS5TDF0D%*5-/_+0L+RD-+H9/-\
M,YR'K:>^2?MM&@A[3.P8S=$/=-MDR*$REL<?M NW^@O0S3A4U )]TRK\9''V
M8\7E?5&-ST+$4C*1L:IG*F)-AFQL0BW[IMD__NZ'ON/BDEZ:$&M;VT_7SQFJ
MH_M8[9ZZ=_32S2&+[IULW5^7KB3-J$E7"-^D'-<#5I$,R4=V?IWR% ,7==0I
M_P)>"V7G7QPNDI)E3FLU5E6Z\41IY":Z#9>)K';SZ--0S"!.[-91&0\(+WXX
MV$A@6HS '<FL51(LY( /!<GR;N5*+#6R2E]2R)NP2KJ^#%FX<PB334AB$N%A
M.#*B17*8;0U_'1.>A(UHM.?=];D[X6**LB=&ZB:L2E)[/M24EL"\G!$[KJL3
M LQ^R4_O7?</6]=H/EZO)?8FY1XS?6.[3.^;XC)STE<B(?K^"X5F\1.-MD_"
MP2T ^.W;V94IB8G[[ U;1V]EZR;G,6R._S<GZ;Z\QQBO<,5,1,'\,N+Y!D&!
MS^2 FJ?4*[Q +@VQGBT'W=U1X+R##E_1JN96L@&I_^C7:"^UAK'^/#"0/]9P
M1]]3)TVI?VCM  /98AT&XA-*W3'?FA"]:PO$IB5K0'Y9EKBMB?A\B8+E^QN-
MH\=3H)*U<@UB_QTQ4!;W67O7[RF9(IXNC6AE5G]X+_8QTG?IJ <?[5MT$WZ&
MH;DBNMJ2,<1IA]W%7G+&UAL56I&LM"6YG45UKM*]N=HPQ:RXTY\H:+=OQ=_2
M"*3],476?H0MP3_GY./L>"#K>6IT,.T'^>UP($OIF(PPU_0@CSQT/8/MY<]G
M+;J7HZ:>@N>9;^?FZ.^P:;](_@5$<'!1@)PL^!VU-E-6=@40 IPI1#!9RZL3
M+9-J">-<\W1(9A9+WT*62);8KV@S4Y&#Z:!I9XEU)>K-4H_PGH;VT(<,Y<^C
M1TF](@L(:L\70SG'ZERM'#=W,)=M8WNLF;D7V'(T5.25P5X\['N":NJQ:EK)
M/:[=[OCIUEK-9 B9M)/J4]I18G^*ZR5!?-T5W;OCH%OD^K^ .L^_@%D%OUO$
M;?F-D(->RK_;P040SC5=#*V+M$BGO:*^K4YVU!:U9^TXF+:58BN?9]KI,."?
M<'7*F#-% 5H1J+#CMDF)/<+WSV,JZ>R:I4:4&\(4E>;A<^_KV[2.E8',#]PC
MH>K0Z9_%,UD!\ G1K-8O)>NJ0@L\W<8\'>T(S2#_=-(U3L)429_!+9;>94AW
M^5<0=UPJ0>NS>W';<I>ENJSI93GHK1=L3M*U^D2G2IT_:\[HPS="HO92=@XR
M;O$FFMT$?,V6II:EYKB,]M9V%G/YT9C.[;WROP"3'-:M%-9<D)(\6HI!G"]G
MR:^2+X []%;_I>:$C@4$6,(V@=2N(Y+L#@,[%X%W1%.Q(=.5$7V2,3Y^>#FB
M.S\PJ08NM_]$$(6.!1RR_Q1)6>Z(DZG3I9!C<CK76NB=W\O2X4++GQ=%//\U
MS.E%\+-W$*<VEYWB_B4%VTV5RHA+&C5O]/EVRJDV)>[TMZ/UVD=@1M5DQOK\
MJ1)I_;KR_%>16J#P&P4/(P/MA"\;IT]$/ZP'2,6=(L!?PE 2NQ)W9XZ,E;9\
M@/JE/'@"7/HM_-V"50(BV[]"I<3@X(XU2H@X_Q^;N^]7H1R\O'<=FELS.['J
M]S0JVF4U,W[7K$6=F9&6F1BL!AR\?1%;XKO=+]7IQ[XM0G:'59CSD/[:O?U6
M]+I791*IN!0[7/PI=J\$4O(S(< 70_?5QUTXX4-ND]H$\;E5#)4',I!-BMVM
M@3 %5@$/*C55;+0T'!/81EH,^[&@YN1X"6X+?=S0M!&)'VL'Q/O1_IIWI1C7
M5OCMK,COZP?1N;CX!=-"^T9Q2NYSZD2T.*3ZO6%4]KTPAPVG-_T><$2X*[U9
MBGQ*7I?W<G,[=U<1MWE[5%RW3;NS)RZ3U(=LLHW4QK1"@8B$?%7F*F\19J3W
M 1%<$+^KB(6Y3]<M=E\]1T.8FCV;"HKL#QB*M4NZ>E\2B+#_Z@06<$_#%NWT
MCJ,MY8EU:F1=&7Z*"WG6NQ.J5:T$.LW^UIHH3&MJQF0I<6(FD_ XS*#Q. &)
MC)8]/]@16]K*@>E%V6A.BK]B"23 JK_IJKZJAE*VQY+&-T;^$:&)VLG*RBJ>
M&>QC&8<5F\4^GKWS$R)//LA3>YOVZI</Q4/-7G$3L'""S)'6UY-&D<-B.FK<
M5BQI<L<[_V/6^N/J>8*&1;@J2:S$#.M.L2_=?HKI=;&4[*7C:E5"B\>)&8^U
M.N^<9> -AAZ7?SP.Y9WY4>Q$6OB_Z1D9+-9+<.R/'N>6-WW1MF6<^&QW8"YY
M/U,!MQ2E46<"RB(.N#\2_ 5@1)R_-)KU[-]4DMZ@[H N5^&!Y=+12TMIFS#[
M(5K.I1:JJR9<>==VF0,FJ@\(Z%G(C,GR:U7=J@@T#@?=AA[8K7[+<NVZLWU"
MFK(L*ZE8WTPYB;JW<*ZTDJ>5)*8M7T18X%4.;72@@JDW^N573W6_\FY21A\W
M 9$DP-E"X7WQ.^J7DBDI=+- /.PXH"5L=_R,UL;]+BRO=[I(^W"1:]9MB^/T
M)6A5&,B0A9#'_OCX,^10\$ES.?Q2G!3:Q%D8B;9!NZL\(&A-%R&1JW=2T>91
M<KT_OD6SQ&1V\B'N9[F,XNNPKK,I#L41&C#P,ZADPL^5^[&!(MSYJZ+LDW3S
M,[QP@86T!5$V:B,K.;5R<#8+6_(1*">',QN%_EK_.!L1/1IAHJ#C+NY_ TI9
MI$(L71]F0X6WE_9ZAO/?RZL*?O@ 7$=W=^90.4L;+ODZHR-E:-*^K+,)*=1)
M$O1SZT9?UP32<"F/I,HK*&HMD;$V7?_NE)ZHO+)6DTQA"K\=*2!_3KRM!,4L
M97O;!F(/UCNL)/*TYB>+CF*/^H1L9%&#90WPM-7S^JZ/-./4KS>8I1V,>6EN
MV/?MJ0,2_?>J;XSN3NO\1T#5*9W"9WA%9$Q_GO^I:05#NY0BUTR;*U(*]3U=
M)Z, -U=;7?/S(XWS+=&\7JH3?P'BBN^_X'1I67M)ZR4P80RSMB97!N9K)%XH
MFSN,HDOQ;S 6#L_(8R[H^%-Z;S&U]?3^9)ZKP>>@<E]#KY]2*YCO"#]I/W=P
M E&NJI<C1G$$AMJH>J/S %=9GY\4^0\A1V]^I_)F.XU1D_&XD3O>C@*8\8ZN
MX3EIL.@E546H &+,2V*"*QXTID^.<@T74;)EAE<6-;9FEZB%3+IO?JPI\=2T
M&$XQ9'4$G33DV3@&?SA4U X%C:'\XFA2\0"M87TH959D2+M$GUW,)6&B8-+4
M:&A;02"VS*B,T[_Y83R;TFGZTRY+KJFF'WN:3%)2DQK\DRFU4"T[/Q8OE_&<
MVQ-O -7E-40\5#VHT!N3>S_(XW\F^LTYMX#9_*Q\?L7:V V[%) <?4&93UUR
M\A)W'![Q*/T^5!0'/-_.V]VZ$Q@/OD2*,NOI>ZRA]IL1T.NX]R<\,Z>-,]H(
ML*J=\."W=XFOD'+'_^!;%7[1D<-YZ\@4]W6.::$E!KZE9145C#E ^YO+EJNX
M$J0B*AT_]_@78&V43F[!P"?5&OL/C1-Y)A;_%QYKH1/9EYD-[*E#7ASZUZ<:
MK%S>MZ)+ONAW."1KF# K[99WM,VM.XO&<GQI#3WIHK\?TA-*;=#;T)F]3215
M<G;=!9ILO4M+5TAB[S,<D7)NI2R>'UB$F@Z#DDP%F;7) KMK_/[H/4K8LXR[
MGJVS/.08M*THJ)HI%D1L5Z/1<3Q5Q->>>VA7Y+</75]4N@KJ@5.&EY7!!QOI
MB%?R]@TDNIM&PU7-R5/M1";;.="Q(>FCHN]23+4WJL:G+[;=#9N7/?.[RJ7;
M?VZ4R2U__!-XT[F[,ZRTY\W 'L:^!S.#K7XQ$PNIT-:Y\3H/0]:"6B^#BCVJ
MW+<Q7E*B:AWBK/DV-Q@$5@&E;I]?>RP44B_*OHWYK!V75S/2V=+5W.RJ.'VL
MZ?IF3"@I_K7_SI#$9BZ6]N%3_&B='LNDK@)U'&<\;CN0!!Z=!3%DN"OKR,(P
MX6]B0&:3P3?A)=3 N'J(OO_-U9=RDC%? U79L>(N$:J1OAF!+F3U2]]?>KSQ
M]Q'+6'C 5BY("3!4+OU9^ROHI=J,2J+89%W@,HI*,N5=UVNU;X+C.9S;1WEK
M4[@L#0D*Q)=V'1&Y._R-:>[X8DSK<5^CU*6-:W4WOA)U)VQO-P)=4]M-'ZFA
MIOKI97Z^%15ZC>(7UG]DVE8I?D_<_ 4@":?Y $]^*3^?LJ0/1HJ%J6B0!,3[
M&Q:7)GIU<67563J[.KP35(' ,!7-7\_W#):SM6>\@2QKTLQN4/%;?T?UF6+K
M( 3U8/"<0^R^>]C,CD:#$E3=]SW/KO3=;:7-\&4:&AJ7/#?,Y.ZM]B 63U%A
M"*P#=VAZQD@N<$R"H7.12*%8<'5P7I6\/V'MVQ/-CR*\<\8Z'DU1D1/7,E,G
MW9,SZJWWROQ)I5TW>0-99]X21,O#0JE2(U.\H*="B\+O&+Q@3^Z3Q_BV#TV=
MX$K@1%[QB=JX*SB#V9"P6I,I,(\%#89\1/.I1;0!FMA53?DX;TJ'D)O*[VRX
M5=J1MW+B,[ET&RIR6J&ES>/*=E3*D!_H3:P[ 8&H844Z':]2[6P7[**T@M,B
M99<>T6BN%U750R; 7YX,D-Q88>/*95%ONS8X4Y2.0&<=<U@7O(XT>%F4 P.'
M&SJ>(7>=PKAW7*D(6(ZNTT_J^1ZER8EU$;@7\&OLH1N]7Q@1^T_X1EXZ42Q"
MW]%D*IOL\;MSH]]N)-OB>(0H*OX6TN)>&50G6TF\V[9VI-PQ5E>U63<^.HW:
M\\0TT2/%@@"2%/KOAG467:*2:@#^;ORR=>SV\R+*(5$\T3&ZL!EZD:)]W/W5
MA2L_MV5G+%<JHW)(AR2=2H6$M%7!NH]2TH^JP0W?%(.\<5L0ILNXBE^X%T3"
MT,5L.:I:D7;):"J@*SI$2VY8"9L2M>]E%^Y<6%)QRVOC:'H&/?4V:'V:X5C=
M&.7);2=_UI"XZ;LO*;8OG"[:O4)$"(-8%EW6'9&-"PB:5?BP_%]+Y)MPFU:V
M$8\2;G&=55Q8KSD? NE$5$)6 QU%K?W8*/TIQ<T+2\=J*>Q;'6I*9-T^9+=Q
M[*'D%2<!2^Z5B-1'Y+M;YUP^,I5(EY>#5=J:^N4IJ-]F#D/S/C]=F?Z:AFS"
M/!&;)7Z>/I&[)Y>\Y,V9.*JA NI>X'2FY9+M/1N'597E."&1*^8I/[JTY2WM
MY[Z3?.AZV;(/(S3!_M.P[T))MD[L\+AH\F;_=OEDN>1A=JI); F<1N-L0!JW
MD2PAT$LH9:-:H(0W0D/)X\)HO#0]>4S\+K,3)CI(V?+852/TK*!JL.%2)0:@
M;;\R&3*F[$_?\R- F <V*H*7DMJ?Z^N^>:R$#7.NMPZG[=5&3'#PI,IU&O8X
M\*XU46ZG6U[I.)N_*=0$9VT>M-RR$ME)S8,H70T^WFG:V(+,?>SK?S%+=--J
M,OUF>/F'F21NT=M#ZBK^-)&U@L46>$&+O7]"G=DO/08\?>7!I;VI'\K=0Y$^
M$LSX7X%I[\$M2:$Z$&/KA%^M+E&0@H"%^MR,O?TT/Q3L'ND;\K,?,*@<"QPR
MRK.%<44JIZ8=3)["5Z ;@ =J*6QR"_*RA9),=?.W9.%O]L?S&?;.-T'5J2]S
M3/W,C^RM=VE$3O7:8+:1!PO1-NAB+_?"T]O+%3NY0 6*3RRS\ <)U6@XQ+C.
MAM%HAR<<U6NDD+&Y7 +BJ@'!UYV\\@S4U43];JR*?(3V&?K#?^6=A4C%/8D7
MBU5.IL[TA6"*S;'@*EYHQ3R7.J:!H' 6(C2.7L)8]'W^!TZC2@WMN13'0Z,'
M<A(;(XKI>;/^A/*P*2YC-+]:7:O'H\$L\ZKE946[UKAH/2NUNLJ'*175RC$2
MTMHQ81JM*51_Q>(DTRMO/>SZY"?H]ZROX',Q'@C,>,>A3&3+_&BS1>XN=8.X
M9F/Q3"<V8:UL/8<_VK7NPL1WFTJOIN1UP%'#E0*\8;J0K6KUE'Y9**@!1$V9
MGY(I)C B_%6&/L@7:WIZ%YJ]E*H +3MIG4-8?/]=F/;GP'6?*>PLEO+K,.%A
M:J-2PTDBU4D&_/6@*V$ZZCUYK8317>Y5Y?\CHSG@IT%K@EM./K75CFZTB[)/
M7WJGN92'7QCWR'@(=M?S>JI.#76WLBN9_+(/C/Z82XG=USZ@IB>?<DL5?8%Z
MQ;@U9RM_5,MWJ#=@Y$C:?2]SY$@#'?8P;K_M*N8UR+^<$,^/NI]((!"FPU'G
M>4ZD_>@BR(AR$9O.FE>6#!?FT@.>!0IJ=Z_3+QQ\^F3=7(&"R/NGA(!X&52B
M$<\Y_R'(]:HE775,X?N>\(P&S>NH\ "9#ANECWFH:EU[O@CWM2^6W38_I$J[
MTQK9!Z.;+@X[@<FYE<0;@0$9;2FWGHD?%+TY\5'C;TQ:,\KU@,0F4OYG6H0_
M-+9F1E,N_9A(;P<[<*CLI?SWUCM23)^4/L\?=>P[:6.U8HGCX.P37)A)%*]$
M-1VH&?1V)NSXVED+*3W9T!J>*,GJ.7')+WS$W&EI::,<^I7GM;_G^<GX9YC4
M[[.LDON&0_UJMJ+5C9O<67')Y8RGAHTM1*&1_F>.("W!LS-MD,AD0;9_GF ]
MME_XI($"/;L!:L"*;9:4;PN+,]F*4N_2^7;/W(5MQY::!\=^=<B*=#B![HPK
MGO*2Y[U-ZR?BI?TOEHM+0E,3W8'%\06G@>A[.H?);B2^J_<T2IJS'^FVUU@7
M7'<[T_ %W@BA\Q[1B<Y"C3R HW=['&W6 3NY!X>%.Q:M%JA$ZA(B!-[QT/6B
MVOTE V_Q0-/TN2OE"^R_ ";C$7>&&Z8^\X/YT<'!9EX?:XKI@)6"]!E_?E4=
M*H?EG>Z+\(YQ>[%OU+K^*"E.!TF-8!!AL_OY1G")1_*5RBZL6JL]'A3Q14;S
M$X90K9B$XE[>&X'5=S"].GFY68V5+L&Z-Z[;-C)W5*MZP>,R6)I_ 2;5DY$=
MFQE]I;Y5@6P$$Q3M,=E0G*,/+Y29)(Q<\Z!C?_/D75RNP1</BHMET9D,'46:
M$:<C:)IY%,X.>P\>_K )3VM< .6:49KA01N0/A#-4]='21US[+@-V$'J$RI1
MR62T9Z7M'8_'N=]%DY:EJ1V'D6<TZ\6-)B>2H_MN!9?1:4$EM9WSAZ+!OG6(
MYNBPD%O'[&J<F?FBZ0Q^M@_ZRZ& ZY8$'9RKI6&&>8>+R*$3%A=0->/L:M>Z
M@I.P/WG1?CG\%DOCT*,3T9<]\-*,MAS AD6%<Q!,9YJJP6;1%I80C1ONW#N]
MR !C>7L[%=8J'9I%5('PTQI+@"_U*[G<RE6$R+9;AL%^X7$4L\S0:)8)Z:\5
M&=7*#F((B-.E&>8\2<9 +$J4_ZM@-NCJ">U_E7=J$_E:!G&$PKR-7\D,D#I&
MJC\563#[G6[#N&?_Y:"3Q+4#18RI3+D VQ,PG,0=(HH[2(C^$?\OP*@ W3Y^
M%@T<*+=^^'@XSQ&FZ=HVI?;:\,/HKR$ 6 CI((@, AZMKT\ "4Z"4'KI?ON?
M#%2+3$^R<=M/,4WQ(L6RAOI.NC-L! <\U;:4E=>59'8JKK:WM 03ZJS2:E[O
MWVFL")32&@NHNJKL*:?3:70ZT,K>B;=]9VIA(YX\(#Y\CA%6U]59<BL17=%,
MEU3*K>J-4(DW&-(NIC$V<+@L#L5=(:)WRY7Q6&@1775*%"U<=#1G5Y84I>F-
M+LY[G,II9OCZ!YT"]V+*=HRE2NQ(U6!OMK?R- ^UK>>6:9ZYG4%>LB%%Y)ZQ
M:#Z@D4&E))-_@<99?9'7I?;^++K68/6Y<8 2\AF9?Z'BJ6;>Z:PCK&SY*-.W
MU,:"X)3]G)S[?&)83#(8:J:W<=!PLK-=JK9TG1FY=;&W6&8+$Z'K-* ^>IE/
M?]<LD [>S.MR=FHEY3FH>$8?YT_L;[?H/O=K_#@]$NTD#C^*?:BT]UV[).(@
M5L[W1%D@V<!6,'IP5$QCJ&Q##]:'7Y0M>K'?=V4'&\-+ *T221)!*E':WOPO
M$^%9D2.%/S14R3TGXM0%#N>= ]P_]C+*3/J>'BVN2,Z[FE'K$Z4NT;ZM\0TS
MN9$$+A[]'@=B);^GEXZB^=.R0LX.QY>+8!?+O$]L%(W@9>K, M4Q>BN_TB P
MPLG76%Q_JI4O9]<SD)+8D2>]CL2^W)"H>*0V9+&('B#STAD!5\<?/Q4$S9#]
M46R"'4E*,_MRO@MF3X%25R%>D<MQ]9CQX'N)M(J3-;:U@0,2Q ^,_2<Z9/=6
M-LZT/QV];4YKMJ4ZR^?=E9F<M)9(JRMW*HD--^10OUS_(V ?@AW__DGRG][(
MN^%C[1LYBZ;^%7:#P-;3D4E.=Z6=#>):#H^FI,Y0+N=*':I$:<D4YCZJJO-U
MSE2]/XQ,I-?43'P/(\3LS8YLF!(I,RQ#R1&$KN4Q?/!OK%7KQI^G%Y*/,5:D
MWUR75D8:;5UNCD_"GV+W0M^J#$F#J#/URO:G#?Z,NYT/12O;^MHR*NO[R:[^
M$88_="R7$B_-9;O,LR#D&'Y^&T"AGG.FFJYJ#8-89;$ETXH8H[R6)3^,,R5Q
M\QX![5P@[_WD/ Q(WSBB?SULX<P_HWVB=6!O':G/>Q[7J11>&*8%.YO"=D=R
M8TZ1R_O.5^FB4W5N[=MZ>*@Z"O]U)]S\OB3<)_5K4'F+GJ'VG,K+9VB),IFW
MD2=3[Y%>;J)LGX*I)<'OS9+4A;SF-DOM6MU3&AR"0L?M> )(3M W!;\KCR.6
MCD_)#/_IE9%"=AWVV53:C5CRJ)SW,VP25&FZC%Y]V]_YHDF;AD3;$<C0&'JD
M&>E'KA+#G"RW,4_J=2=RD[/M3;'7, 30#6DQ?H.#\^1<'MA=@E=PZ2 ]#4*L
MCM+:(R5*_V9'P?-<UK'V+]81!14B2MX<=-$!;:A>\2<,(BW:;-/V![^9X.T@
M=S!7E[46-\K;TH_/%#4],$):_-BNPS]V!@/P_E 0IKN8L@K46-IISZ.2NSA(
M2J"/PB.^%W.!X0*\AH,E,W=S7M3:DL&3K!F/2%^%$NJ1I'O3O;0[)=CEU$WO
MR@/<1$1^2GR>F=PH&=,U ZU>Q=OL%:C:_05 ,B2T?V::G;!^TL&52-6 B"H?
MNS9G6]N3@Z$?3NZ"D2SSS24,=%*)SXN])2RN0T3)*-,$NOFM/6\:<XI]-DZE
M..2*'$W[2?(5/;R3-6LTIHC53K#>!T,C:+C Q87JI9 #<'54#H5=X)!B'RP.
M]LV[U-JA8IB23%A,H6E#+23<1ZL:!?:CCS@CW/*H^%#.L;/8H3/-/Z$[SS@B
M<F?%]Q(73W*L8+!"A6/PY)?A#JZ2]DI1[SS]W47=X_A5^\<OIT&<XX(JDN74
M7.W5-,OI91BU>\VF4J7-,@PC0)+X P^.Z=E.Q'%R$EMFGO(8[5+(R.(0I7EV
MH9HPMBL#J6.C;3K&,[II3OZ!"8?H91:'B-]?0.)'>:'U$I%'%0((?&2=(EC
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M<\&VF'BFNA77,'2UL#I.R1K7ZMQEIN)8W/;>Y'6']?UC^:=#Q -I?#EMC$>
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MM>>**D?E;<2>+/T\Q'^6A$N2_+@.B]Z,%^?@W*F[."SZP6?AS)G>5]S37<7
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M=WMEH??8Z1#+EV$<H8M/+KHBBWJSONV4Q]N#5 QC0B^G$&(6NMV?<G _W+^
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M(]S0K0%?O-RGJ7H=RC*+OP;'!B\L6XF'DH<R/D?2D[BZ.OL>#'Y );$E^#!
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M&AX*YSENO/C:RWZQ*Z!/\N<+Q5*#2TN?A9"*,+%%CY!8@U-&5WKE.'HAL_#
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MF#4%M/TK*6T!>9A_5P'_O]/_ E!+ P04    "  ,@'M:1415]ZL8   ('P
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M[%HTG)757FB(S73%A[#7!]U$X%G8<(>)_CMQ_%<9E/@-^!^O_P)02P,$%
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M<40SIVLR((I$F5SH8S!:Q=%M2AUJ:?,"$,L(,7[N\X2.Y_$)6@4"U[NLUW:
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M-H-@K@WR=;B^O!;^,?1IQ[_ORJ& /T,C@TT;IGAI<)Q&%' R7!\F:C=0=P6
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M-YN^"5UV%2)BM\,9(I(HK=Z+L(P>CJW^77@:AO-M="%<=:CI+BGTCQ,'UCN
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M%Y-AJN[H,,1<X^7@ HB)+8J Z*8Y5Q4X_=*-^Q>OP%0\@D%(,(+KS'SEF M
M<5!_=]Q6VS+T#P8^V?14^9? WQA;#B09;#]V,]UY?(5GKZQJ2FM:/5$*^+^)
M:HLJ-&G"MZF7GZ\:" JM,B^=,S%<C!(BQ""YE)[2+*/?U?EGGE]\3.N[HY$V
M;>@8]]AQ2PJ$@GC@,*_I0GP#W:,Q.FF#/Q]LCQ #_&S-Z]UOVW:DHO+>?,G5
MWVJ%AQWGI1VTNN@XA-6X[C3O6]O-?G 8WZ?5E;*[,=,HIH_W)#_=<I_-9]B6
M.S4H7>HY^RKM.8?N)KAB4I+#8]8,[7MQMO5[8WC#B^R&1@PINM6LDIL@C# &
MZ(&NC7BA+N[8R:Z/6HOI.)&SQ@$8LT$DD<XR6BYV@)(]P1Z:"*H-Z$&PCM3K
M]#6EC<-&OM]S]VSSO99ML9TX.?\]C"79V6)1A*N<,X'&A[4CG%R&'4?#6%#K
MVI&&0PE'$E%+5?E)\QR?73&&S9E_W9<]HFQA_*_NA<A&3%-:9N3S:W76)Z.>
MNC +XMO%,GP\N\)NU1]=;K@X]+)(U#K]B4S,DVM#Z>FV;8$V>3?A#:SBS4.M
M^E./_SV0@+[^7XQ"_DG^G^3_2?Z_!7ES$)HO\H(;IZ@6^UNV_LK6JU&2;^WN
M_X0>L#$':?RSXY\=_Q_H$#9N,9?]9_GW"N(1F0W' 5H1J>29YR::;X*=.\&B
M&#D.'/90B4Y5U7' ]WBI<R3QZ><(G5$1\9 JO^&<OYJ:@YI&P%09R[ F;[A<
M0US^H7<:4*^*/QX"4.P+\M?+O"3H(@J8$X"*)?&&&PIQKF:N1,ZZY+=]/=**
MBTW[=+NOW:HK<WL26'[*PCNQ*)(Q;U>E9KV"'/'(4(_87H1^;<["/_1WDTIK
M0QB.M:MK-"Y;/@ #IW[,ML3T;Q[$2#EM.T1,1$B!MHVD%\](5AT04LWCF]Q3
MY+^E;^NJV>+"M0'BM\E\VAJV*!WM0PKD"B%UC#\:03$S$GZYCWV+E>9DX>NA
M\H S%:K<IE,<Q-_'T<_PJ?ZI-)USJF5YA8>P')EI&5[5T6HDY01%H@RD@Y5G
M;XCQO@"&FV#^P/1Q7@TT<" 5L0<K!VQS!0[\_:<8$,8/*B&6EGG_)5 @A#AU
M>)8MN\==RE<ML6 ^ZDJL!;N)@#D5( #M[9 .NO+9]5WQLS8'QM0I%O'";Q_^
M<Z:9%#L]OB:<_;1#) [A^\32, [MYUH8X)A[":XN8;-%R^;X[2*O%HISF47E
M[*+_24N)#S5RKU86(B[G*>4@AS:UW?O<&ZLZ-HRK<R%W"! !*"'/S!0WF,^5
M%H HZ1P9 2BC'D>%@=6@/S_Q17&,=T"B /2>QCW&RQ" KD,3H WZ^&H$<)HZ
MK?S)AYT6(-_R)$]]T.QP$"PBI-+5)D3F+_Y6MN5#.%A/+[?$I##S^%L/PY;+
M\A:7Q]<L $,&5(7_24T+.#^+NH=0P@5*RKC.3>L.8N38O3.(AWIFR@(0$J!3
M-LJ&?<=-[\Z"]P8,(P!+1G'.;H>I^9:^261$MKMATUJAM9J-^<9NY_@\*6^X
M'WD4<SAPPOS(6*_WW/=]15I#)08E^TP^?Y@4CTT*6[)WJ$@JL7XN6P0O,LC1
M^T2I1H5XF33<J6SJJ+4>FYKNJX#ZTOE[HH'Y6,BF.F;OV>>^_,/<\W;$2[DG
M=P^1N"JKG*E[OKS'V%VU>0_)TAT']V(?( N5%DV5-XVPG0+0%H6U[YSU+E5W
MA@A7G2Z.\R?=I_FN]^((*?G8,>AVG"^*%MTSO?]U$P?7R3*^3#@[TMOCZ0"O
MR[$RFM;[M*)JAS$.NU:3;1,:%IS> PT"?P8S>GM@DR6=2NMXKB&#>)]8TS^P
M^(VM/HOKIM-$&&LYQ8 /HZ3[S(G>XY,_Y;&:P*F9(!B0!8"[<8I<=T-R#%>!
M_=VQJ;6!G+1$=<[4\D6&'J(KQ[W#*%-] @<KWC3<<C%!6S%]4KJ9=4FA96Z*
M*B3PZA'O@J?]3CWPHASO.<8K](W+FJH)Y>V%1W'V5?$]\'>6NR>]WK\?;[T]
M2I/,T)GGK53F1(R-(3MF^0?1 $< LL"S;02@/3 JC \?_Z7)E<;QQ0[,PH C
MO13)AUY03E/7TBZ,;AO@PU&_P#:,?S;#PGEQ=E23D!5H:SHU;=YX>&%L;7G2
M\ZQIS]!)O8Q\M./%Q4,GP102:X"=W D&06^0:?XS*,KUD8-L<!<NV60\AJNS
MDU1N4Q4XMG&9Z%OL<7Y/4?G'[>OC >NW47FW#E\_ CYT$SHL '&5A2F*QK=-
M9]S$&_1I <CI;DKDM-8MA2V^6&5GYDT5QKPK5KOMM@I<4F;U>4]X&:/.U$NT
M^6.FNFK"RQ)3HP-=R!Y,58>5IY98N_:Q%_/G1(W?#K>V%X[?V3BQ<?5EDLZ?
MO<LQM>%G<'\-[M:I6J"I)8WKJ+OKUU4B6QP\*LWA\";WS8I0$ZKG]N+]S.,_
MP3>_?6S [L=U^H&$#J9NB90[._CHXLF)_.?7K\[N5_%7$0,(4LTM)5MOW41U
M.[[:^^%'!N_<9^VGB=[>B(5GF9*@I804I5_$.I<2)T,+S$<Q>6N/OE78#M.3
M!<SQ1(PQ@X>A59O;F/%'[?N/S!0\=>P2@/R^ODX-5O,XQ#EY<G1MZ$WY'B )
M\[A\7M]_ARCVO0#4%3D#W5!K$YI]7 0>]\?7DJN9MTT RE_HA +.Z @!*-.)
MFX+M%X"V^O->\ ^18JYS;(GWN&=* DQ(21COV7[XSK8A[F$&3W?27>+<VI?I
MS[HOE^$C!NT'I]Q^[U P>7#YE[KE07(RV8_^T$QRC.M>Z(4^ >]H9..[:]@6
MR^YUQ_1S(CE[%OJ(%SXM=G=_,+:%)ACTY:BZVT3<#RZL(3=&-)\#P!\=^>D>
M#NZZ!<_MV.^<^X*8-8HF+MG[6('C5&_DN7;T^PS=E^%SPRFGK'JE[)_<6CUL
M(R7FY.\@FI@"9471SUX&47Y\SMO7C5YD/YN6V1+SH6*F!J,9W_6;<6+W!7:S
MZWF9!*8)VGKTAY?40_:3H &%<XH/)=Q6M.P_''4@\>[\QTXI?8K_5@"J+THM
MV),1R@[M?A=I@-5.7[\]IR!_9_;-G$H>Q(9G/^F<8SVLP=ZPE4%,!CHW9H%L
M%&.TDDN-OO)2<8&[JE:",@'-V>/9O.^))7,U%AL7QE\N4VM,^>!8Q^'\L4,C
MIF=X-=(G/MLPE3VU1?E.TO@P^,3=0^B)UR3@P:F"L.R4"S7[NN?>]3P?$3K%
MA<YFIQ*#(K]9^/.,$>:WC_P'9O)%UK Y=<J\(?.'!4R48FV8KY2A9>V8,WNH
MO,<PP+GXF\BA\BM5.T?*'*_PZW ,4S:8)^DE*N2_E4+FUA;P90:V"$"?5F>(
M7)TVH3'U:?-ARFOZO-(LNQP+J$@XH_)-G\Q/,OL1VGC3N]JM?W6+STYAU!"%
MK<5-%S<>:QC)=BIJVWAR)3@R>*_)S3]YS+$@F^1DFU+_QI;ZYKRA>5J(KL.D
MI[LUVV,2)I.!+HD)F-[W,MPY]<+U\-V%>W0CA@B)MQMLOV,5G?N<7$=+K+[O
MR_2)6:O+?\=BP!9.2>A'#JX]<O)1;KEYR\&J >>@M;&5;89=T,7W5FK<8:_\
MA%-UB8?>U5F>R]2R992/N:CI5L\Y4,N=O-3"3_FXVI<M?GFMV<>K^H^)&\92
M$XZ\2Q: Y"P&Y^GKDP(0Q^D'CCKE(P#]?" ,#,SS[@+0<SYY:)PF "7=^@9=
MN5,'YIZ_1>=)1PE ,!@K]A^/$_IOCYS$Q 6LHC99 A!0;D2 "T ==.%B!7R-
M!;  =$%#4@"25J)S?ZSR,TNX#G@M :B@X:F0M'*\<!/IXQM1N!M@=AY:DH\G
M;1> &)X,.M_53BB0'_>$_5%L&%]N6E4 ^I:!D]FTK,#144*H:%<?U<1;$SI.
M)S#'V$4 VCAP% <\&A.B22AII0'*?'X*QE.M[!6F)U^,A5O((P\/;UX5@!XL
MO\&MG$%K"D!B2WL$H-_O"0#,5$0 .C\>@V-7LY<$(-T*@$@[X\[?Q/&U4PI&
MR4M-PHV6"D")+<+%!D5C!2!JO+#I% ]75"8 R3+>XWZR_*! /(.\<6B5GT><
M%/D'*3CB_JVD$%3^_RD,Q^#_*2!+KNT8E)]P"<P_9$C^,[# TX,!)7L<!"#+
MH&-"LL82P@UHDE96^'0#EH/-F%[_-*$<F=W^\CU;N5WS2MU(U05.''*_L=$)
M&"C;, QY$/)]?[CNBZ/]\]P989KH> ]Z_:ZQJC 4SA#M,?U'K^=Q06;WQ'A@
MTD*JY$!)MZG>HQ#52[JW'#[^KE3SU3VDW<*AM#D=&5W3KBNQ&KWR_=N/,$9_
MT.\JPG(Z-4^JY(W'W1X5.1M5TX]$<?\_J5:[>XK53EK-^MPC:>O(Z!H$75,_
M._KM>UA&5+E"4WU&]?LC+SL> 8]>)AT!_7<NI&\_^'O\V$U)7#L&^',/5!P-
MZ_;23NOK)BM/_S&%,*I"J:AKZ3\1DO(B[;;277\JAQ@%CZ\&/9;^,&A]4-_G
M%GG$T%:NN[MCZ6!D/CUEVI&DQGH]V>JC'Y+^\,>^D_-!\R<AB26=7VPS0PZ;
MRH:*?JOM-HS-C8A+055=#3FI&<4I\!S^ZI)EY_;DSW/9,Z/ZOD7:>>\+_8-^
MTVUHZ[8H4BBWC2\E27.><:8N;</X #[L669J'$><04ZXP768X5U;FEE*-JP(
M-O887N=ESM_5=&+W?\PMM00__=/8_C^H>^^HIK;X3S16!,1(+P*Q(2A"+!2%
MD%Q%18R BG0A5[E($W.]M @A49'0B8J"@A"1#D)$" B$1 CE6ND@(*2I=#E'
M!8ZD39R9M][\9N:]>?//K/58*XMU]DK.WOO;/I_/SCX[MSP1.V+TE98Q%%P=
M3:RQAC?9#L\@JZ,-@F4P+29&0!T]Q^G0PW?*@YWO,)LMU0>+#)%-3.:0<6[;
M\(0JS;X_4J=D(%*U<,8[(*_J6_+Z@MBP4B>5EG=W&U9<9+"@&<0/R749[.9!
M>51'D/_#9:0HPW1:VUY_AHE/?.1N-ES@HNPK"/<<7OH8XB:MQ<(]1C_?FRS$
MJA./V_S#W.:[I^94*;,I?[_M1)KO8-[XM\PF9W#$+HSK*BZ?EZH3?1@IA\SD
M__TH)H49.\]#8<+%7]O/).E4WU;6/+/^ZVO4C_=Q1B)K\07)"_9?\UB!83G@
MRE].MRAGF4*[60;$(PPP< ZL("R?!HUO%3.MEVW6?<@3T#>$:/6,XBX@H(=;
M E*P4T?'/M7=W2XWQFG\O(&]E$S' +O(4G/J?WO1T"'9.8&!>RAF\%#K#RKC
M'KAS!.'E'H4>]_ZN1 2?JL::N&05[3B'ZHUZO,,H>&</R'SSX;YWG'YU7?18
M=J,TW'"SI$8&PR-6S_C)C2R#K:]SVM$FM04&LV]+MXI-^]F7WFN[0+;@&FP?
M0W'126^V$Z&RE[D*3F%058,:&M3J'PBB&53?VGK,16Q_T-H=O75PR&19K/$=
MKA_LMQ5,:&B7P;2AW2A78,%[6*KA*#H\,B+&,'M8^DZE784$'XZA-IF2[0V_
M.6=6UZQ5VS?&:8HK77+Z-%\QN@=GDL7N210YG)'!:+/=8D7:[^VB__&2;DC/
MN&YTW=F-N9<_DUGNY)KG*"Q[4YGF=JBC@KH]/$U0?NYLN>Z>N^>#C':6NWZF
M51U?. K'AJP$2[A&R^9R&F*Q,.8B<.C"C2&6LB":Z,@L9C7:!+J$T)\-BWP"
MN2,2_':H08$<\$2J?R$N),8ZWN(^J"E6RWU4;2DY.N%T;KG;\YOYSHP)39=I
MLE2E!!A.%A\4H4@#2Q,F #N9:18>"2ZTJ8_Z$&B<IN%$\ZOS_?P']_'7@O%5
MGA_?1UZ]%Z_>O=I1[=3&*_S.4>E]=ETD_)>4*8.]>B0'LJ9;7I./*?G!EP/6
M[LYRN%-FO'/UEZ2UW_\06@I ?%IE\DN;"ULH_--HIYMI!]YXQM2%Q[QD5YYY
M,\N?/5NL=_!MF<WC7D[GXPIG-KJZZ/'7\:\EQOFT%^<'/)H>%(W?]PXM:8[^
ML5W.S$'U^Z:@@E19+G$-?W-M212X(+U9,/QM]0[;M<<#H_AN1RY?6G4(]E?F
M#6?8/"Y1!@.\R-"RA$:>;:"2?ZIL8FNO')7!7A<(N*("&6S6X3Y"KB?L<;].
MRI6.A% H@WE.;,58LS:2^JS8:]";Q=X _39S1V@9\2Q$+X-"G5K Z)2(EC7M
M+)5^M&'003M)=R*&KSDH:'3"GAE<M Z^:L2L#SW)_QZ0W/?U@PKW3X@J55(
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M22Q8L+?V?&*P*([41E-C;2:>H0D\.''X+L.UD#)0R<$I7"$AY002C/"S:FX
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MPV]&4/,UH$90NY5D.$!$\--)6W ;9[R?$E+/]=!1^_E(-4^GRHX@BX^,1SM
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MU#@74;GUTDE)*D^A"[%>O!_PX$@47*FMW[O)(*W=@Z;Y!-3F2&P[,G%$DV;
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MG$@ NH_G\A<2]S*CP=6O_VQPVC[<[M&/+N3C-@;'$/M]H:B92;]!? ?CIU5
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M@/.QH3ZS09&S+;N^?B[--^[ Q?\33-,E[AR5P1*8QORRR2'4?MY[>P=@KI;
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M!<2(26/=&X8E^"-@[M)/,ASF63GK42M@<>L6C5>ZHI9;)FL$4@IUMY3J=].
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M@Y\:RO\)7$,X&X@,G_E<Y%0^XQ\L> 18J=D+8OFD11HRB!5,7L/49SHS,31
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MY$K#"?<)9(&8B*;%HT"+9,OSE=+>19^ZSXJ?]B-^GE6N]Q5= #J?4#&)4&L
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MMW2Q_T$+CW]40/5UV/\2#/X3 H@5*%UJ/V:Y"QJ*Y"Y6?5V$]+N> CHNH<5
M-*SF#17\P3;I0]8-N_T8Y: !+(73#]VP0?L/G4]O^7EB%!/P(;;9]5SX.:FZ
M#<FF+/=-4'S[:<:Y"U7.R87? QODZ.!7TNK)4X]WD%\57-)[R-7S].,>K-[9
MMB;-]J#IT+4_;D;T^V24/^G_*2-BS_D1GXS[^=[^XY43-<Q WD]K_VU9<_'\
M)VI9N2RL:LG7:IK_=PZ]KU9ZU<PC^_#"#]@_+3"/L?(4C"EGU@H^17Q(WJ9
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M6IFFRT"ML;0&NM')#[R@S1 V?7-N.W^V)C>D8L+\&!147A5Q+SJJ/M!Q4WW
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M:3^BK]23ALVD$%P&K1KA$DWPH>@LG 'L*D8KE91@IRTEC Q3(_E=G%X$$?,
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MM7%6L]=P16%)2I-2CHGIR< *"@'\O/\XQ4S3.3%_,%]:^Q]G0_]'#,9E3C@
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MR/P@7.>8#8ZT/8[<=AQV'\(;COO:O;;_9D)RH'<]26O<9SBL[T6$($CF :N
M3'%/%E55Y@&]S"R/"+*5Y[$B*RE[8#P0RIAH.M:8**Z.:3.D77'8\M:'\*AP
M"V%5@+>HX(BTVUY^>E?Z_NB-7A\D!MO,Z&?O*Q.C60QLAI'I-A\'#=I(R7F<
M5H[.1.%*V "D=P)+D-5\(L4'FN+3$F5Z$D;*CQ2_089U[/7*!P\0AW[JNI$
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M3WP<.U'S\>QM]LW[:?_2[O+_]:$8_B]02P,$%     @ #(![6AX,6R0!.P
MC%0  !,   !I;6<R-#<R,3$U,CA?,CDN:G!G[;QU7!U;FBZ\\00-!'?9P2%8
M<'="T. 2W)V-$]P=-L'=(;A#L!#<W=W=W3]R^IRYI\_I^:9G;D_?OK\[M?^H
M9>^SGO>I5;766ZO@:?II&?#JO:B$* #B^:?]_ ,\/0*(/H@("!,K&.@96UJ9
M6QF9&("()2SUZ(F5&.D9& %/<P!?P M86#A8F!=P<'#P+U_ (V$B(R$B(N&]
M1G^%28Q/2D*$3T1(1LE,0T;.0$Y(1,M#Q_".E8.3@Y2&3XB778B9G8,-XB4\
M/!("$BXR,BX;D C(]I\^GMHA,@$ "!B(7P[ KP<$)!0T#"S<BY?P"!  *(C?
MCC]5O@) 0D!!04)#P<! 0S_7N#W7 :!18=!(& 5@7\OIP)':H#-Y166\(!,L
M;\60'SD&,NO:>K^$Q\3"QL%]0TY!247-\HZ5C9V#4TA81%1,7.+]1P5%)645
M534]?0-#(V,34Y"=O8.CD[.+CZ^??T!@4# X^DM,;%Q\0F)F5G9.;EY^P=>*
MRJKJFMJZ^F\_VMH[.KNZ>WI'Q\8G)J>F9V975M?6-S:WMG=V3T[/SB\NKZYO
M;E&?*4-"0T-!P_VD# 'I^-,?5&@8$D98- $Y.!V;UZ1,7B_0!:,RREM?DC'+
M'V/HVH[ 8P)95MZ<_&3]"^F_C[/W?XGTOW'^-\I/WP&H+P!3$*-0$,_L42&@
M4"&>9@&(4!#/&2A4 !_@<L#]5I---'$7D"M,$S;310MGVH8J-Y:['E[TAG*R
M*(,N_.WC:ZF/=Y&/4D^ #N68B]UFK:G^*[Y*RIM'HG6BXT33M/F 4ZM'ZHA2
MQ=/'9IV'!+&AXR< \1/ =TSA<9TOVN-$P<VE-.[B#&6_E]<CX ;NGCPQ[XKD
M/ND)$)RU-_&YI33>PU#N[)ZOFV^%98*O'F5]Z5Z1Z%/AQL/GMCNFB+251X$G
MP,O<@H=N#_(GP&K^[876V[U-HIDOGY\ **<HUU+O9 Z%;MB> !AB4U]O/+08
M'ONSMJX](CU^F'SUL"7J:;G^RMNDW'=[$W!I0,37=N_S.W?D_N+-_SCS_Y(S
MJ7Q8NU(FW'XZ\W[\*PU;2[/%>J;L-4)]^04YI9^6UO_*IU\)QOW:'8E,:+4!
MH,H&("JJ6/]@\N#P=>?&N\^8)^D95N9W_DK^23U.Z+]F+_0+G'JG6I6YXEJ0
MB@/U]R< IQ6>HO'4YIO889?<GPJ^_IT>\G\1E^]?_4KQ\N&8FH/!9?>%46TN
M7GM'4GJFJON2?<:YM<_DC'Y'.^<O9J7_Z@[]7W@?A5?^N,V^K4D 7D$(%>7
MSJ]AP]7S5N_H4/<6X>?,GYR,DPEFAG)Y)-1JBKT,6'T"W&!:-A<\ 3+@USL]
M8)X FM+W#0^;?'S=9]3',E_A 92 =$C/O_>$P/ $Z.;<>UA_K+:Y)NKNU&J/
MZ%\H:U(GP),&2_:D1PQ%5MGDKE#".'%'G)I5I(C VUC,*9]-+Q=*C!>S9"95
M+.5N9D^2R5=5-80/8OE9=(Y;=%FJ'&>(#_*]WX[A,\$ 5I7WX#9WVOI$-]TW
MV-?-/<"/CB2KF)@Y;&H7A9'@H>?S@+IX!JCCG<26PRX(\!4EYF9EXJ3G&IX
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MXS7\WV+LG&GT6.#V7E&1A/1HYO0=ZH3"WKCO$27A0[KBPH!L(W_\020Z]2=
M(9]:E1%/CTFD&-MMEL2^@B-'F'*;M1D;J&F,B2J<!#&*0U77CLG ZR"*G*>5
M>#Q1I9L7>Z+(OK PA646B=>D@HY[RQ,:\[@]C[+1@I&M;]C_ M*S'";-U][5
M WEN!TW"5-CA%?]H]B'R-4$"^UQO#3^W-ZP8CS$" 7V4D2.4IH;F7"OB:0R$
M7CW8_&LX&[/7H,0V'R?L1TZEJDHAID6R(3+1L6Y]ZE=P?=2Y+PRHWX>N$;B
MC5&'1['_YMKA3R=D(KLQ*-R]#]&R)QC%'=WDG9U\3.A "^<>,ANB?<HUOB7>
M+Q!^.=?*2N5)DMZJ%KA#PFA)Y$I63+K=W=X"$7&FY3TPM?B$G+(T6*(II9*K
M>O:.9GGSJB*,X)G94]GC,#]1LM/+P_7U];3XLUG/\40D&M4 ><D$^K6X 97^
M=D:I4((0&%E> VI!3_'.^0O@,)R0N,X?Q@,R6_NGUW7C[T(*][@T6;<.)LV,
M&)JA;[@D7^UX.KJ=Q=R _-8_OA:V<0*U*Z62C!V&+:0<-#5^#:%=Z1\1))O]
M#@HMQZ'  88> P"JH9/W1&[YBZ9H';")78K>E%N);AT'!*)L':?W\]KARC "
M/=L X^FFL7=!!FR,0WC=.&#VQLT@>9YLJD5T<$=-^1I!P^?O>",T1905O%?P
M4*R,T?.CV+M_N+&JK1Z+'DQ'DJ_>Y K K*'7&'[TZ3HKB T<36PLTFTNP#=H
M6Q#,9?JZ7!&64R?KQAP5H=:[O[,1A&<6&^PUF&%5==2ZV+@_>.]RT#J4RY&Y
MSZ$KR9M=D\G,O8,=U6[2  4B]'1-I&^+I;1C6S+V(_?7!U/@*']XU3:.*C)M
M*VPQF$?P!=:L,#\]\!5"KZ+"Z^_K(P[XY<+>!WT8:%3:$&10[#PHV\8-R.+A
M=\(MBT21F?N?HU"J)!]6;N#IV\ DET$>C<]3]C,2[\C;JX!URN>6 ;-O'H_O
M_;!T>E[]9L-!2F0<=]=VBJX9 !0Z0'M>V;@+AI2M![IE:AVA=,LYX/_+8'(8
M1??I-=3M4RU$=Y>P_0H;,Z/Q.[ W,@<-6C62AN\0K*J%&]8#^C6WFW-<O(Y$
MINOURJ[?&5NF2QP<$2=2<"FN&1A0#/_4N;W\-P(W_SC6J"+M=5;Q=N?HFB%1
M&);5(:Y$- =Q9>HWI15\[R;8:M.'/AX\FW9@NO]J2_3[#H.4Z$QG]6,R6VJC
M="W &/8D>.RMY[SCFB&Q;TI_)=#UWZVUL0H7-Z+*^N'Y)48VP<B XIN?D^4?
MHE*4UP(N<<#9V<834\P#(Y(P6]UHCF"A[2S0^N5JA=B'$D-5D[C73@XWAF/Z
MM=_*Q[1D LV!57X246N#CC0I\=Q;1&INPK%^#TJSC[./E.9A^[$#(.-^R<9X
MF'F),_Q(5K\A;OLUELB%R2ZNS(&"'7?"X8/PM/P;S,E<A/BE T:,.@B;*[GX
M$HA6K6C@6;(B$\:HF!Y!T:F3Z8!]?.+A+7'>E;X_$]$7_'SLY5-KP%:UC"82
MIRDNE!3ZE1)HICL"H'@VQZ4/Q0[_XKO<-!6W?9L1V8M+-A/T__ Y^X? K6=W
MUKCYY%TRZZ.=+AK]D2:Y30P.:B>LS1D3V&G;US&W2KC:02C3C--O*O"MNFQU
M4ZV2SV>E =1V\9>=-A-#P+5IQ#6@&;_4TD<,%N>WW,*%KGK6(P\5.WG59J*G
ML13*FJN?/W=\>1CH.EHSGF4XRF"=^ICAMTA@N\0IU1HL" S:=-0C%!VU\8<H
MGP(A4@% =?(T!>/RM+]_CF&XL(W=#I-;?Z(<*S$X0=J?(C(W<PWCL=CO:,JO
MTV(&Q2G!B,NZ?SC\D6SK+A>LCOHFO\:1LSBW_+))O(.62:/58GU.2R+)T7@8
MXS2@F]^MWQ94M55+3)-7P!;X;JY]BJ5*4E,00:0^S)%6'\%?6P*;P!/.9SRZ
MJQ?I)93E=NHAW_Y=58./<*R3IX+XS$+*)9HR@C\47OCPG!@07(<>4"M4DJWR
M!Y%A4Y.> (0'CU?G&$6L'&:?17HKT?"RERS[DNT*P-_HD4?KTR[EG@ \?.^'
MONQ<I@K\FN$0FG6&FQ&[/W^@W$ Q62<R(#H;.\_ZPI,7Z?;%8TAF-%SV__6V
M*^;0YFRW#GF],KP-J @O)D6C' +,8;63D^T&Z.7.;A NT<^X^\.NYQJLV,\'
M\#.&UKGVLQY=W+_81OQ3F%)6 XC2:G/P,[=.7_^OCM$'O?((Q$U%!^<.5AQ"
MTD@^#S.&6NX%T]+;NTZ7DZ>AYR!Z:>E9:G8CC^WR(/TD+?$;NM@!M\^O. %5
MIR@5$3<[MW*]A&/=O+U\6WD[8I2N,L1WE,\!1%H.?L8_HFV3 5'<2XVMS:'W
MH]3=6_F'?1BB^K]%&*&3W)+T7JOD9LNP_G199P90Y"]5YZEX+FL6ZO<=;J/E
M35QQ<+7"+2W>5M/(O,+.:'2=Q(P](A4M:R?QNZQ,1HQ@,2KH8>_&Q\2X2Y)S
M*K?GDM"2J(A=[@P=+8L"1,!\T=Y" H>*LG_?Z\YLJT?*"_(K"3.R=V4$.YM;
MZ),LD"DY0YURXJ?D$1NE?]_CUXB=ZHR]]?/65%'1D,;%(>]<U\QDH_P.=E-8
MPQG 1(A[MV! >T_%FH,TSYIJ_IXD==E/?%800[6R$T);9M2K-B,ARZG)\CR%
ME>&C_'B>,S&=Z;9>5.;=J26<L3R#*%\C+.=R633A(\^87MT=35Z4'6)25ETB
M>XVO;< FG;<$', HCSVS%>0A.:X]437]]D#BU%"SKR'_(&(PLL_N[UKF1HU?
M\ A<%+:9V=M;F>3<N%N'8V>'G;*5NRWQ0D9=O2"+'H+TPJOYYCNV6ULCKUJ%
M8!FXO;^< (6%\WV;5T;C;%@>Q_U/493<\# <0>D>9^%>K8M[ NWE3IYJSGR%
M"*1D4W+SA/;ZYW31&80S_%#4<)7XJY,O.9\>%P<YSM6=28/-TEB*0D>A2<#<
MMEG]'S:\]CQM>K3K)__FNEVM]@F@Y%YM/.@*'B,.M[H0JZ8HEYOOC^T<=4S(
M#:;ZO*ZRCBP$JPCT%%@KQ/511U\_OHQYLQ_7+-U7#SQ3TT^(N3)76/;Y/AOX
M8MLA-'3$NNS&3A)'5351NX\H5D6S&Z%$HHU@QC*OQ"5-#;)=ZSC,A%C-PB^J
M: 0-3CT ,3BX-XNK<F0:-,7];'G'AV*BA/I-7:!<4U\>L7\&C<-QU[6<XB2=
M5L6"J6>R1Q5"G1P)\B8 7C &.O3,4T;C]B*=UG"/DRI5I63?HMB@0;5Q\LQ2
MWS>ZTE!)N.>C)\2R-PQ#.7+$BK$%'<:1!@%_X^#IW.".%]"OU[*;%M8E[<.)
M2'O4<&<(OFGP##P#&^_:-=C6!-%!["KN#!V1B:^Q)3X=BNRN[R88\,_*6).9
MW#QWCE"0!,I2T9R78,EH_0)!G;T?0DS 1DG,A@\:MW9*IY5 3C"!S:*[96DQ
MCA&L-XLS($;CGU4W[I016/0L!_V"!(M#M*C5+PL1];!QWP'X3V4@O1G<#>X[
M()FM6*1X;S<.R45?<^MB&><9]Z4#_2RR]9&Z<"YX<SW+(8Z;@S6B3+_ZK3GX
M&>B\9H)Y\1ZJ*A+5U>/%.?HA)NLO?F4S=#^>/NIZ(D8<O=VD!/S7,[1SS^$R
M._'9]$06U:'4!^^FJWL7OI7[78/RG+=!^ U[2C9[)]L5S#GSD<X[,3<J^MX0
M%]B#/+P!V'.2*8[*Y8)MG2YT#SD;L_/8=,66[@.;0WYH-</?\SBTA1!=QBK1
MP 8-0VC;DPSJ [PYYH6V.<L/RP_;%UIRW5MYI#'Q\V!4;K$\^C2D@_X=,\3A
M#J:;$HB'92YEPD:B4LLO*AJ]4P1\@>?JZNPEFQ,6\HN**/C^<M6MVP)'P^?G
M+*H1":1N0G)2O-A:W;'+ ]3M09CS8!>W55CVBW2\<L&M#LQ8T1DKND-BUY"-
M<OA6Z1X<-F]Q7=:U.HK2R12__LBY)<R=2]R8B] H#>X:I1;3F"C8A7HB2F!H
M+?':<+AQ&0=PWTJ>\C]\*4/8LINV2[E-\8V)OE$H9\94;N<*ZPV%@P+1-UNO
MI,,":]9"PN^1TF+%F,CZ*4$L U92DR)])E,FMK&CSO*<1L;F4*W;3F1142)%
M+_/*,6-6>6C4$C++ZXRL4W4/@R+%$SK/:6$WAFRBA)1@@)?OC+'_YBM_"MD3
MS)B<Q3<Y&U,Q-# 45^:]7N'H#1"^T,<(J-$B7CVD9CQ&,BWC5G9WZE%T ^$C
MUEXRW>KL6]A\=N?<>HETVE)L.BP+5E(3FPW!/W:,S"2X"VI\_,SM!AD\$$?,
M($WVC649_N0WR_G2]97554MZL4YYG_HJO6)\S%'+VL@3 &7KYTO^S^)K]C(H
M H4+TE? K_&KKWI>8X I/I*K$,Z@1%B+%T67CZ^!<&5>:,[MR9LJ02Z9.W(M
M5Y]] IZ&-<JAQA#10&%A0VM'=3HY4L2I9^H?/^9IIVVSSIH]?(4-W@'&\I=7
M<C'J QEUXLP+.JTYY>MNU*9%AM\UF%DPS/59;*JKS[5QDSJ*Q.EVYZ'!S'/8
MDX5;"W1@"?0.+[S^X9CHUM!E-UFR!S/.^(V9\$U"-H$H?RO@U,4QHTS.>'B"
MQ:PP!4JZTA_/+*CX$[GQ9DQ6V&4H:AT-ZHUL_.QHI_-Q2L=!=1%;S:3L]V\^
M\WT6B"7;Y4F.(:;EBF]"6 ]]"L[7Z^I=0^N/-;_?O9_[Y+QIP2MIF+@KJ \6
MM2>)]QI#B/B.^+&N'GDT>_CO'UH<:6@JBZ8R9AC5Q8/:W[PU%W5?X-,&#S1)
MZB]#A7-ZBKQ+SRX1R35)W%?&+=14WRD7<:5U57JY4),N&S8!BSS1?<5^E24
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MIF@\UFX<T>H)WV0B:-^Q'^J;.:\H?L.\S$?-!F]\D*"T#F:"4![B@7W9:8T
MO]$0@;W#J-;%(B]CLRE\ZH51%5&NL%*[XO[AE0"23Z0;$B9">/4)K:VJNL8
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M8&T=9BF^=65MO)R6,0!T6L:Q#0L:'N:*W3\B::E6#T0P!Y;@O"\CCA2 BQ2
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M!-= <'=W*SS!G>#N'@A,WK>_KVVZ>_6:WZPUL^N?L_>S_9Y][EEWU<O"RP:
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M0*76_]*>>^E6TKZ]#EKR9(RD0B;D?A#F7>\+-H@+4EK-EJ?>EVVXKF'05:S
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M9'A=]F<O<GBN5,UO W9(%TR9$,5+2H9D;Q) %C3C,[ULWDOW _N:8W?.Q2\
MVQ-9E2,4G)(Z>4C4\B93W%DQ$N8+(-&#HUE-/C**66[4P:C::[?V$XGU4"I
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M,87Z^D1:*-=DTPIT68I%6G]?3DVIM[I&B5+VRP]=BXV#(Z<O\1TX.3M\XVA
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MIN(+B_'2#Z.';<TQMGB!92Q!FX@ <%[*NRW-:<^VENUD9$S^MG,T[$&0T5A
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MG#L9@NOM5WGY)DN!Y#05-5+?F$RS5OK;3FV'O/)L8Q*OF**"JI78$7!YUJ_
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M35Q&4;66) &@]OHK'S1R'J%-*L;S#L/?7W;<$(O^HK@]5145>&N*^BHJ;?\
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MMVD*K<>^]8U\T"93BUR*HD7** ZR2:(B(LN#]YI>[?93*-*7;I_8UH/C!\O
MW(<(\B(Q/ZR.%_36_"%DQL[;C\<$HE7U \:]C^*K9B\XZQ"Q:;9;(ZEEJ6+8
M(*)9UZG76+BI_P".=DQ2(B\5W\=?;SR7W+"ZA\J]DW?&BB62;"02\+_KX;P3
M&W82\;'VU\A_-#:INFO,/>-F#NL"9KM&!R,,UIHAZ@C@>RN1_6=5)"RGAO-
M!4%QS),,G&B;(OG##O*T2+P3JU*VW7VKKR+]=FQ''S.D^LULVF?)P9& L+2*
MDT0^U9+5Z?\ HYW@3X_4W2A/QP09B#^,A:*0CV-'?U5S9PA;?PER>@D7ELU&
M=P9:HFPHE=<R!:D)L/1&_EK(_J37D;R4WL=)>;FW9S'3#!O&.Y[!X4[>!)?T
M:)&O7IOS:VG^L_ECFX@&J6;:YU';^LB7QH_;K1:]7<ZJ)MI3@E:TLJ?46D2X
MC04,&RL$AC)CR8+1N$+02GX<MQ6%-4#SQ!%5$553[A2P.0R<.'+V5\A$D!LX
MKE'G7!9'.' /.'$^.VT"IM^3N)^1N-8-G<L3$B8]=9EB5MCL21D->PT5K&9K
MI=@)R&4;^8\L2[15=M\2Z,+JW!K5<5@P!7B*T._QAZKUR[ ^;*E?3-3<Q8CQ
M;G/ T_%IN1\OW_&%MQUEEOQ]EM7EL')V,*Q[,JG-J',,%19=7^&N5UO5O(R4
MR,\TV\#?>Y\+TZPY5@W%OHISSBSGZR]2L3D_'\BY*RO,8=5R!"DTUK1<>Y!P
M?;\-<-X+FE1A. 0CLJ7A[D8.2N)V\DKY%+W19U>04]F\^PC3D0 (.KMI2?LK
MT(D0I.0./8Q5-')G6#*QYSC8$XQ25LI/*E65HX**$;MCD7D,DOFR'>T0%1[B
M&>*,LP/YHJ)V%K=IKH!9,5J9%JW)++4Z6R\["@OOMA/EQ8:M!)D1HQF+\IN(
MCP><0"2-]Z=VVZ:R)%A<T>(G+C:M _,K8V-GD%B0_/.V%K7,^>8I^%5M;9RH
M#%5%[U1(P;1?-D=NQ//F1'OL*#0F+,Y'8*0,JCQ'( />;?CKGB)S#'9]4?)O
M&N59!A--A.$>GKA;E.DLK9RH@6\.SS/.>>J/,[!;J;+!^530J/C: 8M-"B1B
M!XU5?,V2O^=8U(MK:EXBO-Z-Z[N>N0_3MZML]I[Y_A3D;BS Y?JOX+:S#T]V
MD"+FGIHR)G((&'8K94_*T6D;S&3C-Q2Q7+O*J,SC._C<%MDT0U4F:B0>P\_9
M3B![*]6V.+*)RCK0Y6E5/)^5Q8WRU[GD_%ZO"G\J-'GSBK9XUBLAJD!N-$<!
M@6/WS9 UW*FY*B3+J)TB]ZI92X@'S&4J64<R/PO6S<(GXA/@.<;2W(S-5'>B
M!A$ >ZO^5B1HBR0J\>DQNP8DC'9#+A0P;(70CEV A-MJFKZ?!HDMJI,3<<+*
M!AC8D]@((-O1ZNST5D<G%<J@.(==/@Y PUVHPMBZ=)=LB'^+ I4:-*JYAMIT
M0T;A[^U/;J)L4$W0U<T$FR?N51BUF@&1)C5VCB]HFY'O,>,30%W%%>6\8-0%
M5W3<4V]VHOEI.\4ZS]W'UBL=Q[C&12VF57./X=C6(6V=73&1YG>2[#YZUR.\
MB5L2FAV5HW5?-NSGZ^IA-1XS2S&&8[0=K8@A%N\8I[2*-#GAP K:]#BT6E?<
ML9$M^XO'VB8=M9;;;*,QS,7'8E7":(F:V*ZX DYL3CSRBBNN'VCM.L.D66IT
M54]+=]9/I?#/?3]0HT:&[Z, 94":OU"G(YV;&FXD*HHJ*[*))U147??=%32,
MI O2@WK2^.H''.?2<$V\C"N0W[K*^/!V08]#ES7F6V?X$PB+V,0K47',AJFD
MV$>ZR:!$!EL=,]5(!I;2/A/$>OM'Y1[:W+W)[EV]^W3].E!L;FGC@>/95OM[
MNGQ^LF7=_:5]'35S1/S[>WF1ZZMA,BHBKLF;+<:CLBIF@IN6Y$2(FZJB+)K'
MIJ;Q% N> JQQ\HF6EG3,T&.S;3&K:E&\+.W)M9#H(S,N.\Y4Q(M9(DIDES/F
M&C9.-C%CLL,.(9/=_P"[T%Q:F^*+BP)7O_#C6J^).*<[P7*^0\GS7F'+>0F,
MHG14Q;%)DVR9PS"ZU(T:3:?@M)8V-Q*CR)UT3HL(],DK%@MM@AJ3CFS%!)OV
M4D4;*Q=V+7Y#L'L_?X5OQ.G5.B^]-35-02D6W<2EM_?*J_IT"PJ>.14'O7O>
MK9;T]1D-394&05-5?T-S$=K[BCO:Z%<4MO ?1$>@VE39,2:^PANHGWFWFS!?
M:G33TDDB<2PLR2J;AE)!![P18@^D43-CY$303H'A<696 96':"#<$>@@UR['
M])'HNXB=G<D4_I]X-XZLZ6+-=C9I P?'H$G%'IK#D(9^-OS&#K\7LU<E(##L
M,(JHZ0BA)OJ_D;]O63 <7)RYWQB+%2YL1W'E<>@WO6OXW3/2>WS_ #N+M^)%
MD@W#K&H*GL*]BGN*V[A6_.,;7';' ,,DX9>G?8]&QFBJZRX5]IR9*8K*F'"3
M\3<C$307#8M(,UM%7R92.-EL0DB8M0+6'$5LN,ZM$#&25M:_LK-^J[JNZ]=U
M7XK[_BNGU/2:**151$W7113%/KT3\Z?J711P'&E\Q?<GY?7I+4NL>G[#1YB^
MY/R^O1:C6/3]AI/,7W)H(/90'!Y7I>]?<B?7O^K;2<>VGTTEWW72TAY4S2U)
MXBT:*/$6C2$7I?$7TTWS!^.J?@OZ*?1Y@_'1X+^C[:*/,'XZ/!?T44_1X+^B
MBU-(D3[=M'@OZ**B(U)-E3\E^O3EB<&YIX8 6]%-U: %J93A)1141/'\O?J)
MU)/#E3U( -+W=55-NOP74?H-65D6W;3D-=UW3IM[/ZUT4\.";"E[T^/V?KTM
M.I4<'HG7V)JJT;7)[*!P-ZEV3^_'\_\ 5J*IU<,;"]-+IU]VF,I-/I4\$^.F
M%#SJ0$4:92TBHJKTTUE+&XJ57 %5W^B?^-?^ ZBMQM2?YS?_ ,+^54>63Y:9
M#?TE7(E6L6RNW'\EI'&FFF_EJ]0=81J8;3*-..*+;:(1DD@$0=^B*G&]SEZV
MWC?,W8=H$DV.23\(551>.@.1S;D2#?NK4XFVK&Q(LK,95DT@7YVO^<PYW'/A
M5D9IK=UNR\I(]=!M &$U6V*%/?JZT!442*H/&RTCAO.$C&ZM@J[IMX:EPO*C
M?=S16WG*5)B0K)(S%DBYE5/+F!SXTS)ZLP<6WRT1:(</$7X&/<5/O<>_T5=&
M<6KFQC-27I=A$A,JS"A3G ./%10%OS&^P =)T!38"(E4$\-="V_RVZ4PLEY0
MOS,=@NEK!%L.2\ ?3SYDUK>3U/N.1<0D1W:X*WN/1QJ]18<*"T+$2.VRT!DZ
M""BJJ.'^VXIFI.$Z:>)*JJNWCK<,/:MMP<<8>+CPIAC\S2+7[P>=_3>L1/FY
MF1(9)G8EA8^F_.JE=E3W=?9LGY]9)6=5"ZB5'>;^K[.552/X(M]M><OJ_P =
M;J.5>/LN1O:#FF,6F'6I;)VG.H9*RX2.%MLIO5=TX*;_ -EGX:^:WUN]._L_
MKWISKA%M!N&'-@3,!^? WBQ:O2T<K >A*^@/T?;^VX]%;_T?*UYL'*BS8AVZ
M)E\.2WH#Q*?6U<.]KK&&]A_[]P'*  BWW(8C,PZU]=U1%[2C/(?QV37A%HW3
M9\G%%_&P<G4OZ(;4/^[7L]95?=,?*/\ -9F/I;]*UOQUZH>E/(ALL0NZ53[B
MJ[1BTC#OX0KZ-WGM_@A80GE^D_CKZJ_17U0NZ]";ATX[7? S5GC'_A9B7-O0
M)HI#_95\W_JTZ>;;.LL'?56R9F(T+G_Q,5[#[8I(_P#LTSUDTGXEPC87#8=T
MC#<EQC*&R1%4FX[=B-/8$FW@*0K@B+V;#K8_K-V [SY#Y^=&M\C:<O%S5/:!
M'*(I#_[N5B?0*P/TI;\-J\Z,'#D($&YXV1B-Z2\9DC'_ &XA;UUYSMO+'SQI
MYHNU,AQJ/(:+=$WF02)I#14V7<>YOKXZ^3AF:+?X<F(V;(Q;@_QUL5]M^/LK
MZ6^$LFQS8\@N(,GB/XK7##VBO0N3S3>9# KIM$^M;!DP(ABZ #\T^ZC MR7G
M"<$E'NE :B.VPIMONNZZ^\_3.]-OG3.V[V;ALS;\><]X,L*.1]I-?#WJY9]G
MZHW'9(&TQ8>?/"+6XB.5T!^P"K=79?+SVSM<5N(M<SDE'755P6<P!6#DDG'K
M=^P@PXC P?EV6K"+/J'VW)#RNQU94%".KBF0Y6:?W=+*"W>:=M4SYD99S[RD
M VX7[O569?@TP.C.37X"B;(+RTTU4V_W673.O$OQ4E5=4]0[A]]9G2P' TBT
M/G?=FW603FU14)DK%NO9-/[TPI8M89#\%-471J Y 4:2>9-8U:<9XW.DLSH?
MXS42(_<JP:G+<TH\?L2,NYQ;>FQS(Z=F1(=7HLL%"8G_ (PD3M5RRLIX\136
MB4CAPICOINX;Y4LL-OK:/G==9<8WSEVN-,<H9^_V9(_%%J!.=NIF1R;4J0HB
M.&Q\BY"^<0E"2J^63"9$!)E#K>H"O'CS%4&>V#IYOE\( 6$D2X:;>C-$8"\K
ME57.Q[%QON5/,LF"1U31$1Q=U7<D5=,8:2P'96I[LTCYA63X% TCLX\2?::T
M66#<4Y#RDY/S?B/ >0I%7QW+N9][D?&V-YK;8>W"OX\6C*/:VE':6-'!OUL;
M$.P768[AQS<5-T,EJRQ:SJ NW;ZJR&R9+112B0GP%%_4>VWK'96UKV54W6[<
MC$</F@%%,Q4&KW&ZJXC%B\\X3EABCC<B*I)BU@[612?@@21G2BLD3:JV"(\P
M);3QU57_ &[F>+J54$-^"VXV])YWJ2\R.RO\5HLW*ID5>)L3[RCR":_.AR&Z
MK((<Y*AU981777H]/&L*^1'^;D(R**\TI"*'NB1H4))MQ%7-U+9N#'-""4O<
MC[ON_?K )TX[JTQO$\1G,3<TN\BQR12-5CS4^13QJR\KK.QRV<,=TD@TM#71
MG7G7W2!MQ>UD54W1$I*Q&W1RMEHT8-PUR>X#OKT>?0"<<)M%05,E ?#8>Y>U
M/<BH*ZL5OBM8ZAW53^'M5/LT<*=K-)MHHUFC;2WHUFCI\=)<WY4]232:6G4B
MINFVD9=5*#:M8\IU#>0XO*IX-I#KLW@BN:\>*;K;UHUEN$JEQ5SH-2T1V=E!
M5X/DYX1VG%<A3'6E3]XB+"PL;7I3[ZVO9NSV5;L2SG)>4<-PG-L,JH>'5N02
M#DY##S^NF/Y#608$E(=C65-)46;++=HY9QI43OL)+#D-&N]R*;F[*-[:<&UJ
M&'"_.]9I7XG50+&^M7)%U<R\AEQY4H,DN)EY7P6H,@Y%9745/++\&HZ^L=-3
M:&-'!TC1#<<<,1)"EL./I]-ZT9ZAO4>? L[!FI&"R<FJ<K.ZEY#ELW(I&,8I
MA-=33L:@C^/W[.+9574UED#N1$5?)OW,?QI5@/MRKF*\<=MYKR", D7%'KK6
ME%_,)X"M,6K\HM:[EG&DL;4L;"JE<6Y3<R1S69=6]?C''+=AC\2QIIW(^:4=
M3^.UE0R^;[M,^V\1"J]JM7(2W"X/JJ02FW+A6;X5ZU_3MR+BV?9=A.57>15O
M'&08IBMW K</R"5D5MD6>Y4]@N"U&'T+$5V=E,[,,VBNU,!J.GF'-;5'!;:4
M'3D6=+%B?=%*LE^?*L/LOYB7I6IJ^;;6^4YI55<2R:QJ/9VO&.:5-=<\@*&+
M',XGH;&TK85?8<JTW\9P$L*4G6W8*J]YIBD:0K:G)B'"YX#NIVM?LJ0_YAWI
M7&KHKX<LR]W&\FRZEP;'\F#C?+FZ"XR2]J<,MV8=?/E08JS&ZUKD.D8GDT!+
M$EV(M$*JU))A#D1<@3?A]]+K6L I_P"81Z3>;\/<PBR9SY_(^0L%IHMCPBYQ
M[>7^?6$[D3'<?G.<90:NACV3%SG551YM ES6&#\J/%>60#IC'D>2WYB(J2>=
MJ:Q1U*MR(XBL\XY]1G!/&?"G",.+2YMB.+O^F_ N7VZ2IPO*\VB\8\=9#C=A
M9T#_ "3DF.TAPJ:RR*?16<2,]*;8.SM(DC<&E)-Y%E55%^T7J6*18(PBCW0.
M%67%?YB' V:3<B9QAC.[R%3XVUD\&9483E5Y).K@3\@QW.;;,*F@IK:9@>+<
M=YG41:FRMG_FHAOV3+K'F,";B,^84B_&QJP)U/?]_P" J_6?K_\ 3C18KBF4
MW%SF#K.68W>93%AXOQSG&6R&*C#RY!:SJS5JLHAFG2XB?%.1.R)1QVE.'7><
M+6[S+92>/& +W^S\.ZI/&0 $WY=U9)DOK<].N&8O@N79AE=WC%?R'FF:<?T-
M7>8;D5=E$/)N-[@Z'D)C(\:D1!M*.'A=D(#/=< NT7V2:%U'!T'(B !N>/HI
M?&CL#?G6 %_,0X"?R;#<>J*3FB['-0D+7V$'B/+ (7IMYQ[C> _*TTN+'N+F
M!RI?<C18M'-BM'%,XT@GS9;$35IR$OVV_#\=ZC,Z:NVWX?<:Z6XJYHX[YJKK
M6UXYM9MS!HSIHMR[+IK*H*KMKJH;NTQV:U8L,.,9-20GVQM8"IY]8^Z#+Z"X
MO;J595;B#4JR(_PUM/3Z?84:*0@W!%+OHIX;CQH4D3QTE.N*1"%>B?HT4<#3
MM%%A1HHMW4TAW1>G71>GZV]%0*FVEIZL6YTFBG4NZ^]?SZ**-U7Q55T44FBB
MC111HM>EII$H[=$]NH3%<WN:<&L.5*)=W3P7V_GTGA6XW/W5+$UWY4[3;6-J
MLT:8_P )HIVJ=/B^+V4NZ^]?SZ*GH153V^'AOX>*=/HTAY4HYT\E5115Z+OO
MTW^.J]24\554W7WZ**K]O_-7C_I7[?D=0_G>W\M-\0_,VL+>%_*K+\@%?QNT
M7?9/G7E^U/CUUGH!KQXP1R M7$<J1O&=;G2&X#LO5E5"VZ%O\/#61L +=E0+
M(Q/O$VINY;]45?'IUZZ0JIY@5("@Y$4O>G][]O\ 5I-"=PI=8[Q1WI_>_;_5
MHT)W"C6.\5RIZR<?*XX8?OV&NZ;Q_DE%EC1HFYA 60M)<H*[;H"0+57"^#7P
MUY2^LWI7]O>1^7NN,@.;LF7!G+8<="-X4UO1X4I8^A?17I/Z3^I$V/SBQ=NE
M:V)N^+/A,+\"[+XL/M\2, ?I5YK#';E9+D526R1,UQMFP9]J?,O1#@2%3=-N
MX)$43^'=KY0+HDW@C^X9^&#ZV46/MM:OI<VI-J']^P<LC^Q)N/RUTYZ,,K-C
M(JROE%LMU2V6/2@5>GXE5*-E$1=_[2+"D GMW/7JSZ)>J&VCS%389WM'N&'/
MB$'^^P'YB'VZ8Y5'?KM7F[ZO.G1NG0C;U MY,'+@R0?_  YAX$OLN\;']&N_
MN3L<',N.<]Q900BO\/R&M9';?_+'JR24(D3;]H)H-JGQ37TO\Q.G4ZMZ!WOI
MEUU?/[5E0@<_>>%]'V/I-?/KH;?'Z8ZUVCJ%3;Y+<L>4G^*LJZ_^X6%>*3<T
MG*GCC(551<C2UJY>_10^<C(O8?BNXOQT3V;:^""2N-KV[-DX38\PC?T<=)O[
M:^U3QJ=RS\->,4\6M?3PU ^T6KJ6@C6</&(3F*3:JR=*7;-3Z3(EL8+=3+6<
MY(:<K;>NCSRDU\N-)!XHQL(3)JJ ZHD@!]G?IKWK)WSR:VJ3++&7%:?%!8'W
MD@E81$'M C9$OWH1V5\=?J1V; V3S>W),2P7+6'*95M97FC!DOW,TBLY'\8'
MMJ*7E<SB3 >5<SL<SP#',ZCT<?-[?-N1*7*K/C*%AV*RX\!ZCK,9Q"T@9G+D
MU3=NK,.%'DNS[6VLVE 72=&,':Y[@W-K6X5S38I8#"T2 B4&YOVWY&M:0O7+
MD'%--Q71^K?C!S".6N0X==D%UC_')PG8> 8[GN69+1\31,KQ#*LQF9_!RVTK
M:)HLA8:"574=A*^6"9*)E[LKZK<&YUG1QXCE70/&7J&:YHQ#-IU!CMKPWEN*
MX;Q]GAP.;H-3/K:C"N5\(_UB\?YOD#7'F:3V'::PQ:-,*=":M(]A6RH3S3R"
M@@;J@AA<45RMCGK.YUDXSBN89-@G&,&H3"^'>9,K@1(.;P+[(>'_ %(>I:=P
M5PPYBD&PR&>.(9PF&0$RRVCV!VS'G38M2VC3GFRA34?P]='H->I](9UN;4R
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M<=0QARF'V'(K9/J.YD)MHT2/Q;C4[QK(;N+\_OM7*[_\LKAV9D43*[G/N?\
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MF[9!!XO#"[$QQ@$:E0W,P0<%$B@ 6-=Z(6R)[>F^Z+OT7JBI[]=CO6V^*+V
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M4T_T[\%7/*6*\V3^+L13E?#)UQ:T&<PJY*RY&ROJL:>UL;1:THL7(+!^O;
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M.HK<]G\B>K,UPV[28V%!VW;Q7MZ%C]V_K<5N_$./J7$%.4R3UG<O-$R_;S1
M709/97(U?&;W9KXQJGWD'N<<V3O,D1$3Z8>1OTU>6_D-B/)TU%)E]3SQZ)]Q
MR=+9#KP)CB50$QX21<QQ\7L/$=["WH7H[R^V#HJ(MMRM+N+K9YY+&1A_!4#W
M8TO^:O$_G%JSM.J]?R\->@^RM_B52.(I%)$7;;?Z])4NA.X5JGEV!/7&H^84
M<9R5DO&5HUG])%915?LHE7&DQLOQMO;J291A<R?#$/!9!,EMN [,>_Q#F*:Z
M +J4>\O']T>T5L2OG5]M @VU7(;F5EK!AV=9,;V5J776$=N9!E-JGB$B*\!I
M\"TZPYU+<$ CX2*K.U/<GYDT6%%&PI[$_,F@V'.G!6;X1>C[OL1/S:!;LHTL
M&L0:HY\&#:0)M7:0XEC5V423 LJZ>PW*@V$"8R<>7"F1G4)J1%E,.$!@2;$*
MJFF.I*FPXWJ?@1I:Q4\ZU1ALV9@M]'XHR"=*L*V1$ES.(\ELGSD3;F@K&D=L
M<!NY[I$Y,R[!HFQQWG%5ZTI$!Y5-^+++3$!!*O[*1',;>#>X_-//A_!/I'WC
MU&MO=Z;I]WQZ>.I644_63Q/94G34-6_=I.B>[12V%(I(B=-EZZ*6F*:K\/S[
M_GT44W=?>OY]%%)]"[?'11^[3^[M3Q[E^G^[I:FL.ZF*:JOBJ?0JZ*+#NK56
M>JJYSP5NN_\ Z^Y9X_\ _)<[TT\QZZ@E_G8_6?[5JVINJ>"KI6-A5FI])I])
MHOZJ=I:N(!I'JIZ'LFVWV_U:B?\ +^2GT_??PTREI=%6E^$>JI!+V+T]WY?7
MI+BEJ45WWV]Z?ITUOW:0U<?]$_\ &O\ P+5/\_\ #OJ'_./\5_*K+LA_SS9_
M^6O_ *=9C#_HZ?H_N5Y^S_Z=+^F:LNK55*-%B1PHJ,B555/#Q1?C]FG@6%J*
M9I:*-%%&BBC111HHI>U>GQZZC\07J14((-(1"V!N.*J V!.&J)W*@@*D2[)U
M5>U-0SS1QQF:3A&BEB>X 7/W7JPJM(XC3XV( ]9-A]]8-YYR7)<PD52,W6#$
M3K9;; $K4=^'8Q 4'!A3U;9%MWYA%;W(NBZX'!NL<WSW76=I97U)".7ZE"50
M:">#.  3?BU=@@P?E,:'980VI1>3TLUBWO>@WMZ*M2ND?^4+W(&Z PVI.[
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M ^$JRD@<RH8#4!Z*V/JCRQZYZ/PEW'?\%HMN8@>(CQRHA/)7,;-H)Y#58$\
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MSJ'_ #C_ !7\JLLR(U_&[1-O"8[[?COOX+X[ZS&&K-CQE>("UY]W ?Y=*?\
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M[9NU-IX'S-8[*R=R[C8BTP$]P\GL,;BW\N[@U_\ DHA&6 W0]BNR29;<>E-
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M+ ]N9D?=^LX>RJ]N_P B:7=K)\F;7IX7UH?AU\'93@K^;4;]/;#)_.8&$?\
M$H/Q**LP>8'7^,=4&^[NI_\ S4K?<S,/M%7:-GF;Q%W:RJR=1/ 9[-98@O\
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M-!C?@DCSA*K888A,QHS.T@P!&A$@140=MD34<G5&^Y#L&FN\L)ALL:"\9O\
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M90\ETW%DC-ZV[@8M(R*6[7\.R\DRZNP)*:UA5<&D?YNJF6H"W!NRPARW4-M
M;0\!/U*^WR+CY$9D8RB/4#I+'3&2P6QL 7%@6N;'NX[!B=*C<X6R\27PE\!I
M?#(+!1>8*ADN"2W@,2VBPNHXW-L8M?YCL'&0QES*^"LCKDR*O@7PL4V<5F36
M:4&189CF88BW54T+&F+:[RNZ'(DB2(0,MP*YYG=ZP5'6T4DZK\ H)\=AK%P
MUS8JKK8 7+$&Q')2.+<KSQ]$O/X@Q\M&T,5NT94:E=D>[%B @TW#$EF!X)P-
M2Y)_,">IJ2TREOC;'9F.XA8X]!R.ZQCF'&\MQ:ZL<EQ;EK((531Y@UC=;4Q*
M2M8XU\RRNW$VA2'?E5BF@NO 2]4.B>*L:E%M<B164DB0VU6  &GWF[#PMSLD
M'1PEE6#QW$TBL55H61E"O"I9DU$ECXMD3\X#5J%P#;V?Y@5O_&TVKG\?8I"Q
MW\:I\8H)C?(T(L>G3K";-QF?G.3\ERJ)JFH^$H^30#D5^4Q8,AB;5;D; .[
ME;^MLPD?7$!$MK6)-^-BQ:W!.'!P#<<=(/"I#T;'\H'2:0SZ2S#PSJ  #!%B
M#7:?2;-$6!5N1(XUL3$?6G:\AXYG5QCO#TJA*JXGY?SC!9F39='DQ\AR;B3
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M:. HB2;[ 2H2[%VIX>/37Z-I=PVZ+63/"(D?229%L#QL";\#PY<Z^E30OJ(
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MD,\)L>3)!X7Y".1WFB;#3I,-)F+L3?\ ]G[E/BG<*-(X<:T_!_EL<84Y8Y^
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M^=@QBC-Q[%EU<8$9=#,;@HI6[SSPRW8$HA;(%9!YK9$;0%^^O7KJN>O=S/\
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M1VI T\PI#",/K,,&V@'Y)E%)6Q+N4B5?O:O/U;L<R 2RK;NX</1[*9+CSJ+
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MLK6*D<R#PO;GVU>3.C=AX=@OX=M(T_YSRA$GQ9,-8/SC=A-_R1EQT-_.BL&
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ME7X(O1%]VJ^;FXNW8YRLUQ' O,GT\K#F?95Z..29_#C%V-,4I!Q_F&@7R1L
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M$?HWD-CZ0#4$/D5J*S'BCBZQ(<5EF-&CUDV(K46+';%EAB/%<CP&FV6&000
M501%$1.FJ^W?7ET-DS!=WV/=L>,GBZ203VOVE28B?8;U'MWUC=&R.L6?LNY8
M\ X7CD@EL.RRGPN [A665>7T5RXD>-)*//)-Q@3VEB23]I(PAJK,M13Q\HW-
MD\=>E?+SSL\L/-$C'Z2W.*3==-SBS P97+C:*2WB =IB,@%>@.A?-KRX\Q&&
M/TWN*MN9%_EI@8<CTVC>VNW:8RX';62BJJBJJ>'3\O'74)0 PMW5U$01CAQI
M>X%Z)OW?3T_1J%EU"US1X*WMQJEERXT%AR5+D,18S(]SLB0X+3+:*NR=SAJ(
MINO1$\57HFJ&?EX.U8<FX;I/%C[;"NJ265UCC1>TL[$*!ZSQY#C5;.RMNVK#
MDW'<YHL?!A74\DCJB(.]F8A16#2N1JMM2&OA6-GMT1X6Q@Q5^(N3B;D&GN46
ME1?9KROU3]8/D[T_,V+M;YV\3J2"<6(+"3Z)IS&&'I56![":\X=2_5?Y5;'*
MV/MC9NZSKPOCQA8B?1+,T>H>E%8'L-6=,_09;DX<4BI+=CM0W)@V3237(<=U
M^1'B./\ X8CAQV'Y3A@VI]@FX2IU)57G!^NCI=I-!Z>W+Y:__P#,PW]>G1:]
M@.WVUH*_6ETXLVK^KV;8@#5\Q#JL";"VCD+D@:K"Y[ZO$7D>I<5!L(5A5[KU
M><;";$'XD]")UYL?B38HGM770NF/JW\GNHY4Q<^7,VC)8V!RX@8;GOFA:15'
MI<*.\BNB],?5?Y5;],N-N3Y>U9#<+Y,8,5_3+"T@4>EU4=Y K-8\^-,::?BO
M-2([Z=S3[#@NLN!X;@X"D!)_3KTCC9.'GX:9V!+'/A3(&22-E>-U/)D=258>
MD$UZ/Q,S%W#%CSL"6.?"E4,DD;*Z.I_.5E)5AZ0:G1=O!/UZ=H%6?12./@TT
MXX\;;338D;CKABVVVV*=Q&XX:B  *)U5=DU4G\&%'GF94@0%F9B%55'$LS&P
M51VDD =].?(AQH&GR&5($4LS,0JJHXEF8V  '$DD 5@LSD"E:50@,S;<A54\
MV(T#,-?9N,N8XP+P_P"$V+@K[%UYPZO^J'RDZ8R&Q,7*GW7,2X88:!XP1V>.
MY2(V[2A<5YVZK^JCRIZ:G?$Q,C(W7+2X(Q$#1W'9X\C)&WK0N*L+N=([):F+
MB\8I<=B1%CS'+%I9T>++.,Y+CLOI6F;3,HX;). )]IDT"KOVIMRZ3ZUNFP3%
M%L6XG')OQR(1>U['2%(N+FW'M/'C7+G^M7IOQPZ]/9S*MP&.1"'L;7L-#6O8
M$C5QL+\JN43D.#N@SZVR@HJ]7@1JQCA[-R^5)):#[]F5UMW3WU:^5N\2K!NH
MS]KD8_%-&)(AZW@+%1Z2EJWGISZO?*W>)5Q]XCW#:I&-M4L:RQ#UO SL!Z3'
M8<[UF\*RA6,<)4"2S+CN;H+S!HX'<FW<!**JH.#OU$MB3VIKT+MN[;;O."FZ
M;//!E;=*+I+$ZR(WJ92>([0;$<B!7IO9]WV?J#;H]VV/)AR]LE%TEB=71O4R
MDBX[0>(/ @55*:^Y/R^O4TIU&_;;]VLH!:CO7X?;^O4+'2NJG 7-J.]?;MJ(
MRFU.TVXUCN59%78=C=_E5L,MRLQRGL+NP&!%<G3%AUL9R5(2-$9_>2'E;;7M
M%-MU\51-U1-LQ=SZ@ZCP.CNGT@EZDW2=8H$FE6"$%C;7-*UQ'&IYD!F8^ZJD
MUJ'776>T>7O1VY]<;_XQV;:<&;+G$,;2R^% A=]$:\7:PL /6;"N;G.0[SD+
MC"9R[@N=9+%HZ^J?O96(4^%5,[)QKXK)2G68T6!93YEE-.$V3K3;#SIO=JMB
M*O(K:/\ ,CR5\[NC_,%>@MQW/:,/<7D18W :/%D\0@1M\Q,K%4U?JW9U4(02
MVD<:P/DK]3/D]YI^5;>:W3^T9VX[2D;M+!KOGP%%UE&Q4;0SM&1(B*Y+JP5"
M7!47WB[G#&>2>,8.;\;9O$Y(BO14FOS([$E9D5@G),80MJ:3&A7%8^,N"^V8
M/,MD)M*GNWQ/F#TKYF^3DZ[%YE[7E[=U&";>/&K03JO$MCY$#-#*EN(96N 1
M<"MJ\N?,ORN\Z&_:_EUN,$^Q,54JK%)878&R2I* \;FQLCCC8Z;CC7*'.N0U
M?)D1BS@59X_RGA<]VSQ+)HKC<JKGN/*+5MC=[#D*Q(;JKB*/82=[@@XB;IV$
M:+G/IG^L'9_)SJ[)VWK#&RFZ WCW-P2 +, W*/*6)K,7BXAE0WDC)'$@5SOZ
MU_\ I_;Y]1?EYA[QY>9N)#YN=.R')V>3)/@Z@WO3X$V0H8>!D<U8JOARA26"
M%JZ^]/\ RT6<XS!J<A :S+:V#'5ZOF3&7I,B*A'&[$DHX0SI,%]E6R,5(WV5
M:?5.YTT'8O,W.\J,WJ-MZ\HM[PMSZ3SV9TB6\,^+(>+0OC2VF1#?5$2MK%HP
M3X=S6\@T\],+HF/ICS_Z<W'9>O-JC2)YI )\;,A TI-%F0O+#+(NDQS7DUL0
MD[ >-I7H8B,>A#LOM145%_-ONFN>7OZZ[<"#RI4-=O9J)V*FU-(N:7O+V=/H
MW_7IA<D6-J:4!X&I ,E3KUZ_'X?'3+T!0!85*)*J[+MX:?XC>BC2*?OLOT:7
MQ&[A49N&L.-/\Q?A]NC6WHHN>[[ZR#N+^$^[^S_$?V_AGNWUT_6W_*"_;^V?
MY%:;J_\ KS3;WOV=_P#B=];0RU5_B6[ZK_G%_P!O_8Z]AX/]$C_0%>'=T_UG
MD?X4UCNZ^]?SKJW57Q6]%*A*B[]5^&^BI$;4/31]Y=U3?95WZ;]-_HT4^XH7
MN]N_U[Z**9NGO3\Z:**131/#K[_9^;WZ*4<Z9YG^#[%]OP^CWZ6IJ:AKOUW7
MIM]>_P!FBBG>9\/'Q]O3X=-%%)YGP^W^K111YGP^W112*1=5ZHGOW7;;[-%.
M![*8I(G7HO7WZ2G4">Z[>'3?Q_JT44*:)X;+]"_W=%3K)J-K5&I*J^*_GT5+
M2=RIXE^=5_7\-%2+)I&FW"A7!3INJ?0NZ?3MOJ-8[&]ZD *F_;1WBOM3\_Y=
M=/J6]QZ::I[=-M_BB_JT4X<K'G3.Y?>OY_HT4HM>U(JK[25/KTQEU<:.-&Z^
M/<ND\/TTHN> I%5-M2#G3E)0W-43\E6@<(67E!HFA>DBT9L1//)$!V0HJA>4
M*+W%V[["G7;IK1^K>OMGZ41H9]<NX&/4J(NH<?AU&XL#SX7-A6=VW:<K<-,I
M 7%+6)/.PYV'W<:)<7OB7CC;3=XS7!!0[B&^R"5)/*KGF^23J)VM+LIFG>*J
MB)NB>' L_<^K/,/-1I_U&W1+:RDJ&#$\2O'C;@>)O85OF%B;=M,9$5R[GM )
MX=E_Q55O_+R990I3[%C79!4L+57E[#^52O=;!Q88B3* B+'L%4']MA1"$M]Q
M1"W?$V79]@PRBA&F(XL;7!]%09$N4Q/A6TGTTUI0:3&Y\V2_$LH+QL0[^0Z$
MV#/KXSCSX(+7F=H;N*8HB*@DR>P]J(B)AMTZYQ\:/Y';1(<H?Q>'VW_)4^)@
M-EB\X)OW5;1M'?\ )WHC0PYPSI$J5:1^T&)K7>_Y(,0E[VT$4>^YW?LCOMMO
MUU"#;][W64R9Q30Y)^+CQ-^5JWS;M@>(*T@7PB!;CQMZ?35N(0\TWB%3?<<-
MYR07[3CCAJ1'V"0@):VK;>DL'#8/)QN;UML6)!$+(.%*9]R)U555?C[M;.(D
M!$2J/E[>V_9PJX"MM-N%0J>R[*JJJ?3[=+X2@^[260U3D2"FZ^_;IUU/\NY[
MJ?X3GE:L9RRZ=IZ&5,B*B3''(\&&9AW S(F/"R,@P7[II'!2-!7H1"B+T77(
MO/3KO+\K?*S=NL\!%?=<>-(\<,+J)YW6*-V':L9;Q"#P;2%/ US;S=ZPR_+[
MR]W'J?"56W&)$CAU"ZB69Q$CL.T(6+VY$K8\ZYSMY[='3W5V^CDK\-KK*YF&
MXZJR9I08CTQXGI#B&1//(RJ=Q;[;^&R;:^%>9N&[]5;\VX[SDRY6\YV0#)/*
MQ=W=V U,2;FU^ %@!P4 6%?(W+S=QW_=7S]TGDR-RR9"TDLA+.[,>)8GB?0.
M0'   6KSNC?S',<NJGCI['^,;1G(<XA80%SCF8Y([2/\>Y/E>,<L9//Q#*BQ
M7$\_LRLZ6)Q8I,OQ8+\.RBV\.8TZ,8T<7KS^1V;C9.<F;N$9PL1I]$L,0<9,
M4,N)$LT/C2XZZ7.79E=U>-X98V4R"U;:O0LBRSK+D#P(2^ED6_B*K1*&74R"
MQ\3B"05*E2+BU9ID?KEJ8<;U%LX?@]?F&1>F]^I=R*C+DJBITR2E)V;09=;4
M4B-47TZ$YAO(=1-HG8UC#AG*=C)( A:=:0L7@^4>1+)LC;GEOC8.^*XCD^6D
M?PY/=DA20%XU(GQWCG#1NX4-H(+*UJV/T<7.(^3,T<&6#9A&3I-P4!X@'4C*
MX*L>=N8-NW:PK*=45[F0U<6IN'8L=VSJX-H=Q%K+'M0GH\*Y6!4NS@BO)LW(
M2/'(MD+L!>FN5F;]G;E\SL^1*#!+JAF ,,H*GW) %=C&_;P<D=YK5#(V!G>+
M@2R++#)>.1;HX*G@RE3=&',$&X[ZWGA5Q)LZEUN<Z;\NLEE .2?[<II&&9$9
MYU4V0G_)>0'%_M$'=[=?9GZ;/,O=_-/RNQ]YW\Z^H,/(DP\B7@/':)49)B.6
MMXY%\2P ,@9OSJ^L?T\^8.Y^8OES%N6]MKWK#R'Q9I.1E,:HR2D6MK:-U\2W
M-PS=M9>ACO\ J1?UZ[V0P%Z[E8G@*T7DUD]<W4SSB5857,?@U\55W:;<B$K$
MB:;?[)RWWP+8EW4&T01VW+?Y$?5CYI;]UAYC9W1HE>/I39<CP$@!(66= /%R
M)1>SN7)6/5<(@&FQ9B?EE]37F/O757F!F]+&1X^F]HR#!'""0KS( ))Y /C8
MN2J7X(BC38LQ/+V1<[VE?R)E6%XUQO8Y=4<;Q\->Y.R@,IQ^@/&SSR+/GT@4
M='=*RYE8U]=#"59*,J(33,@ B!-DHY'#AF#T=!/L>/NVX9R8V3G-,,6+PI)/
M$\ JLGB2)?PM3,5C]U[LI,AB2SGA^/L*2;<F=D3B.2;5X2Z2VK3SU$#W;\0O
M \0=6D6)Y#QG^95"RR-B:4_%5;(F9<E&Y'FQN1[FUQ*F=O./9W(W\,WUW1<3
M6M[#Y J*>/&*=6-4[\9B/90Y'SJ@^*:Z5G>0\FWR9'S.XR+%C>)=3C(LSB/(
M7&\6..3+2-L=W+:)3,K,T4J>$"A-;)+T (7D#Y#!(PQ-XP&.EPFH N 4)N V
MH$E6%N%="\2>K6!RAS9F'"[F%NT$W&9G)T&)<I?O6(6$CBC*L>Q/(4EPIF-4
M46.EG+R()$!($RV<^68<*8$,^P#TKJ7RVEZ?Z3QNJERA/%D+BL4\,+I&7%)-
M'9A+(3I$963Q$A&IE$9E%R,)N?2[;?M$6ZK+K5Q&2--K>(K,+$$G@%][4%XD
M6U<2.V,9GNU5S$::(D@VLH(DR*BKY7S#XJ,:<TWOVMR0>00-1V\QLE[MU$53
ML7TG>9V^=.]>XO0<DKR]+[N[1^"22L.1H9HYH@?@U%=$H%@ZD,1J4&N[_2WY
MD;ST[UYB]%/(\G3.[R-&8B25BGT%DFB!^ DKHE L'5KD74&MU"6RKNJ^S;Q7
MZ=?4NOI_87MV5J',K!VPN'ZPB5*ZJ6/_ )-NOER9SS#<I9$@?!T8S3P"T*[B
M)=Q;;[;?-SZP?,S?,CJG_EG@2O!L&+!%+D*I*_,S2KK426^**)"NE#[I<LQ!
M(6WSI^KGS(WK)ZI_Y;X4CP]/XD$4DZJ2/F)IE$B^);XHXD*:4^$N69@2%MYO
M\M^OS#>)+WE_%[7C_)YE]Q9=OUT!@K*K@0.0*B#PT]RS=9!B\XFY9JUC$M(]
M+:Q3965#>L(<GL-B2WOPWIOR:W+J/#VS<,?-QTP]PA#,=+LV.[9HQ$CE7@+R
MKJFB<-H<1R)<.C5YJVWHK(W&''R%G013H">!)0F7PP"+6]X LIO8V8<"IK<L
M?U)X_#X>O>4<F:QJ#;TF)9EFC. 469_/WM[38="MI[XTK>78YQ_=.S9[%+(1
ML7JQEM##H9!]_6K2=!YLG4\/3^ <A\67)@@.1)!I2-YF11K\&3(0*ID6Y$I-
MCR!X5BY.GI/VHNWX[.T+2(AD9+ %RHXZ6<6&H<03ZK\*TKG?KYQO#X?&-]!P
M*5D6'\GXSD&=TF11<KB"DS!:')N.\72\J6*VCNJY9-E*S])#;%Q-HV(T:"ZL
MJ3',D;':]G\FL[<Y,_#FS%@W+;YXX'C,1]V>2+)ET.6>-K*,?26A2=F:1?#1
MP+G+8714N2<B*6;P\F JI4J?C82'2;V-AX=KJ')O[H/.O0RLGO4=DS.CDJ-.
MR8\:S8%5\J;&=>%CS##H*R8WF=[1_M)LH[]I*FK'D+YC[QT+USA84,CMT]N.
M5'!DP7)1O%8(LJKR66-F#!AQ*W1K@UO7D%YD[WY>]?X6+CRNW3^X9<>/E07)
MC<2N(UF5>0EC9@RL "R@H20W#>1J@KLN^_P_NZ^JTRZ7*]W#[*^OUK&U-[T^
M/V?KU _\W[:5?BH[T]R_E]>JQY5(>58?DV2L4\B#%?8.2-@ZW!%OM:5A2E*8
MJ,DI! R+1!N.Q=#WVUQOJCS%V_H;=6W/<8\AQ/N$.'&T1"&,H$>_B-8*=<A;
MW3K)("W(-M5ZJW3;]CVOYS=8C-BSN8;:0RD,MI/$#74H5LNDBS7-N-<0,MR?
M29S'#CU8/'PGRG8NNXNVUYA,XY?RG2EVN%*IKY<<775653H2C^\4XZ=7'SU]
M7MISML^KGR:;$R)(CYP].P"19."_-XVD*F1P'$. L.6+^Y($FL. /R5S\;,^
M@'ZB<;>]A$DGTP]=SW2-/?3"RG)>3$N1?4FHY&!J?WHO&QA<^(XUC<X!?^E?
MU0X[RYQ$W&>]//J'R"(F55<=Q8]-@V>9-(BI.>:CL@9,XOGS:C*;1ILOD[)A
M"[4!M&W*>V[]M_U!^0.]>4OF#KC\U.D-KRIL.1Q>;(QL2)[HP;BT^, 895U#
MQ82C$Z@7'6?,"#_[:/.?9O.;H>02^3776X8V)DK$&;%AR=P<:'+1@B/'RBPG
MAEMICF5X[!&1#N[&*EKD++W,8RYD)22EN?ELD89"%D<,X0/O1A>E-"+-FROE
M]JA*;>)$\#37Q0Z>Z:3J7.3 F?P9)(6=9-()N!?B+KSX\N1%J^YV^9N1T?LB
M;MT^YC9#&'@9F?'<-920MV\,DV/ZMDYWTM5LS;@;,<35VPJ$7)ZAA2=256MF
MU;1&QZH<FM$G'_W:)U<CDXGMV'53J'H/?^FI#D2H),(-[LT=[#C[NH?$A)M8
MGA?F164Z:\U=@WQ%PMUMA;@PMH<WA<\K+)R%^Q7 /9<UUWPR],>XPQ)^RE2I
M<M^'*?-^:\_(D*V=C+1@#=?4W51ED1%$5>B)M[->BNB)IY.D\"3+9WR&@!)8
MW8\38DGGPM8]UN)K@/74>/'U?N$>&J+C+D$ ( %%@+V X6)ORY\ZV>ABG]S6
MS.=1N*U/2:/,'X_FTSE2%2.=.0D5-TTFH4E*#@[KX^'N^*:+BET-4J$*DG54
MZI[-&H5$R-J)%JJ.X?[[[%T:A26?N%9!W)_"GP_B+QZ[;_AFWAKJ/_H[J_\
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MI@7QI%"^-I8/QMJT]B]JW(OS(-= VGI01HN9N)_6J;Z!8KZ+]_?]E5$B&_\
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MZ4?%/I3].BBP/.JA-%,< #A61;I_"FWM_B3_ -$[ZZE?_P#4U_OO^16@V_\
MUC_[K_EUM/,%VRF_3W6<A?SJB_9KV9@1WPHC?\P5X?W0?_I*?_"FL;WU;\+T
MU1M2*2)X[)]>CPO31:CNW\-*([&]Z+4(NVI*<#:E[ORW71:G:Z7?VKJ(OV6H
M$AO8TBFB>&R_7I5;54MK4PB55WZI]>@J";T4WQ\572:!Z:+TFFLH N*6D]J>
M/A[%V]NF<A>I4^&C=?>OYUU*J6-[TM&I**:I(GALOUZ**BW7QW7\_AJM4HY4
MY"5/'K]>BBF$2JJ_HW^&I%0,+TMJ;J5CI%Z6D)>WIX[_ )TU [:JEB[::A*B
M^U=^GC_=TVI>7&D)9!,2WV6'#8@@)S7FC;[XX&NR&VTYTD$*(JDFZ=J)\437
M-.M_,+"Z:9MHQP[[U)CZHR-)5"Q(4M?GQ!X#EPK<>G^G9]U S9=*X"R68$F[
M 6+ =W BI#;1P<AK8<UT6FF69@U5O6R2L+<8[/S,H8I(*.*C+#?> *B^:*+V
M;=53E&W[%O75>0-TWJ9I9@ ;L /='98 #@.7"N@R+A;=%X."@1+GER%^?VU-
M'%J;,@VL6%4*-VT_6W.)M2U@J!&RZ<R00 ICV/-BV;1@1@VZJHO7KK8-VW[:
M^GL?Y9%'B <=)MV>COJCBHV:^E@;WX52I9N11@C5/S6'8DVT\V--+YBLB)WO
M1P2.B=H]WE((JH?M>*IKG)@WGJB<2XCLNUD\4L.7KM?[ZW3;.GY=0:47K'FT
M98(CVV=W,E<)5[D5PE,T!.XD %4NB)MTZ+KINQ;'B[=BQQ1Q*' XD\3S)YFY
MK><? @QXECTC6!49OCONBJO<JJOQ+9/O+X[KMK:8L6-#KL=7K-O8.0JZ%4"P
MY53$X2DJHO[2^Y-6&57(+<2*<B*7%Z8I*G7]7ZM+I%6"B 7M]])X]??J \":
MC('941^/U?KTE%,T4M&D/*BDTRBEU5;^<)]%6XT4H"1QJDFR4BL>:O52>C1V
MQ3Q-Z3(;8:!$]JD3FL+ON7\EA>,"1(9$1;"Y+.ZH !WDFWW]E2#',GNQ :[$
MW/( <23Z !>K'&S"@EW;F/LRG4G"Q/D-ON1GF:V8%4ZPS:#!LG$&++<K7)((
M^@*J J^*[+M@H>J=CRMU.RPS$YNB5ENK"-Q 568QRD:'\)G59+'@3;C8VR+[
M+FQX7[2\.^*&0$@@E3)J,89;ZAK"L5X<;5DVW@N^Z*B$BILJ*BINBILNRHJ+
MNB^W68!ORJA^.L=E95C\*]B8Q*N(<>]LFE>@U;I&+\MM.]?W)*'E$XJ JH'=
MWJB;[=4WUJ;JWIV#J!>EI<V!.HI$UICEK2,O'BH(L38$Z0=5A>UJR,6S[ID;
M;)O$,$C;7"X5Y +JC&W!K<1S'&UNR]ZO>WN368E))%ZQU/(FF6R>=,&6VP4W
M773%MML!3<S<,U0  4\5541-5IG6.,NY54',D@ >LGE2J&)LO%C38LN).:\^
M#,BS6.Y0\^')8E,]X_M!YK!N!WC[4WW353'RH,R'Q\62*7'-QJ1@RFW BZDB
MX/II\T<\#F+(1XY1S5E*FQY<" ;'LI%5!125=D%%)5]PBBJ2].O1$U3SLW'V
MW GW#+.G%QXGD<]RH"Q^X</348#,0J@ECP ':3R'MKDJ#ZL\9MGW[/'JR#E6
M$QK^RQ:7D>/79R9,#(:=P1M:2Q@R(,9N%=5XF)G%,T[VR0FW#3JG#^JO-OJ/
MH;=L#$ZYZ6W+:L+=,&+,Q3,ZB:?$G/ZC*CB LT<J@FUP58%3QL3NW0FP=*>9
M.+N,?1?4.WYN];1F28N9 AU"#(B UPNZ$V9;V/"P-P;$<>GZ*^J<FJHMU22P
MFU\P.YIT44# D1.]A]D]G&)#2KL0$FZ+\-EUUC:]VVW?=MCW7:95FP95NK#[
MU8?FLIX,IX@UKV?M^9M>:^!N$9CRHS8@_<1W@\P1S%7;W_1JU50\J-1U6'.N
M8O5MQW6<M\0VO&=JB?+YD,ZN;-44E8GMU[I5$UL40E5VOM'&GQV3?[GQUR7J
M3S>'DKYM]*>8"Y7@2[1E"<(-6J=9)5CEA"K[SF6$.@6QXL".-JP76_3W1G6/
ME]OO177,\>/M6\[6^)'(XOX61(=4,R\"0T+JL@(%P%/837D]PI-RW+N'TOVV
M)3?/?I0M+BFR^I85T+7(L-I+%J'F]26X(\[.I)"1KR(>R[/39'9NHCM[E^M3
MH;&'46U^=71A$NR;[AQY =% $J21^(@[+7C)]WF#$;B_"OD[Y=8_4V[="9.+
M&KQ>;7EOG3"1$#&6? 60C(C%E&ML>=?FXC<W$TBJIU@5Z.+SY/HJO .6',2_
MB+C*^*#C^=VM?&ELYCQWD5HY&"EO/P][RV['![5)0J3#FSL&0:M XB(C:_-Z
M?IW!V4Y/6_24XFV')(EDQKJT4+E29&B=+LJN1<*/=5@0!8\/>G3WG5U*^T[%
MO&!A/F= [MDQ8F;$H(GVO.G=(XY-#$7PYI''"WZHNMV"^Z,;Y>K*2VRG%>5J
MF:7XA4-S&*NZK"$XEO6R5)V16S&G%%&YD.:HO@A=DB.\/WD45VUTCR?^JN3R
MLP]PV/,QANGEMOK YN-P\>.30T2Y&,Y91XJ*Q5H7%I5X:E(5AT[SS^B[#\^]
MWVCK';,Z;8?/7H]F_9\[-KAE17,WRF;$I5GQS,-<<\+WA:[:)%U1MN/,\?P/
MDP<$YOCM_,WF),-5DV=5SGXUC35]L]&ESH4IMHP_?U-H'>T+P$*=ZD'14+7*
M?-?JW-PNFL3S%\O\Q9]KVW,!RET ^)AS@Q$S)\:-"Q2722+$&X8<\)YU>5\G
MS&W=8]0X1Q.M]H6/WED($:NR/[L@L)428#2>%PS7 )(KG'UQ<5Y -GQGZNN+
MA!C-N+7H]%R0$4T9.]XNE3PE%8(0 ?GS\'O4";%W396754E\MO;7TF^C+S2V
M3JS9<OR=ZK9)>D^J\5GQ22"D&Y"/2ZJ6X*N2B%0>!\1(B.+F_ECZPMFGV[I?
M:/JLZ-24;_TP(VS1 MY),'Q068@6+C#G)=A<?J7E9CI0"MK<LYM66O#M-S4]
MC$G+:-IFJ#D"IQ^>TW.QZ!);::L,KH)*MR2<9JB>:D>3_BY$)T#<1$0BUX$^
MH3Z?]XZ:\S)XURCCQ8SM'EQZ&9<F(_T;+BY:)54:9;+9[$'WE)KT!L/U,;SC
M>5^#]0_E9?/V&5$.XX(/B1*%(664)P8^%<$LEF>!DFM;C6KX$6^Q2@KN7< R
M(9&*OI&%ZXCO,@]6G(-A&ZW(X)*L63"D_,M*T\B$RZ#P%LV1(FN*[KTAUAY>
MLN_]/9!R< *&>2/DHX?SD5_UL1':C9UE5%M-U*A3@U(H+=[B5MR+-T@I00LT
MN%.L.!1W0DLI3@@4+U+<W2W%'0H)[@[!'0()E_>[W^^[[OR:<V;.'M][/S/K
MK,$E9/U&4>YYAILNJ>L]-W9ED+Z_;/8^@8R;,ROKXZ0Z;-WPZ<:D-,A%:$'Z
M"P$IBE!N\#J;<6/H'6]/+CB/>;W2<)?$)HG?WI[+PZ% X\^TP;=P=6CL=%,G
M,9.216@:60S3QFZ;-Q4<\]8]?0I)995>GEQUG9C&Y5!S &O)=^QY&OAJ,YSS
M1ZP\>!6XJFL1.?W*XD$O]^GN%W3V-LU<_J43XVK'8DO-W+AILX.EF=$@JT'&
M9-?)=WW!J)+LUVLI(I3)EG)L;^'@9.[\O/EJXG.C7DU'>-=\A-4S*9Y>/\L/
M6+Q^KG<,&ILDN\G6$^&^_3CN4ZF,UR[OC,A8%>/ILK$*!P8Z:1BJM+.%J>1/
MBLAF-]4Y87V%:CSS'[;7UI8Z_'V?*5+)OETN?XE&:P:=>(Y*\;Z]C3AU?;&+
M/\!+1_5Y82/*<QXGM)=RE.$98I2$+?;)P"?308-'M+J*F!T]Z:+^DNQC'O<(
M=/KJQN$JK5%U!$D,^ZPF6T. ^Q=3O&M7@]#HNFYM$-,E"5X-'YX9,=4!*#IB
M>:1JQW]WL*QX<&<Q,RIK\+L&=9'7<_GKPL1/N)TP!:9 <96H<)B1E-](1)9/
MOATZZJ0%3_Q%@478V^/V1^W]R9/".M0R888S)5S)1"$4A/$[ENXN'=<A"N_P
MD XU($U&V3O *\7Y-#P1315$UJYJL#;W\#+ ]B4%LX==3"!NYG2&2G/QMM+F
M[2S;<_=QJJFOF;ZD^"]L:HVDP1I%OA#M*L&:?6EO1*&&(KB2_BAWW#4O@36-
M4OF9DNU.1)=Q'G6!&BE:XVS'QO:/(*7=2?$= #MX![CNOP-D"4T(0J_Y(5C/
MVY2MRSO .<P)JW/;--L(O2V"FUBMJF%".>^-U!W@GQGF@3'#@M2DQCVA2D57
MNDC<BO/^RRAU=RE D&GY^:<H7WB,R7#DAZ@-G]M8Y\KP0J8SBL&-3(GB']1D
MC-#G:G^DM+.0"_>JV.A69*[L#B"7^XS;5_,OJ^3LEZ7G; 8N^2B:,S]!L/.,
M7+B^C*9*_?C+%^(<C#RMXOZ*:Q<[@N7N%$RP? ;&LCG>,YO5O,>4>!Z@J[,;
M076D.%NVRK]69+T090JK*CQQ*O?^X6QM))ZB4001"-!UR?]77.64&0B"<G"0
M:6FA=5;R?DGS>#W[I+"AN;[<A%R]GCY?(W\Y@,M2=VHBMLD4SBVKSH)'\5FM
M+6U!4?C(R)FG^90'J$TEHL)H"1RK:AGH/;=8L.<V+_1>"EWE_.-VJ%0#WV@N
M*^C@X_C-);UV:'S[@O,K\%#'FRCI]0YA3Q,S?Q\G/?8%2]ZH=>0@=/'[WLEG
M YM7>$H$+7F,TAE+3@B5Z29CJ9=6AU5<9=*2;T*?O7NY5./<>'92.N*7J;-Q
M-/)C__P2L<@.DR+,@%SE<!:)#6OW]>L'"/9%=DEL^L$_IVXZ5IU<2RQ!ABU@
M!!,:%M BGU:/]ALI<_6NNC0E4&EOU6)1!KZ3=\]/AGZ*Y>=FE]Z/<2AMBI4I
M0U^:]+5IM_6XA2+'';B=+&]K+0T(V_8\TC,L^==M!;_$&\6@,NN8E<)*G6QV
M2CO=?ULYJN/*T>^,>QMC[@"6CLW"$^3<*9:;TC2_54JU-^WIE?54M(=#^.WR
M6@V #(-F^E-Z? @UQ=*42-$=V4K+_#F1UYZU*Q^(P;+,2X6F#H5UK95<29C)
MT@ZAA^A75%14^H46PZ%=!9]RE2-HW8OZE1K4F2NZ!F5^]@X-*4V7-1!SD5-;
MG-*>R-[F88_M)=RKY%_Y*CSY=1% YZ!D^/ 140G:&UT$>@C2O ]:H/^"&JGF
M\<[^I6TG]]]'W_(_24LWOXHI7S *(]6QG %[&"5:JLA]^N;C!WEUCE!N%VP?
M*8%WL(O,B*"%C-J8=@ML&36UELI#SK"E;]Z(**@4V@B.3Y*J[\%C[P#:F<<2
M=/Z**QD@1E1);&#OMT+9/SC?1<.[JE9T/E!^_NW<4'6"LJZ:R&:!#C@7KO]C
MZB@HO:YJKP2I-B?"':PQE@2-_=\B3VJ\!!R_EJ1(3-&7)%"V-RUT1!3@]'[#
MZ;+T",/S*^0JZ0]AHF=<YV-W'>D9=!%UI:D=#2@TGP-U%$O],*TDFX7\_BE0
M'XW@)QQ+T"_(BR!#,J<)H%>2]N@]J!SPX@ZR(OR=7[?IKWFG3DF(_*LPH3(+
MMXDVA*$T0XC,B8=RRIE69/<>P-M(:\-P&JU^M]F=4\2G:QY@/B"&2#R&^,V9
MI[13V'.="45[H\K+.1F]LWN^1<42,0UU/=W7@^?9U1]ZF3^)$Y_AYJ;I9>?*
MQWMA/I'K;C@,73EX89T?VSDBMK['QC80FF4?FM*_EZK*J^@XMY0XG:R2&%'A
MI*<;DVAV4B8PL,1+'>E5S>@;'":"&*VJ-\Y ?1RIV<9 2ST)G!*&%SSLQ39J
M:_I% B,$B\U .3%O:0W5>"Q0(]+QH'=(0K&?TRKBS?.PB-LX\AKY=T\*J=WU
M(J5,"?Z!%8';]8 K#K>%8-#Q5/RE(VS!)WO(L>R4A(K?=+;)P'7&^2KV:=\(
ME#D;WU734.;'2\5CAX[+0KZ6X]Z=<KZ*VZQT.EKNI<_]UDB#ZVT614NZG']]
MSV!=7OZ)%'O6Y8^3]A4=_KK1/7"F=KK \_ES<0-^.180Y5/O.,^TP$<_SU@?
M(J@T+V88+67:4#P$)7DUKX><AFJ9^B793I+9%S@)_]RP<R1U>>^LR\E63"^B
M"?XD_#CF!TRVUYD9K*7R%5JXMS=/QU;]9FY)3FU(VL%N5]/L(.@L7J&@2L"3
M@(OK-Z84)D+@IY<K9TE FD7.13I/_G##D8NRMZH!\KWJ!CU_(QJ&0__>DV"=
M4U)JW4^=,U4GEH2_S!E8520 H_9IJ7Y5$R%.Y(!581T-S9&FSRT=';^!PF[N
M !_=I515A$T2C&P05ZD)8F8YHFYCR9%*F4R<3@/$;,NY65Z#P9-/]$Z@(\/P
MT>C0!7&=4G4N)U$?#?IVR?BQ4R(]$RH!9OBIF.Y!%/T:>K"JH+)<-O%RKR'*
MD^)W9\&L1Q%Q<6864]6YS'R+1,J>OZN@-PU^0PL!@:MI52%-E@S)_F6CYU$V
MW4]9AX%Q=LG,OQD-+EO&@CZ$1;;:$D-?2T$S27ME_J,V]G;4SC+B$I;Q&_8R
M%::/%<U'H"R%N0['-YVSH6FDP1YTZ-][BK4.QF!W8N*\YT%T=@.;N$&2/"*#
MWTF=M9(M_GU?I^ >+C<1#XCWZ83LJ!;LJK9-;[KA3WK[Q%0258W&Q3%Q!KF_
MJ7EBYCA/]'Z_7.WK +J$\DG7JP0'72SEV<O83L= )<O&2CDWQ@PR,F 8;X?$
MWXL]SYIF+3 9R?>S=):5C1Y&ZG.GF4;%589&HE&:.T!ZR#<-NQUW@W@G]XX%
MI[-!YUTN$[[Z^A"G6)(F<_G7Z6_&C7E?/P)]E3C7TT2%UC_DM9LIK?D\&F9%
M5/C/!(\H76;/C<)-AFS?N5KMI7O6MDPKV'WVJ-I9A$MKI!UFT15CI!M _70?
M-]Z<]:>]C0$=@]+'EJ? ]J(QVGWT?EUNT6>ZB*KSP?FUH086SHSC4>)IQ3IC
MN8$LO2]>.6Q:Q);:I:K"Z-R:8CM-^BCM)0MS\LM#UN?",R(J5R(9QBKGB7K7
M>L@ 5_N8#LR[,>+]<0NQ9'5-7I9"H.@HG/%*X.<7@]"SU&B1,OPMBF0)IAK'
M9J>$N=215HU&:'+W0^&CF@^E%B_8EB,= Q@^XPKHO5^['26K688;B!X*F7_O
M13=OS>I^2Y ^_43D6F(KLGS)@F!^0];=S]=(CV9@BT/4F;1DE^?0J1G)1VS=
M <;@YW3<76EJB*150SG'-\>+AT\K*#XS:T?? 9YUTT\X:*UF"/@4D^Q<HM1R
M;J?ZB$'C-#:1SJZZ[%Z)(N1"0<R*O0LVF7A S\?] HW !T(+Y)$XPIY76PE=
M0W;L>=4PZ'7!7"7-:]A0SH0]BH1U77P9_IKBYEV6NX2?SRL]8^5K6/(XK&OM
MCW@T^]QS7+8M!S7AMX\@ :\)"Z01Z'JFL$:Z]QY<<CN\?$=K'9J)^9YZ:QQ<
MKT7YW)F2S%]7XM8)4P]'F?HI]L2[QO$&00!6&BI!#]_&++(^J4EQ$ET>,96%
MZ59$STDYKTQWDVGXQVOHI?_<-JKVGZ^J\$R*^!PI(+C8]:Z/:SV:EAY@D$0[
MEV'J/J5M^5Z24!6YR=WQ.KDK*.T7@ 3QFCE!XV]<SV;MB$-/,I1H,-DW7#75
M/&((ETDY!F&[4_E\X5^FQ3^ 5C(1&84I;&X&;C0G45MR#DF4D!]SWABN?3N*
MT..KT7C5WAA\)6 A?_@0U[R@8NL 9D"[@*1AV$S_A^&=]#J^/8/%CRL^6X\@
M#QY\1'5\]<@'U/ML9MYRT,M1_M,F12(^&3STKWZ(N;[8%GB^-W8PQB0T+FVN
M[_4G:G*M1KJ:H+$.K4G7?IZVGNV/NAZ&+<G.JEP[/,SK=P#!Y9\R%IM<6DJU
M#0+'0+LH]Q>(]32)F@,J28&ZPW\SA8R*4 Z*>+/D9VJD!0^(N[;MW8Y7'447
M:^J?LA]EL&T:I[J<OKY*BP"]Q?49([I*U!4ZA<H7VYSYMC9RZM_F<^3>4%,\
MRA(>0:,OM[B\:"'>_'77^XA^ZK0//_+IW'1#G?P!)"+-UY$.<73$,@K8&$D!
MC*!:XEGI^6NX/Y/[[RB11(.-DSI%5N:<I!G*!%*SU9'5X:!8*7'-R#N <%9E
MBRV;C_'&KBK9H*Z!(_Z&]06OZ1/;V:% TA-%9&-G/E.H]%Z+Z<R73/S+C#*W
MNOG;/W09#8$KPS<\TH34B4=.YB[SJ_3SL8Y*T89_:WT>V?70J:5;6US[PO.C
MUD<U.']#2!;#N8UW.[J.6L1KJN83OB6HVIBZ=/GSK1^_C8RC"T[LCN_>ZTME
M?1$G5I@P(_21(CX^0H?'MZR>T%_V"=G3S9].0!R.'+;PE+5W6S)[<P>[)ZE^
M'\BUDT-"B_\&XIE]>BE8B-/U4HUPX-(I%G%=OD$;H$I^"N^%>RNN/*I;W?"*
M/=#=V\?05-,MVNLRD4<VQH>.Y29&EYQ,A8@Y9H7?$.J>4P<'6M3&[90?B\5^
M-^+N!@6QTAI:[92FA3&20 7]"3F_?[;^P3K/UI2/6!#9[$TPP$K>@X5>'G<O
MH7O*:X9?#'I,],5>+KHD'4-Y*]\8,?%S3=6<_1"ANH]I$65'AN:;?X]&: 5F
MUV!N5=5YI3)+^'S(G(=<]K:T#U;"@ ;1T\<(/_?4X;5=N5F+2JXEYM[#RH&5
MT%NK8ARR^)C>UFO;3/-^>R-%J/?SWA=\"6^5RS^X+V70.ET/LTA:F;A-_FM5
M>1Q M=D1H&G!?55RA /375K2^21:K:L76LYY!D6\B,>J[S>'J)XYJ8\VG+%X
MP_?V^M(A#WXM?%0GHR!_@%-&SVR1!B[6<66"MCRL M=X:[C*A48"$B]^?/R+
M-QP/])6'N-@9=W3U_Q03$,$C-QJPH[ T8GLXSRC7&AKQE\2E9\\K91O<3LW8
M#W&:NU:\& _WR%N4<#?+R4'BIHG_3K$IR$CC";<4>^3,N'3AG\)6<(%T9X&#
M\%8SE*Q;APN7E^)54S04;HLP<.P]X%WWWL.=QY3VO=J$7"Z=V&7< 5!J-\77
M[M6GO-=Z,9#+W]";!5\1)VP0Q?:S8QR40\,(Y)CJ>%*HKG2Q,AWH5GB 5"U1
MZ9;0%6TZR5T07'B^H&P+,I(@^]:82[J@K"P7SC8& D)XZU6$&-79]\<DWQUB
M%MXH@HL.FK>SXD"DUKG4W2+*&N"L<-.R?D2WGZ!ZQ*.>3!.:>W!(/-NQ_?1^
M0RXA32Z0QT%1AH]7=.[MVO0/O*,M4OG,K+BX-,OT@QZB#'ZDC9X\O@NIS/MY
MS^W@K;*V4PZC#OF==)A '6CAC?NC13K"^*W.5=Q .+[.QYWH.,T[ ,_"A+W,
MK\>W$O42B1N.J++7!Y&4@^/:O&9IKD(4_W*0098:K\]QUY.AVC$;?!S@87&2
M[P7%;3LE:FIN)>^H'_K%K1)G5DJE*#3B(ATYK8<'O#/:@_W_.C@O@&/ERPJK
M H>:=@O&<MNKPZO?;]<551G;3,V%S1>N"^\"N.-LYF<S[0O;T!WG(AJ@6#75
MO8.J!,JRGQ?<?PO/#0Z+?;\,G(JZNN"MW<1_N2>((0D&7\.0US/O&8J0_H81
M--(:K;(@K:Q3(V-LFHC1!3*50JE&%'7])\5%_M'H85EVG?V_5?JD8W$'0]@N
M16 O<HG2C-I(@'ZH-RY=U%QP"-;<V>O >73+RD4U%[%GO/#KNB Y6MSAK63F
M#-B[^>F^Z+-PO+*,$%*OL1\@X;-G'OL_9F*8^>GI%? :ZQF?2EP^-C2 YC48
MD)YA;O]6=*RK)\?\LTC\G=CWFJDN6?MUO_WG<T>_>L&O-+6>XO.K)^:"E2YM
MH!5)B:8P*PV3S6;"$=._'Y1V'MYX2TW$?,!/I>N#>.Z7"/HZGC_"EOYBCXM.
MJ&!0>!!*_<!R\TEW=^-+$)S_+'^7B;&@Q[B7*W<-F!:F8Z5BT5+HC2*^X7&%
MG>PEI(QDO!F\.GW]ZS/P+6XL?[Y<+BR8I11]$CO]V]I!NY+_6C,P"WGM,3RB
MYNWU,?.FNQ\Y[S@@)2AB69H?\B#O/%7CJ+XLA3+TUR<7JNOS:\$V(7*ZM.&C
MPCU1.]HN";#E[^!?&J*HQM2/#;#8K_YG' JYQ(YRNRK2"B0LRJ8_GV^894^H
M=T:T=+^*K.9WH%:^9;#@\B9$,OAZZ\89B6Q71S?"(QJFF+JO.^R;J1X,O4H.
M'6D9SK?2BVPBZ^(/U3ZINA'J=XET+Q;S=F,_J-/<,B+VE3\=F=0>^'7VR3R^
MLK*D;A#'@LAZ2,3!CT=1N&++!708H(V;'J-27('?+@38TMNZ O'%O],244&[
MH1%:<\GG2"'RV' 0@C)<L.=*A12C72S8?3RA&'!/J2:K!>FF82K% GH.%\VI
MKH-N+WN'+-N]$XDHVGO2'C-HHIA#"Z>TOD2]42$&##K_O0SZZO_YF*8GC>:P
MX[990JI5/R3=[LO06JI>K> =(&ING+..+.:OH4A2HGA;@*3VV%^\E^M(?A<7
MC4:\QU1O9 ]D-5L1C2=[$HJU6Z X<L*^YE]2-48C22.+(U1<"M+,W\E>!SYN
M>*+23G^J)MKTA?;/"<(KB,H^SA7EY]#,8I3'UB[ @OJGB,,\]LTI0#AMFO\*
M[UCR#4X-+O[62W[[4<;RWT3+&C-KDV&?Y@6^9O<Y04\(@LB*A)]H!EO,M/<:
M$OZ[R3FT?>8NJ\;'LA;W#VOEV.K>HG3BMJ2[<= H/AV"WV"V#AQ^5D'Q9@TF
MJR":0:3UZ:53BS=%!H76M4;4Q@'+MY:SZ,^=6NM+U;3>%9^3EL(T,YY]6H^E
M6#43 GC=\*]S-7.NSZNE+ :]''S<W?I>M_9CNKU5[JJ3Q72>^%F&E"<X]96[
M[DWG?-#LYN!R:/-9=-3)]H&)_**-.\O'<;/#YDMU^T;+_LFK4].WREE" "-!
MD<<3!?A!QY37I5.+7QV33#3GZ#3LD\;6:<HDLP>[_DWI\5WL1?I]:3TL&"9U
MY3=[5MCZ#8B;G?[[Y-*%P'8SQ6[];)9*'4;]FQB7-J_A1?(/](-[#<H[0B&L
MN5/)"C<<[$O/&NJ;JR>,60PO.Z^UB,N[78Y/ZID/9%P^P;XLKY"P8AEM-=\W
M<D4 ?>Q\YTS[@AN,-W!R?0VYOB\++'U[K/LL"+F1FT/P >^;E@U+Z1XTG@\M
M9DFV]&9&JUS(@4?S@R#H3?1*E],P*:9"=>G)5)ZX;Q8:,L0[9R2$%*W8-(-H
MUC>N*9)6? P]UJ*/MW]_S.0-UP;UF3TO>2I)CF[?)2S;Q@;M[(B+2'$ZCLPW
MS=G,;2;@/!N-B$6$9;J\UR =:++4:/]']ICXZ?K@JPN8V!S^IC%S76;2J.17
MU*I]<*AD38)A1L\/9=F)9N[?KD1M?WYWX7;=T%IM@)&HR=D)8,4.,$-4,IC?
MA]6?V-Q]2>9+60!U(*<*M>-'/7YVWR6:L_JP4>V:1NU/$YTB ?EQ6;<G.X25
MVS.?> WVO'T_OK5U2G28L_]BKU E/68:CV?XU7]!7)&RYIL!^D7!9@D_?-6:
M[&15R(D6Y(<**RC5-Q/S>_BJGK3ZY=C+'*0J[BMG<89,IJ!ZS:D8='FY9W3J
M3-5%6C?NX#K]/T>*#J^^+_>82*Y1*,G]88'L[+!OOBWCM#/O&!UAV\:R%1'+
M.-J=1!:+]P]*SD[J_,20SN<O7^W?,M<5N:I7M"F8#Q9>)4_'7,5W.><[6@LK
M/MT.4@(CF%L$XTA)\2X)29SH#YH/#':WY2<7>ZN\DS<./^YK#)^^TW!;Q%$"
M"NQ>9D+)M8B&(MV_9995>,4.< $>K=.-1T]-4)DD&+O(P%1>@#^??_&K[(RG
M"F/T\RN9>=:/'SBPR>\H??,W4/KQ@C=37$O;NU6X#HS6+"^K<CI)C:_3]N-/
MU)?/,X()([&6,=]%=_)$[%S&^.PN9SS4/8J><7"9J$IPC@<XG)%B9<X#&MNL
M2$=K+=E  SVC/:$A?/SDVJG43[P:<MH($Y^4R/D.'S3N8A-V1D+0_2<U)OXS
M&RH9D*X';2;O;%,,0*?@TN%*5@98\'I8E:*ZX&S=$U:F)>>%5LL]JT?T[2Y]
MV6(/.;?WV L0^93.T@EIP_SN8/9LFRY,R"<-2).,XNE@,50?(WJ=G#AN4)K7
M?@Q)-4,E@X-Z=)TZQ&3(S$VO_[[4GKC(&'38RI;,]JN<$V\V<^]&$?Q^G"J_
M)==E$ROV0,1K_)/YU#$[M2_4?O5:@MSHT\*BE%CC/UI9&L2!%*4,RP$HF3IQ
M*(J]%'M$,1Z>55"\K9J$:H467ZPT[KGB,>*,Y/^ U1\Q&]OZ0EFHWS,VUNU7
M._H2NNXWUZ@0JA_7\W56PH([V??H8=/V7CIQDH6<Y6]Y37Y+#E-[TD5%.[M%
MNL]\MH[JKF\<S)3,O*I1I-<[V0@754@K>)>'/J^/;4CUU,9P7;<C9D! ZK3V
MHR6M:-@--7[!1M&>FR&_3O77SX*W"'0I],4=H&F4ZX*=66M!A#LM)PR/23]M
M0)=\#_<QUU-3WRH4P'FM>G7>"/W[;.Q7+T=HO%]VUR3W>LTW0]7FN?C/%^0Q
MZY5DA0IK>Z339+(=PGF0%C\*R..IM(!0GY\OWO@DVLU5N3 GYN?"ZFZKZ1NO
M_0)C$ES;];+<HS4"]%6&KR;+-Z74MC ?,1SN\JH$%A%#Z;^&WB4\RR2X X@%
ME<Z*(H]QW#Y&^E/4%6JFRS1Y?G^;0JBW2FW<8ULCP-DFJTNA[&F6&',X4 ^/
M_M=%]]WWC#&TJ&W8"EOF5SHK;E#.TKG (-<9Q_QEI9)^.PFE]TR$J:N1":9'
M4=?3BG?V?G.3-RW]@WTJLBZQ4)C[I9*0G?60@BQW<7*+?#OS,2\5BH+LWZ]X
M,"I;E,"#8OC=*;-I75?XT^?[=9B7))!RXX#MA38V$UYQ"1;A&-D?'B4?EB1G
M]!)O'AC_ZQ]*%98^-='GB9:X Y 8S#KL%4-!,L3O&?C!?,PRCXA50C_J_,%C
M/ =M-\W2)>,F4I;WS;N6^8]@@*N-_!)2-/Q=^VGJ(E31'1+RW-W'.L7!LG]@
MY6%\!9*+W48N/,4G$?F7X]<&6A4BPJMN!7R-P,[N/I.:7*A#<>%9;\K<17\^
ME2NKB(,Q@)]1DR:%>;_^LV_$UPU]ELZ0:X[' Y#>K]-^WRBHW,=[MV1J]VKS
M;:6+769R&W#-%K0[4P8NWI']]6"X*C;J^Q%S[8RD ]/*6JR__R?&:)PQ^*GQ
ME?VN)*%Z1"!S=T(WE2*]N,WGY[6S-73B?@EH _2OC]RCY149^"7"6U9=H\$F
M=")DJ1'6*4RY_RJ1?5/:0+?8)XXE]0^@HZ*R!"*PKY&C-"YU1I:E'EI7DV+D
MV)2+XEK*IL*4T=]''_W>!2.OI;C;A>[-"76++USW\-M/XWYRPD:APNM,<EZO
M5 X;;ZZ6AZ73\;5]0#OI4_G^:.BN(RPB1V1_VC']D9SY8!@M=6Z"$.*4H^<M
MI<)RQ==\95L[C@@#+_-7"XZL[\%12+^9CMS28-VNB-?RX@,:GW2?[L,E7;-X
ME&+-J& <C)X<>Z%I)%+U#B%$(]K*5XT'3<KZ \4N,O1[!G$N_IO+!C%D*=,>
MH1?/4TG,>V/UG+\>CY/:O*J.CY+Y/J3X9AI@%'8)_5I1C,K*.C_>00OY8YGT
MF$92FJSS\QWPUG*<?B"&WVD5UJ3\" K0K"G,2R>C.LT=U^#XA(E7,RLW&;K'
MMG@RH 9X_-_WHH)FMR7(4&$.=7]^(<"Y$"984_:>FN/Z#E!-!;GZ#]\\IW3N
M\<WI/WQ+G[]GAM%+G9-=ZR\F)U5W@#M *QV&J?R+P_\>S3$NW $F7]/E341=
MV6Z8FDFO!WW44".=":"ZN@.X@@QDGW*):?KOGMG8G*7][VVZ:9M^_UW] ^*@
MT]S9O_SO(A_V&V@KQ>YMBR#XHXR6EG'ARAB%BA"S?XT-AY(@>""*5./IQ79:
M0"NI831C%,*)5 UBQ*U06G29NU-WDS>WW[:3E:%Y4W155';/AJK/;4/[P1ZR
M:M%H@VG#$S*.-..FM*1#X-?T$QQ-17*52:XO7X($TF,N]D,NVC,M/M8;GX)V
MFO+ZRQYLFAA9J21CU'<Z=I/>4*[+5PH;@>321^@7,3_TFW24W.9EA!9.!:M^
M,3,8[%#4#M_XD^]3VUJ/L?[Y_6RIV\8%+6_1P$^;,A>3-0E$7;Y]:L0@6P$E
MB('5JE-0'1DE6G3M-;/0+D6=S@ "QH&*P$,#26-S972D4TA,K:9R (&V<4J?
MX1@<IJT"XV8D<>K*^'RS7_RS"&&Q(H *9_M3R*10Q##[+J\V.A<%;!UP#JDF
M65D<=JJ8M+*9(]A[Y.Q(%MUR%J9&T/P(=S/'XQ5(SL#A%4Z<I0/1$Q7#W37X
M1,F4FEL/B^3OG;_7L5Y3<NVS<H)F:W7G<KNIY1Z+"W5+Z-JVJ\]\[E<.MD/1
M^'D%8:,M1I)+(6/%8RX7ZDCE,3#0D^8.(*^BK*B4DAQ I"BS4^6A'NZTJX8H
MV#F^-?O50B*]I6VR0O8@8!S#6=2;]EXQ*P'FUI,5Q=]& I+2*AKF]W-7-PE%
MHRBN"C4Z3R&JZ&^-FA6N@EX!#HGM8(W9\(@QL 98E"!8]V$.+6Z\'@7.6IIM
M9$2H,R?+G\'L\HA("\V2EJ3AVL_--.$A(Y.@'>C*4-/+A0B><8.>$P]/[-4-
M&86^FK9;@I2Z6Y9;G6 ((9=A>_+//E'S+_0,EEKD3;"#)N-NK\!7[&3B!M8[
M![]0BN)Q^#A" _US.7-;;$K5*RIB_;%"FT5+?,,";:DAK-$)C(TX^3_L,S<.
ME@_&1L- ^(@RIQ_RR4(]&T+B6&PG9[Q07[5TW#'.O%D/>Q"*4;;U*:B=064J
M6SS.M@/M, \L7K3\:,)OL7 ^&%7P#?:TMVK#[.W.\9JGB<]4+-.!0H%@W I/
M)MI]L4ZJ4**9U:PK@W? 'L+MZ?=4!.?!M^'AP;[XXZI[,'K["S9*MC"AP:0,
ME UFX/4C<6>L?[:2KA']XXP3R'NE 32%MZS4RP2 IX/,4EL%<C.X$:0W78.X
M]9ISQC0H[K6W@W< ?G'?,BW\_7=U^*L6WWR3^=5:PHN_COSCBP=<9=!$EP']
M#<YFIKXZM2G;T^"W-,BEL#.UP\)G@;=6UG-DLQ?X<<0[<I3E'.7F)+KPPC:-
M,-A6RP>]"(/7(B'HQ%7@E['R7P+!7Q95Y)/U^V(&1VHWVCIJC9_."+<.,/[(
M<(/IS&5\])VTTO>NG6@NFVV_A<_>MLUG1SNW6P['&KJRRW@7R>>ZNS14- )%
M(1-E;B2;9QG2ZR7J%F;N<)7-=88/JQ^ A[^F^PS3Z&^KFON)GL3TY9;VK1VQ
MY;[=0<3$UE!CZ<^61AM5U?2Y6:\_N"=MJDER#WUE5AFKKV0GCK"8H:CP[R^Y
M'$\X)ER8",FKQP_H7S!Y:Y=$=##KFQ0%?:AM2A/66MX9Y=T\'!T_.H*V1JGT
M6NE@Z[V=)A%.NKF.%OA!L99IFO,OJ9YOF65_&V]K*M^@S&=Q\:!O^:HR(WM.
M]C"1O>^X@+$]"D?O 0YG<FJ6;0:KGJ^A&E>5@U^W#U%*5D17X;I4070*U&[)
MZ@2+!UC:F.>I*"J6BJ+^R4#_&>\]7[50Z'+9Y+**_R,T1#6O?3>J&B7RQ^,T
M<>.%M@,_=MHBG@GZ@KVRJ\(RV.H]^Y<Z8-A+;WU5@GQPW516G.??2X]79=[Z
MPM/DFF\,S]?9>K;?$?V-H\X!2>881:JZ;M(WWB!EU)T@^ZXMA%F[<.:JY1WC
MTJGDC6LN!H:%U5#%V\.!!$HSD6IAAG'JA9BEL/.1M;$%HLUT%B?PV:0D"Z_!
M9E?Q[Q_R)!LEUF#9=8-NCLA^VO>-" O?KXC25B'G^8_E8=<9"%:&#]Y#+N.T
MBN]-WO3$]TU._^[=D"GHMV$F+A:8LWT>[+O7,,-1=>M&O,\'5I/U?C.E4K6Y
M>FZB-%SD7R\A0.\(E)',U883E?KWRH@^U(GWZSV)&)SO$Y:L1KN=4KQ@>H6;
M)J/R6F;Z-)D1RDC<A:IXV1?+^?(5>P-CXQU@' B,$U^CU3[S3+4@KFS36QF*
M[BG[B7G^<FW]55!);WF*0Z+W4&]5./F?IC5?#D7+0L>]W*K=Z26# .VS^J0;
MC^'-25*BX:J#J\JA6(/%GS8O81Z QPPM'[TUGSSZZ %_9)B]H^.Y2PV4S#QY
M7?\Q*FYH,64D_F*O(569.89/NRGV8Q+B&RF4J$F%.DZ*9%!XE?H.(-[#[;32
M8&].'?)=7,LO+&2FY3FH*O[)Q,)T)7YE*L>@M7^5:<,84PZ'=3^O]>5M6$86
M&II9Q8(RCAGR,L$'I^/1?(@18Y#Q8U_SO:FO)K3I#?:G.A%!63F>]O+?)I\V
MVU/II%Y1K@K(2&G!.)X;,^.[_$L$KP:ZO^>([9-GB#6?*+$PSG3&:G(E$/"^
MJRR^YR>9]ZFT!M>"5#K&1=4L/54#^."8;JJOV?WV!K+2K@'[/MD[<%3&X"+L
M!%KB5[,;,M"%6OPS;R+\>LBT4EF2-]#4FRQ(=CEP@,!2)I5\V:E3LA@+;5G:
ME2H\Y/$[VR'P(SCXN6-438?+(;IAFDC)LNZ"M9?NTQK+]ICX4XOS>"Z4+/VH
M"%)T;^@--X);PE[0#)2:#!=LBH</:U2XH.M<1 PC^&",HET&2KV4;TC Q,Y@
M/_=B^YN?TR($8U$P_/TAV0(42D,Y4#?N*WDO].O^FL^FL8'YAIL(<DG]+ +$
MN#_77">+OR*0+=B7S,RIWQ5&,+:#<]GZMZ3ZI^A/!TF]WW<  H5?HQ2Z7RXI
M:EQS0!XM5"45SH4\8/-]209&>^&MN$6#A8*_PD:=R'A\]JT7:6DZYS2->P;&
M$] 5-VQ[71ES<N_*0)H"L25[?4NN>121]D:HS:O CN8M1"]"!X3A,#VW;W@=
M]#8 -8PVW/-[0U<\^W7QD)PJ-9Z2)=;F*8"84O#1O(=$!R,](X -\##P8?I#
MQE!&]J/W*H9S1Y_GOF;][2;_SOQ,(BU_7*7_D*7I+SEYHV2;U;@_RQ^DVC&=
M$6E$@>'T8D*4/,,;'N_%>.^QHGF4ZL/?M%(Z9WG9N3F\LR:#,P5TJT)$6Q^-
M!#40=3^.QT4Z;#;3BI"SFBI3#J3JL?;-3F>VK\5N.(2WI/-=]E?R-&PU5>(<
M2#74.G>QP4BWFC\W[.?8-%*-&K!..2;E^ XP>V_N;TGJFNJQ$9"V.T"<_@ML
M'J3I#A!O(/56\&,U_791H?4=H#[_PGUO 8XF,,GD[#*H1W<RW3)I"ZBZ;:?R
MPD]4#,E"@U8O-,7UZ_]GTYZ2+1M$:IV5"*)@BJ<)$%<EK7=2X?#3R4>T!2GE
M;44]MDY[XGGO,ZKOU K)-F-\V)_?L(O?P.42(BK^>-[">:/#DYWRH>(JI"C0
MD1$WF0(+83V'LBMG5R:7%5;;%#/(QXK?]-:"^?MSL0TVHG+55G'W*9Q3UJ$W
M;T7D]R9A6Y%X+')ML6JD3[QI>^"T@SK*.SPIXA3NHP2Y!@O:U-RW3 &>>\6_
M"F*^&Q8D5*#^8"6CIB>,I/UW^&RI;<7Y<G:$Z><*UG.DG6N?_VBZB&5,J&V+
MW>D3)I!+!'):BA Q/2CT]>)?Y>$1]:"<%W UUL,!BF@"GU*WUOWI[0\]CU:$
M@AVNC%(GS 4(+HD[9FJM^J+70]K67%)-P9I&#,1[-\UND^5(";#PUB^/$D#?
M\IS^$5""L2K58WP\@TAGD:DA0-+=TJ;*H?*4QBWR92 EZ[QS4@G,D_F++.P)
M%=E<D5>1G=3X@G"JRVL!KA-:$: B:Y1;))!M#3]7^O.3/O(U<(M2\:7.(2^T
MVU-+RP1JY/BI-"ITOZ2:PI@"6+28>V@RTC3<E36KQD$:ZX5\@DS4*  $BFEL
M8Z,SM//'WQ6R"[UFIB+4K,E(W$8HLJ8IOJ)V9!](,2?)0>X5D2\[%\R;/&_R
MNO+7_[F_:,N)U%=2$E0?YTE"JN\5A;<-_^<"OM,JXYB0WS?)A:@6#*F%.GRB
M"T7 B]'N>,S(?Z>218*(OHGPT!:-;=ZQ G9KX3FO]S3VU.\U^0X?2';.7;0K
MDDG77>0-EJAJ U^SRLDPAU(N\^'TQG=?TRE4GHT7-QDRT!.9F]M%KRU*X%2B
M6]Z1Y(36GK]:$'+P:;O-Z#1MMTP9B^-LM%2P;9!?3_:1VUV4GBYT;+XJJ_7V
M8<UEQB-MX&OA'["4=?@8QK!L1)14)-;8S/9X_C(E^UN]PXTF)[3V/2$7'@-,
MFUFWHT]EL. 3U_HQDLMI3K\ZQE_"5&^]Q"S@T/SDV/A]CS?'*Z0(6=)I%;4^
M39J#G?;3RN'Q,OVYY.><] 4,\\Q+9M&#56>.VIX)U\WI5A\B#=T6+G:^5F4F
M,%[MDTXV=Q4< XF+V1BRS5^OTK*TVK1Z;\!5O'].OSTTTZTG>+[TPEEOF:-J
M4)C(_-DZN3:)?.Z,RMXRD=4RQP*XTUM5RG*85V-]NE#+E>4#SS5ZM\5E9/#*
MVV%7]<FZJ:U0MY]=Q6_5Y)#D=7K/(F+:FE(X2:FP2H__J+E#%4&CB[J;QUMX
M,",90\<3(PNB@H>#+EQJ#N_'L ;V!BQ;$[S(+RJ]^3Z)] /38=8/PTRMJY@2
MU-_P5-N:Z;WD>_Y98BXU@\ GH,O+C"X9Q[].*Z[Q07CCZR^R']."W&&I#@D<
MMED5[+1YE7DI1'N$6\^? 'OQ]?8W\7S*RZO]$*CXKL0RS\>1RBQ %@*WHS6B
MN,=<)U6"F;;Q*7)?S.RU[&LS3N9R^8#Y)_G6)SHY56_G!C&1HR<PRX^LR;*G
MP,D$K6@&WN#RSL@KNUS2KUQZT9LUQ:5-08QEBP0&XCOF,XS4DZ +:M5FCC!W
M$II+8C(9,E1X1($(D(M[E%(%[OQ3[,C" .CX)SZX^?VM7Z\I6?W*ETV':\7D
M;YR=B:^;FJCX).$]+Q[-<BKA$AFN:',Z=2?SZ=080SPX?PELI#$0Q#^,02KN
MWP$2_YY._ $Q@X3V5=>,X@S?L?;?'J3-I_J>(%SC'/J^/*G,I65Y"UU>[ KT
MY^BB&R&##T[.R8-[J26<ZUGDW&S^O/V,H%5G9PHARIT*;/'YGOHHAU9HN-XX
M3>SUH:9[>JYSZ#'?G,T9:4U+6%2WQ_,-0M-WU,Y]Y\FD!MI[*/M=RU;IG<D^
MRROH'SDA9DG,F+_:V-(G&J>P]0.=.&-SM_+15:]R%A9'\I6GU_X6_-J]?0^W
MJQ^(/_GJU31O^.QXRP@C;+I^O1NT!4_P5XZ*2('U)$][>R43_?[SBG^7^,-J
M)NQX>JV:R.Z)\);!I>C9;H2+#N.8BR6B3G=CF,NM-&&1G[]@= -9HN"HY>]H
M?#-F1"'S. %LP+90#B@W>U?U#)HN\CS('678R;)#*\GR2,[<\L6:,H<M[F)5
MB5WGRFJWDT&BEO>'\33%J7=2284\'G1:#HZY.;TP,\/@J*!.ZCKU P;G0D.!
M2H,_3YX7N_&0A(KI3RA?=9.&7VAU.'*%3T,#4XN*=D-5A1V]H\O5>?:G]'[L
M&*>&//" !85?$44\\1J[/A7YK)KE%3?2++WDV9XPLYL<FUSF:&1AR3KV]^3,
M):>XPUE<)38OG/DE#?*5Q0:7]J71U&#H>E#X+,?YS ,2?_.5[6AHI[]NLR.S
M5<.;Q%DX'NUW[@ @"HB9<UFP)#G0$+Q^..GYS%#_HGIGRMF%MQC&%&_YKF@?
M7BFL]IWU.VLCB<&S7FIPZ*J6;B\  'CQB?J).1$9M<W9^#X"8@57U+;-T-V\
M@I;%PMSQ3W-);5FQ3G-*+3M]',T\"Y+E9JA6!6_-.48OQ@ '$-CP$LEZHWP>
M\ /)>PP&EZ5PR.[_ ;I%':5XY]O6"J<_+"@J'A/'!C1[V=@D9MY">'U0KR5Y
M+07'0Z 3&/:"'0XC4@V/I5[P^%C=(B5;[AC(N/X.,-$*O_U\!QC3WR6G.U''
MP.NE8/JXV+RY>X,/X:G3MKH#<%;18<]@:'GCP?N7F=WHARV*S?@'8@"(GVU/
M8OE$<7Q$N/"'WJ;4W,+M_S7UQ0@'3)-RN$="SH*@(?A/86IBY_X26@/434F9
M-J^\"L\^MZEE6V9O8K<>4U IE.(=S OWTFX03-%/B"+5M B@*3X[P]ADA8=5
MFFD,TNSBV*4PQ\[%IEFGS2Q;/&>J>^?!E/."P=/>J-FAZGPNWALZA6O6A4FM
M%B0^J")7)$V3>\/IR/&4(;H,YY;; *YXUKNOV.8$5*:E!/1) \1P6TX?SONB
MMDY/Y(0<$/PVY;,*IFH"S>NA)N615:0!-LN,8-/\E.@BQ+),X&IF3-ENF=[X
M#>Y@CZ?A^411=W)C:?D1&B,T5EUUJ\Y/3ZXIW+#IM 3FC-DMWI(NK6/_Q/R6
M=A+? SDBPB,[$8/HF9.T<K)*(@BR6L=T/K^4-6[Z,[&@+K#FD&]5'5(QY5IH
M_W[%D=K!42+>RF[.PH:43Y@US6#Q:\:OVQFN[NM".43Q>O4T08$P_</IQD69
M[&/C"(3ZGL&K(-(O JA^QLUS1)V?1:^!_K+G! -QHFIHZHT4=VW+REIM9W7M
M3;%HG3%C89H0L6K&# @C5:SG\F=:A.=A",:T<453?N7\#B"#.K,E-8YAPPT&
M%;+;>"+.4[CEDE2&MW-NVY!CZKUSJD9R=P"\<ZTP2<JP4:LI#.7/8J0/NXU@
M1Q<56)7TP*B6&FJJE+4Y(?#PF2U+S%R\X@K:]OFY<H\C"J@&$G)_'*E79O-C
M?C%QYKH67S@EG9897;#TD4>AMJB[2.!8+1,NEZRL]M__Q&=V=*P]_FZ_X!,8
M\> V7DM2EJ2>01]]HSBPG62X\CA*<D#)%O4;_CJ7&B5PA#Y_G/&B[A="R*B-
M!)5#C?IT; 0NEFJ^YE"162+*S2O[$^"6]0/)/0 =I9WUN0-$\):?L60#>\OR
MBAS,YU8%?T44F*2QY5S\WW4FAOS;2G)R@<(W3MC,00H._$ <\DZ@23ZRN_IP
M"""4IHUSH'4PH#N5'TN.X+YV'G+675[>ED+K1EAM&TGL9SSP0>E[V%3YQKFM
MN))'.+LPPFU\+&],+ISCWHVN;H9<M5\$D)15_[>KNH=IO$W9N@.@T[ HK)']
M/,)R4("G57U<'G.(FJKR.,7*4USQ&[,OO'S>X7$'Z++MG@ #?7R%?"J1#,]N
M KK'-;XOQC5*O1DW3LOT'%NX=LIM9?FV!+[(AROZ&#UJ2\O)/\H&4=R[V*M1
MI(;JCLWE/Q>[QT#=^+GY1;;4-F1^.KMCZ@A2A&/:?00D5]QTF!4>.@3^Y-M'
M^NM=)"5K_,^POP[]+ ]Q0I'.DAOJTQZJ3<BFWJ(*M(%-'(N>N>&%&C+;,-'N
M6]^CO\:W]L^+12KM3QUGPE.H5WYBS DI05"GO,F5KGOL>Z-C.F%<X828%9*,
M;CZJ=M[5LQB,G0@=3]-A(LG<H?B%DRJJ7&]T,?5P^F)&9 'E<.CQP+(?\O+!
M()30T&&@6:9%]Q61*:B=2# :8;I3J.?'H(R?7+H(GE9R*S[1".T$+U,5DQF0
MK[Z=#J$)>XPBJE$A''%4"/T17HX:R7G5M?<*=[7!D;S>D](#9WY\N 30OG^I
M54L3>U6A_@9XU.G0]S75O2YU+YR'L<;B^U,9=&"^IPF-:=WS(#KRMX+YVA^<
M*3"S.S<>2P1$4%+ 9N&"IHS*5-%!\[D1!@4GF\2$K&9=^<A!C2QE.#)<X\$4
MWXO<CC#B VN%\+QSGC^:93R[$UH^ :T6Y"++ONSRM$*JD*H,M3.>TO('RN#]
MU;9#&F[2%+8_/C8V[7@4V;TJ7_!'<M[GI['S@F9\L,88N9%<A?U"FG9RLH=%
MY>'8\HD"E+BL"IHE7,FXX]*_L"!U]2) _RLUAY.M+;NW\>^6Y\^LTR@^U7-J
M-K6:.&B@@M_;"J,%>X"VH+#0A@VYI42C#ZSTMM8QN8=R2PF#Z%JROX7E<@M@
M$96I3I7)&D/-]8C95HFE7"%0'X]:7@3R'>\&O!?,?]GZR_B'VF Y"NGHCP#M
MN!O'1LE^4=4T3FGUD^(=+3IY.>P\$.@P&LR'L+A?A_ 7=0G+)WGAO* +)S2%
MUG0$G=:C-#7X1I-M6I&_3)3T$E$^#GF.)I+8-1?)AE09"'1<FU.NVLNMESTV
MDO=)*3R'0D+1VSE&,K<[-NVK<'D44NW(UWJ_4(C"DEM*:Z<F>G]60OQL]]SF
M"9FJOMU)(=-^7G[T'Z= 9$B\*BV=R1E+L8;-'.]Z!+JFON!0*>6G6L2,@HT[
MS9O_L4$IIKFY1%J:FFI/%@*6GK\1K#!V][VW7WS[^UCZHZO[=5GO? =@ABQE
M])?YED"&EE:Q U@CQ\A\K(8)I/_%:=S2X>CEU 5DB>Z@#7.O1UZ@J2'CD@\&
M$WE&05Z'+MADWC.G+:K5K?VSRTEQ$ZSE/;[:G1PC[P [0M [P(<\R)!3N3Q:
M1<(;DCP.&3+B16NQW0&6M^\ 24U2XP7W.;*Q9O=/2MD80NAU1#:& WHF+K7)
M STKDOKW_\[E>:]03+'E+QP3ZV]72T!'D)0;=HIVR+K4]_N<"H60L2+>ZZB\
M=,B68,;V&63(@7X+ZZK@#4F=6,S ',9 ^J"G\M@7%T +"#R [JH<&M"@DYJ!
M.(9GWP&$I7).KU)7SG1D[R5M"T""L1N#,5L[M_$L8"RF1VI=_CILZ?+P>O1"
M[P[P%M)\!U@-H+)=',504%U#-T/:!^L3LZH1MR8+WE@ZN.9;^*(+9/WR>D3J
M>O?6ZBH)<EA^"3F4:M^?XEOX[R@I&W+N*35ZA:G]/2?Y!@O#1&F(W0$VY?<3
MH5#H19LDQDDTXR$$M#%SS0F!KIB<)W+DPE:7;G]@XC'P%W165^+#G4.0MWN%
M4JO& _E2+S#?+OQI)1<L/F]A1KYA3XM$@!I8Z2N(TBY]Q@M+"3%(#8KDZ+[,
M.P#=_I47[QR&$C*C=@<(0T@$8T>ELK%S\C.J=(=*3O78Z)8 ^,'V#3O\6#S&
MCP23[J^O5I5G_ %CHWP'T&E;D&>UXG7@O=7^CHF_ UC1CB(*L ,F5Z6@^T1Q
MR0'3+2PB'W>?]4;\ AL\[O\+TK6SL0K?.T4='2'4I(8WKFTZ$V_44_?N:[)4
M#!X\PEK5)=9C"E5XZ=#OCK!3X_ O64['?O?C'CX.F>@IA!S89!PKA4%L(#-3
M$]=>-B$9EY1U&</0\U(QH-3V[B[2"<LZIWJ?^X:]_P[0#"WO!8LPW?9R?,!>
MY)C,OKAP7=L[OO"RK4<+"=X!6HMDCDPNO,\Q^J97T#/;Q&I,<9]FP"CZW6T]
M4F7T=BZ>]U8=BFY"U_1<08;_JP+XODTI@2=W ,%L++M"&SMV)* \7ZM9:JB(
M:113^MY7:F:IOE?Z?E(72!W:1L(OW0ORUJ4RQ_.E+DJ!4I;_I9Z5%65@<7+N
M.]838X2B&[[O,<3]I*E90C<A<3-N)!.QW*ITF 5;/&_HN5,=]*H6?^4.(&^B
M$_T'")_YQ=HE-8F<P'R__PHRMI('Z4"98R_S\K]#JIT>3WP8Q23*WQIG2]&A
MQ>\ M4='*G+S=X 9P\).S*$2+2=VY%:B*5S59"_\Q<W2C#HK%$-CRS2(@2G>
M 5[EW_N\F_<SX<=] RG^C#ZXEV]2C2G/#5A@O66,J\>4?Z*HQORV@<Y@\PM)
MZC%.*FJ8>13%E1HZ/><.$*D9]%\=C25'GVO3'>@[W9KEJCV^EW ?(\\"W@%F
MSR+N1Z*5'SY?$X(YOB].Q\?IEAAZU4UW[IF-Q9._-8.BF\?N (^SL?P*;5)G
MG@4Y5_#I7_#C\/@,XGLYZ:,SZ%NW,>QZGLC-TIR.VID\MAV2#L&,7M\OM_N:
MMTZIW '&I2X\T4MW@)]7D%-.^3L \L7I'>#<\^HPXD;I;@;P_QW^#U!+ P04
M    "  ,@'M:>+=;=09>   $<0  $P   &EM9S(T-S(Q,34R.%\S,"YJ<&?<
MNV54'=VZ)EHK.,&=! L>W"VX2_#@P=W='0($6+@E.$$3@@7"PMW=@[L$=Y?5
MR9=O[\WN<\;H/GW[2M]:/VI4S3G?YWEUSEE5"SH-708P9"5E) '0KY_!KQ\
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MP7(L3_93E_^XC2+0R*2*9FBWM#O5\XPD"%7SN"EFH4'N)I#\B:[@.!7 Q5B
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MN>X5Y"*#(NV'=]K;O.,,PM-YE&JD8DY?^YXOVG2<!#RN_G[$&J;35*VIO?J
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M;CSYL_8+[GU_W]&ZC;F>\?W])C/QQ9QB+P-^?FX/3ELM93>WQ)<\@E%O<=_
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M70/XTQW>GU\\0Y:O>SL,QR)LT=L:10;A/#E 3R>$^9E^2$MS/S4A2YNH:-5
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M]KUI28FG'O>_AHQU!UXX!@TS4<2LO:MTY\,;_Q_@;TP7D\ _??TO4$L#!!0
M   (  R >UK2##F"$0D! !(M 0 3    :6UG,C0W,C$Q-3(X7S,Q+FIP9^R[
M=5C<V[(FW#B$!'>G@P=W]\;=W=W=-<%=@[MK<(?@[N[NEJ!!PY!]]MGGW)G<
M>\^=^\_,-]_BX7G66E7KK:JWJE;_H+M?%E^V %@@-W,3 $!<G H "_C'>#D%
M( L[&UJZ \  D*]KH]>M+4@<,R<G.TXZ.AM'6GTC6P-C6D-;:SHW?3LZ!EIZ
M.@ WGYN=OJ&EL1.1@;&IN0T/\%OK5R"1N1$/4)5%FE[:3LC8S%S,P\%8T4-&
MR=##TI##",C'2\3MQNEF;6=M[*1/Y&9M9>/(Z<8#_ .<\W7^:YL.2/2'BI,E
M#U#@EX!(35J.2,C6P9B(E9:>QI">GI&(C8.6@969F9V=FHB1GI&>CIZ-CH&>
MAI&1DYZ5DX6)Z,\!?+7F8&3"J2 L\J>MUQ4/\,^@7%U=:5V9:&T=3.D8.#@X
MZ.@9Z1@9:5XU:!S=;9STW6AL'-__'4'8V-'0P=S.R=S6ANC76M_ UMF)!PC\
M>PC6=M+2?P'_EBUK:[J_:SLZ*1B;_,?:CDKN=L9T"L:.MLX.AL:OZN__R=1_
M?/3OBD:&?^G9.3M8_1&GD2&=L96QM;&-D^.K+L,?NJ^><PK;&CK_VA47Y@&^
M[M :F1MQ@I@%1 09&-B9V!F8&1A ( XA9B81828V01$V#D8V$/W?SXK;.#KI
MVQ@:__VL^3_.LOV'9SF%'(SUG6P=E&QMK7B TN:&#K:.MB9.W95$<K:NQ@YR
MMN8VOQ:,] RLO]+PIZ?&#N8NQD8B#K;61'_PR&G^&_L<3*P"@B A!B8VD3_L
M"S )"PH)L[]Z)"+ SB@L#/SSK-%OXO[S+.._>Y;NU1DC0T[#OWG_9X$H&MO_
M.;,RYU5T-M)W<#33MR$2,S8PT'?@IOM30/2WV=^4Z?X-R.O"R=S)ROA/% $K
MI[_P?B64TTK?QO3521HC8Q-]9RLG(*^ LYNM@SZ1L+&)N8VYC2F1/I&<OI,9
MD8BM@ZN^@]'_;/)O>'3_9(7N?ZKKOV^]-LNOZ5]=^KKXJ\^-;5Z;V^&UBU_.
M &)R9K9.MHYFMG9$3+3T '9!<6E(R#_N$D0\, T !"ZI*!XX  #^^O.'C/0/
M&=+3%F'H8..0&QVS 3.,FNO)RSD X8\N!QAUOLK!7E8  0"P?WV _V- _#7^
M+OM##/;/DG]QO'0"D&'!,,#Q(,"0 >#(8!#(8"^]8!"OER,8Y"OZ/^Y-:$@H
M&%@P< BX-Z^[X'\8_DOVN@T)_2J&0WK5 P= 0$##PD' (2/ _"&!@@; (*/
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MMSF]VG93M D]M;_:R+WH&2;"1)D;I^W19OKGCWK?Z-+,SP-:S)(%]*>_*I3
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MOK5NJ-$S=!FKF1"/4@EM,ZR]%+_3@3X.A9F-6(5EF1%,57.EI? /C@NC1:D
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MG(;CMM78: B$3PO2D6LH/S9#;9?:PJ:YTJX(U#+:,Z+:IE6N0HYG0-KW 2
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M[WI(!QX(PI#G2Q&C8I7Q6M!<_VI,;G9$0B(?Y)^%R)(H*:VSRN+=MN6)?<9
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MZO':PV^G=ZNQ-B8L:0OSB[>V:O0.9>\^V0@8I4L*,-8)A=3Z[*7-L*55B.4
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M0MHUBE";TUOQMMGSUARY-6W+>9'Q][MZY_22ENS-.)<G$+?.<Y@Q5F/5.%Q
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ML]I>1U\Z+YL2NS)5?OW&I@WTQ.9!1+P9IW%DK5Y]_N*Q7OWL5HI7NQG4=+)
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MOMX=JD#@]EIX@!T*;<<]%)U->[GE$3,>AKG9B@7/()BY*.^@.\F&5T^YO1B
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M)L/^8O;*T&%2Y0LQ4$N\M'U1HB ,O&,@$J@%JYA^]0LL^IF/G/7=&=F&YWF
MD9^%_7@=D[(T\'.V&S---<-FSVK<UF[JX4J:*Q$O32W0]TRE?!</G,[8.P&O
M%!<+^2*@5ZC<.E6RD<)[6Z[!/G@7Z8[74:,&WSR45NVC5>0J5;HZGM>!CKW@
M#"!SHQ'DB4LJFP#G$QXRMP=W(:7&&Z":4Q1;\7@H*Y'GTF/W-K.U*:CGXB_J
M@A^O$ZQ/W-82)=OVJ>OM(AN732>&FQKZ_']Y1#IG2/&FWN79 IF$# -/'D'Q
MSU'U9X>,K_2YV-$B)?.XD?"<!3KYYE2@LK84)2S1@@,NRJ,9Z9C'JY/UJ?;*
MNQJYW_*!:^60?(614)CHX_69%Q;?VH32O!$8$:Q")2/:S.&IL*YX/F9MK4I)
M),H46X,I[@KOBA0C=A4?P+1_:*F[:D@(!YJ96Q ZSJ<!,>MHHDWR296R.ANK
MVB0>OWP+DJ3 /AJIK^>LY05V5C, A2%M^JWC)73'U)H5WER+L 1,.E6PDFQ)
MI@)>6$"B2"_:@2KR;LX0O:II*6&5X'- A.>YG. CX'I<%ZHY7<4\IC8YN.AD
MR)V?TU6H[R1U$+KCHI=9G]T$YXS+ZF682/-L_=HDF+R>8ES5BGD4MS)BL<4\
M@!N:AM0^A\(?Q:!\>EV_F9F$\@WJX5>Z%PH\1[QVYR:GKI$.*>&+'X0\]J_6
M!Y9T7XBNUK2LV>/:OJXM>OE573R+6X';NJ($DI2D2]:W^/G'4;9#F@O+,SCZ
M9)]:RZXN/?T\/M' UE2T2-HPA00*9],FA1+55@ETK+&?]U58YJM+8.S+R"YS
MQ!6Z9%]$T-K=M,$,#;25T=,>CU-5*!&% P"/9$[CTLO/>);CH([S>C$EIG[*
M^<3K60(3UN2^"7/,+\'[FVPE4%/1+[$>0H_X$G(IY>ODL9<G/__\%4L^I+'
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M+S2KTP%CNF%9X8JC+MW MR:H8T^^/<>R]GFH=XAEF$>6/(,O]'OIKA2R<<(
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M3#HDR7XV$/1UHO!';/\!A#)P2+>S>U]P53ER*Q+U/F*1'+.]!A9/T/RR6K7
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M[;LE+:6^*]):RWCO%JD^5)_[.Q^#&6N9M-<IH#4?+=\GM3&%?*[(A@F*"T>
M33?6MD&3%W<??77ET"]B<<RT84[V:FWVN^8?%>]T&_T4<MHWJ>H^A2.S(K(M
M"]%JN0\.#TS4?J9!_Z53;&HP6!VK3K&S"_8U8I*\#"%I26##[B@! SZ"\*;F
M1F,92R[7&0Z DR8YAOL-^SH9W# _K&AQ*U_U:8+'2[(_LKC40>2!M?N-O\))
M;Q$KC)X/9"DV$=(+&6,E%6//^-W0IDXAYR=N8YDTB[S83TIV39:Q7CC]K-E#
M=N]V+W]M[8W9Q0K&=@Z&X./7AQ!7 W'Q=6!LF8?J&DO33'E::M<\F@*(9W '
M\ )0OG.#M8C8*SNF#NBL5M?=#.$P5%M!I]VH58:B6+>Z.?"ZH/=[E]G[P<G#
ML>T3@2?1;54N)[TZ^I,HJ:H1,^LMG;(=%1XUU> E$E&K>=Q=_=)!:7)*R(YI
M#!OU]Q[(SCJEH006M,T'\E)J= D<9#C0X'Y,#X 2&L125&SDOS=F]8V[H>>'
M$7>$[Z)"86D9$P,MPF@F0P^YYFVZ?(ZF4ZPE@50]2QE;C%U,^;Z0:"NYJ103
MK_$1K.\Y)DYZC!H$$QVUE08KAO<W""!'+,*[=4DW^NDA;GT>C) 40PD6"7WC
MM@F7"#.;4QGWN6.T+1HC3^$ZHT5A<_2E_E'86V[+QI@,_'#TMS[ 3?5R\K5\
MXV[PPX5FZ>@-T2:2@7:.3L5AX78;.NM/=:7J/37]:EN2>WG\]_"F>],*46NI
MYMJ9/7UR1TWRQBG;<-L4QT;WI QAU7*YB=Y!YG=$XZ3)N42(J!1M.^]#8#EY
M,47"?OWVIN_^19>JF?]R;F*:FJ_KU8&V+#9?7P]ZFNT>2(87J [R,\RC[!&!
M%1^_N$_$;"%%SD3XK%JVB+&(0-6M3=\TQMBU/&9/CA =+[!#Z?Y*=?EQ3JC<
MD"1^CK;;"<L0J-]<5L!]4?MBTUGG;4BIDSP//;V:HPW&^;%F[1'.^_'<."NQ
M(83T(4=JR17B5.Z2OAC\"3D4"P?3)W[Q1D2)#;H]\&!O#YUX,3U80SJ1UGE/
M:/=I@1R1NN;<)!T!S LJFA)*@#6"*Z'"[V6TF%4=SOXP7M#2V=_]+GC4=+Z5
MNKNZYNQZ, _+#0C+F 1Y_R&"*AT+(1AU6ZORJ"TPEM^YA3%"/<CV7IIHQ6/*
M)154PR9O4A@:DKJ6KXJ 6'OI4"[Y/7+ND@8T6^X(ZT>%FVKTT]0^9H9;TQ&%
M'*^>N Q'4M!_>ANYI]2B(7&&< $@[F_XFVLL8LC^$ZMMZ(2E\P^'A$LH*.T!
M6C4$" KAL^_W  E,^BF7!8?OP2XQ.&5F"!JHW6$UFL'8(0YR1Z%RY/:T-H[:
M,:P$]AAL&%:PV5*>Y,LGVIN&R CDW17KPF!=;3I9:FAI5%C.]T73#CPZZ+>Q
M[GZ;FSH8UE?4+G&A?L,#TO2A\3AAM8X7J*&Q<'%V3#@JY RIY XM6/M0>V>H
M*K_WV0#=1<7.]HVZ/4.2%)4!E+ F"&+4""<Q[#'EQR/<PEY?CL1,C:!O_?'Q
MQ& '>$1=V+NQ8C!+%-)"B8\8TT(94\?>#N*TI3+HX")Y\ 0<GS5Z-[EQ", W
M&&I,P29E>\&/&!F!&UTRES#0PB;M-K@ZF"W$#UD4G@)64W26LJ?Y#T"*[%'\
M#V"7)O[9@/#;23;@48, 8OH6Z>8A5O)*C\4##894AT?T+GK27-6%_:Z(=!P@
MXLU+VRR/BMB"L &"$UKZ!CBY5AD'M3U&"=#]+78B(5 8V9S,P$</'*._U"2-
ME@K,[ZAL7KDS:ZE='NWO?@2_"\:Y&GD4Y"H<V#>^-TKF3LH=3SJ"VR1PRF]'
MM#>_?SE_GN]T+M1#=O9^%W<Y]3[:*@?9 9.&!3Q-@*TAKU9NR*+MV<?$[O)#
MK%6U+N6&2X4\%1>:^ZKV/6/Q>U<5Z(..G+UYQ&J\'R'IEAO&"YQ]KS/N%#E\
MR!O+!_P_G8TJ/M?_W)">?A_9@\ NB&>/[J7_'FSFF*._W6/N:%$3$3 O!%PA
MMS:9V\<I+SYBHJB0^](W/&IU^2%0N8V'>8/@9%!!#]SN3+Y[V(R6%E:"'TPA
M(MT-+XY.R.:P--$;'D0QH--1WVA)*66%VKZM.XB'N? 59YS\FRE>6<#-4O,X
M/]"W-]"1[F+2)C_&6G>_)9EPOM%$>R"XCBEM4UN^A@G;@J7-Y<WW/M^$AC<>
MH=J^SJ]./B>76)S;KX7_ 5#-?[66^P/@H/C*UN4=_9@9_ =@+/,'T*=65=SR
M*.K#)T?Y7.>:UG]:I+&2Q [,2T5D(*IWQK]%GN(/MM=OK>JF7,I3PX*AKPM^
M3XP@A@TK9P1 8_G*]:03RU?4(*>=E1GUY2$QTD9["@\TH%M-"*B/LP68,3TQ
M+^) N/",W.',3 =D\A.#Q[S6MPGG@74'>* )[G?U"'&VT'-ELFP^:_%:-$M\
M8H)7P6<$0A X+.NS624N N[Q>9!(6 4Q6NS9"#1ELK6^';&XD.T#UM[P)_
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M\ L0G)]N0#FX1D8&A'^-9;Q9\ [\87>VK9:H4U)0OE?+K4YL:@D!C /AKIB
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M2%D8HV[I%KEL?$K&RC=/7&QDP.4*,!Y3<E#;:</M,?1)Y]3YR.7D+PMM)F=
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M[01]Q98?B8L>P9E?9W0]LQT?T^U_U=_E7?ZEAZ+P)@F%>(;T6E')'5E)XQ_
M>T5/8>*9<">9*F<.IXP_ %^70%1'.K>LHE6?PI5G9L'#9V<%YF'&CK'Q$>=7
MJ&EL4%_F\K\._'N<MXFZ](Z#AV'R'EY*Z0#SL]6Q]^#QIZZ>F?7H0<[MU;A_
MZ%7TOZW0*JOW-7E/3>DG=_-Z$\KY*PHG4*8B1'+5#"$#6@#Y&&BG#T/.T++P
MUP%0Z%";H"QY4F'*\RO*AF1:;A,C%LN @<<J]$]1=GFUD6(-C$ 2[+*N >OJ
MX?3=9!G7HVF4(\6&RS$]&V(1%CNQ3Q12:@GK[WDEIO/J)_9:-_?@@E@FD*B;
M/Z,B8<OTP00_X:[L1V,ZB&0IIA$<\A7)Z?_F6MTUYYIZMWOH?_AJO\\^EA4R
MKZ]J^<2?S#"M-?9=-=TE\C(+UM/-\P]@AU8G><:UL10;WKX!.+:4- R&2$B.
M),3<&LI+CL"&*BP.W6& E8#F),\3^DH7C+\ !Z2\!/.IIJFV?812Y#VZAR(;
M(8&+XC/>,<&%AV9,QA;*YKY+=6S!>@X.$4L8J'@(#CQY9$NRC<"7=*KC0 LO
MO2YI/JWK0/W3F^WGS+IDG)(;'&'35&6I[U1DW0AQ# D!] #L 'IL    H^!&
M%CDKSU$T,R]D4QO/:$4+#7/? D"'(8>&[C^<,5X&2M/47S>D?&E!B2!<NA3!
M  H/CDA3QUM1QV-"6/^&*_#J7Z";_.^*B?+,XX*ZQ:]&QYEE3;>3*VZD%>.W
M+]%UZY.-IU[!5HNWV3S9P:P\\=%DM"Y?ED)ON ]P2KHF?@?=L+-M5T>P#!"!
M\(@FW5G[].ZBINQU?R!<7.:2\N-+/E.]-TK"K9JQ5_;BFRSBW.LRFK82FO[T
M*ZB*N\+F4@879V[$V&<*4<]"/R*&_S-8QAA\N1HQ8HR(X\(0TZ.2(F=P3/A*
MR<Q:_%*L_7V\VLPF=/X#RY%3J4:YY\@3VMH[[O["Y"*PG!Z/6=D\/,YM Q*$
M<6+OB0Y@ENQB#@P7@GU <D(/I[*^J&=2/1MEZ2J'6!/!1K$>RW]L2O&)_#AW
MSP^KW2%./8$)675M%!.=V@^=P2E0(V&S/DO%8 )"5 B&L ,TR>1?2G'2<1B3
MJ1H84%,VJJ9_GI75"UK6:9WP_79#S3KF7V>4EDF8K4/<2^MR-17T"#L-/"+K
MH#*+4O?^1?1=PK/NI6BVR!&H+O]9K;I*-;0A#^UKXV(N0CT2U+.@_F?3"N-*
M]U$8#_@%F>U8941^QF*<W%B]816E8[J^ "V%JMNPXW2?@8KC0SWO)MSZ%=O=
M4%^PX0ECDX>:@H],&5TMCEYFPQ(^)->"DM@_@1A)97.*PD'2@BX>H1S5YV<*
MH6)%\5E8FSO=\H85:F*'I,A8G;[.,IR_4:=1U:AF1$US5047#FM^:MX73_#8
MYPJC7:)+RF*H,5AEQJ_+H168"YP+R<LW6:J?)AD3WJ>IMP58GK57C/?PZ8WB
MAQV.+LFTHM B=N;$F6\]AI#G^?%1)-"9IY1*7#_2BM1.*<?EVY[%4N\L#6%D
M^(%%G\0Z;-/C&K^$67\ Z^4@.3&J9&RJ^OHB//-*./QMRU#%Y<AP+OZ+I?HG
M:IH9RY8=_"[/?!L\^[#4P%(T:@P+RCK:4N9NU!*B<F.\D&_(0J*4#U95CW=+
M*V)":99\>IC0VK\_FJRF"*CK]VQ3&0H>#>K?H(ZHC>-D%!3Q5'UXUU*F'@73
M&NZ0WT-?;"& P^$R5# GU'16ART?7IM5.W-A:.U-/L\7<,7YJ5*%U+B@=N_F
M,5G"E:9#*T;K.ET:-Y^I;S<F(EJ;*VQ\I T2M8<#&R::X]FTV"9L^/-D(6S-
MLP3.3M96+3V-\9V,C/3KS)R&UZYN'W9;0N5DQO$!@_+1D0PAGPKSD\2\GOI9
M81($,[\$[^?J?UHE0_X,T\W[!Z#Z^^T[NMO#&IO^\8R\\X1>+Y+[3F5^=_48
ME)G$+3,F\+P:OY)!(NPM<GB+3!]7"AX@FY?:7HQ+2SK+6Y"*#$.("8"3V0Q0
M6:;33[9:Z^-K]<R6XV><7RXX3I=(@UNM(=1)/RW^5 '27TQ[)FUW"O=L4$H[
MHG5&Y%6^L-P;]:?=0K=56Z#,G/=L6,KZ7+3 /'O\79V@LH3PB,C%"8H!"0>I
MH,I LVKYU;J)=L#$$'+K'^H^9#JG]^3!FS\M;R2MCK(:<X0=?JC_%Z(U;J>+
MBC=">8LKE)2--AES[+D\_%!R"LH($G;<M!&SA"_2B,E2(!OL[7%V4_S"+;6)
M-#I=9$-,WRW<!+77F4A!FT7YD@AKC<%RV]^$'1--7_6"]<?YG5,;"NH2EI7#
M("933$.TCW ##4XC([6EQ:4J4AW68 EU&>P^U9'D9;(<EMM[I$^.3/7Q)6=!
M.]H!._0I(+YRE^GX, V;6KMR(*X5+CO7:'X,-8;=CL0]"1UB<8M.##;V4(T\
M_!EW@2!BW2=&DV.'; L(UPVM4..#+$G26.2,Q:F>,@9OI(Q>I'$O!]+ N"BC
M0O8/"K;%42D<ZI:(N:&$L#/C)UE7K^4=4*09E'6&<MZ+9,?<7E#S3853)$Z-
M7<,A ])<EC7&['<@D1A?!TM=CSA1O5IX@U9M#FHZKVTJ=AS/&>T4.Z:R$H+(
M)RM9Y*NAYN4Q5[>@<X<%C3+/75PNJW'M]JO1>>P+)1J%^TE"H!XXAKY1^D<4
M7 ^K3I4!1$\+V+;#_4G:G?WZ_G7LSA"3Q0?XG#9KMG.,Y1G6KVW"?/RDE:I7
M@F;EPIR'M%N6N&:GUPJ])YD#3UDGYIV_K"_48A:SA#0,GA YM5D#(;2.(>>W
M.LGE5?'78NFEILZ!D//[*UL*%Y1_(#-\7Y9PRG>F%8<*D^CB>D^)1UCA-K_,
MXHGRGIC39<2A,268#5?3;ZA!>B&=;HL4  I+,69T4T 7QI!726D'PX3$2OWZ
M^UY!CU*36!K4-./: +E]2AJ@%&-& 0:CH7,(^G=G>%1*<JC!T0 #OBH2QU6&
M9:Z@/1T9 9<$G\%CZ&1O,S@:HY9^M:F?\R_A:HS6TO-6)](XKX-?1<\=*]<^
M-H:8D9^6M#FIW!K7X&H<R9;2K7UL6X[,GM6<?1'/C%0@)I*OH*V?,W>=B\T7
M^!'G2-A=5NM4H3=H1#LT89P/QF8RDV.>WY1HUOS;PT@2QEVUF$4+;SC<N]29
MF.:O"_+G6@5NQ(9>3B6[$YQ^5#';J9UO>?7KJU>8?HG0W?G%U#P?=CNP#\/I
M%&:J]VAV7*CH/0&4U&_!4PYO.9(W:6L(5^^O&6&U*5HMXPHEPCYATJZ1.W92
M;CCA2N6MXY$;DJ$TCH6L8'#-$%.N"?SS4U9VZUR($_(=PIABPBDW [38&558
MEE18UHP3]MAPS$\*56-^[%&,0$-#0P4H6Q'"H>I.'23ESYJA83J5X'H0KG+,
M2!:K1Z=@_]YW&E8V=ZI)< I!^O(=D5<M.RZW6ZK#\'"VM-<MDDGML<$C#XY?
MG=GPY#>0>8FI1Z0C#ZS):9?N"C++A,<$H,$SOCH\2Y6/'LNK'-'2@^:U;WHP
M+&+4N7".7!OBHM0-JJ]*(U15./LL/82.D]VQN[\WF>O[".1VA^UNZ"L1\KJ=
M59!F+<W<3HUM@.RU B5ZYQTQ1L'@>K=:V["\I"E'%FSK-8Z0Q'<'[*;0,3W*
ME,6.'POXG7%OUL0JCW:)PU1^5:YJ;*L[HWWX1D8;D*]]S,E><TE?1+N;KT=!
M6< 4*(+R0]R1\H1'(E\K7IF)AJ_,4-I*LBZL@$<_)$E>J_"#P/R(D9BP^691
M@@7!RVG\-R@(IW >@V^6'&53Q]SCA!1UST>]*8. &5I@'?EM >"0)B\/Q[;=
M!I%-7U#A=430S3(3-O& \J.4GQ(4@SN& H(8K1AM*E*:54(^!8(2 X*8+W8^
MA0Q ):$ ]1^/.NQA^<]>^YBKHKV@)U>X1>")P@C!<T0N.X^+*_TA)#^&;-.W
M2Y5+C#$#)U,/]KJ6:D6)@ Z3Q495^>8+CQ XOWP85U4D+5J :Z?<RDQ=^%[=
M[T.YO^1XR'";QC2@FZ3-SI]S)!8A=TRE4.EM7@E@"U_',OAYHJ@<5ZEBS?6
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M9:]<3'"T]BQSOK&<Z#(J7D_IA+L\X!F*MI-_@D:"?H."TH<Z!XP]FJ63XPX
M,B>!EIR*6EDU+:&<,FXDD7'H!A$]YAG3\_,E+P3M;F&/&).L0'TV571S"BWU
M&9=>+"2X15J!Q<[M/?]KEUW6XD=W!IB5K>.9+YSU0_D"DTL*J=99$5\@+CL^
MHO\&KE_GH#:;AJ:@GR51ZQ*B/I>ZP/&M33"M?X@9BMQ3P0GCZ3S:<1X@'6$@
M1"51<%1G=RY$8S%T3O5(V@U9"*,$4)W:9$J[UZW20T=EEW>"M>L+EJI[;%)2
M;"WG?H[@'34@)1SY*UWY6WDP>D]Z.!EW36$W#QU,SRW!A X3T+0*!N!K6F86
MCDQ' >GUPNK*W;-E2X0V'K<W$&D:^<94%/1"LK$;X_F #V!M;>6._^+KEX3Q
MX0:=]?H)9=)+\R>O,_>:<'R9D6IC.(_TM5@S6.J1 J<5]]1X;0N?Y4D6@0M>
M%&'<[IP07-SF^?!A8Z*+\HFN>(V4:L='I#SL('34_Y0I,>K1G\ $M)CX1&?Y
MH.,AJ\D6%0X\CKB-.@1LV=T.S'H*@P-E2OI#+_*H^X)M3RQB" [=%,U\BW-?
M+RIL*IR9NN@OOC[OGZ.UI-UAV<,+=ZIRJ0=X=Q$3$:NW!YRK,_V0[S?C3]8?
M$N[Z9.DST^8B+0&.KQ5OEE1,1YF6NU1\L'IS.LB7HST]LOJU&#LCD]9BZ)40
M2GXVQ_P80JBS+,['1IR7!VSY;^"1+E<W&!^3$W-<'.\ >Z4T.F\)^ "L&,+;
M"01M.+@&_RU?Y<F/F QP-&<[#H_3F#36X&<PC;-VP;(5#LJ-BF9:1$2=B+]\
M[7,7J4U)VJPV&O03%4K-%'C?=YYW^Y'=.S\GN42"9+2=# _A@=*)57:H*2KI
MLO8/4MG1V(<8"A_\'RT@1DR8*L\9FARF&S(+TQWB;U3?DK"6UF7.0,)'!<ZL
M.8#4,F]V^/3%U/%P_*"TW,B;N(FQU/[.\LE441QUTFS5_E\.[QHJ';4H^XX5
M;7;PT_-"-A^)V!!UF_\'!QFQN=GR;D22K4G6?7(/#FF!WE[,U&/<9$PO3@*F
M*$R=4CWIL!ACL-(OV21\UJ=F3_]<%HV8$J=QUKEXDAB;K-#P- ]<0,*^S1Q>
M[Q<.F<^P[HCU(3D &L1_)%YSO=;D$2!/7U.C04S:B>&-4+T 18HU[ A*:56T
M_9+'BQ0WL>1B*G3R9))$2Q.F?\9J?::!Y7H=8<]A 9<^)8JP1X(UY%M"Y>^G
MRSLSP4)! E*CO3#M8)$:#T_19?ZX'D^6 %;_WGIZ!EYJ"J^]3)C+D?2,?=46
M\JC"(SII:[+&1)1_FH=*D&,]U$"&*G^L8>5)7H9O/1YM[4VV>G:=Y!=N;AN^
M$M$A<UF\*N;LD-+[[JJ 6N88DN?)-#L" B(D4G&27)Y$86'M2:*I_\*FSTH
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M&\F/QM)SK0<Y:COHZY("T:5Q;1Y38QT=7I( C(E;=M&$WH+#6*P835V&EZL
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MG,UMJ%1S$*.G'_O,8;6#6F9'^%Y( .@NN#Z;CIJ<VI7<K$ZSH@!)RS4O=C<
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MU\0QM\]D)1C!B*=3@*J[N/2A0[:NOK"L/)(FE@TI #&LI],*0 73G0ZF\60
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M#X"0CPGR >X0 ,.S)S)RC"\LS:T=G>R=K&PLW1B5',UY&;7Y>?GX@;LYX#6
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M15FES,:+"!QAMMC'J'@X]J9S6*!1(333K&CJ0SU][1T@.'8'K)A<VD,'Y^^
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M![__^]-JRQUZUM&JR-@O.V+=R05S7O;9'O*]95AP/-9X.EDNE (+HGEUE'W
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MMDV=9:F<[7[PO7SJY7=87Y0"X\%TBA$[&$=G]$:3Z>DY12WF2)'BU^#EQ/.
M D:-9DA[>YOEQ3 _LCRHDJ:8KR[@\1 O</GDUII5.ZR)A:N+Q8=_C(YR/KPV
M#B,@N+3K$FZP()_&\[*O.9R1BR\] LB2;O-I]"DYHOS,*;L!!?30M==3I/U%
M\SP1?1W22SZA.GOXG9X6!K'<\"WH8_X=8(G46Z>K(3N5M;DI\>NKF*VA\ /\
M\<#1:$P@DR!.Y)G?*(;*)YM:+X*\!1D[H;%9C"7[X6BFE%C;%L.:+P]4]2]C
MV>K065/?W*B151=PN)XCM*KWE[*8- 3K^%(5*PJI6&"8ZZ-@]R'Q'N$)_2$N
M0R&B2&,QK >HL5Q%3*^>ZX-4%0;C,]U)0:D?'T3R>FP+-2J5/S\[W<IFK/5[
M3B'B4/TNDU8A*,9[#:,"0R-OQCMFNGO:U>CK!;5!BZEVBJJY>)#Z1]I@_NR/
M!;C8P$^2( C^W[L"EVN(CE="Q11ZKJOW")[.X@K/ZNJMW>VH!MRHPX)68W^6
M8.X]>*"]WOE@]FV]E2D'5T74  P N[.X#60 ,0$4W5ZE)=WNGWU(9N<[:>U<
M/1L)6_3=[K4_DD!3%XR1@6,L6!MQY.C9K-8U1_279;Y%S,O/! ZC1*'O;L;,
MGVVAPYA4*'H)_,!#15\_5G1FQ6#VA1!S^2];]"?&%1SCKXS#6"<E^,L,MCTU
MQ T,^BG._<>Y%OGOZZZ;BU(Y-GI>@)ECK,'Z76(J"SV-YS/N=T"-W#FQ/E=A
MDD6MJUN]]C,.C-919VNPN.JHA)+3R@&G?@C93S%[Y[8*E8T>5KS[AV3.];/J
M* J4E-L90)B*2'?EKK*7=6W)!Z<TGH+4W'7U4<X28H-@B395$5HKYG'8/7($
M:UW=+UH!H]N&[_8B7WF/:+VIWCDOO.$&_9P?1=\*/KV%JBG759>$EZF_YE=V
M_E4P@I33=&]H786WZE9AXJ#1O[^.@$*&400'6[=3PE%G6I* 1L@>!!T-H"0%
MR%!-8MB!-N18#S\$4$<'D)_HBD"^_]V=&:PJ7W7@!=D<\D^<F.VD@ GR&WW^
M+ P/[@D'BAB#V0$ /PFP-WX*H,#X(P"4H%%UE+\Y=_[_K,.X^P[\'[?_!5!+
M P04    "  ,@'M:/ ?%N+,5  !Y(@  $P   &EM9S(T-S(Q,34R.%\S,RYJ
M<&?M67D\U-O[/Y\99L:,)4MV#9&F5'99RGQ2!JE(B[42RIJ=J*L9))&R18B,
MT'8K!E$J2XJLC2A;2,D2*GN6F?F-EMN]]WOO_=[;M^_WK]^9UVO.S'R><Y[W
M><YSGN?]G&&ULEZ"19M)1B0 L5^V[!=@,0%^B_Z&3=([#]@[N7NX>3@Z'_"1
M-G*W7R.]6WF-DC)@=8#C (-"H5&<&#0:C>7"8'F$>7FXN7DD!(46"4M++I7!
M2^*7R!)4%63EE>27X%>M7ZVDKJ&EK;54@;A15W.CJJ;66H@+B^7!\8CS\HJO
ME</+K?W'C?40N@@ Q E]:N!+@Q!(#DX4&L.%Q4$ "7UM__)P$4! 2"2" \G)
MR<'!?A+$?@8X^#D%9)0WH 2W[T<O]1)2"8[-P,CJT<H7FS5^D%.U\P[AP@J+
MB(J)+Y-?3EBQ4DU=8ZVFEO;&3?HD T.CS3MV[MIM;F%I9>]PX*"CD[.+CZ^?
M_^& P".AQ\-.A)^,B(R+/YN0>"XI.>5B9E;VI<M7KE[+RR^X55AT^T[Q@XJ'
MCRJK'E?7/&UJ?O:\I;6MO>?5Z]XW??T#@V]'Q\8G)J>F/\[,\K,A(S@XD!SH
M!<@0XO#">O@Y.&6440(;MJ/W>PDN50G&".G%9M#*N615S3XLMO-NQ K+J?4L
M&UU _0GTW\,<\EV@?\'\"V16&>#'@(_0!23$1L\/(?DA5CO@1D+L+TA^0 33
MLX  W>S!< 3'!\='I8 3;]_I&%O>E&,!<ZR(_0"H!SN9C:4L0-U![BYG"@&R
M4S<+T%>4OG_) EA +/!@@0&A[ND/Y#" ;U_+ A-8C[F/Q <4OA$)%ICE7,N8
MQ_? Z*G3+,! G&<R^3Y0D7,D%F &;V4!,OJC*<3()+, ?(D%2D/G">#_=?VW
M= W\1M?$)UTBG06%[$&9"X/H)?AQG,?<[&>][]JM'9OJ/ZD-^Z(V>D&MWE>U
M!@MJ,X+8:K_-4#J27<1@?!O4\770'#/XT-<QF3\1^X0_ [#*NROBI>I&&'@D
MI3VROV/] *(>" %3"!;RPPD>7I9_O<0:GJLTEWZ*7&N>*\R4>+[VA;&"D5!>
M;UJ65%)5;=09G28DE8J@8 $!?$^G_),^\D6%$'_FNM.E+C_;RZUX)(_2I#6O
M?K=[<9.,Z\$7_&]T4@6VT3T[T3N&[U=3N1I.^_L9V'N(W5)9L:/L0?0]Y?C8
MYMG>66XZAXBV^G0[?MC_=D0'3U]>(6J\IB>XLDM+-^D]S&,LY4VH61-K+\]7
M\UZ&L]B1N%:*<60'(F#$SVP_S\6V*RJ0_#[1+:FQXWZ5.J8(_9ZYA)#!+%/)
MDH_VG72%^!!RNPV?FQFL?-U/[<[^)?&XLN/7!"K6*)<3-?ME.T*?'E?=S:-D
ME/WN0B4F!XM/L$C@:2!F(U;R"!LL4F@_G2&JR0LM+](:FCYR=,Z4 ]\ZS;_E
M#17!Z:BUADLA/_2MK@MX]F%0OJLGHN&@7'S+NQM*&DZ?#:0,BQU;BA_=^C:4
MF7: [4%;@0M[8S@_[\\_[A:]:+?N(@GT8?I@;^05:7%P@Q&>3:9K=S 9D8"8
M.Y$SB[8F=]-@+O;//BP@,$2>FR) 9)I:?HM)$=N_["A\P^L)Y+K/ TR&URLP
M@Y]W3P^8(EC SID\P?>+T.<'PVQ'"\^VQ[=]^HR0PAG)HK<5RC+O1()H V@O
M WYP*A'P5N!@\;-?4$+G7BG."$^:S$Z<8X$-:M#5[U[K'W9B*0:SG1N9)>DS
M6-#TU0.Y2_G)CXNND5NR2F>YJ#R;O].-_Z2K>TI\_A8_.<$"CTU1:5_1'/AX
MBJE_?P?S_K+_>%/_H$,=C&46F;) SF6F'D5MX#,0O7*O^$A0.\J%KCARDY?<
M> #_L8?*8_7?7ZV0NH3(O;BVI_ )KG5EH@[X\:')+)1[OMUH@*-YIS0IX,W9
M&86"H(9PK8F^I%@Z7>D'PB$@50U9P/H*N:6)!61@<=_?N]GD_\3-D&54;&PW
MEV)OP5@6]ZF[@38K!NG30[#P %+QX;ZQU6_3)P<5F2%.2+,?M_"%3E4M>K(X
MG!%$'!."+K.QH3.HO/8DB][19?5/K43%#3L"E?).Z)P3748ZXL,X0D=O(_R/
M\60#6ZNN:K^<>NX=#?RD+6ZAM2N!Y)([U0SE,W= ETUP/3@8\-\X)]L]_P21
MS( ^\)GU78&/]$!88_0,HF-+=L1A--O!DV86T 8#JI&@;I2?!2(]=K)/ER5Y
M0O!;Z/KGG6#D9Q3B[VA7'6VO:<=Y<@)S9B.-!=(?$]^_O%BF[F>,:E"4>?ER
M_M4I4-J>*/. <5,R-KU$FQROG\03O;NIM[-P#'\VQONECWX2'[,Q[]O(26/,
M:T?7V_Y7JBM"'PE#YF9Y@0)JQ1%IS %>7J=;E)PL\HUFXM @"\10>;39W)-O
M(RQ9$JQCXSH=)W$IS3\FJC'0X739$N4+FF+OGU,T_"1<(WIO'3V,K(E155"&
MPGN8@5FH@S0/+Q; 5.;T*17):SD@1+H3V@-TPL7>H?MA*2FE[W"3GW4S7 \I
M)JRJB;/5:&I!9S!XU,764Z)<IC198"]1UB1N#X5X:YBM%(\<4[M>=B7G:E?'
M*KI-N4!R $HP+9AQ^#"RJ=1%#4&/-JN:#[+FF[/MGM\E#DIV9[, T;][FLWT
M1G<Z06]<]HU/LRG8,3X6$"%1]+T<@WRX3KA>X78CO<R5C.$EW]>GBR1B:,P;
MQ/>QAL"J[$X'ECLU_:PI(BB1IR/**$9Y6A_@7-TI86$HH^58[:;;O'/KB./5
M"](<KA92FPL(.Z,6[62+IRRJ>2#'?9^W\1$P^WUH#,^@<I]RO406Z+26B#I^
MDG^1G\X1;X/M+6?23*Q RZ,%WX_F^2=G$77WNE<^[<$5N707D%6<)8=86BP=
M/3--_G"QCDT873:RP#KWT@]2+/#@%#>QH(<%+JS=]Y&7!7JVE9$N'6VS?'7[
M=E$$#$1#X@*?=-G,;K^(,*'M(=.WD>=ZB!]3S&&\73&;T::RP/0#\JC:'A 4
M.<0,8?.$;BX6>-CH"TTIY,QR/6&!GY:S@* ^'=UZLW1@.9'Q(7U^JPBLW557
M[B7WU,9(+6[EU36@3*SL)=\.?;IPV:M$BJB0 L66MQD4+)P,%/MHE'U;%'>]
M+,,]@P7VF<R' 6<Z!&..\,.BSQO9[)=K?5UVO],F:5 [AO":WK;^KCAH_\?9
M'+,\O<9WN\1=+4W<F>X=;(IDK):85UD8[^ZP4LO$9/HJ=16<O51?EH,@5!R\
M^GOS+P?1EX[6RKB7YRJRRMWA@E*V\8R#C/0'I(=T[)/]>LBLOXF:'7Y@'Q@'
MBS6^K5V)-C:^>#F#?Y+AW(IF 2<6:$IH8<Q=+,.W$R?>^+&=>R"7QZB];TI@
M=5^4M)WQ)>V7VVT5GT).?V4.2!5&.;%%&CY_0@@&NN7)'0RHN%USNB)V9/-K
MF@D[G5I^2:=;2 M>[$_%#MI[2#799&W.5QDY*.D01,0"V@)M98'83V'2Z,_#
MI'S0%8BK+PZ15L"C?MU,O:XC>8.F^\?975UEQE.J[".K2N[>Z:.$]W!+I%]7
M_A"II%IO*/"*PFV*.-2O1O'[RPBS*-44N:YY.11,M$(\X#+M[]N[?@ 7R#5U
M,I139<WKAK6F.L8TP6Z]Q+$Z296'O"-92PRVPY8WZ,VNSY,$<@.U)G5HAA@-
M%]7S29<MS.1K,M?XA&2FUZ6HXXMMA&GNIZ-<K)3#- ?AFS7?4KW=5Z;U[].H
MJT93LUDS5J6[84U75U>S,6UQ<E0PW. U?RUNC\6B%[BY1DE%UUZ#/L2[_/&"
M("7GMM5)@J?EFT?G6& >$S_O;(.+W12SB492BE1"^00;HNF_,6TJ':H'DI_?
M@#<GV+U'K_%4V)V39\5L13W7#T@EK<ET&GAW3GFQR;WR2I$AV)+2O'K+5L+M
MDY67.4.CD+ %L6#UIKT>[79CXT7^HU&S!RFYX=L+,#?=,UK;L!V5O 0<TD4C
M]MJYXK"-W"$VW-%6>KFMO7=3UOH&Z-$8W34F8F\#^Y<F[]X8WG'O(JZ\SS$T
M]S4^#4%WH^TU=ENT5=S0NN_ CJ:."P6A>A;#-V(2K0.>G?'6 T&#88^,%2PJ
M.(HB-O)<QJ ,LB%_DF^M0'E)-2]<]0+??TN!+SDRY=!9I\>%-(Z#+TCE(<Z1
MPWE"6 [Y1A@7">K_B'KZ(0/RK-6OV(5LZ NKW,PD]F=+J][JOE5Z8I)\OO:A
MF7W]UK:M:2C,=&\3\MCO=HG_MA 4<^BFND:AZ^-#]7E%R47+JF<,08AR-S%L
M/85>E%]88+9ZY%6X_UHW6'7&#%&YP@*1]!L'CQV">0[NXH@#2+E94PX>LDOD
M]1;^L/T)RXJ?2@6_/Y394>*[I\*SUF]) <;\?F'DUFAM!:_R=72$^DB>\1LQ
MNJY7T6$M*N1Q*&7?"D>]F4IZ8#TRM_&*5<G+(GX:2$4-:].%)2[U3 QYV^^4
M7S8#ETGZ/@*U^PVRE?><>#0AQ-M#.V)KEFNCH4B=O\+N<JCS5UOU**!,E(H4
M G84Z!'X%L^@Y-\1@L^&J!T5F3]UY#+CB#$[\*> YM\&B[505\SB-R6%IU,T
M$C;F;&\1&D:.J*SJX; ]OI>(%17\8H?D1PCQAMB,@[;7V+D2F.KPWZAS[]BI
M&_1Z/X. 5^"\8]" C.(>E^ ;A#5S10@;9!Q>/]? /XVQC)C*6FEHR4[\E[8R
MA3B3<2:KXLMR3UA4Z]3*2"D'UT,.X>>=]UCN[6FS6$0";U><&4B5?X:4XN3H
MG!!QFKA8)A$PJ$_94])L@72B'A;TR*6NT>0VE?GSZ/=[*OB9R/]Y%$,(AL)@
MG2\5VY38B94]V_51#F(\/<H@Z EWT:T+ZOM4D]./"E?90!T#A-NUR$@0:7S\
M=&',P]F5B55OX&'9/2OM5RR774<RF:"NXO$]Z6FV+?F5!O&Q&0XJU@_*EGM2
MX&;0'[F?MJ3_@ODNYZ6[F-+W3;3>ZJ81)!IQJ\^EN=.KUX59V%Y0,7AC:+[*
M#9$4ZG$?2 0-@%8"#M@<IG)6$B G2!E&$< CL&;A[:\RUD%G_) ?W^PLN9>
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MDE2#P2OC(JX8OC'*X=WX+"$R;Y$<& H6352Z/5SP;]PK?/T=0,7I04%X#HG
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M(2GJ5"H/8%#!^'I*F+=_!I>_U<;Y-.L \K;S_VEFW_F#4"!>F+@A<%N>S)K
MOBWM]X&64[^ OX(]IB.#8&3ZGAXL\.@/6'3^2R7;LCP\S9'O-[CLOZ#^CN#R
MU_W57[@F@@>7+T+X_![A]K,RVFP_3PZFG6K+E.YO!.;+3+E\6YL3:3&LW)+P
MALCQGG--WL]5$.C;7C1)9^.$$=8J=/V1\4;S@$N*=8W**U,OW;J1_,Z?9*E=
MW#J='K,.2$H4A-0"N,C>SI?#)LO7<\.P&KX_$F'S8KD*+,MGRM4D\6O&" $]
M2/21X9HX7V0W JS!UN"X6Q)IHFX"(RGRB@VX(CTT=Z/XM222:<Q51O*MF7#N
MI9*>'7E89-*NDBZ.A?K2NMF')O&8]5VBC6C=MVWIVTV#5FX+P4-)^U[@\7<S
M'L8J4CN"2$M_'&)Z)SDM^U;P)CS)LD-<K"!^6(.,-756!*9O%;2H>%1CQ$2[
MS6:*V&/:; L'L8B@R3 4RQ"UQ@02Y4F$RT?^G6C(:[I^6V/+>_(?I8>_;$(M
M@AK&5LQ6&0V\N]Q.U8?BJY4=MI=V6L7S/^TET_MQX*1D;.L 0[E5]O;2 UX/
M%^I$4@OIW;_ENM%T2YF(S&'^;WL?9H,W2:HP13Y_O+]77]27BV^NY;R"^"B<
M0N+YM5)T8VOJ]CK1_'51><!G]^%AY_FH4)K*3>?TZEJ5:10V22O#AR_ 9_ :
MDAZH@S9[)+1&]@W=PCL!3;"VOG!?S3="^^*3>!'K*^32)\N%6BX'[^61BTZ^
MPL+B8 3/_-_78PW]I U_M%/^B.Y/N7%F)/P,>2T/$0OYOC[\'OEY#C85/L=7
MDR+V1H4T5FXMTM%/[NU6@/ID0K(J7^]'2/^[VD#]8/PM[)('?OCAR+-1!6$Y
MFY_YMHOY94+HD\Q$WCV)RWQ9_J2./FU6S&9BY9-CD_JO/X9/T)G71TW0+%1P
MCW1&>QS+'07S$]$7NEO.G(L]JR5PO #O^6.6J_L6OL^Y;&2FZIV;K557)[%]
M62'X)/V*ASP[Y8F>Z$)ON.5/?=O0((?UF".)Q6FTW^A$J5SW^RAG@L^H!0$Z
M#$7A-G=0;5!\ZY;)$]0)0U$^]%9EVKI^%'OQ>[):&C;*"U#)H)'*M'1P$/0O
MO$CX^@7HNS-\ 3Z]$;XG:P/LQOZ=Q<(K(;QQZK8!05A_HX,Z!!6002NQ6L6>
M"/>F4US5H?:H090EM$2]DUE3M$8;"_$\;5P6V1K:F3N)QPWYHCL&2(8=(- .
ML(EP+6""6NS2- T^-E/Z.8YVV[,RX=6DH]W)( ;'$Q9"TL0O,\I[F#65-N80
MO]6\YZ;CGC1!SP%C>BN*6B9//RCCT"_4.DUCDMJAH6F3<152U9#DF9EA7]-<
MI=;>OB2ZY!L8OF??FA@MJ2SUQGIELJ)H\A+1XBV[W&MZ;)NF4=&$7F"&4W_;
MQ$[2HL#X]K-$$GWEB1F=>:.4)F]? MC@&/R'182H6R+K*YEJ/*-ME;)7T0I^
MLH)C1V+%0"^A4J!!>\>1-.VO0CG-N01S\:@*ZZCFGM\K7$*05&XBO(NLXMG%
M/;K9DL*E:3+>(AG0"#U0UVYEX+(O P(1]7*@/J$_5,CHZ/>"1$Y(;9D;?W\H
M'5WO_035J]08,1.$?\80VU6!-5W@]=-T:1QTP/^<X(I%PG3JWRSRFN[>LRQ*
METT1(I>7UFII>@&" FP%TFUJOZ+#"QP+'_0O7M#R]L+PRRO&)K'SY>B[3IUY
MF'JSG5 0BV-_K:X&@V/9/,AD>T6S&'@92"WE=/+-"G($,0#S6[]GR;8/SVU&
M_ZIE6(PA<4=@KJ(>2&!CQ<[1UL-990AEF85"FNOJ86@<%_"?\/L0,FSM!H52
M2I.[G;0KS5J(');$49>D2Q:;9?Q#XCG:C3/6X-WW[WW5?XA:+&_8:!\PVAPS
M<OC5,9KI]4VP,L\+1BL@WZIQ&NG,'%TB4K1T7)57RO08-F+R;*%?J!\P1=I8
M'DA&MK7L]DDE-EPT?E!_3H3($W&UL#'3/C 76HYH$:5(9_,$BRCFGEA!&/24
MY"NZIEJYN>*9/S!J%P?V^W&]N4MM!%%FBV"1UY/L#6^"ZRPV*=,T&VNL46BT
M@[);!O&!D#NGX]X70*?NUHWO)\&)G@G$BJ ER\5''!IEX$AZ;.1:?9C0P7-=
M"E'E9/BI!B$O?DK,&Q3L&KG1##;#B7UC5+SIWT3&<QCNJN*)G<S1I$Q6_F7'
MF%\2-9N+):;JN#\AAVC-+XJ$F+_0S.V9OJ$IO3,Y3K?LQ.(B\0#9E\6IQY*Z
M:9B$_L#C\DWRWW01=PE<QLW"#+R7<@2>3_BFK_CT>#-GNA9,HW,]#)GS\0<5
MMUFLA]83IRY)GZD7PQ6KF0<T&!EGN4N_YR] R,I+BHWB8A*(< *7UC(F?$4'
MS<JO.#FT-NK'[%9F*/ATP](DOXYLL+"&/"I60&RWU&R&MJ*SV_H8PBKS63G"
MVW-B,P+O(@TT8.8J-CU;=GDK-$&SR:(53#M#AMS?*+\C]1->BE\-"[DXF@XL
M)TPU$;3861579I=H,RU_71JA/FQEZ2#C<\CRNS^?OGI=;#Y,\'FZW/92@BU]
MQ] S/.D8S_ 3VRO^KR/(%!_(ZV!CPU[+KZQ=!!V7S9T<#XO?LFHI2Z>D4/M+
M.UQ@NA>?'!OR2.=6?_AJ^Z'N=JVAMBGDY \6 R->@+]VC0_<Z+KJX$!?%#]$
M,]=)](^>ZVS<ZM(26N@=,3U.M"[:= NY(Y1W58)7K;F&GU,$H,0:Q$?BJFH\
MH0\.8?N54B@S)_2GE\._;\QOR_R,^\DM] 60J(#B9)+]/P&]?U?L)F?Q_$<;
MIS8:6K _1N?;>O]&FO!KN=H(48GPPNZMU-;K8%]4B"=<?^WH&E6 BZFHD!U,
M4_FE]L!Q/:HAGSD7M<<T29B[/UB]*Q3:KP$*I04E] F>I3FZ35:/-17BI4K+
MS$CH-.1Z^-A1$6BL>%(JF4B@W6!ZT.Z,\/36@^ME%@J8Y,'ZXT56I4>M+7N5
M B6T)E:!$2$J(NCYM-M]/4XZJ\GBT?7\$DD0TZ0#!GMN ?]J5!_^M/V=&X^X
MK9(/T$&P[2<]FN6F24H/2JN4\%X6BH,1%&2B_C7SNUFRT])]4<=YTD7\L?P:
M@E%3XU*Y(JZ+C%@5JB0T?[' P(28H4F%AW1PP3SUBJ0;T\RB$W/*FV,SD:Z>
MK5(CN![IX<"L5F/22?T!Y=FAN3\N0\F>_'KLO.&R:)(_];>1;WA! $Y 5IO[
MONR)I,S\7)(=3BM,51?:8.- 4UY(RP9+R@=P\;**XR+/3NCABXL*DLC?Z@[N
M6:_,YZ=)&LW9#[1X7BRY=%SGT,AW+:OVZJ!W^%,&RB"ML6%;@#"8)3PC%HE,
M%HF8DM%J*99'/_$\[BDS2;:%V]^6S5<2="VPZ\F0.+8O3N$B#56UWP607A(1
M47/J->/WF\D6^YG+VQD[5O<7RR@2]"BA$()+B3HH6(43WQWU>R\*0IK!$1PP
M2>LBV'DA:VDRH<.LXV9UT7+?UO8TB;._^-@8DM]?U]G2G7@!#F<^//WUG"C
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M%\ <FN93-YNLE A[2V]&DMHZ 1\+?SG*>TD^38_!Y:SCK=)KCIV9[^&0;!&
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MV"M\--VH_?9@;"O<K)5;J17&S5W]E$O-2"G2$C/ )D,FB"2/<;[ X!2"T=_
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M\G:N?CV;L#C_=-,;D1-#'U8A.0F"<BF&RXIW_8XZ-T[&=7AQ5;H>W"+*E*I
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MW&)<N G")*K.FYXIO;_*#-I^>V*\@28*K%Q+$\AB*G_!XCBO"H:2N)YU,.A
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M-A*;.IO^!Y93.A9,JIHR K'?7:U9VMNCKKU0_?N[?P%^DMPO ]O8<*^NRLY
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M>\YNU8AZ_>* O W9D 1R]WU#6W_ZQL/7UNS#@EB.3#5VME9#(#!,/C#)55.
MF9>,;\+4KJ5]T43[8D_H_IR^S0'U*'?0^=,WEZ98_ R.7Q^.Z%+P*%1B5A]E
M+HQFA'QH:O].R, :<^>:NK3MD6U@H;)P%23XZOB"WD*^\"6G@I-R\+/\UYZR
M^E#Y^%WZ\W5,D*SRPME.-UV3A958L(5Z2@1S[PC:7%/;9>3-#VNUV)].4UHX
M%#THVXVU]CL>Y(>VH/CA[T4:IW1Z3C'KM%[Q!/(-764'Z[,3YN5S#7,'YJ1Y
MR:$6=9/Q='#3/]I<[.(!C0=_ ::&EZ^^7MV4KS.P83$1N)YCO?9L\SCH\MOH
M(0![3FJL!,YV^1"NFF#D7P!(/>;S4?>_ A9FF&G^8PXF(-A69/-+TJ&C?1J0
MX"YT_C+9-"/4^R] [EO))H9)'W[]8G)AD[ZFN@94__!-J9XSN!BR)PI0GR!B
M<\C=>,Q<:9"RK"H9I,5"J\%X.KDD$"=SJJ%2Q$),>4I&MM%K$W\1Z]YZ)5K'
M5;/::=?8]4/@3M1TQ'3-S?]YF6W\Y4-D'UA2ZIZEQ5E\IZ!(D%]_U5S=GHI.
M8QMC%CHE>EXKXW5O./>I5#\M;=5>+\S,S1JSJ4)A@V](\O8+2T2B*"8]@Y=L
M[L5><RX5)/'&8<![ 9J1]+#5L0V IF? >QUP<::B=I&S4S.3?F0::]*1YDT(
MMULI)38M(MMY@ N,OY(+M(M(H4CRLCVD16V^[\PCQ"_4 [VZC)>IN/W@]R38
M9"U,L;]&U@7ZT+E 4RO#@E@BQK[M N2R^?"5"!L +75(>*60'ZFN?Q)8]''N
M^$XQ^!M7)Y05.7[]>HB.@>EU,3Z Q)ZEK(:+B]9>P>]H!AW%1,HJ8W3/L$72
M9^+W,N'&#Y=$PV@G-2G3Z]N[VI*AUO<IG"GNA LV]<E=:C,$+N>_%T=Q7CGC
MCEMN@U\;I_HL('UE<ND@6FH6OV-JV<G]4]# ?-[H&W(B:VPH\FRN4+=2Y'WG
MDZR<?@&O(7<@NTD;Z1YA9KO[BF6./?!RRN].F2G%X8;/E<("#$%0IOMA>6(D
M >\JV(#!]G4U[D1FS;:\>IX\U7K,5L>[H0+O^?9R*)JQ/_VNI.Z.'(YK.S]H
M6\ C:QB,F14PM%!W,R)3%:ZGS2PX9[U_ 4?&XH8>V(6Y<,\X!]W2[*.U.&9]
M'G!+VK:"*VGHML"P]#: =5=GM/^HP+.">Q3LINXJX.;<H74@Z- ,S36-!(?4
MOQ9!)-788 **G/FZ:.%NE^/0XIZ<XU[H*Q2R=R?QY]H0D03?^%?>3=?OQ82I
MKL3.'/W?B!#=?)(;A\(_6349/9Y+#=7HP$\E%ZY@XW&99L?I,[<N\4:UTOI(
M]/BH"AJT6?45PL1QNO*Y'.)=NV_MQ>$FR'P7^53:= ?O-0[S[R#E$KAZ.6HG
MO2BJ(<1N3MW7]]K%TP'"*+!FR%RB ;S"2FU_+VUQ0D84UU'N#L=!!8X.Z>H+
MUS^R.N>)X.XX?]S7F$:H^%"^K[%_]BQ]9A2!].=W4&_"NNUP0H**"D U6L^:
M MFG\I'N;"@,7TN61II6K:<ABQK4U+)6)NX_+L*&OP"=?WFL,Q-X 4,_$.B(
M%I4#7'W77P\V@ ^'FF!MZ<NE"WVR6N%@3QL\ZX21H_A@PS=\!MX&JZ4^1'*"
M*6O=$2.'(]3?-=!R]FV6QK"-ED03VFMI)BN10*GTQ1E57WC)-D7%HR+$Z%'B
MUH5YE^6^OC%V7YV?4P5:2P@2'A?D]-N1HF=20:#9WNX+&P2-:4M+-6L7PDQH
M2]QWF$ZZ^R=Y/YK.D&O@75Z>J1@ODG_U#BYQMWB>)CANJ@)ZI^\07S=1C$V6
M#3?.1[IZ5W> -:]O$*8%>=(%*?:RH=+#PJ/;93\7:[R<96'9JA7Y'MD1,'D)
MOHAP%GL\.!$]G B8EV]I*%L,7TAOE.$C*OG\?:FL5)?"QS3]V>!6/5=R" 9
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M;9! HE6"II*CW_OM@;;!D&D9 %9.W[:EHR6EUB',]RF0G@MJ1S"FCOAE6&,
M] Z@%X51;4*OH?+ML8NY;6.F!0GXU)3RWST)@/K0&E)+FDM).1-'3R\^2.3T
MJO6:1^;X$^7$"(= %L5'[/.<(F^&'YY,F.AI(SV\0.1L=,JV_-8B&OW *W P
M?:6)X-0O<JO#9,OGUZVMQ[,GSW8M94=H#,^+O:7[OE58NA+):VMS0O?RSC4\
M*/5_ZRCUJ0[C;TE-_WR):NQ(@(J=S"SH<L(,T^\?>AMSF [25SG7 9!)9;JC
MBM[[SK0G]J)6,C4](XDKW:TK4(9"I;'V>R(1,C7YV\M"(O.][WKF6IZ?8H)3
M8->/?KF1#Y_[(\:IW#%FGBIDM^ MA %XP9>GSWS_X\V-Q"979R*3;UA(\[%#
M<I0*@QM)_*74G>2C#E5YM<(.0>A&::[/7#:!T-'YX DU(IDA2H:GESG)VE],
MP*JD@<+=M564<@HF"WEET)PGVP<O*?;AB+W-J=CVL RFA@6JVS]?R.\<9X1-
MM2YG20E96VB3O!M)D#B3ZAT@PYFF$8!Y\0P+6!9\/D8QRQ]'Y@Q+?? =(5:-
MQUW.[U0$&EPX>E0N=.ULE$4!,>&>2S?@B8;XIQL$*8M)(8,&$&D7'O%)*&7<
M3D?#><EYT3IZ/*&Q8UHY!RO%6J*=Q8&V*%S*+;#4%F]O3AI[FRGZ2><1%NQP
M=5TVK^\_I^[021JV7M,7RD"]@T3#$?/UY1VQQK.,#Q=R"T+%0<"J9@<6%YR%
M7MD9G'A]')Y0>^I'?>%*0[@I2O19='<)+)Q_ ;7?_P+VTRJ5O(S^JT%/;ZG$
M0!4DYAU[,L9BCD]?2LRMGX9>_])_,/ 3K;Q.L';^N/KI_'GI0VDYC^*>O<%/
MKYK>3MF^^0O@E7YY_3PC^.GL$D:M[=/$8%BEW1L'KY.Y.%-)RK-A&8:N9O:?
M=\4H/(]]_(# +)BM>(6;W[PRD.D"_4<XY'O%@]**[<>DK=FO4ZVZ&TY&51/Z
MW#P!4E<E@:Y2ITB)+U1B(\[O\4UK>LE\^5$:Z$3(02(B<2TX3<MJ*LDIJ\/
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M,^?WSB!K!OUU-,4V%8F+?"POG)1?1PV6ZB)!39MW+7!T='Y?[+-^,-SV\IQ
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M)Q;FANY7A/Z_%<+]_]6%_%T%_#^W_P%02P,$%     @ #(![6J0+T"D%*0
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M2BZ!!4GH^C^_H?<E=',*-;/YNW>':=726L0,H(!:>A=#.5F-(:9,Z0:6,YD
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M#L7%GN,:ON[TD'Y"<U:[&G5$(7-S9QVM*'JEM[!?.FSNRA(3NZ?5+6Q$(UH
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MZG_@O3\(6?M=,,6U*EWASQ]_^)BYIC]#IIUJV]I<M;6 (T[H4C7&&E8$[M4
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M]]+[-P=&_BKGE;NQW02/#F<DB?*#[4JLK(7G^4;RAKP?SK-SQ'ZV_UZ1_/,
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M4=L=F<KFU1THV&H!I+DG>]^/LWXPE.W@D&USB=6C5EITH(>>S7<M^_6)?A)
MJ2_?9T?:1;;13:\!B2E/K]8ZW?ET%;7F[^%GM5MJ[.73W@*_.H/NG+UT^M+5
MI+KW'RZ:6+;Q(I]?'6GG/OWE9%CDHRC+?,2$C*BPQE&QHJ+07?R!](SVZKSH
MB1P;A<1_YY.NY?(P22[M+F/Q[<QQIJRM5<T$GLF_EUY+2?'783RSP;9]E)'R
MR$<Y[P;0@S.8F9NT\7N'ILVQS-X5>2S7:B%!@I"%B)VX.LRB$< 4%$,>($9
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M*[6YILD1%V/2G0*.B,^3.!4XX$0OA0HX4E,9ZD_!G,=,3>(JPHFL<1:7LFC
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MD,3- 4^'RK1'WEY>T/=Z$'C&*"V-7D$*]>RNV\<ZUC"]OJ7ALSHJ8"=).F5
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M!JX1=5UJ4YXU4-*)2NF>0["-T? 2MFW2NC]&5RH4L".@$[HRE0)ON<JSAF5
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MD7F,I2(J0U1& 9-2"Q 0(B"#H$DI,@L1$8D2DU*&R)A2IA*$B$PBQ(A,BI
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M?;QMY' NI26'& BIU(27F$-9@+C]H,0QG=M%WGX1^B%VB+(M8*F@X)&')#Y
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M&V_2&T1H']''R<7ZK^]E['!&VAKL_"*T%S,O_T.%K5#"8\E1:2$QT:;--J6
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MLL+N70B_8%S$?[ZU\RDBW2Y4I]6AVCO;HOS F=3U3 3<[L)^X>6!UZ!!0VS
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MC<D)D/-2VCISN#+F=K )5ZCQ[;.#?WZ0@E_Y%G$)^K5NYQMT*&:B>14OHH2
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MQU09JJUBR@OA(VF[%J*W%G!(SV4QDT^=?!"FMI:,W!3/79+#6T!*'+**';<
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MJ"CX,Z+\N)6+IBNRXO#C\)'BXU?<BZT]0QWOETE@9S$??W(1&6BI=9I K/I
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M.S#<FGP,EXR^YA;L.Z+?8?I2O_?4_OP[<L^TMNW[^S3G[FD>?2A2O'U#30Y
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MN-R[?'T'KF:Q!:_?B/RI3N[TN$^KD%-6U@VS/7KX:8:@[!=2^@;[_\/+@(N
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M3>;%G%@;L@-M[)HR'<G,F8Y PS'\2:Z3VY(GH/*ZV@=*["'L 553\6:\ 87
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MP 9H\6)U4Z+XSY]"@=FOGZ(+HF+ZLJIT.J#'N&SIXY^_OD(_03.Q*K:'39;
M-(CU:.Y>"2QE!ESBA_; H;,26 .]B<Y5D=YC@8XLRBXZ=X]X2K U=^,0^K89
MH0[B(WT*,Z%FMTK_2&P@OHJE-XCNLM=W;11J1W_11JA*8 N]A$/$N651T?RO
MCU S,.,'68")4OC6253Z'.XMUH,,P!@>N9.LC)DU^_PY3(V4@=J%6V.B%81V
M1*Z@]DR/X\BU!MG/6(;WN*_.6%EYN&_V^T*C9VOK7H_B#XX=(?XA@?TOQ0#P
MX]L=55'(CC[$N_JA=^!0=Z7MSONL5EQSVM<4"[7KA4TQM"#E;6TORG??$Y#)
M([AX^+(3#X_>9NW&M=;8Q##'!7H8\*(]=!@-U?]=^%=3P]FT_&K@@=R^X-38
M>5[5*',LI<J[TOI5'F757BJ #E+Y^Y/8:8M>8!(CZ:+0I31/L7.CN!X#>%!_
MV=H)=P>+W]FMMDE@8P0H!?/?/ ;#AX,WX.MK#XG?+BK]8JQ>)[[!O97R=G^X
ME+?@7HK^!G07;Q,!,_&VTV#P:CB S221\+<$X5+CBM+&F3"]O.[A>#V8$6(H
M(I7]BKQ0S"-GEYT"75)-&K)E'#(#0.-:((9KEX-$\Z86':9ZT#O$!I" 4="N
M-&9T:"R.(D>X@#\.;2Q#)F(G4@:HX$YGX,_RE])+3(%FQL#ON#B3Y>)]\^U'
MP)+F("Y5=C:]*G)\W2NEO-C=;Z3FJNJ%L;B3EN=>F646VXK?O]>KTQ9A -V%
M)"(X\'][7 !@D^W2:+<$&]NA&UT>9GHWW8=X LPP/121CM[H,I>877$*:$XU
MC+LMXYEY!C3.!6)X]!SD:=Z4YK&I#O8.\6Z<@'FSW7!P<?]8+%9);/&*%:WH
MI=B_>3 _Y-*KLX9NQMOV?;?7OJ>^6:-:K_,?BQ]X?U!?0PN,KC:LOS[M-FN[
MZ[^LH@J9G.SC%H=[=O(7\I[QC2]:RS^O(<\2RY@W?+ZBST%_>MY8UXA"J^/6
MC]=>=3+!!N:K9E2U7*XS3K%NB!SOU1N_E3?KEA+A\'S_E;\KO(KMG1W7WP-8
MH5J0P(&-/P;658(RJW60.I><I8( [A&[W@ F27@#_I*F\!CH/4$[&1K#14-.
M!(/(FVP%FBL'ODA5?BO.Y)DLF"2A-Y0)6&FDI"^S(<=&@V\T[0H)#"5E) MG
M02E#F0'77288JRE:,H4]II!L%UVI03.4.Y ^ WK?%6(X&!7_>>N3%6FT$XE5
ML].JH-/;1G(FS8@/WQKAA3(&B,DK_ZQ0=\RII=3EQG-/NG>UZX#P*<3K :'J
MN'C'/<%)]-WE67I8&S6;( -$0D_M ,0BG-NORLLCF&"5BA.6M"R@RCCL<\*@
M&I. &&ODUT"7#;!9ZQ'A!F6S*%7/1QV^$9"#RS!":O$[>^@P=)@JY%I.['2D
M<QY(8+\33O9S1J DK5K0O:L5?A>USX7K2%1\N*(N2TRF_(X.@RM >>$R3%-<
M/)=.0N*;Z0W/'RI4'R)9Y@2;RIN= >3I%5[DU(GV+1?ZYGBX>-.WZ% IF%Y,
M<(MP]=0.J()HILFE[_A6 W(CG_X4C>ICN=>/DX:#&=-Z)9&L%D-R-TJJ_BOO
MJI.U&<>]@FRS*IUQ#K_.ZW]YC"[N4[)M*]OQ(*(AIN5]<O3ND5 WC_KZ7VBQ
M_*34=:5 I%4OT2NDGN XCLU:_R@J)D:(" /<*<@KL?_,3P9!252*=(]Y.DO9
MUGX@W%JAF(O>/=># 7/>A)8)%<?'S[4#@7=NE>/8I\!F9O_-G[;02>X_RP-2
M8\EI8@-_$"=?\Q"+.E*+L?$O\N,P^DYT:!OFKR:$[#(V>QCGZ %BF#B4<7,*
M^LK2A$MG@FY.+-2@[I*\UBZ/W3G7C)%=^874"Q.CG(ZM3_^TNQWL]>%9R]M,
M%S&9R"D.-)(V:8^/>@.E@/'B[8W VJK?$-*1NPG!P*2C=""TP"J,#A/KA$^Z
MI&_-YSTZB<#4CQ#4\%904AP'K1R(([Q?LQ_5ZIKIU-(%X7<;'4]:7ABQD)*H
M>:])W2IBIX<$]F4/ G"5P 1'Z%-2Q.>SQ-,D4/* YUI469L#[\PL'G-T/;T9
MO".4-UEA>EVUUN;5MDW[/2MV##[FF_/>A"Z,N-T-!7K2VM$S5B9:D;CJ+@U9
M;P;*I"MDJ->LAI)6*BI+8UZ).]*2I6!@^L[TDZU/GLNF;&K^6%=0%7?.O5H7
M:1A]OUH__ROYQ\V[(2VI>S\<L7^:\Z<<[-*K?7%ROUW:LW4O[-YCSKU^0A>Q
M4PIO.1G$1K1P-X4SDTFPQ,N!:PM2].&R V?)*ZD'R.[#8D-<-<\XA;=7:/\4
MA^YH/];Z]F4#0.RB:GY[-7LC'+/3/#(Q\5&V[YAH13;*6<_\8VUI8]M;8<PP
M\3]-J4,.]**O'["6P$[1_[=*C9D ZFSAS,3BU:U!:J\8PYT\@[-N5=\<2XHC
MCF1_S8VZ\=X[(/8V?+GOVUD>505RY1ICNC7V^VVRLV9&*]@5C%:2.VTT2;BK
MA$VFS,N[&.\O9#RJ3'G&/3&M9Z^SI/6"HK1"@2SYXFT/.28[A-A1FA(?/:G>
ME4#NAJ=(@5;#TF_? BW -8:+)N$#<8]X/SX6Z@/*',="VQLASSH_(0J827W>
M"L:S:AW=W@)._VFI IBL!O)FS/RT61O@?(]'_+D U8(8'K&'F!YH ?6#U3V^
M,TQV)F:7106((.-O\^R:HC#,A#X_OX_,16P0-K0\;-(V_[G/QS"4*D E+8L,
MNDID@;K"IY!-EYHQB1L%MQLR)%8AH!/!JW^1+T+S BU";\*52GZ?F92-4W82
MP]@:LU<$"VPYI+TERV7WA- 8LJDU?AA5]V9,2.18H93P\</MGVMQ$1]Q& 9%
M28W-L/X"@J1,0W/V%\%J F0KA2KP'@GL#A'& X\ 'FR-=C.\$60ID_7(5DL;
ML]T?[PJ.)7$N(L]/:UHWW;58^7!E/-<S2DD0<];Z98,U;K2!?]UD_SI\)Y@/
M[FWWZ[JHU[L'N<5PJ]KN<LN(%MH?>EW)\X[.Q) SL<%;A[_$5.N $X23R\>X
M[ZJ-.%J6ZV? LSLL6G(S7SL;OC_JDXTTQ_[%%5*5TEE?&U[-^=).]%Q9-K/^
M^&"HR+,RZ,:<0I_")ZFWE\HH!0-@R8N%@FMA);N@6K[/,G:"M'H3S$D/X6$4
M\';@RCW0A(R,YGZ^TL-B?YQD,ZA)"5[5Y1%KD_ZM32G<?V=&Q#H0F7NLL!:G
MU&.MRD2D%DI@N\P[KAX"L-!ABE Q?E7**.[&VM5!$EA/(&(0I2?N/U:R_]60
M.652EYLO@4V9GSR&5H(J-FB7^5*FUM81%B6;H *5^3<-+6^WB,RM@%YSOA?R
MJ)K0">[[%)#*$EN,FXN,ET0GA$>Y9'F<+B-0"PA-0IXLA>PZQ8H?EBER./>-
MO=^KYG!Y7###=TM*>WXI+I$QJ9*/#2^?;=7*+)_T_=;JG/M\\G_"F<96;]X$
MIA@:D?\1&V46O@!]JVVBDO8CXG=2OM@P/M*N(0P'#KWA8'?^&QGZ)& ^8=/<
M358#1@TZ+70MA0IMAFA$#GRG33F.SV6GF\1JNM+T^%0X+I$Y5G ?$WZ,>9M)
M,^*.%] ,O?9?T>KM,XN;>R.(0Z1SWXBK%_Q78D=UW',_>[YY^_/7-<IP7[=G
M-SA0U7>H4$:4\(,3]N7B-NZ8QWRD[=YY!G)-X!H4>_%;<,EV/IKP@UXM@=53
MOI@)#A#&*9KH('8.047TA!XZH Q7P$TQGCJAW8<MMM5AA9K\C2KV_KXN5/Q)
M*)TK2.Q'BW>AM^ R%XYAB9<*F]2>%U9=G!7K \]?<P?4H'A&H,Z@!#:Z:=58
M](*F(P@G]"$V$R/@6WRR#>RA-YSJ**SKQC&_P(ID9&CY],;^S?\A[[VBFMK"
MM]\H*E(CTFNV#:09"T4P)EO9@H(0 >E"1%1*Q(B(1 C)5H30L[<** A1$2(U
M*DUI$1)@"P+2FQ*2J'192RE+2#GQ/\:Y..?[SM6Y.V<,UA4)S#7G.W_O\ZPU
MYSN1MPL&E[E*1/0ZQY6HR5=.YE-D6_EOA);/9\CFM+]PVZ<]%Y_.UMWX(8']
MXY58;6Q)@X?$E+WY6:UDTO(]KOYF:G)YP:UW(^K7#/?!Y!^V6>WXY; J)?^6
M?TF>H$$YD+LR"&E',*:W0=:\50[M+D*S*MQQK$^$PE+X/>D&&F#V'9)?>!GW
M5$E7X:?I&'+R.H:H)+0)#7XZ,[P2/3QAE.LV&)4;*S+I.2X-0L5#5P(4;%JO
M?=]Y/<N@*N(@X]3[#HL#;QQB*N@GV\KW>GB895L4]V7-<-?L9GK>Z1UM)6M=
M)!_Z OF>K215%#DHN@3IN!;X6? "=KHR[A2F._:7^LD\O/!C[:&1S2G>-/_5
M4J; <Q\=R -^BO^B*$A@(P;]4D@S"=!1P(F/;.>FDN&0.^#U3J>'0TG#J%J:
M8N2(=BWY>G>TH]*O?K-L&DASCHR-""T,J3.D7:QC)*&<^?[7);!30'L"RIH1
M-F$*WJPL@/!V ]5X^#;HE@2V$R-E[CP\5 )[XK42+.TV&E&FN8[)X8ZG\C._
MI_63C@%&M]$RD P;O4/<-_C,_T@S2P-U#,1R FQZ,VA*PACUGWA;;C.-FLUV
M&[A1W^CGI*/@.SV\%I?_BNDW2S'.O(08;PA*ZOCJ6RBO]9B]G_C6+=NL,/&I
M;X5AH67=U8("+7;.P323ZV<C2-3%!CQ?D62Z9GE1&.MDWG+Y49%=\SE-43RU
MK<\CQ*W[Y[EZL_?[O=_.Z?S#N.N3Z0O1@SP38D9.7MA?->=.3,W? <+%2EC1
M*R$24$;J0KL$E&9D,K?*\+'X#Q:H^2[<"K.=B&N)R:(6^A$K%D_VB[6%5T&/
M&KIL<M,?Q+P;$IALZ!CY-JC)ZVGF;IQ9ZTE>?E'-2HFYFLISBJ-PN)UMA46S
M:QK,"F(DQ]?P+8^F"N'\ATCF?)8\5. PT&##I\M!I>R<S.YT/D8!*F#G=%5G
MO>(M;B?&>K]NZ(OJ@GM65@TLE3OV?>M8&=--NIA.&:UA=0>)E?\&-.\(Y:3"
MRMN6F5!ULZ^:GL9]36B&I[)4F,J,,APS&14=)$"FT3==&#Y1Q*#<"GKZD*PC
MU(4N\5CS/7"_&=_?/I*F?SD.[4PY.VSI[_[]\-S?/ZXP=^?C'[@6)Q3?SMN<
M5#0WQ%0\83(8ROO%K<T[=;S,Y.Q=ILN9HLE9(Q=A!:;C]_:W0IKT/_$S=/]N
M^.O#-9\5>,K^7\]?DRZA&&8=$3;HH*S) SX-UX LCX3F7L[D@<,H U-E05IA
M4IN98W.'%J>QP51\6RJHRQ&U[4EF#5X")&3DE<%L0$\H#"S1]4F1D&HYD=:>
MDT!/EG:VMETL[Y" >X<L Y#?QMUZ/A=CE&SQ2.@%]BG!WWTD2J.6K<.BDBV@
MJ8!^4@@JJF0.O?4G#K+5%<MK\Q$ZPNN]4MU(5R3Y5\Q0E)N4IP-T0.["L<+0
MZ)C$1X7"/Z%J 3Y<H9TB)S8@EK2MML3XM[UZ)MP)["0&\;ONAS19@)B_I;.#
ME=JD]79H21_#1[XK5UYU$II*$XX/R0YDLN&0L=&\*9\ PV-&;%<*UL^25*%;
ML111[O/9(MQF$@[\E@[<YU].,Z\NQ[A7IHJWXQ(GK$%"XKA;XMA1/P=GG^HX
MF3-]EN/ZUIZO)3!GY)CI"DZ42-YC50IVKE2)\B2PB[\W8;-I&R;R" +9!77@
M_J0$EI+[CJ*(,K!<U)@U\H!N@TCVZE2+6 9X.=" Y>/[HTM'H-B_--=6JC&C
MY,$7Y][/ ,]_*IM,GG-QJY0+/&"!=S);^U)<]Y.XMT2]X%2AYX/&-<L]=Z]?
M#W?-Z+LZQQ?_\^:J"J [X_X/D>I^USA"V2GGT@/BV#EK.VVL"7N?4>:Y?K-2
M6MKL^4/RI(%#>H:Z29GJ]O(5P1Y= X6;!,@?G:)[E(OT#'K-8CM&3MQ#K^3>
MO0@Z9)"P.QH&+!7:W[P"J'^C$)>B@@E\9)($IB*T4R^<)0:]R]=P6O<:6$:^
MYH;5513>*H PS6/(%!*%3Y&#G )$:U#/[X47Y-%\)2B<1U$C:4.CP!&!%V<K
M2K8<BN=36A9.0KF\BRM-5GU"S/-9VVCVXAV#@X/SI!/2M+G =XYJ<.!UF;92
M-.#SHP5CN1C%L+6EF*/925'5 &Z!F8J9+.$"?V)'=''@JK19P8O*I(V#30>(
MA..]*,OH2^L*XBZR@E0.TU!(@=_BYKGA''B\&$4DL ,V0G+\'O@,H ]O)>_K
M:V__J[\<V: ;^:QS\S ' _>!?)LV0)U2<EP=:7\AS0_VHGS*A<ZYS_I+<N%B
M=>$I:!B,&;<?# 1/3"7^$1)%2,+)-,A.+JKX.$LU1=M]?SLDE62Y_M<)B@"A
M,%.S:LRG;YP=^Y*5;_#CVB=KGOC4W6*'I$J20>##R)Y\XKD XQZX[H^6Q_L?
MRE>;&!>&8N?49JT-YQ_LC!-'"PA]/UL-_GAWV4 1BN:0=K1@/%KJU YU&_S7
MF!CAZS3&C_"N^(/_24-7UFSWUQ@MRGR:BY*)BDO4I>07;S$IGZW/5 U6K1]U
M:</:=HO'=$MO[3_[L.C/67UXEUYJWCW.),K-U'[2]B5BU%JX[8@?='\=)YWH
MTKDR68(!7 CP[IJU6>$!4'P;2&VC;$-%\158,D3R^LI'Z #HQ_M.GWQ(.A+*
M^WQ]D;?ZMW"/5%,DKK$X3)4)HJME/W..HD'"E;,G1TAV6Y[&\A>_%/!7.3W;
MA'BH$20(<*GE57BD)BD$*@5W">"I9B0;?%P0KQ.I)G0#*]X*>E1\B#?;W0>J
MRUTZ_ZP:(AV+)3P;G?7M?O5B;.;?L>:XTK!HUZXXS/*4-,*H4AG9(U2S%K\A
M_R>!K1U:H3/IP&S97O!YR.3L0)9R(ZHM36]1VX/MSG"KECN;D9JWKN,>RKSI
M]?JTB#9#^YOSC6)OYA+$@?3V&.SIP /VH4F%B1'EU,Y*H2<&V?$SC&BR,'#]
MZ=9OMS(T\DX.9%<5[*VU840+04KS7Y3)+%R5IG![!V%TE<VMTDPC*T$MJX+N
M;-!<N /9S-I&'.=HU(5 -IKLD :L!":W"QKG+;)'KW2MDTY_S(@796]YM5)8
M-=C]Y$;EYH<L(3__4FUBZ*<#)R_<"Y;?<.'5TYOR<F>\$PYONIW_7!F_#I?
MXM])8%^(4IY=I(P@5K@2V$<I<L+$MI;(7[+2X1O.'!8GW6OX?NC]?AN,JMV^
M9ONR:]+L8-)U]L4LEJ[BYEA8U!=Z)*0.X;<4"&)2&DX"[BJM#5BOS5Z'WUVV
M6?&CYL-E%0WU Z^G*6\G6MIN>U!@W"J]Y;S^%^4WRB@!E-=,H:[U>K10251,
MN8Q+GS"#*M=WAZ'5H /K)TC*T%M^.H;== 1JC^;K2F!*PD._UYSIXH=\-Q<5
M IHG^Z]6=S::VM77]IE7Z_LYOJ2?N3=AVN78,OJUGOJ-^[\>E<+Z>(_50Q K
M5TA@#[)_GZ]3J0E)?73I^DHYL^]-/?7'=_U)TK!"5EM9R%#;>7R79\GL^P%B
MF;G50([GN9<9N0&+Q4*GI1B0FB:\M.8*Q>:#U:2F)HP)K]NTX]J]SI=J/]:<
MMKPV^ZG=Z99IT^7"J.$,DA88'0/A%VG?,KXIA HV?C]\,5'[?!TB1.ZK@^7C
M]U&$:VW8?WW'B 5O,NS;,\U.[37YKPQ31!N-%BO%BUZB;4F;6% ]Z,['WJ%<
M9NE N>_^)3(FN<U8/<BOU;<];5GI\@\NY_6,+7P!ML(=^4G:2#VKD:\PH&^1
MODN@24-9/R<RO:K!=C9%'OK9G#VQ88!E@9E,9\D^A[Y*I82=*%FHKID"O[N[
MEVPU3=&R+[$@+"S6.*RCO&<IB.^H?5<HU3<(?Q GAGD/)A3%H^L764 &A4!I
ML1-E,BF7I 8O##-+PUGRIF2_WOHNJ_[PV](L_T5?JY-<8DO)\@NWM +'=-_!
MY],N>5[&L;ZN=])/MG^Z__CRIUN4:VL71;O>3+60#7EB96!1_?9_E:?;_RC@
M^$Q04*7F70<&]P]&ZK4C.P^.J?T\M\]:QB73YM*O]"M_E0::#N-5C@66!+J5
M@ C!U+JCN >GRKI('X/SN?.M8 G[1#_:E*0)[F%0&WP(O*Z;7$Z^?E/M4 .F
M@-C98K 7^%:IZ%DY022T3<B"1E04[HF2W^F/0J>@HKDSH6@D,)S0X,_ 3^CT
M8?REX/K$':-P,+#?V[.DX2?6[Q3XR[1(8/(26&B7$8>RM6GG"-3.J<M(Y34Z
MX.+9.5,I9,5/(35200UO6:6H,\7&TJ%A(ZFUON)'?']'/#PE_R" N6OQ7Y0T
MJ[.C$*^D@!R\AX!BX&SO4T>P\ZJ VU]:6IO('UG5'?^=FLO:@E)VZ(A!-$(S
M$MBF56D[FH]ASI__<Y=8E[;RY^%=NTS73PBMH@X?'<STP5Z&9?QIR7?:K*P#
M:BK<>>?R/.1,UX]IMV^YD6LUZ,.W/)X:-UY2=U)WB[_>4*A^R]IP7(21X8S0
M=,6)OZ:V1]Q$;,8=ZD;9"L)&)+!+U'34D6ZB2TVTG4R..[LB[(8IBKVS^5LO
MXY1]IIZ=X]U0][0=\*5G4FP44YK_;-CS/Z_D:4(\..69%H:39O1(3 MSM+]E
MV$![".7Z#*I?20 =$E!>Y4),/RHP_#D>K1F.X7U/)?"<H]L1VRV-&_QXN;V3
M"#GB?2R0N<(0B.Q:T#K#E$XJO[:5DBR!Z8OW$(<%UFU,?3Q=E6Q..CE$YY"/
M@JO)!J/5%)4Y\W!"D&IU8T)C?F9!J([GH^# )Q"NI0G1O\24)R);Z@)2>?"M
M4DHE5!U%G'PE?D&97*"-;3P:)&#.WUHWGLEAT,QZ_D9KD(Z)"DB13W,7*TG[
MP=U<=91[,%#/4ZZJNU13-^4'2F!_3T+.(-=E_68UKS201U$FG<93%.>RV]L,
MS%[V4[(71^=XNN*/&(1XLU FE<-N=B==A[J VLE/!@?#M8CII#T1H$.[+_SV
M>? 0\<;LV-;AX6.Y <X>5=B%+K79EH\S L_^]'<-U'$0>:CUFX]8-1'X&?'T
M!&_G3*2ESIOY:%.&;<V$Q8Q'H4XHX[\I3R=!_P_6DRF9:ZNR1'<.VB)8*^1L
MUR&'_#KBZBF/\NQK=,6V9ZT?FPW?%@^V?=,R:ZDXT/^ 7*FX#W>J<%Z7/H\1
MJLZ)E4"15'B&=ZFVX-0;\.CT]?WB[HD#O68-3KR>)#'Z-7H/.)6!.E(V M6O
MZ_I!40#!<?!&><"Z4[;GQP8;U!J=PU(1&O8M,S<2IXY#\4"?!,:W?ZAT=T))
MRA=5:8#L$X^R )>D92X"FF.O&;5B1HOZ.5:^]O?7_Q(>9*U?IA:U\REJ$/5/
MP# /#'HW]K 29+9PU?!98P&W#<NO2TV !DF_3^@A8,F2;#XV64*LMKIO],+/
M$AB#DH@ZP&-N@O#L"44@F%J%V0IA6FP-[O-H\D1WMHYSXFT>4Y&(__-E;5\5
M$DZ,/=Y7OF#1J&G7>Z/>R=_Z5-^-<3^\DFW+V$1W]X0N,2B=1%MY(GK<I/V[
M9,UP&V*4+M#(6<MFT]/1FX912GQM\RM+"HV$/^-<1FI2!;BMF!0+S/;I&"^:
M< -_ZPVF'ND(N.=[?(EU BJ*MP@GYO3U.2T8CM!>9R<TV/X83DCAF+%'?2Y?
M;?3"7"T 4=:8P;C4_(J<YR778TMJK9LHUNYKMX@=;R9LEGTN]DE%/C/@G))>
MZ08]VXZ\\!#V46)PO@069K8O5=\LLAD5O#CAM4Q9.20LHES$COT4,.:/@#TM
M4L4P_XO_E->C2[QQBC$;<_FI^N]BS@T4GL)<ZJGE12I+!84AW&)(8"T.DTR5
MN,2NQ?GM*^RS?<M.^HC6 +4ADHT IPSA.768M2?D5FZUYEU6.'(T:)*V<&RR
M]$!A*$83I1Y>/HLV\%E.'0"H:4OUG5Q%X0G (J:IGL>4Y1)3D!N%QWI1V$FH
MP0N16)6';'TUG<KWE_^\=-3+)1_W0QX8*C1\Q5N >V0;W'Q:Z.W?4WNU-\*R
MBG!8=V/%IM9W&]RUVCB8O>)OK,D^9,K$KL$F5?(82V:?A6@C8HL0#?T+Q/-7
MTHO]?'&,Y$6A#UC0,G$0P*:&5^?.6/I4U>?!L;V8X,4-+*JYV=)16W'WVCKG
M9YAO126!4N@SC4/P$L-3FX,/5^AS7-S80QF&9V=L;.P3K;<N>O3/: T6RI<4
MWON6:>OV^8@$=C+.!I*AOF&R%6EM)+J"8Q8A<^ _7O*'($<+_.7'IAQ'"^#L
MJV+?*/SY2,4 G/NF*6/443U/]+V&L-9^\6G,_YL3AAK7Q7+,=3O$:%BG6-X!
M3!GV A>IJ&-X*65?B)ZA]2!X*T:1D'A?0)<5ND(SZW;B=OI&L2K4;S=T_QSP
M]9O47V\E<%A)8C407<@WW^5!XQ@8]%GDV?D"7_/+F=ZA8\ZKV>S^=,QV4-UP
M0?X6<ULWMBH(>^ !_;UAW'"J5MA(SY-O/O'LY@'.A8;#0+32\9R)J%(!M#-S
M+]+&Q97V804#F7&%ZL$<#.#6,Z;I^@J*$(1?75SY _(H]X./MC</H_58P&GT
M_L'R)?4^E).4G&TY6YZ^F)C-&4YN\"\.@')Z>,Z+R0LWE)R:$9N82^%HY ;I
M])G*0%N,0P4"Y@AS9:.HF#7Y!+.-($:0/W"5Z:T.; (OEY:$MAJJ=H(K"E'0
MI:=$.L>J;C,S"17*3W?S_KA;SK"8>8*'4?0EYO(=DE%'>!1-'(1H-C#-9<<4
M/D=H'E/T_,@F;#0[<TSM&EM'-,)/WFB?^CCO18K:Q?S-E&=TH:[F.IH8S2,(
M56-Z!!Y5=<JE_)XQ&I_!0>K,KC76WK40Z7+&C!+$6M!]=V@7CT;5:4_=V<0:
M$.*?A?BN_DV*!E793&+=41H523:'LD_V5^VNTZE-(IW*<H@OYLMJ7"C]EAE6
M9A$ZV.;)<"&]3I0: #?V^1?O/[O?B=JA[6B:XYKN\]DC]T5]@PM?3U,JQ:=7
M[UUZ#,^>-)FZWWI):)/-![UOG2U(Y2M>556E=;_)M6 X]Q6G,6V)BI=\U4H&
MTTVB2BY! 5[9O()XREUN%4:HT[6.E\IFK\E%;:$<1 /J5[*A9!$U$-.*B<^Y
M40ID>_>AG.,B>;IR%LQX\D&(6C8.[>(GWGZ.+8'8'D.H$Z"IIRB_&@F=$.X*
MNO44<@\ '5)V E?_%7;C8PRK>>4$/Z ]><D9ST8; MW5I5)XB+7 ??^^@"B<
M?&T025W6S4-P#'2E6FLY%6^.^Q-4OEWF$S"C\SVA=-1GM@Y=&AQ=-.N9-5S3
MWXQ8/^3UZZ54Y/S'W8#6)?VNY5),;*$DUH5^?"HJ(&\A68@8PHBG4KD<>QI8
MIK7"U:%.?FT+2S<L0*=O24GA!-Y;&,:5O4%+FCC8,'354A3-H:NC+H$RK6OY
M-8O\O?-7Q/<S(%7CCA_)EW]9FCQTB,_3XH?8+I?VESI6>[MZ[#([X5@=Z)GG
M^V#<E5YY+9*4W'H(Q#RC]K5ST"A0$\[C)A^>-]K&3MX_FGF:9L7(O/36\Q#R
MP\$/6W99Y,M7HPKD;K_C'Q2ZR,BFN69>,6WM;VV[L_9A9B#34J1!::Y' !Z+
M21)8C===8>BZD;C/%@ );8NW ^1Z&_PF$<G17;\]CC;)%SH67C(.>070^2?6
M0_JG-0TLH,#R,/'FWBFPJ)#_$.4#^CF"-;DOPLAZ@RC726829EN#'X@5ZO]^
M[:K^-I8NM77-!\6:^'Q$8V^UOPP;H<["?\U@MXAW-M@A4FY@M7XO4-R:[8G=
M-AO#N&-9&H=M00!UY!W3MK3XAB/\6*YR +FG+IM*PD5.$K2A*7:.!/:3_3\[
MY<OYF'@,X(X;(;21U?J7E)R\!R2PD!XJ2_Y2*B<K>[5&0ZP'2;U<2P+8]A2O
MG%LR/2S'G)G8 F7SG7H4/K^_99E 3=[1QZSV-_7O6UBT.&J/@$QI;7_]/KYL
MLZ.(1=[!3*3PMH=C5OX%D<W9?:P:5FU7K^AA%4*)_,&.PR+8NJ1^@>LPFWD"
MUV<*-M3$GB0LE54=)2BRJB^^)*X-*B5&^$8R7;^IM+%W9ID^6@]US;-,6GF=
M__WYRY0B'0_=J?!8!V3(+WJ!^_1<RT-X41;63BDS<%<SU*3)@8H5$RU"S6KA
M.><C[G<8W2Y,P-\[;$(ZAE*.4M2);VG12KC-<#EL2VY!;)K6V=+([XJU Y@)
M-\SQK0;&H'UE(9' -M "ANZ_F!/O!I'_YPZF56J5_LZQGY[#E@N$L_55_19Q
MNHZ5]0/5SO:S8RTM0_SO?"W<&@7 "G5RUR] M$G]GG22*]@S265SQS2$$'F=
MC=MH^;#!N8)HVWERT+S!.*ILAJN*/DQT&?;#*4A%E>P9,"LO]IGP*!0,IC;[
M9I7R\E0L*,E>=0XIWZ.D @@NU-4&"M@4%:F-8:Q14BVE7N75('F#$ 8U@O'-
M*V-')_((C#D=<3'RKGCC1&B3R9U5IX%]S*JM0E.PDY/3V-CT;]33616HP!'X
M_*7N>9U'!>/9'&*:C?V;B-C;]>/1M[>-)@\92>6>63IWF+X)MA;33:<\"'"W
MS%.#>2<L'CR?:5.AO?F4Z[KT=LT-2I7J2JV C< <XNY_09F7B(H]1[I,OMZZ
MBD]M%QPZW*/B@$PP&Y?+: D$+/9C/$M-'H0X:/LV&3[WB#D[W7I6 M/%IB*V
M"N. 8#X]K4E)2(#B*H164#L0VZHZ;6 !&*6:3U(#@(K&E4TY$R$55_8Q;^01
MCH-;XHM'YYK40 +5\FAPL]@**&(^)Y:VY Q5\T1>IP>^'ZYG0BMO)+ *5<IT
M#7,N5:P\!\#C+1 TW$M,:SC&'D])PJF*U<6]+$4ACK^A&+^]XA4/?F=B+W24
M+X$EYMA-_PS;'J*! =+Q"#WROH!]A44SGC%M)23?\*A&.]?7O4L*X<A?^G42
M& U/6^-9BU/#H'SC]Y['.'CS0L_R<WML DO/-U9]FL+" \C]H]:7$)^'H@J(
MSQE"^P=3N]:HTU)9'873;-"GZ7S34MPBDQ0!M^X\G+MN>^<IM6U*V\5 ZZ2@
MKZ&D-J5#D#7PI=R6IIC3XI;+YDU7KDLQ&E]-N9QG=PK*7#<DC^DX5["BGT*L
MEK6I^5Q0]TS=<,/^)@W@>R//=%%-& *I7WH&7>)7@X^EC4VOZMDN[E,ETOWO
MQ!'8V[R),LUC41\"- <KRL;;$!W!S:R4@)V0-AC/LVY;E!V9UJ&GBA6%+H!L
M*W/KC-BT:H @1-[B,Q,GS/I0H;Q.BHKWC$Y^<LE$R'6\[9Y[LS5UERN?SZJ.
M/.)7#I1=U3GR@C50*Y8O73>?E6(R6JC:OE(ARB,A@YFS^4= "EN!MEUH]E%H
MS20&L37%AM)!S_7K%>\7Z@"9$XV"PW2V#H%*\@>Q[P*V <.IC*%]%KDW@:+2
M\K_R=P*<'W9\<Z207C4W;7E$P=QQM-:/.^8W\6?LPXH+I^X?GFX^MT4_Z8\?
MIK-";&?)I4<K,NB6"<2YLU^FU(&@'ZO.]N'SCU^LRZH-560Z5-2(X]:V1A2I
MI@G-^$SY0^V*OKP2Z(UK\U#,A</NJ04I64;R!?ANM4B'7),?;J0'/\W,CQR[
M'DEY36!CDB:4H%: RUMM[:':LHE4WF(K9A/1G6]]VW*E/RI<N[IG"\0]]A*T
M3EA.[%U>5Y)2,M>]U_*(;G_1G._EO%+O1^+.8F^?B1.6#91O4HK+*@IC);"$
MW_2\"(G"+Q5#<'^ -;_(PR10*A'QRST;N90P40VW6:S_!BH 99W!Q,(MC>4S
M]XF+S11=\4&A)Q3)/Z)DQ64O\(8 ?_K=Y<_R2#6(XC]@B9BEB96&154D)*@@
MEDN.?4KR@A*>A%BS7AE4"@ARQ/56C IZ?^A:M3@90.L>8::09:'[ D_0=&88
M(8]6@Z0.C)%"5B,>L.PZOMBB0T@@;PSK>88?\G5)C>6QY"GY7!K:F%@@J.5@
MDC$&I,BB:5OK##1*Z 0E@YUM=0X)Y5&F2*50\CZ(+7#^77?"@@L?Q=L6O2T=
MG<[2Z4EFFBWE'L7Z#2$7+"#SA8IJ_^,A^=\)3T$%-"-U\M/K0KG=E;,/'2OD
M%NPS,>6>\4.KA<EGC=^'W7=9Q(NMEXX#N9IL[JD*FW??'A1BH+N0R\[FWM:S
MB=41HXD'+OH$F*!GTP(??O%.Z]&U#YC/L['+TGCP"W.>,LFEC-*QHL+?+.5N
M3F3AG\R2U43Y-YC;R -->_HLXZ(Y:\J,6]8MI5SX#$YQ&2[7R2-F.6/]@=KV
M'EV2 1C^/:$B+,8AT9(B/YV_NW+XTE#Y18-M('(M>/B'0 +;4B;^4"N!*6$N
M(M(P54/U>&;HFM1]@59L.Z#,6F<QT1*I,(=10,,820W6!43FB;X;25/#PJ,5
MGTD>8'8;<RN4-=Z:D^9EO4*6!;J?/B=&G^[[EGH.Q"WKXUQY*UZB1RV0<LB/
MH?;BRY859=RA\'GD\&FSO2$KT?WN(+P(J8^V!L=3 NWKRK. .VS@ZKF"?2''
M?:RKLJY6K=Z2P&I!FS*]S'&&RX-S])VO3JAYC=$[;Y]0.[/A_ZL7[E\*$(!+
M:3+Z_:!X4YJH1NC T\<<&UC&:)"L@<5WX^N4[;YAFG4WT-M%A61#2'<E"OQ>
MN$GG<FG!IXKZ DB7GYU435'XU!EM1;_$Q^OO_.G95_W99&+UKP&,_]ZR5VI3
MG@EA9V=C=3*-SS)<F$C,Z\>\O2T,(PN;7[L'WMXJZ,)'VJ_Z_PHP5;KSX<?\
MU4.RHJ?Q+4$ L2Q 9CS.;V[D"GIGGB^$*8LU$;/G+)Z:H,='/%?."<4=#.0N
M"4PKQE24OY?9AN$K2V"#)R2PAS0)3!XQ0Q.>3167]8AO8"4P%2Q(?<8:Y:?\
M7S\D^W_["'-)3O2(%4Y+1 #V+&A']KP_'SDFX_&11 &#^<%LBA;IN"B_21Y2
MQ>7#MPEQE'0#:]"AG24[4_XB;$PQV@ .M+,7-Y*\ !3% +W+GTCQ!H;972Z"
M=5DV#GB-"N03$B8T()K(NA?GSM:30VOE!R6QOWWD" X0L26\N8'.MSON7B7W
M#F2J9^1RC [WW6<L[&7,]UT/G8$<,NA.9M89Q'W;WA\BP"-LD,J !+;=+NG0
MXUK9ME35Y!X!5LE=%BMGA]BGQG;86ZQH98IP/-P>_^$QN>:K'LH?0Q$2FHQ(
M6"@/9/.],L@6)#SXK1%TD&9VCB@&JT:R@Q+XH>;=3+[S52<\?JN5KX\=OC#$
M=DOR\]%0L0% _5W.JXCHU8Q6[;N!DR.ZG^Q#'2D(K8NJ780+51S$6^_S<>.+
M'-_@!;EUN]"UQ;N8"UP%O/ON_<T1+T(,C$2%J&-/N4[X8J+1N[7R!T,Q-?%
M_\F!!:,^L:'0M>^J>90QTGP9GBB!*48I4/3:^8LZ0GT)S%[>E+H/Z$XWXZ[[
M'>Z:#8Y<><UQ23^G.2C ;?]2J/,PN2' :*P_M7Y%?EM:3MI%T;U,&Q%6,\[F
M$(I I?V-L@(6%7AQ6I,O+FF=[D'R@W,].EY[NV>:C)PK4%+6?]]4F,Y4]HWH
MVI/,\7JJ?<'4K>C5H''0-0GL-@;PQT)[VN-9>,R(&_L,M , EWK2N2][;D<M
M;A-W-LE X?BR4%NE*3;>'--<#-JMD(#A%OI&R(N3E;^3HDFRAB(*O(5: "$1
M9?Y\3H.K@=(&:MDYF!04<C+<J]WV:J.8L+]+#SP1L2EUM[O]?3NS*]J[,T[
M]9+8=\J>'WQY^(\[IB+Z7B8VE0B'MVJ565EI<><_.>NX%?@^:S%SY/2[N15\
MR#)2>F]B/N 8G?L@6&O,Y#$!8#G0"C,B)NU/Y5^;,$I$Z%Q\FQ7H9-GYLOIP
MHH_>CRLW9FQMTHH]LISS2I8.:;DW=WM'895TU(%ETS;W?)-7PE5*LY3+M3#1
M"U9@+.)VDW']=N%942HU0;P-5^*C0*S&W,E>N_D,$[P0ON7^)%.!Z.2LXY H
MM.3#[ZI,>^K4II*\+%DM"A0$-.?I[,3?DTT7;>T]$9?AE\@Y#VB=-C157YZ%
MPK85N&O,V&[GQ%IVZMPOFAV*R+U#JR(/G?OIEO_X4^FO]O2?'PJ2W]0G$:D[
M><LMHYY1.1<B44BXP_Z,4*PQ\7TLR5X5GIXH8YI^>G>$.]-LS][)$+-]&F>O
MI8ZMP\///$LQK?IUACG)%BL/0L=1ENLX\7\X!#99/( ^1.Y&HR KE+XHS;PM
M 3D_#.[CMAOS,=!)3/5EVTIB'7*L),XBA#L2<PU8@[07,\K+$=M3C\JN]SQK
M2%LW3HQ]$'2]>'!%0=M%Q:.17KWBSO#,"XLZ2J\J[.FTC2 U]6F.34WGJT+Q
MR0"3@]82" UEUMV8R@+3X7R_Y>J_U\2ZFK=;+XU\,!HVT-1=QA'NMGDQ%IJ*
MDZY]JV/L$@;.K>^7REAORGD6>H[O)50SY3LDTC(O1^'NL"I/#5O@LIP>[:JE
MI'$UA(=)=I.4AWYL0SJ ;^9N0^M!O_[IM%XP!L;;=&P[PY4Q52FF?*E3.X>V
MRW'K,OV&&W-CMU"\G@&F2CI1WQX$^;_G@ZCOC_4&=KTW\.FP5'M0_%P">R'$
MKUT--C"[IA'T[BUV$Z7X1F4.Y!VL_9A8Y//U2H#[\:N-5RHRM8 51Z"W[8(Q
MCUR9M-9Z2<H<E3OY!F?!R,?R>Y^QG#&)\!^G)+ [5%+( "N$,KZZ,@*]CQ4L
MR/ 3<_G<L7C!ED>3& /(#:?H#P5Q*+)->L2*59[#NTZF<MB$\AVX,I1ZK!8Z
M,(G=X#TM-GT5.]/@4S0V3KSO/F39Y>?1-$20P"Y@)H?A\3H4#AS:2TL6&\V)
M98:K/UM/(N?7!3UJ1*?VFQ^A?+@B48%?FU[=LU5XJ+<\*MWK5/XXNQ+?A(3<
M^:STFP%Z0&UJP)IY /LTZ)!LX;PSW+UYE_='UL>Z%"%7CK?ZDA_->9@V/F<N
M  ]+8,4BN]$];I6E)F<\)JPJ'NPY;"%*^%+\_(&N"V;L+;=_LT H3[OSR(%*
MVY-&M#/B(9;_!2/;.KQ)FZY95)J=_?'PVI!LSJTFA%(JPXVV\BS#P'O&Q;W5
M_GZA-[-Y$;(Y--E$!_%BN0,@BX.?5(IM%Q\0T86A $'0\W<0\"G J&& A(CZ
M70G,5O9.DQ%1+#@%#,P9%#Z!O%9B?S]V]&.I._/]S+$M8FV@(:<]?5G+8IVN
M, +%VXMXSUA_M@;R4EOXUS(QU!3V$'M@[KLGPR2R;U8\3_>8I7U1I%IS /&M
M^\$CF-4/]ZTZ*TG[&E@+-E</9EA1&SOWX29Z$QM>UPB90;\#]*(T0'&8R<=C
M]G2>'Q<R]N(0TQ>34,Y&'&P"HC*;RKS!DID=0]_GI9MZ50(,#B[=]F9%K8X$
MEK*$T<-!!<? X69S@]Y=4&QI"%FUG[QW7RE>0%$D>0"?OR6(4EQQ>4!/XLB5
M^$.)P4D?*%6S9^XVE9^:S-)1PW?TKBPT>!J-.6Z[?G;8[-8>9 C=(H@PWZ/;
ME*L]E7I.*7625!!/&4BS"D]Z4ODA#FV4=2OIP\$Z\\$L=Q>5_P[B2EQ;+P11
M\P^6E/KP]P\P[F1:VJGZGV3F4O#<47>>]4+]NK70790E/NP'W2$D<C4LTJW8
M7O5 UEMK*LKK"=Y %]1(%V W$UELG3J[:+QL$DE50%.""*UKYDVU1?@FS8$H
M\^WCSB A4>C,2VW$_3G0=.\9R_%!T.$.U;1@N1-MKO?<T@KVA-J[1KN86^6$
M%N7E4T$EG<%KRZ$7]B^'G6$>?V[J6FY_O= SW==-"I;,DX>[\QPCI5]M<3QS
MSRW5V9#R0%:HMDLL5[U^FM)L*3;!HZ4VBE?NAX-P^QJ+9C *F- %V9:Z-CH0
MQ!<QDIZ FZ6FZ4KX\GL_MUXA'+R^Z 0PDXI KW==T1SK@/W 5RYUN=R)O8JV
M@?#(!/0>J%: @Y&.@ZLM%.UIG$J3!E'0AE B[R#Z+QNC#@EZ8,1L7X"0)CQB
M6%DP:V PA#@..E )-SX33L9Y_3E8[0QW"T>O?696Q3F=Z=^75N.5O>V4^+TE
M:,D4JCJ)Y=X';3\6M XC<X:NV=<')0ZO>$#J!#5\>\>_[$F+$P&R\K#)B'?,
M_RJQ\L583;, AQRG?6ZYCZ6]TQT6G_G])93BL<-SOU?8ML=&>S2#/9Y3GC7(
M+HG: XDW:7!BX;L!8O>-:U5 =639ED-*B:4Y_<^?:G4>?O]J!&4OJY+RXEG)
MA0/>)'N==-]7;MY;;6R8/VX,+W_&MZ+_ (U2A>YEL_D[0:_4Z@5\:],^T)[U
MPG]6_ <HS=5VE(A2*)4SL7MH6;O"4A\?,&SI5%KN[CM4?20WS\Z=]>9-8]/;
M?'[H'L)TI'CK[Z>'!\'5A7*^""%H7W"=E&H82Q$-A4(=Y9L;G1Y:^DQI1AN+
M7K35%H0VF0 K=.#'=_Y14Y\::$]QB&T-K8QX7V!_>^<81'<:> I06I2N"SB5
M$+.-)4>I(U EL)>K\UX O6T,P6$ET%_#Y^N!?CXF4?D9R1J4D=+A'?RN6 FL
MI68P?P_/8 :5SU2&G)R';]PO"=&I*7TZ:]@BYB[4H1DO0K/1X9E?/VR/.^'W
MI4F#M__-&T%D&:G2]Y^<DI<=]QG4O+^^%R;G.6::\(-B3_57[WU?>G;EG^OQ
M/U%.:S%3OZ;@PSRZ(M&%#N/-\0KO9-WR0CAIYP;NCZ16WGA]VA N&__NRZ#
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M!0R:\GKB7K&%AD]S2]VT;?/]#A6H/;X"JN@9]B6)=0[T3.ZB=>;1MK2A^4;
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M%+,>Y\DAQLR9_,##ZX1@)/8W) 9N3"*7FBX@0DZ^)V4/R4ZBNS\)LX39E>%
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M!I^(:WH!MB0R\.HSFEBZ*G:;")VR![8BZ8LI(#69#Q:7[>JY6T::6MXMR_^
M/Y9\+9Y%:(OZYBJCLT]/7Z1B=ZS*"TQNED+!^IY&$:UWPKP2@\8NI3>&83[2
MWUAWX2$JUOIBG?DFPMN/4B<W/YVBITYY!:P01JA[IV>E7D&2G6ZL@U&/QR/.
ML\-)H4\/[[N=_WVKQ(SR@6(KNT7YC<(E*) ME2(TK>>>2LP!MJT?='6*[8/,
M4@FP&6+V+*%OF$@!P<&PV.P-4"^B<Q)W\-!=N GL8&<D?\#):T@/NBO@K@Z
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M8SZ]MTY=DM9;FFN3 VUCJD^5::H^,DS/NU1ZR*4IU_O0D_TOF^84'<U</^<
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M>8'WI4_E1M%^]ZZ3ES(^)??^)5*=X44K[ZPZK+8KL9=?;Q-VJL*E].'4VN,
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M"^WD2E6(L$X\N%)@^GP0\I.CP#: CX6^UI$16998@?@'J1%NEC9'2P;6470
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MJT4^@<?:MHA[6Q11Y?9'[X[Y'/ K"7;A4O%^/BGK<O,VSWSP_?.V#O=_F%*
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MH&W2=+W*\\=^X!0^E6SN^)'D&<<-_6 $EZJS>V3J9*@UF_\D+/].R,:D,GA
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M=K2NOK>N*,3[28.PAZ>JFM[R<>VCE%UF4_3Y1YXF+O.// $=3O$+JXN*0!6
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M+%C6K&_5/@.31>S5[I"MF-1(5FL3%1/E(=EB/?=O(5>A0,<_4ZM]3N\XM5R
M]1_>6O&ZB.  9$&9?%Z8=C&*O>ST4Y[(-@+UWW%/ST!;2? .)O0C_KH K"*)
MCJ,J"H<""&7$1- $H(BY 06(J^9A0Q*(6MGGQT#\U45,!;>"*U*66, H#"OG
MU,OOHH "7RHO(\M<JN&S\MO<L]R!_<@Z+N1+[9\4_E>B@S)]RGI I*%P3LCP
M,D QS'Y6-5B&E:&?@T@?TBK#2UE28II40)(1.Y^_@0Z 1L+8J<^BPID5]&60
M!?A?$3R= *)[K>JO;UCWJ-.LD+]6X.NITF'VKP#\3BTNAA4=\@UT*JII;B1
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MAX*3\9$ZK(C= ,34Z"[!!]AZQW.OG).;VUT'!@<'^NO#"@+<WE<4>/3Y$K7
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M*#>\[=32VV03M'#OPNP/\O+?GK68'V-+,TYQ?BVW2GC6WMCA)QM^W4V[?BB
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M2O.,88U'T!WQ4*Z\(/M$YI8,K4_?OKB7=^34S=H<[?BMG)&_@&6\)_-P$%X
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MP ]/F5&DI2RNO:A@'U[$J'Q:2N/"+F)6I4E)L.$B!LQEJ-.416&P(05D O[
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MU;F5^I&:MX@1KV9!AFER3?Z@(H-L#4OQU>V%?\=Q!>"X0/'$@"Q%'S1:R#.
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MD/+APPGTZ8,(!Z?$-_JSL7ZHHB?Y&L3,MZD>^+3>@W6XZZX8+FAY2"'O4R"
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MFH@098B4VGKQ;#G8NSD\@BVEWF[A6P '%7K2?XVJR'WLSM6;^?O:?ACS^,K
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MP4LE74@NPN\U2NLQ*$H_TSIPMP'/QC&M8(CGICJN0J=VR+DB:<&[C\58A7_
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M:FN9+DR/1U[7J]8IQ9J(R<%)[W$D8K!,3,Y\H+L#;V,[[Q."<;+: P36N?@
M:R:V=P]^5E>,RTYZ%W*2Y3;#\AD2$V@?V_%<#-7]%O<:Q"%\,RX^]2L1*BE*
M9%<2J],005DF>^T](EOZ+>E)T.N,M+.'NI\&_]BMS;\O&AE-?3AR?VQT9Q/U
M"%,\0KO[=#Z&8Q04 Y+WF?/Y'4BICU1VO')Z48+>660=0RUJ73'B.1=T?#3
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M@="&R)XV'H3=U73K)Z+-V@RA<>_G/$:8.I^F5ISBOS.@I"DK_9C/Q]:^S=L
MPD@,(\O<BIH?G"F];Z%,PEK[D8)5G:EU]*TD#1DO:1V+P"/A](CVM>DI"U*C
M+R 3+)3-OS4D_L.LYW\]52*KWR/P#R?LJTT;^:^DA_0S=>)\I(HXH^,(5>5V
M]^CY_&5MN _FHPX09J6H7'E6R@#-Y@I8:-/IVZ: 1&6=2# \FG'HN6I=96=
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MCY3%:1DQ<U#F-QH]K5XR%PA-FQ]R^[7KQ-CR<(PH2+^""/%D77/V=@FSD[]
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MVO4!Z:5E/@V1HBP1J]O_NQNUH8=+UY0-'($&NH=)2#BQ@HQB\6046S<ZF]9
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M[V5?_\4/Z/^P]RY039W;VG 4%04QRE5!B'>LB*D"4B%F::FB4HQW%(344D5
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M3AP:$+E(QV#+B*NYEOH[N LPE=B67WQV_^>(V*>X ^*;2-NM;)S!]MQT[LW
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MD'"[2]9].#+ BQ.7\.J!=?GA<3=9\.M+ND"9@:0OZ/_ZGO!%/Z7Z9P.)8 Z
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MK@9;*5:/LY1"'L5\F+-;1;;IH\SBVK'WO(S6F+$=-HFEO8O<K&"5?$%W7V!
M,L=;!:?UK$*E%Z/EINQ]X&&";:LFR9AW!%?')'W&E41LY2+Z>W#H4,(9_4V3
M4-Q$$*%?8<QN@*O_S'PJJ*?8! $^;F:B$I.Y?V&:E?AS5\8P2,"G-L0<_(#V
M-DR<OG&?[:75DLE,L#08I50;2+QRTW2:]P,@V=9"@PN!N![_ "F[P/%@K7B
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M$_,2"2EDT%G"_/>1YX)L;198J]ZK\\9E$U4)/G7<#5)Y78\G8*(*=J0RA:^
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M,,U^N#E+9B"I_/ ?($Q?H.>LS!MSB"V[7(1O-I!0\P#,S@^_D$O8BR53N]U
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M+L%WG^AZ8TYRW\@"!8O7NXXGL>F29>7Q8F,*T69_^&ZDS/JJ"R_EV/@9X?.
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MF<_W3T9,D3;K9P&*GZA982ND4Z1PL ?2LFL>O#P$!S4(+H*SZ*O1^(!*84=
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M^W*SPXW <&]QYAGMA6P+FC0PL\Y*QJR,,V-XP#K5&QJ[F"JC@6&4MS9!*@R
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MC<N=QAF09X%L*3=C=B'3&\++@%SRAD&B!H,1Y_J$Q?J>6LUH$!W//W<]QBI
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M[]8_S+;S]CMMGN>.ZK-GP+N'74M8 F*&LUEI<3%LN*G+R3SGFK<0)4,N[$9
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MQ[S7)0H8VX 8U,CQB.%CQ6]P"12G. -^X8'?Y+RQ,S(\:V!%(^Q=)?G;([:
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M;]EC-CZZ@Y'#=S'I^\@;A).F<=HQ;M9O$%\,R1C &+X,:X"XZ4EQ1 ,8V/*
M6AQ="3]N.4B6%VUXAFR5;7EGG26?FU_J':25VZ9V9:RO5P/"B2V-*4%!&Z3A
MEE(R-PTN*EE9U*Z3S3'8=[FRQK8"G_9LC4ONL[L[M\XBL-KN/MAEM]78.'SM
M\>R;YZ-R6P+*C0/)YW94='-=OQL&G0\PJ_VQ[(.?1=W2%93F:=Q_/1?U_:];
M9,'/:\2 A]&#&I+\H)/PT, >X;J#^!F_WPBU';2<(67>;R+8MNQ->+MY/W,]
MOW'-V4-?$GT#1=TEF<+]/P+7Z^<];<5?C(B5K1Y=9JBSZ>ZEN<ZST^Z^C0PQ
MBEKA52Z[%_#QJMRT[6S5\>XX_\#L6,<ATY:@JWY72ZR1#RDOB> F.KR\X"F>
M+9F#KL:XE\Y#90 S!N0)QBT^%4[FNLUC;@9I0KH)@R0#3LL?F@RL!DWJ2ID;
M517H0CB\#35HUWDWW+?LFNP*6S/N>,.IB;A^HAECKSG=*-K,:8+[/<[#.&4%
M0]3:M&;_PX-),CT7UK>Y[2O:/EP8O+>.\,LAHD8_#C).B,U8R?X%%.M*O^&C
M,KGA)=H/TVT##E#JJ[2-5_"K-C_;?1BQ#]MVY.Z9BCD[..3B(.-LH?+='9<<
M46"EE'&K,#7[:)#/+6 U#?R3#:]4;Z:#L; .S1./!:BUM!%K"GAW&G<?P^2^
MC%;4F*N8QF$?9 FG%^-4I8"T"I!2 ;ZNJAC%P+AVJSJ'&\A[2X2V8.-EK:X8
MAWB-3,7?S/X$N;>TSU.O/@5-X\0O:#HR7C?3S47K[#2NHF@!(_$I)8@O;RH9
MN_N6,Z&1OC9"2<5[*RGX">UU9>*8#\DB8'^KU@22W!.H8\>/1,7_#WMO'M9$
MMNX+Q[81$3 H0Q2$J*@HJ'$ 48FI5K;2#A!G%(2TVHH0,>U $R6D5(0PIQWI
M1B$B(BIB1$$4(04D@6YM168)2J969#)5+8225"I?Q;/O?;YS3N_G]O>=N\^Y
MYS[]QWJ(L:K6RJIW^/W6N];[]I:(J8>TGKF=D]/EX9O>E6:U];7_QOGIX](C
MCQ5T[/4/;__I=,J!^[\E%C;KS_Z>(U DB+K[8@[KM292O2Y--)E'D%B+U\;;
M$FLN2T/.C*F*(Y1Y+,,%I6E\SV 46%IS9-=ESAC4>DTS@VH^XD:NI)GU2I0X
M4)ICOPD)A!)* T/KG<LN#F?0F;8-J3[&_2-]P\/JS 0M<QSF@\:IA2EN1">)
M18B]-'<,G)N@5:92X;1(QACBR[/:0.I7S8,FD@,ZC-OEC&%GD(G^X1_9EX:[
MIA%3%;KFD6@M3(B+4!^4X_WP^Q^>Q#ILJN]:PDW4'%I)S(@<E5!DO[V>(,BT
M3SKPK5D&:B?=@:RG.-G3=D3])+:$;_A?WK\T]DSU-^KERV[XN03%+&@IL4\O
M6; M,?'9=S]ZEO7MUH9ME4FB7MQ=/#DY_>WS.4<]N:E#D;7!%^ZH)Y5>3N55
MF+ED.8A-S-(/&,7  >5$;"^ZDYBT+&,^^*TP*?@$-9&^0B4\"8ZENVCC*=)P
MZWLO2_UVE!6E#42HE0,>\"5EO7-W"K8;2.$%']6 ]MQPUL2.5^R0B--)Q;%J
M\5CNH:Z&(:8^ %V-1*@\^M_"8E5W/55!WF6\S9B%K7BIHZ^XB_$0('$:')'"
MG[HCM"_[CL3A$3(^@YI<&7;XZ-T#;N3+7\$WBC\G+IV*T#)T@UY"9[1HNP2A
M)?N$"D:6I"X5$XKSJ/W4TF#IH6ERN.K0!!5$D*ZA6.M+W!AUP_CN2<S^7^]+
MM@A&E$[?Z<;MVQ5ZQ<";-?WZ1V#@SL>%N.)7QRG*I2/Z:(%4&[E\\B%[VU1Q
M>H%SK\1#U+F.^^N^J"/=V9??YH54K7,8F%U CECG]H)2R+QT^3"8*8(W,U$/
MCX&SAD/8.IA )%^"GP%)+30>LU5%EDZ64+#)!" QAP'SZ[)SH9N]SL-"WEHM
M9Q0O%O6]RU9&O]3"0D$I:,T]IV0U\0BQ&/ON5A%W?_3RC_5N<]8W$(!$!)@!
M20=%9<US-EX#S'CD=?CL>TA#\I#.AL="SQ)XQ);;_#4<7A5]?5<G:AW2,L2A
M\@*1@ P3J:1R8ZY7VZ#. 7U0MSRSF'T=O51?\[W=*RZKULVM).&#Y^SGE0<1
M:S^XV0,6+)1_5XF2I\HVRM\NX[M(1>./]'?;IN8%3PY?>NOPI;#:'X.\Y7L\
M6WY=V$!A462.O=K\U&*FR]S5RQXEFM&(RY8%9]ASMVW5;CXBUW0';8J:(RYZ
M47FO<>VJ*;>]SPD]#S\(T!9B#N=QJU\,W_([H8F5HS3@*2J\C98)W!-+H=%<
MY^@QYCU=8WA433*DGHW<*!3W+D^JTBHG<CNK6:ZX;5_V<.>QI9B[>H!:VS6C
MO'U0-!:L778[JFORY:!*I#YU\\=>$>K1T%^/&/2KT2^48Z #PD[W>J"<DCJ7
M?E2S(DY*I> SN.NZI>'>372*.#22L@3_HJUL16B]TIZW20OV<QP\4H>J_.2,
MN4AF?E%(#V-F"1QV9HD;!18([GQC2$U=S'&AKWJ!>?^"3?OU\"X:8_3/"QT6
M'@]B)<'=TBM/EDGWW-Q6%YSIN6M?UG<W[#,6[D@M6VQS5-XN1RQ./'JO*=I2
M]VQ"T*%IS'FUF^M:?IWF_,QQV]*6*R7<Q\T70E+9O1_%<[TW;Q1X9LS(?WKE
M8.,_/YQS *SQ ?8 "J'>'6Z7<\;Q&UGP1F4J5/XB2QM-X)9I\,QV.2&5;&>"
MX#LI7^V(4G#2H_MY$1IE&CB)OEOC2J[;KJWY/92[IR^LF>>C^ISZY<3=A.MW
M;Q&P(SP,O]P8@*UIL(,TC@3JI8PHK8D_C)'Z-KS 1++KDXJ&TOI8G:Q.$XDP
M/"RHE3E$> NJ@EJA5_8!I>;,]>G@9<-HW'ZTP==J2#?@1KB?T'*:;_O"W/JL
M#L-\UFT#>#OT?&B<=1RSRT2B*!G_ET1T'/:9UXO/<2.O</VS]J#A4RQ%&B_-
MQX.0O7EG;^;1%'EP\6GQW W<9PO5&UC.NP\[W-[WBG*F^(QFG.."A;6-A:<O
MCOMND^.&<JO@R4SJTG;N[;5KKFC3ZU9=V7,AB]:J#E\:N?K6^I_6G=_RY$C@
M@V[:7P=D_B,'9"1'C'<9$W@[T6'#,MY6=!GLIT]H!_:!*9!=J1] /L"BTA>J
MOR;4AB704YS?7:2E?J"OR%^KH8U]'<K.)GZVNAV;<QT5!9AK>:Y7I1F_5]9)
M'%OO\-:KC9YJP O8349GT@8Z#=/P1HDS6H\P<6N:88VY&I1-L3?@B,;5F4@D
MG(;ZUHVT)U5&[K[[/G;3@7*GY0TRIH*I:85.#1$DK)9LR[W;*<,GPY7A,PG3
M' -8N(8T2\-IR,RJ;IV%PW>%YJ6VX"\.!R>]7I&F/D%WKQ,IJ'U.+HOA/FGN
M]!<+0<7Q:)O""4-!<S7S'9YSRV?IEV[PF?-6].KQNS!CQH_+'TN80U,Z)R37
MM7J]?;0AR#-IT1UVY1J7\Z^>3OIUG_/AWR[??'QSDS@H<?TO94#D.GZ34^&6
M["M;@\G_)/X#DJ#]PG\!A2K+>MT9<#+/_^^8T!MEJ8<SCP7&U5'',F80%,0W
MC4Y!@)K#K],XD[G6(<V,J3@!">UX- (*6T4D?HB)M@]" NL3RJI"JT?*!H09
M](6VY:G>MLXC[2,^US)'F1?#;>Z/]U)GVLF_D[C,TAZDW[L2Z.]GWN^W0+Y_
MZ<YO2G;&U38_YTH3%_=WSI?>F>]'&;OQ*?+*<V-1<E'*F;TIE^],NE-NE5&T
MZN%TGX(M-I]N5G KP]T69'E'Q-JL.+'UW:<\RHFSYZ/FK' \#?U3][$%).*$
MZ5'I1FKP/ W*LL9+=\,[-O09]YJE@#%21QDUI-R;) 7%V!S"^'7\> )BR>)/
M9 8/>1X7S:<8UBV%;G[#O_,G#\,\9OV:A2USQ\<1<,7:"W>"L+_Y&+:!M9N(
M:6_ Y@+]$+K5S"(2V4;(O'O;RD,/8G-$*)N%;E'""> !$RG?G$6<&#[%S+\L
ML<T0G&(VO(11.(%?/I!?:R(1/AN.-7YC(FU$>.9J/B$+T+FS8O 2E "(U/B]
MUB='="72W5 [[J !^W]=P1)K&%4!7B,7Z0U9UL:"*:R6!<#VA8\/V2_0LT(R
MCL=9SMFB7_KK?J>FK'EO:;>#\UZTSS@^Y=.5%1^"PB-WB?]3=IWEAWC]9QWR
M(</UA'8F\IVQ%7"]3&C6SE8T1=TPFLM<B>C^13M'@[4_(S>$5R-'P%3>9^5,
M\*D3J BYV^#S+$[W63OS=S&OHZ AP. 1E!WJ]W481"""0\05G^U:.+]1,A.M
MAQ_\BUW[A6IS=Q 8QXVKH9)P.RYAU6A)E93=>0>^+V$'4Q0-4DC!5,^#,GT(
M!%0+3D3O=LOP67"E9.:#>VVE#1:V(3IIN!W\IDJDLW 4"23S$<+3[A1J#UG)
MONMBR99=(E-/BD,7J^:/TJ3?3W)95+>[Y-6CMU=6R'F+<^ /@9O::C<5"F3[
M)F^WG'"Z^MF$2ZK;ZM_[PVG6.^2J!:\4=M(]VR(;S^1YYZ7*-UZ^,%U+6=[B
MM:5X4TA@V>;K%PHC?UE6MXBUC/]/W=SV$[4<,E?8P8PE?&\6JE0+,2= *^Q/
M@_G2?@@6,RQYD]' 6UPV/H%6QMU2HPA( ]0ST)_@>JVNQIRL*1CO0@*2?,B4
M]P0IO5?L YK#O#-;O<E6QH0@T<:L+4;9M8JE 76'Z*I#*U[0-Z@K7GLD::?\
M?N-H*"7]5_H26)F\Z,J\\*EU=_B1P=/5X=/4].;$I7L*UEU!#\Y%.3.>[KOT
M=D=Z^-I+=+? #+G*:^Z:L$3Y[DA5D>?OTJ:M+7MM]B^ZN-9ST]O31>$7N<%W
MSI46#-QNZ;Z9OYW7ZCY9+/CG$I^W''2.!V9_7O^SL9P_DVO&<%\ GR'<;I:
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MZZ6T^;0>>5;MYH;7ML30DH-/-"0.-2C<PRL0,)E^@C^-]W4;?<5U;"$2,&A
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M=>/0\B#\!<))C!GPP&<I; 6=C!J]@5P6F;4]N)S:_%>=MO]_#;('5!J"\Q'
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M^&,ORY87GA[DI+$<YKL$I&G<Q+!.BH^!Z\2%J'_-B34B]3SWM?!#X;YH/ N
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M(/U9I+56V0YN1DIE_6T)*IM::$8WSQ*] -O*JAZS4R6+N8M@X3GQ^ESTD(R
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MH#<1-80MK=G?F;[\K-E9KF_M[-VUK^@"&=P2PDI?*?Q<\XM\:?6;O0KT\*%
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ME%S4>]6AVGX6XL@?C(VH=]S_W+5^P6_]WBTN<3L;>[>]&.C-N^+4'J;+O;1
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ML2AR.YX!O2RFQIWL'>J9'YGA0RR%F\NQ7C!4A'K$Z)^BSH8P[!LT0@4F@ 5
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MQT'L?#<IW<GZ5@EO$*"+2[$U)@IAO""=*S&*-.+.\"G]@B GE#RS8&+.5#2
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ME4J>8QNTM+05N!5C<2MWSO' IH@WN6_ME"$A[UM_\QB-6VC)G4 @G(K.D^L
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M^&/N-*0L$YNHAFT!]3[N_"3 626P?.T$9090542,V#.6DLVAJ1DV("6LMC4
M4HMM ;RVMJKU@*?%JM9OAKP;J,&M0YX'AKS":FIOWZY-5WQ\.>+KTV\-AFA1
M7146."%5^9#1F#C*5W>C#'QBMP'&)B&+[Z)!VHA!?T,,QPW$J_F#;1KF<7BJ
MB;3;1#H18XGX9J^Y17!F:NOD>QJY/=M_PY,#1V\,*&H++\>7;137412BTIU7
M%>>2DCQ5I\0_\X9>&H+AQN7P'ITEWB:NHIS@907L5Z>/[6ZXV!^??(UMKX&/
M^MB4>_"F8DO !75YZLL -O^^R-TI[4S/]M(W_(H]]2W\RVQ9HT*9%9"BYMF
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M+!@TD8:80\QA'1'G=_>LE8O_T6;B?[]B4[@8N-=AS@3U'A\+M(:/<(G2"5_
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M"5$+_F82X4!$;M\3G%AC'O$#SVP20:10$RF7)\-GH1$$6!BB.H+RF ZQ)E'
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M,60+U&,[<J\F2F%K)8G-!AJ@1,#4,89'YL][C\^%"]NAQ#'W.,F.2+L5+6,
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M@0-IA'O+AFGM\$-? >/]QZPYWR+>%W9Z7VW><6G8R&M_\N0_ -\,FV_@\N?
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M(?0";4%\2'2AI_:JVHMU 1]G5#SY7:H'U][  0K!'^<(8V$&X93+I>)2%Z5
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MH2UDQ"?K,:EJI($T"WL*5+*_14UT:[!FS&MT3)H*S&8ZW!NR-1 ^PM8R^KZ
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M6.#DD;N1#P#L_Y;U&$2. (<Y6&;,5>QC'!"<Q;5W<YVQ--LWP&$:EN8*J,Q
MQ)6H7T :MC(0V$[&:E7]AV[T<A.Q:BSYQ]#6$9J,)BT#[DL1;S%F=AH>PLP:
M=+;,+?I"X6'N#.8BB):-.NEV(-V*%U>+F+9-S"CEB-ES)6B!KD+6J?T==$/D
M!8A.M9*_4KBR!#8/.?MV4!Y:T<JE5K:HV/YGWY@_>B3OB4%=\?W$%"I^!!T!
MQ47N?7H]K5.L38/9(L"!(6L0EDNS61[1>55UV2<:0PR$5"4DS*#,0Q= 89=2
M]?(<7U/H?1";QMZ+))52XV/IA6$#3WBO!DYLOA-P8GU//N=MJ:7L5#=OK-[:
M2"KSCS+/_S<CG]DB?9FEY>-=^MGW4YT=]FN!H_XG7%BN /=-.6#4<U/ME\BT
M0N9,6);EFZSH!FP8K8J.7(@G.@7,\MVOBEW'1Y9[GWT;Q]RH J;671^R?UXA
M2:EQ]K7/?OU;("-JTX50_XH)\,\O7<A'_AW>F_[),%/:KWBOG@ #5L*?3;$%
M=!-P[-GR/_VIV[]&BXYP$-^+V(5U.@*H;(2\#80=#SA_]L/_%<GZZQ7_=U[1
MX("9>ZC)W<XJ4]2:J_T.3D"MS94 ;E'.R"LZ<&DS S%;N4B>6GTIAZ^@FNM3
M%&21QN,Q^#(D[2I,5D^[)-'*Q6[DZ8RLP%'68B3K:8=7\J:9P(-EF0'F._[;
M1N"8\49_3W_[D/X\>$C:!6@O9_9M8-<++2CV,2U,CPHXG*WBSF'0PI%.U1.-
MKSGD)')<TL*<I\6<KFZ$^8UT*\1*9-_P/.?Z#?&M@8F>1EXQDB5.W)O_MI:7
MG+6/X@KQ4]$$)3B7X=2(.33Y1BJ$\P_;2U*9-"71YO!$0CJ3K.*;(^R=#UN\
M# 0+Y.*&=LV(9_Z)#3+/J\]J/?8UCZ_S+UT7V'KOW@I^7%]EP;X\5]?O>;L]
M>?;Q!Y84M_VP\'-18=87/Q47M\8[S0_9:7;LFVV2 N_J@3JIN?_\U.(<<7N#
MHEAUF#H_]7I&CJ7 V=SL_F4GHI_="LK*M2$5MXM;>1F7[:SLK7Z(J5D?28HB
MCT9 7/8*U$69;"K2'@QIW=P\?/)FW+73!L)7E9]'%FQ9'SZXY?O3&;J6[;^/
M!B0'J(A=C[1GX:CA'O+P53611$P'IZZ(%[)[%T/$-(K+X;R$>G]<E86,B+-I
MC]VNX1IL"KJ??[=@-;)=R[5DVMUESF]%/93TV=W,M2V8 _,+I.A@G&)S"5*I
MWL?6-2/&U+,[> -[D(LBB"%7C0P_@=8I_<ZP9O4[DN&@$A5MRN $;[A$P;%
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M6-5,C-D\J<!5]!?((:$I^!49<:%J?M%-1?S4O+/X/SGV\L<]3MKOFCVI1/1
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M#^V')^!A%>U.S=X)8?F=K.FU)?%>3YC;ZTK\O';Z^C5&[]W#+;AX]\BVC%[
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M5QMHP%((\V*27KJ"#[#.>0O89BQ^'?U[R?OV1%(*8Q'\U5"_5\TGFRT2==]
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MR]9OX>U\B+U!LP;+K-MD/7ZE+&L$2L;#5?($R21D-(S.ZRM+'TP1'0&M>1O
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M%/!'85W:,.*Z.]U ,[53YLBN(6IN2RF$_(!)2PVT%B\5<TH[RQ7!#+18P=/
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M7;]3 G@OPF'5@]<1W[4/!FC[!R2"W?V[Y?VM& 5W34Y12YG!6LB]JI>2*^N
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M9R*^',M7.I0POL1N(>^ZMDWQE2RNY2T5=?G3DXY<%"_7$%,J%&O1XEBQIXJ
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M&$T?AA] EVY)CA(1!^%EB'85FRX,\ZU^(J3]HH=*BO[<]<]=_\_H.EKB3ID
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MY;)8O&LX\LL/LP50R4:+4S_E\0I?;<S\H<'R*]7M;3N_E/%W9L&G;U4%OEN
MM+\N&7'OP6W_66/;)Z^S'KH.;N*Y(9?CR065U- @ V/98P/C?+HFQL!HRG;O
M[R(<AQ1FXR5Z,[X7S1R%4+M8+1)R74IS.ET' ]AX(HX/YK42(!J7.GO],%15
M+,8\N%K'3K)4G 'VC6L.U,\EM2_12$7E @@160M@U8+#E+U7]P:Z#$8)76PV
M%_CS+;>0I!VCO36>P$5+ =O2B[;-&>)V)F;=Z%TL.:# $@0K\132@44L%WB
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M?Z\L=\EV(5 M =1(-N&>Y]Q*%\"^CV:AV52U@3%,=JD93A>1DQ4[J:?E0AE
MHO>(=8( ?9SF:U1E35/J'MFO\_6GGE-OJI!P2%G%)KZ4M3_6_<A?VLCN0'6;
M!1RPY,6*P>0<XK%*<00V$IJ'U%$Y+G:6A8A1"S6*2,.-BA$+%^. ZT$Y[J+0
MB=>(5)4XBF2ID)'\E$*427JD!".6H4B,V#23;WPX;-JOJ6\>.T0(3M_W:-KA
MNOZWCFT53\G77N'=\G)['HH[PK5LTMH:..NOB5XL1)-(0&!Z>_0IU%3^875*
MNQ0W,/RQ[ +68>>2PHCP8@X;]VY_BSMDF$(#R;$8+-U/ ,-B01_ OY&[_U9+
MTC!B"6>,_ZQX)2O:*BE-!02ZP:9&:-N\CUNHXQYEE1F3EO74D$&ZP8)O]$>@
M0%&=ER9 G\AA4B_$&='MY5C<:N+AY1!TR+Q?\X8)%N#>4O'AU82H1&&>.ZX1
MBC0PF*13&*:#Y8Z=T1^%<Q]B:*Q#KN5EP:*J7.2R@(U1*+YT!1%PK34'.$'G
MR%E;$NR,@TY\_Q-W[ S50;MC/XA6Q^Y*/Q57FR%.KF@K#>$5S>OQ# IKVOEQ
MW0[?]$IYE8&!.-L_Y3 $VS&TPP9C*<4=ILHX,V0%V*^B(X@9-9>_="6^]D[B
M%O5QIP( AERLD_F*17?Q*>=.W@I)\$Q" ZZVG3NG+;IS/JW-*BPOV:9PG<_U
MRS^>]"MM"SU A\K_E4^OD:9(CT);@-8R, [.I+ZD7B$9=E+PO8%539^7&_)2
MK+9_W@&7"!?H!M]3'3<%CEED&%BO/;83B OX)&IDJF(<L1FQ1 J&JE@CD0)6
M<BO&CRMBU=JR8IN\HGO!]CW4@^3O0Y6G%5DB<M1^S6U] K1=5)=.C?$N5L3
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M.(Z<&M6D0F)S!X>A%H_C8W^<&*VN25/RC'V7W^$OS5<P0V&3UWSO59CWAZ$
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MP##EZKRI,1+2#R+<(94%N#(FG;*(0"Z_'3V FJ#(ADA7)\HAG'1Y1%D;&%0
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M*-%11$;V L60",_(5]*Y<\6 FHJ2#)0I>6 U6/MF=@^[JZRTBX'O]FBCL2
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M_X_X0=?B2?(*)'QBC>^_(ZEKD[NDM*I1#0'WR_,HUJ--C+7RNV;% :0E]+1
M#>>;J]NPE>CQ<IA2(38P&3P**YY!F[_F;7? AB%#&YC'DD34"!84@7$4M0[;
MU>)RF2FK[\(L8?,$8E<W0$T(@WJ5I5;R]&=CELM0+;A.ZB_1J4V?>Z2TN,VI
M1B=C'3(JL:^F+)"$Q;PX;Y&[.27X_G 9=6Q4>)>ETM/M6\;,\GGLSS-)=6JW
M2@P87]6ZDQJ41HO8$]PO3P'#F2,R=O4 -^4/CWI'L_SK!X[U=6&_7C]+D!)<
M)^UDJ_ 2D0_!1TD]=?L*).;X;T05["U/N3U4)>18,[I?YD%_(!.=RXE\[.NY
M-K'J,]UE6F0<@VX;F"6P^C4ZI[;J.'6&;D5#X)2J?MUV+CFK/K\'2<XOAA82
MET:043U3V2;45)X)"9]*^XV1K(=$->NQ"IA81RL"^>FJ4CZ_AQ/[C+G.EV>%
M^,%U56EU<:$"M2&WSHS^A23-*6(<11EJ-FIB[!1QXC$-V#@QM.$<<6S14RO2
M5/"3@KT6);T//'3R>2Z14M?R\ DH4@,2@RG4<<5UKU3\7'X!? !E<I(M61@4
MQ2YVN>ES'ZFOSEA;(+^-K1$$>)K C]*%XS9U3MH30E8B3QVQ'B 9!F"F)>R#
MB94\3<0N$W60["Y^/!3>LW-(>J$D6Q1!5@.M,0N8E4@AT0NK>?,D@AC&3B%[
M.=VT6J\NVO:$<$+;MX<5:^LL C21\$,O6\+P7H6>PI^I*,[(SPR8,<SW"7_D
M/[/[7Q_,J$G_P+56>X/G&UXQ>"\<-6S&#68&ZXS/E>DQVWB:+;N3)=ND\3!0
M \5"VOK4Y["4_9">"?@,8]K0)5OO)P;6.PL[BSF&]9F,8Z_@W<5B\M* 'E'J
M:^P'Q%N4;]CZ<P&,IPV__>,^'RO"+H"T#WD.TQ,!'!QQQ'X-*Y.7XU[N"@HY
M_39X6KV,-?"VR>\"?H*X@3I:L<_8\QZ-8::IQ*"#1;S*W,!\7U:3_^R:"%P6
M,*UC:,*5T*K9)(:UQ/DF_B$\,\8.<.&P-B>;?E=X-7N K$:'Q.%7&<YB.]>9
M$L[G,_AK]E LD1Q1.*H=+J)>L@5.W._W(Q7%5D(LV@(T./BIVXB.7LQ-4?+<
MUSI0T1H<)D1[%[1;R@(,F%0]QF+XZIW@L+R>T;00A'98LN;&A2-NQ1]3\X<$
MHZN/S%!&)CK& 5[G>'Z\AVL@, _'.O,U#^TY\8],"L)X8ZKT'GQO 7V2@M/-
MH],R3 5':3<TF7Q@.@28Z0*+M+Y!J?\)N])/)*CM&\?9?V!BPE]JJI"[B!H$
M!G5HTQ& ;&AR#IH)5NHJN**BV? A,K(.&!/)#!@!G=@*.DV46DM4\":E!$#*
M8315WXQM+W!;@+".F%5CKB]3=I+X1-L&BF1!14A4I8US1HX\4Y1,?=_\R4HY
M@O;"LS[PL1L8SI;,IRH$>Q('O_'HQ%*EN"<..7/$RMA"4]DA=)$\$0]*6@%;
M01N&#&):G$IR# 1S\4IG)>&@JRD;%# ,-0(*@VK)!'H(MJZ10(^H\31O XL8
M[N)\);RSCS\0!4J!4CD/+SEEWOGCX] ,Y3NJ0G_3-C(!A;=HDS0@2,$1"BHP
M\HY\TM]9)-Y _:,Z2]\$G[XOZ=D\2U [\DW+:(C'5) &A7YC(XUV4P@__4-Z
M2/]<^3]7_M]FY2B"(UM1$+)FEO":C/S8.)Z) X40^3V4)HFJS5@DP5LD(91\
MX5&NA$.#:7&H<Y"8HXZZ(.U"]W& RH/)?/R;]7[V)"7N08(S_W3K^=,WW"W!
MW]KM::M_82_5Q\?K[TQG!?Q%1&R4I%/R%$CX@%;:645.!E]TU@3A.6H)ERQ;
M05<2G2D7!R';F3^B@(QX=9*:3"*AQW*':%T"3:Z!D*UV7'Z7CVV&:S/E.3[9
MQWV_@'[R6X*#MZ3U!TN*9G#S_I,SZY^<6?_DS/HG9]9_!\XLW.C1\C0\U3[!
M&[\.-MS4;XT," 7(0?S73!P=J>%8;).8-H<>(7/$M%FH19!BUGPO(+)&_"0:
MXVPOQ=-F#T#\?WB-\5*(?^?T@D6V,NIS)!Q=C@?8N@?R0N!3'VZ^&[P%"O6I
MTXVH9J+40L'(#O)/@WQ/]!3^&7B$*8=@NA"F-8&Z0PD8'KE7HC U$D*CP;?
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M8ZH\-W/DEK6@N^?]G1S_#D^PNUA?W_&/1Z4L^0;Y'=1Y\KW8<*MD,ZLE2GG
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MHGN?$Y^TD$%^0J.;5H;/\+*>,G8AL1(KVJ!"8J1CED!O&9FD)7[V!%.=,O!
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MAGT"45U6WK5)_(W89_)L-D;(T!A'2Z*T-E[<O"9(]D,&+2/6X;RENKI\J>T
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M3T.<-5*RCQA.4>-&78B(QO0K!,.D?P82=AE]AJ@LR7-2-M(D@:R<K+-\1@T
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M-#.5,)VI"T@H=E"27I?/?JW4\/([V\Z>H%]QK(-U0[*G$5"<>B3GH,=]/"O
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M]*,?5V6,LM^>^A'LP_!-@61B<&T$)7'(EU(+L;198$DY(^&YE]"6D^*32H,
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M3.9OHZ$X7U_=R4^0B$Q+2N]@&<F<3L:$M_<)#[3:B%1YCRI8P=CWGI4V2 -
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M>L2OZY^XLPT:JQ\B_HCH3PKN;+Q)#J!+4(KE8:+,K&_@R*=7@%SH 3?E(,&
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M6/._32VZ/Z?\V<:T_2C^:TTXW_^EIWI_CCL!,"?,*1)#>(72F 8V-5 W$G-
MQ^05*'7:<1AHS-/\9H0J[HGD"=9TC0FV"Y(,XAS'+.#ZO#CWW*AX\1%$SZ'.
MNC!5%+N,X7/L#7Y_),::</XEZ($OF^0-S<,I[C&E0>B] 9*J= )B+_0"\&O!
M4O@UB,S@]P(ZCZ6[CN#SAK^>$I] #7QWC KA3_+N"__.%*,&H1>DR_)L%F(/
MF/BU39@-UE2;Y<0<[VNH/ZHY.NRD%SBH%=2%B$- OT* PN&\ FBN6S0364!
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M^U+\W[F<?K#.9N)?;?3J E/N7($&&!UK_]$&6G4:")[N_"/G_YUR1LK=R4'
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MZU\Z8L<IZW)MP.+=;N3Q((]16\M&WA9W4D^*][7J/F3I \DJ@65-Q!5*N-!
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M<Q(,0XBOC+GQ.\49R9!LRX,7I:.W.\BQWN;8!H>V9N6KZB^'%/P="L'D(\P
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M8*!#P1>!1RP'6F!%&AOCTT1H J(DX1>4AOFCZ>0X)O8=HM@&%P#YG?XYB+A
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MJ/ZA(+:R)8&KW@ZCX+CJ1T@Q#-RIE#2FA\$*X.T#L\FQ3(KU#E$8J6S5=+5
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M[?/WZ*8(%2'"8)P'5WZ"&^A18-.D62L\ \H/@_=R!7(^8+427M6$.QDG4&=
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MUZ,J":I*B_^N- L*8N 6"8_"!U.5 D7)=8-P$XI9L!-Y0U)WT^+6F@4>D;B
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M1^HUMU9D#*DC1],$C%RF(HVE6WW6DJ\= X/A [(#J,FH",:GX2\R5)&XB22
MZHJ7R %OKXXG,"?:)&48W@?,B7::V4LC?5,YFJX?"-Z%8VCK1S)0]I594.;+
MKU\XPQ;^0-3N_B<G]T]?*? 1<7_6>%$FRQ*W3(Q&(54)K:WG?=[(_'1B$T9#
M7;N$;KQ/WI2WBI!H%DPBV$^<<U#\\'FSBBKIIQL9@@Y6(7\(1Z6EPO)5FKI^
MNKH5V;(Q+*T#PJJTP06N(]2,6MLE^HXVHM\J#\,%]I.M0T*]RDW"CS?=*.ZH
MG3_-CBY*'E^<Y2SI>>KK(Z8_Q=3-E9U4S'C1<##MJ,Q)[TKDB&.&3)T^L<)E
MP>CC8J0%9A%=V?7AU]D\J[VAUQY]V[G *>:$U[+LGU^/&#GRZ+"<KCVV)E4
MMU#_V\ND1SZ/&7%GXN6WVA@[=^&Q=37Y9W_BJ[?[9F1N#7BR<(N/NOK4 ;@4
M_%4@T[B6(_#3BC"ZBN>[D7H+77.ENLG[-?#FUZ*C/BUM(#)$(]$]CB$AD'G
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M^4#^?-_P!79;WT06W[7J$W=I"+CLU7,A]?ZB3-=SX0Q!:Q\96I<,=[/ 5W(
M7!?7DOK@"H^,>,<Z5_()T/9DWLAU*TX+NU:7DBH%.S_5,R9P 47X370.VU[G
M:%IA<C1YCG!Q\H[U73TN]U"3I./+P-,9RU-V?YZZWA\M65L-HR%2/'A[11V2
MZO!^&//N-#+N<T08Q:Z_=!N[58>9Q.U</OF)K=>J#S6>'$OU9%<L/[0T\>GF
MTF57X]_LUQ6MV#)]3F%2_+12];+'3KS]>]4JYLV=M1=J2KN>OU S<4MD$ZU+
M.03*7]"L8WV$U/UR8.B4(N C"3$N.&<070_LEZ[ISHVY&+ABNFG(6=_UI&&5
M)HL.573CMC@;SCY,*LUN-A0?W"X7+7PZ4E< $AN/7GM22W^L]]M]L^& _V;Z
M"^U!K7OZ6J9;IOKSX[[A>95S[8:QIY+U1ROF'/VF:6CA^:8YVP<ONI/5\.3
MP<$S1QE C;RVT;B<MY&V0WL=<=,ME^QZ>7W@G0FZ!S/!_HKO5G8\LE5&#% U
M7D^-:G/LFW>C;S@/6#$^<_WH6I4)$"$Q^^YKC[B,')<\Y\2!G<<\KTC>=['
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M-D8N:1_FZ1BS8!J5E@8L'GE$,.5SQ:')6CI),-J53A(<'$P2!$G^"#9FQ\=
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M-K>!9^8'-]QIE]JWNDV+N%1VZ(#I^%G\[^\%'Z#JHBS&%XS>DK'1HD'BO^[
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M;_!PM*GL7E)X;_S!5;D8+Z)@#_4HZP/$"^TH:O)'Z^H/YZWM%0\!AWDKH^7
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MJ@;)XW: CL;J@U>W]EMB/ ["XU$\PMZ5 #X9>E5HC1NH1,17"/H7$ XYPC_
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M8^"22,('.\DL-[$NC>7[S'PRHVQK%C/J=&Y6&_.B7^U\SR1-\)BM O9D%>[
M3IUKU+(E9<V+,R8O#F1O/*1C.",J,YI4*@YI/P\DH+Z"1049$=T>@Q=))UI1
M4J1G-10 $=/I ^(^R2,Q3:WU<9!::Q:L#*8!01=7',9$T803^+P?7#8C_:2*
ML[,7Z0W_>.>ZCS"]0YA))G8L+=JC96=IG9\D)5T0O^)<2/J9VT+%ZQAN,E/'
MJ>1/0!IC?/AP"=3!Z0VAO@3QZJ<5RZ.0.MYU>#]<]LV 1..[_4D;\DJ^72'F
M=9"B6J3@^E&V?\?'HQ"0YE='-19XCC:,V(HQ2^3AQ=/Q4*7$D!^@?)>-V0QH
M5=[9JK6L;Y.^?4ZL4K(-=GAY[>!ODWHO?/EU[967SK[I5<,-_0]X%EPT[EH%
M3\:V-;T17AM*'-[S&C(T_IB<F&!9>:2P(U;[X][F27@B*E-Q(L"NW)UB\"V9
MS.L5F>"?:BJ%"^KL6'%+=F=G^HLG'V*%"UGATO5\6"&/;>_L;"<X<-:*+.[[
M19J!<;5GZBY=\X</#**A;DG(22*:=&H4-UQ.D&TOE<)1J)S]^%(4QC;F3E=%
M>N=_;,%/A6V?][TB8W;1-(^59Y;<6IVU.#EI:>/:_.0:!1$\L#',GH^(L,6R
M9]'17<@4YU&I'F=W=E'LQXYNP\0_9 ;-&[-QN^LQSZB=\0]_]'77BSUC%CS'
M>4FDI=/*GSP"^E>1=^"=G2=9MRS+14S!-+Q<Q8I.G8DYQ HM_*%)[;QBL[W-
M7]?9S<Z?YU.6.@\MR$Y_4Q\GF*EX\^U2KZ7+2^Y=J2D9G[0TN4&V\^N0+MF\
M\@>2BEJ20[V0Y]&WB13%S4XOX'V<5YU;T*127A0\KFCF3JU=VSWCCGEP%M^I
M,D3HA![.D0@VO.P-M%R#[_B5V(42U"0QB/%-G1?X[81#54?'_;CCQU+OPCO/
M O=E'R*7;^IOI1G8[B'O,RD@GCOH*E>M$[E&*;BO^,?N[8=GA/]D_L1.>:3V
M8M=V:6+\$7Z1X:E->Z4%J]Q3OFNMOIL^ZH%%,JN&,B$="<O?'/4B<WE7,DZ:
MFSY,=?+MW^$,Q;Z>?LX]^XS/3^-G;9Z[NEAO8I)R/IZU:-*5^=VE:U^DQ60.
MORIV"FR2N4R$2XJYMWD5H@A@L5T6\+>I_-K+=RK%)UE,9R.,77I[B8YQBIK;
MV';;RSB!<+C*S_@^OR[[4.>)@9OBP,QM_@/914M.3UER-=UOG&KMM&SR[9BD
M22 $5LC930X*1 H#!6=2Y([9:GY$4)D4CDZUQY-45M/T*F"C_05-;PP>IDY]
M2;AG-NZY?4]4$F;%N5M[\Q Y5S5MD4&'^]J\9$R9\)&J'GD4.!I<9[U!'.1I
MNLK1%[B5Q@E/0[6:J/KB6<)'U"2TM;T&,]Z!,B.HJ7M31]05A:"6KGGX#E7'
MMA(O<4RQ-;ZMS$P44<":P/=87X2V4/>5HO$!QLG.=2%FJ>%IS8]<Q/OY6LH@
M4CM;V&@Q I.TAZ#WE7T=XWXEUI!9SC-54$.&LNZ^NG,TL>@%87 9[U3?%H6B
M]Z5+"N.#H?&$)\:)L>L<[=_\);9%'*IR(@U*+6;46??P>39V5?I;'R2,<U'W
MI)=0HXH*UE.-X@$INCKI)5*PP*)&Z_=J=IA'P]'QWK!$V-K0_5,S]B[W'C63
M^[VL\13^?#>"C45U#$R?.]FZE/33,=9WB8"=+[.CZK:*.SIO L_C*)RI8]R0
MHY=Z)3L[PE+:CMH$_X;$-9)C_^O="7+<('G<?@E-'I?K1QES3>#^,H\Z.+>3
M.%@"VI01BS*([< Z!]"U\&&E%TWYJ6.4!Y#1@Q4^P%OTB5G<0><#^)>1EN1Y
MFK;3($^*H*=T##".M1KZ7&X"O%?'\ E+7$O5$9W1SO9/#RRN9AJIQJ\]MZMH
MNEL;J[$_)33+WMK!94J!L_[2(QNO.Q[=]X)OO:0E_-V9S?J[FKBOFFW#%N$.
M<8)%JC4GWX>I./KX^9Z3E; /F#LGQ2G)./<EE:WP%EE7EM\4[=B\:6XC(LN
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MU#"$7!5GO_QF_M^9$6Z"FA)OT/*,2DMOTOYQ-WN6\=_\K C\#$JY.$H=I^>
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MLRGV]$>MN(PIEHHAJ&C0! .6;0KR>V6DDJRN4IN25M[U.8E(_54.]AS!M%2
MBMO&Z-P\V@J*_!09])4<-Q/^EV<M9ES:,HS\&KQ!:_GF=Q2.S#$[+]J)?OI9
M")T%;?YNT=//=]T_@D6"A$Y.IPMTQ6M$UYAN[ 5 %Z!/UX <]/V.0WIM!7(;
M42VB%RLWZ:O@<GTT:[6OZK*'YL8N+P:T>I'+);$<W,G(:C4EOU403Z$[(,3\
M6@1G.CL>48L[@R@(R^.BC:P1@#QI9+5TZ:QU*%DAJ5;6P+N_UFG!4+)QDJ&)
MAP8F#9JLIPZ&>:#]DDR#Z+91\+J_0@RR0C1=N*+!6I-CF"[\EKB/I]6# I#
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M,&!9+@-6;$\S&_Q98=!_VO"?-OS_O W(/!@+YK3U8(;])).G0\=@K+8FC 9
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M+HJD=Y"B-%K_B#)UT!@04T78B=!1>.4#&LCEFH.V(2#07JX!CYK=#(O6[7)
MZI"><Z7CF<9=[+I 1:E!85+''(5LC#_^6;</\ 9=2>*X@_3]41SVA@Q;?2TD
ML7:K>B,#)CC4S)T8<FV,.+<*X]3/\W]1[A?F<\\YQ=@(7V/!LPJ\-]<CUFI3
MX:W:!9H739$I<^>BM6Z+%)=69M_<DIXV;>_ZMWX;CZP[R'F%$DM#@.6"S#,5
MV&+E23(=Z>NC]3#>((6FR(=*N&LGO%=.\8.P#@)N[0?EKFSEO^;@$ W*_>%;
M(8[4TC#F<S4TC!FF8<Q?]2!Q2(MI.^COU)^4!I2#*0/I[NGBA&B9-7DV5$0>
MFUB>R2':P$]Z3?\[JH<&J)P7YA^.?O \H6<4^YOH&54R^UY1(%+L(,*6R;5V
M;.*5L#Y7SQ E0^J13811,!7S7,^8/T63 9;_)@Y(NB44V@^6OIU+@Z6/Z1D6
MJ-: !F&32#]N=QN7QNT.HA8CW<QUU"7^\P[MXC=?(*K  . IV!S[7L%_VOZ?
MMO^G[0.UO;;O-O\G9"1ABG$U;\A,:G2H0S6J,,>#L73-3?(2WPPWE,CK%][+
M)(\WHH-"MZJ12*=9J8B_?VW]M?LW$>\/WVZ+%6KBLFZT+,SI^%Z3O%S[L=/C
M]E0*0\"R1U_=T[I[]N/X]0PAAQSTDC#BOTJ!U:P287V3YAJ>IH(%6YI \CT^
M="69RG? P:J!# M=4]NAY$2\F::.+Y89X]';\"#EN)>'X1%[8V_S+#>^.)!O
MGS[_JD+,Y.10%P.X\Q9/;RSSXE(70(Q@KO5XFW1(N9]SQ1T*M!R_.P=G6Z5)
M+NSKDE+FZKCSS'EQ@3-VIC^MF,L>G5=U>_7Z:T8W#TK=BQIOU IU3OXOXC_*
M8E76=29;YP_S'K_%\=NHARY;-MZ]67?T["3[\J06Q9SRR^SM;C/L'YX.AA_*
M_YY\-?OW\M7DE CT;4HYTC8&TFX,C[(2OQTDI\D6^S^T+/)O!%ZS_JAGW2DR
M0]_6JF&R&NFY5,[NZ*@#$>Z,VD8N^59&'GKSA>@,C"UE]ZWDM#W4,X) 0.;1
MH/P)\1!A6]&^96GM(.H\# Q\BZ5B&C(:NE/;ODS/&,'IE[B^BO;3\X*@:G@#
M+7%]&55,!POK(IT_90P)ML_&F$0,@@GQ--TBW2)JC*B=V\>0D^(V"&0[RW3N
M#;/TC$LB_%M+PODX99_6+\8Z(9=6N?9G$S-E^%8.%HD4I>@9T7UZQM0FRJ2W
M2$;+_()0*P($'$-%A##!5..BZ=!T$*MH+97,'*@HU%:9)& J9&.QU?L02V.U
M,VO1H[<AOB\#3VLU-@L?WR729E[M>:5X%Z\HR+JP3-&GOI"_>.%\3=ZI9Y?V
MIFD?=#=AIB4Q\F91H\.SX[,5[%N\"8T<)KZMQ'F&6JKIH.GIW>ZR1N1O4G:,
MSE--HC+<JV8$1@:3IPI[O!))=X$CXE#JLU5>U[<<@A(LPSEER71/^N<2<DNR
M :8(D.X:YI(<2\H?!%YG1T*=&2)R>S Q/YAL$!,V7-R70SBCV 6$5O<UK*6N
M<OL#HW%ZQH4FC9Q8N<!Q2KACJB3.JL)1%M,I:SLPL:S@ 7GU8ECP["?\##(U
M?F?G+4AGX18MW=5Z=!]_D>'2WO%;"F3UNBWY9[W67W$^WNS2G8K9-*<VNIN3
M$_FQ3L 4C"Q+96.0EZ(>FW#T98IM8T>[N&=1# \1Y@FIN<[."LI$,?.!;M&)
M/'?G2E3AZ?PH[% +M/91F+]=R0Z,)_QS*>D/OM27I_2,=#/@1RZ #(:?2IG;
M@D@)I%L30!XQ$N3APR741#V#FAM-F8@)*SF^&E%L1R1?(26O@!V94<8L?*OS
M+SJ\N"LM\$ ;F+L$;J OIM2CF/"#W)^JO*?CC%&_XHR?X^'CJ7C)Z8DV.Z-,
MWY5E[71NKC#=R__9YF_=PJX='7'WW(%O;TA.1ZS,F:)>:23,1^:$#<WS7$PF
MA;I)S?V[*X'[*393B,8X(BS% <,G5,YQ-5/GN[@\RS)Q%P:OQ]*-I LBM_6$
M%JPK#O.W+]H1$,1MNZZT=E^30+-+A$]$:,D%[PY=ADA;)1_72HY(IR>C /A2
M"0@]5=XB6G7V"JI(1-Y'(T5@ID6 .':8B)9,N(-TKD,5.PB0B9\(IHSD^!8$
M.X\\%MS6,_SU#"_$"RG.TK%UOFM^J^[<BLF=RHDIC]6A#DH+&Y)3E5F7$]IE
M&*X9']-0_XZ79&'PV5*3GJ2X..\3 F?6K-)G&A,;B1'DU6ZY?-[-=<GL0<WI
MBN!)5#4TMI,YL4 08DHL9X[(XTB(]**VWE-(=B?"I%*E(2RC0/=Q/B&F&H>H
M!8+/U4,L6U[#I:]M+R!^C9VWEK,]=>R6O-"BVPZ#+WC=$1"30.8^'R25P6"P
M"\A/4Z#SKB_I(21LA>1K=V*F"-\C)FPY&,B/:<GVX3;4-1'^#:R8 >P<TE@2
MJW^GXXO"*OY0I= (3[53.8^H@._Q_!?0VJO>/:\?S-;*-$>VG2C/%+6%W&8-
M$J:V!>+F;DRYPN\HV[O=[U!U\L(S5(%V=I@5,5QKRC-Y)%\NNI)K#H9ZOCI+
MPJ7%5QO%/;XQ/*G.E Q467RA^DB+KPJ_XR%1>:ZV5+5BMO7C0UQ\A0PDNK1D
M\PO0++<G6-X3"T@[@02+[ML29*=,-T]65T%36A_?,P#+==_[GX5YF<@ONKR_
M"%'_ER[O?PE1_UJ8]U=*U+\(\_XL14T+\\KJX.S;;%KFV('YL\SQS^+9_Y8Y
M_I5X]J]4CO]+//L7E>-?Q+-IF6-:.WME@R8/3WN$O/*/I$%I"G_=M-W(>NI)
M%?+6KP>^'N;>"M?1N+BC9&TN2)? ;(Y/::@[VM07 ?W >2:AODQ0IU.3V80_
M"S]I6 +UQ),A6 /U#;LGFMQ'_42!]6DK4L/LL^R'U=GI;'2[*"\DBWI /4&F
M!Y$^O[M$53Q;WA,JZKL%O,7:><C?E$0G-H0[3HER<E3&9,7@LIE4J>)68BM:
M[Q%?>[!-VB*O7W"$90W"B\QWF_./..?>DZKN9,.!$>EMI#@GO6RYB?52<K%V
M'4D;T![<1 HO%Z6R:0/ZI-[K2Z[\9$ _J_="JH]3: ,2YB'_5N^597'Q3;([
MM'KOBSD0+=[K9#'ESU2D:?*-WXD1TQKFM*;SSR+FOV@Z_Y>(^;\UG7^E8?XK
M2>>?-<Q_5G2F-<QI1>>L_06UQ?E'3$M'C/,XCP>YDSM+W^(W7[65"Z>M2FUY
MM:7[O,4YCE^*I%^K.>#MI?49WQ#K3^SJ@)Y 7\\>)T-\(9- Z432+@!6#\%]
MB^.@"MPSO O.V$$LI>ID!V^5O7]%,%_D6Q<'5GG%AW%89P.A+94!%\PG>>JL
M':/./;_V9PK2Z!F8UH.?T_NS'OS/RMW_UH/_M7+WKP3A_TNY^Q=!^)^5N_OU
MX&GI[OEO?]NU-W"_N"(<_NY)I]P(/)2>]UIEZCKI?/7;&XFDK^'7PI<M+S47
MQ]K1BMTYHU;VS-@87S)^I3-&);Z>E4)55\UHY-MK)^Q E',#9)%]0W85O?:[
M2/H;*)HT\X\FO)]3>6<\=(.7?K)QG\166\J9L-,YYYR7[:N%FS1NF6-;<U:+
M?L-1U&_TY66B'A\8*X5[ SG8741Q&<5*$-I'#D4(*[$V 5%\ 9J61NU 7HG4
M#K#2E*LM8!,UB)YA-1%/<6B,LU)#47;.=HU/LG2^D5FB&XC/>\ZVBKL=8.+X
M>K]:E3Z!DB8H,4>MLQ0Z5K*6I,;%9VNVU\0OGO#\!MS<<;GIF?"3)/O(;C^M
M:Z#L%TEV#[1V.^CU3;Q?)-F5HYP5,OPQ;B# _RW)+J!EI9-T_9+L2R%:DCVF
M4$%3CC:F@_Z.Y>C^*6L+U#,>3J0E<8X#)_=66V"C9]1=X[72EO\HBNBDP8BA
MZVAQ)Y7X!#6<7OJ 2Y*,(*8]17?(\!5(-E5+<VY0$^)++9PP$3&+T\9MTW'Q
MKQ'%?!V[@5:,H%ZJ@XDI1YV!.QX6B3YHMZ$UK09 NBJPG[[=+)PX=^]97]G0
M)M[*,:%W8V\J FPE[A'7+LNG?6L_^4G\S/LA/[PSF  _)_S+U7UP6YG:;-B%
MI]J"+W,C^FK\UHAR4CT3/TL)=%O5:B.6?7UU,RO#^V*DL7';U6E;!/<TCE&'
M \>V/*/!Z<O&NO>"(&'ZI=^K<_Z?_'"^@['#P<0/J1JP/CWPT3-J)*3(OU=+
M$Y9_Z.A;XM)>J6<<J>P_/'9^:M#(),9+]8P%( -X .(P>9ZXHQ/]#OZ=XJG\
M73\V*A2L-X-W@B#7 RETA=L>P?N$I"_GY$OJBY>4',8VL?J6Q1-CLZ@G@S2/
M0<5!>"Q'.?(KJ!VLDI\G?_H:2$#!]W8AX'L"^UX2&8%DFK9S] R#';Q#&A;Y
MO=-B6D.Q<"ZRDVE!R1*8;868X7+<6"4>Q],5WN-;J],*,U@*]HDV_GA>5G%-
M, =;RQW\NAX_7LP?=GQIC7VBO]" MX9G;U9QX1I6%?'EO7C_;CV#F.]"6(#L
M^9MD$G2/B@>,YYK'5U!MNPEQ#)'L1@K?BKI/R>G3IU$.QU"M]]D!?_@9R:_F
M/#8=L#"7_U3Q/UL%+<E>+>],1AH2J?9$/6-SER:,UC[^K>&6FQ+C?$LY]]C%
M3'P&W#Y9V8%;F18A8*$9A/IG<*BQ-*$(&H$:!ME,XCQ*,=49/.)$U/M^IV?<
MR1GIH.24&MH(V]'(3=M'J,>EO266J4W/W=JK/3$&V;UZ;,*XB^1V8*LQ2-=9
MCNXNE]1%,2C]'Z'@A*J5-*?_)O0,[6&D,@-,-1"@A1D3*'F%T^6#='R)=$0A
M>T4#0.3ZI/T@ING16"M5M:@(UMXJ8-56R__JDVWFH!NL8B/I3+J(HTTM$[YQ
M1*FUNX;I&3XTAW5/LJ)+<Q,=0 I5NV!@E.'Q$E&?/7\:+0BJ8I&^=E-Z_^_@
M8O[TO@-A#%-_2XG\%%M*K<H] 6O\Z1-LCU57_ER+-PJE55?G<4ZBFL WM.JJ
M-Q:.[DUO(D#Y9^P53>29;J2;^J(/2642%R!#N"T>I,$M:Z;^J1 O7>(JB#[1
MM&XBDX)RJ5OR^H7HWNL81*T^[TZ?+IZ$M%C>=>=8N-.WDZNS=EI+'RZ6"OX,
M-"@NX8!1[$QB-IB"KI9 6B%5 =[<Y3BG<[:J0^=$8Q'=8ID,Y.T&93 I$DZ
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MK'+'11'J>8<BDO"0?TF8L2E>6R*<QG8-'U/XXL;)JQPFL--B>RC7G31!ZNR
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MF/K]FS'%-"_@YS-I^='=""T_NE<>PQD/^]BP3B!9$*T^^DG.USC4IS:H@2V
M!A,KKH5^HRZIBKZ\!)L]HR=V"W,$[K\Q?O6S2^<7!!D61SY;8/1^!'Q=]-=P
ME2NW&P5P-'N5LILJ-,?Y<EYTO.YK]"6<O3C\248;5]:#W/)K(\4.6:$%SS2G
MJ:F<;':S _4C*[5) Z:LGG$=:?T:XS8@-Q?08%QM*GDKS[(>V7.0] 1+K-D;
M;<>+Q8):3JY6E)5CTND[X%BG(+DBB<B OI(*%FTW1()2SJ'3U*;$7)2PA&G^
M\3T?Y)/X$\.$-(OK9. 3C]$[LWZAXQY2]3H7PIH)7(9?G[.[AOM]6E\B);>0
MJ7S06S+<OH'BGJ':17H&?PCJI) 9VXE,NI(@1N!RS],;'H/0[5;8MR%NYK)A
M0DX=;TM?C=FKG38^>3</=\14W&D1VP]/ZM[VC<OI]1N$&CA&OJ1C).+;&_EZ
M1?=]S"8VE%V"IRM8&EB;(5"]EH0['C_1@H@O4NZ*\R%DQEGO_,'_4@6&)BTH
M#<G'G*7SB\(X<^.8)AL:GJ4ZV7//P,J)-+0X"FV["$*4VE*("C316>IF4*\X
M=YG$F*Q&Z#MT!UI?JQ%BYX6Z):$@53V12HT;DMS(%: 0X:_P1_ M%G9JTU(.
M2+>\\82*QO:<>VE-/$LE%-E4T/D#.W/OW)^:.WYT=3E"MHEI^==PX%+I ^*]
MD.XRHJV2#[-I<<R=5IX_LF)/H._@QDON\YX$9N/!1N8?"^PFG?#@LYBGGMPL
M3S9WMASLJ!QG:55T?6.0M\GJFNAKKU56?*/N;]4L(2@-F>B#N,BNR,;NG&-N
M4/B:%:L^,R-#P7>3)-F(*J+SCMJ7.5I^QIYPP:>/-=8K?7=G6?[7LJ:3A1LJ
M/M3>B(WD;'<L/XSU6.T$U@KFUD8$MY2W!V(B)=)V%0O67'C&Y<_F/Q<QG?QU
MBXF96;746/[3A'$1P6I(Y1+9 T=2!O=J<NY3HUV'"*_(E-PQS8%[M]RJ7C%.
MY-.UK<SLRC2V@DTL7:<+0JK=R3,P]B.-X:[Z$IV.[$#ZG,6OLJ@JF>8@2*$E
MC?5ZQIHMTA-S7D&3[KQZTA![9]Z,G7<G8A5W;*:DQSY:QPM=#=]Z$:0X6:*Z
MNCXM>U-,ZD*_I6LV]2QF7]E^J 2Z&[U (6,61!-N"3X3F-$3?%@Q>9?Y,QH=
M?:-MN[M"XTW-SQB8IQN= <&@X8:B'6^&[Z])]61&);5NN>+_M;."N$))Y)G7
M,H ?^">>J83J<S5M>!,&?X6[J T4[S-TB_$C78HKB+GSEZUW"1<UYQ3PLE.^
MN?>@>EY'^*9#]<TLA>@$Q3H?YO9NSP_YD475J:S0&/0FA!$H/BV-G,2DO.!Z
M$.\E3PL%]F8P$RF+HME4L[(P%G6C(ZZ'^,I=4$P$7\ =$F3A/)?9Y=:[NZV>
M/O%R4DXX[S!1/>%$V-4@ZVX[ITD.JU<:UI6L6V/=7.[2_.9S<JPC2W,V8!34
MO+A;H()'8]NG^MR_YEV8=]/"7)G'BLSS]C:?O#[%V#IYIGA>8]R4$LD$Z\U1
M0E./]P?3MH3>'KOGRG,J$FG,VY(KD3<,HDQZB;&PYC!^5<$Z*<KZ** OV;1Y
MW61I6,6R8;R/M:KIX.T-_54174B1O4HDH";<$Q6MY5D6UX^G7N?63$]9O;.W
M;73S79?]P4'</KL!\(TUR/\:;_EN 37;(\T,TX1L.6?M6/ %".ZRDH*<X)S-
M/)4M[\)R\4O%EHQOLYNWG WQLGYI'M2;+.MF%CE;I#X2+6>-S[>I4/=%^DK>
MC$:*MV&U$;87I2\LDUXJ\H]/3O=DA11,F?G(FV?NLR/M@KM;YL:Y;>;6TCJQ
ME^FX=U12]KIER"4!<? WY"#_EWV@/P#FZ$UL>RFU=IUN!"VRKF>T>E%/W>C-
M2H,JI&HV^E&#]%:W]NJHD8']_*(2N/<0K'V%9)O0&!X:!])/'?KKAW7$'[!Z
M_2<_-+1O1NW/T#XAO =D,YR;('WFXE/@X\@^T<E/F+DB&&/+HVE%7G[M%I06
MHMTH&ELPP^_>0O28$TO#_ X=&P1;( >:M?$2=LPX=Z@!&7$KWU?QDUT5'J1D
MV6Q^V=VGHAXG6/7\9*?+US,B'4"J408WS^3<,:#,1(.0[NP/@[3D9?1?+'P7
M@CN=H4Z7Z!B(XCX&'G1=(QSHA]_!XGJ;OG\,7-A_JO@?KH*!-/9P^U9R'\&Z
M.<P(D!-Q<MP@S)M-7'50-9$7#$I@<H^X;A/J"#<JN)$B;'U'!')/((&82.%&
M9 \'I*S9:>T&(;HY/)8'%AQ7,'S/CVN.*[99-KZ4EG!C-SE;8"F7?%.)4?B@
M_98G9X;N3PM=6C/[]F[LR-5%S?4?SQGS$CH==S[KYE;K&?C<-&I]HKJ+>C)(
M*:*RW=O2OX*:>W]W2FI0!=]C$0FL=C:]GZZ6T!"/4ZWX)'%'], *HQ27!$U]
M>[,1T5EV0>3F8CUC&LA14.)\BKF>4<<"J4I+O65OR5_$/WUH&H#TCE#1")D9
MC\@XM.UU*+N?5[J=S7EA#N;Y5,OCB"; ">3H+ZO6([MYL>#;M8]8NH60BXSD
MO!7\C#YBHS1ZY"RB":R%M5F([\0_!3LM44F)Q)G/J7(FJ+U'$7"CYT\D/]/D
MM&+C2ECGV"HB/="LV#_5%TV5"OOF>Z219^F=LM8BQ5JM*U(FJD+:KF.HGK%=
M-%CTOS@4&%!=U (&BTF"FDF5:>5:9!2THJ-O#JU*6\<ZJ6>\2++]>U2880;1
M<.=>PI5&_Y1RM%4^+B]X<AK]4]*ALR<0&OVS+VS2'T=0^$<,4_=?1%-U[06^
M%O1&1Q[4Y8UV@([MN#XP:"D5_3V19NV G)G:10/4$ZIG#$/*CBE$.KL^!RJ3
MM^L=#E'KHD_0C(EZ!O6@;?) F*M/:+(!M$I3SW5;&"-EZ=AS"L2X0\!@+C@O
M6M<H("YRAR)MM9@!=??B"GHD^[D4E]&H(]])R@XPDD-M/HWD0 *C,AP,T71_
MB4QG"?Q.,[&$WD* P(".0^I8 GH\/Y59^#/^[C92)_5$6BK)U/0/'7\<S?YN
M_(O/\I%_(>4L-4J>H18@K4NDON\(6]!JKI)%GM8SO@$#N-=I)1P%2G(!D;^C
MEOZ70#[0VFRN5)N0U E!13X=Q!NN3HKH2+!N<SY\1OWPFW7\G>\ ^"6:/6V(
M#U+U#?R1'NL/K5@'-6II/WE:G:CW $V^RAED\QIII"_LR;%-["B81CFURNJ#
M&X/;5*2@7W(4Y&>S]P]:7@LKYE(@RXP @S)<1AFA[4A=JTI:AR@L*!E^C,S4
M(/@R8 KME:Q*ZG7G3DH*^AX=Y\@>*87N^A_+XYB6FD./'$.?/V)>[LA6OEE<
M^OY^\+!W\/H2'ON"1.<YX?3NUTLN5FL)[/N*.?"F<EO^\[FE.YHW:0LL@@(W
M(J,>N?,.+"JNC8.,H@(J#SU86U1J+-Z0X/B!_]%^[_KC;]<WB>R_J3<ZX^X'
M4N]K/YGT'SU,!TZI#NX^TR]W-Q0:@G0_W ,6G=6?^/4L:17%T<XTO]ZWM3@P
MQ#&7)&CW!<X_F<1J6@>ZV:&I3^/; C?DH!]$2B8QG>;7D\JZVF0T$>0F1'$&
MH;D,5]327(8GF,=A[?9LY$_J/+56(=>N8ETVH*87T/1ZB5V$;@[U$T@/_JEG
MC$84\T',E.*,B'R0C2_<Z1.($8D_\QFNH04&OP@%Z?"SGE1J@L,G6K]D6@/S
M*]Q.S[C:ZD*L%-"\D5YAHV&U/<T;>44N:JH3:-JY6DL<K&[#[L"$&E1H1Y\W
MG1/AN^4TG>'IH'XZPT&-,BH^ \+*4)K.<&IK/YVA0:&(9&V!E1L=@ZDSAC1E
MY"EQ%$).)_0,YR=PKC]2#1=#^&J:,U((JA*]M/^['5X]<'=[D0\\J5,431NY
M#RP-3J%TA=2-Z^)WOG_2]KG<?DK#%0MI2L-C-*6A:XT0/S>*9HXLHIDC_6GF
MR!4H+,MBMM?+N]EJ \H8Y(HJ>G![5B^C#]4&:ON HUM\/:"#G&Y*LT8:<VC6
MR-5]5-@%Y$"-GG$9.0ECB> 7,@A4!=_<:]//TCEPT_]D=*<M%2#-<PI.0G@"
MC;)^Q@7&)M$=R26-B27@)5Y!% _4=Y'<L(Y3+ON3E@\TN&IK<]"(%1']Q)&U
M)3!UA@],#1K(L/^41O;UP%V-AK,:C%?@63_P:^&<^1'JKF(M%%NP< ^:S2TE
M+57L&,*6.S(M,G^;VG<-?E%Y%#[YQA+KR<@5Y$_A[K_42LT1>+P\G'@4&<[;
M.7[?['95M*3>VKKYGKS5I2T>"YZ)R8K9XS)QIEGH6/7Z$-'@MQ=67D0B+O::
MON^+=)NXX&WZ3!]_UU..4(35NL(:[JMU*69&T>G6S:6'O097A4(6/L:EBCE&
M*9X7=VRT-=F=%G=5D#8Q_DK\+ <7XVWW9]6?CLK=U/VW 37QOP?4Z-Z R.CT
M43"O[WR#-*\?;@7B5V;HO\]N_H"?T3X1OY51HX!W3C0#>=<%D'?QQ>6AP"&?
MX8#0KA=XL!K!#!A%O65$&N<8VGL&[I'QPI'I05K@?#^?UT\A62'O]81[D@MF
MU8)0\/,#&/.8LQ52^ WBRQH4ZHJYGRB8C%MN!>[Z(9G3V&&.'W)1<R-RA&TR
ML#"-M8]UT&V0U),IEZZT0'7:>R*OFQYAMY]Q[^Z=ORG^:4CP_*?EHAI?8BRB
M0(M8KPYIYN 5NG54&><?B*_H&)1M2G,DNHLP,67#,],<Q6?X*47#:9(BM><C
M^2C"C8P//-JXJ ',_%PG8Z5\#.^ KC(GGI]\:]OE?=^?_B>U"ZL]EJZ: ZO'
M^%Y8GWH>VQY,7HVK4'T=%/CJ1_,%+I^)=GJ=.'/#E=GNKWC_X6GLWK.*]M.:
M<Y,-*J%>N^;<[NOE>8>B.$_31A;V1>XJE:] 1T"# \2FM95W7HTR41"UI:'2
M*&+Z8[7YDC4IS#F5;SAGW[\8YYOPLN+.YB>N%==4QXMVVL[9F*:SY)2)?@\M
M. /3&RS6G$\;+'4-] 8+OY&64)N'2ZCAQWZ14*LN&$.]A+!4]-\*:ABS$:SW
MQ!<B["Z8>/_64,.:5G6B"BOP!-*OH2;K@A63GA.HS>X4W[8%XI/$ J7F'Z@@
M9)IYQ\PGN* NS'-20N,=P\^6ZJ;G.'6BN;Q5#<8GR??0S(SE\5FIL'QCFJQB
ME)^44#:R+B&Q4%9:]%S1-7;4!%&D>>"C@E'D4=VA"-SP%'X[U.,BF.Q+*@)3
MQGF+ZFR5$+-S:S+IZJ@*16VE88?L)$C1 >/Q&-5@TC:GIY\;<PUG@-WE@33E
M_ML4UAK*'W?><JBF0'AU*O!<UTWS)2L7')AXWB7\6LO3](C3)6NN(F)50(#F
MX/%WPJRS[RKSU[_0H6-Q/6,A*=X\(ETB_!SGVF R>^SX!$YL5GYP5*AK="3G
MXKN^]O%O-X=.WXB[1CH*QZC/!LX)2I^Y;80]<\?S"(^-O<SF0_TT=%;9O]#0
M_9.8*NZJ%#>;4<- [#5X(BE&#\ -<&-MVWW=%N*?6+P4J>M5"HB9,+X9&AYZ
M"&,U#I9'Y ,#&.I>)#('3X@U5Q_&%[7:7(3O$/L5K)'XZ8KR'Z-]4E/K%W7$
M;G>@5=(4])8W1SM71I^4&54T]NH9MB\GR V?JSM,V3&.A^:DK#Y6$8 I;N9M
M[3 PB;X17?@R/6'-0_OO2G=9D=LW'DH8JZC<9+\XPSHW7##U:IT"B<L3U\WX
MUR[G..=Y 9%0<<H,U5:5D>K ("<,/67-_J)HM[E+> 5N;'A6!9E@':/>PPUC
M[:"175M])J\K="L,<YT4KW/:V)J_VAJ2.1 3VT'\"9;;(R!T1 =Q:KP16Q3S
MX,8Z_R*5U"\KVLW]12OIW[*B@WXEEO0K6=$%_R671.N*]LLEY3#M*N50/,U/
M.Y#@5>8YGE"2,KK1BA><7%W5Y?1<\%!<DUFWR9"!F>@9.>D;958Z@V@P[84_
M>74MW+A7MW(.V;,P*>GINR34426GYT>V9[0=YQH[H@_,#^:C MLP%QTS N\%
M\\/<XQRP:.>* /XX'Z0^4]'![+J5'!;LV!@CL7U$LNV*Y;-*&M],>:5,#EW,
M.@-SA7W.X@8VO;L<2^\NJZSA/VXX4QCJPZY#-%OQ7MU\2H:84[;\"B3+M)@9
M+9KH;$!8XIEJMA0$^FWMF,_^8+ @&%%3>(9?J05Q3IP,5X/P+\*W>1873*\)
M6NV[_O3XR:<Z6#Y[E+%#E\%^:'^QPT"Q3T7FU"B*+E:B9T2+!E,&Q&8\$\N2
M_FA %SLIN! RHLQQ0XY:<(S@7*Z PRW#9WE*MD^OSNY7")Q^BC7SDM^7WW^V
MO,^[\8AW3TXIU/ *NDYZ!;)>\M,XK<A&3?0\#52B@3=K'-((MF^[L]SF/>>!
MN#ZY$'EE^ %D/J/CH^ :45M08[RF25MREM;TXI(K BPU.50JV:^3%NI-7>V1
MW_#OX1P@3Y-3!ECORD0#J8+^]VA_M1SB&.&'2MH&(Z,Z5RYXXW%1S;RKO;?(
MOG#'N'\(-*OWAKQ##F 7[UD:Z9XX>VR)9?DN1PINL$7GS9\+%>:#NUGJ5,UA
MM<^&[C+U4CM,$N=H6B@7(P<"T,\"81-9M!V,GUQPP*[H299NNM-2!>5Z!KWA
M:\Z-?^_8<=N'Q\57%^VR@!IV/HRT$*NS.,T5_9O4452)2.,GRHJG;G0,J1Y0
M]U ET8 P,?P^4KC$^1_\9YQLRT>RXZAYMXC>1:<,B0 PZB*%[W?93##'LEXO
M- UW-@]=H/Z(-NH9@_"ERZ*0"#O9N#,*\8@/]=MCKTGG=:T\?V3MK=./&Q^$
M>%BX16KA&G%2X.RY!4%+3\YPF259_QC;^-,6DX"[FV^\$/<0!T995*T-S=0<
M3+J?&[5%%*P404V<G-;/SO$"&T4CW_$GO"\8O<M&?2\X3LT^%1A0T>6$+DXU
MCV:>*!<-"Y :*;?/C9L^*L<[^E+DI;:) >G6*0I20,FASIWH/1&9X-L.3.'F
MT5(W:I>;+D,W%RG<BC;^(+( KH)5U]'H6\J*^Y9=S#R!3'1V#+7$V6HVK64'
M M6ZC_L-P<09Y3R%U_L5AL0Y3<Y89E!TP3)^A9H5&93<KZ;+\SZZJ.[\@ET'
M)]&LY ,M84Y=UI*P+ZP577$32]W+]@20"][E)7B\'Y60L?VVM:O)\+/C!IG%
M"+)B3&<^O**8'7:Y)A7+$G:)ZPSCWQ>8\QHD(9Q3%].B\7*G_:=WY<]4;MVV
M:HA'_-N-\)W \:M>JKDC MY/WF6S<WKZNLTK'1.<2V"_3<:][*;$@8E=_QO4
M+6F*FOX;%V"^?+IR424GFFU>E.>[*&1# \8Z+:KZT!22XB=Y4]NZN2U]\'<\
M8'WU+V_ZG@T[7O+^U3Z7CW?ZDJWMPZZ.YVN3UZS9<["*8R!%O]8S)L)[<L?Y
MH*M$AEWP"$?H6.A.K5 #&:H[C-5;';-L](R38><;B9E/@'_>)7D#-7DLU'X,
M+)P0N>N8-L7W5(%G=&&^2V;)0OQ;SG0^,(8P#C"&9!%M#.F"4C<ZOAT 5]/I
M2YB4SEJT02UOXZA9E%''L#W4?+P#Q+V=9++S(L*K)M^RL<.09T.-LRQE1TV4
M%B<C2F:Q:$QS ;.Z>_'TWI*"62^OZ+9GI8<=L[S?F?%#><.6+1)F#8+MAPF1
M>PFBFR>;A+0H<"-.3,!MTQ:^G??&L+3L]4K[4R?Z0LS28J\Z>=M;'5J]/"""
M5^2W9EU3S/W=+\'<= T-DR$UK#J1].+Q(G+E56C(C+<Y6 M:XV7N/G+7G= %
MT3>6/T@5G-NZ.'2-F[N1X.R'==<_N*6U^VVX?G4PB58O,R$QI,QJW6]9M/Z/
M?@:6B",1O%FWF:J [M(\\'+LF9Z1G=NF9^A 6ED42.;2<0_!8L>(1A6,Z4>:
M#Y5I7&@BG&BD"%'"(),O6M(O#TM,G<C4R#7L>CWC+GJO6YA+BG0K9554 -*H
MDN%6[#9#M90:*M7M)F;A,W0!U&-HO/-T/)6:T$09B00<0\2/&P[6'Z=@):N-
M72]NY)[,$;6QAN+LTA_1D_9(FY#9//'V YHHL;D7VE'=7;ETPX^=MV[=]CTY
MJ&L0-6*7GI%T6<_XZ0S2\=K]$U_D'_!'_3>CG1G \V8BY3/1QJLTV]H]%RI+
M7+P75 T^7!%N8TI<!O$OR/!]/M/M1EH7$LO%ZB$_,#5]X'MK] SZBPD(^&(F
M"KXH2=!1:"3\*EJS%J2"=YQ<=*;4XY3)9)*>T7A-GFGP'>I;>52S Q]\BQB&
ML:*=!C7^?^Q]>5A3U]IOK%54U(B**"#;.J&BQJJ( [*K'J5*-2HJ(DJJ%!%0
M(U4+2LAJ10B"DEH''$D1D5*&J( X(!L(0Q4Q*LJH9$!D"F9'(&R2O7?NVK0]
MWSFG]-YS_KC/]]W[] \TSX*LO?9:[WJ']:[?^ZN36X9PE)4I>')AL&*HL[TZ
ML$Q*V,M/S=Z?NTPE_UB>T&PH+R\]*?!T-IRZ^B0SY/*.TY<WW3< >JR"9D\V
ML:[?$N8CQ'[!,!/K1<6/[#9]-/T9IH*>B_(#U^!FI>D'C6M3OH*:M1CMLY5%
M8WND;\W[["[QKX?\-SWD,XP!T:W#?@?1I1TQNE1IN_]5AAO-:?-Y2D6=/5,.
M?+1$_STN)D>;JTNAOQB+9E>>-K&& 'J,HI@3<7]?[&DE=W08IN04MG/S0?4V
MX66\0DF=P_3V,@?%P)!@]P_"\2'!Y97S3RT_@F:_.[\VV/TO%K._6,S^8C'[
MB\7L?R*+&1S;5.HTIDS&&-R16(*X3*2?YUGH1,?!'H658$+%(<5QN]F$WX\A
M 6#8'F0H/8)X^M1@D)> 00+PLUN&V\\A)I9GSKU[.97[TNP*Z[Z(GC77)FI_
MAA0$H.H14F)J*35&RR @AGOD\^C(:!+ZV.%!#("1AW.EU?/T$XED/%PO)9@]
M.B15;1\%94QJ0W[^/'<IT]#@%RNL43[T42'YVJ'^M7)]C@Q$TG.>M=//,T+0
MHF_0FJJC5ZRST!J%?WR)PY('-C%2A9PXP:8'P=WI&F=B7=(:MYA8'2?3A>=R
M0XUKOI9?]X@)80^>@ZZ^'V^C"LFTX(:W'A");#TO'WAR.R*B<#%_ZI,#VV>=
M*O29(ZQYU9BZPM+[LL1Y4]W:29,*\4,?3GY\Z\.C+7,W3=296YQ,&%+_XCW]
M8J1TW*HM:UJ*_2O<50KBN ,]&*JTE0\8M(KL'&YE8B5<$_?=G <_1WT/9R,&
MZSP">C)@$, WL18^1M6346*BEK+CT8%8.URMIW,Q":J>0E=J#6,H&/?HW'68
MB;4LCR?YYBCFKN0T,9:+(P,=K@PCV7 8MWW"P]>*#;,4.5:TK?1;C!HV&ORQ
MS;+;BOR;Z+=B8V4F5GDP4VRLA&$NA=J/J;3V <X=_&6 @@XZ"XK<J'1%YRP#
M- _JY 9 APLP%XU+<CY/#BTEP8LTL=Z).?('+M =CEJ.*2\CG5[8?@ZYB-</
M&*RG]=7H\)[3UV(ETA-70'F>#0-\*"_O'M"O,+*!Z2#.Z(4U>W7"=R_FPJ"6
M&M@C#*L.XWZ+,3$^CD%/H=P.S@E3G7)$!"A8@#;G,%7AOL[["*J0^1OZ;/5X
MS=.-1)CB;F(XLXZ*WN)NXUS_;&(X^ASP+*>%@>E(H%$S#&.(OPR2?H#QVE5"
M&)A=8HCBB&#Z$[A7C^T%S_<S0*)&P0 86>Y)[+-5>A?[XXJ+_V1F>.W[H>SP
M7S [QA*%S^NT8?CCNEP^HH4(#!Q()Q-K/L.8AFO)Y9;P':I-K&MOC$% ]9@P
M-[&>/7?MNYD7!(H^!TS=.V>,K ),W;LKODC?4X/5OC&QEBN2H,6=(83/:W9B
M2-M:!0/(WBKM!)_>P_#N_=_;#G!R0/8#.@)S@X*_B2FN^HS/</^]),Q[F.-1
M<UQ!/F>X[F28#H9:HWSHF& &*"9R4,(W6;$2Z;.5*9C:M^3W-3$F5F P92Z$
MJT.D$ H3ZT<%P[:7@EMU,-<XK%183R)#+B<"?2G"/K6C,>;/!+_/6>E3'R!_
M4 >EKJ0M=&$^CJ NP5[.(?@C@,M=G(B&!@[!0_ \5,5AKBFH>?U"1$8GVC*8
MG"[1L(E54)P'$?ZX5@/VPM^?@&N_%WIF>\,2-?=YU5@F&8/EA 23-D>@];E&
MG32QWJO1KK-YBZI>\_"#*#DZ1@]?XU@X7-Y1\.<3P6[8";2-0\2T]0IZC!7I
MA473<%C' 3U*2ZS'\!/0O*_#.3!<S<:R,96YSHF$/F567@%UV<0:Q;E%97*-
M'C(,W]=$WHC10R/] -J*RHU$$T_C9_9..-L/N=U0)"@MW2;8Z5J\W?5;9+6X
MZX;$KG&A1APS2>.CCA@J-GHY/+GI*70R%]HFG77KWW[S4%C>-CSDDO#%N3V;
M)4W545].U]T9/LY+ECOTX/;+U<ZS/G^5('UYE>>W<$U0G/;JNM#5M8)'-3?B
M##<VK(1;:&KR^X)_*N;1-V.=89P'4WVJX&L3JW$ZR&: QI0?__@YDNJ$R_H#
M MW V]+^)M;/)SM-+![8E4,F.2&@YENUA K)LS0C1VKI(7!RAD-?)P)*Q1@G
MV@HE9P-B"^AP1U4[0"'<@$/:Z#%LRIVA2=D+]H)"Z(&MET+'5R/M$1J##<A[
ML\)V/Z4':;N/H18S3U7)BZ4U,GIL@W$>;2$E-BNL!8@:8XKX)( L] [( :J9
MA)E5-:J"/4:,3P*[P\*#:[$<1W:VCZ:RAEX0:'@"+?D.[%T/^AX.K%L9J),,
M#HEQ>MH1C^ -"XHVEA[P=C!ZM(T;+QC>[T6J9LZ]\Z%N$BO;F0?-'EW>D'SR
MU*W ^F/7M2NZ70T[C,L%-GA'H8DU+'>'84\(.//.UJ'S\B\FUDM$(Q[](6^Z
MNC:$--/'@P+OT0V4B+U9'H ?-52)>B*=1#,Z#G1*72W<K=,O.<8RC&U%CLA-
M*64)&-(><VFX@E0[-$ELX?1O$@R&FX"O6Y<"_U,0_D;'D)P&SC'@Q[D%=I&K
M=?+V_HG-+M-U]N2L]L45#7E)5,KU9H2%K,ZB2U_E3>,U+^!]Y=/44KLCZ0EQ
M[]*7:(KA3]"$WCI7LV-XC@@7+,M?.--JN-_8)PWL,[N"JO?:V8S:F.$95;![
M;&VU!W=.4LRU!.<M.XZE-5D'_9RT?,:\#><^EY,MAD%!R$C*6;!#C0X2GG^]
MH=AN'A$DB[=Y1T_^Z@KGJF[JD1]V'K#==S8(-<-+O"05Q7@D*LJ<<>'D[!4E
MMJOC5K!Y-A[]%Q])#\@^D%FT4;8ED3DEM(#2^.H40S<.>E"/2J ;YJJ!D<1*
M'L/L5MC&)-,61M,3'*C=#J6XQ,:K6,S4.HLZ4!CDI#?3>^C1RIMC;3DOL6R0
M!;(6H9DWJU'_+HGFM973'?T5S$.<^?9=BMR MO=7I3W0AX$BZ&J>6%RD,X/Q
MF,X*K5(045CU=L]B3ZU!3B> %- JKL2JG)M.N*12,?3](/0F76Z(RZ$KT[OD
M:49;SDUZ#SV%EDLR^:1-2\(V88W$[! [%LFR/Y$W->"9\$EP_5 B3A>:[SWV
M65:Y><DW4-XM9^=R_8&*_^T/ :,"*K>)"L(X:XX]]1WSM6>;1\?G F/H 0'Z
M+^40I6E0(3:*>S[E12#Z;X30%K]:JJO'HH;T2"V(TJA<)W7 ZT\+%M:.&[C2
MS>QXB7L9WK-[<U2R[;K9PT.B\RK&?U>\R_;GQY_N6YPQHUZS2UQ+1X!56C.7
M2WEF7PJ^-JS'*_W5BNAJ>K+:SJ98%\LOM0T[TQ#XU94EWK'(U'RW 86O-WS?
M."-^X*F LRTO(WG67:,O2[>D_1!H=(;2Z2(LQ_ #WA'!QMV"7<]<%@KEPJF$
M7RK7^&DU,4^57*SM%R)9_K*3,]"S6K I6[<4&N1HX4>N/ZU(]6Y%K!W7S@A=
MN*FFU.]:]=IQ'>]GLSI1(C)1#Y76-:D1[A+583P4FK&5"'.B>T%:#(Q+T/&@
M-9ZPX#TK%Q87VHXO)'?*%CF-TDU=&;?[WON#X9%.\YXX[&Q8<X,S:OJ:D:F+
M0_@[1>%!QSUFS=BD\KU^&"[ PKS3BL]-K/%TK-U"XIR2?TSH$)3<+\1=E6Q1
MJ<H;J-1@"Z47OKP+)B=$RG9-_W(.\;K#Z+Z@R#UB[TK_GR^0,LL=]T\MSI@^
MA;S>!ITY[S?F>ONJP])J>:'BMEUZ QA*_V*XDV3\E @N.6IBM=OX);?ES7Z6
M]Y'W6ESZN<XE>V>R4-Z>7-U:2TM4;F$>&S-O[<Z\D_O@DLW&+_\V?P_2VV%U
MU2%>M;P8A1TJQ4/I*NL[EV&',25'S6!_/P7F63S+6UJ_ I=ZZ%QB=OY$R]N2
M%0&U R7J!Z<\UF;F^6;>R\V*M+DV(=B1;/[C:?PF81_<9.2'W"T-BJ[O#IA8
M^K<H='GNC%G;A6A.BL\8Y[5A&PW2+/J)_K5D,R5'L_5WNN_U4 W4"=YGG&L\
M<OD4=3>Y/!>Z6X 0F1>)NZ#S9Q\-MIE8.[!7XBZ)$;1*VC ]OQ+-P52NK2;6
M1H,XBZIZ)90:$QGM'!6 [N09H'7)EM!63(JLR..,8$.E<  HN(=6\_ DH2VY
MC4J$P@"'E07_F\+<R] E%S!U=HX[T>/:C*C1QFA.6Z#??DUA]$@.X;U8JI?4
MZ:DX(YMKG"VL."AN><R4BEML3^_ET^]]3*PP W:DX;W-+PO['\_</TLU5,)Y
MM#!FND&D_\9OA?F:A]N=JCJ<QWC&-":=C+4?AN[[KF37@0_ZLWYEUB_.+@J8
M5@[.H'\36Y/;#=NI3YQ1P]*PB>2J!O8HTEIG1@6:6-M#;.;+/ZW9TM_9Q-J\
M<-*)A0K1PSPTLO7MO5=LS=,9JC3QPJ2NF67#V@-].YO52^^,S)C$WO3/!>=2
MF_G]0<%"U)=-S!1%9&'$=+.B!^):&V75*6R/(@?L$RS G8HYD;7=$;F,815M
M>$!8W#"Q?%MK3:S\3:^@_W5GOB1";]W57?ORB'5L2O"^@?L2CDO4=[!G9?0@
M_]YK$7'8^SN@[6^DE[2<G*W>WE \>T()E #$0Z:SXX8_THU[:M/_1-G73QP7
M>\8C-G'*G]3GOL#,CJ<U#9V]\^2UA!D_7&_P7K?^ZY-3D':0#(YYVU#]<R>J
MY%9Y)Q:M"U*61I&NZE4;5'G!Q>/LK8/R@J-+\75\F2VOJ.?\,O?!Q:1KT:)]
MSBX.+DK:YHE?5,*QI-A37V2<FQ'RT\ZV73]5$74P@#LV45C"N^42D2ZLB1^C
M$[4O:0"CA+\8UB49UX4$%T!'L8@?L4T8H6X/5DZYHK"<+QX:Z&$(SM_]<N:A
MJV ]GI1W+L5[:ZJWE^>;<L>?YET;TA/SK[JUV:^W)JUE;TW:"G2/@G*OGROM
ML,Z06\Z[ B*VDLD<G-ZZWZ;@7?5BXDEAI VG3+>A2+UGRZ;IF\]FVLZ>>^#L
M="=S][,3*V_'G$\NI_KE.JK09,6@(!/+BN+\Y!?OJ+-G!4WUD@F02WY7=I8L
M&K_]S.0G'W(N-MP</?W -V&R"P&=NK%$J<6,"X_'7M+]T!BQU3V7K4%5R>V!
MN(0>;EX%XR@?]"3O8^$GM%PXCO"[+C>NVTK(5<FEO&&$9,?++L5 [ZT"AVR\
M^(TH6MC/-5EVO;[%Q(+*=4OH+UOK78]<JUXQ]L/LV8.ZV7TJ5^$7T.W(ZM4)
MELP<.!]F=()R)>!WZ>ULWO9P3]C.<SM!U,W,]^MIW[Z?8^8^IVCGM)VM;L..
MG_TD\GJ+TE]U0)\T;OZEZ]<K!"].DZK."AU2A"1XQ"XTL?H+8U[SB^-'AKA_
MJWIJI_["WNPK<MDEO[$S%BE&J%K5!Z\<+=&M<UA:GN0^?MNI12^3G0LW3;];
M&S%CPSY4E4H/T2K9QTVLF_:%X&-0,%<XO!G&QJ2;2C*27($KVNO"='YJGMC9
M*2WP5N#]TDC&%G?SAK<[<U3\2.]A%0TO?"I(FR3B_##A/N_0XMQX$VO=F77G
M!^][OP\X,-<;_O6F!P6]__#SZ%M#WFA0<R/$BJDV6'J4O-A;O=6 [9)#^\-4
M;_5@AP?V-)W<.12-_J'L)_=DUP%GFRYN\8S;F>(>L3AD^W#KO''/907+IS]:
M]O)RTT]-&[?7=S;Z\O5+FFN\+"Z'??134&Q@=,ENP08U$G'E8*FSW]7=8Y]L
M<;*)UVTY?'9W9X>SPL)Y[;;O$]TMA]I9<X:%1]H,6+W16S;,[9) T5+&$&L,
M!+_\M^<4_S<__9C#Z((.24>,U/A00G4>I6@XL=M!XP#DIIQZ+:?O(.T#F**"
M@B92W49K_:!&ML, ]D<FNO5FVJ[>PT46^.<_QA[33/6A'GE/<155+Z<-2UE"
M%E-: OUP%53[T>_]>LNW'9-V&:0Z&"0>FT<7H^:H\AKO5\JVQ425E/P,QV2<
MDPA^%U5-K1*.:<VS?>X<[--[E*OD%"/1VYST8Y+5\B$A=3*]PE]G=NQ0ZE*N
M<87,6G(U\77 &#VVZ^'YNO59M!95#Y$04^(H*WDO>=1PB08Z!\]2?Z] 5V2)
MXFX< T<"@W)Z/%I396(E;!$3QY)[B:M6=NB9+\F2C8M-K,X9S\RZC"O!!)YN
M )<<64;'-+4SOQ5Q&0:KYLV)] 08&1SS!,\%O016+?13C!J2]7MUO&7N,&RX
M#;=XCQ' +5Y!704&RSW0MLSH9</BH3 H)Q>#3*F)M3R=!7A9'A^@/SD"6I^"
MF5ASGE !W>E#O11:$=O^>JG_XTLIV:1=NHDU?2UAQN2,<1BE;'/0_YS8)[56
M59,9:3L+O@I&P.%]?)'*<AE+/P69DAAZ3DA%@<M\ZH*SE4ZZZ96+8QMMKD.B
MT\G-:C1:89UK'I;<TET_@ !XP^<Q,IT_,GS^DA@OKU/#VS:L7=6V^=*^+:'^
M&HT&N$*Y?2SI6<,OE1OGL*.!X3GO-IR0Y#?_"A!=2/]K33RI\ALLC],'LQ(Y
MO*H'ZX13^$,JU((:R1/0Y3.*C*.N08NQ+>2@B?55'G1Y4O=(%%;_/OXL4?+'
MK)I#A[A!Q.2%F Q+D YE\D+92\'ZH%+R^_AA)E9-/NX%5>^BU=1IM1-YF<?"
M-,UA"-H%?D#^-RQ;@7^". LS$R,?]F9RC=.8DE15$87)+\.F8&_E3:A^4PCT
M/*3<8_+?TCX2P!3=FP9?OB$#=.VFGSK^"8^8V Y]6[-;HE_/E$>2FD>L:)G%
M5+5=9&+=3BPTL:BC@C&_ MW^W0139P@C;E,#BU"C?1MH(1>&V6-O\QEY^BIO
M$O2D#Y2V;Q8&_;%>7>?7?95?[+2;:6(]2M5Q& 36.-"VZ"*RH0&0%_E6F*:*
M24O>OGBKSYS3'S.9_QZ@#93#5<F%<Y&G!.7GX4<XKWD)_RY5UW] _D7"F&"J
M6230R-\J#,4J<9P2]*R:/8))#<M,+(/VYG^89?5X%K(6]BB5<8U.)/05T]YM
M"W,]AGSPS?V$20WG(X;'OO9P'4>(X5C4'+B.,1A<QPF_KV.?E1]1I1EY4<I&
M-1(HV,DZLS)J+("+Z<DL)@(7,XCI<909 X$<<H_)?._KA4#&2A.Q?UU).(7_
MWA_VT,N@IX_!J$+/)6"LEVXV7A*'EY()6!2F=Z.@#'7]I)M&S_BMF"C\%\K!
MCQCYAF.\C7:_1\VHRUC'$8PYL--VCMZP$OQH9OCV'^\$@',2TE;4>[::B;Y_
MPY3JS!OH\=Z>''?1Q%HTP<1Z %=9D2B58<0B-NV^TK@;O'G L,<)ADJAX(;#
M:5=^CV7R2$L>;5U!6]O H=H*;'HA:J-1IDC8#8&;DL,&_J#P.7/^R]B'P?9,
MD;!A+A/#,C4 S^CD:H &TX!,*G63D:\72?SUB"%5YS-#^5JK7WM@@8?:S.J=
MK5GA0BG+)0:K)3W/X>GK%I0V>I=:JEPF]=,LW'7^H*SB"?WPXHL"W^PC!P7V
M+W]JF+&;W68^",^&)B)_4]'&AMPO\ LANVY9E!_$_)8?KK0>E1OT.#BMY=7Z
MM^%GJ]XW/E$G)#O--;'6WN\%"/V[B25R%&S>W DCN.NY.KB3QOG F:ZX;,C\
M@+6BWFK$,&(GBO<@=##8(O3X#3#U[R=L8*O',P7]0T<1F_0]&0R]7WZK_'%3
MU5T1?7PLEW2!YN*JXI7D'-Q% ?_)L*?]V:#O=;V'&R1A('PK]FD3JRFXRZ\1
M_ JK^[>S"ZC:,@QJ^Q:.\V<F5LG64M#YCDXC,\)"HT#S,A@,R-Z"GC>49P_O
M-]C;?Y*Z$1,1O!7 X"8?@>K.?ZJ@%F&IJ(/DKWG^[YKG5/(0-,V\#S\ 8IH'
M);%JASY6:EOI*ZJHKS0PP_8D&>3L:'1A4&E.^>A 7N E23@]2/@<LZ%'A+AO
MU"TMC]">.,P>)G D+JK!P#T>]9_DOL@JMW)[4#6[\^&8RH8M]RH.[9M:&-HS
M>TIFQ<Q9]4NV8I7B&DX!;7:@*BI^E@>>6)(Q6>?V:1'NO=IM05F'?%"0G<W&
MQS?7RZ<L7OAX;.OK@\4Q<U.V/6QV&VSK8O$B6E]?Z_\!,2N]</+IG5&L6SV'
M;8=.BOJYY?'Y+V_%?GWHG%I]\^6BD=LZO#V.>NX'H1B^QX-,]&D(AN]:)*76
M8YDKP:97#,:R(('WX93XE$(OX(W$NI;3Y9:4NT</IY.$;N0CPW)0 ^#*O1S:
MKSL7NA23]= A_O)[$^O%=48G3[ C_G[/\P.#&/Z;B55^BJGS ;281]?%/@!1
M9YEBJE.Q$R;6>]AO^O"-  C+)#WKL/Y .Q6TQ>L^)O=".7<*,>9+S*&*OHYF
MQL4*IQ!5A3RV\Z@$$ZNPGJ[5B6,%KHF$6V$MJI?D@VAKE\M4BGJ\L(/[ GK;
M[<.\UM]\H<FK"F;7=MG4N8UU+KM\81=HFT</07635%;MI<:Q E\J#OU*&JO(
ME)>"6G.UB'20$PS=CV"8<;E@] ,=-QI3#2'2E?RH^!ET6<Y#7>.Y+$FU<# >
M=\)Y==B[-RLSUSU__\;IEQ1H,22OA)F@8!C:.!W<[J8JY90?/^8P6:J2VE85
M*(':ALM)\IK5\(76Z#3^PJK<%I^;9Q?&QO;_I$@^V&I=!E+[3%90F3#C9>N*
M.L?VZ4_-S_/>^U7PFZ7G@I#1V(T[-B?G#7UP*N]D_%@71Y7W".E9U2W2H6B<
M-'R<V)+(/*TBCB4Y[^9=3L,6E*>F93HFQ?D<"#D7MZS,+$:FWOUS/@QUK$'O
MK>TJK&.!\*F"U+=U]Z<'5>!>)0CN!N.3/5HB9& F'J>'KQ_1 *<@G+;DD+,0
ML>2C-%2U!#;Z]_(9C))K.!I%5*WDLHDU""-GL@<"_YYZ)OD^>(RDL>?!VP_0
MN9CQKWQ?E,@1;Q Y?Y+OH1LU.?WJNR,2=B@G]<N#V_?W4SJ86(%;DD]7Z=L&
MP[="'LC>'4[=J#^<8&P]U-.34#X87-D^H/.9+E$?$[3;O7.!;L5,7/8=857"
MD8+]0:[]#I1:RF+FR@E1S?YYQ<Z9QJG;5Z@''CXCS6BRM8AKK-9F^%Z0$&N+
M&\8@U>J'D1/C.N<Q))B]L(@6^I&$.(V983VW?H=%P$B]8)G+4IK!192BX5C_
M^9(H9! ]7W" N*7S4?F)F?Q*YNM:JU.TK6"5[CW6P.Y/8"O/@^AGW-EGU+RA
M;8N],V\\FC_BL3[X9M;I56^OT:.K#%\S1!\?=F&W_*A+?LR9]\^A!=F-7QW)
ML&GIMRV/6W1W<<^LX4B2;=DPCTDE%9L#7Q6OWNFW#JO"M_X2NK#@H&M-R<AW
M]6OWA"FB!?VN"G_9/A#&9<<$J\\1%R\1V$EIP:)ZLV(7ZV(YIVPN&7WRX&L7
MSHSM4XK(12>V/JZ^>-\Q?G;>5-'-U<O/!H0V?2B H9\2ONG7=)7B9E.[! _4
M)U+IPO&$F])58\0Q>@P"5S6Z?A'1@G]445AO:6(=KU)Q8^%?>!@WJLO4I]J?
M@+KX!3I^).GDV[BM#-M0.<M"OTH^$4"M@"N8O**=A"E7=L*&.>"[;-TSKT\<
MW$]/B6N2;R_<%R"RBX*.*\-]1:*1KXK]0G[)W>'L/3=]>\:AZ;D#V6:NK;K$
M,^M3A@=L3&D/>)7[>M$D.[DY.:186)D;/JXS5I<8@],V0=P!?F/%']\<AT20
M3AO'#>1,4#T9PRL-V5XW]JXTZF[,IW2U] )Q^I)2-SQVP7GSUJVV6(UJYXY=
M 57T(TQY6S$@]W=L$'0*1: -_1T;!,-PU3Y0F$'T_ ,V*!53]:??T"^(4[]C
M@W02O=^97FQ0JYW?N=OH/.9N@RW<,0/@WDKT-K&>U!B7@(XZ:27_GVO-I3W6
MSY4.7\B@B-@6\^[7U'M>"F)G&RK-9I0H?T4171R/?'GKR#I["^-K%\\UV3S_
M;2 OQ?W,>=N;XB;;T-Z-<4BW.[!S 8[-_ U%!&/<G3I7.[R4@1%Q&1@1N]A9
M;MRR?:EZX&\PH@N^U4A*XX5 W[M?6!>%[MTHC4KMN6><*WR)W&[*Y];DZ$.)
M<;H8_77J0AY";B<X.*I""T&T\*,J$VN/)'Q.6]X@0HPWY6\S"R>#5,,"ICGS
MG2T"ZJUU"T[]O*?V[ 'Y_-5'?.>6SHSJ?\NXEF9Z+<5@K\>)<7AP;Z\3!-N)
MYSBJ+BT$$?$?/4-AI_,"\YP(L<Z&@>2$DVS5L#'32?['(UOKI^@69"8UU^X]
MR!W*/1(ZY-',/6Y2/-0H (^ZA+5 _PW(XM,9R+@-?=3I*N/8'N2D9[#I@GS*
MM<T\,B^[Z[&)Y65(SO+DY=!6MPREMQYR54;47[_(PX%Z(RRS,Z?S>9]KB9CM
M&^@L$\M':L. ?5Z]3C;V-X)6MU@82^_KTK8C&M!NHVSO4F10;MSTT,/MO$J
M-W 9C*]U-[U;SF!\X]_\BO$U#Y'1@\'O&-]*X4@:#@'/!7\'^>HZE)M%I#W
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MH[[S.'\O6]AGX@CYZZ7^3R_%/"8\$6N$+Y'C1-4YT;>:-$8>IL!]$++1BM;
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MLEXJ.OQPDM?-CL[R-4];^0X%J!2D>XH,BBY,H^@"EAJTDKNO"Y$"?U^7LAH
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M*&X'U0BT[)A&TCXX;(71'KHU-?6RFA>-AN27\./#.,=V35A9?:VDK?LYFYZ
MD6[<<(EN-!1!I@ PG$H<:^,9*/IGD,&KQ;85AW*[1!3TJR*P=K:?YHB)E875
M'ED:Y_3@,3@LN<W1Q!BG";909]'=2#0Z&NQ&:IK4W"+Y"2C#!3Q$L)*(:= >
MPX;E^C1@2(BV!!V6ZZCF6(54E>3-UEE%9B,C0I*+\Z;K!B;^%)@W26?WX"=>
MF_6[6^!(2FMPG$>.^].F]L/&B?1C9 CP9=>&JL6%VAJ1_@BQ3S=/E:/IT*66
M*H;G323,E%(9WRQ$"^4:#Y;Q1Q(QA2Z.N$=,[A)5^I(BNS$Z?D3NLF1_@U;D
M[)H0,,:Z1)2VU;/UJ&]C>GO:J 3X@"K>;5&AI&:%?B>Q0^>JCZ?BA3:"+XA]
M1F?2$F<7\43>+L0KO*Z@?@G.CB7'XW4R[_&ZX&.Y@2K$(B1NG<XL(M=+Q1_A
M7QL9H4:'!]X/B[R5T#;&ZM+N9+_ T$#G0<(J7G:5)D'GI5]/)>=9"693R9B?
MY 0ZRF4R+4>M<_OC;:JJ;X6.@@4Z<2P9UH"-)1?H."+!)*5T0(BK+&_*2\$R
MM60,D5QD'2M)"#DHNS1& M("+Q53\1=O>+[Q?K,,QN%;&56YF?<!.K7^(+6-
MCL"\#=T,!NF>.)W:I>@TUGFUPT!! HVE13<]"2KB,Q@-;7(1C]>Y#?R,M4H-
MS=C[TS344%]YT4F*&FCA+@0BA1+2J;0=BK)K,H/O4J\B=\+PJ(1)!D\H)?W8
MI"./7)!,^II8I .;V(#AZ4#U$]8P 55Y@\) J"9$]"@.L0Q3[?V[?X'A)T(\
MH&.A86M,K'8ML4J 4JEZ3+//2:.0.Y%S4.9QJSQ['[>(J>_Z;O%OC_NR^[?'
M[3(C9T(E\_?'(= XP3\LM/SG!_[F&/#P\\2O#VQG:Q!B=2[S/&[[5:=VM"QO
M#-@/I!>M#(^H=$8K#@';Z3I#DYY'GLADIX8%MC&'65K@H;>KHG<M%6=2VDST
MC2(YF5PN)\Y")P%3#P%%*!.00T^+8X!&?T0.PRWJ;6*]?8L'Z^5Z*T,R]&;,
M2*C_:R6U &J-#GL8(59BU7DWP0H4AS;YII0:Y\?<KHEJ9&[77&BE%V#*5 1Q
M64P_07)*2R7?23*Y)9(87F9I 7,&6Y@!K9^#LCM?'E4_AW##,PL1_ =R+!'<
MP+: O^7@QOS%<A$Y!:IIXG-G+_6PT&)KA7[=:7\J53V+[U&I)2GNQMS[EXU3
M^C2%NFSHVFXES'15>@F5Y^),'J0N"<T%VZ@$>C#1P%3)^(0W5CA0L$@G*I9&
MQ,/ ]WB@LE2&F1%BV@)$N?1[GKM,Q1D!"E&U@MU6;P4EZ?;A4$PCM=AS*>\$
M>!MP=%]C&GJ3J.E"NCS@MS>YI%!)],V=2S%#CD;XL O1:*IJ0WD:3"_^.<RG
M]0H)A5BO\'C735VD#]!/V%VI]"2M%2B"_F4:TLHEEP\UL8P<>I*'7FQ(I;-!
M1CQ"N1I1"NJKX^*N<.,D([]5 BU'!*+1MG-]Z/*NS"9QC97^/I5*.S!J.I-=
MJ(U&L[K;A^GL59(B2:V-4OJM<"*Y6-==(CWA\BG.$><.;D!.N%CCVIA<RP;>
M("*FZ+Y81+JK.*,)L.'E?(X%<7!'A;8S[* KEEOAN&1)JD.*$KS/[,L(%TJ@
MWIQ(OV*$#1KA&I%:7(Q Q19)[,/EJISV8;A'J<)".)$P*J5%$K,0JWR7C_'@
M(LFPD)CB>D>=-"9W)51L,GH,'A>1BR8'6&NC2->,UC'6+J+$:N^ HU<;T\^E
M=21W>_9Y)P[-U^ZDSL2##)?2-K1V(4@!:;GQBNHPSX.4A]&].[ZTUNMR3>@5
M/?;01X,&^.FE!DK%(]V"]2*]O2'A"IQRB>YCETSJ')5*97-;09VD%3':ZT6O
MT#=Y&/3%^"IA<^\]3U6(6;[D%M DX$:U6!.LE X6/C*Q1CEJ:VT*A?VJA!/I
M<A?;Y_3'A'8;/C4%KU-7166C P+J9Q,[_* V#7 9"=6>BC\T,(>VS7TY];G6
M43Q\S^*KQ5?B[J^2+,68.V]_-+_0[3&/:-!^)*Q%;HMDV@C%+<4IP13C5L$7
MS\ >_F#"N(,X;)Q/B%V)]H:'5OF7>#)^C/?XEV1@:HBKZG!3M&!9<H@;U.C1
M@D\3>$1L!U?DFEGI[/IC2YS5Z?I6@\ *@2Y4GQK*10>,'M1!*?VSB;6'B7/\
ME(M0^&=I\%,HV$WEV.N#C4[9[QKU=[JU9?)T<9NVIHS^$2K@K$:)SL[$>LD4
MG4#;1&/"?.B)W7J.H9$ZUY7FI.?=,;&V0_W&-Z(U'6$K)-3E,Y=;Z7;Y;>&4
M-H.V1$Q,'I]<*CVYK3)=Y]-P542.CF4?WX*.HZ>T>L0O(6[YXO%5^EV8[IQ4
M9LZ-RIM^>;,N(D=6QA\;<#\Y6HEO6EP8LA\9&>!AT!S=U1H79[51L*^/*U<U
MZ,C.8<%*C!PYO$+)*9EEM87@ZIZ:6/005[/B.B0<&=E9)_](L/4AP3UL_)1'
M+*A2AR7+I*-E22&%3:I&^<GYZ>Z%WX=4CA]/.CF=F%]'#5FZ-MMM2<Q6>D%?
M.%CU/,2?SCS@E]-D4+R\Z].65W6Y#=EFJ-(*L^5&19I7'%0/]0+G-^Q6X1!#
M,KF,>SU'[P$G^Y6V*[%$T>4#I\K$\@%?@M0L.I$*[^+K$8V0S^_B08NCG\T/
MU!QN0BO.1T^3=L*H_N2S:]'36/]#?_HSF?_P)K3)BM<=BAJ;NXR4B340AN&/
MAZ [)<9[$FHO6CL$8X%_1*T*32S @%:/B7\#K7JQ]<=^9"M:F=L2_PIQ!>#<
MOR)K6?270'D,RT;R)=4/Z"'%QNDT4\87BP6J;>1(@C'K<A@TPGB_<%X#,K;W
M-DRACW$!N0LW$Z'J*_#?W,WJ-ZY&U^*\&<\.28BSS4YP/8R@3DN7W=A67U\'
M56(3N7(\C(.FP8\P]"K?34%7WH $DC@<WFN4H85P8=!:?J@//P*SIJT%*%&
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M8VT##W]7GOHV9#L_I\C7I<Q!]B6^T#"6E_K5X=NO)_=\>N3\ FE.RO*0$Z'
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MGI4!AQ[(&/-N,0.?^<Z=>BMZ12>FI^3M8M_<Y6RFF4SV_&+ VQS-DS*-\#W
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MG]3P0/4'@\'E0^3 U7K*!!"=\+&Y4)>"))_2G26F<AMIYEP:6!8YZ7.I65B
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M!(DT&Z\%G.W85J7#VT6?ZY=C&:A "EMPPJYA-"4LT06Q@VOP$+2W?!N'%:T
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M*.@N4#%_,8&9=S<8?A[YYV^@#3=@?;]VY7\G^X].AF7!);O@W2 R@@L1?()
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M0\@C%XAL=[^@XO*Q:33\4GTIN066<,=S;!D3A "]YY@#WP^U! )'NQV">N;
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M\[N!N^SO\G%+<0M?YQJL'7.27P>$D;^'*T09@!0.Y"F3ZA1"_R=UEN@)W<\
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MVX%/+R5="L(JG2_GX68"@@H2O 4'E3(?AX&W%#?YL;CS5C?%YM+0!53)00Q
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MW'AD<#79V.R2=]E@EDWPHA[AZO7I!ZZE)9\,/0QIG<UCT^LS!GL<AF_G7#V
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MO]2T3.EREX""&[5\M*<+M_>H5AZF:28_AV,M \?%2S[\@*O';.]?BOL>9;&
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MZ2FP+ UOG-GUA 1/XCJ!S</'/"M,F;F[D8UXLN%7)+B5WP?!R0PGW!AH*XO
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M&98"VVS]O]%9$ FTJ90=;$*E?$PA1$H[BQ IY?W_/QO]?S7J7XWZAQJ%K]#
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M4PZSON)^C.Z#(6WAN6H@FS:#X8&2=50Y<Y;3-DZB[HV<0D;3ZQDS8+@G)9W
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MJY\IPD!]>-#NGFJC/6=//>Z !#0)/88WJ)W_8II@+$6F2S*#/45@H[?NGC]
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M'%&*?TH Q5*; F>L)& CEC=@)4V%$I*6&%C/8$:N?CH,*MCDM^N&UH<C=MJ
M_!A/FI[)GW$NR4";&F_;\5#IKT/>R,.7-N.+,QMZ6%3, W[?I+;4/1?QF[:6
MQ#-B))+H_LHA86%,C9]W\I7!R90/HN%DI:G]G\SM*9EZD1N'55]L\]X86Q]N
MUR!SA$^<>\"I:,;IR/Y'Y9ST1MP-AOC5P_DL%N*=ZV^)T2NWMXTY4;8_J>T:
MSS^RIU;<6?T\L$=O,ND=XY9?!2\(T!7>F-</I1Q6<RICNNV).)YRDMP4LGZ3
MZM73;D8(WG6:L>(Q++ATW*\NM"4P? 1PQATY'LTQSDAU# UQDGK-0/A9C$4<
MLYY\01KN+$S5$RE<HMV9=]^W6)(T3L6\,LU?$T'V9N2P&<!_BIE=O2&-.EIH
ML)*HB: +MF.-WP]_&["S%-%Y"SB/E;H)T]8RW8V=O]/1'8QEZ(3N33XSSX_B
MPF%%M/,;Y;H?;JG&: N'3_> ;R"S*Z[0S+>2V$(U7T<=N0P[=W[Z#"U#!-&R
MCNH@@=OP-VAJXZ17X<VW@9(\Z6&]<FY"QY:44\Y96N,,#MCDM:J[LCHZ* IA
ME!TN4=[AA,F+ER,AKR_?3-@>L[.U1'5"U5TW]PGA9(;&MC-$[\0CLB1-AB\*
MAH41&%1!Q,Z7F4=E)+Q^R_J)"!TX.K?RDI7$P;M&UA>L?R+Z9)350<?FVN'.
M0MNCV-J;^$8TQ;P6[V#8 8^5HP<-YY)T&H>AD\-/:Y0C1H3? K_%W222-BE-
MG_'U:T4SH;+3$>_F5-D:)E]CCQT^K,]8H7Z+T^#30J16 ;AP63JE8X(F!X!W
M"U$_CTV6[PEJI^$=0B*"F3F@.Q[ >Q%#0A3-E$LR%X0N-TY!@7JA*T:YR;D2
MUI,2'JM[)58(?%. 3+Z.TI 3'$\H$;=!]40>'I1 C(R_P*FAG+-T)[R_[/X!
MSK=OT.NP($]J6RAJ+IZ/O#D7'"9"Z2VX/>*<K]>0.?+&HI82G<:5LZ<Y9F%7
MI5A 0:_(T_#+IV(KXM),_(J#ZH0TQJ,[T>JAP&.W$MGI1T]._]O:7RHC32"\
MS\1+3U*UGO0;!8?#6,HJ*^F&8*+G-K21Z+3+&O&+$G.*;=W22CH"J04LJ4K,
M=.=N04/*XD&7%&C.6]Y\N.>6GGF)-DOLNT<7T,)TBXJ+F755NO9.G-<JM%S+
MIJ)YC=<FPZL$,V%9>8E4Y@&+6Y6ZY_2QKZ_O3SI]>OI]YH]$:IW]A^Z<^(W5
MUV=J@&DC]F9/O(WUE-R4OOL>FJH%S]*#0X_J.D]6$*31&&_(^-*D:(1F\;SR
M69MAY24V]Q/>$FR'"O/6[M8_D_I7Q'NY,!9[+5=I!9LZQ#XY/-NNB[^"#3Q
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M8S+;3/=9;"VB:E&^##"IT?5P[68O(K^14Z:MEE+>?"P0;N\:RW#E\!4Q(6B
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MG('\5BJ7]KF):ANW7"MDML<1V'4VZE/DCZQ;G"EYXT1C9:%H)2=?^DD7K-V
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M4:;EW"7"6$O9IDUNH7G'@Y=C(2!69X#:H/GXJH#L\::#NOU-:U0?(?Q<]]9
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MZ2J9 MZEG*-Y:QA@0Q2VQ+4%GX6H3FO4LSA!)H7E%M='2YG#B0CMQH*U\#S
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M+G\?WX@LG3"KEA7[E911)$N;HCNYO?PY$[_KC_TU3$%8 =AB@59A"$/L357
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MZA95<L:? (^ B7SMENJZ#)S*N33 _1Q17I'OZ*>MXG@QV'RE-==+$[D6D<O
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M:E(JNLFY+DO&KW[W[ZK)\+ADVH/RR*%_JB;9*:>^"ZI!#CQQ[;5DE##^!;I
M\8(7'89O$5_^12@&^@<BYVB]&3O%R-%"-36/Z8X[8AN1;67JW*'=A[N_E01_
M=1,=:4UVJCQ_<VBLWKVN/'S<R7 M=MHE4_#K\3W_,>V?^O(_/DQ? E7E(!Q*
M*/8-L#+-TEQQSFQ3EB1>RU[&F@$R E>J]'/Q/N4L;+]&Y(B6MH1G2*\2_&V'
MLF4*/P$[,3Z)2<CYAM"MP5V3#2%5P6&]FRSM>BH>%WWRDY5.\0\!B7["?7F#
ME <5$P,:%GD.KXLIAB;:87);>'4Z2U-%;6:Z2(.X7NAQ37R(S+D^\]Z=XYPK
MLIU(1\ZD]]'W.QOZ"+SY3-SOK5O=\];7CG+X88[Z;8+Q]UNDF>]ST'F@JI*(
MI9#@E6'X_"/&60'N.5 M,#'18E"1LUJF-/_[+LK_^&*T1&TBQ-7/1!3Y22EH
M94O);$2/+7$PK+)T=EPFBL,=$7XZ-]+(X-K \AS)>@U('G-V.=BH[EC,23F.
MZ I$MUB*M96Q2>5Q,[1[T:R[L?495:WY.HG?YA 74Q#<H(&:E5?<YW1*UV%.
M:+Z*G$MH=NQS7P^U, NRE9S\/SKR[M[;-T4FCXWL0I(N3;E%R&9^[Q;K/ ]W
M^7I4C/V#;8EVV\;_:GST>^;FA?C_;4<PF'H%%"=-U!DW4S,IA@)3&8V$=\S3
MGKPOL ;:@<O@0GRQ*%? !QZ"ZI7N2]D4CD"FC?(G&PQ\TT.?TG,)D.Z&IVXX
MV) GO#&BM 54-\VDWXA?=(L1VDKGX8-FTD-R&R6[9(U+,>>L6MG<H6"HVELH
M;IRTA,A59A*S/^)36'!)$EN)IA]Q.9A>-I8\7/ZMSX?6S*L5S#%&U)$;-UJZ
M+J2F[N'.5L)'R>B:VUL]_AE0^Z5CXIKC$89VTXW\_+2FHV'(4ON=JHNS;-*C
M3/!6PV^F C!NEB;=Z,/KADA 3)KJ[&V!"R5-N(SFQHUPMZ>MQOMI;N[K:+,(
MK+&^D(C<'*_8XU(W (C!!XGLWPB_.B OV6<#=?V/LH&Y&6.9ZH"3Y('*5A<P
MS4R*Z5",&[Y"K;21S!VU2%2^FIP'4FA+,"]D;X4Z92CX</=&;'\%"K9';>Q,
M9 U]I#_:Y5NU:?!8;4WA0>&A;M^0==51(_2&G$WIJFA=I-$;[QG7))F*P%CZ
M!:#&G[/ZC:PM'MZJI<B@W!"U@P;0L=%@?O;@$YH'0NI<V&A*KP9/VAU6N(49
M78\:R4+3C?-_7TB9^G_8+OK_KR_*:P?"CA.1_]<APB692<;-S$SF3*>9)';C
M6?U?SV&>UOZ33_EC*=YA)AF^A!9 4[?,I#A_RPSIB_O OPZ;2:HBI8$G?.B'
MBSI(/17U4X6O_RH8QS:;2=VKP+K$)8?V7<>N$^\:4[X8?P(]#,8<*]H5';*&
MFT4V.C9L)GUJ$OE2[7)3"6O2O$;;D4WS13/4]&Q#^[%^+%03,,1%GVH F7()
M=M3XZ2+T[#[X WJ1:V>!TV,Q-(>>,VR("JE^!,2+3)=!U1W@ :A;DZ05H QW
M!_0\,OWD!^PP4HAY@'!A'D7%SO-= ]NTW^0&.*5I4D,.X9WH5HW0+?8DOFAH
MH;'5D#G)Y&R.X%3+]S;4X2)0A8HR:3;=TM66![C2K<=BP&@T7ZNTPKN$"[C'
M-72==Q13Q[3"5LNEBSB5ZK=\DV#;K;5I)\VDN3B$/-(0*MY04%PV,#8CPE8K
M3_5/V1UXNA<V2?.QE8K%FZJR5+E9^V:RE^2LQV(3P@Y]" A(#C\ZN7R*@8\9
MN\6F!*BZPH@R$,N3*4MRTC-GY4-J3B+XHA2?UZXET(I2TY$A?N$M!7B=E:66
M/O9+4(>[,467SC*Y+O#>;$W>UA;: J2B=3PW]VBW=,.8_UM!%<I4;_ME1G#A
MYH->?,LPZSVV$!< JFI W&<F35AZNKXP/0#B0JW?1W5CT?"X"K]7AGW<C_G=
M0IDM]0(^;3/W8.^DZ!)DC85]=XO3?1ANJ[B)1FB$5R0K-13'B#&#HL5&YG+Z
M-X3#;G5>;\/WI2,[+;-J&(A-:XDGHK^"A8C0GC9\&[)0K%'^-WEDHE::1^^9
M1($]YWI+,BXZ>_Z_3G*4BNX-#<6Y%-Q*_.Y\RG=!_^K>]^=00X)X$"OLB$R.
MZ-C5SW@[T7BD&/2J<I]^%^2@3=*Y&G?BW?CZ!TB[;AG2H[5IAY:-)MN),FHZ
MG+BGB4M(S1Y>W</=<NIN7+VX,'/2Q&ZK?UYW[WB,Q195C9VK#Q+_*YSKDOG@
MUZC6,X7^&2\?<33[5T<GG$'J;+[?NO*/-]_?<0]@S*P$FZJ9\"[]BQ$->X*M
MIJ#KZ+KS,/L)I2:ZA7G9/0#-\'RBG\_=63+=IK3%+:DJ:Z9S<-NQDZV@C;C1
M@0X[9^,K.!7MR6!+Y!<Z[#N;UDBKW3">"^>V2(EPO.3<7E"R[AISC&7 B6"C
MX\T4.(PRK^,6W@=]A 5IF,LB8@A9;8]JU=\(FI3N/,KNA3>TKI%6^")!=OVG
M7I5C+I0,7Z8;RF^=\9.QEP=K*9><2[:4*)D(((/L7X:WB4._?U,7457UMZ1_
MR+'_BB([8,R0FD2@-;.$_Z$9;-H J4;H@S+#6K1=W4!6E&IM6I6#?@8Z8@UQ
MB8!T0"):";.@]>.O0&;3W'LJD)%F:B[%GGU&$E>O3X^7!,6GEF*>"/6*![I;
MPZ%BS+)BLA4*M1W"CL+03#'7"OT GS64HMOA:4.:22A=@8(:89,RAT=);QF>
M@\@S3Y>$^AWK^:8HQ:LR)3?DQ<:I>')4YU1$T&X9H=LKLGQ,7JWN9&1O_GT.
MHS6<)M $40YWZP"9R/#0]#-M'=[&K"EL$PRPM;1"4R'BH>(+Q,J/.!FW'B!S
M,J]6MY>?*.@*C%73T0,)P()Q16%:8(KZ0XW(E0L@=GB:I2U9F"H/W(%X5_UR
M-%Q<"S[0HQ_+#$BOA(HD_9,Y<);3'MX9+W%$=N^$3.4TVSWW.>DR%^M22JM^
M[FXUTP8[!"=E^&1/KI/0$7(DRH>E )DSG.I/=0JU2>-N-=(XPA/=@1Z^=5G<
M6-'HQ>G"HM /#6>$17W*5#=]&9_3F$HS%;TM*;E77J-\04#HWTQTNX-6V Q<
MB;(\?D\A0"$(.P<MV$1;NJE4#2C"##_");?4Y$5H0P3"SI*L7%-0!Z>KK>M.
M>68QU)>%"X*S3O=@H-9$8Y,Q-CS2IB>?X#";WV-;@ 7BR @-&TY"Z)KI5L$5
MWG8YS1/[%A4BMEIRBXB@C=/$<NQ';#6%>8'!B%6[^PJ\K=N'\-1OM!$(,V?*
M.R*RS_KZS5'_J.QRVW%";PC*8V=.W<S\ZR_%W$97@]1,RA@A(/LKXT%01M?B
M+F&XBXV6@OFL!=2+"(.F-)-LR2U,6 S]+3236@ER\9 ;]%@V!=D'=HK-I,7,
M!XS) #/)6@TV[;6DGCS8,Y(KV4X([P6FHD":<ID8S!UV17^&BPV#"+4Y!1 H
MDIHCMSXI<7[<AWFKQ]D+["@MD#V^8'QX*9I^NU:D9F:!5H$4C6@Q9Z3%3+*O
M243YGI>X )PN<_?8XYB8,LX:;%1T)5.E0R]>E<8F]!RL'9I.BC/%I_H ^35)
ME]\&?[/BXOPM7\Q]\_W<[6Z"./P'XE,1DOI[NNXJ@:)CR(B,$'G+N2E:,TG!
M-KCVY(DRL! XNK4HOS"'FPJW-]O>X3":%;0'1AKA.+XG<(_+W=S)75.V6V4F
MI2D$N=_R;,:* DL\85-!GHKL@#Y4:@HSP'IJWC03WDU%J6"3R)Z['1:T"5\(
M-'4Z,C*BIERAN7!M4/ZOH\,+:TPU4N<XFDUQFW0MK,\*](0)7\-OUBLJ0SOQ
M92@4(L?7=\#O]@=2U (*N@%83*^LO@6WMR?W&1Y@5ZC8,DN2_-Z-2;Q.RF\?
MEQ_LAAS F/.N9PZ^3#=NVOLQ8[9*M3SMZC,?17)50 *+WO%4K$^9KXB:T8V,
MHZQWTI&9"&P]*B0(5VDK=>5&HU]5DQTP'[1!1;'!Z.AYS:'RL9G-"#E-DJK6
M!;3R%LNMKVIL[;RBNC.K;L8I4M&>Q$9J:-\$K\L0>:#YN6%]E1;;0VSYM\26
M/VN9ICZ;AX:I3-2F&?(%Z59>O]+Y.2%KYD^K*K*X7U6^@>!,S@I.2JNA5DC!
M4LHY23OZ1(ET_@S0<L-+5N(HAO>,9.%+613'O([+\=PYVN+M4@KG+S-IQTPZ
M/E=FG(5]31SK--ZD) /?""XK*3X401&4GMAASRF63;L[P@O<Y\%0<Z-?^W@%
M!VH5S@OT^_5I(C5+ZOG&A=HZQ-!$YR2 .>X^/=A6C< ^=OCCVI[3<-*EA!NV
M^V"#$-\/PF%LQ?07)@G$%B@J#**&1KG>!\P%G;G[[V)!_-9D2F;@=DVJLVJ:
M/TRUP9; HJQ)@?731/4+7T(+8*OAZ8N2]?=/#,2%_SU3<*OT1%QX179@Z*]#
MP^,S/S9.E)BXA:*HXO-7 B(G:TO8DT?9;R,/GC2T6Q)V\ $(_ISL%HY]:OH-
MB&%F45Q]GZU[2;&+#=?I2O)4U-FI#?O@_NQ*@67"J>>IFUQ?]+R9-,^Q,%WB
MZY<SV$1SZ(QH54BOD[.X!Q6UD/?S"K_V>QYM3:5)>?R55W-^\[@U9Y^OZ6NP
MZ:X2/D =>(K/7V;<C;%1K?'SX]06,@EO$\!L1B?OH[CZ/57Z--X&5*_);V^I
M%)#C0(=7];]?3>R8Q2'CCHE#4WJ9<_??7;C'N'];7KS6^X#V2;)G#M<*<3 M
M!+X%T+74B3W&[_#GYZ!'Y';@ DC^&TU5LTDON8&H;R7'KSF*6+4KP.DACPFI
M2VUWA>D7+(1U\SG/85LVH<[H%Z]YV^QXZ#X7L;ZJ#J4T#?O!%3D2:ZK$*UGQ
M:BK.,,5@) ^//3.3?A(]D\KKAEYU/Y\Y'P,64['%%?C"!$O'RZ_9EWFN/804
M%ET&G,%O.P: %G_3>VX8S&AE+H%:A)>'7=-;[#DI!X7MPKFX%[934H\\'"^Q
MJX.GQ&^OPJ4M)9\(U,[957KLJW(PFN/9BF_)U51D GT,-;V5_!%V!HV$![7!
MS:8$3JFZHE5/0@,T?!FT.,^/T=6>);$E<&7AZ+ 77%#O([ _%AMN^-$WU>IH
MS]2L\O'DJ.+*%[F"AV-'G9*NAK(IZ!&\"YH=>,BXE=<)+B>4/\5US,6I2DNL
MFK-T-7<I<KI2S:K:-2US$6;S"$EV##[Z^"[G^VE&]V30T?>[)+V3(95YJ\;#
MNGQ2=VGIUX99S[SHC\][KS23=A.,>-UP"Z&WL >L#/=-^8&[ZO&R,OQ?D#.A
M#JR>X"OZ T_>'0_G_:RF*X!/D2]><GU@T27VMWEU%VO(=IP>5<=EVLH3VZ[>
M#ZG@%!(X["P)OOOT9JR+6%IQGU,F.N_7M]H4%ILZS6)&)NR8//>>):VL*Q#,
M/#;]2MC'"TT((T="5=%MT>MMN!^RUM+A&?7;T1]X1&-)=JD\UB/YI\$S4Z9(
M;!-9)DP5X:+OHN^\2;;FWQD8LLP(OS>D&%6<OL&RS B?4[/X+^CU<0+WJLVD
M]'(P!E(P-879^#RPR8_GQ7EO2#)=#]ST#3S.C83C7J(.6H'.YGZL=&77U'7$
MYB!R]O@+;!^Z1C57Q 7F\"\0M.,=UC2\'?&[E$A=%(F=^EF-_([NAY73TSAY
ML:F>FVCTY<F N<!I9D;)%D1_0<(TQG#,I+9ZORN^PGG!=XZ/TCQ,-WC.G(/=
MY%SF LE.3;!4T)J\$AG)H:W#UN:PR+;'U]1=YBZZ@^V$DR[[-H#S6>&"#"X+
M9R*?O@]9ON[C=_5MI;6O5^Y-5GWS=XEL;?XO-R2Z,[I!6#XB#QW^DT:<Y1JE
M' QA)E7L)!9L&0?2..=P]VN%%$YE"\\/$5T6ZTZV1E$1?JZXD=Y2L@YA9&.[
M[[X<FS&3LK!@T;@?H[ZZ3L1*%K\:KJ@<F[DQU'_K7IPSPZ^NT.%$Q\8\"'ZD
MT;>":27;.W%/S &]@=BJIEM$"\!8L-D/L56S"2EA:7?H3L$'NGW)Y'&K3Q'F
MI2EOSW]88$Q1GGTOUQ6=@U^]%^=RZD717^]>SP/DT_B\-03\?VS*(P313]!\
MW(%E *RQ65KRX!?M3V@NE*5@;.J9%&76\!K*DC.2($T()8L"WTG4.\<4K4<9
M*AM: ))T83(!!55*OK^E$:"S OVZ0S.-K75?\Z"^[S5:B-LBQ!'FF'X"6&;2
M -_ -Y4!IZ$!K6S8UB25+%.;=FN&TPE'UR-6+ASB\A[#;QLU (4;"D?GT99Q
M;&0E'MU2+^P86E7&$;05TIR1H+IT;^EFCE([IZ[99,5$;[%5QWPC-YR;'(PX
M5]_S5'2[2SQRLT#*T,](2RHT>LS>#U]8B/3QKV!!1L)D',&]1-F8K:94#=ER
M'4V_24[7TWZNY/KT)Y@\0N#G^2I($=!24%#T/5K\I&2]?ZI8R^OD;;I&;*5A
M!^1Y:24+=.4>TH"ST-O$8C-M:,W$[OX3BB.$2:'!TGGXXCE@HL=X@,LSE5#:
MI@'Q-?29U)I[$LV&\R4GI,L%ACB:.].A[@(W6/U>E#=[O%[=M??7,VT%B3<.
MO_A 4?B5)'UH_#C_Z_N;#^=[=*9?!*R88Y;FXJ^XNTS%H*H*@$/ 2Y:F^/&4
M"\)'%-UZ) R?I]/8T0VQG1MQ7RP078^DM\Q0F[<'^JG=0M3.ER<"R2(,<*8L
M\ EB/9DY_3,<KOPB(G4OF.-?./&J$GT4@21E!=*=&D_=M#N[=SQ!,U3[76C
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M-'S\$!S<1+>*\SO:_?+X0(>WM"3P$&+5RAQ0'#&36O39=8HH825G\&A/S=.
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MD[I-]EF-_<#QP2;*F#-F7XK/>RZ$PP3HNI$F_85ASQZPAC877;^)MQWOSC5
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M%Z&^% N9HWM1I7MD-1C\]!"D#,+34ACB-P-C*8;MCOL6A;T,Q"A$F*P5(U]
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MKDKGM'D&8%/R1V-VJ/>B$@'QR?(8.<'I>4K8*<WKN0I2,HGQ8\$K4'/S^9"
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M\H%QK=J):R\G&"CU(O(J3N-M2$-=33F6*WQ/0D4X8-WG;A$*@@&VV+86"A<
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M_.B-@VQ75HFU0$PFGJR%YW.]6JV-PXYJD(7' ]LR>2PMU?GX!)S-H^LD]D#
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M!R^ T#TBL+;0U&;))C&W4C_^1'*1/\4B(1QXJ]$Y]9B-;G3@JT>D[PM[PO!
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M8>OTM)WH563CSHYJ<TS;9*WP]M[>.(DK[)J.35-39W(G1JT[JSWF6FL:HZQ
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M5,@-BMU8"'\#OQNJ"=?3)0N9O>'&*^9KT.$#<+A1@2UY@CS5 2U@;JB&8%[
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M_\WXB(RBQ#<]RGU!7C:Y8I;6D!7M@U#/\TYJP?FH3D99JQ@'G;@-;935W36
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ME+H>Z)[(81W;82&="HS"^DP&/!:QSBYY9)7G/WO)N-.< \5MTG(>UC53!<I
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M_P>\0L/<JY"J9I7UGD4UZSXSC[<_1A0?P,S"?=C4&:OTV 9VJ3)^/EINS"-
M(M!C>JR86!-?6"GXL="^0,?,KI]Y2UMTY^V;%S^*U\3=BSX\&?:H?-/!&_'4
MT>LL=92&[(**-+)SXC4ZT0QN+@N./4^WU4:YM_(=D-CT1,(FRN56M9JU97WQ
MDZY9X@VB(=?UR969HL'DFLN5MTI&W*)>6[=.U]=.U/I_NJ_)J1Q_HWJ0I-^@
M8?4%&4/-5\%X^<S*M+@2+!D-4H/9K@$V&=C!4MX7G=A\;0(85%W4IK([PF/=
MZHD[T=L&P5 ;6X1M1':'E@PFIQ?DT-?<B^N5I%TG:G7]YLL&)T/*^D;'KM2)
M@E=;GE5.8MV"MT3=6RG\[R;<66=@1@"O-T /6.84O .<?$*EL,TIRV^Y/AVX
M68!/+\1H[U<RBYYN%6$SEJ%]_SC__X@CKTRHP I->GQ3*M8%$0 UZ'_6.;Z1
M<]O \2QXM;WN(WPCPZ[_M8D-@]1M3'2"R$?70 7G)<&&OS#?\S$9;V0U>-6)
MOS$5)F%S+KVYE*^X=&)<(LS&,L"FIT+X"ZJ[5>UJ*<S4<TSV& #;R?5)FDW4
MLY+/N*M40Y0I"@LICC-U']5^4#);06TK7HX F;C[9IW\S(D3_MW91W6SJA-8
M;<*YB6NOAR(S]S(<,%\T4002@*25=9;JPI^.CNQ#HQ BP[50"4Z(K3$7$6#1
M6ZK*H=@AKJ?$"=? 'X?<P*QUQ^ZAD:T!)RY7QJ6%/4],\(GL=#.VS0<);LR_
M%7^P2EQ7R!S--!)NG58/JBNMLJ0VB-SX+T361$:]UXMTU%.L!0Q/GBMRI$S#
MLA[Q#6007!FC(><?J*\2V%=:T OIE]Z(+RAT?EMV(^K5X$1R<6;)L*L;K[8S
M>B@@]6EHG.M+*AP*H71_&;@(C". )F8]K,O$/C5?8=ABJ]#2RKWHL1#S#3Z%
M377@NZ&1ZK>WCU.=G\;06AH=90&*MDC6_,,,?T2(+>8[,)V?:0UG<5<TM%0Y
MHO1'E*)R[B';<H']G^%]E;48Z P62VY>K4ZIH($;]TX03EG?XPFEJWJ*C$SS
M3>A'*">"V03V<-2B%O)YJD-B3,P:>.+4F&W%-X&V6R6(?::&A8;RV)6?9DJ5
M)-CEBHA;],5]Q+6%MBA>286#TRVDFA_?\H*U=BO_9E;;"XV=9@&#AC>!U;0<
MX" DJ*VW+T)R'S,6HE&5W/>;8>4CF^SC*KMAH9/$A;M6VR5*]U+\>&.[SS<*
MNO=-[L .6)5SY+CMU1BIG3:/MI?B@GAG8P'UK*P:P-B!3.C#330"OD6I5><!
M)S".>DIH)YF#;:90 +*$AIIT9*G<!EN-O$22,D7T*,U:M2J+L@1QN:H!' 6.
M*'/'"SI3H[L1KU#U15,>B+NK5=5#M56O2M%QPC>/06Q#&E '8LZ L<)Z@3WV
MJ3GE.W2CKH*M^3M=G0>V1'@JW25(8&:S(0TB,QR5:&5GD/AR392_%%_1)2;?
MX:8U_\P]T[<5V0"WW;H9HA78<UDMM#)N4FC":$&X*,632)5]\ OGQA$"Z!:+
MV[$$\+*<3SC:0=YN(IL3WR&>*,N"15Q52S(YC:#1\KEX%^Z#9.9B>^[%*2DP
ME$ZG:0PO%<;37346D@/W$JOK[8]C%>1-S\?*0RN8WW7[;6R( K[NU!^A<8XL
MKCVS=_<[&^//:(]6T!MIS$!'3)NYO=)-G?189,1:H\\5K^K ?-AW>K@Q.Q!:
MBVHAF[%.L8KN'U,^7/BF(O9:;WQA5Y=$$%<V$M%6PBF5)=B]+;L3Y5EW# Q2
MP8>#'TN1&-S64</*8L&7P.]%HS(3@/V$=ID+S+GF._0?E4O;QT0]+=P8:Y]X
M$K;TT'->*F,MWNM2./$;G<!%LX8Z")!\]A2[GC;Y>R?[._\ZG\YN9D7UB8CD
M5R%8: /S+4OQBD_PL*8%T*$+)H*D-/E ^SFGP]W"!71 -"@DT;UU @\T5IL@
M,#+/TY<AP;K=T;P$](%:?VQSJJTTJ=X&^X3J@'_"%4D#.)F)>5ZT>2BXM>/>
M.I9#='RO^?RM<A;_MUV;[?KK^E^Y9*^6H;.' <1"LF:ZW1;28+?(,(+//6@A
M"6CH"H,YE=_&FO0VWA49_LSY9+10B82^C5/![DD)$TG $J*R/6+!.ZRCNWX#
MFS9(UO+EDS.+:?QUW.T)N#_^+,\HJCJ"#L&JK[L%F=@Z1K^.-97[#8!&1#MW
MBP_"!T:B-W:OYBU57T;/J^:)UI7K0YL#PB_CGWZS!=F*;+WEF9<34#SKX.>+
M+:3?*"4Y%A(8L>)'@YD%C;]^2;O5$$A] SV-\GL++@/AN%+,F;G3_! ZL#W<
MZ(<^T09.U>EDH]NO<7V:+23RC3-/I92%+\0<DW?O8"'G+&.14G;S.S1K6+E:
M@=L/%ZX2DOF+41$3!C*KHP!IQ,3C*_30>]Q2K?\Y\7;1,'@6A']RQ=R9ILU8
M@/D&O@3O@N =M)X7O%!S =\K-:VU=^(Q4<&E"G^">DS3E?>);%%V2SWU+&[?
M-SP)Y8B/J0$/KBB\ 4W7%''.X%1Q!W]!7+CD,[CR.CRA@0C,ACLC-ME0HP!=
M8=,F$ !5X*BW:3>_G5K%$,*",+05=M789$O6'4X.EVUD+63Q_%Y@?G#]<O%1
MQ)_9M4H\[>Y@]'*Q0L1P/1R]MA;VJ+A=5Q(W00$N2>>A:7LZL8#)BE? 0+,0
M3H8PYT7@/>O6P?=A"P9BI;1>"H,[X&O:]>2TXASE%?+'J"JVQ$("L-FEMY_^
M^8?#PW=)K$3AGXHP?IVD#O_"\_S67^\]$/\X>\:!+5NF)T[_=/K\"Q=RS)[6
M.=B$LWJ"' !=(<S1CPE[V&I65J)\:B0;.<Q8@QJT_UQJ J>(IZQR$Z15B+^0
M+$8OWY-2"LK1M.9ZYGDQH-6S-*6GM$A!ZXC<1GY4A+(U UF^%0<C+*1-*G2)
M %LD51,^22G7DD\#M;XB8L4YQBN=[LT$X[2C;D?3RU%V$U#=7:[CN(\H%S%M
M>30"P'\G8F;03VJ.W<%6PZ\%TD?\3['-B+RU@M72J\H6.UZ+ZZ5E)NJI7Y@;
MS(\ =2GK 1ESK'I<O 9)T@/(A(:(5?%N#6<*@>J#4=?]6L-L%=Y.=1C+"PJ7
MP(H,/>Z*+7JDJ#:X<,O$N[6- 29I\@E)0C6!G^-<(TX\*D=EK?P%<&DZMD?K
M8:>OCV1%54#C$VLX=1^$VOE)#M+$HW-B#^Q^ZO;//_K@E9]QGSS^1WWL9?C$
M!X+1?)9F9*$KD-$CP \PXP;06RU\ P3@I,I;CJ]>?7TM/3_.DS0^Y=5]FU?3
MGH$E$]A"5_A3-(FH;S50W%HMIP9L[C=?H]O >W@+CK.6FF: L?+,B]Q77"'N
M0-/'034VN0+]RN/7K9M9<:J7 'S6+([O?8XLKWH^B_>9!,M--3SS"$S"O@R#
MGO4AF)]IU#I=DXJOY;*,1U$RP:TSD-;SC7>Y/FJ@&<BF+A2S;G/#%#LD"*-$
M Z8K[;IY'*TMU7[O?UX'2_Z?KH-IG'6L!=P2K>LY\5Z=P1V]%(T4G,,2M-N/
MM4I6(V!.35Y0"V,Y$IXM#BY[-3QIR,)"1,,3KO^>,73K=7?I/;;;K?[NDK)A
MUW#7NKJUK^2K*G#KK:X3X?I?@4-4=%EPCL01Y;0$;46+3 ?0$2DT=>SP.F8V
M"S[+?2/5%%]=@IY&BEHFDS+O?5+ 0B9.C9/)W-@0U!W9N+FV8!O\[K"%1#G>
MQW*.5[A$5(C.8GOQ6!7,E+_4R5CP3FK?6F.R62"A1($'V4)W.AA[/5[B:6)<
MX-,=U1YN?YI:A4[\)1[42(26-BJV"F"\UU2>ULK=:6<UR.K+Y>BC:F=8EOGF
M4G17==_)B_LZZA)H[:PPU8T0U8W?E1?&D^INYQH21!?P(@B.4XQ"6K 'PF>9
MX?<M?%H"_VFX^2Y_%19L+M5C-"USYC#%_@5OA48PKP?=K0D^W?%J.*GS%5J^
M"1DXPR"C*3J;=-Y!RM7K0Y.*=-QS\,G-E\,!>ZX69&.;S#[A,^!R3>9IR6P>
M#>7 ,9J,#/H:N%/C>HI'A:6:@8R,6^4C2Z7*F3 YL]HPAQL:Y";+HHU'I>SY
M?]J9E65E\1,?VYG!DRFK% Y)U7T-G+=C$<O>13A4AR+CPTZ[-B^Q:KG,^+_I
MQ;,EP&JDA?3+/K I!!IM G]DF6,%63437?_#.]6WJL; "SM1';X<)UQGGIN%
MM).&?M: [XI"Y+A<IQ7A51.C#:S7)M8+,C:?A=MOMFK5\O]4;C!?@30$-]5<
M)U[KT ]:T7DJ7 1*OP*;;^'/K /4-5:Q4@(U-=,^WIU>#F5#/YK(F ]'S]*+
M]",L(O,DI&::O%2FC?H"8^&VZ*,/Q]_D8I>6C+T#2X NI<3[HXRKPBUV=(EI
M-OY"57/+;#Q]L(RW$ W21G$>'T5%00B0A='N8:SNDMQF8+K81[O=NZFC%\U)
MM6ECN6)!:L'LX0F7B/S,F5=+1\+=\DNU3+NXL()>O AC\I@$LM/BR^.5,Q4$
MCT^CPCN@*5P;[1Z9D8,MY?NB0M-6-%,[<+I:Z/-=YT W4,>@<'>K!YI\P18J
MY_G2KG7]_J-41VRM^=*]Z+C)UPIC5W[1,8T^\@-!"\]< :U@D4-#5_;CN:5X
M)R,0-@K@HF;^8J8SNM28BH9HAN@+8;!9LIRQH%-,.Z8-.IA:AN:V2?P4KVMK
MN@S5_2QM4I[X:*K:)%C(U6V'IRL=8'E.HN_4$/YF'U940]*[=^-# P\^;%R5
ML?? +^,7@W\V1^52?O5@W@*ON6(+YYM6.U6;ZX $8!YW*84'D:%#M+.0 Z#Q
M'/XY5Y #5GN? 37S'BK>3_09#RE C2="2X?7F L((.VM=;G*(K#(Z(0I$#MD
MOHNOQ0+-Q03@EEL%:%NIYZA.-2AO@YI@\T<64"RD;QH/QS8VBAO$C<7RD.=B
MX'K<^L+,+/H>K6A>O%MX!GVIYBHM' %R_/*HTMXMI66]8"TT2C91N&3C5/-Y
M(MF_-&F>J8RB3+X-#W@(OY[(9LC+7U+=N;IO&R6(5;D\*S.X&PO5V<KM_5LX
MV1%6-9@32J>TEOK*"QHO9#:LR'PCV-11W<>->)C[?MN*DUY7\;#0OPU1"WW[
M<1H&N7_8FQ3\(1]LZB."0+P+;L!M_9#=LF0SGG;R)MY!M6%,PP[ FR6"Q#O[
MXMU8&>O(I._X\J1\RLJ,B6V=^GN)'^BQL$]K[ZW&R@M)E7%R36JH-.EA_,_#
MBL+;N2782:("ZK$XN.XQTSI'U58'+OANI/?\)2TYUTW>Q-X(VD?&*9+/\E>8
M2R2+4(61!P>.MT3<+BOI\TJ[A79J3YPN0^^^V?@HT9TV-X+M6K^EH'*XVQC@
M56+^&6S2$JB5[,%O5U7%-AGZDM2B4\Q<7HS)4^@^"'HD\):I4PG@+0N'JDIS
M?7\4;RD&%-@>^S*V]EGH8[!J(D?L5Z8,U?@"7R!1=9GKA'G //[R5\_4\CEH
MN&RRK02/O? '$A#B[GS\^S^D=Q_^=H:1J4A[CFQ;OT/.;I@,O1L=?N(]ZY/2
MN\SZT('IEX6OBM[%FB85,Y!P;=)I?#9&0R\@1=H3CX@ ETM99_E3D<P60U:T
M)_ZL:UR(!F-D-8T<SUB)''ID%FC,P!Y%#6OTZK20%T1&J#J^G?;O??HH?Z:X
M,=_])'".@WH%8Q1ODQ\JU!!HC^"N\&XVF<K[#!V_E1<I5?J9;XIM8"75F3<'
MX5^ZQCU)5#]>$ *>%4])2D+6-D73D0I]%4'JHN>C";"@C6(C:'V_%X6V/H*]
M3V/!)S74#-8O$+R/@P8D&XRCZ&?0P])1.XT\%YHJL<&^@LWZ KV'SI"=+UD(
M0ZV&;+=#U_U>Y\F:!/8]7,<V_H9.NB]<]&V'B[LPJ[ Z>CG'$=N5]BTG,ZF;
ML@!-*D4[OT8E@70+231L;IA:%3^YNE$_"8W$H,I'1Y<]DXJ"B\,]T+@%Y_D9
MT/,4?"X'%N3\*'8F/-(3Z1K(&#<Q9Z %A*\_%*73 [6FJ]2=:<V3AFRQZRW\
M>41=+K:AA/VN;_7ELA&E<P>6I*X(;2D,O/QJ\GQF*2IKKJN_6E-1EW4\FP/(
M)YIP,A+;0G-!8QY'3X/_AG2L1=R^%C?_LYB'VC#G\*0@B[=+"SFAN;NL @/V
MW&-?=/B*_*(X4=WCD0U1_B$=QY^&EINWX&]L0S>>K/0ZO]Y"BF"^+,=GO48
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MV"*B9J9#/^]0@:8Z*>)$F38*^ X!SN KT8TM]=$%WIESDT7(-"(3+3:G\=>
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M"I/&WM=[+7F_I_770K\=*W+?[75S[V%WB+V#.I+ZL=HAUI=U-:(7HK=@$XZ
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ML>$"%"/O]\ M'NOW\#QT(L.O#=^:?!0++&(K3_OTK*GKIELA0%/"E9YL>8:
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MOXXJ(=6T* <:4%8IQP#]#N&"+"9Z")S-6(7%<I>#T6??AE*I^$JI:@XLQ]9
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MI7)_SAO.%I>O'^VI).PX 3[_(^;Y3AF2M)*,6'](HGPE;!:C'NVX118R@5L
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MOZI<I\C;&%SR9Y4BMJ>^\NO<#EV,D137";J5J\ 'HJ;7AE]-Q3+[:G7?LVS
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M CQ97<JPT>V7,AU%C?CV/F.0+]&C/GZ@:)VGB3K2ZBO3 X0[Q)HP-+(88]3
M)5T=$<U//$&9.7IW''ZY[FJ+LL,"&)=%.P-Y-U)F6^<R[$CBY**A3D%!04%!
M04%!04%!04%!04%!\7\#F1_^$U!+ P04    "  ,@'M:Q/]E'5LM  #^+P
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MU^!9F"MQ#W5G&/?9&HL$AB=;5_!*$%/5N6>$*+P1Q JD& -,-2/."%#$Q86
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M^!"4/Q'0]ZZ/R3A>@Y%69Y5I_BK>.<&]!6AQZH9_-YLJ2A:@E=QA@T_/J1^
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MH?"ZKD^Z_@9F6D-2DV"ORHR9 ?Z/V_\"4$L#!!0    (  R >UJ3!.5>?RX
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M4.-E^?)5]P:D D\RMLRHWW&S3FR,W^\<>C8FG_[$&'2.P#R-PNW)M[7:?[3
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M.@,Q[!V6K6]T=T /9+AII_1WCEYJ+9E+)9>(E,$+SGM>")_9:RB[RQ,JW^_
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M'S[BY>,7$!02?B8E+2,K)Z^@H:FEK:.KIV]J9FYA";&R?NWBZN;NX>GU]EU
M8%!P2&AL7'Q"8M+[Y)3LG-R\_(*/A9_**RJKJFMJZ^J_MG=T=G7W]/:-CHU/
M3$Y-?Y]97EE=6]_8W-K>.3[Y<7IV_O/B\@H?,60D%!1D%/1?0P8AN?^:#SX*
M*AT7&H&D&OHKIP?TW'X8A$]CLLK:[C'PJ!\1F3B/8!(S\BXS'?\:]>]!_]^-
MV?__UZ#_'O/?0[YK!? Q@!+0/#((,7I\$#(^Z&X&P$8&(9X@XP,2P,\KX/D*
M#*?5"8P%1@68G126R+*7R/*1AD&(IX2 ZG]LD!Z$ CQ@- @PR J" )E(,$R
M]8^&!WPOY8^N 8#CW[M^-P\$,Y%Y 0L8=BB@^F=WI(Y<3&Z,/WUX!5<K\@),
M\'A%I)"O9]^XH2:!L1[@C!7SY_"@/& ?.QZR!O:NU&NQ/6/YYO: GP46)/2>
M:PYGJG%1*P[QT C 23@HPC6"1B=69("1+_(P8>S1NJ]G#U\C:R%;<?]<BHB8
MB&J01FG@^5Q9H-9<':E@D3FUCH6^.X<ZZ7^>Y>\&E%%B.&">]7+> &^Q';G1
MQW(#4VYU%TQM=70'=#5S'!/G?32PQI=IUOHL2E8SC;5F3 [LYQ[CS-"9C^4+
M@HZ^^:,#X5YG&S!&7R_7B+[O/3XUMC>-Y8&MK3^IMI MNM9+]E;3LKE(-JV$
M.@'=/]>)A1"T&>MC-*J^XJ'Q?-P<PLA5%DG;3GL+ ;4<U;@L7B'MM/Q<@>%=
M&-0[W()<7UX?@]%OV.=YFB,^15V_N@.F,@5^]5G>@JH0?3)^QG= 0$,^=)A"
MZPYH(800_^K45>^6G0#3G+;? 5\4MAZ/3%XX=&@W,X_DC.^MQM"Z/4)YB_XV
MU-CVOZT(]AM<+^]A]/@+O*[FAU,^K\33"KL*+0KIM(FO/=$C(<B5J?KCV<$@
ML\XC0%P/V9%6X,V'X\MAI#2O[67HHSXMQU;_[:XYF&P+RC#:9(;+5&(8S]/A
MM8R$^K-,+,U?GW_?B#2@L=E#A>'5#X';^:8?^Z' \L!9HSA3D'(@&PWO"Z27
M+F!Z-]6<S7GXZU#@P+(V<F9!?L,XIBLO.<I8>+B*>#9=UG4EPE+O&#W#@3=Q
MLHQ2DOPG=<%"PP1KE_"!Y:% UN3"Q5NU] W=(CWZ0(;*FJ1$EK'TC%NO3<V1
M_&\:PA+5N]'OI_EN'DTSNC[;H4 ^^:2N.J[/8V+D/-0V2<PO$&U(-/WT?6L<
M!+UE4^]C7TZ]I.L#![DI6[X><CMQ*)<.R$\=,VX'1VKYD?TH1B^/G"8A.^<_
M$8#"0@BDEH$Q<0#V/Q:4\$PQL7R,HR3FF2@7#VP>%\TS$UOW+$UA=)GXTG9!
MH-HJ*"9:$E7F'LMM2?,XR&2U@\8D;;FN&N2/)B,OP/;AI*X;G?)6/!ZX/,L/
MM5H))$SJ"Q=BZEM;KETS=FZZA2 9&%F+I*IQTZ'4&@711J4ZB >)-7U$DG.E
M"'% 89Y'>6-*Y\0BBNV/)K0+)O^] QCS.(!GRU<.NQOI.^"50"YZ+O5#OXQ/
MN\0ITF6)&V")^IQ#@=&\7D9#VK4]S\3"U0%[O37^_NJC@TNPJK+8#\.*0HZ@
M8EDLW#P*:##YJ5D(QT2\5U?+L@;Y4&'1D>-6V,C%4$>25*5&%\/923?AY5H_
M4U !]3ORJ&#70CLF>8>7]EVHFJ!TL<)"WGXFTKRR<1_:S>7U=!5QVY8K_)+V
M(5GO/TP1\" $8,-_N:E)0;),;"PC#36=RM@C?0KO=Q9(1':[ ?-S/\ $S?5T
M)\TC&%J)W"/QOIVI0,!VFY!$ B#'Y\?R74HMZT><TUR'G:C3V.TGP)9\YUO!
MG!$&C+-0_,6!O"H6[@?7U:EB %TO8]_./O%CA_"3J\%/W]><IMY>NF;B? )8
MD2B2(/OKKL%]?>^"N[AO7#8G88+>2@H[J_J0C<I$AO,);&)%W\+A %OS&M-%
M7I##"M]-]1N:2(Q(U/%O%!GG7C$&PSK)W$)W )ZD+;..,PAX%*7N-7E&0:E6
M6/("DJ(HQ0?1LL]3'R!X:)$4FT,5Z#1^I8VO1=-6FBHW/.:CE_=L^>( M:X:
MLTNBXF.O.M=BB]I0TT,-J^\19.2!+<SE.$V#D=D"EVHU%M(2FU6&IKV5[R8&
M)#"L'FSA+U:6]J[W:!9V"0+G?'P[CR(PV>+'QFY>9>VXT\_,J@7W*P]')+"?
M#ND'*<@;9;W^G+I2SDO\_A^.T6]5:?$HQ%K::"21O36'2(A& =ALE'5Z?+4_
MWUC1J'V>(F+45A4*_\&R^;,+?8P7)#855A7!\C7%[>,595+;/LJ4>M%GFD1'
MGFBH."MR:6G=M7V&P^O*@C3RWAJA+ADG,/'O^,"00KH9L)* W+6C%1_NCZ<*
M04JH#LG7%^%K>L=5\?#I4US-,\07ES^V0[(E'K';CGA+"'PQMV$X]/;X?F7/
M>B\3'<OC:7EP-)I=A]V.[YM*H*P-&XRQ(M7&LF[HN@LF0,R%Z,!^J0KR;O0=
M=W-/&YSYE!"XR(_T0(D1-+-_IXJ>=D-_!T1!\>^ :64%L+M^20%NDLD4P?FR
MSG7W:'Q:]&B#:(-:8X9VH^<F8ZS'BU8OS V[BA)A6[.=679;K'UJF->DL[9L
M5M"&@T:L=SE/)(\&N4^WYFX71:HP\\>0X#S&ATLIQ:990VQ*1A1)Q%^<['@3
M3QC++FT];/$[U>?64JQ$TJ*^XHI3?X^ZLF&!O[.I_"$,<:_\8P^,+SY?JUQS
M/-GKB'UV_N[Z:8?C!N7-M4J)!#G0.>JZKSTKUY""\^B'AI]#;NB$)@PN=Z#H
M"OBS(N<>G9?6GX>AY4:+LO&_D15B>QNU#2:/_XU^:4"U>J1R5[YC\EQ-FA8%
M3;-MLQC0-6 S(S7P"!I!!=CT#03!1S)/L3E4?7*&58''^PF,:BBOS):[VGZX
M(:R?B-TX?)TV0MG=C)7R"EX)XD-8"NKLI5N<1$J9W5.?+DH6*I51F."\J/X.
M>:.'U9>L!YY?;43#G&@'L2SGXF =WJJH4<$SKQ<NS/-#66(5=0A@3; =I]-B
MR+=$G0<Z@NP,V@\Q16V+*-)MBDN,FV*PYGI7V+65GNX%.<\R(&>JM79:.5A2
M:YK;6[@IY5O5OTEE3('%LGF4<<93^K2"HH9UV)SCAB>:M9SQT"]JY,TM&B/V
MUDT#$M4QQ%MA7+>0S_)Y+E(6R2,[;YA*C<Y#4&H\7WZ0P0!HO ;4'=0/7T<8
M$1,?RR1[YN=<<O5%,)KY] XY;1LHY"WW?<^HF-S,;2Y^A=-3E7C NMG:83\K
M?X/C[-P B>!X@8VQ-#IM\J>OLH ]H(<]VB'WK2ZT9,^;X6EC;?]H4D>=3#F,
M:O %;WNJ$'-N]C)=(5Y]T%GS3/UUCW@@C-5CGM\#3T^5$_7SDI<3F#R%Y ;F
M<GAU'G4'2!*"LL#W8L!HTO_.M^Z?9N(:&!F]V-DW#IWY;JHG61,]Q]W3P:$"
MDCO;W09'&"'Q$ ?81]1XX#38)%[64)YXLHB]!@\^6::Y\;Z(@G]U5BNUE>C4
MSWEIG3^B<F WB"92X_55O3GP****=4;?P95T5X]'NBYF99?O6A K&EW%:_#Y
MZ=&)W(^ZF';\X2OMRK78L@@O9_LU9OF<54K,B8\5"<I%6C%9IA\5[],QNN*^
M(QI"#QU4K>[J\]GI/X]ZAPYG7T^^ _++H5LR]4TJ/,61YWZ_?0VJ=ZI4P[MV
MNF@&U^EUO T,7A#C_;S&>]AR!(+CCSZ= JKH D<_X5*?:3[? 5L6,.'0?Z.;
MOQLT10*E!]WT@;+J17B.7J$  >FJM)2T] M #<8*Q/+%\LN"8@(QQ#HY8!Z;
M(3YTWLO[4@-Y^DKB"9QS?6\]W\$I5QJLQE]"(L*-,-?T$T*5/HW(#WK_V#9H
M<L78LK>9&K,NU?N>S$/&+*-%2K;?O:FF+%JRS.["[\.7PR#99"Q24Q@1O.PT
M"$U0TIN5P@]E@D\/6QXCS0;&TM'.B_:TRI ZHDOT:_M4$=K?VW$]6MB:U+ZH
MJ?,SW3WA7WE3NU%7-#M>$7<LK&]=8K_'%+GLOV_<I$-VRY:=MK+7"]GGC866
MVW$K^^0->IT6,36%3C?B6M_'>HX$0V[-Q+;34*5[AV](88Y+;%5-H,% RR%I
MU,TPM0W&+PER1>:=O-J_5@KW$V'KSG"=$;S"!U,0;VC7A ]^*M^G\/\ \_V(
MI+0P#AKRV-ILK9^Z]6HYR<1AQX.#R=UOO67O@,Q0H.6#*BK;-5J3)I:WJTWE
M)B>G^ILZ-)B0Q]XA15?<MNR+\>;!1'G!RS&WE35JM]/63-Q/7P>*3" S)RM;
M<6ECI8S>CNB$(%N73-2_V9%]/&C@(FH_?YZ(@RX@Q>=IJWPMQ^";3:%!WS(P
MR8W8O;?@JN"8!.Q[%'5"HC>+_&\:A]%)CM[O5Q_3G8ZOY9Z":[C-HWL+5>@D
M/*?A5?T_A1=2*/BE/#T/9!Y1D/,^X<6RT^\E5W5LDK%RGJM2*\CZ9IV.6^G:
MX<1M.CR^Y_:H9F[=H5'B'$+)^'P0;U/ZNZ.:=:>-+YEZ[SIDCA/;+7V.O,2B
M?^<I?EC9SB*&Q%K:=P37UI,X93#J#OW+)2,L%IWKZ!HNU?#D3X/T^N\&^:L1
M4456B%( .U)S'/',S2E^AK1B9=]+F3M-W=ZR\="RD6$(D;>W^S(C,NO)OO:L
MDC$FGM9MUR@F-G8XU=HE=O?>J[R&ITZ<X5\;?XH=[^M]9#ZC[K*(RF?LS\KI
MH<S85G:VTE733W,M24DBEE5)X"(U*GO$01IY!Q@Z74X]X=9/X3-5GOK*+_?)
MGK3Q;;W/^_.5O/$X?-DN&W?3 K!++V--&U/NLUA.0<KSS]G9BXU29SI2<.2)
MPS,[_N4O&P2-ZK;:,R &JF.M%Y@$Y1BVK@F#NK^8;!5ICI+X ;@L\.1;[.IZ
M#^6#2[P^F) 2B4YCD[!MA?5/==YUQ?;;=-.($+)6WR8Q7,],W#F73%R>KI0)
M>(R[S;D5WO=T,L4B*0<9Y'5GSC=@KV%4!U(;=IKV[95DYL;$@YZXUS;W(*\C
MY1E@K,C%PW? &JC %.Z;<P<,2P//5@R2BQIY/AD9])BF4.A1D;H9Y[X%TPC>
M 5\'CX,E3BB2X!<OCW)17ZW> 0]*LF=@$[G7&C+TW':&">BT+F>\H%=O6"XZ
M>DBN[0U-KT/@A*U7#L]C-D:+&6/"1+Z&=_QDQ!Y&_?37YLEL@RG?-*!6IJ2(
M"B2I</>W0"+90G@PB;J>LC"\W9X;1CL(9#0B!E; K0)7<P>B'QZDR\@*\H(Z
M;I@IBGWDQ%P?HG+ S%X\8RK)X<6)[EE7V30<>I:_/OLPW/H9C5>@VJB55R[+
M3W9:ZLS1VG%[O=J@-PI+A1]Y510I#[+RR,RU<2J1?V"[9FX7J#&9!.984@H;
M+CD%SUYJ=0PZCZ1"$9:9KO>W9<;_LDQ4@^LV4^L?MAR:CCG(+&,L?HCY^L=Y
M]"AN\I(KMGVX?'1 09UZ' XG!(VTL2D2B- ];6?2=1;[B*0Q"A.*"EH\8?KN
M^_(.>,8+&AM&<ROX.&1<1NHRFSJ_YD\[>W+KC@\F7>WBJ?JAAX=K#87H=@1P
M4;MMDETO5(*J\JT?O/QZR)_A9*:YQ'CMO'#S $RR]1_2 M3CH(@5,4QV!Z5$
M2KM:3)]"8%W%WO?1]D!;:'>D-<&< 31[YSZ%=\\:ZDB@ &YJT/J+<$_S3V:&
MBZ-/<KAB,6RCQ5\J=$%&Z:V;F<9S)YZ3&ZU*8EOCSW"*FRY^45'Y&L_:]6@O
M1+XF:QB24IU'M%\V_B37V^X]JR:!_($R3Z<I8TJY?H1A35'GBF*3;&]9(G.E
M8]]R]/VZ[?2,5071F#FJ 3$2*0>\[RK59A1W@,<=\! AX/D(,D3&W<IY?/A6
M=XV\+HL8:V)G-EF,13_[+8I]VE%UC.A?53_H-F-[H 9!PAKU[WI-1\]%84]K
MB4QYO  3C,"T^7JE":E?U0LT*C=\S(9O2&E)PTG%=:&*[B6LBF8$#W* >M1$
MCC+N8DG685S&U/MCT,.X??3,<3..5C4J:I2BGYGUA$T!>/K ["\L(!= IRJA
M5QB9F.E/[H 8$7V$LA>"GB*#:1A3GA' 4!'@%X\'G7/$W &T-C17RS1P_X?!
M#7_I>@PO570>WSSKE/3/PD0U%67:V$E<'/:D^V1M6XW'*<!BS;O9&4:EQ['Q
MAB1Q%*ES*S#1Z[^9@BI:1MCI*PJHU5>,.7 \E$%WD)\WO)ZR@[WV*CTAY)-9
M/RE.CT+I*97O9Q&*MIRL43YD>@PF"4'*!TJ8#D;W2@RY7OG)<<0,[J+#F6HH
M[P!DLS=$3A1>Y"WHB%G]RY(+TMV#_,"4\5<;%0Z%<[./V452WW?@LU< ](^?
MQ=[B$MH/+8,I?J:8I]W$R+LC]8_X#K33.N.IM*JB/R$)*TD\%V&U>YP3P"%=
M<_A$\QML]O7ZT>M],%4-U:],U6L)O)8UQ?*K%G@@!+E@ ""EC@<-=K0<.]KC
M"L('7]Z20I"S5F=@Q/_-B_^*69G8:9;M*19UU$_L$N8U/\F/)(D'?N*)YR>*
M62/A3WI!-6$VYO!&!_,YP2J2]%G)Z?@H\SG;MKIGI)[?W%#<K?7&1-&[F!'K
ME!LOY?=CHJ\VD]9"Z7T;;ME0%5/TN?,XM$Q>XEUL&IEW3!)O@'HU^TIIU)7E
MS\3C/ZF&NSP/>,A363419S#"H:][$[V<9-)LX "<KQ:_=CYI4M3/21P6%6$/
M"C>N#[E7TXZ=CK%2;ZVU$9#\**U*[+%+"8\D!"GOYA-[.E&<[0D#QC@E#R5U
M\B&8VG-Y@/I@\(=RRFK[U'D^<W\2P8[!R!N-6-/Y*]-0X+0V3SY;C]YQJ_U1
M>Q8AL-\^"1,ZI,JXR'+]<G4&70>3Z]/<P'C_YJ8:G7? "8N-Q-GF$S@,@KP6
M-QG=D0F"3N'E ;YAN92028FS-HE3_.?2_:& JN3VO[)-=%L0Y$%QA.SJ;@F^
M _98F&C%<#T8:OU6$IXQA-^'6"^7;5PM1/!'N/0'+YJS_'28HNY>*'4JJS3J
M7Z_MZ2U*X0TKW3J8(2,:*=5^%^:5>M_:T<A?'3P?*6:EF^0<6%RY/25Z!WSC
MAVN.CMMMV?C0W &QGI9W@)$9(II$N'VP]/@^XS0)$UTTA(]&J=57!9C?'W!L
M?N5]BK%E2/4Q37,5,3TCP%T87&O$/&V4)5]]\F[M2Z;XD@E,4-%&;GD\/F\C
M9??\)J+>]'#C1;K#\^MA=*.5-'LE//D'!NT;\T./))'P)Z:/X;P@G)J0X@=*
M5FE?.!A#31VXB^LLY8%>5$U'B>YBX-G1_EL/^C88@\B0Q"$Y,#MQL*@\<NA@
MJCKD@-4'VI(CR\0CI*%V]?F1,W,'+-J!"756^3_6K^Z8*E0O#&/P.P@"7$*W
M$*2CB^//#Z+V; Q7K_?!U)M6;"J6*/V %8,VK5O/ *#T'S.\" 3$%7NX/Y_*
MU*W"@O)8LK;NFU_A:Y'5BJ&,K,'I1IB/\JMW".\ RZ%^@IBT@N$K\KUWEU/O
MJ[G/T$B2AJ69%662 5#EVJU-=E(#1?+ ?!I_ J1K0NN-^DW-6&F)5Y1!BK25
MZ:>Q)3L^\SB+8\XEUU<[$M02CS;C-MS8V?!&S[!"7(,)(/V281&%/:).L5!R
MQJ*0\=UNA0Z3852QIU^QKC6PEZO7[F_-ZF$<8*R1 YO[E0/,)V;!%_X[M_<$
M_0Z1&?9%_8%+V(%0)FXAH D" RY(,"$[[XZH5R4&5HY!6B?Z.SMF49Z13*M^
M;WO%KA'A_0G%[HSC$=_HXU'%\UE^3KDR'C32'3E2FDA6Y(]_L(U_][!Z__*P
MZ96!3  6O-:7%7DGPE2U9;01BV@CQ>^ H?I91.Z2[=J5TU3ZP^ <[R\7_C2H
M.&IV2(MF<22)SI\C$1$F2 QO%4S%\=;5VS-/6CP+(W"YHIXSUV[3;^B%R"DO
MJ.!?+IH<.+D# F8B MZ]H5/\/$UK,9Y+JTBK+KL"01Z6J#EUN,+2@RZ>W0'D
M@/^NYO 38P@''QM)1'UA&K0K3CY"A+(Z)WN+FX&"ZLTHL\37'UG(QX,V+,\G
MB=CKN7..SBHB*CSBE+#2Q][>2LN66T36[UE+9F]%MP<<$X76'H3#H%N:MS&X
MQ5>$K@989J,E,V(.*JFV]D]#QA]T3Z846+"(/;:ZH5E=7L_'A7K_2E2XF+B;
M'8.IO3]"9FQ3?KR4*:]<.>7IJ7=ZU>XO\Z-+LF=^N]MV&/U-/R%V-+?3 .!X
MGF$?Z<#85OSQVE/BD0SM[,:FF(!=)ZWPOJQ2U22[-@5,(:<HN,=1;7SMOJ]D
M/G(1;X.OD,5]M'G1?#V]2,6R':@"T'GA>P?0&T5-W &G/&!R<1;$+NGH('9)
M'GKZ $Q#[Y*+I,JI<M8"R\0KYUV\1)V!3A'"G[X/T_S;[%%M+BT"NS9T"7E[
M'W _)/L&:KW90@I(@!?4,S94R!,\-_%VNY2=,(BYL(#Q=0(,!#F\):BZKFP&
M@0EV&WKA2E4W+:E6IX);5I632U74]M6%%I%@H%<P]]28NUVC8GS%\W$)@8O,
M="<N6#Q^QFDDB\5Y@Y4LM1ARGC*9QI0PY[WBU'904$:D&A=6_T!'5*-#G++E
M*&&/VB?;VU-F/$%G^ @OZ\O3!,B <XX <=K  (]ZHN 1(9*@$%GWY4I%K!(Y
M0UU%?:0-M:%GJ#L26U)"06%>R;.">:F9B4JH4X@)41<NEP[;=*)K3I[Q.W9
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M\#":\W8-\],@HT960584,-S[-9B\5)*JDJN=?!G_Z<?=ULQ[$.3W?X AZ7\
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M>S5N&0/&97D+IE;,NWB[0A.\,?Y2+DF9^+Q&!8WI.34>(2BG8J7[YG14XA'
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M*L^VF5&W\Y4#V4A5K#J?87'<?4=6)'^/@^\^>AQYMV%%ES@6I5&GS(-+:W<
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MYV5_NPU4O7,-6W0A"[%8*]D?O IJ=IQ.GNU$)QC[Q^Y(#G@=YK(49T-+P<(
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M?[2+>L&X&AOB9IHS60OB\.K6RCSFXOTV&/L#:8PA'$S7Y!6IDK=?<:&F&'^
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M[7?*T#$>0)9-#CPM.8G]$LG+9D)G;'C4'"M4TY.T>^=_0Q\)J)G+P_(YXY*
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M;Y@%:7CN*93(=ZP%79]^UVA4-=.K)](T_(W9E<VJXAW:^6#J0@<K"%^$1;[
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M(:'TD/C"QU!8:ZL85?FK95%;[.'_P]A[1C6U=>&_>! 1:=([41&0WJN!'$5
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MB[ 23CVLH/X:;MHL&)52,+41@26CM:C?=I.P3"\/VCHUT'C3@]E^)?Q7O',
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M'B'88N7;357,7LU5-&#7AN/Z]Z(98IC=0N*<H@V(?](Z.(=7ZLC9R#9[#X6
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M9V]-Z-+IEY+HD[QE1#KKH9NL^K<$3B(:[B%F!\#N-, 6>@JQA&.D.DOL6]*
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MJC\$_5$Z*RA^&W4D2*:67Z,U6>2,O:"-&6\-N,G1&'OG3,8%[)*=L;-:NN)
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MU>(Z72>($XG8*6$9@H*<ZSGZ'C_.<A-H2N)^M?S\3? SS"N)1S/N$D2O(NH
M%*\&)8KEK:))%X@]N^G$))(9O E3J3A8+GW8*N#)0.XP58@L1-A-]6&+KQ08
MB^5)= PQ'_ V2K]\Z;7V<#F?CBJW0\)ZZ!.INC Y@]C,X)*0)PIF58;[M8KS
M,QHZ-<9S&IA'*:D:&A*J%IH6TI%Y7%B"+E\R]BH^Z'Z'1UXH]4=Q@?[N.Y33
MJX4&P^9-,#CI4V15YF7K!>W^/61!@ GE/<2-!A#%D&36F)F>U:ND"_ ?^PNK
MKB1I>,N/GTLTH%R@30!82AQ&L(/]".SSAO8>6&GF99E:3^?K14672K+,QBS'
MQRQ4.$+DHKQ,N(NT<Y<\O*E\Q"F2(Z)! O-$8"1K]R&EF 8XI_ON_J"\1;BE
M.QG\#L=%IQTLY>DWM(EM>"?<1%C_6O&V -O*]3BW8?+5HDF7E/O*@?WMK,]\
M*SD2V8?./1HN6T;<)/8W(WD1TV%(O.'&* W8?4N K&X0G&9HP*H(";[RW"D&
MW<-+/H/?(PO72Q,-"<J3>WJ#4JMR41S?*U[(<B^$@O5/7;?(S<H:<>6^A,J=
M7++(KMQWH&;\CD;98(YQI4^_B,J8%@SQ4EO+QE%JMP '_!"\DQ]$^:@L0+R!
M#<805E1#&B!L<+D /8(.^L.*TG!H.0AH\"O0RB-#\- 0L@PE@?^3#T_HSDW+
M9H5HTX>)HXU+O<8.FFF"JM.%ML,;EW73AW9Y^^+2ZU"54=[]KY[?%L)E^MM"
M.79<8&FJ%C];TO6_0]?]RI0[EY%600J&46P!$@T##0IHX];U\KB%W?%\ZLJ(
M9ID)IX/PO9NW&8X*9&87F?XDN<U/(EV^M/5W!< 33&I5U@VK=5VSUY;I_/((
MH^B'%__2M =Z!=D\0V"@^/U$+))2\/M_E[%]#?6+TQ;3 J'(RRS0*:@&N8=:
M]X,&#-0J;JNRZD.?POG_), /OQ?!E'JW3H5:8X%8G$/%N:Y(_ST1OY!! ^K;
MJ+6&-*"O4* 4+TT.H_..GX$(BDPP7;):^]5_.(3F;R*WH$ME9B)R$9 SMG2;
MZ89\/<58BR"H4,](CQDV4B4)E>3S<+8AL"X-.($,OCRLS<%_G@#:U2X9WE6+
M86X'3]S9:T=K1W+KW6)(I#.A.&7V $_BZP_PKY-7B#QX$1RRC81Z#46[#3?W
ML!'ML?)O=I!LR_A'%GP90?GJNZA5ZQN&2D86Q8DL9N;0B3'TQZHG*F\<4$O6
MUOTW^.*>-HRV>-YD/O%M5[9 L%5#W5ODE7YX+#VCZYE!JV9<D]R)SN7)H?:*
M*@IZ/1UM4I\(#C#1U67Y++0R\/I[XEGMUBOPSN4GS,R,&@5>"E)/7$M6$4J?
MZ'W<!^$<)AQ[F\[8%.B8(Z+6NV)6M54B8Q&+[TR7Z:.(A'-GHHXA#M<+D%V(
M2Z3S6GA4\V@1[-4HZ VT/.E%K3P.$<I_-+C--*-)!A56>]G=(\]RI7=,M7"L
MC3G==F&TZT@7SY<)J%/@AQFJ_^\-"U :$)X_DMSNY.AXTSS,#IX].V0LWA=O
MD!,2Q24"APT6B;C*SCAKY/B7^/9-:..)8&W%=ES95IN!1V5947#3'4;3",/:
M\]FC<\YBUY$R3]8N!8B0K%8JI\I0JTF$%1QF-8PDLS@I2NQUP#Y\_17"7'\Z
M0+3?T)  C=J1""U'@%RX6U]/N[%,Z0U[(QGKMNO/8X+O2<DXY6D] F?7.$'G
M>*@GT80-^L3G7$+<VPTF_@Y>Y4-OFG#J *+2M_6RE]4@7)C:SR^$S_B8=-WB
M2<ZSUK$F 6;9+E/L4!;D37EBF9;WH%-%NK148UOV*#HI9%72NYFZ9)Q\XJ&C
M"1^7AH'RFP<#R$=?Z+[X%F)JF ;@BC05<C03- T^%)),JN:7C=Z,VR445-W.
MQ?I\[W]>8[.KKBPOEB%Q+KC9H%67:>>>AEX6(ZNX09!&>]50I'A+B['''FL)
M3(U<X9E  ^@6[P%BK <7LH;,#]#Z1 PCG:#V0<N*;0Y]PJ\-)002-CO\;[CS
MMY?JYC?Y.&%1Y3!HDYMP:W#B5=W\59+%"=2:7U3ERWU573^A./Z'T<2ENN2R
MC"_M"KFF-S74##W?L"G46# :Q)IH0)YKMT],+&_7)8;DA>29)' :EMB8I;S%
MR#DWLL[=:$?###69$N3XV"MJ!NENH_CI5_\;DQ>=.YGQ'\??1W7^2%@_M'JO
M&V3?X^+&>HC<]ML8.JW1/X]F4DHQSG42NRE$>9(Q?$*@3+T-R0-IAKQ <"F?
M6MS['4?(&&\SZ9IN, ?G<U5F"TO4YM#J?[S#]D/*36I=UM^_JCQ0P+)OPSUQ
MD]K=+1T,9Z1DTZE,*0)O@!BIV1TD9I+DR)J4>(P=ZJ==?S-W4D,,*,"S#]H$
M8:^_3E8?=@J?=:F<!%7?6]^N.R9=[!UUMTM(P/Y3?_FWM<=RUA9;1C66TDL3
MU@-GBCM >B>!F5QUE>B1S/3QN9%W,T"9T,N?I[:/?%RR1EJAY[A9L39&$R(6
M4AJ>7_(5U9(:N&.#9L1<T&ZJ\CYT=\2^8D8S5_ZLZ9%3FBU-)Q4:.D?5"DMT
MT@A2.TYWTMWAK*.&5F61A1U7RX@\)"WXT%0EAGQN8W>'L->,"*4!C/40^/ 4
M7@<4I<STPQ2[FXP_TG#=1HZ0M-I+ &E5],\,K\E!F)?83?;KLW)=38>J<_HF
M7)4BN;V'N.?3V3*R^';?>KAYX93/XJ?6^.CL+H2"P3CJCOKCH*M3!.BN!>4U
MPC9=W8RPT"3-3 [L'6N$LM4K!S@/7$(G:0])U3)Y8Q[WU5[-'E_BOMR3[AGC
MQ!_GYNMN6^CB:T'YV@_)/>9[?]71*I(O.S)&)3IK1>5&5>?GJZV'[#2.?.1:
M9+#MRU5XURH?Q>A1LIHNX,8AO*ZPJ>@IH6K\M-;A1OGZ[$SW>$2&L7B<1T$4
MRO H08)C1S%?<\=8U4)VPO=YS&GN7F-!%2W/5M[UE-DSL<V?6;18-&YJB @A
M/?VR/X3/W7SZ(5P4^%<GU-/?<?8N@,X@AM-#J#%5*-!_RE$1IP%O@WG(="O:
M[Z6,",?,(K_3@)4)$$6K"7E77Y5MCP$[^]<XT,%_>3MVZURO*NNA!0@;8E9K
M +*"SJ-&6_RZ7E]&++Z%MWFO ?@-I<7%_'J,WG3<IF[2@"D5LNNLS%!]#1]B
MCLX!I#+W-P[G4:),=7_%H&A [M.I^1!][4GD))2TB(CBZ2?1_>! $ '%OE)-
MQ6"')P-SD$X41!.JUH=U8HDR1[?X(<3>.D@M9H].(;BE:E K5+Y K-,(#8#B
M5S;X5.6?(_P0&YE467?=#6G*-J0UHG1EGP:$0&'FNXAALA*I[4]J^_!OE;$'
M(G=H ',]8<#0-V\OB;HO,*/V[R >5:]C4$2?O: #>0[D.9#GOR7/5N7?F_0U
ML%&'K"[@$._4E*0PZT4#SK$O6>G\CPDDBV6XXCD-Z"R6IW[X <T(02:*[,CE
MD9O_8O81*7\B5M7Z7T5?R/P_O"T/Y#F0YT"> WD.Y/E_01[3+P%G:< ?(:&0
ME>XF&J ^/AR\\6^_K6N;CA ; -]^!=KG"[D#(E=6;=.YMBM)Y70A,8].?'-I
M@.#"E]^OPSK_Q^LP;59]J.>?O@[CK#^?H>4FY?=AI,X"[/=6_=KF-&]V^#?8
MTA\> Z9I-. )]+DYW6,\AJ0!G*A;! CY92EB,H(&J#%N/M^Z&AM;&!L?.VMQ
MJ6]B%ZZUKIPJDJ,)T]#T7NJVF?Q0F\EU0]3 V3KOP_-4@;&DR40$\1#=O6X5
MI8[7;W^F 5^9(-2K9MNF(N7(WRN/AQ$+L_4S@_MUH%\$=;H/1H?]=A/J44:I
M"ERB/_:"'4&VBUGKW-""D 'ZTS-L,:K\?8@>"/DD#4#&DEXO;T,66@3('""J
M>GM@:]ONW%X.D@K0A2>$0RJEZR1I /XPO9I(DYNL_AHT $S_+D*E"PTJHC<2
MDA6!MX+\$A#>X_DO1-5?$R%OT;\A?_V2_J*,4J$&Z-. AJ<T8#8@:?PQXF_;
M*HOD2>JC5P?0ZR6VV/>J_PW(Z0.,!Q@/,!Y@/,#X#V#TJ8XN\CU=&KVT:^=4
MYON'7'J1%/:J?ID%BZ"51QE@.!"YZ8GY6SF,4BK)?HO075 <W6ZF-!45& 1L
M3"6&(T<16^L@3.#]1WKOEU;4XM":G18>3SK*5TL'MS]5NDK]E\C8_K9%HNK_
M?ZB% XP'& \P'F \P'B \0#C <8#C/\UQNH>QJEQFT[8I3,O>3W8-DNF7\PE
M-XS;13%Y3[/<6N!S[5ZIQ)ONDVC _AP#-438/21MPL6Y0]MZ<7:4"*4W1#1O
M1Q3G=%&';$&KQIWN*^&N>W]8R,99."\^/\VJ;U.U>?<_KYSV$)'46\.0#54:
MD'7,[^;SMC ZI-->U&WH_A73N.&$*.HU&G 4H2A@'$L#JCJIC>*(I>H+JJRF
M%U;^\?WNILU(= B9E6$73HF$7Z!^QYQ2EH5$#3?3 '1>LQB<ZW?4Z#>Z37HK
MHQX$65,+N53DN8G.PJ6U#TM3CX;+MRWSWV,\^4TV#S<WEZ>EQ]:LUJ(1+Z_%
M/ZC*$^;,C7,;L4:SH5*=I:\'5JH&J),LZ'JYA7&:^HG".:TVX9$SEL2) '.2
M=8!:'=$2'PK3^EV/+4$UB 8$>X_TA$L[#'K/]WI/H8F5ZO?6<:_UGIE^\3I<
M?+1RK#N'[VW]IHQ8FZ#X/3!%];1LG*NZO_+N,T2H6*..?F2<1^4U[>M5L;&8
M0F?4I>OAHMEZ^E!.^#BB<FIUA-YH!*+U^P 32C99/]]9R2D2[)0%8VC@9\.W
MI"=6SDSQP.+,OYA%88+(<EX%2[KY(XL_K@Z ;^>GYC_>3F4#@7/]2J93Q^NO
MD]WQ'*LDO#H.M':2(+Y@](GHCF]KX! X4VOID^TLKS14YHZML?1W39[[U%N\
M9^W"4<0V8/:Y\I*Z6T?V6GO ISUO^%:Y]\32AXUJTC<?YSRA!=;I^-S2NH%=
MS]7TZHP:583B#)7Y/0UX=?<,B"R"Y%=3>XIPFN)]Z,\KQD5V7=?]*4]E$B"!
M$ WWJ!>)8UBGU4H<,E1I+U)9 "9//8<Y-PK#8+LKIVLL(2 :X.8\>IRXOJ,F
M<7EO-[' F;-,/(Z3O.11P775,\=$K,HP5NM9OP:7"EMP6OP%F_B<RZSV"E7R
M=;$Z&U2!SQ!#T0_AWQ?_F>U^\G+NQ*T?F%4!$6J,7(CEWSMQ9(WGOS<2Z%W-
M)$-(898T0->(_M3[G__Z(R-5H%!E"%ZW,>8PL0;GVXQD?31YDHB8OGQ$GP")
M!%OB)'YZKW'<^E%>Y"R%<M_8$'D8+7LO2X+U07*ITZ.U:8U+;\]&[1[O,W43
MJG2_6^\$50U D3BH/S$,"'?=D8U&9/G45WW<%-&$7W80K)OS2'K&C5'Z-/&5
M<ZU(J?4B=U3S_EV+X-S+:TZUGV,M&?P_2PZA>&.;W 5EM;9,U^@3S;&7E!#(
M-'+R&IX&-/9$92@2G,*HUV$?&ODLU8D\>,L&I;P64'A4MK5DB4.ABP5[_.Z0
M$E]%UFR'][>=.E/=FH&L:*T(">>U#XD/<TXJ*N17"HVZC!:YPX=6 JN3J\NS
MM(U]SA>4IZ3&SKE 3R-M7(N$BQ;A&;W0=U,?I\AL6[OGZ;WK%:RR&7JJ_@1L
MI@7.3>S%:G'M6'M-^[;&''.!GE(6OYUM<2)JLLC^_?(GJQ'7Q HM6??\2R&%
MR_+/'TM6<@>AT;5O.ZCI)$]Z-\0\C"&*N >1+^- HTZX8[LQQ3#JOIL\MJ?)
M_3C,WX" :1$(-4W\U' :1S1MJ+XF-]&2DU9I@I]P27DS"D]@:\9;\/3[RNHI
MMBL[,)M[W<QR\@WTMGEEO%C]I+!(N]^R2\.SQ,UQX^%&3F5]*M*'C@):QD!F
MV]L5H6# [CC=-U,,8.,9Y'&R&SXW]7IE40 S<6[ZLB$6VL+QPXV<Y56RI,1>
M='DPH\K6\;.*\/ZC_9RU]?2C9>-3HY:6WV(KE]9$.#B<+R$=B\GUU* [V>+J
M*6E9"FNP\L&AI3''ZKQ">@]]^\^<P/F'DC7F%69XB@8,BT*V%25"2Z<:H"L;
M-& E7F"?-Z&>A[A-@5)CNT_U4-K.+NG2 )VOV]RB'^KB9O[DYG7D?WR?OQ-S
MC@9\XUZ@+&*V'Z!$4!(\9 ?J":JG<A%]4O=*HKPQHH] [SOAHJ4J0__PT*::
MT8TI%OD+W$.\ *5DT(T3-1MRJF@_#3470V7FH@%QW^E=BHT&C,Q":<"R"KX#
MG46^MT^7_-[;]F@:\ Q)7$0L[:L@IG$QOY3=B><W*!EY89B=*T0.Z*!P&SF
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MC3=Y5Z:3G]KW-?E4=X@E9N284W^7Y5ML%%<$UTS;2J;GT"JLP.3 AQ@U-)G
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M)K3I#++F%66/-GO8;JN.9$<=;C/N'8'E0!@R$(A&L-8WDE^0F$3N+X*^43.
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M0*>@_B)Y6>8.)1W_AL@5_0!;]DX O=L+DW]%-ON?.AK.\Y\T*&!-69,4XM#
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M#3=<UV78WSWT&U$VH<0IQRW#HE CV"EE+]6EQN8 [9$7T\,.YSO)+1-"L"3
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M<K).UOXB.KI+->[R2^YU/,5&"/$F ^JX%#I7"!D*'_/Y>&=,_%Y&X#FL*1!
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M!M'&IU-C^OS]O 3&C(E=TRPI%#6!7-4$[-U\SN40&'BZV[D0?C>:.P5'5CW
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M3$6ESU2ORWX]G+TG@F2I:#TET4J1QPZE%9<5%^V1SWYY_K]QZ5'4][<H5N/
M3?X/R6GV#'[E%XP<1DF*Y<;YB>.O5RS+A=Q+84> FW=_P(5H^;*+0Z!H#_ZA
M%^<:N$N34.LZW8Q#<'8FN%UQ<F%[BS?2,5-QG'T27$C"!]#U1+B0X2]P+F3N
M(O4]+H=U>0/D_/++CA=<R'T48P:8W;@(3)#CUO5\&3\OLC/14?C5$PPQ^*!L
M.RL,_$^G/"ZD9P2?A&><37>G?P7I[7LXP!G)/ 9%Q>CQ$%:M_/;F!W]L_M"7
M223ZALBQM/02N)"^87'?M1@[]CM0*.'H)%O&.)_4)/JX<L%SI0JT<D=KA=?V
M<?AKOL<CG\>"+_AK'O!M5U\'408/'V,'^->2T3AI'JF5PA*:I@\SG)B*C-.7
MJ,EH=)@!=3J.<[!]TH0HBJB9=$R=-R/<5OE"Q3SCM+N[9V$E[SGD5J:A8[]Z
M3(V7;4:[G2N,3?#!S] D 5&54.I5U$CM9HLC.W)L4(L,M)[A7L+8T7B2H3C:
M6,.?F1;J2^97LG@$$T $P#N+Y@1<@GV..'[&55>E2S1]>)E;G2=S!U'%*F*-
M8I0":PE9/45=@P%C>XH4<!2XW)$W]2MI29F=8_5KESD7\!,X.-4,/I+3"*UH
M?X#W13'DJRCF@;0U.I8F0%&G^I(P$4CI,&TC-?/AZ0FY!X$4*]"%X_8AY(R2
MQ<T*"^#7/8>,_ K/N^6W];0*.9L6.[>H1-)!H,D#89#*D%T@\>Z1A$G"DV]'
M*VBPIL5AH(5SF#JX<L4V7+OE%,-XU*!7W>0^)*FF;U77EF"!O2U]?:3E\I&?
M.9> Q@%@Z04Q D4/P6_#K[EB!@48"NBFTGN3D2RA'?06AA6I.*B.QAL#W"2*
MGL^U;Y5(#JT=$VNZCY1[,31RZ$.*!E^VFFUOF;/1N-HYI\2#Z6\GSW?[>EIX
MQ!NINF<[*B/M/B\/PERM)"2O?R;:Y<D=&TU(N/<UP6></NHD:.01%X>?&(<-
M$][A?P(F$H"*AEJ!2#6?BZU<"+;[Z2HJE@N1"#,IG+VOL8%I<8*3SY06CHVV
MDVN+BX-O#I5@N1!^$]??1S\1U88>?92(BN@,12RS@D [>U=4LE. B3(8U1X.
MXHZ'I?T7&4*YC.)&%!;3A-H^G&PJ]"Y(YN093_)!V 6LNY*[6U ^H[A9,N ^
MM>"I%&S?M4M%:7>!\[ )(C%:!LJH!4E&L*-56*?#=^7 'G"D-)I4!4<<:^J'
MGI-1D5H?LTA=AL8#E('U2KNGVM[>,UG5U\:]^4:U6W;Q_98+/,!/))7AI4#7
MK,5O/GP_$M1T3[^8=9*:".R#N2N?;@T)*P[*FF]0['7OO[U:[*-D\21S:!V;
M0YT:7UQ8PB>(YK@H;3OX6?;I**+L3E<MI8OBVNF;1)G*;]4_;ZATMTH]WC3P
M<7/'@.EZK;;N5-GT*I^^L-W)N7_FT1FIU.^N*9=V.7)T5E29O!T@X.UR&1S@
M'*W?O(-;(-[#@;);2KD0=!'XLZNW_]5G./4TEL:D(:WB)_C?QZ./'*G^XTO0
MC#=ME 1;P#'%@,:?U5&C4O09QB1MPV (YB7P_#6CF2S6CH\3=;#TXNR);+&K
MB6V+HR8T.50^=@TON8ZX8;+^R3/5R[&CX+I^ON?0G?AF]+M"YE[_'?O+IBR(
M-[V<#3_%,(^<[_R#>;_M,<_GHD>GX>G0-VN4*.9F3Q"[.F5:<U.F)%4:?D M
M;GAZ4ABUK^$82YF=A91 (+TI1]KUH&*OA^>[)\SW5SWS&1J2BAA<86M?2SV@
M6[K:D'?#M/Y]-[\G[]$\FK^V8GIE/28?XV/GI/?EWM!5?W3P>=OK'Z/3>M]W
M.+_O&M85]*QM2(&)@DY04_:0>0.<_0[^3AQ#'E@((H$IWVYDXP;HE1H3[<]8
MOP384N]',<^'^5N1YJ/J[',1#C>Q]:?L.UWOE3@1G68K^T2\PR\P&HOGK4;W
M$3B[=^?-$G'N+##L<_A.,F^S+N,J:.8Q2)XPSS[83<PCC=16K&0DZV<9/NK'
MG$G^[4N^/_']]D5+>B,YC<KY\+G[IDN\.>-R8/(Z_&JMZI<&688W=9(NPX4\
M?L6%N!(CH>4-*:[4[F8H3JP1+P1'#L.VZ4EF]3=(SFQ<D81'8P+BQ,<94E<"
M>L)4[X5MR,05CSX[KNR#[2S@_YCF<VMC<'2,Z<O:O[: Y\%/Y!&I3IAANU;!
M_)1)MA6]$ 2*'J@]'AHF]- N1U)[K#I,>OZ$UT:8ROFZRLK^L/ )PBO*I>RC
M#8(FN+N&EU+>:AIZ7HU4B7MUWNQDRIDR+F0/X1;.2&FT,X_E8/T5]_34G1Q3
M1<M"1<MT:<$UF\2\;V,XV5M3.:= ST2G.K]D@CMOHS\X^!6.JVI6UNIO2IVF
M:)!5I<'XBK5.52XYHT23:EH+DI'I4_-<'0T-B"9:#I:6Z%B%O?%**59?0'T:
MEX&K<2%NCN)X*Y8%<QOR(XP/[PN/!M-P.W@L42C0U+7%68PA)?98;4R5;)/Y
M1 Z,U(2FS ,5_79VM.E'OJF:@:9'K,(US 8;QOP43S7*18>9A'I9SE_E@9V
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M1H9FO8.%5D/TNH=#SQ;(A2I#S[ ^=XY_;:@CU*^^73=A[@(:CR+YD"TP(1V
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MJA"HJ=9IJ9:QO??!+6;0L\!7 6S!/PYK*[=NZ#45#++(K*N,.&H__0V8O[[
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M%ON7\A>/_(U6-;,?P+C#_PM02P,$%     @ #(![6OTDS/ZU 0D 3L,) !(
M  !I;6<R-#<R,3$U,CA?-2YJ<&?LNG=44]L;-AA%14!$$.E%I7>E-\D5I0M(
M[R B-=($)$(@%Y#>KE0%@:L0>HA  DB+]$LOH4A/@HCT!"4<(83)G9GU??_,
MK"G??&N^6?,[:SUGK:QSSLY^]G[W^S[/.?OLZQD>=,U8WT@?=.[\N7.RYV1!
MH+-%T /0N?_&X]]&_EO;.'?V!<1^^6+9936&<[=!Y]G/,;"?.^L%"8- YR[^
M+S> _M?CW'F&"Q<O,5YF8F:AWX"Y!CI_CH'A_ 6&BQ<O7*!?C:)?!UU@O\AQ
MZ^[]2]<MW!EO!W,JQKSY<%E$M[[KAN4D253IZ8M8)F8N;AY>/C%Q"4DI:645
M535U#<T'#_7T#0R-C*VL;6SM[!T</9YY>GG[^/J%A(:]#(>^BHA['9^0F)2<
MDI6=DYN7__9=P<?2,D1Y1655=4,C&M/4W/*YM;NGMZ]_X)_!H2G<],SLW-?Y
M!0)Q[=OZ]XT?FUOD@Y^_#BE'P._C?WF= S'\%^K_F[S8Z;S.7[C <('Q7U[G
MSH?_>P/[A8NW[E[BN&_!Z!Y\_;9BS&5.W3<?ZKN81)0L23>>OIADYA)5)HB1
M_Z7V/S/[/T<L]O\6L_]"[+_R6@!=83A'GSP&=A 81*-)?DP!_0?_P7_P'_P'
M_U?0OD%$]8TGP!FH-VI@>@!FS87ABP[+I,A/%=;(7KO)><>:7*^,V9FKVT6Z
MM*!,BK]F-W_A=E;MS>:_JOKT%=^77M:W>E^0YLZY+F74)MDOI;H8(9KMOP/1
MC8?9^-D_5^%K2=.+^ NA&\\<4N.(<<RRB->TKJHR0Q@-5O9?2\TI-!*?_S%M
M=S!Z8G8&ZOHG6G@28VK24]+0W.U.3'7RBH1&WX(]*MA^U/@YS('!9=.5'2?J
MU-_L\##Z@=\Q\GW#0,=Z?7S3@%N>D,@9*)8"[WIXV&%FLFV>)'25M'-1N^77
M*,L7(>&,;C$.PZTO?G?\[ +E!?2G3,*EGJ6?^QUW_1"0OSA>_\DJM-*=,RLX
M0[HF7;_ U+5(TN:]4)OUX_Q\*\I2Z8^?1!WOA 29ZZ^'&PRM8]]+;O#,F7"M
MB190WCJ+"7@Z:]<>5B1;^_6/&A=$"*_JW: *0AEI5QE/L3"1RBYPL@HJL>0:
M^L/+9NX"[Z3VZQ[>RJ3+%!5$4^G?IF7.CC*?'"Z\-K-I)EP.  >?@3Q0@#HC
M)1#8AKOC5S,C'M#&754[\_@A<GX'OP]+$@IR>U>E^\3;W>,>DW8R-0R?:O85
M;G[[A\_%]MKEZA%UQN0[G @7]UOIB OK&D_$M\>D I89F<.^Y>WB$,IYR#(H
M50]?(4C:92(B8GJ\ #^+%S568KTFW);O;7<)TI8]:UY9LY:EB34\_0<Y66:K
MV&D;$Y830<LAG"5.P5]%4).VPC_,?\*2%+"#\I<7<?#?0\HC5PSE_3>2\PR]
M$PQ2[.==>'-B_>?ZE7&^-2JEYJ$G2@=>!?[*.+/1>WR0T#G]V!3)O^_K<3X^
M]Q_\_Q*,?\%> 6ND(TH08+)FGK;*J9+T*Y 1*F*4;XG-H1Z%'TE<VUQ0S0]0
M/(IHJH>1?(_#:I^\D_?67;_M(&K^<_RT QZXF@9N#NQSVN<&YBQ:)]L9$<Y+
M3C MP-<C\B[I#!2O'+53;R)ZL]8Q,RGPZ<)Q)T;9Z]4WK^:F UF/E',G[&<@
M1A[:['$"ELS_Y0S4()R *E"X"O";UP-Q9(:=_/B/,S";NB[M:.$IU--8#UXA
MH<DXM]3(MR/URY#@,55E"SZJR&G)&>CI^$(CI3)E;Q_/]F6?C_IP2E:>%7&4
MM/-W_92VG'\0 C8<3E9(0H46\3E5VN2NHS$=+:T/18XNSC^F?>[Z+,]]+B8A
M+#.7V2:8_3O"[KJZ545"S^#"5:7*:1'+5N<QV.")ACZ[WT_LD7",\XTWI' 6
M"S)#LO23H,_EP48S7X@_I:<E'P\IIB![KF[.])IQ5A(;U2L<$0&>5EL8R<?E
MFU5/;=SRW[6Q!91L' P\"ON5]/Y\E,R.VP(WC>GTY%GT,)\)D+V6_\6-!VK2
M;?3"WZW_I?<C,OAU:?Z+ 7Y72#$?=D;N5^6>:)B)UVR^*21!/9T5YF/?C*L\
M QW.;<W[]1"K^ILX.JZ8BN_N!AWZSE:$0?K,"G,"4/LRR\^G6L%!#A2W O=9
M!=D!@M(5T:6/]?:RI@(N3,9R+OH8INGR=?Z:?NI@A^4DPUV/1_+6Z64)C!H"
M[*LWCW$.]5^H9R =\+AY3^8CDGD76SKXNO+H R<@A)1*],X,]1=S-36W(R7&
M:NL1614'108*YK@7 DJ"GW^4&_Y^3H93E@$$V?2UK-"71OCB$"Q](=;OW?F;
MD*^,R@HCY,("33IH$,61S<=Q58X8S<>F8M*-Z>H_30PKI ;U=S=O1#;MH,+A
MBVR R"KU1G.?6R,X75OK1 <&)0M^[SC1@C9:-4V%1GD[=A1L;>/WJJ)N=T$J
M[9V=E3,ZF0H(I:80_2N?-GU%MH[]])^V8=IHW_SK_%'^R'W9O5MMZ+98F4*G
M&E_+R,A"WS6')RW-Q>(^WQ-\BI[1,V:6X;P+3]6%,U!VQ==#!?2R8UU))<OH
MO>].VP\;6B%MC)B_!H(4_&>OW_O0E&OLS/\Z[0]\;9LA:C^0=EGKQ,X/CG;;
M"83@45Q;4ULK:L"YFOLD&G%OSS/KX&=7UCQR(V;C3?)/+R=638U?;&B=W>&R
MAXC&OF@]XOBEQSWN'_HTHB2G C":O!W2OI+&-LN?@'7.K+1U+8NZF5PCZU++
ML8!:!+5J38WY"2% :EA*-]TX]X.!>JFQM/*6<5/.76K]E(J$<B71L1E39*S"
M1\FHW3@)U..TPU?\Q%OH<8+^@_^"<QNK7.TF55 E@EWO*H_/:$#K0+R.,'2\
MM]7*56]C01[Q 1IB.2/KN 4B\R+[9FKUH:_?_'ZS9[K9%D2[7G8&BOL+C"]-
MVON;RBI=JT\@=?Z(/;?%1A53%YDXMCO"17IZ5SDL;R[$H[F;N"G-7':SX1:B
ME+F7X1;:W*ISU_[AT_B[F%=(ZF/8LRRU9T^LW[@5G8$PWCMQ)](_W!J%=QEK
M?<Y C15=46HV.!U6F"$6A^%72-3AQG0T=&)(Q<A[R'7D--_SD*X0?TU1DJE
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M<5.SGP](>GG9^)BU\117I01>SY15YSR-)S-<0WNGX"E_=+JPB;OG<W>GJKH
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M3795P7[UG\-,Y!Z8SH7^6&O/FNVQQ,S\(CY4&O0.YDQU:X,W)%(%6$YT8,^
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MO:E7GR+B+5D]X;W8.FZ6Y<-+";I?E+61"\A!<,CS-.A)Z"! /C&]<^"Y_&4
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M4<@&''%GA/US)'82 @<"5)9SA2HD:P%Y\O/U"?NKC0V WZ+A$[3$#1D+3$P
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M=,VFSN-KQ^HG 7XT+VML'^EKL9%2FK/YV*O5R$S#4<1P\8E[R$H2,"_G,^G
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MAA\C+.R_W\-2_GOF&/(4')^I@R*+=LWS^M3=EGOAO=/&B0@:.?CVM+\K./0
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M.V?8:<;,,4CX (S"7M:1HIF2,+$![&QP9*>;$:G623!40A#)UJ[%DZYP#/*
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M<0?X3%;K"!-M)K6])?@7PJVU-"52A!MB/F<*&A<(5.0$^DJF/O=7_(MV5+W
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M1,^RG+ZPVN8++S<),>?07]7T55\.\B$L)BLD@'6S5U7^4JGFC(ECT%G(<[J
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MU7+>3+Q41I:LR!/KP*-OAY?*.'7I_U#WGE%-=5&[:*R(@$@7I*CT_BJ]YK4
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M&RX:!+5]6=UU5:BZA]E9WBA>QLB8\QKH5JH,L^ERYIYGV/]-N??_&@L67->
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M9B-=[Q)!Q>14S68;[^24["2M@V376;[4Q2B^NB?*DCV06JK=A=5LY]5NN!1
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MB?-NH5KUJ"B!U"LZC(6A(@,NVVA !MU.9KH A9F>Z5)FD48ON7<)GPO5[B
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M"ZF+;S1@K;I!DR8Z9MG?RKZ/_N/V?/T[RTA=]2K[G?S(/MZ4W?M'Y%)+"W&
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M<,EH0M.\^"&/QK%5RI9*NL>KC O22^^A3&UMFN>RR#8,S$R=>!?.1!8Z7_S
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M3Z#']L<JROA56BK>_Y/S>/K]O9+^#5>P;0O#$9_^1N1&N%D/C).5S.)D%Y9
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MPKRM2^F^G%-]UE#]X,J]NA9AGW,K.O'*DN,D69)9[UG_@8IFX";U\:VF:V%
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MAPN,OF(2ZBKU-[T^?4]!5U>!7&IHR\Z)GL=,_DW@XY#_N$)@NNT>(@G'J=T
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MW$,H2CB2YH-B^NP59YPAR99]2W=GPG7A<OFH;)5.\M^4T!N S(=$*AY+Q8<
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M=KJR/LM?- QG#@2G<'Y0%A1X%0#L2RDPT@D9]7FT ]E@9%WRB-3]V7)[Y>:
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M$TD\BTJKWX;?;O^6EOUVG\.CSE'44>3EQTFD,?5KC(-HFUSW1(]#U;09GI"
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MFY X,F1>^V?R+FD1"[G:,"./4'5HZ2 @8CV9K+::Q2XGGMEJI0Q1>"?L#2I
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M"TF XUPB-3@W7(V*5_F9K-SNV:40YN?T9+L0<*6'5K;S5D*]^RW<YA&0T7@
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MCY,UVH]Y8I09RN(%#46MB24@MZ$[-^@2W4R_^7!4<P;?'$=P&36!I:N<47?
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M@C*J-/%WJ-0EJ&_AZPU7[1[FWN;@O046I]I=!E"TL:*P-/>*!V]YX*W+SU<
M!W@DS<(?/'!U)>1H]]D-6^/F">'C>-?$FWO3=79MK9RIE$9VBRW<)"&)Z'NS
MFPQ?-[*>$>O^XH40RL/_#,HC483TVVE4CU!9]&X@%T9;\:HW65:NL7J)LX=\
M=M7AN:FL4FGL4L7=.Q)_?F+/<WQR1L-KFO2RE9Y09K^<SDL9+TDN9C2,1YFS
MF:FL^^-@0ISK6BGN*2[X>BQP)_L"%&AF9QT%O1',!RGFH?Y6A&SE*+LKKV]O
ME/!R?\_U;95XE<]PX9JZA';SIYZ@@E4._",P@2X6S6W<<!_K]0JKW#:O7P.Y
M O0%LX[WB U0?P5YW,K>*_>C"R3_;K8X:OJ--R6E&=Z\3P;QGE.C>\!9%W&C
MY+E;*9CF<=S--[EOI@TIC0R]Y<^\8D[:9!"#&VZ,(8T)^:P^RJ! C-+)<5?E
MI':,\Y/J/8[^ [S+($ZR[R]]7F%ZELO;8LV=HQ_I2Y4;K&H]1H+&L)KDZ38[
M/ZO=C\G3LBW-]?7 SU3_>4K50NN7*]DSB%RXTXZQ>VTC_8FO8X"TV\V+3O5_
M@R(Q/NE1U*)L;R_/0F^/[G1Q\V[(6PE?IAWOSPV9MUYFM^J@+:EZ%S8^Y1O"
M<511KONNM>7J.O;+*Y8:H6RJ?&X3N5'Z"<M@!;%75?+ZAJ'0%CS78D,<29RO
MDD/*=LOLT:YU?SJ!#DD$R:)/+X,AT"N GO)M>*Q*I@J_!Y@%;]=]9N5G?1,K
M!5DA28BXQTZ1PSP7X_<$JIZ9:KAAYA&AI/;FEU9>K*N6!3(FZ=+Z"-!KU OI
M[B$B4W_A_;X/RH3JR/98B&6"C"MJ5VQ1(QPG9KBQW?2/L)K3[FR#IQ,$4PS-
M+'/0%2!ZSTU8"F([_BC3JH6!=F'1<I1=VU+ES>J;W3^MP]$=/)&\L<#5)2H\
MGT-DSH$.Y0J*+%[8=9F^@=B+CZQOCM]Z21M8;%.VR>S<]_OE<+7@TL.#J9>9
MW?36S<#5+(6VDZ2+]P2Z +)XEM>X6R<I/G_5JV]7304"RQ:7<F]?)$N]4GTI
MK]Y-J0:UEGT=:<K A $\D%^SK?0X1]>>T^#K>@C4J$AHROM8D>+P0(]O]M+%
MMK]UZ[;1GKH<N>L44Z7C)>G5G5U*68/B+?Y-3D7(@WK>6QB&>R:Q13M5*NSK
M2:');A93<E&?IS4$/>=5( <7H[N*!057@!$O-!6!!D:DN(/-&B8*7'YOY]1V
M<$N4W&)G#0/AC+Y'W.L89NE./\_J)(_(NL.I^N"G>\2X;'_&6'BKW6II4A$$
MT=7.C2W?=C.JQ=V.+W9L>/4:->R^]?"DQL[\9G7EX)R2A_76LS*GRFJ0\+)2
MJ>O<\&TJP%OJ'+DUZCV/C#-9=$,7Z Y^:W(;A(.&!\JC,UEJ(=?:\G9$X1;V
M983E*\_8(2?3+\5<;GM> WWBEY4:FX(9O;\V6(73T2BH?Z%Y?,];9[Y30YSA
M(?FH=D-=?B;RNQ6.:(?2Y?%V1FYDO3O2U6LUJ&N669CW"4JIOPXR%*L[MH!!
M[1/HP*O"43O "Q ^;>7Y96X[N],$M"L6__U7*ZD!KOU[P8*2S.ORGHO@>;0.
M\RBCU*7OR\,7[;P3F%B]:*OSF8] ^<#W>&G,_B>BXG0P.^'%)#=2.EY%PT6Q
M1\-5T!IY-\FU[%_#AY\B.VX&+@^*1NJ_U#*0)S\BVP'&<6!?@><G3RWJ<28A
MK>(E@1RXM-A?O67_K'CPYF66$$^,^HRK&\W6D,'OWP8JWUV\7#QH:CGLZD+H
M'NI3I)'M 6_AH[J!S$06L\#;EPW@#TJVY4X"0@0FW/*B3F)W^^.D_C?E8)\:
MYQ0SQW:N.'+;MJDRV 6MM9%3Y=&B?&RT2E3W%2 ?=@]K#]9/8Y;/5J$>%??L
ML6>53NCN8BP+$^_1!;X9QOO2JY<'WO]P^[%)CJQ CTGGT +<-2R.I5@G8+[P
MN5EXR88%4&/[N]NC(>IOZW)NIN_<Z?.1Y;%#_P*JRZ.*GVR9=");_XTT3>C&
M>A3@J=2"4PEFUS#SGTZDF;T;R!>KC>]>S7ZVEJX^<[1KHCWI\Z:<:H3&^<1D
MUF/ANRH!YHQTJRAWL&D+S'WE]!W%@><IVC5'\S8$@;6QT) /=G-N(JW/T.8!
MQ643(3SY-1.3YQKBJV2&']['T4A:+WBWOL6VUYMK2">RN?\12]T4&(^W&(P0
M<HZO0!D(9^5]FRPK0^89W&5N,-;S-3FKRUQ/H,A#V*!A\ZEJS$E!M@+Z=6\&
ME%DMZ"H+$D?]SV5/?"[3V@6)2!6>6 WLDR0>6)3KGFUB3[#R]-LTX#W(1]*T
MKVV(01_E%^KE:T[&PCS=_09C8B]>I9[;H1+GO$[4\+>Q+M;L[8(<L<%/JE]D
M!Y+^N%D_6=@TJB\[63N466[^^K/8POLI<.VV.I.D^3UZE2B,:")1 )<6#J,D
MTD*LNE?WNQEM7.2.=F^PN"C;7X!LUL^H1'*^+#C)'/1I9-_.8D:_2A+>B?DX
M>U@4#7^EPCCP>RZKI7M+<JPFNLN[V+ZQA)[/KE&SI=<H+ZR2\5V5SZ/2T%YD
M)^KK5_L9B0QOA^WU)GL?F.GZ-WF4F(3+@L/W H%O%O?YE#<B\_2>TWXSU(-S
M\QF<!!+:9_(Y%VE-9P+)+J0A=^#V^_/-+ROJANH>$ SP14P)EMJOIPIBA^"1
M=_%AW!GA,6-NI3?C77+-9.==PRR9[)F =XGL"# KRQ<:&1I/36[4_/?/\O9<
M7K3)FGM.1%*\]?UJ5:4(,L\JSR:>3)[O"9K<!YK<R4$C04FK*[<U7.C>OI"X
MP9K:"4[_+4^BT=@+S6Y*L,O"67G%C1T2[ *#[1++E=0"U1][%NN-YC=E_DT?
MX$Z.B;.E<*;#D&ML5GW[4Q3A^7W=U$C3J-@X>%9\6-#S$BS1.\]KU6*B%T[K
MWHU:71)2EAT@X]<JT#P*OHO=,N\F)_]QLP_$V-'!39("\^A4R3(9]Y?^DB"M
M#_AW6Y&2RN?X9A!0H7N\U@/,?./3%WFNL.Q\'PSCM22>Y32!NK@]X$.XZ7J,
M'R,:\ &SY9%Y_<D-J_5(Z\V@<XX(!_F47N-BWB=(U^5S[^.+=K5_7'WRJY2$
MC1PO9"5^NOF=R#1[X\8RS/*"0VSIV.9_7E*UEB=.7@%JKP#=P'F7#D\\$GUK
M>\3'>\P%!:-PJJ3=)O)-3?O>U5%86CQU?T$>L*3Z5OC#3\4UH5U6_8#1AC(G
M(OM$G274N-%<1_0%$NSCJKZ.JU]&@.J3][9LDR6X0GD_O'=@9,T@B@&=KZF^
M; ]'[4J?-4W@RQDWWJAGYL5'8))_GJ_>-XP3!)V4HHLZ;]R,M]K7NWOY$RKV
M65MY>$?^Q5/EUD1^O\+'5A.#<LY*%:4)R9DIITX:H\:N==A>90,G6"[>JU,P
M3E)KLD^K0 @F'*_0>#896.=!+S!HU7U+';R::D>14FST9%.O2-#,JW#,]/+'
M?\VUE=ITQ(B&WB=\^Q4 U1!2\7[1;A5*:J59V)?VRWS(TKKG@9!97[GGUK (
MQ1^S^4;%A[/OR@/%_?=_O9HUBT-NR8*23\WB#JW_-/%Z4'GX<M?(<Z=U:TZE
MS)8U&,^F"=*NO%F9RR=T\QS'+V5YW2"YS2]B$\_]AY%^ 2%/UCC"$+QT0=EX
M#L,1JJS+UL]\*![$\>D5:654.U-KG9@M:UKI?SPM>K)V @=O!8K0"@W\GNBV
M>R,D0D9%?M"5\S"+_] SOZED1,3_F*WM/-5!(=E_T#-UO@VU_Q!?VIG^VYF=
M$@?\W,H?Y(S6=H%1;ILE)'*+L$#L'LJ*_5"LGN-3U^3V]#H_N^"#=EH0?%=+
M+V4[KS.@6QL#N]4_;JJ&H^P:Y<8E1DW!A-U\%A5MZ.&?RV@?552\C;FORS<U
M5/^O5) HDI( N@)4_-1\EW02_<Z!Z7*AOZSCGH/ '24:"?)^#.<-R:UWGJRW
MG=0F^U!Y>M)[4W&&+I-!O+HENNYIZ7HM<>5.?7K-*@:?J[.*E+IU$YS""SZG
MZ!B4Y3&B?\F>_#*),>)$3I<V>SHCPS$0V/)&9*OF#WSW-:DR0 49#UE@3S]+
M75B:J$\?;::AAUXC]Q^;EE>X_E5]SIWT6T[N_8>\DN;J^&:B#WPU$58G4Y2/
MKS@]L<)]S#]589]UK:-Z0! /:,K.5)\10NZ:K42ZQB7H*ROJU9G6:;-X&SU8
M>>[#^O2RP!"J)HU/@*88]]<(-#*7C_*K5["7E^_^/A;=^3LYH2,MX$,S*?U(
M*M,8?&;[6<*YZ:&#-8G\A9E'G86TB_FBS9;U_$B!=V$92I^_MD35HKQOY*N>
M&J0HYO]UX^;_SRX=7_+\Y-LD4H"=D"ETKI.15PIRI3VHQJ*^"GW-IV6<S%F>
MB_TC8Y/0Q(2*^1U7TN#(^H(4NM1!2K<I-0P[ =@[W+1C%0K,VS]#>]YQ[*VN
M9,/2SXCW%K(I4E48KP!6L0:;H%J-+:#*RD;#MKY@Y"@Y 2%?F;"*O[ 10DMZ
MWN$FS0[Q#YF"-^AE^6Q:M: 2H_T_5E"_^/F]:0/\$?"@%''S?.WPB'EF2-R;
MYNMF+<P<V*U:%%%^RT]#1_&X(1UVM)3HG%NS Z99)RV^29VR"+8J2J"4VS>C
M[T#JCJDG?"S/H^#+_?*_7OW]7UWT9](7'M=*RP9ZK;KGVC&&6-/V1GP3+GE0
M(AY[V&EB/.*::R5EDY?8Q\X'5=097Y; *8]FWW!66'AAK> L(0/,N +$<V#=
M@;M(',T>+IC#&L*U6A@MHY8-BPB4M:O<-O[QW=UN-M#\84FZQ$U(B/>D*VV@
M>8\ ZX]SB\KPPZP9ZE*M<'>\WWQ7NX#NUR?9&>XQ<5NCPE)3TRH:DZ\NP>$$
M6LR>2-?DL-B\#VNI4"7C:*1-]DP:1<Z3K+IX"QEVJ5*,R\17:RG![KO'?I61
MI5/$7<?*PQ\@O! 9@2Y2V=[5!^H,8[VL1O\Q&R#=M*)(UWH3^4=*@2[G81#-
MLD<MM.!9$<)3UU?+5V:_BD@.[;QFH?70[J%,0>N89O GHNR_UV?B2U< %R=J
M_/,>I'J!L9.!!7;XM=.V>_]=OO3N0\3?9*V2!PS+Q:C"X.+#\=)//:.S)Z_+
MC;,6ZR=\?AD4M<=FN+>??PAZXG#DA?EPG\FP&X,/$"\F7T+]Q@\;44RF5F!T
MWPP_9 ];6?(1U(<;L27NO8LA3%]&05=+.&H8=H=<*.-7=]VL;P2:),P7MN-!
M&)=81>"#X=]E4*<F[,@?_4PJNC<O)G_:(Y=\R&W?GF:X_J)J."IIYV#[U+?>
M&(T2QSLW6KP06M>JM;!SJ,T]CD.)ULC)JVJ_&<C#L<[R#1^\<K6 RW2^$V-<
M$#W]*B[UA\<!.TKUQJA(&&6<5:3K\D97^W5NC."7P_]QO?FW3[S:A_)E===&
M)L 7!L$M_S76CXA?G,;;03/G'.M6_#AMDR"@5B.%ZJ<X#26[,(>$(KE-V$_6
M&;RSU4*=@LNNIJ#/ROE9K9,6ZV%<0&W@-@Z*WC^1T$T:)K'8H/FU]I SZXNN
MS-H&*5E21^6G5A!NV]#OCX;WEN07I9&>MS#UL0:5U%3<;)^LY!;MB^K&T:=,
M3(\:?)DV4\;(E/O$K=FMK+4%TT4TY96?;2BW1RUR<A0$CWU98X38H!1^ZW]-
M7O('EWY$6FM,P!Q"AC;[LNRD _*/5]1A@XL6Y\UCF(K?R5&R$I[=^/[]/8\<
M?V(XQ7DL*A&A79J9^=*^27\D?O$O &L2EK+X@Y"@?H>0KUW\_!Z<B1>9<Z82
ME7%,1>HR:]P<7TS3L*+W16/HD)^)E/T3D;3"97)8@E783%+K*^WZQ*_\$TN8
MQL%L?9$Q%ZEZ@4S>S>R&H[KV[6"R(Z-5$#VB=+[SD;MV[N4DX]JIG/W^; M5
MN?^@# IF,U8!'9/&,NQ<H#5%A3Z$)PQK?KZ7!;C];!3Z*&66;7M?D4FI7Z^:
M_+WQ6*4;@K&RY]!"=-I#,E23A[?(,#4-GMK,01N7M^,\*.C2%KR_361L4:,S
M2?.\)3UM:<IF-#%5FO=I<+ CTEB?W.[M2\Y0<F[J&!\Z$J(/%&N<.->M?QD/
M=1%E<CQW2_)RP>:A==:O (GM=,Y6YBQD$S[FE4!#[)KDY4H=1-NH*5TK;6XW
M65BY-C/26N2 %SKD$'J'L?6+Z@XT.E<=^%T?*GE=,'3 BV$G_'BC"^] ^BDB
M+4$SI,R'Q2'3&,L0_R'79":0&OWS ];<><8\)K:4?SJBOJI :_MVP3LS&7$0
M6UT/Q\;NA1VQ"\YQ!7A']5G6B@+?@G))RONS9,$;'LRY*3-KHG(75Q!N&^B;
M(5(V7N;DL_9EUE]Y/LKP=Q*/YFZ<1_3*>51WCE"7PYP"4[! J],&Q,RC0#]5
MTPRR8)BLUS/NZ5LL>[.]2E=XE%;_5W*1(N)"M+N2!DO0^6KC.1S\1*HQED25
MT7^\5)K)WO"7NEA1?'<#V$7?/0;2K'G85YUJ1*_EA,!(J,:7W/@D1PK@.P)X
M7XH;W:K[_658>)66-H4O!B@&T[_P=5B1+QYC@YQ/O9I?]29"+YTO87<B%T&\
M*X6P5**QR?CY'S?IPLD4,^?]?U> (>ON]T_'S;\'XFX^=H,&/G[&W]\YG.E[
M(+>-+)?/=/SQFWWC]_D5 ':89/TB>/@*4 U# !=6T"(P[.PJ-*0.]- EW5/5
MAP6/<H%209R[3!;.&Z)]!KXZG<O *,B^#/E(#+ES0<I6FQO9]4Y%HSIM2M"X
MU'\H]V_.;N77 B:?;SQ/2W Y6ZN.^R<YSXR.L&NIDS:F1F@PC3U;:[JD+U7!
MXV^V5DK<(W*$GY:^DYJP;,!FZ4K9913<#L00/ ^LA77#0MD9JEN3ARQFA"L)
MKF6+/?MD$:UDA7^> Z./%YL:WZB,O>U;&/B6(E+J:_,A9E^.[%)*B0-UG[0C
MF!J+"&D5M7GX'55)!H%J8/M"BE1_J-GF.2H$M7\O7/A!HCXGM)L;YRYA\E'"
MY7"1>.?G%>#F$C[H^HO'&\@DN7@YH??C<J0B1S?043UJ#>(%N[V-HF#4V/W\
M?PTR*O23[WTOE/1=FZ;V&K9\MVJ47IL'I\_B8+%*?AIQ-1ER@=4&?NRZ)1.=
MNEJO(7_43#C*,-GR9J\C0 ZZ:>R26L[Q0">Y+I\2@\1#$R;<XS$<-H%='W*/
M0XE/UF>W1 >Q@)8WTQ5/%[+1E3!YG2BI]W6=7M71**2?S1U"1DB8([A\FY*J
M2WW?@<H4SO%(29#ONPWA@)$E3*0#K:9U'3TI5@^)$,S/?<1LELE:2I3L<=/!
M5Q>MK[G(^5*51? ZN&6O(6R[G5[["]2;BDS@Z>KYR9A2TAF-EQ4]&ACU^D]^
MN'F"INU!PJ<0I'(4X\V,"_T-D"F9[O<-1@!5I06F7>-X'4Q02B;[DR7FINYI
MPAF'&[,2SUFNVS#I4BW2@;)?MF_[FQ>?,)E0H\429(JY*]G;,CXNKP15U%HR
MG>6A1<,%13."^Q@?<@?ONV^X<R9HL!<I*^,/WZ@P;[=S-"5CND\79J(DQ:"2
M+]N:D=]^*S$\1+ZH'*=MI'&7ZXH+ACFSWX\$B=T< $9Q'W9L'W7</#=YY+5*
MON896!6W]MZ'Q1\+4A;/P6.D,=.#[]8*&!L'?'1'A!7R,YJ;SG7)>@1P!3LE
M4T;\ V;NOYI0/(Y.? .-0T9!!I83.*.T.ES7*)<K&,?2YT2]=* )/0F5!91'
M\])H28A/C*Z@V !%8"S28,:';+IN,7;7UK")9V-*6MZ^I>4+ >&4\S%9-0PZ
M^#-4%$ 9V3X#BO+@'T3T;_<I>I*1RF\PCNG*HYOO4MW48'H]\:F[@NQ"Z?S3
M'<0'[^.?=C6IJ9J&&3I2);KZVB^W4ER%KVMW_&^\C_PJ%J_$8Q9=DBK6:$8G
M8*@[BLQF5#?0V7:R+E4)P"9V\S10I[C=!GR@![A[X4G&.+U6BBM_$I11M^K>
MS*GFN=U6_:11H1#JMR6>1=G8ZYL!CJ1Y'&+ '7< X6I_NO$;P9LS/;_@]$Z:
MU$W,W6^_GTU778Y);G>ELCBJ4SVU=G$(^??XS-KR0R"E5R\]KCHEU41PNR5@
M/EAW'Y0S4U3HY$03Q\DHN'AS]49 3M[9.8;M@U@$(R8.2GZ3XU7BQMBV3NBM
M5V_9R7B5QZP/QP[*Z5]Y0DG^ZRH0C;94*?B#.?X2K@"B0R@7-(^QSM+V]OI&
MQ>(QO2$?Z9P#MA(#)U)(EG=6$.>N ,Q_&R+?&"-ZC/VUH[4>)EL*/IN4.BNT
MS")?3UM:BP8-<]DMC;I<T%1BN$X.K@ I[?B+*X M,>\*D#_C0V@[JBB6PUI3
M3NIX&J(_:VD-[B('O43,E:>;U@/ 01^!;7"'> HOW/-X#QK0PO@J<^UF2^U7
M%]S#%UM/ZGU/7M?XERJZC4#QO$6$'& ']((UD?C=)X;8EQ\GQIO@D4." &X<
MCD!9K@!84,OG<O@'T*?)5RCJ5O"]1PF@?1'O$=V96QT#P^FT:HQ'(G=6::WG
MQ0%8ITLZLT#Z'DUIGUYI%DNC@ZR*V>.:WW!'YV2<1NBZ?2[^=DQ<V:2;DAK,
MDK?&>>MD8>LBCV)KVDY?C.2<4BQ(\0!RM&OE6^&H*9'5Q]3BW7E,5L5Y!!PK
M\!]"C 5GL;<ZP)'G,T8C/[[8.OTSB?-9NW27$$_LF#TZUM+2W/0^_WAT<$!,
MQR90,2G0ZFA6"NX=U<!!.HE)!*/5EWO35P!/\@]KKB1AK!XYGB2K7@EM7AEG
M#;W6=U"-M/;3UNOR?W[6G#:2RO.2,7:RL@L>A;T>3W[;4>CN)[<QR[E1.<MX
M*KUQ7A3^Z$L3'S#ZDW*[S>;4I9ADR/C?UCA=:XJ&5N,V[X/E;7#:QK]Y7@:T
MF-O#,LR0:^8^A_2FR^XA4/EH+I@/(C-26TF!1_0L//E6WBYX5[O^0DHGE&4'
M]ZKLRZ^^P,;00D^/A:81:UU\-EH?M]TNC4LHI4MFX@D-LC_F_/A.LIV\,.9Q
M*TF5"9@TK#?HT&>5,5_HWM-0"$:.^T"#MX';@92,BS7#"7O ^8S:#?$N'T#"
MI!2R2V2U;]VTJV,UE-^ZD$I^?9+R6M-S<RC8,F7>O""Q,J^O44X''5STZ7PJ
M>R,&\DIVAD>80ZG4,T!3Z\1-U[6-[:2ADYFW$X)Q_SM\EBQFGY0[)/YN>/B
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M#-FTUB8(XPV"? ,<!!?E[LUSQE$RO>SS8^P<&)4(6)W]F8AX7:#N^163;[T
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M5IH]\^.")>H\?<;%WD2Z,L4Q/OVO;-HC9'M4_ J0: O<H"]=OR#"+OW=C=@
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MRJ]S[;;<!^]?AZ96@@]0S&DM#;+3!EOH2MM+2;Y*=,L)Z H0%A,,# 2V( G
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MA0N;>EG0![\"W%&;SJ)>7-EL9ZMI;IA*U]-VS-1#VB>/[HDJ:7)!]:T9I*X
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M24S_8XIM\6+[S-F4F E)".E1,CQ9KEC/ M2C%27ZV_3OAV+/0)41V](#SRN
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MH MV'#&!$KAFLS)-'2ZSO'1579.<<GV]:11OSL]1MS6U/O]N\CE@YUHJ3^(
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MD!X2&BD<=+WG *:VOSL#.V1#(B->-HI8B#N*EM62\A14(R*2_-$T>^O WMQ
ME&U<W)$PZ\+FH9YC?^B=:='W?7R!HXZ&W \$NG4B^/!^B2+#=QU4%N%!(:;\
M(,B=3M-.U_?22MQCT:()#.\WN<M6K?FU1'0MG'7*8;%-\3+Z$H:7U11Q59+\
M]6(,=;.8H.4JX8P$J9(5]J/U&<C@S"GOS\,P>Z3.J-(6BWC-Y$$[R*J6B^4]
MBK,EO4@E ^_^5E3MH<+-E+OZ>K-%.:[U4L?+-.#0,-CIW69""X=Z5GB+3%\
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MW.:X49^ZF->@D>4&Q'+*H9^TI8.X0JLF-*.PV))_C;;.1OA_4UC(Q8L5T-=
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M2<#0)A@PO;T79_%B:U*7K5;:Y%'H4'K4LC?TK"H$Z>U6RA'RXF;6N(X_",A
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MT;&*IT:6^$NIKLFX]Z)V:-:M1O]^_@CLC,$OQ[96CV6+-X;\=W:9I3WG;^'
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MER=^$<XWU1?%2+19$>GPF'[H#+@+(Z E!A,$7]W"<'1(PR[V??8(=8O<:U/
M_3[@&[GAP<G+!G/M\H+U]D5F(?(OYV84,\Y6%Y%&9]M_')D:KQW&4:_;C.U5
M([V!D34STW-&K(CA#K8%Z2<&Q.H1+O+OCN<6X@S7N'@&(AB?L>1/;XY%,=_0
M5"@J_=5U*LB%]V1F-F0E!A#F^YE3S$XJY5--\D2Y@[D,E%;3RDO#]$4D% /E
MEG 'C;O+E;FCC:)O#PVAVL%41ONEI!O:IS=HN931XM<.473@Z2 +H<A])]^#
MWD"5LN7H888ZG_.@[S3:TW-W]KM*'KPE35O?=&6"-.03M)E__UFDBZ 5'TSD
M B<&9T_6[L&P4%4\LD9B-3WP"S?6>5T;R]M88)FVO^I&F+!//>_,A\?IC6X'
M_*YU\Y09Q9/PNZNK*AG_6JTB9_JI]$=+23-@*KW-J2 Y'\>9@IWJ [T"76GC
M0&\(<EPN&&]SQ-E;=?(J(D0)JRDIWOI*Y**Q@S.S1[7O^TG'+W85UXOLLK]=
M1/ B>I$$ZY$9.BK]R.*<'2FLA7 E:@G$X*Z>42B;N@B)X[5ZJV@4C*-6A?D+
MGU05%S58V5I6>;OX(E=G1SYM/E&_'Z*T_%FI=E:_<;_4Y4., ,R!#'TM/R[A
M9@/B=)WP__$%OQ11%5]HIC D9>J?G69>9N3T.7UCH#:!H;9K6'!LQA%W,3_#
MPEW5S,. 0V2(;WIP/G5A-:_%PVL=Z0ZD^;3%]S08YW>!L=J]"_5R$1TWW&W=
M>D;8I9E=_NGFHMQV8,)XN;VVGH3SX0(3 MK9;(B,&N!R2"]CFU\=ZK$1:,<J
M>HU<1M.E\<@!;X3X.6!ZB'+S'# J%SUQXG4.N#1*^RD9V6F&]%J8R7],A#NP
MM!#/ 5\Q+,JY.,A;*F_=J"AAH7,OVH$I>F<%R>I^LM*??SDS03$@+ZSTE@HV
ML1;_7:"N-=NR/D6B;F$(21:OSBW5IRDN-+G 7R!A:28?ZX6C9Y.I&^+Y9P37
MLJSZH(BUZ!I;4Z)"<A[F>HV@$&Y8??BSIDDN[D].*&&GU"##3;,K))P!MMV2
M<W=SH%'FJ>9G2D*7+ O*EM5B8P#^Q[V0X5V5B*D!^/>]XA^CQA(ZAY:48*OF
MS06"'Q>EZ.X"]1NR&WK&@Y>D-E%%:?;T>C7Q43^(T#7F>T 6_$"I.*95RM>9
MYP :4 4&B5PXT(X'#L2PL"5XM8.@@^Y.>I/5EPD-0\P#B9PQI9XJ5('VJ=O1
M$HYC 0E6>N-%G^LPZ04-*B=>V!]X_.:$"]FRF\H(/O6'FYVE[M ,M!P#F?D!
M4;:^E$S?P6M$9.S. TX%(M_RYG</RMS<",Z"DHRJ>H>3!48H0B\[<DMA$?<4
M#04B#/V^0]7""H:;W(#]'4"8X=MO4L_<#*.E]M=,>YTV<)/7%24=/?!BII2%
MKS )8_-S0(*D1>EXE-H#HQZ23_TUD%"<^<S:44K]+/2/OGW53E72WZ?RM "7
MCQ"2M(1W_#UC: :Y,-6?_V6D*_\"Q9.6\Q_KF.L=HNZ<"$F"<>WI$XI+ZV2;
M6MFM3*-)KNZ3_!X@R^]ISSO1)KZ.HL5%T_4K%:E,<RW?O=3U+XT*A7\X!USY
M\=N3$]FPT*L0YA+HN4 8F1>V_+.S\H:.1ILS7[N]N)YPU"3^D\-J\I5']^)7
MVBK.M0TJ8*9P"75ELED[]-)1%%']?];N56[=L*HC%YE\^.%H8:V^XWK+> 6P
M$HV84>XQCN& ]3M$>9A4&797-E3QUFVJ!WI,H#+6%*(,_.-,HQ[IZYJDV:8]
M3S72X&V7=/(^!V@Y'S\^>T.+/ -QB2)&,[:NP-<0-CAH$<Q(AO8Y") +H(LS
M]YR[L8*YA;-#N'"S[M"A\?_%W'<]LOF&?^M0K=G:16EK[U)*K;0415'4'OE:
M-8+8@I#6WFJW9NT9JH1:2>VB:H2HF(F6HDBJC92(-_W]3MX_X#UX#YZ#'.3)
ME6M\KL_G?N[GN@NYT%X$>QEL5-_F&X\P+^8D/-;FTXN1[/&691K(?2AK0_4W
M9G[M&09R_0$G4GF(;!G(6U!#HGYB[\-F2*H.6KF1QCI8EFR_>F%9J@K3$1/V
M7OI[!0O6][)\4C8W26%O@-]':;*1X8[]L@-U",7JTAGC]0UPHUWG/6^IU07J
M-2 G\ZN4I8<NG!PO;!K2VNBBA*@L8YVE2]0K"ZY<0XK]-\F#1"%))3"_ZQ3Z
MDO\ZN^)E$7]>KIW+0FF8SPJ-/PX20/S)6P4\O<+1J[7J PVOBTWGE[NZ2KB<
M%!I_'HS7Y,*# P^58^U0>/OHPIX(1P>J&U1WW93YWSE0,?B'Z\#$P@BRZP#U
M^FD[11;T=CO"=0Q\*<\]<D.6FVK$I)G9S2^!I49Z^L[D2_SLP#8DY<K"*OI@
M94(C)5JGJ/6^0L3 HF.[$&%)D%$K<.F)Z](9W16>!-8]W&4L)X]L2?FE7Z%!
MP!_W'9!J\R50E01$PUR>W3SD[A5SN.W8EVK#G-KXXBUSWRY#\]QJ24/C?]-5
M?""=(0]7#Q:E^U;^_O?GL.]H-X@,I<6T!"E,3K0YK==B@2J4AM(B*H^3 I&X
M%9:?N)19$_WZZECTJ/BO9:)RNAVISAZ<=4S\D'>/QQA23[-0ZW#C$VG*10*L
M_R"QC& ,9J0)YO89?,Z0D^)<F2UJ/EH89-VQHPS@ '4&DN6.]M(;+KQG K9/
MN;K6)BF=B-H_-F/8':4(L-# \CM-1IJ3.6CYW*[_<8UEA=R)M^Y?D7\VW6N_
MOB=X(:"%7/91)>S"LT[D=)-SYI?Y$"#SCAC)-IC\>:$SXGFY_%?G;'L%9E02
M['TBA2>3U'N:H<7NN=:VE82\#I'&/R\BD,Z50TR 2:1HL1D-:YPC'SK0'N+]
MM[UG1<OHQ%AA0L>S.[W!F[MC[$:1HY)_S1H:HE?*D J5P#6U27ZZXV"9/ 8R
MR?!Z985_8LHZ-^C2UR$%=*S74'(7T&G<B^KCQ3O<W'"JJC.QK)^KZ:C)>Z*I
MS"N5H6;(6EGKY72$K#_"3#C>:Z,<D//P+3R05%*%4+MU?\OBU!"*3M9BM)LA
MLUWH(MG:F"C84@6Q'U(S*7=M?'(LL,"GV:/O<:_%9V':*V Q%619]O/I1]]\
MU<83&5J._:!^7KMR1N=I^E7[: .6@2CAP)W1#8%C(E@*TGI9\"5 *!#+#IK9
MWGA&]I+(=)]<(C>$=<;J=5XS(77_Z:L>6&HRA<S_K:7YGN;TF$):39K 0/)+
M?C?L;0BZ6T.H%T@9(T>FT6.QDG(#'"R^C$%#$RS3R8V4GO[SM[)P'#T4*N%F
MGRH]<:IC18SSPU ?>\K6OOMK067*.8DBUY*^D'>KH\?+SJTOA*!BS^B8-:RP
MEZF#'3TE6M)0^\B.F=J>]ABN+^75GBJL6)X$LQ<\88<[W2EZ,Z:U)DJ3_L5&
MI>34CUWN&H(,B3O^SZ]LOLD %6P=3M4FC+<RL1B&/]=JOLL0VR)@#*S'#.CQ
MKOFUYK9:MA:CRYD?+8K>MZKDK&1SZRK._;O',][E..>XTN5S\+DH4BSZ&@0\
M)"A.S@D@E*U/I6K=7O8"LK9G<M][@]MH69E2B4<*#6^4!)D*2BR4MU\_D6W*
MEHGH@'_;NYMJ_JTQ>_YT*7H5Q@05/Z%E;#\74@0J=EKF!X=K:-:0+PP*<A<-
M<]?<#<?/$T>Z*K"0GN%?:S;C[%&FPZU.C@Y1<-%2D;:>#,RE2,__ELAE_W,<
M.9L\S -(%@<. -)7&=OFE%LR@*RRF4DPKU35M!SE+XD;PO0+)=5V8E:J5.Y5
M1$9RQ+M*3=*;@'H01PG&MV='GBP*WONWV8C^RFD24A[6+Z>EN7-4"!M2ET^(
M*"TC@(>[ARR,Y1IQLJHZ06_MW]3$:!^=T;&$-$9)YAE%51P.S [3M[5W0W]*
M9P3Y,'"[+RN/: #2(4CN]7TETK)IGEDEUQ2SEKNV9= ;LY@@^&6+O"?/PG-+
MGLBY$<W3I/2YQG<-GCW;&;"N-6P@)8>:._W)WQ:-WC,\W<,!";[ GW""]09;
MNI8&U)O&(C4OC#J)DJTT^"L@_'K$>V6U(#6G^# \;*]H3V=8P<N:8'I]?B-3
M/]84#5[AM1W6>GM[26EIX=CV?Z<M?#A-1GG!DM?8J#*4I^2[Y8Z0VH\JT9&C
MY4M83SZ5#)]*1DRA_)"QU,#D+:))CJM:\IYS<;__!2,/Y<]8Z"\L@+!'"-O@
MV1NDW<KJM%H#Z R(J2*LM@8GXPYX(2HCW9;S9W0OM6[_X.Y\?F(XIP0W^1(9
MW-V99]FB%!6I,\>]O\J4FAH^T..(%5\05*%5RU=8_Y,S.I^R5!HJ_V9;W!@4
M[N?[\A+?=]=J&LE'$9A13O<A3]DE_=5;&BG@0\Q_.QY-%.\,Q_6BY8&F,[Y[
MS[NZNO-5,M0GP#1WLV5"4M.(&HZ##A9Q_022O'2M#'>(P*\:?K:7_4T=G(VX
MA?GEJG?DAI3J,*>4?*&"J[N8>L8L+V,[96]+4ON.* .75]!2OD8W7+DM+,P.
M%/8\Y(R.$'A&EXR0 (  L?\6].#J-&B@_?D7A=SE.""35ZMH1GJU SEU:%6T
M;:YPR@1A Y?M7(2 ]=K2G9.M^$$2MY/-.&/E?_Y[/A!:1G(C7ULOBXT^_V\)
M%@*PFFDO8\/:[T:+]AD[[3XEDAH#?-,MAH[_H,F"VW^8TKWULZULF^7*$U8M
M.UXBOZ3$_N:@,OWCP\33RC.Z?P0)=@$&DN7!88K7VDT'80FD8_'1ECCDA;Z"
MH<"QFLET/_O,2RL:9@[D.,A=ZP\8<U^MR]^076C$?='W/ >U+AN_4"0GVEU.
M_TWN?U\[H,F_;IJL)0#AQU=IT;6;LI&M+<G)8+RQ_'"TT(R/67DK@51U;+SW
M<FY]]M(22 P5HTZ6*4\8MW_#S17PPW]3B&%8B]=_TSK?+3R,U^6]@*Z/F&^.
MED3+J]Y[][B(&E\/P+'IAC9?\:+W73Q->BM-X!HZ\(1Z\Q9$3(/7L_*+Y7S-
M+/6Z<]_:C'=#*I$[I.ZHWP -Y4P>\L?HA>ZP/4D"C!1!A/6SR"WA"Q*1PIYE
M;%!)#[PZ7&7@*,*OL7:G.R,/=ZK;'@EZW3XQL119T/G^Y*Z^!S@BF'SK7I8N
MW>D6K4/3X-.9!@T<&C#"%@E#-ET'LD.6!B(R!UI8?Y2Q_X8SKAX YWJOU/\P
M#J_;[BX^EC&0G26''AG-FV-V=F8_+V&](Z"_UJH\S-FM+6AQ@-.<EP?K-T&!
M3)?DHHR&2B]TD[-.-,EC<*46 3M;,H1LC2OKCY(;N5_UGL@63WDHP_ZQ^YMS
M;Y^.WH>Y$$V+89?_J$_,[?LU.Z?+"-8'9$D>"J<T2?:T,EIHBC"%TRS-.E'V
ME/9H$$]59N$#<D*"-KA.O\=-@^P84D)Z%/@A]Y5:VHU8RRI$,'R-CDM+D 3I
MB:\7K0C?"ST<;(6ND8VD)@)+KP]XV(JSN<[]<%%]'YZN,2@W/#-0FX-74";8
M.$3)3+$!+]4FYFZ[-&"*J2@5"P8!70-)P]K.6MX!QJ=Q)<5_6[@+NE=R-JUF
MMU=6[1TH[60 +9/G6S$:MW!L+V"=:S]S"*B-EH%,YE'<GMC^H2%AM:2"7&L"
M9BSRI!4_D'$GH(S96^48TA:WO+@$2*@L'OIARZ[_$A4!6*\28LFA,L)H?NR9
M0:Q][6^B.'MHKL4A12%, Z2.:<^C0F0>+A@UBX#1VVV_5U+8%A2;V=OJ1B1J
MYXQ?.J-[0AV/R]1B '^WIS+*THQB)811.,46<-69L3#7@_.4V^2LFAWV57+C
M"/):FC?R#K&C/O(B)K5".[B/3;_PP""\-H/(8Y%I@Q'I[>Q\?,!.[UEV9#\
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M_837>M,*M#^@5]2?I))\[A0!#7[4 E*[9;$AQ'7U8[OK=RFF_1.DC:+'?[+
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M;'#7X( UI\KV:]6U?L%:W,%>E,324)J<6W<F-'"R-?'7+K&3RO1/,[.<-K=
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MRH $U%4E$(A)9!Z,^6@04NMI5ZP6752_W3V@EQ^J%K.J$Q+$G.XS"T$<402
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M1)J0+G':L"94V3%3[4;('?-%P!.9G]3G7^?Y@]X_;KBBD]F!I(?U?P B%C+
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MN7LB)Q1_1L<L%ZT":?BHNR&4$OJJ-A'W(?W),>!E><YD1YZ.'%E.0S\4Y5<
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M V\*1[V>KV/=)*)!_Z_Z8$A([<I@N&M0B#/,F^J.V$O_C G+?Y_V@N!H;R!
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M8TU)E6""C8@1"T_#ND4NW2#P%?=O5&;GP1N>3E5E**T.68"H_NRS7F$1YG[
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MLUCQSXGN.9(,_0:?1T^]!3N+WD4'HGY-+X4QFQMC@&:@AL2C($4G4NY.R5[
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MYNG LQTSLY^3-3AS=Z@*4W)]8\6/.>7.N)Z[L[8E9?G)&2M@\W+7.0F&[4L
MF1I%6>?KBT209_*BJ0YQ: .U1#.D(4$\V'B$I2G@MB5"!U3^Z\Q"OX'M*LYG
M9G(38JL6=[/GR^$_T%YU!A7NIXS:U3P;/Z3?/8X^=293#YW3D.S_9X*A&=$7
MST*(G=>0AWD]G3V!)D>1>=N;.Z.U<511+S_-%K60)[),.KI0;;/^>Q )X7FY
M>)VL!S.NC='G\GP0A*00J9<X]A>RW]P6 H!<J/4\4/-0O 8;=.$UGAC?Q\<Q
MUZT-]\4L?Y!\IMCZ'N:%]8JJ<UJX-8/82 7N#_O'>X0R2)JE;IMFLLL@6N"]
MS/#U3T ^D#L#-7D*V+1P(%*-2$ *DR<(5O7XB473<[##Y"_A^1!0!03)CZIO
MB]>;\U?GL9YA$S_Q9W+GKLW 0%NZ4N<0+W8W7D[(8Y% [,V-6QN*_6K2CZ0_
M.\MZ\HPU5EF);T3QQPPJ/8-@;OZ<*S]Q-W<Y<<]H)&GR!?E]?U'5:Y%6E>I_
M6_DA0EW#3=DTW22=Q?U[C\0;'HL]9 W>BZB M';Q6LX=%6],P9OVO0U,52OX
MK42WIGJSX9]'RG\^B$8)NPT%7@*H%$?%08T%G[6B(([.^-\BTGH"CY.)#T)T
MO?5?EJR_'2WH_*R"><O_A:( +P',/_'$-L(.[G&;'D=L=)*:/-9H?YB7>?M<
M:,T$_R+-Q^>'+'5<+USNGC[FQN/CQTDCT[<\U\CTP7B'<.BY>N@X'TV6<2N%
M?^18$D<KB5$3.AR,;UJ:#7CZN/,BR27S90]\"$J'_L$TQM[\TEQ;1Z>>_]'O
M_G9'E>33B?H&?)7I'+[;%G0/DR!7;FYS&I8@*"Q1DT=X-G.V.[6*\]HTL"\P
M@_?JH#P1K*%H%,X@.=QF 0TM=,'#L=OO-'A)ZKAK+7<$QC!AEP"&Y@/M_E#)
M2&$=QP*3J=]?YB5$A"T?S\GSZ"TR6^W_B"737Z2BUM=0UT/<B.!BTJN+=K(,
M21\O/,@0OW0M9T.UY\J3A9K,X[[P?H6IW58?8G)_]KX*H1#+P/0F=9>IZO[5
MVLP"[UH7EN_-!M+K?__P6/L7NI2\;TN!QCDQ^N7"*Y@7.OM:,B;OA9)CWL$^
M@J2)6^@[/3,_Z!]9<XW=3GZ$:GZK6_4K("+MG\G32P"%LJU'\5V]^$2F(RD3
MAW$4EJ^./[7$)2=WBQ3O+;U<>IV'%!/J:HQ$R$$V-)1T)*2:;2= >LC&;*6R
MYHZ65&I^DP]5PU7/8+[HKRC97OS+=BFN_IN:^4/RX_7=H+AQZ?;89]*IQ>$C
MF5(TARZ_(4^CYR_2?#*%S-U5C%*58H8'!EE-S=^DY6Z/26H+_;%/?[.\*%C7
MA8P>7ZJ+QZ/(UYG.W4FW9ORDXLBWB87G+*17\\QT>NC.EJ42O9+X97OA?I3G
M5#_JVY)E(NGFV0 B1F[%5]OVKOR%^IVF6><D61]:X-+5O)760@@4[B(7H!#0
M.FF_9/=P3\!TV:Z_Z8&<R6U1_"A+<7&EZ$AO^OL'B$W9P4L SJO@<SJ^[2T9
M2-*GU/=$&/EPB$\\YVD.YC1<#5I&##H$+XQ%/-PV]Z*'< \E"7;EUK#_&!/,
M%?YZ;Y\/VO\4;DKFF-S #45UJV(J//E^23&XV6A%L\W&- S[\J65+W\3[$\I
M?)ZX9>O#7]1@]D*TY"U=*!R;"47_F:/G'%KW!1\@;YWERS(4N#)]:0ADE74W
M@_8I>ZKX2;,6&B+O2)^-LR/O).RJI!9"CK18=]"TCPLEM;E\QR?R0Y)NSK?D
MY2'F%+J@TVO,E*JE=PF CA9\BR> B#GX4:WF-A2^M.8U'RLQ$!KLN6#C@Q^*
M<U4)C0VL7*X6SBN'@':X>U8Z4J7]>6-;5LN\H7^^7813 B310>CO?#"BR@)A
M[J);0SY$:ZX.>6_%G>\VKBW*K^NG )Z^]M-80""KRFI3'931G<DMR']N>E@X
MFJ1>O#.%]BC39O%L;<U>G8/K@]8W0-%GE$H'6B^0(<9K>MCH>44#V=58L,F,
M5CM?IFWMW+(@5;#7MK7F;&@:"853J\9.YOT4QYS1S/LQM7<N_D[N_DA$KTLE
M%-1S[*]5PC@LFI 4V#_"K$:O,[#NO!^C <."!QR86^V%S6;D]=QBH=:;P?ZS
M$FT5MCD\H\$?%J?U%PI3MV!D1ER9VB,TLY7=GC*VV] TQ]7,;:8R813'J4\G
M2M2_RCTG,H9QCJM4M)^+%B@7T]3+>S!8+&S$,&&DHUN<4);9H"-47+>PNH<J
M18F$LE$H(-P]F5)[D43PQMJW8D).YPSRW]W.:CT\6!^_G-E5/UECH]IU0&6!
MR\_GG^P.9(@YF&ONH3&)6]:?[58-7?-J3W&Z9MVQ1A0''X#.-4/>7-21V>&]
M8B@7./OP>@Z*M[=(#P_JM^"NZ90?+ U 6*]!G;5F_4>Y4@E#?60>7&+"&:&G
M;"F]8]XU4TR81<!XR>X2H.<@3*S$+?0Z".+@X=W@C0EJHNL G%'RU[X:$^;
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MO17>HB".BR^($6$"U=_&V9L?Q5-">QUXW$I@P\2#]0Q5WJQ7>?S]GZL!]UU
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M7)?86@@Q=Q]G_=*P:T'([ SIX[H3*%'G&CDZ()Y2L$X+^"3ZENT^X)^W $X
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M OKL3!W*./C'Z[]]=;FKTG+/-(J?*M%LP],]I6_##;,W6\XS,.Y7J/1 5]+
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M6S,M2O2EKG?J75*7G\[P_1K<Y;#0J?TED#B7$5=PXD,IN2]#7#!&M,0N_4O
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M\;L$,,-6%_I/I764<2T%\5)^%Q+=,F<_=->>QYU![\I_^)W3-7"CQ/X!;;Q
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MUPE7]":F7I[P/C(RR;1+MWT6X#L_86$UZE, "QSWJ*_DH=U'=0;K,L&5EDY
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MR,Z*:-]K=10U.F+@8>?EWQ#?D9E0ZMOCPD_ <!Z[U:)^*<E7O4UF@5N00)-
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MK'\(3K&P%ZQ^'[:N'A#SX8_[QI(5VG;_*>!%])%8+TM[^A:7!P;$TE]AZ)<
M7CK>#Y#^>\,Q2.$J(/894@8Y!14(NK9)T\FG:;EH?9NB:7SR;JG,*M>M)YV
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M7_OBG.#B]10G<]Y\J=KKK::7/)*EG0Q?8<>@,Y%TMM, FHPELF4QG"D>4"]
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MO%*T1#8S\,PO"GI!45N)_56E=O"25N)I)PG_6;@*BFO#$K"<OY11Z6:HK7F
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M.20EUHB\.(V.X_0-=!&5.K+9?'D"JO@@Z^C$GKM.XOY3GB*2V.D!OZOOEO&
M_.,\&V]V&<D?WC)!!EYP+[6M3Y;+='',R-4_'[/S%1\=>!8WK?NM*D37*-T]
MX/'T%<QY71;%P:K)Z@_?;$):]5//Z_QGAC'2<;*(K;-ZC^'&4T,D$O@7'!X:
M?HH6-)),2A5/4#N3,_\C_([>F8P/X??.2?P#32+4K])X()_!YU!U-":R'H-0
M,834^'!U"^6B?\ BCF5NQ5 DS<L9S+'^/$".R]MKK5A/7E\K:TU8O9I6>UR)
M6RR"\J"\O)5HTHMKBG0AFD*(Z*5/WHV/U=N1LW+U;:;E3A_P@<^:?:5&'GWX
MF/J!\-,0HA:L[/LS[3J3=(<F4OC^"[8S*$%XSEX:)LH^+KV[ Z'#-V2,XR)=
M?D:258J _@",JX][7-N:YIQ%/)__(I9\O<4PJAGM["&+6Y7?J5Y=]5!M5TE-
M>+;2/XL48<"8W:C[V./;E?$&Q4\H49MTF\,:;P.NA)X^FZ=)=#S$@SW*$=<+
MG9DE&B32;I9+-6.!Q"[R_$9FIE.OCV*0U^_*_XNZ]XIJJ@N[1O/: >D=A*A(
M;RJ]YE6D"TB'($1 A! C(BU ($J5_@(""@(B36KH("W2E2I=.@D"TA.!L(4D
MG/A=?6><B_/?_B-C)S<9>^VUUK.>9\XUUIX3B<6-?DB4>'1KA.F>2ZQB@K\S
MEYST+T_ G<;0XOL,XYH48;P:P>/??K7F' =Z]&*,WU,CGR/C/36G<.XC)8PM
MT52YTJVC5?RM;9GZ)*E5)<6E;*I$<M@/83OP?%)J\OVFBH5/B87%^T+E54GE
MGW/(W'5,;* -6(2DTJV9Q7 W1Y AS1O'M0H\5.*S+-9GC>IT1VTJ2E@4Z]W*
M-\V6>A"I[KNAIXCG^]0I)7F#'N8'ZQV17+:0<E1M9[L0!YB-SO6/V:+^\9&<
M4LK6N,_NP",E=T.E\>:YEU52HD_U[-A;E+BEQO,O6E086$0$9!OVLCG5I!JB
M9RH$N$E*(L:L>A5!-0#<O%B]7K34:?MJH7B9L6Z+<<EW<Y@6D$NNIF:V7G%$
MWR&UX'O*>I-$])$$!V8;QQ(!HQ]Q!BG'>AI"EQX4U-[\EVD5L8;AIR-S*\QC
M,X8R)C W*KI7X<W;[AP^XL)H8Z"(C4128(5QOL-'HTWVQWI948N?OK##9-^1
MUL_][#=3) P+=QCQ6A0[J'PI_5;Q])->79F:_5*:);(B^>@/:X23)$DC[*NF
MQHKF&#?'<VP4?G 2#PV2-.;5E+E9%1[D,USG&B+O<_ BEB).PE%XNKJ^>\7A
MUSO*MGH-;UBWD )>?ZQ/M *]7GA:YZ#1>+_J<@<V9M;[=Z,2Z124> I:QF+J
M3D$QK5];E4Y!ES)>(=UBK:3S?WD[+=X;_.J:(DWU--&M%2C[IV%1MO>NW14)
M<.;:*<A@CZFFW0._?S_4ST9=*M#4-O;-XP/ FP]8OCF$($D-:6@[(>5/<EE"
M+E%"1[(E76]?SH\D'G(\P[&M_[ADQ(X9">]WRW)=D?;,TY1Q/$A-;* 5BJ9+
MB,#=TU5=[F2DV-JMF+]WR_YJS7_U<?*W'O0IB 0F5U"SM3G+\_LPO*V\!8ZZ
M5VI.06X=9;IE6QPR<B)O= H\"/3\EK;R7P1J;+ZY@2NA^RPE$M@COZ=^"!7O
M=^A=XD'[8,L>UQ?,DO,NY/Q\R8"4ZD>$*+T$(6'5VZ9WI<)T7>B\7I04M_+D
M QG&@F8F) D\9)AY)C9V<!(7IQ$<\U S;/_!?_K%]D9K.M(A-9OS3?)BIGQ)
M S[RA7H0L.,CE$:8M(NW=:X<_YI=;%.KB:&O>?^+4M-"?:]:LYO^DYOI.-Q/
M3.V^Q#=BS5"K*<F6^=5 5;7U+=*WFRATXWD] ;'U;DT=)T6/WMW%L4HS[E)#
ML=U0&L6<#O@'*7Q$H*T6<%S&< 'DW_*W-4PLH1ZMDGEFU]4_O=&]OH1(."OI
M;IUK6OVNX>4 WZ/)/R4D&(TQ]<2&8I\>HM 5-)3;A13>B#??R %5!SOJIOSK
M8K=..K^=<3S0^JJANN[S^$H Y(:44>G)*>C+'B#BU9W$IE1406KI:79_I3CE
MEP)C]="3Q72_N/LUL4RV\\WHP9_PW5A=A4UGV[5+?:].&(@*9'YJ%@T4AQAA
M0'&,V))DFR6TY4C^(VR(.(EKLP[R]?K4W()<!9EHXYJZ9%Y/_H<22D6<(L=Z
MJ+0!F7UU-$/R=&VVU$W:0(_Z[5KOPI=?1DZ<\N'UV[7WNYAX&MLSU@=5:W^9
M+7LIJII%YA/6N?'<)2[>2L*8C#Y.IA<C[%E/)J:9Q^KR!ZOY64R2W@@>N?+,
MP49@'9@??Z.FQ$^58DU ^7DQ 5Z6R<4MI*7N=X<WFG"QMNZ!=0OJI%S8M/%7
M!]?7^.H;W.H1.H\@GT]!M1D4SF R"@"E0]N&8[5%@=WY'@T4MM=_ZLB&'. =
MU9W)&UTMEE$DQ>M]95^65ECW2O0D\E_<AW]!-R^ EO_YSFHD?;AXB2C]"E N
MN'7XO):@>6AHG>Z=H\?W[FY[HO5SE%AA9)=9MD]O7?[KWCNXH\_@86$IJJRF
M#4DYX>''*.V,<\]3P_/,HIHLK)\_*(MLE/%X8O_1NV^EY$3C;I' >V+@XS$3
MM^\>NM:Z5O3/@]+2,Z6E\5*E\: /?YVQ+ESDJC.'U>8._G_LJ_[_+EAW!N6*
M_8G:IA.(^JE5EIXA3,<6-$5(M9W^T-#\3UUGF.PH <M?.4UP]<UI7)C"36&P
MNNS\&:\<@H;#6&3ZK EN#HEV/@FF]85R4YL@[F!>-/=T<;C1M!L3EJ)%NO?]
M'0[/2^I]=WG%8,+-KB_G&/DU)T3%KO%5BG'"[=^K#_Z$J1^'L@WG);LW/73S
MIY589C'%PY57HLO'_"R@C7H%\*D:DV]W>A B>Q0%P@^B%\^RC]&NL3R6\9V_
M>W_!_'.[8A;/_EM3,!NL:91DC[AD;WP>]] -#$=NM?Y?H?QZ:HRF"H*XU=48
M*@04$U.Z=BX: ,$D >F32.+T+/^J!T66(*N^.6<_5CZ%G[4>*\S<-S3Y_<?&
M6Z,\Y@#21V?AJJ[D":!K>>X4=![%>0<(( HPNXPY:-GV.#'$V4]2$#]-*ZZ,
M>LRVMX5XN^?Q7T=^) ^8T"9>];U#8EB,IE>2>O?"EMAQ[B,QB[* (<FV*X#&
M2RH.KS<\&#(S;8])?FSE@E029/C*#H-#LZL3CTPF9-_M8)%BB1[OHZZAD[,T
M6>D@+*>-UE9V',#:,:^0U&TYY);F!I1.MN5<5TUC";*>'WN/4-4S8W4<4H+
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M_YM5 3O4  K_J\>RT(_\<,S/32A?[9LL&QT<DOJB_E_FH?O8'8<31> B^3/
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M69:H)Q^]SU9'P&+H/.^/S8+@:)G"" 0N#\CKO<++)P3M;5-/1$*'M=6II>@
MO)#3D2Y).;\@V\'X>X;E6*7PB&W-]^V#BHM.TX<&!W,_"FJ;)I_)^"XH5;KZ
MU:=L<G+]=@D=6B+"',#<H=\%5+:/3IQ"AVC7J6FM=PA#QF:C:(W*+6AEH7:6
M:]EF*I.)\ER/C;;(=TV53W!_@;0MV<*&^F>-_C?O^R\$>D=GJFDK8SI<(8\@
M](4<#V#ST!>H.7Y+\4N"%/VROF(*G)34L7/QSMCU*3\,T]TI2^@\*LRMJ9UT
M>?;&)W)00;K XR ,.=Y"<SH@X^:WVZ'LF(Y'D.4"859JZW6 J>07K!:6U,X
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MHJ:KU)\]B5UHF/M5IYIT!=/1$:I"4HEI=5JJ,=O6(HFO]'6.7#0KT?$AW2;
M.'[,>OH?/^Y54PH.9F4!]+O9-V9]1U_Y<*DG?FA.^9?4-IE=5IV ^1>S_ Y"
MM(%$GH*(YL'RW"A/5@9/,).V L#8R0SK7F(]I&. G3C!!1;$ZZ<P&'&J069;
MX/?PN$6.-//=7O+PM'E-.@(.E43N\E@?0V@,/<LP!HH&-0KWA/EL1[-H5'CA
M/!I,=,(%>#E[70$CIS7U\Z%;ZFL50;_R=NN9C2U:<]8V-_T#"V1*88^]2T]!
M&DLU<N'YP%D:BS[U(UIZN>62I@J^Y6VHU+S)1[AY85'F;X3P/\2E6#]NGO]*
M=:XH &&_5RP-1'03^=]?"OOX"B95LWB>H(E+NMU:'+GY\^TN2_^MS^V.],%^
MZNK=5-Z98QE?&-EM.4BL+SQ4'1$4B(4[PSL51<4^_'GT>;]>*KDTWRQY/.Z-
MVXC8DK3AOGA167W*QB1N%LM(!XGW92AF]+(L0;*E<(Z&<BU '5'N=R?\4DDR
M0 J]_W_5D&2+@7=YPF !3T,.@\:M)S?44VN^"1JX2OV+;3H%P5GCS6DCN?^T
MRZ"1&3JIW:,4>:)>XPKO]^NMCMHFCK[!KL^?6AP2LF6A:.1^)O]=OQ\+TG]:
M_NYL2\M3;$Y!U:S=2\=E: U8,X9H@?ES,VEVG/8U.N$49**T#U/I?JB6NJP:
MWC7/PGMI U\[++2\'>IN-C>=.W7+OL+VBI^NVL2;#:G1\93X/,;@\7A^C@BK
M7SW2DIVIZ5A;^9C- UQZ7-[/I5I6"I?+.#F1&JX9?(+L(W:N=_'0+HQK2WER
MH"X!L;)&R'N4VW7-S2D2];7%]@606=R3WZ,YW=2W#0;_L6"D#F" VG76UXN\
MHP=)X9#JZ6[PZUPA/T=WB\9<_&)R^>)FIE[6A]FV3+O-8IO15H60TDT5:-R\
M48K]W"_B'+R72X5W]]EU'0R-(? 4),$"4$]!+M,[CJ>@H@J;9AB@C,"#PQ7-
M9G0(7KT:(7+#,"%@B=!;@H^COD!(/YG8T=3 .X)UT_OTZB:4!3\=;&#]C-ON
M$B8=75*V"RHK1WLMMTF:&E_F(=$D:<5!E']@N2HBH>3Q9V&GOR>+]'],H9JZ
MF..PIG5E9JR7+/Q*31IC2M1O%I7U*HF'!$K>L7GSX6?)I'E\8.9X;< <Z8\0
M9+N0'@Y_1FEBM.]!XMOK)^:TX>.C[0$"CM=S"LH:=1BB;SN!?2JKM& 8(6#S
MCI"MX$0\BJYW%-9R(>775D^Z)A*^B:<H-;-U]_I2ZZF%&+A7!+C&ME.>G?(4
M6"!X4&XM)[%<>@3GX&V=5,IV.FB&YX"_*W[%8$H1T()/H[/V/2^YQ3XWI3 9
M!\<0:'3$N/QS[RS@;D;:HR<#8[-QV7*T7\"*&1L*>@*KBU)58J*"C7'$HNK\
MCF ?/OMG+$DA2C^;70WL*W0/9WL['DKLXP U!*'A,[7BA)<B,BEHT4;DID67
MH8U(<FE%CO5MIZ#72G<^>2R"9XZ$P0UW"K.-M.0"+72CMJR:O-E+\KZ@E7K5
M<J. P:RSL.C;N_+YN<:J_1NNGBLVW,0A_<//;L![1(EM%OC<QICU^WP]BTC]
MBYZQ=_--"SZI]G186:XGS#76-@QM[05,YS>LM] K:4='+KC]ALIKM,F)-J9#
M7?LZ11> Y6O2;&-_3J+- R$S.SGW4D+^!6 = KW)7A(,S<;&2*.=G3GT"Z,>
MX_\1.Z^E,9VG T?R5+U\U&T@V 90(&W=JTX_WL+GQNX]:G$,FNI&3NZB1<ID
ME,T^?2LP8)@XR)H3%((.GVD46PSVS;'#J+3S8CK0H<P4/@"#AT0N,>.6<W+!
M%,GEW/,>#5#>Z .MVX["B[-C_?W<"8[=T,NA(0L#%SZWMR;?/VI\,>2GH5G3
M OX&2<JMIR63W&F,TB?:H3.PVMSM%A)F&?+:%\*'DMLCA$1D/GZ!35 2-&/7
M<2OQM-G(__5]9FX>%=YQI*)^\37SH!FUH,7][;O'.?K'\D!4D\SO'&3Z0%?L
M/%_)HVJ_W\)7HSF[%$HT;7ARZ[J<:\N%'G9Q&CT8Y+(2MV4RA=B66:;+8A?+
MR(R>YKY"LH(1DZ;(%+B)CY9P!OP9S?WXC.W04GWNC@FQBZP$\!-.04D8GDHO
MRTX:M[$Q2G%(5'9MBJ);Z9E:492$I_(PE>Q\R'@P(>?P3U&.!'(GOZDE>THP
M0.D@(=3RKY;O*<AUZ36D(6/;@2 ?#6,4,:;'#(V=Y!Y-NP'8=NT[Z;JQQLII
M:O#DPS_].@,GSU&;]_4GL4L&B02#1UDV4</\[C$WY' CFO(1_=44_91'M8/&
M'3^!\I&+.K>[2TJ=^A@LZD2@IN6I"7Q-C?PV*=[Y/)MM5X?5/>6>6_K'I5B$
MFFR&/H(O$9^K["@0S%B=T!;$# JG5U_04H>T0U9+[4I+2'!/HTT<?H#I94;C
MV&:Z$RCW[HEN^3]#@\F.WYR]U&\;>J_F?X7HMFK05[8O$=(#^Z%#"-BI(&K@
MP?&MSN(= UE,F-<X)DU==92KY:CM<%6JX^<JDD3MA*(7V\RO6=TC<LM#CR5/
M^/4P!.*MS.YH'NS;WH\3&E,\Y''N.0!,UJ.VG(*>Y%Y!*[8 ,/R</*B+@#S;
M%><N<\P2=SGS<8#V52"D;&[C^D9! @=3V2F(96%AUC-8O(UG?,2W_Q0TBNU
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MHZC*Y<F#"B4YI3BMLP^_[WW(,IM2=(!#J@]5G^T^NRR3S$^KHKZGLZ F2%7
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M4<R5<;5O[',=6H,%+,7]=!RCG$1 MMA^YN<^":8O[<"_TO\4+OIW$$6;FNR
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M^^YGWD:O@$G%VT'!"7#4 &3FG_N<(+J3[YF_:_M^-FM9CWC^^RO-KGE%IU1
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M[!\T*$5>;T;+A/V:^TA)Y=@EO_KKL=IN1&8Y33@L8.PG((W(SP&!P-H>;^L
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MDE[^WW:0T@'Z"Q>?*G.AU^.\JE]0OZ,8N!<-N&0;J1M@38]RJ]]J0DE(?^D
MVWL"!NC)O0>"=IOLY*?8(/^K=(^_-D.$+KU]''8?;)E,D3C-/ .Y&(5S0+T
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M(Z9["\! 2T-NRDO*U_]#LK]W3R@-<"3)U?1_@0.(QE-?JE?1!?5-[]:CNC9
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M*F%ISS!6*E9AJSIMIRNC(= Q>J_U:C-?TRX]K[!C8TQ;:/.N'^:_:4&;A^<
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MLJT*0C BE-*[;BAV>):]:)2):W+#5U@N@GW0O6Q1B&^7J/)9]_>:Y!9.JFZ
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M]G89(N!K!>55AF8))P+NAQ(B/T8ZQ^#QH #$=X)I*7P;]D_M*(4&),]5#&)
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M.1.6?T2 <L2'3C$Y.U,F%^4XXM%GF\SK2P+8O>14IN)UT\.C9)]?G#7C_N/
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MAPB)20F)$Q5GBQ'GAS,& /K$@ D^M; -!)AP?8L6#+,B-;MXQ75=^;O2[37
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MDON7M4F9*N@4FQ-1J[-=E#IQMV.7E])7WC[&HIV49O/C;[$,=&S/NL6N!KD
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M/B/) U"%\4B3&L[-C4&$0SIM1:96*MO(S&Y?5^J^X9^>]PO]7FWGJ'> E^/
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M&8"@TZNTXTT:Y"=OK7H?M6A_YW5<!UI-5[]FVB&]#P+ )K>5X5)Z>$204VO
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MW/"LPPQ N!0>N'QU[^94(<$J0L;T6790WS#,K=+>\=%S2$O*0D?\H\?MT9Q
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M8;4Q"A7,QY^"V 8("<\.Q:R+=9U*X&&:.K^W\'DO$L_'A33?:Q9!"@H1;4P
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MGJE/@SK<:H.65A0^1?:84L7#OA0P 9<+N$XZRS[/:/ 0I"V'K8@#;Q0.VCN
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M@Z"'AW^P3:!U:V:OR8R<!Q"F^"382_@S-D6Z\BTF<NK"U\"V4Y]5,:R$S8Z
MM?#4ORB*&EI/05&6K846B:H4V7I6%OP;]]JKMM62LWDZ#%S_NQ3B%#J'/AC,
MRDA!HQ=.O& @ BB*&_=$8CYNK7FWXESHBM8(#%X"HMXA46 FMTL NW\2G6N;
M>#TP2W5F.4KA8P=G,:JTP#6C&4?!USE5;?=XBIS_%A^ !]1R='76/OS!L=@W
MA]+CM6FE+_N=/D?%('3NE&M$*+4\Y6B 6TR7%KA()!;F[)?%;VPJZ19FYZ"M
MN!.Y<=;5\RMKH#VE<P::2.1U*%DY40/?2BA;1;PAP#2R]"-QKO*T;GC;%<_I
M?5&Q>'F$_[7/(5^U:N,>*MF4$-:X<1HT!*%2)?"\YN#7LP2=7L"9_R4@/ UV
MUKH%WC)3#XWJ 4K[D%__G?<KR-,J%5NS8M/GT%DESS)O=MSR>2)^[1W+,,/I
MPU+-C,4-,_C"Y()AWUB:$H/]S$)[Y[\CY]-!B!&)0O<_'H?W7=@\AJ:B/NGZ
M>=CN]"\KX[@2T]^+;[2V- %Y6J<32M3IT+^L,QS"-2C[0OM) U<)_<W*L7AG
M/F3J>(R04[#39.D_VGFT<AO(I%6J5;+]ULKZ.1;5!U2>]O!K'YSRM+_'GA5"
M];RV?6ES8; BR),/-"?'^&<3]OPN:+3FG^2O=U^<M"AKO7/>5%"9*G9IB<C=
MT5.@CX>S6KFU0"80S,Z4R>\2(<.3IGJ2EP#*P/,%V+O:4<*CGF5&0@C&XT8/
M%SF.!,> *0A6.@T3*H\P2W1C(M0BSR<K[<T]WE0B[ILD"A:H_U[M2&%.-PNR
M64)> ZTVPW!:W.RA"R6]2*Y+@'-MP0B^NGN9,P_%]0 74.)_-PW( [&EJH<5
MBG^I6)(V1T/B'J>O&<5.4FM8N>N:SEYX_.YL2A];^$&*^E/]H\4]UC>185R2
MJ 8W Z,9'$U&L<85D_U3?1H&?1/]_</2%7IMJ;YN/N4E(Z8YSTW"!3@>&!IO
ME##OB^PC]MM"_/\A<\8/'WP\)K\*GR]0V>EU7"3\7(4TF<O2/O?9RMH<XJZ!
M5U$.K>0R<E]?6H:\<YZ4^.ILQ.4I7MST^O2#5/8<\LJ+-\7^J^J,XY*T"0B%
MGJ6G.WU=#_"*DQB"<5MBJD"?B"KGKOB^$QX6_:UE>G6J(>ZVQ,/(7JK;^^NS
MQ;GK5>*5E9CGZ,T+%L%J=,4%+Z'<+;7WMS4HHFS\-G9S* 'QK[177#BG*#:N
MB+RD<U2Y5OMGV<VQDH2R24G+XI/ YO&FC)7&I$UF$O7^12+,%33/C<IKZ,_8
MH\556Q,<?-=TG3&=@Y$/9ZO\LB)G,!.5'19<)7S(8]."TH>(@FTF-Y+[@/D/
M^8^-T42.BRKD:@H,9T 3S=VH,+C/25 [=L!7M6+ #$1;_&8T%%2!=N-B9#JK
M2B@C9+Q$3NTCTM?Z[NGQM#5D"ADX1@K=PE:^_PC^\T@=FFNQ!KJW;FV2A_>X
MT\Q?EHAE8V%CZ5"UA,R%%W"0"3.XZM"P.#RPT/;YQFR$-BG-2FLU]FORZ=>3
M$S#04"C-SPRL,VA"ETPAQI4(J@7;MIP$'1SJ\:R'[:#9!)"+H/!\1K1(^'7]
MM-_^W:W9P*8Z!J>GQR>20_1I3H;?M6M9!$XIKQR"OLJLBC /,-KY> ^OV4_S
MX0HP5$SP-[K-D#2A'%ORN;R37BJJU&EGD<GYJDU%;F5E[O(*#ZUTDI:&/LO3
MAR5VXR]R)L!"/1V^7[SU0J*Q=]IO?^BWKU6T-J7S\ZFM%E6QBZO6Z%AG?-I)
MF8V'4Y3:%EA7F>G.5VZ9P(5:"[-<BW/V*I :[=S),-RSI/GS-9K=\7.J/V"J
M+B4(CR$A9&T$' .^YU]&5"H?=5#]_<ZV.K!DJ,2F?6O.K*G=TU"(LGSL1_O=
M5<7J9- JAOO7^7'R!8+(>2ZUM5*/[!WUQ89LAG5HX97W^R5=,I1U.S+EFIJ+
M"/*<PNX?RK>5WW4$IFPU7Q&\(D>(Y)]R3,691'X%V6!0+GFB\V!#S6?6#=_!
MM4/F\&P?&D#Y!H.4K'"/AMQ:]+%W(K]GIO]B6@&7JY:-M%P1VS)Z).O+,!K]
MEQ0X>3&^D46B/KB(NP2X(N>%]=&:)#8>C'@GKA]JQ_R^ #<Q)^X7-%:%MMK9
M+PW)=K5,_\HHEG[\2^ESGT7A ^,(7I(KK,< M!H.;M",#)4A'*XI[&:LMH:*
M$/GP^]$2*H;+%+A_2^V0_>ZVILY L>/Z8OXHR/$X@O".4QL;Y%<QRH\])E$)
MI<P>]P.'CLN0+6XB?VIRI7PTR.-]@5(H@Y$RK$RFX@N@<WJPRK.Z15T.1DI9
M04OI/A5UY>DUS=P<%ZS2-V6X28YP:N&>O9M&97D1^Q"?X,[P;HJ-9]-^T3S)
M:9GEZMK KJZ-/NE! XCJ:/Q]7L/K,YNB167P\5VD!Y::IN?,84BIV4B$D'BB
MC^N/*-2_)KT4E&S5S_%4,TU\<AF/#R117$$P&07!JYP UL0-]E*K81O041_]
M0H+[T,UA7D=*LM0W^MIRQKYZ07G(CBLJ7.NW Y7YLN6I0DJ?N#49+2UJBW&9
M\UB +QA<JFL11RG8YN@BH]LIKUFL51BU3%#*D.$*6LL2B7TW$_-RPR0>PS0'
MW2?#AIT6TW6R9WLZ6Q1\,Q;;Q*6YWU#5_S0?P6*-.X*[!K8[A\O -D>LX_;C
M.X1P58.H7"E<;I7HW]\U[>=Z7\4;EI[<3_\[['U\6#Y.-Z(BGL+RJV51Y+3\
MHA.TNH*P&H#1D^X3SDFW+P'8*QPG"4UB\9S?\<W=JIK];+:I"*(<GOI,'@&,
M^;I-MJ*G*_>UHS[CQ4^H.C )5HP>-I#P\DAA2#I#711#;?#.W3! J!@$N:K_
M 8EY37SU4X6^<@6JBGN>RZ+7BC5N%G)@L5B6;9>/WRNEEGN=Z&&,ACGU/-3W
M9Z<YU,%M[MF=.X6.YG$3??!FFH14_"-,WL">>]^[HDM G^F,[@6<U%CAQCRY
M["9_M<'9SAOSV[0J4\\?U,_*SJNG>2+MK.R3I8\("F%8XHD,EB2$V3T7&<+#
M:Z4KK(3Z)]-E;GS!^GR._3ROQAH> :NR\U;T-_5&.3&D[0P@M R+A$JQ^<NL
M)MGEQN%K3,NU;OA4S[.*);X0MCG3U.5+@ D$3*)PO'*^ EXB>@[E=:Z\ O&X
M,\IQ=A)#M%GM5$"9#J=J4ED#"VXAWYU(7<>:L(4@=@]ZDWCO?;\W-W(): [<
M]2T-17&S5@)O0I*P-)%=]PGHD>XN%KQ"H@ NT_H2X !Q[P,^M!HI4Q'B.+$3
M]^*?$N6I;4GY&^S.*NZ C'1P<*NJ3?H9-TY0K"91@OPQ6PW/\ *]"SI#E9GC
M)+I'^I&S0HC>'Y07;4P9+[-TK7 E#S6F+,E@.1Z1U^=^!R3G0WTN*D-EV$.
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MM/D;1_N)D9WNPJ%MZO>BU6\[OQOOG^_ES1R 63IDQEMY/F")Y7#+]'74AK]
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M:H[)4+L]P&)=DG2 =GWJ[Y.VEK*YG>DJ_F)*K."?=EV\D9[Y8@FC94%]CK^
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ML#R"&_E+/J(\/(5WR)_ Y=#FB7>RN9D>LWKGM;(Z)@>%6&8X "\4%G:@0;>
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M1W4H?NMNHCRLQB2>%\^M>=+M0970P<7'SR(WY$D",X&*I<\@'R7[Q"^S8&4
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M>0L12SDMLWUUV^^FQRA(G^,^$C..5P,Z);W+YY5L+-;'1ZR_Z'&X>Y"X8=Z
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MG\R6>&_3EX%KN6I=W_::I@E,EHTK(H5L=V?*F%45],O:F9=+0CM"U?7Y>[<
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M/%GJ\^D_>X](Q5O;]/J.PJKRU[PDAW&G$>P++#XUNE+%4=G#FT)&PQ7Z:=C
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M)WF)SGS&:KJRWU/(%P*U>(C2,^I[7C[EPE"A!V\WS+6?[,I\/;F-!8J?H0G
M(UK#N1<;YX]>  <XQ3_5A3VR%!:GW7O8E/$UK,YRT7)UG/XNFH*'Q["R*$S[
M=C%/OFLR M?DMRPXENK<YIO^<&9_B2W.Y6Q^8?>LX&@^JHH5_X8!DYW@(E/9
MK[,T)/N I61_H4U_;+1J_PJ)*A[^F[#P ZXEA%*JL*X&YO2OTA^/W\5[7))@
M'B93_EBAPOIE-B%JG<Y"1G0O&C!U93JDGX.C-UF5TT>N$>)>3P^G,VEI'JE"
M>DRC.K01>".3ACDEN6H714Z$C=2X8_E.0":C7,8D0C-R:U:K-";Z5%=CMU_;
MZH ',.\Y'T6\_6<#<EO;9CUT@;/7DR/0GSMQ7LD1CKK)*?F)$OGT+/Q181WN
MWEWVX18S%]XL9JNE^@_?B9^Q0/0*]7I\*FG/_,_KYC0-"'#9R;&8FSXE(*9O
M>BN#6R;>YCB7US58\7:C731*(T+(Q;=WLO2**,IVI:^JA]+)_XG];7 /KRN?
MQ!SL)L8:MLYNT/#Y598&V0UUH[)W7W@5"PQ'/A%6%AE$E+;#!HS[;85U\I3\
MWXQV_R#&_H*$0]B)] 1_[)$U'_[%AC*@GU$D>NYU4S,E8UW)E\^O5LTG2@7+
M=U*K'!XN6Q9I#:%9>%5;SF9"'5_B6I0&*#79,C&?\$N<?+=+ 0SA-0:T437Z
MEOKI+J \A?X_\=D[K43(5I"U8\H&SASLG;GA4SU."C:6S(+91=2\0Z^[JBX8
MUS&[/16<A<O.2H>_J#YX%18K4%O\S[\V^_(_&^'XDB2L$*^%KSI1PNV5KLM%
M'AM0XA.5R^.UD+,UU:56=:37PHAJ(ZWRH!)W$<U-TWW9*W;1.]<ES,&/21H(
MUM/LO22A9E8-+<(;SNH": ,G^?J2=;WJ;[9.R%"8NEZ4:LT]GRYV,^?M(/6$
MG!E-RQP P0T%!C,B[K+"E.GSOG:A[E3+>;VWJ.J#7<-36%)](N>YI+[?B'\+
M3C=A,&0PI%6[XEJ5E1*5E22W*TFNU@T2VVXN#(0L," .?TB&-C_/D*-Y._3I
M [.]!WN+E;4P92S:-)(?8)HWU,4I@Y,(Z]&@WYE)?X3A!\>E4UR2:&+%)R$)
MT(?83&GL^+N-.PBV'&]&FQQC#-*T0&+8AP"#9-@(K?G$<HX^H8BOL+P!KFY0
MF*X!1RB>]$RB,';L+Y0\J0,]'V,CHTKQKKUG*@4?G5B5JU];6"?#%_H=[1S<
M[_;VW[Q;6?1],^^+N$C\KZ%Q[@:.-@'$;,54A(!:NH!:GI!7@J+?3K\:_?K-
M8G(U6AW)<-LT.^:2HBL6F;2M,U-E*VS29RLTC;#NU)ZML6C<!"-=D#S;H!J+
M5)\\G72^I3*%P2&0!\B]Z6HG5_T?%?.JB%RT=SL:W"5.%=QJ/(R"T1,'HZP@
M''A7$ST#LW0;Y,11R\+NL,5T>IAR7XKE3G.#U,*"8&L'\,<70WM'Z_:3%Q<I
M*HRP8<Y[<1K85SF<A9B</<M @M%&C=K*#83K;_0-&343@R,J+L&XSM),CUZ!
M/Q1BG%MKC=L_#@+Z6&DBCJI& _H65E+7#^CT(VIEJ>RLIMV.\L30R[>L@T?5
MB$ZBHH6/I29'A;@2JX77$^R(MPNOOK3]KQV/H>(5L+E+$E+NV8@^<+=C$^[9
MFXBZ;.=XVHCIHQ\>C4WQ7ZAW(M8CY0=R>&*8QJU5R%!NG,[]\HDRG[%;TG(8
M\C6)TX"Y\I=US)<DY3:??C: 4+T)K,F]<U6LO\H@= 3GB7A!072FDN.?2Q+<
M/?P\/O0)ZHZ*9S3*RT%DE24/(]7!F@XX8/>0M:$S3W<".L?UVL#?E5E2AN68
M69C%3/<-I>L0Q^# [G($$!^$LUL/[>_D@#[!-F/XPV!</^PK\TQ[5 0FH'H.
M](EQ]\,P(9R_#D1KU12E%ZV8?W(OW4RNP'1>[QQJ=/E:H2B[8UP,SMG,$_J4
MKO@^944Z?-J!L5TF"TLE6PP.^5L)\>%_? +W_Y\%KO:'SO]>&T!?*!RMQ@*I
M"7(8I%-)+(?:ST'WXW9Q29XG? 6U\VSN%FB3>U] NJY?YEFRHGCFZ@VM6I:H
M*:50)CU;\DIB0 H+)>2GEA%E$7W.ZM ,..O7/ 6$H'I^I&G.JU9.Q4C'E"TS
M0K%4[Z@!5=*PY(?X6W(TLHWEF$](07"9N+S>:R Y3#ZTA]DON#"X"GH#=[3@
MUV[MI,2]T>LA.O_'\UPV,\9OST;F9>V/M1>:SUH4:./BB/;9W9PP2=C@)0E
MY>;R.%E?:)3%2;(C97UIJZ>'+)!ZJ;+"5[2ILQ0YFX$C*>'X(ZG%[.8T,[9
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MCZJ,;9\XG-_$Y^(;3I[B.<H[>ZW&'=?)C]@RG] ,RD4=>AR%\F;<9> 4J,:
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MDF!J^[FG)E#\1>>$!\>-F#M,[Q>U1(XIM5E4L\>?-[4B/]S1IKM-_-2]E@?
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M@P]$?R^N+?Q6]G?T]^"+C$$L;:UL1(#MG[/*V/K'ST88/_YHO4UX\R63Z%&
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ML0I#[$F6)(Q6&Q,S4W[8>X.R@9=5L81XLJ([A%A\CQH\R54S;:*"W_C\0SK
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M(^J<F-]XMK'=T7ZV29=XR4)PJ[-TEZ]5W)E.:NJIFC.!RT_(M>'H6,7:$-4
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M:LB*; 5+]]B(.L2]BA:NM!I#[1>'!#O2G^'.>E9TM[K'3]:)L%Z NI[[*5,
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M_YMDK3?!#ZTSD-XOW:D$1SW3ZEH/[)W!KJSDI-JS4*LFM5$B'SB+>5#S(?V
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M>!59OPUDK:PRCV!T6XMRZ)X]Y[]Q?0O?"!8C;AMHI"._Z+O79K*A.^XL^QG
MD0< ).M^Q>/ T5P/JL&[\5";KHK\?/ #4A('BM.IP?F+A0Y+V9R.KGD:M*_+
M!(V@7S$^'>UR(B^,B/KK3!R=V.+>RFH,K*MFM$S/TCA[??*1LXV5G%)][^_H
M&O.?^N3/RYXE1<C \5_)9NU&]EYC29>@R5TRNGS>88$DZX[R?C5%-;GV)@%
MHZ%7!F; @>_5PHV=J8ZCVT'FY7]4]>!*45='C,"QAH^G,:VF@V*EUA2:Z99$
MO]+KTN@RC7ME4<G^<;N\ U #)[F 8)9 F'(UV,YPBJAIP_GB1.KG48$<W.$@
MSI/$W=,SX9Y"@\6Y_U2-&I6F9.VYC5DJCF$F.=6RQ<QUYE>I0UX\%\3/(V6K
MC4RQ"Y1KCZEJ$.T#5F#D[1GTH ^ Y<\MZHUS99.<#?=^C.2J-_'HZ/DK-4YB
MI,PO:M'<"5UT$/.;E Z;*HN]:)1M,/^@-4G7FB]SBE/70[3]P'A7.7R9 _);
M,;<('$/H#GTDKN*05?AO3%VJ(:Z4'_/[%O#1O(M\GPJS?%& .?<M65&!7UOB
M]2H1G5F:%HDNK3I/!OLB+-WGZ4WPWLW[W0(6$>91+2IXXQL_C8U?A=;+XNZA
M*TDSX!"U27C&X*-XM;!^VP+=M.= K"H^N3GM=$*,$9_NLE%G\6&%H9ME/G^,
M!BBW(_O<2_OFNENJ-X:G9B3!\[\Z=/#_DN%=:=Q\4[*OB5-B"75;2V"EPEC#
M*Q,IANGB[=OF)#N[;5 7X625#YH+J+/F*SU#QAV>:M4Q1%NY#(_I*Q07;=##
MSB?_HT?"&LN)H77M,$)3FV(-,)$480BZ68$?J/0/WJS,+-)JK622_%\V %!<
M5?(#>V$7>Z?6F!OIIIG&:[KV])'!B0FMZ_2.KN3Y)2;_SG9[0Y?*EFB*:G<&
MBD>3H@%$3\O=*@!MUM&H[@\6;$F.;?E4#H;&H=G(!DB?1&]5L*1 -Y])AYNK
M$1_8@GI3GZ:.FL9D "GZ#JKD\L"<5)=@)7$O1/&/&29MH(,]R9-+(PK"TA<
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MS ]<V7H.DU:N9F0*[A4+U-SKX^2_.&;!NH[A,BR\X)&1\GCI2+&."BBD*TV
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MOJR$XH6OM />(!_+LE+'2?9GOKHC*% _;QST=^ EF6V[ZJCQUUN P$]O:6G
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M"D1SI]'9I7O5.F4FWDSJYQ^BCR)-9&IUC'*<&G&E!3,[EDNB27'$E F;34/
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M;Z3JW0*<F?-8OTC= AC.!HZ+\#(V\E?;+FLKWFW?&@ #@W?ZY< #HR\"Q-P
M)Y4D;-<WDK)]G1>^\9=MK.<OL#7+;>;RZ/-..JJ:>"I,2"@:S$]$!'&Q*=D/
M< G4C5.O4#\X"C.7Y^%"SJDO[:H%6EV1WOP.$KB&_P.[R__R!D$ F[6WSW4G
M6H#1!.M]VB:B010!O(."*\\88^TCQ>D?2]/,32QKUSMRLZ?S>^Y(3ALZ+-EU
MSURF;D^_V\X,C,]R>M"(W-LO_T%T+]+YF>KS>U_N/&-[YP88L[;J.L<S+EYY
M!,A<9]T"/O$=SEZMDG_Q$L(-:OIHC /YL)DD&E8X=:# JIFC=&=M "U\^6WX
M?AOEJC2\JSY^R,Y,X;%<>>/GHU?230TWQXX7K[>I,S[^C><>KEGX^! E,M))
M(--LX IBB!$&#^I=;@AB)K)@NF% KJG-JZ&@KJF@C>=$Q_$2NMY4IG4V[3/^
MQU8^ZS6&1^U[?W24J/$G[O];JKS_EY\/7KY_17^/XM4:A?*#I]B)SA&N&V)_
MC.+5F=]U1R?H%A!A)($T^VL>H#$-]$?!4J5^T@;1XF+XP+6:S<%2:M&RWDV3
MKGL_8YD'&JRD[JW= F#M$$X(QE-[S\>_ N>*\MF'K2R2F;4FW(/A>6\!,3,2
M.O<3R8D=?+3]5Y8IEE48,ECFU6<XVR9<7#]TF[XNG2OHZ(L5.K $8#GXTV+7
M4VT<E',9(S$)=^@UB_ND+D4O^^[OSYO"C;J[K);*HH)K/\M@/'7*ALXRUZU6
M6QP/I_SJ(,\L6; DH+?.!P1JMFPN3STPTBN#= >PLA]7?X?P4SMNYJ^\'VN[
M\FH^B2W+O\=JNVCL92?U%*,$%G#8]NO=2'H!9O5ZJY+C<B$\T(X;&\)=54@3
M37?6> )SI6"\./_7%*?)EM]*3Z:V#T:'5^>T5V>6K-K @:M%7.$%K[E&"_08
MO_<6OX.30^A3^G1-]30KR]^C?=50\P8@H7-?J=YW:0WDZP.7V#QD'F+7</^
M9<G8Q<:YYA6_)QL9<9M6S5UR&V*L,<-'N'UI-T=#P#]'-R% _XZ\?+$UO+6;
M(K_(9P1D??U-I<AOQ?Y[?%YJ($3\]PO2EF2^B<^)__V^9%B5N)YL1UL0HPG/
M3+:,*TK8Q2=(=MM6-06X$-!J4(=5TDTA;-Q.J5#B7LA8Y(2[PT1H8HXTC%Y9
M1%.H+0#DZ_R/V8_UY/*$2Z$Z)ML>AVNTMT*],Z?NZ<C:;AB U@C8"'RY[G8P
M_G$)O;1+*G/A(5;&K97](#DF4Y5BV@S)):(^G5H+/CQS;LYT^A+ [!9[T#M
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ML Y?7.0H/CC902K'_!L^?+3;WEZT%;%.\6@[_TWR/<?[('V-2CF-B+ RDX,
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M\$OX6OS@):7RA2/ QW4"THSQO .PX_6%7PKOEUS+FNSBN!'/4U$C@R%/35R
M4P^VB/BVQ\#C=%BYW%D?O:S,0L/V='>.Q;WK=8H:/DD*U.(+NK'89^^;[:"N
M'8'9=,8="]:+GN73D-C!)11T^)0,:&/6[HE1%1]/%GCIS/'EK[E*)4?!AWJ-
M@@;65IA[O27 Z$%FSJ//T/(XEJVV/[?X<GT'^ ?2E']GT-><N@G%[.>D/S4Z
MW.K)GN2DWLBO&9M./ZSP>U?;Q4A,;-Q=@B%!4V!&!DJ6X65#6"7$<FE$@&_.
MO-@1S;%@X/;O5Q&$&?,R(.9N49SR+0OL'DBU3P$/ZXM@8&#5Z(G!,;^35>JW
M96EGC:\<R-,AYT=F/7'-DEDHD@7+I*N/DYUAWR,/%B=X2Y:+F8"1TNAI6B\F
M;VL=+Z3U\T&O;9?9D*E"7SXC2QW#;7X;-NEZ(/ML_N!,HEX,$UYFV&SWHQO&
M"W"JV)Z1N_\#JJ+:Z@^/QR\>FJVWZ<WN"+U+6SU5IW/*L.%9.CB-%R-DIOA@
M#HZ]8"-QJC(?]?A[2!'E$8$@,4HGB%"KEJ978]0.L\(DOIH/X:\YL&9>L/MP
MZK>:\SG^(1_Z0:Y J=UCC%-<==R!1&$A$^_UX1[]EA9P:^"@F'X7.&20("M7
MKI-M<5QEW>W0U^Q$%^AOZJL^U73&]Z98+ZYA&Q21K1G O5A@DX+Y!Z\D+Y T
M:(G'D2DF@P:9]99IM^O4,E&!]:0?C:.\_\P.&W1V:1PRO@=IT\SK*8<'E4P/
M6'XI2\'_S>P%A!IB6D&K^T&7L?Z 9?\-/*"O:8=VIW<P?\G*"0.7$6#"?;!F
M1. (.(7'C! D7L,T#G9(QAZE%6NK7--L.^BO*W^3Z5H;^-RK9DLTF'Z/3<"G
MOXOS\M.\NT?WBVFP698$CGE6K.:)N"(]F<6;65D7:O[<B4-:I6PBD@I*S&+H
MH$CE%C@VA#O')!--X_$(C1?7EA[-#;$]L]21C#K[E6_:9J&<-.5UX1#=J>\I
M,-C4;@B]7 FS!/7*JA?8.9?KU(8/K'B8Z:NO?Y<I(EHE3TJF7EK>K'IMM(^;
MT?:TWUWSU+;2Z?\@1%1%U'*\YOCV8RHHJ93!?[<\,#P6I@0%2@X&X26&B(9*
M9"##\0^O5>-A<I6*0QQSS:<D+L;7M1G )&F3YGF^S9S2FZAW?Z ^H0IZ*:S>
M D45RAX >V_^K FO1YSWDJ9I4A^BB(\<8>%#^9[+I[@%.B3A1-N(<MZK<^K5
M &)Y\&S/US9/D7ZD7 NQ>(5=Q>2D@$;FH8$1A4ESJ;R9!O=8@8[A>HO.X?K2
M7\]ACW^PM6S-5AY;R(/(%,I+\/MEI<5N9D$0GS7K8^BJ_M-G$0U5MTG/+CE@
MO7D6-BNC<.Q]PQ-"<?M5+,8HG!DHJMNV=-2G>&V3^*?K6C*QJ5+Q952&+IHR
M!N39ZOV2E&:S!6\A"QL3WE?7T\PV*SA\!UB^&J0^0IO%X<1#I&."D_NE/';J
M?\H&E*\,_F[XME9$8G;V;=#E*F#NB(1M5O)BUZ8/]\)K'"$@-.7S86B$4)<,
M;18<T#B.3CRD,2S %-'YRT.E_2$JH:G;5?.W1>HCY:?,J"Z3M=8?7-\2,*#_
M:2\% '2G$4>L>ML QBC=2&%L+LU1CG4MW>*W((_:[^@(N&534$P!*F? H!<.
MSDUK@'W$<2_"YY1-W+O=)%K'.K?(CG'I)R?_1+J'I\=NPN+L+(&'1ZV3?PI]
M\ =69Z=B,YIHM=)X)G7&."-E1SN .,[6!F4@"&_8O1R_;<*)ACC&[)_(LN3_
M+GZ$<2)U#JF09_H'SLF<BNTQW%[OW-UG3VW:7J5E2)1IQ;&MV;0"2?HUX]K&
MBIT2RJH<?HD^"<PRDCHW@.1J>- Z4(<*TLU4)C=VN#[>7 #[+T2!ITWRL$)-
M)04WO*>=?YD???I__-<? QY\ C  \%Y;$2>[7]5:!I69W0%&<L/W6%-V*:,I
MW/GBZ9(:Z_0PA2:^1)I$>H-=I$9A943D%YP9%]"30JV_MF.MQ;?S1B5;K?GM
MUZJ/'1(I4XIEJCTU[V> _<OJ17LXH0T)63H''@4O21Y@% S1IPE^)83.K-0R
MF9C\S=J]H^I2)H?MHZZ6U5[:3.%[&RY$V7W7D.$-*C^2B&M3C"WJ,W_YO-O"
MD@U:ML!#RSRC=G2-_C'OY-LO(8L^BY<:5 ]5>)1#IC>AC%9 NO$A_0_H7.QK
MZ'[:AQ;SBN%C3MU\J^NR+TYI ;YD9<_:D"Q3=P#@D\W W^FFZ>K_];<K;!1E
MR'9DR[93MU-GR["9#'%"L(=3ARB56PQ^N/7L#\-+N0]]BF*H\G6 N0XMH&:&
MMH"01"Z#?--?()88CFS=+[^!F?O&$Q\<,5AWZ7<';T')N$K$B71Y;R&_?@E!
MC_T(PQNTV'D81Y+YL->)LDYC:>RHB$9Z,FKY:-;0*77BG(Y?IYCLNTW,P*0=
MJS'0G='>= 'V.E2@O/; I*,+>V1M ?F[CE14'R6$927?NZD?KDH0HGSU@'9>
MSZ;'UJO-DIB:Y',OH@XC2T66R67K!=000RU;BC_QU@.KDL2":/1*-0KUD[AG
MHVSQRT 4Z:H[XA#CP45(W*#QOS IK%J"6I<=+-;HZYQ5&M>H\F3QJ'>.^6:6
M<T+<HRWG:FR[NIN;V[HCM5KRWVL6*6Y;(1HCI?,1LT+6!G3OR]0(?]SHO9XT
M^%;5)9/UP;A<!89:<-&OU,GF*.0VK(RME-(0@NH4 8U*I6<SC)X_F:_2S_R6
MI>$;F6DYEVFK7[BK(UY*T&]0SJU#"L$?E3;(K!RC9*6+E](PW"48DD!PC7)T
MES/QHD928,R56&I4;3'</3O#R1T"I+J\'0R*39!5+X<U'D2^57[!=2(>QV0R
M]\[N/5%:[RX0$%+/YI"M5J0AP22I\E!$:DQ&Z("6AO)=T+/7E<<GG$UM$2>+
M)JT=S?F\B<Y(1_7GQ=1DRB]$OHR-'1"_WDW[F3^'?EQ.7%^]<5#7VP+2RQ+8
M^?QX>?;L \AU)]Y'<8@=D:_VTZNB]PEV_!/P?FK,2K%_]GO1$;LVUWB7>62A
ME>4TK8G0A!?623RB;Q>#-7Y)KF_DK9M8RB#A:TX*ULFFENK;-=HLC9WXMT^<
M2]ZJY+I)0J9$.LY$X@Q+/.4,_]0,, AHR>[!:&-:DVW[ 5&IK)CPHP":,Y>1
M";:X%S=>.3I62]SL@M,_K%\A,7*TN?F==LM[V8A[>H.N1(5C*2 (!X@J6QUF
MO/\.\$R6\4496K'J.C6F%OHUWT;RUD7)NWS0&/\.$,B6%!VV0X+</G/K;+.Y
M_J!V+4'?L]C]]PX080QL"7_XWZ54S_M;'_I<_GN8+D07SXYKHJ__L\:E\HPW
MG39<O*T%;'11:4H\R3\U#H58OKO^D1?MYQN(; ,1>'A6HT[<OA5=%(P?SH-;
M6@WTFIL[9OP4TKWG0Y.UK!D/CUQ,RK"WF>7,(SD]I;A<)KFEV&C8TRU!\OHX
MP5A97B1_8-(XJR*UZLRI.)F#:5P6Z/[J580(&_>7$@E>;*;XK:,-&3!VT)JM
MQ*D(J?#L<)TE5^6],(%_E_FYH7_<V"1WO/E1'&S16;:N<[E%_0Z@3[)Z-;04
M]N VKL>5F=I4.] SM!0WW4-Y<G3B1B<.:^D(?^QRN7CU3.S3-QBY3OKOR&@5
MUD*3O_:*]P?(/@%(O_;N]R=@2?9&H_3&VQJ99KO</$RB$@_=Q(FLG*&J%VWB
M.WD[FR:=^E:_3'X5W&J[\RB(H D>Q@TH_/Q\MAOYZ\9WO<N@#\=0,!3&.B=F
MF.9^O%-P3%?T)_8]G4>:4_P%OR)2ZS.#\>78AC!+'I.892.7O'LI])0S_(T1
M=KGD-KOK@>ZBC?9,\Z3\O%B ^>GRL4"M"2"98PV.=&5_I\2S]BM06V*=32V+
MF<6N)P"Y7;@P5K_LP52I$^.=4*YZ[_/P8@1$D[<R%:))8B)5]'B+06-TSP22
M-_!X^U%R950,L1$WSTFU0B@*GF(3.V K+%TNO= +,^9D3!CHURG2<A/ZDM/8
MJUBE/7-]JR4FY/DL _AAJ?BYBD<.6]<X,F!0]S'6H+6M46+D]4((VYPY4-#,
M;A8.C!VX_)%V!W \P.(U=F7V>QPY#0Q:OW[@SF?6[<60JFN_A/Z6\#>51%9V
M5%88<6W).T!Y+CZP;,:3]]$BSQZ<6]U0;EIIOTA"&:=+5>$HM6LA#HVI,:^A
MHXT1I>>C\&K3:*KSD[\#)+2!1;889@/7O77Q;B'6LKDP:Y*G#)Q+K'CCT?Y[
M^BZQ3?VV6;*4/$W[_>5: LS$]<3-0;Y0PS(6THA[3%'OPU2R$VZZ6N0_G(20
MHEF';4@\05VHJ49?]V?^KD4" <%%''^II5-VQE2$SPCNF\+:00<I,B9S\ .@
MR64&*OD.$">FR>5GDRA/6T=N[1SFH0,%PRL#GT>ERR^X',+@6B;3307/M,PE
M'F+UK$BB9?6J_VMJZ!GOQQO3,N\WNFC8)V\U\?"SMX-/S]DL_(!_1IMV,X+$
MB!)#DE!,\ Z3(SP 3.LE(>C#B:'@UTLD:&MB9OW203W0N R,<T0,544HBZ@^
M*5(XPAK6>T&3QNWU::J?&E9,/XV[58C *@\ZT&C\8A]BVE! 74G>#CNG+>4L
M\CCHE&\1G<?LFHUNMP];2(>Z1)3R $/LHRKLWJVI+99//WOMX, S9L;(8)N5
MF>7G(!MC_,A,ER7BJ7=^='U+NS_@R+=;-$6B6(VQVZ!OA/* B6N^6KR$U-6\
M.\_Q.C0%4J%;,?!NVW2E>87<T@+"]<1>,R=W4-5T[/=]WI2%&NRAW8$H&Z>7
MW%@XS73=W_IC&]COY3%,(95-XM#FP79;TD<\O+@AAX5=G7*W'O*X4IUF2TKG
MF<Q]G1;BZMT8B(Q!D;0&>9;TU%-)3 [=^S_U4FYN0LVER=EF<8.:!(D@VF&:
M"3FZ]*BJV:@MNC1P/ @?R=WOE?QF06I,.$>$%:6:!%-%'0[+4Z%/H\1?)E,/
M61.A'__#;N*#Q>2&+9U%/\T]<4:9$]:?3=3&:/G%,:E'#"+">+?*=P#;4WBX
MTFU]N,-T5 _SG_<)\,-A:X;/L@;E_2IKU,,=KV6<$L6:WT[HX_LG!N=5*]5_
MG//@^VVGE0<]ZX4>;/SWWZ;60XPYCID\W+Z'W.71GW &,W4T+P(68*+OWH"6
M^.SZ&P/6K(]>[@>9_5Q\JJ*<ZOHW__ZF9+[KF2=SF[+3+];;]IBR\ES4X':B
M3\+5P;;1+^X=BA+_UU52"\%GBC&L6=9E4(RQ2(F<_/NN/=<[@$=/XLD,-O5H
M)X$+BC 8^\^$]W\;=X"7J1C!V)'0X"U.+(4-TBGZY(*W$LN-$M6>":,%:FIF
M:E*V%'A31G=#D*NY[FLKLK>J@Y(!]S6;""\++#19 &KS)M>L2RC$'0"/'-<G
M+X'QOGEE';:"(T#=7D)0B5N/NA,=T&1W .WF\Z\HSL%DB4FQLO9%,H#UG#HZ
M.;FY9IZN<.8O\VIEN*>W5[J5.2MN^T_HL -01R;3EV 6'#^T35,M8*#?F)"Z
M!+8AE-8'<X>(']HZ(Y]K3$J#97C.(#3CT,=(R,L5R<>@L"N=\<FR.P#E/,X9
M I<E9O+$/_A9\?"TVY!QN:N*@4Q'YL]UT%+B4A-6,F-R1MPBQ-YA,/)CT-_%
MY-7;$L&EPLL1A668KG]6>WFX4T+_9/=B5=:Q?^C[K!S?:]:]DRU!TGU$.;?J
MX2^Y09HW(-A?E 8D&>Z=#%*>US%.%2-S;\E N]FGZLCG;C%'RTL[19AZ\'MP
M-G8V%]-#-,?-K DAFIW.^L$6G<X@7C9)JB72$5DR$%Z*Z<Q\Q+=XZO?IWWU;
MS*CEVS[28KUME'!C&PU+0SVKS%M.46$/L70SQ7> P6[.3CS]Q5J6HC\DCX ?
M&;IKD*?D5HI)+1W&61[0%\-F3O.UV&29";FA_N-+85.8 "&!#7TR5/-IU(!>
M,2MY')3]B=B'N<@BC2QV?@I6BM6N&[,ND@&VKAPQAY.;ET-K-=)^ <$O+7QO
M+F[30M0%L12Q. (SU-0-DI!6UF*K)"8=&&"RZ,&JJ#KH&7NU)$-DS1FMI[XB
M&2?&=;I,*:).,0>*.2<^W=$=['@,1N@^.RRF773/GS9&X6HJ]N!%H'1S^!U
MJS-_[&PMWI#O77N$::+[VR&"!P]-+B51FHC4_AX,Y])1]']N[7HNWS9ZF>_#
M %\..FY_>5EL "/U6N)/+I+M/KS]IEF-*;$H#OS6HL+/OWUD_&.R#_H[<0LZ
MV(H90 <C209;YFK^9*%CXR^L'!EE5O3T_Z78 ]7F:&R#?3J"'U;>442\FIC&
MMQ4O;'.^_^<GN#\WA7U<U++X[< 6&H@]H[&DL!TWMA1!^T)S%@95@X3[ERIE
MI$S5.0T.:2H@M^8:"ONJ1Z<3P&] 3]*&=EN(;@0W4N37 $%2!;PT!NDR^G-P
M$Q5?5C5-FV4P8#+B(WGA\+DW6)DZ,;)DO0>ET1,GF6U#+>N)LD8BPX^8DQ6>
M8JV^R75H0!AD3M)*#^AJ"T(9]$^B:\/ZF!KM:<]6\DY?&&19-?_-0O(+:)-;
M+?P)-#;,T9CW^//7V#L^VT*Z>-TH\QE^VOODK#[ "1X+$^_I'0##'AO=K$L:
MMMQ# G5C"6A$=:4FA"A56SYZREB>Q$0__V=O7=^4DOQ IBBZT$%)LL GUJ/W
M"!:+I3#8G)SNVX"G(BEA'Y,??]Z2T[%AP 19-=!\;T3S-;A0)S2J#S98N)*Y
M&,\]XAP79G'SL/R7/79H/1Q24>$QYV-?*F697@_+ODZ;+="N LJN/LK<$:N^
M-'R>]W;$8"?LM'6(Q_D\&'SQ4;?X?:#JK$4R1C_9G*)17@@U'@F$DJJ()&2%
M3,>*ZCP?Y:UDFP-6M5/Q<M<<'4]?:!%6+W'"<.!_="J,&9M3P9QNA1-8UIG!
M[#=IAV)"ZKL/!^!%+> 7]R=JS:IW.KS2(">DHD)O"R _PC>KK25U*7&+Z^RS
MQ_Z/8?4HQ\\(*%$U@UM]3Z0.73;X24C"!OJJJLWKG^8%IKP&1#,3A'!AP%O,
MD4QRJ*O!U'L'!-\Q)0.2,5<Z;=GX)S7C,'+SR:<+U7VE[2W%<"20(\*("_VC
M]Y/7P(-A:R$T22K6  J<'LK/O.Z)@ZE7KKM<#X-\^KYW='<7[18;]S[YVODE
M[5NU]U?3K3?)E-0,JG%/>J*628AOHQWB^[VU0^# $G];<%:'N.M,:=EM&>0.
MX&QW.)]II>!$9\BMKCUF6;_?AY'F$YSEE$*7(^L:^AQE[T4AX$#FT"WGW9^#
MB+JV)(<B3@TIY;3M9?-GE71C38=(R)Q?5R'#]MX=H+&DWQ?=LV4RT!/S5.RR
MI9L?+5#T_8#ZXQZ3JY5X^7DS;]R52!5,)D12?_BTG>J-U8^_RQO0C18%+)GC
MALI,K6SHC8AJA;5JN5E@Q^Y J,J9MI)^,;VFVW@%QNEMF[S_\42Q7OJN<D>X
M\-KX?OHF?_Q?&QR!]"9O5_AE3N2()%?V.A7&"='E.QAT6>__>PB\/ZMM+Y_W
MG1#2&:O&#UN!"G"241&G+4]SO-'3&K^>0W?BG@S<2&/Y%CQ@"@B:"\_$_*ZD
MU*=K2]$[30VH08/G3] 6F!A,@XM;:I>UE<C4P3AWW*EEL8(N:B0**P9%Q/@6
M %/C^K9%IWS',&XY$A"CN4EGO7&O-B!/GKB42DW(&]ODFL04GBP^N2#*V_P8
M#C+#RK8P@JV1N&)I1$@PHI@1I?HH#TTAY11=UW;"B?@EP6B"P*JPOAQ!5HVE
MDBU"]&-('LGD65,+9#\@M:&-'+)EM5KH78BJI^R"GG6%V@=^7_ME>D#5N&)M
M/LG>-5DS+_):EKS_F*)>DZ@J795-GU65S:,*W=$@ ^&^+^KK97^F-4MS7E20
M(IKDM"2U!=61,3GH&?9,O0/4ZQX'($$0S%*OM23FWI:VRH?T+:1N3($&VCJC
M8O(Y:3S6'N&JUG0SWD?+<W[0H70'<!5S"5GH?/+V>BFV9S/9O">Q6BR5#&-_
M&8,2:-\\_CC,KZNQ^&>:^&!);\/T5X-<T^6PG.$ 2_!'N]ZI9(H#VR\>3QO/
M#N2I=O-.%.B5/@M+>S*\$VHT'G;(G1# (Z>C9-M2^2[)/7FXV4A$GU7#'<RS
MK"K.-3.TV-AZV@9EQIA$-21!*)$[#UZB0)(3W.9FCL'9]N<AC[2LN+CMN!TL
ME0=RM98X)TIUL#^_HVDLQ\3*"9 ^1Z*%!EBM"():AQ1"X+ISN8/:5K+FR\9G
M555X;.FOF'9Z3.\ #@HKJIM.G[9GNKG#5N7E4*D1?C>YQ^*>>-CG2Q>)IA>G
MI.:M.6Q!X,0F4Z+KVA*0J.:SV#?YA,&'?\C4*Q)=R5@Z0#>J&-'-\",6=QPC
M5J+-,]ZFR6@()@F_&E1X]MKMVFG@I6O<HJ9F."$F\,VE,+#V0/)&2R:[7*+<
M]YO9C_21[36KWOHP*U>ZG7KD4XTKT\5FWC4#@_E:!UAW=W=[_L[!R8[C&M\5
M^<0IW^R/P$"V@+0Z0F'9)5DAC"!QXQW J7@[SXE\]Z^#6D>[N)8!],NVZ7*S
MH&W^-%%-P5;=R5CM \*X%)L8R >D,'"LOB:R=,6$-A^SVL^T&M7XZ^H3\*5\
MN10"4QQSG\9:$$E4ZYIS:"FG2L^!\>09KO6$["QCV;6VF&-W*B/&SR9D42O9
M@C=A&&VTP6;)X%,Z0H5(:U&48)Q8*,<BU[M9+'/X]]RF3JD%?:Z8#$>[[#'\
MX>7+ M,T>GRO7R9GU#?.!S(I_[T[#80ML!;S3F/,Y-F;A7]-+9'5M)2$<Y2
M2\1[.23FCMW-'PXONT^\Y=!GAS)@?-&"PSU/0JQ P(W>[N?S(7)(?N*#EP7T
M-_3QK+8M;P+Y=Y,DLP(<O+>KK)9_56?G>)/P(+G)/Q\Q-^NT.J,)D43,=$VK
M;^J;,0.@96"C85UK<O:<)CI"4:R$9C_[3%3^0N:R* "B4I"HY Q9@0#4'IS
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MY6N32_GGHY_LI!Z W&TSSK>Z1M2B,87M%:9<@4=GQM5!PK5)\+G\,K-BPCW
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MJBFL+7?*J%*ID1$/4YH20@,?W2AVBU43!TBA^P"JC%=Y?"<?M0=N1C^=6M,
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M_^MH2S(!Q&??SA F)T%]F;&P&Z>6P7-I%WZUF DL81$NI47,J24FEVJ12_8
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MUP,^[E@:"5?+(PM7ZDSE^AVN(9_=%'FY];^&Z ZH_Z<&Z #@.[R"S044_3T
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MDQ7GHA(KMU/]XJI8XE(FZ5X36O*5<8BWN[#18U^A!9J1'6\/OES>;)A>6].
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M?S;-]\C@ %;F66V)_'%3@T] IT3LBS0E[UI*U[]4?+?9$$_V#;R,A&R=0C\
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MQ#<N"N 3, U[)BXO,4XUW&-LN-3'5II.U=\I0?MA')^I!&SJ9">_GNH1:)\
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MB 95.AI2SG@:E"P]3J\I? >@<S%_<I^^SGH%YA$39T2:AJ/[N\U*90P$R8A
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M8?YR;84?L 7G%\V:NSA-_?^8T[D/]**8X0U#=F!=+3EW)^+)] +RYB0VI@\
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M%:+BMB@FE =6G];[Y6%^+>MW-E8G M(JPA\$!+F9/?XWJ3T"&MC""UL<'M9
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MU.YWI9BHW2G/,1LDLQ?Z*R@;?8YV^IX)J74MA92E'YNJVUJ/(4\W\C\"'@
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M+Q4@M>NPZ0YUQ!\OP<'$ZMT \S_+\T%*YUL3MLZAK9IN7)[V(1.'/;X,E?E
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M@^Y>BGX/NOXO*;I0P%=')<_8IDPS56C -JWB5>DSF47#HHO)%VUZ#'/QR/F
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M[UT"U==%DXJ?*8X+L=I"!U(W^]S::JA=P9TK66%3E^ ZQ;LQ,4RTKQ\EQ,7
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M#X*,2;7;XJ320XE^.J@R7/8=9B3:8$I2F62?+G^\% TC"M]__N3V0,7OT:J
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MB!X7&0Q2ZZLRBR#258@Y#509J]2I_2J,4R7T:2BH'[W2IS%^I ^X7P)?,3F
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MWV;=)F[=,,!)TL?2RL&FKQ0/^1*ZO?V'MI>L>CH/UR_:\^!J%2R\/1MXN4:
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M$/%PT9\6/RYJ17[\_@[UY$((HAPHY/*4*_7*HDL@$Q(*>R5SXHP\R$H P ,
MH"3](!$86$5DU!TZV(M0SG9G%Y8G9'Y?)[P)\.01%F,.<3?>:H[7Y:*6;/?*
M^>\]0:$G\P< SJMJTC%%73J\&E(G;ZV6N0!YGG&<>)@S89U<<GPAKHPD'6VY
M+P% R#0,F[F[Z-]?25/:6&?*(D52B-U$=:6<T%<U4'DS[ZJ;LF3Q=.?AH3M*
M/;95)R"E4YK.\PQ\1A>9#GYCI(@=!S,BW*$=;/STWTMEV6H^#B 5Q)-*I9+
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M7+]%[9]<)TDR/8IHN+@N/!H&E&BT5YF IN7#FHLM&F*WXJ'*''>Z#X">[@=
MK=4#H)[ET!]O0)W6#F:-4KS,;/F!NH?AC,D*B*ACO_N$1)/*IKH16"2?[Y4N
M"+ ";5OF=%2J^A?OUBN;WNCZ.::7YI4MRUJ;FSOBI*?G-=@]ZX255"OC-#8\
M'Z1BC<2W5"I,H.11B*T$ '0J'P @]%?I 91T8([-GX5;S"@5M)OCA)Y2YWMD
MG^S>L?D/9(D<O0.]7:>1M$3QBO*(XTISL/Q40,9G>4J]\+?_N\ER_Y>P[OT*
MD'HF0ET4P3WONFU7F$'3$PMF*.KLS:\<<61#?*:O?A]Z\F;//4<:01W.O_S
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M>G]J:'C\V \M(%K<>?M=9@8F:2 1]FH+X>*P(^#AWT_IA]?:C6M!S5*2]P1
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M@VZ;$$3&FS\GA+Z[<(1WW:=L,$@88?C#X\#\]+V49*6'<(N**+T;].Z8I^-
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M:)J?+HV[TV;@IRDR?./( C&VO+ D'@IU6)"KMJ\=+ 1M8I$]=]366>?"GKD
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MPE$@/QVN02WC6G>((6?P4^II!51E\9YD8>7( >NOP??62W+50_Y-!G%, S%
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M#F&8)(9R0!S,P8K:NYO[QT</S[A!)<S:?HD%(!S?H3)UB(O?#G-!%.."D6-
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MIF?_>JY=,/Q=S\5WSNW_=N1X S#M/J+'OUB ;[OI_. Y@?\6J^.(\6'GK-I
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M<JA.N3&<R'HB^>D(D&VKN>&=8.>]L OTD^129?WB KT9D-50@8FZEX5-5,;
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ME7/*U1V9*@F\AS6>ZXW2K]9]\W/9N:5RME0I5T)IQJ2^H141V.'SP?:0;6$
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MN]H"F\=>OZWHI:I%[(A8*H<.6?I;#/V2EOH+U:<_IV'6Y9T6JE0:<ZTU)BU
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M.N6Z6^0BC6+ZWF*>.@]C<BDEF"]$1@3L3P:08I9 <Q^!C>_])D:SP[)A0D;
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MD<@D+5W2Z(,#!X4.C=60WKQAGTFIHM'-^6'S#?"OWR^L@12*PAXQ5<"H:UC
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M$7 3]B1%>#_S?3GX<!W\=P!H@#Q^;#+L:<W<)4^>A6;0-HM$F&DF2?&^W3&
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MRTJ"27+#G+T;=\L$TO\,U-TEBE47/682[[[:U[;V+;?.!CPK5U\3<)QJNS"
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M"Y4*7;J8X6IL[^D32R?Q!E-43)1-O=VX:5G.](&(,:.XIT]ZPG'H[)SV@G4
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MT1[^+EG6NXTC)/>!2D]2?:\?P:"4MCP>QRCV^:67E5T H\M[@Y,H"]VK.EW
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M[^KR. ^6O<5&I-+2##$I(U$*P;\+6<7T;,LD8:YVB8?<G1)*I@?%\?U%U(U
MK+^2TP8KM9?86]DLJ=)89WW;<O6,KY ,067G HD\%V$^1QC<<3Q5#!O'\,)?
M <CBH&[^RZY+$J!;"\IONP0H%I.HU4F_/)WN];IL[?9IJ0U#0Z:;L*;1G=_+
M#.2XQ2/P;2?#!')Q>[RV _^&5;X KN!6W5RM4]]< 6M;H%G>D[1.[EQ]/EZK
M#U/]+PZL\%!N+BZ\N($51?.&PNH-QMP71@^TKMYNQ=;\W!HN+:[A[Z@\E*A
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MUXM\-,7]<^KE11ZA/6P9JFD1T6-ET/W#9QTP9PZ:R,:-@U<)==DS:Y%I^T1
M<XYMWEAQ")IY!M@=@O() []AY)VM<@IT]A#$YB$!5M2)CW0+#SR_JKAH]](Y
M#$_!7(6G?Q6RG0^H6V&\4^4V2$R1GJXKF/=XJ1[-Z]::-BOFUB'QU#0A-Q,(
M_J@Y<J/7:NC%6[C0]T<TS8J15II2CIWE,:V]$IOJR)0UJE=E<62<D6:9L1$C
MT>@ZQ$/5R="OYHP&V&_5:[C-,V1OKBUQ%\8\?W>7?4::6K[<D$E+IM<!+52'
MWB6";+>I:S>'0".E@&9I&@=G_ZF4G:P";ZN6.T%M:B<K>FM*];B1]KTM/G4;
MC0$B^7>57%^KB/Y&,07K;/[88'8]YQBK%+><O72I_2):E)Y"A76#14)@=P"Y
MP #R;\(F=]B')#[!+\]>6J<%F>$KT 'FA,:0NP<CIPV*74)4M6(U7-.VB<N)
M(L7,\PE]N#,.RX;;^53<<N,K(B(APEF*I!K3AJ3L57X+Q_?-/CS(VK77R1@I
M#78KFD4G_Y5CI\H#TYMTKVV;0;I[(U WTM;![:FL_]@*N [^=B&F$X"BZBT7
M;SE1O]&;@%<K<<$,OH=C[!,.D/H<R9Q5:[#2],1#C:3O[&O3*"^\7_/39*RE
M64UX\+ !G>31BZT[YUQUK#MK4.B]Q/4U6Z8NQLT#,,/DOFA0EGI0"GU4&)4M
M=OZ3>^C^,_FI_Y)78]))Y_*]U.8:KIIMSRW0O92M6DR2ANUW&BT'<<NE0:<B
MB9Y\'(6[Q9%H)VY1Z1D9ACWX<"V-""_(95,7#_OOB.:B0J&$\HV77E<2<T:[
M#D'G?MD2@OD:!,/G3*=VBF:K[#78H5 WXIQV)_PB[E'":2QI]D<QBB<\G1IJ
M2;/ICGJ2=+TWDP(#/2.Y]@GM2SA?C;8L71=.[CGK*N$TU9S''"!LV1#K##MY
M?.FN4\2G8)6/]KA7['- )GFQ>KF>"GYS+@9^=GU1NJXIB3*[*).VH=8ZX<_]
MVVMJ/- *E;?[..6?2GAGUE+]3C?'T8_1'5@$XG*J\Y4$^R9:0QNMRX!*#%V<
MO9VAZ2>WEW@JH7[.IYR_(:;GQ;-VD9::N),H@[:2?($+^9+<B:M?X!=\A+N:
M0C3"*CNS'M,"G>3KBC9=T%)1*M)G_4])RY5R)F%K.CHCR3)+RFPL-B,%%7NU
MAO]K?'RV28\N*V6U;).Z0TS:914>@D*Q[>) Z$I$#W%VG\TE2Q.:#LX.H 3$
MJ^%/H>\>L!?B>Z?55&GNL=(352)7+CEP(S!JY"GU\42>5I79VG^\X9,$C.>?
M[2%869S\[,;W97\9WG&](J]N6D=CN9S'L-= M^<'TY_R8/$R+61RY&O+AVD"
M=[EMJ,II3\_*[7R9ZU+5M<B?2_QU&XZ&/3.]+F'U/AM6^>ENJBL%<FYV;IK+
M+\X5"Q9(:5UPM>O5DIO*K@Y^:XVO+Y4#UYL[Y:6F?[U@KH^Q^_=_N]S3AA;&
M&:*!X9=PNN46;L^H#SZSC>.&-KAW<P"T3IDI+/!G%=F/*"JL]Q D\"LA@JT^
MKO9,M4W9D/1?#4GH&_EE9F[M'/(E9W[@.BW3%JC3'>Z' .><A]"A'E1+'AO1
MN)4L7O&[MA6XB)D?W&?,_!'F5MZV&5^X'LK)IQ:;I8AM&"DA1FY$MQ9>[U%O
M?E'VLZRY6<5X6Z%AQ:TJ8M\4?I6]A/OY9(D 8_V+CY(\B%TB+8]Q3!7-5OJZ
MPC[SC28I7E>!SM?</P1%'VUO9*5R,G NY,\JFX+U/ZO?MOHX(B>F1_+(UA[Q
M'ZR*>KLB3?Q'36"QXX;(H!W:?L+T&8'O[+-/%R$?_,^/#:N^%H<\NOS"1);#
M%_R#<9I/BR2A([=:(:(* ]YOQ9YJM:I@\ +RMD'H ;'=AS>^'! V[#<7BLTL
M-I$RW26315-&^CZ=YLGU>;\LG#)_8#CW>;(%U]_(GH#3'7^A6'?\!K:@R]^N
M'((N!E+]Z)+BGD3X22"!R3XU3KSZI[_SG ;]SU]9-YCW@!6&-L:;];85L2*N
MT .1K9V$&X^[-HVKW6>:%W0I)7I6 0Z.Z7\3QW7,R=7\ZPF/+P<;7._D1CSZ
M(,SG_US7@<VEY\O)#5R<LR6S1V:_;1M1B*\6KP!2# W,^<E?R.JPI1-?QPEM
M,(YQ^=UI3GM5[RHQ!E-;.=/CO^MWSG[_<<RC=MW:WL^:E,Z_;MWHW<8NE=SZ
M$B_<.T&KYNG3C'6VC" [>J'^Z75KJM_]^\+ZFF_/\O5'U ]_\W!9%4=51E9&
M981Z1.<:1^?(%%K=U=DIG,#96SE$%WW-2+]5GQEM)!W<L!@_T(_TW6OIAOZL
MXMSK3"P">N!94WV&8UP$SETRS!ZW15Y!S=K#>6TW<,(ZAC2I;LBQT.Z#N IA
MC1QQ:G6$'XOK*P(KD:;_="+=NFW2K6FJ.,*MY\OK\855]<^*[@U ""5!&/.G
M4Z(?T[5P 0.AG8IH-2<GS$ST2G)M,V_11;(.1FK9QZ<.063Q^FE/OR9%E\D+
M2*J]3#Y/WAU-_93(ISF7XT-<V3R3U)U(G9N,(QXB\"@_L'O7;!+3A\;D6(RD
M.K@@0^U02B?#E/P:B:_/.)_A:BX8"%='?_VK)_$C4+'8( NF[G8/7?/FXW-N
MC$Z]\:',#]F[]WY$37XD)5N.8/UFP[Q0SJ?I+B;1E.!W;^ZA0OD,Z[%-W0+$
M>:X((W (.J7_740\#+^5N#)G*C,@>3'.@<(;?G#0241E&M9$=&44IF6^ .9T
M*XMR=7NFFO^N7C7RA@R7J[ZJY<A%6"3[1CLKC+B<,WN\N2G!%(C+_[X(IH6U
M>KQWV)A=3*42.\;7]X6Y8B+_(V1V9[2.]5P\7>NHX FQ.+(A2?6M#FUUHG"<
M"#OP &W9N7B5IMB E0&2P93O6DJ%Y:RDVZJC9Q4]_?P8R%=>TH\ZE55S_\W?
MXJFAT9>V_S0]WY\DHE" 3-]'OE. E>>OZC@\%_L"4X6&Z[(BG9WUT\AX"Z!R
MOP 1'?;Y0R5^O;03K>K4'M\ W@6H[<06SVR?EU(D'8W4&KSU/.)CQ81FI9FF
M#F]P[X7-Z9(5FPWO;IO2\*[IDH*Y8D,^YT*1[9E@S7'Z>].).V;FL2]J<P;\
MK99,ON.33(M8?&.X+\'+RO\<@IXNS3@LIW>.1DS;WPNR3N;0:%? ;'QU@2%?
M.@7/C]1R:J^L0N=1?FI>3C9/MYNL5E*6:OE@*4=(.AW^)>\>?!7%YGT&&%(9
MG7#Q0Y![0E2."'4:GX<F4C3"=?0]5T(,31NC)]'Q\+,;!W^+0/)+#<^7P4KG
M9CT$[/J#NH9SIA6>O&UZ=3& 6'N**21 ;V1%0\01^-KB;4.&"-,52*"@PLSU
MR<JG-NR]LLN_YRB9GC*+OOYK^)A=].;=*46F(6^ZAVOCN/^P/,6F:2*L DR?
MBM=N9 *<$._!F+!J(! @?5FV#S[K2YZ7/*XCNY()/6^/X0(D;S1!Y*FDT/H6
MEM@B.J9G,Q"%*I%II+1L?E(2 =]='%C31MI*19C6$NY;P_6Z1K@H6:$]FM\N
M-;B\*GW5-SE2:'BS.).L,!B5']M)J;FP^J;K0;=5-T6@WGN/1;C^H*LW0K4L
MV.JNFGR<_+_5PW(*$*3).^BS;+J)#6%AW'@QG7W %L/UZU E65$YPH>@"?&X
ME_Z]3"UK>,3B<6MK:TX&=+&S%71SR;-]75%PM.+TY=='CC^*);G!!R\F[$<?
M@O8.JMGI4J-<U_-J_M<K Z2Z)7\>F3X$;9TKQ:U?F&)CH%03<1LVEW A)H!5
M &>?V<U'B]K2GC2'-#/U$GJIP$N'9QBM=D6BEHDMGM_9[EY=0Y';^9B @.LG
M5[F.5/^2^'^7,G 3J7JHN6-T%.M?XK.=66(WM#Z@FP4EQR>L\/$A#C3"=_S%
M!7JT)H.*BEU6G P.?DYK,I5S-Y,_?IYM-G;>N'CUQ9QK8I:@9#O:2,<)<I9F
M@!;+B.!_O*(7+BZ6*?!/Y;O/?1H)O:66I?]T$1SX2SL&FN/4LZ2-U> M)U^Z
MS#U$$@0UT,&5MV7+QPK+(<NL?/<_12PZ[E0;BG XTY(,.SX#V#RDKA4C*6&
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MI@9O<$]._LK3,<('KZMU(6/<XC([6T*PX[G_1=]+G*.9T$> 588D &-S'6&
ML>-0JJFGKQFU5:2JF%SIT'<@'.H'-NP(\HJC9.($[Q1N",'(#IOB$!YE]GG\
MV85!STJ[V3F9[& I)UC]L+>W KN><TMG(:JX#O76,XS+7V;1Q3V2QUO/T!@F
M4QA8*<:Y%:CS)6?+]I#:W58[$<WQB>5 [E7DGU*<SMMT;=M*/^W2*PUIVB6$
MT^?7#&YA37 =KL1GHS.X%=GM8*IE'[0.%E&?2&TDQZSG2- 2>F GT7)^?">
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M(_?;=H L]Z[JB'9>P'19^13'0L%Y>F3B4>!45P;L3:O4?W>\@P-.QI&W>4?
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M T*;K.AV;;0*F=0U&H6K^_9:#782(QU-F2-/O\J+<^A(<Q:J;;DOU3;!&6Q
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M!!NJ-Q?%4<2U'3^HVZM-]42KT8O]GL1;)_DJ?OGW98X<*QUR#" M<V$'VV4
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MIJ&984NQ!7B05YRFV&>"\X>3NQ@2Q+CU<^KFHSJ\6#S9"LM(OX=S^[O6X Q
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MT^K9:](T3C; CGL4<GRR4O2C]#4__/0Y>]'4BEN_-YOT/*<KF67$%]7Y]DJ
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MA?;.@*%,P"L' RS4ZS'N]M[SNDT>Y95%?56%1Y[+@D&0BA0R3.US$'.3-I1
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MRA!!5I;MB-*=1W3Z'D7_>BDO1AL_ILL<6F&W'6QR%OT/AO2XB%IJ:D1W1)$
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MXHA*US-I]/XYH:SH=+]S4JY ']V&!4:*_TD12GX5'4/C(N50>GY@5C_+>\Z
MH6QPMJT:KQ*GGQSV^JQY;J7.CDZG#-[.;QK\Z_<4__U>:S3Y)V<GG"Q ,:'?
M>#-R5%@5JZ,>.1EYCH0?W#^_ KJ$7)DW;,3&-1-\89;8TF[2?EJO,)#-*T_5
MK]B<CQ[_T-K666CD/B.G4-N@L\!_LT&1AU@8DO6](Y3;LQOD&'_Y!\2Z1G"
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MU/*ZNO19: GW^,[Z8H=UKD&(T<(S3SZNDP $W5%C'F" :W8?T^-6Q( &4O,
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M-7]M0&_IA;#\B0_Y1,.6P7;3H636;,$[&G%;P<D [*0)LIJ';DW?T5N[[32
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M27?H-BUVS(Y_:_;%JHZ ]9%NZ^N#YM I2Z?(YDZ+>4@GN J3 J;8_OVLE#.
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M).'2M3]#FP)*UT:(V)@9"%IPW<[P8&3_OJQ]%V/K#1GW?#*M5VJJVV=U61+
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M(1VM)I2V'(&M>;?10!"/Q8/?G:8%$V=.J8URJIRQ4P0$,;^2/A^H)GE17,&
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MN$1\=12!)'/![(N8((<V+&'EZE:TX1HU_;V-2@-ZS569COW=;38*AZ6K?=7
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M.W@9"S9=7UU?HTQ4LD,"*N$$BA<D_>+$J-Q+B1K<2QO\D>3_=^SB_W)O=N*
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M*Y'X$-4^\Q5M,?^I8_Y+^(Z+0Z%J%*@2[X ?J6+ *LO_O\KI?-G>1574SXR
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MJ ^))P@&B^Z?2Y2 #XG]KOJ^1--8NCFN?BDC?%AIK[-E9V>ZC/2F39ITK.4
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M2?E&=@S8="KHA7K9?+U0L0PUAYGWJYKW3P3CLOZQ)7PV!$Y8N@)GAVE3"GN
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M"94&T4'CWS) !<2)++?JFWAO;9Y5:N.&76KM[8Z7:%."]2N&<WV1DED?>'M
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M9Z=I4E[W!C;-"#<*Z/0_0V,47UY7.*+>,ZK[L>;[TL6LA]\:?S6F4C10T_'
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MO^F<)P$28SYYB DXW)B,#PCYO?KDITICD15&RQXEK)42P.<E_-+<7T6.MT2
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M/P->LH,G%[P3R+%*SHA%/.1X!N"D.S%D*)>22FBMI&-F10/)VSYHO!<+[3Z
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M8C#3;)??*"G258H]%TJ;]FHV!32#CPB[.*I0;F\$"TY)WC6J0%?>CW_-?:F
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MY70F>NSZ'J975ZP.#X_^W"HO(U?,FOJ5U@8NBJ=&A5ABHQ<=<8M/<OHYDE_
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M"5VST/TX_6?^Z7(IHA%"Y^GOS65@R/>/C*?I$BLF'Q%B,%5*G*:C!S^%]W?
M8+9.62L!Q+:8B';I5<NF;#9)YH*=A1<WA4J8&Y9UY'^LXMV "MEN6ONP]@<V
M*#F(7+HX5Y?,(!H;K%:<&7?22MVL$0VH6NJPM==?L;KS:/]1G85K-B%J;L9U
M+R8*6 GD/8ON. Z@#F!?_$8SI3K1/(EH'E#@_8:9GQ Q6D:/2U \_IIMQ$DB
M?T;I0#BWX8UTY@A)P_?]$BI!6Q3/[;/=O;!X4F%P#CJQ<M0+$H=Z&YV\9\C1
MPW/P]Y5Y:#,>DVIB$D1&#A$:<;EQCY4&QKM(OILS)5;,W7M</!&TJ_#6%^G[
MZ5-SUNIC(*<,^AT>ZDRD\C"G=1)IGG^Q&OQ7:<I?9BOB@/&S1EOP6.5,5Y%0
MJ66F<V-E-N%^,RCSZCA[)RNY/C"'L32?I?.L_IR_VD[D7@O(M!8#M,,% 6@*
MOCLOC\/HVE-P#IA#"RV4N!??TE=4NHGMX"6;QN5.DRR-#%L%"/:=%'%43'05
M>G;7_D'FC6\-K$5RA;*_053'LYI"IITR44UHH.4_E[M9<0^ L],$!!O4UX*\
MBUVIUE*&Z9)P@(&R:W<P.$$/OTC^\<V6TN6]7/!0*O:63\_;0(ZN*OFOZ$X]
MD:1!_P?V6HASHL7I4DZ??6@(2!R^S:Y(. SMH&4^Z>-10[QL8HN60^[?7J2D
M6HZ5DHH^-]NV9XUWS(Q5TT>7  0(@V7AC!76T1Q)>PD 'MP#P.R$M8$$>01#
MW!'H$WZMR9"@ )[NJE>;-B(XH28K;A];8I2=&EBEFCXUY$[?EI,0@EM[OBO\
ML+>S>OP/H@O8(;%(-Z0)56]@N<"_?3I25SPO0*M$JO>8H:-W&QYFCAY;31-(
MS+41%LP%9HT[]X>G]R>']&X,!(6J65*0?!V78C\Y*@Z&-O-S2'9/#!R(A39'
MF)%4M )V)!\24]">+U&"(TJO$A7MA3]B[E1*5=JFN?$Z*F!36T%[$ ; ?733
MML>3')[1SV9J6+#TS\DK.+\?0T:C2T%]Q[&_X-J,VK#!8=5>B_ MO]R8+Q_W
M+JQ@&5.&[^4&U.*C %\R$@O)SKBYZ*Y3)DSG";K-=@7LF6P@W4(^68^-\$S4
M&9_? +(N=0K,4 (>04%&7\,K#?VX" $WC2J^!7R(*;$5CKL/GMV3R+SCNI^2
M<O#H3"K26.1*D$7/B+"F?#T\ARU+:@3\8VJE+9NSI$V:O+?\3*UAWG9>MGB9
M_(")XUJ:BW61B:9Y7LRJ;XQ[$V:!X)&]UWS<=?P(T14#](/,*2^O)\//;Q0R
MM_U%]NXLT)U8&:,_#D,%1'6H44QP)::/V0[\J+D%E:B-Z5QUY/ PIF%^ .*M
MN'6YJ3?T<J3T?BK5XZ2B0Y71CQ XY$ N_0VS/&6ZO)[6J%7^H1G;$K?X0USJ
M*T18M0(*[A6VAD[8C4'2K'5[/+1WZKRP[0VY+!42+V"_C)_\<KQ,'K%X37JD
MT"#9Y56?YEU%>2-D"$UQPGKD^=O_GOQHB[;E&C5701T37JW&>0ON5Y16J6WT
M*7'%6D?73HP3%G<6%(,1UD<X<GAB?RKZ2ET^8+N,7*3GHG ]B1:[U<>0:/W:
M5_4R*,A,3RL\:?>\B=NPV-MII_=2P,:;:[A"$.$Y]?^T]YUQ367=UW'004!%
MZ:""2N\B($4D8P$$A R]$P41(0(B($A)5*1(':E*R]"D":&CM BAJ(B1WJ0$
M!*1)Z(&T]X+/S%B8$6?F_[Q?G@_W2_SEW'WV67NMM?<-US1"!]'*V[1368;D
M.7=N#A*R9&8L4W&IM"A ZPWI)(ZH(,'?1E+ S8CLJK^89G*RX]6]?7:7D[SN
M?7"\'',S,1SK:B3)B.?9>:WT2*GDH>?7;MX0J3RH^."!YCY+=%%45/KZD/KJ
MV?=Z":GLBJX'Y2$Q2BWV4H6 1/9=NQ/LX^;4.E,A?EQM"C6]_E:Y''(AV@JR
MQXX*VE-LH7>:4(,/UNCCOH^G@H9=[.6.$2ZW'Q7 U"8)%R78KVD_8''P54^P
MG"B]F-![:N=AV@FC0,30!"JT*^[D3)D_^-*@?R_W4QFQ&,6\W#GV.M-1OX2Z
M UK'8YU^M=/M]Y,_ B[[B5%!EI2O8\Z9X7^ )F$DX^%E)<G8KH:.^!S3$@6K
M_.PJP]5TW2HQ;E[&TU7J)9Z1.=K7,_M<KE]W?_ASJF"SB%W5;'9U7UJKE]O"
M!VPV%02#]%DOWR>7>;LXC6![>8=W8(,<79/=>/Q(4AE]C\*'4#^:6AXKJ4?Y
M>Y^\VC#0\8B.J]^>7=(MRW)GUPS[^60=N'Y*$%&,C98V!G?EPG62!,\.7\PI
M/0SN6K'=FV15NK(F[6CYAGU:9<(FEKK7H^(C'28C@M3Y(EKX4TYI[.'4EBYI
MR?<\WK"[F'C\J-HU+7[6=NDU$8(%(.Y,)!6"U*_=5WAV44%6T!ZO9\N=G@XQ
M2&=)WQG)2J'>AT6WC\ JWKUQG6*)\WK(^N&RG5Q,G,F!(FFVDQ^*@*\K4-XH
M\[8Y%COMI;P$;Y.=X5[:[EZN79+C$:O?YL2[_6C89,,:YXPC\S7:JP6*[VA"
M;D-?U;.NCD+I2"=R38WCWDKYY01&D=-R()QQ&CEQ=ED*E5[1;4;::ZZE,?6X
M]V7N.WQF;R(>+AK-F!%/J1!UO*_-@1LRX:S>R@0Q)2V;5-,FX/AQ\,0]T4-$
MAE"!CMSQ]AF'0R6%9S)A3 H5'1*[RU^XN!![+-7X<VH7=^NX2NZ]PC75;3+Y
M(GG*T[!P33N5JSG#/N<1])1G[^5D!M''I>S#S#!W9EZQF/GG?L9,>[185XRO
M<O/0WDV^C=%;]C@O2^]A*O-T$A+A)R2B/T'4B$PTN5XCM/ Z+?L$D/<*62#E
M/7RQ%NSQ[90H;TX@/\(D*X)S<@T.$8 H0$WW#4GNZJV,Z"6XUT3 N-G?Y*8_
M\(_3]!$\6UB0[S>&B%,-ZS?IB^%;@.Z&#X+7'VE0!BD_!-3"Y3<>^RO/F<./
MO"EI)#S%B7(Z*?-IV22+US;BLKQ5,KOS,GL/#B6(=R2CCQ;6[YT_=PH:X6KT
M?)2R'Z^J]Z"E>7[ZCC_[L62C/KV&,^P/-<J*RQWUEA_T-.3VZD;9-UR+[-2Y
M[)RL<4PW1)P_=U9RH6L,_IQ2B\8;H]GA-0CZ8FP E!%A@[U%$9]C#:6" B50
MRA*PSC(NVSH?QR;+=K.?N91S4':&HID6=KV79PN-^YI\^(1A!W0"HU2EEQCK
MH03YQF%4 XIV<F G(79]M%(MW2)[\H1ND?]@O;7^G$IUK%NF,?927"G2-J][
MH!>3:<(9,SS@&LK'=/;6N2JUA7@5#NQN B_/0X/74@]WT*^FV\_7M3<TL3]4
MK4 )+SRM;VNHE2&/O;VH??2NGG.(OBOMZ:CT5T,)**\!L]FW;_'C]T@J0[/,
M5RC'\/"GV02C>OB!S@M=)(7A@S\L.\@9O7'STD25]$#MW#NG(TVQ=D(ZS(=K
M5.;[38]? K=(/D,3%"*7*PENN% P!LE>S>9]G##K_J@W-PTN&:_37DDS;*%B
M97 N3S:Z]6J).-?D"D-\?+"#\AOS@F,<J===2(,ZEAE[\>&[G2T499X$"-:,
M!3,V3PN:Z&<$_OJH+>'*</Z2T+!=K8.@XK7LY..146;JV8GR^H4)^KDE*Y:A
ML$E4%OD("5 XWX=H&"H0SMZNI( /QJEAH+?=RZ-S3,$AO.U+$!Z/R/,F.IUF
MH6PG=;&:+;DHU5'BR?H!I$=IO69@6J0==-RL7EEP3C!,21WET=A@NIP[C&0C
MI.I7=)+4AK5N+#N<,>DL"9XXO^(9ENQS0J;(O%FX/R'[;/*1VT?\Y4?,%85P
M'_;A\E@R#)&,EPCG<XU&EY>$LJ.E6*,L1KB>/%;1Z([[Q;=39M2D]IBC3I!#
MZ>D$X9S3(G*#.?#<?G0\V =MZT201RQ7$52&?*1QL?78;:2CY'1OUK0)MK4=
M922!XVT$E[HR1=FT?::]=FO5R8_,+-^OO;IF=OJ7>RA7:;'N'T>:>05;1H D
MW)/%_C 1UP?'\N0+3F/PD@U<0T^(D&!7#G%?I2X0^]/*?/SX79*P0);D@RS1
MW"5BH_21>]LX94DX'4MQ! .!9E]@[KTLC+P\=I^.09UN,I3'KZ8K+E9VZL+1
M)^7R7,'Q1IP7WT(-K+BY@QWFQ2UZM=(&"7HZ)/!Q+Z,96N)9;RMR5K4PC KB
M5%;T:/MYKC%<Z;1U&(Q8>>9BNET,T2_,%S<C(6;ROIPM(42W3;OH;(BTNE*S
M[*NV\V3(=!'1G.1##H$+F)$,R$AO%S<<X]X'*85=,B^&+=1J!XZVC$2==X6P
M76'.+^FXJO3,DDYZ]U)(X^O"\MLKM*N%06NKHS<=SC\=93W*H3 *V9,?+A'#
M%9(/-0C1MPY8*PHH6-8)L4K=L<=XOKY>(-)TOC$V-OIZ[]M2\](9A]QW"#UN
M=B![Z903W5>62ZLER='*'(1@\WLW^NU[!<-):KB^_:FW%Q[%NJ1,23JJO^B5
MM#@=S?&<CX* ]X'QYJ@^WN77>'@&OBH>@Z"I9ID*YN,^@D=A3-P$.[T-,IXG
MFZG-L0>7L'.%E$LGE#0D/CJ3H>9Y6GRDB>D!<BXE:'576>TLXWR(CQ)V6^VJ
MSP$'KJ!<KA+^X'K54/W55-W0798"U=S1YS0',A1=4T5TU=N<G;5LN%BL5E.U
M!$JT^GL6[6?2.HIA%T'T/V1NTP>!.$#;;H&F04/TID*HJN-@.[15.$&<-@1\
M<?"N,AL!"@C"LBZ!9OBD$P;96SL[7(J".:>33L^)3,8N#%B;=;KF;*\J)_+I
MB8?\:-:#>#-T1TQ$-5NY-9*R)YB</A8ZO/ZV,U$Q75&^^R^&P>Q*UWE_>!P6
MDFYBS,1IO/?4H3NBJP$IU8Q'\9A;1>:7>8^^\G!B"&D8SM%'!=89UE_6=A/I
MB,]2,+'6OY#09\\RPJ$Z<UHJ-*+!V/.8PTNZLASWV-6)]\5@3;"3)$%X1]=,
M7S)!\GP'^#+D-G1[B=-.6&]8&3@8SGYEKH<065=@SW:G>X)K+*W7)[?C=;R3
M<,2:$/^3:.4NWJ9\!3&$S/N4:I3(R^O3X32:XB_SF^AN_SJI$;W#L,J&UM Q
M;49)R[3#-.I=?Z)JJI>*JC!_FC6'A'$.OSNLK)I8ZN@!-87N]DC%*//[',.8
M0_9X^*IU(<]TI)@L)MK)Q!,DX]4[+MBX(;7;MPMT+K.IF8B/WN?D8&)<=!I:
M_QF8V8@DIHJ^KY8*8D1;A_>@GR5Q%-IQ-6&2=L>;XE_[7FY-;"W)NY_2TV/\
M4VM9\^&@?H8R,7746&'0@KSO77FGH)B#SC\::$J',2,G\;E0=FV6?C5VN1<!
M=3IWTU:/1&5P:HA,B@O+M$^<3G\ZT@SKG9GP6;Y"CB"7@8<*N ^3GRJS>2!Q
M*V'H2ZB>D5INX3F^7K%[<[$_M?'\3$"FGDFU/^X^UG9^CBT]XZ VA^S.Z9&V
M65:W[48%MG=3D^G!^Z^D5%P_'R"$>\6^?$/3-XQVQXR-R46<&;/IOBQYO0Q!
M]GNYEM>"0X7XM8_IC\ :Z%YJ/3E]U+S T*@J;W!LT'I1;?D@T%6FP#NA^<R#
M$] ?O?4>P1![W.('9PY:XR#AXD!-[!=(F?8?UV\Y*]TWJ;R_PW'D%&M'0_3U
MF)4+O/VFFD?H:*<:L@!O($\8,0]J6#$C!RCOABD+M1WJ?S15GA'JMON4#!GR
MW$-E*<0(SA1':3W4JC OOB0T=K2B9CFYL@HAT6[DFT!PJU&@*)HDP3#=2JH7
M]0A/R@VD/$26^J/,ZB#; FO)5MK"*J_+LP197_87']&WTUK0H&LJ=Y";NIP'
M#X?W(? &T%[B\KP_SQZ2R9Q/@!^%O>>UA+@RD[>"_^PIO$W=^Y<.'[S/60+4
M5._.5L'2^ZC F=\O+3Z]I"!(EX\G048'JAD]JG!9_4YZK W'+@FSVZGND-UW
M4^EEHM(?9_"S)$QJI8T;ID:KE]Q\"=$[UP D4$/85:.)PH-UF05W^U+H58BZ
M\&>*8UEN>.GZX^S*>^;XI^4HX@2+D?TF)0B:J95K&1&R'+G62?MS:4VO2#';
MKRF]T5(4X7_G+A)<MMP#'IJ@@D)@C\0DB8=)BC[FICM["=[:<_1VLYZ\O8X_
M(H%^:\1<O$*=B"WRJ7S.,DU4A7M2##)1<5AOA:$P_H;*1D7<VSW2!_E9]5C2
M@VH-<U^P<E2>Q1N'2-=I2(5<Y#1:COA9@VX^+<8E52-U+('9$Y;MV&?9#"VM
MDNDF'R _00]E\Y24S2PM:[$/SP;)S.[VEFESC%F!$+3P%-%FWII"R[K1W!*>
MO3=7I <)2)T2[)I8;UJSPY6^I,Y6P1-3"U,8RN$N$C_JRH (/J\LFP"K&SC8
M[E#B0U.GR$IN>/CX?7ENY#T'V=UR/Q='B 9K9AYP5+>Z=DWCZ*7+>O=5? 3,
M(D=O'O\AR2C:AG#^1PMMZ9!K'O9',TYEQ^F[^"%+H@U()ATNB9#5F\+L' VB
M,5(Z%A&%%*11.R4$;;M>OM;+=00+7([D+A*4X(9?6+ZMZ)!@> ,N@JYN]Z8;
M)B;O[#NP-MH9:9=EIYC8\E..;*M=3*3YT9LVY)&Q4LKZ0*\949(13I)TP0&B
M J0:SN6]IWW68:SLR=S=N$?I<XSF1<R@%!^N-KW\5IE@L\Q89?VR&/=:!<:'
M!8$&T+&7080)#QW<JP)T+^/=0O1C(@1FL_0 IS#K55DM[Q?[9-!("^<3/T4#
MSFE!RQ6%KDPYD7XDH46-)Y0<1GC8O-7G(('>SG.T=7%=(23KX>;3/D9UU8)S
MW*DNV3#/SF27V^+-9')3Y7S^3P6GX^_>P*NQ[.6[5L\E.=,XW094W79*-X+&
MFS;56Y@0B0/[(XL1F%P&E0)\9^+%D0HZ&<A>5( ,X4AA<<MLB8\ YR+9JG>W
M(L?C9 =-E8=USG6V<AP^5-!=5Z/6<7,I#$G%-_76Z\(0MHM^&!E\<7;;.P_5
M5 [!NSDJK;EWO7^Y"^Z9U*N\R%'%RY*GCY.)2HDSN^EI9C /3F, +'&X+IXU
MZ:G[QF,$980-0"IPV:ZS=Z;J>UENM"AA#XO-3QHF<>(#_!R7#&U/O.R?/!_B
M\E3= 8,?68X@/ZH^#N^D@EB6G$(0/$HPMQ'H?OO[N0E,Q7N[KU!X6I(CU*\"
M_7DN=S>#A:!*P3%TI!//0YD\[,G^^KH/K3P_ICP]ILV @Q^HZVAXMZK,PQ":
M"^EN;VC/"6H8L>!Q7Y&J'YD:+F!Y7VT\$*WXR]VGULWL+Q\G:R0<'&%)S/4J
MG7D4ZU =2+Y)#D /E4!+!J<5AGQ$<>S^R7BU>AY?1;XN2*H'0V.Y6QT[-\\=
MRJ17'U&<IJ[\1$VF68^%I3GV>J<[?G*OFMA"I9F['[2XC;+G8*M,Z TJJ-%R
M_7\%A<&;*!R$U!NA?-"]0_':W(?"?SZL8=EO'^=^J[C9$]]XA.\VHM3J?I#
MY=6;E*OO\W9A,/"=S5)/$C"<&()M2,-+W88.C)4484=(U"A6UZ/<>)<E5YB
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M^M_UO^M_U_^N?W+Q4'O^'U!+ P04    "  ,@'M:D3GP<0HB 0",-0$ $@
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M,0,4)((_3,)2@,X8"'>^&:)HY=.O*;R-8$0S2L]2N38&T,WV(5/!3Q2^_0]
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M<#6:QC>JE6"C'DI6 8DU L3:.?UM0U%V?NVC^>4Y=CG+,(F!2<TG7^JYXNT
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MYY7OG\92,.5IF$2N2L-OLK9=T@VR>J 5NR#,I8<W/T)1?U]3!N@5UU_,O\;
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M5$'+=W75U"!OY0CO5EG? $Z,L1^\PK@B&O_P\>.3@I=0LU<+!?<58M \3ST
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M'_O"4*>;IZ5DN?A<(]>_V5$K99:"5]83UUY8AHV6R\;4%Z6P+?^9RO]/+>"
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M=3IB8YK_.TON/79^-VUH*7(D9624<2K$8?)GL ;2YC/&B2(M*0,33%M-RG8
MDM(IEI1W.$V9#BF0$[![R/PG30G_DILF4:X)&8\@,3SJZH:1D=P-9S]^<@KF
MQXK=D&=>U+^_8JF4;/'IZ+&1=\3.F2A&$@XXC1M3$&V&G,7;R&;26U3>7Y*M
MTG+,!9H<Z'0E!H"2*$=:)#/#RS7;\;YU$B5PF-9IY]1)A4=EW?Y[;A,IR6.T
M 9?@M0RK_WJSFJ+/IN-?OI2XCICQ0/6^6Y%P];FF*<2@'%P5#N]%WTH]O!=F
M> @6/,H%R^1$: )$R#:,BA7(_M(:BI'$1&Y*C#%[WE>A(IWDQ9/*;CXA3.Z7
MLT@\98A;]VKR9FPXWZ37(3(-LT$"&[14UNW2&#QB'&"5;/E#@QYLFG2B&1YR
MXXG"*/?I9 ) %YT&Z5GR28-1G*=L#\U'S,\ HW(R:YB5V$-)?+CRG$US,H8G
M%XUXY/AHMPX],1^I#.$ZKOTE#^P[!<BUI%>7#77.^K4>J")=Z>#[VWL,-MKA
M3DH-&&P6M$MA7D_0]V&A$]'@E,+<1GE-VTB]))5'JC2 =BP-!R"%++$C92RF
M.^NR1.DZJ/%%[P#NN?1A9,9!ZA\?(!>L9A\ZO5@W?\9RANQ<*;^#,I;((86V
MJ'IC U0EJI#6#XI<0$/V/9 XWR_V('M /H*+(SM!IR[<6 ]O71G(M8<.7"^K
M=",:=F*2N/!OO[#I[T-T7M7E5$L<IHA) =;/ZI\G\$;X X]"OA4(?66><E#F
MX^!D(MB<1=DP@UX'>K&'H'W HH@(?0:S1*F0#SC!;Q9:\XBW*!@HJ%P2)KV/
MUH$872\7_E,SC9_7H>?.+\MJ8RE*7$&%+,JN,6C.!R0FU# 1?;L3BS7\N%M,
M;0"%GTCQ?LHHK1XN+ "DE#VR-\LP/;0N.0HXZAP<]F26"V]U#:KV)Q%/LP:G
MAL,:D-K3V_F@YDV)2^1<5>SK5J1 V= >5"Y5<UR,N:B;$*>+2T  ]EFW:1N1
M:,6/LF']S?W+L, %%5)?)T":$^%!7VJ[7:L2DLWXL-B-UI46KM0$RFB:7 O%
M3\7ME[V.PJK/Q;0&F(XRD.3KX56A34L<'3:;N(]D&"AF_)]?TA4B )>XX%,@
M8B5L;YK35P,5;C3&Q8JX*QLRYVSH-\D^$3R_/G42\M0P9HI.:UK[:_&VQ.WZ
M%$Z---AN%; -^/SV^_12;U]\:R"_;T/?D[&//;P%-<*XO<]L'J[DYW]_2JY[
M!9B3)@] #+$2992Z4:9'HOSH+$:!W'DA2.B8A -=10:E7DMRV=O(6#LKLCEQ
MY^+BXL%K%Q9.MN:;$,(CHM:X6237&'^U%.F11\7N*ZRB"UTOAW1YWYXL83O[
MLO1-!]&*$N.AL,XJ;HC.0FIUE#^VD[JINF;!8YYA && YL/@,DQN8(PM[=6&
M-S(3JRPGZ00B9NBO$SL1MP0J6F_W/^<99+WY\9%QD-W:/6':E/ZL,&AK%ZEP
M@'3]Z/]%V)O')9G];^,T+::F9*:6EDQ966Y4:J823#9FYAB9J;DR9NXI-6IB
M(DRYX,Y,ILYH2>66J9&YE2*H@$Z9^Y:8LDV+"WG?I7BG@ ]]GN7W_/%\O[^_
MX77?]SGG?:[W=9WS7AK-JE6QZBC/T #M"@!2.Y[YN?SX<$SN\535\[4[7Q[L
MNS?#=(EAA>MMU __-.O\ZK16^%=7KO=T]S<45^E@VN2LBJ9Q9)!<B836U+2:
MJW%1-]=@T;?-K-K@;M"?(EQ*$VE?"S,JS,<XM0SD)S.P%9A,W1! SBQ^- U5
MB"]D=8:UB,DUK/D_!0O;9"BY4K:&8&&$?I?"4R#E%BN4E6RH"09DH,::+<,4
M^X%^-E7C4\OG0FMN]K*G>T_E;(&7YQW7T)CKD::= =,)CZ[\R20!3IT8BAU"
M8@L:"%QI*8M5I&TS. "[,,$6_FRXF=GL*]E&IC31OL=7TC?34Q=JGS*XS.%0
M8)8</,6-^9#T=.*]=\_?NVB_RHM0+D_#M0C]TAO@9WIBC<Q!3OMLY6_2@QNS
M<.QJ!/4$](R'(P>@(^!9J=/+EPSFB/5N2\=QA0$T[M.F^WR.IDO2)3J-UIJ9
M6T5.[7.1CRX.K02!S4/CQL*:5HRP3_>?9Z3=EXVX.P[^2_";A%.Y[U'7[P#O
MCU\^LG"XW_+JT800S-M?0:MG[^[<_>JWX7'+" "]KGX/Q5">36B<_5KNT^9]
M>?Q97K5)M%95:I5'H^'9B^\7NKYDY<]7O;*WV9[D[+C=ZQLOZ=K_73+\"^M[
M+X=]?)&>_+Z3I%#IMGW!-.9C^EUR4&M6(I6"T))E"&G_R*M95^<29']?P!T0
M87CUHF]W5&]8)L2<WNG"@>*VM-Z]XC4Z^O&]!JK:+'R*'"IHQ$DUSJQBM/*H
MZ:B8G<8[+9 BJV%7Y69M!(NLEK C_V$PV?^'M8ADSJ"1D)_\E-2MU.:&$+*S
MF79%GS*!<A;=AY]ZN;HN_(^ ;_KWEVI85Y!XNZS[)<YA!_R_Y71*\[^H2%X)
M\!OF:,\+)<XB#7R'0G?,6FXC#8<FY/=K9TL00W$: >QYG ;#.SY4:G[V\U#D
M).ZY_YGE8],_#W[3T_SJ^/RT6<*1I=G :Y=J7 ]VQK 'JOT=2N\&69^^]^3X
M2T<;O?T&QJ$AGX??KEAL>_W,>UG[BK=A($XGC1UJV^2?CSJG>5^_$?CZYGK#
MX>M/J[SNV\49.8_%[7<=2:8A3>[AWS#S@85<AI;HF\5#@)9--!5EU-RQQ5\&
M%M)C<Z)=SGP(.7.EA>K*>!D9F__GF,W=O:U&&_=5K7_R5+N=N0G IL1..LL.
M"1;4"9<3)::NN2MX.('L/!C,R#6-)=R9=3TV-/%YFTT\82PD[G1\,*S.N+5V
MQBY7*R[!EM<J);XK\?PP'K4P M9E;:[3T5690ZK=\S#.DKIH =TTGHE-19LB
M.L!3WN<[=^U1INFIO[XS*5D[L)!,=*I5@FF@ @VU_@+5@>L[5E1NDW]%O-T'
M%0K)E%A^:F' 1J@=Y03V*-0>5H2)118/1?RTDH/0WQ5PV#37.)VX?PVF5B@R
M[A0GU/CUJN3VY\1N;!Z0K,&P<P+X?T43O\?<K.]'(R]%K%1VDC-60BDB\"I/
M6@HL=#7I[T/#0!UJ"BK>@IX@K#W'=\WJ"# ?$1>Z JRL*XP[VP%^>N/FLKI!
MZ[S@JJDNP/=,)?2O_+Y2;RSPAG^6/V9N)!Z0/Y(IB9"*@0P&+$CV([M8R0%Z
MT)\@3:&^>_6XS \BEQ%*S\OOD9"$G,\_*G$%ORG"YPUKZZ*269 YAM90 (B*
M;\%D,8Q#Q;Z)YE@L$%VW@3SAQ2G&JO!E]N 2E6/NL-NXW8:I#KI6YEK[YD2(
MV7^$E\!?#"P(08N'F/0HBWF+AAU7&[S:7A;Z-#'K7PP-'6.F?9X^HWM%<9T<
MVJNGT/A;_I?"&C*2ID*!JV&*-S8(79(^/9WZ.\H1-%:HN8MHV;I,.$/)V9.$
M_HD7!QBV(%9Z"XQ/JUG*6M"8+:K(DC^V2FMKJAN)'AL+"X[+AV&",()2]"[(
MJ4:YHB?(D<H)D!&A*CIQ+X2L)?4BMC,.@?9BC;0<.J$;!]@DQ^$W1OA8-(H/
M !_3S)!+:S#=_@J>7YOBX8.9F\1E])X4OYE'6PNIS=_>*/VHB2Q6GJETVRSH
MH!Z%X0Q\E=+E:;)PL%BH,L\%(X58-CQE#?8L7J9=+$V79\:NP?1D.F-$;X#B
M/HIR UE<FH[,/OQ!I$20Q=H4=IB@+KQ!2=+-$*SR=2":QT TLG=)Y"C_23$>
M8$;KY#\O[.[?%<9OL"A<-7\E7$@Q/ JZ%DJ0CPD(1ZBRG+B3XC)@T>@&6N H
M18L9CZ O",W)GWAW _3:0B@!5W([K8I\T\7D=@RTKYF*-I,%RYN%(/Y[H<F-
MV^1/,&'43(6JG*8PG6&M4VQ3*!7368F*0I6NDJFD4JU=Y,TA4#EHVL$;*]S-
M8>D3,66S);LA?_P!RO6XP 2A:4Z\ZYCQL%:<P^MU\O_DV7M][)9M%W?S&Q!L
M_ 3. [29E\2!3J?&QKO78)JQ"QD!-I >0#X%R4&VL+O#W(G3-$!T!?F=N&32
MWA?Z7KFHP-*P#\>)?UM1]::@R)^8XZC(<DB[:Z4R[2KC2)4B>?P]5J9KCX5Z
MJQ7_Z-IY=> T26_1AT?H"I1,$Y=NJ"-/981' I/2C''F5F]H;-(=R@L2XM-_
M8W@QM>O]-W6YM)ULR+I_;)EK'A4I,*A-[%PQSHK#:W]J-[14.O'?Y.68"#[O
M++N;U]_E:BE-+12LP5*8&Q3_,'6!Y1QR./V6FVPCV)]-CG!%=BCLALF1ZGR5
M3UXWBFS2&5A &C+,U(IL-CPP@K(MA2*0&>@]2CY"8:@>*"T+:_[MI-1&LK :
M0A!+3P.L3E=+0?^\L)8TAF@PEFP$+;X*<1W(6RMX+BV-_T,#?SN!<AI0R28=
MA.Y\Y"!TT:8!DTJBOT+*$]#606E?>)N53F5K)&^LHLDG^N^'/5L*>6G%(%VF
M]9W[ KFS9$2Q0D=I=6LP83QO'JT/MU2H%8-9"MW&M.9__0B?YJ%]-*"!M(\<
M&!"NB%Y(-\\Q6#UKP-^T9181R,W'0DA2!N#$X3^G*N40%;?C^SD31:$Q0C+^
MYLG?0KY*74=HY>+4E'L@*9J\"2IV'4;O_#1M_3U8FK^;M)YX,E/LYDIFXW8Q
M532"NJ?5&H>7_B(+]4 ;2EQ2C/.]]0N(MV1I&Z@B"13T(TZ"& $\AQQ,Y<$%
ME)P:M#XQ"5HGQFL3W+N'('A7"^T6PQ@T.)O7R=\FTXC!I##W0<;^ #4GUMSE
M)S M3[=@.7I<JI]+*8NPB^M]I(@F=X0IC$C3T]O!T(Y^"JMN.1E]&,J%\[2%
M7ARE,)AC*PY >.#4&>BA )&*V(4^+/.4TX@&D>#W1K<YQDVCUM14YD;(#5!;
M%=,RB;:QL8V 4SKQIV:\6'Z![0HLY7#02@#?8#%"#JF44ZTQ<%+/]^W.X;\U
MZ)C6A?*K9YA& (:#W$QT'8ZE9S(/YYT:V,^"V,"PR*DKQ_(DQ +IPK'67ZVF
MX&P2&JH4DC<2I*8(.%O8%M.NT''5[?F%VH\1U"D?ZB1)7+T*Y0FQWT]0HH(Z
M>1@V/IVOIMA+ZL$UZ&4MD3.*^,DH#R!4"._"9I%AJ$ P1KG5X Q]YBX0F8(^
M&!F @DX"I5W*_4ZWJB5-]U\<\.HJ2E)D6/H$S#4775+A?>\*2U8C>@)Z\_%"
MQ#K9)4-, A$.KA>'II!V\K_G^K"_H^?%,<4F EE)4W*L^I/UESF[UPNCTO($
M+OBMD3AX[:*K@ZE$^\S0^W$KY\6D1-]ZPSTC2^$5<@UZ/Q4Z@)S_]IC40WM>
M3NOP?:PP#&L)34,?40RT4)+1NY4*NC\3;00A!,MLJBXQ"NS/0AO(#@S)O,6F
MQ;2MTWR"33MO+#E*Y&)/,\(.RK#7:V8,=S=EL6_X',<\^(\>60>HR+2Q"M=Q
MD8V<]CUX(&L-%E"\>L6+O_1?_O)_"1G<#[(D -/5#X=:A=SE5/)5%L^@<\6+
MB\TMPB='RTPK"?;2DR-6&%4"/F" $4R_;]_I%;!/7F#-U\XK=WUXZ>U,88D9
MB,A<*&+W*49>CBR4Z?5(X>Q^U4B%&B **]D'T<2TK):BZ2E_FVSTGIDUF(95
MO]:KC1VG=.])6:H*0^)AX(_G=6\[Q\[(S(J2,W"2YN64TT%?@;>S?V6[$E'/
MYZ,-C]\0FSDFO/^<\KY'E>M^B9A$=&*I5G'[4K8Y5[TX.TC&W0.:U ^^>LZ8
MINZ\UA?C99T2,?SJ"P.C-_P&:!B9&Z2;7?R:N_WU;U2IWVG#2S=[U(M$Y;9]
MVFPS1\V; Y_#OM/2/_X/+?VV7CA)R^8W-'/(61=T:>TT6-32]\Y4[OBCX2O]
MU(7W XUK,)YI]XVC)Q.LTTHUJ=4STQK0SHK^ZZ&13R$G+DN#>?Q3]9%AHIN=
MZPRM@<R11 J=.K%:D0KX\^>CBGUSA?HV2IM*\=$M*[P07O21RT\O:J,EDW9=
MFKO,W=_6##08FHS%2MR[6FH;+M#@D.DY4"\]U"V\[)W=$D:%M&,&L8FY@X 4
M%F0E)E7[$EP<T[J^XD:SX;40'??RCK\3U] 2W#(V>')C?P8Q7.0[Y<L-V,=(
MVQS$&(_+<9BYG.WZ+.GT>L6V%^3#O5<+D+95OI3GKRK#!]GNE6D<4-/D7FGX
M8!7*PACY:MSR(DC8(K9Y&-[B_F\GF5&K1@XI\JAH.?:N]+3%:OG!ODI"WWV;
M\D%AD8J,IG3KJU;(B;DUF)>-Q-Y3*:J*31<HPY"[]#'0>__]ATK@V*0W170C
MI^)40GR"&#$QS+DPTXS3:5A-0F(S9^>\001[<="*EJ50K:L?7EB:\G('T)7
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M5%&W[WI%E;S">K,X;4/N^PN;'9*Z98>&VPI4=!(G_4ZOOS,X:'VUA_<5FQ!
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M#NIE5@X3=]80QAWE#X+;QM#[(B_('$&SP? BN:2QF;*T>T//2N^J*XES ]'
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M53S1%GH/Z@DIDHV O>@-Z1 43-]71.Y<^ &BB522&^CJ$0':D-@XA>@D0!I
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M,52B!674= !98CTV$B:SD^=B+B/3$8 ;7X^X%WH(6 J[N_K5%</*J4)O)@8
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MIR_,FJZY7637Z99L[]IRPKP_D;Z78+=MF/WFCH<<ASZS=RIN([B+<.\LZ=3
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MQ:>B-\80H0@C5;%?"S[%H)(&R#Q"FN*#!FYZ")G7&_3")"?Z7F&?, :'7OV
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M24V*WDC*.05:_@P%9A1>>0NGJ1^N49OLL'.%/-&3N9]R!"4J4 D4=RE6#'V
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M*QW_F?U]$:%O$ 8;L97W;LCPZGGX0AECYI8U _VW3ED7K #GG9^Z7C3X+6A
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M?;H]:R<A>X%EDM,1U)7/LOK^9N:=!ZN5S'\F?3!='P3Z1\BK HQI6(-WNSJ
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M^=RUG&@TL(U/'8?K"U\5G&0-18RH%6?3X)SB:1=YCC@PPP"Q:S2;[L8BAL]
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M\Z6QUX]N^F4E7P&PDC*/LQ;QS:8[8KY(9Z%2R,-)R&BADA@\-B1MW)LX3+Z
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MXU!^F1-(5F<(>*/+ZC9Y7H_",E&#_BMC(V<-RI0R1<+V9H$3]ED3V$'@E.F
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M?K/VK\Z"WI(_35+RW_&:,S/T+U!+ P04    "  ,@'M:"T>(N]!#  "]1P
M$@   &EM9S(T-S(Q,34R.%\W+FIP9\2Z95P=SY<^V$@@)$@@N <)[NZ28"%X
MT(L$=W?+Q=T)D.#!78([!/?@;A?W>W&_R_>W,[,SNSO[^>_LBZW^G%?=7=U/
MU:GG/.=4P>?AZ\";3])RT@ " @+P]?D"X$O !^ E"@HJRHN7J*BH:&@O7Z'C
M8J"_?HU.A/,6"Y>,F(*<C)B4E)*&E8Z2BIF:E)2>CX&9G8.;FYN"3D"$GU.8
ME8N;\Y].$-#0T-!?HQ-B8!!ROB-]Q_G_NL$[ >R7"&((-D@(5  B-@(2-@*\
M!Z   (07"/]JP+\U!$0DY!<HJ"_17KU^?J#N#8"(@(2$B(STX@4R\O-=W^?[
M #+V"YQW'!(H;U4,4:D<<3G]XW^]I):L[L)3G8#2<!DY!:"]PB<@)"*F?4]'
MS\#(S</+QR\@^.&CE+2,K-PGM2_J&II:VCK&)J9FYA:65LXNKF[N'IY>@4'!
M(:%AX1$)B=^3DE-^_$S-R<W++R@L*B[Y75-;5]_0V-3\I[NGMZ]_8'!H<FIZ
M9G9N?F%Q [*YM;VSN[=_ #L[O[B\NKZYO?L'%P* A/#O[?\6%_8S+D1D9"1D
MU']P(2"Z__, -O*+=QPH.!(JJ(:.;ZDX_5_B2L;_JNY"H^92A>(9.4V\PJ?A
MWJ"%_0/M7\C^UX %_(^0_0>P_P/7(H".A/ \>4C8@!AP?4>?X_?J_P?C<EUQ
MZ^].!5D)1@HNE843T0?'Z 7$H#;A*1H06JH<Z"1%F4$@MIS+RWII'MJSS.A'
M-*Y.@O0[O[\Q6KK?C?N=,-?.FR7OG[ ,A6DR TERAA=(8L'.U-W-_2$7E00W
MBHN3U\I3=1BBD(,_-T7N7*TFPJKL![U-J*M^(M*S=Z];^%E5(FA@>1&_,<J0
MT/TDMBBLTIM#U)F1^,25WK=*7G>E1A_'5)WO.<L[M!/^#AEI]61R"G,B>*QR
M/&&X&P\15O"$A/P\KB0&!57Q:LK9_.:I[S7@NL[O3PQ!U_IZ.@IX1:]%7GA_
MF0Y+E0^=,HD1*CK.L20C@OG["1QPQ20UM/$=+;<,#.B>1\#LW]QH/"K%OJN!
M/NSX2IY,0F8M* F3V6$I"*&^73]BC:R=R(@]?!Q]>7,W6E8^**=H@M)85 5X
M:7A;Q('!=+\.=H[-G?$/XN2I-))'_M/-E\J>N%PY@%Z2!#\1_TYKVI\[S-R\
M!PG-0)G&U)F"1LN3R]=2$19()M$-+[<4\Z (R/[[$3.PL421\8BOK>T3K*YM
M)/><( _;;.4GA0F;4$;9/DT_.- =LV*!5-$&X\TPAI"PH(U,6A%8F,CFA-7W
MH+Z8CVWF])K628DX<CE]L[B'(A1>)U3T^6\_Z<>"B?AS/BDBPL%+O)X;ZS]>
M^5G1#WR>9?.1D9$&6#\JV+21CALQ$0,>E]]+^W+I-*2\Z8+-*6F;Q7"Q!E)1
MNB%Y>ZZO>Z4C.AZ+$Z: <5V9,$CSYZ<,9S&+F3%#=&4P6IT9N1!E63T[]S,5
M 93F41!$)J16[Q.(J;1X(7OIZN?7>D^CAI6I$5=D-IW9Q#^+Z+-G2\-YBW*X
M4VFAFE&\)BR-#2+#Z'-XEJ(MZTNCWHJQ?]Q3.Z==B>QM[5A^(K/2] \S&)_A
M]0F2TR-55L/L4HH\DC?%_<:OYBD)D&L_2L/2#9.:V6]#E<"?W,,?-/,\/BA%
MW&MEY(1H?Y2K?IW0\_:O&X"CX'@^ZNH)^W; PKLSBR$GS%U\GB5 F3B.:@U(
M[/DV!ZKSK*'?=/<2;[?EC_8&5&08TCBMC)KUO?Y)MUR^77!22H@DL)YX*$Y>
M0!L=@.?ZKD\3]13+"KFZ&L%$5=$Q<([,>HC[$/QFH6L]K5Q>IKTQ42+SH.]P
M,-:Y^<=#X[:R[% <*D\H7;"/C#OT^N-D6:UWBX*GW:DYJ!#,=!3/)==$%.J)
M] +IU^&BG\CX6*Q1QX\TK76R;N2_DWUE>!D?2+^^/=27*K*H9)]BI8-&7_9%
M<7-96A?0&*8.G;IKJ$JC$2+JSX\3E3;3!5WRP/13G"LLX8!]8Q5T1 5MYS;W
M7F=(EB06YA^;=N#]%[6H+.QHJ*+LRX:?0/]L\?M*F[O>OI_AR194VAF+G-3=
M."@DOX1=*IENP+F'&NW"==.L+G(7\[13^1'[QC5O)&L\_0.VN+C3S7>-QZW2
M^I\H9ETQ9/K8S N6QU)T%-(U=GC&?QSR:K$UDOY%K6 JW;5&Z>KJVK..GA:E
MN_'^/&U?MANK:FQ(E^+*K<$IK$)J<O*5'073B@+-0LTB4QC&'M!5=O%SH\8"
ML6(^4SR*AOJQXJ=8AF/JFC_/BJ0]D15O>8D,M165U@7,"08Z4$;6VU.7'12.
MNC?R$TDE:;$.H\QDV/38%8>QV[?GF6 ?=I7,+LYF>):N[FM<R]$>1^3J?A3L
M[Z %2]PX'NH+;);3Z<P:Q>VWXS75GQVQ@!0MRI%&@A7U>>/3KFDY_'!-VQSU
M"D-=S*:>F&XRGQ3(-F.5 Q;E05W TA^(.LM"Y-?X-:)C<;)+7!7Q%_\3<R:G
M@GE;$I>W1Q=8$@CV57*_WSRJ$NRC#B.U=S<.)EKW2MT_#(.)!D+X6^7@ !I%
M\.J8?),-1M#5]6=E8T>3>!)D.^3,EUVXP"%%V.QU"K$-CJ6[1HVN%5;!BHP0
M,)L8-EQ$:>[PE9^JVK:=:D]PV=UK 'JF4&0Y!YW7KO5'_^U964U$&E4DQM%?
M73:U+D9@14X 0^BXY]:G:YK^VM'0'/+U'7-$"6^4J4-+*'7ZS"$X1+,^DQZ:
MT8/SL=DLRQQQ+=O.)!-X B'$?#,72P*T4B CT+2E8F$V!Y<TH;F:U#.A^4A3
M T,JJ@^9CIUX;1 V\H4;]QXO_7B6O"G?2LM,5W[0%W?L7+$:COX-?5>^;HQO
MFC/OE+#V<@Y.E9,A&):GI IVQ I#7>I>1?NC]E9KZ*X&.*,0IE$94$MMYKD-
M/A0D6\!@%"[S?=+4.>'6"&&3&V'A)N!4"OHMK=BC0(^73>2-YV37J_#\P5<(
M=IQ<#<6=_77&_;!W+"X*2JIS+D(KS%H]O_W;WLMU.^0(O#EFR7PY3H27[VT(
M$9'I9#![7]LP%]V,YK/U5H(ZREX#F;04D%'DTE7HZ&YSLV7KJ7[-PO8Q5F6J
M?1@SPU2HE877>:=>FN"^%?,[PIY&.\O?$QOB(RMV1AF+AH3MCIF>A6X*.ZSM
M+\+R,*0/T)V?/-WZH.45EL:FB(GW"-L?HK#WTV&'NIF5&Q1X^C+%(G71,8\@
M205!DX2CV)J!M"9DMK&7]C;$H9I0@G#09]B+X*2*#(?FF8S4VAI=/&O/=U*2
MC8ON2 V,3NQRV5C2L3V+7 N/I??2"&^:\&W<7=+CA#NN?WMIU'DJ9$9=PP'"
M]R$K#Z/D(_W%*]E10?(PHB!6V2[^VYL3IIDB(">"_G_=JGP,:>+WD/NI^_H\
MOOSF4 M8)Y<R.NA7G"B'9.Y7?I)W)&L^:HK+F&17?V+]*3RCK7/4EV^JD#>[
MZRCEF9P+,7AEN>B3$JCN74T:CATS^9CG-.:02_(8:_!!!\MS8Z\\&:*G9QR<
M>X[4GKUNN](@YGV_[&OIG>=KZ6;N+>5Y;B5*$6Y'DZ7*#OIC3&&1HFQ(<JHW
M7'NZ&Y'!RHWF^F)J<R;IE.2DLSDP1=ANW>Z"\I'^6NJRZ,K<5<J1X&K8]'T6
M;>L<XZCO*]+E@<YB.VFT7K<+GOR).L&(G.9G612?K2*%"_R/37MQMIH\M/"Q
MWAHT_",PV+76;^@ "X9'NN[>RR4->Q\-(4Q58%().+1?^V@C"&X-W3'H>05,
M_S.J9?S"F@7+UJ-YTJS"$TR=[SF>]O.EEB="GJ"D%_UM=IK8EALBBA2D]56G
M]MLD/\VXPDF\^_;PC,Y@=;*=MUV#O8#US?B3%!RX]PR$ ](LYAZ!4H+;WWE7
M'4.'6D)VW586SI9YQ4B-B@\RL::X#X_?Y:8I)]FQ]:C*B%S\IF:0L0MN^T+Q
MI]G^1MHEZ_8Z$0X@TL !2*D<_8*5\TS. ?=470P^5FAU)[/D*M:%%@N$WP_C
MZ<N.[N5I^K<ZY0?NN*ZMP5*::BF"))O?.N!2<L?O.!\0%>6(D(DO#/YKET5P
M(,C\F=BR/,6@5$I/C#G#35DS!V".SB[HF;4*;M7AB]-W]*J@2/5XQ7<<O%MC
MF!(#(FVWQ1=9H5"+4ZNO+>8@Z_F3[ZT?'-%0$VNSP&W'4WA+<. /5QX<&&_-
MNL&F@P-X,@_4@DH/]X-PP!\'#/NB[8Y5.OUD3**#:I?1_]!#"0?^EE:5)4%G
M$Q+Z*>N,)AI=5KCJ"9TPT<JM;$MIHO>F7#:'<%6DY(K^/[@"0I?/YUG[(^8C
MF[+L-@9G=JYQ4V^RUB*_,P3C^/38'XXGG(Q9?BXB5">/EQ;"HLU?KE0A#.W+
M#6^7[25)1X9&XQ,[Z8I&K1^DII@K:C\V)X\155+'J^+<*2TM^ LP;%]V49H$
M<$0HA6JD)"^J=^O?J':+)\@AO#8KR?0@ZN9$/Q+MR:Q%6)CXU[\89;W586W#
MC*4MOW#GJBG[?+5%'41DAK$_E>4HCB<LX[*VY/6B<L%\Z>H27&OHTWKK%-WF
MG-5-?CDY2Q &!S8/Q>% 50X<V"NV=JL O7N.8<KL.1$V$?KOI9R"_1%2BJZS
ML9C:;_*2UPA^37SLOG^'.K]CM^I-T99E'/QP.%.Z&RVSD9P:?WA7HK\V;)V_
MUH\;,Y*_ J@)F9-I>E(_3AF(:TMM:8&Z=UOOJ=5QFEYD(9V2NO.<[.(ZQ 73
MA?@R7QR:G!Y6%'Q93O/IN5"1\I#^)86KC/ _--1,'Z6JEJQ[7LB:+-\$&C)7
MQU6+-K*&H7\7D,P/G,?\V"E[X*U*[A/1T^]B_J++##9_FK'>E5:_#:P68]AR
MX-!HI^&6VPA+3]MP2XEK2YDWUJ8][QK: &U3!\9Y:YC_62JN3-%L;><[L^+#
M0*Y1\(B7-E&C.!FB,?%K\=Y-S/H$7 C^DW[UU$Z>H$9>LNCL,41G1RR.A Q^
M(3+?K->*O=_26,%%&+!*92;^5I@]3C;S4.9*J]= D/"IM9\.6DW-,S?' A&Z
M>EY#D>)33[VN#<>E;(OU6'2BNKEFSADKL(@#:[G5(8B$%*Z&\:N('8B0O':%
M*7\,#:? !6 R73=R<Z7Y_.XGR! ^E:^T[!%U?UG%F^<YSH_=T/E;>&S51[;X
MUDV3&FJ73@<E9?(EWYG!D4]+$NO=3>BAZ/)[8#1 TAUZ(M43W8_4VU=M"^JY
M%-7^TP!)P]K4P^6@;<7N)CZ.X7F9^Q?!7_</N"<7(AP^N:9;MRHB.H&%>AX5
M>P]I?BR<%2DY/65+/CRQ/_FX."M80I_3>O8G@CX;\7]HF&H0VMLI85;6X+K:
M?+OUGCG94;SB50ZNX-U7GINW9M5/N(-6LZDC;@Z6E<1Z ?87\ROOFFDE^-$5
M7^VBHI)G['][OV(]:UO(F[#H%^%VSW%/.XUMIFE8A<V8GCA>SY6:ME%[U^X:
M+:9C/>%JSFR]K:>$GH;$0&W_/1NP0&K]%W$/U#V*^NI=-.;%GU#3:I5]5F8'
MDM:B6_PH-WD*=?$S-D0^]?=-&M"HY+<8C+M=1_)Q]E)]E51;N!U7Y)KU$\3"
MA@/]L_YPP/"9O"=49X\=%S.C;'@47H&/1:1W!1,J4YSY78AB%!W]1]UXG.J2
M@@(BZ(L(-1DJW_IN*F'M;WZOT[YDD+DOW>Z' [&R2AMZ>DXZNA/CD-.WAV\;
M\6?E\ *:]DHB3!(OGPF8K**,K65<K=9@\^2IX1;M8%(8!4QZ4VP>A_7&BA!=
M_/'VLM(+QCFVBCYUV=@MYYGO*>@GLJ(.]A+#9=/-N<'ZW R5ZFM.Y9:\TE;,
MQ6@:?X/49-@'CN"XK?,*3EQ8V[LZM2NY4NLLX#DR9NI\*(U\P:!24L@"'BZY
MS9T?M58M1RZ6GK45:8UD'R7KP1Y_BQHCA1DE^$9:HG".8]V2'(/<%\?LO2_Y
MQM'M@3$%M\)-W_ M\?YA3AN;J4IW Z19+%78Y>09?%G(,S<#_V'J\N6:2M5K
M5Z6''I]8=W ^(2!5..J>!HE26HHR3A:TGO^J]2CTB%(=0EC$&EJ^JQ CG85U
M:V3P:7#XE"S>';$^L[(MKE^(\I $L@GV:E,:%J%,<4>2N5TELZBQOIE!\@Q>
MAJ9C_ZKMS]<Q/^D*!:1Q$FQ=B*8F=$>>>*>HTI3JY')23PYDDS:C![%#]1;&
MV!T$^E%1>8S6^C))FVM3#S T"$+>! ]@I(N]]H^JEZ4T%F',8$QN"W:Q5]&6
M@RB0RSL+KO48O0D?=K[FPQM7.D7DF":>*7*T=GFF6(;_-K8,^DC+F4,KYR%5
M-:W6+3_*85Y1$S)-563UYUU]+ZF1([IN!'?ON;[XVY;]BF$P'E]@R0OS#!9U
M=7['/%88.(B$1&:9A5MW>$RG_#L&0U-Y"@)BB@S[UFMG<G[RI3"%](?:&6F]
M%Y;7_(US*9G9G[,K6[-3E;;XO\O,R;'V>$W481!I)/\Q13G^P6S,@G/-*>Y]
M?*%CZ<F%M9.R\Q+\.T2K1<&!B+VN^) /# -4K3+]#(5[[<PSU.K0F5_6IBW2
ML]RS3<EGTBR-U E.",!7EP' J,4^.$:LRO[K/5E==<"I]6NM5?IAPHDP[&JA
M5\F+G8Y-"H#[%Q7M>.M9+FO.?16BK::@X[CREA]_CS$"W_,&!O"/>P$C,+*U
M!R7NUV(UNN#^N\'=H\>YNR;IE87[U9DIC?\NCG$D?DJ&RG&'VC@6NXGZH:>>
M6^,F/VL)0=$XIP9]VJ:$NW,RC94? W @];O2#9XKN7"F[,,[3UN$WMY;><+J
MQWTMNC,C\*O*#9#'*8_"!RV)I\@WQ'99>^_"-GYX<^U"5?1PKAWJGSR_81M4
M\JU;?Y 3S!J^;>L8WW*U*BG"_O(""4#HQ!OU4'JBK3GX1O;M1="J:97(\=8P
MW>.9>^4#LJ:";G]8!T2]8I_X!O(L6KZVBET,2?)RP $WA8[KB0IMR^(OOH=3
MI[?E'<,[G.";[SY2]5DG2X=N?:@7YQO#[^Z^LXJM4S67[ K;6W(_$2>?3+CK
M6_ZF?6PD6^1JC.UU9]L$)6LZ'.#C7]<?-Y.$S6HMS6B9@ 6/RT\G@Y7N71_J
M'YC;93@GYC,CZ"LD _XSY5)#^ )W8;P14$L-0:UI<U=MNQ-C1*DHYV#;O%T_
MT9\5;)T=:*Y96![A=CR1OL1P0"F!-\9BB]Q2?^,[I^L A3_/P>H[V#,S1G,;
M'#@)@GXB?\W!%XJ17??%,+$PP&X5@HBH<Z\(>JYNS_S\\&>('47I?1NCP"Q5
M"-D&U1S3/1RHZ&6FV6DKB?Q]^/=@ I_[B]2K$O82%( \:5AJO?'8R+_L)(C@
MTWGXME8(*W72SY^DY@EHR.39E;^>!Z.S%O8MS=V;K+G7FWB82P+W;$FPFR9"
MEI&"<.S+YAQ>+ZJ:OBI95&,KAK#H1^R#F]\Q%B<Z;VU><Y<21F4LK),B13EX
M0R+A "#C;6Z)M131EI]1UZJP#6O&D35"0@H@C$+D.-0+B\=T.'!P\-SSI3]_
M:Y5Q&,*OEEG[V":_NF'BR+!!Q%+I0D(XL_I:F[:QM4G]-6EV/8Q\4O[M#K+=
M \/@3DN$93R*TP''7.;W_._LJIU<+LAG5N:J:LO,++C^235U_O\45BRM.8+_
MF_H":6A,JU2%AQT)4P;OFGS"HF4RFOZ=6Z1Q$X(G$H+75J(2U"#<E<7+5F--
M38%=P9C9LD6QD4MZ*<5]E;JR3@Z&="_12BOLY9NU.)) I1BP8*?U46EL\.T;
M,K\]L3\UWPA]&RT2^T437)8^<KRD]J:M<P.S?,S+/FXEQ4%Q/J)'HN@C_@DM
MJ#I;/A#L+?]>1A.Q-_AB2_;(D_QS5INRD U_I>R4B?;%L/:L!'TR;>((]H_K
M+:06RVWG.=1\3[Y(5S(#29AI[WE7?MU0?Z/^\U(4<W08Q =9<)9^-71,-VHS
MD&OR'B7N.]# HIF%#8P4*>-\P9',E/E[D?TZJ;<_6S^6I. 72@I> NU(HI(O
MV:!]7=_$\4NU(H$NX:^VZ^=Z^;@(W:LW7@IL6G\K#'1G*@.MWOFD-27]-1,0
MZ%09J( T56*OTEW-^IMNC^_XMIFL;?.EQ+*J1-_T^=:D[EO+U4_:R-+G1(R8
M9_K(33\+0^A5O(FSI_ X-_6D>+L.W\3GX(YUO&5++Q]BQ13KPB7T#[8X?>WK
MF(7+EQ5B2C7$N[T9:IJ).PT3Y9-]:U-CAFWCTRC]FWHK+D;JZ8:+3+#K#I!/
MY(YN!-/,D\%<D3J+@4*HUB3KQ3X<F%GNF4A<<>*G7B8'O]IF]9'QR:1,73"/
M-X]Q"#?=BHY)\R-]/.[!62 %F!HKB%US-?9=!*IN?DPG.JPR]T K<EF+-_84
MUBEL_>K*%^' U!<AT'G?MR!U"N1$8_NB&\_QT;P5;D>D5=1;B%A _=H-AB#%
M3>+-F86@SJ'R[> >*Q7 _YQ)O9]Z=GON4?DG6G+1R4N$WO;2UY;GF:M&.[+A
MU_T_.L(J'M@ZT"9\*]J,*[?!K0<]-(4C]5Z/<&#KXA^1UQ3UGT4>ELC-K_7'
M#SV"XKX,%16L40,*U4U++Y5?,N.FFQ>*7O9Z4&RDA)7YJ*#?Y;?U)A5%=RO9
MNA6MQW>^4/2L=$G66@_/3YKE_VOZ,P8@WRG9OVO/*&6J"][B0\ D&;;9/-3^
M%&3*:CR9&]OS 7._U[OMZ*+)COML\POZ:"U"L@#=@77"I \%2]MO!7=O5]H1
MKE%A_$I>VTTW=_HE<>1U=N'$0#W?#[:N+[80O2TU9,--T=LXT5#/*"/VHK9Q
MCSPKU88O8A$.#J^**LN,Y+V3:M]*704Q'I-N;%%25>!6.*97[RE8- 16'%?<
M3-A<OGZ1N@[2D7/<+J]RU] F"(P)(G42<N79J]48Q^,]8?WB65^Y;BOI+96P
MNHCVWE<2 MDA&_*Y=%K5INU2JR4/<DR,L:K;#6@5OPN)@W!G'<F9X:\O%YEB
M5W&BT/)Q'$;G2Y!93Q?],BH(3"*5"6CE*[80[,LYER#E56,;(I9*D/;MV?4J
M26@4ZWOM/-OB15]F]>49<!?3O^5P_Y?2#E+(35K1OHJ%G"'8L2!OLGF8L"-3
M*TDR[G5([,X S5=$P<D'KL8 /:K]=S!'&':,1%.5V](6*25+,O5*^+Y&.]4@
M3T?(9F/=M&BO*]FT]'O\8Z%/2XUATJWU)S\*;EZKMTT?5XJN>9L+#[R+HVU+
M7,+5IL9L"7R;'B! 'J2,RK!Y&.VVV].<49&\N)6<G,S LNQ&'/6&*A=E?&@/
MY/C*B_C$!]O;V7O#FS=-3M &#=?2(F3?3GC C;5_N3UW+I-I[(E>SU)N4\AD
MQD5/((FE&O=:6?'4I=>$,<)HO:0YFW%!3 RQS5HN?F>BS#1AZBA!I-5FMA-<
M3"NM!MV_47XQ5/R^V!B_%.7'-3V;>71^# 7$1+]P?Q14@2TL4-$-PYG3CB^G
M\Q]YLEEGM]A\)RD3=844Y;ZLI .LPB@>?"THKG -'O%8[.;>E5AR+EAYH8^7
M'A!\/?@D7!HBF<LQ.#[DMPNK:'\6'I1ET>8]J7;1^?JKH^Y()%H+(Y(2C?$3
MC@=*>)4&[V[*V&&\U<&4:8/BFS.C9HE)LFH&EDNG0E MK;G=[QG?U1^5<I^(
MEX8I FS96!7M+ND2[MPN+0D;SI;TC-FEF&4IU")V'U[RWF!]($]6B9VLU(T4
M4;T_PISDTA%VQV%\7#ZOY7C@BC74#"L_?G_ 6JET^'>C+(-W<_;J-AX.F.GK
M[NT(I66G1IKV]A@_@NR6@?TD4G1WO'Q[84WLY(@OB=:X1H6Y2 %B@LDUD4O[
MS=\=:6N*.N)_YANT[+P@DS$2?V0BH==^Z!CH3U*KN07'?^CC=5;X]5C_K#SV
M?[,<-Y)I%:X:W."<&/3EP&C$H/$>#">U?2OLT6Q'NJ[G;W'H=J.^\4S.<6QP
M/:8Y%]\XWN"_]:S/OFY(86Z$ RZG!C<ORRV_N)3TY>S?D27OYLR=/2D]8;2?
MV\M-&\Y<1(I(+S\='. E^0:B;T)+DX9N/CS1-GB-AX*"JYJY0%AWAKQZCD<D
M7G"@T[JDO)I[1K""8\EU[]+ /\#]GWP9Z=\W1@7$2"P$"ZKS=,NCCZ)>JC+7
M%VEV[>X<9MZ,\5=\Z%S%G8-,;S?'+>^KE)F^_HTQ)K=?U^(^ZK4FD:CRP?'%
M$$& Q;:RPV<;0J0;]9)DW<)B&;Y2&73H(),8V[[83RK$HI(1+?^ _HXV!^S1
M4IF-\(LP;EL-H7DZSV3EDF*JR%CV8-L5;4X4QW1(&V(URX->]LI:&KTKX>(Z
M5[9J&1+GK@-R% Z[!VIU2<&BXM"C$D-Z>K-9787^ZK*N1.G"4JV[ZE(/:]1G
M"AM1#3<^W5!*<V"71TF^N464>]*P.4795W;U$VNZ?HA_[AO>M\,876H-8O1=
M@^-4;8*+$)(6K0K;+9P/G&C4CA/?HP)OU7#^C#$-LE'7^K/F$7HFLY.%_K(K
MS"[_5IT;J<?,A/\<"K?IZ4NPK05=SL)^-6N3)@'T=!5'WU"-G:<B.A0*&H"<
MG/N/!E;WO)L[1^>\ZX_+FY6*M<G7#GKAZ#AE 0S$=/W0YDN*8/RO"E)XN'S8
M2CN>-DK).[SK4>R'LW$X$RIE,*%/Q50U'QTIU1(*@?7[]<";"628'JA?&(<Y
M7K8EZ3M4"O^KW'^N[B# -*SW+D 6LQA4"H+689"DTYUD:O3@D'Y-I494FGIP
MA@3T)W5=H/;4!'<?;TU?P:92<\*VZ9")F0P=/R&)S*=#'[72?1W>8):^&NS,
MB04C=F9RQZ0?T%]"=T]X@= .U=HF://\4MZJ::;POLGO>_KO[5J<A07+SC$6
MB&(X-TLZDW5MDOWRT,>"7,PLJQ2UX?=Y<9PARXZUQ4<%]3X4$'>8]$^>GEG)
M,0@:O@"57%#IN70"$Y,?YZOFS$"R9_YBTK>LO@E*&_1A/%\",?6BY!L*US2H
MHFSQ,RJ).Z^VG"(<>/%6;O2V3KZH\M02V6N(RHE,5F?KNHO5YQ G>W9A'Z^=
M%-[R]RED%QB^A,/B)#N$0/PE$!C3^A>%+>R27VR#^B]W6^(M'+#5OKY5V#X^
MVR9<BS)?$J@HJ6J5@0,4.JB/P01P0$H.5.>T\))I5RQ,E#4 *RIY+B)2I"*>
MQK$9H?N-$QP(HXDMJLS)BS<*WW(.DF+NN4)L==Z  X'<%#C+!XL%^7F]W I4
M83.17X7,I$_G90.AE6ITY2&_-%P=L9T^L<Z>_[Z_G-H1D/:)[ETRO7L*K:#=
M4MV/]+82OM&AX'WWYOXP*LK7DAO&4!MC_8,ZY, 4B[-/+)(,[30F*UBE8<JP
M[AXS*W\D>58#XR=+KA$(F:S$<]U)$2N[/ *V;<Z[^7M^5%^U9?\1W/DJ8L/T
M.8*C(3OCOB.-"K9Q<-1W=83I&<WJT$QU6^YMHZ?! 0]Q_F54I3]M5'S:QMIO
MMK504*>)BR7RB]<B.S6[I5EK;4>K\7(5KQSJ)AEU<<F-B@<PUE":X  VN*=4
M;])'O/5CY15)-QSXG$]M37%ML@0'?(EG3.NF>.B:$]R5&IJEJJ(J?R  ]S@
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M/JC>A;Z<%M(J=1#"Y:365^_&$**&L'9<\&.-^7V?8Y_Q14I<5G4T[LLY0QE
M.H*8];ND I[!4&N<33I.LE,!N5.:RFN$?SODW_K'^SE]Z&^@GD2-)C'Z]I._
M[6!J)RY<E"/[NJZJ@'@<$WVRYTQ3H;?LALOSZL:T]Y3\0X=834>WZ/]&2KZ2
M8"_:6EP;=]"/MZ_?V>Q(7IAP$"Y$1_:I ++_HY3ZLH_>C@&X%?O!\B3C%)!7
M:?"G>Q;_G1 C<%M;D+KE!B8G3J E(?3,)YQQ6[\J0H#1_6"L0:LNFN=1N6^/
MVL__%X?65D&_C[7WUP&"M4,J4&I_4W]OO=?%+ 1UBIIB9E[B4HE=:R+UV=?@
M"+C%K]K]D;4.1Z;LED$"[8\<7D*G[W<'07R'3]6YHUNJB@?-]3UZS,CQE?:7
MN\U>SQC%"Y R31@0OL:$<5ZN#>#JU?TDD--V>A#GSZH;IJW:[93^V&UM58\?
MV==%-)-7[,7IXWSD-@>'T'Y(@5<-Y0._9E53?Z+_V:M*6O0(>ICXX-_6:PNZ
MU; )=UJTC1(WU-YDT>R;RLOE?/+%9O_,GV<S:.A\G^17#.U)<*, F6IW>%!S
MHRQKQ!WJ$9%N%HK7PNE4?"JF5+&&<<H.-YAO.*Q_2Z@X,KQVU8+])LAR]VA'
M7]8NY(R"/&* FT:(+AT_[F?R4K-TA[*[CDW:@59$^P 2[";ORYW87;\0K!^=
MP/%T%^LU!R$C*<:GK*^O]1)&K\ZY9D_614<>;<0GE%IY!U7MW1ZWQL]9BN4X
M#O!%!L"'/\=B])40SYP85TYKS(I>+; RQ=@S2@7$Q:,V@9^IKW\_2B >W9;R
MAZW5OQ:]+'R%]T194O"&18?ITS0>8]#TJ 'Y7BZ=8+8MW/];21N$RJVI@M<E
M!B?OSK[*(\_3CX=-_%04DV7EH@,CB^NHMKG$]P.'16.W?TAN3F)>[EY@-_;4
M$=-(_55<AC5NAPK X?C(X4>:)(JG1>EPY<Z3U%2.'%7]['F.\CQ*WU2'T>'3
M>&EH[";T]42!68=)SRZZ>])AF&!:S)#1=3YHF@HHE]LS%#4J@*XOKSL?J^/3
MJ7#\E&(B<LFXJ]\2L5C?B](_9_D@3\^!Y2!\> [\R#NZ;6")? <1%-B8A*BI
MFI">9E#1$AC->L_%?FKNN5],[J&5O CG1C>;]Y\6T&84-.(87TNQ5GSY\3!+
M&R-"8B2..<@";C/V:[R-6^SV/C/73V/P!(#B'0IR:?P@_NJGUFV'&^X/\4I(
M&C\+*CU[!?J>D ?1N+QE'(9:-%_Y@V7S67IO$ZQ$"]*;=FI#2GTW.M39;68V
M3"F8DD\3_3Q''FET?#_G^>ME/WE, E,:M#P$1HC?9/P%^ZT*_.>WR_:HG?B+
M^U-_E)7V"0*QQ@N?TK3$/37@R\U1@4]6#V:C-WYL=(F*VJ=D5K"HJ^[+ZI63
M2P<>CE@(>#!$1JQ*V-I+:*&:&=S.<G@0R24N1ME?Y<RUX1T#^-4>65*$" ]/
M;0V-L2[6H>LE:)A Q%1^^[F]D"X4K)T(8XR4XWG\Z*8;;7Y]5<N1BQ:9X$>M
M?[L4\+CC?W^V_5\$97IEZZN'E<YEQA4Y/S&U6P90 VDX*=A75?Z0'*26]= B
MBB8WO567W6EX*-B.6_SQ'3=QAC_3^UY_"=E*9&A[A_SR'1&1:F8E<-E**K"<
M;LF7+#HX2>GN,-DG3N6@L^GG.AQ,$\Z*+6Y%Q!>>BJCPBS/((.A2][7B0L0.
M7' O8X1H _=>H%,TS]>?GC='NO'+^.TE394M!F>*M,UZ^7-B;1KXB2$P#R13
M7F- K='164&/-S;,#'JM;=]XFDD?W@OV+^; ,73-\]7385(JQUC)3O+WGS1(
M,KX??,XB3;]O82O7H6,4QL_E?7-@3!C_4\5FZ&#L+'+CQ^ .N$FT#$S.N5,(
M)Y*1J;ZQC3\7QX/[P$;^@5*8.QS5"N8@6M'KO2;KD]:';.*;4;6#"]R.]ZZ_
M8FK#C5$!&W@$D4'3$&ECPLE>.Z<*XS1,C(W$_^N"-O>HE,BRBA[+?)2,(N12
M5$!*Z92_N:SC47^?3TIB][W@[-H7/RVY0M!"GK3:ME5G&IZP:S"=\'&+_31\
MQ_^;'JN%^@*,2\ZW*^H[Z<Z>LXQ(80,8/P>&>_*4'*!8!:SBO_HJ4K?!)<(O
M#Z9$-\-->VX5\ ,EI7D0<0;/8[R0AACNI=NPAGV?6AN1FRWSXN2_7D17QVUS
MPQ,N@?'1? G%(V.]K'WX;K7UC?Z)B$E4-"5B,4:;BR\8 .=-?D33=+!ST:1W
MA%8GA0FX:;2S+1@,:Z3&&Z+K7?"/*XQ^:,3<]+Z8 HZ4"P(AB$=(O+9O,E%;
M1E"6BJ!X(D-KLB>Z)IASFSCBK&W+JO%X[O*4\MGO[6QO_<35,X_Q8J1K#VXH
MR$II^\H<<6: /^4']W<[QM)R\#>#QS+LE>$8NM@Q(^7)/8FI_7&GTH'VD%_B
M1%8G^<VSE/?OR..^>GO^<?WDBI$!XO.#V%KH!<IH23UR8*L*R 2_5P&D(,:\
MUO^;"\/_D/^T?_^>I<CQ4@'_=FLQ2*WC7T41ICEBH_1YX08D#ANQJVN@'RRK
MJ[M>FHV4U)N(>L_Y8ZN"#4C)C5B3G^MX]N1X9YIC7<' 7CV+[1P58.I(&PE8
MI N T/$!NR[K)B<Y0FGQ2@4$YM;G9M5RV]J5GWDP(Q^T'H,TQ;TIBF./N;(;
M)[HBUQJML__TW=;*EDJ]UUFCT\%PR!(]X3_#1FJ_J(C]U+*DQWN5?NC&I2?O
M>Q.Q4\?#3+!YT3N*'+H7Z;C<AM5U_.1,KRGZ ?;\B?J.:>L,WJ(KR[SIW=0^
M$L>AC6!JDP>U FXP A28Q@QG&#)NAD;>I+!S/*DU\JCQ;%/+?1KC&2K /#
MTBOO40':"Y4F9\3(C$>BWMN,FKI\UWC3K/J4PF[CU+T)I3B;F8/@)DYGMUV
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M^F7<=-@C,WV5(_8>[WW&C+JB0=!U"1+;B4%\C.4[<J>,]>W]E@'='JNR8J^
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MMFD6A$M1[+!'/=:'0T-#"VFS7&;:&\I)PBA.B.7YMQ#"KQW.T(TE'!<%_-K
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MU4GV5\V"F<&5"8C\Q5)8V7]@!?Z%#93ZQGSHW^S5^!A61@'\%]YC3"[&:N:
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MARW+34+:5,.>GLL;JCFH<1EZ'S\37HFD6X4S^P2]<R(/1YG4I.,8W >8$Q3
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M'Y9P&L2X'TB2NG5DO1CFSX'Y<))M!6"WH8&#P:E=S%&9! I\"#- MXG^W*
MG#7Y)OU_FN!_1#;Y,*E?6]-7:3 JMQE;\%1X=-*N):!:3D?MS/O%[A(1B!.B
M?S"DJ"J0(-.6^2S/O_:Y<HY /4\TROW ?1+ 6 =GU1$H0WK@=1/5Q'$-#JW\
M&CFU^60F?$>+_I0(Q%$[<7]%;3=%+Y3#%.;*.BS^ 9"<.5<O18 T \^0U!W
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M[:N?U0,>A?6/Z/B_:[1-0U555<_ ^G:JVE2__\RH0&$AF$VASR3QBB$?H]A
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MO'#<8:GS\^^R;;E6@RLQ;1VKKM3;#=QP']P)<DL/*6G<ZIG!E[VC7R?@LB@
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MF=S[/RG9&O]7!(G^\M$4!1"U-7BLWX P:M!VM(YS9;QA9O*52B@VA:WLBX6
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M)(HS/P&HR5$ 8:X4 +$-:([P.4#N4.?GUJ#_(A+6;44> ?P=* "ZTSI'B-5
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MS9OW96D"9L/$&H_3" [(_]><(>C<"H]O9"!JL^3GR!&4$!^"OWU#Z==XBDW
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MCDLH@"Z9UN*@R49?TNE+,OT,IWG3M!0Q:XX%U)$C73Y:;^2)K3-@>C!4,"A
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MY5D>4O(,$QR#)/>.+'/];S[>(74%G1X,+1C^;#HD"D;NA]ZZ]H)*W74$.R,
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M<-CXT^B5P!"Z.-7T(\[!+XX_S&NOCR-_"0Y+4/(G/==0*[UR7I;2?JH91I#
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M7K]D-=\[GW>XMV^6=M%A(VR:J@\Y;UTDP\A;W\@NA$X2%T9(1E"3 '_8#$F
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M&C^'^7^&"L7*B_,P6MA3-\[<V0:\\#J\/O/[S5Y/6]7N'G)C/$,2.L"B>D2
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M2J\D,.N/LY?$B:RL+&YJNJNFNGOX07[/TL*EGA^>454'0C93Z0C<$,9_M]6
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MM.8U@L)F@ CQFI,!-Q&_MG,0:%7$R<T4(24+D[\.@G96JXF/.)@J'BIC5<H
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MZKX-[U+TTLY0$%FC:MZV>8BC/GH8A8E!AGW#T847N]G^>F6F_Y-^/8ZW^SZ
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M!I]I#!$1HJC=/1(@AF]*%K%_XDH"(%((3F2^=^BVN4 GA&H2 -5'E$8X39(
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M#U(-80"XZ$_^@\]_\/D//O_!YW\&'R%7I?7CY9.9L#=;K!)Z)I,5S[68+!F
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M(:A70ZA!+<(4EY?;Y/?<I1RQ9R:.=<94PD2"/*X730]$>9@X[H-R@[8H%@S
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M:M3]6"MJBB^P<SF7?Y[Z'"UR12D7,T>'KBTN)=N2SAGUGI%.OXFS]IYA *;
MW4/@3MB'](#)N%$5X<RT .BEQ)X@6+O*OOET(RYKRM;0!R'91677%Y>/CDM[
MZG7;GC*!0RL<W%G55):G0KU_K,A%1Z#>FL@\P?!-5PXO$?(]L<38B>^Z3?LI
M5;DV8*L1"/8]T*MFJ..MG7!.1TC.7[%A]YHZOGXL.-?,UY_NVQ@:)6URP(JN
M_>%=)6)6+CPG7]L0']#%LU"% (%#O"V5S?15A)/>SZK/%&8_Q&%'9D=^F>".
MU0];8QP*O +:X0:;V>==.;='+Z].3V>_9&]=GZ_JYC\8N ):S >[A@=7,L,P
MLZ.CN9\5'+XU\/:'<@S/I\I"..DWDFB^(;+7/NG1'UUHBQH/#D<*K30);YJ'
MZ0X6Y/1.O77/&#,DCRB,P!#U TDEBPXGIWT3=WRJJA;RT432'++[TOJDRM-D
MCQOZ3X\Y)#@^[F#YJU"%:<[8<*$B8/LMMHX&$MQ:$ _(VZ0-?_?3%-_U<8)1
M)8%MW98$>9!>XFGJ"VO<[8[G5BDF$OR%"".*ON8@#<;6DL737W\343P\YA88
M4=?F75?]Y:*N6[122@X79$-0//$TWX5;G)SE:C$CI3N-($KAN_+M\-/F+R>X
M1(5+T6457@M.E;"%G:KPE* %C3M3B:"2H$V'!AU?ZV3<U.&XVVF1@ +9CB6)
M&,J[D6@Y03.3&_B2;Z-< U*A5_T3=^RK[YV8P4FB\:UM)=LRN[?X=,*XJXZW
MJ#2OGT#N, !G/GS)-AV0CTP)<3 X:E!54G:4ZX807G=S&)V_E%O)0QLB<<YQ
MB0LEA5<-A/Y&]G]?78]Q4NCVSMRL;? ;5DPI<ML>_86*KK<+F!Q!FC:^Z81R
M+'X$5L4YWQ8_P:3\VX0?80TILM>]C,B?[M*].,(CT</!5APS+ICOLR\8Z2UX
MX0!<^V/I_M&TB#?YQ.L(EY.5_^MBHU^1D!\UB@!3:FKYB@F]9B<$?%+H)EY8
MD^L&"*E6E9.(^:KE$QO[YL,6']$MW*#+XCUQQ<ZGIFP3Y-9X'[J%Y?8Y<S%?
MW$81:(.TTU;#;V)2+6$FZO$/<5'R<6JX5]18S$?A4@[0(,"3K2XO8GN&?/-I
MQ(S_T]1#1T175SE]E85EK?SAFNBS>H7Q&I)/=$G0DKE!Q#R1W&T"RA9)[7UF
M]"[_C/%E_ERF&?G959;PS04[D#4VTBQ;WTZ@S[*JDOUEYEE"@+-H\..XNF 7
M9CYG]#A4QU@VT<A^?\EQS*,_R/:[<QU$VU@&9D#L=QN3REC^DK(-F@^PS!33
M2^UY(^R8UD9]J=&U'\HAS\5%NJ1^X;N/^(BB@-C(Z_?[,BPS6K:D@GEB.NI5
M_955R@/"YLV&X2 -<EN%O?/=YPB\SD1,0B]U!P&RYUZ-"..LF0@)TG9]DD+Z
MYDN4TX85\4YYCG]^VLH%/5X8]N;.9'7AL_?S8FTVFO:' 7"XL=-@;P',.%/I
M)@$R:I?=<B-Y<?G+>V\"RC!+#JEP^.TB^AL&>8^=N]_)SU%GN9@-0#OSHB_5
M'3K362N7UK;Q4B,4;!PB3@GE(E.DJB86NL,TR)U4WFB$N\>9)O2THWX5M^3/
M_3CQJ(K5S,@X[Z#A>BT7D3(TO+B5E?RNIWL;$O?ML5Y?Y]6OFG$:XJ(OWN=<
MT1XUFR.Y-A[BEG4^]\P5)[Z<<&T;W4XQ^J)KCT,O#4Z2'N(>)7,N3Y@Y8"W8
M92X) J],T=(AN#II\8S7T3VWQ0-BW[%XMFO)[)-<"OV#[@]IRI!_UXJJ @:!
MOSH1TOL=;^AKW7R/%8F:35'S4NH\#6)KNI&28(,?$MZL(_KHV)V( MF4JYSK
M_-%\*J;M?$D)Z8]6DV^UK?F1DN%3Y7/%4F5.=V,2W\/\-]2&Y4M'T$.T<NV?
MZR H)4-RACP#A5&A:4Z.OS3.G^HH*$H?<!*?H?3(/(K)C=D4P@>JVKGN-T;Z
MP"^0_9]VW\>NCN:Z];>S=_3;MJU?G.KAC[.%]>JH30%KOK<N8^"0(@KHE()K
M?W@>%C\I_X;U]6E=E\?'GGI]+E"^XD!^[UG?J:"V!32!2]9@ P-\!U\[JZ-'
MDVNJ< :]G27D'2#4#A:Z+Z -]]%XWPP-F,:D.9Z^YA6C$<!'F&C$UM9!7WF4
M7:MS7TY7L;:=+;/B2Y\+9I\PA)E;$!MK4Z9AU:";Y1YHR0[KF=N?S;E%U4*=
MIS]['E,@^CLTA7*OO6W@&QRO;1C8+%G E?#B.+]LI,D_O'(_0>\O"=7CI\;C
MZ@=-FX>*/TX2<="! \QF0^9!*>Q5C\RNGS2$<\"F.@FD @H:R??)K^\]3VDE
M^69Q?>F?'(U7. B,I)@!K2V2K\B<VOIEC+2:F7&635+/ZT)>DS))0V9GD+("
MRE[H]F^N\.PN& YX?RH8<)=>OEYKCI3.O#X;X>5Y3+2LOTF48R"6_>O^3!*5
MA2"/-C'!_L@!AB]+J_<KNEAUZ^%TVJ8.<N-"/L7R).=^[RDM2]E?+\%!*/CG
M_NG*$&N"7W(&Q=CY8WEYB#P>C>R[M#^CEEV=/SB')/596^DS "$N\KD/<=:7
M[OAY"L>DZ+(K3HD6L:@P[[3;;)7T16I>SFC'SKQV3042 T^48C!(NS%FFO'Q
MIR(B")[G!U\ZV_SY@%!_WA9RS#ZL]SUQH\P%>JA(L+9VB.(F^&5O/\^^[C@1
MQKS9;C,T#M5=DCR@#>.Q6EFI%/-3,W60O#V!XOW\*J.\K8$%C_3AZDWU2<F[
MZW(R4<O39X_H\GVOSQNHT:][C3PONZ^]U)Y1>IM7V6:UQ#)X_ETY<M4O0ETK
M=W>L"=N;S>S'F9YKWT3\,9;Q*C=1F+9PS4+XPJ\B/H&M+E?-2ZM+I'#>;T>]
M1!(_DR.97Y;M5QJ2?-5JR)#]IEEONQ]3W$EC2/T)PV##\A \,6LD(#6;"HF#
M:7?2ERC&)(^-6,R(EP8<ZD,^*'^M;H4EQG^$**: A\D>J;R+D;VR[YS?O! N
MU>-+! #. XY_V=_BU_TZRO;#VPAE 9'R^2T)AZ$7B<3?U^G;)[T2E>U]9>9S
M9]K=2:F64C<XKJD-03"4;NW:3'G,/1R33:R5PEU);4T\:"=K>8<$V@K-T;YL
M>6U.\%YH.WB=>PU\& 1B '[#P<:6/:@*TD&$NB4#8$]D /9Y281D&@L;JJ,V
MNX\!,'#9D.9A #JV,7FHS5?AETW!.L'*_\YQ\']S'6L_^+N&..09E*?9V;0%
MB5/\EQ>7+[1+7(K)BPI\KA8UHS5AXL]%#^<78@".A0=G(9,L>HK;\E5$G&#P
M7X>"X;NY;&\FYDW1QF9>R9L81VRCT'B7^(K6KOGH"08@1U>/ 6AZHGMP<^4X
M _ C-P\U+E.>S0!8(+0VUK7B]P1=&("+[$P,@*;HT788@'>KK645 4X%\SS!
M[-R+*\VL:;4O9IAAW7VF+_HX\ P JV&KP)U7\^^ &,7$V\^O;]RW=.X4])CE
M]>=]W2Z0O&WRKW9RZ9=WPE"_30>T5KF!%1.E[ARYUM(9=&PC_CV!6E]<@G\@
M'N)C&I(:VAG2L8LE37*]DE@635<[J-\VG1MX?2UV:.D'X)7%V_BWQU[$T(8^
M-8COEO%:21(LG_#)A+QE/^N4)9E_WX/B-7_Y#1/[T1Q91/W9Y1);M7B0)3@8
MCY(5:=M3;Y#@18D%^BT&:XF^KK&&>U/Z:KM2;=Q-OT+DK73#A6C/+LYEX=W:
M&JEV+M^(:Y1Y+K?MN6NIG1&G)G3>K-HE7SX)1R:!W5'-6:O2AV=4=>E,9_X6
M(]W]FAA(.T5<8X<T2#H,[MK+E2[N6H )%19@!=D@#2*#F['2YH32%6%,Y6#R
MI>7+;2)GO.JWN#73-DLP AJDY0,]A;TMT52KBP''YQ+T3T^GK<4X+">J^O79
MT,S_!5/3(TX7U-2X*38GN'M6S%8A5E_:O;1VK.]@;)3V>FW&\J:*ND392H@0
M>C%S:S[1I-]74YI O[X;;?AYH!1=<RYEWW8TY(V,SG<FQRSN(G>GUY3WCINE
M:5LE/ZLS\+==KK<M.]:E\^?.)B@=R1$AWHQ"=,CWOUED ,(UQL'[E[WC#TY>
MUN1IZ]:U#M7,3@1[ZL;+UM52PQ-QN &UT9VQH(6%HC72RV!PWF].3;OE>#\_
MS\1W]\AN)C#^#NK%7U>958^K/1Y/,+4.-EZ[D5'LEKJ-?19E9X!$(GGO)GX;
M<'SSE>_"J=YC?&&C#5U_L_FO >CW7%81^T0TH-@LK.M(QZZ_,S#+XO&:&=V&
M-GROKED:]M5M]MO94<W?W$E-ZO3Q\YS1=T[&J%7,ZZ/Q;$>9%ZQ2P*]E,IC.
M^]?,H]B/^F>E JN=WJ9U;IF)+PG^.:U*<UJ4N^#I'(FAEJJW$-O6P#.9#^3?
M6^I\)(T@J0YKAJWG1 BU1?AE%R7C%69WX%. [#7Q]=L QS*YF"VTR=E@O9#K
M8$XH*77'W#\#6!VDG*)L\11Y@^F[T-G'G_@ *J(JY6C4OR:6X&IA/2L#<#<N
M@0%XUEP;ST:=7%E*&O.3E$+O_)S*YG'<B'[>K"\*';YC=R,3+V^IR=5? VUD
M<_/%QF7?QM37A*QV758DMLF]2#"FD_'TMKJ!^HW#;(0GQJRE.GB@./G<>Y=<
M)7Z5\B^-?[;ZA<0Z.3!M8=$0 @O-,EQ6 [^ZXIW?L[K>D-U-L"#E4BK68LN_
MQ5^R<;-4ZI\'%6"CE%VLG\3IY>L-2CS)=;KE^TP&D5X40C6"FR4!@_ ZH,@A
M,^45GK_8TEY]3= 5%#,[>9Q:(+Z4_6?0T8+GJ'FE"V5X)Q*J89E>VHH@FG/U
M?([54-7-1Y/RDW'6OIH2!/I5_Q<& Y+RW4;:'ZJKLY<4)QR,5CO?>,7I3#/'
MO#G/A@"Z[.9,0E\^4GT3I? E;LT!@XD2T7^36 DH!G@8FX3NE5?^-R 4>2YK
MB-]:6$F0CI-]K>GRPF_,%3Z&I)ZF"^W&36Z+5WW:\[LP&JNC&'&*RHJHEDX[
M_HD?P#VW!,JZO)M(ULR9E+YH/_I@]#JN(DC<"H9.5+:J W1,>W(]O@*0%CW9
M4/7'+/^TNJTJG4$17?B.1Z- 5P:IMA_S-+*''),(VB?R5^"Z0X*LOTF^Y-!\
MN,9T3&!FL=(*3,3WSBTJLX?]G66V<K1W8&.L^],?C_OK%0IM?Q.C [$Q57U^
ML[;J\_D.+2<>YMQ1;NH4%2;];/R;M_%_"X9U2T2%9W2,6RNX&]Q ^@TWCY<E
M5YEGGL9Y8S$CWUTVP(F:4FM<WZ0O[%:>>C+DPXX\:Q;0K!"E/#1%IX6;XAO)
M[NG/^]JP0W$Y 2'\:]",6LO,@ECA\UU>L35A@"):WGFUIPT__XC 4?!MOXSX
MA.XDMPJH=CFPN? )F2ZY4AI(*T6K,\F3_(;WB%P6%?B4,=.S/1Z7I]-J_3SZ
MSIXWOC,^4^,1*NP?MV)1.0@V$T<ZQO-_CN*F1G%XWEN*?72U0U248]OO3]/+
M+/Z<@X. %5$?COM5M#9J86:[T=R)LUG2]: LE?S8-3%*5S.D63O*29@:E+4-
M;QL KDYS;\+O+=AG3&I% 4D"O,3%)T,UY[Q6@%:3TGY/SGUL+I[H_A*3)%_H
MRAO_905LP@#\:99 #",1;Y^(W2UU/PPLT9+$E1MR/U4>DV@UYKCU, ,Q%*S!
M$UKRJ-;MT"/^-6I"EACYVG'M^/RE&Q5"G$%Y ,X.\AW;Q\^5A;@5$ W"_C'S
M0$SWISUSF[:U>WPR.F^*M<; 8F)W>1MT-1865_Y<<9]LE>) EJ"Q /C8X- :
MT5P<?&HDN39N!$/IV.TU>9TEDD@URJ8]R$MW7T(X3;?P2.(^'ZO]]!!PU:NN
MO49Q;%+W%<QCI4P('ZU45MG':G/WA]RGYKI79:V/E3L I.&Q_R;7+.AEU!64
M1\.>+V:Z,$=KH<T$&F)T^&,E]'!K:W W@M8:V% (#8'[A8CT6&+$ Q SC]_=
ML+A5:BS7)/P886VQD_U'/B(=7F'FE_R(S@"LJSZ9/&]G9,,=(&T,WM \^[%A
MXX_9E[UER<X : GM,@ )J+6+,EH;DZ@]Z;TL$1H_JL.A%;6U!#_:.SY$Q6I4
M<-4^;$)%-$F[OW2S,/-N%[&"68KEJF"!D3OIEU.:_F//BI;O(R5+,Q2M&WT;
MMP(:',RO&$C= O:OY)G-_;YLJAT8V?=_<UI.D#'\OP!02P$"% ,4    "  ,
M@'M:N1;G11K2!  :JCD &0              @ $     8VLP,# Q-3,T,3,S
M+3(P,C0Q,C,Q+FAT;5!+ 0(4 Q0    (  R >UHI5L[[J)$! /8X&  9
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M:S P,#$U,S0Q,S,M97@Q,%\T+FAT;5!+ 0(4 Q0    (  R >UH*3%5V5AH
M /?#   7              "  3&C!@!C:S P,#$U,S0Q,S,M97@Q,%\U+FAT
M;5!+ 0(4 Q0    (  R >UJ'CGJF920  !D5 0 7              "  ;R]
M!@!C:S P,#$U,S0Q,S,M97@Q,%\V+FAT;5!+ 0(4 Q0    (  R >UHZ1YI\
M\C   ,WJ 0 7              "  5;B!@!C:S P,#$U,S0Q,S,M97@Q.5\Q
M+FAT;5!+ 0(4 Q0    (  R >UH/FG^NH0,   $0   7              "
M 7T3!P!C:S P,#$U,S0Q,S,M97@R,U\Q+FAT;5!+ 0(4 Q0    (  R >UI.
MB/99^P0  .XK   7              "  5,7!P!C:S P,#$U,S0Q,S,M97@R
M,U\R+FAT;5!+ 0(4 Q0    (  R >UK@A.WL$0D  +@_   7
M  "  8,<!P!C:S P,#$U,S0Q,S,M97@S,5\Q+FAT;5!+ 0(4 Q0    (  R
M>UH,4#SZ_P@  -$_   7              "  <DE!P!C:S P,#$U,S0Q,S,M
M97@S,5\R+FAT;5!+ 0(4 Q0    (  R >UIM3\3WJ08  +$F   7
M      "  ?TN!P!C:S P,#$U,S0Q,S,M97@S,E\Q+FAT;5!+ 0(4 Q0    (
M  R >UHWL)7PX 4  &D@   7              "  =LU!P!C:S P,#$U,S0Q
M,S,M97@S,E\R+FAT;5!+ 0(4 Q0    (  R >UIF@. $VJT   37   2
M          "  ? [!P!I;6<R-#<R,3$U,CA?,"YJ<&=02P$"% ,4    "  ,
M@'M:XYX: ^IR!P#TT@D $@              @ 'ZZ0< :6UG,C0W,C$Q-3(X
M7S$N:G!G4$L! A0#%     @ #(![6M_I5IYD* $ ED\! !,
M ( !%%T/ &EM9S(T-S(Q,34R.%\Q,"YJ<&=02P$"% ,4    "  ,@'M:04F>
M:(Q  0!S=P$ $P              @ &IA1  :6UG,C0W,C$Q-3(X7S$Q+FIP
M9U!+ 0(4 Q0    (  R >UI.TI6$/ZP! (W* 0 3              "  6;&
M$0!I;6<R-#<R,3$U,CA?,3(N:G!G4$L! A0#%     @ #(![6A]=RN40/P
M$48  !,              ( !UG(3 &EM9S(T-S(Q,34R.%\Q,RYJ<&=02P$"
M% ,4    "  ,@'M:D(^Y%(&R 0#BR0$ $P              @ $7LA, :6UG
M,C0W,C$Q-3(X7S$T+FIP9U!+ 0(4 Q0    (  R >UIJQKC9@$@  %93   3
M              "  <ED%0!I;6<R-#<R,3$U,CA?,34N:G!G4$L! A0#%
M  @ #(![6KTT_YAE40  2V4  !,              ( !>JT5 &EM9S(T-S(Q
M,34R.%\Q-BYJ<&=02P$"% ,4    "  ,@'M:"/AJR0^_ 0"KP0$ $P
M        @ $0_Q4 :6UG,C0W,C$Q-3(X7S$W+FIP9U!+ 0(4 Q0    (  R
M>UJ)UA[:>$0  -14   3              "  5"^%P!I;6<R-#<R,3$U,CA?
M,3@N:G!G4$L! A0#%     @ #(![6L \-Y"L)   3"D  !,
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M-#<R,3$U,CA?,C(N:G!G4$L! A0#%     @ #(![6E:<9VJ>CP$ 7,,! !,
M             ( !1U@> &EM9S(T-S(Q,34R.%\R,RYJ<&=02P$"% ,4
M"  ,@'M:AW&MS+*;  "+R0  $P              @ $6Z!\ :6UG,C0W,C$Q
M-3(X7S(T+FIP9U!+ 0(4 Q0    (  R >UHH@N*/J$$  #9%   3
M      "  ?F#( !I;6<R-#<R,3$U,CA?,C4N:G!G4$L! A0#%     @ #(![
M6CLIS,(@@0  DX,  !,              ( !TL4@ &EM9S(T-S(Q,34R.%\R
M-BYJ<&=02P$"% ,4    "  ,@'M:1415]ZL8   ('P  $P
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M-S(Q,34R.%\S,"YJ<&=02P$"% ,4    "  ,@'M:T@PY@A$) 0 2+0$ $P
M            @ &TY"0 :6UG,C0W,C$Q-3(X7S,Q+FIP9U!+ 0(4 Q0    (
M  R >UK@^=JA!#<  !\\   3              "  ?;M)0!I;6<R-#<R,3$U
M,CA?,S(N:G!G4$L! A0#%     @ #(![6CP'Q;BS%0  >2(  !,
M     ( !*R4F &EM9S(T-S(Q,34R.%\S,RYJ<&=02P$"% ,4    "  ,@'M:
MBNY4IJ%Y  #@?   $P              @ $/.R8 :6UG,C0W,C$Q-3(X7S,T
M+FIP9U!+ 0(4 Q0    (  R >UJD"] I!2D  %(R   3              "
M >&T)@!I;6<R-#<R,3$U,CA?,S4N:G!G4$L! A0#%     @ #(![6I)*1%='
M_ D :2(. !,              ( !%]XF &EM9S(T-S(Q,34R.%\S-BYJ<&=0
M2P$"% ,4    "  ,@'M:Q/]E'5LM  #^+P  $P              @ &/VC
M:6UG,C0W,C$Q-3(X7S,W+FIP9U!+ 0(4 Q0    (  R >UJ3!.5>?RX  (4R
M   3              "  1L(,0!I;6<R-#<R,3$U,CA?,S@N:G!G4$L! A0#
M%     @ #(![6IOR1[OR-P  \SP  !,              ( !RS8Q &EM9S(T
M-S(Q,34R.%\S.2YJ<&=02P$"% ,4    "  ,@'M:F!/$REI" 0!.+P( $@
M            @ 'N;C$ :6UG,C0W,C$Q-3(X7S0N:G!G4$L! A0#%     @
M#(![6OTDS/ZU 0D 3L,) !(              ( !>+$R &EM9S(T-S(Q,34R
M.%\U+FIP9U!+ 0(4 Q0    (  R >UJ1.?!Q"B(! (PU 0 2
M  "  5VS.P!I;6<R-#<R,3$U,CA?-BYJ<&=02P$"% ,4    "  ,@'M:"T>(
MN]!#  "]1P  $@              @ &7U3P :6UG,C0W,C$Q-3(X7S<N:G!G
M4$L! A0#%     @ #(![6I>_6\TA/0  /T8  !(              ( !EQD]
M &EM9S(T-S(Q,34R.%\X+FIP9U!+ 0(4 Q0    (  R >UHV!*A&H:0  .O%
M   2              "  >A6/0!I;6<R-#<R,3$U,CA?.2YJ<&=02P4&
/ #8 -@#I#0  N?L]

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>ck0001534133-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ck0001534133="http://www.calcimedica.com/20241231"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ck0001534133-20241231.xsd" xlink:type="simple"/>
    <context id="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_8369d456-272d-4458-8976-3a21b4c87005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_83845047-b7fc-4928-ac21-ffa4a320df4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_845be1e9-b257-47a6-89d4-733d8a31d6b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8830f19b-6e6b-4da2-87ee-d99253ee1c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="C_8b167b7a-8a24-4ea0-afb0-63b670541fba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8c641589-eb1e-4352-b3c3-0711c499ace9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8f498825-0f78-45b4-812c-02787d22cde8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8f77e296-92c8-4ecd-b45a-a2ad8b02e258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9114dadf-db78-4d1a-9686-04c4b1e69723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ck0001534133:CalcimedicaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9148156f-8f5b-4f26-a742-6ef0c92f952d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_9170e96f-73fb-4585-913b-5bcc555319ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_941b1d38-af1f-420f-8b15-8eeae975a34e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_94f7d9a0-cccf-4f75-aaa7-442f61778e94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_95022a81-928c-45a6-b8a7-62e7dea3a945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_95e6491a-8251-490e-bafc-9db3d1602a4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_980a3e42-f670-42e5-8f84-d7c4be19f842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_987f342a-1b48-420e-b0a0-87f4ebbe2eda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="C_9aebc674-6f2c-4fb4-9168-add0619306fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9cbbe523-fc5d-4e57-a1bb-191ddd2df6a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a0f4c105-a524-4767-9181-31be89a91199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a121b500-f9d5-4d26-a4b4-8bb964013862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a170fca3-5c49-41df-8bf6-368143137572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a3c816ce-23b8-4647-a3b2-a0060ab3f6a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="C_a67be958-f1a5-440f-a088-2296882808da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a707849b-9622-4270-8a14-4ccfb2234b96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a737ee8b-67fc-459e-b42a-32cd72a6e241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-19</instant>
        </period>
    </context>
    <context id="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a9629230-9e39-4a56-a202-86fdb80c3901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="C_aad10afc-0c1f-499f-9814-0ecba7487b5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="C_ad05ad10-c218-4a2f-a090-5ef614c472a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PreMergerCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="C_adccbd9d-5ceb-49f3-a3cc-4d2f76546d2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="C_aea932f0-6864-4a4a-9a5a-1599150cb972">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b01b6d69-47c9-4adc-964a-cc6cc14542a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b03d45f7-69af-4721-9c4f-7cb355d6aace">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b1ab3b90-45a9-4502-8252-c2e3034f292f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b204b444-02a9-4a57-97f1-861675088d01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b2211e17-6778-4571-a5e3-51c977da82ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_b73cefba-244b-4823-bb60-351dd5a123bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b775c5ab-ecf3-4dc4-bd12-7d3ef78e0d1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b8300b81-b096-4f13-9331-757ab5e2f317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b8a91730-f365-453b-88eb-5b8de08b2053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bb626b12-389d-4561-abdc-fe33a5ce2554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bd15498b-f283-433b-97df-4b894a6ee8ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_bd4f7398-6d5e-489b-97c8-45a8789eb5d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-19</instant>
        </period>
    </context>
    <context id="C_bdbc227c-2a4a-4d04-b7f6-a194d9ac93f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_be96bce5-b6c0-422a-8b27-379ef3caef19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-19</instant>
        </period>
    </context>
    <context id="C_bef37a75-2e84-42ae-986f-82da4e7d2f72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c0b760ce-71ec-459a-969d-1893bdf340e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c45d60ac-8593-48c7-9b05-a42201654937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ConfidentiallyMarketedPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c4c9215d-494d-4c49-9611-ee223ffc9c1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c70580a4-0982-4309-ab8b-2dc5eefb571c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c873a01a-651f-4a0f-bd98-70853e6ca684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_cb68adaa-9134-4f3e-97c2-816971662c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cde8f9cc-6117-4cfa-a5bd-4b469cb961fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_ce86957a-ac6f-4086-9a65-13bded447356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-19</instant>
        </period>
    </context>
    <context id="C_d409c238-cc99-40c2-b647-976b6c07fe00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d641d938-a033-4dcf-9434-c6445ce1a637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_d64e8688-0946-4276-a0e6-cc735d684d5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-19</startDate>
            <endDate>2024-01-19</endDate>
        </period>
    </context>
    <context id="C_d7c558d7-f9b7-46bd-a5cd-d32a30cceb1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d7d378ac-3c97-4599-8815-59e8ff3b8864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="C_d8023328-2b80-4187-9be9-a472d3a65beb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_d86661b2-0167-43cd-a6cc-c51935f0976c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_db94281f-2ca5-41c5-a7e1-183957513bcf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="C_dbe96887-2004-4bbd-8983-4028ca3f98b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_dcc03654-bedf-421b-b7f5-47598128324e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">ck0001534133:FederalResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_dd320420-0211-43de-95df-09b44d9868c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ddbe6d36-a378-4c84-83c6-f0933ab42deb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_de62953f-9a13-4e2a-a3fc-a8e40d129029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ck0001534133:AvenueVentureOpportunitiesFundIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_de781a1c-b261-4323-9d34-9ecb0869f1f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e084ac77-ce86-42c4-b795-1e5530dcff59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e44a92b5-7664-4c8b-9ed0-b69338c26422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e4bb7cdd-0b6c-4d2b-8e43-6a6963cfc0c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-20</instant>
        </period>
    </context>
    <context id="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e68758c4-3c29-4782-a87c-bcd7ee800eef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="C_e6df5d02-68f7-49d4-ba51-986d32e23a91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e7f86347-68d3-405b-8913-ba0bee5ee23b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:DirectorsEmployeesOrConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_eb167185-a0eb-45f5-beb2-ad40dbc114b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ck0001534133:WarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ebe2620f-35df-4233-a846-f1495ccf0b18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="C_ed61293c-a493-4af6-9c31-23d8600a5a0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-17</startDate>
            <endDate>2023-03-17</endDate>
        </period>
    </context>
    <context id="C_eec723ad-c5c5-4de8-86cf-24ffe53a2b58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-20</startDate>
            <endDate>2024-12-20</endDate>
        </period>
    </context>
    <context id="C_eee5683f-33b3-4fbc-8cb5-42b8e91c1adb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f0009405-42d5-4625-a5e9-57af57ac1cfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreferredStockWarrantsAndCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f113b0a6-620c-4aff-a136-ac77a52a078b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f20344e5-6e5f-49aa-9b9f-b8ff66728e89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:PrivateCalcimedicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f3e6c3db-a6a2-4f7d-99b3-1a4978c878f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f49ac070-365e-4892-838a-facd93bf557c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PostMergerCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f6e2608c-dccd-43a5-9232-ce7da8fd0bfa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f6e6eee2-3a7f-426a-995a-4c63812334ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="C_f8437473-43cf-4eea-9960-4a41c9ab6907">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f9e065dc-a9c1-4a5e-8636-0c7b7506b76b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ShelfRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="C_01046067-75e4-47eb-859f-fdf6441b00c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="C_020d633a-de37-4a19-a0ef-493644e25660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_03f70fa6-7284-496f-8c00-e58bf2ff1f48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_045dcafc-a4b7-4b72-a786-a17062bc9899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_050c9307-b322-43a4-84b0-69234ed20231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_09ae4982-7ccd-472c-a057-58036e311ec9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0a03a7ba-0a9b-4bcb-b58e-debbbef7f6e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0ad991e6-bbac-44ce-ac44-e428594773e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0c6e1adc-65fd-4bc0-9b3f-a6a4ebc29353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0d5c75d7-eaac-4f4b-9ade-6f0a083bd65e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="C_0e263a22-52cd-4e60-a0a1-c92ee05526be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1001d2cb-3125-43a0-ab65-f1fef2c3edd3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="C_13118ae0-e9f5-4a7c-aa30-bab5991ca143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_14ff6f4d-845b-4bfc-a43d-d0314b89a420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="C_15e96634-9a83-4453-90fd-00b4f16e88b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1da4e079-61e5-45cc-a979-3a9615ff0665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1f43280b-4e22-429e-aa7d-ecce70368956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_207c4b97-0faa-4d0f-809e-69e530a8d044">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">ck0001534133:PostMergerTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21b81df1-47cd-44ce-92dc-0822f330b821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_223da16c-eed7-4903-afb0-2d505376e14c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_23e9b7c7-df34-4cf7-85aa-9468c513006d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_26ea50cb-0ee9-4b54-a249-f320c2ea018f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">ck0001534133:PreMergerCalcimedicaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001534133:CalcimedicaPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="C_27307737-cae3-4ea7-a928-4b907971a80f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_288a2c47-1d31-472c-b116-f7fc50bd5783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheACommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_29a301bb-4522-43d7-947b-4686e790d21a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">ck0001534133:GraybugVisionIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_29cd52ec-1662-4876-b968-95dcdb404231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_2ac23ecf-2158-4a2f-ade7-ea9d3539490e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_2ca88b50-4b1e-42cb-b72d-edd91da9a612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2f7897d6-1a4a-489c-9fd4-bf5c88b81551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ck0001534133:AuxoraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_30130670-4924-4031-bbd1-78ccb2dff022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_306bebf7-53a9-4887-b0b4-ecae6be09590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_373a9e72-7343-4090-b130-badbbfa67767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_376beb3d-3fc1-445d-b41b-a5cae382b0e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3a88b2b4-b053-4f3c-a6d0-2084b134a77e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="C_3b524ec9-8b7f-49d0-b33b-310d8a3db4b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3c08a61f-703c-4719-8fb8-4579c9288562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3cab47fb-e5c1-4496-85a3-0d4ea86c41fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3e3444e7-6081-449c-be1a-618a48f9ddb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3f53ad55-92a4-4198-b148-88d91cc0fe54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2024-01-19</startDate>
            <endDate>2024-01-19</endDate>
        </period>
    </context>
    <context id="C_42f60701-1d3e-46b2-9f02-e6238294dfdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_46095950-bb43-4840-adef-994b8db12bbd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4d206da2-83dd-40ec-8dd2-a7ed991121fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5157ff3b-9b07-4690-aab3-d94da0ef7278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">ck0001534133:AmendedAndRestatedCertificateOfIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_53c253cb-c903-45b5-b952-e3bd63a5ace1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5466f951-37bb-4006-839b-3b789d141025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_559c60a1-fc91-4c05-9f90-246f875e3dbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-20</instant>
        </period>
    </context>
    <context id="C_5628ed6b-5082-4559-afdb-16e2688469bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="C_56e4115b-d428-4783-a18e-66c26fd1da5d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2025-03-21</instant>
        </period>
    </context>
    <context id="C_56f08610-d053-44c8-b481-e6a9fd87daf4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_58198596-8919-43f6-85a6-830ab130f2c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:ConfidentiallyMarketedPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_5c21d041-cc6f-4faa-beac-30a23e6d407a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5d75438a-331f-4b70-b3ef-65f18fddf6b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="C_5dde241e-162e-4824-aff5-4a7186f81373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_60695399-bb34-4681-86ba-e8a3bfb9d100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_640fa722-803d-451f-878d-cea21bde32c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68dde00d-5365-4647-8868-3a6b2d18e226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ck0001534133:TrancheAAndTrancheBCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-19</startDate>
            <endDate>2024-01-19</endDate>
        </period>
    </context>
    <context id="C_6989cb5e-e674-4c1b-a3f4-8bde59a0e20c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6ae5bd8b-50f0-4642-b868-3aa969e2fa5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ck0001534133:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-20</instant>
        </period>
    </context>
    <context id="C_6f09c985-ab40-4e3f-a4e4-e71945759749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ck0001534133:GraybugMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_7161dd77-2036-4b7b-a3c9-8408ec371ec2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ck0001534133:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_75c3f7c7-0b54-4282-baac-1431db556fd7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="C_78496b12-3f28-430e-9d56-1d9d320d8e3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-20</instant>
        </period>
    </context>
    <context id="C_7a9252ad-93b8-4655-9d47-d20409702eab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ck0001534133:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="C_7b2ce76f-1ac6-463d-9417-582f1d672621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7bf4d914-a107-476f-b07c-94d28143819c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ck0001534133:TwoThousandAndTwentyFourPrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="C_7c3efb00-1230-4736-ad23-faf73bdf57a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7c5c9cab-f1bd-4526-94d8-3164adc3b2f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-01</endDate>
        </period>
    </context>
    <context id="C_7ee9e19d-1d4a-450f-9f03-e831fc128d22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534133</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001534133:LoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_Segment">
        <measure>ck0001534133:Segment</measure>
    </unit>
    <unit id="U_Contract">
        <measure>ck0001534133:Contract</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1c6b85ab-c4c4-4749-bbe0-2ba05a3f1fc3">FY</dei:DocumentFiscalPeriodFocus>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_5466f951-37bb-4006-839b-3b789d141025"
      id="F_156bf09a-46d5-4825-b957-c2f209d2bcb6">false</ecd:NonRule10b51ArrAdoptedFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_260b0144-ace8-4327-8dac-1b2f723b18e9">0001534133</dei:EntityCentralIndexKey>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_5466f951-37bb-4006-839b-3b789d141025"
      id="F_68f77b38-c52f-4acc-9e97-294a6d3a4829">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_5466f951-37bb-4006-839b-3b789d141025"
      id="F_29c2de4d-da4f-4659-ad57-31f6ba55417f">false</ecd:Rule10b51ArrTrmntdFlag>
    <dei:AmendmentFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_cc7c5a6c-91be-4683-8b65-3d5c37cdc94b">false</dei:AmendmentFlag>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_5466f951-37bb-4006-839b-3b789d141025"
      id="F_3ee68c06-cd9c-46c2-a659-db48d0d52a40">false</ecd:Rule10b51ArrAdoptedFlag>
    <dei:SecurityExchangeName
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_02879790-34df-4b21-9555-1c6f87e49426">NASDAQ</dei:SecurityExchangeName>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      id="F_16371737-8ec4-45fa-a0b0-e6e4270790f5"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842"
      id="F_2307ffdb-2705-4620-ac9a-fe22cc657fdc"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_7d54053a-642e-4e39-bfc6-b012d14346a8">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <dei:DocumentType
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_7c9b82fe-ccb4-45ed-b85b-b58b819a6f00">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_da14a549-f480-4bc3-a9dd-cf5e62e39194">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_9ba52346-919f-4de7-a4cd-845dbead23fc">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_67f7ecfd-fb68-4d17-bf4b-224cab788d66">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_e2dc81d1-a5ed-4b8b-887e-1297ceed0975">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_17e72bc2-4059-4001-be2d-203e70f754c1">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c8f2c3bd-c4e2-424d-8c37-2cd4fbd759be">001-39538</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_36d30c49-6235-43c5-aa02-e7c0a4b8d532">CalciMedica, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c96ffed5-fbe1-458f-853b-e73c30f6b0f1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c6a89b1c-4678-4de9-963c-ed5e2863693e">45-2120079</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_a4df7de9-2ede-495c-9088-b22bdc74f067">505 Coast Boulevard South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_56b5740f-301f-47ce-a713-24a1018631fc">Suite 307</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_bac6d7a9-cee3-4c40-aaf8-25485b7343ce">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_432b7bb3-8f1b-4d1e-9ac4-ffe9eee3119c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_48ac4cef-e7b8-4cea-a050-583098e30b0e">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_3b80390b-1621-409f-a51e-dacbb5288318">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_b517db88-5afb-4a81-a30f-6c84c5b1e248">952-5500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_b1025cb5-36da-4b26-9cf1-529ef382004d">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_24a4698c-240d-4e85-bda6-7d76d6b5b944">CALC</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_9c733c0e-ffaa-415b-9082-d9b416eb2fcc">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_56602347-a689-444b-b72c-a9ea3e9e09ce">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_98846907-925f-4d3d-8437-db78a980159f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_e579a3f5-4049-4880-a76e-755e547695da">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_41fd1107-712a-4044-833f-5ef20ee61fed">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_9183b504-7978-4163-983e-2cf1a7b97910">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_3ef75084-f542-48e3-b458-b7b8482f7ce8">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_520d5948-0764-4dae-9988-a606c469a308">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_50bbfb29-8321-400b-9ce3-1ec3229a249e">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_0ae45297-9cc0-4696-8b22-d5947f6c6ad9">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_f91cb1cb-ee7b-46ad-8c39-ca87c694117b">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_3b524ec9-8b7f-49d0-b33b-310d8a3db4b4"
      decimals="-5"
      id="F_821753a1-1941-480f-ba51-8c066fb1c1b7"
      unitRef="U_USD">27900000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_56e4115b-d428-4783-a18e-66c26fd1da5d"
      decimals="0"
      id="F_3f309146-945f-437c-8cf4-f4f251e533ed"
      unitRef="U_shares">13481917</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_32d3180a-9a94-4365-b4c4-dc679c3c049a">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;                                                                              &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s definitive Proxy Statement (the &#x201c;Proxy Statement&#x201d;) for the 2025 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission not later than April 30, 2025 are incorporated by reference into Part III of this Annual Report on Form 10-K&lt;/span&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1810a607-3443-4023-b8d4-a1724431bd0f">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybersecurity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk management and strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have implemented and maintain information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical computer networks, third party hosted services, communications systems, hardware and software, and our critical data, including intellectual property, confidential information that is proprietary, strategic or competitive in nature, and our clinical trial data (&#x201c;Information Systems and Data&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depending on the environment and system, we implement and maintain various technical, physical, and organizational measures, processes, standards and policies designed to manage and mitigate material risks from cybersecurity threats to our Information Systems and Data, including, for example: an incident response and disaster recovery plan, disaster recovery testing, data encryption for certain data, asset management, system monitoring and multi-factor authentication for certain systems, employee training and cybersecurity insurance.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;    &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use a third-party information technology consultant to help identify, assess and manage the Company&#x2019;s cybersecurity threats and risks. This consultant reports to and works with our management team, including our Chief Scientific Officer and President and Chief Operating Officer to identify and assess risks from cybersecurity threats by monitoring and evaluating our threat environment using various methods and tools including for example by subscribing to reports and services that identify cybersecurity threats, leveraging certain system monitoring tools, and leveraging tools provided through Microsoft Office 365.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our assessment and management of material risks from cybersecurity threats are taken into account as part of the Company&#x2019;s risk management processes.  For example, our senior management works with our information technology consultant to evaluate material risks from cybersecurity threats against our overall business objectives.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use third-party service providers, including cybersecurity consultants, to assist us from time to time to identify, assess, and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We use third-party service providers to perform a variety of critical functions throughout our business, such as hosting providers, application providers, contract research organizations, contract manufacturing organizations, and other third-party service providers. We review the cybersecurity risks associated with the use of these providers. Depending on the nature of the services provided, the sensitivity of the Information Systems and Data at issue, and the identity of the provider, our vendor management process may involve different levels of assessment and due diligence designed to help identify cybersecurity risks associated with a vendor, as well as the imposition of security related contractual obligations on the vendor.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For a description of the risks from cybersecurity threats that may materially affect the Company and how they may do so, see our risk factors under Part 1. Item 1A. Risk Factors in this Annual Report on Form 10-K, including &#x201c;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our information technology systems, or those of our CROs, contractors, consultants, or other third parties with whom we work, may fail or suffer security breaches, loss or leakage of data, and other disruptions, which could result in a material disruption of our product candidates&#x2019; development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board of Directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; considerations into the Company&#x2019;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors receives periodic reports as needed from management &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_f2f20ad2-7498-4f33-9be4-70af46cd3696">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_e898a58b-1ed1-4161-a341-40c39b9105df">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_2939e5c7-750a-44ae-8396-0baac5757125">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board of Directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; considerations into the Company&#x2019;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.&lt;/span&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_7011ad2f-e113-4463-b71a-7cf4db6cf5ae">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors is responsible for overseeing the Company&#x2019;s cybersecurity risk management processes, including oversight and mitigation of risks from cybersecurity threats.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_cd4ea0d0-14b8-4a5e-b380-66ee74485d71">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including our Chief Scientific Officer, President and Chief Operating Officer, Chief Financial Officer, Vice President Finance and General Counsel who also serves as our compliance officer. These members of management have prior work experience in various roles involving managing information security programs and are informed about and monitor the prevention, mitigation, detection and remediation of cybersecurity incidents.&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_69b375e7-f53b-4c22-88bc-41f1823c216d">&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; considerations into the Company&#x2019;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have adopted a Cybersecurity Incident Response Policy which is designed to escalate certain cybersecurity incidents to a Cybersecurity Incident Management Team consisting of our Chief Scientific Officer, President and Chief Operating Officer, General Counsel and our information technology consultant. Depending on the circumstances, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;cybersecurity incidents are reported to our Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Senior management works to help the Company mitigate and remediate cybersecurity incidents of which they are notified in addition to notifying the Audit Committee of the Board of Directors, as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors receives periodic reports as needed from management &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_ef6c1e23-369f-4620-bf41-834c5adb9ea5">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; considerations into the Company&#x2019;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Our President and Chief Operating Officer is also responsible for managing budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other security-related reports.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_76ede3b5-83db-4206-8c73-0f2db7a8ddb0">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Chief Scientific Officer and our President and Chief Operating Officer are responsible for engaging appropriate personnel and companies, helping to integrate cybersecurity risk&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; considerations into the Company&#x2019;s overall risk management strategy, and communicating key priorities to relevant employees and personnel.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_014c1e9e-a94d-439b-b222-f6a93cd4ba44">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_68cfad4b-f38e-488d-8358-491a915d9e9a">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_0daf7908-34fe-400b-815e-2b7b023cff69">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Audit Committee of the Board of Directors receives periodic reports as needed from management &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes the Company has implemented to address them. The Audit Committee also has access to various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <dei:AuditorFirmId
      contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba"
      id="F_ae982109-d058-4c18-ac37-b4d90dfc9eac">659</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_245b2c13-7878-4a99-a36a-a659aff49660">42</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_53f1fd28-297f-41c0-8102-1599fa38c4f8">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (and subsidiaries)(the Company) as of December 31, 2024, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#x2019; equity and cash flows for the year then ended, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December 31, 2024, and the consolidated results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheet of CalciMedica, Inc. (the Company) as of December 31, 2023, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba"
      id="F_32b220a0-af7d-4311-a684-93e5c652d2b1">Moss Adams LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_9170e96f-73fb-4585-913b-5bcc555319ba"
      id="F_692fde7d-9272-47a2-aaf9-58a9f7abf59e">San Diego, California</dei:AuditorLocation>
    <dei:AuditorName
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_ffdc59d4-2f7c-4c59-96b4-6fa6038d3499">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1bf875d8-37ab-48ab-8cc4-c81d76ce1244">San Diego, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_2780b112-c1d6-4925-9dc6-a9e4fcadd97d"
      unitRef="U_USD">7935000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_ebacc942-8c13-4d71-81fe-49539c43c07f"
      unitRef="U_USD">5530000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_bd4cd37a-bf15-43ca-afec-f346f458421b"
      unitRef="U_USD">10734000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_02329e11-db08-4435-ba98-5ba216fcc1b5"
      unitRef="U_USD">5708000</us-gaap:ShortTermInvestments>
    <ck0001534133:PrepaidClinicalTrialExpenses
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_e90d565c-c1a6-4cf8-a6a0-73c5c8f9fe2b"
      unitRef="U_USD">748000</ck0001534133:PrepaidClinicalTrialExpenses>
    <ck0001534133:PrepaidClinicalTrialExpenses
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_d4b46e1a-afd4-4896-93ea-239b47385b43"
      unitRef="U_USD">71000</ck0001534133:PrepaidClinicalTrialExpenses>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_5d5de457-7f2a-4374-a96a-0fbaf3247d9d"
      unitRef="U_USD">248000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_e5b5d823-9bc2-4dd7-a12f-1bf743f2a076"
      unitRef="U_USD">296000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_0c09fc0a-257f-4ac5-9e19-a2657727c276"
      unitRef="U_USD">19665000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_a910a36c-54f6-4ea7-a42a-efe39388328a"
      unitRef="U_USD">11605000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_33a1617e-c71c-4b9f-ab88-b143c0b652c2"
      unitRef="U_USD">119000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_af6f1cd3-3614-485b-b879-3e01d72724ac"
      unitRef="U_USD">167000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssets
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_922805ad-1a69-496f-9ebe-d5095f8c410e"
      unitRef="U_USD">10000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_f3b5e200-775e-4d4d-8821-b4b5e658fabd"
      unitRef="U_USD">413000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_7c54ae0a-d7b9-4f42-9e5e-0e5ff65c859b"
      unitRef="U_USD">19794000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_97b41a6a-9bc7-48c7-886d-16c37b2b6e92"
      unitRef="U_USD">12185000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_00e06b31-8163-4a56-84b9-07cc7c06f730"
      unitRef="U_USD">1998000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_e7145d4d-525b-4214-973d-ffc447d7511b"
      unitRef="U_USD">1419000</us-gaap:AccountsPayableCurrent>
    <ck0001534133:AccruedClinicalTrialCosts
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_f25c5fea-b439-4304-a13d-199f515b6fbe"
      unitRef="U_USD">820000</ck0001534133:AccruedClinicalTrialCosts>
    <ck0001534133:AccruedClinicalTrialCosts
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_ce38fb8b-0715-4c70-8a31-0dbc273d9a0b"
      unitRef="U_USD">1141000</ck0001534133:AccruedClinicalTrialCosts>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_4c42e759-4345-4546-80b0-be10bcbb29d5"
      unitRef="U_USD">866000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_baf02023-ca54-49af-96fa-d96d5875a7cf"
      unitRef="U_USD">1468000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_4f13db4a-e110-4868-82ef-c9ff901a24c8"
      unitRef="U_USD">3684000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_787aa739-fa3a-4ad5-985e-e8a51301bc63"
      unitRef="U_USD">4028000</us-gaap:LiabilitiesCurrent>
    <ck0001534133:WarrantLiability
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_b001c859-08b4-47cd-88fc-471061ff0ad3"
      unitRef="U_USD">1700000</ck0001534133:WarrantLiability>
    <ck0001534133:WarrantLiability
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_5f58ac53-5cc1-4c03-8efe-2f71253b2930"
      unitRef="U_USD">0</ck0001534133:WarrantLiability>
    <us-gaap:Liabilities
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_afe145af-de2b-4666-98cb-2c99a4baee51"
      unitRef="U_USD">5384000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_cdadd2f8-3329-430a-889d-c85a41166aa9"
      unitRef="U_USD">4028000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="4"
      id="F_1cd59486-b41b-4ad0-86fd-97bfbb274e3d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="4"
      id="F_fdccb848-cf5e-430a-a1c5-2777490d86d2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_d9ae101b-e1cb-406b-bad5-c5392c346856"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_e6fd2ce1-45be-40db-9b5c-b2b26b7e35c2"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_a4da38cb-27cc-4025-83df-ad6a30dd0ce5"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_d02a974c-6a37-458d-8c18-7f98918c8b51"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_16a62d31-fb1b-46c4-8f13-c18a4a4ea417"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_b4e1c57a-5758-4143-b6fb-3d2decdedbce"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_9ecf9690-b957-44fe-956e-4721161086b2"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_c971065d-d5d3-4b06-8bed-73ca409e8f32"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="4"
      id="F_b81d5030-3418-40a9-bcb4-4473e61c6637"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="4"
      id="F_09d2cde0-c9ae-4f9b-a314-7a50dac0cf9c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_9155d60e-1834-4ab7-9787-b3f57dc2c715"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_48e6fb55-8f38-4c70-81a0-07002ee3a3ac"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_0ced8084-bbda-4a4d-9098-82cd71709f7f"
      unitRef="U_shares">13481917</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_d0d6bd94-eb73-4dfd-9f2d-d55f907e63c6"
      unitRef="U_shares">13481917</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_1c0eca0b-0860-4a5a-a2fa-33c4f68dad0d"
      unitRef="U_shares">5754505</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_3b61fd19-a573-4637-89fe-e71f583f1316"
      unitRef="U_shares">5754505</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_6b56bce3-5723-468d-b7c6-745b0459c5e7"
      unitRef="U_USD">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_b600b49a-435a-4b90-bfab-c7203e640ea5"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_dda9faa0-f7e8-41b9-bfb0-7fc76c3baeea"
      unitRef="U_USD">174166000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_85de7a60-9c61-431e-b286-56c793bb044a"
      unitRef="U_USD">154218000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_af0a3c1f-376e-4998-ae73-862b13c42c9e"
      unitRef="U_USD">-159764000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_cea6db69-6e2d-4f1c-8fa4-a3c8cd33fc82"
      unitRef="U_USD">-146064000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_7e0b1a59-7e52-467e-9f80-b1c3bee23ccf"
      unitRef="U_USD">4000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_5c736c4b-42ca-44d0-8462-9e5b6b8a5984"
      unitRef="U_USD">2000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_4ed8c4cb-bc8d-4e80-9843-1f2898c36a6b"
      unitRef="U_USD">14410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_48c41702-8508-485f-a5c2-5c97ac648f27"
      unitRef="U_USD">8157000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_4645d67b-ff5d-407f-a2b2-c4b5e034e752"
      unitRef="U_USD">19794000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_6f1d2b3c-0e91-4e63-9cbe-8c977349bace"
      unitRef="U_USD">12185000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_157094b2-ca93-4ac7-a9f3-385ca7b5325a"
      unitRef="U_USD">14478000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_043584c6-de24-4660-8a08-fa4b2c957988"
      unitRef="U_USD">15859000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_c6db79b7-a66c-40ca-83e1-dcf922f261c3"
      unitRef="U_USD">9726000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_6c0ca840-776a-4b3a-82d1-c3777b496e2f"
      unitRef="U_USD">22216000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_f1be9412-0add-4dea-96b5-cc2b9f2b1d32"
      unitRef="U_USD">24204000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_9693a49b-fef8-43e0-8bdd-a8bdf34dfe06"
      unitRef="U_USD">38075000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_ff6d5db0-d1d9-45d7-9397-fa0447930ef4"
      unitRef="U_USD">-24204000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_2c7195b0-e1e2-4c23-beac-bdd316cce3e7"
      unitRef="U_USD">-38075000</us-gaap:OperatingIncomeLoss>
    <ck0001534133:ChangesInFairValueOfFinancialInstruments
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_27f22baf-fd6c-4bbb-aaf7-a3fd31f7bace"
      unitRef="U_USD">9490000</ck0001534133:ChangesInFairValueOfFinancialInstruments>
    <ck0001534133:ChangesInFairValueOfFinancialInstruments
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_1b7f4549-6eee-47dc-8467-9e4e81f1fc59"
      unitRef="U_USD">3168000</ck0001534133:ChangesInFairValueOfFinancialInstruments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_af632f21-6d1b-4a7b-9a54-5862cb28fe43"
      unitRef="U_USD">1014000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_b7030efd-d361-46ce-b9d6-024939f5f20b"
      unitRef="U_USD">550000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_11f138ed-2587-416b-a4b9-f55eaae9d13b"
      unitRef="U_USD">10504000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_a32c9729-9b99-4afd-8feb-4a0a454cb573"
      unitRef="U_USD">3718000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_42a83ae5-0b53-40c4-adfb-53cb2ed1c45e"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_b2a2bc26-31a3-4bdf-9653-6ff580b20a9e"
      unitRef="U_USD">-34357000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_8345247b-dfd1-4cae-a649-68bd4423cfb9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_7eaa5e52-a93e-422a-841e-31d0c0455e2b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="2"
      id="F_9b1b23c9-3f25-42f3-81ad-9f2b03a8153d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="2"
      id="F_f8e375cf-d4d3-44b3-864a-3eba7b78b3cd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_016ec5d3-8cdc-4acb-abfc-691a703cf21a"
      unitRef="U_shares">11245915</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_556d09da-09c8-4787-bb7a-5e910844873f"
      unitRef="U_shares">11245915</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_bcfda22f-a662-4af5-acd8-c02adf89760b"
      unitRef="U_shares">4486258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_e35261cd-5652-485a-9730-0beac4258671"
      unitRef="U_shares">4486258</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_f0242d8a-2ac0-45a1-b295-d0f9894e0091"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_29b4d6cf-da97-4ed1-a8de-dfad803cf19d"
      unitRef="U_USD">-34357000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_9dd26545-4424-4207-ba61-b62d66b6117b"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_c8109612-d8dd-49df-a3d4-a3625443da7e"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_3aaaeb0c-3be3-4564-97f2-fd0ef0863d4c"
      unitRef="U_USD">-13698000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d06e6c9d-cdce-436e-921f-767ebb3d4a70"
      unitRef="U_USD">-34355000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3"
      decimals="INF"
      id="F_ab24e10f-14e8-4037-ba21-105f4312a6c4"
      unitRef="U_shares">5754505</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3"
      decimals="-3"
      id="F_e8557881-e164-4ced-91f9-c2bb3f52e517"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a707849b-9622-4270-8a14-4ccfb2234b96"
      decimals="-3"
      id="F_9b9fcb3e-6800-4e2f-9f11-b6070dd3f17f"
      unitRef="U_USD">154218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_30130670-4924-4031-bbd1-78ccb2dff022"
      decimals="-3"
      id="F_13de27f5-cd24-4bb4-888f-85b701109d0d"
      unitRef="U_USD">-146064000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d409c238-cc99-40c2-b647-976b6c07fe00"
      decimals="-3"
      id="F_c6c347d9-4de6-4e6f-a3e4-51e4c41a631c"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_4ad33535-a27c-4849-81a0-b500464f60ff"
      unitRef="U_USD">8157000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_b376b56f-0cf5-494e-a49a-fc86d5255af2"
      unitRef="U_USD">2313000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_0ed4b9b0-f88c-4a44-b6d9-2b455fc5bde6"
      unitRef="U_USD">2313000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="INF"
      id="F_018b4df0-e2a0-4503-ac7f-6e9b1739eba0"
      unitRef="U_shares">4985610</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="-3"
      id="F_d0382624-fb8d-4aa2-a9ae-b65a1356cbd7"
      unitRef="U_USD">2000</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_5158385a-fd3e-4386-8a38-c07b0aff5f14"
      unitRef="U_USD">7903000</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1977f94e-ae79-4534-a3cd-2a17bd2200ca"
      unitRef="U_USD">7905000</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet>
    <ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_2c3e5c4d-77e4-47ad-ba04-b81f5692aee5"
      unitRef="U_USD">660000</ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement>
    <ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_df3d9040-1d57-4b09-aa8f-1b7a624ddfa8"
      unitRef="U_USD">660000</ck0001534133:IssuanceOfWarrantsInConnectionWithPrivatePlacement>
    <ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="INF"
      id="F_a270c6c1-b3ff-4f25-8994-8c1086e599bb"
      unitRef="U_shares">2720000</ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNetShares>
    <ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="-3"
      id="F_fa672d82-fbc9-4d37-a8e5-9ae49f9e9fd4"
      unitRef="U_USD">1000</ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet>
    <ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_ffe5b8a6-fcd0-4a63-b231-e459135b2871"
      unitRef="U_USD">9003000</ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet>
    <ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_ea450620-9838-4936-b798-197d87048b89"
      unitRef="U_USD">9004000</ck0001534133:IssuanceOfCommonSharesFromUnderwrittenPublicOfferingNet>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="INF"
      id="F_610c29e8-1562-436c-96df-c4349901b0bd"
      unitRef="U_shares">8950</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_2ee1fc07-de33-45cc-b02a-123ef4aea4e0"
      unitRef="U_USD">49000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_2035499a-e8af-48aa-940b-5e6ba5e2928b"
      unitRef="U_USD">49000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="INF"
      id="F_39003da1-c23c-4ad1-b941-00ccf5f5aea8"
      unitRef="U_shares">12852</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e084ac77-ce86-42c4-b795-1e5530dcff59"
      decimals="-3"
      id="F_a1db75f3-b0f6-4c5a-864a-4277cafa27a8"
      unitRef="U_USD">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_3a35ba1d-6506-4b34-a20c-af3c82ecb11c"
      unitRef="U_USD">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_bb626b12-389d-4561-abdc-fe33a5ce2554"
      decimals="-3"
      id="F_9c5d4c1b-fe02-47ce-98c2-25a7577dfb23"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_13937b26-5dd6-4876-a178-ecc52f6246cb"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_1da4e079-61e5-45cc-a979-3a9615ff0665"
      decimals="-3"
      id="F_b6c0c22b-d600-45b0-b3a7-31df46d17a47"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1cd8b801-1180-4fb9-8a82-d319016e115e"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_8f498825-0f78-45b4-812c-02787d22cde8"
      decimals="INF"
      id="F_ea17a1e9-9697-4f49-ab18-b2741a5fea1d"
      unitRef="U_shares">13481917</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_8f498825-0f78-45b4-812c-02787d22cde8"
      decimals="-3"
      id="F_5e63e0d3-4b3b-4e6f-86b9-64d50e8c5adb"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_53c253cb-c903-45b5-b952-e3bd63a5ace1"
      decimals="-3"
      id="F_c2f189c5-b288-452b-99a0-7dbf2ce1d0cd"
      unitRef="U_USD">174166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_845be1e9-b257-47a6-89d4-733d8a31d6b2"
      decimals="-3"
      id="F_bf408b53-0117-4df2-a574-3e062beb0480"
      unitRef="U_USD">-159764000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d7c558d7-f9b7-46bd-a5cd-d32a30cceb1d"
      decimals="-3"
      id="F_549b93a0-f9fa-4db1-bec1-118a28013a49"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_dc2e8dee-46f6-457a-b90e-9f5c3030d0e6"
      unitRef="U_USD">14410000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_640fa722-803d-451f-878d-cea21bde32c6"
      decimals="INF"
      id="F_5fda962c-e4d1-4959-a932-52c6e6287685"
      unitRef="U_shares">84820880</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_640fa722-803d-451f-878d-cea21bde32c6"
      decimals="-3"
      id="F_10e8c446-2eec-4799-8d5c-df1576e67b56"
      unitRef="U_USD">62071000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00"
      decimals="INF"
      id="F_15e90213-9164-4bc9-be1d-3bbcdb407103"
      unitRef="U_shares">84165</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_dddf5c70-9a08-4f51-ba92-a7e88e5ffe00"
      decimals="-3"
      id="F_7f7ba5d0-f7a2-4d29-a564-f91fcf3fdbe3"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f3e6c3db-a6a2-4f7d-99b3-1a4978c878f9"
      decimals="-3"
      id="F_c8646c88-f9ac-4c81-9030-3411b1c28d95"
      unitRef="U_USD">40402000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2ca88b50-4b1e-42cb-b72d-edd91da9a612"
      decimals="-3"
      id="F_8c58ebdc-a22c-43c7-acbc-3e0366ddffa4"
      unitRef="U_USD">-111707000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842"
      decimals="-3"
      id="F_4848422c-a885-466f-ab68-86f45f222856"
      unitRef="U_USD">-71304000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_f0b7e994-726d-4fe8-90a2-97bd36f1a959"
      unitRef="U_USD">12039000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_ec86efd9-1844-4dfe-ba6b-5b237f62f969"
      unitRef="U_USD">12039000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ck0001534133:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_bd15498b-f283-433b-97df-4b894a6ee8ad"
      decimals="INF"
      id="F_36c6d0cd-4234-447e-b0e4-588c01226979"
      unitRef="U_shares">-84820880</ck0001534133:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <ck0001534133:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_bd15498b-f283-433b-97df-4b894a6ee8ad"
      decimals="-3"
      id="F_279d3628-d754-48ed-87f9-4e89e9e39711"
      unitRef="U_USD">-62071000</ck0001534133:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_7db3b8df-059e-48e3-b0b5-10cff97ab399"
      unitRef="U_shares">2442852</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_55c3016e-4240-451e-958e-f582de4df7f3"
      unitRef="U_USD">62071000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_c9f85f64-f030-4412-898e-5a238eff08ba"
      unitRef="U_USD">62071000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_3cab47fb-e5c1-4496-85a3-0d4ea86c41fe"
      decimals="4"
      id="F_cca9bead-660b-430b-80ea-278ac91a9753"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_55f6bac9-de10-4fe3-9272-c0ffc0005686"
      unitRef="U_shares">1571433</ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMergerShares>
    <ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_715eaa04-9020-48b1-85f5-d249a947efd5"
      unitRef="U_USD">29218000</ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger>
    <ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_7748ddfa-771a-43ed-a4a9-25c2b91fbe17"
      unitRef="U_USD">29218000</ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_bec77713-9c38-4b15-9de0-f70df18923b6"
      unitRef="U_shares">596363</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNetShares>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_8b8b0172-c26f-4195-862c-008dee7ea308"
      unitRef="U_USD">10340000</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet>
    <ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_dfa775e8-1a49-41b4-a231-4dc66d37e2d9"
      unitRef="U_USD">10340000</ck0001534133:IssuanceOfCommonSharesFromPrivatePlacementNet>
    <ck0001534133:StockIssuedDuringPeriodSharesConversionOfPromissoryNotes
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_c7110590-c237-41a5-9cbd-a70fb86036e8"
      unitRef="U_shares">590031</ck0001534133:StockIssuedDuringPeriodSharesConversionOfPromissoryNotes>
    <ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_6af08284-56f5-468d-a166-b3ceb63b287e"
      unitRef="U_USD">3245000</ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes>
    <ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_276c84f6-97f0-4faf-9603-3b776e98ce12"
      unitRef="U_USD">3245000</ck0001534133:StockIssuedDuringPeriodValueConversionOfPromissoryNotes>
    <ck0001534133:ExerciseAndConversionOfC2WarrantsShares
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_51ad86dd-546e-44fb-86ee-6236c6838566"
      unitRef="U_shares">80254</ck0001534133:ExerciseAndConversionOfC2WarrantsShares>
    <ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_5a11153c-1601-43b8-bf59-943876853b70"
      unitRef="U_USD">442000</ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock>
    <ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_f262d43e-cee0-43d0-b379-98013c627223"
      unitRef="U_USD">442000</ck0001534133:ConversionOfSeriesC2WarrantIntoCommonStock>
    <ck0001534133:ConversionOfPromissoryNoteWarrantsIntoCommonStockShare
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_5ce23b87-d05e-49aa-aafc-2388b403fe72"
      unitRef="U_shares">152875</ck0001534133:ConversionOfPromissoryNoteWarrantsIntoCommonStockShare>
    <ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_898e162c-e2e0-42fb-822f-6fa74c43cc6d"
      unitRef="U_USD">841000</ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock>
    <ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_8c87b7db-3566-451f-953a-efb2694b7daf"
      unitRef="U_USD">841000</ck0001534133:ConversionOfPromissoryNoteWarrantIntoCommonstock>
    <ck0001534133:MergerTransactionCosts
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_fcd4c060-13a6-4f2e-b95b-d0ad5c31cc79"
      unitRef="U_USD">-4545000</ck0001534133:MergerTransactionCosts>
    <ck0001534133:MergerTransactionCosts
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_7e799fce-6a51-4077-8840-631ef0c42d51"
      unitRef="U_USD">-4545000</ck0001534133:MergerTransactionCosts>
    <ck0001534133:RestrictedStockUnitsNetSettlementShares
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_75cdd762-b0e6-41ac-85d0-08cf7bf2e920"
      unitRef="U_shares">143960</ck0001534133:RestrictedStockUnitsNetSettlementShares>
    <ck0001534133:RestrictedStockUnitsNetSettlement
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_f5f763f1-0d81-4be8-b0b7-c10e0b354308"
      unitRef="U_USD">-297000</ck0001534133:RestrictedStockUnitsNetSettlement>
    <ck0001534133:RestrictedStockUnitsNetSettlement
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_dafd2d2c-df18-4db0-8e86-85e61d546aac"
      unitRef="U_USD">-297000</ck0001534133:RestrictedStockUnitsNetSettlement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_094e0b49-ba43-4932-87a6-8f7a901e4977"
      unitRef="U_USD">216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_dfb5d8bf-677a-472a-84c7-69a52cf94ca6"
      unitRef="U_USD">216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_a8a3c05b-ff83-47ca-9f27-a156b762fbcf"
      decimals="INF"
      id="F_b458385e-c511-44f5-82b8-1c94ebd5e63e"
      unitRef="U_shares">92572</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_3b53cea2-d26b-4a9d-bfe0-d9c5bc176f67"
      decimals="-3"
      id="F_e8cdb640-5851-4ec7-bd57-1664e711e6d9"
      unitRef="U_USD">246000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_e6d51a7c-583c-417e-89bc-d603efd815c7"
      unitRef="U_USD">246000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_a3c816ce-23b8-4647-a3b2-a0060ab3f6a7"
      decimals="-3"
      id="F_2c3b5779-e3fe-4da9-b59c-0c364dca5ea9"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_0d5409af-6aee-4e4a-a1c2-6d4a205877c5"
      unitRef="U_USD">2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_b1ab3b90-45a9-4502-8252-c2e3034f292f"
      decimals="-3"
      id="F_903d6bbc-5d26-4dda-a0e4-b1ff81a3f305"
      unitRef="U_USD">-34357000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_3fee33b8-7c43-4c11-ba03-1147a16d6d0b"
      unitRef="U_USD">-34357000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3"
      decimals="INF"
      id="F_d4831b49-d4f0-4661-91b5-b9e56e274739"
      unitRef="U_shares">5754505</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_1c6f8a28-7921-4f56-8d58-d4f414d97ac3"
      decimals="-3"
      id="F_092d76c3-7def-413e-9caa-ee27b2c8761c"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a707849b-9622-4270-8a14-4ccfb2234b96"
      decimals="-3"
      id="F_50ee0259-0a70-41c4-958a-b9168c836673"
      unitRef="U_USD">154218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_30130670-4924-4031-bbd1-78ccb2dff022"
      decimals="-3"
      id="F_f59b6af7-6883-4187-babf-b9afc76edde3"
      unitRef="U_USD">-146064000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d409c238-cc99-40c2-b647-976b6c07fe00"
      decimals="-3"
      id="F_11c1fca3-d104-47b8-b2bd-2290bb9f979d"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_b592c9c8-397d-4694-a42c-f6cc4a64fc80"
      unitRef="U_USD">8157000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_00108339-4338-4cf7-98ea-20258321ceb3"
      unitRef="U_USD">-13700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_f8c3c2ad-8c04-445a-a431-d8ffecd712ee"
      unitRef="U_USD">-34357000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_748ba0a8-17fd-45f0-8558-147e6ed97102"
      unitRef="U_USD">2313000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_fc0b53a7-1659-4c83-9e5d-74a315a91c6b"
      unitRef="U_USD">12039000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_7d4b0f2f-f698-4467-b723-5c60e15d9bef"
      unitRef="U_USD">58000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_f06bbcc6-4801-4720-9eda-6dc1aa17eaf4"
      unitRef="U_USD">58000</us-gaap:Depreciation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_b56c7214-4a13-482a-95a2-4383fddf1467"
      unitRef="U_USD">-9490000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_907cc9a2-19b3-4b65-aaf7-6ec1ca0be488"
      unitRef="U_USD">-1146000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_a99a80d9-7788-43a3-b522-6fb5f7c05c26"
      unitRef="U_USD">0</ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_0cbfcfbf-546a-4776-b0b0-c560ddb7f6d3"
      unitRef="U_USD">-2022000</ck0001534133:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ck0001534133:TransactionCostsAssoicatedWithWarrants
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_b55fc1a4-e083-49f3-b7c9-df3cbf671f3f"
      unitRef="U_USD">776000</ck0001534133:TransactionCostsAssoicatedWithWarrants>
    <ck0001534133:TransactionCostsAssoicatedWithWarrants
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_39c29ea3-8e04-4d09-b8f7-4fdb026f84dd"
      unitRef="U_USD">0</ck0001534133:TransactionCostsAssoicatedWithWarrants>
    <ck0001534133:NonCashInterestExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_4a7f42d0-f209-482a-af8d-619da94d5196"
      unitRef="U_USD">0</ck0001534133:NonCashInterestExpense>
    <ck0001534133:NonCashInterestExpense
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_c0c9bc9b-42c9-4878-b5ac-fe367e4a2181"
      unitRef="U_USD">110000</ck0001534133:NonCashInterestExpense>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_52f4e1e9-d853-471b-86cd-deca4011c29e"
      unitRef="U_USD">608000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_9e5bae6f-1e20-4823-a5d5-af8fd82106a9"
      unitRef="U_USD">145000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_e5593b68-559e-4a17-8ffb-53fb57f6e902"
      unitRef="U_USD">228000</ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets>
    <ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_150d19bd-189b-4a5a-96ca-519f4d9cf7e1"
      unitRef="U_USD">-2997000</ck0001534133:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1a4f7540-4875-4f3e-a829-2df028a5e5f1"
      unitRef="U_USD">601000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_316d7808-8abd-4a42-bfbe-bbcfbc8ef7ec"
      unitRef="U_USD">-1427000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_b714f58a-a95b-4c5b-b01b-059b73d08d7c"
      unitRef="U_USD">-868000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_a6c410f1-c363-4061-b887-6597ace3a066"
      unitRef="U_USD">-1837000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_e22a6d8a-d0cd-4875-aef8-d7ddf099f131"
      unitRef="U_USD">-21146000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_4841b6cf-705b-481b-9ae6-e2947aece9c5"
      unitRef="U_USD">-25730000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_75aa1d78-c2ed-440e-82b6-943116291fe7"
      unitRef="U_USD">29002000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_74bc7550-1038-43e3-9e0b-e1fa5aee57fc"
      unitRef="U_USD">6118000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_62af5fdd-11a7-4271-aad3-3cd1a9987ecf"
      unitRef="U_USD">24587000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_60be3133-7efa-4c7a-86e2-345fc039d777"
      unitRef="U_USD">15080000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_9aa8a004-142e-447b-a3ba-d1d7a08fd343"
      unitRef="U_USD">8000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d5224ca0-375b-429c-8375-26660cb9994f"
      unitRef="U_USD">78000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_95432b67-b7fb-454f-8813-1e492cce0fdc"
      unitRef="U_USD">-4423000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_b0d313be-d723-4ae1-a342-34514a6308dc"
      unitRef="U_USD">8884000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_6bb01a6e-03b6-4492-8c78-027ab2bf2ef7"
      unitRef="U_USD">27905000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_dbb35a38-4bd5-4b3d-a69e-421667fc149f"
      unitRef="U_USD">10340000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_8c3465f5-c9cd-4631-9c13-0820dc26a0b6"
      unitRef="U_USD">0</ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash>
    <ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_b5f3e909-e6d5-4582-b542-a8ef49a67afc"
      unitRef="U_USD">-14859000</ck0001534133:PaymentsOfAcquisitionOfBusinessesNetOfCash>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_81e17678-9547-4368-aaa0-ea6589451fda"
      unitRef="U_USD">20000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d9f671d7-c2f4-4a7b-9ea7-83d6274a668f"
      unitRef="U_USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_b5f0f226-e522-4cc9-a2d4-31fcf243ab67"
      unitRef="U_USD">0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_21c19457-f010-441e-a632-4fbafa7cf829"
      unitRef="U_USD">4545000</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_9238f38e-7246-4027-93f5-dfb0beb425ef"
      unitRef="U_USD">49000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_a375f209-0e9b-4d71-a405-df51657a8c71"
      unitRef="U_USD">246000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1f6e665a-3356-4083-955d-6c11f22f84c7"
      unitRef="U_USD">27974000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_5800aea3-4ff3-46ad-b9d5-bc0d45d00458"
      unitRef="U_USD">20900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_d8adb3ae-72e7-42ea-8a94-67d3a8ab0be4"
      unitRef="U_USD">2405000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_1ce1ce69-d2f0-46a5-84fd-5f25e987de01"
      unitRef="U_USD">4054000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_e0b20d47-744e-4619-9bcc-9d5884c18e07"
      unitRef="U_USD">5530000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842"
      decimals="-3"
      id="F_3ee5a153-23ff-4fa0-9630-5c8e2be0d158"
      unitRef="U_USD">1476000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_25e34185-6a2a-4484-8456-869abd333290"
      unitRef="U_USD">7935000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_4f1779ed-ad0f-4ba2-8d66-372d61187a7d"
      unitRef="U_USD">5530000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_4905f382-11d1-41a3-a2d7-00ed6501dd9c"
      unitRef="U_USD">0</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_c7ae0799-438e-451e-b094-b55a20637ccc"
      unitRef="U_USD">62071000</us-gaap:ConversionOfStockAmountIssued1>
    <ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_d6e4ea80-cacf-4561-9190-3433fa2c5165"
      unitRef="U_USD">0</ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger>
    <ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_997f8464-730b-44dd-bf87-56d4d376d118"
      unitRef="U_USD">29218000</ck0001534133:IssuanceOfCommonStockToGraybugStockholdersAsAResultOfTheMerger>
    <ck0001534133:ShortTermInvestmentsAssumedInTheMerger
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1f311f8d-5dbc-4d2a-9d23-c36bf9ce5255"
      unitRef="U_USD">0</ck0001534133:ShortTermInvestmentsAssumedInTheMerger>
    <ck0001534133:ShortTermInvestmentsAssumedInTheMerger
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_643e815d-1b5f-40b1-9a88-98f96430884c"
      unitRef="U_USD">9776000</ck0001534133:ShortTermInvestmentsAssumedInTheMerger>
    <ck0001534133:PrepaidExpensesAndOtherCurrentAssets
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_294f4d1b-0242-408f-aebc-8a1ec8b80579"
      unitRef="U_USD">0</ck0001534133:PrepaidExpensesAndOtherCurrentAssets>
    <ck0001534133:PrepaidExpensesAndOtherCurrentAssets
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_ee95afed-54d7-46de-a58d-c681ae72adcc"
      unitRef="U_USD">2096000</ck0001534133:PrepaidExpensesAndOtherCurrentAssets>
    <ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_0db26eac-5223-4101-8cd2-469782d744a5"
      unitRef="U_USD">0</ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger>
    <ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d8165f10-38b8-4119-bc7f-f728250c1f6a"
      unitRef="U_USD">2258000</ck0001534133:AccountsPayableAndAccruedLiabilitiesAssumedInTheMerger>
    <ck0001534133:ConversionOfC2WarrantsToCommonStock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_f6884d4f-3b98-4445-a921-b0cbf14771ee"
      unitRef="U_USD">0</ck0001534133:ConversionOfC2WarrantsToCommonStock>
    <ck0001534133:ConversionOfC2WarrantsToCommonStock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_aa8c5615-4d93-440b-b774-d75f04b0e66d"
      unitRef="U_USD">442000</ck0001534133:ConversionOfC2WarrantsToCommonStock>
    <ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_af3cc21c-7774-49e4-9799-bb2b893a4d57"
      unitRef="U_USD">0</ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock>
    <ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d7ad9be8-2dc1-4bb4-be66-671027b4f09a"
      unitRef="U_USD">3245000</ck0001534133:ConversionOfConvertiblePromissoryNotesToCommonStock>
    <ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_7f5ade1a-645e-460f-9e8f-e3860767e920"
      unitRef="U_USD">0</ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock>
    <ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_8df60294-0f94-42ce-a050-0be557c5df3a"
      unitRef="U_USD">841000</ck0001534133:ConversionOfConvertiblePromissoryNoteWarrantsToCommonStock>
    <ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_0f4d3ede-0ce0-4b57-ba0f-9a0633604f47"
      unitRef="U_USD">78000</ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses>
    <ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_50961ca4-6e30-472d-a24d-6621b78c9690"
      unitRef="U_USD">45000</ck0001534133:FinancingCostsIncludedInAccountsPayableAndAccruedExpenses>
    <ck0001534133:RestrictedStockUnitsNetSettlement
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_1d3aad87-391e-4a88-b4e9-efdb9a9ef843"
      unitRef="U_USD">0</ck0001534133:RestrictedStockUnitsNetSettlement>
    <ck0001534133:RestrictedStockUnitsNetSettlement
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_9490791f-3950-42cf-b271-90b2d2e9d027"
      unitRef="U_USD">-297000</ck0001534133:RestrictedStockUnitsNetSettlement>
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_a18a5ed6-6c6f-4a54-bc44-d7e16356f2f4"
      unitRef="U_USD">0</us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1>
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_5995a3e6-1632-4b2e-b713-6ef98246234c"
      unitRef="U_USD">216000</us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1>
    <us-gaap:NatureOfOperations
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_f7acc863-3e39-4dac-b241-003cb6f16326">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1. Nature of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;CalciMedica, Inc. (&#x201c;CalciMedica&#x201d; or the &#x201c;Company&#x201d;) (f/k/a Graybug Vision, Inc.) was incorporated in the state of Delaware in February 2015, following the conversion of Graybug, LLC, which was organized in May 2011, and has its principal operations in La Jolla, California. The Company is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory processes and direct cellular damage.&#x200b; The Company had a wholly owned subsidiary, CalciMedica Subsidiary, Inc., incorporated in Delaware in October 2006, which survived the Merger as more fully described below. The CalciMedica Subsidiary entity was dissolved and combined with the Company as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reverse Merger Transaction&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 20, 2023, Graybug Vision, Inc. (&#x201c;Graybug&#x201d;) completed a reverse merger transaction in accordance with the terms and conditions of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended on February 10, 2023 (the &#x201c;Merger Agreement&#x201d;), by and among Graybug, Camaro Merger Sub, Inc., a wholly owned subsidiary of Graybug (&#x201c;Merger Sub&#x201d;), and CalciMedica, Inc. (&#x201c;Private CalciMedica&#x201d;), pursuant to which Merger Sub merged with and into Private CalciMedica, with Private CalciMedica surviving as a wholly owned subsidiary of Graybug (the &#x201c;Merger&#x201d;). Additionally, on March 20, 2023, Graybug changed its name from &#x201c;Graybug Vision, Inc.&#x201d; to &#x201c;CalciMedica, Inc.&#x201d; and Private CalciMedica changed its name from &#x201c;CalciMedica, Inc.&#x201d; to &#x201c;CalciMedica Subsidiary, Inc.&#x201d; At the completion of the Merger, the prior Private CalciMedica equity holders and the prior Graybug equity holders owned &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively of the combined company, in each case, on a fully diluted basis using the treasury stock method and excluding out-of-the-money options and warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Merger was accounted for as a reverse recapitalization, with Private CalciMedica being treated as the acquirer for accounting purposes. See discussions of the transactions in connection with the Merger in Note 3 - Merger and Related Transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has experienced net losses and negative cash flows from operating activities since its inception. The Company has an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;159.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of December 31, 2024, and a net loss of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the year ended December 31, 2024. Total operating expenses for the year ended December 31, 2024 were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Substantially all of the Company&#x2019;s operating losses resulted from expenses incurred in connection with its research and development programs and from general and administrative costs associated with its operations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expects to incur significant expenses and increasing operating losses for the foreseeable future as the Company initiates and continues the preclinical and clinical development of its product candidates and adds personnel necessary to operate as a company with an advanced clinical pipeline of product candidates. The Company expects that its operating losses will fluctuate significantly from quarter-to-quarter and year-to-year due to timing of clinical development programs.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From inception to December 31, 2024, the Company has completed financings from the sale of preferred stock, warrants and common stock for total net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, including the 204 Private Placement and 2024 Follow-On described below, and has issued convertible debt for net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In connection with the Merger, the Company received approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of cash, cash equivalents and short-term investments. As of December 31, 2024, the Company had cash, cash equivalents and short-term investments of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;closed the 2024 Private Placement (as defined in Note 7 below) on January 23, 2024 and the second closing of this private placement occurred on February 5, 2024. Gross proceeds from the transaction were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million with net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in commissions and other transaction expenses. The Company closed a confidentially marketed public offering (the &#x201c;2024 Follow On&#x201d;) in October 2024 of the Company&#x2019;s common stock for gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and transaction costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million resulting in net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. On February 28, 2025, the Company entered into the (&#x201c;Loan Agreement&#x201d;) with Avenue Venture Opportunities Fund II, L.P. and Avenue Capital Management II, L.P. for an initial $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of gross proceeds (see Note 13).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company intends to seek additional funding through public and private financings, debt financings, collaboration agreements, strategic alliances and licensing agreements. Although the Company has been successful in raising capital in the past, there is no assurance of success in obtaining such additional financing on terms acceptable to us, it at all, and there is no assurance that the Company will be able to enter into collaborations or other arrangements. If the Company is unable to obtain funding when required or on acceptable terms, the Company may be required to scale back or discontinue the advancement of the product candidates, reduce headcount, file for bankruptcy, reorganize, merge with another entity or cease operations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Based on the Company&#x2019;s current operating plans, management believes its cash, cash equivalents, short-term investments and additional financing in February 2025, will be sufficient to fund its operations for the period of at least one year following the issuance of these financial statements.&lt;/span&gt;</us-gaap:NatureOfOperations>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_9114dadf-db78-4d1a-9686-04c4b1e69723"
      decimals="2"
      id="F_c64dbe80-d1cc-41d3-9523-55a6a4d29d72"
      unitRef="U_pure">0.72</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_29a301bb-4522-43d7-947b-4686e790d21a"
      decimals="2"
      id="F_069e1257-c2e3-40cc-b3e9-c3b53ee53864"
      unitRef="U_pure">0.28</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_59eafbf0-1736-4dd2-b536-3c179f3be9d1"
      unitRef="U_USD">-159800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_99b47221-b0ad-4780-b765-d413f816e99c"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLoss>
    <us-gaap:OperatingExpenses
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_5a180fc0-4e8b-4509-9ad0-3e5bc9521cb1"
      unitRef="U_USD">24200000</us-gaap:OperatingExpenses>
    <ck0001534133:TotalNetProceeds
      contextRef="C_f0009405-42d5-4625-a5e9-57af57ac1cfe"
      decimals="-5"
      id="F_0ce540e8-5c72-4ee2-99a4-744c1fb3b68d"
      unitRef="U_USD">140700000</ck0001534133:TotalNetProceeds>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_c45d60ac-8593-48c7-9b05-a42201654937"
      decimals="-5"
      id="F_cd4a6dfa-c867-4e02-955e-33d70bb99a29"
      unitRef="U_USD">8600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_2285f3db-8e79-4c3f-9414-8ddcbe31513f"
      unitRef="U_USD">29400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_cfaf50a1-8eeb-47dd-9f30-e4c69d897439"
      unitRef="U_USD">18700000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <ck0001534133:GrossProceedsFromThePrivatePlacement
      contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"
      decimals="-5"
      id="F_13453952-23e0-48fc-8d31-1fc4dec91fb4"
      unitRef="U_USD">20400000</ck0001534133:GrossProceedsFromThePrivatePlacement>
    <ck0001534133:NetProceedsFromPrivatePlacement
      contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"
      decimals="-5"
      id="F_24db6107-3713-4d20-8d2e-47fa067902e9"
      unitRef="U_USD">19000000</ck0001534133:NetProceedsFromPrivatePlacement>
    <ck0001534133:CommissionsAndOtherTransactionExpenses
      contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"
      decimals="-5"
      id="F_e6fca0a7-488c-4ee5-8ead-2f3be7afc5ed"
      unitRef="U_USD">1400000</ck0001534133:CommissionsAndOtherTransactionExpenses>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8"
      decimals="-5"
      id="F_79d9af6a-7626-44eb-b4b0-6e07276cf55d"
      unitRef="U_USD">10200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8"
      decimals="-5"
      id="F_71bc4c4d-db43-4804-a52b-1031ad28c28b"
      unitRef="U_USD">900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_58198596-8919-43f6-85a6-830ab130f2c8"
      decimals="-5"
      id="F_6e16072a-14c4-4855-9b41-b5554a0f4ce4"
      unitRef="U_USD">9300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="C_f6e6eee2-3a7f-426a-995a-4c63812334ed"
      decimals="-5"
      id="F_f74eb1db-f439-4208-bab4-819bb22e53ad"
      unitRef="U_USD">10000000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_543ce4c7-e62d-4a87-bf81-a076484f8fd6">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Update (&#x201c;ASU&#x201d;), of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). The consolidated financial statements include the accounts of the Company for the year ended December 31, 2024 and the Company and CalciMedica Subsidiary, Inc. for the year ended December 31, 2023. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#x2019;s activity from March 21, 2023 through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and assets and liabilities at their acquisition date fair value. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the merger exchange ratio of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0288&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to accruals for research and development expenses, valuation of warrants and valuation of equity awards. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk and other Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments, which potentially subject the Company to concentration of risk, consist principally of cash and cash equivalents. The Company&#x2019;s cash is deposited with major federally insured U.S. financial institutions. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is dependent on contract manufacturing organizations (&#x201c;CMO&#x201d;) to supply products for research and development of its product candidates, including preclinical and clinical studies, and for commercialization of its product candidates, if approved. The Company&#x2019;s development programs could be adversely affected by any significant interruption in CMO&#x2019;s operations or by a significant interruption in the supply of active pharmaceutical ingredients and other components.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Products developed by the Company require approval from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance the Company&#x2019;s product candidates will receive the necessary approvals. If the Company is denied approvals, approvals are delayed, or the Company is unable to maintain approvals received, such events could have a materially adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents consist of readily available cash in checking accounts, money market funds and commercial paper. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company invests excess cash in commercial paper, U.S. treasury bills and U.S. government sponsored entities, such as mortgage-backed securities. These investments are included in short-term investments on the balance sheet, classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Realized gains and losses on the sale of these securities are recognized in net loss.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The financial information is regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources. The Company&#x2019;s CODM is its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_7d54053a-642e-4e39-bfc6-b012d14346a8;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company&#x2019;s singular focus is on developing highly selective calcium release-activated calcium channel inhibitors to improve outcomes for patients with acute inflammatory indications. No significant revenue has been generated since inception, and all tangible assets are held in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company operates as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment focused on developing and commercializing innovative therapeutics primarily in the U.S. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the chief executive officer, who is the Company's CODM, in assessing segment performance and deciding how to allocate resources on a consolidated basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information about reported segment loss and significant segment expenses for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:15.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment research and development &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(a) (b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,607&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment general and administrative &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation (see Note 8)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense (see Note 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reconciliation of profit or loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustments and reconciling items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consolidated operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;a)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;840,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2,449,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;1,473,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;9,590,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;b)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;31,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Option&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As permitted under ASC 825, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has elected the fair value option to account for its convertible promissory notes due to certain embedded features within the notes. The Company recognizes the convertible promissory notes at fair value with changes in fair value recognized in the consolidated statements of operations located on the change in fair value of financial instruments line item. Changes in fair value as a result of the Company&#x2019;s own credit risk is reflected in other income in the consolidated statements of operations. As a result of applying the fair value option, direct costs and fees related to the convertible promissory notes were expensed as incurred and not deferred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases office space with an original lease term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;twelve months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and does &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t have a right-of-use asset or lease liability recorded. The Company's policy is not to record leases with an original term of twelve months or less on the consolidated balance sheets. The Company recognizes lease expense for this short-term lease on a straight-line basis over the term of the lease. The lease is accounted for under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and has been classified as an operating lease. Rent expense recognized for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;274,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs consist primarily of salaries, payroll taxes, employee benefits and stock-based compensation for those individuals involved in ongoing research and development efforts, as well as fees paid to consultants, external research fees, license fees paid to third parties for use of their intellectual property, laboratory supplies and development of compound materials, associated overhead expenses and facilities and depreciation costs. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. All research and development costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates preclinical studies and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on the Company&#x2019;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers,  and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. The estimates are trued up to reflect the best information available at the time of the financial statement issuance. Although the Company does not expect its estimates to be materially different from amounts actually incurred, the Company&#x2019;s estimate of the status and timing of services performed relative to the actual status and timing of services performed may vary.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;General and Administrative Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to executive, finance, business development, legal, human resources and support functions, including professional fees for auditing, tax, consulting and patent-related services, rent and utilities and insurance.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs related to filing and pursuing patent applications are expensed as incurred since recoverability of such expenditures is uncertain.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company capitalizes costs that are directly associated with equity financings until such financings are consummated, at which time such costs are recorded against the gross proceeds of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations and comprehensive loss. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had deferred costs associated with its ATM Facility (as defined in Note 7)  and expensed these costs in the Company&#x2019;s consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Private CalciMedica has issued various freestanding warrants to purchase shares of its convertible preferred stock. Prior to the Merger, Private CalciMedica adjusted the carrying value of such convertible preferred stock warrants to the estimated fair value at each reporting date, with any related increases or decreases in the fair value being recorded within other income (expense) in the consolidated statements of operations and comprehensive loss. Pursuant to the Merger Agreement, the Series C convertible preferred stock warrants became warrants to purchase shares of the combined company's common stock. As a result of the Merger, the warrants no longer meet the requirements for liability accounting and, as such, Private CalciMedica adjusted the value of the warrants to the estimated fair value as of the Merger date and reclassified them to stockholders' equity (deficit).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the 2024 Private Placement, certain warrants to purchase common stock were deemed freestanding warrants and are reflected in the Company&#x2019;s balance sheet as a liability as of and for the period ending December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense represents the cost of the grant date fair value of employee stock options recognized over the requisite service period of the awards (usually the vesting period) on a straight-line basis. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model (&#x201c;Black-Scholes&#x201d;). Forfeitures are recognized as a reduction of stock-based compensation expense as they occur. Equity-based compensation expense is classified in the statements of operations in the same manner in which the award recipients&#x2019; payroll costs are classified or in which the award recipients&#x2019; service payments are classified. The fair value of each stock option grant is estimated on the date of grant using Black Scholes. The following summarizes the inputs used:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the closing stock price the day prior to the grant date for the fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The risk-free interest ra&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;te is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities similar to the expected term of the awards.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Volatility&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses an average volatility for comparable publicly-traded biopharmaceutical companies over a period equal to the expected term of the stock award grant as CalciMedica does not yet have sufficient historical trading history for its own stock. CalciMedica will continue to apply this method until a sufficient amount of historical information over a period equal to the expected term of the stock-based awards becomes available.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Term&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company used the simplified method to calc&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ulate the expected term for all grants during all periods, which is based on the midpoint between the vesting date and the end of the contractual term.&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has never paid and has no present intention to pay cash dividends.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources which are excluded from net loss. The Company&#x2019;s only element of other comprehensive loss is unrealized gains and losses on marketable securities and short-term investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s board of directors reviews and approves transactions with directors, officers and holders of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or more of its voting securities and their affiliates, each a related party. The material facts as to the related party&#x2019;s relationship or interest in the transaction are disclosed to its board of directors prior to their consideration of such transaction, and the transaction is not considered approved by its board of directors unless a majority of the directors who are not interested in the transaction approve the transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Beginning in November 2020, Private CalciMedica has paid consulting fees monthly to a consulting firm affiliated with the Company&#x2019;s interim chief financial officer in connection with its consulting agreement. CalciMedica recorded expense &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;521,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;during years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2024, the Company granted a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to a consulting firm affiliated with the Company&#x2019;s interim chief financial officer. The Company recorded expense of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; general and administrative expense for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Net loss is equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. The Company calculates diluted net loss per share using the more dilutive of the (1) treasury stock method, if-converted method, or contingently issuable share method, as applicable, or (2) the two-class method. For warrants, the calculation of diluted net loss per share requires that, to the extent the average fair value of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to net loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the warrants for the period.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In all periods presented, the Company&#x2019;s outstanding preferred stock, stock options, preferred, common and convertible promissory note warrants, and outstanding convertible promissory notes were excluded from the calculation of loss per share because the effect would be antidilutive. Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per share.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt with Conversion and Other Options (Subtopic 470-20)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The ASU provides guidance that simplified the accounting for certain financial instruments with characteristics of liabilities and equity. The new guidance reduced the number of accounting models for convertible debt and convertible preferred stock instruments and made certain disclosure amendments intended to improve the information provided to users. The guidance also amended the derivative guidance for the &#x201c;own stock&#x201d; scope exception, which exempts qualifying instruments from being accounted for as derivatives if certain criteria are met. Finally, the standard changed the way certain convertible instruments are treated when calculating earnings per share. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this ASU as of January 1, 2024, which did not have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU 2023-07 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;entity&#x2019;s financial statements. The Company adopted the new accounting standard retrospectively for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements related disclosures, however, we have added additional footnote disclosure as part of the adoption.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued final guidance in ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (ASC 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; requiring entities to provide additional information in the rate reconciliation and disclosures about income taxes paid. For public business entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company has adopted this ASU No. 2023-09 effective December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; which requires public entities to disclose in the notes to financial statements, of additional specified information about certain costs and expenses. For public business entities, the guidance is effective for annual periods beginning after December 15, 2026 and interim periods after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact that this guidance will have on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_3f4ba1e7-f48c-466e-90c4-15a1f8b98a44">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Update (&#x201c;ASU&#x201d;), of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). The consolidated financial statements include the accounts of the Company for the year ended December 31, 2024 and the Company and CalciMedica Subsidiary, Inc. for the year ended December 31, 2023. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Since Private CalciMedica was determined to be the accounting acquirer in connection with the Merger, for periods prior to the Merger, the consolidated financial statements were prepared on a stand-alone basis for Private CalciMedica and did not include the combined entities activity or financial position. Subsequent to the Merger, the consolidated financial statements as of and for the year ended December 31, 2024 include Graybug&#x2019;s activity from March 21, 2023 through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and assets and liabilities at their acquisition date fair value. Historical share and per share figures of Private CalciMedica have been retroactively restated based on the merger exchange ratio of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0288&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ck0001534133:StockholdersEquityNoteStockSplitExchangeRatio
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="4"
      id="F_cfec8440-d48e-460c-8eee-3cc88eda589a"
      unitRef="U_pure">0.0288</ck0001534133:StockholdersEquityNoteStockSplitExchangeRatio>
    <us-gaap:UseOfEstimates
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c056a2b4-66df-48cd-aecf-9dc8328d6631">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the Company&#x2019;s consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#x2019;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#x2019;s consolidated financial statements relate to accruals for research and development expenses, valuation of warrants and valuation of equity awards. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1db503be-6514-4ec0-a1df-025f97e449f4">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of Credit Risk and other Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments, which potentially subject the Company to concentration of risk, consist principally of cash and cash equivalents. The Company&#x2019;s cash is deposited with major federally insured U.S. financial institutions. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is dependent on contract manufacturing organizations (&#x201c;CMO&#x201d;) to supply products for research and development of its product candidates, including preclinical and clinical studies, and for commercialization of its product candidates, if approved. The Company&#x2019;s development programs could be adversely affected by any significant interruption in CMO&#x2019;s operations or by a significant interruption in the supply of active pharmaceutical ingredients and other components.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Products developed by the Company require approval from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance the Company&#x2019;s product candidates will receive the necessary approvals. If the Company is denied approvals, approvals are delayed, or the Company is unable to maintain approvals received, such events could have a materially adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1fcb84ce-ea73-4862-a773-8e0bfe4f4604">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents consist of readily available cash in checking accounts, money market funds and commercial paper. The Company considers all highly liquid investments with an original maturity of three months or less from the date of purchase to be cash equivalents.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_29bc78c1-3c6c-4e13-a4dc-4c99c498190b">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-term Investments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company invests excess cash in commercial paper, U.S. treasury bills and U.S. government sponsored entities, such as mortgage-backed securities. These investments are included in short-term investments on the balance sheet, classified as available-for-sale and reported at fair value with unrealized gains and losses included in accumulated other comprehensive loss. Realized gains and losses on the sale of these securities are recognized in net loss.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c1186ffc-edc8-44ed-8a68-8af10ab27a0e">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The financial information is regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;), in deciding how to allocate resources. The Company&#x2019;s CODM is its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_7d54053a-642e-4e39-bfc6-b012d14346a8;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company&#x2019;s singular focus is on developing highly selective calcium release-activated calcium channel inhibitors to improve outcomes for patients with acute inflammatory indications. No significant revenue has been generated since inception, and all tangible assets are held in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company operates as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment focused on developing and commercializing innovative therapeutics primarily in the U.S. The accounting policies of the segment are the same as those described in the summary of significant accounting policies.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The determination of a single business segment is consistent with the consolidated financial information regularly reviewed by the chief executive officer, who is the Company's CODM, in assessing segment performance and deciding how to allocate resources on a consolidated basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information about reported segment loss and significant segment expenses for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:15.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment research and development &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(a) (b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,607&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment general and administrative &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation (see Note 8)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense (see Note 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reconciliation of profit or loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustments and reconciling items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consolidated operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;a)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;840,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2,449,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;1,473,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;9,590,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;b)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;31,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="INF"
      id="F_bc69329c-8094-48df-b8e2-07e413828634"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_d6ef33bb-2d17-4ffe-8971-47a9ca2a60fd">The CODM makes decisions on resource allocation, assesses performance of the business, and monitors budget versus actual results using income from operations. Net loss is also a measure that is considered in monitoring budget versus actual results. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_e53f569e-caff-4b4c-90ff-bc9ac756d331">
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:92.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:64.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:15.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.28%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment research and development &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(a) (b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,607&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Segment general and administrative &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(b)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation (see Note 8)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense (see Note 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reconciliation of profit or loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustments and reconciling items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consolidated operating loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,204&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;a)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;840,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2,449,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;1,473,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;9,590,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;b)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;31,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related to research and development and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;28,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"
      decimals="-3"
      id="F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"
      unitRef="U_USD">13607000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821"
      decimals="-3"
      id="F_12d5696b-58c6-49ec-90f5-83f181092884"
      unitRef="U_USD">13380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"
      decimals="-3"
      id="F_1b6e4946-31e1-4a92-b886-3a04ed5d247c"
      unitRef="U_USD">8226000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821"
      decimals="-3"
      id="F_f4539e24-1082-434c-9e72-eaee54ca8723"
      unitRef="U_USD">12598000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"
      decimals="-3"
      id="F_900a088c-90d0-4fa7-9946-33f2f64eb734"
      unitRef="U_USD">-2313000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821"
      decimals="-3"
      id="F_a2b68cdb-9968-4cc9-81c7-094e460c0288"
      unitRef="U_USD">-12039000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"
      decimals="-3"
      id="F_3a898c4b-f83f-41aa-a3d3-e95de775339c"
      unitRef="U_USD">58000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821"
      decimals="-3"
      id="F_84c7e58a-3b31-4127-895b-9107a92725c6"
      unitRef="U_USD">58000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_dbe96887-2004-4bbd-8983-4028ca3f98b2"
      decimals="-3"
      id="F_0399a133-4504-4e88-9092-c3f9948181d8"
      unitRef="U_USD">-24204000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_21b81df1-47cd-44ce-92dc-0822f330b821"
      decimals="-3"
      id="F_edfa38ff-03d2-4eb5-b5b0-037244bd661a"
      unitRef="U_USD">-38075000</us-gaap:OperatingIncomeLoss>
    <ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_b7ccc669-f654-458d-a0f2-289a41002e40"
      unitRef="U_USD">0</ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems>
    <ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_bb3d3464-8fb5-4292-8d52-98b52114b851"
      unitRef="U_USD">0</ck0001534133:SegmentReportingAdjustmentsAndReconcilingItems>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_923d0e8a-4536-48e3-ad8f-8f14b82a1e59"
      unitRef="U_USD">-24204000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_c0bfd697-a23f-4f40-a755-01a356d4479f"
      unitRef="U_USD">-38075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672"
      decimals="0"
      id="F_22f46de0-f902-47fc-a7d4-88e4ede9d65c"
      unitRef="U_USD">840000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c"
      decimals="0"
      id="F_6216c01a-e8a1-4e68-9003-d0114c262167"
      unitRef="U_USD">2449000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_050c9307-b322-43a4-84b0-69234ed20231"
      decimals="0"
      id="F_06c4905f-6ecf-4015-a44b-cc521fa0b8f2"
      unitRef="U_USD">1473000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317"
      decimals="0"
      id="F_d70ca794-eb9b-4647-8264-b81f2c1ab8c2"
      unitRef="U_USD">9590000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:Depreciation
      contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672"
      decimals="0"
      id="F_2fd6a4a4-a295-4880-a150-6dfbf8079180"
      unitRef="U_USD">31000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c"
      decimals="0"
      id="F_f993458c-05fe-4e7b-9c0d-a5061c51285c"
      unitRef="U_USD">29000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_050c9307-b322-43a4-84b0-69234ed20231"
      decimals="0"
      id="F_83626ab2-01f4-4cf4-8b62-894e02c69bf2"
      unitRef="U_USD">28000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317"
      decimals="0"
      id="F_3253d41d-5d1a-4511-9df1-97ea76caf24c"
      unitRef="U_USD">28000</us-gaap:Depreciation>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_2ec16e52-ea49-4ddc-bbb5-c98d0188e7be">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Option&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As permitted under ASC 825, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has elected the fair value option to account for its convertible promissory notes due to certain embedded features within the notes. The Company recognizes the convertible promissory notes at fair value with changes in fair value recognized in the consolidated statements of operations located on the change in fair value of financial instruments line item. Changes in fair value as a result of the Company&#x2019;s own credit risk is reflected in other income in the consolidated statements of operations. As a result of applying the fair value option, direct costs and fees related to the convertible promissory notes were expensed as incurred and not deferred.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_014b0caf-8f27-41e5-b14a-573030524f8b">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases office space with an original lease term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;twelve months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and does &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t have a right-of-use asset or lease liability recorded. The Company's policy is not to record leases with an original term of twelve months or less on the consolidated balance sheets. The Company recognizes lease expense for this short-term lease on a straight-line basis over the term of the lease. The lease is accounted for under ASC 842, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and has been classified as an operating lease. Rent expense recognized for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;274,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      id="F_752675e8-6438-4930-b549-fad199a5f1b4">P12M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <ck0001534133:RightOfUseAssetOrLeaseLiability
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_3a743cec-b32d-4ae0-9791-a0938653f9a1"
      unitRef="U_USD">0</ck0001534133:RightOfUseAssetOrLeaseLiability>
    <ck0001534133:RentExpenses
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_13e0604b-af60-4f2e-a083-f21cb33caa75"
      unitRef="U_USD">121000</ck0001534133:RentExpenses>
    <ck0001534133:RentExpenses
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_23167040-4ff6-48ea-9555-1ca557f8b1bf"
      unitRef="U_USD">274000</ck0001534133:RentExpenses>
    <ck0001534133:AccruedResearchAndDevelopmentCostsPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_f9ad4022-2a33-4c59-a4d1-0ada427b60a9">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs consist primarily of salaries, payroll taxes, employee benefits and stock-based compensation for those individuals involved in ongoing research and development efforts, as well as fees paid to consultants, external research fees, license fees paid to third parties for use of their intellectual property, laboratory supplies and development of compound materials, associated overhead expenses and facilities and depreciation costs. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. All research and development costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company estimates preclinical studies and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on the Company&#x2019;s behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of effort to be expended in each period. These estimates are based on communications with the third-party service providers,  and on information available at each balance sheet date. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. The estimates are trued up to reflect the best information available at the time of the financial statement issuance. Although the Company does not expect its estimates to be materially different from amounts actually incurred, the Company&#x2019;s estimate of the status and timing of services performed relative to the actual status and timing of services performed may vary.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</ck0001534133:AccruedResearchAndDevelopmentCostsPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_d449fdf7-9f1f-4d87-b0f9-dea642dac8f4">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;General and Administrative Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to executive, finance, business development, legal, human resources and support functions, including professional fees for auditing, tax, consulting and patent-related services, rent and utilities and insurance.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <ck0001534133:PatentsCostsPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_fc37adaa-3123-4a79-8951-13fb3cf6f60b">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs related to filing and pursuing patent applications are expensed as incurred since recoverability of such expenditures is uncertain.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</ck0001534133:PatentsCostsPolicyTextBlock>
    <us-gaap:DeferredPolicyAcquisitionCostsTextBlock1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_788661e8-d344-4ff1-aaf3-f2f5f2d53fdb">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company capitalizes costs that are directly associated with equity financings until such financings are consummated, at which time such costs are recorded against the gross proceeds of the offering. Should an in-process equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations and comprehensive loss. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had deferred costs associated with its ATM Facility (as defined in Note 7)  and expensed these costs in the Company&#x2019;s consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredPolicyAcquisitionCostsTextBlock1>
    <ck0001534133:WarrantLiabilityPolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_78e4c56c-02d0-4e1c-8a0f-a46e831090d4">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Private CalciMedica has issued various freestanding warrants to purchase shares of its convertible preferred stock. Prior to the Merger, Private CalciMedica adjusted the carrying value of such convertible preferred stock warrants to the estimated fair value at each reporting date, with any related increases or decreases in the fair value being recorded within other income (expense) in the consolidated statements of operations and comprehensive loss. Pursuant to the Merger Agreement, the Series C convertible preferred stock warrants became warrants to purchase shares of the combined company's common stock. As a result of the Merger, the warrants no longer meet the requirements for liability accounting and, as such, Private CalciMedica adjusted the value of the warrants to the estimated fair value as of the Merger date and reclassified them to stockholders' equity (deficit).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the 2024 Private Placement, certain warrants to purchase common stock were deemed freestanding warrants and are reflected in the Company&#x2019;s balance sheet as a liability as of and for the period ending December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</ck0001534133:WarrantLiabilityPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_cf67fea0-c92a-47f1-b8a8-bddf44f5f0ea">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense represents the cost of the grant date fair value of employee stock options recognized over the requisite service period of the awards (usually the vesting period) on a straight-line basis. The Company estimates the fair value of stock option grants using the Black-Scholes option pricing model (&#x201c;Black-Scholes&#x201d;). Forfeitures are recognized as a reduction of stock-based compensation expense as they occur. Equity-based compensation expense is classified in the statements of operations in the same manner in which the award recipients&#x2019; payroll costs are classified or in which the award recipients&#x2019; service payments are classified. The fair value of each stock option grant is estimated on the date of grant using Black Scholes. The following summarizes the inputs used:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the closing stock price the day prior to the grant date for the fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The risk-free interest ra&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;te is based on the U.S. Treasury yield in effect at the time of grant for zero coupon U.S. Treasury notes with maturities similar to the expected term of the awards.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Volatility&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses an average volatility for comparable publicly-traded biopharmaceutical companies over a period equal to the expected term of the stock award grant as CalciMedica does not yet have sufficient historical trading history for its own stock. CalciMedica will continue to apply this method until a sufficient amount of historical information over a period equal to the expected term of the stock-based awards becomes available.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Term&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company used the simplified method to calc&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ulate the expected term for all grants during all periods, which is based on the midpoint between the vesting date and the end of the contractual term.&lt;/span&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Dividend Yield&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has never paid and has no present intention to pay cash dividends.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_6e50f19c-535d-460e-88ce-bdb05449d34e">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes net deferred tax assets to the extent that the Company believes these assets are more likely than not to be realized. In making such a determination, management considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If management determines that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, management would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) management determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, management recognizes the largest amount of tax benefit that is more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% likely to be realized upon ultimate settlement with the related tax authority. The Company recognizes interest and penalties related to unrecognized tax benefits within income tax expense. Any accrued interest and penalties are included within the related tax liability.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <ck0001534133:TaxPostionMinimumPercentageOfTaxBenefit
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_c35665eb-09e0-4f2f-933b-781503b1c420"
      unitRef="U_pure">0.50</ck0001534133:TaxPostionMinimumPercentageOfTaxBenefit>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_ba31fcd2-4ddc-41ed-b7d5-e4e741b43ce7">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources which are excluded from net loss. The Company&#x2019;s only element of other comprehensive loss is unrealized gains and losses on marketable securities and short-term investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <ck0001534133:RelatedPartyTransactionsPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_f6ec1ffc-8af8-471c-83f2-fd745f8e0e58">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s board of directors reviews and approves transactions with directors, officers and holders of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or more of its voting securities and their affiliates, each a related party. The material facts as to the related party&#x2019;s relationship or interest in the transaction are disclosed to its board of directors prior to their consideration of such transaction, and the transaction is not considered approved by its board of directors unless a majority of the directors who are not interested in the transaction approve the transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Beginning in November 2020, Private CalciMedica has paid consulting fees monthly to a consulting firm affiliated with the Company&#x2019;s interim chief financial officer in connection with its consulting agreement. CalciMedica recorded expense &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;521,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;during years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2024, the Company granted a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to a consulting firm affiliated with the Company&#x2019;s interim chief financial officer. The Company recorded expense of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; general and administrative expense for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</ck0001534133:RelatedPartyTransactionsPolicyTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_36ba18a4-78f3-485b-8253-a12f296d6103"
      unitRef="U_pure">0.05</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="C_f20344e5-6e5f-49aa-9b9f-b8ff66728e89"
      decimals="0"
      id="F_1fbea5b7-a156-4353-a927-94ecf611cb6c"
      unitRef="U_USD">289000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="C_9148156f-8f5b-4f26-a742-6ef0c92f952d"
      decimals="0"
      id="F_739a3934-1696-41c2-81eb-c4ea559d3192"
      unitRef="U_USD">521000</us-gaap:CostsAndExpensesRelatedParty>
    <ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
      contextRef="C_5628ed6b-5082-4559-afdb-16e2688469bc"
      decimals="0"
      id="F_37c9ca0b-fbed-47af-8ab3-fe0ec759fa60"
      unitRef="U_shares">10000</ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants>
    <ck0001534133:CompanyRecordedExpense
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_1521e2cb-319d-441d-a42f-b7dbd3335a34"
      unitRef="U_USD">13000</ck0001534133:CompanyRecordedExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_d3819c96-66ff-466c-afd4-b99169955dcc">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Net loss is equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of shares of common stock outstanding during the period. The Company calculates diluted net loss per share using the more dilutive of the (1) treasury stock method, if-converted method, or contingently issuable share method, as applicable, or (2) the two-class method. For warrants, the calculation of diluted net loss per share requires that, to the extent the average fair value of the underlying shares for the reporting period exceeds the exercise price of the warrants and the presumed exercise of such securities are dilutive to net loss per share for the period, adjustments to net loss used in the calculation are required to remove the change in fair value of the warrants for the period.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In all periods presented, the Company&#x2019;s outstanding preferred stock, stock options, preferred, common and convertible promissory note warrants, and outstanding convertible promissory notes were excluded from the calculation of loss per share because the effect would be antidilutive. Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per share.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_96f818c8-df31-4cde-bd0d-c2d5b5730ec2">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt with Conversion and Other Options (Subtopic 470-20)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The ASU provides guidance that simplified the accounting for certain financial instruments with characteristics of liabilities and equity. The new guidance reduced the number of accounting models for convertible debt and convertible preferred stock instruments and made certain disclosure amendments intended to improve the information provided to users. The guidance also amended the derivative guidance for the &#x201c;own stock&#x201d; scope exception, which exempts qualifying instruments from being accounted for as derivatives if certain criteria are met. Finally, the standard changed the way certain convertible instruments are treated when calculating earnings per share. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted this ASU as of January 1, 2024, which did not have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU 2023-07 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. This guidance expands public entities&#x2019; segment disclosures primarily by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment&#x2019;s profit or loss and assets. The amendments are required to be applied retrospectively to all prior periods presented in an&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;entity&#x2019;s financial statements. The Company adopted the new accounting standard retrospectively for the fiscal year 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial statements related disclosures, however, we have added additional footnote disclosure as part of the adoption.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued final guidance in ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (ASC 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; requiring entities to provide additional information in the rate reconciliation and disclosures about income taxes paid. For public business entities, the guidance is effective for annual periods beginning after December 15, 2024. The Company has adopted this ASU No. 2023-09 effective December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; which requires public entities to disclose in the notes to financial statements, of additional specified information about certain costs and expenses. For public business entities, the guidance is effective for annual periods beginning after December 15, 2026 and interim periods after December 15, 2027, with early adoption permitted. The Company is currently assessing the impact that this guidance will have on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_7d1ce435-6f45-42ae-a645-ed9b8ef639ef">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3. Merger and Related Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As described in Note 1 - Nature of Business, Private CalciMedica merged with a wholly-owned subsidiary of Graybug on March 20, 2023. The Merger was accounted for as a reverse recapitalization under U.S. GAAP. Private CalciMedica was considered the accounting acquirer for financial reporting purposes. This determination is based on the facts that, immediately following the Merger: (i) former Private CalciMedica stockholders owned a substantial majority of the voting rights of the combined company; Private CalciMedica designated a majority (five of seven) of the initial members of the board of directors of the combined company; and former Private CalciMedica's senior management held all key positions in senior management of the combined company. The transaction is accounted for as a reverse recapitalization of Graybug by Private CalciMedica similar to the issuance of equity for the net assets of Graybug, which are primarily cash and cash equivalents, short-term investments and other non-operating assets. It was concluded that any in-process research and development assets that remained as of the Merger would be de minimis when compared to the cash, cash equivalents and short-term investments obtained through the Merger.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under reverse recapitalization accounting, the assets and liabilities of Graybug were recorded at their fair value, which approximated book value due to the short-term nature of the instruments. The Company's consolidated financial statements reflect the issuance of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,571,433&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares to the former stockholders of Graybug.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding share of Private CalciMedica capital stock (after giving effect to the automatic conversion of all shares of Private CalciMedica preferred stock into shares of Private CalciMedica common stock, the automatic exercise of certain Private CalciMedica warrants to purchase shares of Private CalciMedica common stock in accordance with their terms (the &#x201c;Private CalciMedica warrant exercises&#x201d;), the conversion of Private CalciMedica convertible promissory notes into Private CalciMedica common stock and the closing of the 2023 Private Placement (as defined and discussed in Note 7 - Convertible Preferred Stock, Common Stock, and Stockholders' Equity (Deficit)), was converted into the right to receive &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0288&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug common stock, which resulted in the issuance by Graybug of an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,946,540&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug common stock to the stockholders of Private CalciMedica in a transaction exempt from registration under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), in reliance on Section 4(a)(2) of the Securities Act and the rules promulgated thereunder. In addition, Graybug assumed the Private CalciMedica 2006 Stock Plan (See Note 8 - Stock-Based Compensation), and each outstanding and unexercised option to purchase Private CalciMedica common stock and each outstanding and unexercised warrant to purchase Private CalciMedica common stock (excluding the warrants which were automatically exercised pursuant to the Private CalciMedica warrant exercises) became options and warrants, respectively, to purchase shares of Graybug common stock. Immediately following the consummation of the Merger prior Private CalciMedica and Graybug stockholders collectively own approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Company, respectively, on a fully diluted basis.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the reverse recapitalization, Private CalciMedica received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of cash, cash equivalents and short-term investments, net of transaction costs.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Private CalciMedica also obtained prepaid and other current assets of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and assumed payables and accrued expenses of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Private CalciMedica also incurred transaction costs of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is recorded as a reduction to additional paid-in capital in the accompanying consolidated statement of convertible preferred stock and stockholders' equity (deficit). The Company also recorded one-time charges of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the acceleration of the Graybug stock awards and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in severance charges that are recorded in the consolidated statements of operations and comprehensive loss for the for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 17, 2023, in connection with the transactions contemplated by the Merger Agreement and following a special meeting of Graybug&#x2019;s stockholders, Graybug filed an Amended and Restated Certificate of Incorporation effecting a reverse stock split of Graybug&#x2019;s common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, at a ratio of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:1.&lt;/span&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_23e9b7c7-df34-4cf7-85aa-9468c513006d"
      decimals="INF"
      id="F_f6bbcb61-f58d-4d07-8ba3-138f8db295d4"
      unitRef="U_shares">1571433</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <ck0001534133:StockIssuedDuringPeriodPrivatePlacement
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="4"
      id="F_2bb32946-9a59-4f61-918e-5bdc3d187f76"
      unitRef="U_shares">0.0288</ck0001534133:StockIssuedDuringPeriodPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="INF"
      id="F_fd000c85-d6a4-4a1c-85ac-20835be69799"
      unitRef="U_shares">3946540</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_9114dadf-db78-4d1a-9686-04c4b1e69723"
      decimals="2"
      id="F_c7c94cfc-b1e1-4738-aeb8-30a79311908b"
      unitRef="U_pure">0.72</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_29a301bb-4522-43d7-947b-4686e790d21a"
      decimals="2"
      id="F_0f236f96-2d39-4a3e-92a9-fbc4b688bff2"
      unitRef="U_pure">0.28</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_da498a4e-d2d5-42c0-8591-35c817ca561b"
      unitRef="U_USD">29400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_c13d0b7d-584d-4506-a54e-ad5d7daf2b35"
      unitRef="U_USD">2100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_0e52c6a1-723d-4381-9475-4402be59a606"
      unitRef="U_USD">2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <ck0001534133:BusinessCombinationConsiderationTransferedCostIncurred
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_eeec1eff-3a64-41b2-a3b7-2ce72391857a"
      unitRef="U_USD">4600000</ck0001534133:BusinessCombinationConsiderationTransferedCostIncurred>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_c5227faf-c4ef-4cc6-8803-f2653a417248"
      unitRef="U_USD">10500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:SeveranceCosts1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-5"
      id="F_7738726a-bacf-45a5-93e6-a93ff29e97c1"
      unitRef="U_USD">5700000</us-gaap:SeveranceCosts1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_db94281f-2ca5-41c5-a7e1-183957513bcf"
      decimals="4"
      id="F_8f7aa96e-665c-462b-a5ec-bf41115e2c9e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_ed61293c-a493-4af6-9c31-23d8600a5a0a"
      decimals="0"
      id="F_1fb3e159-3cb1-4d2f-8ea7-11f3a50acc33"
      unitRef="U_pure">14</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_eeb44080-2132-4dd3-97fc-e5b80e2deee7">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's assets and liabilities which are measured at fair value include short-term investments and warrants for common stock. The Warrants for preferred stock (&#x201c;Preferred Warrants&#x201d;) and warrants for common stock related to the convertible promissory notes (&#x201c;Convertible Promissory Note Warrants&#x201d;) were all accounted for at fair value prior to the Merger (see Note 7 -&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Preferred Stock, Common Stock and Stockholders&#x2019; Equity). All assets and liabilities recorded at fair value are revalued at each measurement period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Common Warrants (as defined in Note 7 below) were valued using Black-Scholes utilizing the following inputs; (i) a risk-free interest rate; (ii) volatility based on the expected term of the Common Warrant; (iii) and an exercise price and stock price on the date of the transaction. Several different scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the Common Warrants can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following three levels:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 1:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 2:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 3:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.222%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.353%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.112%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.362000000000002%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.918000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.918000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage-backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are highly liquid investments which are actively traded. The pricing information on the Company&#x2019;s money market funds is based on quoted prices in active markets for identical securities. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Commercial paper and U.S. Government sponsored entities - mortgage-backed are classified as Level 2 with in the hierarchy and are carried at fair value with unrealized gains and losses included in other comprehensive income (loss) as a component of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;stockholders&#x2019; equity until realized. The Company estimates the fair values of these securities by taking into consideration valuations obtained from third-party pricing sources.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, there were no transfers between Level 1, Level 2 and Level 3.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; fair value liabilities existed as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Initial Fair Value of Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeiture of warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in Fair Value of Preferred Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company&#x2019;s financial assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage-backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Government sponsored entities - mortgage backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2023, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. The Company had short-term investments in unrealized gain positions as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_4e55e61d-ef2c-406c-8dc4-0bedc5f4991b">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.333%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.222%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:43.353%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.112%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.362000000000002%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.918000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.918000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.334%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage-backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_95022a81-928c-45a6-b8a7-62e7dea3a945"
      decimals="-3"
      id="F_eabe1860-9603-4c96-a5f1-fcaef3a5d06c"
      unitRef="U_USD">6117000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_5dde241e-162e-4824-aff5-4a7186f81373"
      decimals="-3"
      id="F_a34f50b8-a931-48b4-91f6-bfb3ae8a57d3"
      unitRef="U_USD">6117000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80"
      decimals="-3"
      id="F_a03a5a31-90d7-40ae-80fa-9fbedc95b9fb"
      unitRef="U_USD">746000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_b204b444-02a9-4a57-97f1-861675088d01"
      decimals="-3"
      id="F_ad239a8b-18a8-4c7d-aa2c-9e2732dfacd9"
      unitRef="U_USD">746000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b"
      decimals="-3"
      id="F_ed6a502e-57ab-4062-b097-9ea69fabf489"
      unitRef="U_USD">749000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5"
      decimals="-3"
      id="F_6274af48-cc90-4410-a232-9a1db3667a75"
      unitRef="U_USD">749000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb"
      decimals="-3"
      id="F_c87b141e-0c79-4070-ac30-28d8aae17ba2"
      unitRef="U_USD">6117000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1"
      decimals="-3"
      id="F_f002ef05-3f2b-496d-9188-678d943cb263"
      unitRef="U_USD">1495000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_88765192-4128-4cf7-8b90-47ad987844f4"
      unitRef="U_USD">7612000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_a0aa7580-7a81-499e-bdfa-3d3ea4de5a80"
      decimals="-3"
      id="F_6723b0c9-e014-4446-8429-bc4cdd41eddc"
      unitRef="U_USD">6573000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_b204b444-02a9-4a57-97f1-861675088d01"
      decimals="-3"
      id="F_7f06f063-99d0-42a1-a49e-779db3d36657"
      unitRef="U_USD">6573000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_b1179138-e4ef-4eb7-a6c7-840ec680dc7b"
      decimals="-3"
      id="F_d606eb88-1aa2-4a01-bde4-2c78d3ee4ec7"
      unitRef="U_USD">3227000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_9c472ad2-0b36-4cba-b1d5-e15c9bb82fd5"
      decimals="-3"
      id="F_e2a3a92f-5ce6-4949-87b0-a7a1bf4ae397"
      unitRef="U_USD">3227000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_045dcafc-a4b7-4b72-a786-a17062bc9899"
      decimals="-3"
      id="F_0a5e922f-f949-4a1e-b448-3feacf621ac1"
      unitRef="U_USD">934000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_e44a92b5-7664-4c8b-9ed0-b69338c26422"
      decimals="-3"
      id="F_19c610b8-6530-4748-adcb-581c9300edc8"
      unitRef="U_USD">934000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1"
      decimals="-3"
      id="F_f490a684-0437-4be3-a2b1-e60b572fe807"
      unitRef="U_USD">10734000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_c3f73468-cf4e-4346-8b94-21eacbb6941b"
      unitRef="U_USD">10734000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f626a51f-07ff-4e3e-a4dc-92ef5bea52fb"
      decimals="-3"
      id="F_bd626d1e-a1d3-4790-9e77-0b83d57d95cf"
      unitRef="U_USD">6117000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7c3efb00-1230-4736-ad23-faf73bdf57a1"
      decimals="-3"
      id="F_54259a47-24c9-4e90-9c74-4d2d33984b8b"
      unitRef="U_USD">12229000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_aab7862a-505f-4e2b-a1f4-79cb07e2bd01"
      unitRef="U_USD">18346000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_bdbc227c-2a4a-4d04-b7f6-a194d9ac93f1"
      decimals="-3"
      id="F_1364a00c-b1aa-46d6-a772-9536db16d6c3"
      unitRef="U_USD">3634000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f113b0a6-620c-4aff-a136-ac77a52a078b"
      decimals="-3"
      id="F_36f83854-bc1c-4eb0-b619-c3281d2ab4dd"
      unitRef="U_USD">3634000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_09ae4982-7ccd-472c-a057-58036e311ec9"
      decimals="-3"
      id="F_a1ad1548-675a-457a-8021-0b57df331bf4"
      unitRef="U_USD">1738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_8b167b7a-8a24-4ea0-afb0-63b670541fba"
      decimals="-3"
      id="F_a3884f7a-85d8-4e4b-9b5c-b97901417095"
      unitRef="U_USD">1738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_bef37a75-2e84-42ae-986f-82da4e7d2f72"
      decimals="-3"
      id="F_2070b4f6-3a0b-4261-9fa7-82dec76aac86"
      unitRef="U_USD">3634000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9"
      decimals="-3"
      id="F_0da2e116-05db-4b8d-a45d-d187e53b642c"
      unitRef="U_USD">1738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_62887960-7f79-4fc2-b366-38dcdf18a259"
      unitRef="U_USD">5372000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_09ae4982-7ccd-472c-a057-58036e311ec9"
      decimals="-3"
      id="F_92f35f79-386a-48ac-9dde-d9666fd87c13"
      unitRef="U_USD">5213000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_8b167b7a-8a24-4ea0-afb0-63b670541fba"
      decimals="-3"
      id="F_9452b77b-055d-45a8-b5a9-adb1e08b97f9"
      unitRef="U_USD">5213000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_a170fca3-5c49-41df-8bf6-368143137572"
      decimals="-3"
      id="F_ad79f8be-1709-496d-9474-efa806983597"
      unitRef="U_USD">495000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_eee5683f-33b3-4fbc-8cb5-42b8e91c1adb"
      decimals="-3"
      id="F_6f7e1250-a936-4815-9b30-7829d20b460d"
      unitRef="U_USD">495000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9"
      decimals="-3"
      id="F_7315b82b-c678-4224-bbe6-4ac81967a90f"
      unitRef="U_USD">5708000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_ee6fc64d-dbd8-47c9-a51a-f206e1d4935b"
      unitRef="U_USD">5708000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_bef37a75-2e84-42ae-986f-82da4e7d2f72"
      decimals="-3"
      id="F_3c62347e-fe7a-4100-a29b-7097dc5a07e9"
      unitRef="U_USD">3634000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_15e96634-9a83-4453-90fd-00b4f16e88b9"
      decimals="-3"
      id="F_f4b87217-3326-4670-a57c-bb9b7f197042"
      unitRef="U_USD">7446000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_a7c05211-2f0a-45cb-a376-4ac04555ea86"
      unitRef="U_USD">11080000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_c4c9215d-494d-4c49-9611-ee223ffc9c1e"
      decimals="-3"
      id="F_47fdd395-c613-4578-8043-d8d5fa5a815a"
      unitRef="U_USD">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_a67be958-f1a5-440f-a088-2296882808da"
      decimals="-3"
      id="F_09b0e14d-9124-435d-b072-0e57ba57175c"
      unitRef="U_USD">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_373a9e72-7343-4090-b130-badbbfa67767"
      decimals="-3"
      id="F_49564718-4baf-4fb0-bc6d-c73d7048598c"
      unitRef="U_USD">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_525fa771-249a-48de-ade1-dbd441ab95d9"
      unitRef="U_USD">1700000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_be150b6d-dcc6-49cc-b714-e2db9ca64299"
      unitRef="U_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_c2962d35-1cc6-4942-8080-aa599dfee8da">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;&#160;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Initial Fair Value of Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeiture of warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in Fair Value of Preferred Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,290&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_eb167185-a0eb-45f5-beb2-ad40dbc114b5"
      decimals="-3"
      id="F_ecb61a1f-4088-4ac8-a56d-c141bd912522"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc"
      decimals="-3"
      id="F_f0cdd5dd-6d4c-4cb7-9547-df6e7853a304"
      unitRef="U_USD">11190000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <ck0001534133:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants
      contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc"
      decimals="-3"
      id="F_1d263b10-3137-4e1b-bf8f-92044f00b0bf"
      unitRef="U_USD">-200000</ck0001534133:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisForfeitureOfWarrants>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="C_b73cefba-244b-4823-bb60-351dd5a123bc"
      decimals="-3"
      id="F_809e2714-5f6f-4dcb-a46b-473f330f061f"
      unitRef="U_USD">-9290000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_b775c5ab-ecf3-4dc4-bd12-7d3ef78e0d1d"
      decimals="-3"
      id="F_658c3308-b49c-49b2-b182-60284155a91d"
      unitRef="U_USD">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1b85e83c-fbaa-4811-a5e3-6850a4aff5d9">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company&#x2019;s financial assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. Government sponsored entities - mortgage-backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,372&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,213&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S Government sponsored entities - mortgage backed securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,708&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_83845047-b7fc-4928-ac21-ffa4a320df4c"
      decimals="-3"
      id="F_d93ab6f8-7996-4dd9-88b8-e310059a742d"
      unitRef="U_USD">6117000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_83845047-b7fc-4928-ac21-ffa4a320df4c"
      decimals="-3"
      id="F_25503905-f5ba-4d56-b372-342831979e95"
      unitRef="U_USD">6117000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862"
      decimals="-3"
      id="F_56b64c22-3f83-4bba-a48c-8f2436ebf60f"
      unitRef="U_USD">746000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862"
      decimals="-3"
      id="F_664aa5a7-01f9-4baf-a864-bf00e53d6ede"
      unitRef="U_USD">746000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"
      decimals="-3"
      id="F_a46fca70-6529-468d-8f72-d26ef6ca9772"
      unitRef="U_USD">749000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"
      decimals="-3"
      id="F_f61bab1c-99f2-43fd-8247-faa138e64646"
      unitRef="U_USD">749000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_a886c813-1810-4171-9b00-6b062be2eb33"
      unitRef="U_USD">7612000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_a7c503bd-065a-4b89-a7fe-ed8c96efd34b"
      unitRef="U_USD">7612000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862"
      decimals="-3"
      id="F_12d0dd18-015e-44f9-acfb-f773ab1e02ae"
      unitRef="U_USD">6571000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862"
      decimals="-3"
      id="F_91c25b84-e086-4eb5-b5d3-624436782021"
      unitRef="U_USD">2000</ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_a121b500-f9d5-4d26-a4b4-8bb964013862"
      decimals="-3"
      id="F_b7fb2b07-2582-4bcb-abb9-1a582f770404"
      unitRef="U_USD">6573000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"
      decimals="-3"
      id="F_757226db-4675-4e72-9299-0da9fe1d15c1"
      unitRef="U_USD">3225000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"
      decimals="-3"
      id="F_ff18c037-0980-46b1-a705-b158e8be2481"
      unitRef="U_USD">2000</ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_b19e298f-7e19-4ea9-8404-5d1aad6cc07c"
      decimals="-3"
      id="F_651c73ba-d186-4d7c-8060-e6230e789019"
      unitRef="U_USD">3227000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_95e6491a-8251-490e-bafc-9db3d1602a4a"
      decimals="-3"
      id="F_c8bcefa3-a183-445f-874a-35c33c2fdb2d"
      unitRef="U_USD">934000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_95e6491a-8251-490e-bafc-9db3d1602a4a"
      decimals="-3"
      id="F_81201ad3-6f70-41d1-bd9d-0f0cee3023c8"
      unitRef="U_USD">934000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_eac12908-317f-46f6-84e8-9d04d7ee5be7"
      unitRef="U_USD">10730000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_b05d990a-557f-4ad4-a7ba-535569798ca8"
      unitRef="U_USD">4000</ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_47848bc5-e238-43d2-81f5-05012cd3da33"
      unitRef="U_USD">10734000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_017f856d-7912-4630-adb9-61d3d5bc33d9"
      unitRef="U_USD">18342000</ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_314a446d-861d-4b80-959b-3fdb56539dca"
      unitRef="U_USD">4000</ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c3c70a9c-c54b-4c3b-b8f3-8af241795cf3"
      decimals="-3"
      id="F_17b59a26-1a1d-4ac6-8a17-f3f02d624c66"
      unitRef="U_USD">18346000</us-gaap:AssetsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433"
      decimals="-3"
      id="F_882fe99a-1235-4bf4-bd78-227020f404e5"
      unitRef="U_USD">3634000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_0fa45ba0-8dbf-4a9f-850e-6676ef753433"
      decimals="-3"
      id="F_111fba95-839e-47bf-b7dc-91e6b1b07615"
      unitRef="U_USD">3634000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"
      decimals="-3"
      id="F_8823006e-3e52-4af5-8636-6c2699a37ce7"
      unitRef="U_USD">1738000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"
      decimals="-3"
      id="F_f535a734-5d03-41f1-ac15-e77dd0c370eb"
      unitRef="U_USD">1738000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_8a3eadb5-35b3-47e0-92b1-70a5514165d1"
      unitRef="U_USD">5372000</ck0001534133:CashAndCashEquivalentsFairValueDisclosureAmortizedCostBasis>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_7628beab-9965-438e-84c6-d704bcf0449c"
      unitRef="U_USD">5372000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"
      decimals="-3"
      id="F_eb34a8ce-56fd-4a30-bc6b-28f0d959ebe4"
      unitRef="U_USD">5211000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"
      decimals="-3"
      id="F_ba26be3e-8921-48bc-b2af-e787ba0156b5"
      unitRef="U_USD">2000</ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_eab3e6b6-ab5e-4bfc-86da-c432345e81f7"
      decimals="-3"
      id="F_41d6940d-ed76-4d93-91c6-675d62be5e6e"
      unitRef="U_USD">5213000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_46095950-bb43-4840-adef-994b8db12bbd"
      decimals="-3"
      id="F_64b1faf4-91c7-40e3-a58d-a75c19fcf8c4"
      unitRef="U_USD">495000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_46095950-bb43-4840-adef-994b8db12bbd"
      decimals="-3"
      id="F_0d5dc049-12c6-4b97-b0b6-53c14b86ef10"
      unitRef="U_USD">495000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_3d875628-3c0c-46de-8a6e-6335c973b512"
      unitRef="U_USD">5706000</ck0001534133:ShortTermInvestmentFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_5c28bac7-fde0-4752-afd8-f5b659d6c544"
      unitRef="U_USD">2000</ck0001534133:ShortTermInvestmentFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <ck0001534133:ShortTermInvestmentFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_2674389a-ad81-4b28-a70a-7f77d37e46f1"
      unitRef="U_USD">5708000</ck0001534133:ShortTermInvestmentFairValueDisclosure>
    <ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_75f63048-1a11-4886-a257-df2d7a72b193"
      unitRef="U_USD">11078000</ck0001534133:AssetsFairValueDisclosureAmortizedCostBasis>
    <ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_5c664052-9022-4a71-be7b-63b4993c5ec7"
      unitRef="U_USD">2000</ck0001534133:AssetsFairValueDisclosureAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c873a01a-651f-4a0f-bd98-70853e6ca684"
      decimals="-3"
      id="F_d66a1f2a-eeac-442a-bf61-87430af3bc15"
      unitRef="U_USD">11080000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_0abdee0c-b9d1-4078-b4c7-a7b88e27c3ee">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Convertible Promissory Notes and Convertible Promissory Note Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2022, the Private CalciMedica board of directors approved a convertible promissory note financing pursuant to which it could issue and sell up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of notes convertible into shares of common stock (the &#x201c;convertible promissory notes&#x201d;) and Convertible Promissory Note Warrants. The funding and issuance of the convertible promissory notes for gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and Convertible Promissory Note Warrants to purchase shares of the Private CalciMedica&#x2019;s common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share took place in multiple closings through October 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2022, the Private CalciMedica board of directors amended the convertible promissory notes and Convertible Promissory Note Warrants to issue up to an additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (for a total of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million) and added the automatic conversion for a &#x201c;de-SPAC&#x201d; business combination or reverse merger transaction. In November 2022, Private CalciMedica issued additional convertible promissory notes for gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and Convertible Promissory Note Warrants to purchase shares of Private CalciMedica&#x2019;s common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The convertible promissory notes accrued interest at a rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum and had a maturity date of December 31, 2023. Immediately prior to the effective time of the Merger, all outstanding convertible promissory notes and unpaid and accrued interest automatically converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,487,104&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Private CalciMedica&#x2019;s common stock at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;a conversion price based on the equivalent valuation of the cash price paid per share by the private placement investors purchasing shares of common stock in the private placement multiplied by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Such shares of common stock were then converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;590,031&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug common stock at the effective time of the Merger in accordance with the Merger Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with each purchase of a convertible promissory note, Private CalciMedica issued to each holder of such convertible promissory note Convertible Promissory Note Warrant to purchase shares of the Private CalciMedica&#x2019;s common stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Each holder of the Convertible Promissory Note Warrants had the right to purchase up to a number of shares of Private CalciMedica&#x2019;s common stock equal to (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (&#x201c;Warrant Coverage&#x201d;) of the principal amount of the convertible promissory note purchased by such holder concurrently therewith, divided by (ii) the cash price paid per share by the investors in the qualified financing or an initial public offering, as applicable, or in the case of a &#x201c;de-SPAC&#x201d; business combination or a reverse merger transaction between Private CalciMedica and a publicly traded company (a &#x201c;Public Combination&#x201d;), the equivalent valuation of the lower of the cash price per share by the investors purchasing shares in the publicly traded company in connection with such Public Combination or the cash price per shares by the investors purchasing shares of Private CalciMedica&#x2019;s common stock in connection with such Public Combination, in each case, rounding down to the nearest whole share and subject to the terms of the convertible promissory notes; provided, however, that any holder that purchased convertible promissory notes in excess of the holder&#x2019;s pro rata commitment (as defined in the convertible promissory notes) received a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% Warrant Coverage on the principal amount of the convertible promissory notes that is in excess of its pro rata commitment. The Convertible Promissory Note Warrants had a five-year term. In connection with the Merger, the Convertible Promissory Note Warrants were automatically net exercised in accordance with the terms of the Convertible Promissory Note Warrants. Immediately prior to the effective time of the Merger, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,308,047&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Convertible Promissory Note Warrants were converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,308,047&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Private CalciMedica's common stock, which were converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;152,875&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug's common stock, based on the principal amount of the convertible promissory note.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the Merger, the Convertible Promissory Note Warrants were not deemed equity and were classified as a liability on the balance sheets. The Convertible Promissory Note Warrants were valued using a series of Monte Carlo simulations and Black-Scholes to determine the fair value, probability weighted for difference scenarios. The Monte Carlo simulations determined the liquidity event price. The Black-Scholes warrant value is discounted from the respective event date using the risk-free rate. The Black-Scholes valuation included standard assumptions such as exercise price, expected term, risk-free rate, volatility, and a dividend yield of zero. The Company estimated initial fair value of the Convertible Promissory Note Warrants utilizing the following range of assumptions for the difference scenarios: exercise price ($&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.01&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), risk-free rate (&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.02&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%), volatility (&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%),&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;expected term (&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; - &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4.6&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years). As of the date of the Merger, the Convertible Promissory Note Warrants which were converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;152,871&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock were revalued, using the price of the common stock of Graybug of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="C_d641d938-a033-4dcf-9434-c6445ce1a637"
      decimals="-5"
      id="F_1c59b9da-8cb0-4944-985e-0867b5af57f1"
      unitRef="U_USD">5000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_d641d938-a033-4dcf-9434-c6445ce1a637"
      decimals="-5"
      id="F_aa3476eb-b0a5-4092-9293-146e422914bf"
      unitRef="U_USD">3500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2ac23ecf-2158-4a2f-ade7-ea9d3539490e"
      decimals="2"
      id="F_9d9943e2-ac1a-45e9-8d73-887f9926060e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ck0001534133:DebtInstrumentPeriodicPaymentPrincipalAdditional
      contextRef="C_56f08610-d053-44c8-b481-e6a9fd87daf4"
      decimals="-5"
      id="F_5b12ccf9-b1b4-4cd1-82b9-f02b80cf67ac"
      unitRef="U_USD">3500000</ck0001534133:DebtInstrumentPeriodicPaymentPrincipalAdditional>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="C_56f08610-d053-44c8-b481-e6a9fd87daf4"
      decimals="-5"
      id="F_a98195aa-00bd-4dcc-ab33-6cf20a2bae16"
      unitRef="U_USD">8500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_f8437473-43cf-4eea-9960-4a41c9ab6907"
      decimals="-5"
      id="F_6705025b-3c10-4108-92c2-5c5598302d30"
      unitRef="U_USD">5000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_7a9252ad-93b8-4655-9d47-d20409702eab"
      decimals="2"
      id="F_da6b2b3c-4bdf-445b-aec8-99f84288c8a1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_f8437473-43cf-4eea-9960-4a41c9ab6907"
      decimals="2"
      id="F_62c14d32-0ca8-4529-ac2b-0c3a517d73ea"
      unitRef="U_pure">0.06</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_94f7d9a0-cccf-4f75-aaa7-442f61778e94"
      decimals="0"
      id="F_1956a015-4775-423c-bfea-7a3c4fee90ee"
      unitRef="U_shares">20487104</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <ck0001534133:PublicCombinationMultipliedCashPricePaidPerShare
      contextRef="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719"
      decimals="2"
      id="F_73dc71cf-2b74-4a2b-afd6-a1aba5ee1a7f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.85</ck0001534133:PublicCombinationMultipliedCashPricePaidPerShare>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_6f09c985-ab40-4e3f-a4e4-e71945759749"
      decimals="0"
      id="F_c55b23ae-a1c6-4607-82a4-c5737c2ae0e6"
      unitRef="U_shares">590031</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1"
      decimals="2"
      id="F_30f4289f-206f-4d91-86e9-339e051ddcf2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ck0001534133:PercentageOfWarrantCoverage
      contextRef="C_e4bb7cdd-0b6c-4d2b-8e43-6a6963cfc0c5"
      decimals="2"
      id="F_e81832eb-8c67-4abf-9b24-fc595247b5d8"
      unitRef="U_pure">0.15</ck0001534133:PercentageOfWarrantCoverage>
    <ck0001534133:PercentageOfWarrantCoverage
      contextRef="C_a56a3a2f-8fe3-491c-bfe6-a1f00177f719"
      decimals="2"
      id="F_2d66bff6-f940-4807-80a6-5d08650e7b39"
      unitRef="U_pure">0.40</ck0001534133:PercentageOfWarrantCoverage>
    <ck0001534133:ConvertiblePromissoryNoteWarrantsConvertible
      contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1"
      decimals="0"
      id="F_933f8e00-d450-4a90-9596-6d6fe6dd8c81"
      unitRef="U_shares">5308047</ck0001534133:ConvertiblePromissoryNoteWarrantsConvertible>
    <ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted
      contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1"
      decimals="0"
      id="F_daa04998-93cc-45c7-b1bd-f7ce16292144"
      unitRef="U_shares">5308047</ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted>
    <ck0001534133:ExchangeOfStockForStock
      contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1"
      decimals="0"
      id="F_582f5249-bf37-4e95-893f-629c1a3dfc79"
      unitRef="U_shares">152875</ck0001534133:ExchangeOfStockForStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_01046067-75e4-47eb-859f-fdf6441b00c1"
      decimals="2"
      id="F_ee2d5052-f1f3-4c5b-93b5-ac8c4b34f247"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e"
      decimals="4"
      id="F_291a769a-d2ed-48ff-abda-ef226ad1d5b1"
      unitRef="U_pure">0.0302</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb"
      decimals="4"
      id="F_89219e8d-dd3d-43e3-b64b-ddc48777bd11"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e"
      decimals="2"
      id="F_aff5da8d-9551-48ff-b464-915bb99de271"
      unitRef="U_pure">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb"
      decimals="2"
      id="F_603beb6c-5288-442c-a4d5-fd385165e648"
      unitRef="U_pure">0.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_941b1d38-af1f-420f-8b15-8eeae975a34e"
      id="F_8ec6dc37-fda2-4176-ba37-db7f389b3c78">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_d8023328-2b80-4187-9be9-a472d3a65beb"
      id="F_fd6a379f-32ae-476f-9a2e-2be505dba468">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted
      contextRef="C_78496b12-3f28-430e-9d56-1d9d320d8e3f"
      decimals="0"
      id="F_cdbb5b02-8a1a-4ad6-9526-75b986c4e0c8"
      unitRef="U_shares">152871</ck0001534133:ConvertiblePromissoryNoteWarrantsCommonStockConverted>
    <ck0001534133:ExpectedPerShare
      contextRef="C_78496b12-3f28-430e-9d56-1d9d320d8e3f"
      decimals="2"
      id="F_b6a03029-e574-4b9f-87ae-3583c50f8c42"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.5</ck0001534133:ExpectedPerShare>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_de667007-db1d-4cbe-94f8-897a956cfb49">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. Accrued Expenses&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued payroll and other employee benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;531&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued severance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_30c92a75-07bf-491d-bdf2-262eb3c077e1">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:93.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued payroll and other employee benefits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;531&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued severance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <ck0001534133:AccruedPayrollAndOtherEmployeeBenefits
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_a6f77d1d-e123-460f-af0e-725de5993dae"
      unitRef="U_USD">531000</ck0001534133:AccruedPayrollAndOtherEmployeeBenefits>
    <ck0001534133:AccruedPayrollAndOtherEmployeeBenefits
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_b73bd0c3-2b22-4017-a71c-e4a440e20bbc"
      unitRef="U_USD">935000</ck0001534133:AccruedPayrollAndOtherEmployeeBenefits>
    <ck0001534133:AccruedSeveranceExpense
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_90d6c2a9-9aec-4be3-8ca8-63bb8eff2c7d"
      unitRef="U_USD">0</ck0001534133:AccruedSeveranceExpense>
    <ck0001534133:AccruedSeveranceExpense
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_8e8a75ad-895e-4448-ba15-7c840f043019"
      unitRef="U_USD">89000</ck0001534133:AccruedSeveranceExpense>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_64a5808f-dbd0-4817-ae53-25a30d2d40c4"
      unitRef="U_USD">286000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_78e942dc-ed76-404b-8b0a-ed2003a792d8"
      unitRef="U_USD">345000</us-gaap:AccruedProfessionalFeesCurrent>
    <ck0001534133:AccruedOther
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_7d27e1e0-283a-4edb-84e4-346f3bd31a5e"
      unitRef="U_USD">49000</ck0001534133:AccruedOther>
    <ck0001534133:AccruedOther
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_00a57576-506b-465d-98f8-b511b5855965"
      unitRef="U_USD">99000</ck0001534133:AccruedOther>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_fef60471-4b21-4570-a096-9a181be4bace"
      unitRef="U_USD">866000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_c8c04a80-d792-4c89-9c74-f2d3de0d7401"
      unitRef="U_USD">1468000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <ck0001534133:TemporaryEquityDisclosureTextblock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1c3c1233-ec00-47d0-8f0a-2ce1ef07e342">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7. Convertible Preferred Stock, Common Stock and Stockholders' Deficit&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Authorized Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's current Amended and Restated Certificate of Incorporation authorizes &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of preferred stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Immediately prior to the effective time of the Merger, the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,820,880&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Private CalciMedica preferred stock were converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,820,880&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; outstanding shares of Private CalciMedica's common stock to be exchanged for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,442,852&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug's common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon completion of the Merger on March 20, 2023, as the accounting acquirer, Private CalciMedica is deemed to have issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,571,433&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its common stock to Graybug shareholders.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Private Placement of Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Immediately prior to the consummation of the Merger, Private CalciMedica completed a private placement financing pursuant to which certain investors purchased approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares of Private CalciMedica&#x2019;s common stock (the &#x201c;2023 Private Placement&#x201d;) for gross proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In conjunction with the Merger, immediately prior to the effective time of the Merger, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,706,997&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Private CalciMedica common stock were converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;596,363&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Graybug&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 19, 2024, the Company entered into a Securities Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) with certain accredited investors, in which the Company sold the following securities to the accredited investors in a private placement transaction (the &#x201c;2024 Private Placement&#x201d;): (i) an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,985,610&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock; (ii) to certain investors, in lieu of shares of common stock, pre-funded warrants (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306,506&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock and exercisable at any time; (iii) Tranche A Common Warrants (the &#x201c;Tranche A Common Warrants&#x201d;) to purchase an aggregate of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,058&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants); and (iv) Tranche B Common Warrants (the &#x201c;Tranche B Common Warrants&#x201d; and together with the Tranche A Common Warrants, the &#x201c;Common Warrants&#x201d;) to purchase an aggregate of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,058&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock (or Pre-Funded Warrants in lieu thereof and, in such case, shares of common stock issuable upon exercise of such Pre-Funded Warrants). At date of issuance, the fair value of the common stock was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million using the relative fair value method and is included in equity at December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company issued placement agent warrants (&#x201c;Placement Agent Warrants&#x201d;) to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67,908&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at the initial closing of the 2024 Private Placement and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,839&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at the second closing of the 2024 Private Placement, at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75,746&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Common Warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The initial closing of the 2024 Private Placement occurred on January 23, 2024 and the second closing occurred on February 5, 2024. Gross proceeds from the transaction were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million with net proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million after deducting $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in commissions and other transaction costs. The Tranche A Common Warrants expired unexercised on July 29, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Underwritten Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 1, 2024, the Company closed an underwritten public offering of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,720,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its common stock at a price to the public of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (the &#x201c;2024 Follow-On&#x201d;). The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In addition, the Company granted the underwriters a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;30-day&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; option &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to purchase up to an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;408,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its common stock at the public offering price, less underwriting discounts and commissions, which option expired unexercised.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Shelf Registration Statement and At the Market Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2023, the Company filed a shelf registration statement on Form S-3 (the &#x201c;Shelf Registration Statement&#x201d;). The Shelf Registration Statement permits the offering, issuance and sale of common stock, preferred stock, debt securities and warrants having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in one or more offerings and in any combination of the foregoing.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Shelf Registration Statement contains two prospectuses, a base prospectus and an at-the-market offering prospectus, as supplemented on March 29, 2024  (as supplemented, the &#x201c;Original Prospectus Supplement&#x201d;), that covered the offering, issuance and sale of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of common stock pursuant to an at-the-market offering agreement (&#x201c;ATM Agreement&#x201d;) with H.C Wainwright &amp;amp; Co., LLC (&#x201c;Wainwright&#x201d;), acting as sales agent (&#x201c;ATM Facility&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 1, 2024, the Company closed the 2024 Follow-On and sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,720,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of its common stock at a price to the public of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share pursuant to the Shelf Registration Statement. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2024 Follow-on, on October 30, 2024, the Company suspended sales of common stock under the ATM Facility pursuant to the Original Prospectus Supplement, and until December 20, 2024, did not offer for sale any shares of common stock. The Company filed a prospectus supplement (the &#x201c;Current Prospectus Supplement&#x201d;) with the SEC on December 20, 2024 for an aggregate gross sales price of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,450,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of shares of common stock to be sold pursuant to the ATM Facility.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company intends to use the net proceeds from the ATM Facility for general corporate purposes, which may include research and development expenses, clinical trial expenses, capital expenditures and working capital. The ATM Facility will terminate upon the earlier of (i) the sale of all of the shares of our common stock provided for in the at the market offering prospectus or (ii) termination of the ATM Agreement as permitted therein. The ATM Agreement may be terminated at any time by either party upon written notice. During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,950&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares sold under the ATM Facility. As of December 31, 2024, the Company has sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;101,522&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock for net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;319,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, after deducting $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of commissions and settlement expenses paid under the ATM Facility and approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million remains available for sale under the ATM Facility. As of December 31, 2024, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million remains available for sale under the Shelf Registration Statement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred and Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognized a change in fair value of the Preferred Stock Warrants for each of the years ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2023 of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;795,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The change in fair value for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023 was due to the conversion of Preferred Warrants to common stock warrants as part of the Merger.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In November 2020, Private CalciMedica granted a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to a consulting firm affiliated with its former interim chief financial officer in connection with its consulting agreement. The warrant has a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-year term, an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.19&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and vests ratably over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months commencing on the effective date. At the date of issuance, the fair value of the warrant was determined to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, utilizing Black-Scholes with the following assumptions: expected term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, risk-free rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which has been recognized as general and administrative expense over the vesting period. In conjunction with the Merger, the warrant converted to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,520&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants of CalciMedica at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In October 2022, Private CalciMedica granted warrants to certain officers and directors to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;496,970&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock. In conjunction with the Merger, the warrants converted to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,313&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants of CalciMedica at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The warrants have a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;-year term and vest ratably over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months. At the date of issuance, the fair value of the warrants collectively was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, risk free rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The warrants are classified as equity, and the Company expensed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to general and administrative expense for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the 2024 Private Placement, the Company issued Tranche A Common Warrants, Tranche B Common Warrants and Pre-Funded Warrants. Tranche A Common Warrants were exercisable until July 29, 2024. The Tranche B Common Warrants are exercisable upon the earlier of December 31, 2026 or 30 days following the Company&#x2019;s public disclosure of topline results from the Company&#x2019;s planned Phase 2 clinical trial in patients with acute kidney injury. The purchase price per share and accompanying Common Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.827&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (or $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3915&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for directors, employees or consultants of the Company participating in the 2024 Private Placement) (or $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8269&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant and accompanying Common Warrants, which represented the price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.827&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and accompanying Common Warrants minus the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share exercise price of each such Pre-Funded Warrant).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Tranche A Common Warrants had a strike price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.36&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, were not deemed equity and were classified as a liability in the Company&#x2019;s condensed consolidated balance sheets. At the date of issuance, the fair value of the Tranche A Common Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million utilizing Black-Scholes with the following assumptions: expected term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;0.94&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years, risk-free interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of the balance sheet date of December 31, 2024, the value of the Tranche A Common Warrants was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;nil&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with the change in fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;respectively, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;being recorded in consolidated statements of operations in other income as the Tranche A Common Warrants expired unexercised on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 27, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Tranche B Common Warrants have a strike price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, are not deemed equity and are classified as a liability in the Company&#x2019;s consolidated balance sheets. At the date of issuance, the fair value of the Tranche B Common Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million utilizing Black-Scholes with the following assumptions: expected term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1.69&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years, risk-free interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of the balance sheet date of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the value of the Tranche B Common Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, with the change in fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, respectively, being recorded in the condensed consolidated statements of operations in other income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Pre-Funded Warrants have a strike price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, are deemed equity and included in the equity section of the Company&#x2019;s consolidated balance sheets. At date of issuance, the fair value of the Pre-Funded Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million using the relative fair value method and is included in stockholders&#x2019; equity at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Placement Agent Warrants have a strike price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, are deemed equity and included in the equity section of the Company&#x2019;s consolidated balance sheets. At date of issuance, the fair value of the Placement Agent Warrants was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million using the relative fair value method and is included in equity at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In May 2024, the Company granted a warrant to a consulting firm affiliated with its chief financial officer to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock. At the date of issuance, the fair value of the warrant was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and was determined utilizing Black-Scholes and will be recognized as general and administrative expense over the vesting periods. Assumptions used in the valuation were as follows: expected term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;twelve months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, risk free rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, volatility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and a dividend yield of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The warrant is classified as equity, and the Company expensed &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; general and administrative expense for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</ck0001534133:TemporaryEquityDisclosureTextblock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278"
      decimals="INF"
      id="F_4e11e398-3c7a-48e5-bc78-7dc4f3c22570"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278"
      decimals="4"
      id="F_c469fa18-3c37-4e29-8cb1-d92e287c294b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278"
      decimals="INF"
      id="F_b6ec8001-e40e-4598-9a26-823b71cfe62a"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_5157ff3b-9b07-4690-aab3-d94da0ef7278"
      decimals="4"
      id="F_ecef860b-e344-4003-a415-2eb65417b9b0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_26ea50cb-0ee9-4b54-a249-f320c2ea018f"
      decimals="0"
      id="F_7743bd1d-125f-488a-8125-99cd002aed29"
      unitRef="U_shares">84820880</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_f49ac070-365e-4892-838a-facd93bf557c"
      decimals="0"
      id="F_3055e21a-1515-4417-9c72-bbf73f9617fb"
      unitRef="U_shares">84820880</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_ddbe6d36-a378-4c84-83c6-f0933ab42deb"
      decimals="0"
      id="F_8b4e75f5-7d6d-49da-9467-c3223dbb54e0"
      unitRef="U_shares">2442852</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_559c60a1-fc91-4c05-9f90-246f875e3dbf"
      decimals="INF"
      id="F_4320de13-ad84-49e9-a29c-2b0c61be6916"
      unitRef="U_shares">1571433</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"
      decimals="-5"
      id="F_8c1104df-9eaf-4512-9516-34cdff140468"
      unitRef="U_shares">20700000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0802fbe0-fae7-4e85-82cd-0802e35fb08b"
      decimals="-5"
      id="F_5344b915-0c22-475e-8c8f-afabe2ac90c7"
      unitRef="U_USD">10300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_ad05ad10-c218-4a2f-a090-5ef614c472a0"
      decimals="INF"
      id="F_152b47aa-50b8-46de-ad47-8bfa43e59e22"
      unitRef="U_shares">20706997</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="C_987f342a-1b48-420e-b0a0-87f4ebbe2eda"
      decimals="INF"
      id="F_648874b8-3ebf-4372-bcbf-e4e31d3b3259"
      unitRef="U_shares">596363</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51"
      decimals="0"
      id="F_849222d5-e13e-421e-adc9-f16d244509da"
      unitRef="U_shares">4985610</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_a737ee8b-67fc-459e-b42a-32cd72a6e241"
      decimals="0"
      id="F_ad151e54-656a-4bb0-9fa5-ee2814d00821"
      unitRef="U_shares">306506</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_bd4f7398-6d5e-489b-97c8-45a8789eb5d7"
      decimals="0"
      id="F_3013994a-f0d3-432c-92c3-ce3d23fa123b"
      unitRef="U_shares">2646058</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_68dde00d-5365-4647-8868-3a6b2d18e226"
      decimals="0"
      id="F_75cb8692-f821-4f66-a7aa-db4d9b426198"
      unitRef="U_shares">2646058</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:EquityFairValueDisclosure
      contextRef="C_be96bce5-b6c0-422a-8b27-379ef3caef19"
      decimals="-5"
      id="F_95892c2a-3894-4b74-af7e-f1be50cc8dd5"
      unitRef="U_USD">8500000</us-gaap:EquityFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_ce86957a-ac6f-4086-9a65-13bded447356"
      decimals="0"
      id="F_e61a7d63-9958-446f-ae96-fe95e3c34743"
      unitRef="U_shares">67908</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_7bf4d914-a107-476f-b07c-94d28143819c"
      decimals="0"
      id="F_e6bcce9d-cea4-4783-86f6-1a9fd525aa50"
      unitRef="U_shares">7839</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_ce86957a-ac6f-4086-9a65-13bded447356"
      decimals="4"
      id="F_b749bde1-bdb2-454a-841f-45e44dd0a212"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ConversionOfStockDescription
      contextRef="C_3f53ad55-92a4-4198-b148-88d91cc0fe54"
      id="F_42be6590-f7b6-4116-846a-13857315e5c2">Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of 75,746 Common Warrants.</us-gaap:ConversionOfStockDescription>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_d7b806ba-8a0b-43e9-b41a-918e7e839c51"
      decimals="0"
      id="F_3e7631d0-ce13-4617-a5c3-0f0c5edacf50"
      unitRef="U_shares">75746</us-gaap:ConversionOfStockSharesConverted1>
    <ck0001534133:GrossProceedsFromThePrivatePlacement
      contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864"
      decimals="-5"
      id="F_d369c00d-0924-4fca-acf8-43292839f996"
      unitRef="U_USD">20400000</ck0001534133:GrossProceedsFromThePrivatePlacement>
    <ck0001534133:NetProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864"
      decimals="-5"
      id="F_52c58e37-f14e-405b-b0b6-ff45353baec9"
      unitRef="U_USD">19000000</ck0001534133:NetProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_d7d378ac-3c97-4599-8815-59e8ff3b8864"
      decimals="-5"
      id="F_58de3e38-4b24-4217-a1c5-dadd1b040322"
      unitRef="U_USD">1400000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_aad10afc-0c1f-499f-9814-0ecba7487b5e"
      decimals="0"
      id="F_d9b03cf0-798f-4efd-b859-13b830fc5efa"
      unitRef="U_shares">2720000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_ebe2620f-35df-4233-a846-f1495ccf0b18"
      decimals="2"
      id="F_2bf73894-fb87-4986-a151-250072b5743e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_adccbd9d-5ceb-49f3-a3cc-4d2f76546d2e"
      decimals="-5"
      id="F_cd9d7610-8625-437e-98fb-51c5c6b77e2b"
      unitRef="U_USD">10200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ck0001534133:UnderwritersOptionPeriod
      contextRef="C_7c5c9cab-f1bd-4526-94d8-3164adc3b2f5"
      id="F_cadc5c2c-bc05-4d7d-8e00-b5e9c5d7841a">P30D</ck0001534133:UnderwritersOptionPeriod>
    <ck0001534133:MaximumNumberOfAdditionalSharesIssued
      contextRef="C_aad10afc-0c1f-499f-9814-0ecba7487b5e"
      decimals="0"
      id="F_5767bc9b-4ed5-489f-bda0-7c8374ddd08a"
      unitRef="U_shares">408000</ck0001534133:MaximumNumberOfAdditionalSharesIssued>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_f9e065dc-a9c1-4a5e-8636-0c7b7506b76b"
      decimals="-5"
      id="F_43e0bc73-5b51-4ba1-a39c-767c36f8a95a"
      unitRef="U_USD">100000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9"
      decimals="-5"
      id="F_010344b9-3483-45fa-a272-8d14b2780a4d"
      unitRef="U_USD">17300000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_1001d2cb-3125-43a0-ab65-f1fef2c3edd3"
      decimals="0"
      id="F_b8a24042-9f5e-488b-94b1-a4690645c6d0"
      unitRef="U_shares">2720000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_3a88b2b4-b053-4f3c-a6d0-2084b134a77e"
      decimals="2"
      id="F_3ef81f16-3c3b-4c61-9506-6ec2513e90db"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.75</us-gaap:SharesIssuedPricePerShare>
    <ck0001534133:ProceedsFromFollowOnOffering
      contextRef="C_0d5c75d7-eaac-4f4b-9ade-6f0a083bd65e"
      decimals="-5"
      id="F_5c21b58c-2882-4dd2-aec6-f77cd5a2b4e4"
      unitRef="U_USD">10200000</ck0001534133:ProceedsFromFollowOnOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_eec723ad-c5c5-4de8-86cf-24ffe53a2b58"
      decimals="0"
      id="F_f34e3982-ffeb-4b5d-ae4d-0e63ac815817"
      unitRef="U_shares">4450000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9"
      decimals="0"
      id="F_c6ecf3e8-e32f-4866-ab2b-7613f19703b6"
      unitRef="U_shares">8950</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_8369d456-272d-4458-8976-3a21b4c87005"
      decimals="0"
      id="F_9cba1aff-8105-4f7f-9b54-639e5f8e4211"
      unitRef="U_shares">101522</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_b03d45f7-69af-4721-9c4f-7cb355d6aace"
      decimals="0"
      id="F_e27e5303-65fe-4c69-a03b-b9279fafa245"
      unitRef="U_USD">319000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9"
      decimals="0"
      id="F_627a021b-663e-4cd8-8538-e44fc22ff2c4"
      unitRef="U_USD">13000</us-gaap:PaymentsOfStockIssuanceCosts>
    <ck0001534133:SaleOfStockRemainingSalesAmount
      contextRef="C_4e650fe4-18c8-41ec-bd75-5a4b2e310cc9"
      decimals="-5"
      id="F_e044be8a-fec2-4346-9f16-529f59dc186e"
      unitRef="U_USD">4500000</ck0001534133:SaleOfStockRemainingSalesAmount>
    <ck0001534133:ShelfRegistrationStatementAvaliableForSale
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_e5a65259-135d-414e-a754-9d3afaeb1203"
      unitRef="U_USD">89500000</ck0001534133:ShelfRegistrationStatementAvaliableForSale>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_b01b6d69-47c9-4adc-964a-cc6cc14542a7"
      decimals="0"
      id="F_41f785c8-ea40-4ad5-bac9-c7ef332ee507"
      unitRef="U_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_0ad991e6-bbac-44ce-ac44-e428594773e9"
      decimals="0"
      id="F_0f12b6dc-9514-4a4e-be1f-a8d5e3efcd6a"
      unitRef="U_USD">795000</us-gaap:FairValueAdjustmentOfWarrants>
    <ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      decimals="INF"
      id="F_22b9d821-82b8-4433-b9b1-dff15c625258"
      unitRef="U_shares">400000</ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7"
      id="F_46cd6e72-f3de-4e0d-88a8-91efdd0d9bff">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7"
      decimals="2"
      id="F_e0f3fd2a-20d6-48e7-99b8-33cfd64291b3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.19</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      id="F_debc6564-1a1b-4d92-90c0-5bd3c8169d09">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_75c3f7c7-0b54-4282-baac-1431db556fd7"
      decimals="0"
      id="F_0d9a79ca-a5e8-4c9e-a7a8-a39c9e56e44a"
      unitRef="U_USD">120000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      id="F_c20ffe98-51cb-4621-912c-a3c15ddade63">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      decimals="4"
      id="F_42f03ea1-24a1-4a0c-b97c-546335126684"
      unitRef="U_pure">0.0096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      decimals="3"
      id="F_725b87ea-6ef0-480d-9ece-51c15be5156b"
      unitRef="U_pure">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_e5fe45dc-2ad7-4ab2-a784-811c3d9bf0ea"
      decimals="2"
      id="F_c7ade3dc-da39-482a-97b7-43c2e3f326c3"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_14ff6f4d-845b-4bfc-a43d-d0314b89a420"
      decimals="0"
      id="F_d8984707-9e51-4c32-af3a-5dc922c9a9df"
      unitRef="U_shares">11520</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_207c4b97-0faa-4d0f-809e-69e530a8d044"
      decimals="2"
      id="F_e875bb85-bf44-4f02-8c20-2ee4fc16aa61"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
      contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231"
      decimals="INF"
      id="F_927fb763-6a55-423c-bede-819dceff79d3"
      unitRef="U_shares">496970</ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_c0b760ce-71ec-459a-969d-1893bdf340e8"
      decimals="0"
      id="F_6014a76f-99d5-4189-b584-15c54bb2c901"
      unitRef="U_shares">14313</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c0b760ce-71ec-459a-969d-1893bdf340e8"
      decimals="2"
      id="F_5b1b7e41-8c72-470a-aac1-b0db98b5909a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.42</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_b2211e17-6778-4571-a5e3-51c977da82ba"
      id="F_8a47c45d-78fd-4cb7-83e4-fd7f2cc56a0d">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_1f43280b-4e22-429e-aa7d-ecce70368956"
      id="F_924f7d26-b15a-43b3-a0ca-cda4472051ce">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_4d206da2-83dd-40ec-8dd2-a7ed991121fe"
      id="F_cc6b49b4-695c-4060-8f51-3164d28174e8">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_b2211e17-6778-4571-a5e3-51c977da82ba"
      decimals="0"
      id="F_518bd398-66da-4ba9-90e9-d89702c295d6"
      unitRef="U_USD">125000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231"
      id="F_85ec6fb8-273a-487c-893c-a84966fa8ea0">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231"
      decimals="4"
      id="F_17aca340-fbfa-49ca-a4a1-de4e577c2460"
      unitRef="U_pure">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231"
      decimals="2"
      id="F_6345b16c-bfd0-4799-b5a2-2a107d6d7cc0"
      unitRef="U_pure">0.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_29cd52ec-1662-4876-b968-95dcdb404231"
      decimals="2"
      id="F_cfd09a7e-3120-45ae-9a21-a2169975c557"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_376beb3d-3fc1-445d-b41b-a5cae382b0e7"
      decimals="0"
      id="F_c819d915-4c2d-48d1-a0d6-92fb41758adb"
      unitRef="U_USD">6000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_7161dd77-2036-4b7b-a3c9-8408ec371ec2"
      decimals="0"
      id="F_eb3965ef-c5ff-46cb-9abe-f96933eb15c1"
      unitRef="U_USD">90000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_42f60701-1d3e-46b2-9f02-e6238294dfdc"
      decimals="3"
      id="F_8ab56bdf-8407-4337-b9de-cd8219470923"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.827</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_e7f86347-68d3-405b-8913-ba0bee5ee23b"
      decimals="4"
      id="F_7d86de1e-1a5b-4eb3-8794-e9677a3cd182"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.3915</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_223da16c-eed7-4903-afb0-2d505376e14c"
      decimals="4"
      id="F_a6520b75-31f2-4aa4-bf16-d49e2d09efc2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.8269</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_60695399-bb34-4681-86ba-e8a3bfb9d100"
      decimals="3"
      id="F_5ea67b52-769d-49f6-8b1c-7b08947cd1ba"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.827</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantExercisePriceDecrease
      contextRef="C_0c6e1adc-65fd-4bc0-9b3f-a6a4ebc29353"
      decimals="4"
      id="F_9f640422-b6a2-4015-aa7b-4875a77f8cb6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:WarrantExercisePriceDecrease>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783"
      decimals="2"
      id="F_08e90628-032b-4517-ab44-1878d4e56875"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.36</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783"
      decimals="-5"
      id="F_73c42f0d-2c8e-42b0-a210-b5baed527727"
      unitRef="U_USD">4100000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"
      id="F_fdde7a50-65ea-4c58-ae34-1305c44073df">P0Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"
      decimals="3"
      id="F_b6e4e0de-7747-4cdd-8b1b-01c39b2d928f"
      unitRef="U_pure">0.049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"
      decimals="2"
      id="F_cf539352-93b4-4c29-af4a-074b398b3ff2"
      unitRef="U_pure">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"
      decimals="2"
      id="F_364aafd4-a576-4017-81d3-3d793567e98b"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783"
      decimals="-6"
      id="F_b78ddb1c-2bdc-4206-bc33-d630e58053a9"
      unitRef="U_USD">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_ca35f515-9789-4c9a-bc5c-80822da0b0e3"
      decimals="-5"
      id="F_866a342d-c278-4508-8fb6-609884585e7a"
      unitRef="U_USD">4100000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_288a2c47-1d31-472c-b116-f7fc50bd5783"
      id="F_fd607b49-932f-4a59-99ae-d18206a80582">2024-07-27</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08"
      decimals="2"
      id="F_07667ef6-b167-44a2-8331-1268f7466342"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08"
      decimals="-5"
      id="F_592b5fb2-ad0d-4e3a-b719-0e9315d6666e"
      unitRef="U_USD">7100000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590"
      id="F_6b907705-99ba-42ad-99e9-9c6f242c0951">P1Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590"
      decimals="3"
      id="F_a1e8e636-a3d5-4c32-a55d-f6867546a08c"
      unitRef="U_pure">0.045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590"
      decimals="2"
      id="F_aa42956a-a5bc-4daa-a8c9-1cfe0966d46e"
      unitRef="U_pure">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590"
      decimals="2"
      id="F_740b6007-8b01-4269-8655-2a5e17195b64"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_a48fce7f-548c-4ccb-89c0-d55b1f566c08"
      decimals="-5"
      id="F_20cc6637-0213-4cc3-8c1e-80e8ba24085a"
      unitRef="U_USD">3400000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_306bebf7-53a9-4887-b0b4-ecae6be09590"
      decimals="-5"
      id="F_e4517fba-10a5-4772-9243-3542128318ce"
      unitRef="U_USD">300000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_0a03a7ba-0a9b-4bcb-b58e-debbbef7f6e6"
      decimals="-5"
      id="F_8cc8d2c0-90ff-4439-88a9-3e8a65cc1320"
      unitRef="U_USD">3700000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_9aebc674-6f2c-4fb4-9168-add0619306fd"
      decimals="4"
      id="F_538e0090-b6f5-4354-a93b-e4b99d7a538a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_9aebc674-6f2c-4fb4-9168-add0619306fd"
      decimals="-5"
      id="F_5f232c6b-16ff-4e08-a1b7-6cc4903b8bfc"
      unitRef="U_USD">500000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a"
      decimals="4"
      id="F_5d5186ad-c07b-4aa8-bc80-7258220b0886"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_5ccf6ca8-6fa8-4b6f-a882-b53c868a6c7a"
      decimals="-5"
      id="F_d85f11e5-c928-4170-a256-94a6b351e8b1"
      unitRef="U_USD">100000</us-gaap:FairValueNetAssetLiability>
    <ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
      contextRef="C_5628ed6b-5082-4559-afdb-16e2688469bc"
      decimals="INF"
      id="F_3ca67bcc-ab6a-4a3f-8ee6-6ceeb1d9704f"
      unitRef="U_shares">10000</ck0001534133:StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_a9629230-9e39-4a56-a202-86fdb80c3901"
      decimals="0"
      id="F_bd5bd88e-fb36-4acd-9e0d-04e7ae3f1ff9"
      unitRef="U_USD">20000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"
      id="F_4ab35490-1f5a-418f-b9fc-af459cb6a1e0">P12M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"
      decimals="4"
      id="F_8e29d987-8dd9-45a1-9f7e-9e57ccdec203"
      unitRef="U_pure">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"
      decimals="2"
      id="F_309492d5-256b-4947-b507-717627c8f856"
      unitRef="U_pure">0.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"
      decimals="2"
      id="F_924e9f0b-00ec-40af-997f-14a70488eb94"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_f8d4e432-a005-4bdb-8dec-799ceb0d1eae"
      decimals="0"
      id="F_a1bc8b3b-9b0f-4cdd-a68b-9f108e816c4d"
      unitRef="U_USD">13000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_e11eaa09-8bde-4255-8fc0-26e80283f45a">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8. Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Equity Incentive Plan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company adopted 2023 Equity Incentive Plan (the &#x201c;2023 Plan&#x201d;), which became effective at the closing of the Merger and replaced our 2020 Equity Incentive Plan (&#x201c;2020 Plan&#x201d;) on the effective date of the Merger. As of the effective date of the Merger, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock available for grant under the 2023 Plan. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 Plan of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of shares of the Company&#x2019;s common stock outstanding (or a lesser number determined by the Company&#x2019;s board of directors). As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;228,475&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;options have been returned of whic&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;h &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;223,743&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(granted under the 2020 Plan) are unavailable for future grant. Effective January 1, 2024, the shares reserved for issuance under the 2023 Plan was increased by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287,725&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares. Effective March 28, 2024, the Board approved an increase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares reserved under the 2023 Plan. This increase was subsequently approved by the stockholders of the Company on August 27, 2024. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;820,266&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; s&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;hares were available for grant under the 2023 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;2023 Employee Stock Purchase Plan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company adopted the 2023 Employee Stock Purchase Plan (the &#x201c;2023 ESPP&#x201d;) which became effective at the closing of the Merger. As of the effective time of the Merger, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock reserved for issuance under the 2023 ESPP. In addition, the share reserve is subject to annual increases each January 1 for the first ten years following approval of the 2023 ESPP of the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total number of shares of the Company&#x2019;s common stock outstanding on December 31 of the preceding calendar year, (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;195,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock, or (iii) such lesser number of shares of the Company&#x2019;s common stock as determined by the Company&#x2019;s board of directors. An annual increase of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57,545&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock was automatically added to the share reserve under the 2023 ESPP on January 1, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares have been issued under the 2023 ESPP.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock option transactions for the 2023 Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.435%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.152%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.353%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.466%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.687%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Remaining Contractual Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,739,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.99&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,326,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;228,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,350,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,852&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; options exercised and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,326,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; options granted during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024. The weighted-average fair value of options granted during the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, respectively. The total fair value of shares vested was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (which includes $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to the acceleration of vesting of the Graybug stock awards at the date of the Merger) for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and December 31, 2023, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, stock-based compensation not yet recognized is $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which the Company expects to recognize over an estimated weighted-average term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%-&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.56&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;97&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%-&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSU&#x201d;)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of RSUs is determined on the date of grant based on the market price of the Company&#x2019;s common stock on that date. The aggregate grant date fair value of RSUs vested during the year ended December 31, 2024 was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;nil&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes restricted stock unit activity for the CalciMedica Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.183%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.158%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.61%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.799%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.158%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.093%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited/Cancelled (expired)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The stock-based compensation expense for the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, includes one-time charges for the acceleration of vesting of the Graybug stock options at the date of the Merger of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in research and development and general and administrative expenses, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Common stock reserved for future issuance consists of the following at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,352,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares available for issuance under the 2023 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;807,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares available under the 2023 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;122,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,107,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6ae5bd8b-50f0-4642-b868-3aa969e2fa5c"
      decimals="INF"
      id="F_f4e16f12-21d1-4eaf-95b3-8650fcfd8e5c"
      unitRef="U_shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan
      contextRef="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2"
      decimals="2"
      id="F_d8e6aa48-04f2-4617-84d2-ddbcd2653f53"
      unitRef="U_pure">0.05</ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_90d20219-f8e3-43b1-88e1-2a68636ce3b2"
      decimals="0"
      id="F_464882a7-0e38-446b-a4e0-89c55d607643"
      unitRef="U_shares">228475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant
      contextRef="C_f6e2608c-dccd-43a5-9232-ce7da8fd0bfa"
      decimals="0"
      id="F_1b5173ab-1466-41cd-b74d-4f6c20049599"
      unitRef="U_shares">223743</ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnvailableForGrant>
    <ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved
      contextRef="C_8830f19b-6e6b-4da2-87ee-d99253ee1c18"
      decimals="0"
      id="F_9f5d1c9e-916a-4f38-b1cd-044214a0063b"
      unitRef="U_shares">287725</ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e68758c4-3c29-4782-a87c-bcd7ee800eef"
      decimals="INF"
      id="F_9562330a-fe60-4cfd-b851-d8488c7cc357"
      unitRef="U_shares">1500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188"
      decimals="0"
      id="F_9a1ae17c-a0b6-43c8-b384-d767c2908ccd"
      unitRef="U_shares">820266</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <ck0001534133:CommonStockCapitalSharesReservedForFutureIssuanceInitial
      contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b"
      decimals="INF"
      id="F_d6ff8e20-6457-4aa8-a058-3ccaee329718"
      unitRef="U_shares">65000</ck0001534133:CommonStockCapitalSharesReservedForFutureIssuanceInitial>
    <ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="2"
      id="F_5edd4158-8a03-409c-81f7-e73bbf6c89bf"
      unitRef="U_pure">0.01</ck0001534133:PercentageOfAggregateNumberOfSharesOfCommonStockOutstandingOnLastDayOfPrecedingYearAddedToPlan>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b"
      decimals="INF"
      id="F_adcd0dec-7de4-4001-aaa1-e2f78c71b82a"
      unitRef="U_shares">195000</us-gaap:CommonStockSharesIssued>
    <ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="0"
      id="F_23d0257a-0c3b-43f8-a365-ff2dbca5055e"
      unitRef="U_shares">57545</ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesReserved>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="INF"
      id="F_5d5e25aa-c6d3-4aaf-a8c5-0b1c70dd9b30"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_b3dfc004-6af7-4659-89c2-40cfd7bb2ba9">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock option transactions for the 2023 Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.435%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.152%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.111%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.353%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.466%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.178%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.687%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Remaining Contractual Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,739,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.99&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,326,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;228,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,350,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="INF"
      id="F_b3225068-517e-45df-aead-538077f3a061"
      unitRef="U_shares">1739270</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="2"
      id="F_c0cd0dfb-9f57-4046-9472-e0bb31857fee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      id="F_0ae6d96d-afbd-4c89-aa49-60bd26b39a17">P6Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_e2e64915-4b6d-4fac-a812-87e51f2d5687"
      unitRef="U_USD">76000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="INF"
      id="F_9fcf89db-7443-411a-9eda-bd82762c9c00"
      unitRef="U_shares">1326500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_ae3b7943-8fb2-4ebf-9d2b-ef4ee826144c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_4f80ea95-94b9-488b-bfc6-ee3249988c46"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_cd545079-e4b3-4742-9377-560f5a0a51aa"
      unitRef="U_USD">4000</ck0001534133:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="INF"
      id="F_2b61abd8-c60b-4b6d-a57d-47251012fa57"
      unitRef="U_shares">12852</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_b805f643-8475-4a40-ad63-78307c663ee9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="INF"
      id="F_9f7f338d-8f12-49e7-8a4e-8a78f72f6834"
      unitRef="U_shares">228475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_06d2a23b-e3af-4436-833c-4fa0974b20a6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">75.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_5bd2319d-2e75-4f6d-832f-331e706e6cac"
      unitRef="U_shares">2824443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="2"
      id="F_e3760b3c-353d-470d-aba3-348aeed701b2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_8e21eadd-5504-445e-9e5d-2514af94d8a9">P8Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_8f4a0a9d-6634-4104-b324-4bb1a157c916"
      unitRef="U_USD">316000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_bb46f7f3-653e-444a-9881-c5052055d694"
      unitRef="U_shares">1350852</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="2"
      id="F_e0b548f3-f584-425c-bdae-b70df0cf4c85"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_beb72d85-d220-4e46-8896-2ca5b4341cea">P7Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_6e2418b5-6ed6-4fd3-b18a-afdd02fd00ff"
      unitRef="U_USD">210000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="0"
      id="F_bf7827bc-a8dd-4d1f-8cb9-f69baf4eaaa6"
      unitRef="U_shares">12852</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="0"
      id="F_d2c30811-69b7-414c-bad0-743b85e12420"
      unitRef="U_shares">1326500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="2"
      id="F_13cbe293-194d-4bba-be6a-a4566a609030"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_aea932f0-6864-4a4a-9a5a-1599150cb972"
      decimals="2"
      id="F_d62d711f-a7c8-4f02-bbd9-71145ac7b868"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      decimals="-5"
      id="F_38122036-8df8-4a56-a965-e2fd9275db54"
      unitRef="U_USD">5000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_aea932f0-6864-4a4a-9a5a-1599150cb972"
      decimals="-5"
      id="F_c1371519-990d-4dad-9100-8b7e5bbaebe3"
      unitRef="U_USD">11900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_23e9b7c7-df34-4cf7-85aa-9468c513006d"
      decimals="-5"
      id="F_2cfbd71f-4321-4b40-bd34-8a53f4a9f769"
      unitRef="U_USD">10500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_6989cb5e-e674-4c1b-a3f4-8bde59a0e20c"
      decimals="-5"
      id="F_f0e81b5d-d170-41c4-91f6-42c8b4c7dea1"
      unitRef="U_USD">10500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b"
      decimals="-5"
      id="F_e0579a69-590e-4bd9-a595-fc32694b82ae"
      unitRef="U_USD">4700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_f8ae9f30-ef9f-4202-ad11-bda1bf434b79"
      id="F_bae75c90-e4cd-407d-8402-47d9a8a8fc6e">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_0e5abc60-4735-47f5-bb3d-673bd5c45884">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following is the range of underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%-&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.56&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;97&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%-&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="4"
      id="F_752879c0-a8d6-496c-abf1-d995d7b32682"
      unitRef="U_pure">0.0315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_7b2ce76f-1ac6-463d-9417-582f1d672621"
      decimals="3"
      id="F_b23934dd-34cb-48d9-89b4-c238fb3feb32"
      unitRef="U_pure">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_e6df5d02-68f7-49d4-ba51-986d32e23a91"
      decimals="4"
      id="F_995ae2dc-38bf-4cca-aa2f-47ea7f36b778"
      unitRef="U_pure">0.0356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_54818ba8-80c5-4ab4-ae75-88647ddcce5f"
      unitRef="U_pure">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_7b2ce76f-1ac6-463d-9417-582f1d672621"
      decimals="2"
      id="F_ca484aa9-332a-44ee-81df-18a441c58d26"
      unitRef="U_pure">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_e6df5d02-68f7-49d4-ba51-986d32e23a91"
      decimals="2"
      id="F_0f882906-e093-4cdf-84d2-06cf8e07d1b9"
      unitRef="U_pure">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_4b48ccb6-207c-4457-b2fc-810b2666a5ec">P6Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      id="F_5f66810d-3464-4ec1-b3e8-979111d3212c">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_7059cf66-b517-4eff-bf4d-ab1a20603967"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="2"
      id="F_83c2165b-7dab-4880-bc8e-f595b9456107"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193"
      decimals="0"
      id="F_9caf1434-f0a7-481f-aaf2-45a2543ba879"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_270f01ee-49d4-4dc4-bbe7-6a414037c913">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes restricted stock unit activity for the CalciMedica Plans:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.183%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.158%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.61%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:3.799%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.158%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.093%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited/Cancelled (expired)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_3c08a61f-703c-4719-8fb8-4579c9288562"
      decimals="INF"
      id="F_38234ca5-87bd-42f5-a9ac-5a4a369633f6"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_3c08a61f-703c-4719-8fb8-4579c9288562"
      decimals="0"
      id="F_84b5e87c-05bf-42c3-9916-bbcc277859f3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193"
      decimals="INF"
      id="F_1738e391-fcd2-4313-85cc-6084ad8c8e7d"
      unitRef="U_shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_f00c8c38-7ab0-4fba-aebe-dc2c92350193"
      decimals="2"
      id="F_5530a4e6-b3f4-40ab-b168-9d01c319e206"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_a0f4c105-a524-4767-9181-31be89a91199"
      decimals="INF"
      id="F_dce38992-9d31-4c0a-b038-ad43ce80e9ff"
      unitRef="U_shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_a0f4c105-a524-4767-9181-31be89a91199"
      decimals="2"
      id="F_79e71abe-ab60-4f73-91d8-e234933894bf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_a985303f-f798-4ef0-9878-be7445857f0d">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_807fb73d-e3ae-4819-9d7c-6c3aa5b21672"
      decimals="-3"
      id="F_bfb229d6-a454-410d-9dc2-64b10fb96424"
      unitRef="U_USD">840000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d64e8688-0946-4276-a0e6-cc735d684d5c"
      decimals="-3"
      id="F_341ecdfd-77a0-43e3-853d-86e699dfdbfd"
      unitRef="U_USD">2449000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_050c9307-b322-43a4-84b0-69234ed20231"
      decimals="-3"
      id="F_b3807b1e-50e7-4920-92cc-a07299b7dbd5"
      unitRef="U_USD">1473000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b8300b81-b096-4f13-9331-757ab5e2f317"
      decimals="-3"
      id="F_1b5f0a7e-b28b-4602-9e8c-cacd9741744a"
      unitRef="U_USD">9590000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_19ae7772-32d6-4b4d-afc2-a02db0875fba"
      unitRef="U_USD">2313000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_fdd32925-791c-4718-9355-2d51a2830a71"
      unitRef="U_USD">12039000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_020d633a-de37-4a19-a0ef-493644e25660"
      decimals="-5"
      id="F_d61ec3be-31eb-45ef-abc9-17b73184711b"
      unitRef="U_USD">1900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_cb68adaa-9134-4f3e-97c2-816971662c99"
      decimals="-5"
      id="F_c5fe53de-ca74-4087-94cb-9afa579d7e7b"
      unitRef="U_USD">8600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_7bae8f69-0d97-48e4-9582-d99208a4b075">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Common stock reserved for future issuance consists of the following at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.48%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,352,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares available for issuance under the 2023 Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;807,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares available under the 2023 ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;122,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,107,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</ck0001534133:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="0"
      id="F_f1e3ccd8-c52f-4829-96df-2c0910119fad"
      unitRef="U_shares">3352621</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="0"
      id="F_3bee4597-3cb3-4a88-a7e2-c3174a69274c"
      unitRef="U_shares">2824443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1a9d6d73-ba5d-4307-a4ea-2686eff48188"
      decimals="0"
      id="F_51fb175a-0535-4f16-818c-e2a675cc89ef"
      unitRef="U_shares">807414</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6ae57ed5-7760-47cf-85d3-13bdcc0f6a2b"
      decimals="0"
      id="F_3e8ee07d-c850-46c3-a480-e5775d397435"
      unitRef="U_shares">122545</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="0"
      id="F_f06d27c4-764a-43f9-8ae3-2989a0c72ff4"
      unitRef="U_shares">7107023</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_5929931d-960a-4e2e-8634-8d29dc96c34a">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues liabilities for such matters when future expenditures are probable and such expenditures can be reasonably estimated.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has historically entered into contracts in the normal course of business with contract development and manufacturing organizations, for the manufacturing process development and the preclinical/clinical supply manufacturing, and its vendors for preclinical research studies and other services or products for operating purposes. These contracts generally provide for termination on notice of 60 to 90 days. As of December 31, 2024, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;there are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;seven&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; such contracts, with one CMO related to its development of Auxora and one acquired as a result of the Merger with approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of associated costs, respectively, still in effect for future services, and there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unpaid cancellation or other related costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company may also, from time to time, become party or subject to various other legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. Some of these proceedings have involved, and may involve in the future, claims that are subject to substantial uncertainties and unascertainable damages.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Lease Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has an operating lease for office space in La Jolla, California. In &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, an amendment was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;executed for a twelve month term as of January 1, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and therefore qualifies for the short-term lease exception. Since the lease was amended and renewed in December 2024 for an additional twelve month term it therefore qualifies for the short-term lease exception. Base rent for this lease is approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; monthly.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Rent expense for the years ended December 31, 2024 and 2023 wa&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;274,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;respectively, which is included in operating expenses.&lt;/span&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ck0001534133:NumberOfContractCurrentlyInEffect
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="0"
      id="F_9cf706ba-bed7-4b57-8546-2b77b120323f"
      unitRef="U_Contract">7</ck0001534133:NumberOfContractCurrentlyInEffect>
    <ck0001534133:ContractualObligationOfContractInEffect
      contextRef="C_2f7897d6-1a4a-489c-9fd4-bf5c88b81551"
      decimals="-5"
      id="F_6192b6ac-d706-48bb-8771-a75ef94849ad"
      unitRef="U_USD">1300000</ck0001534133:ContractualObligationOfContractInEffect>
    <ck0001534133:ContractualObligationOfContractInEffect
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_224299a9-7618-4b06-920c-3e9af7e6565d"
      unitRef="U_USD">1200000</ck0001534133:ContractualObligationOfContractInEffect>
    <ck0001534133:UnpaidCancellationAndOtherRelatedCosts
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="INF"
      id="F_ff21963b-4303-4289-a57c-1f0f47822600"
      unitRef="U_USD">0</ck0001534133:UnpaidCancellationAndOtherRelatedCosts>
    <ck0001534133:LeaseAmendmentDate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_61abf9e2-f08b-4b52-890e-4220ea035350">2024-12</ck0001534133:LeaseAmendmentDate>
    <ck0001534133:LeaseExecutedTermPeriod
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_1b336449-7a1b-4520-bd1a-eaca16594a75">executed for a twelve month term as of January 1, 2025</ck0001534133:LeaseExecutedTermPeriod>
    <ck0001534133:BaseRent
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_742a8135-f837-4350-9632-549f1dbcac03"
      unitRef="U_USD">10500</ck0001534133:BaseRent>
    <ck0001534133:RentExpenses
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_da220dea-d7f6-40c9-b80a-56b9e06a0f3e"
      unitRef="U_USD">121000</ck0001534133:RentExpenses>
    <ck0001534133:RentExpenses
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_5d1487b9-3954-4d42-b1b9-3887788742f4"
      unitRef="U_USD">274000</ck0001534133:RentExpenses>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_2e940ec2-c62a-4cf9-bff6-a379a7efe198">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10. Employee Benefits&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In January 2007, Private CalciMedica adopted a defined contribution 401(k) plan for substantially all employees. Contributions made by CalciMedica to the 401(k) plan were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_d5c00c54-f731-4885-a5ea-f8c26ef050f9"
      unitRef="U_USD">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_d9f4afc9-e940-428b-a701-41ea3f3ae4e7"
      unitRef="U_USD">78000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_b40f5005-5d57-41b2-905a-1f2a42371c5e">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The effective tax rate if the Company&#x2019;s provision (benefit) for income taxes differs from the federal statutory rate as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax computed at federal statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,877&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax, net of federal tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits, net of uncertain positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of (a) temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and (b) operating losses and tax credit carryforwards. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of deferred tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credit carry forwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company provided a full valuation allowance on the net deferred tax asset because management has determined that it is more-likely-than-not that the Company will not earn income sufficient to realize the deferred tax assets during the carryforward period. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has federal and state NOLs available of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;296.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;nil&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to offset future taxable income, if any, for federal and state income tax purposes. The federal and state NOLs expire beginning in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of post-2017 federal NOL carryforwards that carry forward indefinitely. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, under the Tax Act the amount of net operating losses generated in taxable periods beginning after December 31, 2017, that the Company is permitted to deduct in any taxable year is limited to 80% of taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The Tax Act generally eliminates the ability to carry back any net operating loss to prior taxable years, while allowing post-2017 unused net operating losses to be carried forward indefinitely.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has federal and state research and development credit carryforwards available of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Federal research and development carryforwards expire beginning in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. State research and development carryforwards do not expire.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;) specifically by IRC &#xa7;382, the Company&#x2019;s ability to use net operating loss carryforwards to offset future taxable income is limited if the Company experiences a cumulative change in ownership of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% within a three-year testing period. The Company has not completed an ownership change analysis pursuant to IRC Section 382. If ownership changes within the meaning of IRC Section 382 are identified as having occurred, the amount of remaining tax attribute carryforwards available to offset future taxable income and income tax expense in future years may be significantly reduced. Any limitation may result in the expiration of a portion of the NOL carryforwards before utilization.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the Company&#x2019;s unrecognized tax benefits is summarized as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions in connection with the reverse merger&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Reduction for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for uncertainty in income taxes in accordance with ASC 740 Income Taxes. Tax positions are evaluated in a two-step process, whereby the Company first determines whether it is more likely than not that a tax position will be sustained upon examination by the tax authority, including resolutions of any related appeals or litigation processes, based on technical merit. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. Income tax positions must meet a more likely than not recognition threshold to be recognized. The Company&#x2019;s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrual for interest and penalties and has not recognized interest and/ or penalties in the statements of operations and comprehensive loss for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. Uncertain tax positions are evaluated based upon the facts and circumstances that exist at each reporting period. Subsequent changes in judgment based upon new information may lead to changes in recognition, derecognition,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and measurement. Adjustments may result, for example, upon resolution of an issue with the taxing authorities or expiration of a statute of limitations barring an assessment for an issue.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, unrecognized tax benefits associated with uncertain tax positions was approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million respectively. If recognized, this would affect the effective tax rate, subject to valuation allowance. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did not recognize any interest and penalties associated with unrecognized tax benefits. Due to net operating losses incurred, tax years from inception remain open to examination by the Federal and State taxing jurisdictions to which we are subject. The Company is not currently under Internal Revenue Services (IRS), state or local tax examination.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_b6e10054-5e07-4f49-8540-7adca63aa9fe">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The effective tax rate if the Company&#x2019;s provision (benefit) for income taxes differs from the federal statutory rate as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax computed at federal statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,877&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State tax, net of federal tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits, net of uncertain positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_037cac5d-a39d-496c-9e02-4e7ba73727a9"
      unitRef="U_USD">-2877000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_7b8e71b2-9fd2-46c8-9192-2be28c633f4f"
      unitRef="U_USD">-7214000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_2c9b2e77-1441-495b-8948-875ff5e2a38f"
      unitRef="U_USD">611000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_e7fca187-fef9-4d4e-bf6c-71ffdfc161f1"
      unitRef="U_USD">1000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <ck0001534133:IncomeTaxReconciliationPermanentDifferences
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_fefe0ad0-3817-4b0b-be4d-e607b5a9a3eb"
      unitRef="U_USD">166000</ck0001534133:IncomeTaxReconciliationPermanentDifferences>
    <ck0001534133:IncomeTaxReconciliationPermanentDifferences
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_99707584-8501-44a4-a83d-68da601adc6a"
      unitRef="U_USD">-50000</ck0001534133:IncomeTaxReconciliationPermanentDifferences>
    <ck0001534133:IncomeTaxRateReconciliationWarrantLiability
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_a8704949-3082-4dd6-8d00-447dbb563074"
      unitRef="U_USD">1993000</ck0001534133:IncomeTaxRateReconciliationWarrantLiability>
    <ck0001534133:IncomeTaxRateReconciliationWarrantLiability
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_11bd2db6-c2c0-4625-9faf-150fc3df7516"
      unitRef="U_USD">665000</ck0001534133:IncomeTaxRateReconciliationWarrantLiability>
    <ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_ea450571-2320-49ef-8185-24ac83390a2f"
      unitRef="U_USD">-1050000</ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions>
    <ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_60acc350-f4f1-41fc-933a-eca79d653c8b"
      unitRef="U_USD">-705000</ck0001534133:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditNetOfUncertainPositions>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_f549281e-df6c-48ed-bdd1-1b55b1e8a2fb"
      unitRef="U_USD">5475000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_2f0fad20-ff05-41df-8c56-0f0139312dc1"
      unitRef="U_USD">8534000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_30051c41-7ec9-4742-81c2-69d76c65de88"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_681ce29e-b880-4c02-ae20-c9ff8d8f9691"
      unitRef="U_USD">1000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_79f7177c-131f-436f-ac5e-5a53cf7e62a8">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of deferred tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:89.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;62,407&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;58,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credit carry forwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,475&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_1d49f58f-093d-4964-a104-2c903cb02f38"
      unitRef="U_USD">62407000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_562a0e36-8899-4fac-a75f-80cb64255ba3"
      unitRef="U_USD">58535000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_61b47429-f045-4ba6-8d42-24702d1d4371"
      unitRef="U_USD">10356000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_6dae4ac9-dccb-4942-b062-0302c67ea107"
      unitRef="U_USD">9865000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_56952a19-acfc-46ee-a227-6eab488c4dc6"
      unitRef="U_USD">13506000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_13430b36-2f36-418e-8cdf-145f967b57e0"
      unitRef="U_USD">12403000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_a53a67f2-558d-4e6a-934d-ce302ebc1d0c"
      unitRef="U_USD">2026000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_500088b4-6c02-46a8-9022-9b41b4bf993b"
      unitRef="U_USD">1700000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <ck0001534133:DeferredTaxAssetsAccruedCompensation
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_956d8f2f-24e4-4b61-a054-9b46ba52a610"
      unitRef="U_USD">180000</ck0001534133:DeferredTaxAssetsAccruedCompensation>
    <ck0001534133:DeferredTaxAssetsAccruedCompensation
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_16bd89cc-be39-4c5a-8e06-3eee07de0b87"
      unitRef="U_USD">93000</ck0001534133:DeferredTaxAssetsAccruedCompensation>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_11540615-9e1c-4e94-a57e-2a81441a39a8"
      unitRef="U_USD">88475000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_f90fa8fe-ef7c-4880-8f59-b79e2d95a795"
      unitRef="U_USD">82596000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_a9d21930-bc67-4b9e-8ed4-9dba616abc39"
      unitRef="U_USD">15000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_2d2c855f-57f1-49de-bc20-0a05400c0a26"
      unitRef="U_USD">21000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_0874ffdf-36d9-41b9-952c-149f3e847e36"
      unitRef="U_USD">15000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_bd9fb78e-8d77-4413-9ff0-8f085556e20b"
      unitRef="U_USD">21000</us-gaap:DeferredIncomeTaxLiabilities>
    <ck0001534133:NetDeferredTaxAsset
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_4f02d6fe-a558-4ca2-a16c-1addf6f8cfc2"
      unitRef="U_USD">88460000</ck0001534133:NetDeferredTaxAsset>
    <ck0001534133:NetDeferredTaxAsset
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_b523af58-6b5a-48d5-b66b-4343cc314371"
      unitRef="U_USD">82575000</ck0001534133:NetDeferredTaxAsset>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_5ac20074-e1ac-43ca-b38a-6cf14f8701b5"
      unitRef="U_USD">88460000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_be210f22-4df5-4797-aecb-94a035264a71"
      unitRef="U_USD">82575000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_34b5f081-fc84-4ca4-b581-da377c13b613"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_3d7aadcf-a1d1-438e-b100-325ad701d141"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_ea1e7f13-9f56-457e-9b7e-0b36d52d8e3b"
      unitRef="U_USD">296900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="INF"
      id="F_6a4e6671-478d-4d83-a388-fafa4f5e05aa"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear
      contextRef="C_dd320420-0211-43de-95df-09b44d9868c0"
      id="F_3e663186-c0ea-470b-bbb1-e9d075001af9">2026</ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear>
    <ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear
      contextRef="C_3e3444e7-6081-449c-be1a-618a48f9ddb6"
      id="F_93b12aee-9437-4cc7-ac62-8ee4ef409d88">2026</ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_5d75438a-331f-4b70-b3ef-65f18fddf6b9"
      decimals="-5"
      id="F_3b580f12-8c47-43d8-a40f-960b0f63cc84"
      unitRef="U_USD">194700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_809539c1-d539-4a25-abf4-a68a7f76676b">In addition, under the Tax Act the amount of net operating losses generated in taxable periods beginning after December 31, 2017, that the Company is permitted to deduct in any taxable year is limited to 80% of taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_13118ae0-e9f5-4a7c-aa30-bab5991ca143"
      decimals="-5"
      id="F_d0f6406e-69a8-4e87-94be-10dd1c8f4174"
      unitRef="U_USD">13300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b8a91730-f365-453b-88eb-5b8de08b2053"
      decimals="-5"
      id="F_0a4acff0-319e-48e9-ab3b-0551c22d0a9d"
      unitRef="U_USD">3100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear
      contextRef="C_dcc03654-bedf-421b-b7f5-47598128324e"
      id="F_afc74938-dfdf-42bb-8748-4c9dac32fe80">2027</ck0001534133:OperatingLossCarryForwardsExpirationBeginningYear>
    <ck0001534133:PercentageOfChangeInOwnership
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_ab048d31-c61e-447b-a3fa-536c0ae55f6c"
      unitRef="U_pure">0.50</ck0001534133:PercentageOfChangeInOwnership>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_ea910230-0e41-4471-8464-60b650e48324">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the Company&#x2019;s unrecognized tax benefits is summarized as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions in connection with the reverse merger&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;word-break:break-word;"&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Reduction for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;334&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_980a3e42-f670-42e5-8f84-d7c4be19f842"
      decimals="-3"
      id="F_ca162ebe-56ef-47b6-8f69-1daad5892922"
      unitRef="U_USD">7506000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_0f50a30d-0770-4b87-bc47-fe715fd0f9d8"
      unitRef="U_USD">2846000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_6f3c81a4-38a8-42e0-9805-2fd1a09fadc4"
      unitRef="U_USD">21000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_2f4bf2f8-750b-4fb2-87fc-69df0a7abc61"
      unitRef="U_USD">847000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_bedbd649-84d6-457d-8203-53534003b4d9"
      unitRef="U_USD">140000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-3"
      id="F_285b1574-86b2-4207-9c77-b338f963a623"
      unitRef="U_USD">11080000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_5131a8a2-afea-4f9b-892f-6fc7231efb50"
      unitRef="U_USD">334000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_2f51bfd2-9880-48c6-9109-d25d51e70074"
      unitRef="U_USD">68000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-3"
      id="F_b0b71001-71d8-4473-b36a-7d295ece9c16"
      unitRef="U_USD">11482000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="0"
      id="F_7263e44b-bcf4-4cff-8f02-5dd6d4f11bb3"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="0"
      id="F_2555fa51-3a4d-405b-8cea-a9abf828519f"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <ck0001534133:UnrecognizedTaxBenefitsNet
      contextRef="C_e60c5ac0-fbed-4436-b273-9e0dd0fe899e"
      decimals="-5"
      id="F_96413c37-a408-4d7a-bea0-6cd7ce250c54"
      unitRef="U_USD">11800000</ck0001534133:UnrecognizedTaxBenefitsNet>
    <ck0001534133:UnrecognizedTaxBenefitsNet
      contextRef="C_0e263a22-52cd-4e60-a0a1-c92ee05526be"
      decimals="-5"
      id="F_dd307b1e-2783-4d88-a435-86b560888fae"
      unitRef="U_USD">9100000</ck0001534133:UnrecognizedTaxBenefitsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_2cede081-9fdb-4de4-8631-27753e8a7b15">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,886,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,486,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;288,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average placement agent warrants outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,913&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average number of shares used to calculate basic and diluted net loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,245,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,486,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.729%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.976%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.976%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,739,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,970,368&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;276,437&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,794,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,016,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_9c54410c-66fd-4d04-9c03-743e5ebd57dc">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of basic and diluted net loss per share (in thousands, except per share amounts):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="8" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,886,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,486,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;288,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average placement agent warrants outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70,913&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average number of shares used to calculate basic and diluted net loss per share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,245,915&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,486,258&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss per share - basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="-3"
      id="F_73ee8a4e-4f56-4fa2-91bb-7a317c0a125b"
      unitRef="U_USD">-13700000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="-3"
      id="F_91bda301-0fee-4d82-a65d-3fa3c10e76f0"
      unitRef="U_USD">-34357000</us-gaap:NetIncomeLoss>
    <ck0001534133:WeightedAverageCommonSharesOutstandingBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_51bd7957-72ae-435c-b23d-b34119470e0e"
      unitRef="U_shares">10886920</ck0001534133:WeightedAverageCommonSharesOutstandingBasic>
    <ck0001534133:WeightedAverageCommonSharesOutstandingDiluted
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_c3c6860c-b0ce-4497-990d-adcf72111a69"
      unitRef="U_shares">10886920</ck0001534133:WeightedAverageCommonSharesOutstandingDiluted>
    <ck0001534133:WeightedAverageCommonSharesOutstandingBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_95f1aac2-c3d1-4913-aeee-5429c7a555b5"
      unitRef="U_shares">4486258</ck0001534133:WeightedAverageCommonSharesOutstandingBasic>
    <ck0001534133:WeightedAverageCommonSharesOutstandingDiluted
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_340ba866-e870-45cb-a9fa-eaf4afdfe16f"
      unitRef="U_shares">4486258</ck0001534133:WeightedAverageCommonSharesOutstandingDiluted>
    <ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_71a54436-f8f9-4f0e-9edb-84bfe26b7915"
      unitRef="U_shares">288082</ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic>
    <ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_2e039b8e-645c-4bb9-9723-9807e765a2f1"
      unitRef="U_shares">288082</ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted>
    <ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_36f82238-1a56-49e5-b903-00199a4d7461"
      unitRef="U_shares">0</ck0001534133:WeightedAveragePreFundedWarrantsOutstandingBasic>
    <ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_3c862d9d-3c65-4807-bc63-494da8ed5a1d"
      unitRef="U_shares">0</ck0001534133:WeightedAveragePreFundedWarrantsOutstandingDiluted>
    <ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_e9c7c9e6-7a67-4b52-a0ec-9cebc1377185"
      unitRef="U_shares">70913</ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic>
    <ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_b36844bf-41a5-4d75-9e00-11469f29389b"
      unitRef="U_shares">70913</ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted>
    <ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_c2b4fc39-7b87-4e03-9c87-9ca4e5868608"
      unitRef="U_shares">0</ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingBasic>
    <ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_a86c2ade-147c-4be8-a4e6-19ab94ec14b0"
      unitRef="U_shares">0</ck0001534133:WeightedAveragePlacementAgentWarrantsOutstandingDiluted>
    <ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_7299348f-a2d5-41d8-bca7-b39dbdb88159"
      unitRef="U_shares">11245915</ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare>
    <ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_2f774ea6-6a37-476f-b7ca-4d506b652db6"
      unitRef="U_shares">11245915</ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare>
    <ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_2a4d49b9-523b-451e-88ec-f32ba2aa2792"
      unitRef="U_shares">4486258</ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateBasicNetIncomeLossPerShare>
    <ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_20a8cd05-083c-4b09-b240-3fb3a8700ecc"
      unitRef="U_shares">4486258</ck0001534133:WeightedAverageNumberOfSharesUsedToCalculateDilutedNetIncomeLossPerShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_ee6bf770-a5b0-437c-99c6-4405da3606f8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="2"
      id="F_a8815ee2-d474-4245-aa82-e6414be716fb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="2"
      id="F_2e87e340-b60a-4884-9398-2248dee55754"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="2"
      id="F_cf337349-e50c-49ae-84b2-6d25265ffabc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-7.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_ef5f96f7-c252-440e-9919-509ffd102f4c">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.729%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.976%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:17.976%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,824,443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,739,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,970,368&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;276,437&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,794,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,016,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_de781a1c-b261-4323-9d34-9ecb0869f1f7"
      decimals="0"
      id="F_ea4d54e7-7f89-463d-9c37-cf22234f7ff7"
      unitRef="U_shares">2824443</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8c641589-eb1e-4352-b3c3-0711c499ace9"
      decimals="0"
      id="F_87e4ce6f-6293-4b38-8ac7-149970772ef3"
      unitRef="U_shares">1739747</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_03f70fa6-7284-496f-8c00-e58bf2ff1f48"
      decimals="0"
      id="F_94699f11-e731-44f7-86ce-a0d7d1b71454"
      unitRef="U_shares">2970368</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_27307737-cae3-4ea7-a928-4b907971a80f"
      decimals="0"
      id="F_f4547a91-c5c6-40b8-9f9b-5babfe9d9a2a"
      unitRef="U_shares">276437</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      decimals="0"
      id="F_074e1830-907e-4a1c-9489-68a3f12066d3"
      unitRef="U_shares">5794811</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c70580a4-0982-4309-ab8b-2dc5eefb571c"
      decimals="0"
      id="F_23b5de85-f701-46d5-9ec4-12fa99e9bbeb"
      unitRef="U_shares">2016184</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_5c21d041-cc6f-4faa-beac-30a23e6d407a"
      id="F_07838bea-0052-4f5a-a65f-254d87476e72">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 28, 2025 (the &#x201c;Closing Date&#x201d;), the Company the Loan Agreement with Avenue Venture Opportunities Fund II, L.P. (&#x201c;Lender&#x201d;) and Avenue Capital Management II, L.P., as administrative agent and collateral agent, for growth capital loans in an aggregate principal amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Loan&#x201d;), with (i) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; funded on the Closing Date (&#x201c;Tranche 1&#x201d;), (ii) up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,500,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to be made available to the Company between September 1, 2025 and March 31, 2026, subject to, among other things, the Company&#x2019;s achievement of certain milestones with respect to certain of its ongoing clinical trials (&#x201c;Tranche 2&#x201d;) and (iii) up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to be made available to the Company between October 1, 2025 and March 31, 2026, subject to, among other things, (a) the Company&#x2019;s achievement of additional milestones with respect to certain of its ongoing clinical trials and (b) the mutual written agreement of the Company and the Lender (upon its investment committee approval). &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#x2019;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The Loan bears interest at an annual rate equal to the greater of (a) the sum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% plus the prime rate as reported in The Wall Street Journal and (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. The Loan is secured by a lien upon and security interest in all of the Company&#x2019;s assets, including intellectual property, subject to agreed exceptions. The maturity date of the Loan is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 1, 2028&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Maturity Date&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrant&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Loan, pursuant to the funding of Tranche 1 on the Closing Date, the Company issued to the Lender a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;641,163&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock of the Company (the &#x201c;Warrant&#x201d;) at an exercise price per share equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.32&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Stock Purchase Price&#x201d;). The Warrant is exercisable until &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;February 28, 2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Expiration Date&#x201d;) and upon a change of control, the Lender would be entitled to receive the shares of common stock underlying the Warrant without payment of the exercise price.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a"
      decimals="0"
      id="F_ffe447da-5f28-46e4-82d6-9897db244a14"
      unitRef="U_USD">32500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_9cbbe523-fc5d-4e57-a1bb-191ddd2df6a0"
      decimals="0"
      id="F_6332ab84-ecf8-49e9-870f-f9025414e6a7"
      unitRef="U_USD">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_cde8f9cc-6117-4cfa-a5bd-4b469cb961fe"
      decimals="0"
      id="F_5ec4bbe3-bf80-407e-8bef-0f26bb3aca7e"
      unitRef="U_USD">7500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_de62953f-9a13-4e2a-a3fc-a8e40d129029"
      decimals="0"
      id="F_9be8e7a7-e76e-4279-b91c-25d97da7e21d"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentTerms
      contextRef="C_8f77e296-92c8-4ecd-b45a-a2ad8b02e258"
      id="F_2e1bc201-437a-489d-b2d1-75508525b307">The Company will make interest only payments until the 18 month anniversary of the Closing Date, subject to a 6-month extension upon the Company&#x2019;s achievement of certain milestones with respect to certain of its ongoing clinical trials and funding of the full amount under Tranche 2.</us-gaap:LongTermDebtMaturitiesRepaymentTerms>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_7ee9e19d-1d4a-450f-9f03-e831fc128d22"
      decimals="4"
      id="F_fe1e5548-e25e-4611-8a7b-1498b7d25556"
      unitRef="U_pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_305196fc-be7f-4dc1-ba9b-58e8fa9d636a"
      decimals="4"
      id="F_a2335e7a-2963-4e8d-af76-6db07802b166"
      unitRef="U_pure">0.1275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_f6e6eee2-3a7f-426a-995a-4c63812334ed"
      id="F_d8a5285c-3b93-458c-a4c6-9720da412eda">2028-09-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c"
      decimals="0"
      id="F_12cde7c7-5baa-4aef-99ac-871e7f8c279e"
      unitRef="U_shares">641163</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c"
      decimals="2"
      id="F_c9f8266f-ce80-465c-a50f-3e7952adea00"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_d86661b2-0167-43cd-a6cc-c51935f0976c"
      id="F_b003cecf-86dc-4f3a-aa32-9c5b53b68037">2030-02-28</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"
          xlink:label="F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_12d5696b-58c6-49ec-90f5-83f181092884"
          xlink:label="F_12d5696b-58c6-49ec-90f5-83f181092884"
          xlink:type="locator"/>
        <link:footnote id="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d" xlink:label="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based compensation expense of $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">840,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">2,449,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">1,473,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">9,590,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"
          xlink:to="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_12d5696b-58c6-49ec-90f5-83f181092884"
          xlink:to="FNT_acf231ef-3cc0-4677-9423-2d66f70aa09d"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_f4539e24-1082-434c-9e72-eaee54ca8723"
          xlink:label="F_f4539e24-1082-434c-9e72-eaee54ca8723"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_1b6e4946-31e1-4a92-b886-3a04ed5d247c"
          xlink:label="F_1b6e4946-31e1-4a92-b886-3a04ed5d247c"
          xlink:type="locator"/>
        <link:footnote id="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08" xlink:label="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation expense of $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">31,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">29,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related to research and development and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> and $</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">28,000</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, related general and administration have been excluded for the years ended December 31, 2024 and 2023, respectively.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_f4539e24-1082-434c-9e72-eaee54ca8723"
          xlink:to="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_5bfb76f2-93ac-4dd9-87de-37b1ffd351c1"
          xlink:to="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_12d5696b-58c6-49ec-90f5-83f181092884"
          xlink:to="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_1b6e4946-31e1-4a92-b886-3a04ed5d247c"
          xlink:to="FNT_0bece4c7-f934-4c10-a82d-ca84e65ffd08"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
